<SEC-DOCUMENT>0000790526-23-000003.txt : 20230301
<SEC-HEADER>0000790526-23-000003.hdr.sgml : 20230301
<ACCEPTANCE-DATETIME>20230301173106
ACCESSION NUMBER:		0000790526-23-000003
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		109
CONFORMED PERIOD OF REPORT:	20221231
FILED AS OF DATE:		20230301
DATE AS OF CHANGE:		20230301

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			RadNet, Inc.
		CENTRAL INDEX KEY:			0000790526
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MEDICAL LABORATORIES [8071]
		IRS NUMBER:				133326724
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33307
		FILM NUMBER:		23695229

	BUSINESS ADDRESS:	
		STREET 1:		1510 COTNER AVE
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90025
		BUSINESS PHONE:		3104787808

	MAIL ADDRESS:	
		STREET 1:		1510 COTNER AVE
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90025

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PRIMEDEX HEALTH SYSTEMS INC
		DATE OF NAME CHANGE:	19930518

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CCC FRANCHISING CORP
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>rdnt-20221231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:ee66d8ee-1013-4282-8e3e-c307b1c04f3f,g:1b6e48fd-cb3e-498b-b299-6015491264f8,d:f3f80771944f4fc58015abda42dc47d1--><html xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:rdnt="http://www.radnet.com/20221231" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns="http://www.w3.org/1999/xhtml" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:srt="http://fasb.org/srt/2022" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>rdnt-20221231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV80L2ZyYWc6NjJjOTQ4ODQyYjI0NDlmNGEyNzY4ZGFmMzhjYWJmY2YvdGFibGU6ZmUzNTQ5YmY5MDhjNGYwYTk1ZTFiYzIzYWUxNGU2Y2YvdGFibGVyYW5nZTpmZTM1NDliZjkwOGM0ZjBhOTVlMWJjMjNhZTE0ZTZjZl8zLTEtMS0xLTI5NDg5_cb7e5e94-8829-45e1-93a1-b23e2971b9c5">0000790526</ix:nonNumeric><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV80L2ZyYWc6NjJjOTQ4ODQyYjI0NDlmNGEyNzY4ZGFmMzhjYWJmY2YvdGFibGU6ZmUzNTQ5YmY5MDhjNGYwYTk1ZTFiYzIzYWUxNGU2Y2YvdGFibGVyYW5nZTpmZTM1NDliZjkwOGM0ZjBhOTVlMWJjMjNhZTE0ZTZjZl80LTEtMS0xLTI5NDg5_cae92718-9cca-4743-afc3-2e8d0a9cab54">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV80L2ZyYWc6NjJjOTQ4ODQyYjI0NDlmNGEyNzY4ZGFmMzhjYWJmY2YvdGFibGU6ZmUzNTQ5YmY5MDhjNGYwYTk1ZTFiYzIzYWUxNGU2Y2YvdGFibGVyYW5nZTpmZTM1NDliZjkwOGM0ZjBhOTVlMWJjMjNhZTE0ZTZjZl82LTEtMS0xLTI5NDg5_692829a0-57fd-47cd-b8ec-a426464853de">FY</ix:nonNumeric><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV80L2ZyYWc6NjJjOTQ4ODQyYjI0NDlmNGEyNzY4ZGFmMzhjYWJmY2YvdGFibGU6ZmUzNTQ5YmY5MDhjNGYwYTk1ZTFiYzIzYWUxNGU2Y2YvdGFibGVyYW5nZTpmZTM1NDliZjkwOGM0ZjBhOTVlMWJjMjNhZTE0ZTZjZl83LTEtMS0xLTI5NDg5_1c415ddf-00cd-4818-81de-aaca427f3dd3">2022</ix:nonNumeric><ix:nonNumeric contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" name="us-gaap:GovernmentAssistanceStatementOfFinancialPositionExtensibleEnumeration" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjc0ODc3OTE4MzYxNA_386ac154-db8d-4eee-8934-81984fec863f">http://fasb.org/us-gaap/2022#ContractWithCustomerLiabilityCurrent</ix:nonNumeric><ix:nonNumeric contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" name="us-gaap:ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjc0ODc3OTE4MzYxMw_9c7fb964-0c31-457d-ab68-df24d21cb8df">http://fasb.org/us-gaap/2022#GainLossOnTerminationOfLease</ix:nonNumeric><ix:nonNumeric contextRef="i482c7936fa5a4a3396fa482dbd02d9a1_D20220101-20221231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjQzNTk_cd22a3ff-fb8c-47a1-9018-2d91908dd609">P3Y</ix:nonNumeric><ix:nonNumeric contextRef="i482c7936fa5a4a3396fa482dbd02d9a1_D20220101-20221231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjQzNzk_0e815b97-2caf-4c2a-88cf-151ad3b1dacb">P5Y</ix:nonNumeric><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="us-gaap:DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmY3ZDdlMDY0Y2UzOTQyYWVhZjFkMzRhNTc4MTBmMjA1L3RhYmxlcmFuZ2U6ZjdkN2UwNjRjZTM5NDJhZWFmMWQzNGE1NzgxMGYyMDVfMy0yLTEtMS03NjcxMw_04d809f9-cf99-45ef-aa56-16be46b5f8b6">http://fasb.org/us-gaap/2022#InterestExpenseDebt</ix:nonNumeric><ix:nonNumeric contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" name="us-gaap:DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmY3ZDdlMDY0Y2UzOTQyYWVhZjFkMzRhNTc4MTBmMjA1L3RhYmxlcmFuZ2U6ZjdkN2UwNjRjZTM5NDJhZWFmMWQzNGE1NzgxMGYyMDVfNC0yLTEtMS03NjcyMQ_2c91ab05-c7d0-4ed6-a9f1-aefed9da243a">http://fasb.org/us-gaap/2022#InterestExpenseDebt</ix:nonNumeric><ix:nonNumeric contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" name="us-gaap:DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmY3ZDdlMDY0Y2UzOTQyYWVhZjFkMzRhNTc4MTBmMjA1L3RhYmxlcmFuZ2U6ZjdkN2UwNjRjZTM5NDJhZWFmMWQzNGE1NzgxMGYyMDVfNC0yLTEtMS0yOTQ4OQ_869911ef-bcba-451f-8629-1684d55fda21">http://fasb.org/us-gaap/2022#InterestExpenseDebt</ix:nonNumeric><ix:nonNumeric contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" name="us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTozNDY2MGIzODgyOWY0NDQ5YWU5YzQ1YmYzZTBlZmM1ZC90YWJsZXJhbmdlOjM0NjYwYjM4ODI5ZjQ0NDlhZTljNDViZjNlMGVmYzVkXzExLTAtMS0xLTI5NDg5_464c3404-1439-4afe-a7f8-0d3a4f94b53d">http://www.radnet.com/20221231#PropertyPlantAndEquipmentNetIncludingRightOfUseAssets</ix:nonNumeric><ix:nonNumeric contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" name="us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTozNDY2MGIzODgyOWY0NDQ5YWU5YzQ1YmYzZTBlZmM1ZC90YWJsZXJhbmdlOjM0NjYwYjM4ODI5ZjQ0NDlhZTljNDViZjNlMGVmYzVkXzExLTAtMS0xLTI5NDg5_bc4c3e84-e956-46a8-b461-0698bb31e9ec">http://www.radnet.com/20221231#PropertyPlantAndEquipmentNetIncludingRightOfUseAssets</ix:nonNumeric><ix:nonNumeric contextRef="ice63a1a32cb9452b8b46714c1c61a7da_D20220101-20221231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzgyNA_592b111d-5e4b-4ce1-b2c6-e023d3e9049f">P3Y</ix:nonNumeric><ix:nonNumeric contextRef="ice63a1a32cb9452b8b46714c1c61a7da_D20220101-20221231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzg0NA_4b31c3d7-9086-4991-8c69-3f75d38c24fd">P5Y</ix:nonNumeric><ix:nonNumeric contextRef="i2c047b53ccb14b03a3aee6426354f41c_D20220101-20221231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzM4NDgyOTA3MDIzMDM_73f2d802-1880-44ce-b1e9-1beab990455e">P2Y</ix:nonNumeric><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" xsi:nil="true" name="us-gaap:SubsequentEventsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMTIvZnJhZzo0YTY2ZjE3NjIwZWE0OGIxYjY2ZjA2ZDU4YjQzNGQ2YS90ZXh0cmVnaW9uOjRhNjZmMTc2MjBlYTQ4YjFiNjZmMDZkNThiNDM0ZDZhXzUwNQ_5417e950-dfa1-4d82-8b72-23528ccc1b93" escape="true"></ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="rdnt-20221231.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85e5b321a4fb4792b5778ddcc45d31e2_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="icfa616adc19f40628e3dfcc4deec4d62_I20230223"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-02-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i04caedaa83604a6990f3710c9c56c537_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibbc4f4e3e435497ba4218694b84e7170_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i72c8ccfb1d004dff8edb67a140b34692_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8c322d1717c4ac1bdf35faa1ec15017_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08ae2120de2d443a9249395c939d9db2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8827fd8aae0c45ac99829a7fb259f75c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CapitationArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b9fb24ebf5447db9eb3e2b703507952_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CapitationArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93e177287d564fa0be95b081ae11ddd8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CapitationArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88190c6477b54e7c8dd36138e1b559d5_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d953a41c6d9468dbca0b44fc5f607e3_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia3e2118a10c34ab7a36716b00a6d7689_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i631fe7e868d0484cb4e25a85cae0a91e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iac4cd4d1f8df442897db11d5620d8aff_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ce0185d244440a4acb3004eca085a56_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i404f0df0019f440299547782ff0ce012_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99fcac4f0fc74d8aace4c8852be510de_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibbbe6648075f46b597abbe27ffaf1a51_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd177ca06f0e4f359d97359a10eeb1bd_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i006b7ea314fc4246a62dc2614396fb18_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i298a24d3aaec41ea8698fd195ead858e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d5e574cdbd04637a34823f382a6c58a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic79d3a1f3d0f4fc49bb4724de0a7156c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i081fa83c5ad549cebb5ab4d974f827b3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i101eecb916e744b7aaed50d001dc9bab_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i23849d87eb184c1b9a2d7f9eb8115fbb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b2862b69f4a469795d00c8dfea6afd9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff5a453e0ae34e3ea23964a503b82dff_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5dcbd877ab784f1894ed73e70da01d83_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb50bc5a13564f6a97eb669524009c18_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib946969776ca45ccae82cbfc0c191797_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i949f0d96ac8d4f8facf965ee05a37476_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e0d2a5109214eacb7c4927e040de2c1_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f3ededd5ee04ec4aa19a0abbf3d7f77_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic1adea4000aa4578a36583c8f938f522_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AcquisitionsAndAssetPurchasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63bfeffb69d140e6b2f2ea03ff67d0bf_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AcquisitionsAndAssetPurchasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a58f6df7fad437ea356f767cbc04a2e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AcquisitionsAndAssetPurchasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic6418d4bd1d040b8a16164a6790b1f63_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AcquisitionsAndAssetPurchasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1f7abf905284fcaa40bc6081a6bd921_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i886a120ecc15453ab356ce266fd3fcf8_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28b7664a3050400f83608253e0d1c4ba_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i972be9663bfb45d4a202f7cf617a88c3_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic6625f4cf6e34dd2acb014782fcfff34_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27608790e25740878c35acf6d5e205e7_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6567c2edd74c415e809b3f8dfbc69d6f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd09aa04b85b458ca4b4ac2d646daf7b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0b5e62c4b8e424ba71aa7824dcf3fa1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2cbbe88e8caf4501bfffaebc7f2878cf_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ada6464a5b842509b8bf074c4eab6e6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie96fcf0fd181417d9610fba554c8f505_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0d0862fed0f44bf87195bfcd4b82674_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie1933fa68c2f4a878ab49bbb7e97074b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0eb334b8be644046940eed543ae94157_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98a74a949db8402da4aef3fe694b8e90_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf1451719c2f414a821e66141f27fa18_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AcquisitionsAndAssetPurchasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib31322494eca4d5aa1547d0971dc8ac9_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AcquisitionsAndAssetPurchasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab8ee29b0f704d5582d80f8a1f293200_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AcquisitionsAndAssetPurchasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc05bb1c3a004d69a9dd0f6792cba7d0_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AcquisitionsAndAssetPurchasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1688320e5de4822882dee9ca4e4c9cb_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0cf47a4282e4868ac20435f2c4eb0f9_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id48fff5740844b57bc700c378e450fa7_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8850d8ea71334023bc7208f43133ccc1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90205585203d45b9a541218bf94ecb8f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9617cb12c1c84a2495a0468f42ec6183_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib807cb0974544fe1bde03d660c5eaaf7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8a329c56c57456a87d52725a451b145_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14c67953a7094a6fbf13726da1a68618_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50107d7096d5469e97d67a3ff03b72b3_D20221101-20221101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2022-11-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7182ccdde7ae4a0fa8aa3492db312246_I20221101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i651e6cbf14d5467d82c4f381868cde06_D20221101-20221101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:ArizonaDiagnosticsGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2022-11-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0852a96e84d740afa49bfe5d275671e7_I20221101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:ArizonaDiagnosticsGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7f3ec194c084b988bc8b154c1692068_I20220401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:FrederickHealthHospitalIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:FrederickCountyRadiologyLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76afbed304204c709d14268fe2fc7759_D20220120-20220120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-20</xbrli:startDate><xbrli:endDate>2022-01-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iebda58f2b50646b69966fddb55d1e9eb_I20220120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0037eb0ed88b4354b067862baa4cefa3_D20220120-20220120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-20</xbrli:startDate><xbrli:endDate>2022-01-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic091556638644c818849ee8b176872d4_I20220120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a34e2b02c7643fd994177cb578613e4_D20211022-20211022"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DRTLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-22</xbrli:startDate><xbrli:endDate>2021-10-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12d9fd3f8cce41bd8567698b43e666dd_D20210824-20210824"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:TangentAssociatesLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-24</xbrli:startDate><xbrli:endDate>2021-08-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22bc4ace41264830b19ecc0fff6de4f9_I20210824"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:TangentAssociatesLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d60f61c473f4e6fb2d9dbbff4ddca06_I20210101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:SimiValleyImagingGroupLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f28b0b82f124664841343311ab008f6_D20210101-20210101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i890b17585af645948aa4f2d397196445_I20210101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:SimiAdventistMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="center"><xbrli:measure>rdnt:center</xbrli:measure></xbrli:unit><xbrli:unit id="loan"><xbrli:measure>rdnt:loan</xbrli:measure></xbrli:unit><xbrli:context id="i247583bd1aa946988c453d719d97edc0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i087e7761e7004e5c94660aa94d151210_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1795eae17b55485abc0e544e061a5958_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:ScriptSenderLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i6562ef04abd84649a113083dcc1c41e7_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:OperatingExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:ScriptSenderLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i735b0a42768a4a3bb87d2987dc055d34_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:OperatingExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:ScriptSenderLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a0a659fcb0242ad8761501bd118570a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CommercialInsurance1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f6559bea918495a87128bf382ef7d5a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CommercialInsurance1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d2544245c6946048647d180b4e3e7e7_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CommercialInsurance1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if9e89507dbdf4fca9acbc6d655b0924f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicare1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6010c9500ed44ea7ac66cbb102ea5441_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicare1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67dc9135b9ab4673a47ea479a7047db1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicare1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id3adc65b8a2046e69efeb8d95f9b16e0_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicaid1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ee2b0d6cc73495f962207b14a58c057_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicaid1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72206c79090b41468a17cf51393b0102_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicaid1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc941d1b7b8b42c1b2b229203d2d1f68_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:WorkersCompensationPersonalInjury1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c9a14a2aa8d4c7c92e4d32b28aa7ae3_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:WorkersCompensationPersonalInjury1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibeee80a28c534eb29afad1b7014b9af5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:WorkersCompensationPersonalInjury1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72030050603b4a6492bb961b6905bcdd_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCarePatientServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26f7c190fd9c4fe4b401e5498a9420a5_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCarePatientServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb79b974d4be492a91371479cbb32335_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCarePatientServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d125c78b6c146b6a159d4a476805404_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCareManagementServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iecbeb484fb484458a8ffbf37a3d961c9_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCareManagementServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1abd100dae3f4030bbd2f3ea40e56b5e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCareManagementServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie2a7006c766b4cac84f74a1f76450698_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:SoftwareAndTeleradiologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i508713e09e2f4d37aa8f9bcfe4c9028b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:SoftwareAndTeleradiologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia70d2c625846491db5b174a1557fbcb8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:SoftwareAndTeleradiologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8b9db45f8f642ba842535ed1f326b09_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i87b7580faff74b7e95b97fc7b8c8893a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i25437a7752974cd98b29076a22f18504_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia31edfbd04f643e3b9f3f2aeff39f4ca_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:ImagingCenterSegmentRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57f34400483a431dbea4dc0dabc4bc32_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:ImagingCenterSegmentRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3094571dace8441cabbda1c2dbba52bf_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:ImagingCenterSegmentRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied16739f0ee74364a87daf31d0d396a3_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:AIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i460e15926d1d435b8a643a732b488ddf_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:AIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63b1d1c0666a4b70a0380796de7d23ed_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:AIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idece277420ff4a9fa6789878bb4d04bc_D20200101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i506dbb6a5e1c4160b81aac201c17a8cf_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50ecee342add4902a22e3378fadbd827_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8140fafc99c43f698a11c6792fc6450_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:PaycheckProtectionProgramLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if6fd3b8a94554fd9a4f614d18e1c3d63_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60bbb306d434427baf7094fc97918fdc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i74debba71c9649e0ab1a9f9fa2f11ff8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id1424599069048eca25bf6f55f5a8042_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb757d76ce5b4ce18bf379dfb73a3226_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52b880c3739c4f62a055717f8fc7fe42_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:PatientServicesNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ERADMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i808cdb9ce8d34cef9d7fda485b899b3d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:PatientServicesNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ERADMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifea7caca315b42ef9d31633ec1af9648_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:PatientServicesNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ERADMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5869b7b9a94482aabb1927c7e98515c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2023-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia02f2d80dbdb4136890d844ee82e5b49_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rdnt:ProperyAndEquipmentNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib6d26e6f10e14cd5ac6652e62c41e88f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rdnt:ProperyAndEquipmentNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08bec0508e764dbfb8c49be4488435e0_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if16babfd8b114d728c8e4199a210fee5_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i808152f195914b788e6da3420f3e8cb9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8537d011842e4b6199b64ca17ec351e6_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i422a4c2558d84288a00576b3a91e71c6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:ReinsuranceContractAxis"><us-gaap:ReinsuranceContractAxis.domain>Health Insurance Member</us-gaap:ReinsuranceContractAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c48d7e622fc4e26963a033683816e48_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:ReinsuranceContractAxis"><us-gaap:ReinsuranceContractAxis.domain>Health Insurance Member</us-gaap:ReinsuranceContractAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i65433954d0d74893ad517dc34d70e910_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rdnt:BlueShieldMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94d07cae465b4a45933c903e5b869937_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rdnt:BlueShieldMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="incentiveplan"><xbrli:measure>rdnt:incentivePlan</xbrli:measure></xbrli:unit><xbrli:context id="id1fdbe2d3c964be6888f0365aa0b975b_I20210415"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-04-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i482c7936fa5a4a3396fa482dbd02d9a1_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rdnt:RestatedPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7258cf171ca64de4a7443899de9f7975_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rdnt:RestatedPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9758ca019cab44059e02dbe1b53445b3_I20161231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:Caps2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="agreement"><xbrli:measure>rdnt:agreement</xbrli:measure></xbrli:unit><xbrli:context id="ie96d50e803ed49a29734c6b96972c575_I20161231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditDerivativesByContractTypeAxis">rdnt:September2020CapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia630db7cb89b488da168bd28e8987f04_I20161231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditDerivativesByContractTypeAxis">rdnt:October2020CapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e6a00bde60944ccb589e7330bf8c34a_I20161231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">rdnt:Caps2016Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e878af77c394477a09c4eedcb52e0b2_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i632dbbb6dc124502b35355b0bb82bf56_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46bd994b9ae04e96b753c7e89fbf1818_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f99c4d1a5b6480abea6d0ff11b1fee6_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c59e16c960f444e80b8f6cd2c3aff6d_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditDerivativesByContractTypeAxis">rdnt:October2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2a260029b444ab89b7e9377824da6fc_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditDerivativesByContractTypeAxis">rdnt:October2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19c179308c4b45ca97aed3c7ba7f064d_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b43962e0b0141068c1c9e2b72b13361_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iefafe9554bff40dcb084b9218d53528b_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPS1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i193fb1139b6443c59e7e807e0683c634_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPS1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i23d7f29089b64d22895c3d43381dbb7f_I20200701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib04c7e5c38284425adee6a4423c7156c_D20200701-20231031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2023-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9048c2d946984a73a9b463cc83780401_D20231101-20251031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-11-01</xbrli:startDate><xbrli:endDate>2025-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i477bfe5294834112a6af03501b8e3fa5_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b432aaed4704e9eaaee35896216be8f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie48b611c24514f819e0afaa0b9e33107_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07817c4f1db542b1bd7ec426e43a3030_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58d81670414d4f9b8cc9fd7500dd2200_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i063f2f5729ee435f8d4852d04201ea0c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1355b8403e694c14801d61d67f909c67_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:ContingentMilestoneConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i239e3d4ca4304f1ab838f88d83fe9529_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:CashHoldbackMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie27fb48dea7a43e496f5d4e770f84de3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:ContingentMilestoneConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i11ed45440ab0437dbd546007b43ffbf8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:CashHoldbackMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec85947be77b4e02afe08d88f3901b7e_I20221001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MontclairMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i315f9ce8303d42fbb74147d9754e4496_I20221101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec83e5acff394eac92ff9ba28bb2e1ec_I20221101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:ContingentMilestoneConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if870a8803b5347588b2a78fdf3b1dabf_I20221101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:CashHoldbackMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i350d6392e4a642769b8a9824e7855129_D20221101-20221101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2022-11-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72596dac70a143edab1f533e55146f8a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:ContingentMilestoneConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia30202f136744654aca43922c68c719e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i60714a92713744d0a7ef51e5a96354bd_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if47d16ba9eb44f57b85358ec1634a856_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3798b3922a04943acbf92ec8317c957_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a2b769e8cef41f6ac4d466fe758123d_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0237b2107cb4cbf8ff50093346bdf89_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i453f8cd3681340bbadd382f3b137a70c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MontclairMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5398be82ea374f1981ccf7e382e72ef3_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MontclairMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1cf96aa8943147168551f098e2d58c2a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MontclairMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf93bd34e5d546fcbe757031ae9bb387_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e47a0bf0feb4c3b8860d3345451141f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie490b42ee8164ea9be2f0eda5934c310_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i804d8cc7449544638b1eefbdb8975b75_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i68ac6da733e34c689df37c278c132480_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa27e287074e451696981ce012df35d6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39f8a4ef27dd454bb81ce09e12cfb471_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i79c1f314aa17465097ef0df412a24c6c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06780380ef034b1a885d689dfb1011eb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2abc2bb208ac4de69fd3a4d8e27425a2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d33c478c74c4c5ebaae8d80880f704a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i00898b4e70c54a4384ea59c45556e995_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if895037caf4f4ecdb06fe18bfec769a6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b7afa03cd544db6979077730ed44669_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i073ba5e6253341968d7e3516327451a9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec52dfb722a4447db7f7c2e52080d41b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if060f0a3047f484587fcaf8727158a53_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie81addc4a43045808d4c9dbf8c419ac8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f30a42447ea455195dbea5eb27643c7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a9534b2492f4341a32a7b6c05873d87_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MontclairMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d69f978a5e545b59d1932ca7f532e37_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MontclairMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63cacf5ad31b4575a01903e9faa4d633_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MontclairMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i262f245ca0594ae0ac2e01228b468096_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MontclairMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife7c65edeb504ccfb67de601c6de474e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7761dd1ec2754fbd87eac5dbd64b9695_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ce47813748d41d199f7f86a1dfd426b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d11c112b7384fe3b9ac73abcd84790d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i68cb6719a36646579aa32aed365bd98e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93f4dc716811412781fdf04a461f52d0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d6f4cc7b7b3447bbb1069e43d3898ab_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6183df40beac48aaad7cae1b8fc18cf7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i872140f492c640d8b8e8a6c1e04bd0d6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i133140d2b4cb48a9bbe5445819d6ad6a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc57a71039044ca88fabf7ced3a359f8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id0f9e4af159e4119a9b961b547b9038e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4eb1b2eda4f64d6e9ef32ec67df449b3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:BarclaysMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8cfe249b156b4148afe2824bb962e98f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:BarclaysMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9eddaf97c45f47fc9a3e3499d9c2b938_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:TruistMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iedc6b67a64d84652974967909a8eed47_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:TruistMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i97956fc643d247dbb60da5865beb89eb_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5457051aa2ff41adadb9d14aeb2cf08f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4fb9164d19204098ae94cbd87a23b9c8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a2f8fa41f874e60b776bf0389800e5e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a13cd9e9617451c8d173c251b8d9e0e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i733c80ddcad5463c9dbb1c25b49f2c67_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="investment"><xbrli:measure>rdnt:investment</xbrli:measure></xbrli:unit><xbrli:context id="i66d4d733653e4eb4a3ad6c433ebdfb6a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:MedicVisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47e82ebf9ddc4469a95c70fcc3d63d41_D20180201-20180201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:TurnerImagingSystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-02-01</xbrli:startDate><xbrli:endDate>2018-02-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9104bade5d0a4187930fd11fdbf5d05b_I20190101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:TurnerImagingSystemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie8654cdfc8db49acb180ade8667b818b_I20191011"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:TurnerImagingSystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-10-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic070f0614e2e4747984c1d8809073028_D20191105-20191105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:WhiteRabbitaiIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-05</xbrli:startDate><xbrli:endDate>2019-11-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="jointventure"><xbrli:measure>rdnt:jointVenture</xbrli:measure></xbrli:unit><xbrli:context id="ia3c6f10cf71d436f8d6f89d025cb5660_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:GlendaleAdvancedImagingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rdnt:DignityHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">rdnt:JointVentureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b1c789f4aa54283a927ee786764619c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:GlendaleAdvancedImagingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rdnt:DignityHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">rdnt:JointVentureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6bc50d516cca4bf2ac566ca32f16fa45_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i556dfe7e8b354868acf1bd22f0b04c11_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8217add0ca2e4d579d49cd56dd4ce0dc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:JointVentureInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9eecc7ea77b94b6d843c47a92a34de8c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:JointVentureInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida002f69ec1f41d5b17282e7b20fc172_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0acf107e72724cc497da946604ddb76c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1616cf57656c47db88833796ec62d482_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i825f9b68a0534968996704634645bbdc_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:ArizonaDiagnosticsGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04323c12bfcc46fca5f3765bc9b181de_I20220101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:IFRCLLCSubsidiaryOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i45f00f44ca7b4343afb1b0392c335273_I20220101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:IFRCLLCSubsidiaryTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e2bd41f61084dc99c6046940c937f26_I20221001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MontclairRadiologicalAssociatesPAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29413aeb2a174d91ba07be32e53f164d_I20221201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:ChelseaDignosticRadiologyPCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c31a5dab37e45d28652fdb0fa620376_I20221209"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:NorthJerseyImagingCenterLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i78a124f13cce4bf08e493835bf6a3457_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:BusinessAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie8d992d40a6c4dd78532f351f5124719_I20221101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:IFRCLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4d32c5f421b43f999b15581ffd8c753_I20221101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:JointVentureWithCalvertMedicalImagingCentersLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:IFRCLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i892eb956660d4426a7b9ce4343939007_I20210201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:PersonalHealthImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia8d26a04836f440696fff1b778498ee4_I20210201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:ZPElmontLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03820b19954941189242f879d3d1aa9b_I20210201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:ZPFreeportLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0ea208abb7a45c18b6150540a583cc3_I20210201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:BroadwayMedicalImagingLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35c9649190e94adda0f107310a8a289e_I20210201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:A3235HempsteadLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ab3ab4d55ef4b02aa47ad2b6dad4bc7_I20210201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:SLZMRealtyLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i579ab9cf65534af294a6f7e07668dd6a_I20210201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:A2012SunriseMerrickLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie5f5572dd74743ab9a87be7f25a33b9f_I20210301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:ZPBaysideLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i902807f4b9a9416c9b47104b5ad819a0_I20210301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:ZPLaureltonLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc21e27c33b04e1daa07fac76223e671_I20210301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:ZPSmithLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc6548d74e7444118bd3d64d387c8399_I20210401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:ZP907NorthernLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib8ef5a13ccba4f0081c5203b3d794eca_I20210501"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:WilliamMKellyMDIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-05-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iace4174421504d128d1891aedd6863a3_I20210501"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:A60thStreetMRILLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-05-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaaf8fe80680b48ab82ec3deb6b41a4af_I20210501"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:ZPParkchesterLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-05-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a182964d2994db6afa278022e5ec78c_I20210601"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:ZPEasternLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7aacc9fd1cc4c3e8c39d3650be587c0_I20211201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MidDelawareImagingPAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i759bb752ba514fd0a9e92dbd00a4ba03_I20211206"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:WilliamMKellyMDIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff8ceedaa8534baf9af84ee6fdb44f29_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:WilliamMKellyMDIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb914ba8860c4d42942ab37aebd6805d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:BusinessAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95d5f4cf07934fb790f6972ad191259f_I20221101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:IncomeApproachValuationTechniqueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia40099a2511a4e60a8a104b2b81cfad0_D20220120-20220120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rdnt:OtherSellersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-20</xbrli:startDate><xbrli:endDate>2022-01-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8ce100f294545feaf01b49a483d7835_I20220120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rdnt:OtherSellersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb0178640b0547a4a348e983673f24ad_I20220120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:ContingentMilestoneConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i38534e3fc3794da0bea27b49adae6a77_I20220120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:CashHoldbackMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if0842a81b02a40418df2e51489f2137e_D20220120-20220120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rdnt:CertainSellerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-20</xbrli:startDate><xbrli:endDate>2022-01-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if97396e4c19841b98639a9937dfa4fa7_I20220120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9fc3884748a4f9c85f668dbc7c8621a_I20220120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf4d7228420748d7a6ca4943a5dc578d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:IncomeApproachValuationTechniqueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id2af135c82bc4cca8c8fab8df3985632_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:IncomeApproachValuationTechniqueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1073a8921d2c4ba78783ba6bcf89733f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2500cde4d73845a3ac979c61b31fffb3_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7c3caf821ac4264bfedf6a1cf1e1cff_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic20227de97324a8da0150abd7d29ff60_I20220120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rdnt:OtherSellersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4f8df70221f4cb2841fe32fb6094aa8_D20220120-20220120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:BusinessAcquisitionContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-20</xbrli:startDate><xbrli:endDate>2022-01-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79751a12a5c14657a85da985b3d864c7_I20220120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:CashHoldbackMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i68c4c04cc28b411e853a2689c03e9923_I20220120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6165260d2cac4c499c9451f3f1214d18_I20220120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if1af841cdb3f4cd0ad5ac44de8df9eb9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:IncomeApproachValuationTechniqueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5fc2355ac8fb4b73b314ebd1371b0448_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:IncomeApproachValuationTechniqueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5968e7309954164b239ff2880b7fa11_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i14058b49fc714ecb8b39c3fe337c4c47_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab70d35c2cb440ccba0a783f0cdde440_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifac3d3f48c90447d9920ba9922709d73_I20220401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:FrederickCountyRadiologyLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="location"><xbrli:measure>rdnt:location</xbrli:measure></xbrli:unit><xbrli:context id="i2f87ecd615944571b918d5b62820eda3_I20220401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:FrederickCountyRadiologyLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i38c6fdf76c844677a1750f13333889fa_I20220401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:FrederickHealthHospitalIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:FrederickCountyRadiologyLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rdnt:FixedAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f0903465ba04ac2995029cdb8fbb03f_I20220401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:FrederickHealthHospitalIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:FrederickCountyRadiologyLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63d0ac5d5bab47479964de4ca123d1f5_D20220401-20220401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:FrederickCountyRadiologyLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb19233e68ff4d41a7e808f8715f8f2c_D20220401-20220401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:FrederickCountyRadiologyLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18b22b6c335a45639d3204cacdeb3610_I20220401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:FrederickHealthHospitalIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:FrederickCountyRadiologyLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3feff49292e04c30a61b84bfc33cae41_D20220401-20220401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:FrederickHealthHospitalIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:FrederickCountyRadiologyLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i241f863ca19c468d9943aac255502e19_I20220615"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:AdvancedRadiologyAtCapitalRegionLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i59cfe8ed7dfb4ae09b7c26c7e2734e56_D20220615-20220615"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:AdvancedRadiologyAtCapitalRegionLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-15</xbrli:startDate><xbrli:endDate>2022-06-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37eb4b7a2a86440dbba3d35c820120cb_I20220615"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:DimensionHealthCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:AdvancedRadiologyAtCapitalRegionLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5a702b1c1bc4189a7b7944db5b5fabd_D20220615-20220615"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:DimensionHealthCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:AdvancedRadiologyAtCapitalRegionLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-15</xbrli:startDate><xbrli:endDate>2022-06-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i987cdd48ce1c4476ae4f5b205442e647_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:SimiValleyImagingGroupLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc1689b570374d14852bee5675a09ab0_I20210101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:SimiValleyImagingGroupLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:SimiValleyImagingGroupLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if68e59e75ef34799af1d02aff32b5aae_D20210101-20210101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:SimiValleyImagingGroupLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3b6622be19547c48017c645b19e93da_I20210101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:SimiValleyImagingGroupLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:SimiAdventistMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90a1726c6bee4422b356584ebb692aa7_D20210101-20210101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:SimiValleyImagingGroupLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:SimiAdventistMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9086fb31eefc4ef396dce636b41d760c_D20210901-20210901"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:WestValleyImagingGroupLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-01</xbrli:startDate><xbrli:endDate>2021-09-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i428ad0d44a1346558061485e679164b4_I20210831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:WestValleyImagingGroupLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd38436b6e0c4c099ae9632c1d4929cf_I20210901"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:WestValleyImagingGroupLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ed54666eaf94b7bb7053f98d1280ca4_D20210901-20210901"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-01</xbrli:startDate><xbrli:endDate>2021-09-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i237fcfddc1b842039f5586e2d3b311f4_D20210901-20210901"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">rdnt:TarzanaMedicalCenterLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-01</xbrli:startDate><xbrli:endDate>2021-09-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5726eab9b6d42fa88ccbbd9685ed8a6_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ImagingCentersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70656be41c694318a241edacdeceec2c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ImagingCentersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f9bff8ba8074226b0ec1f1f6f82e960_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ImagingCentersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74a6538627074503a346c001073d75b6_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:AIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ae0b29c79ef48768e36dcfc86e3ae27_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:AIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i752bed455bf6494e806b337523329451_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:AIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i668dae88a2914d8f85a4a37e9114214e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ImagingCentersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad55eccace614330a9a10e68dc84d72a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:AIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idba042321a6d496fb90b273b2d065e08_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ImagingCentersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8fff7583d4414b91a34f6aefc3dae941_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:AIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i611c6f40576041af971fff090e96cc52_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ImagingCentersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24072ed80ca2499296f569d92fce4296_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:AIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1e54694556947f19c007ab6032e164a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:ManagementServiceContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i414955456ed943bfb2a5a55163f53cf9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:ManagementServiceContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4aa6fe1b19fa4032b19af61fea4d1770_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:CovenantNotToCompeteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1302a37a97cd4b139f598c14f70e6a6f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:CovenantNotToCompeteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iddb0cd692be2450194003830cb8eade8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d300af724bd42fa81df479bcd52a561_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:PatentAndTrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f97cf28159d4af1b51bd03a44af0b3e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:PatentAndTrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5437e74731804fadaa4b067a3e9a1079_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:DevelopedTechnologySoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i79c0ea2a5c9d4435ba5a05f5371abd25_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:DevelopedTechnologySoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia5494245554a4a8c8f993a496d898612_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide5c8507870d42c2934aea55608ad13f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24d947bc9cc64b21a3c0655f38ee8f28_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3d853d4f3b647c5b17405fc7cbc9ec7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86f01866d4c84b9bbfb9f6decd26c6f6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i00b2de31a74241f0b34c082e030c3988_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id97a7eba2f0b4e619a60a313e21c6dd0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia8674635644f472eba0908b3c0584e97_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibdcafabfcf7040c3b97ef14ac3b23f01_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd3d3e3e547648dd8ffe8630809ea423_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86ebeca091034ef29127281116eaa2a8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i628e73d9b5b54e3bab985a48e170406a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6dc531e92c3b4e048c61c11ad6d1e801_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i08ea7357bc1b48619f5f3b7216b20254_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie245ad8af20a43b28a6758228cc88b11_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rdnt:MedicalEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab7ce7f316034c05b56c7a6f0d599bb4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rdnt:ComputerandOfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1c8ab68fe024b7a8859d4b269c75b02_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7fd7963b7541486ba64acd58081d4289_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rdnt:MedicalEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4939d9e3309469392b03a7b6fed19d2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rdnt:ComputerandOfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i522481570141465585681f5b994a0bcb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54b3674416244d4db4d21de83d7cbbde_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7864c4b6f44e46a09a513ac84d7d21ec_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i38719d8a10de43ad8f49713e3df85eba_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i78f5077e0f824294be47554965869037_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2923158472984ab081c98c126fa64e96_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementEighthAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia72ba28711ea41c3b84011425ee45d0f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d9d403debfc473bafd93ca110c28e57_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d36672d0c054968b7578c42cf79bd8c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:SunTrustMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic33fc421ee274ecb81ba734b51c43318_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:SunTrustMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib78b9355051b47d5a52646928c50c333_I20210423"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i659ee446c43548e9bf27ed0a4061b5ab_I20210423"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:FirstLienCreditAgreementSeventhAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56152cb4c4e24493b5d3fdbbd09acf47_D20210423-20210423"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-23</xbrli:startDate><xbrli:endDate>2021-04-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie23d788887204110a462554db069f44b_D20210423-20210423"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:FirstLienCreditAgreementSeventhAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-23</xbrli:startDate><xbrli:endDate>2021-04-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieec8243d9ccc44119f604da882ab8f72_I20221007"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:TruistMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ecd3750a3b74bbda768365b8ab639d7_I20221007"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:TruistMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementEighthAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i199f459e5ce14f77a34aef36dbc62bff_I20221007"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:TruistMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:FirstLienCreditAgreementSeventhAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iccbc7b1f30b74634bd5e6b0535972448_D20210423-20210423"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:TruistMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:FirstLienCreditAgreementSeventhAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-23</xbrli:startDate><xbrli:endDate>2021-04-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b41d8242f3040fb8331b37d34fcd9d2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4318f7e3746943799936274358bb5174_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ee298d0e61e459396a35b628ee2244d_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i25ec9150f13743ed97836354e90ebc7e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id97b4431c3884e1faeb084da481dbb28_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1571e82796a8423a8fe38d602a05f3eb_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia957fac5b3fc45788abdc13188550c17_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib804538af1af4cbda91f1ab7a1b84f7b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i557a45553f2a40f7b25201fe169750a7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f520487af9f4cf3a4d4e00bacc10a81_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i312118f202904e5e9d26cd7cb00d4237_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i856b0cb40d214a9b97efb4927aab7f8f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie662bee09b1e4c1c86dbd8597e67cc62_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIVMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99932cd267fb439fa22c5eb34b7ae0f0_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i839055751cc8442db5204c49d1284938_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69798f67de99449889ab8f63e5cf75a3_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15eb2be8a2ff48a9809e5a01d2e32851_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelVMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia5b95a7d5c6a44a18f1590d4463611c0_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if100b11b6bb44e928235b214abe522c1_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i13cb963d1f784637aecd1c03103d2861_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab1c1f0acbf94f9f961d2a94fecafbce_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i702897b2a6b14e748e4098af38ad1e19_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic20f8711184c443c87d2fa221b9f3d6b_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id37173de0c834f2b9f115f5a5a19cc27_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9b5190de9024ab58119dd3bf9d43ea3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4b317995bde4bada86bdf0ce0b815cd_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70fb120699d84c7f82b9624968f97599_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice18c3446a25450bb2c8f0569aa819e7_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e033e1356e54eb3be45b1693fd1314c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:TruistMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a3f767fc5374ada83d6ae22aa651dd9_D20230331-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:TruistMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-31</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04e208e3692545da8ee7fd87c877961c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:TruistMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3519d8c4e9ee47ba8c1300676d007bb0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2463bc0c023b4f5aa0e500c7b7681aec_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i928b06213e75428c90178a1d1b5152f7_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f6c0892ace746fbaf4c00e519257a16_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id93b58eb3f8545c19a363c18ea54314e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id934500bc63546f682c7f9670a1350a8_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8268de3b978748b782a432f7902bf9eb_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i278e51ae3e69452d872b324b2fceb548_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id603dde9dba24bd185acda0ba6834023_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1dadee5b8a024acb8b292c439ee5d113_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id994e3544668477991d25e93154861e5_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae4da6a9b69c4e0f8084fdf5c94b4fb0_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3b1eb6913ea4657973a8239914f6e42_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:TruistMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementEighthAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92fc6849db614c54bc09a2666a961e01_I20200828"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementEighthAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0632c03edc1443a6b0a38f3cd1a783d9_I20190418"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-04-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="amendment"><xbrli:measure>rdnt:amendment</xbrli:measure></xbrli:unit><xbrli:context id="i09ba2d9a36f045b797d41b04329dd854_I20190418"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-04-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c5c4e38ab5d4390807495b2aa90ba6a_I20190418"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-04-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia96560b5f1de48ab9fbe2db67aecf4d1_D20190418-20190418"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-18</xbrli:startDate><xbrli:endDate>2019-04-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa6deb986aee4e51833223a5764529e4_I20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:TruistMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67ae41392b3144c99363c75225255999_I20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:TruistMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i85a7d0e0c6ca48769139d10c3a615b9e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:PaycheckProtectionProgramLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc2f697097964cab9a6567723aee030c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:PaycheckProtectionProgramLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7dff0590fe940f8998c972ad3a5986d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:PaycheckProtectionProgramLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1e56ddb23564f81949b77940a641b57_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0118bb2b3716434fb951fa28970f2707_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice63a1a32cb9452b8b46714c1c61a7da_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib19ac757adb3497f895598bf7d1fb0f6_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8cff5897a0c648b19e7125d13cd0a0f5_D20211231-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-31</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c9c24367d914d6f8d3b8b89c6ac650c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i01d34ce5690d41ac9b7da0025a908d74_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if220aac49baf4022b602bb8b0e79c955_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:RavenHoldingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1012d26028ec46ccb4bd6809233ed3bc_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i094c5d904be44087995cd941fc4d5daf_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i44c5111cc15c410d9c005a8bde3cad3a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d5bebaa0e7442d1b5f5cca875bb344e_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9acfb04e9f5b4b67ac85b9574a34698b_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f429bcc5e2b462cb9501b7c563ba31b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i910ced2457b140f4b0ed9010ea0b124a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i913337c7aa3b4295af9870b33b64248f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b0bb841e3944cc1903ad3a519ea4d82_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie0a58125fd60480dad3bda99ec884d22_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0787e0bf64654960aed460942168553d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1c839443b66471eb59beee8617975d2_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:FutureServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6277f9dca3d1402c9da0e7e331ab1e01_D20220101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="tranche"><xbrli:measure>rdnt:tranche</xbrli:measure></xbrli:unit><xbrli:context id="i0f44d430f1174158bf7fe50617e713ac_D20220101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i62c3cbb4a9964a25abbdcb253fb4024f_D20220101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50296a953a0a449b97171c09173e2621_D20220101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockOptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idaacd756f4c9498d91cf9c5a87b822e2_D20220101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockOptionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icec298142c894a2b86d0c42a0627070b_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockOptionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c047b53ccb14b03a3aee6426354f41c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:LongTermIncentivePlanSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4881d8775eb54b72a12eb858c7e4a554_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:LongTermIncentivePlanSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if4019e7dc01941058ad36f53dc8d3d21_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:LongTermIncentivePlanSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b0e1dc8b96c4fc384f33bcb572e740a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:LongTermIncentivePlanSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7b8b14610224ea59f307a3d2cbe26ba_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:LongTermIncentivePlanSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d84eba07ea94e52a84e38c42643cc0b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rdnt:RestatedPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="if3f80771944f4fc58015abda42dc47d1_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xL2ZyYWc6NzQ2NDBiODZkOGQ5NGJjZjhhZGNjMmNmYmM1MmZlODgvdGV4dHJlZ2lvbjo3NDY0MGI4NmQ4ZDk0YmNmOGFkY2MyY2ZiYzUyZmU4OF8zNDk3_70f600a1-a24e-4c9c-84e5-292025229b07">10-K</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="dei:DocumentAnnualReport" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xL2ZyYWc6NzQ2NDBiODZkOGQ5NGJjZjhhZGNjMmNmYmM1MmZlODgvdGV4dHJlZ2lvbjo3NDY0MGI4NmQ4ZDk0YmNmOGFkY2MyY2ZiYzUyZmU4OF8zNDk4_030ce708-81db-4e1c-8d65-0b72715f0eb2">&#9746;</ix:nonNumeric>  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the fiscal year ended <ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xL2ZyYWc6NzQ2NDBiODZkOGQ5NGJjZjhhZGNjMmNmYmM1MmZlODgvdGV4dHJlZ2lvbjo3NDY0MGI4NmQ4ZDk0YmNmOGFkY2MyY2ZiYzUyZmU4OF8yMTE_7bb12c30-9643-496c-a752-869178a4c117"><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xL2ZyYWc6NzQ2NDBiODZkOGQ5NGJjZjhhZGNjMmNmYmM1MmZlODgvdGV4dHJlZ2lvbjo3NDY0MGI4NmQ4ZDk0YmNmOGFkY2MyY2ZiYzUyZmU4OF8yMTE_2edb23db-874b-4e5e-bd07-fb4f54e6f705">December&#160;31</ix:nonNumeric>, 2022</ix:nonNumeric></span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xL2ZyYWc6NzQ2NDBiODZkOGQ5NGJjZjhhZGNjMmNmYmM1MmZlODgvdGV4dHJlZ2lvbjo3NDY0MGI4NmQ4ZDk0YmNmOGFkY2MyY2ZiYzUyZmU4OF8zNTAy_19cbbded-fbe3-4d30-9c1d-145d5ec8452a">&#9744;</ix:nonNumeric>  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF     </span></div><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">     1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;For the transition period from    to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">      </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission file number <ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xL2ZyYWc6NzQ2NDBiODZkOGQ5NGJjZjhhZGNjMmNmYmM1MmZlODgvdGV4dHJlZ2lvbjo3NDY0MGI4NmQ4ZDk0YmNmOGFkY2MyY2ZiYzUyZmU4OF8zNTAz_d66d9137-d283-4c0f-88cd-dbb7c1c59a74">001-33307</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xL2ZyYWc6NzQ2NDBiODZkOGQ5NGJjZjhhZGNjMmNmYmM1MmZlODgvdGV4dHJlZ2lvbjo3NDY0MGI4NmQ4ZDk0YmNmOGFkY2MyY2ZiYzUyZmU4OF8zNDk1_5fcff722-235f-4a21-985d-66051b4d9eef">RadNet, Inc.</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.865%"><tr><td style="width:1.0%"></td><td style="width:26.853%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.322%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xL2ZyYWc6NzQ2NDBiODZkOGQ5NGJjZjhhZGNjMmNmYmM1MmZlODgvdGFibGU6M2E4ZjZiMDcyNGZmNDY0ZThhZTdhNjlhZjkxZTZkNDkvdGFibGVyYW5nZTozYThmNmIwNzI0ZmY0NjRlOGFlN2E2OWFmOTFlNmQ0OV8wLTAtMS0xLTI5NDg5_22855676-26a2-4a49-b6b0-e665f40456f3">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xL2ZyYWc6NzQ2NDBiODZkOGQ5NGJjZjhhZGNjMmNmYmM1MmZlODgvdGFibGU6M2E4ZjZiMDcyNGZmNDY0ZThhZTdhNjlhZjkxZTZkNDkvdGFibGVyYW5nZTozYThmNmIwNzI0ZmY0NjRlOGFlN2E2OWFmOTFlNmQ0OV8wLTItMS0xLTI5NDg5_fa8d8b46-364c-4fbf-8e04-2085d79483d9">13-3326724</ix:nonNumeric></span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or other jurisdiction of<br/>incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(I.R.S. Employer<br/>Identification No.)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xL2ZyYWc6NzQ2NDBiODZkOGQ5NGJjZjhhZGNjMmNmYmM1MmZlODgvdGFibGU6M2E4ZjZiMDcyNGZmNDY0ZThhZTdhNjlhZjkxZTZkNDkvdGFibGVyYW5nZTozYThmNmIwNzI0ZmY0NjRlOGFlN2E2OWFmOTFlNmQ0OV8zLTAtMS0xLTI5NDg5_8803e92b-c012-4989-9c15-ae96a2a38b30">1510 Cotner Avenue</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xL2ZyYWc6NzQ2NDBiODZkOGQ5NGJjZjhhZGNjMmNmYmM1MmZlODgvdGFibGU6M2E4ZjZiMDcyNGZmNDY0ZThhZTdhNjlhZjkxZTZkNDkvdGFibGVyYW5nZTozYThmNmIwNzI0ZmY0NjRlOGFlN2E2OWFmOTFlNmQ0OV80LTAtMS0xLTI5NDg5_ed6bbad0-d6c1-4ab6-9169-d6d344819567">Los Angeles,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xL2ZyYWc6NzQ2NDBiODZkOGQ5NGJjZjhhZGNjMmNmYmM1MmZlODgvdGFibGU6M2E4ZjZiMDcyNGZmNDY0ZThhZTdhNjlhZjkxZTZkNDkvdGFibGVyYW5nZTozYThmNmIwNzI0ZmY0NjRlOGFlN2E2OWFmOTFlNmQ0OV80LTEtMS0xLTI5NDg5_181d2a79-5ca8-44e0-b029-f2f5b7f274eb">California</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xL2ZyYWc6NzQ2NDBiODZkOGQ5NGJjZjhhZGNjMmNmYmM1MmZlODgvdGFibGU6M2E4ZjZiMDcyNGZmNDY0ZThhZTdhNjlhZjkxZTZkNDkvdGFibGVyYW5nZTozYThmNmIwNzI0ZmY0NjRlOGFlN2E2OWFmOTFlNmQ0OV80LTItMS0xLTI5NDg5_394a08e3-c804-4dfa-be23-14eee7becfc4">90025</ix:nonNumeric></span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Registrant&#8217;s telephone number, including area code: (<ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xL2ZyYWc6NzQ2NDBiODZkOGQ5NGJjZjhhZGNjMmNmYmM1MmZlODgvdGV4dHJlZ2lvbjo3NDY0MGI4NmQ4ZDk0YmNmOGFkY2MyY2ZiYzUyZmU4OF8zNDk5_1be2fa27-b317-44ef-811b-2efcf86bff61">310</ix:nonNumeric>) <ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xL2ZyYWc6NzQ2NDBiODZkOGQ5NGJjZjhhZGNjMmNmYmM1MmZlODgvdGV4dHJlZ2lvbjo3NDY0MGI4NmQ4ZDk0YmNmOGFkY2MyY2ZiYzUyZmU4OF8zNTA5_cb49c18c-15f3-4271-b0a3-50b475b41b32">478-7808</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:36.820%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.058%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.822%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xL2ZyYWc6NzQ2NDBiODZkOGQ5NGJjZjhhZGNjMmNmYmM1MmZlODgvdGFibGU6MzY0ZGZiMWUzZjg5NDI0ZjhjNDUxODU4MzM1MzJjMzEvdGFibGVyYW5nZTozNjRkZmIxZTNmODk0MjRmOGM0NTE4NTgzMzUzMmMzMV8xLTAtMS0xLTI5NDg5_7f28fc42-04e1-4b29-b4e3-0b3fc510871d">Common Stock, $.0001 par value</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xL2ZyYWc6NzQ2NDBiODZkOGQ5NGJjZjhhZGNjMmNmYmM1MmZlODgvdGFibGU6MzY0ZGZiMWUzZjg5NDI0ZjhjNDUxODU4MzM1MzJjMzEvdGFibGVyYW5nZTozNjRkZmIxZTNmODk0MjRmOGM0NTE4NTgzMzUzMmMzMV8xLTEtMS0xLTI5NDg5_c36644d0-7d82-4e16-8156-52e8d4cacc48">RDNT</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xL2ZyYWc6NzQ2NDBiODZkOGQ5NGJjZjhhZGNjMmNmYmM1MmZlODgvdGFibGU6MzY0ZGZiMWUzZjg5NDI0ZjhjNDUxODU4MzM1MzJjMzEvdGFibGVyYW5nZTozNjRkZmIxZTNmODk0MjRmOGM0NTE4NTgzMzUzMmMzMV8xLTItMS0xLTI5NDg5_3c41f380-f664-4ce1-a40c-2f4c435f4f7f">NASDAQ Global Market</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(g) of the Act: None</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. <ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="dei:EntityWellKnownSeasonedIssuer" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xL2ZyYWc6NzQ2NDBiODZkOGQ5NGJjZjhhZGNjMmNmYmM1MmZlODgvdGV4dHJlZ2lvbjo3NDY0MGI4NmQ4ZDk0YmNmOGFkY2MyY2ZiYzUyZmU4OF8zNTA0_588e0c6a-4975-49b6-a40d-6569643bfeef">Yes</ix:nonNumeric>&#160; &#160; </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="dei:EntityVoluntaryFilers" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xL2ZyYWc6NzQ2NDBiODZkOGQ5NGJjZjhhZGNjMmNmYmM1MmZlODgvdGV4dHJlZ2lvbjo3NDY0MGI4NmQ4ZDk0YmNmOGFkY2MyY2ZiYzUyZmU4OF8zNTA2_65d717de-3449-4932-bbbe-4048adc9b521">No</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. &#160;<ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xL2ZyYWc6NzQ2NDBiODZkOGQ5NGJjZjhhZGNjMmNmYmM1MmZlODgvdGV4dHJlZ2lvbjo3NDY0MGI4NmQ4ZDk0YmNmOGFkY2MyY2ZiYzUyZmU4OF8zNTAw_f1cd8843-20de-48d4-a4b1-560b7d7edf2a">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). <ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xL2ZyYWc6NzQ2NDBiODZkOGQ5NGJjZjhhZGNjMmNmYmM1MmZlODgvdGV4dHJlZ2lvbjo3NDY0MGI4NmQ4ZDk0YmNmOGFkY2MyY2ZiYzUyZmU4OF8zNTA3_e2790930-c03b-4d5e-a0cb-26ae0e3f4837">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer&#8221;, &#8220;smaller reporting company&#8221;, and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act. (Check one):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.695%"><tr><td style="width:1.0%"></td><td style="width:34.819%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.724%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.736%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.321%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xL2ZyYWc6NzQ2NDBiODZkOGQ5NGJjZjhhZGNjMmNmYmM1MmZlODgvdGFibGU6ZDQ3NDU4ZmNmMjI2NGI4MDkxZTk1MTdiYzdkZDY2MjUvdGFibGVyYW5nZTpkNDc0NThmY2YyMjY0YjgwOTFlOTUxN2JjN2RkNjYyNV8wLTAtMS0xLTI5NDg5_23d8e0d2-082d-4d5d-8b01-2a5eda428222">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9746;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="dei:EntitySmallBusiness" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xL2ZyYWc6NzQ2NDBiODZkOGQ5NGJjZjhhZGNjMmNmYmM1MmZlODgvdGFibGU6ZDQ3NDU4ZmNmMjI2NGI4MDkxZTk1MTdiYzdkZDY2MjUvdGFibGVyYW5nZTpkNDc0NThmY2YyMjY0YjgwOTFlOTUxN2JjN2RkNjYyNV8xLTMtMS0xLTI5NDg5_c466613d-fc06-4afc-8f50-3916b6f52ac7">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xL2ZyYWc6NzQ2NDBiODZkOGQ5NGJjZjhhZGNjMmNmYmM1MmZlODgvdGFibGU6ZDQ3NDU4ZmNmMjI2NGI4MDkxZTk1MTdiYzdkZDY2MjUvdGFibGVyYW5nZTpkNDc0NThmY2YyMjY0YjgwOTFlOTUxN2JjN2RkNjYyNV8yLTMtMS0xLTI5NDg5_258e330a-a940-425f-af07-139d85c154c3">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="dei:IcfrAuditorAttestationFlag" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xL2ZyYWc6NzQ2NDBiODZkOGQ5NGJjZjhhZGNjMmNmYmM1MmZlODgvdGV4dHJlZ2lvbjo3NDY0MGI4NmQ4ZDk0YmNmOGFkY2MyY2ZiYzUyZmU4OF8zNTEw_0ec553f0-8d9b-4041-bd76-222ff1969852">&#9746;</ix:nonNumeric></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.   &#9744;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant&#8217;s executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b).    &#9744;</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xL2ZyYWc6NzQ2NDBiODZkOGQ5NGJjZjhhZGNjMmNmYmM1MmZlODgvdGV4dHJlZ2lvbjo3NDY0MGI4NmQ4ZDk0YmNmOGFkY2MyY2ZiYzUyZmU4OF8xNzU5MjE4NjA0OTA3Ng_bd7d2045-01dc-4c07-a2f3-e776efd46888">&#9746;</ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate market value of the registrant&#8217;s common stock held by non-affiliates of the registrant was approximately $<ix:nonFraction unitRef="usd" contextRef="i85e5b321a4fb4792b5778ddcc45d31e2_I20220630" decimals="-8" name="dei:EntityPublicFloat" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xL2ZyYWc6NzQ2NDBiODZkOGQ5NGJjZjhhZGNjMmNmYmM1MmZlODgvdGV4dHJlZ2lvbjo3NDY0MGI4NmQ4ZDk0YmNmOGFkY2MyY2ZiYzUyZmU4OF8yODEw_6e9dc371-5f1a-4500-af39-20b60917679c">1.0</ix:nonFraction> billion on June&#160;30, 2022 (the last business day of the registrant&#8217;s most recently completed second fiscal quarter) based on the closing price for the common stock on the NASDAQ Global Market on June&#160;30, 2022.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of shares of the registrant&#8217;s common stock outstanding on February&#160;23, 2023, was <ix:nonFraction unitRef="shares" contextRef="icfa616adc19f40628e3dfcc4deec4d62_I20230223" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xL2ZyYWc6NzQ2NDBiODZkOGQ5NGJjZjhhZGNjMmNmYmM1MmZlODgvdGV4dHJlZ2lvbjo3NDY0MGI4NmQ4ZDk0YmNmOGFkY2MyY2ZiYzUyZmU4OF8zMDYy_f70858c2-c5cd-4490-900a-a42a381bc5e8">57,836,244</ix:nonFraction>.</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOCUMENTS INCORPORATED BY REFERENCE</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xL2ZyYWc6NzQ2NDBiODZkOGQ5NGJjZjhhZGNjMmNmYmM1MmZlODgvdGV4dHJlZ2lvbjo3NDY0MGI4NmQ4ZDk0YmNmOGFkY2MyY2ZiYzUyZmU4OF8zNTAx_d9fe02c5-214d-4915-983c-0cfcb18532ad" escape="true">Portions of the registrant&#8217;s definitive proxy statement for the 2023 Annual Meeting of Stockholders are incorporated herein by reference in Part III of this annual report on Form 10-K to the extent stated herein. Such proxy statement will be filed with the Securities and Exchange Commission pursuant to Regulation 14A not later than 120 days after the close of the registrant&#8217;s fiscal year.</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="if3f80771944f4fc58015abda42dc47d1_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RADNET, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:10.027%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:80.159%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.514%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">FORM 10-K ITEM</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PAGE</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if3f80771944f4fc58015abda42dc47d1_13">PART I.</a></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if3f80771944f4fc58015abda42dc47d1_16">Business</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#if3f80771944f4fc58015abda42dc47d1_16">1</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if3f80771944f4fc58015abda42dc47d1_19">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#if3f80771944f4fc58015abda42dc47d1_19">17</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1B.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if3f80771944f4fc58015abda42dc47d1_22">Unresolved Staff Comments</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#if3f80771944f4fc58015abda42dc47d1_22">28</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if3f80771944f4fc58015abda42dc47d1_25">Properties</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#if3f80771944f4fc58015abda42dc47d1_25">28</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if3f80771944f4fc58015abda42dc47d1_28">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#if3f80771944f4fc58015abda42dc47d1_28">28</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if3f80771944f4fc58015abda42dc47d1_31">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#if3f80771944f4fc58015abda42dc47d1_31">29</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if3f80771944f4fc58015abda42dc47d1_34">PART II.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 5.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if3f80771944f4fc58015abda42dc47d1_37">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#if3f80771944f4fc58015abda42dc47d1_37">30</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">[Reserved]</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#if3f80771944f4fc58015abda42dc47d1_40">31</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 7.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if3f80771944f4fc58015abda42dc47d1_43">Management&#8217;s Discussion and Analysis of Financial Condition&#160;and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#if3f80771944f4fc58015abda42dc47d1_43">32</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;7A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if3f80771944f4fc58015abda42dc47d1_46">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#if3f80771944f4fc58015abda42dc47d1_46">49</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 8.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if3f80771944f4fc58015abda42dc47d1_49">Financial Statements and Supplementary Data</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#if3f80771944f4fc58015abda42dc47d1_49">50</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if3f80771944f4fc58015abda42dc47d1_115">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#if3f80771944f4fc58015abda42dc47d1_115">92</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if3f80771944f4fc58015abda42dc47d1_118">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#if3f80771944f4fc58015abda42dc47d1_118">92</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9B.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if3f80771944f4fc58015abda42dc47d1_124">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#if3f80771944f4fc58015abda42dc47d1_124">94</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9C.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if3f80771944f4fc58015abda42dc47d1_127">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</a></span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if3f80771944f4fc58015abda42dc47d1_130">PART III.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 10.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if3f80771944f4fc58015abda42dc47d1_133">Directors, Executive Officers and Corporate Governance</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#if3f80771944f4fc58015abda42dc47d1_133">94</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 11.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if3f80771944f4fc58015abda42dc47d1_136">Executive Compensation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#if3f80771944f4fc58015abda42dc47d1_136">94</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 12.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if3f80771944f4fc58015abda42dc47d1_139">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#if3f80771944f4fc58015abda42dc47d1_139">94</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 13.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if3f80771944f4fc58015abda42dc47d1_142">Certain Relationships and Related Transactions, and Director Independence</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#if3f80771944f4fc58015abda42dc47d1_142">94</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 14.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if3f80771944f4fc58015abda42dc47d1_145">Principal Accountant Fees and Services</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#if3f80771944f4fc58015abda42dc47d1_145">94</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if3f80771944f4fc58015abda42dc47d1_151">PART IV.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 15.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if3f80771944f4fc58015abda42dc47d1_151">Exhibits and Financial Statement Schedules</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#if3f80771944f4fc58015abda42dc47d1_151">96</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 16.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if3f80771944f4fc58015abda42dc47d1_157">Form 10-K Summary</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#if3f80771944f4fc58015abda42dc47d1_160">100</a></span></div></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i</span></div></div></div><div id="if3f80771944f4fc58015abda42dc47d1_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cautionary Note Regarding Forward-Looking Statements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This annual report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements reflect current views about future events and are based on our currently available financial, economic and competitive data and on current business plans. Forward-looking statements can generally be identified by terminology such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;predict,&#8221; &#8220;potential,&#8221; &#8220;continue,&#8221; &#8220;assumption&#8221; or the negative of these terms or other comparable terminology.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forward looking statements in this annual report include statements or inferences we make about:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">anticipated trends in our revenues, operating expenses or capital expenditures, and our financial guidance;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expected future market acceptance for our products or services, and our competitive strengths in the markets we serve;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">potential timing and impact of changes in regulations impacting our business;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">the expected impact of the COVID-19 pandemic on our business, suppliers, payors, customers, referral sources, partners, patients and employees;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">our ability to successfully acquire and integrate new imaging operations; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">economic and costs savings anticipated to be derived from our investment in artificial intelligence and machine learning products and solutions.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forward-looking statements are neither historical facts nor assurances of future performance.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because forward-looking statements relate to the future, they are inherently subject to known and unknown risks, uncertainties and other factors that are difficult to predict and out of our control.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our actual results, levels of activity, performance or achievements may be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Important factors that could cause our actual results to differ materially from those indicated or implied in our forward-looking statements include factors listed in Item 1 &#8212; &#8220;Business,&#8221; Item 1A&#8212; &#8220;Risk Factors,&#8221; Item 3&#8212; &#8220;Legal Proceedings,&#8221; Item 7 &#8212; &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; and elsewhere in this annual report and in other reports that we file with the Securities and Exchange Commission.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any forward-looking statement in this annual report is based on information currently available to us and speaks only as of the date of this report.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not undertake any responsibility to release publicly any revisions to these forward-looking statements to take into account events or circumstances that occur after the date of this annual report or any unanticipated events which may cause actual results to differ from those expressed or implied by the forward-looking statements contained in this annual report, except to the extent required by law.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii</span></div></div></div><div id="if3f80771944f4fc58015abda42dc47d1_13"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div id="if3f80771944f4fc58015abda42dc47d1_16"></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:10.190%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.610%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Business</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Overview</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a leading national provider of diagnostic imaging services in the United States based on number of locations and annual imaging revenue.  We have been in business since 1985.  At December 31, 2022, we operated directly or indirectly through joint ventures with hospitals, 357 centers located in Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York.&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our centers provide physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders and may reduce unnecessary invasive procedures, often reducing the cost and amount of care for patients. Our services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. The vast majority of our centers offer multi-modality imaging services, a key point of differentiation from our competitors. Our multi-modality strategy diversifies revenue streams, reduces exposure to reimbursement changes and provides patients and referring physicians one location to serve the needs of multiple procedures.  Integral to the imaging center business is our software arm headed by eRAD, Inc., which sells computerized systems that distribute, display, store and retrieve digital images. Internationally, our subsidiary Heart and Lung Imaging LLC, provides teleradiology services for remote interpretation of images on behalf of providers within the framework of the United Kingdom's National Health Service.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We seek to develop leading positions in regional markets in order to leverage operational efficiencies. We develop our imaging business through a combination of organic growth and acquisitions. Our scale and density within selected geographies provide close, long-term relationships with key payors, radiology groups and referring physicians. Each of our center-level and regional operations teams is responsible for managing relationships with local physicians and payors, meeting our standards of patient service, and maintaining profitability. We provide training programs, standardized policies and procedures, and sharing of best practices among the physicians in our regional networks.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have also established an Artificial Intelligence (AI) division, that develops and deploys AI suites to enhance radiologist interpretations of breast, lung and prostate images.  The division is led by DeepHealth, and includes our acquisitions of Aidence Holding B.V. and Quantib B.V., both based in The Netherlands.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Available Information</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All reports we file with the Securities and Exchange Commission are available free of charge via EDGAR through the SEC website at</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"> www.sec.gov</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We also maintain a website at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.radnet.com </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">where we make available, free of charge, our annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and all amendments to those reports as soon as reasonably practicable after the material is electronically filed with, or furnished to, the Securities and Exchange Commission. References to our website in this report are provided as a convenience and the information contained on, or otherwise accessible through, the website is not incorporated by reference into, nor does it form a part of this annual report on Form 10-K or any other document that we file with the Securities and Exchange Commission.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Industry Overview</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diagnostic imaging involves the use of non-invasive procedures to generate representations of internal anatomy and function that can be recorded on film or digitized for display on a video monitor. Diagnostic imaging procedures facilitate the early diagnosis and treatment of diseases and disorders and may reduce unnecessary invasive procedures, often minimizing the cost and amount of care for patients. Diagnostic imaging procedures include MRI, CT, PET, nuclear medicine, ultrasound, mammography, X-ray and fluoroscopy.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While X-ray remains the most commonly performed diagnostic imaging procedure, the fastest growing and higher margin procedures are MRI, CT and PET. The rapid growth in PET scans is attributable to the increasing recognition of the efficacy of PET scans in the diagnosis and monitoring of cancer. The number of MRI and CT scans performed annually in the United States continues to grow due to their wider acceptance by physicians and payors, an increasing number of applications for their use and a general increase in demand due to the aging population.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although currently small in scope, AI methods are now being employed to aid radiologists in scan interpretation by quickly allowing comparison to large imaging databases to enable pinpoint diagnosis in shorter time frames.  In addition, AI methods can keep track of individuals needing procedures on a regular basis (i.e. mammograms, follow ups, etc.) and alert our staff to contact the patient and schedule appointments.  </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Diagnostic Imaging Settings</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diagnostic imaging services are typically provided in one of the following settings:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fixed-site, freestanding outpatient diagnostic centers</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These centers range from single-modality to multi-modality centers and are generally not owned by hospitals or clinics. These centers depend upon physician referrals for their patients and generally do not maintain dedicated, contractual relationships with hospitals or clinics. In fact, these centers may compete with hospitals or clinics that have their own imaging systems to provide services to these patients. These centers bill third-party payors, such as managed care organizations, insurance companies, Medicare or Medicaid. All of our wholly owned centers are in this category.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Hospitals</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many hospitals provide both inpatient and outpatient diagnostic imaging services, typically on site or at a dedicated center located on or nearby the hospital campus.  These centers can be owned and operated by the hospital and provide imaging services to inpatients as ordered or outpatients through physician referrals. The hospital normally bills third-party payors such as managed care organizations, insurance companies, Medicare or Medicaid. We have entered into joint ventures with certain hospitals to both provide and manage their diagnostic imaging services, allowing them to leverage our industry expertise.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Mobile Imaging</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While many hospitals own or lease their own equipment, certain hospitals provide diagnostic imaging services by contracting with providers of mobile imaging services. Using specially designed trailers, mobile imaging service providers transport imaging equipment and provide services to hospitals and clinics on a part-time or full-time basis, thus allowing small to mid-size hospitals and clinics that do not have the patient demand to justify fixed on-site access to advanced diagnostic imaging technology. Diagnostic imaging providers contract directly with the hospital or clinic and are typically reimbursed directly by them. We do not provide mobile imaging services.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Diagnostic Imaging Modalities</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The principal diagnostic imaging modalities we use at our centers are:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">MRI</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MRI has become widely accepted as the standard diagnostic tool for a wide and fast-growing variety of clinical applications for soft tissue anatomy, such as those found in the brain, spinal cord, abdomen, heart and interior ligaments of body joints such as the knee. MRI uses a strong magnetic field in conjunction with low energy electromagnetic waves that are processed by a computer to produce high-resolution, three-dimensional, cross-sectional images of body tissue. A typical MRI examination takes from 20 to 45 minutes. MRI systems are designed as either open or closed and have magnetic field strength of 0.2 Tesla to 3.0 Tesla.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CT</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CT provides higher resolution images than conventional X-rays, but generally not as well defined as those produced by MRI. CT uses a computer to direct the movement of an X-ray tube to produce multiple cross-sectional images of a particular organ or area of the body. CT is used to detect tumors and other conditions affecting bones and internal organs. It is also used to detect the occurrence of strokes, hemorrhages and infections. A typical CT examination takes from 15 to 45 minutes.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">PET</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PET scanning involves the administration of a radiopharmaceutical agent with a positron-emitting isotope and the measurement of the distribution of that isotope to create images for diagnostic purposes. PET scans provide the capability to determine how metabolic activity impacts other aspects of physiology in the disease process by correlating the reading for the </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PET with other tools such as CT or MRI. PET technology has been found highly effective and appropriate in certain clinical circumstances for the detection and assessment of tumors throughout the body, the evaluation of some cardiac conditions and the assessment of epilepsy seizure sites. The information provided by PET technology often obviates the need to perform further highly invasive or diagnostic surgical procedures.  In addition, we employ combined PET/CT systems that blend the PET and CT imaging modalities into one scanner. </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nuclear Medicine</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nuclear medicine uses short-lived radioactive isotopes that release small amounts of radiation that can be recorded by a gamma camera and processed by a computer to produce an image of various anatomical structures or to assess the function of various organs such as the heart, kidneys, thyroid and bones. Nuclear medicine is used primarily to study anatomic and metabolic functions. </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">X-ray</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X-rays use roentgen rays to penetrate the body and record images of organs and structures on film. Digital X-ray systems add computer image processing capability to traditional X-ray images, which provides faster transmission of images with a higher resolution and the capability to store images more cost-effectively. </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Ultrasound</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ultrasound imaging uses sound waves and their echoes to visualize and locate internal organs. It is particularly useful in viewing soft tissues that do not X-ray well. Ultrasound is used in pregnancy to avoid X-ray exposure as well as in gynecological, urologic, vascular, cardiac and breast applications. </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Mammography</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mammography is a specialized form of radiology using low dosage X-rays to visualize breast tissue and is the primary screening tool for breast cancer. Mammography procedures and related services assist in the diagnosis of and treatment planning for breast cancer. </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fluoroscopy</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fluoroscopy uses ionizing radiation combined with a video viewing system for real time monitoring of organs.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Industry Trends</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe the diagnostic imaging services industry will continue to grow as a result of a number of factors, including the following:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Escalating Demand for Healthcare Services from an Aging Population</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">According to the United States Census Bureau estimates released in February 2022, the number of US residents age over 65 stands at 55 million, representing 17% of the population, and according to the Pew Research Center, is expected to reach 81 million, or 19% of the total population by 2050.  Because diagnostic imaging use tends to increase as a person ages, we believe the aging population will generate more demand for diagnostic imaging procedures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Greater Consumer Awareness of and Demand for Preventive Diagnostic Screening</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diagnostic imaging, such as elective full-body scans, is increasingly being used as a screening tool for preventive care procedures. Consumer awareness of diagnostic imaging as a less invasive and preventive screening method has added to the growth in diagnostic imaging procedures. We believe that further technological advancements allowing for early diagnosis of diseases and disorders using less invasive procedures will create additional demand for diagnostic imaging.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New Effective Applications for Diagnostic Imaging Technology</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New technological developments are expected to extend the clinical uses of diagnostic imaging technology and increase the number of scans performed. Recent technological advancements include:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:49.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">MRI spectroscopy, which can differentiate malignant from benign lesions;</span></div><div style="padding-left:49.5pt;text-align:justify"><span><br/></span></div><div style="padding-left:49.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">MRI angiography, which can produce three-dimensional images of body parts and assess the status of blood vessels;</span></div><div style="padding-left:49.5pt;text-align:justify"><span><br/></span></div><div style="padding-left:49.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">enhancements in teleradiology systems, which permit the digital transmission of radiological images from one location to another for interpretation by radiologists at remote locations,</span></div><div style="padding-left:49.5pt;text-align:justify"><span><br/></span></div><div style="padding-left:49.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">the development of combined PET/CT and PET/MRI scanners, which combine technologies to create a powerful diagnostic imaging system; and</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:49.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">use of augmented reality technologies make it possible to create three dimensional images that physicians can examine through virtual reality headsets or print using a three dimensional printer.</span></div><div style="padding-left:49.5pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional improvements in imaging technologies, contrast agents and scan capabilities are leading to new non-invasive diagnostic imaging application, including methods of diagnosing blockages in the heart&#8217;s vital coronary arteries, liver metastases, pelvic diseases and vascular abnormalities without exploratory surgery. We believe that the use of the diagnostic capabilities of MRI and other imaging services will continue to increase because they are cost-effective, time-efficient and non-invasive, as compared to alternative procedures, including surgery, and that newer technologies and future technological advancements will further increase the use of imaging services. At the same time, the industry has increasingly used upgrades to existing equipment to expand applications, extend the useful life of existing equipment, improve image quality, reduce image acquisition time and increase the volume of scans that can be performed. We believe the use of equipment upgrades rather than equipment replacements will continue, as we do not foresee new imaging technologies on the near-term horizon that will displace MRI, CT or PET as the principal advanced diagnostic imaging modalities.&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Utilization of Artificial Intelligence</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AI has the potential to significantly change the medical imaging industry.  Current AI applications are focused on comparing images against large databases and flagging areas of concern for the radiologist.  This is expected to result in improved quality, particularly with diseases, injuries, or conditions that are difficult to detect without supplemental technology.  AI can also improve business processes to better effectively serve customers and improve reimbursement and collections accuracy.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Competitive Strengths</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Scale and Position as the Largest Provider of Freestanding, Fixed-site Outpatient Diagnostic Imaging Services in the United States, Based on Number of Centers and Revenue</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As of December 31, 2022, we operated, directly or indirectly through joint ventures with hospitals, 357 centers in Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York.&#160;Our size and scale allow us to achieve operating, sourcing and administrative efficiencies, including equipment and medical supply sourcing savings and favorable maintenance contracts from equipment manufacturers and other suppliers. Our specific knowledge of our geographic markets drives strong relationships with key payors, radiology groups and referring physicians within our markets.&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Comprehensive "Multi-Modality" Diagnostic Imaging Offering</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The vast majority of our centers offer multiple types of imaging procedures, driving strong relationships with referring physicians and payors in our markets and a diversified revenue base. At each of our multi-modality centers, we offer patients and referring physicians one location to serve their needs for multiple procedures. This prevents multiple patient visits or unnecessary travel between locations, thereby increasing patient throughput and decreasing costs and time delays. Our revenue is generated by a broad mix of modalities. We believe our multi-modality strategy lessens our exposure to reimbursement changes in any specific modality.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Competitive Pricing</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business focus, scale, resources and access to technology afford us with certain operating efficiencies.  As such, we believe our fees are generally lower than hospital fees for the services we provide.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Facility Density in Many Highly Populated Areas of the United States</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The strategic organization of our diagnostic imaging centers into regional networks concentrated in major population centers in seven states offers unique benefits to our patients, our referring physicians, our payors and us. We are able to increase the convenience of our services to patients by implementing scheduling systems within geographic regions, where practical. For example, many of our diagnostic imaging centers within a particular region can access the patient appointment calendars of other centers within the same regional network to efficiently allocate time available and to meet a patient's appointment, date, time, or location preferences. The grouping of our centers within regional networks enables us to easily move technologists and other personnel, as well as equipment, from over-utilized to under-utilized centers on an as-needed basis, and drive referrals. Our organization of referral networks results in increased patient throughput, greater operating efficiencies, better equipment utilization rates and improved response time for our patients. We believe our networks of centers and tailored service offerings for geographic areas drive local physician referrals, make us an attractive candidate for selection as a preferred provider by third-party payors and create economies of scale.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Strong Relationships with Payors and Diversified Payor Mix</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue is derived from a diverse mix of payors, including private payors, managed care capitated payors and government payors, which should mitigate our exposure to possible unfavorable reimbursement trends within any one payor class. In addition, our experience with capitation arrangements has provided us with the expertise to manage utilization and pricing effectively, resulting in a predictable and recurring stream of revenue. We believe that third-party payors representing large groups of patients often prefer to enter into managed care contracts with providers that offer a broad array of diagnostic imaging services at convenient locations throughout a geographic area. In 2022, we received approximately 55% of our net service revenue from commercial insurance payors, 11% from managed care capitated payors, 22% from Medicare and 3% from Medicaid.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Strong Relationships with Experienced and Highly Regarded Radiologists</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our contracted radiologists have outstanding credentials, strong relationships with referring physicians, and a broad mix of sub-specialties. The collective experience and expertise of these radiologists translates into more accurate and efficient service to patients.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Experienced and Committed Management Team</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our senior and executive management teams have created our differentiated approach based on their comprehensive understanding of the diagnostic imaging industry and the dynamics of our regional markets. We have a track record of successful acquisitions and integration of acquired businesses into RadNet, and have managed the business through a variety of economic and reimbursement cycles.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Technologically Advanced Operations</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, we created an AI division that now hosts the combined efforts of our acquisitions of DeepHealth, Aidence Holding B.V. and Quantib B.V..</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The division is currently focused on developing improved medical interpretation of scans within the fields of mammography, lung and prostate imaging. Combined with our established eRad subsidiary, which develops and sells computerized imaging data storage and retrieval systems, we have assembled an industry leading team of software developers to create radiology workflow solutions that improve patient care.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Strategy</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Maximize Performance at Our Existing Centers</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We intend to enhance our operations and increase scan volume and revenue at our existing centers by expanding physician relationships and increasing the procedure offerings.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Focus on Profitable Contracting</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We regularly evaluate our contracts with third-party payors, industry vendors and radiology groups, as well as our equipment and real property leases, to determine how we may improve the terms to increase our revenues and reduce our expenses. Because many of our contracts with third party payors are short-term in nature, we can regularly renegotiate these contracts, if necessary. We believe our position as a leading provider of diagnostic imaging services and our long-term </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">relationships with physician groups in our markets enable us to obtain more favorable contract terms than would be available to smaller or less experienced imaging services providers.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Optimize Operating Efficiencies</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We try to maximize our equipment utilization by adding, upgrading and re-deploying equipment where we experience excess demand. We will continue to trim excess operating and general and administrative costs where it is feasible to do so. We may also continue to use, where appropriate, highly trained radiology physician assistants to perform, under appropriate supervision of radiologists, basic services traditionally performed by radiologists. We will continue to upgrade our advanced information technology system to create cost reductions for our centers in areas such as image storage, support personnel and financial management.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Expand Our Networks</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We intend to continue to expand the number of our centers both organically and through targeted acquisitions, using a disciplined approach for evaluating and entering new areas, including consideration of whether we have adequate financial resources to expand. Our current plans are to strengthen our market presence in geographic areas where we currently have existing operations and to expand into neighboring and other areas where we believe we can compete effectively. We perform extensive due diligence before developing a new facility or acquiring an existing facility or entering into a joint venture with a hospital to manage a facility, including surveying local referral sources and radiologists, as well as examining the demographics, reimbursement environment, competitive landscape and intrinsic demand of the geographic market. We generally will only enter new markets where:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">there is sufficient patient demand for outpatient diagnostic imaging services;</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we believe we can gain significant market share;</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we can build key referral relationships or we have already established such relationships; and</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">payors are receptive to our entry into the market.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Expand Our Joint Ventures</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our growth strategy we have entered into joint ventures with hospitals, health systems or radiology practices that were formed for the purpose of owning and operating diagnostic imaging centers. We have created a number of joint ventures in key markets with well-established hospital systems to manage additional centers. We intend to continue to expand in established markets through additional joint ventures, particularly with hospital systems. We believe that these joint ventures strengthen and expand our strength in markets where we are already established.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Services</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We offer a comprehensive set of imaging services including MRI, CT, PET, nuclear medicine, X-ray, ultrasound, mammography, fluoroscopy and other related procedures. We focus on providing standardized high quality imaging services, regardless of location, to ensure patients, physicians and payors consistency in service and quality. To ensure the high quality of our services, we monitor patient satisfaction, timeliness of services to patients and reports to physicians.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The key features of our services include:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">patient-friendly, non-clinical environments;</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">a 24-hour turnaround on routine examinations;</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">interpretations within one to two hours, if needed;</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">flexible patient scheduling, including same-day appointments;</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">extended operating hours, including weekends;</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:54pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">reports delivered by courier, facsimile or email;</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">availability of second opinions and consultations;</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">availability of sub-specialty interpretations at no additional charge; and</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">standardized fee schedules by region.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Radiology Professionals</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the states in which we provide services (except Florida and Arizona), a lay person or any entity other than a professional corporation or similar professional organization is not allowed to practice medicine, including by employing professional persons or by having any ownership interest or profit participation in or control over any medical professional practice. This doctrine is commonly referred to as the prohibition on the &#8220;corporate practice&#8221; of medicine. In order to comply with this prohibition, we contract with medical groups to provide professional medical services in our centers, including the supervision and interpretation of diagnostic imaging procedures. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We contract with a consolidated medical group (the "Group") which consists of professional corporations owned or controlled by individuals within our senior management that provide professional medical services in Arizona, California, Delaware, Maryland, New Jersey and New York.  At locations where the Group does not provide professional medical services, we have entered into long-term contracts with third-party radiology groups in the area to provide physician services at those centers.  These third-party radiology practice groups maintain full control over the provision of professional services, including supervision and interpretation of diagnostic imaging procedures, in our diagnostic imaging centers.  Each medical group maintains control over the physicians it employs, and is responsible for staffing the facility with qualified professional medical personnel.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under management agreements with the Group or other third-party radiology practices, we provide the use of our diagnostic imaging equipment, technical and management services, and administration of the non-medical functions of the professional medical practices at our centers, including the provision of non-medical staff, accounting services, billing and collection, medical and office supplies, transcription services, maintenance of medical records, and marketing. As compensation for the services furnished under management contracts with our medical groups, we receive technical fees for the use of our diagnostic imaging equipment and technical services and an agreed percentage of the medical practice billings for, or collections from, services provided at our centers. The medical groups retain the professional reimbursements associated with imaging procedures after deducting management service fees paid to us.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, we perform certain management services for a portion of the professional groups with whom we contract who provide professional radiology services at local hospitals. For performing these management services, which include billing, collecting, transcription and medical coding, we receive management fees, that depending on the agreement are calculated at a fixed or variable rate.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Payors</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fees charged for diagnostic imaging services performed at our centers are paid by a diverse mix of payors, as illustrated for the following periods presented in the table below:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% of Net Service Fee Revenue</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial Insurance </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1)</span></div></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Managed Care Capitated Payors</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Includes co-payments, direct patient payments and payments through contracts with physician groups and other non-insurance company payors.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commercial Insurance</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Generally, insurance companies reimburse us, directly or indirectly, including through the Group or through the contracted radiology groups, on the basis of agreed upon rates. These rates are negotiated and may differ materially with rates set forth in the Medicare Physician Fee Schedule for the particular service. The patients may be responsible for certain co-payments or deductibles.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Managed Care Capitation Agreements</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under these agreements that are generally between the medical groups and the payor (which in most cases are large medical groups or Independent Practice Associations), the payor pays a pre-determined amount per-member per-month in exchange for the radiology group providing all necessary covered services to the managed care members included in the agreement. These contracts pass much of the financial risk of providing outpatient diagnostic imaging services, including the risk of over-use, from the payor to the radiology practice group and, as a result of our management agreement with the radiology practice group, to us.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that through our comprehensive utilization management, or UM, program we have become highly skilled at assessing and moderating the risks associated with the capitation agreements, so that these agreements are profitable for us. Our UM program is managed by our UM department, which consists of staff who are actively involved with the referring physicians and payor management in both prospective and retrospective review programs. Our UM program includes features such as physician education combined with peer review procedures which are designed to manage our costs while ensuring that patients receive appropriate care.</span></div><div style="text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medicare/Medicaid</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medicare is the federal health insurance program for people age 65 or older and people under age 65 with certain disabilities. Medicaid, funded by both the federal government and states, is a state-administered health insurance program for qualifying low-income and medically needy persons. For services for which we bill Medicare directly or indirectly, including through contracted radiologists, we are paid under the Medicare Physician Fee Schedule. Under the Protecting Access to Medicare Act of 2014, Congress introduced a new quality incentive program that, effective January 1, 2016, reduces Medicare payments for certain CT services reimbursed through the Medicare Physician Fee Schedule that are furnished using equipment that does not meet certain dose optimization and management standards. Medicare patients usually pay a 20% co-payment unless they have secondary insurance. Medicaid rates are set by the individual states for each state program and Medicaid patients may be responsible for a modest co-payment.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contracts with Physician Groups and Other Non-Insurance Company Payors</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For some of our contracts with physician groups and other providers, we do not bill payors, but instead accept agreed upon rates for our radiology services. These rates are typically at or below the rates set forth in the current Medicare Fee Schedule for the particular service. However, we often agree to a specified rate for MRI and CT procedures that is not tied to the Medicare Fee Schedule.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Imaging Centers</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our centers are primarily located in geographic networks that we refer to as regions. The majority of our centers are multi-modality sites, offering various combinations of MRI, CT, PET, nuclear medicine, ultrasound, X-ray, fluoroscopy services and other related procedures. A portion of our centers are single-modality sites, offering either X-ray or MRI services. Consistent with our regional network strategy, we locate our single-modality centers near multi-modality centers, to help accommodate overflow in targeted demographic areas.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the number of our centers operated directly or managed through joint ventures for each year during the five-year period ended December 31, 2022:</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:46.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.713%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total centers owned or managed (at beginning of the year)</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">344&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Centers added by:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internal development</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Centers closed or sold</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total centers owned or managed (at year end)</span></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">344&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Diagnostic Imaging Equipment</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table indicates, as of December 31, 2022, the quantity of principal diagnostic equipment available at our centers operated directly or through joint venture investments:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.543%"><tr><td style="width:1.0%"></td><td style="width:58.931%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.696%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.589%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.696%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.589%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.699%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment Count</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MRI</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CT</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PET/CT</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mammography</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">387&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">358&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ultrasound</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">818&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">760&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">689&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X-ray</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">415&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nuclear Medicine</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fluoroscopy</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equipment</span></td><td colspan="2" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,433</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,276</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,089</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The average age of our MRI and CT units is less than five years, and the average age of our PET units is less than four years. The useful life of our MRI, CT and PET units is typically ten years.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Facility Acquisitions</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding our facility acquisitions can be found within Item 7 - &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221;, as well as Note 4 to our consolidated financial statements included in this annual report on Form 10-K.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Information Technology</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our corporate headquarters and many of our centers are interconnected through a state-of-the-art information technology system. This system, which is compliant with the Health Insurance Portability and Accountability Act of 1996, is comprised of a number of integrated applications and provides a single operating platform for billing and collections, electronic medical records, practice management and image management.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This technology has created cost reductions for our centers in areas such as image storage, support personnel and financial management and has further allowed us to optimize the productivity of all aspects of our business by enabling us to:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">capture patient demographic, history and billing information at point-of-service;</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">automatically generate bills and electronically file claims with third-party payors;</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">record and store diagnostic report images in digital format;</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">digitally transmit in real-time diagnostic images from one location to another, thus enabling networked radiologists to cover larger geographic markets by using the specialized training of other networked radiologists;</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">perform claims, rejection and collection analysis; and</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">perform sophisticated financial analysis, such as analyzing cost and profitability, volume, charges, current activity and patient case mix, with respect to each of our managed care contracts.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have developed our own Radiology Information System through our team of software development engineers, which is used as our front desk patient tracking system.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Human Capital Management Strategy</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The primary goal of our talent management strategy is to attract and retain engaged, talented, and diverse team members to establish RadNet as the employer of choice. We seek to drive performance by enabling effective leadership that results in a positive patient experience delivered by talented and engaged team members. To achieve this, leaders across the enterprise partner to develop and deliver talent and culture programs, create total rewards strategies, and provide efficient and effective people operations.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">We believe the strength of our workforce is critical to the success of our mission to provide comprehensive radiology solutions and change the future of healthcare. We invest in our employees to ensure their confidence and competence in their roles, as well as to provide a path for professional career development. We value an ethical culture where diversity is embraced, good health and safety are promoted, and employees are empowered to share their ideas and opinions. We strive to care for our team members and are concerned about their total well-being.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Headcount and Labor Representation.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">At December 31, 2022, we had a total of 6,946 full-time, 509 part-time and 1,612 per diem employees, including those employed by the Group. These numbers include 221 full-time and 78 part-time physicians and 2,251 full-time, 353 part-time and 1,083 per-diem technologists.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Diversity, Equity, Inclusion, &amp; Belonging.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">We are committed to creating an inclusive work environment where team members can be their best and authentic selves. With diversity comes a plethora of different perspectives and these different perspectives breed innovative ideas that enable us to lead radiology forward. Our relationship with Jobs.Vision.Success SoCal, a nonprofit, non-sectarian social service agency, is one example of our support and sponsorship of community outreach and enrichment programs for underserved populations. As a foundational practice, all employees are required to complete cultural competence training annually.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Employee Listening. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">We believe in ensuring every team member feels valued, seen, and heard; therefore, we have various avenues for all to share ideas and provide feedback. Piloting initiatives such as the Connections Roadshow and new employee listening platforms enabled senior leaders to hear from team members at all levels of the organization to gain insights on various topics including quality, engagement, innovation, customer service, patient focus, diversity, equity, inclusion, and belonging. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Total Well-being.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">We subscribe to the belief that if we take care of our people, they will in turn, take care of our patients. Prioritizing and promoting wellness allows our team members to be their best selves at work and at home. Concerning ourselves with the physical, mental, emotional, and social well-being of each team member enables us to attract and retain top talent. Beyond fair and equitable pay, we offer a wide range of benefit plan options that include, but are not limited to, medical insurance, health savings accounts, family support services, nutrition and exercise programs, and financial education. We evaluate our total well-being packages regularly to remain competitive, align with legislative changes, and respond to the needs of our team members. Based on survey feedback, we recently replaced our wellness platform and introduced Navigate Wellness to better address what our team members care about most. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Talent Development.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Equipping our people to perform excellently is one of our top priorities. With companies across the country facing unprecedented, post-pandemic labor shortages, attrition, and turnover, we are doubling down on our People and Culture initiatives. We have established a Talent &amp; Culture Center of Expertise to focus on the employee experience from beginning to end. With a heightened focus on upskilling our existing workforce, our investment in new training and development platforms and piloting a coaching capabilities builder program for our leaders, we are promoting timely and effective feedback that fosters trust, respect, teamwork, growth, and excellence. Furthermore, our tuition reimbursement program encourages team members at all levels of the enterprise to seek additional skills.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sales and Marketing</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our sales and marketing team employs a multi-pronged approach to marketing, including physician, payor and sports marketing programs, each of which are described below:</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Physician Marketing</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each customer service representative on our physician marketing team is responsible for marketing activity on behalf of one or more centers. The representatives act as a liaison between the facility and referring physicians, holding meetings periodically and on an as-needed basis with them and their staff to present educational programs on new applications and uses of our systems and to address particular patient service issues that have arisen. In our experience, consistent hands-on contact with a referring physician and his or her staff generates goodwill and increases referrals to our centers. The representatives also continually seek to establish referral relationships with new physicians and physician groups. In addition to a base salary, each representative receives a bonus based upon success.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Payor Marketing</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our marketing team regularly meets with managed care organizations and insurance companies to solicit contracts and meet with existing contracting payors to solidify those relationships. The comprehensiveness of our services, the geographic location of our centers and the reputation of the physicians with whom we contract all serve as tools for obtaining new or repeat business from payors.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sports Marketing Program</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our west coast operations renders in stadium digital X-ray for the following organizations: Los Angeles Clippers, Dodgers, Kings and Lakers. In exchange, we receive season tickets and parking.  Contract lengths vary from yearly up to five years. We also provide radiology services at select imaging centers for the Anaheim Ducks, Los Angeles Angels, Los Angeles  Rams, Oakland Athletics, San Francisco 49ers and student athletes of the University of Southern California.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through our east coast operations, we have entered into sponsorship agreements with the Baltimore Ravens of the National Football League and the Baltimore Orioles of Major League Baseball which permit us to state we are the imaging partner to each organization. Both agreements last through 2023.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Suppliers</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We acquire our major diagnostic imaging equipment directly from original equipment manufacturers or through third party financing companies and purchase medical supplies from various national vendors.  Our diagnostic imaging equipment represents a cornerstone investment of the company as it provides our customers the latest in imaging technology.  We employ direct purchase or finance arrangements to accomplish our needs with such firms as GE, Hologic, Key Equipment, Philips, Siemens and Spectrum.  We have excellent working relationships with our providers who are of comparable stature in the event one becomes unavailable.  At December 31, 2022, our liabilities for operating arrangements of radiology equipment amounted to approximately $13.7 million.  If we open or acquire additional imaging centers, we may incur material equipment lease obligations.  See Note 9, Leases, to our consolidated financial statements included in this annual report on Form 10-K for further information.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Timely and effective maintenance is essential for achieving high utilization rates of our imaging equipment.  In order to ensure operational efficiency, we have maintenance arrangements with&#160;the various service arms of the original equipment manufacturers that supply our imaging equipment.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Competition</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our competitors include independent imaging operators and smaller regional operators, as well as hospitals and hospital groups that operate their own imaging services.  In addition, some physician practices have established their own diagnostic imaging centers within their group practices. </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We compete principally on the basis of our reputation, our ability to provide multiple modalities at many of our centers, the location of our centers, the quality of our diagnostic imaging services and technologists and our ability to establish and maintain relationships with healthcare providers and referring physicians. See &#8220;Competitive Strengths&#8221; above. Some of our competitors may now or in the future have access to greater financial resources than we do, which could allow them to establish more centers and provide access to newer, more advanced equipment.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of the Group and our third party contracted radiology practices has entered into agreements with its physician shareholders and full-time employed radiologists that generally prohibit those shareholders and radiologists from competing for </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a period of two to five years within defined geographic regions after they cease to be owners or employees, as applicable. In certain states, like California, a covenant not to compete is enforced in limited circumstances involving the sale of a business. In other states, a covenant not to compete will be enforced only:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">to the extent it is necessary to protect a legitimate business interest of the party seeking enforcement;</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">if it does not unreasonably restrain the party against whom enforcement is sought; and</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">if it is not contrary to public interest.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Enforceability of a non-compete covenant is determined by a court based on all of the facts and circumstances of the specific case at the time enforcement is sought. For this reason, it is not possible to predict whether or to what extent a court will enforce the contracted radiology practices&#8217; covenants. The inability of the contracted radiology practices or us to enforce a radiologist&#8217;s non-compete covenants could result in increased competition from individuals who are knowledgeable about our business strategies and operations.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liability Insurance</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain insurance policies with coverage we believe is appropriate in light of the risks attendant to our business and consistent with industry practice. We maintain general liability insurance and professional liability insurance in commercially reasonable amounts. Additionally, we maintain workers&#8217; compensation insurance on all of our employees. Coverage is placed on a statutory basis and corresponds to individual state&#8217;s requirements. However, adequate liability insurance may not be available to us in the future at acceptable costs or at all. In addition, insurers from which we purchase such insurance may experience financial hardship which would impact their ability to pay covered policyholder claims.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to our agreements with physician groups with whom we contract, including the Group, each must maintain medical malpractice insurance for each physician in the group, having coverage limits of not less than $1.0 million per incident and $3.0 million in the aggregate per year.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">California&#8217;s medical malpractice cap further reduces our exposure. California places a $250,000 limit on non-economic damages for medical malpractice cases. Non-economic damages are defined as compensation for pain, suffering, inconvenience, physical impairment, disfigurement and other non-pecuniary injury. The cap applies whether the case is for injury or death, and it allows only one $250,000 recovery in a wrongful death case. No cap applies to economic damages. Other states in which we now operate do not have similar limitations and in those states we believe our insurance coverage to be sufficient.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Regulation</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The healthcare industry is highly regulated, and changes in the regulatory environment could significantly affect our operations in the future. Our ability to operate profitably will depend in part upon us, and the contracted radiology practices and their affiliated physicians, obtaining and maintaining all necessary licenses and other approvals, and operating in compliance with applicable healthcare regulations. We believe that healthcare regulations will continue to change. Therefore, we monitor developments in healthcare law and modify our operations from time to time as the business and regulatory environment changes.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Facilities Licensing and Certification Laws</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ownership, construction, operation, expansion and acquisition of diagnostic imaging centers are subject to various federal and state laws, regulations and approvals concerning licensing of centers and personnel. In addition, free-standing diagnostic imaging centers that provide services not performed as part of a physician's office must meet Medicare requirements to be certified as an independent diagnostic testing facility before it can be authorized to bill the Medicare program. </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Corporate Practice of Medicine</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the states in which we operate, other than Florida and Arizona, a lay person or any entity other than a professional corporation or other similar professional organization is not allowed to practice medicine, including by employing professional persons or by having any ownership interest or profit participation in or control over any medical professional practice. The </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">laws of such states also prohibit a lay person or a non-professional entity from exercising control over the medical judgments or decisions of physicians and from engaging in certain financial arrangements, such as splitting professional fees with physicians. We structure our relationships with the radiology practices, including the purchase of diagnostic imaging centers, in a manner that we believe keeps us from engaging in the practice of medicine, exercising control over the medical judgments or decisions of the radiology practices or their physicians, or violating the prohibitions against fee-splitting.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medicare and Medicaid Fraud and Abuse &#8211; Federal Anti-kickback Statute</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2022, approximately 22% of our net service revenue generated at our diagnostic imaging centers was derived from federal government sponsored healthcare programs (Medicare) and 3% from state sponsored programs (Medicaid).</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal law known as the Anti-kickback Statute prohibits the knowing and willful offer, payment, solicitation or receipt of any form of remuneration in return for, or to induce, (i) the referral of a person, (ii) the furnishing or arranging for the furnishing of items or services reimbursable under the Medicare, Medicaid or other governmental programs or (iii) the purchase, lease or order or arranging or recommending purchasing, leasing or ordering of any item or service reimbursable under the Medicare, Medicaid or other governmental programs. Noncompliance with the federal Anti-kickback Statute can result in exclusion from the Medicare, Medicaid or other governmental programs and civil and criminal penalties.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Anti-kickback Statute is broad, and it prohibits many arrangements and practices that are lawful in businesses outside of the healthcare industry. To create better clarity, the Office of the Inspector General of the U.S. Department of Health and Human Services (OIG) has issued regulations as "safe harbor" guidelines which if met in form and substance, will assure healthcare providers that they will not be prosecuted for violation of the Anti&#8211;kickback Statute.  The OIG issued a final rule on November 20, 2020, as part of the Regulatory Sprint to Coordinated Care initiative by the U.S. Department of Health and Human Services that, among other things, established new "safe harbors" under the Anti-kickback Statute for certain value-based compensation arrangements.  Although full compliance with these provisions ensures against prosecution under the federal Anti-kickback Statute, the failure of a transaction or arrangement to fit within a specific safe harbor does not necessarily mean that the transaction or arrangement is illegal or that prosecution under the federal Anti-kickback Statute will be pursued.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although some of our arrangements may not fall within a safe harbor, we believe that such business arrangements do not violate the Anti-kickback Statute because we are careful to structure them to reflect fair value and ensure that the reasons underlying our decision to enter into a business arrangement comport with reasonable interpretations of the Anti-kickback Statute. However, even though we continuously strive to comply with the requirements of the Anti-kickback Statute, liability under the Anti-kickback Statute may still arise because of the intentions or actions of the parties with whom we do business. While we are not aware of any such intentions or actions, we have only limited knowledge regarding the intentions or actions underlying those arrangements. Conduct and business arrangements that do not fully satisfy one of these safe harbor provisions may result in increased scrutiny by government enforcement authorities such as the Office of the Inspector General.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medicare and Medicaid Fraud and Abuse &#8211; Stark Law</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Ethics in Patient Referral Act of 1989, commonly known as the Stark Law, prohibits a physician from referring Medicare patients to an entity providing designated health services in which the physician (or immediate family member) has an ownership or investment interest or with which the physician (or immediate family member) has entered into a compensation arrangement. The Stark Law also prohibits the entity from billing for any such prohibited referral. The penalties for violating the Stark Law include a prohibition on payment by these governmental programs and civil penalties of as much as $15,000 for each violation referral and $100,000 for participation in a circumvention scheme. The regulations governing the Stark Law were also recently amended as part of the Regulatory Sprint to Coordinated Care initiative.  These new regulations, which among other things establish new exceptions for value-based arrangements, were published by the Centers for Medicare &amp; Medicaid Services (CMS) on November 20, 2020.  We believe that, although we receive fees under our service agreements for management and administrative services, we are not in a position to make or influence referrals of patients.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Stark Law, radiology and certain other imaging services and radiation therapy services and supplies are services included in the designated health services subject to the self-referral prohibition. Such services include the professional and technical components of any diagnostic test or procedure using X-rays, ultrasound or other imaging services, CT, MRI, radiation therapy and diagnostic mammography services (but not screening mammography services). PET and nuclear medicine procedures are also included as designated health services under the Stark Law. The Stark Law, however, excludes from designated health services: (i) X-ray, fluoroscopy or ultrasound procedures that require the insertion of a needle, catheter, tube or probe through the skin or into a body orifice; (ii) radiology procedures that are integral to the performance of, and performed </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">during, non-radiological medical procedures; and (iii) invasive or interventional radiology, because the radiology services in these procedures are merely incidental or secondary to another procedure that the physician has ordered.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Stark Law provides that a request by a radiologist for diagnostic radiology services or a request by a radiation oncologist for radiation therapy, if such services are furnished by or under the supervision of such radiologist or radiation oncologist pursuant to a consultation requested by another physician, does not constitute a referral by a referring physician. If such requirements are met, the Stark Law self-referral prohibition would not apply to such services. The effect of the Stark Law on the radiology practices, therefore, will depend on the precise scope of services furnished by each such practice&#8217;s radiologists and whether such services derive from consultations or are self-generated.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that, other than self-referred patients, all of the services covered by the Stark Law provided by the contracted radiology practices derive from requests for consultation by non-affiliated physicians. Therefore, we believe that the Stark Law is not implicated by the financial relationships between our operations and the contracted radiology practices. In addition, we believe that we have structured our acquisitions of the assets of existing practices, and we intend to structure any future acquisitions, so as not to violate the Anti-kickback Statute, Stark Law and the regulations related to these laws. Specifically, we believe the consideration paid by us to physicians to acquire the tangible and intangible assets associated with their practices is consistent with fair value in arms&#8217; length transactions and is not intended to induce the referral of patients or other business generated by such physicians. Should any such practice be deemed to constitute an arrangement designed to induce the referral of Medicare or Medicaid patients, then our acquisitions could be viewed as possibly violating anti-kickback and anti-referral laws and regulations. A determination of liability under any such laws could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medicare and Medicaid Fraud and Abuse &#8211; General</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The federal government embarked on an initiative to audit all Medicare carriers, which are the companies that adjudicate and pay Medicare claims. These audits are expected to intensify governmental scrutiny of individual providers. An unsatisfactory audit of any of our diagnostic imaging centers or contracted radiology practices could result in any or all of the following: significant repayment obligations, exclusion from Medicare, Medicaid or other governmental programs, and civil and criminal penalties.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal regulatory and law enforcement authorities have increased enforcement activities with respect to Medicare and Medicaid fraud and abuse regulations and other reimbursement laws and rules, including laws and regulations that govern our activities and the activities of the radiology practices. The federal government also has increased funding to fight healthcare fraud and is coordinating its enforcement efforts among various agencies, such as the U.S. Department of Justice, the U.S. Department of Health and Human Services Office of Inspector General, and state Medicaid fraud control units. The government may investigate our or the radiology practices&#8217; activities, claims may be made against us or the radiology practices and these increased enforcement activities may directly or indirectly have an adverse effect on our business, financial condition and results of operations.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">State Anti-kickback and Physician Self-referral Laws</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many states have adopted laws similar to the federal Anti-kickback Statute and the Stark Law. Some of these state prohibitions apply to services and the referral of patients for healthcare services reimbursed by any source, not only the Medicare and Medicaid programs. Although we believe that we comply with both federal and state anti-kickback laws and self-referral laws, any finding of a violation of these laws could subject us to criminal and civil penalties or possible exclusion from federal or state healthcare programs. Such penalties would adversely affect our financial performance and our ability to operate our business.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Federal False Claims Act</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The federal False Claims Act provides, in part, that the federal government may bring a lawsuit against any person who it believes has knowingly presented, or caused to be presented, a false or fraudulent request for payment from the federal government, or who has made a false statement or used a false record to get a claim approved. The federal False Claims Act further provides that a lawsuit thereunder may be initiated in the name of the United States by an individual, a &#8220;whistleblower,&#8221; who is an original source of the allegations. The government has taken the position that claims presented in violation of the federal Anti-kickback Statute or Stark Law may be considered a violation of the federal False Claims Act. Penalties include civil penalties of not less than $5,500 and not more than $11,000 for each false claim, plus three times the amount of damages that the federal government sustained because of the act of that person.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, states are being encouraged to adopt false claims acts similar to the federal False Claims Act, which establish liability for submission of fraudulent claims to the State Medicaid program and contain whistleblower provisions. Even in instances when a whistleblower action is dismissed with no judgment or settlement, we may incur substantial legal fees and other costs relating to an investigation. Future actions under the False Claims Act may result in significant fines and legal fees, which would adversely affect our financial performance and our ability to operate our business.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that we are in compliance with the rules and regulations that apply to the federal False Claims Act as well as its state counterparts.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Healthcare Reform Legislation</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Healthcare reform legislation enacted in the first quarter of 2010 by the Patient Protection and Affordable Care Act or PPACA, specifically requires the U.S. Department of Health and Human Services, in computing physician practice expense relative value units, to increase the equipment utilization factor for advanced diagnostic imaging services (such as MRI, CT and PET) from a presumed utilization rate of 50% to 65% for 2010 through 2012, 70% in 2013, and 75% thereafter. Excluded from the adjustment is low-technology imaging modalities such as ultrasound, X-ray and fluoroscopy. The Health Care and Education Reconciliation Act of 2010 (H.R. 4872), or Reconciliation Act, which was passed by the Senate and approved by the President on March 30, 2010, amends the provision for higher presumed utilization of advanced diagnostic imaging services to a presumed rate of 75%. The higher utilization rate was fully implemented in the beginning of 2011 and replaced the phase-in approach provided in the PPACA. This utilization rate was further increased to 90% by the American Taxpayer Relief Act of 2012, effective as of January 1, 2014.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aim of increased utilization of diagnostic imaging services is to spread the cost of the equipment and services over a greater number of scans, resulting in a lower cost per scan. These changes have precipitated reductions in federal reimbursement for medical imaging and have resulted in decreased revenue for the scans we perform for Medicare beneficiaries. Other changes in reimbursement for services rendered by Medicare Advantage plans may also reduce the revenues we receive for services rendered to Medicare Advantage enrollees.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 22, 2017, President Trump signed into law the Tax Cuts and Jobs Act (the &#8220;Tax Act&#8221;). Among numerous changes to the tax code, the Tax Act repealed the individual mandate tax penalty (the &#8220;Individual Mandate&#8221;), a PPACA provision that required individuals to pay additional taxes if he or she was uninsured during the year.  Repeal of the Individual Mandate may lead to more people being uninsured, and could raise premium rates for insured persons. Such a development could affect reimbursement, coverage, and utilization of diagnostic imaging services in ways that are currently unpredictable.  Other changes to the PPACA (whether through legislation or judicial action), including further rollbacks of the PPACA being sought by congressional and state members of the Republican Party, or expansion of the PPACA (including, but not limited to, the development of a "public option" that would compete with private insurers to offer coverage to both individuals and those with employer sponsored insurance) being sought by the Biden Administration, could have similarly unpredictable effects.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Insurance Portability and Accountability Act of 1996</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Congress enacted the Health Insurance Portability and Accountability Act of 1996, or HIPAA, in part, to combat healthcare fraud and to protect the privacy and security of patients&#8217; individually identifiable healthcare information. &#160;HIPAA, among other things, amends existing crimes and criminal penalties for Medicare fraud and enacts new federal healthcare fraud crimes, including actions affecting non-government healthcare benefit programs. Under HIPAA, a healthcare benefit program includes any private plan or contract affecting interstate commerce under which any medical benefit, item or service is provided. A person or entity that knowingly and willfully obtains the money or property of any healthcare benefit program by means of false or fraudulent representations in connection with the delivery of healthcare services is subject to a fine or imprisonment, or potentially both. In addition, HIPAA authorizes the imposition of civil money penalties against entities that employ or enter into contracts with excluded Medicare or Medicaid program participants if such entities provide services to federal health program beneficiaries. A finding of liability under HIPAA could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, HIPAA requires healthcare providers and their business associates to maintain the privacy and security of individually identifiable protected health information (&#8220;PHI&#8221;). HIPAA imposes federal standards for electronic transactions, for the security of electronic health information and for protecting the privacy of PHI. The Health Information Technology for Economic and Clinical Health Act of 2009 (&#8220;HITECH&#8221;), signed into law on February 17, 2009, dramatically expanded, among other things, (1) the scope of HIPAA to now apply directly to &#8220;business associates,&#8221; or independent contractors who receive or obtain PHI in connection with providing a service to a covered entity, (2) substantive security and privacy obligations, </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">including new federal security breach notification requirements to affected individuals, DHHS and prominent media outlets, of certain breaches of unsecured PHI, (3) restrictions on marketing communications and a prohibition on covered entities or business associates from receiving remuneration in exchange for PHI, and (4) the civil and criminal penalties that may be imposed for HIPAA violations, increasing the annual cap in penalties from $25,000 to $1.5 million per year.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, many states have enacted comparable privacy and security statutes or regulations that, in some cases, are more stringent than HIPAA requirements. In those cases it may be necessary to modify our operations and procedures to comply with the more stringent state laws, which may entail significant and costly changes for us. We believe that we are in compliance with such state laws and regulations. However, if we fail to comply with applicable state laws and regulations, we could be subject to additional sanctions.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that we are in compliance with the current HIPAA requirements, as amended by HITECH, and comparable state laws, but we anticipate that we may encounter certain costs associated with future compliance. Moreover, we cannot guarantee that enforcement agencies or courts will not make interpretations of the HIPAA standards that are inconsistent with ours, or the interpretations of our contracted radiology practices or their affiliated physicians. A finding of liability under the HIPAA standards may result in significant criminal and civil penalties. Noncompliance also may result in exclusion from participation in government programs, including Medicare and Medicaid. These actions could have a material adverse effect on our business, financial condition, and results of operations.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">U.S. Food and Drug Administration or FDA</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA has issued the requisite pre-market approval for all of the MRI and CT systems we use.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our mammography systems are regulated by the FDA pursuant to the Mammography Quality Standards Act of 1992, as amended by the Mammography Quality Standards Reauthorization Acts of 1998 and 2004 (collectively, the &#8220;MQSA&#8221;). All mammography centers are required to meet the applicable MQSA requirements, including quality standards, be accredited by an approved accreditation body or state agency and certified by the FDA or an FDA-approved certifying state agency. Pursuant to the accreditation process, each facility providing mammography services must comply with certain standards that include, among other things, annual inspection of the facility's equipment, personnel (interpreting physicians, technologists and medical physicists) and practices.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compliance with these MQSA requirements and standards is required to obtain Medicare payment for services provided to beneficiaries and to avoid various sanctions, including monetary penalties, or suspension of certification. Although the Mammography Accreditation Program of the American College of Radiology is an approved accreditation body and currently accredits all of our centers which provide mammography services, and although we anticipate continuing to meet the requirements for accreditation, if we lose such accreditation, the FDA could revoke our certification. Congress has extended Medicare benefits to include coverage of screening mammography but coverage is subject to the facility performing the mammography meeting prescribed quality standards described above. The Medicare requirements to meet the standards apply to diagnostic mammography and image quality examination as well as screening mammography.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Radiologist Licensing</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The radiologists providing professional medical services at our centers are subject to licensing and related regulations by the states in which they provide services. As a result, we require the radiology groups with which we contract to require those radiologists to have and maintain appropriate licensure. We do not believe that such laws and regulations will either prohibit or require licensure approval of our business operations, although no assurances can be made that such laws and regulations will not be interpreted to extend such prohibitions or requirements to our operations.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Insurance Laws and Regulation</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">States in which we operate have adopted certain laws and regulations affecting risk assumption in the healthcare industry, including those that subject any physician or physician network engaged in risk-based managed care to comply with applicable insurance laws and regulations. These laws and regulations may require physicians and physician networks to meet minimum capital requirements and other safety and soundness requirements. Implementing additional regulations or compliance requirements could result in substantial costs to the contracted radiology practices, limiting their ability to enter into capitated or other risk-sharing managed care arrangements and indirectly affecting our revenue from the contracted practices.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">U.S. Federal Budget</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We derive a substantial portion of our revenue from direct billings to governmental healthcare programs, such as Medicare and Medicaid, and private health insurance companies and/or health plans, including but not limited to those participating in the Medicare Advantage program. As a result, any negative changes in governmental capitation or fee-for-service rates or methods of reimbursement for the services we provide could have a significant adverse impact on our revenue and financial results.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because governmental healthcare programs generally reimburse on a fee schedule basis rather than on a charge-related basis, we generally cannot increase our revenues from these programs by increasing the amount of charges for services. Moreover, if our costs increase, we may not be able to recover our increased costs from these programs. Government and private payors have taken and may continue to take steps to control the cost, eligibility for, use, and delivery of healthcare services as a result of budgetary constraints, cost containment pressures and other reasons. We believe that these trends in cost containment will continue. These cost containment measures, and other market changes in non-governmental insurance plans have generally restricted our ability to recover, or shift to non-governmental payors, any increased costs that we experience. Our integrated care business and financial operations may be materially affected by these developments.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Environmental Matters</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The facilities we operate or manage generate hazardous and medical waste subject to federal and state requirements regarding handling and disposal. We believe that the facilities that we operate and manage are currently in compliance in all material respects with applicable federal, state and local statutes and ordinances regulating the handling and disposal of such materials. We do not believe that we will be required to expend any material additional amounts in order to remain in compliance with these laws and regulations or that compliance will materially affect our capital expenditures, earnings or competitive position.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compliance Program</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain a program to monitor compliance with federal and state laws and regulations applicable to healthcare entities. We have a compliance officer who is charged with implementing and supervising our compliance program, which includes the adoption of (i) Standards of Conduct for our employees and affiliates and (ii) a process that specifies how employees, affiliates and others may report regulatory or ethical concerns to our compliance officer. We believe that our compliance program meets the relevant standards provided by the Office of Inspector General of the Department of Health and Human Services.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An important part of our compliance program consists of conducting periodic audits of various aspects of our operations and that of the contracted radiology practices. We also conduct mandatory educational programs designed to familiarize our employees with the regulatory requirements and specific elements of our compliance program.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="if3f80771944f4fc58015abda42dc47d1_19"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Risk Factors</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General Economic and Industry Risks </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Adverse changes in general domestic and worldwide economic conditions could adversely affect our operating results, financial condition, and liquidity.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We are subject to risk arising from adverse changes in general domestic and global economic conditions, including recession or economic slowdown and disruption of credit markets. Concerns about the systemic impact of potential long-term and wide-spread recession, inflation, energy costs, geopolitical issues, the availability and cost of credit have contributed to increased market volatility and diminished expectations for near-term growth in the United States and many global economies. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Continued turbulence in domestic and international markets and economies may adversely affect our liquidity and financial condition, and the liquidity and financial condition of our patients.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Patients may transition work, leaving insurance programs, or defer non-emergency procedures which could reduce overall demand for our services.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">A decline in global economic conditions could also have a significant impact on the financial condition and operations of our third party payors, contracting radiology groups, equipment manufacturers and other suppliers. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">A downturn in the economic environment can also lead to increased risk of collection on our accounts receivable and impairment of goodwill, possible reductions in liquidity, as well as the risk of failure of derivative counterparties and other </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">financial institutions. These and other economic factors can materially adversely affect our business, results of operations, financial condition and stock price.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Increasing interest rates or disruption of credit markets could adversely affect our financial condition and liquidity.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In response to recent macroeconomic concerns, the United States and other western countries have implemented monetary policies focused on suppressing inflation, including increasing interest rates.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We operate in an industry that requires significant amounts of capital to fund operations, particularly the initial start-up and development expenses of new diagnostic imaging centers and the acquisition of additional centers and new diagnostic imaging equipment.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">To meet these capital requirements we have incurred various indebtedness including senior secured credit facilities and equipment leases.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Most of our indebtedness is borrowed under terms with variable interest rates.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We have purchased, and may in the future purchase, forward swaps or other derivative instruments designed to hedge the risk of changes in interest rates.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The use of such hedging activities may not be effective to offset any, or more than a portion, of the adverse financial effects of unfavorable movements in interest rates over the limited time the hedges are in place.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If these market conditions continue, we may experience increased expenses associated with borrowing and resulting decreases in profitability.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Moreover, continued disruption in credit markets could render it more difficult for us to timely replacing maturing liabilities or to expand credit facilities, which would adversely affect our liquidity and financial condition.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">We face various risks related to health epidemics and other outbreaks, which may have a material adverse effect on our business, financial condition, results of operations and cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We face various risks related to health epidemics and other outbreaks, including the global outbreak of COVID-19 (including the virus' variants that have emerged and could emerge in the future):</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Restrictions intended to slow the spread of COVID-19, including quarantines, government-mandated actions, stay-at-home orders and other restrictions, have led and may in the future lead to periods where procedure volumes drop significantly;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Disruptions in supply chains can affect the cost and availability of reagents and other materials needed for certain procedures; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Significant portions of our workforce may be unable to work illness, quarantines, facility closures, ineffective remote work arrangements or technology failures or limitations;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">General economic downturns as a result of COVID-19 may affect demand or pricing for our services; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Volatility in the global capital markets may result in a decrease in the price of our common stock, or an increase in our cost of capital. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our results of operations have recovered from the initial outbreak of COVID-19, but a further outbreak or similar pandemic event would negatively impact our results of operations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In addition, changes to statutes, regulations or regulatory policies or practices as a result of, in response to or otherwise relating to COVID-19, including the wind-down of the COVID-19 Public Health Emergency (PHE) and similar federal and state regulatory measures, could affect us in substantial and unpredictable ways. Given the many uncertainties and far-reaching consequences of potential developments, we cannot assure that the COVID-19 outbreak or similar event will not require extended or additional diagnostic center closures and other disruptions to our business or will not materially and adversely affect our business, results of operations and financial condition for significant periods of time moving forward.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Business interruptions due to natural disasters or other external events beyond our control can adversely affect our business, financial condition or results of operations.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our operations can be subject to external events beyond our control, such as the effects of earthquakes, fires, floods, severe weather, public health issues, power failures, telecommunication loss, and other natural and man-made events, some of which may be intensified by the effects of climate change and changing weather patterns. Our corporate headquarters and over 100 of our radiology centers are located in California, which is subject to wildfires, blackouts, and potentially damaging earthquakes. In addition, several of our centers located in parts of the east coast have suffered from weather events that caused us to temporarily close centers.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">These or other similar events could cause disruption or interruption to our operations and significantly impact our employees.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Any disruption to our services may result in decreases in revenues or increased operating and capital expenses.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Historically, when we have experienced a reduction in business due to inclement weather or external events for a period of </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">time, our operations have returned to a normalized level, but we have not experience a significant increase of procedures that would fully compensate for the revenues lost during the slower periods.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Changes in the method or rates of third-party reimbursement could have a negative impact on our results</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">A significant portion of our business is derived from federal and state reimbursement programs such as Medicare or Medicaid.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">From time to time those programs implement changes designed to contain healthcare costs, some of which have resulted in decreased reimbursement rates for diagnostic imaging services that impact our business. On November 22, 2022, Centers for Medicare and Medicaid Services (&#8220;CMS&#8221;)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">released the 2022 Medicare Physician Fee Schedule final rule, which contained significant payment reductions effective January 1, 2023 for radiology services as a result of changes to relative value units, redistributive effects of the CMS proposed clinical labor pricing update and statutorily mandated budget neutrality rules. The Consolidated Appropriations Act of 2023, enacted on December 29, 2022, mitigated to a certain extent the reimbursement cuts, but did not completely eliminate them. Furthermore, absent further and more permanent intervention from Congress, CMS could propose and impose similar or more significant reimbursement cuts in the months and years ahead</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">.   </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">One of the principal objectives of health maintenance organizations and preferred provider organizations is to control the cost of healthcare services. Managed care contracting has become very competitive, and reimbursement schedules are at or below Medicare reimbursement levels. The expansion of health maintenance organizations, preferred provider organizations and other managed care organizations within the geographic areas covered by our network could have a negative impact on the utilization and pricing of our services, because these organizations will exert greater control over patients&#8217; access to diagnostic imaging services, the selections of the provider of such services and reimbursement rates for those services. Relatedly, reimbursement rate cuts may be pursued as a cost-saving measure by third party payors resulting from the implementation of the federal No Surprises Act (H.R. 133) and similar insurer-provider payment dispute laws, which also may negatively impact our revenue.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Any reduction in the rate that we can charge for our imaging services under these programs will reduce our net revenues and our operating margins per procedure under those reimbursement programs. Unless we can secure additional procedure volumes, increase utilization of our equipment, or change the overall mix of service procedures that we provide, a decline in reimbursement rates will reduce our net revenues and results of operations. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">We experience competition from other diagnostic imaging companies and hospitals, and this competition could adversely affect our revenue and business.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The market for diagnostic imaging services is highly competitive. We compete for patients principally on the basis of our reputation, our ability to provide multiple modalities at many of our centers, the location of our centers and the quality of our diagnostic imaging services. Our competitors include independent imaging operators, such as Akumin, Inc., which recently acquired Alliance Healthcare Services, and smaller regional operators, as well as hospitals, clinics and radiology groups that operate their own imaging equipment. Some of our competitors may have, now or in the future, access to greater financial resources than we do and may have access to newer, more advanced equipment. If we are unable to successfully compete, our business and financial condition would be adversely affected.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Technological change in our industry could reduce the demand for our services and require us to incur significant costs to upgrade our equipment.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The development of new technologies or refinements of existing modalities may require us to upgrade and enhance our existing equipment before we may otherwise intend. Many companies currently manufacture diagnostic imaging equipment. Competition among manufacturers for a greater share of the diagnostic imaging equipment market may result in technological advances in the speed and imaging capacity of new equipment. In addition, advances in technology may enable physicians and others to perform diagnostic imaging procedures without us.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our scale in both the number of our locations and the number and types of imaging equipment we offer is one of our competitive advantages.  If the development of new technologies accelerates the obsolescence of our current equipment, we may lose some of our competitive advantage.  We may also be required to accelerate the depreciation on existing equipment and incur significant capital expenditures to acquire the new technologies.  We may not have the financial ability to acquire the new or improved equipment and may not be able to maintain a competitive equipment base.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Business Risks</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If our contracted radiology practices terminate their agreements with us, our business could substantially diminish.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our business is substantially dependent on the radiology groups that we contract with to provide medical services. The radiology groups are party to substantially all of the managed care contracts from which we derive revenue.  Under the terms of our management agreements, these radiology groups must use their best efforts to provide medical services at our centers as well as any new centers that we open or acquire in their areas of operation. Although our management agreements are for multiple years, the radiology groups have the right to terminate the agreements if we default on our obligations and fail to cure the default. Also, the various radiology groups&#8217; ability to continue performing under the management agreements may be curtailed or eliminated due to the radiology groups&#8217; own financial difficulties, loss of physicians or other circumstances. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If any of our contracted radiology groups cannot perform their obligations to us, we would need to contract with one or more other radiology groups to provide the professional medical services. We may not be able to locate radiology groups willing to provide those services on terms acceptable to us, if at all. In addition, the radiology group&#8217;s relationships with referring physicians are largely responsible for the revenue generated at the centers they service. Any replacement radiology group&#8217;s relationships with referring physicians may not be as extensive as those of the terminated group. The termination of a management agreement with a radiology group could result in both short and long-term loss of revenue and adversely affect our performance and competitive position in the markets served by the departing radiology group.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are dependent on the ability of our contracted radiology practices, including the Group, to hire and retain qualified radiologists.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">At times, there has been a shortage of qualified radiologists in some of the regional markets we serve. Competition in recruiting radiologists may make it difficult for our contracted radiology practices to maintain adequate levels of radiologists. If a significant number of radiologists terminate their relationships with our contracted radiology practices and those radiology practices cannot recruit sufficient qualified radiologists to fulfill their obligations under our agreements with them, our ability to maximize the use of our diagnostic imaging centers and our financial results could be adversely affected. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We are experiencing tighter labor conditions in some of the markets we serve.  As a result our contracting radiological practices have experienced increased salary and professional services expenses.  Increased expenses for the contracting radiological practices, including the Group, impacts our financial results because the management fee we receive from them, which is based on a percentage of their collections, is adjusted annually to take into account their expenses. Neither we, nor our contracted radiology practices, maintain insurance on the lives of any affiliated physicians. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our ability to generate revenue depends in large part on referrals from physicians.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We depend on unaffiliated physicians and other third parties who have no contractual obligations to refer patients to us for a substantial portion of the services we perform. If a sufficiently large number of these physicians and other third parties were to discontinue referring patients to us, our imaging procedure volume would decrease, which would reduce our net revenue and operating margins. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Further, commercial third-party payors have implemented managed care programs that could limit the ability of physicians to refer patients to us. For example, health maintenance organizations sometimes contract directly with providers and require their enrollees to obtain these services exclusively from those contracted providers. Some insurance companies and self-insured employers also limit these services to contracted providers. These &#8220;closed panel&#8221; systems are now common in the managed care environment. Other systems such as preferred physician organizations create an economic disincentive for referrals to providers outside the system&#8217;s designated panel of providers. We seek to be the designated provider under these systems. If we are unable to compete successfully for these managed care contracts, our net revenues and our prospects for growth could be adversely affected.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may become subject to professional malpractice liability, which could be costly and negatively impact our reputation and  business.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The physicians employed by our contracted radiology groups are from time to time subject to malpractice claims. We structure our relationships with the radiology groups under our management agreements in a manner that we believe does not constitute the practice of medicine by us, or subject us to professional malpractice claims for acts or omissions of physicians employed by the contracted radiology practices. Nevertheless, claims relating to services provided by the contracted radiology practices have been asserted against us in the past and may be asserted against us in the future. In addition, we may be subject to other professional liability claims, including for improper use or malfunction of our diagnostic imaging equipment, or for accidental contamination, or injury from exposure to radiation. </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We seek to manage this risk through the purchase of professional liability insurance. Any claim made against us that is not fully covered by insurance could be costly to defend, result in a substantial damage award against us and divert the attention of our management from our operations, all of which could have an adverse effect on our financial performance. In addition, </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">successful claims against us may adversely affect our business or reputation. Although California places a $250,000 limit on non-economic damages for medical malpractice cases, no limit applies to economic damages and no such limits exist in the other states in which we provide services.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Even if we purchase professional liability insurance we are dependent on the creditworthiness of the insurance provider.  For a period of time ending in July 2017 we purchased professional liability insurance from Fairway Physicians Insurance Company, A Risk Retention Group (&#8220;Fairway&#8221;).  Fairway experienced financial hardship.  As a result, on August 29, 2017, the District of Columbia Department of Insurance, Securities and Banking (&#8220;DISB&#8221;) found that Fairway was statutorily insolvent and that its continued operation would be hazardous to its policyholders, creditors and the general public. On October 25, 2017, the Superior Court for the District of Columbia issued an order authorizing the DISB Commissioner to liquidate Fairway. Fairway&#8217;s liquidation is currently pending, and it is presently unknown whether the Fairway liquidation estate will be able to pay covered policyholder claims, including claims asserted against us.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not receive payment from some of our healthcare provider customers because of their financial circumstances.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We contract with commercial insurance and managed care providers to provide diagnostic imaging services to their members. Some of our healthcare provider customers do not have significant financial resources, liquidity or access to capital. If these customers experience financial difficulties they may be unable to pay us for the services that we provide. A significant deterioration in general or local economic conditions could have a material adverse effect on the financial health of certain of our healthcare provider customers. If our health care provider customers suffer financial hardship they could delay or default on their payment obligations to us, reducing our accounts receivable and negatively impacting our results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Capitation fee arrangements could reduce our operating margins.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For the year ended December 31, 2022, we derived approximately 11% of our total net revenue from capitation arrangements, and we expect to continue to derive a significant portion of our revenue from capitation arrangements in the future. Under capitation arrangements, the payor pays us a pre-determined amount per-patient per-month, and in exchange we are required to provide all necessary covered services to the patients covered under the arrangement. These contracts pass much of the financial risk of providing diagnostic imaging services, including the risk of over-use, from the payor to us as the provider. Our ability to generate profit from these arrangements is dependent on our ability to correctly forecast demand for services for the patient base, negotiate appropriate pre-determined amounts with the payor and efficiently manage the utilization of those services. If we are not successful in forecasting demand patients or enrollees covered by these contracts require more frequent or extensive care than anticipated, or if we are not efficient in managing the utilization of services under these capitation arrangements, we would incur unanticipated costs not offset by additional revenue, which would reduce operating margins.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disruption or malfunction in our information systems could adversely affect our business.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on information technology systems to process, transmit and store electronic information. A significant portion of the communication between personnel, customers, business partners, and suppliers depends on information technology. We rely on our information systems to perform functions critical to our ability to operate, including patient scheduling, billing, collections, image storage and image transmission. We also use information technology systems and networks in our operations and supporting departments such as marketing, accounting, finance, and human resources. The future success and growth of our business depends on streamlined processes made available through information systems, global communications, internet activity and other network processes.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our information technology system is vulnerable to damage or interruption from:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">earthquakes, fires, floods and other natural disasters;</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">power losses, computer systems failures, internet and telecommunications or data network failures, operator negligence, improper operation by or supervision of employees, physical and electronic losses of data and similar events; and</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">computer viruses, security attacks and breaches, coordinated attacks by hackers or activist entities seeking to disrupt operations or misappropriate information and other breaches of security; and</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">acts of vandalism or theft, misplaced or lost data, programming or human errors and similar events.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">These threats are constantly changing, increasing the difficulty of successfully defending against them or implementing adequate preventive measures. We maintain multiple layers of security measures and are continuously enhancing </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">our security technologies to address new threats.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our defenses are monitored and routinely tested internally and by external parties. Emerging and advanced security threats, including coordinated attacks, require additional layers of security which may disrupt or impact efficiency of operations.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We have in the past experienced unauthorized access to our network and could again face attempts by others to gain unauthorized access to information or to introduce malicious software to disrupt the operation of our information technology systems. Any unauthorized access to our information technology systems could have a material adverse impact on our business or operations. Responding to such incidents could require us to incur significant costs related to rebuilding internal systems, defending against litigation, responding to regulatory inquiries or actions, paying damages, complying with consumer protection laws or taking other remedial steps with respect to third parties. An extended interruption in our information technology system&#8217;s function could significantly limit our ability to conduct our business and generate revenue.  If our data storage system was compromised, it could also give rise to unwanted media attention, materially damage our payor and physician relationships, and harm our business reputation.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">While we maintain cyber liability insurance, our insurance may not be sufficient to protect against all losses we may incur if we suffer significant or multiple attacks.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our success depends in part on our key personnel and loss of key executives could adversely affect our operations. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our success depends in part on our ability to attract and retain qualified senior and executive management, and managerial and technical personnel. The loss of the services of Dr. Howard G. Berger, our President and Chief Executive Officer, and Norman R. Hames or Stephen M. Forthuber, our Chief Operating Officers, West Coast and East Coast, respectively, could hinder our ability to execute our business strategy and have a significant negative impact on our operations. We believe that they could not easily be replaced with executives of equal experience and capabilities, which would adversely affect our business.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Former employees and radiology practices we have previously contracted with could use the experience and relationships developed while employed or under contract with us to compete with us.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">A former executive, manager or other key employee who joins one of our competitors could use the relationships he or she established with third party payors, radiologists or referring physicians while our employee and the industry knowledge he or she acquired during that tenure to enhance the new employer&#8217;s ability to compete with us.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The agreements with most of our radiology practices contain non-compete provisions; however the enforceability of these provisions is generally subject to a &#8220;reasonableness&#8221; standard determined by a court based on the facts and circumstances of the specific case at the time enforcement is sought. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Many of the states in which we operate do not enforce agreements that prohibit a former employee from competing with a former employer. As a result, many of our employees whose employment is terminated are free to compete with us, subject to prohibitions on the use of trade secret information and, depending on the terms of the employee&#8217;s employment agreement, on solicitation of existing employees and customers (if enforceable). </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our inability to enforce radiologists&#8217; non-compete provisions could result in increased competition from individuals who are knowledgeable about our business strategies and operations.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">The future growth of our imaging business is partially dependent on our ability to continue to identify, complete and successfully integrate acquired businesses.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Historically, we have experienced substantial growth through acquisitions that have increased our size, scope and geographic distribution. During the past two fiscal years, we have completed 24 acquisitions. These acquisitions have added 35 centers to our fixed-site outpatient diagnostic imaging services. Our ability to successfully expand through acquiring centers, developing new centers, adding equipment at existing centers, and directly or indirectly entering into contractual relationships with high-quality radiology practices depends upon many factors, including our ability to:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">identify attractive and willing candidates for acquisitions;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">identify locations in existing or new markets for development of new centers;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">comply with legal requirements affecting our arrangements with contracted radiology practices;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">obtain regulatory approvals where necessary and comply with licensing and certification requirements applicable to our diagnostic imaging centers, the contracted radiology practices and their associated physicians;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">recruit a sufficient number of qualified radiology technologists and other non-medical personnel;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expand our infrastructure and management; and</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">compete for opportunities.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may not be able to compete effectively for the acquisition of diagnostic imaging centers. Our competitors may have more established operating histories and greater resources than we do. Competition may also make any acquisitions more </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">expensive.  If we are unable to successfully grow our business through acquisitions it could have an adverse effect on our financial condition and results of operations. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our failure to successfully, and in a timely manner, integrate acquired businesses and/or new lines of businesses could reduce our profitability.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We may never realize expected synergies or capitalize on expected business opportunities in connection with an acquisition.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Moreover, assumptions underlying estimates of expected cost savings may be inaccurate, or general industry and business conditions may deteriorate. Integrating operations requires significant efforts and expense on our part. Our management may have its attention diverted while trying to integrate an acquisition. Personnel may leave or be terminated because of an acquisition. If these factors limit our ability to integrate the operations of an acquisition successfully or on a timely basis, our expectations of future results of operations, including certain cost savings and synergies as a result of the acquisition, may not be met.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the past we have acquired, and may again in the future acquire, companies that create a new line of business. The process of integrating the acquired business, technology, service and research and development component into our business and operations and entry into a new line of business in which we are inexperienced may result in unforeseen operating difficulties and expenditures. In developing a new line of business, we may invest significant time and resources that take away the attention of management that would otherwise be available for ongoing development of our business. In addition, there can be no assurance that our new lines of business will ultimately be successful. The failure to successfully manage these risks in the development and implementation of new lines of business could have a material, adverse effect on our business, financial condition, and results of operations.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">We may not generate the expected benefits from our recent investment in AI technologies.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We believe that technology advancements including AI will significantly impact diagnostic imaging services in the future.  As part of our growth strategy we have acquired or invested in a number of AI companies and technologies, including DeepHealth, Inc., NeuroLogix, Inc., WhiteRabbit.ai, Aidence Holding B.V. and Quantib B.V.  Our focus in AI technologies is aimed at developing solutions that improve the quality of diagnostic imaging, reduce operating costs, and correspondingly improve our competitive position.  The success of our AI investments will depend upon a number of factors, some of which are out of our control, such as:</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">our ability to effectively integrate the operations of the acquired companies, including retaining key personnel;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the timeline and related expenses associated with applying for regulatory approvals necessary for commercialization; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">whether any of our existing or future AI products will receive European CE or U.S. FDA 510(k) clearance or other clearances and or regulatory approvals necessary for commercialization;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">whether our AI solutions will prove effective for improving health care quality, patient services or business procedures;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">our ability to successfully commercialize and secure market acceptance of our AI solutions from patients and health care providers; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">the development of competing technologies by other companies, and the relative efficacy, cost and ease of use of those technologies. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">There is no guarantee that we will receive the anticipated benefits from the investments we have made and may continue to make in the area of AI.  Any failure would result in reduced operating profits and the potential impairment of goodwill related to those investments, which would further impact our profitability.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Healthcare and Regulatory Risks</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The regulatory framework in which we operate is uncertain and evolving.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we believe that we are operating in compliance with applicable federal and state laws, neither our current or anticipated business operations nor the operations of our contracted radiology practices have been the subject of judicial or regulatory interpretation. We cannot assure you that a review of our business by courts or regulatory authorities will not result in a determination that could adversely affect our operations. In addition, healthcare laws and regulations may change significantly in the future in a way that restricts our operations. We continuously monitor these developments and modify our operations from time to time as the regulatory environment changes. We cannot assure you however, that we will be able to adapt our operations to address new regulations or that new regulations will not adversely affect our business.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain states have enacted statutes or adopted regulations affecting risk assumption in the healthcare industry, including statutes and regulations that subject any physician or physician network engaged in risk-based managed care </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">contracting to comply with applicable insurance laws. These laws, if adopted in the states in which we operate, may require physicians and physician networks to meet minimum capital requirements and other safety and soundness requirements. Implementing additional regulations or compliance requirements could result in substantial costs to us and the contracted radiology practices and limit our ability to enter into capitation or other risk-sharing managed care arrangements.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be impacted by eligibility changes to government and private insurance programs.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to potential decreased availability of healthcare through private employers, the number of patients who are uninsured or participate in governmental programs may increase. Healthcare reform legislation will increase the participation of individuals in the Medicaid program in states that elect to participate in the expanded Medicaid coverage. A shift in payor mix from managed care and other private payors to government payors as well as an increase in the number of uninsured patients may result in a reduction in the rates of reimbursement or an increase in uncollectible receivables or uncompensated care, with a corresponding decrease in net revenue. Changes in the eligibility requirements for governmental programs and state decisions on whether to participate in the expansion of such programs also could increase the number of patients who participate in such programs and the number of uninsured patients. Even for those patients who remain in private insurance plans, changes to those plans could increase patient financial responsibility, resulting in a greater risk of uncollectible receivables. Furthermore, additional changes to, or rollback of, the Patient Protection and Affordable Care Act, whether through legislation or judicial action, may also affect reimbursement and coverage in ways that are currently unpredictable. These factors and events could have a material adverse effect on our business, financial condition, and results of operations.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Complying with federal and state regulations is an expensive and time-consuming process, and any failure to comply could result in substantial penalties.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are directly or indirectly, through the radiology practices with which we contract, subject to extensive regulation by both the federal government and the state governments in which we provide services, including:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the federal False Claims Act;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the federal Medicare and Medicaid Anti-Kickback Statute, and state anti-kickback prohibitions;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">federal and state billing and claims submission laws and regulations;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">HIPAA, as amended by HITECH, and comparable state laws;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the federal physician self-referral prohibition commonly known as the Stark Law and state equivalents;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">state laws that prohibit the corporate practice of medicine and prohibit similar fee-splitting arrangements;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">federal and state laws governing the diagnostic imaging and therapeutic equipment we use in our business concerning patient safety, equipment operating specifications and radiation exposure levels; </span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">state laws governing reimbursement for diagnostic services related to services compensable under workers' compensation rules; and</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">federal and state environmental and health and safety laws.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If our operations are found to be in violation of any of the laws and regulations to which we or the radiology practices with which we contract are subject, we may be subject to penalties, including civil and criminal penalties, damages, fines and the curtailment of our operations. Any penalties, damages, fines or curtailment of our operations, individually or in the aggregate, could adversely affect our ability to operate our business and our financial results. The risks of our being found in violation of these laws and regulations is increased by the fact that many of them have not been fully interpreted by the regulatory authorities or the courts, and their provisions are open to a variety of interpretations. Any action brought against us for violation of these laws or regulations, even if we successfully defend against it, could cause us to incur significant legal expenses and divert our management&#8217;s attention from the operation of our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">State and federal anti-kickback and anti-self-referral laws may adversely affect income.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Various federal and state laws govern financial arrangements among healthcare providers. The federal Anti-Kickback Statute prohibits the knowing and willful offer, payment, solicitation or receipt of any form of remuneration in return for, or to induce, the referral of Medicare, Medicaid, or other federal healthcare program patients, or in return for, or to induce, the purchase, lease or order of items or services that are covered by Medicare, Medicaid, or other federal healthcare programs. Similarly, many state laws prohibit the solicitation, payment or receipt of remuneration in return for, or to induce the referral of patients in private as well as government programs. Violation of these anti-kickback laws may result in substantial civil or criminal penalties for individuals or entities and/or exclusion from federal or state healthcare programs. We believe we are operating in compliance with applicable law and believe that our arrangements with providers would not be found to violate the anti-kickback laws. However, these laws could be interpreted in a manner inconsistent with our operations.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal law prohibiting certain physician self-referrals, known as the Stark Law, prohibits a physician from referring Medicare or Medicaid patients to an entity for certain &#8220;designated health services&#8221; if the physician has a prohibited financial relationship with that entity, unless an exception applies. Certain radiology services are considered &#8220;designated health services&#8221; under the Stark Law. Although we believe our operations do not violate the Stark Law, our activities may be challenged. If a challenge is successful, it could have an adverse effect on our operations. In addition, legislation may be enacted in the future that further addresses Medicare and Medicaid fraud and abuse or imposes additional regulatory burdens on us.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, under the Deficit Recovery Act, states enacting false claims statutes similar to the federal False Claims Act, which establish liability for submission of fraudulent claims to the State Medicaid program and contain qui tam or whistleblower provisions, receive an increased percentage of any recovery from a State Medicaid judgment or settlement. Adoption of new false claims statutes in states where we operate may impose additional burdens on us.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we fail to comply with various licensure, certification and accreditation standards, we may be subject to loss of licensure, certification or accreditation, which would adversely affect our operations.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ownership, construction, operation, expansion and acquisition of our diagnostic imaging centers are subject to various federal and state laws, regulations and approvals concerning licensing of personnel, other required certificates for certain types of healthcare facilities and certain medical equipment. In addition, freestanding diagnostic imaging centers that provide services independent of a physician&#8217;s office must be enrolled by Medicare as an independent diagnostic treatment facility, or IDTF, to bill the Medicare program. Medicare carriers have discretion in applying the IDTF requirements and therefore the application of these requirements may vary from jurisdiction to jurisdiction. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, federal legislation requires all suppliers that provide the technical component of diagnostic MRI, PET/CT, CT, and nuclear medicine to be accredited by an accreditation organization designated by CMS (which currently include the American College of Radiology (ACR), the Intersocietal Accreditation Commission (IAC) and the Joint Commission). Our MRI, CT, nuclear medicine, ultrasound and mammography centers are currently accredited by the American College of Radiology. We may not be able to receive the required regulatory approvals or accreditation for any future acquisitions, expansions or replacements, and the failure to obtain these approvals could limit the opportunity to expand our services.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Credentialing of physicians is required by our payors prior to commencing payment. We have experienced a slowdown in the credentialing of our physicians over the last several years which has lengthened our billing and collection cycle, and could negatively impact our ability to collect revenue from patients covered by Medicare.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our centers are subject to periodic inspection by governmental and other authorities to assure continued compliance with the various standards necessary for licensure and certification. If any facility loses its certification under the Medicare program, then the facility will be ineligible to receive reimbursement from the Medicare and Medicaid programs. For the year ended December 31, 2022, approximately 22% and 3% of our net service fee revenue came from Medicare and various state Medicaid programs, respectively. A change in the applicable certification status of one of our centers could adversely affect our other centers and in turn us as a whole. </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our agreements with the contracted radiology practices must be structured to avoid the corporate practice of medicine and fee-splitting.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The laws of certain states prohibit us from exercising control over the medical judgments or decisions of physicians and from engaging in certain financial arrangements, such as splitting professional fees with physicians. These laws are enforced by state courts and regulatory authorities, each with broad discretion. A component of our business has been to enter into management agreements with radiology practices. We provide management, administrative, technical and other non-medical services to the radiology practices in exchange for a service fee typically based on a percentage of the practice&#8217;s revenue. We structure our relationships with the radiology practices, including the purchase of diagnostic imaging centers, in a manner that we believe keeps us from engaging in the practice of medicine or exercising control over the medical judgments or decisions of the radiology practices or their physicians, or violating the prohibitions against fee-splitting. State laws and enforcement efforts regarding corporate practice of medicine and fee-splitting are often subject to change.  As a consequence, there can be no assurance that our present arrangements with the Group or the physicians providing medical services and medical supervision at our imaging centers will not be challenged, and, if challenged, that they will not be found to violate the corporate practice of medicine or fee splitting prohibitions, thus subjecting us to potential damages, injunction and/or civil and criminal penalties or require us to restructure our arrangements in a way that would affect the control or quality of our services and/or change the amounts we receive under our management agreements. </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">If we fail to comply with federal and state privacy and information security laws mandating protection of certain confidential data against disclosure, including cybersecurity attacks, we may be subject to government or private actions.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We must comply with numerous federal and state laws and regulations governing the collection, dissemination, access, use, security and privacy of PHI, including HIPAA and its implementing privacy and security regulations, as amended by the federal HITECH Act (collectively, &#8220;HIPAA&#8221;). Information security risks have significantly increased in recent years in part because of the proliferation of new technologies, and the increased sophistication and activities of organized crime, hackers, terrorists and other external parties, including foreign state agents. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Failure to adequately protect and maintain the integrity of our information systems (including our networks) and data, or to defend against cybersecurity attacks, could subject us to monetary fines, civil suits, civil penalties or criminal sanctions.  We could also be required to disclose the breach publicly, which may damage our business reputation with our patients and vendors and cause a further material adverse effect on our results of operations, financial position, and cash flows.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Some of our imaging modalities use radioactive materials, which generate regulated waste and could subject us to liabilities for injuries or violations of environmental and health and safety laws.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of our imaging procedures use radioactive materials, which generate medical and other regulated wastes. For example, patients are injected with a radioactive substance before undergoing a PET scan. Storage, use and disposal of these materials and waste products present the risk of accidental environmental contamination and physical injury. We are subject to federal, state and local regulations governing storage, handling and disposal of these materials. We could incur significant costs and the diversion of our management&#8217;s attention in order to comply with current or future environmental and health and safety laws and regulations. Also, we cannot completely eliminate the risk of accidental contamination or injury from these hazardous materials. Although we maintain professional liability insurance coverage in amounts we believe is consistent with industry practice in the event of an accident, we could be held liable for any resulting damages, and any liability could exceed the limits of or fall outside the coverage of our professional liability insurance.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Risks</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Because we have high fixed costs, lower scan volumes and revenues could adversely affect our business.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The principal components of our expenses are debt service, capital lease payments, depreciation, compensation paid to technologists, salaries, real estate lease expenses and equipment maintenance costs. Because a majority of these expenses are fixed, a relatively small change in our revenue could have a disproportionate effect on our operating and financial results depending on the source of our revenue. Thus, decreased revenue as a result of lower scan volumes per system could result in lower margins, which would materially adversely affect the profitability our business.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our substantial debt could adversely affect our financial condition and prevent us from fulfilling our obligations under our outstanding indebtedness.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our current substantial indebtedness and any future indebtedness we incur could adversely affect our financial condition. We are highly leveraged. As of December 31, 2022 term loan indebtedness, excluding related discount, was $864.1 million, of which the Barclays credit facility term loans were $714.1 million and the Truist credit facility term loan was $150.0 million. Our substantial indebtedness could also:</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">make it difficult for us to satisfy our payment obligations with respect to our outstanding indebtedness;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">require us to dedicate a substantial portion of our cash flow from operations to payments on our debt, reducing the availability of our cash flow to fund working capital, capital expenditures, acquisitions and other general corporate purposes;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expose us to the risk of interest rate increases on our variable rate borrowings, including borrowings under our new senior secured credit facilities;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increase our vulnerability to adverse general economic and industry conditions;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">limit our flexibility in planning for, or reacting to, changes in our business and the industry in which we operate;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">place us at a competitive disadvantage compared to our competitors that have less debt; and</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">limit our ability to borrow additional funds on terms that are satisfactory to us or at all.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">A restriction in our ability to make capital expenditures would restrict our growth and could adversely affect our business.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We operate in a capital intensive, high fixed-cost industry that requires significant amounts of capital to fund operations, particularly the initial start-up and development expenses of new diagnostic imaging centers and the acquisition of </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">additional centers and new diagnostic imaging equipment. We incur capital expenditures to, among other things, upgrade and replace equipment for existing centers and expand within our existing markets and enter new markets. If we open or acquire additional imaging centers, we may have to incur material capital lease obligations. To the extent we are unable to generate sufficient cash from our operations, funds are not available under our credit facilities or we are unable to structure or obtain financing through operating leases, finance leases or long-term installment notes, we may be unable to meet the capital expenditure requirements necessary to support the maintenance and continued growth of our operations.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">We may be required to recognize an impairment of our goodwill, other intangible assets, or other long-lived assets, which could have an adverse effect on our financial position and results of operations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">When we acquire businesses we are generally required to allocate the purchase price to various assets including goodwill and other intangible assets.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">During 2020 we ceased employing certain indefinite lived trade names with a total value of $4.2 million and they were written off in full.  We are required to perform impairment tests for goodwill and other indefinite-lived intangible assets annually and whenever events or circumstances indicate that it is more likely than not that impairment exists.  We are also required to perform an impairment test of definite lived intangible or other long-lived assets when indicators of impairment are present. A decline in the Company's operating results, future estimated cash flows and other assumptions could impact our estimated fair values, potentially leading to a material impairment of goodwill, other intangible assets, or other long-lived assets, which could adversely affect our financial position and results of operations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our credit facilities and instruments governing our other indebtedness restrict certain operations of our business.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our credit facilities contain affirmative and negative covenants which restrict, among other things, our ability to:</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pay dividends or make certain other restricted payments or investments;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">incur additional indebtedness and certain disqualified equity interests;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">create liens (other than permitted liens) securing indebtedness or trade payables;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">sell certain assets or merge with or into other companies or otherwise dispose of all or substantially all of our assets;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">enter into certain transactions with affiliates;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">create restrictions on dividends or other payments by our restricted subsidiaries; and</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">create guarantees of indebtedness by restricted subsidiaries.</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of these restrictions could affect our ability to operate our business and may limit our ability to take advantage of potential business opportunities as they arise. A failure to comply with these covenants and restrictions would permit the relevant creditors to declare all amounts borrowed under the applicable agreement governing such indebtedness, together with accrued interest and fees, to be immediately due and payable. If the indebtedness under our credit facilities is accelerated, we may not have sufficient assets to repay amounts due under the credit facilities or on other indebtedness then outstanding.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Capital Markets Risks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Possible volatility in our stock price could negatively affect us and our stockholders.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The trading price of our common stock on the NASDAQ Global Market has fluctuated significantly in the past. During the period from January 1, 2021 through December 31, 2022, the trading price of our common stock fluctuated from a high of $38.84 per share to a low of $12.03 per share. In the past, we have experienced a drop in stock price following an announcement of disappointing earnings or earnings guidance. Any such announcement in the future could lead to a similar drop in stock price. The price of our common stock could also be subject to wide fluctuations in the future as a result of a number of other factors, including the following:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in expectations as to future financial performance or buy/sell recommendations of securities analysts;</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our, or a competitor&#8217;s, announcement of new services, or significant acquisitions, strategic partnerships, joint ventures or capital commitments; and</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the operating and stock price performance of other comparable companies.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the U.S. securities markets periodically experience significant price and volume fluctuations. These fluctuations often have been unrelated to the operating performance of companies in these markets. Broad market and industry factors may lead to volatility in the price of our common stock, regardless of our operating performance. </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the past, following periods of volatility in the market price of an individual company&#8217;s securities, securities class action litigation often has been instituted against that company. The institution of similar litigation against us could result in substantial costs and a diversion of management&#8217;s attention and resources, which could negatively affect our business, results of operations or financial condition.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Provisions of the Delaware General Corporation Law and our organizational documents may discourage an acquisition of us.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the future, we could become the subject of an unsolicited attempted takeover of our company. Although an unsolicited takeover could be in the best interests of our stockholders, our organizational documents and the General Corporation Law of the State of Delaware both contain provisions that will impede the removal of directors and may discourage a third-party from making a proposal to acquire us. For example, the provisions:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">permit the board of directors to increase its own size, within the maximum limitations set forth in the bylaws, and fill the resulting vacancies;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">authorize the issuance of shares of preferred stock in one or more series without a stockholder vote;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">establish an advance notice procedure for stockholder proposals to be brought before an annual meeting of our stockholders, including proposed nominations of persons for election to the board of directors; and</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">prohibit transfers and/or acquisitions of stock (without consent of the Board of Directors ) that would result in any stockholder owning greater than 5% of the currently outstanding stock resulting in a limitation on net operating loss carryovers, capital loss carryovers, general business credit carryovers, alternative minimum tax credit carryovers and foreign tax credit carryovers, as well as any loss or deduction attributable to a &#8220;net unrealized built-in loss&#8221; within the meaning of Section 382 of the internal revenue code of 1986, as amended.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to Section 203 of the Delaware General Corporation Law, which could have the effect of delaying or preventing a change in control.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="if3f80771944f4fc58015abda42dc47d1_22"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 1B.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Unresolved Staff Comments</span></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="if3f80771944f4fc58015abda42dc47d1_25"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Properties</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our corporate headquarters is located in adjoining premises at 1508, 1510 and 1516 Cotner Avenue, Los Angeles, California 90025, and approximately 21,500 square feet is occupied under these leases, which including options, expire June&#160;30, 2027. We also have a regional office of approximately 39,000 square feet in Baltimore, Maryland under a lease, which including options, expires September&#160;30, 2028. In addition, we lease approximately 36,700 square feet of warehouse space nationwide, which expire at various dates, including options, through December&#160;31, 2028. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2022, we operated directly or indirectly through joint ventures with hospitals, 357 centers located in Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York.  We lease the premises at which these facilities are located and do not have options to purchase the facilities we rent. Our most common initial term varies in length from 5 to 15 years. Including renewal options negotiated with the landlord, we can have a total span of 10 to 35 years at the facilities we lease. We also lease smaller satellite X-Ray locations on mutually renewable terms, usually lasting one year. Rental increases can range from 1% to 10% on an annual basis, depending on the location and market conditions where we do business.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, total square footage operated directly or indirectly under lease, including medical office, administrative and warehouse locations, was approximately 2.8 million square feet.  All leasing activity described relates solely to our Imaging Center segment, as our AI segment leasing activity is immaterial.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="if3f80771944f4fc58015abda42dc47d1_28"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Legal Proceedings</span></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are engaged from time to time in the defense of lawsuits arising out of the ordinary course and conduct of our business. We believe that the outcome of our current litigation will not have a material adverse impact on our business, financial condition and results of operations. However, we could be subsequently named as a defendant in other lawsuits that could adversely affect us.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="if3f80771944f4fc58015abda42dc47d1_31"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Mine Safety Disclosures</span></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><div id="if3f80771944f4fc58015abda42dc47d1_34"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II</span></div><div id="if3f80771944f4fc58015abda42dc47d1_37"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 5.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Market for the Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</span></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Principal Trading Market</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common stock is quoted on the NASDAQ Global Market under the symbol &#8220;RDNT&#8221;.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Holders</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As of  February&#160;23, 2023, the number of holders of record of our common stock was 1,136.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dividends</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have never declared or paid cash dividends on our capital stock and we do not expect to pay any dividends in the foreseeable future. We currently intend to retain future earnings, if any, to finance the growth and development of our business. Our current credit facilities place restrictions on our ability to issue dividends. See discussion under &#8220;Liquidity and Capital Resources&#8221; regarding our current credit facilities. Payment of future dividends, if any, will be at the discretion of our board of directors and will depend on our financial condition, results of operations, capital requirements and such other factors as the board of directors deems relevant.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Performance Graph</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following graph compares the yearly percentage change in cumulative total stockholder return of our common stock during the period from 2017 to 2022 with (i) the cumulative total return of the S&amp;P 500 index and (ii) the cumulative total return of the S&amp;P 500 &#8211; Healthcare Sector index. The comparison assumes $100 was invested on December&#160;29, 2017 in our common stock and in each of the foregoing indices and the reinvestment of dividends through December&#160;30, 2022. The stock price performance on the following graph is not necessarily indicative of future stock price performance.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This graph shall not be deemed incorporated by reference by any general statement incorporating by reference this Form 10-K into any filing under the Securities Act or under the Exchange Act, except to the extent that RadNet specifically incorporates this information by reference, and shall not otherwise be deemed filed under the Securities Act or the Exchange Act.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><img src="rdnt-20221231_g1.jpg" alt="rdnt-20221231_g1.jpg" style="height:480px;margin-bottom:5pt;vertical-align:text-bottom;width:613px"/></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:41.462%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.654%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ANNUAL RETURN PERCENTAGE<br/>Years Ending</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Company / Index</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12/31/18</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12/31/19</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12/31/20</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12/31/21</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12/30/22</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">RadNet, Inc.</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.69</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.61</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.86</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37.46)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">S&amp;P 500 Index</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.38)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.49</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.71</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.11)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">S&amp;P Health Care Sector</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.47&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.82</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.45</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.13</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.95)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:29.975%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.654%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Base</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">INDEXED RETURNS<br/>Years Ending</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Period</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Company / Index</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12/29/17</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12/31/18</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12/31/19</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12/31/20</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12/31/21</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12/30/22</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">RadNet, Inc.</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.69</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200.99</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193.76</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298.12</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186.44</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">S&amp;P 500 Index</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95.62</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125.72</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148.85</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191.58</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156.88</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">S&amp;P Health Care Sector</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.47</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128.64</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145.93</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184.07</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180.47</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Sales of Unregistered Securities</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2022, we acquired a 75% controlling interest in Heart and Lung Imaging Limited in part by issuing 359,002 shares at $19.06 per share with a fair value of $6.8 million.  The shares of common stock were issued to the four holders of the outstanding equity of Heart and Lung Imaging Limited.  The shares were issued without registration on the basis of the exemption for private placement transactions provided by Section 4(a)(2) of the Securities Act.</span></div><div id="if3f80771944f4fc58015abda42dc47d1_40"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Reserved</span></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not Required.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><div id="if3f80771944f4fc58015abda42dc47d1_43"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations (&#8220;MD&amp;A&#8221;) is intended to help the reader understand the results of operations and financial condition of RadNet Inc. MD&amp;A is provided as a supplement to, and should be read in conjunction with, our consolidated financial statements and the accompanying notes included in this annual report on Form 10-K.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a national provider of diagnostic imaging services in the United States. At December 31, 2022, we operated directly or indirectly through joint ventures with hospitals, 357 centers located in Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Our operations comprise two segments for financial reporting purposes for this reporting period, Imaging Centers and Artificial Intelligence. For further financial information about these segments, see Note 5, Segment Reporting, in the notes accompanying our consolidated financial statement included in this annual report on Form 10-K..</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our centers provide physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders and may reduce unnecessary invasive procedures, often reducing the cost and amount of care for patients.  Integral to the imaging center business is our software arm headed by eRAD, Inc., which sells computerized systems that distribute, display, store and retrieve digital images. Internationally, our subsidiary Heart and Lung Imaging LLC, provides teleradiology services for remote interpretation of images on behalf of providers within the framework of the United Kingdom's National Health Service.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have also established an Artificial Intelligence (AI) division, that develops and deploys AI suites to enhance radiologist interpretations of breast, lung and prostate images.  The division is led by DeepHealth, and includes our acquisitions of Aidence Holding B.V. and Quantib B.V., both based in The Netherlands.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The following table shows our centers in operation at year end and revenues for the years ended December 31, 2022, 2021 and 2020:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Centers in operation</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue (millions)</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,430&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,315&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,072&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue is derived from a diverse mix of payors, including private payors, managed care capitated payors and government payors. We believe our payor diversity mitigates our exposure to possible unfavorable reimbursement trends within any one payor class. In addition, our experience with capitation arrangements over the last several years has provided us with the expertise to manage utilization and pricing effectively, resulting in a predictable stream of revenue. Our service fee revenue, net of contractual allowances and discounts, implicit price concessions, and revenue under capitation arrangements for the years ended December 31, 2022, 2021 and 2020 are summarized in the following table (in thousands):</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In Thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial insurance</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">785,128&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743,462&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">584,035&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311,124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280,911&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217,928&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,279&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,731&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,619&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Workers' compensation/personal injury</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,339&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,478&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other patient revenue</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,849&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,398&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,314&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management fee revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,630&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software and teleradiology</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,238&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,525&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,798&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,428&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,436&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue under capitation arrangements</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152,045&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148,334&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140,118&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Imaging center segment revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,425,665&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,313,662&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,071,840&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AI segment revenue</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,396&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,415&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,430,061&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,315,077&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,071,840&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We typically experience some seasonality to our business. During the first quarter of each year we generally experience the lowest volumes of procedures and the lowest level of revenue for any quarter during the year. This is primarily the result of two factors. First, our volumes and revenue are typically impacted by winter weather conditions in our northeastern operations. It is common for snowstorms and other inclement weather to result in patient appointment cancellations and, in some cases, imaging center closures. Second, in recent years, we have observed greater participation in high deductible health plans by patients. As these high deductibles reset in January for most of these patients, we have observed that patients utilize medical services less during the first quarter, when&#160;securing medical care&#160;will result in significant out-of-pocket expenditures.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. The following table shows the number of systems that we had in operation as of the years ended December 31, 2022, 2021 and 2020: </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MRI</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CT</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PET/CT</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mammography</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">387&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">358&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ultrasound</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">818&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">760&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">689&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X-ray</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">415&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nuclear Medicine</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fluoroscopy</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equipment</span></td><td colspan="2" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,433</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,276</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,089</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acquisitions, Equity Investments and Joint Venture Activity</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following discussion summarizes certain details concerning our acquisition or disposition of centers, our equity investment and our joint venture transaction.  See Note 4, Acquisitions, Dispositions and Business Venture Activity and Note 2,  Summary of Significant Accounting Policies to our consolidated financial statements included in this annual report on Form 10-K for further information.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Imaging Center Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Radiology Practice Acquisitions:</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022 and 2021, we completed the acquisition of certain assets of the following entities, which either engage directly in the practice of radiology or associated businesses.  The primary reason for these acquisitions was to strengthen our presence in the Delaware, Maryland, New Jersey and New York markets.  These acquisitions are reported as part of our Imaging Center segment.  We made a fair value determination of the acquired assets and assumed liabilities and the following were recorded (in thousands):</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">2022:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.783%"><tr><td style="width:1.0%"></td><td style="width:12.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.869%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.193%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.531%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.984%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.963%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.020%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.208%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.988%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Entity </span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date Acquired</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total  Consideration</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property &amp; Equipment</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Assets</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible Assets</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IFRC LLC*&#94;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/1/2022</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,200</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,910</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,703</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,271</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,703)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IFRC LLC*&#94;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/1/2022</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,800</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,103</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">857</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,697</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(857)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Heart and Lung Imaging Limited+</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/1/2022</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,000</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,200</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,800</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Montclair Radiological Associates, P.A.*#</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10/1/2022</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,877</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,414</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,665</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,690</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,168)</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,124)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chelsea Dignostic Radiology, P.C.*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/1/2022</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,800</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,132</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North Jersey Imaging Center, LLC*</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/9/2022</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$142,781</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$22,015</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$7,225</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$106,045</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$16,325</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$(2,145)</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$(6,684)</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*Fair Value Determination is Final</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#94; IFRC LLC acquisitions consisted of three subsidiaries of IFRC, one of which was purchased separately by a joint venture with Calvert Medical Imaging Centers, LLC.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">#</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Montclair Radiological Associates includes a liability for  $1.2 million in contingent consideration.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">+See detailed description of the Heart and Lung Imaging Limited acquisition below. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">2021:</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:15.128%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Entity </span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date Acquired</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total  Consideration</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property &amp; Equipment</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Assets</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible Assets</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Assets</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personal Health Imaging PLLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/1/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,995</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">576</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">608</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,355</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(608)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP Elmont LLC*</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/1/2021</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,194</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,112</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,005</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP Freeport LLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/1/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,065</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,668</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,328</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Broadway Medical Imaging LLC*</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/1/2021</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,155</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,076</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(446)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3235 Hempstead LLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/1/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,386</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,667</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,649</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SLZM Realty LLC*</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/1/2021</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,671</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,617</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,974</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2012 Sunrise Merrick LLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/1/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,428</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,741</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,617</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(335)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP Bayside LLC*</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/1/2021</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,545</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,385</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,191</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,191)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP Laurelton LLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/1/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,658</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,530</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,418</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,418)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP Smith LLC*</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/1/2021</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,978</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,581</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,214</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,214)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP 907 Northern LLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4/1/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">562</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">507</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,817</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,817)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">William M. Kelly MD, Inc.* &#94;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5/1/2021</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,750</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">990</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,379</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,710</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,379)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60th Street MRI, LLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5/1/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP Parkchester LLC*</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5/1/2021</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(311)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP Eastern LLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6/1/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,868</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,801</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,951</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,951)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tangent Associates LLC**</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/24/2021</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,025</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">379</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,636</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mid Delaware Imaging P.A.</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/1/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,023</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,260</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">William M. Kelly MD, Inc.* &#94;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/6/2021</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,404</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">701</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,653</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">William M. Kelly MD, Inc.* &#94;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/31/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,346</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,197</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(323)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">79,716</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">35,949</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12,993</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">40,864</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,671</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">232</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(12,993)</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*Fair Value Determination is Final</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">** All stock purchase through issuing 67,658 shares of our common stock.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#94; William M. Kelly MD acquisitions consisted of various subsidiaries purchased separately.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Heart and Lung Imaging Limited</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On November 1, 2022, we acquired a 75% controlling interest in Heart and Lung Imaging Limited (&#8220;HLI&#8221;).  HLI is a teleradiology concern which operates in the United Kingdom with the National Healthcare Service to screen high risk populations for cardiac and lung conditions.  HLI&#8217;s operations are included in our imaging center segment for reporting purposes. The transaction was accounted for as the acquisition of a business with a total purchase consideration of approximately $31.9 million, including: i) shares with a fair value of $6.8 million (359,002 shares issued at $19.06 per share), ii) cash of $6.3 million and iii) contingent consideration of $10.8 million ($10.2 million in contingent milestone consideration and cash holdback of $0.6 million to be issued 24 months after acquisition subject to adjustment for any indemnification claims) and iv) noncontrolling interest of $8.0 million. We recorded $0.6 million in current assets, $15.8 million in intangible assets, $0.6 million current liabilities and $16.2 million in goodwill in connection with this transaction.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As part of the purchase price allocation, we determined the identifiable intangible assets are customer relationships and trade names. The fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using a rate of 19.0%. The cash flows were based on estimated earnings from existing customers, and the discount rate applied was benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Artificial Intelligence Segment</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Aidence Holding B.V.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On January 20, 2022, we completed our acquisition of all the equity interests of Aidence Holding B.V. ("Aidence") an artificial intelligence enterprise focused on lung cancer screening.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Aidence is reported as part of our artificial intelligence segment and was acquired to enhance our AI capabilities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The transaction was accounted for as an acquisition of a business and total purchase consideration was determined to be approximately $45.2&#160;million including i) 1,117,872 shares issued at $26.80 per share with a fair value of $30.0&#160;million ii) cash of $1.8&#160;million and iii) contingent consideration of $11.9&#160;million ($7.4&#160;million in milestones to be settled in shares or cash at our election and a share holdback of $4.5&#160;million) and iv) a settlement of a loan from RadNet of $1.5&#160;million.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In addition we paid certain seller closing costs through the issuance of 23,362 shares at a fair value of $0.6&#160;million.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As a result of this transaction, we recorded $1.0&#160;million in current assets, $0.2&#160;million in property and equipment, $27.7&#160;million in intangible assets (including developed technology of $21.1&#160;million and IPR&amp;D of $5.5&#160;million), $3.2&#160;million in current liabilities, a deferred tax liability of $3.5&#160;million, and $22.9&#160;million in goodwill.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In performing the purchase price allocation, we considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of the Aidence business.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As part of the purchase price allocation, we determined the identifiable intangible assets are developed technology, IPR&amp;D, trade names, and customer relationships. The fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using rates ranging from 15% to 17%. The cash flows were based on estimates used to price the transaction, and the discount rates applied were benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The developed technology consists of artificial intelligence powered applications for lung nodule management and early lung cancer diagnosis and reporting.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The IPR&amp;D asset relates primarily to an in-process project for a customer relationship management offering to manage patients that are found with Incidental Pulmonary Nodules and has not reached technological feasibility as of the acquisition date. The asset recorded relates to one project, and the Company expects to complete the project in the next twelve months. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The useful lives for the developed technology asset was set at 7 years, for customer relationships 5.4 years, and trade names was 7 years. The calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. Factors contributing to the recognition of the amount of goodwill were primarily based on anticipated strategic and synergistic benefits that are expected to be realized from the acquisition. These benefits include expanding the Company's AI capabilities to drive revenue growth.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Quantib B.V.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 20, 2022, we completed our acquisition of all the equity interests of Quantib B.V. ("Quantib") an artificial intelligence enterprise focused on prostate cancer screening.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Quantib is reported as part of our artificial intelligence segment, and was acquired to enhance our AI capabilities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transaction was accounted for as an acquisition of a business and total purchase consideration was determined to be approximately $42.3&#160;million including i) 965,058 shares issued at $26.80 per share with a fair value of $25.9&#160;million ii) cash of $11.8&#160;million and iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">contingent consideration consisting of 113,303 shares with a fair value at the date of close of $3.0&#160;million and cash of $1.6&#160;million both to be released 18 months after acquisition subject to adjustment for any indemnification claims. As a result of this transaction, we recorded $2.4&#160;million in current assets, $0.1&#160;million in property and equipment, $21.3&#160;million in intangible assets (including developed technology of $19.6&#160;million and IPR&amp;D of $0.7&#160;million), $0.7&#160;million in current liabilities, $6.7&#160;million in long-term debt and deferred tax liabilities, and $26.4&#160;million in goodwill.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In performing the purchase price allocation, we considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of the Quantib business.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As part of the purchase price allocation, we determined the identifiable intangible assets are developed technology, IPR&amp;D, trade names, and customer relationships. The fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using rates ranging from 50% to 55%. The cash flows were based on </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">estimates used to price the transaction, and the discount rates applied were benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The developed technology consists of artificial intelligence powered applications for neurological and prostate imaging scans and reporting.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The useful lives for the developed technology asset was set at seven years, customer relationships three years, and trade names seven years. The calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. Factors contributing to the recognition of the amount of goodwill were primarily based on anticipated strategic and synergistic benefits that are expected to be realized from the acquisition. These benefits include expanding the Company's AI capabilities to drive revenue growth.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As disclosed above, for the acquisitions of Aidence and Quantib, the Company used the income approach to determine the fair value of developed technology and IPR&amp;D acquired in business combinations. This approach determines fair value by estimating the after-tax cash flows attributable to the respective assets over their useful lives and then discounting these after-tax cash flows back to a present value. The Company bases its revenue assumptions on estimates of relevant market sizes, expected market growth rates, expected trends in technology and expected product introductions by competitors. The value of the in-process projects is based on the project's stage of completion, the complexity of the work completed as of the acquisition date, the projected costs to complete, the expected introduction date, the estimated cash flows to be generated upon commercial release and the estimated useful life of the technology. The Company believes that the estimated developed technology and IPR&amp;D amounts represent the fair value at the date of acquisition and do not exceed the amount a third-party would pay for the assets. The significant assumptions used to estimate the fair value of intangible assets include discount rates and certain assumptions that form the basis of the forecasted results, specifically, revenue growth rates, EBITDA margins and obsolescence factors. These significant assumptions are forward looking and could be affected by future economic and market conditions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Subsidiary activity</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Formation of majority owned subsidiaries</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Frederick County Radiology, LLC</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2022 we formed Frederick County Radiology, LLC ("FCR"), a partnership with Frederick Health Hospital, Inc. ("Hospital").  The operation offers multi-modality services out of six locations in Frederick, Maryland.  We contributed the operations of four centers to the enterprise and Hospital contributed $5.4 million in fixed assets, $3.0 million in equipment, and  $11.0 million in goodwill.  As a result of the transaction, we recognized a gain of $6.6 million to additional paid in capital and retained a 65% controlling economic interest in FCR and Hospital retains an $11.1 million or 35% noncontrolling economic interest in FCR.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Advanced Radiology at Capital Region, LLC</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 15, 2022 we entered into Advanced Radiology at Capital Region, LLC, a partnership with Dimension Health Corporation. ("Dimension"), an affiliate of the University of Maryland.  The operation will provide multi-modality services out of two yet to be determined locations in the Largo, Maryland area.  The venture was initially capitalized with nominal amounts of $5.1&#160;thousand for a 51% economic interest  from us and $4.9&#160;thousand from Dimension for a 49% economic interest.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Simi Valley Imaging Group, LLC</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2021 we entered into the Simi Valley Imaging Group, LLC, a partnership with Simi Valley Hospital and Health Services ("Simi Adventist").  The operation will offer multi-modality imaging services out of two locations in Ventura County, California.  Total investment in the venture is $0.4 million. RadNet contributed $0.3 million in assets for a 60.0% economic interest and Simi Adventist contributed assets totaling $0.1 million for a 40.0% economic interest.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sale of ownership interest  in a majority owned subsidiary</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective September 1, 2021 we completed the sale of a 24.9% ownership interest in our majority owned subsidiary West Valley Imaging Group, LLC for $13.1 million to Tarzana Medical Center, LLC.  After the sale, our ownership interest in the subsidiary has reduced from 75.0% to 50.1% and we retain a controlling financial interest in the subsidiary.  We recognized in additional paid in capital on our consolidated balance sheets, $4.2 million excess in consideration over the carrying value of the sold economic interest.  Post the sale of our ownership interest we acquired from Tarzana Medical Center, LLC, certain tangible and intangible business assets for purchase consideration of approximately $5.2 million.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Investments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medic Vision, based in Israel, specializes in software packages that provide compliant radiation dose structured reporting and enhanced images from reduced dose CT scans.  On March 24, 2017, we acquired an initial 12.50% equity interest in Medic Vision - Imaging Solutions Ltd for $1.0 million. We also received an option to exercise warrants to acquire up to an additional 12.50% equity interest for $1.4 million within one year from the initial share purchase date, if exercised in full. On March 1, 2018 we exercised our warrant in part and acquired an additional 1.96% for $0.2 million. Our initial equity interest has been diluted to 12.25% and our total equity investment stands at 14.21%.  In accordance with accounting guidance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as we exercise no significant influence over Medic Vision&#8217;s operations, the investment is recorded at its cost of $1.2 million, given that the fair value is not readily determinable. No observable price changes or impairment in our investment was noted as of the year ended December 31, 2022.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Turner Imaging Systems, based in Utah, develops and markets portable X-ray imaging systems that provide a user the ability to acquire X-ray images wherever and whenever they are needed. On February 1, 2018, we purchased 2.1 million preferred shares in Turner Imaging Systems for $2.0 million.  On January 1, 2019 we funded a convertible promissory note in the amount of $143,000 that converted to an additional 80,000 preferred shares on October 11, 2019.  No observable price changes or impairment in our investment was noted for the year ended December 31, 2022.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WhiteRabbit.ai Inc., based in California, is currently developing an artificial intelligence suite which aims to improve the speed and accuracy of cancer detection in radiology and improve patient care. On November 5, 2019 we acquired an equity interest in the company for $1.0 million and also loaned the company $2.5 million in support of its operations.  No observable price changes or impairment in our investment was noted for the year ended December 31, 2022.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Joint venture investment contributions to Arizona Diagnostic Radiology Group</span></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December 31, 2022 and 2021, we made an additional equity contributions of $1.4 million each year to Arizona Diagnostic Radiology Group ("ADRG", our joint venture with Dignity Health).</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2022 we contributed eight of our imaging centers to ADRG with a carrying value of $12.7 million and recorded a loss of $0.5 million which was calculated as the difference between the fair value and carrying value of such imaging centers which included equipment and other assets and an allocation of goodwill to such imaging centers.  We accounted for the transaction as an adjustment to our equity investment for the value of the assets contributed.  To maintain our 49% economic interest in ADRG, we received a distribution from the partnership of $4.5 million to reduce our overall investment to $8.3 million.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth, for the periods indicated, the percentage that certain items in the statements of operations bears to net revenue for the years 2022, 2021 and 2020.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">REVENUE</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service fee revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue under capitation arrangements</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.3&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Provider relief funding</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OPERATING EXPENSES</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of operations, excluding depreciation and amortization</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.4&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.4&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.1&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease abandonment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on sale and disposal of equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on impairment</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.8&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.4&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">INCOME FROM OPERATIONS</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OTHER INCOME AND EXPENSES</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in earnings of joint ventures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash change in fair value of interest rate hedge</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss (gain) on extinguishment of debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expenses</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">INCOME (LOSS) BEFORE INCOME TAXES</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for  income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NET INCOME (LOSS)</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NET INCOME (LOSS) ATTRIBUTABLE TO RADNET, INC.</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">COMMON STOCKHOLDERS</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Imaging Center Segment</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Year Ended December 31, 2022 Compared to the Year Ended December 31, 2021 </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We grow through a combination of organic growth as well as acquisitions and joint ventures.  In the discussion below same center metrics are based on imaging centers that were in operation throughout the period of January 1, 2021 through December 31, 2022.  Excluded amounts relate to imaging centers that were acquired or divested between January 1, 2021 through December 31, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Total Revenue inclusive of Provider Relief Funding for 2021&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-top:5pt;padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.760%"><tr><td style="width:1.0%"></td><td style="width:39.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.777%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In Thousands</span></td><td colspan="12" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ Increase/(Decrease)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenue</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,425,665</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,322,772</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$102,893</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Same Center Revenue</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,275,333</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,239,587</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$35,746</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excluded</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$150,333</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$83,185</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Overall revenue change was driven by procedure volume growth of 2.7% compared to the same period in the prior year. On a same center basis, the increase in revenue was largely attributable to product mix as advanced radiology procedures of MRI, PET, and CT expanded at combined 5.5% to provide the major portion of the revenue growth.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Expenses</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating expenses for the twelve months ended December 31, 2022 increased approximately $117.8 million, or 9.5%, from $1.24 billion for the twelve months ended December 31, 2021 to $1.35 billion for the twelve months ended December 31, 2022.  The following table sets forth our cost of operations and total operating expenses for the twelve months ended December 31, 2022 and 2021 (in thousands):</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Salaries and professional reading fees, excluding stock-based compensation</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">778,586&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">683,772&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,988&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,407&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building and equipment rental</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,058&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,924&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical supplies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,712&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,423&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">*</span></div></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249,249&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232,416&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,240,593&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,117,942&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,524&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease abandonment charges</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,675&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on sale and disposal of equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,506&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,246&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance costs</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">926&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">744&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,353,549&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,235,780&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Includes billing fees, office supplies, repairs and maintenance, insurance, business tax and license, outside services, telecommunications, utilities, marketing, travel and other expenses.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160; Salaries and professional reading fees, excluding stock-based compensation and severance</span></div><div style="margin-top:5pt;padding-left:31.5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.614%"><tr><td style="width:1.0%"></td><td style="width:39.272%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.810%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In Thousands</span></td><td colspan="12" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Salaries and Professional Fees</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ Increase/(Decrease)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$778,586</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$683,772</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$94,814</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9%</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Same Center</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$709,525</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$639,124</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$70,401</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.0%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excluded</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$69,061</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$44,648</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr></table></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Similar to the prior year, growth in procedure volumes precipitated increases in salary expenses both to meet additional professional staffing needs and retain our skilled work force in the current tight labor market.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Stock-based compensation</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation decreased $2.4 million, or 10.3%, to approximately $21.0 million for the twelve months ended December 31, 2022 compared to $23.4 million for the twelve months ended December 31, 2021. The decrease was a result of a series of pandemic related one time employee bonus stock awards amounting to $8.9 million that were awarded in the second quarter of 2021. There were no similar one time awards granted in 2022.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Building and equipment rental</span></div><div style="margin-top:5pt;padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.614%"><tr><td style="width:1.0%"></td><td style="width:39.272%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.810%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In Thousands</span></td><td colspan="12" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building &amp; Equipment Rental</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ Increase/(Decrease)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$123,058</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$121,924</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,134</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9%</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Same Center </span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$100,663</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$104,163</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($3,500)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.4)%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excluded</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$22,395</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$17,761</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr></table></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Overall building and rental remained flat year over year. On a same center basis, the decrease in building and equipment rent was reflective of savings from facilities that were abandoned in Dec 2021 and buyout of radiology equipment lease contracts during the year.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Medical supplies</span></div><div style="margin-top:5pt;padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.614%"><tr><td style="width:1.0%"></td><td style="width:39.272%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.810%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In Thousands</span></td><td colspan="12" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Supplies Expense</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ Increase/(Decrease)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$68,712</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$56,423</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$12,289</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.8%</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Same Center</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$62,274</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$52,872</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$9,402</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.8%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excluded</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$6,438</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3,551</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr></table></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Increased medical supplies expense corresponds to the 5.5% growth in advanced radiology volumes as noted above combined with price increases for contrast agents and higher utilization of isotopes employed in PET and CT procedures.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Other operating expenses</span></div><div style="margin-top:5pt;padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.760%"><tr><td style="width:1.0%"></td><td style="width:39.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.777%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In Thousands</span></td><td colspan="12" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Operating Expenses</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ Increase/(Decrease)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$249,249</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$232,416</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$16,833</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2%</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Same Center</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$224,174</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$214,488</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$9,684</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excluded</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$25,075</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$17,928</span></td><td colspan="2" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr></table></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The rise in other operating expenses is attributable to additional professional fees associated with our acquisition activity, contractor services, equipment and maintenance and software upgrades all in support of our expansion accompanied with increased procedure volumes.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Additional segment operating and non operating expenses:</span></div><div style="margin-top:5pt;padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:80.555%"><tr><td style="width:1.0%"></td><td style="width:46.631%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.967%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.967%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.967%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.968%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In Thousands</span></td><td colspan="12" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ Increase/(Decrease)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and Amortization</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$109,524</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$96,173</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$13,351</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9%</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss  on disposal of equipment and other</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,506</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,246</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,260</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">nm</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash change in fair value of interest rate swaps</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($39,621)</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($21,670)</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(17,951)</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">nm </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expenses*</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3,467</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$6,859</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(3,393)</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">nm</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$926</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$744</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$183</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.5%</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nm=not meaningful</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other expenses in 2022 and 2021 included approximately $0.7 million and $6.0 million of debt extinguishment and restructuring charges, respectively, which related to refinancing of our credit facilities with Truist in 2022 and Barclays in 2021.  See Note 8 Credit Facilities and Notes Payable included in the notes to our consolidated financial statements.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lease abandonment charges</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We closely monitor patient levels at our imaging centers and occasionally divest or shut down centers in an effort to maximize utilization rates.  In the post-pandemic period of 2021, while overall procedure volumes had returned to pre-pandemic levels, we experienced lower utilization rates at imaging centers that were based in urban centers as a result of increased telecommuting and migration of the work force to spending more time in residential areas.  In response we terminated leases at some centers, consolidating procedural volumes into fewer more active imaging centers, and reduced administrative office space. We recorded a one-time charge of approximately $19.7 million at December 31, 2021 related to leased facilities abandonment. The lease abandonment charges include the impairment of associated right of use assets of $12.6 million and write off of related leasehold improvements of approximately $7.1 million.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impairment Charges</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2020, we ceased employing certain indefinite lived trade names with a total value of $4.2 million and they were written off in full.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest expense</span></div><div style="margin-top:5pt;padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.684%"><tr><td style="width:1.0%"></td><td style="width:41.757%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.188%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In Thousands</span></td><td colspan="12" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Expense</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ Increase/(Decrease)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Interest Expense</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$50,841</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$48,830</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,011</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash Paid for Interest</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$39,151</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$29,042</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$10,109</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.8%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The rise in adjusted interest expense is attributable to a higher overall loan balances in combination with increased variable interest rates paid on those balances compared to the same period in the prior year. During 2002 we refinanced our Truist term loan which added an additional $108.0 million in obligations to our balance sheet in the fourth quarter. Based on recent increases in global interests rates, we expect the effective interest rates on our senior credit facilities, and our related interest expense, to continue to rise in the near term. See &#8220;Liquidity and Capital Resources&#8221; below for more details on our credit facilities.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> See the Derivative Instruments section of Note 2 to the consolidated financial statements included in this annual report on Form 10-K and Item 7A, Quantitative and Qualitative Disclosure About Market Risk below for more details on our derivative transactions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity in earnings from unconsolidated joint ventures</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the twelve months ended December 31, 2022 we recognized equity in earnings from unconsolidated joint ventures of  $10.4 million versus $11.0 million for the twelve months ended December 31, 2021, a decrease of $0.6 million or 5.3%.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Gain on extinguishment of debt and related expenses</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2020, we received a loan in the amount of $4.0 million through the Paycheck Protection Program.  The Program has provisions that if met, allow the loan to be forgiven.  In December 2020, we met the eligibility requirements for forgiveness of loans and recorded a gain on extinguishment of debt of approximately $4.0 million.  See Note 8 Credit Facilities and Notes Payable included in this annual report on Form 10-K.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AI Segment</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our AI segment develops and deploys clinical applications to enhance interpretation of medical images and improve patient outcomes with a current emphasis on brain, breast, prostate, and pulmonary diagnostics.  We are developing our AI segment initially through acquisition activity.  The operations of Nulogix and Deephealth comprise the results for 2021.  Our 2022 results include our recent additions of Aidence and Quantib.  The  breakdown of revenue and expenses of the segment for the twelve months ended December 31, 2022 and 2021 are as follows:</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">                               </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.906%"><tr><td style="width:1.0%"></td><td style="width:34.570%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.344%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In Thousands</span></td><td colspan="9" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Twelve Months Ended December 31,</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ Increase/(Decrease)</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Statement of Operations</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$4,396</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$1,415</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$2,981</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Salaries and Wages</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$15,799</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,938</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$12,861</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Stock compensation</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,782</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,796</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">986</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Other operating</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,171</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,572</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Depreciation &amp; Amort.</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,353</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">520</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,833</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Other operating loss</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Severance</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">30,149</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,853</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">24,296</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from Operations</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(25,753)</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(4,438)</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(21,315)</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(903)</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">622</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,525)</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before taxes</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(24,850)</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(5,060)</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(19,790)</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,743)</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,743)</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment net loss</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">($22,107)</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">($5,060)</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">($17,047)</span></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Year Ended December 31, 2021 Compared to the Year Ended December 31, 2020 </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the comparison of results of operations for the year ended December 31, 2021 to the year ended December 31, 2020, please see Item 7, Management's Discussion and Analysis of Financial Condition and Operations in our Form 10-K for the year ended December 31, 2021, filed with the SEC on March 1, 2022.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-GAAP Financial Measures</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use both GAAP and non-GAAP metrics to measure our financial results. We believe that, in addition to GAAP metrics, non-GAAP metrics such as Adjusted EBITDA and Free Cash Flow assist us in measuring our core operations from period to period as well as our cash generated from operations and ability to service our debt obligations.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Adjusted EBITDA</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Adjusted EBITDA metric removes non-cash and non-recurring charges that occur in the affected period and provides a basis for measuring the Company&#8217;s core financial performance against other periods.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We define Adjusted EBITDA as earnings before interest, taxes, depreciation and amortization, as adjusted to exclude losses or gains on the disposal of equipment, other income or loss, loss on debt extinguishment, bargain purchase gains, loss on de-consolidation of joint ventures and non-cash equity compensation.&#160; Adjusted EBITDA includes equity earnings in unconsolidated operations and subtracts allocations of earnings to non-controlling interests in subsidiaries, and is adjusted for non-cash or one-time events that take place during the period.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted EBITDA is a non-GAAP financial measure used as an analytical indicator by us and the healthcare industry to assess business performance, and is a measure of leverage capacity and ability to service debt. Adjusted EBITDA should not be considered a measure of financial performance under GAAP, and Adjusted EBITDA should not be considered in isolation or </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as alternatives to net income, cash flows generated by operating, investing or financing activities or other financial statement data presented in the consolidated financial statements as an indicator of financial performance or liquidity.  Adjusted EBITDA is not a measurement determined in accordance with GAAP and is therefore susceptible to varying methods of calculation and this metric, as presented, may not be comparable to other similarly titled measures of other companies.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of the nearest comparable GAAP financial measure, net income, to Adjusted EBITDA for the years ended December 31, 2022, 2021, and 2020, respectively (in thousands):</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.251%"><tr><td style="width:1.0%"></td><td style="width:55.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.687%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.687%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.690%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net  income (loss) attributable to RadNet, Inc. common stockholders</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,650&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,727&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,840)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income Taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,361&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,560&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">895&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Expense</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,841&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,830&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,882&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">946&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">744&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,353&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,877&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,694&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,795&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash employee stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,770&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,203&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,405&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on sale and disposal of equipment</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,529&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,246&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on impairment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss (gain) on extinguishment of debt and related expenses</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">731&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,044&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,047)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,833&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,438&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash change in fair value of interest rate hedge</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,621)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,670)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,528&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other adjustment to joint venture investment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(565)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal settlement and related expenses</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,197&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">831&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease abandonment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,675&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non operational rent expenses</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,297&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transaction costs HLH,  Aidence Holding B.V. &amp; Quantib B.V</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">927&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation adjustment for contingent consideration</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in estimate related to refund liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,089&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 82pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted EBITDA Including Losses from AI Segment and Provider Relief Funding</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$192,474</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$218,928</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$139,461</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider relief funding</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,110)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26,264)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 82pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted EBITDA including losses from AI Segment and excluding benefit from Provider Relief Funding</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$192,474</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$209,818</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$113,197</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA Losses from AI segment</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,575&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,121&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,757&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 82pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted EBITDA excluding Losses from AI Segment and Provider Relief Funding</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$209,049</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$211,939</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$114,954</span></td></tr></table></div><div style="text-align:justify;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following table is a reconciliation of GAAP net income for our AI Segment to Adjusted EBITDA for the years ended December 31, 2022, 2021 and 2020 respectively.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.514%"><tr><td style="width:1.0%"></td><td style="width:42.228%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.490%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.543%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Twelve Months Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment net loss</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,107)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,060)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,463)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock Compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,782&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,796&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,065&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation &amp; Amortization</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,353&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">520&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income)</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(903)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">622&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,743)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted EBITDA AI Segment</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(16,575)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,121)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,757)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of key balance sheet data as of December 31, 2022 and December 31, 2021 and income statement data for the twelve months ended December 31, 2022, 2021 and 2020 (in thousands):</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.005%"><tr><td style="width:1.0%"></td><td style="width:60.330%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.963%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.186%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.567%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet Data for the period ended December 31,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,834&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134,606&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166,357&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,062&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Working capital (exclusive of current operating lease liability)</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41,932)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,932&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders' equity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">491,452&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346,157&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income Statement data for the twelve months ended December 31,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,430,061&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,315,077&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,071,840&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to RadNet common stockholders</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,650&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,727&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,840)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in a capital intensive, high fixed-cost industry that requires significant amounts of capital to fund operations. In addition to operations, we require a significant amount of capital for the initial start-up and development of new diagnostic imaging centers, the acquisition of additional centers and new diagnostic imaging equipment. Because our cash flows from operations have been insufficient to fund all of these capital requirements, we have depended on the availability of financing under credit arrangements with third parties.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic initially resulted in a reduction of procedure volumes as people "sheltered in place" and deferred elective procedures, resulting in a corresponding decrease in operating revenues for the year ended December 31, 2020.  For 2021 our procedural volumes returned to pre-pandemic levels.  However, the COVID-19 pandemic continues to evolve and significant additional outbreaks could again result in periods where we experience decreased procedural volumes.  Any suspended reduction in procedures would negatively affect our revenues, profitability and working capital position.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have credit available from our current credit facilities and borrowing under those facilities is subject to continued compliance with lending covenants.  We currently meet those requirements, but substantial and sustained operating losses could impact our ability to borrow under those facilities.  If we are not able to meet such requirements, we may be required to seek additional financing and there can be no assurance that we will be able to obtain financing from other sources on terms acceptable to us, if at all.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On a continuing basis, we also consider various transactions to increase shareholder value and enhance our business results, including acquisitions, divestitures and joint ventures. These types of transactions may result in future cash proceeds or payments but the general timing, size or success of any acquisition, divestiture or joint venture effort and the related potential capital commitments cannot be predicted. We expect to fund any future acquisitions primarily with cash flow from operations and borrowings, including borrowing from amounts available under our senior secured credit facilities or through new equity or debt issuances.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and our subsidiaries or affiliates may from time to time, in our sole discretion, purchase, repay, redeem or retire any of our outstanding debt or equity securities in privately negotiated or open market transactions, by tender offer or otherwise.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sources and Uses of Cash</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes key components of our sources and uses of cash for the twelve  months ended December 31, in thousands:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.573%"><tr><td style="width:1.0%"></td><td style="width:49.484%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.926%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.926%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.929%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash Flow Data</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Cash provided by operating activities</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146,417&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,491&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233,759&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Cash used in investing activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(246,949)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(221,511)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(126,244)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Cash provided by (used in) financing activities</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,647&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,673&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,561)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash provided by operating activities for the period ended December 31, 2020 was benefited by the receipt of $39.5 million in CMS advances recorded as deferred revenue.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash used in investing activities for the twelve months ended December 31, 2022, included purchases of  property and equipment for approximately $119.5 million, acquired imaging businesses and other operations for $130.0 million and an equity contribution to a joint venture operation of $1.4 million.  As part of our business operations we continually evaluate investment opportunities.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash provided by financing activities for the twelve months ended December 31, 2022 was related mainly to the refinancing of our Truist term loan obligations with the Second Amended and Restated Revolving Credit and Term Loan Agreement on October 10, 2023.  Please see Note 8, Credit Facilities and Notes Payable in the notes to consolidated financial statements included in this annual report on Form 10-K for more information.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into factoring agreements with various institutions and sold certain accounts receivable under non-recourse agreements in exchange for notes receivables from the buyers. These transactions are accounted for as a reduction in accounts receivable as the agreements transfer effective control over and risk related to the receivables to the buyers. Proceeds on notes receivables are reflected as operating activities on our statement of cash flows and on our balance sheet as prepaid expenses and other current assets for the current portion and deposits and other for the long term portion.   Amounts remaining to be collected on these agreements were $15.4 million and  $17.7 million at December 31, 2022 and December 31, 2021, respectively.  We do not utilize factoring arrangements as an integral part of our financing for working capital.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Senior Credit Facilities:</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain secured credit facilities with Barclays Bank PLC and with Truist.  The Barclays credit facilities are comprised of first lien term loans and a revolving credit facility of $195.0 million. The Truist credit facilities are comprised of a term loan and a revolving credit facility of $50.0 million.  As of December 31, 2022, we were in compliance with all covenants under our credit facilities.  Deferred financing costs on our revolving credit lines at December 31, 2022, net of accumulated amortization, totaled $2.3 million, with $1.7 million related to Barclays and $0.6 million related to Truist.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in our consolidated balance sheets at December 31, 2022 are $851.7 million of total term loan debt (net of unamortized discounts of $12.4 million) displayed below in thousands:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Face Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Discount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Carrying<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Barclays First Lien Term Loans</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">714,125&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,127)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">702,998&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Truist Term Loan Agreement</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,254)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148,746&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Term Loans</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">864,125&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,381)</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">851,744&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had no outstanding balance under our $195.0 million Barclays Revolving Credit Facility at December 31, 2022 and had reserved $7.6 million for certain letters of credit.  The remaining $187.4 million of our Barclays Revolving Credit Facility was available to draw upon as of  December 31, 2022.  We also had no balance under our $50.0 million Truist </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revolving Credit Facility related to our consolidated subsidiary NJIN at December 31, 2022, and with no letters of credit reserved against the facility, the full amount was available to draw upon.  For more information on our secured credit facilities see Note 8 to our consolidated financial statements in this annual report.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contractual Commitments</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our future obligations for notes payable, lines of credit, and equipment and building operating leases for the next five years and thereafter include (dollars in thousands):</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:29.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.913%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.037%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2027</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes payable</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,750&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,750&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,500&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,500&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,750&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">677,875&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">864,125&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and fees on notes payable</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,767&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,868&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,575&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,284&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,359&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,904&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337,757&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases (1)</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,371&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,436&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,941&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,872&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,136&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499,326&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">941,082&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173,888&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173,054&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,016&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167,656&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262,245&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,194,105&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,142,964&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Includes interest component of operating lease obligations.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We have service agreements with various vendors under which they have agreed to be responsible for the maintenance and repair of a majority of our equipment for a fee that is based on the type and age of the equipment. Under these agreements, we are committed to minimum payments of approximately $43.3 million in 2023.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Securities and Exchange Commission defines critical accounting estimates as those that are both most important to the portrayal of a company&#8217;s financial condition and results of operations and require management&#8217;s most difficult, subjective or complex judgment, often as a result of the need to make estimates about the effect of matters that are inherently uncertain and may change in subsequent periods.&#160;In Note 2 to our consolidated financial statements in this annual report on Form 10-K we discuss our significant accounting policies, including those that do not require management to make difficult, subjective or complex judgments or estimates. The critical areas involving management&#8217;s judgments and estimates are described below.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">USE OF ESTIMATES - The financial statements have been prepared in accordance with U.S. generally accepted accounting principles (GAAP), which requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. These estimates and assumptions affect various matters, including our reported amounts of assets and liabilities in our consolidated balance sheets at the dates of the financial statements; our disclosure of contingent assets and liabilities at the dates of the financial statements; and our reported amounts of revenues and expenses in our consolidated statements of operations during the reporting periods. These estimates involve judgments with respect to numerous factors that are difficult to predict and are beyond management&#8217;s control. As a result, actual amounts could materially differ from these estimates.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">REVENUES &#8211; Our revenues generally relate to net patient fees&#160;received from various payors and patients themselves under contracts in which our performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period when our obligations to provide diagnostic services are satisfied. Our performance obligations for diagnostic services are generally satisfied over a period of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payor (Medicare, Medicaid, managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent upon the terms provided by Medicare and Medicaid, or negotiated with managed care health plans and commercial insurance companies. The payment arrangements with third-party payors for the services we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As it relates to the Group, this service fee revenue includes payments for both the professional medical interpretation revenue recognized by them as well as the payment for all other aspects related to our providing the imaging services, for which we earn management fees. As it relates to other centers, this service fee revenue is earned through providing the use of our diagnostic imaging equipment and the provision of technical services as well as providing administration services such as clerical and administrative personnel, bookkeeping and accounting services, billing and collection, provision of medical and </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">office supplies, secretarial, reception and transcription services, maintenance of medical records, and advertising, marketing and promotional activities.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenues are based upon the estimated amounts we expect to be entitled to receive from patients and third-party payors. Estimates of contractual allowances under managed care and commercial insurance plans are based upon the payment terms specified in the related contractual agreements. Revenues related to uninsured patients and copayment and deductible amounts for patients who have health care coverage may have discounts applied (uninsured discounts and contractual discounts). We also record estimated implicit price concessions (based primarily on historical collection experience) related to uninsured accounts to record self-pay revenues at the estimated amounts we expect to collect.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under capitation arrangements with various health plans, we earn a per-enrollee amount each month for making available diagnostic imaging services to all plan enrollees under the capitation arrangement. Revenue under capitation arrangements is recognized in the period in which we are obligated to provide services to plan enrollees under contracts with various health plans.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PROVIDER RELIEF FUND (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">COVID-19 STIMULUS FUNDING</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) - The Provider Relief Fund offers government assistance to eligible providers throughout the healthcare system in support of certain expenses or lost revenue attributable to the coronavirus pandemic. We received $9.1 million and $26.3 million in Provider Relief funding for the years ended December 31, 2021 and 2020, respectively. Generally, the department of Health and Human Services ("HHS") does not intend to recoup funds as long as a provider's lost revenue and increased expenses exceed the amount of provider relief funding one has received. HHS reserves the right to audit Relief Fund recipients in the future to ensure that this requirement is met and collect any Relief Fund amounts that were made in error or exceed lost revenue or increased expenses due to the pandemic. Failure to comply with the terms and conditions may be grounds for recoupment.  Based on our assessment recognition of the revenue previously recognized remained appropriate.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ACCOUNTS RECEIVABLE &#8211; Substantially all of our accounts receivable are due under fee-for-service contracts from third party payors, such as insurance companies and government-sponsored healthcare programs, or directly from patients. Services are generally provided pursuant to one-year contracts with healthcare providers. We continuously monitor collections from our payors and maintain an allowance for bad debts based upon specific payor collection issues that we have identified and our historical experience.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BUSINESS COMBINATION &#8211; When the qualifications for business combination accounting treatment are met, it requires us to recognize separately from goodwill the assets acquired and the liabilities assumed at their acquisition date fair values. Goodwill as of the acquisition date is measured as the excess of consideration transferred over the net of the acquisition date fair values of the assets acquired and the liabilities assumed. While we use our best estimates and assumptions to accurately value assets acquired and liabilities assumed at the acquisition date, our estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, we record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. Upon the conclusion of the measurement period or final determination of the values of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to our consolidated statements of operations.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GOODWILL AND INDEFINITE LIVED INTANGIBLES &#8211; Goodwill totaled $677.7 million and $513.8 million at December 31, 2022 and December 31, 2021, respectively. Indefinite lived intangible assets were $24.1 million at December 31, 2022 and $20.6 million at December 31, 2021 and are associated with the value of certain trade name intangibles and in process research and development (IPR&amp;D). Goodwill, trade name intangibles and IPR&amp;D are recorded as a result of business combinations. When we determine the carrying value of goodwill exceeds its fair value, an impairment charge would be recognized which should not exceed the total amount of goodwill allocated to that reporting unit. We determined fair values for each of the reporting units using the market approach, when available and appropriate, or the income approach, or a combination of both. We assess the valuation methodology based upon the relevance and availability of the data at the time we perform the valuation. If multiple valuation methodologies are used, the results are weighted appropriately.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We tested goodwill, trade name and IPR&amp;D for impairment&#160;on October 1, 2022.  In 2020 we ceased employing certain indefinite lived trade names with a total value of $4.2 million and they were written off in full as of December 31, 2020.  Our annual impairment test as of October 1, 2022 noted no other impairment, and we have not identified any indicators of impairment through December 31, 2022.  </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Standards</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 3, Recent Accounting and Reporting Standards to the consolidated financial statements included in this annual report for further information.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Additional Information</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional information concerning RadNet, Inc., including our consolidated subsidiaries, for each of the years ended December 31, 2022, 2021 and 2020 is included in the consolidated financial statements and notes thereto in this annual report.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="if3f80771944f4fc58015abda42dc47d1_46"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 7A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Quantitative and Qualitative Disclosures About Market Risk</span></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Exchange Risk.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We generate substantially all of our revenues and incur substantially all of our expenses in United States dollars.  As a  result, our financial results are unlikely to be materially affected by changes in foreign currency exchange rates or weak economic conditions in foreign markets.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to foreign exchange risk with respect to revenues and expenses denominated in the Euro, Canadian Dollar, Hungarian Forint and Pound Sterling. We have Artificial Intelligence operations in the Netherlands, radiology services in the United Kingdom, and maintain research and development centers in Canada and Hungary. At the present time, we do not have any foreign currency exchange contracts to mitigate this risk. At December 31, 2022, a hypothetical 1% decline in the currency exchange rates between the U.S. dollar against these currencies, would have resulted in an annual increase of approximately $0.2 million in operating expenses. </span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Sensitivity.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We pay interest on various types of debt instruments to our suppliers and lending institutions. The agreements entail either fixed or variable interest rates.&#160; Instruments which have fixed rates are mainly leases on radiology equipment. Variable rate interest obligations relate primarily to amounts borrowed under our outstanding credit facilities.&#160;Accordingly, our interest expense and consequently, our earnings, are affected by changes in short term interest rates. However due to our purchase of swaps, described below, the effects of interest rate changes are limited.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We can elect Eurodollar or Base Rate (Prime) interest rate options on amounts outstanding under the First Lien Term Loans.  At December 31, 2022, we had $214.1 million outstanding subject to a Eurodollar election on First Lien Term Loans and our effective 3 month LIBOR rate plus applicable margin was 4.73%. A hypothetical 1% increase in the adjusted Eurodollar rates under the Restated Credit Agreement over the current Eurodollar rate would result in an increase of $2.1 million in annual interest expense and a corresponding decrease in income before taxes. At December 31, 2022, we had $1.8 million loan amount principal outstanding subject to an alternate base rate election on First Lien Term Loans with an effective rate of 9.50%.  A hypothetical 1% increase in the alternative base rate under the First Lien Credit Agreement over the current alternative base rate would result in an increase of $18.0 thousand in annual interest expense and a corresponding decrease in income before taxes.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2022, we had $150.0 million outstanding subject to an adjusted SOFR election on the Truist Restated Credit and Term Loan Agreement. We can elect SOFR or Base Rate interest options on amounts outstanding under the Truist Restated Credit and Term Loan Agreement.  At December 31, 2022, our effective SOFR rate plus applicable margin was 6.28%.  A hypothetical 1% increase in the adjusted Eurodollar rates under the Truist Restated Credit and Term Loan Agreement would result in an increase of approximately $1.5 million in annual interest expense and a corresponding decrease in income before taxes.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2019, we entered into four forward interest rate agreements ("2019 Swaps").  The 2019 Swaps have total notional amounts of $500,000,000, consisting of two agreements of $50,000,000 each and two agreements of  $200,000,000 each.   The 2019 Swaps will secure a constant interest rate associated with portions of our variable rate bank debt and have an effective date of October 13, 2020. They will mature in October 2023 for the smaller notional and October 2025 for the larger notional. Under these arrangements, we arranged the 2019 Swaps with locked in 1 month LIBOR rates at 1.96% for the $100,000,000 notional and at 2.05%  for the $400,000,000 notional.  As of the effective date, we will be liable for premium payments if interest rates decline below arranged rates, but will receive payments under the 2019 Swaps if interest rates rise above the arranged rates.</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><div id="if3f80771944f4fc58015abda42dc47d1_49"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 8.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Financial Statements and Supplementary Data</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><div id="if3f80771944f4fc58015abda42dc47d1_52"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:164%">Report of Independent Registered Public Accounting Firm</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:164%">To the Stockholders and the Board of Directors of RadNet, Inc.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:164%">Opinion on the Financial Statements</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We have audited the accompanying consolidated balance sheets of RadNet, Inc. and subsidiaries</span><span style="background-color:#f4f4f4;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(the Company) as of December 31, 2022 and 2021, the related consolidated statements of operations, comprehensive income (loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> equity and cash flows for each of the three years in the period ended December 31, 2022, and the related notes</span><span style="background-color:#f4f4f4;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(collectively referred to as the &#8220;consolidated financial statements&#8221;). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at December 31, 2022 and 2021, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2022, in conformity with U.S. generally accepted accounting principles. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial reporting as of December 31, 2022, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework), and our report dated March 1, 2023 expressed an unqualified opinion thereon.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:164%">Basis for Opinion</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:164%">Critical Audit Matters</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The critical audit matters communicated below are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.982%"><tr><td style="width:1.0%"></td><td style="width:16.824%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.844%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:78.932%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Accounting for Revenue Recognition</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Description of</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">the Matter</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For the year ended December 31, 2022, the Company&#8217;s service fee revenue was $1,278 million. As discussed in Note 2 to the consolidated financial statements, service fee revenue is based upon the estimated amounts the Company expects to be entitled to receive from patients and third-party payors (Medicare, Medicaid, managed care health plans and commercial insurance companies). Estimates of contractual allowances and implicit price concessions associated with third-party payors and any amounts due directly from patients, are based upon historical collection experience from such payors. The contractual allowance estimation process is periodically reviewed to consider and incorporate updates to laws and regulations, changes in business and economic conditions and contractual terms resulting from contract negotiations and renewals. The Company also records estimated implicit price concessions (based primarily on historical collection experience) related to amounts due directly from patients to record these revenues and accounts receivable at the estimated amounts the Company expects to collect.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Auditing management&#8217;s estimates of contractual allowances and implicit price concessions was complex and judgmental due to the significant data inputs and subjective assumptions utilized in determining related amounts.</span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.982%"><tr><td style="width:1.0%"></td><td style="width:16.824%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.844%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:78.932%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">How We</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Addressed the</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Matter in Our</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Audit</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We obtained an understanding, evaluated the design, and tested the operating effectiveness of controls that address the risks of material misstatement relating to the measurement of service fee revenue. This included testing controls related to management&#8217;s review of the significant assumptions and inputs used in the determination of the estimated amount that would be collected for services rendered during the period. We also tested controls over the current and historical data used by management in determining this estimate, including the completeness and accuracy of the data.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">To test the estimated contractual allowances and implicit price concessions, we performed audit procedures that included, among others, assessing methodologies and evaluating the significant assumptions discussed above and testing the completeness and accuracy of the underlying data used by the Company in its estimates. We compared the significant assumptions used by management to current industry and economic trends and considered changes, if any, to the Company&#8217;s business and other relevant factors. We also assessed the historical accuracy of management&#8217;s estimates as a source of potential corroborative or contrary evidence.</span></div><div style="text-align:justify"><span><br/></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Acquisition of Aidence Holding B.V. &amp; Quantib B.V.: Valuation of Developed Technology &amp; IPR&amp;D</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Description of</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">the Matter</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As discussed in Note 4 to the consolidated financial statements, the Company completed its acquisitions of Aidence Holding B.V. (&#8220;Aidence&#8221;) and Quantib B.V. (&#8220;Quantib&#8221;) for net consideration of $45.2 million and $42.3 million, respectively, on January 20, 2022.  The transactions were accounted for as business combinations. <br/></span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Auditing the Company&#8217;s accounting for its acquisitions of Aidence and Quantib was complex due to the significant estimation required by management in determining the fair value of developed technology and in-process research and development (&#8220;IPR&amp;D&#8221;) intangible assets of $26.6 million for Aidence and $20.3 million for Quantib. The significant estimation uncertainty was primarily due to the complexity of the valuation models used and the sensitivity of the fair value estimates to the significant underlying assumptions. The Company used an income approach to measure the fair value of the developed technology and IPR&amp;D intangible assets. The significant assumptions used to estimate the value of the intangible assets included discount rates and certain assumptions that form the basis of the forecasted results (e.g., revenue growth rates, EBITDA margin and obsolescence factors). These significant assumptions are forward looking and could be affected by future economic and market conditions.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">How We <br/>Addressed the <br/>Matter in Our <br/>Audit<br/></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We obtained an understanding, evaluated the design, and tested the operating effectiveness of controls over the Company&#8217;s accounting for the acquisitions. We tested controls over the recognition and measurement of developed technology and IPR&amp;D intangible assets, including management&#8217;s review of the valuation model and underlying assumptions used to develop such estimates.<br/></span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">To test the estimated fair value of the developed technology and IPR&amp;D intangible assets, we performed audit procedures that included, among others, evaluating the Company's selection of the valuation methodology, evaluating the completeness and accuracy of the underlying data and reasonableness of significant assumptions such as revenue growth rates, EBITDA margin and obsolescence factors. For example, we compared the forecasted results, which were derived based on the significant assumptions discussed above, to current industry, market and economic trends, to the assumptions used in other acquisitions and to other guideline companies within the same industry. We involved our valuation specialists to assist in our evaluation of the methodology used and reasonableness of the significant assumptions including the discount rate.</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">/s/ <ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="dei:AuditorName" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81Mi9mcmFnOjYxZGE2MWY1ZmNhZjRjNmM5OTBkYzdlZmQ3ZTAyODdjL3RleHRyZWdpb246NjFkYTYxZjVmY2FmNGM2Yzk5MGRjN2VmZDdlMDI4N2NfMzU1NQ_a4f60e0a-1145-4511-ac33-2aa29d1a9629">Ernst &amp; Young LLP</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We have served as the Company&#8217;s auditor since 2007. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="dei:AuditorLocation" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81Mi9mcmFnOjYxZGE2MWY1ZmNhZjRjNmM5OTBkYzdlZmQ3ZTAyODdjL3RleHRyZWdpb246NjFkYTYxZjVmY2FmNGM2Yzk5MGRjN2VmZDdlMDI4N2NfMzU1Nw_8ff3287b-de36-403d-8667-b33e33413970">Los Angeles, California</ix:nonNumeric></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">March 1, 2023</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><div id="if3f80771944f4fc58015abda42dc47d1_55"></div><hr style="page-break-after:always"/><div style="min-height:18pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RADNET, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(IN THOUSANDS EXCEPT SHARE AND PER SHARE DATA)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CURRENT ASSETS</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfNC0xLTEtMS0yOTQ4OQ_23a77391-bd62-46c2-be9e-d10e0b54b5d1">127,834</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfNC0zLTEtMS0yOTQ4OQ_8be1b183-a64e-4126-adc6-24173d9073fd">134,606</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfNS0xLTEtMS0yOTQ4OQ_4d2c6ccd-4c6a-4c37-bd7e-b3385640e5f0">166,357</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfNS0zLTEtMS0yOTQ4OQ_20503b60-b4f8-4596-a0c4-a140df979823">135,062</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due from affiliates</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:DueFromRelatedPartiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfNi0xLTEtMS0yOTQ4OQ_d3793a0c-a43f-4da3-8516-04283c1e6407">18,971</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" name="us-gaap:DueFromRelatedPartiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfNi0zLTEtMS0yOTQ4OQ_0f5238b5-c19f-419b-93f7-7bc7145a33b6">5,384</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfNy0xLTEtMS0yOTQ4OQ_f6b2b496-07a8-4b6c-bd78-80e678945aba">54,022</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfNy0zLTEtMS0yOTQ4OQ_502e0cca-a9a3-4226-9620-10b0ac504858">49,212</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfOC0xLTEtMS0yOTQ4OQ_484a02bb-3087-4060-a865-8c49bf2e51f5">367,184</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfOC0zLTEtMS0yOTQ4OQ_25f9d1e6-53e5-4a9f-ae7a-e4df58f55d41">324,264</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PROPERTY, EQUIPMENT AND RIGHT-OF-USE ASSETS</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMTAtMS0xLTEtMjk0ODk_8a1c47a6-d934-4503-a38b-0c1554c82ffe">565,961</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMTAtMy0xLTEtMjk0ODk_2aa65719-7222-4fd8-9aa7-f042256af721">484,247</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use-assets</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMTEtMS0xLTEtMjk0ODk_bd451d67-9fbe-4c77-aa37-557f8fba3b85">603,524</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMTEtMy0xLTEtMjk0ODk_92634f85-47a1-48e6-9ffc-ae44e11e43c2">584,291</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property, equipment and right-of-use-assets</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="rdnt:PropertyPlantAndEquipmentNetIncludingRightOfUseAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMTItMS0xLTEtMjk0ODk_bcf00137-3bfc-4c98-b50b-073c3f2aaed4">1,169,485</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" name="rdnt:PropertyPlantAndEquipmentNetIncludingRightOfUseAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMTItMy0xLTEtMjk0ODk_a3075092-1e77-4e17-964c-c7a0702bda1c">1,068,538</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OTHER ASSETS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMTQtMS0xLTEtMjk0ODk_c4a751d9-fc8f-4aa3-8f49-aef4841e0746">677,665</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMTQtMy0xLTEtMjk0ODk_67db10ae-62e0-41fc-a7c7-30896cc9edcd">513,820</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMTUtMS0xLTEtMjk0ODk_10c0c68e-bb65-44c6-b11e-b9345532c0cb">106,228</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMTUtMy0xLTEtMjk0ODk_fb2fe312-5bea-49ca-b45c-892b0c83e59a">56,603</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing costs</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:DeferredFinanceCostsNoncurrentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMTYtMS0xLTEtMjk0ODk_7f95cb34-01c9-4b81-964f-24768c12578c">2,280</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" name="us-gaap:DeferredFinanceCostsNoncurrentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMTYtMy0xLTEtMjk0ODk_a78c080c-af96-4157-86d3-844c6eaeee66">2,135</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in joint ventures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMTctMS0xLTEtMjk0ODk_c066835a-ff8b-4a1a-ba67-107178278dd6">57,893</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMTctMy0xLTEtMjk0ODk_acf76537-476d-4190-88de-2e6284bcd5ff">42,229</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets, net</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMTgtMS0xLTEtMjk0ODk_3ef560b3-e2de-49a2-bb45-6625abe5dd9d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMTgtMy0xLTEtMjk0ODk_ba3c6a11-fd59-435c-b3b7-a83b1a24e230">14,853</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deposits and other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:DepositsAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMTktMS0xLTEtMjk0ODk_2f52d126-9273-4157-abc2-700c99c3bd2a">53,172</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" name="us-gaap:DepositsAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMTktMy0xLTEtMjk0ODk_a2c0f5e5-dd76-4380-8599-0a2064a60bac">36,032</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMjAtMS0xLTEtMjk0ODk_a646a4e6-5b40-4d47-99ee-527faadeb748">2,433,907</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMjAtMy0xLTEtMjk0ODk_00df06c0-fa3c-4366-b6a9-58df4aae1be7">2,058,474</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES AND EQUITY</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CURRENT LIABILITIES</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable, accrued expenses and other</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMjMtMS0xLTEtMjk0ODk_58d04c82-42e1-4ec9-9fb0-d0bee37c82b3">369,595</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMjMtMy0xLTEtMjk0ODk_ebf74ef9-2c17-4b08-aaf0-219a17351aae">263,937</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to affiliates</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:DueToAffiliateCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMjQtMS0xLTEtMjk0ODk_fe901214-6fd8-4c21-87a7-2b15c417f475">23,100</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" name="us-gaap:DueToAffiliateCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMjQtMy0xLTEtMjk0ODk_c7c93604-0873-4534-a141-bd771b33def3">23,530</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMjUtMS0xLTEtMjk0ODk_c8af268e-6913-462e-a5bb-154050756d75">4,021</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMjUtMy0xLTEtMjk0ODk_10c01c21-28f8-4582-b6a9-142b72ad7dfa">10,701</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liability</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMjctMS0xLTEtMjk0ODk_2abc4866-4c9b-4ead-8380-54fa68f4b7d1">57,607</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMjctMy0xLTEtMjk0ODk_1dfc1d20-a0a0-428c-889d-a69dbeedc0af">65,452</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of notes payable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:NotesPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMjgtMS0xLTEtMjk0ODk_b8916b49-83af-4fbd-bb57-e851d666523e">12,400</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" name="us-gaap:NotesPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMjgtMy0xLTEtMjk0ODk_a756941e-4246-4547-a263-5dfb5eca44ee">11,164</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMjktMS0xLTEtMjk0ODk_9b670596-9247-40ca-8dd3-9ce9e2cd7341">466,723</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMjktMy0xLTEtMjk0ODk_aa703e7d-0d04-457c-b2b2-ac278f03942c">374,784</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LONG-TERM LIABILITIES</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liability</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMzItMS0xLTEtMjk0ODk_4b24f35a-b954-4586-8ae5-f1fcd923c831">604,117</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMzItMy0xLTEtMjk0ODk_16d7d576-d2e7-4dc7-bde6-f0ad886ec6bd">577,675</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes payable, net of current portion</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:LongTermNotesPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMzMtMS0xLTEtMjk0ODk_1a2a0485-e811-4468-ba35-fa60f397b7dd">839,344</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" name="us-gaap:LongTermNotesPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMzMtMy0xLTEtMjk0ODk_488fc16c-ef21-4779-852d-056014c3b7d3">743,498</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMzQtMS0xLTEtNzY0NzE_90c00864-ca24-42b9-a417-b449d27410d3">9,256</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMzQtMy0xLTEtNzY0NzE_4bc3fdc8-7168-4e76-a59a-60fbb3723705">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMzQtMS0xLTEtMjk0ODk_269cfbe6-0673-495d-abd5-a15089c9da8f">23,015</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMzQtMy0xLTEtMjk0ODk_173c7f07-7ac6-42f5-a8ca-4f4224545538">16,360</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMzUtMS0xLTEtMjk0ODk_6c769617-d896-414a-b6e5-d2f7272b934e">1,942,455</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMzUtMy0xLTEtMjk0ODk_15539b15-0886-4d44-882a-3de8565c51b6">1,712,317</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EQUITY</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RadNet, Inc. stockholders' equity:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock - $<ix:nonFraction unitRef="usdPerShare" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMzgtMC0xLTEtMjk0ODkvdGV4dHJlZ2lvbjphNDcwNmEwODRkY2U0ZDA1OThiMmM4OGM2OWMwYzcyMV8xOQ_5e1c1fb4-3ac3-4dc9-bdb9-d8d5f78c356d"><ix:nonFraction unitRef="usdPerShare" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMzgtMC0xLTEtMjk0ODkvdGV4dHJlZ2lvbjphNDcwNmEwODRkY2U0ZDA1OThiMmM4OGM2OWMwYzcyMV8xOQ_848af894-0e30-4505-a98c-925f50625f2d">.0001</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMzgtMC0xLTEtMjk0ODkvdGV4dHJlZ2lvbjphNDcwNmEwODRkY2U0ZDA1OThiMmM4OGM2OWMwYzcyMV8zMw_2070e395-c987-4770-98a2-4d86807d71e7"><ix:nonFraction unitRef="shares" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMzgtMC0xLTEtMjk0ODkvdGV4dHJlZ2lvbjphNDcwNmEwODRkY2U0ZDA1OThiMmM4OGM2OWMwYzcyMV8zMw_8926c1b8-e8f3-4d7c-bce3-3ab03bedf96c">200,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMzgtMC0xLTEtMjk0ODkvdGV4dHJlZ2lvbjphNDcwNmEwODRkY2U0ZDA1OThiMmM4OGM2OWMwYzcyMV81NQ_4fe09bdd-bb46-477d-a799-557c9e8981e0"><ix:nonFraction unitRef="shares" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMzgtMC0xLTEtMjk0ODkvdGV4dHJlZ2lvbjphNDcwNmEwODRkY2U0ZDA1OThiMmM4OGM2OWMwYzcyMV81NQ_f53f4714-a3e4-4207-8dd1-d2ec87afab78">57,723,125</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMzgtMC0xLTEtMjk0ODkvdGV4dHJlZ2lvbjphNDcwNmEwODRkY2U0ZDA1OThiMmM4OGM2OWMwYzcyMV82Mg_55de06ba-509a-447d-b539-ef82ef895ccd"><ix:nonFraction unitRef="shares" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMzgtMC0xLTEtMjk0ODkvdGV4dHJlZ2lvbjphNDcwNmEwODRkY2U0ZDA1OThiMmM4OGM2OWMwYzcyMV82Mg_76dabad5-7334-41d1-bafe-ca275a62a79a">53,548,227</ix:nonFraction></ix:nonFraction> shares issued and outstanding at December 31, 2022 and 2021 respectively</span></div></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMzgtMS0xLTEtMjk0ODk_ad823a5d-d251-408d-b548-a6f10eeee66a">6</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMzgtMy0xLTEtMjk0ODk_854c03e3-e744-4c1b-824a-f6712ae0fbd7">5</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in-capital</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMzktMS0xLTEtMjk0ODk_89eb245b-1c44-41aa-8a24-b97d256e7a28">436,288</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMzktMy0xLTEtMjk0ODk_3ab6a354-38b5-43e1-8440-8121fe3fb8f6">342,592</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfNDAtMS0xLTEtMjk0ODk_9e2c456b-8990-4bd8-ba6b-dbe5393b8c70">20,677</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfNDAtMy0xLTEtMjk0ODk_f0a036ac-fb3c-423d-96cd-16285eb0b7ad">20,421</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfNDEtMS0xLTEtMjk0ODk_d58bda4b-3c8c-4bb1-a421-00352cda0a09">82,622</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfNDEtMy0xLTEtMjk0ODk_60633d48-97ff-4b01-8594-17ebe3390fe0">93,272</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total RadNet, Inc.'s stockholders' equity</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfNDItMS0xLTEtMjk0ODk_4ae7083b-b84a-4fea-b319-f13e50d0699f">332,995</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfNDItMy0xLTEtMjk0ODk_2be2f495-5323-471e-a136-8f844943d03c">228,904</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:MinorityInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfNDMtMS0xLTEtMjk0ODk_d6720d9d-926f-4856-adc4-8497f2645248">158,457</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" name="us-gaap:MinorityInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfNDMtMy0xLTEtMjk0ODk_40d6afb3-789c-4597-a678-5259c8db89fe">117,253</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfNDQtMS0xLTEtMjk0ODk_e9935f6a-ec37-433c-af11-f7124e8337aa">491,452</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfNDQtMy0xLTEtMjk0ODk_38adc072-836b-40e1-8325-404f8f8000fa">346,157</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and equity</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfNDUtMS0xLTEtMjk0ODk_d4b3fa62-f886-420b-8cd3-191d3b8db520">2,433,907</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfNDUtMy0xLTEtMjk0ODk_9f1a0388-0b50-4b34-8a08-a45c79f4cb93">2,058,474</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these financial statements.</span></div><div style="height:14.4pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><div id="if3f80771944f4fc58015abda42dc47d1_58"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RADNET, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(IN THOUSANDS EXCEPT SHARE AND PER SHARE DATA)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">REVENUE</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service fee revenue</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72c8ccfb1d004dff8edb67a140b34692_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMy0xLTEtMS0yOTQ4OQ_e2ba9a36-5dc0-433f-ac59-aaa6aa10a781">1,278,016</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8c322d1717c4ac1bdf35faa1ec15017_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMy0zLTEtMS0yOTQ4OQ_508581d3-4649-4f34-be3a-fb1984e0fe81">1,166,743</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08ae2120de2d443a9249395c939d9db2_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMy01LTEtMS0yOTQ4OQ_b1eeafdd-5da4-4965-9913-b9a4e27deb00">931,722</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue under capitation arrangements</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8827fd8aae0c45ac99829a7fb259f75c_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfNC0xLTEtMS0yOTQ4OQ_7f536d2c-5bd9-450e-8c88-26de8a7acfa1">152,045</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b9fb24ebf5447db9eb3e2b703507952_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfNC0zLTEtMS0yOTQ4OQ_decf7007-4abd-4802-8f35-719f1d3796d6">148,334</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93e177287d564fa0be95b081ae11ddd8_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfNC01LTEtMS0yOTQ4OQ_d25fbe33-ff77-4c10-9558-d0abece4ee67">140,118</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfNS0xLTEtMS0yOTQ4OQ_ef372cba-fab0-4113-b710-81cdb206f6f4">1,430,061</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfNS0zLTEtMS0yOTQ4OQ_44563d78-5b8d-4475-bec7-79221a1e8cd0">1,315,077</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfNS01LTEtMS0yOTQ4OQ_a097a7bb-914b-4069-a487-87ea78257902">1,071,840</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider relief funding</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:RevenueNotFromContractWithCustomer" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfNi0xLTEtMS0yOTQ4OQ_55a6c759-a691-45ed-b21a-46156d7579ea">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:RevenueNotFromContractWithCustomer" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfNi0zLTEtMS0yOTQ4OQ_b8443b72-87e0-4b78-b5ac-535fffcb1173">9,110</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" name="us-gaap:RevenueNotFromContractWithCustomer" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfNi01LTEtMS0yOTQ4OQ_816a7272-6920-4315-8579-baea6dc3b30d">26,264</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OPERATING EXPENSES</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of operations, excluding depreciation and amortization</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="rdnt:OperatingExpensesExcludingDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfOC0xLTEtMS0yOTQ4OQ_b1c4bfc4-58df-4725-9ed2-a8337ac1dd10">1,264,346</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="rdnt:OperatingExpensesExcludingDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfOC0zLTEtMS0yOTQ4OQ_ed838f7c-fb68-48c3-b8a3-31de36e62ae1">1,123,274</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" name="rdnt:OperatingExpensesExcludingDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfOC01LTEtMS0yOTQ4OQ_eec35004-611b-496d-930e-c11cad278df2">965,902</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease abandonment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:GainLossOnTerminationOfLease" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfOS0xLTEtMS0yOTQ4OQ_49011bc3-82b3-4eb0-9b8f-49403ea0c1e2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:GainLossOnTerminationOfLease" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfOS0zLTEtMS0yOTQ4OQ_631b41cb-bb83-46b9-9bf4-6b683d0250a5">19,675</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" name="us-gaap:GainLossOnTerminationOfLease" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfOS01LTEtMS0yOTQ4OQ_72dcabf2-73ae-4381-9415-775bc4e1355e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMTAtMS0xLTEtMjk0ODk_293e5ce2-3d7c-4f1c-a138-d96e90f7ccc6">115,877</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMTAtMy0xLTEtMjk0ODk_4e2fa667-fae1-4c5a-abd5-8f3d873721a0">96,694</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMTAtNS0xLTEtMjk0ODk_9739309d-43f3-4590-a84d-f62645347a6c">86,795</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on sale and disposal of equipment and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:GainLossOnDispositionOfAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMTEtMS0xLTEtMjk0ODk_6cdb49c3-9a1b-4223-9b1d-37c46429d3ef">2,529</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:GainLossOnDispositionOfAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMTEtMy0xLTEtMjk0ODk_fdbf1e48-031b-4b17-baf6-512ab3cda186">1,246</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:GainLossOnDispositionOfAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMTEtNS0xLTEtMjk0ODk_927cc024-0b04-4d4d-9df4-09323b7d8b8c">1,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on impairment</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:GoodwillAndIntangibleAssetImpairment" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMTItMS0xLTEtMjk0ODk_126c44ac-1d64-4832-bbc1-5261d28ad2f3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:GoodwillAndIntangibleAssetImpairment" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMTItMy0xLTEtMjk0ODk_02a103d6-993a-4ed0-8d42-d0d94e653d15">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" name="us-gaap:GoodwillAndIntangibleAssetImpairment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMTItNS0xLTEtMjk0ODk_ba82b981-0755-4a2a-9a73-ee7dc4e8549d">4,170</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:SeveranceCosts1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMTMtMS0xLTEtMjk0ODk_91b98ead-62f3-4c40-9209-8dfcbb3a1603">946</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:SeveranceCosts1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMTMtMy0xLTEtMjk0ODk_4dde0347-b45d-4501-bd74-fd709da4faf1">744</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" name="us-gaap:SeveranceCosts1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMTMtNS0xLTEtMjk0ODk_dd260ee8-d183-4c68-9e52-85064fa4ef10">4,353</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMTQtMS0xLTEtMjk0ODk_231a4eed-e73f-4e6a-b1d8-77f17819594f">1,383,698</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMTQtMy0xLTEtMjk0ODk_73698403-efc0-4acb-8208-85e88548b0b5">1,241,633</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMTQtNS0xLTEtMjk0ODk_c5fba895-8e75-492f-b79b-51ef90002f74">1,062,420</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">INCOME FROM OPERATIONS</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMTUtMS0xLTEtMjk0ODk_bac10ba7-235b-4616-a633-587c3bb8f383">46,363</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMTUtMy0xLTEtMjk0ODk_f760d4bb-7a52-4337-9864-b6c7bce7b7f4">82,554</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMTUtNS0xLTEtMjk0ODk_8a660091-2fe2-4368-adee-0c3486e8d58d">35,684</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OTHER INCOME AND EXPENSES</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMTgtMS0xLTEtMjk0ODk_d5610241-c7bc-4972-aafd-9e766290e4fc">50,841</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMTgtMy0xLTEtMjk0ODk_241d3ad9-e793-494c-8fd0-f7579d580821">48,830</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMTgtNS0xLTEtMjk0ODk_f0d95958-9009-4c7a-97a1-f0a31a1bcad5">45,882</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in earnings of joint ventures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMTktMS0xLTEtMjk0ODk_ad4c4dc6-6397-42c8-b01b-8d77af8e729f">10,390</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMTktMy0xLTEtMjk0ODk_be4f4248-74bf-41b5-ad14-3104bbcfe52f">10,967</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMTktNS0xLTEtMjk0ODk_08ec1e4c-4597-4ad9-aaca-e006dd6ca9d9">7,945</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash change in fair value of interest rate swaps</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMjAtMS0xLTEtMjk0ODk_16c52c2c-745a-4753-b0ec-7fd774201edb">39,621</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMjAtMy0xLTEtMjk0ODk_f1883fcf-1c68-4586-ba78-3ea6c62d80a0">21,670</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMjAtNS0xLTEtMjk0ODk_3b8416b2-055a-4fad-b012-f84e699f3218">2,528</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss (gain) on extinguishment of debt and related expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" sign="-" name="rdnt:GainLossOnExtinguishmentOfDebtAndOtherExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMjItMS0xLTEtMjk0ODk_2abd6c89-0fa8-4780-ada5-3e97ed8d4b6a">731</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" sign="-" name="rdnt:GainLossOnExtinguishmentOfDebtAndOtherExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMjItMy0xLTEtMjk0ODk_64043d58-2fb4-4e37-9ce4-d158492e01b5">6,044</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" name="rdnt:GainLossOnExtinguishmentOfDebtAndOtherExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMjItNS0xLTEtMjk0ODk_45b19cab-299c-42a0-9748-f8f12606a283">4,047</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expenses</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMjMtMS0xLTEtMjk0ODk_7be4af29-65dc-48b0-9085-ccef3baac479">1,833</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMjMtMy0xLTEtMjk0ODk_7eb3726a-7012-4401-b60b-90c3518019e1">1,438</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMjMtNS0xLTEtMjk0ODk_4b82bb7b-f129-4fba-be6c-343b91a6af75">120</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMjQtMS0xLTEtMjk0ODk_f49ba89c-e176-423e-840b-39b08087869d">3,394</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMjQtMy0xLTEtMjk0ODk_2e0d88f0-efe5-4545-9b46-ea13cab4ab32">23,675</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMjQtNS0xLTEtMjk0ODk_5f351cd3-a788-47bb-8126-d32b3f601219">36,538</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">INCOME (LOSS) BEFORE INCOME TAXES</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMjUtMS0xLTEtMjk0ODk_e28769b1-36d4-442c-af8f-a49c2807adbf">42,969</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMjUtMy0xLTEtMjk0ODk_9b7de2ee-d856-4ca6-bb96-00783384dd5f">58,879</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMjUtNS0xLTEtMjk0ODk_b43467a5-eefc-44be-8d46-da7edf914e81">854</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMjYtMS0xLTEtMjk0ODk_38a7542a-6a57-4b5a-b431-17477524d445">9,361</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMjYtMy0xLTEtMjk0ODk_bf88c924-e976-4063-b3ea-fae8dbbdf61f">14,560</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMjYtNS0xLTEtMjk0ODk_8b0b421b-332c-4a7a-95fc-ea4455ecfe2a">895</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NET INCOME (LOSS)</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMjctMS0xLTEtMjk0ODk_1e258e74-1203-4acc-b7db-eb66dde472f0">33,608</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMjctMy0xLTEtMjk0ODk_319a7815-2009-473f-a47b-fdf3fd825467">44,319</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMjctNS0xLTEtMjk0ODk_24448e84-034f-4034-a6ce-511dae559d26">1,749</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMjgtMS0xLTEtMjk0ODk_17fab1c3-d1e1-4516-b90f-49ff4968cebe">22,958</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMjgtMy0xLTEtMjk0ODk_64466c3c-b207-4283-8544-245e03165a2c">19,592</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMjgtNS0xLTEtMjk0ODk_f150c186-dc4c-4497-b63b-aca302780c99">13,091</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NET INCOME (LOSS)  ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMzAtMS0xLTEtMjk0ODk_920ef47f-e019-4c7c-ad8c-0114b828bd5e">10,650</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMzAtMy0xLTEtMjk0ODk_290be361-b28f-4579-835e-342a960106c4">24,727</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMzAtNS0xLTEtMjk0ODk_2603723a-2476-4663-a8b6-cee8a88ae2e5">14,840</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">BASIC NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMzItMS0xLTEtMjk0ODk_efff96d1-648f-4395-9c3b-16d80d1f58ae">0.19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMzItMy0xLTEtMjk0ODk_1d40e043-7774-4b0d-8c6e-2154926c6834">0.47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMzItNS0xLTEtMjk0ODk_046dbd7b-b16e-4a25-830d-806ec4c6b941">0.29</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DILUTED NET  INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMzQtMS0xLTEtMjk0ODk_d14c0e8e-4182-4590-bf27-eea7c2548c32">0.17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMzQtMy0xLTEtMjk0ODk_9f228fdb-9989-42e5-8ba9-f1177465babf">0.46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMzQtNS0xLTEtMjk0ODk_b50ee219-09f5-4bbe-85a3-f0e215e3541e">0.29</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">WEIGHTED AVERAGE SHARES OUTSTANDING</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMzctMS0xLTEtMjk0ODk_f3eb5f93-387d-4ff2-96b7-0f0b14ac1b9a">56,293,336</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMzctMy0xLTEtMjk0ODk_9537b1d2-c0ab-4712-a161-5da10d607119">52,496,679</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMzctNS0xLTEtMjk0ODk_f2ab258f-393c-4a83-b09f-ea7a720db75d">50,891,791</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMzgtMS0xLTEtMjk0ODk_cedbfdb0-9ed2-439d-a904-c822190c0efb">57,320,870</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMzgtMy0xLTEtMjk0ODk_bdf0a84f-8ffd-4b59-be58-9e641cd3bc51">53,421,033</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMzgtNS0xLTEtMjk0ODk_fbf79b25-f4d4-40c6-9e80-bce339326d46">50,891,791</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><div id="if3f80771944f4fc58015abda42dc47d1_61"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RADNET, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(IN THOUSANDS)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NET  INCOME (LOSS)</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82MS9mcmFnOjkwODkzZGY3ZGQ2NDQ1OWI4MDgzY2ExMDRmMDE2YWQ5L3RhYmxlOjE1ZDllZGQ2YzZlNjQ3NTJiMmZjNjk2ZTAxYTYxOTRjL3RhYmxlcmFuZ2U6MTVkOWVkZDZjNmU2NDc1MmIyZmM2OTZlMDFhNjE5NGNfMi0xLTEtMS0yOTQ4OQ_82f3597c-6dcb-4846-81de-753bc234899a">33,608</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82MS9mcmFnOjkwODkzZGY3ZGQ2NDQ1OWI4MDgzY2ExMDRmMDE2YWQ5L3RhYmxlOjE1ZDllZGQ2YzZlNjQ3NTJiMmZjNjk2ZTAxYTYxOTRjL3RhYmxlcmFuZ2U6MTVkOWVkZDZjNmU2NDc1MmIyZmM2OTZlMDFhNjE5NGNfMi0zLTEtMS0yOTQ4OQ_dbae9924-0c85-416e-8618-e1548f190241">44,319</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82MS9mcmFnOjkwODkzZGY3ZGQ2NDQ1OWI4MDgzY2ExMDRmMDE2YWQ5L3RhYmxlOjE1ZDllZGQ2YzZlNjQ3NTJiMmZjNjk2ZTAxYTYxOTRjL3RhYmxlcmFuZ2U6MTVkOWVkZDZjNmU2NDc1MmIyZmM2OTZlMDFhNjE5NGNfMi01LTEtMS0yOTQ4OQ_56fd8f7e-80b3-4a04-8f0a-06d912919b38">1,749</ix:nonFraction>)</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82MS9mcmFnOjkwODkzZGY3ZGQ2NDQ1OWI4MDgzY2ExMDRmMDE2YWQ5L3RhYmxlOjE1ZDllZGQ2YzZlNjQ3NTJiMmZjNjk2ZTAxYTYxOTRjL3RhYmxlcmFuZ2U6MTVkOWVkZDZjNmU2NDc1MmIyZmM2OTZlMDFhNjE5NGNfMy0xLTEtMS0yOTQ4OQ_995b36b9-b5d7-4c99-8e4b-28970ca88293">3,943</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82MS9mcmFnOjkwODkzZGY3ZGQ2NDQ1OWI4MDgzY2ExMDRmMDE2YWQ5L3RhYmxlOjE1ZDllZGQ2YzZlNjQ3NTJiMmZjNjk2ZTAxYTYxOTRjL3RhYmxlcmFuZ2U6MTVkOWVkZDZjNmU2NDc1MmIyZmM2OTZlMDFhNjE5NGNfMy0zLTEtMS0yOTQ4OQ_f4cbfa0a-d524-44e8-8ac2-9a63b46937c5">65</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82MS9mcmFnOjkwODkzZGY3ZGQ2NDQ1OWI4MDgzY2ExMDRmMDE2YWQ5L3RhYmxlOjE1ZDllZGQ2YzZlNjQ3NTJiMmZjNjk2ZTAxYTYxOTRjL3RhYmxlcmFuZ2U6MTVkOWVkZDZjNmU2NDc1MmIyZmM2OTZlMDFhNjE5NGNfMy01LTEtMS0yOTQ4OQ_e1ff6b4d-f1c5-482b-abfe-a4e5738b34a4">101</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of cash flow hedge, net of taxes</span></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82MS9mcmFnOjkwODkzZGY3ZGQ2NDQ1OWI4MDgzY2ExMDRmMDE2YWQ5L3RhYmxlOjE1ZDllZGQ2YzZlNjQ3NTJiMmZjNjk2ZTAxYTYxOTRjL3RhYmxlcmFuZ2U6MTVkOWVkZDZjNmU2NDc1MmIyZmM2OTZlMDFhNjE5NGNfNC0xLTEtMS0yOTQ4OQ_4fb01974-eb89-4452-b37d-a4cf897d5830">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82MS9mcmFnOjkwODkzZGY3ZGQ2NDQ1OWI4MDgzY2ExMDRmMDE2YWQ5L3RhYmxlOjE1ZDllZGQ2YzZlNjQ3NTJiMmZjNjk2ZTAxYTYxOTRjL3RhYmxlcmFuZ2U6MTVkOWVkZDZjNmU2NDc1MmIyZmM2OTZlMDFhNjE5NGNfNC0zLTEtMS0yOTQ4OQ_72b65fc5-b840-4ed2-8204-f8ec81211d1e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82MS9mcmFnOjkwODkzZGY3ZGQ2NDQ1OWI4MDgzY2ExMDRmMDE2YWQ5L3RhYmxlOjE1ZDllZGQ2YzZlNjQ3NTJiMmZjNjk2ZTAxYTYxOTRjL3RhYmxlcmFuZ2U6MTVkOWVkZDZjNmU2NDc1MmIyZmM2OTZlMDFhNjE5NGNfNC01LTEtMS0yOTQ4OQ_80235c12-8172-44c5-b18f-bb14b61bb2b9">19,372</ix:nonFraction>)</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of cash flow hedge from prior periods reclassified to earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82MS9mcmFnOjkwODkzZGY3ZGQ2NDQ1OWI4MDgzY2ExMDRmMDE2YWQ5L3RhYmxlOjE1ZDllZGQ2YzZlNjQ3NTJiMmZjNjk2ZTAxYTYxOTRjL3RhYmxlcmFuZ2U6MTVkOWVkZDZjNmU2NDc1MmIyZmM2OTZlMDFhNjE5NGNfNS0xLTEtMS0yOTQ4OQ_5f6d9c71-5598-4cd7-9fbf-1e539ac7b80b">3,687</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82MS9mcmFnOjkwODkzZGY3ZGQ2NDQ1OWI4MDgzY2ExMDRmMDE2YWQ5L3RhYmxlOjE1ZDllZGQ2YzZlNjQ3NTJiMmZjNjk2ZTAxYTYxOTRjL3RhYmxlcmFuZ2U6MTVkOWVkZDZjNmU2NDc1MmIyZmM2OTZlMDFhNjE5NGNfNS0zLTEtMS0yOTQ4OQ_abfcd1a7-8d71-45ab-89e2-aa0ac4b6222e">3,695</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82MS9mcmFnOjkwODkzZGY3ZGQ2NDQ1OWI4MDgzY2ExMDRmMDE2YWQ5L3RhYmxlOjE1ZDllZGQ2YzZlNjQ3NTJiMmZjNjk2ZTAxYTYxOTRjL3RhYmxlcmFuZ2U6MTVkOWVkZDZjNmU2NDc1MmIyZmM2OTZlMDFhNjE5NGNfNS01LTEtMS0yOTQ4OQ_ec7ab212-14ca-4b4a-8e96-09c555da8110">3,448</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">COMPREHENSIVE INCOME (LOSS)</span></td><td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82MS9mcmFnOjkwODkzZGY3ZGQ2NDQ1OWI4MDgzY2ExMDRmMDE2YWQ5L3RhYmxlOjE1ZDllZGQ2YzZlNjQ3NTJiMmZjNjk2ZTAxYTYxOTRjL3RhYmxlcmFuZ2U6MTVkOWVkZDZjNmU2NDc1MmIyZmM2OTZlMDFhNjE5NGNfNi0xLTEtMS0yOTQ4OQ_aef73133-279d-4ed1-96c0-6b50bb47fbea">33,352</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82MS9mcmFnOjkwODkzZGY3ZGQ2NDQ1OWI4MDgzY2ExMDRmMDE2YWQ5L3RhYmxlOjE1ZDllZGQ2YzZlNjQ3NTJiMmZjNjk2ZTAxYTYxOTRjL3RhYmxlcmFuZ2U6MTVkOWVkZDZjNmU2NDc1MmIyZmM2OTZlMDFhNjE5NGNfNi0zLTEtMS0yOTQ4OQ_2488e892-93ee-4063-a00a-08cb26f38803">47,949</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82MS9mcmFnOjkwODkzZGY3ZGQ2NDQ1OWI4MDgzY2ExMDRmMDE2YWQ5L3RhYmxlOjE1ZDllZGQ2YzZlNjQ3NTJiMmZjNjk2ZTAxYTYxOTRjL3RhYmxlcmFuZ2U6MTVkOWVkZDZjNmU2NDc1MmIyZmM2OTZlMDFhNjE5NGNfNi01LTEtMS0yOTQ4OQ_31e42284-49a4-49c4-8404-5f90e22d806e">17,774</ix:nonFraction>)</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less comprehensive income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82MS9mcmFnOjkwODkzZGY3ZGQ2NDQ1OWI4MDgzY2ExMDRmMDE2YWQ5L3RhYmxlOjE1ZDllZGQ2YzZlNjQ3NTJiMmZjNjk2ZTAxYTYxOTRjL3RhYmxlcmFuZ2U6MTVkOWVkZDZjNmU2NDc1MmIyZmM2OTZlMDFhNjE5NGNfNy0xLTEtMS0yOTQ4OQ_2245b11d-29df-4ff0-917b-d6203feb32da">22,958</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82MS9mcmFnOjkwODkzZGY3ZGQ2NDQ1OWI4MDgzY2ExMDRmMDE2YWQ5L3RhYmxlOjE1ZDllZGQ2YzZlNjQ3NTJiMmZjNjk2ZTAxYTYxOTRjL3RhYmxlcmFuZ2U6MTVkOWVkZDZjNmU2NDc1MmIyZmM2OTZlMDFhNjE5NGNfNy0zLTEtMS0yOTQ4OQ_c59f1d8f-8cb6-4264-9ec9-8ca9f38458b1">19,592</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82MS9mcmFnOjkwODkzZGY3ZGQ2NDQ1OWI4MDgzY2ExMDRmMDE2YWQ5L3RhYmxlOjE1ZDllZGQ2YzZlNjQ3NTJiMmZjNjk2ZTAxYTYxOTRjL3RhYmxlcmFuZ2U6MTVkOWVkZDZjNmU2NDc1MmIyZmM2OTZlMDFhNjE5NGNfNy01LTEtMS0yOTQ4OQ_832f07cc-e9fc-4e05-bacc-8f1cfa5fc3fd">13,091</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">COMPREHENSIVE INCOME (LOSS) ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82MS9mcmFnOjkwODkzZGY3ZGQ2NDQ1OWI4MDgzY2ExMDRmMDE2YWQ5L3RhYmxlOjE1ZDllZGQ2YzZlNjQ3NTJiMmZjNjk2ZTAxYTYxOTRjL3RhYmxlcmFuZ2U6MTVkOWVkZDZjNmU2NDc1MmIyZmM2OTZlMDFhNjE5NGNfOS0xLTEtMS0yOTQ4OQ_0726d927-60fe-44ff-ab04-75c2f78d594e">10,394</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82MS9mcmFnOjkwODkzZGY3ZGQ2NDQ1OWI4MDgzY2ExMDRmMDE2YWQ5L3RhYmxlOjE1ZDllZGQ2YzZlNjQ3NTJiMmZjNjk2ZTAxYTYxOTRjL3RhYmxlcmFuZ2U6MTVkOWVkZDZjNmU2NDc1MmIyZmM2OTZlMDFhNjE5NGNfOS0zLTEtMS0yOTQ4OQ_faa6757f-9371-4660-8a44-07be01afb90e">28,357</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82MS9mcmFnOjkwODkzZGY3ZGQ2NDQ1OWI4MDgzY2ExMDRmMDE2YWQ5L3RhYmxlOjE1ZDllZGQ2YzZlNjQ3NTJiMmZjNjk2ZTAxYTYxOTRjL3RhYmxlcmFuZ2U6MTVkOWVkZDZjNmU2NDc1MmIyZmM2OTZlMDFhNjE5NGNfOS01LTEtMS0yOTQ4OQ_8e317d47-eed6-4f7a-a07b-8935812ca1f9">30,865</ix:nonFraction>)</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these financial statements.&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><div id="if3f80771944f4fc58015abda42dc47d1_64"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RADNET, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENT OF EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(IN THOUSANDS EXCEPT SHARE DATA)&#160;</span></div><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.685%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Additional</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Accumulated Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Radnet, Inc.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Paid-in</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Comprehensive</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Accumulated</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Stockholders'</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Noncontrolling</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(Loss) Income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Deficit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Equity</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">BALANCE - JANUARY 1, 2020</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i88190c6477b54e7c8dd36138e1b559d5_I20191231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMTgtMS0xLTEtMjk0ODk_a6d68748-efcd-4f3e-8468-2ee8beb8a0ff">50,314,328</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88190c6477b54e7c8dd36138e1b559d5_I20191231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMTgtMy0xLTEtMjk0ODk_955836d5-b4ea-42d9-9f15-2d3d0d88be85">5</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d953a41c6d9468dbca0b44fc5f607e3_I20191231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMTgtNS0xLTEtMjk0ODk_984a2dcc-7212-43e2-a8fd-90db9db88b20">262,865</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia3e2118a10c34ab7a36716b00a6d7689_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMTgtNy0xLTEtMjk0ODk_3cd6f327-96ad-4d1f-8109-bf28422fabdd">8,026</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i631fe7e868d0484cb4e25a85cae0a91e_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMTgtOS0xLTEtMjk0ODk_3b28f266-78b1-4530-ab58-dc51945e60e3">103,159</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac4cd4d1f8df442897db11d5620d8aff_I20191231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMTgtMTEtMS0xLTI5NDg5_6f94fd25-2085-4ae8-bcf6-fdc9d65c847c">151,685</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ce0185d244440a4acb3004eca085a56_I20191231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMTgtMTMtMS0xLTI5NDg5_e5a1f620-42c3-429a-9ca1-00f7dc3e6258">81,454</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i404f0df0019f440299547782ff0ce012_I20191231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMTgtMTUtMS0xLTI5NDg5_5a009793-cd26-4b72-a369-739758e7de75">233,139</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Shares issued under the equity compensation plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i99fcac4f0fc74d8aace4c8852be510de_D20200101-20201231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMjAtMS0xLTEtMjk0ODk_c63c6ed2-495f-4af0-8611-0d2850c6791e">491,674</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of common stock under the DeepHealth equity compensation plan</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibbbe6648075f46b597abbe27ffaf1a51_D20200101-20201231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMjEtMS0xLTEtMjk0ODk_752a1662-a732-48b4-a887-ca36703653a1">10,920</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd177ca06f0e4f359d97359a10eeb1bd_D20200101-20201231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMjItNS0xLTEtMjk0ODk_3292c0ff-ddbe-4d97-b708-aabe2698d4b1">12,463</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i006b7ea314fc4246a62dc2614396fb18_D20200101-20201231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMjItMTEtMS0xLTI5NDg5_29d7d7ad-4d65-42a1-815d-54b599008f0a">12,463</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMjItMTUtMS0xLTI5NDg5_a1bef0d6-522f-476f-8eeb-0417d79c08a4">12,463</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of common stock for acquisitions</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i99fcac4f0fc74d8aace4c8852be510de_D20200101-20201231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMjMtMS0xLTEtMjk0ODk_8d834108-9be5-471b-87fc-339951a63544">823,615</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd177ca06f0e4f359d97359a10eeb1bd_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMjMtNS0xLTEtMjk0ODk_b57914de-165e-4566-9eaa-37238d2f14e3">33,011</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i006b7ea314fc4246a62dc2614396fb18_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMjMtMTEtMS0xLTI5NDg5_e719c83a-1786-48b3-b62f-e70baa28b4ca">33,011</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMjMtMTUtMS0xLTI5NDg5_45765f61-9da9-4890-9d79-b699c79cb19f">33,011</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Tax effect on gain on sale of noncontrolling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd177ca06f0e4f359d97359a10eeb1bd_D20200101-20201231" decimals="-3" name="rdnt:AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMjQtNS0xLTEtMjk0ODk_2436c494-b8fd-443c-8db4-7d1eff14ff3d">551</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i006b7ea314fc4246a62dc2614396fb18_D20200101-20201231" decimals="-3" name="rdnt:AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMjQtMTEtMS0xLTI5NDg5_86e20f80-1a87-4b15-8bf6-c40c8d5d2144">551</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" name="rdnt:AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMjQtMTUtMS0xLTI5NDg5_4724c19d-319b-4471-8148-5b96d2f286c0">551</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Distributions paid to noncontrolling&#160;interests</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i298a24d3aaec41ea8698fd195ead858e_D20200101-20201231" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMjUtMTMtMS0xLTI5NDg5_2096a531-b513-42e8-ab68-3943b7f3bb6c">1,985</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMjUtMTUtMS0xLTI5NDg5_de535a47-0933-4130-8014-20cda8efef40">1,985</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Change in cumulative foreign currency&#160;translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d5e574cdbd04637a34823f382a6c58a_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMjYtNy0xLTEtMjk0ODk_a825f07b-896e-47e5-af27-e1236aa19e15">101</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i006b7ea314fc4246a62dc2614396fb18_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMjYtMTEtMS0xLTI5NDg5_036176da-ba36-4217-8e5c-f743452a683a">101</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMjYtMTUtMS0xLTI5NDg5_5b5d9ec7-d658-41c0-992b-b77a89982aa0">101</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Change in fair value cash flow hedge,&#160;net of taxes</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d5e574cdbd04637a34823f382a6c58a_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMjctNy0xLTEtMjk0ODk_a48a2e15-a4dd-4300-802f-e20879a215d6">19,372</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i006b7ea314fc4246a62dc2614396fb18_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMjctMTEtMS0xLTI5NDg5_ce97bd56-ec5a-4e5f-8f02-ff1a1db622cc">19,372</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMjctMTUtMS0xLTI5NDg5_ee9b34d7-2804-4aae-a277-42c90217d84c">19,372</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Change in fair value of cash flow hedge from prior periods reclassified to earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d5e574cdbd04637a34823f382a6c58a_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMjgtNy0xLTEtMjk0ODk_50526dbe-df04-4228-9cf4-66ab7384f4c2">3,448</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i006b7ea314fc4246a62dc2614396fb18_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMjgtMTEtMS0xLTI5NDg5_d020d2d9-741a-415b-adf4-76cfb1004aa7">3,448</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMjgtMTUtMS0xLTI5NDg5_a87f07a9-51fa-49dd-af48-6f476c0485c7">3,448</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net (loss) income</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic79d3a1f3d0f4fc49bb4724de0a7156c_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMjktOS0xLTEtMjk0ODk_f49ac660-2262-4a0d-80a4-ad377815b401">14,840</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i006b7ea314fc4246a62dc2614396fb18_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMjktMTEtMS0xLTI5NDg5_e2ea232a-3203-4a56-8a28-e977cf9e578f">14,840</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i298a24d3aaec41ea8698fd195ead858e_D20200101-20201231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMjktMTMtMS0xLTI5NDg5_4fb1b172-d8af-4d3a-a5d8-ea29a843b973">13,091</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMjktMTUtMS0xLTI5NDg5_6e68ccf5-79dc-4a25-b1f5-b1249d0dd062">1,749</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">BALANCE - DECEMBER 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i081fa83c5ad549cebb5ab4d974f827b3_I20201231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMzAtMS0xLTEtMjk0ODk_11f355ab-1bc3-4235-8f5b-da3f5b0ce796">51,640,537</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i081fa83c5ad549cebb5ab4d974f827b3_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMzAtMy0xLTEtMjk0ODk_db9f7a18-f954-4f27-9633-0a823ac307a0">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i101eecb916e744b7aaed50d001dc9bab_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMzAtNS0xLTEtMjk0ODk_a6a68d86-6fc8-45d9-a16c-37c03923b9ea">307,788</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i23849d87eb184c1b9a2d7f9eb8115fbb_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMzAtNy0xLTEtMjk0ODk_fd97def1-2b7e-4534-95b5-05f663e75a9f">24,051</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b2862b69f4a469795d00c8dfea6afd9_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMzAtOS0xLTEtMjk0ODk_114a5857-00bc-4349-a1ce-c27803bad650">117,999</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff5a453e0ae34e3ea23964a503b82dff_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMzAtMTEtMS0xLTI5NDg5_9a7f7611-7a52-472e-b17e-4bcad0882bce">165,743</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dcbd877ab784f1894ed73e70da01d83_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMzAtMTMtMS0xLTI5NDg5_7b62877e-0a0b-4cbd-b29d-833084db8984">92,560</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb50bc5a13564f6a97eb669524009c18_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMzAtMTUtMS0xLTI5NDg5_dbdc1479-5931-4dda-8f2c-bf7a9a9b0d5b">258,303</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of stock upon exercise of options</span></td><td colspan="2" style="background-color:#eeeeee;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib946969776ca45ccae82cbfc0c191797_D20210101-20211231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMzEtMS0xLTEtMjk0ODk_42e69304-9603-4500-9d8c-81da17e51da2">53,960</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i949f0d96ac8d4f8facf965ee05a37476_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMzEtNS0xLTEtMjk0ODk_0f30a3d7-a065-47b6-8fa8-0ff241f0710a">488</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e0d2a5109214eacb7c4927e040de2c1_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMzEtMTEtMS0xLTI5NDg5_311d5b20-47e0-4e54-8420-9fd856947b87">488</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMzEtMTUtMS0xLTI5NDg5_f4f40e95-5218-42de-9c1f-d6c21f5b8209">488</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Shares issued under the equity compensation plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib946969776ca45ccae82cbfc0c191797_D20210101-20211231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMzItMS0xLTEtMjk0ODk_bba99d32-852a-480f-a989-b88de89fcb17">1,212,758</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of common stock under the DeepHealth equity compensation plan</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9f3ededd5ee04ec4aa19a0abbf3d7f77_D20210101-20211231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMzMtMS0xLTEtMjk0ODk_aa2888a3-3bd9-4be8-a55d-b5e70dc11279">471,162</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i949f0d96ac8d4f8facf965ee05a37476_D20210101-20211231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMzQtNS0xLTEtMjk0ODk_468e2fee-8eb3-42ca-a7c7-37b962935eea">25,284</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e0d2a5109214eacb7c4927e040de2c1_D20210101-20211231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMzQtMTEtMS0xLTI5NDg5_4b063d64-ba06-4ce7-bae7-40a62b26aba7">25,284</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMzQtMTUtMS0xLTI5NDg5_7dafe557-f9f3-47a0-95c6-814da23b84d4">25,284</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of common stock for acquisitions and asset purchases</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic1adea4000aa4578a36583c8f938f522_D20210101-20211231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMzUtMS0xLTEtMjk0ODk_083011f4-6cd7-4dca-8236-86d97b34d41d">82,658</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63bfeffb69d140e6b2f2ea03ff67d0bf_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMzUtNS0xLTEtMjk0ODk_4fd56e80-9d25-48fa-83d9-f0bfdd255833">2,498</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a58f6df7fad437ea356f767cbc04a2e_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMzUtMTEtMS0xLTI5NDg5_8fe4a4d5-982c-4350-a506-a55e20a83f74">2,498</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6418d4bd1d040b8a16164a6790b1f63_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMzUtMTUtMS0xLTI5NDg5_6fa8ad91-a28b-4050-a26a-91c8da65cc6e">2,498</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Release of holdback shares from the purchase of DeepHealth</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9f3ededd5ee04ec4aa19a0abbf3d7f77_D20210101-20211231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMzYtMS0xLTEtMjk0ODk_14b6d434-2d2b-4230-8158-9aa3e5f643a5">91,517</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1f7abf905284fcaa40bc6081a6bd921_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMzYtNS0xLTEtMjk0ODk_dd0fdceb-8e7e-4f0b-b5c7-6ee9f8ed59f0">2,413</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i886a120ecc15453ab356ce266fd3fcf8_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMzYtMTEtMS0xLTI5NDg5_e3123f33-a062-479e-972f-8f7dccb08296">2,413</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28b7664a3050400f83608253e0d1c4ba_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMzYtMTUtMS0xLTI5NDg5_31c4fda3-fa05-4f4c-8245-c78f9484938e">2,413</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Forfeiture of restricted stock</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ib946969776ca45ccae82cbfc0c191797_D20210101-20211231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMzctMS0xLTEtMjk0ODk_7c729bbb-7dbe-4352-962e-693075a7b1a6">4,365</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i949f0d96ac8d4f8facf965ee05a37476_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMzctNS0xLTEtMjk0ODk_cf0ff9d6-5008-4094-b1ca-3b48581e2c22">81</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e0d2a5109214eacb7c4927e040de2c1_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMzctMTEtMS0xLTI5NDg5_fb247a63-302f-478c-980b-d4f2b7e92ee8">81</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMzctMTUtMS0xLTI5NDg5_9fc5c593-665b-45b8-b2b1-596c1925f5dc">81</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Gain on contribution of assets to majority owned subsidiary</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i949f0d96ac8d4f8facf965ee05a37476_D20210101-20211231" decimals="-3" name="rdnt:AdjustmentsToAdditionalPaidInCapitalGainOnContributionOfAssetsToSubsidiary" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMzgtNS0xLTEtMjk0ODk_b90286a8-7a3d-470f-a7d6-6f654ed0acc9">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e0d2a5109214eacb7c4927e040de2c1_D20210101-20211231" decimals="-3" name="rdnt:AdjustmentsToAdditionalPaidInCapitalGainOnContributionOfAssetsToSubsidiary" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMzgtMTEtMS0xLTI5NDg5_3f685992-7243-4866-bac6-5ca7423f22a5">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="rdnt:AdjustmentsToAdditionalPaidInCapitalGainOnContributionOfAssetsToSubsidiary" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMzgtMTUtMS0xLTI5NDg5_1f9d1b5f-62fe-4c64-975a-701a387437e7">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Contribution from noncontrolling partner</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i972be9663bfb45d4a202f7cf617a88c3_D20210101-20211231" decimals="-3" name="rdnt:NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMzktMTMtMS0xLTI5NDg5_023612db-d7a6-418a-bfe4-1a811f8a4fca">123</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="rdnt:NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMzktMTUtMS0xLTI5NDg5_195a57e7-e9ba-4bb0-a45e-eaed4e10fe56">123</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sale of economic interests in majority owned subsidiary, net of taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i949f0d96ac8d4f8facf965ee05a37476_D20210101-20211231" decimals="-3" name="us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNDAtNS0xLTEtMjk0ODk_b9ccde98-3e18-4acc-8980-50acc3760c0c">4,206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e0d2a5109214eacb7c4927e040de2c1_D20210101-20211231" decimals="-3" name="us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNDAtMTEtMS0xLTI5NDg5_8bd9269a-ba1c-4d33-b9bb-f50e5d36a409">4,206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i972be9663bfb45d4a202f7cf617a88c3_D20210101-20211231" decimals="-3" name="us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNDAtMTMtMS0xLTI5NDg5_b347a752-5ba2-463a-b2b5-f59be2e08d98">7,404</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNDAtMTUtMS0xLTI5NDg5_fbcba8f3-6bc0-4349-8479-32514042285c">11,610</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Distributions paid to noncontrolling interests</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i972be9663bfb45d4a202f7cf617a88c3_D20210101-20211231" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNDEtMTMtMS0xLTI5NDg5_7469b8fc-46e1-49bd-8f7b-85d4adbee422">2,426</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNDEtMTUtMS0xLTI5NDg5_34e5164a-c61a-465b-a252-bdaaa68fe80e">2,426</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Change in cumulative foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic6625f4cf6e34dd2acb014782fcfff34_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNDMtNy0xLTEtMjk0ODk_8669b3b6-7b06-44ae-a15e-1766c462294a">65</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e0d2a5109214eacb7c4927e040de2c1_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNDMtMTEtMS0xLTI5NDg5_2ba6380e-7386-4c7d-847b-2a662c443357">65</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNDMtMTUtMS0xLTI5NDg5_d1fdc007-9eb8-46da-b527-6d72145ed75e">65</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Change in fair value of cash flow hedge from prior periods reclassified to earnings</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6625f4cf6e34dd2acb014782fcfff34_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNDQtNy0xLTEtMjk0ODk_9016d2f4-2e25-4f7f-85f6-09590cc79778">3,695</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e0d2a5109214eacb7c4927e040de2c1_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNDQtMTEtMS0xLTI5NDg5_c7fb5496-718a-4fa7-bdda-1aaf3b8d5b65">3,695</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNDQtMTUtMS0xLTI5NDg5_3e09c9db-fd2b-4613-9cd0-b14b39972e45">3,695</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27608790e25740878c35acf6d5e205e7_D20210101-20211231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNDUtOS0xLTEtMjk0ODk_f727f97c-0654-4a53-abbd-e6ce4a5e270c">24,727</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e0d2a5109214eacb7c4927e040de2c1_D20210101-20211231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNDUtMTEtMS0xLTI5NDg5_41d921ad-9fd6-47ea-af40-4d98e06506ce">24,727</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i972be9663bfb45d4a202f7cf617a88c3_D20210101-20211231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNDUtMTMtMS0xLTI5NDg5_6df5ace8-837e-4950-bef2-43ab3eaa9a50">19,592</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNDUtMTUtMS0xLTI5NDg5_9ffcffd6-0129-4ac0-b27c-8b24e4b0db85">44,319</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">BALANCE - DECEMBER 31, 2021</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6567c2edd74c415e809b3f8dfbc69d6f_I20211231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNDYtMS0xLTEtMjk0ODk_84304518-0f53-435c-8b50-741c76d89e36">53,548,227</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6567c2edd74c415e809b3f8dfbc69d6f_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNDYtMy0xLTEtMjk0ODk_09a300a7-9dd0-4a62-b895-8cf4815ac6ee">5</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd09aa04b85b458ca4b4ac2d646daf7b_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNDYtNS0xLTEtMjk0ODk_574db440-36d0-4fb0-b328-eafaea243f04">342,592</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0b5e62c4b8e424ba71aa7824dcf3fa1_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNDYtNy0xLTEtMjk0ODk_49c18de9-48e9-4c6a-b7f4-9d7cf4413146">20,421</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2cbbe88e8caf4501bfffaebc7f2878cf_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNDYtOS0xLTEtMjk0ODk_f5e8abcb-ccb0-48a1-8139-eaab01803752">93,272</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ada6464a5b842509b8bf074c4eab6e6_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNDYtMTEtMS0xLTI5NDg5_378507f8-66de-4e57-815f-2f6c7f97acc4">228,904</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie96fcf0fd181417d9610fba554c8f505_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNDYtMTMtMS0xLTI5NDg5_251c66e0-bcf3-431f-ae76-eac62a43664f">117,253</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNDYtMTUtMS0xLTI5NDg5_97280d1b-8faa-42bc-a6b9-f8a16bdb0b04">346,157</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of stock upon exercise of options</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib0d0862fed0f44bf87195bfcd4b82674_D20220101-20221231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNDctMS0xLTEtNjIxNTI_b9f035ee-bba5-4b42-b7ed-38f7eb2d1f72">25,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0d0862fed0f44bf87195bfcd4b82674_D20220101-20221231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNDctMy0xLTEtNjQ1MTY_23112a33-dc2f-483d-b099-af65ca7481a3">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1933fa68c2f4a878ab49bbb7e97074b_D20220101-20221231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNDctNS0xLTEtNjIyMjA_29a9b7d1-a4b9-4eb5-8654-3899ccefea50">294</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eb334b8be644046940eed543ae94157_D20220101-20221231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNDctMTEtMS0xLTYyMzMw_509bebb5-f8f3-4b44-99a0-4dccce848e31">295</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNDctMTUtMS0xLTYyNDQz_a90f7752-8b8e-4c68-b037-695c974eeb69">295</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Shares issued under the equity compensation plan</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib0d0862fed0f44bf87195bfcd4b82674_D20220101-20221231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNDgtMS0xLTEtNjIxNjA_8c32d6eb-d7ad-4244-bdb7-e0683a678f70">725,577</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of common stock to settle DeepHealth contingent consideration </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i98a74a949db8402da4aef3fe694b8e90_D20220101-20221231" decimals="INF" name="rdnt:SharesIssuedSharesSettlementOfContingentConsideration" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNDktMS0xLTEtNjIxNjg_21c658b4-2d64-4c05-a83e-44b11c40d119">781,577</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.685%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of common stock under the DeepHealth equity compensation plan</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i98a74a949db8402da4aef3fe694b8e90_D20220101-20221231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNTAtMS0xLTEtNjk5MjU_76756cbe-c4df-454e-9911-434d2906854e">204,160</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1933fa68c2f4a878ab49bbb7e97074b_D20220101-20221231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNTAtNS0xLTEtNjIyMjg_2ac190bf-dff1-40cb-aeaf-ce9d0993b28f">23,543</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eb334b8be644046940eed543ae94157_D20220101-20221231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNTAtMTEtMS0xLTY0NTA0_9ff17458-48a6-4ea0-a5e4-9a7bf6b5e332">23,543</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNTAtMTUtMS0xLTYyNDUx_70560c6c-dcd7-43e4-b3bc-659c3992adb9">23,543</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of common stock for  acquisitions</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idf1451719c2f414a821e66141f27fa18_D20220101-20221231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNTEtMS0xLTEtNjIxNzc_acb26c6d-b792-4d31-8358-b80c6ab4b97b">2,465,294</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib31322494eca4d5aa1547d0971dc8ac9_D20220101-20221231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNTEtNS0xLTEtNjIyMzY_cd97bd92-f46c-4251-b0d7-45bdb331d3e8">63,311</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8ee29b0f704d5582d80f8a1f293200_D20220101-20221231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNTEtMTEtMS0xLTYyMzQw_20f42515-8a89-4b7d-a2b9-4f749b7fc25f">63,311</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc05bb1c3a004d69a9dd0f6792cba7d0_D20220101-20221231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNTEtMTUtMS0xLTYyNDU5_7e2512ac-5fbe-4589-a1c1-ff6da7aebdc6">63,311</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Forfeiture of restricted stock and share cancellation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ib0d0862fed0f44bf87195bfcd4b82674_D20220101-20221231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNTItMS0xLTEtNjIxODc_84c3ccbe-3fad-4357-b894-9544c163cc8c">26,710</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1933fa68c2f4a878ab49bbb7e97074b_D20220101-20221231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNTItNS0xLTEtNjIyNDQ_ef0425f6-59d8-4b55-ad19-6462f9a46243">75</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0eb334b8be644046940eed543ae94157_D20220101-20221231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNTItMTEtMS0xLTYyMzQ4_be1eb15c-acdb-4444-a3d7-3f8718cc6d4c">75</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNTItMTUtMS0xLTYyNDY3_892da4ec-7300-4290-bef8-3d983957da6f">75</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Contribution from noncontrolling partner</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1688320e5de4822882dee9ca4e4c9cb_D20220101-20221231" decimals="-3" name="rdnt:NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNTQtMTMtMS0xLTYyNDEw_f160b3b3-95e4-4902-895e-630f6d6dae57">19,139</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="rdnt:NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNTQtMTUtMS0xLTYyNDc2_d6ecedcc-8a27-4f71-ae07-aaa174feee11">19,139</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sale of economic interests in majority owned subsidiary, net of taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1933fa68c2f4a878ab49bbb7e97074b_D20220101-20221231" decimals="-3" name="us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNTUtNS0xLTEtNjIyNTM_72497f6c-4899-40f5-b753-a062ae69173d">6,623</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eb334b8be644046940eed543ae94157_D20220101-20221231" decimals="-3" name="us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNTUtMTEtMS0xLTYyMzYy_0e00eb52-bcfd-40e8-bb3f-e77758c16af4">6,623</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNTUtMTUtMS0xLTYyNDg0_bd60c394-0b42-4ba5-9c3f-72c3948fc399">6,623</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Distributions paid to noncontrolling interests</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id1688320e5de4822882dee9ca4e4c9cb_D20220101-20221231" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNTYtMTMtMS0xLTYyNDE4_59877a91-32c4-4971-a17a-209405ce5d4a">893</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNTYtMTUtMS0xLTYyNDky_14cc0db5-1656-4f2f-b277-bcd65d2d5aee">893</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Change in cumulative foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0cf47a4282e4868ac20435f2c4eb0f9_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNTgtNy0xLTEtNjIyODI_b6ae2a7f-bcb1-48b7-86c6-4449950e41d9">3,943</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0eb334b8be644046940eed543ae94157_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNTgtMTEtMS0xLTYyMzcw_0eed0ff5-102a-4f28-aa5b-13eda6196b99">3,943</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNTgtMTUtMS0xLTYyNTAw_d6e268a3-061e-4b4d-9246-72d97a5450a6">3,943</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Change in fair value of cash flow hedge from prior periods reclassified to earnings</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0cf47a4282e4868ac20435f2c4eb0f9_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNTktNy0xLTEtNjIyOTA_f232b4eb-7b40-4e04-951e-45fc66f2f611">3,687</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eb334b8be644046940eed543ae94157_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNTktMTEtMS0xLTYyMzc4_47bfc339-6508-443c-95b8-3bd87a31c728">3,687</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNTktMTUtMS0xLTYyNTA4_dad26efc-2a3f-41e0-8aa4-bb607a318cb2">3,687</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id48fff5740844b57bc700c378e450fa7_D20220101-20221231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNjEtOS0xLTEtNjIzMTQ_16fcb529-0f2c-42e4-9d97-e132a2b9f7c8">10,650</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eb334b8be644046940eed543ae94157_D20220101-20221231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNjEtMTEtMS0xLTYyMzk0_79d55b82-84cc-4203-aaa0-60cbd74c896c">10,650</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1688320e5de4822882dee9ca4e4c9cb_D20220101-20221231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNjEtMTMtMS0xLTYyNDI2_710c96f9-4baf-45b8-a048-fe06c1b6af3d">22,958</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNjEtMTUtMS0xLTYyNTI0_df6f3d6b-db07-46f0-ae78-36f571b84778">33,608</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">BALANCE - DECEMBER 31, 2022</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8850d8ea71334023bc7208f43133ccc1_I20221231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNjEtMS0xLTEtNjIxOTY_b9d47f81-a827-4ae9-8aaf-19e1551604e7">57,723,125</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8850d8ea71334023bc7208f43133ccc1_I20221231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNjEtMy0xLTEtNjIyMTI_687102a8-bdf6-4dd9-a277-c85a3d1315ee">6</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90205585203d45b9a541218bf94ecb8f_I20221231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNjEtNS0xLTEtNjIyNjE_71abc8fc-8a5b-4c4f-9a49-c2c45c707777">436,288</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9617cb12c1c84a2495a0468f42ec6183_I20221231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNjItNy0xLTEtNjIyOTg_e9f283f0-261b-42ad-9e4d-514947e2d0ce">20,677</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib807cb0974544fe1bde03d660c5eaaf7_I20221231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNjItOS0xLTEtNjIzMjI_4a666409-5f7b-43d1-8472-e39fcc8c28f4">82,622</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8a329c56c57456a87d52725a451b145_I20221231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNjItMTEtMS0xLTYyNDAy_6c3364e4-4a5f-4b14-b016-671c4605fb9d">332,995</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14c67953a7094a6fbf13726da1a68618_I20221231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNjItMTMtMS0xLTYyNDM0_543c9b51-acba-4da5-a7f9-39dcd29fd997">158,457</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNjItMTUtMS0xLTYyNTI0_249681df-a49c-43b7-9b59-bcb7f3ce9d6d">491,452</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:20pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these financial statements.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><div id="if3f80771944f4fc58015abda42dc47d1_67"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RADNET, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(IN THOUSANDS)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CASH FLOWS FROM OPERATING ACTIVITIES</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMy0xLTEtMS0yOTQ4OQ_2c99273a-9d3f-4d64-92cb-4ea103d4fca9">33,608</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMy0zLTEtMS0yOTQ4OQ_3b32e2b9-d1f6-417d-9e9e-878a32b2bc36">44,319</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMy01LTEtMS0yOTQ4OQ_8ee3688a-d28e-4697-b20e-1354bc41a610">1,749</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net income (loss)&#160;to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNS0xLTEtMS0yOTQ4OQ_ceeb3ac9-30e7-43fc-9a7a-61d3be44e8d8">115,877</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNS0zLTEtMS0yOTQ4OQ_dfd9a464-3500-4de3-bd47-29c3a9e03a0c">96,694</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNS01LTEtMS0yOTQ4OQ_848804ea-42a8-40e1-b7ee-c2210d8a6f4b">86,795</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNi0xLTEtMS0yOTQ4OQ_8315c1f9-59ee-4f11-a375-c4483f3efe57">68,847</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNi0zLTEtMS0yOTQ4OQ_f8073d9a-7978-4a65-8959-81b2a4a6f41c">73,967</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNi01LTEtMS0yOTQ4OQ_d60343f0-66f7-43ab-94e7-73e29d84aac8">67,915</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease abandonment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:GainLossOnTerminationOfLease" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNy0xLTEtMS0yOTQ4OQ_8b24335b-d28b-4364-962e-2e413c36ec4a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:GainLossOnTerminationOfLease" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNy0zLTEtMS0yOTQ4OQ_4b9280d3-ffae-4533-8f2b-7f73b57d2aee">19,675</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" name="us-gaap:GainLossOnTerminationOfLease" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNy01LTEtMS0yOTQ4OQ_9ea730bc-09fb-48ba-a152-2c6808383425">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in earnings of joint ventures, net of dividends</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfOC0xLTEtMS0yOTQ4OQ_3d0641fd-d3b6-4d28-9f7f-25925401ad15">5,952</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfOC0zLTEtMS0yOTQ4OQ_24be0095-0673-42a5-8b92-d4b06873ed5d">6,260</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfOC01LTEtMS0yOTQ4OQ_362067ee-0374-47e9-9415-4e390ef307fa">1,577</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization and write off of deferred financing costs and loan discount</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfOS0xLTEtMS0yOTQ4OQ_3f2a8a2f-ca68-4d03-af45-98a91ec38ea0">2,693</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfOS0zLTEtMS0yOTQ4OQ_f02bdceb-6b4b-4bce-9ead-bf470a1a3461">3,254</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfOS01LTEtMS0yOTQ4OQ_ec24a12b-38b2-4cd0-894a-ccd426927f1d">4,413</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on sale and disposal of equipment and other</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:GainLossOnDispositionOfAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMTAtMS0xLTEtMjk0ODk_21b7f550-618b-4f9e-a655-c502550de012">2,529</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:GainLossOnDispositionOfAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMTAtMy0xLTEtMjk0ODk_ecc7f933-3ad7-47f2-8e6a-6b9cae87f26c">1,246</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:GainLossOnDispositionOfAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMTAtNS0xLTEtMjk0ODk_943c4c19-f321-422f-804c-036ce3ae7d67">1,200</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss (gain) on extinguishment of debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMTEtMS0xLTEtMjk0ODk_dcf56240-65bb-415c-b992-e4652b307700">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMTEtMy0xLTEtMjk0ODk_d625c4a0-c9f2-4e31-a036-48496a599561">1,496</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMTEtNS0xLTEtMjk0ODk_e8396a67-b3bd-4b94-9cff-aaf1c647caeb">4,047</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on impairment</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:GoodwillAndIntangibleAssetImpairment" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMTQtMS0xLTEtMjk0ODk_ab176dda-5921-40ed-a319-5c1a94d3d215">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:GoodwillAndIntangibleAssetImpairment" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMTQtMy0xLTEtMjk0ODk_167564e7-7cf5-45e5-b298-eb629e72a48f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" name="us-gaap:GoodwillAndIntangibleAssetImpairment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMTQtNS0xLTEtMjk0ODk_5d7a1dad-c022-4e57-973b-1eaebd45da06">4,170</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of cash flow hedge</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:AmortizationOfDeferredHedgeGains" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMTUtMS0xLTEtMjk0ODk_f31564b3-5f07-4995-8de0-5a4db54cd7dd">3,687</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:AmortizationOfDeferredHedgeGains" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMTUtMy0xLTEtMjk0ODk_6718fdd1-2478-4fcf-87ff-380aa2928517">3,695</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" name="us-gaap:AmortizationOfDeferredHedgeGains" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMTUtNS0xLTEtMjk0ODk_d11ce372-33f6-4dd1-b234-0c8bd6b134f5">3,448</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash change in fair value of interest rate swap</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:UnrealizedGainLossOnDerivatives" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMTYtMS0xLTEtMjk0ODk_d8d17153-30f6-4959-9ce7-73d173d9e9e6">39,621</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:UnrealizedGainLossOnDerivatives" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMTYtMy0xLTEtMjk0ODk_be76fc91-3f2a-4527-ba61-9eb9531c9e5e">21,670</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:UnrealizedGainLossOnDerivatives" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMTYtNS0xLTEtMjk0ODk_0714c338-14dc-4b72-9981-e4591b295c27">2,528</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMTctMS0xLTEtMjk0ODk_1c6662cd-35c0-4bde-8328-0d8d8bf012b6">23,770</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMTctMy0xLTEtMjk0ODk_e2154b6e-c9c6-4899-b473-7d1adb9d5234">25,203</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMTctNS0xLTEtMjk0ODk_6dcf6d31-73fb-45dc-b7ec-830bea2bc8ea">12,405</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non cash item in other expenses</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="rdnt:IncreaseDecreaseInNoncashItem" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMTgtMS0xLTEtMjk0ODk_44350d1c-9761-4e1e-a5ee-a9e9968c9844">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="rdnt:IncreaseDecreaseInNoncashItem" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMTgtMy0xLTEtMjk0ODk_4af1b636-b32d-4e41-aff7-237b6cf725c7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" sign="-" name="rdnt:IncreaseDecreaseInNoncashItem" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMTgtNS0xLTEtMjk0ODk_f4e40cca-3ab9-460f-a362-a850aeae0026">242</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in value of contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMTktMS0xLTEtMjk0ODk_f2744a91-f02e-41a3-b4e0-7ffd1ea5a65c">325</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMTktMy0xLTEtMjk0ODk_7bc516c9-4872-48f6-95e8-1e1fa422074d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMTktNS0xLTEtMjk0ODk_2ee39d4f-c825-4085-9045-e49c34b9ada6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions:</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMjEtMS0xLTEtMjk0ODk_d0697343-5bf3-469e-aa94-f20f0eb550b3">30,078</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMjEtMy0xLTEtMjk0ODk_a5905a64-03f8-4ac8-aa99-a04dda87d973">5,890</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMjEtNS0xLTEtMjk0ODk_a3b5764c-157a-438f-8b8a-74384467648c">25,206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherCurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMjItMS0xLTEtMjk0ODk_b5f7841c-57c1-4bb9-b5f2-4e40fae4a9c3">3,327</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherCurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMjItMy0xLTEtMjk0ODk_ccbf9c1c-0620-4c5e-8d7c-27a8e4655f52">15,777</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherCurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMjItNS0xLTEtMjk0ODk_994e3c4f-56cb-499f-84b6-f5802811f7f0">6,588</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMjMtMS0xLTEtMjk0ODk_00822cd4-9deb-47dd-82df-f05be026755d">12,166</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMjMtMy0xLTEtMjk0ODk_f0103793-cd5a-4f41-ba95-e38f83174dc7">662</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMjMtNS0xLTEtMjk0ODk_79dec725-b525-45fb-a9c9-b5c73cf91ad9">5,425</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred taxes</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMjQtMS0xLTEtMjk0ODk_6b4869ca-805b-4cf3-913e-dcdd5f030600">13,356</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMjQtMy0xLTEtMjk0ODk_23a4783f-59ca-4f3e-b2b5-142e1fda3da2">19,834</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMjQtNS0xLTEtMjk0ODk_400d50aa-157a-4a0b-a47d-e4ee87a6393c">611</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMjUtMS0xLTEtMjk0ODk_0e01495a-c3fc-437f-8d24-aa315a6ed9b7">68,943</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMjUtMy0xLTEtMjk0ODk_ef5a2132-e84f-4e7f-8074-f49dc1221444">72,553</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMjUtNS0xLTEtMjk0ODk_86a278a8-c831-46a5-a6e1-2a9ec0fbc987">53,906</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDeferredRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMjYtMS0xLTEtMjk0ODk_99255ce8-8a0d-4511-a35b-8a3ca12e7c0e">7,316</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDeferredRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMjYtMy0xLTEtMjk0ODk_b2f5e370-9434-4865-8c19-0f3143a0ac2c">28,319</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInDeferredRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMjYtNS0xLTEtMjk0ODk_e139456d-3458-464e-9110-992cfbd34ec0">37,941</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable, accrued expenses and other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMjctMS0xLTEtMjk0ODk_fffcc93f-bb94-4b30-88d4-f05db7f2cafe">49,778</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMjctMy0xLTEtMjk0ODk_cd116a8b-792b-4696-b9d4-889e9d65d971">9,915</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMjctNS0xLTEtMjk0ODk_c3d4410e-681e-4dbc-b8cc-5383b7ae9012">45,069</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMjgtMS0xLTEtMjk0ODk_a4b14a8f-93a0-4c81-9c95-ae015a6f7826">146,417</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMjgtMy0xLTEtMjk0ODk_bd1dd80e-5d1f-42de-963e-e8ddbca416ae">149,491</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMjgtNS0xLTEtMjk0ODk_2ca62773-50da-4ab7-8db9-d2d17350f30f">233,759</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CASH FLOWS FROM INVESTING ACTIVITIES</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of imaging centers and other operations</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:PaymentsToAcquireBuildings" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMzAtMS0xLTEtMjk0ODk_55389320-2521-442a-93ea-7d097aa174b1">129,961</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToAcquireBuildings" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMzAtMy0xLTEtMjk0ODk_e9875478-a64a-48ef-8ccd-6168101dcc8f">77,691</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToAcquireBuildings" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMzAtNS0xLTEtMjk0ODk_90bc6fb6-3182-4aa0-98fa-87217df5eb6e">31,265</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:PaymentsToAcquireOtherPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMzItMS0xLTEtMjk0ODk_e5733212-0a13-4334-9f67-cc94917df805">119,451</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToAcquireOtherPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMzItMy0xLTEtMjk0ODk_ce552f12-d153-4333-bfb8-b0d126407f5c">137,874</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToAcquireOtherPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMzItNS0xLTEtMjk0ODk_7d03adbe-8e83-4308-8566-123c0672af8a">94,172</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of intangible assets</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:PaymentsToAcquireIntangibleAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMzMtMS0xLTEtMjk0ODk_3ed9e6fe-0c28-40c2-aeda-87f8505f3df4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToAcquireIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMzMtMy0xLTEtMjk0ODk_3486480a-02dc-4038-94d9-25259c25a9ab">5,130</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToAcquireIntangibleAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMzMtNS0xLTEtMjk0ODk_6b3edd73-b625-4738-9373-db1870a95139">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sale of equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMzQtMS0xLTEtMjk0ODk_f9359571-5f12-4087-b158-4c155c03b737">3,904</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMzQtMy0xLTEtMjk0ODk_7e44e2e1-211e-4017-8027-e86f101b40b3">625</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMzQtNS0xLTEtMjk0ODk_c9e98a4b-a1e6-4044-90e1-cadeb1ab7325">828</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity contributions in existing and purchase of interest in joint ventures</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:PaymentsToAcquireInterestInJointVenture" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNDAtMS0xLTEtMjk0ODk_38dc6555-65f6-4051-b8ed-2584f0519ac0">1,441</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToAcquireInterestInJointVenture" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNDAtMy0xLTEtMjk0ODk_4f1ed210-ef9b-48d2-a55e-346e1debd61a">1,441</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToAcquireInterestInJointVenture" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNDAtNS0xLTEtMjk0ODk_9363146d-4839-4d73-8e66-f74593505486">1,635</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNDEtMS0xLTEtMjk0ODk_7fb45614-da55-4262-a0c7-a780669d5423">246,949</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNDEtMy0xLTEtMjk0ODk_be12d4fa-f995-4d83-96b6-5a665c7d2ab8">221,511</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNDEtNS0xLTEtMjk0ODk_a3040bf6-651e-49a9-97cc-08ecc530ad87">126,244</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CASH FLOWS FROM FINANCING ACTIVITIES</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments on term loan debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:RepaymentsOfDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNDMtMS0xLTEtNzcwMzI_f049c71a-59b0-40f0-8239-d1194a1dcf36">53,750</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:RepaymentsOfDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNDMtMy0xLTEtNzcwMzI_086c6434-6c92-4eae-8a84-7742bab3a28d">619,529</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" name="us-gaap:RepaymentsOfDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNDMtNS0xLTEtNzcwMzI_c4daf8eb-df72-4550-8f06-93e6e6c74cac">43,296</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal payments on notes and leases payable other than term loan debt</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNDMtMS0xLTEtMjk0ODk_aa6cb4a2-ec8c-492c-b3bc-fc2058bb5fd5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNDMtMy0xLTEtMjk0ODk_e09b2e0a-76c6-447c-8abe-087224cbfd88">3,302</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" name="us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNDMtNS0xLTEtMjk0ODk_7e58a9b4-38b2-45f8-a8f3-1170dd07bd7f">3,562</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional deferred finance costs on revolving loan amendment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNDUtMS0xLTEtMjk0ODk_56148619-25f0-4dcc-afec-9b6344363f75">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNDUtMy0xLTEtMjk0ODk_042ca89a-7e54-4343-a807-df9e8e129e7a">938</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNDUtNS0xLTEtMjk0ODk_030522dc-7cd1-4ed9-b517-a2518c9b70c9">741</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from debt issuance, net of issuance costs</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNDYtMS0xLTEtMjk0ODk_a25f4411-2611-48ae-be99-c5c9a96bba86">147,996</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNDYtMy0xLTEtMjk0ODk_f3ee9cc7-fd10-4601-a599-ebbd7399dd56">717,307</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNDYtNS0xLTEtMjk0ODk_32b9cc64-4649-4e47-a7ad-b4a9329f224e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from paycheck protection program loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="rdnt:ProceedsFromGovernmentAssistance" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNDctMS0xLTEtMjk0ODk_075ae98a-60ee-47ef-81e1-c3c4585ddbe5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="rdnt:ProceedsFromGovernmentAssistance" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNDctMy0xLTEtMjk0ODk_950c8622-a4b6-4b7e-a2b4-d948e385f0a4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" name="rdnt:ProceedsFromGovernmentAssistance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNDctNS0xLTEtMjk0ODk_716c9851-4f36-455b-bc2c-a9d08d81dd44">4,023</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributions paid to noncontrolling interests</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:PaymentsToMinorityShareholders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNDgtMS0xLTEtMjk0ODk_7776b5ec-f202-46ac-82d4-9faf28b99b32">893</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToMinorityShareholders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNDgtMy0xLTEtMjk0ODk_e6ad9807-0680-4ca8-80ac-dd3497713782">2,426</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToMinorityShareholders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNDgtNS0xLTEtMjk0ODk_274b9f83-4bab-403c-a623-040500d38533">1,985</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sale of economic interest in majority owned subsidiary </span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNDktMS0xLTEtMjk0ODk_7ce9b692-dd85-43f8-a90e-2c1569875b9d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNDktMy0xLTEtMjk0ODk_bdd55f1f-c027-4636-a9de-4bc077a5376e">13,073</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNDktNS0xLTEtMjk0ODk_c15907b9-4ded-4ee7-b8b3-050e37e2fa25">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from revolving credit facility</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNTEtMS0xLTEtMjk0ODk_72bf550f-91f9-4a45-aa58-6c9db533baa2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNTEtMy0xLTEtMjk0ODk_263856dc-469e-4701-bfb8-5ca17238d7f8">128,300</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNTEtNS0xLTEtMjk0ODk_3aa7b9cf-3127-45c4-a2af-c69ef2fb4297">250,900</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments on revolving credit facility</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:RepaymentsOfLinesOfCredit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNTItMS0xLTEtMjk0ODk_c460763f-10e4-4d86-9087-b382b428d69b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:RepaymentsOfLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNTItMy0xLTEtMjk0ODk_23b55b97-820e-496f-a603-0b547f8c80d4">128,300</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" name="us-gaap:RepaymentsOfLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNTItNS0xLTEtMjk0ODk_06545cde-6b96-4556-a542-0fbe6691602c">250,900</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from issuance of common stock upon exercise of options</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNTQtMS0xLTEtMjk0ODk_32c69898-152e-4a9f-9f29-f7ff74775733">294</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNTQtMy0xLTEtMjk0ODk_21fe2ec4-e0bd-4792-bad9-de7bf338ee26">488</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNTQtNS0xLTEtMjk0ODk_eff2f035-deba-484d-9357-398887cabf0e">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in) financing activities</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNTUtMS0xLTEtMjk0ODk_7372b930-d2f5-4094-870e-8436760b9eb9">93,647</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNTUtMy0xLTEtMjk0ODk_31fba30e-b3fa-4aee-9603-8c7cfc40c875">104,673</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNTUtNS0xLTEtMjk0ODk_cf4753a8-85f2-46f3-937e-6974122d5c34">45,561</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EFFECT OF EXCHANGE RATE CHANGES ON CASH</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNTYtMS0xLTEtMjk0ODk_d6b39ef9-82ad-41ab-845d-ddaaf6a59a14">113</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNTYtMy0xLTEtMjk0ODk_e8cf22f0-5d24-4d81-9054-3cde8d2066cb">65</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNTYtNS0xLTEtMjk0ODk_ca4ac324-6545-475d-b765-2550558e301a">101</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNTctMS0xLTEtMjk0ODk_898ab2b7-ed9c-47eb-a87d-e512deb167bd">6,772</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNTctMy0xLTEtMjk0ODk_305a2cc8-b50c-44a1-9d15-ed62d6b98571">32,588</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNTctNS0xLTEtMjk0ODk_293686d7-47b2-42db-9b29-d59f824321c9">61,853</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CASH AND CASH EQUIVALENTS, beginning of period</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNTgtMS0xLTEtMjk0ODk_30c0eec1-8261-4c38-955e-c46c3ef2633d">134,606</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb50bc5a13564f6a97eb669524009c18_I20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNTgtMy0xLTEtMjk0ODk_8df57236-f24d-4cb1-90d1-a355a6877a27">102,018</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i404f0df0019f440299547782ff0ce012_I20191231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNTgtNS0xLTEtMjk0ODk_63b36f53-21bd-4b3e-8fb1-ae8a55cd02c8">40,165</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CASH AND CASH EQUIVALENTS, end of period</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNTktMS0xLTEtMjk0ODk_c718a634-82e2-4bc7-a06e-4f224a6cfe28">127,834</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNTktMy0xLTEtMjk0ODk_a1d9fc9e-6588-445e-98ea-0ffe6e371c64">134,606</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb50bc5a13564f6a97eb669524009c18_I20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNTktNS0xLTEtMjk0ODk_3168b237-ee19-42c2-8004-22ada9591337">102,018</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid during the period for interest</span></td><td style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNjEtMS0xLTEtMjk0ODk_70c0ccd4-99a7-4c09-a93c-fc9ff8a0226f">39,151</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNjEtMy0xLTEtMjk0ODk_69f7a3ab-8115-44fd-9cd6-9aaa2af93ae2">29,042</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNjEtNS0xLTEtMjk0ODk_8fe42390-cb42-42f0-82d0-4c8dc20b29b3">39,521</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid during the period for income taxes</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNjItMS0xLTEtMjk0ODk_9ce3a030-8cc1-4343-a9bc-eaf9aa19d143">587</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNjItMy0xLTEtMjk0ODk_7dd46ab0-787b-47cd-962b-a21455af2ff0">1,950</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNjItNS0xLTEtMjk0ODk_cc5c5ba3-794a-4a6a-b3a8-a213fcff11f7">5,069</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these financial statements.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RADNET, INC. AND SUBSIDIARIES</span></div><div style="text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS (CONTINUED)</span></div><div style="text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Supplemental Schedule of Non-Cash Investing and Financing Activities</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We acquired equipment and certain leasehold improvements for approximately $<ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-5" name="rdnt:EquipmentAcquiredAndLeaseholdImprovements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RleHRyZWdpb246NDM2NWMxMTMwMzU0NGRjMGFkNmNmZTQzMmE2YjIzOTZfNDA1_9cc486d2-225a-4200-90b0-18fa179b226e">111.8</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-5" name="rdnt:EquipmentAcquiredAndLeaseholdImprovements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RleHRyZWdpb246NDM2NWMxMTMwMzU0NGRjMGFkNmNmZTQzMmE2YjIzOTZfNDA5_9f0ac2cc-7e80-45d7-95ef-7f74212495fe">63.9</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-5" name="rdnt:EquipmentAcquiredAndLeaseholdImprovements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RleHRyZWdpb246NDM2NWMxMTMwMzU0NGRjMGFkNmNmZTQzMmE2YjIzOTZfNDE3_f9de490c-ab00-469a-be13-23b4006cc319">52.0</ix:nonFraction> million during the years ended December 31, 2022, 2021 and 2020, respectively, that we had not paid for as of December 31, 2022, 2021 and 2020, respectively. The offsetting amount due was recorded in our consolidated balance sheets under accounts payable, accrued expenses and other.</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2022, we issued <ix:nonFraction unitRef="shares" contextRef="i50107d7096d5469e97d67a3ff03b72b3_D20221101-20221101" decimals="INF" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RleHRyZWdpb246NDM2NWMxMTMwMzU0NGRjMGFkNmNmZTQzMmE2YjIzOTZfMTA5OTUxMTYzNzg5Nw_6cdc681c-b381-4d96-bb43-0de024e0a22f">359,002</ix:nonFraction> shares of our common stock to complete our purchase of Heart and Lung Imaging Limited.  The shares were ascribed a value of $<ix:nonFraction unitRef="usd" contextRef="i7182ccdde7ae4a0fa8aa3492db312246_I20221101" decimals="-5" name="us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RleHRyZWdpb246NDM2NWMxMTMwMzU0NGRjMGFkNmNmZTQzMmE2YjIzOTZfMTA5OTUxMTYzNzk1MA_756644e2-6964-4e31-9bf7-c65735968a93">6.8</ix:nonFraction> million.</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2022  we made a contribution to our joint venture Arizona Diagnostic Radiology Group of $<ix:nonFraction unitRef="usd" contextRef="i651e6cbf14d5467d82c4f381868cde06_D20221101-20221101" decimals="-5" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RleHRyZWdpb246NDM2NWMxMTMwMzU0NGRjMGFkNmNmZTQzMmE2YjIzOTZfMTA5OTUxMTYzODkzNA_12ff0ac4-14c8-4ea5-9706-3e522d75b1c7">12.7</ix:nonFraction> million in equipment and other assets. We recorded an offset to due to affiliates of $<ix:nonFraction unitRef="usd" contextRef="i651e6cbf14d5467d82c4f381868cde06_D20221101-20221101" decimals="-5" name="us-gaap:ProceedsFromDividendsReceived" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RleHRyZWdpb246NDM2NWMxMTMwMzU0NGRjMGFkNmNmZTQzMmE2YjIzOTZfMTA5OTUxMTYzODk0NQ_f4ec59f2-d3ea-4a52-8e8e-e46b5389dac1">4.5</ix:nonFraction> million to reduce our overall investment to $<ix:nonFraction unitRef="usd" contextRef="i0852a96e84d740afa49bfe5d275671e7_I20221101" decimals="-5" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RleHRyZWdpb246NDM2NWMxMTMwMzU0NGRjMGFkNmNmZTQzMmE2YjIzOTZfMTA5OTUxMTYzODk1Mg_6d511b35-26ba-4e2a-bf75-5574f0cea5be">8.3</ix:nonFraction> million.</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2022 we received $<ix:nonFraction unitRef="usd" contextRef="ib7f3ec194c084b988bc8b154c1692068_I20220401" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RleHRyZWdpb246NDM2NWMxMTMwMzU0NGRjMGFkNmNmZTQzMmE2YjIzOTZfMTA5OTUxMTYzNzcwOA_fb713c13-5e77-4ca0-a288-777ea1be193e">8.4</ix:nonFraction> million in fixed assets and equipment from our partner in Frederick County Radiology, LLC.  See Note 4, Facility Acquisitions contained herein.</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 20, 2022, we issued <ix:nonFraction unitRef="shares" contextRef="i76afbed304204c709d14268fe2fc7759_D20220120-20220120" decimals="INF" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RleHRyZWdpb246NDM2NWMxMTMwMzU0NGRjMGFkNmNmZTQzMmE2YjIzOTZfMTA5OTUxMTYzNzcwMA_92e7cdd6-0fe3-4fc7-803b-9b7aaf8d13be">1,141,234</ix:nonFraction> shares of our common stock to complete our purchase of Aidence Holding B.V.  The shares were ascribed a value of $<ix:nonFraction unitRef="usd" contextRef="iebda58f2b50646b69966fddb55d1e9eb_I20220120" decimals="-5" name="us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RleHRyZWdpb246NDM2NWMxMTMwMzU0NGRjMGFkNmNmZTQzMmE2YjIzOTZfMTA5OTUxMTYzNzcwNA_8af89aa1-57df-4017-8cf8-e097b72936c8">30.6</ix:nonFraction> million.</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 20, 2022, we issued <ix:nonFraction unitRef="shares" contextRef="i0037eb0ed88b4354b067862baa4cefa3_D20220120-20220120" decimals="INF" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RleHRyZWdpb246NDM2NWMxMTMwMzU0NGRjMGFkNmNmZTQzMmE2YjIzOTZfMTA5OTUxMTYzNzY5MA_f24052bd-5277-42cd-ac3d-df688c14f2d8">965,058</ix:nonFraction> shares to complete our purchase of Quantib B.V. The shares were ascribed a value of $<ix:nonFraction unitRef="usd" contextRef="ic091556638644c818849ee8b176872d4_I20220120" decimals="-5" name="us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RleHRyZWdpb246NDM2NWMxMTMwMzU0NGRjMGFkNmNmZTQzMmE2YjIzOTZfMTA5OTUxMTYzNzY5NA_72ed632f-94df-4aa7-b932-e604682fd9d3">25.9</ix:nonFraction> million.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 22, 2021 we completed our purchase of specific technology assets of DRT LLC in part by issuing <ix:nonFraction unitRef="shares" contextRef="i0a34e2b02c7643fd994177cb578613e4_D20211022-20211022" decimals="-5" name="us-gaap:NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RleHRyZWdpb246NDM2NWMxMTMwMzU0NGRjMGFkNmNmZTQzMmE2YjIzOTZfMTA5OTUxMTYzNTk2OQ_f10cb3a1-029e-4f0b-ba40-42743f8acc82">15,000</ix:nonFraction> shares of our common stock to complete the transaction.  The shares were ascribed a value of $<ix:nonFraction unitRef="usd" contextRef="i0a34e2b02c7643fd994177cb578613e4_D20211022-20211022" decimals="-5" name="rdnt:NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RleHRyZWdpb246NDM2NWMxMTMwMzU0NGRjMGFkNmNmZTQzMmE2YjIzOTZfMTA5OTUxMTYzNTk3Mw_9cd8a7b4-2994-4860-9c14-a296e2ff687e">0.4</ix:nonFraction>&#160;million.</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 24, 2021, we completed our stock purchase of Tangent Associates LLC by issuing <ix:nonFraction unitRef="shares" contextRef="i12d9fd3f8cce41bd8567698b43e666dd_D20210824-20210824" decimals="INF" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RleHRyZWdpb246NDM2NWMxMTMwMzU0NGRjMGFkNmNmZTQzMmE2YjIzOTZfMTA5OTUxMTYzNTk4MA_ca456b3b-f0ac-428f-8305-323aff1f7135">67,658</ix:nonFraction> shares of our common stock to complete the transaction. The shares were ascribed a value of $<ix:nonFraction unitRef="usd" contextRef="i22bc4ace41264830b19ecc0fff6de4f9_I20210824" decimals="-3" name="us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RleHRyZWdpb246NDM2NWMxMTMwMzU0NGRjMGFkNmNmZTQzMmE2YjIzOTZfMTA5OTUxMTYzNTk4NA_a169ca5d-7334-4c8b-9e66-cce52e66e9c5">2.0</ix:nonFraction>&#160;million.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2021 we entered into the Simi Valley Imaging Group, LLC, partnership agreement with Simi Valley Hospital and Health Services ("Simi Adventist"). Of the total combined assets of $<ix:nonFraction unitRef="usd" contextRef="i5d60f61c473f4e6fb2d9dbbff4ddca06_I20210101" decimals="-5" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RleHRyZWdpb246NDM2NWMxMTMwMzU0NGRjMGFkNmNmZTQzMmE2YjIzOTZfMTA5OTUxMTYzNjkyMg_66a5ee59-dff0-4c30-b82d-93ff8a9145c3">0.4</ix:nonFraction>&#160;million, RadNet transferred $<ix:nonFraction unitRef="usd" contextRef="i1f28b0b82f124664841343311ab008f6_D20210101-20210101" decimals="-5" name="us-gaap:NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RleHRyZWdpb246NDM2NWMxMTMwMzU0NGRjMGFkNmNmZTQzMmE2YjIzOTZfMTA5OTUxMTYzNjkxMw_560cca55-a10a-454c-91a5-308bfc5d8076">0.3</ix:nonFraction>&#160;million and Simi Adventist contributed the remaining $<ix:nonFraction unitRef="usd" contextRef="i890b17585af645948aa4f2d397196445_I20210101" decimals="-5" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RleHRyZWdpb246NDM2NWMxMTMwMzU0NGRjMGFkNmNmZTQzMmE2YjIzOTZfMTA5OTUxMTYzNjkwNg_59c57a5c-17a2-4297-b74d-c8ee6b4731da">0.1</ix:nonFraction>&#160;million.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We entered into finance lease debt of approximately $<ix:nonFraction unitRef="usd" contextRef="ifb50bc5a13564f6a97eb669524009c18_I20201231" decimals="-2" name="us-gaap:FinanceLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RleHRyZWdpb246NDM2NWMxMTMwMzU0NGRjMGFkNmNmZTQzMmE2YjIzOTZfMTA5OTUxMTYzOTUwMg_669750a8-1a4a-4188-a2fa-9a831cba1a22">20.0</ix:nonFraction>&#160;thousand during the twelve months ended December 31, 2020.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><div id="if3f80771944f4fc58015abda42dc47d1_70"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RADNET, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div id="if3f80771944f4fc58015abda42dc47d1_73"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> NOTE 1 &#8211; <ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83My9mcmFnOjIyNGJmNDY1YTJmYzRiYzVhNjY5ZDQyYzMzMzljOTIyL3RleHRyZWdpb246MjI0YmY0NjVhMmZjNGJjNWE2NjlkNDJjMzMzOWM5MjJfNzE5OA_5215db7f-1cee-4a35-b9fd-4d9443181fb2" continuedAt="iaff211584426411ea12a28c7327f621b" escape="true">NATURE OF BUSINESS</ix:nonNumeric></span></div><ix:continuation id="iaff211584426411ea12a28c7327f621b" continuedAt="i9aa86c837eba4e82b8aeae6f84596fc6"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a national provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. At December 31, 2022, we operated directly or indirectly through joint ventures with hospitals, <ix:nonFraction unitRef="center" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="INF" name="rdnt:NumberOfCenters" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83My9mcmFnOjIyNGJmNDY1YTJmYzRiYzVhNjY5ZDQyYzMzMzljOTIyL3RleHRyZWdpb246MjI0YmY0NjVhMmZjNGJjNWE2NjlkNDJjMzMzOWM5MjJfMjMz_3a7f8c16-c140-4237-b962-918077c7675c">357</ix:nonFraction> centers located in Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Our centers provide physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Our services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. The vast majority of our centers offer multi-modality imaging services. Our multi-modality strategy diversifies revenue streams, reduces exposure to reimbursement changes and provides patients and referring physicians one location to serve the needs of multiple procedures.  In addition to our center operations, we have certain other subsidiaries that develop Artificial Intelligence ("AI") products and solutions that are designed to enhance interpretation of radiographic images. Our operations comprise <ix:nonFraction unitRef="loan" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83My9mcmFnOjIyNGJmNDY1YTJmYzRiYzVhNjY5ZDQyYzMzMzljOTIyL3RleHRyZWdpb246MjI0YmY0NjVhMmZjNGJjNWE2NjlkNDJjMzMzOWM5MjJfMzg0ODI5MDcxMjg1NQ_5000b2ee-ee6c-4e63-8474-feeefa8fea3f">two</ix:nonFraction> segments for financial reporting purposes for this reporting period, Imaging Centers and Artificial Intelligence. For further financial information about these segments, see Note 5, Segment Reporting.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements include the accounts of RadNet, Inc. as well as its subsidiaries in which RadNet has a controlling financial interest. The consolidated financial statements also include certain variable interest entities in which we are the primary beneficiary (as described in more detail below). All material intercompany transactions and balances have been eliminated upon consolidation.   All of these affiliated entities are referred to collectively as &#8220;RadNet&#8221;, &#8220;we&#8221;, &#8220;us&#8221;, &#8220;our&#8221; or the &#8220;Company&#8221; in this report.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounting regulations stipulate that generally any entity with a) insufficient equity to finance its activities without additional subordinated financial support provided by any parties, or b) equity holders that, as a group, lack the characteristics which evidence a controlling financial interest, is considered a Variable Interest Entity (&#8220;VIE&#8221;). We consolidate all VIEs in which we are the primary beneficiary. We determine whether we are the primary beneficiary of a VIE through a qualitative analysis that identifies which variable interest holder has the controlling financial interest in the VIE. The variable interest holder who has both of the following has the controlling financial interest and is the primary beneficiary: (1) the power to direct the activities of the VIE that most significantly impact the VIE&#8217;s economic performance and (2) the obligation to absorb losses of, or the right to receive benefits from, the VIE that could potentially be significant to the VIE. In performing our analysis, we consider all relevant facts and circumstances, including: the design and activities of the VIE, the terms of the contracts the VIE has entered into, the nature of the VIE&#8217;s variable interests issued and how they were negotiated with or marketed to potential investors, and which parties participated significantly in the design or redesign of the entity.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIEs that we consolidate as the primary beneficiary consist of professional corporations which are owned or controlled by individuals within our senior management and provide professional medical services for centers in Arizona, California, Delaware, Maryland, New Jersey and New York.  These VIEs are collectively referred to as the Group.  RadNet provides non-medical, technical and administrative services to the Group for which it receives a management fee, pursuant to the related management agreements. Through the management agreements we have exclusive authority over all non-medical decision making related to the ongoing business operations and we determine the annual budget. The Group has insignificant operating assets and liabilities, and de minimis equity.  Substantially all cash flows of the Group after expenses, including professional salaries, are transferred to us. We consolidate the revenue and expenses, assets and liabilities of the Group.  The creditors of the Group do not have recourse to our general credit and there are no other arrangements that could expose us to losses on behalf of the Group. However, RadNet may be required to provide financial support to cover any operating expenses in excess of operating revenues.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Group on a combined basis recognized $<ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-5" name="us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityRevenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83My9mcmFnOjIyNGJmNDY1YTJmYzRiYzVhNjY5ZDQyYzMzMzljOTIyL3RleHRyZWdpb246MjI0YmY0NjVhMmZjNGJjNWE2NjlkNDJjMzMzOWM5MjJfNDU3MQ_146b486c-b855-4ea8-8952-8aec22f80658">189.1</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-5" name="us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityRevenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83My9mcmFnOjIyNGJmNDY1YTJmYzRiYzVhNjY5ZDQyYzMzMzljOTIyL3RleHRyZWdpb246MjI0YmY0NjVhMmZjNGJjNWE2NjlkNDJjMzMzOWM5MjJfNDU3NQ_f87d1acd-deff-42d8-8310-a22f4e5ddff5">179.6</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-5" name="us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityRevenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83My9mcmFnOjIyNGJmNDY1YTJmYzRiYzVhNjY5ZDQyYzMzMzljOTIyL3RleHRyZWdpb246MjI0YmY0NjVhMmZjNGJjNWE2NjlkNDJjMzMzOWM5MjJfNDU4Mw_2b2f3459-91ea-40d7-b7f1-d35b8ea45b0d">147.6</ix:nonFraction> million of revenue, net of management services fees to RadNet, for the years ended December 31, 2022, 2021, and 2020, respectively and $<ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-5" name="us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83My9mcmFnOjIyNGJmNDY1YTJmYzRiYzVhNjY5ZDQyYzMzMzljOTIyL3RleHRyZWdpb246MjI0YmY0NjVhMmZjNGJjNWE2NjlkNDJjMzMzOWM5MjJfNDY5NQ_b8706717-c5de-45b6-be28-ff81d1229942">189.1</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-5" name="us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83My9mcmFnOjIyNGJmNDY1YTJmYzRiYzVhNjY5ZDQyYzMzMzljOTIyL3RleHRyZWdpb246MjI0YmY0NjVhMmZjNGJjNWE2NjlkNDJjMzMzOWM5MjJfNDY5OQ_f695afc3-aab8-45ba-84e5-dd60350eb5df">179.6</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-5" name="us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83My9mcmFnOjIyNGJmNDY1YTJmYzRiYzVhNjY5ZDQyYzMzMzljOTIyL3RleHRyZWdpb246MjI0YmY0NjVhMmZjNGJjNWE2NjlkNDJjMzMzOWM5MjJfNDcwNw_5e092261-4ded-4925-b690-b6956820046e">147.6</ix:nonFraction> million of operating expenses for the years ended December 31, 2022, 2021, and 2020, respectively. RadNet, Inc. recognized $<ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-5" name="us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83My9mcmFnOjIyNGJmNDY1YTJmYzRiYzVhNjY5ZDQyYzMzMzljOTIyL3RleHRyZWdpb246MjI0YmY0NjVhMmZjNGJjNWE2NjlkNDJjMzMzOWM5MjJfNDgwNg_84af274f-314c-4771-97aa-adb88bc0481f">786.5</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-5" name="us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83My9mcmFnOjIyNGJmNDY1YTJmYzRiYzVhNjY5ZDQyYzMzMzljOTIyL3RleHRyZWdpb246MjI0YmY0NjVhMmZjNGJjNWE2NjlkNDJjMzMzOWM5MjJfNDgxMA_8a93e01e-69bf-47a0-adc5-54e38be3199b">749.2</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-5" name="us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83My9mcmFnOjIyNGJmNDY1YTJmYzRiYzVhNjY5ZDQyYzMzMzljOTIyL3RleHRyZWdpb246MjI0YmY0NjVhMmZjNGJjNWE2NjlkNDJjMzMzOWM5MjJfNDgxOA_83b9b001-f793-4141-864f-63a37f09d0eb">600.7</ix:nonFraction> million of total billed net service fee revenue for the years ended December 31, 2022, 2021, and 2020, respectively, for management services provided to the Group relating primarily to the technical portion of billed revenue.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cash flows of the Group are included in the accompanying consolidated statements of cash flows. All intercompany balances and transactions have been eliminated in consolidation. In our consolidated balance sheets at December 31, 2022 and December 31, 2021, we have included approximately $<ix:nonFraction unitRef="usd" contextRef="i247583bd1aa946988c453d719d97edc0_I20221231" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83My9mcmFnOjIyNGJmNDY1YTJmYzRiYzVhNjY5ZDQyYzMzMzljOTIyL3RleHRyZWdpb246MjI0YmY0NjVhMmZjNGJjNWE2NjlkNDJjMzMzOWM5MjJfNTI3OQ_306c8a58-b1f1-478a-be73-8c03476a0ba3">110.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i087e7761e7004e5c94660aa94d151210_I20211231" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83My9mcmFnOjIyNGJmNDY1YTJmYzRiYzVhNjY5ZDQyYzMzMzljOTIyL3RleHRyZWdpb246MjI0YmY0NjVhMmZjNGJjNWE2NjlkNDJjMzMzOWM5MjJfNTI4Ng_1f9f01da-46ec-4031-ba3e-4ff55fdf820a">89.2</ix:nonFraction> million, respectively, of accounts </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i9aa86c837eba4e82b8aeae6f84596fc6" continuedAt="i7114b89625a540e881df5b1525431483"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">receivable and approximately $<ix:nonFraction unitRef="usd" contextRef="i247583bd1aa946988c453d719d97edc0_I20221231" decimals="-5" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83My9mcmFnOjIyNGJmNDY1YTJmYzRiYzVhNjY5ZDQyYzMzMzljOTIyL3RleHRyZWdpb246MjI0YmY0NjVhMmZjNGJjNWE2NjlkNDJjMzMzOWM5MjJfNTM0NQ_143b7f37-18fc-4fa3-8246-b1c1eb5ca312">16.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i087e7761e7004e5c94660aa94d151210_I20211231" decimals="-5" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83My9mcmFnOjIyNGJmNDY1YTJmYzRiYzVhNjY5ZDQyYzMzMzljOTIyL3RleHRyZWdpb246MjI0YmY0NjVhMmZjNGJjNWE2NjlkNDJjMzMzOWM5MjJfNTM1Mg_73cf6a5b-7578-4c59-a0ef-d649e3824df0">14.4</ix:nonFraction> million of accounts payable and accrued liabilities related to the Group, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At all of our centers not serviced by the Group we have entered into long-term contracts with medical groups to provide professional services at those centers, including supervision and interpretation of diagnostic imaging procedures. The medical groups maintain full control over the physicians they employ. Through our management agreements, we make available to the medical groups the imaging centers, including all furniture, fixtures and medical equipment therein.  The medical groups are compensated for their services from the professional component of the global net service fee revenue and after deducting management service fees paid to us, we have no economic controlling interest in these medical groups. As such, the financial results of these groups are not consolidated in our financial statements.</span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i7114b89625a540e881df5b1525431483">We also own a <ix:nonFraction unitRef="number" contextRef="i1795eae17b55485abc0e544e061a5958_I20221231" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83My9mcmFnOjIyNGJmNDY1YTJmYzRiYzVhNjY5ZDQyYzMzMzljOTIyL3RleHRyZWdpb246MjI0YmY0NjVhMmZjNGJjNWE2NjlkNDJjMzMzOWM5MjJfNjI2OQ_9d41f947-becb-4603-8e97-ad28e7020201">49</ix:nonFraction>% economic interest in ScriptSender, LLC, which provides services for secure data transmission of medical information. Through a management agreement, RadNet provides management and accounting services and receives an agreed upon fee. ScriptSender LLC is dependent on us to finance its own activities, and as such we determined that it is a VIE but we are not a primary beneficiary since we do not have the power to direct the activities of the entity that most significantly impact the entity&#8217;s economic performance.  We have continued to finance ScriptSender during it's development phase and our maximum exposure to loss is $<ix:nonFraction unitRef="usd" contextRef="i1795eae17b55485abc0e544e061a5958_I20221231" decimals="-5" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83My9mcmFnOjIyNGJmNDY1YTJmYzRiYzVhNjY5ZDQyYzMzMzljOTIyL3RleHRyZWdpb246MjI0YmY0NjVhMmZjNGJjNWE2NjlkNDJjMzMzOWM5MjJfNjg5Nw_9288a247-8354-4561-9637-e295f6d929d7">3.3</ix:nonFraction> million, which represents our receivable balance from the entity.  Maximum exposure to loss is the loss that we would absorb in the event that all of the assets of ScriptSender are deemed worthless.  We paid operating expenses for the venture of $<ix:nonFraction unitRef="usd" contextRef="i6562ef04abd84649a113083dcc1c41e7_D20220101-20221231" decimals="-5" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83My9mcmFnOjIyNGJmNDY1YTJmYzRiYzVhNjY5ZDQyYzMzMzljOTIyL3RleHRyZWdpb246MjI0YmY0NjVhMmZjNGJjNWE2NjlkNDJjMzMzOWM5MjJfNzEzOA_24046bf4-4b05-4049-b747-0d135f5aaf8e">2.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i735b0a42768a4a3bb87d2987dc055d34_D20210101-20211231" decimals="-5" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83My9mcmFnOjIyNGJmNDY1YTJmYzRiYzVhNjY5ZDQyYzMzMzljOTIyL3RleHRyZWdpb246MjI0YmY0NjVhMmZjNGJjNWE2NjlkNDJjMzMzOWM5MjJfNzE0NQ_174fccca-7752-4bcc-a4a3-c9dc0494a03c">1.6</ix:nonFraction> million for the years ended December 31, 2022, and December 31, 2021, respectively.</ix:continuation>  </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="if3f80771944f4fc58015abda42dc47d1_76"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 2 - <ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDA4MDY_b2d54bb5-4748-4d2d-a063-e1370066c767" continuedAt="i367ff2a4f87240909303c82f0302e079" escape="true">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ix:nonNumeric></span></div><ix:continuation id="i367ff2a4f87240909303c82f0302e079" continuedAt="ib12d42900a6a42f0ab92aa37074a7a1c"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDA3Nzg_f00d341c-94a3-4403-b0d4-5d3c57befa32" escape="true">PRINCIPLES OF CONSOLIDATION &#8211; The operating activities of subsidiaries are included in the accompanying consolidated financial statements (&#8220;financial statements&#8221;) from the date of acquisition. Investments in companies in which we have the ability to exercise significant influence, but not control, are accounted for by the equity method. All intercompany transactions and balances, with our consolidated entities and the unsettled amount of intercompany transactions with our equity method investees, have been eliminated in consolidation. As stated in Note 1 above, the Group consists of VIEs and we consolidate the operating activities and balance sheets of each. Additionally, we determined that our unconsolidated joint venture, ScriptSender, LLC, is also a VIE as it is dependent on our operational funding but we are not a primary beneficiary since RadNet does not have the power to direct the activities of the entity that most significantly impact the entity&#8217;s economic performance.</ix:nonNumeric> </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDA3NzE_51ca7580-285e-4f18-8c74-d8aa20a9fd61" escape="true">USE OF ESTIMATES - The financial statements have been prepared in accordance with U.S. generally accepted accounting principles (GAAP), which requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. These estimates and assumptions affect various matters, including our reported amounts of assets and liabilities in our consolidated balance sheets at the dates of the financial statements; our disclosure of contingent assets and liabilities at the dates of the financial statements; and our reported amounts of revenues and expenses in our consolidated statements of operations during the reporting periods. These estimates involve judgments with respect to numerous factors that are difficult to predict and are beyond management&#8217;s control. As a result, actual amounts could materially differ from these estimates.</ix:nonNumeric></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="us-gaap:RevenueRecognitionPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDA4MDM_308e3fc8-1459-4fb2-b65b-aa456f97d8ad" continuedAt="i2b04141e712c4cd99ff2fde339c7fea8" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">REVENUES &#8211; Our revenues generally relate to net patient fees&#160;received from various payors and patients themselves under contracts in which our performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period when our obligations to provide diagnostic services are satisfied. Our performance obligations for diagnostic services are generally satisfied over a period of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payor (Medicare, Medicaid, managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent upon the terms provided by Medicare and Medicaid, or negotiated with managed care health plans and commercial insurance companies. The payment arrangements with third-party payors for the services we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As it relates to the Group, this service fee revenue includes payments for both the professional medical interpretation revenue recognized by them as well as the payment for all other aspects related to our providing the imaging services, for which we earn management fees. As it relates to other centers, this service fee revenue is earned through providing the use of our </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ib12d42900a6a42f0ab92aa37074a7a1c" continuedAt="i6959d6fd6ad641e2a8b36b0a575592a3"><ix:continuation id="i2b04141e712c4cd99ff2fde339c7fea8"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">diagnostic imaging equipment and the provision of technical services as well as providing administration services such as clerical and administrative personnel, bookkeeping and accounting services, billing and collection, provision of medical and office supplies, secretarial, reception and transcription services, maintenance of medical records, and advertising, marketing and promotional activities.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenues are based upon the estimated amounts we expect to be entitled to receive from patients and third-party payors. Estimates of contractual allowances under managed care and commercial insurance plans are based upon the payment terms specified in the related contractual agreements. Revenues related to uninsured patients and copayment and deductible amounts for patients who have health care coverage may have discounts applied (uninsured discounts and contractual discounts). We also record estimated implicit price concessions (based primarily on historical collection experience) related to uninsured accounts to record self-pay revenues at the estimated amounts we expect to collect.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under capitation arrangements with various health plans, we earn a per-enrollee amount each month for making available diagnostic imaging services to all plan enrollees under the capitation arrangement. Revenue under capitation arrangements is recognized in the period in which we are obligated to provide services to plan enrollees under contracts with various health plans.</span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="us-gaap:ScheduleOfPrincipalTransactionsRevenueTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDA3ODM_ea309984-0871-4667-af93-7906717c003b" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our total service fee revenues for the years ended December 31, 2022, 2021, and 2020 are presented in the table below.  Our imaging center revenue is displayed as the estimated service fee, broken down by classification of insurance coverage type.  Additional revenues are earned from our management services provided to joint ventures and our software and AI subsidiaries.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In Thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial insurance</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0a659fcb0242ad8761501bd118570a_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmE0YzU3MjkwZWQ5YTQ3NWRhZTU5MGM1YjQzNDM3M2M5L3RhYmxlcmFuZ2U6YTRjNTcyOTBlZDlhNDc1ZGFlNTkwYzViNDM0MzczYzlfMS0xLTEtMS0yOTQ4OQ_cf6e0cfc-6d37-4593-aa1e-276d09e9fa02">785,128</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f6559bea918495a87128bf382ef7d5a_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmE0YzU3MjkwZWQ5YTQ3NWRhZTU5MGM1YjQzNDM3M2M5L3RhYmxlcmFuZ2U6YTRjNTcyOTBlZDlhNDc1ZGFlNTkwYzViNDM0MzczYzlfMS0zLTEtMS0yOTQ4OQ_597d8783-5308-4a50-b3a5-d196d0f2c0fb">743,462</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d2544245c6946048647d180b4e3e7e7_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmE0YzU3MjkwZWQ5YTQ3NWRhZTU5MGM1YjQzNDM3M2M5L3RhYmxlcmFuZ2U6YTRjNTcyOTBlZDlhNDc1ZGFlNTkwYzViNDM0MzczYzlfMS01LTEtMS0yOTQ4OQ_334a6abe-0e80-4ab9-b821-b1d519cdeed9">584,035</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9e89507dbdf4fca9acbc6d655b0924f_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmE0YzU3MjkwZWQ5YTQ3NWRhZTU5MGM1YjQzNDM3M2M5L3RhYmxlcmFuZ2U6YTRjNTcyOTBlZDlhNDc1ZGFlNTkwYzViNDM0MzczYzlfMi0xLTEtMS0yOTQ4OQ_0130684e-bc85-49ac-9121-c962e9fb390f">311,124</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6010c9500ed44ea7ac66cbb102ea5441_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmE0YzU3MjkwZWQ5YTQ3NWRhZTU5MGM1YjQzNDM3M2M5L3RhYmxlcmFuZ2U6YTRjNTcyOTBlZDlhNDc1ZGFlNTkwYzViNDM0MzczYzlfMi0zLTEtMS0yOTQ4OQ_b4e2742b-27b9-4028-9856-5230a6f375e2">280,911</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67dc9135b9ab4673a47ea479a7047db1_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmE0YzU3MjkwZWQ5YTQ3NWRhZTU5MGM1YjQzNDM3M2M5L3RhYmxlcmFuZ2U6YTRjNTcyOTBlZDlhNDc1ZGFlNTkwYzViNDM0MzczYzlfMi01LTEtMS0yOTQ4OQ_461d6ea5-d97b-46dc-b32c-e3810d868fef">217,928</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3adc65b8a2046e69efeb8d95f9b16e0_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmE0YzU3MjkwZWQ5YTQ3NWRhZTU5MGM1YjQzNDM3M2M5L3RhYmxlcmFuZ2U6YTRjNTcyOTBlZDlhNDc1ZGFlNTkwYzViNDM0MzczYzlfMy0xLTEtMS0yOTQ4OQ_1833d6e0-f87a-44bb-8f68-093f19cb9587">38,279</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ee2b0d6cc73495f962207b14a58c057_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmE0YzU3MjkwZWQ5YTQ3NWRhZTU5MGM1YjQzNDM3M2M5L3RhYmxlcmFuZ2U6YTRjNTcyOTBlZDlhNDc1ZGFlNTkwYzViNDM0MzczYzlfMy0zLTEtMS0yOTQ4OQ_02894861-0d29-4169-863e-2ae368de7fda">34,731</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72206c79090b41468a17cf51393b0102_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmE0YzU3MjkwZWQ5YTQ3NWRhZTU5MGM1YjQzNDM3M2M5L3RhYmxlcmFuZ2U6YTRjNTcyOTBlZDlhNDc1ZGFlNTkwYzViNDM0MzczYzlfMy01LTEtMS0yOTQ4OQ_b49f2d76-b455-49e2-93c1-0487e1f327bd">25,619</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Workers' compensation/personal injury</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc941d1b7b8b42c1b2b229203d2d1f68_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmE0YzU3MjkwZWQ5YTQ3NWRhZTU5MGM1YjQzNDM3M2M5L3RhYmxlcmFuZ2U6YTRjNTcyOTBlZDlhNDc1ZGFlNTkwYzViNDM0MzczYzlfNC0xLTEtMS0yOTQ4OQ_c636e02f-f1a7-4aa0-8db5-0502a8fc3864">51,339</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c9a14a2aa8d4c7c92e4d32b28aa7ae3_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmE0YzU3MjkwZWQ5YTQ3NWRhZTU5MGM1YjQzNDM3M2M5L3RhYmxlcmFuZ2U6YTRjNTcyOTBlZDlhNDc1ZGFlNTkwYzViNDM0MzczYzlfNC0zLTEtMS0yOTQ4OQ_c2e95eca-48e1-417d-a6cb-0c2937e909af">44,235</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibeee80a28c534eb29afad1b7014b9af5_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmE0YzU3MjkwZWQ5YTQ3NWRhZTU5MGM1YjQzNDM3M2M5L3RhYmxlcmFuZ2U6YTRjNTcyOTBlZDlhNDc1ZGFlNTkwYzViNDM0MzczYzlfNC01LTEtMS0yOTQ4OQ_d85c080a-6142-4fcd-b833-748741fc199f">33,478</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other patient revenue</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72030050603b4a6492bb961b6905bcdd_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmE0YzU3MjkwZWQ5YTQ3NWRhZTU5MGM1YjQzNDM3M2M5L3RhYmxlcmFuZ2U6YTRjNTcyOTBlZDlhNDc1ZGFlNTkwYzViNDM0MzczYzlfNS0xLTEtMS0yOTQ4OQ_45c27a45-2b70-4c5d-bf20-c4e75590ac49">31,849</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26f7c190fd9c4fe4b401e5498a9420a5_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmE0YzU3MjkwZWQ5YTQ3NWRhZTU5MGM1YjQzNDM3M2M5L3RhYmxlcmFuZ2U6YTRjNTcyOTBlZDlhNDc1ZGFlNTkwYzViNDM0MzczYzlfNS0zLTEtMS0yOTQ4OQ_e68d8fc3-1287-4ebe-8218-e009c1b148b4">19,398</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb79b974d4be492a91371479cbb32335_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmE0YzU3MjkwZWQ5YTQ3NWRhZTU5MGM1YjQzNDM3M2M5L3RhYmxlcmFuZ2U6YTRjNTcyOTBlZDlhNDc1ZGFlNTkwYzViNDM0MzczYzlfNS01LTEtMS0yOTQ4OQ_01265597-9285-408c-a5f1-b9e6d58476a2">25,314</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management fee revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d125c78b6c146b6a159d4a476805404_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmE0YzU3MjkwZWQ5YTQ3NWRhZTU5MGM1YjQzNDM3M2M5L3RhYmxlcmFuZ2U6YTRjNTcyOTBlZDlhNDc1ZGFlNTkwYzViNDM0MzczYzlfNi0xLTEtMS0yOTQ4OQ_900af79b-a743-4561-a14e-4a146c78895d">22,235</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecbeb484fb484458a8ffbf37a3d961c9_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmE0YzU3MjkwZWQ5YTQ3NWRhZTU5MGM1YjQzNDM3M2M5L3RhYmxlcmFuZ2U6YTRjNTcyOTBlZDlhNDc1ZGFlNTkwYzViNDM0MzczYzlfNi0zLTEtMS0yOTQ4OQ_4c41c1b9-624a-4fb3-8dbe-dad036b2ea0a">19,630</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1abd100dae3f4030bbd2f3ea40e56b5e_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmE0YzU3MjkwZWQ5YTQ3NWRhZTU5MGM1YjQzNDM3M2M5L3RhYmxlcmFuZ2U6YTRjNTcyOTBlZDlhNDc1ZGFlNTkwYzViNDM0MzczYzlfNi01LTEtMS0yOTQ4OQ_8f23a721-b746-40ef-81d2-533d7cb0b842">11,253</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software and teleradiology</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2a7006c766b4cac84f74a1f76450698_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmE0YzU3MjkwZWQ5YTQ3NWRhZTU5MGM1YjQzNDM3M2M5L3RhYmxlcmFuZ2U6YTRjNTcyOTBlZDlhNDc1ZGFlNTkwYzViNDM0MzczYzlfNy0xLTEtMS0yOTQ4OQ_f02d49de-8c6a-43e0-bf0f-8b8e6d57877d">14,238</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i508713e09e2f4d37aa8f9bcfe4c9028b_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmE0YzU3MjkwZWQ5YTQ3NWRhZTU5MGM1YjQzNDM3M2M5L3RhYmxlcmFuZ2U6YTRjNTcyOTBlZDlhNDc1ZGFlNTkwYzViNDM0MzczYzlfNy0zLTEtMS0yOTQ4OQ_7890d241-8228-42db-9af4-1cc084556f24">10,525</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia70d2c625846491db5b174a1557fbcb8_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmE0YzU3MjkwZWQ5YTQ3NWRhZTU5MGM1YjQzNDM3M2M5L3RhYmxlcmFuZ2U6YTRjNTcyOTBlZDlhNDc1ZGFlNTkwYzViNDM0MzczYzlfNy01LTEtMS0yOTQ4OQ_078435e3-dbc8-4f43-a697-224ecfda7e0a">10,798</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8b9db45f8f642ba842535ed1f326b09_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmE0YzU3MjkwZWQ5YTQ3NWRhZTU5MGM1YjQzNDM3M2M5L3RhYmxlcmFuZ2U6YTRjNTcyOTBlZDlhNDc1ZGFlNTkwYzViNDM0MzczYzlfOC0xLTEtMS0yOTQ4OQ_40dc2879-27b1-40fb-b84c-123897457cfb">19,428</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87b7580faff74b7e95b97fc7b8c8893a_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmE0YzU3MjkwZWQ5YTQ3NWRhZTU5MGM1YjQzNDM3M2M5L3RhYmxlcmFuZ2U6YTRjNTcyOTBlZDlhNDc1ZGFlNTkwYzViNDM0MzczYzlfOC0zLTEtMS0yOTQ4OQ_19c6aa49-35ea-4219-bd96-9a3b6ce99355">12,436</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25437a7752974cd98b29076a22f18504_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmE0YzU3MjkwZWQ5YTQ3NWRhZTU5MGM1YjQzNDM3M2M5L3RhYmxlcmFuZ2U6YTRjNTcyOTBlZDlhNDc1ZGFlNTkwYzViNDM0MzczYzlfOC01LTEtMS0yOTQ4OQ_96649dc5-fdec-403c-a3d3-5a3435ebaf36">23,297</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue under capitation arrangements</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8827fd8aae0c45ac99829a7fb259f75c_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmE0YzU3MjkwZWQ5YTQ3NWRhZTU5MGM1YjQzNDM3M2M5L3RhYmxlcmFuZ2U6YTRjNTcyOTBlZDlhNDc1ZGFlNTkwYzViNDM0MzczYzlfOS0xLTEtMS02MTU2Ng_decea57d-665d-4e44-804d-c69eead66f91">152,045</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b9fb24ebf5447db9eb3e2b703507952_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmE0YzU3MjkwZWQ5YTQ3NWRhZTU5MGM1YjQzNDM3M2M5L3RhYmxlcmFuZ2U6YTRjNTcyOTBlZDlhNDc1ZGFlNTkwYzViNDM0MzczYzlfOS0zLTEtMS02MTU3NA_5431945f-3d69-4beb-9de6-470cee2dac0e">148,334</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93e177287d564fa0be95b081ae11ddd8_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmE0YzU3MjkwZWQ5YTQ3NWRhZTU5MGM1YjQzNDM3M2M5L3RhYmxlcmFuZ2U6YTRjNTcyOTBlZDlhNDc1ZGFlNTkwYzViNDM0MzczYzlfOS01LTEtMS02MTU4Mg_4b8bf74f-3b60-4679-a680-7a243f209ba6">140,118</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Imaging center segment revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31edfbd04f643e3b9f3f2aeff39f4ca_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmE0YzU3MjkwZWQ5YTQ3NWRhZTU5MGM1YjQzNDM3M2M5L3RhYmxlcmFuZ2U6YTRjNTcyOTBlZDlhNDc1ZGFlNTkwYzViNDM0MzczYzlfOS0xLTEtMS0yOTQ4OQ_ec3806f0-b08f-454a-b120-da9bce9b54bf">1,425,665</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57f34400483a431dbea4dc0dabc4bc32_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmE0YzU3MjkwZWQ5YTQ3NWRhZTU5MGM1YjQzNDM3M2M5L3RhYmxlcmFuZ2U6YTRjNTcyOTBlZDlhNDc1ZGFlNTkwYzViNDM0MzczYzlfOS0zLTEtMS0yOTQ4OQ_26432108-4fd7-440f-a9ec-4509aad86b2e">1,313,662</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3094571dace8441cabbda1c2dbba52bf_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmE0YzU3MjkwZWQ5YTQ3NWRhZTU5MGM1YjQzNDM3M2M5L3RhYmxlcmFuZ2U6YTRjNTcyOTBlZDlhNDc1ZGFlNTkwYzViNDM0MzczYzlfOS01LTEtMS0yOTQ4OQ_7067cc7c-25ce-421e-a275-fc21805f2b26">1,071,840</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AI segment revenue</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied16739f0ee74364a87daf31d0d396a3_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmE0YzU3MjkwZWQ5YTQ3NWRhZTU5MGM1YjQzNDM3M2M5L3RhYmxlcmFuZ2U6YTRjNTcyOTBlZDlhNDc1ZGFlNTkwYzViNDM0MzczYzlfMTAtMS0xLTEtMjk0ODk_021b80f5-a053-4445-b2c9-3cae729950a8">4,396</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i460e15926d1d435b8a643a732b488ddf_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmE0YzU3MjkwZWQ5YTQ3NWRhZTU5MGM1YjQzNDM3M2M5L3RhYmxlcmFuZ2U6YTRjNTcyOTBlZDlhNDc1ZGFlNTkwYzViNDM0MzczYzlfMTAtMy0xLTEtMjk0ODk_b954f933-23f5-4b6f-a8c8-a635ddc258b0">1,415</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63b1d1c0666a4b70a0380796de7d23ed_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmE0YzU3MjkwZWQ5YTQ3NWRhZTU5MGM1YjQzNDM3M2M5L3RhYmxlcmFuZ2U6YTRjNTcyOTBlZDlhNDc1ZGFlNTkwYzViNDM0MzczYzlfMTAtNS0xLTEtMjk0ODk_044df8d2-00fa-498c-8cd5-f5f7a2d1bb98">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmE0YzU3MjkwZWQ5YTQ3NWRhZTU5MGM1YjQzNDM3M2M5L3RhYmxlcmFuZ2U6YTRjNTcyOTBlZDlhNDc1ZGFlNTkwYzViNDM0MzczYzlfMTEtMS0xLTEtMjk0ODk_8dc8781b-a595-4a03-b4d6-07e4ead458b4">1,430,061</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmE0YzU3MjkwZWQ5YTQ3NWRhZTU5MGM1YjQzNDM3M2M5L3RhYmxlcmFuZ2U6YTRjNTcyOTBlZDlhNDc1ZGFlNTkwYzViNDM0MzczYzlfMTEtMy0xLTEtMjk0ODk_cc268b86-5bc1-4768-b31d-ef405454f565">1,315,077</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmE0YzU3MjkwZWQ5YTQ3NWRhZTU5MGM1YjQzNDM3M2M5L3RhYmxlcmFuZ2U6YTRjNTcyOTBlZDlhNDc1ZGFlNTkwYzViNDM0MzczYzlfMTEtNS0xLTEtMjk0ODk_2735b195-cac0-4148-8a79-1ce9d8d17ca2">1,071,840</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">GOVERNMENT ASSISTANCE: COVID-19 PANDEMIC AND CARES ACT FUNDING -  On March 11, 2020 the World Health Organization (WHO) designated COVID-19 as a global pandemic.  To aid businesses and stimulate the national economy, Congress passed The Coronavirus Aid, Relief, and Economic Security ("CARES") Act, which was signed in to law on March 27, 2020.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Beginning in the second quarter of 2020 and through the twelve months ended December 31, 2021, we received funding from the various programs established by the CARES Act as follows:</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:23.5pt">$<ix:nonFraction unitRef="usd" contextRef="idece277420ff4a9fa6789878bb4d04bc_D20200101-20211231" decimals="-5" name="rdnt:AdvanceMedicarePayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNTk0MA_d8b8b54a-6e97-48a3-88fe-9473358de801">39.6</ix:nonFraction> million total of accelerated Medicare payments received, $<ix:nonFraction unitRef="usd" contextRef="i506dbb6a5e1c4160b81aac201c17a8cf_D20200101-20201231" decimals="-5" name="rdnt:AdvanceMedicarePayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNTk5Mg_697ff1b4-d66d-4509-ac2b-66c48fd58e93">39.5</ix:nonFraction> million for the twelve months ended December 31, 2020 and $<ix:nonFraction unitRef="usd" contextRef="i50ecee342add4902a22e3378fadbd827_D20210101-20211231" decimals="-5" name="rdnt:AdvanceMedicarePayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNjAzMA_b3abf76f-c44b-4801-9a9a-572c419a1778">0.1</ix:nonFraction> million for the twelve months ended December 31, 2021.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="padding-left:45pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:23.5pt">$<ix:nonFraction unitRef="usd" contextRef="ic8140fafc99c43f698a11c6792fc6450_D20200101-20201231" decimals="-5" name="us-gaap:ProceedsFromLoans" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNjA2Ng_f3295110-9bf9-4868-be20-586051ccacdf">4.0</ix:nonFraction> million from the Paycheck Protection Program during the twelve months ended December 31, 2020.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:23.5pt">$<ix:nonFraction unitRef="usd" contextRef="idece277420ff4a9fa6789878bb4d04bc_D20200101-20211231" decimals="-5" name="rdnt:ProceedsFromProviderReliefFunding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNjE1OA_43cc6981-d90c-4bb4-b1ed-279b929a175c">35.4</ix:nonFraction> million total Provider Relief Funding, $<ix:nonFraction unitRef="usd" contextRef="i506dbb6a5e1c4160b81aac201c17a8cf_D20200101-20201231" decimals="-5" name="rdnt:ProceedsFromProviderReliefFunding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNjE5Mg_516b7e79-432b-4dae-b2fe-b3400212ddd6">26.3</ix:nonFraction> million received for the twelve months ended December 31, 2020 and $<ix:nonFraction unitRef="usd" contextRef="i50ecee342add4902a22e3378fadbd827_D20210101-20211231" decimals="-5" name="rdnt:ProceedsFromProviderReliefFunding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNjI1NA_8e91d02a-64dd-478d-9f5f-db0016b15db8">9.1</ix:nonFraction> million received for the twelve months ended December 31, 2021.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The accelerated Medicare payments were recorded to deferred revenue in our consolidated balance sheet and are being applied to revenue as services are performed beginning in 2021.  Based on terms released on October 1, 2020, through the Continuing Appropriations Act, 2021 and Other Extensions Act, such accelerated payments are interest free for inpatient acute care hospitals for 29 months (seven months for medical groups), and the program currently requires CMS to recoup the payments </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i6959d6fd6ad641e2a8b36b0a575592a3" continuedAt="ifc4b8048c19c4f9ea9b68ed620b7d1d7"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">beginning one year after receipt by the provider, by withholding future Medicare fee-for-service payments for claims at a rate of 25% for the first 11 months, and 50% for the 6 months afterward, until the full accelerated payment has been recouped.  The program currently requires any outstanding balance remaining after 29 months to be repaid by the provider or be subject to an interest rate currently set at 4%. We applied the accelerated Medicare payments to revenue in the amount of $<ix:nonFraction unitRef="usd" contextRef="i50ecee342add4902a22e3378fadbd827_D20210101-20211231" decimals="-5" name="rdnt:RepaymentOfAdvanceMedicarePayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTc0ODkxNg_30067b24-ae9e-4be8-818c-32fd67616ce3">8.4</ix:nonFraction> million for the twelve months ended December 31, 2022 and $<ix:nonFraction unitRef="usd" contextRef="if6fd3b8a94554fd9a4f614d18e1c3d63_D20220101-20221231" decimals="-5" name="rdnt:RepaymentOfAdvanceMedicarePayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTcyMDg4Mg_c5748cda-9613-4e0d-968b-c23bf668e75d">30.2</ix:nonFraction> million for the twelve months ended December 31, 2021.  As of December 31, 2022, approximately $<ix:nonFraction unitRef="usd" contextRef="i60bbb306d434427baf7094fc97918fdc_I20221231" decimals="-5" name="us-gaap:GovernmentAssistanceAmountCumulative" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTcyMDE5NQ_4ba00297-70de-4132-895c-38e21ad36cc7">1.0</ix:nonFraction> million  of Medicare payments received remain in d<span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjc0ODc3OTE4MzYxNA_386ac154-db8d-4eee-8934-81984fec863f">eferred revenue</span>.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The $<ix:nonFraction unitRef="usd" contextRef="ic8140fafc99c43f698a11c6792fc6450_D20200101-20201231" decimals="-5" name="us-gaap:ProceedsFromLoans" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNjgzNg_f3295110-9bf9-4868-be20-586051ccacdf">4.0</ix:nonFraction> million secured from the Paycheck Protection Program was accounted for as debt and in December 2020 we met the eligibility requirements under the government guidelines for forgiveness and the loans were written off to gain on extinguishment of debt.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Provider Relief Funding is displayed as such on our consolidated statements of operations in the year received.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The CARES Act also provides for the deferral of the employer-paid portion of the social security payroll tax with <ix:nonFraction unitRef="number" contextRef="i74debba71c9649e0ab1a9f9fa2f11ff8_I20211231" decimals="INF" name="rdnt:CaresActRefundableClaimPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNzI5Mg_103d0dba-18b8-46f6-937d-28bd8201a00a">50</ix:nonFraction>% due by December 31, 2021 and <ix:nonFraction unitRef="number" contextRef="i60bbb306d434427baf7094fc97918fdc_I20221231" decimals="INF" name="rdnt:CaresActRefundableClaimPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNzMyNA_dfd05a40-a68a-420c-9aae-ddb49b3dc121">50</ix:nonFraction>% due by December 31,2022. We elected to defer $<ix:nonFraction unitRef="usd" contextRef="id1424599069048eca25bf6f55f5a8042_I20201231" decimals="-5" name="rdnt:SocialSecurityTaxEmployerDeferralCARESAct" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNzM2OQ_96a9a619-4144-4b7e-9944-c644d4f38824">16.3</ix:nonFraction> million of this tax through December 31, 2020 which has been paid as of December 31, 2022.  The CARES Act also provided a refundable employer tax credit ("ERC") equal to <ix:nonFraction unitRef="number" contextRef="id1424599069048eca25bf6f55f5a8042_I20201231" decimals="INF" name="rdnt:CaresActRefundableClaimPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNzQ5MA_45990f30-bbed-493b-9e85-4792273be0ac">50</ix:nonFraction>% of qualified wages, including certain health insurance costs, that can be used to offset payroll tax liabilities.  In the year ending December 31, 2021, we recognized an employee retention credit as a reduction to cost of operations totaling of $<ix:nonFraction unitRef="usd" contextRef="ibb757d76ce5b4ce18bf379dfb73a3226_D20210701-20210930" decimals="-5" name="rdnt:IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNzcwNA_0f682cd4-a43c-45fc-ac3f-3884ba732a78">7.7</ix:nonFraction> million.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="us-gaap:ReceivablesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDA4NTA_e43b08ce-08ea-4b23-9f2f-099bb977ae1d" continuedAt="ib85a767ab29e4231a57aae8b5926c4d4" escape="true">ACCOUNTS RECEIVABLE &#8211; Substantially all of our accounts receivable are due under fee-for-service contracts from third party payors, such as insurance companies and government-sponsored healthcare programs, or directly from patients. Services are generally provided pursuant to one-year contracts with healthcare providers. We continuously monitor collections from our payors and maintain an allowance for bad debts based upon specific payor collection issues that we have identified and our historical experience.</ix:nonNumeric></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ib85a767ab29e4231a57aae8b5926c4d4">We have entered into factoring agreements with various institutions and sold certain accounts receivable under non-recourse agreements in exchange for notes receivables from the buyers. These transactions are accounted for as a reduction in accounts receivable as the agreements transfer effective control over and risk related to the receivables to the buyers. Proceeds on notes receivables are reflected as operating activities on our statement of cash flows and on our balance sheet as prepaid expenses and other current assets for the current portion and deposits and other for the long term portion.</ix:continuation>   Amounts remaining to be collected on these agreements were $<ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-5" name="rdnt:ContractsReceivableFactoringReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTY5NDAyMw_29f3f010-7b83-4c08-9e8f-549a37273702">15.4</ix:nonFraction> million and  $<ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-5" name="rdnt:ContractsReceivableFactoringReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTY5NDAxNg_4fb38af4-dfaa-49cd-bfc1-ef132f02d9cd">17.7</ix:nonFraction> million at December 31, 2022 and December 31, 2021, respectively.  We do not utilize factoring arrangements as an integral part of our financing for working capital.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ACCOUNTS PAYABLE AND ACCRUED EXPENSES - <ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDk0NzgwMjM2NjExNw_bc139f30-4181-4297-8cbb-e6d8276a68a4" continuedAt="i06742be3fc35473abcc272649197cfbc" escape="true">Accounts payable and accrued expenses were comprised of the following (in thousands):</ix:nonNumeric></span></div><div style="text-align:justify;text-indent:36pt"><ix:continuation id="i06742be3fc35473abcc272649197cfbc"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.502%"><tr><td style="width:1.0%"></td><td style="width:67.931%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.951%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.665%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.953%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjg0MWMwYzI3MGQzNjQ1MDE5YTI1NGZkYjNkOWQ2MGUzL3RhYmxlcmFuZ2U6ODQxYzBjMjcwZDM2NDUwMTlhMjU0ZmRiM2Q5ZDYwZTNfMi0xLTEtMS01NzgyNg_34268587-5ce4-4294-9167-7e71c9af4490">102,678</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjg0MWMwYzI3MGQzNjQ1MDE5YTI1NGZkYjNkOWQ2MGUzL3RhYmxlcmFuZ2U6ODQxYzBjMjcwZDM2NDUwMTlhMjU0ZmRiM2Q5ZDYwZTNfMi0zLTEtMS01NzgyNg_c7bfff03-99ca-4caf-8845-0f40d36a6fcb">86,461</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjg0MWMwYzI3MGQzNjQ1MDE5YTI1NGZkYjNkOWQ2MGUzL3RhYmxlcmFuZ2U6ODQxYzBjMjcwZDM2NDUwMTlhMjU0ZmRiM2Q5ZDYwZTNfMy0xLTEtMS01NzgyNg_4919187f-03b9-4606-ac1e-d6e309609e26">181,574</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjg0MWMwYzI3MGQzNjQ1MDE5YTI1NGZkYjNkOWQ2MGUzL3RhYmxlcmFuZ2U6ODQxYzBjMjcwZDM2NDUwMTlhMjU0ZmRiM2Q5ZDYwZTNfMy0zLTEtMS01NzgyNg_de00dbf1-25db-4c5c-9272-a5b19b9d5d36">93,420</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued salary and benefits</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjg0MWMwYzI3MGQzNjQ1MDE5YTI1NGZkYjNkOWQ2MGUzL3RhYmxlcmFuZ2U6ODQxYzBjMjcwZDM2NDUwMTlhMjU0ZmRiM2Q5ZDYwZTNfNC0xLTEtMS01NzgyNg_a6d3ef2c-3185-4513-abd0-524f0ea32fe1">62,072</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjg0MWMwYzI3MGQzNjQ1MDE5YTI1NGZkYjNkOWQ2MGUzL3RhYmxlcmFuZ2U6ODQxYzBjMjcwZDM2NDUwMTlhMjU0ZmRiM2Q5ZDYwZTNfNC0zLTEtMS01NzgyNg_7ab7ab16-8e67-4963-b9a2-dcefd488883a">62,425</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional fees</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjg0MWMwYzI3MGQzNjQ1MDE5YTI1NGZkYjNkOWQ2MGUzL3RhYmxlcmFuZ2U6ODQxYzBjMjcwZDM2NDUwMTlhMjU0ZmRiM2Q5ZDYwZTNfNS0xLTEtMS01NzgyNg_08948f7e-7794-47f1-971b-13709fddb3b0">23,271</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjg0MWMwYzI3MGQzNjQ1MDE5YTI1NGZkYjNkOWQ2MGUzL3RhYmxlcmFuZ2U6ODQxYzBjMjcwZDM2NDUwMTlhMjU0ZmRiM2Q5ZDYwZTNfNS0zLTEtMS01NzgyNg_f54feb61-a0cd-4e54-85f3-228dfe7fe930">21,631</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjg0MWMwYzI3MGQzNjQ1MDE5YTI1NGZkYjNkOWQ2MGUzL3RhYmxlcmFuZ2U6ODQxYzBjMjcwZDM2NDUwMTlhMjU0ZmRiM2Q5ZDYwZTNfNi0xLTEtMS01NzgyNg_be9456ef-a352-4808-8911-0b1e582e5e54">369,595</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjg0MWMwYzI3MGQzNjQ1MDE5YTI1NGZkYjNkOWQ2MGUzL3RhYmxlcmFuZ2U6ODQxYzBjMjcwZDM2NDUwMTlhMjU0ZmRiM2Q5ZDYwZTNfNi0zLTEtMS01NzgyNg_1e22ad23-5fc2-4bc4-a541-fc04a164977a">263,937</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDA4MjE_c729a612-e65e-4061-93a1-65900d6d0cdf" continuedAt="id001482d6829470d91919176e0fa1bcd" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SOFTWARE REVENUE RECOGNITION &#8211; We have developed and sell Picture Archiving Communications Systems (&#8220;PACS&#8221;) and related services. The PACS sales are made primarily through our sales force and generally include hardware, software, installation, training and first-year warranty support. Hardware which is not unique or special purpose, is purchased from a third-party and resold to customers with a small mark-up.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div></ix:nonNumeric><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="id001482d6829470d91919176e0fa1bcd">We have determined that our core software products, such as PACS, are essential to most of our arrangements as hardware, software and related services are sold as an integrated package.  Revenue is recognized when a performance obligation is satisfied by transferring a promised good or service to a customer.</ix:continuation> </span></div><div style="text-align:justify;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December 31, 2022, 2021 and 2020, we recorded approximately $<ix:nonFraction unitRef="usd" contextRef="i52b880c3739c4f62a055717f8fc7fe42_D20220101-20221231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTY5NDA2Mw_5df38f07-8af1-4ad0-9fa2-08338f7b09c4">13.2</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i808cdb9ce8d34cef9d7fda485b899b3d_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTY5NDA1Ng_1bf8b267-fc1b-4836-8b22-cab8ce2578d6">10.5</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="ifea7caca315b42ef9d31633ec1af9648_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTY5NDA0OQ_59d679dd-6a89-4755-800d-cd2156d49770">8.6</ix:nonFraction> million, respectively, in revenue related to our software business which is included in net service fee revenue in our consolidated statement of operations. At December 31, 2022 we had deferred revenue of approximately $<ix:nonFraction unitRef="usd" contextRef="ib5869b7b9a94482aabb1927c7e98515c_I20221231" decimals="-5" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTY5NDA3MQ_fe85c05b-616c-4502-ba88-b74fddc57432">0.9</ix:nonFraction> million associated with these sales which we expect to recognize into revenue over the next <ix:nonNumeric contextRef="ib5869b7b9a94482aabb1927c7e98515c_I20221231" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTAxNTg_ce0269d2-414b-4039-90f0-c81a27ac0732">12</ix:nonNumeric> months.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ifc4b8048c19c4f9ea9b68ed620b7d1d7" continuedAt="i25c77624ce79476b996e62cc71498f0b"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="us-gaap:ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDA4MDc_e85d1356-0380-4526-9d7e-fae1cd392005" escape="true">SOFTWARE DEVELOPMENT COSTS &#8211; When we develop our own software and artificial intelligence solutions we capitalize and amortize those costs over their useful life. Costs related to the research and development of new software products and enhancements to existing software intended for resale to our customers are expensed as incurred.</ix:nonNumeric></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="us-gaap:ConcentrationRiskCreditRisk" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDA4MTM_96789813-1dde-4337-b9ed-1f156a9cd2dc" escape="true">CONCENTRATION OF CREDIT RISKS &#8211; Financial instruments that potentially subject us to credit risk are primarily cash equivalents and accounts receivable. We have placed our cash and cash equivalents with one major financial institution. At times, the cash in the financial institution is temporarily in excess of the amount insured by the Federal Deposit Insurance Corporation, or FDIC. Substantially all of our accounts receivable are due under fee-for-service contracts from third party payors, such as insurance companies and government-sponsored healthcare programs, or directly from patients. We continuously monitor collections and maintain an allowance for bad debts based upon our historical collection experience. In addition, we have notes receivable stemming from our factoring of accounts receivable as stated above.  Companies with which we factor our receivables are well known established buyers of such instruments, have agreed to assume the full risk of their collection.</ix:nonNumeric></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDA4MTU_fabfdf28-c492-4e23-80a2-2e3300639a10" escape="true">CASH AND CASH EQUIVALENTS &#8211; We consider all highly liquid investments that mature in three months or less when purchased to be cash equivalents. The carrying amount of cash and cash equivalents approximates the fair market value.</ix:nonNumeric></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="us-gaap:DeferredChargesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDA4MTA_92ea48b0-5f97-409a-bd4e-eb28ef6c506d" continuedAt="i845013edb5fa44bc8ea44a08dea8756d" escape="true">DEFERRED FINANCING COSTS &#8211; Costs of financing are deferred and amortized using the effective interest rate method.  Deferred financing costs are related to our revolving credit facilities. </ix:nonNumeric>Deferred financing costs, net of accumulated amortization, were $<ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-5" name="us-gaap:DeferredFinanceCostsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTE5OTI_45b72012-bd43-427b-a1b8-47672a79193e">2.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-5" name="us-gaap:DeferredFinanceCostsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTE5OTk_6a3cce32-b0d3-46de-b8c0-3cf793271c42">2.1</ix:nonFraction> million for the twelve months ended at December 31, 2022 and 2021, respectively.  See Note 8, Credit Facilities and <ix:continuation id="i845013edb5fa44bc8ea44a08dea8756d">Notes Payable for more information on our revolving lines of credit.</ix:continuation></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDA3Njc_78df791d-a33a-432b-a62b-ec48a9943500" escape="true">PROPERTY AND EQUIPMENT &#8211; Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation and amortization of property and equipment are provided using the straight-line method over the estimated useful lives, which range from <ix:nonNumeric contextRef="ia02f2d80dbdb4136890d844ee82e5b49_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTI0NTI_fe44c549-f293-4437-adda-bc937c49dd66">3</ix:nonNumeric> to <ix:nonNumeric contextRef="ib6d26e6f10e14cd5ac6652e62c41e88f_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTI0NTg_ce8cc1b1-4648-4f5a-949e-27553582054f">15</ix:nonNumeric> years. Leasehold improvements are amortized at the lesser of lease term or their estimated useful lives, which range from <ix:nonNumeric contextRef="i08bec0508e764dbfb8c49be4488435e0_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTI1Nzc_945e2faa-c4b3-45e2-80de-d797ec4940a7">3</ix:nonNumeric> to <ix:nonNumeric contextRef="if16babfd8b114d728c8e4199a210fee5_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTI1ODM_2c0873ae-ab80-4818-b220-92c65d7a913e">15</ix:nonNumeric> years. Maintenance and repairs are charged to expense as incurred.</ix:nonNumeric></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="us-gaap:BusinessCombinationsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDA4MTE_2865a021-d45a-4245-8556-6e918cf1e68f" escape="true">BUSINESS COMBINATION &#8211; When the qualifications for business combination accounting treatment are met, it requires us to recognize separately from goodwill the assets acquired and the liabilities assumed at their acquisition date fair values. Goodwill as of the acquisition date is measured as the excess of consideration transferred over the net of the acquisition date fair values of the assets acquired and the liabilities assumed. While we use our best estimates and assumptions to accurately value assets acquired and liabilities assumed at the acquisition date, our estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, we record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. Upon the conclusion of the measurement period or final determination of the values of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to our consolidated statements of operations.</ix:nonNumeric></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDA4NTg_bf473e9a-c311-4f91-a5d1-91662039a2f1" continuedAt="i8537b2ca3c054647b220907558e0b67b" escape="true">GOODWILL AND INDEFINITE LIVED INTANGIBLES</ix:nonNumeric> &#8211; Goodwill totaled $<ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTM3OTE_d24f03c5-ddaa-4ad1-8cd5-173aca08d682">677.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTM3OTg_e1107e86-0fe4-4ca7-90c4-6ba0b5c799ed">513.8</ix:nonFraction> million at December 31, 2022 and December 31, 2021, respectively. Indefinite lived intangible assets at  were $<ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-5" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTM4NzM_23123592-edc7-4c7a-a1c9-3226910ef17f">24.1</ix:nonFraction> million at December 31, 2022 and $<ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-5" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMzg0ODI5MDc4NjYzMQ_4b3d19ab-c0a5-4c59-8c62-b9ac078480aa">20.6</ix:nonFraction> million at December 31, 2021 and are associated with the value of certain trade name intangibles and in process research and development (IPR&amp;D). <ix:continuation id="i8537b2ca3c054647b220907558e0b67b">Goodwill, trade name intangibles and IPR&amp;D are recorded as a result of business combinations. When we determine the carrying value of goodwill exceeds its fair value, an impairment charge would be recognized which should not exceed the total amount of goodwill allocated to that reporting unit. We determined fair values for each of the reporting units using the market approach, when available and appropriate, or the income approach, or a combination of both. We assess the valuation methodology based upon the relevance and availability of the data at the time we perform the valuation. If multiple valuation methodologies are used, the results are weighted appropriately.</ix:continuation>  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We tested goodwill, trade name and IPR&amp;D for impairment&#160;on October 1, 2022.  In 2020 we ceased employing certain indefinite lived trade names with a total value of $<ix:nonFraction unitRef="usd" contextRef="i808152f195914b788e6da3420f3e8cb9_D20200101-20201231" decimals="-5" name="us-gaap:GoodwillAndIntangibleAssetImpairment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTQ4MDQ_ba4ce47f-df6d-4e30-9128-3d54eb5d7e84">4.2</ix:nonFraction> million and they were written off in full as of December 31, 2020.  Our annual impairment test as of October 1, 2022 noted no other impairment, and we have not identified any indicators of impairment through December 31, 2022.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDA3NTE_025f76ea-b966-44f1-879d-27828595a221" continuedAt="i8e0101a916684d96925500aa348e8598" escape="true">LONG-LIVED ASSETS &#8211; We evaluate our long-lived assets (property and equipment) and intangibles, other than goodwill and indefinite lived intangible assets, for impairment when events or changes indicate the carrying amount of an asset may not be recoverable. Accounting standards requires that if the sum of the undiscounted expected future cash flows from a long-lived asset or definite-lived intangible is less than the carrying value of that asset, an asset impairment charge must be recognized. The amount of the impairment charge is calculated as the excess of the asset&#8217;s carrying value over its fair value, which generally represents the discounted future cash flows from that asset or in the case of assets we expect to sell, at fair value less costs to sell.  At December 31, 2021 we recorded a <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjc0ODc3OTE4MzYxMw_9c7fb964-0c31-457d-ab68-df24d21cb8df">write off charge</span> of $<ix:nonFraction unitRef="usd" contextRef="i8537d011842e4b6199b64ca17ec351e6_D20210101-20211231" decimals="-5" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTU4MDQ_9b6c0cac-f0bb-40af-8a8e-cf33e7101a58">7.1</ix:nonFraction> million in leasehold improvements for </ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i25c77624ce79476b996e62cc71498f0b" continuedAt="i93880f7c24f94b5aaf65e9a406efc818"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i8e0101a916684d96925500aa348e8598">facilities that we abandoned. See the Leases discussion below for more information.  Other than this, we determined that there were no events or changes in circumstances that indicated our long-lived assets were impaired during any periods presented.</ix:continuation></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDA4NDM_a5dbed53-a8a7-4f34-8719-a3db63812c67" escape="true">INCOME TAXES &#8211; Income tax expense is computed using an asset and liability method and using expected annual effective tax rates. Under this method, deferred income tax assets and liabilities result from temporary differences in the financial reporting bases and the income tax reporting bases of assets and liabilities. The measurement of deferred tax assets is reduced, if necessary, by the amount of any tax benefit that, based on available evidence, is not expected to be realized. When it appears more likely than not that deferred taxes will not be realized, a valuation allowance is recorded to reduce the deferred tax asset to its estimated realizable value. For net deferred tax assets we consider estimates of future taxable income in determining whether our net deferred tax assets are more likely than not to be realized. See Note 10, Income Taxes, for more information.</ix:nonNumeric></span></div><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="us-gaap:LesseeLeasesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDA3OTc_85d47c31-1f2e-48ef-a185-35a32eac6e5c" continuedAt="ie00c828d3f6148a69427a819861000a0" escape="true"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LEASES - We determine if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (&#8220;ROU&#8221;) assets, current operating lease liabilities, and long term operating lease liability in our consolidated balance sheets. Finance leases are included in property and equipment, current finance lease liability, and long-term finance lease liability in our consolidated balance sheets.  ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As most of our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. We use the implicit rate when readily determinable. We include options to extend a lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term. For a contract in which we are a lessee that contains fixed payments for both lease and non-lease components, we have elected to account for the components as a single lease component, as permitted. For finance leases, interest expense on the lease liability is recognized using the effective interest method and amortization of the ROU asset is recognized on a straight-line basis over the shorter of the estimated useful life of the asset or the lease term. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ROU assets are tested for impairment if circumstances suggest that the carrying amount may not be recoverable. No events have occurred such as fire, flood, or other acts which have impaired the integrity of our ROU assets as of December 31, 2022. Our facility leases require us to maintain insurance policies which would cover major damage to our facilities. We maintain business interruption insurance to cover loss of business due to a facility becoming non-operational under certain circumstances. Our equipment leases are covered by warranty and service contracts which cover repairs and provide regular maintenance to keep the equipment in functioning order.</span></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie00c828d3f6148a69427a819861000a0">After a management review of post pandemic patient traffic to centers during the fourth quarter of 2021, it was noted that although overall volumes had returned to pre-pandemic levels, certain imaging locations did not experience the same levels of activity as beforehand.  This was due in part to lower utilization rates of commercial space from telecommuting, accompanied by the migration of those workers out of congested urban centers to residential areas.  Based on this analysis, management decided to consolidate volumes into fewer centers and reduce administrative office space in response to the demographic changes experienced.  To complete the closure of these locations, we took a lease abandonment charge of approximately $<ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-5" name="rdnt:OperatingLeaseLeaseAbandonmentCharge" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTk2OTk_4887e745-2a94-468d-a860-faa334ebebb6">12.6</ix:nonFraction> million at December 31, 2021.</ix:continuation> </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="rdnt:UninsuredRisksPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDA4MTg_742002cc-d905-4d46-bd27-2b4d1c8c321b" continuedAt="i12d1cef5c0a8407597831f0fddca8ca6" escape="true">UNINSURED RISKS &#8211; On November 1, 2013 we entered into a high-deductible workers&#8217; compensation insurance policy. </ix:nonNumeric>We have recorded liabilities of $<ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-5" name="us-gaap:WorkersCompensationLiabilityCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjA0NzA_ef1370ef-8634-43e7-8b1d-a7a44b19d7d3">3.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-5" name="us-gaap:WorkersCompensationLiabilityCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjA0Nzc_9fc23310-4d4d-4a9a-afda-bcdc0110aabe">3.5</ix:nonFraction> million at December 31, 2022 and December 31, 2021, respectively, for the estimated future cash obligations associated with the unpaid portion of the workers compensation claims incurred.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i12d1cef5c0a8407597831f0fddca8ca6" continuedAt="ie9ee43f68fb24f61bfb64453b522fad6">We and our affiliated physicians carry an annual medical malpractice insurance policy that protects us for claims that are filed during the policy year and that fall within policy limits.</ix:continuation> The policy has a deductible which is $<ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="INF" name="rdnt:MedicalMalpracticeDeductiblePerIncidence" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjA4ODM_f7d175a4-a559-4f6b-a964-7d9481cddcd4">10,000</ix:nonFraction> per incidence for all years covered by this report.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:continuation id="ie9ee43f68fb24f61bfb64453b522fad6" continuedAt="ifdd56856f038438aa2f5a120cf03b4ca"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2008, in order to eliminate the exposure for claims not reported during the regular malpractice policy period, we purchased a medical malpractice claims made tail policy, which provides coverage for any claims reported in the event that our medical malpractice policy expires. As of December 31, 2022, this policy remains in effect.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ifdd56856f038438aa2f5a120cf03b4ca">We have entered into an arrangement with Blue Shield to administer and process claims under a self-insured plan that provides health insurance coverage for our employees and dependents.</ix:continuation> We have recorded liabilities as of December 31, 2022 and 2021 of $<ix:nonFraction unitRef="usd" contextRef="i422a4c2558d84288a00576b3a91e71c6_I20221231" decimals="-5" name="us-gaap:SelfInsuranceReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjE1MTM_90f05120-0b8d-4e5b-a41d-55d0c02ddf19">7.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i6c48d7e622fc4e26963a033683816e48_I20211231" decimals="-5" name="us-gaap:SelfInsuranceReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjE1MjA_b2c86452-7944-4a87-bbd6-b846c386c836">6.3</ix:nonFraction> million, respectively, for the estimated future cash obligations associated with the unpaid portion of the medical and dental claims incurred by our participants. Additionally, we entered into an agreement with Blue </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i93880f7c24f94b5aaf65e9a406efc818" continuedAt="i1d81d856eeee499fadf7c3e9c111d243"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shield for a stop loss policy that provides coverage for any claims that exceed $<ix:nonFraction unitRef="usd" contextRef="i65433954d0d74893ad517dc34d70e910_I20221231" decimals="INF" name="rdnt:MedicalInsuranceStopLossPolicyClaimAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjE4MTE_3d008877-4676-4a67-90f6-181bae45e294">250,000</ix:nonFraction> up to a maximum of $<ix:nonFraction unitRef="usd" contextRef="i94d07cae465b4a45933c903e5b869937_I20221231" decimals="INF" name="rdnt:MedicalInsuranceStopLossPolicyClaimAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjE4MzM_2b1336ff-4dbb-44ab-b6ff-db6c4eb58be4">1.0</ix:nonFraction> million in order for us to limit our exposure for unusual or catastrophic claims.&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="us-gaap:PostemploymentBenefitPlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDA3ODA_49c2c22c-9c28-4478-86e5-5d4c2c3b5e6f" escape="true">EMPLOYEE BENEFIT PLAN &#8211; We adopted a profit-sharing/savings plan pursuant to Section 401(k) of the Internal Revenue Code that covers substantially all non-professional employees. Eligible employees may contribute on a tax-deferred basis a percentage of compensation, up to the maximum allowable under tax law. Employee contributions vest immediately.</ix:nonNumeric> We can elect to provide a matching contribution in the amount to a maximum of <ix:nonFraction unitRef="number" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="INF" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjIzNDE_47dbd0d8-efca-4b02-ac4c-5df5e1214d67">1.0</ix:nonFraction>% per <ix:nonFraction unitRef="number" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="INF" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjIzNDg_7d040754-07bc-4a24-bc31-a9c76b07071c">4.0</ix:nonFraction>% of employee contribution, and have done so since 2017.  We contributed $<ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-5" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjI0MjI_fd6a7a7b-dee5-4dd1-a677-00eec79c6baf">3.0</ix:nonFraction> million in matching for each of the twelve months ended December 31, 2022 and December 31, 2021.  For the year ended December 31, 2020, we elected <ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="INF" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjI1MTA_e3c1eb01-8490-4001-b5d6-f1e0d1d50a0a">not</ix:nonFraction> to provide a matching contribution.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="us-gaap:CompensationRelatedCostsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDA3ODY_91c853be-4023-46ef-9bc6-db761930b00d" escape="true">EQUITY BASED COMPENSATION &#8211; We have <ix:nonFraction unitRef="incentiveplan" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="INF" name="rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDk0NzgwMjM2NjExOA_57d3d608-f38f-48c2-ba8d-927c730ae962">one</ix:nonFraction> long-term incentive plan that we adopted in 2006 and which we first amended and restated as of April 20, 2015, and again on March 9, 2017, and currently as of April 15, 2021 (the &#8220;Restated Plan&#8221;). The Restated Plan was approved by our stockholders at our annual stockholders meeting on June 10, 2021. We have reserved <ix:nonFraction unitRef="shares" contextRef="id1fdbe2d3c964be6888f0365aa0b975b_I20210415" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjQwMjU_7d71d979-39f7-46db-b21b-49eb41072229">16,500,000</ix:nonFraction> shares of common stock for issuance under the Restated Plan which can be issued in the form of incentive and/or nonstatutory stock options, restricted and/or unrestricted stock, stock units, and stock appreciation rights.  Terms and conditions of awards can be direct grants or based on achieving a performance metric and we also consider probability of achievement of performance conditions when determining expense recognition. For the awards where vesting is probable, equity-based compensation is recognized over the related vesting period. Stock options and warrants generally vest over <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjQzNTk_cd22a3ff-fb8c-47a1-9018-2d91908dd609">three</span> to <ix:nonNumeric contextRef="i7258cf171ca64de4a7443899de9f7975_D20220101-20221231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjQzNjU_e6ad3728-93ce-4f3d-98ed-6ccb66de1331">five years</ix:nonNumeric> and expire <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjQzNzk_0e815b97-2caf-4c2a-88cf-151ad3b1dacb">five</span> to <ix:nonNumeric contextRef="i7258cf171ca64de4a7443899de9f7975_D20220101-20221231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjQzODU_4308b39c-c602-42cd-b496-41bdb8a5c0d9">ten years</ix:nonNumeric> from date of grant.  We determine the compensation expense for each stock option award using the Black Scholes, or similar, valuation model.  Those models require that our management make certain estimates concerning risk free interest rates and volatility in the trading price of our common stock. The compensation expense recognized for all equity-based awards is recognized over the awards&#8217; service periods. Equity-based compensation is classified in operating expenses within the same line item as the majority of the cash compensation paid to employees.  In connection with our acquisition of DeepHealth Inc. on June 1, 2020, we assumed the DeepHealth, Inc. 2017 Equity Incentive Plan, including outstanding options awards that can be exercised for our common stock.  No additional awards will be granted under the DeepHealth, Inc. 2017 Equity Incentive Plan.  See Note 11, Stock-Based Compensation, for more information.</ix:nonNumeric></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDA3Nzc_683013e3-0e2e-40ee-97c0-faa56ffff057" escape="true">FOREIGN CURRENCY TRANSLATION &#8211; For our operations in Canada, Europe and the United Kingdom, the functional currency of our foreign subsidiaries is the local currency. Assets and liabilities denominated in foreign currencies are translated using the exchange rate at the balance sheet dates. Revenues and expenses are translated using average exchange rates prevailing during the reporting period. Any translation adjustments resulting from this process are shown separately as a component of accumulated other comprehensive income (loss). Gains and losses related to the foreign currency portion of international transactions are included in the determination of net income.</ix:nonNumeric>  <ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="rdnt:ScheduleOfForeignCurrencyTranslationAmountsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDk0NzgwMjQzOTAyMw_5e8b2713-db60-446e-851a-ff320bbc501a" continuedAt="i88c69859efc74661b968280c9b5567b5" escape="true">The following is a reconciliation of Foreign Currency Translation amounts for the years ended December 31, 2022, 2021 and 2020 is provided below (in thousands):</ix:nonNumeric></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><ix:continuation id="i88c69859efc74661b968280c9b5567b5"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:50.584%"><tr><td style="width:1.0%"></td><td style="width:58.148%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.956%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.339%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.957%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency Translation</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i404f0df0019f440299547782ff0ce012_I20191231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjY4MDRjZTRmMmVjMTRmMzM5N2Y1MTBiNDE4MzcwNmZjL3RhYmxlcmFuZ2U6NjgwNGNlNGYyZWMxNGYzMzk3ZjUxMGI0MTgzNzA2ZmNfMS0yLTEtMS03MzgwMQ_0399f6bf-8b9b-4484-8abd-a4b1f9201c25">276</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency Translation Adjustments</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjY4MDRjZTRmMmVjMTRmMzM5N2Y1MTBiNDE4MzcwNmZjL3RhYmxlcmFuZ2U6NjgwNGNlNGYyZWMxNGYzMzk3ZjUxMGI0MTgzNzA2ZmNfMi0yLTEtMS03MzgwMQ_53769d39-c349-46bb-b5bc-a47a3848249a">101</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb50bc5a13564f6a97eb669524009c18_I20201231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjY4MDRjZTRmMmVjMTRmMzM5N2Y1MTBiNDE4MzcwNmZjL3RhYmxlcmFuZ2U6NjgwNGNlNGYyZWMxNGYzMzk3ZjUxMGI0MTgzNzA2ZmNfMy0yLTEtMS03MzgwMQ_108f526c-59d7-4c9d-90b3-377ed8acf5a4">377</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency Translation Adjustments</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjY4MDRjZTRmMmVjMTRmMzM5N2Y1MTBiNDE4MzcwNmZjL3RhYmxlcmFuZ2U6NjgwNGNlNGYyZWMxNGYzMzk3ZjUxMGI0MTgzNzA2ZmNfNC0yLTEtMS03MzgwMQ_3432c366-c206-47bb-a75c-175df7e7d484">65</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjY4MDRjZTRmMmVjMTRmMzM5N2Y1MTBiNDE4MzcwNmZjL3RhYmxlcmFuZ2U6NjgwNGNlNGYyZWMxNGYzMzk3ZjUxMGI0MTgzNzA2ZmNfNS0yLTEtMS03MzgwMQ_f49d697c-b51e-42b0-bb19-de8bc5ae6872">442</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency Translation Adjustments</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjY4MDRjZTRmMmVjMTRmMzM5N2Y1MTBiNDE4MzcwNmZjL3RhYmxlcmFuZ2U6NjgwNGNlNGYyZWMxNGYzMzk3ZjUxMGI0MTgzNzA2ZmNfNi0yLTEtMS03MzgwMQ_8212757c-7338-47fd-955b-f434c899cb1a">3,943</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjY4MDRjZTRmMmVjMTRmMzM5N2Y1MTBiNDE4MzcwNmZjL3RhYmxlcmFuZ2U6NjgwNGNlNGYyZWMxNGYzMzk3ZjUxMGI0MTgzNzA2ZmNfNy0yLTEtMS03MzgwMQ_f8c4da39-775c-467c-82d4-a648247185ad">4,385</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">OTHER <ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDA3NzU_4cf55960-9b15-40e1-8f01-f75a72201a8e" continuedAt="i8093e5afe482488486997680755ffc0f" escape="true">COMPREHENSIVE INCOME (LOSS) &#8211; Accounting guidance</ix:nonNumeric></span><ix:continuation id="i8093e5afe482488486997680755ffc0f"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">establishes rules for reporting and displaying other comprehensive income (loss) and its components. Our foreign currency translation adjustments,  changes in the fair value of cash flow hedges, and the amortization of balances associated with derivatives previously classified as cash flow hedges are included in other comprehensive income (loss). The components of other comprehensive income (loss) for the twelve month periods ended December 31, 2022, December 31, 2021, and December 31, 2020 are included in the consolidated statements of comprehensive income (loss).</span></ix:continuation></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="us-gaap:CommitmentsAndContingenciesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDA4MDE_4bf64625-1cb6-4d5c-a008-1e36b7db2067" continuedAt="i8bb74c75f968429b96e6a7c7e05040c6" escape="true">COMMITMENTS AND CONTINGENCIES - We are party to various legal proceedings, claims, and regulatory, tax or government inquiries and investigations that arise in the ordinary course of business. With respect to these matters, we evaluate the developments on a regular basis and accrue a liability when we believe a loss is probable and the amount can be reasonably estimated. Based on current information, we do not believe that reasonably possible or probable losses associated with pending legal proceedings would either individually or in the aggregate, have a material adverse effect on our business and </ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i1d81d856eeee499fadf7c3e9c111d243" continuedAt="i35cab9a37a094fac9bae92cdc9eac1b1"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i8bb74c75f968429b96e6a7c7e05040c6">consolidated financial statements. However, the outcome of these matters is inherently uncertain. Therefore, if one or more of these matters were resolved against us for amounts in excess of management's expectations, our results of operations and financial condition, including in a particular reporting period in which any such outcome becomes probable and estimable, could be materially adversely affected.</ix:continuation></span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="us-gaap:DerivativesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDA4NjA_0606be69-1766-4981-bdde-c40dd5018151" continuedAt="i9d0d6437387d4f89b048346ae083ef0f" escape="true">DERIVATIVE INSTRUMENTS </ix:nonNumeric></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2016 CAPS</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarter of 2016, we entered into <ix:nonFraction unitRef="agreement" contextRef="i9758ca019cab44059e02dbe1b53445b3_I20161231" decimals="INF" name="us-gaap:DerivativeAssetNumberOfInstrumentsHeld" format="ixt-sec:numwordsen" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjc4ODc_d170bf90-e595-449d-8fdb-dd55f8d13a3d">two</ix:nonFraction> forward interest rate cap agreements ("2016 Caps"). The 2016 Caps matured in September and October 2020. The 2016 Caps had notional amounts of $<ix:nonFraction unitRef="usd" contextRef="ie96d50e803ed49a29734c6b96972c575_I20161231" decimals="INF" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjgwMzM_02264690-fd7b-4c1d-ab78-368e9e5c9c66">150,000,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ia630db7cb89b488da168bd28e8987f04_I20161231" decimals="INF" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjgwNDA_ef1cebef-0fc6-4fb2-acee-4771c553178f">350,000,000</ix:nonFraction>, respectively, which were designated at inception as cash flow hedges of future cash interest payments associated with portions of our variable rate bank debt. Under these arrangements, we purchased a cap on 3 month LIBOR at <ix:nonFraction unitRef="number" contextRef="i2e6a00bde60944ccb589e7330bf8c34a_I20161231" decimals="INF" name="us-gaap:DerivativeBasisSpreadOnVariableRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjgyNjg_608ea0cc-6cdd-4b01-837d-37590824f118">2.0</ix:nonFraction>%. We were liable for a $<ix:nonFraction unitRef="usd" contextRef="i9758ca019cab44059e02dbe1b53445b3_I20161231" decimals="-5" name="us-gaap:FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjgyOTM_bc9ad75d-94f2-402b-a209-fea0f604e05f">5.3</ix:nonFraction> million premium to enter into the caps which accrued to current liabilities on our balance sheet and paid over the life of the 2016 Caps.  <ix:continuation id="i9d0d6437387d4f89b048346ae083ef0f" continuedAt="i00a1d5284411466bb6c5514a39987778">The gain or loss of the hedge (i.e. change in fair value) was reported as a component of accumulated other comprehensive income (loss) in the consolidated statement of equity.</ix:continuation></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDA4MzM_46ab0b24-3922-45af-8acb-b017fb58dc9d" continuedAt="ia58bb4d148de4eb78acd67dad9b5cb6c" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A tabular presentation of the effect of derivative instruments on our consolidated statement of comprehensive (loss) income, net of taxes is as follows (amounts in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.836%"><tr><td style="width:1.0%"></td><td style="width:28.663%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.648%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.389%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Interest Rate Contracts</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the twelve months ended</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Gain (Loss) Recognized on Derivative, net of taxes</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location of Gain (Loss) Recognized<br/>in Income on Derivative</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i5e878af77c394477a09c4eedcb52e0b2_D20220101-20221231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjA2Y2E4MDgzZDhlMDQ4NzA5YzRlOGQ4YzJkYjJhMDNjL3RhYmxlcmFuZ2U6MDZjYTgwODNkOGUwNDg3MDljNGU4ZDhjMmRiMmEwM2NfMy0xLTEtMS0yOTQ4OQ_99248f48-9c4f-4954-9f5c-f8878933494c">&#8212;</ix:nonFraction></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i632dbbb6dc124502b35355b0bb82bf56_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjA2Y2E4MDgzZDhlMDQ4NzA5YzRlOGQ4YzJkYjJhMDNjL3RhYmxlcmFuZ2U6MDZjYTgwODNkOGUwNDg3MDljNGU4ZDhjMmRiMmEwM2NfNC0xLTEtMS0yOTQ4OQ_03a68c1f-b4a7-4d17-b78e-58ee371e2e6f">&#8212;</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i46bd994b9ae04e96b753c7e89fbf1818_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjA2Y2E4MDgzZDhlMDQ4NzA5YzRlOGQ4YzJkYjJhMDNjL3RhYmxlcmFuZ2U6MDZjYTgwODNkOGUwNDg3MDljNGU4ZDhjMmRiMmEwM2NfNS0xLTEtMS0yOTQ4OQ_20d398ef-5172-4538-81ff-9eccf0ab1e06">788</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Loss</span></td></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2019 SWAPS</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2019, we entered into <ix:nonFraction unitRef="agreement" contextRef="i9f99c4d1a5b6480abea6d0ff11b1fee6_I20190630" decimals="INF" name="us-gaap:DerivativeAssetNumberOfInstrumentsHeld" format="ixt-sec:numwordsen" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjg4NDQ_94e91105-7932-45e5-ac07-d0fde990edf2">four</ix:nonFraction> forward interest rate agreements ("2019 swaps").  The 2019 swaps have total notional amounts of $<ix:nonFraction unitRef="usd" contextRef="i9f99c4d1a5b6480abea6d0ff11b1fee6_I20190630" decimals="INF" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjg5NDM_2938326a-c99d-42ff-b1e0-bbacd0b3e3f9">500,000,000</ix:nonFraction>, consisting of <ix:nonFraction unitRef="agreement" contextRef="i5c59e16c960f444e80b8f6cd2c3aff6d_I20190630" decimals="INF" name="us-gaap:DerivativeAssetNumberOfInstrumentsHeld" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjc0ODc3OTExMDU3Ng_d29bfc61-35c2-49e3-b90e-b32891c276f1">two</ix:nonFraction> agreements of $<ix:nonFraction unitRef="usd" contextRef="i5c59e16c960f444e80b8f6cd2c3aff6d_I20190630" decimals="INF" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjg5Nzk_06c27837-45b2-4c33-8f74-dc395bf4e89d">50,000,000</ix:nonFraction> each and <ix:nonFraction unitRef="agreement" contextRef="ie2a260029b444ab89b7e9377824da6fc_I20190630" decimals="INF" name="us-gaap:DerivativeAssetNumberOfInstrumentsHeld" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjc0ODc3OTExMDU4NA_938168ac-525e-4084-aeeb-b3daae1e7671">two</ix:nonFraction> agreements of  $<ix:nonFraction unitRef="usd" contextRef="ie2a260029b444ab89b7e9377824da6fc_I20190630" decimals="INF" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjkwMTA_c02c4305-ba32-4e68-bb66-7ff14536b37e">200,000,000</ix:nonFraction> each.  <ix:continuation id="i00a1d5284411466bb6c5514a39987778" continuedAt="i79cc12cc84d44e71aa6bab428196458d"> The 2019 swaps will secure a constant interest rate associated with portions of our variable rate bank debt and have an effective date of October 13, 2020. They will mature in October 2023 for the two smaller notional and October 2025 for the two larger notional.</ix:continuation> Under these arrangements, we arranged the 2019 swaps with locked in 1 month LIBOR rates at <ix:nonFraction unitRef="number" contextRef="i19c179308c4b45ca97aed3c7ba7f064d_I20190630" decimals="INF" name="us-gaap:DerivativeBasisSpreadOnVariableRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjkzNzY_9d2e4445-edd9-4389-aad8-6cadb84dc8bf">1.96</ix:nonFraction>% for the $<ix:nonFraction unitRef="usd" contextRef="i0b43962e0b0141068c1c9e2b72b13361_I20190630" decimals="INF" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjkzODc_5bb350a3-acf8-403d-86dd-c757cab8e4b0">100,000,000</ix:nonFraction> notional and at <ix:nonFraction unitRef="number" contextRef="iefafe9554bff40dcb084b9218d53528b_I20190630" decimals="INF" name="us-gaap:DerivativeBasisSpreadOnVariableRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjk0MDY_521a19bf-ea60-46a0-8411-d8cc3ea699a2">2.05</ix:nonFraction>% for the $<ix:nonFraction unitRef="usd" contextRef="i193fb1139b6443c59e7e807e0683c634_I20190630" decimals="INF" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjk0MTc_5e8a1dce-9584-47c8-903a-ce9440f951a5">400,000,000</ix:nonFraction> notional. <ix:continuation id="i79cc12cc84d44e71aa6bab428196458d" continuedAt="i6e47c57690d84c958a9d7be91ae73051">As of the effective date, we will be liable for premium payments if interest rates decline below arranged rates, but will receive interest payments if rates remain above the arranged rates.</ix:continuation></span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i6e47c57690d84c958a9d7be91ae73051">At inception, we designated our 2019 Swaps as cash flow hedges of floating-rate borrowings. In accordance with accounting guidance, derivatives that have been designated and qualify as cash flow hedging instruments are reported at fair value. The gain or loss on the effective portion of the hedge (i.e. change in fair value) is reported as a component of accumulated comprehensive income (loss) in the consolidated statement of equity.</ix:continuation>  The remaining gain or loss, if any, is recognized currently in earnings.  The cash flows for both our $<ix:nonFraction unitRef="usd" contextRef="i193fb1139b6443c59e7e807e0683c634_I20190630" decimals="INF" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMzAxMzk_5e8a1dce-9584-47c8-903a-ce9440f951a5">400,000,000</ix:nonFraction> notional interest rate swap contract locked in at <ix:nonFraction unitRef="number" contextRef="iefafe9554bff40dcb084b9218d53528b_I20190630" decimals="INF" name="us-gaap:DerivativeBasisSpreadOnVariableRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMzAxOTI_521a19bf-ea60-46a0-8411-d8cc3ea699a2">2.05</ix:nonFraction>% due October 2025 and our $<ix:nonFraction unitRef="usd" contextRef="i0b43962e0b0141068c1c9e2b72b13361_I20190630" decimals="INF" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMzAyMjA_5bb350a3-acf8-403d-86dd-c757cab8e4b0">100,000,000</ix:nonFraction> notional interest rate swap contract locked in at <ix:nonFraction unitRef="number" contextRef="i19c179308c4b45ca97aed3c7ba7f064d_I20190630" decimals="INF" name="us-gaap:DerivativeBasisSpreadOnVariableRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMzAyNzM_9d2e4445-edd9-4389-aad8-6cadb84dc8bf">1.96</ix:nonFraction>% do not match the cash flows for our First Lien Term Loans and so we have determined that they are not currently effective as cash flow hedges. Accordingly, all changes in their fair value after April 1, 2020 for the $<ix:nonFraction unitRef="usd" contextRef="i193fb1139b6443c59e7e807e0683c634_I20190630" decimals="INF" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMzA0OTI_5e8a1dce-9584-47c8-903a-ce9440f951a5">400,000,000</ix:nonFraction> notional and after July 1, 2020 for the $<ix:nonFraction unitRef="usd" contextRef="i0b43962e0b0141068c1c9e2b72b13361_I20190630" decimals="INF" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMzA1MzU_5bb350a3-acf8-403d-86dd-c757cab8e4b0">100,000,000</ix:nonFraction> notional will be recognized in earnings.&#160;As of July 1, 2020, the total change in fair value relating to swaps included in other comprehensive income was approximately $<ix:nonFraction unitRef="usd" contextRef="i23d7f29089b64d22895c3d43381dbb7f_I20200701" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMzA3MDU_2f5500da-683f-4e3f-9219-75ccc9d8d00e">24.4</ix:nonFraction> million, net of taxes.  This amount will be amortized to interest expense through October 2023 at approximately $<ix:nonFraction unitRef="usd" contextRef="ib04c7e5c38284425adee6a4423c7156c_D20200701-20231031" decimals="-5" name="rdnt:MonthlyAmortizationOfDeferredHedgeGains" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMzA4MTI_5edc2de0-6ec3-4c1d-8c5e-e8c92568d23b">0.4</ix:nonFraction> million per month and continuing at approximately $<ix:nonFraction unitRef="usd" contextRef="i9048c2d946984a73a9b463cc83780401_D20231101-20251031" decimals="-5" name="rdnt:MonthlyAmortizationOfDeferredHedgeGains" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMzA4NTc_a0b67b05-9117-4c7b-9b4f-c20c379dda0b">0.3</ix:nonFraction> million per month through October 2025.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ia58bb4d148de4eb78acd67dad9b5cb6c" continuedAt="i27e9254b08634a57bc4a9b888f649f39">A tabular presentation of the effect of derivative instruments on our consolidated statement of comprehensive loss of the 2019 swaps is as follows (amounts in thousands):</ix:continuation></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i35cab9a37a094fac9bae92cdc9eac1b1" continuedAt="iab0976222d644ed786364f48e3c3cd20"><ix:continuation id="i27e9254b08634a57bc4a9b888f649f39"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:28.958%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.065%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Interest Rate Contracts - Effective Portion</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the twelve months ended</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Loss Recognized on Derivative, net of taxes</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location of Loss Recognized<br/>in Income on Derivative</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i477bfe5294834112a6af03501b8e3fa5_D20220101-20221231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmVkMjE4OGRjNDI0NjQzNzZhNDVhMjE1MTFkNjQyMDBhL3RhYmxlcmFuZ2U6ZWQyMTg4ZGM0MjQ2NDM3NmE0NWEyMTUxMWQ2NDIwMGFfMy0xLTEtMS0yOTQ4OQ_5a96721a-50f3-4cc9-b95c-abb8d1e15419">&#8212;</ix:nonFraction></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i9b432aaed4704e9eaaee35896216be8f_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmVkMjE4OGRjNDI0NjQzNzZhNDVhMjE1MTFkNjQyMDBhL3RhYmxlcmFuZ2U6ZWQyMTg4ZGM0MjQ2NDM3NmE0NWEyMTUxMWQ2NDIwMGFfNC0xLTEtMS0yOTQ4OQ_51b79261-7a15-4d85-8d72-086ef0e31143">&#8212;</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(<ix:nonFraction unitRef="usd" contextRef="ie48b611c24514f819e0afaa0b9e33107_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmVkMjE4OGRjNDI0NjQzNzZhNDVhMjE1MTFkNjQyMDBhL3RhYmxlcmFuZ2U6ZWQyMTg4ZGM0MjQ2NDM3NmE0NWEyMTUxMWQ2NDIwMGFfNS0xLTEtMS0yOTQ4OQ_91aeb7ab-6196-4b97-a9bd-162862663dd6">20,160</ix:nonFraction>)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Loss</span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A tabular presentation of the effect of derivative instruments on our statement of operations of the 2019 Swaps for the Swaps that became ineffective in 2020 is as follows (amounts in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Interest Rate Contracts - Ineffective Portion</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the twelve months ended</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of gain (loss) recognized in income on derivative (current period ineffective portion)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of gain (loss) recognized in Income on derivative (current period ineffective portion)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of loss reclassified from accumulated other comprehensive income (loss) into income (prior period effective portion)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of loss reclassified from accumulated other comprehensive income (loss) into income (prior period effective portion)</span></td></tr><tr style="height:8pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i477bfe5294834112a6af03501b8e3fa5_D20220101-20221231" decimals="-3" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmY3ZDdlMDY0Y2UzOTQyYWVhZjFkMzRhNTc4MTBmMjA1L3RhYmxlcmFuZ2U6ZjdkN2UwNjRjZTM5NDJhZWFmMWQzNGE1NzgxMGYyMDVfMy0xLTEtMS02MTc5MQ_e656b8dc-7b8b-48a8-b215-b1850bfda30b">39,621</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmY3ZDdlMDY0Y2UzOTQyYWVhZjFkMzRhNTc4MTBmMjA1L3RhYmxlcmFuZ2U6ZjdkN2UwNjRjZTM5NDJhZWFmMWQzNGE1NzgxMGYyMDVfMy0yLTEtMS03NjcxMw_04d809f9-cf99-45ef-aa56-16be46b5f8b6">Other Income (Expense)</span></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(<ix:nonFraction unitRef="usd" contextRef="i07817c4f1db542b1bd7ec426e43a3030_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmY3ZDdlMDY0Y2UzOTQyYWVhZjFkMzRhNTc4MTBmMjA1L3RhYmxlcmFuZ2U6ZjdkN2UwNjRjZTM5NDJhZWFmMWQzNGE1NzgxMGYyMDVfMy0zLTEtMS02MTc5OQ_4a335e79-d5fe-418f-84b4-1ddd124f6b62">3,687</ix:nonFraction>)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Interest Expense</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i9b432aaed4704e9eaaee35896216be8f_D20210101-20211231" decimals="-3" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmY3ZDdlMDY0Y2UzOTQyYWVhZjFkMzRhNTc4MTBmMjA1L3RhYmxlcmFuZ2U6ZjdkN2UwNjRjZTM5NDJhZWFmMWQzNGE1NzgxMGYyMDVfMy0xLTEtMS0yOTQ4OQ_991e1445-2a65-40ff-bc93-faa6cb9a97e9">21,670</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmY3ZDdlMDY0Y2UzOTQyYWVhZjFkMzRhNTc4MTBmMjA1L3RhYmxlcmFuZ2U6ZjdkN2UwNjRjZTM5NDJhZWFmMWQzNGE1NzgxMGYyMDVfNC0yLTEtMS03NjcyMQ_2c91ab05-c7d0-4ed6-a9f1-aefed9da243a">Other Income (Expense)</span></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(<ix:nonFraction unitRef="usd" contextRef="i58d81670414d4f9b8cc9fd7500dd2200_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmY3ZDdlMDY0Y2UzOTQyYWVhZjFkMzRhNTc4MTBmMjA1L3RhYmxlcmFuZ2U6ZjdkN2UwNjRjZTM5NDJhZWFmMWQzNGE1NzgxMGYyMDVfMy0zLTEtMS0yOTQ4OQ_7edc9d0f-1985-4a94-9e00-da817356cb4f">3,695</ix:nonFraction>)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Expense</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(<ix:nonFraction unitRef="usd" contextRef="ie48b611c24514f819e0afaa0b9e33107_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmY3ZDdlMDY0Y2UzOTQyYWVhZjFkMzRhNTc4MTBmMjA1L3RhYmxlcmFuZ2U6ZjdkN2UwNjRjZTM5NDJhZWFmMWQzNGE1NzgxMGYyMDVfNC0xLTEtMS0yOTQ4OQ_b71561d6-5183-4f7d-8d68-eff7424070cf">2,528</ix:nonFraction>)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmY3ZDdlMDY0Y2UzOTQyYWVhZjFkMzRhNTc4MTBmMjA1L3RhYmxlcmFuZ2U6ZjdkN2UwNjRjZTM5NDJhZWFmMWQzNGE1NzgxMGYyMDVfNC0yLTEtMS0yOTQ4OQ_869911ef-bcba-451f-8629-1684d55fda21">Other Income (Expense)</span></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(<ix:nonFraction unitRef="usd" contextRef="i063f2f5729ee435f8d4852d04201ea0c_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmY3ZDdlMDY0Y2UzOTQyYWVhZjFkMzRhNTc4MTBmMjA1L3RhYmxlcmFuZ2U6ZjdkN2UwNjRjZTM5NDJhZWFmMWQzNGE1NzgxMGYyMDVfNC0zLTEtMS0yOTQ4OQ_eed20e28-58f0-46b8-a04a-fc7dced46975">3,448</ix:nonFraction>)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Expense</span></td></tr></table></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONTINGENT CONSIDERATION - </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Aidence Holding B.V.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 20, 2022, we completed our acquisition of all the equity interests of Aidence Holding B.V. ("Aidence") an artificial intelligence enterprise centered on lung cancer screening.  As part of the purchase agreement, we will pay up to $<ix:nonFraction unitRef="usd" contextRef="iebda58f2b50646b69966fddb55d1e9eb_I20220120" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTcwODE0NQ_b36e653b-2ef0-495b-a5cf-73cbd0335e3e">10.0</ix:nonFraction> million consideration upon the completion of <ix:nonFraction unitRef="loan" contextRef="iebda58f2b50646b69966fddb55d1e9eb_I20220120" decimals="INF" name="rdnt:BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTcwODE1Mw_20fd4966-e9e7-439e-b31e-138af7a07f5f">two</ix:nonFraction> identified milestones in RadNet common shares or cash at our election.  This contingency had a value of approximately $<ix:nonFraction unitRef="usd" contextRef="i1355b8403e694c14801d61d67f909c67_I20221231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTcwODEzMw_85f9c27a-49d4-4c9e-9027-3c37a26f3ee7">7.2</ix:nonFraction> million on December 31, 2022. The amount is reviewed quarterly and adjusted to fair value based on the yield rate of S&amp;P B-rated corporate bonds and the probability of FDA approval, which has been currently determined by management to be <ix:nonFraction unitRef="number" contextRef="iebda58f2b50646b69966fddb55d1e9eb_I20220120" decimals="INF" name="rdnt:BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneOne" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTcwODE1OQ_7aaa291a-fecf-4b7e-99f1-2bad0840d798">80</ix:nonFraction>% for milestone one and <ix:nonFraction unitRef="number" contextRef="iebda58f2b50646b69966fddb55d1e9eb_I20220120" decimals="INF" name="rdnt:BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneTwo" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTcwODE2Mw_3ca5320f-e308-48bb-a4c1-42f666be432e">70</ix:nonFraction>% for milestone two.  In addition, there is a remaining general holdback of $<ix:nonFraction unitRef="usd" contextRef="i239e3d4ca4304f1ab838f88d83fe9529_I20221231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTc0Mzc3Nw_51d8fb7d-673d-4325-bc5d-8e6b178a3671">4.0</ix:nonFraction> million to be issued in shares of our common stock subject to adjustment for any indemnification claims.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Quantib B.V.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 20, 2022, we completed our acquisition of all the equity interests of Quantib B.V. ("Quantib") an artificial intelligence enterprise centered on prostate cancer screening.  As part of the purchase agreement, we will issue <ix:nonNumeric contextRef="i0037eb0ed88b4354b067862baa4cefa3_D20220120-20220120" name="rdnt:BusinessCombinationContingentConsiderationLiabilityPeriod" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTY5NTA4NA_f508bef7-6a10-4446-9cdb-28f1f1a80666">18</ix:nonNumeric> months after acquisition, <ix:nonFraction unitRef="shares" contextRef="ic091556638644c818849ee8b176872d4_I20220120" decimals="INF" name="rdnt:BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTcwODE2Nw_95c4c485-5bca-48ed-a0ea-3826ca51cbc5">113,303</ix:nonFraction> shares of our common stock with an initial fair value at the date of close of $<ix:nonFraction unitRef="usd" contextRef="ic091556638644c818849ee8b176872d4_I20220120" decimals="-5" name="rdnt:BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTcwODE3Mw_dc9b5cd7-bb7a-4fe0-85d8-e86552291872">3.0</ix:nonFraction> million subject to adjustment for any indemnification claims and will be adjusted to fair value in subsequent periods. This contingency had a value of approximately $<ix:nonFraction unitRef="usd" contextRef="ie27fb48dea7a43e496f5d4e770f84de3_I20221231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTc0Mzg4OQ_0965bc0a-3d06-4411-b798-d2a5fcc3f644">2.1</ix:nonFraction> million as of December 31, 2022. In addition, there is a general holdback of $<ix:nonFraction unitRef="usd" contextRef="i11ed45440ab0437dbd546007b43ffbf8_I20221231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTc0MzgwMA_1e6d489a-7b6e-44fc-96a5-22f208aa785e">1.6</ix:nonFraction> million to be issued in cash subject to adjustment for any indemnification claims.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Montclair</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 1, 2022, we completed our acquisition of Montclair Radiological Associates. As part of the purchase agreement, we recorded $<ix:nonFraction unitRef="usd" contextRef="iec85947be77b4e02afe08d88f3901b7e_I20221001" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTcyOTg5Mg_b74b3591-d12d-4fa9-9215-cb651179f5e3">1.2</ix:nonFraction> million in contingent consideration to be determined by obtaining specific EBITDA targets within a defined time frame.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Heart and Lung Imaging Limited</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2022, we completed our acquisition of <ix:nonFraction unitRef="number" contextRef="i315f9ce8303d42fbb74147d9754e4496_I20221101" decimals="2" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTc0Mzg5Nw_5a25d7cd-423e-48d8-bede-a9532ed233ca">75</ix:nonFraction>% of the equity interests of Heart and Lung Imaging Limited. The purchase included $<ix:nonFraction unitRef="usd" contextRef="iec83e5acff394eac92ff9ba28bb2e1ec_I20221101" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTcyOTA5Mw_c1873b3a-f808-4387-a77f-fadf7bad2143">10.2</ix:nonFraction> million in contingent milestone consideration and cash holdback of $<ix:nonFraction unitRef="usd" contextRef="if870a8803b5347588b2a78fdf3b1dabf_I20221101" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTcyOTE1Ng_2739444f-6cbb-4c92-9f8e-b795c3927c6d">0.6</ix:nonFraction> million to be issued <ix:nonNumeric contextRef="i350d6392e4a642769b8a9824e7855129_D20221101-20221101" name="rdnt:BusinessCombinationContingentConsiderationLiabilityPeriod" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTcyOTE3Mw_ce981d75-6722-4b77-bc6c-efa5202bae0a">24</ix:nonNumeric> months after acquisition subject to adjustment for any indemnification claims, which will be adjusted to fair value in </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="iab0976222d644ed786364f48e3c3cd20" continuedAt="iff175da9f9bc4bdb8d4263df4f1d469e"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">subsequent periods.  The milestone contingency had a value of approximately $<ix:nonFraction unitRef="usd" contextRef="i72596dac70a143edab1f533e55146f8a_I20221231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTc0Mzk2Ng_e9bc7a20-83ac-4768-94e1-6d30d853ad70">11.1</ix:nonFraction> million as of December 31, 2022.   The contingent consideration is determined by the achievement of a specific number of physician reads.</span></div><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDk0NzgwMjQxNDU0MQ_2c3b9f96-cfa6-4616-aba6-6ef0ba5c9f47" escape="true"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A tabular rollforward of contingent consideration is as follows (amounts in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">     </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.964%"><tr><td style="width:1.0%"></td><td style="width:12.505%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.480%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.505%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.480%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.505%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.480%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.505%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.480%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.505%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.480%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.505%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.480%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.505%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.485%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="42" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the twelve months ended December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Entity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Account</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 1, 2022 Balance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Issuance of contingent consideration</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of  income (loss) recognized on contingent consideration</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Currency Translation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022 Balance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aidence</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Long Term Liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia30202f136744654aca43922c68c719e_I20211231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmQ1MWUyYjY2Y2U0NTQ0MjA5MDY3NzM2ZGY3YzVhMjIzL3RhYmxlcmFuZ2U6ZDUxZTJiNjZjZTQ1NDQyMDkwNjc3MzZkZjdjNWEyMjNfMi0yLTEtMS02NDc3Ng_56c4dedf-cf6a-4d56-a4d0-16a8470d8df7">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60714a92713744d0a7ef51e5a96354bd_D20220101-20221231" decimals="-3" name="rdnt:BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmQ1MWUyYjY2Y2U0NTQ0MjA5MDY3NzM2ZGY3YzVhMjIzL3RhYmxlcmFuZ2U6ZDUxZTJiNjZjZTQ1NDQyMDkwNjc3MzZkZjdjNWEyMjNfMi00LTEtMS02NDc4NA_eee9ca6f-4bad-4d8a-aab6-7f22ad843858">11,453</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i60714a92713744d0a7ef51e5a96354bd_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmQ1MWUyYjY2Y2U0NTQ0MjA5MDY3NzM2ZGY3YzVhMjIzL3RhYmxlcmFuZ2U6ZDUxZTJiNjZjZTQ1NDQyMDkwNjc3MzZkZjdjNWEyMjNfMi02LTEtMS02NDc5Mg_754d9f01-149d-4c10-a597-552e3abc6f7a">362</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60714a92713744d0a7ef51e5a96354bd_D20220101-20221231" decimals="-3" name="rdnt:BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmQ1MWUyYjY2Y2U0NTQ0MjA5MDY3NzM2ZGY3YzVhMjIzL3RhYmxlcmFuZ2U6ZDUxZTJiNjZjZTQ1NDQyMDkwNjc3MzZkZjdjNWEyMjNfMi03LTEtMS02NDgwMA_72c163eb-0280-458b-bee0-05b5a92ffe6d">67</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if47d16ba9eb44f57b85358ec1634a856_I20221231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmQ1MWUyYjY2Y2U0NTQ0MjA5MDY3NzM2ZGY3YzVhMjIzL3RhYmxlcmFuZ2U6ZDUxZTJiNjZjZTQ1NDQyMDkwNjc3MzZkZjdjNWEyMjNfMi04LTEtMS02NDgwOA_664bfc72-ecf8-4761-8af2-2fb9961bf13a">11,158</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quantib</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued Expenses &amp; Other Long Term Liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3798b3922a04943acbf92ec8317c957_I20211231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmQ1MWUyYjY2Y2U0NTQ0MjA5MDY3NzM2ZGY3YzVhMjIzL3RhYmxlcmFuZ2U6ZDUxZTJiNjZjZTQ1NDQyMDkwNjc3MzZkZjdjNWEyMjNfMy00LTEtMS03MzA3Mw_61e01552-73c6-4bcd-81f0-70d1b854d7fd">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a2b769e8cef41f6ac4d466fe758123d_D20220101-20221231" decimals="-3" name="rdnt:BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmQ1MWUyYjY2Y2U0NTQ0MjA5MDY3NzM2ZGY3YzVhMjIzL3RhYmxlcmFuZ2U6ZDUxZTJiNjZjZTQ1NDQyMDkwNjc3MzZkZjdjNWEyMjNfMy02LTEtMS03MzA5MQ_2a6535ef-03e3-4d3a-a6cf-f8e0586c17e2">4,581</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6a2b769e8cef41f6ac4d466fe758123d_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmQ1MWUyYjY2Y2U0NTQ0MjA5MDY3NzM2ZGY3YzVhMjIzL3RhYmxlcmFuZ2U6ZDUxZTJiNjZjZTQ1NDQyMDkwNjc3MzZkZjdjNWEyMjNfMy04LTEtMS03MzEwMg_6b54bbea-e039-4a3f-a8b6-8e4c80671d48">903</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a2b769e8cef41f6ac4d466fe758123d_D20220101-20221231" decimals="-3" name="rdnt:BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmQ1MWUyYjY2Y2U0NTQ0MjA5MDY3NzM2ZGY3YzVhMjIzL3RhYmxlcmFuZ2U6ZDUxZTJiNjZjZTQ1NDQyMDkwNjc3MzZkZjdjNWEyMjNfMy0xMC0xLTEtNzMxMTA_7c1c106b-7079-41c7-9129-363a6ef76b95">31</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0237b2107cb4cbf8ff50093346bdf89_I20221231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmQ1MWUyYjY2Y2U0NTQ0MjA5MDY3NzM2ZGY3YzVhMjIzL3RhYmxlcmFuZ2U6ZDUxZTJiNjZjZTQ1NDQyMDkwNjc3MzZkZjdjNWEyMjNfMy0xMi0xLTEtNzMxMTg_91574904-337e-48ec-afd7-15f11feed085">3,709</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Montclair</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued Expenses</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i453f8cd3681340bbadd382f3b137a70c_I20211231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmQ1MWUyYjY2Y2U0NTQ0MjA5MDY3NzM2ZGY3YzVhMjIzL3RhYmxlcmFuZ2U6ZDUxZTJiNjZjZTQ1NDQyMDkwNjc3MzZkZjdjNWEyMjNfNC00LTEtMS03Mjk3NQ_049f9413-3342-433e-a7b9-c4b251bd68f1">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5398be82ea374f1981ccf7e382e72ef3_D20220101-20221231" decimals="-3" name="rdnt:BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmQ1MWUyYjY2Y2U0NTQ0MjA5MDY3NzM2ZGY3YzVhMjIzL3RhYmxlcmFuZ2U6ZDUxZTJiNjZjZTQ1NDQyMDkwNjc3MzZkZjdjNWEyMjNfNC02LTEtMS03Mjk4Mw_c4490def-d9af-4966-a2d5-045c3686642d">1,200</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5398be82ea374f1981ccf7e382e72ef3_D20220101-20221231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmQ1MWUyYjY2Y2U0NTQ0MjA5MDY3NzM2ZGY3YzVhMjIzL3RhYmxlcmFuZ2U6ZDUxZTJiNjZjZTQ1NDQyMDkwNjc3MzZkZjdjNWEyMjNfNC04LTEtMS03Mjk5MQ_44c8184e-2904-4d90-92bb-09f4f4196462">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5398be82ea374f1981ccf7e382e72ef3_D20220101-20221231" decimals="-3" name="rdnt:BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmQ1MWUyYjY2Y2U0NTQ0MjA5MDY3NzM2ZGY3YzVhMjIzL3RhYmxlcmFuZ2U6ZDUxZTJiNjZjZTQ1NDQyMDkwNjc3MzZkZjdjNWEyMjNfNC0xMC0xLTEtNzI5OTk_fe5d4816-1680-418c-95b8-402a083c6e29">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1cf96aa8943147168551f098e2d58c2a_I20221231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmQ1MWUyYjY2Y2U0NTQ0MjA5MDY3NzM2ZGY3YzVhMjIzL3RhYmxlcmFuZ2U6ZDUxZTJiNjZjZTQ1NDQyMDkwNjc3MzZkZjdjNWEyMjNfNC0xMi0xLTEtNzMwMDc_bd977963-931a-4773-aee0-178872124e3a">1,200</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Heart and Lung Limited</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued Expenses &amp; Other Long Term Liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf93bd34e5d546fcbe757031ae9bb387_I20211231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmQ1MWUyYjY2Y2U0NTQ0MjA5MDY3NzM2ZGY3YzVhMjIzL3RhYmxlcmFuZ2U6ZDUxZTJiNjZjZTQ1NDQyMDkwNjc3MzZkZjdjNWEyMjNfNS00LTEtMS03MzAxNw_5db10869-f64d-4f7a-9c1d-76b1c28436d2">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e47a0bf0feb4c3b8860d3345451141f_D20220101-20221231" decimals="-3" name="rdnt:BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmQ1MWUyYjY2Y2U0NTQ0MjA5MDY3NzM2ZGY3YzVhMjIzL3RhYmxlcmFuZ2U6ZDUxZTJiNjZjZTQ1NDQyMDkwNjc3MzZkZjdjNWEyMjNfNS02LTEtMS03MzAzMw_e1f5c1e9-4d2c-4667-bb0a-6151a93f00b5">10,814</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e47a0bf0feb4c3b8860d3345451141f_D20220101-20221231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmQ1MWUyYjY2Y2U0NTQ0MjA5MDY3NzM2ZGY3YzVhMjIzL3RhYmxlcmFuZ2U6ZDUxZTJiNjZjZTQ1NDQyMDkwNjc3MzZkZjdjNWEyMjNfNS04LTEtMS03MzA0MQ_dec566a5-82e3-4259-84ae-a21759292e55">566</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e47a0bf0feb4c3b8860d3345451141f_D20220101-20221231" decimals="-3" name="rdnt:BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmQ1MWUyYjY2Y2U0NTQ0MjA5MDY3NzM2ZGY3YzVhMjIzL3RhYmxlcmFuZ2U6ZDUxZTJiNjZjZTQ1NDQyMDkwNjc3MzZkZjdjNWEyMjNfNS0xMC0xLTEtNzMwNDk_b77b22b3-0f63-4bda-b1df-4ee8417d4267">276</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie490b42ee8164ea9be2f0eda5934c310_I20221231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmQ1MWUyYjY2Y2U0NTQ0MjA5MDY3NzM2ZGY3YzVhMjIzL3RhYmxlcmFuZ2U6ZDUxZTJiNjZjZTQ1NDQyMDkwNjc3MzZkZjdjNWEyMjNfNS0xMi0xLTEtNzMwNTc_d14b8c7a-5876-4bd9-a79f-73c254c25dca">11,656</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">   </span></div><div style="margin-top:5pt;text-align:justify;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Fair Value Measurements section below for the fair value of contingent consideration at December 31, 2022.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDA4Mjg_3ead4853-0613-47be-8b54-e2aed1e272b6" continuedAt="i9412a13fc2574825ab32dee7285b5839" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FAIR VALUE MEASUREMENTS &#8211; Assets and liabilities subject to fair value measurements are required to be disclosed within a fair value hierarchy. The fair value hierarchy ranks the quality and reliability of inputs used to determine fair value. Accordingly, assets and liabilities carried at, or permitted to be carried at, fair value are classified within the fair value hierarchy in one of the following categories based on the lowest level input that is significant to a fair value measurement:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;1&#8212;Fair value is determined by using unadjusted quoted prices that are available in active markets for identical assets and liabilities.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;2&#8212;Fair value is determined by using inputs other than Level&#160;1 quoted prices that are directly or indirectly observable. Inputs can include quoted prices for similar assets and liabilities in active markets or quoted prices for identical assets and liabilities in inactive markets. Related inputs can also include those used in valuation or other pricing models such as interest rates and yield curves that can be corroborated by observable market data.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;3&#8212;Fair value is determined by using inputs that are unobservable and not corroborated by market data. Use of these inputs involves significant and subjective judgment.</span></div></ix:nonNumeric><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Derivatives:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="us-gaap:FairValueByBalanceSheetGroupingTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDA4Mjk_a9f50e4b-5bcf-407a-b6a7-fd88a5d39c91" continuedAt="ib4cfd4855d944edebff835c8ea884249" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the estimated fair values of certain of our financial assets that are subject to fair value measurements, and the classification of these assets in our consolidated balance sheets, as follows (in thousands):</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.641%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Current Assets and Deposits and Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 SWAPS - Interest Rate Contracts</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i804d8cc7449544638b1eefbdb8975b75_I20221231" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjg2NTU5YTQ4MzBkNTQ5MDU4MjVlYTBiZTRjY2M4M2VmL3RhYmxlcmFuZ2U6ODY1NTlhNDgzMGQ1NDkwNTgyNWVhMGJlNGNjYzgzZWZfMy0xLTEtMS0yOTQ4OQ_a35bfaf7-b1a4-4c00-b39b-1b16d18af25b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ac6da733e34c689df37c278c132480_I20221231" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjg2NTU5YTQ4MzBkNTQ5MDU4MjVlYTBiZTRjY2M4M2VmL3RhYmxlcmFuZ2U6ODY1NTlhNDgzMGQ1NDkwNTgyNWVhMGJlNGNjYzgzZWZfMy0zLTEtMS0yOTQ4OQ_2f7f0bbf-9a51-4e3e-8a2e-9aa2f02e60d9">23,302</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa27e287074e451696981ce012df35d6_I20221231" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjg2NTU5YTQ4MzBkNTQ5MDU4MjVlYTBiZTRjY2M4M2VmL3RhYmxlcmFuZ2U6ODY1NTlhNDgzMGQ1NDkwNTgyNWVhMGJlNGNjYzgzZWZfMy01LTEtMS0yOTQ4OQ_8f4492a4-4e9a-4e22-8c6b-92a166c62688">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39f8a4ef27dd454bb81ce09e12cfb471_I20221231" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjg2NTU5YTQ4MzBkNTQ5MDU4MjVlYTBiZTRjY2M4M2VmL3RhYmxlcmFuZ2U6ODY1NTlhNDgzMGQ1NDkwNTgyNWVhMGJlNGNjYzgzZWZfMy03LTEtMS0yOTQ4OQ_a684e9f0-3b9f-475d-8858-344a7eab8064">23,302</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="iff175da9f9bc4bdb8d4263df4f1d469e" continuedAt="icb8d40375a424a07acf7c9621c7a83c6"><div style="margin-top:5pt;text-align:center"><ix:continuation id="ib4cfd4855d944edebff835c8ea884249" continuedAt="i79256ce6c9274f9f8b636551bdab3757"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.641%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other non-current liabilities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 SWAPS - Interest Rate Contracts</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79c1f314aa17465097ef0df412a24c6c_I20211231" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjJjZDY1YTcwZmYzOTRiNjU4ZDcxMjUyMTljNDgzNDU1L3RhYmxlcmFuZ2U6MmNkNjVhNzBmZjM5NGI2NThkNzEyNTIxOWM0ODM0NTVfMy0xLTEtMS0yOTQ4OQ_ff947cda-5883-4ea0-b207-8ed8b4f31ddb">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06780380ef034b1a885d689dfb1011eb_I20211231" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjJjZDY1YTcwZmYzOTRiNjU4ZDcxMjUyMTljNDgzNDU1L3RhYmxlcmFuZ2U6MmNkNjVhNzBmZjM5NGI2NThkNzEyNTIxOWM0ODM0NTVfMy0zLTEtMS0yOTQ4OQ_7b902d12-52c6-4576-8444-07b735ba9366">16,319</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2abc2bb208ac4de69fd3a4d8e27425a2_I20211231" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjJjZDY1YTcwZmYzOTRiNjU4ZDcxMjUyMTljNDgzNDU1L3RhYmxlcmFuZ2U6MmNkNjVhNzBmZjM5NGI2NThkNzEyNTIxOWM0ODM0NTVfMy01LTEtMS0yOTQ4OQ_505221e1-c466-4b35-a343-8fd8ef263fac">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d33c478c74c4c5ebaae8d80880f704a_I20211231" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjJjZDY1YTcwZmYzOTRiNjU4ZDcxMjUyMTljNDgzNDU1L3RhYmxlcmFuZ2U6MmNkNjVhNzBmZjM5NGI2NThkNzEyNTIxOWM0ODM0NTVfMy03LTEtMS0yOTQ4OQ_ec26685a-025b-40b2-ba03-60c0c69fcae9">16,319</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="text-indent:36pt"><span><br/></span></div><ix:continuation id="i9412a13fc2574825ab32dee7285b5839" continuedAt="iac8815bb1198430fa0321c7e56d8058d"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of these contracts was determined using Level 2 inputs. More specifically, the fair value was determined by calculating the value of the difference between the fixed interest rate of the interest rate swaps and the counterparty&#8217;s forward LIBOR curve. The forward LIBOR curve is readily available in the public markets or can be derived from information available in the public markets.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Contingent Consideration:</span></div><ix:continuation id="i79256ce6c9274f9f8b636551bdab3757" continuedAt="ibad013eae5fc462b8b30f2ec5e8b580c"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the estimated fair values of contingencies and holdback relating to our Aidence Holding B.V. and Quantib B.V. acquisitions on January 20, 2022, and the Heart and Lung Imaging Limited acquisition on November 1, 2022 that are subject to fair value measurements and the classification of these liabilities on our consolidated balance sheets, as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:49.779%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.632%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other non-current liabilities</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aidence Holding B.V. milestone consideration</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00898b4e70c54a4384ea59c45556e995_I20221231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmY2YzI5MjZkYjJhNTQ1NWNhNWFmMTM1NTY0ZGY2NDAwL3RhYmxlcmFuZ2U6ZjZjMjkyNmRiMmE1NDU1Y2E1YWYxMzU1NjRkZjY0MDBfMy0xLTEtMS02MTg3NA_c860fc47-0178-4a5c-823b-d66fbbfba525">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if895037caf4f4ecdb06fe18bfec769a6_I20221231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmY2YzI5MjZkYjJhNTQ1NWNhNWFmMTM1NTY0ZGY2NDAwL3RhYmxlcmFuZ2U6ZjZjMjkyNmRiMmE1NDU1Y2E1YWYxMzU1NjRkZjY0MDBfMy0zLTEtMS02MTg3NA_c624660e-90d7-4dfe-bcd8-cbda0472685d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b7afa03cd544db6979077730ed44669_I20221231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmY2YzI5MjZkYjJhNTQ1NWNhNWFmMTM1NTY0ZGY2NDAwL3RhYmxlcmFuZ2U6ZjZjMjkyNmRiMmE1NDU1Y2E1YWYxMzU1NjRkZjY0MDBfMy01LTEtMS02MTg3NA_c9c8531c-c896-4ef8-a26d-19b7aab2958a">11,158</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i073ba5e6253341968d7e3516327451a9_I20221231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmY2YzI5MjZkYjJhNTQ1NWNhNWFmMTM1NTY0ZGY2NDAwL3RhYmxlcmFuZ2U6ZjZjMjkyNmRiMmE1NDU1Y2E1YWYxMzU1NjRkZjY0MDBfMy03LTEtMS02MTg3NA_569e5961-5d6c-4b28-97b2-5642673b4719">11,158</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quantib B.V. holdback of <ix:nonFraction unitRef="shares" contextRef="ic091556638644c818849ee8b176872d4_I20220120" decimals="INF" name="rdnt:BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmY2YzI5MjZkYjJhNTQ1NWNhNWFmMTM1NTY0ZGY2NDAwL3RhYmxlcmFuZ2U6ZjZjMjkyNmRiMmE1NDU1Y2E1YWYxMzU1NjRkZjY0MDBfNC0wLTEtMS02MTg3NC90ZXh0cmVnaW9uOmUzOGNmZTcyN2YxYzQyODM4MzJiMmNhMmE1ZGUyOTkyXzEwOTk1MTE2Mjc4NDA_95c4c485-5bca-48ed-a0ea-3826ca51cbc5">113,303</ix:nonFraction> shares of RadNet common stock</span></div></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec52dfb722a4447db7f7c2e52080d41b_I20221231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmY2YzI5MjZkYjJhNTQ1NWNhNWFmMTM1NTY0ZGY2NDAwL3RhYmxlcmFuZ2U6ZjZjMjkyNmRiMmE1NDU1Y2E1YWYxMzU1NjRkZjY0MDBfNC0xLTEtMS02MTg3NA_fc257a47-be79-4570-a60f-b60219fedfdb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if060f0a3047f484587fcaf8727158a53_I20221231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmY2YzI5MjZkYjJhNTQ1NWNhNWFmMTM1NTY0ZGY2NDAwL3RhYmxlcmFuZ2U6ZjZjMjkyNmRiMmE1NDU1Y2E1YWYxMzU1NjRkZjY0MDBfNC0zLTEtMS02MTg3NA_13b10e02-a13d-46ff-b9e1-7c7bf5c5582e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie81addc4a43045808d4c9dbf8c419ac8_I20221231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmY2YzI5MjZkYjJhNTQ1NWNhNWFmMTM1NTY0ZGY2NDAwL3RhYmxlcmFuZ2U6ZjZjMjkyNmRiMmE1NDU1Y2E1YWYxMzU1NjRkZjY0MDBfNC01LTEtMS02MTg3NA_ce21e361-62bd-4fca-97af-493c9cd3107a">3,709</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f30a42447ea455195dbea5eb27643c7_I20221231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmY2YzI5MjZkYjJhNTQ1NWNhNWFmMTM1NTY0ZGY2NDAwL3RhYmxlcmFuZ2U6ZjZjMjkyNmRiMmE1NDU1Y2E1YWYxMzU1NjRkZjY0MDBfNC03LTEtMS02MTg3NA_77142a05-e0ed-411f-9db1-ef98e8093b63">3,709</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Montclair Radiological Associates</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a9534b2492f4341a32a7b6c05873d87_I20221231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmY2YzI5MjZkYjJhNTQ1NWNhNWFmMTM1NTY0ZGY2NDAwL3RhYmxlcmFuZ2U6ZjZjMjkyNmRiMmE1NDU1Y2E1YWYxMzU1NjRkZjY0MDBfNS0xLTEtMS02OTEwOQ_ab9396cb-1dcd-4117-9a39-03b56d5acc9f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d69f978a5e545b59d1932ca7f532e37_I20221231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmY2YzI5MjZkYjJhNTQ1NWNhNWFmMTM1NTY0ZGY2NDAwL3RhYmxlcmFuZ2U6ZjZjMjkyNmRiMmE1NDU1Y2E1YWYxMzU1NjRkZjY0MDBfNS0zLTEtMS02OTEwOQ_d837f50e-72e0-473c-b256-95e7d9fa8c42">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63cacf5ad31b4575a01903e9faa4d633_I20221231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmY2YzI5MjZkYjJhNTQ1NWNhNWFmMTM1NTY0ZGY2NDAwL3RhYmxlcmFuZ2U6ZjZjMjkyNmRiMmE1NDU1Y2E1YWYxMzU1NjRkZjY0MDBfNS01LTEtMS02OTEwOQ_44ef94c7-764e-49dc-977a-46a9e40ae468">1,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i262f245ca0594ae0ac2e01228b468096_I20221231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmY2YzI5MjZkYjJhNTQ1NWNhNWFmMTM1NTY0ZGY2NDAwL3RhYmxlcmFuZ2U6ZjZjMjkyNmRiMmE1NDU1Y2E1YWYxMzU1NjRkZjY0MDBfNS03LTEtMS02OTEwOQ_ed2eaa45-4f34-4028-8926-52554cff8929">1,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Heart and Lung Imaging Limited</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife7c65edeb504ccfb67de601c6de474e_I20221231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmY2YzI5MjZkYjJhNTQ1NWNhNWFmMTM1NTY0ZGY2NDAwL3RhYmxlcmFuZ2U6ZjZjMjkyNmRiMmE1NDU1Y2E1YWYxMzU1NjRkZjY0MDBfNS0xLTEtMS02NzE1Ng_bc123414-3c1b-4ef3-8770-06c9e4580cfc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7761dd1ec2754fbd87eac5dbd64b9695_I20221231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmY2YzI5MjZkYjJhNTQ1NWNhNWFmMTM1NTY0ZGY2NDAwL3RhYmxlcmFuZ2U6ZjZjMjkyNmRiMmE1NDU1Y2E1YWYxMzU1NjRkZjY0MDBfNS0zLTEtMS02NzE1Ng_f8048dcb-2e6d-4a27-846d-35ad3dbbc5e5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ce47813748d41d199f7f86a1dfd426b_I20221231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmY2YzI5MjZkYjJhNTQ1NWNhNWFmMTM1NTY0ZGY2NDAwL3RhYmxlcmFuZ2U6ZjZjMjkyNmRiMmE1NDU1Y2E1YWYxMzU1NjRkZjY0MDBfNS01LTEtMS02NzE1Ng_dc67ee96-fc09-4ccd-a1c3-14d663b6f06e">11,656</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d11c112b7384fe3b9ac73abcd84790d_I20221231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmY2YzI5MjZkYjJhNTQ1NWNhNWFmMTM1NTY0ZGY2NDAwL3RhYmxlcmFuZ2U6ZjZjMjkyNmRiMmE1NDU1Y2E1YWYxMzU1NjRkZjY0MDBfNS03LTEtMS02NzE1Ng_6c6ec160-a8c0-4c85-be0f-8551f3dcda45">11,656</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div><span><br/></span></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of these liabilities was determined using Level 3 inputs.  For Aidence Holding B.V., the  milestone contingent liability was adjusted to fair value based on the yield rate of S&amp;P B-rated corporate bonds and the probability of FDA approval.  For the Quantib B.V holdback shares, the fair value was determined by calculating the value of estimated shares issuable as of the reporting date (which was $<ix:nonFraction unitRef="usdPerShare" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="2" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTcxNTczMQ_583c4c7b-ec08-4252-b8f5-4e817b5aef72">18.83</ix:nonFraction>) translated at the current exchange rate at December 31, 2022, the time period related to the contractual settlement term, and the probability of issuing the shares.  For Montclair Radiological Associates the contingent consideration is determined by obtaining specific EBITDA targets within a defined time frame.  For Heat Lung Imaging Limited the contingent consideration is determined by the achievement of a specific number of physician reads.  As significant inputs for the contingent consideration of Aidence B.V., Quantib B.V., Montclair Radiological Associates and Heart Lung Imaging Limited are not observable and cannot be corroborated by observable market data they are classified as Level 3.</span></div></ix:continuation><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Long Term Debt</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:continuation id="ibad013eae5fc462b8b30f2ec5e8b580c" continuedAt="ibc7b22a68cea4cf8bd73a1f49953e288"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the estimated fair value and carrying amount of our Truist (Term Loan Agreement) and Barclays (First Lien Term Loans) long-term debt as follows (in thousands):</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:46.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.713%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Face Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan Agreement and First Lien Term Loans</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68cb6719a36646579aa32aed365bd98e_I20221231" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjE3N2I2MmI2NDYzZDQ4ZTBiODZiYTlkY2Y0ZmE2MTdjL3RhYmxlcmFuZ2U6MTc3YjYyYjY0NjNkNDhlMGI4NmJhOWRjZjRmYTYxN2NfMi0xLTEtMS0yOTQ4OQ_b28a1114-15ab-4617-a7ec-759d1785dabb">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93f4dc716811412781fdf04a461f52d0_I20221231" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjE3N2I2MmI2NDYzZDQ4ZTBiODZiYTlkY2Y0ZmE2MTdjL3RhYmxlcmFuZ2U6MTc3YjYyYjY0NjNkNDhlMGI4NmJhOWRjZjRmYTYxN2NfMi0zLTEtMS0yOTQ4OQ_6a092ada-94f8-40a0-acc2-8cdd8d90dab9">843,594</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d6f4cc7b7b3447bbb1069e43d3898ab_I20221231" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjE3N2I2MmI2NDYzZDQ4ZTBiODZiYTlkY2Y0ZmE2MTdjL3RhYmxlcmFuZ2U6MTc3YjYyYjY0NjNkNDhlMGI4NmJhOWRjZjRmYTYxN2NfMi01LTEtMS0yOTQ4OQ_f9e40bfc-6145-4a32-8aa7-8fc4808c3691">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6183df40beac48aaad7cae1b8fc18cf7_I20221231" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjE3N2I2MmI2NDYzZDQ4ZTBiODZiYTlkY2Y0ZmE2MTdjL3RhYmxlcmFuZ2U6MTc3YjYyYjY0NjNkNDhlMGI4NmJhOWRjZjRmYTYxN2NfMi03LTEtMS0yOTQ4OQ_1b1a29d0-de57-420d-b813-3f9f80deba73">843,594</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjE3N2I2MmI2NDYzZDQ4ZTBiODZiYTlkY2Y0ZmE2MTdjL3RhYmxlcmFuZ2U6MTc3YjYyYjY0NjNkNDhlMGI4NmJhOWRjZjRmYTYxN2NfMi05LTEtMS0yOTQ4OQ_41ce3148-858f-4fbb-b2ef-c4de92a1983d">864,125</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="icb8d40375a424a07acf7c9621c7a83c6" continuedAt="i939c0b291c2d424da2ef435d9ec1f828"><div style="margin-top:5pt;text-align:center"><ix:continuation id="ibc7b22a68cea4cf8bd73a1f49953e288"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:46.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.713%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Face Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan Agreement and First Lien Term Loans</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i872140f492c640d8b8e8a6c1e04bd0d6_I20211231" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmEyYjdiYWE1N2Q0NzQyYmVhZDUzZmM1YTM0ZDUwMmIxL3RhYmxlcmFuZ2U6YTJiN2JhYTU3ZDQ3NDJiZWFkNTNmYzVhMzRkNTAyYjFfMi0xLTEtMS0yOTQ4OQ_e993d2d0-950d-4ec0-9318-1eb0cc21a416">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i133140d2b4cb48a9bbe5445819d6ad6a_I20211231" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmEyYjdiYWE1N2Q0NzQyYmVhZDUzZmM1YTM0ZDUwMmIxL3RhYmxlcmFuZ2U6YTJiN2JhYTU3ZDQ3NDJiZWFkNTNmYzVhMzRkNTAyYjFfMi0zLTEtMS0yOTQ4OQ_3f083a59-0095-4b40-9f18-2e3cefbb866c">766,973</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc57a71039044ca88fabf7ced3a359f8_I20211231" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmEyYjdiYWE1N2Q0NzQyYmVhZDUzZmM1YTM0ZDUwMmIxL3RhYmxlcmFuZ2U6YTJiN2JhYTU3ZDQ3NDJiZWFkNTNmYzVhMzRkNTAyYjFfMi01LTEtMS0yOTQ4OQ_d00e7a0a-ba27-4197-95de-5da5d2787581">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0f9e4af159e4119a9b961b547b9038e_I20211231" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmEyYjdiYWE1N2Q0NzQyYmVhZDUzZmM1YTM0ZDUwMmIxL3RhYmxlcmFuZ2U6YTJiN2JhYTU3ZDQ3NDJiZWFkNTNmYzVhMzRkNTAyYjFfMi03LTEtMS0yOTQ4OQ_8c5b6270-f457-4010-88d8-d9401ed14ef5">766,973</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmEyYjdiYWE1N2Q0NzQyYmVhZDUzZmM1YTM0ZDUwMmIxL3RhYmxlcmFuZ2U6YTJiN2JhYTU3ZDQ3NDJiZWFkNTNmYzVhMzRkNTAyYjFfMi05LTEtMS0yOTQ4OQ_1c3a061b-d89a-414d-b5d8-326f9c95e18b">767,875</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Barclays revolving credit facility had <ix:nonFraction unitRef="usd" contextRef="i4eb1b2eda4f64d6e9ef32ec67df449b3_I20221231" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMzM0OTE_4e7f01bc-a17f-4f1e-9552-e912c9a522c0"><ix:nonFraction unitRef="usd" contextRef="i8cfe249b156b4148afe2824bb962e98f_I20211231" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMzM0OTE_603e8e54-d0c5-4b69-ab97-f60d9ea6482d">no</ix:nonFraction></ix:nonFraction> aggregate principal amount outstanding as of December 31, 2022 and December 31, 2021, respectively.  Our Truist revolving credit facility had <ix:nonFraction unitRef="usd" contextRef="i9eddaf97c45f47fc9a3e3499d9c2b938_I20211231" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMzM2MDg_41eb79b5-5e91-427e-b3cc-11957c6bfb6c"><ix:nonFraction unitRef="usd" contextRef="iedc6b67a64d84652974967909a8eed47_I20221231" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMzM2MDg_8de8df85-e878-4be1-9bc6-4f27884f4a6f">no</ix:nonFraction></ix:nonFraction> aggregate principal amount outstanding as of December 31, 2022 and December 31, 2021, respectively.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:continuation id="iac8815bb1198430fa0321c7e56d8058d"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair values of our long-term debt, which is discussed in Note 8, was determined using Level 2 inputs for the Barclays and Truist term loans. Level 2 inputs primarily related to comparable market prices.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider the carrying amounts of cash and cash equivalents, receivables, other current assets, current liabilities and other notes payables to approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization or payment. Additionally, we consider the carrying amount of our capital lease obligations to approximate their fair value because the weighted average interest rate used to formulate the carrying amounts approximates current market rates.</span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDA4NTQ_9d0b2261-540b-48bf-adee-a9ed0c5feaa8" escape="true">EARNINGS PER SHARE - <ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDA3NjU_3a72b8f0-c98b-415b-9ffd-a7e2c6cb19cb" continuedAt="id9052eb03cf74920a5b93e05ad47d96e" escape="true">Earnings per share is based upon the weighted average number of shares of common stock and common stock equivalents outstanding, net of common stock held in treasury, as follows (in thousands except share and per share data):</ix:nonNumeric></ix:nonNumeric></span></div><ix:continuation id="id9052eb03cf74920a5b93e05ad47d96e"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:62.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to RadNet, Inc. common stockholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmRmMWNhNzE2YTVlZjQxMGJhMDY4ZTdiYTEzOTg0YTVhL3RhYmxlcmFuZ2U6ZGYxY2E3MTZhNWVmNDEwYmEwNjhlN2JhMTM5ODRhNWFfMi0xLTEtMS0yOTQ4OQ_819ed944-8c2c-4ac4-9c0a-29d0e13c5196">10,650</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmRmMWNhNzE2YTVlZjQxMGJhMDY4ZTdiYTEzOTg0YTVhL3RhYmxlcmFuZ2U6ZGYxY2E3MTZhNWVmNDEwYmEwNjhlN2JhMTM5ODRhNWFfMi0zLTEtMS0yOTQ4OQ_875cc96c-4fa5-4d96-9319-0c84f51fcd3f">24,727</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmRmMWNhNzE2YTVlZjQxMGJhMDY4ZTdiYTEzOTg0YTVhL3RhYmxlcmFuZ2U6ZGYxY2E3MTZhNWVmNDEwYmEwNjhlN2JhMTM5ODRhNWFfMi01LTEtMS0yOTQ4OQ_cbd44ee6-cc14-4aa7-97b7-c13dda96fa17">14,840</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BASIC NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding during the period</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmRmMWNhNzE2YTVlZjQxMGJhMDY4ZTdiYTEzOTg0YTVhL3RhYmxlcmFuZ2U6ZGYxY2E3MTZhNWVmNDEwYmEwNjhlN2JhMTM5ODRhNWFfNS0xLTEtMS0yOTQ4OQ_dd1209ac-281d-4371-8ec8-a642818768ea">56,293,336</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmRmMWNhNzE2YTVlZjQxMGJhMDY4ZTdiYTEzOTg0YTVhL3RhYmxlcmFuZ2U6ZGYxY2E3MTZhNWVmNDEwYmEwNjhlN2JhMTM5ODRhNWFfNS0zLTEtMS0yOTQ4OQ_cd1ed13f-6b11-446b-b8cd-23764ea0fbdd">52,496,679</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmRmMWNhNzE2YTVlZjQxMGJhMDY4ZTdiYTEzOTg0YTVhL3RhYmxlcmFuZ2U6ZGYxY2E3MTZhNWVmNDEwYmEwNjhlN2JhMTM5ODRhNWFfNS01LTEtMS0yOTQ4OQ_e9651785-11d6-43aa-a9db-53921d0b5a4d">50,891,791</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net income (loss) per share attributable to RadNet, Inc. common stockholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmRmMWNhNzE2YTVlZjQxMGJhMDY4ZTdiYTEzOTg0YTVhL3RhYmxlcmFuZ2U6ZGYxY2E3MTZhNWVmNDEwYmEwNjhlN2JhMTM5ODRhNWFfNi0xLTEtMS0yOTQ4OQ_0735a6d4-58b1-4faf-b12b-97610937369b">0.19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmRmMWNhNzE2YTVlZjQxMGJhMDY4ZTdiYTEzOTg0YTVhL3RhYmxlcmFuZ2U6ZGYxY2E3MTZhNWVmNDEwYmEwNjhlN2JhMTM5ODRhNWFfNi0zLTEtMS0yOTQ4OQ_20edc25f-8438-4587-978f-2204c1a56895">0.47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmRmMWNhNzE2YTVlZjQxMGJhMDY4ZTdiYTEzOTg0YTVhL3RhYmxlcmFuZ2U6ZGYxY2E3MTZhNWVmNDEwYmEwNjhlN2JhMTM5ODRhNWFfNi01LTEtMS0yOTQ4OQ_75fb85f9-9de0-4e83-92e8-f14c94f949e2">0.29</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DILUTED NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</span></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmRmMWNhNzE2YTVlZjQxMGJhMDY4ZTdiYTEzOTg0YTVhL3RhYmxlcmFuZ2U6ZGYxY2E3MTZhNWVmNDEwYmEwNjhlN2JhMTM5ODRhNWFfOC0xLTEtMS0yOTQ4OQ_b2806af3-dd3d-43b9-98ac-e8f4f4b5f19a">56,293,336</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmRmMWNhNzE2YTVlZjQxMGJhMDY4ZTdiYTEzOTg0YTVhL3RhYmxlcmFuZ2U6ZGYxY2E3MTZhNWVmNDEwYmEwNjhlN2JhMTM5ODRhNWFfOC0zLTEtMS0yOTQ4OQ_98d1c0d3-9240-4b69-a851-0c33df1f0513">52,496,679</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmRmMWNhNzE2YTVlZjQxMGJhMDY4ZTdiYTEzOTg0YTVhL3RhYmxlcmFuZ2U6ZGYxY2E3MTZhNWVmNDEwYmEwNjhlN2JhMTM5ODRhNWFfOC01LTEtMS0yOTQ4OQ_ef46b989-32ab-4846-ab2d-b4b1226763a1">50,891,791</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add nonvested restricted stock subject only to service vesting</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesRestrictedStock" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmRmMWNhNzE2YTVlZjQxMGJhMDY4ZTdiYTEzOTg0YTVhL3RhYmxlcmFuZ2U6ZGYxY2E3MTZhNWVmNDEwYmEwNjhlN2JhMTM5ODRhNWFfOS0xLTEtMS0yOTQ4OQ_96f9fa4e-c0ae-404b-b1a1-5a9ab8384f0d">172,139</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesRestrictedStock" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmRmMWNhNzE2YTVlZjQxMGJhMDY4ZTdiYTEzOTg0YTVhL3RhYmxlcmFuZ2U6ZGYxY2E3MTZhNWVmNDEwYmEwNjhlN2JhMTM5ODRhNWFfOS0zLTEtMS0yOTQ4OQ_4bd88578-9087-43e9-abe2-b06491ac43c9">259,539</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesRestrictedStock" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmRmMWNhNzE2YTVlZjQxMGJhMDY4ZTdiYTEzOTg0YTVhL3RhYmxlcmFuZ2U6ZGYxY2E3MTZhNWVmNDEwYmEwNjhlN2JhMTM5ODRhNWFfOS01LTEtMS0yOTQ4OQ_80a05cf6-e007-46cb-ad5b-b4d71ccd868b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add additional shares issuable upon exercise of stock options, warrants and holdback shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="0" name="us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmRmMWNhNzE2YTVlZjQxMGJhMDY4ZTdiYTEzOTg0YTVhL3RhYmxlcmFuZ2U6ZGYxY2E3MTZhNWVmNDEwYmEwNjhlN2JhMTM5ODRhNWFfMTAtMS0xLTEtMjk0ODk_ec5279bd-b2cc-46de-9785-7e589d5cfe6b">855,395</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="0" name="us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmRmMWNhNzE2YTVlZjQxMGJhMDY4ZTdiYTEzOTg0YTVhL3RhYmxlcmFuZ2U6ZGYxY2E3MTZhNWVmNDEwYmEwNjhlN2JhMTM5ODRhNWFfMTAtMy0xLTEtMjk0ODk_bd239f76-a25b-4b68-8e80-36435be71373">664,815</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="0" name="us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmRmMWNhNzE2YTVlZjQxMGJhMDY4ZTdiYTEzOTg0YTVhL3RhYmxlcmFuZ2U6ZGYxY2E3MTZhNWVmNDEwYmEwNjhlN2JhMTM5ODRhNWFfMTAtNS0xLTEtMjk0ODk_fa308016-f216-4646-bd96-6d3a53fa2a32">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares used in calculating diluted net income per share</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmRmMWNhNzE2YTVlZjQxMGJhMDY4ZTdiYTEzOTg0YTVhL3RhYmxlcmFuZ2U6ZGYxY2E3MTZhNWVmNDEwYmEwNjhlN2JhMTM5ODRhNWFfMTEtMS0xLTEtMjk0ODk_4cca8635-5cce-4068-9957-38655ef7f2ec">57,320,870</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmRmMWNhNzE2YTVlZjQxMGJhMDY4ZTdiYTEzOTg0YTVhL3RhYmxlcmFuZ2U6ZGYxY2E3MTZhNWVmNDEwYmEwNjhlN2JhMTM5ODRhNWFfMTEtMy0xLTEtMjk0ODk_6175364b-ec50-4028-ab6e-341fe92b07fb">53,421,033</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmRmMWNhNzE2YTVlZjQxMGJhMDY4ZTdiYTEzOTg0YTVhL3RhYmxlcmFuZ2U6ZGYxY2E3MTZhNWVmNDEwYmEwNjhlN2JhMTM5ODRhNWFfMTEtNS0xLTEtMjk0ODk_7852c99b-bfac-40b4-b48c-c94fefcae488">50,891,791</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in fair value associated with contingently issuable shares</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" sign="-" name="rdnt:AdjustmentToNetIncomeAttributableToAssumedShareSettlements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmRmMWNhNzE2YTVlZjQxMGJhMDY4ZTdiYTEzOTg0YTVhL3RhYmxlcmFuZ2U6ZGYxY2E3MTZhNWVmNDEwYmEwNjhlN2JhMTM5ODRhNWFfMTItMS0xLTEtNjUzNDI_d150f1e8-2a06-4dff-b2ac-178603bdd2cc">724</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="rdnt:AdjustmentToNetIncomeAttributableToAssumedShareSettlements" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmRmMWNhNzE2YTVlZjQxMGJhMDY4ZTdiYTEzOTg0YTVhL3RhYmxlcmFuZ2U6ZGYxY2E3MTZhNWVmNDEwYmEwNjhlN2JhMTM5ODRhNWFfMTItMy0xLTEtNjUzNzk_8b4189ed-bc75-4854-a432-6253ef5b32ee">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" name="rdnt:AdjustmentToNetIncomeAttributableToAssumedShareSettlements" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmRmMWNhNzE2YTVlZjQxMGJhMDY4ZTdiYTEzOTg0YTVhL3RhYmxlcmFuZ2U6ZGYxY2E3MTZhNWVmNDEwYmEwNjhlN2JhMTM5ODRhNWFfMTItNS0xLTEtNjUzODc_9d90b697-b9ab-4d62-a526-d1039d6123ab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to RadNet, Inc's common stockholders for diluted share calculation</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmRmMWNhNzE2YTVlZjQxMGJhMDY4ZTdiYTEzOTg0YTVhL3RhYmxlcmFuZ2U6ZGYxY2E3MTZhNWVmNDEwYmEwNjhlN2JhMTM5ODRhNWFfMTMtMS0xLTEtNjUzNTg_d0ce0d82-2814-497b-a1c4-82d40f44f668">9,926</ix:nonFraction></span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmRmMWNhNzE2YTVlZjQxMGJhMDY4ZTdiYTEzOTg0YTVhL3RhYmxlcmFuZ2U6ZGYxY2E3MTZhNWVmNDEwYmEwNjhlN2JhMTM5ODRhNWFfMTMtMy0xLTEtNjUzOTk_f1fda5ac-c19e-46d8-b5b4-040f9a9ab8ad">24,727</ix:nonFraction></span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(<ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmRmMWNhNzE2YTVlZjQxMGJhMDY4ZTdiYTEzOTg0YTVhL3RhYmxlcmFuZ2U6ZGYxY2E3MTZhNWVmNDEwYmEwNjhlN2JhMTM5ODRhNWFfMTMtNS0xLTEtNjU0MDc_2005c0ab-b9af-44d8-ba50-6ae9e777ca85">14,840</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net income (loss) per share attributable to RadNet, Inc. common stockholders</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmRmMWNhNzE2YTVlZjQxMGJhMDY4ZTdiYTEzOTg0YTVhL3RhYmxlcmFuZ2U6ZGYxY2E3MTZhNWVmNDEwYmEwNjhlN2JhMTM5ODRhNWFfMTItMS0xLTEtMjk0ODk_091c0158-981f-4ae1-9bf9-ba280cc902fa">0.17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmRmMWNhNzE2YTVlZjQxMGJhMDY4ZTdiYTEzOTg0YTVhL3RhYmxlcmFuZ2U6ZGYxY2E3MTZhNWVmNDEwYmEwNjhlN2JhMTM5ODRhNWFfMTItMy0xLTEtMjk0ODk_b7c2cb2e-ddf1-4b4e-9446-9b628cd268a1">0.46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmRmMWNhNzE2YTVlZjQxMGJhMDY4ZTdiYTEzOTg0YTVhL3RhYmxlcmFuZ2U6ZGYxY2E3MTZhNWVmNDEwYmEwNjhlN2JhMTM5ODRhNWFfMTItNS0xLTEtMjk0ODk_d09981b2-ade6-48f4-bfcf-92fd30705d87">0.29</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and non-vested restricted awards excluded from the computation of diluted per share amounts as their effect would be antidilutive:</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested restricted stock subject to service vesting</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i97956fc643d247dbb60da5865beb89eb_D20220101-20221231" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmRmMWNhNzE2YTVlZjQxMGJhMDY4ZTdiYTEzOTg0YTVhL3RhYmxlcmFuZ2U6ZGYxY2E3MTZhNWVmNDEwYmEwNjhlN2JhMTM5ODRhNWFfMTUtMS0xLTEtMjk0ODk_a36d892c-e576-4869-866e-b84c25d5579b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5457051aa2ff41adadb9d14aeb2cf08f_D20210101-20211231" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmRmMWNhNzE2YTVlZjQxMGJhMDY4ZTdiYTEzOTg0YTVhL3RhYmxlcmFuZ2U6ZGYxY2E3MTZhNWVmNDEwYmEwNjhlN2JhMTM5ODRhNWFfMTUtMy0xLTEtMjk0ODk_f349b8f0-6f96-4d9f-bcc5-1f6ae300d713">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4fb9164d19204098ae94cbd87a23b9c8_D20200101-20201231" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmRmMWNhNzE2YTVlZjQxMGJhMDY4ZTdiYTEzOTg0YTVhL3RhYmxlcmFuZ2U6ZGYxY2E3MTZhNWVmNDEwYmEwNjhlN2JhMTM5ODRhNWFfMTUtNS0xLTEtMjk0ODk_1ce44663-dad9-4008-b318-3ccf304b72d5">329,159</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issuable upon the exercise of stock options</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6a2f8fa41f874e60b776bf0389800e5e_D20220101-20221231" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmRmMWNhNzE2YTVlZjQxMGJhMDY4ZTdiYTEzOTg0YTVhL3RhYmxlcmFuZ2U6ZGYxY2E3MTZhNWVmNDEwYmEwNjhlN2JhMTM5ODRhNWFfMTYtMS0xLTEtMjk0ODk_ba163edd-f980-48b6-b2a9-9f28a5ab12c4">152,723</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6a13cd9e9617451c8d173c251b8d9e0e_D20210101-20211231" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmRmMWNhNzE2YTVlZjQxMGJhMDY4ZTdiYTEzOTg0YTVhL3RhYmxlcmFuZ2U6ZGYxY2E3MTZhNWVmNDEwYmEwNjhlN2JhMTM5ODRhNWFfMTYtMy0xLTEtMjk0ODk_97b15154-d7ea-40cc-93d9-c8c44597dace">47,792</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i733c80ddcad5463c9dbb1c25b49f2c67_D20200101-20201231" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmRmMWNhNzE2YTVlZjQxMGJhMDY4ZTdiYTEzOTg0YTVhL3RhYmxlcmFuZ2U6ZGYxY2E3MTZhNWVmNDEwYmEwNjhlN2JhMTM5ODRhNWFfMTYtNS0xLTEtMjk0ODk_55f2c5d7-71eb-422e-bbfc-c23e8965fb04">554,444</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:36pt"><span><br/></span></div><ix:continuation id="i939c0b291c2d424da2ef435d9ec1f828" continuedAt="i70c3c249d40d4c6faeed69fca2b19e4e"><div style="text-align:justify;text-indent:36pt"><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="us-gaap:EquityMethodInvestmentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDA3NzY_5d7dd4ac-a8f3-4463-89d6-68705be0681c" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">INVESTMENTS IN EQUITY SECURITIES- As of December 31, 2022, we have <ix:nonFraction unitRef="investment" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="INF" name="rdnt:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNjU5NzA2OTg4MzMxOA_5e120e9f-ac3d-4f68-9410-d59636c76b13">three</ix:nonFraction> equity investments for which a fair value is not readily determinable and we do not have significant influence and therefore the total amounts invested are recognized at cost.  In accordance with accounting guidance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">if there is no readily determinable fair value, the guidance allows entities the ability to measure investments at cost less impairment, whereby impairment is based on a qualitative assessment.</span></ix:nonNumeric></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medic Vision, based in Israel, specializes in software packages that provide compliant radiation dose structured reporting and enhanced images from reduced dose CT scans.  Our investment of $<ix:nonFraction unitRef="usd" contextRef="i66d4d733653e4eb4a3ad6c433ebdfb6a_I20221231" decimals="-5" name="us-gaap:EquityMethodInvestmentAggregateCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMzU5Njg_ee2e9302-d3de-4816-98c5-1913cb8463a8">1.2</ix:nonFraction> million, represents a <ix:nonFraction unitRef="number" contextRef="i66d4d733653e4eb4a3ad6c433ebdfb6a_I20221231" decimals="4" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTY3MTExNA_522a39b0-0c34-4e79-b49b-6e21fbc4bc14">14.21</ix:nonFraction>% equity interest in the company.  No observable price changes or impairment in our investment was noted as of the year ended December 31, 2022.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Turner Imaging Systems, based in Utah, develops and markets portable X-ray imaging systems that provide a user the ability to acquire X-ray images wherever and whenever they are needed. On February 1, 2018, we purchased <ix:nonFraction unitRef="shares" contextRef="i47e82ebf9ddc4469a95c70fcc3d63d41_D20180201-20180201" decimals="-5" name="rdnt:EquityMethodInvestmentSharesPurchased" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMzYzNDQ_b6f8a361-ef51-4281-9fff-25d61e75eb99">2.1</ix:nonFraction> million preferred shares in Turner Imaging Systems for $<ix:nonFraction unitRef="usd" contextRef="i47e82ebf9ddc4469a95c70fcc3d63d41_D20180201-20180201" decimals="-5" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMzYzOTQ_67815294-6e25-4829-b0b6-1989e14d62ca">2.0</ix:nonFraction> million.  On January 1, 2019 we funded a convertible promissory note in the amount of $<ix:nonFraction unitRef="usd" contextRef="i9104bade5d0a4187930fd11fdbf5d05b_I20190101" decimals="-3" name="us-gaap:ShortTermBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMzY0NzU_9588e311-da91-42a8-b2e8-9f9a05cef72f">0.1</ix:nonFraction> million that converted to an additional <ix:nonFraction unitRef="shares" contextRef="ie8654cdfc8db49acb180ade8667b818b_I20191011" decimals="INF" name="us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMzY1MTA_d2af7084-a33f-4ac9-8661-cddd634d4fa7">80,000</ix:nonFraction> preferred shares on October 11, 2019.  No observable price changes or impairment in our investment was noted for the year ended December 31, 2022.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WhiteRabbit.ai Inc., based in California, is currently developing an artificial intelligence suite which aims to improve the speed and accuracy of cancer detection in radiology and improve patient care. On November 5, 2019 we acquired an equity interest in the company for $<ix:nonFraction unitRef="usd" contextRef="ic070f0614e2e4747984c1d8809073028_D20191105-20191105" decimals="-5" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMzY5MTg_aaee44ee-9bbc-41ae-83d9-d7a7b42ff366">1.0</ix:nonFraction> million and also loaned the company $<ix:nonFraction unitRef="usd" contextRef="ic070f0614e2e4747984c1d8809073028_D20191105-20191105" decimals="-5" name="us-gaap:PaymentsToFundLongtermLoansToRelatedParties" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMzY5NDk_387a9eee-cb84-4bed-a664-ac684c887831">2.5</ix:nonFraction> million in support of its operations.  No observable price changes or impairment in our investment was noted for the year ended December 31, 2022.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="us-gaap:InvestmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDA4MzU_0e4420dc-0cee-4a2a-9c8f-3c21a611d47a" escape="true">INVESTMENT IN JOINT VENTURES &#8211; We have <ix:nonFraction unitRef="jointventure" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="INF" name="rdnt:NumberofUnconsolidatedJointVentures" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMzcxMTc_385c7d89-6f82-4fcd-b2c0-ad784edd0c91">13</ix:nonFraction> unconsolidated joint ventures with ownership interests ranging from <ix:nonFraction unitRef="number" contextRef="ia3c6f10cf71d436f8d6f89d025cb5660_D20220101-20221231" decimals="2" name="us-gaap:VariableInterestEntityOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMzcxODg_c49d3534-d01a-4ed6-80ce-194a40df6562">35</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i4b1c789f4aa54283a927ee786764619c_D20220101-20221231" decimals="2" name="us-gaap:VariableInterestEntityOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMzcxOTQ_88e61cfd-466a-45d5-aa9e-9d6ee0b6c0f4">55</ix:nonFraction>%. These joint ventures represent partnerships with hospitals, health systems or radiology practices and were formed for the purpose of owning and operating diagnostic imaging centers.&#160;&#160;Professional services at the joint venture diagnostic imaging centers are performed by contracted radiology practices or a radiology practice that participates in the joint venture.&#160;&#160;Our investment in these joint ventures is accounted for under the equity method, as we do not have a controlling financial interest in such ventures. We evaluate our investment in joint ventures, including cost in excess of book value (equity method goodwill) for impairment whenever indicators of impairment exist. No indicators of impairment existed as of December 31, 2022.</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Joint venture investment and financial information</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="us-gaap:EquityMethodInvestmentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDA4Mzc_30ef043f-2f6d-40a6-bdc5-83ccfa11f2d0" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of our investment in joint ventures during the years ended December 31, 2022 and December 31, 2021 (in thousands):</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:84.090%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.710%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb50bc5a13564f6a97eb669524009c18_I20201231" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjMxNjUyMjQ5N2EyMzQyMWFhNDMzNTk3ZWRlNjNmNDlmL3RhYmxlcmFuZ2U6MzE2NTIyNDk3YTIzNDIxYWE0MzM1OTdlZGU2M2Y0OWZfMC0xLTEtMS0yOTQ4OQ_da7dbff5-816d-4f8d-ab1a-304fcfc49f82">34,528</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity contributions in existing and purchase of interest in joint ventures</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="rdnt:EquityContributionsInExistingAndPurchaseOfInterestInJointVentures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjMxNjUyMjQ5N2EyMzQyMWFhNDMzNTk3ZWRlNjNmNDlmL3RhYmxlcmFuZ2U6MzE2NTIyNDk3YTIzNDIxYWE0MzM1OTdlZGU2M2Y0OWZfMS0xLTEtMS0yOTQ4OQ_523ee4fb-a989-4ab1-9265-d09d8f420e3f">1,441</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in earnings in these joint ventures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjMxNjUyMjQ5N2EyMzQyMWFhNDMzNTk3ZWRlNjNmNDlmL3RhYmxlcmFuZ2U6MzE2NTIyNDk3YTIzNDIxYWE0MzM1OTdlZGU2M2Y0OWZfMi0xLTEtMS0yOTQ4OQ_71a4a6d3-9d0b-459c-9a85-b077b4de909a">10,967</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distribution of earnings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:EquityMethodInvestmentDividendsOrDistributions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjMxNjUyMjQ5N2EyMzQyMWFhNDMzNTk3ZWRlNjNmNDlmL3RhYmxlcmFuZ2U6MzE2NTIyNDk3YTIzNDIxYWE0MzM1OTdlZGU2M2Y0OWZfNy0xLTEtMS0yOTQ4OQ_ae6d60ea-2190-400c-88f6-32ec30a0c169">4,707</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjMxNjUyMjQ5N2EyMzQyMWFhNDMzNTk3ZWRlNjNmNDlmL3RhYmxlcmFuZ2U6MzE2NTIyNDk3YTIzNDIxYWE0MzM1OTdlZGU2M2Y0OWZfOC0xLTEtMS0yOTQ4OQ_3d714637-4ba0-4421-9dd5-c93f038fe43a">42,229</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity contributions in existing and purchase of interest in joint ventures</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="rdnt:EquityContributionsInExistingAndPurchaseOfInterestInJointVentures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjMxNjUyMjQ5N2EyMzQyMWFhNDMzNTk3ZWRlNjNmNDlmL3RhYmxlcmFuZ2U6MzE2NTIyNDk3YTIzNDIxYWE0MzM1OTdlZGU2M2Y0OWZfOS0xLTEtMS0yOTQ4OQ_7491b7b4-8482-4b21-abe5-c90e30fa601d">9,712</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in earnings in these joint ventures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjMxNjUyMjQ5N2EyMzQyMWFhNDMzNTk3ZWRlNjNmNDlmL3RhYmxlcmFuZ2U6MzE2NTIyNDk3YTIzNDIxYWE0MzM1OTdlZGU2M2Y0OWZfMTAtMS0xLTEtMjk0ODk_1f67f20f-12d3-457c-a221-6d6a43e9c895">10,390</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distribution of earnings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:EquityMethodInvestmentDividendsOrDistributions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjMxNjUyMjQ5N2EyMzQyMWFhNDMzNTk3ZWRlNjNmNDlmL3RhYmxlcmFuZ2U6MzE2NTIyNDk3YTIzNDIxYWE0MzM1OTdlZGU2M2Y0OWZfMTEtMS0xLTEtMjk0ODk_49261a40-0d5d-4df3-85f1-41beeeb647a1">4,438</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjMxNjUyMjQ5N2EyMzQyMWFhNDMzNTk3ZWRlNjNmNDlmL3RhYmxlcmFuZ2U6MzE2NTIyNDk3YTIzNDIxYWE0MzM1OTdlZGU2M2Y0OWZfMTItMS0xLTEtMjk0ODk_1a11f547-d46c-4ae0-a409-fcb2e3d0ec9c">57,893</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We charged management service fees from the centers underlying these joint ventures of approximately  $<ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-5" name="rdnt:ManagementServiceFees" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDAzNTE_2bf813dc-f1bd-4c91-a964-8eedf49f8322">22.2</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-5" name="rdnt:ManagementServiceFees" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDAzNTU_d5c8bec9-b7a1-4b44-bb24-531628e15da7">19.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-5" name="rdnt:ManagementServiceFees" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDAzNjI_0c806156-ee75-4d2a-81fb-b4bf57d499ee">11.3</ix:nonFraction> million for the years ended December 31, 2022, 2021 and 2020, respectively.  We eliminate any unrealized portion of our management service fees with our equity in earnings of joint ventures.  As we have the ability to exercise significant influence over our joint venture entities, we consider them related parties.  Amounts transacted between ourselves and the entities in the ordinary course of business are disclosed on our balance sheet in the due from/to affiliate accounts.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i70c3c249d40d4c6faeed69fca2b19e4e"><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="rdnt:JointVentureInvestmentAndFinancialInformationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDA3NjA_2bac19c5-78b5-4ab9-97e2-feae08fe2454" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of key unaudited financial data for these joint ventures as of December 31, 2022 and 2021, respectively, and for the years ended December 31, 2022, 2021 and 2020, respectively, (in thousands):</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance Sheet Data:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bc50d516cca4bf2ac566ca32f16fa45_I20221231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjAxZGVhMjhlNTgyYTRkYzE5YTMyY2ZhZmFmMGIxM2Q3L3RhYmxlcmFuZ2U6MDFkZWEyOGU1ODJhNGRjMTlhMzJjZmFmYWYwYjEzZDdfMi0xLTEtMS0yOTQ4OQ_cc053636-ffa2-4f88-8e23-5db3df8f5fc7">39,304</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i556dfe7e8b354868acf1bd22f0b04c11_I20211231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjAxZGVhMjhlNTgyYTRkYzE5YTMyY2ZhZmFmMGIxM2Q3L3RhYmxlcmFuZ2U6MDFkZWEyOGU1ODJhNGRjMTlhMzJjZmFmYWYwYjEzZDdfMi0zLTEtMS0yOTQ4OQ_e2061bb0-30e3-46b1-ab53-9c7b8d9f91d9">37,186</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bc50d516cca4bf2ac566ca32f16fa45_I20221231" decimals="-3" name="us-gaap:AssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjAxZGVhMjhlNTgyYTRkYzE5YTMyY2ZhZmFmMGIxM2Q3L3RhYmxlcmFuZ2U6MDFkZWEyOGU1ODJhNGRjMTlhMzJjZmFmYWYwYjEzZDdfMy0xLTEtMS0yOTQ4OQ_982c39a0-5e43-444a-9954-0c9873e91108">134,694</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i556dfe7e8b354868acf1bd22f0b04c11_I20211231" decimals="-3" name="us-gaap:AssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjAxZGVhMjhlNTgyYTRkYzE5YTMyY2ZhZmFmMGIxM2Q3L3RhYmxlcmFuZ2U6MDFkZWEyOGU1ODJhNGRjMTlhMzJjZmFmYWYwYjEzZDdfMy0zLTEtMS0yOTQ4OQ_037584f9-de8d-462e-9e0a-b892081644af">73,592</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6bc50d516cca4bf2ac566ca32f16fa45_I20221231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjAxZGVhMjhlNTgyYTRkYzE5YTMyY2ZhZmFmMGIxM2Q3L3RhYmxlcmFuZ2U6MDFkZWEyOGU1ODJhNGRjMTlhMzJjZmFmYWYwYjEzZDdfNC0xLTEtMS0yOTQ4OQ_b5f53663-737a-406a-9bae-422373a1b2eb">29,588</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i556dfe7e8b354868acf1bd22f0b04c11_I20211231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjAxZGVhMjhlNTgyYTRkYzE5YTMyY2ZhZmFmMGIxM2Q3L3RhYmxlcmFuZ2U6MDFkZWEyOGU1ODJhNGRjMTlhMzJjZmFmYWYwYjEzZDdfNC0zLTEtMS0yOTQ4OQ_4cf7c3cd-4f9f-4dfe-bad8-594876a809bf">12,919</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6bc50d516cca4bf2ac566ca32f16fa45_I20221231" decimals="-3" name="us-gaap:LiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjAxZGVhMjhlNTgyYTRkYzE5YTMyY2ZhZmFmMGIxM2Q3L3RhYmxlcmFuZ2U6MDFkZWEyOGU1ODJhNGRjMTlhMzJjZmFmYWYwYjEzZDdfNS0xLTEtMS0yOTQ4OQ_6700a293-e9a4-49a4-a3ae-451c6d4136ac">37,952</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i556dfe7e8b354868acf1bd22f0b04c11_I20211231" decimals="-3" name="us-gaap:LiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjAxZGVhMjhlNTgyYTRkYzE5YTMyY2ZhZmFmMGIxM2Q3L3RhYmxlcmFuZ2U6MDFkZWEyOGU1ODJhNGRjMTlhMzJjZmFmYWYwYjEzZDdfNS0zLTEtMS0yOTQ4OQ_ef38c759-c719-449c-adab-f112339d4d1f">22,370</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net assets</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8217add0ca2e4d579d49cd56dd4ce0dc_I20221231" decimals="-3" name="us-gaap:EquityMethodInvestmentAggregateCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjAxZGVhMjhlNTgyYTRkYzE5YTMyY2ZhZmFmMGIxM2Q3L3RhYmxlcmFuZ2U6MDFkZWEyOGU1ODJhNGRjMTlhMzJjZmFmYWYwYjEzZDdfNi0xLTEtMS0yOTQ4OQ_63b57a51-8805-4084-ab10-8efd7b3edd31">106,458</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9eecc7ea77b94b6d843c47a92a34de8c_I20211231" decimals="-3" name="us-gaap:EquityMethodInvestmentAggregateCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjAxZGVhMjhlNTgyYTRkYzE5YTMyY2ZhZmFmMGIxM2Q3L3RhYmxlcmFuZ2U6MDFkZWEyOGU1ODJhNGRjMTlhMzJjZmFmYWYwYjEzZDdfNi0zLTEtMS0yOTQ4OQ_67d525a9-2a6c-4c15-8255-c13121837041">75,489</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Book value of RadNet joint venture interests</span></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8217add0ca2e4d579d49cd56dd4ce0dc_I20221231" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjAxZGVhMjhlNTgyYTRkYzE5YTMyY2ZhZmFmMGIxM2Q3L3RhYmxlcmFuZ2U6MDFkZWEyOGU1ODJhNGRjMTlhMzJjZmFmYWYwYjEzZDdfNy0xLTEtMS0yOTQ4OQ_3d510955-1d7f-44e6-ae26-bb368af855f6">49,564</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9eecc7ea77b94b6d843c47a92a34de8c_I20211231" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjAxZGVhMjhlNTgyYTRkYzE5YTMyY2ZhZmFmMGIxM2Q3L3RhYmxlcmFuZ2U6MDFkZWEyOGU1ODJhNGRjMTlhMzJjZmFmYWYwYjEzZDdfNy0zLTEtMS0yOTQ4OQ_5409aede-ae92-4669-8588-6800009a8372">34,930</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost in excess of book value of acquired joint venture interests accounted for as equity method goodwill</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8217add0ca2e4d579d49cd56dd4ce0dc_I20221231" decimals="-3" name="us-gaap:EquityMethodInvestmentUnderlyingEquityInNetAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjAxZGVhMjhlNTgyYTRkYzE5YTMyY2ZhZmFmMGIxM2Q3L3RhYmxlcmFuZ2U6MDFkZWEyOGU1ODJhNGRjMTlhMzJjZmFmYWYwYjEzZDdfOC0xLTEtMS0yOTQ4OQ_9bff0508-edf4-4890-978f-e2d9be68f2a6">8,329</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9eecc7ea77b94b6d843c47a92a34de8c_I20211231" decimals="-3" name="us-gaap:EquityMethodInvestmentUnderlyingEquityInNetAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjAxZGVhMjhlNTgyYTRkYzE5YTMyY2ZhZmFmMGIxM2Q3L3RhYmxlcmFuZ2U6MDFkZWEyOGU1ODJhNGRjMTlhMzJjZmFmYWYwYjEzZDdfOC0zLTEtMS0yOTQ4OQ_245a7777-43eb-4bbf-be73-c83106814df2">7,299</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total value of RadNet joint venture interests</span></td><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8217add0ca2e4d579d49cd56dd4ce0dc_I20221231" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjAxZGVhMjhlNTgyYTRkYzE5YTMyY2ZhZmFmMGIxM2Q3L3RhYmxlcmFuZ2U6MDFkZWEyOGU1ODJhNGRjMTlhMzJjZmFmYWYwYjEzZDdfOS0xLTEtMS0yOTQ4OQ_27cbc02d-f901-42d2-b037-965aa1f6e2d4">57,893</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9eecc7ea77b94b6d843c47a92a34de8c_I20211231" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjAxZGVhMjhlNTgyYTRkYzE5YTMyY2ZhZmFmMGIxM2Q3L3RhYmxlcmFuZ2U6MDFkZWEyOGU1ODJhNGRjMTlhMzJjZmFmYWYwYjEzZDdfOS0zLTEtMS0yOTQ4OQ_79796d67-f3e8-4158-b4a4-10aa7d3c52c9">42,229</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida002f69ec1f41d5b17282e7b20fc172_D20220101-20221231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmIxM2VjMDExMTg0NDQ5ZDk4Yjg4NWVkNWZkYzdiNDI0L3RhYmxlcmFuZ2U6YjEzZWMwMTExODQ0NDlkOThiODg1ZWQ1ZmRjN2I0MjRfMS0xLTEtMS0yOTQ4OQ_78067dde-a626-43ed-819a-08940dce3c1d">145,256</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0acf107e72724cc497da946604ddb76c_D20210101-20211231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmIxM2VjMDExMTg0NDQ5ZDk4Yjg4NWVkNWZkYzdiNDI0L3RhYmxlcmFuZ2U6YjEzZWMwMTExODQ0NDlkOThiODg1ZWQ1ZmRjN2I0MjRfMS0zLTEtMS0yOTQ4OQ_111a9a20-5e3a-4783-abae-701f76e3e0b6">129,023</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1616cf57656c47db88833796ec62d482_D20200101-20201231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmIxM2VjMDExMTg0NDQ5ZDk4Yjg4NWVkNWZkYzdiNDI0L3RhYmxlcmFuZ2U6YjEzZWMwMTExODQ0NDlkOThiODg1ZWQ1ZmRjN2I0MjRfMS01LTEtMS0yOTQ4OQ_55a3afc4-8ffd-4ff8-87f3-19c5f582ab21">101,921</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida002f69ec1f41d5b17282e7b20fc172_D20220101-20221231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmIxM2VjMDExMTg0NDQ5ZDk4Yjg4NWVkNWZkYzdiNDI0L3RhYmxlcmFuZ2U6YjEzZWMwMTExODQ0NDlkOThiODg1ZWQ1ZmRjN2I0MjRfMi0xLTEtMS0yOTQ4OQ_1a6fe5bc-b001-4b1e-a99c-6f5b87a25ed3">21,169</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0acf107e72724cc497da946604ddb76c_D20210101-20211231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmIxM2VjMDExMTg0NDQ5ZDk4Yjg4NWVkNWZkYzdiNDI0L3RhYmxlcmFuZ2U6YjEzZWMwMTExODQ0NDlkOThiODg1ZWQ1ZmRjN2I0MjRfMi0zLTEtMS0yOTQ4OQ_1465571c-aa3d-4421-a757-a4184fe88026">21,893</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1616cf57656c47db88833796ec62d482_D20200101-20201231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmIxM2VjMDExMTg0NDQ5ZDk4Yjg4NWVkNWZkYzdiNDI0L3RhYmxlcmFuZ2U6YjEzZWMwMTExODQ0NDlkOThiODg1ZWQ1ZmRjN2I0MjRfMi01LTEtMS0yOTQ4OQ_1e9acaab-4dfb-4be1-9702-6415d612af6e">16,850</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:5pt;text-align:justify"><span><br/></span></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December 31, 2022 and 2021, we made an additional equity contributions of $<ix:nonFraction unitRef="usd" contextRef="i825f9b68a0534968996704634645bbdc_D20220101-20221231" decimals="-5" name="rdnt:EquityMethodInvestmentAdditionalContribution" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTczODkwNA_8f6d343b-deea-4085-af95-b9b03a303a16"><ix:nonFraction unitRef="usd" contextRef="i825f9b68a0534968996704634645bbdc_D20220101-20221231" decimals="-5" name="rdnt:EquityMethodInvestmentAdditionalContribution" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTczODkwNA_c03a82bd-3b4f-4ce3-9544-ddda71746d3e">1.4</ix:nonFraction></ix:nonFraction> million each year to Arizona Diagnostic Radiology Group ("ADRG", our joint venture with Dignity Health).</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2022, we contributed <ix:nonFraction unitRef="center" contextRef="i0852a96e84d740afa49bfe5d275671e7_I20221101" decimals="INF" name="rdnt:NumberOfAssetsSold" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTc0Mzc2OA_136fab7a-7cb8-4bc3-ae4a-a49f9979ca22">eight</ix:nonFraction> of our imaging centers to ADRG of $<ix:nonFraction unitRef="usd" contextRef="i651e6cbf14d5467d82c4f381868cde06_D20221101-20221101" decimals="-5" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTczOTA4Ng_1aaa1bed-a09c-479a-adff-2444909b8b6a">12.7</ix:nonFraction> million and recorded a loss of $<ix:nonFraction unitRef="usd" contextRef="i0852a96e84d740afa49bfe5d275671e7_I20221101" decimals="-5" sign="-" name="us-gaap:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTc0MDU1MA_2bafd1bd-7f32-4fa5-8d47-7f57982c89a4">0.5</ix:nonFraction> million which was calculated as the difference between the sale price and carrying value of such imaging centers which included equipment and other assets and an allocation of goodwill to such imaging centers.  We recorded $<ix:nonFraction unitRef="usd" contextRef="i651e6cbf14d5467d82c4f381868cde06_D20221101-20221101" decimals="-5" name="us-gaap:ProceedsFromDividendsReceived" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTc0MDc5Ng_210420d2-02bc-4b3e-bf5b-3b4033be213e">4.5</ix:nonFraction> million of the sale price as an offset to due to affiliates while the remaining $<ix:nonFraction unitRef="usd" contextRef="i0852a96e84d740afa49bfe5d275671e7_I20221101" decimals="-5" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTc0MDg3NA_d0a8208e-eab0-4f56-bb65-7f44052b50f2">8.3</ix:nonFraction> million was recorded as investment in joint venture on our balance sheet.  We accounted for the transaction as an adjustment to our equity investment for the value of the assets contributed.  To maintain our <ix:nonFraction unitRef="number" contextRef="i0852a96e84d740afa49bfe5d275671e7_I20221101" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTczOTI1NA_e40eb071-db23-41c7-ac58-05a3363aa096">49</ix:nonFraction>% economic interest in ADRG, we received a distribution from the partnership of $<ix:nonFraction unitRef="usd" contextRef="i651e6cbf14d5467d82c4f381868cde06_D20221101-20221101" decimals="-5" name="us-gaap:ProceedsFromDividendsReceived" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTc0Mzc2MA_ea4d77dd-0196-41b8-8532-93dfea72e033">4.5</ix:nonFraction> million to reduce our overall investment to $<ix:nonFraction unitRef="usd" contextRef="i0852a96e84d740afa49bfe5d275671e7_I20221101" decimals="-5" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTczOTM3Mg_d0a8208e-eab0-4f56-bb65-7f44052b50f2">8.3</ix:nonFraction> million.</span></div></ix:continuation><div><span><br/></span></div><div id="if3f80771944f4fc58015abda42dc47d1_79"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 3 - <ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83OS9mcmFnOjZjZTNiOGNjYjhmMTQ4Mjg4NWRlNTk1NzdlYTFlOTQ1L3RleHRyZWdpb246NmNlM2I4Y2NiOGYxNDgyODg1ZGU1OTU3N2VhMWU5NDVfNDAzNA_236ad15b-7c46-4030-80f2-1415514a8bd1" continuedAt="id685db5878eb497494098852643e70fb" escape="true"><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83OS9mcmFnOjZjZTNiOGNjYjhmMTQ4Mjg4NWRlNTk1NzdlYTFlOTQ1L3RleHRyZWdpb246NmNlM2I4Y2NiOGYxNDgyODg1ZGU1OTU3N2VhMWU5NDVfNDAzNA_60742bc4-4128-4030-8a32-9ae25a6118ec" continuedAt="i8afca62dbb4d4f34a4008d71bbb835cc" escape="true">RECENT ACCOUNTING STANDARDS</ix:nonNumeric></ix:nonNumeric></span></div><ix:continuation id="id685db5878eb497494098852643e70fb" continuedAt="ida05a3a777694788b1984951e55b28a2"><ix:continuation id="i8afca62dbb4d4f34a4008d71bbb835cc" continuedAt="id290df98eea443848db86f1c5aa8be4b"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting standards adopted</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Over the course of 2020 through 2022, the FASB issued different Accounting Standards Updates (ASUs) in regards to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848).  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASU 2020-04 and ASU 2021-01 addressed optional expedients and exceptions for applying generally accepted accounting principals to certain contract modifications, hedging relationships, and derivatives that referenced London Inter-bank Offered Rate (LIBOR) or another reference rate expected to be discontinued.  The provisions originally were set to expire on December 31, 2022.  The date of LIBOR cessation was finalized as June 30, 2023, which is beyond the current sunset date of Topic 848 and hence the need to extend the time allotted for accounting relief. ASU 2022-06 deferred the sunset date of the provision out to December 31, 2024. The adoption of the provisions under these ASUs did not have a material effect on our consolidated financial statements.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, the FASB issued ASU 2021-10 ("ASU 2021-10"), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Assistance (Topic 832), Disclosures by Business Entities about Government Assistance.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASU 2021-10 requires entities to provide disclosures on material government assistance transactions for annual reporting periods. The disclosures include information around the nature of the assistance, the related accounting policies used to account for government assistance, the effect of government assistance on the entity&#8217;s financial statements, and any significant terms and conditions of the agreements, including commitments and contingencies. The new standard was effective for financial statements issued for annual reporting periods beginning after December 15, 2021. As ASU 2021-10 only impacts annual financial statement footnote disclosures, the adoption did not have a material effect on our consolidated financial statements.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the FASB issued ASU 2021-08 ("ASU 2021-08"), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations (Topic 805), Accounting for Contract Assets and Contract Liabilities from Contracts with Customers.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASU 2021-08 requires an acquirer in a business combination to recognize and measure contract assets and contract liabilities in accordance with Accounting Standards </span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ida05a3a777694788b1984951e55b28a2"><ix:continuation id="id290df98eea443848db86f1c5aa8be4b">Codification Topic 606. ASU 2021-08 is effective for fiscal years beginning after December 15, 2022 and early adoption is permitted. The adoption did not have a material effect on our consolidated financial statements.</ix:continuation></ix:continuation></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="if3f80771944f4fc58015abda42dc47d1_82"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 4 &#8211; <ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfNDk2OA_4553d01e-d7b6-4174-b2cc-16564d8d5d38" continuedAt="i0be3c73b5d5344bba3bf41b7f2a0bbea" escape="true">BUSINESS COMBINATIONS AND RELATED ACTIVITY</ix:nonNumeric></span></div><ix:continuation id="i0be3c73b5d5344bba3bf41b7f2a0bbea" continuedAt="ia2e6dea19caa45e5b6695327261c0e00"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Imaging Center Segment</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022 and 2021, we completed the acquisition of certain assets of the following entities, which either engage directly in the practice of radiology or associated businesses.  The primary reason for these acquisitions was to strengthen our presence in the Delaware, Maryland, New Jersey and New York markets.  <ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfNDk3MA_ccd3db48-4e04-416e-a2b2-970f568a1869" continuedAt="i3579ad51b3f34b84bd988c242c49c5f0" escape="true">We made a fair value determination of the acquired assets and assumed liabilities and the following were recorded (in thousands):</ix:nonNumeric></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:continuation id="i3579ad51b3f34b84bd988c242c49c5f0" continuedAt="ib448cb73ecb246e8b00482522e1d65f3"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">2022:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:12.734%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.478%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.922%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.975%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.170%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.934%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Entity </span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date Acquired</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Purchase  Consideration</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property &amp; Equipment</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Assets</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible Assets</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IFRC LLC*&#94;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/1/2022</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04323c12bfcc46fca5f3765bc9b181de_I20220101" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfMS0yLTEtMS03NDU5MA_7ab1eee5-fb40-4e85-a19d-e394c8d30dd7">8,200</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04323c12bfcc46fca5f3765bc9b181de_I20220101" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfMS0zLTEtMS03NDU5MA_e10373b0-c3be-4238-9f1c-75463627f56d">2,910</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04323c12bfcc46fca5f3765bc9b181de_I20220101" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfMS00LTEtMS03NDU5MA_d76d255c-9b3a-4537-bfa4-888debb57ac6">1,703</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04323c12bfcc46fca5f3765bc9b181de_I20220101" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfMS01LTEtMS03NDU5MA_e15a6dc7-fc69-49cc-ab09-baf3db29ba0f">5,271</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04323c12bfcc46fca5f3765bc9b181de_I20220101" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfMS02LTEtMS03NDU5MA_b792dc48-0b47-4834-9b23-f686fcade227">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04323c12bfcc46fca5f3765bc9b181de_I20220101" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfMS03LTEtMS03NDU5MA_9af017ce-519b-43c8-bf8d-3c7aa37744f0">19</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04323c12bfcc46fca5f3765bc9b181de_I20220101" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfMS04LTEtMS03NDU5MA_8c7f657f-51b5-4608-9daf-1d0e9d24ccbe">1,703</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IFRC LLC*&#94;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/1/2022</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45f00f44ca7b4343afb1b0392c335273_I20220101" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfMi0yLTEtMS03NDU5OA_6b0960f9-c850-4036-970e-8f5859f8907c">4,800</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45f00f44ca7b4343afb1b0392c335273_I20220101" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfMi0zLTEtMS03NDU5OA_4ef211bc-390e-419e-84fc-3d5043717611">2,103</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45f00f44ca7b4343afb1b0392c335273_I20220101" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfMi00LTEtMS03NDU5OA_7c576ff7-458f-4ffb-bf70-25a013917f78">857</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45f00f44ca7b4343afb1b0392c335273_I20220101" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfMi01LTEtMS03NDU5OA_3f8a385c-a306-44bf-9301-c761ca0ea60f">2,697</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45f00f44ca7b4343afb1b0392c335273_I20220101" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfMi02LTEtMS03NDU5OA_d12a308d-fd40-48a8-8b83-202dd4aa72db">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45f00f44ca7b4343afb1b0392c335273_I20220101" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfMi03LTEtMS03NDU5OA_b5400b8d-f287-4f8b-9394-42cbab7ec3b1">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i45f00f44ca7b4343afb1b0392c335273_I20220101" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfMi04LTEtMS03NDU5OA_3391c265-5e70-42aa-9dfd-5e7fb2f8281a">857</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Montclair Radiological Associates, P.A.*#</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10/1/2022</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e2bd41f61084dc99c6046940c937f26_I20221001" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfMy0yLTEtMS03NDYwNg_d71cd718-196f-4130-9451-312b4d4fe646">94,877</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e2bd41f61084dc99c6046940c937f26_I20221001" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfMy0zLTEtMS03NDYwNg_e3cc2745-4d9b-4c5c-b1b4-81a5226d3630">16,414</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e2bd41f61084dc99c6046940c937f26_I20221001" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfMy00LTEtMS03NDYwNg_db687c44-7160-4c95-a5af-c8662941a296">4,665</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e2bd41f61084dc99c6046940c937f26_I20221001" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfMy01LTEtMS03NDYwNg_650020ef-f0ba-4c50-b45d-5d1901e8869e">79,690</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e2bd41f61084dc99c6046940c937f26_I20221001" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfMy02LTEtMS03NDYwNg_90540568-5f28-4ad3-b2ff-af658269b0a1">400</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9e2bd41f61084dc99c6046940c937f26_I20221001" decimals="-3" sign="-" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfMy03LTEtMS03NDYwNg_8421487b-0254-4b1a-a168-85f88602441c">2,168</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9e2bd41f61084dc99c6046940c937f26_I20221001" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfMy04LTEtMS03NDYwNg_125c49d0-129b-45b2-ae2c-e5f4d1d016c6">4,124</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Heart and Lung Imaging Limited+</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/1/2022</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i315f9ce8303d42fbb74147d9754e4496_I20221101" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfNC0yLTEtMS03OTIwMg_d23b8455-8ad6-425b-9b56-a8097afd3f31">32,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i315f9ce8303d42fbb74147d9754e4496_I20221101" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfNC0zLTEtMS03OTIwMg_90452e2c-acdc-4cc5-89a1-e03a2796a015">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i315f9ce8303d42fbb74147d9754e4496_I20221101" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfNC00LTEtMS03OTIwMg_854d0fc7-3ae4-4168-9ecf-e0be6e43ff0b">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i315f9ce8303d42fbb74147d9754e4496_I20221101" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfNC01LTEtMS03OTIwMg_039e2ef3-0168-4ae6-992b-a2689bfbe262">16,200</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i315f9ce8303d42fbb74147d9754e4496_I20221101" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfNC02LTEtMS03OTIwMg_f1a56a93-9f78-447a-aad9-8f41f166035d">15,800</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i315f9ce8303d42fbb74147d9754e4496_I20221101" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfNC03LTEtMS03OTIwMg_8147235b-2743-4919-b0cd-1225890a0b07">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i315f9ce8303d42fbb74147d9754e4496_I20221101" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfNC04LTEtMS03OTIwMg_6c559959-3c61-4b1a-bbc3-cae8fc162933">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chelsea Diagnostic Radiology, P.C.*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/1/2022</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29413aeb2a174d91ba07be32e53f164d_I20221201" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfNC0yLTEtMS03NDYxNA_c3d29a9f-0aa0-449c-ba22-41b136a14666">2,800</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29413aeb2a174d91ba07be32e53f164d_I20221201" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfNC0zLTEtMS03NDYxNA_507f23c7-2bad-4126-97ca-15598c49281d">568</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29413aeb2a174d91ba07be32e53f164d_I20221201" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfNC00LTEtMS03NDYxNA_9ce22718-37df-4b34-906c-64c13863f99b">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29413aeb2a174d91ba07be32e53f164d_I20221201" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfNC01LTEtMS03NDYxNA_5101c9ea-d328-442b-a077-1bac5cd926d9">2,132</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29413aeb2a174d91ba07be32e53f164d_I20221201" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfNC02LTEtMS03NDYxNA_9fac63e3-1fd4-4443-9e8f-89b3b27fff7e">100</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29413aeb2a174d91ba07be32e53f164d_I20221201" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfNC03LTEtMS03NDYxNA_6922be16-8f96-4801-878c-073b1e6e9af3">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29413aeb2a174d91ba07be32e53f164d_I20221201" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfNC04LTEtMS03NDYxNA_f7939189-0910-43ec-8383-377dc3c2a1ff">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North Jersey Imaging Center, LLC*</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/9/2022</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c31a5dab37e45d28652fdb0fa620376_I20221209" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfMS0yLTEtMS02Mjg0Nw_327f323c-1bec-4fcb-95a4-0c587baa5ec2">104</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c31a5dab37e45d28652fdb0fa620376_I20221209" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfMS0zLTEtMS02Mjg0Nw_1505aa4f-fc5f-4b2e-86e9-02bbea1e0fb3">20</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c31a5dab37e45d28652fdb0fa620376_I20221209" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfMS00LTEtMS02Mjg0Nw_eac30a4e-d7a5-4af3-9023-ccb32bc154df">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c31a5dab37e45d28652fdb0fa620376_I20221209" decimals="-3" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfMS01LTEtMS02Mjg0Nw_2c6f3c83-d01a-44ff-9bc4-dbcb746e9772">55</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c31a5dab37e45d28652fdb0fa620376_I20221209" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfMS02LTEtMS02Mjg0Nw_0180918d-7332-44b0-954e-1fde16529cf8">25</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c31a5dab37e45d28652fdb0fa620376_I20221209" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfMS03LTEtMS02Mjg0Nw_28d67590-8320-42c5-8107-4c1db1d3b0c4">4</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c31a5dab37e45d28652fdb0fa620376_I20221209" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfMS04LTEtMS02Mjg0Nw_80c6fe19-1b45-4044-8d71-0c19c99ae11e">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i78a124f13cce4bf08e493835bf6a3457_I20221231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfNS0yLTEtMS02MDIyOQ_2a8751c0-c602-4f55-ac98-8c41e7183dd5">142,781</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i78a124f13cce4bf08e493835bf6a3457_I20221231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfNS0zLTEtMS02MDIyOQ_bc82e580-8229-4dbe-a1a7-d60c3674d18d">22,015</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i78a124f13cce4bf08e493835bf6a3457_I20221231" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfNS00LTEtMS02MDIyOQ_2c849461-2301-4d48-9297-4587e7a8b2fe">7,225</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i78a124f13cce4bf08e493835bf6a3457_I20221231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfNS01LTEtMS02MDIyOQ_51e31c0e-ed92-4e8a-a785-a1cf7e8cdf26">106,045</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i78a124f13cce4bf08e493835bf6a3457_I20221231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfNS02LTEtMS02MDIyOQ_0c0b7828-29bd-4603-bde5-46ac5c2f0992">16,325</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$(<ix:nonFraction unitRef="usd" contextRef="i78a124f13cce4bf08e493835bf6a3457_I20221231" decimals="-3" sign="-" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfNS03LTEtMS02MDIyOQ_6ee3b4f2-0701-466c-be12-e589d7b8dfe6">2,145</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$(<ix:nonFraction unitRef="usd" contextRef="i78a124f13cce4bf08e493835bf6a3457_I20221231" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfNS04LTEtMS02MDIyOQ_38398696-a77b-4c2f-ba1e-0d7a0510fb74">6,684</ix:nonFraction>)</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*Fair Value Determination is Final</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#94; IFRC LLC acquisitions consisted of <ix:nonFraction unitRef="loan" contextRef="ie8d992d40a6c4dd78532f351f5124719_I20221101" decimals="INF" name="rdnt:BusinessCombinationNumberOfSubsidiariesAcquired" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY1MjM4Nw_c330400e-3414-47a9-9618-36c9fdbe5a66">three</ix:nonFraction> subsidiaries of IFRC, <ix:nonFraction unitRef="loan" contextRef="ic4d32c5f421b43f999b15581ffd8c753_I20221101" decimals="INF" name="rdnt:BusinessCombinationNumberOfSubsidiariesAcquired" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMjc0ODc3OTEyNTAyMA_3a8aab58-74da-490e-90a6-8ff403c8af64">one</ix:nonFraction> of which was purchased separately by a joint venture with Calvert Medical Imaging Centers, LLC.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">#</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Montclair Radiological Associates includes a liability for $<ix:nonFraction unitRef="usd" contextRef="i9e2bd41f61084dc99c6046940c937f26_I20221001" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY1MjcwNQ_d442fbf0-64bf-4737-aedd-f50681f16747">1.2</ix:nonFraction> million in contingent consideration.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">+See detailed description of the Heart and Lung Imaging Limited acquisition below. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">2021:</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ia2e6dea19caa45e5b6695327261c0e00" continuedAt="id84cc0c683e04cef8b55bab3f6cadc58"><ix:continuation id="ib448cb73ecb246e8b00482522e1d65f3"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:15.128%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Entity </span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date Acquired</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Purchase  Consideration</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property &amp; Equipment</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Assets</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible Assets</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personal Health Imaging PLLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/1/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i892eb956660d4426a7b9ce4343939007_I20210201" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMS0yLTEtMS0yOTQ4OQ_f6731087-3744-4d63-a077-d0fc1c47dd71">2,995</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i892eb956660d4426a7b9ce4343939007_I20210201" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMS0zLTEtMS0yOTQ4OQ_0b11558e-0542-45b4-b76d-cbb0666d52e9">576</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i892eb956660d4426a7b9ce4343939007_I20210201" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMS00LTEtMS0yOTQ4OQ_f4cb27bf-c6d7-4852-8fa0-a39dac8f3241">608</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i892eb956660d4426a7b9ce4343939007_I20210201" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMS01LTEtMS0yOTQ4OQ_954668ac-1bb0-4c51-bf1e-2ab71dd963c8">2,355</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i892eb956660d4426a7b9ce4343939007_I20210201" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMS02LTEtMS0yOTQ4OQ_435524a7-bd8f-468a-bea0-c4ff3b4d3f8f">50</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i892eb956660d4426a7b9ce4343939007_I20210201" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMS03LTEtMS0yOTQ4OQ_f99f5110-9571-4cf5-b091-4a6e9b510b4a">14</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i892eb956660d4426a7b9ce4343939007_I20210201" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMS04LTEtMS0yOTQ4OQ_661040a6-dea4-4cc4-99a3-a7fc2c1eea02">608</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP Elmont LLC*</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/1/2021</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8d26a04836f440696fff1b778498ee4_I20210201" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMi0yLTEtMS0yOTQ4OQ_40a0c42b-158b-4c1c-ba60-6152a188ac39">2,194</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8d26a04836f440696fff1b778498ee4_I20210201" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMi0zLTEtMS0yOTQ4OQ_6542b1cb-8f43-4910-afdc-0544ec99ff0d">1,112</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8d26a04836f440696fff1b778498ee4_I20210201" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMi00LTEtMS0yOTQ4OQ_93d348b5-41c4-458c-b299-67097fe5b85e">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8d26a04836f440696fff1b778498ee4_I20210201" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMi01LTEtMS0yOTQ4OQ_c6b65f0f-f54e-4f55-bba6-309f433658f0">1,005</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8d26a04836f440696fff1b778498ee4_I20210201" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMi02LTEtMS0yOTQ4OQ_5c7e2411-ba00-40bd-af41-01364b8cc2ff">50</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8d26a04836f440696fff1b778498ee4_I20210201" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMi03LTEtMS0yOTQ4OQ_0becf64f-307d-44b2-a8d3-290fd23f02a0">27</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8d26a04836f440696fff1b778498ee4_I20210201" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMi04LTEtMS0yOTQ4OQ_120dac3e-7080-4248-8873-3b95b19039eb">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP Freeport LLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/1/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03820b19954941189242f879d3d1aa9b_I20210201" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMy0yLTEtMS0yOTQ4OQ_f32bb3e9-decc-4817-8aa3-99e9c515b92f">6,065</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03820b19954941189242f879d3d1aa9b_I20210201" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMy0zLTEtMS0yOTQ4OQ_2b85d9cf-7800-4849-acf1-b79eddc3cd64">4,668</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03820b19954941189242f879d3d1aa9b_I20210201" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMy00LTEtMS0yOTQ4OQ_dd9b3969-2735-4533-9ca3-b1525d77480b">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03820b19954941189242f879d3d1aa9b_I20210201" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMy01LTEtMS0yOTQ4OQ_7dcd3739-4f55-4915-bd3d-c9555d7f85b9">1,328</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03820b19954941189242f879d3d1aa9b_I20210201" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMy02LTEtMS0yOTQ4OQ_6eea7d2d-b9b1-4418-bbb3-c175b8ba5144">40</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03820b19954941189242f879d3d1aa9b_I20210201" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMy03LTEtMS0yOTQ4OQ_b9a07c37-3b6c-44e7-9f88-b8ef534e1b04">29</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03820b19954941189242f879d3d1aa9b_I20210201" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMy04LTEtMS0yOTQ4OQ_5e7db57b-e711-4a7d-98a2-4f1704aacb17">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Broadway Medical Imaging LLC*</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/1/2021</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0ea208abb7a45c18b6150540a583cc3_I20210201" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfNC0yLTEtMS0yOTQ4OQ_a259845b-d71b-45d5-b7c5-c9db278e675b">1,155</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0ea208abb7a45c18b6150540a583cc3_I20210201" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfNC0zLTEtMS0yOTQ4OQ_550b87b4-6959-4722-a26f-947fa786380c">1,076</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0ea208abb7a45c18b6150540a583cc3_I20210201" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfNC00LTEtMS0yOTQ4OQ_56cd47f3-f21f-4ced-aab4-b2b34b40aa76">446</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0ea208abb7a45c18b6150540a583cc3_I20210201" decimals="-3" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfNC01LTEtMS0yOTQ4OQ_1fee6a23-c32e-413f-8ead-e2decf24aa63">6</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0ea208abb7a45c18b6150540a583cc3_I20210201" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfNC02LTEtMS0yOTQ4OQ_17c88afc-0f15-455b-915d-bdd38ffd9bb8">50</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0ea208abb7a45c18b6150540a583cc3_I20210201" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfNC03LTEtMS0yOTQ4OQ_5b5d0ba9-a2c9-4f3a-8a2b-259f785c9b5c">23</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia0ea208abb7a45c18b6150540a583cc3_I20210201" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfNC04LTEtMS0yOTQ4OQ_ce49d221-f5d1-4deb-8934-270ae3c76809">446</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3235 Hempstead LLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/1/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35c9649190e94adda0f107310a8a289e_I20210201" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfNS0yLTEtMS0yOTQ4OQ_b0870908-18bd-4e5b-aace-3bd82a365c0a">9,386</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35c9649190e94adda0f107310a8a289e_I20210201" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfNS0zLTEtMS0yOTQ4OQ_825750d9-f076-44ed-a7b1-90dedbcbeaef">5,667</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35c9649190e94adda0f107310a8a289e_I20210201" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfNS00LTEtMS0yOTQ4OQ_134463f2-56bb-4f34-b5e0-ec81bac7cc61">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35c9649190e94adda0f107310a8a289e_I20210201" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfNS01LTEtMS0yOTQ4OQ_25825027-12dc-4f31-9b53-bf177e9a48bc">3,649</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35c9649190e94adda0f107310a8a289e_I20210201" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfNS02LTEtMS0yOTQ4OQ_6ef6ca09-184c-4d18-bde7-1c0584e0e3e1">70</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35c9649190e94adda0f107310a8a289e_I20210201" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfNS03LTEtMS0yOTQ4OQ_9c505754-94d7-4e12-8920-6afe4a244c76">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35c9649190e94adda0f107310a8a289e_I20210201" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfNS04LTEtMS0yOTQ4OQ_1d0df79b-a933-4250-9f82-26afc1a1dcda">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SLZM Realty LLC*</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/1/2021</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab3ab4d55ef4b02aa47ad2b6dad4bc7_I20210201" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfNi0yLTEtMS0yOTQ4OQ_9dc67f73-8024-4d9c-820a-f32096f4f6a6">13,671</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab3ab4d55ef4b02aa47ad2b6dad4bc7_I20210201" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfNi0zLTEtMS0yOTQ4OQ_00ef53f5-1d51-48a7-9e54-5db1e0f3572b">4,617</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab3ab4d55ef4b02aa47ad2b6dad4bc7_I20210201" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfNi00LTEtMS0yOTQ4OQ_3c2908f0-f438-4074-8a12-7959a4fe1ce5">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab3ab4d55ef4b02aa47ad2b6dad4bc7_I20210201" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfNi01LTEtMS0yOTQ4OQ_600ef6b0-d23d-4df9-93b7-a9e079d1e01b">8,974</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab3ab4d55ef4b02aa47ad2b6dad4bc7_I20210201" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfNi02LTEtMS0yOTQ4OQ_5780543d-af0f-4f9a-94f7-ee1ce97144cb">80</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab3ab4d55ef4b02aa47ad2b6dad4bc7_I20210201" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfNi03LTEtMS0yOTQ4OQ_8a3da106-6025-48a9-82cd-a6cf720904ab">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab3ab4d55ef4b02aa47ad2b6dad4bc7_I20210201" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfNi04LTEtMS0yOTQ4OQ_de14df60-7894-47cd-8153-2b8c11b3a3a7">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2012 Sunrise Merrick LLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/1/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i579ab9cf65534af294a6f7e07668dd6a_I20210201" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfNy0yLTEtMS0yOTQ4OQ_c2ac48d2-4b40-471a-86fd-9ab003e5e2e5">11,428</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i579ab9cf65534af294a6f7e07668dd6a_I20210201" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfNy0zLTEtMS0yOTQ4OQ_e44326b9-7ce6-4068-8005-350aada63d82">2,741</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i579ab9cf65534af294a6f7e07668dd6a_I20210201" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfNy00LTEtMS0yOTQ4OQ_309e9018-9ed9-4c5f-b03a-50688a6aa38c">335</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i579ab9cf65534af294a6f7e07668dd6a_I20210201" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfNy01LTEtMS0yOTQ4OQ_3da239e0-ac17-491b-b8ca-c540c8fdb524">8,617</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i579ab9cf65534af294a6f7e07668dd6a_I20210201" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfNy02LTEtMS0yOTQ4OQ_aff022b2-5b9c-4f19-9b04-a840b110df3d">70</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i579ab9cf65534af294a6f7e07668dd6a_I20210201" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfNy03LTEtMS0yOTQ4OQ_ea43e6c9-5728-4cc5-bf47-b4e57e250a8c">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i579ab9cf65534af294a6f7e07668dd6a_I20210201" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfNy04LTEtMS0yOTQ4OQ_2a72f09f-274a-457c-965f-8f8d9f958645">335</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP Bayside LLC*</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/1/2021</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5f5572dd74743ab9a87be7f25a33b9f_I20210301" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfOC0yLTEtMS0yOTQ4OQ_15645fca-fefc-4d05-94b0-ff53d4049681">3,545</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5f5572dd74743ab9a87be7f25a33b9f_I20210301" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfOC0zLTEtMS0yOTQ4OQ_9cb0b5ac-9694-454a-a930-cd8138ec431c">3,385</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5f5572dd74743ab9a87be7f25a33b9f_I20210301" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfOC00LTEtMS0yOTQ4OQ_74da3f3a-65f8-4783-9ce5-fd37c8b8332d">2,191</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5f5572dd74743ab9a87be7f25a33b9f_I20210301" decimals="-3" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfOC01LTEtMS0yOTQ4OQ_603fe2a1-97ce-4749-b52f-d9db06259e9c">40</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5f5572dd74743ab9a87be7f25a33b9f_I20210301" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfOC02LTEtMS0yOTQ4OQ_c8129246-b468-4040-835f-2b3f0073cb9a">50</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5f5572dd74743ab9a87be7f25a33b9f_I20210301" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfOC03LTEtMS0yOTQ4OQ_48953abd-9228-4ed0-8dca-e910e9b5448a">70</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5f5572dd74743ab9a87be7f25a33b9f_I20210301" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfOC04LTEtMS0yOTQ4OQ_96dc8019-e5e2-4486-9de0-64dc2bee4e36">2,191</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP Laurelton LLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/1/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i902807f4b9a9416c9b47104b5ad819a0_I20210301" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfOS0yLTEtMS0yOTQ4OQ_778066e6-323a-4e9f-aae9-da4b7d899f45">2,658</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i902807f4b9a9416c9b47104b5ad819a0_I20210301" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfOS0zLTEtMS0yOTQ4OQ_0bef6201-8588-4e03-a010-78612c77b3f9">2,530</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i902807f4b9a9416c9b47104b5ad819a0_I20210301" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfOS00LTEtMS0yOTQ4OQ_a5f8eaa3-4ceb-408f-b912-685589e18a59">1,418</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i902807f4b9a9416c9b47104b5ad819a0_I20210301" decimals="-3" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfOS01LTEtMS0yOTQ4OQ_9699ff03-5aad-4686-a0f8-d1b21afb2c42">32</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i902807f4b9a9416c9b47104b5ad819a0_I20210301" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfOS02LTEtMS0yOTQ4OQ_c2b46bdb-6857-4863-97cd-4d954ec488a3">50</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i902807f4b9a9416c9b47104b5ad819a0_I20210301" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfOS03LTEtMS0yOTQ4OQ_e754cac5-da08-4a68-b82c-221948a30bc4">46</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i902807f4b9a9416c9b47104b5ad819a0_I20210301" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfOS04LTEtMS0yOTQ4OQ_c9008686-7f06-43da-94bc-98dffa2d7682">1,418</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP Smith LLC*</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/1/2021</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc21e27c33b04e1daa07fac76223e671_I20210301" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTAtMi0xLTEtMjk0ODk_209fa9a2-7780-4816-b778-435ffae3f6a7">3,978</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc21e27c33b04e1daa07fac76223e671_I20210301" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTAtMy0xLTEtMjk0ODk_22c242b2-07d6-40f6-89cf-2dbe485a17b8">3,581</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc21e27c33b04e1daa07fac76223e671_I20210301" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTAtNC0xLTEtMjk0ODk_ee7f41ed-004f-4d64-be1a-f40ff5f9cd36">2,214</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc21e27c33b04e1daa07fac76223e671_I20210301" decimals="-3" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTAtNS0xLTEtMjk0ODk_1dc6d136-6f06-450b-9203-30cb9481b8d1">347</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc21e27c33b04e1daa07fac76223e671_I20210301" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTAtNi0xLTEtMjk0ODk_f0afc138-df45-4c9c-bb01-b33c496bd226">50</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc21e27c33b04e1daa07fac76223e671_I20210301" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTAtNy0xLTEtMjk0ODk_e4e10256-cc79-419c-890b-60c7ebc3b336">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifc21e27c33b04e1daa07fac76223e671_I20210301" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTAtOC0xLTEtMjk0ODk_e72be863-1fdc-4c07-ab35-6cc5c6a1c4a7">2,214</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP 907 Northern LLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4/1/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc6548d74e7444118bd3d64d387c8399_I20210401" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTEtMi0xLTEtMjk0ODk_b4a28389-ae58-4ba9-9cfd-063d6a05dcc4">562</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc6548d74e7444118bd3d64d387c8399_I20210401" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTEtMy0xLTEtMjk0ODk_457d1741-92ed-40f0-a817-736a15404a25">507</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc6548d74e7444118bd3d64d387c8399_I20210401" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTEtNC0xLTEtMjk0ODk_d9323fc4-b5dd-4b33-89a8-c424b58a8bdc">1,817</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc6548d74e7444118bd3d64d387c8399_I20210401" decimals="-3" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTEtNS0xLTEtMjk0ODk_df65bbad-ed57-49ed-a93b-f50692edeed5">5</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc6548d74e7444118bd3d64d387c8399_I20210401" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTEtNi0xLTEtMjk0ODk_51656c5c-565b-46e8-b0ec-4098c96a825f">50</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc6548d74e7444118bd3d64d387c8399_I20210401" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTEtNy0xLTEtMjk0ODk_a4b857cb-1851-4bda-b242-f6251cda1ce5">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibc6548d74e7444118bd3d64d387c8399_I20210401" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTEtOC0xLTEtMjk0ODk_0f70224b-c6c5-4c33-99bc-1145c1620351">1,817</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">William M. Kelly MD, Inc.* &#94;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5/1/2021</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8ef5a13ccba4f0081c5203b3d794eca_I20210501" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTItMi0xLTEtMjk0ODk_01d7068e-d29b-4f53-bb01-7041587e3805">3,750</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8ef5a13ccba4f0081c5203b3d794eca_I20210501" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTItMy0xLTEtMjk0ODk_62f53f8d-31fc-4ea6-9ed6-749968717c19">990</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8ef5a13ccba4f0081c5203b3d794eca_I20210501" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTItNC0xLTEtMjk0ODk_866e6009-80ae-4c33-822b-8d8c98173820">1,379</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8ef5a13ccba4f0081c5203b3d794eca_I20210501" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTItNS0xLTEtMjk0ODk_12a74292-5b83-4975-8f75-180bc838105a">2,710</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8ef5a13ccba4f0081c5203b3d794eca_I20210501" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTItNi0xLTEtMjk0ODk_68c117e6-1ee8-4dc8-8465-01300538ae2a">50</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8ef5a13ccba4f0081c5203b3d794eca_I20210501" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTItNy0xLTEtMjk0ODk_b72f922d-64cf-4652-baf7-bb3dde5e1a94">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib8ef5a13ccba4f0081c5203b3d794eca_I20210501" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTItOC0xLTEtMjk0ODk_ff12b6ec-b5c9-4465-8862-6e98bbb2fd6e">1,379</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60th Street MRI, LLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5/1/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iace4174421504d128d1891aedd6863a3_I20210501" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTMtMi0xLTEtMjk0ODk_7c9a9c74-c823-4588-b5ce-ac65f61af026">400</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iace4174421504d128d1891aedd6863a3_I20210501" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTMtMy0xLTEtMjk0ODk_6f3a0cd4-5436-47b1-b8a4-94d895c7d0bf">85</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iace4174421504d128d1891aedd6863a3_I20210501" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTMtNC0xLTEtMjk0ODk_fd286cab-b5a7-4289-b772-8b5689452304">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iace4174421504d128d1891aedd6863a3_I20210501" decimals="-3" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTMtNS0xLTEtMjk0ODk_172fdde8-04cb-4531-a8a8-2430802eed50">290</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iace4174421504d128d1891aedd6863a3_I20210501" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTMtNi0xLTEtMjk0ODk_7e282a9c-9045-4af9-8f25-2f71514de24a">25</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iace4174421504d128d1891aedd6863a3_I20210501" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTMtNy0xLTEtMjk0ODk_a5467900-00b7-48ca-b3d0-185df906e595">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iace4174421504d128d1891aedd6863a3_I20210501" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTMtOC0xLTEtMjk0ODk_548a1522-57f2-4ffc-b402-65bf7013c627">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP Parkchester LLC*</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5/1/2021</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaaf8fe80680b48ab82ec3deb6b41a4af_I20210501" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTQtMi0xLTEtMjk0ODk_dbcf5030-b486-4b49-bce3-d14d30b5fa78">263</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaaf8fe80680b48ab82ec3deb6b41a4af_I20210501" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTQtMy0xLTEtMjk0ODk_a66f1dd1-d3fe-4393-a377-f8ae5684f141">213</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaaf8fe80680b48ab82ec3deb6b41a4af_I20210501" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTQtNC0xLTEtMjk0ODk_134b52aa-f04a-446c-9c1b-9f3f3ecdf1c6">311</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaaf8fe80680b48ab82ec3deb6b41a4af_I20210501" decimals="-3" name="us-gaap:Goodwill" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTQtNS0xLTEtMjk0ODk_0f64d673-239b-489c-a0fa-dc5a449da113">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaaf8fe80680b48ab82ec3deb6b41a4af_I20210501" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTQtNi0xLTEtMjk0ODk_c7c08a1d-995a-47e0-962f-63477622e23b">50</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaaf8fe80680b48ab82ec3deb6b41a4af_I20210501" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTQtNy0xLTEtMjk0ODk_b473a34e-1752-48cc-bfb8-82de360688c4">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaaf8fe80680b48ab82ec3deb6b41a4af_I20210501" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTQtOC0xLTEtMjk0ODk_7ca94bbc-1be4-42ef-867e-ab7f651587a5">311</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP Eastern LLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6/1/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a182964d2994db6afa278022e5ec78c_I20210601" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTUtMi0xLTEtMjk0ODk_d8e54bc4-7f15-4bc0-84f0-628bb4cb3b5d">2,868</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a182964d2994db6afa278022e5ec78c_I20210601" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTUtMy0xLTEtMjk0ODk_ceefe9f0-e9c0-491f-9101-ec85854cb852">2,801</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a182964d2994db6afa278022e5ec78c_I20210601" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTUtNC0xLTEtMjk0ODk_d240d631-6151-4501-8a09-4d436e646f01">1,951</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a182964d2994db6afa278022e5ec78c_I20210601" decimals="-3" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTUtNS0xLTEtMjk0ODk_046a97e9-dd29-4474-a72d-b4dd106041aa">17</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a182964d2994db6afa278022e5ec78c_I20210601" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTUtNi0xLTEtMjk0ODk_7adb44eb-dd69-4edd-a454-2cf15ac6c336">50</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a182964d2994db6afa278022e5ec78c_I20210601" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTUtNy0xLTEtMjk0ODk_64e26fc9-aeb0-401e-bb0a-2c6fe95c8f27">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a182964d2994db6afa278022e5ec78c_I20210601" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTUtOC0xLTEtMjk0ODk_63a7a73b-8a62-4590-8e6b-a396c0218d05">1,951</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tangent Associates LLC**</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/24/2021</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22bc4ace41264830b19ecc0fff6de4f9_I20210824" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTYtMi0xLTEtMjk0ODk_11a86418-4efc-4d12-8108-de1bc02853e9">2,025</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22bc4ace41264830b19ecc0fff6de4f9_I20210824" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTYtMy0xLTEtMjk0ODk_58ec83c9-a85f-4fa8-b537-f0997926bc92">10</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22bc4ace41264830b19ecc0fff6de4f9_I20210824" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTYtNC0xLTEtMjk0ODk_ae273998-8dbe-4d39-878f-500866911a09">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22bc4ace41264830b19ecc0fff6de4f9_I20210824" decimals="-3" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTYtNS0xLTEtMjk0ODk_f905f38a-fb5d-41e0-b76a-0de9ab1764f5">379</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22bc4ace41264830b19ecc0fff6de4f9_I20210824" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTYtNi0xLTEtMjk0ODk_64a74a89-e123-4fc1-885b-a97b0e636ee8">1,636</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22bc4ace41264830b19ecc0fff6de4f9_I20210824" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTYtNy0xLTEtMjk0ODk_3077c06b-fda8-40f7-bd15-4e7771448419">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22bc4ace41264830b19ecc0fff6de4f9_I20210824" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTYtOC0xLTEtMjk0ODk_53b6a664-c953-47d5-933c-02f4947974ee">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mid Delaware Imaging P.A.</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/1/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7aacc9fd1cc4c3e8c39d3650be587c0_I20211201" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTctMi0xLTEtMjk0ODk_8384a329-a925-47c1-b9d0-a382d727eea3">6,023</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7aacc9fd1cc4c3e8c39d3650be587c0_I20211201" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTctMy0xLTEtMjk0ODk_6354f776-a8b6-4211-874d-3323fb50519e">590</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7aacc9fd1cc4c3e8c39d3650be587c0_I20211201" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTctNC0xLTEtMjk0ODk_5e6e2ab3-8efd-4795-aebe-e9092bf6aa50">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7aacc9fd1cc4c3e8c39d3650be587c0_I20211201" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTctNS0xLTEtMjk0ODk_2b31b2fb-b94e-432d-920b-30175c25267c">5,260</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7aacc9fd1cc4c3e8c39d3650be587c0_I20211201" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTctNi0xLTEtMjk0ODk_1b5a67c3-d2c2-4f69-a9b9-f2a15e9d9272">150</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7aacc9fd1cc4c3e8c39d3650be587c0_I20211201" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTctNy0xLTEtMjk0ODk_3e536522-acd4-4db1-913f-05e826904b06">23</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7aacc9fd1cc4c3e8c39d3650be587c0_I20211201" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTctOC0xLTEtMjk0ODk_7349180a-f300-4913-9ef2-0dbac4eda4ec">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">William M. Kelly MD, Inc.* &#94;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/6/2021</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i759bb752ba514fd0a9e92dbd00a4ba03_I20211206" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTgtMi0xLTEtMjk0ODk_819b9d64-9025-43bf-ac12-f0d0ef13d671">4,404</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i759bb752ba514fd0a9e92dbd00a4ba03_I20211206" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTgtMy0xLTEtMjk0ODk_153315c1-386f-4707-8382-2cef1b40d8f2">701</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i759bb752ba514fd0a9e92dbd00a4ba03_I20211206" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTgtNC0xLTEtMjk0ODk_84fc80a8-dbe0-461d-a0a9-f985699a5e95">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i759bb752ba514fd0a9e92dbd00a4ba03_I20211206" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTgtNS0xLTEtMjk0ODk_cb3db720-eb9c-4d5e-b911-62433ee07932">3,653</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i759bb752ba514fd0a9e92dbd00a4ba03_I20211206" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTgtNi0xLTEtMjk0ODk_cf75625b-94d1-4d8a-95e1-f8ccb7fa8dfe">50</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i759bb752ba514fd0a9e92dbd00a4ba03_I20211206" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTgtNy0xLTEtMjk0ODk_0092262a-d67a-4f2c-8b61-08f84321fb47">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i759bb752ba514fd0a9e92dbd00a4ba03_I20211206" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTgtOC0xLTEtMjk0ODk_886554fe-1cef-45c6-995b-75898a7e8133">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">William M. Kelly MD, Inc.* &#94;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/31/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff8ceedaa8534baf9af84ee6fdb44f29_I20211231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTktMi0xLTEtMjk0ODk_fa20b021-557e-484e-87d2-856e80334aea">2,346</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff8ceedaa8534baf9af84ee6fdb44f29_I20211231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTktMy0xLTEtMjk0ODk_d7eb0d8b-e5f3-422d-a2b4-4951a545cf82">99</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff8ceedaa8534baf9af84ee6fdb44f29_I20211231" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTktNC0xLTEtMjk0ODk_6ceb1136-8798-40e5-a76d-2377490f93ff">323</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff8ceedaa8534baf9af84ee6fdb44f29_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTktNS0xLTEtMjk0ODk_19b28c12-abb2-4096-bd2e-f360a4e59e0e">2,197</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff8ceedaa8534baf9af84ee6fdb44f29_I20211231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTktNi0xLTEtMjk0ODk_30d38be0-fd61-43fa-b8df-2d869dbef120">50</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff8ceedaa8534baf9af84ee6fdb44f29_I20211231" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTktNy0xLTEtMjk0ODk_a668a3f3-5e6c-4322-8492-b9ef97621e65">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff8ceedaa8534baf9af84ee6fdb44f29_I20211231" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTktOC0xLTEtMjk0ODk_a41865d4-7426-4df5-9244-20754c14b4c4">323</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ibb914ba8860c4d42942ab37aebd6805d_I20211231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMjAtMi0xLTEtMjk0ODk_a786d1ce-5e7a-4604-912f-bac954a3858c">79,716</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ibb914ba8860c4d42942ab37aebd6805d_I20211231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMjAtMy0xLTEtMjk0ODk_10807c14-c4ab-434f-b785-e422dae8ea4a">35,949</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ibb914ba8860c4d42942ab37aebd6805d_I20211231" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMjAtNC0xLTEtMjk0ODk_bc7bab56-c82b-4ef4-b19b-89a1f288605e">12,993</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ibb914ba8860c4d42942ab37aebd6805d_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMjAtNS0xLTEtMjk0ODk_6d1107f7-3b52-49e5-9258-80034c149b7d">40,864</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ibb914ba8860c4d42942ab37aebd6805d_I20211231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMjAtNi0xLTEtMjk0ODk_91df56e0-58cb-4284-93be-3ea0964965fe">2,671</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ibb914ba8860c4d42942ab37aebd6805d_I20211231" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMjAtNy0xLTEtMjk0ODk_2349084f-1319-4d7f-861e-f7f195cc4d68">232</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$(<ix:nonFraction unitRef="usd" contextRef="ibb914ba8860c4d42942ab37aebd6805d_I20211231" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMjAtOC0xLTEtMjk0ODk_287b9b09-034f-4e8e-8e9e-b56c30170c12">12,993</ix:nonFraction>)</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*Fair Value Determination is Final</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">** All stock purchase through issuing <ix:nonFraction unitRef="shares" contextRef="i12d9fd3f8cce41bd8567698b43e666dd_D20210824-20210824" decimals="-3" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfNjc2_be04497d-f17c-4368-bfb2-37638d3dde59">67,658</ix:nonFraction> shares of our common stock.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#94; William M. Kelly MD acquisitions consisted of various subsidiaries purchased separately.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Heart and Lung Imaging Limited</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On November 1, 2022, we acquired a <ix:nonFraction unitRef="number" contextRef="i315f9ce8303d42fbb74147d9754e4496_I20221101" decimals="2" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY1NTEzNw_97b096e0-cc64-4749-8652-c46fa3ddfeb6">75</ix:nonFraction>% controlling interest in Heart and Lung Imaging Limited (&#8220;HLI&#8221;).  HLI is a teleradiology concern which operates in the United Kingdom with the National Healthcare Service to screen high risk populations for cardiac and lung conditions.  HLI&#8217;s operations are included in our imaging center segment for reporting purposes. The transaction was accounted for as the acquisition of a business with a total purchase consideration of approximately $<ix:nonFraction unitRef="usd" contextRef="i350d6392e4a642769b8a9824e7855129_D20221101-20221101" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY1NTE1Mw_412ccc3e-eecb-4c0e-8ceb-bd1494b8a531">31.9</ix:nonFraction> million, including: i) shares with a fair value of $<ix:nonFraction unitRef="usd" contextRef="i350d6392e4a642769b8a9824e7855129_D20221101-20221101" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY1NTE3MQ_a41823d3-1d5e-49d7-b582-7db9c31215e5">6.8</ix:nonFraction> million (<ix:nonFraction unitRef="shares" contextRef="i350d6392e4a642769b8a9824e7855129_D20221101-20221101" decimals="INF" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY1NTE4MQ_cf27f190-edcf-4640-be90-9d9042eaf4d7">359,002</ix:nonFraction> shares issued at $<ix:nonFraction unitRef="usdPerShare" contextRef="i315f9ce8303d42fbb74147d9754e4496_I20221101" decimals="2" name="us-gaap:BusinessAcquisitionSharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY1NTE4OQ_54849221-0565-4336-8f88-9e88524a1269">19.06</ix:nonFraction> per share), ii) cash of $<ix:nonFraction unitRef="usd" contextRef="i350d6392e4a642769b8a9824e7855129_D20221101-20221101" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY1NTIwNQ_602c4cc8-beb9-413e-943c-2303e1dbec30">6.3</ix:nonFraction> million and iii) contingent consideration of $<ix:nonFraction unitRef="usd" contextRef="i315f9ce8303d42fbb74147d9754e4496_I20221101" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY2MzQ2Nw_54af6721-1f3c-4912-9dbb-628166e8fc30">10.8</ix:nonFraction> million ($<ix:nonFraction unitRef="usd" contextRef="iec83e5acff394eac92ff9ba28bb2e1ec_I20221101" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY1NTIzNw_c1873b3a-f808-4387-a77f-fadf7bad2143">10.2</ix:nonFraction> million in contingent milestone consideration and cash holdback of $<ix:nonFraction unitRef="usd" contextRef="if870a8803b5347588b2a78fdf3b1dabf_I20221101" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY1NTI1Mg_2739444f-6cbb-4c92-9f8e-b795c3927c6d">0.6</ix:nonFraction> million to be issued <ix:nonNumeric contextRef="i350d6392e4a642769b8a9824e7855129_D20221101-20221101" name="rdnt:BusinessCombinationContingentConsiderationLiabilityPeriod" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY1NjUzOQ_ce981d75-6722-4b77-bc6c-efa5202bae0a">24</ix:nonNumeric> months after acquisition subject to adjustment for any indemnification claims) and iv) noncontrolling interest of $<ix:nonFraction unitRef="usd" contextRef="i315f9ce8303d42fbb74147d9754e4496_I20221101" decimals="-5" name="us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY2MzU3MQ_1fceb202-4ef9-4d7c-abd1-c7f5cc877631">8.0</ix:nonFraction> million. We recorded $<ix:nonFraction unitRef="usd" contextRef="i315f9ce8303d42fbb74147d9754e4496_I20221101" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY1NTI2Nw_ad5ca104-ae82-406b-8d16-79b72d8ba439">0.6</ix:nonFraction> million in current assets, $<ix:nonFraction unitRef="usd" contextRef="i315f9ce8303d42fbb74147d9754e4496_I20221101" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY1NjUxMw_a64292aa-6007-4e25-813c-a4d6283e5a61">15.8</ix:nonFraction> million in intangible assets, $<ix:nonFraction unitRef="usd" contextRef="i315f9ce8303d42fbb74147d9754e4496_I20221101" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY1NTI4Mg_01005cbd-daf5-41a3-96ce-a8ef053e1517">0.6</ix:nonFraction> million current liabilities and $<ix:nonFraction unitRef="usd" contextRef="i315f9ce8303d42fbb74147d9754e4496_I20221101" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY1NTQzNA_f6bb8d9f-279f-49f1-a86f-ca216de69059">16.2</ix:nonFraction> million in goodwill in connection with this transaction.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As part of the purchase price allocation, we determined the identifiable intangible assets are customer relationships and trade names. The fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using a rate of <ix:nonFraction unitRef="number" contextRef="i95d5f4cf07934fb790f6972ad191259f_I20221101" decimals="3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY2NTEyOQ_8e30b8a2-cc99-47e2-bbce-3c2065d26b0e">19.0</ix:nonFraction>%. The cash flows were based on estimated earnings from existing customers, and the discount rate applied was benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="id84cc0c683e04cef8b55bab3f6cadc58" continuedAt="i25693f8e66e2483d806273af797f1168"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Artificial Intelligence Segment</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Aidence Holding B.V.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On January 20, 2022, we completed our acquisition of all the equity interests of Aidence Holding B.V. ("Aidence") an artificial intelligence enterprise focused on lung cancer screening.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Aidence is reported as part of our artificial intelligence segment and was acquired to enhance our AI capabilities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The transaction was accounted for as an acquisition of a business and total purchase consideration was determined to be approximately $<ix:nonFraction unitRef="usd" contextRef="i76afbed304204c709d14268fe2fc7759_D20220120-20220120" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY3Njg0OQ_e131e93d-7185-4bc0-8b77-4d15b20e9a39">45.2</ix:nonFraction>&#160;million including i) <ix:nonFraction unitRef="shares" contextRef="ia40099a2511a4e60a8a104b2b81cfad0_D20220120-20220120" decimals="INF" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY3Njg1Nw_f502538a-d281-4a67-a523-f1d8f7fe4f28">1,117,872</ix:nonFraction> shares issued at $<ix:nonFraction unitRef="usdPerShare" contextRef="ic8ce100f294545feaf01b49a483d7835_I20220120" decimals="2" name="us-gaap:BusinessAcquisitionSharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY3Njg2MQ_0cb1a2a1-952e-4cee-bcf9-dd774a7952d5">26.80</ix:nonFraction> per share with a fair value of $<ix:nonFraction unitRef="usd" contextRef="ia40099a2511a4e60a8a104b2b81cfad0_D20220120-20220120" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY3Njg2NQ_305f3861-e64a-4c60-bb2a-90ed0589d5ca">30.0</ix:nonFraction>&#160;million ii) cash of $<ix:nonFraction unitRef="usd" contextRef="i76afbed304204c709d14268fe2fc7759_D20220120-20220120" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY3Njg2OQ_1561222d-7dd1-4ba3-8494-f101d235abfd">1.8</ix:nonFraction>&#160;million and iii) contingent consideration of $<ix:nonFraction unitRef="usd" contextRef="iebda58f2b50646b69966fddb55d1e9eb_I20220120" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY3NjkwMQ_d7088ddf-531b-4221-9e05-5a3909112c31">11.9</ix:nonFraction>&#160;million ($<ix:nonFraction unitRef="usd" contextRef="ifb0178640b0547a4a348e983673f24ad_I20220120" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY3Njg3Nw_78f5b074-9a28-44df-8f9a-2cc900e9f83d">7.4</ix:nonFraction>&#160;million in milestones to be settled in shares or cash at our election and a share holdback of $<ix:nonFraction unitRef="usd" contextRef="i38534e3fc3794da0bea27b49adae6a77_I20220120" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY3Njg4NQ_8f8cf454-c920-4c1f-a322-b0828c2226d6">4.5</ix:nonFraction>&#160;million) and iv) a settlement of a loan from RadNet of $<ix:nonFraction unitRef="usd" contextRef="iebda58f2b50646b69966fddb55d1e9eb_I20220120" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY3Njg5Mw_c88b6f08-cd86-4dda-94fb-d0debc4610d3">1.5</ix:nonFraction>&#160;million.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In addition we paid certain seller closing costs through the issuance of <ix:nonFraction unitRef="shares" contextRef="if0842a81b02a40418df2e51489f2137e_D20220120-20220120" decimals="INF" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY3NjkyMQ_35e4812a-64b9-4877-8fba-6e03f8327e1c">23,362</ix:nonFraction> shares at a fair value of $<ix:nonFraction unitRef="usd" contextRef="if0842a81b02a40418df2e51489f2137e_D20220120-20220120" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY3NjkyNQ_14ab5bc7-52cd-482c-bf19-6124ba51468f">0.6</ix:nonFraction>&#160;million.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As a result of this transaction, we recorded $<ix:nonFraction unitRef="usd" contextRef="iebda58f2b50646b69966fddb55d1e9eb_I20220120" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY3NjkyOQ_eeaba242-ca16-4bb4-9802-2a3bca7803dd">1.0</ix:nonFraction>&#160;million in current assets, $<ix:nonFraction unitRef="usd" contextRef="iebda58f2b50646b69966fddb55d1e9eb_I20220120" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY3NjkzOA_100eb7f3-77bc-4716-8aec-74846a2a66c3">0.2</ix:nonFraction>&#160;million in property and equipment, $<ix:nonFraction unitRef="usd" contextRef="iebda58f2b50646b69966fddb55d1e9eb_I20220120" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY3Njk3OQ_6b28c8f0-ce78-4c0c-997d-09191e283555">27.7</ix:nonFraction>&#160;million in intangible assets (including developed technology of $<ix:nonFraction unitRef="usd" contextRef="if97396e4c19841b98639a9937dfa4fa7_I20220120" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY3NzAxOQ_83eb4da9-8401-4ade-8b35-e34c8a3c3663">21.1</ix:nonFraction>&#160;million and IPR&amp;D of $<ix:nonFraction unitRef="usd" contextRef="ie9fc3884748a4f9c85f668dbc7c8621a_I20220120" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY3Njk5NQ_a66a0eda-4c5a-4e72-b10e-9ae85b8b1b09">5.5</ix:nonFraction>&#160;million), $<ix:nonFraction unitRef="usd" contextRef="iebda58f2b50646b69966fddb55d1e9eb_I20220120" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY3NzAwMw_c15e088a-116f-4975-b924-102dd846f94b">3.2</ix:nonFraction>&#160;million in current liabilities, a deferred tax liability of $<ix:nonFraction unitRef="usd" contextRef="iebda58f2b50646b69966fddb55d1e9eb_I20220120" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY3NzAxMQ_cb927906-0e97-45c5-8391-3f6a5d1d3dcf">3.5</ix:nonFraction>&#160;million, and $<ix:nonFraction unitRef="usd" contextRef="iebda58f2b50646b69966fddb55d1e9eb_I20220120" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY3NzAyNw_42a53e05-ea5f-4894-9d15-75380c0ece5f">22.9</ix:nonFraction>&#160;million in goodwill.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In performing the purchase price allocation, we considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of the Aidence business.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As part of the purchase price allocation, we determined the identifiable intangible assets are developed technology, IPR&amp;D, trade names, and customer relationships. The fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using rates ranging from <ix:nonFraction unitRef="number" contextRef="iaf4d7228420748d7a6ca4943a5dc578d_I20221231" decimals="2" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY4NTI0Ng_9c9c55f2-ebfe-44e5-9559-1edb49223915">15</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="id2af135c82bc4cca8c8fab8df3985632_I20221231" decimals="2" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY4NTI1MA_e2ac30f2-9da6-43b0-8e28-3efdf54eaa2a">17</ix:nonFraction>%. The cash flows were based on estimates used to price the transaction, and the discount rates applied were benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The developed technology consists of artificial intelligence powered applications for lung nodule management and early lung cancer diagnosis and reporting.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The IPR&amp;D asset relates primarily to an in-process project for a customer relationship management offering to manage patients that are found with Incidental Pulmonary Nodules and has not reached technological feasibility as of the acquisition date. The asset recorded relates to one project, and the Company expects to complete the project in the next twelve months. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The useful lives for the developed technology asset was set at <ix:nonNumeric contextRef="i1073a8921d2c4ba78783ba6bcf89733f_D20220101-20221231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY4NjM4MA_85e6d5aa-ba2b-42e3-a440-9db107913416">7</ix:nonNumeric> years, for customer relationships <ix:nonNumeric contextRef="i2500cde4d73845a3ac979c61b31fffb3_D20220101-20221231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY4NjM4NQ_01256fbc-9dd3-42e4-ba8e-e88d035f0e31">5.4</ix:nonNumeric> years, and trade names was <ix:nonNumeric contextRef="if7c3caf821ac4264bfedf6a1cf1e1cff_D20220101-20221231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY4NjM5MA_77159aa4-dc39-4826-a020-76ce493bd6c2">7</ix:nonNumeric> years. The calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. Factors contributing to the recognition of the amount of goodwill were primarily based on anticipated strategic and synergistic benefits that are expected to be realized from the acquisition. These benefits include expanding the Company's AI capabilities to drive revenue growth.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Quantib B.V.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 20, 2022, we completed our acquisition of all the equity interests of Quantib B.V. ("Quantib") an artificial intelligence enterprise focused on prostate cancer screening.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Quantib is reported as part of our artificial intelligence segment, and was acquired to enhance our AI capabilities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transaction was accounted for as an acquisition of a business and total purchase consideration was determined to be approximately $<ix:nonFraction unitRef="usd" contextRef="i0037eb0ed88b4354b067862baa4cefa3_D20220120-20220120" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY4MDQwMQ_cd566391-6067-4ef6-a42b-abf693ba09b0">42.3</ix:nonFraction>&#160;million including i) <ix:nonFraction unitRef="shares" contextRef="i0037eb0ed88b4354b067862baa4cefa3_D20220120-20220120" decimals="INF" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY4MDQwOQ_4c3c0d40-27fe-4a37-91d3-08460eab47e8">965,058</ix:nonFraction> shares issued at $<ix:nonFraction unitRef="usdPerShare" contextRef="ic20227de97324a8da0150abd7d29ff60_I20220120" decimals="2" name="us-gaap:BusinessAcquisitionSharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY4MDQxMw_3a85ae03-0370-4783-9a7c-f8188c4bcf9c">26.80</ix:nonFraction> per share with a fair value of $<ix:nonFraction unitRef="usd" contextRef="i0037eb0ed88b4354b067862baa4cefa3_D20220120-20220120" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY4MDQxNw_64915d40-61a2-40af-a671-de1adc34dc2e">25.9</ix:nonFraction>&#160;million ii) cash of $<ix:nonFraction unitRef="usd" contextRef="i0037eb0ed88b4354b067862baa4cefa3_D20220120-20220120" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY4MDQyNQ_88f29167-2a6e-426e-b605-1ec1e59386c6">11.8</ix:nonFraction>&#160;million and iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">contingent consideration consisting of <ix:nonFraction unitRef="shares" contextRef="if4f8df70221f4cb2841fe32fb6094aa8_D20220120-20220120" decimals="INF" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY4MDQzNw_5719bd15-310c-4443-9926-0ed2222da213">113,303</ix:nonFraction> shares with a fair value at the date of close of $<ix:nonFraction unitRef="usd" contextRef="if4f8df70221f4cb2841fe32fb6094aa8_D20220120-20220120" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY4MDQ0MQ_120b4c94-69a8-4d13-9b6c-e069d571bbfb">3.0</ix:nonFraction>&#160;million and cash of $<ix:nonFraction unitRef="usd" contextRef="i79751a12a5c14657a85da985b3d864c7_I20220120" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY4MDQ0OQ_bdd47519-a0bc-4a7b-8c8e-eee3027c33d4">1.6</ix:nonFraction>&#160;million both to be released <ix:nonNumeric contextRef="i0037eb0ed88b4354b067862baa4cefa3_D20220120-20220120" name="rdnt:BusinessCombinationContingentConsiderationLiabilityPeriod" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY4MDQ1Nw_f5777d06-557e-4420-b9df-916f7fb20416">18</ix:nonNumeric> months after acquisition subject to adjustment for any indemnification claims. As a result of this transaction, we recorded $<ix:nonFraction unitRef="usd" contextRef="ic091556638644c818849ee8b176872d4_I20220120" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY4MDQ2Mw_8bca68e5-c300-4506-99d5-c544cc101f96">2.4</ix:nonFraction>&#160;million in current assets, $<ix:nonFraction unitRef="usd" contextRef="ic091556638644c818849ee8b176872d4_I20220120" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY4MDQ3Mg_537c2435-7c98-4476-a903-dcad88081abf">0.1</ix:nonFraction>&#160;million in property and equipment, $<ix:nonFraction unitRef="usd" contextRef="ic091556638644c818849ee8b176872d4_I20220120" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY4MDQ4MA_c0e8a4d0-43f3-43e9-a62a-1df085911d4e">21.3</ix:nonFraction>&#160;million in intangible assets (including developed technology of $<ix:nonFraction unitRef="usd" contextRef="i68c4c04cc28b411e853a2689c03e9923_I20220120" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY4OTI1MQ_6dce6329-dbd5-4004-a959-86c194827ca2">19.6</ix:nonFraction>&#160;million and IPR&amp;D of $<ix:nonFraction unitRef="usd" contextRef="i6165260d2cac4c499c9451f3f1214d18_I20220120" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY4OTI2Ng_7bda8b00-d1cb-41ed-a9bd-28782b5d2a79">0.7</ix:nonFraction>&#160;million), $<ix:nonFraction unitRef="usd" contextRef="ic091556638644c818849ee8b176872d4_I20220120" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY4MDUwMA_2c113dfb-131a-499e-b9d1-cd1465c79047">0.7</ix:nonFraction>&#160;million in current liabilities, $<ix:nonFraction unitRef="usd" contextRef="ic091556638644c818849ee8b176872d4_I20220120" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY4MDUwOA_a65da63e-48d2-4f59-ace9-9942f7e8a95f">6.7</ix:nonFraction>&#160;million in long-term debt and deferred tax liabilities, and $<ix:nonFraction unitRef="usd" contextRef="ic091556638644c818849ee8b176872d4_I20220120" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY4MDQ4OA_ad55feb4-b661-4dbe-9c33-3ca7fc47de46">26.4</ix:nonFraction>&#160;million in goodwill.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In performing the purchase price allocation, we considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of the Quantib business.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As part of the purchase price allocation, we determined the identifiable intangible assets are developed technology, IPR&amp;D, trade names, and customer relationships. The fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using rates ranging from <ix:nonFraction unitRef="number" contextRef="if1af841cdb3f4cd0ad5ac44de8df9eb9_I20221231" decimals="2" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY4MzYyOA_c5ad68c1-26bb-4872-a046-9cb71683f8df">50</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i5fc2355ac8fb4b73b314ebd1371b0448_I20221231" decimals="2" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY4MzYzMg_098514ff-ef9f-4627-81e8-acd3d6451e09">55</ix:nonFraction>%. The cash flows were based on </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i25693f8e66e2483d806273af797f1168"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">estimates used to price the transaction, and the discount rates applied were benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The developed technology consists of artificial intelligence powered applications for neurological and prostate imaging scans and reporting.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The useful lives for the developed technology asset was set at <ix:nonNumeric contextRef="ib5968e7309954164b239ff2880b7fa11_D20220101-20221231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfNDk0NzgwMjM4NDIzMg_8d83b7e0-fe29-42b9-8d6b-bfb96f445796">seven years</ix:nonNumeric>, customer relationships <ix:nonNumeric contextRef="i14058b49fc714ecb8b39c3fe337c4c47_D20220101-20221231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY4NDc4NQ_63c98db3-499b-4925-bbcf-343945117eb3">three years</ix:nonNumeric>, and trade names <ix:nonNumeric contextRef="iab70d35c2cb440ccba0a783f0cdde440_D20220101-20221231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfNDk0NzgwMjM4NDIzNA_8bbc9ece-a338-474a-a0fd-8f19be92af8b">seven years</ix:nonNumeric>. The calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. Factors contributing to the recognition of the amount of goodwill were primarily based on anticipated strategic and synergistic benefits that are expected to be realized from the acquisition. These benefits include expanding the Company's AI capabilities to drive revenue growth.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As disclosed above, for the acquisitions of Aidence and Quantib, the Company uses the income approach to determine the fair value of developed technology and IPR&amp;D acquired in business combinations. This approach determines fair value by estimating the after-tax cash flows attributable to the respective assets over their useful lives and then discounting these after-tax cash flows back to a present value. The Company bases its revenue assumptions on estimates of relevant market sizes, expected market growth rates, expected trends in technology and expected product introductions by competitors. The value of the in-process projects is based on the project's stage of completion, the complexity of the work completed as of the acquisition date, the projected costs to complete, the expected introduction date, the estimated cash flows to be generated upon commercial release and the estimated useful life of the technology. The Company believes that the estimated developed technology and IPR&amp;D amounts represent the fair value at the date of acquisition and do not exceed the amount a third-party would pay for the assets. The significant assumptions used to estimate the fair value of intangible assets include discount rates and certain assumptions that form the basis of the forecasted results, specifically, revenue growth rates, EBITDA margins and obsolescence factors. These significant assumptions are forward looking and could be affected by future economic and market conditions.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Subsidiary activity</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Formation of majority owned subsidiaries</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Frederick County Radiology, LLC</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2022 we formed Frederick County Radiology, LLC ("FCR"), a partnership with Frederick Health Hospital, Inc. ("Hospital").  The operation offers multi-modality services out of <ix:nonFraction unitRef="location" contextRef="ifac3d3f48c90447d9920ba9922709d73_I20220401" decimals="INF" name="rdnt:NumberOfLocationOfferingMultiModalityServices" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTYzNDU3NA_67a6ad8e-237c-46da-94d8-92e266496c67">six</ix:nonFraction> locations in Frederick, Maryland.  We contributed the operations of <ix:nonFraction unitRef="center" contextRef="i2f87ecd615944571b918d5b62820eda3_I20220401" decimals="INF" name="rdnt:NumberOfCentersContributed" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTYzNDU4NA_a86834a7-c338-498b-abd8-3bd2e68a4408">four</ix:nonFraction> centers to the enterprise and Hospital contributed $<ix:nonFraction unitRef="usd" contextRef="i38c6fdf76c844677a1750f13333889fa_I20220401" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTYzNDU4OQ_fe358fe1-35cf-4522-80b6-91828f1dae11">5.4</ix:nonFraction> million in fixed assets, $<ix:nonFraction unitRef="usd" contextRef="i9f0903465ba04ac2995029cdb8fbb03f_I20220401" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTYzNDU5Mw_49d6de5e-8902-4005-8235-a08dac4b2a1a">3.0</ix:nonFraction> million in equipment, and  $<ix:nonFraction unitRef="usd" contextRef="ib7f3ec194c084b988bc8b154c1692068_I20220401" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTYzNDU5Nw_fd0d5c5c-9559-4da7-90a4-6a7dd2096be9">11.0</ix:nonFraction> million in goodwill.  As a result of the transaction, we recognized a gain of $<ix:nonFraction unitRef="usd" contextRef="i63d0ac5d5bab47479964de4ca123d1f5_D20220401-20220401" decimals="-5" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY4OTA5MA_01bbd81c-e506-4a9f-959d-50e131684cd7">6.6</ix:nonFraction> million to additional paid in capital and retained a <ix:nonFraction unitRef="number" contextRef="ibb19233e68ff4d41a7e808f8715f8f2c_D20220401-20220401" decimals="2" name="us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTYzNDYwMQ_86ae20b8-2428-4402-9bd0-10ec95a51140">65</ix:nonFraction>% controlling economic interest in FCR and Hospital retains an $<ix:nonFraction unitRef="usd" contextRef="i18b22b6c335a45639d3204cacdeb3610_I20220401" decimals="-5" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTYzNDYwNQ_0e851b43-0d2c-469e-ac05-bf018dac9f3b">11.1</ix:nonFraction> million or <ix:nonFraction unitRef="number" contextRef="i3feff49292e04c30a61b84bfc33cae41_D20220401-20220401" decimals="2" name="us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTYzNDYwOQ_8c12d2d6-1995-494f-bb29-0f25f2c90c52">35</ix:nonFraction>% noncontrolling economic interest in FCR.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Advanced Radiology at Capital Region, LLC</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 15, 2022 we entered into Advanced Radiology at Capital Region, LLC, a partnership with Dimension Health Corporation. ("Dimension"), an affiliate of the University of Maryland.  The operation will provide multi-modality services out of <ix:nonFraction unitRef="location" contextRef="i241f863ca19c468d9943aac255502e19_I20220615" decimals="INF" name="rdnt:NumberOfLocationOfferingMultiModalityServices" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTYzNDY1Ng_b64364e8-3dd4-4f0f-a536-76fa9c2976a2">two</ix:nonFraction> yet to be determined locations in the Largo, Maryland area.  The venture was initially capitalized with nominal amounts of $<ix:nonFraction unitRef="usd" contextRef="i59cfe8ed7dfb4ae09b7c26c7e2734e56_D20220615-20220615" decimals="-2" name="us-gaap:PaymentsToAcquireInterestInJointVenture" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTYzNDY2Mw_591292f8-2a0a-47b5-9284-8c00a88261fb">5.1</ix:nonFraction>&#160;thousand for a <ix:nonFraction unitRef="number" contextRef="i59cfe8ed7dfb4ae09b7c26c7e2734e56_D20220615-20220615" decimals="2" name="us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTYzNDY3MQ_09a298b2-2432-410d-ae48-29f2487ecb18">51</ix:nonFraction>% economic interest  from us and $<ix:nonFraction unitRef="usd" contextRef="i37eb4b7a2a86440dbba3d35c820120cb_I20220615" decimals="-2" name="us-gaap:EquityMethodInvestmentAggregateCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTYzNDY3OQ_1c437dfc-c26c-44bb-9ed0-869e55141221">4.9</ix:nonFraction>&#160;thousand from Dimension for a <ix:nonFraction unitRef="number" contextRef="ic5a702b1c1bc4189a7b7944db5b5fabd_D20220615-20220615" decimals="2" name="us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTYzNDY3NQ_eb7d5072-b069-4e40-98f1-a81cbc64080c">49</ix:nonFraction>% economic interest.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Simi Valley Imaging Group, LLC</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2021 we entered into the Simi Valley Imaging Group, LLC, a partnership with Simi Valley Hospital and Health Services ("Simi Adventist").  The operation will offer multi-modality imaging services out of <ix:nonFraction unitRef="location" contextRef="i987cdd48ce1c4476ae4f5b205442e647_I20221231" decimals="INF" name="rdnt:NumberOfLocations" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfNjU5NzA2OTgyNTkxNg_8d27f76d-f04a-4c5f-9999-b272bf2139dc">two</ix:nonFraction> locations in Ventura County, California.  Total investment in the venture is $<ix:nonFraction unitRef="usd" contextRef="ibc1689b570374d14852bee5675a09ab0_I20210101" decimals="-5" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfNDA5MA_6fa95bfd-f116-4911-b4e9-d20dea0ab5ed">0.4</ix:nonFraction> million. RadNet contributed $<ix:nonFraction unitRef="usd" contextRef="if68e59e75ef34799af1d02aff32b5aae_D20210101-20210101" decimals="-5" name="us-gaap:NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfNDExMw_5f2e23ac-3308-4bd2-b2a4-08ec04504c44">0.3</ix:nonFraction> million in assets for a <ix:nonFraction unitRef="number" contextRef="if68e59e75ef34799af1d02aff32b5aae_D20210101-20210101" decimals="3" name="us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfNDEzMg_524238ea-d043-472d-a9b8-5e4ec37cdc39">60.0</ix:nonFraction>% economic interest and Simi Adventist contributed assets totaling $<ix:nonFraction unitRef="usd" contextRef="ia3b6622be19547c48017c645b19e93da_I20210101" decimals="-5" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfNDIwMA_bff21b95-097d-4438-b801-b41a1c476145">0.1</ix:nonFraction> million for a <ix:nonFraction unitRef="number" contextRef="i90a1726c6bee4422b356584ebb692aa7_D20210101-20210101" decimals="3" name="us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfNDIwOQ_535871e7-56ba-43cb-a45e-e10feffb4b07">40.0</ix:nonFraction>% economic interest.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sale of ownership interest  in a majority owned subsidiary</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective September 1, 2021 we completed the sale of a <ix:nonFraction unitRef="number" contextRef="i9086fb31eefc4ef396dce636b41d760c_D20210901-20210901" decimals="3" name="rdnt:NoncontrollingInterestPercentOfOwnershipSold" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfNDM0NQ_8bb1825b-4436-48b7-b9eb-3d18597f8b76">24.9</ix:nonFraction>% ownership interest in our majority owned subsidiary West Valley Imaging Group, LLC for $<ix:nonFraction unitRef="usd" contextRef="i9086fb31eefc4ef396dce636b41d760c_D20210901-20210901" decimals="-5" name="rdnt:ProceedsFromSaleOfInterestInMinorityShareholders" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfNDQzNQ_d1230edf-e3ae-445d-9e8f-875d69a649a2">13.1</ix:nonFraction> million to Tarzana Medical Center, LLC.  After the sale, our ownership interest in the subsidiary has reduced from <ix:nonFraction unitRef="number" contextRef="i428ad0d44a1346558061485e679164b4_I20210831" decimals="3" name="us-gaap:MinorityInterestOwnershipPercentageByParent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfNDU0NQ_dae15d3d-6b6a-4751-8573-c724f1f7b34a">75.0</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="idd38436b6e0c4c099ae9632c1d4929cf_I20210901" decimals="3" name="us-gaap:MinorityInterestOwnershipPercentageByParent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfNDU1MQ_8223b3ad-b5d1-4455-bc94-ca0ac68653ed">50.1</ix:nonFraction>% and we retain a controlling financial interest in the subsidiary.  We recognized in additional paid in capital on our consolidated balance sheets, $<ix:nonFraction unitRef="usd" contextRef="i9ed54666eaf94b7bb7053f98d1280ca4_D20210901-20210901" decimals="-5" name="us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfNDcwMQ_af12a1d1-2b96-41fb-a435-c8482e7e7bd2">4.2</ix:nonFraction> million excess in consideration over the carrying value of the sold economic interest.  Post the sale of our ownership interest we acquired from Tarzana Medical Center, LLC, certain tangible and intangible business assets for purchase consideration of approximately $<ix:nonFraction unitRef="usd" contextRef="i237fcfddc1b842039f5586e2d3b311f4_D20210901-20210901" decimals="-5" name="us-gaap:PaymentsToAcquireIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfNDk2Mg_f3a104de-f4f0-4873-ad1c-096658ffbb04">5.2</ix:nonFraction> million.</span></div></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76</span></div></div></div><div id="if3f80771944f4fc58015abda42dc47d1_1340"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 5 &#8211; <ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGV4dHJlZ2lvbjozODBlMmQ4YTNiZjY0OGFjYWYyYTFlZTZmODk2Y2ZmNF80OTQ3ODAyMzI3ODkz_5e265b91-97c2-4f06-9414-859f8fd5bee9" continuedAt="ibad77966e47a4b5a9b3b12d10ba87f14" escape="true">SEGMENT REPORTING</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ibad77966e47a4b5a9b3b12d10ba87f14" continuedAt="i84b252cb4b2243f9a4a85688b52ec857"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our reportable segments are described below:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Imaging Center</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. The vast majority of our centers offer multi-modality imaging services, a strategy that diversifies revenue streams, reduces exposure to reimbursement changes and provides patients and referring physicians one location to serve the needs of multiple procedures.  We also provide teleradiolgy services in the United Kingdom though our Heart&amp;Lung Health subsidiary.  Included in the segment is our eRad subsidiary, which designs the underlying critical scheduling, data storage and retrieval systems necessary for imaging center operation.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Artificial Intelligence ("AI")</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our AI segment develops and deploys clinical applications to enhance interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our chief operating decision maker ("CODM"), who is also our CEO, evaluates the financial performance of our segments based upon their respective revenue and segmented internal profit and loss statements prepared on a basis not consistent with GAAP.  We do not report balance sheet information by segment since it is not reviewed by our CODM.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGV4dHJlZ2lvbjozODBlMmQ4YTNiZjY0OGFjYWYyYTFlZTZmODk2Y2ZmNF80OTQ3ODAyMzI3ODk0_50270c62-a6d4-4785-8dd3-88d033894a61" continuedAt="i765542a3d9d244988d2fe9a04283c2e7" escape="true">The table below present segment information reconciled to our financial results, with segment operating income or loss including revenue less cost of operations, depreciation and amortization, and other operating expenses to the extent specifically identified by segment (in thousands):</ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">77</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i84b252cb4b2243f9a4a85688b52ec857"><div style="text-align:justify"><ix:continuation id="i765542a3d9d244988d2fe9a04283c2e7"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.619%"><tr><td style="width:1.0%"></td><td style="width:32.994%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.965%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.410%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.967%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Twelve Months Ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Revenue:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ib5726eab9b6d42fa88ccbbd9685ed8a6_D20220101-20221231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8zLTEtMS0xLTU3OTM1_f54527a2-4e81-4eee-a1ae-3a479c28cd06">1,425,665</ix:nonFraction>&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i70656be41c694318a241edacdeceec2c_D20210101-20211231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8zLTMtMS0xLTU3OTM1_657d6014-9d88-420c-9257-330f3f260e28">1,313,662</ix:nonFraction>&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i6f9bff8ba8074226b0ec1f1f6f82e960_D20200101-20201231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8zLTUtMS0xLTYzMjMw_b4037c23-c15f-408d-aae0-32bb2c88e60a">1,071,840</ix:nonFraction>&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i74a6538627074503a346c001073d75b6_D20220101-20221231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV80LTEtMS0xLTU3OTM1_5a5773d1-01fa-428c-8e89-41bf67060717">4,396</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i4ae0b29c79ef48768e36dcfc86e3ae27_D20210101-20211231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV80LTMtMS0xLTU3OTM1_81550aab-920a-4786-b2a5-fb705dd2575c">1,415</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i752bed455bf6494e806b337523329451_D20200101-20201231" decimals="-3" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV80LTUtMS0xLTYzMjMw_a39260d7-0114-4082-ba90-4ed6aa84ce6a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total revenue</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV81LTEtMS0xLTU3OTM1_6b7e7e9f-2e09-423c-92d1-35385f9439f8">1,430,061</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV81LTMtMS0xLTU3OTM1_d61dcbf3-3779-463a-bf92-bd0e6fc35ac6">1,315,077</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV81LTUtMS0xLTYzMjMw_0808558c-5714-48a5-8c2a-330dedc9d1a9">1,071,840</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Cost of Operations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ib5726eab9b6d42fa88ccbbd9685ed8a6_D20220101-20221231" decimals="-3" name="us-gaap:OperatingCostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV84LTEtMS0xLTU3OTQ0_1e62584c-a982-4f2d-b803-ccc1902588bf">1,240,593</ix:nonFraction>&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i70656be41c694318a241edacdeceec2c_D20210101-20211231" decimals="-3" name="us-gaap:OperatingCostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV84LTMtMS0xLTU3OTQ0_98e2226d-8f58-43f5-92ce-8c385787479b">1,130,543</ix:nonFraction>&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i6f9bff8ba8074226b0ec1f1f6f82e960_D20200101-20201231" decimals="-3" name="us-gaap:OperatingCostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV84LTUtMS0xLTYzMjMw_1c3f8ea7-e750-4d28-b119-612c3509056e">967,250</ix:nonFraction>&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i74a6538627074503a346c001073d75b6_D20220101-20221231" decimals="-3" name="us-gaap:OperatingCostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV85LTEtMS0xLTU3OTQ0_e7782eb8-192f-425f-997d-286ce40f25fe">23,753</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i4ae0b29c79ef48768e36dcfc86e3ae27_D20210101-20211231" decimals="-3" name="us-gaap:OperatingCostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV85LTMtMS0xLTU3OTQ0_173dad3e-dda9-4524-8bd5-4a0067e55ad2">5,333</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i752bed455bf6494e806b337523329451_D20200101-20201231" decimals="-3" name="us-gaap:OperatingCostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV85LTUtMS0xLTYzMjMw_88df5ba9-f189-47ca-a92a-dca4dd9f1bb7">2,822</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total cost of operations</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:OperatingCostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8xMC0xLTEtMS01Nzk0NA_3fb3cc14-0c6d-484e-9486-8b7ff41426f6">1,264,346</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:OperatingCostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8xMC0zLTEtMS01Nzk0NA_c6220029-8db5-41eb-937b-da23ee5ba76a">1,135,876</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" name="us-gaap:OperatingCostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8xMC01LTEtMS02MzIzMA_389a06b5-e0ca-4f7b-9544-82ca859e1c1f">970,072</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:23pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 8.2pt;text-indent:-7.2pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Depreciation and Amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ib5726eab9b6d42fa88ccbbd9685ed8a6_D20220101-20221231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8xMy0xLTEtMS01Nzk0OA_dd9cbde8-4e5d-4d6c-855b-de88bbd3b527">109,524</ix:nonFraction>&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i70656be41c694318a241edacdeceec2c_D20210101-20211231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8xMy0zLTEtMS01Nzk0OA_17b3635d-b09b-40a9-b98f-6b5c05ae0036">96,174</ix:nonFraction>&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i6f9bff8ba8074226b0ec1f1f6f82e960_D20200101-20201231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8xMy01LTEtMS02MzIzMA_45f250a1-8848-476c-a08c-00934df1eccd">86,396</ix:nonFraction>&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i74a6538627074503a346c001073d75b6_D20220101-20221231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8xNC0xLTEtMS01Nzk0OA_ce751523-4e0f-473d-aab8-73b205e92762">6,353</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i4ae0b29c79ef48768e36dcfc86e3ae27_D20210101-20211231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8xNC0zLTEtMS01Nzk0OA_76354b0f-cc6c-4e45-8524-c00887bf75e0">520</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i752bed455bf6494e806b337523329451_D20200101-20201231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8xNC01LTEtMS02MzIzMA_f75ed4d3-4515-4c62-a993-2033e6664f53">399</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total depreciation and amortization</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8xNS0xLTEtMS01Nzk0OA_99b1069b-889d-4e95-94b3-1e3418079593">115,877</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8xNS0zLTEtMS01Nzk0OA_541915a6-64f6-4d84-8e14-3bd5d6dfeea1">96,694</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8xNS01LTEtMS02MzIzMA_f32e2747-0154-4298-8188-88afb6c74ae5">86,795</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 8.2pt;text-indent:-7.2pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Loss on Disposal of Equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ib5726eab9b6d42fa88ccbbd9685ed8a6_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8xOC0xLTEtMS01Nzk0OA_677f4100-de2f-443a-92e7-5261ea655f24">2,506</ix:nonFraction>&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i70656be41c694318a241edacdeceec2c_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8xOC0zLTEtMS01Nzk0OA_31d1f8f9-0dd5-453c-94fc-3a3b433d1121">8,319</ix:nonFraction>&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i6f9bff8ba8074226b0ec1f1f6f82e960_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8xOC01LTEtMS02MzIzMA_a42e44cf-05aa-41c4-8065-71adf673351d">1,200</ix:nonFraction>&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i74a6538627074503a346c001073d75b6_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8xOS0xLTEtMS01Nzk0OA_3d035aa5-b63e-405a-95aa-d5061c129063">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i4ae0b29c79ef48768e36dcfc86e3ae27_D20210101-20211231" decimals="-3" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8xOS0zLTEtMS01Nzk0OA_66f61af2-c2b6-4ab1-8450-e94325617807">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i752bed455bf6494e806b337523329451_D20200101-20201231" decimals="-3" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8xOS01LTEtMS02MzIzMA_2d9f99f6-65f5-4ef8-ae27-bd5b280f424b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total loss (gain)</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8yMC0xLTEtMS01Nzk0OA_820a9f1f-5c9d-4ec2-b087-7b325f17c8bd">2,529</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8yMC0zLTEtMS01Nzk0OA_c13b1dd8-16fe-4b67-ab99-4b072826b100">8,319</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8yMC01LTEtMS02MzIzMA_4a472623-2eae-40ab-bb35-c98be78936fa">1,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Severance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ib5726eab9b6d42fa88ccbbd9685ed8a6_D20220101-20221231" decimals="-3" name="us-gaap:SeveranceCosts1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8yMy0xLTEtMS01Nzk0OA_7a92c6bc-92c0-4da1-ad81-d0803dd3a778">926</ix:nonFraction>&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i70656be41c694318a241edacdeceec2c_D20210101-20211231" decimals="-3" name="us-gaap:SeveranceCosts1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8yMy0zLTEtMS01Nzk0OA_ae15be74-878f-4766-a900-fe2cb6e13367">744</ix:nonFraction>&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i6f9bff8ba8074226b0ec1f1f6f82e960_D20200101-20201231" decimals="-3" name="us-gaap:SeveranceCosts1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8yMy01LTEtMS02MzIzMA_12997c71-ae0b-42a5-852f-d9562775d417">4,353</ix:nonFraction>&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i74a6538627074503a346c001073d75b6_D20220101-20221231" decimals="-3" name="us-gaap:SeveranceCosts1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8yNC0xLTEtMS01Nzk0OA_6f53ef74-2bb0-4bec-9fd7-c81bc08b899f">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i4ae0b29c79ef48768e36dcfc86e3ae27_D20210101-20211231" decimals="-3" name="us-gaap:SeveranceCosts1" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8yNC0zLTEtMS01Nzk0OA_955e78a1-6d69-413c-b43d-0cc6dbeb114b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i752bed455bf6494e806b337523329451_D20200101-20201231" decimals="-3" name="us-gaap:SeveranceCosts1" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8yNC01LTEtMS02MzIzMA_71df385c-8871-4dc5-b793-746ed216e5d6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total severance</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:SeveranceCosts1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8yNS0xLTEtMS01Nzk0OA_6b86d06d-de52-4abb-85b1-746410fdc373">946</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:SeveranceCosts1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8yNS0zLTEtMS01Nzk0OA_15856548-f8d6-45c2-8384-7681147abbdc">744</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" name="us-gaap:SeveranceCosts1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8yNS01LTEtMS02MzIzMA_fb2569a8-ff5d-42d4-a995-cea1c97a88fb">4,353</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Income from Operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ib5726eab9b6d42fa88ccbbd9685ed8a6_D20220101-20221231" decimals="-3" name="rdnt:OperatingIncomeLossExcludingReliefFunding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8yOC0xLTEtMS01Nzk0OA_cdfc179d-aa5c-47ca-aa5d-8e337bce85ac">72,116</ix:nonFraction>&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i70656be41c694318a241edacdeceec2c_D20210101-20211231" decimals="-3" name="rdnt:OperatingIncomeLossExcludingReliefFunding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8yOC0zLTEtMS01Nzk0OA_026af416-1f87-4626-8cfe-fe4355442f73">77,882</ix:nonFraction>&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i6f9bff8ba8074226b0ec1f1f6f82e960_D20200101-20201231" decimals="-3" name="rdnt:OperatingIncomeLossExcludingReliefFunding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8yOC01LTEtMS02MzIzMA_d36f4c0d-83d4-4d5e-bc01-1f8cf4f26a66">12,641</ix:nonFraction>&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i74a6538627074503a346c001073d75b6_D20220101-20221231" decimals="-3" sign="-" name="rdnt:OperatingIncomeLossExcludingReliefFunding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8yOS0xLTEtMS01Nzk0OA_5ecc4843-f92f-4d5c-b2d3-d7e626d09b88">25,753</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i4ae0b29c79ef48768e36dcfc86e3ae27_D20210101-20211231" decimals="-3" sign="-" name="rdnt:OperatingIncomeLossExcludingReliefFunding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8yOS0zLTEtMS01Nzk0OA_ebba234e-dcc5-472e-b37a-e5fa6b28ead5">4,438</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i752bed455bf6494e806b337523329451_D20200101-20201231" decimals="-3" sign="-" name="rdnt:OperatingIncomeLossExcludingReliefFunding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8yOS01LTEtMS02MzIzMA_b0b2fe6e-7f67-4a0c-a93f-91d51c3e4985">3,221</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total income from operations</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="rdnt:OperatingIncomeLossExcludingReliefFunding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8zMC0xLTEtMS01Nzk0OA_365d9ff7-a0cf-4a11-bb29-0ac3a9c971e2">46,363</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="rdnt:OperatingIncomeLossExcludingReliefFunding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8zMC0zLTEtMS01Nzk0OA_19f2cbe3-d200-4512-89f7-8920c5f5a926">73,444</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" name="rdnt:OperatingIncomeLossExcludingReliefFunding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8zMC01LTEtMS02MzIzMA_1dcb1810-1be1-45ca-9544-f2c38be2ca53">9,420</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr></table></ix:continuation></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For proper comparative purposes, Imaging Center segment revenue for the years 2021 and 2020 exclude Provider Relief Funding of $<ix:nonFraction unitRef="usd" contextRef="i50ecee342add4902a22e3378fadbd827_D20210101-20211231" decimals="-5" name="rdnt:ProceedsFromProviderReliefFunding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGV4dHJlZ2lvbjozODBlMmQ4YTNiZjY0OGFjYWYyYTFlZTZmODk2Y2ZmNF8zODQ4MjkwNjk5ODg5_8e91d02a-64dd-478d-9f5f-db0016b15db8">9.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i506dbb6a5e1c4160b81aac201c17a8cf_D20200101-20201231" decimals="-5" name="rdnt:ProceedsFromProviderReliefFunding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGV4dHJlZ2lvbjozODBlMmQ4YTNiZjY0OGFjYWYyYTFlZTZmODk2Y2ZmNF8xMDk5NTExNjMwNzIz_516b7e79-432b-4dae-b2fe-b3400212ddd6">26.3</ix:nonFraction> million for the twelve months ended December 31, 2021 and 2020, respectively as it represents a form of direct Government stimulus.  <ix:nonFraction unitRef="usd" contextRef="if6fd3b8a94554fd9a4f614d18e1c3d63_D20220101-20221231" decimals="-5" name="rdnt:ProceedsFromProviderReliefFunding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGV4dHJlZ2lvbjozODBlMmQ4YTNiZjY0OGFjYWYyYTFlZTZmODk2Y2ZmNF8zODQ4MjkwNjk5ODk4_2728673a-10ed-4b39-a406-d18094653628">No</ix:nonFraction> such funds were received for the twelve months ended December 31, 2022.</span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div id="if3f80771944f4fc58015abda42dc47d1_85"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 6 &#8211; <ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RleHRyZWdpb246ZDgwMTVkODBhY2Q2NDBkMTgzZjlkNWUzYTFmYTEyYmVfMTE3Mg_8da29869-e637-4e3b-be98-d3166e8c6015" continuedAt="ic304c63386e646618207b27348010767" escape="true">GOODWILL AND OTHER INTANGIBLE ASSETS</ix:nonNumeric></span></div><ix:continuation id="ic304c63386e646618207b27348010767" continuedAt="i30dc540ef78f48e88c277d4149a56f5f"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is recorded as a result of business combinations. The following is a reconciliation of Goodwill by business segment <ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RleHRyZWdpb246ZDgwMTVkODBhY2Q2NDBkMTgzZjlkNWUzYTFmYTEyYmVfMTE3Nw_a3f2a3fd-3ecb-46e0-a0b7-6667f857d11d" continuedAt="i7ce9859c93fe45e7b2e4fb306fd7dc2f" escape="true">for the years ended December 31, 2021 and December 31, 2022 is provided below (in thousands):</ix:nonNumeric></span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:continuation id="i30dc540ef78f48e88c277d4149a56f5f"><div style="margin-top:5pt"><ix:continuation id="i7ce9859c93fe45e7b2e4fb306fd7dc2f"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">                </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.672%"><tr><td style="width:1.0%"></td><td style="width:33.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.482%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.596%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.482%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.937%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.482%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.139%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Imaging Center</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Artificial Intelligence</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i668dae88a2914d8f85a4a37e9114214e_I20201231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOjdiOGRiNjU1MDJmMjQyOWJiYmE3MWM0ZDQ1ZGFmODJkL3RhYmxlcmFuZ2U6N2I4ZGI2NTUwMmYyNDI5YmJiYTcxYzRkNDVkYWY4MmRfMS0yLTEtMS03MDY5OQ_42726449-2d5b-4255-9e94-214d0672dfac">448,269</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad55eccace614330a9a10e68dc84d72a_I20201231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOjdiOGRiNjU1MDJmMjQyOWJiYmE3MWM0ZDQ1ZGFmODJkL3RhYmxlcmFuZ2U6N2I4ZGI2NTUwMmYyNDI5YmJiYTcxYzRkNDVkYWY4MmRfMS00LTEtMS03MDY5OQ_774b04d8-3098-4f4f-b9a9-6aa0fa8faaee">24,610</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb50bc5a13564f6a97eb669524009c18_I20201231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOjdiOGRiNjU1MDJmMjQyOWJiYmE3MWM0ZDQ1ZGFmODJkL3RhYmxlcmFuZ2U6N2I4ZGI2NTUwMmYyNDI5YmJiYTcxYzRkNDVkYWY4MmRfMC0xLTEtMS0yOTQ4OQ_24ce4033-20d3-4857-b451-0ccc0b7022b4">472,879</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70656be41c694318a241edacdeceec2c_D20210101-20211231" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOjdiOGRiNjU1MDJmMjQyOWJiYmE3MWM0ZDQ1ZGFmODJkL3RhYmxlcmFuZ2U6N2I4ZGI2NTUwMmYyNDI5YmJiYTcxYzRkNDVkYWY4MmRfMi0yLTEtMS03MDY5OQ_dd480d20-9b40-463a-96f3-82b7eb56d126">40,864</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ae0b29c79ef48768e36dcfc86e3ae27_D20210101-20211231" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOjdiOGRiNjU1MDJmMjQyOWJiYmE3MWM0ZDQ1ZGFmODJkL3RhYmxlcmFuZ2U6N2I4ZGI2NTUwMmYyNDI5YmJiYTcxYzRkNDVkYWY4MmRfMi00LTEtMS03MDY5OQ_1eb30abc-1c12-4868-a00e-b5a879b78ca8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOjdiOGRiNjU1MDJmMjQyOWJiYmE3MWM0ZDQ1ZGFmODJkL3RhYmxlcmFuZ2U6N2I4ZGI2NTUwMmYyNDI5YmJiYTcxYzRkNDVkYWY4MmRfMS0xLTEtMS0yOTQ4OQ_86461191-4f3c-4c30-999a-f70f7196c337">40,864</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Measurement period and other adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70656be41c694318a241edacdeceec2c_D20210101-20211231" decimals="-3" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOjdiOGRiNjU1MDJmMjQyOWJiYmE3MWM0ZDQ1ZGFmODJkL3RhYmxlcmFuZ2U6N2I4ZGI2NTUwMmYyNDI5YmJiYTcxYzRkNDVkYWY4MmRfMy0yLTEtMS03MDY5OQ_c76d2c2c-ea5f-4bca-aa8f-7f78944a52eb">77</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ae0b29c79ef48768e36dcfc86e3ae27_D20210101-20211231" decimals="-3" name="us-gaap:GoodwillPurchaseAccountingAdjustments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOjdiOGRiNjU1MDJmMjQyOWJiYmE3MWM0ZDQ1ZGFmODJkL3RhYmxlcmFuZ2U6N2I4ZGI2NTUwMmYyNDI5YmJiYTcxYzRkNDVkYWY4MmRfMy00LTEtMS03MDY5OQ_83981126-9bf8-4d2c-bf21-f4683226d63c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOjdiOGRiNjU1MDJmMjQyOWJiYmE3MWM0ZDQ1ZGFmODJkL3RhYmxlcmFuZ2U6N2I4ZGI2NTUwMmYyNDI5YmJiYTcxYzRkNDVkYWY4MmRfMi0xLTEtMS02MDQwMg_c9807050-b2a0-4863-9712-0d42899ef54d">77</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idba042321a6d496fb90b273b2d065e08_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOjdiOGRiNjU1MDJmMjQyOWJiYmE3MWM0ZDQ1ZGFmODJkL3RhYmxlcmFuZ2U6N2I4ZGI2NTUwMmYyNDI5YmJiYTcxYzRkNDVkYWY4MmRfNC0yLTEtMS03MDY5OQ_9d2290ca-20fb-4ead-9859-61f6ca13dc61">489,210</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fff7583d4414b91a34f6aefc3dae941_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOjdiOGRiNjU1MDJmMjQyOWJiYmE3MWM0ZDQ1ZGFmODJkL3RhYmxlcmFuZ2U6N2I4ZGI2NTUwMmYyNDI5YmJiYTcxYzRkNDVkYWY4MmRfNC00LTEtMS03MDY5OQ_bbd70f6d-2fcc-41cf-a92a-260c4ec2e1f7">24,610</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOjdiOGRiNjU1MDJmMjQyOWJiYmE3MWM0ZDQ1ZGFmODJkL3RhYmxlcmFuZ2U6N2I4ZGI2NTUwMmYyNDI5YmJiYTcxYzRkNDVkYWY4MmRfMi0xLTEtMS0yOTQ4OQ_658d5f5b-1ca5-4bec-b7fc-be69c21d1a34">513,820</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5726eab9b6d42fa88ccbbd9685ed8a6_D20220101-20221231" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOjdiOGRiNjU1MDJmMjQyOWJiYmE3MWM0ZDQ1ZGFmODJkL3RhYmxlcmFuZ2U6N2I4ZGI2NTUwMmYyNDI5YmJiYTcxYzRkNDVkYWY4MmRfNi0yLTEtMS03MDY5OQ_430279c8-cf3a-4f55-bebb-c82fffd60e2d">120,551</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74a6538627074503a346c001073d75b6_D20220101-20221231" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOjdiOGRiNjU1MDJmMjQyOWJiYmE3MWM0ZDQ1ZGFmODJkL3RhYmxlcmFuZ2U6N2I4ZGI2NTUwMmYyNDI5YmJiYTcxYzRkNDVkYWY4MmRfNi00LTEtMS03MDY5OQ_1b96fe6d-5d4b-407c-8339-d3600b66d2c1">48,697</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOjdiOGRiNjU1MDJmMjQyOWJiYmE3MWM0ZDQ1ZGFmODJkL3RhYmxlcmFuZ2U6N2I4ZGI2NTUwMmYyNDI5YmJiYTcxYzRkNDVkYWY4MmRfMy0xLTEtMS0yOTQ4OQ_80cda6f4-58e8-46f6-947d-bc71a08581b0">169,248</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disposals</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib5726eab9b6d42fa88ccbbd9685ed8a6_D20220101-20221231" decimals="-3" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOjdiOGRiNjU1MDJmMjQyOWJiYmE3MWM0ZDQ1ZGFmODJkL3RhYmxlcmFuZ2U6N2I4ZGI2NTUwMmYyNDI5YmJiYTcxYzRkNDVkYWY4MmRfNy0yLTEtMS03Mjc5OQ_394d74aa-5cbb-4543-a2ba-9e6655dea957">4,200</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74a6538627074503a346c001073d75b6_D20220101-20221231" decimals="-3" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOjdiOGRiNjU1MDJmMjQyOWJiYmE3MWM0ZDQ1ZGFmODJkL3RhYmxlcmFuZ2U6N2I4ZGI2NTUwMmYyNDI5YmJiYTcxYzRkNDVkYWY4MmRfNy00LTEtMS03Mjc5OQ_5d042427-b2d1-49d6-b7d0-0ed0ef209345">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOjdiOGRiNjU1MDJmMjQyOWJiYmE3MWM0ZDQ1ZGFmODJkL3RhYmxlcmFuZ2U6N2I4ZGI2NTUwMmYyNDI5YmJiYTcxYzRkNDVkYWY4MmRfNy02LTEtMS03Mjc5OQ_e780ac1e-09ca-40bd-b0ae-4c9ffdbeb74c">4,200</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Measurement period and other adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib5726eab9b6d42fa88ccbbd9685ed8a6_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOjdiOGRiNjU1MDJmMjQyOWJiYmE3MWM0ZDQ1ZGFmODJkL3RhYmxlcmFuZ2U6N2I4ZGI2NTUwMmYyNDI5YmJiYTcxYzRkNDVkYWY4MmRfNy0yLTEtMS03MDY5OQ_d1bfe439-fbd7-4b34-9905-7a8f9e1b8a51">106</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74a6538627074503a346c001073d75b6_D20220101-20221231" decimals="-3" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOjdiOGRiNjU1MDJmMjQyOWJiYmE3MWM0ZDQ1ZGFmODJkL3RhYmxlcmFuZ2U6N2I4ZGI2NTUwMmYyNDI5YmJiYTcxYzRkNDVkYWY4MmRfNy00LTEtMS03MDY5OQ_c2166ec4-f693-4c17-bfe3-83c2f31edc7e">147</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOjdiOGRiNjU1MDJmMjQyOWJiYmE3MWM0ZDQ1ZGFmODJkL3RhYmxlcmFuZ2U6N2I4ZGI2NTUwMmYyNDI5YmJiYTcxYzRkNDVkYWY4MmRfNS0xLTEtMS0yOTQ4OQ_d3b01326-0e9f-47ff-94a8-41b0494d68fa">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5726eab9b6d42fa88ccbbd9685ed8a6_D20220101-20221231" decimals="-3" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOjdiOGRiNjU1MDJmMjQyOWJiYmE3MWM0ZDQ1ZGFmODJkL3RhYmxlcmFuZ2U6N2I4ZGI2NTUwMmYyNDI5YmJiYTcxYzRkNDVkYWY4MmRfOC0yLTEtMS03MDY5OQ_637aa0d3-3954-4f4b-b538-92a566b72af6">1,028</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74a6538627074503a346c001073d75b6_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOjdiOGRiNjU1MDJmMjQyOWJiYmE3MWM0ZDQ1ZGFmODJkL3RhYmxlcmFuZ2U6N2I4ZGI2NTUwMmYyNDI5YmJiYTcxYzRkNDVkYWY4MmRfOC00LTEtMS03MDY5OQ_e810f968-9a22-4a71-bcdd-b7297ab4e92e">2,272</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOjdiOGRiNjU1MDJmMjQyOWJiYmE3MWM0ZDQ1ZGFmODJkL3RhYmxlcmFuZ2U6N2I4ZGI2NTUwMmYyNDI5YmJiYTcxYzRkNDVkYWY4MmRfNi0xLTEtMS02MDQ2NA_467bf98c-f9e4-4071-afd7-43c747bac960">1,244</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i611c6f40576041af971fff090e96cc52_I20221231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOjdiOGRiNjU1MDJmMjQyOWJiYmE3MWM0ZDQ1ZGFmODJkL3RhYmxlcmFuZ2U6N2I4ZGI2NTUwMmYyNDI5YmJiYTcxYzRkNDVkYWY4MmRfOS0yLTEtMS03MDY5OQ_88b7b71b-1cf2-4216-ae97-04a59dcc0a59">606,483</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24072ed80ca2499296f569d92fce4296_I20221231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOjdiOGRiNjU1MDJmMjQyOWJiYmE3MWM0ZDQ1ZGFmODJkL3RhYmxlcmFuZ2U6N2I4ZGI2NTUwMmYyNDI5YmJiYTcxYzRkNDVkYWY4MmRfOS00LTEtMS03MDY5OQ_f77414f7-b682-42aa-adf7-26212cd05eb0">71,182</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOjdiOGRiNjU1MDJmMjQyOWJiYmE3MWM0ZDQ1ZGFmODJkL3RhYmxlcmFuZ2U6N2I4ZGI2NTUwMmYyNDI5YmJiYTcxYzRkNDVkYWY4MmRfNi0xLTEtMS0yOTQ4OQ_9a67e51a-794a-4c83-8571-85364e98f647">677,665</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of goodwill from these acquisitions that is deductible for tax purposes as of December 31, 2022 is $<ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-5" name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RleHRyZWdpb246ZDgwMTVkODBhY2Q2NDBkMTgzZjlkNWUzYTFmYTEyYmVfMjk2_743b7058-6172-43cf-b79d-e1b5a0b352eb">154.9</ix:nonFraction> million.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other intangible assets are primarily related to our business combinations and software development.  They include the estimated fair values of such items as service agreements, customer lists, covenants not to compete, acquired technologies, and trade names.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total amortization expense was $<ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-5" name="us-gaap:AdjustmentForAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RleHRyZWdpb246ZDgwMTVkODBhY2Q2NDBkMTgzZjlkNWUzYTFmYTEyYmVfNjAz_1da72e36-a702-4d54-872b-2f79c4fcf2be">10.1</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-5" name="us-gaap:AdjustmentForAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RleHRyZWdpb246ZDgwMTVkODBhY2Q2NDBkMTgzZjlkNWUzYTFmYTEyYmVfNjA3_90e77761-afea-4d7f-a7fd-7eda11aeaef4">4.4</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-5" name="us-gaap:AdjustmentForAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RleHRyZWdpb246ZDgwMTVkODBhY2Q2NDBkMTgzZjlkNWUzYTFmYTEyYmVfNjE1_5dbf6a53-6e42-4261-b0f5-c658ca8d88ba">3.7</ix:nonFraction> million for the years ended December 31, 2022, 2021 and 2020, respectively.  Intangible assets are amortized using the straight-line method over their useful life determined at acquisition. Management service agreements are amortized over <ix:nonNumeric contextRef="ic1e54694556947f19c007ab6032e164a_D20220101-20221231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RleHRyZWdpb246ZDgwMTVkODBhY2Q2NDBkMTgzZjlkNWUzYTFmYTEyYmVfODMw_4d88f5cd-75e1-493b-b968-a991df907026">25</ix:nonNumeric> years using the straight line method.  Software development is capitalized and amortized over the useful life of the software when placed into service.  Trade names are reviewed annually for impairment.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RleHRyZWdpb246ZDgwMTVkODBhY2Q2NDBkMTgzZjlkNWUzYTFmYTEyYmVfMTE3OQ_4264ea3e-fe91-41f8-9276-d443c4f5495d" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables shows annual amortization expense, by asset classes that will be recorded over the next five years (in thousands):&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:22.464%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.332%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted average amortization period remaining in years</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Management Service Contracts</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i414955456ed943bfb2a5a55163f53cf9_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfMS0xLTEtMS0yOTQ4OQ_a3541cda-caca-46a9-8f15-b58476de6ca2">2,287</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i414955456ed943bfb2a5a55163f53cf9_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfMS0zLTEtMS0yOTQ4OQ_6f4593e4-f76d-4751-9415-f5850fe32cbb">2,287</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i414955456ed943bfb2a5a55163f53cf9_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfMS01LTEtMS0yOTQ4OQ_ab962601-f527-4c90-a500-e4a72e06943b">2,287</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i414955456ed943bfb2a5a55163f53cf9_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfMS03LTEtMS0yOTQ4OQ_1579a147-d925-4490-9062-f6df2519fbbf">2,287</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i414955456ed943bfb2a5a55163f53cf9_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfMS05LTEtMS0yOTQ4OQ_e82e07b3-654e-4da2-85b0-9c397461da30">2,287</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i414955456ed943bfb2a5a55163f53cf9_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfMS0xMS0xLTEtMjk0ODk_bb7778fb-038d-4f85-869c-c46847d76d52">8,958</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i414955456ed943bfb2a5a55163f53cf9_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfMS0xMy0xLTEtMjk0ODk_a24400d2-0343-4afe-9cf8-848affc55bfb">20,393</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic1e54694556947f19c007ab6032e164a_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfMS0xNS0xLTEtMjk0ODk_ab81959a-60ac-4ac2-bb0a-e41bce5a5f4c">8.9</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Covenant not to compete and other contracts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4aa6fe1b19fa4032b19af61fea4d1770_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfMi0xLTEtMS0yOTQ4OQ_07046127-b82d-412c-9aa8-477f689ae488">1,319</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4aa6fe1b19fa4032b19af61fea4d1770_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfMi0zLTEtMS0yOTQ4OQ_599afd8a-55b2-4d49-94b2-bab1e8b5eb45">891</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4aa6fe1b19fa4032b19af61fea4d1770_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfMi01LTEtMS0yOTQ4OQ_64be64e1-2917-42d4-8a46-43ba89e69bba">642</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4aa6fe1b19fa4032b19af61fea4d1770_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfMi03LTEtMS0yOTQ4OQ_ebd0d2dd-8848-48bc-9563-01694e7a25c9">356</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4aa6fe1b19fa4032b19af61fea4d1770_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfMi05LTEtMS0yOTQ4OQ_39cf3ae0-510e-4be4-a400-0208e2d2fed5">72</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4aa6fe1b19fa4032b19af61fea4d1770_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfMi0xMS0xLTEtMjk0ODk_52cb0e1b-cf2e-4f2f-9006-90ce2c269b52">40</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4aa6fe1b19fa4032b19af61fea4d1770_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfMi0xMy0xLTEtMjk0ODk_98ac2321-1d73-4c3f-94a3-4128bf52b01b">3,320</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1302a37a97cd4b139f598c14f70e6a6f_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfMi0xNS0xLTEtMjk0ODk_02718fee-912b-4567-a85d-4531e80010e9">3.1</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Customer Relationships</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iddb0cd692be2450194003830cb8eade8_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfMy0xLTEtMS02OTc0OA_1d3a4987-480c-401f-90b3-10e39abb7ca4">1,244</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iddb0cd692be2450194003830cb8eade8_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfMy0zLTEtMS02OTc0OA_04f73774-ab72-4411-92e1-7ceeea3fd030">1,244</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iddb0cd692be2450194003830cb8eade8_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfMy01LTEtMS02OTc0OA_724ed811-b30b-4426-915c-ef9efdde8be6">1,112</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iddb0cd692be2450194003830cb8eade8_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfMy03LTEtMS02OTc0OA_6644e00a-2e36-4b36-aa63-9e9e7f5502eb">991</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iddb0cd692be2450194003830cb8eade8_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfMy05LTEtMS02OTc0OA_a79450a2-ce65-4f7b-841d-2854e0ec644a">816</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iddb0cd692be2450194003830cb8eade8_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfMy0xMS0xLTEtNjk3NDg_de597f28-f089-4774-8152-457f4c53c4da">12,396</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iddb0cd692be2450194003830cb8eade8_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfMy0xMy0xLTEtNjk3NDg_e76e2f55-8161-4b42-a51f-4e72a34738b4">17,803</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i14058b49fc714ecb8b39c3fe337c4c47_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfMy0xNS0xLTEtNjk3NDg_148a501e-9b51-438d-bb09-c5e160d4fec1">18.6</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Patent and Trademarks</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d300af724bd42fa81df479bcd52a561_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfNC0xLTEtMS02OTc2MQ_11615ae9-9850-470d-a9bb-c528afe9dda1">298</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d300af724bd42fa81df479bcd52a561_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfNC0zLTEtMS02OTc2MQ_c6c31c6a-a640-4b29-b23f-ad1f2504aeef">298</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d300af724bd42fa81df479bcd52a561_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfNC01LTEtMS02OTc2MQ_f221c10c-44d8-4435-a0b0-d0b22a1fd829">298</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d300af724bd42fa81df479bcd52a561_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfNC03LTEtMS02OTc2MQ_6bd830d8-b0b2-4c2e-a992-a6cec809bba1">298</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d300af724bd42fa81df479bcd52a561_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfNC05LTEtMS02OTc2MQ_d3745204-b370-4702-bc43-e83be9913280">298</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d300af724bd42fa81df479bcd52a561_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfNC0xMS0xLTEtNjk3NjE_a1a11204-5735-427c-80e5-d7aa811b6e85">322</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d300af724bd42fa81df479bcd52a561_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfNC0xMy0xLTEtNjk3NjE_358efc0d-3071-4523-9475-61155c0492b5">1,812</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5f97cf28159d4af1b51bd03a44af0b3e_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfNC0xNS0xLTEtNjk3NjE_4c1a59cc-5166-4a74-97ea-207dedd181b2">6.4</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Developed Technology &amp; Software</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5437e74731804fadaa4b067a3e9a1079_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfMy0xLTEtMS0yOTQ4OQ_f7055cdf-9efd-46eb-83c3-ac6f6a02cd5f">6,297</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5437e74731804fadaa4b067a3e9a1079_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfMy0zLTEtMS0yOTQ4OQ_1b7e7a31-beec-4ed4-b97a-27bd5fa88778">6,297</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5437e74731804fadaa4b067a3e9a1079_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfMy01LTEtMS0yOTQ4OQ_de0b085d-9338-4966-8cc9-d134b645eba3">6,297</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5437e74731804fadaa4b067a3e9a1079_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfMy03LTEtMS0yOTQ4OQ_32dfbe6c-31bb-4637-9e5b-bfec1d902611">6,257</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5437e74731804fadaa4b067a3e9a1079_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfMy05LTEtMS0yOTQ4OQ_8ac905d2-e778-4a73-9154-ec70cc122fd6">5,722</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5437e74731804fadaa4b067a3e9a1079_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfMy0xMS0xLTEtMjk0ODk_4a47d3d6-a821-4105-8c70-729eadd126ce">7,196</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5437e74731804fadaa4b067a3e9a1079_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfMy0xMy0xLTEtMjk0ODk_6da866a9-c670-4662-9b37-2bff60b29875">38,066</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i79c0ea2a5c9d4435ba5a05f5371abd25_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfMy0xNS0xLTEtMjk0ODk_e49ca10a-1e93-413e-8586-35ca3a1c28b1">6.7</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trade Names amortized</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5494245554a4a8c8f993a496d898612_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfNC0xLTEtMS0yOTQ4OQ_c90e676e-8923-4f18-99de-ba9d82b42b77">305</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5494245554a4a8c8f993a496d898612_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfNC0zLTEtMS0yOTQ4OQ_3ed213e7-dc8d-4c1f-a918-6c1114c84f72">77</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5494245554a4a8c8f993a496d898612_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfNC01LTEtMS0yOTQ4OQ_d429dec4-6c23-40bb-ac29-0acc80f59f16">77</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5494245554a4a8c8f993a496d898612_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfNC03LTEtMS0yOTQ4OQ_b09a9d7b-3c91-4084-9763-d5e3ed303ca0">77</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5494245554a4a8c8f993a496d898612_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfNC05LTEtMS0yOTQ4OQ_9ed819ac-cbde-4e2d-81c0-95aef4613dcf">77</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5494245554a4a8c8f993a496d898612_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfNC0xMS0xLTEtMjk0ODk_a7afdfe2-f476-4b72-bbc4-d69f6ee177cd">89</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5494245554a4a8c8f993a496d898612_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfNC0xMy0xLTEtMjk0ODk_858fe2e4-790b-4ff5-a5ab-3b608b41d5e7">702</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iab70d35c2cb440ccba0a783f0cdde440_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfNC0xNS0xLTEtMjk0ODk_72404f14-4f70-4b90-860d-0061a00185e9">4.5</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trade Names indefinite life</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide5c8507870d42c2934aea55608ad13f_I20221231" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfNS0xMS0xLTEtMjk0ODk_75b24a68-cfb3-4200-b1c8-cd3d79ed2c52">7,100</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide5c8507870d42c2934aea55608ad13f_I20221231" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfNS0xMy0xLTEtMjk0ODk_6beb459b-1491-4587-8d7d-556873029175">7,100</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">IPR&amp;D</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24d947bc9cc64b21a3c0655f38ee8f28_I20221231" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfNi0xMS0xLTEtMjk0ODk_b5dc6602-eba2-45c9-909a-b7f5ef8e390b">17,032</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24d947bc9cc64b21a3c0655f38ee8f28_I20221231" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfNi0xMy0xLTEtMjk0ODk_eda3216c-c6c0-437b-a251-3ec935f891d8">17,032</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Annual Amortization</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfNy0xLTEtMS0yOTQ4OQ_f12fda51-188f-4996-ab56-25e68b36b945">11,750</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfNy0zLTEtMS0yOTQ4OQ_a6e8aca6-56c8-404e-8a0f-1154d6434771">11,094</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfNy01LTEtMS0yOTQ4OQ_38aea5b9-d39c-403e-9074-346508cf2520">10,713</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfNy03LTEtMS0yOTQ4OQ_a96a353d-b26a-461e-bc0c-d27b8741d598">10,266</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfNy05LTEtMS0yOTQ4OQ_ad17efd1-821b-4e83-b178-dd96c12fd9b0">9,272</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfNy0xMS0xLTEtMjk0ODk_b3d8dbe1-aaa1-459e-8739-009ce47f9634">53,133</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfNy0xMy0xLTEtMjk0ODk_ec2e652e-aa82-4800-a999-b8a09aba3e33">106,228</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="if3f80771944f4fc58015abda42dc47d1_91"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 7 - <ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85MS9mcmFnOjVkZTIwNzU2YmQ5YTQxMWRiYzI4NjJhODYxOWIzOGQzL3RleHRyZWdpb246NWRlMjA3NTZiZDlhNDExZGJjMjg2MmE4NjE5YjM4ZDNfNTY3_2cacab2f-562d-44ba-b3d4-0868ca243442" continuedAt="i91708870f66641399db08cf738b8300e" escape="true">PROPERTY AND EQUIPMENT</ix:nonNumeric></span></div><ix:continuation id="i91708870f66641399db08cf738b8300e" continuedAt="i3f0362e45dcb476bb72b45cd0d4a090b"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85MS9mcmFnOjVkZTIwNzU2YmQ5YTQxMWRiYzI4NjJhODYxOWIzOGQzL3RleHRyZWdpb246NWRlMjA3NTZiZDlhNDExZGJjMjg2MmE4NjE5YjM4ZDNfNTcw_7dd19b31-2949-4e20-a7bd-05d3059c350d" continuedAt="ia126d48a041944449b5640eb632d803a" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment and accumulated depreciation and amortization are as follows (in thousands):</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i3f0362e45dcb476bb72b45cd0d4a090b" continuedAt="i73ced35f2ab14cdabb8ecd09ee19fbe2"><div style="margin-top:5pt;text-align:center"><ix:continuation id="ia126d48a041944449b5640eb632d803a"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3d853d4f3b647c5b17405fc7cbc9ec7_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85MS9mcmFnOjVkZTIwNzU2YmQ5YTQxMWRiYzI4NjJhODYxOWIzOGQzL3RhYmxlOmUwNWZmY2Q3MDY3ZTRlZjBiOGRkOGI2OWExYjUyNzU1L3RhYmxlcmFuZ2U6ZTA1ZmZjZDcwNjdlNGVmMGI4ZGQ4YjY5YTFiNTI3NTVfMi0xLTEtMS0yOTQ4OQ_12bea3f8-67a7-4f4f-bf4b-2c0137a85a90">250</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86f01866d4c84b9bbfb9f6decd26c6f6_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85MS9mcmFnOjVkZTIwNzU2YmQ5YTQxMWRiYzI4NjJhODYxOWIzOGQzL3RhYmxlOmUwNWZmY2Q3MDY3ZTRlZjBiOGRkOGI2OWExYjUyNzU1L3RhYmxlcmFuZ2U6ZTA1ZmZjZDcwNjdlNGVmMGI4ZGQ4YjY5YTFiNTI3NTVfMi0zLTEtMS0yOTQ4OQ_ae3612c1-ae29-4746-81e3-a83cf1655df9">250</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical equipment</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00b2de31a74241f0b34c082e030c3988_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85MS9mcmFnOjVkZTIwNzU2YmQ5YTQxMWRiYzI4NjJhODYxOWIzOGQzL3RhYmxlOmUwNWZmY2Q3MDY3ZTRlZjBiOGRkOGI2OWExYjUyNzU1L3RhYmxlcmFuZ2U6ZTA1ZmZjZDcwNjdlNGVmMGI4ZGQ4YjY5YTFiNTI3NTVfMy0xLTEtMS0yOTQ4OQ_213b4b75-1204-4956-99d2-f22ba00526c2">649,034</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id97a7eba2f0b4e619a60a313e21c6dd0_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85MS9mcmFnOjVkZTIwNzU2YmQ5YTQxMWRiYzI4NjJhODYxOWIzOGQzL3RhYmxlOmUwNWZmY2Q3MDY3ZTRlZjBiOGRkOGI2OWExYjUyNzU1L3RhYmxlcmFuZ2U6ZTA1ZmZjZDcwNjdlNGVmMGI4ZGQ4YjY5YTFiNTI3NTVfMy0zLTEtMS0yOTQ4OQ_15be0112-50d2-4bb9-b3aa-b5bb10dd7062">560,301</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer and office equipment, furniture and fixtures</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8674635644f472eba0908b3c0584e97_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85MS9mcmFnOjVkZTIwNzU2YmQ5YTQxMWRiYzI4NjJhODYxOWIzOGQzL3RhYmxlOmUwNWZmY2Q3MDY3ZTRlZjBiOGRkOGI2OWExYjUyNzU1L3RhYmxlcmFuZ2U6ZTA1ZmZjZDcwNjdlNGVmMGI4ZGQ4YjY5YTFiNTI3NTVfNC0xLTEtMS0yOTQ4OQ_524487f5-0bf6-4d01-86c0-13719508d0ea">119,467</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdcafabfcf7040c3b97ef14ac3b23f01_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85MS9mcmFnOjVkZTIwNzU2YmQ5YTQxMWRiYzI4NjJhODYxOWIzOGQzL3RhYmxlOmUwNWZmY2Q3MDY3ZTRlZjBiOGRkOGI2OWExYjUyNzU1L3RhYmxlcmFuZ2U6ZTA1ZmZjZDcwNjdlNGVmMGI4ZGQ4YjY5YTFiNTI3NTVfNC0zLTEtMS0yOTQ4OQ_be24980b-3d40-4623-8b00-855c083bce22">144,766</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software development costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd3d3e3e547648dd8ffe8630809ea423_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85MS9mcmFnOjVkZTIwNzU2YmQ5YTQxMWRiYzI4NjJhODYxOWIzOGQzL3RhYmxlOmUwNWZmY2Q3MDY3ZTRlZjBiOGRkOGI2OWExYjUyNzU1L3RhYmxlcmFuZ2U6ZTA1ZmZjZDcwNjdlNGVmMGI4ZGQ4YjY5YTFiNTI3NTVfNS0xLTEtMS0yOTQ4OQ_d1ccfc59-b0d9-493d-883f-4e08d18e8878">36,015</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86ebeca091034ef29127281116eaa2a8_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85MS9mcmFnOjVkZTIwNzU2YmQ5YTQxMWRiYzI4NjJhODYxOWIzOGQzL3RhYmxlOmUwNWZmY2Q3MDY3ZTRlZjBiOGRkOGI2OWExYjUyNzU1L3RhYmxlcmFuZ2U6ZTA1ZmZjZDcwNjdlNGVmMGI4ZGQ4YjY5YTFiNTI3NTVfNS0zLTEtMS0yOTQ4OQ_83d10fb2-e29d-4b4f-bb20-53229643b6b2">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i628e73d9b5b54e3bab985a48e170406a_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85MS9mcmFnOjVkZTIwNzU2YmQ5YTQxMWRiYzI4NjJhODYxOWIzOGQzL3RhYmxlOmUwNWZmY2Q3MDY3ZTRlZjBiOGRkOGI2OWExYjUyNzU1L3RhYmxlcmFuZ2U6ZTA1ZmZjZDcwNjdlNGVmMGI4ZGQ4YjY5YTFiNTI3NTVfNi0xLTEtMS0yOTQ4OQ_2b2180db-3b49-4f92-98ae-e9d3f6aa2d55">501,963</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dc531e92c3b4e048c61c11ad6d1e801_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85MS9mcmFnOjVkZTIwNzU2YmQ5YTQxMWRiYzI4NjJhODYxOWIzOGQzL3RhYmxlOmUwNWZmY2Q3MDY3ZTRlZjBiOGRkOGI2OWExYjUyNzU1L3RhYmxlcmFuZ2U6ZTA1ZmZjZDcwNjdlNGVmMGI4ZGQ4YjY5YTFiNTI3NTVfNi0zLTEtMS0yOTQ4OQ_e40cb279-87c4-48ea-9ee4-1cc1dac06f99">441,921</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment originally acquired under finance/capital lease</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85MS9mcmFnOjVkZTIwNzU2YmQ5YTQxMWRiYzI4NjJhODYxOWIzOGQzL3RhYmxlOmUwNWZmY2Q3MDY3ZTRlZjBiOGRkOGI2OWExYjUyNzU1L3RhYmxlcmFuZ2U6ZTA1ZmZjZDcwNjdlNGVmMGI4ZGQ4YjY5YTFiNTI3NTVfNy0xLTEtMS0yOTQ4OQ_62c687f1-d49d-4f3f-90b1-762c752c3e8a">13,971</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85MS9mcmFnOjVkZTIwNzU2YmQ5YTQxMWRiYzI4NjJhODYxOWIzOGQzL3RhYmxlOmUwNWZmY2Q3MDY3ZTRlZjBiOGRkOGI2OWExYjUyNzU1L3RhYmxlcmFuZ2U6ZTA1ZmZjZDcwNjdlNGVmMGI4ZGQ4YjY5YTFiNTI3NTVfNy0zLTEtMS0yOTQ4OQ_9c8b40aa-fab8-4102-bc05-346e58380cb2">13,984</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment cost</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85MS9mcmFnOjVkZTIwNzU2YmQ5YTQxMWRiYzI4NjJhODYxOWIzOGQzL3RhYmxlOmUwNWZmY2Q3MDY3ZTRlZjBiOGRkOGI2OWExYjUyNzU1L3RhYmxlcmFuZ2U6ZTA1ZmZjZDcwNjdlNGVmMGI4ZGQ4YjY5YTFiNTI3NTVfOC0xLTEtMS0yOTQ4OQ_e69749cb-1e38-482e-8b36-885e92583d5f">1,320,700</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85MS9mcmFnOjVkZTIwNzU2YmQ5YTQxMWRiYzI4NjJhODYxOWIzOGQzL3RhYmxlOmUwNWZmY2Q3MDY3ZTRlZjBiOGRkOGI2OWExYjUyNzU1L3RhYmxlcmFuZ2U6ZTA1ZmZjZDcwNjdlNGVmMGI4ZGQ4YjY5YTFiNTI3NTVfOC0zLTEtMS0yOTQ4OQ_ce745406-7946-4de0-8c59-2da7c1796390">1,161,222</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85MS9mcmFnOjVkZTIwNzU2YmQ5YTQxMWRiYzI4NjJhODYxOWIzOGQzL3RhYmxlOmUwNWZmY2Q3MDY3ZTRlZjBiOGRkOGI2OWExYjUyNzU1L3RhYmxlcmFuZ2U6ZTA1ZmZjZDcwNjdlNGVmMGI4ZGQ4YjY5YTFiNTI3NTVfOS0xLTEtMS0yOTQ4OQ_e8b18a88-f0ce-48d6-a890-6d998699153a">754,739</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85MS9mcmFnOjVkZTIwNzU2YmQ5YTQxMWRiYzI4NjJhODYxOWIzOGQzL3RhYmxlOmUwNWZmY2Q3MDY3ZTRlZjBiOGRkOGI2OWExYjUyNzU1L3RhYmxlcmFuZ2U6ZTA1ZmZjZDcwNjdlNGVmMGI4ZGQ4YjY5YTFiNTI3NTVfOS0zLTEtMS0yOTQ4OQ_1fb1b08a-72ea-49cc-a3b2-7502ebb40e44">676,975</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85MS9mcmFnOjVkZTIwNzU2YmQ5YTQxMWRiYzI4NjJhODYxOWIzOGQzL3RhYmxlOmUwNWZmY2Q3MDY3ZTRlZjBiOGRkOGI2OWExYjUyNzU1L3RhYmxlcmFuZ2U6ZTA1ZmZjZDcwNjdlNGVmMGI4ZGQ4YjY5YTFiNTI3NTVfMTItMS0xLTEtMjk0ODk_437c11e7-9500-409d-ad84-8afde0252734">565,961</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85MS9mcmFnOjVkZTIwNzU2YmQ5YTQxMWRiYzI4NjJhODYxOWIzOGQzL3RhYmxlOmUwNWZmY2Q3MDY3ZTRlZjBiOGRkOGI2OWExYjUyNzU1L3RhYmxlcmFuZ2U6ZTA1ZmZjZDcwNjdlNGVmMGI4ZGQ4YjY5YTFiNTI3NTVfMTItMy0xLTEtMjk0ODk_f5ab751b-3359-4cef-a619-dbc11d166d9e">484,247</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in our property and equipment at December 31, 2022  is approximately $<ix:nonFraction unitRef="usd" contextRef="i08ea7357bc1b48619f5f3b7216b20254_I20221231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85MS9mcmFnOjVkZTIwNzU2YmQ5YTQxMWRiYzI4NjJhODYxOWIzOGQzL3RleHRyZWdpb246NWRlMjA3NTZiZDlhNDExZGJjMjg2MmE4NjE5YjM4ZDNfMjEw_8bf23b17-59ce-4ef5-b559-8ce10b0e8c80">73.4</ix:nonFraction> million total of construction in process amounts consisting of $<ix:nonFraction unitRef="usd" contextRef="ie245ad8af20a43b28a6758228cc88b11_I20221231" decimals="-5" name="us-gaap:ConstructionInProgressGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85MS9mcmFnOjVkZTIwNzU2YmQ5YTQxMWRiYzI4NjJhODYxOWIzOGQzL3RleHRyZWdpb246NWRlMjA3NTZiZDlhNDExZGJjMjg2MmE4NjE5YjM4ZDNfMjY4_c0a8651a-babb-495d-88c3-2a6fb282ecbd">26.6</ix:nonFraction> million in medical equipment, $<ix:nonFraction unitRef="usd" contextRef="iab7ce7f316034c05b56c7a6f0d599bb4_I20221231" decimals="-5" name="us-gaap:ConstructionInProgressGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85MS9mcmFnOjVkZTIwNzU2YmQ5YTQxMWRiYzI4NjJhODYxOWIzOGQzL3RleHRyZWdpb246NWRlMjA3NTZiZDlhNDExZGJjMjg2MmE4NjE5YjM4ZDNfMjkz_aeb3fe79-124e-4cc4-886f-488df07d8e64">5.3</ix:nonFraction> million in computer and office equipment, $<ix:nonFraction unitRef="usd" contextRef="idd3d3e3e547648dd8ffe8630809ea423_I20221231" decimals="-5" name="us-gaap:ConstructionInProgressGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85MS9mcmFnOjVkZTIwNzU2YmQ5YTQxMWRiYzI4NjJhODYxOWIzOGQzL3RleHRyZWdpb246NWRlMjA3NTZiZDlhNDExZGJjMjg2MmE4NjE5YjM4ZDNfMTA5OTUxMTYyODgyMA_bfe759a9-af4b-48db-925e-0aa59dd4409c">0.4</ix:nonFraction> million in software development and $<ix:nonFraction unitRef="usd" contextRef="i628e73d9b5b54e3bab985a48e170406a_I20221231" decimals="-5" name="us-gaap:ConstructionInProgressGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85MS9mcmFnOjVkZTIwNzU2YmQ5YTQxMWRiYzI4NjJhODYxOWIzOGQzL3RleHRyZWdpb246NWRlMjA3NTZiZDlhNDExZGJjMjg2MmE4NjE5YjM4ZDNfMzM0_06aa4769-50c9-4600-aa04-cf777a7e8306">41.1</ix:nonFraction> million in leasehold improvements.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in our property and equipment at December 31, 2021 is approximately $<ix:nonFraction unitRef="usd" contextRef="ie1c8ab68fe024b7a8859d4b269c75b02_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85MS9mcmFnOjVkZTIwNzU2YmQ5YTQxMWRiYzI4NjJhODYxOWIzOGQzL3RleHRyZWdpb246NWRlMjA3NTZiZDlhNDExZGJjMjg2MmE4NjE5YjM4ZDNfMTA5OTUxMTYyOTE3Mw_36e8fcff-0ae3-490f-aada-49125b57fa08">18.1</ix:nonFraction> million total of construction in process amounts consisting of $<ix:nonFraction unitRef="usd" contextRef="i7fd7963b7541486ba64acd58081d4289_I20211231" decimals="-5" name="us-gaap:ConstructionInProgressGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85MS9mcmFnOjVkZTIwNzU2YmQ5YTQxMWRiYzI4NjJhODYxOWIzOGQzL3RleHRyZWdpb246NWRlMjA3NTZiZDlhNDExZGJjMjg2MmE4NjE5YjM4ZDNfMTA5OTUxMTYyOTE3OQ_3fdc29e6-55c9-4c42-8670-853aa4bf3089">2.6</ix:nonFraction> million in medical equipment, $<ix:nonFraction unitRef="usd" contextRef="ia4939d9e3309469392b03a7b6fed19d2_I20211231" decimals="-5" name="us-gaap:ConstructionInProgressGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85MS9mcmFnOjVkZTIwNzU2YmQ5YTQxMWRiYzI4NjJhODYxOWIzOGQzL3RleHRyZWdpb246NWRlMjA3NTZiZDlhNDExZGJjMjg2MmE4NjE5YjM4ZDNfMTA5OTUxMTYyOTE4Ng_3e4c7fb8-58a6-4ee2-b085-cb51bf85867f">6.1</ix:nonFraction> million in computer and office equipment, and $<ix:nonFraction unitRef="usd" contextRef="i6dc531e92c3b4e048c61c11ad6d1e801_I20211231" decimals="-5" name="us-gaap:ConstructionInProgressGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85MS9mcmFnOjVkZTIwNzU2YmQ5YTQxMWRiYzI4NjJhODYxOWIzOGQzL3RleHRyZWdpb246NWRlMjA3NTZiZDlhNDExZGJjMjg2MmE4NjE5YjM4ZDNfMTA5OTUxMTYyOTI0Mg_704f2389-e263-4609-a0c7-5a43169ed1d3">9.3</ix:nonFraction> million in leasehold improvements.</span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i73ced35f2ab14cdabb8ecd09ee19fbe2">Depreciation and amortization expense of property and equipment, including amortization of equipment under finance leases, for the years ended December 31, 2022, 2021 and 2020 was $<ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-5" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85MS9mcmFnOjVkZTIwNzU2YmQ5YTQxMWRiYzI4NjJhODYxOWIzOGQzL3RleHRyZWdpb246NWRlMjA3NTZiZDlhNDExZGJjMjg2MmE4NjE5YjM4ZDNfNTM0_c2a258f4-257b-45c4-b98c-b1512a9bdb00">105.6</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-5" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85MS9mcmFnOjVkZTIwNzU2YmQ5YTQxMWRiYzI4NjJhODYxOWIzOGQzL3RleHRyZWdpb246NWRlMjA3NTZiZDlhNDExZGJjMjg2MmE4NjE5YjM4ZDNfNTM4_41cca87f-0796-41b5-b01b-5b54d077bb25">92.3</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-5" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85MS9mcmFnOjVkZTIwNzU2YmQ5YTQxMWRiYzI4NjJhODYxOWIzOGQzL3RleHRyZWdpb246NWRlMjA3NTZiZDlhNDExZGJjMjg2MmE4NjE5YjM4ZDNfNTQ2_d61f0743-e761-4798-bbb1-a420f9d63f61">83.1</ix:nonFraction> million, respectively.</ix:continuation> </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="if3f80771944f4fc58015abda42dc47d1_97"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 8 - <ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfOTg3Mg_dbf636de-464e-4180-b30c-273134e8b608" continuedAt="i67adf6c357df450daed9082b6341cdbb" escape="true">CREDIT FACILITIES AND NOTES PAYABLE</ix:nonNumeric></span></div><ix:continuation id="i67adf6c357df450daed9082b6341cdbb" continuedAt="ie6e2f654a31247cb8f1f552f65cedbac"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="us-gaap:ScheduleOfDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfOTg2OA_fdbcf2df-699f-43d9-a1c0-72c83ae1ed47" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022 and December 31, 2021 our debt obligations consisted of the following (in thousands):</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Lien Term Loans collateralized by RadNet's tangible and intangible assets</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i522481570141465585681f5b994a0bcb_I20221231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOmRjNTNhNDE2MzA5YjQ1NDE5M2I5Njk2ODRkYWViNmRhL3RhYmxlcmFuZ2U6ZGM1M2E0MTYzMDliNDU0MTkzYjk2OTY4NGRhZWI2ZGFfMS0xLTEtMS0yOTQ4OQ_fb7bb527-481a-4901-962e-b2290cf48596">714,125</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54b3674416244d4db4d21de83d7cbbde_I20211231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOmRjNTNhNDE2MzA5YjQ1NDE5M2I5Njk2ODRkYWViNmRhL3RhYmxlcmFuZ2U6ZGM1M2E0MTYzMDliNDU0MTkzYjk2OTY4NGRhZWI2ZGFfMS0zLTEtMS0yOTQ4OQ_26eeea88-47b8-49d3-a6fa-67694124376d">721,375</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount on First Lien Term Loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i522481570141465585681f5b994a0bcb_I20221231" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOmRjNTNhNDE2MzA5YjQ1NDE5M2I5Njk2ODRkYWViNmRhL3RhYmxlcmFuZ2U6ZGM1M2E0MTYzMDliNDU0MTkzYjk2OTY4NGRhZWI2ZGFfMi0xLTEtMS0yOTQ4OQ_aacfc4d2-a8ae-4a16-8f32-fb684cbdc9a1">11,127</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54b3674416244d4db4d21de83d7cbbde_I20211231" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOmRjNTNhNDE2MzA5YjQ1NDE5M2I5Njk2ODRkYWViNmRhL3RhYmxlcmFuZ2U6ZGM1M2E0MTYzMDliNDU0MTkzYjk2OTY4NGRhZWI2ZGFfMi0zLTEtMS0yOTQ4OQ_8f39c874-6a5d-44aa-a711-c1098c6ff3f1">13,213</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan Agreement collateralized by NJIN's tangible and intangible assets</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7864c4b6f44e46a09a513ac84d7d21ec_I20221231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOmRjNTNhNDE2MzA5YjQ1NDE5M2I5Njk2ODRkYWViNmRhL3RhYmxlcmFuZ2U6ZGM1M2E0MTYzMDliNDU0MTkzYjk2OTY4NGRhZWI2ZGFfMy0xLTEtMS0yOTQ4OQ_8395a2f5-2c78-451c-ae69-e5523eb70a84">150,000</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38719d8a10de43ad8f49713e3df85eba_I20211231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOmRjNTNhNDE2MzA5YjQ1NDE5M2I5Njk2ODRkYWViNmRhL3RhYmxlcmFuZ2U6ZGM1M2E0MTYzMDliNDU0MTkzYjk2OTY4NGRhZWI2ZGFfMy0zLTEtMS0yOTQ4OQ_30df9359-1e44-46ad-8dda-2f311bb0f57a">46,500</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount on NJIN Term Loan Agreement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7864c4b6f44e46a09a513ac84d7d21ec_I20221231" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOmRjNTNhNDE2MzA5YjQ1NDE5M2I5Njk2ODRkYWViNmRhL3RhYmxlcmFuZ2U6ZGM1M2E0MTYzMDliNDU0MTkzYjk2OTY4NGRhZWI2ZGFfNC0xLTEtMS0yOTQ4OQ_6055d763-2d45-4148-b601-66745c6f0d89">1,254</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38719d8a10de43ad8f49713e3df85eba_I20211231" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOmRjNTNhNDE2MzA5YjQ1NDE5M2I5Njk2ODRkYWViNmRhL3RhYmxlcmFuZ2U6ZGM1M2E0MTYzMDliNDU0MTkzYjk2OTY4NGRhZWI2ZGFfNC0zLTEtMS0yOTQ4OQ_219c6e85-b984-4367-8f06-a847273dd6c1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt obligations</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOmRjNTNhNDE2MzA5YjQ1NDE5M2I5Njk2ODRkYWViNmRhL3RhYmxlcmFuZ2U6ZGM1M2E0MTYzMDliNDU0MTkzYjk2OTY4NGRhZWI2ZGFfNS0xLTEtMS0yOTQ4OQ_ecfd2b3c-6313-4bb9-ac58-2ab94bc741ef">851,744</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOmRjNTNhNDE2MzA5YjQ1NDE5M2I5Njk2ODRkYWViNmRhL3RhYmxlcmFuZ2U6ZGM1M2E0MTYzMDliNDU0MTkzYjk2OTY4NGRhZWI2ZGFfNS0zLTEtMS0yOTQ4OQ_c254cade-e081-4045-bebc-8ff07bedfa44">754,662</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOmRjNTNhNDE2MzA5YjQ1NDE5M2I5Njk2ODRkYWViNmRhL3RhYmxlcmFuZ2U6ZGM1M2E0MTYzMDliNDU0MTkzYjk2OTY4NGRhZWI2ZGFfNi0xLTEtMS0yOTQ4OQ_ecabfdb1-ccb6-4760-9d62-025296c508c0">12,400</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOmRjNTNhNDE2MzA5YjQ1NDE5M2I5Njk2ODRkYWViNmRhL3RhYmxlcmFuZ2U6ZGM1M2E0MTYzMDliNDU0MTkzYjk2OTY4NGRhZWI2ZGFfNi0zLTEtMS0yOTQ4OQ_1e4527ea-ef12-4567-9f14-38112b9569e3">11,164</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term portion debt obligations</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOmRjNTNhNDE2MzA5YjQ1NDE5M2I5Njk2ODRkYWViNmRhL3RhYmxlcmFuZ2U6ZGM1M2E0MTYzMDliNDU0MTkzYjk2OTY4NGRhZWI2ZGFfNy0xLTEtMS0yOTQ4OQ_22b7758d-7d9f-4be8-8cd5-c01b2d378ec3">839,344</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOmRjNTNhNDE2MzA5YjQ1NDE5M2I5Njk2ODRkYWViNmRhL3RhYmxlcmFuZ2U6ZGM1M2E0MTYzMDliNDU0MTkzYjk2OTY4NGRhZWI2ZGFfNy0zLTEtMS0yOTQ4OQ_87bcddd8-d90c-4730-9a39-6a7a44319718">743,498</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfOTg2Mg_65597823-e62e-4510-baef-297cc5093b27" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a listing of annual principal maturities of notes payable exclusive of all related discounts and repayments on our revolving credit facilities for years ending December&#160;31 (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:84.090%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.710%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOmYyMDIzNTVkYzAzNTQxODA5YTRkMzU2YzZmYjE3MTQzL3RhYmxlcmFuZ2U6ZjIwMjM1NWRjMDM1NDE4MDlhNGQzNTZjNmZiMTcxNDNfMC0xLTEtMS0yOTQ4OQ_f7a13e4e-e7e3-4060-a0cc-3595521370e7">14,750</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOmYyMDIzNTVkYzAzNTQxODA5YTRkMzU2YzZmYjE3MTQzL3RhYmxlcmFuZ2U6ZjIwMjM1NWRjMDM1NDE4MDlhNGQzNTZjNmZiMTcxNDNfMS0xLTEtMS0yOTQ4OQ_1e9ca1e8-c8e1-47c2-b87b-b2efeaadb2c1">14,750</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOmYyMDIzNTVkYzAzNTQxODA5YTRkMzU2YzZmYjE3MTQzL3RhYmxlcmFuZ2U6ZjIwMjM1NWRjMDM1NDE4MDlhNGQzNTZjNmZiMTcxNDNfMi0xLTEtMS0yOTQ4OQ_5293cd2c-7ed1-4276-9627-a205b4d14bed">18,500</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOmYyMDIzNTVkYzAzNTQxODA5YTRkMzU2YzZmYjE3MTQzL3RhYmxlcmFuZ2U6ZjIwMjM1NWRjMDM1NDE4MDlhNGQzNTZjNmZiMTcxNDNfMy0xLTEtMS0yOTQ4OQ_fa77c5df-0a10-4a87-af14-dbd3d6972945">18,500</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOmYyMDIzNTVkYzAzNTQxODA5YTRkMzU2YzZmYjE3MTQzL3RhYmxlcmFuZ2U6ZjIwMjM1NWRjMDM1NDE4MDlhNGQzNTZjNmZiMTcxNDNfNC0xLTEtMS0yOTQ4OQ_04dc23d5-1609-4686-b83a-badd2a9e2ae3">119,750</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOmYyMDIzNTVkYzAzNTQxODA5YTRkMzU2YzZmYjE3MTQzL3RhYmxlcmFuZ2U6ZjIwMjM1NWRjMDM1NDE4MDlhNGQzNTZjNmZiMTcxNDNfNS0xLTEtMS0yOTQ4OQ_f3a182fe-6642-4c62-ba54-cc4d784ce54a">677,875</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total notes payable obligations</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOmYyMDIzNTVkYzAzNTQxODA5YTRkMzU2YzZmYjE3MTQzL3RhYmxlcmFuZ2U6ZjIwMjM1NWRjMDM1NDE4MDlhNGQzNTZjNmZiMTcxNDNfNi0xLTEtMS0yOTQ4OQ_a43fccaf-cb2e-4843-a508-d65b945ca995">864,125</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had <ix:nonFraction unitRef="usd" contextRef="i78f5077e0f824294be47554965869037_I20221231" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfMzg2_28c23e62-6d7a-4aef-a86d-5cecb17b9c89">no</ix:nonFraction> outstanding balance under our $<ix:nonFraction unitRef="usd" contextRef="i2923158472984ab081c98c126fa64e96_I20221231" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfNDE5_c6f1edb7-82b7-4798-bba4-2c325c4e1618">195.0</ix:nonFraction> million Barclays Revolving Credit Facility at December 31, 2022 and had reserved an additional $<ix:nonFraction unitRef="usd" contextRef="ia72ba28711ea41c3b84011425ee45d0f_I20221231" decimals="-5" name="us-gaap:LettersOfCreditOutstandingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfNDk0_5b5276db-d608-4c1a-b921-83c5f68c87f8">7.6</ix:nonFraction> million for certain letters of credit.  The remaining $<ix:nonFraction unitRef="usd" contextRef="i2d9d403debfc473bafd93ca110c28e57_I20221231" decimals="-5" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfNTQz_6f8cb3c9-51f5-4820-9fc0-5a61afd00d8b">187.4</ix:nonFraction> million of our Barclays Revolving Credit Facility was available to draw upon as of  December 31, 2022.  We also had <ix:nonFraction unitRef="usd" contextRef="i1d36672d0c054968b7578c42cf79bd8c_I20221231" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfNjM5_62e087ef-8b49-44a9-8018-36db80f157ee">no</ix:nonFraction> balance under our $<ix:nonFraction unitRef="usd" contextRef="ic33fc421ee274ecb81ba734b51c43318_I20221231" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfNjYw_f3516232-3e0f-48cd-8c7d-09db7c72f629">50.0</ix:nonFraction> million Truist Revolving Credit Facility related to our consolidated subsidiary NJIN at December 31, 2022, and with no letters </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ie6e2f654a31247cb8f1f552f65cedbac" continuedAt="i116496e3d0b549f0829fc0aa5e697de0"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of credit reserved against the facility, the full amount was available to draw upon. At December 31, 2022 we were in compliance with all covenants under our credit facilities.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Amendments to Credit Facilities</span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Barclays: Second Amended and Restated First Lien Credit and Guaranty Agreement</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 23, 2021, we entered into the Second Amended and Restated First Lien Credit and Guaranty Agreement (the  "Restated Credit Agreement") which provides for $<ix:nonFraction unitRef="usd" contextRef="ib78b9355051b47d5a52646928c50c333_I20210423" decimals="-5" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfMTE2MQ_58b12361-5722-4b08-8961-f06ed5aa3544">725.0</ix:nonFraction> million of senior secured first lien term loans (the "First Lien Term Loans") and a $<ix:nonFraction unitRef="usd" contextRef="i2923158472984ab081c98c126fa64e96_I20221231" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfMTI0MA_c6f1edb7-82b7-4798-bba4-2c325c4e1618">195.0</ix:nonFraction> million senior secured revolving credit facility (the "Barclays Revolving Credit Facility"). The proceeds of the First Lien Term Loans were used to refinance loans outstanding under our prior first lien credit agreement and provide funding for current and future operations. Total costs of the Restated Credit Agreement amounted to approximately $<ix:nonFraction unitRef="usd" contextRef="i659ee446c43548e9bf27ed0a4061b5ab_I20210423" decimals="-5" name="us-gaap:DeferredFinanceCostsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfMTU4MQ_366a54f6-3da1-4034-b46a-a9ea98ba76f7">14.9</ix:nonFraction> million segregated as follows: $<ix:nonFraction unitRef="usd" contextRef="i659ee446c43548e9bf27ed0a4061b5ab_I20210423" decimals="-5" name="us-gaap:DebtInstrumentUnamortizedDiscountCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfMTYwNw_c6ff1f5b-d3db-4a34-84fe-b80ab12b01e2">8.8</ix:nonFraction> million capitalized to discount and deferred finance cost, $<ix:nonFraction unitRef="usd" contextRef="i56152cb4c4e24493b5d3fdbbd09acf47_D20210423-20210423" decimals="-5" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfMTcwMg_599104dc-6168-4724-bd6d-5ea1201a61dd">6.0</ix:nonFraction> million charged to loss on early extinguishment of debt and related expenses and $<ix:nonFraction unitRef="usd" contextRef="ie23d788887204110a462554db069f44b_D20210423-20210423" decimals="-5" name="us-gaap:AmortizationOfDeferredCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfMTc1Nw_8a196050-565e-4296-80c8-db255e9acaab">0.1</ix:nonFraction> million written off to interest expense.  Amounts capitalized will be amortized over the remaining terms of the respective credit facilities under the Restated Credit Agreement.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Truist: Second Amended and Restated Revolving Credit and Term Loan Agreement</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 7, 2022, we entered into the Second Amended and Restated Revolving Credit and Term Loan Agreement (the "Restated Credit and Term Loan Agreement") which provides for a $<ix:nonFraction unitRef="usd" contextRef="ieec8243d9ccc44119f604da882ab8f72_I20221007" decimals="-5" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfMTA5OTUxMTY0OTM2OQ_14350059-4ce8-4469-b6c7-aa2e91e1c50b">150.0</ix:nonFraction> million of a secured term loan (the "Truist Term Loan") and a $<ix:nonFraction unitRef="usd" contextRef="i6ecd3750a3b74bbda768365b8ab639d7_I20221007" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfMTA5OTUxMTY0OTY4Nw_95e8b813-fd88-412e-8184-4306cd03d62d">50.0</ix:nonFraction> million secured revolving credit facility (the "Truist Revolving Credit Facility").  Both loans were secured by our simultaneous entry into the Second Amended and Restated Guaranty and Security Agreement on the same date.  The proceeds were were used to refinance the outstanding balance under our prior term loan agreement and provide funding for current and future operations. Total costs of the Restated Credit and Term Loan Agreement amounted to approximately $<ix:nonFraction unitRef="usd" contextRef="i199f459e5ce14f77a34aef36dbc62bff_I20221007" decimals="-5" name="us-gaap:DeferredFinanceCostsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfMTA5OTUxMTY1Mjc0OA_9bd12a7d-0c83-42c0-84b2-9246036e0859">2.7</ix:nonFraction> million segregated as follows: $<ix:nonFraction unitRef="usd" contextRef="i199f459e5ce14f77a34aef36dbc62bff_I20221007" decimals="-5" name="us-gaap:DebtInstrumentUnamortizedDiscountCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfMTA5OTUxMTY1Mjc2Ng_a15a0a71-6f16-4a91-9fbd-88ddae9c5503">2.0</ix:nonFraction> million capitalized to discount and deferred finance cost and $<ix:nonFraction unitRef="usd" contextRef="iccbc7b1f30b74634bd5e6b0535972448_D20210423-20210423" decimals="-5" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfMTA5OTUxMTY1Mjc4Mw_87c83058-0d62-47bc-bc11-d022d6de8536">0.7</ix:nonFraction> million expensed to loss on extinguishment of debt and related expenses in other expense.  Amounts capitalized will be amortized over the remaining terms of the respective credit facilities under the Restated Credit and Term Loan Agreement.</span></div><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="rdnt:ScheduleOfLeverageRatioTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfMTU5NDI5MTg2MzM3NjQ_8b962515-3c73-44e1-83b6-b6f3f16cdf64" continuedAt="i79b0b5db183c4d68ab7540674d0c5f8d" escape="true"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All obligations under the Second Amended and Restated Credit and Term Loan Agreement bear interest at either a SOFR or a Base Rate (each as defined in the Restated Credit and Term Loan Agreement), plus an applicable margin according to the following schedule:</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.128%"><tr><td style="width:1.0%"></td><td style="width:8.790%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.761%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.697%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.700%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pricing Level</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Leverage Ratio</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Applicable Margin for SOFR Loans</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Applicable Margin for Base Rate Loans</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Applicable Margin for Letter of Credit Fees</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Applicable Percentage for Commitment Fee</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than or equal to <ix:nonFraction unitRef="number" contextRef="i8b41d8242f3040fb8331b37d34fcd9d2_I20221231" decimals="INF" name="rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOjBmNmFhYzUyZTNjNTRmODJhNjI0ODZiYTQ4YTQ5M2IxL3RhYmxlcmFuZ2U6MGY2YWFjNTJlM2M1NGY4MmE2MjQ4NmJhNDhhNDkzYjFfMS0xLTEtMS02Mzg2OC90ZXh0cmVnaW9uOjdiNmEwNjRmZWY0NjQ3NTFhOWI4Y2JiNzc1Y2EyODkwXzI5_0a4127c4-9126-4d64-8b3f-db91728c3f6b">3.00</ix:nonFraction>:1.00</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4318f7e3746943799936274358bb5174_D20220101-20221231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOjBmNmFhYzUyZTNjNTRmODJhNjI0ODZiYTQ4YTQ5M2IxL3RhYmxlcmFuZ2U6MGY2YWFjNTJlM2M1NGY4MmE2MjQ4NmJhNDhhNDkzYjFfMS0yLTEtMS02Mzg2OC90ZXh0cmVnaW9uOjg4MWRlNWY4YmE0ZTRmYWVhMjA3YzgyMGQ3NjU4YjgzXzU_5a4986b5-52dd-41cb-a8aa-86ddbc8d4914">2.50</ix:nonFraction>%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2ee298d0e61e459396a35b628ee2244d_D20220101-20221231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOjBmNmFhYzUyZTNjNTRmODJhNjI0ODZiYTQ4YTQ5M2IxL3RhYmxlcmFuZ2U6MGY2YWFjNTJlM2M1NGY4MmE2MjQ4NmJhNDhhNDkzYjFfMS0zLTEtMS02Mzg2OC90ZXh0cmVnaW9uOmI2NzQzMTFmNzkyMTQ5YTJiZTg2MjRjNWNiZGIwNTMwXzU_f0ecc19b-9264-4931-8c59-3210c593dfd9">1.50</ix:nonFraction>%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i25ec9150f13743ed97836354e90ebc7e_D20220101-20221231" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOjBmNmFhYzUyZTNjNTRmODJhNjI0ODZiYTQ4YTQ5M2IxL3RhYmxlcmFuZ2U6MGY2YWFjNTJlM2M1NGY4MmE2MjQ4NmJhNDhhNDkzYjFfMS00LTEtMS02Mzg2OC90ZXh0cmVnaW9uOjIwNjc3ZGE2MjRiMTQyMzI4ZmIwODU3NWEzN2Y1NGJmXzU_a4b23842-3479-4e77-a4b5-8a8b438cd843">2.50</ix:nonFraction>%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i25ec9150f13743ed97836354e90ebc7e_D20220101-20221231" decimals="INF" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOjBmNmFhYzUyZTNjNTRmODJhNjI0ODZiYTQ4YTQ5M2IxL3RhYmxlcmFuZ2U6MGY2YWFjNTJlM2M1NGY4MmE2MjQ4NmJhNDhhNDkzYjFfMS01LTEtMS02Mzg2OC90ZXh0cmVnaW9uOmIwYjM2MWUyMDMyMzQ1MjY5N2Q1OWU4MmVkNGE2NGQwXzU_e6b1c0a9-97ee-42eb-8de0-dcf118792331">0.45</ix:nonFraction>%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">II</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than <ix:nonFraction unitRef="number" contextRef="id97b4431c3884e1faeb084da481dbb28_I20221231" decimals="INF" name="rdnt:DebtInstrumentCovenantLeverageRatioMaximum" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOjBmNmFhYzUyZTNjNTRmODJhNjI0ODZiYTQ4YTQ5M2IxL3RhYmxlcmFuZ2U6MGY2YWFjNTJlM2M1NGY4MmE2MjQ4NmJhNDhhNDkzYjFfMi0xLTEtMS02Mzg2OC90ZXh0cmVnaW9uOmQ3ODFkY2Q3MzhjMDRlOGViOWMzYzdkOWNhNTRkNTJiXzE0_5052a5f5-fd31-4a9b-b693-4c7b91dace11">3.00</ix:nonFraction>:1.00 but greater than or equal to <ix:nonFraction unitRef="number" contextRef="id97b4431c3884e1faeb084da481dbb28_I20221231" decimals="INF" name="rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOjBmNmFhYzUyZTNjNTRmODJhNjI0ODZiYTQ4YTQ5M2IxL3RhYmxlcmFuZ2U6MGY2YWFjNTJlM2M1NGY4MmE2MjQ4NmJhNDhhNDkzYjFfMi0xLTEtMS02Mzg2OC90ZXh0cmVnaW9uOmQ3ODFkY2Q3MzhjMDRlOGViOWMzYzdkOWNhNTRkNTJiXzUx_e006a772-6bf4-4905-8555-72f4770a8b9d">2.50</ix:nonFraction>:1.00</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1571e82796a8423a8fe38d602a05f3eb_D20220101-20221231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOjBmNmFhYzUyZTNjNTRmODJhNjI0ODZiYTQ4YTQ5M2IxL3RhYmxlcmFuZ2U6MGY2YWFjNTJlM2M1NGY4MmE2MjQ4NmJhNDhhNDkzYjFfMi0yLTEtMS02Mzg2OC90ZXh0cmVnaW9uOjVjMGI1NDliY2FhZTRiZmRhYWRkM2IzMzVmMGY4NGVlXzU_92e02792-b01e-4a8a-9307-32437ffc24ab">2.25</ix:nonFraction>%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia957fac5b3fc45788abdc13188550c17_D20220101-20221231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOjBmNmFhYzUyZTNjNTRmODJhNjI0ODZiYTQ4YTQ5M2IxL3RhYmxlcmFuZ2U6MGY2YWFjNTJlM2M1NGY4MmE2MjQ4NmJhNDhhNDkzYjFfMi0zLTEtMS02Mzg2OC90ZXh0cmVnaW9uOmUyODU4ZWJlOGJkNzQxNTBiZWY5MzhmYWM1OTMzYmM5XzU_85212080-5b23-4f3c-858c-560b25669221">1.25</ix:nonFraction>%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib804538af1af4cbda91f1ab7a1b84f7b_D20220101-20221231" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOjBmNmFhYzUyZTNjNTRmODJhNjI0ODZiYTQ4YTQ5M2IxL3RhYmxlcmFuZ2U6MGY2YWFjNTJlM2M1NGY4MmE2MjQ4NmJhNDhhNDkzYjFfMi00LTEtMS02Mzg2OC90ZXh0cmVnaW9uOmI2MWM4YmQxMmMwMjRiOGI4MGY5OTMxODQ5Mjk1YjYxXzU_addf6e6e-d705-4721-a4a5-b43e85fdb777">2.25</ix:nonFraction>%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib804538af1af4cbda91f1ab7a1b84f7b_D20220101-20221231" decimals="INF" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOjBmNmFhYzUyZTNjNTRmODJhNjI0ODZiYTQ4YTQ5M2IxL3RhYmxlcmFuZ2U6MGY2YWFjNTJlM2M1NGY4MmE2MjQ4NmJhNDhhNDkzYjFfMi01LTEtMS02Mzg2OC90ZXh0cmVnaW9uOmI2MDI4ZGMzNDc0ZDQwN2Q4MTRkMzUwN2JjYTg0OTdhXzU_0f5ba1fa-39dc-416c-9c29-073740dd4b60">0.40</ix:nonFraction>%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">III</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than <ix:nonFraction unitRef="number" contextRef="i557a45553f2a40f7b25201fe169750a7_I20221231" decimals="INF" name="rdnt:DebtInstrumentCovenantLeverageRatioMaximum" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOjBmNmFhYzUyZTNjNTRmODJhNjI0ODZiYTQ4YTQ5M2IxL3RhYmxlcmFuZ2U6MGY2YWFjNTJlM2M1NGY4MmE2MjQ4NmJhNDhhNDkzYjFfMy0xLTEtMS02Mzg2OC90ZXh0cmVnaW9uOmFjNWNlZjZjN2Q2YzRlZWZiMTEzMGQ1YzQzYTYxZmYxXzE1_ba46fd7f-5b77-4ca4-aa86-d11efc3fcbdf">2.50</ix:nonFraction>:1.00 but greater than or equal to</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i557a45553f2a40f7b25201fe169750a7_I20221231" decimals="INF" name="rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOjBmNmFhYzUyZTNjNTRmODJhNjI0ODZiYTQ4YTQ5M2IxL3RhYmxlcmFuZ2U6MGY2YWFjNTJlM2M1NGY4MmE2MjQ4NmJhNDhhNDkzYjFfMy0xLTEtMS02Mzg2OC90ZXh0cmVnaW9uOmFjNWNlZjZjN2Q2YzRlZWZiMTEzMGQ1YzQzYTYxZmYxXzUy_cb1db7e9-3aa8-45a1-9ec4-8c200d635911">2.00</ix:nonFraction>:1.00</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4f520487af9f4cf3a4d4e00bacc10a81_D20220101-20221231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOjBmNmFhYzUyZTNjNTRmODJhNjI0ODZiYTQ4YTQ5M2IxL3RhYmxlcmFuZ2U6MGY2YWFjNTJlM2M1NGY4MmE2MjQ4NmJhNDhhNDkzYjFfMy0yLTEtMS02Mzg2OC90ZXh0cmVnaW9uOjU4NDA3MzI4YzI0ODQ5NmVhMjQ4YTFiZjdhYzIxNzdmXzU_d1c5f8b0-26a7-453d-b9e6-b807fe6ceb25">2.00</ix:nonFraction>%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i312118f202904e5e9d26cd7cb00d4237_D20220101-20221231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOjBmNmFhYzUyZTNjNTRmODJhNjI0ODZiYTQ4YTQ5M2IxL3RhYmxlcmFuZ2U6MGY2YWFjNTJlM2M1NGY4MmE2MjQ4NmJhNDhhNDkzYjFfMy0zLTEtMS02Mzg2OC90ZXh0cmVnaW9uOmExZGJlYjE5OTZkMjQwMzc5YjIxMTk3YzZkNjJhYzgzXzU_f03f178d-a3d6-4585-b379-eeefe77f2b0b">1.00</ix:nonFraction>%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i856b0cb40d214a9b97efb4927aab7f8f_D20220101-20221231" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOjBmNmFhYzUyZTNjNTRmODJhNjI0ODZiYTQ4YTQ5M2IxL3RhYmxlcmFuZ2U6MGY2YWFjNTJlM2M1NGY4MmE2MjQ4NmJhNDhhNDkzYjFfMy00LTEtMS02Mzg2OC90ZXh0cmVnaW9uOjFkYWQ2YWI5ZjYwOTQzYzg5YjcxMzJmZDgxMzY2YmYzXzU_43fc644e-900b-4503-82a9-748f28614c59">2.00</ix:nonFraction>%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i856b0cb40d214a9b97efb4927aab7f8f_D20220101-20221231" decimals="INF" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOjBmNmFhYzUyZTNjNTRmODJhNjI0ODZiYTQ4YTQ5M2IxL3RhYmxlcmFuZ2U6MGY2YWFjNTJlM2M1NGY4MmE2MjQ4NmJhNDhhNDkzYjFfMy01LTEtMS02Mzg2OC90ZXh0cmVnaW9uOmQ2ZWRhNmMxZjU1ODQxNGVhMDdiOTJkMDY4OWJlZWEwXzU_01b5aac0-490f-4dba-acc4-171f74f5070c">0.35</ix:nonFraction>%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IV</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than <ix:nonFraction unitRef="number" contextRef="ie662bee09b1e4c1c86dbd8597e67cc62_I20221231" decimals="INF" name="rdnt:DebtInstrumentCovenantLeverageRatioMaximum" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOjBmNmFhYzUyZTNjNTRmODJhNjI0ODZiYTQ4YTQ5M2IxL3RhYmxlcmFuZ2U6MGY2YWFjNTJlM2M1NGY4MmE2MjQ4NmJhNDhhNDkzYjFfNC0xLTEtMS02Mzg2OC90ZXh0cmVnaW9uOmE5ZjRjMWMxNzljZDRhODU5ZTc0MTRhMjllNDBjZDJmXzE0_d7c94fdd-43e6-4937-8210-d15f916bf002">2.00</ix:nonFraction>:1.00 but greater than or equal to <ix:nonFraction unitRef="number" contextRef="ie662bee09b1e4c1c86dbd8597e67cc62_I20221231" decimals="INF" name="rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOjBmNmFhYzUyZTNjNTRmODJhNjI0ODZiYTQ4YTQ5M2IxL3RhYmxlcmFuZ2U6MGY2YWFjNTJlM2M1NGY4MmE2MjQ4NmJhNDhhNDkzYjFfNC0xLTEtMS02Mzg2OC90ZXh0cmVnaW9uOmE5ZjRjMWMxNzljZDRhODU5ZTc0MTRhMjllNDBjZDJmXzUx_0c8fd2d8-0b20-40eb-a302-ed61a1fc759c">1.50</ix:nonFraction>:1.00</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i99932cd267fb439fa22c5eb34b7ae0f0_D20220101-20221231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOjBmNmFhYzUyZTNjNTRmODJhNjI0ODZiYTQ4YTQ5M2IxL3RhYmxlcmFuZ2U6MGY2YWFjNTJlM2M1NGY4MmE2MjQ4NmJhNDhhNDkzYjFfNC0yLTEtMS02Mzg2OC90ZXh0cmVnaW9uOjcyMzJjMmYyODAyNDQxZDdiNTI1ZWZiYWQ4ZTZiNmE2XzU_64ad564f-7ab3-4fb1-9454-1638992a8f0c">1.75</ix:nonFraction>%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i839055751cc8442db5204c49d1284938_D20220101-20221231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOjBmNmFhYzUyZTNjNTRmODJhNjI0ODZiYTQ4YTQ5M2IxL3RhYmxlcmFuZ2U6MGY2YWFjNTJlM2M1NGY4MmE2MjQ4NmJhNDhhNDkzYjFfNC0zLTEtMS02Mzg2OC90ZXh0cmVnaW9uOjg2NjI4Zjg0ZGI4ZDQzYTk5MzI2MmM1NWRhMzJmNTJkXzU_08b106d3-7950-4162-816b-4daf8a2a8412">0.75</ix:nonFraction>%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i69798f67de99449889ab8f63e5cf75a3_D20220101-20221231" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOjBmNmFhYzUyZTNjNTRmODJhNjI0ODZiYTQ4YTQ5M2IxL3RhYmxlcmFuZ2U6MGY2YWFjNTJlM2M1NGY4MmE2MjQ4NmJhNDhhNDkzYjFfNC00LTEtMS02Mzg2OC90ZXh0cmVnaW9uOjI0YzNjMDEyNmNjYjQ1ODlhMzYyMDM2NWNjZTU1ZGQzXzU_a39c47c3-98e3-4792-ba5e-10ec82321978">1.75</ix:nonFraction>%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i69798f67de99449889ab8f63e5cf75a3_D20220101-20221231" decimals="INF" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOjBmNmFhYzUyZTNjNTRmODJhNjI0ODZiYTQ4YTQ5M2IxL3RhYmxlcmFuZ2U6MGY2YWFjNTJlM2M1NGY4MmE2MjQ4NmJhNDhhNDkzYjFfNC01LTEtMS02Mzg2OC90ZXh0cmVnaW9uOjI2OWU0ZjE3N2IxNjRkNWY4Y2M1ZmU1MGI5NTRkZmE2XzU_6b093134-9817-4ffe-bee8-31bfdc810824">0.30</ix:nonFraction>%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">V</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than <ix:nonFraction unitRef="number" contextRef="i15eb2be8a2ff48a9809e5a01d2e32851_I20221231" decimals="INF" name="rdnt:DebtInstrumentCovenantLeverageRatioMaximum" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOjBmNmFhYzUyZTNjNTRmODJhNjI0ODZiYTQ4YTQ5M2IxL3RhYmxlcmFuZ2U6MGY2YWFjNTJlM2M1NGY4MmE2MjQ4NmJhNDhhNDkzYjFfNS0xLTEtMS02Mzg2OC90ZXh0cmVnaW9uOjUxYTQ3NGExYzE0MTRkNGY5YzY0ODA3OTEyOTM4MWMxXzE0_2cb09600-14b3-4dca-81d1-22a320e6ffa9">1.50</ix:nonFraction>:1.00</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia5b95a7d5c6a44a18f1590d4463611c0_D20220101-20221231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOjBmNmFhYzUyZTNjNTRmODJhNjI0ODZiYTQ4YTQ5M2IxL3RhYmxlcmFuZ2U6MGY2YWFjNTJlM2M1NGY4MmE2MjQ4NmJhNDhhNDkzYjFfNS0yLTEtMS02Mzg2OC90ZXh0cmVnaW9uOjA5ZjYyNzYxODllYzQzZWViYTY5OGI2MjVhZTY4MzFkXzU_888d848f-d2a9-43c7-97b3-947f91c1d09c">1.50</ix:nonFraction>%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if100b11b6bb44e928235b214abe522c1_D20220101-20221231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOjBmNmFhYzUyZTNjNTRmODJhNjI0ODZiYTQ4YTQ5M2IxL3RhYmxlcmFuZ2U6MGY2YWFjNTJlM2M1NGY4MmE2MjQ4NmJhNDhhNDkzYjFfNS0zLTEtMS02Mzg2OC90ZXh0cmVnaW9uOjM1MjNlMWNiNmMyMTQyZDVhMjU4MWM0YTU5Y2I1YzJhXzU_4946ef18-4018-49e8-a661-daead96b245e">0.50</ix:nonFraction>%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i13cb963d1f784637aecd1c03103d2861_D20220101-20221231" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOjBmNmFhYzUyZTNjNTRmODJhNjI0ODZiYTQ4YTQ5M2IxL3RhYmxlcmFuZ2U6MGY2YWFjNTJlM2M1NGY4MmE2MjQ4NmJhNDhhNDkzYjFfNS00LTEtMS02Mzg2OC90ZXh0cmVnaW9uOjJlNzVjZjVlZDEyYTQ3NTU4Y2M0YmI2YWE5OTcyOGExXzU_b6d5d50f-61ec-406e-8b42-012c5b95e1ec">1.50</ix:nonFraction>%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i13cb963d1f784637aecd1c03103d2861_D20220101-20221231" decimals="INF" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOjBmNmFhYzUyZTNjNTRmODJhNjI0ODZiYTQ4YTQ5M2IxL3RhYmxlcmFuZ2U6MGY2YWFjNTJlM2M1NGY4MmE2MjQ4NmJhNDhhNDkzYjFfNS01LTEtMS02Mzg2OC90ZXh0cmVnaW9uOmRlODIzYjhmOWY3MzQzZTliZjU3ODdlMzI4MzU2OTgxXzU_74006324-2846-4e91-8a56-5206d564495e">0.30</ix:nonFraction>%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Senior Credit Facilities:</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;text-decoration:underline">First Lien Term Loans:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The First Lien Term Loans under the Restated Credit Agreement bear interest at either a Eurodollar Rate or an Alternate Base Rate (in each case, as defined in the Restated Credit Agreement), plus an applicable margin.  The applicable </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i116496e3d0b549f0829fc0aa5e697de0" continuedAt="i5b2d8c2e59c54f07aa9a394cd37943d7"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">margin for Eurodollar Rate term loans under the Restated Credit Agreement is <ix:nonFraction unitRef="number" contextRef="iab1c1f0acbf94f9f961d2a94fecafbce_D20210101-20211231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfMjI5Mg_f7d9a304-80b9-49be-84e3-7c23f4c9b279">3.25</ix:nonFraction>% per annum, with a reduction to <ix:nonFraction unitRef="number" contextRef="i702897b2a6b14e748e4098af38ad1e19_D20210101-20210331" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfMjMyNg_da586858-a197-4a66-9d19-75e90eb90caf">3.0</ix:nonFraction>% per annum upon delivery by us of financial statements evidencing a first lien net leverage ratio of <ix:nonFraction unitRef="number" contextRef="ic20f8711184c443c87d2fa221b9f3d6b_I20210331" decimals="INF" name="rdnt:DebtInstrumentLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfMjQyOQ_47b14c01-83fe-4e90-b1bd-759307cc90ea">3.50</ix:nonFraction> to 1.00 or less.  Such statements were delivered by us on May 27, 2021. At December 31, 2022 the effective Eurodollar Rate and the Alternate Base Rate for the First Lien Term Loans under the Restated Credit Agreement was <ix:nonFraction unitRef="number" contextRef="id37173de0c834f2b9f115f5a5a19cc27_I20221231" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfMjYzNg_f40dd372-c177-4405-85c4-007fd327f548">4.73</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="ia9b5190de9024ab58119dd3bf9d43ea3_I20221231" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfMjY0Mw_d4229174-2d6c-4166-9f9d-fc45ad478865">7.50</ix:nonFraction>%, respectively and the applicable margin for the Eurodollar Rate and Alternate Base Rate First Lien Term Loans under the Restated Credit Agreement was <ix:nonFraction unitRef="number" contextRef="ia4b317995bde4bada86bdf0ce0b815cd_D20220101-20221231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfMjc5Ng_568a45c6-634f-4d68-a550-c53e098ed99b">3.00</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i70fb120699d84c7f82b9624968f97599_D20220101-20221231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfMjgwMw_fb87253b-6c4b-4f98-a84e-8508351a3c9c">2.00</ix:nonFraction>%, respectively.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Restated Credit Agreement provides for quarterly payments of principal for the First Lien Term Loan in the amount of approximately $<ix:nonFraction unitRef="usd" contextRef="ice18c3446a25450bb2c8f0569aa819e7_D20220101-20221231" decimals="-5" name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfMjk1Nw_605fb0ca-ed9e-4442-909b-6f3546d48df8">1.8</ix:nonFraction> million.  The  First Lien Term Loan will mature on April 23, 2028 unless otherwise accelerated under the terms of the Restated Credit Agreement.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Truist Term Loan:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Truist Term Loan currently bears interest at a three month SOFR election of <ix:nonFraction unitRef="number" contextRef="i2e033e1356e54eb3be45b1693fd1314c_D20220101-20221231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfMTA5OTUxMTY0OTEwMQ_b53715f8-b583-41ca-a892-67d94d46c073">4.28</ix:nonFraction>% plus an applicable margin and fees based on Pricing Level III described above.</span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The scheduled amortization of the Truist Term Loan begins March 31, 2023 with quarterly payments of $<ix:nonFraction unitRef="usd" contextRef="i6a3f767fc5374ada83d6ae22aa651dd9_D20230331-20230331" decimals="-5" name="us-gaap:DebtInstrumentPeriodicPayment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfMTA5OTUxMTY0OTQxMA_05837fc6-ec51-4249-9003-92f824916ccc">1.9</ix:nonFraction> million, representing <ix:nonFraction unitRef="number" contextRef="i6a3f767fc5374ada83d6ae22aa651dd9_D20230331-20230331" decimals="INF" name="rdnt:DebtInstrumentPeriodicPaymentPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfMTA5OTUxMTY0OTU0NA_412409f9-d1a9-4e6b-879d-9a2884af1416">1.00</ix:nonFraction>% of the original principal balance. At scheduled intervals, the quarterly amortization increases by $<ix:nonFraction unitRef="usd" contextRef="i04e208e3692545da8ee7fd87c877961c_I20230331" decimals="-5" name="rdnt:DebtInstrumentPeriodicPaymentTermsAmortizationIncrease" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfMTA5OTUxMTY0OTU4NA_41f7a07a-f504-417a-b992-2027b8723057">0.9</ix:nonFraction> million, with the remaining balance to be paid at maturity.  The Truist Term Loan will mature on October 10, 2027 unless otherwise accelerated under the terms of the  Credit Agreement.</span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:54pt"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Revolving Credit Facilities:</span></div><div style="padding-right:4.5pt;text-align:justify"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Barclays Revolving Credit Facility:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Barclays Revolving Credit Facility under the Restated Credit Agreement is a $<ix:nonFraction unitRef="usd" contextRef="i2923158472984ab081c98c126fa64e96_I20221231" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfNDc2OA_c6f1edb7-82b7-4798-bba4-2c325c4e1618">195.0</ix:nonFraction> million senior secured revolving credit facility. Associated with the Barclays Revolving Credit Facility are deferred financing costs, net of accumulated amortization, of $<ix:nonFraction unitRef="usd" contextRef="i2d9d403debfc473bafd93ca110c28e57_I20221231" decimals="-5" name="us-gaap:DeferredFinanceCostsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfMTA5OTUxMTY1NTkwMw_1d2b97a8-0d65-4747-967a-7208662b2dd0">1.7</ix:nonFraction> million at December 31, 2022.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:continuation id="i79b0b5db183c4d68ab7540674d0c5f8d"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revolving loans borrowed under the Barclays Revolving Credit Facility bear interest at either a Eurodollar Rate or an Alternate Base Rate (in each case, as defined in the Restated Credit Agreement) plus an applicable margin which adjusts depending on our first lien net leverage ratio, according to the following schedule:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.181%"><tr><td style="width:1.0%"></td><td style="width:31.850%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.508%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">First Lien Leverage Ratio</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Eurodollar Rate Spread</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Base Rate Spread</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&gt; <ix:nonFraction unitRef="number" contextRef="i3519d8c4e9ee47ba8c1300676d007bb0_I20221231" decimals="INF" name="rdnt:DebtInstrumentLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOmY4MjliNzM5ODFhYjRlYWRiNzgyOTg2NzY4ZDg2MjMxL3RhYmxlcmFuZ2U6ZjgyOWI3Mzk4MWFiNGVhZGI3ODI5ODY3NjhkODYyMzFfMi0wLTEtMS0yOTQ4OS90ZXh0cmVnaW9uOjY4ZDBiNWIyODY4YTRhNGNiZjRjYWQ5NzdiNjlkMWY3XzY_fc707e01-2c6f-4430-a8bb-dfc934149332">3.50</ix:nonFraction>x</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2463bc0c023b4f5aa0e500c7b7681aec_D20220101-20221231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOmY4MjliNzM5ODFhYjRlYWRiNzgyOTg2NzY4ZDg2MjMxL3RhYmxlcmFuZ2U6ZjgyOWI3Mzk4MWFiNGVhZGI3ODI5ODY3NjhkODYyMzFfMi0xLTEtMS0yOTQ4OS90ZXh0cmVnaW9uOmMyODQyYTdmOWQyYzQ2NzI5ZTA5ZDBhODAxYWU0ODVkXzQ_d5caa135-ab3b-4670-a892-81e5289b5d53">3.25</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i928b06213e75428c90178a1d1b5152f7_D20220101-20221231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOmY4MjliNzM5ODFhYjRlYWRiNzgyOTg2NzY4ZDg2MjMxL3RhYmxlcmFuZ2U6ZjgyOWI3Mzk4MWFiNGVhZGI3ODI5ODY3NjhkODYyMzFfMi0yLTEtMS0yOTQ4OS90ZXh0cmVnaW9uOjNmMDIwNmE1NTY0ODQ4YmZiZjIxOGFlZDg5NzJkYTcxXzQ_85b29603-3660-4b71-9fd6-6d19d24dcefd">2.25</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&gt; <ix:nonFraction unitRef="number" contextRef="i6f6c0892ace746fbaf4c00e519257a16_I20221231" decimals="INF" name="rdnt:DebtInstrumentLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOmY4MjliNzM5ODFhYjRlYWRiNzgyOTg2NzY4ZDg2MjMxL3RhYmxlcmFuZ2U6ZjgyOWI3Mzk4MWFiNGVhZGI3ODI5ODY3NjhkODYyMzFfMy0wLTEtMS0yOTQ4OS90ZXh0cmVnaW9uOjFiZTQwNmYwNzkzNTRjYmRhYjUxYTRhOGZjN2Y4M2ZhXzY_246ebf80-587b-4085-a14b-691236cbc2c9">3.00</ix:nonFraction>x but &#8804; <ix:nonFraction unitRef="number" contextRef="id93b58eb3f8545c19a363c18ea54314e_I20221231" decimals="INF" name="rdnt:DebtInstrumentLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOmY4MjliNzM5ODFhYjRlYWRiNzgyOTg2NzY4ZDg2MjMxL3RhYmxlcmFuZ2U6ZjgyOWI3Mzk4MWFiNGVhZGI3ODI5ODY3NjhkODYyMzFfMy0wLTEtMS0yOTQ4OS90ZXh0cmVnaW9uOjFiZTQwNmYwNzkzNTRjYmRhYjUxYTRhOGZjN2Y4M2ZhXzE2_3c630bc5-118e-47fb-bda6-358097a5d673">3.50</ix:nonFraction>x</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id934500bc63546f682c7f9670a1350a8_D20220101-20221231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOmY4MjliNzM5ODFhYjRlYWRiNzgyOTg2NzY4ZDg2MjMxL3RhYmxlcmFuZ2U6ZjgyOWI3Mzk4MWFiNGVhZGI3ODI5ODY3NjhkODYyMzFfMy0xLTEtMS0yOTQ4OS90ZXh0cmVnaW9uOjFlZjNiZDQzMDExYzQ3MGViNTU2ODM3YWYxMDcyMGMwXzQ_3591e8fc-8952-4ba3-a423-e792f04ee406">3.00</ix:nonFraction>%</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8268de3b978748b782a432f7902bf9eb_D20220101-20221231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOmY4MjliNzM5ODFhYjRlYWRiNzgyOTg2NzY4ZDg2MjMxL3RhYmxlcmFuZ2U6ZjgyOWI3Mzk4MWFiNGVhZGI3ODI5ODY3NjhkODYyMzFfMy0yLTEtMS0yOTQ4OS90ZXh0cmVnaW9uOjU4YzgwY2VkNWNiNTQ0MGZhNjhjYzZmMDhlMTZkMDhhXzQ_11df197b-a58b-41d9-a234-922a8ad478f8">2.00</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8804; <ix:nonFraction unitRef="number" contextRef="i278e51ae3e69452d872b324b2fceb548_I20221231" decimals="INF" name="rdnt:DebtInstrumentLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOmY4MjliNzM5ODFhYjRlYWRiNzgyOTg2NzY4ZDg2MjMxL3RhYmxlcmFuZ2U6ZjgyOWI3Mzk4MWFiNGVhZGI3ODI5ODY3NjhkODYyMzFfNC0wLTEtMS0yOTQ4OS90ZXh0cmVnaW9uOmU0Y2Q0NjJiNjA0MDQzOWU4N2MxMmQzNDk2YWIwOWYwXzY_85f3dd76-29ae-4e14-8676-b9d49b23ca95">3.00</ix:nonFraction>x</span></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id603dde9dba24bd185acda0ba6834023_D20220101-20221231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOmY4MjliNzM5ODFhYjRlYWRiNzgyOTg2NzY4ZDg2MjMxL3RhYmxlcmFuZ2U6ZjgyOWI3Mzk4MWFiNGVhZGI3ODI5ODY3NjhkODYyMzFfNC0xLTEtMS0yOTQ4OS90ZXh0cmVnaW9uOjllNGNhZWJkMjVlOTQ5YzViMTQ1OTU5MTM4YjA2YzI3XzQ_05a66731-62a7-4287-9ca0-a32ee576a6d9">2.75</ix:nonFraction>%</span></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1dadee5b8a024acb8b292c439ee5d113_D20220101-20221231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOmY4MjliNzM5ODFhYjRlYWRiNzgyOTg2NzY4ZDg2MjMxL3RhYmxlcmFuZ2U6ZjgyOWI3Mzk4MWFiNGVhZGI3ODI5ODY3NjhkODYyMzFfNC0yLTEtMS0yOTQ4OS90ZXh0cmVnaW9uOjFiYTZkNjdiZDNlMDRlN2Y5MzJiNmU4MWJmZDJhMjQ5XzQ_4594ed60-a08b-485b-b8a2-91334ce7a5e3">1.75</ix:nonFraction>%</span></div></td></tr></table></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, the effective interest rate for borrowings on revolving loans under the Barclays Revolving Credit Facility stood at <ix:nonFraction unitRef="number" contextRef="i2d9d403debfc473bafd93ca110c28e57_I20221231" decimals="3" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfNTM4OA_113a2980-7835-4f3b-9cc5-c76c9b3cf74c">9.5</ix:nonFraction>%.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For letters of credit issued under the Barclays Revolving Credit Facility, letter of credit fees accrue at the applicable margin for Eurodollar rate revolving loans which is currently <ix:nonFraction unitRef="number" contextRef="id994e3544668477991d25e93154861e5_D20220101-20221231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfNTU3Nw_c12aa6a1-0f68-4a63-8b9d-ab56975afcbd">3.00</ix:nonFraction>% and fronting fees accrue at <ix:nonFraction unitRef="number" contextRef="iae4da6a9b69c4e0f8084fdf5c94b4fb0_D20220101-20221231" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfNTYwOA_194f962b-3e56-4a1f-bcfe-dd048de0c5cd">0.125</ix:nonFraction>% per annum, in each case on the average aggregate daily maximum amount available to be drawn under all letters of credit issued under the Restated Credit Agreement. In addition, a commitment fee of <ix:nonFraction unitRef="number" contextRef="iae4da6a9b69c4e0f8084fdf5c94b4fb0_D20220101-20221231" decimals="INF" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfNTgwOA_ad771064-1920-409a-9c98-de7bfa3d1881">0.50</ix:nonFraction>% per annum accrues on the unused revolver commitments under the Barclays Revolving Credit Facility.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Barclays Revolving Credit Facility will terminate on April 23, 2026 unless otherwise accelerated in accordance with the terms of the Restated Credit Agreement.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Truist Revolving Credit Facility:</span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Associated with the Truist Revolving Credit Facility of $<ix:nonFraction unitRef="usd" contextRef="i6ecd3750a3b74bbda768365b8ab639d7_I20221007" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfMTA5OTUxMTY0NzE4NA_95e8b813-fd88-412e-8184-4306cd03d62d">50.0</ix:nonFraction> million are deferred financing costs, net of accumulated amortization, of  $<ix:nonFraction unitRef="usd" contextRef="ia3b1eb6913ea4657973a8239914f6e42_I20221231" decimals="-5" name="us-gaap:DeferredFinanceCostsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfMTA5OTUxMTY1MjU0NA_a65faa19-4eca-4756-9731-af3ca8b98093">0.6</ix:nonFraction> million at December 31, 2022.  As of December 31, 2022, NJIN had no borrowings under the Truist Revolving Credit Facility. </span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:54pt"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Truist Revolving Credit Facility bears interest with different margins based on types of borrowings at a Pricing Level III as noted in the pricing grid above.  The Truist Revolving Credit Facility terminates on the earliest of (i) </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i5b2d8c2e59c54f07aa9a394cd37943d7"><div style="padding-right:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">October 7, 2027, (ii) the date on which the Revolving Commitments are terminated pursuant to Section 2.8 of the Truist Restated Credit Agreement, or (iii) the date on which all amounts outstanding under the Truist Restated Credit Agreement have been declared or have automatically become due and payable (whether by acceleration or otherwise).  </span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:54pt"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Recent Amendments to prior Credit Facilities</span></div><div style="padding-right:4.5pt;text-align:justify"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Barclays Credit Facilities:</span></div><div style="margin-top:10pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 28, 2020, RadNet Management, Inc. and RadNet, Inc. entered into Amendment No. 8, Consent and Incremental Joinder Agreement to Credit and Guaranty Agreement (the "Eighth Amendment").  The Eighth Amendment amended the prior first lien credit agreement to add $<ix:nonFraction unitRef="usd" contextRef="i92fc6849db614c54bc09a2666a961e01_I20200828" decimals="INF" name="rdnt:LineofCreditFacilityIncreaseBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfNzA0MQ_5a84366e-58bd-41d6-9c60-3aa39556af9f">57.5</ix:nonFraction> million of revolving commitments to the prior Barclays revolving credit facility increasing the maximum borrowing capacity under the prior Barclays revolving credit facility to $<ix:nonFraction unitRef="usd" contextRef="i2923158472984ab081c98c126fa64e96_I20221231" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfNzIxMw_c6f1edb7-82b7-4798-bba4-2c325c4e1618">195.0</ix:nonFraction> million while leaving the maturity date of July 1, 2023 unchanged.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 18, 2019 we entered into the following <ix:nonFraction unitRef="amendment" contextRef="i0632c03edc1443a6b0a38f3cd1a783d9_I20190418" decimals="INF" name="rdnt:DebtInstrumentNumberOfAmendments" format="ixt-sec:numwordsen" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfNzMyNA_07906c9f-19af-43a4-a33f-cc206fc1076a">two</ix:nonFraction> amendments to the prior first lien credit agreement: (i) Amendment No. 6, Consent and Incremental Joinder Agreement to Credit and Guaranty Agreement (the &#8220;Sixth Amendment&#8221;); and (ii) Amendment No. 7 to Credit and Guaranty Agreement (the &#8220;Seventh Amendment&#8221;).  Among other things, the Sixth Amendment amended the prior first lien credit agreement to issue $<ix:nonFraction unitRef="usd" contextRef="i09ba2d9a36f045b797d41b04329dd854_I20190418" decimals="-5" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfNzY4Mg_b91fbfd4-ae67-47c5-8714-72077a2b3848">100.0</ix:nonFraction> million in incremental first lien term loans and to add an additional $<ix:nonFraction unitRef="usd" contextRef="i1c5c4e38ab5d4390807495b2aa90ba6a_I20190418" decimals="INF" name="rdnt:LineofCreditFacilityIncreaseBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfNzc0Nw_49880fe4-a65d-4a9b-873a-d4d0cbe8a2dd">20.0</ix:nonFraction> million of revolving commitments to the prior Barclays revolving credit facility.  The Seventh Amendment amended the prior first lien credit agreement to extend the maturity date of the prior Barclays revolving credit facility by an additional <ix:nonNumeric contextRef="ia96560b5f1de48ab9fbe2db67aecf4d1_D20190418-20190418" name="rdnt:DebtInstrumentExtensionPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfNzk4Ng_f275a681-72df-43f2-82e3-8275d3d7b938">two years</ix:nonNumeric> to July 1, 2023, unless sooner terminated in accordance with the terms of the prior first lien credit agreement.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The prior first lien credit agreement was amended and restated by the Restated Credit Agreement described above, and the prior first lien term loans and prior Barclays revolving credit facility under the prior first lien credit agreement were refinanced and replaced by the First Lien Term Loans and the Barclays Revolving Credit Facility provided under the Restated Credit Agreement described above.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;text-decoration:underline">Truist Credit Facilities:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On August 31, 2018, under the Amended and Restated Revolving Credit and Term Loan Agreement (A&amp;R Agreement), NJIN secured a term loan commitment of $<ix:nonFraction unitRef="usd" contextRef="iaa6deb986aee4e51833223a5764529e4_I20180831" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfMTA5OTUxMTY1NzY4OA_ca92c5e7-8897-4b02-a354-f1d9798e954e">60.0</ix:nonFraction> million and established revolving credit facility of $<ix:nonFraction unitRef="usd" contextRef="i67ae41392b3144c99363c75225255999_I20180831" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfMTA5OTUxMTY1Nzg0OQ_c62bb085-c690-4ad3-9fce-ede2bc901eab">30.0</ix:nonFraction> million.  The agreement had a maturity date of August 31, 2023 and was refinanced on October 10, 2022 by the Second Amended and Restated Revolving Credit and Term Loan Agreement.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-top:10pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Paycheck Protection Program</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Paycheck Protection Program (PPP) includes funds available for loans to small business and Medicare providers to support operations during the COVID-19 pandemic. The funds are administered by the Small Business Administration (SBA), through approved lenders and do not require collateral or personal guarantees.  We received our loans based on being a Medicare provider. The terms and conditions for participation require entities to certify that economic uncertainty related to the COVID-19 pandemic makes the loan necessary to support their current operations, and that they will use the funds to retain workers (e.g., by paying salaries, providing paid sick/medical leave and health insurance benefits) and pay certain debts (mortgage obligations) and expenses (e.g. rent, utilities, telephone).  The loans have a <ix:nonFraction unitRef="number" contextRef="i85a7d0e0c6ca48769139d10c3a615b9e_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfOTM1Mw_fc2186be-f471-4ceb-be5b-b2bf3cb04684">1.0</ix:nonFraction>% fixed interest rate and are due in <ix:nonNumeric contextRef="ifc2f697097964cab9a6567723aee030c_D20220101-20221231" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfOTM5MQ_f3494e01-43e7-41f2-8fea-8b64aa7dffab">2</ix:nonNumeric> years.  The loans are eligible for forgiveness subject to salary limitations and employee retention levels. Certain of our consolidated subsidiaries received <ix:nonFraction unitRef="loan" contextRef="ifc2f697097964cab9a6567723aee030c_D20220101-20221231" decimals="INF" name="rdnt:DebtInstrumentNumberofLoansReceived" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfOTU0Ng_21b10cc1-c3fb-4f6d-95cf-1622e23d57ea">four</ix:nonFraction> loans totaling $<ix:nonFraction unitRef="usd" contextRef="ie7dff0590fe940f8998c972ad3a5986d_I20221231" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfOTU2NA_a7e287f8-960d-4e04-9867-a1517f4f1ca5">4.0</ix:nonFraction> million.  We accounted for the funds received as debt and recorded a liability for the full amount of proceeds received and accrued interest over the term of the loans.  In December 2020 we met the eligibility requirements for forgiveness and the loans were written off to gain on debt extinguishment.</span></div></ix:continuation><div style="padding-right:4.5pt;text-align:justify"><span><br/></span></div><div style="text-indent:54pt"><span><br/></span></div><div id="if3f80771944f4fc58015abda42dc47d1_100"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 9 &#8211; <ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90ZXh0cmVnaW9uOmEyZmUyZjYyM2Q4ZTQ5MjdhZDY3ZWMxMDE1NzQ5YzEzXzIwNDY_5b88b17a-eb66-4ea8-a13f-40f257e5ad48" continuedAt="ifd8bd4a20ee84303911fb8c7382fd974" escape="true">LEASES</ix:nonNumeric></span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ifd8bd4a20ee84303911fb8c7382fd974" continuedAt="i691f3a26e74c4c1494ab0eb3b264ebc8">Our material lease contracts are for facilities and advanced radiology equipment.   In regards to our imaging, administrative and warehouse facilities, the most common initial lease term varies in length from <ix:nonNumeric contextRef="ic1e56ddb23564f81949b77940a641b57_I20221231" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90ZXh0cmVnaW9uOmEyZmUyZjYyM2Q4ZTQ5MjdhZDY3ZWMxMDE1NzQ5YzEzXzIzMQ_c1528c36-70ed-4537-84ef-d4d77a2ddeba">5</ix:nonNumeric> to <ix:nonNumeric contextRef="i0118bb2b3716434fb951fa28970f2707_I20221231" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90ZXh0cmVnaW9uOmEyZmUyZjYyM2Q4ZTQ5MjdhZDY3ZWMxMDE1NzQ5YzEzXzIzNw_cc2c1cd7-8c5d-4d46-9a1f-d10695543ebd">15</ix:nonNumeric> years. Including renewal options negotiated with the landlord, we can have a total span of <ix:nonNumeric contextRef="ic1e56ddb23564f81949b77940a641b57_I20221231" name="us-gaap:LesseeOperatingLeaseRenewalTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90ZXh0cmVnaW9uOmEyZmUyZjYyM2Q4ZTQ5MjdhZDY3ZWMxMDE1NzQ5YzEzXzMyNQ_cc5c9a6a-f619-44c7-81de-045b0e4c33c8">10</ix:nonNumeric> to <ix:nonNumeric contextRef="i0118bb2b3716434fb951fa28970f2707_I20221231" name="us-gaap:LesseeOperatingLeaseRenewalTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90ZXh0cmVnaW9uOmEyZmUyZjYyM2Q4ZTQ5MjdhZDY3ZWMxMDE1NzQ5YzEzXzMzMQ_82ead483-baf4-4efb-a28b-653a34131580">35</ix:nonNumeric> years at these locations, and we do not enter into purchase options on the underlying property.  We also lease smaller satellite X-Ray locations on mutually renewable terms, usually lasting one year.  Leases for advanced radiology and office equipment have terms generally lasting from <ix:nonNumeric contextRef="ice63a1a32cb9452b8b46714c1c61a7da_D20220101-20221231" name="rdnt:LesseeLeaseTermofContract" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90ZXh0cmVnaW9uOmEyZmUyZjYyM2Q4ZTQ5MjdhZDY3ZWMxMDE1NzQ5YzEzXzYxNA_91b629ae-29af-43a8-8d4b-4d0b0b917785">5</ix:nonNumeric> to <ix:nonNumeric contextRef="ib19ac757adb3497f895598bf7d1fb0f6_D20220101-20221231" name="rdnt:LesseeLeaseTermofContract" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90ZXh0cmVnaW9uOmEyZmUyZjYyM2Q4ZTQ5MjdhZDY3ZWMxMDE1NzQ5YzEzXzYyMA_0c08b362-95e7-4031-a7d3-498446bcecb7">8</ix:nonNumeric> years.  All leases are classified as operating or finance for accounting purposes, depending on the terms of the agreement.  Our Incremental Borrowing Rate ("IBR") used to discount the stream of lease payments is closely related to the interest rates </ix:continuation></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i691f3a26e74c4c1494ab0eb3b264ebc8" continuedAt="if792fc3eda2e46069b47a410e01f8fbb"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">charged on our collateralized debt obligations and our IBR is adjusted when those rates experience a substantial change.  During 2021, we satisfied all liabilities classified as finance leases, and only operating leases remain.</span></div><div style="text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90ZXh0cmVnaW9uOmEyZmUyZjYyM2Q4ZTQ5MjdhZDY3ZWMxMDE1NzQ5YzEzXzIwNDI_2bfe29e8-f122-4f25-992c-5fa25aacd24f" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The components of lease expense were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:58.197%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.251%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.252%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="6" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTo3ODJiYmM2OWUzMGE0MjNmOTZkNTc3OGM5ZDc2MGMyZi90YWJsZXJhbmdlOjc4MmJiYzY5ZTMwYTQyM2Y5NmQ1Nzc4YzlkNzYwYzJmXzQtMS0xLTEtMjk0ODk_d33f9420-2798-45ab-afed-e4dd3a7a78ac">107,475</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTo3ODJiYmM2OWUzMGE0MjNmOTZkNTc3OGM5ZDc2MGMyZi90YWJsZXJhbmdlOjc4MmJiYzY5ZTMwYTQyM2Y5NmQ1Nzc4YzlkNzYwYzJmXzQtMi0xLTEtMjk0ODk_bf1b0633-fc02-49bc-8943-81f278a78806">121,578</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Depreciation of leased equipment</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTo3ODJiYmM2OWUzMGE0MjNmOTZkNTc3OGM5ZDc2MGMyZi90YWJsZXJhbmdlOjc4MmJiYzY5ZTMwYTQyM2Y5NmQ1Nzc4YzlkNzYwYzJmXzctMS0xLTEtMjk0ODk_d4d42cdb-316a-4eb0-ac0f-579643f611e6">2,896</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTo3ODJiYmM2OWUzMGE0MjNmOTZkNTc3OGM5ZDc2MGMyZi90YWJsZXJhbmdlOjc4MmJiYzY5ZTMwYTQyM2Y5NmQ1Nzc4YzlkNzYwYzJmXzctMi0xLTEtMjk0ODk_8632ba7f-4e83-4ab7-b7db-65e4f18380f9">3,068</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Interest on lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTo3ODJiYmM2OWUzMGE0MjNmOTZkNTc3OGM5ZDc2MGMyZi90YWJsZXJhbmdlOjc4MmJiYzY5ZTMwYTQyM2Y5NmQ1Nzc4YzlkNzYwYzJmXzgtMS0xLTEtMjk0ODk_3c5935db-c900-4e8e-9a38-6347af3cf5a8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTo3ODJiYmM2OWUzMGE0MjNmOTZkNTc3OGM5ZDc2MGMyZi90YWJsZXJhbmdlOjc4MmJiYzY5ZTMwYTQyM2Y5NmQ1Nzc4YzlkNzYwYzJmXzgtMi0xLTEtMjk0ODk_f8da1ad0-cbef-484c-8caf-a7c6ce0a5363">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total finance lease cost</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="rdnt:FinanceLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTo3ODJiYmM2OWUzMGE0MjNmOTZkNTc3OGM5ZDc2MGMyZi90YWJsZXJhbmdlOjc4MmJiYzY5ZTMwYTQyM2Y5NmQ1Nzc4YzlkNzYwYzJmXzktMS0xLTEtMjk0ODk_3f4e3620-9544-43ae-a8ac-5a21d3aac4f8">2,896</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="rdnt:FinanceLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTo3ODJiYmM2OWUzMGE0MjNmOTZkNTc3OGM5ZDc2MGMyZi90YWJsZXJhbmdlOjc4MmJiYzY5ZTMwYTQyM2Y5NmQ1Nzc4YzlkNzYwYzJmXzktMi0xLTEtMjk0ODk_4140bf8f-cd3b-40fb-89e4-6a893fa927c7">3,114</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1) Operating lease cost above for the year ended December 31, 2021 included $<ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-5" name="rdnt:OperatingLeaseLeaseAbandonmentCharge" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90ZXh0cmVnaW9uOmEyZmUyZjYyM2Q4ZTQ5MjdhZDY3ZWMxMDE1NzQ5YzEzXzEyMjY_72371db8-b949-41ef-bca8-5633360ad578">12.6</ix:nonFraction> million in lease abandonment charges.  Please see our discussion in the Leases section of Note 2, Summary of Significant Accounting Policies.</span></div></ix:nonNumeric><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90ZXh0cmVnaW9uOmEyZmUyZjYyM2Q4ZTQ5MjdhZDY3ZWMxMDE1NzQ5YzEzXzIwMzU_f0ac15e1-65aa-464f-88de-3e99fc95d231" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Supplemental cash flow information related to leases was as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="6" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Operating cash flows from operating leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTowMWYxYWE4MTMzYmQ0OTc2YmY2ZTA3MWFjNzBiNjQxYy90YWJsZXJhbmdlOjAxZjFhYTgxMzNiZDQ5NzZiZjZlMDcxYWM3MGI2NDFjXzQtMS0xLTEtMjk0ODk_9d85e171-76a0-49bc-ac29-bcf1cea0b891">108,004</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTowMWYxYWE4MTMzYmQ0OTc2YmY2ZTA3MWFjNzBiNjQxYy90YWJsZXJhbmdlOjAxZjFhYTgxMzNiZDQ5NzZiZjZlMDcxYWM3MGI2NDFjXzQtMi0xLTEtMjk0ODk_536b588b-1979-4fab-b485-7835d50cb97c">110,288</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Operating cash flows from financing leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTowMWYxYWE4MTMzYmQ0OTc2YmY2ZTA3MWFjNzBiNjQxYy90YWJsZXJhbmdlOjAxZjFhYTgxMzNiZDQ5NzZiZjZlMDcxYWM3MGI2NDFjXzUtMS0xLTEtMjk0ODk_3288c59e-d92c-4fd9-ad46-026857ba667c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTowMWYxYWE4MTMzYmQ0OTc2YmY2ZTA3MWFjNzBiNjQxYy90YWJsZXJhbmdlOjAxZjFhYTgxMzNiZDQ5NzZiZjZlMDcxYWM3MGI2NDFjXzUtMi0xLTEtMjk0ODk_3deb9788-32dc-4782-8242-df0a0aab45b9">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Financing cash flows from financing leases</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTowMWYxYWE4MTMzYmQ0OTc2YmY2ZTA3MWFjNzBiNjQxYy90YWJsZXJhbmdlOjAxZjFhYTgxMzNiZDQ5NzZiZjZlMDcxYWM3MGI2NDFjXzYtMS0xLTEtMjk0ODk_75fdeb22-4060-4abb-a3bb-401e98f4c31c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTowMWYxYWE4MTMzYmQ0OTc2YmY2ZTA3MWFjNzBiNjQxYy90YWJsZXJhbmdlOjAxZjFhYTgxMzNiZDQ5NzZiZjZlMDcxYWM3MGI2NDFjXzYtMi0xLTEtMjk0ODk_c246f0dd-a4c9-4b3c-b2d0-cdc59eed1516">3,304</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use &amp; Equipment assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Operating leases</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTowMWYxYWE4MTMzYmQ0OTc2YmY2ZTA3MWFjNzBiNjQxYy90YWJsZXJhbmdlOjAxZjFhYTgxMzNiZDQ5NzZiZjZlMDcxYWM3MGI2NDFjXzgtMS0xLTEtMjk0ODk_04d5ab4b-d080-419b-8eb8-5cc38db7b85b">88,080</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTowMWYxYWE4MTMzYmQ0OTc2YmY2ZTA3MWFjNzBiNjQxYy90YWJsZXJhbmdlOjAxZjFhYTgxMzNiZDQ5NzZiZjZlMDcxYWM3MGI2NDFjXzgtMi0xLTEtMjk0ODk_95310301-c2c1-496b-9b4b-57a91d1d91af">186,695</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1) On December 31, 2021 we reduced our liability and eliminated the related right-of-use assets for future lease options at facilities that we elected to abandon.  The amount of liability and right-of-use asset reduction amounted to approximately $<ix:nonFraction unitRef="usd" contextRef="i8cff5897a0c648b19e7125d13cd0a0f5_D20211231-20211231" decimals="-5" name="rdnt:OperatingLeaseRightOfUseAssetDecreaseDueToAbandonment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90ZXh0cmVnaW9uOmEyZmUyZjYyM2Q4ZTQ5MjdhZDY3ZWMxMDE1NzQ5YzEzXzEwOTk1MTE2Mjk4NDY_6cdf49a6-839d-4a1c-b85c-faecf1465b97"><ix:nonFraction unitRef="usd" contextRef="i8cff5897a0c648b19e7125d13cd0a0f5_D20211231-20211231" decimals="-5" name="rdnt:OperatingLeaseLiabilityDecreaseDueToAbandonment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90ZXh0cmVnaW9uOmEyZmUyZjYyM2Q4ZTQ5MjdhZDY3ZWMxMDE1NzQ5YzEzXzEwOTk1MTE2Mjk4NDY_d0ca2c3b-e3d2-4b1a-83b3-f75643936d79">3.3</ix:nonFraction></ix:nonFraction> million.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="rdnt:AssetsAndLiabilitiesLesseeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90ZXh0cmVnaW9uOmEyZmUyZjYyM2Q4ZTQ5MjdhZDY3ZWMxMDE1NzQ5YzEzXzIwMzk_1715e5a6-b598-4cb6-821f-2e8389611764" continuedAt="i57277d62e904454ab0a0dd4f52d0fe61" escape="true">Supplemental balance sheet information related to leases was as follows:</ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">84</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="if792fc3eda2e46069b47a410e01f8fbb"><div style="margin-top:5pt;text-align:center"><ix:continuation id="i57277d62e904454ab0a0dd4f52d0fe61"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(In thousands, except lease term and discount rates)</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Leases</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTozNDY2MGIzODgyOWY0NDQ5YWU5YzQ1YmYzZTBlZmM1ZC90YWJsZXJhbmdlOjM0NjYwYjM4ODI5ZjQ0NDlhZTljNDViZjNlMGVmYzVkXzQtMS0xLTEtMjk0ODk_5c3908ec-a850-47f5-a108-bb302d92f794">603,524</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTozNDY2MGIzODgyOWY0NDQ5YWU5YzQ1YmYzZTBlZmM1ZC90YWJsZXJhbmdlOjM0NjYwYjM4ODI5ZjQ0NDlhZTljNDViZjNlMGVmYzVkXzQtMi0xLTEtMjk0ODk_0323fbf3-fe6f-4d27-bf0b-626cb10a2019">584,291</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liability</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTozNDY2MGIzODgyOWY0NDQ5YWU5YzQ1YmYzZTBlZmM1ZC90YWJsZXJhbmdlOjM0NjYwYjM4ODI5ZjQ0NDlhZTljNDViZjNlMGVmYzVkXzUtMS0xLTEtMjk0ODk_c18ab1fd-ef50-4cc9-a394-99377454baaa">57,607</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTozNDY2MGIzODgyOWY0NDQ5YWU5YzQ1YmYzZTBlZmM1ZC90YWJsZXJhbmdlOjM0NjYwYjM4ODI5ZjQ0NDlhZTljNDViZjNlMGVmYzVkXzUtMi0xLTEtMjk0ODk_873383c6-73c1-4aee-b0e3-d3102bcb43ac">65,452</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTozNDY2MGIzODgyOWY0NDQ5YWU5YzQ1YmYzZTBlZmM1ZC90YWJsZXJhbmdlOjM0NjYwYjM4ODI5ZjQ0NDlhZTljNDViZjNlMGVmYzVkXzYtMS0xLTEtMjk0ODk_adaeae30-2257-485b-bd2a-2efcfbb34a42">604,117</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTozNDY2MGIzODgyOWY0NDQ5YWU5YzQ1YmYzZTBlZmM1ZC90YWJsZXJhbmdlOjM0NjYwYjM4ODI5ZjQ0NDlhZTljNDViZjNlMGVmYzVkXzYtMi0xLTEtMjk0ODk_131d4156-0c7c-4ddb-8fa2-ceba8a68d1fc">577,675</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total operating lease liabilities</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTozNDY2MGIzODgyOWY0NDQ5YWU5YzQ1YmYzZTBlZmM1ZC90YWJsZXJhbmdlOjM0NjYwYjM4ODI5ZjQ0NDlhZTljNDViZjNlMGVmYzVkXzctMS0xLTEtMjk0ODk_86ade26a-88da-4c6e-90ef-545ed49dfeb3">661,724</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTozNDY2MGIzODgyOWY0NDQ5YWU5YzQ1YmYzZTBlZmM1ZC90YWJsZXJhbmdlOjM0NjYwYjM4ODI5ZjQ0NDlhZTljNDViZjNlMGVmYzVkXzctMi0xLTEtMjk0ODk_048bb0a4-cfd5-4cae-a6ac-e3dcb4c14629">643,127</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance Leases</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment at cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTozNDY2MGIzODgyOWY0NDQ5YWU5YzQ1YmYzZTBlZmM1ZC90YWJsZXJhbmdlOjM0NjYwYjM4ODI5ZjQ0NDlhZTljNDViZjNlMGVmYzVkXzEwLTEtMS0xLTI5NDg5_e2366280-c259-40c7-90f1-906c70dee0d9">13,971</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTozNDY2MGIzODgyOWY0NDQ5YWU5YzQ1YmYzZTBlZmM1ZC90YWJsZXJhbmdlOjM0NjYwYjM4ODI5ZjQ0NDlhZTljNDViZjNlMGVmYzVkXzEwLTItMS0xLTI5NDg5_ee57ddbe-9e29-4a2c-8585-206bf6fb3909">13,984</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTozNDY2MGIzODgyOWY0NDQ5YWU5YzQ1YmYzZTBlZmM1ZC90YWJsZXJhbmdlOjM0NjYwYjM4ODI5ZjQ0NDlhZTljNDViZjNlMGVmYzVkXzExLTAtMS0xLTI5NDg5_464c3404-1439-4afe-a7f8-0d3a4f94b53d"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTozNDY2MGIzODgyOWY0NDQ5YWU5YzQ1YmYzZTBlZmM1ZC90YWJsZXJhbmdlOjM0NjYwYjM4ODI5ZjQ0NDlhZTljNDViZjNlMGVmYzVkXzExLTAtMS0xLTI5NDg5_bc4c3e84-e956-46a8-b461-0698bb31e9ec">Accumulated depreciation</span></span></span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTozNDY2MGIzODgyOWY0NDQ5YWU5YzQ1YmYzZTBlZmM1ZC90YWJsZXJhbmdlOjM0NjYwYjM4ODI5ZjQ0NDlhZTljNDViZjNlMGVmYzVkXzExLTEtMS0xLTI5NDg5_de8f105b-dd3f-4a20-8a52-f629f32a5f07">12,171</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTozNDY2MGIzODgyOWY0NDQ5YWU5YzQ1YmYzZTBlZmM1ZC90YWJsZXJhbmdlOjM0NjYwYjM4ODI5ZjQ0NDlhZTljNDViZjNlMGVmYzVkXzExLTItMS0xLTI5NDg5_92dcf491-35d1-4af0-83a4-dc2ef1c25475">9,287</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment, net</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTozNDY2MGIzODgyOWY0NDQ5YWU5YzQ1YmYzZTBlZmM1ZC90YWJsZXJhbmdlOjM0NjYwYjM4ODI5ZjQ0NDlhZTljNDViZjNlMGVmYzVkXzEyLTEtMS0xLTI5NDg5_caed2bbc-9604-4a83-82bc-9d5cb41b8ec2">1,801</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTozNDY2MGIzODgyOWY0NDQ5YWU5YzQ1YmYzZTBlZmM1ZC90YWJsZXJhbmdlOjM0NjYwYjM4ODI5ZjQ0NDlhZTljNDViZjNlMGVmYzVkXzEyLTItMS0xLTI5NDg5_d4cf05bd-6b7c-4d46-a664-df3223d602cd">4,697</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Remaining Lease Term</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases - years</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTozNDY2MGIzODgyOWY0NDQ5YWU5YzQ1YmYzZTBlZmM1ZC90YWJsZXJhbmdlOjM0NjYwYjM4ODI5ZjQ0NDlhZTljNDViZjNlMGVmYzVkXzE4LTEtMS0xLTI5NDg5_e53c7c89-214b-4633-b36b-da0819596ce2">10.9</ix:nonNumeric></span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTozNDY2MGIzODgyOWY0NDQ5YWU5YzQ1YmYzZTBlZmM1ZC90YWJsZXJhbmdlOjM0NjYwYjM4ODI5ZjQ0NDlhZTljNDViZjNlMGVmYzVkXzE4LTItMS0xLTI5NDg5_9f10de71-07b9-4c5b-b951-b2f02a63e0d6">10.4</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Discount Rate</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTozNDY2MGIzODgyOWY0NDQ5YWU5YzQ1YmYzZTBlZmM1ZC90YWJsZXJhbmdlOjM0NjYwYjM4ODI5ZjQ0NDlhZTljNDViZjNlMGVmYzVkXzIyLTEtMS0xLTI5NDg5_5416b4e3-b35b-460a-847d-7a42da92f6ee">6.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTozNDY2MGIzODgyOWY0NDQ5YWU5YzQ1YmYzZTBlZmM1ZC90YWJsZXJhbmdlOjM0NjYwYjM4ODI5ZjQ0NDlhZTljNDViZjNlMGVmYzVkXzIyLTItMS0xLTI5NDg5_a84d3acb-e7d1-40c2-8721-7e03301fd4d7">6.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90ZXh0cmVnaW9uOmEyZmUyZjYyM2Q4ZTQ5MjdhZDY3ZWMxMDE1NzQ5YzEzXzIwNDM_0444f58c-c0c6-465e-8312-5d52b98989d4" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Maturities of lease liabilities were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"></td><td style="width:59.904%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.896%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Operating Leases</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year Ending December 31,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTo1MDhlYWJjODU1MjM0OWQ5OTZmNDkyYjA0Y2ZiNDQ5OS90YWJsZXJhbmdlOjUwOGVhYmM4NTUyMzQ5ZDk5NmY0OTJiMDRjZmI0NDk5XzMtMS0xLTEtMjk0ODk_75e1041b-e2b1-4630-8160-d7321b33f7b5">92,371</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTo1MDhlYWJjODU1MjM0OWQ5OTZmNDkyYjA0Y2ZiNDQ5OS90YWJsZXJhbmdlOjUwOGVhYmM4NTUyMzQ5ZDk5NmY0OTJiMDRjZmI0NDk5XzQtMS0xLTEtMjk0ODk_dbcc09eb-55fb-4549-9db8-5e3897e38a85">92,436</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTo1MDhlYWJjODU1MjM0OWQ5OTZmNDkyYjA0Y2ZiNDQ5OS90YWJsZXJhbmdlOjUwOGVhYmM4NTUyMzQ5ZDk5NmY0OTJiMDRjZmI0NDk5XzUtMS0xLTEtMjk0ODk_4d7b699f-3157-47ac-84f9-d5e5c4152ff0">88,941</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTo1MDhlYWJjODU1MjM0OWQ5OTZmNDkyYjA0Y2ZiNDQ5OS90YWJsZXJhbmdlOjUwOGVhYmM4NTUyMzQ5ZDk5NmY0OTJiMDRjZmI0NDk5XzYtMS0xLTEtMjk0ODk_eed0ec7c-a912-4736-ad47-fee2125ecb0f">85,872</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTo1MDhlYWJjODU1MjM0OWQ5OTZmNDkyYjA0Y2ZiNDQ5OS90YWJsZXJhbmdlOjUwOGVhYmM4NTUyMzQ5ZDk5NmY0OTJiMDRjZmI0NDk5XzctMS0xLTEtMjk0ODk_96d44903-6088-4c87-8d8b-993b2d0b7ab8">82,136</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTo1MDhlYWJjODU1MjM0OWQ5OTZmNDkyYjA0Y2ZiNDQ5OS90YWJsZXJhbmdlOjUwOGVhYmM4NTUyMzQ5ZDk5NmY0OTJiMDRjZmI0NDk5XzgtMS0xLTEtMjk0ODk_18f93d3d-b18b-4417-95a0-5dd5482b8ed3">499,326</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total Lease Payments</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTo1MDhlYWJjODU1MjM0OWQ5OTZmNDkyYjA0Y2ZiNDQ5OS90YWJsZXJhbmdlOjUwOGVhYmM4NTUyMzQ5ZDk5NmY0OTJiMDRjZmI0NDk5XzktMS0xLTEtMjk0ODk_b9dff2d6-85b5-4803-914e-627b1e30dcab">941,082</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTo1MDhlYWJjODU1MjM0OWQ5OTZmNDkyYjA0Y2ZiNDQ5OS90YWJsZXJhbmdlOjUwOGVhYmM4NTUyMzQ5ZDk5NmY0OTJiMDRjZmI0NDk5XzEwLTEtMS0xLTI5NDg5_9351b12d-f2a5-4bf3-ad94-34472cd97b9e">279,358</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTo1MDhlYWJjODU1MjM0OWQ5OTZmNDkyYjA0Y2ZiNDQ5OS90YWJsZXJhbmdlOjUwOGVhYmM4NTUyMzQ5ZDk5NmY0OTJiMDRjZmI0NDk5XzExLTEtMS0xLTI5NDg5_e5ff420e-e5d4-4cd9-9122-5939673eaa11">661,724</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, we have additional operating leases for facilities and medical equipment that have not yet commenced of  approximately $<ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-5" name="rdnt:LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90ZXh0cmVnaW9uOmEyZmUyZjYyM2Q4ZTQ5MjdhZDY3ZWMxMDE1NzQ5YzEzXzE5NDc_89d35649-2584-419a-a094-5b6cd98b227c">11.8</ix:nonFraction> million.  These operating leases will commence in 2023 with lease terms of <ix:nonNumeric contextRef="ic1e56ddb23564f81949b77940a641b57_I20221231" name="us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90ZXh0cmVnaW9uOmEyZmUyZjYyM2Q4ZTQ5MjdhZDY3ZWMxMDE1NzQ5YzEzXzIwMTc_89ef3028-caa5-43d9-893e-dca2aa258e5c">1</ix:nonNumeric> to <ix:nonNumeric contextRef="i0118bb2b3716434fb951fa28970f2707_I20221231" name="us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90ZXh0cmVnaW9uOmEyZmUyZjYyM2Q4ZTQ5MjdhZDY3ZWMxMDE1NzQ5YzEzXzIwMjM_09c28e94-c3c1-42f0-8876-fe1e5d5086f8">15</ix:nonNumeric> years.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="if3f80771944f4fc58015abda42dc47d1_106"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 10 &#8211; <ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90ZXh0cmVnaW9uOmRlNDcyZGZjNTQ5MzQ0NzhhMWY4MjM2NjVkYTk3YWQxXzQ5MzQ_4aff2f1b-8b42-4c04-a591-9316b8d9f2f7" continuedAt="id0c2f1ca6c5644d8aa0061a20300d395" escape="true">INCOME TAXES</ix:nonNumeric></span></div><ix:continuation id="id0c2f1ca6c5644d8aa0061a20300d395" continuedAt="ia2141116b57443fb99f74dfeb882b697"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90ZXh0cmVnaW9uOmRlNDcyZGZjNTQ5MzQ0NzhhMWY4MjM2NjVkYTk3YWQxXzQ5NDc4MDIzNDExMzM_3728fc66-bea5-4951-a2ff-14109c444bb1" continuedAt="icc7652cb4c9b4d5c85c9e23d3260bb88" escape="true">For the years ended December 31, 2022, 2021 and 2020, we have the following income (loss) before income taxes (in thousands):</ix:nonNumeric></span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ia2141116b57443fb99f74dfeb882b697" continuedAt="ie187dacdaefb44c1a2e902fddb43e8fb"><div style="text-align:justify"><ix:continuation id="icc7652cb4c9b4d5c85c9e23d3260bb88"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">US Domestic</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpjOTFmNzg1MWU1NmI0N2EzOWI2MDE0YTk1NGJhYzkxOC90YWJsZXJhbmdlOmM5MWY3ODUxZTU2YjQ3YTM5YjYwMTRhOTU0YmFjOTE4XzItMS0xLTEtNzg2OTk_92cdfcae-f5cf-4805-9bc2-b07c6acd0f5a">59,529</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpjOTFmNzg1MWU1NmI0N2EzOWI2MDE0YTk1NGJhYzkxOC90YWJsZXJhbmdlOmM5MWY3ODUxZTU2YjQ3YTM5YjYwMTRhOTU0YmFjOTE4XzItMy0xLTEtNzg2OTk_3eb906e0-9dae-4b51-b4ad-33bfc4226370">58,806</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpjOTFmNzg1MWU1NmI0N2EzOWI2MDE0YTk1NGJhYzkxOC90YWJsZXJhbmdlOmM5MWY3ODUxZTU2YjQ3YTM5YjYwMTRhOTU0YmFjOTE4XzItNS0xLTEtNzg2OTk_032518b7-2ee5-41c3-bb36-d8d3b39362b4">986</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpjOTFmNzg1MWU1NmI0N2EzOWI2MDE0YTk1NGJhYzkxOC90YWJsZXJhbmdlOmM5MWY3ODUxZTU2YjQ3YTM5YjYwMTRhOTU0YmFjOTE4XzMtMS0xLTEtNzg2OTk_60313160-bdf3-4ae0-a7d3-c7183c3bd9fc">16,560</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpjOTFmNzg1MWU1NmI0N2EzOWI2MDE0YTk1NGJhYzkxOC90YWJsZXJhbmdlOmM5MWY3ODUxZTU2YjQ3YTM5YjYwMTRhOTU0YmFjOTE4XzMtMy0xLTEtNzg2OTk_2d3b1831-174a-4132-ab86-2137d647c2bd">73</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpjOTFmNzg1MWU1NmI0N2EzOWI2MDE0YTk1NGJhYzkxOC90YWJsZXJhbmdlOmM5MWY3ODUxZTU2YjQ3YTM5YjYwMTRhOTU0YmFjOTE4XzMtNS0xLTEtNzg2OTk_0ec7c4e6-4885-4135-85e1-69d69a8d5730">132</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before income taxes</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpjOTFmNzg1MWU1NmI0N2EzOWI2MDE0YTk1NGJhYzkxOC90YWJsZXJhbmdlOmM5MWY3ODUxZTU2YjQ3YTM5YjYwMTRhOTU0YmFjOTE4XzQtMS0xLTEtNzg2OTk_3477fb99-f32b-4e24-8298-5b40a0c42a63">42,969</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpjOTFmNzg1MWU1NmI0N2EzOWI2MDE0YTk1NGJhYzkxOC90YWJsZXJhbmdlOmM5MWY3ODUxZTU2YjQ3YTM5YjYwMTRhOTU0YmFjOTE4XzQtMy0xLTEtNzg2OTk_f69cdca6-2dd2-4df6-adf8-1f7ff0d6b5db">58,879</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpjOTFmNzg1MWU1NmI0N2EzOWI2MDE0YTk1NGJhYzkxOC90YWJsZXJhbmdlOmM5MWY3ODUxZTU2YjQ3YTM5YjYwMTRhOTU0YmFjOTE4XzQtNS0xLTEtNzg2OTk_51bb2c30-264d-4a06-badf-4ca0e387ae83">854</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90ZXh0cmVnaW9uOmRlNDcyZGZjNTQ5MzQ0NzhhMWY4MjM2NjVkYTk3YWQxXzQ5Mjc_592a2e72-aa54-424e-ab43-685862c05479" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December 31, 2022, 2021 and 2020, we recognized income tax expense comprised of the following (in thousands):</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal current tax</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTphN2Q2ZTRhMTQxMWY0MzQzYjRhZDQ2NzIwNDgyNTY0OC90YWJsZXJhbmdlOmE3ZDZlNGExNDExZjQzNDNiNGFkNDY3MjA0ODI1NjQ4XzItMS0xLTEtMjk0ODk_305351ee-108a-4954-92c8-50c91ed919a0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTphN2Q2ZTRhMTQxMWY0MzQzYjRhZDQ2NzIwNDgyNTY0OC90YWJsZXJhbmdlOmE3ZDZlNGExNDExZjQzNDNiNGFkNDY3MjA0ODI1NjQ4XzItMy0xLTEtMjk0ODk_51f7c7a4-5277-4639-90da-5da2af7a626a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTphN2Q2ZTRhMTQxMWY0MzQzYjRhZDQ2NzIwNDgyNTY0OC90YWJsZXJhbmdlOmE3ZDZlNGExNDExZjQzNDNiNGFkNDY3MjA0ODI1NjQ4XzItNS0xLTEtMjk0ODk_d71af590-805e-4e46-9b4d-556cf819270b">256</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State current tax</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTphN2Q2ZTRhMTQxMWY0MzQzYjRhZDQ2NzIwNDgyNTY0OC90YWJsZXJhbmdlOmE3ZDZlNGExNDExZjQzNDNiNGFkNDY3MjA0ODI1NjQ4XzMtMS0xLTEtMjk0ODk_059e55dd-5e70-4de6-8c90-84c045720705">371</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTphN2Q2ZTRhMTQxMWY0MzQzYjRhZDQ2NzIwNDgyNTY0OC90YWJsZXJhbmdlOmE3ZDZlNGExNDExZjQzNDNiNGFkNDY3MjA0ODI1NjQ4XzMtMy0xLTEtMjk0ODk_15b24cb3-4d40-4c92-a6dd-a032c4df28d6">2,191</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTphN2Q2ZTRhMTQxMWY0MzQzYjRhZDQ2NzIwNDgyNTY0OC90YWJsZXJhbmdlOmE3ZDZlNGExNDExZjQzNDNiNGFkNDY3MjA0ODI1NjQ4XzMtNS0xLTEtMjk0ODk_7bcce65d-4093-429e-b230-4575d856501f">1,608</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign current tax</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTphN2Q2ZTRhMTQxMWY0MzQzYjRhZDQ2NzIwNDgyNTY0OC90YWJsZXJhbmdlOmE3ZDZlNGExNDExZjQzNDNiNGFkNDY3MjA0ODI1NjQ4XzQtMS0xLTEtNzU5NDI_cccafbc1-95f0-4475-a4be-481e906b77ed">87</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTphN2Q2ZTRhMTQxMWY0MzQzYjRhZDQ2NzIwNDgyNTY0OC90YWJsZXJhbmdlOmE3ZDZlNGExNDExZjQzNDNiNGFkNDY3MjA0ODI1NjQ4XzQtMy0xLTEtNzU5NDI_837f5b99-6009-44e7-939b-e466b895b446">18</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTphN2Q2ZTRhMTQxMWY0MzQzYjRhZDQ2NzIwNDgyNTY0OC90YWJsZXJhbmdlOmE3ZDZlNGExNDExZjQzNDNiNGFkNDY3MjA0ODI1NjQ4XzQtNS0xLTEtNzU5NDI_0699fcf0-0005-4ddb-9131-b319950faf5b">27</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal deferred tax</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTphN2Q2ZTRhMTQxMWY0MzQzYjRhZDQ2NzIwNDgyNTY0OC90YWJsZXJhbmdlOmE3ZDZlNGExNDExZjQzNDNiNGFkNDY3MjA0ODI1NjQ4XzUtMS0xLTEtMjk0ODk_73c02d5e-5f5f-4b11-bd80-8e9cfc7fed96">6,470</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTphN2Q2ZTRhMTQxMWY0MzQzYjRhZDQ2NzIwNDgyNTY0OC90YWJsZXJhbmdlOmE3ZDZlNGExNDExZjQzNDNiNGFkNDY3MjA0ODI1NjQ4XzUtMy0xLTEtMjk0ODk_2e90b2e6-8e1e-4455-8d7b-617ba34e4eac">9,831</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTphN2Q2ZTRhMTQxMWY0MzQzYjRhZDQ2NzIwNDgyNTY0OC90YWJsZXJhbmdlOmE3ZDZlNGExNDExZjQzNDNiNGFkNDY3MjA0ODI1NjQ4XzUtNS0xLTEtMjk0ODk_3dd160a3-6b6f-4a6b-962f-234633486428">303</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State deferred tax</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTphN2Q2ZTRhMTQxMWY0MzQzYjRhZDQ2NzIwNDgyNTY0OC90YWJsZXJhbmdlOmE3ZDZlNGExNDExZjQzNDNiNGFkNDY3MjA0ODI1NjQ4XzYtMS0xLTEtMjk0ODk_3a25ce92-e25a-40ae-97ed-2d14415da65d">5,863</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTphN2Q2ZTRhMTQxMWY0MzQzYjRhZDQ2NzIwNDgyNTY0OC90YWJsZXJhbmdlOmE3ZDZlNGExNDExZjQzNDNiNGFkNDY3MjA0ODI1NjQ4XzYtMy0xLTEtMjk0ODk_a5e9120f-eee4-4005-96ba-435b514776cd">6,902</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTphN2Q2ZTRhMTQxMWY0MzQzYjRhZDQ2NzIwNDgyNTY0OC90YWJsZXJhbmdlOmE3ZDZlNGExNDExZjQzNDNiNGFkNDY3MjA0ODI1NjQ4XzYtNS0xLTEtMjk0ODk_9095f910-9024-416d-acf8-352c030ed2ec">3,035</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign deferred tax</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTphN2Q2ZTRhMTQxMWY0MzQzYjRhZDQ2NzIwNDgyNTY0OC90YWJsZXJhbmdlOmE3ZDZlNGExNDExZjQzNDNiNGFkNDY3MjA0ODI1NjQ4XzgtMS0xLTEtNzU5NTA_4b645365-4cf4-4826-8da1-bf647f7da9bf">3,430</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTphN2Q2ZTRhMTQxMWY0MzQzYjRhZDQ2NzIwNDgyNTY0OC90YWJsZXJhbmdlOmE3ZDZlNGExNDExZjQzNDNiNGFkNDY3MjA0ODI1NjQ4XzgtMy0xLTEtNzU5NTA_15a0b517-3d1a-45f3-b25d-b4f288d79a3a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTphN2Q2ZTRhMTQxMWY0MzQzYjRhZDQ2NzIwNDgyNTY0OC90YWJsZXJhbmdlOmE3ZDZlNGExNDExZjQzNDNiNGFkNDY3MjA0ODI1NjQ4XzgtNS0xLTEtNzU5NTA_ca3fec43-9a8a-47bc-ae8d-1e369b659d67">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTphN2Q2ZTRhMTQxMWY0MzQzYjRhZDQ2NzIwNDgyNTY0OC90YWJsZXJhbmdlOmE3ZDZlNGExNDExZjQzNDNiNGFkNDY3MjA0ODI1NjQ4XzgtMS0xLTEtMjk0ODk_71a327c6-5d69-47b6-8c6e-61f1ffa1142b">9,361</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTphN2Q2ZTRhMTQxMWY0MzQzYjRhZDQ2NzIwNDgyNTY0OC90YWJsZXJhbmdlOmE3ZDZlNGExNDExZjQzNDNiNGFkNDY3MjA0ODI1NjQ4XzgtMy0xLTEtMjk0ODk_516eec83-dfcd-419c-9d0f-f9288e549438">14,560</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTphN2Q2ZTRhMTQxMWY0MzQzYjRhZDQ2NzIwNDgyNTY0OC90YWJsZXJhbmdlOmE3ZDZlNGExNDExZjQzNDNiNGFkNDY3MjA0ODI1NjQ4XzgtNS0xLTEtMjk0ODk_1be86abd-f2fc-4e94-be6b-2591155d9e5f">895</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90ZXh0cmVnaW9uOmRlNDcyZGZjNTQ5MzQ0NzhhMWY4MjM2NjVkYTk3YWQxXzQ5NDA_021f1336-908c-4197-9c1b-4d6670b238c8" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the statutory U.S. federal rate and effective rates is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:60.854%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.178%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.551%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.551%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.178%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.551%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.551%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.779%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.407%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="24" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal tax</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzItMS0xLTEtMjk0ODk_230e029b-7c1e-42c2-980b-3e0ba63f8da3">9,023</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzItNS0xLTEtMjk0ODk_4047e4cc-4724-41dd-8094-a3c8ad538d84">12,365</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzItOS0xLTEtMjk0ODk_a0c31b97-4f0d-4b80-9cb3-0630664fe73c">179</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State franchise tax, net of federal benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzMtMS0xLTEtMjk0ODk_a2100cba-8d8b-474a-adc3-cfac8c1a1802">595</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzMtNS0xLTEtMjk0ODk_5290d697-a56d-4043-bec5-87efbdfca708">4,198</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzMtOS0xLTEtMjk0ODk_368ee22a-beff-4df8-922e-0d51b004c7f6">779</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Non deductible expenses</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzQtMS0xLTEtMjk0ODk_ab242155-5a7f-4805-9329-aede1610903d">305</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzQtNS0xLTEtMjk0ODk_bb2bbc46-8340-4258-9f9f-dc5de9e8f8d1">93</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzQtOS0xLTEtMjk0ODk_b7b41041-fbd5-4243-a6b0-fa899c77f78c">224</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Officer Compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzUtMS0xLTEtNzcxNDA_1534dc30-4cb7-4150-b7b6-35767c1d7d14">759</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzUtNS0xLTEtNzcxNDg_6f706c75-8a18-49bb-90a0-d2b9faebe9ef">291</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzUtOS0xLTEtNzcxNTY_10559dd6-a8a2-4ec6-88d5-42baf18038bf">77</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests in partnerships</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:IncomeTaxReconciliationMinorityInterestIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzUtMS0xLTEtMjk0ODk_62220a46-0244-42d8-a5aa-c492dc4fa36f">4,821</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxReconciliationMinorityInterestIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzUtNS0xLTEtMjk0ODk_f5203571-cc6c-4920-b07d-a56d3ebb51ed">4,114</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxReconciliationMinorityInterestIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzUtOS0xLTEtMjk0ODk_90f3cf25-e7f1-4654-a936-1b5f3f719f81">2,748</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzYtMS0xLTEtMjk0ODk_b20aef3c-b4db-448a-b67f-5cccc1bf526f">6,124</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzYtNS0xLTEtMjk0ODk_c0e334db-ada4-48e7-a0d0-0d7d551857aa">249</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzYtOS0xLTEtMjk0ODk_a81cd0ff-709a-4b7d-87a4-f46551982df6">33</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Return to provision</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzctMS0xLTEtMjk0ODk_1a2ec169-0c46-4997-8e81-d14102995c18">234</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzctNS0xLTEtMjk0ODk_1f562315-ee8e-4184-9e83-e86d8d475028">2,530</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzctOS0xLTEtMjk0ODk_1fb2ec87-07ba-4445-98a3-faecabda6e13">2,252</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PPP Loan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="rdnt:EffectiveIncomeTaxRateReconciliationPPPLoanAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzgtMS0xLTEtMjk0ODk_74108667-91d7-479f-b288-17128a7c9196">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="rdnt:EffectiveIncomeTaxRateReconciliationPPPLoanAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzgtNS0xLTEtMjk0ODk_ebfc80c4-8200-4bcb-b183-6d3365e4caa8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" sign="-" name="rdnt:EffectiveIncomeTaxRateReconciliationPPPLoanAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzgtOS0xLTEtMjk0ODk_2054a516-19cb-4ef0-a515-e43c70deb85b">850</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred true-ups and other</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzEwLTEtMS0xLTI5NDg5_2ae68545-f95c-4dfe-a01e-595be29884e8">1,451</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzEwLTUtMS0xLTI5NDg5_f2d320aa-324f-4edd-ba04-36b98ed3d5b6">5,009</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzEwLTktMS0xLTI5NDg5_7d6af867-69d0-4e52-b6d7-be59eac5c921">4,840</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign rate differential</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzEyLTEtMS0xLTc3MTY4_098ebae3-eafc-4e45-abd5-4cb962ca2486">737</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzEyLTUtMS0xLTc3MTc2_42c2f328-cf3c-4d1a-b4fd-d3ee213b97b0">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzExLTktMS0xLTc3ODEw_03b6b1e0-22bc-4d55-a49b-f9437952c440">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncertain tax provisions</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationTaxContingencies" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzExLTEtMS0xLTI5NDg5_94404b92-bd44-438c-ae73-be8be8b66f21">749</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationTaxContingencies" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzExLTUtMS0xLTI5NDg5_b2737eac-30f6-4e1c-be92-c4fbf1d8b1be">321</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxReconciliationTaxContingencies" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzExLTktMS0xLTI5NDg5_b3985469-8eb1-4484-9d77-66d88a49712e">1,036</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other differences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:IncomeTaxReconciliationOtherReconcilingItems" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzEyLTEtMS0xLTI5NDg5_367df38f-44ee-4929-84a4-a674ca2951fe">79</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxReconciliationOtherReconcilingItems" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzEyLTUtMS0xLTI5NDg5_cc9f6807-4bb3-4784-a2fa-cbfe6a54fee0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxReconciliationOtherReconcilingItems" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzEyLTktMS0xLTI5NDg5_cb43c3c4-a3bc-4730-9019-92188d4d95e1">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzEzLTEtMS0xLTI5NDg5_18d27e61-a690-42ca-be57-e13437f4fee9">9,361</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzEzLTUtMS0xLTI5NDg5_7869dd7b-6e05-49a7-9d13-1d0e0a111237">14,560</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzEzLTktMS0xLTI5NDg5_f11dafac-6fee-4679-b2b0-f76e7d49308a">895</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred income taxes reflect the net tax effects of temporary differences between carrying amounts of assets and liabilities for financial and income tax reporting purposes and operating loss carryforwards.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90ZXh0cmVnaW9uOmRlNDcyZGZjNTQ5MzQ0NzhhMWY4MjM2NjVkYTk3YWQxXzQ5Mzg_559dc19a-d427-41ec-84f7-0e2ef023769b" continuedAt="i47a4636a09ed4f02950fa019b0100bcf" escape="true">Our deferred tax assets and liabilities comprise the following (in thousands):</ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ie187dacdaefb44c1a2e902fddb43e8fb" continuedAt="i31e30176391f4e6f880c6ad2d78990a0"><div style="margin-top:5pt"><ix:continuation id="i47a4636a09ed4f02950fa019b0100bcf"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating losses</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpiNzU0MWMyZWUxNzA0OTQ1YmI2YTYwNTAxNWU4NDNhZS90YWJsZXJhbmdlOmI3NTQxYzJlZTE3MDQ5NDViYjZhNjA1MDE1ZTg0M2FlXzItMS0xLTEtMjk0ODk_90bb5b23-c3c8-4f16-8082-5a54642f128a">68,124</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpiNzU0MWMyZWUxNzA0OTQ1YmI2YTYwNTAxNWU4NDNhZS90YWJsZXJhbmdlOmI3NTQxYzJlZTE3MDQ5NDViYjZhNjA1MDE1ZTg0M2FlXzItMy0xLTEtMjk0ODk_f0d04d2f-3a3e-44fd-b884-cdcbd4b9170e">57,663</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpiNzU0MWMyZWUxNzA0OTQ1YmI2YTYwNTAxNWU4NDNhZS90YWJsZXJhbmdlOmI3NTQxYzJlZTE3MDQ5NDViYjZhNjA1MDE1ZTg0M2FlXzMtMS0xLTEtMjk0ODk_81cc7692-190f-4c41-aa68-91db713d3e7c">3,941</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpiNzU0MWMyZWUxNzA0OTQ1YmI2YTYwNTAxNWU4NDNhZS90YWJsZXJhbmdlOmI3NTQxYzJlZTE3MDQ5NDViYjZhNjA1MDE1ZTg0M2FlXzMtMy0xLTEtMjk0ODk_4284aacf-4877-4114-9556-37befcab657d">3,275</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="rdnt:DeferredTaxAssetsOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpiNzU0MWMyZWUxNzA0OTQ1YmI2YTYwNTAxNWU4NDNhZS90YWJsZXJhbmdlOmI3NTQxYzJlZTE3MDQ5NDViYjZhNjA1MDE1ZTg0M2FlXzQtMS0xLTEtMjk0ODk_356401a2-0069-4024-a57e-8c069a043829">142,347</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" name="rdnt:DeferredTaxAssetsOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpiNzU0MWMyZWUxNzA0OTQ1YmI2YTYwNTAxNWU4NDNhZS90YWJsZXJhbmdlOmI3NTQxYzJlZTE3MDQ5NDViYjZhNjA1MDE1ZTg0M2FlXzQtMy0xLTEtMjk0ODk_4f8d845c-f1a1-4945-a93a-9503a1722731">141,440</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpiNzU0MWMyZWUxNzA0OTQ1YmI2YTYwNTAxNWU4NDNhZS90YWJsZXJhbmdlOmI3NTQxYzJlZTE3MDQ5NDViYjZhNjA1MDE1ZTg0M2FlXzctMS0xLTEtMjk0ODk_8d82cb1f-e624-4c96-a711-01c4c3b1483d">4,387</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpiNzU0MWMyZWUxNzA0OTQ1YmI2YTYwNTAxNWU4NDNhZS90YWJsZXJhbmdlOmI3NTQxYzJlZTE3MDQ5NDViYjZhNjA1MDE1ZTg0M2FlXzctMy0xLTEtMjk0ODk_48084dae-e993-4865-bcf7-5de0489c0000">2,993</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpiNzU0MWMyZWUxNzA0OTQ1YmI2YTYwNTAxNWU4NDNhZS90YWJsZXJhbmdlOmI3NTQxYzJlZTE3MDQ5NDViYjZhNjA1MDE1ZTg0M2FlXzgtMS0xLTEtMjk0ODk_08802b3b-2e62-4b50-acff-088e7d63cbdd">3,071</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpiNzU0MWMyZWUxNzA0OTQ1YmI2YTYwNTAxNWU4NDNhZS90YWJsZXJhbmdlOmI3NTQxYzJlZTE3MDQ5NDViYjZhNjA1MDE1ZTg0M2FlXzgtMy0xLTEtMjk0ODk_6797bf5d-457f-4427-b193-955d214b5bf0">2,711</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpiNzU0MWMyZWUxNzA0OTQ1YmI2YTYwNTAxNWU4NDNhZS90YWJsZXJhbmdlOmI3NTQxYzJlZTE3MDQ5NDViYjZhNjA1MDE1ZTg0M2FlXzktMS0xLTEtMjk0ODk_c8e4bdfe-df53-4a98-af1a-4ff1bd4c4d9d">6,541</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpiNzU0MWMyZWUxNzA0OTQ1YmI2YTYwNTAxNWU4NDNhZS90YWJsZXJhbmdlOmI3NTQxYzJlZTE3MDQ5NDViYjZhNjA1MDE1ZTg0M2FlXzktMy0xLTEtMjk0ODk_933324d9-9701-40b5-afb6-29bd1177e1a5">7,532</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpiNzU0MWMyZWUxNzA0OTQ1YmI2YTYwNTAxNWU4NDNhZS90YWJsZXJhbmdlOmI3NTQxYzJlZTE3MDQ5NDViYjZhNjA1MDE1ZTg0M2FlXzEwLTEtMS0xLTI5NDg5_e039d5aa-2540-4064-a252-fbc697fb9ce5">12,095</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpiNzU0MWMyZWUxNzA0OTQ1YmI2YTYwNTAxNWU4NDNhZS90YWJsZXJhbmdlOmI3NTQxYzJlZTE3MDQ5NDViYjZhNjA1MDE1ZTg0M2FlXzEwLTMtMS0xLTI5NDg5_c0169986-aab6-4462-b7d4-e63360faa05d">5,066</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Deferred Tax Assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpiNzU0MWMyZWUxNzA0OTQ1YmI2YTYwNTAxNWU4NDNhZS90YWJsZXJhbmdlOmI3NTQxYzJlZTE3MDQ5NDViYjZhNjA1MDE1ZTg0M2FlXzExLTEtMS0xLTI5NDg5_b6c5c469-0819-4113-ad7c-66b5981f5a57">216,316</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpiNzU0MWMyZWUxNzA0OTQ1YmI2YTYwNTAxNWU4NDNhZS90YWJsZXJhbmdlOmI3NTQxYzJlZTE3MDQ5NDViYjZhNjA1MDE1ZTg0M2FlXzExLTMtMS0xLTI5NDg5_4f778b1d-eff7-41b2-b31b-b26d37a6e636">210,548</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpiNzU0MWMyZWUxNzA0OTQ1YmI2YTYwNTAxNWU4NDNhZS90YWJsZXJhbmdlOmI3NTQxYzJlZTE3MDQ5NDViYjZhNjA1MDE1ZTg0M2FlXzEzLTEtMS0xLTI5NDg5_08e22f20-3ba4-45e3-b627-69631e6635f7">9,214</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpiNzU0MWMyZWUxNzA0OTQ1YmI2YTYwNTAxNWU4NDNhZS90YWJsZXJhbmdlOmI3NTQxYzJlZTE3MDQ5NDViYjZhNjA1MDE1ZTg0M2FlXzEzLTMtMS0xLTI5NDg5_a546f94b-ebaf-4adb-87bc-3a165a7a983d">12,134</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpiNzU0MWMyZWUxNzA0OTQ1YmI2YTYwNTAxNWU4NDNhZS90YWJsZXJhbmdlOmI3NTQxYzJlZTE3MDQ5NDViYjZhNjA1MDE1ZTg0M2FlXzE0LTEtMS0xLTI5NDg5_5201b994-ab9a-4ca2-a817-a11ce724244b">38,820</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpiNzU0MWMyZWUxNzA0OTQ1YmI2YTYwNTAxNWU4NDNhZS90YWJsZXJhbmdlOmI3NTQxYzJlZTE3MDQ5NDViYjZhNjA1MDE1ZTg0M2FlXzE0LTMtMS0xLTI5NDg5_8680dab9-4045-45d7-bf5f-2f3eb57736b7">33,973</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpiNzU0MWMyZWUxNzA0OTQ1YmI2YTYwNTAxNWU4NDNhZS90YWJsZXJhbmdlOmI3NTQxYzJlZTE3MDQ5NDViYjZhNjA1MDE1ZTg0M2FlXzE1LTEtMS0xLTI5NDg5_f3156a11-65af-4057-8fdb-a260dfb025cc">18,640</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpiNzU0MWMyZWUxNzA0OTQ1YmI2YTYwNTAxNWU4NDNhZS90YWJsZXJhbmdlOmI3NTQxYzJlZTE3MDQ5NDViYjZhNjA1MDE1ZTg0M2FlXzE1LTMtMS0xLTI5NDg5_e24b389d-9016-4cfa-8ab4-d85650ff197d">9,133</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use asset</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="rdnt:DeferredTaxLiabilitiesOperatingRightOfUseAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpiNzU0MWMyZWUxNzA0OTQ1YmI2YTYwNTAxNWU4NDNhZS90YWJsZXJhbmdlOmI3NTQxYzJlZTE3MDQ5NDViYjZhNjA1MDE1ZTg0M2FlXzE2LTEtMS0xLTI5NDg5_2ea9d3c2-3869-4437-9e82-d563457646ed">129,802</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" name="rdnt:DeferredTaxLiabilitiesOperatingRightOfUseAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpiNzU0MWMyZWUxNzA0OTQ1YmI2YTYwNTAxNWU4NDNhZS90YWJsZXJhbmdlOmI3NTQxYzJlZTE3MDQ5NDViYjZhNjA1MDE1ZTg0M2FlXzE2LTMtMS0xLTI5NDg5_7db66f76-e955-4afa-9bfb-3070e5e1806f">128,868</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outside basis difference</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="rdnt:DeferredTaxLiabilitiesOutsideBasisDifference" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpiNzU0MWMyZWUxNzA0OTQ1YmI2YTYwNTAxNWU4NDNhZS90YWJsZXJhbmdlOmI3NTQxYzJlZTE3MDQ5NDViYjZhNjA1MDE1ZTg0M2FlXzE3LTEtMS0xLTI5NDg5_181aa13e-b0bd-4b05-a78d-d2e15524ca2a">20,015</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" name="rdnt:DeferredTaxLiabilitiesOutsideBasisDifference" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpiNzU0MWMyZWUxNzA0OTQ1YmI2YTYwNTAxNWU4NDNhZS90YWJsZXJhbmdlOmI3NTQxYzJlZTE3MDQ5NDViYjZhNjA1MDE1ZTg0M2FlXzE3LTMtMS0xLTI5NDg5_809f2c69-adab-4846-83bf-93f97434eaec">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpiNzU0MWMyZWUxNzA0OTQ1YmI2YTYwNTAxNWU4NDNhZS90YWJsZXJhbmdlOmI3NTQxYzJlZTE3MDQ5NDViYjZhNjA1MDE1ZTg0M2FlXzE4LTEtMS0xLTI5NDg5_8078e7d3-00f0-4a65-98bc-be6167ade3cc">9,081</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpiNzU0MWMyZWUxNzA0OTQ1YmI2YTYwNTAxNWU4NDNhZS90YWJsZXJhbmdlOmI3NTQxYzJlZTE3MDQ5NDViYjZhNjA1MDE1ZTg0M2FlXzE4LTMtMS0xLTI5NDg5_0f49fd93-e0b4-4dc0-94d5-7d95292c4ecb">11,587</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Deferred Tax Liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpiNzU0MWMyZWUxNzA0OTQ1YmI2YTYwNTAxNWU4NDNhZS90YWJsZXJhbmdlOmI3NTQxYzJlZTE3MDQ5NDViYjZhNjA1MDE1ZTg0M2FlXzE5LTEtMS0xLTI5NDg5_7e8a13f8-c5bb-49a5-90b1-ac21679b9861">225,572</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpiNzU0MWMyZWUxNzA0OTQ1YmI2YTYwNTAxNWU4NDNhZS90YWJsZXJhbmdlOmI3NTQxYzJlZTE3MDQ5NDViYjZhNjA1MDE1ZTg0M2FlXzE5LTMtMS0xLTI5NDg5_4fba1650-f123-44a3-904e-4796f642927c">195,695</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Deferred Tax (Liability) Asset</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpiNzU0MWMyZWUxNzA0OTQ1YmI2YTYwNTAxNWU4NDNhZS90YWJsZXJhbmdlOmI3NTQxYzJlZTE3MDQ5NDViYjZhNjA1MDE1ZTg0M2FlXzIxLTEtMS0xLTI5NDg5_c6135d26-41b9-4620-b677-63a1a0359990">9,256</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpiNzU0MWMyZWUxNzA0OTQ1YmI2YTYwNTAxNWU4NDNhZS90YWJsZXJhbmdlOmI3NTQxYzJlZTE3MDQ5NDViYjZhNjA1MDE1ZTg0M2FlXzIxLTMtMS0xLTI5NDg5_c93b58ae-0325-4b80-bb31-f19424331330">14,853</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, we had federal net operating loss carryforwards of approximately $<ix:nonFraction unitRef="usd" contextRef="i1c9c24367d914d6f8d3b8b89c6ac650c_I20221231" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90ZXh0cmVnaW9uOmRlNDcyZGZjNTQ5MzQ0NzhhMWY4MjM2NjVkYTk3YWQxXzYxNA_1c818024-026b-4913-b794-f29527f2eb68">231.5</ix:nonFraction> million, which is comprised of definite and indefinite net operating losses.  We had federal net operating loss carryforwards of approximately $<ix:nonFraction unitRef="usd" contextRef="i1c9c24367d914d6f8d3b8b89c6ac650c_I20221231" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90ZXh0cmVnaW9uOmRlNDcyZGZjNTQ5MzQ0NzhhMWY4MjM2NjVkYTk3YWQxXzYyNw_ca385c09-7906-436a-a65e-e4cdafe7a209">165.2</ix:nonFraction> million, which expire at various intervals from the years 2026 to 2037, and had carryforwards of $<ix:nonFraction unitRef="usd" contextRef="i1c9c24367d914d6f8d3b8b89c6ac650c_I20221231" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90ZXh0cmVnaW9uOmRlNDcyZGZjNTQ5MzQ0NzhhMWY4MjM2NjVkYTk3YWQxXzY5OA_2abd158c-7b26-42c9-a61e-ac90bff338f0">66.3</ix:nonFraction> million of net operating losses which do not expire.  Federal net operating losses generated in tax years following December 31, 2017 carryover indefinitely and may be used to offset up to 80% of future taxable net income.  We also had state net operating loss carryforwards of approximately $<ix:nonFraction unitRef="usd" contextRef="i01d34ce5690d41ac9b7da0025a908d74_I20221231" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90ZXh0cmVnaW9uOmRlNDcyZGZjNTQ5MzQ0NzhhMWY4MjM2NjVkYTk3YWQxXzk2Ng_11624267-7280-476c-ac73-8dc51fc2a373">271.7</ix:nonFraction> million, which expire at various intervals from the years 2024 through 2042. As of December 31, 2022, $<ix:nonFraction unitRef="usd" contextRef="if220aac49baf4022b602bb8b0e79c955_I20221231" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90ZXh0cmVnaW9uOmRlNDcyZGZjNTQ5MzQ0NzhhMWY4MjM2NjVkYTk3YWQxXzEwNDg_b68003ec-5e27-4dc7-b69e-5ab690de5470">24.9</ix:nonFraction> million of our federal net operating loss carryforwards acquired in connection with the 2011 acquisition of Raven Holdings U.S., Inc. and the 2019 acquisition of Nulogix Health, Inc. are subject to limitations related to their utilization under Section 382 of the Internal Revenue Code.  We also had foreign net operating loss carryforwards of approximately $<ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-5" name="rdnt:ForeignOperatingLossCarryforwardsSubjectToExpiration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90ZXh0cmVnaW9uOmRlNDcyZGZjNTQ5MzQ0NzhhMWY4MjM2NjVkYTk3YWQxXzM4NDgyOTA3MDc2NTg_60a8ba01-c799-47ed-8872-1c23357dd004">19.8</ix:nonFraction> million, which begin to expire from years 2023 to 2027, in addition to $<ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-5" name="rdnt:ForeignOperatingLossCarryforwardsNotSubjectToExpiration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90ZXh0cmVnaW9uOmRlNDcyZGZjNTQ5MzQ0NzhhMWY4MjM2NjVkYTk3YWQxXzM4NDgyOTA3MDc3Mjk_49588387-cfc2-4ba5-ba25-0e3ea1df2835">11.0</ix:nonFraction> million which do not expire and are carried over indefinitely.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We considered all evidence available when determining whether deferred tax assets are more likely-than-not to be realized, including projected future taxable income, scheduled reversals of deferred tax liabilities, prudent tax planning strategies, and recent financial operations. The evaluation of this evidence requires significant judgment about the forecasts of future taxable income, based on the plans and estimates we are using to manage the underlying businesses. In evaluating the objective evidence that historical results provide, we consider three years of cumulative operating income. As of December 31, 2022, we have determined that deferred tax assets of $<ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-5" name="rdnt:DeferredTaxAssetsTaxBenefitMayNotBeRealized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90ZXh0cmVnaW9uOmRlNDcyZGZjNTQ5MzQ0NzhhMWY4MjM2NjVkYTk3YWQxXzE5ODk_44940926-e206-4619-8b12-d2aae82e67c8">216.3</ix:nonFraction> million are more likely-than-not to be realized. We have also determined deferred tax liabilities of $<ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90ZXh0cmVnaW9uOmRlNDcyZGZjNTQ5MzQ0NzhhMWY4MjM2NjVkYTk3YWQxXzIwOTk_0e611729-3485-4003-86b5-acd5a94f5733">38.8</ix:nonFraction> million are related to book basis in goodwill that has an indefinite life.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We file consolidated income tax returns in the U.S. federal jurisdiction and various states and foreign jurisdictions. We continue to reinvest earnings of the non-US entities for the foreseeable future and therefore have not recognized any U.S. tax expense on these earnings. With limited exceptions, we are no longer subject to U.S. federal, state and local, or non-U.S. income tax examinations by tax authorities for years before 2018.  We do not anticipate the results of any open examinations would result in a material change to our financial position.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90ZXh0cmVnaW9uOmRlNDcyZGZjNTQ5MzQ0NzhhMWY4MjM2NjVkYTk3YWQxXzQ5Mjk_0dd96da5-0a55-46c0-b55b-344e15cd6b34" continuedAt="i85c56f57a78b42979cf2f75eb150f2ec" escape="true">A reconciliation of the total gross amounts of unrecognized tax benefits for the years ended are as follows (in thousands):</ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">87</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i31e30176391f4e6f880c6ad2d78990a0"><div style="margin-top:5pt"><ix:continuation id="i85c56f57a78b42979cf2f75eb150f2ec"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of year</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTo2ODcyYjVjMTEyMDY0MTk5YTk4OWJkODkxZjllNGUxZC90YWJsZXJhbmdlOjY4NzJiNWMxMTIwNjQxOTlhOTg5YmQ4OTFmOWU0ZTFkXzItMS0xLTEtMjk0ODk_31b0368b-85b4-459f-ae18-c013079cd40f">5,088</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb50bc5a13564f6a97eb669524009c18_I20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTo2ODcyYjVjMTEyMDY0MTk5YTk4OWJkODkxZjllNGUxZC90YWJsZXJhbmdlOjY4NzJiNWMxMTIwNjQxOTlhOTg5YmQ4OTFmOWU0ZTFkXzItMy0xLTEtMjk0ODk_269ef468-cf68-4cbf-9671-1b2df44e20af">5,484</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i404f0df0019f440299547782ff0ce012_I20191231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTo2ODcyYjVjMTEyMDY0MTk5YTk4OWJkODkxZjllNGUxZC90YWJsZXJhbmdlOjY4NzJiNWMxMTIwNjQxOTlhOTg5YmQ4OTFmOWU0ZTFkXzItNS0xLTEtMjk0ODk_ac948333-56e5-471d-9eda-a4db6c6555f1">4,320</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to prior year tax positions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTo2ODcyYjVjMTEyMDY0MTk5YTk4OWJkODkxZjllNGUxZC90YWJsZXJhbmdlOjY4NzJiNWMxMTIwNjQxOTlhOTg5YmQ4OTFmOWU0ZTFkXzMtMS0xLTEtMjk0ODk_4198a654-3893-4aeb-9a2e-6ea120b9a748">55</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTo2ODcyYjVjMTEyMDY0MTk5YTk4OWJkODkxZjllNGUxZC90YWJsZXJhbmdlOjY4NzJiNWMxMTIwNjQxOTlhOTg5YmQ4OTFmOWU0ZTFkXzMtMy0xLTEtMjk0ODk_b4501797-c1cc-47d8-8626-668abb387ecd">317</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTo2ODcyYjVjMTEyMDY0MTk5YTk4OWJkODkxZjllNGUxZC90YWJsZXJhbmdlOjY4NzJiNWMxMTIwNjQxOTlhOTg5YmQ4OTFmOWU0ZTFkXzMtNS0xLTEtMjk0ODk_cd20b637-c455-4fd4-9dbc-9261fe7b0f77">1,382</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to current year tax positions</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTo2ODcyYjVjMTEyMDY0MTk5YTk4OWJkODkxZjllNGUxZC90YWJsZXJhbmdlOjY4NzJiNWMxMTIwNjQxOTlhOTg5YmQ4OTFmOWU0ZTFkXzQtMS0xLTEtMjk0ODk_68ea8dee-9585-47d1-8daf-e64be3d6e3db">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTo2ODcyYjVjMTEyMDY0MTk5YTk4OWJkODkxZjllNGUxZC90YWJsZXJhbmdlOjY4NzJiNWMxMTIwNjQxOTlhOTg5YmQ4OTFmOWU0ZTFkXzQtMy0xLTEtMjk0ODk_f8be2536-6b71-4327-af11-fb9c6c35fd2a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTo2ODcyYjVjMTEyMDY0MTk5YTk4OWJkODkxZjllNGUxZC90YWJsZXJhbmdlOjY4NzJiNWMxMTIwNjQxOTlhOTg5YmQ4OTFmOWU0ZTFkXzQtNS0xLTEtMjk0ODk_76ae3353-491c-4d25-8b71-f40ab133f599">3</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expiration of the statute of limitations for the assessment of taxes</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTo2ODcyYjVjMTEyMDY0MTk5YTk4OWJkODkxZjllNGUxZC90YWJsZXJhbmdlOjY4NzJiNWMxMTIwNjQxOTlhOTg5YmQ4OTFmOWU0ZTFkXzUtMS0xLTEtMjk0ODk_ce52ca20-bbf2-4f9c-a68d-756cede3a153">999</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTo2ODcyYjVjMTEyMDY0MTk5YTk4OWJkODkxZjllNGUxZC90YWJsZXJhbmdlOjY4NzJiNWMxMTIwNjQxOTlhOTg5YmQ4OTFmOWU0ZTFkXzUtMy0xLTEtMjk0ODk_e50db56d-b599-4fe6-857b-e0f3058a95a6">713</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTo2ODcyYjVjMTEyMDY0MTk5YTk4OWJkODkxZjllNGUxZC90YWJsZXJhbmdlOjY4NzJiNWMxMTIwNjQxOTlhOTg5YmQ4OTFmOWU0ZTFkXzUtNS0xLTEtMjk0ODk_58c859df-e4e9-477a-ad86-75f80ebeb63d">221</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase (decrease) related to change in rate</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="rdnt:UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTo2ODcyYjVjMTEyMDY0MTk5YTk4OWJkODkxZjllNGUxZC90YWJsZXJhbmdlOjY4NzJiNWMxMTIwNjQxOTlhOTg5YmQ4OTFmOWU0ZTFkXzYtMS0xLTEtMjk0ODk_cf41de8c-1ea5-4b19-a737-0e3f94e5a391">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231" decimals="-3" name="rdnt:UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTo2ODcyYjVjMTEyMDY0MTk5YTk4OWJkODkxZjllNGUxZC90YWJsZXJhbmdlOjY4NzJiNWMxMTIwNjQxOTlhOTg5YmQ4OTFmOWU0ZTFkXzYtMy0xLTEtMjk0ODk_989cc2db-7c37-4856-acd1-885ff8ebc865">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231" decimals="-3" name="rdnt:UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTo2ODcyYjVjMTEyMDY0MTk5YTk4OWJkODkxZjllNGUxZC90YWJsZXJhbmdlOjY4NzJiNWMxMTIwNjQxOTlhOTg5YmQ4OTFmOWU0ZTFkXzYtNS0xLTEtMjk0ODk_340db602-3afc-43a1-b2fc-3e15c0731776">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of year</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTo2ODcyYjVjMTEyMDY0MTk5YTk4OWJkODkxZjllNGUxZC90YWJsZXJhbmdlOjY4NzJiNWMxMTIwNjQxOTlhOTg5YmQ4OTFmOWU0ZTFkXzctMS0xLTEtMjk0ODk_489e5838-c3ca-49cd-87b1-09915ad22878">4,144</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTo2ODcyYjVjMTEyMDY0MTk5YTk4OWJkODkxZjllNGUxZC90YWJsZXJhbmdlOjY4NzJiNWMxMTIwNjQxOTlhOTg5YmQ4OTFmOWU0ZTFkXzctMy0xLTEtMjk0ODk_98514185-4262-4935-ab21-4de6590e4577">5,088</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb50bc5a13564f6a97eb669524009c18_I20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTo2ODcyYjVjMTEyMDY0MTk5YTk4OWJkODkxZjllNGUxZC90YWJsZXJhbmdlOjY4NzJiNWMxMTIwNjQxOTlhOTg5YmQ4OTFmOWU0ZTFkXzctNS0xLTEtMjk0ODk_af4a1fdb-8af7-437a-a5bb-0e629a4618de">5,484</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2022, we had unrecognized tax benefits of $<ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90ZXh0cmVnaW9uOmRlNDcyZGZjNTQ5MzQ0NzhhMWY4MjM2NjVkYTk3YWQxXzI4ODU_c29eb604-cd10-4e1d-96f4-6c530be6dc25">4.1</ix:nonFraction> million of which $<ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-5" name="rdnt:UnrecognizedTaxBenefitsTaxImpactIfRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90ZXh0cmVnaW9uOmRlNDcyZGZjNTQ5MzQ0NzhhMWY4MjM2NjVkYTk3YWQxXzI4OTc_39ec519e-8991-4d09-9a3d-ab1608059e75">3.4</ix:nonFraction> million will affect the effective tax rate if recognized.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize accrued interest and penalties related to unrecognized tax benefits in income tax expense. During the year ended December 31, 2022 the Company accrued approximately $<ix:nonFraction unitRef="usd" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="-3" name="rdnt:UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90ZXh0cmVnaW9uOmRlNDcyZGZjNTQ5MzQ0NzhhMWY4MjM2NjVkYTk3YWQxXzMxMjY_32ff587d-af9c-4b0f-af63-d20cdebe3d88">2</ix:nonFraction> thousand of interest and penalties. As of December 31, 2022, accrued interest and penalties amounted to approximately $<ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90ZXh0cmVnaW9uOmRlNDcyZGZjNTQ5MzQ0NzhhMWY4MjM2NjVkYTk3YWQxXzMyMjM_5b4e4b6f-80b8-49bd-bdae-40005f40be81">0.4</ix:nonFraction> million.  We do not anticipate the uncertain tax position to change materially within the next 12 months.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On March 27, 2020, the United States enacted the Coronavirus Aid, Relief and Economic Security Act (CARES Act). The Cares Act is an emergency economic stimulus package that includes spending and tax breaks to strengthen the United States economy and fund a nationwide effort to curtail the effect of COVID-19. The CARES Act provides sweeping tax changes in response to the COVID-19 pandemic, some of the more significant provisions are removal of certain limitations on utilization of net operating losses, increasing the loss carryback period for certain losses to five years, and increasing the ability to deduct interest expense, as well as amending certain provisions of the previously enacted Tax Cuts and Jobs Act. At December 31, 2020, we have taken advantage of the accelerated tax depreciation related to qualified improvement property and the Paycheck Protection Program loan allowed under the CARES Act.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On December 27, 2020, the United States enacted the Consolidated Appropriations Act of 2021 (&#8220;CAA&#8221;). The CAA includes provisions extending certain CARES Act provisions and adds coronavirus relief, tax and health extenders.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Inflation Reduction Act 2022 which incorporates a Corporate Alternative Minimum Tax (CAMT) was signed on August 16, 2022.  The changes will affect for the tax years beginning after December 31, 2022.  The new tax will require companies to compute two separate calculations for federal income tax purposes and pay the greater of the new minimum tax or their regular tax liability.  We will be monitoring the impacts of the act to determine if this will have a impact on us for years beginning after December 31, 2022. As of year-end it is not expected to have a material impact for us.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The Creating Helpful Incentives to Produce Semiconductors (CHIPS) Act of 2022 was signed into law on August 9, 2022 to boost domestic semiconductor manufacturing and encourage US research activities.  The act provided a 25% investment credit intended to promote domestic production of semiconductors. This act is not expected to have a material impact for us.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The Tax Cuts and Jobs Act of 2017 subjects a U.S. shareholder to tax on global intangible low-taxed income ("GILTI") earned by certain foreign subsidiaries. An entity can make an accounting policy election to either recognize deferred taxes for temporary basis differences expected to reverse as GILTI in future years or to provide for the tax expense related to GILTI in the year the tax is incurred as a period expense only. We have elected to account for GILTI in the year the tax is incurred.</span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="if3f80771944f4fc58015abda42dc47d1_109"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 11 &#8211; <ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzMxMjQ_a367e1c6-e47e-4923-87c6-6f95c80591e3" continuedAt="i4afea979e5694396952ee6edb60351a7" escape="true">STOCK-BASED COMPENSATION</ix:nonNumeric></span></div><ix:continuation id="i4afea979e5694396952ee6edb60351a7" continuedAt="ic6447bd194de44c9ac81e33a210d24bb"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Incentive Plans</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have <ix:nonFraction unitRef="incentiveplan" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="INF" name="rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzM4NDgyOTA3MDIwMDQ_ee4cdd4b-6e5a-4583-bec2-af01477df12d">one</ix:nonFraction> long-term equity incentive plan, the RadNet, Inc. Equity Incentive Plan, which we first amended and restated April 20, 2015, again on March 9, 2017 and currently as of April 15, 2021 (the "Restated Plan&#8221;). The Restated Plan was most recently approved by our stockholders at our annual stockholders meeting on June 10, 2021.  We have reserved for issuance under the 2017 Restated Plan <ix:nonFraction unitRef="shares" contextRef="id1fdbe2d3c964be6888f0365aa0b975b_I20210415" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzQ2MQ_7d71d979-39f7-46db-b21b-49eb41072229">16,500,000</ix:nonFraction> shares of common stock.  We can issue options (incentive and non-qualified), stock awards, stock appreciation rights, stock units and cash awards under the Restated Plan.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">88</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ic6447bd194de44c9ac81e33a210d24bb" continuedAt="ic2feb3fd9a7c4fc698fd738a815ed439"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Options</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain options granted under the Restated Plan to employees are intended to qualify as incentive stock options under existing tax regulations. Stock options generally vest over <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzgyNA_592b111d-5e4b-4ce1-b2c6-e023d3e9049f">three</span> to <ix:nonNumeric contextRef="ib19ac757adb3497f895598bf7d1fb0f6_D20220101-20221231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzgzMA_6d37fcd3-aebd-42ad-8104-0058070a7662">five years</ix:nonNumeric> and expire <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzg0NA_4b31c3d7-9086-4991-8c69-3f75d38c24fd">five</span> to <ix:nonNumeric contextRef="ib19ac757adb3497f895598bf7d1fb0f6_D20220101-20221231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzg1MA_3891af07-1236-4326-9c1b-10735cbf3dfa">ten years</ix:nonNumeric> from the date of grant.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzMxMjY_6778dd9a-d3cb-4c95-8801-9eb676f887db" continuedAt="ic919e613d80c4de3b5fc1aa21d504928" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes all of our option transactions for the twelve months ended December 31, 2022:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:44.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.822%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.822%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.822%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.824%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding Options<br/>Under the 2006 Plan</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise price<br/>Per Common Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Remaining<br/>Contractual<br/>Life(in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2021</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZToyZGFhNzg2NTJlZTU0MDc2YjY3ODA5MzRlYzNiZTBjNS90YWJsZXJhbmdlOjJkYWE3ODY1MmVlNTQwNzZiNjc4MDkzNGVjM2JlMGM1XzEtMi0xLTEtMjk0ODk_72440b0d-7310-463d-a458-79b4cc25de77">473,939</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZToyZGFhNzg2NTJlZTU0MDc2YjY3ODA5MzRlYzNiZTBjNS90YWJsZXJhbmdlOjJkYWE3ODY1MmVlNTQwNzZiNjc4MDkzNGVjM2JlMGM1XzEtNC0xLTEtMjk0ODk_bb0ffad8-c6a3-4039-afeb-ee0340c87ff5">9.38</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1012d26028ec46ccb4bd6809233ed3bc_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZToyZGFhNzg2NTJlZTU0MDc2YjY3ODA5MzRlYzNiZTBjNS90YWJsZXJhbmdlOjJkYWE3ODY1MmVlNTQwNzZiNjc4MDkzNGVjM2JlMGM1XzItMi0xLTEtMjk0ODk_2abd873a-eb3f-424a-a795-8feb9d17a0d0">229,975</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1012d26028ec46ccb4bd6809233ed3bc_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZToyZGFhNzg2NTJlZTU0MDc2YjY3ODA5MzRlYzNiZTBjNS90YWJsZXJhbmdlOjJkYWE3ODY1MmVlNTQwNzZiNjc4MDkzNGVjM2JlMGM1XzItNC0xLTEtMjk0ODk_b97e6c69-8ca4-4659-a8ee-893459584f7a">28.36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZToyZGFhNzg2NTJlZTU0MDc2YjY3ODA5MzRlYzNiZTBjNS90YWJsZXJhbmdlOjJkYWE3ODY1MmVlNTQwNzZiNjc4MDkzNGVjM2JlMGM1XzMtMi0xLTEtMjk0ODk_2a3105c6-e766-494f-9316-ab2c443dffc7">25,000</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZToyZGFhNzg2NTJlZTU0MDc2YjY3ODA5MzRlYzNiZTBjNS90YWJsZXJhbmdlOjJkYWE3ODY1MmVlNTQwNzZiNjc4MDkzNGVjM2JlMGM1XzMtNC0xLTEtMjk0ODk_5d2a550a-a418-40b6-a83c-27920f25dec6">11.75</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZToyZGFhNzg2NTJlZTU0MDc2YjY3ODA5MzRlYzNiZTBjNS90YWJsZXJhbmdlOjJkYWE3ODY1MmVlNTQwNzZiNjc4MDkzNGVjM2JlMGM1XzUtMi0xLTEtMjk0ODk_36e2ab0b-a5f8-452c-93c7-db8baeb87e33">678,914</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZToyZGFhNzg2NTJlZTU0MDc2YjY3ODA5MzRlYzNiZTBjNS90YWJsZXJhbmdlOjJkYWE3ODY1MmVlNTQwNzZiNjc4MDkzNGVjM2JlMGM1XzUtNC0xLTEtMjk0ODk_1bc0ff06-0df4-4f3d-b245-5f57d01807f6">15.72</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZToyZGFhNzg2NTJlZTU0MDc2YjY3ODA5MzRlYzNiZTBjNS90YWJsZXJhbmdlOjJkYWE3ODY1MmVlNTQwNzZiNjc4MDkzNGVjM2JlMGM1XzUtNi0xLTEtMjk0ODk_ad2ca416-25c0-4a9a-a8fc-2f82dcb54184">6.07</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZToyZGFhNzg2NTJlZTU0MDc2YjY3ODA5MzRlYzNiZTBjNS90YWJsZXJhbmdlOjJkYWE3ODY1MmVlNTQwNzZiNjc4MDkzNGVjM2JlMGM1XzUtOC0xLTEtMjk0ODk_aee96d35-f921-428c-b71c-f8944b2429f1">4,416,774</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 31, 2022</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZToyZGFhNzg2NTJlZTU0MDc2YjY3ODA5MzRlYzNiZTBjNS90YWJsZXJhbmdlOjJkYWE3ODY1MmVlNTQwNzZiNjc4MDkzNGVjM2JlMGM1XzYtMi0xLTEtMjk0ODk_a4f73a80-508e-4dd7-9688-564266c95fed">483,969</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZToyZGFhNzg2NTJlZTU0MDc2YjY3ODA5MzRlYzNiZTBjNS90YWJsZXJhbmdlOjJkYWE3ODY1MmVlNTQwNzZiNjc4MDkzNGVjM2JlMGM1XzYtNC0xLTEtMjk0ODk_a0d61877-3fbc-4f18-b61c-4fc753302029">11.01</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZToyZGFhNzg2NTJlZTU0MDc2YjY3ODA5MzRlYzNiZTBjNS90YWJsZXJhbmdlOjJkYWE3ODY1MmVlNTQwNzZiNjc4MDkzNGVjM2JlMGM1XzYtNi0xLTEtMjk0ODk_829d20c3-f055-4cbe-9c61-e2942ae7572d">4.93</ix:nonNumeric></span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZToyZGFhNzg2NTJlZTU0MDc2YjY3ODA5MzRlYzNiZTBjNS90YWJsZXJhbmdlOjJkYWE3ODY1MmVlNTQwNzZiNjc4MDkzNGVjM2JlMGM1XzYtOC0xLTEtMjk0ODk_de1a3fdb-af19-4700-9671-09cb2693ac39">4,381,451</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aggregate intrinsic value in the table above represents the total pretax intrinsic value (the difference between our closing stock price on December 31, 2022 and the exercise price, multiplied by the number of in-the-money options as applicable) that would have been received by the holder had all holders exercised their options on December 31, 2022.  As of December 31, 2022, total unrecognized stock-based compensation expense related to non-vested employee awards was $<ix:nonFraction unitRef="usd" contextRef="i094c5d904be44087995cd941fc4d5daf_I20221231" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzE1MzQ_115fd655-6827-4c15-80d9-273d93fc231b">1.1</ix:nonFraction> million which is expected to be recognized over a weighted average period of approximately <ix:nonNumeric contextRef="i44c5111cc15c410d9c005a8bde3cad3a_D20220101-20221231" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzE2MjA_76ffafb3-9194-4ed0-a162-bcfc4b5b34dd">2.32</ix:nonNumeric> years.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:174%">DeepHealth Options</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of fiscal 2020, in connection with the completion of the DeepHealth acquisition, we granted&#160;<ix:nonFraction unitRef="shares" contextRef="i3d5bebaa0e7442d1b5f5cca875bb344e_D20200401-20200630" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzE3NjI_a48bebb5-4769-4aba-9bce-3bb80ffc518c">412,434</ix:nonFraction>&#160;options at a grant date fair value of $<ix:nonFraction unitRef="usdPerShare" contextRef="i9acfb04e9f5b4b67ac85b9574a34698b_D20200401-20200630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzE4MDM_8d3ccf6e-c2cc-4207-9ea6-b33fdb2caa3e">16.93</ix:nonFraction>&#160;per share unit to DeepHealth employees in replacement of their stock options that were outstanding as of the closing date.  As of December 31, 2022, total unrecognized stock based compensation expense related to non-vested DeepHealth options was approximately $<ix:nonFraction unitRef="usd" contextRef="i3f429bcc5e2b462cb9501b7c563ba31b_I20221231" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzIwNTE_81728ed0-90ea-4e36-a935-59c19133c0a2">0.6</ix:nonFraction> million which is expected to be recognized over a weighted average period of approximately <ix:nonNumeric contextRef="i910ced2457b140f4b0ed9010ea0b124a_D20220101-20221231" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzIxMzc_79202a66-b748-4e19-9125-9ede3e6731bb">0.74</ix:nonNumeric> years.</span></div><div style="margin-top:10pt;text-align:justify"><ix:continuation id="ic919e613d80c4de3b5fc1aa21d504928"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"><tr><td style="width:1.0%"></td><td style="width:46.197%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.161%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.161%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.912%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.069%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outstanding Options<br/>Under the Deep Health Plan</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise price<br/>Per Common Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Remaining<br/>Contractual Life<br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2021</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i913337c7aa3b4295af9870b33b64248f_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZTowYWEyMDJlNmJiOTM0NGRjOWYxZWY1MWJkM2IyOWMzOS90YWJsZXJhbmdlOjBhYTIwMmU2YmI5MzQ0ZGM5ZjFlZjUxYmQzYjI5YzM5XzEtMi0xLTEtMjk0ODk_0f7e03af-1791-4231-b747-295ba91556fb">320,660</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usdPerShare" contextRef="i913337c7aa3b4295af9870b33b64248f_I20211231" xsi:nil="true" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZTowYWEyMDJlNmJiOTM0NGRjOWYxZWY1MWJkM2IyOWMzOS90YWJsZXJhbmdlOjBhYTIwMmU2YmI5MzQ0ZGM5ZjFlZjUxYmQzYjI5YzM5XzEtNC0xLTEtNTg0MTg_de9b3d88-e652-40fe-ae54-9cfa56cff105"></ix:nonFraction></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i910ced2457b140f4b0ed9010ea0b124a_D20220101-20221231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZTowYWEyMDJlNmJiOTM0NGRjOWYxZWY1MWJkM2IyOWMzOS90YWJsZXJhbmdlOjBhYTIwMmU2YmI5MzQ0ZGM5ZjFlZjUxYmQzYjI5YzM5XzMtMi0xLTEtMjk0ODk_3daa22cd-9233-4885-b6b1-3d44b90612d8">203,678</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i910ced2457b140f4b0ed9010ea0b124a_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZTowYWEyMDJlNmJiOTM0NGRjOWYxZWY1MWJkM2IyOWMzOS90YWJsZXJhbmdlOjBhYTIwMmU2YmI5MzQ0ZGM5ZjFlZjUxYmQzYjI5YzM5XzMtNC0xLTEtNTg0MTg_929299a9-96a6-46dd-9ebc-24e1289150e9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2022</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3f429bcc5e2b462cb9501b7c563ba31b_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZTowYWEyMDJlNmJiOTM0NGRjOWYxZWY1MWJkM2IyOWMzOS90YWJsZXJhbmdlOjBhYTIwMmU2YmI5MzQ0ZGM5ZjFlZjUxYmQzYjI5YzM5XzQtMi0xLTEtMjk0ODk_46792936-2820-4822-9de9-bd60fa2e5ae8">116,982</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3f429bcc5e2b462cb9501b7c563ba31b_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZTowYWEyMDJlNmJiOTM0NGRjOWYxZWY1MWJkM2IyOWMzOS90YWJsZXJhbmdlOjBhYTIwMmU2YmI5MzQ0ZGM5ZjFlZjUxYmQzYjI5YzM5XzQtNC0xLTEtNTg0MTg_a6171d63-578b-4914-a3ef-0ff6423e57dd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i910ced2457b140f4b0ed9010ea0b124a_D20220101-20221231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZTowYWEyMDJlNmJiOTM0NGRjOWYxZWY1MWJkM2IyOWMzOS90YWJsZXJhbmdlOjBhYTIwMmU2YmI5MzQ0ZGM5ZjFlZjUxYmQzYjI5YzM5XzQtNi0xLTEtMjk0ODk_f683c2da-4000-4d43-848b-829fe76fd102">6.80</ix:nonNumeric></span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f429bcc5e2b462cb9501b7c563ba31b_I20221231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZTowYWEyMDJlNmJiOTM0NGRjOWYxZWY1MWJkM2IyOWMzOS90YWJsZXJhbmdlOjBhYTIwMmU2YmI5MzQ0ZGM5ZjFlZjUxYmQzYjI5YzM5XzQtOC0xLTEtMjk0ODk_ea44db3f-7f30-407b-8e68-8f96bdfb1a1d">2,202,771</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3f429bcc5e2b462cb9501b7c563ba31b_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZTowYWEyMDJlNmJiOTM0NGRjOWYxZWY1MWJkM2IyOWMzOS90YWJsZXJhbmdlOjBhYTIwMmU2YmI5MzQ0ZGM5ZjFlZjUxYmQzYjI5YzM5XzUtMi0xLTEtMjk0ODk_f903c9fc-79a5-4e16-aac7-8b217fb323f8">76,909</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3f429bcc5e2b462cb9501b7c563ba31b_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZTowYWEyMDJlNmJiOTM0NGRjOWYxZWY1MWJkM2IyOWMzOS90YWJsZXJhbmdlOjBhYTIwMmU2YmI5MzQ0ZGM5ZjFlZjUxYmQzYjI5YzM5XzUtNC0xLTEtNTg0MTg_e4220e7b-82af-4323-9563-fcf218fd11cb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i910ced2457b140f4b0ed9010ea0b124a_D20220101-20221231" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZTowYWEyMDJlNmJiOTM0NGRjOWYxZWY1MWJkM2IyOWMzOS90YWJsZXJhbmdlOjBhYTIwMmU2YmI5MzQ0ZGM5ZjFlZjUxYmQzYjI5YzM5XzUtNi0xLTEtMjk0ODk_54c21fa3-1098-4d2d-b1ea-11b1c728e814">6.80</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f429bcc5e2b462cb9501b7c563ba31b_I20221231" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZTowYWEyMDJlNmJiOTM0NGRjOWYxZWY1MWJkM2IyOWMzOS90YWJsZXJhbmdlOjBhYTIwMmU2YmI5MzQ0ZGM5ZjFlZjUxYmQzYjI5YzM5XzUtOC0xLTEtMjk0ODk_88587d61-1760-46fa-bd8d-f97747ebf51a">1,448,198</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Awards (&#8220;RSA&#8217;s&#8221;)</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Restated Plan permits the award of restricted stock awards (&#8220;RSA&#8217;s&#8221;). As of December 31, 2022, we have issued a total of <ix:nonFraction unitRef="shares" contextRef="i3b0bb841e3944cc1903ad3a519ea4d82_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzIyOTQ_8150f139-bbb7-42d5-9c8f-dac7114dbe51">7,892,930</ix:nonFraction> RSA&#8217;s of which <ix:nonFraction unitRef="shares" contextRef="ie0a58125fd60480dad3bda99ec884d22_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzIzMTI_73986ccc-de53-43b2-b1fc-c7b22b84b97c">536,767</ix:nonFraction> were unvested at December 31, 2022 . <ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzMxMTg_bd6cfc83-3b8b-4bca-8c16-b43cefa270aa" continuedAt="ic6e00faf925247caac2e155c5b2c07db" escape="true">The following summarizes all unvested RSA&#8217;s activities during the twelve months ended December 31, 2022:</ix:nonNumeric></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ic6e00faf925247caac2e155c5b2c07db" continuedAt="ia5ee37cbe7fa4bc198d41c066d2d2767">&#160;</ix:continuation></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">89</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ic2feb3fd9a7c4fc698fd738a815ed439" continuedAt="i0af1c4bdf1eb4245aa8bcdebdbf6099b"><div style="margin-top:5pt;text-align:justify"><ix:continuation id="ia5ee37cbe7fa4bc198d41c066d2d2767"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSA's</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average<br/>Remaining<br/>Contractual<br/>Term (Years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSA's unvested at December 31, 2021</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0787e0bf64654960aed460942168553d_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZTo5MDVkMzAwYmY3OGY0MjAxODYzY2U5Njk3YzY0ZjBjZS90YWJsZXJhbmdlOjkwNWQzMDBiZjc4ZjQyMDE4NjNjZTk2OTdjNjRmMGNlXzEtMS0xLTEtMjk0ODk_338b97a4-8790-43e2-9459-dc8395da5928">456,075</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0787e0bf64654960aed460942168553d_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZTo5MDVkMzAwYmY3OGY0MjAxODYzY2U5Njk3YzY0ZjBjZS90YWJsZXJhbmdlOjkwNWQzMDBiZjc4ZjQyMDE4NjNjZTk2OTdjNjRmMGNlXzEtNS0xLTEtMjk0ODk_df9e351b-c733-414c-9a64-c7a024c27605">20.06</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes during the period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3b0bb841e3944cc1903ad3a519ea4d82_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZTo5MDVkMzAwYmY3OGY0MjAxODYzY2U5Njk3YzY0ZjBjZS90YWJsZXJhbmdlOjkwNWQzMDBiZjc4ZjQyMDE4NjNjZTk2OTdjNjRmMGNlXzMtMS0xLTEtMjk0ODk_78177af7-9f1d-4341-80e6-979b5ebdb744">649,901</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3b0bb841e3944cc1903ad3a519ea4d82_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZTo5MDVkMzAwYmY3OGY0MjAxODYzY2U5Njk3YzY0ZjBjZS90YWJsZXJhbmdlOjkwNWQzMDBiZjc4ZjQyMDE4NjNjZTk2OTdjNjRmMGNlXzMtNS0xLTEtMjk0ODk_f1f1e93b-ff72-49be-aec8-434008ed8a0c">26.33</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i3b0bb841e3944cc1903ad3a519ea4d82_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZTo5MDVkMzAwYmY3OGY0MjAxODYzY2U5Njk3YzY0ZjBjZS90YWJsZXJhbmdlOjkwNWQzMDBiZjc4ZjQyMDE4NjNjZTk2OTdjNjRmMGNlXzQtMS0xLTEtMjk0ODk_f3d3e369-c7d4-4fdb-87b2-198384554dfa">563,731</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3b0bb841e3944cc1903ad3a519ea4d82_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZTo5MDVkMzAwYmY3OGY0MjAxODYzY2U5Njk3YzY0ZjBjZS90YWJsZXJhbmdlOjkwNWQzMDBiZjc4ZjQyMDE4NjNjZTk2OTdjNjRmMGNlXzQtNS0xLTEtMjk0ODk_9d738cdb-ee5d-486a-a131-1c17826e6537">21.62</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i3b0bb841e3944cc1903ad3a519ea4d82_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZTo5MDVkMzAwYmY3OGY0MjAxODYzY2U5Njk3YzY0ZjBjZS90YWJsZXJhbmdlOjkwNWQzMDBiZjc4ZjQyMDE4NjNjZTk2OTdjNjRmMGNlXzUtMS0xLTEtMjk0ODk_c169616c-90b3-4e00-8f72-07b8bc07b073">5,478</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3b0bb841e3944cc1903ad3a519ea4d82_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZTo5MDVkMzAwYmY3OGY0MjAxODYzY2U5Njk3YzY0ZjBjZS90YWJsZXJhbmdlOjkwNWQzMDBiZjc4ZjQyMDE4NjNjZTk2OTdjNjRmMGNlXzUtNS0xLTEtMjk0ODk_8289f15a-d2b6-47ce-bd7d-fcdbc23bcb3e">23.76</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSA's unvested at December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie0a58125fd60480dad3bda99ec884d22_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZTo5MDVkMzAwYmY3OGY0MjAxODYzY2U5Njk3YzY0ZjBjZS90YWJsZXJhbmdlOjkwNWQzMDBiZjc4ZjQyMDE4NjNjZTk2OTdjNjRmMGNlXzYtMS0xLTEtMjk0ODk_0838214b-4976-472d-b8a0-3e1c9b7fd682">536,767</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3b0bb841e3944cc1903ad3a519ea4d82_D20220101-20221231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZTo5MDVkMzAwYmY3OGY0MjAxODYzY2U5Njk3YzY0ZjBjZS90YWJsZXJhbmdlOjkwNWQzMDBiZjc4ZjQyMDE4NjNjZTk2OTdjNjRmMGNlXzYtMy0xLTEtMjk0ODk_be5366fb-1994-43da-8590-7bf4c973f488">1.01</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie0a58125fd60480dad3bda99ec884d22_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZTo5MDVkMzAwYmY3OGY0MjAxODYzY2U5Njk3YzY0ZjBjZS90YWJsZXJhbmdlOjkwNWQzMDBiZjc4ZjQyMDE4NjNjZTk2OTdjNjRmMGNlXzYtNS0xLTEtMjk0ODk_22e4e7fb-918c-46e4-be80-809bd4912957">23.84</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine the fair value of all RSA&#8217;s based of the closing price of our common stock on award date.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other stock bonus awards</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Restated Plan also permits the award of stock bonuses not subject to any future service period. These awards are valued and expensed based on the closing price of our common stock on the date of award. During the twelve months ended December 31, 2022 we issued <ix:nonFraction unitRef="shares" contextRef="ia1c839443b66471eb59beee8617975d2_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzI4MTc_b2b75db0-f2dc-4fb8-b17e-cdf0f7dec501">41,000</ix:nonFraction> shares relating to these awards, approximately amounting to $<ix:nonFraction unitRef="usd" contextRef="ia1c839443b66471eb59beee8617975d2_D20220101-20221231" decimals="-5" name="rdnt:ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzI4ODA_41fed97f-f14c-4e83-a64b-eb7cbff9721e">0.8</ix:nonFraction> million of compensation expense.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance based stock units ("PSUs")</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2022, we granted certain employees PSUs with a target award of <ix:nonFraction unitRef="shares" contextRef="i6277f9dca3d1402c9da0e7e331ab1e01_D20220101-20220131" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzM4NDgyOTA3MDIwNTM_3c24aab5-223f-4c5c-87af-f4054bc62b27">25,683</ix:nonFraction> shares of our common stock. The PSUs will vest in <ix:nonFraction unitRef="tranche" contextRef="i6277f9dca3d1402c9da0e7e331ab1e01_D20220101-20220131" decimals="INF" name="rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzM4NDgyOTA3MDIwNjY_d1ef6dbd-2ccb-44b4-a9d3-274162063eb8">two</ix:nonFraction> equal parts, starting <ix:nonNumeric contextRef="i6277f9dca3d1402c9da0e7e331ab1e01_D20220101-20220131" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzM4NDgyOTA3MDIwNzI_12ed73e1-2ac6-4d1a-9f8c-d039f51930a5">three years</ix:nonNumeric> from the grant date based on continuous service, with the number of shares earned (<ix:nonFraction unitRef="number" contextRef="i0f44d430f1174158bf7fe50617e713ac_D20220101-20220131" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzM4NDgyOTA3MDIwNTc_311ae493-a783-4e5c-ad0b-dc6bcef1b6ba">0</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i62c3cbb4a9964a25abbdcb253fb4024f_D20220101-20220131" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzM4NDgyOTA3MDIwNjE_05524a72-0958-4872-98e5-c7d63508e604">200</ix:nonFraction>% of the target award) depending upon the extent to which we achieve a performance condition as determined by the board of directors over the period from January 1, 2022 through December 31, 2022.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance based stock options ("PSOs")</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2022, we granted certain employees PSOs to purchase a maximum of <ix:nonFraction unitRef="shares" contextRef="i50296a953a0a449b97171c09173e2621_D20220101-20220131" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzM4NDgyOTA3MDIwODI_26c786ca-30f8-443a-9ee0-810dc6c623c1">111,925</ix:nonFraction> shares of our common stock. The PSOs will vest in <ix:nonFraction unitRef="tranche" contextRef="i50296a953a0a449b97171c09173e2621_D20220101-20220131" decimals="INF" name="rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzM4NDgyOTA3MDIwODY_72a29977-04a1-462a-8315-4c31a66cdf09">three</ix:nonFraction> equal parts, starting <ix:nonNumeric contextRef="i50296a953a0a449b97171c09173e2621_D20220101-20220131" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzM4NDgyOTA3MDIwOTM_882ac929-0ea5-4e12-9d38-b2cd4e0b9c2d">three years</ix:nonNumeric> from the grant date based on continuous service, with the number of shares earned (<ix:nonFraction unitRef="number" contextRef="idaacd756f4c9498d91cf9c5a87b822e2_D20220101-20220131" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzM4NDgyOTA3MDIxMDE_d95ea9f5-9796-400d-a134-21566dcf6275">0</ix:nonFraction> shares to <ix:nonFraction unitRef="shares" contextRef="icec298142c894a2b86d0c42a0627070b_I20220131" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzM4NDgyOTA3MDIxMDU_0a649be8-de81-4c88-8852-d48185bbba5a">111,925</ix:nonFraction> shares) depending upon the extent to which we achieve a performance condition as determined by the board of directors over the period from January 1, 2022 through December 31, 2022.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long Term Incentive Plan shares ("LTIPs")</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we issue stock-based compensation to certain employees in our AI segment in the form of Stock Units and Restricted Stock Awards, subject to certain restrictions.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The awards represent a form of long term incentive and are reflective of a general practice within the software industry.  The units and shares vest ratably over a <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzM4NDgyOTA3MDIzMDM_73f2d802-1880-44ce-b1e9-1beab990455e">two</span> to <ix:nonNumeric contextRef="i4881d8775eb54b72a12eb858c7e4a554_D20220101-20221231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzY1OTcwNjk3NzIzNjU_efd6afe4-b312-4ede-8302-70a869bfa512">four year</ix:nonNumeric> period, conditioned on continued employment through the vesting periods. We determine the fair value of all LTIPs based on the closing price of our common stock on the award date.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzQ5NDc4MDIzMzAzNjA_0ca1dc4f-5257-44d1-bcb6-8a8a590cb699" continuedAt="i463d6196beca456d98f4ece76e8bbc3d" escape="true">The following summarizes all unvested LTIPs activities during the twelve months ended December 31, 2022:</ix:nonNumeric></span></div><div style="margin-top:10pt;text-align:justify"><ix:continuation id="i463d6196beca456d98f4ece76e8bbc3d"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.099%"><tr><td style="width:1.0%"></td><td style="width:61.642%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.822%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.545%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.822%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.545%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.824%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">LTIPs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Remaining<br/>Contractual<br/>Term (Years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Fair Value</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LTIPs unvested at December 31, 2021</span></td><td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if4019e7dc01941058ad36f53dc8d3d21_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZTo0NmY4ZjE2M2Y5YzY0YTVjODIzZGIxZjhmYTlmYTRiNC90YWJsZXJhbmdlOjQ2ZjhmMTYzZjljNjRhNWM4MjNkYjFmOGZhOWZhNGI0XzEtMS0xLTEtNjA2Njk_152f08f2-2dd0-4409-bc01-c3687e860045">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if4019e7dc01941058ad36f53dc8d3d21_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZTo0NmY4ZjE2M2Y5YzY0YTVjODIzZGIxZjhmYTlmYTRiNC90YWJsZXJhbmdlOjQ2ZjhmMTYzZjljNjRhNWM4MjNkYjFmOGZhOWZhNGI0XzEtNS0xLTEtNjA2Njk_d36c7e3a-f7e5-482a-b03f-718fbd09b915">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes during the period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5b0e1dc8b96c4fc384f33bcb572e740a_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZTo0NmY4ZjE2M2Y5YzY0YTVjODIzZGIxZjhmYTlmYTRiNC90YWJsZXJhbmdlOjQ2ZjhmMTYzZjljNjRhNWM4MjNkYjFmOGZhOWZhNGI0XzMtMS0xLTEtNjA2Njk_8a66f918-3b05-4ad5-bd7b-75ebd030b7ac">180,612</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5b0e1dc8b96c4fc384f33bcb572e740a_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZTo0NmY4ZjE2M2Y5YzY0YTVjODIzZGIxZjhmYTlmYTRiNC90YWJsZXJhbmdlOjQ2ZjhmMTYzZjljNjRhNWM4MjNkYjFmOGZhOWZhNGI0XzMtNS0xLTEtNjA2Njk_d1260c6c-01d0-441a-9bda-fa9c00d6c43d">19.56</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited or Canceled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i5b0e1dc8b96c4fc384f33bcb572e740a_D20220101-20221231" decimals="INF" name="rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZTo0NmY4ZjE2M2Y5YzY0YTVjODIzZGIxZjhmYTlmYTRiNC90YWJsZXJhbmdlOjQ2ZjhmMTYzZjljNjRhNWM4MjNkYjFmOGZhOWZhNGI0XzUtMS0xLTEtNjA2Njk_d8e5f156-5834-4cb8-8ab5-e77227924299">11,141</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5b0e1dc8b96c4fc384f33bcb572e740a_D20220101-20221231" decimals="2" name="rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZTo0NmY4ZjE2M2Y5YzY0YTVjODIzZGIxZjhmYTlmYTRiNC90YWJsZXJhbmdlOjQ2ZjhmMTYzZjljNjRhNWM4MjNkYjFmOGZhOWZhNGI0XzUtNS0xLTEtNjA2Njk_308f5385-3387-4aad-a9f0-c0a8e5c74d34">19.50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LTIPs unvested at December 31, 2022</span></td><td colspan="2" style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia7b8b14610224ea59f307a3d2cbe26ba_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZTo0NmY4ZjE2M2Y5YzY0YTVjODIzZGIxZjhmYTlmYTRiNC90YWJsZXJhbmdlOjQ2ZjhmMTYzZjljNjRhNWM4MjNkYjFmOGZhOWZhNGI0XzYtMS0xLTEtNjA2Njk_99018221-b73b-4b6e-856f-e3b98b589d71">169,471</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5b0e1dc8b96c4fc384f33bcb572e740a_D20220101-20221231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZTo0NmY4ZjE2M2Y5YzY0YTVjODIzZGIxZjhmYTlmYTRiNC90YWJsZXJhbmdlOjQ2ZjhmMTYzZjljNjRhNWM4MjNkYjFmOGZhOWZhNGI0XzYtMy0xLTEtNjA2Njk_965b5df1-5c65-4381-a1c2-ee835be0ca25">2.69</ix:nonNumeric></span></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia7b8b14610224ea59f307a3d2cbe26ba_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZTo0NmY4ZjE2M2Y5YzY0YTVjODIzZGIxZjhmYTlmYTRiNC90YWJsZXJhbmdlOjQ2ZjhmMTYzZjljNjRhNWM4MjNkYjFmOGZhOWZhNGI0XzYtNS0xLTEtNjA2Njk_fc20160a-dc44-4df6-a4d8-487aed7ebbc8">19.56</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Plan summary</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i0af1c4bdf1eb4245aa8bcdebdbf6099b">In summary, of the <ix:nonFraction unitRef="shares" contextRef="id1fdbe2d3c964be6888f0365aa0b975b_I20210415" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzI5ODY_7d71d979-39f7-46db-b21b-49eb41072229">16,500,000</ix:nonFraction> shares of common stock reserved for issuance under the Restated Plan at December 31, 2022, there remain <ix:nonFraction unitRef="shares" contextRef="i2d84eba07ea94e52a84e38c42643cc0b_I20221231" decimals="INF" name="us-gaap:DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzMwNzg_93a65523-f3f4-43d7-8bd9-335ebb2416aa">2,017,233</ix:nonFraction> shares available for future awards.</ix:continuation></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91</span></div></div></div><div id="if3f80771944f4fc58015abda42dc47d1_115"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.577%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;9.&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Changes In and Disagreements with Accountants on Accounting and Financial Disclosure</span></td></tr></table></div><div style="text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="text-indent:36pt"><span><br/></span></div><div id="if3f80771944f4fc58015abda42dc47d1_118"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.577%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 9A</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Controls and Procedures</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the supervision of our management, including our Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures under Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended, as of December 31, 2022. Based on this evaluation, our Principal Executive Officer and Principal Financial Officer concluded that our disclosure controls and procedures were effective as of December 31, 2022. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Limitations on Effectiveness of Controls and Procedures</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with existing policies or procedures may deteriorate. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Management's Report on Internal Control over Financial Reporting</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management is responsible for establishing and maintaining adequate internal control over financial reporting. Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. generally accepted accounting principles (&#8220;GAAP&#8221;). Internal control over financial reporting includes policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP, and that receipts and expenditures of the Company are transacted in accordance with authorizations of management and directors of the Company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the Company&#8217;s assets that could have a material effect on the financial statements.</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management, under the supervision of our Principal Executive Officer and Principal Financial Officer, conducted an assessment of the effectiveness of its internal control over financial reporting as of December 31, 2022 based on the criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (&#8220;COSO&#8221;). Based on this assessment, management concluded that our internal control over financial reporting was effective as of December 31, 2022.</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ernst &amp; Young LLP, the Company&#8217;s independent registered public accounting firm, has audited the Company&#8217;s internal control over financial reporting as of December 31, 2022, as stated in their report, which is included below in this Annual Report on Form 10-K.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) occurred during the&#160;quarter ended&#160;December&#160;31, 2022,&#160;that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92</span></div></div></div><div id="if3f80771944f4fc58015abda42dc47d1_121"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">To the Stockholders and the Board of Directors of RadNet, Inc.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Opinion on Internal Control Over Financial Reporting</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We have audited RadNet, Inc. and subsidiaries&#8217; internal control over financial reporting as of December 31, 2022, based on criteria established in Internal Control&#8212;Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework), (the COSO criteria). In our opinion, RadNet, Inc. and subsidiaries (the Company) maintained, in all material respects, effective internal control over financial reporting as of December 31, 2022, based on the COSO criteria.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheets of the Company as of December 31, 2022 and 2021, the related consolidated statements of operations, comprehensive income (loss), equity and cash flows for each of the three years in the period ended December 31, 2022, and the related notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">and our report dated March 1, 2023 expressed an unqualified opinion thereon.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Basis for Opinion</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company&#8217;s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Management&#8217;s Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company&#8217;s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Definition and Limitations of Internal Control Over Financial Reporting</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">/s/ Ernst &amp; Young LLP</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Los Angeles, California</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">March 1, 2023</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">93</span></div></div></div><div id="if3f80771944f4fc58015abda42dc47d1_124"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.577%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;9B.&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Other Information.</span></td></tr></table></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="if3f80771944f4fc58015abda42dc47d1_127"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.577%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;9C.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.</span></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="if3f80771944f4fc58015abda42dc47d1_130"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART III</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div id="if3f80771944f4fc58015abda42dc47d1_133"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.577%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 10.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Directors, Executive Officers and Corporate Governance</span></td></tr></table></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item 10 will be included under the captions &#8220;Directors,&#8221; &#8220;Executive Officers,&#8221; &#8220;Corporate Governance,&#8221; and &#8220;Delinquent Section 16(a) Reports&#8221; in our definitive Proxy Statement for the 2023 Annual Meeting of Stockholders to be filed with the SEC within 120 days after the end of our fiscal year (the &#8220;Proxy Statement&#8221;) and is incorporated herein by reference.</span></div><div style="text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have adopted a code of financial ethics applicable to our directors, officers and employees which is designed to deter wrongdoing and to promote:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:49.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">honest and ethical conduct;</span></div><div style="padding-left:49.5pt;text-align:justify"><span><br/></span></div><div style="padding-left:49.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">full, fair, accurate, timely and understandable disclosure in reports and documents that we file with the SEC and in our other public communications;</span></div><div style="padding-left:49.5pt;text-align:justify"><span><br/></span></div><div style="padding-left:49.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">compliance with applicable laws, rules and regulations, including insider trading compliance; and</span></div><div style="padding-left:49.5pt;text-align:justify"><span><br/></span></div><div style="padding-left:49.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">accountability for adherence to the code and prompt internal reporting of violations of the code, including illegal or unethical behavior regarding accounting or auditing practices.</span></div><div style="padding-left:49.5pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You may obtain a copy of our Code of Financial Ethics on our website at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">www.radnet.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> under Investor Relations&#160;&#8212;&#160;Corporate Governance. The Audit Committee is responsible for reviewing the Code of Financial Ethics and amending as necessary. Any amendments will be disclosed on our website.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="if3f80771944f4fc58015abda42dc47d1_136"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.577%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 11.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Executive Compensation</span></td></tr></table></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item 11 will be included under the captions &#8220;Compensation of Directors,&#8221; &#8220;Compensation Committee Report,&#8221; &#8220;Compensation Discussion and Analysis,&#8221; and "Executive Compensation Tables" in the Proxy Statement and is incorporated herein by reference.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="if3f80771944f4fc58015abda42dc47d1_139"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.577%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 12.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span></td></tr></table></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item 12 will be included under the captions &#8220;Security Ownership of Certain Beneficial Owners and Management&#8221; and &#8220;Equity Compensation Plan Information&#8221; in the Proxy Statement and is incorporated herein by reference.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="if3f80771944f4fc58015abda42dc47d1_142"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.577%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 13.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Certain Relationships and Related Transactions, and Director Independence</span></td></tr></table></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item 13 will be included under the captions &#8220;Compensation of Directors," "Compensation Committee Report," "Compensation Discussion and Analysis", and "Executive Compensation Tables" in the Proxy Statement and is incorporated herein by reference.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="if3f80771944f4fc58015abda42dc47d1_145"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.577%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 14.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Principal Accountant Fees and Services</span></td></tr></table></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item 14 will be included under the caption &#8220;Fees Paid to Auditors&#8221; in the Proxy Statement and is incorporated herein by reference.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">94</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">95</span></div></div></div><div id="if3f80771944f4fc58015abda42dc47d1_148"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART IV</span></div><div style="text-align:center"><span><br/></span></div><div id="if3f80771944f4fc58015abda42dc47d1_151"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.577%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 15.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibits and Financial Statements Schedule</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">(a) Documents filed as part of this annual report on Form 10-K</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:84.677%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.732%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.191%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1) Financial Statements</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Page No</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">The following financial statements are included in this report</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if3f80771944f4fc58015abda42dc47d1_52">Report of Independent Registered Public Accounting Firm</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  (PCAOB ID:<ix:nonNumeric contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231" name="dei:AuditorFirmId" id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xNTEvZnJhZzo4OTM3OGM0ZmY4Mjc0NzZhYTM3Y2JlMGEyZTI3YjdkNC90YWJsZTo3MDVkYWU3OGE4YzE0MmNjODYyZWNhYjE1YWY3OGVkMy90YWJsZXJhbmdlOjcwNWRhZTc4YThjMTQyY2M4NjJlY2FiMTVhZjc4ZWQzXzUtMC0xLTEtMjk0ODkvdGV4dHJlZ2lvbjoxZjM2ZGFlZjI0MjQ0MDE1ODk2MzVhZGQ1M2FkOGM3OF83MQ_44daf3f0-ce1d-4dfa-bcc0-156162ebdb03">42</ix:nonNumeric>)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#if3f80771944f4fc58015abda42dc47d1_52">51</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if3f80771944f4fc58015abda42dc47d1_55">Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#if3f80771944f4fc58015abda42dc47d1_55">53</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if3f80771944f4fc58015abda42dc47d1_58">Consolidated Statements of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#if3f80771944f4fc58015abda42dc47d1_58">54</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if3f80771944f4fc58015abda42dc47d1_61">Consolidated Statements of Comprehensive (Loss) Income</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#if3f80771944f4fc58015abda42dc47d1_61">55</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if3f80771944f4fc58015abda42dc47d1_64">Consolidated Statements of Equity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#if3f80771944f4fc58015abda42dc47d1_64">56</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if3f80771944f4fc58015abda42dc47d1_67">Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#if3f80771944f4fc58015abda42dc47d1_67">58</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if3f80771944f4fc58015abda42dc47d1_70">Notes to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64 to 86</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(2) Financial Statement Schedules</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Schedules are omitted because they are not applicable or the required information is shown in the consolidated financial statements or notes thereto.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">96</span></div></div></div><div id="if3f80771944f4fc58015abda42dc47d1_154"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(3) Exhibits </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following exhibits are filed herewith or incorporated by reference herein:</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.573%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit No.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description of Exhibit</span></td></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000101968708004043/radnet_8k-ex301.htm">Certificate of Incorporation of RadNet, Inc., a Delaware corporation (incorporated by reference to exhibit filed with Form 8-K on September 4, 2008).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000101968708004043/radnet_8k-ex302.htm">Certificate of Amendment to Certificate of Incorporation of RadNet, Inc., a Delaware corporation, dated September 2, 2008 (incorporated by reference to exhibit filed with Form 8-K on September 4, 2008).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000790526/000168316820000383/radnet_ex0301.htm">Amended and Restated Bylaws of RadNet, Inc., a Delaware corporation (incorporated by reference to Exhibit 3.1 of the Form 8-K filed on February 6, 2020)</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000168316822008645/radnet_s3asr.htm">Description of Securities (incorporated by reference the Description of Common Stock contained in the registration statement on Form S-3ASR filed on December 2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000168316822008645/radnet_s3asr.htm">7</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000168316822008645/radnet_s3asr.htm">, 20</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22).</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000790526/000168316821002819/radnet_s8.htm">Equity Incentive Plan, amended and restated as of April 15, 2021 (incorporated by reference to Exhibit 99.1 filed with Form S-8 on July 2, 2021).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000790526/000168316821002819/radnet_ex9901.htm">Form of Incentive Stock Option Agreement for the Equity Incentive Plan (incorporated by reference to Exhibit 99.3 filed with Form S-8 registration statement on July 2, 2021).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000790526/000168316821002819/radnet_ex9903.htm">Form of Nonstatutory Stock Option Agreement for the Equity Incentive Plan (incorporated by reference to Exhibit 99.3 filed with Form S-8 registration statement on July 2, 2021).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000790526/000168316821002819/radnet_ex9904.htm">Form of Stock Award Agreement for the Equity Incentive Plan (incorporated by reference to Exhibit 99.4 filed with Form S-8 registration statement on July 2, 2021).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000790526/000168316821002819/radnet_ex9905.htm">Form of Stock Units Agreement (deferred settlement) for the Equity Incentive Plan (incorporated by reference to Exhibit 99.5 filed with Form S-8 registration statement on July 2, 2021).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000101968716006165/radnet_8k-ex1001.htm">Nonqualified Deferred Compensation Plan, effective as of May 5, 2016 (incorporated by reference to exhibit filed with Form 8-K on May 9, 2016).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000790526/000168316821002545/radnet_8k-ex1001.htm">Form of Indemnification Agreement between the Company and each of its officers and directors (incorporated by reference to exhibit filed with Form 8-K on June 14, 2021).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000079052622000006/radnet-employmentagreement.htm">Employment Agreement dated as of June 12, 1992 with Howard G. Berger, M.D. (incorporated by reference to exhibit filed with an amendment to Form 8-K report for June 12, 1992; refiled herewith</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">).*</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span><br/></span></div><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000119312504041365/dex101.htm">Amendment to Employment Agreement dated January 30, 2004 with Howard G. Berger, M.D. (incorporated by reference to exhibit filed with Form 10-Q for the quarter ended January 31, 2004).*</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.10</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000101968716005474/radnet_ex1017.htm">Second Amendment to Employment Agreement dated November 16, 2015 with Howard G. Berger, M.D. (incorporated by reference to exhibit filed with Form 10-K on March 15, 2016</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">).*</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.11</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000168316822006170/radnet_ex1001.htm">Employment Agreement dated September 1, 2022 with Mark D. Stolper  (incorporated by reference to Exhibit 10.1  filed with the Form 8-K on September 2, 2022).*</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">97</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.573%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.12</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000168316822006170/radnet_ex1002.htm">Employment Agreement dated September 1, 2022 with Stephen M. Forthuber (incorporated by reference to Exhibit 10.2  filed with the Form 8-K on September 2, 2022).*</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.13</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000168316822006170/radnet_ex1003.htm">Employment Agreement dated September 1, 2022 with Norman R. Hames  (incorporated by reference to Exhibit 10.3 filed with the Form 8-K on September 2, 2022).*</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.14</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000168316822006170/radnet_ex1004.htm">Employment Agreement dated September 1, 2022 with Mital Patel (incorporated by reference to Exhibit 10.4 filed with the Form 8-K on September 2, 2022).*</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.15</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="davidjkatz_employmentagr.htm">Employment Agreement dated September 1, 2022 with David J. Katz (filed herewith).*</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.16</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000079052622000006/radnet-rwilsonamendedandre.htm">Amended and Restated Severance Agreement dated January 26, 2022 with Ruth Wilson.*</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.17</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/790526/000079052622000006/radnet-cgordonamendedandre.htm">Amended and Restated Severance Agreement dated February 24, 2022 with Christine Gordon</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.*</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.18</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000119312504015956/dex1016.htm">Amended and Restated Management and Service Agreement between Radnet Management, Inc. and Beverly Radiology Medical Group III dated January 1, 2004 (incorporated by reference to exhibit filed with Form 10-K for the year ended October 31, 2003).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.19</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000168316821001536/radnet_ex1001.htm">Second Amended and Restated First Lien Credit and Guaranty Agreement, dated as of April 23, 2021, by and among RadNet Management, Inc., a California corporation, RadNet, Inc., a Delaware corporation, certain subsidiaries and affiliates of RadNet Management, Inc., as Guarantors, the Lenders and other financial institutions from time to time party thereto, and Barclays Bank PLC, as Administrative Agent and Collateral Agent (incorporated by reference to exhibit filed with Form 8-K on April 26, 2021).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a10k2022exhibit211.htm">List of Subsidiaries.</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a10k2022exhibit231.htm">Consent of Independent Registered Public Accounting Firm.</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if3f80771944f4fc58015abda42dc47d1_163">Power of Attorney (included on signature page attached hereto).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="q42022exhibit311.htm">CEO Certification pursuant to Section 302.</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="q42022exhibit312.htm">CFO Certification pursuant to Section 302.</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="q42022exhibit321.htm">CEO Certification pursuant to Section 906.</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> **</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="q42022exhibit322.htm">CFO Certification pursuant to Section 906.</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> **</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Instance Document</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Schema Document</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Calculation Linkbase Document</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Label Linkbase Document</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">98</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.573%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Presentation Linkbase Document</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Definition Linkbase Document</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)</span></div></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;Indicates management contract or compensatory plan.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">**&#160;&#160;&#160;&#160;Furnished herewith.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">99</span></div></div></div><div id="if3f80771944f4fc58015abda42dc47d1_157"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 16. &#160;10-K Summary</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None</span></div><div id="if3f80771944f4fc58015abda42dc47d1_160"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:44.141%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.585%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.820%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.054%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RADNET, INC.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: March 1, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;HOWARD &#160;G. BERGER, M.D .</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Howard G. Berger, M.D., President,</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Executive Officer and Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="if3f80771944f4fc58015abda42dc47d1_163"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">POWER OF ATTORNEY</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below hereby severally constitutes and appoints Howard G. Berger, M.D. and Mark D. Stolper, and each of them, his or her true and lawful attorney-in-fact and agent, with full power of substitution and re-substitution for him or her and in his or her name, place and stead, in any and all capacities to sign any and all amendments to this report, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the SEC, granting unto said attorney-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite or necessary fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that each said attorneys-in-fact and agents or any of them or their or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of registrant in the capacities and on the dates indicated.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:3.585%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.215%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ HOWARD G. BERGER, M.D.</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Howard G. Berger, M.D., Director, Chief Executive Officer and President</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: March 1, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ GREGORY E. SPURLOCK</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gregory E. Spurlock, Director</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: March 1, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ RUTH VILLIGER-WILSON</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ruth Villiger-Wilson, Director</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: March 1, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ DAVID L. SWARTZ</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">David L. Swartz, Director</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:5.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.458%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: March 1, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ LAWRENCE L. LEVITT</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Lawrence L. Levitt, Director</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: March 1, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ LAURA P. JACOBS</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Laura P. Jacobs, Director</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: March 1, 2023</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ CHRISTINE GORDON</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Christine Gordon, Director</span></td></tr><tr style="height:14pt"><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: March 1, 2022</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ MARK D. STOLPER</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Mark D. Stolper, Chief Financial Officer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> (Principal Accounting Officer)</span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: March 1, 2023</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.15
<SEQUENCE>2
<FILENAME>davidjkatz_employmentagr.htm
<DESCRIPTION>EX-10.15
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>davidjkatz_employmentagr</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1055;"><!-- davidjkatz_employmentagr001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="davidjkatz_employmentagr001.jpg" title="slide1" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">EMPLOYMENT AGREEMENT  This Employment Agreement (&#8220;Agreement&#8221;) is entered into as of September 1, 2022 (the  &#8220;Execution Date&#8221;), by and between RADNET MANAGEMENT, INC., a Delaware corporation  (the &#8220;Company&#8221;), and David J. Katz (the &#8220;Employee&#8482;). As of the Execution Date, the Company  is a wholly-owned subsidiary of RadNet, Inc., a Delaware corporation (&#8220;RNI&#8221; and together with  the Company and any RNI or Company affiliated entity is collectively the &#8220;Group&#8221;).  In consideration of the mutual covenants and conditions set forth herein, and other good  and valuable consideration, the parties hereby agree as follows:  1. Employment. The Company hereby agrees to continue to employ Employee in the  capacity of Executive Vice President and General Counsel and Corporate Secretary of RNI and  the Company. Employee accepts such continued employment and agrees to perform such services  as are customary to such offices and as shall from time to time be assigned to him by the Company  and which may include services to and positions with other Group entities for no additional  compensation. Employee shall report to the Company&#8217;s Chief Executive Officer and shall  primarily work at the Company&#8217;s facilities at 1510 Cotner Ave., Los Angeles, California subject  to required business travel. Employee&#8217;s employment hereunder shall commence on the Execution  Date and shall continue until terminated as provided in Section 4. Employee&#8217;s employment will  be on a full-time basis requiring the devotion of such amount of his professional time as is  necessary for the efficient operation of the business of the Company. Employee&#8217;s employment  with the Company is at-will and either Employee or the Group may terminate Employee&#8217;s  employment at any time and for any reason or no reason in each case subject to the terms and  provisions of this Agreement. The at-will nature of Employee&#8217;s employment cannot be changed  except in a written agreement (that has been approved by the RNI Board of Directors (&#8220;Board&#8221;)  which has been executed by the parties and which expressly recites that such at-will employment  is being modified. Notwithstanding the above, and effective as of Effective Date, with prior  written notice to the Company Chief Executive Officer, Employee shall be permitted to provide  outside consulting services or hold directorships in companies, and/or positions with charitable  organizations, trusts, passive business interests and personal investments, provided that doing so  does not create a conflict of interest, and as long as such services are not provided to any competitor  of the Group and do not materially interfere with Employee&#8217;s performance of services to the  Group. Notwithstanding the foregoing, Employee may, without notice, continue after the  Effective Date to provide such activities that Employee provided prior to the Effective Date.  2. Compensation and Benefits.  2.1. Salary. As ofthe Execution Date, for the performance of Employee&#8217;s duties  hereunder, the Company shall pay Employee an annual salary of $575,000 (&#8220;Base  Compensation&#8221;), payable (after deducting required withholdings) in accordance with the  Company&#8217;s ordinary payroll practices.  2.2. Bonus. Employee will be eligible to participate in all Group bonus or  incentive compensation or nonqualified deferred compensation plans that are generally available  to Group executive officers.  SMRH:4859-6275-5885.3 -1- </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- davidjkatz_employmentagr002.jpg -->
<DIV style="padding-top:2em;">
<IMG src="davidjkatz_employmentagr002.jpg" title="slide2" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">2.3. Benefits. Employee shall be entitled to such medical, disability and life  insurance coverage and such sick leave and holiday and vacation benefits, if any, and any other  benefits as are made available to Group executive officers, all in accordance with the applicable  benefits policies and programs in effect from time to time. Employee will accrue paid vacation on  a pro-rata basis, in an amount equivalent to six (6) weeks per calendar year, subject to any and all  accrual caps and rules and procedures established by Company policy regarding the use and  accrual of vacation. Employee shall also be covered by any Group directors and officers liability  insurance coverage during Employee&#8217;s employment with the Company, as well as such other  insurance coverage as the Group approves and/or is required by law.  2.4. Reimbursement of Expenses. Employee shall be entitled to be reimbursed  for all reasonable and necessary expenses, including but not limited to expenses for travel, meals  and entertainment, incurred by Employee in connection with and reasonably related to the  furtherance of the Company&#8217;s business; provided, however, that the Company requires as a  condition to such reimbursements, that Employee comply with the Company&#8217;s expense  reimbursement policies. Reasonable and necessary telephone, and internet expenses will be  reimbursed in accordance with Company policy. In an effort to facilitate reimbursement of  Employee&#8217;s travel expenses, the Company shall provide Employee with an automobile allowance  in the amount of $800 per calendar month. Additionally, the Company shall reimburse and/or pay  for Employee&#8217;s state bar fees, and other professional fees and subscriptions as approved by the  Company.  2.5. Annual Review. The Board or, if delegated by such Board, its  Compensation and Management Development Committee, will on an annual basis review  Employee&#8217;s performance and compensation hereunder (including salary, bonus and/or equity  incentives).  2.6. Change in Control. Upon a Change in Control, the time-based vesting  conditions of Employee&#8217;s then-outstanding (if any) unvested Equity Awards (as defined below)  shall be deemed to be fully satisfied.     3. Definitions. This section provides certain definitions that are used in this  Agreement.  3.1. &quot;Adverse Change in Duties&quot; means an action or series of actions taken by  the Company and/or the Board or Company Board of Directors, without Employee's prior  written consent, which results in any one or more of the following:  (i) a change in Employee's reporting structure, positions, titles, job  duties or job functions which results in a material diminution of his  status, control, authority or level of responsibility;  (ii) a requirement by the Company that Employee be based or perform  his duties more than ten miles away from the location specified in  Section 1;  (iii) a reduction by the Company in Employee's Base Compensation; or  SMRH:4859-6275-5885.3 -2- </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- davidjkatz_employmentagr003.jpg -->
<DIV style="padding-top:2em;">
<IMG src="davidjkatz_employmentagr003.jpg" title="slide3" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">(iv) for a Protected Fiscal Year, Employee&#8217;s Post CiC Annual Incentive  Compensation is less than the Post CiC Annual Incentive Compensation  Threshold.  3.2. &#8220;Cause&#8221; shall mean any one or more of the following:  (i) Employee's conviction of (or plea of guilty or nolo contendere to)  (A) any felony or (B) any misdemeanor involving fraud or dishonesty  in connection with the performance of his duties hereunder or moral  turpitude;  (ii) the willful and continued failure of Employee to substantially  perform his duties with the Company (other than any such failure  resulting from illness or Disability) after a written demand for  substantial performance from the Company is delivered to Employee,  which demand identifies the manner in which it is claimed Employee  has not substantially performed his duties,  (iii) Employee has willfully engaged in misconduct which has, or can  reasonably be expected to have, a material adverse effect on the Group;  or  (iv) Employee's material breach of this Agreement or any other written  agreement with the Group.  No act or failure to act on Employee's part shall be considered &quot;willful&quot; unless  Employee acted in bad faith or without a reasonable belief that Employee's action  or omission was in the best interest of the Group.  Solely to the extent that the Board determines in its reasonable discretion that the  Cause conduct is curable, Employee shall have ten (10) business days after receipt  of notice that the Group believes it has grounds to terminate Employee's  employment for Cause to entirely cure the Cause conduct under subsections (ii)  through (iv) above and its consequences to the satisfaction of the Board and thereby  avoid termination of Employee's employment for Cause if so determined by the  Board in its sole discretion. During any time period when the Group believes that  (or is in the process of investigating whether) Employee may have committed an  act of Cause (or has committed an act which could result in constituting Cause  under any of the above subsection), the Company may in its discretion place  Employee on a leave of absence and/or preclude Employee from utilizing Group  resources or having access to Group premises. If after Employee's Termination  Date which occurred due to a reason other than termination by the Company for  Cause, the Group discovers that Employee's employment could have been  terminated for Cause, then the Group may in its discretion recharacterize such  termination as a termination for Cause  3.3. &#8220;Change in Control&#8221; has the same meaning provided to it (as of the  Execution Date) in the RNI Equity Incentive Plan, as amended.  SMRI:4859-6275-5885.3 -3- </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- davidjkatz_employmentagr004.jpg -->
<DIV style="padding-top:2em;">
<IMG src="davidjkatz_employmentagr004.jpg" title="slide4" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">3.4. &#8220;Disability&#8221; shall mean that for a period of at least 120 days during any  twelve (12) consecutive month period on account of a mental or physical condition, Employee is  unable to perform the essential functions of his job for the Company, with or without reasonable  accommodation. The determination of Employee&#8217;s Disability shall be made by a medical  physician selected or agreed to by the Group unless there is mutual agreement of the Company  and Employee or his personal representative. All costs relating to the determination of whether  Employee has incurred a Disability shall be paid by the Company. Employee shall submit to any  examination that is reasonably required by an examining physician for purposes of determining  whether a Disability exists.  3.5. &#8220;Equity Awards&#8221; means all outstanding stock options, stock appreciation  rights, restricted stock, restricted stock units and any other deferred equity compensation granted  to Employee by RNI.  3.6. &#8220;Fiscal Year&#8221; means the fiscal year for RNI.  3.7. &#8220;Good Reason&#8221; means any one or more of the following have occurred  without Employee's prior written consent:  (i) the Company&#8217;s material breach of this Agreement or any other  written agreement between the Company and Employee; or  (ii) an Adverse Change in Duties.  In order for Employee to resign his employment for Good Reason, Employee must  provide written notice to the Company within ninety (90) days of the initial  existence of the alleged Good Reason event and such notice must reasonably  describe the facts claimed by Employee to constitute Good Reason and the alleged  Good Reason event remains unremedied by the Company for a period of sixty (60)  days following the Company&#8217;s receipt of such written notice and Employee must  resign his employment for Good Reason within sixty (60) business days after the  expiration of the Company&#8217;s sixty (60) day remedy period in which the Company  did not cure or remedy the Good Reason event.  3.8. &#8220;Incentive Compensation&#8221; means, for the applicable Fiscal Year, the sum  of Employee&#8217;s cash bonus, stock awards, restricted stock units, performance stock units, option  awards, and other equity and non-equity incentive compensation as measured on their respective  grant dates in accordance with the rules of SEC Regulation S-K Item 402(c) (or as described in  any successor provision(s) or definition(s)).  3.9. &#8220;Pre CiC 3 Year Average Incentive Compensation&#8221; means the average of  the Incentive Compensation for the three Fiscal Years immediately preceding the Fiscal Year of a  Change in Control. If Employee was employed by the Group for less than such three prior Fiscal  Years then the Pre CiC 3 Year Average Incentive Compensation shall be calculated based only on  the prior Fiscal Years in which Employee was employed by the Group.  SMRH:4859-6275-5885.3 -4- </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- davidjkatz_employmentagr005.jpg -->
<DIV style="padding-top:2em;">
<IMG src="davidjkatz_employmentagr005.jpg" title="slide5" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">3.10. &#8220;Pre CiC Year Incentive Compensation&#8221; means Incentive Compensation for  the Fiscal Year immediately preceding the Fiscal Year of a Change in Control. If Employee was  not employed by the Group in the prior Fiscal Year then the Pre CiC Year Incentive Compensation  shall equal zero.  3.11. &#8220;Prior 3 Year Average Cash Bonus&#8221; means the dollar amount that is equal  to the average cash portion of the annual bonus (if any) that was paid to Employee for the three  Fiscal Years immediately preceding the Fiscal Year of the Termination Date. If Employee was  employed by the Group for less than such three prior Fiscal Years then the Prior 3 Year Average  Cash Bonus shall be calculated based only on the prior Fiscal Years in which Employee was  employed by the Group.  3.12. &#8220;Prior Year Cash Bonus&#8221; means the dollar amount that is equal to the cash  portion of the annual bonus (if any) that was paid to Employee for the Fiscal Year immediately  preceding the Fiscal Year of the Termination Date. If Employee was not employed by the Group  in the prior Fiscal Year then the Prior Year Cash Bonus shall equal zero.  3.13. &#8220;Post CiC Annual Incentive Compensation&#8221; means the Incentive  Compensation for a Protected Fiscal Year.  3.14. &#8220;Post CiC Annual Incentive Compensation Threshold&#8221; means, for a  Protected Fiscal Year, the lesser of (1) $1,000,000 or (2) the product of fifty percent (50%)  multiplied by the greater of the (i) Pre CiC 3 Year Average Incentive Compensation or the (ii) Pre  CiC Year Incentive Compensation.  3.15. &#8220;Protected Fiscal Year&#8221; means each of the first two complete Fiscal Years  immediately following the Fiscal Year in which the Change in Control occurs.  3.16. &#8220;Severance Bonus&#8221; means, as of the Termination Date, the greater of the  Prior 3 Year Average Cash Bonus or the Prior Year Cash Bonus.  3.17. &#8220;Severance Pay&#8221; means a dollar amount that is equal to: (1) if the  Termination Date occurs before March 1, 2025, then $3,000,000 or (2) if the Termination Date  occurs on or after March 1, 2025, then (i) if the Years of Service is less than ten, the greater of (a)  the sum of Employee&#8217;s Base Compensation (measured as of the day before the Termination Date)  plus the Severance Bonus, or (b) 200%, of Employee&#8217;s Base Compensation (measured as of the  day before the Termination Date) or (ii) if the Years of Service is at least ten, the sum of 200% of  Employee&#8217;s Base Compensation (measured as of the day before the Termination Date) plus 200%  of the Severance Bonus.  3.18. &#8220;Years of Service&#8221; means, as of the Termination Date, the total whole  number of years that the Employee had been continuously employed by the Group. For example,  if Employee&#8217;s commencement of employment with the Group was January 1, 2020 and the  Termination Date was December 30, 2024, the Years of Service would equal four.  4, Termination.  SMRH:4859-6275-5885.3 -5- </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- davidjkatz_employmentagr006.jpg -->
<DIV style="padding-top:2em;">
<IMG src="davidjkatz_employmentagr006.jpg" title="slide6" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">4.1. Termination Events. Employee&#8217;s employment hereunder will terminate  upon the earliest occurrence of any of the following events (such last day of employment is the  &#8220;Termination Date&#8221;).  (a) Employee dies.  (b) the Company, by written notice to Employee or his personal  representative, terminates Employee&#8217;s employment due to Employee&#8217;s Disability.  (&copy;) Employee&#8217;s employment is terminated by the Company for Cause.  (d) Employee&#8217;s employment is terminated by the Company for any  reason, other than for Cause or Disability, which the Company may do at any time and for any or  no reason. For the avoidance of doubt, a Change in Control, on its own, shall not constitute a  termination, even if Employee&#8217;s employer changes as a result of such Change in Control.  (e) Employee terminates his employment due to Good Reason.  3) Employee voluntarily terminates his employment for any reason  other than Good Reason, which Employee may do at any time with at least thirty (30) days&#8217;  advance notice to the Company. The Company may elect to accept Employee&#8217;s voluntary  resignation and accelerate the timing of the Termination Date without any obligation to make any  further payments to Employee except for compensation then owed and due to Employee under  Section 4.2(a).  42. Effects of Termination.    (a) Upon termination of Employee&#8217;s employment hereunder for any  reason, the Company will pay Employee all compensation then owed and due to Employee and  unpaid through the Termination Date (including without limitation Base Compensation and  Employee&#8217;s properly documented expense reimbursements). Employee may also be eligible for  additional compensation as provided below in this Section 4.2.  (b) If Employee&#8217;s employment is terminated under Sections 4.1(a) or  (b), provided that Employee (or his representative) timely signs and does not revoke a complete  and general release of claims in a form to be reasonably determined by the Company (the  &#8220;Release&#8482;), and is in material compliance with this Agreement, upon the Termination Date the  time-based vesting conditions of Employee&#8217;s unvested Equity Awards shall be deemed to be fully  satisfied, and subject to other terms of the Plan and applicable award agreement, Employee (or his  representative) shall have up until the first anniversary of the Termination Date (or the applicable  expiration date if earlier) to exercise his vested stock options including for avoidance of doubt  those stock options which became vested pursuant to this Section 4.2(b). Additionally, if such  termination occurred under Section 4.1(b), then not later than the fifteenth (15&#8482;) day after the  effective date of the Release, the Company shall also provide Employee with a lump sum payment  equal to the sum of Employee&#8217;s Base Compensation (measured as of the day before the  SMRH:4859-6275-5885.3 -6- </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- davidjkatz_employmentagr007.jpg -->
<DIV style="padding-top:2em;">
<IMG src="davidjkatz_employmentagr007.jpg" title="slide7" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">Termination Date) plus the Severance Bonus (provided that if Code Section 409A would be  violated by the foregoing timing of payment then the timing of payment shall instead be made as  provided in Section 4.2(c)(i)). Notwithstanding the foregoing, (x) the timing of all payments  hereunder is subject to Section 5.16 and (y) the Release must be executed by Employee and  become effective by its own terms within no more than 55 days after the Termination Date. Any  outstanding equity compensation awards which had performance based vesting conditions that had  yet to be satisfied shall be forfeited without consideration on the Termination Date.  (c) If Employee&#8217;s employment is terminated under Sections 4.1(d) or (&cent;),  provided that Employee timely signs and does not revoke the Release in accordance with Section  4.2(b) and is in material compliance with this Agreement, then (subject to Section 5.16 and the  following provisions in this paragraph) (i) the Company shall provide Employee with the  Severance Pay, paid in substantially equal installments over the 24 months following the  Termination Date in accordance with the Company&#8217;s regular payroll practices provided however  that the first such installment (in a dollar amount covering the time period from the Termination  Date through the date of such first installment) shall commence with the fifteenth day after the  effective date of the Release and the last installment shall occur on the second anniversary of the  Termination Date and (ii) the time-based vesting conditions of Employee&#8217;s unvested Equity  Awards shall be deemed to be fully satisfied on the Termination Date. If a Change in Control had  occurred within twelve months prior to the Termination Date then the Severance Pay shall instead  be paid in a single lump sum on the fifteenth day after the effective date of the Release. However,  notwithstanding the foregoing, to the extent any portion (or all) of the Severance Pay that would  be paid in a lump sum would violate Code Section 409A, then such amount shall instead be paid  in installments pursuant to the installment payment provisions of this section. Any outstanding  equity compensation awards which had performance based vesting conditions that had yet to be  satisfied shall be forfeited without consideration on the Termination Date.  In addition, conditioned on the timely effectiveness of the Release, the Company shall (1)  pay the cost of the premium for Employee to receive continuation coverage (as defined in the  Consolidation Omnibus Budget Reconciliation Act of 1985, as amended (&#8220;COBRA&#8221;)) under the  Company&#8217;s (or RNI&#8217;s) group medical plan until the earlier of (a) the second anniversary of the  Termination Date or (b) the maximum time for which COBRA continuation coverage is permitted  under applicable law or (c) the date on which Employee obtains substantially equivalent benefits  from another party and (2) continue to provide Employee with life insurance coverage in  accordance with the Company&#8217;s (or RNI&#8217;s) benefits program until the earlier of (d) the second  anniversary of the Termination Date or (&cent;) the date on which Employee obtains substantially  equivalent benefits from another party (the foregoing items (1) and (2) are collectively the &#8220;Health  Benefits&#8221;). If Employee secures other employment and has access to benefits offered by the new  employer, Employee agrees that he will promptly notify the Company in writing of such  employment and coverage. In no event will the Company&#8217;s payment of the cost for such COBRA  premiums extend beyond the total continuation coverage period for Employee under COBRA. If  Employee was not covered under a Company or RNI group medical plan on the Termination Date  and was instead covered under another medical plan (&#8220;Other Plan&#8221;), then the Company shall each  calendar month provide Employee with a cash payment equal to the lesser of the amount the  Company would have had to pay for COBRA coverage if Employee was covered on a Company  SMRH:4859-6275-5885.3 -7- </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- davidjkatz_employmentagr008.jpg -->
<DIV style="padding-top:2em;">
<IMG src="davidjkatz_employmentagr008.jpg" title="slide8" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">or RNI group medical plan or the amount needed to maintain Employee&#8217;s coverage under the Other  Plan with any such payments terminating on the earlier occurrence of clause (b) or (c) above.  Notwithstanding the foregoing, if the Company determines, in its sole discretion, that its  payment of the premiums on Employee&#8217;s behalf would result in a violation of the  nondiscrimination rules of Code Section 105(h)(2) or any statute or regulation of similar effect  (including but not limited to the 2010 Patient Protection and Affordable Care Act, as amended by  the 2010 Health Care and Education Reconciliation Act), then the Company shall instead each  month during the period in which Employee is receiving continuation coverage provide Employee  with a taxable payment equal to the amount of the Company-portion of the premiums which  Employee may, but is not required to, use towards the cost of coverage.  4.3. Confidentiality Agreement and Return of Property. During Employee&#8217;s  employment with the Group, the parties acknowledge that the Company has provided and will  continue to provide to Employee confidential information and trade secrets of the Group and its  business. In connection with such confidential information, Employee acknowledges that has he  previously executed the confidentiality agreement attached as Exhibit A and that he reaffirms his  duties and obligations under such agreement and that he will remain in compliance with this  confidentiality agreement as may be amended from time to time by the Company. Upon or before  the Termination Date, Employee shall return to the Company any and all confidential information relating  to the Group and its business and shall not retain any copies, reproductions, summaries, or facsimiles of  such confidential information.  5. General Provisions.     5.1. Assignment. Employee shall not assign or delegate any of his rights or  obligations under this Agreement without the prior written consent of the Company, and any  attempted assignment without the Company&#8217;s consent shall be void ab initio. The Company may  assign this Agreement to any successor of the Company or any purchaser of all or substantially all  of the assets of the Company.  5.2. Entire Agreement. This Agreement contains the entire agreement between  the parties with respect to the subject matter hereof and supersedes any and all prior agreements  between the parties relating to such subject matter including without limitation the employment  agreement by and between Employee and the Company dated March 2, 2020. In the case of any  conflict between the terms of this Agreement and any equity compensation award agreement or  similar instrument between the Parties, the terms of this Agreement shall control except in the case  of an equity compensation award that is outstanding as of the Execution Date and in such case the  outstanding equity compensation agreement shall control with respect to terms that are more  favorable to Employee than under this Agreement.  5.3. Modifications. This Agreement may be changed or modified only by an  agreement in writing signed by both parties hereto.  5.4. Successors and Assigns. The provisions of this Agreement shall inure to  the benefit of, and be binding upon, the Company and its successors and permitted assigns and  Employee and Employee&#8217;s legal representatives, heirs, legatees, distributees, assigns and  SMRH:4859-6275-5885.3 -8- </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- davidjkatz_employmentagr009.jpg -->
<DIV style="padding-top:2em;">
<IMG src="davidjkatz_employmentagr009.jpg" title="slide9" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">transferees by operation of law, whether or not any such person shall have become a party to this  Agreement and have agreed in writing to join and be bound by the terms and conditions hereof.  5.5. Governing Law. This Agreement is performable in whole or in part in Los  Angeles County, California wherein exclusive venue shall lie for any proceeding, claim or  controversy. This Agreement and the rights of the parties hereunder shall be governed by and  construed in accordance with the laws of the State of California, including all matters of  construction, validity, performance and enforcement, and without giving effect to principles of  conflict of laws. Notwithstanding the foregoing, the Parties represent and agree that the Company  is engaged in interstate commerce, and as such Section 5.12 of this Agreement will be interpreted  and enforced pursuant to the Federal Arbitration Act, 9 U.S.C. Section 1, ef seq., and not any  contrary state law.    5.6. Severability. If any provision of this Agreement is held by a court of  competent jurisdiction to be invalid, void or unenforceable, the remaining provisions shall  nevertheless continue in full force and effect.  5.7. Further Assurances. The parties will execute such further instruments and  take such further actions as may be reasonably necessary to carry out the intent of this Agreement.  5.8. Notices. Any notices or other communications required or permitted  hereunder shall be in writing and shall be deemed received by the recipient when delivered  personally or, if mailed, five days after the date of deposit in the United States mail, certified or  registered, postage prepaid and addressed, in the case of the Company, to Radnet Management,  Inc., 1510 Cotner Ave., Los Angeles, CA 90025-3303, attention: Chief Executive Officer; and in  the case of Employee, to the address shown for Employee on the signature page hereof.  5.9. No Waiver. The failure of either party to enforce any provision of this  Agreement shall not be construed as a waiver of that provision, nor prevent that party thereafter  from enforcing that provision of any other provision of this Agreement.  5.10. Legal Fees and Expenses. In the event of any disputes under this  Agreement, each party shall be responsible for its own legal fees and expenses which it may incur  in resolving such dispute, unless otherwise prohibited by applicable law or a court of competent  jurisdiction.  5.11. Counterparts. This Agreement may be executed in counterparts, each of  which shall be deemed to be an original, but all of which together shall constitute one and the same  instrument.  5.12. Arbitration. Except as may otherwise be expressly provided in a written  agreement by and between the Group and Employee, any controversy, dispute or claim (&#8220;Claim&#8221;)  whatsoever between Employee, on the one hand, and Group, or any of its employees, directors,  officers, and agents (collectively &#8220;Company Parties&#8221;), on the other hand, except as excluded  below, shall be resolved by binding arbitration, at the request of either party, in accordance with  the Employment Arbitration Rules and Mediation Procedures of the American Arbitration  SMRH:4859-6275-5885.3 -9- </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- davidjkatz_employmentagr010.jpg -->
<DIV style="padding-top:2em;">
<IMG src="davidjkatz_employmentagr010.jpg" title="slide10" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">Association (&#8220;AAA&#8221;) or other similar organization agreed to by the parties. The claims covered  by this Agreement include, but are not limited to, claims for wages and other compensation, claims  for breach of contract (express or implied), tort claims, claims for discrimination or harassment  (including, but not limited to, based on race, sex, sexual orientation, religion, national origin, age,  marital status, medical condition, or disability), and claims for violation of any federal, state, or  other government law, statute, regulation or ordinance, except for claims for worker&#8217;s  compensation or unemployment insurance benefits. Nothing contained in this Agreement shall  prohibit Employee from filing a charge of discrimination with the Equal Employment Opportunity  Commission and/or the Department of Fair Employment and Housing, and cooperating in the  investigation of such.  This provision does not apply to or cover claims based upon a benefit plan  that contains an arbitration or other dispute resolution procedure, in which case the provisions of  such plan shall apply. Further, either Employee or the Group in a court of competent jurisdiction,  may seek to compel arbitration under this Agreement, to enforce an arbitration award or to obtain  preliminary injunctive and/or other equitable relief in support of claims to be prosecuted in an  arbitration to the extent allowed by California Code of Civil Procedure Section 1281.8.  The chosen arbitration administrator shall give each party a list of names  drawn from its panel of employment arbitrators. The arbitrator shall apply California substantive  law and the California Evidence Code to the proceeding. The demand for arbitration must be in  writing and made within the applicable statute of limitations period. The arbitration shall take  place in Los Angeles County, California. The parties shall be entitled to conduct reasonable  discovery, including, without limitation, conducting depositions, requesting documents and  propounding interrogatories. The arbitrator shall have the authority to resolve discovery disputes,  including but not limited to determining what constitutes reasonable discovery. The arbitrator  shall prepare in writing and provide to the parties a decision and award, which shall include factual  findings and the reasons upon which a decision is based. Except as may be stated otherwise above,  any and all arbitration proceedings shall be conducted in accordance with the Employment  Arbitration Rules and Mediation Procedures of the AAA.  Except as otherwise required by law, the decision of the arbitrator shall be  binding and conclusive on the parties. Judgment upon the award rendered by the arbitrator may  be entered in any court having proper jurisdiction. The fees for the arbitrator shall be paid by the  Group. Each party shall bear its or his own fees and costs incurred in connection with the  arbitration except for any attorneys&#8217; fees or costs which are awarded to a party by the Arbitrator  pursuant to a statute or contract which provides for recovery of such fees and/or costs from the  other party.  The arbitrator&#8217;s authority to resolve disputes and make awards under this  Agreement is limited to disputes between (1) Employee as an individual and the Group and (2)  Employee as an individual and any past or present owner, shareholder, director, officer, partner,  member, associate, employee, intern, service provider, consultant or agent of the Group. No  arbitration award or decision will have any preclusive effect as to issues or arbitrable claims in any  dispute with anyone who is not a named party to the arbitration. Employee and the Group agree  that each may file claims against the other only in their individual capacities, and may not file  SMRI:4859-6275-5885.3 -10- </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- davidjkatz_employmentagr011.jpg -->
<DIV style="padding-top:2em;">
<IMG src="davidjkatz_employmentagr011.jpg" title="slide11" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">claims as a plaintiff and/or participate as a class member in any pending or future class and/or  collective action against the other. Employee and the Group agree that any class, collective, or  representative claims that are found not subject to arbitration under this Agreement shall be  resolved in court, and are stayed pending the outcome of the arbitration. Employee and the Group  agree that a court, not an arbitrator, shall determine whether any claims must proceed on a class or  collective basis.  Except as provided in this Agreement, arbitration shall be the sole, exclusive  and final remedy for any dispute between Employee and the Group. Both the Group and the  Employee understand and agree that by using arbitration to resolve any Claims between Employee  and Company or any or all the Company Parties they are giving up any right that they may have  to a judge or jury trial with regard to those Claims.  5.13. Group Policies. Employee understands and agrees that he will subject to  and will fully comply with all Group policies and procedures (as each may be amended from time  to time) including without limitation any insider trading policy, policy on recoupment of  compensation, stock ownership guidelines, or policy on confidentiality and proprietary  information.  5.14. Representations and Covenants. Employee represents and warrants to the  Group all of the following items referenced in this Section. Employee has the legal right to enter  into this Agreement and to perform the obligations on Employee&#8217;s part to be performed hereunder  in accordance with its terms, and Employee is not a party to any agreement or understanding,  written or oral, and is not subject to any restriction, which, in either case, could prevent Employee  from entering into this Agreement or performing Employee&#8217;s duties and obligations hereunder.  Except as Employee has disclosed in writing to the Group, Employee is not bound by the terms of  any agreement with any previous employer or other party to refrain from using or disclosing any  trade secret or confidential or proprietary information in the course of Employee&#8217;s work for the  Group or to refrain from competing, directly or indirectly, with the business of such previous  employer or any other party. Employee&#8217;s performance of all the terms of this Agreement and as  an employee of the Company does not and will not breach any agreement to keep in confidence  proprietary information, knowledge or data acquired by Employee in confidence or in trust prior  to Employee&#8217;s work for the Group, and Employee will not disclose to the Group or induce the  Group to use any confidential information or material belonging to any previous employer or  others. Employee will not make (or direct or ask anyone to make) any disparaging statements (oral  or written) about the Group or any of its officers, directors, managers, employees, members,  stockholders, representatives or agents, or any of the Group&#8217;s products or services or work-in-  progress. Employee shall cooperate with the Group and its representatives before and after the  Termination Date in connection with any action, investigation, proceeding, litigation or otherwise  with regard to matters in which Employee has knowledge as a result of Employee&#8217;s service with  the Group. Notwithstanding the foregoing, Employee understands that pursuant to 18 U.S.C.  1833(b), an individual shall not be held criminally or civilly liable under any Federal or State trade  secret law for the disclosure of a trade secret that (A) is made (i) in confidence to a Federal, State,  or local government official, either directly or indirectly, or to an attorney; and (ii) solely for the  purpose of reporting or investigating a suspected violation of law; or (B) is made in a complaint  or other document filed in a lawsuit or other proceeding, if such filing is made under seal. Further,  SMRH:4859-6275-5885.3 -11- </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- davidjkatz_employmentagr012.jpg -->
<DIV style="padding-top:2em;">
<IMG src="davidjkatz_employmentagr012.jpg" title="slide12" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">an individual who files a lawsuit for retaliation by an employer for reporting a suspected violation  of law may disclose the trade secret to the attorney of the individual and use the trade secret  information in the court proceeding, if the individual (1) files any document containing the trade  secret under seal; and (2) does not disclose the trade secret, except pursuant to court order.  Employee understands that nothing in this Agreement precludes Employee from reporting possible  violations of federal law or regulation to any governmental agency or entity, including but not  limited to the Department of Justice, the Securities and Exchange Commission, the Congress, and  any agency Inspector General, or making other disclosures that are protected under the  whistleblower provisions of federal law or regulation. Employee does not need the prior  authorization to make any such reports or disclosures and Employee is not required to notify the  Group that Employee has made such reports or disclosures.  5.15. Force Majeure. If due to labor disputes, government regulations, war,  pandemic, natural disaster, other calamity, or other similar unexpected unique circumstances  (collectively, &#8220;Force Majeure&#8221;) the Company in good faith believes it is unable to fully utilize  Employee&#8217;s services or cannot fully provide Employee with the compensation and benefits  required under this Agreement, then the Company shall have the right upon twenty-four (24) hours  prior written notice to Employee to suspend/reduce Employee&#8217;s services and/or reduce/eliminate  compensation and benefits for the duration of such Force Majeure, or for any part thereof; provided  that such suspension or reduction in compensation and benefits shall end as soon as such Force  Majeure event is over (as determined in good faith by the Company). This Section 5.15 shall apply  only if at the time of a Force Majeure event, the Companys Chief Executive Officer is someone  who was a Company executive officer on the Execution Date.  5.16. Taxes and Section 409A. All payments made by the Group to Employee  will be subject to tax withholding in amounts determined by the Group pursuant to applicable laws  or regulations and Employee shall be solely responsible for any taxes, additional taxes, excise  taxes, penalties and/or interest imposed on Employee as a result of this Agreement or due to any  other payments or benefits provided by the Group.  To the maximum extent permitted, this Agreement is intended to not  constitute a &#8220;nonqualified deferred compensation plan&#8221; within the meaning of Internal Revenue  Code Section 409A (&#8220;Section 409A&#8221;) but in any event will be interpreted to comply with Section  409A. In the event this Agreement or any benefit paid under this Agreement or otherwise by the  Group to Employee is deemed to be subject to Section 409A, Employee consents to the Group's  adoption of such conforming amendments as the Group deems advisable or necessary, in its sole  discretion (but without an obligation to do so), to comply with Section 409A and avoid the  imposition of taxes under Section 409A.  For purposes of this Agreement, a termination of employment means a  &#8220;separation from service&#8221; as defined in Section 409A. Each payment made pursuant to any  provision of this Agreement or otherwise shall be considered a separate payment and not one of a  series of payments for purposes of Section 409A. To the extent any nonqualified deferred  compensation payment to Employee could be paid in one or more of Employee&#8217;s taxable years  depending upon Employee completing certain employment-related actions (including without  SMRH:4859-6275-5885.3 -12- </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- davidjkatz_employmentagr013.jpg -->
<DIV style="padding-top:2em;">
<IMG src="davidjkatz_employmentagr013.jpg" title="slide13" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">limitation executing the Release), then any such payments will commence or occur in the later  taxable year to the extent required by Section 409A.  If upon Employee&#8217;s &#8220;separation from service&#8221; within the meaning of  Section 409A, Employee is then a &#8220;specified employee&#8221; (as defined in Section 409A) of RNI, then  solely to the extent necessary to comply with Section 409A and avoid the imposition of taxes under  Section 409A, the Group shall defer payment of &#8220;nonqualified deferred compensation&#8221; subject to  Section 409A payable as a result of and within six (6) months following such &#8220;separation from  service&#8221; until the earlier of (i) the first business day of the seventh month following Employee&#8217;s  &#8220;separation from service,&#8221; or (ii) ten (10) days after the Company receives written confirmation of  Employee&#8217;s death. Any such delayed payments shall be made without interest.  IN WITNESS WHEREOF, the Company and Employee have executed this Agreement,  effective as of the Execution Date.  COMPANY: EMPLOYEE:  RADNET MANAGEMENT, INC. DAVID J. KATZ  By: poor pho nz  Howard G. Berger, M.D., President    SMRH:4859-6275-5885.3 -13- </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- davidjkatz_employmentagr014.jpg -->
<DIV style="padding-top:2em;">
<IMG src="davidjkatz_employmentagr014.jpg" title="slide14" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">EXHIBIT A  CONFIDENTIALITY AGREEMENT  SMRH:4859-6275-5885.3 -14- </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>3
<FILENAME>a10k2022exhibit211.htm
<DESCRIPTION>EX-21.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i072b5f559da04efd828f1bfa044558f7_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 21.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SUBSIDIARIES</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.982%"><tr><td style="width:1.0%"></td><td style="width:78.302%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.586%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.612%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of Subsidiary</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Jurisdiction of Organization</font></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Radnet Managed Imaging Services, Inc.</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Radnet Management, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Radnet Management I, Inc.</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Radnet Management II, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Radnet Sub, Inc.</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beach Imaging Group, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostic Village, LLC</font></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FRI II, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FRI, Inc.</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Glendale Advanced Imaging Center, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mission Advanced Imaging Center, LLC</font></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Orange County Radiation Oncology, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pacific Imaging Partners, Inc.</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rolling Oaks Imaging Corporation</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rolling Oaks Radiology, Inc.</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Santa Monica Imaging Group, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SoCal MR Site Management, Inc.</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valley Imaging Partners, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ventura County Imaging Group, LLC</font></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Valley Imaging Group, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RMIS Imaging Services, Inc.</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advanced Imaging Partners, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advanced NA, LLC</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">American Radiology Services of Delaware, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">American Radiology Services LLC</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arizona Diagnostic Radiology Group, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arizona Imaging Services, LLC</font></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Community Imaging Partners, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DeepHealth, Inc.</font></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware Imaging Partners, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostic Imaging Services, Inc.</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ide Imaging Partners, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Image Medical Corporation</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mid Rockland Imaging Partners, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nulogix Health, Inc.</font></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Orange County Radiation Oncology, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PantheonXT Partners, LLC</font></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quantib Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Radiologix, Inc.</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Radiology Alliance Delivery Systems, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Radiology and Nuclear Medicine Imaging Partners, Inc.</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Radsite LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raven Holdings U.S., Inc.</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.982%"><tr><td style="width:1.0%"></td><td style="width:78.302%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.586%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.612%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RMI Scheduling, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Simi Valley Imaging Group, LLC</font></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasure Coast Imaging Partners, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Questar Imaging, Inc.</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Questar Victorville, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Scriptsender, LLC</font></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kepdoktor Kft</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hungary</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advanced Imaging at Timonium Crossing, LLC</font></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advanced Imaging Center at St. Joseph Medical Center, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advanced PET Imaging of Maryland, L.P.</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advanced Radiology, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advanced &#47;Upper Chesapeake Health Center, LLC</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Baltimore County Radiology, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Baltimore Washington Imaging Center, LLC</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Calvert Medical Imaging Centers, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carroll County Radiology, LLC</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Franklin Imaging, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Frederick County Radiology, LLC</font></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater Baltimore Diagnostic Imaging Partnership</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Montgomery Community Magnetic Imaging Center Limited Partnership</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mount Airy Imaging Center, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Radar Medical Systems, LLC</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michigan</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DH AI International Holdings B.V.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quantib B.V.</font></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aidence B.V.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Imaging On Call, LLC</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Imaging Services Company of New York, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Park West Circle Realty, LLC</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Garden State Radiology Network, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Diagnostics of New Jersey, LLC</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integrated Health Network, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey Imaging Network, LLC</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey Imaging Partners, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">eRad, Inc.</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pennsylvania</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare Rhode Island, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rhode Island</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Roentgen Reinsurance Company, Ltd</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Turks and Caicos</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aidence UK, Ltd</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Heart and Lung Imaging Limited</font></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>4
<FILENAME>a10k2022exhibit231.htm
<DESCRIPTION>EX-23.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i7f79c69a3c3a44c9a3f647a8f5e6b7ba_1"></div><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="text-align:right"><font style="background-color:#ffffff;color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:209%">Exhibit 23.1</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:150%">Consent of Independent Registered Public Accounting Firm</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">We consent to the incorporation by reference in the following Registration Statements&#58;      </font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">a.</font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%;padding-left:11.07pt">Registration Statement (Form S-3ASR No. 333-269025) of RadNet, Inc.,</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">b.</font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%;padding-left:10.5pt">Registration Statement (Form S-8 Nos. 333-176324, 333-206311 and 333-219824) pertaining to the 2006 Equity Incentive Plan&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">c.</font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%;padding-left:11.07pt">Registration Statement (Form S-8 No. 333-238874) pertaining to the 2017 Stock Incentive Plan of DeepHealth, Inc.&#59; and</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">d.</font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%;padding-left:10.5pt">Registration Statement (Form S-8 No. 333-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%"> </font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">257638) pertaining to the RadNet, Inc. Equity Incentive Plan&#59;</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:150%">of our reports dated March 1, 2023, with respect to the consolidated financial statements of RadNet, Inc. and subsidiaries and the effectiveness of internal control over financial reporting of RadNet, Inc. and subsidiaries included in this Annual Report (Form 10-K) of RadNet, Inc. and subsidiaries for the year ended December 31, 2022.</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:164%">&#47;s&#47; Ernst &#38; Young LLP</font></div><div><font><br></font></div><div><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:164%">Los Angeles, California</font></div><div><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">March 1, 2023</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>5
<FILENAME>q42022exhibit311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i3079322a6e904e5b80ea633712710431_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right;text-indent:198pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 31.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Howard G. Berger, M.D., certify that&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;I have reviewed this report on Form 10-K of RadNet, Inc.&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:1.979%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:0.1%"></td><td style="width:2.732%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.235%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:1.979%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">c.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:1.979%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">d.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:0.1%"></td><td style="width:2.732%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.235%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:0.1%"></td><td style="width:2.732%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.235%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated&#58; March 1, 2023</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;&#160;Howard G. Berger, M.D.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Howard G. Berger, M.D.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">President, Chief Executive Officer and Chairman of the Board of Directors</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>6
<FILENAME>q42022exhibit312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ibd7dcd4409784c39823c8b34db784757_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 31.2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Mark D. Stolper, certify that&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;I have reviewed this report on Form 10-K of RadNet, Inc.&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">have&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:1.979%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:0.1%"></td><td style="width:2.732%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.235%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:0.1%"></td><td style="width:2.732%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.235%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">c.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:1.979%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">d.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:1.979%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.387%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated&#58; March 1, 2023</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;Mark D. Stolper</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Mark D. Stolper</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Executive Vice President</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">and Chief Financial Officer</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>7
<FILENAME>q42022exhibit321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="id1caa432cc064b9f990c45023f7b6825_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 32.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Annual Report of RadNet, Inc. (the &#8220;Company&#8221;) on Form 10-K for the twelve month period ended December 31, 2022, as filed with the Securities and Exchange Commission on March 1, 2023 (the &#8220;Report&#8221;), I, Howard G. Berger, M.D., Chairman and Chief Executive Officer of the Company, certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of, and for the periods presented in the Report.</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;&#160;Howard G. Berger, M.D.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Howard G. Berger, M.D.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman, President and Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 1, 2023</font></td></tr></table></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A signed original of this written statement required by Section 906 has been provided to the Company and will be furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>8
<FILENAME>q42022exhibit322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i65eaef8cf65a483da5dc1389efdf0b1e_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 32.2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Annual Report of RadNet, Inc. (the &#8220;Company&#8221;) on Form 10-K for the twelve month period ended December 31, 2022, as filed with the Securities and Exchange Commission on March 1, 2023 (the &#8220;Report&#8221;), I, Mark D. Stolper, Chief Financial Officer of the Company, certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of, and for the periods presented in the Report.</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;&#160;Mark D. Stolper</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark D. Stolper</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 1, 2023</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A signed original of this written statement required by Section 906 has been provided to the Company and will be furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>9
<FILENAME>rdnt-20221231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:ee66d8ee-1013-4282-8e3e-c307b1c04f3f,g:1b6e48fd-cb3e-498b-b299-6015491264f8-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:rdnt="http://www.radnet.com/20221231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.radnet.com/20221231">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rdnt-20221231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rdnt-20221231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rdnt-20221231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rdnt-20221231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="COVERPAGE" roleURI="http://www.radnet.com/role/COVERPAGE">
        <link:definition>0000001 - Document - COVER PAGE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AUDITINFORMATION" roleURI="http://www.radnet.com/role/AUDITINFORMATION">
        <link:definition>0000002 - Document - AUDIT INFORMATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETS" roleURI="http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS">
        <link:definition>0000003 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>0000004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFOPERATIONS" roleURI="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS">
        <link:definition>0000005 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" roleURI="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS">
        <link:definition>0000006 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTOFEQUITY" roleURI="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY">
        <link:definition>0000007 - Statement - CONSOLIDATED STATEMENT OF EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>0000008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical" roleURI="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical">
        <link:definition>0000009 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NATUREOFBUSINESS" roleURI="http://www.radnet.com/role/NATUREOFBUSINESS">
        <link:definition>0000010 - Disclosure - NATURE OF BUSINESS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES">
        <link:definition>0000011 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RECENTACCOUNTINGSTANDARDS" roleURI="http://www.radnet.com/role/RECENTACCOUNTINGSTANDARDS">
        <link:definition>0000012 - Disclosure - RECENT ACCOUNTING STANDARDS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSCOMBINATIONSANDRELATEDACTIVITY" roleURI="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITY">
        <link:definition>0000013 - Disclosure - BUSINESS COMBINATIONS AND RELATED ACTIVITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTREPORTING" roleURI="http://www.radnet.com/role/SEGMENTREPORTING">
        <link:definition>0000014 - Disclosure - SEGMENT REPORTING</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETS" roleURI="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETS">
        <link:definition>0000015 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PROPERTYANDEQUIPMENT" roleURI="http://www.radnet.com/role/PROPERTYANDEQUIPMENT">
        <link:definition>0000016 - Disclosure - PROPERTY AND EQUIPMENT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CREDITFACILITIESANDNOTESPAYABLE" roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLE">
        <link:definition>0000017 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASES" roleURI="http://www.radnet.com/role/LEASES">
        <link:definition>0000018 - Disclosure - LEASES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXES" roleURI="http://www.radnet.com/role/INCOMETAXES">
        <link:definition>0000019 - Disclosure - INCOME TAXES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATION" roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATION">
        <link:definition>0000020 - Disclosure - STOCK-BASED COMPENSATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUBSEQUENTEVENTS" roleURI="http://www.radnet.com/role/SUBSEQUENTEVENTS">
        <link:definition>0000021 - Disclosure - SUBSEQUENT EVENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies">
        <link:definition>0000022 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables">
        <link:definition>0000023 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSCOMBINATIONSANDRELATEDACTIVITYTables" roleURI="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYTables">
        <link:definition>0000024 - Disclosure - BUSINESS COMBINATIONS AND RELATED ACTIVITY (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTREPORTINGTables" roleURI="http://www.radnet.com/role/SEGMENTREPORTINGTables">
        <link:definition>0000025 - Disclosure - SEGMENT REPORTING (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSTables" roleURI="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables">
        <link:definition>0000026 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PROPERTYANDEQUIPMENTTables" roleURI="http://www.radnet.com/role/PROPERTYANDEQUIPMENTTables">
        <link:definition>0000027 - Disclosure - PROPERTY AND EQUIPMENT (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CREDITFACILITIESANDNOTESPAYABLETables" roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLETables">
        <link:definition>0000028 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESTables" roleURI="http://www.radnet.com/role/LEASESTables">
        <link:definition>0000029 - Disclosure - LEASES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESTables" roleURI="http://www.radnet.com/role/INCOMETAXESTables">
        <link:definition>0000030 - Disclosure - INCOME TAXES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONTables" roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables">
        <link:definition>0000031 - Disclosure - STOCK-BASED COMPENSATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NATUREOFBUSINESSDetailsNarrative" roleURI="http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative">
        <link:definition>0000032 - Disclosure - NATURE OF BUSINESS (Details Narrative)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofNetRevenue" roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofNetRevenue">
        <link:definition>0000033 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Summary of Net Revenue)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsAccountsPayableandAccruedExpenses" roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsAccountsPayableandAccruedExpenses">
        <link:definition>0000034 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Accounts Payable and Accrued Expenses)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative" roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative">
        <link:definition>0000035 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Narrative)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative_1" roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative_1">
        <link:definition>0000035 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Narrative)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsReconciliationofForeignCurrencyTranslation" roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsReconciliationofForeignCurrencyTranslation">
        <link:definition>0000036 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Reconciliation of Foreign Currency Translation)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives" roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives">
        <link:definition>0000037 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Derivatives)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsContingentConsideration" roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsContingentConsideration">
        <link:definition>0000038 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Contingent Consideration)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements" roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements">
        <link:definition>0000039 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Fair Value Measurements)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare" roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare">
        <link:definition>0000040 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Earnings Per Share)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsInvestmentinJointVentures" roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsInvestmentinJointVentures">
        <link:definition>0000041 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Investment in Joint Ventures)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures" roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures">
        <link:definition>0000042 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Key Financial Data on Joint Ventures)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDeferredRevenueRecognition" roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDeferredRevenueRecognition">
        <link:definition>0000043 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Deferred Revenue Recognition)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDeferredRevenueRecognition_1" roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDeferredRevenueRecognition_1">
        <link:definition>0000043 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Deferred Revenue Recognition)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsandLiabilitiesAssumed" roleURI="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsandLiabilitiesAssumed">
        <link:definition>0000044 - Disclosure - BUSINESS COMBINATIONS AND RELATED ACTIVITY (Details - Assets and Liabilities Assumed)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative" roleURI="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative">
        <link:definition>0000045 - Disclosure - BUSINESS COMBINATIONS AND RELATED ACTIVITY (Details - Narrative)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTREPORTINGDetails" roleURI="http://www.radnet.com/role/SEGMENTREPORTINGDetails">
        <link:definition>0000046 - Disclosure - SEGMENT REPORTING (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill" roleURI="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill">
        <link:definition>0000047 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Details - Schedule of Goodwill)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSDetailsNarrative" roleURI="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsNarrative">
        <link:definition>0000048 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Details - Narrative)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule" roleURI="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule">
        <link:definition>0000049 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Details - Annual Amortization Schedule)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PROPERTYANDEQUIPMENTDetails" roleURI="http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetails">
        <link:definition>0000050 - Disclosure - PROPERTY AND EQUIPMENT (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PROPERTYANDEQUIPMENTDetailsNarrative" roleURI="http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetailsNarrative">
        <link:definition>0000051 - Disclosure - PROPERTY AND EQUIPMENT (Details - Narrative)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt" roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt">
        <link:definition>0000052 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Details - Schedule of Debt)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CREDITFACILITIESANDNOTESPAYABLEDetailsAnnualNotePayableMaturities" roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAnnualNotePayableMaturities">
        <link:definition>0000053 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Details - Annual Note Payable Maturities)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CREDITFACILITIESANDNOTESPAYABLEDetailsAdditionalInformation" roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAdditionalInformation">
        <link:definition>0000054 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Details - Additional Information)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CREDITFACILITIESANDNOTESPAYABLEDetailsSecondAmendedandRestatedFirstLienCreditandGuarantyAgreement" roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSecondAmendedandRestatedFirstLienCreditandGuarantyAgreement">
        <link:definition>0000055 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Details- Second Amended and Restated First Lien Credit and Guaranty Agreement)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails" roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails">
        <link:definition>0000056 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Details - Margin Spread Based on Leverage Ratio, Debt Instrument) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities" roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities">
        <link:definition>0000057 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Details - Senior Credit Facilities)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities" roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities">
        <link:definition>0000058 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Details - Revolving Credit Facilities)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio" roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio">
        <link:definition>0000059 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Details - Margin Spread Based on Leverage Ratio)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstoPriorCreditFacilities" roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstoPriorCreditFacilities">
        <link:definition>0000060 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Details - Recent Amendments to Prior Credit Facilities)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESDetailsAdditionalInformation" roleURI="http://www.radnet.com/role/LEASESDetailsAdditionalInformation">
        <link:definition>0000061 - Disclosure - LEASES (Details - Additional Information)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESDetailsLeaseCost" roleURI="http://www.radnet.com/role/LEASESDetailsLeaseCost">
        <link:definition>0000062 - Disclosure - LEASES (Details - Lease Cost)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESDetailsSupplementalCashFlows" roleURI="http://www.radnet.com/role/LEASESDetailsSupplementalCashFlows">
        <link:definition>0000063 - Disclosure - LEASES (Details - Supplemental Cash Flows)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESDetailsSupplementalBalanceSheet" roleURI="http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet">
        <link:definition>0000064 - Disclosure - LEASES (Details - Supplemental Balance Sheet)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESDetailsMaturitiesofOperatingandFinanceLease" roleURI="http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease">
        <link:definition>0000065 - Disclosure - LEASES (Details - Maturities of Operating and Finance Lease)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESDetailsMaturitiesofOperatingandFinanceLease_1" roleURI="http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease_1">
        <link:definition>0000065 - Disclosure - LEASES (Details - Maturities of Operating and Finance Lease)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDetails" roleURI="http://www.radnet.com/role/IncomeTaxesDetails">
        <link:definition>0000066 - Disclosure - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESDetailsIncomeLossBeforeIncomeTaxes" roleURI="http://www.radnet.com/role/INCOMETAXESDetailsIncomeLossBeforeIncomeTaxes">
        <link:definition>0000067 - Disclosure - INCOME TAXES (Details - Income (Loss) Before Income Taxes )</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESDetailsIncomeTaxExpense" roleURI="http://www.radnet.com/role/INCOMETAXESDetailsIncomeTaxExpense">
        <link:definition>0000068 - Disclosure - INCOME TAXES (Details - Income Tax Expense)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESDetailsReconciliationoftheStatutoryUSFederalRateandEffectiveRates" roleURI="http://www.radnet.com/role/INCOMETAXESDetailsReconciliationoftheStatutoryUSFederalRateandEffectiveRates">
        <link:definition>0000069 - Disclosure - INCOME TAXES (Details - Reconciliation of the Statutory U.S. Federal Rate and Effective Rates)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESDetailsDeferredTaxAssetsandLiabilities" roleURI="http://www.radnet.com/role/INCOMETAXESDetailsDeferredTaxAssetsandLiabilities">
        <link:definition>0000070 - Disclosure - INCOME TAXES (Details - Deferred Tax Assets and Liabilities)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESDetailsNarrative" roleURI="http://www.radnet.com/role/INCOMETAXESDetailsNarrative">
        <link:definition>0000071 - Disclosure - INCOME TAXES (Details - Narrative)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESDetailsUnrecognizedTaxBenefit" roleURI="http://www.radnet.com/role/INCOMETAXESDetailsUnrecognizedTaxBenefit">
        <link:definition>0000072 - Disclosure - INCOME TAXES (Details - Unrecognized Tax Benefit)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONDetailsNarrative" roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative">
        <link:definition>0000073 - Disclosure - STOCK-BASED COMPENSATION (Details Narrative)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants" roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants">
        <link:definition>0000074 - Disclosure - STOCK-BASED COMPENSATION (Details-Outstanding options and warrants)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONDetailsRSUsandLTIPs" roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUsandLTIPs">
        <link:definition>0000075 - Disclosure - STOCK-BASED COMPENSATION (Details - RSU's and LTIPs)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="rdnt_ComputerandOfficeEquipmentMember" abstract="true" name="ComputerandOfficeEquipmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_ProperyAndEquipmentNetMember" abstract="false" name="ProperyAndEquipmentNetMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_MedicalEquipmentMember" abstract="true" name="MedicalEquipmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_LeverageRatioAxis" abstract="true" name="LeverageRatioAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="rdnt_EquipmentAcquiredAndLeaseholdImprovements" abstract="false" name="EquipmentAcquiredAndLeaseholdImprovements" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue" abstract="false" name="ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_NumberOfCenters" abstract="false" name="NumberOfCenters" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="rdnt_TangentAssociatesLLCMember" abstract="true" name="TangentAssociatesLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets" abstract="false" name="DeferredTaxLiabilitiesOperatingRightOfUseAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_MonthlyAmortizationOfDeferredHedgeGains" abstract="false" name="MonthlyAmortizationOfDeferredHedgeGains" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_OperatingLeaseLeaseAbandonmentCharge" abstract="false" name="OperatingLeaseLeaseAbandonmentCharge" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_OperatingExpensesExcludingDepreciationAndAmortization" abstract="false" name="OperatingExpensesExcludingDepreciationAndAmortization" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_TarzanaMedicalCenterLLCMember" abstract="true" name="TarzanaMedicalCenterLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_ZPEasternLLCMember" abstract="true" name="ZPEasternLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_DignityHealthMember" abstract="true" name="DignityHealthMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_LeverageRatioThreeMember" abstract="true" name="LeverageRatioThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_Medicare1Member" abstract="true" name="Medicare1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_DebtInstrumentExtensionPeriod" abstract="false" name="DebtInstrumentExtensionPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="rdnt_NumberOfCentersContributed" abstract="false" name="NumberOfCentersContributed" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="rdnt_PricingLevelVMember" abstract="true" name="PricingLevelVMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_FirstLienCreditAgreementSeventhAmendmentMember" abstract="true" name="FirstLienCreditAgreementSeventhAmendmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_A2012SunriseMerrickLLCMember" abstract="true" name="A2012SunriseMerrickLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_RestatedAgreementMember" abstract="true" name="RestatedAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_LongTermIncentivePlanSharesMember" abstract="true" name="LongTermIncentivePlanSharesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_FinanceLeaseCost" abstract="false" name="FinanceLeaseCost" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_DeferredTaxLiabilitiesOutsideBasisDifference" abstract="false" name="DeferredTaxLiabilitiesOutsideBasisDifference" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution" abstract="false" name="BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_GainLossOnExtinguishmentOfDebtAndOtherExpenses" abstract="false" name="GainLossOnExtinguishmentOfDebtAndOtherExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_IFRCLLCSubsidiaryTwoMember" abstract="true" name="IFRCLLCSubsidiaryTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum" abstract="false" name="DebtInstrumentCovenantLiquidityRatioRequiredMinimum" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="rdnt_NoncontrollingInterestPercentOfOwnershipSold" abstract="false" name="NoncontrollingInterestPercentOfOwnershipSold" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="rdnt_ContingentMilestoneConsiderationMember" abstract="true" name="ContingentMilestoneConsiderationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_WeightedAverageRemainingContractualLife" abstract="true" name="WeightedAverageRemainingContractualLife" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rdnt_CovenantNotToCompeteMember" abstract="true" name="CovenantNotToCompeteMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_AssetsAndLiabilitiesLesseeTableTextBlock" abstract="false" name="AssetsAndLiabilitiesLesseeTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="rdnt_HealthCareManagementServiceMember" abstract="true" name="HealthCareManagementServiceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_MontclairMember" abstract="true" name="MontclairMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares" abstract="false" name="BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="rdnt_OperatingLeaseLiabilityDecreaseDueToAbandonment" abstract="false" name="OperatingLeaseLiabilityDecreaseDueToAbandonment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_PricingLevelIVMember" abstract="true" name="PricingLevelIVMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_BlueShieldMember" abstract="true" name="BlueShieldMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest" abstract="false" name="AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_BusinessAcquisitionContingentConsiderationMember" abstract="true" name="BusinessAcquisitionContingentConsiderationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_ZP907NorthernLLCMember" abstract="true" name="ZP907NorthernLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_LeverageRatioDomain" abstract="true" name="LeverageRatioDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_EquityMethodInvestmentSharesPurchased" abstract="false" name="EquityMethodInvestmentSharesPurchased" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="rdnt_September2020CapMember" abstract="false" name="September2020CapMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_PricingLevelIMember" abstract="true" name="PricingLevelIMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_AdjustmentToNetIncomeAttributableToAssumedShareSettlements" abstract="false" name="AdjustmentToNetIncomeAttributableToAssumedShareSettlements" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation" abstract="false" name="BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized" abstract="false" name="DeferredTaxAssetsTaxBenefitMayNotBeRealized" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" abstract="true" name="FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rdnt_ImagingCentersMember" abstract="true" name="ImagingCentersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_ContractsReceivableFactoringReceivable" abstract="false" name="ContractsReceivableFactoringReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_RepaymentOfAdvanceMedicarePayments" abstract="false" name="RepaymentOfAdvanceMedicarePayments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_QuantibMember" abstract="true" name="QuantibMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_DeferredTaxAssetsOperatingLeaseLiabilities" abstract="false" name="DeferredTaxAssetsOperatingLeaseLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_MidDelawareImagingPAMember" abstract="true" name="MidDelawareImagingPAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_NumberofUnconsolidatedJointVentures" abstract="false" name="NumberofUnconsolidatedJointVentures" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="rdnt_DRTLLCMember" abstract="true" name="DRTLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_FirstLienTermLoanMember" abstract="false" name="FirstLienTermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_PricingLevelIIIMember" abstract="true" name="PricingLevelIIIMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_AidenceMember" abstract="true" name="AidenceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_PersonalHealthImagingMember" abstract="true" name="PersonalHealthImagingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_SharesIssuedSharesSettlementOfContingentConsideration" abstract="false" name="SharesIssuedSharesSettlementOfContingentConsideration" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="rdnt_WilliamMKellyMDIncMember" abstract="true" name="WilliamMKellyMDIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_TruistMember" abstract="true" name="TruistMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_ChelseaDignosticRadiologyPCMember" abstract="true" name="ChelseaDignosticRadiologyPCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_AdjustmentsToAdditionalPaidInCapitalGainOnContributionOfAssetsToSubsidiary" abstract="false" name="AdjustmentsToAdditionalPaidInCapitalGainOnContributionOfAssetsToSubsidiary" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_PerformanceBasedStockUnitsMember" abstract="true" name="PerformanceBasedStockUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_DevelopedTechnologySoftwareMember" abstract="true" name="DevelopedTechnologySoftwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_A3235HempsteadLLCMember" abstract="true" name="A3235HempsteadLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized" abstract="false" name="UnrecognizedTaxBenefitsTaxImpactIfRecognized" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_TurnerImagingSystemsMember" abstract="true" name="TurnerImagingSystemsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_ArizonaDiagnosticsGroupMember" abstract="true" name="ArizonaDiagnosticsGroupMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate" abstract="false" name="UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest" abstract="false" name="NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_A2019SWAPS1Member" abstract="true" name="A2019SWAPS1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_HealthCarePatientServiceOtherMember" abstract="true" name="HealthCarePatientServiceOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_AcquisitionsAndAssetPurchasesMember" abstract="true" name="AcquisitionsAndAssetPurchasesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_MontclairRadiologicalAssociatesPAMember" abstract="true" name="MontclairRadiologicalAssociatesPAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_Caps2016Member" abstract="false" name="Caps2016Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_ZPBaysideLLCMember" abstract="true" name="ZPBaysideLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_LesseeLeaseTermofContract" abstract="false" name="LesseeLeaseTermofContract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="rdnt_DimensionHealthCorporationMember" abstract="true" name="DimensionHealthCorporationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_SimiValleyImagingGroupLLCMember" abstract="true" name="SimiValleyImagingGroupLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_NumberOfLocationOfferingMultiModalityServices" abstract="false" name="NumberOfLocationOfferingMultiModalityServices" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="rdnt_MedicalMalpracticeDeductiblePerIncidence" abstract="false" name="MedicalMalpracticeDeductiblePerIncidence" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" abstract="true" name="OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rdnt_COVID19PandemicMember" abstract="true" name="COVID19PandemicMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_ERADMember" abstract="true" name="ERADMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod" abstract="false" name="UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_RestatedPlanMember" abstract="false" name="RestatedPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_PatentAndTrademarksMember" abstract="true" name="PatentAndTrademarksMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_AuditorInformationAbstract" abstract="true" name="AuditorInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rdnt_SoftwareAndTeleradiologyMember" abstract="true" name="SoftwareAndTeleradiologyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_PerformanceBasedStockOptionsMember" abstract="true" name="PerformanceBasedStockOptionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued" abstract="false" name="NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_AggregateIntrinsicValue" abstract="true" name="AggregateIntrinsicValue" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneTwo" abstract="false" name="BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneTwo" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="rdnt_DebtInstrumentNumberofLoansReceived" abstract="false" name="DebtInstrumentNumberofLoansReceived" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="rdnt_CertainSellerMember" abstract="true" name="CertainSellerMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_IFRCLLCMember" abstract="true" name="IFRCLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration" abstract="false" name="BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_FrederickCountyRadiologyLLCMember" abstract="true" name="FrederickCountyRadiologyLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_SunTrustMember" abstract="true" name="SunTrustMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_AdvanceMedicarePayments" abstract="false" name="AdvanceMedicarePayments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_ScheduleOfLeverageRatioTableTextBlock" abstract="false" name="ScheduleOfLeverageRatioTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="rdnt_FixedAssetsMember" abstract="true" name="FixedAssetsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_NumberOfLocations" abstract="false" name="NumberOfLocations" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="rdnt_LineofCreditFacilityIncreaseBorrowingCapacity" abstract="false" name="LineofCreditFacilityIncreaseBorrowingCapacity" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease" abstract="false" name="DebtInstrumentPeriodicPaymentTermsAmortizationIncrease" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_October2025Member" abstract="true" name="October2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_DebtInstrumentPeriodicPaymentPercent" abstract="false" name="DebtInstrumentPeriodicPaymentPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod" abstract="false" name="BusinessCombinationContingentConsiderationLiabilityPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="rdnt_AdvancedRadiologyAtCapitalRegionLLCMember" abstract="true" name="AdvancedRadiologyAtCapitalRegionLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_SocialSecurityTaxEmployerDeferralCARESAct" abstract="false" name="SocialSecurityTaxEmployerDeferralCARESAct" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_IncreaseDecreaseInNoncashItem" abstract="false" name="IncreaseDecreaseInNoncashItem" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_Medicaid1Member" abstract="true" name="Medicaid1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_ProceedsFromGovernmentAssistance" abstract="false" name="ProceedsFromGovernmentAssistance" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_ZPLaureltonLLCMember" abstract="true" name="ZPLaureltonLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_ScriptSenderLLCMember" abstract="true" name="ScriptSenderLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_PricingLevelIIMember" abstract="true" name="PricingLevelIIMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_JointVentureWithCalvertMedicalImagingCentersLLCMember" abstract="true" name="JointVentureWithCalvertMedicalImagingCentersLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_SimiAdventistMember" abstract="true" name="SimiAdventistMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_TermLoanMember" abstract="true" name="TermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_IFRCLLCSubsidiaryOneMember" abstract="true" name="IFRCLLCSubsidiaryOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_UninsuredRisksPolicyTextBlock" abstract="false" name="UninsuredRisksPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="rdnt_ZPElmontLLCMember" abstract="true" name="ZPElmontLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_OperatingIncomeLossExcludingReliefFunding" abstract="false" name="OperatingIncomeLossExcludingReliefFunding" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_OperatingLeaseRightOfUseAssetDecreaseDueToAbandonment" abstract="false" name="OperatingLeaseRightOfUseAssetDecreaseDueToAbandonment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_LeverageRatioOneMember" abstract="true" name="LeverageRatioOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_DeepHealthIncMember" abstract="true" name="DeepHealthIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_CashFlowLesseeAbstract" abstract="true" name="CashFlowLesseeAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rdnt_JointVentureMember" abstract="true" name="JointVentureMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_EarningPerShareBasicAndDilutedAbstract" abstract="true" name="EarningPerShareBasicAndDilutedAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rdnt_BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones" abstract="false" name="BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestments" abstract="false" name="EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestments" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="rdnt_WhiteRabbitaiIncMember" abstract="true" name="WhiteRabbitaiIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_A2019SWAPSMember" abstract="true" name="A2019SWAPSMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_CashHoldbackMember" abstract="true" name="CashHoldbackMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_October2023Member" abstract="true" name="October2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock" abstract="false" name="JointVentureInvestmentAndFinancialInformationTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="rdnt_MedicVisionMember" abstract="false" name="MedicVisionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_WorkersCompensationPersonalInjury1Member" abstract="true" name="WorkersCompensationPersonalInjury1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_ProceedsFromProviderReliefFunding" abstract="false" name="ProceedsFromProviderReliefFunding" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_ImagingCenterSegmentRevenueMember" abstract="true" name="ImagingCenterSegmentRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_GlendaleAdvancedImagingMember" abstract="true" name="GlendaleAdvancedImagingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_AIMember" abstract="true" name="AIMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="rdnt_HeartAndLungImagingLimitedMember" abstract="true" name="HeartAndLungImagingLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_ZPSmithLLCMember" abstract="true" name="ZPSmithLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_ManagementServiceFees" abstract="false" name="ManagementServiceFees" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_PaycheckProtectionProgramLoansMember" abstract="true" name="PaycheckProtectionProgramLoansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_LeverageRatioFiveMember" abstract="true" name="LeverageRatioFiveMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_ForeignOperatingLossCarryforwardsSubjectToExpiration" abstract="false" name="ForeignOperatingLossCarryforwardsSubjectToExpiration" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_PropertyPlantAndEquipmentNetIncludingRightOfUseAssets" abstract="false" name="PropertyPlantAndEquipmentNetIncludingRightOfUseAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_JointVentureInterestMember" abstract="true" name="JointVentureInterestMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_NorthJerseyImagingCenterLLCMember" abstract="true" name="NorthJerseyImagingCenterLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_ForeignOperatingLossCarryforwardsNotSubjectToExpiration" abstract="false" name="ForeignOperatingLossCarryforwardsNotSubjectToExpiration" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_BusinessAcquisitionsMember" abstract="true" name="BusinessAcquisitionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_LeverageRatioTwoMember" abstract="true" name="LeverageRatioTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_FirstLienCreditAgreementSixthAmendmentMember" abstract="true" name="FirstLienCreditAgreementSixthAmendmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_ManagementServiceContractsMember" abstract="true" name="ManagementServiceContractsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_CommercialInsurance1Member" abstract="true" name="CommercialInsurance1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_LeasesWeightedAverageDiscountRateAbstract" abstract="true" name="LeasesWeightedAverageDiscountRateAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rdnt_ProceedsFromSaleOfInterestInMinorityShareholders" abstract="false" name="ProceedsFromSaleOfInterestInMinorityShareholders" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_BroadwayMedicalImagingLLCMember" abstract="true" name="BroadwayMedicalImagingLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_BusinessCombinationNumberOfSubsidiariesAcquired" abstract="false" name="BusinessCombinationNumberOfSubsidiariesAcquired" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="rdnt_FirstLienCreditAgreementEighthAmendmentMember" abstract="true" name="FirstLienCreditAgreementEighthAmendmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="rdnt_DebtInstrumentLeverageRatio" abstract="false" name="DebtInstrumentLeverageRatio" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount" abstract="false" name="LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_EffectiveIncomeTaxRateReconciliationPPPLoanAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationPPPLoanAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_PatientServicesNetMember" abstract="true" name="PatientServicesNetMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_DebtInstrumentCovenantLeverageRatioMaximum" abstract="false" name="DebtInstrumentCovenantLeverageRatioMaximum" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="rdnt_SLZMRealtyLLCMember" abstract="true" name="SLZMRealtyLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_KeyFinancialDataForJointVentures" abstract="true" name="KeyFinancialDataForJointVentures" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rdnt_CapitationArrangementsMember" abstract="true" name="CapitationArrangementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" abstract="true" name="RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rdnt_NumberOfAssetsSold" abstract="false" name="NumberOfAssetsSold" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="rdnt_OtherSellersMember" abstract="true" name="OtherSellersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_DebtInstrumentNumberOfAmendments" abstract="false" name="DebtInstrumentNumberOfAmendments" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="rdnt_October2020CapMember" abstract="false" name="October2020CapMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct" abstract="false" name="IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_FirstLienCreditAgreementMember" abstract="true" name="FirstLienCreditAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_RavenHoldingsMember" abstract="true" name="RavenHoldingsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_FutureServiceMember" abstract="true" name="FutureServiceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_EquityContributionsInExistingAndPurchaseOfInterestInJointVentures" abstract="false" name="EquityContributionsInExistingAndPurchaseOfInterestInJointVentures" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneOne" abstract="false" name="BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneOne" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="rdnt_ZPParkchesterLLCMember" abstract="true" name="ZPParkchesterLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_CaresActRefundableClaimPercentage" abstract="false" name="CaresActRefundableClaimPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward" abstract="true" name="InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rdnt_WeightedAverageRemainingLeaseTermAbstract" abstract="true" name="WeightedAverageRemainingLeaseTermAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rdnt_BarclaysMember" abstract="true" name="BarclaysMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_MedicalInsuranceStopLossPolicyClaimAmount" abstract="false" name="MedicalInsuranceStopLossPolicyClaimAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_ZPFreeportLLCMember" abstract="true" name="ZPFreeportLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_WestValleyImagingGroupLLCMember" abstract="true" name="WestValleyImagingGroupLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_EquityMethodInvestmentAdditionalContribution" abstract="false" name="EquityMethodInvestmentAdditionalContribution" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_A60thStreetMRILLCMember" abstract="true" name="A60thStreetMRILLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_ScheduleOfForeignCurrencyTranslationAmountsTableTextBlock" abstract="false" name="ScheduleOfForeignCurrencyTranslationAmountsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="rdnt_FrederickHealthHospitalIncMember" abstract="true" name="FrederickHealthHospitalIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>10
<FILENAME>rdnt-20221231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:ee66d8ee-1013-4282-8e3e-c307b1c04f3f,g:1b6e48fd-cb3e-498b-b299-6015491264f8-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="rdnt-20221231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_8f890216-edc4-492e-bf18-2a6a639e8cd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_3391e4bc-f2d4-4855-a7d6-f64de4816c8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8f890216-edc4-492e-bf18-2a6a639e8cd7" xlink:to="loc_us-gaap_AssetsCurrent_3391e4bc-f2d4-4855-a7d6-f64de4816c8c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PropertyPlantAndEquipmentNetIncludingRightOfUseAssets_43506c0c-7b6d-4401-a157-5f7a68611d99" xlink:href="rdnt-20221231.xsd#rdnt_PropertyPlantAndEquipmentNetIncludingRightOfUseAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8f890216-edc4-492e-bf18-2a6a639e8cd7" xlink:to="loc_rdnt_PropertyPlantAndEquipmentNetIncludingRightOfUseAssets_43506c0c-7b6d-4401-a157-5f7a68611d99" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_3d1dc8cf-4b06-4297-a147-70924c5e002c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8f890216-edc4-492e-bf18-2a6a639e8cd7" xlink:to="loc_us-gaap_Goodwill_3d1dc8cf-4b06-4297-a147-70924c5e002c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_48ca7582-1e03-4478-baf1-e26ca23b54df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8f890216-edc4-492e-bf18-2a6a639e8cd7" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_48ca7582-1e03-4478-baf1-e26ca23b54df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_9c37df46-377b-47e4-91cb-554d197e6c11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNoncurrentNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8f890216-edc4-492e-bf18-2a6a639e8cd7" xlink:to="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_9c37df46-377b-47e4-91cb-554d197e6c11" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_8120db9b-6836-47ab-af05-fede416afc16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8f890216-edc4-492e-bf18-2a6a639e8cd7" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_8120db9b-6836-47ab-af05-fede416afc16" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_cc12a31e-39ec-455b-8620-fd2a49f9da69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8f890216-edc4-492e-bf18-2a6a639e8cd7" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_cc12a31e-39ec-455b-8620-fd2a49f9da69" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositsAssets_ebd8cf51-9da2-4f24-8299-c785a33462fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepositsAssets"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_8f890216-edc4-492e-bf18-2a6a639e8cd7" xlink:to="loc_us-gaap_DepositsAssets_ebd8cf51-9da2-4f24-8299-c785a33462fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_fc80f296-984a-4a11-a715-913ecd13ca80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_30306f6b-f588-4769-a227-222aee4af487" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_fc80f296-984a-4a11-a715-913ecd13ca80" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_30306f6b-f588-4769-a227-222aee4af487" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_6a0fa784-9dbc-42c2-8fba-669aa501f705" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_fc80f296-984a-4a11-a715-913ecd13ca80" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_6a0fa784-9dbc-42c2-8fba-669aa501f705" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueFromRelatedPartiesCurrent_64ab8b1f-fa44-4c7e-ae78-53e5c519c6e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueFromRelatedPartiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_fc80f296-984a-4a11-a715-913ecd13ca80" xlink:to="loc_us-gaap_DueFromRelatedPartiesCurrent_64ab8b1f-fa44-4c7e-ae78-53e5c519c6e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_6b6e4ec4-fc16-49fe-a1eb-6a2ae49e4b68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_fc80f296-984a-4a11-a715-913ecd13ca80" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_6b6e4ec4-fc16-49fe-a1eb-6a2ae49e4b68" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_0d2d7b3d-04f2-40c5-ad26-1cff8d7fdbc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_ef04d0b9-77c6-43c0-a43d-e8254eddac36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_0d2d7b3d-04f2-40c5-ad26-1cff8d7fdbc3" xlink:to="loc_us-gaap_CommonStockValue_ef04d0b9-77c6-43c0-a43d-e8254eddac36" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_4cf962a9-293f-4bf8-8d14-54d2d298b933" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_0d2d7b3d-04f2-40c5-ad26-1cff8d7fdbc3" xlink:to="loc_us-gaap_AdditionalPaidInCapital_4cf962a9-293f-4bf8-8d14-54d2d298b933" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_8a57851c-a11b-40ac-92f8-b6079fc716e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_0d2d7b3d-04f2-40c5-ad26-1cff8d7fdbc3" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_8a57851c-a11b-40ac-92f8-b6079fc716e9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_c6d34ca8-308d-4e55-99f0-8d19f0245a8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_0d2d7b3d-04f2-40c5-ad26-1cff8d7fdbc3" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_c6d34ca8-308d-4e55-99f0-8d19f0245a8e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PropertyPlantAndEquipmentNetIncludingRightOfUseAssets_d2f88a05-4409-4a88-91c6-d2a525a72629" xlink:href="rdnt-20221231.xsd#rdnt_PropertyPlantAndEquipmentNetIncludingRightOfUseAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_2010ff74-6e9e-4406-afa3-62b595aea9cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_rdnt_PropertyPlantAndEquipmentNetIncludingRightOfUseAssets_d2f88a05-4409-4a88-91c6-d2a525a72629" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_2010ff74-6e9e-4406-afa3-62b595aea9cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_075603e1-1f55-4d95-a0d9-5a900caf2eb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_rdnt_PropertyPlantAndEquipmentNetIncludingRightOfUseAssets_d2f88a05-4409-4a88-91c6-d2a525a72629" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_075603e1-1f55-4d95-a0d9-5a900caf2eb1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_5e2d2f9c-0b7b-4491-a7ce-114aef4c5b00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_d08be282-08be-4740-b13c-90b16495bc35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_5e2d2f9c-0b7b-4491-a7ce-114aef4c5b00" xlink:to="loc_us-gaap_Liabilities_d08be282-08be-4740-b13c-90b16495bc35" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a4863bec-cd54-425b-aed3-42de79358d50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_5e2d2f9c-0b7b-4491-a7ce-114aef4c5b00" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a4863bec-cd54-425b-aed3-42de79358d50" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_a6dcb2af-5d05-4304-a4b0-3eab2499d759" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_c7da2dde-3eaf-4d4a-a460-7e932d87e476" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_a6dcb2af-5d05-4304-a4b0-3eab2499d759" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_c7da2dde-3eaf-4d4a-a460-7e932d87e476" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_2d98e4c1-e131-43f3-b22e-59118f4fce3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_a6dcb2af-5d05-4304-a4b0-3eab2499d759" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_2d98e4c1-e131-43f3-b22e-59118f4fce3d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_45aed56c-6801-4344-ba6e-9f77d729b177" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_a6dcb2af-5d05-4304-a4b0-3eab2499d759" xlink:to="loc_us-gaap_LiabilitiesCurrent_45aed56c-6801-4344-ba6e-9f77d729b177" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable_d64290e3-ea3c-4196-b8ad-6aa93f9b6b7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermNotesPayable"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_a6dcb2af-5d05-4304-a4b0-3eab2499d759" xlink:to="loc_us-gaap_LongTermNotesPayable_d64290e3-ea3c-4196-b8ad-6aa93f9b6b7b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_1c19a200-5bfc-4673-a5f7-4690a0f37b85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_a6dcb2af-5d05-4304-a4b0-3eab2499d759" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_1c19a200-5bfc-4673-a5f7-4690a0f37b85" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_df3201c5-0d75-433e-8aea-ae5eadca158c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_5e0cd4c7-7a3d-42c6-8aa3-1bc2ed3d62ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_df3201c5-0d75-433e-8aea-ae5eadca158c" xlink:to="loc_us-gaap_StockholdersEquity_5e0cd4c7-7a3d-42c6-8aa3-1bc2ed3d62ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_0288aecc-8d50-423b-a151-4a06290598b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_df3201c5-0d75-433e-8aea-ae5eadca158c" xlink:to="loc_us-gaap_MinorityInterest_0288aecc-8d50-423b-a151-4a06290598b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_874dad9b-3f72-420b-82b3-94f228fc3c04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_6641df0c-c183-44f2-b35e-35a23441efee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_874dad9b-3f72-420b-82b3-94f228fc3c04" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_6641df0c-c183-44f2-b35e-35a23441efee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToAffiliateCurrent_ffa802b9-ba32-4ad4-932d-7f834aa792be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToAffiliateCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_874dad9b-3f72-420b-82b3-94f228fc3c04" xlink:to="loc_us-gaap_DueToAffiliateCurrent_ffa802b9-ba32-4ad4-932d-7f834aa792be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_9e16a21a-11da-47c5-b57b-7363def6d3bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_874dad9b-3f72-420b-82b3-94f228fc3c04" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_9e16a21a-11da-47c5-b57b-7363def6d3bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_f33f0659-5c25-4975-a9dd-d5e6af7c017c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_874dad9b-3f72-420b-82b3-94f228fc3c04" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_f33f0659-5c25-4975-a9dd-d5e6af7c017c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableCurrent_57d0f4b3-bc22-43e7-aefe-5e23617687c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_874dad9b-3f72-420b-82b3-94f228fc3c04" xlink:to="loc_us-gaap_NotesPayableCurrent_57d0f4b3-bc22-43e7-aefe-5e23617687c4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="rdnt-20221231.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b523fcc5-1693-4a6d-9f26-26ce590d078a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_a2f80c75-2cf1-4ce6-9abb-1a54d630c244" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_b523fcc5-1693-4a6d-9f26-26ce590d078a" xlink:to="loc_us-gaap_ProfitLoss_a2f80c75-2cf1-4ce6-9abb-1a54d630c244" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_4baadf83-9528-4bca-8da9-9914ca811fcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_b523fcc5-1693-4a6d-9f26-26ce590d078a" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_4baadf83-9528-4bca-8da9-9914ca811fcb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_2de80038-4453-4cf8-a961-d6b4ed483ff6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_731e9133-c785-41e6-a2d7-f969d958ddbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeveranceCosts1"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_2de80038-4453-4cf8-a961-d6b4ed483ff6" xlink:to="loc_us-gaap_SeveranceCosts1_731e9133-c785-41e6-a2d7-f969d958ddbf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnTerminationOfLease_f7eb9275-53f3-42a3-be21-c487ba523339" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnTerminationOfLease"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_2de80038-4453-4cf8-a961-d6b4ed483ff6" xlink:to="loc_us-gaap_GainLossOnTerminationOfLease_f7eb9275-53f3-42a3-be21-c487ba523339" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets_339403a8-d7ce-4b1d-8971-5f5e6c9f6d86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_2de80038-4453-4cf8-a961-d6b4ed483ff6" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets_339403a8-d7ce-4b1d-8971-5f5e6c9f6d86" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OperatingExpensesExcludingDepreciationAndAmortization_17492a89-c09c-42dc-8a0c-4f20861ab865" xlink:href="rdnt-20221231.xsd#rdnt_OperatingExpensesExcludingDepreciationAndAmortization"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_2de80038-4453-4cf8-a961-d6b4ed483ff6" xlink:to="loc_rdnt_OperatingExpensesExcludingDepreciationAndAmortization_17492a89-c09c-42dc-8a0c-4f20861ab865" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_79bc6e24-c725-449e-b965-d3864676a4c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_2de80038-4453-4cf8-a961-d6b4ed483ff6" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_79bc6e24-c725-449e-b965-d3864676a4c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_46ed03f2-5a6e-4de7-b233-24cccf1915ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_2de80038-4453-4cf8-a961-d6b4ed483ff6" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_46ed03f2-5a6e-4de7-b233-24cccf1915ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_4e4cd59f-a200-4ded-8dde-5db1d2ac57d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GainLossOnExtinguishmentOfDebtAndOtherExpenses_0ba9717d-1e70-41c0-8618-35d094c12eab" xlink:href="rdnt-20221231.xsd#rdnt_GainLossOnExtinguishmentOfDebtAndOtherExpenses"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_4e4cd59f-a200-4ded-8dde-5db1d2ac57d0" xlink:to="loc_rdnt_GainLossOnExtinguishmentOfDebtAndOtherExpenses_0ba9717d-1e70-41c0-8618-35d094c12eab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_0af44f60-d218-4c0a-bed6-1731acea0b14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_4e4cd59f-a200-4ded-8dde-5db1d2ac57d0" xlink:to="loc_us-gaap_InterestExpenseDebt_0af44f60-d218-4c0a-bed6-1731acea0b14" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_dbba296b-8027-469b-8148-c7ef649d2b09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_4e4cd59f-a200-4ded-8dde-5db1d2ac57d0" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_dbba296b-8027-469b-8148-c7ef649d2b09" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_5b605bde-70b6-48bc-8e90-e472465a9514" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_4e4cd59f-a200-4ded-8dde-5db1d2ac57d0" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_5b605bde-70b6-48bc-8e90-e472465a9514" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1_294b5a9d-50ad-41b6-b8c6-7513ae2734f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_4e4cd59f-a200-4ded-8dde-5db1d2ac57d0" xlink:to="loc_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1_294b5a9d-50ad-41b6-b8c6-7513ae2734f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_30797791-6e40-4e89-8e78-a6d37d96a274" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_332c7415-943f-4152-806e-64c4ef5873e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_30797791-6e40-4e89-8e78-a6d37d96a274" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_332c7415-943f-4152-806e-64c4ef5873e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_b6e89c68-9105-471a-afb6-8adc28ecc39f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_30797791-6e40-4e89-8e78-a6d37d96a274" xlink:to="loc_us-gaap_OperatingExpenses_b6e89c68-9105-471a-afb6-8adc28ecc39f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueNotFromContractWithCustomer_57cf0269-f117-42ca-ac48-91b659b92448" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueNotFromContractWithCustomer"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_30797791-6e40-4e89-8e78-a6d37d96a274" xlink:to="loc_us-gaap_RevenueNotFromContractWithCustomer_57cf0269-f117-42ca-ac48-91b659b92448" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_a602ac18-0d6b-4ce3-b898-70c0a325134b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_10d7e540-cfc3-43aa-bd54-5df4ccfe331a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_a602ac18-0d6b-4ce3-b898-70c0a325134b" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_10d7e540-cfc3-43aa-bd54-5df4ccfe331a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_9e7ac785-2298-4062-b88e-95539ac2a718" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_a602ac18-0d6b-4ce3-b898-70c0a325134b" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_9e7ac785-2298-4062-b88e-95539ac2a718" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="simple" xlink:href="rdnt-20221231.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_458f9d7b-dad8-4937-b28d-50ca86fbcef5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_6432c49b-f1c5-428a-84d8-60bba81a3bc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_458f9d7b-dad8-4937-b28d-50ca86fbcef5" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_6432c49b-f1c5-428a-84d8-60bba81a3bc7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_962778cb-1c09-4716-a44a-5393f22c5cef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_458f9d7b-dad8-4937-b28d-50ca86fbcef5" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_962778cb-1c09-4716-a44a-5393f22c5cef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_efabf418-e2c5-4fd5-a5db-da0079b7a91d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_7edc20d2-bfb4-4a7b-9313-4f10ae94bd6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_efabf418-e2c5-4fd5-a5db-da0079b7a91d" xlink:to="loc_us-gaap_ProfitLoss_7edc20d2-bfb4-4a7b-9313-4f10ae94bd6a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_e3ad9307-63b7-448d-a5fe-928718e8a2f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_efabf418-e2c5-4fd5-a5db-da0079b7a91d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_e3ad9307-63b7-448d-a5fe-928718e8a2f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_f164b976-499d-4545-a7bd-9c7bbb26bb4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_efabf418-e2c5-4fd5-a5db-da0079b7a91d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_f164b976-499d-4545-a7bd-9c7bbb26bb4f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_fc955a2e-4e12-4782-a5d4-31e406160424" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_efabf418-e2c5-4fd5-a5db-da0079b7a91d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_fc955a2e-4e12-4782-a5d4-31e406160424" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="rdnt-20221231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_29b5acd4-ebcb-472f-91e8-48a897a9f052" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ProceedsFromGovernmentAssistance_d1803d54-ee3c-4dc8-800c-73ca0c8aa530" xlink:href="rdnt-20221231.xsd#rdnt_ProceedsFromGovernmentAssistance"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_29b5acd4-ebcb-472f-91e8-48a897a9f052" xlink:to="loc_rdnt_ProceedsFromGovernmentAssistance_d1803d54-ee3c-4dc8-800c-73ca0c8aa530" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_ff736019-b167-4d3b-b386-9217ad9c9003" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_29b5acd4-ebcb-472f-91e8-48a897a9f052" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_ff736019-b167-4d3b-b386-9217ad9c9003" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities_0360dbcf-9e86-4dbf-909b-226bd5d37bfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_29b5acd4-ebcb-472f-91e8-48a897a9f052" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities_0360dbcf-9e86-4dbf-909b-226bd5d37bfa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_ac723a05-4875-486f-9d8c-5190067e977c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_29b5acd4-ebcb-472f-91e8-48a897a9f052" xlink:to="loc_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_ac723a05-4875-486f-9d8c-5190067e977c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_dcc7dfb4-919e-43f5-abbb-040ecb1e5a65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_29b5acd4-ebcb-472f-91e8-48a897a9f052" xlink:to="loc_us-gaap_RepaymentsOfDebt_dcc7dfb4-919e-43f5-abbb-040ecb1e5a65" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_45716fc8-f48e-4009-9b93-1ebba5dac8da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_29b5acd4-ebcb-472f-91e8-48a897a9f052" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_45716fc8-f48e-4009-9b93-1ebba5dac8da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_bcf6addc-c1e0-4dae-8135-66cbc9ff5451" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_29b5acd4-ebcb-472f-91e8-48a897a9f052" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_bcf6addc-c1e0-4dae-8135-66cbc9ff5451" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_24212195-33f9-4235-81e7-7be48b2c98cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_29b5acd4-ebcb-472f-91e8-48a897a9f052" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_24212195-33f9-4235-81e7-7be48b2c98cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_6204010f-91d7-4985-8a23-7d492477c3ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_29b5acd4-ebcb-472f-91e8-48a897a9f052" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_6204010f-91d7-4985-8a23-7d492477c3ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_a2c13d73-9ee6-473c-8cd3-f5d89ec1dfcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_29b5acd4-ebcb-472f-91e8-48a897a9f052" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_a2c13d73-9ee6-473c-8cd3-f5d89ec1dfcc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a25aee78-da84-4ee6-9829-0357b33aae51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_7288acf8-458f-4976-94c9-2335c9a9fc5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a25aee78-da84-4ee6-9829-0357b33aae51" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_7288acf8-458f-4976-94c9-2335c9a9fc5f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_4f704711-c551-4b93-8bf5-26adecbb57c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a25aee78-da84-4ee6-9829-0357b33aae51" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_4f704711-c551-4b93-8bf5-26adecbb57c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_a55705a4-303f-4269-9068-206cca62dcb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a25aee78-da84-4ee6-9829-0357b33aae51" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_a55705a4-303f-4269-9068-206cca62dcb8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_99a13101-ef11-4ee6-be19-b765a73900e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a25aee78-da84-4ee6-9829-0357b33aae51" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_99a13101-ef11-4ee6-be19-b765a73900e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_8768c0e0-1a26-4a02-8542-7b6dc99bc532" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a25aee78-da84-4ee6-9829-0357b33aae51" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_8768c0e0-1a26-4a02-8542-7b6dc99bc532" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_d2e48217-c274-479e-9793-e0d8d42a5d2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a25aee78-da84-4ee6-9829-0357b33aae51" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_d2e48217-c274-479e-9793-e0d8d42a5d2e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_6ff9fa65-6388-402d-9655-47685c5135db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a25aee78-da84-4ee6-9829-0357b33aae51" xlink:to="loc_us-gaap_ProfitLoss_6ff9fa65-6388-402d-9655-47685c5135db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_03bad208-fca8-4701-acef-f64bbb37dbdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a25aee78-da84-4ee6-9829-0357b33aae51" xlink:to="loc_us-gaap_ShareBasedCompensation_03bad208-fca8-4701-acef-f64bbb37dbdf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_62ec9f6d-f991-497b-a483-a56c43fa7a9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a25aee78-da84-4ee6-9829-0357b33aae51" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_62ec9f6d-f991-497b-a483-a56c43fa7a9b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDeferredHedgeGains_39387a45-91e3-4fb1-835e-a853195f3627" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfDeferredHedgeGains"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a25aee78-da84-4ee6-9829-0357b33aae51" xlink:to="loc_us-gaap_AmortizationOfDeferredHedgeGains_39387a45-91e3-4fb1-835e-a853195f3627" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_80aa5704-21ba-4466-b576-2c0e12b42a15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a25aee78-da84-4ee6-9829-0357b33aae51" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_80aa5704-21ba-4466-b576-2c0e12b42a15" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_IncreaseDecreaseInNoncashItem_4ea3211f-be84-4ed2-b4a3-1a2cf33bd9f1" xlink:href="rdnt-20221231.xsd#rdnt_IncreaseDecreaseInNoncashItem"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a25aee78-da84-4ee6-9829-0357b33aae51" xlink:to="loc_rdnt_IncreaseDecreaseInNoncashItem_4ea3211f-be84-4ed2-b4a3-1a2cf33bd9f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets_09fb373e-be9e-40e0-9079-7e2d7b88d390" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a25aee78-da84-4ee6-9829-0357b33aae51" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets_09fb373e-be9e-40e0-9079-7e2d7b88d390" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_9a2f8a38-23f7-4fab-91df-d36b495edec3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a25aee78-da84-4ee6-9829-0357b33aae51" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_9a2f8a38-23f7-4fab-91df-d36b495edec3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_4f2ea70c-5854-49f1-81be-9a91042605ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a25aee78-da84-4ee6-9829-0357b33aae51" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_4f2ea70c-5854-49f1-81be-9a91042605ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_fa2c8f75-c914-45e3-bde4-9cb1bd5986b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="16" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a25aee78-da84-4ee6-9829-0357b33aae51" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_fa2c8f75-c914-45e3-bde4-9cb1bd5986b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnDerivatives_7bb4f96e-7f1c-4115-8e65-769ac7888e47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnDerivatives"/>
    <link:calculationArc order="17" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a25aee78-da84-4ee6-9829-0357b33aae51" xlink:to="loc_us-gaap_UnrealizedGainLossOnDerivatives_7bb4f96e-7f1c-4115-8e65-769ac7888e47" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_d7ea7be8-0bff-4421-8801-2e443a89f829" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="18" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a25aee78-da84-4ee6-9829-0357b33aae51" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_d7ea7be8-0bff-4421-8801-2e443a89f829" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_4fe7d2a5-5876-4b9e-8636-c55660753c48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets"/>
    <link:calculationArc order="19" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a25aee78-da84-4ee6-9829-0357b33aae51" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_4fe7d2a5-5876-4b9e-8636-c55660753c48" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnTerminationOfLease_13ccce04-ddf5-4b6f-8c0d-0a3819f37b09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnTerminationOfLease"/>
    <link:calculationArc order="20" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a25aee78-da84-4ee6-9829-0357b33aae51" xlink:to="loc_us-gaap_GainLossOnTerminationOfLease_13ccce04-ddf5-4b6f-8c0d-0a3819f37b09" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_9544e0de-4ea4-4ce8-98c5-4106bbda694d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:calculationArc order="21" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a25aee78-da84-4ee6-9829-0357b33aae51" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_9544e0de-4ea4-4ce8-98c5-4106bbda694d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5daf3737-6efe-4ef1-a57c-0a3a8c5d30c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInJointVenture_0de4ab02-3b9e-4675-8bc6-0b76f66e081e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireInterestInJointVenture"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5daf3737-6efe-4ef1-a57c-0a3a8c5d30c3" xlink:to="loc_us-gaap_PaymentsToAcquireInterestInJointVenture_0de4ab02-3b9e-4675-8bc6-0b76f66e081e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBuildings_bbc4e0e5-d293-44b3-b4c9-ab4ac0bd3f05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBuildings"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5daf3737-6efe-4ef1-a57c-0a3a8c5d30c3" xlink:to="loc_us-gaap_PaymentsToAcquireBuildings_bbc4e0e5-d293-44b3-b4c9-ab4ac0bd3f05" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment_328b8994-26c9-47eb-8900-03ca0f836c34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5daf3737-6efe-4ef1-a57c-0a3a8c5d30c3" xlink:to="loc_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment_328b8994-26c9-47eb-8900-03ca0f836c34" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_c6b2d0f4-5360-4a98-8614-e2f24873122e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5daf3737-6efe-4ef1-a57c-0a3a8c5d30c3" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_c6b2d0f4-5360-4a98-8614-e2f24873122e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_0700f715-a495-47f9-814e-5c46e394f428" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5daf3737-6efe-4ef1-a57c-0a3a8c5d30c3" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_0700f715-a495-47f9-814e-5c46e394f428" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f48de7b6-46ba-49b2-8e81-49ed0f5fd4bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7d175484-eaf6-4120-89fe-fe454c53475f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f48de7b6-46ba-49b2-8e81-49ed0f5fd4bd" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7d175484-eaf6-4120-89fe-fe454c53475f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_df4dc5b7-874f-440e-97b7-1c8978453930" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f48de7b6-46ba-49b2-8e81-49ed0f5fd4bd" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_df4dc5b7-874f-440e-97b7-1c8978453930" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_954543c1-9352-4b15-963e-ec71e4060f10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f48de7b6-46ba-49b2-8e81-49ed0f5fd4bd" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_954543c1-9352-4b15-963e-ec71e4060f10" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_530cf1f9-e76a-4c98-b169-e59a2d23bdb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f48de7b6-46ba-49b2-8e81-49ed0f5fd4bd" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_530cf1f9-e76a-4c98-b169-e59a2d23bdb6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare" xlink:type="simple" xlink:href="rdnt-20221231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a1835eeb-5d7e-49d2-8393-7f29f4e470b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_4eaa2bde-0393-4fae-9674-6cc06b96b6d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a1835eeb-5d7e-49d2-8393-7f29f4e470b2" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_4eaa2bde-0393-4fae-9674-6cc06b96b6d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_d362f906-9e9a-4fa4-8146-8f600d06cb60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesRestrictedStock"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a1835eeb-5d7e-49d2-8393-7f29f4e470b2" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_d362f906-9e9a-4fa4-8146-8f600d06cb60" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_bd48e9a4-296b-4ada-be6d-ed2a72d417ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a1835eeb-5d7e-49d2-8393-7f29f4e470b2" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_bd48e9a4-296b-4ada-be6d-ed2a72d417ff" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures" xlink:type="simple" xlink:href="rdnt-20221231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentAggregateCost_6c5a77a0-2c7b-41fc-af39-7d28271b9eca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_607e3d5e-0e84-4304-9bf4-0ec1854bf737" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EquityMethodInvestmentAggregateCost_6c5a77a0-2c7b-41fc-af39-7d28271b9eca" xlink:to="loc_us-gaap_AssetsCurrent_607e3d5e-0e84-4304-9bf4-0ec1854bf737" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent_6ac0c11b-98e4-42eb-85d2-e0ca28c988c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EquityMethodInvestmentAggregateCost_6c5a77a0-2c7b-41fc-af39-7d28271b9eca" xlink:to="loc_us-gaap_AssetsNoncurrent_6ac0c11b-98e4-42eb-85d2-e0ca28c988c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_b3d1051a-8127-4526-991b-8f602aae8363" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EquityMethodInvestmentAggregateCost_6c5a77a0-2c7b-41fc-af39-7d28271b9eca" xlink:to="loc_us-gaap_LiabilitiesCurrent_b3d1051a-8127-4526-991b-8f602aae8363" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_e9355333-d541-4d05-aef5-e438a7bb4eb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EquityMethodInvestmentAggregateCost_6c5a77a0-2c7b-41fc-af39-7d28271b9eca" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_e9355333-d541-4d05-aef5-e438a7bb4eb9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsandLiabilitiesAssumed" xlink:type="simple" xlink:href="rdnt-20221231.xsd#BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsandLiabilitiesAssumed"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsandLiabilitiesAssumed" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_7fd15898-d7f0-4e21-9c0f-be01e1940531" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_b949c109-33f0-42df-81c3-821641baa249" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_7fd15898-d7f0-4e21-9c0f-be01e1940531" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_b949c109-33f0-42df-81c3-821641baa249" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_bc84f8d4-dbf3-4e30-b6b2-bb060970fa6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_7fd15898-d7f0-4e21-9c0f-be01e1940531" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_bc84f8d4-dbf3-4e30-b6b2-bb060970fa6a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset_69a04e63-2b55-4985-811d-17112b0429ba" xlink:href="rdnt-20221231.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_7fd15898-d7f0-4e21-9c0f-be01e1940531" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset_69a04e63-2b55-4985-811d-17112b0429ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities_cd047930-b026-42e2-99c4-d56f41e4251e" xlink:href="rdnt-20221231.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_7fd15898-d7f0-4e21-9c0f-be01e1940531" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities_cd047930-b026-42e2-99c4-d56f41e4251e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther_34cae66a-4d21-46f0-adc8-ab87933d1740" xlink:href="rdnt-20221231.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_7fd15898-d7f0-4e21-9c0f-be01e1940531" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther_34cae66a-4d21-46f0-adc8-ab87933d1740" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_3f6c8f3c-d1e0-4279-b9d0-beb5acd35743" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_7fd15898-d7f0-4e21-9c0f-be01e1940531" xlink:to="loc_us-gaap_Goodwill_3f6c8f3c-d1e0-4279-b9d0-beb5acd35743" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule" xlink:type="simple" xlink:href="rdnt-20221231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_67497265-513d-40c2-8257-e7f66fe08c69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_35811d3e-480c-4155-8db7-c329cdebdc09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_67497265-513d-40c2-8257-e7f66fe08c69" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_35811d3e-480c-4155-8db7-c329cdebdc09" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_dac4cb1f-18a1-4beb-a44e-c4d86e365a1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_67497265-513d-40c2-8257-e7f66fe08c69" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_dac4cb1f-18a1-4beb-a44e-c4d86e365a1e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_277e4964-b54c-438f-a74e-0368c5677582" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_64668fc1-0ef6-404b-8806-c227e46d40f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_277e4964-b54c-438f-a74e-0368c5677582" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_64668fc1-0ef6-404b-8806-c227e46d40f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_8f97bf55-4c18-40b8-9dff-f200a74c3aea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_277e4964-b54c-438f-a74e-0368c5677582" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_8f97bf55-4c18-40b8-9dff-f200a74c3aea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_076c150d-cc97-4b59-80c2-5cab0fbf798a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_277e4964-b54c-438f-a74e-0368c5677582" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_076c150d-cc97-4b59-80c2-5cab0fbf798a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_915ed7d9-f603-46bb-b6ed-199bef9dea68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_277e4964-b54c-438f-a74e-0368c5677582" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_915ed7d9-f603-46bb-b6ed-199bef9dea68" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_2192c86a-ccf4-43fa-9ecd-b2f60ba82f85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_277e4964-b54c-438f-a74e-0368c5677582" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_2192c86a-ccf4-43fa-9ecd-b2f60ba82f85" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_16ed29de-3eee-4cbe-a463-d9ac2452b3b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_277e4964-b54c-438f-a74e-0368c5677582" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_16ed29de-3eee-4cbe-a463-d9ac2452b3b6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetails" xlink:type="simple" xlink:href="rdnt-20221231.xsd#PROPERTYANDEQUIPMENTDetails"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_c90ab845-7aea-4871-8d42-7f9a704696eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_3c4d0ac0-211c-4925-b509-56e64134f534" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_c90ab845-7aea-4871-8d42-7f9a704696eb" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_3c4d0ac0-211c-4925-b509-56e64134f534" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_ad438758-f636-4360-8de2-b53f291d8f01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_c90ab845-7aea-4871-8d42-7f9a704696eb" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_ad438758-f636-4360-8de2-b53f291d8f01" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_f1729cfd-7f67-4b86-a6ca-64c4629b3659" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_45b8b67e-24b3-46ee-946b-d7dc5c5cf572" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_f1729cfd-7f67-4b86-a6ca-64c4629b3659" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_45b8b67e-24b3-46ee-946b-d7dc5c5cf572" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_c4362cbb-9d73-4851-982d-9544678e6bcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_f1729cfd-7f67-4b86-a6ca-64c4629b3659" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_c4362cbb-9d73-4851-982d-9544678e6bcb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt" xlink:type="simple" xlink:href="rdnt-20221231.xsd#CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_a499d97b-4d03-408f-887f-2c85570632b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_5a4f4448-b036-430b-a9c7-cbf9202bb277" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_a499d97b-4d03-408f-887f-2c85570632b0" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_5a4f4448-b036-430b-a9c7-cbf9202bb277" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_448a5890-b4dc-4898-a69c-16a0542760a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_a499d97b-4d03-408f-887f-2c85570632b0" xlink:to="loc_us-gaap_LongTermDebtCurrent_448a5890-b4dc-4898-a69c-16a0542760a3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAnnualNotePayableMaturities" xlink:type="simple" xlink:href="rdnt-20221231.xsd#CREDITFACILITIESANDNOTESPAYABLEDetailsAnnualNotePayableMaturities"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAnnualNotePayableMaturities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_68541015-b3fd-4efa-9394-911aef0b6ff3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_b123499a-40da-4f37-87de-b1a5e133e3e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_68541015-b3fd-4efa-9394-911aef0b6ff3" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_b123499a-40da-4f37-87de-b1a5e133e3e9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_9f146123-9d19-4258-acac-a5878622dfff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_68541015-b3fd-4efa-9394-911aef0b6ff3" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_9f146123-9d19-4258-acac-a5878622dfff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_b761c969-3765-4794-9ede-287c529ec2f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_68541015-b3fd-4efa-9394-911aef0b6ff3" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_b761c969-3765-4794-9ede-287c529ec2f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_7efb41ac-4c77-4773-90fc-604597401f63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_68541015-b3fd-4efa-9394-911aef0b6ff3" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_7efb41ac-4c77-4773-90fc-604597401f63" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_31b353e2-e67f-40a2-8c06-4d3533b34952" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_68541015-b3fd-4efa-9394-911aef0b6ff3" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_31b353e2-e67f-40a2-8c06-4d3533b34952" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_ecea90b1-1ee5-4d67-b0a2-c3706a2b377a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_68541015-b3fd-4efa-9394-911aef0b6ff3" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_ecea90b1-1ee5-4d67-b0a2-c3706a2b377a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/LEASESDetailsLeaseCost" xlink:type="simple" xlink:href="rdnt-20221231.xsd#LEASESDetailsLeaseCost"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/LEASESDetailsLeaseCost" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FinanceLeaseCost_eb576f9f-18a7-43b1-a25f-2a581f7e9456" xlink:href="rdnt-20221231.xsd#rdnt_FinanceLeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_854d62e0-8f33-49e4-b065-028c56c0dddc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_rdnt_FinanceLeaseCost_eb576f9f-18a7-43b1-a25f-2a581f7e9456" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_854d62e0-8f33-49e4-b065-028c56c0dddc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_b89d814a-a60c-4054-ac57-3c8edc73907d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_rdnt_FinanceLeaseCost_eb576f9f-18a7-43b1-a25f-2a581f7e9456" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_b89d814a-a60c-4054-ac57-3c8edc73907d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet" xlink:type="simple" xlink:href="rdnt-20221231.xsd#LEASESDetailsSupplementalBalanceSheet"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_f4deb8a7-71a5-46d8-8f01-7604e1a01567" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_de307b82-ad3b-456a-bd73-10be074dfaaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_f4deb8a7-71a5-46d8-8f01-7604e1a01567" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_de307b82-ad3b-456a-bd73-10be074dfaaa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_3b502639-43fa-47a7-9386-1ac392cae3a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_f4deb8a7-71a5-46d8-8f01-7604e1a01567" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_3b502639-43fa-47a7-9386-1ac392cae3a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_3d87c746-6108-490a-8adc-bd6cf8571135" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_a4bbb08c-9a27-4f59-925c-fb03714fe824" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset_3d87c746-6108-490a-8adc-bd6cf8571135" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_a4bbb08c-9a27-4f59-925c-fb03714fe824" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization_f2507907-82d3-42c1-834d-1905b4402fc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset_3d87c746-6108-490a-8adc-bd6cf8571135" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization_f2507907-82d3-42c1-834d-1905b4402fc5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease" xlink:type="simple" xlink:href="rdnt-20221231.xsd#LEASESDetailsMaturitiesofOperatingandFinanceLease"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_86113d76-ee03-4175-9e8e-85e4d4b4f156" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_8d6aa88b-d523-4e69-bdc6-110afd81b85e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_86113d76-ee03-4175-9e8e-85e4d4b4f156" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_8d6aa88b-d523-4e69-bdc6-110afd81b85e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_71b2e499-4421-44b1-b569-ff610386c218" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_86113d76-ee03-4175-9e8e-85e4d4b4f156" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_71b2e499-4421-44b1-b569-ff610386c218" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_61eab601-4d7c-4f75-b91d-ac85b58b24eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_86113d76-ee03-4175-9e8e-85e4d4b4f156" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_61eab601-4d7c-4f75-b91d-ac85b58b24eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_5d49ba42-d5a2-49f9-b2db-c09646aa8848" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_86113d76-ee03-4175-9e8e-85e4d4b4f156" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_5d49ba42-d5a2-49f9-b2db-c09646aa8848" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_2a86a997-40af-42a8-b583-c585184d37eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_86113d76-ee03-4175-9e8e-85e4d4b4f156" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_2a86a997-40af-42a8-b583-c585184d37eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_6ebb5190-bb14-46f2-ae94-89d35585962a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_86113d76-ee03-4175-9e8e-85e4d4b4f156" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_6ebb5190-bb14-46f2-ae94-89d35585962a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease_1" xlink:type="simple" xlink:href="rdnt-20221231.xsd#LEASESDetailsMaturitiesofOperatingandFinanceLease_1"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_cbb981bb-488c-41ee-80f5-7a723840c242" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_ca644c20-234d-4aea-848f-8edf794e7bca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_cbb981bb-488c-41ee-80f5-7a723840c242" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_ca644c20-234d-4aea-848f-8edf794e7bca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_5ffa8b90-39d8-431a-939e-0230180ed359" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_cbb981bb-488c-41ee-80f5-7a723840c242" xlink:to="loc_us-gaap_OperatingLeaseLiability_5ffa8b90-39d8-431a-939e-0230180ed359" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/INCOMETAXESDetailsIncomeLossBeforeIncomeTaxes" xlink:type="simple" xlink:href="rdnt-20221231.xsd#INCOMETAXESDetailsIncomeLossBeforeIncomeTaxes"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/INCOMETAXESDetailsIncomeLossBeforeIncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_68432ee9-76e0-43f6-86e8-843c66993990" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_c33fbe57-6cf9-420e-b59f-e0ab2473da22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_68432ee9-76e0-43f6-86e8-843c66993990" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_c33fbe57-6cf9-420e-b59f-e0ab2473da22" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_1330c8e2-1171-40a9-afec-d84ffedb5a3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_68432ee9-76e0-43f6-86e8-843c66993990" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_1330c8e2-1171-40a9-afec-d84ffedb5a3d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/INCOMETAXESDetailsIncomeTaxExpense" xlink:type="simple" xlink:href="rdnt-20221231.xsd#INCOMETAXESDetailsIncomeTaxExpense"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/INCOMETAXESDetailsIncomeTaxExpense" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_76398f1b-fb6a-43f2-b541-51d73f9d1a8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_e0cbd57d-ac66-46a8-839c-35291df5d126" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_76398f1b-fb6a-43f2-b541-51d73f9d1a8d" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_e0cbd57d-ac66-46a8-839c-35291df5d126" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_eae9c779-2771-481f-bd4a-eed018fbbfe8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_76398f1b-fb6a-43f2-b541-51d73f9d1a8d" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_eae9c779-2771-481f-bd4a-eed018fbbfe8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_4ffeceec-a767-40f2-9635-c1a6f6eb4ad6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_76398f1b-fb6a-43f2-b541-51d73f9d1a8d" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_4ffeceec-a767-40f2-9635-c1a6f6eb4ad6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_e9ab52fe-d56d-422c-b719-84372175b0f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_76398f1b-fb6a-43f2-b541-51d73f9d1a8d" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_e9ab52fe-d56d-422c-b719-84372175b0f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_eca41616-d339-4ff0-b614-c3ecdd1ea575" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_76398f1b-fb6a-43f2-b541-51d73f9d1a8d" xlink:to="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_eca41616-d339-4ff0-b614-c3ecdd1ea575" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_11f87466-47a2-4ff2-9a72-166a308a7496" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_76398f1b-fb6a-43f2-b541-51d73f9d1a8d" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_11f87466-47a2-4ff2-9a72-166a308a7496" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/INCOMETAXESDetailsReconciliationoftheStatutoryUSFederalRateandEffectiveRates" xlink:type="simple" xlink:href="rdnt-20221231.xsd#INCOMETAXESDetailsReconciliationoftheStatutoryUSFederalRateandEffectiveRates"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/INCOMETAXESDetailsReconciliationoftheStatutoryUSFederalRateandEffectiveRates" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_8d92838f-af79-4059-80e6-fe5f3e01d5c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_6ddb6430-9e2d-4cdc-b3cc-f911f581230d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_8d92838f-af79-4059-80e6-fe5f3e01d5c9" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_6ddb6430-9e2d-4cdc-b3cc-f911f581230d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_c9aad719-618c-4e42-8660-9a8630e5fa45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_8d92838f-af79-4059-80e6-fe5f3e01d5c9" xlink:to="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_c9aad719-618c-4e42-8660-9a8630e5fa45" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_43267344-a17d-4582-8007-fb9387e30f08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_8d92838f-af79-4059-80e6-fe5f3e01d5c9" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_43267344-a17d-4582-8007-fb9387e30f08" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_112ce9e2-4b2e-4988-b878-f04a9ca55de5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_8d92838f-af79-4059-80e6-fe5f3e01d5c9" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_112ce9e2-4b2e-4988-b878-f04a9ca55de5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_84698b62-fbde-4731-a4c2-f5f92c6561a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_8d92838f-af79-4059-80e6-fe5f3e01d5c9" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_84698b62-fbde-4731-a4c2-f5f92c6561a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_3d59b29e-8dd6-426e-aff5-4aa94c1470c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_8d92838f-af79-4059-80e6-fe5f3e01d5c9" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_3d59b29e-8dd6-426e-aff5-4aa94c1470c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_0e71a30e-255d-4a36-a6a7-a9e220681dcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_8d92838f-af79-4059-80e6-fe5f3e01d5c9" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_0e71a30e-255d-4a36-a6a7-a9e220681dcb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxContingencies_40f312c6-3594-42e1-9721-35d54704f8dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationTaxContingencies"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_8d92838f-af79-4059-80e6-fe5f3e01d5c9" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxContingencies_40f312c6-3594-42e1-9721-35d54704f8dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_2d7eb4e9-f9b3-431c-8e8e-c26971c30aa8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_8d92838f-af79-4059-80e6-fe5f3e01d5c9" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_2d7eb4e9-f9b3-431c-8e8e-c26971c30aa8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EffectiveIncomeTaxRateReconciliationPPPLoanAmount_8f9a4340-1735-44a4-99c5-f329bd9f6521" xlink:href="rdnt-20221231.xsd#rdnt_EffectiveIncomeTaxRateReconciliationPPPLoanAmount"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_8d92838f-af79-4059-80e6-fe5f3e01d5c9" xlink:to="loc_rdnt_EffectiveIncomeTaxRateReconciliationPPPLoanAmount_8f9a4340-1735-44a4-99c5-f329bd9f6521" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense_4cbd066f-6bd2-4065-bba2-1691f3c8fbc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_8d92838f-af79-4059-80e6-fe5f3e01d5c9" xlink:to="loc_us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense_4cbd066f-6bd2-4065-bba2-1691f3c8fbc7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_4646a796-69c1-4417-ad43-006fc6a91d1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_8d92838f-af79-4059-80e6-fe5f3e01d5c9" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_4646a796-69c1-4417-ad43-006fc6a91d1d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/INCOMETAXESDetailsDeferredTaxAssetsandLiabilities" xlink:type="simple" xlink:href="rdnt-20221231.xsd#INCOMETAXESDetailsDeferredTaxAssetsandLiabilities"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/INCOMETAXESDetailsDeferredTaxAssetsandLiabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_e9aea705-6c67-47e9-a332-2cf28498ece1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_81bdfb1d-d8b4-428f-b6de-ee895cbb5369" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_e9aea705-6c67-47e9-a332-2cf28498ece1" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_81bdfb1d-d8b4-428f-b6de-ee895cbb5369" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_e62f6c8d-6e48-4f1e-8d3b-b32d0fe25422" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_e9aea705-6c67-47e9-a332-2cf28498ece1" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_e62f6c8d-6e48-4f1e-8d3b-b32d0fe25422" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeferredTaxAssetsOperatingLeaseLiabilities_00a1e592-6e86-49e6-8b82-fa02d32569ba" xlink:href="rdnt-20221231.xsd#rdnt_DeferredTaxAssetsOperatingLeaseLiabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_e9aea705-6c67-47e9-a332-2cf28498ece1" xlink:to="loc_rdnt_DeferredTaxAssetsOperatingLeaseLiabilities_00a1e592-6e86-49e6-8b82-fa02d32569ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_c5fabe74-f482-4735-9e8e-37cbaf783bbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_e9aea705-6c67-47e9-a332-2cf28498ece1" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_c5fabe74-f482-4735-9e8e-37cbaf783bbb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_6d50fe12-e0c9-4747-b2ea-984f3b38c2d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_e9aea705-6c67-47e9-a332-2cf28498ece1" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_6d50fe12-e0c9-4747-b2ea-984f3b38c2d2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_2d2b9a84-dae2-4ac8-b336-aebd6c13de3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_e9aea705-6c67-47e9-a332-2cf28498ece1" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_2d2b9a84-dae2-4ac8-b336-aebd6c13de3d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_40a22706-01bc-45d5-8041-aeb96e384286" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_e9aea705-6c67-47e9-a332-2cf28498ece1" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_40a22706-01bc-45d5-8041-aeb96e384286" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_5155d5e6-d677-48a0-a45c-1d9d06580eca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_6fd6a60d-efc0-4fae-89c0-be13fd809294" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_5155d5e6-d677-48a0-a45c-1d9d06580eca" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_6fd6a60d-efc0-4fae-89c0-be13fd809294" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_10e31432-672f-44e2-ab90-d0ae2470d5ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_5155d5e6-d677-48a0-a45c-1d9d06580eca" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_10e31432-672f-44e2-ab90-d0ae2470d5ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets_6928ed0e-5015-4bcd-9115-ae700972864e" xlink:href="rdnt-20221231.xsd#rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_5155d5e6-d677-48a0-a45c-1d9d06580eca" xlink:to="loc_rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets_6928ed0e-5015-4bcd-9115-ae700972864e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_a29e45ad-0e12-4a1f-b280-05401b3d64bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_5155d5e6-d677-48a0-a45c-1d9d06580eca" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_a29e45ad-0e12-4a1f-b280-05401b3d64bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeferredTaxLiabilitiesOutsideBasisDifference_e3047a88-db8c-44f8-b6c2-83f424f33e6f" xlink:href="rdnt-20221231.xsd#rdnt_DeferredTaxLiabilitiesOutsideBasisDifference"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_5155d5e6-d677-48a0-a45c-1d9d06580eca" xlink:to="loc_rdnt_DeferredTaxLiabilitiesOutsideBasisDifference_e3047a88-db8c-44f8-b6c2-83f424f33e6f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_7453d63d-f388-442c-91c8-e2f7d487ef73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_5155d5e6-d677-48a0-a45c-1d9d06580eca" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_7453d63d-f388-442c-91c8-e2f7d487ef73" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_c2e9696f-036a-4619-bc20-7bdf1ec560e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_541ad09a-0352-44e5-afa5-0dee46ad4765" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_c2e9696f-036a-4619-bc20-7bdf1ec560e2" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_541ad09a-0352-44e5-afa5-0dee46ad4765" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_85595fdf-03fa-460e-a761-3ff35f694c75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_c2e9696f-036a-4619-bc20-7bdf1ec560e2" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_85595fdf-03fa-460e-a761-3ff35f694c75" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_2051cf42-a932-43c5-b74f-7ca9aeb96afc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_683dfc5c-4be7-469a-bf07-75022730cd86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_2051cf42-a932-43c5-b74f-7ca9aeb96afc" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_683dfc5c-4be7-469a-bf07-75022730cd86" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_8384c7e0-acb9-407d-9ee9-c19e057c2a44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_2051cf42-a932-43c5-b74f-7ca9aeb96afc" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_8384c7e0-acb9-407d-9ee9-c19e057c2a44" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>11
<FILENAME>rdnt-20221231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:ee66d8ee-1013-4282-8e3e-c307b1c04f3f,g:1b6e48fd-cb3e-498b-b299-6015491264f8-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="rdnt-20221231.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended" id="i7f357c2281834e05aec9afe02aecc15a_CONSOLIDATEDSTATEMENTSOFOPERATIONS">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_04d1472d-6a1e-4dcd-a45e-bf5dc0048263" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_dc419765-4f96-4fb0-af66-59b871caa3c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_04d1472d-6a1e-4dcd-a45e-bf5dc0048263" xlink:to="loc_us-gaap_RevenuesAbstract_dc419765-4f96-4fb0-af66-59b871caa3c0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7d97e47d-2647-467c-bdb1-0fdab8379ee7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_dc419765-4f96-4fb0-af66-59b871caa3c0" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7d97e47d-2647-467c-bdb1-0fdab8379ee7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueNotFromContractWithCustomer_8a2dff22-92d9-4e5c-8e5e-b427d67973cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueNotFromContractWithCustomer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_dc419765-4f96-4fb0-af66-59b871caa3c0" xlink:to="loc_us-gaap_RevenueNotFromContractWithCustomer_8a2dff22-92d9-4e5c-8e5e-b427d67973cd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_4a5a79ea-688f-4c2e-8098-50fcb7f328c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_04d1472d-6a1e-4dcd-a45e-bf5dc0048263" xlink:to="loc_us-gaap_OperatingExpensesAbstract_4a5a79ea-688f-4c2e-8098-50fcb7f328c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OperatingExpensesExcludingDepreciationAndAmortization_58e75d56-5069-4cf4-82d3-1932a4401f4f" xlink:href="rdnt-20221231.xsd#rdnt_OperatingExpensesExcludingDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4a5a79ea-688f-4c2e-8098-50fcb7f328c8" xlink:to="loc_rdnt_OperatingExpensesExcludingDepreciationAndAmortization_58e75d56-5069-4cf4-82d3-1932a4401f4f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnTerminationOfLease_e2a5091e-60ae-4b2b-ad38-b16cf6f149c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnTerminationOfLease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4a5a79ea-688f-4c2e-8098-50fcb7f328c8" xlink:to="loc_us-gaap_GainLossOnTerminationOfLease_e2a5091e-60ae-4b2b-ad38-b16cf6f149c5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_df0423a1-d4ed-4e77-97fc-082ce78abe55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4a5a79ea-688f-4c2e-8098-50fcb7f328c8" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_df0423a1-d4ed-4e77-97fc-082ce78abe55" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets_37676490-4026-4e17-bfd2-7249b7833b47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4a5a79ea-688f-4c2e-8098-50fcb7f328c8" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets_37676490-4026-4e17-bfd2-7249b7833b47" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_ec927871-cf96-45fb-88d1-9cda55197051" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4a5a79ea-688f-4c2e-8098-50fcb7f328c8" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_ec927871-cf96-45fb-88d1-9cda55197051" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_c24944e4-51c9-47e9-be44-35ae601be836" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeveranceCosts1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4a5a79ea-688f-4c2e-8098-50fcb7f328c8" xlink:to="loc_us-gaap_SeveranceCosts1_c24944e4-51c9-47e9-be44-35ae601be836" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_49e988e3-8f13-4ad2-99cc-ed3d9670ca58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4a5a79ea-688f-4c2e-8098-50fcb7f328c8" xlink:to="loc_us-gaap_OperatingExpenses_49e988e3-8f13-4ad2-99cc-ed3d9670ca58" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_0da1ecfc-3116-4e7c-ac98-dbbe85de566f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_04d1472d-6a1e-4dcd-a45e-bf5dc0048263" xlink:to="loc_us-gaap_OperatingIncomeLoss_0da1ecfc-3116-4e7c-ac98-dbbe85de566f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpensesAbstract_804239ac-d1dd-4c87-b0aa-580078dbac2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_04d1472d-6a1e-4dcd-a45e-bf5dc0048263" xlink:to="loc_us-gaap_OtherExpensesAbstract_804239ac-d1dd-4c87-b0aa-580078dbac2e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_d35f6b1b-9ff4-4c1e-b99a-7dee3e4a99bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherExpensesAbstract_804239ac-d1dd-4c87-b0aa-580078dbac2e" xlink:to="loc_us-gaap_InterestExpenseDebt_d35f6b1b-9ff4-4c1e-b99a-7dee3e4a99bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_07300782-9678-41c4-9632-b79ad89d3e1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherExpensesAbstract_804239ac-d1dd-4c87-b0aa-580078dbac2e" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_07300782-9678-41c4-9632-b79ad89d3e1c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1_88c6b7ac-175a-4237-a7f8-78b19e5f9825" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherExpensesAbstract_804239ac-d1dd-4c87-b0aa-580078dbac2e" xlink:to="loc_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1_88c6b7ac-175a-4237-a7f8-78b19e5f9825" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GainLossOnExtinguishmentOfDebtAndOtherExpenses_ef2088a1-056f-4c47-9685-5bf19c1ea3e3" xlink:href="rdnt-20221231.xsd#rdnt_GainLossOnExtinguishmentOfDebtAndOtherExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherExpensesAbstract_804239ac-d1dd-4c87-b0aa-580078dbac2e" xlink:to="loc_rdnt_GainLossOnExtinguishmentOfDebtAndOtherExpenses_ef2088a1-056f-4c47-9685-5bf19c1ea3e3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_8f329128-ca69-470e-872e-3445b8cf5ce5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherExpensesAbstract_804239ac-d1dd-4c87-b0aa-580078dbac2e" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_8f329128-ca69-470e-872e-3445b8cf5ce5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_f119b4f0-4026-47e6-9356-d893059678fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherExpensesAbstract_804239ac-d1dd-4c87-b0aa-580078dbac2e" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_f119b4f0-4026-47e6-9356-d893059678fd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_66f7f174-181e-4615-825e-30042879891e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_04d1472d-6a1e-4dcd-a45e-bf5dc0048263" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_66f7f174-181e-4615-825e-30042879891e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_9cac600b-981e-4c75-b9ad-17bf5cc06711" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_04d1472d-6a1e-4dcd-a45e-bf5dc0048263" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_9cac600b-981e-4c75-b9ad-17bf5cc06711" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_ed7ebb43-1708-4bd7-ae74-ad8ae525fa65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_04d1472d-6a1e-4dcd-a45e-bf5dc0048263" xlink:to="loc_us-gaap_ProfitLoss_ed7ebb43-1708-4bd7-ae74-ad8ae525fa65" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2aee31d8-8579-4c31-8d45-fed365f212b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_04d1472d-6a1e-4dcd-a45e-bf5dc0048263" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2aee31d8-8579-4c31-8d45-fed365f212b7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_aeb78598-bf28-4ca6-98f8-92074d922c5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_04d1472d-6a1e-4dcd-a45e-bf5dc0048263" xlink:to="loc_us-gaap_NetIncomeLoss_aeb78598-bf28-4ca6-98f8-92074d922c5b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_a579d355-d020-40fb-a8ea-14dd0df116ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_04d1472d-6a1e-4dcd-a45e-bf5dc0048263" xlink:to="loc_us-gaap_EarningsPerShareBasic_a579d355-d020-40fb-a8ea-14dd0df116ae" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_3a306df5-c0ee-40ca-baff-5ff0a84d3325" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_04d1472d-6a1e-4dcd-a45e-bf5dc0048263" xlink:to="loc_us-gaap_EarningsPerShareDiluted_3a306df5-c0ee-40ca-baff-5ff0a84d3325" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EarningPerShareBasicAndDilutedAbstract_7725d069-6657-41d2-baac-bbd2f440eeb1" xlink:href="rdnt-20221231.xsd#rdnt_EarningPerShareBasicAndDilutedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_04d1472d-6a1e-4dcd-a45e-bf5dc0048263" xlink:to="loc_rdnt_EarningPerShareBasicAndDilutedAbstract_7725d069-6657-41d2-baac-bbd2f440eeb1" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a55c9020-4d45-4ad8-9f41-3ceec3f8f42b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_EarningPerShareBasicAndDilutedAbstract_7725d069-6657-41d2-baac-bbd2f440eeb1" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a55c9020-4d45-4ad8-9f41-3ceec3f8f42b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_086be00f-7edf-4f90-a64a-7c115736cd18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_EarningPerShareBasicAndDilutedAbstract_7725d069-6657-41d2-baac-bbd2f440eeb1" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_086be00f-7edf-4f90-a64a-7c115736cd18" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_01cd6aa7-42f1-439b-8fe8-6c95426d7a94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_04d1472d-6a1e-4dcd-a45e-bf5dc0048263" xlink:to="loc_us-gaap_StatementTable_01cd6aa7-42f1-439b-8fe8-6c95426d7a94" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_c443e1aa-d181-4ec5-9a42-c59c0b3081ff" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_01cd6aa7-42f1-439b-8fe8-6c95426d7a94" xlink:to="loc_srt_ProductOrServiceAxis_c443e1aa-d181-4ec5-9a42-c59c0b3081ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c443e1aa-d181-4ec5-9a42-c59c0b3081ff_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_c443e1aa-d181-4ec5-9a42-c59c0b3081ff" xlink:to="loc_srt_ProductsAndServicesDomain_c443e1aa-d181-4ec5-9a42-c59c0b3081ff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_3198e122-b8e1-4cf1-bc9d-46ac91c95418" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_c443e1aa-d181-4ec5-9a42-c59c0b3081ff" xlink:to="loc_srt_ProductsAndServicesDomain_3198e122-b8e1-4cf1-bc9d-46ac91c95418" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCarePatientServiceMember_4b66e29a-4e71-445c-9698-f44cdbf3f78b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthCarePatientServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_3198e122-b8e1-4cf1-bc9d-46ac91c95418" xlink:to="loc_us-gaap_HealthCarePatientServiceMember_4b66e29a-4e71-445c-9698-f44cdbf3f78b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CapitationArrangementsMember_e34bd136-6f61-4004-9310-f5d2314e42f4" xlink:href="rdnt-20221231.xsd#rdnt_CapitationArrangementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_3198e122-b8e1-4cf1-bc9d-46ac91c95418" xlink:to="loc_rdnt_CapitationArrangementsMember_e34bd136-6f61-4004-9310-f5d2314e42f4" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY" xlink:type="simple" xlink:href="rdnt-20221231.xsd#CONSOLIDATEDSTATEMENTOFEQUITY"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY" xlink:type="extended" id="ia9d1715065754801a2be3f7fbf2b862d_CONSOLIDATEDSTATEMENTOFEQUITY">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_1cbe8ef7-475d-4528-a857-95b22bb71851" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cbf6a691-b4c7-4c2a-9034-6378f14d8c27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1cbe8ef7-475d-4528-a857-95b22bb71851" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cbf6a691-b4c7-4c2a-9034-6378f14d8c27" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_a0156b69-30c4-41ef-b794-8b2d7e209a1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cbf6a691-b4c7-4c2a-9034-6378f14d8c27" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_a0156b69-30c4-41ef-b794-8b2d7e209a1b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9bbbcf76-4d9d-4715-8700-561458d5bbb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cbf6a691-b4c7-4c2a-9034-6378f14d8c27" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9bbbcf76-4d9d-4715-8700-561458d5bbb0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_5b46942d-1f0b-4068-9f9d-3a90848e3fb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cbf6a691-b4c7-4c2a-9034-6378f14d8c27" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_5b46942d-1f0b-4068-9f9d-3a90848e3fb5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_b8e4e5a5-667a-4a08-88df-8f7e3c2f259f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cbf6a691-b4c7-4c2a-9034-6378f14d8c27" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_b8e4e5a5-667a-4a08-88df-8f7e3c2f259f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_70943a41-025f-492c-ae7b-c2303d14ac9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cbf6a691-b4c7-4c2a-9034-6378f14d8c27" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_70943a41-025f-492c-ae7b-c2303d14ac9e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SharesIssuedSharesSettlementOfContingentConsideration_66884b4a-e569-427e-8a56-8a832b828654" xlink:href="rdnt-20221231.xsd#rdnt_SharesIssuedSharesSettlementOfContingentConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cbf6a691-b4c7-4c2a-9034-6378f14d8c27" xlink:to="loc_rdnt_SharesIssuedSharesSettlementOfContingentConsideration_66884b4a-e569-427e-8a56-8a832b828654" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_c178f3c6-5736-4bb8-9bf5-da0714a95abe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cbf6a691-b4c7-4c2a-9034-6378f14d8c27" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_c178f3c6-5736-4bb8-9bf5-da0714a95abe" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_16940bce-73f1-41fa-9e56-2215ff8802bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cbf6a691-b4c7-4c2a-9034-6378f14d8c27" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_16940bce-73f1-41fa-9e56-2215ff8802bd" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_5d4be12f-40a9-4c9e-ab35-fcaff51835dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cbf6a691-b4c7-4c2a-9034-6378f14d8c27" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_5d4be12f-40a9-4c9e-ab35-fcaff51835dc" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest_8650b0f1-ee66-44ea-8780-6a2c209d04f6" xlink:href="rdnt-20221231.xsd#rdnt_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cbf6a691-b4c7-4c2a-9034-6378f14d8c27" xlink:to="loc_rdnt_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest_8650b0f1-ee66-44ea-8780-6a2c209d04f6" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_7f67aa40-18b6-4f7b-804e-3b5c4cceb521" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cbf6a691-b4c7-4c2a-9034-6378f14d8c27" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_7f67aa40-18b6-4f7b-804e-3b5c4cceb521" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_fc94c171-b41d-464e-b323-bc0ecb8e0889" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cbf6a691-b4c7-4c2a-9034-6378f14d8c27" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_fc94c171-b41d-464e-b323-bc0ecb8e0889" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_e4f81afe-c9ab-49ff-a601-95f82d6611f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cbf6a691-b4c7-4c2a-9034-6378f14d8c27" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_e4f81afe-c9ab-49ff-a601-95f82d6611f8" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_ae1772db-d55e-4250-a069-536b52089dd9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cbf6a691-b4c7-4c2a-9034-6378f14d8c27" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_ae1772db-d55e-4250-a069-536b52089dd9" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_8c650f9a-25aa-4ae3-b19b-9ce2a27d0c6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cbf6a691-b4c7-4c2a-9034-6378f14d8c27" xlink:to="loc_us-gaap_ProfitLoss_8c650f9a-25aa-4ae3-b19b-9ce2a27d0c6a" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_80879bf6-7887-4ae2-aa8a-eaa0bc42a6af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cbf6a691-b4c7-4c2a-9034-6378f14d8c27" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_80879bf6-7887-4ae2-aa8a-eaa0bc42a6af" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_1d0beaba-81b6-4ef6-9d55-e4fb43875646" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cbf6a691-b4c7-4c2a-9034-6378f14d8c27" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_1d0beaba-81b6-4ef6-9d55-e4fb43875646" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_1e3588b9-cc7e-40c8-b413-2a00179a2555" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cbf6a691-b4c7-4c2a-9034-6378f14d8c27" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_1e3588b9-cc7e-40c8-b413-2a00179a2555" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited_8648d61a-2af5-456e-99c7-45a28a3a7139" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cbf6a691-b4c7-4c2a-9034-6378f14d8c27" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited_8648d61a-2af5-456e-99c7-45a28a3a7139" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AdjustmentsToAdditionalPaidInCapitalGainOnContributionOfAssetsToSubsidiary_a6261035-6c4b-4beb-8987-54785bd06ea9" xlink:href="rdnt-20221231.xsd#rdnt_AdjustmentsToAdditionalPaidInCapitalGainOnContributionOfAssetsToSubsidiary"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cbf6a691-b4c7-4c2a-9034-6378f14d8c27" xlink:to="loc_rdnt_AdjustmentsToAdditionalPaidInCapitalGainOnContributionOfAssetsToSubsidiary_a6261035-6c4b-4beb-8987-54785bd06ea9" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest_1d169ec4-1855-4312-8287-186cbcb9fc48" xlink:href="rdnt-20221231.xsd#rdnt_NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cbf6a691-b4c7-4c2a-9034-6378f14d8c27" xlink:to="loc_rdnt_NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest_1d169ec4-1855-4312-8287-186cbcb9fc48" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_60a22bab-a229-48c6-b98b-d16f2047736d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cbf6a691-b4c7-4c2a-9034-6378f14d8c27" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_60a22bab-a229-48c6-b98b-d16f2047736d" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_626b42d8-933f-4b47-80cb-71e5e0d56f29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_76505db7-e8a3-48fe-a988-b791036cf21c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_397734fa-b22f-4be1-afed-06318628016b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1cbe8ef7-475d-4528-a857-95b22bb71851" xlink:to="loc_us-gaap_StatementTable_397734fa-b22f-4be1-afed-06318628016b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_4234e7cf-6dbf-4afd-952c-9b8ed34af944" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_397734fa-b22f-4be1-afed-06318628016b" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_4234e7cf-6dbf-4afd-952c-9b8ed34af944" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_4234e7cf-6dbf-4afd-952c-9b8ed34af944_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_4234e7cf-6dbf-4afd-952c-9b8ed34af944" xlink:to="loc_us-gaap_EquityComponentDomain_4234e7cf-6dbf-4afd-952c-9b8ed34af944_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_c6c19e94-c2d6-43ca-91bd-b4dfe104db4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_4234e7cf-6dbf-4afd-952c-9b8ed34af944" xlink:to="loc_us-gaap_EquityComponentDomain_c6c19e94-c2d6-43ca-91bd-b4dfe104db4a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_02dbae20-754b-42a0-9976-35b49272ae34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_c6c19e94-c2d6-43ca-91bd-b4dfe104db4a" xlink:to="loc_us-gaap_ParentMember_02dbae20-754b-42a0-9976-35b49272ae34" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_523f2b2a-fea5-46a5-91b2-07fde2aa2984" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_02dbae20-754b-42a0-9976-35b49272ae34" xlink:to="loc_us-gaap_CommonStockMember_523f2b2a-fea5-46a5-91b2-07fde2aa2984" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_000b6e04-8bca-4e4c-b894-18c32849a43f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_02dbae20-754b-42a0-9976-35b49272ae34" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_000b6e04-8bca-4e4c-b894-18c32849a43f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_99e46df4-3113-4afc-a07c-28d5894d1575" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_02dbae20-754b-42a0-9976-35b49272ae34" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_99e46df4-3113-4afc-a07c-28d5894d1575" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_6dca2057-4729-4a49-abb0-6eef990adcc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_02dbae20-754b-42a0-9976-35b49272ae34" xlink:to="loc_us-gaap_RetainedEarningsMember_6dca2057-4729-4a49-abb0-6eef990adcc7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_c13db788-a05a-4312-9e32-9ff09905295e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_c6c19e94-c2d6-43ca-91bd-b4dfe104db4a" xlink:to="loc_us-gaap_NoncontrollingInterestMember_c13db788-a05a-4312-9e32-9ff09905295e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_c032b543-d0a1-4582-a337-921ee2ba2f10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_397734fa-b22f-4be1-afed-06318628016b" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_c032b543-d0a1-4582-a337-921ee2ba2f10" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c032b543-d0a1-4582-a337-921ee2ba2f10_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_c032b543-d0a1-4582-a337-921ee2ba2f10" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c032b543-d0a1-4582-a337-921ee2ba2f10_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_779e5529-2147-4c92-84d5-e5ce1fc4c863" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_c032b543-d0a1-4582-a337-921ee2ba2f10" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_779e5529-2147-4c92-84d5-e5ce1fc4c863" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AcquisitionsAndAssetPurchasesMember_9b9d471e-e178-43f5-948b-efa7d7efea10" xlink:href="rdnt-20221231.xsd#rdnt_AcquisitionsAndAssetPurchasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_779e5529-2147-4c92-84d5-e5ce1fc4c863" xlink:to="loc_rdnt_AcquisitionsAndAssetPurchasesMember_9b9d471e-e178-43f5-948b-efa7d7efea10" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeepHealthIncMember_fb0848a1-6984-4d47-a3bf-c28546a8a270" xlink:href="rdnt-20221231.xsd#rdnt_DeepHealthIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_779e5529-2147-4c92-84d5-e5ce1fc4c863" xlink:to="loc_rdnt_DeepHealthIncMember_fb0848a1-6984-4d47-a3bf-c28546a8a270" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical" xlink:type="simple" xlink:href="rdnt-20221231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical" xlink:type="extended" id="id5924e5ab55343a18a6bcc6ab86fcb74_CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_de541be3-3327-4156-b3cf-e375be62929e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquipmentAcquiredAndLeaseholdImprovements_2f42e9f3-da53-44cd-9393-9d97f42d1290" xlink:href="rdnt-20221231.xsd#rdnt_EquipmentAcquiredAndLeaseholdImprovements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_de541be3-3327-4156-b3cf-e375be62929e" xlink:to="loc_rdnt_EquipmentAcquiredAndLeaseholdImprovements_2f42e9f3-da53-44cd-9393-9d97f42d1290" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_6c6a8650-abef-44df-b4f0-749ede7555d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_de541be3-3327-4156-b3cf-e375be62929e" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_6c6a8650-abef-44df-b4f0-749ede7555d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_ff0c0df5-8efa-4305-a35c-f441e2ef45d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_de541be3-3327-4156-b3cf-e375be62929e" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_ff0c0df5-8efa-4305-a35c-f441e2ef45d0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_a8d39f37-36cd-416a-9116-ecfa54639138" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_de541be3-3327-4156-b3cf-e375be62929e" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_a8d39f37-36cd-416a-9116-ecfa54639138" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDividendsReceived_0f13fc9d-772a-43c5-badc-aa2238fb5612" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDividendsReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_de541be3-3327-4156-b3cf-e375be62929e" xlink:to="loc_us-gaap_ProceedsFromDividendsReceived_0f13fc9d-772a-43c5-badc-aa2238fb5612" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_6d84a4ef-bc1d-4992-9956-b6393d4e4509" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_de541be3-3327-4156-b3cf-e375be62929e" xlink:to="loc_us-gaap_EquityMethodInvestments_6d84a4ef-bc1d-4992-9956-b6393d4e4509" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_7480706f-ee17-4fb7-9947-c1a2aa2ce530" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_de541be3-3327-4156-b3cf-e375be62929e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_7480706f-ee17-4fb7-9947-c1a2aa2ce530" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1_c68e0691-b795-4947-9275-ced9f5f64cd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_de541be3-3327-4156-b3cf-e375be62929e" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1_c68e0691-b795-4947-9275-ced9f5f64cd8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued_f1ca013b-f3b2-4967-8a3c-f547c6960eb2" xlink:href="rdnt-20221231.xsd#rdnt_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_de541be3-3327-4156-b3cf-e375be62929e" xlink:to="loc_rdnt_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued_f1ca013b-f3b2-4967-8a3c-f547c6960eb2" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_b8472ed4-b77c-4a28-9e0e-a93e33838094" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_de541be3-3327-4156-b3cf-e375be62929e" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_b8472ed4-b77c-4a28-9e0e-a93e33838094" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1_084d398b-6cdd-4310-942c-06fc87028448" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_de541be3-3327-4156-b3cf-e375be62929e" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1_084d398b-6cdd-4310-942c-06fc87028448" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_d7631a17-2e55-41b1-8f55-b5312182a5bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_de541be3-3327-4156-b3cf-e375be62929e" xlink:to="loc_us-gaap_FinanceLeaseLiability_d7631a17-2e55-41b1-8f55-b5312182a5bd" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_9fc1060e-310a-42e6-a295-d660fc0e3c35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_de541be3-3327-4156-b3cf-e375be62929e" xlink:to="loc_us-gaap_StatementTable_9fc1060e-310a-42e6-a295-d660fc0e3c35" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_1ff00675-92d6-4004-9a45-703133c8720b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_9fc1060e-310a-42e6-a295-d660fc0e3c35" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_1ff00675-92d6-4004-9a45-703133c8720b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1ff00675-92d6-4004-9a45-703133c8720b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1ff00675-92d6-4004-9a45-703133c8720b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1ff00675-92d6-4004-9a45-703133c8720b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7c7d0502-7468-4df0-932e-9af115da820f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1ff00675-92d6-4004-9a45-703133c8720b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7c7d0502-7468-4df0-932e-9af115da820f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AidenceMember_27fba763-6978-4f89-9be8-d1b69f6ec6ac" xlink:href="rdnt-20221231.xsd#rdnt_AidenceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7c7d0502-7468-4df0-932e-9af115da820f" xlink:to="loc_rdnt_AidenceMember_27fba763-6978-4f89-9be8-d1b69f6ec6ac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_QuantibMember_752260d6-1760-4e55-9ba1-4792f3fab702" xlink:href="rdnt-20221231.xsd#rdnt_QuantibMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7c7d0502-7468-4df0-932e-9af115da820f" xlink:to="loc_rdnt_QuantibMember_752260d6-1760-4e55-9ba1-4792f3fab702" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DRTLLCMember_93a1502c-5669-422d-aa07-5cda4959d5fe" xlink:href="rdnt-20221231.xsd#rdnt_DRTLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7c7d0502-7468-4df0-932e-9af115da820f" xlink:to="loc_rdnt_DRTLLCMember_93a1502c-5669-422d-aa07-5cda4959d5fe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TangentAssociatesLLCMember_b3b42505-57d9-4b4d-b93d-8e5459b9070a" xlink:href="rdnt-20221231.xsd#rdnt_TangentAssociatesLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7c7d0502-7468-4df0-932e-9af115da820f" xlink:to="loc_rdnt_TangentAssociatesLLCMember_b3b42505-57d9-4b4d-b93d-8e5459b9070a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_20affda8-7ddd-4480-b1d3-98af2ac01bc7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_9fc1060e-310a-42e6-a295-d660fc0e3c35" xlink:to="loc_dei_LegalEntityAxis_20affda8-7ddd-4480-b1d3-98af2ac01bc7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_20affda8-7ddd-4480-b1d3-98af2ac01bc7_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_20affda8-7ddd-4480-b1d3-98af2ac01bc7" xlink:to="loc_dei_EntityDomain_20affda8-7ddd-4480-b1d3-98af2ac01bc7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_da53c4d3-071e-4b56-aa0c-290426dbe1e2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_20affda8-7ddd-4480-b1d3-98af2ac01bc7" xlink:to="loc_dei_EntityDomain_da53c4d3-071e-4b56-aa0c-290426dbe1e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FrederickHealthHospitalIncMember_9c6bb7a7-6151-4c26-b8cd-429bb75ee311" xlink:href="rdnt-20221231.xsd#rdnt_FrederickHealthHospitalIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_da53c4d3-071e-4b56-aa0c-290426dbe1e2" xlink:to="loc_rdnt_FrederickHealthHospitalIncMember_9c6bb7a7-6151-4c26-b8cd-429bb75ee311" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SimiValleyImagingGroupLLCMember_7882571c-010d-4af9-b575-176e8ebf9b11" xlink:href="rdnt-20221231.xsd#rdnt_SimiValleyImagingGroupLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_da53c4d3-071e-4b56-aa0c-290426dbe1e2" xlink:to="loc_rdnt_SimiValleyImagingGroupLLCMember_7882571c-010d-4af9-b575-176e8ebf9b11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SimiAdventistMember_52f105f2-43f6-4d54-854d-5eb7c158e27f" xlink:href="rdnt-20221231.xsd#rdnt_SimiAdventistMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_da53c4d3-071e-4b56-aa0c-290426dbe1e2" xlink:to="loc_rdnt_SimiAdventistMember_52f105f2-43f6-4d54-854d-5eb7c158e27f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_6a6ac837-8694-4010-96ec-7c966a5b2743" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_9fc1060e-310a-42e6-a295-d660fc0e3c35" xlink:to="loc_srt_OwnershipAxis_6a6ac837-8694-4010-96ec-7c966a5b2743" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_6a6ac837-8694-4010-96ec-7c966a5b2743_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_6a6ac837-8694-4010-96ec-7c966a5b2743" xlink:to="loc_srt_OwnershipDomain_6a6ac837-8694-4010-96ec-7c966a5b2743_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_2d32ca3a-4d48-434e-8812-d7e7c62c9acf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_6a6ac837-8694-4010-96ec-7c966a5b2743" xlink:to="loc_srt_OwnershipDomain_2d32ca3a-4d48-434e-8812-d7e7c62c9acf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FrederickCountyRadiologyLLCMember_c98b7752-f903-4c81-b71e-27c253c70f68" xlink:href="rdnt-20221231.xsd#rdnt_FrederickCountyRadiologyLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_2d32ca3a-4d48-434e-8812-d7e7c62c9acf" xlink:to="loc_rdnt_FrederickCountyRadiologyLLCMember_c98b7752-f903-4c81-b71e-27c253c70f68" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_1eada5a9-6b81-465c-8ed6-7d5ac8580c2a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_9fc1060e-310a-42e6-a295-d660fc0e3c35" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_1eada5a9-6b81-465c-8ed6-7d5ac8580c2a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_1eada5a9-6b81-465c-8ed6-7d5ac8580c2a_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_1eada5a9-6b81-465c-8ed6-7d5ac8580c2a" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_1eada5a9-6b81-465c-8ed6-7d5ac8580c2a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_3b340195-f1b3-41e1-bef6-8383a0082bd1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_1eada5a9-6b81-465c-8ed6-7d5ac8580c2a" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_3b340195-f1b3-41e1-bef6-8383a0082bd1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ArizonaDiagnosticsGroupMember_17ba7c44-4a39-4e29-8bb2-8f986c2b34fb" xlink:href="rdnt-20221231.xsd#rdnt_ArizonaDiagnosticsGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_3b340195-f1b3-41e1-bef6-8383a0082bd1" xlink:to="loc_rdnt_ArizonaDiagnosticsGroupMember_17ba7c44-4a39-4e29-8bb2-8f986c2b34fb" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20221231.xsd#NATUREOFBUSINESSDetailsNarrative"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative" xlink:type="extended" id="i518968e4731a4b20987d6d7c106b603c_NATUREOFBUSINESSDetailsNarrative">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_31bfef08-30d6-4e99-b20e-311fb45a96de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberOfCenters_635e3059-6a78-486f-ae1c-ad8c1575b1a9" xlink:href="rdnt-20221231.xsd#rdnt_NumberOfCenters"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_31bfef08-30d6-4e99-b20e-311fb45a96de" xlink:to="loc_rdnt_NumberOfCenters_635e3059-6a78-486f-ae1c-ad8c1575b1a9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_9427979b-4da9-42fd-b8d7-ab5207029f69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_31bfef08-30d6-4e99-b20e-311fb45a96de" xlink:to="loc_us-gaap_NumberOfReportableSegments_9427979b-4da9-42fd-b8d7-ab5207029f69" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues_96b061bb-3883-4a06-bcb0-9c4823502488" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_31bfef08-30d6-4e99-b20e-311fb45a96de" xlink:to="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues_96b061bb-3883-4a06-bcb0-9c4823502488" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense_5e5ec739-25f5-4b11-99e0-e551086191a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_31bfef08-30d6-4e99-b20e-311fb45a96de" xlink:to="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense_5e5ec739-25f5-4b11-99e0-e551086191a8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax_2cca3421-83c3-417d-8558-568b933ede59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_31bfef08-30d6-4e99-b20e-311fb45a96de" xlink:to="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax_2cca3421-83c3-417d-8558-568b933ede59" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_2badc9b1-4bdc-4c07-a3de-bfe243ba77dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_31bfef08-30d6-4e99-b20e-311fb45a96de" xlink:to="loc_us-gaap_Assets_2badc9b1-4bdc-4c07-a3de-bfe243ba77dc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_e868ab98-3b18-4dfd-8240-a5f1b524b0eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_31bfef08-30d6-4e99-b20e-311fb45a96de" xlink:to="loc_us-gaap_Liabilities_e868ab98-3b18-4dfd-8240-a5f1b524b0eb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_ae6897d8-f12f-4313-a99a-65022246e6b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_31bfef08-30d6-4e99-b20e-311fb45a96de" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_ae6897d8-f12f-4313-a99a-65022246e6b6" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_00c95d59-781e-4d74-988a-206fb3af41e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_31bfef08-30d6-4e99-b20e-311fb45a96de" xlink:to="loc_us-gaap_EquityMethodInvestments_00c95d59-781e-4d74-988a-206fb3af41e8" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_ffab9cb1-677a-45c3-9a71-b82a10904f1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_31bfef08-30d6-4e99-b20e-311fb45a96de" xlink:to="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_ffab9cb1-677a-45c3-9a71-b82a10904f1b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_76bef731-49ab-436e-9b0e-b89fd81bcbc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_31bfef08-30d6-4e99-b20e-311fb45a96de" xlink:to="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_76bef731-49ab-436e-9b0e-b89fd81bcbc9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_41e2747c-a130-4ec7-99d2-b49acd46c4a5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_76bef731-49ab-436e-9b0e-b89fd81bcbc9" xlink:to="loc_srt_ConsolidatedEntitiesAxis_41e2747c-a130-4ec7-99d2-b49acd46c4a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_41e2747c-a130-4ec7-99d2-b49acd46c4a5_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_41e2747c-a130-4ec7-99d2-b49acd46c4a5" xlink:to="loc_srt_ConsolidatedEntitiesDomain_41e2747c-a130-4ec7-99d2-b49acd46c4a5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_aacdaf7c-8c76-437f-b03e-f0168ab39338" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_41e2747c-a130-4ec7-99d2-b49acd46c4a5" xlink:to="loc_srt_ConsolidatedEntitiesDomain_aacdaf7c-8c76-437f-b03e-f0168ab39338" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_3163a54c-3cb9-4cea-969b-23185915cefd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_aacdaf7c-8c76-437f-b03e-f0168ab39338" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_3163a54c-3cb9-4cea-969b-23185915cefd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_bd5c8062-15cc-4f66-a304-1584f4810309" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_76bef731-49ab-436e-9b0e-b89fd81bcbc9" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_bd5c8062-15cc-4f66-a304-1584f4810309" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_bd5c8062-15cc-4f66-a304-1584f4810309_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_bd5c8062-15cc-4f66-a304-1584f4810309" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_bd5c8062-15cc-4f66-a304-1584f4810309_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_9da547da-86d1-4391-9f18-7d7d5d826b6d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_bd5c8062-15cc-4f66-a304-1584f4810309" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_9da547da-86d1-4391-9f18-7d7d5d826b6d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ScriptSenderLLCMember_e42c85f2-9ac3-423b-8598-888af77c360e" xlink:href="rdnt-20221231.xsd#rdnt_ScriptSenderLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_9da547da-86d1-4391-9f18-7d7d5d826b6d" xlink:to="loc_rdnt_ScriptSenderLLCMember_e42c85f2-9ac3-423b-8598-888af77c360e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_2cb67f04-6924-4523-9549-2e3a88f8c0df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_76bef731-49ab-436e-9b0e-b89fd81bcbc9" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_2cb67f04-6924-4523-9549-2e3a88f8c0df" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_2cb67f04-6924-4523-9549-2e3a88f8c0df_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_2cb67f04-6924-4523-9549-2e3a88f8c0df" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_2cb67f04-6924-4523-9549-2e3a88f8c0df_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_7f095b43-69d8-48a2-a196-6ad6a0011944" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_2cb67f04-6924-4523-9549-2e3a88f8c0df" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_7f095b43-69d8-48a2-a196-6ad6a0011944" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenseMember_0649b9fe-5d73-4e01-8366-39454c9c662f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_7f095b43-69d8-48a2-a196-6ad6a0011944" xlink:to="loc_us-gaap_OperatingExpenseMember_0649b9fe-5d73-4e01-8366-39454c9c662f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_49b4e47d-c1a1-411d-ba52-dfe2d728c514" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_76bef731-49ab-436e-9b0e-b89fd81bcbc9" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_49b4e47d-c1a1-411d-ba52-dfe2d728c514" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_49b4e47d-c1a1-411d-ba52-dfe2d728c514_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_49b4e47d-c1a1-411d-ba52-dfe2d728c514" xlink:to="loc_us-gaap_RelatedPartyDomain_49b4e47d-c1a1-411d-ba52-dfe2d728c514_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_cfc17280-2efb-4772-bd4f-63103d7c9283" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_49b4e47d-c1a1-411d-ba52-dfe2d728c514" xlink:to="loc_us-gaap_RelatedPartyDomain_cfc17280-2efb-4772-bd4f-63103d7c9283" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvesteeMember_622bde27-bd33-4581-abd3-e588a1399b78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvesteeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_cfc17280-2efb-4772-bd4f-63103d7c9283" xlink:to="loc_us-gaap_EquityMethodInvesteeMember_622bde27-bd33-4581-abd3-e588a1399b78" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofNetRevenue" xlink:type="simple" xlink:href="rdnt-20221231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofNetRevenue"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofNetRevenue" xlink:type="extended" id="id1ea73bcc8f74dafb90df5b888ee1f49_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofNetRevenue">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_356b9d3d-641f-43e6-aca7-746cc03f2c38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b4221fbe-1e58-454c-9b4d-206db98d9f94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_356b9d3d-641f-43e6-aca7-746cc03f2c38" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b4221fbe-1e58-454c-9b4d-206db98d9f94" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_8cbc2f17-15b6-4094-897e-3a621fc28ae3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_356b9d3d-641f-43e6-aca7-746cc03f2c38" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_8cbc2f17-15b6-4094-897e-3a621fc28ae3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_42c1351d-23e5-43c6-8ec9-33802b406e55" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_8cbc2f17-15b6-4094-897e-3a621fc28ae3" xlink:to="loc_srt_ProductOrServiceAxis_42c1351d-23e5-43c6-8ec9-33802b406e55" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_42c1351d-23e5-43c6-8ec9-33802b406e55_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_42c1351d-23e5-43c6-8ec9-33802b406e55" xlink:to="loc_srt_ProductsAndServicesDomain_42c1351d-23e5-43c6-8ec9-33802b406e55_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_72ce0699-c190-4f1e-b5ff-71d12ab4f67c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_42c1351d-23e5-43c6-8ec9-33802b406e55" xlink:to="loc_srt_ProductsAndServicesDomain_72ce0699-c190-4f1e-b5ff-71d12ab4f67c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ImagingCenterSegmentRevenueMember_1f6ac639-c046-4718-b751-185be22a7cd1" xlink:href="rdnt-20221231.xsd#rdnt_ImagingCenterSegmentRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_72ce0699-c190-4f1e-b5ff-71d12ab4f67c" xlink:to="loc_rdnt_ImagingCenterSegmentRevenueMember_1f6ac639-c046-4718-b751-185be22a7cd1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CommercialInsurance1Member_626af5d6-52c0-49fb-9222-b6b0436a59cb" xlink:href="rdnt-20221231.xsd#rdnt_CommercialInsurance1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_ImagingCenterSegmentRevenueMember_1f6ac639-c046-4718-b751-185be22a7cd1" xlink:to="loc_rdnt_CommercialInsurance1Member_626af5d6-52c0-49fb-9222-b6b0436a59cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_Medicare1Member_dabecbaf-3ebf-4f6b-877c-b007af3e5a19" xlink:href="rdnt-20221231.xsd#rdnt_Medicare1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_ImagingCenterSegmentRevenueMember_1f6ac639-c046-4718-b751-185be22a7cd1" xlink:to="loc_rdnt_Medicare1Member_dabecbaf-3ebf-4f6b-877c-b007af3e5a19" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_Medicaid1Member_21eef9b2-3012-47e2-a7ac-1195defd5090" xlink:href="rdnt-20221231.xsd#rdnt_Medicaid1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_ImagingCenterSegmentRevenueMember_1f6ac639-c046-4718-b751-185be22a7cd1" xlink:to="loc_rdnt_Medicaid1Member_21eef9b2-3012-47e2-a7ac-1195defd5090" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WorkersCompensationPersonalInjury1Member_ea8e7210-5afb-4f01-a250-efba34d53ad0" xlink:href="rdnt-20221231.xsd#rdnt_WorkersCompensationPersonalInjury1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_ImagingCenterSegmentRevenueMember_1f6ac639-c046-4718-b751-185be22a7cd1" xlink:to="loc_rdnt_WorkersCompensationPersonalInjury1Member_ea8e7210-5afb-4f01-a250-efba34d53ad0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HealthCarePatientServiceOtherMember_2f1ff9d3-7273-47e9-b730-fa2b31495304" xlink:href="rdnt-20221231.xsd#rdnt_HealthCarePatientServiceOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_ImagingCenterSegmentRevenueMember_1f6ac639-c046-4718-b751-185be22a7cd1" xlink:to="loc_rdnt_HealthCarePatientServiceOtherMember_2f1ff9d3-7273-47e9-b730-fa2b31495304" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HealthCareManagementServiceMember_0b9e5a59-f407-4bf2-919f-52647b2cd9a9" xlink:href="rdnt-20221231.xsd#rdnt_HealthCareManagementServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_ImagingCenterSegmentRevenueMember_1f6ac639-c046-4718-b751-185be22a7cd1" xlink:to="loc_rdnt_HealthCareManagementServiceMember_0b9e5a59-f407-4bf2-919f-52647b2cd9a9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SoftwareAndTeleradiologyMember_7b5378ef-4f12-4022-a232-ace6b7874834" xlink:href="rdnt-20221231.xsd#rdnt_SoftwareAndTeleradiologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_ImagingCenterSegmentRevenueMember_1f6ac639-c046-4718-b751-185be22a7cd1" xlink:to="loc_rdnt_SoftwareAndTeleradiologyMember_7b5378ef-4f12-4022-a232-ace6b7874834" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareOtherMember_c2431213-2c37-4e4e-942c-209fb192ca5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthCareOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_ImagingCenterSegmentRevenueMember_1f6ac639-c046-4718-b751-185be22a7cd1" xlink:to="loc_us-gaap_HealthCareOtherMember_c2431213-2c37-4e4e-942c-209fb192ca5d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CapitationArrangementsMember_d0e224fa-982c-4cde-b07f-b76372c1c824" xlink:href="rdnt-20221231.xsd#rdnt_CapitationArrangementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_ImagingCenterSegmentRevenueMember_1f6ac639-c046-4718-b751-185be22a7cd1" xlink:to="loc_rdnt_CapitationArrangementsMember_d0e224fa-982c-4cde-b07f-b76372c1c824" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AIMember_19bfc4f6-9e13-4db3-aeb9-64eb03d7b042" xlink:href="rdnt-20221231.xsd#rdnt_AIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_72ce0699-c190-4f1e-b5ff-71d12ab4f67c" xlink:to="loc_rdnt_AIMember_19bfc4f6-9e13-4db3-aeb9-64eb03d7b042" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20221231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative" xlink:type="extended" id="i4e823e942bc645aaa2c0db4a2ef3772c_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AdvanceMedicarePayments_282ba732-b460-4c6c-8b4f-4552539e397e" xlink:href="rdnt-20221231.xsd#rdnt_AdvanceMedicarePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_rdnt_AdvanceMedicarePayments_282ba732-b460-4c6c-8b4f-4552539e397e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLoans_40b606aa-7a28-4719-95a9-d5f9d358e8d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLoans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_ProceedsFromLoans_40b606aa-7a28-4719-95a9-d5f9d358e8d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ProceedsFromProviderReliefFunding_7ce4d8c3-4ac1-4c98-a789-60524f73a57d" xlink:href="rdnt-20221231.xsd#rdnt_ProceedsFromProviderReliefFunding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_rdnt_ProceedsFromProviderReliefFunding_7ce4d8c3-4ac1-4c98-a789-60524f73a57d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RepaymentOfAdvanceMedicarePayments_3ea88ca8-a93f-44b1-9401-c084d7fc79a7" xlink:href="rdnt-20221231.xsd#rdnt_RepaymentOfAdvanceMedicarePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_rdnt_RepaymentOfAdvanceMedicarePayments_3ea88ca8-a93f-44b1-9401-c084d7fc79a7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GovernmentAssistanceAmountCumulative_581f3391-5488-4c0c-8bf4-94e33b423b9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GovernmentAssistanceAmountCumulative"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_GovernmentAssistanceAmountCumulative_581f3391-5488-4c0c-8bf4-94e33b423b9e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GovernmentAssistanceStatementOfFinancialPositionExtensibleEnumeration_186011b8-a1e4-45dc-bcc0-ef7a37e38288" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GovernmentAssistanceStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_GovernmentAssistanceStatementOfFinancialPositionExtensibleEnumeration_186011b8-a1e4-45dc-bcc0-ef7a37e38288" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CaresActRefundableClaimPercentage_a6307051-3ecb-4e82-97e5-e8d95cfc410e" xlink:href="rdnt-20221231.xsd#rdnt_CaresActRefundableClaimPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_rdnt_CaresActRefundableClaimPercentage_a6307051-3ecb-4e82-97e5-e8d95cfc410e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SocialSecurityTaxEmployerDeferralCARESAct_9caed4cf-08cb-40aa-8b0b-73a92ff94ffe" xlink:href="rdnt-20221231.xsd#rdnt_SocialSecurityTaxEmployerDeferralCARESAct"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_rdnt_SocialSecurityTaxEmployerDeferralCARESAct_9caed4cf-08cb-40aa-8b0b-73a92ff94ffe" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct_daa9fe7b-b537-486d-b511-1c4421510d31" xlink:href="rdnt-20221231.xsd#rdnt_IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_rdnt_IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct_daa9fe7b-b537-486d-b511-1c4421510d31" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ContractsReceivableFactoringReceivable_0ad75fd5-48ce-4e49-8a5c-212de70a41ff" xlink:href="rdnt-20221231.xsd#rdnt_ContractsReceivableFactoringReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_rdnt_ContractsReceivableFactoringReceivable_0ad75fd5-48ce-4e49-8a5c-212de70a41ff" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_623b9d6c-e948-44df-bdac-767c53bc6c55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_623b9d6c-e948-44df-bdac-767c53bc6c55" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_103a0aa5-1dd0-4840-b21e-f8582b80633a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_103a0aa5-1dd0-4840-b21e-f8582b80633a" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_8914f231-06b8-45e9-916d-3cf972fcf2c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_8914f231-06b8-45e9-916d-3cf972fcf2c0" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_4000af0a-f5d2-4c87-9722-5423c9f36e0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_Goodwill_4000af0a-f5d2-4c87-9722-5423c9f36e0d" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_77a68920-fb6d-4d67-a3fd-24271518ca4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_77a68920-fb6d-4d67-a3fd-24271518ca4a" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_74809235-9945-4fed-8ff0-047deb8b7ab3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_74809235-9945-4fed-8ff0-047deb8b7ab3" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_9189547d-6780-4bba-931d-c226f343a9b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_9189547d-6780-4bba-931d-c226f343a9b6" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_0db075b0-4c13-4fca-8f7f-e3beac7a60c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_0db075b0-4c13-4fca-8f7f-e3beac7a60c0" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OperatingLeaseLeaseAbandonmentCharge_c4d097a5-d265-4fec-ba6f-e31f2df212d7" xlink:href="rdnt-20221231.xsd#rdnt_OperatingLeaseLeaseAbandonmentCharge"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_rdnt_OperatingLeaseLeaseAbandonmentCharge_c4d097a5-d265-4fec-ba6f-e31f2df212d7" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WorkersCompensationLiabilityCurrent_2649bdd1-46dc-4738-8f6d-a3f8ba28d240" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WorkersCompensationLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_WorkersCompensationLiabilityCurrent_2649bdd1-46dc-4738-8f6d-a3f8ba28d240" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MedicalMalpracticeDeductiblePerIncidence_ed95c60f-6f8e-4e4b-a0be-833c1cb85219" xlink:href="rdnt-20221231.xsd#rdnt_MedicalMalpracticeDeductiblePerIncidence"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_rdnt_MedicalMalpracticeDeductiblePerIncidence_ed95c60f-6f8e-4e4b-a0be-833c1cb85219" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfInsuranceReserve_4e2bd48d-81dd-45cf-b812-1ebbf05b364a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SelfInsuranceReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_SelfInsuranceReserve_4e2bd48d-81dd-45cf-b812-1ebbf05b364a" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MedicalInsuranceStopLossPolicyClaimAmount_d7587332-7aba-4d7a-b0b4-e33f6e17ddec" xlink:href="rdnt-20221231.xsd#rdnt_MedicalInsuranceStopLossPolicyClaimAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_rdnt_MedicalInsuranceStopLossPolicyClaimAmount_d7587332-7aba-4d7a-b0b4-e33f6e17ddec" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_31b70ae7-a56d-4c78-9ffc-1cbcc4ee5ae4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_31b70ae7-a56d-4c78-9ffc-1cbcc4ee5ae4" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_b40bfb85-b749-4010-bb38-d9afe98ff46b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_b40bfb85-b749-4010-bb38-d9afe98ff46b" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_95482530-1524-43e8-b73f-6755ed298ad9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_95482530-1524-43e8-b73f-6755ed298ad9" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans_801a207e-cd00-45c0-9684-65f1cf15be7a" xlink:href="rdnt-20221231.xsd#rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans_801a207e-cd00-45c0-9684-65f1cf15be7a" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_2701bebe-546d-4948-b228-6d0c5c04ee00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_2701bebe-546d-4948-b228-6d0c5c04ee00" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_c4298c2d-37b2-4a07-9275-0d322c54892d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_c4298c2d-37b2-4a07-9275-0d322c54892d" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_da9fbaec-d3ab-41e0-b61d-0efec7e6e78c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_da9fbaec-d3ab-41e0-b61d-0efec7e6e78c" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNumberOfInstrumentsHeld_632fb06f-3f7e-462f-b842-fab2948bfb7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetNumberOfInstrumentsHeld"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_DerivativeAssetNumberOfInstrumentsHeld_632fb06f-3f7e-462f-b842-fab2948bfb7b" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_481a3583-8f84-4011-bf53-46d5342e737e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_481a3583-8f84-4011-bf53-46d5342e737e" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeBasisSpreadOnVariableRate_12396e71-0e18-49f9-8f02-0bd1963f43ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeBasisSpreadOnVariableRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_DerivativeBasisSpreadOnVariableRate_12396e71-0e18-49f9-8f02-0bd1963f43ed" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized_0fba57d8-4b1d-4087-a0df-1ed839035642" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized_0fba57d8-4b1d-4087-a0df-1ed839035642" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_995542b7-1c11-410a-9ec7-980a7712427b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_StockholdersEquity_995542b7-1c11-410a-9ec7-980a7712427b" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MonthlyAmortizationOfDeferredHedgeGains_4594370a-fb11-426e-8428-942762797408" xlink:href="rdnt-20221231.xsd#rdnt_MonthlyAmortizationOfDeferredHedgeGains"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_rdnt_MonthlyAmortizationOfDeferredHedgeGains_4594370a-fb11-426e-8428-942762797408" xlink:type="arc" order="35"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_1728b58d-b5c7-4fc2-86f8-071592b9c5a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_1728b58d-b5c7-4fc2-86f8-071592b9c5a7" xlink:type="arc" order="36"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones_815f4b19-8532-4529-b4ef-36a10dc07862" xlink:href="rdnt-20221231.xsd#rdnt_BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_rdnt_BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones_815f4b19-8532-4529-b4ef-36a10dc07862" xlink:type="arc" order="37"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_2138b0df-60e3-46cf-b160-8babad9cf751" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_2138b0df-60e3-46cf-b160-8babad9cf751" xlink:type="arc" order="38"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneOne_6a4cd74d-6276-4430-9e8f-6623bcb51a02" xlink:href="rdnt-20221231.xsd#rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneOne"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneOne_6a4cd74d-6276-4430-9e8f-6623bcb51a02" xlink:type="arc" order="39"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneTwo_397fc82f-d59e-4580-8d07-837742e0313a" xlink:href="rdnt-20221231.xsd#rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneTwo_397fc82f-d59e-4580-8d07-837742e0313a" xlink:type="arc" order="40"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod_5df7f6b0-2724-46d3-94fd-dbcd0a141b04" xlink:href="rdnt-20221231.xsd#rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod_5df7f6b0-2724-46d3-94fd-dbcd0a141b04" xlink:type="arc" order="41"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares_dcd2a22e-f10d-4cd2-80b4-188c0cde61a7" xlink:href="rdnt-20221231.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares_dcd2a22e-f10d-4cd2-80b4-188c0cde61a7" xlink:type="arc" order="42"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution_4715d6ac-0ce6-4d21-96ca-b81b82b12661" xlink:href="rdnt-20221231.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution_4715d6ac-0ce6-4d21-96ca-b81b82b12661" xlink:type="arc" order="43"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_a7d5037f-2f00-4b3b-9ca3-7ca2d8695718" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_LineOfCredit_a7d5037f-2f00-4b3b-9ca3-7ca2d8695718" xlink:type="arc" order="44"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestments_72e86fb4-63d2-48e5-8e8e-fba94050e953" xlink:href="rdnt-20221231.xsd#rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestments_72e86fb4-63d2-48e5-8e8e-fba94050e953" xlink:type="arc" order="45"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentAggregateCost_18f82dc0-b9c1-4275-aa2c-eef82daadccf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_EquityMethodInvestmentAggregateCost_18f82dc0-b9c1-4275-aa2c-eef82daadccf" xlink:type="arc" order="46"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_49ad4d3e-d0a9-498f-ac4a-5d6feb5e5c5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_49ad4d3e-d0a9-498f-ac4a-5d6feb5e5c5a" xlink:type="arc" order="47"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_03e0bc26-7a28-4fdd-aacc-41ce082e7e8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_03e0bc26-7a28-4fdd-aacc-41ce082e7e8e" xlink:type="arc" order="48"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityMethodInvestmentSharesPurchased_0557be36-cb6f-421d-b063-3c5bd44928d7" xlink:href="rdnt-20221231.xsd#rdnt_EquityMethodInvestmentSharesPurchased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_rdnt_EquityMethodInvestmentSharesPurchased_0557be36-cb6f-421d-b063-3c5bd44928d7" xlink:type="arc" order="49"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_b0bf2ad5-b364-4813-8f46-54bf687b0e6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_ShortTermBorrowings_b0bf2ad5-b364-4813-8f46-54bf687b0e6d" xlink:type="arc" order="50"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_fb20f416-8f6f-48f1-987a-a5ebe9d5c055" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_fb20f416-8f6f-48f1-987a-a5ebe9d5c055" xlink:type="arc" order="51"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_7182b117-68d8-4564-be55-a9174d991e13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToFundLongtermLoansToRelatedParties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_7182b117-68d8-4564-be55-a9174d991e13" xlink:type="arc" order="52"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberofUnconsolidatedJointVentures_1f446ce4-5fb6-4ff4-8b56-ecde4fc6300b" xlink:href="rdnt-20221231.xsd#rdnt_NumberofUnconsolidatedJointVentures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_rdnt_NumberofUnconsolidatedJointVentures_1f446ce4-5fb6-4ff4-8b56-ecde4fc6300b" xlink:type="arc" order="53"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityOwnershipPercentage_e7699f61-648a-47f2-9532-7b118eb7c068" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_VariableInterestEntityOwnershipPercentage_e7699f61-648a-47f2-9532-7b118eb7c068" xlink:type="arc" order="54"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ManagementServiceFees_0e2e7a4b-559b-4e39-a4d6-a65bd97632df" xlink:href="rdnt-20221231.xsd#rdnt_ManagementServiceFees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_rdnt_ManagementServiceFees_0e2e7a4b-559b-4e39-a4d6-a65bd97632df" xlink:type="arc" order="55"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityMethodInvestmentAdditionalContribution_1c5b4ab4-e6ee-474f-8c62-e21e9f668e20" xlink:href="rdnt-20221231.xsd#rdnt_EquityMethodInvestmentAdditionalContribution"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_rdnt_EquityMethodInvestmentAdditionalContribution_1c5b4ab4-e6ee-474f-8c62-e21e9f668e20" xlink:type="arc" order="56"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberOfAssetsSold_90e43042-d3c5-4159-9c49-e6b409328c79" xlink:href="rdnt-20221231.xsd#rdnt_NumberOfAssetsSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_rdnt_NumberOfAssetsSold_90e43042-d3c5-4159-9c49-e6b409328c79" xlink:type="arc" order="57"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_c33c2554-daa4-48fa-9860-27cd589ef1c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_c33c2554-daa4-48fa-9860-27cd589ef1c6" xlink:type="arc" order="58"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDividendsReceived_aa74219a-6853-4c28-acb6-aff06614fc87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDividendsReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_ProceedsFromDividendsReceived_aa74219a-6853-4c28-acb6-aff06614fc87" xlink:type="arc" order="59"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_728e478f-1ba3-4ef1-ac4d-2ef5c24900a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_EquityMethodInvestments_728e478f-1ba3-4ef1-ac4d-2ef5c24900a3" xlink:type="arc" order="60"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cb1966b5-f8f8-4cda-bc2c-d03f08d95428" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cb1966b5-f8f8-4cda-bc2c-d03f08d95428" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis_a7efa7cf-d841-4ff0-aa65-9d7b184ac72c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cb1966b5-f8f8-4cda-bc2c-d03f08d95428" xlink:to="loc_us-gaap_UnusualOrInfrequentItemAxis_a7efa7cf-d841-4ff0-aa65-9d7b184ac72c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_a7efa7cf-d841-4ff0-aa65-9d7b184ac72c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_a7efa7cf-d841-4ff0-aa65-9d7b184ac72c" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_a7efa7cf-d841-4ff0-aa65-9d7b184ac72c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_9428a886-8df7-42d4-9a5e-1b71b4b4e84e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_a7efa7cf-d841-4ff0-aa65-9d7b184ac72c" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_9428a886-8df7-42d4-9a5e-1b71b4b4e84e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_COVID19PandemicMember_6d483b15-209e-48f1-ad20-1ccd61c2f83f" xlink:href="rdnt-20221231.xsd#rdnt_COVID19PandemicMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain_9428a886-8df7-42d4-9a5e-1b71b4b4e84e" xlink:to="loc_rdnt_COVID19PandemicMember_6d483b15-209e-48f1-ad20-1ccd61c2f83f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_0811a726-77c3-4ae0-8c91-4060abc7214f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cb1966b5-f8f8-4cda-bc2c-d03f08d95428" xlink:to="loc_us-gaap_DebtInstrumentAxis_0811a726-77c3-4ae0-8c91-4060abc7214f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_0811a726-77c3-4ae0-8c91-4060abc7214f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_0811a726-77c3-4ae0-8c91-4060abc7214f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_0811a726-77c3-4ae0-8c91-4060abc7214f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_795c9426-27dc-4adc-8cd3-86ec1b903dae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_0811a726-77c3-4ae0-8c91-4060abc7214f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_795c9426-27dc-4adc-8cd3-86ec1b903dae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PaycheckProtectionProgramLoansMember_7c356c83-88df-4e99-b0e2-82044b6fc884" xlink:href="rdnt-20221231.xsd#rdnt_PaycheckProtectionProgramLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_795c9426-27dc-4adc-8cd3-86ec1b903dae" xlink:to="loc_rdnt_PaycheckProtectionProgramLoansMember_7c356c83-88df-4e99-b0e2-82044b6fc884" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BarclaysMember_772195e0-8bf3-45ce-bae8-56ba08c27b85" xlink:href="rdnt-20221231.xsd#rdnt_BarclaysMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_795c9426-27dc-4adc-8cd3-86ec1b903dae" xlink:to="loc_rdnt_BarclaysMember_772195e0-8bf3-45ce-bae8-56ba08c27b85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TruistMember_5500b5e1-fda4-4560-b4c9-4543cb4ea8dc" xlink:href="rdnt-20221231.xsd#rdnt_TruistMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_795c9426-27dc-4adc-8cd3-86ec1b903dae" xlink:to="loc_rdnt_TruistMember_5500b5e1-fda4-4560-b4c9-4543cb4ea8dc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_acf64a1d-d0f6-4a69-87b8-abeeb33ed43c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cb1966b5-f8f8-4cda-bc2c-d03f08d95428" xlink:to="loc_srt_ProductOrServiceAxis_acf64a1d-d0f6-4a69-87b8-abeeb33ed43c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_acf64a1d-d0f6-4a69-87b8-abeeb33ed43c_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_acf64a1d-d0f6-4a69-87b8-abeeb33ed43c" xlink:to="loc_srt_ProductsAndServicesDomain_acf64a1d-d0f6-4a69-87b8-abeeb33ed43c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_10e74b96-4213-4108-b538-ae1cfe0186ba" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_acf64a1d-d0f6-4a69-87b8-abeeb33ed43c" xlink:to="loc_srt_ProductsAndServicesDomain_10e74b96-4213-4108-b538-ae1cfe0186ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PatientServicesNetMember_c1a08d8b-2dcc-4514-ab43-0e8365f2f280" xlink:href="rdnt-20221231.xsd#rdnt_PatientServicesNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_10e74b96-4213-4108-b538-ae1cfe0186ba" xlink:to="loc_rdnt_PatientServicesNetMember_c1a08d8b-2dcc-4514-ab43-0e8365f2f280" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_ef314c31-d835-4161-8a9a-31afaace642f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cb1966b5-f8f8-4cda-bc2c-d03f08d95428" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_ef314c31-d835-4161-8a9a-31afaace642f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ef314c31-d835-4161-8a9a-31afaace642f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ef314c31-d835-4161-8a9a-31afaace642f" xlink:to="loc_us-gaap_SegmentDomain_ef314c31-d835-4161-8a9a-31afaace642f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_32770b1e-6669-4d43-9dfd-cdd9dd8ba21d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ef314c31-d835-4161-8a9a-31afaace642f" xlink:to="loc_us-gaap_SegmentDomain_32770b1e-6669-4d43-9dfd-cdd9dd8ba21d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ERADMember_5787c63c-6972-4a72-8ddc-ac692424060f" xlink:href="rdnt-20221231.xsd#rdnt_ERADMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_32770b1e-6669-4d43-9dfd-cdd9dd8ba21d" xlink:to="loc_rdnt_ERADMember_5787c63c-6972-4a72-8ddc-ac692424060f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ImagingCentersMember_38fadbc7-9f4e-4af3-a6c4-64f2b75f40c2" xlink:href="rdnt-20221231.xsd#rdnt_ImagingCentersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_32770b1e-6669-4d43-9dfd-cdd9dd8ba21d" xlink:to="loc_rdnt_ImagingCentersMember_38fadbc7-9f4e-4af3-a6c4-64f2b75f40c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_5d868568-f4a6-4df5-a4f1-b2cd39058ec4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cb1966b5-f8f8-4cda-bc2c-d03f08d95428" xlink:to="loc_srt_RangeAxis_5d868568-f4a6-4df5-a4f1-b2cd39058ec4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5d868568-f4a6-4df5-a4f1-b2cd39058ec4_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_5d868568-f4a6-4df5-a4f1-b2cd39058ec4" xlink:to="loc_srt_RangeMember_5d868568-f4a6-4df5-a4f1-b2cd39058ec4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cdb31e97-cb65-4519-a5a2-51f225469504" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_5d868568-f4a6-4df5-a4f1-b2cd39058ec4" xlink:to="loc_srt_RangeMember_cdb31e97-cb65-4519-a5a2-51f225469504" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_48203bc3-dcdd-4251-b5a1-fa07093672b0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_cdb31e97-cb65-4519-a5a2-51f225469504" xlink:to="loc_srt_MinimumMember_48203bc3-dcdd-4251-b5a1-fa07093672b0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_c28eae78-6e38-4e1a-b0e1-521c9433ecf2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_cdb31e97-cb65-4519-a5a2-51f225469504" xlink:to="loc_srt_MaximumMember_c28eae78-6e38-4e1a-b0e1-521c9433ecf2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e9e445b1-7bfd-48e3-9f99-690223fdacff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cb1966b5-f8f8-4cda-bc2c-d03f08d95428" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e9e445b1-7bfd-48e3-9f99-690223fdacff" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e9e445b1-7bfd-48e3-9f99-690223fdacff_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e9e445b1-7bfd-48e3-9f99-690223fdacff" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e9e445b1-7bfd-48e3-9f99-690223fdacff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_02aa2643-eb9f-457a-b6fb-838b867b674d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e9e445b1-7bfd-48e3-9f99-690223fdacff" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_02aa2643-eb9f-457a-b6fb-838b867b674d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ProperyAndEquipmentNetMember_b249f774-b22e-413c-8878-dbf3ca1cc598" xlink:href="rdnt-20221231.xsd#rdnt_ProperyAndEquipmentNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_02aa2643-eb9f-457a-b6fb-838b867b674d" xlink:to="loc_rdnt_ProperyAndEquipmentNetMember_b249f774-b22e-413c-8878-dbf3ca1cc598" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_c9da8887-0573-40f4-abe5-1c71be3a6cfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_02aa2643-eb9f-457a-b6fb-838b867b674d" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_c9da8887-0573-40f4-abe5-1c71be3a6cfc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_9c264554-8c6a-4899-a13f-88574f6a200c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_02aa2643-eb9f-457a-b6fb-838b867b674d" xlink:to="loc_us-gaap_ConstructionInProgressMember_9c264554-8c6a-4899-a13f-88574f6a200c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_c93ef595-c406-4675-abec-f5d30d8ce40d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cb1966b5-f8f8-4cda-bc2c-d03f08d95428" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_c93ef595-c406-4675-abec-f5d30d8ce40d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_c93ef595-c406-4675-abec-f5d30d8ce40d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_c93ef595-c406-4675-abec-f5d30d8ce40d" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_c93ef595-c406-4675-abec-f5d30d8ce40d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_02320a2b-6a50-46ff-b77b-c49f044e001b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_c93ef595-c406-4675-abec-f5d30d8ce40d" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_02320a2b-6a50-46ff-b77b-c49f044e001b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_b73a69ba-aaa5-4d67-86fc-891f5cf00b88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_02320a2b-6a50-46ff-b77b-c49f044e001b" xlink:to="loc_us-gaap_TradeNamesMember_b73a69ba-aaa5-4d67-86fc-891f5cf00b88" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceContractAxis_18bd414c-0cac-4424-ae8a-d3f1e05ddef4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceContractAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cb1966b5-f8f8-4cda-bc2c-d03f08d95428" xlink:to="loc_us-gaap_ReinsuranceContractAxis_18bd414c-0cac-4424-ae8a-d3f1e05ddef4" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_352ec7ab-8901-4769-9ff9-59105900eea4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cb1966b5-f8f8-4cda-bc2c-d03f08d95428" xlink:to="loc_srt_CounterpartyNameAxis_352ec7ab-8901-4769-9ff9-59105900eea4" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_352ec7ab-8901-4769-9ff9-59105900eea4_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_352ec7ab-8901-4769-9ff9-59105900eea4" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_352ec7ab-8901-4769-9ff9-59105900eea4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_70b9c1a2-2494-4127-8aa7-6992253b06ed" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_352ec7ab-8901-4769-9ff9-59105900eea4" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_70b9c1a2-2494-4127-8aa7-6992253b06ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BlueShieldMember_af27530d-1d2a-459f-8eb5-146643977c2e" xlink:href="rdnt-20221231.xsd#rdnt_BlueShieldMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_70b9c1a2-2494-4127-8aa7-6992253b06ed" xlink:to="loc_rdnt_BlueShieldMember_af27530d-1d2a-459f-8eb5-146643977c2e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DignityHealthMember_1963c231-c2da-48c9-ad17-6ae9cdd6b09f" xlink:href="rdnt-20221231.xsd#rdnt_DignityHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_70b9c1a2-2494-4127-8aa7-6992253b06ed" xlink:to="loc_rdnt_DignityHealthMember_1963c231-c2da-48c9-ad17-6ae9cdd6b09f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_f7ab6e5a-b536-4896-b29a-1f1ca72ce7a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cb1966b5-f8f8-4cda-bc2c-d03f08d95428" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_f7ab6e5a-b536-4896-b29a-1f1ca72ce7a1" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f7ab6e5a-b536-4896-b29a-1f1ca72ce7a1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f7ab6e5a-b536-4896-b29a-1f1ca72ce7a1" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f7ab6e5a-b536-4896-b29a-1f1ca72ce7a1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f35fd62b-c44b-43b5-8779-8a536a62339d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f7ab6e5a-b536-4896-b29a-1f1ca72ce7a1" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f35fd62b-c44b-43b5-8779-8a536a62339d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_QuantibMember_49d3d0e6-45e3-4916-b426-755d56d56473" xlink:href="rdnt-20221231.xsd#rdnt_QuantibMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f35fd62b-c44b-43b5-8779-8a536a62339d" xlink:to="loc_rdnt_QuantibMember_49d3d0e6-45e3-4916-b426-755d56d56473" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MontclairMember_e82aeb4a-0931-4902-b6bf-a7cd5547df60" xlink:href="rdnt-20221231.xsd#rdnt_MontclairMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f35fd62b-c44b-43b5-8779-8a536a62339d" xlink:to="loc_rdnt_MontclairMember_e82aeb4a-0931-4902-b6bf-a7cd5547df60" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HeartAndLungImagingLimitedMember_aa39945c-9eff-419f-bfad-11f4e528f02b" xlink:href="rdnt-20221231.xsd#rdnt_HeartAndLungImagingLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f35fd62b-c44b-43b5-8779-8a536a62339d" xlink:to="loc_rdnt_HeartAndLungImagingLimitedMember_aa39945c-9eff-419f-bfad-11f4e528f02b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AidenceMember_83dd7b22-ea09-421e-bcd5-50372cc58c98" xlink:href="rdnt-20221231.xsd#rdnt_AidenceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f35fd62b-c44b-43b5-8779-8a536a62339d" xlink:to="loc_rdnt_AidenceMember_83dd7b22-ea09-421e-bcd5-50372cc58c98" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_3f818785-46c1-4824-b761-c51736fee3e8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cb1966b5-f8f8-4cda-bc2c-d03f08d95428" xlink:to="loc_dei_LegalEntityAxis_3f818785-46c1-4824-b761-c51736fee3e8" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_3f818785-46c1-4824-b761-c51736fee3e8_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_3f818785-46c1-4824-b761-c51736fee3e8" xlink:to="loc_dei_EntityDomain_3f818785-46c1-4824-b761-c51736fee3e8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_9a3ce541-17f1-4502-adc2-091e405c9ddd" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_3f818785-46c1-4824-b761-c51736fee3e8" xlink:to="loc_dei_EntityDomain_9a3ce541-17f1-4502-adc2-091e405c9ddd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GlendaleAdvancedImagingMember_0b49c52b-55e6-4d14-a53c-b2e12987f155" xlink:href="rdnt-20221231.xsd#rdnt_GlendaleAdvancedImagingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_9a3ce541-17f1-4502-adc2-091e405c9ddd" xlink:to="loc_rdnt_GlendaleAdvancedImagingMember_0b49c52b-55e6-4d14-a53c-b2e12987f155" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_ecb26260-30c9-43c8-8821-c35b2707de77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cb1966b5-f8f8-4cda-bc2c-d03f08d95428" xlink:to="loc_us-gaap_PlanNameAxis_ecb26260-30c9-43c8-8821-c35b2707de77" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_ecb26260-30c9-43c8-8821-c35b2707de77_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_ecb26260-30c9-43c8-8821-c35b2707de77" xlink:to="loc_us-gaap_PlanNameDomain_ecb26260-30c9-43c8-8821-c35b2707de77_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_4eb7f5c1-84e0-4fcb-a323-55e7bb8ef0be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_ecb26260-30c9-43c8-8821-c35b2707de77" xlink:to="loc_us-gaap_PlanNameDomain_4eb7f5c1-84e0-4fcb-a323-55e7bb8ef0be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedPlanMember_82b1be51-ded5-4094-b843-c0f84f27d46b" xlink:href="rdnt-20221231.xsd#rdnt_RestatedPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_4eb7f5c1-84e0-4fcb-a323-55e7bb8ef0be" xlink:to="loc_rdnt_RestatedPlanMember_82b1be51-ded5-4094-b843-c0f84f27d46b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuritiesFinancingTransactionAxis_8372d204-92fe-4d80-98cd-5d18b51711f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuritiesFinancingTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cb1966b5-f8f8-4cda-bc2c-d03f08d95428" xlink:to="loc_us-gaap_SecuritiesFinancingTransactionAxis_8372d204-92fe-4d80-98cd-5d18b51711f8" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_8372d204-92fe-4d80-98cd-5d18b51711f8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuritiesFinancingTransactionTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionAxis_8372d204-92fe-4d80-98cd-5d18b51711f8" xlink:to="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_8372d204-92fe-4d80-98cd-5d18b51711f8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_ed649b74-6afd-4a2d-872c-d913478ab594" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuritiesFinancingTransactionTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionAxis_8372d204-92fe-4d80-98cd-5d18b51711f8" xlink:to="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_ed649b74-6afd-4a2d-872c-d913478ab594" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_Caps2016Member_b057ec4d-f18a-4631-833b-a245af22501f" xlink:href="rdnt-20221231.xsd#rdnt_Caps2016Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_ed649b74-6afd-4a2d-872c-d913478ab594" xlink:to="loc_rdnt_Caps2016Member_b057ec4d-f18a-4631-833b-a245af22501f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_A2019SWAPSMember_b4f0ffae-d467-458c-840a-0bd637b9c618" xlink:href="rdnt-20221231.xsd#rdnt_A2019SWAPSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_ed649b74-6afd-4a2d-872c-d913478ab594" xlink:to="loc_rdnt_A2019SWAPSMember_b4f0ffae-d467-458c-840a-0bd637b9c618" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_A2019SWAPS1Member_e387c52b-0baf-4893-98cc-d3e6d2d22852" xlink:href="rdnt-20221231.xsd#rdnt_A2019SWAPS1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_ed649b74-6afd-4a2d-872c-d913478ab594" xlink:to="loc_rdnt_A2019SWAPS1Member_e387c52b-0baf-4893-98cc-d3e6d2d22852" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditDerivativesByContractTypeAxis_60aabb99-b8a2-42d7-9495-750cd088c6c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditDerivativesByContractTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cb1966b5-f8f8-4cda-bc2c-d03f08d95428" xlink:to="loc_us-gaap_CreditDerivativesByContractTypeAxis_60aabb99-b8a2-42d7-9495-750cd088c6c0" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditDerivativesContractTypeDomain_60aabb99-b8a2-42d7-9495-750cd088c6c0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditDerivativesContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditDerivativesByContractTypeAxis_60aabb99-b8a2-42d7-9495-750cd088c6c0" xlink:to="loc_us-gaap_CreditDerivativesContractTypeDomain_60aabb99-b8a2-42d7-9495-750cd088c6c0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditDerivativesContractTypeDomain_333df92b-7683-4c27-945a-49ef72842a50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditDerivativesContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditDerivativesByContractTypeAxis_60aabb99-b8a2-42d7-9495-750cd088c6c0" xlink:to="loc_us-gaap_CreditDerivativesContractTypeDomain_333df92b-7683-4c27-945a-49ef72842a50" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_September2020CapMember_e356916f-f91b-4bd3-b404-17a09c403c40" xlink:href="rdnt-20221231.xsd#rdnt_September2020CapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditDerivativesContractTypeDomain_333df92b-7683-4c27-945a-49ef72842a50" xlink:to="loc_rdnt_September2020CapMember_e356916f-f91b-4bd3-b404-17a09c403c40" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_October2020CapMember_6af58ec9-bad5-4fec-bb19-92c4b12fe73e" xlink:href="rdnt-20221231.xsd#rdnt_October2020CapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditDerivativesContractTypeDomain_333df92b-7683-4c27-945a-49ef72842a50" xlink:to="loc_rdnt_October2020CapMember_6af58ec9-bad5-4fec-bb19-92c4b12fe73e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_October2023Member_bcbb44a0-701a-4c51-b88f-691fca5d814b" xlink:href="rdnt-20221231.xsd#rdnt_October2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditDerivativesContractTypeDomain_333df92b-7683-4c27-945a-49ef72842a50" xlink:to="loc_rdnt_October2023Member_bcbb44a0-701a-4c51-b88f-691fca5d814b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_October2025Member_9c4976aa-8681-4227-a2a6-86d852d52f16" xlink:href="rdnt-20221231.xsd#rdnt_October2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditDerivativesContractTypeDomain_333df92b-7683-4c27-945a-49ef72842a50" xlink:to="loc_rdnt_October2025Member_9c4976aa-8681-4227-a2a6-86d852d52f16" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_c884720e-5e87-4689-9fd9-f23bdecf41ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cb1966b5-f8f8-4cda-bc2c-d03f08d95428" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_c884720e-5e87-4689-9fd9-f23bdecf41ad" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_c884720e-5e87-4689-9fd9-f23bdecf41ad_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_c884720e-5e87-4689-9fd9-f23bdecf41ad" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_c884720e-5e87-4689-9fd9-f23bdecf41ad_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_a8ee4597-2673-41f2-98a8-8f991d39cf50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_c884720e-5e87-4689-9fd9-f23bdecf41ad" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_a8ee4597-2673-41f2-98a8-8f991d39cf50" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_Caps2016Member_dc2effcc-1bb3-4b0d-a106-48d254c9b901" xlink:href="rdnt-20221231.xsd#rdnt_Caps2016Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_a8ee4597-2673-41f2-98a8-8f991d39cf50" xlink:to="loc_rdnt_Caps2016Member_dc2effcc-1bb3-4b0d-a106-48d254c9b901" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_a2b5ee91-5486-48f8-b329-b5ea3d1e6625" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_a8ee4597-2673-41f2-98a8-8f991d39cf50" xlink:to="loc_us-gaap_InterestRateSwapMember_a2b5ee91-5486-48f8-b329-b5ea3d1e6625" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_ea487407-b556-4cd4-8d29-a284ad3092b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cb1966b5-f8f8-4cda-bc2c-d03f08d95428" xlink:to="loc_us-gaap_VariableRateAxis_ea487407-b556-4cd4-8d29-a284ad3092b8" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_ea487407-b556-4cd4-8d29-a284ad3092b8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_ea487407-b556-4cd4-8d29-a284ad3092b8" xlink:to="loc_us-gaap_VariableRateDomain_ea487407-b556-4cd4-8d29-a284ad3092b8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_b186051e-e0eb-4115-9c71-6e3521d02177" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_ea487407-b556-4cd4-8d29-a284ad3092b8" xlink:to="loc_us-gaap_VariableRateDomain_b186051e-e0eb-4115-9c71-6e3521d02177" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_ba6d361b-effb-4bbe-a03e-c73bade2e601" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_b186051e-e0eb-4115-9c71-6e3521d02177" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_ba6d361b-effb-4bbe-a03e-c73bade2e601" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_74eabec0-4fa2-4b82-b340-af841a070611" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cb1966b5-f8f8-4cda-bc2c-d03f08d95428" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_74eabec0-4fa2-4b82-b340-af841a070611" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_74eabec0-4fa2-4b82-b340-af841a070611_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_74eabec0-4fa2-4b82-b340-af841a070611" xlink:to="loc_us-gaap_EquityComponentDomain_74eabec0-4fa2-4b82-b340-af841a070611_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_abc294ca-3eac-4988-b891-c0cdf8264c1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_74eabec0-4fa2-4b82-b340-af841a070611" xlink:to="loc_us-gaap_EquityComponentDomain_abc294ca-3eac-4988-b891-c0cdf8264c1b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_200e6eef-c7e8-4e70-ae5b-f2783cf5151e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_abc294ca-3eac-4988-b891-c0cdf8264c1b" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_200e6eef-c7e8-4e70-ae5b-f2783cf5151e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_6b64a20c-bf59-4097-8a43-c9513ed7ed5c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cb1966b5-f8f8-4cda-bc2c-d03f08d95428" xlink:to="loc_srt_StatementScenarioAxis_6b64a20c-bf59-4097-8a43-c9513ed7ed5c" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_6b64a20c-bf59-4097-8a43-c9513ed7ed5c_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_6b64a20c-bf59-4097-8a43-c9513ed7ed5c" xlink:to="loc_srt_ScenarioUnspecifiedDomain_6b64a20c-bf59-4097-8a43-c9513ed7ed5c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_d6319cde-5d11-41cf-8ab3-865f1800c0cf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_6b64a20c-bf59-4097-8a43-c9513ed7ed5c" xlink:to="loc_srt_ScenarioUnspecifiedDomain_d6319cde-5d11-41cf-8ab3-865f1800c0cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_add6befe-b9c5-40fd-a385-a6b94ebadd98" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_d6319cde-5d11-41cf-8ab3-865f1800c0cf" xlink:to="loc_srt_ScenarioForecastMember_add6befe-b9c5-40fd-a385-a6b94ebadd98" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_3dd4362b-bc08-40c5-a40f-c5761e2ef8f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cb1966b5-f8f8-4cda-bc2c-d03f08d95428" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_3dd4362b-bc08-40c5-a40f-c5761e2ef8f1" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_3dd4362b-bc08-40c5-a40f-c5761e2ef8f1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_3dd4362b-bc08-40c5-a40f-c5761e2ef8f1" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_3dd4362b-bc08-40c5-a40f-c5761e2ef8f1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_91c031a2-edf4-4315-bee0-236ed7cdd2c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_3dd4362b-bc08-40c5-a40f-c5761e2ef8f1" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_91c031a2-edf4-4315-bee0-236ed7cdd2c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_b052a590-e91e-41c0-97da-ca5cce234cb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_91c031a2-edf4-4315-bee0-236ed7cdd2c8" xlink:to="loc_us-gaap_SubsequentEventMember_b052a590-e91e-41c0-97da-ca5cce234cb0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_242ccdf9-65ed-420a-aedc-e9a479db7ea3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cb1966b5-f8f8-4cda-bc2c-d03f08d95428" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_242ccdf9-65ed-420a-aedc-e9a479db7ea3" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_242ccdf9-65ed-420a-aedc-e9a479db7ea3_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_242ccdf9-65ed-420a-aedc-e9a479db7ea3" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_242ccdf9-65ed-420a-aedc-e9a479db7ea3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_e7b51bb4-dde3-4ef6-a766-90e1a900adbb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_242ccdf9-65ed-420a-aedc-e9a479db7ea3" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_e7b51bb4-dde3-4ef6-a766-90e1a900adbb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MedicVisionMember_599c9a96-3030-425a-9247-a134939d90a3" xlink:href="rdnt-20221231.xsd#rdnt_MedicVisionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_e7b51bb4-dde3-4ef6-a766-90e1a900adbb" xlink:to="loc_rdnt_MedicVisionMember_599c9a96-3030-425a-9247-a134939d90a3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TurnerImagingSystemsMember_1a5f9298-9cda-46ab-a900-e40d770579b2" xlink:href="rdnt-20221231.xsd#rdnt_TurnerImagingSystemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_e7b51bb4-dde3-4ef6-a766-90e1a900adbb" xlink:to="loc_rdnt_TurnerImagingSystemsMember_1a5f9298-9cda-46ab-a900-e40d770579b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WhiteRabbitaiIncMember_3bb58597-c6dc-48c9-8830-ca2871a35cbf" xlink:href="rdnt-20221231.xsd#rdnt_WhiteRabbitaiIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_e7b51bb4-dde3-4ef6-a766-90e1a900adbb" xlink:to="loc_rdnt_WhiteRabbitaiIncMember_3bb58597-c6dc-48c9-8830-ca2871a35cbf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ArizonaDiagnosticsGroupMember_a166cde3-8e50-4572-b6e8-6279f328e6bf" xlink:href="rdnt-20221231.xsd#rdnt_ArizonaDiagnosticsGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_e7b51bb4-dde3-4ef6-a766-90e1a900adbb" xlink:to="loc_rdnt_ArizonaDiagnosticsGroupMember_a166cde3-8e50-4572-b6e8-6279f328e6bf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_aa7d63dc-6db3-4258-b600-574ba33fde34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cb1966b5-f8f8-4cda-bc2c-d03f08d95428" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_aa7d63dc-6db3-4258-b600-574ba33fde34" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_aa7d63dc-6db3-4258-b600-574ba33fde34_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_aa7d63dc-6db3-4258-b600-574ba33fde34" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_aa7d63dc-6db3-4258-b600-574ba33fde34_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_22c50e84-0e18-4b62-a040-43c336c0fe36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_aa7d63dc-6db3-4258-b600-574ba33fde34" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_22c50e84-0e18-4b62-a040-43c336c0fe36" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_d39f42e7-4fb8-4e28-9a62-796f1cb125f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_22c50e84-0e18-4b62-a040-43c336c0fe36" xlink:to="loc_us-gaap_CommercialPaperMember_d39f42e7-4fb8-4e28-9a62-796f1cb125f8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_afa07913-2eda-4f09-9fd3-fcd4f62008eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cb1966b5-f8f8-4cda-bc2c-d03f08d95428" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_afa07913-2eda-4f09-9fd3-fcd4f62008eb" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_afa07913-2eda-4f09-9fd3-fcd4f62008eb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_afa07913-2eda-4f09-9fd3-fcd4f62008eb" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_afa07913-2eda-4f09-9fd3-fcd4f62008eb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_273b3217-767b-4a19-8762-de67562976fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_afa07913-2eda-4f09-9fd3-fcd4f62008eb" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_273b3217-767b-4a19-8762-de67562976fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_JointVentureMember_35f604e8-bb91-4739-9555-b6ae023c6471" xlink:href="rdnt-20221231.xsd#rdnt_JointVentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_273b3217-767b-4a19-8762-de67562976fc" xlink:to="loc_rdnt_JointVentureMember_35f604e8-bb91-4739-9555-b6ae023c6471" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_55cfe0fd-d186-4340-9a40-e88492f398f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cb1966b5-f8f8-4cda-bc2c-d03f08d95428" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_55cfe0fd-d186-4340-9a40-e88492f398f0" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_55cfe0fd-d186-4340-9a40-e88492f398f0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_55cfe0fd-d186-4340-9a40-e88492f398f0" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_55cfe0fd-d186-4340-9a40-e88492f398f0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_89bfc211-dc37-4fb8-ad11-733f81cc6b9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_55cfe0fd-d186-4340-9a40-e88492f398f0" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_89bfc211-dc37-4fb8-ad11-733f81cc6b9d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ContingentMilestoneConsiderationMember_dd3ad5da-d83e-4d7a-9735-4fbed1f39112" xlink:href="rdnt-20221231.xsd#rdnt_ContingentMilestoneConsiderationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_89bfc211-dc37-4fb8-ad11-733f81cc6b9d" xlink:to="loc_rdnt_ContingentMilestoneConsiderationMember_dd3ad5da-d83e-4d7a-9735-4fbed1f39112" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CashHoldbackMember_f538e36b-e512-48ee-85a6-3e1181b0a6e3" xlink:href="rdnt-20221231.xsd#rdnt_CashHoldbackMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_89bfc211-dc37-4fb8-ad11-733f81cc6b9d" xlink:to="loc_rdnt_CashHoldbackMember_f538e36b-e512-48ee-85a6-3e1181b0a6e3" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative_1" xlink:type="simple" xlink:href="rdnt-20221231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative_1"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative_1" xlink:type="extended" id="i253f3ef8d8614d59bd5c7a537c3ecfc7_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative_1">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AdvanceMedicarePayments_282ba732-b460-4c6c-8b4f-4552539e397e" xlink:href="rdnt-20221231.xsd#rdnt_AdvanceMedicarePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_rdnt_AdvanceMedicarePayments_282ba732-b460-4c6c-8b4f-4552539e397e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLoans_40b606aa-7a28-4719-95a9-d5f9d358e8d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLoans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_ProceedsFromLoans_40b606aa-7a28-4719-95a9-d5f9d358e8d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ProceedsFromProviderReliefFunding_7ce4d8c3-4ac1-4c98-a789-60524f73a57d" xlink:href="rdnt-20221231.xsd#rdnt_ProceedsFromProviderReliefFunding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_rdnt_ProceedsFromProviderReliefFunding_7ce4d8c3-4ac1-4c98-a789-60524f73a57d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RepaymentOfAdvanceMedicarePayments_3ea88ca8-a93f-44b1-9401-c084d7fc79a7" xlink:href="rdnt-20221231.xsd#rdnt_RepaymentOfAdvanceMedicarePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_rdnt_RepaymentOfAdvanceMedicarePayments_3ea88ca8-a93f-44b1-9401-c084d7fc79a7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GovernmentAssistanceAmountCumulative_581f3391-5488-4c0c-8bf4-94e33b423b9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GovernmentAssistanceAmountCumulative"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_GovernmentAssistanceAmountCumulative_581f3391-5488-4c0c-8bf4-94e33b423b9e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GovernmentAssistanceStatementOfFinancialPositionExtensibleEnumeration_186011b8-a1e4-45dc-bcc0-ef7a37e38288" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GovernmentAssistanceStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_GovernmentAssistanceStatementOfFinancialPositionExtensibleEnumeration_186011b8-a1e4-45dc-bcc0-ef7a37e38288" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CaresActRefundableClaimPercentage_a6307051-3ecb-4e82-97e5-e8d95cfc410e" xlink:href="rdnt-20221231.xsd#rdnt_CaresActRefundableClaimPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_rdnt_CaresActRefundableClaimPercentage_a6307051-3ecb-4e82-97e5-e8d95cfc410e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SocialSecurityTaxEmployerDeferralCARESAct_9caed4cf-08cb-40aa-8b0b-73a92ff94ffe" xlink:href="rdnt-20221231.xsd#rdnt_SocialSecurityTaxEmployerDeferralCARESAct"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_rdnt_SocialSecurityTaxEmployerDeferralCARESAct_9caed4cf-08cb-40aa-8b0b-73a92ff94ffe" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct_daa9fe7b-b537-486d-b511-1c4421510d31" xlink:href="rdnt-20221231.xsd#rdnt_IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_rdnt_IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct_daa9fe7b-b537-486d-b511-1c4421510d31" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ContractsReceivableFactoringReceivable_0ad75fd5-48ce-4e49-8a5c-212de70a41ff" xlink:href="rdnt-20221231.xsd#rdnt_ContractsReceivableFactoringReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_rdnt_ContractsReceivableFactoringReceivable_0ad75fd5-48ce-4e49-8a5c-212de70a41ff" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_623b9d6c-e948-44df-bdac-767c53bc6c55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_623b9d6c-e948-44df-bdac-767c53bc6c55" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_103a0aa5-1dd0-4840-b21e-f8582b80633a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_103a0aa5-1dd0-4840-b21e-f8582b80633a" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_8914f231-06b8-45e9-916d-3cf972fcf2c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_8914f231-06b8-45e9-916d-3cf972fcf2c0" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_4000af0a-f5d2-4c87-9722-5423c9f36e0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_Goodwill_4000af0a-f5d2-4c87-9722-5423c9f36e0d" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_77a68920-fb6d-4d67-a3fd-24271518ca4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_77a68920-fb6d-4d67-a3fd-24271518ca4a" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_74809235-9945-4fed-8ff0-047deb8b7ab3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_74809235-9945-4fed-8ff0-047deb8b7ab3" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_9189547d-6780-4bba-931d-c226f343a9b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_9189547d-6780-4bba-931d-c226f343a9b6" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_0db075b0-4c13-4fca-8f7f-e3beac7a60c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_0db075b0-4c13-4fca-8f7f-e3beac7a60c0" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OperatingLeaseLeaseAbandonmentCharge_c4d097a5-d265-4fec-ba6f-e31f2df212d7" xlink:href="rdnt-20221231.xsd#rdnt_OperatingLeaseLeaseAbandonmentCharge"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_rdnt_OperatingLeaseLeaseAbandonmentCharge_c4d097a5-d265-4fec-ba6f-e31f2df212d7" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WorkersCompensationLiabilityCurrent_2649bdd1-46dc-4738-8f6d-a3f8ba28d240" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WorkersCompensationLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_WorkersCompensationLiabilityCurrent_2649bdd1-46dc-4738-8f6d-a3f8ba28d240" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MedicalMalpracticeDeductiblePerIncidence_ed95c60f-6f8e-4e4b-a0be-833c1cb85219" xlink:href="rdnt-20221231.xsd#rdnt_MedicalMalpracticeDeductiblePerIncidence"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_rdnt_MedicalMalpracticeDeductiblePerIncidence_ed95c60f-6f8e-4e4b-a0be-833c1cb85219" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfInsuranceReserve_4e2bd48d-81dd-45cf-b812-1ebbf05b364a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SelfInsuranceReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_SelfInsuranceReserve_4e2bd48d-81dd-45cf-b812-1ebbf05b364a" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MedicalInsuranceStopLossPolicyClaimAmount_d7587332-7aba-4d7a-b0b4-e33f6e17ddec" xlink:href="rdnt-20221231.xsd#rdnt_MedicalInsuranceStopLossPolicyClaimAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_rdnt_MedicalInsuranceStopLossPolicyClaimAmount_d7587332-7aba-4d7a-b0b4-e33f6e17ddec" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_31b70ae7-a56d-4c78-9ffc-1cbcc4ee5ae4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_31b70ae7-a56d-4c78-9ffc-1cbcc4ee5ae4" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_b40bfb85-b749-4010-bb38-d9afe98ff46b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_b40bfb85-b749-4010-bb38-d9afe98ff46b" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_95482530-1524-43e8-b73f-6755ed298ad9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_95482530-1524-43e8-b73f-6755ed298ad9" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans_801a207e-cd00-45c0-9684-65f1cf15be7a" xlink:href="rdnt-20221231.xsd#rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans_801a207e-cd00-45c0-9684-65f1cf15be7a" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_2701bebe-546d-4948-b228-6d0c5c04ee00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_2701bebe-546d-4948-b228-6d0c5c04ee00" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_c4298c2d-37b2-4a07-9275-0d322c54892d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_c4298c2d-37b2-4a07-9275-0d322c54892d" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_da9fbaec-d3ab-41e0-b61d-0efec7e6e78c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_da9fbaec-d3ab-41e0-b61d-0efec7e6e78c" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNumberOfInstrumentsHeld_632fb06f-3f7e-462f-b842-fab2948bfb7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetNumberOfInstrumentsHeld"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_DerivativeAssetNumberOfInstrumentsHeld_632fb06f-3f7e-462f-b842-fab2948bfb7b" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_481a3583-8f84-4011-bf53-46d5342e737e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_481a3583-8f84-4011-bf53-46d5342e737e" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeBasisSpreadOnVariableRate_12396e71-0e18-49f9-8f02-0bd1963f43ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeBasisSpreadOnVariableRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_DerivativeBasisSpreadOnVariableRate_12396e71-0e18-49f9-8f02-0bd1963f43ed" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized_0fba57d8-4b1d-4087-a0df-1ed839035642" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized_0fba57d8-4b1d-4087-a0df-1ed839035642" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_995542b7-1c11-410a-9ec7-980a7712427b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_StockholdersEquity_995542b7-1c11-410a-9ec7-980a7712427b" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MonthlyAmortizationOfDeferredHedgeGains_4594370a-fb11-426e-8428-942762797408" xlink:href="rdnt-20221231.xsd#rdnt_MonthlyAmortizationOfDeferredHedgeGains"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_rdnt_MonthlyAmortizationOfDeferredHedgeGains_4594370a-fb11-426e-8428-942762797408" xlink:type="arc" order="35"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_1728b58d-b5c7-4fc2-86f8-071592b9c5a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_1728b58d-b5c7-4fc2-86f8-071592b9c5a7" xlink:type="arc" order="36"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones_815f4b19-8532-4529-b4ef-36a10dc07862" xlink:href="rdnt-20221231.xsd#rdnt_BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_rdnt_BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones_815f4b19-8532-4529-b4ef-36a10dc07862" xlink:type="arc" order="37"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_2138b0df-60e3-46cf-b160-8babad9cf751" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_2138b0df-60e3-46cf-b160-8babad9cf751" xlink:type="arc" order="38"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneOne_6a4cd74d-6276-4430-9e8f-6623bcb51a02" xlink:href="rdnt-20221231.xsd#rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneOne"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneOne_6a4cd74d-6276-4430-9e8f-6623bcb51a02" xlink:type="arc" order="39"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneTwo_397fc82f-d59e-4580-8d07-837742e0313a" xlink:href="rdnt-20221231.xsd#rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneTwo_397fc82f-d59e-4580-8d07-837742e0313a" xlink:type="arc" order="40"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod_5df7f6b0-2724-46d3-94fd-dbcd0a141b04" xlink:href="rdnt-20221231.xsd#rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod_5df7f6b0-2724-46d3-94fd-dbcd0a141b04" xlink:type="arc" order="41"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares_dcd2a22e-f10d-4cd2-80b4-188c0cde61a7" xlink:href="rdnt-20221231.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares_dcd2a22e-f10d-4cd2-80b4-188c0cde61a7" xlink:type="arc" order="42"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution_4715d6ac-0ce6-4d21-96ca-b81b82b12661" xlink:href="rdnt-20221231.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution_4715d6ac-0ce6-4d21-96ca-b81b82b12661" xlink:type="arc" order="43"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_a7d5037f-2f00-4b3b-9ca3-7ca2d8695718" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_LineOfCredit_a7d5037f-2f00-4b3b-9ca3-7ca2d8695718" xlink:type="arc" order="44"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestments_72e86fb4-63d2-48e5-8e8e-fba94050e953" xlink:href="rdnt-20221231.xsd#rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestments_72e86fb4-63d2-48e5-8e8e-fba94050e953" xlink:type="arc" order="45"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentAggregateCost_18f82dc0-b9c1-4275-aa2c-eef82daadccf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_EquityMethodInvestmentAggregateCost_18f82dc0-b9c1-4275-aa2c-eef82daadccf" xlink:type="arc" order="46"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_49ad4d3e-d0a9-498f-ac4a-5d6feb5e5c5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_49ad4d3e-d0a9-498f-ac4a-5d6feb5e5c5a" xlink:type="arc" order="47"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_03e0bc26-7a28-4fdd-aacc-41ce082e7e8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_03e0bc26-7a28-4fdd-aacc-41ce082e7e8e" xlink:type="arc" order="48"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityMethodInvestmentSharesPurchased_0557be36-cb6f-421d-b063-3c5bd44928d7" xlink:href="rdnt-20221231.xsd#rdnt_EquityMethodInvestmentSharesPurchased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_rdnt_EquityMethodInvestmentSharesPurchased_0557be36-cb6f-421d-b063-3c5bd44928d7" xlink:type="arc" order="49"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_b0bf2ad5-b364-4813-8f46-54bf687b0e6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_ShortTermBorrowings_b0bf2ad5-b364-4813-8f46-54bf687b0e6d" xlink:type="arc" order="50"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_fb20f416-8f6f-48f1-987a-a5ebe9d5c055" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_fb20f416-8f6f-48f1-987a-a5ebe9d5c055" xlink:type="arc" order="51"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_7182b117-68d8-4564-be55-a9174d991e13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToFundLongtermLoansToRelatedParties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_7182b117-68d8-4564-be55-a9174d991e13" xlink:type="arc" order="52"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberofUnconsolidatedJointVentures_1f446ce4-5fb6-4ff4-8b56-ecde4fc6300b" xlink:href="rdnt-20221231.xsd#rdnt_NumberofUnconsolidatedJointVentures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_rdnt_NumberofUnconsolidatedJointVentures_1f446ce4-5fb6-4ff4-8b56-ecde4fc6300b" xlink:type="arc" order="53"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityOwnershipPercentage_e7699f61-648a-47f2-9532-7b118eb7c068" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_VariableInterestEntityOwnershipPercentage_e7699f61-648a-47f2-9532-7b118eb7c068" xlink:type="arc" order="54"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ManagementServiceFees_0e2e7a4b-559b-4e39-a4d6-a65bd97632df" xlink:href="rdnt-20221231.xsd#rdnt_ManagementServiceFees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_rdnt_ManagementServiceFees_0e2e7a4b-559b-4e39-a4d6-a65bd97632df" xlink:type="arc" order="55"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityMethodInvestmentAdditionalContribution_1c5b4ab4-e6ee-474f-8c62-e21e9f668e20" xlink:href="rdnt-20221231.xsd#rdnt_EquityMethodInvestmentAdditionalContribution"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_rdnt_EquityMethodInvestmentAdditionalContribution_1c5b4ab4-e6ee-474f-8c62-e21e9f668e20" xlink:type="arc" order="56"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberOfAssetsSold_90e43042-d3c5-4159-9c49-e6b409328c79" xlink:href="rdnt-20221231.xsd#rdnt_NumberOfAssetsSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_rdnt_NumberOfAssetsSold_90e43042-d3c5-4159-9c49-e6b409328c79" xlink:type="arc" order="57"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_c33c2554-daa4-48fa-9860-27cd589ef1c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_c33c2554-daa4-48fa-9860-27cd589ef1c6" xlink:type="arc" order="58"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDividendsReceived_aa74219a-6853-4c28-acb6-aff06614fc87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDividendsReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_ProceedsFromDividendsReceived_aa74219a-6853-4c28-acb6-aff06614fc87" xlink:type="arc" order="59"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_728e478f-1ba3-4ef1-ac4d-2ef5c24900a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_EquityMethodInvestments_728e478f-1ba3-4ef1-ac4d-2ef5c24900a3" xlink:type="arc" order="60"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cb1966b5-f8f8-4cda-bc2c-d03f08d95428" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cb1966b5-f8f8-4cda-bc2c-d03f08d95428" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis_a7efa7cf-d841-4ff0-aa65-9d7b184ac72c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cb1966b5-f8f8-4cda-bc2c-d03f08d95428" xlink:to="loc_us-gaap_UnusualOrInfrequentItemAxis_a7efa7cf-d841-4ff0-aa65-9d7b184ac72c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_a7efa7cf-d841-4ff0-aa65-9d7b184ac72c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_a7efa7cf-d841-4ff0-aa65-9d7b184ac72c" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_a7efa7cf-d841-4ff0-aa65-9d7b184ac72c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_9428a886-8df7-42d4-9a5e-1b71b4b4e84e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_a7efa7cf-d841-4ff0-aa65-9d7b184ac72c" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_9428a886-8df7-42d4-9a5e-1b71b4b4e84e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_COVID19PandemicMember_6d483b15-209e-48f1-ad20-1ccd61c2f83f" xlink:href="rdnt-20221231.xsd#rdnt_COVID19PandemicMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain_9428a886-8df7-42d4-9a5e-1b71b4b4e84e" xlink:to="loc_rdnt_COVID19PandemicMember_6d483b15-209e-48f1-ad20-1ccd61c2f83f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_0811a726-77c3-4ae0-8c91-4060abc7214f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cb1966b5-f8f8-4cda-bc2c-d03f08d95428" xlink:to="loc_us-gaap_DebtInstrumentAxis_0811a726-77c3-4ae0-8c91-4060abc7214f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_0811a726-77c3-4ae0-8c91-4060abc7214f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_0811a726-77c3-4ae0-8c91-4060abc7214f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_0811a726-77c3-4ae0-8c91-4060abc7214f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_795c9426-27dc-4adc-8cd3-86ec1b903dae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_0811a726-77c3-4ae0-8c91-4060abc7214f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_795c9426-27dc-4adc-8cd3-86ec1b903dae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PaycheckProtectionProgramLoansMember_7c356c83-88df-4e99-b0e2-82044b6fc884" xlink:href="rdnt-20221231.xsd#rdnt_PaycheckProtectionProgramLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_795c9426-27dc-4adc-8cd3-86ec1b903dae" xlink:to="loc_rdnt_PaycheckProtectionProgramLoansMember_7c356c83-88df-4e99-b0e2-82044b6fc884" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BarclaysMember_772195e0-8bf3-45ce-bae8-56ba08c27b85" xlink:href="rdnt-20221231.xsd#rdnt_BarclaysMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_795c9426-27dc-4adc-8cd3-86ec1b903dae" xlink:to="loc_rdnt_BarclaysMember_772195e0-8bf3-45ce-bae8-56ba08c27b85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TruistMember_5500b5e1-fda4-4560-b4c9-4543cb4ea8dc" xlink:href="rdnt-20221231.xsd#rdnt_TruistMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_795c9426-27dc-4adc-8cd3-86ec1b903dae" xlink:to="loc_rdnt_TruistMember_5500b5e1-fda4-4560-b4c9-4543cb4ea8dc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_acf64a1d-d0f6-4a69-87b8-abeeb33ed43c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cb1966b5-f8f8-4cda-bc2c-d03f08d95428" xlink:to="loc_srt_ProductOrServiceAxis_acf64a1d-d0f6-4a69-87b8-abeeb33ed43c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_acf64a1d-d0f6-4a69-87b8-abeeb33ed43c_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_acf64a1d-d0f6-4a69-87b8-abeeb33ed43c" xlink:to="loc_srt_ProductsAndServicesDomain_acf64a1d-d0f6-4a69-87b8-abeeb33ed43c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_10e74b96-4213-4108-b538-ae1cfe0186ba" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_acf64a1d-d0f6-4a69-87b8-abeeb33ed43c" xlink:to="loc_srt_ProductsAndServicesDomain_10e74b96-4213-4108-b538-ae1cfe0186ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PatientServicesNetMember_c1a08d8b-2dcc-4514-ab43-0e8365f2f280" xlink:href="rdnt-20221231.xsd#rdnt_PatientServicesNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_10e74b96-4213-4108-b538-ae1cfe0186ba" xlink:to="loc_rdnt_PatientServicesNetMember_c1a08d8b-2dcc-4514-ab43-0e8365f2f280" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_ef314c31-d835-4161-8a9a-31afaace642f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cb1966b5-f8f8-4cda-bc2c-d03f08d95428" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_ef314c31-d835-4161-8a9a-31afaace642f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ef314c31-d835-4161-8a9a-31afaace642f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ef314c31-d835-4161-8a9a-31afaace642f" xlink:to="loc_us-gaap_SegmentDomain_ef314c31-d835-4161-8a9a-31afaace642f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_32770b1e-6669-4d43-9dfd-cdd9dd8ba21d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ef314c31-d835-4161-8a9a-31afaace642f" xlink:to="loc_us-gaap_SegmentDomain_32770b1e-6669-4d43-9dfd-cdd9dd8ba21d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ERADMember_5787c63c-6972-4a72-8ddc-ac692424060f" xlink:href="rdnt-20221231.xsd#rdnt_ERADMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_32770b1e-6669-4d43-9dfd-cdd9dd8ba21d" xlink:to="loc_rdnt_ERADMember_5787c63c-6972-4a72-8ddc-ac692424060f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ImagingCentersMember_38fadbc7-9f4e-4af3-a6c4-64f2b75f40c2" xlink:href="rdnt-20221231.xsd#rdnt_ImagingCentersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_32770b1e-6669-4d43-9dfd-cdd9dd8ba21d" xlink:to="loc_rdnt_ImagingCentersMember_38fadbc7-9f4e-4af3-a6c4-64f2b75f40c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_5d868568-f4a6-4df5-a4f1-b2cd39058ec4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cb1966b5-f8f8-4cda-bc2c-d03f08d95428" xlink:to="loc_srt_RangeAxis_5d868568-f4a6-4df5-a4f1-b2cd39058ec4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5d868568-f4a6-4df5-a4f1-b2cd39058ec4_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_5d868568-f4a6-4df5-a4f1-b2cd39058ec4" xlink:to="loc_srt_RangeMember_5d868568-f4a6-4df5-a4f1-b2cd39058ec4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cdb31e97-cb65-4519-a5a2-51f225469504" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_5d868568-f4a6-4df5-a4f1-b2cd39058ec4" xlink:to="loc_srt_RangeMember_cdb31e97-cb65-4519-a5a2-51f225469504" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_48203bc3-dcdd-4251-b5a1-fa07093672b0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_cdb31e97-cb65-4519-a5a2-51f225469504" xlink:to="loc_srt_MinimumMember_48203bc3-dcdd-4251-b5a1-fa07093672b0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_c28eae78-6e38-4e1a-b0e1-521c9433ecf2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_cdb31e97-cb65-4519-a5a2-51f225469504" xlink:to="loc_srt_MaximumMember_c28eae78-6e38-4e1a-b0e1-521c9433ecf2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e9e445b1-7bfd-48e3-9f99-690223fdacff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cb1966b5-f8f8-4cda-bc2c-d03f08d95428" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e9e445b1-7bfd-48e3-9f99-690223fdacff" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e9e445b1-7bfd-48e3-9f99-690223fdacff_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e9e445b1-7bfd-48e3-9f99-690223fdacff" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e9e445b1-7bfd-48e3-9f99-690223fdacff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_02aa2643-eb9f-457a-b6fb-838b867b674d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e9e445b1-7bfd-48e3-9f99-690223fdacff" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_02aa2643-eb9f-457a-b6fb-838b867b674d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ProperyAndEquipmentNetMember_b249f774-b22e-413c-8878-dbf3ca1cc598" xlink:href="rdnt-20221231.xsd#rdnt_ProperyAndEquipmentNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_02aa2643-eb9f-457a-b6fb-838b867b674d" xlink:to="loc_rdnt_ProperyAndEquipmentNetMember_b249f774-b22e-413c-8878-dbf3ca1cc598" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_c9da8887-0573-40f4-abe5-1c71be3a6cfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_02aa2643-eb9f-457a-b6fb-838b867b674d" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_c9da8887-0573-40f4-abe5-1c71be3a6cfc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_9c264554-8c6a-4899-a13f-88574f6a200c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_02aa2643-eb9f-457a-b6fb-838b867b674d" xlink:to="loc_us-gaap_ConstructionInProgressMember_9c264554-8c6a-4899-a13f-88574f6a200c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_c93ef595-c406-4675-abec-f5d30d8ce40d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cb1966b5-f8f8-4cda-bc2c-d03f08d95428" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_c93ef595-c406-4675-abec-f5d30d8ce40d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_c93ef595-c406-4675-abec-f5d30d8ce40d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_c93ef595-c406-4675-abec-f5d30d8ce40d" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_c93ef595-c406-4675-abec-f5d30d8ce40d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_02320a2b-6a50-46ff-b77b-c49f044e001b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_c93ef595-c406-4675-abec-f5d30d8ce40d" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_02320a2b-6a50-46ff-b77b-c49f044e001b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_b73a69ba-aaa5-4d67-86fc-891f5cf00b88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_02320a2b-6a50-46ff-b77b-c49f044e001b" xlink:to="loc_us-gaap_TradeNamesMember_b73a69ba-aaa5-4d67-86fc-891f5cf00b88" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_352ec7ab-8901-4769-9ff9-59105900eea4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cb1966b5-f8f8-4cda-bc2c-d03f08d95428" xlink:to="loc_srt_CounterpartyNameAxis_352ec7ab-8901-4769-9ff9-59105900eea4" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_352ec7ab-8901-4769-9ff9-59105900eea4_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_352ec7ab-8901-4769-9ff9-59105900eea4" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_352ec7ab-8901-4769-9ff9-59105900eea4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_70b9c1a2-2494-4127-8aa7-6992253b06ed" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_352ec7ab-8901-4769-9ff9-59105900eea4" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_70b9c1a2-2494-4127-8aa7-6992253b06ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BlueShieldMember_af27530d-1d2a-459f-8eb5-146643977c2e" xlink:href="rdnt-20221231.xsd#rdnt_BlueShieldMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_70b9c1a2-2494-4127-8aa7-6992253b06ed" xlink:to="loc_rdnt_BlueShieldMember_af27530d-1d2a-459f-8eb5-146643977c2e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DignityHealthMember_1963c231-c2da-48c9-ad17-6ae9cdd6b09f" xlink:href="rdnt-20221231.xsd#rdnt_DignityHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_70b9c1a2-2494-4127-8aa7-6992253b06ed" xlink:to="loc_rdnt_DignityHealthMember_1963c231-c2da-48c9-ad17-6ae9cdd6b09f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_f7ab6e5a-b536-4896-b29a-1f1ca72ce7a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cb1966b5-f8f8-4cda-bc2c-d03f08d95428" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_f7ab6e5a-b536-4896-b29a-1f1ca72ce7a1" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f7ab6e5a-b536-4896-b29a-1f1ca72ce7a1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f7ab6e5a-b536-4896-b29a-1f1ca72ce7a1" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f7ab6e5a-b536-4896-b29a-1f1ca72ce7a1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f35fd62b-c44b-43b5-8779-8a536a62339d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f7ab6e5a-b536-4896-b29a-1f1ca72ce7a1" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f35fd62b-c44b-43b5-8779-8a536a62339d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_QuantibMember_49d3d0e6-45e3-4916-b426-755d56d56473" xlink:href="rdnt-20221231.xsd#rdnt_QuantibMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f35fd62b-c44b-43b5-8779-8a536a62339d" xlink:to="loc_rdnt_QuantibMember_49d3d0e6-45e3-4916-b426-755d56d56473" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MontclairMember_e82aeb4a-0931-4902-b6bf-a7cd5547df60" xlink:href="rdnt-20221231.xsd#rdnt_MontclairMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f35fd62b-c44b-43b5-8779-8a536a62339d" xlink:to="loc_rdnt_MontclairMember_e82aeb4a-0931-4902-b6bf-a7cd5547df60" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HeartAndLungImagingLimitedMember_aa39945c-9eff-419f-bfad-11f4e528f02b" xlink:href="rdnt-20221231.xsd#rdnt_HeartAndLungImagingLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f35fd62b-c44b-43b5-8779-8a536a62339d" xlink:to="loc_rdnt_HeartAndLungImagingLimitedMember_aa39945c-9eff-419f-bfad-11f4e528f02b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AidenceMember_83dd7b22-ea09-421e-bcd5-50372cc58c98" xlink:href="rdnt-20221231.xsd#rdnt_AidenceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f35fd62b-c44b-43b5-8779-8a536a62339d" xlink:to="loc_rdnt_AidenceMember_83dd7b22-ea09-421e-bcd5-50372cc58c98" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_3f818785-46c1-4824-b761-c51736fee3e8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cb1966b5-f8f8-4cda-bc2c-d03f08d95428" xlink:to="loc_dei_LegalEntityAxis_3f818785-46c1-4824-b761-c51736fee3e8" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_3f818785-46c1-4824-b761-c51736fee3e8_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_3f818785-46c1-4824-b761-c51736fee3e8" xlink:to="loc_dei_EntityDomain_3f818785-46c1-4824-b761-c51736fee3e8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_9a3ce541-17f1-4502-adc2-091e405c9ddd" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_3f818785-46c1-4824-b761-c51736fee3e8" xlink:to="loc_dei_EntityDomain_9a3ce541-17f1-4502-adc2-091e405c9ddd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GlendaleAdvancedImagingMember_0b49c52b-55e6-4d14-a53c-b2e12987f155" xlink:href="rdnt-20221231.xsd#rdnt_GlendaleAdvancedImagingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_9a3ce541-17f1-4502-adc2-091e405c9ddd" xlink:to="loc_rdnt_GlendaleAdvancedImagingMember_0b49c52b-55e6-4d14-a53c-b2e12987f155" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_ecb26260-30c9-43c8-8821-c35b2707de77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cb1966b5-f8f8-4cda-bc2c-d03f08d95428" xlink:to="loc_us-gaap_PlanNameAxis_ecb26260-30c9-43c8-8821-c35b2707de77" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_ecb26260-30c9-43c8-8821-c35b2707de77_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_ecb26260-30c9-43c8-8821-c35b2707de77" xlink:to="loc_us-gaap_PlanNameDomain_ecb26260-30c9-43c8-8821-c35b2707de77_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_4eb7f5c1-84e0-4fcb-a323-55e7bb8ef0be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_ecb26260-30c9-43c8-8821-c35b2707de77" xlink:to="loc_us-gaap_PlanNameDomain_4eb7f5c1-84e0-4fcb-a323-55e7bb8ef0be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedPlanMember_82b1be51-ded5-4094-b843-c0f84f27d46b" xlink:href="rdnt-20221231.xsd#rdnt_RestatedPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_4eb7f5c1-84e0-4fcb-a323-55e7bb8ef0be" xlink:to="loc_rdnt_RestatedPlanMember_82b1be51-ded5-4094-b843-c0f84f27d46b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuritiesFinancingTransactionAxis_8372d204-92fe-4d80-98cd-5d18b51711f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuritiesFinancingTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cb1966b5-f8f8-4cda-bc2c-d03f08d95428" xlink:to="loc_us-gaap_SecuritiesFinancingTransactionAxis_8372d204-92fe-4d80-98cd-5d18b51711f8" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_8372d204-92fe-4d80-98cd-5d18b51711f8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuritiesFinancingTransactionTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionAxis_8372d204-92fe-4d80-98cd-5d18b51711f8" xlink:to="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_8372d204-92fe-4d80-98cd-5d18b51711f8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_ed649b74-6afd-4a2d-872c-d913478ab594" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuritiesFinancingTransactionTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionAxis_8372d204-92fe-4d80-98cd-5d18b51711f8" xlink:to="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_ed649b74-6afd-4a2d-872c-d913478ab594" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_Caps2016Member_b057ec4d-f18a-4631-833b-a245af22501f" xlink:href="rdnt-20221231.xsd#rdnt_Caps2016Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_ed649b74-6afd-4a2d-872c-d913478ab594" xlink:to="loc_rdnt_Caps2016Member_b057ec4d-f18a-4631-833b-a245af22501f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_A2019SWAPSMember_b4f0ffae-d467-458c-840a-0bd637b9c618" xlink:href="rdnt-20221231.xsd#rdnt_A2019SWAPSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_ed649b74-6afd-4a2d-872c-d913478ab594" xlink:to="loc_rdnt_A2019SWAPSMember_b4f0ffae-d467-458c-840a-0bd637b9c618" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_A2019SWAPS1Member_e387c52b-0baf-4893-98cc-d3e6d2d22852" xlink:href="rdnt-20221231.xsd#rdnt_A2019SWAPS1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_ed649b74-6afd-4a2d-872c-d913478ab594" xlink:to="loc_rdnt_A2019SWAPS1Member_e387c52b-0baf-4893-98cc-d3e6d2d22852" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditDerivativesByContractTypeAxis_60aabb99-b8a2-42d7-9495-750cd088c6c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditDerivativesByContractTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cb1966b5-f8f8-4cda-bc2c-d03f08d95428" xlink:to="loc_us-gaap_CreditDerivativesByContractTypeAxis_60aabb99-b8a2-42d7-9495-750cd088c6c0" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditDerivativesContractTypeDomain_60aabb99-b8a2-42d7-9495-750cd088c6c0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditDerivativesContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditDerivativesByContractTypeAxis_60aabb99-b8a2-42d7-9495-750cd088c6c0" xlink:to="loc_us-gaap_CreditDerivativesContractTypeDomain_60aabb99-b8a2-42d7-9495-750cd088c6c0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditDerivativesContractTypeDomain_333df92b-7683-4c27-945a-49ef72842a50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditDerivativesContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditDerivativesByContractTypeAxis_60aabb99-b8a2-42d7-9495-750cd088c6c0" xlink:to="loc_us-gaap_CreditDerivativesContractTypeDomain_333df92b-7683-4c27-945a-49ef72842a50" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_September2020CapMember_e356916f-f91b-4bd3-b404-17a09c403c40" xlink:href="rdnt-20221231.xsd#rdnt_September2020CapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditDerivativesContractTypeDomain_333df92b-7683-4c27-945a-49ef72842a50" xlink:to="loc_rdnt_September2020CapMember_e356916f-f91b-4bd3-b404-17a09c403c40" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_October2020CapMember_6af58ec9-bad5-4fec-bb19-92c4b12fe73e" xlink:href="rdnt-20221231.xsd#rdnt_October2020CapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditDerivativesContractTypeDomain_333df92b-7683-4c27-945a-49ef72842a50" xlink:to="loc_rdnt_October2020CapMember_6af58ec9-bad5-4fec-bb19-92c4b12fe73e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_October2023Member_bcbb44a0-701a-4c51-b88f-691fca5d814b" xlink:href="rdnt-20221231.xsd#rdnt_October2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditDerivativesContractTypeDomain_333df92b-7683-4c27-945a-49ef72842a50" xlink:to="loc_rdnt_October2023Member_bcbb44a0-701a-4c51-b88f-691fca5d814b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_October2025Member_9c4976aa-8681-4227-a2a6-86d852d52f16" xlink:href="rdnt-20221231.xsd#rdnt_October2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditDerivativesContractTypeDomain_333df92b-7683-4c27-945a-49ef72842a50" xlink:to="loc_rdnt_October2025Member_9c4976aa-8681-4227-a2a6-86d852d52f16" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_c884720e-5e87-4689-9fd9-f23bdecf41ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cb1966b5-f8f8-4cda-bc2c-d03f08d95428" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_c884720e-5e87-4689-9fd9-f23bdecf41ad" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_c884720e-5e87-4689-9fd9-f23bdecf41ad_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_c884720e-5e87-4689-9fd9-f23bdecf41ad" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_c884720e-5e87-4689-9fd9-f23bdecf41ad_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_a8ee4597-2673-41f2-98a8-8f991d39cf50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_c884720e-5e87-4689-9fd9-f23bdecf41ad" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_a8ee4597-2673-41f2-98a8-8f991d39cf50" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_Caps2016Member_dc2effcc-1bb3-4b0d-a106-48d254c9b901" xlink:href="rdnt-20221231.xsd#rdnt_Caps2016Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_a8ee4597-2673-41f2-98a8-8f991d39cf50" xlink:to="loc_rdnt_Caps2016Member_dc2effcc-1bb3-4b0d-a106-48d254c9b901" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_a2b5ee91-5486-48f8-b329-b5ea3d1e6625" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_a8ee4597-2673-41f2-98a8-8f991d39cf50" xlink:to="loc_us-gaap_InterestRateSwapMember_a2b5ee91-5486-48f8-b329-b5ea3d1e6625" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_ea487407-b556-4cd4-8d29-a284ad3092b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cb1966b5-f8f8-4cda-bc2c-d03f08d95428" xlink:to="loc_us-gaap_VariableRateAxis_ea487407-b556-4cd4-8d29-a284ad3092b8" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_ea487407-b556-4cd4-8d29-a284ad3092b8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_ea487407-b556-4cd4-8d29-a284ad3092b8" xlink:to="loc_us-gaap_VariableRateDomain_ea487407-b556-4cd4-8d29-a284ad3092b8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_b186051e-e0eb-4115-9c71-6e3521d02177" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_ea487407-b556-4cd4-8d29-a284ad3092b8" xlink:to="loc_us-gaap_VariableRateDomain_b186051e-e0eb-4115-9c71-6e3521d02177" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_ba6d361b-effb-4bbe-a03e-c73bade2e601" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_b186051e-e0eb-4115-9c71-6e3521d02177" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_ba6d361b-effb-4bbe-a03e-c73bade2e601" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_74eabec0-4fa2-4b82-b340-af841a070611" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cb1966b5-f8f8-4cda-bc2c-d03f08d95428" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_74eabec0-4fa2-4b82-b340-af841a070611" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_74eabec0-4fa2-4b82-b340-af841a070611_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_74eabec0-4fa2-4b82-b340-af841a070611" xlink:to="loc_us-gaap_EquityComponentDomain_74eabec0-4fa2-4b82-b340-af841a070611_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_abc294ca-3eac-4988-b891-c0cdf8264c1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_74eabec0-4fa2-4b82-b340-af841a070611" xlink:to="loc_us-gaap_EquityComponentDomain_abc294ca-3eac-4988-b891-c0cdf8264c1b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_200e6eef-c7e8-4e70-ae5b-f2783cf5151e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_abc294ca-3eac-4988-b891-c0cdf8264c1b" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_200e6eef-c7e8-4e70-ae5b-f2783cf5151e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_6b64a20c-bf59-4097-8a43-c9513ed7ed5c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cb1966b5-f8f8-4cda-bc2c-d03f08d95428" xlink:to="loc_srt_StatementScenarioAxis_6b64a20c-bf59-4097-8a43-c9513ed7ed5c" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_6b64a20c-bf59-4097-8a43-c9513ed7ed5c_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_6b64a20c-bf59-4097-8a43-c9513ed7ed5c" xlink:to="loc_srt_ScenarioUnspecifiedDomain_6b64a20c-bf59-4097-8a43-c9513ed7ed5c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_d6319cde-5d11-41cf-8ab3-865f1800c0cf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_6b64a20c-bf59-4097-8a43-c9513ed7ed5c" xlink:to="loc_srt_ScenarioUnspecifiedDomain_d6319cde-5d11-41cf-8ab3-865f1800c0cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_add6befe-b9c5-40fd-a385-a6b94ebadd98" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_d6319cde-5d11-41cf-8ab3-865f1800c0cf" xlink:to="loc_srt_ScenarioForecastMember_add6befe-b9c5-40fd-a385-a6b94ebadd98" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_3dd4362b-bc08-40c5-a40f-c5761e2ef8f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cb1966b5-f8f8-4cda-bc2c-d03f08d95428" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_3dd4362b-bc08-40c5-a40f-c5761e2ef8f1" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_3dd4362b-bc08-40c5-a40f-c5761e2ef8f1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_3dd4362b-bc08-40c5-a40f-c5761e2ef8f1" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_3dd4362b-bc08-40c5-a40f-c5761e2ef8f1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_91c031a2-edf4-4315-bee0-236ed7cdd2c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_3dd4362b-bc08-40c5-a40f-c5761e2ef8f1" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_91c031a2-edf4-4315-bee0-236ed7cdd2c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_b052a590-e91e-41c0-97da-ca5cce234cb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_91c031a2-edf4-4315-bee0-236ed7cdd2c8" xlink:to="loc_us-gaap_SubsequentEventMember_b052a590-e91e-41c0-97da-ca5cce234cb0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_242ccdf9-65ed-420a-aedc-e9a479db7ea3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cb1966b5-f8f8-4cda-bc2c-d03f08d95428" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_242ccdf9-65ed-420a-aedc-e9a479db7ea3" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_242ccdf9-65ed-420a-aedc-e9a479db7ea3_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_242ccdf9-65ed-420a-aedc-e9a479db7ea3" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_242ccdf9-65ed-420a-aedc-e9a479db7ea3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_e7b51bb4-dde3-4ef6-a766-90e1a900adbb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_242ccdf9-65ed-420a-aedc-e9a479db7ea3" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_e7b51bb4-dde3-4ef6-a766-90e1a900adbb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MedicVisionMember_599c9a96-3030-425a-9247-a134939d90a3" xlink:href="rdnt-20221231.xsd#rdnt_MedicVisionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_e7b51bb4-dde3-4ef6-a766-90e1a900adbb" xlink:to="loc_rdnt_MedicVisionMember_599c9a96-3030-425a-9247-a134939d90a3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TurnerImagingSystemsMember_1a5f9298-9cda-46ab-a900-e40d770579b2" xlink:href="rdnt-20221231.xsd#rdnt_TurnerImagingSystemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_e7b51bb4-dde3-4ef6-a766-90e1a900adbb" xlink:to="loc_rdnt_TurnerImagingSystemsMember_1a5f9298-9cda-46ab-a900-e40d770579b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WhiteRabbitaiIncMember_3bb58597-c6dc-48c9-8830-ca2871a35cbf" xlink:href="rdnt-20221231.xsd#rdnt_WhiteRabbitaiIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_e7b51bb4-dde3-4ef6-a766-90e1a900adbb" xlink:to="loc_rdnt_WhiteRabbitaiIncMember_3bb58597-c6dc-48c9-8830-ca2871a35cbf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ArizonaDiagnosticsGroupMember_a166cde3-8e50-4572-b6e8-6279f328e6bf" xlink:href="rdnt-20221231.xsd#rdnt_ArizonaDiagnosticsGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_e7b51bb4-dde3-4ef6-a766-90e1a900adbb" xlink:to="loc_rdnt_ArizonaDiagnosticsGroupMember_a166cde3-8e50-4572-b6e8-6279f328e6bf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_aa7d63dc-6db3-4258-b600-574ba33fde34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cb1966b5-f8f8-4cda-bc2c-d03f08d95428" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_aa7d63dc-6db3-4258-b600-574ba33fde34" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_aa7d63dc-6db3-4258-b600-574ba33fde34_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_aa7d63dc-6db3-4258-b600-574ba33fde34" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_aa7d63dc-6db3-4258-b600-574ba33fde34_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_22c50e84-0e18-4b62-a040-43c336c0fe36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_aa7d63dc-6db3-4258-b600-574ba33fde34" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_22c50e84-0e18-4b62-a040-43c336c0fe36" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_d39f42e7-4fb8-4e28-9a62-796f1cb125f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_22c50e84-0e18-4b62-a040-43c336c0fe36" xlink:to="loc_us-gaap_CommercialPaperMember_d39f42e7-4fb8-4e28-9a62-796f1cb125f8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_afa07913-2eda-4f09-9fd3-fcd4f62008eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cb1966b5-f8f8-4cda-bc2c-d03f08d95428" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_afa07913-2eda-4f09-9fd3-fcd4f62008eb" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_afa07913-2eda-4f09-9fd3-fcd4f62008eb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_afa07913-2eda-4f09-9fd3-fcd4f62008eb" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_afa07913-2eda-4f09-9fd3-fcd4f62008eb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_273b3217-767b-4a19-8762-de67562976fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_afa07913-2eda-4f09-9fd3-fcd4f62008eb" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_273b3217-767b-4a19-8762-de67562976fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_JointVentureMember_35f604e8-bb91-4739-9555-b6ae023c6471" xlink:href="rdnt-20221231.xsd#rdnt_JointVentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_273b3217-767b-4a19-8762-de67562976fc" xlink:to="loc_rdnt_JointVentureMember_35f604e8-bb91-4739-9555-b6ae023c6471" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_55cfe0fd-d186-4340-9a40-e88492f398f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cb1966b5-f8f8-4cda-bc2c-d03f08d95428" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_55cfe0fd-d186-4340-9a40-e88492f398f0" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_55cfe0fd-d186-4340-9a40-e88492f398f0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_55cfe0fd-d186-4340-9a40-e88492f398f0" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_55cfe0fd-d186-4340-9a40-e88492f398f0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_89bfc211-dc37-4fb8-ad11-733f81cc6b9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_55cfe0fd-d186-4340-9a40-e88492f398f0" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_89bfc211-dc37-4fb8-ad11-733f81cc6b9d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ContingentMilestoneConsiderationMember_dd3ad5da-d83e-4d7a-9735-4fbed1f39112" xlink:href="rdnt-20221231.xsd#rdnt_ContingentMilestoneConsiderationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_89bfc211-dc37-4fb8-ad11-733f81cc6b9d" xlink:to="loc_rdnt_ContingentMilestoneConsiderationMember_dd3ad5da-d83e-4d7a-9735-4fbed1f39112" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CashHoldbackMember_f538e36b-e512-48ee-85a6-3e1181b0a6e3" xlink:href="rdnt-20221231.xsd#rdnt_CashHoldbackMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_89bfc211-dc37-4fb8-ad11-733f81cc6b9d" xlink:to="loc_rdnt_CashHoldbackMember_f538e36b-e512-48ee-85a6-3e1181b0a6e3" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives" xlink:type="simple" xlink:href="rdnt-20221231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives" xlink:type="extended" id="ib6fc60ae1c854575b57457cd414c13d8_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAssetsLineItems_9beca4ef-716b-44fe-9531-d3799bb3e493" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OffsettingAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_dac59c85-912b-42c5-ae35-7e17121d9032" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_9beca4ef-716b-44fe-9531-d3799bb3e493" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_dac59c85-912b-42c5-ae35-7e17121d9032" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_59ece0c8-c301-4258-a5ef-b21b1b284feb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_9beca4ef-716b-44fe-9531-d3799bb3e493" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_59ece0c8-c301-4258-a5ef-b21b1b284feb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_9ff02f46-fc24-4dbd-bb1e-9f07fd005800" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_9beca4ef-716b-44fe-9531-d3799bb3e493" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_9ff02f46-fc24-4dbd-bb1e-9f07fd005800" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_af3e3aa9-c490-4a8f-82fc-43315fb8c522" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_9beca4ef-716b-44fe-9531-d3799bb3e493" xlink:to="loc_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_af3e3aa9-c490-4a8f-82fc-43315fb8c522" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAssetsTable_5b374c2b-f600-4f6e-8dc9-84e373d00b17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OffsettingAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_9beca4ef-716b-44fe-9531-d3799bb3e493" xlink:to="loc_us-gaap_OffsettingAssetsTable_5b374c2b-f600-4f6e-8dc9-84e373d00b17" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_d3f62ad9-4455-42b2-9446-ec9c377d15dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OffsettingAssetsTable_5b374c2b-f600-4f6e-8dc9-84e373d00b17" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_d3f62ad9-4455-42b2-9446-ec9c377d15dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_d3f62ad9-4455-42b2-9446-ec9c377d15dd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_d3f62ad9-4455-42b2-9446-ec9c377d15dd" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_d3f62ad9-4455-42b2-9446-ec9c377d15dd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_f9bfd051-f1f0-436f-ba89-2937486929d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_d3f62ad9-4455-42b2-9446-ec9c377d15dd" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_f9bfd051-f1f0-436f-ba89-2937486929d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_4ca0496a-d151-4c11-bd43-b7a03444600d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateCapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_f9bfd051-f1f0-436f-ba89-2937486929d7" xlink:to="loc_us-gaap_InterestRateCapMember_4ca0496a-d151-4c11-bd43-b7a03444600d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_2d5eca1f-db83-4a60-9d34-10fa5befe660" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_f9bfd051-f1f0-436f-ba89-2937486929d7" xlink:to="loc_us-gaap_InterestRateSwapMember_2d5eca1f-db83-4a60-9d34-10fa5befe660" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_a109451d-893e-42f4-8f03-25217bcf09ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OffsettingAssetsTable_5b374c2b-f600-4f6e-8dc9-84e373d00b17" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_a109451d-893e-42f4-8f03-25217bcf09ec" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_a109451d-893e-42f4-8f03-25217bcf09ec_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_a109451d-893e-42f4-8f03-25217bcf09ec" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_a109451d-893e-42f4-8f03-25217bcf09ec_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_284948a0-5241-416b-8bd6-99fd9d134e49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_a109451d-893e-42f4-8f03-25217bcf09ec" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_284948a0-5241-416b-8bd6-99fd9d134e49" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_3e08df04-e89d-4b0f-a488-da456d016472" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_284948a0-5241-416b-8bd6-99fd9d134e49" xlink:to="loc_us-gaap_InterestExpenseMember_3e08df04-e89d-4b0f-a488-da456d016472" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsContingentConsideration" xlink:type="simple" xlink:href="rdnt-20221231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsContingentConsideration"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsContingentConsideration" xlink:type="extended" id="i9d3a4a31d0ae440b94a27f0d0801e1cb_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsContingentConsideration">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_0f83948a-644b-4cc9-b171-d2b9e05e88ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionContingentConsiderationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_1f98c1b3-dad2-4891-86e6-b6e08464e005" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_0f83948a-644b-4cc9-b171-d2b9e05e88ae" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_1f98c1b3-dad2-4891-86e6-b6e08464e005" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration_9a773396-aa63-4a3d-bf9b-c0bf23f96e4a" xlink:href="rdnt-20221231.xsd#rdnt_BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_0f83948a-644b-4cc9-b171-d2b9e05e88ae" xlink:to="loc_rdnt_BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration_9a773396-aa63-4a3d-bf9b-c0bf23f96e4a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_f3ae307f-f20a-48f0-9fe6-02c23240f7e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_0f83948a-644b-4cc9-b171-d2b9e05e88ae" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_f3ae307f-f20a-48f0-9fe6-02c23240f7e2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation_7da1c519-79f9-44e9-89a6-a8d5a4cc8ea4" xlink:href="rdnt-20221231.xsd#rdnt_BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_0f83948a-644b-4cc9-b171-d2b9e05e88ae" xlink:to="loc_rdnt_BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation_7da1c519-79f9-44e9-89a6-a8d5a4cc8ea4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_2006662f-6782-4b46-8243-9ef771209525" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_457b2318-04a7-4169-a1b2-daf44a9852d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_0f83948a-644b-4cc9-b171-d2b9e05e88ae" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_457b2318-04a7-4169-a1b2-daf44a9852d1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_ca8155bc-b96e-4abb-bba5-f958b73288ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_457b2318-04a7-4169-a1b2-daf44a9852d1" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_ca8155bc-b96e-4abb-bba5-f958b73288ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ca8155bc-b96e-4abb-bba5-f958b73288ba_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_ca8155bc-b96e-4abb-bba5-f958b73288ba" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ca8155bc-b96e-4abb-bba5-f958b73288ba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_66d51d49-20c5-4d80-aa50-cf4116449cdd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_ca8155bc-b96e-4abb-bba5-f958b73288ba" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_66d51d49-20c5-4d80-aa50-cf4116449cdd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AidenceMember_981acdc0-65a4-4b68-9319-19a733e3a136" xlink:href="rdnt-20221231.xsd#rdnt_AidenceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_66d51d49-20c5-4d80-aa50-cf4116449cdd" xlink:to="loc_rdnt_AidenceMember_981acdc0-65a4-4b68-9319-19a733e3a136" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_QuantibMember_9eb6cdd5-2231-47d0-852d-bc9c0d472bb4" xlink:href="rdnt-20221231.xsd#rdnt_QuantibMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_66d51d49-20c5-4d80-aa50-cf4116449cdd" xlink:to="loc_rdnt_QuantibMember_9eb6cdd5-2231-47d0-852d-bc9c0d472bb4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MontclairMember_19e4b00a-6ca0-44ba-a2e7-1185823fbd57" xlink:href="rdnt-20221231.xsd#rdnt_MontclairMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_66d51d49-20c5-4d80-aa50-cf4116449cdd" xlink:to="loc_rdnt_MontclairMember_19e4b00a-6ca0-44ba-a2e7-1185823fbd57" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HeartAndLungImagingLimitedMember_28937015-6e83-41dc-b1e2-b547dd66ebd8" xlink:href="rdnt-20221231.xsd#rdnt_HeartAndLungImagingLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_66d51d49-20c5-4d80-aa50-cf4116449cdd" xlink:to="loc_rdnt_HeartAndLungImagingLimitedMember_28937015-6e83-41dc-b1e2-b547dd66ebd8" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements" xlink:type="simple" xlink:href="rdnt-20221231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements" xlink:type="extended" id="i064c1211abfa40cb85c4b8343e6f06d5_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_ebf8d606-8d6c-4009-b537-48202e752bc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_8a1c346d-ac23-4c6c-9544-9e9f712975db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_ebf8d606-8d6c-4009-b537-48202e752bc3" xlink:to="loc_us-gaap_DerivativeAssets_8a1c346d-ac23-4c6c-9544-9e9f712975db" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_913d2b9a-d431-45f9-a49b-a4b7b60b39fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_ebf8d606-8d6c-4009-b537-48202e752bc3" xlink:to="loc_us-gaap_DerivativeLiabilities_913d2b9a-d431-45f9-a49b-a4b7b60b39fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract_157edb30-23cb-492c-8237-41056f4da69f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_ebf8d606-8d6c-4009-b537-48202e752bc3" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract_157edb30-23cb-492c-8237-41056f4da69f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_e401686f-898b-4559-8f21-52438d1bb833" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract_157edb30-23cb-492c-8237-41056f4da69f" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_e401686f-898b-4559-8f21-52438d1bb833" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_02779290-efff-41e0-87f4-cd6c1735e0c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_ebf8d606-8d6c-4009-b537-48202e752bc3" xlink:to="loc_us-gaap_SharePrice_02779290-efff-41e0-87f4-cd6c1735e0c6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_a5b4d051-5351-4292-9369-8423ddc2c1fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_ebf8d606-8d6c-4009-b537-48202e752bc3" xlink:to="loc_us-gaap_DebtInstrumentFairValue_a5b4d051-5351-4292-9369-8423ddc2c1fc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_581a0eb9-40ee-4194-ac9f-6d3e399c4106" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_ebf8d606-8d6c-4009-b537-48202e752bc3" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_581a0eb9-40ee-4194-ac9f-6d3e399c4106" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_5cb73555-01cd-4771-a9a8-e4ed0da515e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_581a0eb9-40ee-4194-ac9f-6d3e399c4106" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_5cb73555-01cd-4771-a9a8-e4ed0da515e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_5cb73555-01cd-4771-a9a8-e4ed0da515e3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_5cb73555-01cd-4771-a9a8-e4ed0da515e3" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_5cb73555-01cd-4771-a9a8-e4ed0da515e3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_566d3c35-4de6-4296-bce8-cd57e71f1891" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_5cb73555-01cd-4771-a9a8-e4ed0da515e3" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_566d3c35-4de6-4296-bce8-cd57e71f1891" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_53945465-ea91-4826-aa90-7e86ff5e04a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_566d3c35-4de6-4296-bce8-cd57e71f1891" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_53945465-ea91-4826-aa90-7e86ff5e04a0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_c774eb17-817a-4a75-84ab-3ba51a522606" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_53945465-ea91-4826-aa90-7e86ff5e04a0" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_c774eb17-817a-4a75-84ab-3ba51a522606" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ff034d66-dfef-44c5-86e8-097534acdf75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_581a0eb9-40ee-4194-ac9f-6d3e399c4106" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ff034d66-dfef-44c5-86e8-097534acdf75" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ff034d66-dfef-44c5-86e8-097534acdf75_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ff034d66-dfef-44c5-86e8-097534acdf75" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ff034d66-dfef-44c5-86e8-097534acdf75_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_dd66af70-adcf-494d-b2d1-faa3f046b1c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ff034d66-dfef-44c5-86e8-097534acdf75" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_dd66af70-adcf-494d-b2d1-faa3f046b1c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_7a574545-b438-4c56-867e-4d8c79293587" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_dd66af70-adcf-494d-b2d1-faa3f046b1c5" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_7a574545-b438-4c56-867e-4d8c79293587" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_9e46b73a-0c3b-4df9-84b2-ebaf49c64b2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_dd66af70-adcf-494d-b2d1-faa3f046b1c5" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_9e46b73a-0c3b-4df9-84b2-ebaf49c64b2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_dcb937e0-908d-4287-ba7f-a578ed8b04f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_dd66af70-adcf-494d-b2d1-faa3f046b1c5" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_dcb937e0-908d-4287-ba7f-a578ed8b04f1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_0001fc56-a250-4275-a435-1af176bf148b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_581a0eb9-40ee-4194-ac9f-6d3e399c4106" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_0001fc56-a250-4275-a435-1af176bf148b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_0001fc56-a250-4275-a435-1af176bf148b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_0001fc56-a250-4275-a435-1af176bf148b" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_0001fc56-a250-4275-a435-1af176bf148b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_3e060aae-564d-4050-92cf-3c08f0e4119a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_0001fc56-a250-4275-a435-1af176bf148b" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_3e060aae-564d-4050-92cf-3c08f0e4119a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_de3cf343-dba3-4481-85e1-bfb7dd7c7c6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3e060aae-564d-4050-92cf-3c08f0e4119a" xlink:to="loc_us-gaap_InterestRateSwapMember_de3cf343-dba3-4481-85e1-bfb7dd7c7c6d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_583ce98f-f8f2-46be-906e-620b3b300f70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_581a0eb9-40ee-4194-ac9f-6d3e399c4106" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_583ce98f-f8f2-46be-906e-620b3b300f70" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_583ce98f-f8f2-46be-906e-620b3b300f70_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_583ce98f-f8f2-46be-906e-620b3b300f70" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_583ce98f-f8f2-46be-906e-620b3b300f70_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d43db6c5-c1b4-4293-9912-59f00e70a595" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_583ce98f-f8f2-46be-906e-620b3b300f70" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d43db6c5-c1b4-4293-9912-59f00e70a595" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_QuantibMember_84f1eb69-a51f-4a24-994c-1d989f359fc9" xlink:href="rdnt-20221231.xsd#rdnt_QuantibMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d43db6c5-c1b4-4293-9912-59f00e70a595" xlink:to="loc_rdnt_QuantibMember_84f1eb69-a51f-4a24-994c-1d989f359fc9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HeartAndLungImagingLimitedMember_bbb43ee0-9201-4e4d-9037-fcaca813cb76" xlink:href="rdnt-20221231.xsd#rdnt_HeartAndLungImagingLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d43db6c5-c1b4-4293-9912-59f00e70a595" xlink:to="loc_rdnt_HeartAndLungImagingLimitedMember_bbb43ee0-9201-4e4d-9037-fcaca813cb76" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AidenceMember_a873bc80-9f59-4c5d-861a-edae77c6d1c0" xlink:href="rdnt-20221231.xsd#rdnt_AidenceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d43db6c5-c1b4-4293-9912-59f00e70a595" xlink:to="loc_rdnt_AidenceMember_a873bc80-9f59-4c5d-861a-edae77c6d1c0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MontclairMember_7bf69c74-7ddd-4cb8-8d38-4796f7b7e76c" xlink:href="rdnt-20221231.xsd#rdnt_MontclairMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d43db6c5-c1b4-4293-9912-59f00e70a595" xlink:to="loc_rdnt_MontclairMember_7bf69c74-7ddd-4cb8-8d38-4796f7b7e76c" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare" xlink:type="simple" xlink:href="rdnt-20221231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare" xlink:type="extended" id="i2fa4d62721e24c93932f84eb48ce8a4c_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_bdd01a28-d754-4581-829f-92e92d6eff7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_beda07a7-0d32-4479-ae59-8616127f7414" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_bdd01a28-d754-4581-829f-92e92d6eff7d" xlink:to="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_beda07a7-0d32-4479-ae59-8616127f7414" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_ae47dd95-db1c-4eab-b997-e21414e436d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_beda07a7-0d32-4479-ae59-8616127f7414" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_ae47dd95-db1c-4eab-b997-e21414e436d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_e35afeae-6978-48af-a95f-8af0d300b2c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_bdd01a28-d754-4581-829f-92e92d6eff7d" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_e35afeae-6978-48af-a95f-8af0d300b2c1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_5dccad10-8631-4684-83fb-f45313f00eb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_e35afeae-6978-48af-a95f-8af0d300b2c1" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_5dccad10-8631-4684-83fb-f45313f00eb7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_5dccad10-8631-4684-83fb-f45313f00eb7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_5dccad10-8631-4684-83fb-f45313f00eb7" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_5dccad10-8631-4684-83fb-f45313f00eb7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f4f648a9-16ea-41e2-b48a-697c4d09c557" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_5dccad10-8631-4684-83fb-f45313f00eb7" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f4f648a9-16ea-41e2-b48a-697c4d09c557" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_78b64d4c-5af4-4a68-b4a3-5d8eed967b0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f4f648a9-16ea-41e2-b48a-697c4d09c557" xlink:to="loc_us-gaap_RestrictedStockMember_78b64d4c-5af4-4a68-b4a3-5d8eed967b0b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_0ad3c78a-216e-4c65-add4-5d9328502249" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f4f648a9-16ea-41e2-b48a-697c4d09c557" xlink:to="loc_us-gaap_EmployeeStockOptionMember_0ad3c78a-216e-4c65-add4-5d9328502249" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures" xlink:type="simple" xlink:href="rdnt-20221231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures" xlink:type="extended" id="i0646c86870db495699bf2b5b003f5f7a_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_cad3ecfd-5fe0-493f-a5c7-b148570a49fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_KeyFinancialDataForJointVentures_6e02cdbc-2837-408b-8ca9-fe51238d68e1" xlink:href="rdnt-20221231.xsd#rdnt_KeyFinancialDataForJointVentures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_cad3ecfd-5fe0-493f-a5c7-b148570a49fe" xlink:to="loc_rdnt_KeyFinancialDataForJointVentures_6e02cdbc-2837-408b-8ca9-fe51238d68e1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_6d3a024e-2087-4b2e-bd2a-d97f4961e30e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_KeyFinancialDataForJointVentures_6e02cdbc-2837-408b-8ca9-fe51238d68e1" xlink:to="loc_us-gaap_AssetsCurrent_6d3a024e-2087-4b2e-bd2a-d97f4961e30e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent_aa217f3a-e40c-4194-a17c-d5b4c57fb7da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_KeyFinancialDataForJointVentures_6e02cdbc-2837-408b-8ca9-fe51238d68e1" xlink:to="loc_us-gaap_AssetsNoncurrent_aa217f3a-e40c-4194-a17c-d5b4c57fb7da" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_5ca1d26f-e315-4ded-bdd7-fd137b14d880" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_KeyFinancialDataForJointVentures_6e02cdbc-2837-408b-8ca9-fe51238d68e1" xlink:to="loc_us-gaap_LiabilitiesCurrent_5ca1d26f-e315-4ded-bdd7-fd137b14d880" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_1b1be351-4ea9-4765-9563-87df2cf2c345" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_KeyFinancialDataForJointVentures_6e02cdbc-2837-408b-8ca9-fe51238d68e1" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_1b1be351-4ea9-4765-9563-87df2cf2c345" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentAggregateCost_c65633c8-f6f4-49e8-8b29-dd438a4dee52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_KeyFinancialDataForJointVentures_6e02cdbc-2837-408b-8ca9-fe51238d68e1" xlink:to="loc_us-gaap_EquityMethodInvestmentAggregateCost_c65633c8-f6f4-49e8-8b29-dd438a4dee52" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_d45912eb-34da-4863-be76-27ba0f4d50b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_KeyFinancialDataForJointVentures_6e02cdbc-2837-408b-8ca9-fe51238d68e1" xlink:to="loc_us-gaap_EquityMethodInvestments_d45912eb-34da-4863-be76-27ba0f4d50b2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets_fc9eb1c9-88e5-4803-95e3-bd571592a0db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_KeyFinancialDataForJointVentures_6e02cdbc-2837-408b-8ca9-fe51238d68e1" xlink:to="loc_us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets_fc9eb1c9-88e5-4803-95e3-bd571592a0db" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_630e6b59-0cc1-4181-a806-355f1dce312b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_KeyFinancialDataForJointVentures_6e02cdbc-2837-408b-8ca9-fe51238d68e1" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_630e6b59-0cc1-4181-a806-355f1dce312b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_5b66ac75-9d82-44fd-9e7b-4ec5f9d61fae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_KeyFinancialDataForJointVentures_6e02cdbc-2837-408b-8ca9-fe51238d68e1" xlink:to="loc_us-gaap_Revenues_5b66ac75-9d82-44fd-9e7b-4ec5f9d61fae" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_2a172f34-6baa-47cf-976b-0fc833a2c00a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_KeyFinancialDataForJointVentures_6e02cdbc-2837-408b-8ca9-fe51238d68e1" xlink:to="loc_us-gaap_ProfitLoss_2a172f34-6baa-47cf-976b-0fc833a2c00a" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_156f694f-d1f2-4b23-b3b8-9635997d5552" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_cad3ecfd-5fe0-493f-a5c7-b148570a49fe" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_156f694f-d1f2-4b23-b3b8-9635997d5552" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_86346ce8-ce0b-49bb-95b6-078b981a6eb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_156f694f-d1f2-4b23-b3b8-9635997d5552" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_86346ce8-ce0b-49bb-95b6-078b981a6eb3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_86346ce8-ce0b-49bb-95b6-078b981a6eb3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_86346ce8-ce0b-49bb-95b6-078b981a6eb3" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_86346ce8-ce0b-49bb-95b6-078b981a6eb3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_1968e71a-2a31-4d1b-aa03-5c54924b5c83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_86346ce8-ce0b-49bb-95b6-078b981a6eb3" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_1968e71a-2a31-4d1b-aa03-5c54924b5c83" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember_28964920-bcc0-45cb-9b82-045981da953a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_1968e71a-2a31-4d1b-aa03-5c54924b5c83" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember_28964920-bcc0-45cb-9b82-045981da953a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_161cf5d0-55fb-4c20-96bf-3d24feb120de" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_156f694f-d1f2-4b23-b3b8-9635997d5552" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_161cf5d0-55fb-4c20-96bf-3d24feb120de" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_161cf5d0-55fb-4c20-96bf-3d24feb120de_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_161cf5d0-55fb-4c20-96bf-3d24feb120de" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_161cf5d0-55fb-4c20-96bf-3d24feb120de_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_d50c310b-61a5-4ade-b401-880b7d0d8afe" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_161cf5d0-55fb-4c20-96bf-3d24feb120de" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_d50c310b-61a5-4ade-b401-880b7d0d8afe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_JointVentureInterestMember_d3ffebed-9073-4a3c-b91c-ced0dd6f4337" xlink:href="rdnt-20221231.xsd#rdnt_JointVentureInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_d50c310b-61a5-4ade-b401-880b7d0d8afe" xlink:to="loc_rdnt_JointVentureInterestMember_d3ffebed-9073-4a3c-b91c-ced0dd6f4337" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDeferredRevenueRecognition" xlink:type="simple" xlink:href="rdnt-20221231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDeferredRevenueRecognition"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDeferredRevenueRecognition" xlink:type="extended" id="i628b92c2e9734217be4bae2e0f775c01_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDeferredRevenueRecognition">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_af66200d-f3fe-4613-ac4c-192086809610" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_d7216666-8a6c-449a-bdd5-162e80c0fb30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_af66200d-f3fe-4613-ac4c-192086809610" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_d7216666-8a6c-449a-bdd5-162e80c0fb30" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_6400edc5-5f67-489c-b300-58b7f7888291" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_af66200d-f3fe-4613-ac4c-192086809610" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_6400edc5-5f67-489c-b300-58b7f7888291" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_9bdb7e84-66a0-4d26-b469-73fad5dce6df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_af66200d-f3fe-4613-ac4c-192086809610" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_9bdb7e84-66a0-4d26-b469-73fad5dce6df" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_0f60b29b-b628-4af5-84f5-457852b514ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_9bdb7e84-66a0-4d26-b469-73fad5dce6df" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_0f60b29b-b628-4af5-84f5-457852b514ca" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDeferredRevenueRecognition_1" xlink:type="simple" xlink:href="rdnt-20221231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDeferredRevenueRecognition_1"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDeferredRevenueRecognition_1" xlink:type="extended" id="i2a15f2f8e0324ad0b7f0b337bc5190ae_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDeferredRevenueRecognition_1">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_af66200d-f3fe-4613-ac4c-192086809610" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_d7216666-8a6c-449a-bdd5-162e80c0fb30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_af66200d-f3fe-4613-ac4c-192086809610" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_d7216666-8a6c-449a-bdd5-162e80c0fb30" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_6400edc5-5f67-489c-b300-58b7f7888291" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_af66200d-f3fe-4613-ac4c-192086809610" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_6400edc5-5f67-489c-b300-58b7f7888291" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_9bdb7e84-66a0-4d26-b469-73fad5dce6df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_af66200d-f3fe-4613-ac4c-192086809610" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_9bdb7e84-66a0-4d26-b469-73fad5dce6df" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsandLiabilitiesAssumed" xlink:type="simple" xlink:href="rdnt-20221231.xsd#BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsandLiabilitiesAssumed"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsandLiabilitiesAssumed" xlink:type="extended" id="i378206eb8415437ba0c8cc79080d56d6_BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsandLiabilitiesAssumed">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_8e131fe8-f2db-4859-b332-cefc93454fb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_62dd588b-71a9-47c7-9441-4d3a06bb0237" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8e131fe8-f2db-4859-b332-cefc93454fb0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_62dd588b-71a9-47c7-9441-4d3a06bb0237" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_ac2332db-01d9-4b79-8c6e-8146c96e98f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8e131fe8-f2db-4859-b332-cefc93454fb0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_ac2332db-01d9-4b79-8c6e-8146c96e98f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset_155f013d-8d65-4d47-b4f4-b9ff19999e4c" xlink:href="rdnt-20221231.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8e131fe8-f2db-4859-b332-cefc93454fb0" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset_155f013d-8d65-4d47-b4f4-b9ff19999e4c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_9233f780-e915-4de1-a107-8ce8c8033385" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8e131fe8-f2db-4859-b332-cefc93454fb0" xlink:to="loc_us-gaap_Goodwill_9233f780-e915-4de1-a107-8ce8c8033385" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther_7467a977-bb1b-4375-8af5-ff9c8e1c1de7" xlink:href="rdnt-20221231.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8e131fe8-f2db-4859-b332-cefc93454fb0" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther_7467a977-bb1b-4375-8af5-ff9c8e1c1de7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities_55a4857d-2b20-40b0-bbe1-9549eca606d6" xlink:href="rdnt-20221231.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8e131fe8-f2db-4859-b332-cefc93454fb0" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities_55a4857d-2b20-40b0-bbe1-9549eca606d6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_03e9b2cb-471a-4da0-9047-396372ad5207" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8e131fe8-f2db-4859-b332-cefc93454fb0" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_03e9b2cb-471a-4da0-9047-396372ad5207" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_fe374cba-9be7-45bb-8307-4a96bd05985b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8e131fe8-f2db-4859-b332-cefc93454fb0" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_fe374cba-9be7-45bb-8307-4a96bd05985b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_5a003dd8-05f9-4576-8843-abe41407ad30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8e131fe8-f2db-4859-b332-cefc93454fb0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_5a003dd8-05f9-4576-8843-abe41407ad30" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationNumberOfSubsidiariesAcquired_b5525d16-0b37-4f08-a6c0-72b276a78a40" xlink:href="rdnt-20221231.xsd#rdnt_BusinessCombinationNumberOfSubsidiariesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8e131fe8-f2db-4859-b332-cefc93454fb0" xlink:to="loc_rdnt_BusinessCombinationNumberOfSubsidiariesAcquired_b5525d16-0b37-4f08-a6c0-72b276a78a40" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0e956483-5cc1-4c66-8de9-4fa0aa41ef0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8e131fe8-f2db-4859-b332-cefc93454fb0" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0e956483-5cc1-4c66-8de9-4fa0aa41ef0a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_d3d929df-48ea-4a20-98ec-6b672e43c3b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0e956483-5cc1-4c66-8de9-4fa0aa41ef0a" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_d3d929df-48ea-4a20-98ec-6b672e43c3b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d3d929df-48ea-4a20-98ec-6b672e43c3b9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_d3d929df-48ea-4a20-98ec-6b672e43c3b9" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d3d929df-48ea-4a20-98ec-6b672e43c3b9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e8e21f15-11f4-4ecf-835c-0ec46007dc6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_d3d929df-48ea-4a20-98ec-6b672e43c3b9" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e8e21f15-11f4-4ecf-835c-0ec46007dc6a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_IFRCLLCSubsidiaryOneMember_e43b5d33-268b-437e-9c86-71edab72c47b" xlink:href="rdnt-20221231.xsd#rdnt_IFRCLLCSubsidiaryOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e8e21f15-11f4-4ecf-835c-0ec46007dc6a" xlink:to="loc_rdnt_IFRCLLCSubsidiaryOneMember_e43b5d33-268b-437e-9c86-71edab72c47b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_IFRCLLCSubsidiaryTwoMember_995d4120-cc98-4b1f-8d86-2f226c8bcfa2" xlink:href="rdnt-20221231.xsd#rdnt_IFRCLLCSubsidiaryTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e8e21f15-11f4-4ecf-835c-0ec46007dc6a" xlink:to="loc_rdnt_IFRCLLCSubsidiaryTwoMember_995d4120-cc98-4b1f-8d86-2f226c8bcfa2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MontclairRadiologicalAssociatesPAMember_24401a8c-a34b-433d-893c-0c75cd56798e" xlink:href="rdnt-20221231.xsd#rdnt_MontclairRadiologicalAssociatesPAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e8e21f15-11f4-4ecf-835c-0ec46007dc6a" xlink:to="loc_rdnt_MontclairRadiologicalAssociatesPAMember_24401a8c-a34b-433d-893c-0c75cd56798e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HeartAndLungImagingLimitedMember_b6327b27-0e98-427c-8659-e7f72245ab32" xlink:href="rdnt-20221231.xsd#rdnt_HeartAndLungImagingLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e8e21f15-11f4-4ecf-835c-0ec46007dc6a" xlink:to="loc_rdnt_HeartAndLungImagingLimitedMember_b6327b27-0e98-427c-8659-e7f72245ab32" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ChelseaDignosticRadiologyPCMember_b975cf93-ab68-4c70-88cf-7ef9ae875cba" xlink:href="rdnt-20221231.xsd#rdnt_ChelseaDignosticRadiologyPCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e8e21f15-11f4-4ecf-835c-0ec46007dc6a" xlink:to="loc_rdnt_ChelseaDignosticRadiologyPCMember_b975cf93-ab68-4c70-88cf-7ef9ae875cba" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NorthJerseyImagingCenterLLCMember_4df9de28-ac59-4c1a-a4e9-106cf750e883" xlink:href="rdnt-20221231.xsd#rdnt_NorthJerseyImagingCenterLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e8e21f15-11f4-4ecf-835c-0ec46007dc6a" xlink:to="loc_rdnt_NorthJerseyImagingCenterLLCMember_4df9de28-ac59-4c1a-a4e9-106cf750e883" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_IFRCLLCMember_97058172-5d39-433a-a33a-8639bd17298b" xlink:href="rdnt-20221231.xsd#rdnt_IFRCLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e8e21f15-11f4-4ecf-835c-0ec46007dc6a" xlink:to="loc_rdnt_IFRCLLCMember_97058172-5d39-433a-a33a-8639bd17298b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PersonalHealthImagingMember_c8ebbd2e-61c3-466c-9ac3-27e9cf5968b5" xlink:href="rdnt-20221231.xsd#rdnt_PersonalHealthImagingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e8e21f15-11f4-4ecf-835c-0ec46007dc6a" xlink:to="loc_rdnt_PersonalHealthImagingMember_c8ebbd2e-61c3-466c-9ac3-27e9cf5968b5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ZPElmontLLCMember_5b210eb3-e86f-49e5-ad75-239277f711f2" xlink:href="rdnt-20221231.xsd#rdnt_ZPElmontLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e8e21f15-11f4-4ecf-835c-0ec46007dc6a" xlink:to="loc_rdnt_ZPElmontLLCMember_5b210eb3-e86f-49e5-ad75-239277f711f2" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ZPFreeportLLCMember_314f514b-afab-4001-9273-cb9ddc36c6a5" xlink:href="rdnt-20221231.xsd#rdnt_ZPFreeportLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e8e21f15-11f4-4ecf-835c-0ec46007dc6a" xlink:to="loc_rdnt_ZPFreeportLLCMember_314f514b-afab-4001-9273-cb9ddc36c6a5" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BroadwayMedicalImagingLLCMember_5c21bbd6-3f27-444b-8752-551f12072544" xlink:href="rdnt-20221231.xsd#rdnt_BroadwayMedicalImagingLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e8e21f15-11f4-4ecf-835c-0ec46007dc6a" xlink:to="loc_rdnt_BroadwayMedicalImagingLLCMember_5c21bbd6-3f27-444b-8752-551f12072544" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_A3235HempsteadLLCMember_c6d6af87-436f-4a93-a069-e279c1ebaf22" xlink:href="rdnt-20221231.xsd#rdnt_A3235HempsteadLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e8e21f15-11f4-4ecf-835c-0ec46007dc6a" xlink:to="loc_rdnt_A3235HempsteadLLCMember_c6d6af87-436f-4a93-a069-e279c1ebaf22" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SLZMRealtyLLCMember_e59c5ab4-7200-4c05-8859-6a1c9a649d04" xlink:href="rdnt-20221231.xsd#rdnt_SLZMRealtyLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e8e21f15-11f4-4ecf-835c-0ec46007dc6a" xlink:to="loc_rdnt_SLZMRealtyLLCMember_e59c5ab4-7200-4c05-8859-6a1c9a649d04" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_A2012SunriseMerrickLLCMember_87946a61-5f9f-4f24-a1a6-da18ab32bc3b" xlink:href="rdnt-20221231.xsd#rdnt_A2012SunriseMerrickLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e8e21f15-11f4-4ecf-835c-0ec46007dc6a" xlink:to="loc_rdnt_A2012SunriseMerrickLLCMember_87946a61-5f9f-4f24-a1a6-da18ab32bc3b" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ZPBaysideLLCMember_1469d4c3-5461-4936-abab-ff8fdfe100ec" xlink:href="rdnt-20221231.xsd#rdnt_ZPBaysideLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e8e21f15-11f4-4ecf-835c-0ec46007dc6a" xlink:to="loc_rdnt_ZPBaysideLLCMember_1469d4c3-5461-4936-abab-ff8fdfe100ec" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ZPLaureltonLLCMember_858ab16d-3971-4c57-aba2-97ca657c00ab" xlink:href="rdnt-20221231.xsd#rdnt_ZPLaureltonLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e8e21f15-11f4-4ecf-835c-0ec46007dc6a" xlink:to="loc_rdnt_ZPLaureltonLLCMember_858ab16d-3971-4c57-aba2-97ca657c00ab" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ZPSmithLLCMember_a5ff78be-1d20-4f46-9ba7-68af93420ab4" xlink:href="rdnt-20221231.xsd#rdnt_ZPSmithLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e8e21f15-11f4-4ecf-835c-0ec46007dc6a" xlink:to="loc_rdnt_ZPSmithLLCMember_a5ff78be-1d20-4f46-9ba7-68af93420ab4" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ZP907NorthernLLCMember_73e3a90a-d687-4094-8aaa-576ec000d56c" xlink:href="rdnt-20221231.xsd#rdnt_ZP907NorthernLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e8e21f15-11f4-4ecf-835c-0ec46007dc6a" xlink:to="loc_rdnt_ZP907NorthernLLCMember_73e3a90a-d687-4094-8aaa-576ec000d56c" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WilliamMKellyMDIncMember_a582071c-ecc4-42e2-805c-70a614f2e46c" xlink:href="rdnt-20221231.xsd#rdnt_WilliamMKellyMDIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e8e21f15-11f4-4ecf-835c-0ec46007dc6a" xlink:to="loc_rdnt_WilliamMKellyMDIncMember_a582071c-ecc4-42e2-805c-70a614f2e46c" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_A60thStreetMRILLCMember_82826dcd-eea5-4fdf-923a-34e39c1d0fb3" xlink:href="rdnt-20221231.xsd#rdnt_A60thStreetMRILLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e8e21f15-11f4-4ecf-835c-0ec46007dc6a" xlink:to="loc_rdnt_A60thStreetMRILLCMember_82826dcd-eea5-4fdf-923a-34e39c1d0fb3" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ZPParkchesterLLCMember_eabdbd7f-b41c-461e-a2cc-12773d8a9401" xlink:href="rdnt-20221231.xsd#rdnt_ZPParkchesterLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e8e21f15-11f4-4ecf-835c-0ec46007dc6a" xlink:to="loc_rdnt_ZPParkchesterLLCMember_eabdbd7f-b41c-461e-a2cc-12773d8a9401" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ZPEasternLLCMember_053de7a7-4cf6-41c3-99cc-8a73a4959ff9" xlink:href="rdnt-20221231.xsd#rdnt_ZPEasternLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e8e21f15-11f4-4ecf-835c-0ec46007dc6a" xlink:to="loc_rdnt_ZPEasternLLCMember_053de7a7-4cf6-41c3-99cc-8a73a4959ff9" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TangentAssociatesLLCMember_1f0cf911-c3a2-476c-94fc-222182b25ee1" xlink:href="rdnt-20221231.xsd#rdnt_TangentAssociatesLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e8e21f15-11f4-4ecf-835c-0ec46007dc6a" xlink:to="loc_rdnt_TangentAssociatesLLCMember_1f0cf911-c3a2-476c-94fc-222182b25ee1" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MidDelawareImagingPAMember_cdb406ba-7a2a-42a1-8a9a-dc605191e9d8" xlink:href="rdnt-20221231.xsd#rdnt_MidDelawareImagingPAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e8e21f15-11f4-4ecf-835c-0ec46007dc6a" xlink:to="loc_rdnt_MidDelawareImagingPAMember_cdb406ba-7a2a-42a1-8a9a-dc605191e9d8" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionsMember_f0e962d1-d388-42e6-bc52-6e4778b05658" xlink:href="rdnt-20221231.xsd#rdnt_BusinessAcquisitionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e8e21f15-11f4-4ecf-835c-0ec46007dc6a" xlink:to="loc_rdnt_BusinessAcquisitionsMember_f0e962d1-d388-42e6-bc52-6e4778b05658" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_ec0f293b-f500-4b71-956f-4896751d9624" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0e956483-5cc1-4c66-8de9-4fa0aa41ef0a" xlink:to="loc_dei_LegalEntityAxis_ec0f293b-f500-4b71-956f-4896751d9624" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_ec0f293b-f500-4b71-956f-4896751d9624_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_ec0f293b-f500-4b71-956f-4896751d9624" xlink:to="loc_dei_EntityDomain_ec0f293b-f500-4b71-956f-4896751d9624_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_abae9b98-6f0f-4de4-b4db-20474658e7af" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_ec0f293b-f500-4b71-956f-4896751d9624" xlink:to="loc_dei_EntityDomain_abae9b98-6f0f-4de4-b4db-20474658e7af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_JointVentureWithCalvertMedicalImagingCentersLLCMember_d0c5dbc4-3f40-4374-b217-b3070b7290d5" xlink:href="rdnt-20221231.xsd#rdnt_JointVentureWithCalvertMedicalImagingCentersLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_abae9b98-6f0f-4de4-b4db-20474658e7af" xlink:to="loc_rdnt_JointVentureWithCalvertMedicalImagingCentersLLCMember_d0c5dbc4-3f40-4374-b217-b3070b7290d5" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20221231.xsd#BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative" xlink:type="extended" id="ib3bf35835134449ba2cca1c68b064a06_BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_8e4eb44c-3a2e-4c2e-b343-e03b8da887db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_8e4eb44c-3a2e-4c2e-b343-e03b8da887db" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_9e56d99d-54f0-4aba-ab19-2cf909cb8c6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_9e56d99d-54f0-4aba-ab19-2cf909cb8c6b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_f6c3d726-bafd-4e7a-9843-f06acf03a9e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_f6c3d726-bafd-4e7a-9843-f06acf03a9e8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_e39990b5-a123-430e-a987-717725a93faa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_e39990b5-a123-430e-a987-717725a93faa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice_c641ba4a-00f0-4dd2-bbcc-cc3df2587762" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:to="loc_us-gaap_BusinessAcquisitionSharePrice_c641ba4a-00f0-4dd2-bbcc-cc3df2587762" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_363e0b36-5789-44e6-aa04-af7fa51b4d72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_363e0b36-5789-44e6-aa04-af7fa51b4d72" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_17c6ccc5-886d-4d92-a3aa-497df9554613" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_17c6ccc5-886d-4d92-a3aa-497df9554613" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod_53280ce1-6e47-4800-96f5-1bd7b54bdeb0" xlink:href="rdnt-20221231.xsd#rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:to="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod_53280ce1-6e47-4800-96f5-1bd7b54bdeb0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_6203bcd5-7825-4511-b87c-7bef75f80cf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_6203bcd5-7825-4511-b87c-7bef75f80cf0" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_28c92088-ce53-4df7-8c0d-dc7bcde94081" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_28c92088-ce53-4df7-8c0d-dc7bcde94081" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_cede8370-f31b-4e19-a47c-ab641b93fbe5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_cede8370-f31b-4e19-a47c-ab641b93fbe5" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_0518a5cf-5208-4b7e-8348-34e007d8c36c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_0518a5cf-5208-4b7e-8348-34e007d8c36c" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_f6ed998b-4bed-445b-8d36-1387a1cce583" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_f6ed998b-4bed-445b-8d36-1387a1cce583" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_866b2d02-ada6-4724-9a99-4c269455725a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:to="loc_us-gaap_Goodwill_866b2d02-ada6-4724-9a99-4c269455725a" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_70eae7ea-b21d-4084-bf17-bfccf23dfef9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_70eae7ea-b21d-4084-bf17-bfccf23dfef9" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities_4a6b486f-6dab-4b69-ab4b-0361761e1f8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities_4a6b486f-6dab-4b69-ab4b-0361761e1f8f" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_0f264da2-4b75-4413-af25-0213b1545467" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_0f264da2-4b75-4413-af25-0213b1545467" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_7092c04a-1ae5-4e84-b317-d7b7b7a188f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_7092c04a-1ae5-4e84-b317-d7b7b7a188f5" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_99e9310d-e617-4051-9e67-a1b75bd1b7fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_99e9310d-e617-4051-9e67-a1b75bd1b7fe" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_53824996-88c3-4331-a1f7-9b3cbce2d4ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_53824996-88c3-4331-a1f7-9b3cbce2d4ce" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberOfLocationOfferingMultiModalityServices_7884d9a2-452c-47b0-8d65-babc3aa1d35e" xlink:href="rdnt-20221231.xsd#rdnt_NumberOfLocationOfferingMultiModalityServices"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:to="loc_rdnt_NumberOfLocationOfferingMultiModalityServices_7884d9a2-452c-47b0-8d65-babc3aa1d35e" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_516bb490-41da-4de8-bb95-95d211776e5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_516bb490-41da-4de8-bb95-95d211776e5e" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_bed1d77a-8077-4b3a-8016-39eadbd9148a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_bed1d77a-8077-4b3a-8016-39eadbd9148a" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest_6a9e122b-873d-470e-8fd5-871fa0557add" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:to="loc_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest_6a9e122b-873d-470e-8fd5-871fa0557add" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_fd0a8947-efbe-4021-aeb2-20251f5f43a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:to="loc_us-gaap_EquityMethodInvestments_fd0a8947-efbe-4021-aeb2-20251f5f43a3" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest_f9cbfeb4-7dd4-455c-aa1c-72cc5c843331" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:to="loc_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest_f9cbfeb4-7dd4-455c-aa1c-72cc5c843331" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInJointVenture_a1e4705a-d79a-4831-b2a4-ecbfa218b570" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireInterestInJointVenture"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:to="loc_us-gaap_PaymentsToAcquireInterestInJointVenture_a1e4705a-d79a-4831-b2a4-ecbfa218b570" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentAggregateCost_f9c53306-7131-4b6c-873a-68141b69b139" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:to="loc_us-gaap_EquityMethodInvestmentAggregateCost_f9c53306-7131-4b6c-873a-68141b69b139" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberOfLocations_fd598ba6-a3ba-4bc6-ab89-5083c8e55376" xlink:href="rdnt-20221231.xsd#rdnt_NumberOfLocations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:to="loc_rdnt_NumberOfLocations_fd598ba6-a3ba-4bc6-ab89-5083c8e55376" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_45671519-8e02-4beb-b170-ee5208638555" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_45671519-8e02-4beb-b170-ee5208638555" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1_6a03fa14-3e0c-4c69-8f02-5928d2d70746" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1_6a03fa14-3e0c-4c69-8f02-5928d2d70746" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NoncontrollingInterestPercentOfOwnershipSold_fe033645-8001-43c3-9f1d-cb33e9974a61" xlink:href="rdnt-20221231.xsd#rdnt_NoncontrollingInterestPercentOfOwnershipSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:to="loc_rdnt_NoncontrollingInterestPercentOfOwnershipSold_fe033645-8001-43c3-9f1d-cb33e9974a61" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ProceedsFromSaleOfInterestInMinorityShareholders_e17e9d84-91b7-4d88-bc5a-b21e4e8d5c90" xlink:href="rdnt-20221231.xsd#rdnt_ProceedsFromSaleOfInterestInMinorityShareholders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:to="loc_rdnt_ProceedsFromSaleOfInterestInMinorityShareholders_e17e9d84-91b7-4d88-bc5a-b21e4e8d5c90" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_06504022-204a-41de-902d-ead402645ff4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_06504022-204a-41de-902d-ead402645ff4" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_5ea4ea19-0f7c-43c0-ada3-49bd41b2f5e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_5ea4ea19-0f7c-43c0-ada3-49bd41b2f5e1" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_f63142ab-91ff-434b-b215-a53193a193f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_f63142ab-91ff-434b-b215-a53193a193f1" xlink:type="arc" order="35"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberOfCentersContributed_bc4d6fa8-87f2-4b27-85b4-c24629c6149a" xlink:href="rdnt-20221231.xsd#rdnt_NumberOfCentersContributed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:to="loc_rdnt_NumberOfCentersContributed_bc4d6fa8-87f2-4b27-85b4-c24629c6149a" xlink:type="arc" order="36"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5b56215d-7b33-4fa5-96eb-aef09746383f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5b56215d-7b33-4fa5-96eb-aef09746383f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_fc3c20be-7191-4e34-9f02-09811f4f592f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5b56215d-7b33-4fa5-96eb-aef09746383f" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_fc3c20be-7191-4e34-9f02-09811f4f592f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fc3c20be-7191-4e34-9f02-09811f4f592f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_fc3c20be-7191-4e34-9f02-09811f4f592f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fc3c20be-7191-4e34-9f02-09811f4f592f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_87d2c1c8-29a8-4c2d-858c-7d90df0582be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_fc3c20be-7191-4e34-9f02-09811f4f592f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_87d2c1c8-29a8-4c2d-858c-7d90df0582be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HeartAndLungImagingLimitedMember_79e10bde-af00-4f43-b6e6-b0391852aa2d" xlink:href="rdnt-20221231.xsd#rdnt_HeartAndLungImagingLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_87d2c1c8-29a8-4c2d-858c-7d90df0582be" xlink:to="loc_rdnt_HeartAndLungImagingLimitedMember_79e10bde-af00-4f43-b6e6-b0391852aa2d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AidenceMember_76fde9b5-13f6-4ac4-a609-c2d477a724cf" xlink:href="rdnt-20221231.xsd#rdnt_AidenceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_87d2c1c8-29a8-4c2d-858c-7d90df0582be" xlink:to="loc_rdnt_AidenceMember_76fde9b5-13f6-4ac4-a609-c2d477a724cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_QuantibMember_f8c09ac9-63bd-4539-a18b-9ad52116df41" xlink:href="rdnt-20221231.xsd#rdnt_QuantibMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_87d2c1c8-29a8-4c2d-858c-7d90df0582be" xlink:to="loc_rdnt_QuantibMember_f8c09ac9-63bd-4539-a18b-9ad52116df41" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_3accd345-6022-40e6-aae0-0942616c97c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5b56215d-7b33-4fa5-96eb-aef09746383f" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_3accd345-6022-40e6-aae0-0942616c97c4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_3accd345-6022-40e6-aae0-0942616c97c4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_3accd345-6022-40e6-aae0-0942616c97c4" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_3accd345-6022-40e6-aae0-0942616c97c4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_7932dd9a-3970-4dc2-8d7b-499c88246bde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_3accd345-6022-40e6-aae0-0942616c97c4" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_7932dd9a-3970-4dc2-8d7b-499c88246bde" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ContingentMilestoneConsiderationMember_3ad218e4-e71d-44ec-b282-4f8511414d30" xlink:href="rdnt-20221231.xsd#rdnt_ContingentMilestoneConsiderationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_7932dd9a-3970-4dc2-8d7b-499c88246bde" xlink:to="loc_rdnt_ContingentMilestoneConsiderationMember_3ad218e4-e71d-44ec-b282-4f8511414d30" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CashHoldbackMember_22e88d98-a587-4a05-830d-7785e8f3e076" xlink:href="rdnt-20221231.xsd#rdnt_CashHoldbackMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_7932dd9a-3970-4dc2-8d7b-499c88246bde" xlink:to="loc_rdnt_CashHoldbackMember_22e88d98-a587-4a05-830d-7785e8f3e076" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionContingentConsiderationMember_73a2356d-451c-4857-911c-e846ce1eb542" xlink:href="rdnt-20221231.xsd#rdnt_BusinessAcquisitionContingentConsiderationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_7932dd9a-3970-4dc2-8d7b-499c88246bde" xlink:to="loc_rdnt_BusinessAcquisitionContingentConsiderationMember_73a2356d-451c-4857-911c-e846ce1eb542" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_f9d08fd6-afe2-4ada-8599-1248a6e5fa13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5b56215d-7b33-4fa5-96eb-aef09746383f" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_f9d08fd6-afe2-4ada-8599-1248a6e5fa13" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_f9d08fd6-afe2-4ada-8599-1248a6e5fa13_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_f9d08fd6-afe2-4ada-8599-1248a6e5fa13" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_f9d08fd6-afe2-4ada-8599-1248a6e5fa13_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_c049bc87-bc02-4d1c-8e56-f4ff4ff9e979" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_f9d08fd6-afe2-4ada-8599-1248a6e5fa13" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_c049bc87-bc02-4d1c-8e56-f4ff4ff9e979" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_fb4257f2-357e-4d89-8abf-82345697ac0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_c049bc87-bc02-4d1c-8e56-f4ff4ff9e979" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_fb4257f2-357e-4d89-8abf-82345697ac0f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis_0befe101-054e-48d4-8988-55080181035a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5b56215d-7b33-4fa5-96eb-aef09746383f" xlink:to="loc_us-gaap_ValuationTechniqueAxis_0befe101-054e-48d4-8988-55080181035a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_0befe101-054e-48d4-8988-55080181035a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationTechniqueAxis_0befe101-054e-48d4-8988-55080181035a" xlink:to="loc_us-gaap_ValuationTechniqueDomain_0befe101-054e-48d4-8988-55080181035a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_b998563d-9102-4066-b099-7b22c69e8a01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationTechniqueAxis_0befe101-054e-48d4-8988-55080181035a" xlink:to="loc_us-gaap_ValuationTechniqueDomain_b998563d-9102-4066-b099-7b22c69e8a01" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeApproachValuationTechniqueMember_b6cbbdfe-dc35-4b34-acc2-28a242b837ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeApproachValuationTechniqueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationTechniqueDomain_b998563d-9102-4066-b099-7b22c69e8a01" xlink:to="loc_us-gaap_IncomeApproachValuationTechniqueMember_b6cbbdfe-dc35-4b34-acc2-28a242b837ab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_34bade17-dc16-47aa-8c52-a5baa10f2562" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5b56215d-7b33-4fa5-96eb-aef09746383f" xlink:to="loc_srt_CounterpartyNameAxis_34bade17-dc16-47aa-8c52-a5baa10f2562" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_34bade17-dc16-47aa-8c52-a5baa10f2562_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_34bade17-dc16-47aa-8c52-a5baa10f2562" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_34bade17-dc16-47aa-8c52-a5baa10f2562_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_18c02717-5610-45e8-8e83-a14d8287e423" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_34bade17-dc16-47aa-8c52-a5baa10f2562" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_18c02717-5610-45e8-8e83-a14d8287e423" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OtherSellersMember_dbcbe165-22e5-4e76-bfd2-699019fa7301" xlink:href="rdnt-20221231.xsd#rdnt_OtherSellersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_18c02717-5610-45e8-8e83-a14d8287e423" xlink:to="loc_rdnt_OtherSellersMember_dbcbe165-22e5-4e76-bfd2-699019fa7301" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CertainSellerMember_194501db-7fc4-4357-b210-f286a2348d6f" xlink:href="rdnt-20221231.xsd#rdnt_CertainSellerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_18c02717-5610-45e8-8e83-a14d8287e423" xlink:to="loc_rdnt_CertainSellerMember_194501db-7fc4-4357-b210-f286a2348d6f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FrederickCountyRadiologyLLCMember_8ff74966-b352-46cc-a326-d270ad9d7ebd" xlink:href="rdnt-20221231.xsd#rdnt_FrederickCountyRadiologyLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_18c02717-5610-45e8-8e83-a14d8287e423" xlink:to="loc_rdnt_FrederickCountyRadiologyLLCMember_8ff74966-b352-46cc-a326-d270ad9d7ebd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_904f3ef2-cba0-466a-9932-0d248d8015ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5b56215d-7b33-4fa5-96eb-aef09746383f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_904f3ef2-cba0-466a-9932-0d248d8015ea" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_904f3ef2-cba0-466a-9932-0d248d8015ea_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_904f3ef2-cba0-466a-9932-0d248d8015ea" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_904f3ef2-cba0-466a-9932-0d248d8015ea_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_508823d7-b368-436c-be76-842f4333fbe0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_904f3ef2-cba0-466a-9932-0d248d8015ea" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_508823d7-b368-436c-be76-842f4333fbe0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_fa5793eb-38d3-4dc6-8929-c19cce8e1115" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_508823d7-b368-436c-be76-842f4333fbe0" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_fa5793eb-38d3-4dc6-8929-c19cce8e1115" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_80cd037b-6590-47c9-896e-95f5b3e86778" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_508823d7-b368-436c-be76-842f4333fbe0" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_80cd037b-6590-47c9-896e-95f5b3e86778" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_2a04377e-0435-4ebc-81f2-e0af546d464b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_508823d7-b368-436c-be76-842f4333fbe0" xlink:to="loc_us-gaap_CustomerRelationshipsMember_2a04377e-0435-4ebc-81f2-e0af546d464b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_ae2ddb02-dca6-4b08-8603-9ba9ccc8055b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_508823d7-b368-436c-be76-842f4333fbe0" xlink:to="loc_us-gaap_TradeNamesMember_ae2ddb02-dca6-4b08-8603-9ba9ccc8055b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_df9901dd-8d5b-4fad-b2d3-d61528dab6b3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5b56215d-7b33-4fa5-96eb-aef09746383f" xlink:to="loc_srt_RangeAxis_df9901dd-8d5b-4fad-b2d3-d61528dab6b3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_df9901dd-8d5b-4fad-b2d3-d61528dab6b3_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_df9901dd-8d5b-4fad-b2d3-d61528dab6b3" xlink:to="loc_srt_RangeMember_df9901dd-8d5b-4fad-b2d3-d61528dab6b3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_311b1a74-9e75-4c97-aed0-66f04dd701b0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_df9901dd-8d5b-4fad-b2d3-d61528dab6b3" xlink:to="loc_srt_RangeMember_311b1a74-9e75-4c97-aed0-66f04dd701b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_4934b263-9636-4f6a-8d7b-1ffa2b0c3180" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_311b1a74-9e75-4c97-aed0-66f04dd701b0" xlink:to="loc_srt_MinimumMember_4934b263-9636-4f6a-8d7b-1ffa2b0c3180" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_de3f60e5-79a3-41ce-a393-ce4f4a0f75af" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_311b1a74-9e75-4c97-aed0-66f04dd701b0" xlink:to="loc_srt_MaximumMember_de3f60e5-79a3-41ce-a393-ce4f4a0f75af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_1fee5be8-1cae-4e28-af4a-3cc9d0044928" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5b56215d-7b33-4fa5-96eb-aef09746383f" xlink:to="loc_srt_OwnershipAxis_1fee5be8-1cae-4e28-af4a-3cc9d0044928" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_1fee5be8-1cae-4e28-af4a-3cc9d0044928_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_1fee5be8-1cae-4e28-af4a-3cc9d0044928" xlink:to="loc_srt_OwnershipDomain_1fee5be8-1cae-4e28-af4a-3cc9d0044928_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_7cce6105-dfae-412b-94a8-cf8863b4354a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_1fee5be8-1cae-4e28-af4a-3cc9d0044928" xlink:to="loc_srt_OwnershipDomain_7cce6105-dfae-412b-94a8-cf8863b4354a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FrederickCountyRadiologyLLCMember_8e28fa49-b246-4404-af8a-a9bab3c69f5e" xlink:href="rdnt-20221231.xsd#rdnt_FrederickCountyRadiologyLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_7cce6105-dfae-412b-94a8-cf8863b4354a" xlink:to="loc_rdnt_FrederickCountyRadiologyLLCMember_8e28fa49-b246-4404-af8a-a9bab3c69f5e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AdvancedRadiologyAtCapitalRegionLLCMember_583d506f-b5ba-4446-90bc-bfef4fb9e262" xlink:href="rdnt-20221231.xsd#rdnt_AdvancedRadiologyAtCapitalRegionLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_7cce6105-dfae-412b-94a8-cf8863b4354a" xlink:to="loc_rdnt_AdvancedRadiologyAtCapitalRegionLLCMember_583d506f-b5ba-4446-90bc-bfef4fb9e262" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SimiValleyImagingGroupLLCMember_5bf08037-250f-4255-aedf-ec2e58e59e74" xlink:href="rdnt-20221231.xsd#rdnt_SimiValleyImagingGroupLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_7cce6105-dfae-412b-94a8-cf8863b4354a" xlink:to="loc_rdnt_SimiValleyImagingGroupLLCMember_5bf08037-250f-4255-aedf-ec2e58e59e74" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WestValleyImagingGroupLLCMember_087d5e7b-0ce8-4f7a-8256-0de0e81a09fc" xlink:href="rdnt-20221231.xsd#rdnt_WestValleyImagingGroupLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_7cce6105-dfae-412b-94a8-cf8863b4354a" xlink:to="loc_rdnt_WestValleyImagingGroupLLCMember_087d5e7b-0ce8-4f7a-8256-0de0e81a09fc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e55d4f61-b1ff-4ca7-bd2f-53b0d8069431" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5b56215d-7b33-4fa5-96eb-aef09746383f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e55d4f61-b1ff-4ca7-bd2f-53b0d8069431" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e55d4f61-b1ff-4ca7-bd2f-53b0d8069431_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e55d4f61-b1ff-4ca7-bd2f-53b0d8069431" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e55d4f61-b1ff-4ca7-bd2f-53b0d8069431_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_89df6021-ee73-4174-aad1-4ee46fa67699" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e55d4f61-b1ff-4ca7-bd2f-53b0d8069431" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_89df6021-ee73-4174-aad1-4ee46fa67699" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FixedAssetsMember_43fe9648-52bb-44f9-9802-2d8dfcd5656f" xlink:href="rdnt-20221231.xsd#rdnt_FixedAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_89df6021-ee73-4174-aad1-4ee46fa67699" xlink:to="loc_rdnt_FixedAssetsMember_43fe9648-52bb-44f9-9802-2d8dfcd5656f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_01b8aa0d-02e0-4d94-85fa-a623dbb5e15f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_89df6021-ee73-4174-aad1-4ee46fa67699" xlink:to="loc_us-gaap_EquipmentMember_01b8aa0d-02e0-4d94-85fa-a623dbb5e15f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_fad4531e-8eb8-47f6-9716-1040fc687869" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5b56215d-7b33-4fa5-96eb-aef09746383f" xlink:to="loc_dei_LegalEntityAxis_fad4531e-8eb8-47f6-9716-1040fc687869" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_fad4531e-8eb8-47f6-9716-1040fc687869_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_fad4531e-8eb8-47f6-9716-1040fc687869" xlink:to="loc_dei_EntityDomain_fad4531e-8eb8-47f6-9716-1040fc687869_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_e22d4171-9dff-436c-9083-d3b6826ebb9f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_fad4531e-8eb8-47f6-9716-1040fc687869" xlink:to="loc_dei_EntityDomain_e22d4171-9dff-436c-9083-d3b6826ebb9f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FrederickHealthHospitalIncMember_ccfd5eb7-a217-4223-86d3-127447936ff0" xlink:href="rdnt-20221231.xsd#rdnt_FrederickHealthHospitalIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_e22d4171-9dff-436c-9083-d3b6826ebb9f" xlink:to="loc_rdnt_FrederickHealthHospitalIncMember_ccfd5eb7-a217-4223-86d3-127447936ff0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DimensionHealthCorporationMember_a79e2b00-0309-497d-b28f-71956bfe994a" xlink:href="rdnt-20221231.xsd#rdnt_DimensionHealthCorporationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_e22d4171-9dff-436c-9083-d3b6826ebb9f" xlink:to="loc_rdnt_DimensionHealthCorporationMember_a79e2b00-0309-497d-b28f-71956bfe994a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SimiValleyImagingGroupLLCMember_4322c066-2cf2-4db2-8b7c-8eea28124d61" xlink:href="rdnt-20221231.xsd#rdnt_SimiValleyImagingGroupLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_e22d4171-9dff-436c-9083-d3b6826ebb9f" xlink:to="loc_rdnt_SimiValleyImagingGroupLLCMember_4322c066-2cf2-4db2-8b7c-8eea28124d61" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SimiAdventistMember_8616ddbd-5513-4de4-83d3-68551392b285" xlink:href="rdnt-20221231.xsd#rdnt_SimiAdventistMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_e22d4171-9dff-436c-9083-d3b6826ebb9f" xlink:to="loc_rdnt_SimiAdventistMember_8616ddbd-5513-4de4-83d3-68551392b285" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FrederickCountyRadiologyLLCMember_5f74b9ff-50f2-41bb-bbec-3aed41417ade" xlink:href="rdnt-20221231.xsd#rdnt_FrederickCountyRadiologyLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_e22d4171-9dff-436c-9083-d3b6826ebb9f" xlink:to="loc_rdnt_FrederickCountyRadiologyLLCMember_5f74b9ff-50f2-41bb-bbec-3aed41417ade" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_b4f07bdb-e158-465a-a2a1-0786ce0fa754" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5b56215d-7b33-4fa5-96eb-aef09746383f" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_b4f07bdb-e158-465a-a2a1-0786ce0fa754" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_b4f07bdb-e158-465a-a2a1-0786ce0fa754_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_b4f07bdb-e158-465a-a2a1-0786ce0fa754" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_b4f07bdb-e158-465a-a2a1-0786ce0fa754_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_5ebe3fa2-e363-4a49-8a0b-bac7792b04a9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_b4f07bdb-e158-465a-a2a1-0786ce0fa754" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_5ebe3fa2-e363-4a49-8a0b-bac7792b04a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FrederickCountyRadiologyLLCMember_5ac16057-0623-45d3-bf0b-1bd69ccd2c2a" xlink:href="rdnt-20221231.xsd#rdnt_FrederickCountyRadiologyLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_5ebe3fa2-e363-4a49-8a0b-bac7792b04a9" xlink:to="loc_rdnt_FrederickCountyRadiologyLLCMember_5ac16057-0623-45d3-bf0b-1bd69ccd2c2a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_214e9f2a-28c3-44f8-a3b5-3a54f5f6cebc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5b56215d-7b33-4fa5-96eb-aef09746383f" xlink:to="loc_srt_ConsolidatedEntitiesAxis_214e9f2a-28c3-44f8-a3b5-3a54f5f6cebc" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_214e9f2a-28c3-44f8-a3b5-3a54f5f6cebc_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_214e9f2a-28c3-44f8-a3b5-3a54f5f6cebc" xlink:to="loc_srt_ConsolidatedEntitiesDomain_214e9f2a-28c3-44f8-a3b5-3a54f5f6cebc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_c0b7e782-dfb5-4b47-8343-af66a156333c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_214e9f2a-28c3-44f8-a3b5-3a54f5f6cebc" xlink:to="loc_srt_ConsolidatedEntitiesDomain_c0b7e782-dfb5-4b47-8343-af66a156333c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SubsidiariesMember_e66a0602-0b10-4f3b-8fbc-9ba64f6ebc87" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SubsidiariesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_c0b7e782-dfb5-4b47-8343-af66a156333c" xlink:to="loc_srt_SubsidiariesMember_e66a0602-0b10-4f3b-8fbc-9ba64f6ebc87" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b720a95a-5a0e-4ac2-802a-15f99a515504" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5b56215d-7b33-4fa5-96eb-aef09746383f" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b720a95a-5a0e-4ac2-802a-15f99a515504" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b720a95a-5a0e-4ac2-802a-15f99a515504_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b720a95a-5a0e-4ac2-802a-15f99a515504" xlink:to="loc_us-gaap_EquityComponentDomain_b720a95a-5a0e-4ac2-802a-15f99a515504_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_4536a7c3-d732-4c9e-bd52-480c05149ee7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b720a95a-5a0e-4ac2-802a-15f99a515504" xlink:to="loc_us-gaap_EquityComponentDomain_4536a7c3-d732-4c9e-bd52-480c05149ee7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_eb67875c-490b-42b7-9cfa-682f228ed678" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_4536a7c3-d732-4c9e-bd52-480c05149ee7" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_eb67875c-490b-42b7-9cfa-682f228ed678" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_d41f9c95-8ff3-4c20-9f1f-58e91fe62c9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5b56215d-7b33-4fa5-96eb-aef09746383f" xlink:to="loc_us-gaap_AssetAcquisitionAxis_d41f9c95-8ff3-4c20-9f1f-58e91fe62c9d" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_d41f9c95-8ff3-4c20-9f1f-58e91fe62c9d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AssetAcquisitionAxis_d41f9c95-8ff3-4c20-9f1f-58e91fe62c9d" xlink:to="loc_us-gaap_AssetAcquisitionDomain_d41f9c95-8ff3-4c20-9f1f-58e91fe62c9d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_723dc715-b52d-478a-b3ec-fe9bf8474175" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AssetAcquisitionAxis_d41f9c95-8ff3-4c20-9f1f-58e91fe62c9d" xlink:to="loc_us-gaap_AssetAcquisitionDomain_723dc715-b52d-478a-b3ec-fe9bf8474175" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TarzanaMedicalCenterLLCMember_a9bc9c5c-a7ef-46f1-9579-2ba06885eb32" xlink:href="rdnt-20221231.xsd#rdnt_TarzanaMedicalCenterLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionDomain_723dc715-b52d-478a-b3ec-fe9bf8474175" xlink:to="loc_rdnt_TarzanaMedicalCenterLLCMember_a9bc9c5c-a7ef-46f1-9579-2ba06885eb32" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SEGMENTREPORTINGDetails" xlink:type="simple" xlink:href="rdnt-20221231.xsd#SEGMENTREPORTINGDetails"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SEGMENTREPORTINGDetails" xlink:type="extended" id="i37dcc335609a4f71a5bd2ceb7ddeab42_SEGMENTREPORTINGDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_f9fd787c-514f-4ab6-94a5-2479527e3071" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_1c4443d7-2ef4-484d-872f-d61ee14c8af9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f9fd787c-514f-4ab6-94a5-2479527e3071" xlink:to="loc_us-gaap_Revenues_1c4443d7-2ef4-484d-872f-d61ee14c8af9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_245f2059-0c1f-478e-89c2-34ef6dac1482" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f9fd787c-514f-4ab6-94a5-2479527e3071" xlink:to="loc_us-gaap_OperatingCostsAndExpenses_245f2059-0c1f-478e-89c2-34ef6dac1482" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_6ba18b77-7b19-4698-a7d2-49957a52c9c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f9fd787c-514f-4ab6-94a5-2479527e3071" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_6ba18b77-7b19-4698-a7d2-49957a52c9c1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_6f763953-e300-4c2e-b6bb-64fc429bb795" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f9fd787c-514f-4ab6-94a5-2479527e3071" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_6f763953-e300-4c2e-b6bb-64fc429bb795" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_c4c9aa6e-ef37-4e8a-b929-525357aa8bbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeveranceCosts1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f9fd787c-514f-4ab6-94a5-2479527e3071" xlink:to="loc_us-gaap_SeveranceCosts1_c4c9aa6e-ef37-4e8a-b929-525357aa8bbc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OperatingIncomeLossExcludingReliefFunding_9bc20d17-3fe2-49f4-a660-dcdeedfbd721" xlink:href="rdnt-20221231.xsd#rdnt_OperatingIncomeLossExcludingReliefFunding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f9fd787c-514f-4ab6-94a5-2479527e3071" xlink:to="loc_rdnt_OperatingIncomeLossExcludingReliefFunding_9bc20d17-3fe2-49f4-a660-dcdeedfbd721" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ProceedsFromProviderReliefFunding_06ef7575-37c9-4264-bee8-b0bff181443f" xlink:href="rdnt-20221231.xsd#rdnt_ProceedsFromProviderReliefFunding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f9fd787c-514f-4ab6-94a5-2479527e3071" xlink:to="loc_rdnt_ProceedsFromProviderReliefFunding_06ef7575-37c9-4264-bee8-b0bff181443f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_080e6d50-3568-43a0-b81c-384581b7121a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f9fd787c-514f-4ab6-94a5-2479527e3071" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_080e6d50-3568-43a0-b81c-384581b7121a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_4f20d584-32ee-46cf-95fb-6d5a0f758958" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_080e6d50-3568-43a0-b81c-384581b7121a" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_4f20d584-32ee-46cf-95fb-6d5a0f758958" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_4f20d584-32ee-46cf-95fb-6d5a0f758958_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_4f20d584-32ee-46cf-95fb-6d5a0f758958" xlink:to="loc_us-gaap_SegmentDomain_4f20d584-32ee-46cf-95fb-6d5a0f758958_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ace83661-d80f-4de9-8fda-589d3879e58b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_4f20d584-32ee-46cf-95fb-6d5a0f758958" xlink:to="loc_us-gaap_SegmentDomain_ace83661-d80f-4de9-8fda-589d3879e58b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ImagingCentersMember_77baa5c8-c078-45d2-97a7-b6262cb928e3" xlink:href="rdnt-20221231.xsd#rdnt_ImagingCentersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_ace83661-d80f-4de9-8fda-589d3879e58b" xlink:to="loc_rdnt_ImagingCentersMember_77baa5c8-c078-45d2-97a7-b6262cb928e3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AIMember_85624274-e504-41f9-880f-ec3b648f003e" xlink:href="rdnt-20221231.xsd#rdnt_AIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_ace83661-d80f-4de9-8fda-589d3879e58b" xlink:to="loc_rdnt_AIMember_85624274-e504-41f9-880f-ec3b648f003e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis_66a4af50-9c4a-4c73-9a81-3ef6200aeba9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_080e6d50-3568-43a0-b81c-384581b7121a" xlink:to="loc_us-gaap_UnusualOrInfrequentItemAxis_66a4af50-9c4a-4c73-9a81-3ef6200aeba9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_66a4af50-9c4a-4c73-9a81-3ef6200aeba9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_66a4af50-9c4a-4c73-9a81-3ef6200aeba9" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_66a4af50-9c4a-4c73-9a81-3ef6200aeba9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_a866dfa4-b1ee-49bf-bdf9-7669706d4e5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_66a4af50-9c4a-4c73-9a81-3ef6200aeba9" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_a866dfa4-b1ee-49bf-bdf9-7669706d4e5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_COVID19PandemicMember_fe9a6ba3-a445-48d9-9d0e-0f0189a07e58" xlink:href="rdnt-20221231.xsd#rdnt_COVID19PandemicMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain_a866dfa4-b1ee-49bf-bdf9-7669706d4e5d" xlink:to="loc_rdnt_COVID19PandemicMember_fe9a6ba3-a445-48d9-9d0e-0f0189a07e58" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill" xlink:type="simple" xlink:href="rdnt-20221231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill" xlink:type="extended" id="id07173d042d04752be799b8af4120ecd_GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_b332d2b3-ead2-4251-900b-1ebce1c86cc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_ca4a7955-2b66-4abd-9a46-e5d016a10123" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_b332d2b3-ead2-4251-900b-1ebce1c86cc3" xlink:to="loc_us-gaap_GoodwillRollForward_ca4a7955-2b66-4abd-9a46-e5d016a10123" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ff774f7b-80a5-461d-8ff5-dca71e98516d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_ca4a7955-2b66-4abd-9a46-e5d016a10123" xlink:to="loc_us-gaap_Goodwill_ff774f7b-80a5-461d-8ff5-dca71e98516d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_205736ce-92ce-47af-aba8-3d49fb0bf2f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_ca4a7955-2b66-4abd-9a46-e5d016a10123" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_205736ce-92ce-47af-aba8-3d49fb0bf2f3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_af3a83da-58e5-4b14-bcd9-59a075fe8ba4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_ca4a7955-2b66-4abd-9a46-e5d016a10123" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_af3a83da-58e5-4b14-bcd9-59a075fe8ba4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_66b6b888-ce7c-499f-9c14-38be2fd9c05d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_ca4a7955-2b66-4abd-9a46-e5d016a10123" xlink:to="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_66b6b888-ce7c-499f-9c14-38be2fd9c05d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_d7a21d83-53de-4e1a-a9ee-788a3adbb2c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_ca4a7955-2b66-4abd-9a46-e5d016a10123" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_d7a21d83-53de-4e1a-a9ee-788a3adbb2c7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_9a3f4d71-6f8e-4d29-8289-d9cd3405c8f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_a5200fe4-7d05-4748-bf4b-002564348fb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_b332d2b3-ead2-4251-900b-1ebce1c86cc3" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_a5200fe4-7d05-4748-bf4b-002564348fb6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_e709e97b-0e18-4ad4-813e-8920de8eeac3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_a5200fe4-7d05-4748-bf4b-002564348fb6" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_e709e97b-0e18-4ad4-813e-8920de8eeac3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e709e97b-0e18-4ad4-813e-8920de8eeac3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e709e97b-0e18-4ad4-813e-8920de8eeac3" xlink:to="loc_us-gaap_SegmentDomain_e709e97b-0e18-4ad4-813e-8920de8eeac3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_7b644a11-c3db-4c28-bc99-1bad594ee5f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e709e97b-0e18-4ad4-813e-8920de8eeac3" xlink:to="loc_us-gaap_SegmentDomain_7b644a11-c3db-4c28-bc99-1bad594ee5f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ImagingCentersMember_52a37207-cb7f-41c6-97a4-c131bf13926d" xlink:href="rdnt-20221231.xsd#rdnt_ImagingCentersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_7b644a11-c3db-4c28-bc99-1bad594ee5f4" xlink:to="loc_rdnt_ImagingCentersMember_52a37207-cb7f-41c6-97a4-c131bf13926d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AIMember_d6316fd9-4f9c-4f94-ac7c-498cc2cbe40a" xlink:href="rdnt-20221231.xsd#rdnt_AIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_7b644a11-c3db-4c28-bc99-1bad594ee5f4" xlink:to="loc_rdnt_AIMember_d6316fd9-4f9c-4f94-ac7c-498cc2cbe40a" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20221231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSDetailsNarrative"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsNarrative" xlink:type="extended" id="i79351dce6d9046c7ba8c1f0954ee208d_GOODWILLANDOTHERINTANGIBLEASSETSDetailsNarrative">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b5f61741-1643-4841-abb0-ebc23bdc4297" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_f8e88981-6d4a-4f31-a7d6-bbfd5cb9c2cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b5f61741-1643-4841-abb0-ebc23bdc4297" xlink:to="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_f8e88981-6d4a-4f31-a7d6-bbfd5cb9c2cf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_41dd92f2-fbb7-465f-8db7-597701ff8d72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b5f61741-1643-4841-abb0-ebc23bdc4297" xlink:to="loc_us-gaap_AdjustmentForAmortization_41dd92f2-fbb7-465f-8db7-597701ff8d72" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_528c94d3-7bc8-4a5f-bc78-2f9dc320c3e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b5f61741-1643-4841-abb0-ebc23bdc4297" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_528c94d3-7bc8-4a5f-bc78-2f9dc320c3e4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9c306b3d-22b5-4fc3-80d4-dc05f395f7cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b5f61741-1643-4841-abb0-ebc23bdc4297" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9c306b3d-22b5-4fc3-80d4-dc05f395f7cc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b1c664c3-8160-468b-a705-0d353efafaed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9c306b3d-22b5-4fc3-80d4-dc05f395f7cc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b1c664c3-8160-468b-a705-0d353efafaed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b1c664c3-8160-468b-a705-0d353efafaed_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b1c664c3-8160-468b-a705-0d353efafaed" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b1c664c3-8160-468b-a705-0d353efafaed_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1c9dd65d-92f5-41c2-8585-106bf500294e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b1c664c3-8160-468b-a705-0d353efafaed" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1c9dd65d-92f5-41c2-8585-106bf500294e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ManagementServiceContractsMember_bbe67e30-c8bd-4d06-baeb-ae21685668d8" xlink:href="rdnt-20221231.xsd#rdnt_ManagementServiceContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1c9dd65d-92f5-41c2-8585-106bf500294e" xlink:to="loc_rdnt_ManagementServiceContractsMember_bbe67e30-c8bd-4d06-baeb-ae21685668d8" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule" xlink:type="simple" xlink:href="rdnt-20221231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule" xlink:type="extended" id="ifa1e1c21319e49a781eb316ed0aeb090_GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9d9d3edc-4471-4fea-866f-c2e6d6ed197e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_1b8a9546-132f-4c1a-93b6-4b3cfd711177" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9d9d3edc-4471-4fea-866f-c2e6d6ed197e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_1b8a9546-132f-4c1a-93b6-4b3cfd711177" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_eba9dcef-72b0-48ae-b3ae-92e7cf9bb3be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9d9d3edc-4471-4fea-866f-c2e6d6ed197e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_eba9dcef-72b0-48ae-b3ae-92e7cf9bb3be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_6aefd6d6-9a46-45da-a71f-b7ce7d807886" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9d9d3edc-4471-4fea-866f-c2e6d6ed197e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_6aefd6d6-9a46-45da-a71f-b7ce7d807886" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_e75a380e-e84f-44d6-8240-243e8f7c3935" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9d9d3edc-4471-4fea-866f-c2e6d6ed197e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_e75a380e-e84f-44d6-8240-243e8f7c3935" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_c43f7ee9-5a93-40a0-96c6-2efad2451752" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9d9d3edc-4471-4fea-866f-c2e6d6ed197e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_c43f7ee9-5a93-40a0-96c6-2efad2451752" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_e4846429-b844-475c-9dce-5f6147f0b46c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9d9d3edc-4471-4fea-866f-c2e6d6ed197e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_e4846429-b844-475c-9dce-5f6147f0b46c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_e8364da0-69f9-44f4-9694-8eed957dd6b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9d9d3edc-4471-4fea-866f-c2e6d6ed197e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_e8364da0-69f9-44f4-9694-8eed957dd6b4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_639fa944-0dd8-4dde-81b4-3c7487aa4ad0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9d9d3edc-4471-4fea-866f-c2e6d6ed197e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_639fa944-0dd8-4dde-81b4-3c7487aa4ad0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_b31e9cf6-b8a8-45f9-9757-4a76af293693" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9d9d3edc-4471-4fea-866f-c2e6d6ed197e" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_b31e9cf6-b8a8-45f9-9757-4a76af293693" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c952fe0f-f0da-4c06-a1b2-244d1556fdb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_b31e9cf6-b8a8-45f9-9757-4a76af293693" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c952fe0f-f0da-4c06-a1b2-244d1556fdb7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c952fe0f-f0da-4c06-a1b2-244d1556fdb7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c952fe0f-f0da-4c06-a1b2-244d1556fdb7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c952fe0f-f0da-4c06-a1b2-244d1556fdb7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c3f4b39a-14e4-4360-a10a-de06310c4987" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c952fe0f-f0da-4c06-a1b2-244d1556fdb7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c3f4b39a-14e4-4360-a10a-de06310c4987" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ManagementServiceContractsMember_342959dc-cc66-4e56-8798-8a99f2cc72f5" xlink:href="rdnt-20221231.xsd#rdnt_ManagementServiceContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c3f4b39a-14e4-4360-a10a-de06310c4987" xlink:to="loc_rdnt_ManagementServiceContractsMember_342959dc-cc66-4e56-8798-8a99f2cc72f5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CovenantNotToCompeteMember_4ebb8f14-8832-40fe-9d58-fa052d171bed" xlink:href="rdnt-20221231.xsd#rdnt_CovenantNotToCompeteMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c3f4b39a-14e4-4360-a10a-de06310c4987" xlink:to="loc_rdnt_CovenantNotToCompeteMember_4ebb8f14-8832-40fe-9d58-fa052d171bed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_e0922fde-3487-44d1-aff1-a35e66ca7e0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c3f4b39a-14e4-4360-a10a-de06310c4987" xlink:to="loc_us-gaap_CustomerRelationshipsMember_e0922fde-3487-44d1-aff1-a35e66ca7e0f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PatentAndTrademarksMember_5280355f-6914-4967-939b-a0d7dfc38c89" xlink:href="rdnt-20221231.xsd#rdnt_PatentAndTrademarksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c3f4b39a-14e4-4360-a10a-de06310c4987" xlink:to="loc_rdnt_PatentAndTrademarksMember_5280355f-6914-4967-939b-a0d7dfc38c89" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DevelopedTechnologySoftwareMember_8a68aeab-0556-414f-8f46-ebd1d611eef4" xlink:href="rdnt-20221231.xsd#rdnt_DevelopedTechnologySoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c3f4b39a-14e4-4360-a10a-de06310c4987" xlink:to="loc_rdnt_DevelopedTechnologySoftwareMember_8a68aeab-0556-414f-8f46-ebd1d611eef4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_cb5295a0-396f-4b51-a56e-8bc7fb1c8291" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c3f4b39a-14e4-4360-a10a-de06310c4987" xlink:to="loc_us-gaap_TradeNamesMember_cb5295a0-396f-4b51-a56e-8bc7fb1c8291" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_defe2c6a-04d7-437b-89fa-e67c3920ef07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_c8faae9e-1c3f-46fb-b1e9-3282c738aa73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_defe2c6a-04d7-437b-89fa-e67c3920ef07" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_c8faae9e-1c3f-46fb-b1e9-3282c738aa73" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_94b3069d-1921-4ef7-bce1-7a4b4a5889ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_defe2c6a-04d7-437b-89fa-e67c3920ef07" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_94b3069d-1921-4ef7-bce1-7a4b4a5889ba" xlink:type="arc" order="2" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_94ee665d-97ed-4e5c-97fe-c1868308bf57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_94b3069d-1921-4ef7-bce1-7a4b4a5889ba" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_94ee665d-97ed-4e5c-97fe-c1868308bf57" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_94ee665d-97ed-4e5c-97fe-c1868308bf57_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_94ee665d-97ed-4e5c-97fe-c1868308bf57" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_94ee665d-97ed-4e5c-97fe-c1868308bf57_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_4406931b-d3ae-4031-a8c7-33bb40711b61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_94ee665d-97ed-4e5c-97fe-c1868308bf57" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_4406931b-d3ae-4031-a8c7-33bb40711b61" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_21c23370-8dfa-49bc-bea6-1fcadaf89d27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_4406931b-d3ae-4031-a8c7-33bb40711b61" xlink:to="loc_us-gaap_TradeNamesMember_21c23370-8dfa-49bc-bea6-1fcadaf89d27" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember_aa7533d1-3ebd-43ee-886c-7467fcc52658" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_4406931b-d3ae-4031-a8c7-33bb40711b61" xlink:to="loc_us-gaap_SoftwareDevelopmentMember_aa7533d1-3ebd-43ee-886c-7467fcc52658" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetails" xlink:type="simple" xlink:href="rdnt-20221231.xsd#PROPERTYANDEQUIPMENTDetails"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetails" xlink:type="extended" id="i41ad6f76a02e4363b7a9ab47a8db3303_PROPERTYANDEQUIPMENTDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2a83f1e5-a310-4be6-b9cc-17a6ed477181" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_6822aa6e-1208-426c-99cc-ca09a7deab9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2a83f1e5-a310-4be6-b9cc-17a6ed477181" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_6822aa6e-1208-426c-99cc-ca09a7deab9d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_542177ab-c695-4a1c-ae3c-b67d007f2f74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2a83f1e5-a310-4be6-b9cc-17a6ed477181" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_542177ab-c695-4a1c-ae3c-b67d007f2f74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_a7bde383-3e55-4d13-bb00-26ae0421656f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2a83f1e5-a310-4be6-b9cc-17a6ed477181" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_a7bde383-3e55-4d13-bb00-26ae0421656f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_12241be5-838f-4492-bd9e-7a85b604cdcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2a83f1e5-a310-4be6-b9cc-17a6ed477181" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_12241be5-838f-4492-bd9e-7a85b604cdcb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_94961d42-9427-47f0-acc0-7131b281af6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2a83f1e5-a310-4be6-b9cc-17a6ed477181" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_94961d42-9427-47f0-acc0-7131b281af6d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_70be58b3-dac4-4426-8344-eb1a1d64e7df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2a83f1e5-a310-4be6-b9cc-17a6ed477181" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_70be58b3-dac4-4426-8344-eb1a1d64e7df" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e498919a-62a2-41e2-8211-cc4966606400" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_70be58b3-dac4-4426-8344-eb1a1d64e7df" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e498919a-62a2-41e2-8211-cc4966606400" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e498919a-62a2-41e2-8211-cc4966606400_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e498919a-62a2-41e2-8211-cc4966606400" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e498919a-62a2-41e2-8211-cc4966606400_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_da1a0a2c-65dd-4097-8a3b-06052bde2a22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e498919a-62a2-41e2-8211-cc4966606400" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_da1a0a2c-65dd-4097-8a3b-06052bde2a22" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_8ef2c83b-c50b-49f8-8ee5-8d7fc5faa74d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_da1a0a2c-65dd-4097-8a3b-06052bde2a22" xlink:to="loc_us-gaap_LandMember_8ef2c83b-c50b-49f8-8ee5-8d7fc5faa74d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_135ee55c-c2e0-4c3c-b152-7b2af4ace029" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_da1a0a2c-65dd-4097-8a3b-06052bde2a22" xlink:to="loc_us-gaap_EquipmentMember_135ee55c-c2e0-4c3c-b152-7b2af4ace029" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_4e2cf689-d3f2-4476-8179-a3d8fcffbc98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_da1a0a2c-65dd-4097-8a3b-06052bde2a22" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_4e2cf689-d3f2-4476-8179-a3d8fcffbc98" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_a11f161f-1437-47f9-9f65-f6912afee447" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_da1a0a2c-65dd-4097-8a3b-06052bde2a22" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_a11f161f-1437-47f9-9f65-f6912afee447" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20221231.xsd#PROPERTYANDEQUIPMENTDetailsNarrative"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetailsNarrative" xlink:type="extended" id="i6f2725a438f94829aa801038a5930a51_PROPERTYANDEQUIPMENTDetailsNarrative">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_72852579-df26-4c71-a406-7bfa1912ac80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_f8e172aa-a7d3-4f1a-acc8-cfb6f9a1d286" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_72852579-df26-4c71-a406-7bfa1912ac80" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_f8e172aa-a7d3-4f1a-acc8-cfb6f9a1d286" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross_650b9ca4-e737-4ea4-abc6-65fc3495001a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_72852579-df26-4c71-a406-7bfa1912ac80" xlink:to="loc_us-gaap_ConstructionInProgressGross_650b9ca4-e737-4ea4-abc6-65fc3495001a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_d0818090-8642-4f41-b984-efcb95ec3aed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_72852579-df26-4c71-a406-7bfa1912ac80" xlink:to="loc_us-gaap_DepreciationAndAmortization_d0818090-8642-4f41-b984-efcb95ec3aed" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5ec764ee-7bf0-4aa2-98d8-d0564354fe8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_72852579-df26-4c71-a406-7bfa1912ac80" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5ec764ee-7bf0-4aa2-98d8-d0564354fe8a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_382bf6f5-39e4-45ff-ad34-2c2508a3a5f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5ec764ee-7bf0-4aa2-98d8-d0564354fe8a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_382bf6f5-39e4-45ff-ad34-2c2508a3a5f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_382bf6f5-39e4-45ff-ad34-2c2508a3a5f3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_382bf6f5-39e4-45ff-ad34-2c2508a3a5f3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_382bf6f5-39e4-45ff-ad34-2c2508a3a5f3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_694e6edb-1f32-4735-ac95-c4bbefbca1b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_382bf6f5-39e4-45ff-ad34-2c2508a3a5f3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_694e6edb-1f32-4735-ac95-c4bbefbca1b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_4cac276c-4923-465f-a035-2ea35b3f84db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_694e6edb-1f32-4735-ac95-c4bbefbca1b6" xlink:to="loc_us-gaap_ConstructionInProgressMember_4cac276c-4923-465f-a035-2ea35b3f84db" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MedicalEquipmentMember_f17c6af5-3bfd-41ca-9f6f-36d5051cc902" xlink:href="rdnt-20221231.xsd#rdnt_MedicalEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_694e6edb-1f32-4735-ac95-c4bbefbca1b6" xlink:to="loc_rdnt_MedicalEquipmentMember_f17c6af5-3bfd-41ca-9f6f-36d5051cc902" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ComputerandOfficeEquipmentMember_1ad63814-a85f-4711-ae56-6344b2d5f468" xlink:href="rdnt-20221231.xsd#rdnt_ComputerandOfficeEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_694e6edb-1f32-4735-ac95-c4bbefbca1b6" xlink:to="loc_rdnt_ComputerandOfficeEquipmentMember_1ad63814-a85f-4711-ae56-6344b2d5f468" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember_e2735553-786b-4045-8964-8831d68cc0b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_694e6edb-1f32-4735-ac95-c4bbefbca1b6" xlink:to="loc_us-gaap_SoftwareDevelopmentMember_e2735553-786b-4045-8964-8831d68cc0b7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_f90157a6-982a-4544-993b-3e7075eb7218" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_694e6edb-1f32-4735-ac95-c4bbefbca1b6" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_f90157a6-982a-4544-993b-3e7075eb7218" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt" xlink:type="simple" xlink:href="rdnt-20221231.xsd#CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt" xlink:type="extended" id="i2473c12a6e274e25ae16775a7458f9a1_CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_6a55ca49-4666-4da6-b4a0-21d7848981c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_e371bb2f-9d61-4bab-974e-ad4c9f7368af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6a55ca49-4666-4da6-b4a0-21d7848981c0" xlink:to="loc_us-gaap_LongTermDebt_e371bb2f-9d61-4bab-974e-ad4c9f7368af" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_96ba086d-9ad1-42f2-881d-75323028b187" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6a55ca49-4666-4da6-b4a0-21d7848981c0" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_96ba086d-9ad1-42f2-881d-75323028b187" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_19b852c5-04d1-49b9-bc80-b9c43218d4ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_8fba5c44-fd84-4e3c-9f81-09dc59a0c7d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6a55ca49-4666-4da6-b4a0-21d7848981c0" xlink:to="loc_us-gaap_LongTermDebtCurrent_8fba5c44-fd84-4e3c-9f81-09dc59a0c7d2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_cfe70ed1-310c-451f-bab0-b3c8391ed1ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6a55ca49-4666-4da6-b4a0-21d7848981c0" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_cfe70ed1-310c-451f-bab0-b3c8391ed1ad" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_b44f8efc-01c0-42ef-9919-3c0ddce7eb72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6a55ca49-4666-4da6-b4a0-21d7848981c0" xlink:to="loc_us-gaap_DebtInstrumentTable_b44f8efc-01c0-42ef-9919-3c0ddce7eb72" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_85daf0da-4688-406b-8135-0323ee90e3d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_b44f8efc-01c0-42ef-9919-3c0ddce7eb72" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_85daf0da-4688-406b-8135-0323ee90e3d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_85daf0da-4688-406b-8135-0323ee90e3d3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_85daf0da-4688-406b-8135-0323ee90e3d3" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_85daf0da-4688-406b-8135-0323ee90e3d3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_4e648d3b-8319-4495-9775-690bd2345881" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_85daf0da-4688-406b-8135-0323ee90e3d3" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_4e648d3b-8319-4495-9775-690bd2345881" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TermLoanMember_8572844f-3830-4cbc-ade5-baa26b894b58" xlink:href="rdnt-20221231.xsd#rdnt_TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4e648d3b-8319-4495-9775-690bd2345881" xlink:to="loc_rdnt_TermLoanMember_8572844f-3830-4cbc-ade5-baa26b894b58" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_e5f93f79-eab2-432a-bb0b-ea54cca63503" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_b44f8efc-01c0-42ef-9919-3c0ddce7eb72" xlink:to="loc_us-gaap_DebtInstrumentAxis_e5f93f79-eab2-432a-bb0b-ea54cca63503" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e5f93f79-eab2-432a-bb0b-ea54cca63503_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_e5f93f79-eab2-432a-bb0b-ea54cca63503" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e5f93f79-eab2-432a-bb0b-ea54cca63503_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_f840989a-ae0c-4360-b772-0a65dbdba066" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_e5f93f79-eab2-432a-bb0b-ea54cca63503" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_f840989a-ae0c-4360-b772-0a65dbdba066" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienTermLoanMember_5f448d1d-9df9-49d7-b449-a53851b3e057" xlink:href="rdnt-20221231.xsd#rdnt_FirstLienTermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f840989a-ae0c-4360-b772-0a65dbdba066" xlink:to="loc_rdnt_FirstLienTermLoanMember_5f448d1d-9df9-49d7-b449-a53851b3e057" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedAgreementMember_92609847-eee8-454d-98e0-7ee110e8c1d4" xlink:href="rdnt-20221231.xsd#rdnt_RestatedAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f840989a-ae0c-4360-b772-0a65dbdba066" xlink:to="loc_rdnt_RestatedAgreementMember_92609847-eee8-454d-98e0-7ee110e8c1d4" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAdditionalInformation" xlink:type="simple" xlink:href="rdnt-20221231.xsd#CREDITFACILITIESANDNOTESPAYABLEDetailsAdditionalInformation"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAdditionalInformation" xlink:type="extended" id="if070f2c871c24f73a0c318d90fd3c67a_CREDITFACILITIESANDNOTESPAYABLEDetailsAdditionalInformation">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_658b3481-2c55-46ea-922d-0333239ff7e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_f05ba7a2-441c-44b6-abb2-cf037d03a6b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_658b3481-2c55-46ea-922d-0333239ff7e9" xlink:to="loc_us-gaap_LineOfCredit_f05ba7a2-441c-44b6-abb2-cf037d03a6b6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_6c43a2bc-c800-4508-aa9a-9f542302a923" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_658b3481-2c55-46ea-922d-0333239ff7e9" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_6c43a2bc-c800-4508-aa9a-9f542302a923" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_645aa83f-b72f-46e3-8d7f-85a35c54a4ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_658b3481-2c55-46ea-922d-0333239ff7e9" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_645aa83f-b72f-46e3-8d7f-85a35c54a4ff" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_5045a401-ab38-4a8d-a676-83785bce3489" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_658b3481-2c55-46ea-922d-0333239ff7e9" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_5045a401-ab38-4a8d-a676-83785bce3489" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_f8d21f47-8b71-4845-bc8c-5ccd7ea7ee19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_658b3481-2c55-46ea-922d-0333239ff7e9" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_f8d21f47-8b71-4845-bc8c-5ccd7ea7ee19" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_876e118b-90a1-4e87-a2d9-f16cf32e8174" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_f8d21f47-8b71-4845-bc8c-5ccd7ea7ee19" xlink:to="loc_us-gaap_CreditFacilityAxis_876e118b-90a1-4e87-a2d9-f16cf32e8174" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_876e118b-90a1-4e87-a2d9-f16cf32e8174_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_876e118b-90a1-4e87-a2d9-f16cf32e8174" xlink:to="loc_us-gaap_CreditFacilityDomain_876e118b-90a1-4e87-a2d9-f16cf32e8174_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_646ebf09-a89b-427d-8f1e-f76209ad0b55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_876e118b-90a1-4e87-a2d9-f16cf32e8174" xlink:to="loc_us-gaap_CreditFacilityDomain_646ebf09-a89b-427d-8f1e-f76209ad0b55" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_2881dc4a-6508-4a24-b52d-a04c15deb687" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_646ebf09-a89b-427d-8f1e-f76209ad0b55" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_2881dc4a-6508-4a24-b52d-a04c15deb687" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_0de83962-926d-4a7a-98a0-9a3567022b0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_f8d21f47-8b71-4845-bc8c-5ccd7ea7ee19" xlink:to="loc_us-gaap_DebtInstrumentAxis_0de83962-926d-4a7a-98a0-9a3567022b0e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_0de83962-926d-4a7a-98a0-9a3567022b0e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_0de83962-926d-4a7a-98a0-9a3567022b0e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_0de83962-926d-4a7a-98a0-9a3567022b0e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_6235d199-c71d-4655-9a2c-148c98024573" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_0de83962-926d-4a7a-98a0-9a3567022b0e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_6235d199-c71d-4655-9a2c-148c98024573" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementMember_c463d490-27c6-408a-aa61-96fa8a1154cd" xlink:href="rdnt-20221231.xsd#rdnt_FirstLienCreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6235d199-c71d-4655-9a2c-148c98024573" xlink:to="loc_rdnt_FirstLienCreditAgreementMember_c463d490-27c6-408a-aa61-96fa8a1154cd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementEighthAmendmentMember_1558e2ea-7219-4fd5-9c7c-10a4497a9b10" xlink:href="rdnt-20221231.xsd#rdnt_FirstLienCreditAgreementEighthAmendmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6235d199-c71d-4655-9a2c-148c98024573" xlink:to="loc_rdnt_FirstLienCreditAgreementEighthAmendmentMember_1558e2ea-7219-4fd5-9c7c-10a4497a9b10" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_847238b7-d513-4e7f-a5b1-73855d26dd57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_f8d21f47-8b71-4845-bc8c-5ccd7ea7ee19" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_847238b7-d513-4e7f-a5b1-73855d26dd57" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_847238b7-d513-4e7f-a5b1-73855d26dd57_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_847238b7-d513-4e7f-a5b1-73855d26dd57" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_847238b7-d513-4e7f-a5b1-73855d26dd57_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_0d144f68-46d4-41cc-93d1-9a48c0ed4b23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_847238b7-d513-4e7f-a5b1-73855d26dd57" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_0d144f68-46d4-41cc-93d1-9a48c0ed4b23" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BarclaysMember_9baf66e4-c2f8-4445-a77c-d441b4aeda47" xlink:href="rdnt-20221231.xsd#rdnt_BarclaysMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_0d144f68-46d4-41cc-93d1-9a48c0ed4b23" xlink:to="loc_rdnt_BarclaysMember_9baf66e4-c2f8-4445-a77c-d441b4aeda47" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SunTrustMember_0234c0bc-f320-4edd-8594-721ba7996685" xlink:href="rdnt-20221231.xsd#rdnt_SunTrustMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_0d144f68-46d4-41cc-93d1-9a48c0ed4b23" xlink:to="loc_rdnt_SunTrustMember_0234c0bc-f320-4edd-8594-721ba7996685" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_707b20ee-0bc6-4acf-8825-93e0fac28c68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_f8d21f47-8b71-4845-bc8c-5ccd7ea7ee19" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_707b20ee-0bc6-4acf-8825-93e0fac28c68" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_707b20ee-0bc6-4acf-8825-93e0fac28c68_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_707b20ee-0bc6-4acf-8825-93e0fac28c68" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_707b20ee-0bc6-4acf-8825-93e0fac28c68_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_15c0b9d8-25e7-4698-83d5-9a20213f8673" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_707b20ee-0bc6-4acf-8825-93e0fac28c68" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_15c0b9d8-25e7-4698-83d5-9a20213f8673" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_fe48a413-eb8d-4509-b69f-e5ef3dbdd019" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_15c0b9d8-25e7-4698-83d5-9a20213f8673" xlink:to="loc_us-gaap_LineOfCreditMember_fe48a413-eb8d-4509-b69f-e5ef3dbdd019" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSecondAmendedandRestatedFirstLienCreditandGuarantyAgreement" xlink:type="simple" xlink:href="rdnt-20221231.xsd#CREDITFACILITIESANDNOTESPAYABLEDetailsSecondAmendedandRestatedFirstLienCreditandGuarantyAgreement"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSecondAmendedandRestatedFirstLienCreditandGuarantyAgreement" xlink:type="extended" id="i1d4138a4942948a2b8c6a9474613abe5_CREDITFACILITIESANDNOTESPAYABLEDetailsSecondAmendedandRestatedFirstLienCreditandGuarantyAgreement">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_74d34670-42f8-4a7f-80c5-0ebd2a011548" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_57527667-74bf-415b-a6a6-2644f4443814" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_74d34670-42f8-4a7f-80c5-0ebd2a011548" xlink:to="loc_us-gaap_LineOfCredit_57527667-74bf-415b-a6a6-2644f4443814" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_dd5672c1-cffe-4948-9e8f-50abebe56d96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_74d34670-42f8-4a7f-80c5-0ebd2a011548" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_dd5672c1-cffe-4948-9e8f-50abebe56d96" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_0572a313-a492-41bd-9542-1fac3d2a028e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_74d34670-42f8-4a7f-80c5-0ebd2a011548" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_0572a313-a492-41bd-9542-1fac3d2a028e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountCurrent_aee0add8-dab4-4b5d-838e-9d451392f4ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_74d34670-42f8-4a7f-80c5-0ebd2a011548" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountCurrent_aee0add8-dab4-4b5d-838e-9d451392f4ad" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_8c3d571d-48ab-4ef5-895e-7cccfcf652c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_74d34670-42f8-4a7f-80c5-0ebd2a011548" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_8c3d571d-48ab-4ef5-895e-7cccfcf652c7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_a90f6378-d04c-4455-ab83-6f56434afdf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_74d34670-42f8-4a7f-80c5-0ebd2a011548" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_a90f6378-d04c-4455-ab83-6f56434afdf9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDeferredCharges_bbb7e933-d382-46d7-8678-88001903d88d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfDeferredCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_74d34670-42f8-4a7f-80c5-0ebd2a011548" xlink:to="loc_us-gaap_AmortizationOfDeferredCharges_bbb7e933-d382-46d7-8678-88001903d88d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_106c97f3-5ebb-4429-90f9-eb887e588f7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_74d34670-42f8-4a7f-80c5-0ebd2a011548" xlink:to="loc_us-gaap_DebtInstrumentTable_106c97f3-5ebb-4429-90f9-eb887e588f7e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_d961f7f6-9354-49d6-a457-86aa1883a7e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_106c97f3-5ebb-4429-90f9-eb887e588f7e" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_d961f7f6-9354-49d6-a457-86aa1883a7e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d961f7f6-9354-49d6-a457-86aa1883a7e0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d961f7f6-9354-49d6-a457-86aa1883a7e0" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d961f7f6-9354-49d6-a457-86aa1883a7e0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_f09f9c99-ec74-479b-aa0f-b7a1174b6bc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d961f7f6-9354-49d6-a457-86aa1883a7e0" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_f09f9c99-ec74-479b-aa0f-b7a1174b6bc9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediumTermNotesMember_4828248d-3c0a-420a-b313-ea690b632c9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MediumTermNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_f09f9c99-ec74-479b-aa0f-b7a1174b6bc9" xlink:to="loc_us-gaap_MediumTermNotesMember_4828248d-3c0a-420a-b313-ea690b632c9d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_1261b371-a001-47cf-b087-2933de8cf47c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_f09f9c99-ec74-479b-aa0f-b7a1174b6bc9" xlink:to="loc_us-gaap_LineOfCreditMember_1261b371-a001-47cf-b087-2933de8cf47c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementSeventhAmendmentMember_a99f0f00-8d92-4f2c-bcb4-69c66e51ab01" xlink:href="rdnt-20221231.xsd#rdnt_FirstLienCreditAgreementSeventhAmendmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_f09f9c99-ec74-479b-aa0f-b7a1174b6bc9" xlink:to="loc_rdnt_FirstLienCreditAgreementSeventhAmendmentMember_a99f0f00-8d92-4f2c-bcb4-69c66e51ab01" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_d5d9348a-522d-43e0-841a-393a28af6f28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_106c97f3-5ebb-4429-90f9-eb887e588f7e" xlink:to="loc_us-gaap_CreditFacilityAxis_d5d9348a-522d-43e0-841a-393a28af6f28" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_d5d9348a-522d-43e0-841a-393a28af6f28_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_d5d9348a-522d-43e0-841a-393a28af6f28" xlink:to="loc_us-gaap_CreditFacilityDomain_d5d9348a-522d-43e0-841a-393a28af6f28_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_67ee4bb5-d719-49c8-9afc-e93e81964ad2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_d5d9348a-522d-43e0-841a-393a28af6f28" xlink:to="loc_us-gaap_CreditFacilityDomain_67ee4bb5-d719-49c8-9afc-e93e81964ad2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_180ca5df-c1c0-4c7f-a7c0-3c9bdebcca78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_67ee4bb5-d719-49c8-9afc-e93e81964ad2" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_180ca5df-c1c0-4c7f-a7c0-3c9bdebcca78" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_b804f3f7-f0b7-48d3-a12c-1e7fe192c0e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_106c97f3-5ebb-4429-90f9-eb887e588f7e" xlink:to="loc_us-gaap_DebtInstrumentAxis_b804f3f7-f0b7-48d3-a12c-1e7fe192c0e5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b804f3f7-f0b7-48d3-a12c-1e7fe192c0e5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_b804f3f7-f0b7-48d3-a12c-1e7fe192c0e5" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b804f3f7-f0b7-48d3-a12c-1e7fe192c0e5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_6aca5850-8575-453c-a55b-18baef3d896b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_b804f3f7-f0b7-48d3-a12c-1e7fe192c0e5" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_6aca5850-8575-453c-a55b-18baef3d896b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementEighthAmendmentMember_810917f4-c0ac-43ed-86a7-0ad4abb8d659" xlink:href="rdnt-20221231.xsd#rdnt_FirstLienCreditAgreementEighthAmendmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6aca5850-8575-453c-a55b-18baef3d896b" xlink:to="loc_rdnt_FirstLienCreditAgreementEighthAmendmentMember_810917f4-c0ac-43ed-86a7-0ad4abb8d659" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_52f96595-e7db-4146-ba7e-fe015baa3ac2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_106c97f3-5ebb-4429-90f9-eb887e588f7e" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_52f96595-e7db-4146-ba7e-fe015baa3ac2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_52f96595-e7db-4146-ba7e-fe015baa3ac2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_52f96595-e7db-4146-ba7e-fe015baa3ac2" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_52f96595-e7db-4146-ba7e-fe015baa3ac2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_b68488dc-98fe-4651-b92b-2756d50eeef3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_52f96595-e7db-4146-ba7e-fe015baa3ac2" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_b68488dc-98fe-4651-b92b-2756d50eeef3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BarclaysMember_8d6b8b1b-e88b-4ec4-a679-8628d35923c7" xlink:href="rdnt-20221231.xsd#rdnt_BarclaysMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_b68488dc-98fe-4651-b92b-2756d50eeef3" xlink:to="loc_rdnt_BarclaysMember_8d6b8b1b-e88b-4ec4-a679-8628d35923c7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TruistMember_486542e7-775a-4208-bf24-17c56cab579e" xlink:href="rdnt-20221231.xsd#rdnt_TruistMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_b68488dc-98fe-4651-b92b-2756d50eeef3" xlink:to="loc_rdnt_TruistMember_486542e7-775a-4208-bf24-17c56cab579e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails" xlink:type="simple" xlink:href="rdnt-20221231.xsd#CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails" xlink:type="extended" id="i3c3327a213a84cf68c73d7538e85da6c_CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_fef99469-5b34-4f01-9b24-d4b37d4ffef4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum_b3934115-0e26-4773-8f49-fc470fea66a4" xlink:href="rdnt-20221231.xsd#rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fef99469-5b34-4f01-9b24-d4b37d4ffef4" xlink:to="loc_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum_b3934115-0e26-4773-8f49-fc470fea66a4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentCovenantLeverageRatioMaximum_78d3edc4-aee1-4afc-bad3-e95bae0f9c84" xlink:href="rdnt-20221231.xsd#rdnt_DebtInstrumentCovenantLeverageRatioMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fef99469-5b34-4f01-9b24-d4b37d4ffef4" xlink:to="loc_rdnt_DebtInstrumentCovenantLeverageRatioMaximum_78d3edc4-aee1-4afc-bad3-e95bae0f9c84" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_b1572628-6617-487d-bbdf-fddd6faae880" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fef99469-5b34-4f01-9b24-d4b37d4ffef4" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_b1572628-6617-487d-bbdf-fddd6faae880" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_37a80d01-803c-4a5d-b74d-42d4626cdee6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fef99469-5b34-4f01-9b24-d4b37d4ffef4" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_37a80d01-803c-4a5d-b74d-42d4626cdee6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_a2111d57-aa4f-42d3-aa69-6f7b2bbbff97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fef99469-5b34-4f01-9b24-d4b37d4ffef4" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_a2111d57-aa4f-42d3-aa69-6f7b2bbbff97" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_383affd2-161a-4c92-99af-8afabf795d16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fef99469-5b34-4f01-9b24-d4b37d4ffef4" xlink:to="loc_us-gaap_DebtInstrumentTable_383affd2-161a-4c92-99af-8afabf795d16" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_a3449b28-255f-47cc-b323-db2719ea9a4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_383affd2-161a-4c92-99af-8afabf795d16" xlink:to="loc_us-gaap_CreditFacilityAxis_a3449b28-255f-47cc-b323-db2719ea9a4b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_a3449b28-255f-47cc-b323-db2719ea9a4b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_a3449b28-255f-47cc-b323-db2719ea9a4b" xlink:to="loc_us-gaap_CreditFacilityDomain_a3449b28-255f-47cc-b323-db2719ea9a4b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_abef07d5-62ab-4022-b012-ca7133d2126d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_a3449b28-255f-47cc-b323-db2719ea9a4b" xlink:to="loc_us-gaap_CreditFacilityDomain_abef07d5-62ab-4022-b012-ca7133d2126d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_ce5aaf54-7951-4a9d-a059-715c30e1804a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_abef07d5-62ab-4022-b012-ca7133d2126d" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_ce5aaf54-7951-4a9d-a059-715c30e1804a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioAxis_e22e4d1f-7248-47cf-a6a1-1e956cee9932" xlink:href="rdnt-20221231.xsd#rdnt_LeverageRatioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_383affd2-161a-4c92-99af-8afabf795d16" xlink:to="loc_rdnt_LeverageRatioAxis_e22e4d1f-7248-47cf-a6a1-1e956cee9932" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain_e22e4d1f-7248-47cf-a6a1-1e956cee9932_default" xlink:href="rdnt-20221231.xsd#rdnt_LeverageRatioDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_rdnt_LeverageRatioAxis_e22e4d1f-7248-47cf-a6a1-1e956cee9932" xlink:to="loc_rdnt_LeverageRatioDomain_e22e4d1f-7248-47cf-a6a1-1e956cee9932_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain_17b85a6c-2f52-4522-a4bc-61bfac2996f9" xlink:href="rdnt-20221231.xsd#rdnt_LeverageRatioDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_rdnt_LeverageRatioAxis_e22e4d1f-7248-47cf-a6a1-1e956cee9932" xlink:to="loc_rdnt_LeverageRatioDomain_17b85a6c-2f52-4522-a4bc-61bfac2996f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIMember_d987089a-28dc-4581-8513-727cb551e535" xlink:href="rdnt-20221231.xsd#rdnt_PricingLevelIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_17b85a6c-2f52-4522-a4bc-61bfac2996f9" xlink:to="loc_rdnt_PricingLevelIMember_d987089a-28dc-4581-8513-727cb551e535" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIIMember_5d601ff7-0ade-4948-a28a-1313f3eae45a" xlink:href="rdnt-20221231.xsd#rdnt_PricingLevelIIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_17b85a6c-2f52-4522-a4bc-61bfac2996f9" xlink:to="loc_rdnt_PricingLevelIIMember_5d601ff7-0ade-4948-a28a-1313f3eae45a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIIIMember_f16c35b8-f366-4dbf-85a6-43892031446b" xlink:href="rdnt-20221231.xsd#rdnt_PricingLevelIIIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_17b85a6c-2f52-4522-a4bc-61bfac2996f9" xlink:to="loc_rdnt_PricingLevelIIIMember_f16c35b8-f366-4dbf-85a6-43892031446b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIVMember_8d863306-19c9-4cd4-821f-561cc07ef0be" xlink:href="rdnt-20221231.xsd#rdnt_PricingLevelIVMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_17b85a6c-2f52-4522-a4bc-61bfac2996f9" xlink:to="loc_rdnt_PricingLevelIVMember_8d863306-19c9-4cd4-821f-561cc07ef0be" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelVMember_5d7739f7-2a1e-422a-aa7a-3c0007b27168" xlink:href="rdnt-20221231.xsd#rdnt_PricingLevelVMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_17b85a6c-2f52-4522-a4bc-61bfac2996f9" xlink:to="loc_rdnt_PricingLevelVMember_5d7739f7-2a1e-422a-aa7a-3c0007b27168" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_568de8cb-549f-43d9-baca-469241ac6c93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_383affd2-161a-4c92-99af-8afabf795d16" xlink:to="loc_us-gaap_DebtInstrumentAxis_568de8cb-549f-43d9-baca-469241ac6c93" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_568de8cb-549f-43d9-baca-469241ac6c93_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_568de8cb-549f-43d9-baca-469241ac6c93" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_568de8cb-549f-43d9-baca-469241ac6c93_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_0f623cfd-9f98-4234-8317-76f88322bc20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_568de8cb-549f-43d9-baca-469241ac6c93" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_0f623cfd-9f98-4234-8317-76f88322bc20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedAgreementMember_8965c87f-cdac-4780-96be-fa98a6bc3ca8" xlink:href="rdnt-20221231.xsd#rdnt_RestatedAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0f623cfd-9f98-4234-8317-76f88322bc20" xlink:to="loc_rdnt_RestatedAgreementMember_8965c87f-cdac-4780-96be-fa98a6bc3ca8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_bd49dfec-e25d-4f4e-99f4-294a325607b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_383affd2-161a-4c92-99af-8afabf795d16" xlink:to="loc_us-gaap_VariableRateAxis_bd49dfec-e25d-4f4e-99f4-294a325607b8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_bd49dfec-e25d-4f4e-99f4-294a325607b8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_bd49dfec-e25d-4f4e-99f4-294a325607b8" xlink:to="loc_us-gaap_VariableRateDomain_bd49dfec-e25d-4f4e-99f4-294a325607b8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_3dacd4e4-2f4f-487d-b97e-160342d69b17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_bd49dfec-e25d-4f4e-99f4-294a325607b8" xlink:to="loc_us-gaap_VariableRateDomain_3dacd4e4-2f4f-487d-b97e-160342d69b17" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EurodollarMember_f631b34d-a109-4999-b9d0-529270527de3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EurodollarMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_3dacd4e4-2f4f-487d-b97e-160342d69b17" xlink:to="loc_us-gaap_EurodollarMember_f631b34d-a109-4999-b9d0-529270527de3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_b74ef954-20fe-4c3d-a7d0-c036d4974846" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BaseRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_3dacd4e4-2f4f-487d-b97e-160342d69b17" xlink:to="loc_us-gaap_BaseRateMember_b74ef954-20fe-4c3d-a7d0-c036d4974846" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities" xlink:type="simple" xlink:href="rdnt-20221231.xsd#CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities" xlink:type="extended" id="ibe1ac964ebb3456fbfe663d577d2a5c2_CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_cbe5d86a-f733-4708-b586-d046dfa8e548" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_3359a296-c08d-4526-bc49-03c0cb5db642" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cbe5d86a-f733-4708-b586-d046dfa8e548" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_3359a296-c08d-4526-bc49-03c0cb5db642" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentLeverageRatio_b6e06868-9de0-4bbd-8915-5726a2c32449" xlink:href="rdnt-20221231.xsd#rdnt_DebtInstrumentLeverageRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cbe5d86a-f733-4708-b586-d046dfa8e548" xlink:to="loc_rdnt_DebtInstrumentLeverageRatio_b6e06868-9de0-4bbd-8915-5726a2c32449" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_20042c05-9e09-4e5a-ad9c-21c981985d80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cbe5d86a-f733-4708-b586-d046dfa8e548" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_20042c05-9e09-4e5a-ad9c-21c981985d80" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_68f67abf-17bc-494d-8844-73b34971a221" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cbe5d86a-f733-4708-b586-d046dfa8e548" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_68f67abf-17bc-494d-8844-73b34971a221" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPayment_92c38359-8673-4a0a-999d-0673883881cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentPeriodicPayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cbe5d86a-f733-4708-b586-d046dfa8e548" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPayment_92c38359-8673-4a0a-999d-0673883881cf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentPeriodicPaymentPercent_2d5109cc-5b71-45ec-b413-3e08b0645962" xlink:href="rdnt-20221231.xsd#rdnt_DebtInstrumentPeriodicPaymentPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cbe5d86a-f733-4708-b586-d046dfa8e548" xlink:to="loc_rdnt_DebtInstrumentPeriodicPaymentPercent_2d5109cc-5b71-45ec-b413-3e08b0645962" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease_36c28e45-b9db-4eb3-9ac5-a04685c8cc12" xlink:href="rdnt-20221231.xsd#rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cbe5d86a-f733-4708-b586-d046dfa8e548" xlink:to="loc_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease_36c28e45-b9db-4eb3-9ac5-a04685c8cc12" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_abf8db17-e1e4-4f96-8841-eea139e94f6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cbe5d86a-f733-4708-b586-d046dfa8e548" xlink:to="loc_us-gaap_DebtInstrumentTable_abf8db17-e1e4-4f96-8841-eea139e94f6f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_89a511f7-2832-4c1a-8b7e-5c4b6e1b8250" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_abf8db17-e1e4-4f96-8841-eea139e94f6f" xlink:to="loc_us-gaap_CreditFacilityAxis_89a511f7-2832-4c1a-8b7e-5c4b6e1b8250" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_89a511f7-2832-4c1a-8b7e-5c4b6e1b8250_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_89a511f7-2832-4c1a-8b7e-5c4b6e1b8250" xlink:to="loc_us-gaap_CreditFacilityDomain_89a511f7-2832-4c1a-8b7e-5c4b6e1b8250_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_8776ee72-4fa7-4b81-87cf-ad4cd180a91f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_89a511f7-2832-4c1a-8b7e-5c4b6e1b8250" xlink:to="loc_us-gaap_CreditFacilityDomain_8776ee72-4fa7-4b81-87cf-ad4cd180a91f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_d1af234e-3906-4d6c-8cac-58d2f95aa1ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_8776ee72-4fa7-4b81-87cf-ad4cd180a91f" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_d1af234e-3906-4d6c-8cac-58d2f95aa1ca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_bf893cb0-f422-4d01-a99c-7a7013c9fdae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_abf8db17-e1e4-4f96-8841-eea139e94f6f" xlink:to="loc_us-gaap_DebtInstrumentAxis_bf893cb0-f422-4d01-a99c-7a7013c9fdae" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_bf893cb0-f422-4d01-a99c-7a7013c9fdae_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_bf893cb0-f422-4d01-a99c-7a7013c9fdae" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_bf893cb0-f422-4d01-a99c-7a7013c9fdae_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_fcc44173-e752-4de0-818d-af0ed62a8d9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_bf893cb0-f422-4d01-a99c-7a7013c9fdae" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_fcc44173-e752-4de0-818d-af0ed62a8d9e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementSixthAmendmentMember_c8195be1-6116-482d-96f4-dee6ee9edc7d" xlink:href="rdnt-20221231.xsd#rdnt_FirstLienCreditAgreementSixthAmendmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fcc44173-e752-4de0-818d-af0ed62a8d9e" xlink:to="loc_rdnt_FirstLienCreditAgreementSixthAmendmentMember_c8195be1-6116-482d-96f4-dee6ee9edc7d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienTermLoanMember_62c9ff81-630f-43aa-9d61-21af8eee33ff" xlink:href="rdnt-20221231.xsd#rdnt_FirstLienTermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fcc44173-e752-4de0-818d-af0ed62a8d9e" xlink:to="loc_rdnt_FirstLienTermLoanMember_62c9ff81-630f-43aa-9d61-21af8eee33ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_41978346-efc3-47e0-baab-6e062c9de8b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_abf8db17-e1e4-4f96-8841-eea139e94f6f" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_41978346-efc3-47e0-baab-6e062c9de8b6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_41978346-efc3-47e0-baab-6e062c9de8b6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_41978346-efc3-47e0-baab-6e062c9de8b6" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_41978346-efc3-47e0-baab-6e062c9de8b6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_673405ac-c373-42b0-b2f7-4ddbe11a0529" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_41978346-efc3-47e0-baab-6e062c9de8b6" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_673405ac-c373-42b0-b2f7-4ddbe11a0529" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_2c873a8b-3e49-4964-ac3b-1791d1dd5a77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_673405ac-c373-42b0-b2f7-4ddbe11a0529" xlink:to="loc_us-gaap_LineOfCreditMember_2c873a8b-3e49-4964-ac3b-1791d1dd5a77" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TermLoanMember_bebc683c-3342-4f20-9b79-db19f86467db" xlink:href="rdnt-20221231.xsd#rdnt_TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_673405ac-c373-42b0-b2f7-4ddbe11a0529" xlink:to="loc_rdnt_TermLoanMember_bebc683c-3342-4f20-9b79-db19f86467db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediumTermNotesMember_f7f67495-c185-4270-873c-a5b0d4b075f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MediumTermNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_673405ac-c373-42b0-b2f7-4ddbe11a0529" xlink:to="loc_us-gaap_MediumTermNotesMember_f7f67495-c185-4270-873c-a5b0d4b075f9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_36dbcc3d-e147-4106-8635-6d258730b191" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_abf8db17-e1e4-4f96-8841-eea139e94f6f" xlink:to="loc_us-gaap_VariableRateAxis_36dbcc3d-e147-4106-8635-6d258730b191" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_36dbcc3d-e147-4106-8635-6d258730b191_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_36dbcc3d-e147-4106-8635-6d258730b191" xlink:to="loc_us-gaap_VariableRateDomain_36dbcc3d-e147-4106-8635-6d258730b191_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_f9c15e99-1782-4b0c-85bd-ffe96eb55865" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_36dbcc3d-e147-4106-8635-6d258730b191" xlink:to="loc_us-gaap_VariableRateDomain_f9c15e99-1782-4b0c-85bd-ffe96eb55865" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EurodollarMember_07d30f17-e3bc-44f5-bdc2-aba5fe231803" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EurodollarMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_f9c15e99-1782-4b0c-85bd-ffe96eb55865" xlink:to="loc_us-gaap_EurodollarMember_07d30f17-e3bc-44f5-bdc2-aba5fe231803" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_fed93d93-edf2-4fd4-99b4-020457d6e0fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BaseRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_f9c15e99-1782-4b0c-85bd-ffe96eb55865" xlink:to="loc_us-gaap_BaseRateMember_fed93d93-edf2-4fd4-99b4-020457d6e0fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_006316a6-c2ab-4beb-b0f3-834f71c9a5ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_f9c15e99-1782-4b0c-85bd-ffe96eb55865" xlink:to="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_006316a6-c2ab-4beb-b0f3-834f71c9a5ab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioAxis_732c66f5-bd10-4e52-8e25-7f84e4a3782c" xlink:href="rdnt-20221231.xsd#rdnt_LeverageRatioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_abf8db17-e1e4-4f96-8841-eea139e94f6f" xlink:to="loc_rdnt_LeverageRatioAxis_732c66f5-bd10-4e52-8e25-7f84e4a3782c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain_732c66f5-bd10-4e52-8e25-7f84e4a3782c_default" xlink:href="rdnt-20221231.xsd#rdnt_LeverageRatioDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_rdnt_LeverageRatioAxis_732c66f5-bd10-4e52-8e25-7f84e4a3782c" xlink:to="loc_rdnt_LeverageRatioDomain_732c66f5-bd10-4e52-8e25-7f84e4a3782c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain_1aaca713-6746-4234-85a5-533b78ccb36f" xlink:href="rdnt-20221231.xsd#rdnt_LeverageRatioDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_rdnt_LeverageRatioAxis_732c66f5-bd10-4e52-8e25-7f84e4a3782c" xlink:to="loc_rdnt_LeverageRatioDomain_1aaca713-6746-4234-85a5-533b78ccb36f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioFiveMember_fa55df96-2101-4c8a-8a1d-cf5a3a9b9781" xlink:href="rdnt-20221231.xsd#rdnt_LeverageRatioFiveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_1aaca713-6746-4234-85a5-533b78ccb36f" xlink:to="loc_rdnt_LeverageRatioFiveMember_fa55df96-2101-4c8a-8a1d-cf5a3a9b9781" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioThreeMember_240a3f5c-ca67-4a0f-8353-bc79ba428a03" xlink:href="rdnt-20221231.xsd#rdnt_LeverageRatioThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_1aaca713-6746-4234-85a5-533b78ccb36f" xlink:to="loc_rdnt_LeverageRatioThreeMember_240a3f5c-ca67-4a0f-8353-bc79ba428a03" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_be054afc-8655-43d3-9b5a-5559429d7ef2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_abf8db17-e1e4-4f96-8841-eea139e94f6f" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_be054afc-8655-43d3-9b5a-5559429d7ef2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_be054afc-8655-43d3-9b5a-5559429d7ef2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_be054afc-8655-43d3-9b5a-5559429d7ef2" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_be054afc-8655-43d3-9b5a-5559429d7ef2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_ceeea233-f90e-469c-8818-4470c46972e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_be054afc-8655-43d3-9b5a-5559429d7ef2" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_ceeea233-f90e-469c-8818-4470c46972e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BarclaysMember_729a1efa-a4a8-45e0-84b7-e3da412c36ac" xlink:href="rdnt-20221231.xsd#rdnt_BarclaysMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_ceeea233-f90e-469c-8818-4470c46972e9" xlink:to="loc_rdnt_BarclaysMember_729a1efa-a4a8-45e0-84b7-e3da412c36ac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TruistMember_c8e84671-6acd-4a4f-9610-d9001be7168f" xlink:href="rdnt-20221231.xsd#rdnt_TruistMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_ceeea233-f90e-469c-8818-4470c46972e9" xlink:to="loc_rdnt_TruistMember_c8e84671-6acd-4a4f-9610-d9001be7168f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_2e21d391-d24b-407b-9041-2dd9dec9879d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_abf8db17-e1e4-4f96-8841-eea139e94f6f" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_2e21d391-d24b-407b-9041-2dd9dec9879d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_2e21d391-d24b-407b-9041-2dd9dec9879d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_2e21d391-d24b-407b-9041-2dd9dec9879d" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_2e21d391-d24b-407b-9041-2dd9dec9879d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_3643a252-8d89-4b60-ae25-75dbba7b52ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_2e21d391-d24b-407b-9041-2dd9dec9879d" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_3643a252-8d89-4b60-ae25-75dbba7b52ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_23e1e036-86f6-4918-8dee-d9c6a8611303" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_3643a252-8d89-4b60-ae25-75dbba7b52ff" xlink:to="loc_us-gaap_SubsequentEventMember_23e1e036-86f6-4918-8dee-d9c6a8611303" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities" xlink:type="simple" xlink:href="rdnt-20221231.xsd#CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities" xlink:type="extended" id="ia17865b3e8f4460fac3477f022c6bcf7_CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_903734f1-fddb-425f-847e-a2f59657b965" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_04f81e1a-130e-4ca6-9791-5ba03568cb11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_903734f1-fddb-425f-847e-a2f59657b965" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_04f81e1a-130e-4ca6-9791-5ba03568cb11" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_a406a0be-1e75-4b33-9d28-9dbdce591ac7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_903734f1-fddb-425f-847e-a2f59657b965" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_a406a0be-1e75-4b33-9d28-9dbdce591ac7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_f035a33e-ccc1-49b0-bf9f-e373729bc605" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_903734f1-fddb-425f-847e-a2f59657b965" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_f035a33e-ccc1-49b0-bf9f-e373729bc605" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_b8b97857-f6e2-4700-bb04-b7b008902f11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_903734f1-fddb-425f-847e-a2f59657b965" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_b8b97857-f6e2-4700-bb04-b7b008902f11" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_6d827c47-12f6-463c-a83e-dda0cbfc7782" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_903734f1-fddb-425f-847e-a2f59657b965" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_6d827c47-12f6-463c-a83e-dda0cbfc7782" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_d3c296d9-2637-48c5-8de8-ef22a155e1ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_903734f1-fddb-425f-847e-a2f59657b965" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_d3c296d9-2637-48c5-8de8-ef22a155e1ca" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_79577d3f-c744-4fa5-8ab9-d7868569a71b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_903734f1-fddb-425f-847e-a2f59657b965" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_79577d3f-c744-4fa5-8ab9-d7868569a71b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_e7f61cd6-29dc-459a-8720-50651968f25c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_79577d3f-c744-4fa5-8ab9-d7868569a71b" xlink:to="loc_us-gaap_CreditFacilityAxis_e7f61cd6-29dc-459a-8720-50651968f25c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_e7f61cd6-29dc-459a-8720-50651968f25c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_e7f61cd6-29dc-459a-8720-50651968f25c" xlink:to="loc_us-gaap_CreditFacilityDomain_e7f61cd6-29dc-459a-8720-50651968f25c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_0bc2652d-2d45-41b4-bbe4-d0579a81bea7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_e7f61cd6-29dc-459a-8720-50651968f25c" xlink:to="loc_us-gaap_CreditFacilityDomain_0bc2652d-2d45-41b4-bbe4-d0579a81bea7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_d1f6a958-7416-4104-a4dd-af33cdf4b078" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_0bc2652d-2d45-41b4-bbe4-d0579a81bea7" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_d1f6a958-7416-4104-a4dd-af33cdf4b078" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_489f54e0-797a-4d3a-960a-16f2f2b5ea62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_0bc2652d-2d45-41b4-bbe4-d0579a81bea7" xlink:to="loc_us-gaap_LetterOfCreditMember_489f54e0-797a-4d3a-960a-16f2f2b5ea62" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_3c6828e1-b0bd-442a-8da6-b847b5e72163" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_79577d3f-c744-4fa5-8ab9-d7868569a71b" xlink:to="loc_us-gaap_DebtInstrumentAxis_3c6828e1-b0bd-442a-8da6-b847b5e72163" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_3c6828e1-b0bd-442a-8da6-b847b5e72163_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_3c6828e1-b0bd-442a-8da6-b847b5e72163" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_3c6828e1-b0bd-442a-8da6-b847b5e72163_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9870ba39-4011-41b7-a451-9305bacacb56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_3c6828e1-b0bd-442a-8da6-b847b5e72163" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9870ba39-4011-41b7-a451-9305bacacb56" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementSixthAmendmentMember_337a04e9-89a2-4ff4-bd96-01fc84661acc" xlink:href="rdnt-20221231.xsd#rdnt_FirstLienCreditAgreementSixthAmendmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9870ba39-4011-41b7-a451-9305bacacb56" xlink:to="loc_rdnt_FirstLienCreditAgreementSixthAmendmentMember_337a04e9-89a2-4ff4-bd96-01fc84661acc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_d8c47a80-fbe8-4ee9-8731-9447dcbb5a0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_79577d3f-c744-4fa5-8ab9-d7868569a71b" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_d8c47a80-fbe8-4ee9-8731-9447dcbb5a0a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_d8c47a80-fbe8-4ee9-8731-9447dcbb5a0a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_d8c47a80-fbe8-4ee9-8731-9447dcbb5a0a" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_d8c47a80-fbe8-4ee9-8731-9447dcbb5a0a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_62e3ad92-df96-4f2d-b35d-13d7a1d95996" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_d8c47a80-fbe8-4ee9-8731-9447dcbb5a0a" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_62e3ad92-df96-4f2d-b35d-13d7a1d95996" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BarclaysMember_801065e6-58b2-4ed9-8f0c-23e85877d2b9" xlink:href="rdnt-20221231.xsd#rdnt_BarclaysMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_62e3ad92-df96-4f2d-b35d-13d7a1d95996" xlink:to="loc_rdnt_BarclaysMember_801065e6-58b2-4ed9-8f0c-23e85877d2b9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TruistMember_afdb2497-5b99-4aa6-8f6c-8d4fc0883509" xlink:href="rdnt-20221231.xsd#rdnt_TruistMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_62e3ad92-df96-4f2d-b35d-13d7a1d95996" xlink:to="loc_rdnt_TruistMember_afdb2497-5b99-4aa6-8f6c-8d4fc0883509" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_3c5e29e3-a998-4351-b0c4-b1d24056769c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_79577d3f-c744-4fa5-8ab9-d7868569a71b" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_3c5e29e3-a998-4351-b0c4-b1d24056769c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_3c5e29e3-a998-4351-b0c4-b1d24056769c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_3c5e29e3-a998-4351-b0c4-b1d24056769c" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_3c5e29e3-a998-4351-b0c4-b1d24056769c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_4f90e93f-e9b9-46ae-b98f-1e48554ed94b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_3c5e29e3-a998-4351-b0c4-b1d24056769c" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_4f90e93f-e9b9-46ae-b98f-1e48554ed94b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_792d79c7-abd8-4e2c-80f2-c7b091251a5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4f90e93f-e9b9-46ae-b98f-1e48554ed94b" xlink:to="loc_us-gaap_LineOfCreditMember_792d79c7-abd8-4e2c-80f2-c7b091251a5d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_d6152080-fd34-4099-8117-a19ea873b4e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4f90e93f-e9b9-46ae-b98f-1e48554ed94b" xlink:to="loc_us-gaap_LetterOfCreditMember_d6152080-fd34-4099-8117-a19ea873b4e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioAxis_9198a347-0092-4de6-bb0c-1511808ddd8e" xlink:href="rdnt-20221231.xsd#rdnt_LeverageRatioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_79577d3f-c744-4fa5-8ab9-d7868569a71b" xlink:to="loc_rdnt_LeverageRatioAxis_9198a347-0092-4de6-bb0c-1511808ddd8e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain_9198a347-0092-4de6-bb0c-1511808ddd8e_default" xlink:href="rdnt-20221231.xsd#rdnt_LeverageRatioDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_rdnt_LeverageRatioAxis_9198a347-0092-4de6-bb0c-1511808ddd8e" xlink:to="loc_rdnt_LeverageRatioDomain_9198a347-0092-4de6-bb0c-1511808ddd8e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain_be235811-c3ad-4264-a83e-1b72e7fbf24b" xlink:href="rdnt-20221231.xsd#rdnt_LeverageRatioDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_rdnt_LeverageRatioAxis_9198a347-0092-4de6-bb0c-1511808ddd8e" xlink:to="loc_rdnt_LeverageRatioDomain_be235811-c3ad-4264-a83e-1b72e7fbf24b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioThreeMember_81d5f23d-80dc-4763-89a1-519317846f2e" xlink:href="rdnt-20221231.xsd#rdnt_LeverageRatioThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_be235811-c3ad-4264-a83e-1b72e7fbf24b" xlink:to="loc_rdnt_LeverageRatioThreeMember_81d5f23d-80dc-4763-89a1-519317846f2e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_23173a66-526c-439d-a634-ea0e6f2c8f68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_79577d3f-c744-4fa5-8ab9-d7868569a71b" xlink:to="loc_us-gaap_VariableRateAxis_23173a66-526c-439d-a634-ea0e6f2c8f68" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_23173a66-526c-439d-a634-ea0e6f2c8f68_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_23173a66-526c-439d-a634-ea0e6f2c8f68" xlink:to="loc_us-gaap_VariableRateDomain_23173a66-526c-439d-a634-ea0e6f2c8f68_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_dcc50999-1206-4033-a08d-01f6033fc770" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_23173a66-526c-439d-a634-ea0e6f2c8f68" xlink:to="loc_us-gaap_VariableRateDomain_dcc50999-1206-4033-a08d-01f6033fc770" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EurodollarMember_44bd28ec-9d9d-4d69-a5ff-93bd9624681d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EurodollarMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_dcc50999-1206-4033-a08d-01f6033fc770" xlink:to="loc_us-gaap_EurodollarMember_44bd28ec-9d9d-4d69-a5ff-93bd9624681d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio" xlink:type="simple" xlink:href="rdnt-20221231.xsd#CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio" xlink:type="extended" id="ibaa75554032b4aa299022da0f43bb576_CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_7cf13d55-658e-42ec-a6a1-1e420cfab6fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentLeverageRatio_1a354f6e-a321-499f-bd1b-a61a649964f9" xlink:href="rdnt-20221231.xsd#rdnt_DebtInstrumentLeverageRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_7cf13d55-658e-42ec-a6a1-1e420cfab6fd" xlink:to="loc_rdnt_DebtInstrumentLeverageRatio_1a354f6e-a321-499f-bd1b-a61a649964f9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_0daaea5a-98ac-43e7-a6ed-30c8be20417e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_7cf13d55-658e-42ec-a6a1-1e420cfab6fd" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_0daaea5a-98ac-43e7-a6ed-30c8be20417e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_e39589f4-410a-4d79-83e8-15f6e9b07b89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_7cf13d55-658e-42ec-a6a1-1e420cfab6fd" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_e39589f4-410a-4d79-83e8-15f6e9b07b89" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_d9dccd78-a37e-485e-98db-b6c09efdd053" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_e39589f4-410a-4d79-83e8-15f6e9b07b89" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_d9dccd78-a37e-485e-98db-b6c09efdd053" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d9dccd78-a37e-485e-98db-b6c09efdd053_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d9dccd78-a37e-485e-98db-b6c09efdd053" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d9dccd78-a37e-485e-98db-b6c09efdd053_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_fa8cd5e9-5d5b-44f8-8949-cb64de1326db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d9dccd78-a37e-485e-98db-b6c09efdd053" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_fa8cd5e9-5d5b-44f8-8949-cb64de1326db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_0355c4b6-47ba-4249-aea8-b2808d71d866" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_fa8cd5e9-5d5b-44f8-8949-cb64de1326db" xlink:to="loc_us-gaap_LineOfCreditMember_0355c4b6-47ba-4249-aea8-b2808d71d866" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_b1fc68c1-a151-4112-a43a-99f1311e9ba2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_e39589f4-410a-4d79-83e8-15f6e9b07b89" xlink:to="loc_us-gaap_CreditFacilityAxis_b1fc68c1-a151-4112-a43a-99f1311e9ba2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_b1fc68c1-a151-4112-a43a-99f1311e9ba2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_b1fc68c1-a151-4112-a43a-99f1311e9ba2" xlink:to="loc_us-gaap_CreditFacilityDomain_b1fc68c1-a151-4112-a43a-99f1311e9ba2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_7df0cbe9-33bb-4acb-8c41-fa4ac31e4760" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_b1fc68c1-a151-4112-a43a-99f1311e9ba2" xlink:to="loc_us-gaap_CreditFacilityDomain_7df0cbe9-33bb-4acb-8c41-fa4ac31e4760" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_510c8fb8-57cd-4245-b455-aa41a0547e32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_7df0cbe9-33bb-4acb-8c41-fa4ac31e4760" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_510c8fb8-57cd-4245-b455-aa41a0547e32" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_1be08ca4-9ac4-46c4-8205-ad7cdf8d00a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_e39589f4-410a-4d79-83e8-15f6e9b07b89" xlink:to="loc_us-gaap_VariableRateAxis_1be08ca4-9ac4-46c4-8205-ad7cdf8d00a8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_1be08ca4-9ac4-46c4-8205-ad7cdf8d00a8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_1be08ca4-9ac4-46c4-8205-ad7cdf8d00a8" xlink:to="loc_us-gaap_VariableRateDomain_1be08ca4-9ac4-46c4-8205-ad7cdf8d00a8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_411888f7-a848-4adf-9f56-b6eec7e28b05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_1be08ca4-9ac4-46c4-8205-ad7cdf8d00a8" xlink:to="loc_us-gaap_VariableRateDomain_411888f7-a848-4adf-9f56-b6eec7e28b05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EurodollarMember_fd9a09de-01bf-440d-b88d-740baea61000" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EurodollarMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_411888f7-a848-4adf-9f56-b6eec7e28b05" xlink:to="loc_us-gaap_EurodollarMember_fd9a09de-01bf-440d-b88d-740baea61000" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_e64bcad4-acb8-4b28-a7d8-e7e2d90e8d78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BaseRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_411888f7-a848-4adf-9f56-b6eec7e28b05" xlink:to="loc_us-gaap_BaseRateMember_e64bcad4-acb8-4b28-a7d8-e7e2d90e8d78" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_d39ba2b4-d77d-4d84-86ff-c29f40c56c30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_e39589f4-410a-4d79-83e8-15f6e9b07b89" xlink:to="loc_us-gaap_DebtInstrumentAxis_d39ba2b4-d77d-4d84-86ff-c29f40c56c30" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d39ba2b4-d77d-4d84-86ff-c29f40c56c30_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_d39ba2b4-d77d-4d84-86ff-c29f40c56c30" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d39ba2b4-d77d-4d84-86ff-c29f40c56c30_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_379475d7-8594-44f5-bc53-51438e0d9c9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_d39ba2b4-d77d-4d84-86ff-c29f40c56c30" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_379475d7-8594-44f5-bc53-51438e0d9c9c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementMember_be7de133-707c-4b29-b066-6fae9808dfc4" xlink:href="rdnt-20221231.xsd#rdnt_FirstLienCreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_379475d7-8594-44f5-bc53-51438e0d9c9c" xlink:to="loc_rdnt_FirstLienCreditAgreementMember_be7de133-707c-4b29-b066-6fae9808dfc4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioAxis_eb490233-c22b-4f9f-ba79-24953c774dfb" xlink:href="rdnt-20221231.xsd#rdnt_LeverageRatioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_e39589f4-410a-4d79-83e8-15f6e9b07b89" xlink:to="loc_rdnt_LeverageRatioAxis_eb490233-c22b-4f9f-ba79-24953c774dfb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain_eb490233-c22b-4f9f-ba79-24953c774dfb_default" xlink:href="rdnt-20221231.xsd#rdnt_LeverageRatioDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_rdnt_LeverageRatioAxis_eb490233-c22b-4f9f-ba79-24953c774dfb" xlink:to="loc_rdnt_LeverageRatioDomain_eb490233-c22b-4f9f-ba79-24953c774dfb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain_2f58410e-6337-449f-9dfd-c40c57cebe77" xlink:href="rdnt-20221231.xsd#rdnt_LeverageRatioDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_rdnt_LeverageRatioAxis_eb490233-c22b-4f9f-ba79-24953c774dfb" xlink:to="loc_rdnt_LeverageRatioDomain_2f58410e-6337-449f-9dfd-c40c57cebe77" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioOneMember_264bfe77-1794-4c13-9074-16033ece8a26" xlink:href="rdnt-20221231.xsd#rdnt_LeverageRatioOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_2f58410e-6337-449f-9dfd-c40c57cebe77" xlink:to="loc_rdnt_LeverageRatioOneMember_264bfe77-1794-4c13-9074-16033ece8a26" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioTwoMember_4fb8232f-a594-4414-8145-054cf16ad5df" xlink:href="rdnt-20221231.xsd#rdnt_LeverageRatioTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_2f58410e-6337-449f-9dfd-c40c57cebe77" xlink:to="loc_rdnt_LeverageRatioTwoMember_4fb8232f-a594-4414-8145-054cf16ad5df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioThreeMember_47680506-620d-4c64-bd01-463f002c13ce" xlink:href="rdnt-20221231.xsd#rdnt_LeverageRatioThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_2f58410e-6337-449f-9dfd-c40c57cebe77" xlink:to="loc_rdnt_LeverageRatioThreeMember_47680506-620d-4c64-bd01-463f002c13ce" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_f9ddbd9d-245c-4d50-b713-d67180fadbcd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_e39589f4-410a-4d79-83e8-15f6e9b07b89" xlink:to="loc_srt_RangeAxis_f9ddbd9d-245c-4d50-b713-d67180fadbcd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f9ddbd9d-245c-4d50-b713-d67180fadbcd_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_f9ddbd9d-245c-4d50-b713-d67180fadbcd" xlink:to="loc_srt_RangeMember_f9ddbd9d-245c-4d50-b713-d67180fadbcd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d749905e-d6a1-4a49-b5f6-271ac8016e07" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_f9ddbd9d-245c-4d50-b713-d67180fadbcd" xlink:to="loc_srt_RangeMember_d749905e-d6a1-4a49-b5f6-271ac8016e07" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e3e8ea54-8f72-415e-a890-dc164c80e38b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d749905e-d6a1-4a49-b5f6-271ac8016e07" xlink:to="loc_srt_MinimumMember_e3e8ea54-8f72-415e-a890-dc164c80e38b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_38135fed-ffaf-41f8-a7d6-993bdc4b2675" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d749905e-d6a1-4a49-b5f6-271ac8016e07" xlink:to="loc_srt_MaximumMember_38135fed-ffaf-41f8-a7d6-993bdc4b2675" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstoPriorCreditFacilities" xlink:type="simple" xlink:href="rdnt-20221231.xsd#CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstoPriorCreditFacilities"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstoPriorCreditFacilities" xlink:type="extended" id="i14cc49b505a74d6487c6aaf805334194_CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstoPriorCreditFacilities">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_01732dbd-0a11-4281-a31e-5e77ee04e716" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity_1bac5762-eb4f-4189-a879-7f3e4818b125" xlink:href="rdnt-20221231.xsd#rdnt_LineofCreditFacilityIncreaseBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_01732dbd-0a11-4281-a31e-5e77ee04e716" xlink:to="loc_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity_1bac5762-eb4f-4189-a879-7f3e4818b125" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_113f1ac9-68ba-4883-90cb-605f8ef2efa3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_01732dbd-0a11-4281-a31e-5e77ee04e716" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_113f1ac9-68ba-4883-90cb-605f8ef2efa3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentNumberOfAmendments_b1180cdb-1eda-4819-b8b9-874eae98a02b" xlink:href="rdnt-20221231.xsd#rdnt_DebtInstrumentNumberOfAmendments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_01732dbd-0a11-4281-a31e-5e77ee04e716" xlink:to="loc_rdnt_DebtInstrumentNumberOfAmendments_b1180cdb-1eda-4819-b8b9-874eae98a02b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_156463fe-0933-4571-8e83-890381e8fb87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_01732dbd-0a11-4281-a31e-5e77ee04e716" xlink:to="loc_us-gaap_LineOfCredit_156463fe-0933-4571-8e83-890381e8fb87" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentExtensionPeriod_e12127c3-6f76-418c-a165-da218bf74866" xlink:href="rdnt-20221231.xsd#rdnt_DebtInstrumentExtensionPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_01732dbd-0a11-4281-a31e-5e77ee04e716" xlink:to="loc_rdnt_DebtInstrumentExtensionPeriod_e12127c3-6f76-418c-a165-da218bf74866" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_7b66940a-9111-4b98-9b9e-aff3853a4d13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_01732dbd-0a11-4281-a31e-5e77ee04e716" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_7b66940a-9111-4b98-9b9e-aff3853a4d13" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_ac89453e-04bc-4851-a7c2-237493efc189" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_01732dbd-0a11-4281-a31e-5e77ee04e716" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_ac89453e-04bc-4851-a7c2-237493efc189" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_1c72078d-6cce-4e6e-bfa2-ba146daf7a56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_01732dbd-0a11-4281-a31e-5e77ee04e716" xlink:to="loc_us-gaap_DebtInstrumentTerm_1c72078d-6cce-4e6e-bfa2-ba146daf7a56" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentNumberofLoansReceived_9edec359-ca07-4605-b68c-5f3171aad4c1" xlink:href="rdnt-20221231.xsd#rdnt_DebtInstrumentNumberofLoansReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_01732dbd-0a11-4281-a31e-5e77ee04e716" xlink:to="loc_rdnt_DebtInstrumentNumberofLoansReceived_9edec359-ca07-4605-b68c-5f3171aad4c1" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_9cc6a93b-f248-4ae3-9bd1-9af8d52c9f5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_01732dbd-0a11-4281-a31e-5e77ee04e716" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_9cc6a93b-f248-4ae3-9bd1-9af8d52c9f5d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_259e5519-1ec4-46f0-84f7-db62e87f950c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_9cc6a93b-f248-4ae3-9bd1-9af8d52c9f5d" xlink:to="loc_us-gaap_CreditFacilityAxis_259e5519-1ec4-46f0-84f7-db62e87f950c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_259e5519-1ec4-46f0-84f7-db62e87f950c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_259e5519-1ec4-46f0-84f7-db62e87f950c" xlink:to="loc_us-gaap_CreditFacilityDomain_259e5519-1ec4-46f0-84f7-db62e87f950c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_ee36421d-c94c-476e-9d4e-4856cb3a7081" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_259e5519-1ec4-46f0-84f7-db62e87f950c" xlink:to="loc_us-gaap_CreditFacilityDomain_ee36421d-c94c-476e-9d4e-4856cb3a7081" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_ae3317c8-6375-44b2-8e43-dbf7ee140098" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_ee36421d-c94c-476e-9d4e-4856cb3a7081" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_ae3317c8-6375-44b2-8e43-dbf7ee140098" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_1f7a16aa-a148-41cb-a239-d7cfbf2d2adf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_9cc6a93b-f248-4ae3-9bd1-9af8d52c9f5d" xlink:to="loc_us-gaap_DebtInstrumentAxis_1f7a16aa-a148-41cb-a239-d7cfbf2d2adf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1f7a16aa-a148-41cb-a239-d7cfbf2d2adf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_1f7a16aa-a148-41cb-a239-d7cfbf2d2adf" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1f7a16aa-a148-41cb-a239-d7cfbf2d2adf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ce401c0e-3dd6-4682-a28a-af288b7c51fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_1f7a16aa-a148-41cb-a239-d7cfbf2d2adf" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ce401c0e-3dd6-4682-a28a-af288b7c51fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementEighthAmendmentMember_5c829edf-0277-415c-8036-173c81235923" xlink:href="rdnt-20221231.xsd#rdnt_FirstLienCreditAgreementEighthAmendmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ce401c0e-3dd6-4682-a28a-af288b7c51fd" xlink:to="loc_rdnt_FirstLienCreditAgreementEighthAmendmentMember_5c829edf-0277-415c-8036-173c81235923" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementSixthAmendmentMember_87c2e58a-3654-4a2b-8a30-2843229e8043" xlink:href="rdnt-20221231.xsd#rdnt_FirstLienCreditAgreementSixthAmendmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ce401c0e-3dd6-4682-a28a-af288b7c51fd" xlink:to="loc_rdnt_FirstLienCreditAgreementSixthAmendmentMember_87c2e58a-3654-4a2b-8a30-2843229e8043" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PaycheckProtectionProgramLoansMember_773c0b5a-8683-435a-ac04-51c8c27c0faf" xlink:href="rdnt-20221231.xsd#rdnt_PaycheckProtectionProgramLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ce401c0e-3dd6-4682-a28a-af288b7c51fd" xlink:to="loc_rdnt_PaycheckProtectionProgramLoansMember_773c0b5a-8683-435a-ac04-51c8c27c0faf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_2031f77e-32da-4bf1-901f-8bae547e9064" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_9cc6a93b-f248-4ae3-9bd1-9af8d52c9f5d" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_2031f77e-32da-4bf1-901f-8bae547e9064" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_2031f77e-32da-4bf1-901f-8bae547e9064_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_2031f77e-32da-4bf1-901f-8bae547e9064" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_2031f77e-32da-4bf1-901f-8bae547e9064_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_bce8e4dd-350e-4ad7-b9e7-393f621cd21f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_2031f77e-32da-4bf1-901f-8bae547e9064" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_bce8e4dd-350e-4ad7-b9e7-393f621cd21f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BarclaysMember_5820d373-c118-42d7-b80b-9e0c613d9422" xlink:href="rdnt-20221231.xsd#rdnt_BarclaysMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_bce8e4dd-350e-4ad7-b9e7-393f621cd21f" xlink:to="loc_rdnt_BarclaysMember_5820d373-c118-42d7-b80b-9e0c613d9422" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TruistMember_9e2c5768-1790-4222-b6fb-10a7688fd0fc" xlink:href="rdnt-20221231.xsd#rdnt_TruistMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_bce8e4dd-350e-4ad7-b9e7-393f621cd21f" xlink:to="loc_rdnt_TruistMember_9e2c5768-1790-4222-b6fb-10a7688fd0fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_41ec6d50-941c-4946-8598-74aa3537051a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_9cc6a93b-f248-4ae3-9bd1-9af8d52c9f5d" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_41ec6d50-941c-4946-8598-74aa3537051a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_41ec6d50-941c-4946-8598-74aa3537051a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_41ec6d50-941c-4946-8598-74aa3537051a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_41ec6d50-941c-4946-8598-74aa3537051a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_6654e131-5e4d-4230-9839-9e008e0efa78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_41ec6d50-941c-4946-8598-74aa3537051a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_6654e131-5e4d-4230-9839-9e008e0efa78" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_96fe6039-2bf5-4e3e-91a7-1bcaccdfdb23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6654e131-5e4d-4230-9839-9e008e0efa78" xlink:to="loc_us-gaap_LineOfCreditMember_96fe6039-2bf5-4e3e-91a7-1bcaccdfdb23" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediumTermNotesMember_a31a0ae3-8052-441b-b83d-d1ac7508ab02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MediumTermNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6654e131-5e4d-4230-9839-9e008e0efa78" xlink:to="loc_us-gaap_MediumTermNotesMember_a31a0ae3-8052-441b-b83d-d1ac7508ab02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis_5db58bbc-1382-4ced-bf9b-993bb2cdb72d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_9cc6a93b-f248-4ae3-9bd1-9af8d52c9f5d" xlink:to="loc_us-gaap_UnusualOrInfrequentItemAxis_5db58bbc-1382-4ced-bf9b-993bb2cdb72d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_5db58bbc-1382-4ced-bf9b-993bb2cdb72d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_5db58bbc-1382-4ced-bf9b-993bb2cdb72d" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_5db58bbc-1382-4ced-bf9b-993bb2cdb72d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_4f754595-5193-4347-bcd2-da51eeeac110" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_5db58bbc-1382-4ced-bf9b-993bb2cdb72d" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_4f754595-5193-4347-bcd2-da51eeeac110" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_COVID19PandemicMember_6f9edd70-2607-4419-83f5-dfa1c9c0fdb5" xlink:href="rdnt-20221231.xsd#rdnt_COVID19PandemicMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain_4f754595-5193-4347-bcd2-da51eeeac110" xlink:to="loc_rdnt_COVID19PandemicMember_6f9edd70-2607-4419-83f5-dfa1c9c0fdb5" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/LEASESDetailsAdditionalInformation" xlink:type="simple" xlink:href="rdnt-20221231.xsd#LEASESDetailsAdditionalInformation"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/LEASESDetailsAdditionalInformation" xlink:type="extended" id="ibf7b273b28c34431addf53fb5141a868_LEASESDetailsAdditionalInformation">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_474b1f72-03d6-41ee-97a3-46ea3dbb8d8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_36a7e92b-f704-4bd9-85d2-54cbb0bcdb8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_474b1f72-03d6-41ee-97a3-46ea3dbb8d8c" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_36a7e92b-f704-4bd9-85d2-54cbb0bcdb8e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_a448c2d1-454f-4772-b15d-d0732cc3ba7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_474b1f72-03d6-41ee-97a3-46ea3dbb8d8c" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_a448c2d1-454f-4772-b15d-d0732cc3ba7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LesseeLeaseTermofContract_452145d0-59d9-4cbf-8497-d67474e2957c" xlink:href="rdnt-20221231.xsd#rdnt_LesseeLeaseTermofContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_474b1f72-03d6-41ee-97a3-46ea3dbb8d8c" xlink:to="loc_rdnt_LesseeLeaseTermofContract_452145d0-59d9-4cbf-8497-d67474e2957c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount_8ddf4bb2-9380-4fe6-b21a-fb68692d4b29" xlink:href="rdnt-20221231.xsd#rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_474b1f72-03d6-41ee-97a3-46ea3dbb8d8c" xlink:to="loc_rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount_8ddf4bb2-9380-4fe6-b21a-fb68692d4b29" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_0eef37e3-8db3-48fa-961d-3370fb9f6ea8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_474b1f72-03d6-41ee-97a3-46ea3dbb8d8c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_0eef37e3-8db3-48fa-961d-3370fb9f6ea8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_dbe6d46a-1b89-4792-b54b-bed7a91e8541" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_474b1f72-03d6-41ee-97a3-46ea3dbb8d8c" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_dbe6d46a-1b89-4792-b54b-bed7a91e8541" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_00620e10-dfdc-446b-a4a2-6dd196b1ed07" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_dbe6d46a-1b89-4792-b54b-bed7a91e8541" xlink:to="loc_srt_RangeAxis_00620e10-dfdc-446b-a4a2-6dd196b1ed07" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_00620e10-dfdc-446b-a4a2-6dd196b1ed07_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_00620e10-dfdc-446b-a4a2-6dd196b1ed07" xlink:to="loc_srt_RangeMember_00620e10-dfdc-446b-a4a2-6dd196b1ed07_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_05cbe515-db81-447a-8905-4e7333478bb6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_00620e10-dfdc-446b-a4a2-6dd196b1ed07" xlink:to="loc_srt_RangeMember_05cbe515-db81-447a-8905-4e7333478bb6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_74a8e102-e134-4dda-b14e-7df1213797ef" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_05cbe515-db81-447a-8905-4e7333478bb6" xlink:to="loc_srt_MinimumMember_74a8e102-e134-4dda-b14e-7df1213797ef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ba090f0e-1372-409e-b315-98f7b6e8e0ed" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_05cbe515-db81-447a-8905-4e7333478bb6" xlink:to="loc_srt_MaximumMember_ba090f0e-1372-409e-b315-98f7b6e8e0ed" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/INCOMETAXESDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20221231.xsd#INCOMETAXESDetailsNarrative"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/INCOMETAXESDetailsNarrative" xlink:type="extended" id="ifef7803c41564a5a816fcab3df3d2d38_INCOMETAXESDetailsNarrative">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_607d0bfe-e2a0-4e85-93f6-c062a948a877" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_e5c2b7c9-9bcf-43e7-9df0-7f68f89f08c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_607d0bfe-e2a0-4e85-93f6-c062a948a877" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_e5c2b7c9-9bcf-43e7-9df0-7f68f89f08c0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_8c0b0aee-ffea-4596-8f3b-35e3e3711c7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_607d0bfe-e2a0-4e85-93f6-c062a948a877" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_8c0b0aee-ffea-4596-8f3b-35e3e3711c7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_781b4e6b-f399-4b7f-aceb-1e2dd87f4e70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_607d0bfe-e2a0-4e85-93f6-c062a948a877" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_781b4e6b-f399-4b7f-aceb-1e2dd87f4e70" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_be320a61-d12e-47b3-9bcd-b6c2d1205398" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_607d0bfe-e2a0-4e85-93f6-c062a948a877" xlink:to="loc_us-gaap_OperatingLossCarryforwards_be320a61-d12e-47b3-9bcd-b6c2d1205398" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized_4903ecd3-0687-4f6e-907d-dcc001acd269" xlink:href="rdnt-20221231.xsd#rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_607d0bfe-e2a0-4e85-93f6-c062a948a877" xlink:to="loc_rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized_4903ecd3-0687-4f6e-907d-dcc001acd269" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_00d92dc5-e4f5-40d4-9282-85e8001b2bf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_607d0bfe-e2a0-4e85-93f6-c062a948a877" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_00d92dc5-e4f5-40d4-9282-85e8001b2bf0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_39b08467-5577-4ffe-8d47-5c198881cf12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_607d0bfe-e2a0-4e85-93f6-c062a948a877" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_39b08467-5577-4ffe-8d47-5c198881cf12" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized_a2d4e52c-56d9-4ffb-8702-44759bd89be7" xlink:href="rdnt-20221231.xsd#rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_607d0bfe-e2a0-4e85-93f6-c062a948a877" xlink:to="loc_rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized_a2d4e52c-56d9-4ffb-8702-44759bd89be7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod_967d2f48-3e90-4791-b7c2-ea6ee19720e4" xlink:href="rdnt-20221231.xsd#rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_607d0bfe-e2a0-4e85-93f6-c062a948a877" xlink:to="loc_rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod_967d2f48-3e90-4791-b7c2-ea6ee19720e4" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_e45db076-58c2-43c5-920f-f72a6414ce3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_607d0bfe-e2a0-4e85-93f6-c062a948a877" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_e45db076-58c2-43c5-920f-f72a6414ce3d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ForeignOperatingLossCarryforwardsSubjectToExpiration_fbcbb551-ba2f-47dd-9bf9-ab75b2588201" xlink:href="rdnt-20221231.xsd#rdnt_ForeignOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_607d0bfe-e2a0-4e85-93f6-c062a948a877" xlink:to="loc_rdnt_ForeignOperatingLossCarryforwardsSubjectToExpiration_fbcbb551-ba2f-47dd-9bf9-ab75b2588201" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ForeignOperatingLossCarryforwardsNotSubjectToExpiration_afb2b9e9-b119-4cad-9dbb-d99f66213cd5" xlink:href="rdnt-20221231.xsd#rdnt_ForeignOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_607d0bfe-e2a0-4e85-93f6-c062a948a877" xlink:to="loc_rdnt_ForeignOperatingLossCarryforwardsNotSubjectToExpiration_afb2b9e9-b119-4cad-9dbb-d99f66213cd5" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_2b6deb9a-c8a2-4ba5-8291-86a13cab3573" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_607d0bfe-e2a0-4e85-93f6-c062a948a877" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_2b6deb9a-c8a2-4ba5-8291-86a13cab3573" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_0614e9fb-9147-43a7-9e67-960aa10e20cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_2b6deb9a-c8a2-4ba5-8291-86a13cab3573" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_0614e9fb-9147-43a7-9e67-960aa10e20cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0614e9fb-9147-43a7-9e67-960aa10e20cb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0614e9fb-9147-43a7-9e67-960aa10e20cb" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0614e9fb-9147-43a7-9e67-960aa10e20cb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ecfc2e56-1c05-40de-b3bf-ef0bb99b00da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0614e9fb-9147-43a7-9e67-960aa10e20cb" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ecfc2e56-1c05-40de-b3bf-ef0bb99b00da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RavenHoldingsMember_78355e10-2e2a-416c-a078-be91d5f38e0b" xlink:href="rdnt-20221231.xsd#rdnt_RavenHoldingsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ecfc2e56-1c05-40de-b3bf-ef0bb99b00da" xlink:to="loc_rdnt_RavenHoldingsMember_78355e10-2e2a-416c-a078-be91d5f38e0b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_faad6e79-a1dc-4cd3-80c7-d689f75e9516" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_2b6deb9a-c8a2-4ba5-8291-86a13cab3573" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_faad6e79-a1dc-4cd3-80c7-d689f75e9516" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_faad6e79-a1dc-4cd3-80c7-d689f75e9516_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_faad6e79-a1dc-4cd3-80c7-d689f75e9516" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_faad6e79-a1dc-4cd3-80c7-d689f75e9516_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_83bd8ea3-3270-4a54-841d-1de2ae5a0965" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_faad6e79-a1dc-4cd3-80c7-d689f75e9516" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_83bd8ea3-3270-4a54-841d-1de2ae5a0965" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_b6a1163b-8cc2-4a12-8381-a370a7f9a87d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_83bd8ea3-3270-4a54-841d-1de2ae5a0965" xlink:to="loc_us-gaap_DomesticCountryMember_b6a1163b-8cc2-4a12-8381-a370a7f9a87d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_e42d29fd-43fb-49df-8e38-ef029414fc56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_83bd8ea3-3270-4a54-841d-1de2ae5a0965" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_e42d29fd-43fb-49df-8e38-ef029414fc56" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20221231.xsd#STOCKBASEDCOMPENSATIONDetailsNarrative"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative" xlink:type="extended" id="i62d43480d02949df91da654618adbdcc_STOCKBASEDCOMPENSATIONDetailsNarrative">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e9833ae6-7aa9-46f3-8ea7-f277232d4126" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans_66fa9021-b4f5-40a0-b4a2-f1c16824d709" xlink:href="rdnt-20221231.xsd#rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e9833ae6-7aa9-46f3-8ea7-f277232d4126" xlink:to="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans_66fa9021-b4f5-40a0-b4a2-f1c16824d709" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_1039b98c-28be-4c7c-915c-c436cf1df5f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e9833ae6-7aa9-46f3-8ea7-f277232d4126" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_1039b98c-28be-4c7c-915c-c436cf1df5f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_3a198b01-5bc9-4bfc-b5ed-1a8c5707c65e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e9833ae6-7aa9-46f3-8ea7-f277232d4126" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_3a198b01-5bc9-4bfc-b5ed-1a8c5707c65e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_31a441db-8e35-4985-a26a-3ad2abf5d609" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e9833ae6-7aa9-46f3-8ea7-f277232d4126" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_31a441db-8e35-4985-a26a-3ad2abf5d609" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_d5ec377a-45cd-408c-a45d-36ce7aee3355" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e9833ae6-7aa9-46f3-8ea7-f277232d4126" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_d5ec377a-45cd-408c-a45d-36ce7aee3355" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_be10ef13-1378-4c05-8415-1e460d71df30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e9833ae6-7aa9-46f3-8ea7-f277232d4126" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_be10ef13-1378-4c05-8415-1e460d71df30" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2c6b93e5-614b-491d-b74c-dbd63437aabd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e9833ae6-7aa9-46f3-8ea7-f277232d4126" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2c6b93e5-614b-491d-b74c-dbd63437aabd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ad25be40-f4ad-4e35-8358-2fc0f939a5d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e9833ae6-7aa9-46f3-8ea7-f277232d4126" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ad25be40-f4ad-4e35-8358-2fc0f939a5d1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_deeeebf3-7749-4e26-8b8c-4653659ec523" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e9833ae6-7aa9-46f3-8ea7-f277232d4126" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_deeeebf3-7749-4e26-8b8c-4653659ec523" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0783bf9b-0a50-49fd-9848-cdffdc2db24c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e9833ae6-7aa9-46f3-8ea7-f277232d4126" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0783bf9b-0a50-49fd-9848-cdffdc2db24c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue_b1a37abc-3eae-4c1f-b90a-155f8b8ce58d" xlink:href="rdnt-20221231.xsd#rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e9833ae6-7aa9-46f3-8ea7-f277232d4126" xlink:to="loc_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue_b1a37abc-3eae-4c1f-b90a-155f8b8ce58d" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance_f46f654b-0b00-48c7-b16e-ec95cb4e04e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e9833ae6-7aa9-46f3-8ea7-f277232d4126" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance_f46f654b-0b00-48c7-b16e-ec95cb4e04e8" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5824bb70-0239-4a35-bcf7-a71d40685858" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e9833ae6-7aa9-46f3-8ea7-f277232d4126" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5824bb70-0239-4a35-bcf7-a71d40685858" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_f2bb33e5-9aab-41c2-bbed-ab5735289a8c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5824bb70-0239-4a35-bcf7-a71d40685858" xlink:to="loc_srt_RangeAxis_f2bb33e5-9aab-41c2-bbed-ab5735289a8c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f2bb33e5-9aab-41c2-bbed-ab5735289a8c_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_f2bb33e5-9aab-41c2-bbed-ab5735289a8c" xlink:to="loc_srt_RangeMember_f2bb33e5-9aab-41c2-bbed-ab5735289a8c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_93a2c665-8545-4e21-b770-b04934b00238" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_f2bb33e5-9aab-41c2-bbed-ab5735289a8c" xlink:to="loc_srt_RangeMember_93a2c665-8545-4e21-b770-b04934b00238" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_7014452e-7969-46d7-8bb9-4de94b02d1d5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_93a2c665-8545-4e21-b770-b04934b00238" xlink:to="loc_srt_MinimumMember_7014452e-7969-46d7-8bb9-4de94b02d1d5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_3ebb70d1-8447-4e01-979a-38453570edda" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_93a2c665-8545-4e21-b770-b04934b00238" xlink:to="loc_srt_MaximumMember_3ebb70d1-8447-4e01-979a-38453570edda" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_3f5a6996-4d33-48d1-a8ed-5d6526126e45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5824bb70-0239-4a35-bcf7-a71d40685858" xlink:to="loc_us-gaap_AwardTypeAxis_3f5a6996-4d33-48d1-a8ed-5d6526126e45" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3f5a6996-4d33-48d1-a8ed-5d6526126e45_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_3f5a6996-4d33-48d1-a8ed-5d6526126e45" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3f5a6996-4d33-48d1-a8ed-5d6526126e45_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ef33fe65-fd5e-455d-b1c6-2c89faa3b79c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_3f5a6996-4d33-48d1-a8ed-5d6526126e45" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ef33fe65-fd5e-455d-b1c6-2c89faa3b79c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_99ba6375-bc20-417b-a341-626f9a5f0249" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ef33fe65-fd5e-455d-b1c6-2c89faa3b79c" xlink:to="loc_us-gaap_RestrictedStockMember_99ba6375-bc20-417b-a341-626f9a5f0249" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FutureServiceMember_5143d1f2-dca5-4461-937e-5869cacefd95" xlink:href="rdnt-20221231.xsd#rdnt_FutureServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ef33fe65-fd5e-455d-b1c6-2c89faa3b79c" xlink:to="loc_rdnt_FutureServiceMember_5143d1f2-dca5-4461-937e-5869cacefd95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_ee9f0501-e086-4aee-99cc-ed75e53b0957" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ef33fe65-fd5e-455d-b1c6-2c89faa3b79c" xlink:to="loc_us-gaap_EmployeeStockOptionMember_ee9f0501-e086-4aee-99cc-ed75e53b0957" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PerformanceBasedStockOptionsMember_7ee15a09-f224-4c10-bcf5-fa28beca7410" xlink:href="rdnt-20221231.xsd#rdnt_PerformanceBasedStockOptionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ef33fe65-fd5e-455d-b1c6-2c89faa3b79c" xlink:to="loc_rdnt_PerformanceBasedStockOptionsMember_7ee15a09-f224-4c10-bcf5-fa28beca7410" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LongTermIncentivePlanSharesMember_ab436e1d-1b5e-484c-9a4b-24a1b4a123bf" xlink:href="rdnt-20221231.xsd#rdnt_LongTermIncentivePlanSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ef33fe65-fd5e-455d-b1c6-2c89faa3b79c" xlink:to="loc_rdnt_LongTermIncentivePlanSharesMember_ab436e1d-1b5e-484c-9a4b-24a1b4a123bf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_2f563914-5cc2-49c3-8a0b-f6237e2a78bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5824bb70-0239-4a35-bcf7-a71d40685858" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_2f563914-5cc2-49c3-8a0b-f6237e2a78bc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2f563914-5cc2-49c3-8a0b-f6237e2a78bc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_2f563914-5cc2-49c3-8a0b-f6237e2a78bc" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2f563914-5cc2-49c3-8a0b-f6237e2a78bc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_22ec9d76-a3bb-4897-9b8f-33e4a15d274f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_2f563914-5cc2-49c3-8a0b-f6237e2a78bc" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_22ec9d76-a3bb-4897-9b8f-33e4a15d274f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeepHealthIncMember_05db526a-55ab-4f4d-a16d-9d29cacde497" xlink:href="rdnt-20221231.xsd#rdnt_DeepHealthIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_22ec9d76-a3bb-4897-9b8f-33e4a15d274f" xlink:to="loc_rdnt_DeepHealthIncMember_05db526a-55ab-4f4d-a16d-9d29cacde497" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_d953199f-a2b5-42e6-820e-beefcb591553" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5824bb70-0239-4a35-bcf7-a71d40685858" xlink:to="loc_us-gaap_PlanNameAxis_d953199f-a2b5-42e6-820e-beefcb591553" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_d953199f-a2b5-42e6-820e-beefcb591553_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_d953199f-a2b5-42e6-820e-beefcb591553" xlink:to="loc_us-gaap_PlanNameDomain_d953199f-a2b5-42e6-820e-beefcb591553_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_a2d104a0-1175-48fe-83bc-d3c148a729f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_d953199f-a2b5-42e6-820e-beefcb591553" xlink:to="loc_us-gaap_PlanNameDomain_a2d104a0-1175-48fe-83bc-d3c148a729f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedPlanMember_5c94ca10-70d0-4115-8250-908d26ac4f94" xlink:href="rdnt-20221231.xsd#rdnt_RestatedPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_a2d104a0-1175-48fe-83bc-d3c148a729f3" xlink:to="loc_rdnt_RestatedPlanMember_5c94ca10-70d0-4115-8250-908d26ac4f94" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants" xlink:type="simple" xlink:href="rdnt-20221231.xsd#STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants" xlink:type="extended" id="ie5daf1de7eb34b0888eb77c7207ee3f3_STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f3776189-a637-4b8d-a344-010b204e29d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0917c9c0-e70a-4561-8fc8-68d66ecf6329" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f3776189-a637-4b8d-a344-010b204e29d9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0917c9c0-e70a-4561-8fc8-68d66ecf6329" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_8e37d18d-e6b5-44f1-9e4b-d8826b53ca12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0917c9c0-e70a-4561-8fc8-68d66ecf6329" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_8e37d18d-e6b5-44f1-9e4b-d8826b53ca12" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_fc2141e4-89b9-4174-8181-2332d3a6c22e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0917c9c0-e70a-4561-8fc8-68d66ecf6329" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_fc2141e4-89b9-4174-8181-2332d3a6c22e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_18b3abab-a8ef-4f96-854a-b3abe2612ffb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0917c9c0-e70a-4561-8fc8-68d66ecf6329" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_18b3abab-a8ef-4f96-854a-b3abe2612ffb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0a7d4d89-1882-40d7-975e-28454421ad88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_16f58fc7-db43-4281-9f83-326c9c6e8161" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f3776189-a637-4b8d-a344-010b204e29d9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_16f58fc7-db43-4281-9f83-326c9c6e8161" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_624728ea-a112-4fd8-94e7-ddb363d7fa45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f3776189-a637-4b8d-a344-010b204e29d9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_624728ea-a112-4fd8-94e7-ddb363d7fa45" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_937fe78d-0ce6-420e-81a2-913e707b777a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_624728ea-a112-4fd8-94e7-ddb363d7fa45" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_937fe78d-0ce6-420e-81a2-913e707b777a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_e0822f16-6cee-4d33-9c85-4103b5375dfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_624728ea-a112-4fd8-94e7-ddb363d7fa45" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_e0822f16-6cee-4d33-9c85-4103b5375dfc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c3dabcaa-6b44-4560-9402-1d2d9d604143" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_624728ea-a112-4fd8-94e7-ddb363d7fa45" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c3dabcaa-6b44-4560-9402-1d2d9d604143" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_cc5c3c1f-627b-43e5-bf4d-1b2531cf118d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_186775e1-aa33-4560-84be-99d390839723" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f3776189-a637-4b8d-a344-010b204e29d9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_186775e1-aa33-4560-84be-99d390839723" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WeightedAverageRemainingContractualLife_4c9db36b-3e4a-4e3e-9fa0-ab0e91c2a9ff" xlink:href="rdnt-20221231.xsd#rdnt_WeightedAverageRemainingContractualLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f3776189-a637-4b8d-a344-010b204e29d9" xlink:to="loc_rdnt_WeightedAverageRemainingContractualLife_4c9db36b-3e4a-4e3e-9fa0-ab0e91c2a9ff" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_7740cc92-08e0-4b6a-91cb-b83180745b66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_WeightedAverageRemainingContractualLife_4c9db36b-3e4a-4e3e-9fa0-ab0e91c2a9ff" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_7740cc92-08e0-4b6a-91cb-b83180745b66" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_473b2097-1b7f-4992-bf30-02b7073d6c48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_WeightedAverageRemainingContractualLife_4c9db36b-3e4a-4e3e-9fa0-ab0e91c2a9ff" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_473b2097-1b7f-4992-bf30-02b7073d6c48" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AggregateIntrinsicValue_a7fe2cc5-c3c8-4d6e-98b1-dfa3359fffc3" xlink:href="rdnt-20221231.xsd#rdnt_AggregateIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f3776189-a637-4b8d-a344-010b204e29d9" xlink:to="loc_rdnt_AggregateIntrinsicValue_a7fe2cc5-c3c8-4d6e-98b1-dfa3359fffc3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_90dd7865-972a-41f6-87e4-42e9482c931a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_AggregateIntrinsicValue_a7fe2cc5-c3c8-4d6e-98b1-dfa3359fffc3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_90dd7865-972a-41f6-87e4-42e9482c931a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_67d0c235-b521-4741-ad41-ae431120c548" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_AggregateIntrinsicValue_a7fe2cc5-c3c8-4d6e-98b1-dfa3359fffc3" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_67d0c235-b521-4741-ad41-ae431120c548" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f2181152-fe6d-4471-8233-c575c8a4d009" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f3776189-a637-4b8d-a344-010b204e29d9" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f2181152-fe6d-4471-8233-c575c8a4d009" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_4ddddd30-fad9-4fa5-82f8-85a6e1007c1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f2181152-fe6d-4471-8233-c575c8a4d009" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_4ddddd30-fad9-4fa5-82f8-85a6e1007c1b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4ddddd30-fad9-4fa5-82f8-85a6e1007c1b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_4ddddd30-fad9-4fa5-82f8-85a6e1007c1b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4ddddd30-fad9-4fa5-82f8-85a6e1007c1b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fe3cebc3-6394-4078-b9ea-6ca2078ed4f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_4ddddd30-fad9-4fa5-82f8-85a6e1007c1b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fe3cebc3-6394-4078-b9ea-6ca2078ed4f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeepHealthIncMember_9e76abef-7392-47e4-95d7-ad7f00bd3cc7" xlink:href="rdnt-20221231.xsd#rdnt_DeepHealthIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fe3cebc3-6394-4078-b9ea-6ca2078ed4f2" xlink:to="loc_rdnt_DeepHealthIncMember_9e76abef-7392-47e4-95d7-ad7f00bd3cc7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_f2fd8edb-ba4b-4fe7-a58f-98b91f384ce5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f2181152-fe6d-4471-8233-c575c8a4d009" xlink:to="loc_us-gaap_AwardTypeAxis_f2fd8edb-ba4b-4fe7-a58f-98b91f384ce5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f2fd8edb-ba4b-4fe7-a58f-98b91f384ce5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_f2fd8edb-ba4b-4fe7-a58f-98b91f384ce5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f2fd8edb-ba4b-4fe7-a58f-98b91f384ce5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e3ce9376-4172-486b-91e1-8104ee18f861" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_f2fd8edb-ba4b-4fe7-a58f-98b91f384ce5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e3ce9376-4172-486b-91e1-8104ee18f861" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember_942d72d0-43af-4bb1-9750-7e11869d9b61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e3ce9376-4172-486b-91e1-8104ee18f861" xlink:to="loc_us-gaap_StockOptionMember_942d72d0-43af-4bb1-9750-7e11869d9b61" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUsandLTIPs" xlink:type="simple" xlink:href="rdnt-20221231.xsd#STOCKBASEDCOMPENSATIONDetailsRSUsandLTIPs"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUsandLTIPs" xlink:type="extended" id="i9f8d23994fa74947bcb213ec7dea7cb2_STOCKBASEDCOMPENSATIONDetailsRSUsandLTIPs">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c8638450-2919-4819-8371-36b4d657dbbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_18bd7825-4eba-4256-adfb-54e76a2ee486" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c8638450-2919-4819-8371-36b4d657dbbd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_18bd7825-4eba-4256-adfb-54e76a2ee486" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_6344ba72-200c-449e-a222-754425c05394" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_18bd7825-4eba-4256-adfb-54e76a2ee486" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_6344ba72-200c-449e-a222-754425c05394" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c14bbd56-d786-4d6d-9c7c-232977cbc408" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_18bd7825-4eba-4256-adfb-54e76a2ee486" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c14bbd56-d786-4d6d-9c7c-232977cbc408" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_20cddeeb-ce01-41ca-a0ea-2610df8c9516" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_18bd7825-4eba-4256-adfb-54e76a2ee486" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_20cddeeb-ce01-41ca-a0ea-2610df8c9516" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_d2c4f967-5c93-416d-bbff-02cbceda808c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_18bd7825-4eba-4256-adfb-54e76a2ee486" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_d2c4f967-5c93-416d-bbff-02cbceda808c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_5477013a-c402-451a-a634-97817f2860b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_f7fcac7b-d01f-415f-a7d6-4cd12c0edaea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c8638450-2919-4819-8371-36b4d657dbbd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_f7fcac7b-d01f-415f-a7d6-4cd12c0edaea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0c3e22f4-e794-4126-b2d5-5e87ae295d6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c8638450-2919-4819-8371-36b4d657dbbd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0c3e22f4-e794-4126-b2d5-5e87ae295d6f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_68d2cc15-4b19-4232-a17d-d40c5b4efb64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0c3e22f4-e794-4126-b2d5-5e87ae295d6f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_68d2cc15-4b19-4232-a17d-d40c5b4efb64" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_d0e1dee8-095e-4316-998a-36c718543db9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0c3e22f4-e794-4126-b2d5-5e87ae295d6f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_d0e1dee8-095e-4316-998a-36c718543db9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_abb38109-96da-414e-a8c2-705b7855071f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0c3e22f4-e794-4126-b2d5-5e87ae295d6f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_abb38109-96da-414e-a8c2-705b7855071f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_fc941bf1-d12d-4803-a887-012111cda136" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0c3e22f4-e794-4126-b2d5-5e87ae295d6f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_fc941bf1-d12d-4803-a887-012111cda136" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_dee671a9-8449-4ffd-99b9-7bc1a9cc558f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches_f324b71b-e6be-431f-a3b0-a676a75a84bc" xlink:href="rdnt-20221231.xsd#rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c8638450-2919-4819-8371-36b4d657dbbd" xlink:to="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches_f324b71b-e6be-431f-a3b0-a676a75a84bc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_51232bcf-a4be-40c5-981a-4eb254fd832b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c8638450-2919-4819-8371-36b4d657dbbd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_51232bcf-a4be-40c5-981a-4eb254fd832b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_ac0154f4-d92d-4ec1-99c7-25c9cb8cbbdd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c8638450-2919-4819-8371-36b4d657dbbd" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_ac0154f4-d92d-4ec1-99c7-25c9cb8cbbdd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_1fbc4e90-8ce6-4bcf-b510-b1335eee0455" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c8638450-2919-4819-8371-36b4d657dbbd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_1fbc4e90-8ce6-4bcf-b510-b1335eee0455" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_bed83a72-ae25-45d0-8063-000489f7e228" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c8638450-2919-4819-8371-36b4d657dbbd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_bed83a72-ae25-45d0-8063-000489f7e228" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod_f2e9c4c4-4705-4803-996b-567f7012a387" xlink:href="rdnt-20221231.xsd#rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c8638450-2919-4819-8371-36b4d657dbbd" xlink:to="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod_f2e9c4c4-4705-4803-996b-567f7012a387" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue_faa508bc-9311-4770-9572-805c81c02967" xlink:href="rdnt-20221231.xsd#rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c8638450-2919-4819-8371-36b4d657dbbd" xlink:to="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue_faa508bc-9311-4770-9572-805c81c02967" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_055344a3-9ada-4160-bfbf-467a8b47b711" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c8638450-2919-4819-8371-36b4d657dbbd" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_055344a3-9ada-4160-bfbf-467a8b47b711" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_d9f8f3d4-8856-4d06-b590-a43dd92dd412" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_055344a3-9ada-4160-bfbf-467a8b47b711" xlink:to="loc_us-gaap_AwardTypeAxis_d9f8f3d4-8856-4d06-b590-a43dd92dd412" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d9f8f3d4-8856-4d06-b590-a43dd92dd412_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_d9f8f3d4-8856-4d06-b590-a43dd92dd412" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d9f8f3d4-8856-4d06-b590-a43dd92dd412_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_628e50c5-48a2-4399-a86b-0bbe80d045c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_d9f8f3d4-8856-4d06-b590-a43dd92dd412" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_628e50c5-48a2-4399-a86b-0bbe80d045c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_0d2781fa-bca6-455d-87fe-f703ca71db65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_628e50c5-48a2-4399-a86b-0bbe80d045c3" xlink:to="loc_us-gaap_RestrictedStockMember_0d2781fa-bca6-455d-87fe-f703ca71db65" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PerformanceBasedStockUnitsMember_65872d25-56b9-44cf-a4b1-64c7f6c42aad" xlink:href="rdnt-20221231.xsd#rdnt_PerformanceBasedStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_628e50c5-48a2-4399-a86b-0bbe80d045c3" xlink:to="loc_rdnt_PerformanceBasedStockUnitsMember_65872d25-56b9-44cf-a4b1-64c7f6c42aad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PerformanceBasedStockOptionsMember_0addf653-14ad-4f6e-bfb2-760d50f4a9c8" xlink:href="rdnt-20221231.xsd#rdnt_PerformanceBasedStockOptionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_628e50c5-48a2-4399-a86b-0bbe80d045c3" xlink:to="loc_rdnt_PerformanceBasedStockOptionsMember_0addf653-14ad-4f6e-bfb2-760d50f4a9c8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LongTermIncentivePlanSharesMember_5bbefbe4-ead4-4cac-863f-04ef28afc976" xlink:href="rdnt-20221231.xsd#rdnt_LongTermIncentivePlanSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_628e50c5-48a2-4399-a86b-0bbe80d045c3" xlink:to="loc_rdnt_LongTermIncentivePlanSharesMember_5bbefbe4-ead4-4cac-863f-04ef28afc976" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_875e5b9c-2dd5-4377-a9e8-bc35d6d46232" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_055344a3-9ada-4160-bfbf-467a8b47b711" xlink:to="loc_srt_RangeAxis_875e5b9c-2dd5-4377-a9e8-bc35d6d46232" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_875e5b9c-2dd5-4377-a9e8-bc35d6d46232_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_875e5b9c-2dd5-4377-a9e8-bc35d6d46232" xlink:to="loc_srt_RangeMember_875e5b9c-2dd5-4377-a9e8-bc35d6d46232_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a4cca480-4c40-4800-be9e-58d375252e41" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_875e5b9c-2dd5-4377-a9e8-bc35d6d46232" xlink:to="loc_srt_RangeMember_a4cca480-4c40-4800-be9e-58d375252e41" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_520f3c14-8886-4b23-90ba-a6f0622afc4b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_a4cca480-4c40-4800-be9e-58d375252e41" xlink:to="loc_srt_MinimumMember_520f3c14-8886-4b23-90ba-a6f0622afc4b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_d3ce2d80-40bc-443b-842a-2ae71645f3ea" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_a4cca480-4c40-4800-be9e-58d375252e41" xlink:to="loc_srt_MaximumMember_d3ce2d80-40bc-443b-842a-2ae71645f3ea" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PropertyPlantAndEquipmentNetIncludingRightOfUseAssets_84404959-464d-4b7d-b7bf-0192ae75e309" xlink:href="rdnt-20221231.xsd#rdnt_PropertyPlantAndEquipmentNetIncludingRightOfUseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="loc_rdnt_PropertyPlantAndEquipmentNetIncludingRightOfUseAssets_84404959-464d-4b7d-b7bf-0192ae75e309" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnTerminationOfLease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnTerminationOfLease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="loc_us-gaap_GainLossOnTerminationOfLease" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="loc_us-gaap_InterestExpenseDebt" xlink:type="arc" order="2"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>12
<FILENAME>rdnt-20221231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:ee66d8ee-1013-4282-8e3e-c307b1c04f3f,g:1b6e48fd-cb3e-498b-b299-6015491264f8-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_d3dc7a58-3510-4cad-b9d1-2d3c25c91efa_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_FirstLienCreditAgreementSeventhAmendmentMember_c10bc6df-87ab-4477-a9c2-0aa2f774f809_terseLabel_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementSeventhAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment No. 7 First Lien Credit Agreement</link:label>
    <link:label id="lab_rdnt_FirstLienCreditAgreementSeventhAmendmentMember_label_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementSeventhAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Credit Agreement Seventh Amendment [Member]</link:label>
    <link:label id="lab_rdnt_FirstLienCreditAgreementSeventhAmendmentMember_documentation_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementSeventhAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Credit Agreement Seventh Amendment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementSeventhAmendmentMember" xlink:href="rdnt-20221231.xsd#rdnt_FirstLienCreditAgreementSeventhAmendmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_FirstLienCreditAgreementSeventhAmendmentMember" xlink:to="lab_rdnt_FirstLienCreditAgreementSeventhAmendmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PricingLevelIIMember_3cdd327b-bae4-447d-9e33-881a08c69fd7_terseLabel_en-US" xlink:label="lab_rdnt_PricingLevelIIMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level II</link:label>
    <link:label id="lab_rdnt_PricingLevelIIMember_label_en-US" xlink:label="lab_rdnt_PricingLevelIIMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level II [Member]</link:label>
    <link:label id="lab_rdnt_PricingLevelIIMember_documentation_en-US" xlink:label="lab_rdnt_PricingLevelIIMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level II [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIIMember" xlink:href="rdnt-20221231.xsd#rdnt_PricingLevelIIMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PricingLevelIIMember" xlink:to="lab_rdnt_PricingLevelIIMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod_683c26e1-0dda-4b89-84e9-be9dd64aeda1_terseLabel_en-US" xlink:label="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combination, contingent consideration, liability, period</link:label>
    <link:label id="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod_label_en-US" xlink:label="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Period</link:label>
    <link:label id="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod_documentation_en-US" xlink:label="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod" xlink:href="rdnt-20221231.xsd#rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod" xlink:to="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_2edfd80c-7a8e-4d9a-8093-47a22f17fd5d_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign current tax</link:label>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_24161010-fc06-4d3f-af92-ab037bb780d5_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FOREIGN CURRENCY TRANSLATION</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_JointVentureInterestMember_33000a36-da2b-4d42-8886-96c6eeca1669_terseLabel_en-US" xlink:label="lab_rdnt_JointVentureInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint Venture Interest</link:label>
    <link:label id="lab_rdnt_JointVentureInterestMember_label_en-US" xlink:label="lab_rdnt_JointVentureInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint Venture Interest [Member]</link:label>
    <link:label id="lab_rdnt_JointVentureInterestMember_documentation_en-US" xlink:label="lab_rdnt_JointVentureInterestMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint Venture Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_JointVentureInterestMember" xlink:href="rdnt-20221231.xsd#rdnt_JointVentureInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_JointVentureInterestMember" xlink:to="lab_rdnt_JointVentureInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_MedicalMalpracticeDeductiblePerIncidence_f060ae93-21be-47fa-abd8-38bc1f7c24ab_terseLabel_en-US" xlink:label="lab_rdnt_MedicalMalpracticeDeductiblePerIncidence" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical malpractice deductible per incidence</link:label>
    <link:label id="lab_rdnt_MedicalMalpracticeDeductiblePerIncidence_label_en-US" xlink:label="lab_rdnt_MedicalMalpracticeDeductiblePerIncidence" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Malpractice Deductible Per Incidence</link:label>
    <link:label id="lab_rdnt_MedicalMalpracticeDeductiblePerIncidence_documentation_en-US" xlink:label="lab_rdnt_MedicalMalpracticeDeductiblePerIncidence" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Malpractice Deductible Per Incidence</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MedicalMalpracticeDeductiblePerIncidence" xlink:href="rdnt-20221231.xsd#rdnt_MedicalMalpracticeDeductiblePerIncidence"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_MedicalMalpracticeDeductiblePerIncidence" xlink:to="lab_rdnt_MedicalMalpracticeDeductiblePerIncidence" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_5bf61492-4b51-4e85-aebd-f70e666e25aa_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets, net</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_8a340e3d-e36b-41fd-8e92-0907fc725fb6_totalLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total notes payable obligations</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_8c7e64a2-76cc-42a2-9c1d-d8a1ba8f9588_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment, net</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_ce3d87c3-d14b-4f79-a737-6c4d3c89cf75_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State current tax</link:label>
    <link:label id="lab_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_label_en-US" xlink:label="lab_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Income Tax Expense (Benefit), Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:to="lab_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_822be44e-5cd5-4515-81f4-f6acbc05fc72_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_MidDelawareImagingPAMember_dad0d5c8-dcfb-48c7-8432-128b614fbaca_terseLabel_en-US" xlink:label="lab_rdnt_MidDelawareImagingPAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mid Delaware Imaging P.A.</link:label>
    <link:label id="lab_rdnt_MidDelawareImagingPAMember_label_en-US" xlink:label="lab_rdnt_MidDelawareImagingPAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mid Delaware Imaging P.A. [Member]</link:label>
    <link:label id="lab_rdnt_MidDelawareImagingPAMember_documentation_en-US" xlink:label="lab_rdnt_MidDelawareImagingPAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mid Delaware Imaging P.A.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MidDelawareImagingPAMember" xlink:href="rdnt-20221231.xsd#rdnt_MidDelawareImagingPAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_MidDelawareImagingPAMember" xlink:to="lab_rdnt_MidDelawareImagingPAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_a8689778-6e4d-4a83-8589-841444183d2b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_60a9aace-41e9-4326-bf56-c64578d08d01_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_df1e2aff-0eb1-4f33-842c-374a8b7a1a1d_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease debt</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_e2d00155-c3f8-4247-a870-cfa1472c0911_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Agreement and First Lien Term Loans</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GovernmentAssistanceAmountCumulative_f177d90e-56e9-4e28-86b3-de19f284d79e_terseLabel_en-US" xlink:label="lab_us-gaap_GovernmentAssistanceAmountCumulative" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount in deferred revenue</link:label>
    <link:label id="lab_us-gaap_GovernmentAssistanceAmountCumulative_label_en-US" xlink:label="lab_us-gaap_GovernmentAssistanceAmountCumulative" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Assistance, Amount, Cumulative</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GovernmentAssistanceAmountCumulative" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GovernmentAssistanceAmountCumulative"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GovernmentAssistanceAmountCumulative" xlink:to="lab_us-gaap_GovernmentAssistanceAmountCumulative" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ZP907NorthernLLCMember_ef6e716f-a028-4124-9ff7-c865600ff876_terseLabel_en-US" xlink:label="lab_rdnt_ZP907NorthernLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZP 907 Northern LLC</link:label>
    <link:label id="lab_rdnt_ZP907NorthernLLCMember_label_en-US" xlink:label="lab_rdnt_ZP907NorthernLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZP 907 Northern LLC [Member]</link:label>
    <link:label id="lab_rdnt_ZP907NorthernLLCMember_documentation_en-US" xlink:label="lab_rdnt_ZP907NorthernLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZP 907 Northern LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ZP907NorthernLLCMember" xlink:href="rdnt-20221231.xsd#rdnt_ZP907NorthernLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ZP907NorthernLLCMember" xlink:to="lab_rdnt_ZP907NorthernLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_a070ebff-7b3d-459f-a5ea-32b6d3a61e07_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Separately Recognized Transactions [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Separately Recognized Transactions [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:to="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_b83d7ae3-c505-4293-85f6-1cc35a449e8b_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in-capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeApproachValuationTechniqueMember_58144aaf-9718-4af1-b6af-e65994878366_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeApproachValuationTechniqueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation, Income Approach</link:label>
    <link:label id="lab_us-gaap_IncomeApproachValuationTechniqueMember_label_en-US" xlink:label="lab_us-gaap_IncomeApproachValuationTechniqueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation, Income Approach [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeApproachValuationTechniqueMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeApproachValuationTechniqueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeApproachValuationTechniqueMember" xlink:to="lab_us-gaap_IncomeApproachValuationTechniqueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_52bcb4bc-ad4f-41f4-a533-1f4c7ba5db70_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_03140cd3-ec91-488e-b718-12f1de2b5e1b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis spread on variable rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_2432ca6a-18ed-4f05-b84b-bb89095c6d90_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_e399ca18-05ad-4ace-b46d-1d174d1c7df4_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of stock upon exercise of options (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_ceee3581-e00d-4a4c-a4fb-6e0ec6d71216_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PerformanceBasedStockOptionsMember_78a228aa-2991-4fd6-a9a6-912ef862841d_terseLabel_en-US" xlink:label="lab_rdnt_PerformanceBasedStockOptionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Based Stock Options</link:label>
    <link:label id="lab_rdnt_PerformanceBasedStockOptionsMember_label_en-US" xlink:label="lab_rdnt_PerformanceBasedStockOptionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Based Stock Options [Member]</link:label>
    <link:label id="lab_rdnt_PerformanceBasedStockOptionsMember_documentation_en-US" xlink:label="lab_rdnt_PerformanceBasedStockOptionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Based Stock Options</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PerformanceBasedStockOptionsMember" xlink:href="rdnt-20221231.xsd#rdnt_PerformanceBasedStockOptionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PerformanceBasedStockOptionsMember" xlink:to="lab_rdnt_PerformanceBasedStockOptionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_f0e08bed-d93d-4011-9158-3c9adc3e147e_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Deferred Tax (Liability) Asset</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_5f973627-11d6-479d-89c6-705e71732ced_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_c46d913d-8aa3-4bb8-8f1f-e041c49f326d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationTechniqueAxis_86e541ae-91c9-4a9e-91b3-f6455f73dbe8_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Axis]</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueAxis_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueAxis" xlink:to="lab_us-gaap_ValuationTechniqueAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock_e82a33b5-b55e-4a0e-a3b8-48b651feefeb_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EQUITY BASED COMPENSATION</link:label>
    <link:label id="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Related Costs, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:to="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_d7213193-4a7b-45c1-92e4-92f002a79e08_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of stock for acquisitions (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_07ab7fa1-32bc-44a6-933a-b68ec94ab56b_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_f49fd1da-70a5-4751-afe1-517e380c0f34_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain" xlink:to="lab_us-gaap_MeasurementInputTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_e2b3d39e-975a-4f4e-aa14-6207880e2622_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_6cb0c39c-26ad-4769-a19a-4566bf7d17ec_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares for which the exercise price exceeds average market price of common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_cef41a8f-f410-4265-8f06-fb2305caab2c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0251dea7-95b3-4b13-a547-513350a4da9f_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfDeferredHedgeGains_714e6ede-37fd-44d7-b79f-c23f9529e1da_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfDeferredHedgeGains" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of cash flow hedge</link:label>
    <link:label id="lab_us-gaap_AmortizationOfDeferredHedgeGains_label_en-US" xlink:label="lab_us-gaap_AmortizationOfDeferredHedgeGains" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Deferred Hedge Gains</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDeferredHedgeGains" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfDeferredHedgeGains"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfDeferredHedgeGains" xlink:to="lab_us-gaap_AmortizationOfDeferredHedgeGains" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_b9cb3696-e884-4c4b-b999-c4517dc7fa3f_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_46c6a93d-7898-4bc9-8849-f8d2640ceb9c_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_TruistMember_65d2ea1a-d59d-4fdd-a8b1-81ff0da29a75_terseLabel_en-US" xlink:label="lab_rdnt_TruistMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Truist</link:label>
    <link:label id="lab_rdnt_TruistMember_label_en-US" xlink:label="lab_rdnt_TruistMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Truist [Member]</link:label>
    <link:label id="lab_rdnt_TruistMember_documentation_en-US" xlink:label="lab_rdnt_TruistMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Truist</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TruistMember" xlink:href="rdnt-20221231.xsd#rdnt_TruistMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_TruistMember" xlink:to="lab_rdnt_TruistMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_4f8f735f-4cf1-40db-9c50-840bdddac00c_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Discount Rate</link:label>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Discount Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:to="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseMember_d3de7a9b-3a7d-43d3-a8ad-f6e6b375a6e4_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseMember_label_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseMember" xlink:to="lab_us-gaap_InterestExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipAxis_ab8947d6-8dbc-4b7d-98a9-3076c452dc7e_terseLabel_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:label id="lab_srt_OwnershipAxis_label_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipAxis" xlink:to="lab_srt_OwnershipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_MedicalEquipmentMember_81fc8944-3066-4b63-bcb3-e30e6be6b819_terseLabel_en-US" xlink:label="lab_rdnt_MedicalEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Equipment</link:label>
    <link:label id="lab_rdnt_MedicalEquipmentMember_label_en-US" xlink:label="lab_rdnt_MedicalEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Equipment [Member]</link:label>
    <link:label id="lab_rdnt_MedicalEquipmentMember_documentation_en-US" xlink:label="lab_rdnt_MedicalEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MedicalEquipmentMember" xlink:href="rdnt-20221231.xsd#rdnt_MedicalEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_MedicalEquipmentMember" xlink:to="lab_rdnt_MedicalEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_24e15180-93f0-417f-9bfc-c6a8c3583ec5_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increases related to current year tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_c8e8b710-8906-474e-8347-6956ac946064_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_4c07aa7a-8fab-446a-aedb-69375553b79c_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation of leased equipment</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationTechniqueDomain_678a04f9-4ae6-432c-8787-60ff86089bd1_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Domain]</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueDomain_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueDomain" xlink:to="lab_us-gaap_ValuationTechniqueDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_Medicaid1Member_05496a83-1b18-4e69-8c1d-87a519b26f57_terseLabel_en-US" xlink:label="lab_rdnt_Medicaid1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid</link:label>
    <link:label id="lab_rdnt_Medicaid1Member_label_en-US" xlink:label="lab_rdnt_Medicaid1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid1 [Member]</link:label>
    <link:label id="lab_rdnt_Medicaid1Member_documentation_en-US" xlink:label="lab_rdnt_Medicaid1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_Medicaid1Member" xlink:href="rdnt-20221231.xsd#rdnt_Medicaid1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_Medicaid1Member" xlink:to="lab_rdnt_Medicaid1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_cbd4645e-5aac-422a-b1cf-65a5f41a09e7_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_29cd58c8-436f-48db-957b-2d8a9bd1e8aa_periodStartLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_40cd1c2b-4a52-4541-8a2b-664bfd871c13_periodEndLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_2cacd570-fe30-494e-aecb-e1f5d502000a_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_755b86ec-7262-4ca9-b49e-5c3c6aaa7d08_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FAIR VALUE MEASUREMENTS</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_IFRCLLCSubsidiaryOneMember_f8a52589-f638-4df0-bcb4-d29eb1b9f938_terseLabel_en-US" xlink:label="lab_rdnt_IFRCLLCSubsidiaryOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">I F R C L L C Subsidiary One</link:label>
    <link:label id="lab_rdnt_IFRCLLCSubsidiaryOneMember_label_en-US" xlink:label="lab_rdnt_IFRCLLCSubsidiaryOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">I F R C L L C Subsidiary One [Member]</link:label>
    <link:label id="lab_rdnt_IFRCLLCSubsidiaryOneMember_documentation_en-US" xlink:label="lab_rdnt_IFRCLLCSubsidiaryOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">I F R C L L C Subsidiary One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_IFRCLLCSubsidiaryOneMember" xlink:href="rdnt-20221231.xsd#rdnt_IFRCLLCSubsidiaryOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_IFRCLLCSubsidiaryOneMember" xlink:to="lab_rdnt_IFRCLLCSubsidiaryOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_RestatedAgreementMember_ef5a9d3d-76b3-4de6-863a-958e1b3afd38_terseLabel_en-US" xlink:label="lab_rdnt_RestatedAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restated Agreement</link:label>
    <link:label id="lab_rdnt_RestatedAgreementMember_label_en-US" xlink:label="lab_rdnt_RestatedAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restated Agreement [Member]</link:label>
    <link:label id="lab_rdnt_RestatedAgreementMember_documentation_en-US" xlink:label="lab_rdnt_RestatedAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restated Agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedAgreementMember" xlink:href="rdnt-20221231.xsd#rdnt_RestatedAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_RestatedAgreementMember" xlink:to="lab_rdnt_RestatedAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionSharePrice_de08eb7f-b3d9-470f-a391-e1caf2f1f987_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Price per share (dollars per share)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionSharePrice_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionSharePrice" xlink:to="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherExpensesAbstract_00a87c87-2562-44dc-873d-43fe5c97202c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OTHER INCOME AND EXPENSES</link:label>
    <link:label id="lab_us-gaap_OtherExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OtherExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherExpensesAbstract" xlink:to="lab_us-gaap_OtherExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_a1083d1b-48dd-40e0-9bc9-ffbd05cd9a14_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_CovenantNotToCompeteMember_8a32f25d-323a-4403-94bd-a0557f436cea_terseLabel_en-US" xlink:label="lab_rdnt_CovenantNotToCompeteMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covenant not to compete and other contracts</link:label>
    <link:label id="lab_rdnt_CovenantNotToCompeteMember_label_en-US" xlink:label="lab_rdnt_CovenantNotToCompeteMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covenant Not To Compete [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CovenantNotToCompeteMember" xlink:href="rdnt-20221231.xsd#rdnt_CovenantNotToCompeteMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_CovenantNotToCompeteMember" xlink:to="lab_rdnt_CovenantNotToCompeteMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_f20110e0-ebf3-46d8-8fff-aae85303dcf3_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DRTLLCMember_ffaa7535-0812-4b33-b4a1-5d1b2f3a67c6_terseLabel_en-US" xlink:label="lab_rdnt_DRTLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DRT LLC</link:label>
    <link:label id="lab_rdnt_DRTLLCMember_label_en-US" xlink:label="lab_rdnt_DRTLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DRT LLC [Member]</link:label>
    <link:label id="lab_rdnt_DRTLLCMember_documentation_en-US" xlink:label="lab_rdnt_DRTLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DRT LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DRTLLCMember" xlink:href="rdnt-20221231.xsd#rdnt_DRTLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DRTLLCMember" xlink:to="lab_rdnt_DRTLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrent_e687012d-3e0d-450a-8e32-5ed966f76e20_negatedLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrent" xlink:to="lab_us-gaap_LiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_fee4934d-d5dc-4fa6-959d-68c67276cd66_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total credit facilities outstanding</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_9301b1bd-39b7-401e-9a07-039e80c3ae06_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_HeartAndLungImagingLimitedMember_e469e82c-0d79-4407-aac5-aa37641ff8ba_terseLabel_en-US" xlink:label="lab_rdnt_HeartAndLungImagingLimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Heart and Lung Imaging Limited</link:label>
    <link:label id="lab_rdnt_HeartAndLungImagingLimitedMember_label_en-US" xlink:label="lab_rdnt_HeartAndLungImagingLimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Heart and Lung Imaging Limited [Member]</link:label>
    <link:label id="lab_rdnt_HeartAndLungImagingLimitedMember_documentation_en-US" xlink:label="lab_rdnt_HeartAndLungImagingLimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Heart and Lung Imaging Limited</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HeartAndLungImagingLimitedMember" xlink:href="rdnt-20221231.xsd#rdnt_HeartAndLungImagingLimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_HeartAndLungImagingLimitedMember" xlink:to="lab_rdnt_HeartAndLungImagingLimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_0cb6febd-8824-45f9-854a-49e6eb6841b3_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale to noncontrolling interests, net of taxes</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase from Sale of Parent Equity Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:to="lab_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_e44469f5-0906-4078-b0fd-2822914cdc28_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_MonthlyAmortizationOfDeferredHedgeGains_a7874d7c-ba36-4c05-bb62-638f9ca01bf4_terseLabel_en-US" xlink:label="lab_rdnt_MonthlyAmortizationOfDeferredHedgeGains" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Monthly amortization of deferred hedge gains</link:label>
    <link:label id="lab_rdnt_MonthlyAmortizationOfDeferredHedgeGains_label_en-US" xlink:label="lab_rdnt_MonthlyAmortizationOfDeferredHedgeGains" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Monthly Amortization Of Deferred Hedge Gains</link:label>
    <link:label id="lab_rdnt_MonthlyAmortizationOfDeferredHedgeGains_documentation_en-US" xlink:label="lab_rdnt_MonthlyAmortizationOfDeferredHedgeGains" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Monthly Amortization Of Deferred Hedge Gains</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MonthlyAmortizationOfDeferredHedgeGains" xlink:href="rdnt-20221231.xsd#rdnt_MonthlyAmortizationOfDeferredHedgeGains"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_MonthlyAmortizationOfDeferredHedgeGains" xlink:to="lab_rdnt_MonthlyAmortizationOfDeferredHedgeGains" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_57f63f37-f6d3-4aa1-914d-80bc8158a0cb_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_c8c19a5e-b8bf-4559-8e79-fa5fe4797279_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of operating lease liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_7ea6e57d-3f41-4c91-8d2d-c44beb23876e_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of operating lease liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ZPFreeportLLCMember_ac112ec4-96df-4a81-8d8b-dbddf8e7ad91_terseLabel_en-US" xlink:label="lab_rdnt_ZPFreeportLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZP Freeport LLC</link:label>
    <link:label id="lab_rdnt_ZPFreeportLLCMember_label_en-US" xlink:label="lab_rdnt_ZPFreeportLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZP Freeport LLC [Member]</link:label>
    <link:label id="lab_rdnt_ZPFreeportLLCMember_documentation_en-US" xlink:label="lab_rdnt_ZPFreeportLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZP Freeport LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ZPFreeportLLCMember" xlink:href="rdnt-20221231.xsd#rdnt_ZPFreeportLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ZPFreeportLLCMember" xlink:to="lab_rdnt_ZPFreeportLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_db3049ea-3e54-4581-8fb4-4ba0992a0f9a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other differences</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:to="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_956d2eef-3dc6-4a2b-a616-1b31a150aee4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneTwo_3e2cece5-e3c1-4656-b25d-49a0dd2633e0_terseLabel_en-US" xlink:label="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of FDA approval and payout, milestone two</link:label>
    <link:label id="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneTwo_label_en-US" xlink:label="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Percent Of FDA Approval And Payout, Milestone Two</link:label>
    <link:label id="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneTwo_documentation_en-US" xlink:label="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneTwo" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Percent Of FDA Approval And Payout, Milestone Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneTwo" xlink:href="rdnt-20221231.xsd#rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneTwo" xlink:to="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityAxis_9da8ce59-ed59-44e8-a656-85b311fef860_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lender Name [Axis]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lender Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis" xlink:to="lab_us-gaap_LineOfCreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_LeverageRatioAxis_4c2dfe06-57a8-4e3c-a937-d8dea6da1e54_terseLabel_en-US" xlink:label="lab_rdnt_LeverageRatioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio [Axis]</link:label>
    <link:label id="lab_rdnt_LeverageRatioAxis_label_en-US" xlink:label="lab_rdnt_LeverageRatioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio [Axis]</link:label>
    <link:label id="lab_rdnt_LeverageRatioAxis_documentation_en-US" xlink:label="lab_rdnt_LeverageRatioAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioAxis" xlink:href="rdnt-20221231.xsd#rdnt_LeverageRatioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_LeverageRatioAxis" xlink:to="lab_rdnt_LeverageRatioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_NoncontrollingInterestPercentOfOwnershipSold_cfe007bd-8f2b-4684-b4f4-6ebb85e85750_terseLabel_en-US" xlink:label="lab_rdnt_NoncontrollingInterestPercentOfOwnershipSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest, percent of ownership sold</link:label>
    <link:label id="lab_rdnt_NoncontrollingInterestPercentOfOwnershipSold_label_en-US" xlink:label="lab_rdnt_NoncontrollingInterestPercentOfOwnershipSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Percent Of Ownership Sold</link:label>
    <link:label id="lab_rdnt_NoncontrollingInterestPercentOfOwnershipSold_documentation_en-US" xlink:label="lab_rdnt_NoncontrollingInterestPercentOfOwnershipSold" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Percent Of Ownership Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NoncontrollingInterestPercentOfOwnershipSold" xlink:href="rdnt-20221231.xsd#rdnt_NoncontrollingInterestPercentOfOwnershipSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_NoncontrollingInterestPercentOfOwnershipSold" xlink:to="lab_rdnt_NoncontrollingInterestPercentOfOwnershipSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_26df9c8f-12c2-4396-8285-cf3d3d4751f9_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property &amp; Equipment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_0f4639fd-ab8e-406d-8676-53132df0ccd4_netLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_697f22cb-6d21-40d4-8853-21e82c13cb86_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term portion debt obligations</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_8bd665d0-4076-4977-9674-4c83557af802_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Return to provision</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:to="lab_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1_1d8f1acd-b0ce-49f1-b42d-c427015e3134_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contributions</link:label>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1_label_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash or Part Noncash Acquisition, Value of Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1" xlink:to="lab_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_7bebd610-152c-4442-87cc-44883b6fc75a_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_5c55767e-48e3-4aff-b178-a13bd7557f50_terseLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BRMG and NY Groups accounts payable</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_WhiteRabbitaiIncMember_aa97c18d-be07-409a-a457-82e7041f6f5c_terseLabel_en-US" xlink:label="lab_rdnt_WhiteRabbitaiIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">WhiteRabbit.ai Inc.</link:label>
    <link:label id="lab_rdnt_WhiteRabbitaiIncMember_label_en-US" xlink:label="lab_rdnt_WhiteRabbitaiIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">White Rabbit.ai Inc. [Member]</link:label>
    <link:label id="lab_rdnt_WhiteRabbitaiIncMember_documentation_en-US" xlink:label="lab_rdnt_WhiteRabbitaiIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">WhiteRabbit.ai Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WhiteRabbitaiIncMember" xlink:href="rdnt-20221231.xsd#rdnt_WhiteRabbitaiIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_WhiteRabbitaiIncMember" xlink:to="lab_rdnt_WhiteRabbitaiIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_a35fd0d2-2cea-4f9b-8784-8ee3fd67985b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases - years</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f750c668-0d7b-439d-98f6-91f83fa22427_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_454be506-a50e-4c91-92fd-2e32af346896_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement period and other adjustments</link:label>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_56fd6a6b-e274-4d87-83a7-57d67366aa06_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH FLOWS FROM INVESTING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue_2b731414-355d-4a1a-af2e-2237935deaf0_terseLabel_en-US" xlink:label="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award, Equity Instruments Other Than Options, Forfeited Or Cancelled Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award, Equity Instruments Other Than Options, Forfeited Or Cancelled Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue_documentation_en-US" xlink:label="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award, Equity Instruments Other Than Options, Forfeited Or Cancelled Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue" xlink:href="rdnt-20221231.xsd#rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue" xlink:to="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_37ed4a99-c5ff-4a8e-8718-8bf87feff47e_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_cb43e054-8fcc-42ad-8e9f-d8f61f9955ca_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_e1ab2c77-d4d3-4cb1-91e1-e8882bd4f2eb_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_137c5aac-7b8c-4826-a6d7-31247dd620b6_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SOFTWARE REVENUE RECOGNITION</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_e1d3d2d1-e5da-4848-bfe6-bb0a6e6a8519_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements and Changes in Accounting Principles [Abstract]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_988fc387-3f92-4f8c-9880-7f873c48ff9d_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_ba1a75fd-b0ac-4bd4-b7d8-0a39b7209a24_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise price Per Common Share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_2283f752-3ae3-4123-9b94-bf181a51e49e_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate</link:label>
    <link:label id="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_label_en-US" xlink:label="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:to="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_166d9b04-5531-4da6-b784-b25a7ccc6d0a_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PP&amp;E useful life</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_1d7ae442-2777-44d0-8885-ce41e53fbfc7_terseLabel_en-US" xlink:label="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customer [Line Items]</link:label>
    <link:label id="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_label_en-US" xlink:label="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customer [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_AcquisitionsAndAssetPurchasesMember_1433701c-486b-4957-9712-b706fe275db5_terseLabel_en-US" xlink:label="lab_rdnt_AcquisitionsAndAssetPurchasesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions And Asset Purchases</link:label>
    <link:label id="lab_rdnt_AcquisitionsAndAssetPurchasesMember_label_en-US" xlink:label="lab_rdnt_AcquisitionsAndAssetPurchasesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions And Asset Purchases [Member]</link:label>
    <link:label id="lab_rdnt_AcquisitionsAndAssetPurchasesMember_documentation_en-US" xlink:label="lab_rdnt_AcquisitionsAndAssetPurchasesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions And Asset Purchases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AcquisitionsAndAssetPurchasesMember" xlink:href="rdnt-20221231.xsd#rdnt_AcquisitionsAndAssetPurchasesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_AcquisitionsAndAssetPurchasesMember" xlink:to="lab_rdnt_AcquisitionsAndAssetPurchasesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_OperatingExpensesExcludingDepreciationAndAmortization_11e87b45-3600-428b-a84a-5e7bd903acfd_terseLabel_en-US" xlink:label="lab_rdnt_OperatingExpensesExcludingDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of operations, excluding depreciation and amortization</link:label>
    <link:label id="lab_rdnt_OperatingExpensesExcludingDepreciationAndAmortization_label_en-US" xlink:label="lab_rdnt_OperatingExpensesExcludingDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses, Excluding Depreciation And Amortization</link:label>
    <link:label id="lab_rdnt_OperatingExpensesExcludingDepreciationAndAmortization_documentation_en-US" xlink:label="lab_rdnt_OperatingExpensesExcludingDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses, Excluding Depreciation And Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OperatingExpensesExcludingDepreciationAndAmortization" xlink:href="rdnt-20221231.xsd#rdnt_OperatingExpensesExcludingDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_OperatingExpensesExcludingDepreciationAndAmortization" xlink:to="lab_rdnt_OperatingExpensesExcludingDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fc4478ca-e5a7-4787-b55e-79ab2a9c81db_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeveranceCosts1_0f27571c-9ee6-49c5-bc88-5336cd25ed14_terseLabel_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance costs</link:label>
    <link:label id="lab_us-gaap_SeveranceCosts1_e82c80bc-d3c5-4ad5-94d6-543841321fc8_verboseLabel_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance</link:label>
    <link:label id="lab_us-gaap_SeveranceCosts1_label_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeveranceCosts1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeveranceCosts1" xlink:to="lab_us-gaap_SeveranceCosts1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_aca9f961-cc4b-4bd8-b71b-401e3f99b211_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_ec38a75a-d9ec-4e8c-9388-f95e7111bb2e_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionAxis_a1b1313d-4660-444b-b780-76e340dc5471_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionAxis" xlink:to="lab_us-gaap_AssetAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_FrederickCountyRadiologyLLCMember_9f55ba5e-ae60-4f24-ba79-8a7ded5053cf_terseLabel_en-US" xlink:label="lab_rdnt_FrederickCountyRadiologyLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Frederick County Radiology, LLC</link:label>
    <link:label id="lab_rdnt_FrederickCountyRadiologyLLCMember_label_en-US" xlink:label="lab_rdnt_FrederickCountyRadiologyLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Frederick County Radiology, LLC [Member]</link:label>
    <link:label id="lab_rdnt_FrederickCountyRadiologyLLCMember_documentation_en-US" xlink:label="lab_rdnt_FrederickCountyRadiologyLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Frederick County Radiology, LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FrederickCountyRadiologyLLCMember" xlink:href="rdnt-20221231.xsd#rdnt_FrederickCountyRadiologyLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_FrederickCountyRadiologyLLCMember" xlink:to="lab_rdnt_FrederickCountyRadiologyLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireInterestInJointVenture_ed9ff9f0-6389-4d0c-93e6-70f33f487c28_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInterestInJointVenture" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity contributions in existing and purchase of interest in joint ventures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireInterestInJointVenture_0409908d-ba1d-4773-85ec-b27d36f6334a_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInterestInJointVenture" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to acquire additional interest in subsidiaries</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireInterestInJointVenture_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInterestInJointVenture" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Interest in Joint Venture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInJointVenture" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireInterestInJointVenture"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireInterestInJointVenture" xlink:to="lab_us-gaap_PaymentsToAcquireInterestInJointVenture" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_FinanceLeaseCost_9c176ea3-6ea3-4f2f-8d81-887e0aa85728_totalLabel_en-US" xlink:label="lab_rdnt_FinanceLeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total finance lease cost</link:label>
    <link:label id="lab_rdnt_FinanceLeaseCost_label_en-US" xlink:label="lab_rdnt_FinanceLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Cost</link:label>
    <link:label id="lab_rdnt_FinanceLeaseCost_documentation_en-US" xlink:label="lab_rdnt_FinanceLeaseCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FinanceLeaseCost" xlink:href="rdnt-20221231.xsd#rdnt_FinanceLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_FinanceLeaseCost" xlink:to="lab_rdnt_FinanceLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ContractsReceivableFactoringReceivable_6b0411a3-93e4-4f90-a9ed-625b0f1302f2_terseLabel_en-US" xlink:label="lab_rdnt_ContractsReceivableFactoringReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Factoring receivable</link:label>
    <link:label id="lab_rdnt_ContractsReceivableFactoringReceivable_label_en-US" xlink:label="lab_rdnt_ContractsReceivableFactoringReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contracts Receivable, Factoring Receivable</link:label>
    <link:label id="lab_rdnt_ContractsReceivableFactoringReceivable_documentation_en-US" xlink:label="lab_rdnt_ContractsReceivableFactoringReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contracts Receivable, Factoring Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ContractsReceivableFactoringReceivable" xlink:href="rdnt-20221231.xsd#rdnt_ContractsReceivableFactoringReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ContractsReceivableFactoringReceivable" xlink:to="lab_rdnt_ContractsReceivableFactoringReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_fb4bab3f-fc88-4c22-bdad-8f732290286c_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_f3122302-ae2a-4bfd-bb05-8ade9e092637_terseLabel_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software developed for internal use</link:label>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_label_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:to="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_October2023Member_d3e41fc6-ceeb-467c-b6f9-edfd2e7166c2_terseLabel_en-US" xlink:label="lab_rdnt_October2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 2023</link:label>
    <link:label id="lab_rdnt_October2023Member_label_en-US" xlink:label="lab_rdnt_October2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 2023 [Member]</link:label>
    <link:label id="lab_rdnt_October2023Member_documentation_en-US" xlink:label="lab_rdnt_October2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_October2023Member" xlink:href="rdnt-20221231.xsd#rdnt_October2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_October2023Member" xlink:to="lab_rdnt_October2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_NumberOfCentersContributed_38a94fed-d90a-4313-8062-ff34ecfa6b89_terseLabel_en-US" xlink:label="lab_rdnt_NumberOfCentersContributed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of centers contributed</link:label>
    <link:label id="lab_rdnt_NumberOfCentersContributed_label_en-US" xlink:label="lab_rdnt_NumberOfCentersContributed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Centers Contributed</link:label>
    <link:label id="lab_rdnt_NumberOfCentersContributed_documentation_en-US" xlink:label="lab_rdnt_NumberOfCentersContributed" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Centers Contributed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberOfCentersContributed" xlink:href="rdnt-20221231.xsd#rdnt_NumberOfCentersContributed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_NumberOfCentersContributed" xlink:to="lab_rdnt_NumberOfCentersContributed" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_748a676c-ca44-4306-987b-014ea2e9785e_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term liabilities assumed</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct_0d2d8616-e5a2-418f-8575-713bb4d97471_terseLabel_en-US" xlink:label="lab_rdnt_IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduction in deferred social security taxes</link:label>
    <link:label id="lab_rdnt_IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct_label_en-US" xlink:label="lab_rdnt_IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Social Security Tax, Employer, Deferral, CARES Act</link:label>
    <link:label id="lab_rdnt_IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct_documentation_en-US" xlink:label="lab_rdnt_IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Social Security Tax, Employer, Deferral, CARES Act</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct" xlink:href="rdnt-20221231.xsd#rdnt_IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct" xlink:to="lab_rdnt_IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_1c0e0cc3-5fc0-4f2c-8495-fa418aa333e6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_FutureServiceMember_41280e29-53dd-409f-90c6-9ad74e4d5618_terseLabel_en-US" xlink:label="lab_rdnt_FutureServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future Service</link:label>
    <link:label id="lab_rdnt_FutureServiceMember_label_en-US" xlink:label="lab_rdnt_FutureServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future Service [Member]</link:label>
    <link:label id="lab_rdnt_FutureServiceMember_documentation_en-US" xlink:label="lab_rdnt_FutureServiceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future Services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FutureServiceMember" xlink:href="rdnt-20221231.xsd#rdnt_FutureServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_FutureServiceMember" xlink:to="lab_rdnt_FutureServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_e7ed7ae3-b2f4-4a20-9498-be8472cc865a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessCombinationNumberOfSubsidiariesAcquired_57c34103-0058-4300-8294-62548baf5820_terseLabel_en-US" xlink:label="lab_rdnt_BusinessCombinationNumberOfSubsidiariesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of subsidiaries acquired</link:label>
    <link:label id="lab_rdnt_BusinessCombinationNumberOfSubsidiariesAcquired_label_en-US" xlink:label="lab_rdnt_BusinessCombinationNumberOfSubsidiariesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Number Of Subsidiaries Acquired</link:label>
    <link:label id="lab_rdnt_BusinessCombinationNumberOfSubsidiariesAcquired_documentation_en-US" xlink:label="lab_rdnt_BusinessCombinationNumberOfSubsidiariesAcquired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Number Of Subsidiaries Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationNumberOfSubsidiariesAcquired" xlink:href="rdnt-20221231.xsd#rdnt_BusinessCombinationNumberOfSubsidiariesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessCombinationNumberOfSubsidiariesAcquired" xlink:to="lab_rdnt_BusinessCombinationNumberOfSubsidiariesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_0b67d59f-4687-4856-9ca7-f3424b3f7d2a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_EffectiveIncomeTaxRateReconciliationPPPLoanAmount_f946a1cd-22dd-42bb-9175-9de5e249249d_terseLabel_en-US" xlink:label="lab_rdnt_EffectiveIncomeTaxRateReconciliationPPPLoanAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PPP Loan</link:label>
    <link:label id="lab_rdnt_EffectiveIncomeTaxRateReconciliationPPPLoanAmount_label_en-US" xlink:label="lab_rdnt_EffectiveIncomeTaxRateReconciliationPPPLoanAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, PPP Loan, Amount</link:label>
    <link:label id="lab_rdnt_EffectiveIncomeTaxRateReconciliationPPPLoanAmount_documentation_en-US" xlink:label="lab_rdnt_EffectiveIncomeTaxRateReconciliationPPPLoanAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, PPP Loan, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EffectiveIncomeTaxRateReconciliationPPPLoanAmount" xlink:href="rdnt-20221231.xsd#rdnt_EffectiveIncomeTaxRateReconciliationPPPLoanAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_EffectiveIncomeTaxRateReconciliationPPPLoanAmount" xlink:to="lab_rdnt_EffectiveIncomeTaxRateReconciliationPPPLoanAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_0762048e-2dc0-4db0-aa53-f58fb1b06f23_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PricingLevelIIIMember_2e966382-17cc-42cb-a97b-be8369c73a03_terseLabel_en-US" xlink:label="lab_rdnt_PricingLevelIIIMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level III</link:label>
    <link:label id="lab_rdnt_PricingLevelIIIMember_label_en-US" xlink:label="lab_rdnt_PricingLevelIIIMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level III [Member]</link:label>
    <link:label id="lab_rdnt_PricingLevelIIIMember_documentation_en-US" xlink:label="lab_rdnt_PricingLevelIIIMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level III [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIIIMember" xlink:href="rdnt-20221231.xsd#rdnt_PricingLevelIIIMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PricingLevelIIIMember" xlink:to="lab_rdnt_PricingLevelIIIMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_6d7e05a1-1cf3-48bb-aac9-88cd521662c6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less current portion</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_fa9dfe4d-d609-4bab-9612-2176c38e664f_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_1a35c550-e993-4919-a867-b401518e745c_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_06e36f04-c705-4125-9b24-4dd9ac8ec676_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeiture of restricted stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-Based Payment Arrangement, Forfeited</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebt_37c82549-0ee5-4631-b37c-326ad875ac88_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt" xlink:to="lab_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_7a692422-1d1c-402e-9a17-5f96170932f4_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity_2c54f967-bd5d-4628-9ebb-58e50a0df73d_terseLabel_en-US" xlink:label="lab_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit facility, increase borrowing capacity</link:label>
    <link:label id="lab_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity_label_en-US" xlink:label="lab_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Increase Borrowing Capacity</link:label>
    <link:label id="lab_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity_documentation_en-US" xlink:label="lab_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Increase Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity" xlink:href="rdnt-20221231.xsd#rdnt_LineofCreditFacilityIncreaseBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity" xlink:to="lab_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_fbed0726-0eec-4012-b6c7-c9732a139547_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EQUITY</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_2f4bc6d5-570c-400d-92f4-569e2904ab56_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_IncreaseDecreaseInNoncashItem_df4339f7-dd71-4a22-9978-b8f039486ae0_negatedTerseLabel_en-US" xlink:label="lab_rdnt_IncreaseDecreaseInNoncashItem" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non cash item in other expenses</link:label>
    <link:label id="lab_rdnt_IncreaseDecreaseInNoncashItem_label_en-US" xlink:label="lab_rdnt_IncreaseDecreaseInNoncashItem" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase Decrease In Noncash Item</link:label>
    <link:label id="lab_rdnt_IncreaseDecreaseInNoncashItem_documentation_en-US" xlink:label="lab_rdnt_IncreaseDecreaseInNoncashItem" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase Decrease In Noncash Item</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_IncreaseDecreaseInNoncashItem" xlink:href="rdnt-20221231.xsd#rdnt_IncreaseDecreaseInNoncashItem"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_IncreaseDecreaseInNoncashItem" xlink:to="lab_rdnt_IncreaseDecreaseInNoncashItem" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLoans_affd5b33-5597-419d-861a-5089a5571bbe_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLoans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from loans</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLoans_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLoans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Loans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLoans" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLoans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLoans" xlink:to="lab_us-gaap_ProceedsFromLoans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_66f6f291-61ee-482e-aba7-a28fda6eb03e_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of RadNet stock issued in acquisition</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Value Assigned</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:to="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_761b0b26-03c4-4189-b039-995a4c974e24_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liability</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_b4826f3f-4cfe-40d3-af39-c03b33faa4b3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_7d662d29-3848-41bd-bdcc-dcca06414fdf_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized expense weighted average period</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ZPEasternLLCMember_1609acbc-66ea-44e2-85a2-d9bff6806395_terseLabel_en-US" xlink:label="lab_rdnt_ZPEasternLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZP Eastern LLC</link:label>
    <link:label id="lab_rdnt_ZPEasternLLCMember_label_en-US" xlink:label="lab_rdnt_ZPEasternLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZP Eastern LLC [Member]</link:label>
    <link:label id="lab_rdnt_ZPEasternLLCMember_documentation_en-US" xlink:label="lab_rdnt_ZPEasternLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZP Eastern LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ZPEasternLLCMember" xlink:href="rdnt-20221231.xsd#rdnt_ZPEasternLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ZPEasternLLCMember" xlink:to="lab_rdnt_ZPEasternLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_8f7f7aa5-8ffe-42a3-a5ad-b06b8f24f364_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration transferred</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_eb488b0a-c3be-437e-a58b-538678bf088c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value of Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_5f1b5dda-3e3f-4fc3-99e8-995e76eff2f4_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_cb0dbddd-1788-411b-9b5b-0a0f55862bff_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_7bda4476-b2af-4348-8457-b0209441da94_terseLabel_en-US" xlink:label="lab_rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Leases</link:label>
    <link:label id="lab_rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_label_en-US" xlink:label="lab_rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Assets And Liabilities Lessee [Abstract]</link:label>
    <link:label id="lab_rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_documentation_en-US" xlink:label="lab_rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Assets And Liabilities Lessee [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:href="rdnt-20221231.xsd#rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:to="lab_rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_d75054ad-efdb-45c4-b5a0-3431f63be208_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUBSEQUENT EVENTS</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OffsettingAssetsLineItems_d4a180d7-187b-4fa1-9e9f-5d7dee91b377_terseLabel_en-US" xlink:label="lab_us-gaap_OffsettingAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offsetting Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_OffsettingAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_OffsettingAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offsetting Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OffsettingAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OffsettingAssetsLineItems" xlink:to="lab_us-gaap_OffsettingAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_JointVentureMember_4cda6871-6db1-4605-819a-78b958041583_terseLabel_en-US" xlink:label="lab_rdnt_JointVentureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint Venture</link:label>
    <link:label id="lab_rdnt_JointVentureMember_label_en-US" xlink:label="lab_rdnt_JointVentureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint Venture [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_JointVentureMember" xlink:href="rdnt-20221231.xsd#rdnt_JointVentureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_JointVentureMember" xlink:to="lab_rdnt_JointVentureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_WeightedAverageRemainingLeaseTermAbstract_8bdb24ce-6738-4c19-a262-6df4b0576174_terseLabel_en-US" xlink:label="lab_rdnt_WeightedAverageRemainingLeaseTermAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Lease Term</link:label>
    <link:label id="lab_rdnt_WeightedAverageRemainingLeaseTermAbstract_label_en-US" xlink:label="lab_rdnt_WeightedAverageRemainingLeaseTermAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Lease Term [Abstract]</link:label>
    <link:label id="lab_rdnt_WeightedAverageRemainingLeaseTermAbstract_documentation_en-US" xlink:label="lab_rdnt_WeightedAverageRemainingLeaseTermAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Lease Term [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WeightedAverageRemainingLeaseTermAbstract" xlink:href="rdnt-20221231.xsd#rdnt_WeightedAverageRemainingLeaseTermAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_WeightedAverageRemainingLeaseTermAbstract" xlink:to="lab_rdnt_WeightedAverageRemainingLeaseTermAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_fa876a89-49ed-4044-8d78-d2dfdb50d950_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d3ba765d-fbc1-47c4-89d8-72a291ccd2ec_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a5986e4d-8d76-4124-885e-360149744a0f_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance, value</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0dfd96c7-d6f1-43de-9931-55420d878d55_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance, value</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_40ced215-2e9e-40a2-8fd4-a3dc9cd04da9_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating losses</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_4fb51378-0707-4c42-aea5-619ac75c5e71_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PRINCIPLES OF CONSOLIDATION</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueNotFromContractWithCustomer_f1b0dd70-06e2-448b-83bd-68dc7bf2e779_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueNotFromContractWithCustomer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provider relief funding</link:label>
    <link:label id="lab_us-gaap_RevenueNotFromContractWithCustomer_label_en-US" xlink:label="lab_us-gaap_RevenueNotFromContractWithCustomer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Not from Contract with Customer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueNotFromContractWithCustomer" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueNotFromContractWithCustomer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueNotFromContractWithCustomer" xlink:to="lab_us-gaap_RevenueNotFromContractWithCustomer" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_729e2ac0-ccea-49ba-8cdb-cc8eb64047d8_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_2fca1c7d-3379-4ea0-872d-deb1fcb786c6_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_6387fe46-ff1a-4821-8e7d-2921322be0bb_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock - par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_LeverageRatioDomain_c13ac244-1aa7-4dd1-94f8-8149cd1df8b3_terseLabel_en-US" xlink:label="lab_rdnt_LeverageRatioDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio [Domain]</link:label>
    <link:label id="lab_rdnt_LeverageRatioDomain_label_en-US" xlink:label="lab_rdnt_LeverageRatioDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio [Domain]</link:label>
    <link:label id="lab_rdnt_LeverageRatioDomain_documentation_en-US" xlink:label="lab_rdnt_LeverageRatioDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Leverage Ratio [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain" xlink:href="rdnt-20221231.xsd#rdnt_LeverageRatioDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_LeverageRatioDomain" xlink:to="lab_rdnt_LeverageRatioDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_c86c50f8-5879-4ded-be3a-af2e6f9f659f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value cash flow hedge,&#160;net of taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBuildings_bedd2cac-a0fc-454b-b911-22fe887b4151_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBuildings" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of imaging centers and other operations</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBuildings_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBuildings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Buildings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBuildings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBuildings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBuildings" xlink:to="lab_us-gaap_PaymentsToAcquireBuildings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_17c6163e-9d2c-4bab-bd9f-7c3aa3a59592_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuritiesFinancingTransactionAxis_13df31b7-e2bc-461e-9eaf-aad4d0ee3bf7_terseLabel_en-US" xlink:label="lab_us-gaap_SecuritiesFinancingTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities Financing Transaction [Axis]</link:label>
    <link:label id="lab_us-gaap_SecuritiesFinancingTransactionAxis_label_en-US" xlink:label="lab_us-gaap_SecuritiesFinancingTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities Financing Transaction [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuritiesFinancingTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuritiesFinancingTransactionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionAxis" xlink:to="lab_us-gaap_SecuritiesFinancingTransactionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_5e793fc2-a5ee-4b81-b2d9-c87ebf1051b7_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_AdvancedRadiologyAtCapitalRegionLLCMember_e9ab15b6-8102-4abf-8541-2220db29f045_terseLabel_en-US" xlink:label="lab_rdnt_AdvancedRadiologyAtCapitalRegionLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advanced Radiology at Capital Region, LLC</link:label>
    <link:label id="lab_rdnt_AdvancedRadiologyAtCapitalRegionLLCMember_label_en-US" xlink:label="lab_rdnt_AdvancedRadiologyAtCapitalRegionLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advanced Radiology at Capital Region, LLC [Member]</link:label>
    <link:label id="lab_rdnt_AdvancedRadiologyAtCapitalRegionLLCMember_documentation_en-US" xlink:label="lab_rdnt_AdvancedRadiologyAtCapitalRegionLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advanced Radiology at Capital Region, LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AdvancedRadiologyAtCapitalRegionLLCMember" xlink:href="rdnt-20221231.xsd#rdnt_AdvancedRadiologyAtCapitalRegionLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_AdvancedRadiologyAtCapitalRegionLLCMember" xlink:to="lab_rdnt_AdvancedRadiologyAtCapitalRegionLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_8372cff7-2896-43af-8b1a-ba0381625665_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_658c5d36-08fa-4851-85e9-6dd34ac908ec_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_6c6fa716-d745-43e5-9145-3f35b16c2846_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization year 2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_130aefa9-2289-4d05-9f11-5d58ea3edbb1_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less comprehensive income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_41810bd4-7b21-4491-b69b-a1aef972c690_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign deferred tax</link:label>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Foreign Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_07fa9292-a9ce-42c6-81a3-2dfde2e92477_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DERIVATIVE INSTRUMENTS</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_52474f80-9882-4d3a-8e15-60efa69dc501_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_WeightedAverageRemainingContractualLife_cb76b65b-1233-4902-842b-291ff47615b0_terseLabel_en-US" xlink:label="lab_rdnt_WeightedAverageRemainingContractualLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Contractual Life(in years)</link:label>
    <link:label id="lab_rdnt_WeightedAverageRemainingContractualLife_label_en-US" xlink:label="lab_rdnt_WeightedAverageRemainingContractualLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Contractual Life</link:label>
    <link:label id="lab_rdnt_WeightedAverageRemainingContractualLife_documentation_en-US" xlink:label="lab_rdnt_WeightedAverageRemainingContractualLife" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Contractual Life abstract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WeightedAverageRemainingContractualLife" xlink:href="rdnt-20221231.xsd#rdnt_WeightedAverageRemainingContractualLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_WeightedAverageRemainingContractualLife" xlink:to="lab_rdnt_WeightedAverageRemainingContractualLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_d9102ccf-1519-45f7-ad32-14d5d4a733e9_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from revolving credit facility</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DueFromRelatedPartiesCurrent_b7193fb1-af6b-4f60-8317-a6f4fd854f33_terseLabel_en-US" xlink:label="lab_us-gaap_DueFromRelatedPartiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due from affiliates</link:label>
    <link:label id="lab_us-gaap_DueFromRelatedPartiesCurrent_label_en-US" xlink:label="lab_us-gaap_DueFromRelatedPartiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due from Related Parties, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueFromRelatedPartiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueFromRelatedPartiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DueFromRelatedPartiesCurrent" xlink:to="lab_us-gaap_DueFromRelatedPartiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_7a253a64-7b56-49af-98d1-a0ade2072364_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USE OF ESTIMATES</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockOptionMember_786e4038-04bb-4c15-b4ba-e2a1bf785dfb_terseLabel_en-US" xlink:label="lab_us-gaap_StockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Option</link:label>
    <link:label id="lab_us-gaap_StockOptionMember_label_en-US" xlink:label="lab_us-gaap_StockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockOptionMember" xlink:to="lab_us-gaap_StockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_3b808ee1-b692-46d6-9ce8-b786faf9db04_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Purchase Consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_CashFlowLesseeAbstract_51035b3a-3cb6-4a3c-9edc-45b458f04d32_terseLabel_en-US" xlink:label="lab_rdnt_CashFlowLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for amounts included in the measurement of lease liabilities:</link:label>
    <link:label id="lab_rdnt_CashFlowLesseeAbstract_label_en-US" xlink:label="lab_rdnt_CashFlowLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Lessee [Abstract]</link:label>
    <link:label id="lab_rdnt_CashFlowLesseeAbstract_documentation_en-US" xlink:label="lab_rdnt_CashFlowLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Lessee [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CashFlowLesseeAbstract" xlink:href="rdnt-20221231.xsd#rdnt_CashFlowLesseeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_CashFlowLesseeAbstract" xlink:to="lab_rdnt_CashFlowLesseeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_OperatingLeaseLeaseAbandonmentCharge_4c81d56b-ba70-4fbc-a07d-ef710aaff51d_terseLabel_en-US" xlink:label="lab_rdnt_OperatingLeaseLeaseAbandonmentCharge" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease abandonment charges</link:label>
    <link:label id="lab_rdnt_OperatingLeaseLeaseAbandonmentCharge_label_en-US" xlink:label="lab_rdnt_OperatingLeaseLeaseAbandonmentCharge" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Lease Abandonment Charge</link:label>
    <link:label id="lab_rdnt_OperatingLeaseLeaseAbandonmentCharge_documentation_en-US" xlink:label="lab_rdnt_OperatingLeaseLeaseAbandonmentCharge" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Lease Abandonment Charge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OperatingLeaseLeaseAbandonmentCharge" xlink:href="rdnt-20221231.xsd#rdnt_OperatingLeaseLeaseAbandonmentCharge"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_OperatingLeaseLeaseAbandonmentCharge" xlink:to="lab_rdnt_OperatingLeaseLeaseAbandonmentCharge" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_c4c813bd-126a-4930-bfcf-a4bef1d85863_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable, accrued expenses and other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_a8e73813-e548-4c1a-87c8-75ac5636f512_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INCOME TAXES</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPayment_bb0d2dec-3340-4cc3-836a-60ddff209e3e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt periodic payment</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPayment_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPayment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentPeriodicPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentPeriodicPayment" xlink:to="lab_us-gaap_DebtInstrumentPeriodicPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ProceedsFromSaleOfInterestInMinorityShareholders_517cdee7-fd9a-4370-897d-028dc37878a0_terseLabel_en-US" xlink:label="lab_rdnt_ProceedsFromSaleOfInterestInMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of interest in minority shareholders</link:label>
    <link:label id="lab_rdnt_ProceedsFromSaleOfInterestInMinorityShareholders_label_en-US" xlink:label="lab_rdnt_ProceedsFromSaleOfInterestInMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Sale Of Interest In Minority Shareholders</link:label>
    <link:label id="lab_rdnt_ProceedsFromSaleOfInterestInMinorityShareholders_documentation_en-US" xlink:label="lab_rdnt_ProceedsFromSaleOfInterestInMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Sale Of Interest In Minority Shareholders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ProceedsFromSaleOfInterestInMinorityShareholders" xlink:href="rdnt-20221231.xsd#rdnt_ProceedsFromSaleOfInterestInMinorityShareholders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ProceedsFromSaleOfInterestInMinorityShareholders" xlink:to="lab_rdnt_ProceedsFromSaleOfInterestInMinorityShareholders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_b1908ec0-1c65-4302-92be-e0c5d4acd555_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ScheduleOfForeignCurrencyTranslationAmountsTableTextBlock_113120c5-9346-48c6-824c-dd592a5775da_terseLabel_en-US" xlink:label="lab_rdnt_ScheduleOfForeignCurrencyTranslationAmountsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Foreign Currency Translation Amounts</link:label>
    <link:label id="lab_rdnt_ScheduleOfForeignCurrencyTranslationAmountsTableTextBlock_label_en-US" xlink:label="lab_rdnt_ScheduleOfForeignCurrencyTranslationAmountsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Foreign Currency Translation Amounts [Table Text Block]</link:label>
    <link:label id="lab_rdnt_ScheduleOfForeignCurrencyTranslationAmountsTableTextBlock_documentation_en-US" xlink:label="lab_rdnt_ScheduleOfForeignCurrencyTranslationAmountsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Foreign Currency Translation Amounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ScheduleOfForeignCurrencyTranslationAmountsTableTextBlock" xlink:href="rdnt-20221231.xsd#rdnt_ScheduleOfForeignCurrencyTranslationAmountsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ScheduleOfForeignCurrencyTranslationAmountsTableTextBlock" xlink:to="lab_rdnt_ScheduleOfForeignCurrencyTranslationAmountsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingCostsAndExpenses_93afd7d9-b9c9-4f2c-bbcf-6fcb77bf02bc_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Operations</link:label>
    <link:label id="lab_us-gaap_OperatingCostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingCostsAndExpenses" xlink:to="lab_us-gaap_OperatingCostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_ed554545-6ed1-4a54-a6c8-fa0f36ab17ad_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BASIC NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_780e2c16-4296-413c-bba8-adfe38bde253_netLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic net (loss) income per share attributable to RadNet, inc. common stockholders (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressGross_6a3a64e8-0276-4d2d-87d7-f31fd0226aa8_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in progress, gross</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressGross_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressGross" xlink:to="lab_us-gaap_ConstructionInProgressGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_092414ce-965e-4b10-8b6b-202b151609b8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToMinorityShareholders_8b36d360-949a-403e-ab3b-1b2026bf8c03_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToMinorityShareholders" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions paid to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_PaymentsToMinorityShareholders_label_en-US" xlink:label="lab_us-gaap_PaymentsToMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToMinorityShareholders" xlink:to="lab_us-gaap_PaymentsToMinorityShareholders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract_24780275-60d6-40a3-8a82-fc75f6dfabc1_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_12d55b45-268a-4551-83f8-d25dc680d4c5_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipDomain_e2bd6bc3-d8aa-496e-b641-67bca4d9b5dc_terseLabel_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:label id="lab_srt_OwnershipDomain_label_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipDomain" xlink:to="lab_srt_OwnershipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_bb079cd7-f265-47e0-8142-3513a69fc0bd_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_2264d158-f7ec-4c6a-b27a-e16e703308d6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_65ea0600-2544-473b-871a-a56326878709_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_633eefe6-92c0-4483-99a9-d2aa22a5cbee_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_A2012SunriseMerrickLLCMember_5db2530b-8c9f-4149-846d-8167650f847e_terseLabel_en-US" xlink:label="lab_rdnt_A2012SunriseMerrickLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2012 Sunrise Merrick LLC</link:label>
    <link:label id="lab_rdnt_A2012SunriseMerrickLLCMember_label_en-US" xlink:label="lab_rdnt_A2012SunriseMerrickLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2012 Sunrise Merrick LLC [Member]</link:label>
    <link:label id="lab_rdnt_A2012SunriseMerrickLLCMember_documentation_en-US" xlink:label="lab_rdnt_A2012SunriseMerrickLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2012 Sunrise Merrick LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_A2012SunriseMerrickLLCMember" xlink:href="rdnt-20221231.xsd#rdnt_A2012SunriseMerrickLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_A2012SunriseMerrickLLCMember" xlink:to="lab_rdnt_A2012SunriseMerrickLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_e347ff82-0df9-4a70-af70-0e8e1b4f273c_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_JointVentureWithCalvertMedicalImagingCentersLLCMember_b6b5ff39-ac37-40f7-9388-c8ec9dbd36d2_terseLabel_en-US" xlink:label="lab_rdnt_JointVentureWithCalvertMedicalImagingCentersLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint Venture With Calvert Medical Imaging Centers LLC</link:label>
    <link:label id="lab_rdnt_JointVentureWithCalvertMedicalImagingCentersLLCMember_label_en-US" xlink:label="lab_rdnt_JointVentureWithCalvertMedicalImagingCentersLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint Venture With Calvert Medical Imaging Centers LLC [Member]</link:label>
    <link:label id="lab_rdnt_JointVentureWithCalvertMedicalImagingCentersLLCMember_documentation_en-US" xlink:label="lab_rdnt_JointVentureWithCalvertMedicalImagingCentersLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint Venture With Calvert Medical Imaging Centers LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_JointVentureWithCalvertMedicalImagingCentersLLCMember" xlink:href="rdnt-20221231.xsd#rdnt_JointVentureWithCalvertMedicalImagingCentersLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_JointVentureWithCalvertMedicalImagingCentersLLCMember" xlink:to="lab_rdnt_JointVentureWithCalvertMedicalImagingCentersLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_b3cd94e3-998c-4d44-b70f-18b8bddd8e7d_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INCOME TAXES</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_2553e9bc-56a4-492a-860d-d207f0255b02_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_af145710-67c9-4ca3-bd75-a983d6cf1a57_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, renewal term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_f415e99a-d547-4bc3-bfc7-9981dbc758f9_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CURRENT ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionDomain_18d7718d-5012-4718-8d7d-209709a16768_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Domain]</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionDomain_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionDomain" xlink:to="lab_us-gaap_AssetAcquisitionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLenderDomain_c7a5723a-568a-4ee4-8867-ef2a717a4e69_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Lender [Domain]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLenderDomain_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Lender [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain" xlink:to="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_cfc3ae86-a803-4069-be7e-1610bb708322_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_7c3449be-89d8-4c10-ba23-bbb3ce20758e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_9f028829-30e0-4219-98ea-2b982972c323_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_f4a18317-6e44-46db-9c0b-f311335e40b3_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Tax Deferred Expense, Reserve and Accrual, Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_031277c3-7260-4c24-9140-d488d808506c_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable at the end (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PricingLevelIMember_17fb346d-8d85-45a7-b54d-db0dc8731da6_terseLabel_en-US" xlink:label="lab_rdnt_PricingLevelIMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level I</link:label>
    <link:label id="lab_rdnt_PricingLevelIMember_label_en-US" xlink:label="lab_rdnt_PricingLevelIMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level I [Member]</link:label>
    <link:label id="lab_rdnt_PricingLevelIMember_documentation_en-US" xlink:label="lab_rdnt_PricingLevelIMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level I [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIMember" xlink:href="rdnt-20221231.xsd#rdnt_PricingLevelIMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PricingLevelIMember" xlink:to="lab_rdnt_PricingLevelIMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_2ece7b0f-7563-4a1d-8d82-641bbc804ea8_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_MontclairMember_820f56d6-75c2-4083-8334-0a7cc2b7db73_terseLabel_en-US" xlink:label="lab_rdnt_MontclairMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Montclair</link:label>
    <link:label id="lab_rdnt_MontclairMember_label_en-US" xlink:label="lab_rdnt_MontclairMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Montclair [Member]</link:label>
    <link:label id="lab_rdnt_MontclairMember_documentation_en-US" xlink:label="lab_rdnt_MontclairMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Montclair</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MontclairMember" xlink:href="rdnt-20221231.xsd#rdnt_MontclairMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_MontclairMember" xlink:to="lab_rdnt_MontclairMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_0ba9c78f-7096-493b-9245-eaad4b69cfac_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH FLOWS FROM OPERATING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_d12bbeae-c34b-40ce-b35f-004b48775915_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing cash flows from financing leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_97c07f52-8642-4338-a451-4b3e394d4333_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredChargesPolicyTextBlock_d33dd2f6-aca3-4865-9cd2-492c3996e046_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredChargesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DEFERRED FINANCING COSTS</link:label>
    <link:label id="lab_us-gaap_DeferredChargesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DeferredChargesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Charges, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredChargesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredChargesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredChargesPolicyTextBlock" xlink:to="lab_us-gaap_DeferredChargesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_FirstLienTermLoanMember_39e319bf-81f6-4f59-9adb-7c87c51a4b90_terseLabel_en-US" xlink:label="lab_rdnt_FirstLienTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Term Loans</link:label>
    <link:label id="lab_rdnt_FirstLienTermLoanMember_label_en-US" xlink:label="lab_rdnt_FirstLienTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Term Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienTermLoanMember" xlink:href="rdnt-20221231.xsd#rdnt_FirstLienTermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_FirstLienTermLoanMember" xlink:to="lab_rdnt_FirstLienTermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_5c769602-db4f-4698-b919-f878110aee7d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ManagementServiceFees_2a051384-abd8-4ef7-8018-8435f7b60854_terseLabel_en-US" xlink:label="lab_rdnt_ManagementServiceFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management service fees</link:label>
    <link:label id="lab_rdnt_ManagementServiceFees_label_en-US" xlink:label="lab_rdnt_ManagementServiceFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management Service Fees</link:label>
    <link:label id="lab_rdnt_ManagementServiceFees_documentation_en-US" xlink:label="lab_rdnt_ManagementServiceFees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management service fees.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ManagementServiceFees" xlink:href="rdnt-20221231.xsd#rdnt_ManagementServiceFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ManagementServiceFees" xlink:to="lab_rdnt_ManagementServiceFees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_8a221005-2932-441d-94ec-c89c88ea143a_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RECENT ACCOUNTING STANDARDS</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities_4484308b-c7e4-4192-9050-ba013f328835_negatedLabel_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right of Use Liabilities</link:label>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities_label_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Operating Lease Liabilities</link:label>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities_documentation_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Operating Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" xlink:href="rdnt-20221231.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" xlink:to="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_NumberofUnconsolidatedJointVentures_019065b5-b27d-4e08-abaf-6df389067a9b_terseLabel_en-US" xlink:label="lab_rdnt_NumberofUnconsolidatedJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of unconsolidated joint ventures</link:label>
    <link:label id="lab_rdnt_NumberofUnconsolidatedJointVentures_label_en-US" xlink:label="lab_rdnt_NumberofUnconsolidatedJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Unconsolidated Joint Ventures</link:label>
    <link:label id="lab_rdnt_NumberofUnconsolidatedJointVentures_documentation_en-US" xlink:label="lab_rdnt_NumberofUnconsolidatedJointVentures" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Unconsolidated Joint Ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberofUnconsolidatedJointVentures" xlink:href="rdnt-20221231.xsd#rdnt_NumberofUnconsolidatedJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_NumberofUnconsolidatedJointVentures" xlink:to="lab_rdnt_NumberofUnconsolidatedJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_WestValleyImagingGroupLLCMember_3d54f7cf-2b48-4817-a0e6-2f2b67b43b9e_terseLabel_en-US" xlink:label="lab_rdnt_WestValleyImagingGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">West Valley Imaging Group, LLC</link:label>
    <link:label id="lab_rdnt_WestValleyImagingGroupLLCMember_label_en-US" xlink:label="lab_rdnt_WestValleyImagingGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">West Valley Imaging Group, LLC [Member]</link:label>
    <link:label id="lab_rdnt_WestValleyImagingGroupLLCMember_documentation_en-US" xlink:label="lab_rdnt_WestValleyImagingGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">West Valley Imaging Group, LLC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WestValleyImagingGroupLLCMember" xlink:href="rdnt-20221231.xsd#rdnt_WestValleyImagingGroupLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_WestValleyImagingGroupLLCMember" xlink:to="lab_rdnt_WestValleyImagingGroupLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_422d2541-b59c-45a8-a02e-ff1c6944e53c_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LONG-LIVED ASSETS</link:label>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ImagingCenterSegmentRevenueMember_ed01a280-9382-4acc-a6f3-0d11926f7b8c_verboseLabel_en-US" xlink:label="lab_rdnt_ImagingCenterSegmentRevenueMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Imaging center segment revenue</link:label>
    <link:label id="lab_rdnt_ImagingCenterSegmentRevenueMember_label_en-US" xlink:label="lab_rdnt_ImagingCenterSegmentRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Imaging Center Segment Revenue [Member]</link:label>
    <link:label id="lab_rdnt_ImagingCenterSegmentRevenueMember_documentation_en-US" xlink:label="lab_rdnt_ImagingCenterSegmentRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Imaging Center Segment Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ImagingCenterSegmentRevenueMember" xlink:href="rdnt-20221231.xsd#rdnt_ImagingCenterSegmentRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ImagingCenterSegmentRevenueMember" xlink:to="lab_rdnt_ImagingCenterSegmentRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesAbstract_74fccd1e-a6a0-44db-8e24-edbbc0e36ad0_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_df5df7ed-f22b-4c1a-a421-65d00a0017c5_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee [Axis]</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:to="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessAcquisitionContingentConsiderationMember_228532d6-d30d-4430-a580-b6de77c67d7a_terseLabel_en-US" xlink:label="lab_rdnt_BusinessAcquisitionContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acsuition Contingent Consideration</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionContingentConsiderationMember_label_en-US" xlink:label="lab_rdnt_BusinessAcquisitionContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition Contingent Consideration [Member]</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionContingentConsiderationMember_documentation_en-US" xlink:label="lab_rdnt_BusinessAcquisitionContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition Contingent Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionContingentConsiderationMember" xlink:href="rdnt-20221231.xsd#rdnt_BusinessAcquisitionContingentConsiderationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessAcquisitionContingentConsiderationMember" xlink:to="lab_rdnt_BusinessAcquisitionContingentConsiderationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_2444db29-f753-4493-b9f0-aeae4aa37b77_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Different between the sales price and carrying value</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Difference Between Carrying Amount and Underlying Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" xlink:to="lab_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_RepaymentOfAdvanceMedicarePayments_e3f4c4bb-38f4-45a0-9870-43c9456b24fd_terseLabel_en-US" xlink:label="lab_rdnt_RepaymentOfAdvanceMedicarePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of advance medicare payments</link:label>
    <link:label id="lab_rdnt_RepaymentOfAdvanceMedicarePayments_label_en-US" xlink:label="lab_rdnt_RepaymentOfAdvanceMedicarePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment Of Advance Medicare Payments</link:label>
    <link:label id="lab_rdnt_RepaymentOfAdvanceMedicarePayments_documentation_en-US" xlink:label="lab_rdnt_RepaymentOfAdvanceMedicarePayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment Of Advance Medicare Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RepaymentOfAdvanceMedicarePayments" xlink:href="rdnt-20221231.xsd#rdnt_RepaymentOfAdvanceMedicarePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_RepaymentOfAdvanceMedicarePayments" xlink:to="lab_rdnt_RepaymentOfAdvanceMedicarePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_EquipmentAcquiredAndLeaseholdImprovements_c170fe5c-53f0-4671-ba22-55600edd1e41_terseLabel_en-US" xlink:label="lab_rdnt_EquipmentAcquiredAndLeaseholdImprovements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment acquired and leasehold improvements</link:label>
    <link:label id="lab_rdnt_EquipmentAcquiredAndLeaseholdImprovements_label_en-US" xlink:label="lab_rdnt_EquipmentAcquiredAndLeaseholdImprovements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment Acquired and Leasehold Improvements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquipmentAcquiredAndLeaseholdImprovements" xlink:href="rdnt-20221231.xsd#rdnt_EquipmentAcquiredAndLeaseholdImprovements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_EquipmentAcquiredAndLeaseholdImprovements" xlink:to="lab_rdnt_EquipmentAcquiredAndLeaseholdImprovements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_7be814ba-946e-43c4-996d-412d46ed46c2_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock - outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_c171d193-0b77-438c-80fa-4d2ea6ff005e_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_09d389dc-7aac-467b-9134-62a047c3fd2c_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_986a0bee-9256-4d00-93d7-eb46e64213b7_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in joint ventures</link:label>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_467c113e-edbe-4b71-8802-e594f2447331_periodStartLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_29e20af9-14e0-4cf7-85ec-7e97d0e8f904_periodEndLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_9233b00c-1099-424e-b9d7-f64d7af6656a_verboseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total value of RadNet joint venture interests</link:label>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_label_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:to="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_A3235HempsteadLLCMember_7037161f-67d8-4bcc-9933-a61e9616837a_terseLabel_en-US" xlink:label="lab_rdnt_A3235HempsteadLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3235 Hempstead LLC</link:label>
    <link:label id="lab_rdnt_A3235HempsteadLLCMember_label_en-US" xlink:label="lab_rdnt_A3235HempsteadLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3235 Hempstead LLC [Member]</link:label>
    <link:label id="lab_rdnt_A3235HempsteadLLCMember_documentation_en-US" xlink:label="lab_rdnt_A3235HempsteadLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3235 Hempstead LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_A3235HempsteadLLCMember" xlink:href="rdnt-20221231.xsd#rdnt_A3235HempsteadLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_A3235HempsteadLLCMember" xlink:to="lab_rdnt_A3235HempsteadLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_0b04ce56-f852-4f0a-80fb-071d324bd84d_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_6a96e3cb-738e-45f3-90c7-4ffbc3a9f252_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, beginning balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_36ee4df0-6a7b-431a-a5ad-b96649637b72_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, ending balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_60eabde6-1a00-4f7a-9556-ea37ba3d562e_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BarclaysMember_e2424f75-a2d2-4f8e-bd9f-0f12d8c2defc_terseLabel_en-US" xlink:label="lab_rdnt_BarclaysMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Barclays</link:label>
    <link:label id="lab_rdnt_BarclaysMember_label_en-US" xlink:label="lab_rdnt_BarclaysMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Barclays [Member]</link:label>
    <link:label id="lab_rdnt_BarclaysMember_documentation_en-US" xlink:label="lab_rdnt_BarclaysMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Barclays [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BarclaysMember" xlink:href="rdnt-20221231.xsd#rdnt_BarclaysMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BarclaysMember" xlink:to="lab_rdnt_BarclaysMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_c5de17d9-a025-416e-98a7-9e226f13f43a_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_83959ed8-74bc-4efe-84d3-b7b48768e71c_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_27489321-33b1-4602-a639-d40e161741fd_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_7ff22a3e-2e05-463d-8358-96c6424aac19_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liability, net</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_145c77e7-dcc3-41ab-9588-1380589dfc32_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ZPParkchesterLLCMember_369ec8e7-17cc-4a72-a768-16b50ce6a6b3_terseLabel_en-US" xlink:label="lab_rdnt_ZPParkchesterLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZP Parkchester LLC</link:label>
    <link:label id="lab_rdnt_ZPParkchesterLLCMember_label_en-US" xlink:label="lab_rdnt_ZPParkchesterLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZP Parkchester LLC [Member]</link:label>
    <link:label id="lab_rdnt_ZPParkchesterLLCMember_documentation_en-US" xlink:label="lab_rdnt_ZPParkchesterLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZP Parkchester LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ZPParkchesterLLCMember" xlink:href="rdnt-20221231.xsd#rdnt_ZPParkchesterLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ZPParkchesterLLCMember" xlink:to="lab_rdnt_ZPParkchesterLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilities_64ba0545-4041-4e43-b18e-ae3596cbe202_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilities" xlink:to="lab_us-gaap_DerivativeLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_LeasesWeightedAverageDiscountRateAbstract_35951e9f-dfc7-4478-9ff3-2b6c2c72e5de_terseLabel_en-US" xlink:label="lab_rdnt_LeasesWeightedAverageDiscountRateAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Discount Rate</link:label>
    <link:label id="lab_rdnt_LeasesWeightedAverageDiscountRateAbstract_label_en-US" xlink:label="lab_rdnt_LeasesWeightedAverageDiscountRateAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases Weighted Average Discount Rate [Abstract]</link:label>
    <link:label id="lab_rdnt_LeasesWeightedAverageDiscountRateAbstract_documentation_en-US" xlink:label="lab_rdnt_LeasesWeightedAverageDiscountRateAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases Weighted Average Discount Rate [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeasesWeightedAverageDiscountRateAbstract" xlink:href="rdnt-20221231.xsd#rdnt_LeasesWeightedAverageDiscountRateAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_LeasesWeightedAverageDiscountRateAbstract" xlink:to="lab_rdnt_LeasesWeightedAverageDiscountRateAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesPayableCurrent_c41bf5e0-cd2e-4dea-b53c-ec6435958fda_terseLabel_en-US" xlink:label="lab_us-gaap_NotesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of notes payable</link:label>
    <link:label id="lab_us-gaap_NotesPayableCurrent_label_en-US" xlink:label="lab_us-gaap_NotesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayableCurrent" xlink:to="lab_us-gaap_NotesPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_838f9a86-0fbd-491d-866a-7b1a4004a231_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable, accrued expenses and other</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_855aaac5-3d5b-4d0c-9970-54d168db2789_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepositsAssets_1448e12e-88bb-4dd2-8dc5-6d6935a8eee9_terseLabel_en-US" xlink:label="lab_us-gaap_DepositsAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deposits and other</link:label>
    <link:label id="lab_us-gaap_DepositsAssets_label_en-US" xlink:label="lab_us-gaap_DepositsAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deposits Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositsAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepositsAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepositsAssets" xlink:to="lab_us-gaap_DepositsAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_ffd99f7b-69c3-44c7-83a3-a904aba9daa6_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock - $.0001 par value, 200,000,000 shares authorized; 57,723,125 and 53,548,227 shares issued and outstanding at December 31, 2022 and 2021 respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_b1a56c4d-922b-4aa2-8645-e1f3cf10839c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_4ba1dda8-46a1-4257-a293-ab464b0d4cba_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum_7dc27336-6dec-47bc-97a7-ede9b8091c75_terseLabel_en-US" xlink:label="lab_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage ratio, greater than</link:label>
    <link:label id="lab_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum_label_en-US" xlink:label="lab_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Liquidity Ratio Required, Minimum</link:label>
    <link:label id="lab_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum_documentation_en-US" xlink:label="lab_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Liquidity Ratio Required, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum" xlink:href="rdnt-20221231.xsd#rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum" xlink:to="lab_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditDerivativesContractTypeDomain_5e66f538-9151-40d3-b0fa-c7097f613d26_terseLabel_en-US" xlink:label="lab_us-gaap_CreditDerivativesContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Derivatives Contract Type [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditDerivativesContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_CreditDerivativesContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Derivatives Contract Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditDerivativesContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditDerivativesContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditDerivativesContractTypeDomain" xlink:to="lab_us-gaap_CreditDerivativesContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_303f421d-a29a-4cf4-83d3-e91126de8d7a_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_757f8293-96e2-4162-9ea2-6b59065242a5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effect of Derivative Instruments on Comprehensive (Loss) Income</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1_ba4cf025-a72c-4ae9-bc6c-33cd39cfbead_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash change in fair value of interest rate swaps</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Fair Value of Hedged Item in Interest Rate Fair Value Hedge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1" xlink:to="lab_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_da934ac7-5b40-4d9a-8e84-b45e70c796ec_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH AND CASH EQUIVALENTS, beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9b6ef793-eeec-4188-ad1e-2dee9d606728_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH AND CASH EQUIVALENTS, end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_774a2f50-24ac-4a90-8d4e-dfc56f272647_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_424fb0fa-de3a-4053-9335-57c3ec6763bb_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_662bc0e3-ba51-443a-891a-184755219e03_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CURRENT LIABILITIES</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_bfb14c4c-1cdd-48ad-9f8b-63eb99ab6ad4_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_d674ac21-e30b-4a98-9b40-ec17845a3fa3_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred true-ups and other</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:to="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_0045f1ab-270c-43f5-8fb3-08abf3aa2253_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_FirstLienCreditAgreementMember_3f2acad1-23d9-4590-bbf8-e8ccb9ecdade_terseLabel_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Credit Agreement</link:label>
    <link:label id="lab_rdnt_FirstLienCreditAgreementMember_label_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Credit Agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementMember" xlink:href="rdnt-20221231.xsd#rdnt_FirstLienCreditAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_FirstLienCreditAgreementMember" xlink:to="lab_rdnt_FirstLienCreditAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_ce0d8d47-adb9-4932-ab14-7992f1e14dc9_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest on lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestExpense" xlink:to="lab_us-gaap_FinanceLeaseInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_3c60eb30-3556-4341-9679-ed62e33fb163_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee contribution, percent</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ParentMember_6c438624-907d-4e0f-8238-e44e8f561de9_terseLabel_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Radnet, Inc. Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_ParentMember_label_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ParentMember" xlink:to="lab_us-gaap_ParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DimensionHealthCorporationMember_0a3025e8-b25d-4e2e-9f6d-23f559e978d4_terseLabel_en-US" xlink:label="lab_rdnt_DimensionHealthCorporationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dimension Health Corporation</link:label>
    <link:label id="lab_rdnt_DimensionHealthCorporationMember_label_en-US" xlink:label="lab_rdnt_DimensionHealthCorporationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dimension Health Corporation [Member]</link:label>
    <link:label id="lab_rdnt_DimensionHealthCorporationMember_documentation_en-US" xlink:label="lab_rdnt_DimensionHealthCorporationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dimension Health Corporation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DimensionHealthCorporationMember" xlink:href="rdnt-20221231.xsd#rdnt_DimensionHealthCorporationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DimensionHealthCorporationMember" xlink:to="lab_rdnt_DimensionHealthCorporationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_df7c90d7-3c37-4e2b-88a9-b477fb6240c4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_e026ab16-81d8-4a89-a3a4-fc51704c7ab3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Remaining Contractual Term (Years)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_cb09688e-8ca6-4630-a24f-cadbf305b0cf_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeBasisSpreadOnVariableRate_6af4b871-2fbb-4ae0-ba46-8b880ec7acc9_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeBasisSpreadOnVariableRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis spread on variable rate</link:label>
    <link:label id="lab_us-gaap_DerivativeBasisSpreadOnVariableRate_label_en-US" xlink:label="lab_us-gaap_DerivativeBasisSpreadOnVariableRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeBasisSpreadOnVariableRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeBasisSpreadOnVariableRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeBasisSpreadOnVariableRate" xlink:to="lab_us-gaap_DerivativeBasisSpreadOnVariableRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_35adc4ae-0197-4788-8a2a-d6f38c6e2cbc_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_LeverageRatioOneMember_fb4c85f9-9fed-46a2-9d94-2cc1f4977542_terseLabel_en-US" xlink:label="lab_rdnt_LeverageRatioOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">&gt; 3.50x</link:label>
    <link:label id="lab_rdnt_LeverageRatioOneMember_label_en-US" xlink:label="lab_rdnt_LeverageRatioOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio One [Member]</link:label>
    <link:label id="lab_rdnt_LeverageRatioOneMember_documentation_en-US" xlink:label="lab_rdnt_LeverageRatioOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioOneMember" xlink:href="rdnt-20221231.xsd#rdnt_LeverageRatioOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_LeverageRatioOneMember" xlink:to="lab_rdnt_LeverageRatioOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_9720138b-262e-4a51-84ee-c80305f7c324_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average amortization period remaining in years</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Remaining Amortization Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_ab970b5e-b8b7-4f7f-adb4-581eaeace1cc_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_d457df12-b262-48f7-a38c-ecca8e5c206b_terseLabel_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BUSINESS COMBINATIONS AND RELATED ACTIVITY</link:label>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mergers, Acquisitions and Dispositions Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:to="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_74e35288-3a35-45b4-9b99-c32aee397da4_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressMember" xlink:to="lab_us-gaap_ConstructionInProgressMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_0ede5e6f-e7aa-4c74-9791-2dc9d7ede813_terseLabel_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets:</link:label>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Deferred Tax Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e49284b4-6a24-40a3-80e7-a9dca6848204_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_05279c3a-e477-4ceb-9989-e13dd7ff8702_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment_8f8f1834-85ba-49ee-82ab-26a30d023cbe_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Other Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_a521edad-4e9b-4f6e-a9c7-c5d3b16659b6_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable at the end (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_463d4ee3-7d73-4053-9cdc-c3eadbd637bf_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_29094ba2-d43d-4e43-a421-f21c6fb6a492_verboseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and Amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_11ed6440-f5b4-41a8-b7b9-40e9a39d4d0d_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unused capacity, commitment fee percentage</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Unused Capacity, Commitment Fee Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:to="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_NumberOfLocations_250a80a7-b96a-48f1-8881-13a36c024a4f_terseLabel_en-US" xlink:label="lab_rdnt_NumberOfLocations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of locations</link:label>
    <link:label id="lab_rdnt_NumberOfLocations_label_en-US" xlink:label="lab_rdnt_NumberOfLocations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Locations</link:label>
    <link:label id="lab_rdnt_NumberOfLocations_documentation_en-US" xlink:label="lab_rdnt_NumberOfLocations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Locations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberOfLocations" xlink:href="rdnt-20221231.xsd#rdnt_NumberOfLocations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_NumberOfLocations" xlink:to="lab_rdnt_NumberOfLocations" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_AdjustmentToNetIncomeAttributableToAssumedShareSettlements_d72450b4-4747-4585-843d-f64862eecc0c_terseLabel_en-US" xlink:label="lab_rdnt_AdjustmentToNetIncomeAttributableToAssumedShareSettlements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in fair value associated with contingently issuable shares</link:label>
    <link:label id="lab_rdnt_AdjustmentToNetIncomeAttributableToAssumedShareSettlements_label_en-US" xlink:label="lab_rdnt_AdjustmentToNetIncomeAttributableToAssumedShareSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment To Net Income Attributable To Assumed Share Settlements</link:label>
    <link:label id="lab_rdnt_AdjustmentToNetIncomeAttributableToAssumedShareSettlements_documentation_en-US" xlink:label="lab_rdnt_AdjustmentToNetIncomeAttributableToAssumedShareSettlements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment To Net Income Attributable To Assumed Share Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AdjustmentToNetIncomeAttributableToAssumedShareSettlements" xlink:href="rdnt-20221231.xsd#rdnt_AdjustmentToNetIncomeAttributableToAssumedShareSettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_AdjustmentToNetIncomeAttributableToAssumedShareSettlements" xlink:to="lab_rdnt_AdjustmentToNetIncomeAttributableToAssumedShareSettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PaycheckProtectionProgramLoansMember_9e8a0f4d-30df-4314-806b-81e4e23b4c07_terseLabel_en-US" xlink:label="lab_rdnt_PaycheckProtectionProgramLoansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Paycheck Protection Program Loans</link:label>
    <link:label id="lab_rdnt_PaycheckProtectionProgramLoansMember_label_en-US" xlink:label="lab_rdnt_PaycheckProtectionProgramLoansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Paycheck Protection Program Loans [Member]</link:label>
    <link:label id="lab_rdnt_PaycheckProtectionProgramLoansMember_documentation_en-US" xlink:label="lab_rdnt_PaycheckProtectionProgramLoansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Paycheck Protection Program Loans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PaycheckProtectionProgramLoansMember" xlink:href="rdnt-20221231.xsd#rdnt_PaycheckProtectionProgramLoansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PaycheckProtectionProgramLoansMember" xlink:to="lab_rdnt_PaycheckProtectionProgramLoansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_5e288cef-108a-4014-8eee-c189a69b13be_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization year thereafter</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_752d5737-a587-45e5-ad6b-5891ed193ddc_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, term of contract</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract_f80ef88d-2b75-4791-a333-57ae503c7b70_terseLabel_en-US" xlink:label="lab_us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of Notes Payables [Abstract]</link:label>
    <link:label id="lab_us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract_label_en-US" xlink:label="lab_us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of Long-Term Debt and Capital Lease Obligations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract" xlink:to="lab_us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_aea237df-5a3c-4c32-838b-1d95a16964cc_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_KeyFinancialDataForJointVentures_68de30c5-c7b1-474b-8209-1b458782cc6f_terseLabel_en-US" xlink:label="lab_rdnt_KeyFinancialDataForJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Data:</link:label>
    <link:label id="lab_rdnt_KeyFinancialDataForJointVentures_label_en-US" xlink:label="lab_rdnt_KeyFinancialDataForJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Key Financial Data For Joint Ventures</link:label>
    <link:label id="lab_rdnt_KeyFinancialDataForJointVentures_documentation_en-US" xlink:label="lab_rdnt_KeyFinancialDataForJointVentures" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Key Financial Data For Joint Ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_KeyFinancialDataForJointVentures" xlink:href="rdnt-20221231.xsd#rdnt_KeyFinancialDataForJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_KeyFinancialDataForJointVentures" xlink:to="lab_rdnt_KeyFinancialDataForJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PersonalHealthImagingMember_2e2c58b2-ab7a-49a1-b49f-b28ea5070fc6_terseLabel_en-US" xlink:label="lab_rdnt_PersonalHealthImagingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Personal Health Imaging PLLC</link:label>
    <link:label id="lab_rdnt_PersonalHealthImagingMember_label_en-US" xlink:label="lab_rdnt_PersonalHealthImagingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Personal Health Imaging [Member]</link:label>
    <link:label id="lab_rdnt_PersonalHealthImagingMember_documentation_en-US" xlink:label="lab_rdnt_PersonalHealthImagingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Personal Health Imaging</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PersonalHealthImagingMember" xlink:href="rdnt-20221231.xsd#rdnt_PersonalHealthImagingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PersonalHealthImagingMember" xlink:to="lab_rdnt_PersonalHealthImagingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_c7f04e82-8a4b-4720-88c6-458c146fcac9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BlueShieldMember_06abad53-d6b8-4947-8b20-586f7a9ec9f0_terseLabel_en-US" xlink:label="lab_rdnt_BlueShieldMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blue Shield</link:label>
    <link:label id="lab_rdnt_BlueShieldMember_label_en-US" xlink:label="lab_rdnt_BlueShieldMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blue Shield [Member]</link:label>
    <link:label id="lab_rdnt_BlueShieldMember_documentation_en-US" xlink:label="lab_rdnt_BlueShieldMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blue Shield [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BlueShieldMember" xlink:href="rdnt-20221231.xsd#rdnt_BlueShieldMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BlueShieldMember" xlink:to="lab_rdnt_BlueShieldMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_8a0524b6-c14c-444e-a567-128c1578010f_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_c4f6e519-161e-4d32-9baf-a02b7f4eec69_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSA's</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_539c24e9-cb7e-4e77-b7fc-f5aefd23018a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flows from operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_915c464c-a418-496c-9a38-9e4da4682c7e_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issuable upon the exercise of stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ComputerandOfficeEquipmentMember_56b895b9-fcd2-49ce-a982-2bc72f8b9e70_terseLabel_en-US" xlink:label="lab_rdnt_ComputerandOfficeEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer and Office Equipment</link:label>
    <link:label id="lab_rdnt_ComputerandOfficeEquipmentMember_label_en-US" xlink:label="lab_rdnt_ComputerandOfficeEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer and Office Equipment [Member]</link:label>
    <link:label id="lab_rdnt_ComputerandOfficeEquipmentMember_documentation_en-US" xlink:label="lab_rdnt_ComputerandOfficeEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer and Office Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ComputerandOfficeEquipmentMember" xlink:href="rdnt-20221231.xsd#rdnt_ComputerandOfficeEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ComputerandOfficeEquipmentMember" xlink:to="lab_rdnt_ComputerandOfficeEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_October2025Member_6ae9e21d-394b-42f8-a765-a25edf66d25a_terseLabel_en-US" xlink:label="lab_rdnt_October2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 2025</link:label>
    <link:label id="lab_rdnt_October2025Member_label_en-US" xlink:label="lab_rdnt_October2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 2025 [Member]</link:label>
    <link:label id="lab_rdnt_October2025Member_documentation_en-US" xlink:label="lab_rdnt_October2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 2025 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_October2025Member" xlink:href="rdnt-20221231.xsd#rdnt_October2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_October2025Member" xlink:to="lab_rdnt_October2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDividendsReceived_c990f897-78b1-41f2-8a07-0cb404541e9a_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDividendsReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Received a dividend from the partnership</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDividendsReceived_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDividendsReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Dividends Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDividendsReceived" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDividendsReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDividendsReceived" xlink:to="lab_us-gaap_ProceedsFromDividendsReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_1d889e2e-3df0-4976-9a3e-65e143df70b0_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of stock upon exercise of options</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SelfInsuranceReserve_8a1f71d8-f86a-4714-a4d2-644b6b4202d2_terseLabel_en-US" xlink:label="lab_us-gaap_SelfInsuranceReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Self-insurance accrual</link:label>
    <link:label id="lab_us-gaap_SelfInsuranceReserve_label_en-US" xlink:label="lab_us-gaap_SelfInsuranceReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Self Insurance Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfInsuranceReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SelfInsuranceReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SelfInsuranceReserve" xlink:to="lab_us-gaap_SelfInsuranceReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_61c4e10c-3b2c-40fc-a0b8-bd7e91e0f65b_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock - authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_1b864712-4f06-44f3-9481-b4a491e5ee78_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_1bd845ed-344e-4ebd-b289-fdd569ec0aae_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities goodwill</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_a4228f4c-2b1a-4e20-8a41-583e79d2092c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_20a762f5-482a-4853-a083-4542f0349e3c_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_a0c09a53-a295-4572-9120-316cbc4021fa_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsAbstract_2cd9c05a-6c9a-4fe0-9803-bf077e8edd22_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OTHER ASSETS</link:label>
    <link:label id="lab_us-gaap_OtherAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_OtherAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsAbstract" xlink:to="lab_us-gaap_OtherAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a349b3b3-f3f7-4ece-ab9c-559acaa43854_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_b4d793b1-6d25-42f8-b144-840fb82d6eae_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HealthCarePatientServiceMember_50e8b558-70c1-470c-8aee-22c078894215_terseLabel_en-US" xlink:label="lab_us-gaap_HealthCarePatientServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service fee revenue</link:label>
    <link:label id="lab_us-gaap_HealthCarePatientServiceMember_label_en-US" xlink:label="lab_us-gaap_HealthCarePatientServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care, Patient Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCarePatientServiceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthCarePatientServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HealthCarePatientServiceMember" xlink:to="lab_us-gaap_HealthCarePatientServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PropertyPlantAndEquipmentNetIncludingRightOfUseAssets_3412643c-12ef-42c4-8605-db8cb36e4d89_totalLabel_en-US" xlink:label="lab_rdnt_PropertyPlantAndEquipmentNetIncludingRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total property, equipment and right-of-use-assets</link:label>
    <link:label id="lab_rdnt_PropertyPlantAndEquipmentNetIncludingRightOfUseAssets_label_en-US" xlink:label="lab_rdnt_PropertyPlantAndEquipmentNetIncludingRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property Plant and Equipment Net Including Right of Use Assets</link:label>
    <link:label id="lab_rdnt_PropertyPlantAndEquipmentNetIncludingRightOfUseAssets_documentation_en-US" xlink:label="lab_rdnt_PropertyPlantAndEquipmentNetIncludingRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property Plant and Equipment Net Including Right of Use Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PropertyPlantAndEquipmentNetIncludingRightOfUseAssets" xlink:href="rdnt-20221231.xsd#rdnt_PropertyPlantAndEquipmentNetIncludingRightOfUseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PropertyPlantAndEquipmentNetIncludingRightOfUseAssets" xlink:to="lab_rdnt_PropertyPlantAndEquipmentNetIncludingRightOfUseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_3acd8d27-e036-46cd-8d36-e1104b2564a6_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_55de73bf-b2a3-44e9-bab2-086e1a222be2_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityTable" xlink:to="lab_us-gaap_LineOfCreditFacilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemDomain_0f451ab1-b971-410f-8c26-36f1caf6fba8_terseLabel_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Domain]</link:label>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemDomain_label_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain" xlink:to="lab_us-gaap_UnusualOrInfrequentItemDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_2915ba8e-0bab-443a-9284-bd2993547c8a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:to="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_TarzanaMedicalCenterLLCMember_b4fc230a-6cdf-4204-bb5e-617086e1e794_terseLabel_en-US" xlink:label="lab_rdnt_TarzanaMedicalCenterLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tarzana Medical Center, LLC</link:label>
    <link:label id="lab_rdnt_TarzanaMedicalCenterLLCMember_label_en-US" xlink:label="lab_rdnt_TarzanaMedicalCenterLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tarzana Medical Center, LLC [Member]</link:label>
    <link:label id="lab_rdnt_TarzanaMedicalCenterLLCMember_documentation_en-US" xlink:label="lab_rdnt_TarzanaMedicalCenterLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tarzana Medical Center, LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TarzanaMedicalCenterLLCMember" xlink:href="rdnt-20221231.xsd#rdnt_TarzanaMedicalCenterLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_TarzanaMedicalCenterLLCMember" xlink:to="lab_rdnt_TarzanaMedicalCenterLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WorkersCompensationLiabilityCurrent_c27803a0-462b-4c04-a16a-691a20189371_terseLabel_en-US" xlink:label="lab_us-gaap_WorkersCompensationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Workers' compensation liability, current</link:label>
    <link:label id="lab_us-gaap_WorkersCompensationLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_WorkersCompensationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Workers' Compensation Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WorkersCompensationLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WorkersCompensationLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WorkersCompensationLiabilityCurrent" xlink:to="lab_us-gaap_WorkersCompensationLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset_f0899494-5a7d-43eb-9f08-5cac3cc4cca0_verboseLabel_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right of Use Assets</link:label>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset_label_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Right Of Use Asset</link:label>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset_documentation_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Right Of Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" xlink:href="rdnt-20221231.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" xlink:to="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_CertainSellerMember_84c2c456-f1cd-496c-b9b2-63287a6c6d5d_terseLabel_en-US" xlink:label="lab_rdnt_CertainSellerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certain Seller</link:label>
    <link:label id="lab_rdnt_CertainSellerMember_label_en-US" xlink:label="lab_rdnt_CertainSellerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certain Seller [Member]</link:label>
    <link:label id="lab_rdnt_CertainSellerMember_documentation_en-US" xlink:label="lab_rdnt_CertainSellerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certain Seller</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CertainSellerMember" xlink:href="rdnt-20221231.xsd#rdnt_CertainSellerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_CertainSellerMember" xlink:to="lab_rdnt_CertainSellerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_HealthCareManagementServiceMember_d2869758-d99f-4a9f-a7c9-4825ac4abe9b_terseLabel_en-US" xlink:label="lab_rdnt_HealthCareManagementServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management fee revenue</link:label>
    <link:label id="lab_rdnt_HealthCareManagementServiceMember_label_en-US" xlink:label="lab_rdnt_HealthCareManagementServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care, Management Service [Member]</link:label>
    <link:label id="lab_rdnt_HealthCareManagementServiceMember_documentation_en-US" xlink:label="lab_rdnt_HealthCareManagementServiceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care, Management Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HealthCareManagementServiceMember" xlink:href="rdnt-20221231.xsd#rdnt_HealthCareManagementServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_HealthCareManagementServiceMember" xlink:to="lab_rdnt_HealthCareManagementServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_77a4e48c-4a4a-4184-aa2d-60070d058076_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow, Supplemental Disclosures</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermBorrowings_9d936c87-1bd0-4500-91c6-aced96e0e319_verboseLabel_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible promissory note</link:label>
    <link:label id="lab_us-gaap_ShortTermBorrowings_label_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermBorrowings" xlink:to="lab_us-gaap_ShortTermBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_23b95d3f-76d4-4910-835d-63552e0fb853_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_d8ae13d9-5246-40aa-8d32-3e859bef440f_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_37ecb988-8982-4a2a-9f59-c3466f94653c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrecognized Tax Benefits</link:label>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_e0377f7b-3686-4653-8ce9-045ffa982498_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments on revolving credit facility</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:to="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_de1840a4-b858-4325-a81a-6eb96de63744_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEGMENT REPORTING</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_259ef7c9-3f98-422c-ab96-eeb6cd2d1b39_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:to="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_81e0948c-94b5-4035-b17b-267df7517a2c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill and Other Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets and Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_12bc950a-b2fd-4831-b9d5-fa66eab3f1c1_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Officer Compensation</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_SocialSecurityTaxEmployerDeferralCARESAct_f2250982-6e56-4159-94ea-7ef1df05f3df_terseLabel_en-US" xlink:label="lab_rdnt_SocialSecurityTaxEmployerDeferralCARESAct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred social security taxes</link:label>
    <link:label id="lab_rdnt_SocialSecurityTaxEmployerDeferralCARESAct_label_en-US" xlink:label="lab_rdnt_SocialSecurityTaxEmployerDeferralCARESAct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Social Security Tax, Employer, Deferral, CARES Act</link:label>
    <link:label id="lab_rdnt_SocialSecurityTaxEmployerDeferralCARESAct_documentation_en-US" xlink:label="lab_rdnt_SocialSecurityTaxEmployerDeferralCARESAct" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Social Security Tax, Employer, Deferral, CARES Act</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SocialSecurityTaxEmployerDeferralCARESAct" xlink:href="rdnt-20221231.xsd#rdnt_SocialSecurityTaxEmployerDeferralCARESAct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_SocialSecurityTaxEmployerDeferralCARESAct" xlink:to="lab_rdnt_SocialSecurityTaxEmployerDeferralCARESAct" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest_435b8384-f8fe-4f7c-97cc-db7aed9cb707_terseLabel_en-US" xlink:label="lab_rdnt_NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contribution from noncontrolling partner</link:label>
    <link:label id="lab_rdnt_NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest_label_en-US" xlink:label="lab_rdnt_NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase Contribution From Noncontrolling Interest</link:label>
    <link:label id="lab_rdnt_NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest_documentation_en-US" xlink:label="lab_rdnt_NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase Contribution From Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest" xlink:href="rdnt-20221231.xsd#rdnt_NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest" xlink:to="lab_rdnt_NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_2a9a0435-3850-4fd7-ba74-6635464e5355_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Deferred Tax (Liability) Asset</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilities" xlink:to="lab_us-gaap_DeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2bc3db2c-0901-40b1-bfd8-66ec79b4668a_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_WilliamMKellyMDIncMember_8801cd04-826d-48bb-9722-586fef71b29e_terseLabel_en-US" xlink:label="lab_rdnt_WilliamMKellyMDIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">William M. Kelly MD, Inc.</link:label>
    <link:label id="lab_rdnt_WilliamMKellyMDIncMember_label_en-US" xlink:label="lab_rdnt_WilliamMKellyMDIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">William M. Kelly MD, Inc [Member]</link:label>
    <link:label id="lab_rdnt_WilliamMKellyMDIncMember_documentation_en-US" xlink:label="lab_rdnt_WilliamMKellyMDIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">William M. Kelly MD, Inc</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WilliamMKellyMDIncMember" xlink:href="rdnt-20221231.xsd#rdnt_WilliamMKellyMDIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_WilliamMKellyMDIncMember" xlink:to="lab_rdnt_WilliamMKellyMDIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_dae28df1-3566-4413-a260-e1837e7bce23_terseLabel_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember_5cc86c04-a279-4a4a-9aa4-54e3f6cfddff_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee or Group of Investees</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee or Group of Investees [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember" xlink:to="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets_ebadb5d8-2bc8-4918-8bd3-bb20476c0953_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on sale and disposal of equipment and other</link:label>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets_efd7e55f-9643-42be-98bf-053fee3026e1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on sale and disposal of equipment and other</link:label>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets_label_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnDispositionOfAssets" xlink:to="lab_us-gaap_GainLossOnDispositionOfAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_0ba55580-9674-47ae-99b1-fb3d3177650f_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_9ee972fb-02bd-43b8-ad1a-8c25c833dd3a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ProceedsFromProviderReliefFunding_ca40aa74-3d55-4e58-84a6-56350fb6f6ed_terseLabel_en-US" xlink:label="lab_rdnt_ProceedsFromProviderReliefFunding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from provider relief funding</link:label>
    <link:label id="lab_rdnt_ProceedsFromProviderReliefFunding_label_en-US" xlink:label="lab_rdnt_ProceedsFromProviderReliefFunding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Provider Relief Funding</link:label>
    <link:label id="lab_rdnt_ProceedsFromProviderReliefFunding_documentation_en-US" xlink:label="lab_rdnt_ProceedsFromProviderReliefFunding" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Provider Relief Funding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ProceedsFromProviderReliefFunding" xlink:href="rdnt-20221231.xsd#rdnt_ProceedsFromProviderReliefFunding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ProceedsFromProviderReliefFunding" xlink:to="lab_rdnt_ProceedsFromProviderReliefFunding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_a3fce1df-b59f-427a-87aa-a1c311fde203_negatedLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount on debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue_759c43c4-085b-4a1b-81c7-09b3c0cf340f_terseLabel_en-US" xlink:label="lab_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of stock upon exercise of options</link:label>
    <link:label id="lab_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue_label_en-US" xlink:label="lab_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-based Payment Award, Options, Grants In Period, Gross, Value</link:label>
    <link:label id="lab_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue_documentation_en-US" xlink:label="lab_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-based Payment Award, Options, Grants In Period, Gross, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue" xlink:href="rdnt-20221231.xsd#rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue" xlink:to="lab_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_a9b78700-8d8e-4e89-929e-6f2bbaf9f458_negatedLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_EquityMethodInvestmentSharesPurchased_36183e92-0334-445e-a968-f9bef83aad79_terseLabel_en-US" xlink:label="lab_rdnt_EquityMethodInvestmentSharesPurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares purchased (in shares)</link:label>
    <link:label id="lab_rdnt_EquityMethodInvestmentSharesPurchased_label_en-US" xlink:label="lab_rdnt_EquityMethodInvestmentSharesPurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Shares Purchased</link:label>
    <link:label id="lab_rdnt_EquityMethodInvestmentSharesPurchased_documentation_en-US" xlink:label="lab_rdnt_EquityMethodInvestmentSharesPurchased" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Shares Purchased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityMethodInvestmentSharesPurchased" xlink:href="rdnt-20221231.xsd#rdnt_EquityMethodInvestmentSharesPurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_EquityMethodInvestmentSharesPurchased" xlink:to="lab_rdnt_EquityMethodInvestmentSharesPurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_0df4aa95-9fc9-4db9-a1f7-61903a1b0bf8_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of economic interest in majority owned subsidiary</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sales of Business, Affiliate and Productive Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:to="lab_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_HealthCarePatientServiceOtherMember_f783e882-3396-4e10-b25f-aa67481064b9_terseLabel_en-US" xlink:label="lab_rdnt_HealthCarePatientServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other patient revenue</link:label>
    <link:label id="lab_rdnt_HealthCarePatientServiceOtherMember_label_en-US" xlink:label="lab_rdnt_HealthCarePatientServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care, Patient Service Other [Member]</link:label>
    <link:label id="lab_rdnt_HealthCarePatientServiceOtherMember_documentation_en-US" xlink:label="lab_rdnt_HealthCarePatientServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care, Patient Service Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HealthCarePatientServiceOtherMember" xlink:href="rdnt-20221231.xsd#rdnt_HealthCarePatientServiceOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_HealthCarePatientServiceOtherMember" xlink:to="lab_rdnt_HealthCarePatientServiceOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_RestatedPlanMember_df054fa7-b921-4ee1-9910-80a0182e3065_terseLabel_en-US" xlink:label="lab_rdnt_RestatedPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restated Plan</link:label>
    <link:label id="lab_rdnt_RestatedPlanMember_label_en-US" xlink:label="lab_rdnt_RestatedPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restated Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedPlanMember" xlink:href="rdnt-20221231.xsd#rdnt_RestatedPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_RestatedPlanMember" xlink:to="lab_rdnt_RestatedPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_25c4b88f-3234-46b0-a65f-bd512ce5d01e_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_64a4303f-848b-4685-9467-3451285194d3_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of common shares outstanding during the period (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DebtInstrumentCovenantLeverageRatioMaximum_6f687aa3-e3ce-40b1-8957-b5a4f77da338_terseLabel_en-US" xlink:label="lab_rdnt_DebtInstrumentCovenantLeverageRatioMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage ratio, less than</link:label>
    <link:label id="lab_rdnt_DebtInstrumentCovenantLeverageRatioMaximum_label_en-US" xlink:label="lab_rdnt_DebtInstrumentCovenantLeverageRatioMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Leverage Ratio, Maximum</link:label>
    <link:label id="lab_rdnt_DebtInstrumentCovenantLeverageRatioMaximum_documentation_en-US" xlink:label="lab_rdnt_DebtInstrumentCovenantLeverageRatioMaximum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Leverage Ratio, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentCovenantLeverageRatioMaximum" xlink:href="rdnt-20221231.xsd#rdnt_DebtInstrumentCovenantLeverageRatioMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DebtInstrumentCovenantLeverageRatioMaximum" xlink:to="lab_rdnt_DebtInstrumentCovenantLeverageRatioMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_9cd6a4d6-b5f1-491b-be4f-87ed6a8afbae_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity interest percentage</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_6a9ce497-f8fa-4238-9f3a-5db31f4749e2_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested restricted stock subject to service vesting</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_586103f8-0365-4cd7-98fc-15785db910ca_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_2700fdb2-2b66-41ee-a749-551453b8e2a8_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues_fe91f9f0-280a-4d75-a061-97add583edcd_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BRMG and NY Groups revenues</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Measure of Activity, Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues" xlink:to="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_e2b3162d-e18d-49d4-892d-c4ef2f463b8f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revolving Credit Facility, Notes Payable, and Capital Lease Obligations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ManagementServiceContractsMember_3a545d64-5572-4d6d-a1ac-b35381d90ece_terseLabel_en-US" xlink:label="lab_rdnt_ManagementServiceContractsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management Service Contracts</link:label>
    <link:label id="lab_rdnt_ManagementServiceContractsMember_label_en-US" xlink:label="lab_rdnt_ManagementServiceContractsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management Service Contracts [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ManagementServiceContractsMember" xlink:href="rdnt-20221231.xsd#rdnt_ManagementServiceContractsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ManagementServiceContractsMember" xlink:to="lab_rdnt_ManagementServiceContractsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_18725be2-352b-44d5-8d6a-25e8504bdd80_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain" xlink:to="lab_us-gaap_ShortTermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_dde082fa-4d9d-4b74-b55a-0cbde95008b1_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity a Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_0c9f209f-3483-4162-96ec-9fd2315e7be1_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer matching contribution, percent</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Employer Matching Contribution, Percent of Match</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BroadwayMedicalImagingLLCMember_893055f8-2bfb-42ca-89d8-48467e27bc7f_terseLabel_en-US" xlink:label="lab_rdnt_BroadwayMedicalImagingLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Broadway Medical Imaging LLC</link:label>
    <link:label id="lab_rdnt_BroadwayMedicalImagingLLCMember_label_en-US" xlink:label="lab_rdnt_BroadwayMedicalImagingLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Broadway Medical Imaging LLC [Member]</link:label>
    <link:label id="lab_rdnt_BroadwayMedicalImagingLLCMember_documentation_en-US" xlink:label="lab_rdnt_BroadwayMedicalImagingLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Broadway Medical Imaging LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BroadwayMedicalImagingLLCMember" xlink:href="rdnt-20221231.xsd#rdnt_BroadwayMedicalImagingLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BroadwayMedicalImagingLLCMember" xlink:to="lab_rdnt_BroadwayMedicalImagingLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ChelseaDignosticRadiologyPCMember_fcb857d8-2fe6-49e6-b9d7-3a4a0caa86ad_terseLabel_en-US" xlink:label="lab_rdnt_ChelseaDignosticRadiologyPCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chelsea Dignostic Radiology, P.C.</link:label>
    <link:label id="lab_rdnt_ChelseaDignosticRadiologyPCMember_label_en-US" xlink:label="lab_rdnt_ChelseaDignosticRadiologyPCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chelsea Dignostic Radiology, P.C. [Member]</link:label>
    <link:label id="lab_rdnt_ChelseaDignosticRadiologyPCMember_documentation_en-US" xlink:label="lab_rdnt_ChelseaDignosticRadiologyPCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chelsea Dignostic Radiology, P.C.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ChelseaDignosticRadiologyPCMember" xlink:href="rdnt-20221231.xsd#rdnt_ChelseaDignosticRadiologyPCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ChelseaDignosticRadiologyPCMember" xlink:to="lab_rdnt_ChelseaDignosticRadiologyPCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_fef8d3e2-97ce-4c7d-8c5a-3f42f2ce920b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_cc97f168-4544-4691-ae6b-c796ded2acb6_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LEASES</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsNoncurrent_a4b01d6c-a940-4551-8ef0-4403ce4aa7c6_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent assets</link:label>
    <link:label id="lab_us-gaap_AssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_AssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNoncurrent" xlink:to="lab_us-gaap_AssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_47907d06-e915-45b7-a6e6-e7dae442ffe6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_788018f8-b468-49e4-8b5d-0b8f3d74b62a_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">STOCK-BASED COMPENSATION</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_d5e9cb91-b9b5-478f-a111-88e7d1a5edfd_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_c962ffb1-24e4-47ce-b125-ae15de87ba29_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Products and Services [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Products and Services [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:to="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_f010c7f9-c9b3-4d97-899f-305fdde22f3f_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_e85ab417-b193-499c-95e8-0ab94b7985f6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposals</link:label>
    <link:label id="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_label_en-US" xlink:label="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Written off Related to Sale of Business Unit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:to="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_b05cae0a-1a3b-4887-a816-1c5ca1ac54c3_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PPP loans, maturity term</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenseMember_308afc9f-a101-4af1-a8b2-15adcc97543c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expense</link:label>
    <link:label id="lab_us-gaap_OperatingExpenseMember_label_en-US" xlink:label="lab_us-gaap_OperatingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenseMember" xlink:to="lab_us-gaap_OperatingExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_c6ee61b3-71ed-4140-9fbc-05f694f79e69_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_EquityMethodInvestmentAdditionalContribution_b092a2bc-d5ef-48b1-a1c5-3215bcf835dd_terseLabel_en-US" xlink:label="lab_rdnt_EquityMethodInvestmentAdditionalContribution" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional contribution</link:label>
    <link:label id="lab_rdnt_EquityMethodInvestmentAdditionalContribution_label_en-US" xlink:label="lab_rdnt_EquityMethodInvestmentAdditionalContribution" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Additional Contribution</link:label>
    <link:label id="lab_rdnt_EquityMethodInvestmentAdditionalContribution_documentation_en-US" xlink:label="lab_rdnt_EquityMethodInvestmentAdditionalContribution" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Additional Contribution</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityMethodInvestmentAdditionalContribution" xlink:href="rdnt-20221231.xsd#rdnt_EquityMethodInvestmentAdditionalContribution"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_EquityMethodInvestmentAdditionalContribution" xlink:to="lab_rdnt_EquityMethodInvestmentAdditionalContribution" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EurodollarMember_cab4afcd-06db-46c0-a57b-5469d4b580d9_terseLabel_en-US" xlink:label="lab_us-gaap_EurodollarMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eurodollar Rate Spread</link:label>
    <link:label id="lab_us-gaap_EurodollarMember_label_en-US" xlink:label="lab_us-gaap_EurodollarMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eurodollar [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EurodollarMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EurodollarMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EurodollarMember" xlink:to="lab_us-gaap_EurodollarMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_AidenceMember_f91b1df9-0c92-4993-88cc-5f338e64cdd0_terseLabel_en-US" xlink:label="lab_rdnt_AidenceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aidence</link:label>
    <link:label id="lab_rdnt_AidenceMember_label_en-US" xlink:label="lab_rdnt_AidenceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aidence [Member]</link:label>
    <link:label id="lab_rdnt_AidenceMember_documentation_en-US" xlink:label="lab_rdnt_AidenceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aidence</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AidenceMember" xlink:href="rdnt-20221231.xsd#rdnt_AidenceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_AidenceMember" xlink:to="lab_rdnt_AidenceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_bbe2286d-65fa-4193-8607-7cd4e9a6552f_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_489d38ba-75d8-46a5-9ffe-e8ff2a972dc5_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_October2020CapMember_7609621e-2939-423a-87de-fca320c008d1_terseLabel_en-US" xlink:label="lab_rdnt_October2020CapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 2020</link:label>
    <link:label id="lab_rdnt_October2020CapMember_label_en-US" xlink:label="lab_rdnt_October2020CapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 2020 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_October2020CapMember" xlink:href="rdnt-20221231.xsd#rdnt_October2020CapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_October2020CapMember" xlink:to="lab_rdnt_October2020CapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LandMember_4d31fc8a-5891-4502-bba8-8f7e2903c7ff_terseLabel_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:label id="lab_us-gaap_LandMember_label_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LandMember" xlink:to="lab_us-gaap_LandMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_743512be-10ce-4972-8a01-b47174d7e72b_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DILUTED NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d627baf7-c356-4a8f-bcb8-47bff1fd94d9_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_1f7cf446-bb44-4d16-8f74-7b8144e1081b_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment, Long-Lived Asset, Held-for-Use, Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_label_en-US" xlink:label="lab_us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment, Long-Lived Asset, Held-for-Use, Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:to="lab_us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_710bdffe-c1b5-4c3d-8f1a-1120d490a377_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill deductible for tax purpose</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Goodwill, Expected Tax Deductible Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:to="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_522ed66e-bd35-442a-a4ec-05f20cdaa855_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_LeverageRatioFiveMember_b1456022-17b8-4fed-8bd7-09501f5088f6_terseLabel_en-US" xlink:label="lab_rdnt_LeverageRatioFiveMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.5 or less</link:label>
    <link:label id="lab_rdnt_LeverageRatioFiveMember_label_en-US" xlink:label="lab_rdnt_LeverageRatioFiveMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Five [Member]</link:label>
    <link:label id="lab_rdnt_LeverageRatioFiveMember_documentation_en-US" xlink:label="lab_rdnt_LeverageRatioFiveMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioFiveMember" xlink:href="rdnt-20221231.xsd#rdnt_LeverageRatioFiveMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_LeverageRatioFiveMember" xlink:to="lab_rdnt_LeverageRatioFiveMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_936e8bcb-3e03-4184-b746-b3a0f85637ec_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_FixedAssetsMember_22f92b2f-45d2-4c12-9358-4c4821666746_terseLabel_en-US" xlink:label="lab_rdnt_FixedAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed Assets</link:label>
    <link:label id="lab_rdnt_FixedAssetsMember_label_en-US" xlink:label="lab_rdnt_FixedAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed Assets [Member]</link:label>
    <link:label id="lab_rdnt_FixedAssetsMember_documentation_en-US" xlink:label="lab_rdnt_FixedAssetsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FixedAssetsMember" xlink:href="rdnt-20221231.xsd#rdnt_FixedAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_FixedAssetsMember" xlink:to="lab_rdnt_FixedAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_9f3f80f9-641c-4b33-8c72-cc2969a18d4f_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_6e18f8e0-2185-4a41-89bd-df857532f7ca_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_9de13c6d-2605-4904-9ed7-cb1b12beee92_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities_8d8cef49-92d2-4151-84db-4dd49a04b79b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement of loan</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Financial Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_097a49a6-beac-40a2-8a27-c0ea63264571_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) on disposition of property plant equipment</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_004393df-57e0-4c28-a73e-b6f13a505dad_negatedNetLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on Disposal of Equipment</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2820bc57-ab4e-4518-aa47-aed26d2423fb_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_f39e36c0-ca80-4cd5-ab87-4d87d06e0fe5_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_6086b497-ae42-485a-bb60-f59a4388a838_negatedLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_8d415698-6710-4875-8ce0-ac3593a215b0_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment at cost</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, before Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermNotesPayable_e919f06e-825f-4b59-9240-4c8bae3d7c2d_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermNotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes payable, net of current portion</link:label>
    <link:label id="lab_us-gaap_LongTermNotesPayable_label_en-US" xlink:label="lab_us-gaap_LongTermNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermNotesPayable" xlink:to="lab_us-gaap_LongTermNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1_39efab45-8c4c-46ac-a5a5-6ec82bca2ba9_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1_label_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash or Part Noncash Acquisition, Noncash Financial or Equity Instrument Consideration, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1" xlink:to="lab_us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_acebb734-224e-4d3f-aee7-833f914a00f0_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss carryforwards, subject to expiration</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_SLZMRealtyLLCMember_bb17dcaf-b9bd-49ae-88cf-95176c024de4_terseLabel_en-US" xlink:label="lab_rdnt_SLZMRealtyLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SLZM Realty LLC</link:label>
    <link:label id="lab_rdnt_SLZMRealtyLLCMember_label_en-US" xlink:label="lab_rdnt_SLZMRealtyLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SLZM Realty LLC [Member]</link:label>
    <link:label id="lab_rdnt_SLZMRealtyLLCMember_documentation_en-US" xlink:label="lab_rdnt_SLZMRealtyLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SLZM Realty LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SLZMRealtyLLCMember" xlink:href="rdnt-20221231.xsd#rdnt_SLZMRealtyLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_SLZMRealtyLLCMember" xlink:to="lab_rdnt_SLZMRealtyLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_02e36dce-5653-49a8-b6c2-0204d9a0b8a6_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, remaining performance obligation, amount</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_16fc968a-e4fb-42c3-9395-349dadbaa6a0_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based payment award, expiration period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_f961e835-3c95-4c81-9e22-2777db35c0c7_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_3441cf1d-684f-44ce-89a3-2f767d767d05_terseLabel_en-US" xlink:label="lab_rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases</link:label>
    <link:label id="lab_rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_label_en-US" xlink:label="lab_rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Assets And Liabilities Lessee [Abstract]</link:label>
    <link:label id="lab_rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_documentation_en-US" xlink:label="lab_rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Assets And Liabilities Lessee [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:href="rdnt-20221231.xsd#rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:to="lab_rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_d1dea8c1-2ae8-4883-b5a6-b79035aaf079_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit facility, borrowings available</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Remaining Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities_f546a984-2002-4b01-9936-d57ba68da7ab_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal payments on notes and leases payable other than term loan debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of Long-Term Debt, Long-Term Lease Obligation, and Capital Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount_2b250f17-c61a-4e87-9ce1-354bfcd2ad17_terseLabel_en-US" xlink:label="lab_rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease not yet commenced</link:label>
    <link:label id="lab_rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount_label_en-US" xlink:label="lab_rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee Operating Lease Lease Not Yet Commenced Undiscounted Amount</link:label>
    <link:label id="lab_rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount_documentation_en-US" xlink:label="lab_rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee Operating Lease Lease Not Yet Commenced Undiscounted Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount" xlink:href="rdnt-20221231.xsd#rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount" xlink:to="lab_rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_764293b7-19de-4cda-953a-f009f499c35f_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_LeverageRatioThreeMember_1e261447-2cfe-402f-b0b9-7d4bbb530dda_terseLabel_en-US" xlink:label="lab_rdnt_LeverageRatioThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">&#8804; 3.00x</link:label>
    <link:label id="lab_rdnt_LeverageRatioThreeMember_label_en-US" xlink:label="lab_rdnt_LeverageRatioThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Three [Member]</link:label>
    <link:label id="lab_rdnt_LeverageRatioThreeMember_documentation_en-US" xlink:label="lab_rdnt_LeverageRatioThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Three [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioThreeMember" xlink:href="rdnt-20221231.xsd#rdnt_LeverageRatioThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_LeverageRatioThreeMember" xlink:to="lab_rdnt_LeverageRatioThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_A60thStreetMRILLCMember_bce780f0-d1a2-47cf-8022-c64664165baa_terseLabel_en-US" xlink:label="lab_rdnt_A60thStreetMRILLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">60th Street MRI, LLC</link:label>
    <link:label id="lab_rdnt_A60thStreetMRILLCMember_label_en-US" xlink:label="lab_rdnt_A60thStreetMRILLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">60th Street MRI, LLC [Member]</link:label>
    <link:label id="lab_rdnt_A60thStreetMRILLCMember_documentation_en-US" xlink:label="lab_rdnt_A60thStreetMRILLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">60th Street MRI, LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_A60thStreetMRILLCMember" xlink:href="rdnt-20221231.xsd#rdnt_A60thStreetMRILLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_A60thStreetMRILLCMember" xlink:to="lab_rdnt_A60thStreetMRILLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_3ce195b2-297a-4957-9b21-49770db595da_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_91edc572-a2ae-4a08-a766-f048aecd63b2_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_7b08efdc-f6c3-4f73-86f0-9ec856fbcee3_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock_80d35625-2bf9-4dc4-9155-12688d3056af_terseLabel_en-US" xlink:label="lab_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Joint Venture Investment and Financial Information</link:label>
    <link:label id="lab_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock_label_en-US" xlink:label="lab_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint Venture Investment and Financial Information [Table Text Block]</link:label>
    <link:label id="lab_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock_documentation_en-US" xlink:label="lab_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint Venture Investment and Financial Information</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock" xlink:href="rdnt-20221231.xsd#rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock" xlink:to="lab_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_a80bac60-9d15-4d12-b85b-2f1e59107fc8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of LTIPs</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Nonvested Share Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_bc6bb34e-74b6-4306-abad-cb8204086bfa_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_15bccad7-5083-4812-87b1-db57eecf6de4_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_976ad898-0986-4cc1-9a3e-a32803fae631_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable at the end</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_e5424ec0-ef6f-44aa-8d61-15d4eb6add47_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity compensation</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_f07fa2a0-a493-46d5-aa4d-9731aa914899_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesDomain" xlink:to="lab_srt_ConsolidatedEntitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized_8859c12d-c080-4c66-985b-c1fdf5240d41_terseLabel_en-US" xlink:label="lab_rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets, tax benefit may not be realized</link:label>
    <link:label id="lab_rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized_label_en-US" xlink:label="lab_rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Benefit May Not Be Realized</link:label>
    <link:label id="lab_rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized_documentation_en-US" xlink:label="lab_rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Benefit May Not Be Realized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized" xlink:href="rdnt-20221231.xsd#rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized" xlink:to="lab_rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReinsuranceContractAxis_ef1f07b3-4042-4dd8-8b1e-36f791b51f8e_terseLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceContractAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Policy, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ReinsuranceContractAxis_label_en-US" xlink:label="lab_us-gaap_ReinsuranceContractAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Contract [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceContractAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceContractAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReinsuranceContractAxis" xlink:to="lab_us-gaap_ReinsuranceContractAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_4289cf85-f363-4a4d-96f3-aa423a33c05a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Reconciliation of Income Tax Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_25090b1f-f414-4a70-9d3f-58e5aede7f19_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_d231c9a9-ade2-465f-94c6-6b2180b07947_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State franchise tax, net of federal benefit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_51dc092a-79c3-44c7-b294-cb6d0cbc83f6_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration liability, measurement input</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_aa7d0815-3afc-48e1-bbfe-2607e366f4d2_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_de48aefa-ce6a-4077-9170-a07d925ac69f_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_77d16c24-0dc5-451f-84e8-9724ae9344c5_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3ebe2a42-ed84-4198-b910-405d839d10e1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_c677ac1d-1d09-432e-963a-361b96b8db3b_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration transferred</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_823b7380-3cfc-4f89-acf9-77dc26d159f9_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CONCENTRATION OF CREDIT RISKS</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_dfd829dd-588e-4a17-9fff-ec645391c6d4_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis" xlink:to="lab_us-gaap_MeasurementInputTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_ad77f9d7-703e-4a54-8a83-64e297b1f366_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountCurrent_07b92689-5ff2-462a-9c3d-b620547825f2_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, unamortized discount, current</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountCurrent_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountCurrent" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_9701cf55-fa72-4314-b352-2dcb4f71d533_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_a91134f7-77d4-49ab-b7b2-719b60cfc370_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued professional fees</link:label>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Professional Fees, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:to="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_1839ad39-7502-4a7a-b875-30c90eb827ee_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets_0c8b2878-fe75-49d3-85f9-29601342f9f1_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Current Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_CapitationArrangementsMember_bc5d44cb-ea78-4837-ad7b-a7ffb2dd37ff_terseLabel_en-US" xlink:label="lab_rdnt_CapitationArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue under capitation arrangements</link:label>
    <link:label id="lab_rdnt_CapitationArrangementsMember_label_en-US" xlink:label="lab_rdnt_CapitationArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitation Arrangements [Member]</link:label>
    <link:label id="lab_rdnt_CapitationArrangementsMember_documentation_en-US" xlink:label="lab_rdnt_CapitationArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitation Arrangements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CapitationArrangementsMember" xlink:href="rdnt-20221231.xsd#rdnt_CapitationArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_CapitationArrangementsMember" xlink:to="lab_rdnt_CapitationArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_b54fdecb-2d72-44a7-8019-520fd66b39c8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in cumulative foreign currency&#160;translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_e6ad8dd2-a51a-4db0-a756-e0d2ad2e3e26_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EARNINGS PER SHARE</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_26387e1d-30b1-4361-a2f0-6a56d30172af_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_d1fe3a68-ca2b-478c-9d2d-ac7e510bd085_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_f41cb3f8-be57-4c56-9626-ebf35cb7ee45_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment at cost</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_0dc5b0a5-dbee-4f4f-b546-db209443b883_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets_6ad4002d-c51b-4c51-9921-971562a9364b_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost in excess of book value of acquired joint venture interests accounted for as equity method goodwill</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Underlying Equity in Net Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets" xlink:to="lab_us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_a2bce009-1a3d-4233-b9a2-0f08c922f125_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_b1ecd6da-b26f-4025-b4ce-720479c2bd6a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_dfca9c4a-e6c2-4f8e-a194-0d7e69b5f237_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity in earnings of joint ventures</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_f63e5b66-561d-4389-bb47-ceeeed73ca9a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity in earnings in these joint ventures</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_6d7fe6c0-fe5e-4c29-a85a-0631d534268c_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization year 2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_NumberOfLocationOfferingMultiModalityServices_96f23832-3953-4bee-9a08-6c0cc4187c91_terseLabel_en-US" xlink:label="lab_rdnt_NumberOfLocationOfferingMultiModalityServices" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of location</link:label>
    <link:label id="lab_rdnt_NumberOfLocationOfferingMultiModalityServices_label_en-US" xlink:label="lab_rdnt_NumberOfLocationOfferingMultiModalityServices" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Location Offering Multi-Modality Services</link:label>
    <link:label id="lab_rdnt_NumberOfLocationOfferingMultiModalityServices_documentation_en-US" xlink:label="lab_rdnt_NumberOfLocationOfferingMultiModalityServices" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Location Offering Multi-Modality Services</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberOfLocationOfferingMultiModalityServices" xlink:href="rdnt-20221231.xsd#rdnt_NumberOfLocationOfferingMultiModalityServices"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_NumberOfLocationOfferingMultiModalityServices" xlink:to="lab_rdnt_NumberOfLocationOfferingMultiModalityServices" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_99f2a431-d4fb-4ab0-b950-f0368c83b9ea_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_14ba51ef-8b33-4b96-89cb-f771d8104f63_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_7cd4ac2b-e29f-496e-9950-524b9b3c61a7_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NATURE OF BUSINESS</link:label>
    <link:label id="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Description and Basis of Presentation [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:to="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ScriptSenderLLCMember_13bada55-c160-4b29-9a59-3aeba1f5bdb9_terseLabel_en-US" xlink:label="lab_rdnt_ScriptSenderLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ScriptSender LLC</link:label>
    <link:label id="lab_rdnt_ScriptSenderLLCMember_label_en-US" xlink:label="lab_rdnt_ScriptSenderLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Script Sender LLC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ScriptSenderLLCMember" xlink:href="rdnt-20221231.xsd#rdnt_ScriptSenderLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ScriptSenderLLCMember" xlink:to="lab_rdnt_ScriptSenderLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense_9f0089ce-71d8-400b-8cd2-8b54a9fb3c32_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests in partnerships</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Noncontrolling Interest Income (Loss), Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense" xlink:to="lab_us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1df17716-e48c-46bb-8117-5984b7e9f54c_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e16c9c70-71ef-45f9-b081-97da09427a7e_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Lease Payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_ac5e9088-9413-46f7-9a3d-c6f834c7674e_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET INCOME (LOSS)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_17cd51d9-9332-4cd9-a2e6-d18451ce969e_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET INCOME (LOSS)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_fbbc91a1-c92f-4217-b5cf-8b44f73642a1_verboseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_b713f9b9-cbee-4a91-8d6b-927437f6e5be_netLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_4eec84d5-67a7-405d-b7ac-8169b4642f93_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Primary Beneficiary</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Primary Beneficiary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:to="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_3255ec6d-cd02-416c-961f-dabc6593c1e7_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution_7541e5a6-f747-4559-b029-7f3782e88125_terseLabel_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisition, equity interest issued or issuable, fair value of additional shares issued after execution</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution_label_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Fair Value Of Additional Shares Issued After Execution</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution_documentation_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Fair Value Of Additional Shares Issued After Execution</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution" xlink:href="rdnt-20221231.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution" xlink:to="lab_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward_e09f17fe-8ee7-4c45-beed-c2f7f7f73705_terseLabel_en-US" xlink:label="lab_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures [Roll Forward]</link:label>
    <link:label id="lab_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward_label_en-US" xlink:label="lab_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures [Roll Forward]</link:label>
    <link:label id="lab_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward_documentation_en-US" xlink:label="lab_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward" xlink:href="rdnt-20221231.xsd#rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward" xlink:to="lab_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_6333f786-ff1c-4c94-b625-eedaf9e97f7a_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_f7edc8d0-98d9-4d21-a475-42f7323296ff_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnTerminationOfLease_a0ead377-0390-4551-9e67-3b87d34ac2ad_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnTerminationOfLease" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease abandonment charges</link:label>
    <link:label id="lab_us-gaap_GainLossOnTerminationOfLease_label_en-US" xlink:label="lab_us-gaap_GainLossOnTerminationOfLease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Termination of Lease</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnTerminationOfLease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnTerminationOfLease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnTerminationOfLease" xlink:to="lab_us-gaap_GainLossOnTerminationOfLease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_585aac92-266d-4e58-addd-cca3ed208e9a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BUSINESS COMBINATION</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsPolicy" xlink:to="lab_us-gaap_BusinessCombinationsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized_4c92c67f-cb1b-46a4-9002-9417ab36985e_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate caps premium liability</link:label>
    <link:label id="lab_us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized_label_en-US" xlink:label="lab_us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Guarantee Insurance Contracts, Unearned Premium Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized" xlink:to="lab_us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_1abb18d2-aafa-459a-a26f-d2acd03aab5f_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit facilities available</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_85856743-8a52-4511-8a38-01cdd961ba91_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expenses with related party</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Expenses from Transactions with Related Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:to="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_1cda93b8-bdc9-49e9-9657-dc239d8133bf_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_a8a897df-c008-4c03-93ef-f1c5404d98e8_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_EarningPerShareBasicAndDilutedAbstract_73e2957b-bdfa-4d75-85b2-354d872ff3b0_terseLabel_en-US" xlink:label="lab_rdnt_EarningPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">WEIGHTED AVERAGE SHARES OUTSTANDING</link:label>
    <link:label id="lab_rdnt_EarningPerShareBasicAndDilutedAbstract_label_en-US" xlink:label="lab_rdnt_EarningPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earning Per Share, Basic and Diluted [Abstract]</link:label>
    <link:label id="lab_rdnt_EarningPerShareBasicAndDilutedAbstract_documentation_en-US" xlink:label="lab_rdnt_EarningPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earning Per Share, Basic and Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EarningPerShareBasicAndDilutedAbstract" xlink:href="rdnt-20221231.xsd#rdnt_EarningPerShareBasicAndDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_EarningPerShareBasicAndDilutedAbstract" xlink:to="lab_rdnt_EarningPerShareBasicAndDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_479dcf3c-f383-4686-b4f8-8c34bd7b2c78_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_17a02233-066b-419a-b1cd-4b15880885db_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f5073d0b-9c28-4267-934b-36a30f7b1bbf_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_ce256261-cc39-42aa-b1d6-474e486637ba_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from debt issuance, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_215ef363-78db-457d-b0d2-1db1d8d2f913_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis" xlink:to="lab_us-gaap_ShortTermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_c06e081d-ae3b-4b5c-80e5-cf4cbe992485_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions by Acquisition, Contingent Consideration</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1b11e706-6601-4866-b827-6dcce005b8e3_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_a9de5d43-dc8a-427f-a021-4e30f3644514_negatedLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expiration of the statute of limitations for the assessment of taxes</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_11ed57e8-9241-4f45-b324-5f93abe7efa7_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock for acquisitions</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_4d770fb7-fdb0-4d37-af23-ea72350335e6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions Acquired Assets and Assumed Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_TangentAssociatesLLCMember_10aac501-e3d4-4aff-ab6a-bbf38c06cd79_terseLabel_en-US" xlink:label="lab_rdnt_TangentAssociatesLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tangent Associates LLC</link:label>
    <link:label id="lab_rdnt_TangentAssociatesLLCMember_label_en-US" xlink:label="lab_rdnt_TangentAssociatesLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tangent Associates LLC [Member]</link:label>
    <link:label id="lab_rdnt_TangentAssociatesLLCMember_documentation_en-US" xlink:label="lab_rdnt_TangentAssociatesLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tangent Associates LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TangentAssociatesLLCMember" xlink:href="rdnt-20221231.xsd#rdnt_TangentAssociatesLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_TangentAssociatesLLCMember" xlink:to="lab_rdnt_TangentAssociatesLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticCountryMember_465fb424-888a-4724-8f53-eed46465ddc0_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority</link:label>
    <link:label id="lab_us-gaap_DomesticCountryMember_label_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCountryMember" xlink:to="lab_us-gaap_DomesticCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_TurnerImagingSystemsMember_c26a7301-9804-45a1-ba4a-c3dfe1a64af7_terseLabel_en-US" xlink:label="lab_rdnt_TurnerImagingSystemsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Turner Imaging Systems</link:label>
    <link:label id="lab_rdnt_TurnerImagingSystemsMember_label_en-US" xlink:label="lab_rdnt_TurnerImagingSystemsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Turner Imaging Systems [Member]</link:label>
    <link:label id="lab_rdnt_TurnerImagingSystemsMember_documentation_en-US" xlink:label="lab_rdnt_TurnerImagingSystemsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Turner Imaging Systems [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TurnerImagingSystemsMember" xlink:href="rdnt-20221231.xsd#rdnt_TurnerImagingSystemsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_TurnerImagingSystemsMember" xlink:to="lab_rdnt_TurnerImagingSystemsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_3b9bd01b-b16e-476a-988a-e62d391dd8b7_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments on term loan debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfDebt" xlink:to="lab_us-gaap_RepaymentsOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_765388d5-63cc-4779-8e33-cc407bf60fef_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total property and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_640e3dc7-5379-4103-8b73-59af6ba54d13_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_a4bb1f1b-a047-4e46-8cfd-115e5979843f_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET INCOME (LOSS) ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_5624de18-78a8-4a84-86fb-bd6abf6f74ec_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) attributable to RadNet, Inc. common stockholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_727f0389-2fd8-407e-86be-565fd0442105_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:to="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_429c9481-4775-4365-9601-a2e593a51d0e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Annual Principal Maturities of Notes Payable</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-Term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_82158e00-27d6-4b33-82c4-fad29b5adb2d_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited_7a67e44a-8482-4821-9066-ebc42fd8b64b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeiture of restricted stock</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-Based Payment Arrangement, Forfeited</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetNumberOfInstrumentsHeld_344bd671-f84d-4121-80b7-fc2ba037483d_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetNumberOfInstrumentsHeld" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of forward interest rate cap agreements</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetNumberOfInstrumentsHeld_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetNumberOfInstrumentsHeld" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Number of Instruments Held</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNumberOfInstrumentsHeld" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetNumberOfInstrumentsHeld"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetNumberOfInstrumentsHeld" xlink:to="lab_us-gaap_DerivativeAssetNumberOfInstrumentsHeld" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_f5f7f79c-bf8c-40e9-9a51-10850eb9f270_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table]</link:label>
    <link:label id="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_label_en-US" xlink:label="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_TermLoanMember_26a1ec7d-c2d1-454b-a0a4-e188fb5a14e3_terseLabel_en-US" xlink:label="lab_rdnt_TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan</link:label>
    <link:label id="lab_rdnt_TermLoanMember_label_en-US" xlink:label="lab_rdnt_TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TermLoanMember" xlink:href="rdnt-20221231.xsd#rdnt_TermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_TermLoanMember" xlink:to="lab_rdnt_TermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_69fd54dc-5aba-4590-af2d-c7b609fa0bcf_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_36af15c7-2cff-41fe-bfa4-70e0d5de0d6f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in valuation allowance</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_13db76e7-caa9-41e3-aeee-48bb919396c5_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award vesting rights, percentage</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_70d37524-eec3-4147-83d4-8d7b9e9285b0_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LEASES</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_806edf3f-3a21-42c3-9933-ddaafbbbef03_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, lease not yet commenced, term of contract</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not yet Commenced, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" xlink:to="lab_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_a383be12-4156-4f27-b47e-923c6d767180_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_SoftwareAndTeleradiologyMember_ab4ca652-4579-4a99-8751-8d1ea4bcbea3_verboseLabel_en-US" xlink:label="lab_rdnt_SoftwareAndTeleradiologyMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software and teleradiology</link:label>
    <link:label id="lab_rdnt_SoftwareAndTeleradiologyMember_label_en-US" xlink:label="lab_rdnt_SoftwareAndTeleradiologyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software and Teleradiology [Member]</link:label>
    <link:label id="lab_rdnt_SoftwareAndTeleradiologyMember_documentation_en-US" xlink:label="lab_rdnt_SoftwareAndTeleradiologyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Imaging On Call [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SoftwareAndTeleradiologyMember" xlink:href="rdnt-20221231.xsd#rdnt_SoftwareAndTeleradiologyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_SoftwareAndTeleradiologyMember" xlink:to="lab_rdnt_SoftwareAndTeleradiologyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_GainLossOnExtinguishmentOfDebtAndOtherExpenses_5d48f4a8-d294-4170-bd53-a3ac6944e076_negatedLabel_en-US" xlink:label="lab_rdnt_GainLossOnExtinguishmentOfDebtAndOtherExpenses" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss (gain) on extinguishment of debt and related expenses</link:label>
    <link:label id="lab_rdnt_GainLossOnExtinguishmentOfDebtAndOtherExpenses_label_en-US" xlink:label="lab_rdnt_GainLossOnExtinguishmentOfDebtAndOtherExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) On Extinguishment Of Debt And Other Expenses</link:label>
    <link:label id="lab_rdnt_GainLossOnExtinguishmentOfDebtAndOtherExpenses_documentation_en-US" xlink:label="lab_rdnt_GainLossOnExtinguishmentOfDebtAndOtherExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) On Extinguishment Of Debt And Other Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GainLossOnExtinguishmentOfDebtAndOtherExpenses" xlink:href="rdnt-20221231.xsd#rdnt_GainLossOnExtinguishmentOfDebtAndOtherExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_GainLossOnExtinguishmentOfDebtAndOtherExpenses" xlink:to="lab_rdnt_GainLossOnExtinguishmentOfDebtAndOtherExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock_3dd45423-0871-41a2-b940-136e2105d380_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SOFTWARE DEVELOPMENT COSTS</link:label>
    <link:label id="lab_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research, Development, and Computer Software, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" xlink:to="lab_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_d025661f-3e8e-41d3-87ec-80b25030bf18_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_12b6d7c8-be9e-4962-85c6-c6cf78f13510_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangibles</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Goodwill and Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_4ca48901-295b-479c-8c82-65ebbdf432f8_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_bd6af5f0-ea47-4b9f-9143-419c117e8634_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_e2a450ba-dc78-4ff4-b2b1-733cca96b5df_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HealthCareOtherMember_2e2f6c59-6cfb-42fb-9dbd-06c833c7e2ab_terseLabel_en-US" xlink:label="lab_us-gaap_HealthCareOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_HealthCareOtherMember_label_en-US" xlink:label="lab_us-gaap_HealthCareOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care, Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareOtherMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthCareOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HealthCareOtherMember" xlink:to="lab_us-gaap_HealthCareOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_LeverageRatioTwoMember_9d3f5796-e415-43ad-90fd-840bdd7b3a2f_terseLabel_en-US" xlink:label="lab_rdnt_LeverageRatioTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">&gt; 3.00x but &#8804; 3.50x</link:label>
    <link:label id="lab_rdnt_LeverageRatioTwoMember_label_en-US" xlink:label="lab_rdnt_LeverageRatioTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Two [Member]</link:label>
    <link:label id="lab_rdnt_LeverageRatioTwoMember_documentation_en-US" xlink:label="lab_rdnt_LeverageRatioTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioTwoMember" xlink:href="rdnt-20221231.xsd#rdnt_LeverageRatioTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_LeverageRatioTwoMember" xlink:to="lab_rdnt_LeverageRatioTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_66976cbb-745a-438b-92dd-6b84d4e49191_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:to="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease_133d16ea-9663-4e57-902b-6bd075eec7ea_terseLabel_en-US" xlink:label="lab_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt periodic payment, amortization increase</link:label>
    <link:label id="lab_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease_label_en-US" xlink:label="lab_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment Terms, Amortization Increase</link:label>
    <link:label id="lab_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease_documentation_en-US" xlink:label="lab_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment Terms, Amortization Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease" xlink:href="rdnt-20221231.xsd#rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease" xlink:to="lab_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_5ebf3b19-5f49-4b2f-b161-1315e20263cc_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssets_07f732ae-2c6c-4dbc-a01c-0625487766a3_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Assets and Deposits and Other</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_label_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssets" xlink:to="lab_us-gaap_DerivativeAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_A2019SWAPSMember_ed57e5d2-6af0-4ac8-8d32-b711dd419b1f_terseLabel_en-US" xlink:label="lab_rdnt_A2019SWAPSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 SWAPS</link:label>
    <link:label id="lab_rdnt_A2019SWAPSMember_label_en-US" xlink:label="lab_rdnt_A2019SWAPSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 SWAPS [Member]</link:label>
    <link:label id="lab_rdnt_A2019SWAPSMember_documentation_en-US" xlink:label="lab_rdnt_A2019SWAPSMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 SWAPS [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_A2019SWAPSMember" xlink:href="rdnt-20221231.xsd#rdnt_A2019SWAPSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_A2019SWAPSMember" xlink:to="lab_rdnt_A2019SWAPSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax_e25e0220-0e52-4124-a9bb-efdfc1b79a41_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management services provided to BRMG and NY Groups</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Measure of Activity, Income or Loss before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax" xlink:to="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_81a39e1a-7a12-497b-bb59-ddec641886f2_verboseLabel_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In-process research and development</link:label>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_label_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:to="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_d51a829a-5080-4b10-94c2-605c9a333e7c_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain" xlink:to="lab_us-gaap_RelatedPartyTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxContingencies_e9f448ee-fe9d-4ef5-a9d0-65371e599e73_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Uncertain tax provisions</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxContingencies_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Contingency, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationTaxContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:to="lab_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_SharesIssuedSharesSettlementOfContingentConsideration_8a7adfda-4fbd-4c04-a498-aeef68aac710_terseLabel_en-US" xlink:label="lab_rdnt_SharesIssuedSharesSettlementOfContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock to settle DeepHealth contingent consideration (in shares)</link:label>
    <link:label id="lab_rdnt_SharesIssuedSharesSettlementOfContingentConsideration_label_en-US" xlink:label="lab_rdnt_SharesIssuedSharesSettlementOfContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Settlement Of Contingent Consideration</link:label>
    <link:label id="lab_rdnt_SharesIssuedSharesSettlementOfContingentConsideration_documentation_en-US" xlink:label="lab_rdnt_SharesIssuedSharesSettlementOfContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Settlement Of Contingent Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SharesIssuedSharesSettlementOfContingentConsideration" xlink:href="rdnt-20221231.xsd#rdnt_SharesIssuedSharesSettlementOfContingentConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_SharesIssuedSharesSettlementOfContingentConsideration" xlink:to="lab_rdnt_SharesIssuedSharesSettlementOfContingentConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_3395e9f6-9dc1-49a9-958b-f494465e25e6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ZPSmithLLCMember_cfc26bd8-2937-4668-9540-45dbf6bd8d88_terseLabel_en-US" xlink:label="lab_rdnt_ZPSmithLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZP Smith LLC</link:label>
    <link:label id="lab_rdnt_ZPSmithLLCMember_label_en-US" xlink:label="lab_rdnt_ZPSmithLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZP Smith LLC [Member]</link:label>
    <link:label id="lab_rdnt_ZPSmithLLCMember_documentation_en-US" xlink:label="lab_rdnt_ZPSmithLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZP Smith LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ZPSmithLLCMember" xlink:href="rdnt-20221231.xsd#rdnt_ZPSmithLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ZPSmithLLCMember" xlink:to="lab_rdnt_ZPSmithLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_0a1b210c-311c-4425-bb79-9bcc36e9e077_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ERADMember_dcf20f5b-8273-46ed-9162-2e4af9541a2f_terseLabel_en-US" xlink:label="lab_rdnt_ERADMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">eRAD</link:label>
    <link:label id="lab_rdnt_ERADMember_label_en-US" xlink:label="lab_rdnt_ERADMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">eRAD [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ERADMember" xlink:href="rdnt-20221231.xsd#rdnt_ERADMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ERADMember" xlink:to="lab_rdnt_ERADMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_927caa3a-45bc-4a93-9ccc-4c4722676c52_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_CaresActRefundableClaimPercentage_12d13b3c-c086-4af5-afb7-ff67191b6527_terseLabel_en-US" xlink:label="lab_rdnt_CaresActRefundableClaimPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Refundable claim percentage</link:label>
    <link:label id="lab_rdnt_CaresActRefundableClaimPercentage_label_en-US" xlink:label="lab_rdnt_CaresActRefundableClaimPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cares Act, Refundable Claim Percentage</link:label>
    <link:label id="lab_rdnt_CaresActRefundableClaimPercentage_documentation_en-US" xlink:label="lab_rdnt_CaresActRefundableClaimPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cares Act, Refundable Claim Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CaresActRefundableClaimPercentage" xlink:href="rdnt-20221231.xsd#rdnt_CaresActRefundableClaimPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_CaresActRefundableClaimPercentage" xlink:to="lab_rdnt_CaresActRefundableClaimPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SubsidiariesMember_bed3f0c2-4d86-4f83-b8ee-cb6f2b061ef8_terseLabel_en-US" xlink:label="lab_srt_SubsidiariesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiaries</link:label>
    <link:label id="lab_srt_SubsidiariesMember_label_en-US" xlink:label="lab_srt_SubsidiariesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiaries [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SubsidiariesMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SubsidiariesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SubsidiariesMember" xlink:to="lab_srt_SubsidiariesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation_a00d8f00-c9a5-4729-8ff2-d3f70d9d7892_terseLabel_en-US" xlink:label="lab_rdnt_BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency Translation</link:label>
    <link:label id="lab_rdnt_BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation_label_en-US" xlink:label="lab_rdnt_BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Contingent Consideration Arrangements Change In Currency Translation</link:label>
    <link:label id="lab_rdnt_BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation_documentation_en-US" xlink:label="lab_rdnt_BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Contingent Consideration Arrangements Change In Currency Translation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation" xlink:href="rdnt-20221231.xsd#rdnt_BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation" xlink:to="lab_rdnt_BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_534a8de7-635a-4260-b332-39aebd6508d8_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisition, percentage of voting interests acquired</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Percentage of Voting Interests Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_AIMember_a556a8db-ae13-4546-94cd-2e177b6776db_verboseLabel_en-US" xlink:label="lab_rdnt_AIMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AI segment revenue</link:label>
    <link:label id="lab_rdnt_AIMember_987aed5c-29a3-4be4-8a1c-34e7cc6c26ed_terseLabel_en-US" xlink:label="lab_rdnt_AIMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AI</link:label>
    <link:label id="lab_rdnt_AIMember_label_en-US" xlink:label="lab_rdnt_AIMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AI [Member]</link:label>
    <link:label id="lab_rdnt_AIMember_documentation_en-US" xlink:label="lab_rdnt_AIMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AIMember" xlink:href="rdnt-20221231.xsd#rdnt_AIMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_AIMember" xlink:to="lab_rdnt_AIMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PatentAndTrademarksMember_898bec81-7c6d-4d95-bbcf-67dda1365ef8_terseLabel_en-US" xlink:label="lab_rdnt_PatentAndTrademarksMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patent and Trademarks</link:label>
    <link:label id="lab_rdnt_PatentAndTrademarksMember_label_en-US" xlink:label="lab_rdnt_PatentAndTrademarksMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patent and Trademarks [Member]</link:label>
    <link:label id="lab_rdnt_PatentAndTrademarksMember_documentation_en-US" xlink:label="lab_rdnt_PatentAndTrademarksMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patent and Trademarks</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PatentAndTrademarksMember" xlink:href="rdnt-20221231.xsd#rdnt_PatentAndTrademarksMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PatentAndTrademarksMember" xlink:to="lab_rdnt_PatentAndTrademarksMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_67f9fa13-fd5d-4087-be20-c1f2dfbd6160_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ZPBaysideLLCMember_c2e10789-1240-4c67-b884-b6b79b42e828_terseLabel_en-US" xlink:label="lab_rdnt_ZPBaysideLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZP Bayside LLC</link:label>
    <link:label id="lab_rdnt_ZPBaysideLLCMember_label_en-US" xlink:label="lab_rdnt_ZPBaysideLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZP Bayside LLC [Member]</link:label>
    <link:label id="lab_rdnt_ZPBaysideLLCMember_documentation_en-US" xlink:label="lab_rdnt_ZPBaysideLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZP Bayside LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ZPBaysideLLCMember" xlink:href="rdnt-20221231.xsd#rdnt_ZPBaysideLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ZPBaysideLLCMember" xlink:to="lab_rdnt_ZPBaysideLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_SimiAdventistMember_df81d57a-85f3-4997-91fc-157571796cda_terseLabel_en-US" xlink:label="lab_rdnt_SimiAdventistMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Simi Adventist</link:label>
    <link:label id="lab_rdnt_SimiAdventistMember_label_en-US" xlink:label="lab_rdnt_SimiAdventistMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Simi Adventist [Member]</link:label>
    <link:label id="lab_rdnt_SimiAdventistMember_documentation_en-US" xlink:label="lab_rdnt_SimiAdventistMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Simi Adventist</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SimiAdventistMember" xlink:href="rdnt-20221231.xsd#rdnt_SimiAdventistMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_SimiAdventistMember" xlink:to="lab_rdnt_SimiAdventistMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneOne_316296a1-b083-4301-943c-60d052c7c9ae_terseLabel_en-US" xlink:label="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneOne" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of FDA approval and payout, milestone one</link:label>
    <link:label id="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneOne_label_en-US" xlink:label="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneOne" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Percent Of FDA Approval And Payout, Milestone One</link:label>
    <link:label id="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneOne_documentation_en-US" xlink:label="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneOne" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Percent Of FDA Approval And Payout, Milestone One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneOne" xlink:href="rdnt-20221231.xsd#rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneOne"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneOne" xlink:to="lab_rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneOne" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_f70e3c5f-ba2b-4530-be79-df9fcfa5b7df_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_193cc180-e2d2-4b24-8343-6c06d9fba6b5_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_43924d29-1f7d-41e3-aceb-af551b8380ee_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CREDIT FACILITIES AND NOTES PAYABLE</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_98d8abeb-b4db-4311-bb8c-ecffc880571b_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_ad07cbd9-734c-4f4f-beb3-ebb7d913806e_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_d6a79259-3643-4c21-96ca-943e7a517402_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Non deductible expenses</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_39fb5971-7418-4cd2-801f-c5f439403989_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ZPElmontLLCMember_4b277e15-a1bf-428b-8708-92b6ef98fa5c_terseLabel_en-US" xlink:label="lab_rdnt_ZPElmontLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZP Elmont LLC</link:label>
    <link:label id="lab_rdnt_ZPElmontLLCMember_label_en-US" xlink:label="lab_rdnt_ZPElmontLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZP Elmont LLC [Member]</link:label>
    <link:label id="lab_rdnt_ZPElmontLLCMember_documentation_en-US" xlink:label="lab_rdnt_ZPElmontLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZP Elmont LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ZPElmontLLCMember" xlink:href="rdnt-20221231.xsd#rdnt_ZPElmontLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ZPElmontLLCMember" xlink:to="lab_rdnt_ZPElmontLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_adf09a6c-7752-4b0d-9ea2-5ef86bf55c38_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:to="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MediumTermNotesMember_f22d9dca-7406-4657-bc61-d1a6ea521bbb_terseLabel_en-US" xlink:label="lab_us-gaap_MediumTermNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medium-term Notes</link:label>
    <link:label id="lab_us-gaap_MediumTermNotesMember_label_en-US" xlink:label="lab_us-gaap_MediumTermNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medium-term Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediumTermNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MediumTermNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MediumTermNotesMember" xlink:to="lab_us-gaap_MediumTermNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_e6961e32-c3df-44e6-939f-6d157204cd4d_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_b7e7ff25-543d-43d4-955f-9e9f501ca201_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_8da47583-59a9-4610-9977-6c46f69ca853_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemAxis_4f7ec96b-df8d-4b6d-9189-b46881aeed0b_terseLabel_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Axis]</link:label>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemAxis_label_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis" xlink:to="lab_us-gaap_UnusualOrInfrequentItemAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_05e2ccbf-1745-4891-a3da-894bee82e06d_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_901111d7-9542-414a-b18d-4922e8118f4c_terseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BRMG and NY Groups accounts receivable</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_7ada55f0-1479-4f17-905c-9ef78ab907d0_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Contingent Consideration [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Contingent Consideration [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionContingentConsiderationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_0edbc71a-e17c-4342-b647-90dfb1d0a0ee_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_64286e6a-f507-49f4-a238-94615965018c_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 SWAPS - Interest Rate Contracts</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_89672f42-3f17-4b22-966d-1db399e5f04c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts Payable and Accrued Expenses</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_6007540e-9e13-4435-8fa9-9028b194845e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_1d775cf9-39f0-49da-837e-aabaefa014ed_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_QuantibMember_0b8cadf2-2f8d-4200-905b-9181489848f4_terseLabel_en-US" xlink:label="lab_rdnt_QuantibMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quantib</link:label>
    <link:label id="lab_rdnt_QuantibMember_842344eb-b619-441e-812d-73b9a5326ab3_verboseLabel_en-US" xlink:label="lab_rdnt_QuantibMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quantib B.V.</link:label>
    <link:label id="lab_rdnt_QuantibMember_label_en-US" xlink:label="lab_rdnt_QuantibMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quantib [Member]</link:label>
    <link:label id="lab_rdnt_QuantibMember_documentation_en-US" xlink:label="lab_rdnt_QuantibMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quantib</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_QuantibMember" xlink:href="rdnt-20221231.xsd#rdnt_QuantibMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_QuantibMember" xlink:to="lab_rdnt_QuantibMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_a86bd5f6-4676-46ce-a774-1c1c9c4643e7_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RadNet, Inc. stockholders' equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:to="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_41a2ff77-dfc9-4b62-89f7-84439e49e011_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued salary and benefits</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e38bdd1a-c0a1-4266-8157-961956d0ecd8_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INCOME (LOSS) BEFORE INCOME TAXES</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6307ca73-5165-4f8c-9cd4-f50d644e9da7_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_0d2f9941-ab1c-4c9a-be0f-fa561001ae4a_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_06cb8809-c547-441f-b640-3c478cb2e331_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_71f6e106-2c33-490d-b76b-dd1ddee11ec1_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ScheduleOfLeverageRatioTableTextBlock_5ce736e2-1740-4391-acb7-2a2deea627fc_terseLabel_en-US" xlink:label="lab_rdnt_ScheduleOfLeverageRatioTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Leverage Ratio</link:label>
    <link:label id="lab_rdnt_ScheduleOfLeverageRatioTableTextBlock_label_en-US" xlink:label="lab_rdnt_ScheduleOfLeverageRatioTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Leverage Ratio [Table Text Block]</link:label>
    <link:label id="lab_rdnt_ScheduleOfLeverageRatioTableTextBlock_documentation_en-US" xlink:label="lab_rdnt_ScheduleOfLeverageRatioTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Leverage Ratio [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ScheduleOfLeverageRatioTableTextBlock" xlink:href="rdnt-20221231.xsd#rdnt_ScheduleOfLeverageRatioTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ScheduleOfLeverageRatioTableTextBlock" xlink:to="lab_rdnt_ScheduleOfLeverageRatioTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_bd9dd114-d907-4a5c-a30f-528ffbac97cb_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Add additional shares issuable upon exercise of stock options, warrants and holdback shares (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateCapMember_4124e561-19db-4eb1-a3f8-e11ff1172128_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateCapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cap</link:label>
    <link:label id="lab_us-gaap_InterestRateCapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateCapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateCapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateCapMember" xlink:to="lab_us-gaap_InterestRateCapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_b6cf21ce-1fc4-44e7-9b21-af658ceff7d0_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH AND CASH EQUIVALENTS</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_f796b493-4a4f-4fbe-87b8-3549c69c6bd9_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMPREHENSIVE INCOME (LOSS)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_296eb649-7b6d-496f-aed1-918cecfea0ac_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestments_694bae6c-3137-413d-85dc-75789d8d4955_terseLabel_en-US" xlink:label="lab_rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of investments</link:label>
    <link:label id="lab_rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestments_label_en-US" xlink:label="lab_rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Number Of Investments</link:label>
    <link:label id="lab_rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestments_documentation_en-US" xlink:label="lab_rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Number Of Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestments" xlink:href="rdnt-20221231.xsd#rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestments" xlink:to="lab_rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_ede9121c-1392-43fa-aebd-e9cdd04c2015_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss (gain) on extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_48bb63c9-5825-43db-b7ba-70e3c61b83f5_negatedLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_591f8ed0-ff44-4ff5-97f7-1bd2a00aa797_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACCOUNTS RECEIVABLE</link:label>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:to="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_OtherSellersMember_38fda81b-b840-48f7-aed8-7e957f0b9e15_terseLabel_en-US" xlink:label="lab_rdnt_OtherSellersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Sellers</link:label>
    <link:label id="lab_rdnt_OtherSellersMember_label_en-US" xlink:label="lab_rdnt_OtherSellersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Sellers [Member]</link:label>
    <link:label id="lab_rdnt_OtherSellersMember_documentation_en-US" xlink:label="lab_rdnt_OtherSellersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Sellers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OtherSellersMember" xlink:href="rdnt-20221231.xsd#rdnt_OtherSellersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_OtherSellersMember" xlink:to="lab_rdnt_OtherSellersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_dee41957-3a79-413c-a151-c39b97cedcdd_terseLabel_en-US" xlink:label="lab_rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use &amp; Equipment assets obtained in exchange for lease obligations:</link:label>
    <link:label id="lab_rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_label_en-US" xlink:label="lab_rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right Of Use Asset Obtained In Exchange For Lease Liability [Abstract]</link:label>
    <link:label id="lab_rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_documentation_en-US" xlink:label="lab_rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right Of Use Asset Obtained In Exchange For Lease Liability [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:href="rdnt-20221231.xsd#rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:to="lab_rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SoftwareDevelopmentMember_a5441276-d07a-4932-9ea7-25ba2e49aec4_terseLabel_en-US" xlink:label="lab_us-gaap_SoftwareDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software development costs</link:label>
    <link:label id="lab_us-gaap_SoftwareDevelopmentMember_label_en-US" xlink:label="lab_us-gaap_SoftwareDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SoftwareDevelopmentMember" xlink:to="lab_us-gaap_SoftwareDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_dd96223c-4b7c-407c-bb3a-6dfc607b8ceb_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation</link:label>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_3f44be8f-052d-49a5-834b-73bc0644e8f6_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_025e3334-2b63-4462-b899-9b86af10da4b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_4aaa2d14-8c0e-451a-9a5f-c38bd487e483_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent</link:label>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:to="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_4b49630e-a178-43e5-a130-95dd97d856fa_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OPERATING EXPENSES</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_SunTrustMember_128a86e9-393b-43f6-b3e7-4316c0dbe010_terseLabel_en-US" xlink:label="lab_rdnt_SunTrustMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SunTrust</link:label>
    <link:label id="lab_rdnt_SunTrustMember_label_en-US" xlink:label="lab_rdnt_SunTrustMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SunTrust [Member]</link:label>
    <link:label id="lab_rdnt_SunTrustMember_documentation_en-US" xlink:label="lab_rdnt_SunTrustMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SunTrust [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SunTrustMember" xlink:href="rdnt-20221231.xsd#rdnt_SunTrustMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_SunTrustMember" xlink:to="lab_rdnt_SunTrustMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration_d155e856-7b7d-422a-a5da-ea0407ff72cc_terseLabel_en-US" xlink:label="lab_rdnt_BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of contingent consideration</link:label>
    <link:label id="lab_rdnt_BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration_label_en-US" xlink:label="lab_rdnt_BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Issuance Of Contingent Consideration</link:label>
    <link:label id="lab_rdnt_BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration_documentation_en-US" xlink:label="lab_rdnt_BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Issuance Of Contingent Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration" xlink:href="rdnt-20221231.xsd#rdnt_BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration" xlink:to="lab_rdnt_BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_89fb0a71-f1d5-430e-9dfc-c6615a571fb9_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_220d5710-5aa5-4134-a924-dd7eb15ad682_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessAcquisitionsMember_3c71f4f0-ab65-47a4-b8d6-9406de2057d3_terseLabel_en-US" xlink:label="lab_rdnt_BusinessAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisitions</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionsMember_label_en-US" xlink:label="lab_rdnt_BusinessAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisitions [Member]</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionsMember_documentation_en-US" xlink:label="lab_rdnt_BusinessAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionsMember" xlink:href="rdnt-20221231.xsd#rdnt_BusinessAcquisitionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessAcquisitionsMember" xlink:to="lab_rdnt_BusinessAcquisitionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnDerivatives_e613beb6-f71f-4cfe-b1fb-1578243855fd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnDerivatives" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash change in fair value of interest rate swap</link:label>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnDerivatives_label_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnDerivatives" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Derivatives</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnDerivatives" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnDerivatives"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrealizedGainLossOnDerivatives" xlink:to="lab_us-gaap_UnrealizedGainLossOnDerivatives" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_bac9d806-499e-4b39-a6d5-32e0cdfd997b_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred financing costs, net of accumulated amortization</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNet" xlink:to="lab_us-gaap_DeferredFinanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3452efe2-ac4f-461a-ad4d-36097f415d01_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorName_7203e4ec-7cae-4e9c-9d40-b3f06e3fb219_terseLabel_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:label id="lab_dei_AuditorName_label_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName" xlink:to="lab_dei_AuditorName" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest_bf088b86-b791-4b4b-9458-2d2069ff3f77_negatedTerseLabel_en-US" xlink:label="lab_rdnt_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax effect on gain on sale of noncontrolling interest</link:label>
    <link:label id="lab_rdnt_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest_label_en-US" xlink:label="lab_rdnt_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Additional Paid in Capital, Income Tax Effect from Sale of Noncontrolling Interest</link:label>
    <link:label id="lab_rdnt_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest_documentation_en-US" xlink:label="lab_rdnt_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Additional Paid in Capital, Income Tax Effect from Sale of Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest" xlink:href="rdnt-20221231.xsd#rdnt_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest" xlink:to="lab_rdnt_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharePrice_7a942a12-22e7-4c7e-a716-1dbdf8d47fff_terseLabel_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share price</link:label>
    <link:label id="lab_us-gaap_SharePrice_label_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharePrice" xlink:to="lab_us-gaap_SharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_5963ee4b-c227-4520-b7e2-dfa0f988bc91_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforward</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_GlendaleAdvancedImagingMember_6122d600-c16c-4bb5-99f0-718b462eba08_terseLabel_en-US" xlink:label="lab_rdnt_GlendaleAdvancedImagingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Glendale Advanced Imaging</link:label>
    <link:label id="lab_rdnt_GlendaleAdvancedImagingMember_label_en-US" xlink:label="lab_rdnt_GlendaleAdvancedImagingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Glendale Advanced Imaging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GlendaleAdvancedImagingMember" xlink:href="rdnt-20221231.xsd#rdnt_GlendaleAdvancedImagingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_GlendaleAdvancedImagingMember" xlink:to="lab_rdnt_GlendaleAdvancedImagingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_6d72fa79-e597-4c60-97c1-754c5c3bac88_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increases related to prior year tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_5c89474a-de3e-4e01-8ca2-73b3689b5bad_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Periodic payment, principal</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment, Principal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:to="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_AssetsAndLiabilitiesLesseeTableTextBlock_670244e9-d1a8-4d82-9f13-015cf87c7ab7_terseLabel_en-US" xlink:label="lab_rdnt_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Assets and Liabilities Lessee</link:label>
    <link:label id="lab_rdnt_AssetsAndLiabilitiesLesseeTableTextBlock_label_en-US" xlink:label="lab_rdnt_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets And Liabilities Lessee [Table Text Block]</link:label>
    <link:label id="lab_rdnt_AssetsAndLiabilitiesLesseeTableTextBlock_documentation_en-US" xlink:label="lab_rdnt_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Table Text Block] for Assets And Liabilities Lessee [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:href="rdnt-20221231.xsd#rdnt_AssetsAndLiabilitiesLesseeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:to="lab_rdnt_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DevelopedTechnologySoftwareMember_cf12115e-3110-46dc-b628-691e90b149c2_terseLabel_en-US" xlink:label="lab_rdnt_DevelopedTechnologySoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology &amp; Software</link:label>
    <link:label id="lab_rdnt_DevelopedTechnologySoftwareMember_label_en-US" xlink:label="lab_rdnt_DevelopedTechnologySoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology &amp; Software [Member]</link:label>
    <link:label id="lab_rdnt_DevelopedTechnologySoftwareMember_documentation_en-US" xlink:label="lab_rdnt_DevelopedTechnologySoftwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed technology [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DevelopedTechnologySoftwareMember" xlink:href="rdnt-20221231.xsd#rdnt_DevelopedTechnologySoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DevelopedTechnologySoftwareMember" xlink:to="lab_rdnt_DevelopedTechnologySoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquipmentMember_76bef280-1c45-4088-b787-19ad486a4aa6_terseLabel_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical equipment</link:label>
    <link:label id="lab_us-gaap_EquipmentMember_label_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquipmentMember" xlink:to="lab_us-gaap_EquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock_9a90c98d-813c-44b7-b181-ed38e27dbbed_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Service Fee Revenue</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Principal Transactions Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock" xlink:to="lab_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_0b507510-9342-4589-8481-8bc3a19adc67_terseLabel_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIBOR</link:label>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_label_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:to="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_71dcdebd-949c-400e-997a-ced3dbbb33dd_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net revenue</link:label>
    <link:label id="lab_us-gaap_Revenues_6940e914-5d98-4016-a586-9d3b3bd56f6d_verboseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue:</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_41f957ca-1459-4bae-a496-6d61a6e7fe49_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_AuditorInformationAbstract_label_en-US" xlink:label="lab_rdnt_AuditorInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Information [Abstract]</link:label>
    <link:label id="lab_rdnt_AuditorInformationAbstract_documentation_en-US" xlink:label="lab_rdnt_AuditorInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AuditorInformationAbstract" xlink:href="rdnt-20221231.xsd#rdnt_AuditorInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_AuditorInformationAbstract" xlink:to="lab_rdnt_AuditorInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_0301445d-3e8f-4941-b87d-5647a1a3fdc7_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State deferred tax</link:label>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_Caps2016Member_fc3e3dcc-4fe6-4e61-9d61-36ec7680f997_terseLabel_en-US" xlink:label="lab_rdnt_Caps2016Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2016 Caps</link:label>
    <link:label id="lab_rdnt_Caps2016Member_label_en-US" xlink:label="lab_rdnt_Caps2016Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2016 Caps [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_Caps2016Member" xlink:href="rdnt-20221231.xsd#rdnt_Caps2016Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_Caps2016Member" xlink:to="lab_rdnt_Caps2016Member" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_OperatingIncomeLossExcludingReliefFunding_9b01ac5b-9b84-47bd-a156-7fccf33094c5_terseLabel_en-US" xlink:label="lab_rdnt_OperatingIncomeLossExcludingReliefFunding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from Operations</link:label>
    <link:label id="lab_rdnt_OperatingIncomeLossExcludingReliefFunding_label_en-US" xlink:label="lab_rdnt_OperatingIncomeLossExcludingReliefFunding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss) Excluding Relief Funding</link:label>
    <link:label id="lab_rdnt_OperatingIncomeLossExcludingReliefFunding_documentation_en-US" xlink:label="lab_rdnt_OperatingIncomeLossExcludingReliefFunding" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss) Excluding Relief Funding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OperatingIncomeLossExcludingReliefFunding" xlink:href="rdnt-20221231.xsd#rdnt_OperatingIncomeLossExcludingReliefFunding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_OperatingIncomeLossExcludingReliefFunding" xlink:to="lab_rdnt_OperatingIncomeLossExcludingReliefFunding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_51e92416-b4fc-4513-8bbd-4095a57245ea_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid during the period for interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_6c9dc839-44d1-4bda-a2ec-18e87572aab8_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_IFRCLLCSubsidiaryTwoMember_db989624-5711-48a3-b967-fc8d30ba0bec_terseLabel_en-US" xlink:label="lab_rdnt_IFRCLLCSubsidiaryTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">I F R C L L C Subsidiary Two</link:label>
    <link:label id="lab_rdnt_IFRCLLCSubsidiaryTwoMember_label_en-US" xlink:label="lab_rdnt_IFRCLLCSubsidiaryTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">I F R C L L C Subsidiary Two [Member]</link:label>
    <link:label id="lab_rdnt_IFRCLLCSubsidiaryTwoMember_documentation_en-US" xlink:label="lab_rdnt_IFRCLLCSubsidiaryTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">I F R C L L C Subsidiary Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_IFRCLLCSubsidiaryTwoMember" xlink:href="rdnt-20221231.xsd#rdnt_IFRCLLCSubsidiaryTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_IFRCLLCSubsidiaryTwoMember" xlink:to="lab_rdnt_IFRCLLCSubsidiaryTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_73976540-4dca-40ed-928c-dbf2e18ee39b_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_4572ce26-722a-40a8-8784-effd83856737_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total RadNet, Inc.'s stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_97631fc8-aec0-4664-9019-843a6edf0ab3_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_379e7ef6-1c66-4002-8b4e-5300180f43d2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DueToAffiliateCurrent_4a416ac7-76b6-46b2-8e70-dc8d5f0d1244_terseLabel_en-US" xlink:label="lab_us-gaap_DueToAffiliateCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due to affiliates</link:label>
    <link:label id="lab_us-gaap_DueToAffiliateCurrent_label_en-US" xlink:label="lab_us-gaap_DueToAffiliateCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due to Affiliate, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToAffiliateCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToAffiliateCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DueToAffiliateCurrent" xlink:to="lab_us-gaap_DueToAffiliateCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_0a734cd2-2133-4aef-9f41-e01b3c269c18_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:to="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_08de88b9-8209-4bd3-9c86-9336bdb892af_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOther" xlink:to="lab_us-gaap_DeferredTaxAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_d788d6a3-55c5-43b6-bef7-b5c81d3a5483_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization year 2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_OperatingLeaseLiabilityDecreaseDueToAbandonment_06047404-dc3d-48b7-88ea-1f1849bff0a0_terseLabel_en-US" xlink:label="lab_rdnt_OperatingLeaseLiabilityDecreaseDueToAbandonment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liability, decrease due to abandonment</link:label>
    <link:label id="lab_rdnt_OperatingLeaseLiabilityDecreaseDueToAbandonment_label_en-US" xlink:label="lab_rdnt_OperatingLeaseLiabilityDecreaseDueToAbandonment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Decrease Due To Abandonment</link:label>
    <link:label id="lab_rdnt_OperatingLeaseLiabilityDecreaseDueToAbandonment_documentation_en-US" xlink:label="lab_rdnt_OperatingLeaseLiabilityDecreaseDueToAbandonment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Decrease Due To Abandonment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OperatingLeaseLiabilityDecreaseDueToAbandonment" xlink:href="rdnt-20221231.xsd#rdnt_OperatingLeaseLiabilityDecreaseDueToAbandonment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_OperatingLeaseLiabilityDecreaseDueToAbandonment" xlink:to="lab_rdnt_OperatingLeaseLiabilityDecreaseDueToAbandonment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_b33bc0c6-97af-4349-92b9-331c9318023e_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_SimiValleyImagingGroupLLCMember_c299c53e-1181-4d13-a554-bcf50b2580d5_terseLabel_en-US" xlink:label="lab_rdnt_SimiValleyImagingGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Simi Valley Imaging Group, LLC</link:label>
    <link:label id="lab_rdnt_SimiValleyImagingGroupLLCMember_label_en-US" xlink:label="lab_rdnt_SimiValleyImagingGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Simi Valley Imaging Group, LLC [Member]</link:label>
    <link:label id="lab_rdnt_SimiValleyImagingGroupLLCMember_documentation_en-US" xlink:label="lab_rdnt_SimiValleyImagingGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Simi Valley Imaging Group, LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SimiValleyImagingGroupLLCMember" xlink:href="rdnt-20221231.xsd#rdnt_SimiValleyImagingGroupLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_SimiValleyImagingGroupLLCMember" xlink:to="lab_rdnt_SimiValleyImagingGroupLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_57220fab-2c6d-4fe2-8ead-7653c7cd3921_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_fe533797-71de-4238-ba4e-9cfe4c34c45f_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_887b5732-2274-4dc7-9e7d-b4ed83e0be78_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_CashHoldbackMember_6e082d14-ce1f-4c55-9d7c-fd90a3cb455c_terseLabel_en-US" xlink:label="lab_rdnt_CashHoldbackMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Holdback</link:label>
    <link:label id="lab_rdnt_CashHoldbackMember_label_en-US" xlink:label="lab_rdnt_CashHoldbackMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Holdback [Member]</link:label>
    <link:label id="lab_rdnt_CashHoldbackMember_documentation_en-US" xlink:label="lab_rdnt_CashHoldbackMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Holdback</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CashHoldbackMember" xlink:href="rdnt-20221231.xsd#rdnt_CashHoldbackMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_CashHoldbackMember" xlink:to="lab_rdnt_CashHoldbackMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_4f19f66d-b851-4511-8846-ff60d71140ab_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_135e04fa-3a97-47f9-a2f9-964a42616abb_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_f7905d7e-0c2c-4275-863d-4153979866b3_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Lease, Cost</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_7bf7ec05-552a-4630-be14-a0081b08c528_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares available in grant (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_bf61d5fa-4336-4070-8e68-38a84fc870e4_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration to guarantee share value issued</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_b408e7db-b1f2-479b-94a8-2c17abe20c28_periodStartLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beggining balance</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_279fbafc-3411-4d64-a7e3-107c956b2423_periodEndLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_28697ec4-a100-4985-928d-53722cd291c3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of RSA Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_4ded63a9-4447-4495-8896-84dded506570_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">REVENUES</link:label>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_AggregateIntrinsicValue_dfb85108-6f5a-4253-a6e3-b9a3914f330e_terseLabel_en-US" xlink:label="lab_rdnt_AggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value</link:label>
    <link:label id="lab_rdnt_AggregateIntrinsicValue_label_en-US" xlink:label="lab_rdnt_AggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value</link:label>
    <link:label id="lab_rdnt_AggregateIntrinsicValue_documentation_en-US" xlink:label="lab_rdnt_AggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AggregateIntrinsicValue" xlink:href="rdnt-20221231.xsd#rdnt_AggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_AggregateIntrinsicValue" xlink:to="lab_rdnt_AggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_d7666fcd-f4af-42e1-8ec3-b9cee48510d4_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_382d006f-2731-47b7-98ad-1a0f4b15fffa_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_9129b315-551e-42bd-8bae-7532320ebb79_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Effective Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_bc2d70d5-df9e-443a-8861-8cf65a1eda2d_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of stock for acquisitions</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ImagingCentersMember_ce55c02d-046f-47d5-bdf8-39bf4f6b6b50_terseLabel_en-US" xlink:label="lab_rdnt_ImagingCentersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Imaging Centers</link:label>
    <link:label id="lab_rdnt_ImagingCentersMember_label_en-US" xlink:label="lab_rdnt_ImagingCentersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Imaging Centers [Member]</link:label>
    <link:label id="lab_rdnt_ImagingCentersMember_documentation_en-US" xlink:label="lab_rdnt_ImagingCentersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Imaging Centers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ImagingCentersMember" xlink:href="rdnt-20221231.xsd#rdnt_ImagingCentersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ImagingCentersMember" xlink:to="lab_rdnt_ImagingCentersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_NumberOfCenters_2168ed18-b25c-4836-9fb1-3793838ad094_terseLabel_en-US" xlink:label="lab_rdnt_NumberOfCenters" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of centers</link:label>
    <link:label id="lab_rdnt_NumberOfCenters_label_en-US" xlink:label="lab_rdnt_NumberOfCenters" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Centers</link:label>
    <link:label id="lab_rdnt_NumberOfCenters_documentation_en-US" xlink:label="lab_rdnt_NumberOfCenters" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Centers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberOfCenters" xlink:href="rdnt-20221231.xsd#rdnt_NumberOfCenters"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_NumberOfCenters" xlink:to="lab_rdnt_NumberOfCenters" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LetterOfCreditMember_97b32510-43b5-4bf0-ba9f-339ec48a8f10_terseLabel_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit</link:label>
    <link:label id="lab_us-gaap_LetterOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LetterOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LetterOfCreditMember" xlink:to="lab_us-gaap_LetterOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_c1a9b00f-52af-41a1-beb7-e165ba238c30_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer and office equipment, furniture and fixtures</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_2c1cf53c-02ef-4864-8b99-fb87d2a936a5_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term operating lease liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_49e744da-d0c5-42fb-be8e-99b8c4eb5ba2_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ProceedsFromGovernmentAssistance_c37eadb8-291f-42a7-acab-59538e757e69_terseLabel_en-US" xlink:label="lab_rdnt_ProceedsFromGovernmentAssistance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from paycheck protection program loans</link:label>
    <link:label id="lab_rdnt_ProceedsFromGovernmentAssistance_label_en-US" xlink:label="lab_rdnt_ProceedsFromGovernmentAssistance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Government Assistance</link:label>
    <link:label id="lab_rdnt_ProceedsFromGovernmentAssistance_documentation_en-US" xlink:label="lab_rdnt_ProceedsFromGovernmentAssistance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Government Assistance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ProceedsFromGovernmentAssistance" xlink:href="rdnt-20221231.xsd#rdnt_ProceedsFromGovernmentAssistance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ProceedsFromGovernmentAssistance" xlink:to="lab_rdnt_ProceedsFromGovernmentAssistance" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ArizonaDiagnosticsGroupMember_c51f86c1-8a82-4464-ae8a-969d45eb188f_terseLabel_en-US" xlink:label="lab_rdnt_ArizonaDiagnosticsGroupMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arizona Diagnostics Group</link:label>
    <link:label id="lab_rdnt_ArizonaDiagnosticsGroupMember_label_en-US" xlink:label="lab_rdnt_ArizonaDiagnosticsGroupMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arizona Diagnostics Group [Member]</link:label>
    <link:label id="lab_rdnt_ArizonaDiagnosticsGroupMember_documentation_en-US" xlink:label="lab_rdnt_ArizonaDiagnosticsGroupMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arizona Diagnostics Group</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ArizonaDiagnosticsGroupMember" xlink:href="rdnt-20221231.xsd#rdnt_ArizonaDiagnosticsGroupMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ArizonaDiagnosticsGroupMember" xlink:to="lab_rdnt_ArizonaDiagnosticsGroupMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_f3dcb1c2-9911-4bfb-9a6b-0fea732034a2_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected employee contribution</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:to="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_a11e1c9f-a8aa-43bc-987f-dfb779e5c57b_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches_07e7e305-167b-4090-8834-f8b85ea3b5fb_terseLabel_en-US" xlink:label="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of vesting traches</link:label>
    <link:label id="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches_label_en-US" xlink:label="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number Of Vesting Tranches</link:label>
    <link:label id="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches_documentation_en-US" xlink:label="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number Of Vesting Tranches</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches" xlink:href="rdnt-20221231.xsd#rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches" xlink:to="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_eebb2052-ff05-458d-8c8c-28352aefea6c_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite lived intangible assets</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_34a49507-f09d-4f6c-946a-1235de0dab5e_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_feca3d8f-af2f-427d-b2f4-42be0e6b1ff5_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_6e7f4732-81c3-40a8-8d64-13a86cf9468c_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock issued upon conversion (in shares)</link:label>
    <link:label id="lab_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_label_en-US" xlink:label="lab_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock, Shares Issued upon Conversion</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:to="lab_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_5ce3b286-159f-42fc-8bb9-00b8ca562168_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</link:label>
    <link:label id="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_label_en-US" xlink:label="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_65a8de91-8c36-4d47-bd37-e148d3424bd5_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_db8f48d4-e68d-418d-86c7-d51a956c7b52_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_e69f6fbb-103f-4e6c-ac56-b04fc0b05252_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMPREHENSIVE INCOME (LOSS)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_05748c94-e8ca-4c19-9f17-22f0ac4b9adc_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_6bb9a056-c13b-4cde-8c04-f67257cab7c2_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity in earnings of joint ventures, net of dividends</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments, Net of Dividends or Distributions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_873fa1c4-a17c-41a1-8b64-b4af389fbb82_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSA's unvested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_ee7762a8-7a0b-4cda-8d6b-527547bb3b23_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_7a5d1669-a632-46ea-8502-12cbfc906196_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other expenses</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_11be5d66-23a1-47ac-a886-63340f2f4b95_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1fa5b0b7-f16c-4bda-8a6c-f21a1af712aa_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in value of contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_9a63b596-fb9e-4f0b-80f8-4b1ea37f11ee_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of income (loss) recognized on contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_87e268a8-cc1b-4e71-8e4a-671453ac67d4_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use-assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_25ced741-0575-467e-a23d-5e974049b4a4_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b3eefc98-a91d-4f97-bae9-214d65d5fb2b_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive (Loss) Income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorFirmId_9c55fcd0-6135-466c-9ab9-9c89ae939c67_terseLabel_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:label id="lab_dei_AuditorFirmId_label_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId" xlink:to="lab_dei_AuditorFirmId" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_78567675-f549-420d-ac93-7bc263300e79_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_d7d3b8ea-83f5-42b3-ab20-fbad71162fd6_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_2add4999-fef0-4a0a-bb0f-53f74f236577_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Options Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_24a5acd2-bdb3-4dc2-8bee-ce9f10a4b4e9_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INCOME FROM OPERATIONS</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_db41a3f4-96fc-4c5a-95a0-b3a7c98bdf40_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACCOUNTING STANDARDS ADOPTED AND ACCOUNTING STANDARDS NOT YET ADOPTED</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod_0f12fd09-db36-4d88-a16e-9d018121eeac_negatedTerseLabel_en-US" xlink:label="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award, Equity Instruments Other Than Options, Forfeited Or Cancelled In Period</link:label>
    <link:label id="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod_label_en-US" xlink:label="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award, Equity Instruments Other Than Options, Forfeited Or Cancelled In Period</link:label>
    <link:label id="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod_documentation_en-US" xlink:label="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award, Equity Instruments Other Than Options, Forfeited Or Cancelled In Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod" xlink:href="rdnt-20221231.xsd#rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod" xlink:to="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones_d663affb-13ca-4cee-b1ba-9d9d7adb0760_terseLabel_en-US" xlink:label="lab_rdnt_BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of identified milestones</link:label>
    <link:label id="lab_rdnt_BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones_label_en-US" xlink:label="lab_rdnt_BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Number Of Identified Milestones</link:label>
    <link:label id="lab_rdnt_BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones_documentation_en-US" xlink:label="lab_rdnt_BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Number Of Identified Milestones</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones" xlink:href="rdnt-20221231.xsd#rdnt_BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones" xlink:to="lab_rdnt_BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_LongTermIncentivePlanSharesMember_c176960c-86d5-4a71-a2cb-3f64158ec1dc_terseLabel_en-US" xlink:label="lab_rdnt_LongTermIncentivePlanSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LTIPs</link:label>
    <link:label id="lab_rdnt_LongTermIncentivePlanSharesMember_label_en-US" xlink:label="lab_rdnt_LongTermIncentivePlanSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Incentive Plan Shares [Member]</link:label>
    <link:label id="lab_rdnt_LongTermIncentivePlanSharesMember_documentation_en-US" xlink:label="lab_rdnt_LongTermIncentivePlanSharesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Incentive Plan Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LongTermIncentivePlanSharesMember" xlink:href="rdnt-20221231.xsd#rdnt_LongTermIncentivePlanSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_LongTermIncentivePlanSharesMember" xlink:to="lab_rdnt_LongTermIncentivePlanSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_f10f60ff-6bb2-49ef-854e-2fce60ec33d8_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ZPLaureltonLLCMember_de8b91e4-c933-43fa-9cb1-6cd3ebf59dc8_terseLabel_en-US" xlink:label="lab_rdnt_ZPLaureltonLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZP Laurelton LLC</link:label>
    <link:label id="lab_rdnt_ZPLaureltonLLCMember_label_en-US" xlink:label="lab_rdnt_ZPLaureltonLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZP Laurelton LLC [Member]</link:label>
    <link:label id="lab_rdnt_ZPLaureltonLLCMember_documentation_en-US" xlink:label="lab_rdnt_ZPLaureltonLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZP Laurelton LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ZPLaureltonLLCMember" xlink:href="rdnt-20221231.xsd#rdnt_ZPLaureltonLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ZPLaureltonLLCMember" xlink:to="lab_rdnt_ZPLaureltonLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetImpairment_350826e1-df2e-4821-b11a-36aff7ab9794_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on impairment</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetImpairment_c038ed97-b3bb-4879-b597-6058c64df498_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on impairment</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetImpairment_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Asset Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_594780d9-bc74-4165-9736-ecbac412527a_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_label_en-US" xlink:label="lab_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:to="lab_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvesteeMember_7c00b61a-4ef3-4597-a6c4-742fb5a0df93_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvesteeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investee</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvesteeMember_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvesteeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investee [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvesteeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvesteeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvesteeMember" xlink:to="lab_us-gaap_EquityMethodInvesteeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_27b83e3e-1072-474c-a535-37693e553497_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign rate differential</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2f2d6cdd-7c03-47fc-a61f-2a827ca76b7f_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income (loss)&#160;to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_1c2155dc-6184-4ac6-b3c4-bb5efb39fba5_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GOODWILL AND OTHER INTANGIBLE ASSETS</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_c73dca5b-762d-48e9-854f-1b575dee8584_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_fe009de0-c1e0-4419-b9c7-17cf924d509c_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PROPERTY AND EQUIPMENT</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_2ec7ef2a-5042-4afc-88e2-5fcf748b3933_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_1a53a7c7-faef-4192-840b-22cf67e27ce6_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_81ef301a-4a11-4f3e-a5df-a5168bc21098_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_cd6996f6-76ab-4e5f-a456-515db590f3ed_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal deferred tax</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_2addd7b6-664f-4526-8591-2b410154f290_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of long lived asset</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment, Long-Lived Asset, Held-for-Use</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:to="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_db80fe66-f45c-4284-bb17-d49defa0220b_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_4fa6c078-7569-4569-94cd-2b0eccbe99aa_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_8a137e45-f851-4721-9634-75ab783c021d_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BASIC NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_4bfeeccc-a9be-4401-9da3-bbc185861312_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_eb6fe4b6-ec2b-4825-8ad7-ad9e157cbf01_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of common shares used in calculating diluted net income per share (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_OperatingLeaseRightOfUseAssetDecreaseDueToAbandonment_116cfd18-8938-4186-b0a8-737418579c31_terseLabel_en-US" xlink:label="lab_rdnt_OperatingLeaseRightOfUseAssetDecreaseDueToAbandonment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease asset decrease due to abandonment</link:label>
    <link:label id="lab_rdnt_OperatingLeaseRightOfUseAssetDecreaseDueToAbandonment_label_en-US" xlink:label="lab_rdnt_OperatingLeaseRightOfUseAssetDecreaseDueToAbandonment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Decrease Due To Abandonment</link:label>
    <link:label id="lab_rdnt_OperatingLeaseRightOfUseAssetDecreaseDueToAbandonment_documentation_en-US" xlink:label="lab_rdnt_OperatingLeaseRightOfUseAssetDecreaseDueToAbandonment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Decrease Due To Abandonment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OperatingLeaseRightOfUseAssetDecreaseDueToAbandonment" xlink:href="rdnt-20221231.xsd#rdnt_OperatingLeaseRightOfUseAssetDecreaseDueToAbandonment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_OperatingLeaseRightOfUseAssetDecreaseDueToAbandonment" xlink:to="lab_rdnt_OperatingLeaseRightOfUseAssetDecreaseDueToAbandonment" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_03d58998-47bc-4582-9ce5-e0236507e0c4_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BaseRateMember_d90cf78c-e342-4f73-aa3e-85e4c0e236c8_terseLabel_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate Spread</link:label>
    <link:label id="lab_us-gaap_BaseRateMember_label_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BaseRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BaseRateMember" xlink:to="lab_us-gaap_BaseRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_5abb5d3f-cefd-40ac-bbfb-99fa4a244ee7_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsGross" xlink:to="lab_us-gaap_DeferredFinanceCostsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_f0efeabf-21e0-4fed-b253-93f6d9d801e8_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DeepHealthIncMember_4e65698a-6aca-4924-80a7-fb06cd405cd6_terseLabel_en-US" xlink:label="lab_rdnt_DeepHealthIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DeepHealth, Inc.</link:label>
    <link:label id="lab_rdnt_DeepHealthIncMember_label_en-US" xlink:label="lab_rdnt_DeepHealthIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DeepHealth, Inc. [Member]</link:label>
    <link:label id="lab_rdnt_DeepHealthIncMember_documentation_en-US" xlink:label="lab_rdnt_DeepHealthIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DeepHealth, Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeepHealthIncMember" xlink:href="rdnt-20221231.xsd#rdnt_DeepHealthIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DeepHealthIncMember" xlink:to="lab_rdnt_DeepHealthIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DebtInstrumentNumberOfAmendments_e29b50f1-4b6c-4a3f-95d4-99bd5efeda2f_terseLabel_en-US" xlink:label="lab_rdnt_DebtInstrumentNumberOfAmendments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of amendments</link:label>
    <link:label id="lab_rdnt_DebtInstrumentNumberOfAmendments_label_en-US" xlink:label="lab_rdnt_DebtInstrumentNumberOfAmendments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Number Of Amendments</link:label>
    <link:label id="lab_rdnt_DebtInstrumentNumberOfAmendments_documentation_en-US" xlink:label="lab_rdnt_DebtInstrumentNumberOfAmendments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Number Of Amendments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentNumberOfAmendments" xlink:href="rdnt-20221231.xsd#rdnt_DebtInstrumentNumberOfAmendments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DebtInstrumentNumberOfAmendments" xlink:to="lab_rdnt_DebtInstrumentNumberOfAmendments" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ContingentMilestoneConsiderationMember_72bf92cd-2fb8-4194-a8bf-6f0da2944518_terseLabel_en-US" xlink:label="lab_rdnt_ContingentMilestoneConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Milestone Consideration</link:label>
    <link:label id="lab_rdnt_ContingentMilestoneConsiderationMember_label_en-US" xlink:label="lab_rdnt_ContingentMilestoneConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Milestone Consideration [Member]</link:label>
    <link:label id="lab_rdnt_ContingentMilestoneConsiderationMember_documentation_en-US" xlink:label="lab_rdnt_ContingentMilestoneConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Milestone Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ContingentMilestoneConsiderationMember" xlink:href="rdnt-20221231.xsd#rdnt_ContingentMilestoneConsiderationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ContingentMilestoneConsiderationMember" xlink:to="lab_rdnt_ContingentMilestoneConsiderationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_882e2ab2-e223-46ac-b04a-d597634b73a9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_90d4c485-22e3-456b-b0b7-fcd3fedbbf10_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate value exercisable</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuritiesFinancingTransactionTypeDomain_263f7a14-2340-44ad-a2c2-ecd66b74390d_terseLabel_en-US" xlink:label="lab_us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities Financing Transaction [Domain]</link:label>
    <link:label id="lab_us-gaap_SecuritiesFinancingTransactionTypeDomain_label_en-US" xlink:label="lab_us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities Financing Transaction [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuritiesFinancingTransactionTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:to="lab_us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PatientServicesNetMember_6c11e390-6a7c-45e0-a07b-c2d841bf8907_verboseLabel_en-US" xlink:label="lab_rdnt_PatientServicesNetMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net service fee revenue</link:label>
    <link:label id="lab_rdnt_PatientServicesNetMember_label_en-US" xlink:label="lab_rdnt_PatientServicesNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patient Services, Net [Member]</link:label>
    <link:label id="lab_rdnt_PatientServicesNetMember_documentation_en-US" xlink:label="lab_rdnt_PatientServicesNetMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patient Services, Net [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PatientServicesNetMember" xlink:href="rdnt-20221231.xsd#rdnt_PatientServicesNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PatientServicesNetMember" xlink:to="lab_rdnt_PatientServicesNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_Medicare1Member_9bb86343-833a-4ca0-91a8-173c2521e166_terseLabel_en-US" xlink:label="lab_rdnt_Medicare1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare</link:label>
    <link:label id="lab_rdnt_Medicare1Member_label_en-US" xlink:label="lab_rdnt_Medicare1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare1 [Member]</link:label>
    <link:label id="lab_rdnt_Medicare1Member_documentation_en-US" xlink:label="lab_rdnt_Medicare1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_Medicare1Member" xlink:href="rdnt-20221231.xsd#rdnt_Medicare1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_Medicare1Member" xlink:to="lab_rdnt_Medicare1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_7fdc2bb8-b8de-42c2-b3ee-106ee9a72f3f_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ForeignOperatingLossCarryforwardsNotSubjectToExpiration_09245fc1-ba4b-4f62-ae00-afbbb14d029c_terseLabel_en-US" xlink:label="lab_rdnt_ForeignOperatingLossCarryforwardsNotSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Operating Loss Carryforwards, Not Subject To Expiration</link:label>
    <link:label id="lab_rdnt_ForeignOperatingLossCarryforwardsNotSubjectToExpiration_label_en-US" xlink:label="lab_rdnt_ForeignOperatingLossCarryforwardsNotSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Operating Loss Carryforwards, Not Subject To Expiration</link:label>
    <link:label id="lab_rdnt_ForeignOperatingLossCarryforwardsNotSubjectToExpiration_documentation_en-US" xlink:label="lab_rdnt_ForeignOperatingLossCarryforwardsNotSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Operating Loss Carryforwards, Not Subject To Expiration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ForeignOperatingLossCarryforwardsNotSubjectToExpiration" xlink:href="rdnt-20221231.xsd#rdnt_ForeignOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ForeignOperatingLossCarryforwardsNotSubjectToExpiration" xlink:to="lab_rdnt_ForeignOperatingLossCarryforwardsNotSubjectToExpiration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_90574cd0-af46-4cfa-aaa2-237f22018ebf_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investment in Joint Ventures</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:to="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_85b00a57-c3c1-492a-b206-51fcbd01b0d4_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock - issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_c352c0f9-501e-4fd0-a0e8-c579ee59699d_verboseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of investment</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_549f96c7-6c1d-4e27-8c90-acd845e53cb4_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Book value of RadNet joint venture interests</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_NorthJerseyImagingCenterLLCMember_cb5eb6ed-8b61-45b5-8195-afb0c943a012_terseLabel_en-US" xlink:label="lab_rdnt_NorthJerseyImagingCenterLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">North Jersey Imaging Center, LLC</link:label>
    <link:label id="lab_rdnt_NorthJerseyImagingCenterLLCMember_label_en-US" xlink:label="lab_rdnt_NorthJerseyImagingCenterLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">North Jersey Imaging Center, LLC [Member]</link:label>
    <link:label id="lab_rdnt_NorthJerseyImagingCenterLLCMember_documentation_en-US" xlink:label="lab_rdnt_NorthJerseyImagingCenterLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">North Jersey Imaging Center, LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NorthJerseyImagingCenterLLCMember" xlink:href="rdnt-20221231.xsd#rdnt_NorthJerseyImagingCenterLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_NorthJerseyImagingCenterLLCMember" xlink:to="lab_rdnt_NorthJerseyImagingCenterLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_AdjustmentsToAdditionalPaidInCapitalGainOnContributionOfAssetsToSubsidiary_2596bfb9-0056-4d6a-9803-a776534b634a_negatedTerseLabel_en-US" xlink:label="lab_rdnt_AdjustmentsToAdditionalPaidInCapitalGainOnContributionOfAssetsToSubsidiary" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on contribution of assets to majority owned subsidiary</link:label>
    <link:label id="lab_rdnt_AdjustmentsToAdditionalPaidInCapitalGainOnContributionOfAssetsToSubsidiary_label_en-US" xlink:label="lab_rdnt_AdjustmentsToAdditionalPaidInCapitalGainOnContributionOfAssetsToSubsidiary" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Gain on Contribution Of Assets To Subsidiary</link:label>
    <link:label id="lab_rdnt_AdjustmentsToAdditionalPaidInCapitalGainOnContributionOfAssetsToSubsidiary_documentation_en-US" xlink:label="lab_rdnt_AdjustmentsToAdditionalPaidInCapitalGainOnContributionOfAssetsToSubsidiary" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Gain on Contribution Of Assets To Subsidiary</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AdjustmentsToAdditionalPaidInCapitalGainOnContributionOfAssetsToSubsidiary" xlink:href="rdnt-20221231.xsd#rdnt_AdjustmentsToAdditionalPaidInCapitalGainOnContributionOfAssetsToSubsidiary"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_AdjustmentsToAdditionalPaidInCapitalGainOnContributionOfAssetsToSubsidiary" xlink:to="lab_rdnt_AdjustmentsToAdditionalPaidInCapitalGainOnContributionOfAssetsToSubsidiary" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_UninsuredRisksPolicyTextBlock_766e7ef6-7545-4385-bc9b-432ed37ff09e_terseLabel_en-US" xlink:label="lab_rdnt_UninsuredRisksPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNINSURED RISKS</link:label>
    <link:label id="lab_rdnt_UninsuredRisksPolicyTextBlock_label_en-US" xlink:label="lab_rdnt_UninsuredRisksPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Uninsured Risks [Policy Text Block]</link:label>
    <link:label id="lab_rdnt_UninsuredRisksPolicyTextBlock_documentation_en-US" xlink:label="lab_rdnt_UninsuredRisksPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Uninsured Risks [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_UninsuredRisksPolicyTextBlock" xlink:href="rdnt-20221231.xsd#rdnt_UninsuredRisksPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_UninsuredRisksPolicyTextBlock" xlink:to="lab_rdnt_UninsuredRisksPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_ca788b18-622d-471e-884a-60ecc731ba61_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_6825725e-71a1-423b-8339-7d63705bf4fd_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, face amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityAbstract_8a745253-9dea-430a-b38c-b819918a9655_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease cost:</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityAbstract_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityAbstract" xlink:to="lab_us-gaap_FinanceLeaseLiabilityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_f56dc0ef-7685-45bd-a3d8-6a0f3c4591a3_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INVESTMENT IN JOINT VENTURES</link:label>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentPolicyTextBlock" xlink:to="lab_us-gaap_InvestmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_3a2ed5af-5285-413f-8d8f-295254f82ef5_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMPREHENSIVE INCOME (LOSS) ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_EquityContributionsInExistingAndPurchaseOfInterestInJointVentures_6a232bb6-08d4-4263-bd42-9fe0887977ff_terseLabel_en-US" xlink:label="lab_rdnt_EquityContributionsInExistingAndPurchaseOfInterestInJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity contributions in existing and purchase of interest in joint ventures</link:label>
    <link:label id="lab_rdnt_EquityContributionsInExistingAndPurchaseOfInterestInJointVentures_label_en-US" xlink:label="lab_rdnt_EquityContributionsInExistingAndPurchaseOfInterestInJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Contributions in Existing and Purchase of Interest in Joint Ventures</link:label>
    <link:label id="lab_rdnt_EquityContributionsInExistingAndPurchaseOfInterestInJointVentures_documentation_en-US" xlink:label="lab_rdnt_EquityContributionsInExistingAndPurchaseOfInterestInJointVentures" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity contributions in existing joint ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityContributionsInExistingAndPurchaseOfInterestInJointVentures" xlink:href="rdnt-20221231.xsd#rdnt_EquityContributionsInExistingAndPurchaseOfInterestInJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_EquityContributionsInExistingAndPurchaseOfInterestInJointVentures" xlink:to="lab_rdnt_EquityContributionsInExistingAndPurchaseOfInterestInJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_September2020CapMember_bc700d3a-0ae0-48c0-93ed-c0328844f031_terseLabel_en-US" xlink:label="lab_rdnt_September2020CapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">September 2020</link:label>
    <link:label id="lab_rdnt_September2020CapMember_label_en-US" xlink:label="lab_rdnt_September2020CapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">September 2020 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_September2020CapMember" xlink:href="rdnt-20221231.xsd#rdnt_September2020CapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_September2020CapMember" xlink:to="lab_rdnt_September2020CapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_f635db3a-79ef-4c33-aa05-54ef74275a48_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of common stock upon exercise of options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DebtInstrumentPeriodicPaymentPercent_d1d7d9e8-b238-4347-931f-6608b179f523_terseLabel_en-US" xlink:label="lab_rdnt_DebtInstrumentPeriodicPaymentPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt periodic payment, percent of total amount</link:label>
    <link:label id="lab_rdnt_DebtInstrumentPeriodicPaymentPercent_label_en-US" xlink:label="lab_rdnt_DebtInstrumentPeriodicPaymentPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment, Percent</link:label>
    <link:label id="lab_rdnt_DebtInstrumentPeriodicPaymentPercent_documentation_en-US" xlink:label="lab_rdnt_DebtInstrumentPeriodicPaymentPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentPeriodicPaymentPercent" xlink:href="rdnt-20221231.xsd#rdnt_DebtInstrumentPeriodicPaymentPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DebtInstrumentPeriodicPaymentPercent" xlink:to="lab_rdnt_DebtInstrumentPeriodicPaymentPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_f2b8e1ee-9992-4b6b-8079-a39c2b7b08df_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_70c917f6-0fdf-4e42-a168-c782a00f6568_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity's Reporting Status Current</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_616631f8-bcac-49c3-ba3b-33bb39407670_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss carryforwards, not subject to expiration</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DeferredTaxAssetsOperatingLeaseLiabilities_e7e9abb4-3ffc-42e7-aa3c-8fb917d6dd81_terseLabel_en-US" xlink:label="lab_rdnt_DeferredTaxAssetsOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liability</link:label>
    <link:label id="lab_rdnt_DeferredTaxAssetsOperatingLeaseLiabilities_label_en-US" xlink:label="lab_rdnt_DeferredTaxAssetsOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Lease Liabilities</link:label>
    <link:label id="lab_rdnt_DeferredTaxAssetsOperatingLeaseLiabilities_documentation_en-US" xlink:label="lab_rdnt_DeferredTaxAssetsOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeferredTaxAssetsOperatingLeaseLiabilities" xlink:href="rdnt-20221231.xsd#rdnt_DeferredTaxAssetsOperatingLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DeferredTaxAssetsOperatingLeaseLiabilities" xlink:to="lab_rdnt_DeferredTaxAssetsOperatingLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_COVID19PandemicMember_cb10f387-80dc-4455-836a-6b208f16e512_terseLabel_en-US" xlink:label="lab_rdnt_COVID19PandemicMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">C O V I D19 Pandemic</link:label>
    <link:label id="lab_rdnt_COVID19PandemicMember_label_en-US" xlink:label="lab_rdnt_COVID19PandemicMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">C O V I D19 Pandemic [Member]</link:label>
    <link:label id="lab_rdnt_COVID19PandemicMember_documentation_en-US" xlink:label="lab_rdnt_COVID19PandemicMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">C O V I D19 Pandemic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_COVID19PandemicMember" xlink:href="rdnt-20221231.xsd#rdnt_COVID19PandemicMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_COVID19PandemicMember" xlink:to="lab_rdnt_COVID19PandemicMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PerformanceBasedStockUnitsMember_1909d73a-680e-4658-806d-828ecc41e2a3_terseLabel_en-US" xlink:label="lab_rdnt_PerformanceBasedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Based Stock Units</link:label>
    <link:label id="lab_rdnt_PerformanceBasedStockUnitsMember_label_en-US" xlink:label="lab_rdnt_PerformanceBasedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Based Stock Units [Member]</link:label>
    <link:label id="lab_rdnt_PerformanceBasedStockUnitsMember_documentation_en-US" xlink:label="lab_rdnt_PerformanceBasedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Based Stock Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PerformanceBasedStockUnitsMember" xlink:href="rdnt-20221231.xsd#rdnt_PerformanceBasedStockUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PerformanceBasedStockUnitsMember" xlink:to="lab_rdnt_PerformanceBasedStockUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract_ee03b7c6-446b-4251-b737-56945f002bee_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PROPERTY, EQUIPMENT AND RIGHT-OF-USE ASSETS</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net, Including and Excluding Capital Leased Asset [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_WorkersCompensationPersonalInjury1Member_ea8211e6-e014-4378-9f24-49eff640f5d4_terseLabel_en-US" xlink:label="lab_rdnt_WorkersCompensationPersonalInjury1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Workers' compensation/personal injury</link:label>
    <link:label id="lab_rdnt_WorkersCompensationPersonalInjury1Member_label_en-US" xlink:label="lab_rdnt_WorkersCompensationPersonalInjury1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Workers' Compensation/Personal Injury1 [Member]</link:label>
    <link:label id="lab_rdnt_WorkersCompensationPersonalInjury1Member_documentation_en-US" xlink:label="lab_rdnt_WorkersCompensationPersonalInjury1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Workers' Compensation/Personal Injury1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WorkersCompensationPersonalInjury1Member" xlink:href="rdnt-20221231.xsd#rdnt_WorkersCompensationPersonalInjury1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_WorkersCompensationPersonalInjury1Member" xlink:to="lab_rdnt_WorkersCompensationPersonalInjury1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DebtInstrumentNumberofLoansReceived_c87c11fc-1989-452e-85d5-b3186d3a3eaa_terseLabel_en-US" xlink:label="lab_rdnt_DebtInstrumentNumberofLoansReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of PPP loans received</link:label>
    <link:label id="lab_rdnt_DebtInstrumentNumberofLoansReceived_label_en-US" xlink:label="lab_rdnt_DebtInstrumentNumberofLoansReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Number of Loans Received</link:label>
    <link:label id="lab_rdnt_DebtInstrumentNumberofLoansReceived_documentation_en-US" xlink:label="lab_rdnt_DebtInstrumentNumberofLoansReceived" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Number of Loans Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentNumberofLoansReceived" xlink:href="rdnt-20221231.xsd#rdnt_DebtInstrumentNumberofLoansReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DebtInstrumentNumberofLoansReceived" xlink:to="lab_rdnt_DebtInstrumentNumberofLoansReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares_c65ab467-b08f-4f56-b0ff-ca455d4bff23_terseLabel_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisition, equity interest issued or issuable, additional number of shares</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares_label_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Additional Number of Shares</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares_documentation_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Additional Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares" xlink:href="rdnt-20221231.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares" xlink:to="lab_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3db0f70d-d210-446a-ba4b-b49458c36e47_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_7893fd5b-3414-4d2f-8ad1-ad857166f41b_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2e815621-53cc-4b5f-a7ff-f3e2b11277db_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EFFECT OF EXCHANGE RATE CHANGES ON CASH</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_059fb465-acb0-482b-a29d-ae9114655477_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_f51b49df-26e3-407c-af49-8bf8c5a1ee4b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Annual Amortization Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_34e98588-c091-42c5-b61f-b451db6f84a8_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Separately Recognized Transactions [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Separately Recognized Transactions [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" xlink:to="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_FirstLienCreditAgreementEighthAmendmentMember_154d252a-1fcd-4208-9cf1-caa3a709d244_terseLabel_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementEighthAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Credit Agreement Eighth Amendment</link:label>
    <link:label id="lab_rdnt_FirstLienCreditAgreementEighthAmendmentMember_label_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementEighthAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Credit Agreement Eighth Amendment [Member]</link:label>
    <link:label id="lab_rdnt_FirstLienCreditAgreementEighthAmendmentMember_documentation_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementEighthAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Credit Agreement Eighth Amendment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementEighthAmendmentMember" xlink:href="rdnt-20221231.xsd#rdnt_FirstLienCreditAgreementEighthAmendmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_FirstLienCreditAgreementEighthAmendmentMember" xlink:to="lab_rdnt_FirstLienCreditAgreementEighthAmendmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_4b93e688-4a60-4908-9354-d09f38f70fd5_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_85e5853a-b5b1-4888-8959-f1f1f05c8e4a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase agreements</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_cd6fcd89-f269-4d20-953e-66089620a97b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_c49e7a47-d1ec-486b-bc09-8a75d6f256a6_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_cf915444-fd0a-4107-b726-d71ce79ceb60_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt obligations</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_11db92d7-41bf-4754-af7f-2e56d52d5b76_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expenses</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_9fc3bbaa-aea7-4f91-8b16-d49b7a1f1f3a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combination, contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ForeignOperatingLossCarryforwardsSubjectToExpiration_b019023b-0f28-44e5-b35d-d30d0fc483f7_terseLabel_en-US" xlink:label="lab_rdnt_ForeignOperatingLossCarryforwardsSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Operating Loss Carryforwards, Subject To Expiration</link:label>
    <link:label id="lab_rdnt_ForeignOperatingLossCarryforwardsSubjectToExpiration_label_en-US" xlink:label="lab_rdnt_ForeignOperatingLossCarryforwardsSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Operating Loss Carryforwards, Subject To Expiration</link:label>
    <link:label id="lab_rdnt_ForeignOperatingLossCarryforwardsSubjectToExpiration_documentation_en-US" xlink:label="lab_rdnt_ForeignOperatingLossCarryforwardsSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Operating Loss Carryforwards, Subject To Expiration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ForeignOperatingLossCarryforwardsSubjectToExpiration" xlink:href="rdnt-20221231.xsd#rdnt_ForeignOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ForeignOperatingLossCarryforwardsSubjectToExpiration" xlink:to="lab_rdnt_ForeignOperatingLossCarryforwardsSubjectToExpiration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_49bc1be8-5dc6-4c8b-b710-cdf650944945_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans_cc05e93c-5901-4ae4-8659-cdc080a29683_terseLabel_en-US" xlink:label="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of plans</link:label>
    <link:label id="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans_label_en-US" xlink:label="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Plans</link:label>
    <link:label id="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans_documentation_en-US" xlink:label="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans" xlink:href="rdnt-20221231.xsd#rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans" xlink:to="lab_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_28db8abd-7dd0-4bf4-83f9-19aef36ea2d0_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_a363fa96-1b4e-4271-85ec-4fc66cb098d9_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_MedicVisionMember_402f6b42-839d-4cdc-a91b-481bb5f95b26_terseLabel_en-US" xlink:label="lab_rdnt_MedicVisionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medic Vision</link:label>
    <link:label id="lab_rdnt_MedicVisionMember_label_en-US" xlink:label="lab_rdnt_MedicVisionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medic Vision [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MedicVisionMember" xlink:href="rdnt-20221231.xsd#rdnt_MedicVisionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_MedicVisionMember" xlink:to="lab_rdnt_MedicVisionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_21d61c2d-dd90-4df4-8ee5-ec4043a0acaa_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid during the period for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_f53f318e-881c-47c4-a323-235e3d27cea5_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_eca35e68-0d68-456a-b67f-1f79800b394c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:to="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_5577d89a-d58a-47d1-8b02-0b132d6b2d5f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Amortization Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_caed2130-ba7b-4905-aec8-285c37373bf2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_685cd1cb-708d-4085-98e1-2f98d9fe0904_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">REVENUE</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_12e2245e-d428-42bb-b4ed-2c84abd056b3_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortiztion total</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_b3e0aec4-221b-4ba0-ae9b-a8c1203ec206_negatedLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions paid to noncontrolling&#160;interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_455d5947-1905-4c15-bc67-b9a74a75b9a9_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, remaining performance obligation, expected timing of satisfaction, period</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_52d4b372-9f5c-4f13-842f-40f874dcc3cd_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_3a624c6d-7c8e-43d7-b116-454d5a3b5b26_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional amounts</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:to="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_72dd3f06-ea12-4108-8142-cbbf8123f0b2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_80017718-b1e1-4580-a87e-23771f31ad2c_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PROPERTY AND EQUIPMENT</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_94835940-a111-400a-9674-3aab19b5f3a8_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate value outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_89909b6b-4386-4fde-b59e-ebda092484c4_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_80347a12-f015-44ae-b855-597a0e3a1d12_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesAxis" xlink:to="lab_srt_ConsolidatedEntitiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization_d7b9d97e-3368-4d5b-bbe1-6ad11c816c62_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions_52ae6642-a08c-428e-9654-bb1446f271b1_negatedLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution of earnings</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Equity Method Investment, Distribution</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentDividendsOrDistributions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:to="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_MedicalInsuranceStopLossPolicyClaimAmount_64f8b3bb-f8ff-468f-864c-8b2b0d22d8eb_terseLabel_en-US" xlink:label="lab_rdnt_MedicalInsuranceStopLossPolicyClaimAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stop loss policy claim amount</link:label>
    <link:label id="lab_rdnt_MedicalInsuranceStopLossPolicyClaimAmount_label_en-US" xlink:label="lab_rdnt_MedicalInsuranceStopLossPolicyClaimAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Insurance, Stop Loss Policy Claim Amount</link:label>
    <link:label id="lab_rdnt_MedicalInsuranceStopLossPolicyClaimAmount_documentation_en-US" xlink:label="lab_rdnt_MedicalInsuranceStopLossPolicyClaimAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Insurance, Stop Loss Policy Claim Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MedicalInsuranceStopLossPolicyClaimAmount" xlink:href="rdnt-20221231.xsd#rdnt_MedicalInsuranceStopLossPolicyClaimAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_MedicalInsuranceStopLossPolicyClaimAmount" xlink:to="lab_rdnt_MedicalInsuranceStopLossPolicyClaimAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_4c3dd331-d90b-4393-81f6-1065cb8a978f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_b8cfc3e7-195e-415f-9851-2b9a4e21ec96_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued under the equity compensation plan (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_c1837541-8200-4de9-8a7d-7e803a13ee75_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional deferred finance costs on revolving loan amendment</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_89ee4d38-7456-423a-adee-e69bfc8d2843_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_8978b9c1-76eb-425a-a071-3063c36098ab_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DebtInstrumentExtensionPeriod_0286d660-d8db-42de-95dc-f2820b403e92_terseLabel_en-US" xlink:label="lab_rdnt_DebtInstrumentExtensionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, extension period</link:label>
    <link:label id="lab_rdnt_DebtInstrumentExtensionPeriod_label_en-US" xlink:label="lab_rdnt_DebtInstrumentExtensionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Extension Period</link:label>
    <link:label id="lab_rdnt_DebtInstrumentExtensionPeriod_documentation_en-US" xlink:label="lab_rdnt_DebtInstrumentExtensionPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Extension Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentExtensionPeriod" xlink:href="rdnt-20221231.xsd#rdnt_DebtInstrumentExtensionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DebtInstrumentExtensionPeriod" xlink:to="lab_rdnt_DebtInstrumentExtensionPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CumulativeTranslationAdjustmentSummaryRollForward_0a809e6a-1220-4fdc-8fd5-0f6467a2fe77_terseLabel_en-US" xlink:label="lab_us-gaap_CumulativeTranslationAdjustmentSummaryRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency Translation</link:label>
    <link:label id="lab_us-gaap_CumulativeTranslationAdjustmentSummaryRollForward_label_en-US" xlink:label="lab_us-gaap_CumulativeTranslationAdjustmentSummaryRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Translation Adjustment Summary [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CumulativeTranslationAdjustmentSummaryRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CumulativeTranslationAdjustmentSummaryRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CumulativeTranslationAdjustmentSummaryRollForward" xlink:to="lab_us-gaap_CumulativeTranslationAdjustmentSummaryRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_68f75746-ccc6-47b1-9c59-6a583bd3e87c_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization year 2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_e2cd9298-c4e6-49c9-ab35-d74eb77c14cc_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of gain (loss) recognized in income on derivative (current period ineffective portion)</link:label>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_label_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Gain (Loss) on Derivative, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_ade46bf3-98cd-4999-8d32-33bf4b1a4203_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_a0ef3bd3-c226-466f-9f53-c9a453b37e0e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of intangible assets</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_61f13ad8-2045-411a-be3b-88ecfb19fce7_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of intangible assets</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_MontclairRadiologicalAssociatesPAMember_c1f3529c-e8f6-45aa-b2a8-278aee51687f_terseLabel_en-US" xlink:label="lab_rdnt_MontclairRadiologicalAssociatesPAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Montclair Radiological Associates, P.A.</link:label>
    <link:label id="lab_rdnt_MontclairRadiologicalAssociatesPAMember_label_en-US" xlink:label="lab_rdnt_MontclairRadiologicalAssociatesPAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Montclair Radiological Associates, P.A. [Member]</link:label>
    <link:label id="lab_rdnt_MontclairRadiologicalAssociatesPAMember_documentation_en-US" xlink:label="lab_rdnt_MontclairRadiologicalAssociatesPAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Montclair Radiological Associates, P.A.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MontclairRadiologicalAssociatesPAMember" xlink:href="rdnt-20221231.xsd#rdnt_MontclairRadiologicalAssociatesPAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_MontclairRadiologicalAssociatesPAMember" xlink:to="lab_rdnt_MontclairRadiologicalAssociatesPAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_c3d4b8be-38c1-43a9-b2e5-b955d4ccb2c9_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_RavenHoldingsMember_396c5b7a-d1f4-47c6-8b5d-d1ddf2473f11_terseLabel_en-US" xlink:label="lab_rdnt_RavenHoldingsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raven Holdings</link:label>
    <link:label id="lab_rdnt_RavenHoldingsMember_label_en-US" xlink:label="lab_rdnt_RavenHoldingsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raven Holdings [Member]</link:label>
    <link:label id="lab_rdnt_RavenHoldingsMember_documentation_en-US" xlink:label="lab_rdnt_RavenHoldingsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raven Holdings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RavenHoldingsMember" xlink:href="rdnt-20221231.xsd#rdnt_RavenHoldingsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_RavenHoldingsMember" xlink:to="lab_rdnt_RavenHoldingsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_87247583-09c3-4330-a631-ae1074cf5be8_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorLocation_785e87e3-dfa1-45ae-b1b0-ece63402aeef_terseLabel_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:label id="lab_dei_AuditorLocation_label_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation" xlink:to="lab_dei_AuditorLocation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OffsettingAssetsTable_3657c191-fb77-4ae6-93c9-dd23528e10db_terseLabel_en-US" xlink:label="lab_us-gaap_OffsettingAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offsetting Assets [Table]</link:label>
    <link:label id="lab_us-gaap_OffsettingAssetsTable_label_en-US" xlink:label="lab_us-gaap_OffsettingAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offsetting Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OffsettingAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OffsettingAssetsTable" xlink:to="lab_us-gaap_OffsettingAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_649464e4-5510-4103-af01-8a0d027f8812_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Add nonvested restricted stock subject only to service vesting (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares, Restricted Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesRestrictedStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_b8781ed6-4db4-46b9-b3c1-d3eae5d9050b_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_2f894169-e6fd-4874-b822-8fd3bd34f52e_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal current tax</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DebtInstrumentLeverageRatio_3f03f3ef-220e-433b-bba9-564af3d0c594_terseLabel_en-US" xlink:label="lab_rdnt_DebtInstrumentLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, leverage ratio</link:label>
    <link:label id="lab_rdnt_DebtInstrumentLeverageRatio_label_en-US" xlink:label="lab_rdnt_DebtInstrumentLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Leverage Ratio</link:label>
    <link:label id="lab_rdnt_DebtInstrumentLeverageRatio_documentation_en-US" xlink:label="lab_rdnt_DebtInstrumentLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Leverage Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentLeverageRatio" xlink:href="rdnt-20221231.xsd#rdnt_DebtInstrumentLeverageRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DebtInstrumentLeverageRatio" xlink:to="lab_rdnt_DebtInstrumentLeverageRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_FrederickHealthHospitalIncMember_1477efef-633f-4881-bb17-75b71755f67f_terseLabel_en-US" xlink:label="lab_rdnt_FrederickHealthHospitalIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Frederick Health Hospital, Inc.</link:label>
    <link:label id="lab_rdnt_FrederickHealthHospitalIncMember_label_en-US" xlink:label="lab_rdnt_FrederickHealthHospitalIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Frederick Health Hospital, Inc. [Member]</link:label>
    <link:label id="lab_rdnt_FrederickHealthHospitalIncMember_documentation_en-US" xlink:label="lab_rdnt_FrederickHealthHospitalIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Frederick Health Hospital, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FrederickHealthHospitalIncMember" xlink:href="rdnt-20221231.xsd#rdnt_FrederickHealthHospitalIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_FrederickHealthHospitalIncMember" xlink:to="lab_rdnt_FrederickHealthHospitalIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_43b210c6-568b-4314-a73c-058892d7cbc6_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_16b0c4a6-e2d1-4266-a340-40aaeec33aee_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0db2027e-c9ad-4f9d-8dd6-cedc5879fdb0_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued_026024ac-1d13-49b6-94d1-5986bbd306b3_terseLabel_en-US" xlink:label="lab_rdnt_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of shares issued in acquisition</link:label>
    <link:label id="lab_rdnt_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued_label_en-US" xlink:label="lab_rdnt_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash or Part Noncash Acquisition, Noncash Financial or Equity Instrument Consideration, Value Issued</link:label>
    <link:label id="lab_rdnt_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued_documentation_en-US" xlink:label="lab_rdnt_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash or Part Noncash Acquisition, Noncash Financial or Equity Instrument Consideration, Value Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued" xlink:href="rdnt-20221231.xsd#rdnt_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued" xlink:to="lab_rdnt_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_4a3fef43-5ccc-478a-b34d-1741fcbf790b_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization period</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_e3353022-ae6f-41f3-9caa-c154df09726e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_dfd7a850-bbb4-4fac-b75a-a66e77806527_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of cash flow hedge from prior periods reclassified to earnings</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_690bcb1a-df9a-48a9-bfb6-a9ad4934d595_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of cash flow hedge from prior periods reclassified to earnings</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfDeferredCharges_f28036f0-1444-4130-806f-c2b0804b206e_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfDeferredCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of deferred charges</link:label>
    <link:label id="lab_us-gaap_AmortizationOfDeferredCharges_label_en-US" xlink:label="lab_us-gaap_AmortizationOfDeferredCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Deferred Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDeferredCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfDeferredCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfDeferredCharges" xlink:to="lab_us-gaap_AmortizationOfDeferredCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_8f29ad22-ef6b-469b-a34a-89f5b59427f3_terseLabel_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of credit outstanding, amount</link:label>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_label_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:to="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3ca1663d-e258-446a-9a0d-d1c0c526e78c_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service fee revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_4444b726-6c63-4b20-869d-197fb1c029a6_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock for sale of unregistered securities for the DeepHealth acquisition (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_a6880baa-ba78-4090-831d-54d1da6b9d86_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued as consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Equity Interests Issued and Issuable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy_f0f71b60-5a1b-4291-b998-c94ce5f6c0bd_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GOODWILL AND INDEFINITE LIVED INTANGIBLES</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Intangible Assets, Indefinite-Lived, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrentAbstract_42a944da-bb2f-43d5-8798-6118c0cc5a2f_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LONG-TERM LIABILITIES</link:label>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_b300d84f-6672-48ff-8683-32aabd97aae5_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DignityHealthMember_c10a9e37-e65b-47a1-b790-e9c69e9f2db3_terseLabel_en-US" xlink:label="lab_rdnt_DignityHealthMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dignity Health</link:label>
    <link:label id="lab_rdnt_DignityHealthMember_label_en-US" xlink:label="lab_rdnt_DignityHealthMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dignity Health [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DignityHealthMember" xlink:href="rdnt-20221231.xsd#rdnt_DignityHealthMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DignityHealthMember" xlink:to="lab_rdnt_DignityHealthMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_ea48a8da-53d9-4009-aa99-40ef4ec55a67_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity a Voluntary Filer</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_cbb9ee8b-3488-4527-9c36-82f4379d7acb_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization expense</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAndAmortization" xlink:to="lab_us-gaap_DepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease_019469eb-6c30-492e-9bc4-c04a63268b04_terseLabel_en-US" xlink:label="lab_us-gaap_CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency Translation Adjustments</link:label>
    <link:label id="lab_us-gaap_CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Translation Adjustment, Net of Tax, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease" xlink:to="lab_us-gaap_CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PostemploymentBenefitPlansPolicy_cd084a21-30f4-4a5a-aff3-aab6fb1c52f7_terseLabel_en-US" xlink:label="lab_us-gaap_PostemploymentBenefitPlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EMPLOYEE BENEFIT PLAN</link:label>
    <link:label id="lab_us-gaap_PostemploymentBenefitPlansPolicy_label_en-US" xlink:label="lab_us-gaap_PostemploymentBenefitPlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Postemployment Benefit Plans, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PostemploymentBenefitPlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PostemploymentBenefitPlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PostemploymentBenefitPlansPolicy" xlink:to="lab_us-gaap_PostemploymentBenefitPlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioForecastMember_ab1d6412-af13-4aab-9d67-94a7d2cc1de8_terseLabel_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast</link:label>
    <link:label id="lab_srt_ScenarioForecastMember_label_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioForecastMember" xlink:to="lab_srt_ScenarioForecastMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod_2a6aad35-232c-4ec8-b9e4-d278252399c1_terseLabel_en-US" xlink:label="lab_rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits, income tax penalties and interest accrued during period</link:label>
    <link:label id="lab_rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod_label_en-US" xlink:label="lab_rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued During Period</link:label>
    <link:label id="lab_rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod_documentation_en-US" xlink:label="lab_rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod" xlink:href="rdnt-20221231.xsd#rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod" xlink:to="lab_rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_30a27f35-86df-4b53-a11c-0af034465600_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_26307b6a-93e6-46f0-9519-6fcd46c8e6df_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_de653e5c-6815-484c-b5e9-47eb941a5e21_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization and write off of deferred financing costs and loan discount</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_3f978083-987d-4821-9b5a-4accf12a7364_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest_6e82795c-98e9-48e7-9cf2-7fbf377bd7ee_terseLabel_en-US" xlink:label="lab_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Economic interest</link:label>
    <link:label id="lab_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest_label_en-US" xlink:label="lab_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Limited Liability Company (LLC) or Limited Partnership (LP), Managing Member or General Partner, Ownership Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest" xlink:to="lab_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_c4f3507e-0ad9-4c27-8b71-f0a28a38098d_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Deferred Tax Assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_4ee4ef97-2063-4c82-96a0-253826282cbf_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_42187a47-860e-4cde-bf45-8e3de53e4356_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combination, noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:to="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_LesseeLeaseTermofContract_4dc14a68-757c-4409-a9b7-b7a5dc8de577_terseLabel_en-US" xlink:label="lab_rdnt_LesseeLeaseTermofContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease term of contract</link:label>
    <link:label id="lab_rdnt_LesseeLeaseTermofContract_label_en-US" xlink:label="lab_rdnt_LesseeLeaseTermofContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee Lease Term of Contract</link:label>
    <link:label id="lab_rdnt_LesseeLeaseTermofContract_documentation_en-US" xlink:label="lab_rdnt_LesseeLeaseTermofContract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee Lease Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LesseeLeaseTermofContract" xlink:href="rdnt-20221231.xsd#rdnt_LesseeLeaseTermofContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_LesseeLeaseTermofContract" xlink:to="lab_rdnt_LesseeLeaseTermofContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense_d4554855-70e3-4304-8ec2-65ce6fad3f8b_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BRMG and NY Groups operating expenses</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Measure of Activity, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense" xlink:to="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_905b01fc-6f6d-448a-a6ab-e7273e5ce2b5_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits, income tax penalties and interest accrued</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_59daaf6d-41dd-4ade-ba38-271632785dd8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_e84dfe0d-a45e-49ad-bf8e-ba1683b0daf2_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) attributable to RadNet, Inc's common stockholders for diluted share calculation</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_079609d3-d740-4a0a-b670-ae245b9e0c0e_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DILUTED NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_55b7c34f-b281-45f9-909d-03d3b1349ef8_netLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted net income (loss) per share attributable to RadNet, Inc. common stockholders (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PricingLevelIVMember_de63ca75-f4de-494a-8cf3-81f82a9cce17_terseLabel_en-US" xlink:label="lab_rdnt_PricingLevelIVMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level IV</link:label>
    <link:label id="lab_rdnt_PricingLevelIVMember_label_en-US" xlink:label="lab_rdnt_PricingLevelIVMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level IV [Member]</link:label>
    <link:label id="lab_rdnt_PricingLevelIVMember_documentation_en-US" xlink:label="lab_rdnt_PricingLevelIVMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level IV [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIVMember" xlink:href="rdnt-20221231.xsd#rdnt_PricingLevelIVMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PricingLevelIVMember" xlink:to="lab_rdnt_PricingLevelIVMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_4fb3264a-34e6-4361-8640-17e3049389ca_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of equipment</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_061e3347-3eba-49f6-8984-c7dc7b751e23_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based payment award, award vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByParent_7be3a1c9-b6bd-45c7-b7db-8833a49d0fb8_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest, ownership percentage by parent</link:label>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByParent_label_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Ownership Percentage by Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:to="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ProperyAndEquipmentNetMember_12b53740-0da0-42dc-a34e-f2f8715157e0_terseLabel_en-US" xlink:label="lab_rdnt_ProperyAndEquipmentNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Propery and equipment, net</link:label>
    <link:label id="lab_rdnt_ProperyAndEquipmentNetMember_label_en-US" xlink:label="lab_rdnt_ProperyAndEquipmentNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Propery and Equipment, Net [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ProperyAndEquipmentNetMember" xlink:href="rdnt-20221231.xsd#rdnt_ProperyAndEquipmentNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ProperyAndEquipmentNetMember" xlink:to="lab_rdnt_ProperyAndEquipmentNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_e0f10ffd-3bd4-4bd0-acdf-55601fa5f582_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_9a64ecb7-0550-4ef1-9f2a-bf52c9059618_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options and non-vested restricted awards excluded from the computation of diluted per share amounts as their effect would be antidilutive:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted, Other Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:to="lab_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_c382e424-3c13-49e0-8e36-b494623bb48f_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_78188708-d9c5-45c2-b43a-12fd34b3e249_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefit, Balance at beginning of year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_7064b8c0-f588-4a54-95fc-f7571cd6e7f1_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefit, Balance at end of year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized_5493ce40-87b3-4fd7-b88a-4cef61de9be7_terseLabel_en-US" xlink:label="lab_rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits, tax impact if recognized</link:label>
    <link:label id="lab_rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized_label_en-US" xlink:label="lab_rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Tax Impact If Recognized</link:label>
    <link:label id="lab_rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized_documentation_en-US" xlink:label="lab_rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Tax Impact If Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized" xlink:href="rdnt-20221231.xsd#rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized" xlink:to="lab_rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_8acc9a61-8571-4b0a-a69a-2e1fcca65336_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Domestic</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_d2067cd4-ec89-444f-9697-8897bec76765_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitment fee percentage</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Commitment Fee Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:to="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_ae572988-2ad8-4da3-948d-301ce1a1f9be_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_label_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentForAmortization" xlink:to="lab_us-gaap_AdjustmentForAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_75dd28e4-ad6f-48f5-baa7-45605d3e8554_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Operating Lease Liability</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_48c452ed-0aeb-471a-ad6d-ba992e5bac1f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_CommercialInsurance1Member_1a55fa26-6969-4d40-ae42-a0cf69ee88ca_terseLabel_en-US" xlink:label="lab_rdnt_CommercialInsurance1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial insurance</link:label>
    <link:label id="lab_rdnt_CommercialInsurance1Member_label_en-US" xlink:label="lab_rdnt_CommercialInsurance1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Insurance1 [Member]</link:label>
    <link:label id="lab_rdnt_CommercialInsurance1Member_documentation_en-US" xlink:label="lab_rdnt_CommercialInsurance1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Insurance1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CommercialInsurance1Member" xlink:href="rdnt-20221231.xsd#rdnt_CommercialInsurance1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_CommercialInsurance1Member" xlink:to="lab_rdnt_CommercialInsurance1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_AdvanceMedicarePayments_8ee01701-feaf-498c-bad0-38b44a1630ca_terseLabel_en-US" xlink:label="lab_rdnt_AdvanceMedicarePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advance medicare payments</link:label>
    <link:label id="lab_rdnt_AdvanceMedicarePayments_label_en-US" xlink:label="lab_rdnt_AdvanceMedicarePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advance Medicare Payments</link:label>
    <link:label id="lab_rdnt_AdvanceMedicarePayments_documentation_en-US" xlink:label="lab_rdnt_AdvanceMedicarePayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advance Medicare Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AdvanceMedicarePayments" xlink:href="rdnt-20221231.xsd#rdnt_AdvanceMedicarePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_AdvanceMedicarePayments" xlink:to="lab_rdnt_AdvanceMedicarePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_41d60755-23c1-497b-adb9-05eb079083d5_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_NumberOfAssetsSold_9e372efb-9e87-4657-a31b-b799409699a2_terseLabel_en-US" xlink:label="lab_rdnt_NumberOfAssetsSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of assets sold</link:label>
    <link:label id="lab_rdnt_NumberOfAssetsSold_label_en-US" xlink:label="lab_rdnt_NumberOfAssetsSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Assets Sold</link:label>
    <link:label id="lab_rdnt_NumberOfAssetsSold_documentation_en-US" xlink:label="lab_rdnt_NumberOfAssetsSold" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Assets Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberOfAssetsSold" xlink:href="rdnt-20221231.xsd#rdnt_NumberOfAssetsSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_NumberOfAssetsSold" xlink:to="lab_rdnt_NumberOfAssetsSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_7ccdf0b6-3332-40aa-9866-991d64f59f97_verboseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to fund loan to related parties</link:label>
    <link:label id="lab_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_label_en-US" xlink:label="lab_us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Fund Long-Term Loans to Related Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToFundLongtermLoansToRelatedParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:to="lab_us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_5ac1e370-37aa-4a80-a307-58b7d40ebc32_terseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsPolicy_bccd7152-6b57-4293-9606-19bc0dbcdc84_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EQUITY INVESTMENTS AT FAIR VALUE</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsPolicy_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsPolicy" xlink:to="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DeferredTaxLiabilitiesOutsideBasisDifference_30262b76-d4e8-4137-bbcb-da6ccc7474ba_negatedLabel_en-US" xlink:label="lab_rdnt_DeferredTaxLiabilitiesOutsideBasisDifference" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outside basis difference</link:label>
    <link:label id="lab_rdnt_DeferredTaxLiabilitiesOutsideBasisDifference_label_en-US" xlink:label="lab_rdnt_DeferredTaxLiabilitiesOutsideBasisDifference" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Outside Basis Difference</link:label>
    <link:label id="lab_rdnt_DeferredTaxLiabilitiesOutsideBasisDifference_documentation_en-US" xlink:label="lab_rdnt_DeferredTaxLiabilitiesOutsideBasisDifference" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Outside Basis Difference</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeferredTaxLiabilitiesOutsideBasisDifference" xlink:href="rdnt-20221231.xsd#rdnt_DeferredTaxLiabilitiesOutsideBasisDifference"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DeferredTaxLiabilitiesOutsideBasisDifference" xlink:to="lab_rdnt_DeferredTaxLiabilitiesOutsideBasisDifference" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_FirstLienCreditAgreementSixthAmendmentMember_615c9828-41a2-4d07-b586-b8e28271038c_terseLabel_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementSixthAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment No. 6 First Lien Credit Agreement</link:label>
    <link:label id="lab_rdnt_FirstLienCreditAgreementSixthAmendmentMember_label_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementSixthAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Credit Agreement Sixth Amendment [Member]</link:label>
    <link:label id="lab_rdnt_FirstLienCreditAgreementSixthAmendmentMember_documentation_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementSixthAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Credit Agreement Sixth Amendment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementSixthAmendmentMember" xlink:href="rdnt-20221231.xsd#rdnt_FirstLienCreditAgreementSixthAmendmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_FirstLienCreditAgreementSixthAmendmentMember" xlink:to="lab_rdnt_FirstLienCreditAgreementSixthAmendmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest_828acae4-c851-41d9-ab78-a5600ab63c50_terseLabel_en-US" xlink:label="lab_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minority partner ownership percent</link:label>
    <link:label id="lab_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest_label_en-US" xlink:label="lab_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Limited Liability Company or Limited Partnership, Members or Limited Partners, Ownership Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest" xlink:to="lab_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate_9922fe84-4e9a-41b1-a78f-fe033a7e1b13_terseLabel_en-US" xlink:label="lab_rdnt_UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) related to change in rate</link:label>
    <link:label id="lab_rdnt_UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate_label_en-US" xlink:label="lab_rdnt_UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase (Decrease) Change in Enacted Tax Rate</link:label>
    <link:label id="lab_rdnt_UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate_documentation_en-US" xlink:label="lab_rdnt_UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase (Decrease) Change in Enacted Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate" xlink:href="rdnt-20221231.xsd#rdnt_UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate" xlink:to="lab_rdnt_UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_1fcaf913-1032-4eb1-b636-f3db03ade3c9_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Deferred Tax Liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GovernmentAssistanceStatementOfFinancialPositionExtensibleEnumeration_cf5a4a5a-ae41-45bc-aae2-bf4eaf6933f6_terseLabel_en-US" xlink:label="lab_us-gaap_GovernmentAssistanceStatementOfFinancialPositionExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Assistance, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_GovernmentAssistanceStatementOfFinancialPositionExtensibleEnumeration_label_en-US" xlink:label="lab_us-gaap_GovernmentAssistanceStatementOfFinancialPositionExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Assistance, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GovernmentAssistanceStatementOfFinancialPositionExtensibleEnumeration" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GovernmentAssistanceStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GovernmentAssistanceStatementOfFinancialPositionExtensibleEnumeration" xlink:to="lab_us-gaap_GovernmentAssistanceStatementOfFinancialPositionExtensibleEnumeration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_f36a2f26-184e-483d-ad45-a6235c93eaef_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total property and equipment cost</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityOwnershipPercentage_cf6efccb-cb21-4eca-84d2-dbeb972bb3a9_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Economic interest</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityOwnershipPercentage_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:to="lab_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_952de120-c2f5-4654-be86-c0951cd1da52_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flows from financing leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Payment on Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:to="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditDerivativesByContractTypeAxis_5b0a24cd-963c-4de4-a9cd-132c634eb743_terseLabel_en-US" xlink:label="lab_us-gaap_CreditDerivativesByContractTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Derivatives Contract Type [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditDerivativesByContractTypeAxis_label_en-US" xlink:label="lab_us-gaap_CreditDerivativesByContractTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Derivatives Contract Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditDerivativesByContractTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditDerivativesByContractTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditDerivativesByContractTypeAxis" xlink:to="lab_us-gaap_CreditDerivativesByContractTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_3816ba08-c0ac-4543-a25a-ed237717805b_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Promissory note</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_7d77922e-9990-4ff2-a3a9-a194df87206c_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization year 2027</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_adc35a4f-d369-41e8-9a67-f518cc6867eb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_IFRCLLCMember_6692a3b8-50c6-4694-86cf-711bb4b3b952_terseLabel_en-US" xlink:label="lab_rdnt_IFRCLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">I F R C L L C</link:label>
    <link:label id="lab_rdnt_IFRCLLCMember_label_en-US" xlink:label="lab_rdnt_IFRCLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">I F R C L L C [Member]</link:label>
    <link:label id="lab_rdnt_IFRCLLCMember_documentation_en-US" xlink:label="lab_rdnt_IFRCLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">I F R C L L C</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_IFRCLLCMember" xlink:href="rdnt-20221231.xsd#rdnt_IFRCLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_IFRCLLCMember" xlink:to="lab_rdnt_IFRCLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PricingLevelVMember_8985bec9-d07e-4847-a0a4-2c930e67791c_terseLabel_en-US" xlink:label="lab_rdnt_PricingLevelVMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level V</link:label>
    <link:label id="lab_rdnt_PricingLevelVMember_label_en-US" xlink:label="lab_rdnt_PricingLevelVMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level V [Member]</link:label>
    <link:label id="lab_rdnt_PricingLevelVMember_documentation_en-US" xlink:label="lab_rdnt_PricingLevelVMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level V [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelVMember" xlink:href="rdnt-20221231.xsd#rdnt_PricingLevelVMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PricingLevelVMember" xlink:to="lab_rdnt_PricingLevelVMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNoncurrentNet_3b93672a-1882-453a-91af-02f4026a1c18_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred financing costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNoncurrentNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Noncurrent, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNoncurrentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:to="lab_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_bcbe00f9-dd22-4998-9ad5-de7ad92ff54e_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_8f1c349c-1a00-4115-ad07-4c02ee45467e_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_6797d5ce-96be-423f-a687-4f79b702d7df_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal tax</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b79476c3-8b69-4277-ae34-d23e1129c00e_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH FLOWS FROM FINANCING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_A2019SWAPS1Member_17aea99e-21e5-4606-9a01-797f96bb46ca_terseLabel_en-US" xlink:label="lab_rdnt_A2019SWAPS1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 SWAPS1</link:label>
    <link:label id="lab_rdnt_A2019SWAPS1Member_label_en-US" xlink:label="lab_rdnt_A2019SWAPS1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 SWAPS1 [Member]</link:label>
    <link:label id="lab_rdnt_A2019SWAPS1Member_documentation_en-US" xlink:label="lab_rdnt_A2019SWAPS1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 SWAPS1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_A2019SWAPS1Member" xlink:href="rdnt-20221231.xsd#rdnt_A2019SWAPS1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_A2019SWAPS1Member" xlink:to="lab_rdnt_A2019SWAPS1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance_6e205530-d966-4d35-a5b6-ce4d5765b9aa_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares available for future issuance, options, warrants, shares of restricted stock and other bonus awards (in shares)</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Arrangement with Individual, Common Stock Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance" xlink:to="lab_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentAggregateCost_673ad82d-6f93-4509-b666-d3a69c87eb8f_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentAggregateCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total net assets</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentAggregateCost_6cb7fd2c-ec7b-4d65-84ff-5156c3ea93cf_totalLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentAggregateCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total net assets</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentAggregateCost_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentAggregateCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Aggregate Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentAggregateCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentAggregateCost" xlink:to="lab_us-gaap_EquityMethodInvestmentAggregateCost" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets_4325504d-6afd-48be-84a7-434bb55990a7_negatedTerseLabel_en-US" xlink:label="lab_rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use asset</link:label>
    <link:label id="lab_rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets_label_en-US" xlink:label="lab_rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Operating Right-Of-Use Assets</link:label>
    <link:label id="lab_rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets_documentation_en-US" xlink:label="lab_rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Operating Right-Of-Use Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets" xlink:href="rdnt-20221231.xsd#rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets" xlink:to="lab_rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther_b1bfd556-fd0b-417f-bfd0-d2527bf374f3_verboseLabel_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther_label_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets (Liabilities), Other</link:label>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther_documentation_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets (Liabilities), Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther" xlink:href="rdnt-20221231.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther" xlink:to="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>13
<FILENAME>rdnt-20221231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:ee66d8ee-1013-4282-8e3e-c307b1c04f3f,g:1b6e48fd-cb3e-498b-b299-6015491264f8-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.radnet.com/role/COVERPAGE" xlink:type="simple" xlink:href="rdnt-20221231.xsd#COVERPAGE"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/COVERPAGE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_bb0e9f20-3ae4-4f57-b523-f5d95103e2cc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_d64e6e87-cf14-41c1-81cf-082752ff53a4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bb0e9f20-3ae4-4f57-b523-f5d95103e2cc" xlink:to="loc_dei_DocumentType_d64e6e87-cf14-41c1-81cf-082752ff53a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_92368afa-8cbe-4f4d-a1f2-ed35d2486bf6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bb0e9f20-3ae4-4f57-b523-f5d95103e2cc" xlink:to="loc_dei_DocumentAnnualReport_92368afa-8cbe-4f4d-a1f2-ed35d2486bf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_ce90e994-09bf-45f3-8125-61542b7ab2c4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bb0e9f20-3ae4-4f57-b523-f5d95103e2cc" xlink:to="loc_dei_DocumentPeriodEndDate_ce90e994-09bf-45f3-8125-61542b7ab2c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_7fc4b9f0-72a2-45da-8a63-27fb0b12f5fd" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bb0e9f20-3ae4-4f57-b523-f5d95103e2cc" xlink:to="loc_dei_CurrentFiscalYearEndDate_7fc4b9f0-72a2-45da-8a63-27fb0b12f5fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_fe53e1a9-5c58-4e96-bde8-0bd3f172456a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bb0e9f20-3ae4-4f57-b523-f5d95103e2cc" xlink:to="loc_dei_DocumentTransitionReport_fe53e1a9-5c58-4e96-bde8-0bd3f172456a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_9f7f1091-fc20-40e0-9054-7ff6d1fad639" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bb0e9f20-3ae4-4f57-b523-f5d95103e2cc" xlink:to="loc_dei_EntityFileNumber_9f7f1091-fc20-40e0-9054-7ff6d1fad639" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_216d917a-8a87-402c-a140-2eae3e3318a1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bb0e9f20-3ae4-4f57-b523-f5d95103e2cc" xlink:to="loc_dei_EntityRegistrantName_216d917a-8a87-402c-a140-2eae3e3318a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_55410dcd-8f90-424d-acc3-1845d50b6a12" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bb0e9f20-3ae4-4f57-b523-f5d95103e2cc" xlink:to="loc_dei_EntityIncorporationStateCountryCode_55410dcd-8f90-424d-acc3-1845d50b6a12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_44314e82-f290-44af-996b-d03f83c64f0c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bb0e9f20-3ae4-4f57-b523-f5d95103e2cc" xlink:to="loc_dei_EntityTaxIdentificationNumber_44314e82-f290-44af-996b-d03f83c64f0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_24d42b35-c2aa-4983-8426-463b4164f0ea" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bb0e9f20-3ae4-4f57-b523-f5d95103e2cc" xlink:to="loc_dei_EntityAddressAddressLine1_24d42b35-c2aa-4983-8426-463b4164f0ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_257fdb23-6b8b-4f02-a8c5-4739a348f3ef" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bb0e9f20-3ae4-4f57-b523-f5d95103e2cc" xlink:to="loc_dei_EntityAddressCityOrTown_257fdb23-6b8b-4f02-a8c5-4739a348f3ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_3d90e300-e215-44e8-a7a4-98f347b4d6b2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bb0e9f20-3ae4-4f57-b523-f5d95103e2cc" xlink:to="loc_dei_EntityAddressStateOrProvince_3d90e300-e215-44e8-a7a4-98f347b4d6b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_3c06611a-2612-44c8-8d49-db0ecb24284e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bb0e9f20-3ae4-4f57-b523-f5d95103e2cc" xlink:to="loc_dei_EntityAddressPostalZipCode_3c06611a-2612-44c8-8d49-db0ecb24284e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_397c15aa-35f4-44fe-8753-6f189d20493e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bb0e9f20-3ae4-4f57-b523-f5d95103e2cc" xlink:to="loc_dei_CityAreaCode_397c15aa-35f4-44fe-8753-6f189d20493e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_9a4c52dc-84cf-4a6f-a2ec-191a4dc79c7b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bb0e9f20-3ae4-4f57-b523-f5d95103e2cc" xlink:to="loc_dei_LocalPhoneNumber_9a4c52dc-84cf-4a6f-a2ec-191a4dc79c7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_adc75383-1765-428b-b58c-4d7d9d2c95b3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bb0e9f20-3ae4-4f57-b523-f5d95103e2cc" xlink:to="loc_dei_Security12bTitle_adc75383-1765-428b-b58c-4d7d9d2c95b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_894eaa12-7acd-4af6-aea6-035f186fc68c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bb0e9f20-3ae4-4f57-b523-f5d95103e2cc" xlink:to="loc_dei_TradingSymbol_894eaa12-7acd-4af6-aea6-035f186fc68c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_b232be71-bdad-4d29-8dcf-4a72b86f2974" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bb0e9f20-3ae4-4f57-b523-f5d95103e2cc" xlink:to="loc_dei_SecurityExchangeName_b232be71-bdad-4d29-8dcf-4a72b86f2974" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_e8036ba3-8f8d-44e2-962f-19d874f1eb97" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bb0e9f20-3ae4-4f57-b523-f5d95103e2cc" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_e8036ba3-8f8d-44e2-962f-19d874f1eb97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_5ab2d58b-1a30-4996-9265-92c5d528a620" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bb0e9f20-3ae4-4f57-b523-f5d95103e2cc" xlink:to="loc_dei_EntityVoluntaryFilers_5ab2d58b-1a30-4996-9265-92c5d528a620" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_0cdd6c6f-e654-47d9-bf62-4bd07bb8cd25" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bb0e9f20-3ae4-4f57-b523-f5d95103e2cc" xlink:to="loc_dei_EntityCurrentReportingStatus_0cdd6c6f-e654-47d9-bf62-4bd07bb8cd25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_c6f449d0-1e21-4e33-9c18-1275180e3250" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bb0e9f20-3ae4-4f57-b523-f5d95103e2cc" xlink:to="loc_dei_EntityInteractiveDataCurrent_c6f449d0-1e21-4e33-9c18-1275180e3250" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_f00c3c8f-8239-42f3-99ed-acdd516e337a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bb0e9f20-3ae4-4f57-b523-f5d95103e2cc" xlink:to="loc_dei_EntityFilerCategory_f00c3c8f-8239-42f3-99ed-acdd516e337a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_0a8f6fb4-15e7-4ee3-a03b-88454d2460b4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bb0e9f20-3ae4-4f57-b523-f5d95103e2cc" xlink:to="loc_dei_EntitySmallBusiness_0a8f6fb4-15e7-4ee3-a03b-88454d2460b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_97e37634-ca40-4f78-82b4-30c05ed46630" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bb0e9f20-3ae4-4f57-b523-f5d95103e2cc" xlink:to="loc_dei_EntityEmergingGrowthCompany_97e37634-ca40-4f78-82b4-30c05ed46630" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_6fa4134c-07cf-4de5-9eef-e030cf57d0be" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bb0e9f20-3ae4-4f57-b523-f5d95103e2cc" xlink:to="loc_dei_IcfrAuditorAttestationFlag_6fa4134c-07cf-4de5-9eef-e030cf57d0be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_ee68b687-fc08-41b8-8e53-61c89998b499" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bb0e9f20-3ae4-4f57-b523-f5d95103e2cc" xlink:to="loc_dei_EntityShellCompany_ee68b687-fc08-41b8-8e53-61c89998b499" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_6b19b2ab-e48f-43ce-a71a-c2eda37d60a4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bb0e9f20-3ae4-4f57-b523-f5d95103e2cc" xlink:to="loc_dei_EntityPublicFloat_6b19b2ab-e48f-43ce-a71a-c2eda37d60a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_3b3b38d4-43a0-46e7-8a94-3a8ed94ac1af" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bb0e9f20-3ae4-4f57-b523-f5d95103e2cc" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_3b3b38d4-43a0-46e7-8a94-3a8ed94ac1af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_5873fbb8-d43b-486a-94b6-1ef24b846b76" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bb0e9f20-3ae4-4f57-b523-f5d95103e2cc" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_5873fbb8-d43b-486a-94b6-1ef24b846b76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_5881431a-0b64-437d-88d2-42d3d8b14f57" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bb0e9f20-3ae4-4f57-b523-f5d95103e2cc" xlink:to="loc_dei_EntityCentralIndexKey_5881431a-0b64-437d-88d2-42d3d8b14f57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_6536a7c9-cdc5-4eb7-a845-4a9f1ab00694" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bb0e9f20-3ae4-4f57-b523-f5d95103e2cc" xlink:to="loc_dei_AmendmentFlag_6536a7c9-cdc5-4eb7-a845-4a9f1ab00694" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_3ba4ebcf-33ca-421f-9f9f-baa4c363928f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bb0e9f20-3ae4-4f57-b523-f5d95103e2cc" xlink:to="loc_dei_DocumentFiscalPeriodFocus_3ba4ebcf-33ca-421f-9f9f-baa4c363928f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_55dcdcf4-a4e0-41a3-ab72-f121249ba728" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bb0e9f20-3ae4-4f57-b523-f5d95103e2cc" xlink:to="loc_dei_DocumentFiscalYearFocus_55dcdcf4-a4e0-41a3-ab72-f121249ba728" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/AUDITINFORMATION" xlink:type="simple" xlink:href="rdnt-20221231.xsd#AUDITINFORMATION"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/AUDITINFORMATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AuditorInformationAbstract_918fbfba-4c8d-4816-ae25-75be23056958" xlink:href="rdnt-20221231.xsd#rdnt_AuditorInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_35873495-12ba-432e-a557-9bd22a536b10" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_AuditorInformationAbstract_918fbfba-4c8d-4816-ae25-75be23056958" xlink:to="loc_dei_AuditorName_35873495-12ba-432e-a557-9bd22a536b10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_66a8d265-ce4d-454d-828e-f3afd88355c6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_AuditorInformationAbstract_918fbfba-4c8d-4816-ae25-75be23056958" xlink:to="loc_dei_AuditorLocation_66a8d265-ce4d-454d-828e-f3afd88355c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_da654f9b-6fcd-48cc-b9e1-5c95ad23e93d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_AuditorInformationAbstract_918fbfba-4c8d-4816-ae25-75be23056958" xlink:to="loc_dei_AuditorFirmId_da654f9b-6fcd-48cc-b9e1-5c95ad23e93d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="rdnt-20221231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_0e5804a0-f11c-4995-bfd1-e415d5c4c8d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_d23eb738-0d96-4e3d-8c09-800e8758e0b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0e5804a0-f11c-4995-bfd1-e415d5c4c8d2" xlink:to="loc_us-gaap_AssetsAbstract_d23eb738-0d96-4e3d-8c09-800e8758e0b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_567111ab-7a91-4099-86f3-b264611de9d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d23eb738-0d96-4e3d-8c09-800e8758e0b7" xlink:to="loc_us-gaap_AssetsCurrentAbstract_567111ab-7a91-4099-86f3-b264611de9d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_22c4572b-3b2d-4d4d-a200-7a8ddc0dd5e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_567111ab-7a91-4099-86f3-b264611de9d6" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_22c4572b-3b2d-4d4d-a200-7a8ddc0dd5e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_dd3786bd-d917-4a04-b56f-8103e7a6c958" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_567111ab-7a91-4099-86f3-b264611de9d6" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_dd3786bd-d917-4a04-b56f-8103e7a6c958" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueFromRelatedPartiesCurrent_85d89f8e-1b24-4666-8576-20b65d29dc73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueFromRelatedPartiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_567111ab-7a91-4099-86f3-b264611de9d6" xlink:to="loc_us-gaap_DueFromRelatedPartiesCurrent_85d89f8e-1b24-4666-8576-20b65d29dc73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_3670b2e8-fc99-4c11-992c-4215944796f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_567111ab-7a91-4099-86f3-b264611de9d6" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_3670b2e8-fc99-4c11-992c-4215944796f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_f160a0f2-ba3d-4054-a787-dff3065ddfbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_567111ab-7a91-4099-86f3-b264611de9d6" xlink:to="loc_us-gaap_AssetsCurrent_f160a0f2-ba3d-4054-a787-dff3065ddfbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract_bd5a825f-ff3b-473e-b2f1-fd41f5d84a5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d23eb738-0d96-4e3d-8c09-800e8758e0b7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract_bd5a825f-ff3b-473e-b2f1-fd41f5d84a5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_e6cb9901-ea37-4583-bc18-6e988d925f92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract_bd5a825f-ff3b-473e-b2f1-fd41f5d84a5c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_e6cb9901-ea37-4583-bc18-6e988d925f92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_87b8cf59-5964-4799-9cb8-5a532f39f54e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract_bd5a825f-ff3b-473e-b2f1-fd41f5d84a5c" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_87b8cf59-5964-4799-9cb8-5a532f39f54e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PropertyPlantAndEquipmentNetIncludingRightOfUseAssets_6cd418ad-8f3d-4ba2-81eb-1f224840b271" xlink:href="rdnt-20221231.xsd#rdnt_PropertyPlantAndEquipmentNetIncludingRightOfUseAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract_bd5a825f-ff3b-473e-b2f1-fd41f5d84a5c" xlink:to="loc_rdnt_PropertyPlantAndEquipmentNetIncludingRightOfUseAssets_6cd418ad-8f3d-4ba2-81eb-1f224840b271" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsAbstract_9866cc47-6e51-418d-9a60-e47b0b87dd5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d23eb738-0d96-4e3d-8c09-800e8758e0b7" xlink:to="loc_us-gaap_OtherAssetsAbstract_9866cc47-6e51-418d-9a60-e47b0b87dd5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_3fa3c3b2-95d2-4049-9619-f3f8f2198d25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_9866cc47-6e51-418d-9a60-e47b0b87dd5c" xlink:to="loc_us-gaap_Goodwill_3fa3c3b2-95d2-4049-9619-f3f8f2198d25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_a41a42fd-cd68-480d-8b89-a6f137cca400" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_9866cc47-6e51-418d-9a60-e47b0b87dd5c" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_a41a42fd-cd68-480d-8b89-a6f137cca400" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_25cb4c27-6902-4363-bd63-c2b93a786f6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNoncurrentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_9866cc47-6e51-418d-9a60-e47b0b87dd5c" xlink:to="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_25cb4c27-6902-4363-bd63-c2b93a786f6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_56cebbf1-5ee4-4a67-b4f9-0f200f299c3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_9866cc47-6e51-418d-9a60-e47b0b87dd5c" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_56cebbf1-5ee4-4a67-b4f9-0f200f299c3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_2a7c9b6f-a5ca-43f4-aeae-862b876fbbc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_9866cc47-6e51-418d-9a60-e47b0b87dd5c" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_2a7c9b6f-a5ca-43f4-aeae-862b876fbbc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositsAssets_b5dff300-d97b-428e-af33-46125a3e094f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepositsAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_9866cc47-6e51-418d-9a60-e47b0b87dd5c" xlink:to="loc_us-gaap_DepositsAssets_b5dff300-d97b-428e-af33-46125a3e094f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_c12a95a6-c27f-43bf-8465-e483b3a0360d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d23eb738-0d96-4e3d-8c09-800e8758e0b7" xlink:to="loc_us-gaap_Assets_c12a95a6-c27f-43bf-8465-e483b3a0360d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_86359204-6de3-4a2d-9ff5-27935ad3d696" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0e5804a0-f11c-4995-bfd1-e415d5c4c8d2" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_86359204-6de3-4a2d-9ff5-27935ad3d696" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_63245a01-2324-40f5-912d-391f1a57cbe9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_86359204-6de3-4a2d-9ff5-27935ad3d696" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_63245a01-2324-40f5-912d-391f1a57cbe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_f9be0176-3e1d-4248-869b-d9784582a8a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_63245a01-2324-40f5-912d-391f1a57cbe9" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_f9be0176-3e1d-4248-869b-d9784582a8a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToAffiliateCurrent_f271cfac-a3d3-40da-8534-d71207a68c9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToAffiliateCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_63245a01-2324-40f5-912d-391f1a57cbe9" xlink:to="loc_us-gaap_DueToAffiliateCurrent_f271cfac-a3d3-40da-8534-d71207a68c9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_82ee7019-a0e2-4130-9768-a60ae42bf3be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_63245a01-2324-40f5-912d-391f1a57cbe9" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_82ee7019-a0e2-4130-9768-a60ae42bf3be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_4c1ac5e0-16d6-4ebb-a92b-6b09820967a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_63245a01-2324-40f5-912d-391f1a57cbe9" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_4c1ac5e0-16d6-4ebb-a92b-6b09820967a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableCurrent_42d8ccc1-3953-4908-a30d-068dbfd6ebce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_63245a01-2324-40f5-912d-391f1a57cbe9" xlink:to="loc_us-gaap_NotesPayableCurrent_42d8ccc1-3953-4908-a30d-068dbfd6ebce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_0d5c20f5-e548-4036-a8de-5d3d0d48f4ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_63245a01-2324-40f5-912d-391f1a57cbe9" xlink:to="loc_us-gaap_LiabilitiesCurrent_0d5c20f5-e548-4036-a8de-5d3d0d48f4ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract_e1bcad5c-6b51-4a84-8e77-1404e81a94ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_86359204-6de3-4a2d-9ff5-27935ad3d696" xlink:to="loc_us-gaap_LiabilitiesNoncurrentAbstract_e1bcad5c-6b51-4a84-8e77-1404e81a94ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_cff073d8-22e6-43ad-8f74-c8049a878fdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_e1bcad5c-6b51-4a84-8e77-1404e81a94ae" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_cff073d8-22e6-43ad-8f74-c8049a878fdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable_f3d9b940-a3f8-4c7d-b1c3-2e4080ca982c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermNotesPayable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_e1bcad5c-6b51-4a84-8e77-1404e81a94ae" xlink:to="loc_us-gaap_LongTermNotesPayable_f3d9b940-a3f8-4c7d-b1c3-2e4080ca982c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_f5359362-a7d5-415c-a4a9-bb5298cd606b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_e1bcad5c-6b51-4a84-8e77-1404e81a94ae" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_f5359362-a7d5-415c-a4a9-bb5298cd606b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_562666d5-f135-445a-9a56-a2783e2ac95a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_e1bcad5c-6b51-4a84-8e77-1404e81a94ae" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_562666d5-f135-445a-9a56-a2783e2ac95a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_88ea7850-5697-4f11-9111-b1c9067db783" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_e1bcad5c-6b51-4a84-8e77-1404e81a94ae" xlink:to="loc_us-gaap_Liabilities_88ea7850-5697-4f11-9111-b1c9067db783" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_e45b7f59-02dd-4a33-8cd6-94e719567775" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_86359204-6de3-4a2d-9ff5-27935ad3d696" xlink:to="loc_us-gaap_StockholdersEquityAbstract_e45b7f59-02dd-4a33-8cd6-94e719567775" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_d6753df2-6751-49e7-988c-8fb154578f17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_e45b7f59-02dd-4a33-8cd6-94e719567775" xlink:to="loc_us-gaap_StockholdersEquityNoteAbstract_d6753df2-6751-49e7-988c-8fb154578f17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_ce10bfc4-5110-48ae-9af1-268db28e4510" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_d6753df2-6751-49e7-988c-8fb154578f17" xlink:to="loc_us-gaap_CommonStockValue_ce10bfc4-5110-48ae-9af1-268db28e4510" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_2774af08-b269-4c89-89bc-10563fdc638b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_d6753df2-6751-49e7-988c-8fb154578f17" xlink:to="loc_us-gaap_AdditionalPaidInCapital_2774af08-b269-4c89-89bc-10563fdc638b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_19e968c2-f458-4c97-b692-082309063bfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_d6753df2-6751-49e7-988c-8fb154578f17" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_19e968c2-f458-4c97-b692-082309063bfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_34ae73f6-c1f9-40bf-89d3-b16fc30b2acb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_d6753df2-6751-49e7-988c-8fb154578f17" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_34ae73f6-c1f9-40bf-89d3-b16fc30b2acb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_350e9bac-60ce-4c1a-8381-34654b956632" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_d6753df2-6751-49e7-988c-8fb154578f17" xlink:to="loc_us-gaap_StockholdersEquity_350e9bac-60ce-4c1a-8381-34654b956632" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_1d3fcdc7-e377-40e6-b7f0-d285bb0dd6f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_e45b7f59-02dd-4a33-8cd6-94e719567775" xlink:to="loc_us-gaap_MinorityInterest_1d3fcdc7-e377-40e6-b7f0-d285bb0dd6f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c7d37e2a-1b62-43cb-bb7f-3198985b5cfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_e45b7f59-02dd-4a33-8cd6-94e719567775" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c7d37e2a-1b62-43cb-bb7f-3198985b5cfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_2e48203f-32ba-492d-85a2-c5459d93e1a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_86359204-6de3-4a2d-9ff5-27935ad3d696" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_2e48203f-32ba-492d-85a2-c5459d93e1a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="rdnt-20221231.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_474e7494-f834-40cf-b019-40c464e6ceaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_43748cff-1d97-4008-ac8a-47a23b3110aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_474e7494-f834-40cf-b019-40c464e6ceaf" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_43748cff-1d97-4008-ac8a-47a23b3110aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_52f1c4d0-a8ee-4c20-97f8-ef37aa33d1c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_474e7494-f834-40cf-b019-40c464e6ceaf" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_52f1c4d0-a8ee-4c20-97f8-ef37aa33d1c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_2a768aae-1036-464a-9ab6-45d6078bc1e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_474e7494-f834-40cf-b019-40c464e6ceaf" xlink:to="loc_us-gaap_CommonStockSharesIssued_2a768aae-1036-464a-9ab6-45d6078bc1e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_d12d6c67-6186-4e6d-8761-b46192a551e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_474e7494-f834-40cf-b019-40c464e6ceaf" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_d12d6c67-6186-4e6d-8761-b46192a551e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="rdnt-20221231.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_364f9c17-a25c-4ca6-bd92-2b6e93f23ae4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_01cd6aa7-42f1-439b-8fe8-6c95426d7a94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_364f9c17-a25c-4ca6-bd92-2b6e93f23ae4" xlink:to="loc_us-gaap_StatementTable_01cd6aa7-42f1-439b-8fe8-6c95426d7a94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_c443e1aa-d181-4ec5-9a42-c59c0b3081ff" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_01cd6aa7-42f1-439b-8fe8-6c95426d7a94" xlink:to="loc_srt_ProductOrServiceAxis_c443e1aa-d181-4ec5-9a42-c59c0b3081ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_3198e122-b8e1-4cf1-bc9d-46ac91c95418" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_c443e1aa-d181-4ec5-9a42-c59c0b3081ff" xlink:to="loc_srt_ProductsAndServicesDomain_3198e122-b8e1-4cf1-bc9d-46ac91c95418" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCarePatientServiceMember_4b66e29a-4e71-445c-9698-f44cdbf3f78b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthCarePatientServiceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_3198e122-b8e1-4cf1-bc9d-46ac91c95418" xlink:to="loc_us-gaap_HealthCarePatientServiceMember_4b66e29a-4e71-445c-9698-f44cdbf3f78b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CapitationArrangementsMember_e34bd136-6f61-4004-9310-f5d2314e42f4" xlink:href="rdnt-20221231.xsd#rdnt_CapitationArrangementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_3198e122-b8e1-4cf1-bc9d-46ac91c95418" xlink:to="loc_rdnt_CapitationArrangementsMember_e34bd136-6f61-4004-9310-f5d2314e42f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_04d1472d-6a1e-4dcd-a45e-bf5dc0048263" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_01cd6aa7-42f1-439b-8fe8-6c95426d7a94" xlink:to="loc_us-gaap_StatementLineItems_04d1472d-6a1e-4dcd-a45e-bf5dc0048263" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_dc419765-4f96-4fb0-af66-59b871caa3c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_04d1472d-6a1e-4dcd-a45e-bf5dc0048263" xlink:to="loc_us-gaap_RevenuesAbstract_dc419765-4f96-4fb0-af66-59b871caa3c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7d97e47d-2647-467c-bdb1-0fdab8379ee7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_dc419765-4f96-4fb0-af66-59b871caa3c0" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7d97e47d-2647-467c-bdb1-0fdab8379ee7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueNotFromContractWithCustomer_8a2dff22-92d9-4e5c-8e5e-b427d67973cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueNotFromContractWithCustomer"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_dc419765-4f96-4fb0-af66-59b871caa3c0" xlink:to="loc_us-gaap_RevenueNotFromContractWithCustomer_8a2dff22-92d9-4e5c-8e5e-b427d67973cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_4a5a79ea-688f-4c2e-8098-50fcb7f328c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_04d1472d-6a1e-4dcd-a45e-bf5dc0048263" xlink:to="loc_us-gaap_OperatingExpensesAbstract_4a5a79ea-688f-4c2e-8098-50fcb7f328c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OperatingExpensesExcludingDepreciationAndAmortization_58e75d56-5069-4cf4-82d3-1932a4401f4f" xlink:href="rdnt-20221231.xsd#rdnt_OperatingExpensesExcludingDepreciationAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4a5a79ea-688f-4c2e-8098-50fcb7f328c8" xlink:to="loc_rdnt_OperatingExpensesExcludingDepreciationAndAmortization_58e75d56-5069-4cf4-82d3-1932a4401f4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnTerminationOfLease_e2a5091e-60ae-4b2b-ad38-b16cf6f149c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnTerminationOfLease"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4a5a79ea-688f-4c2e-8098-50fcb7f328c8" xlink:to="loc_us-gaap_GainLossOnTerminationOfLease_e2a5091e-60ae-4b2b-ad38-b16cf6f149c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_df0423a1-d4ed-4e77-97fc-082ce78abe55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4a5a79ea-688f-4c2e-8098-50fcb7f328c8" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_df0423a1-d4ed-4e77-97fc-082ce78abe55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets_37676490-4026-4e17-bfd2-7249b7833b47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4a5a79ea-688f-4c2e-8098-50fcb7f328c8" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets_37676490-4026-4e17-bfd2-7249b7833b47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_ec927871-cf96-45fb-88d1-9cda55197051" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4a5a79ea-688f-4c2e-8098-50fcb7f328c8" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_ec927871-cf96-45fb-88d1-9cda55197051" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_c24944e4-51c9-47e9-be44-35ae601be836" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeveranceCosts1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4a5a79ea-688f-4c2e-8098-50fcb7f328c8" xlink:to="loc_us-gaap_SeveranceCosts1_c24944e4-51c9-47e9-be44-35ae601be836" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_49e988e3-8f13-4ad2-99cc-ed3d9670ca58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4a5a79ea-688f-4c2e-8098-50fcb7f328c8" xlink:to="loc_us-gaap_OperatingExpenses_49e988e3-8f13-4ad2-99cc-ed3d9670ca58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_0da1ecfc-3116-4e7c-ac98-dbbe85de566f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_04d1472d-6a1e-4dcd-a45e-bf5dc0048263" xlink:to="loc_us-gaap_OperatingIncomeLoss_0da1ecfc-3116-4e7c-ac98-dbbe85de566f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpensesAbstract_804239ac-d1dd-4c87-b0aa-580078dbac2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_04d1472d-6a1e-4dcd-a45e-bf5dc0048263" xlink:to="loc_us-gaap_OtherExpensesAbstract_804239ac-d1dd-4c87-b0aa-580078dbac2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_d35f6b1b-9ff4-4c1e-b99a-7dee3e4a99bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherExpensesAbstract_804239ac-d1dd-4c87-b0aa-580078dbac2e" xlink:to="loc_us-gaap_InterestExpenseDebt_d35f6b1b-9ff4-4c1e-b99a-7dee3e4a99bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_07300782-9678-41c4-9632-b79ad89d3e1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherExpensesAbstract_804239ac-d1dd-4c87-b0aa-580078dbac2e" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_07300782-9678-41c4-9632-b79ad89d3e1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1_88c6b7ac-175a-4237-a7f8-78b19e5f9825" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherExpensesAbstract_804239ac-d1dd-4c87-b0aa-580078dbac2e" xlink:to="loc_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1_88c6b7ac-175a-4237-a7f8-78b19e5f9825" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GainLossOnExtinguishmentOfDebtAndOtherExpenses_ef2088a1-056f-4c47-9685-5bf19c1ea3e3" xlink:href="rdnt-20221231.xsd#rdnt_GainLossOnExtinguishmentOfDebtAndOtherExpenses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherExpensesAbstract_804239ac-d1dd-4c87-b0aa-580078dbac2e" xlink:to="loc_rdnt_GainLossOnExtinguishmentOfDebtAndOtherExpenses_ef2088a1-056f-4c47-9685-5bf19c1ea3e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_8f329128-ca69-470e-872e-3445b8cf5ce5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherExpensesAbstract_804239ac-d1dd-4c87-b0aa-580078dbac2e" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_8f329128-ca69-470e-872e-3445b8cf5ce5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_f119b4f0-4026-47e6-9356-d893059678fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherExpensesAbstract_804239ac-d1dd-4c87-b0aa-580078dbac2e" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_f119b4f0-4026-47e6-9356-d893059678fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_66f7f174-181e-4615-825e-30042879891e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_04d1472d-6a1e-4dcd-a45e-bf5dc0048263" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_66f7f174-181e-4615-825e-30042879891e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_9cac600b-981e-4c75-b9ad-17bf5cc06711" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_04d1472d-6a1e-4dcd-a45e-bf5dc0048263" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_9cac600b-981e-4c75-b9ad-17bf5cc06711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_ed7ebb43-1708-4bd7-ae74-ad8ae525fa65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_04d1472d-6a1e-4dcd-a45e-bf5dc0048263" xlink:to="loc_us-gaap_ProfitLoss_ed7ebb43-1708-4bd7-ae74-ad8ae525fa65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2aee31d8-8579-4c31-8d45-fed365f212b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_04d1472d-6a1e-4dcd-a45e-bf5dc0048263" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2aee31d8-8579-4c31-8d45-fed365f212b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_aeb78598-bf28-4ca6-98f8-92074d922c5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_04d1472d-6a1e-4dcd-a45e-bf5dc0048263" xlink:to="loc_us-gaap_NetIncomeLoss_aeb78598-bf28-4ca6-98f8-92074d922c5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_a579d355-d020-40fb-a8ea-14dd0df116ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_04d1472d-6a1e-4dcd-a45e-bf5dc0048263" xlink:to="loc_us-gaap_EarningsPerShareBasic_a579d355-d020-40fb-a8ea-14dd0df116ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_3a306df5-c0ee-40ca-baff-5ff0a84d3325" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_04d1472d-6a1e-4dcd-a45e-bf5dc0048263" xlink:to="loc_us-gaap_EarningsPerShareDiluted_3a306df5-c0ee-40ca-baff-5ff0a84d3325" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EarningPerShareBasicAndDilutedAbstract_7725d069-6657-41d2-baac-bbd2f440eeb1" xlink:href="rdnt-20221231.xsd#rdnt_EarningPerShareBasicAndDilutedAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_04d1472d-6a1e-4dcd-a45e-bf5dc0048263" xlink:to="loc_rdnt_EarningPerShareBasicAndDilutedAbstract_7725d069-6657-41d2-baac-bbd2f440eeb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a55c9020-4d45-4ad8-9f41-3ceec3f8f42b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_EarningPerShareBasicAndDilutedAbstract_7725d069-6657-41d2-baac-bbd2f440eeb1" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a55c9020-4d45-4ad8-9f41-3ceec3f8f42b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_086be00f-7edf-4f90-a64a-7c115736cd18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_EarningPerShareBasicAndDilutedAbstract_7725d069-6657-41d2-baac-bbd2f440eeb1" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_086be00f-7edf-4f90-a64a-7c115736cd18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="simple" xlink:href="rdnt-20221231.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_2078364e-daea-4b64-9623-76f6f150c126" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_a734fb0f-de0a-4b46-a163-f79d2d40b74a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_2078364e-daea-4b64-9623-76f6f150c126" xlink:to="loc_us-gaap_ProfitLoss_a734fb0f-de0a-4b46-a163-f79d2d40b74a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_5f535421-03c2-4790-92df-b48a89aad6c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_2078364e-daea-4b64-9623-76f6f150c126" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_5f535421-03c2-4790-92df-b48a89aad6c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_c05525b1-530e-4260-beaf-c3b07aa5fff1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_2078364e-daea-4b64-9623-76f6f150c126" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_c05525b1-530e-4260-beaf-c3b07aa5fff1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_e92cb5e2-5d42-48a6-9c94-041a13a77150" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_2078364e-daea-4b64-9623-76f6f150c126" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_e92cb5e2-5d42-48a6-9c94-041a13a77150" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_7a420a45-1806-4c85-893e-5250c6cfb688" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_2078364e-daea-4b64-9623-76f6f150c126" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_7a420a45-1806-4c85-893e-5250c6cfb688" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_f3bffb2b-1073-4066-a115-e7acad63fe13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_2078364e-daea-4b64-9623-76f6f150c126" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_f3bffb2b-1073-4066-a115-e7acad63fe13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_f7da532a-3798-4f86-bd8c-aad773a10355" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_2078364e-daea-4b64-9623-76f6f150c126" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_f7da532a-3798-4f86-bd8c-aad773a10355" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY" xlink:type="simple" xlink:href="rdnt-20221231.xsd#CONSOLIDATEDSTATEMENTOFEQUITY"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_f9414001-73c1-4383-93b7-2a1484843baf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_397734fa-b22f-4be1-afed-06318628016b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_f9414001-73c1-4383-93b7-2a1484843baf" xlink:to="loc_us-gaap_StatementTable_397734fa-b22f-4be1-afed-06318628016b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_4234e7cf-6dbf-4afd-952c-9b8ed34af944" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_397734fa-b22f-4be1-afed-06318628016b" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_4234e7cf-6dbf-4afd-952c-9b8ed34af944" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_c6c19e94-c2d6-43ca-91bd-b4dfe104db4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_4234e7cf-6dbf-4afd-952c-9b8ed34af944" xlink:to="loc_us-gaap_EquityComponentDomain_c6c19e94-c2d6-43ca-91bd-b4dfe104db4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_02dbae20-754b-42a0-9976-35b49272ae34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c6c19e94-c2d6-43ca-91bd-b4dfe104db4a" xlink:to="loc_us-gaap_ParentMember_02dbae20-754b-42a0-9976-35b49272ae34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_523f2b2a-fea5-46a5-91b2-07fde2aa2984" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_02dbae20-754b-42a0-9976-35b49272ae34" xlink:to="loc_us-gaap_CommonStockMember_523f2b2a-fea5-46a5-91b2-07fde2aa2984" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_000b6e04-8bca-4e4c-b894-18c32849a43f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_02dbae20-754b-42a0-9976-35b49272ae34" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_000b6e04-8bca-4e4c-b894-18c32849a43f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_99e46df4-3113-4afc-a07c-28d5894d1575" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_02dbae20-754b-42a0-9976-35b49272ae34" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_99e46df4-3113-4afc-a07c-28d5894d1575" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_6dca2057-4729-4a49-abb0-6eef990adcc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_02dbae20-754b-42a0-9976-35b49272ae34" xlink:to="loc_us-gaap_RetainedEarningsMember_6dca2057-4729-4a49-abb0-6eef990adcc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_c13db788-a05a-4312-9e32-9ff09905295e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c6c19e94-c2d6-43ca-91bd-b4dfe104db4a" xlink:to="loc_us-gaap_NoncontrollingInterestMember_c13db788-a05a-4312-9e32-9ff09905295e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_c032b543-d0a1-4582-a337-921ee2ba2f10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_397734fa-b22f-4be1-afed-06318628016b" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_c032b543-d0a1-4582-a337-921ee2ba2f10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_779e5529-2147-4c92-84d5-e5ce1fc4c863" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_c032b543-d0a1-4582-a337-921ee2ba2f10" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_779e5529-2147-4c92-84d5-e5ce1fc4c863" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AcquisitionsAndAssetPurchasesMember_9b9d471e-e178-43f5-948b-efa7d7efea10" xlink:href="rdnt-20221231.xsd#rdnt_AcquisitionsAndAssetPurchasesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_779e5529-2147-4c92-84d5-e5ce1fc4c863" xlink:to="loc_rdnt_AcquisitionsAndAssetPurchasesMember_9b9d471e-e178-43f5-948b-efa7d7efea10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeepHealthIncMember_fb0848a1-6984-4d47-a3bf-c28546a8a270" xlink:href="rdnt-20221231.xsd#rdnt_DeepHealthIncMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_779e5529-2147-4c92-84d5-e5ce1fc4c863" xlink:to="loc_rdnt_DeepHealthIncMember_fb0848a1-6984-4d47-a3bf-c28546a8a270" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_1cbe8ef7-475d-4528-a857-95b22bb71851" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_397734fa-b22f-4be1-afed-06318628016b" xlink:to="loc_us-gaap_StatementLineItems_1cbe8ef7-475d-4528-a857-95b22bb71851" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cbf6a691-b4c7-4c2a-9034-6378f14d8c27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1cbe8ef7-475d-4528-a857-95b22bb71851" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cbf6a691-b4c7-4c2a-9034-6378f14d8c27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_a0156b69-30c4-41ef-b794-8b2d7e209a1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cbf6a691-b4c7-4c2a-9034-6378f14d8c27" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_a0156b69-30c4-41ef-b794-8b2d7e209a1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9bbbcf76-4d9d-4715-8700-561458d5bbb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cbf6a691-b4c7-4c2a-9034-6378f14d8c27" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9bbbcf76-4d9d-4715-8700-561458d5bbb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_5b46942d-1f0b-4068-9f9d-3a90848e3fb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cbf6a691-b4c7-4c2a-9034-6378f14d8c27" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_5b46942d-1f0b-4068-9f9d-3a90848e3fb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_b8e4e5a5-667a-4a08-88df-8f7e3c2f259f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cbf6a691-b4c7-4c2a-9034-6378f14d8c27" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_b8e4e5a5-667a-4a08-88df-8f7e3c2f259f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_70943a41-025f-492c-ae7b-c2303d14ac9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cbf6a691-b4c7-4c2a-9034-6378f14d8c27" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_70943a41-025f-492c-ae7b-c2303d14ac9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SharesIssuedSharesSettlementOfContingentConsideration_66884b4a-e569-427e-8a56-8a832b828654" xlink:href="rdnt-20221231.xsd#rdnt_SharesIssuedSharesSettlementOfContingentConsideration"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cbf6a691-b4c7-4c2a-9034-6378f14d8c27" xlink:to="loc_rdnt_SharesIssuedSharesSettlementOfContingentConsideration_66884b4a-e569-427e-8a56-8a832b828654" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_c178f3c6-5736-4bb8-9bf5-da0714a95abe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cbf6a691-b4c7-4c2a-9034-6378f14d8c27" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_c178f3c6-5736-4bb8-9bf5-da0714a95abe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_16940bce-73f1-41fa-9e56-2215ff8802bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cbf6a691-b4c7-4c2a-9034-6378f14d8c27" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_16940bce-73f1-41fa-9e56-2215ff8802bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_5d4be12f-40a9-4c9e-ab35-fcaff51835dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cbf6a691-b4c7-4c2a-9034-6378f14d8c27" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_5d4be12f-40a9-4c9e-ab35-fcaff51835dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest_8650b0f1-ee66-44ea-8780-6a2c209d04f6" xlink:href="rdnt-20221231.xsd#rdnt_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cbf6a691-b4c7-4c2a-9034-6378f14d8c27" xlink:to="loc_rdnt_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest_8650b0f1-ee66-44ea-8780-6a2c209d04f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_7f67aa40-18b6-4f7b-804e-3b5c4cceb521" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cbf6a691-b4c7-4c2a-9034-6378f14d8c27" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_7f67aa40-18b6-4f7b-804e-3b5c4cceb521" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_fc94c171-b41d-464e-b323-bc0ecb8e0889" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cbf6a691-b4c7-4c2a-9034-6378f14d8c27" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_fc94c171-b41d-464e-b323-bc0ecb8e0889" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_e4f81afe-c9ab-49ff-a601-95f82d6611f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cbf6a691-b4c7-4c2a-9034-6378f14d8c27" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_e4f81afe-c9ab-49ff-a601-95f82d6611f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_ae1772db-d55e-4250-a069-536b52089dd9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cbf6a691-b4c7-4c2a-9034-6378f14d8c27" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_ae1772db-d55e-4250-a069-536b52089dd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_8c650f9a-25aa-4ae3-b19b-9ce2a27d0c6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cbf6a691-b4c7-4c2a-9034-6378f14d8c27" xlink:to="loc_us-gaap_ProfitLoss_8c650f9a-25aa-4ae3-b19b-9ce2a27d0c6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_80879bf6-7887-4ae2-aa8a-eaa0bc42a6af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cbf6a691-b4c7-4c2a-9034-6378f14d8c27" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_80879bf6-7887-4ae2-aa8a-eaa0bc42a6af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_1d0beaba-81b6-4ef6-9d55-e4fb43875646" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cbf6a691-b4c7-4c2a-9034-6378f14d8c27" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_1d0beaba-81b6-4ef6-9d55-e4fb43875646" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_1e3588b9-cc7e-40c8-b413-2a00179a2555" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cbf6a691-b4c7-4c2a-9034-6378f14d8c27" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_1e3588b9-cc7e-40c8-b413-2a00179a2555" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited_8648d61a-2af5-456e-99c7-45a28a3a7139" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cbf6a691-b4c7-4c2a-9034-6378f14d8c27" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited_8648d61a-2af5-456e-99c7-45a28a3a7139" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AdjustmentsToAdditionalPaidInCapitalGainOnContributionOfAssetsToSubsidiary_a6261035-6c4b-4beb-8987-54785bd06ea9" xlink:href="rdnt-20221231.xsd#rdnt_AdjustmentsToAdditionalPaidInCapitalGainOnContributionOfAssetsToSubsidiary"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cbf6a691-b4c7-4c2a-9034-6378f14d8c27" xlink:to="loc_rdnt_AdjustmentsToAdditionalPaidInCapitalGainOnContributionOfAssetsToSubsidiary_a6261035-6c4b-4beb-8987-54785bd06ea9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest_1d169ec4-1855-4312-8287-186cbcb9fc48" xlink:href="rdnt-20221231.xsd#rdnt_NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cbf6a691-b4c7-4c2a-9034-6378f14d8c27" xlink:to="loc_rdnt_NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest_1d169ec4-1855-4312-8287-186cbcb9fc48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_60a22bab-a229-48c6-b98b-d16f2047736d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cbf6a691-b4c7-4c2a-9034-6378f14d8c27" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_60a22bab-a229-48c6-b98b-d16f2047736d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_626b42d8-933f-4b47-80cb-71e5e0d56f29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cbf6a691-b4c7-4c2a-9034-6378f14d8c27" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_626b42d8-933f-4b47-80cb-71e5e0d56f29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_76505db7-e8a3-48fe-a988-b791036cf21c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cbf6a691-b4c7-4c2a-9034-6378f14d8c27" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_76505db7-e8a3-48fe-a988-b791036cf21c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="rdnt-20221231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_eeb5a435-f4d3-48c9-801e-0b5328f6c58b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9754298d-b729-4562-9e02-ab3fa0661585" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_eeb5a435-f4d3-48c9-801e-0b5328f6c58b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9754298d-b729-4562-9e02-ab3fa0661585" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_73cfd022-a6b5-40fe-ae66-b2365ff5ef09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9754298d-b729-4562-9e02-ab3fa0661585" xlink:to="loc_us-gaap_ProfitLoss_73cfd022-a6b5-40fe-ae66-b2365ff5ef09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d6ee1ab2-c44f-4e07-a749-55cb5a541364" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9754298d-b729-4562-9e02-ab3fa0661585" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d6ee1ab2-c44f-4e07-a749-55cb5a541364" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_02341bed-3060-41df-9437-4a20940c790b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d6ee1ab2-c44f-4e07-a749-55cb5a541364" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_02341bed-3060-41df-9437-4a20940c790b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_e0f691c5-64f9-48fc-a3ab-ec76c9ebab8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d6ee1ab2-c44f-4e07-a749-55cb5a541364" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_e0f691c5-64f9-48fc-a3ab-ec76c9ebab8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnTerminationOfLease_62876aae-b789-414d-8ef7-740b96ca0601" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnTerminationOfLease"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d6ee1ab2-c44f-4e07-a749-55cb5a541364" xlink:to="loc_us-gaap_GainLossOnTerminationOfLease_62876aae-b789-414d-8ef7-740b96ca0601" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_9e2b71ee-a893-45a2-a3e3-7ecb20fd750a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d6ee1ab2-c44f-4e07-a749-55cb5a541364" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_9e2b71ee-a893-45a2-a3e3-7ecb20fd750a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_87bee0df-c123-4f32-8a8e-e616f9799ad1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d6ee1ab2-c44f-4e07-a749-55cb5a541364" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_87bee0df-c123-4f32-8a8e-e616f9799ad1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets_e4d72e10-b04f-4014-af2f-b922301c6d89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d6ee1ab2-c44f-4e07-a749-55cb5a541364" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets_e4d72e10-b04f-4014-af2f-b922301c6d89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_e601fa13-161d-4f29-9c5a-88034a5e1b52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d6ee1ab2-c44f-4e07-a749-55cb5a541364" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_e601fa13-161d-4f29-9c5a-88034a5e1b52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_ca39a32e-14e3-4d5f-b14a-46eaa0005407" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d6ee1ab2-c44f-4e07-a749-55cb5a541364" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_ca39a32e-14e3-4d5f-b14a-46eaa0005407" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDeferredHedgeGains_ddb9d0c0-089c-4e53-a8a2-eeb5389ce557" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfDeferredHedgeGains"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d6ee1ab2-c44f-4e07-a749-55cb5a541364" xlink:to="loc_us-gaap_AmortizationOfDeferredHedgeGains_ddb9d0c0-089c-4e53-a8a2-eeb5389ce557" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnDerivatives_06d642a2-a64c-4d69-9d22-e247fc3cd638" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnDerivatives"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d6ee1ab2-c44f-4e07-a749-55cb5a541364" xlink:to="loc_us-gaap_UnrealizedGainLossOnDerivatives_06d642a2-a64c-4d69-9d22-e247fc3cd638" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_25ca25d9-cd73-497a-a23d-499c6a00dda8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d6ee1ab2-c44f-4e07-a749-55cb5a541364" xlink:to="loc_us-gaap_ShareBasedCompensation_25ca25d9-cd73-497a-a23d-499c6a00dda8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_IncreaseDecreaseInNoncashItem_b88cb4fe-eb16-4865-94e3-4d98b3a65f3d" xlink:href="rdnt-20221231.xsd#rdnt_IncreaseDecreaseInNoncashItem"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d6ee1ab2-c44f-4e07-a749-55cb5a541364" xlink:to="loc_rdnt_IncreaseDecreaseInNoncashItem_b88cb4fe-eb16-4865-94e3-4d98b3a65f3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_6813e312-c48a-4dbf-bcbc-f823b44283e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d6ee1ab2-c44f-4e07-a749-55cb5a541364" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_6813e312-c48a-4dbf-bcbc-f823b44283e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_033e8a0d-1732-4ae2-af00-ea4a8e426a70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d6ee1ab2-c44f-4e07-a749-55cb5a541364" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_033e8a0d-1732-4ae2-af00-ea4a8e426a70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_e9919eb5-0f97-4520-95c5-90e36e217083" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_033e8a0d-1732-4ae2-af00-ea4a8e426a70" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_e9919eb5-0f97-4520-95c5-90e36e217083" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_7ecf510d-1317-4fea-b37c-f35f760b43c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_033e8a0d-1732-4ae2-af00-ea4a8e426a70" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_7ecf510d-1317-4fea-b37c-f35f760b43c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_45e49a7b-1295-4e9a-88f5-2d63b88ad10f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_033e8a0d-1732-4ae2-af00-ea4a8e426a70" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_45e49a7b-1295-4e9a-88f5-2d63b88ad10f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_f662f11e-2835-494f-b641-e5eab12ae2e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_033e8a0d-1732-4ae2-af00-ea4a8e426a70" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_f662f11e-2835-494f-b641-e5eab12ae2e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_198cd1ba-9c6e-4341-bb10-d6c928e24a69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_033e8a0d-1732-4ae2-af00-ea4a8e426a70" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_198cd1ba-9c6e-4341-bb10-d6c928e24a69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_77eb3444-b53d-4c15-9b85-71054703495d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_033e8a0d-1732-4ae2-af00-ea4a8e426a70" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_77eb3444-b53d-4c15-9b85-71054703495d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_60197c60-e4ba-4c9c-8c2c-1090223c5b73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_033e8a0d-1732-4ae2-af00-ea4a8e426a70" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_60197c60-e4ba-4c9c-8c2c-1090223c5b73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6eb3fcdd-5ea5-4902-8ff3-8a5a3d70ac73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9754298d-b729-4562-9e02-ab3fa0661585" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6eb3fcdd-5ea5-4902-8ff3-8a5a3d70ac73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4bc0f725-9fad-4b7d-b8e3-1ca97e509ab2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_eeb5a435-f4d3-48c9-801e-0b5328f6c58b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4bc0f725-9fad-4b7d-b8e3-1ca97e509ab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBuildings_6e3feafc-c61b-496b-8681-d742a0da5637" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBuildings"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4bc0f725-9fad-4b7d-b8e3-1ca97e509ab2" xlink:to="loc_us-gaap_PaymentsToAcquireBuildings_6e3feafc-c61b-496b-8681-d742a0da5637" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment_5d811f98-54dc-434b-9883-b9d9e17db397" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4bc0f725-9fad-4b7d-b8e3-1ca97e509ab2" xlink:to="loc_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment_5d811f98-54dc-434b-9883-b9d9e17db397" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_1548a964-0a6f-4957-8ac8-3ebb7c00c1d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4bc0f725-9fad-4b7d-b8e3-1ca97e509ab2" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_1548a964-0a6f-4957-8ac8-3ebb7c00c1d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_ef2c2682-3bac-4f7d-8b15-db0aa402352d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4bc0f725-9fad-4b7d-b8e3-1ca97e509ab2" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_ef2c2682-3bac-4f7d-8b15-db0aa402352d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInJointVenture_e73570e9-21b5-432e-811c-7f4985083105" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireInterestInJointVenture"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4bc0f725-9fad-4b7d-b8e3-1ca97e509ab2" xlink:to="loc_us-gaap_PaymentsToAcquireInterestInJointVenture_e73570e9-21b5-432e-811c-7f4985083105" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ec7db9ad-6c78-4b85-b66c-0301a4933628" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4bc0f725-9fad-4b7d-b8e3-1ca97e509ab2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ec7db9ad-6c78-4b85-b66c-0301a4933628" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2e04b01e-fdeb-48c4-9f9b-e952c07ab8a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_eeb5a435-f4d3-48c9-801e-0b5328f6c58b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2e04b01e-fdeb-48c4-9f9b-e952c07ab8a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_e4d1bad6-7361-4b9c-b379-858877125d35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2e04b01e-fdeb-48c4-9f9b-e952c07ab8a6" xlink:to="loc_us-gaap_RepaymentsOfDebt_e4d1bad6-7361-4b9c-b379-858877125d35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities_3596172b-c93c-444c-a16a-db15d856a6f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2e04b01e-fdeb-48c4-9f9b-e952c07ab8a6" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities_3596172b-c93c-444c-a16a-db15d856a6f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_e333e082-f1df-46d5-b306-ae024dc2f3a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2e04b01e-fdeb-48c4-9f9b-e952c07ab8a6" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_e333e082-f1df-46d5-b306-ae024dc2f3a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_778311a5-d0d3-4453-a397-4d0f88c225bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2e04b01e-fdeb-48c4-9f9b-e952c07ab8a6" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_778311a5-d0d3-4453-a397-4d0f88c225bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ProceedsFromGovernmentAssistance_bb457336-9fc6-4012-a690-51467a3c0392" xlink:href="rdnt-20221231.xsd#rdnt_ProceedsFromGovernmentAssistance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2e04b01e-fdeb-48c4-9f9b-e952c07ab8a6" xlink:to="loc_rdnt_ProceedsFromGovernmentAssistance_bb457336-9fc6-4012-a690-51467a3c0392" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_4b9a23d1-762e-444a-973f-d4823152ec91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2e04b01e-fdeb-48c4-9f9b-e952c07ab8a6" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_4b9a23d1-762e-444a-973f-d4823152ec91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_f0fbc597-0ff6-41b0-86e8-2ce9f9606bd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2e04b01e-fdeb-48c4-9f9b-e952c07ab8a6" xlink:to="loc_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_f0fbc597-0ff6-41b0-86e8-2ce9f9606bd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_35492a68-10ab-429d-b716-496b500304eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2e04b01e-fdeb-48c4-9f9b-e952c07ab8a6" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_35492a68-10ab-429d-b716-496b500304eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_32eb5297-9d0a-45d8-abad-05186a7c6b1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2e04b01e-fdeb-48c4-9f9b-e952c07ab8a6" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_32eb5297-9d0a-45d8-abad-05186a7c6b1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_e467e28a-d468-4012-af2b-27126da43ccc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2e04b01e-fdeb-48c4-9f9b-e952c07ab8a6" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_e467e28a-d468-4012-af2b-27126da43ccc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_347d1dce-c4f6-422b-b76b-a60e9127f648" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2e04b01e-fdeb-48c4-9f9b-e952c07ab8a6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_347d1dce-c4f6-422b-b76b-a60e9127f648" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4e3a3f9e-171c-4713-b6de-ae723e2a9e67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_eeb5a435-f4d3-48c9-801e-0b5328f6c58b" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4e3a3f9e-171c-4713-b6de-ae723e2a9e67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_4c6a915f-5a96-4318-97f0-bf7a9326a0d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_eeb5a435-f4d3-48c9-801e-0b5328f6c58b" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_4c6a915f-5a96-4318-97f0-bf7a9326a0d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4ac5103a-528d-41f2-8a0a-9e3042035509" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_eeb5a435-f4d3-48c9-801e-0b5328f6c58b" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4ac5103a-528d-41f2-8a0a-9e3042035509" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2f924bd4-fe57-43bd-ac76-16fc75e0415d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_eeb5a435-f4d3-48c9-801e-0b5328f6c58b" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2f924bd4-fe57-43bd-ac76-16fc75e0415d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_4d1a986c-e5ef-4f82-8a1c-02a2d54f40df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_eeb5a435-f4d3-48c9-801e-0b5328f6c58b" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_4d1a986c-e5ef-4f82-8a1c-02a2d54f40df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_6f5c0b6b-7f19-4481-b153-5f2e76ae4d2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_4d1a986c-e5ef-4f82-8a1c-02a2d54f40df" xlink:to="loc_us-gaap_InterestPaidNet_6f5c0b6b-7f19-4481-b153-5f2e76ae4d2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_3063ac0d-9c1f-4e88-9327-b3fc46828592" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_4d1a986c-e5ef-4f82-8a1c-02a2d54f40df" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_3063ac0d-9c1f-4e88-9327-b3fc46828592" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical" xlink:type="simple" xlink:href="rdnt-20221231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_f338c411-e673-4117-a3fc-4afca93fb80b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_9fc1060e-310a-42e6-a295-d660fc0e3c35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f338c411-e673-4117-a3fc-4afca93fb80b" xlink:to="loc_us-gaap_StatementTable_9fc1060e-310a-42e6-a295-d660fc0e3c35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_1ff00675-92d6-4004-9a45-703133c8720b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_9fc1060e-310a-42e6-a295-d660fc0e3c35" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_1ff00675-92d6-4004-9a45-703133c8720b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7c7d0502-7468-4df0-932e-9af115da820f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1ff00675-92d6-4004-9a45-703133c8720b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7c7d0502-7468-4df0-932e-9af115da820f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AidenceMember_27fba763-6978-4f89-9be8-d1b69f6ec6ac" xlink:href="rdnt-20221231.xsd#rdnt_AidenceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7c7d0502-7468-4df0-932e-9af115da820f" xlink:to="loc_rdnt_AidenceMember_27fba763-6978-4f89-9be8-d1b69f6ec6ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_QuantibMember_752260d6-1760-4e55-9ba1-4792f3fab702" xlink:href="rdnt-20221231.xsd#rdnt_QuantibMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7c7d0502-7468-4df0-932e-9af115da820f" xlink:to="loc_rdnt_QuantibMember_752260d6-1760-4e55-9ba1-4792f3fab702" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DRTLLCMember_93a1502c-5669-422d-aa07-5cda4959d5fe" xlink:href="rdnt-20221231.xsd#rdnt_DRTLLCMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7c7d0502-7468-4df0-932e-9af115da820f" xlink:to="loc_rdnt_DRTLLCMember_93a1502c-5669-422d-aa07-5cda4959d5fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TangentAssociatesLLCMember_b3b42505-57d9-4b4d-b93d-8e5459b9070a" xlink:href="rdnt-20221231.xsd#rdnt_TangentAssociatesLLCMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7c7d0502-7468-4df0-932e-9af115da820f" xlink:to="loc_rdnt_TangentAssociatesLLCMember_b3b42505-57d9-4b4d-b93d-8e5459b9070a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_20affda8-7ddd-4480-b1d3-98af2ac01bc7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_9fc1060e-310a-42e6-a295-d660fc0e3c35" xlink:to="loc_dei_LegalEntityAxis_20affda8-7ddd-4480-b1d3-98af2ac01bc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_da53c4d3-071e-4b56-aa0c-290426dbe1e2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_20affda8-7ddd-4480-b1d3-98af2ac01bc7" xlink:to="loc_dei_EntityDomain_da53c4d3-071e-4b56-aa0c-290426dbe1e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FrederickHealthHospitalIncMember_9c6bb7a7-6151-4c26-b8cd-429bb75ee311" xlink:href="rdnt-20221231.xsd#rdnt_FrederickHealthHospitalIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_da53c4d3-071e-4b56-aa0c-290426dbe1e2" xlink:to="loc_rdnt_FrederickHealthHospitalIncMember_9c6bb7a7-6151-4c26-b8cd-429bb75ee311" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SimiValleyImagingGroupLLCMember_7882571c-010d-4af9-b575-176e8ebf9b11" xlink:href="rdnt-20221231.xsd#rdnt_SimiValleyImagingGroupLLCMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_da53c4d3-071e-4b56-aa0c-290426dbe1e2" xlink:to="loc_rdnt_SimiValleyImagingGroupLLCMember_7882571c-010d-4af9-b575-176e8ebf9b11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SimiAdventistMember_52f105f2-43f6-4d54-854d-5eb7c158e27f" xlink:href="rdnt-20221231.xsd#rdnt_SimiAdventistMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_da53c4d3-071e-4b56-aa0c-290426dbe1e2" xlink:to="loc_rdnt_SimiAdventistMember_52f105f2-43f6-4d54-854d-5eb7c158e27f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_6a6ac837-8694-4010-96ec-7c966a5b2743" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_9fc1060e-310a-42e6-a295-d660fc0e3c35" xlink:to="loc_srt_OwnershipAxis_6a6ac837-8694-4010-96ec-7c966a5b2743" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_2d32ca3a-4d48-434e-8812-d7e7c62c9acf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_6a6ac837-8694-4010-96ec-7c966a5b2743" xlink:to="loc_srt_OwnershipDomain_2d32ca3a-4d48-434e-8812-d7e7c62c9acf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FrederickCountyRadiologyLLCMember_c98b7752-f903-4c81-b71e-27c253c70f68" xlink:href="rdnt-20221231.xsd#rdnt_FrederickCountyRadiologyLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_2d32ca3a-4d48-434e-8812-d7e7c62c9acf" xlink:to="loc_rdnt_FrederickCountyRadiologyLLCMember_c98b7752-f903-4c81-b71e-27c253c70f68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_1eada5a9-6b81-465c-8ed6-7d5ac8580c2a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_9fc1060e-310a-42e6-a295-d660fc0e3c35" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_1eada5a9-6b81-465c-8ed6-7d5ac8580c2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_3b340195-f1b3-41e1-bef6-8383a0082bd1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_1eada5a9-6b81-465c-8ed6-7d5ac8580c2a" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_3b340195-f1b3-41e1-bef6-8383a0082bd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ArizonaDiagnosticsGroupMember_17ba7c44-4a39-4e29-8bb2-8f986c2b34fb" xlink:href="rdnt-20221231.xsd#rdnt_ArizonaDiagnosticsGroupMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_3b340195-f1b3-41e1-bef6-8383a0082bd1" xlink:to="loc_rdnt_ArizonaDiagnosticsGroupMember_17ba7c44-4a39-4e29-8bb2-8f986c2b34fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_de541be3-3327-4156-b3cf-e375be62929e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_9fc1060e-310a-42e6-a295-d660fc0e3c35" xlink:to="loc_us-gaap_StatementLineItems_de541be3-3327-4156-b3cf-e375be62929e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquipmentAcquiredAndLeaseholdImprovements_2f42e9f3-da53-44cd-9393-9d97f42d1290" xlink:href="rdnt-20221231.xsd#rdnt_EquipmentAcquiredAndLeaseholdImprovements"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_de541be3-3327-4156-b3cf-e375be62929e" xlink:to="loc_rdnt_EquipmentAcquiredAndLeaseholdImprovements_2f42e9f3-da53-44cd-9393-9d97f42d1290" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_6c6a8650-abef-44df-b4f0-749ede7555d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_de541be3-3327-4156-b3cf-e375be62929e" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_6c6a8650-abef-44df-b4f0-749ede7555d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_ff0c0df5-8efa-4305-a35c-f441e2ef45d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_de541be3-3327-4156-b3cf-e375be62929e" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_ff0c0df5-8efa-4305-a35c-f441e2ef45d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_a8d39f37-36cd-416a-9116-ecfa54639138" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_de541be3-3327-4156-b3cf-e375be62929e" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_a8d39f37-36cd-416a-9116-ecfa54639138" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDividendsReceived_0f13fc9d-772a-43c5-badc-aa2238fb5612" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDividendsReceived"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_de541be3-3327-4156-b3cf-e375be62929e" xlink:to="loc_us-gaap_ProceedsFromDividendsReceived_0f13fc9d-772a-43c5-badc-aa2238fb5612" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_6d84a4ef-bc1d-4992-9956-b6393d4e4509" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_de541be3-3327-4156-b3cf-e375be62929e" xlink:to="loc_us-gaap_EquityMethodInvestments_6d84a4ef-bc1d-4992-9956-b6393d4e4509" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_7480706f-ee17-4fb7-9947-c1a2aa2ce530" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_de541be3-3327-4156-b3cf-e375be62929e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_7480706f-ee17-4fb7-9947-c1a2aa2ce530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1_c68e0691-b795-4947-9275-ced9f5f64cd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_de541be3-3327-4156-b3cf-e375be62929e" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1_c68e0691-b795-4947-9275-ced9f5f64cd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued_f1ca013b-f3b2-4967-8a3c-f547c6960eb2" xlink:href="rdnt-20221231.xsd#rdnt_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_de541be3-3327-4156-b3cf-e375be62929e" xlink:to="loc_rdnt_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued_f1ca013b-f3b2-4967-8a3c-f547c6960eb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_b8472ed4-b77c-4a28-9e0e-a93e33838094" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_de541be3-3327-4156-b3cf-e375be62929e" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_b8472ed4-b77c-4a28-9e0e-a93e33838094" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1_084d398b-6cdd-4310-942c-06fc87028448" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_de541be3-3327-4156-b3cf-e375be62929e" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1_084d398b-6cdd-4310-942c-06fc87028448" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_d7631a17-2e55-41b1-8f55-b5312182a5bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_de541be3-3327-4156-b3cf-e375be62929e" xlink:to="loc_us-gaap_FinanceLeaseLiability_d7631a17-2e55-41b1-8f55-b5312182a5bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/NATUREOFBUSINESS" xlink:type="simple" xlink:href="rdnt-20221231.xsd#NATUREOFBUSINESS"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/NATUREOFBUSINESS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_888d288b-fafa-4c93-b303-224fd5f155d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_f16d6539-df92-42fa-8821-e61e142f6861" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_888d288b-fafa-4c93-b303-224fd5f155d6" xlink:to="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_f16d6539-df92-42fa-8821-e61e142f6861" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="simple" xlink:href="rdnt-20221231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_7e76171c-c3dd-49d8-a2db-e3fe91e81397" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_0a652731-4c60-4884-a347-c613738aa8e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7e76171c-c3dd-49d8-a2db-e3fe91e81397" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_0a652731-4c60-4884-a347-c613738aa8e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/RECENTACCOUNTINGSTANDARDS" xlink:type="simple" xlink:href="rdnt-20221231.xsd#RECENTACCOUNTINGSTANDARDS"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/RECENTACCOUNTINGSTANDARDS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_741d5435-869b-4247-bca4-9aeb7a3ac3df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_77ca4ee2-9178-49db-bd3d-a311ba89e5dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_741d5435-869b-4247-bca4-9aeb7a3ac3df" xlink:to="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_77ca4ee2-9178-49db-bd3d-a311ba89e5dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITY" xlink:type="simple" xlink:href="rdnt-20221231.xsd#BUSINESSCOMBINATIONSANDRELATEDACTIVITY"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_89029ed6-39e9-4150-889a-d693a299841d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_daeb6e44-2203-4b52-93db-c25251cc7887" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_89029ed6-39e9-4150-889a-d693a299841d" xlink:to="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_daeb6e44-2203-4b52-93db-c25251cc7887" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SEGMENTREPORTING" xlink:type="simple" xlink:href="rdnt-20221231.xsd#SEGMENTREPORTING"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SEGMENTREPORTING" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_2d30a8d5-7df6-4182-a0f5-22a2a7bc3a55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_b42b4840-6e96-4349-b1af-e331047510fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_2d30a8d5-7df6-4182-a0f5-22a2a7bc3a55" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_b42b4840-6e96-4349-b1af-e331047510fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETS" xlink:type="simple" xlink:href="rdnt-20221231.xsd#GOODWILLANDOTHERINTANGIBLEASSETS"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_16c6ccb9-4eeb-4c24-9ebc-b7d4658fe556" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_f61e42c0-9b49-42c1-9556-72da2f227b16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_16c6ccb9-4eeb-4c24-9ebc-b7d4658fe556" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_f61e42c0-9b49-42c1-9556-72da2f227b16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/PROPERTYANDEQUIPMENT" xlink:type="simple" xlink:href="rdnt-20221231.xsd#PROPERTYANDEQUIPMENT"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/PROPERTYANDEQUIPMENT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_2db2be6d-1d31-4858-9a45-86c40a9f2980" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_0bdd6ac6-ee76-4398-8727-57cd9a940938" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_2db2be6d-1d31-4858-9a45-86c40a9f2980" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_0bdd6ac6-ee76-4398-8727-57cd9a940938" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLE" xlink:type="simple" xlink:href="rdnt-20221231.xsd#CREDITFACILITIESANDNOTESPAYABLE"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_40557e05-cfca-4be2-a937-b49be3c3273f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_462ce3d0-da28-4edf-80e8-e23a074bf665" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_40557e05-cfca-4be2-a937-b49be3c3273f" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_462ce3d0-da28-4edf-80e8-e23a074bf665" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/LEASES" xlink:type="simple" xlink:href="rdnt-20221231.xsd#LEASES"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/LEASES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_b98baf71-7648-49dd-95d8-f6a880257435" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_602850fe-3c43-4f2a-8d7f-f9ace4f8ace2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b98baf71-7648-49dd-95d8-f6a880257435" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_602850fe-3c43-4f2a-8d7f-f9ace4f8ace2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/INCOMETAXES" xlink:type="simple" xlink:href="rdnt-20221231.xsd#INCOMETAXES"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/INCOMETAXES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_f84f28c7-0b6a-42c1-af41-60029ad50486" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_812754a1-9772-4c9b-8c8d-c267f2f8f78d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f84f28c7-0b6a-42c1-af41-60029ad50486" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_812754a1-9772-4c9b-8c8d-c267f2f8f78d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATION" xlink:type="simple" xlink:href="rdnt-20221231.xsd#STOCKBASEDCOMPENSATION"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/STOCKBASEDCOMPENSATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_41f0b486-a5dc-4f7f-8d73-ff6705cbcaa7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_7816a0e5-c92f-4466-bcf7-a4dc3f1416ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_41f0b486-a5dc-4f7f-8d73-ff6705cbcaa7" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_7816a0e5-c92f-4466-bcf7-a4dc3f1416ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUBSEQUENTEVENTS" xlink:type="simple" xlink:href="rdnt-20221231.xsd#SUBSEQUENTEVENTS"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUBSEQUENTEVENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_33a1a167-f564-40e5-a163-395911aa9365" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_5fd229ff-499f-4761-89de-917b8ef81558" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_33a1a167-f564-40e5-a163-395911aa9365" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_5fd229ff-499f-4761-89de-917b8ef81558" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="simple" xlink:href="rdnt-20221231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_b585e9d4-f47d-4564-8e52-34eb7ea1ad06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_4cbb2961-5d3b-4f51-8239-ee56383740b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b585e9d4-f47d-4564-8e52-34eb7ea1ad06" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_4cbb2961-5d3b-4f51-8239-ee56383740b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_4062c2e2-575d-4611-846c-6c70dab28f8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b585e9d4-f47d-4564-8e52-34eb7ea1ad06" xlink:to="loc_us-gaap_UseOfEstimates_4062c2e2-575d-4611-846c-6c70dab28f8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock_c2aac543-f5ef-4286-9aea-9ee1999d0c56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b585e9d4-f47d-4564-8e52-34eb7ea1ad06" xlink:to="loc_us-gaap_RevenueRecognitionPolicyTextBlock_c2aac543-f5ef-4286-9aea-9ee1999d0c56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock_e2aad076-a2da-48ed-b181-0ab0fbc759e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b585e9d4-f47d-4564-8e52-34eb7ea1ad06" xlink:to="loc_us-gaap_ReceivablesPolicyTextBlock_e2aad076-a2da-48ed-b181-0ab0fbc759e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_7b7cd567-c849-4bfe-a8e2-997cf222404f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b585e9d4-f47d-4564-8e52-34eb7ea1ad06" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_7b7cd567-c849-4bfe-a8e2-997cf222404f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock_b2b98a3f-fe4b-4b24-b85a-ee6ce06383de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b585e9d4-f47d-4564-8e52-34eb7ea1ad06" xlink:to="loc_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock_b2b98a3f-fe4b-4b24-b85a-ee6ce06383de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_6103fb61-0c40-4a4a-bf2a-1a2a5a5b56fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b585e9d4-f47d-4564-8e52-34eb7ea1ad06" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_6103fb61-0c40-4a4a-bf2a-1a2a5a5b56fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_e67ddae9-4b6e-45d7-9555-e91abf547a5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b585e9d4-f47d-4564-8e52-34eb7ea1ad06" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_e67ddae9-4b6e-45d7-9555-e91abf547a5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredChargesPolicyTextBlock_42a7ef0a-b40f-4d08-b741-b00995e2b37d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredChargesPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b585e9d4-f47d-4564-8e52-34eb7ea1ad06" xlink:to="loc_us-gaap_DeferredChargesPolicyTextBlock_42a7ef0a-b40f-4d08-b741-b00995e2b37d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_4ca47dbe-7483-4961-9902-00038d852dfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b585e9d4-f47d-4564-8e52-34eb7ea1ad06" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_4ca47dbe-7483-4961-9902-00038d852dfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy_2a9f0c6b-035a-4ba2-a859-1d70a179a8e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b585e9d4-f47d-4564-8e52-34eb7ea1ad06" xlink:to="loc_us-gaap_BusinessCombinationsPolicy_2a9f0c6b-035a-4ba2-a859-1d70a179a8e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy_0f268296-c297-4e10-97e4-768529d988d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b585e9d4-f47d-4564-8e52-34eb7ea1ad06" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy_0f268296-c297-4e10-97e4-768529d988d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_02a7dd9e-6a25-4a43-a361-8d5b68536b09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b585e9d4-f47d-4564-8e52-34eb7ea1ad06" xlink:to="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_02a7dd9e-6a25-4a43-a361-8d5b68536b09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_57cccd92-1fb1-4516-91b2-bd861a74fef1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b585e9d4-f47d-4564-8e52-34eb7ea1ad06" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_57cccd92-1fb1-4516-91b2-bd861a74fef1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_b401fc94-9def-422a-8ce2-dad703f9f0a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b585e9d4-f47d-4564-8e52-34eb7ea1ad06" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_b401fc94-9def-422a-8ce2-dad703f9f0a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_UninsuredRisksPolicyTextBlock_a06c4dc5-e19c-4d91-a503-7e3d0d66f279" xlink:href="rdnt-20221231.xsd#rdnt_UninsuredRisksPolicyTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b585e9d4-f47d-4564-8e52-34eb7ea1ad06" xlink:to="loc_rdnt_UninsuredRisksPolicyTextBlock_a06c4dc5-e19c-4d91-a503-7e3d0d66f279" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PostemploymentBenefitPlansPolicy_1084fc8f-ee46-4302-9513-2f412185fea1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PostemploymentBenefitPlansPolicy"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b585e9d4-f47d-4564-8e52-34eb7ea1ad06" xlink:to="loc_us-gaap_PostemploymentBenefitPlansPolicy_1084fc8f-ee46-4302-9513-2f412185fea1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock_02168664-0ca9-4bd2-937c-d6c602733f2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b585e9d4-f47d-4564-8e52-34eb7ea1ad06" xlink:to="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock_02168664-0ca9-4bd2-937c-d6c602733f2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_0ab4e4f7-bdbd-4428-87a6-c51c368ed526" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b585e9d4-f47d-4564-8e52-34eb7ea1ad06" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_0ab4e4f7-bdbd-4428-87a6-c51c368ed526" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_cb802638-af6a-4dcc-b85b-d9ab01506d7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b585e9d4-f47d-4564-8e52-34eb7ea1ad06" xlink:to="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_cb802638-af6a-4dcc-b85b-d9ab01506d7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_ed6c0f57-d6eb-4f0b-9860-d066a32feca6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b585e9d4-f47d-4564-8e52-34eb7ea1ad06" xlink:to="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_ed6c0f57-d6eb-4f0b-9860-d066a32feca6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_48d576cc-007a-4688-b86b-6c6a87b9166b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b585e9d4-f47d-4564-8e52-34eb7ea1ad06" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_48d576cc-007a-4688-b86b-6c6a87b9166b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_77c17272-4150-413a-ad3c-6b8167fe2a3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b585e9d4-f47d-4564-8e52-34eb7ea1ad06" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_77c17272-4150-413a-ad3c-6b8167fe2a3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_9e376783-2d4e-4f37-8e1f-93edff66ccd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b585e9d4-f47d-4564-8e52-34eb7ea1ad06" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_9e376783-2d4e-4f37-8e1f-93edff66ccd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsPolicy_6ffd655f-3ad5-48ae-bafb-ca270f22acdc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsPolicy"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b585e9d4-f47d-4564-8e52-34eb7ea1ad06" xlink:to="loc_us-gaap_EquityMethodInvestmentsPolicy_6ffd655f-3ad5-48ae-bafb-ca270f22acdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock_380dcac2-5a8e-4886-b3b6-53456bc6013f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b585e9d4-f47d-4564-8e52-34eb7ea1ad06" xlink:to="loc_us-gaap_InvestmentPolicyTextBlock_380dcac2-5a8e-4886-b3b6-53456bc6013f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_8d4edb28-2982-4f64-a8be-291cb45b4004" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b585e9d4-f47d-4564-8e52-34eb7ea1ad06" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_8d4edb28-2982-4f64-a8be-291cb45b4004" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="simple" xlink:href="rdnt-20221231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_52bbdbc0-27c5-4e2d-8dde-1c3d5c49e992" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock_aa0774ab-aa09-4dfe-bc39-9a13dce8ad37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_52bbdbc0-27c5-4e2d-8dde-1c3d5c49e992" xlink:to="loc_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock_aa0774ab-aa09-4dfe-bc39-9a13dce8ad37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_0e4180c4-e25b-4ef5-b50d-6cf5d3d9bb3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_52bbdbc0-27c5-4e2d-8dde-1c3d5c49e992" xlink:to="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_0e4180c4-e25b-4ef5-b50d-6cf5d3d9bb3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_e09ee0dd-342c-468d-aa66-a2ca223b7215" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_52bbdbc0-27c5-4e2d-8dde-1c3d5c49e992" xlink:to="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_e09ee0dd-342c-468d-aa66-a2ca223b7215" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_8c8b5c34-d39b-4319-b85a-56ac0e1a854a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_52bbdbc0-27c5-4e2d-8dde-1c3d5c49e992" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_8c8b5c34-d39b-4319-b85a-56ac0e1a854a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_daceac8f-e32f-433a-9262-cb761dee022b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_52bbdbc0-27c5-4e2d-8dde-1c3d5c49e992" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_daceac8f-e32f-433a-9262-cb761dee022b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_3be503fe-8f4c-4a04-82d4-24d697ac4335" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_52bbdbc0-27c5-4e2d-8dde-1c3d5c49e992" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_3be503fe-8f4c-4a04-82d4-24d697ac4335" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock_fd7f9239-fb7d-49c8-90a8-1d4c62e5cf33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_52bbdbc0-27c5-4e2d-8dde-1c3d5c49e992" xlink:to="loc_us-gaap_EquityMethodInvestmentsTextBlock_fd7f9239-fb7d-49c8-90a8-1d4c62e5cf33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock_ae43f512-446f-4e6a-ac27-e5cb3412aeff" xlink:href="rdnt-20221231.xsd#rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_52bbdbc0-27c5-4e2d-8dde-1c3d5c49e992" xlink:to="loc_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock_ae43f512-446f-4e6a-ac27-e5cb3412aeff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ScheduleOfForeignCurrencyTranslationAmountsTableTextBlock_f53814e9-cd36-4fe9-9eb3-4d9a90004c29" xlink:href="rdnt-20221231.xsd#rdnt_ScheduleOfForeignCurrencyTranslationAmountsTableTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_52bbdbc0-27c5-4e2d-8dde-1c3d5c49e992" xlink:to="loc_rdnt_ScheduleOfForeignCurrencyTranslationAmountsTableTextBlock_f53814e9-cd36-4fe9-9eb3-4d9a90004c29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYTables" xlink:type="simple" xlink:href="rdnt-20221231.xsd#BUSINESSCOMBINATIONSANDRELATEDACTIVITYTables"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_2865d4ce-1a2e-4300-a5e5-fd4051be198f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_8369e709-fd3d-48f0-b419-c87d093d8c11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_2865d4ce-1a2e-4300-a5e5-fd4051be198f" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_8369e709-fd3d-48f0-b419-c87d093d8c11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SEGMENTREPORTINGTables" xlink:type="simple" xlink:href="rdnt-20221231.xsd#SEGMENTREPORTINGTables"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SEGMENTREPORTINGTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_2cd0ca7c-e6b8-4a2e-a4a9-b0ca0ce10f1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_3efabd00-632a-401d-ad15-25d1a730d7ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_2cd0ca7c-e6b8-4a2e-a4a9-b0ca0ce10f1f" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_3efabd00-632a-401d-ad15-25d1a730d7ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables" xlink:type="simple" xlink:href="rdnt-20221231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSTables"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cc65f74f-b945-41bb-8187-c657970eaf40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_a7b021a1-fefa-4222-b547-5fa9b537d05d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cc65f74f-b945-41bb-8187-c657970eaf40" xlink:to="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_a7b021a1-fefa-4222-b547-5fa9b537d05d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_d0bc47e5-621a-48cc-844b-cd89cb8acbc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cc65f74f-b945-41bb-8187-c657970eaf40" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_d0bc47e5-621a-48cc-844b-cd89cb8acbc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/PROPERTYANDEQUIPMENTTables" xlink:type="simple" xlink:href="rdnt-20221231.xsd#PROPERTYANDEQUIPMENTTables"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/PROPERTYANDEQUIPMENTTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_17e38571-3da1-418f-8715-35e443f85a91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_25d5ffbc-1447-441e-b192-280efec7254b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_17e38571-3da1-418f-8715-35e443f85a91" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_25d5ffbc-1447-441e-b192-280efec7254b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLETables" xlink:type="simple" xlink:href="rdnt-20221231.xsd#CREDITFACILITIESANDNOTESPAYABLETables"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_9f60fe10-3359-4867-b685-04dbe5dffcd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_cebc4c25-682d-4fca-a88d-4277de3acfb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_9f60fe10-3359-4867-b685-04dbe5dffcd0" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_cebc4c25-682d-4fca-a88d-4277de3acfb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_e5daefeb-174e-44b7-82f7-ae3b65384e33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_9f60fe10-3359-4867-b685-04dbe5dffcd0" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_e5daefeb-174e-44b7-82f7-ae3b65384e33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ScheduleOfLeverageRatioTableTextBlock_39415fe0-d151-4cde-9983-a976f5ffe9c9" xlink:href="rdnt-20221231.xsd#rdnt_ScheduleOfLeverageRatioTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_9f60fe10-3359-4867-b685-04dbe5dffcd0" xlink:to="loc_rdnt_ScheduleOfLeverageRatioTableTextBlock_39415fe0-d151-4cde-9983-a976f5ffe9c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/LEASESTables" xlink:type="simple" xlink:href="rdnt-20221231.xsd#LEASESTables"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/LEASESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_676d959d-246d-46cf-a92f-6dc2bcbf1939" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_9dabd5bf-67f7-4157-a5d1-d5f0aa45aacd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_676d959d-246d-46cf-a92f-6dc2bcbf1939" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_9dabd5bf-67f7-4157-a5d1-d5f0aa45aacd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_aa792ecf-8183-409f-8a55-4388248e1701" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_676d959d-246d-46cf-a92f-6dc2bcbf1939" xlink:to="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_aa792ecf-8183-409f-8a55-4388248e1701" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AssetsAndLiabilitiesLesseeTableTextBlock_33166f9d-edb6-40f3-820b-64ae0e4361ef" xlink:href="rdnt-20221231.xsd#rdnt_AssetsAndLiabilitiesLesseeTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_676d959d-246d-46cf-a92f-6dc2bcbf1939" xlink:to="loc_rdnt_AssetsAndLiabilitiesLesseeTableTextBlock_33166f9d-edb6-40f3-820b-64ae0e4361ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_095984a7-5551-4135-bcf9-03c62d1b53b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_676d959d-246d-46cf-a92f-6dc2bcbf1939" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_095984a7-5551-4135-bcf9-03c62d1b53b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/INCOMETAXESTables" xlink:type="simple" xlink:href="rdnt-20221231.xsd#INCOMETAXESTables"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/INCOMETAXESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_862e9a48-e124-4e0d-b53a-6e6ba24f75f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_ff8450bf-d262-4019-b6ef-ec7eac02c343" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_862e9a48-e124-4e0d-b53a-6e6ba24f75f4" xlink:to="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_ff8450bf-d262-4019-b6ef-ec7eac02c343" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_ba987587-83d1-48c8-ac84-9e8f7ca1f149" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_862e9a48-e124-4e0d-b53a-6e6ba24f75f4" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_ba987587-83d1-48c8-ac84-9e8f7ca1f149" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_d6e29bd4-db45-456b-9ed1-8d6a034a58bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_862e9a48-e124-4e0d-b53a-6e6ba24f75f4" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_d6e29bd4-db45-456b-9ed1-8d6a034a58bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_37c8dedf-ba02-4e0f-aaf3-9fcb89e334e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_862e9a48-e124-4e0d-b53a-6e6ba24f75f4" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_37c8dedf-ba02-4e0f-aaf3-9fcb89e334e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_7468b088-9e9d-4aa9-b9f4-85742f79370f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_862e9a48-e124-4e0d-b53a-6e6ba24f75f4" xlink:to="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_7468b088-9e9d-4aa9-b9f4-85742f79370f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables" xlink:type="simple" xlink:href="rdnt-20221231.xsd#STOCKBASEDCOMPENSATIONTables"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9f99c70d-7d6d-4a2c-8663-93600aeed4d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_77bd978c-f46e-4c94-99b6-1cfea0526daa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9f99c70d-7d6d-4a2c-8663-93600aeed4d1" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_77bd978c-f46e-4c94-99b6-1cfea0526daa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_48a1808b-d0cd-45db-9ccf-9519b108dbe7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9f99c70d-7d6d-4a2c-8663-93600aeed4d1" xlink:to="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_48a1808b-d0cd-45db-9ccf-9519b108dbe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_3019f67a-3db3-43e6-9cff-7e8bc2a5bf53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9f99c70d-7d6d-4a2c-8663-93600aeed4d1" xlink:to="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_3019f67a-3db3-43e6-9cff-7e8bc2a5bf53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20221231.xsd#NATUREOFBUSINESSDetailsNarrative"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2075301d-91ec-483e-96bc-dc73bee5ac6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_76bef731-49ab-436e-9b0e-b89fd81bcbc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2075301d-91ec-483e-96bc-dc73bee5ac6f" xlink:to="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_76bef731-49ab-436e-9b0e-b89fd81bcbc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_41e2747c-a130-4ec7-99d2-b49acd46c4a5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_76bef731-49ab-436e-9b0e-b89fd81bcbc9" xlink:to="loc_srt_ConsolidatedEntitiesAxis_41e2747c-a130-4ec7-99d2-b49acd46c4a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_aacdaf7c-8c76-437f-b03e-f0168ab39338" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_41e2747c-a130-4ec7-99d2-b49acd46c4a5" xlink:to="loc_srt_ConsolidatedEntitiesDomain_aacdaf7c-8c76-437f-b03e-f0168ab39338" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_3163a54c-3cb9-4cea-969b-23185915cefd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_aacdaf7c-8c76-437f-b03e-f0168ab39338" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_3163a54c-3cb9-4cea-969b-23185915cefd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_bd5c8062-15cc-4f66-a304-1584f4810309" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_76bef731-49ab-436e-9b0e-b89fd81bcbc9" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_bd5c8062-15cc-4f66-a304-1584f4810309" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_9da547da-86d1-4391-9f18-7d7d5d826b6d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_bd5c8062-15cc-4f66-a304-1584f4810309" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_9da547da-86d1-4391-9f18-7d7d5d826b6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ScriptSenderLLCMember_e42c85f2-9ac3-423b-8598-888af77c360e" xlink:href="rdnt-20221231.xsd#rdnt_ScriptSenderLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_9da547da-86d1-4391-9f18-7d7d5d826b6d" xlink:to="loc_rdnt_ScriptSenderLLCMember_e42c85f2-9ac3-423b-8598-888af77c360e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_2cb67f04-6924-4523-9549-2e3a88f8c0df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_76bef731-49ab-436e-9b0e-b89fd81bcbc9" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_2cb67f04-6924-4523-9549-2e3a88f8c0df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_7f095b43-69d8-48a2-a196-6ad6a0011944" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_2cb67f04-6924-4523-9549-2e3a88f8c0df" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_7f095b43-69d8-48a2-a196-6ad6a0011944" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenseMember_0649b9fe-5d73-4e01-8366-39454c9c662f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_7f095b43-69d8-48a2-a196-6ad6a0011944" xlink:to="loc_us-gaap_OperatingExpenseMember_0649b9fe-5d73-4e01-8366-39454c9c662f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_49b4e47d-c1a1-411d-ba52-dfe2d728c514" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_76bef731-49ab-436e-9b0e-b89fd81bcbc9" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_49b4e47d-c1a1-411d-ba52-dfe2d728c514" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_cfc17280-2efb-4772-bd4f-63103d7c9283" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_49b4e47d-c1a1-411d-ba52-dfe2d728c514" xlink:to="loc_us-gaap_RelatedPartyDomain_cfc17280-2efb-4772-bd4f-63103d7c9283" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvesteeMember_622bde27-bd33-4581-abd3-e588a1399b78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvesteeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_cfc17280-2efb-4772-bd4f-63103d7c9283" xlink:to="loc_us-gaap_EquityMethodInvesteeMember_622bde27-bd33-4581-abd3-e588a1399b78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_31bfef08-30d6-4e99-b20e-311fb45a96de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_76bef731-49ab-436e-9b0e-b89fd81bcbc9" xlink:to="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_31bfef08-30d6-4e99-b20e-311fb45a96de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberOfCenters_635e3059-6a78-486f-ae1c-ad8c1575b1a9" xlink:href="rdnt-20221231.xsd#rdnt_NumberOfCenters"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_31bfef08-30d6-4e99-b20e-311fb45a96de" xlink:to="loc_rdnt_NumberOfCenters_635e3059-6a78-486f-ae1c-ad8c1575b1a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_9427979b-4da9-42fd-b8d7-ab5207029f69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_31bfef08-30d6-4e99-b20e-311fb45a96de" xlink:to="loc_us-gaap_NumberOfReportableSegments_9427979b-4da9-42fd-b8d7-ab5207029f69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues_96b061bb-3883-4a06-bcb0-9c4823502488" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_31bfef08-30d6-4e99-b20e-311fb45a96de" xlink:to="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues_96b061bb-3883-4a06-bcb0-9c4823502488" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense_5e5ec739-25f5-4b11-99e0-e551086191a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_31bfef08-30d6-4e99-b20e-311fb45a96de" xlink:to="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense_5e5ec739-25f5-4b11-99e0-e551086191a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax_2cca3421-83c3-417d-8558-568b933ede59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_31bfef08-30d6-4e99-b20e-311fb45a96de" xlink:to="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax_2cca3421-83c3-417d-8558-568b933ede59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_2badc9b1-4bdc-4c07-a3de-bfe243ba77dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_31bfef08-30d6-4e99-b20e-311fb45a96de" xlink:to="loc_us-gaap_Assets_2badc9b1-4bdc-4c07-a3de-bfe243ba77dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_e868ab98-3b18-4dfd-8240-a5f1b524b0eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_31bfef08-30d6-4e99-b20e-311fb45a96de" xlink:to="loc_us-gaap_Liabilities_e868ab98-3b18-4dfd-8240-a5f1b524b0eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_ae6897d8-f12f-4313-a99a-65022246e6b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_31bfef08-30d6-4e99-b20e-311fb45a96de" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_ae6897d8-f12f-4313-a99a-65022246e6b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_00c95d59-781e-4d74-988a-206fb3af41e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_31bfef08-30d6-4e99-b20e-311fb45a96de" xlink:to="loc_us-gaap_EquityMethodInvestments_00c95d59-781e-4d74-988a-206fb3af41e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_ffab9cb1-677a-45c3-9a71-b82a10904f1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_31bfef08-30d6-4e99-b20e-311fb45a96de" xlink:to="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_ffab9cb1-677a-45c3-9a71-b82a10904f1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofNetRevenue" xlink:type="simple" xlink:href="rdnt-20221231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofNetRevenue"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofNetRevenue" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_e2f7b174-5f37-4885-bf7d-fafd86074f79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_8cbc2f17-15b6-4094-897e-3a621fc28ae3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e2f7b174-5f37-4885-bf7d-fafd86074f79" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_8cbc2f17-15b6-4094-897e-3a621fc28ae3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_42c1351d-23e5-43c6-8ec9-33802b406e55" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_8cbc2f17-15b6-4094-897e-3a621fc28ae3" xlink:to="loc_srt_ProductOrServiceAxis_42c1351d-23e5-43c6-8ec9-33802b406e55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_72ce0699-c190-4f1e-b5ff-71d12ab4f67c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_42c1351d-23e5-43c6-8ec9-33802b406e55" xlink:to="loc_srt_ProductsAndServicesDomain_72ce0699-c190-4f1e-b5ff-71d12ab4f67c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ImagingCenterSegmentRevenueMember_1f6ac639-c046-4718-b751-185be22a7cd1" xlink:href="rdnt-20221231.xsd#rdnt_ImagingCenterSegmentRevenueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_72ce0699-c190-4f1e-b5ff-71d12ab4f67c" xlink:to="loc_rdnt_ImagingCenterSegmentRevenueMember_1f6ac639-c046-4718-b751-185be22a7cd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CommercialInsurance1Member_626af5d6-52c0-49fb-9222-b6b0436a59cb" xlink:href="rdnt-20221231.xsd#rdnt_CommercialInsurance1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_ImagingCenterSegmentRevenueMember_1f6ac639-c046-4718-b751-185be22a7cd1" xlink:to="loc_rdnt_CommercialInsurance1Member_626af5d6-52c0-49fb-9222-b6b0436a59cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_Medicare1Member_dabecbaf-3ebf-4f6b-877c-b007af3e5a19" xlink:href="rdnt-20221231.xsd#rdnt_Medicare1Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_ImagingCenterSegmentRevenueMember_1f6ac639-c046-4718-b751-185be22a7cd1" xlink:to="loc_rdnt_Medicare1Member_dabecbaf-3ebf-4f6b-877c-b007af3e5a19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_Medicaid1Member_21eef9b2-3012-47e2-a7ac-1195defd5090" xlink:href="rdnt-20221231.xsd#rdnt_Medicaid1Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_ImagingCenterSegmentRevenueMember_1f6ac639-c046-4718-b751-185be22a7cd1" xlink:to="loc_rdnt_Medicaid1Member_21eef9b2-3012-47e2-a7ac-1195defd5090" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WorkersCompensationPersonalInjury1Member_ea8e7210-5afb-4f01-a250-efba34d53ad0" xlink:href="rdnt-20221231.xsd#rdnt_WorkersCompensationPersonalInjury1Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_ImagingCenterSegmentRevenueMember_1f6ac639-c046-4718-b751-185be22a7cd1" xlink:to="loc_rdnt_WorkersCompensationPersonalInjury1Member_ea8e7210-5afb-4f01-a250-efba34d53ad0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HealthCarePatientServiceOtherMember_2f1ff9d3-7273-47e9-b730-fa2b31495304" xlink:href="rdnt-20221231.xsd#rdnt_HealthCarePatientServiceOtherMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_ImagingCenterSegmentRevenueMember_1f6ac639-c046-4718-b751-185be22a7cd1" xlink:to="loc_rdnt_HealthCarePatientServiceOtherMember_2f1ff9d3-7273-47e9-b730-fa2b31495304" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HealthCareManagementServiceMember_0b9e5a59-f407-4bf2-919f-52647b2cd9a9" xlink:href="rdnt-20221231.xsd#rdnt_HealthCareManagementServiceMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_ImagingCenterSegmentRevenueMember_1f6ac639-c046-4718-b751-185be22a7cd1" xlink:to="loc_rdnt_HealthCareManagementServiceMember_0b9e5a59-f407-4bf2-919f-52647b2cd9a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SoftwareAndTeleradiologyMember_7b5378ef-4f12-4022-a232-ace6b7874834" xlink:href="rdnt-20221231.xsd#rdnt_SoftwareAndTeleradiologyMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_ImagingCenterSegmentRevenueMember_1f6ac639-c046-4718-b751-185be22a7cd1" xlink:to="loc_rdnt_SoftwareAndTeleradiologyMember_7b5378ef-4f12-4022-a232-ace6b7874834" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareOtherMember_c2431213-2c37-4e4e-942c-209fb192ca5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthCareOtherMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_ImagingCenterSegmentRevenueMember_1f6ac639-c046-4718-b751-185be22a7cd1" xlink:to="loc_us-gaap_HealthCareOtherMember_c2431213-2c37-4e4e-942c-209fb192ca5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CapitationArrangementsMember_d0e224fa-982c-4cde-b07f-b76372c1c824" xlink:href="rdnt-20221231.xsd#rdnt_CapitationArrangementsMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_ImagingCenterSegmentRevenueMember_1f6ac639-c046-4718-b751-185be22a7cd1" xlink:to="loc_rdnt_CapitationArrangementsMember_d0e224fa-982c-4cde-b07f-b76372c1c824" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AIMember_19bfc4f6-9e13-4db3-aeb9-64eb03d7b042" xlink:href="rdnt-20221231.xsd#rdnt_AIMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_72ce0699-c190-4f1e-b5ff-71d12ab4f67c" xlink:to="loc_rdnt_AIMember_19bfc4f6-9e13-4db3-aeb9-64eb03d7b042" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_356b9d3d-641f-43e6-aca7-746cc03f2c38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_8cbc2f17-15b6-4094-897e-3a621fc28ae3" xlink:to="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_356b9d3d-641f-43e6-aca7-746cc03f2c38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b4221fbe-1e58-454c-9b4d-206db98d9f94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_356b9d3d-641f-43e6-aca7-746cc03f2c38" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b4221fbe-1e58-454c-9b4d-206db98d9f94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsAccountsPayableandAccruedExpenses" xlink:type="simple" xlink:href="rdnt-20221231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsAccountsPayableandAccruedExpenses"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsAccountsPayableandAccruedExpenses" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_ae2c2ca0-7b0f-401f-82fe-6a209e735d60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_e5888789-1a99-4e69-84fe-5cc58dd2abaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ae2c2ca0-7b0f-401f-82fe-6a209e735d60" xlink:to="loc_us-gaap_AccountsPayableCurrent_e5888789-1a99-4e69-84fe-5cc58dd2abaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_96401845-8131-4ada-925d-cfaf659b75db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ae2c2ca0-7b0f-401f-82fe-6a209e735d60" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_96401845-8131-4ada-925d-cfaf659b75db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_59b4825e-77dd-4a87-a0d0-9e9e637644d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ae2c2ca0-7b0f-401f-82fe-6a209e735d60" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_59b4825e-77dd-4a87-a0d0-9e9e637644d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_bc4ede4f-1650-4431-a380-c92de2bbcc1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ae2c2ca0-7b0f-401f-82fe-6a209e735d60" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_bc4ede4f-1650-4431-a380-c92de2bbcc1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_23529cb3-2f8b-4b9d-99df-dd455e3b2056" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ae2c2ca0-7b0f-401f-82fe-6a209e735d60" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_23529cb3-2f8b-4b9d-99df-dd455e3b2056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20221231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_ea549743-3296-44db-9055-f15eee70b633" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cb1966b5-f8f8-4cda-bc2c-d03f08d95428" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ea549743-3296-44db-9055-f15eee70b633" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cb1966b5-f8f8-4cda-bc2c-d03f08d95428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis_a7efa7cf-d841-4ff0-aa65-9d7b184ac72c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cb1966b5-f8f8-4cda-bc2c-d03f08d95428" xlink:to="loc_us-gaap_UnusualOrInfrequentItemAxis_a7efa7cf-d841-4ff0-aa65-9d7b184ac72c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_9428a886-8df7-42d4-9a5e-1b71b4b4e84e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_a7efa7cf-d841-4ff0-aa65-9d7b184ac72c" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_9428a886-8df7-42d4-9a5e-1b71b4b4e84e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_COVID19PandemicMember_6d483b15-209e-48f1-ad20-1ccd61c2f83f" xlink:href="rdnt-20221231.xsd#rdnt_COVID19PandemicMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain_9428a886-8df7-42d4-9a5e-1b71b4b4e84e" xlink:to="loc_rdnt_COVID19PandemicMember_6d483b15-209e-48f1-ad20-1ccd61c2f83f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_0811a726-77c3-4ae0-8c91-4060abc7214f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cb1966b5-f8f8-4cda-bc2c-d03f08d95428" xlink:to="loc_us-gaap_DebtInstrumentAxis_0811a726-77c3-4ae0-8c91-4060abc7214f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_795c9426-27dc-4adc-8cd3-86ec1b903dae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_0811a726-77c3-4ae0-8c91-4060abc7214f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_795c9426-27dc-4adc-8cd3-86ec1b903dae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PaycheckProtectionProgramLoansMember_7c356c83-88df-4e99-b0e2-82044b6fc884" xlink:href="rdnt-20221231.xsd#rdnt_PaycheckProtectionProgramLoansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_795c9426-27dc-4adc-8cd3-86ec1b903dae" xlink:to="loc_rdnt_PaycheckProtectionProgramLoansMember_7c356c83-88df-4e99-b0e2-82044b6fc884" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BarclaysMember_772195e0-8bf3-45ce-bae8-56ba08c27b85" xlink:href="rdnt-20221231.xsd#rdnt_BarclaysMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_795c9426-27dc-4adc-8cd3-86ec1b903dae" xlink:to="loc_rdnt_BarclaysMember_772195e0-8bf3-45ce-bae8-56ba08c27b85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TruistMember_5500b5e1-fda4-4560-b4c9-4543cb4ea8dc" xlink:href="rdnt-20221231.xsd#rdnt_TruistMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_795c9426-27dc-4adc-8cd3-86ec1b903dae" xlink:to="loc_rdnt_TruistMember_5500b5e1-fda4-4560-b4c9-4543cb4ea8dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_acf64a1d-d0f6-4a69-87b8-abeeb33ed43c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cb1966b5-f8f8-4cda-bc2c-d03f08d95428" xlink:to="loc_srt_ProductOrServiceAxis_acf64a1d-d0f6-4a69-87b8-abeeb33ed43c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_10e74b96-4213-4108-b538-ae1cfe0186ba" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_acf64a1d-d0f6-4a69-87b8-abeeb33ed43c" xlink:to="loc_srt_ProductsAndServicesDomain_10e74b96-4213-4108-b538-ae1cfe0186ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PatientServicesNetMember_c1a08d8b-2dcc-4514-ab43-0e8365f2f280" xlink:href="rdnt-20221231.xsd#rdnt_PatientServicesNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_10e74b96-4213-4108-b538-ae1cfe0186ba" xlink:to="loc_rdnt_PatientServicesNetMember_c1a08d8b-2dcc-4514-ab43-0e8365f2f280" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_ef314c31-d835-4161-8a9a-31afaace642f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cb1966b5-f8f8-4cda-bc2c-d03f08d95428" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_ef314c31-d835-4161-8a9a-31afaace642f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_32770b1e-6669-4d43-9dfd-cdd9dd8ba21d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ef314c31-d835-4161-8a9a-31afaace642f" xlink:to="loc_us-gaap_SegmentDomain_32770b1e-6669-4d43-9dfd-cdd9dd8ba21d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ERADMember_5787c63c-6972-4a72-8ddc-ac692424060f" xlink:href="rdnt-20221231.xsd#rdnt_ERADMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_32770b1e-6669-4d43-9dfd-cdd9dd8ba21d" xlink:to="loc_rdnt_ERADMember_5787c63c-6972-4a72-8ddc-ac692424060f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ImagingCentersMember_38fadbc7-9f4e-4af3-a6c4-64f2b75f40c2" xlink:href="rdnt-20221231.xsd#rdnt_ImagingCentersMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_32770b1e-6669-4d43-9dfd-cdd9dd8ba21d" xlink:to="loc_rdnt_ImagingCentersMember_38fadbc7-9f4e-4af3-a6c4-64f2b75f40c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_5d868568-f4a6-4df5-a4f1-b2cd39058ec4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cb1966b5-f8f8-4cda-bc2c-d03f08d95428" xlink:to="loc_srt_RangeAxis_5d868568-f4a6-4df5-a4f1-b2cd39058ec4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cdb31e97-cb65-4519-a5a2-51f225469504" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_5d868568-f4a6-4df5-a4f1-b2cd39058ec4" xlink:to="loc_srt_RangeMember_cdb31e97-cb65-4519-a5a2-51f225469504" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_48203bc3-dcdd-4251-b5a1-fa07093672b0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_cdb31e97-cb65-4519-a5a2-51f225469504" xlink:to="loc_srt_MinimumMember_48203bc3-dcdd-4251-b5a1-fa07093672b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_c28eae78-6e38-4e1a-b0e1-521c9433ecf2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_cdb31e97-cb65-4519-a5a2-51f225469504" xlink:to="loc_srt_MaximumMember_c28eae78-6e38-4e1a-b0e1-521c9433ecf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e9e445b1-7bfd-48e3-9f99-690223fdacff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cb1966b5-f8f8-4cda-bc2c-d03f08d95428" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e9e445b1-7bfd-48e3-9f99-690223fdacff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_02aa2643-eb9f-457a-b6fb-838b867b674d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e9e445b1-7bfd-48e3-9f99-690223fdacff" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_02aa2643-eb9f-457a-b6fb-838b867b674d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ProperyAndEquipmentNetMember_b249f774-b22e-413c-8878-dbf3ca1cc598" xlink:href="rdnt-20221231.xsd#rdnt_ProperyAndEquipmentNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_02aa2643-eb9f-457a-b6fb-838b867b674d" xlink:to="loc_rdnt_ProperyAndEquipmentNetMember_b249f774-b22e-413c-8878-dbf3ca1cc598" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_c9da8887-0573-40f4-abe5-1c71be3a6cfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_02aa2643-eb9f-457a-b6fb-838b867b674d" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_c9da8887-0573-40f4-abe5-1c71be3a6cfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_9c264554-8c6a-4899-a13f-88574f6a200c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_02aa2643-eb9f-457a-b6fb-838b867b674d" xlink:to="loc_us-gaap_ConstructionInProgressMember_9c264554-8c6a-4899-a13f-88574f6a200c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_c93ef595-c406-4675-abec-f5d30d8ce40d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cb1966b5-f8f8-4cda-bc2c-d03f08d95428" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_c93ef595-c406-4675-abec-f5d30d8ce40d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_02320a2b-6a50-46ff-b77b-c49f044e001b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_c93ef595-c406-4675-abec-f5d30d8ce40d" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_02320a2b-6a50-46ff-b77b-c49f044e001b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_b73a69ba-aaa5-4d67-86fc-891f5cf00b88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_02320a2b-6a50-46ff-b77b-c49f044e001b" xlink:to="loc_us-gaap_TradeNamesMember_b73a69ba-aaa5-4d67-86fc-891f5cf00b88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceContractAxis_18bd414c-0cac-4424-ae8a-d3f1e05ddef4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceContractAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cb1966b5-f8f8-4cda-bc2c-d03f08d95428" xlink:to="loc_us-gaap_ReinsuranceContractAxis_18bd414c-0cac-4424-ae8a-d3f1e05ddef4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_352ec7ab-8901-4769-9ff9-59105900eea4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cb1966b5-f8f8-4cda-bc2c-d03f08d95428" xlink:to="loc_srt_CounterpartyNameAxis_352ec7ab-8901-4769-9ff9-59105900eea4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_70b9c1a2-2494-4127-8aa7-6992253b06ed" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_352ec7ab-8901-4769-9ff9-59105900eea4" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_70b9c1a2-2494-4127-8aa7-6992253b06ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BlueShieldMember_af27530d-1d2a-459f-8eb5-146643977c2e" xlink:href="rdnt-20221231.xsd#rdnt_BlueShieldMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_70b9c1a2-2494-4127-8aa7-6992253b06ed" xlink:to="loc_rdnt_BlueShieldMember_af27530d-1d2a-459f-8eb5-146643977c2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DignityHealthMember_1963c231-c2da-48c9-ad17-6ae9cdd6b09f" xlink:href="rdnt-20221231.xsd#rdnt_DignityHealthMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_70b9c1a2-2494-4127-8aa7-6992253b06ed" xlink:to="loc_rdnt_DignityHealthMember_1963c231-c2da-48c9-ad17-6ae9cdd6b09f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_f7ab6e5a-b536-4896-b29a-1f1ca72ce7a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cb1966b5-f8f8-4cda-bc2c-d03f08d95428" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_f7ab6e5a-b536-4896-b29a-1f1ca72ce7a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f35fd62b-c44b-43b5-8779-8a536a62339d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f7ab6e5a-b536-4896-b29a-1f1ca72ce7a1" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f35fd62b-c44b-43b5-8779-8a536a62339d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_QuantibMember_49d3d0e6-45e3-4916-b426-755d56d56473" xlink:href="rdnt-20221231.xsd#rdnt_QuantibMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f35fd62b-c44b-43b5-8779-8a536a62339d" xlink:to="loc_rdnt_QuantibMember_49d3d0e6-45e3-4916-b426-755d56d56473" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MontclairMember_e82aeb4a-0931-4902-b6bf-a7cd5547df60" xlink:href="rdnt-20221231.xsd#rdnt_MontclairMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f35fd62b-c44b-43b5-8779-8a536a62339d" xlink:to="loc_rdnt_MontclairMember_e82aeb4a-0931-4902-b6bf-a7cd5547df60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HeartAndLungImagingLimitedMember_aa39945c-9eff-419f-bfad-11f4e528f02b" xlink:href="rdnt-20221231.xsd#rdnt_HeartAndLungImagingLimitedMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f35fd62b-c44b-43b5-8779-8a536a62339d" xlink:to="loc_rdnt_HeartAndLungImagingLimitedMember_aa39945c-9eff-419f-bfad-11f4e528f02b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AidenceMember_83dd7b22-ea09-421e-bcd5-50372cc58c98" xlink:href="rdnt-20221231.xsd#rdnt_AidenceMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f35fd62b-c44b-43b5-8779-8a536a62339d" xlink:to="loc_rdnt_AidenceMember_83dd7b22-ea09-421e-bcd5-50372cc58c98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_3f818785-46c1-4824-b761-c51736fee3e8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cb1966b5-f8f8-4cda-bc2c-d03f08d95428" xlink:to="loc_dei_LegalEntityAxis_3f818785-46c1-4824-b761-c51736fee3e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_9a3ce541-17f1-4502-adc2-091e405c9ddd" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_3f818785-46c1-4824-b761-c51736fee3e8" xlink:to="loc_dei_EntityDomain_9a3ce541-17f1-4502-adc2-091e405c9ddd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GlendaleAdvancedImagingMember_0b49c52b-55e6-4d14-a53c-b2e12987f155" xlink:href="rdnt-20221231.xsd#rdnt_GlendaleAdvancedImagingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_9a3ce541-17f1-4502-adc2-091e405c9ddd" xlink:to="loc_rdnt_GlendaleAdvancedImagingMember_0b49c52b-55e6-4d14-a53c-b2e12987f155" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_ecb26260-30c9-43c8-8821-c35b2707de77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cb1966b5-f8f8-4cda-bc2c-d03f08d95428" xlink:to="loc_us-gaap_PlanNameAxis_ecb26260-30c9-43c8-8821-c35b2707de77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_4eb7f5c1-84e0-4fcb-a323-55e7bb8ef0be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_ecb26260-30c9-43c8-8821-c35b2707de77" xlink:to="loc_us-gaap_PlanNameDomain_4eb7f5c1-84e0-4fcb-a323-55e7bb8ef0be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedPlanMember_82b1be51-ded5-4094-b843-c0f84f27d46b" xlink:href="rdnt-20221231.xsd#rdnt_RestatedPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_4eb7f5c1-84e0-4fcb-a323-55e7bb8ef0be" xlink:to="loc_rdnt_RestatedPlanMember_82b1be51-ded5-4094-b843-c0f84f27d46b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuritiesFinancingTransactionAxis_8372d204-92fe-4d80-98cd-5d18b51711f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuritiesFinancingTransactionAxis"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cb1966b5-f8f8-4cda-bc2c-d03f08d95428" xlink:to="loc_us-gaap_SecuritiesFinancingTransactionAxis_8372d204-92fe-4d80-98cd-5d18b51711f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_ed649b74-6afd-4a2d-872c-d913478ab594" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuritiesFinancingTransactionTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionAxis_8372d204-92fe-4d80-98cd-5d18b51711f8" xlink:to="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_ed649b74-6afd-4a2d-872c-d913478ab594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_Caps2016Member_b057ec4d-f18a-4631-833b-a245af22501f" xlink:href="rdnt-20221231.xsd#rdnt_Caps2016Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_ed649b74-6afd-4a2d-872c-d913478ab594" xlink:to="loc_rdnt_Caps2016Member_b057ec4d-f18a-4631-833b-a245af22501f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_A2019SWAPSMember_b4f0ffae-d467-458c-840a-0bd637b9c618" xlink:href="rdnt-20221231.xsd#rdnt_A2019SWAPSMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_ed649b74-6afd-4a2d-872c-d913478ab594" xlink:to="loc_rdnt_A2019SWAPSMember_b4f0ffae-d467-458c-840a-0bd637b9c618" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_A2019SWAPS1Member_e387c52b-0baf-4893-98cc-d3e6d2d22852" xlink:href="rdnt-20221231.xsd#rdnt_A2019SWAPS1Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_ed649b74-6afd-4a2d-872c-d913478ab594" xlink:to="loc_rdnt_A2019SWAPS1Member_e387c52b-0baf-4893-98cc-d3e6d2d22852" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditDerivativesByContractTypeAxis_60aabb99-b8a2-42d7-9495-750cd088c6c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditDerivativesByContractTypeAxis"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cb1966b5-f8f8-4cda-bc2c-d03f08d95428" xlink:to="loc_us-gaap_CreditDerivativesByContractTypeAxis_60aabb99-b8a2-42d7-9495-750cd088c6c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditDerivativesContractTypeDomain_333df92b-7683-4c27-945a-49ef72842a50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditDerivativesContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditDerivativesByContractTypeAxis_60aabb99-b8a2-42d7-9495-750cd088c6c0" xlink:to="loc_us-gaap_CreditDerivativesContractTypeDomain_333df92b-7683-4c27-945a-49ef72842a50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_September2020CapMember_e356916f-f91b-4bd3-b404-17a09c403c40" xlink:href="rdnt-20221231.xsd#rdnt_September2020CapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditDerivativesContractTypeDomain_333df92b-7683-4c27-945a-49ef72842a50" xlink:to="loc_rdnt_September2020CapMember_e356916f-f91b-4bd3-b404-17a09c403c40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_October2020CapMember_6af58ec9-bad5-4fec-bb19-92c4b12fe73e" xlink:href="rdnt-20221231.xsd#rdnt_October2020CapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditDerivativesContractTypeDomain_333df92b-7683-4c27-945a-49ef72842a50" xlink:to="loc_rdnt_October2020CapMember_6af58ec9-bad5-4fec-bb19-92c4b12fe73e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_October2023Member_bcbb44a0-701a-4c51-b88f-691fca5d814b" xlink:href="rdnt-20221231.xsd#rdnt_October2023Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditDerivativesContractTypeDomain_333df92b-7683-4c27-945a-49ef72842a50" xlink:to="loc_rdnt_October2023Member_bcbb44a0-701a-4c51-b88f-691fca5d814b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_October2025Member_9c4976aa-8681-4227-a2a6-86d852d52f16" xlink:href="rdnt-20221231.xsd#rdnt_October2025Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditDerivativesContractTypeDomain_333df92b-7683-4c27-945a-49ef72842a50" xlink:to="loc_rdnt_October2025Member_9c4976aa-8681-4227-a2a6-86d852d52f16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_c884720e-5e87-4689-9fd9-f23bdecf41ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cb1966b5-f8f8-4cda-bc2c-d03f08d95428" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_c884720e-5e87-4689-9fd9-f23bdecf41ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_a8ee4597-2673-41f2-98a8-8f991d39cf50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_c884720e-5e87-4689-9fd9-f23bdecf41ad" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_a8ee4597-2673-41f2-98a8-8f991d39cf50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_Caps2016Member_dc2effcc-1bb3-4b0d-a106-48d254c9b901" xlink:href="rdnt-20221231.xsd#rdnt_Caps2016Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_a8ee4597-2673-41f2-98a8-8f991d39cf50" xlink:to="loc_rdnt_Caps2016Member_dc2effcc-1bb3-4b0d-a106-48d254c9b901" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_a2b5ee91-5486-48f8-b329-b5ea3d1e6625" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_a8ee4597-2673-41f2-98a8-8f991d39cf50" xlink:to="loc_us-gaap_InterestRateSwapMember_a2b5ee91-5486-48f8-b329-b5ea3d1e6625" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_ea487407-b556-4cd4-8d29-a284ad3092b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cb1966b5-f8f8-4cda-bc2c-d03f08d95428" xlink:to="loc_us-gaap_VariableRateAxis_ea487407-b556-4cd4-8d29-a284ad3092b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_b186051e-e0eb-4115-9c71-6e3521d02177" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_ea487407-b556-4cd4-8d29-a284ad3092b8" xlink:to="loc_us-gaap_VariableRateDomain_b186051e-e0eb-4115-9c71-6e3521d02177" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_ba6d361b-effb-4bbe-a03e-c73bade2e601" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_b186051e-e0eb-4115-9c71-6e3521d02177" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_ba6d361b-effb-4bbe-a03e-c73bade2e601" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_74eabec0-4fa2-4b82-b340-af841a070611" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cb1966b5-f8f8-4cda-bc2c-d03f08d95428" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_74eabec0-4fa2-4b82-b340-af841a070611" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_abc294ca-3eac-4988-b891-c0cdf8264c1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_74eabec0-4fa2-4b82-b340-af841a070611" xlink:to="loc_us-gaap_EquityComponentDomain_abc294ca-3eac-4988-b891-c0cdf8264c1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_200e6eef-c7e8-4e70-ae5b-f2783cf5151e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_abc294ca-3eac-4988-b891-c0cdf8264c1b" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_200e6eef-c7e8-4e70-ae5b-f2783cf5151e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_6b64a20c-bf59-4097-8a43-c9513ed7ed5c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cb1966b5-f8f8-4cda-bc2c-d03f08d95428" xlink:to="loc_srt_StatementScenarioAxis_6b64a20c-bf59-4097-8a43-c9513ed7ed5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_d6319cde-5d11-41cf-8ab3-865f1800c0cf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_6b64a20c-bf59-4097-8a43-c9513ed7ed5c" xlink:to="loc_srt_ScenarioUnspecifiedDomain_d6319cde-5d11-41cf-8ab3-865f1800c0cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_add6befe-b9c5-40fd-a385-a6b94ebadd98" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_d6319cde-5d11-41cf-8ab3-865f1800c0cf" xlink:to="loc_srt_ScenarioForecastMember_add6befe-b9c5-40fd-a385-a6b94ebadd98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_3dd4362b-bc08-40c5-a40f-c5761e2ef8f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cb1966b5-f8f8-4cda-bc2c-d03f08d95428" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_3dd4362b-bc08-40c5-a40f-c5761e2ef8f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_91c031a2-edf4-4315-bee0-236ed7cdd2c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_3dd4362b-bc08-40c5-a40f-c5761e2ef8f1" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_91c031a2-edf4-4315-bee0-236ed7cdd2c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_b052a590-e91e-41c0-97da-ca5cce234cb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_91c031a2-edf4-4315-bee0-236ed7cdd2c8" xlink:to="loc_us-gaap_SubsequentEventMember_b052a590-e91e-41c0-97da-ca5cce234cb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_242ccdf9-65ed-420a-aedc-e9a479db7ea3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cb1966b5-f8f8-4cda-bc2c-d03f08d95428" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_242ccdf9-65ed-420a-aedc-e9a479db7ea3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_e7b51bb4-dde3-4ef6-a766-90e1a900adbb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_242ccdf9-65ed-420a-aedc-e9a479db7ea3" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_e7b51bb4-dde3-4ef6-a766-90e1a900adbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MedicVisionMember_599c9a96-3030-425a-9247-a134939d90a3" xlink:href="rdnt-20221231.xsd#rdnt_MedicVisionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_e7b51bb4-dde3-4ef6-a766-90e1a900adbb" xlink:to="loc_rdnt_MedicVisionMember_599c9a96-3030-425a-9247-a134939d90a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TurnerImagingSystemsMember_1a5f9298-9cda-46ab-a900-e40d770579b2" xlink:href="rdnt-20221231.xsd#rdnt_TurnerImagingSystemsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_e7b51bb4-dde3-4ef6-a766-90e1a900adbb" xlink:to="loc_rdnt_TurnerImagingSystemsMember_1a5f9298-9cda-46ab-a900-e40d770579b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WhiteRabbitaiIncMember_3bb58597-c6dc-48c9-8830-ca2871a35cbf" xlink:href="rdnt-20221231.xsd#rdnt_WhiteRabbitaiIncMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_e7b51bb4-dde3-4ef6-a766-90e1a900adbb" xlink:to="loc_rdnt_WhiteRabbitaiIncMember_3bb58597-c6dc-48c9-8830-ca2871a35cbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ArizonaDiagnosticsGroupMember_a166cde3-8e50-4572-b6e8-6279f328e6bf" xlink:href="rdnt-20221231.xsd#rdnt_ArizonaDiagnosticsGroupMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_e7b51bb4-dde3-4ef6-a766-90e1a900adbb" xlink:to="loc_rdnt_ArizonaDiagnosticsGroupMember_a166cde3-8e50-4572-b6e8-6279f328e6bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_aa7d63dc-6db3-4258-b600-574ba33fde34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cb1966b5-f8f8-4cda-bc2c-d03f08d95428" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_aa7d63dc-6db3-4258-b600-574ba33fde34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_22c50e84-0e18-4b62-a040-43c336c0fe36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_aa7d63dc-6db3-4258-b600-574ba33fde34" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_22c50e84-0e18-4b62-a040-43c336c0fe36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_d39f42e7-4fb8-4e28-9a62-796f1cb125f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_22c50e84-0e18-4b62-a040-43c336c0fe36" xlink:to="loc_us-gaap_CommercialPaperMember_d39f42e7-4fb8-4e28-9a62-796f1cb125f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_afa07913-2eda-4f09-9fd3-fcd4f62008eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cb1966b5-f8f8-4cda-bc2c-d03f08d95428" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_afa07913-2eda-4f09-9fd3-fcd4f62008eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_273b3217-767b-4a19-8762-de67562976fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_afa07913-2eda-4f09-9fd3-fcd4f62008eb" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_273b3217-767b-4a19-8762-de67562976fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_JointVentureMember_35f604e8-bb91-4739-9555-b6ae023c6471" xlink:href="rdnt-20221231.xsd#rdnt_JointVentureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_273b3217-767b-4a19-8762-de67562976fc" xlink:to="loc_rdnt_JointVentureMember_35f604e8-bb91-4739-9555-b6ae023c6471" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_55cfe0fd-d186-4340-9a40-e88492f398f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cb1966b5-f8f8-4cda-bc2c-d03f08d95428" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_55cfe0fd-d186-4340-9a40-e88492f398f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_89bfc211-dc37-4fb8-ad11-733f81cc6b9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_55cfe0fd-d186-4340-9a40-e88492f398f0" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_89bfc211-dc37-4fb8-ad11-733f81cc6b9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ContingentMilestoneConsiderationMember_dd3ad5da-d83e-4d7a-9735-4fbed1f39112" xlink:href="rdnt-20221231.xsd#rdnt_ContingentMilestoneConsiderationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_89bfc211-dc37-4fb8-ad11-733f81cc6b9d" xlink:to="loc_rdnt_ContingentMilestoneConsiderationMember_dd3ad5da-d83e-4d7a-9735-4fbed1f39112" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CashHoldbackMember_f538e36b-e512-48ee-85a6-3e1181b0a6e3" xlink:href="rdnt-20221231.xsd#rdnt_CashHoldbackMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_89bfc211-dc37-4fb8-ad11-733f81cc6b9d" xlink:to="loc_rdnt_CashHoldbackMember_f538e36b-e512-48ee-85a6-3e1181b0a6e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cb1966b5-f8f8-4cda-bc2c-d03f08d95428" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AdvanceMedicarePayments_282ba732-b460-4c6c-8b4f-4552539e397e" xlink:href="rdnt-20221231.xsd#rdnt_AdvanceMedicarePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_rdnt_AdvanceMedicarePayments_282ba732-b460-4c6c-8b4f-4552539e397e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLoans_40b606aa-7a28-4719-95a9-d5f9d358e8d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLoans"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_ProceedsFromLoans_40b606aa-7a28-4719-95a9-d5f9d358e8d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ProceedsFromProviderReliefFunding_7ce4d8c3-4ac1-4c98-a789-60524f73a57d" xlink:href="rdnt-20221231.xsd#rdnt_ProceedsFromProviderReliefFunding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_rdnt_ProceedsFromProviderReliefFunding_7ce4d8c3-4ac1-4c98-a789-60524f73a57d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RepaymentOfAdvanceMedicarePayments_3ea88ca8-a93f-44b1-9401-c084d7fc79a7" xlink:href="rdnt-20221231.xsd#rdnt_RepaymentOfAdvanceMedicarePayments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_rdnt_RepaymentOfAdvanceMedicarePayments_3ea88ca8-a93f-44b1-9401-c084d7fc79a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GovernmentAssistanceAmountCumulative_581f3391-5488-4c0c-8bf4-94e33b423b9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GovernmentAssistanceAmountCumulative"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_GovernmentAssistanceAmountCumulative_581f3391-5488-4c0c-8bf4-94e33b423b9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GovernmentAssistanceStatementOfFinancialPositionExtensibleEnumeration_186011b8-a1e4-45dc-bcc0-ef7a37e38288" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GovernmentAssistanceStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_GovernmentAssistanceStatementOfFinancialPositionExtensibleEnumeration_186011b8-a1e4-45dc-bcc0-ef7a37e38288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CaresActRefundableClaimPercentage_a6307051-3ecb-4e82-97e5-e8d95cfc410e" xlink:href="rdnt-20221231.xsd#rdnt_CaresActRefundableClaimPercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_rdnt_CaresActRefundableClaimPercentage_a6307051-3ecb-4e82-97e5-e8d95cfc410e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SocialSecurityTaxEmployerDeferralCARESAct_9caed4cf-08cb-40aa-8b0b-73a92ff94ffe" xlink:href="rdnt-20221231.xsd#rdnt_SocialSecurityTaxEmployerDeferralCARESAct"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_rdnt_SocialSecurityTaxEmployerDeferralCARESAct_9caed4cf-08cb-40aa-8b0b-73a92ff94ffe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct_daa9fe7b-b537-486d-b511-1c4421510d31" xlink:href="rdnt-20221231.xsd#rdnt_IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_rdnt_IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct_daa9fe7b-b537-486d-b511-1c4421510d31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ContractsReceivableFactoringReceivable_0ad75fd5-48ce-4e49-8a5c-212de70a41ff" xlink:href="rdnt-20221231.xsd#rdnt_ContractsReceivableFactoringReceivable"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_rdnt_ContractsReceivableFactoringReceivable_0ad75fd5-48ce-4e49-8a5c-212de70a41ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_623b9d6c-e948-44df-bdac-767c53bc6c55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_623b9d6c-e948-44df-bdac-767c53bc6c55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_103a0aa5-1dd0-4840-b21e-f8582b80633a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_103a0aa5-1dd0-4840-b21e-f8582b80633a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_8914f231-06b8-45e9-916d-3cf972fcf2c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_8914f231-06b8-45e9-916d-3cf972fcf2c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_4000af0a-f5d2-4c87-9722-5423c9f36e0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_Goodwill_4000af0a-f5d2-4c87-9722-5423c9f36e0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_77a68920-fb6d-4d67-a3fd-24271518ca4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_77a68920-fb6d-4d67-a3fd-24271518ca4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_74809235-9945-4fed-8ff0-047deb8b7ab3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_74809235-9945-4fed-8ff0-047deb8b7ab3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_9189547d-6780-4bba-931d-c226f343a9b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_9189547d-6780-4bba-931d-c226f343a9b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_0db075b0-4c13-4fca-8f7f-e3beac7a60c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_0db075b0-4c13-4fca-8f7f-e3beac7a60c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OperatingLeaseLeaseAbandonmentCharge_c4d097a5-d265-4fec-ba6f-e31f2df212d7" xlink:href="rdnt-20221231.xsd#rdnt_OperatingLeaseLeaseAbandonmentCharge"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_rdnt_OperatingLeaseLeaseAbandonmentCharge_c4d097a5-d265-4fec-ba6f-e31f2df212d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WorkersCompensationLiabilityCurrent_2649bdd1-46dc-4738-8f6d-a3f8ba28d240" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WorkersCompensationLiabilityCurrent"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_WorkersCompensationLiabilityCurrent_2649bdd1-46dc-4738-8f6d-a3f8ba28d240" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MedicalMalpracticeDeductiblePerIncidence_ed95c60f-6f8e-4e4b-a0be-833c1cb85219" xlink:href="rdnt-20221231.xsd#rdnt_MedicalMalpracticeDeductiblePerIncidence"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_rdnt_MedicalMalpracticeDeductiblePerIncidence_ed95c60f-6f8e-4e4b-a0be-833c1cb85219" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfInsuranceReserve_4e2bd48d-81dd-45cf-b812-1ebbf05b364a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SelfInsuranceReserve"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_SelfInsuranceReserve_4e2bd48d-81dd-45cf-b812-1ebbf05b364a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MedicalInsuranceStopLossPolicyClaimAmount_d7587332-7aba-4d7a-b0b4-e33f6e17ddec" xlink:href="rdnt-20221231.xsd#rdnt_MedicalInsuranceStopLossPolicyClaimAmount"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_rdnt_MedicalInsuranceStopLossPolicyClaimAmount_d7587332-7aba-4d7a-b0b4-e33f6e17ddec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_31b70ae7-a56d-4c78-9ffc-1cbcc4ee5ae4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_31b70ae7-a56d-4c78-9ffc-1cbcc4ee5ae4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_b40bfb85-b749-4010-bb38-d9afe98ff46b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_b40bfb85-b749-4010-bb38-d9afe98ff46b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_95482530-1524-43e8-b73f-6755ed298ad9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_95482530-1524-43e8-b73f-6755ed298ad9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans_801a207e-cd00-45c0-9684-65f1cf15be7a" xlink:href="rdnt-20221231.xsd#rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans_801a207e-cd00-45c0-9684-65f1cf15be7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_2701bebe-546d-4948-b228-6d0c5c04ee00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_2701bebe-546d-4948-b228-6d0c5c04ee00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_c4298c2d-37b2-4a07-9275-0d322c54892d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_c4298c2d-37b2-4a07-9275-0d322c54892d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_da9fbaec-d3ab-41e0-b61d-0efec7e6e78c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_da9fbaec-d3ab-41e0-b61d-0efec7e6e78c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNumberOfInstrumentsHeld_632fb06f-3f7e-462f-b842-fab2948bfb7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetNumberOfInstrumentsHeld"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_DerivativeAssetNumberOfInstrumentsHeld_632fb06f-3f7e-462f-b842-fab2948bfb7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_481a3583-8f84-4011-bf53-46d5342e737e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_481a3583-8f84-4011-bf53-46d5342e737e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeBasisSpreadOnVariableRate_12396e71-0e18-49f9-8f02-0bd1963f43ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeBasisSpreadOnVariableRate"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_DerivativeBasisSpreadOnVariableRate_12396e71-0e18-49f9-8f02-0bd1963f43ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized_0fba57d8-4b1d-4087-a0df-1ed839035642" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized_0fba57d8-4b1d-4087-a0df-1ed839035642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_995542b7-1c11-410a-9ec7-980a7712427b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_StockholdersEquity_995542b7-1c11-410a-9ec7-980a7712427b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MonthlyAmortizationOfDeferredHedgeGains_4594370a-fb11-426e-8428-942762797408" xlink:href="rdnt-20221231.xsd#rdnt_MonthlyAmortizationOfDeferredHedgeGains"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_rdnt_MonthlyAmortizationOfDeferredHedgeGains_4594370a-fb11-426e-8428-942762797408" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_1728b58d-b5c7-4fc2-86f8-071592b9c5a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:presentationArc order="37" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_1728b58d-b5c7-4fc2-86f8-071592b9c5a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones_815f4b19-8532-4529-b4ef-36a10dc07862" xlink:href="rdnt-20221231.xsd#rdnt_BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones"/>
    <link:presentationArc order="38" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_rdnt_BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones_815f4b19-8532-4529-b4ef-36a10dc07862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_2138b0df-60e3-46cf-b160-8babad9cf751" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="39" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_2138b0df-60e3-46cf-b160-8babad9cf751" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneOne_6a4cd74d-6276-4430-9e8f-6623bcb51a02" xlink:href="rdnt-20221231.xsd#rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneOne"/>
    <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneOne_6a4cd74d-6276-4430-9e8f-6623bcb51a02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneTwo_397fc82f-d59e-4580-8d07-837742e0313a" xlink:href="rdnt-20221231.xsd#rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneTwo"/>
    <link:presentationArc order="41" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneTwo_397fc82f-d59e-4580-8d07-837742e0313a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod_5df7f6b0-2724-46d3-94fd-dbcd0a141b04" xlink:href="rdnt-20221231.xsd#rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod"/>
    <link:presentationArc order="42" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod_5df7f6b0-2724-46d3-94fd-dbcd0a141b04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares_dcd2a22e-f10d-4cd2-80b4-188c0cde61a7" xlink:href="rdnt-20221231.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares"/>
    <link:presentationArc order="43" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares_dcd2a22e-f10d-4cd2-80b4-188c0cde61a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution_4715d6ac-0ce6-4d21-96ca-b81b82b12661" xlink:href="rdnt-20221231.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution"/>
    <link:presentationArc order="44" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution_4715d6ac-0ce6-4d21-96ca-b81b82b12661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_a7d5037f-2f00-4b3b-9ca3-7ca2d8695718" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="45" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_LineOfCredit_a7d5037f-2f00-4b3b-9ca3-7ca2d8695718" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestments_72e86fb4-63d2-48e5-8e8e-fba94050e953" xlink:href="rdnt-20221231.xsd#rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestments"/>
    <link:presentationArc order="46" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestments_72e86fb4-63d2-48e5-8e8e-fba94050e953" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentAggregateCost_18f82dc0-b9c1-4275-aa2c-eef82daadccf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <link:presentationArc order="47" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_EquityMethodInvestmentAggregateCost_18f82dc0-b9c1-4275-aa2c-eef82daadccf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_49ad4d3e-d0a9-498f-ac4a-5d6feb5e5c5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="48" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_49ad4d3e-d0a9-498f-ac4a-5d6feb5e5c5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_03e0bc26-7a28-4fdd-aacc-41ce082e7e8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:presentationArc order="49" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_03e0bc26-7a28-4fdd-aacc-41ce082e7e8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityMethodInvestmentSharesPurchased_0557be36-cb6f-421d-b063-3c5bd44928d7" xlink:href="rdnt-20221231.xsd#rdnt_EquityMethodInvestmentSharesPurchased"/>
    <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_rdnt_EquityMethodInvestmentSharesPurchased_0557be36-cb6f-421d-b063-3c5bd44928d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_b0bf2ad5-b364-4813-8f46-54bf687b0e6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:presentationArc order="51" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_ShortTermBorrowings_b0bf2ad5-b364-4813-8f46-54bf687b0e6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_fb20f416-8f6f-48f1-987a-a5ebe9d5c055" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <link:presentationArc order="52" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_fb20f416-8f6f-48f1-987a-a5ebe9d5c055" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_7182b117-68d8-4564-be55-a9174d991e13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToFundLongtermLoansToRelatedParties"/>
    <link:presentationArc order="53" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_7182b117-68d8-4564-be55-a9174d991e13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberofUnconsolidatedJointVentures_1f446ce4-5fb6-4ff4-8b56-ecde4fc6300b" xlink:href="rdnt-20221231.xsd#rdnt_NumberofUnconsolidatedJointVentures"/>
    <link:presentationArc order="54" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_rdnt_NumberofUnconsolidatedJointVentures_1f446ce4-5fb6-4ff4-8b56-ecde4fc6300b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityOwnershipPercentage_e7699f61-648a-47f2-9532-7b118eb7c068" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityOwnershipPercentage"/>
    <link:presentationArc order="55" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_VariableInterestEntityOwnershipPercentage_e7699f61-648a-47f2-9532-7b118eb7c068" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ManagementServiceFees_0e2e7a4b-559b-4e39-a4d6-a65bd97632df" xlink:href="rdnt-20221231.xsd#rdnt_ManagementServiceFees"/>
    <link:presentationArc order="56" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_rdnt_ManagementServiceFees_0e2e7a4b-559b-4e39-a4d6-a65bd97632df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityMethodInvestmentAdditionalContribution_1c5b4ab4-e6ee-474f-8c62-e21e9f668e20" xlink:href="rdnt-20221231.xsd#rdnt_EquityMethodInvestmentAdditionalContribution"/>
    <link:presentationArc order="57" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_rdnt_EquityMethodInvestmentAdditionalContribution_1c5b4ab4-e6ee-474f-8c62-e21e9f668e20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberOfAssetsSold_90e43042-d3c5-4159-9c49-e6b409328c79" xlink:href="rdnt-20221231.xsd#rdnt_NumberOfAssetsSold"/>
    <link:presentationArc order="58" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_rdnt_NumberOfAssetsSold_90e43042-d3c5-4159-9c49-e6b409328c79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_c33c2554-daa4-48fa-9860-27cd589ef1c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity"/>
    <link:presentationArc order="59" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_c33c2554-daa4-48fa-9860-27cd589ef1c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDividendsReceived_aa74219a-6853-4c28-acb6-aff06614fc87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDividendsReceived"/>
    <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_ProceedsFromDividendsReceived_aa74219a-6853-4c28-acb6-aff06614fc87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_728e478f-1ba3-4ef1-ac4d-2ef5c24900a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="61" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_5491b235-234b-4113-8e1a-04fc9170c60d" xlink:to="loc_us-gaap_EquityMethodInvestments_728e478f-1ba3-4ef1-ac4d-2ef5c24900a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative_1" xlink:type="simple" xlink:href="rdnt-20221231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative_1"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsReconciliationofForeignCurrencyTranslation" xlink:type="simple" xlink:href="rdnt-20221231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsReconciliationofForeignCurrencyTranslation"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsReconciliationofForeignCurrencyTranslation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_62e4f13d-95d1-4c30-8de7-659f79dc4967" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CumulativeTranslationAdjustmentSummaryRollForward_36bcdfc2-2acb-4b8f-bc61-fb87fd9834ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CumulativeTranslationAdjustmentSummaryRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_62e4f13d-95d1-4c30-8de7-659f79dc4967" xlink:to="loc_us-gaap_CumulativeTranslationAdjustmentSummaryRollForward_36bcdfc2-2acb-4b8f-bc61-fb87fd9834ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_79986654-b5aa-4ad9-86a5-eea918b74c88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CumulativeTranslationAdjustmentSummaryRollForward_36bcdfc2-2acb-4b8f-bc61-fb87fd9834ca" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_79986654-b5aa-4ad9-86a5-eea918b74c88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease_05fb641e-591f-4bc9-ae61-0da8aefc10f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CumulativeTranslationAdjustmentSummaryRollForward_36bcdfc2-2acb-4b8f-bc61-fb87fd9834ca" xlink:to="loc_us-gaap_CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease_05fb641e-591f-4bc9-ae61-0da8aefc10f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_f4602bfd-0cec-4ddf-afe3-cb4b0451cc65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CumulativeTranslationAdjustmentSummaryRollForward_36bcdfc2-2acb-4b8f-bc61-fb87fd9834ca" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_f4602bfd-0cec-4ddf-afe3-cb4b0451cc65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives" xlink:type="simple" xlink:href="rdnt-20221231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_2f732af8-9d8a-4e13-9a4a-719c8afe9c9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAssetsTable_5b374c2b-f600-4f6e-8dc9-84e373d00b17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OffsettingAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2f732af8-9d8a-4e13-9a4a-719c8afe9c9c" xlink:to="loc_us-gaap_OffsettingAssetsTable_5b374c2b-f600-4f6e-8dc9-84e373d00b17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_d3f62ad9-4455-42b2-9446-ec9c377d15dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsTable_5b374c2b-f600-4f6e-8dc9-84e373d00b17" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_d3f62ad9-4455-42b2-9446-ec9c377d15dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_f9bfd051-f1f0-436f-ba89-2937486929d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_d3f62ad9-4455-42b2-9446-ec9c377d15dd" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_f9bfd051-f1f0-436f-ba89-2937486929d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_4ca0496a-d151-4c11-bd43-b7a03444600d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateCapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_f9bfd051-f1f0-436f-ba89-2937486929d7" xlink:to="loc_us-gaap_InterestRateCapMember_4ca0496a-d151-4c11-bd43-b7a03444600d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_2d5eca1f-db83-4a60-9d34-10fa5befe660" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_f9bfd051-f1f0-436f-ba89-2937486929d7" xlink:to="loc_us-gaap_InterestRateSwapMember_2d5eca1f-db83-4a60-9d34-10fa5befe660" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_a109451d-893e-42f4-8f03-25217bcf09ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsTable_5b374c2b-f600-4f6e-8dc9-84e373d00b17" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_a109451d-893e-42f4-8f03-25217bcf09ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_284948a0-5241-416b-8bd6-99fd9d134e49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_a109451d-893e-42f4-8f03-25217bcf09ec" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_284948a0-5241-416b-8bd6-99fd9d134e49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_3e08df04-e89d-4b0f-a488-da456d016472" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_284948a0-5241-416b-8bd6-99fd9d134e49" xlink:to="loc_us-gaap_InterestExpenseMember_3e08df04-e89d-4b0f-a488-da456d016472" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAssetsLineItems_9beca4ef-716b-44fe-9531-d3799bb3e493" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OffsettingAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsTable_5b374c2b-f600-4f6e-8dc9-84e373d00b17" xlink:to="loc_us-gaap_OffsettingAssetsLineItems_9beca4ef-716b-44fe-9531-d3799bb3e493" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_dac59c85-912b-42c5-ae35-7e17121d9032" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_9beca4ef-716b-44fe-9531-d3799bb3e493" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_dac59c85-912b-42c5-ae35-7e17121d9032" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_59ece0c8-c301-4258-a5ef-b21b1b284feb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_9beca4ef-716b-44fe-9531-d3799bb3e493" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_59ece0c8-c301-4258-a5ef-b21b1b284feb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_9ff02f46-fc24-4dbd-bb1e-9f07fd005800" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_9beca4ef-716b-44fe-9531-d3799bb3e493" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_9ff02f46-fc24-4dbd-bb1e-9f07fd005800" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_af3e3aa9-c490-4a8f-82fc-43315fb8c522" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_9beca4ef-716b-44fe-9531-d3799bb3e493" xlink:to="loc_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_af3e3aa9-c490-4a8f-82fc-43315fb8c522" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsContingentConsideration" xlink:type="simple" xlink:href="rdnt-20221231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsContingentConsideration"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsContingentConsideration" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_6cdaa382-ff5b-402a-81dd-befa1fe29feb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_457b2318-04a7-4169-a1b2-daf44a9852d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6cdaa382-ff5b-402a-81dd-befa1fe29feb" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_457b2318-04a7-4169-a1b2-daf44a9852d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_ca8155bc-b96e-4abb-bba5-f958b73288ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_457b2318-04a7-4169-a1b2-daf44a9852d1" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_ca8155bc-b96e-4abb-bba5-f958b73288ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_66d51d49-20c5-4d80-aa50-cf4116449cdd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_ca8155bc-b96e-4abb-bba5-f958b73288ba" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_66d51d49-20c5-4d80-aa50-cf4116449cdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AidenceMember_981acdc0-65a4-4b68-9319-19a733e3a136" xlink:href="rdnt-20221231.xsd#rdnt_AidenceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_66d51d49-20c5-4d80-aa50-cf4116449cdd" xlink:to="loc_rdnt_AidenceMember_981acdc0-65a4-4b68-9319-19a733e3a136" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_QuantibMember_9eb6cdd5-2231-47d0-852d-bc9c0d472bb4" xlink:href="rdnt-20221231.xsd#rdnt_QuantibMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_66d51d49-20c5-4d80-aa50-cf4116449cdd" xlink:to="loc_rdnt_QuantibMember_9eb6cdd5-2231-47d0-852d-bc9c0d472bb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MontclairMember_19e4b00a-6ca0-44ba-a2e7-1185823fbd57" xlink:href="rdnt-20221231.xsd#rdnt_MontclairMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_66d51d49-20c5-4d80-aa50-cf4116449cdd" xlink:to="loc_rdnt_MontclairMember_19e4b00a-6ca0-44ba-a2e7-1185823fbd57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HeartAndLungImagingLimitedMember_28937015-6e83-41dc-b1e2-b547dd66ebd8" xlink:href="rdnt-20221231.xsd#rdnt_HeartAndLungImagingLimitedMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_66d51d49-20c5-4d80-aa50-cf4116449cdd" xlink:to="loc_rdnt_HeartAndLungImagingLimitedMember_28937015-6e83-41dc-b1e2-b547dd66ebd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_0f83948a-644b-4cc9-b171-d2b9e05e88ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionContingentConsiderationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_457b2318-04a7-4169-a1b2-daf44a9852d1" xlink:to="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_0f83948a-644b-4cc9-b171-d2b9e05e88ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_1f98c1b3-dad2-4891-86e6-b6e08464e005" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_0f83948a-644b-4cc9-b171-d2b9e05e88ae" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_1f98c1b3-dad2-4891-86e6-b6e08464e005" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration_9a773396-aa63-4a3d-bf9b-c0bf23f96e4a" xlink:href="rdnt-20221231.xsd#rdnt_BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_0f83948a-644b-4cc9-b171-d2b9e05e88ae" xlink:to="loc_rdnt_BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration_9a773396-aa63-4a3d-bf9b-c0bf23f96e4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_f3ae307f-f20a-48f0-9fe6-02c23240f7e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_0f83948a-644b-4cc9-b171-d2b9e05e88ae" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_f3ae307f-f20a-48f0-9fe6-02c23240f7e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation_7da1c519-79f9-44e9-89a6-a8d5a4cc8ea4" xlink:href="rdnt-20221231.xsd#rdnt_BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_0f83948a-644b-4cc9-b171-d2b9e05e88ae" xlink:to="loc_rdnt_BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation_7da1c519-79f9-44e9-89a6-a8d5a4cc8ea4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_2006662f-6782-4b46-8243-9ef771209525" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_0f83948a-644b-4cc9-b171-d2b9e05e88ae" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_2006662f-6782-4b46-8243-9ef771209525" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements" xlink:type="simple" xlink:href="rdnt-20221231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_f6b86cfd-1c61-477f-8884-d443b2325556" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_581a0eb9-40ee-4194-ac9f-6d3e399c4106" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f6b86cfd-1c61-477f-8884-d443b2325556" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_581a0eb9-40ee-4194-ac9f-6d3e399c4106" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_5cb73555-01cd-4771-a9a8-e4ed0da515e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_581a0eb9-40ee-4194-ac9f-6d3e399c4106" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_5cb73555-01cd-4771-a9a8-e4ed0da515e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_566d3c35-4de6-4296-bce8-cd57e71f1891" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_5cb73555-01cd-4771-a9a8-e4ed0da515e3" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_566d3c35-4de6-4296-bce8-cd57e71f1891" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_53945465-ea91-4826-aa90-7e86ff5e04a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_566d3c35-4de6-4296-bce8-cd57e71f1891" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_53945465-ea91-4826-aa90-7e86ff5e04a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_c774eb17-817a-4a75-84ab-3ba51a522606" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_53945465-ea91-4826-aa90-7e86ff5e04a0" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_c774eb17-817a-4a75-84ab-3ba51a522606" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ff034d66-dfef-44c5-86e8-097534acdf75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_581a0eb9-40ee-4194-ac9f-6d3e399c4106" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ff034d66-dfef-44c5-86e8-097534acdf75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_dd66af70-adcf-494d-b2d1-faa3f046b1c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ff034d66-dfef-44c5-86e8-097534acdf75" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_dd66af70-adcf-494d-b2d1-faa3f046b1c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_7a574545-b438-4c56-867e-4d8c79293587" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_dd66af70-adcf-494d-b2d1-faa3f046b1c5" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_7a574545-b438-4c56-867e-4d8c79293587" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_9e46b73a-0c3b-4df9-84b2-ebaf49c64b2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_dd66af70-adcf-494d-b2d1-faa3f046b1c5" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_9e46b73a-0c3b-4df9-84b2-ebaf49c64b2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_dcb937e0-908d-4287-ba7f-a578ed8b04f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_dd66af70-adcf-494d-b2d1-faa3f046b1c5" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_dcb937e0-908d-4287-ba7f-a578ed8b04f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_0001fc56-a250-4275-a435-1af176bf148b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_581a0eb9-40ee-4194-ac9f-6d3e399c4106" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_0001fc56-a250-4275-a435-1af176bf148b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_3e060aae-564d-4050-92cf-3c08f0e4119a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_0001fc56-a250-4275-a435-1af176bf148b" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_3e060aae-564d-4050-92cf-3c08f0e4119a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_de3cf343-dba3-4481-85e1-bfb7dd7c7c6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3e060aae-564d-4050-92cf-3c08f0e4119a" xlink:to="loc_us-gaap_InterestRateSwapMember_de3cf343-dba3-4481-85e1-bfb7dd7c7c6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_583ce98f-f8f2-46be-906e-620b3b300f70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_581a0eb9-40ee-4194-ac9f-6d3e399c4106" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_583ce98f-f8f2-46be-906e-620b3b300f70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d43db6c5-c1b4-4293-9912-59f00e70a595" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_583ce98f-f8f2-46be-906e-620b3b300f70" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d43db6c5-c1b4-4293-9912-59f00e70a595" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_QuantibMember_84f1eb69-a51f-4a24-994c-1d989f359fc9" xlink:href="rdnt-20221231.xsd#rdnt_QuantibMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d43db6c5-c1b4-4293-9912-59f00e70a595" xlink:to="loc_rdnt_QuantibMember_84f1eb69-a51f-4a24-994c-1d989f359fc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HeartAndLungImagingLimitedMember_bbb43ee0-9201-4e4d-9037-fcaca813cb76" xlink:href="rdnt-20221231.xsd#rdnt_HeartAndLungImagingLimitedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d43db6c5-c1b4-4293-9912-59f00e70a595" xlink:to="loc_rdnt_HeartAndLungImagingLimitedMember_bbb43ee0-9201-4e4d-9037-fcaca813cb76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AidenceMember_a873bc80-9f59-4c5d-861a-edae77c6d1c0" xlink:href="rdnt-20221231.xsd#rdnt_AidenceMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d43db6c5-c1b4-4293-9912-59f00e70a595" xlink:to="loc_rdnt_AidenceMember_a873bc80-9f59-4c5d-861a-edae77c6d1c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MontclairMember_7bf69c74-7ddd-4cb8-8d38-4796f7b7e76c" xlink:href="rdnt-20221231.xsd#rdnt_MontclairMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d43db6c5-c1b4-4293-9912-59f00e70a595" xlink:to="loc_rdnt_MontclairMember_7bf69c74-7ddd-4cb8-8d38-4796f7b7e76c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_ebf8d606-8d6c-4009-b537-48202e752bc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_581a0eb9-40ee-4194-ac9f-6d3e399c4106" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_ebf8d606-8d6c-4009-b537-48202e752bc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_8a1c346d-ac23-4c6c-9544-9e9f712975db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_ebf8d606-8d6c-4009-b537-48202e752bc3" xlink:to="loc_us-gaap_DerivativeAssets_8a1c346d-ac23-4c6c-9544-9e9f712975db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_913d2b9a-d431-45f9-a49b-a4b7b60b39fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_ebf8d606-8d6c-4009-b537-48202e752bc3" xlink:to="loc_us-gaap_DerivativeLiabilities_913d2b9a-d431-45f9-a49b-a4b7b60b39fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract_157edb30-23cb-492c-8237-41056f4da69f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_ebf8d606-8d6c-4009-b537-48202e752bc3" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract_157edb30-23cb-492c-8237-41056f4da69f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_e401686f-898b-4559-8f21-52438d1bb833" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract_157edb30-23cb-492c-8237-41056f4da69f" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_e401686f-898b-4559-8f21-52438d1bb833" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_02779290-efff-41e0-87f4-cd6c1735e0c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_ebf8d606-8d6c-4009-b537-48202e752bc3" xlink:to="loc_us-gaap_SharePrice_02779290-efff-41e0-87f4-cd6c1735e0c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_a5b4d051-5351-4292-9369-8423ddc2c1fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_ebf8d606-8d6c-4009-b537-48202e752bc3" xlink:to="loc_us-gaap_DebtInstrumentFairValue_a5b4d051-5351-4292-9369-8423ddc2c1fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare" xlink:type="simple" xlink:href="rdnt-20221231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_8d619075-efdd-4906-9eb6-10a617a45bab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_3fcd6e4d-5518-441e-b95f-fcc29e913de1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8d619075-efdd-4906-9eb6-10a617a45bab" xlink:to="loc_us-gaap_NetIncomeLoss_3fcd6e4d-5518-441e-b95f-fcc29e913de1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_ce1141fc-0742-4a2e-b499-59cc4df7de7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8d619075-efdd-4906-9eb6-10a617a45bab" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_ce1141fc-0742-4a2e-b499-59cc4df7de7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_800c8f3b-3fe4-4d0c-be39-5e16085fb673" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_ce1141fc-0742-4a2e-b499-59cc4df7de7a" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_800c8f3b-3fe4-4d0c-be39-5e16085fb673" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_f24ab8b6-ca55-4601-b574-3ae1acbf0707" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_ce1141fc-0742-4a2e-b499-59cc4df7de7a" xlink:to="loc_us-gaap_EarningsPerShareBasic_f24ab8b6-ca55-4601-b574-3ae1acbf0707" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_6fcacbb2-807c-454e-96d8-3a47715122f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8d619075-efdd-4906-9eb6-10a617a45bab" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_6fcacbb2-807c-454e-96d8-3a47715122f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3466fbb7-ac24-4035-9854-c057c8c2dc39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_6fcacbb2-807c-454e-96d8-3a47715122f8" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3466fbb7-ac24-4035-9854-c057c8c2dc39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_abfed461-294c-4019-a52b-afd4f43857bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesRestrictedStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_6fcacbb2-807c-454e-96d8-3a47715122f8" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_abfed461-294c-4019-a52b-afd4f43857bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_82adaf3f-cc49-4786-8a72-413938a315bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_6fcacbb2-807c-454e-96d8-3a47715122f8" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_82adaf3f-cc49-4786-8a72-413938a315bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_89d90ea3-48ec-430b-9b18-67fe87c5abe6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_6fcacbb2-807c-454e-96d8-3a47715122f8" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_89d90ea3-48ec-430b-9b18-67fe87c5abe6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AdjustmentToNetIncomeAttributableToAssumedShareSettlements_51407f88-4f92-4da4-aff3-bea98cc80846" xlink:href="rdnt-20221231.xsd#rdnt_AdjustmentToNetIncomeAttributableToAssumedShareSettlements"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_6fcacbb2-807c-454e-96d8-3a47715122f8" xlink:to="loc_rdnt_AdjustmentToNetIncomeAttributableToAssumedShareSettlements_51407f88-4f92-4da4-aff3-bea98cc80846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_5119a5ca-1f68-4847-8270-38f41c65af33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_6fcacbb2-807c-454e-96d8-3a47715122f8" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_5119a5ca-1f68-4847-8270-38f41c65af33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_7fe68dd3-4930-423e-9665-36d004e32e6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_6fcacbb2-807c-454e-96d8-3a47715122f8" xlink:to="loc_us-gaap_EarningsPerShareDiluted_7fe68dd3-4930-423e-9665-36d004e32e6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_e35afeae-6978-48af-a95f-8af0d300b2c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8d619075-efdd-4906-9eb6-10a617a45bab" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_e35afeae-6978-48af-a95f-8af0d300b2c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_5dccad10-8631-4684-83fb-f45313f00eb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_e35afeae-6978-48af-a95f-8af0d300b2c1" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_5dccad10-8631-4684-83fb-f45313f00eb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f4f648a9-16ea-41e2-b48a-697c4d09c557" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_5dccad10-8631-4684-83fb-f45313f00eb7" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f4f648a9-16ea-41e2-b48a-697c4d09c557" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_78b64d4c-5af4-4a68-b4a3-5d8eed967b0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f4f648a9-16ea-41e2-b48a-697c4d09c557" xlink:to="loc_us-gaap_RestrictedStockMember_78b64d4c-5af4-4a68-b4a3-5d8eed967b0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_0ad3c78a-216e-4c65-add4-5d9328502249" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f4f648a9-16ea-41e2-b48a-697c4d09c557" xlink:to="loc_us-gaap_EmployeeStockOptionMember_0ad3c78a-216e-4c65-add4-5d9328502249" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_bdd01a28-d754-4581-829f-92e92d6eff7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_e35afeae-6978-48af-a95f-8af0d300b2c1" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_bdd01a28-d754-4581-829f-92e92d6eff7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_beda07a7-0d32-4479-ae59-8616127f7414" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_bdd01a28-d754-4581-829f-92e92d6eff7d" xlink:to="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_beda07a7-0d32-4479-ae59-8616127f7414" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_ae47dd95-db1c-4eab-b997-e21414e436d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_beda07a7-0d32-4479-ae59-8616127f7414" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_ae47dd95-db1c-4eab-b997-e21414e436d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsInvestmentinJointVentures" xlink:type="simple" xlink:href="rdnt-20221231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsInvestmentinJointVentures"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsInvestmentinJointVentures" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_c332c594-5167-41c8-8b78-60bf93cfec0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward_2e8da5b3-3fb6-42ba-9581-0f2504650b69" xlink:href="rdnt-20221231.xsd#rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c332c594-5167-41c8-8b78-60bf93cfec0d" xlink:to="loc_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward_2e8da5b3-3fb6-42ba-9581-0f2504650b69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_7418cc60-d480-4044-8be6-84ac8ac5b34a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward_2e8da5b3-3fb6-42ba-9581-0f2504650b69" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_7418cc60-d480-4044-8be6-84ac8ac5b34a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityContributionsInExistingAndPurchaseOfInterestInJointVentures_13a9077a-98ce-4a60-b69f-8521a0479049" xlink:href="rdnt-20221231.xsd#rdnt_EquityContributionsInExistingAndPurchaseOfInterestInJointVentures"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward_2e8da5b3-3fb6-42ba-9581-0f2504650b69" xlink:to="loc_rdnt_EquityContributionsInExistingAndPurchaseOfInterestInJointVentures_13a9077a-98ce-4a60-b69f-8521a0479049" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_37d113df-ac8e-450c-a0f4-b530d3cd7e35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward_2e8da5b3-3fb6-42ba-9581-0f2504650b69" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_37d113df-ac8e-450c-a0f4-b530d3cd7e35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_284c6e18-59d9-4766-999d-07077f942eee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentDividendsOrDistributions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward_2e8da5b3-3fb6-42ba-9581-0f2504650b69" xlink:to="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_284c6e18-59d9-4766-999d-07077f942eee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_37474af4-fa6c-4889-8017-45c065087f2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward_2e8da5b3-3fb6-42ba-9581-0f2504650b69" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_37474af4-fa6c-4889-8017-45c065087f2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures" xlink:type="simple" xlink:href="rdnt-20221231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_d2452b17-7761-4dbd-a44b-a24a3f2e3af9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_156f694f-d1f2-4b23-b3b8-9635997d5552" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d2452b17-7761-4dbd-a44b-a24a3f2e3af9" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_156f694f-d1f2-4b23-b3b8-9635997d5552" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_86346ce8-ce0b-49bb-95b6-078b981a6eb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_156f694f-d1f2-4b23-b3b8-9635997d5552" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_86346ce8-ce0b-49bb-95b6-078b981a6eb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_1968e71a-2a31-4d1b-aa03-5c54924b5c83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_86346ce8-ce0b-49bb-95b6-078b981a6eb3" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_1968e71a-2a31-4d1b-aa03-5c54924b5c83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember_28964920-bcc0-45cb-9b82-045981da953a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_1968e71a-2a31-4d1b-aa03-5c54924b5c83" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember_28964920-bcc0-45cb-9b82-045981da953a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_161cf5d0-55fb-4c20-96bf-3d24feb120de" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_156f694f-d1f2-4b23-b3b8-9635997d5552" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_161cf5d0-55fb-4c20-96bf-3d24feb120de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_d50c310b-61a5-4ade-b401-880b7d0d8afe" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_161cf5d0-55fb-4c20-96bf-3d24feb120de" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_d50c310b-61a5-4ade-b401-880b7d0d8afe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_JointVentureInterestMember_d3ffebed-9073-4a3c-b91c-ced0dd6f4337" xlink:href="rdnt-20221231.xsd#rdnt_JointVentureInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_d50c310b-61a5-4ade-b401-880b7d0d8afe" xlink:to="loc_rdnt_JointVentureInterestMember_d3ffebed-9073-4a3c-b91c-ced0dd6f4337" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_cad3ecfd-5fe0-493f-a5c7-b148570a49fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_156f694f-d1f2-4b23-b3b8-9635997d5552" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_cad3ecfd-5fe0-493f-a5c7-b148570a49fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_KeyFinancialDataForJointVentures_6e02cdbc-2837-408b-8ca9-fe51238d68e1" xlink:href="rdnt-20221231.xsd#rdnt_KeyFinancialDataForJointVentures"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_cad3ecfd-5fe0-493f-a5c7-b148570a49fe" xlink:to="loc_rdnt_KeyFinancialDataForJointVentures_6e02cdbc-2837-408b-8ca9-fe51238d68e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_6d3a024e-2087-4b2e-bd2a-d97f4961e30e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_KeyFinancialDataForJointVentures_6e02cdbc-2837-408b-8ca9-fe51238d68e1" xlink:to="loc_us-gaap_AssetsCurrent_6d3a024e-2087-4b2e-bd2a-d97f4961e30e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent_aa217f3a-e40c-4194-a17c-d5b4c57fb7da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_KeyFinancialDataForJointVentures_6e02cdbc-2837-408b-8ca9-fe51238d68e1" xlink:to="loc_us-gaap_AssetsNoncurrent_aa217f3a-e40c-4194-a17c-d5b4c57fb7da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_5ca1d26f-e315-4ded-bdd7-fd137b14d880" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_KeyFinancialDataForJointVentures_6e02cdbc-2837-408b-8ca9-fe51238d68e1" xlink:to="loc_us-gaap_LiabilitiesCurrent_5ca1d26f-e315-4ded-bdd7-fd137b14d880" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_1b1be351-4ea9-4765-9563-87df2cf2c345" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_KeyFinancialDataForJointVentures_6e02cdbc-2837-408b-8ca9-fe51238d68e1" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_1b1be351-4ea9-4765-9563-87df2cf2c345" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentAggregateCost_c65633c8-f6f4-49e8-8b29-dd438a4dee52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_KeyFinancialDataForJointVentures_6e02cdbc-2837-408b-8ca9-fe51238d68e1" xlink:to="loc_us-gaap_EquityMethodInvestmentAggregateCost_c65633c8-f6f4-49e8-8b29-dd438a4dee52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_d45912eb-34da-4863-be76-27ba0f4d50b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_KeyFinancialDataForJointVentures_6e02cdbc-2837-408b-8ca9-fe51238d68e1" xlink:to="loc_us-gaap_EquityMethodInvestments_d45912eb-34da-4863-be76-27ba0f4d50b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets_fc9eb1c9-88e5-4803-95e3-bd571592a0db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_KeyFinancialDataForJointVentures_6e02cdbc-2837-408b-8ca9-fe51238d68e1" xlink:to="loc_us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets_fc9eb1c9-88e5-4803-95e3-bd571592a0db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_630e6b59-0cc1-4181-a806-355f1dce312b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_KeyFinancialDataForJointVentures_6e02cdbc-2837-408b-8ca9-fe51238d68e1" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_630e6b59-0cc1-4181-a806-355f1dce312b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_5b66ac75-9d82-44fd-9e7b-4ec5f9d61fae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_KeyFinancialDataForJointVentures_6e02cdbc-2837-408b-8ca9-fe51238d68e1" xlink:to="loc_us-gaap_Revenues_5b66ac75-9d82-44fd-9e7b-4ec5f9d61fae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_2a172f34-6baa-47cf-976b-0fc833a2c00a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_KeyFinancialDataForJointVentures_6e02cdbc-2837-408b-8ca9-fe51238d68e1" xlink:to="loc_us-gaap_ProfitLoss_2a172f34-6baa-47cf-976b-0fc833a2c00a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDeferredRevenueRecognition" xlink:type="simple" xlink:href="rdnt-20221231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDeferredRevenueRecognition"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDeferredRevenueRecognition" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_75ac9e88-eacb-4ca9-9539-c9ccea1b6669" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_9bdb7e84-66a0-4d26-b469-73fad5dce6df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_75ac9e88-eacb-4ca9-9539-c9ccea1b6669" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_9bdb7e84-66a0-4d26-b469-73fad5dce6df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_0f60b29b-b628-4af5-84f5-457852b514ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_9bdb7e84-66a0-4d26-b469-73fad5dce6df" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_0f60b29b-b628-4af5-84f5-457852b514ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_af66200d-f3fe-4613-ac4c-192086809610" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_9bdb7e84-66a0-4d26-b469-73fad5dce6df" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_af66200d-f3fe-4613-ac4c-192086809610" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_d7216666-8a6c-449a-bdd5-162e80c0fb30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_af66200d-f3fe-4613-ac4c-192086809610" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_d7216666-8a6c-449a-bdd5-162e80c0fb30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_6400edc5-5f67-489c-b300-58b7f7888291" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_af66200d-f3fe-4613-ac4c-192086809610" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_6400edc5-5f67-489c-b300-58b7f7888291" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDeferredRevenueRecognition_1" xlink:type="simple" xlink:href="rdnt-20221231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDeferredRevenueRecognition_1"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDeferredRevenueRecognition_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsandLiabilitiesAssumed" xlink:type="simple" xlink:href="rdnt-20221231.xsd#BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsandLiabilitiesAssumed"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsandLiabilitiesAssumed" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_20725aab-47d8-42d3-a35f-36b2092997eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0e956483-5cc1-4c66-8de9-4fa0aa41ef0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_20725aab-47d8-42d3-a35f-36b2092997eb" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0e956483-5cc1-4c66-8de9-4fa0aa41ef0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_d3d929df-48ea-4a20-98ec-6b672e43c3b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0e956483-5cc1-4c66-8de9-4fa0aa41ef0a" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_d3d929df-48ea-4a20-98ec-6b672e43c3b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e8e21f15-11f4-4ecf-835c-0ec46007dc6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_d3d929df-48ea-4a20-98ec-6b672e43c3b9" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e8e21f15-11f4-4ecf-835c-0ec46007dc6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_IFRCLLCSubsidiaryOneMember_e43b5d33-268b-437e-9c86-71edab72c47b" xlink:href="rdnt-20221231.xsd#rdnt_IFRCLLCSubsidiaryOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e8e21f15-11f4-4ecf-835c-0ec46007dc6a" xlink:to="loc_rdnt_IFRCLLCSubsidiaryOneMember_e43b5d33-268b-437e-9c86-71edab72c47b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_IFRCLLCSubsidiaryTwoMember_995d4120-cc98-4b1f-8d86-2f226c8bcfa2" xlink:href="rdnt-20221231.xsd#rdnt_IFRCLLCSubsidiaryTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e8e21f15-11f4-4ecf-835c-0ec46007dc6a" xlink:to="loc_rdnt_IFRCLLCSubsidiaryTwoMember_995d4120-cc98-4b1f-8d86-2f226c8bcfa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MontclairRadiologicalAssociatesPAMember_24401a8c-a34b-433d-893c-0c75cd56798e" xlink:href="rdnt-20221231.xsd#rdnt_MontclairRadiologicalAssociatesPAMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e8e21f15-11f4-4ecf-835c-0ec46007dc6a" xlink:to="loc_rdnt_MontclairRadiologicalAssociatesPAMember_24401a8c-a34b-433d-893c-0c75cd56798e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HeartAndLungImagingLimitedMember_b6327b27-0e98-427c-8659-e7f72245ab32" xlink:href="rdnt-20221231.xsd#rdnt_HeartAndLungImagingLimitedMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e8e21f15-11f4-4ecf-835c-0ec46007dc6a" xlink:to="loc_rdnt_HeartAndLungImagingLimitedMember_b6327b27-0e98-427c-8659-e7f72245ab32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ChelseaDignosticRadiologyPCMember_b975cf93-ab68-4c70-88cf-7ef9ae875cba" xlink:href="rdnt-20221231.xsd#rdnt_ChelseaDignosticRadiologyPCMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e8e21f15-11f4-4ecf-835c-0ec46007dc6a" xlink:to="loc_rdnt_ChelseaDignosticRadiologyPCMember_b975cf93-ab68-4c70-88cf-7ef9ae875cba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NorthJerseyImagingCenterLLCMember_4df9de28-ac59-4c1a-a4e9-106cf750e883" xlink:href="rdnt-20221231.xsd#rdnt_NorthJerseyImagingCenterLLCMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e8e21f15-11f4-4ecf-835c-0ec46007dc6a" xlink:to="loc_rdnt_NorthJerseyImagingCenterLLCMember_4df9de28-ac59-4c1a-a4e9-106cf750e883" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_IFRCLLCMember_97058172-5d39-433a-a33a-8639bd17298b" xlink:href="rdnt-20221231.xsd#rdnt_IFRCLLCMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e8e21f15-11f4-4ecf-835c-0ec46007dc6a" xlink:to="loc_rdnt_IFRCLLCMember_97058172-5d39-433a-a33a-8639bd17298b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PersonalHealthImagingMember_c8ebbd2e-61c3-466c-9ac3-27e9cf5968b5" xlink:href="rdnt-20221231.xsd#rdnt_PersonalHealthImagingMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e8e21f15-11f4-4ecf-835c-0ec46007dc6a" xlink:to="loc_rdnt_PersonalHealthImagingMember_c8ebbd2e-61c3-466c-9ac3-27e9cf5968b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ZPElmontLLCMember_5b210eb3-e86f-49e5-ad75-239277f711f2" xlink:href="rdnt-20221231.xsd#rdnt_ZPElmontLLCMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e8e21f15-11f4-4ecf-835c-0ec46007dc6a" xlink:to="loc_rdnt_ZPElmontLLCMember_5b210eb3-e86f-49e5-ad75-239277f711f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ZPFreeportLLCMember_314f514b-afab-4001-9273-cb9ddc36c6a5" xlink:href="rdnt-20221231.xsd#rdnt_ZPFreeportLLCMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e8e21f15-11f4-4ecf-835c-0ec46007dc6a" xlink:to="loc_rdnt_ZPFreeportLLCMember_314f514b-afab-4001-9273-cb9ddc36c6a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BroadwayMedicalImagingLLCMember_5c21bbd6-3f27-444b-8752-551f12072544" xlink:href="rdnt-20221231.xsd#rdnt_BroadwayMedicalImagingLLCMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e8e21f15-11f4-4ecf-835c-0ec46007dc6a" xlink:to="loc_rdnt_BroadwayMedicalImagingLLCMember_5c21bbd6-3f27-444b-8752-551f12072544" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_A3235HempsteadLLCMember_c6d6af87-436f-4a93-a069-e279c1ebaf22" xlink:href="rdnt-20221231.xsd#rdnt_A3235HempsteadLLCMember"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e8e21f15-11f4-4ecf-835c-0ec46007dc6a" xlink:to="loc_rdnt_A3235HempsteadLLCMember_c6d6af87-436f-4a93-a069-e279c1ebaf22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SLZMRealtyLLCMember_e59c5ab4-7200-4c05-8859-6a1c9a649d04" xlink:href="rdnt-20221231.xsd#rdnt_SLZMRealtyLLCMember"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e8e21f15-11f4-4ecf-835c-0ec46007dc6a" xlink:to="loc_rdnt_SLZMRealtyLLCMember_e59c5ab4-7200-4c05-8859-6a1c9a649d04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_A2012SunriseMerrickLLCMember_87946a61-5f9f-4f24-a1a6-da18ab32bc3b" xlink:href="rdnt-20221231.xsd#rdnt_A2012SunriseMerrickLLCMember"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e8e21f15-11f4-4ecf-835c-0ec46007dc6a" xlink:to="loc_rdnt_A2012SunriseMerrickLLCMember_87946a61-5f9f-4f24-a1a6-da18ab32bc3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ZPBaysideLLCMember_1469d4c3-5461-4936-abab-ff8fdfe100ec" xlink:href="rdnt-20221231.xsd#rdnt_ZPBaysideLLCMember"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e8e21f15-11f4-4ecf-835c-0ec46007dc6a" xlink:to="loc_rdnt_ZPBaysideLLCMember_1469d4c3-5461-4936-abab-ff8fdfe100ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ZPLaureltonLLCMember_858ab16d-3971-4c57-aba2-97ca657c00ab" xlink:href="rdnt-20221231.xsd#rdnt_ZPLaureltonLLCMember"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e8e21f15-11f4-4ecf-835c-0ec46007dc6a" xlink:to="loc_rdnt_ZPLaureltonLLCMember_858ab16d-3971-4c57-aba2-97ca657c00ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ZPSmithLLCMember_a5ff78be-1d20-4f46-9ba7-68af93420ab4" xlink:href="rdnt-20221231.xsd#rdnt_ZPSmithLLCMember"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e8e21f15-11f4-4ecf-835c-0ec46007dc6a" xlink:to="loc_rdnt_ZPSmithLLCMember_a5ff78be-1d20-4f46-9ba7-68af93420ab4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ZP907NorthernLLCMember_73e3a90a-d687-4094-8aaa-576ec000d56c" xlink:href="rdnt-20221231.xsd#rdnt_ZP907NorthernLLCMember"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e8e21f15-11f4-4ecf-835c-0ec46007dc6a" xlink:to="loc_rdnt_ZP907NorthernLLCMember_73e3a90a-d687-4094-8aaa-576ec000d56c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WilliamMKellyMDIncMember_a582071c-ecc4-42e2-805c-70a614f2e46c" xlink:href="rdnt-20221231.xsd#rdnt_WilliamMKellyMDIncMember"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e8e21f15-11f4-4ecf-835c-0ec46007dc6a" xlink:to="loc_rdnt_WilliamMKellyMDIncMember_a582071c-ecc4-42e2-805c-70a614f2e46c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_A60thStreetMRILLCMember_82826dcd-eea5-4fdf-923a-34e39c1d0fb3" xlink:href="rdnt-20221231.xsd#rdnt_A60thStreetMRILLCMember"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e8e21f15-11f4-4ecf-835c-0ec46007dc6a" xlink:to="loc_rdnt_A60thStreetMRILLCMember_82826dcd-eea5-4fdf-923a-34e39c1d0fb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ZPParkchesterLLCMember_eabdbd7f-b41c-461e-a2cc-12773d8a9401" xlink:href="rdnt-20221231.xsd#rdnt_ZPParkchesterLLCMember"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e8e21f15-11f4-4ecf-835c-0ec46007dc6a" xlink:to="loc_rdnt_ZPParkchesterLLCMember_eabdbd7f-b41c-461e-a2cc-12773d8a9401" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ZPEasternLLCMember_053de7a7-4cf6-41c3-99cc-8a73a4959ff9" xlink:href="rdnt-20221231.xsd#rdnt_ZPEasternLLCMember"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e8e21f15-11f4-4ecf-835c-0ec46007dc6a" xlink:to="loc_rdnt_ZPEasternLLCMember_053de7a7-4cf6-41c3-99cc-8a73a4959ff9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TangentAssociatesLLCMember_1f0cf911-c3a2-476c-94fc-222182b25ee1" xlink:href="rdnt-20221231.xsd#rdnt_TangentAssociatesLLCMember"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e8e21f15-11f4-4ecf-835c-0ec46007dc6a" xlink:to="loc_rdnt_TangentAssociatesLLCMember_1f0cf911-c3a2-476c-94fc-222182b25ee1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MidDelawareImagingPAMember_cdb406ba-7a2a-42a1-8a9a-dc605191e9d8" xlink:href="rdnt-20221231.xsd#rdnt_MidDelawareImagingPAMember"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e8e21f15-11f4-4ecf-835c-0ec46007dc6a" xlink:to="loc_rdnt_MidDelawareImagingPAMember_cdb406ba-7a2a-42a1-8a9a-dc605191e9d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionsMember_f0e962d1-d388-42e6-bc52-6e4778b05658" xlink:href="rdnt-20221231.xsd#rdnt_BusinessAcquisitionsMember"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e8e21f15-11f4-4ecf-835c-0ec46007dc6a" xlink:to="loc_rdnt_BusinessAcquisitionsMember_f0e962d1-d388-42e6-bc52-6e4778b05658" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_ec0f293b-f500-4b71-956f-4896751d9624" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0e956483-5cc1-4c66-8de9-4fa0aa41ef0a" xlink:to="loc_dei_LegalEntityAxis_ec0f293b-f500-4b71-956f-4896751d9624" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_abae9b98-6f0f-4de4-b4db-20474658e7af" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_ec0f293b-f500-4b71-956f-4896751d9624" xlink:to="loc_dei_EntityDomain_abae9b98-6f0f-4de4-b4db-20474658e7af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_JointVentureWithCalvertMedicalImagingCentersLLCMember_d0c5dbc4-3f40-4374-b217-b3070b7290d5" xlink:href="rdnt-20221231.xsd#rdnt_JointVentureWithCalvertMedicalImagingCentersLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_abae9b98-6f0f-4de4-b4db-20474658e7af" xlink:to="loc_rdnt_JointVentureWithCalvertMedicalImagingCentersLLCMember_d0c5dbc4-3f40-4374-b217-b3070b7290d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_8e131fe8-f2db-4859-b332-cefc93454fb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0e956483-5cc1-4c66-8de9-4fa0aa41ef0a" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_8e131fe8-f2db-4859-b332-cefc93454fb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_62dd588b-71a9-47c7-9441-4d3a06bb0237" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8e131fe8-f2db-4859-b332-cefc93454fb0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_62dd588b-71a9-47c7-9441-4d3a06bb0237" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_ac2332db-01d9-4b79-8c6e-8146c96e98f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8e131fe8-f2db-4859-b332-cefc93454fb0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_ac2332db-01d9-4b79-8c6e-8146c96e98f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset_155f013d-8d65-4d47-b4f4-b9ff19999e4c" xlink:href="rdnt-20221231.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8e131fe8-f2db-4859-b332-cefc93454fb0" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset_155f013d-8d65-4d47-b4f4-b9ff19999e4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_9233f780-e915-4de1-a107-8ce8c8033385" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8e131fe8-f2db-4859-b332-cefc93454fb0" xlink:to="loc_us-gaap_Goodwill_9233f780-e915-4de1-a107-8ce8c8033385" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther_7467a977-bb1b-4375-8af5-ff9c8e1c1de7" xlink:href="rdnt-20221231.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8e131fe8-f2db-4859-b332-cefc93454fb0" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther_7467a977-bb1b-4375-8af5-ff9c8e1c1de7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities_55a4857d-2b20-40b0-bbe1-9549eca606d6" xlink:href="rdnt-20221231.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8e131fe8-f2db-4859-b332-cefc93454fb0" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities_55a4857d-2b20-40b0-bbe1-9549eca606d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_03e9b2cb-471a-4da0-9047-396372ad5207" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8e131fe8-f2db-4859-b332-cefc93454fb0" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_03e9b2cb-471a-4da0-9047-396372ad5207" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_fe374cba-9be7-45bb-8307-4a96bd05985b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8e131fe8-f2db-4859-b332-cefc93454fb0" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_fe374cba-9be7-45bb-8307-4a96bd05985b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_5a003dd8-05f9-4576-8843-abe41407ad30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8e131fe8-f2db-4859-b332-cefc93454fb0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_5a003dd8-05f9-4576-8843-abe41407ad30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationNumberOfSubsidiariesAcquired_b5525d16-0b37-4f08-a6c0-72b276a78a40" xlink:href="rdnt-20221231.xsd#rdnt_BusinessCombinationNumberOfSubsidiariesAcquired"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8e131fe8-f2db-4859-b332-cefc93454fb0" xlink:to="loc_rdnt_BusinessCombinationNumberOfSubsidiariesAcquired_b5525d16-0b37-4f08-a6c0-72b276a78a40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20221231.xsd#BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_ff8718e1-c17c-43c4-8cbb-e78e52792e63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5b56215d-7b33-4fa5-96eb-aef09746383f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_ff8718e1-c17c-43c4-8cbb-e78e52792e63" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5b56215d-7b33-4fa5-96eb-aef09746383f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_fc3c20be-7191-4e34-9f02-09811f4f592f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5b56215d-7b33-4fa5-96eb-aef09746383f" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_fc3c20be-7191-4e34-9f02-09811f4f592f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_87d2c1c8-29a8-4c2d-858c-7d90df0582be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_fc3c20be-7191-4e34-9f02-09811f4f592f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_87d2c1c8-29a8-4c2d-858c-7d90df0582be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HeartAndLungImagingLimitedMember_79e10bde-af00-4f43-b6e6-b0391852aa2d" xlink:href="rdnt-20221231.xsd#rdnt_HeartAndLungImagingLimitedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_87d2c1c8-29a8-4c2d-858c-7d90df0582be" xlink:to="loc_rdnt_HeartAndLungImagingLimitedMember_79e10bde-af00-4f43-b6e6-b0391852aa2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AidenceMember_76fde9b5-13f6-4ac4-a609-c2d477a724cf" xlink:href="rdnt-20221231.xsd#rdnt_AidenceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_87d2c1c8-29a8-4c2d-858c-7d90df0582be" xlink:to="loc_rdnt_AidenceMember_76fde9b5-13f6-4ac4-a609-c2d477a724cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_QuantibMember_f8c09ac9-63bd-4539-a18b-9ad52116df41" xlink:href="rdnt-20221231.xsd#rdnt_QuantibMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_87d2c1c8-29a8-4c2d-858c-7d90df0582be" xlink:to="loc_rdnt_QuantibMember_f8c09ac9-63bd-4539-a18b-9ad52116df41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_3accd345-6022-40e6-aae0-0942616c97c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5b56215d-7b33-4fa5-96eb-aef09746383f" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_3accd345-6022-40e6-aae0-0942616c97c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_7932dd9a-3970-4dc2-8d7b-499c88246bde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_3accd345-6022-40e6-aae0-0942616c97c4" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_7932dd9a-3970-4dc2-8d7b-499c88246bde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ContingentMilestoneConsiderationMember_3ad218e4-e71d-44ec-b282-4f8511414d30" xlink:href="rdnt-20221231.xsd#rdnt_ContingentMilestoneConsiderationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_7932dd9a-3970-4dc2-8d7b-499c88246bde" xlink:to="loc_rdnt_ContingentMilestoneConsiderationMember_3ad218e4-e71d-44ec-b282-4f8511414d30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CashHoldbackMember_22e88d98-a587-4a05-830d-7785e8f3e076" xlink:href="rdnt-20221231.xsd#rdnt_CashHoldbackMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_7932dd9a-3970-4dc2-8d7b-499c88246bde" xlink:to="loc_rdnt_CashHoldbackMember_22e88d98-a587-4a05-830d-7785e8f3e076" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionContingentConsiderationMember_73a2356d-451c-4857-911c-e846ce1eb542" xlink:href="rdnt-20221231.xsd#rdnt_BusinessAcquisitionContingentConsiderationMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_7932dd9a-3970-4dc2-8d7b-499c88246bde" xlink:to="loc_rdnt_BusinessAcquisitionContingentConsiderationMember_73a2356d-451c-4857-911c-e846ce1eb542" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_f9d08fd6-afe2-4ada-8599-1248a6e5fa13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5b56215d-7b33-4fa5-96eb-aef09746383f" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_f9d08fd6-afe2-4ada-8599-1248a6e5fa13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_c049bc87-bc02-4d1c-8e56-f4ff4ff9e979" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_f9d08fd6-afe2-4ada-8599-1248a6e5fa13" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_c049bc87-bc02-4d1c-8e56-f4ff4ff9e979" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_fb4257f2-357e-4d89-8abf-82345697ac0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_c049bc87-bc02-4d1c-8e56-f4ff4ff9e979" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_fb4257f2-357e-4d89-8abf-82345697ac0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis_0befe101-054e-48d4-8988-55080181035a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5b56215d-7b33-4fa5-96eb-aef09746383f" xlink:to="loc_us-gaap_ValuationTechniqueAxis_0befe101-054e-48d4-8988-55080181035a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_b998563d-9102-4066-b099-7b22c69e8a01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueAxis_0befe101-054e-48d4-8988-55080181035a" xlink:to="loc_us-gaap_ValuationTechniqueDomain_b998563d-9102-4066-b099-7b22c69e8a01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeApproachValuationTechniqueMember_b6cbbdfe-dc35-4b34-acc2-28a242b837ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeApproachValuationTechniqueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueDomain_b998563d-9102-4066-b099-7b22c69e8a01" xlink:to="loc_us-gaap_IncomeApproachValuationTechniqueMember_b6cbbdfe-dc35-4b34-acc2-28a242b837ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_34bade17-dc16-47aa-8c52-a5baa10f2562" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5b56215d-7b33-4fa5-96eb-aef09746383f" xlink:to="loc_srt_CounterpartyNameAxis_34bade17-dc16-47aa-8c52-a5baa10f2562" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_18c02717-5610-45e8-8e83-a14d8287e423" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_34bade17-dc16-47aa-8c52-a5baa10f2562" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_18c02717-5610-45e8-8e83-a14d8287e423" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OtherSellersMember_dbcbe165-22e5-4e76-bfd2-699019fa7301" xlink:href="rdnt-20221231.xsd#rdnt_OtherSellersMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_18c02717-5610-45e8-8e83-a14d8287e423" xlink:to="loc_rdnt_OtherSellersMember_dbcbe165-22e5-4e76-bfd2-699019fa7301" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CertainSellerMember_194501db-7fc4-4357-b210-f286a2348d6f" xlink:href="rdnt-20221231.xsd#rdnt_CertainSellerMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_18c02717-5610-45e8-8e83-a14d8287e423" xlink:to="loc_rdnt_CertainSellerMember_194501db-7fc4-4357-b210-f286a2348d6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FrederickCountyRadiologyLLCMember_8ff74966-b352-46cc-a326-d270ad9d7ebd" xlink:href="rdnt-20221231.xsd#rdnt_FrederickCountyRadiologyLLCMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_18c02717-5610-45e8-8e83-a14d8287e423" xlink:to="loc_rdnt_FrederickCountyRadiologyLLCMember_8ff74966-b352-46cc-a326-d270ad9d7ebd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_904f3ef2-cba0-466a-9932-0d248d8015ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5b56215d-7b33-4fa5-96eb-aef09746383f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_904f3ef2-cba0-466a-9932-0d248d8015ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_508823d7-b368-436c-be76-842f4333fbe0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_904f3ef2-cba0-466a-9932-0d248d8015ea" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_508823d7-b368-436c-be76-842f4333fbe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_fa5793eb-38d3-4dc6-8929-c19cce8e1115" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_508823d7-b368-436c-be76-842f4333fbe0" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_fa5793eb-38d3-4dc6-8929-c19cce8e1115" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_80cd037b-6590-47c9-896e-95f5b3e86778" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_508823d7-b368-436c-be76-842f4333fbe0" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_80cd037b-6590-47c9-896e-95f5b3e86778" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_2a04377e-0435-4ebc-81f2-e0af546d464b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_508823d7-b368-436c-be76-842f4333fbe0" xlink:to="loc_us-gaap_CustomerRelationshipsMember_2a04377e-0435-4ebc-81f2-e0af546d464b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_ae2ddb02-dca6-4b08-8603-9ba9ccc8055b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_508823d7-b368-436c-be76-842f4333fbe0" xlink:to="loc_us-gaap_TradeNamesMember_ae2ddb02-dca6-4b08-8603-9ba9ccc8055b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_df9901dd-8d5b-4fad-b2d3-d61528dab6b3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5b56215d-7b33-4fa5-96eb-aef09746383f" xlink:to="loc_srt_RangeAxis_df9901dd-8d5b-4fad-b2d3-d61528dab6b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_311b1a74-9e75-4c97-aed0-66f04dd701b0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_df9901dd-8d5b-4fad-b2d3-d61528dab6b3" xlink:to="loc_srt_RangeMember_311b1a74-9e75-4c97-aed0-66f04dd701b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_4934b263-9636-4f6a-8d7b-1ffa2b0c3180" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_311b1a74-9e75-4c97-aed0-66f04dd701b0" xlink:to="loc_srt_MinimumMember_4934b263-9636-4f6a-8d7b-1ffa2b0c3180" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_de3f60e5-79a3-41ce-a393-ce4f4a0f75af" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_311b1a74-9e75-4c97-aed0-66f04dd701b0" xlink:to="loc_srt_MaximumMember_de3f60e5-79a3-41ce-a393-ce4f4a0f75af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_1fee5be8-1cae-4e28-af4a-3cc9d0044928" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5b56215d-7b33-4fa5-96eb-aef09746383f" xlink:to="loc_srt_OwnershipAxis_1fee5be8-1cae-4e28-af4a-3cc9d0044928" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_7cce6105-dfae-412b-94a8-cf8863b4354a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_1fee5be8-1cae-4e28-af4a-3cc9d0044928" xlink:to="loc_srt_OwnershipDomain_7cce6105-dfae-412b-94a8-cf8863b4354a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FrederickCountyRadiologyLLCMember_8e28fa49-b246-4404-af8a-a9bab3c69f5e" xlink:href="rdnt-20221231.xsd#rdnt_FrederickCountyRadiologyLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_7cce6105-dfae-412b-94a8-cf8863b4354a" xlink:to="loc_rdnt_FrederickCountyRadiologyLLCMember_8e28fa49-b246-4404-af8a-a9bab3c69f5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AdvancedRadiologyAtCapitalRegionLLCMember_583d506f-b5ba-4446-90bc-bfef4fb9e262" xlink:href="rdnt-20221231.xsd#rdnt_AdvancedRadiologyAtCapitalRegionLLCMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_7cce6105-dfae-412b-94a8-cf8863b4354a" xlink:to="loc_rdnt_AdvancedRadiologyAtCapitalRegionLLCMember_583d506f-b5ba-4446-90bc-bfef4fb9e262" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SimiValleyImagingGroupLLCMember_5bf08037-250f-4255-aedf-ec2e58e59e74" xlink:href="rdnt-20221231.xsd#rdnt_SimiValleyImagingGroupLLCMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_7cce6105-dfae-412b-94a8-cf8863b4354a" xlink:to="loc_rdnt_SimiValleyImagingGroupLLCMember_5bf08037-250f-4255-aedf-ec2e58e59e74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WestValleyImagingGroupLLCMember_087d5e7b-0ce8-4f7a-8256-0de0e81a09fc" xlink:href="rdnt-20221231.xsd#rdnt_WestValleyImagingGroupLLCMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_7cce6105-dfae-412b-94a8-cf8863b4354a" xlink:to="loc_rdnt_WestValleyImagingGroupLLCMember_087d5e7b-0ce8-4f7a-8256-0de0e81a09fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e55d4f61-b1ff-4ca7-bd2f-53b0d8069431" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5b56215d-7b33-4fa5-96eb-aef09746383f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e55d4f61-b1ff-4ca7-bd2f-53b0d8069431" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_89df6021-ee73-4174-aad1-4ee46fa67699" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e55d4f61-b1ff-4ca7-bd2f-53b0d8069431" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_89df6021-ee73-4174-aad1-4ee46fa67699" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FixedAssetsMember_43fe9648-52bb-44f9-9802-2d8dfcd5656f" xlink:href="rdnt-20221231.xsd#rdnt_FixedAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_89df6021-ee73-4174-aad1-4ee46fa67699" xlink:to="loc_rdnt_FixedAssetsMember_43fe9648-52bb-44f9-9802-2d8dfcd5656f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_01b8aa0d-02e0-4d94-85fa-a623dbb5e15f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_89df6021-ee73-4174-aad1-4ee46fa67699" xlink:to="loc_us-gaap_EquipmentMember_01b8aa0d-02e0-4d94-85fa-a623dbb5e15f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_fad4531e-8eb8-47f6-9716-1040fc687869" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5b56215d-7b33-4fa5-96eb-aef09746383f" xlink:to="loc_dei_LegalEntityAxis_fad4531e-8eb8-47f6-9716-1040fc687869" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_e22d4171-9dff-436c-9083-d3b6826ebb9f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_fad4531e-8eb8-47f6-9716-1040fc687869" xlink:to="loc_dei_EntityDomain_e22d4171-9dff-436c-9083-d3b6826ebb9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FrederickHealthHospitalIncMember_ccfd5eb7-a217-4223-86d3-127447936ff0" xlink:href="rdnt-20221231.xsd#rdnt_FrederickHealthHospitalIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_e22d4171-9dff-436c-9083-d3b6826ebb9f" xlink:to="loc_rdnt_FrederickHealthHospitalIncMember_ccfd5eb7-a217-4223-86d3-127447936ff0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DimensionHealthCorporationMember_a79e2b00-0309-497d-b28f-71956bfe994a" xlink:href="rdnt-20221231.xsd#rdnt_DimensionHealthCorporationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_e22d4171-9dff-436c-9083-d3b6826ebb9f" xlink:to="loc_rdnt_DimensionHealthCorporationMember_a79e2b00-0309-497d-b28f-71956bfe994a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SimiValleyImagingGroupLLCMember_4322c066-2cf2-4db2-8b7c-8eea28124d61" xlink:href="rdnt-20221231.xsd#rdnt_SimiValleyImagingGroupLLCMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_e22d4171-9dff-436c-9083-d3b6826ebb9f" xlink:to="loc_rdnt_SimiValleyImagingGroupLLCMember_4322c066-2cf2-4db2-8b7c-8eea28124d61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SimiAdventistMember_8616ddbd-5513-4de4-83d3-68551392b285" xlink:href="rdnt-20221231.xsd#rdnt_SimiAdventistMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_e22d4171-9dff-436c-9083-d3b6826ebb9f" xlink:to="loc_rdnt_SimiAdventistMember_8616ddbd-5513-4de4-83d3-68551392b285" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FrederickCountyRadiologyLLCMember_5f74b9ff-50f2-41bb-bbec-3aed41417ade" xlink:href="rdnt-20221231.xsd#rdnt_FrederickCountyRadiologyLLCMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_e22d4171-9dff-436c-9083-d3b6826ebb9f" xlink:to="loc_rdnt_FrederickCountyRadiologyLLCMember_5f74b9ff-50f2-41bb-bbec-3aed41417ade" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_b4f07bdb-e158-465a-a2a1-0786ce0fa754" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5b56215d-7b33-4fa5-96eb-aef09746383f" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_b4f07bdb-e158-465a-a2a1-0786ce0fa754" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_5ebe3fa2-e363-4a49-8a0b-bac7792b04a9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_b4f07bdb-e158-465a-a2a1-0786ce0fa754" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_5ebe3fa2-e363-4a49-8a0b-bac7792b04a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FrederickCountyRadiologyLLCMember_5ac16057-0623-45d3-bf0b-1bd69ccd2c2a" xlink:href="rdnt-20221231.xsd#rdnt_FrederickCountyRadiologyLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_5ebe3fa2-e363-4a49-8a0b-bac7792b04a9" xlink:to="loc_rdnt_FrederickCountyRadiologyLLCMember_5ac16057-0623-45d3-bf0b-1bd69ccd2c2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_214e9f2a-28c3-44f8-a3b5-3a54f5f6cebc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5b56215d-7b33-4fa5-96eb-aef09746383f" xlink:to="loc_srt_ConsolidatedEntitiesAxis_214e9f2a-28c3-44f8-a3b5-3a54f5f6cebc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_c0b7e782-dfb5-4b47-8343-af66a156333c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_214e9f2a-28c3-44f8-a3b5-3a54f5f6cebc" xlink:to="loc_srt_ConsolidatedEntitiesDomain_c0b7e782-dfb5-4b47-8343-af66a156333c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SubsidiariesMember_e66a0602-0b10-4f3b-8fbc-9ba64f6ebc87" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SubsidiariesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_c0b7e782-dfb5-4b47-8343-af66a156333c" xlink:to="loc_srt_SubsidiariesMember_e66a0602-0b10-4f3b-8fbc-9ba64f6ebc87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b720a95a-5a0e-4ac2-802a-15f99a515504" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5b56215d-7b33-4fa5-96eb-aef09746383f" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b720a95a-5a0e-4ac2-802a-15f99a515504" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_4536a7c3-d732-4c9e-bd52-480c05149ee7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b720a95a-5a0e-4ac2-802a-15f99a515504" xlink:to="loc_us-gaap_EquityComponentDomain_4536a7c3-d732-4c9e-bd52-480c05149ee7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_eb67875c-490b-42b7-9cfa-682f228ed678" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_4536a7c3-d732-4c9e-bd52-480c05149ee7" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_eb67875c-490b-42b7-9cfa-682f228ed678" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_d41f9c95-8ff3-4c20-9f1f-58e91fe62c9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5b56215d-7b33-4fa5-96eb-aef09746383f" xlink:to="loc_us-gaap_AssetAcquisitionAxis_d41f9c95-8ff3-4c20-9f1f-58e91fe62c9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_723dc715-b52d-478a-b3ec-fe9bf8474175" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionAxis_d41f9c95-8ff3-4c20-9f1f-58e91fe62c9d" xlink:to="loc_us-gaap_AssetAcquisitionDomain_723dc715-b52d-478a-b3ec-fe9bf8474175" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TarzanaMedicalCenterLLCMember_a9bc9c5c-a7ef-46f1-9579-2ba06885eb32" xlink:href="rdnt-20221231.xsd#rdnt_TarzanaMedicalCenterLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionDomain_723dc715-b52d-478a-b3ec-fe9bf8474175" xlink:to="loc_rdnt_TarzanaMedicalCenterLLCMember_a9bc9c5c-a7ef-46f1-9579-2ba06885eb32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5b56215d-7b33-4fa5-96eb-aef09746383f" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_8e4eb44c-3a2e-4c2e-b343-e03b8da887db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_8e4eb44c-3a2e-4c2e-b343-e03b8da887db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_9e56d99d-54f0-4aba-ab19-2cf909cb8c6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_9e56d99d-54f0-4aba-ab19-2cf909cb8c6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_f6c3d726-bafd-4e7a-9843-f06acf03a9e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_f6c3d726-bafd-4e7a-9843-f06acf03a9e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_e39990b5-a123-430e-a987-717725a93faa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_e39990b5-a123-430e-a987-717725a93faa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice_c641ba4a-00f0-4dd2-bbcc-cc3df2587762" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:to="loc_us-gaap_BusinessAcquisitionSharePrice_c641ba4a-00f0-4dd2-bbcc-cc3df2587762" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_363e0b36-5789-44e6-aa04-af7fa51b4d72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_363e0b36-5789-44e6-aa04-af7fa51b4d72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_17c6ccc5-886d-4d92-a3aa-497df9554613" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_17c6ccc5-886d-4d92-a3aa-497df9554613" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod_53280ce1-6e47-4800-96f5-1bd7b54bdeb0" xlink:href="rdnt-20221231.xsd#rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:to="loc_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod_53280ce1-6e47-4800-96f5-1bd7b54bdeb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_6203bcd5-7825-4511-b87c-7bef75f80cf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_6203bcd5-7825-4511-b87c-7bef75f80cf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_28c92088-ce53-4df7-8c0d-dc7bcde94081" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_28c92088-ce53-4df7-8c0d-dc7bcde94081" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_cede8370-f31b-4e19-a47c-ab641b93fbe5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_cede8370-f31b-4e19-a47c-ab641b93fbe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_0518a5cf-5208-4b7e-8348-34e007d8c36c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_0518a5cf-5208-4b7e-8348-34e007d8c36c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_f6ed998b-4bed-445b-8d36-1387a1cce583" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_f6ed998b-4bed-445b-8d36-1387a1cce583" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_866b2d02-ada6-4724-9a99-4c269455725a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:to="loc_us-gaap_Goodwill_866b2d02-ada6-4724-9a99-4c269455725a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_70eae7ea-b21d-4084-bf17-bfccf23dfef9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_70eae7ea-b21d-4084-bf17-bfccf23dfef9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities_4a6b486f-6dab-4b69-ab4b-0361761e1f8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities_4a6b486f-6dab-4b69-ab4b-0361761e1f8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_0f264da2-4b75-4413-af25-0213b1545467" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_0f264da2-4b75-4413-af25-0213b1545467" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_7092c04a-1ae5-4e84-b317-d7b7b7a188f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_7092c04a-1ae5-4e84-b317-d7b7b7a188f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_99e9310d-e617-4051-9e67-a1b75bd1b7fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_99e9310d-e617-4051-9e67-a1b75bd1b7fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_53824996-88c3-4331-a1f7-9b3cbce2d4ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_53824996-88c3-4331-a1f7-9b3cbce2d4ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberOfLocationOfferingMultiModalityServices_7884d9a2-452c-47b0-8d65-babc3aa1d35e" xlink:href="rdnt-20221231.xsd#rdnt_NumberOfLocationOfferingMultiModalityServices"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:to="loc_rdnt_NumberOfLocationOfferingMultiModalityServices_7884d9a2-452c-47b0-8d65-babc3aa1d35e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_516bb490-41da-4de8-bb95-95d211776e5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_516bb490-41da-4de8-bb95-95d211776e5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_bed1d77a-8077-4b3a-8016-39eadbd9148a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_bed1d77a-8077-4b3a-8016-39eadbd9148a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest_6a9e122b-873d-470e-8fd5-871fa0557add" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:to="loc_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest_6a9e122b-873d-470e-8fd5-871fa0557add" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_fd0a8947-efbe-4021-aeb2-20251f5f43a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:to="loc_us-gaap_EquityMethodInvestments_fd0a8947-efbe-4021-aeb2-20251f5f43a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest_f9cbfeb4-7dd4-455c-aa1c-72cc5c843331" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:to="loc_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest_f9cbfeb4-7dd4-455c-aa1c-72cc5c843331" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInJointVenture_a1e4705a-d79a-4831-b2a4-ecbfa218b570" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireInterestInJointVenture"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:to="loc_us-gaap_PaymentsToAcquireInterestInJointVenture_a1e4705a-d79a-4831-b2a4-ecbfa218b570" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentAggregateCost_f9c53306-7131-4b6c-873a-68141b69b139" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:to="loc_us-gaap_EquityMethodInvestmentAggregateCost_f9c53306-7131-4b6c-873a-68141b69b139" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberOfLocations_fd598ba6-a3ba-4bc6-ab89-5083c8e55376" xlink:href="rdnt-20221231.xsd#rdnt_NumberOfLocations"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:to="loc_rdnt_NumberOfLocations_fd598ba6-a3ba-4bc6-ab89-5083c8e55376" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_45671519-8e02-4beb-b170-ee5208638555" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_45671519-8e02-4beb-b170-ee5208638555" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1_6a03fa14-3e0c-4c69-8f02-5928d2d70746" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1_6a03fa14-3e0c-4c69-8f02-5928d2d70746" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NoncontrollingInterestPercentOfOwnershipSold_fe033645-8001-43c3-9f1d-cb33e9974a61" xlink:href="rdnt-20221231.xsd#rdnt_NoncontrollingInterestPercentOfOwnershipSold"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:to="loc_rdnt_NoncontrollingInterestPercentOfOwnershipSold_fe033645-8001-43c3-9f1d-cb33e9974a61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ProceedsFromSaleOfInterestInMinorityShareholders_e17e9d84-91b7-4d88-bc5a-b21e4e8d5c90" xlink:href="rdnt-20221231.xsd#rdnt_ProceedsFromSaleOfInterestInMinorityShareholders"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:to="loc_rdnt_ProceedsFromSaleOfInterestInMinorityShareholders_e17e9d84-91b7-4d88-bc5a-b21e4e8d5c90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_06504022-204a-41de-902d-ead402645ff4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_06504022-204a-41de-902d-ead402645ff4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_5ea4ea19-0f7c-43c0-ada3-49bd41b2f5e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_5ea4ea19-0f7c-43c0-ada3-49bd41b2f5e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_f63142ab-91ff-434b-b215-a53193a193f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_f63142ab-91ff-434b-b215-a53193a193f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberOfCentersContributed_bc4d6fa8-87f2-4b27-85b4-c24629c6149a" xlink:href="rdnt-20221231.xsd#rdnt_NumberOfCentersContributed"/>
    <link:presentationArc order="37" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_475e5f80-0823-4eb5-a421-8d9697e700b0" xlink:to="loc_rdnt_NumberOfCentersContributed_bc4d6fa8-87f2-4b27-85b4-c24629c6149a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SEGMENTREPORTINGDetails" xlink:type="simple" xlink:href="rdnt-20221231.xsd#SEGMENTREPORTINGDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SEGMENTREPORTINGDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_1e1b3e49-2545-47a5-998c-42f12f37cce3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_080e6d50-3568-43a0-b81c-384581b7121a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_1e1b3e49-2545-47a5-998c-42f12f37cce3" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_080e6d50-3568-43a0-b81c-384581b7121a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_4f20d584-32ee-46cf-95fb-6d5a0f758958" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_080e6d50-3568-43a0-b81c-384581b7121a" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_4f20d584-32ee-46cf-95fb-6d5a0f758958" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ace83661-d80f-4de9-8fda-589d3879e58b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_4f20d584-32ee-46cf-95fb-6d5a0f758958" xlink:to="loc_us-gaap_SegmentDomain_ace83661-d80f-4de9-8fda-589d3879e58b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ImagingCentersMember_77baa5c8-c078-45d2-97a7-b6262cb928e3" xlink:href="rdnt-20221231.xsd#rdnt_ImagingCentersMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_ace83661-d80f-4de9-8fda-589d3879e58b" xlink:to="loc_rdnt_ImagingCentersMember_77baa5c8-c078-45d2-97a7-b6262cb928e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AIMember_85624274-e504-41f9-880f-ec3b648f003e" xlink:href="rdnt-20221231.xsd#rdnt_AIMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_ace83661-d80f-4de9-8fda-589d3879e58b" xlink:to="loc_rdnt_AIMember_85624274-e504-41f9-880f-ec3b648f003e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis_66a4af50-9c4a-4c73-9a81-3ef6200aeba9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_080e6d50-3568-43a0-b81c-384581b7121a" xlink:to="loc_us-gaap_UnusualOrInfrequentItemAxis_66a4af50-9c4a-4c73-9a81-3ef6200aeba9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_a866dfa4-b1ee-49bf-bdf9-7669706d4e5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_66a4af50-9c4a-4c73-9a81-3ef6200aeba9" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_a866dfa4-b1ee-49bf-bdf9-7669706d4e5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_COVID19PandemicMember_fe9a6ba3-a445-48d9-9d0e-0f0189a07e58" xlink:href="rdnt-20221231.xsd#rdnt_COVID19PandemicMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain_a866dfa4-b1ee-49bf-bdf9-7669706d4e5d" xlink:to="loc_rdnt_COVID19PandemicMember_fe9a6ba3-a445-48d9-9d0e-0f0189a07e58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_f9fd787c-514f-4ab6-94a5-2479527e3071" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_080e6d50-3568-43a0-b81c-384581b7121a" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_f9fd787c-514f-4ab6-94a5-2479527e3071" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_1c4443d7-2ef4-484d-872f-d61ee14c8af9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f9fd787c-514f-4ab6-94a5-2479527e3071" xlink:to="loc_us-gaap_Revenues_1c4443d7-2ef4-484d-872f-d61ee14c8af9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_245f2059-0c1f-478e-89c2-34ef6dac1482" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f9fd787c-514f-4ab6-94a5-2479527e3071" xlink:to="loc_us-gaap_OperatingCostsAndExpenses_245f2059-0c1f-478e-89c2-34ef6dac1482" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_6ba18b77-7b19-4698-a7d2-49957a52c9c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f9fd787c-514f-4ab6-94a5-2479527e3071" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_6ba18b77-7b19-4698-a7d2-49957a52c9c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_6f763953-e300-4c2e-b6bb-64fc429bb795" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f9fd787c-514f-4ab6-94a5-2479527e3071" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_6f763953-e300-4c2e-b6bb-64fc429bb795" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedNetLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_c4c9aa6e-ef37-4e8a-b929-525357aa8bbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeveranceCosts1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f9fd787c-514f-4ab6-94a5-2479527e3071" xlink:to="loc_us-gaap_SeveranceCosts1_c4c9aa6e-ef37-4e8a-b929-525357aa8bbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OperatingIncomeLossExcludingReliefFunding_9bc20d17-3fe2-49f4-a660-dcdeedfbd721" xlink:href="rdnt-20221231.xsd#rdnt_OperatingIncomeLossExcludingReliefFunding"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f9fd787c-514f-4ab6-94a5-2479527e3071" xlink:to="loc_rdnt_OperatingIncomeLossExcludingReliefFunding_9bc20d17-3fe2-49f4-a660-dcdeedfbd721" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ProceedsFromProviderReliefFunding_06ef7575-37c9-4264-bee8-b0bff181443f" xlink:href="rdnt-20221231.xsd#rdnt_ProceedsFromProviderReliefFunding"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f9fd787c-514f-4ab6-94a5-2479527e3071" xlink:to="loc_rdnt_ProceedsFromProviderReliefFunding_06ef7575-37c9-4264-bee8-b0bff181443f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill" xlink:type="simple" xlink:href="rdnt-20221231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c8304f1d-0b40-4384-9ef7-7731893593b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_a5200fe4-7d05-4748-bf4b-002564348fb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c8304f1d-0b40-4384-9ef7-7731893593b5" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_a5200fe4-7d05-4748-bf4b-002564348fb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_e709e97b-0e18-4ad4-813e-8920de8eeac3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_a5200fe4-7d05-4748-bf4b-002564348fb6" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_e709e97b-0e18-4ad4-813e-8920de8eeac3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_7b644a11-c3db-4c28-bc99-1bad594ee5f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e709e97b-0e18-4ad4-813e-8920de8eeac3" xlink:to="loc_us-gaap_SegmentDomain_7b644a11-c3db-4c28-bc99-1bad594ee5f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ImagingCentersMember_52a37207-cb7f-41c6-97a4-c131bf13926d" xlink:href="rdnt-20221231.xsd#rdnt_ImagingCentersMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_7b644a11-c3db-4c28-bc99-1bad594ee5f4" xlink:to="loc_rdnt_ImagingCentersMember_52a37207-cb7f-41c6-97a4-c131bf13926d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AIMember_d6316fd9-4f9c-4f94-ac7c-498cc2cbe40a" xlink:href="rdnt-20221231.xsd#rdnt_AIMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_7b644a11-c3db-4c28-bc99-1bad594ee5f4" xlink:to="loc_rdnt_AIMember_d6316fd9-4f9c-4f94-ac7c-498cc2cbe40a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_b332d2b3-ead2-4251-900b-1ebce1c86cc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_a5200fe4-7d05-4748-bf4b-002564348fb6" xlink:to="loc_us-gaap_GoodwillLineItems_b332d2b3-ead2-4251-900b-1ebce1c86cc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_ca4a7955-2b66-4abd-9a46-e5d016a10123" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_b332d2b3-ead2-4251-900b-1ebce1c86cc3" xlink:to="loc_us-gaap_GoodwillRollForward_ca4a7955-2b66-4abd-9a46-e5d016a10123" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ff774f7b-80a5-461d-8ff5-dca71e98516d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_ca4a7955-2b66-4abd-9a46-e5d016a10123" xlink:to="loc_us-gaap_Goodwill_ff774f7b-80a5-461d-8ff5-dca71e98516d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_205736ce-92ce-47af-aba8-3d49fb0bf2f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_ca4a7955-2b66-4abd-9a46-e5d016a10123" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_205736ce-92ce-47af-aba8-3d49fb0bf2f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_af3a83da-58e5-4b14-bcd9-59a075fe8ba4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_ca4a7955-2b66-4abd-9a46-e5d016a10123" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_af3a83da-58e5-4b14-bcd9-59a075fe8ba4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_66b6b888-ce7c-499f-9c14-38be2fd9c05d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_ca4a7955-2b66-4abd-9a46-e5d016a10123" xlink:to="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_66b6b888-ce7c-499f-9c14-38be2fd9c05d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_d7a21d83-53de-4e1a-a9ee-788a3adbb2c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_ca4a7955-2b66-4abd-9a46-e5d016a10123" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_d7a21d83-53de-4e1a-a9ee-788a3adbb2c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_9a3f4d71-6f8e-4d29-8289-d9cd3405c8f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_ca4a7955-2b66-4abd-9a46-e5d016a10123" xlink:to="loc_us-gaap_Goodwill_9a3f4d71-6f8e-4d29-8289-d9cd3405c8f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20221231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSDetailsNarrative"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsNarrative" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_24f62e87-a2ed-4bc0-a63a-f927a7fb9c42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9c306b3d-22b5-4fc3-80d4-dc05f395f7cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_24f62e87-a2ed-4bc0-a63a-f927a7fb9c42" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9c306b3d-22b5-4fc3-80d4-dc05f395f7cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b1c664c3-8160-468b-a705-0d353efafaed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9c306b3d-22b5-4fc3-80d4-dc05f395f7cc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b1c664c3-8160-468b-a705-0d353efafaed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1c9dd65d-92f5-41c2-8585-106bf500294e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b1c664c3-8160-468b-a705-0d353efafaed" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1c9dd65d-92f5-41c2-8585-106bf500294e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ManagementServiceContractsMember_bbe67e30-c8bd-4d06-baeb-ae21685668d8" xlink:href="rdnt-20221231.xsd#rdnt_ManagementServiceContractsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1c9dd65d-92f5-41c2-8585-106bf500294e" xlink:to="loc_rdnt_ManagementServiceContractsMember_bbe67e30-c8bd-4d06-baeb-ae21685668d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b5f61741-1643-4841-abb0-ebc23bdc4297" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9c306b3d-22b5-4fc3-80d4-dc05f395f7cc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b5f61741-1643-4841-abb0-ebc23bdc4297" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_f8e88981-6d4a-4f31-a7d6-bbfd5cb9c2cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b5f61741-1643-4841-abb0-ebc23bdc4297" xlink:to="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_f8e88981-6d4a-4f31-a7d6-bbfd5cb9c2cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_41dd92f2-fbb7-465f-8db7-597701ff8d72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b5f61741-1643-4841-abb0-ebc23bdc4297" xlink:to="loc_us-gaap_AdjustmentForAmortization_41dd92f2-fbb7-465f-8db7-597701ff8d72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_528c94d3-7bc8-4a5f-bc78-2f9dc320c3e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b5f61741-1643-4841-abb0-ebc23bdc4297" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_528c94d3-7bc8-4a5f-bc78-2f9dc320c3e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule" xlink:type="simple" xlink:href="rdnt-20221231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d3d009e9-61b7-4cfe-a62c-b75a7b8ee566" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_b31e9cf6-b8a8-45f9-9757-4a76af293693" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d3d009e9-61b7-4cfe-a62c-b75a7b8ee566" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_b31e9cf6-b8a8-45f9-9757-4a76af293693" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c952fe0f-f0da-4c06-a1b2-244d1556fdb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_b31e9cf6-b8a8-45f9-9757-4a76af293693" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c952fe0f-f0da-4c06-a1b2-244d1556fdb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c3f4b39a-14e4-4360-a10a-de06310c4987" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c952fe0f-f0da-4c06-a1b2-244d1556fdb7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c3f4b39a-14e4-4360-a10a-de06310c4987" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ManagementServiceContractsMember_342959dc-cc66-4e56-8798-8a99f2cc72f5" xlink:href="rdnt-20221231.xsd#rdnt_ManagementServiceContractsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c3f4b39a-14e4-4360-a10a-de06310c4987" xlink:to="loc_rdnt_ManagementServiceContractsMember_342959dc-cc66-4e56-8798-8a99f2cc72f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CovenantNotToCompeteMember_4ebb8f14-8832-40fe-9d58-fa052d171bed" xlink:href="rdnt-20221231.xsd#rdnt_CovenantNotToCompeteMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c3f4b39a-14e4-4360-a10a-de06310c4987" xlink:to="loc_rdnt_CovenantNotToCompeteMember_4ebb8f14-8832-40fe-9d58-fa052d171bed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_e0922fde-3487-44d1-aff1-a35e66ca7e0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c3f4b39a-14e4-4360-a10a-de06310c4987" xlink:to="loc_us-gaap_CustomerRelationshipsMember_e0922fde-3487-44d1-aff1-a35e66ca7e0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PatentAndTrademarksMember_5280355f-6914-4967-939b-a0d7dfc38c89" xlink:href="rdnt-20221231.xsd#rdnt_PatentAndTrademarksMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c3f4b39a-14e4-4360-a10a-de06310c4987" xlink:to="loc_rdnt_PatentAndTrademarksMember_5280355f-6914-4967-939b-a0d7dfc38c89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DevelopedTechnologySoftwareMember_8a68aeab-0556-414f-8f46-ebd1d611eef4" xlink:href="rdnt-20221231.xsd#rdnt_DevelopedTechnologySoftwareMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c3f4b39a-14e4-4360-a10a-de06310c4987" xlink:to="loc_rdnt_DevelopedTechnologySoftwareMember_8a68aeab-0556-414f-8f46-ebd1d611eef4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_cb5295a0-396f-4b51-a56e-8bc7fb1c8291" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c3f4b39a-14e4-4360-a10a-de06310c4987" xlink:to="loc_us-gaap_TradeNamesMember_cb5295a0-396f-4b51-a56e-8bc7fb1c8291" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9d9d3edc-4471-4fea-866f-c2e6d6ed197e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_b31e9cf6-b8a8-45f9-9757-4a76af293693" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9d9d3edc-4471-4fea-866f-c2e6d6ed197e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_1b8a9546-132f-4c1a-93b6-4b3cfd711177" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9d9d3edc-4471-4fea-866f-c2e6d6ed197e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_1b8a9546-132f-4c1a-93b6-4b3cfd711177" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_eba9dcef-72b0-48ae-b3ae-92e7cf9bb3be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9d9d3edc-4471-4fea-866f-c2e6d6ed197e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_eba9dcef-72b0-48ae-b3ae-92e7cf9bb3be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_6aefd6d6-9a46-45da-a71f-b7ce7d807886" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9d9d3edc-4471-4fea-866f-c2e6d6ed197e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_6aefd6d6-9a46-45da-a71f-b7ce7d807886" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_e75a380e-e84f-44d6-8240-243e8f7c3935" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9d9d3edc-4471-4fea-866f-c2e6d6ed197e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_e75a380e-e84f-44d6-8240-243e8f7c3935" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_c43f7ee9-5a93-40a0-96c6-2efad2451752" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9d9d3edc-4471-4fea-866f-c2e6d6ed197e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_c43f7ee9-5a93-40a0-96c6-2efad2451752" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_e4846429-b844-475c-9dce-5f6147f0b46c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9d9d3edc-4471-4fea-866f-c2e6d6ed197e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_e4846429-b844-475c-9dce-5f6147f0b46c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_e8364da0-69f9-44f4-9694-8eed957dd6b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9d9d3edc-4471-4fea-866f-c2e6d6ed197e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_e8364da0-69f9-44f4-9694-8eed957dd6b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_639fa944-0dd8-4dde-81b4-3c7487aa4ad0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9d9d3edc-4471-4fea-866f-c2e6d6ed197e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_639fa944-0dd8-4dde-81b4-3c7487aa4ad0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_94b3069d-1921-4ef7-bce1-7a4b4a5889ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d3d009e9-61b7-4cfe-a62c-b75a7b8ee566" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_94b3069d-1921-4ef7-bce1-7a4b4a5889ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_94ee665d-97ed-4e5c-97fe-c1868308bf57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_94b3069d-1921-4ef7-bce1-7a4b4a5889ba" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_94ee665d-97ed-4e5c-97fe-c1868308bf57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_4406931b-d3ae-4031-a8c7-33bb40711b61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_94ee665d-97ed-4e5c-97fe-c1868308bf57" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_4406931b-d3ae-4031-a8c7-33bb40711b61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_21c23370-8dfa-49bc-bea6-1fcadaf89d27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_4406931b-d3ae-4031-a8c7-33bb40711b61" xlink:to="loc_us-gaap_TradeNamesMember_21c23370-8dfa-49bc-bea6-1fcadaf89d27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember_aa7533d1-3ebd-43ee-886c-7467fcc52658" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_4406931b-d3ae-4031-a8c7-33bb40711b61" xlink:to="loc_us-gaap_SoftwareDevelopmentMember_aa7533d1-3ebd-43ee-886c-7467fcc52658" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_defe2c6a-04d7-437b-89fa-e67c3920ef07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_94b3069d-1921-4ef7-bce1-7a4b4a5889ba" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_defe2c6a-04d7-437b-89fa-e67c3920ef07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_c8faae9e-1c3f-46fb-b1e9-3282c738aa73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_defe2c6a-04d7-437b-89fa-e67c3920ef07" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_c8faae9e-1c3f-46fb-b1e9-3282c738aa73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_a9b476be-425c-4ca5-b1a8-06a6eab1c165" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d3d009e9-61b7-4cfe-a62c-b75a7b8ee566" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_a9b476be-425c-4ca5-b1a8-06a6eab1c165" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetails" xlink:type="simple" xlink:href="rdnt-20221231.xsd#PROPERTYANDEQUIPMENTDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_3b67e036-60c3-4031-9cae-451b10b89c83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_70be58b3-dac4-4426-8344-eb1a1d64e7df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_3b67e036-60c3-4031-9cae-451b10b89c83" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_70be58b3-dac4-4426-8344-eb1a1d64e7df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e498919a-62a2-41e2-8211-cc4966606400" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_70be58b3-dac4-4426-8344-eb1a1d64e7df" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e498919a-62a2-41e2-8211-cc4966606400" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_da1a0a2c-65dd-4097-8a3b-06052bde2a22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e498919a-62a2-41e2-8211-cc4966606400" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_da1a0a2c-65dd-4097-8a3b-06052bde2a22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_8ef2c83b-c50b-49f8-8ee5-8d7fc5faa74d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_da1a0a2c-65dd-4097-8a3b-06052bde2a22" xlink:to="loc_us-gaap_LandMember_8ef2c83b-c50b-49f8-8ee5-8d7fc5faa74d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_135ee55c-c2e0-4c3c-b152-7b2af4ace029" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_da1a0a2c-65dd-4097-8a3b-06052bde2a22" xlink:to="loc_us-gaap_EquipmentMember_135ee55c-c2e0-4c3c-b152-7b2af4ace029" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_4e2cf689-d3f2-4476-8179-a3d8fcffbc98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_da1a0a2c-65dd-4097-8a3b-06052bde2a22" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_4e2cf689-d3f2-4476-8179-a3d8fcffbc98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_a11f161f-1437-47f9-9f65-f6912afee447" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_da1a0a2c-65dd-4097-8a3b-06052bde2a22" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_a11f161f-1437-47f9-9f65-f6912afee447" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2a83f1e5-a310-4be6-b9cc-17a6ed477181" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_70be58b3-dac4-4426-8344-eb1a1d64e7df" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2a83f1e5-a310-4be6-b9cc-17a6ed477181" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_6822aa6e-1208-426c-99cc-ca09a7deab9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2a83f1e5-a310-4be6-b9cc-17a6ed477181" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_6822aa6e-1208-426c-99cc-ca09a7deab9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_542177ab-c695-4a1c-ae3c-b67d007f2f74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2a83f1e5-a310-4be6-b9cc-17a6ed477181" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_542177ab-c695-4a1c-ae3c-b67d007f2f74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_a7bde383-3e55-4d13-bb00-26ae0421656f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2a83f1e5-a310-4be6-b9cc-17a6ed477181" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_a7bde383-3e55-4d13-bb00-26ae0421656f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_12241be5-838f-4492-bd9e-7a85b604cdcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2a83f1e5-a310-4be6-b9cc-17a6ed477181" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_12241be5-838f-4492-bd9e-7a85b604cdcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_94961d42-9427-47f0-acc0-7131b281af6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2a83f1e5-a310-4be6-b9cc-17a6ed477181" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_94961d42-9427-47f0-acc0-7131b281af6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20221231.xsd#PROPERTYANDEQUIPMENTDetailsNarrative"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetailsNarrative" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_491bb474-baf6-4027-a27c-4e4f320f9ae2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5ec764ee-7bf0-4aa2-98d8-d0564354fe8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_491bb474-baf6-4027-a27c-4e4f320f9ae2" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5ec764ee-7bf0-4aa2-98d8-d0564354fe8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_382bf6f5-39e4-45ff-ad34-2c2508a3a5f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5ec764ee-7bf0-4aa2-98d8-d0564354fe8a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_382bf6f5-39e4-45ff-ad34-2c2508a3a5f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_694e6edb-1f32-4735-ac95-c4bbefbca1b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_382bf6f5-39e4-45ff-ad34-2c2508a3a5f3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_694e6edb-1f32-4735-ac95-c4bbefbca1b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_4cac276c-4923-465f-a035-2ea35b3f84db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_694e6edb-1f32-4735-ac95-c4bbefbca1b6" xlink:to="loc_us-gaap_ConstructionInProgressMember_4cac276c-4923-465f-a035-2ea35b3f84db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MedicalEquipmentMember_f17c6af5-3bfd-41ca-9f6f-36d5051cc902" xlink:href="rdnt-20221231.xsd#rdnt_MedicalEquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_694e6edb-1f32-4735-ac95-c4bbefbca1b6" xlink:to="loc_rdnt_MedicalEquipmentMember_f17c6af5-3bfd-41ca-9f6f-36d5051cc902" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ComputerandOfficeEquipmentMember_1ad63814-a85f-4711-ae56-6344b2d5f468" xlink:href="rdnt-20221231.xsd#rdnt_ComputerandOfficeEquipmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_694e6edb-1f32-4735-ac95-c4bbefbca1b6" xlink:to="loc_rdnt_ComputerandOfficeEquipmentMember_1ad63814-a85f-4711-ae56-6344b2d5f468" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember_e2735553-786b-4045-8964-8831d68cc0b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_694e6edb-1f32-4735-ac95-c4bbefbca1b6" xlink:to="loc_us-gaap_SoftwareDevelopmentMember_e2735553-786b-4045-8964-8831d68cc0b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_f90157a6-982a-4544-993b-3e7075eb7218" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_694e6edb-1f32-4735-ac95-c4bbefbca1b6" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_f90157a6-982a-4544-993b-3e7075eb7218" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_72852579-df26-4c71-a406-7bfa1912ac80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5ec764ee-7bf0-4aa2-98d8-d0564354fe8a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_72852579-df26-4c71-a406-7bfa1912ac80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_f8e172aa-a7d3-4f1a-acc8-cfb6f9a1d286" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_72852579-df26-4c71-a406-7bfa1912ac80" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_f8e172aa-a7d3-4f1a-acc8-cfb6f9a1d286" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross_650b9ca4-e737-4ea4-abc6-65fc3495001a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_72852579-df26-4c71-a406-7bfa1912ac80" xlink:to="loc_us-gaap_ConstructionInProgressGross_650b9ca4-e737-4ea4-abc6-65fc3495001a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_d0818090-8642-4f41-b984-efcb95ec3aed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_72852579-df26-4c71-a406-7bfa1912ac80" xlink:to="loc_us-gaap_DepreciationAndAmortization_d0818090-8642-4f41-b984-efcb95ec3aed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt" xlink:type="simple" xlink:href="rdnt-20221231.xsd#CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_53aada64-4d3c-4356-8590-f87e2859042b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_b44f8efc-01c0-42ef-9919-3c0ddce7eb72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_53aada64-4d3c-4356-8590-f87e2859042b" xlink:to="loc_us-gaap_DebtInstrumentTable_b44f8efc-01c0-42ef-9919-3c0ddce7eb72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_85daf0da-4688-406b-8135-0323ee90e3d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b44f8efc-01c0-42ef-9919-3c0ddce7eb72" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_85daf0da-4688-406b-8135-0323ee90e3d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_4e648d3b-8319-4495-9775-690bd2345881" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_85daf0da-4688-406b-8135-0323ee90e3d3" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_4e648d3b-8319-4495-9775-690bd2345881" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TermLoanMember_8572844f-3830-4cbc-ade5-baa26b894b58" xlink:href="rdnt-20221231.xsd#rdnt_TermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4e648d3b-8319-4495-9775-690bd2345881" xlink:to="loc_rdnt_TermLoanMember_8572844f-3830-4cbc-ade5-baa26b894b58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_e5f93f79-eab2-432a-bb0b-ea54cca63503" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b44f8efc-01c0-42ef-9919-3c0ddce7eb72" xlink:to="loc_us-gaap_DebtInstrumentAxis_e5f93f79-eab2-432a-bb0b-ea54cca63503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_f840989a-ae0c-4360-b772-0a65dbdba066" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_e5f93f79-eab2-432a-bb0b-ea54cca63503" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_f840989a-ae0c-4360-b772-0a65dbdba066" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienTermLoanMember_5f448d1d-9df9-49d7-b449-a53851b3e057" xlink:href="rdnt-20221231.xsd#rdnt_FirstLienTermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f840989a-ae0c-4360-b772-0a65dbdba066" xlink:to="loc_rdnt_FirstLienTermLoanMember_5f448d1d-9df9-49d7-b449-a53851b3e057" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedAgreementMember_92609847-eee8-454d-98e0-7ee110e8c1d4" xlink:href="rdnt-20221231.xsd#rdnt_RestatedAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f840989a-ae0c-4360-b772-0a65dbdba066" xlink:to="loc_rdnt_RestatedAgreementMember_92609847-eee8-454d-98e0-7ee110e8c1d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_6a55ca49-4666-4da6-b4a0-21d7848981c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b44f8efc-01c0-42ef-9919-3c0ddce7eb72" xlink:to="loc_us-gaap_DebtInstrumentLineItems_6a55ca49-4666-4da6-b4a0-21d7848981c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_e371bb2f-9d61-4bab-974e-ad4c9f7368af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6a55ca49-4666-4da6-b4a0-21d7848981c0" xlink:to="loc_us-gaap_LongTermDebt_e371bb2f-9d61-4bab-974e-ad4c9f7368af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_96ba086d-9ad1-42f2-881d-75323028b187" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6a55ca49-4666-4da6-b4a0-21d7848981c0" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_96ba086d-9ad1-42f2-881d-75323028b187" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_19b852c5-04d1-49b9-bc80-b9c43218d4ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6a55ca49-4666-4da6-b4a0-21d7848981c0" xlink:to="loc_us-gaap_LongTermDebt_19b852c5-04d1-49b9-bc80-b9c43218d4ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_8fba5c44-fd84-4e3c-9f81-09dc59a0c7d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6a55ca49-4666-4da6-b4a0-21d7848981c0" xlink:to="loc_us-gaap_LongTermDebtCurrent_8fba5c44-fd84-4e3c-9f81-09dc59a0c7d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_cfe70ed1-310c-451f-bab0-b3c8391ed1ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6a55ca49-4666-4da6-b4a0-21d7848981c0" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_cfe70ed1-310c-451f-bab0-b3c8391ed1ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAnnualNotePayableMaturities" xlink:type="simple" xlink:href="rdnt-20221231.xsd#CREDITFACILITIESANDNOTESPAYABLEDetailsAnnualNotePayableMaturities"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAnnualNotePayableMaturities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_3a051e55-0653-4859-b474-292bf88fa4ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract_6e6765ef-3655-4f66-b6d3-2a85b7e439ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_3a051e55-0653-4859-b474-292bf88fa4ca" xlink:to="loc_us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract_6e6765ef-3655-4f66-b6d3-2a85b7e439ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_4581c596-cb0d-4ec7-9c47-092c8109a28b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract_6e6765ef-3655-4f66-b6d3-2a85b7e439ac" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_4581c596-cb0d-4ec7-9c47-092c8109a28b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_3ca3a4b6-f7ac-42fd-be1d-e5c5a880e38f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract_6e6765ef-3655-4f66-b6d3-2a85b7e439ac" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_3ca3a4b6-f7ac-42fd-be1d-e5c5a880e38f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_d0fa59af-e09c-425f-acfc-85eae694871e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract_6e6765ef-3655-4f66-b6d3-2a85b7e439ac" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_d0fa59af-e09c-425f-acfc-85eae694871e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_51009887-dbe6-4a72-856b-4050026d7898" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract_6e6765ef-3655-4f66-b6d3-2a85b7e439ac" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_51009887-dbe6-4a72-856b-4050026d7898" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_291068f9-9e9b-48fd-a306-d3c7c62b12b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract_6e6765ef-3655-4f66-b6d3-2a85b7e439ac" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_291068f9-9e9b-48fd-a306-d3c7c62b12b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_3224f9a3-0595-427d-beea-f9d972cdf8d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract_6e6765ef-3655-4f66-b6d3-2a85b7e439ac" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_3224f9a3-0595-427d-beea-f9d972cdf8d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_f969d775-3776-4095-88a7-bc78a8d7be5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract_6e6765ef-3655-4f66-b6d3-2a85b7e439ac" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_f969d775-3776-4095-88a7-bc78a8d7be5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAdditionalInformation" xlink:type="simple" xlink:href="rdnt-20221231.xsd#CREDITFACILITIESANDNOTESPAYABLEDetailsAdditionalInformation"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAdditionalInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_0d87929a-7aa3-49dd-a2e2-7ad396bcdf33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_f8d21f47-8b71-4845-bc8c-5ccd7ea7ee19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_0d87929a-7aa3-49dd-a2e2-7ad396bcdf33" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_f8d21f47-8b71-4845-bc8c-5ccd7ea7ee19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_876e118b-90a1-4e87-a2d9-f16cf32e8174" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_f8d21f47-8b71-4845-bc8c-5ccd7ea7ee19" xlink:to="loc_us-gaap_CreditFacilityAxis_876e118b-90a1-4e87-a2d9-f16cf32e8174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_646ebf09-a89b-427d-8f1e-f76209ad0b55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_876e118b-90a1-4e87-a2d9-f16cf32e8174" xlink:to="loc_us-gaap_CreditFacilityDomain_646ebf09-a89b-427d-8f1e-f76209ad0b55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_2881dc4a-6508-4a24-b52d-a04c15deb687" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_646ebf09-a89b-427d-8f1e-f76209ad0b55" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_2881dc4a-6508-4a24-b52d-a04c15deb687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_0de83962-926d-4a7a-98a0-9a3567022b0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_f8d21f47-8b71-4845-bc8c-5ccd7ea7ee19" xlink:to="loc_us-gaap_DebtInstrumentAxis_0de83962-926d-4a7a-98a0-9a3567022b0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_6235d199-c71d-4655-9a2c-148c98024573" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_0de83962-926d-4a7a-98a0-9a3567022b0e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_6235d199-c71d-4655-9a2c-148c98024573" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementMember_c463d490-27c6-408a-aa61-96fa8a1154cd" xlink:href="rdnt-20221231.xsd#rdnt_FirstLienCreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6235d199-c71d-4655-9a2c-148c98024573" xlink:to="loc_rdnt_FirstLienCreditAgreementMember_c463d490-27c6-408a-aa61-96fa8a1154cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementEighthAmendmentMember_1558e2ea-7219-4fd5-9c7c-10a4497a9b10" xlink:href="rdnt-20221231.xsd#rdnt_FirstLienCreditAgreementEighthAmendmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6235d199-c71d-4655-9a2c-148c98024573" xlink:to="loc_rdnt_FirstLienCreditAgreementEighthAmendmentMember_1558e2ea-7219-4fd5-9c7c-10a4497a9b10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_847238b7-d513-4e7f-a5b1-73855d26dd57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_f8d21f47-8b71-4845-bc8c-5ccd7ea7ee19" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_847238b7-d513-4e7f-a5b1-73855d26dd57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_0d144f68-46d4-41cc-93d1-9a48c0ed4b23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_847238b7-d513-4e7f-a5b1-73855d26dd57" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_0d144f68-46d4-41cc-93d1-9a48c0ed4b23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BarclaysMember_9baf66e4-c2f8-4445-a77c-d441b4aeda47" xlink:href="rdnt-20221231.xsd#rdnt_BarclaysMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_0d144f68-46d4-41cc-93d1-9a48c0ed4b23" xlink:to="loc_rdnt_BarclaysMember_9baf66e4-c2f8-4445-a77c-d441b4aeda47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SunTrustMember_0234c0bc-f320-4edd-8594-721ba7996685" xlink:href="rdnt-20221231.xsd#rdnt_SunTrustMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_0d144f68-46d4-41cc-93d1-9a48c0ed4b23" xlink:to="loc_rdnt_SunTrustMember_0234c0bc-f320-4edd-8594-721ba7996685" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_707b20ee-0bc6-4acf-8825-93e0fac28c68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_f8d21f47-8b71-4845-bc8c-5ccd7ea7ee19" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_707b20ee-0bc6-4acf-8825-93e0fac28c68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_15c0b9d8-25e7-4698-83d5-9a20213f8673" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_707b20ee-0bc6-4acf-8825-93e0fac28c68" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_15c0b9d8-25e7-4698-83d5-9a20213f8673" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_fe48a413-eb8d-4509-b69f-e5ef3dbdd019" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_15c0b9d8-25e7-4698-83d5-9a20213f8673" xlink:to="loc_us-gaap_LineOfCreditMember_fe48a413-eb8d-4509-b69f-e5ef3dbdd019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_658b3481-2c55-46ea-922d-0333239ff7e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_f8d21f47-8b71-4845-bc8c-5ccd7ea7ee19" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_658b3481-2c55-46ea-922d-0333239ff7e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_f05ba7a2-441c-44b6-abb2-cf037d03a6b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_658b3481-2c55-46ea-922d-0333239ff7e9" xlink:to="loc_us-gaap_LineOfCredit_f05ba7a2-441c-44b6-abb2-cf037d03a6b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_6c43a2bc-c800-4508-aa9a-9f542302a923" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_658b3481-2c55-46ea-922d-0333239ff7e9" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_6c43a2bc-c800-4508-aa9a-9f542302a923" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_645aa83f-b72f-46e3-8d7f-85a35c54a4ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_658b3481-2c55-46ea-922d-0333239ff7e9" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_645aa83f-b72f-46e3-8d7f-85a35c54a4ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_5045a401-ab38-4a8d-a676-83785bce3489" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_658b3481-2c55-46ea-922d-0333239ff7e9" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_5045a401-ab38-4a8d-a676-83785bce3489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSecondAmendedandRestatedFirstLienCreditandGuarantyAgreement" xlink:type="simple" xlink:href="rdnt-20221231.xsd#CREDITFACILITIESANDNOTESPAYABLEDetailsSecondAmendedandRestatedFirstLienCreditandGuarantyAgreement"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSecondAmendedandRestatedFirstLienCreditandGuarantyAgreement" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_09fd4bba-7eb8-4dc6-b91c-a4c7f41bac2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_106c97f3-5ebb-4429-90f9-eb887e588f7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_09fd4bba-7eb8-4dc6-b91c-a4c7f41bac2e" xlink:to="loc_us-gaap_DebtInstrumentTable_106c97f3-5ebb-4429-90f9-eb887e588f7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_d961f7f6-9354-49d6-a457-86aa1883a7e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_106c97f3-5ebb-4429-90f9-eb887e588f7e" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_d961f7f6-9354-49d6-a457-86aa1883a7e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_f09f9c99-ec74-479b-aa0f-b7a1174b6bc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d961f7f6-9354-49d6-a457-86aa1883a7e0" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_f09f9c99-ec74-479b-aa0f-b7a1174b6bc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediumTermNotesMember_4828248d-3c0a-420a-b313-ea690b632c9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MediumTermNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_f09f9c99-ec74-479b-aa0f-b7a1174b6bc9" xlink:to="loc_us-gaap_MediumTermNotesMember_4828248d-3c0a-420a-b313-ea690b632c9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_1261b371-a001-47cf-b087-2933de8cf47c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_f09f9c99-ec74-479b-aa0f-b7a1174b6bc9" xlink:to="loc_us-gaap_LineOfCreditMember_1261b371-a001-47cf-b087-2933de8cf47c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementSeventhAmendmentMember_a99f0f00-8d92-4f2c-bcb4-69c66e51ab01" xlink:href="rdnt-20221231.xsd#rdnt_FirstLienCreditAgreementSeventhAmendmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_f09f9c99-ec74-479b-aa0f-b7a1174b6bc9" xlink:to="loc_rdnt_FirstLienCreditAgreementSeventhAmendmentMember_a99f0f00-8d92-4f2c-bcb4-69c66e51ab01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_d5d9348a-522d-43e0-841a-393a28af6f28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_106c97f3-5ebb-4429-90f9-eb887e588f7e" xlink:to="loc_us-gaap_CreditFacilityAxis_d5d9348a-522d-43e0-841a-393a28af6f28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_67ee4bb5-d719-49c8-9afc-e93e81964ad2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_d5d9348a-522d-43e0-841a-393a28af6f28" xlink:to="loc_us-gaap_CreditFacilityDomain_67ee4bb5-d719-49c8-9afc-e93e81964ad2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_180ca5df-c1c0-4c7f-a7c0-3c9bdebcca78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_67ee4bb5-d719-49c8-9afc-e93e81964ad2" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_180ca5df-c1c0-4c7f-a7c0-3c9bdebcca78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_b804f3f7-f0b7-48d3-a12c-1e7fe192c0e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_106c97f3-5ebb-4429-90f9-eb887e588f7e" xlink:to="loc_us-gaap_DebtInstrumentAxis_b804f3f7-f0b7-48d3-a12c-1e7fe192c0e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_6aca5850-8575-453c-a55b-18baef3d896b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_b804f3f7-f0b7-48d3-a12c-1e7fe192c0e5" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_6aca5850-8575-453c-a55b-18baef3d896b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementEighthAmendmentMember_810917f4-c0ac-43ed-86a7-0ad4abb8d659" xlink:href="rdnt-20221231.xsd#rdnt_FirstLienCreditAgreementEighthAmendmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6aca5850-8575-453c-a55b-18baef3d896b" xlink:to="loc_rdnt_FirstLienCreditAgreementEighthAmendmentMember_810917f4-c0ac-43ed-86a7-0ad4abb8d659" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_52f96595-e7db-4146-ba7e-fe015baa3ac2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_106c97f3-5ebb-4429-90f9-eb887e588f7e" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_52f96595-e7db-4146-ba7e-fe015baa3ac2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_b68488dc-98fe-4651-b92b-2756d50eeef3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_52f96595-e7db-4146-ba7e-fe015baa3ac2" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_b68488dc-98fe-4651-b92b-2756d50eeef3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BarclaysMember_8d6b8b1b-e88b-4ec4-a679-8628d35923c7" xlink:href="rdnt-20221231.xsd#rdnt_BarclaysMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_b68488dc-98fe-4651-b92b-2756d50eeef3" xlink:to="loc_rdnt_BarclaysMember_8d6b8b1b-e88b-4ec4-a679-8628d35923c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TruistMember_486542e7-775a-4208-bf24-17c56cab579e" xlink:href="rdnt-20221231.xsd#rdnt_TruistMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_b68488dc-98fe-4651-b92b-2756d50eeef3" xlink:to="loc_rdnt_TruistMember_486542e7-775a-4208-bf24-17c56cab579e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_74d34670-42f8-4a7f-80c5-0ebd2a011548" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_106c97f3-5ebb-4429-90f9-eb887e588f7e" xlink:to="loc_us-gaap_DebtInstrumentLineItems_74d34670-42f8-4a7f-80c5-0ebd2a011548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_57527667-74bf-415b-a6a6-2644f4443814" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_74d34670-42f8-4a7f-80c5-0ebd2a011548" xlink:to="loc_us-gaap_LineOfCredit_57527667-74bf-415b-a6a6-2644f4443814" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_dd5672c1-cffe-4948-9e8f-50abebe56d96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_74d34670-42f8-4a7f-80c5-0ebd2a011548" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_dd5672c1-cffe-4948-9e8f-50abebe56d96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_0572a313-a492-41bd-9542-1fac3d2a028e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_74d34670-42f8-4a7f-80c5-0ebd2a011548" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_0572a313-a492-41bd-9542-1fac3d2a028e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountCurrent_aee0add8-dab4-4b5d-838e-9d451392f4ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_74d34670-42f8-4a7f-80c5-0ebd2a011548" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountCurrent_aee0add8-dab4-4b5d-838e-9d451392f4ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_8c3d571d-48ab-4ef5-895e-7cccfcf652c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_74d34670-42f8-4a7f-80c5-0ebd2a011548" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_8c3d571d-48ab-4ef5-895e-7cccfcf652c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_a90f6378-d04c-4455-ab83-6f56434afdf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_74d34670-42f8-4a7f-80c5-0ebd2a011548" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_a90f6378-d04c-4455-ab83-6f56434afdf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDeferredCharges_bbb7e933-d382-46d7-8678-88001903d88d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfDeferredCharges"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_74d34670-42f8-4a7f-80c5-0ebd2a011548" xlink:to="loc_us-gaap_AmortizationOfDeferredCharges_bbb7e933-d382-46d7-8678-88001903d88d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails" xlink:type="simple" xlink:href="rdnt-20221231.xsd#CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_38ed167a-ee51-4c9f-8bf7-1e2cc34b1db4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_383affd2-161a-4c92-99af-8afabf795d16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_38ed167a-ee51-4c9f-8bf7-1e2cc34b1db4" xlink:to="loc_us-gaap_DebtInstrumentTable_383affd2-161a-4c92-99af-8afabf795d16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_a3449b28-255f-47cc-b323-db2719ea9a4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_383affd2-161a-4c92-99af-8afabf795d16" xlink:to="loc_us-gaap_CreditFacilityAxis_a3449b28-255f-47cc-b323-db2719ea9a4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_abef07d5-62ab-4022-b012-ca7133d2126d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_a3449b28-255f-47cc-b323-db2719ea9a4b" xlink:to="loc_us-gaap_CreditFacilityDomain_abef07d5-62ab-4022-b012-ca7133d2126d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_ce5aaf54-7951-4a9d-a059-715c30e1804a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_abef07d5-62ab-4022-b012-ca7133d2126d" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_ce5aaf54-7951-4a9d-a059-715c30e1804a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioAxis_e22e4d1f-7248-47cf-a6a1-1e956cee9932" xlink:href="rdnt-20221231.xsd#rdnt_LeverageRatioAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_383affd2-161a-4c92-99af-8afabf795d16" xlink:to="loc_rdnt_LeverageRatioAxis_e22e4d1f-7248-47cf-a6a1-1e956cee9932" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain_17b85a6c-2f52-4522-a4bc-61bfac2996f9" xlink:href="rdnt-20221231.xsd#rdnt_LeverageRatioDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioAxis_e22e4d1f-7248-47cf-a6a1-1e956cee9932" xlink:to="loc_rdnt_LeverageRatioDomain_17b85a6c-2f52-4522-a4bc-61bfac2996f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIMember_d987089a-28dc-4581-8513-727cb551e535" xlink:href="rdnt-20221231.xsd#rdnt_PricingLevelIMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_17b85a6c-2f52-4522-a4bc-61bfac2996f9" xlink:to="loc_rdnt_PricingLevelIMember_d987089a-28dc-4581-8513-727cb551e535" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIIMember_5d601ff7-0ade-4948-a28a-1313f3eae45a" xlink:href="rdnt-20221231.xsd#rdnt_PricingLevelIIMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_17b85a6c-2f52-4522-a4bc-61bfac2996f9" xlink:to="loc_rdnt_PricingLevelIIMember_5d601ff7-0ade-4948-a28a-1313f3eae45a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIIIMember_f16c35b8-f366-4dbf-85a6-43892031446b" xlink:href="rdnt-20221231.xsd#rdnt_PricingLevelIIIMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_17b85a6c-2f52-4522-a4bc-61bfac2996f9" xlink:to="loc_rdnt_PricingLevelIIIMember_f16c35b8-f366-4dbf-85a6-43892031446b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIVMember_8d863306-19c9-4cd4-821f-561cc07ef0be" xlink:href="rdnt-20221231.xsd#rdnt_PricingLevelIVMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_17b85a6c-2f52-4522-a4bc-61bfac2996f9" xlink:to="loc_rdnt_PricingLevelIVMember_8d863306-19c9-4cd4-821f-561cc07ef0be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelVMember_5d7739f7-2a1e-422a-aa7a-3c0007b27168" xlink:href="rdnt-20221231.xsd#rdnt_PricingLevelVMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_17b85a6c-2f52-4522-a4bc-61bfac2996f9" xlink:to="loc_rdnt_PricingLevelVMember_5d7739f7-2a1e-422a-aa7a-3c0007b27168" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_568de8cb-549f-43d9-baca-469241ac6c93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_383affd2-161a-4c92-99af-8afabf795d16" xlink:to="loc_us-gaap_DebtInstrumentAxis_568de8cb-549f-43d9-baca-469241ac6c93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_0f623cfd-9f98-4234-8317-76f88322bc20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_568de8cb-549f-43d9-baca-469241ac6c93" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_0f623cfd-9f98-4234-8317-76f88322bc20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedAgreementMember_8965c87f-cdac-4780-96be-fa98a6bc3ca8" xlink:href="rdnt-20221231.xsd#rdnt_RestatedAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0f623cfd-9f98-4234-8317-76f88322bc20" xlink:to="loc_rdnt_RestatedAgreementMember_8965c87f-cdac-4780-96be-fa98a6bc3ca8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_bd49dfec-e25d-4f4e-99f4-294a325607b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_383affd2-161a-4c92-99af-8afabf795d16" xlink:to="loc_us-gaap_VariableRateAxis_bd49dfec-e25d-4f4e-99f4-294a325607b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_3dacd4e4-2f4f-487d-b97e-160342d69b17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_bd49dfec-e25d-4f4e-99f4-294a325607b8" xlink:to="loc_us-gaap_VariableRateDomain_3dacd4e4-2f4f-487d-b97e-160342d69b17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EurodollarMember_f631b34d-a109-4999-b9d0-529270527de3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EurodollarMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_3dacd4e4-2f4f-487d-b97e-160342d69b17" xlink:to="loc_us-gaap_EurodollarMember_f631b34d-a109-4999-b9d0-529270527de3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_b74ef954-20fe-4c3d-a7d0-c036d4974846" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BaseRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_3dacd4e4-2f4f-487d-b97e-160342d69b17" xlink:to="loc_us-gaap_BaseRateMember_b74ef954-20fe-4c3d-a7d0-c036d4974846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_fef99469-5b34-4f01-9b24-d4b37d4ffef4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_383affd2-161a-4c92-99af-8afabf795d16" xlink:to="loc_us-gaap_DebtInstrumentLineItems_fef99469-5b34-4f01-9b24-d4b37d4ffef4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum_b3934115-0e26-4773-8f49-fc470fea66a4" xlink:href="rdnt-20221231.xsd#rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fef99469-5b34-4f01-9b24-d4b37d4ffef4" xlink:to="loc_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum_b3934115-0e26-4773-8f49-fc470fea66a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentCovenantLeverageRatioMaximum_78d3edc4-aee1-4afc-bad3-e95bae0f9c84" xlink:href="rdnt-20221231.xsd#rdnt_DebtInstrumentCovenantLeverageRatioMaximum"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fef99469-5b34-4f01-9b24-d4b37d4ffef4" xlink:to="loc_rdnt_DebtInstrumentCovenantLeverageRatioMaximum_78d3edc4-aee1-4afc-bad3-e95bae0f9c84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_b1572628-6617-487d-bbdf-fddd6faae880" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fef99469-5b34-4f01-9b24-d4b37d4ffef4" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_b1572628-6617-487d-bbdf-fddd6faae880" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_37a80d01-803c-4a5d-b74d-42d4626cdee6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fef99469-5b34-4f01-9b24-d4b37d4ffef4" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_37a80d01-803c-4a5d-b74d-42d4626cdee6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_a2111d57-aa4f-42d3-aa69-6f7b2bbbff97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fef99469-5b34-4f01-9b24-d4b37d4ffef4" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_a2111d57-aa4f-42d3-aa69-6f7b2bbbff97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities" xlink:type="simple" xlink:href="rdnt-20221231.xsd#CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_e440c00a-0b80-458a-b9fb-a308cb7f2457" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_abf8db17-e1e4-4f96-8841-eea139e94f6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e440c00a-0b80-458a-b9fb-a308cb7f2457" xlink:to="loc_us-gaap_DebtInstrumentTable_abf8db17-e1e4-4f96-8841-eea139e94f6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_89a511f7-2832-4c1a-8b7e-5c4b6e1b8250" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_abf8db17-e1e4-4f96-8841-eea139e94f6f" xlink:to="loc_us-gaap_CreditFacilityAxis_89a511f7-2832-4c1a-8b7e-5c4b6e1b8250" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_8776ee72-4fa7-4b81-87cf-ad4cd180a91f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_89a511f7-2832-4c1a-8b7e-5c4b6e1b8250" xlink:to="loc_us-gaap_CreditFacilityDomain_8776ee72-4fa7-4b81-87cf-ad4cd180a91f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_d1af234e-3906-4d6c-8cac-58d2f95aa1ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_8776ee72-4fa7-4b81-87cf-ad4cd180a91f" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_d1af234e-3906-4d6c-8cac-58d2f95aa1ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_bf893cb0-f422-4d01-a99c-7a7013c9fdae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_abf8db17-e1e4-4f96-8841-eea139e94f6f" xlink:to="loc_us-gaap_DebtInstrumentAxis_bf893cb0-f422-4d01-a99c-7a7013c9fdae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_fcc44173-e752-4de0-818d-af0ed62a8d9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_bf893cb0-f422-4d01-a99c-7a7013c9fdae" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_fcc44173-e752-4de0-818d-af0ed62a8d9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementSixthAmendmentMember_c8195be1-6116-482d-96f4-dee6ee9edc7d" xlink:href="rdnt-20221231.xsd#rdnt_FirstLienCreditAgreementSixthAmendmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fcc44173-e752-4de0-818d-af0ed62a8d9e" xlink:to="loc_rdnt_FirstLienCreditAgreementSixthAmendmentMember_c8195be1-6116-482d-96f4-dee6ee9edc7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienTermLoanMember_62c9ff81-630f-43aa-9d61-21af8eee33ff" xlink:href="rdnt-20221231.xsd#rdnt_FirstLienTermLoanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fcc44173-e752-4de0-818d-af0ed62a8d9e" xlink:to="loc_rdnt_FirstLienTermLoanMember_62c9ff81-630f-43aa-9d61-21af8eee33ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_41978346-efc3-47e0-baab-6e062c9de8b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_abf8db17-e1e4-4f96-8841-eea139e94f6f" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_41978346-efc3-47e0-baab-6e062c9de8b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_673405ac-c373-42b0-b2f7-4ddbe11a0529" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_41978346-efc3-47e0-baab-6e062c9de8b6" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_673405ac-c373-42b0-b2f7-4ddbe11a0529" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_2c873a8b-3e49-4964-ac3b-1791d1dd5a77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_673405ac-c373-42b0-b2f7-4ddbe11a0529" xlink:to="loc_us-gaap_LineOfCreditMember_2c873a8b-3e49-4964-ac3b-1791d1dd5a77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TermLoanMember_bebc683c-3342-4f20-9b79-db19f86467db" xlink:href="rdnt-20221231.xsd#rdnt_TermLoanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_673405ac-c373-42b0-b2f7-4ddbe11a0529" xlink:to="loc_rdnt_TermLoanMember_bebc683c-3342-4f20-9b79-db19f86467db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediumTermNotesMember_f7f67495-c185-4270-873c-a5b0d4b075f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MediumTermNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_673405ac-c373-42b0-b2f7-4ddbe11a0529" xlink:to="loc_us-gaap_MediumTermNotesMember_f7f67495-c185-4270-873c-a5b0d4b075f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_36dbcc3d-e147-4106-8635-6d258730b191" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_abf8db17-e1e4-4f96-8841-eea139e94f6f" xlink:to="loc_us-gaap_VariableRateAxis_36dbcc3d-e147-4106-8635-6d258730b191" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_f9c15e99-1782-4b0c-85bd-ffe96eb55865" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_36dbcc3d-e147-4106-8635-6d258730b191" xlink:to="loc_us-gaap_VariableRateDomain_f9c15e99-1782-4b0c-85bd-ffe96eb55865" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EurodollarMember_07d30f17-e3bc-44f5-bdc2-aba5fe231803" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EurodollarMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_f9c15e99-1782-4b0c-85bd-ffe96eb55865" xlink:to="loc_us-gaap_EurodollarMember_07d30f17-e3bc-44f5-bdc2-aba5fe231803" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_fed93d93-edf2-4fd4-99b4-020457d6e0fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BaseRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_f9c15e99-1782-4b0c-85bd-ffe96eb55865" xlink:to="loc_us-gaap_BaseRateMember_fed93d93-edf2-4fd4-99b4-020457d6e0fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_006316a6-c2ab-4beb-b0f3-834f71c9a5ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_f9c15e99-1782-4b0c-85bd-ffe96eb55865" xlink:to="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_006316a6-c2ab-4beb-b0f3-834f71c9a5ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioAxis_732c66f5-bd10-4e52-8e25-7f84e4a3782c" xlink:href="rdnt-20221231.xsd#rdnt_LeverageRatioAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_abf8db17-e1e4-4f96-8841-eea139e94f6f" xlink:to="loc_rdnt_LeverageRatioAxis_732c66f5-bd10-4e52-8e25-7f84e4a3782c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain_1aaca713-6746-4234-85a5-533b78ccb36f" xlink:href="rdnt-20221231.xsd#rdnt_LeverageRatioDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioAxis_732c66f5-bd10-4e52-8e25-7f84e4a3782c" xlink:to="loc_rdnt_LeverageRatioDomain_1aaca713-6746-4234-85a5-533b78ccb36f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioFiveMember_fa55df96-2101-4c8a-8a1d-cf5a3a9b9781" xlink:href="rdnt-20221231.xsd#rdnt_LeverageRatioFiveMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_1aaca713-6746-4234-85a5-533b78ccb36f" xlink:to="loc_rdnt_LeverageRatioFiveMember_fa55df96-2101-4c8a-8a1d-cf5a3a9b9781" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioThreeMember_240a3f5c-ca67-4a0f-8353-bc79ba428a03" xlink:href="rdnt-20221231.xsd#rdnt_LeverageRatioThreeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_1aaca713-6746-4234-85a5-533b78ccb36f" xlink:to="loc_rdnt_LeverageRatioThreeMember_240a3f5c-ca67-4a0f-8353-bc79ba428a03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_be054afc-8655-43d3-9b5a-5559429d7ef2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_abf8db17-e1e4-4f96-8841-eea139e94f6f" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_be054afc-8655-43d3-9b5a-5559429d7ef2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_ceeea233-f90e-469c-8818-4470c46972e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_be054afc-8655-43d3-9b5a-5559429d7ef2" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_ceeea233-f90e-469c-8818-4470c46972e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BarclaysMember_729a1efa-a4a8-45e0-84b7-e3da412c36ac" xlink:href="rdnt-20221231.xsd#rdnt_BarclaysMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_ceeea233-f90e-469c-8818-4470c46972e9" xlink:to="loc_rdnt_BarclaysMember_729a1efa-a4a8-45e0-84b7-e3da412c36ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TruistMember_c8e84671-6acd-4a4f-9610-d9001be7168f" xlink:href="rdnt-20221231.xsd#rdnt_TruistMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_ceeea233-f90e-469c-8818-4470c46972e9" xlink:to="loc_rdnt_TruistMember_c8e84671-6acd-4a4f-9610-d9001be7168f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_2e21d391-d24b-407b-9041-2dd9dec9879d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_abf8db17-e1e4-4f96-8841-eea139e94f6f" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_2e21d391-d24b-407b-9041-2dd9dec9879d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_3643a252-8d89-4b60-ae25-75dbba7b52ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_2e21d391-d24b-407b-9041-2dd9dec9879d" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_3643a252-8d89-4b60-ae25-75dbba7b52ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_23e1e036-86f6-4918-8dee-d9c6a8611303" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_3643a252-8d89-4b60-ae25-75dbba7b52ff" xlink:to="loc_us-gaap_SubsequentEventMember_23e1e036-86f6-4918-8dee-d9c6a8611303" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_cbe5d86a-f733-4708-b586-d046dfa8e548" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_abf8db17-e1e4-4f96-8841-eea139e94f6f" xlink:to="loc_us-gaap_DebtInstrumentLineItems_cbe5d86a-f733-4708-b586-d046dfa8e548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_3359a296-c08d-4526-bc49-03c0cb5db642" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cbe5d86a-f733-4708-b586-d046dfa8e548" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_3359a296-c08d-4526-bc49-03c0cb5db642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentLeverageRatio_b6e06868-9de0-4bbd-8915-5726a2c32449" xlink:href="rdnt-20221231.xsd#rdnt_DebtInstrumentLeverageRatio"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cbe5d86a-f733-4708-b586-d046dfa8e548" xlink:to="loc_rdnt_DebtInstrumentLeverageRatio_b6e06868-9de0-4bbd-8915-5726a2c32449" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_20042c05-9e09-4e5a-ad9c-21c981985d80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cbe5d86a-f733-4708-b586-d046dfa8e548" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_20042c05-9e09-4e5a-ad9c-21c981985d80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_68f67abf-17bc-494d-8844-73b34971a221" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cbe5d86a-f733-4708-b586-d046dfa8e548" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_68f67abf-17bc-494d-8844-73b34971a221" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPayment_92c38359-8673-4a0a-999d-0673883881cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentPeriodicPayment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cbe5d86a-f733-4708-b586-d046dfa8e548" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPayment_92c38359-8673-4a0a-999d-0673883881cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentPeriodicPaymentPercent_2d5109cc-5b71-45ec-b413-3e08b0645962" xlink:href="rdnt-20221231.xsd#rdnt_DebtInstrumentPeriodicPaymentPercent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cbe5d86a-f733-4708-b586-d046dfa8e548" xlink:to="loc_rdnt_DebtInstrumentPeriodicPaymentPercent_2d5109cc-5b71-45ec-b413-3e08b0645962" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease_36c28e45-b9db-4eb3-9ac5-a04685c8cc12" xlink:href="rdnt-20221231.xsd#rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cbe5d86a-f733-4708-b586-d046dfa8e548" xlink:to="loc_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease_36c28e45-b9db-4eb3-9ac5-a04685c8cc12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities" xlink:type="simple" xlink:href="rdnt-20221231.xsd#CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_e6c4639b-8263-43b9-85c9-a27c8c954a40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_79577d3f-c744-4fa5-8ab9-d7868569a71b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e6c4639b-8263-43b9-85c9-a27c8c954a40" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_79577d3f-c744-4fa5-8ab9-d7868569a71b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_e7f61cd6-29dc-459a-8720-50651968f25c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_79577d3f-c744-4fa5-8ab9-d7868569a71b" xlink:to="loc_us-gaap_CreditFacilityAxis_e7f61cd6-29dc-459a-8720-50651968f25c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_0bc2652d-2d45-41b4-bbe4-d0579a81bea7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_e7f61cd6-29dc-459a-8720-50651968f25c" xlink:to="loc_us-gaap_CreditFacilityDomain_0bc2652d-2d45-41b4-bbe4-d0579a81bea7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_d1f6a958-7416-4104-a4dd-af33cdf4b078" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_0bc2652d-2d45-41b4-bbe4-d0579a81bea7" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_d1f6a958-7416-4104-a4dd-af33cdf4b078" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_489f54e0-797a-4d3a-960a-16f2f2b5ea62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_0bc2652d-2d45-41b4-bbe4-d0579a81bea7" xlink:to="loc_us-gaap_LetterOfCreditMember_489f54e0-797a-4d3a-960a-16f2f2b5ea62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_3c6828e1-b0bd-442a-8da6-b847b5e72163" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_79577d3f-c744-4fa5-8ab9-d7868569a71b" xlink:to="loc_us-gaap_DebtInstrumentAxis_3c6828e1-b0bd-442a-8da6-b847b5e72163" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9870ba39-4011-41b7-a451-9305bacacb56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_3c6828e1-b0bd-442a-8da6-b847b5e72163" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9870ba39-4011-41b7-a451-9305bacacb56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementSixthAmendmentMember_337a04e9-89a2-4ff4-bd96-01fc84661acc" xlink:href="rdnt-20221231.xsd#rdnt_FirstLienCreditAgreementSixthAmendmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9870ba39-4011-41b7-a451-9305bacacb56" xlink:to="loc_rdnt_FirstLienCreditAgreementSixthAmendmentMember_337a04e9-89a2-4ff4-bd96-01fc84661acc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_d8c47a80-fbe8-4ee9-8731-9447dcbb5a0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_79577d3f-c744-4fa5-8ab9-d7868569a71b" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_d8c47a80-fbe8-4ee9-8731-9447dcbb5a0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_62e3ad92-df96-4f2d-b35d-13d7a1d95996" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_d8c47a80-fbe8-4ee9-8731-9447dcbb5a0a" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_62e3ad92-df96-4f2d-b35d-13d7a1d95996" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BarclaysMember_801065e6-58b2-4ed9-8f0c-23e85877d2b9" xlink:href="rdnt-20221231.xsd#rdnt_BarclaysMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_62e3ad92-df96-4f2d-b35d-13d7a1d95996" xlink:to="loc_rdnt_BarclaysMember_801065e6-58b2-4ed9-8f0c-23e85877d2b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TruistMember_afdb2497-5b99-4aa6-8f6c-8d4fc0883509" xlink:href="rdnt-20221231.xsd#rdnt_TruistMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_62e3ad92-df96-4f2d-b35d-13d7a1d95996" xlink:to="loc_rdnt_TruistMember_afdb2497-5b99-4aa6-8f6c-8d4fc0883509" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_3c5e29e3-a998-4351-b0c4-b1d24056769c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_79577d3f-c744-4fa5-8ab9-d7868569a71b" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_3c5e29e3-a998-4351-b0c4-b1d24056769c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_4f90e93f-e9b9-46ae-b98f-1e48554ed94b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_3c5e29e3-a998-4351-b0c4-b1d24056769c" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_4f90e93f-e9b9-46ae-b98f-1e48554ed94b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_792d79c7-abd8-4e2c-80f2-c7b091251a5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4f90e93f-e9b9-46ae-b98f-1e48554ed94b" xlink:to="loc_us-gaap_LineOfCreditMember_792d79c7-abd8-4e2c-80f2-c7b091251a5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_d6152080-fd34-4099-8117-a19ea873b4e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4f90e93f-e9b9-46ae-b98f-1e48554ed94b" xlink:to="loc_us-gaap_LetterOfCreditMember_d6152080-fd34-4099-8117-a19ea873b4e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioAxis_9198a347-0092-4de6-bb0c-1511808ddd8e" xlink:href="rdnt-20221231.xsd#rdnt_LeverageRatioAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_79577d3f-c744-4fa5-8ab9-d7868569a71b" xlink:to="loc_rdnt_LeverageRatioAxis_9198a347-0092-4de6-bb0c-1511808ddd8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain_be235811-c3ad-4264-a83e-1b72e7fbf24b" xlink:href="rdnt-20221231.xsd#rdnt_LeverageRatioDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioAxis_9198a347-0092-4de6-bb0c-1511808ddd8e" xlink:to="loc_rdnt_LeverageRatioDomain_be235811-c3ad-4264-a83e-1b72e7fbf24b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioThreeMember_81d5f23d-80dc-4763-89a1-519317846f2e" xlink:href="rdnt-20221231.xsd#rdnt_LeverageRatioThreeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_be235811-c3ad-4264-a83e-1b72e7fbf24b" xlink:to="loc_rdnt_LeverageRatioThreeMember_81d5f23d-80dc-4763-89a1-519317846f2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_23173a66-526c-439d-a634-ea0e6f2c8f68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_79577d3f-c744-4fa5-8ab9-d7868569a71b" xlink:to="loc_us-gaap_VariableRateAxis_23173a66-526c-439d-a634-ea0e6f2c8f68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_dcc50999-1206-4033-a08d-01f6033fc770" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_23173a66-526c-439d-a634-ea0e6f2c8f68" xlink:to="loc_us-gaap_VariableRateDomain_dcc50999-1206-4033-a08d-01f6033fc770" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EurodollarMember_44bd28ec-9d9d-4d69-a5ff-93bd9624681d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EurodollarMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_dcc50999-1206-4033-a08d-01f6033fc770" xlink:to="loc_us-gaap_EurodollarMember_44bd28ec-9d9d-4d69-a5ff-93bd9624681d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_903734f1-fddb-425f-847e-a2f59657b965" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_79577d3f-c744-4fa5-8ab9-d7868569a71b" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_903734f1-fddb-425f-847e-a2f59657b965" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_04f81e1a-130e-4ca6-9791-5ba03568cb11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_903734f1-fddb-425f-847e-a2f59657b965" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_04f81e1a-130e-4ca6-9791-5ba03568cb11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_a406a0be-1e75-4b33-9d28-9dbdce591ac7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_903734f1-fddb-425f-847e-a2f59657b965" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_a406a0be-1e75-4b33-9d28-9dbdce591ac7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_f035a33e-ccc1-49b0-bf9f-e373729bc605" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_903734f1-fddb-425f-847e-a2f59657b965" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_f035a33e-ccc1-49b0-bf9f-e373729bc605" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_b8b97857-f6e2-4700-bb04-b7b008902f11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_903734f1-fddb-425f-847e-a2f59657b965" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_b8b97857-f6e2-4700-bb04-b7b008902f11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_6d827c47-12f6-463c-a83e-dda0cbfc7782" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_903734f1-fddb-425f-847e-a2f59657b965" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_6d827c47-12f6-463c-a83e-dda0cbfc7782" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_d3c296d9-2637-48c5-8de8-ef22a155e1ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_903734f1-fddb-425f-847e-a2f59657b965" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_d3c296d9-2637-48c5-8de8-ef22a155e1ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio" xlink:type="simple" xlink:href="rdnt-20221231.xsd#CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_d737c988-5503-4030-851e-5e804e36b230" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_e39589f4-410a-4d79-83e8-15f6e9b07b89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_d737c988-5503-4030-851e-5e804e36b230" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_e39589f4-410a-4d79-83e8-15f6e9b07b89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_d9dccd78-a37e-485e-98db-b6c09efdd053" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_e39589f4-410a-4d79-83e8-15f6e9b07b89" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_d9dccd78-a37e-485e-98db-b6c09efdd053" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_fa8cd5e9-5d5b-44f8-8949-cb64de1326db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d9dccd78-a37e-485e-98db-b6c09efdd053" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_fa8cd5e9-5d5b-44f8-8949-cb64de1326db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_0355c4b6-47ba-4249-aea8-b2808d71d866" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_fa8cd5e9-5d5b-44f8-8949-cb64de1326db" xlink:to="loc_us-gaap_LineOfCreditMember_0355c4b6-47ba-4249-aea8-b2808d71d866" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_b1fc68c1-a151-4112-a43a-99f1311e9ba2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_e39589f4-410a-4d79-83e8-15f6e9b07b89" xlink:to="loc_us-gaap_CreditFacilityAxis_b1fc68c1-a151-4112-a43a-99f1311e9ba2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_7df0cbe9-33bb-4acb-8c41-fa4ac31e4760" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_b1fc68c1-a151-4112-a43a-99f1311e9ba2" xlink:to="loc_us-gaap_CreditFacilityDomain_7df0cbe9-33bb-4acb-8c41-fa4ac31e4760" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_510c8fb8-57cd-4245-b455-aa41a0547e32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_7df0cbe9-33bb-4acb-8c41-fa4ac31e4760" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_510c8fb8-57cd-4245-b455-aa41a0547e32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_1be08ca4-9ac4-46c4-8205-ad7cdf8d00a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_e39589f4-410a-4d79-83e8-15f6e9b07b89" xlink:to="loc_us-gaap_VariableRateAxis_1be08ca4-9ac4-46c4-8205-ad7cdf8d00a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_411888f7-a848-4adf-9f56-b6eec7e28b05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_1be08ca4-9ac4-46c4-8205-ad7cdf8d00a8" xlink:to="loc_us-gaap_VariableRateDomain_411888f7-a848-4adf-9f56-b6eec7e28b05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EurodollarMember_fd9a09de-01bf-440d-b88d-740baea61000" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EurodollarMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_411888f7-a848-4adf-9f56-b6eec7e28b05" xlink:to="loc_us-gaap_EurodollarMember_fd9a09de-01bf-440d-b88d-740baea61000" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_e64bcad4-acb8-4b28-a7d8-e7e2d90e8d78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BaseRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_411888f7-a848-4adf-9f56-b6eec7e28b05" xlink:to="loc_us-gaap_BaseRateMember_e64bcad4-acb8-4b28-a7d8-e7e2d90e8d78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_d39ba2b4-d77d-4d84-86ff-c29f40c56c30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_e39589f4-410a-4d79-83e8-15f6e9b07b89" xlink:to="loc_us-gaap_DebtInstrumentAxis_d39ba2b4-d77d-4d84-86ff-c29f40c56c30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_379475d7-8594-44f5-bc53-51438e0d9c9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_d39ba2b4-d77d-4d84-86ff-c29f40c56c30" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_379475d7-8594-44f5-bc53-51438e0d9c9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementMember_be7de133-707c-4b29-b066-6fae9808dfc4" xlink:href="rdnt-20221231.xsd#rdnt_FirstLienCreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_379475d7-8594-44f5-bc53-51438e0d9c9c" xlink:to="loc_rdnt_FirstLienCreditAgreementMember_be7de133-707c-4b29-b066-6fae9808dfc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioAxis_eb490233-c22b-4f9f-ba79-24953c774dfb" xlink:href="rdnt-20221231.xsd#rdnt_LeverageRatioAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_e39589f4-410a-4d79-83e8-15f6e9b07b89" xlink:to="loc_rdnt_LeverageRatioAxis_eb490233-c22b-4f9f-ba79-24953c774dfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain_2f58410e-6337-449f-9dfd-c40c57cebe77" xlink:href="rdnt-20221231.xsd#rdnt_LeverageRatioDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioAxis_eb490233-c22b-4f9f-ba79-24953c774dfb" xlink:to="loc_rdnt_LeverageRatioDomain_2f58410e-6337-449f-9dfd-c40c57cebe77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioOneMember_264bfe77-1794-4c13-9074-16033ece8a26" xlink:href="rdnt-20221231.xsd#rdnt_LeverageRatioOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_2f58410e-6337-449f-9dfd-c40c57cebe77" xlink:to="loc_rdnt_LeverageRatioOneMember_264bfe77-1794-4c13-9074-16033ece8a26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioTwoMember_4fb8232f-a594-4414-8145-054cf16ad5df" xlink:href="rdnt-20221231.xsd#rdnt_LeverageRatioTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_2f58410e-6337-449f-9dfd-c40c57cebe77" xlink:to="loc_rdnt_LeverageRatioTwoMember_4fb8232f-a594-4414-8145-054cf16ad5df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioThreeMember_47680506-620d-4c64-bd01-463f002c13ce" xlink:href="rdnt-20221231.xsd#rdnt_LeverageRatioThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_2f58410e-6337-449f-9dfd-c40c57cebe77" xlink:to="loc_rdnt_LeverageRatioThreeMember_47680506-620d-4c64-bd01-463f002c13ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_f9ddbd9d-245c-4d50-b713-d67180fadbcd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_e39589f4-410a-4d79-83e8-15f6e9b07b89" xlink:to="loc_srt_RangeAxis_f9ddbd9d-245c-4d50-b713-d67180fadbcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d749905e-d6a1-4a49-b5f6-271ac8016e07" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_f9ddbd9d-245c-4d50-b713-d67180fadbcd" xlink:to="loc_srt_RangeMember_d749905e-d6a1-4a49-b5f6-271ac8016e07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e3e8ea54-8f72-415e-a890-dc164c80e38b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d749905e-d6a1-4a49-b5f6-271ac8016e07" xlink:to="loc_srt_MinimumMember_e3e8ea54-8f72-415e-a890-dc164c80e38b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_38135fed-ffaf-41f8-a7d6-993bdc4b2675" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d749905e-d6a1-4a49-b5f6-271ac8016e07" xlink:to="loc_srt_MaximumMember_38135fed-ffaf-41f8-a7d6-993bdc4b2675" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_7cf13d55-658e-42ec-a6a1-1e420cfab6fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_e39589f4-410a-4d79-83e8-15f6e9b07b89" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_7cf13d55-658e-42ec-a6a1-1e420cfab6fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentLeverageRatio_1a354f6e-a321-499f-bd1b-a61a649964f9" xlink:href="rdnt-20221231.xsd#rdnt_DebtInstrumentLeverageRatio"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_7cf13d55-658e-42ec-a6a1-1e420cfab6fd" xlink:to="loc_rdnt_DebtInstrumentLeverageRatio_1a354f6e-a321-499f-bd1b-a61a649964f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_0daaea5a-98ac-43e7-a6ed-30c8be20417e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_7cf13d55-658e-42ec-a6a1-1e420cfab6fd" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_0daaea5a-98ac-43e7-a6ed-30c8be20417e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstoPriorCreditFacilities" xlink:type="simple" xlink:href="rdnt-20221231.xsd#CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstoPriorCreditFacilities"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstoPriorCreditFacilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_83dbb2c2-6c11-40f4-adcd-3e3f7d6ab293" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_9cc6a93b-f248-4ae3-9bd1-9af8d52c9f5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_83dbb2c2-6c11-40f4-adcd-3e3f7d6ab293" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_9cc6a93b-f248-4ae3-9bd1-9af8d52c9f5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_259e5519-1ec4-46f0-84f7-db62e87f950c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_9cc6a93b-f248-4ae3-9bd1-9af8d52c9f5d" xlink:to="loc_us-gaap_CreditFacilityAxis_259e5519-1ec4-46f0-84f7-db62e87f950c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_ee36421d-c94c-476e-9d4e-4856cb3a7081" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_259e5519-1ec4-46f0-84f7-db62e87f950c" xlink:to="loc_us-gaap_CreditFacilityDomain_ee36421d-c94c-476e-9d4e-4856cb3a7081" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_ae3317c8-6375-44b2-8e43-dbf7ee140098" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_ee36421d-c94c-476e-9d4e-4856cb3a7081" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_ae3317c8-6375-44b2-8e43-dbf7ee140098" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_1f7a16aa-a148-41cb-a239-d7cfbf2d2adf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_9cc6a93b-f248-4ae3-9bd1-9af8d52c9f5d" xlink:to="loc_us-gaap_DebtInstrumentAxis_1f7a16aa-a148-41cb-a239-d7cfbf2d2adf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ce401c0e-3dd6-4682-a28a-af288b7c51fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_1f7a16aa-a148-41cb-a239-d7cfbf2d2adf" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ce401c0e-3dd6-4682-a28a-af288b7c51fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementEighthAmendmentMember_5c829edf-0277-415c-8036-173c81235923" xlink:href="rdnt-20221231.xsd#rdnt_FirstLienCreditAgreementEighthAmendmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ce401c0e-3dd6-4682-a28a-af288b7c51fd" xlink:to="loc_rdnt_FirstLienCreditAgreementEighthAmendmentMember_5c829edf-0277-415c-8036-173c81235923" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementSixthAmendmentMember_87c2e58a-3654-4a2b-8a30-2843229e8043" xlink:href="rdnt-20221231.xsd#rdnt_FirstLienCreditAgreementSixthAmendmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ce401c0e-3dd6-4682-a28a-af288b7c51fd" xlink:to="loc_rdnt_FirstLienCreditAgreementSixthAmendmentMember_87c2e58a-3654-4a2b-8a30-2843229e8043" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PaycheckProtectionProgramLoansMember_773c0b5a-8683-435a-ac04-51c8c27c0faf" xlink:href="rdnt-20221231.xsd#rdnt_PaycheckProtectionProgramLoansMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ce401c0e-3dd6-4682-a28a-af288b7c51fd" xlink:to="loc_rdnt_PaycheckProtectionProgramLoansMember_773c0b5a-8683-435a-ac04-51c8c27c0faf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_2031f77e-32da-4bf1-901f-8bae547e9064" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_9cc6a93b-f248-4ae3-9bd1-9af8d52c9f5d" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_2031f77e-32da-4bf1-901f-8bae547e9064" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_bce8e4dd-350e-4ad7-b9e7-393f621cd21f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_2031f77e-32da-4bf1-901f-8bae547e9064" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_bce8e4dd-350e-4ad7-b9e7-393f621cd21f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BarclaysMember_5820d373-c118-42d7-b80b-9e0c613d9422" xlink:href="rdnt-20221231.xsd#rdnt_BarclaysMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_bce8e4dd-350e-4ad7-b9e7-393f621cd21f" xlink:to="loc_rdnt_BarclaysMember_5820d373-c118-42d7-b80b-9e0c613d9422" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TruistMember_9e2c5768-1790-4222-b6fb-10a7688fd0fc" xlink:href="rdnt-20221231.xsd#rdnt_TruistMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_bce8e4dd-350e-4ad7-b9e7-393f621cd21f" xlink:to="loc_rdnt_TruistMember_9e2c5768-1790-4222-b6fb-10a7688fd0fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_41ec6d50-941c-4946-8598-74aa3537051a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_9cc6a93b-f248-4ae3-9bd1-9af8d52c9f5d" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_41ec6d50-941c-4946-8598-74aa3537051a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_6654e131-5e4d-4230-9839-9e008e0efa78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_41ec6d50-941c-4946-8598-74aa3537051a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_6654e131-5e4d-4230-9839-9e008e0efa78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_96fe6039-2bf5-4e3e-91a7-1bcaccdfdb23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6654e131-5e4d-4230-9839-9e008e0efa78" xlink:to="loc_us-gaap_LineOfCreditMember_96fe6039-2bf5-4e3e-91a7-1bcaccdfdb23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediumTermNotesMember_a31a0ae3-8052-441b-b83d-d1ac7508ab02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MediumTermNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6654e131-5e4d-4230-9839-9e008e0efa78" xlink:to="loc_us-gaap_MediumTermNotesMember_a31a0ae3-8052-441b-b83d-d1ac7508ab02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis_5db58bbc-1382-4ced-bf9b-993bb2cdb72d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_9cc6a93b-f248-4ae3-9bd1-9af8d52c9f5d" xlink:to="loc_us-gaap_UnusualOrInfrequentItemAxis_5db58bbc-1382-4ced-bf9b-993bb2cdb72d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_4f754595-5193-4347-bcd2-da51eeeac110" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_5db58bbc-1382-4ced-bf9b-993bb2cdb72d" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_4f754595-5193-4347-bcd2-da51eeeac110" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_COVID19PandemicMember_6f9edd70-2607-4419-83f5-dfa1c9c0fdb5" xlink:href="rdnt-20221231.xsd#rdnt_COVID19PandemicMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain_4f754595-5193-4347-bcd2-da51eeeac110" xlink:to="loc_rdnt_COVID19PandemicMember_6f9edd70-2607-4419-83f5-dfa1c9c0fdb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_01732dbd-0a11-4281-a31e-5e77ee04e716" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_9cc6a93b-f248-4ae3-9bd1-9af8d52c9f5d" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_01732dbd-0a11-4281-a31e-5e77ee04e716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity_1bac5762-eb4f-4189-a879-7f3e4818b125" xlink:href="rdnt-20221231.xsd#rdnt_LineofCreditFacilityIncreaseBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_01732dbd-0a11-4281-a31e-5e77ee04e716" xlink:to="loc_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity_1bac5762-eb4f-4189-a879-7f3e4818b125" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_113f1ac9-68ba-4883-90cb-605f8ef2efa3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_01732dbd-0a11-4281-a31e-5e77ee04e716" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_113f1ac9-68ba-4883-90cb-605f8ef2efa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentNumberOfAmendments_b1180cdb-1eda-4819-b8b9-874eae98a02b" xlink:href="rdnt-20221231.xsd#rdnt_DebtInstrumentNumberOfAmendments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_01732dbd-0a11-4281-a31e-5e77ee04e716" xlink:to="loc_rdnt_DebtInstrumentNumberOfAmendments_b1180cdb-1eda-4819-b8b9-874eae98a02b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_156463fe-0933-4571-8e83-890381e8fb87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_01732dbd-0a11-4281-a31e-5e77ee04e716" xlink:to="loc_us-gaap_LineOfCredit_156463fe-0933-4571-8e83-890381e8fb87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentExtensionPeriod_e12127c3-6f76-418c-a165-da218bf74866" xlink:href="rdnt-20221231.xsd#rdnt_DebtInstrumentExtensionPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_01732dbd-0a11-4281-a31e-5e77ee04e716" xlink:to="loc_rdnt_DebtInstrumentExtensionPeriod_e12127c3-6f76-418c-a165-da218bf74866" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_7b66940a-9111-4b98-9b9e-aff3853a4d13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_01732dbd-0a11-4281-a31e-5e77ee04e716" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_7b66940a-9111-4b98-9b9e-aff3853a4d13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_ac89453e-04bc-4851-a7c2-237493efc189" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_01732dbd-0a11-4281-a31e-5e77ee04e716" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_ac89453e-04bc-4851-a7c2-237493efc189" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_1c72078d-6cce-4e6e-bfa2-ba146daf7a56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_01732dbd-0a11-4281-a31e-5e77ee04e716" xlink:to="loc_us-gaap_DebtInstrumentTerm_1c72078d-6cce-4e6e-bfa2-ba146daf7a56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentNumberofLoansReceived_9edec359-ca07-4605-b68c-5f3171aad4c1" xlink:href="rdnt-20221231.xsd#rdnt_DebtInstrumentNumberofLoansReceived"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_01732dbd-0a11-4281-a31e-5e77ee04e716" xlink:to="loc_rdnt_DebtInstrumentNumberofLoansReceived_9edec359-ca07-4605-b68c-5f3171aad4c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/LEASESDetailsAdditionalInformation" xlink:type="simple" xlink:href="rdnt-20221231.xsd#LEASESDetailsAdditionalInformation"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/LEASESDetailsAdditionalInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_601d8b60-7d17-43d3-a589-55c5d4a2be9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_dbe6d46a-1b89-4792-b54b-bed7a91e8541" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_601d8b60-7d17-43d3-a589-55c5d4a2be9d" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_dbe6d46a-1b89-4792-b54b-bed7a91e8541" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_00620e10-dfdc-446b-a4a2-6dd196b1ed07" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_dbe6d46a-1b89-4792-b54b-bed7a91e8541" xlink:to="loc_srt_RangeAxis_00620e10-dfdc-446b-a4a2-6dd196b1ed07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_05cbe515-db81-447a-8905-4e7333478bb6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_00620e10-dfdc-446b-a4a2-6dd196b1ed07" xlink:to="loc_srt_RangeMember_05cbe515-db81-447a-8905-4e7333478bb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_74a8e102-e134-4dda-b14e-7df1213797ef" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_05cbe515-db81-447a-8905-4e7333478bb6" xlink:to="loc_srt_MinimumMember_74a8e102-e134-4dda-b14e-7df1213797ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ba090f0e-1372-409e-b315-98f7b6e8e0ed" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_05cbe515-db81-447a-8905-4e7333478bb6" xlink:to="loc_srt_MaximumMember_ba090f0e-1372-409e-b315-98f7b6e8e0ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_474b1f72-03d6-41ee-97a3-46ea3dbb8d8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_dbe6d46a-1b89-4792-b54b-bed7a91e8541" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_474b1f72-03d6-41ee-97a3-46ea3dbb8d8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_36a7e92b-f704-4bd9-85d2-54cbb0bcdb8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_474b1f72-03d6-41ee-97a3-46ea3dbb8d8c" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_36a7e92b-f704-4bd9-85d2-54cbb0bcdb8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_a448c2d1-454f-4772-b15d-d0732cc3ba7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_474b1f72-03d6-41ee-97a3-46ea3dbb8d8c" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_a448c2d1-454f-4772-b15d-d0732cc3ba7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LesseeLeaseTermofContract_452145d0-59d9-4cbf-8497-d67474e2957c" xlink:href="rdnt-20221231.xsd#rdnt_LesseeLeaseTermofContract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_474b1f72-03d6-41ee-97a3-46ea3dbb8d8c" xlink:to="loc_rdnt_LesseeLeaseTermofContract_452145d0-59d9-4cbf-8497-d67474e2957c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount_8ddf4bb2-9380-4fe6-b21a-fb68692d4b29" xlink:href="rdnt-20221231.xsd#rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_474b1f72-03d6-41ee-97a3-46ea3dbb8d8c" xlink:to="loc_rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount_8ddf4bb2-9380-4fe6-b21a-fb68692d4b29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_0eef37e3-8db3-48fa-961d-3370fb9f6ea8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_474b1f72-03d6-41ee-97a3-46ea3dbb8d8c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_0eef37e3-8db3-48fa-961d-3370fb9f6ea8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/LEASESDetailsLeaseCost" xlink:type="simple" xlink:href="rdnt-20221231.xsd#LEASESDetailsLeaseCost"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/LEASESDetailsLeaseCost" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_c799eee2-077c-426b-8f54-047efdf74007" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_0be71b28-c692-4b44-ac2f-0d08b8801921" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c799eee2-077c-426b-8f54-047efdf74007" xlink:to="loc_us-gaap_OperatingLeaseCost_0be71b28-c692-4b44-ac2f-0d08b8801921" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityAbstract_348e7236-861c-4508-b351-aeaaa552e878" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c799eee2-077c-426b-8f54-047efdf74007" xlink:to="loc_us-gaap_FinanceLeaseLiabilityAbstract_348e7236-861c-4508-b351-aeaaa552e878" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_cd9c6b2d-f110-4a36-a782-24f02cdebe38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilityAbstract_348e7236-861c-4508-b351-aeaaa552e878" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_cd9c6b2d-f110-4a36-a782-24f02cdebe38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_67ab46b2-ba9f-44cd-b170-bd4f620343d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilityAbstract_348e7236-861c-4508-b351-aeaaa552e878" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_67ab46b2-ba9f-44cd-b170-bd4f620343d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FinanceLeaseCost_5a79e43a-0a83-4317-907e-130a5f51c7c8" xlink:href="rdnt-20221231.xsd#rdnt_FinanceLeaseCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilityAbstract_348e7236-861c-4508-b351-aeaaa552e878" xlink:to="loc_rdnt_FinanceLeaseCost_5a79e43a-0a83-4317-907e-130a5f51c7c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OperatingLeaseLeaseAbandonmentCharge_c488a162-8348-41fa-9b1d-2025be1394df" xlink:href="rdnt-20221231.xsd#rdnt_OperatingLeaseLeaseAbandonmentCharge"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c799eee2-077c-426b-8f54-047efdf74007" xlink:to="loc_rdnt_OperatingLeaseLeaseAbandonmentCharge_c488a162-8348-41fa-9b1d-2025be1394df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/LEASESDetailsSupplementalCashFlows" xlink:type="simple" xlink:href="rdnt-20221231.xsd#LEASESDetailsSupplementalCashFlows"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/LEASESDetailsSupplementalCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_308a5a57-6745-40e9-9788-cc5de2441855" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CashFlowLesseeAbstract_60e7512f-6fa9-47f6-9a08-b2a3d2861ba2" xlink:href="rdnt-20221231.xsd#rdnt_CashFlowLesseeAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_308a5a57-6745-40e9-9788-cc5de2441855" xlink:to="loc_rdnt_CashFlowLesseeAbstract_60e7512f-6fa9-47f6-9a08-b2a3d2861ba2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_8d3eefd9-72f2-4321-b2f4-284e9b2d2067" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_CashFlowLesseeAbstract_60e7512f-6fa9-47f6-9a08-b2a3d2861ba2" xlink:to="loc_us-gaap_OperatingLeasePayments_8d3eefd9-72f2-4321-b2f4-284e9b2d2067" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_efe0d7d6-be77-49b8-8a8d-cc87f08ef15f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_CashFlowLesseeAbstract_60e7512f-6fa9-47f6-9a08-b2a3d2861ba2" xlink:to="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_efe0d7d6-be77-49b8-8a8d-cc87f08ef15f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_54c7b26d-0bfa-4fd4-9ec9-1440a94245d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_CashFlowLesseeAbstract_60e7512f-6fa9-47f6-9a08-b2a3d2861ba2" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_54c7b26d-0bfa-4fd4-9ec9-1440a94245d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_48174dda-3d38-4070-bee3-cf73cab79751" xlink:href="rdnt-20221231.xsd#rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_308a5a57-6745-40e9-9788-cc5de2441855" xlink:to="loc_rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_48174dda-3d38-4070-bee3-cf73cab79751" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3c520315-a91e-441a-9780-d06317e5e298" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_48174dda-3d38-4070-bee3-cf73cab79751" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3c520315-a91e-441a-9780-d06317e5e298" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OperatingLeaseRightOfUseAssetDecreaseDueToAbandonment_6c40182f-ce87-46bb-a30c-ed8005d930ae" xlink:href="rdnt-20221231.xsd#rdnt_OperatingLeaseRightOfUseAssetDecreaseDueToAbandonment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_308a5a57-6745-40e9-9788-cc5de2441855" xlink:to="loc_rdnt_OperatingLeaseRightOfUseAssetDecreaseDueToAbandonment_6c40182f-ce87-46bb-a30c-ed8005d930ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OperatingLeaseLiabilityDecreaseDueToAbandonment_791f5e24-69b4-4f1f-82bf-fcd72649b40d" xlink:href="rdnt-20221231.xsd#rdnt_OperatingLeaseLiabilityDecreaseDueToAbandonment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_308a5a57-6745-40e9-9788-cc5de2441855" xlink:to="loc_rdnt_OperatingLeaseLiabilityDecreaseDueToAbandonment_791f5e24-69b4-4f1f-82bf-fcd72649b40d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet" xlink:type="simple" xlink:href="rdnt-20221231.xsd#LEASESDetailsSupplementalBalanceSheet"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_80e4d2c9-7f0c-45a6-99b9-c04de7791fb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_9ef28f25-73ed-4b0c-bafe-b3bc9463147d" xlink:href="rdnt-20221231.xsd#rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_80e4d2c9-7f0c-45a6-99b9-c04de7791fb7" xlink:to="loc_rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_9ef28f25-73ed-4b0c-bafe-b3bc9463147d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_cd02c110-a285-40dd-a835-cc670a1f1ea6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_9ef28f25-73ed-4b0c-bafe-b3bc9463147d" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_cd02c110-a285-40dd-a835-cc670a1f1ea6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_b534e30c-3c08-4657-a20c-b0186a2bff16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_9ef28f25-73ed-4b0c-bafe-b3bc9463147d" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_b534e30c-3c08-4657-a20c-b0186a2bff16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_0749afa9-185c-4cc0-a6ee-e39e04ad6384" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_9ef28f25-73ed-4b0c-bafe-b3bc9463147d" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_0749afa9-185c-4cc0-a6ee-e39e04ad6384" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_7d430533-bcf5-43ab-ad53-95ff22729020" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_9ef28f25-73ed-4b0c-bafe-b3bc9463147d" xlink:to="loc_us-gaap_OperatingLeaseLiability_7d430533-bcf5-43ab-ad53-95ff22729020" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_76d9dee9-0cba-42ec-a943-83a6e1975b97" xlink:href="rdnt-20221231.xsd#rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_80e4d2c9-7f0c-45a6-99b9-c04de7791fb7" xlink:to="loc_rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_76d9dee9-0cba-42ec-a943-83a6e1975b97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_3404cf34-8173-4ee9-9c3f-677f80de7326" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_76d9dee9-0cba-42ec-a943-83a6e1975b97" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_3404cf34-8173-4ee9-9c3f-677f80de7326" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_9ddc7b06-e160-4003-82bd-46c66341dd7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_76d9dee9-0cba-42ec-a943-83a6e1975b97" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_9ddc7b06-e160-4003-82bd-46c66341dd7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization_519fa77d-1de9-4869-9409-a0cdcc2417bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_76d9dee9-0cba-42ec-a943-83a6e1975b97" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization_519fa77d-1de9-4869-9409-a0cdcc2417bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_4b0b98a2-cabc-4038-b27b-0f2fd4c6e31e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_76d9dee9-0cba-42ec-a943-83a6e1975b97" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_4b0b98a2-cabc-4038-b27b-0f2fd4c6e31e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WeightedAverageRemainingLeaseTermAbstract_af23da52-b4a3-4779-ba24-4a2cd2a3d445" xlink:href="rdnt-20221231.xsd#rdnt_WeightedAverageRemainingLeaseTermAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_80e4d2c9-7f0c-45a6-99b9-c04de7791fb7" xlink:to="loc_rdnt_WeightedAverageRemainingLeaseTermAbstract_af23da52-b4a3-4779-ba24-4a2cd2a3d445" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_fe3ff5f5-d2b0-4a27-8a6d-1f3d9e2717c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_WeightedAverageRemainingLeaseTermAbstract_af23da52-b4a3-4779-ba24-4a2cd2a3d445" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_fe3ff5f5-d2b0-4a27-8a6d-1f3d9e2717c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeasesWeightedAverageDiscountRateAbstract_802c1740-89bf-4a6a-aa85-af4a6d92c4c7" xlink:href="rdnt-20221231.xsd#rdnt_LeasesWeightedAverageDiscountRateAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_80e4d2c9-7f0c-45a6-99b9-c04de7791fb7" xlink:to="loc_rdnt_LeasesWeightedAverageDiscountRateAbstract_802c1740-89bf-4a6a-aa85-af4a6d92c4c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_1b6097ea-5a83-425a-8c40-8490c58a656c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeasesWeightedAverageDiscountRateAbstract_802c1740-89bf-4a6a-aa85-af4a6d92c4c7" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_1b6097ea-5a83-425a-8c40-8490c58a656c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease" xlink:type="simple" xlink:href="rdnt-20221231.xsd#LEASESDetailsMaturitiesofOperatingandFinanceLease"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_53ffbbc8-076e-4b0c-b77f-0e585f4d4b6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_74927fd5-b7e3-4050-9007-3cfbbfa29b9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_53ffbbc8-076e-4b0c-b77f-0e585f4d4b6a" xlink:to="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_74927fd5-b7e3-4050-9007-3cfbbfa29b9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_6a362247-912f-4363-af0d-a74e54fee69e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_74927fd5-b7e3-4050-9007-3cfbbfa29b9e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_6a362247-912f-4363-af0d-a74e54fee69e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_2f10010a-bd1d-47cb-b6b1-d188b33b3f8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_74927fd5-b7e3-4050-9007-3cfbbfa29b9e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_2f10010a-bd1d-47cb-b6b1-d188b33b3f8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_8a2eec85-453c-4a4a-9a96-51a70f2603d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_74927fd5-b7e3-4050-9007-3cfbbfa29b9e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_8a2eec85-453c-4a4a-9a96-51a70f2603d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_8d963f1d-eec1-48b9-818a-9ada9d73873a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_74927fd5-b7e3-4050-9007-3cfbbfa29b9e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_8d963f1d-eec1-48b9-818a-9ada9d73873a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0c866d1e-14cd-4035-b1cd-c3856566328e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_74927fd5-b7e3-4050-9007-3cfbbfa29b9e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0c866d1e-14cd-4035-b1cd-c3856566328e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_a8f99cb3-2966-4125-bd3e-0b1206f2cb99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_74927fd5-b7e3-4050-9007-3cfbbfa29b9e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_a8f99cb3-2966-4125-bd3e-0b1206f2cb99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_61854ac8-c687-4a20-ac9e-826fbb4689dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_74927fd5-b7e3-4050-9007-3cfbbfa29b9e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_61854ac8-c687-4a20-ac9e-826fbb4689dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_82ca81da-ff45-4edc-95f1-6c69d949e933" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_74927fd5-b7e3-4050-9007-3cfbbfa29b9e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_82ca81da-ff45-4edc-95f1-6c69d949e933" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_473bba1d-8d82-467c-b12d-5ab0ab4f3fc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_74927fd5-b7e3-4050-9007-3cfbbfa29b9e" xlink:to="loc_us-gaap_OperatingLeaseLiability_473bba1d-8d82-467c-b12d-5ab0ab4f3fc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease_1" xlink:type="simple" xlink:href="rdnt-20221231.xsd#LEASESDetailsMaturitiesofOperatingandFinanceLease_1"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="rdnt-20221231.xsd#IncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/IncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_f8d0b280-7a0f-4bbf-a9b3-15e57a6ef6f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/INCOMETAXESDetailsIncomeLossBeforeIncomeTaxes" xlink:type="simple" xlink:href="rdnt-20221231.xsd#INCOMETAXESDetailsIncomeLossBeforeIncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/INCOMETAXESDetailsIncomeLossBeforeIncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_f68a6bdb-499d-4958-bb09-b8b3955bed28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_539790df-9899-4463-bc64-9c50164bc53b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f68a6bdb-499d-4958-bb09-b8b3955bed28" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_539790df-9899-4463-bc64-9c50164bc53b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_8679de22-a053-4801-9061-68736c080dfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f68a6bdb-499d-4958-bb09-b8b3955bed28" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_8679de22-a053-4801-9061-68736c080dfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_b3bc24c6-1a05-420e-8388-456cf0fe52d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f68a6bdb-499d-4958-bb09-b8b3955bed28" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_b3bc24c6-1a05-420e-8388-456cf0fe52d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/INCOMETAXESDetailsIncomeTaxExpense" xlink:type="simple" xlink:href="rdnt-20221231.xsd#INCOMETAXESDetailsIncomeTaxExpense"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/INCOMETAXESDetailsIncomeTaxExpense" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_19e0e879-cc11-4fd4-a9d2-1040952eb56b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_af82ed4b-942a-464b-98cd-a973b65706d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_19e0e879-cc11-4fd4-a9d2-1040952eb56b" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_af82ed4b-942a-464b-98cd-a973b65706d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_8bbf7261-c170-41dd-89df-3e428a3d29fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_19e0e879-cc11-4fd4-a9d2-1040952eb56b" xlink:to="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_8bbf7261-c170-41dd-89df-3e428a3d29fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_7f495cbb-aa22-44ea-9be4-ddad0a123324" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_19e0e879-cc11-4fd4-a9d2-1040952eb56b" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_7f495cbb-aa22-44ea-9be4-ddad0a123324" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_54a33c02-b00c-4c6d-90c3-eaf2635227ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_19e0e879-cc11-4fd4-a9d2-1040952eb56b" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_54a33c02-b00c-4c6d-90c3-eaf2635227ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_5eb46371-c0e1-46c7-ae93-7167d54a5231" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_19e0e879-cc11-4fd4-a9d2-1040952eb56b" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_5eb46371-c0e1-46c7-ae93-7167d54a5231" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_7279b9c7-3ef8-4bbf-b231-a7a15d0d5fc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_19e0e879-cc11-4fd4-a9d2-1040952eb56b" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_7279b9c7-3ef8-4bbf-b231-a7a15d0d5fc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_25bd602c-c85b-40f4-b10d-60349616e40c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_19e0e879-cc11-4fd4-a9d2-1040952eb56b" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_25bd602c-c85b-40f4-b10d-60349616e40c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/INCOMETAXESDetailsReconciliationoftheStatutoryUSFederalRateandEffectiveRates" xlink:type="simple" xlink:href="rdnt-20221231.xsd#INCOMETAXESDetailsReconciliationoftheStatutoryUSFederalRateandEffectiveRates"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/INCOMETAXESDetailsReconciliationoftheStatutoryUSFederalRateandEffectiveRates" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_8adc1819-1d7c-4a91-9493-b0fc621ed0ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_a7d3fc25-6615-4015-9e11-1e9f469153b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8adc1819-1d7c-4a91-9493-b0fc621ed0ba" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_a7d3fc25-6615-4015-9e11-1e9f469153b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_839c907c-9d84-4702-ba9f-8f8af4484a2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8adc1819-1d7c-4a91-9493-b0fc621ed0ba" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_839c907c-9d84-4702-ba9f-8f8af4484a2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_d75e1701-ef9f-4788-9f14-890c34398e07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8adc1819-1d7c-4a91-9493-b0fc621ed0ba" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_d75e1701-ef9f-4788-9f14-890c34398e07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_fc81b9d9-82df-4ada-9e37-9344c08f4603" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8adc1819-1d7c-4a91-9493-b0fc621ed0ba" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_fc81b9d9-82df-4ada-9e37-9344c08f4603" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense_25801b6e-c886-4b4b-b44b-ea3fce3b9e3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8adc1819-1d7c-4a91-9493-b0fc621ed0ba" xlink:to="loc_us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense_25801b6e-c886-4b4b-b44b-ea3fce3b9e3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_1968e234-52a4-4b06-b438-1fcc296ea3a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8adc1819-1d7c-4a91-9493-b0fc621ed0ba" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_1968e234-52a4-4b06-b438-1fcc296ea3a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_8ea5330e-18e9-458c-a063-aed09334d3d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8adc1819-1d7c-4a91-9493-b0fc621ed0ba" xlink:to="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_8ea5330e-18e9-458c-a063-aed09334d3d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EffectiveIncomeTaxRateReconciliationPPPLoanAmount_2ded39df-5770-4ab2-a262-5e638e121890" xlink:href="rdnt-20221231.xsd#rdnt_EffectiveIncomeTaxRateReconciliationPPPLoanAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8adc1819-1d7c-4a91-9493-b0fc621ed0ba" xlink:to="loc_rdnt_EffectiveIncomeTaxRateReconciliationPPPLoanAmount_2ded39df-5770-4ab2-a262-5e638e121890" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_c2f5e002-98da-4b3a-9d8d-3f520b15b6d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8adc1819-1d7c-4a91-9493-b0fc621ed0ba" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_c2f5e002-98da-4b3a-9d8d-3f520b15b6d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_e2f75fa7-54a4-4c03-ae18-31f4597a47b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8adc1819-1d7c-4a91-9493-b0fc621ed0ba" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_e2f75fa7-54a4-4c03-ae18-31f4597a47b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxContingencies_5a92e939-0f01-4259-a43a-249e6f935602" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationTaxContingencies"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8adc1819-1d7c-4a91-9493-b0fc621ed0ba" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxContingencies_5a92e939-0f01-4259-a43a-249e6f935602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_9aaf4d3d-6732-49ac-a2fe-49079bd234be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8adc1819-1d7c-4a91-9493-b0fc621ed0ba" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_9aaf4d3d-6732-49ac-a2fe-49079bd234be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_797d6e1d-5648-48f8-a6aa-b84926fade6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8adc1819-1d7c-4a91-9493-b0fc621ed0ba" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_797d6e1d-5648-48f8-a6aa-b84926fade6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/INCOMETAXESDetailsDeferredTaxAssetsandLiabilities" xlink:type="simple" xlink:href="rdnt-20221231.xsd#INCOMETAXESDetailsDeferredTaxAssetsandLiabilities"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/INCOMETAXESDetailsDeferredTaxAssetsandLiabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_7c4db709-f5b5-4f06-9375-2749abee8d80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_914d2d12-3303-4005-a677-c5a9d6ffb5e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_7c4db709-f5b5-4f06-9375-2749abee8d80" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_914d2d12-3303-4005-a677-c5a9d6ffb5e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_8cc30b8d-3450-499a-a679-437d1f0705b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_914d2d12-3303-4005-a677-c5a9d6ffb5e5" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_8cc30b8d-3450-499a-a679-437d1f0705b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_3d74515c-f178-4af3-bd54-81c86eafcb83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_914d2d12-3303-4005-a677-c5a9d6ffb5e5" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_3d74515c-f178-4af3-bd54-81c86eafcb83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeferredTaxAssetsOperatingLeaseLiabilities_3e27a23f-01a1-4c7f-9f34-200e8f7a6488" xlink:href="rdnt-20221231.xsd#rdnt_DeferredTaxAssetsOperatingLeaseLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_914d2d12-3303-4005-a677-c5a9d6ffb5e5" xlink:to="loc_rdnt_DeferredTaxAssetsOperatingLeaseLiabilities_3e27a23f-01a1-4c7f-9f34-200e8f7a6488" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_2fda2fcd-1378-4daa-835a-d9a4729d824f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_914d2d12-3303-4005-a677-c5a9d6ffb5e5" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_2fda2fcd-1378-4daa-835a-d9a4729d824f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_0cfc2368-bd40-47c4-9edb-37321986f13b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_914d2d12-3303-4005-a677-c5a9d6ffb5e5" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_0cfc2368-bd40-47c4-9edb-37321986f13b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_5b210cf9-cd92-426d-b8f9-a03d29546b2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_914d2d12-3303-4005-a677-c5a9d6ffb5e5" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_5b210cf9-cd92-426d-b8f9-a03d29546b2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_60e9e456-9337-41bd-ad73-0d3fe149dab4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_914d2d12-3303-4005-a677-c5a9d6ffb5e5" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_60e9e456-9337-41bd-ad73-0d3fe149dab4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_a622200e-a23c-4890-bb51-fe71702f66bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_914d2d12-3303-4005-a677-c5a9d6ffb5e5" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_a622200e-a23c-4890-bb51-fe71702f66bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract_aa2aa230-e1ff-4d9f-a9ff-9937e81ed6eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_7c4db709-f5b5-4f06-9375-2749abee8d80" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesAbstract_aa2aa230-e1ff-4d9f-a9ff-9937e81ed6eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_4ad08bf6-0273-4873-a3d5-5bf0ddf5af52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_aa2aa230-e1ff-4d9f-a9ff-9937e81ed6eb" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_4ad08bf6-0273-4873-a3d5-5bf0ddf5af52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_e4672e5c-e893-41e2-be99-6018181b9a2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_aa2aa230-e1ff-4d9f-a9ff-9937e81ed6eb" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_e4672e5c-e893-41e2-be99-6018181b9a2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_fe3bfed1-6b07-4f18-9f06-354a42972c7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_aa2aa230-e1ff-4d9f-a9ff-9937e81ed6eb" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_fe3bfed1-6b07-4f18-9f06-354a42972c7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets_38efe44c-fed4-4a23-ac20-71717fba71ae" xlink:href="rdnt-20221231.xsd#rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_aa2aa230-e1ff-4d9f-a9ff-9937e81ed6eb" xlink:to="loc_rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets_38efe44c-fed4-4a23-ac20-71717fba71ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeferredTaxLiabilitiesOutsideBasisDifference_c08520d6-fb9e-4c64-95fb-64bef25d787b" xlink:href="rdnt-20221231.xsd#rdnt_DeferredTaxLiabilitiesOutsideBasisDifference"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_aa2aa230-e1ff-4d9f-a9ff-9937e81ed6eb" xlink:to="loc_rdnt_DeferredTaxLiabilitiesOutsideBasisDifference_c08520d6-fb9e-4c64-95fb-64bef25d787b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_d87993f2-1459-4f95-be2b-59a27f878333" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_aa2aa230-e1ff-4d9f-a9ff-9937e81ed6eb" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_d87993f2-1459-4f95-be2b-59a27f878333" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_32ae4874-4d83-4421-a3fd-48a95433728b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_aa2aa230-e1ff-4d9f-a9ff-9937e81ed6eb" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_32ae4874-4d83-4421-a3fd-48a95433728b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_e5b38d02-187c-439d-80db-829558ef62ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_aa2aa230-e1ff-4d9f-a9ff-9937e81ed6eb" xlink:to="loc_us-gaap_DeferredTaxLiabilities_e5b38d02-187c-439d-80db-829558ef62ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_a11b9701-8d06-4fdc-a9c2-a540897eb56e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_aa2aa230-e1ff-4d9f-a9ff-9937e81ed6eb" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_a11b9701-8d06-4fdc-a9c2-a540897eb56e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/INCOMETAXESDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20221231.xsd#INCOMETAXESDetailsNarrative"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/INCOMETAXESDetailsNarrative" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_e0517daa-17a5-446d-a99a-f961233e1c0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_2b6deb9a-c8a2-4ba5-8291-86a13cab3573" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e0517daa-17a5-446d-a99a-f961233e1c0f" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_2b6deb9a-c8a2-4ba5-8291-86a13cab3573" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_0614e9fb-9147-43a7-9e67-960aa10e20cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_2b6deb9a-c8a2-4ba5-8291-86a13cab3573" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_0614e9fb-9147-43a7-9e67-960aa10e20cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ecfc2e56-1c05-40de-b3bf-ef0bb99b00da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0614e9fb-9147-43a7-9e67-960aa10e20cb" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ecfc2e56-1c05-40de-b3bf-ef0bb99b00da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RavenHoldingsMember_78355e10-2e2a-416c-a078-be91d5f38e0b" xlink:href="rdnt-20221231.xsd#rdnt_RavenHoldingsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ecfc2e56-1c05-40de-b3bf-ef0bb99b00da" xlink:to="loc_rdnt_RavenHoldingsMember_78355e10-2e2a-416c-a078-be91d5f38e0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_faad6e79-a1dc-4cd3-80c7-d689f75e9516" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_2b6deb9a-c8a2-4ba5-8291-86a13cab3573" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_faad6e79-a1dc-4cd3-80c7-d689f75e9516" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_83bd8ea3-3270-4a54-841d-1de2ae5a0965" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_faad6e79-a1dc-4cd3-80c7-d689f75e9516" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_83bd8ea3-3270-4a54-841d-1de2ae5a0965" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_b6a1163b-8cc2-4a12-8381-a370a7f9a87d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_83bd8ea3-3270-4a54-841d-1de2ae5a0965" xlink:to="loc_us-gaap_DomesticCountryMember_b6a1163b-8cc2-4a12-8381-a370a7f9a87d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_e42d29fd-43fb-49df-8e38-ef029414fc56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_83bd8ea3-3270-4a54-841d-1de2ae5a0965" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_e42d29fd-43fb-49df-8e38-ef029414fc56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_607d0bfe-e2a0-4e85-93f6-c062a948a877" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_2b6deb9a-c8a2-4ba5-8291-86a13cab3573" xlink:to="loc_us-gaap_OperatingLossCarryforwardsLineItems_607d0bfe-e2a0-4e85-93f6-c062a948a877" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_e5c2b7c9-9bcf-43e7-9df0-7f68f89f08c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_607d0bfe-e2a0-4e85-93f6-c062a948a877" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_e5c2b7c9-9bcf-43e7-9df0-7f68f89f08c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_8c0b0aee-ffea-4596-8f3b-35e3e3711c7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_607d0bfe-e2a0-4e85-93f6-c062a948a877" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_8c0b0aee-ffea-4596-8f3b-35e3e3711c7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_781b4e6b-f399-4b7f-aceb-1e2dd87f4e70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_607d0bfe-e2a0-4e85-93f6-c062a948a877" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_781b4e6b-f399-4b7f-aceb-1e2dd87f4e70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_be320a61-d12e-47b3-9bcd-b6c2d1205398" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_607d0bfe-e2a0-4e85-93f6-c062a948a877" xlink:to="loc_us-gaap_OperatingLossCarryforwards_be320a61-d12e-47b3-9bcd-b6c2d1205398" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized_4903ecd3-0687-4f6e-907d-dcc001acd269" xlink:href="rdnt-20221231.xsd#rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_607d0bfe-e2a0-4e85-93f6-c062a948a877" xlink:to="loc_rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized_4903ecd3-0687-4f6e-907d-dcc001acd269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_00d92dc5-e4f5-40d4-9282-85e8001b2bf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_607d0bfe-e2a0-4e85-93f6-c062a948a877" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_00d92dc5-e4f5-40d4-9282-85e8001b2bf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_39b08467-5577-4ffe-8d47-5c198881cf12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_607d0bfe-e2a0-4e85-93f6-c062a948a877" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_39b08467-5577-4ffe-8d47-5c198881cf12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized_a2d4e52c-56d9-4ffb-8702-44759bd89be7" xlink:href="rdnt-20221231.xsd#rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_607d0bfe-e2a0-4e85-93f6-c062a948a877" xlink:to="loc_rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized_a2d4e52c-56d9-4ffb-8702-44759bd89be7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod_967d2f48-3e90-4791-b7c2-ea6ee19720e4" xlink:href="rdnt-20221231.xsd#rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_607d0bfe-e2a0-4e85-93f6-c062a948a877" xlink:to="loc_rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod_967d2f48-3e90-4791-b7c2-ea6ee19720e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_e45db076-58c2-43c5-920f-f72a6414ce3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_607d0bfe-e2a0-4e85-93f6-c062a948a877" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_e45db076-58c2-43c5-920f-f72a6414ce3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ForeignOperatingLossCarryforwardsSubjectToExpiration_fbcbb551-ba2f-47dd-9bf9-ab75b2588201" xlink:href="rdnt-20221231.xsd#rdnt_ForeignOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_607d0bfe-e2a0-4e85-93f6-c062a948a877" xlink:to="loc_rdnt_ForeignOperatingLossCarryforwardsSubjectToExpiration_fbcbb551-ba2f-47dd-9bf9-ab75b2588201" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ForeignOperatingLossCarryforwardsNotSubjectToExpiration_afb2b9e9-b119-4cad-9dbb-d99f66213cd5" xlink:href="rdnt-20221231.xsd#rdnt_ForeignOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_607d0bfe-e2a0-4e85-93f6-c062a948a877" xlink:to="loc_rdnt_ForeignOperatingLossCarryforwardsNotSubjectToExpiration_afb2b9e9-b119-4cad-9dbb-d99f66213cd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/INCOMETAXESDetailsUnrecognizedTaxBenefit" xlink:type="simple" xlink:href="rdnt-20221231.xsd#INCOMETAXESDetailsUnrecognizedTaxBenefit"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/INCOMETAXESDetailsUnrecognizedTaxBenefit" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_284de42f-7882-4650-83fc-3970754fa907" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_52ee2f61-9294-45aa-93a2-b56868b6e991" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_284de42f-7882-4650-83fc-3970754fa907" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_52ee2f61-9294-45aa-93a2-b56868b6e991" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_0d0c03a7-a3c6-4486-a481-915ba35aa378" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_52ee2f61-9294-45aa-93a2-b56868b6e991" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_0d0c03a7-a3c6-4486-a481-915ba35aa378" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_a62d3ca7-b64b-4824-9269-580e3ec3d464" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_52ee2f61-9294-45aa-93a2-b56868b6e991" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_a62d3ca7-b64b-4824-9269-580e3ec3d464" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_b3f94775-aac5-4753-9f57-e23132d336aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_52ee2f61-9294-45aa-93a2-b56868b6e991" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_b3f94775-aac5-4753-9f57-e23132d336aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_4fcadb2d-64c2-4e26-bd59-7cdc66563855" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_52ee2f61-9294-45aa-93a2-b56868b6e991" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_4fcadb2d-64c2-4e26-bd59-7cdc66563855" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate_ac061627-a01a-4895-baad-db4e0ea01a2c" xlink:href="rdnt-20221231.xsd#rdnt_UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_52ee2f61-9294-45aa-93a2-b56868b6e991" xlink:to="loc_rdnt_UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate_ac061627-a01a-4895-baad-db4e0ea01a2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_f0fdf35d-7d57-4df1-b116-0d40a4336fcf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_52ee2f61-9294-45aa-93a2-b56868b6e991" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_f0fdf35d-7d57-4df1-b116-0d40a4336fcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20221231.xsd#STOCKBASEDCOMPENSATIONDetailsNarrative"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d966ec5c-002e-4f8d-8e36-ef5a2649f0d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5824bb70-0239-4a35-bcf7-a71d40685858" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d966ec5c-002e-4f8d-8e36-ef5a2649f0d0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5824bb70-0239-4a35-bcf7-a71d40685858" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_f2bb33e5-9aab-41c2-bbed-ab5735289a8c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5824bb70-0239-4a35-bcf7-a71d40685858" xlink:to="loc_srt_RangeAxis_f2bb33e5-9aab-41c2-bbed-ab5735289a8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_93a2c665-8545-4e21-b770-b04934b00238" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_f2bb33e5-9aab-41c2-bbed-ab5735289a8c" xlink:to="loc_srt_RangeMember_93a2c665-8545-4e21-b770-b04934b00238" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_7014452e-7969-46d7-8bb9-4de94b02d1d5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_93a2c665-8545-4e21-b770-b04934b00238" xlink:to="loc_srt_MinimumMember_7014452e-7969-46d7-8bb9-4de94b02d1d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_3ebb70d1-8447-4e01-979a-38453570edda" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_93a2c665-8545-4e21-b770-b04934b00238" xlink:to="loc_srt_MaximumMember_3ebb70d1-8447-4e01-979a-38453570edda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_3f5a6996-4d33-48d1-a8ed-5d6526126e45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5824bb70-0239-4a35-bcf7-a71d40685858" xlink:to="loc_us-gaap_AwardTypeAxis_3f5a6996-4d33-48d1-a8ed-5d6526126e45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ef33fe65-fd5e-455d-b1c6-2c89faa3b79c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_3f5a6996-4d33-48d1-a8ed-5d6526126e45" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ef33fe65-fd5e-455d-b1c6-2c89faa3b79c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_99ba6375-bc20-417b-a341-626f9a5f0249" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ef33fe65-fd5e-455d-b1c6-2c89faa3b79c" xlink:to="loc_us-gaap_RestrictedStockMember_99ba6375-bc20-417b-a341-626f9a5f0249" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FutureServiceMember_5143d1f2-dca5-4461-937e-5869cacefd95" xlink:href="rdnt-20221231.xsd#rdnt_FutureServiceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ef33fe65-fd5e-455d-b1c6-2c89faa3b79c" xlink:to="loc_rdnt_FutureServiceMember_5143d1f2-dca5-4461-937e-5869cacefd95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_ee9f0501-e086-4aee-99cc-ed75e53b0957" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ef33fe65-fd5e-455d-b1c6-2c89faa3b79c" xlink:to="loc_us-gaap_EmployeeStockOptionMember_ee9f0501-e086-4aee-99cc-ed75e53b0957" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PerformanceBasedStockOptionsMember_7ee15a09-f224-4c10-bcf5-fa28beca7410" xlink:href="rdnt-20221231.xsd#rdnt_PerformanceBasedStockOptionsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ef33fe65-fd5e-455d-b1c6-2c89faa3b79c" xlink:to="loc_rdnt_PerformanceBasedStockOptionsMember_7ee15a09-f224-4c10-bcf5-fa28beca7410" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LongTermIncentivePlanSharesMember_ab436e1d-1b5e-484c-9a4b-24a1b4a123bf" xlink:href="rdnt-20221231.xsd#rdnt_LongTermIncentivePlanSharesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ef33fe65-fd5e-455d-b1c6-2c89faa3b79c" xlink:to="loc_rdnt_LongTermIncentivePlanSharesMember_ab436e1d-1b5e-484c-9a4b-24a1b4a123bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_2f563914-5cc2-49c3-8a0b-f6237e2a78bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5824bb70-0239-4a35-bcf7-a71d40685858" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_2f563914-5cc2-49c3-8a0b-f6237e2a78bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_22ec9d76-a3bb-4897-9b8f-33e4a15d274f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_2f563914-5cc2-49c3-8a0b-f6237e2a78bc" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_22ec9d76-a3bb-4897-9b8f-33e4a15d274f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeepHealthIncMember_05db526a-55ab-4f4d-a16d-9d29cacde497" xlink:href="rdnt-20221231.xsd#rdnt_DeepHealthIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_22ec9d76-a3bb-4897-9b8f-33e4a15d274f" xlink:to="loc_rdnt_DeepHealthIncMember_05db526a-55ab-4f4d-a16d-9d29cacde497" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_d953199f-a2b5-42e6-820e-beefcb591553" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5824bb70-0239-4a35-bcf7-a71d40685858" xlink:to="loc_us-gaap_PlanNameAxis_d953199f-a2b5-42e6-820e-beefcb591553" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_a2d104a0-1175-48fe-83bc-d3c148a729f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_d953199f-a2b5-42e6-820e-beefcb591553" xlink:to="loc_us-gaap_PlanNameDomain_a2d104a0-1175-48fe-83bc-d3c148a729f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedPlanMember_5c94ca10-70d0-4115-8250-908d26ac4f94" xlink:href="rdnt-20221231.xsd#rdnt_RestatedPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_a2d104a0-1175-48fe-83bc-d3c148a729f3" xlink:to="loc_rdnt_RestatedPlanMember_5c94ca10-70d0-4115-8250-908d26ac4f94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e9833ae6-7aa9-46f3-8ea7-f277232d4126" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5824bb70-0239-4a35-bcf7-a71d40685858" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e9833ae6-7aa9-46f3-8ea7-f277232d4126" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans_66fa9021-b4f5-40a0-b4a2-f1c16824d709" xlink:href="rdnt-20221231.xsd#rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e9833ae6-7aa9-46f3-8ea7-f277232d4126" xlink:to="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans_66fa9021-b4f5-40a0-b4a2-f1c16824d709" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_1039b98c-28be-4c7c-915c-c436cf1df5f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e9833ae6-7aa9-46f3-8ea7-f277232d4126" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_1039b98c-28be-4c7c-915c-c436cf1df5f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_3a198b01-5bc9-4bfc-b5ed-1a8c5707c65e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e9833ae6-7aa9-46f3-8ea7-f277232d4126" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_3a198b01-5bc9-4bfc-b5ed-1a8c5707c65e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_31a441db-8e35-4985-a26a-3ad2abf5d609" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e9833ae6-7aa9-46f3-8ea7-f277232d4126" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_31a441db-8e35-4985-a26a-3ad2abf5d609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_d5ec377a-45cd-408c-a45d-36ce7aee3355" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e9833ae6-7aa9-46f3-8ea7-f277232d4126" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_d5ec377a-45cd-408c-a45d-36ce7aee3355" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_be10ef13-1378-4c05-8415-1e460d71df30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e9833ae6-7aa9-46f3-8ea7-f277232d4126" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_be10ef13-1378-4c05-8415-1e460d71df30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2c6b93e5-614b-491d-b74c-dbd63437aabd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e9833ae6-7aa9-46f3-8ea7-f277232d4126" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2c6b93e5-614b-491d-b74c-dbd63437aabd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ad25be40-f4ad-4e35-8358-2fc0f939a5d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e9833ae6-7aa9-46f3-8ea7-f277232d4126" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ad25be40-f4ad-4e35-8358-2fc0f939a5d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_deeeebf3-7749-4e26-8b8c-4653659ec523" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e9833ae6-7aa9-46f3-8ea7-f277232d4126" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_deeeebf3-7749-4e26-8b8c-4653659ec523" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0783bf9b-0a50-49fd-9848-cdffdc2db24c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e9833ae6-7aa9-46f3-8ea7-f277232d4126" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0783bf9b-0a50-49fd-9848-cdffdc2db24c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue_b1a37abc-3eae-4c1f-b90a-155f8b8ce58d" xlink:href="rdnt-20221231.xsd#rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e9833ae6-7aa9-46f3-8ea7-f277232d4126" xlink:to="loc_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue_b1a37abc-3eae-4c1f-b90a-155f8b8ce58d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance_f46f654b-0b00-48c7-b16e-ec95cb4e04e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e9833ae6-7aa9-46f3-8ea7-f277232d4126" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance_f46f654b-0b00-48c7-b16e-ec95cb4e04e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants" xlink:type="simple" xlink:href="rdnt-20221231.xsd#STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7565e7a1-8ebf-4e95-bcb1-758b2fdd9bf5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f2181152-fe6d-4471-8233-c575c8a4d009" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7565e7a1-8ebf-4e95-bcb1-758b2fdd9bf5" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f2181152-fe6d-4471-8233-c575c8a4d009" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_4ddddd30-fad9-4fa5-82f8-85a6e1007c1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f2181152-fe6d-4471-8233-c575c8a4d009" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_4ddddd30-fad9-4fa5-82f8-85a6e1007c1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fe3cebc3-6394-4078-b9ea-6ca2078ed4f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_4ddddd30-fad9-4fa5-82f8-85a6e1007c1b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fe3cebc3-6394-4078-b9ea-6ca2078ed4f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeepHealthIncMember_9e76abef-7392-47e4-95d7-ad7f00bd3cc7" xlink:href="rdnt-20221231.xsd#rdnt_DeepHealthIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fe3cebc3-6394-4078-b9ea-6ca2078ed4f2" xlink:to="loc_rdnt_DeepHealthIncMember_9e76abef-7392-47e4-95d7-ad7f00bd3cc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_f2fd8edb-ba4b-4fe7-a58f-98b91f384ce5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f2181152-fe6d-4471-8233-c575c8a4d009" xlink:to="loc_us-gaap_AwardTypeAxis_f2fd8edb-ba4b-4fe7-a58f-98b91f384ce5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e3ce9376-4172-486b-91e1-8104ee18f861" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_f2fd8edb-ba4b-4fe7-a58f-98b91f384ce5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e3ce9376-4172-486b-91e1-8104ee18f861" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember_942d72d0-43af-4bb1-9750-7e11869d9b61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e3ce9376-4172-486b-91e1-8104ee18f861" xlink:to="loc_us-gaap_StockOptionMember_942d72d0-43af-4bb1-9750-7e11869d9b61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f3776189-a637-4b8d-a344-010b204e29d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f2181152-fe6d-4471-8233-c575c8a4d009" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f3776189-a637-4b8d-a344-010b204e29d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0917c9c0-e70a-4561-8fc8-68d66ecf6329" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f3776189-a637-4b8d-a344-010b204e29d9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0917c9c0-e70a-4561-8fc8-68d66ecf6329" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_8e37d18d-e6b5-44f1-9e4b-d8826b53ca12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0917c9c0-e70a-4561-8fc8-68d66ecf6329" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_8e37d18d-e6b5-44f1-9e4b-d8826b53ca12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_fc2141e4-89b9-4174-8181-2332d3a6c22e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0917c9c0-e70a-4561-8fc8-68d66ecf6329" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_fc2141e4-89b9-4174-8181-2332d3a6c22e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_18b3abab-a8ef-4f96-854a-b3abe2612ffb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0917c9c0-e70a-4561-8fc8-68d66ecf6329" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_18b3abab-a8ef-4f96-854a-b3abe2612ffb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0a7d4d89-1882-40d7-975e-28454421ad88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_0917c9c0-e70a-4561-8fc8-68d66ecf6329" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0a7d4d89-1882-40d7-975e-28454421ad88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_16f58fc7-db43-4281-9f83-326c9c6e8161" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f3776189-a637-4b8d-a344-010b204e29d9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_16f58fc7-db43-4281-9f83-326c9c6e8161" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_624728ea-a112-4fd8-94e7-ddb363d7fa45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f3776189-a637-4b8d-a344-010b204e29d9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_624728ea-a112-4fd8-94e7-ddb363d7fa45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_937fe78d-0ce6-420e-81a2-913e707b777a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_624728ea-a112-4fd8-94e7-ddb363d7fa45" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_937fe78d-0ce6-420e-81a2-913e707b777a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_e0822f16-6cee-4d33-9c85-4103b5375dfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_624728ea-a112-4fd8-94e7-ddb363d7fa45" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_e0822f16-6cee-4d33-9c85-4103b5375dfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c3dabcaa-6b44-4560-9402-1d2d9d604143" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_624728ea-a112-4fd8-94e7-ddb363d7fa45" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c3dabcaa-6b44-4560-9402-1d2d9d604143" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_cc5c3c1f-627b-43e5-bf4d-1b2531cf118d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_624728ea-a112-4fd8-94e7-ddb363d7fa45" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_cc5c3c1f-627b-43e5-bf4d-1b2531cf118d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_186775e1-aa33-4560-84be-99d390839723" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f3776189-a637-4b8d-a344-010b204e29d9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_186775e1-aa33-4560-84be-99d390839723" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WeightedAverageRemainingContractualLife_4c9db36b-3e4a-4e3e-9fa0-ab0e91c2a9ff" xlink:href="rdnt-20221231.xsd#rdnt_WeightedAverageRemainingContractualLife"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f3776189-a637-4b8d-a344-010b204e29d9" xlink:to="loc_rdnt_WeightedAverageRemainingContractualLife_4c9db36b-3e4a-4e3e-9fa0-ab0e91c2a9ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_7740cc92-08e0-4b6a-91cb-b83180745b66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_WeightedAverageRemainingContractualLife_4c9db36b-3e4a-4e3e-9fa0-ab0e91c2a9ff" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_7740cc92-08e0-4b6a-91cb-b83180745b66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_473b2097-1b7f-4992-bf30-02b7073d6c48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_WeightedAverageRemainingContractualLife_4c9db36b-3e4a-4e3e-9fa0-ab0e91c2a9ff" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_473b2097-1b7f-4992-bf30-02b7073d6c48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AggregateIntrinsicValue_a7fe2cc5-c3c8-4d6e-98b1-dfa3359fffc3" xlink:href="rdnt-20221231.xsd#rdnt_AggregateIntrinsicValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f3776189-a637-4b8d-a344-010b204e29d9" xlink:to="loc_rdnt_AggregateIntrinsicValue_a7fe2cc5-c3c8-4d6e-98b1-dfa3359fffc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_90dd7865-972a-41f6-87e4-42e9482c931a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_AggregateIntrinsicValue_a7fe2cc5-c3c8-4d6e-98b1-dfa3359fffc3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_90dd7865-972a-41f6-87e4-42e9482c931a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_67d0c235-b521-4741-ad41-ae431120c548" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_AggregateIntrinsicValue_a7fe2cc5-c3c8-4d6e-98b1-dfa3359fffc3" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_67d0c235-b521-4741-ad41-ae431120c548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUsandLTIPs" xlink:type="simple" xlink:href="rdnt-20221231.xsd#STOCKBASEDCOMPENSATIONDetailsRSUsandLTIPs"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUsandLTIPs" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_78f5bf8e-fc2a-444d-8ac9-3cf226ab757b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_055344a3-9ada-4160-bfbf-467a8b47b711" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_78f5bf8e-fc2a-444d-8ac9-3cf226ab757b" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_055344a3-9ada-4160-bfbf-467a8b47b711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_d9f8f3d4-8856-4d06-b590-a43dd92dd412" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_055344a3-9ada-4160-bfbf-467a8b47b711" xlink:to="loc_us-gaap_AwardTypeAxis_d9f8f3d4-8856-4d06-b590-a43dd92dd412" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_628e50c5-48a2-4399-a86b-0bbe80d045c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_d9f8f3d4-8856-4d06-b590-a43dd92dd412" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_628e50c5-48a2-4399-a86b-0bbe80d045c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_0d2781fa-bca6-455d-87fe-f703ca71db65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_628e50c5-48a2-4399-a86b-0bbe80d045c3" xlink:to="loc_us-gaap_RestrictedStockMember_0d2781fa-bca6-455d-87fe-f703ca71db65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PerformanceBasedStockUnitsMember_65872d25-56b9-44cf-a4b1-64c7f6c42aad" xlink:href="rdnt-20221231.xsd#rdnt_PerformanceBasedStockUnitsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_628e50c5-48a2-4399-a86b-0bbe80d045c3" xlink:to="loc_rdnt_PerformanceBasedStockUnitsMember_65872d25-56b9-44cf-a4b1-64c7f6c42aad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PerformanceBasedStockOptionsMember_0addf653-14ad-4f6e-bfb2-760d50f4a9c8" xlink:href="rdnt-20221231.xsd#rdnt_PerformanceBasedStockOptionsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_628e50c5-48a2-4399-a86b-0bbe80d045c3" xlink:to="loc_rdnt_PerformanceBasedStockOptionsMember_0addf653-14ad-4f6e-bfb2-760d50f4a9c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LongTermIncentivePlanSharesMember_5bbefbe4-ead4-4cac-863f-04ef28afc976" xlink:href="rdnt-20221231.xsd#rdnt_LongTermIncentivePlanSharesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_628e50c5-48a2-4399-a86b-0bbe80d045c3" xlink:to="loc_rdnt_LongTermIncentivePlanSharesMember_5bbefbe4-ead4-4cac-863f-04ef28afc976" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_875e5b9c-2dd5-4377-a9e8-bc35d6d46232" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_055344a3-9ada-4160-bfbf-467a8b47b711" xlink:to="loc_srt_RangeAxis_875e5b9c-2dd5-4377-a9e8-bc35d6d46232" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a4cca480-4c40-4800-be9e-58d375252e41" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_875e5b9c-2dd5-4377-a9e8-bc35d6d46232" xlink:to="loc_srt_RangeMember_a4cca480-4c40-4800-be9e-58d375252e41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_520f3c14-8886-4b23-90ba-a6f0622afc4b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_a4cca480-4c40-4800-be9e-58d375252e41" xlink:to="loc_srt_MinimumMember_520f3c14-8886-4b23-90ba-a6f0622afc4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_d3ce2d80-40bc-443b-842a-2ae71645f3ea" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_a4cca480-4c40-4800-be9e-58d375252e41" xlink:to="loc_srt_MaximumMember_d3ce2d80-40bc-443b-842a-2ae71645f3ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c8638450-2919-4819-8371-36b4d657dbbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_055344a3-9ada-4160-bfbf-467a8b47b711" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c8638450-2919-4819-8371-36b4d657dbbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_18bd7825-4eba-4256-adfb-54e76a2ee486" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c8638450-2919-4819-8371-36b4d657dbbd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_18bd7825-4eba-4256-adfb-54e76a2ee486" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_6344ba72-200c-449e-a222-754425c05394" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_18bd7825-4eba-4256-adfb-54e76a2ee486" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_6344ba72-200c-449e-a222-754425c05394" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c14bbd56-d786-4d6d-9c7c-232977cbc408" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_18bd7825-4eba-4256-adfb-54e76a2ee486" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c14bbd56-d786-4d6d-9c7c-232977cbc408" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_20cddeeb-ce01-41ca-a0ea-2610df8c9516" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_18bd7825-4eba-4256-adfb-54e76a2ee486" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_20cddeeb-ce01-41ca-a0ea-2610df8c9516" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_d2c4f967-5c93-416d-bbff-02cbceda808c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_18bd7825-4eba-4256-adfb-54e76a2ee486" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_d2c4f967-5c93-416d-bbff-02cbceda808c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_5477013a-c402-451a-a634-97817f2860b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_18bd7825-4eba-4256-adfb-54e76a2ee486" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_5477013a-c402-451a-a634-97817f2860b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_f7fcac7b-d01f-415f-a7d6-4cd12c0edaea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c8638450-2919-4819-8371-36b4d657dbbd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_f7fcac7b-d01f-415f-a7d6-4cd12c0edaea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0c3e22f4-e794-4126-b2d5-5e87ae295d6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c8638450-2919-4819-8371-36b4d657dbbd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0c3e22f4-e794-4126-b2d5-5e87ae295d6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_68d2cc15-4b19-4232-a17d-d40c5b4efb64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0c3e22f4-e794-4126-b2d5-5e87ae295d6f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_68d2cc15-4b19-4232-a17d-d40c5b4efb64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_d0e1dee8-095e-4316-998a-36c718543db9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0c3e22f4-e794-4126-b2d5-5e87ae295d6f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_d0e1dee8-095e-4316-998a-36c718543db9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_abb38109-96da-414e-a8c2-705b7855071f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0c3e22f4-e794-4126-b2d5-5e87ae295d6f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_abb38109-96da-414e-a8c2-705b7855071f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_fc941bf1-d12d-4803-a887-012111cda136" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0c3e22f4-e794-4126-b2d5-5e87ae295d6f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_fc941bf1-d12d-4803-a887-012111cda136" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_dee671a9-8449-4ffd-99b9-7bc1a9cc558f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0c3e22f4-e794-4126-b2d5-5e87ae295d6f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_dee671a9-8449-4ffd-99b9-7bc1a9cc558f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches_f324b71b-e6be-431f-a3b0-a676a75a84bc" xlink:href="rdnt-20221231.xsd#rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c8638450-2919-4819-8371-36b4d657dbbd" xlink:to="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches_f324b71b-e6be-431f-a3b0-a676a75a84bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_51232bcf-a4be-40c5-981a-4eb254fd832b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c8638450-2919-4819-8371-36b4d657dbbd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_51232bcf-a4be-40c5-981a-4eb254fd832b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_ac0154f4-d92d-4ec1-99c7-25c9cb8cbbdd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c8638450-2919-4819-8371-36b4d657dbbd" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_ac0154f4-d92d-4ec1-99c7-25c9cb8cbbdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_1fbc4e90-8ce6-4bcf-b510-b1335eee0455" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c8638450-2919-4819-8371-36b4d657dbbd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_1fbc4e90-8ce6-4bcf-b510-b1335eee0455" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_bed83a72-ae25-45d0-8063-000489f7e228" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c8638450-2919-4819-8371-36b4d657dbbd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_bed83a72-ae25-45d0-8063-000489f7e228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod_f2e9c4c4-4705-4803-996b-567f7012a387" xlink:href="rdnt-20221231.xsd#rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c8638450-2919-4819-8371-36b4d657dbbd" xlink:to="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod_f2e9c4c4-4705-4803-996b-567f7012a387" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue_faa508bc-9311-4770-9572-805c81c02967" xlink:href="rdnt-20221231.xsd#rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c8638450-2919-4819-8371-36b4d657dbbd" xlink:to="loc_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue_faa508bc-9311-4770-9572-805c81c02967" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>davidjkatz_employmentagr001.jpg
<TEXT>
begin 644 davidjkatz_employmentagr001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MP7$SR6TB1Q1PL79BI &W&1SZXH \P^&.LZCH/C35_!^N:A-< K]HM);F0DX
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M(MBRR,2)'#$$8QM4="<MCBN.\(Z+JG@GXH:G#9:;J<_AV^(0SM"?E?J&/ R
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHR,XSSZ44 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !12 @C(((/<4M !1110 4444 %%%% !1110 4444 %%%-
M$B$*0ZD-P#GK0 ZBD1U= Z,&4C((.013)IX;:(RSRI%&O5W8*!^)H DHHHH
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MT!MRH&!4'''4FJ[ZWJVL^-_!LUM>QV]O?Z;)>BU>$NJ$Q@G<0XWGD@=,>^:
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M%8(BV%1LDD]!4OBV?5_$>@3Z+HFEW4;WR^3-=W:^3'!&?O'!.YCCC@$5VE%
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MRJQ>,*58.P^4,V[IG@#KDU8U67Q)KGA35XY/#CV1N-/DMH[02QO*\SKC<2"
M$7IUR<DX&!796VIV%XDCVM];3I$,R-%*K!![X/'0T6NIV%\[)9WUM<,@RPAE
M5R/K@T >=C2=;)^'B#1KK&CP@7N6B&PB(1\'=SR">.Q%=SXFBFN/#&IVUO:/
M=2SVTD20KM^8LI ^\0,<UJT4 >(Z3\+=3O\ X43Z)J5@+36(;MKJSDDD0CD*
M"I*DD @$'IS@]JZFR3QI/\/HM&U/2)#J+%+6::.XB^:V) 9L[\[]F1]2#7HM
M% 'F'Q'^'0UCPU:Q:!I\YU&WD4P[KKB),8*_.^ .GW?[HJ#QOH'BSQ;\-]*T
MM])?^V(9HWN2UQ%L.U'4L#O[D@_C7J4<\,S2+%*CF-MCA6!VMUP?0\BH(M5T
M^?49-/AO;>2]B7?) D@9T&0,L!R.HZT >8Z_X0\2>*_"WASPL;$:;:64</VV
M[N)8W.](]G[M48DCENN,Y'2NTDL;JPUO0;?3]+E?3+&WDA>598U" JH3"E@3
M]TYXXSQFNEHH \_\8> /[4\8:#XGTR-%O+2]A-XI./,B5P=WNR_J/H*R/%WA
M3Q!J7Q:T?Q%9Z5)-I]@L*R,)HE9]KLQV@N.S#KBO4S-$LZP&5!,REEC+#<0,
M9('H,C\ZH7/B/0[)(GNM9T^!)<B-I;E%#X.#C)YY!% &):)K0U_3K6TT.33M
M"BDGN+F2:XC+O(^]L!4=OEWN3^73%<[\2_#6O^(_$WAZZTO2GFM]+F,DLC3Q
M)O!9&PH+9_@/4"N]@\1:)=74=M;ZQI\UQ*2(XH[E&9R!DX .3P,UIT ,B=I(
M4=HGB9@"8W(ROL<$C/T)KG]2CU!O&>DW4.ESS6=M!/%+.LD0 ,ACP0"X) V'
M/'TS71T4 ><:!X!;POJ7B[4+>S^T?;R4L88V0$1L,L.2  &;'4<)]*H_"_P_
MXD\$Z#JMM?:%))<2R":!8KF$JQP%VDE^/7Z ]\ ^CW6LZ;9:C;:?<WT$5Y=?
MZB!G&^3Z"KU 'G#> [?4O UTFI:)<?V[<0L9L7(S)<L,F08DV8WG/..!TK-\
M.Z)XOT_X6ZIX5U#1)'N'AEALY([J$KMD!X;+\8)/3/!]J]9HH YOQ-X<@\:^
M$Y=/O[5K::1-T7F[6>"0=#E21]<'D$BL*'1-;T[X;Z1X;&F-=2';!J'DS1@+
M 'S(%+,,EER!]3G%>@T$X&3TH \G^(?PW_M'1K'_ (1C1Y8]3BF60.;E1Y:@
M<J2[\'.#\N?N]:M^+?!&J>./"NFWD\":?XIL0O+R*4D(QN&Y2< GD>AX[YKN
M1XET(VT5RNLV#02S>1'*MRA5I/[H(.,^U7X+J"Z5VMYHY0CF-]C [6'53Z$>
ME 'FWC[1/$/CGPG9Z:OA\VNHK.DLLLMQ"8DPK!MK!BQ!)'\-1_$3PEKNL^!-
M&\-Z5IHN);7R7EF6:-(P4C9"!N()Y.>G2O4J* .!O(_$YT&"STOP_-:ZC<6L
M%G=7CW<0$"+D$IM<DD;F(.!USVQ6I'8W=YXLUP7VCRC2K^RBM/.:6(A@AEW9
M4,6PPEXXSQR!72SW$-LBM/*D:LZQJ7;&68X4#W)(%2T >46G@#4M!^$^J^'K
M2S^V:GJ$TF621% &X!6)8CC:H.!DY;IUJ;1_#7B"S^#4WA6722-2DCFA&;B/
MRP'=FW$ACT!Z8Z_IZC10!YUX5T;Q%X<\%Z=IYT*WGU73TF$$K7BB,&1RQS@9
MQ@C(]JT8-*UZ/4/"EQ=0"Z>PMI1?S><N3)(@!V@]0"#Z<5VE8Q\5Z(NL1:4U
M\!=RR-%&#&^QY%^\@DQL+#NN<^U '/>-/ $6OZ[HVOV*I'J-C>0/-G $T*N"
M0?\ :&./;(]*TOB#I&H:_P"#+[2--@62XN@JAGD"*F&#9/Y5T[,%4LQ  &23
MVJAI.NZ9KBW+:9=I<K;3&"5D!PK@ D9(YX(Y&10!C_#_ $C4/#_@NQT?4(5C
MN;564LKAT;+LPQCGOWQ6=\.+SQ-<#7+?Q'<1W36M[Y<5Q'C:3C+*" ,A20.G
M!R.U=S341(T"(JJHZ*HP!0!YA\2/!FO>)O%.BZAI=M"T&G$,YEG";SO#8'7T
MQS763PZM<>,-*U :8%M+>UF@E9KA=P:5HCD =0OE^O.?SN'Q9H0O9K+^T8S=
M0_ZR$*Q9/J *N:?J]AJOG?8;E)C"VR4+D%&QG!!Z<4 <EXF\!)J?C30O$]@L
M<=W:W2&\R<>;$/XO=A@#Z?2JGB3P'J,?CFU\9^&&MOMZ<75K<N52<;=N00#@
ME>/3@'USZ+10!B0R^(+V^@\VUMM.LTPTV9?.EE/]U< !5]SDGT'6N9CD\?Z/
MIOB&\O[S1IG\Y6T\7#%8T3=@Y(QQMQ@9SG]?0:1E5L;@#@YY'>@"GH]U<WVB
MV5W>6_V>YF@1Y8<_<8C)%>9KX2\;IH1TXP:-)/#J,=Z;QY7\R]99=XW<<8'<
MYX  %>LUF7>OZ=8ZY8://,5OK\.UO&$)#!!DY/0?C0!:C:]73T:2.![W8"R*
MY6/?W )!./?'X5P_A;1?&/ACPQ)ID%GHLEPTLLJ3/?2;5+MGE1%SCZC->@T4
M >>/\,=_@[4K"74FDUR_N!>RZCC;F=3E..H0=,=LDBM/1[?QO-%(^OR:7O@A
M=((K21U%Q(> TA(^5<=  >N<< 5V%8.J>,=%T74XM.OYKJ.ZF.V%%L9Y/-.
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M NUUY0^8E@PVYYV@#C').>(?^$TUG5=6\-0Z.EC%;:U8RW ^TJ[/"R+WP0&
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M)N9M!N9&O)1"R*C 85,D#.7 88S]PUZ!0 4444 %%%% !1110 4444 %%%%
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M6E7UB]T6,L\$$BEMW +%1T/3-;->>>&_&&D7EKXG\7P1N+01PR29*[\I%RA
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M(O[J%FV@G(&2?0=3]* -"J.IZSINC1I+J=[!:1N2%>9MJY^IX%8&@^*+B_\
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MD[O8#WKT^::.W@DFE;;'&I=V] !DFJVEZI9:UIL&HZ=.)[2<$QR $;@"0>"
M>H- '+>(O#.OMXG@\2>&+RQM]0-K]EN8+T.894W;@<J,Y!_I71Z)::C:V!_M
M:[CNKZ5S)*T2E8U)  5 3D* !]>2>36E10!P5WX4\3Z9XMU#5O"VI:=';:IL
M:[M[]'8(ZC&] O4X[$C^6++^$=3L-?TWQ!IMY#<ZE';-:WXNV9%ND9MY((#;
M"'R0,$8P.@KM*I:MJUCH>G2ZAJ,X@M8AEW*EL?@ 30!Q6J?#^\O_  YX@M4G
MM5U'7KA9KF4EO+B56!55&,M@#J<9))]JE\=K?Q:5X5AB:VCO1K%LH+,6CW!6
M]@2/PKJG\0:7%?Z?8R76VZU!2]K&4;]X NX\XP.!WI]]H6DZI<Q7%_IEI=31
M#$;SPJY7Z9'N: .:O?!4OB6]U&\\1?94:XL#800VK-((4+;RY=@N6W $?*,8
M[YJ.'PEK5_8Z/I6O75C+9:5<1SK- 7\VY\L$(&4C"<D$X)SCMFNX50JA5 "@
M8 '04M '+:%H.JV&O>(;Z[GM1%JKI(GV<L7A94V#[PP> #]1[URL/P^\5Q:%
MI>F'4]'V:1J4=];$0R9G*L6S*>Q^8\ <^M>A6>N:??:QJ&E6\Q:\L-GVB,H1
MMWC*\D8/'I6C0!R-GH?B/3O%FJZG#=:9+::@D+NCHZOYL<6SC&0JD@'N<<>]
M8\/P[U$^#=*TJ2^M8M2T>\^UV5W$C,I;>SX93@XRV.#V%>C5F-X@TU/$,>A-
M<$:C)$9EB\ML%!U.[&/UH R3X?U*YUJ37;MK+[?'8M9VL,9?RUW$%G9B,DY'
M  X'KGCG8? &NP>!='\.)=:<7TV]%TLY+X?:Y< KCU8@\]A7I=% %6YM!J.E
M2V=ZBXN(3',J'(^88."?KUKG_ 3367ANVT+4-L>I:8IMY(^ 613A'7U4KMY]
M<CJ*V-:U[3M TN;4=1F:.UA.)&2-GVGW"@XZBKD)@N5AO$16+1YCD*_,%;!Q
MZ@' X]A0 ^4R"%S"$:7:=@<D*3VR1G KB= \$747AW5]!\0/975CJ$\D_P#H
MVY64NVX_>]" 0?:NYJ&[NH+&UDN;F01PQC<S'L/Z_2@#D+7PQXDC\'/X?N-8
ML)@J+#!<-:ON6-3QN&_#': .V/>M[7?#]KXF\/3:5JJAEF7EH\C8XZ.ON#S5
MY-0MI)XH%9O-DC$H0QL"JGH6!'R]_O8Y!'8U2NO$>G6U[)9*TUS=1 &6&T@>
M9HLC(W[ =N>P.">U '/ZWX*O]6\&:/X?BU&W@^PBW,DS0E_,,0P,#(P"0#79
MQ>;Y2^=L,F/FV9QGVS5/3-9L-8$_V&?S#;N(Y59&1D; ."K $'!'45?H *\[
MU#X?:Q<Q^)K*WUV"/3M:E:Y*26V^59" -NXG[G [9],=3Z)10!Q&G^#];MO%
M&G:W=:O9SM9V)LO*2U9-RDYZ[ST..W0>M9Z_#.[DT6ZL9M6@CE_M$ZI93VUN
MRFWN">X9SN7VZ^]>CUD:WXFTGP[)8IJEUY!O9O)A)1B"WN0,#J.30!BV'A77
M$\76WB'4=>MYY8[,V<D<5EL#IOW<'<<'(&3SWQCMI^,_#?\ PEOA:[T87/V9
MIBC++LW;2K!AD9&>E)!XST.YN=3MX;MGDTR7RKP")OW)YRQX^Z"IRPX&/2MU
M'26-9(V5T8!E93D$'H0: .1E\(ZF-;L/$$&KQ?VU%;-;73RVV8;B,G<!L5@5
MVGISG@9S6)XKTMO#/@N]WZFR7FL:E&U]?"W!B3>0&W+SB(*N.I//7FO2Z0@,
M"" 0>"#0!YCX:>9=2BTVSUC0-9T^^#+>Q:;9B)HD*-ARR,0/[N&]0!6MX?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M)[2XNEBDM9]N#\W((Z9QGIQVSW.G1W<6GP+?2))=[<RF,84,>2%X^Z,X&><
M9YH X+X;;?%D>H>+M5C2XN;FZ>&U$BAEMX$QA4!^[DDY]<5O3V>D^"&USQ(
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MR2Y(PO&&!VGG([53M/!FM^';_0+:QL[75]+LK$PF.XN/*2&Y:0NT^W!SUP,
MGZ53TWP?XILO#^D6$VG6<LNG:W_: 9;H ,@9B<9'!.[@>G7TH Z6U\8ZQ-J6
MLZ/-H4,>KV-JMW# EV72X0]M^P8.>.G7\ZGTGQE+K6@Z!J-G:0/)JLWEM")C
M^Y4!BYSMYV[3V&3CUJ"+3KZQ^)%_XEO(X;?2I-/6V,LLZ@H5.[<1T [=:C\'
MZ)%;>)]?U"SNQ-I1G*V<2,"D;N$:?;CC&X*/J&'U .HUS4)]*T2[OK6QEOIX
M8RR6T7WI#Z"N=LO&%]+XIG\.O;Z?<7RV)NT-O<D*C!@IBDR"5()!SCH>E:_B
M^PU+5/"M_9:1*L5]*JB-F<H" P+*2.1E01^-<Q::%XFM/%&FZS'I.D000:?)
M:/96]P1Y>6#<-M ))'H,9/)H J67Q*UFY\,Z9XCDT2T33KF\%M*!<DR?-(4#
M*,8P"!G/)YX YKH=2UJ]U5];LM*M;2:WTZ,QSRW#'$DVW<8U '& 1ECGDXQQ
M7+V7@OQ);_"ZQ\-?9;+[9!?+*S-=$*4$WFYR%/T_#/-:J>'/$NBZSJQT9-/F
MTW6G:XG2YG<-;3LN'*X7YP>PXZ#I0!<^$W_)+]#_ .N;_P#HQZ@\3>.-1\/V
M^J7DEC:P064JI!%=2%9+X?*6:/'89/8].<5I?#[1-3\.>#;+2=5^S>=;A@OV
M=BPVEBW)('/....*YG5_!OBJZ7Q7:Q-ID\>K%GAO9G;SE3C$&,8"C'!S@9)Y
MSP ;5YXLU@^-+?P_I^G6;"YT_P"VQS3SL-HW8^8!>W/ SGCD5FW7C_6H?!DF
MO+I5L'L;Y[/482[,(]K[3(A'4 ]OUXJ[8^'/$ \;Z?KUY'IHCM]*^PO'%<.6
M+;MV1E,8[=??VJ/1]/C\-:#JVG^+9](M+/4[NXE39=G:RRY+)AT7H/3.?04
M=);ZK/=^(VLH#!)9QV:7$D@4[LN2$ YQR%8^W'K7/?%LA? K,RE@MY;' &2?
MWJ]!6A\.]$ET/PA;13SRSS3?O2\HPP3 $:D=L(%&.QS1X^T/5?$>@IIVEK9[
MS/'*[W,S(%V,&  5&SG&.V/>@#FKAH_%_P 3-)ET6!K0Z"Q.HS31^3*RL!LC
M"'#E3@\D8&ZI?'&A7VK^/-.ET:Z^QZM::9-=6\@X$C++$-CGNI#L/QK7UWPQ
MJ]SJVF^)=%:RL]>@7R[J*21C!<QGJC,%!..QV_R%75T_6Y?&5CK$UK81V\=A
M):S*EV[.K.Z/E1Y0# ; .2,Y[8P0#G6\3P^*K#PY,\'V;4+;78H;VT?[T$H2
M3(Y[=P?\#5M0/^%^.<#_ )%O/_DP*LZWX"BOO&NE^)K"5;>X@G1KR(\+.J@X
M;@??&<<]O3%+_86OCXGGQ*(---B;'^S]GVM_,V>9O\S'EXS_ +.?QH V_$FN
M#0--CG2#[1<W$\=K;0EMHDE=MJ@G!P.Y..U9DOB/4]*\56.B:I!:2+J<<AL[
MJ'=&HE09,;@ENV,,#SZ59\9^&Y/$NB)!:W"VVH6LZ7=G.PR$F3E<^QZ''Z]*
MJ/H>LZOK>E:MK$.GPOI*2O!!;7#R+-,Z;<LS1@HH[ !CDYSQ@@%+PAXK\2^)
M[H7#Z580Z2ES/;S2+,QD4I]T@'J">.WT'>I\1;F2\\4>$?#;R%+#4+MI+M<X
M$RQX(C/J#DY'?BM?P!H&K^&]-O+'4TLBLMU)<QR6T[N?G.2I#(N,>N>?05:\
M8>%?^$FMK*2WNOL>I:?<"YL[G9N"N/X2.,J>,_04 :&KZ!I^LZ2=.N;>,0K@
MQ;4'[IE.5*^A&*S?[=U+5=8U73]#2T3^RRB2RW:LPEE8;MBA2-H QEN>3T.*
ME@_X2RZA2WOXM*M P(FN;2YDD?'^PC1@ ^Y8X]#6='X=UO0?$^JZGH7V&YM-
M4"R3VUY,\1CF48WJRHV0>X('UH S)_B1>2:%H6IV6FPEK[4ETRYMYI2&BF)(
M(! P1\O7W'%6;;Q)XON?$&J^'ELM'%_:1QSQW)>3R?+<' *_>+9&,Y Z_CG7
M?P[U6TT30]/TE[&9[+5EU>YFN97B\V0$G:H5&XYQDG(P.M;=GHWB*V\=ZMKS
M6VF-;W=JL$48O) X*9*EOW6/F)YZX_VL<@&2WQ)U&;PAX;URTTRV+:K?I8R1
M22GY7+,OR\=#L/)/&>AJ]'XPUZP\07^B:MI-M->"Q>^L!8.Q$X7K&=W.[/&>
M,^E<;JN@:SX5\">$='NEL7N[?Q+ 8'BF=DD+&5ANR@*C)QQGU]J['6/".L>(
M+G4-2N9;2PU!M->QLEMIW<1EB2S,^U3SP.%X&>M "Z=XTOY?%MEH4[Z;<RW5
MH\SI;[D:TE4 F.3YFSUQG@\=*QO^%B^)/^$1N?$9TW3?LMC>_9YXU,A>11)L
M)3GY< CDYSSP,<Z-KX5\3Q:SX>U(KH,7]EVTMN]O!YBJ0R@ AMO.2.F!MS_%
M6:/ ?B;_ (5UJGAMETC[1>7IN%E^TR%54N'/'E9R"H'XYXQ@@'1R^)-6L_B3
M;^'[W[%'IMW;O/:SB%M\K+UCSOP"!SG'/H,\;?AZ\OM1TYKR\DM7CFE<VQMX
MV4-#N(1CECDLH#=NM<GXQ&F^*8['1&O8HO$<%[#A+*;?);$\R') .WR]Q)P.
M=HKOH(([:WB@A0)%$@1% P%4# % '&>*O%FK:$-6N-EA:6UE&K6HO 7;4#MW
M.$VL"N.G(//)P*S?%5[J.I7_ ($N[>>""&\NXYTB>%GV.82<L0XW !B,8'UJ
MSJ?A'Q'<ZKXF-O=:8UIK-L84FN [3P#RROEJ ,!23GKQDG!-)<^%O$\EEX5
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M[;S'@D;[QBP0.>.O ]#0!:CU_6==U'5;+25@LI-.MHBZW";V:XD3>(SR %'
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M,7V0%HLR!R"V[YAP<=.>>>A +=SJ'B6]\?W^@66K6UI;KIJ74<ILMYB9G*X
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MDC<89'4$,/0@]:2WMX;6!(+>&.&%!A8XU"JH]@.E244 %%%% !1110 4444
M%%%% !1110 4444 %%%% $<%O#:Q"*WACBC'(2-0H'X"I*** "BBB@ HHHH
M**** "BBB@ HHHH B%M )?-$$8DSG>$&<_6I:** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MZWOAU_R3K0/^O*/^59][X G.I:M-I.O3:?9ZPK?;K3R%E5W8$%U+?=)SS_\
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M*DN+2_9!<6Z6$T;6:-SO\UOEDQGG 'M0!WM%9NOWM]I^BSW.G6JW-TFT+&[
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M)8\Y/RJ#[8Y2_P##?B6^U'PG=F#24_L4EI@+V0^82NP[?W/H >>YQVR>]HH
MY[PQ?ZU>3ZG'JK:?+%#/BVGL=^QE.<J2W5EXR1QDXZ@U1\0^'M8N?&FB:_I+
MV7^B12V\R71885_XE"CDCGC([<]QUP 4    =A2T >=V?A7Q-:V/BV$P:07U
MV666,_;9,1>8NT@_N>< Y]_;K3!X/\66-YI6LZ3<Z5!JEO9)I]W;322/;SQ)
M]U@P0,&_#CU]?1Z* *.DPZA#8@ZI<1S7LAWR^2"(T.!\J9YVC'4\GD\9Q7$:
M=+K2?$WQHNDP:?,"+/>MW.\15O)^4@JC9'7(X^M>BU2@TC3+6]EO;?3K2&[E
M_P!9/'"JN_U8#)H X9/ .L:/<:'+HUSI]RMF)FN(;\.(S-(<F9 H/S#) !Z
M8SR36>W@#Q;!H%UI5M<Z,X?6/[1BF>25" '##(V,,G X[>K9X]6HH Y'Q3X>
MUC6+OP[JM@]C%J&ES-*\$[N8FWIA@&"Y."..!GVZ51'A#5KOQ=KUYJ*V#:9K
M%B+&7R;AQ*JA2NX*8\9.>F[CU..>\HH XCPWH/C#3([?2-0U33I-&LRHAG@#
MK=21H1L1OX5!  )&3CCOFH9_!^L:OJ6EW.K1Z3'<V%VLXU.T=_M$B*21&5*
M<]"=Q'^S7>T4 8/C/2M0USPK?:5IPMO.NXS$7N)614!'7Y58D]../KV//3>$
MM=GUCPA=/'I9@T.VD@G0W,A,V^,1G'[O&, 'GU([9/?T4 >>:-X1\7Z&LFAV
MFM6(\-M(QCE*N+R")CDHA V@\\,2<9SCM6UHVA:I9>+]=U6Z6R:UU7R?DCE<
MO'Y:;!P5 .<G/3'O74T4 >>:+X/\6^'3)HVF:SIX\.M*SQO+&YNH%8Y*IC"]
MS@G/)SCM6H?#NL:=XSU77=+EL9DU2**.1+IG0P&-=H8;0=_K@[?K77T4 >>:
MWI_A[0/ =QX1NKU);R[MY)(8F($MQ.S$AE7U\PC [8]B:Z_P[I9T7P_96#N9
M)HXP9Y6.3)*>78GN2Q)_&KDMA9SWD-W-:027, (BF>,%XP>NUNHS[58H Y'6
M_#^O3^-K'7M)O+$116C6DD-ZCL(]S;C)&%QEN@Y(X'6N'U+0-1\+^&=-\-WF
ML:0&N]6,T#7$+K$RJ6D/F/N!4D[,!<'/&3G(]FJ"\L;34+=K>]M8+F!NL<T8
M=3^!XH \]T.77?.N])DB\,SW%_;R/)<Z9<2N5;H&F+ G!S@<DY'3 .+MGX G
MN/AJ/"&L7$'[H8@NK7<2I#;E8AL<@\8[CTKL[+3[+3;<6]A9V]K".D<$01?R
M Q5F@#CM*T+Q1>6\EIXMU*PN+,0O"L=BCJTX92A:4MQT)^4#&3GL*K^'?#/B
MS21%I%WKMK-H-J5\AXXV%VZ*>(V/W548QD9....W<T4 <_XST.^\0^'FLM.N
MHH+A98YE$P)BEVG.R0#JI[\'Z5BMX:\6-K-UJBZGI<$]UI9LV\F%QY,BES&4
MR>@+ DGTZ>G=44 <;I'A2_7Q<GB+4DTVUNH[=X)!IV[%V6P=\FX#&"#@<]>O
M%3^._#NI^)]-MK&PEM(5CN$N&><MG*'(  '0UU=% '(77AG51XFMO%%C<6<6
MJ&V^R7EO)N:"6/.X;6 W!@<<D'_&AJ/@2^N/#&N65O/9_P!I:[.9KR=PP1!V
M5 ,DX QDXSDGVKOJ* .'O_"VN7>K>%;Y)--0:(C;X]TG[QF78<''0* >><YI
M+;P9JFC+K5AH]Y9_V5JLCRE+E&+VK2##[=IPPQT!Q]>]=S10!R6I^![:X^'Z
M>&+"4P&VC3[)<,?FCE0[E?(Z'.<X]34=WX M9;KPW+#<.@TD[9F/WKI.&^<]
MR9%5CGKEJ[&B@#D/$/AS6=:?5+1I-,N-+O4"QQW<;,]JVP*73'![D#CGOS6G
M9:3JFGSZ/;P:FKZ796?V>XBEBW2SNJA5?=VZ9/\ ]?C<HH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M&2"^[ SSA?6NJO\ 4]3T'7-$\-Z3IUF]G<6LB6SR3,#'Y*+C<,?=&1TR3[4
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M"=.>2<G';BM>U\7:W'XJT&SU*SL8]/UV&5[186=IH2BA_P!X3\IRI P!U[T
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M?I78QQI%&L<:*B*,*JC  ] *=0!P^M^#-6U;3+"[&L1IXDL;EKJ&[$1$(8@
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MD>"KW3Y+.%]:D$,Z20EE#C.3G/3C[N,^] 'H^H7T&F6$][<^9Y$"%W,<;2,
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M.N -^.,#C)';B@#O**X=M8UG3?&__",2ZDEPNH6;7%C=36REX74_,KJFT,,
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M-^'(?#MO>*DHEFO;I[J=UC$:[VQPJ#A0 !_4FLF^\$W6J6\]CJ&MM<Z=+?\
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MY::K8#]UJ%JP23D88$8Q@^G],@PZC\/=,U30UL;NZO9+Q9A<KJ1E_P!($P
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MOIY]2C2&ZN/W:L\:?=4 )M SSD#/O0!BZ;>ZMI/B?PA8G5GN;+5K*4RVTD:
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M!S_P[M19>+O&]LLLTJQWD*AYGWN1L.,L>3Z9/-)+I4+?'1&$]VI?13<L%N7
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M !1110 4444 %%><^+M0U,:GK@M=8N@-/L!<6]KIVT-#(%9BUP6&"IP,+GD
MX7UK1ZOXAU>[\#-'K<EHNM6,K721P1D!EB#;UR,ACGOD @<=B >GUB3^(UM_
M%UIX?>RG#W4#S)<DKY9"8R!SG/(Z@=:X./QCJ^CZ=XBL);^2[NK;6(M/LKNX
M12RB7&"P4 $J QZ<GVK3?3)=,^+'AX/J5[>I)876/M3!BK94D@@# .1QT&.*
M /1***\TFU/5-,U[Q3H=[J=ZSR6R76C2J07PQV;%&,$B1E7G.10!Z3(Q2-F"
M,Y4$A5QEO89XK(\,^(8_$NG37<=I/:^5<R6SQ3XW!D.#T)'7T)KF/"VM7OB'
M3]'L9KNXCU*SEF35RC@,'A.TH>,?,S*>.P.,5R33:GIG@3Q%K]AK-S;/INN7
M#QVT(41R$SJ"),@EAAN@('L: /6I=5GC\10:6NF73P2P-*U\H'DQD' 0GU/]
M1^&G7%3:K?0_$FQB:]N&T^XTB6Y-F%!574KR" #TS]XGD^]4=$NM8\4>&+#Q
M3;ZZ+&5[EIIHI2#;I;*[!HRO'. "6)SUY - '3Z-XD76-:UC2_L-Q:RZ6\:2
M&8K\^\%@1M)XQ@]<\]JW*\FN;:\N?&GQ'-KJ]UI_V>WM)P;7:'9EMB0"Q!PO
M'(&"?4=^\\&:I<ZUX,TC4KPAKFXME:1@,;FZ$X]\9H W:*X?XDWVIZ=;Z%+I
MNIS6AGU:"UD1%4JZN2>>-W\/0$ @G/ME16FL'XBWOA4^*=7-C)IRZ@9BT?GJ
MV_855MN%4YR<+VXQ0!Z;17ENF:QJEWX%T9+W6YHKLZH]K*50_:;Q$D9?+4CE
M6( RW& ,DCFDTPZ_KT?C70H-2U"SN;">-].:2YS+$64L(V<$[E. .2<9ZDC-
M 'J=%<#X5U;_ (2T:))!/=HEE9^9?@74@/G[MBQN,_-RDC'//"]F.>^H R;/
M5+^X\1:AI\VCS6]G;HC0WS2 I.2.0!VQ_3MQG6KS^VO+]?&7C*P?6KMX+:QA
MEBSMS;LRL3M&W'8'I7,VEUK5OX*\*>*I/$6ISW<U[#%+ \H\EXW?:59<<G Z
MDD\G&., 'LU8,_B.2#QG:>'WT]PEU!)-'=F5<'9C("CGN.N*YFREU#QK<^*H
M8]6N=-O-.OS9V9@D8+"J?QL@(#[SN^]GCITI\N9?BCX7E:[2Y+Z/.&EC4*'(
MVY<8.0#G@=J /0:;(S)&[*A=@"0@(!8^G/%>9W%[?Q> /&DHU*^,^FZA<K:S
M&X;?&J!=HW9R0,G@U9T75KCQ5KT.C75]=0Q6>D6US(+>8Q/<32JI+EE(.%R.
M!@9;G/% '4>%?$3>);"[N7LFLWMKR6T:)I YRA )R..N>F?K6[7C.F:M>:)H
M3Z5:W#M<:CXIN;,W,LOE.P#<_/M.UF( S@XW'H<$=QX:LO$&G>(;R/4;J :9
M<1>9;6CWSW4T;J5#$,Z*Q3D=2<$CUH ZZBJ]]]H_L^Y^R.B7/E-Y32?=5\':
M3[9Q7F%EXFN- CNFU1=4M-<M-+G=K&]N&E@OI%VMYL3$D<;6RJXP&/'% 'J]
M%>8Z3:^*+L>'M;@U.*.UE5/MLLNJ/*MTLF "L9C"(X+?*!CG YIO@W3]4UW4
M==-YXFU=H--UJXMHXA-M\Q ,89@ >X(Q@ @\<T >H5F1:A?OXCN-/DTJ1+&.
M!9([_P P%9')P4V]01Z^WTSP6@ZCJ9M+SP??7]S+KL.I^2;E[AUD:V(\P3 @
MY V @#IN*YZFM"?5;O1/''B$"[N[R&UT(7T-I+)N 96;(4 =]H&3D\]: /0*
M*X'0+>]U+0O#7B7_ (22XCED"37_ )C%XKCS.#$$R%3#':,#CW-9%O)XE\6^
M'9=<TB_2SU(7KE6EU&18[9$<CRGAV;?N@$[LDDYSC H ]5HKR_Q+?:I8W^H7
M&KSW\.D7*Q?8]6TR9_+L?E7(DB!Z$G[QSD'C'&/3U8.H93E2,@CO0!$]W;QW
M<5J\R+/,K-'&3RP7&XCZ9'YU-7GNIZ="_P :=)<R70,FFS2$"YD !5E   ;
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MTU%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 <CJ'@"SO]7U2_74]1M4U6)8[VWMY%5)=JE02<9'
M!['G\:@T[X=Q:9<:+-#KFIO_ &0KK;K*4<8<!6'*\#: ,#IUZDUVM% '%O\
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MZ ^C7>D'3D^P7;;IH=[89LYW=<@YYR.:I^/_ !#?>&_"EYJ6F&T:ZMU5S%<
MME"P7( (/!/TXKJ%.44GN* ,8>$M"6:QF&GH);!=MJX=@8NYQSU/<]^]%WX2
MT2^U":^GL@TTZ".<+(RI.HZ"1 0K]!]X&MAW2)"\CJB*,EF. *Y;QIXCOM#T
M[3[O3#:2)/?0VTQDRQ"N1]W!QG![T ;%QX?TNZU.WU&:U#7=M_J)=[ Q]OE
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M6^7:K%NHR^3CIUS0!RMDWBSQ-X2MM?TS4[>SO&E><W$^HR")$#$&-X!'L
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M(G=$MQ&/D5H^C9ZG<"3GMQBK:ZIJ7B77/!4L^HZA91ZMI\\EU!;3F-6**,$
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M;SE@4/O9HPS9QG<1P3U->K7&BZ;=:5_9<EI&+#;M^SQY1-OIA<<>W2J3^#M
META=*DT\-IZG<MN97*#IVSTX''2@#E_$>CZ;IOB?P.]C86]KB^>,>0@C4 QL
MV-HXY/.:SM+32/%3>-=/\3W"Q7::DT>^255D@ME(\KRRWW0"&/'&6YZUW-QX
M0T*[^R?:+(R&S_X]RTTA,7.<J=W!]_IZ4NH>$/#VK:G'J.H:/:7-V@ $LB9)
MQTSV/XT <#=.NM>.+C1I=5BMH?[)@^PKJ5H)?,C8'S,!F7YSQGOP>F*S;WPU
M8077@339-0.L0_;I[9KDJ5\R( GR^IRH)8=?45ZGK/A70O$)B.K:7;7;0C$;
M2+RH] 1SCVI+OPIH=Z]FT^GH39*%M@C,@A Z;0I !]Q0!<TG2;/0]*M]-T^(
MQ6ENI6-"Q; R3U))/)KG/'=Q8!]"LKM7EGN-03[- 9 D,CKS^])5OD&<X R3
MBNPK.UC0=*U^V6WU:PANXD;<HD7.T^H/44 >,ZDEL?"WQ)L;B2T<V]['/$EO
MQ$LA R47<2#G(/;/Y#I9-)LM!\9>![O3+?R;F_BN$NG#,6N ( P#$GGGFNPD
M\!^%9#,3H=FOGJ$D\M-FY1T!QCC@<=\#TJ=O"&A/-9S-8!I+(8MF,KYB_P!W
MGC_(H \EU 6&M? G4M9OHK:377N&>YE<#S4F\_ 7)Y&(S@+Z5[E$P:%"I!!
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M:.?O$GGH*](\*RB;PEH[^9YC?8H-QW9.?+7.?>@"^]_9QW7V9[N!;C ;RC(
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MW"R_99%EMI(7*/"Z]"I'3^50IX5L%M;V-YKJ2>^C$5S=O+^^D0# 7=C@8SP
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MV&-7BOI(]B$D[1M((&3G% %#4K*ZTOPIXF@U+5Y;RYNHY[JVD!\N0(D"#HF
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M&S;V"NH.0'4':V/<'H/052_X5SX76WL[>*PEABLW\R!8;N:/8_\ ?^5QEO\
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M#>_R/G/RG/RKG^$8'M0!2\-A9/B=X[4C@KIX//7]RU2_"E0OPUTE1T'G ?\
M?YZV+/PEHVGZA>W]K;S17%ZH6=EN9<. , 8W8&!P,#@=*MZ+H>G^'M.33],@
M:&U0EEC,C/@DDGEB3U)H X73;?2?%>I^-K#6IV-U#=F(.[*#;6X4;&B)SMY#
M$GUP:72Y++5_B))I6H%+ZP@T:!M-6\7?YR-]^7#<,QX!..@^M=5J_@GPWKVJ
M0ZEJ>D6]S=P_=D8'YAV# '##V;-6M2\.:3JTMM->6:M-:_ZB6-VC>,>@92"
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M=2@M+C*QQ1W$*,?LQC7!C9^GS$MQW.:[/_A"/#7]F_V=_9$'V/S?.\CG;O\
M7&>M3:EX1\/:Q)!)J.CVEU) H2-Y8PQ"CH,]Q[&@!WA6.WA\+Z?#:7\M_;1Q
M;(KJ7[TJ@D ^XP.#W&#7">#]!76-4\9,=2U.S*Z[<+_H=T8P>G4=#UKU#R8_
M(\D(HBV[-@& !C&*PH_ _AF)W=-&M@TC[W.#\S>IYH YSQ!H>C:EX 317N3-
M>Z4(K&VNHD'F_:D50 F3U/&1GCG)&,C*L-5G;P1XLO;F'RO&EK!+'?L$"RJ
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MO@D[4Q@ <GG&[WJ>#X?V=O'K2)J^JD:PA2[WR1,6R,9!,><[<K]">^".NHH
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MRF-S)*5! E\HE< [OFSW''- #Y/A[X>ENI+B6WG=Y85AG!N9-LZJ,+Y@!PY
M[GTIP\ Z NG:?8K%="+3Y#);L+N0.F1@C<&S@C QTP*Z>B@#E]0^'GAG4M8;
M5)[!DNG7;*89GC$J^CA2 1QSZ]ZL:IX*T/5KZVO9K:2&YMH_*26TF>!O+_N$
MH1E>.G:N@J*Z:X6UD:UCCDN O[M)7**3[D D?D: ,[0/#6E^&;66WTJ!X8I9
M#(X:5WRQ[_,3C\*@U;P?HVM:M!JEY!+]LAC,0DAG>(LF<[6VD9&<\>]/\):U
M-XA\+6.JW$,<,MPK%HXR2JX8CC/TK:H Y6U^'GAVQ6,6<%S;F*5YHFBNY%,;
M-UVD-P.O'3D^M;FE:19Z-;20V:.!+*TTKR.7>1VZLS$Y)X'Y5>HH \_\2:;<
MZG\3= G%EJ/V*TAFCENX-R!'<#;A@<D=CV]:Z&X\%Z%=:/-I4]H\EI<2^=.I
MN)-TSY!W.P;+'*CJ>PK4&I6C:J=,693=K#Y[1@\JF< GZG^55M$EUN6.\_MN
MWM(76Y=;86S$AH>-I;/\77_"@!NH^&]+U;3X+.]@>5+=@\$AF?S8F'1EDSN!
M]\U8T_1[/3'FDMT<SSD&:>61I)),# RS$G '0=!5ZB@"C:Z18V>J7VI00*EW
M?;/M$@ZOL&%_2JEOX4T6VN]0N8[1C+J(Q>>9/)(LPQCYE9B.A(Z<"MFB@#DX
M/AMX6MU@5;"4K;S>= &NI3Y+<\)\WRCGH.O?-2W_ ,/O#.I:VVKW.G;KI\>;
MME94EQTWJ#AOQZ]\UTLDBQ1/(YPJ L3Z 5RF@Z[X@UU-*U6"TL3HU\)&=2S+
M-;J"0ASDA\@<@ 8]3UH O:KX+T/6-434KJUD6\"[&FMYGA:1./E<H1N' X-6
M]!\/:9X:T\6&E0-!;@YV&1GY_P"!$XK4HH R[SP]IE_K%GJUQ#(]]9[OL\HG
MD7R]PPV & Y'!XYJJG@[0X[?48$MIEBU)R]X!=S?O6/4D[^_0XZBMZB@"MI]
MA;Z78PV5HKK;PJ%C5Y&<J!T&6)/ZUFR>%-*;4KK48UN;>]NR#/-;W,D;284*
M =I ( ''IU%4= \2:AJ7C'Q'HE[;6T2:5Y'EM"S,7$BEN2<=MO&.N>M=30!C
M2^$]"FT"30Y-.C;3I#N>$ELLV<[BV=Q;/.<YJ+2/!F@Z)IMQ86EB&@N5V3><
MQD:1>FTEB3M&>!TK>HH Y[P_X(\/>&+AY]*L/*F<%0[R-(44G.U=Q.T9].O>
MHU\ >&UT^\T\6,@M+N3?+"+F4*><X&&X7)SM'&?H*Z6B@#$N?"6CW4%E&\,R
MO8J5M9TN9%FB!X($F[=C'&":;=>#M!O-%?2)[(M8RR^=+&)Y 97SG<[!MSG.
M#\Q/0>@K<#*Q8!@2IP<'H:6@#$/A+1VU&RU!HKI[NR4K;RO>SL4!ZCE^0>^<
MY'!K;I"0,9(&:H:IK5AI&DR:E=W""V0<,K [R> J^I)X% $K:;:-JT>J-#F]
MCA:W67<>(V(8C&<=5';/%0Z;H.F:/<WUQ86HAEOIO/N6#,?,?GG!/'4],5HT
MA( ))P!U)H RM=\-:5XEMTM]6@DN(4;<(Q<21KGL2%8 D=L]*C;PKI4DUO+,
MMY.;>198UGOYY%#J<@[6<@X('45K^;'Y7FAP8]N[<#D8]:Y+P]K^O>([?3-:
MLXK Z/>22K)"X99H45F56#9(8G;R-HQG\: -!?!6A)'J$8@NBNHKMN]U].?.
M''WLOUP,9],CH2*:_@?0)+73[9K6X,.G,'M%%[./)8="/GZCMZ=JL>+=5NM#
M\*:EJEDD+SVL+2JLP)4X'L15G1-0.HZ-I]S,T8N;BTBG=%/3<H)P.N,F@#BM
M$\,7%YXY\2ZAK&DWL-M>^5]EF%SY>45<,C".3)R<<'(.*ZN^\(:'J)L#<6;@
M:?M^R)#<21+"5Z%51@ 1ZXS4VE/K1U#4TU4Z?]G68&R%J6+B(Y_U@/?@=/>M
M&.XAF)$4T;D9SM8&@#+N_"NC7M_/?36A%S<((YWBF>/SE' #A6 <8&,-GCBL
M[7;?6+RY3P_9Z3;+H-S;>5<7GG!#"N2&18P.?EX&.!GVKJ:C\^'>J>;'N8D*
MNX9)'7'TH BFTZSN--;3IK6*2R:/RC R@H4QC&/2LS0_!WA[PTLXTC2X;;SQ
MB4Y+EAZ98DX]NE;+S11'$DJ)T/S,!WQ_.D>XABD2.2:-'?A59@"WT'>@#$TC
MP3X;T'49-0TO2+>VNG!!D0$D ]0N3A?PQ6Q>6=OJ%E/9W48DMYT,<B$D;E(P
M1Q[5A^*_$\?A_P#LVW5XA=:A>Q6J>9R(PQ.7(R.  >XYJUH]SJ4%O-_;MUIS
MCSB+6XMVV"6/MN4]&^A- #M,\,:-H]R+FRLPDPC\I':1W*)Q\J[B=J\#@8%:
M%[96NI6<MG>V\5Q;2C#Q2J&5A[@T^:>&W4--*D:DX!=@ 3^-->ZMXXEE>>)8
MV^ZY< 'Z&@#$T_P-X:TK3[JQL=)BAM[L8G56;,@_NEB<X]LXJ1O!V@/:6EJV
MGJ8+-]]LGF/B)NQ7G@CMZ58U%]6.H:4=-FL5LFE;[9Y^2[)MR!'CC/!ZUH37
M5O;E1//%$6^Z'<+GZ9H PM2\-6,,6HZC8:<TNJSV[QAA.0TA*E0"6;&!GOT[
M5F^!?!\&E>'=+&IZ6D.IV:X(,@=0XR-Z@$J"0>N >N:[)I$1E#.JECA03C)]
MJ;'/#,A>*6-T!P65@0* ,^W\.Z3:ZM-JL-H%OIQB6;>Q+CT.3R/;M45GX3T+
M3[D3VNFPQLLAE1024C?^\B$[5/N .IK1CNX;R&4V5U!*RY7<K!U5O?!]>V17
M/_#_ ,07OB?PC!JNH+"MQ)+*I$*E5 5R!@$D]!ZT );V>MZOXB$VN6-I;Z?I
MMR\MAY4N]YV(*H[#^'"LW'JP]*UM1\/:5J]W;W=]:":XMO\ 4R%V!C]Q@C!]
MZFU;5;+1-,N-1OYEAMX$+LQ/7 S@>I]!68VJ7VJ0:'?:/<V,=G<NCW2W)RYC
M90=B8.-_- $R^$M#2XNYUL=LMX,7+B5P91_M<\TU_!OAV31DT>32H'T]'\Q(
M'RRHWJN3Q^'J?6M6:\M;=7:>YAB$>-Y=PNW/3.>E.-S;K-'"T\8ED&40N-S#
MV'>@#(?P=X>DTF#2CI4 L('\R.!<JH;^]P>3[FIE\,Z0NIPZE]E)O84"1S&5
MRRJ,<<GIQT[]ZT)[NVMC&)[B*(R':@D<+N/H,]:FH S-)\.Z/H4EU)I>GP6C
MW3[YC&,;S_AR>.G)J_<0175O+;SH)(94*.C=&4C!!_"DN+B"UA::XFCAB7EG
MD8*H^I- N8&MQ<+-&8"-PD##:1ZYZ4 0RZ78S)9I):Q,EFZR6R[>(F4$ CTP
M"15:[\/:5?:K!J=S:"2]M_\ 4S;V!C^F#Q[^M7X+F"ZB$MO-'-&>CQL&'YBH
MM2^UC3+HV,L$5V(F,4EP"8U;'!;':@#.3PCH49O2E@ ;X8NB)'S-_O<\_P"'
M%7],TJRT:R6ST^ 06RG*QJ20OTR>*BM+QK71+:XUB]LEE\M?.GC;9"6/]TL>
MF>E7XY$E0/&ZNAZ,IR#0 ZBBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /-=8T>/7?C')87,]Q%:
MMX?5I!;S&)GQ.V 6'..<X'H,US5EK&LVLEMX1>Z>>UCUZ:R2ZNY63S(HU#)$
MSKSRQ XZCCI7J]]X:T^^UE-8)N(-02 VWGP3,A,6=VTCH1GGI4%YX,T*_P##
MXT2XLM]F',@R[;PY.2^_.[<23DYYS0!1\(Z)JFAZKJJ7=];-9W)2:VL(I7D^
MS=0VW?R%)YQTS5_QIJUUH7@S5M3LD+W-O;EH_ESM/3=CT&<_A5G0O#FG>'8)
M(K!)<RD&26:9I7?'0%F).!G@=.OK6C<6\5W;2V]Q&LD,J%)$89#*1@@_A0!Y
MMKL#>'-/\*Z[I%Q<M<RWEM;W69VD^V1RCG=G.YL]#VSQVK'AT9-0D^(:W&H:
MHR:>Y>V7[;)\C")F#9SDX(Z$D>U>CV7@_2+!K01I/)%9,6M(9IWDC@/JH)ZC
M)QG..V*BB\%:7$-6VRWV=67;>$W+9?M^!QQQVH E\$WUQJ?@?1;R[D,EQ+9Q
MF1SU8XQD^YZU0\;M"\NAVLES.6EO=PT^W(#WP5&)0DL $&0S$G&!SSBMW1='
MM=!TJ'3;(R_9H1B-99"Y4>@)[57UWPQIGB)[.2_CE$]E(9+>:&5HY(R<9PRD
M'G _*@#G?AW-=+?^)].G!CBM-0 A@\YI1"&0$JK'MGMC R:[*^MH;NQGM[B,
M212(0RGN*S-'\)Z/H-_=7NGP2QS7)S)NG=P3@ G#$C)P,GK[UJW5N+JUD@:2
M2,.,%HFVL/H>U 'B&GZ?:Q_LX+J,<0CO%W,)T)5\BZ*CD>Q(_&NXU4M#\9O#
MZQLR+/87!E520'P.,COBMJT\#Z)9^&9_#JQSR:5,I4V\L[,%!8M\ISD?,<_6
MF6W@+0;;4[74EBNGO;9"D<\EY*S@$8Y);GCC'3VH XK3C(WPA\;$E2YNM1+'
M.1U.>>]=;J'BB]T*WTZ"V\-:KJJO:(YELT#*IQC:??C/XU:M_ ^CV^GW^GC[
M8]GJ$KRW,3W<F'9OO'((//?GFMVTM8[*TBMHBYCC7:OF.7./J>30!YUIUA:7
M?QIOI9K$0R/HT5P4;&Z.4N,G(_B'3(]*YUS+'\,?B !=7>ZSURX2!S<.755:
M-0"V<D8)X.:]5O/"ND7VOP:W-;M]OA38)$E90ZYR P!PV#R,U7_X0?P^=-U#
M3C9RFTU&8W%W&;N;][(3DL3OSR0,XZX% '&2>'K6U\8^$UBN;]3J]A<)?M]K
M<M<!(T8 G.1RQ^[CVQ66]_/X7T'Q?IVG7+V]E;ZS#;Q-([,+:*7;OP<Y Y/?
MC/KS7I[^%=(DO-.NWAG:?3@5M'-W-F($ '^+G( !SFFQ^$=$C_M(?8V==3R;
MQ99Y)%E)&,D,Q /TQB@# TCPS=Z1XOMM534-+MK6ZB:&2SLX71;D[=P< N1N
M&,[L<@'UKNJY_P />"M \+2R2Z38F&1QM+O*\A"YSM&XG Z=.N!G-=!0!X;I
MGA6PU7P5XLU:6>:"_L]3O)+:X%RZ+ R?," #@9R03C-;<[1Z]*K7*MJ>J#P[
M$]Q:W*A(+-F7<9,X)$C$\ #/') Q7<IX+T"-YBEDX2><W$L'VB7R7D/)8Q[M
MAZ#MVHU#P9X?U35SJEYIXDO&C$3R"5U#H/X64, P]B#0!YW8KK6J>"/!^II;
MQ:ZMM;RM=Z9<RC?.N=HD /WF4# SGKZFDNIM,GTOP'<Z-)>);-X@$9BG9E9,
MRN[1NN<$JW&3D\=:[ZR\ ^&]-^SFRLI[=K;>(FBO9U90V-PR'R0=HX/'%2S>
M"= GMK&W>SE$5A)YUL$NI4*29)WY5@2V23N.3SUH X;QA;2V>J:U=:S;/=Z)
M>-&L>JV9WS:45 !!7J%S@G'7/.<XKU>-UDC61&#(P!5AT(/>L6?PAHMR;SSK
M>=TO65[F,W<VR4@ ?,N[!X4 \<XYS6VJA5"J % P .@H \RU_0K?6_C"--NY
M;L65SH3O+''<.JLWF;/7C@*<# ) SGG-*WT>Z\73^)+ W=A%/I]V;*V>Y5Y;
MBUB15$<B$.-N>6SC).<DXP/19O#>ESZ_'KDD4QU&)/+2474H 7^[M#;<>HQ@
M]ZHZMX"\-ZWJZ:I?::'NQ@,Z2.@D Z!PI ;\?3'3B@#F-!DC\1^,;O1];N(M
M4ATO3;80;US%=LZY>?:203]T \XR<5R!W6WPJU=H7=6A\2-'&X8[E7S$7 /7
M& !7K6M>$-!U>YM[^]TTRW-G&4B,,C1L4_N?*0"/8\<^YKF? WADS>%M<T+7
M]$FM[2ZU&:98I2%#1E@5P4;((*C],$T 6-353\9=.MLNL5SH\WFK&Y3<=V,G
M'?'?K7!3!W^!TDQGG$J:NR!Q,V<&8*<\_-QZYKUFV\"^'+2^AO8;%Q=Q(42=
MKJ5G /\ M%LGV)Z=JA_X5[X9_LB32OL,_P!@DE$[0?;9]I?KN^_Z\_EZ4 <C
MXU\,6'ARRT)[%[PO/XBM6D,UT[[BWWB03@DE%//>KDF@V.L_%76].O\ [1-8
MR:9%*]N;F0*S%SZ'I[#CVKLM3\,:5K%I9VU_%/-%9R++!F[E!5QT8L&!8CL2
M2::GA728]5FU-4NQ>S1>3),+Z?)3GC[_ &SQZ'D<T ><:=+<GX<^%4N));G3
MH]7:WNX\%WEA62147:.7487*@'('3 -=5X/TDVWB[Q)>6\%S;Z2SQ1V43AXH
MPVW]\4C.!M+;<''KCBL[Q1X'@M-/TJSTCP^VHZ1!=//<V0OY%EW%2%:-W?@9
M9BP!&3CWK2\'Z$]AJ+7=MI=_I%AY)C^RW=^TYD8D$'9N8)CYAUR<]* .QN;:
M&\MI;:YB26"52DD;C*LIZ@CTKQV2PM+7]G_49+:VAADDFD#O&@!;%Z0,GO@
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M!(L%TQ:X*W$@DE)ZEI V\\<<GIQTJ71=#T_P_8+8Z9%)%:I]R-YY) OL-['
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M\:P:S#']N>]DMKA)2"T5N$ BQZ+C)!&.<FNIN?".@WALS-IT9^Q($M@K,@B
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MEX7 Z 9'':@#MJ9%-%/$LL,B21MT=&!!_$5Q/CR\>#Q#X0MKC/\ 9-SJ#)=
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MWW\,3$CDH<Y7/H<"M>_1=%U'XB0>'86M'ATNWD$5JNP)(4?+(.@.W;ROIZT
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MV  P+=EVE-G]T ]AQ@F@#U47UH98XA=0&250T:>8,N#T('<5/7#> -4NO%4
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M,,@<*?0X/!KE?$'B::U\2Z#9Z;JEA)#<WRVUW;(H>5<JS9+;OE'R@8VY]^U
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MW-K;WD#074$4\+8W1RH&4X]0:KOHVER6D=H^FV;6T9W)"T"E%/J%Q@=35VN
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M6[$@2PN&4D'!Y'O0!9HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M/R,RY"^<2?PQ^E>^?V?9;MWV2WW$8SY8SC&/3TI/[-L=NW[%;[<YQY2XS^5
M'FFLZAI=C\4DGMVMY(8_#<PD@MY%!E4$LL8QW(' KGEU730W@.YBU.V^Q0WB
MG[';?-'8J5.$9B"Y<]]QR<' KVU;"S5PZVD =<881C(QT[4U--L(E58[*V0+
M)YJA8E&'_O#C[WOUH \BN[MGL?B-H]B2^KS7YF2U4$O+#A"^!Z%0PS[CU%;W
MAZ^\*>)=;T74[&]U"^U6W1@L3,?]$4KAQ(   .W/4],UZ*((5G:=8D$K@!I
MHW$#H":;#:6UN\CP6\43R<NR(%+?7'6@":O*;%O#U_\ %WQ1+J$]C)$EO:B-
MY9@ '"\X.>HKU:JO]F6'_/C;?]^E_P * /,O%^I:';?#?6=$TVXBGM;62)!)
MYRE"TD^\QJ3G<54\]^1WS5G53HI^+?A!;<V!MTL9E0(4*@8S&!VZ\K^E>C?8
M+,QB,VD'E@[@OEC&?7&*/L-GO5_LL&]<!6\L9&.F* /&KVXL)?AW\28K.6W=
M?[7DD5(F!^4F+Y@!VR#S[&NDU*'2;WQ=X1E\,/8?:+:1Y)WM=N$M-A#!MO0$
MD 9[GMS72>+?"_\ ;OAF\TG3EM+-[M0CS-%T4$'@+C)X%;5E:+#;CS8+9)W7
M$QA3"L?QY_.@#R#4;W[1X0U^73YDNX(/%#75Y% X<O:AP2<#.5R ?3 -=3J4
MMOK7Q)\*:AH-S'<&*&<WD]NRNHMRHVJY'JQ.T'OD]J[N*SMH-WDV\,>X8.Q
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M]SM\^"*7;TWH&Q^=2*JH@1%"JHP !@ 4 +1110 4444 %%%% !1110 4444
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MD C;DX1"O_CV2/?WJ]JJ2Z?X:\(>.+0-<S:5:0I>+&<M/;R(JO\ 4@G(S[T
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M\*/8W%ZNOV)M[=Q'(_F=&.<#'4YP<8ZX.*T_[;TS^RH]4%["UC* 8YE;(?/
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MEA<!(),QL.JGY?O?[/7VIR^(]*?3[:^2Z+070)@VQ.6E ZE4 W$8YR!TYZ4
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M9X<[%;:#@X)ZX..E9_PYO+B_\ Z5=75S+<S2(Y::5RS/^\8 DGVQ0!U%%%%
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MV]Y<06SC>]NH!<J![@'/3@U[<]M!*X>2&-W'1F4$BB.V@A8M%#&C'@E5 )H
MX3PK+X9UGQ3'K6C:G?ZI>_8S%+-*YVPQ9R%<;1R6S@=>">U6?B#JMAIE[X=-
M['%&[WC>3J%P6\JS8+]]@" Q.< $X[]J[2.*.%=L4:(N<X50!FB2*.9=LL:N
MO7##(H \(:\M9_#GQ+M(-1:_GD=;E9#'AI8P%W/@ #&3U QWKTFQ?5==T/3+
MGPWXAL[>U2V2.3?9>?N< 9PV]>G3O77"&(%R(T!?AL*/F^OK3E544*BA5 P
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MGBUJ^O+ZS*B#3T$*O!P%<.JHI$8'7)P0.,FLC2[3P[/X#\<Q72VGVPW]VN,
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MZ+/&=7@N[1A"AQ);&-2)&9.JA>^?;U%:7BB/4/#OCJ'4M)B=E\10C3I1&/\
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M158R,P,8!SU/4?G6'X4;PSJ6FZ'I-^^KOKVFR1_\2IY9E\F:,XWXQM4#.>O
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M$M[W2XLMJ=NOEAH77Y9 .0KC</TK*^%NNZ7I&BZ\M]?0PR2:Q/-'&6R\B,$
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M)I^K>*-)T6<P7D\GFK%Y\B0PO*8X\XWN%!VK[FO-M.=(/A#J?A'5(6&O1K/
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M%M!:33:O:+'> -;GS ?-![CV]^U8,GQ/\/R:[I6GV-['<Q7GF-+.JMMC"J<
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M=Z -R.&*+_5QHG 'RJ!P.@IS*KJ58!E(P01D$5AV/C3PUJ4%Y-::U:216?\
MQ\/OVA!G&><<9[CBEM/&/AV^G>&UU>VD=+7[8X#<+#Q\Y/0#D>_- %^^LYVT
MBYMM+FCL;EXV$,HB!$;GH=O0\U4\.Z/=:59NVI7PO]3N"&N;KRA&'(&% 4<
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M/!OPPN)9;>-XM3A1V9U!5$+*23G@< _C7MIMH"23!&2>OR#FC[+;XQY$7_?
MH \NB\1:%IOB'QCHGB[;";Z<R(\D;'[3;,@544@9. . .Y..<U-$^DGXL:&D
ML-O;1P>']L-O<,I:!MXVKR>'"$^^,UZ5):6TTL<LEO$\D7^K=D!*?0]J<UO"
M[[FAC+'N5!- ' _"F>W>/Q5#;2Q-$FOW1A2-@56,[=I4#^$\X[5'JDUC)\<=
M+2=[=S%I$F0[*=C[\CKT..:]#2&*+/EQHF>NU0,TA@A+[S%&6_O;1F@#P[2M
M6TNT\,*K?9!M\6N8)'D/E6622DK*K#*@ X!.._:K<.H:%-J7CV/4=9E:VNS8
M%;N/;'(>@$J@!1M5F0YQC&.3GGV-K.U>-HVMH61OO*4!!^HIQM;=F9F@B+,
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MMK+P]96]G:2VEJB8A@F9F=$R2N=W(.,'!Z=.U:3(K8W*#@Y&1T-*<X..O;-
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M<' QR*]<KGO%WARY\36=G;07\5H+>[CNMSVYEW,AR!PZX'K0!R>I36.H>/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M.BMNG#!4W 9P >.HQR!767VK:?=?%?P[)%.DD9T^<+(!E=SE-HSV.!T]QZT
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MQP<=:ZGQ-'-!X*U%DO;E;FULI)$N8WV.71"0QQ@<D<C&/:@#>HKS?1;FTO\
MP+IEQ=>)KN+5;ZWBC5UOV+"XDPJ_)G^\1QC%=@WB/3[?78="GDF74)(C(BM"
MP615&25;&#] <T ;%%8L?BC3I-(&IXN4@9Q'&KV[J\K'H$4C+Y[8S3;+Q=I%
MY'J)>9[2331F\ANT\MX5QD,0>Q'((R#0!N45S\'C'3)]0?3Q'>)>"W%S'!)
M5>:(G&Y >3WXZ\=*BE\<Z+%HNG:QNN'T_4)1##.L)P&+;1N'49(/;M0!TM%<
MM9^,#=>+]4T4Z9>)%811LT_E9&6#DDX.=I"C;QDG/%9.E>*_#WAKP6VJ0W&L
MWNE_:Y%:>XC:1XV+8(.0"J[N!GN: ._HK*FUZ&"]T^T:TNS)?)O0B,$(!@G?
MSQC(S]15%?&VD&ZLXW-Q';WLGE6EY)$1!._8*WOSC. <<9H Z.J<.FPQ:C-?
MLTDMQ(-JM(V1$O&50?P@X!/J>N<"G:G?Q:5I5WJ$^3#:PO,X&,D*"2!GOQ7'
M^$K>;QCH$7B#6;R[+WS.\%O;7,D$=M'N(51L(W-QDEL\F@#NJ*X#0O%=[8ZO
MXB\.:D9=0O-)VRVSQJ#+/ X!&X# ++N7)XSFN3M=;O)OA_'XT?\ M=-;AAG9
MKF+!MYMS.JAE)QL7"] #D4 >UT5Y:-.T*WO/#FJ7^H>([&YGG@BCA>9S%=3@
M+AGSN'.2.HR <"NTU?Q=I>C-<B?[1,+10]VUO$9!;*>A?'3CG')QSB@#>HK%
MN?%.GPK;>0MS?/<V_P!JBCLX3(QBXP_H <\9Z]LUGS_$3PW!8Z=>?;))(-0?
MRX'BA=LMSD'C@C'3K[4 =516=H>M6GB#28M2L?-\B1F4"6,HP*L5((/N#3M:
M3?HE[AY$986=6C<HP91D$$'/4"@"_17DWAP:-J'@.SUC7?$6I+?W,6)WCU:5
M6#%]HQ&'P#TX _"NSD\56&AW5IH-_-=W6J"T#GRK9V,Q4 $K@?,2><#..<XQ
M0!TU%<8WQ0\.C3C?+]O>*)BMR$LW+6I!P?-X^3FM'5?&VBZ/<V5O<RSL]]&T
MEN8H&=9 %W *0,$G@ #))(]: .BHKA-:\3V'B;X?^))M,N;VUNM/MI3)&=]O
M/#(J%EW#@@''X\UKV>OVNFZ!H4<WGSWEW:Q^3;PIOEDQ&"QQZ#N3C\S0!TE%
M<M+X_P!'AT.\U9H[TQ6,WD7</V<^;;MZNIZ#IS[UH+XCMF;256UNR=3R8<1@
M[0!DEN>!@YS0!LT5SESXVTFTGC$HNOLLES]E%ZL), ESMP7_ -X8STSWIVK>
M,M,T?[4TT=W-!9D"[N+>$R1P$XX8CN 02 #@$>M '0T4R&:.X@CFA=7BD4.C
MJ<A@1D$5SMQXWTR"X=!;WLT$=X+%[J*(-$LQ(7:3G(P6 )QC/&<T =+17E>D
M>)(?#7B_QN;P:G=V\,\# 1(]P84$9+,23\JC/K].E=M<>+M.C.GQVB7&H3ZA
M US;0VJ@L\0 );YBH Y'4C)XH WJ*\Y\;:U8^(?AO)J^F7%PI@NX$P'>)HW\
MY%9'4$9(!/!R.XK2U!#'\7=%999MLNFW&Z,R$IE2N"%S@'YCTH [2BLKQ,N[
MPMJWSR(1:2L&C<HP(4D$$$$<BN'\#^/-.LO#'AO3M0CU"-KB)($O9;=A TO]
MWS#U/Z>] 'IM%<WJGC73=)^UR20W<UK9.([NY@C#) QQP>=QQD9V@XSS701S
MQS6Z7$3B2)T#HR<AE(R"/6@"2BN'?XJ:$L%Y,EGJ\L=E<-!=&.R)\C&,N^3\
MJY)'//!XK;N/%=@B1&RCGU*26V^UK%9[&;RNS?,RCGL,Y.#@<&@#=HKCY?B3
MH4=AIEXJ7\D6HL4A\NV)(D!(,;=@^01MY-,@^)6E3WMI9#3=:6[NXGDB@>R*
MLVTX(Y/7@\]!CDB@#LZ*X@?%'1VTM]073M8:*"5HKM5L\FT*G!,IS@8SG ).
M.U6M8O\ 0Y_&'AF.YBOY+QS(]A/"&6 [DR=S9 ;Y5Z<]>F#0!UM%<19^-=0F
MU'Q,K:'=R0Z4P5(T>$$8CW'<=_4]L9X]ZMZ%XP-WX3TO5-1LYX[J_"+#"NS-
MP[#/[L;N%P"<L1@#)H ZRJRV,"W[WV':X9-@+2,P1>X52<+G S@#.!G.!C$M
MO&^DRQZJ;GS[*;2W5;J"X4;UW?<(VE@P;(Q@G.17.S7GVCXNZ WV#5+&>6SN
M6E2Y8,CKM780%=E7'S9Q@YQGK0!Z-169XAU631/#]_J<5H]TUK \WEJRKPJD
MDDDCCCMD^@-9ECXK T#2+B_M+@:AJ$:>3:IY9DN&V!F9 'P%YSR1@=<4 =-1
M6-H_B6RUB^O;!([BUO[(@3VMR@5U!Z,,$AE/8@D5'XG\6:?X3MK>XU&&[>*>
M58@T$)<*2<?,>@_F>P- &[17)V?C_3KN\O[-]/U6UN[.W^T_9[FUV2319QNC
M7))Y]<=?K4-C\2]$OK)[[R-0M[%+,WANI[?$1 8*4# D%\D# ^G6@#1UWPE;
MZ]K6DZI->W,,NER&6W2()MW'&=V5)/W1WKH:Y^#Q=:-J]GI=Y97VGW5[&9+4
M72(%FP,D JS ,!CY3@\BFZ3XPM=7M]8D2QO;=M)=H[B*X\M6+*"2!AR.@ZD@
M'/7K@ Z*BN)?4]&O_''ANXN;#5;?5KBUF:S\T!8U3:68/ABI;'89QD9QVI_$
M76H+[P1K\5M:7\\=H&C:[MV"QQRC'!^<,P!/. 0._3@ ]"HKEM)UV&P\/Z!9
M+;W%W>3:=%*((-FX($4%B790!D@=>3TK4\/>(;#Q-I8O[ R; [121RKM>)UZ
MJP[$4 :M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MGLI?+D&#G&?2K>FZ?#I>GPV4!D:.(?>D<L[DG)9B>I)))/J: /(?#>FV^G6
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MR,CI10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MAV)(KYQM/?[I]O3-+XA\5Z=X8^R'45N=MU,L*/%"74,<X!/KP>!D\=*D\+7
MN/#.G_N;F%X[>.*2.Y@>%U8(,C# '\1Q[USWQ,NEL8/"]T\<LBQZ_;L4B7<[
M?))P!W/M0!J:7XXTG4I]2MY%NM/N=.C\VYAOXO*98L9\SJ<K_GN*=;>--/FN
M].AFMKVTCU(?Z#<7$86.<XR ,,2I(Y 8*37'^)?#=YXUU?6=0TZ"ZMHCHOV&
M%[B%K<W$WF>9C:X#;< *20!SQFK5]]M\:6/A:T_LJ]LKRRU""\OA<6KQ1PB(
M,&"LPPV6(VA2>.3B@#J)?&%HEQ.D5E>W$%O>+937,*H429BHVD%@W!902%QS
M69:ZKI$'C+Q&]CI^I3:REM%)<HWR)(J_*H3>P ^O /49[\WK.GW)UZ[U/PS9
M:SIOB+[;L:(V\GV*^4/CS'8C8!MYSD'/0'@G5T]IY?BGXCD73[Y;>YL(X8;F
M2RD1&D0'*AV4#'/7.#CC- %"3Q58Z_\ "RWU?Q7IVH?9)KC>3:8P2)6" %6!
M"C"K\V,GUZUWU]KD-I?K80VUQ?7IB,S6]L4W)'G&X[V4 $\#G)YXX->12V^J
M2? 0>'3H&KIJ4<JQ"(V;G>1/YA(P"0H7'S' ).!G%=B'O-%^(=SX@>RO[G1]
M9M(HPT-H[R6TD8X#QA=Z@C)SCJ>>U &G/\1="@\.G6S]K>W2?[-,B0'?#+D
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MZUI<FFI:7=F;427%NZDD,L;#/5B#CCCKT-=YX<3&F&5='BTF.9_,2U5%1PI
MP9 O <XZ<X&!VH UZ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **S;_6[/3[E;5_.FNFC,HM[>
M)I'V X+$#H/KUZ#)XK.G\=>';?1K;5WOR;&YD\I)A"^ ^<8;CY#G^]B@#HZ
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MJ"B,PO-DC  ??@E2,[<?AS3KKQY8P:GJFFP:;JMY>Z;L,T5O;9)#*6R"2!C
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M$KGEO0_6N1U:PEL?#=[<3V]PD.J>)EU"WMC"Q80!EW.R@$C(YP1G&/H/;:*
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M^LKJVU)[5)6/DGR"Y3<R*^3R.?RZUG?%>PNM2^&FKV]G \\V(W$:#)(616;
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M&GN1K".%POFD%?*Z8X?#X&,;1ZU0BL6T+Q;X@CUOPK=ZM::E<FZM+FSM/M
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M"8V#'<6[8SC/..*L)I6JQ^,O&6H'2[@VVHV44-JX9/WC+&5(QNR.3WQ7H-%
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M 3T/0 #IS6SX$T"Y\/\ AYX;S"W5U<RW<L8((B+MG9D=<#'/KFNFHH ****
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MR29"(,X)QDL>...]5?"\]MJ1TK2[OPEJRZQI[Q^9)=M)]F@:,@-(K%B,XS@
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M"3=B*-2 V0<[@"<Y)/(KO?B!IVIZMX8M+G28"][8W<.H);/PTFS)*>F>?TH
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M!9(NY!5FP1W!P:=I_B^UU*YT^.*POE@U$,UI=,J>5(%4MG(8E<@<!@#[<''
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MXIF;)C'4D ]"H)SP*W?%UQJ_BGX=:O'#X=OK66]\M+:UDB_?N5<%F<#A!@
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MSLT %%%% !1110 4444 %%%% !167?Z_:V-^FGB.>ZO6B,_V>V3<ZQ@XW')
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M'.,58A\?:3/=Z9&EO?\ V74G6*UO7M]L+N5W!<DALGUVX]^M '545RFH^/\
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MMNBQ'&"['.,D@  ')]!DU<\+>)[+Q7I3WUDKIY4S031O@E)%QD9'!'(((]:
M-NBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M2[$EHPV@[LL .2,M]>#5SQ-X=U;Q#K?C2WL[.Y2/4+*V6VEEB9$FDA8,4R<
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MJ5]\3-1O)-.N$TJZT1M,^U++&,.7W%@ ^X#'&<9SV[TWPC'XVTK3K/PW>Z3
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MA$GEP _))G#XSG:,#WZ\  FI+GQ]:P64^J0Z==W6BVTQAFOX=I48.&94SN9
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M9EDB7]Z7WDJN[[HSCU^O6@",?$N[?P_=:PGABX:'3YW@U)1=+FW9& 8+Q\^
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MGW4&I0%+*_GGP]JFW'E*F">3W! YR<]*N+H_BA1X0SIEFW]C &8+>?>_<F+
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MB.XWD!1$_&3D@8(&"?K6LFNZN=4?2Y=$2*[:T^TP2?:&:W;#!2CR"/Y6&0<
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M2HM2FFN9C#" X_U:OM;+]?05GW/C75-3/@^[TBUACLM7G;<LT[*[%4?*-A"
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M,AMN5.>",'GN: .HB@AMPXABCC#L7;8H&YCU)QU)]:BBU&RGOI[&&[@DN[<
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M!N^88"$ ]E"(/^ U)X=TWQE$;:VU_4;!K2SQMDLPWFW6!A=^> .YQU(KL**
M.<\<Z)J'B3PI>:-IYME>[ 5I+B1E" ,&R %.>F.U4]2TGQ/JN@+H@ETW3H9(
M1!<7,4KSR%, $(I1 "1D9).,UU]% '"7O@R_TZ_\.MX=%F]AI43Q?8[UV"[F
M&!-P#E^3^?'6LQ? 'B"/POK6F_;-.>>YU;^TK=L.JN=Z-ANNW[O09^M>G44
M<)JWASQ2OB&T\3:+=:>FI-;BUOK2<OY$B!BP*G&<C/M^'2MMK?Q/%;Z?Y5U8
M2W#W8?4#(K!%A[I$!SQP!GZGK7044 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% %*;6-+MKU;*?4K.*[;&V!YU5SGIA2<\U=K@O&_A30
M1X2U,MI\,^JW0*VUPZ!KB6Y<_NP'Z_>QP. H[ 5V6F07%KI-G;W<_P!HN8H$
M268C'F.% +?B<F@"W1110 4444 %%%97B;57T/POJFJ1KNDM;:25%/0L%.,^
MV<4 27FO:1I\Y@N]3M()E7<T<DRAE'J1G('O5JTO;2_B,MG<PW$8;:7B<. <
M XR/J/SKDOA9:JO@2SOY&,UYJ1:ZNIWY>5V8]3WP,"I;J2S\"6YM].MD>76-
M3"VEHHVJDD@4,2><(-I8X'&<4 =?17)_\)-J-CXG_P"$?U&UM&N+BU>XL+B.
M0QQSE/O1D'<5('.1G@&L"T^(FO7/@_3?%']B6IL)[GR984N#YS9E,:E,C'7
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M/;0S*/O(?,3(<=0.0?45-8>,=;>Z\-RZCI=G!8:VH2,QSEI8Y#'O!(QC:<'
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MLV8I<I^Y<$G!PS<\9V]!5S4->F/B./P]I:PMJ!MC=RR3Y,<46[:.!R6+=N.
M3GID WZR[/Q'I&H7YL;6_BDN@GF"/D%TR1N7/WAD$97(KBM9\6ZCJO@+Q/'%
M;P66JZ8LMO?Q&0L%78V'C; SG@C('>N@\(6<LGA31[RYM+ WT6GQI:RJ"2$,
M:X!8C(SW _6@#>U'4['2+)KS4;N&UME(!DF<*,GH.>]6(I4GA2:)@T<BAE8=
MP>0:\D&H:UJG@?XA-JIMI%@GNX<HS':R(J@(#P$ '7KGMWK>T;Q)K.FWWAC2
MM0TVVATW4;;RK=Q<-).ICBW9DXV\@#@$XSUH ] JK?ZC9:7:FYO[J&V@!P9)
M7"KZ]3]#7 W7Q.F_L\ZQIUC]LL%N?*\B."9I7C#%3() NP'(R$/;!R,XKK?$
MTB7'@?6)0IV2:;,P#J0<&,GD'H?:@"O_ ,)_X2P3_P )%IV ,D^>/\]Q^==$
MK*Z!E8,K#((.017F_AO5EB^&F@6=QHEW-;W45M922E4,>V5E0L?FSCYO2MK6
MO%,OA+5[&WU.WCCT&9#&NH LQCD"_*CK[XX(ZT =?17)7_BJ_P!'\/6MWJ=E
M%'J%].L%M:Q>8^TMD@OA2W !)"@GC S6:OQ#GT^'69=7TR?R+")9;>[CM)H(
M[G<P4)B1?E;<RCJ>I/:@#OZ*YK^T?$L6K+93Z?;&&>U:5+R%2T=O(/\ EG("
MP+#&,,-N?05@W/Q U)/AQI?BN*SM ]Q,L<UNQ8@9D*95@?;OGK[<@'H=4M+U
M?3]:M6N=-NH[F%)&B9TZ!EZBN1L-0U^?XGZ_:>=9R6]G:0F&%E9 RL'8?,&.
MUMV 6P>!P*BTKQO':^!6U:32K>UG>_DLX+.W^1&F,A49.!C)R2<9ZG':@#T"
MBN1D\3:KI/B6QT35K:SDDU*%VLKBW9HXS*BY,;[MQ'LPS_NUS2_$;Q.?#5WX
MB.BZ9_9^GW;P72"Y?S' =5_=C;CC/4]?3CD ],O;VVTZTDN[R=(+>,9>1S@+
MSCG\ZR(/&_A>YQY6OZ<P+;0QN% SZ9)QGVK5EE2?37E0Y1X2RG'4$5Q?PKM+
M>]^$6DVMU"DT$L<RR1NN0P,K@@B@#O000"#D'O17D_@K5=1T2V\5:#IL$FI1
MZ/J"P6*2/_JTD9@=Q_NK@D_CTK7_ .$WU.Z/BC3K-]-EO=)M5N8+R+<T,@()
M8%<G##&."1GKB@#T&BO/M/\ %UWIGA+PO'>>7/J6J6T9B9(Y9<1B)6:1U0%B
M><8'4D<@9(V/"/B>\UV?4;._TZ6WGLI %G$$D44Z'E2HD 8'U!]N>: .IK*G
M\2:1:ZE%I\]\D5S-)Y4:NI"N^,[ V-I;D<9SS6C.)F@<6[HDQ'R-(A90?< C
M/YBO)?!NLMIOPR@UK5DM;\?;)3:Q/#^]:Z>9@IWDD#DDY ! SUH ]>HKDW\2
M:GI7B.PT;5X+1WU.%S9S6^Y$$R#+1OG)Q@C##_OD53\+^*?$OB&]1WT>QATZ
M&[N+6[F6Y+,K)D H"!D9 &2,\]!CD [BL[3=>TK6+B[@TV_ANI+1@D_E-N"$
MYP,]#T/3TKF-;U+6?^%G:+I-K=VT5L]K-<;'A9LD#;\V&&>^.F.<YKG+?4=8
MTCQ7\0[[2+2SG^S20SSBYD9?D2$G:@4<L>>N ,=\\ 'K=%<6_CQ+BVT5;6%H
M[G4;);Y\VTMP((R!_#&,L2QQU X))Z ZGA'7[S7].G>_TV>QN;>=H6$D3QK,
M!TD0. =I]#R* .@HKSS_ (2_Q==KKJV&BZ4\VD7!24?:V974(&VH0H+/R>H4
M#IR:DM_B1%J]KIATN/9-=VANIB]M+<B !BFW;$,DEE89) PN>X% '?U!=WEO
M86SW-U,L4*8R['C). /J20 />N!?Q_KPTS2;C_A'ECFN=273IH[AI(27.2K1
MAD&4(&=QY'3!Q2>))/$EQ;>&&U*/3[*X;7(T,,8:921YFQB=RY7 !VXSG!R.
M@ .WTK6].UN*673KI)UAD,4H *M&XZJP(!!^M7ZY*/4KV?Q!J6D:+#IB7MG#
M%+J%S+$P66:13L4*IST7)8DX&!@UAW7Q+O\ _A&].U*STFW:YEU0:7>6\EP0
M8ILXPO&"" >21C(X/- 'I-%<!<^*O%VFZMHNF7^D:4+C4Y9XD,5RY7*#*M]W
MA>0>YZ\"JZ>-?%<UKX@BATO26O-"=OM,AGD$4B!=P"+C.[ /4@=.N> #T>BN
M1N/%5Z^F^'[V"WM[6SU.V^T7-]=-F*S!C#JI&Y2Q8G Y%8+?$W4/^$$NO$":
M?:/)8ZB;&Y D8*P#*-T8QGG>."1CWH ],HKC(_%NJ:;XHN-,\0VEE!;#3GU"
M.:TD9]BH<.K;@,G'.0/_ *TFG^(/$5_#HNIQ:5;RZ9J; O'&Q$MK$PRDC,3A
MN.2 !C..>M '7T5YS>?$+4'M9M1TG3Y+R"&Z:%;--/N'DN(U?8SK,!L4Y#$#
M!Z<G/ ZKQ/XDB\-^%YM9D@=RJJ(X6^4L[D!5/IR>?3F@#<K'U;Q5HNALRZA>
MB+84\TK&SB+><*9"H.P$]"V!63<>(M5T'Q#I5CK:VDUIJK>3#/:QLAAGXPC!
MF.5/.&&#[=ZQ/!\-]=^/O&T5[-9W$)FMTN4:W)$@\H@!07.T>QW9]J .VO\
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MC)VGCCGH?6EM_"7B63Q)K-_<?V5!;:MIWV5XXF=C 0I557@9ZC)X[X%>C44
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MY"[,^U25"@=.<Y ]Z@U?2O&'B;P?JEKJ%O86UW=0B"&TAG)1?F!:1WP<G@
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MDN'S$L2J/FXZ#('!)/MUJOX1T?Q7X5\)V>B+9Z-<-;!P)FOY5W;G9L[?)/\
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MV2>3C@#U/2@!-1^(=_I1CEO+2TB)U$6K:<SG[2L+-M64D$@9Z@$#(Z'O6A8
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MKGU-5O%=I-9^)_#_ (FC7=;6326][W\N&08\S'HI S[&NP5@RAE(*D9!!X-
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MP2EEFF2,X=PP.U>Y"D'('4$X$DOC;4KSQ+I>FZ-9V,MMJ>G&]MYYY6!'3[P
MXP,\#))QR* .ZHKS&/Q]XHG\*:GK,>EZ6/['N)8+S,SD3>61N\L8XX.<L?PK
M2U/QGK;>(M%TW1=/L)(M7LFN;>6ZE<%<(&&\ < 9Z#=GVH [RBO/+7XB7L=A
MJ%MJ>GPQZY9ZA'8&*$NT3M)DHXP"^,!C@ GCWXM0^+-=2;5+:73//-O9-=VU
MZ;.>U@<KUB?S 2&[C!P1Z4 =S17GL/C?7HH_"E_?Z?8)IVNO!!MBD<S))(F5
M;^[M)[<D#'.>DJ^,]3O]?O+#3CIRRV6H+;3:?<*XN7@WJK3H=P!&"6 QTZGM
M0!WC*K8W*#@Y&1T-+7 :]XXU30TU.^N+>QAM;.Z$,=E,6%Q=1?*#*ASC&6./
ME_AZTBWNN2_&B2P^V6QM(=*,R1&%L!&F4$?>^_\ */FZ>U '9:7K.GZU%/+I
MUTES'!,UO(R9^61<97]1^=7J\ZTSQV;3PSK^IWFFVD4]IK4E@D%I\JS290!B
MQZDECEL=!TK5F\1:OH7B/3M+UK[%<1:J&2TN+:-HA',H!V.&9OE.>&'/M0!V
M%9\NNZ3!=W-K-J5HEQ;1>?/$TRAHX\9W,,Y P1S[UY_)XZ\5GPWJ6O1V>DBV
MTJ^EAN8LR%Y41PIV=@0"3D]?08Y[:70;+4=535IX+=W^SF-%:$9.X8;>?XQC
M  Z#GKG@ N6FLZ;?O$EI?03F:+SHO+<$2(#@E3T(!X..F1GK5ZN$\6Z6GAOX
M<7$VG.(KG3)/MT$JH%Q)YFY\*. I#,NWI@XKL["Z%_IUK>!2@GA24*3TW ''
MZT 6***Y3XA^(M2\+>%)M6TV*UDDBD16%P&(PS!> ,<\^M '5T5P_P#PDWB#
M2/&EEI.NVUB]IJJRFR>S+[HG0;C&Y;[V1CYL#Z>F;!XZUFTU/0X-4?3O-U.Y
M:UGL8(RTED[9\O<X<JW;(X//% 'I55-1TRRU:T-KJ%M'<VY.3'(,J?J*XJP\
M5ZW&WBRQU2>R_M+20IM5BMF E5ES&V"_.XD+CC![\UH:OJ^OZ=+9VDEUIMJI
MM3)-J,\),<D^<")(@X;)Z]3P* -A]0T/PS_9VD>9%:?:7$-I;(IY)/0 =!S]
M*T;R\M["TEN[N588(EW/(W117DNM>(KOQ-I7@#6+>V@6^FU0@1.Y6,R+N7.0
M"0I(SW.*Z2'Q-K,.IZSX<\10V?VM=.DOK6XLBRQRQ<J5PV2&!H [/3M1M-6T
M^&_L9A-:SKNCD (##\>:;=Z5I]]=6UU=V5O//:L6@DDC#-&3U*D].WY5Y[X7
M\1G1OAWX0L8 #>ZC&R1$Q/*$5 S.^Q/F; QP.Y&2!S73>%=>U74[_4['4["5
M%M&4P7WV22WCN4;/19.0PZ'DT =14<\\-K \]Q*D42#+/(P55'N34E<9K=Z]
M]\2]!T \VL-O+J4Z'I(P^2//KM;)QZX/:@#L(I4GA26/.QU#+E2#@\]#R/QJ
M*]OK73K?S[N98H]P49Y+,> J@<EB> !R:X_Q5XHUC2;O4O):QLK6SM1- ;M#
M(U\X!9E0*P*@ 8)P>36)XDU;4=>7P+J-K/%:VVH7T$L<+P&0QR;'.68, PY'
MRX'3.: /0-&\0:9X@@FETVY\WR)#%,C(R/$X_A96 (/U%:=>;6=UK-O\5;RV
MN]2M3!:Z4MS,(K,JK@LN_ WD[CM'S$G@8Q26_P 0-:O(;'5K+2KFZL+FY$;6
M2:9.)4A)XE$WW&XP2, <XSWH ]*HKAH==\7WOB?5-+M+/2?+TZYMQ+([N-T4
MB[B!ZO@@YP ,=#GCN: "LJYU;1[C5CX=GN(Y+V6(R-;8).SN21P/SJ+Q/KZ^
M'M,CF"++=75Q':6L3-@/-(<*"?0<D^P-<G</J5C\5-*EUJ[M)88]*NI%F@A,
M04 KO!!9NF <Y[T =QIFCZ=HMNT&F6<-I"QW%(EVC/TI^I:G9:/I\M]J%PEO
M;1#+R-T'Y=:X-?'FM36^F:M:Z7<7=E>2@/8PZ9.9(H6SB3SON-V) &.< ]Z?
MKFN:KXB\*^)[O1Y+./3K2.YM-DT1=[C8I$C!@P"CD[>#G&3UQ0!V-E;Z-J<U
MOXAM+:VEGG@7RKP1C>8SR!G&>]:=>;Z5K^I:4_@'389+.73M5L]CJ+=E=#'$
M&R#N[D],=JN-XUU#3AXCAO(K>ZN-.NX+6U\E#$)7F"[ V6; !89/H#0!WE9V
MMZ[IOAW3C?ZK<BWMMZQ[RI;YF. , $UASW7BZUGO;68V3P?8&N(M2BMRJQ3
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MP!SW%:5>/^.[_6]:^'MGK$[6<.G7EU;RQV@B;S4C9P8R9-V"2,$C:.OM7L%
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MU!4%"C$_/UP<_@!5/2]>\2^(-(LO$6DI:/9W%QM_L^0 -]G#E2WF;OO\9QC
MY')YH [BBN,CUW6?$%QXA71)K:V&DSFUA6:(OY\RC+[^1A<G QSQG/:L%OB!
MK>K1^$I-&%C%_;1EAFCN(F;RIHQ\W(;E<]!C/'7G@ ]/DD6*)Y'SM12QP"3@
M>PJAHNNZ=XALWN],G,T"2M"7,;)\R]1A@#WKFK#5?$5_JO\ PCTE]80:C86J
MS:A=01&16=RWEHJMC V@,Q/T&,YK!\(:CJNF?#R[GMA:O=C6)TN9I"$B@4R?
MO)/F(R ,X&>X]* /5**\V@\9ZP[^+[2VN;:Y;1[5+JUN9[9DWJ5+,K*",],
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M;R3QQ:>(8;ZUBBM;1K2.U^RD_*3GJ''3CM3_  ?X5N/"XU42W\=V+^]>\)6
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5FR>'M%FU(:E+
MI%@]^&#BZ:V0RAAC!W8SD8&/I6E10 4444 %06UC:67F?9;6&#S7+R>5&%WL
M>YQU/O4]% !1110 4444 %%%% !1110 4444 ,\F+SO.\M/-V[=^T;L>F?2G
MT44 5S8V9N/M!M(#/G/F>6-V?KUJQ110 R:&*XB,4T221GJKJ"#^!I_2BB@
MHHHH **** *[6%F]QY[VD#39!\PQ@MD=.<9JQ110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444R::*W@DGGD6.
M*-2[NYPJJ!DDGL* 'T5R^F?$#0M5U:'38VNX+BX!-M]JM7B6X Y)0L.>.:Z&
M\NX+"RFO+J01P0H9)'/\*@9)H GHKF=+\>:)JNL)I2?;+6\E!:!+RU>'SP,D
ME-P&>!FNFH **** "BBLO7]=MO#FE2ZE>Q7#VL7,C0IN*#U(STH U**YD>.M
M)B%F]]'>Z?#>;?L\]W;E(G+9V@N,A2<=&(KIJ "BBB@ HHHH **** "BBN<3
MQC:R:Y=:-%IVI/?6J"26,1*,(>C EL$'VH Z.BL[2]8AU22ZB6"YMYK5PDL5
MPFUAD9!')R#ZCT/I6C0 4444 %%9.A^(;77SJ MH;B)K"[:TF6= IWJ 3CD\
M<BM:@ HHHH **** "BBB@ HK.US6(]!TF74);6[NDC*CRK2+S)&R0.%R/6H)
MO$=K;^([#0Y(+H7-]$\L4AC CP@!8$YSGD=J -BBLG1_$%MK5WJ5M#!<PR:?
M.()A.@7+%0P*\GC!'7%7[RY6SLYKEHY)%B0N4B7<S8[ >M $]%9^A:S:^(=$
MM-6L@XM[I-Z"0 ,.<8."1GCUK0H **** "BLG7_$%KX<LXKJ[AN9(I)T@S @
M;:78*"V2,#)%.EUR*+Q'!HAL[UI9H#.+A828% .-I?LWM[CUH U***R;G7HK
M;Q#!H[65^\DT#3BXC@+0J%SD%O[W'3'<>M &M165H.OVOB&VNIK6&XB%M<O:
MR+<(%;>F,\9/'-)<^(;6U\2V6A207/VF\CDDBD"#R\( 6&<YSR.@[T :U%%%
M !132Z"01EE#L"0N>2!C)Q^(_.G4 %%%% !1110 44A(52S$  9)/:LW4-:C
ML+K3819WETM_+Y:S6T>](N,AG.>%YZT :=%%9EQK/V?Q#9Z1]@O7^TQ/)]K2
M+,$>W^%F[$\_IZT :=%%% !139)$B4-(ZH"P4%CC))P!]22!3J "BBLS5]8_
MLF2P7[!>78N[E;<M;1;Q#G^-_11ZT :=%%% !115'6M431=%O-3E@FGCM8FE
M=(0"Q4#)QD@<#F@"]17+2^.;&&R\.W1L[LQZZ\4=NP"XC:3! ?YO0]L]*ZF@
M HK+UC7[+13;1S^;+<W4GEV]M F^65NIP/0#J3@#N:IR>*XK74;&RO\ 2M2L
MGOI1# \J1LC/@G!9'8#IWQ_.@#H**** "BBB@ HHILCE(V<(SE03M7J?84 .
MHK$\->)K?Q-#?R6]M<6YL;R2RE2<*&WIC/0D=ZVZ "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MDY.<Y-='8Z==6NJ:A=3ZI/<PW+*8K9U 2W &"%QR<^_I0!HT444 %<G\3O\
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MT^,P1M;!2#"< IA@1V&#VKB_&WA>W\,?#[6K2VU&[FEU344NE23YB',J%BN
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M2M*ZJ TC  L?4@<4 24444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M)N(I)%5=XV]0#R5QG^8!ZU17"PWFJ:3\4+/29M5N+ZUU"PDG=)E4+%(IXV
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M;(1[8#U =W=5!/IG/M0!E:GX"_M328K2XUJZ>X%VEY-=O&A>61/N<#"JH'&
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MR65W&\:S0ACEER$P5)ZY!K-\*Z=:R>*?&>EW'VZXM+]((_.NUD!N%$127YR
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M50!S@D<YQD^M*/A]IJ6%SI<=Y?QZ/<3^=)IRR*(LD@E0=N\*2,E0WKZUUM%
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M3ZCJ#2:4<VI#1@ ],D!,'C ^@]>:Z2B@#C;+SO%GB*TO[_P_<Z?%HTDWE/>
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M5KHVGI9VBL(UR6>1R[R,>K,QY9CW)J[10 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 45C>(?%&F>&+>&749)!YTBQ1I'&6+,3@>P^I(K9H ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M%)*HF3 "2[B<[L<KQ75ZWH5[X@@/EW%QI#V\DC1B,0N)RR !FR&QU8>O)]J
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M%TA.X\H@*J3CYMN, =>IGL;^_P!=T:XN46.VLX9)I55\@W#*$4#U 5I.?<4
M1:=XH35O$=YIEDEG+#9N8YI1>#S58#G]UMSC=\N<]JD\2^)8?#R6:G[,UQ=R
MF.)+BY$"G R3N(/L,>]9RZ)<ZKXABU.;3?[&GMUGA:X@F1I+A'!5>0.@X?YA
MPP'!ZU)J&C7*:5_8[V<_B&UNA()9]0N8PT)( '\(XZG(Y'OG@ 9J?C-].U%[
M)[*/[1!;P32Q&<[I/-?9MA^7YRIZ].2H[Y")XX23Q+)I"V8W1WXL3'YO[_\
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C HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>davidjkatz_employmentagr002.jpg
<TEXT>
begin 644 davidjkatz_employmentagr002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***04 +1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %(*6D% "T444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !2"EI!0 M%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4@I:04 +1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %(*6B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBD% "T444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1167K>JSZ9#"MG827][<2>7# K!%S@DEW/"J .N#V&.: -2BN7\/\
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M^M+QY5M;J"=HCMD$4@8H?0XZ4 6**KB_LVO6LENX#=JNXP"0>8!Z[<YQ5B@
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MOA^PMXGNGBCA5$:[_P!:5 X+<#G&.PKSC4+VS'Q*\3:?K^O3:1!=6L"6K.L
MCG@\OYUW2QMCYBW (R2?2O6*JWFF:?J)0WUC;71C^YY\2OM^F1Q0!Y3)H^CQ
M^+_AQ91(]W8"*]2.2^52\R*F8R>!E>A7CH16=K,<</A7XHV-G$J6\-]#(L<0
M&U22A; '3[O/_P!:O99M(TRYNX[N?3K26YCQLFD@5G7!R,,1D8IEOHFDVCRO
M;:790M*I20QVZ*74]0<#D'TH \\\1WVF7^L_#ZZLKFUN,:@L)FB=6SA!\NX=
M<%AQZFKGA[4+2S^*GC:UNKF&&XN3:&")R%:4+"Q8@=\#DFNT;P_HKB(-H^GL
M(1MB!MD.P9)PO''))X]:M/86<EPUP]I T[)Y9D,8+%/[N<9Q[4 >&:/>R6GP
MF\&71N+B+3;;4Y?[0FM@K-;YDDV.P(8?*65N0?X>^*TO$%MITOA_Q/JWA;5K
M_5YKR&!=1=-C1>6K*"/E1<OLW9ZX7=G&1GV%;"S2"2!+2!89,[XQ& K?4=#2
MVME:V-N+>TMH;>$9(CBC"+S[#B@#SK4?$7AF_P#'/@F_L-1L7C7[1'YJR >6
M&APJ-V4DD#:<'/:O3*J6^EZ?:;?L]A:P[6+KY<*KACU(P.IP,_2K= 'A\EXW
M_"O?&&GVDA:]AUJ>XNK2,9D^SB9-^5[ C/7@@'WKJM8NK'7O&/@J]\/W$4]Q
M&[R2O P;R[4I\P?'W0<@ 'N:]!CMH(9998H8TDE(,CJ@!<CID]Z2"UM[7=]G
M@BBW'+>6@7)]\4 228\M]W3!SBO*/"=\=.U/P_9V.JVWB'1;C<MD,#[9IPV'
M[V#R@&%;.,9'L#ZS4,5I;02&2&WAC=A@LB $_B* /#-4UO3X?@UK>@R7&W58
MKZ0R6I1M\8^V!MS#'RC!')XR0.I%=._BK2=&^(6NR^(9@FF:M96_]GW4B,T<
MD2IAT& >"SL?Q->F&UMV9V,$1:3&\E!EL=,^N*=+!#/M\V*.3:<KO4'!]10!
MY3J<FBCQK\.((((;:PC%Z8K>XXVH4 B8JW(W$ KGG/N*W?!=_93>//&L%K=V
M[JUS!*D<3*<_N@'88//S<'T/N:[DP0F;SC%&9<8WE1NQZ9J2@#A_BW=6D'P\
MOH[IK?,SQK&LS ;CO4G:#U( )P/>L?5=1T.;XO>$9+:\T]XDLYU5HY4*KE?W
M8X/&<_+^E>H44 > VUU]LTGQRVGG[<D7B);^2VMYLO-;K-N9DQSC@'</2NLW
MZ%XGL]2U'P?]MO-8.ERP?:YI9V\H,,B([S@L2> .G7Z^I44 >-:AXHT74?#'
M@N&W>07.EZI8BZM5MV+VYC!5@RA<CH< =<'&<&M&]O(=7\9^-=/TJ^A;4+G1
M4@@C60!C*HDW)@]&&0".H[XKU, #.!UZTM 'F/@_Q)HFL:?H.CMI$TVO:0L<
M,D$EJW^ALHVNY<C:O"D]<DX'6N/U/5;6^\-0O$ES9O:ZY'-<Z5%:,L5B/-/+
ML%Y=B0>3WPJC%>_44 >?Z=J47_"TM9O@)?LKZ3#@F%PS,I9BH&/O 'E>N>/6
MNL\/^(-/\3:1'J>FN[VTA*C>A5@1Z@UI2*7C90[(2" RXRON,\57T^PBTVT%
MO$TC_,7>25MSNQ.2S'N?_P!0XH XKQO<RZ)XR\->(;J.XDT6T6XCNGB0N+=G
M4!9& YQUY[8]^>?@NTFF^)UPD-WY.H6B&U=K251+F!E &5'))&/7/%>OT4 >
M3VT&GWGA'P?%)>ZAI6J6]BR0:A;QM_H\B+&'BD7'1LYP<9V=?5IU/51H_AQM
M7TWRPVI7!DU6UT\LZ*"2LJ1%24,I)^;''+8R1CUJB@#PF>QO[GPW\0K"TTW5
MGFN+R">%9K>0O)&)(R>2.6QDXZXSQ7=:G'!XF\4>%[W2ED\C3'DN)[CR&01Q
ME,"/Y@#ECCY1R .<<9[RB@#Q^PG\WX9>.4>"Y\RZOKQX5>W?,GF ;",CG)K<
MOKR.5/ <T<5U)'!<(962VD/E@P/'\V%X^8XYKT2B@#AM&F:T^*'BFVN+*[ U
M#[*\$GV=C$Z)#M8E\;0,\=>IJEX2T2[TWQ;J.A94Z'I4_P!MLU#?=:8':A]D
M_><?[0/I7=ZI9RZAI=U9PW<MG+-&R+<0_?C)'WA[BJN@:+_8>FBV>\GOKACO
MGN[@YDF; &3]  !["@#5KPGQ*]_JOA?Q#!+H^I0:@FJ!Q96MD\<"1AU/FL5
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M.GZ@;:)H8B@*A0>023GGUKHH+RUNBXM[F&8QG:XC<-M/H<=*\DU2YO;'P_\
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MH_(4;S+D\C'.[I61K^J>'[WP/\/TL[FSQ!J=FLL?F#?" I$@8<$<XR>.Q]*
M/8KW6M+TV98K[4;2VD< JDTRH2#P.":>=5TX7OV(W]J+OC]P9EW\]/ESFO)?
M%.JZ=<_\)ZMK>VMB?(6*X29O,FO)%B.SRP3A4YZ@$GD\5=OI5M/"7A+QUIKB
M[FTFV@AO3#AO,MV0+*,#^)2<X['.>E 'J,%Y:W,DL<%S#+)$=LBQR!BA]"!T
MIE[J-CIL0DOKR"V1C@--($!/MFJ7AJTGM=&1[S_C\NF:YN/EQAW.=O\ P$87
M_@-<UXNU.QMO'>@0RS6]C>)!/+'J%XY$4:$!755R%9R!W. /7@4 ==_;6E?9
M(+O^TK/[-.P6&7SUVR$G "G."<^E.LM6T[4I9XK&_MKF2W;;,L,JN8SZ-@\=
M#7@SW%E+\*]3MS<PS3Q>(R5!9=X1I%Y '0'!/&.AKK-;CDL?B?JD>@1P0W3>
M$W,"1 *&D\[C '5L#C\* -OQYXN.GKIJ:+KMNMVVIPVUQ;QF.1BA;# @@D$<
M#CIFN\=UBC:1V"HH+,QZ #O7BFMZ]X?O/AKX0AL[RT66UO[/S8&D DA*Y#E@
M>1SG)/7.>]>V(ZR(KHP96&0P.010!F6WB30[RRGO;75[&:UM\>=-'.K)'_O$
M' I;CQ%HMK'%)<:M91)+'YL;/.H#)_>&3T]ZX'[!<Z3XWU;PI%$PTSQ'(+Z-
ME'RQKP+I21R"P  ]-PIGB#6=/_X2GQ3:)<Q:3<0:='%+(_S2WN49E2)6)4*,
MX.%).>V,T >CWVKZ=IMB+V[O(8K9@"DA;(?(R-N/O$CL,YJ-=>TEM*&J+J-L
MUB>!.) 5)SC /KGC'7->0^'/$=II-_X+U'4;M#HZZ,;'SL[DMKK(9@Q'0E H
M]OSK:U[5/#-MI&GRZ981)87.OQR1:A(S+;I<;<F?&1N QC'"D@^G(!VM[XTT
M*ST"[UG[<DMM;95UCSO#X^X5ZAO8@>O2J%SKECK-KH%Q%XFBTZ2:XBD-O#(C
M-<D@9AP><989Q_\ JX**\M[B]^*J1:A]N>XTV)HI<+F8"W?)4* "HR!D#&".
M3G)VM4UW1[CPKX%G6]MG$>I62L0P."J8;KZ$@'T[T =_JGB+2=%8+J%[' Q7
M>006*KG&YL [5SQDX%%WXCT6P^R?:M4M(OM@S;YE'[P8SN'^SCG/2N,\/ZA%
MI?CSQ?!K]Y#"UXT5Q:O.X5);8*P&TG@X! (KD;.W73/"G@:SUB2.'/B 3PP3
MX#1VY+[<AN=I.#S_ 'ATH ]BT?Q!I/B".:32;^&[6%]DGEGE#[BL#XCZA>Z7
MHMA=65]+:DZC;Q2;" '1G&021D#CL16;X=NK;_A<OBZ)+B+=);VNU XRS*GS
M8'<COZ5>^*<4<G@]'F($$-_:R2AERI3S5!S[8.3GTH WM(\4Z%K]S<6^E:I;
M7<UN?WB1/DCG&1ZCW&12P^)M%GU!;&/483</NV Y"R;?O;&/#8[X)QS7!^*+
M(Z_XM@N?"<D4ES;:/=Q37%LX,8+H!"FY> V23CTP:J>'=3\*ZY8Z%:-!J<NM
MZ?-"!I\MQ,/LLD>%:0\[511D\]N,9.* .XN/B!X4MH]\NN6NSSS;EE)8!QC.
M<#@#</FZ<]:TM5\0:9HJH;VX8%U9U2*)Y7*#[S;4!.T9&3T%>9R7VG3^!/B,
MT$]NTDU]<D$$;G4JH7W()W8_'%5;;6;;1]>TW4O$%W?#2M2TBUAMKZVGDVQR
MHN)$<H?[Q).<\_C0!U_COQK!IW@I;_2+P2-?,D=O<0J64*7 =@P& 0"<=\_2
MHM-M]+M/&ED]OXNUIC<I))!I%S-*ZL I#$^8"V/E)&[OTZUR_BH:)I_POC@T
MJUDL+6YU2.>WBN9"9)T#+NE"L2P4]>>V#QFNH\0:QIC_ !'\%S+J%JT0CO"7
M$RE0'10O.<<D$#U(H U-#\=Z9K-SJR_OK>&PD8>9/;R1C8J*S,Q(PO)/!P<8
MXYK3TOQ/I>L79M+22?[1Y/G^7/:RPDQD@!AO49!)KA5O]+@N/B!I>KQ7,J2W
M)FDMXHVW-"T2+O4X]N/?%2^']8?1=:O%DU9=?T2STI[F._2,//;J&7]RS+PQ
M(&1GGY>V* /3:Y>ZO-(/Q!LXFUF[74X[20+IT9;RG7[Q9@!C=CWSP*V-$UFS
M\0:/;:I8,S6UPI*;Q@C!((([$$$5R&M2*?C-X<;G;%8SB1L':A8':">@)P<4
M 4XKY/&OB?7]+DN]9L3;M EC+;17$#6_R%V9\J%4L21\_4# ]^]U'4[/1-.^
MUZC<^7"FU"[+EG8\ !5&2Q/8"N0\(74+_$/QFX?Y;F>V\AB"!+LBPQ4GJ 1V
MJ]\2+U[#PU#.M@MTBWL)ED:'S?LJ Y,VWN5QQ[GF@"_'XTT5HM3>66>W?2P&
MO(IK=UDB4]&VXR0>N1FJ]C\0O#>I:A86=M>2,]\N;>1H'6-VQG9O(QNQV_#K
MQ7 G5+6/Q+XK"?VI.EYH82&XN;=\S$*_S=!A22 . "3@"K,%U;1>!_ $4H87
M%I?6SRJ8F+1*H8.3QP!D9H ]%TWQ1I.K2ZC%9S2O)IS%+I6@D0QL,\?,!D\'
MI5_3[^#5-/@OK4N;>= \9>-D)4]#M8 C\17!^)=#O8O'%O/I3A;7Q% ;+4 K
M8V[!N\T>YC#)GMD5U&J>)[#0M6TO2I[:\W7SB**6* F&,DA5#MT&20!C/4=*
M -J66.&)Y975(T4LS,<!0.236!:^-M&N[RRMD:Y0W\336;O;L%N549)0XY..
M<'!]JT=?DGA\.ZE);6BWDZVLACMF7<)3M.%([@],=Z\>M]0\W6_ ^K)I^NS?
M9!*EWFR=8XG,0 BB0 * "#R!TQECC@ ]!;XG^%Q!-.+FZ:&"8PSNMI(1"00,
MO\ORC) YP3Z<5MZGK=E;,MGBXNKB>$R""S!:3R^A?@C [ Y'/3FO+Y[I+CX;
M^/88XYS)<ZM<20*8'!D5W4J5XYR ?RK1T[4Y/#?BZ'5;ZSO[C3=1TFVMX9[>
MU>3R)(P08F4#().3]3^0!O?"N\%]X3N)5N)IXQJ%R(VG=F<)O^4,6YS@CKS7
M0ZOXAM-(N;>T:&YNKVY5WAM;5 TCJ@!8\D  9'4C/;-<Q\*V<:3K"RV%[:22
M:K<3XN82FX,W&#T.,8.">12^+M0EMO&.EV]S8WITV6UD!NK"V+S/*3@0[U&Y
M%(YX(SQS@&@#3G^(7AVVTG3]3GN9X[6_E,,3M;N KAMK!SC"D'/7T.,XIUIX
M[TJ\_M14@U".;38Q--!/;&.1HB,^8J-@E<#Z^W(KR^P2ZA\*V%H=%U57M?%:
MW;J;21R(E<EFR <D=#U^IKN83+)\;7NQ;7?V)]#^S>>;:01F7SM^W<5Q]W)_
M2@#H(/%VG76A6.L01W$EK?3+#;[4&YV8[1QGCG\NIXK>KSSPCH5UI7BW4=(V
MJVBZ7.UY8D,24>=?]7_P &3W_> ]Z[K4+>2[TVZMHI/+DFA>-'_ND@@&@#"N
M/'>D6T*7<B7?]F/,8!J(BS;[PVTY.<A<Y&XC;QP:KR>*)Y_B"?#7V"Z6T^P-
M*TJX!8LZJ'!#950-PSP<GVS7)6D-[)\*)_!,VE7:ZTBM9*C6[F)_GR)1)MV[
M,'.<]JU!'/X;^)>FM+97UY"WA]+(3VT!==Z2 DL>@X&?Q'K0!D^"O&=AX6\.
MWD>I1:G)$FJSI+<+"\J6ZEPJ^9(>GZGVYKT74/$=M8W<EI%;7-]<Q0?:)8K1
M5)CCYPQW,!S@X R3CI7ETZ7<OPG\5Z>--U,WMUJ<LD,)L)@TBO*K*P&WI@$^
MU3W=M_9OB2;5M4\+:CK>D:M9VZQK;6C/+;R1Q[&1D;! /)YXYH [*7XE^'TA
MTV6+[=<1ZBCM;-#:N0Y4$[ 3C+Y&W:,G)&<9S71:/JD.M:3;:E;QS1Q7";E2
M=-CKSC!':O/;T#3-;\$?9O#UW:6MM/<3206MF[+;)*C*N\J"-WS98#.#G\?4
M.HH **** "BBB@ HHHH **** "BBB@ HHHH **** "D%+2"@!:*** "BBB@
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M\]O6@"U<VMO>VTEM=01SP2##QRJ&5A[@]:H'PUH)ACA.B:<8HL^6AM4(7/7
MQQ4VH:SIFE-$NH:A:VK2G$8FE5"W..,^Y'YT_P#M33_MOV+[?:_:]F_R/.7?
MMQG.W.<8[T 0W>@:/?W$-Q>:79W$T VQ/+ K%!Z#(Z5)>:-I>HS)-?:;9W4J
M#"// KLHZX!(XK(U[QSH.AZ#/JK:C:W"1EHXTAF5C)* /D&,\\C/H#DU)-J$
M5YK^C/9>)+)+:02EK)"CM>#:<%3G("D$\>AH TH]$TJ*_-_'IEDEZ6+&X6W4
M29/4[L9R<G\ZA7PUH2W$DXT:P$TDHG=_LZ9:09PY..O)Y]S1:^)-$OIYX;35
M;.>2W0R3+',K&-1U)QTH_P"$ET3^SDU#^U;3[)(YC2;S1M9AU ]3P?RH GDT
M?3)KQ[R33K1[J2,Q/,T*EV0C!4G&2,=JP+S0=:N-5AT^VN-/L_"B)&6MH82)
MF*MDQ_W0AP,^V1CG-=+9WEKJ%K'=6=Q%<6\@RDD3AE8>Q%1:AJNGZ3"LNH7D
M%K&QPK2N%R?:@"Y5:[TZQOVB:\L[>X,+;HS-$K[#ZC(X/':LCQ%XKL-&\)W.
MMPW=M,OD.]J0X99G"DJ 0>>1VKB)O%UWI>CV>KCQ9#=F_A@A>TE2(^1.[)OD
M4J!PH9OE.>W:@#T6;P[H=RS&?1M/E+.TC%[5&R[?>8Y'4X&3WQ3HM!T:"[2Z
MATFPCN4QMF2V0.N!@8(&1QQ7*:8;N/Q?9%?'L5[IURLDD.FS1Q&:8;6SAEP2
M 5)Z=B*ZFX\0Z/:7ZV%QJ=I%=,0HB>4!B3T'U/I0 ]=$TE)GF72[)99)!*[B
MW0,SC.&)QR>3S[FK]9FI^(M'T:18]1U""W<@-AVY5<XW-_=7/&3@9I+WQ)HF
MG2O%>:M9PR)$9F1YE#!./F(SG'(H T3%&95E**9%4JKXY ."1GT.!^0J-[&T
MDO([N2U@:YC4JDS1@NH/4!NH%9<WB_P]!#'-)J]JL3QK()-V556&5+'HN>V<
M9[5MT 5'TS3WL18O8VS68X^SF%3'_P!\XQ3YK&TN+3[)-:P26V /)>,%,#I\
MIXI;R]M=.M7NKVXBM[=,;I)6"J,G Y/N<5FC6;+6;34+;3-2,=Y!&1)M3$L!
M(.TE'''MD<T :B6T$<CR)!&LCJ%9@@!8#H">X%,6QM%C6-;6 (OW5$8P._ K
MS8ZYK#_"?P]KCZK,EVUS;FY<!1YRO,%(;C@8/;'2O4: &/#%)MWQ(VW[NY0<
M?2DD@AF(,L4;D=-R@XKE]+UK2[.?Q!?3>*X[VSBN%+K(1LLL\; PX.3_ "]:
MT;'QAX>U+4(+&SU:WFNKB/S8HU)RZ[=W'OCG'44 :ZP0I(9%BC5SU8* 3^-/
M(!!!&0>H-)+(D,3RRN$C12S,QP !U)K)L/%.BZG=Q6MI>AYIHS+"K1LGFH.K
M)N W#W&10!JQQ1Q+MC147KA1@4HC179PBAVZL!R:R&\6:&FH)8MJ""9YC;JV
MQO+,HZQ^9C;O_P!G.?:C4O%6B:1/)%?7RQ&+;YS>6S)#N^[YC $)GMN(S0!L
MTC(KC#*&&<X(S6??:[IVGS"">=C.8S-Y4,3ROY8.-Y5 2%SWQBJ5UXT\-V>F
MV>HSZQ;)9WC;;>;=E7.<'IZ'KGIWH WJ*P+3QMX=O[$7EIJ*SQM.;95CB<R-
M*.2JQ[=Q(!SP.G/2N9\'>)%&J>-+K4=5N7TVQN8_+>\++Y*;22-I *\]L T
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MJLY+K;><@1;:-B"54#J3A>?0=JU[K3H+VX@EN-TBP,)$B)^0.#D,1W([9Z$
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M6@:QK$5IJ4D[W+1W$ULL:I%"QW#*A1@%L9(]@>]7AX.\/_V$=$.F1-II;?\
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MBQM@5C\I3Y2\)G.T<=,\XH \>6=(_P!GK13+*K;;F'($G.!<YQGL<?E^%>U
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MX>,-TR&).!]:X_4HDM?#,,[RQKIMYXQ6YL5<X'V?<P+ '^$GGZ'WKW.6"*8
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MEOW<:8QCH0%!Z<G)%>[44 >>V&L1:)XL\6KJ-K=I]LDAGM8_L[-]H'DJA5<
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M4 9$G@[PU*TC2:#IKM+)YKEK9#N;U/'6IQX;T-;V.\&D60NHU"I-Y"[U &
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M!OFL1?6WVM1DP>:OF 8SG;G/3F@!%TK3D\K;86H\G BQ"OR8Z;>./PIPTZQ
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M^5KJ5O,QTRI8CCMQQVK(G^&/A&Y%X)=*!6[D,KKYSX5R02R#/R$X&<8X&.E
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M.J:E;7'AF\5?$NFV[W >*91_HY'W&R"#N_A!^M=]%8VD-O';Q6L$<$?W(DC
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M.*ZRB@#B/A8UU;^#K?2;S3;^TN+$NDAN8?+5B9&/R$_>&".1QSUJ/4!=Z?\
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MEG@ :2+E74'HVT@'!['H:XGQYXL1)="&BZY(DDFK0V\L<&/+F0MA_GV_-@@
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MJ(S_ &-I79U+* 2 <JI/0$?F =WK^LV6M>!O$%QIE].DME;3[C$TD$L,J(2
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MM?+>+<IP')8,#Z=1G'8_#R[TQ]-N[:SM=2M;LSM=WB:E:^1+(\I)\S;TP2I
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M.OK,7T;/9W%S'M2X*@%E Z@@'/(&:X#4/#^NSV'CJSM?#%S;KJOV9[1%>/:
M@&02&QN[G&1G/).,]+K6F:KJ.O\ @NXATJ[$.GB47;DH/*WQA!QNYP1GC/%
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MW'.,=Z ."\,W21?&3789KRP,LEA"I2U^12ZG[N-QRRCC^@K7^$'_ "2W1O\
MMM_Z.DKI8O#VBP-&T.D6,;11^5&5MT!5.NT<<#D\5/I^E:?I,+0Z=8VUG$QW
M%+>)4!/K@"@#D-.FCN?BKXDL-4C5G-E;BQ649#6Y4^;MSU!<\_3VK@KR&>'X
M&:["7>2QBUADL&)R/LZSH!C_ &<AJ]KOM(TW4WB>_P!/M;IHCF-IHE<H?8D<
M4L^F:?=6Z6]Q8VTT$?W(Y(595^@(P* +,80(/+"A3EOEZ'/.?QSFO--4%[X4
M\<WUKI495/%$(-LZID07:_*S8]-K;SG^Z:])@@AMH5A@B2*)!A4C4*JCV HD
M@AEDBDDB1WB8M&S*"4)!!(/8X)'XT >?:K<:3I/C:QTN&>TT^ZMM&*?;+V7]
MU%!NQM2,D!G)7).>@YSTKBO"^M6FG:!X"GOIXGTBUN[M;D[B5MY69_)9QV'4
MKGIR>U>WW.F6%[<0W%U8VT\\!S%)+$K-&?\ 9)'% TO3UM9+5;"U%O(2SQ"%
M=C'U(Q@T >=^([_PA;Z'JUU9Q?;+>]U"W:>XANG^S-<%N"SJ2 %V@MCU7OTS
MK74(6^(7BT2:O9W<ESHVU'@*HDCA6^5!D[BH![D\&O5_[.L18_819V_V0C'D
M>4OEXZ_=QBB+3K*"6.6&SMXY(X_*1TB4%4Z[00.![4 >2WUWI5]\&/#KI/:S
M3V3V"%@X+0OO0,I]#@'(]JZ>QU".U^+>N6NJLB&ZLH#ISR-A6B4'S%7/&=Q)
M('I78)I.FQQ")-/M5C#%@BPJ ">IQCJ:?-IUC<0Q0SV=O+%%CRT>)65,=, C
MC% 'AFJV5I!\/[D+L;1G\3C^SO- QY!(W;"?X"0WY$^]>@Q-IMC\8-L!MH-^
MA88(R@-ME!' ]%'Y>U=M+:V\X42P12!>%WH#CZ4T65H'#BUA#CHWEC(H ATK
M5K#7-.CU#3;E+FTER$E3.#@D'K[@U;DD2*-I)'5$4%F9C@ #N320PQ6\0BAC
M2.->B(H 'X"E=%D0HZAE/!5AD&@#Q_P':>%]5\ WEGJU[:1O-=72G?=A&4,W
M4#<,<8^M7/%6KZ/J_B'P)-'/;36JZA*%>1E(=%^7?_NED.#WQ7IO]FV/_/E;
M_P#?I?\ "E:QM'"AK6!MHPN8P<#T% 'F<9T9O%?Q*=GLBPM8A\Q0]8"'_P#'
ML ^^ >:YZ.YT^?PQ\+SJ$UM):QW+)/YS HN!P&SP,?+P?:O;?L%GEC]D@RW4
M^6.:YKQ'X4N=5U?1;NQDLK>'3)VG\IXC^]8C!!QC QB@#EKR#3H_$WB[5-+-
MNFE_V ;>XFB=1"UR<[5&."VW;[\CUK/TG4TL-(^&NI3R(VC6Z2PW4NX&."9D
MVH7/1<989/3)KV$6L'D>3Y$0B/6/8-OY4+:VZ0M"L$0B;DH$&T_A0!P.F6%M
MK'Q(\236WEW.AWFG10790[HI;CIC(X)"=<=,BH_ J:A_:;^'K^.58O"\KQPR
MG[LZN,0G/JL9<8]&6NUU>PO+C1)K/1KY=+NF \JX6 .(^<GY3QSR/QI=%TD:
M39NCSM<W4TAFN;EE"F:0@ G Z#   [  4 >36$WA_/B#0?&=[J%MJ$^H2N]L
M)9@EVC,"C(JC!S\N,#/RCMFKGVW1]&\3ZWIGBN>^TZ&_@@>SD-U,B-$(0AC)
M0X+*01SG)]:];:&)Y5E:)#(OW7*C(^AH>*.4J9(T<H=REE!VGU% &1X3MK2S
M\+V-O86US;6:*PABN23($W'!.>1D<X/0'':O/+2_ATW58)-$UB'5=*O=8V2Z
M)<@&>UE:4EI(B#N&U@6P>,9/?->NTQ88E<.L:!PNW<%&<=<?2@#QV*]TV7PW
M\46-W9R237%P4(=<NOE@)CU&XX!]>F2:?I?B'35U#PS#/=+8S'P[ IU)%\V:
M<\ V\?# '=DG@MG@8KV*FE$9E9E4LOW21R/I0!X+HNKZ?;_"GPO;37<<4UOK
M\32I(=I0"=F8G/HI!/ID9ZBN_CU'3#\:/W=[;&671?*XF!W/YH8*!TSMYP.H
MYKO%54&%4 =< 4M '&_$;4[?3-)TUKFVC9'U&%1=31EX[-LY$Q (R1SCMGKZ
M'D=)UG3;+Q/XVDN-5EECN=/MFBNKM-GG 1."P^4+M)( ( !R ,Y%>P48&<XY
M]: /)%O-#OO W@N-_$7]D7\5H/LNHQNNR&5(D62.3)QSNY!]/SJQWNIFX\*Z
M]J44,UAINJ7D5Y>6B?N)@ZA5NN. N2WS=,\]Q7LM% '$:1'%J7Q0O=>TN2.;
M2VTF.VEN(&S'-<>83PPX<J@ R,XSCVJ7X@M!"/#=U=J/L=MK,<MQ(R;DC41R
M#<WH 2.3[5V5% 'COC#0[GQ1JFOZSX7 N;>72([9Y(#E+R59PSJI!^;]VNW(
M^G6MSPQ?>%O$&I:7<Z7I^HSZC:;P[7DUPQL?EPX9G)!).!C.3G/:O1J* .&^
M)*WMNN@:Q;VTUU:Z9J27%W!"NYMF"-X'?;G]:Q/%,D/C3P;K5YX4TF25YDA>
M:<VAC>]V.K>6,@,^%!.1[ 9SQZI10!YYJ-W;^,=8\(W6BYD:SO#/=-Y9S:H$
M(:-S_"Q.!MSD]<$"H-8T74K3Q]-9Z=&5TGQ/$!>N,[87CYE..Q>/*]LDY[5Z
M510!Y?KSIH/Q*NM0UJTU*31]0LX88+JS,N(70D>6PB.>2V1GN>.]9OB>SL[>
M#P2FEZ1-9V$.LI<FW,3L8X=XR[@YVYP3@\C//->Q44 >9^*KJ/0O'\.KZI:W
MLF@7>GK ;NSDE @D5W;+",]#N_S@U4N(TT75O#WB'3-$O8?#T-W<&:*.-VE)
MEC5!.\;?,.=WOC'KBO5Z* ///"MP+CXI>)[U+>\%K?6]JUO+):2HK;$*MRRC
M'/3/7M5WQ] ?[1\*Z@;>>2&SU57F>.)I!$A4C<P ) SMYKMJ* .*M-)CUCX@
MW^N)"_\ 9;Z6MC)YD95;MRQ+<$?, N!GISCL:H?#_3-2M=2O=.OV#V6@326F
MGN6W%EDVL,^ZIM7Z.179:_I<VM:-/86^I76FRR;=MU:MMD3# \'WQC\:?H^E
M1:-IR6D4LLQ!+R33'+RN3EG8]R30!D>/[BZM?!E])9Z6FI2?(#!)#YH"[AE]
MG\6T<@>H![5Q%I,EO\2%U0QZY<:?-H#VQO[FSE8O)YNYCC;\BXQQA5]!SSZ[
M10!XLOFGX.>&;(6MXUU#J$ DA6UD+J5E+'("^G-=)XNT>_3Q;IFI:(XB76T.
MFZACABA4LL@']Y5#_D*]%K TSPK#I^N7.K3:EJ-_/(S^2EW.72U5CEEC7H <
M ?0"@#<BC2&)(HU"QHH55'0 =!7 0Z?>>#?B'JVK?9+BYT/6U1Y)+:-I6MIE
M_O(N3M.6.X XR*]"HH \]OUDUOXI^&]2L+:YEL;"WN//N6MG6-2RX4!F !/^
M[DBJGAC2;V_T+Q[IK07=E+J>IWLEM)<6TD0:.085AN49!_.O3:* /(KRUO\
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MUNF^TM'YR1RPO&9(_P"^NX#<ON,UYGX6N+&+X2^(9#IL.J3PW%R[V@^^RNV
M3CD+@9R.H4XZ4_2K^";XC>%KZ*ZN[RV;3Y+<3"T98DDVC]W& O &>Y..YXH
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ML5R]O(D(;LK.0 &X/!_&FQZMHMIJ-S;Z3;NJW,3W%Y<0P,L<050H/W<%R6'
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MH"@GY2!^??H:?@1=7@FU:SOI[N\TZWDC6PO;VW:&>52I+*VX L%X 8@9R?P
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MCMG"S-;\[Q&21AN@R"#7$_\ "/ZTE_XU%OX9NK:WU?38XK15FC.&$97#'?\
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M5;'68KG4))-@&U6)VQ+N "XQT &>YZT =M<_$>WC75S:Z'JMRVDOMN@L:J$
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MX?N=*OG+7DC3727)N"S8+EUQSP!@@<=.E/\ %>BZE=>*/#&N6%NMTFE2S^?
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MAJT\5::-/OKBYCM=P=T@95WD$$9)!/!';%:\,;10I&TKRLH ,CXW-[G  S]
M*XFRNO#FB6^O^(M#TQ_L]H!;W$%A"B+)Y:B0NJ_*.!(03W"]^[H?B1 XTJ:7
M0M4BL]54"UN-BL))"NX(%#;AGH"0 >O3F@#MZ*Y"V\>Q20Z]]JT:_MKO18UF
MN+1C&SM&RE@RD-M/ )//TR>*IVGQ.MIFTR>ZT34K/2]1V)#J$RJ(Q(PX4\Y
M[!NA^G- ';)<P23R0)/&TT8!>-7!90>F1VS@_E4M><>&C9:1\3?B#+MAM;2"
M*SFD*J%51Y)9V('XD_C6PWCM;9=-N]1TBZL]+U*18[:[D9259ON^:G5 W8\^
M^* .OJ*6VM[AXGF@BD>)M\;.@)1O49Z&L'3?%:W^M:WI<EF;2;20&D:>8!75
M@2K#'\.!DD],]*9-XPBBM=-#6Z17VHQ&>&VN)Q$$C&,M(Y'R_>48 )R>!P<
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M4#=A,)DL1GC 'N>E;8\6/J,VE6>D6Z->:A8+J)%PQ"V\!Q@MMZDDX 'H>>*
M-O3M7T[5TF?3KV"[6"0Q2-"X8*X .,CZU=K@OALT[7OBXW4<<<YUJ3S$C;<H
M.Q<X.!D?A7=R%Q&QC56< [59L GMDX./R- #J*\ZTGXB:M?VUYJ=QH<,6D:?
M<7,5].ESN:,1KN!12 7R>.W)'3DUH6/C2_GU/2T?2GEL=0)0RV\4N;-\ @2;
ME (.1\PP!@]: .GU72+#6[,V>HVXGMR<F,L0#]<$9J>RL[?3[.*TM8_+@B&$
M3).!]3S7$MX]OK6?2FO[*TMEU#4!9&Q>4BZ@5F9%D8'L2 >G1AR:LW?C*[.L
MZCIUA'9&ZLIEC%C<R%+BX4A29(QW7YC@8.=IY&10!VE%<H_B+5-4U'6+3P_;
MVK_V2RQR-<D_Z1+MW&-<?<P,#<<\GI@9K%F^)%[=P^&9M'TN"4:Q,\#QW$Y5
MX9$R&0X& ,_Q<G'\- 'HM1SS1VT#S3.$C099CV%<79>+M;C_ .$EL+[3(+K6
M-)"RPP6!8K<)(,IC=SD=#^@J/2?&%Y>>*9?#MY+I]V9M/:ZCFL00(F!P8G&Y
MLD9Z@_A0!U^E:M8ZYIL6HZ=.)[24L(Y " VUBIZ^X-,AUO3KC69](AN5>^@C
M$LL04_*I.,YQCK[UY/X0\0>(_#/PNTC5(].LIM"LS(+H&1OM+H9F!=1C "D]
M#DG':NRA;S_BA<W-DT9>?P]%)&SC*DF9]I..<=* .VHKA]'\8ZIJ_AR:8V]K
M!K4>H_V>UH59E1]P!SR"0%R^>.%-=N@8(H<@MCD@8!/TH 6BN3\=>)-3\-6^
MDOIMM:SM?:A%9$7#L,%SQC ] 1GMD<&J;>)=?M[V#1+U;2+5C#)=33VMI-=1
M)$)"L8$:G=E@#R2 ,>IQ0!TNL^(--T".W?49VB%Q*L,6V-FW.3@#@''7J<"M
M.O,/$6KZCK'@.&35=,EL+J+6+6(AXV190)DQ(H;D*<]#R*VO%?B?6-(NKY;<
M6-G;VMIY\$EXID-ZX!+(BJX*X ZX/)Z8H [6BO-)];UG6]<\$7MIJ$%G;:G#
M+.MM);&0(XBYR0P+9#D#ICWJYJ7C'69QJ%SH-L;@6-R]NEI_9\\OVHHP#XF7
MY4Y#8Z^_H #NYIDMX'FE)"(,L0">/H.:IZ+K=AXATN/4M-E:6TD9E1RA0G:Q
M4\$ CD&N?CU_5?$6I3:?HSPZ;+9VT$]VUW 96664%A"5#+@@#YCGO@>M5/A&
M''@?,NWS#?7)8*!@'S#G!ZD>YY_2@#NZ*HZQ]K&CW;6%PEO<K&6262+S N.?
MNY&>/?\ /I7G?A?Q5J5A\/O#CW%W#>:AK5T+:V>2-OW99VW/(2V7QCMMZ@>]
M 'J5%<A9^(=2TWQK%X9UIH;G[;"T]C=P0F/.W)='7)&1C@@],9Y-=?0!'//'
M;PR2R$[44NP52QP/0#D_A5+0M<L?$>CPZKILC26DQ81NR%2=K%3P>>H-<CI#
MZW)\7==BN;^%K6"T@,:?9B,Q,6(53OX(;.6.<XZ#BN6T'7M=\-?#C3-8@>S_
M +*@U"6*6#:7EG1[E@2&R I!)P.<XR3VH ]HHK@=5\6:I=:EKEIHK.CZ5B.-
M%T^2Y^TS;-VUF481>0OKG)X KKM#O;K4=#L[R^LGLKJ6(-+;OUC;N* -"BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3'NY"GU Z9]^M $]<-XOMKR;QYX/N[>PNI[>QDG>YDBB+*@= J\_4'Z5W-%
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M93$T4IZLCA6X/H1VJ]K'AS4/%.@:II^KW4-N+R,)!#;9=("K!@Y8A2[;@.P
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M6)HOE_=<<'=SWX]ZJZ*NM2^(_&T6FFQ,,MZ$!G=E:&3R$&[ 4[QTXROW>O-
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M&:T*D[?-8*%*D$;=J@E@H/OFNR;7+#3(M*T^UM[FXFNH-UK:Q;2_E(HR6+L
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MPS?7]W;VRW(6.1!YB%]N1C.!W&>3TQWH Z^VMH+*UBM;:)(H(4"1QH,!5'
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M<+'(<X_'IC/I4WB36O$GA^?PW:QW>GW,FH78M)I)+9E^9@<,,-P!QQU..HH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M-U9(R26VLP&"W/7Z$UGZCX1\1^()?&3OIWV"74I+.XLF>='0M"H^1\'.3]"
M0>2 "?6Z* .5TK5_%&H0*=1\-G3O*C8SK]ICE:9L8"Q@' !)SEB,8QSG(XRQ
M\/>(+7X4Z+H#Z!<MJ%I?K-(H>$@*MP9<AO,')4X[]QQUKUVH9[NVM6B6XN(H
MFE<)&)'"EV/0#/4^U #XG,D*2-&\;,H)1\;E]C@D9^AIMS(\5K+(D,D[JI(C
MCQN8^@R0/S(IHO;4WILA<P_:PGF&#>-X3.-VWKC/>IZ /*]&\&:S=?!I/#-U
M;-I^JVLAEB,S(Z.XF,J\JQX/ .>F>]=#H,_B&XECEU'PG;Z4;9&>5H98I&N&
MP0%C /R@YR22.@'<FNLAO;6XN)[>&YADF@($T:."T9(R P[<>M3T >6#2?$'
M_"M1HYT"\^W?VE]H*"2#!3[5YV<^9_=X^OMS6S<6>K3?%73]:71KL:?%IC6S
MREXN'8[NF_/'0^_MS7=44 >6GPYKU]X*\3Z<=)EM[J[UEM0MDFFCQ)&9TDQE
M6.&PI'/&<<UTLVF7?B/Q-HFJ7>GSZ?!I(DE"3NA>65U  &QF&T#.2>IQ@=ZZ
MVD)"@DD #DDT >03^'?%I^'K^$DT%6>VO!(MU]KCV3H;@R?(,Y!Y_BQP/7BN
MML+#5O\ A9EQK4^ERPV<VF1VN_S8VVR!RQX#9QVSC\*ZD:G8$X%];$_]=5_Q
MJU0!YGJ/AK5M3U=-2M=%;2==BOSMU*VG189[8.>95#$L2@Z;3SCG&0$M-'\4
M^&]4U#3K+P[IVL6%W=27-O?SS)$;?S#DK(I!9@I)Z=1W[#TVB@#BK+1]5M/B
M7>:U)9-)9/ID=HLD;QC=(K DA2W KGK_ ,)^(+OX3:CX<73I!?SWK2QJ\\6P
M(T_F]0W'';U]J]6HH \]N;+Q5H?B[4-9T?18]5LM:2(W-G-=)"]O(B[/O<@@
MCKC/^,EYHNO2^,/".K2:?&Z:='<B[%O(BK'YJ[55 2"P7H3@9QGOBN^HH \Q
MNO"NNWX\?I]A>!=;CC-D7EC.61-I5L,<9X_#TK2U33K[7M.TZVUSP@MS:^0?
M,2*ZC-Q:R_* 58E1_>SM/8=>E=K>7MKI]L]S>W,5O @RTLSA%'U)J2&:*X@C
MG@D62*10Z.AR&4C((/<8H X?3[KQ)X4TKP_IUW:KJ"RW!@N)Y;L>;"C28C49
MYD8*><?W3VYKNZH6EWI.IW4DUG/9W5Q:DQ.\3*[1$\E21R,XZ5?H IZK:O?:
M/?6D1423V\D2ENF64@9_.O,F\->*7\$^%]&DT51-I.H07$C)=QMN2,MGKC!.
MX8&3T.<<9]9HH \]UK3O$]WXDUF_TK3GLWN=(%E;7+3QY$H9GW$!LC[VT$9(
M(!^F?9>&O$<'B3PYJ\'AVQM#:12P72-?!F9G !E9@I+$\^I..2*]2HH XSP#
MHNL^'UU2QO[6!+5[^>XAG6;<TH=ACY0/E&!W.>G%=G5*WU?3KS4+BPMKZ":[
MMQF:&-PS1\X^8#I]*NT <?XWT75=:O/#[:=;12)IVI17TK23!-P3^%>#R<]\
M5I2S^(+B^LQ'IT%K;ARUS+YZR2% "0BC&/F8 $D\"MZB@#S*?PAK]S\//$6A
M-;0+>:C?R7$+?: 5"O('^8X&",$<#T_#>N=,UB7Q-X9ODL8_LVFP2QW!:X ;
M,B*ORC'(&WU&<UU]-D02Q/&Q8*P*G:Q4X/H1R/J* /--&CUF^TCQAI5E8P.E
MYJU_#'=//M6/<Q5MZXSQG(QG/?&.=:+PQ?:;XG\-/8VT;Z9I%D]FTCS .P94
M&X+CMMYY'6NAT7PUI7AXW!TR&:+[0YDE#W,L@9SU;#L?F/<]36M0!Y]IOAKQ
M!H6E:UX>LH;2>RO99I+.[>7'D+)U61<9)&205SGOBF^+/#^GP^"=-T"RU!8=
M4TU[?^S6!#2^<"%4E<YP<DGL!SVKT.LT^']).O\ ]NFQB.IB/RA<D?,%_E[9
MZXXH PO%'A&XOO#&G66AW"6UYI-Q%=V9D'RO)&",/]=QR?6JMUHWBGQ=X:U"
MPUX6>E/- $A2UD,G[T,KAV/8 H!@9X)YZ5W-% ')^&SXUEF@C\0PZ=;06JD/
M);REWNVVX!QT4<Y/?(' %=9110!R_CKPU=>)-(MAIUREOJ5A=I>VCR#*&1,X
M#>QSUK/O?#OB/Q?X<U#3O$LMC8B>$1PQV#,X#AE;>Y;K\R# '8GFNXJA::UI
MM]J-UI]K>137=ICSXD.3'GIG\J .8D\/ZWKK>'8M<CMHDTBX2[FEBG:1KF:-
M2$*Y PI)+'//0>IK,A\+^(4T+QI9?8+17URXFF@_TO(7S %.[Y>W7]*])HH
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MMQVKGO#6F>(O#<;^%W\*07T<<KBTUB1H]GELQ(:0$$DC/3J>GO0!TUE?:/\
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MEBUJR:?*S)/)O#"5OE7;P", $_,>>QDL_"OB>/Q%H6LM'HL'V&R>U:TAWJB
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M&.41%]L:JLIV=FW'!/3ZT =9KFMP:!8+>7$%U.C2I$$MHO,?+' X]*OR0Q3
M"6-' Z;E!Q7G6IZUXSTGP>;S49(;.[@U&.$.T<;FX@>155F"L51N3G''IBKV
MI:GKTGQ/C\/6FJI;64VEF[R+97=&$FW@GOQWXY/% '<JJHH5%"J.@ P!6/)X
MELX_%D/AQHK@7DMNUPCE!Y94=><YS^%<%/KWBR#P)J^KRZU']JT2]FM_W=LF
M+ORY=I\S(X!''RX]<GM/JOVO5OBGX?>TNOL,UQH<CF54$C1@G)V@\9]R#]*
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M/4#D]:TDT'Q?HWB0Z]I5OITQU*"*+4+"2X95C9!M1U?'.%QGCUP.>/1:* .
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M7RVD]V8(R_D6Z[I'QV4=S0!A7?@/3KWPYJ.E3SS/-J$WVF>](7S&F!!5L 8
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M< 6'RXXYY]JL:XOB'6=+UVSCT8V]O<:=);P(\\1DFFD7;N;!PJJ/?G/0X H
MH1?$/5"VAS2^%Y!9:S$/LKI=HSF4Q[PI7  !Z D].2!TJY;^-[X0>(8KS0Q%
MJ6BHLTEM'=!E>)E+!@^!S@'(Q69_8FO)I?@> :/(TFBM&UUBXBQ\L9C^7YN2
M>OTHO]-U6WU3QWJESI[16-_IGEPR^<A/[J)QDJ#D9SQ^N* +$?Q%OHX]$U"_
M\.O;:)JHB1;L7*NT<D@RN4 SMSQGKCG':JWAZZL]%\?_ !(O)ML-I;+932%%
M^ZHA=F.!^)J/1M,U+Q-X"\)Z9)9_9;**.UN)[HRJ^](U#*$ YRQ"YR!MY^]5
MB/PAJ&I:[XZ74+0V]AKT4,<$PE5BIC0KD@'/4@C]: -*X\:W.FP:5J6IZ6L&
MCZDZ(LZ3%I+8N"4\U-N #QD@\$XY[V+#Q?+/K>N:9?Z?%8R:7$)PSW);SXCG
M#CY!A>.>I!.,5BR^&-<U[PIH_AG6;6"*&SFB%Y=";>L\47W=@ZY; SN QD]:
MF\4Z-8Z_XTT$VM\OGJ9H+^&%@?,MEPS(Y'3Y]@P?[Y]* +]]XV^P#3+6ZMX+
M74KZ W)BFF8I!&,?>8+DMSC '4'GCFE;_$NWET2*XFL3!?27K60AD=A&6 R9
M ^W)CV\YVY[8[U/XKT/7T\36'B?PR+::\@@:TN;2Y?:LT);<,-V(/^>QKZ]H
M'BK6--TS5XY+.W\0Z?=?:(;=7/DB,J%:(MU;.,D\=<>] %O2_$$/C*'6]#NM
M/B=X4VYR[6URC#@AMH/!X(ZCM2W=_;?#WPYI&GJ;95EN/LZR3R&*"'<6<DL<
ME5'( /MD]ZUO#[>(;E6NM?AM;-RNV.SMG\P+SRS-W)XP!P.>N>$\307UU;V\
M%OI5IJEF[D7EK<LJAX\'&W<"-P;!Y_,=: +6B7U]?VDKZA9):RQS-&HCD,B2
M* "'5L#(.:Y6UUG7I_BGJNF@6K6UI8(R0F5E4[FSN)P?F/ Z<"M/P-X>N/#F
MGW]NZ>1:S7C36EGYOF?9HR!\N[Z@G R!GJ>35630];LOB/=Z]806D]E>620R
M^;,4=&0DX P<YX&<\9SVP0"EH'CW7=<TDZO'X49K!$GW&&Z#R,Z$@*B8RV<8
MSZYXZ9MV'C2[F\41>'YX[!KRXLVN$$$Q)MY!@F*5>H//WO\ QVL[0O"GB/3_
M (8ZCX<W06FHL)?L]Q%.2#O8MU !7@XSSUHLO"WB./Q3X?UC[#HMC#96[VDM
MI;R.5CC./F7Y1DGG [<9)H T-*\;7U_X>U>[FTZ"'5-/NS9?81*6WRY"J-V!
M]XL #BC4/&E\+W4++2[2.YN-.C7S]D$\ZR3E=QB4QH0N/[S'J<8X-3CP?(GQ
M%?7H98TT^:%9+BW'62Y3<J/CI@*YY]0*HWWA[Q7HWBW4-6\*R:9+::IL:ZM;
M[<HCE4!=ZE>N1R?<]^* ,W6=3DUGQ'\.M1GT^XT^>:ZN-]M<H5DC(3&#D X[
M@XY!KO/$6MP^'= N]5G0NENF1&O5V) 5>_4D"N:UCPUKUWK/A2]66UO&TN>2
M:ZEDD,1<N,':H4X4=N?3ZUO>+- 7Q/X9O=),ODO,H,4O]R12&4_3(&?:@#'M
M?%&MW&O1:9_9,IBN8&>.]^PW$<5O( 3LDWJ,C X8$9/&!FJ>C^,]9U>=M&%M
M9V_B*VNF2\MY$<QQ0#I*&SR#E<>I/0#)J[H=MXZ5$&MSZ4QLXR(5MI) ;M]I
M4&5B#A><\+G.#CBLRY\&>(%O=*U^QEL!XDBD<WTTUQ(89XVX,8&S.T8&T<;?
M<\T 3W'BSQ5-XNU3P]IFCZ8\UI DZ2S7;A2I/?"YR>..@YR33++XD'4]*TEH
M+%H=1O9IH9H3%).+<PX\P[47<_WDXX^]UXJE#-J\7QEUMM/L[2XD.F6XECEN
M&C"GL0VTY&>O'^%2W/P^U:RL-+U#1]0A_P"$BL;F>[D:;<(+AIB#(A Y"\ #
MZ>^0 +J/Q#US2O#&J:I=>'2K:=<K&SS"6W2XB9@JO&'3).3R">/4YQ6S9>)=
M9C\8QZ'J^GV<8N;-[N!K6<NR!3@H^0,GD<C ^O;-\2>&/%?BGP5>:;>3Z8NH
M7S1!U2618+=$8/\ +\K%F)X)..WISHW>AZY<>.=-UY(M.2*WLGMI5^TN7RY!
M)7]W@A2.,XS[4 5?#?CBY\0O:W$'V![0O(+Z!2PN+$*KE=X)^;)4#( &3QGJ
M*\'C[5+R#3-1LM%N+NQO9PCPQ65QYD,1) E\S;L88 ) ]>IQFI(/"6KZAK6E
M:CK%MIEM>VBLMW?6,K;[U60KL*[%P,G)R3TXZ\1^&O#/C#0%30/[2L'\/0.3
M%=8?[7Y><^6!]T'MGL.G84 7(?&5S?>(KK2[1K 7-K?+;R6$^Y9VAW*&F4D@
M$;26  Z=Z[6N$UOPIK'B"[C2^@TS_1[\7%IJ<4SK<P0B3<$VA,%MOR_>QW.2
M.=;1-0UJ?Q3K5G?2V$UA"P-L;4-NB!/"2$C&[') Y'T(H R?&6HZS;^-_".G
MV-U!%;7D\S%7B8Y9(S]XAAE?FZ<<C/-8UM<:W;?$WQX^CP6<LZ6]F[-<NRKE
M8.% '/)SWXQ74>+?#FJ:KK7A_5](FLUN=*EE8Q7>X(ZR*%/*@G(QT[YZU1LO
M#OB2R\3^)M8$6E2'5HH8XD-U(NPQKLRW[H]02<#.#QSUH =;^/6O]/T(V]L8
MKO5+1KM@+>6X$**0#\L8RV6('48[]@=CPIK>H:S:78U/3)K.>VN&B#O \27"
M_P ,B*XW $=CG'K7)6O@3Q18:3X?FT^^TZVUK1D>V&7=[>Y@;!(?Y05.>P!Z
M9SZ=UHEMJD-L\NLW,,U[,VYTM@PAB & J!N?<D\DGZ4 <?82_P!N_&G5H[P%
MXM#LXDM(F.55Y &:0#LV#MSZ5V-]I%E<ZK8:M*%CN-/+LLN ,HR,K*3Z<@_4
M"L37/"M\WB>W\4>'[FW@U5(3;3Q70;R;F+.0&*\J00.1GH/2M*VM=:OYU;6/
ML=O;Q]+>RF=_-)!!WLRK\O)^7'ID\8H YZ;QMJC^$!XPL[2VDTD.SM:LK>>8
M ^TN&!QG@MMV]#UXY=_PE^M:EXR?1=&M].>VDTQ+^"YN&?[KD $@=>OW>.O7
MC!JV?@C7[+PK<>#UO;&319'9$O&9Q<1P,=S)Y>TJ3R0#N'7..U7;;POJ^F^/
M9-:L8-._LY=,73H8&N75P$^92?W9 Y 7&3QSSTH Q7^(WB*+P?<>))-+T];?
M3+LVM]%YC[IR)%0F+LHRP^]N[^E;.H>)_$1\??\ ",Z9:::5DTW[:D]PSG9\
M^T%@,9Z$8'J#D8-8W_"!^)CX!UWP]OTE9]3OFN1,+B0K&K,K,,&/D_+@?7/&
M.5G?6T^-%G]G@T\WJ^'!YT,D[B,CSSG:X0G.=IY7H"/>@#0T_P ;ZW=Z)=>?
MIEK;ZKI^HK9ZBSR8@MHNK7'S,"4"\XSSZXJ%/B!J4FF>+6MX["ZN-!1)4G"R
M1Q3QLK-]TDD$!?7!]:=J'@+5I-,CGM;VS?67U==5NA<*WV>5@,"+C+;5& /7
M&>,\1OX&\22S^*Y)+_2F_P"$AMHXI2L<B^6ZH4.!D\ ,?4GCI0!9L?&6O'4/
M"RZA:Z<MKX@@+1B#?OA81APQ)."#G[H'']XT6/C#7#:^)[:_CL5U?294BMX8
M;=]LV\XB;&_)#DJ  1@]ST$DGA'6P_@XQRV!70(]DBM(X\X^7Y8(^4XX /XG
MTYCA@T7Q;\1M/U_2+R*ZBL+-UNWA;*.Q?]RI]2")&YZ80^E '=6PN%M8A=/&
M]P%'F-$A52W? )) _$UPWAWQGJNO:A;VZMIT5TEPRZAI<L+QW-K$-V&!9_GY
MV9(7'S5WU<#'X0U^_O\ 1;O69]+:[TIQ(M];!Q-<$*1Y;Y  4Y!/)SCH,T <
MUI6N:YX;\+^)]9L8].>QL];N7EBN YDFS*H(4@@)@'@G=D]O7I-0\?-+?WEO
MI>H:2@MK8,J,INYIISDL@CB<. N!DX/7MBJY\":Z_@S7- DNM,WZI=O<F91)
MA-[;F&/8A<?C2V'@#6=,UN]OK"^TVSCU*T6&Z6.W9C$X!R8LG W'YCD=2>#W
M (M9U5]<@^'&JR1K$]W?Q3,BG(4M$20*O:/_ ,EJ\2?]@ZVJK%X(\2QZ3X8M
M'U#2W?0YUE0^7( P5=H4\\\<YXY[5MZ=X<U2U^(.I>(9I[,VMY L'E(&WJJ?
M=.3QGUH ?XTUW5]"_L<Z5%92F]U".R=+D,/O@X(8'C[OH:QI?%7B72=<U+1-
M3&F27']GO?Z?<11.$<)]Z-UW$\<X.>WOBK'Q-:06_AE8)XH;@Z];>6\HW*#A
M^2,C(Z=ZM7?AC5;^>_U.ZGL#JDUBUA;(J,(H(V.68G[S,?PZ8[DT 8Z^-?$M
MGX7LO$&HVVE-!J,-NEI!#Y@83RL.7)R-FW+8'/0>YV9M=U?1_%NG:-J+V]Q;
MZK'(+:[C@*>5,JY*,NXY4CIR#V.>M0OX(N-1^'=MX8U*[BCGM%B6WNK92=IC
MQM;#=^#GZU>MM U2]US3=6UV[M7ETV-Q!%:(P1I'&UI&W'TR .V<YH R])\7
M:O/IWB"WU 6,>N:==?988(X6".7P(6(+DD,2.A& #5[^W]1M/'\&B7C6;VK:
M4UX\T<+(^Y7"GJQ^7J<?J:GG\'03>/X/$_FD;+8QR0=GD'"/^"LX_P"^?2HK
MOPYJ5Q\08=>\VR-BEFUDT+!M[(Q#$^F<_I0!QGQ"U/5=?^$%_K*R6L6FW,D;
M);^4QD\GSU"-OW?>)"G&, $CKS777OB#4;G6[[1])!C>Q@B9YC:F8&1U9@I^
M8 +@+ZD[NV*P+OX:ZZ_A.^\)VVO6G]B22![436Q,T:^8'V%@<8!![9/L.FKJ
M?@W7H]?&N^']<@M-0GMDM[X36^Z*?;T<+DX(Z=^._7(!TWAR_P!0U/P_9WFJ
M:>VGWTB'SK9OX&!(_(XR!Z&N T*XO+;XO^-FLK#[8Y%J&7SECVCRQSSUKTC3
M+)["PCMY;J6ZE!+23R_>=F)).!P!D\ < 8 Z5S=AX1U/3?%.LZ[;:O9&75/+
M\R.73V8($7 P1*/QH SO$OB#5_#W@"\\2Q:?9V.JO*!<PR1,^3YGE)R",D+M
M^8Y! '&*=>:YXKL_'%GH!N-+9-4MGEBD^SO_ **4Y(QN_><>NWDYX P;&O\
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M>E\1^&9=:U'2=2L]3?3[[3'D,4@A65660 ."IQU X.>/>@#BM4\8>(['X?\
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MMCXEMO[7E_XGTC/,WD+^[W#! '?CB@#-@U/Q##JWA+49M7$\&N )-8^0J11
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MT?G';,(ADD';QGZ&@#MZ*X:3QKJ\NMZ/I=EI-G))J>G"]CDDNV"H=H)#?)D
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M!R",*!S@#)([ BJ>N:GXQT3PCI<FHZG%'J(U:*VF:W5&\Z)R,;OE^4XZX H
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MXQDC_(Z:B@ K"M]*U$>,+G5[F>V>U:V%M;Q*K!XEW;B<G@ECC/\ NKZ5NT4
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M2%4=23U8]<#IBH_$OA&+7[JQU*WNWT_5[!BUM>1H'P#U1E/WE/IQ]>371T4
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M3]*&GPKK.GM=!IXV8Q,(PW.#R,GL!3-3\!Z]<77B:*SU'34L=:C"[IK=FFB
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M5O?0&)%$32#AHBH!P#QAB<C'UJF^J^+[@>,0-8@M_P"QG+0;;)<N!%Y@!R6
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MC=61V4A67 R!MXP0>3SCBMK0-"M?#VG-:6K._F3//+(^,R2.<LQ   ^@'04
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M9E*?<VD !<9/&.YSUIUKX(CAURSUBXUS5KR\M(3 C321@,A(."%09Z?4]\T
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% '*:OX1G?Q.GB?0[Y+/51#]G
MF2:+?#<QYSA@""#T^8'L*T%TO4-0D5M9N8#"@8"UM$94;<I7YV8Y;@G P!SS
MG K;HH X.#P)J$7AI_";ZG"^@L^ YC;[2(=V[R\YV]>-WIVS5Z'PWJ]MXXFU
MR&;3UM?L'V"&WV/E45BR$GZ\'VKKJ* /,#\.-;;P%-X9-_I^Z2]^U>?L?CY]
M^,?48^E/D?5?^%Q'[+>::+[^PD$T<H8QD^:<JN#N!'!Y[=N<UZ940MX%E,BP
MQB0]6"C/YT </?> +X"PO=.U6$:M;ZC+J$TD\!\FXD<8.4!R-JX Y/&>YS3+
MCP!JUX?$L=QK\!CUR.(2,++YE95"G W@ 8' R3ZDXY] HH Y5O#-XLOAZYDU
M.W7^PT<8%JQ$H,9CS]_Y?E.<<\UE:4?#WC7QW;^)](,MQ'I]JT,ER8FCC>0G
MY%PP!8J-Y)[;EKOZ155!A5"CT Q0!0EMM3;7H+B._1-,6!EEM#""SR$C:P?J
M,#/'^1H444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MTNYO[C<8K>,R,%&2V.P'<GH!ZF@""VU[3[S7K[18)MU[8QQR3ICA0^<#/<X
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MAE33Q=*\D9B$KW#.\:9SM0G[H^E5-6\6:OH7AS2-0U'18H[FZNHK:[@6YW&
MNV,K@$/QSC(ZCK5X^([F/Q]'X<EL4$$MDUU%<I+N)PP7#*0-O?H3V]Z (1\/
MO#Q\+GPY+;S3:6'WQQ2S,3$V2<JV<CDG\SZUEZ_X-@TKP+J6FZ#I;WKW;)YZ
M2SL\LD889VLQZA1\HR #^O>44 >6Z%H,4^HVDVBZ=XITQH)E,[ZI<,L3Q9&]
M-C,V_(R. !WSQ6\?A3X1,#0BQG6/SA-&JW4@$+9)^3YOEZ]OZ5VE% &%#X/T
M2WUR/6(;0QW<<*0#;(P0JHVKN7.&(' )S5+2OAQX7T763JMCIWEW <NBF5BD
M;'J50G _IVKJJ* .2O/AKX6OKV^NIK!P]]DW").ZH['JVT'&[WQ[]>:Z2PL+
M;3+"&RM$*6\*[8U+LY ^K$D_B:LT4 %8E_X3TC4-4.I2Q3QWCH(I);>YDA,J
M#^%MC#(K;HH Y3Q#-K-LL&@:#H"26EU;-#]L\Y4BL^"HRF,L .<#&>E=)96<
M&GV,%G;($@@C6.-1V4# J>B@ JAJ^BV&N6T4&H0M+'%*)H]LKQE7 (!!4@YY
M/>K]% &+_P (EH9TN^TU['S+6_;?="65W:9N.6=B6SP,<\8XJK9> ?"^GW=I
M=VVD1"XM/]3([N[+SG.6)R1@8)SC'&*Z2N7\=^([[PMH*:C96]O,3<1Q.)BW
M 9L9 '7\Q0!/:>!?#%CKS:W;:/!'J+,6\X%N&/4A<[0?< 4+X(T!(-2A6TG$
M>IDF\47DW[XDY)/S]^GTXZ<5T-8?C#6+O0/"FHZK910RSVL1D"S$[3CZ<G]*
M -+3M/M=*T^&QLHS%;0*$CCWEMJCH 22:M53TB[?4-%L;V5562XMXY6"] 64
M$X]N:N4 8EYX1T/4-4_M.ZLC)>[/+\[SI VWKCANGM4^E>'=(T2:XFTZPB@F
MN"#-(,EY,=,L<DUJ5FP/K!\07230VBZ0L*&"12?.:0_>!'3 _J/>@"I'X-\/
MQ:BU]'IJ+,TOGLH=_+,G7?Y>=F[/.<9I+WP5X<U+67U:\TJ&>^D3RWD<L0PQ
M@97.TD#OC(K>HH YVU\"^&K%K-K;2UB>S_X]V65\Q^I!W9R>Y[U8U?PEH.O7
MUO>ZGIL5Q<V_$<A+ XSG!P1N'L<BMJB@#C=7^'.@7VB1Z1:Z3:Q6_FL_F>8Z
MO$S#!D7&=[>FXX^N,5V*@*H S@#')S2UGZXVJIHMVVB);OJ03]PMP2$+9[X]
ML_CB@#0K&L_"FAZ?<7D]KIT:2WJ%+EMS-YJGJ&R>:T8))8M/BDOVA298@9V0
MXC#8^;!/;.>M6* .<7P%X7CM(+:/2(HX[=G:(H[JR%\;B&!W9.!W["MJQL+3
M3+-+2R@2"!,X1!W/))]23R2>35FB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#SC0F:Z^.7B
M9[LGS;6QABM5)R!$P4L1Z<X_,UV^J0V:)'JETA+::)+B-AU7]VRM]?E)X^E9
M>M>$(=1URVUZQO9].U>W3RA<1 ,LL><[)$/##\C[\#%RUT>[DD276=16_9 =
MD<=N(8E)!!;;EB3@D<MCD\4 <5/XB\0_\*]'CJ'4_FQ]H_LPQ1FW,6_;LW;?
M,W!><[OO#IBM!M3U[5O'+:99:S]CL+C18[^,?94=XF:0KP3G)P.<Y'MWJS#\
M/Q#HL_AX:K(?#TLF];0PCS(U+[S&)<_<)]5SC/-:B^&I8_%C:]%?*C?818I;
MB#Y%C#%EYW9R"?ICM0!Y_'XH\62_#T^*#K:"73[L026ZVD82Z43!"7."02#_
M  [1757]WX@N?B)/H-IK*VEFVE"[5A:H[QL9=GRD\$_+WR.3QT(C7X<E/!MS
MX9767%K<7'VAY/LXW@[P^!SC[P%9\LLDOQGBMX-9A2[CT)8I'5%97<3,2C)G
M@X(. <_A0!2LO'FN+,GAJZ8W.KKJLM@U[;QQHTD2)NWJKD()#D#!X'OTJYJV
MH>,=%\.^);IY[B&VMX5N-/N;M;=YU/1HV"$J1GD$C/.*V+[X<:=?Z";&6\NE
MOS=M?_VE&0DPN&/+C& !C  [ #N,TLO@:ZO= OM/U+Q%=WUS>0K;O=2Q*-D8
M_A1!@ D\DG).!G- &?::AKUGK_A*>\UIKNWUJ%DGMOLZ(B,(?,5EQSG/!R3G
M/;@53LO$>K3>*+?3M3U"ZTG5C?$FRN8U%I=6P8@"%PI.[;@_>Y((/MT,_@RX
MG?P\[:P0VB#]U_HPQ(=NW+<_W<#COS[4#P4\\%C::CJ\MY9V5X+R%&B"ON4D
MJI?.=H)[8/ &<4 <IJWBG6M.FM;M-5>YF_ML6<T=O$#9+"SD"/<5!,@&,D$D
M'()[5JZ'9W\GQ0\6*-=O=L$5KM1Q$P(='8 C9]U23C;CKR34G_"L%70X]&C\
M0Z@EC;78NK2/9&?*;>7Y)&7Y)ZGOGGBMN+PI+;>);S6K;6;I)+R"..XB9$*R
M/&N$<\#'N!C//;B@#B[;QSK,7@NW>6[674KW76TN.Y,0_=*7(W;<;20.@Z=,
MYYK=EU'5-%\?V'AW^T;F[L]5LY7CDG1&DMI4!.X$* 5/H>_MQ4MO\.;8>%KG
M0;S4I[B&2Z-Y#,L:QR02EMV5//?^9%;%KX;*ZLNKW]\UYJ45N;:";RE18E/)
M(4<;B>I_  4 >9V>O>*F\ V/BM]?NIYH]1$,EN(8Q$T9F*'?A<\\#@@#C SS
M7M5<7;?#N"W\'#PR-7O/LGG^<SJD8=COWXY4X&X ^O'6NR0,J*&;>P'+8QF@
M#"\8WEU8^'9)K748=/<RQHUQ(A<A6< A  <N0< 8//YUR4>KZRFH^*]/6\U.
MUBM],2^M&NA$\T3?-G'##:VWHV2.>AKL_$WAZ+Q+I2V;W=Q:21S)<0W%N0'C
MD0Y5AFL3_A7JG4;Z^?Q#JKS7UK]FN68QGS/O G&W &&("J !UZT <K!JNO66
M@^"?$<^OWMS+J5[;V=Q:L$$+1R!LG 7.[Y?O$]^,=*U-0O)_$OAGQGJ;ZC=V
ML>GM=6MM%"Y5%$2<LP'W]QSD'.!C&#S6Q)\/;>30=&T@ZO?_ &?2+E+FV;;%
MNW)]S=\G(&3]<\YHG^'=FU]JL]KJVIV4.JJ1>VMO(@CE8C!;E25)ZD@CTZ<4
M :?@?_D0?#O_ &#;?_T6M;]9^B:3%H6C6NF03SS0VT:QQM.P+!0  . /2KD\
M;RP.D<S0NPP)% )7W ((_.@#QGPQ-_PA^IZ%KLKA=+UY&L+LGI'.LC^4Y^H&
MWV&:O:G$UWXQ\':_<0M%<ZEJ3LBOU2!4Q$OMD9<CU<^E=E_P@6G3>$/^$:OK
MFYO+(2B1&E"!UP^_ *J!UR.F<$U/KWA%-=U73+]M3O+5M-D\VVC@6/:&Z$G<
MI)X&,9Q0!R?C'5=1AM_$]WI^J7L]SIVQX19,(X;$!02)=QVR,>21AB,C@5-=
MW.LZA\1=-TM->OK6TOM'^U2) (QY;9 .S*\9QU;<1DXQQC3NOAK8W;ZN)-8U
M9;;529+FVCF58S(0!OP%SGC.,X/<$<5;M? T=KKEEJRZSJ+W%G:FTC\SRV!0
M\G.4SUY]N@XXH YO3]5U/_A%9K6YUZX62T\02:<)]F^YNH4?'EK@?ZPC^+L
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M1@=2373T4 <SX?\ !PT"2%CK6J:@(1LB6^FWB-,$84# STY.3@8& 373444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M,%L$9(YP/<^@H ]%HKQKPSJ']L^$? UM=O)J.H/]I*V$T@$,Z(SH'F)!.U
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M6%O]B%S#&ZRPE"9"I<$ [B<XP3@==O !ZK6-KGB?3- GL8+VXC2:]G6&*,N
M>3RQST4=S3/!]I!8>&+2UM=0N-0M8@RPW-P06= QQ@CJO8'N,=L5S'Q&@MV\
M1>"WFBB.[5E1V=1RN#P<]O:@#KH)-2?Q#(6NK!](>V5K>.//G[\C+$]"N#U'
MM^-[[;:^8D?VF'?(S*B^8,L5." .Y!ZUP&G6MD?C5JL<4,)MY]"C+*H!5P9
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ML!@D'O\ 6@#:HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MN/B9I.DZ?JEC=:7<VTSRI;A7975> S@GZX 'XT =NB)%&L<:JB* JJHP !T
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M,T^SUK2M0N&M[+4[*YF52YCAG5V"YQG .<9(_.KCND<;22,JHH)9F.  .YH
M=6<- T87_P!O&DV/VS?O^T?9T\S=Z[L9SSUKFT\4M>?$>PTW3M5MKK3)K.:2
M6.':VUUVXRPYZ'/XUTHUW23J?]FC4[3[=T^S^<N_/IC.<^U #YM&TNYOTOY]
M-LY;Q%VK</ K2*/0,1D#DU6/A?P^T4,3:%IAC@SY2&TCQ'DY.T8XR?2N>O\
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M1T]/.ELR0=ZX^ZW=<@'!'0XSD<5=T75K;7=%L]4LVS!=1"1<]1GJ#[@Y!^E
M%^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M6)/()'RC-=SX=T]&T+3/MU['K%U9[ECU!XL%B"5W#)/..-V>>O>G:WX.\/\
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MVE0$K[?3VZ5&?"7A\V;6ATBT,#3BY93&/FE!)WD]2>3^=;-% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% '#Z_P"(_%6BNFJ_V78_V(MRD$ENSL;ME9P@<8^49)&%Y.,<
M]<=Q7#?$RSNI/#4FKZ;K$]K=Z8ZSPHC QR.IQM*XY8YP!ZXXKL(;M,6\-P\4
M5Y+'O\@N-V0/FP.X'K0!9HHHH **** "H;I+A[9UM)HX9R/DDEC,BJ?=0RY_
M,5-10!P/A;5_&7BCP;:ZY!>:+%/<;REL]E+M^5V7!<2Y&=O]WO6SX0\71^)[
M&\,UL;*^T^=K:]MV?<(W7J0W&1P?R-8_PHNK>T^$NDSW$\<,,:SEY)&"JH\Y
M^I/2O.[D7W]B^*O%D(N(=*U;5X4)VYW68<[I"I'(;*CW!8<@T >ZV^K:;=QS
M26VH6DR0_P"M:.96$?\ O$'C\:X*+Q!K?BW1Y]4\/^(;'3#'<RQ^1=(C(L"G
M:')(+!L_-_=YQCN;NB6.BW7BZ#6+?Q(NJ7<]DT!A@6((T(P=SA!V) &?4"N8
M\.V=G<? ?7C/;P2%$OG4N@)5EWE2/0@XQ0!ZE8WJ1Z?IZ7VHVDMW- I\Q'"K
M.P7+,@SR.">.U-N-0AOM%NY])U6R#!61+K>LL4;X_BP<<'MFO-K_ $^PO;WX
M7M=V\3M/!Y<I:,$R*+<$*V>JY/0^IXI+*QLXU^*>GI:P+9PJ)([<1C8C>0QR
M%Z Y /U% ';CQ78:+;Z)9ZSK-C-?WJ &='5(VPA8R=<!25P#W)&*N6K:@WBN
M]WZM9RZ=]G3RK%%'FQ/QEV/7!Y_.N$MI[:#3/A5-<31Q1*@7S'. ";4@#/N<
M#ZTZZ9XOB5XJFT6./[9)X<\Z!X@/GD)R#QU)^7GV% 'I"ZII[WILDO[5KL=8
M!,I<?\!SFDN-7TVT\[[1J%I#Y&/-\R95\O.<;LGC.#C/H:\DU/[/=_ ?2+S3
MU1M6@DMS:O&<RB[,H#D=RY.XGUZUMVFC:5=_%GQ(ESI]G*PTV%RAC4C>^X.V
M/4YY/7GWH ]"FU.PMK-+R>^MHK5P"D[RJJ-GIAB<'-26UU;WL GM9XIX6) D
MB<,IQP>17D/A2TO-1\!^#GTK6H+/6[7[6]K!=?O$G02,K*>XP"H!'0=*[#P5
MXETZ3PY$UU;P://)J$MHUNTGR/<ER6$9/4%B>G?([4 =I1110 5Y[XTUKQ/X
M:\*:MKK7UO%)%=;+6U\A67RC($4L>26*_-VQG':O0J\]^-<FSX87XX^>6%>?
M^N@/]* +GB&?Q/H^@ZEJ4&K0RPQ:=).C/:J'CE7##V8$;ATXQWK7\,>(+;5=
M%TI9]1M9=5FL(9YX5D7S,LBDG8.0,GTJOXU8?\*TULY&#IDN#_VS-<;;66G6
M4?PLEM[>"":0 LZ*%+%K;+9(ZDMC\: .]T:XN#>ZRUWKEE?01W&8HX0JFTCQ
MG9(0>ON?3\K]EJ^F:DSK8:C:73(,L()U<J/?!KS+3K73KB;XF6E[="RLI+M%
MDGC'^JROWL?7K^-;WA>[U*#QI+I6N):7>H#35EBU2TR!/ 'PH=/X3DD@YP><
M4 =Y5*\UC3-.D6.^U&TM789"SSJA(Z9P35VO-/%D<]OX@UK5-$O[.XFALD75
M](O>!- %9E*-U4X+#CC)YH [V\UK2]/@BGO-1M((I1F-Y)E4./4$GD<]:FGO
M[.UM!=SW4,=N0")6<!3GI@]\]J\JL-<LD\63#5-1N= T^^TBS.FB<1!/)"$O
M$6E1N0S'N,^_%-AN]+\+Z_X/9+NX'A9([N.WNKIB464D@.6P!M(.%/H2>E '
M>:YXWT+0] &KO?V\\,GRVZQ2@^<W P"/3(R>U+/?K>>)-&>P\36*VC++OL4*
M.UY\IP5;.?E()X]#7"^.%T%?AUJTWAZ.,V<FJ0W$]S%(7BDE:1=Y4Y(P. <8
M / [UK>([RQNOBEX!N;6YMYHW^WCS8G5@?W0 Y'OD?7- ';7>NZ3I]TEM>:G
M:6\[D 1RS*IYZ=3WP<>M.NM;TJQG$%WJ5G!,5+[)9U5MH&2V">F.]>:Z1<:?
M<^"?'.G:TRI?K=WCWD<W#DD9C90>HP%"X_NC%5=.LY6\8?#R#7(DDO%TJ4RK
M.H+!@N4W9_B''7G(H ]8T_4K'5;1;K3[N"ZMV.!)#('7/ID5:KA?AV\":CXP
MMH51537)7 3&,,J=OJ#7=4 9-SXHT"R,XN=:L(C RI*'N%!C9LX!YX)P>/8U
M+<>(-&M5@:XU6RB$Z[XB\Z@.N"=PYY& >>E<!I,&B-\5?'RZI'9;3#: "X"_
MZLP_O,9[?=S^%<S86D, ^'\-\L1M3J=V]J)N"+8DF+=GUZCZB@#V1_$.CI8P
M7K:G:_9K@%H9!(") .I7UQ3;KQ)HEE8P7USJMI':3G;%.91L<^@/0UQEI]FT
M/XQO;3I#9V,FCB/3APD?$@9U7L#DDD#L*H>'?#/_  D/A3QCIQ^73+O5+A]+
M(/RH0V5D0C^'<!C''!]: /2;C6-.M9H(;B]ABDG4O$';&Y0,DCV%9OAN[6/P
M^\]WXCM]7CCED+7Z[$0*&. 2OR\#C-8O@/5;OQ-8C6]6B\EK:W^PE9!M_>@_
MOV(Z8)"#VVM7!17OE?#BRGC;S--MO%/FZB(@' MA,6^8#^'.T_E0!W<'B:2]
M^*EKIUCJZW.F2:;),\"!<)(& !SC/3GD]ZZM-=TE[\6*:C:FZ+%!$)1N+#JH
M]2.XZUY[J6N:=??%6PGTK4[*:6719X8)8Y0P,I;*+D<9]!U_2J'AJ?POK?AG
M1]-U*]O_ .U["6-3I9F994N4)&X(!G&<L3T&3G% 'ITOB/18+T6<NJ6B7)D$
M0C:4 ESC"_[W(XZ\UIUY#<7":3<?:M,O;;5]$N=;43:5< +<6UUYW+1L#N.'
M&=I[>V:]>H BN;J"RMI+FZFC@@C&YY)&"JH]23TJM9:SINI),UG?6\X@.)=D
M@/E\9^8=OQKD_B?<36.EZ/J#1M+IMGJD$]^B)N/E*<@D>@.#]<5B^,KC2-;T
M77[_ ,*QIJ%_-:1?;KFSD9MT2NA\OCC<4W].0%Y[4 >@V_B/1;J26.#5;1WB
MC\UP)1\J?WO]WWZ5FW_CWPS8V,US_:]I/L@:X6.&4.[J"1\H'7D$5A:+?^#=
M9UVQUBQU:YOKZV@?+23-BWB*G=Y@(  SQSW(K \.V.GS? :^N+6"VEOQI]XC
MR1(&D&6<[21SR ./84 >A:=XOTJ[\/6.K7%U!;"ZC0^67R1(4#E!QEB >PJM
MXAU6QU+PA-<V/BFWTF.1@J:B&4A&!R5P2.>",<$5QL?B/2%T[P&JWME;S)9&
M,:M-)F.T80QB2,#.TR$$#YN%QT)XKG;Z^A/PM^(-L;])W_MIG3?A9'#2Q88J
M  -V"1@#H<=* /9I_$.C:8Z6M]K-G'<+$)&$TRJQ7CYB.V?Z\5;TW5+#6+07
M>FWD%W;EBOF0N&&1U''>N OI;"Y^+WA5FEMI=NERLA+ X;^$CMGKC'/6KOP[
MN;:36?&,4,T3'^V9'5$<'Y=JC( [9[T =[6+X@UFST^SG@DU$VERT)='10S1
M@?Q'*D*N>,L,5M5YAI^M6>C^+/&UCK]XMM<7DBO:F?CSH?+PJIG[V,XVCN?K
M0!T/@S7S)\/M'U/6;W=<7,?S2/RTCEFX '4X'0#M5C6O&6G6G@_4-;TZZ@NC
M!%((P&_Y:JI.QAU!'<'!KR[2M4BL?#_@+4KN>Z70[6&>"ZN+5B/L\S'"E]O.
M,<?0GUYZ#5/^$>MO 7C&\T2X=X;^%B]Y/<$I<SE26"!N"<'DCJ3CJ* +BLT_
M]AZD/B%<6<5R85EM9%5C<S<$J@.-N=P! &.G%=?>^,?#FG3W$%UK5G'-;#,T
M?F LG.,$#G/MUKB_%^J:=+X*\(S)J-H8UU.Q8L)EP0N-W?MD$^E7;34]'/QD
MU64W=D&32(E,AE7J'8MR?1<9P3P/P !N:[J^FWNCZ;<V_BE-,AN;B-X+B$JQ
MN!GF-0>N<X/''<=JD?QA9)XR/AXI,'CM?/DE,+[02P51G&,?>);H,#GK7D]E
MJ=BOPCM8'OK=3%KZ[8S,HVH)PW SP #GZ<UWUSJ=E8?&2.2YN%C2ZT%(X&P2
M)&\]CA<=>.?IS0!M>'+VS6PU2]_X20:I:K>2.UQ(RB.V& ?+#=,*".?>K]IX
MCTB^N/L\-ZHG\OS1'*K1,R?W@& )'N.*\JU&X;5O!WC"'1;B.\E37VNIK>VD
M#O);@QY( SD$KU[[371ZW>6OBCQ5X-OM"NX;A;6:2YN)HF!\F H,[_[N>F#W
MSZ&@#HV\?>%$\S.N6N(Y3"Y!)","!R<<#)')X]ZT;[7M-TZ18[FYPYC\[$<;
M283^\=H.%]SQP?2O)K*YLY_ 7Q-59(I'EU:\**""6W8V8'4Y(./H:T]3DM;E
M[#5='\31:-K46C0G=.RO;7<1W$1D'@D,K<CD9Z4 >J6]Q%=VT5S XDAE0/&X
MZ,I&0?RJ'4M0ATK39[ZX65H8$WL(HS(Q'LH&35/PQ<S7GA;2[BXL?L,KVR%K
M;_GGQT]A['D=ZM:LC2:-?(BEG:WD"J!DD[3Q0!YYKGBYM9\&Z'X@L;J[T\-J
M5NLJ'=&A1I,$,<?,,#G!(ZUVNE^*]%UBYO;>RO5:6S&Z974IA?[PW 97W'%>
M3QZC93?!OPU9K.AGM]0MQ-&1@KME);.?0=?3/-;FMZC!;_%#6+I;>/4$/AED
MCMP=RW#A]WE#&<DKSCKB@#N+/QCHM]=);PW$HDEC:6#?;R*+A%Y+1$CYQ@9^
M7/%0>$_%]MXK_M!K>&:)+:Z>%!)"ZDJH7)8D8#;B?EZ@8R*X&PUFUE\2^!KY
M+ZXN+..*:*0QVKI!!(8=JQ(H7J,[<<GIDUT/PON(X6\2:7*)([U=9N9VB>-@
M1&Q7:Q)&.>WK0!Z%6+J?BO2-)EGCN9Y";95:Y,,+R"W5NAD*@[ 1SSVYK:KR
M?Q+J2W.K>,["1+BSD^P^7%!:VS%]1;R6P[.J[BJ], @8SG(XH [C4_&_AW29
M(H[O4D#S0^?$J*S[TVELC .<@<?4>M+<>,]$M[..Z^T2S1M;K='R('D:.%AE
M7<*"4!'KBO/+#4[";Q=\/96E CM=+>&5I4*".0Q* #N ZG@'OVJU=W5GX?\
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M]-;PG<M=S79L_#K7,X(EF.G9>0'KN.<G/O7844 <2O@ID5%72_#"JA)4#2P
MI.,X^;C.!^5;>GZ#$EG;V^H66F2+:R^;;)#:A4A8=&4'.&R3R/6MNB@ HHHH
M *IZAI.G:JB)J-A:WBQG*"XA60*?49'%7** *,NBZ5/IJZ=-IMI)8I]VV>%3
M&/HN,5"/#6A!;91HVGXM<BW'V9/W63D[>/EY]*U** *0T;2QYV--LQY_$N(%
M_><Y^;CGGGFEL=*T[3-_V"PM;7?C?Y$2INQTS@5<HH *S[K0M(O;G[3=Z793
MS\?O98%9N.G)&>*T** *=_I&FZHL2ZAI]K=B)MT8GA5]A]1D<4^ZTZRO;(V5
MW9V\]J0 8)8PR8'0;2,59HH JG3+!M..G&RMC8E2AMO*7RROIMQC%1#1-)#0
ML-+LMT "Q'[.F8P.@7CC'M5^B@"C/HVEW5]'?7&FVDUW%]R>2!6=?HQ&14DN
MF6$]VMW+96TERF-LSQ*7&.F&QFK5% %2UTS3[&1Y+2QMK>1QAFBA5"WU('-6
MZ** .-T[P=(GC77=:U.UTVZM]3\@QQMF1H#&FWC<F#GKVQ[UTUUI&F7KJ]WI
MUI<,J[5:6%7('H,CI5RB@"O=V%G?QK'>6D%PBG*K-&' /L"*G1%C1410J*,!
M5& !2T4 1&W@,+PF&,Q2;MZ;1M;=R<COG)SZYJ&#2M.M8I8K>PM88Y1B1(X5
M4./< <U;HH JV^FV-HRM;65M"5&U3%$JX'7' ]S2II]E'>/>)9VZW3C#3+$H
M=OJV,]JLT4 4TTC3(KK[5'IUHEQDGS5@4/D]\XS5RBB@!LL4<T3Q2HLD;@JR
M,,A@>H([U';6EM90^3:V\4$6<[(D"KGZ"IJ* *T&G6-JDB6]G;Q+*<R".)5#
MGU.!S4D=O!$&$<,:!OO!5 S]:EHH J?V5IQ@B@^P6ODPMOCC\E=J-Z@8X-/^
MPVF9#]E@S(V]SY8^9NF3ZGWJQ10! +*U!!%M"".A$8XIT5M;PL6B@CC8C&50
M XJ6B@ J&6TMIYHYI;>*26+/ENZ LF>N#VJ:B@")K6W:V-LT$1@*[3$4&W'I
MCIB@VMN8EB,$1C7[J%!@?05+10! ;*U*A3;0E1T'EC H-E:EBQMH23U/EBIZ
M* *_V&SQC[+!C_KF*E,,1*DQH2HPI*C@>U/HH BBMH("3%#'&3P2B@9IT<,4
M.?*B1,]=J@9I]% #$BCC+%$52QRQ48R?4TC00NJJT2,JXP"H(&.E244 %%%%
M "*JH,*H R3@#UI:** $5%1=J*%'H!B@  D@ $]3ZTM% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M\EKJ$3I;JS3,<J(@OWMV0-I'<'D4ZR\1Z3J&H-I\%WB\$8E\B6-HG9#QN4.
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M3D_W@,_A7+^)Y;V]U;Q1ILVG:DC263"QCL+8A+W]R1OED7EMI. I(';#$XH
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M)'S $_WF[51.G:[:^,M=\5:=8ZF9K>]6>&RELY EY"RA'V_+@.,\$<XSVR:
M/5)O$ ACM(VTV[.HW2-(FGAHO."J1N8G?L &1_%W Z\5DR_$?0X=+BOI$O1F
M]%C-"(,O;3;L%9,' Q]3G'&:PO$'VBX\4:5XG_X1Z]U32GLS97-FUHWGVSEM
M^\1L 3UP2...M,UZTC.AZ?+I7ABYL!+K-M=-##8-YICC8%I)50'!ZX!Y(_(
M'8:1XLM-7UNZTC['?6=W;PK<!+R'RS+$QP'49SC/!R 0>*ROB'<KIT>@Z@UQ
M<Q)'J]NL@B=\.A+9!1?O?D:@BDD?XP_VB++4/L4NBK:K<-92J@E\XOM)*\?*
M>IX'3K6CXZM[J6QTBXM;6:Y^QZK;W,J0)O<1J3N(4<GKT'- $,'Q#LISJ,']
MDZM%J%A#]H>PFA5)I(>,R("V".>F<^U6;;QI!>>'M,UFVTN_EBU&=88(5,7F
M<YPQ^? 'RG/.1W'!JK#I\VK_ !'MO$,4%Q#8VFG-;;IX6B:61GS@*V&P!W(Q
MGIFJ'A#0KG3/%&IZ651M%TJX:>Q.>5DG4,4Q_L O_P!_* /0**** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BL2;Q1IB^(QX?2]@&H-;O,<N"(R&555AGJ2_ Z\'VK%\%^
M*);FQU!?$&JVGVF/5[BQ@9]D/F!"  JYY/YGF@#M:*JWNI6&FHKW][;6J,<*
MT\JH"?;)JRCK(@=&#*PR"#D$4 +17(6WB&^\2>)]1TS1Y$M;#2V$=S>E!(TL
MQ'^K0= %[DY],#K5[39=>M_$T]CJ<UO<6#6WFVD\4)1R0P#"3DC(W+C&,^G6
M@#H:*I0:QI=S>-:0:E9RW*DAH8YU9QCKE0<\4R?7=(M5E:XU6QA6%PDIDN$4
M(QZ!LG@\'@^E &A15,:MIIO8K(:A:FZF3S(X/.7>ZXSN"YR1@'FHKCQ!HUH9
M1<ZO80F)@LGF7*+L)S@')X)P?R- &C152YU73K.VCN;J_M8+>7 CEEF55?(R
M,$G!XYI/[6TW[/!<?VA:^1.P6&3SEVR$G "G."2>.* +E%9Z:[I$B7+IJMBR
MVO\ Q\$7"$0_[_/R_C2C6]):P%^-4LC9EM@N!<)Y9;.,;LXSF@"_39(TFC:.
M5%>-P596&01Z$4I954L6 4#))/&*SK7Q!H]],T5KJEI-(J>9M293E/[P]5XZ
MCB@"W:V-I8JRVEK!;JQRPBC" GWQ4BPQI(\B1HKR8WL% +8X&3WK)_X2SP[Y
MD*#7-/+3N8X@+A3O8'&!SSSQ5K4M5T_3T*7FH16CNI*EG 8#^\ <\#U(Q0!;
M2"&-MR1(K>JJ!2I#%'))(D2*\A!=E4 L0,9)[\5P7@#Q3>7/PZO-;UJ\^UO:
M2W!:;"C<B<C& !]*Z2QU)=(T+3AX@U&);^6(-(9"%+/C<P4#L,XZ<#% &Y16
M9<>(M%M;"&_GU:RCM)SB*8SKMD.<84YY_"K&GZK8:M#)-IUY!=11R&)WA<,%
M<=5)'?D?G0!;HKBY_&=IK$7B.PTN\>WN=.A/EW"*"6<(7. RD8& ,]\G'8T>
M!?%UEJ'AO1;?4-9MI=9N;<,T3RKYCGGMZXYQ0!V3Q1R@"1%<#IN&:#&AC\LH
MI3IMQQ^59]WXAT>PN&M[O4[6&52H=7E V%NF[TSVS6@P+QD*Y4D<,N,CW&>*
M &&V@,31&&/RW&&3:,-]12Q6\$  AACC 4*-B@8 Z#CM7 >&+KQ!K]MXE$GB
M2XAFT[5;BRMW^SV^S9'C:7'EY/7G!%:O@+Q=+XC\$1ZWJRP6KHTBS2 [8\*?
MO\]!^/8T =;M 8M@9/!.*:\,4C*SQHS*<J64$CZ52L=<TS4[A[>TO8I)T4.T
M71]IZ-M/.T^O2HHO$VBS7L5I'J=NTTK%(@&XD8=55NC$=P#D4 :/D1>9YGE)
MOZ[MHS^='D1>9YGE)OZ[MHS^=9)\7^'!>+9_VW8&X:58!&)U),AZ+QW_ /K>
MM<W\1O%,5CX<NAI>M-;ZA!-&F( &#$NJM&6*D!@I)P"&XSTH [QHXW969%++
MT)'(IU%97_"2Z+]KCM3J, DDD\J,EL*\G]P-]TM_L@Y]J -)XHY0!(BOCIN&
M:5HHW0(Z*RCH",BL>[\7^';&>>"YUFSCE@95E4RC*,QP ?0Y[>QJ3Q/X@MO"
M_AR]UFZ5GBMDSL7J[$@*OXD@4 :(MX 01#'D=#M'%.\J, @1I@G)^4<GUKF-
M(T_7=2T*WOM0UVXM]1N(Q-LMHXQ##GE4VLI+ 9 .3D\\BK6CZG<:?X:M'\2W
M*IJ&]X7)3!F<.P&Q ,MD#( &2.U &X+>$$D0QY/4[1S7+^(/#6JW&M6FL:%?
M6<,]M \'V2]@+P.K$$GY2"K<*,CL/SUAXHT,Z9-J)U2V6T@;;-(S[?+;^ZP/
M*GV(S4$7C/PW-<+!'K5F9&A\]?WF 4QDG/3@<D=10 FBZ%<6MZVJ:I-;3:F\
M7DYM8?*BCCW;MJC))Y Y)_*MQ(TCSL15SR<#&:R+;Q9H%WIEQJ4.K6OV.W<I
M-*[[!&WH=V,'^=1VOC3PW?:A;V-MK-K)=7"+)#&'Y<$9&/?'..OM0!N$ C!
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M7%J+A-GG6[[73W!_SQ3=$T:#0M,CLH)9YL?-)/<2%Y)6[LS'J>!^  [5HT4
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M?8U+10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M%9@9D92%'7(!(QQQ76ZS>63_ !4\$26D\/V;[-=+F-AM"M&!&..@)& /4<4
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ME7(PY!SG!/0U=G\9Z);74<,UQ(D4DYMENC"P@\X$@IYF,9R"/3(QFN+NR?\
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MQ"EQ\[=STX[<$UVFB:RFN64ETEG>V@29X=EW"8V;:<;@#V- &E1110 4444
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MTS0[JWNENM4UB?5)X\^3YD21)%D8)"H!\Q&1DD\' QSG;HHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@M&&'?A2=V,#/<XZ\9%<U_Q/XM5\ ZWJVCW32VUM=17:6MON9'=-L>57[I;
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MYBV+DAU++M^;!X&>M<MK\6K'7O!&M2:'<>39RW7G6]G%YC6ZR(!&& [X')'
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MBO2Z* "O+8=/\1:'I'BCPU_8EQ?Q7YNY[.]@D4IME5OE?<0=P/USG\:]2HH
M\R?0M>>T^'\/]BSAM%,7VP^?#A0L80X^?GD9X[5<L='UBV\0>.[R31YVAU6.
M(6>)8?WI6,H1C?QDMGG' /TKT&B@#RRXT#Q!)X2\#6*Z%<FYT:_MI[M//@X2
M(8.#YF#G/'TYQ6Q!9:S#X[\0ZH=#NS:7ME'# XF@RS(".GF9 .>,_CBN[HH
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M]P&U4*;(LF!-M0@X/;GUQFGWD>I:E%X$>/0]3C73+A'N?-@"E%5 I;:#GKG
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MQ&%&?F(!SG  (YX-5M%\/W]OXCTO4M(TF\T(2DMK%F\J?96!7^!0Q&[=TQT
MYQT(!:'Q4M_[,&JGP_JRZ9%,T-W<E4VVY#[.0#EO?;G&>I-;]QXI$EXUIHUA
M)JLT=NES+Y4BHJ(X)3YF/+, 2 .PY(XSP'AH:AJWPZUS0+32YGEO+R[ABN6*
M>2 SD%F).1MYXP3TQ[;^CZ'J/@SQ=>3P6,^H:7J-I;1O-"5\R&6"/8 5)'RL
M.XZ'KB@"Y=?$O3(-"T[5H;&^GAO;L6;*L8#P2YP4=<YW#!X .<>]6K+QS;R:
MGJ5AJ>G76ERV-G]O(N"K%[<9R^$)QCTZUR-]X,UJ#P[91V^FM-=S^(QK5S!#
M+&%MTR3L!9@"0-HXXSFMC4;#74^(]]KEIH4ES;/H+647F21!7FW[PK N#M/W
M2?Z<T ;&G>+6U86X.BW!MKVSDNK>1)8Y!*B[?D.#PYWC@G'7G@UP/B:?1;_X
M-6-]I6D_8;2+45$$#*&>(^>0V,9ZD'@'OBNA\/Z+?:7XG2_TC1;_ $G3&MY&
MU'39)8S$TV!L$ #$9SG)^5<#\*R5\)>(IOA$NA?V4\>I6U]]H$,D\6)5\XR?
M*P8CH<<XYH [#3O&PN]>;1-0T6^TV\EB::U2XV'[2BYS@@X!QV)KA/$LVAZI
M\ M2NM(T9=/M8;A?*A< M&XN%5F!YP2"1P>AQTKN9=/O]8\7:;KT^G3V<&DV
M\WEPR-&9KB20 8&URH4 =R.3Z<UQG_"+^)/^%,ZEX;&B3#4Y[LM'&9H2I4S"
M3=G?@< CUSCZT =CJ>I:7;^._#EG<Z-)-J<\,_V.^.T+&%C+.HYSDCCI_%]:
MQM-\=:[O\5WMSHCW%OI=T4,,-PN851!N R/F/!;\:N:Q9:Q?>.?!^K1:)=_9
M=.2X%T6EA!3S8P@X\SG!&3CMTS4WA?2M6T;Q1XD2ZTY3IVHWS7:7C3)MVE<;
M=F2V<\<@#&>>Q -2V\5&]L- NK:Q$HU@_*HG&8AM+$GCG !SZ'CO6A8ZI<W>
ML:C92Z7<VT-H4$=U)C9<;AD[?ITKEO >@-INK:SF7S;&QNY;;3%.?W*/M>10
M.F VU1_NGUK<T_7=1G\6W^C7NE"V@BB\ZUN5G5_.3(!+*.5R3QGT/I0!T%%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M,M<OI]5\ ^$==U*Q5[T:E8RK)& \D@9LG:,9&?[N?2@#URF31F6!XUE>(LI
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MF59]KLR#+^6FTAMON5R1QGK0!U=9VNZ)9>(M&N-*U!9&MIP WEN4;@@@@CW
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ML-P79&CC"X^Z,CDC/'(Z8-==10!R?BKP]?W6NZ+XCTGRWO=*,@:VD?8+F-P
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *Y[QY#%/\/\
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M-J5FUV@U"<VZG#;?*4A6R^<^P SS75:/>7&H:1:W=W9M9W$L8:2W8Y,;=QG
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M*-@#(//. >*IZG\.[O6;;Q#?2W$5KJ^I74%S;&-BRV[0+MCR<<DY;) [\=*
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MUUNI:=KGB/6K74X].?29-+L[D6C74D;L]S+'L!PC,-JXZGKGI0!+:^/)6O\
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M\+1KF%?-$T<T73@X'(/4?6N%N=.U7PSX%\":==V3QW]IXAA_=B9")2S2-M#
MD#.[;SC\J[C^S=1U'Q)+XDN-+GMC!I[6=M9M)$99&=LLS$-M '  W>I]B 8G
MP\UU-(^%_A:W2$3WM_++!;0F38&/F2,23@X4 <D ]N.:Z*/Q;>+K.H:%/I<8
MU>WM?M=O&MP?+NX^AVL5R"#Q@BN5TSP?XBT[P7X6:.S3^U_#]U)*;1Y4VW".
MS;@K@X!VMQGN#[5U%GI=W?>-O^$JU"T.GP6^GFTB@FD4R9+[F=MI*@ <#D]S
MQ0 _2O&9U?PYI>J6]E$)]0N?LZVKW!RC G<"=G50K$C'0=:H:S\18K$:JUG'
M8S_V7+Y4T,UZ(YIF !<1)@YQG'.,D$4WPSX?6W^(&OW]O<"73%<201#E8[B9
M5:4@_0+T_OD>M5K33_&/A7Q+JT6DZ9:ZKI.JWCWJ22W0A^RR.<MN!!)&>P%
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M=$!^T#[0V7)0)\OR<],\XH ET;QCJ&MWH-K!9&)+UK6ZL6<BZME#%?,8=P<
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MEH/A*RTG4TMA-:*8PUO*75QDD'E1@\T ='1110 4444 %%%% !1110 4444
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MINFV>D:?%8V$(AMHAA$!)ZG)))Y)))))ZU;HHH **** "BBB@ HHHH ****
M,S6] T_Q%9K::DDTD </LCG>,%@<@G:1G!YK11!'&J L0H !8DD_4GK3J* "
MBBB@#)E\,Z/-XCC\02V2OJ<<?E),6;Y5Y_ASC/)YQGFM:BB@ HHHH **** "
MBBB@#(UGPUIFOS6DNH)<.UI()8/+N9(PCCHV%8#(SUK64;5"C. ,<G)I:* "
MJU_86VJ:?<6%Y%YMM<(8Y4R1N4]1D<U9HH I:3I%AH>FQ:?IMLEO:Q#"HO\
M,D\D^YJ[110 4444 %%%% !1110 4444 %%%% !1110 4444 97_  CFEG7A
MK9MW.I!/+$YF<D)_=QNQMYSC&,\UJT44 %%%% !1110 4444 %%%% #0BARX
M4!FZG')IU%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MQ,,<%LD]<@1DC)Q70SRQ-H&B7.E7=QI'B2#3HOL>D^86$J$C]V4898':>>H
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
D0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>davidjkatz_employmentagr003.jpg
<TEXT>
begin 644 davidjkatz_employmentagr003.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***04 +1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %(*6D% "T444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !2"EI!0 M%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4@I:04 +1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %(*6D% "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !2"EHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B@
MD#J>M% !1110 4444 %%%% !1110 44A(&,D<TM !1110 4444 %%%% !13/
M.B\_R/-3S@N_R]PW;<XSCTSWI] !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !2"EI!0 M%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !7/>)M9ELKC2](LW*:AJTQBBDV[O*11NDDP>,A>F>Y'7I70UPOB6-H?B
MIX,O'X@9;N -@\.8\@'Z\_D: +[SZ=!XXT^S_P"$CO3>PV;H=-W,ZS#&?,?
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MG>Y^QRPPEX;A)> 6?[JG+'.[&!ZT =K=>*;**ZCM;2*?4;B2T^VB.TV$^1D
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MB\M-B&6)NQX;:5/J":L6WC>VN-8LM-DTS4;:34(7FL9)T15N0J[B!\V5..S
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MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JCJNE6VL6BP7
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MBY6WA:3R(V&07P...<=<4 =!17(ZAXWCAUWP_9V5K<75KJB23BYBCW*\8C+
M(.I.2I/H/KQ-I%SI/_"6^(9(-2OGN8TA:[@N2ZPVXVG!0,  " 22.* .HHK
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MJG> &9$!^\RJ03R.N!DU2N_B-:)+H8T_3;O4(M95C:RQ% &9024P3D,#@'(
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MX'.2 /9LME<V^M->^'+75[6]EU(B[TNZMI&LK@>8=TP9AM3@;PP/7 Q7JE%
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MJCZ=?K976FQ1QS-;L%WKR5]N/7OQ7>T4 >,VGAS7K/P%H1.D7+WFD:Z+^6S
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MD)#2,P(R.>#VKGOL5_)X*\?68TN_%Q?ZA<3VJ&U<&9'"!2./53].] '6ZO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M)W!1G!^4YZU5U3Q5KO\ PCME-;^&=4@OKQF66..-9GM4!^]U +'C:#]2#C!
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MC+*!N]..#TK-?P9K4FC:U9Z)]LCTQ);>\TJSU+&5E1MSQ@,20G  W<9[?Q$
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%)2T@H 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** *]]96^I6%Q8W<
M8EMKB-HI4)(W*1@CBJVB:'IOAW3(].TJU2WMH^0J\DGN23R3[FM&B@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "J&JZ)I>N6XM]5T^WO(ADJLT8;:3W'H?I5^B@#/TG0M)T*!H=*T
MZVLT?!<0QA=V.F3U/XUH444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%(*6B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BF&:)94B,J"1\[$+#+8ZX'
M?%/!!&0<@T %%%% !1110 444C,%4LQ  Y)/:@!:*16#J&4@J1D$'@BEH **
M** "BBDR,XR,]<4 +1110 4444 %%%% !137=(HVDD941069F.  .I)I(I8Y
MX4FAD22)U#(Z'(8'H01U% #Z**A>ZMX[F.V>XB6XE!,<3. S@=2!U.* )J**
M* "BBB@ HHJFVK:<FI)IS7]LM\XRML95\PC&>%SGIS0!<HHIJ2))NV.K;25.
MTYP1VH =1110 444CNL:%W8*JC)). !0 M%16US;WENMQ:SQSPOG;)$P96P<
M'!''45+0 4444 %%%4;[6M+TN6*._P!1M+5Y3B-9YE0OVXR>: +U%%% !115
M:?4+*VN[>TGNX(KFY)$$3R -+@9.T'DX]J +-%5K?4+*[FGAMKN":6W(69(Y
M QC)[,!T/!Z^E6: "BBB@ HHHH **** "BBJD^JV%K?VUA/>01WESGR8&<!Y
M, DD+U(X- %NBBB@ HHHH **** "BBB@ HHJ*YN8+.VDN;F5(8(E+/(YPJ@=
M230!+1573M2L]7L(KZPN$N+67/ERIT;!(./Q!JU0 4444 %%%% !14,UW;V\
MT,4TJQO.Q6(,<;VQG ]\9./8^E34 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 444E "T444 %%%% !1110 4444 %%%%
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M6<,%[9Q),6MKCSHV5B1U*J0P(Z$5J:SJUMH6D7&I7>_R80,A!EF)(55 ]22
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M'OC0KN#@AMK# ['- ':45ST/BD7": T.GRO_ &PAD0"1/W*!0Q9N>1@CIGG
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MK^6KQ*)%;.&W%L 8QC/S'/W>M-;XA6O]D:%JL>GW!L=7E6!)G95$$A) $G/
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M%I':6@NX9PS 3Q\Y;GH%P<C^E=!HMS>WFD6UU?Q1Q3S()#'&" H(R <\Y]:
M+]%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M+GL3GC/&?SJ"33=1UKQ5IGB"\TN:RCT>"?R+9YHVEGED4 XVL5"@# RPR3R
M!F@#%\&VI\4/XF36=+@E@&ORDNUPQ>*2-8PH7"@X&!@Y'4\5T/Q(A6;X=:Z&
M1&*VCN-X!P0.HSW_ %]*J> -/U;2IM>BU+2;BU2^U2>_AEDFB<;7V@(=CDAN
M#VQ[UJ>.+*[U+P;J>GV-B]Y<W<#0I&KHNTD<,2Q P#CWH R=$\5W%O+X<TN]
MT>2UMM1M0EK<O.I9G2,-AD'*@@<<YYP0*CT[Q1IEC/XRNAH7V&?2RLUXRLI:
MY8H2"2.!P/4]?K5:\T_7;B]\%SKX?NP-)R;H&>WXS'Y>!^\YZ9^A'?BDTO3?
M$5IKGC.^_L#*ZF8GM8[B>$I+L&PH^&.-P)/3&,]^H!U.B:Y=:K*OF6=N+9X!
M-'=VEWY\3G."H.U>15W6]8M= T:ZU2\+>1;IN8(,LQS@*!W)) 'N:Y3PCX:N
M-)\37=_9Z9+HFDSVP633I)DD#7&<[T",P50..V<]*VO&_A^;Q1X/U#1[:9(9
MYU0QN_W0RNKC/L2N/QH Y#79+Z?XG^!9[W2[>S>0W15HY_,=OW0^5_E&"/Q'
M)YK;M?'-S<^'_$>I?V3$LNA74\$\/VLE9!$N696V=>N 1^(K)EL/&6M>)O"N
MIWV@VUH=)><3DWZL)-Z*NX;02!U(')XYQP:;+X;\264/C/1['38+BTUJ2YNH
MKV2Z"X:6/!CV8SG/ )(&.<T :-UXAUJ?QYH%E;0VRV=U827?EM.RECA<[B%/
M3/ QSUR*73O%6D6%[XQO;C2$TXZ9+&;R:-@SW)*G:< #GH!SU:HGT3Q)!K_A
M?5H]/M)9+6S>RNXEN\+$"%PX8J"PXY 'Y]:K2^"=3U.?QO:W2+;6VNF)[:X6
M0-L*#@,O7J ?H: -:T\>"37K/3+FRAVWD3ND]G=?:%C91DI)\J[21T(R">!4
MWAWQC<>(5L+FWT^W>PNV=3+;W9E>V8*6 E38-I(&.IP2!S46@S>.)Q';ZU8V
M=FMHF'N8[@2M>L%(!"X^12?F.>>V/3-TSPM?GQ=IVMKI$6BW48;^U);>=3%>
M[DY"HO\ M\Y8 \?Q=: /0719$9'4,K#!5AD$5Y!X#\1WWASX=VMW_9"SZ7'?
M/'-.+D*Z!YBN5CVG< 2.I']:]?D9EC9D3>P!(7.,GTS7F%KX0\26OPQD\-"T
MM6NWN_-WFY^3;YPDZXSGC'2@#H=8\;BTU34-/L4LGGT]$>;[5<F+S&8;A&F%
M.3C')X!(Z\XHGXBW=S/H,6FZ \[ZQ!+)&DL_E-&\8^9&RN  >^>G:FOHWBO1
M?%U[KFB6ME=6VK)&;RRN;@HT,JKMRK@$$?A^%3W6A>('\5^&]6=(;LZ?'.+M
M_/V M*,8C7'1>V>2,4 )<>/;J,7%M]CL;;4K&&.2[MKF\X+LNXQ1E0<G&/FQ
M@$@8/.)K+Q\;W5?#%JFE/'#KT<[J\LI62 Q*2P9-O.2, Y]_:H;O1O%.C^-;
M_6- 2QO;'5%0W-K=2F(Q2(FT,I /! &>/\:=K?A[Q!+JWAC7+=K2]U#2FN/M
M$4DAA1Q,N#M.TX"]!GG&,]Z &:IX_O-.T7Q)>C2(&DT2Y6!T^UG:X8*0P.S_
M &AQ]>:M6WB_48?$VF:9J^FV]M;ZM;R2V<L5P793&H9ED& !P<\$X]3UKG=3
M\'>++S1O%EDT6F2-K=Q'*C1SLOED!,Y!7D?+CKDGG K8U#P_K>H>)O"=^;2W
M2VTN":.Y'VGDF6,(0/EYQC/O0!S7Q%UR^\1_"N_U2WMK9=&FF182[-YQ59@!
M)TQAB/N]<'.>U=GK7B^6WUB[TG3(X6N;.)99VG21URP)5 (P2"0,DGID<'MR
M5YX'\7OX"N?!48TN6R20?9KU[AU?RQ*'"LFT\CGG/L*V[SP]XKT_Q8_B/0SI
M<DNH6\<6HVEP[A-Z#"NC 9P!QCC\<\ #9OB%JK1>'7@\/&*36))(3!=RM')%
M*H. 05'RYP=WIVS7::1-J$^DV\NJVL5K?LO[Z&)]ZJ<]CWXP:Y'6/#OB2_U#
MPO>R&RN9M.NWN+K$S(/F_A0;3\JCC)Y..G-=V.G/6@#F[G7[V\UZ]T70X[1[
MBPBCDNI;ISM!?=L0!><G;DD]..#GC N_B9*O@X:[:Z2/,AOQ8WEK+-\T+[P"
M!@8;@\9*]?PK5ET+5M,\<7OB#2EM[FWU&W2*[M9I3$PDC&$=6VL",9!''7/-
M8VI_#[4Y_!TVEVLMDU_>ZF=2O)979$#EPQ5<*Q(X R<=,^U '::'/K,]K,=;
ML[:UN%F98Q;RF17CP,-D\@\D8]JR/$GB?4='\3:%I-G86UPNJ&50\LY0JR+G
M'"G Y'//?BNGA,K0H9T1)2!O5'+*#Z D#/Y"N6\1^']4U3QAX;U6T%G]FTIY
M7D$LS*[^8H4@ (1P!GKSTXZT 9$/C/Q3<6^O0Q:1I?VS1'87$AN7\J10NX!!
MC.<9ZD <>O&G#XU.J1Z#;:;!&FHZO:?;%6XR4AC RV<<DYX&,>O;%5X/#OB"
M*Z\62M%IC#6L>2!=R#R\1^7\W[KTYX[\>]4K3P5K>F0>&M0M6LFU71;<V<L/
MG-Y5U"1SABF5;/(X/UH LW?CV\L+'Q);W%A;'6=#C$TD8E8131,N5=3@GN,J
M>_>IK7Q+XIET5-0N-&LXTNS;?97CF+K%'(N9))NF%7@\>N,\9JOJ?@W5=3L_
M$MT_V%=4UN!+58S,WEVT2K@?/LRQ).3\H].U2ZMX8U^]\)>'["!]/6ZTR>!Y
MX))7:"Y6(8VD[,\D X*\'Z4 5)/%$NN^%O'%A/)9W#Z=8R!;NRR(IUD@9@0I
M+8(Q@_,1[UT7@+_DGWA[_L'P_P#H KGG\*>*7N/%4KR:.W]O6BPE5>5?*81&
M,#[IX ;.>^.@SQU7A/3;S1_"VG:9?B#S[.!8"T$A=6"C .2H//IB@#9HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "D%+2"@
M!:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M** "BBB@ HHHH **H:OK.GZ#I[WVIW M[9#AI"K-C\ ":O(RNBNIRK#(/M0
MM%%&0<X/3K0 4444 %%&1G&>:S="U[3_ !'IWV_396D@\QHR60J0RG!&#0!I
M457O;VWTZRFO+IRD$*EY&"EL >P!)K'D\:Z%%I6EZB]TXM]4=8[0^4Q+LQ
MZ<=>^.AH Z"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *Y/QMJ4R2Z+H-LS
M))K-X()'1L,L"C=+CODKQGMGZ5UE<5X\LY8M1\-^(HU)CTF^S<D#)2"0;';'
MH."?09/:@"QJD^GV7C'PMI3Z!"X<3+9WF5 M=D98JB]>BJ.P_*ET.6QU/Q#X
MFLYO#T%G<(84NG8I(;L,K%2V!C&.QSUH\1:7J5_XM\,ZC9VHEM--EEDF;S@I
M(D39\H[XZ]L]*DT2PU2V\9>(-0N[)(K._P#)\EQ.&8>6I7YE[9Z]Z (O!=^Z
M76M>&YYI)9='N0D3RMEC;N-\>2>3@$KD]<"NK<L$8H SX.T,< GW/.*X[P;9
MFZ\1>)?$_P PAU*X2&VXP'BA78)![,<X/< 'O79T >17.K:GX@\ ?$!M7CMY
M%L[NY@B"L6$1C1  H*].IW9SDGBMWPYXKO;/_A%=(O=&,%GJ-FL=M=_:%9BZ
M1!OF0#Y01TYS["J"^%/$<.C^-]&2RMW@U:[GNK6X-P 7,N/E*]@N.2?P'>KE
MUX?UV=_!&W3T T0J;LF=3G"!/D]>A/..U $U[\2HH;8:A9V*7FG"X,)\N<_:
M&0,4:18@IRNX'C()'.!7>*RNBNIRK#(/J*\ZT+1_&OA?S?#]A#8W.D&=WMM1
MFEP]NCMN(,?\3 DD=B>]>BJ"% +%B!U/4T <WXP\3W7A>+3[E+"*XL[BZ2VG
MF>9D^S[S@.0%.5_^MZTQ/%5PGC__ (1BZM+:(/:FZ@F6X9FD7)&-NP -P3C/
M3UK4\2:-%XA\.:AI,N MU"T88_PM_"WX'!_"N%O?ASJ,_A?2Y$O"GBB&6-KB
M_1OF*LHBD )["/'IG;TR: +]WXA-QJ'A>YU3PW9R_;;TQV5VMQO\D,#M< H#
ME@H;'ICG/271K:'_ (6KXM@$,7D365J98_+^5RP?)/;G)SGKFIO%6AZI<W_A
MI=(T^*2TTFY6X;=.$X52H0#'IWI+'2];M?B#KFNOIT9M+JU2&!1<C<S1]"1T
M&?QQ0!Q.DW%Y:?L[WKV011BY61RY5E4RD': #D\X[5U6GZ@^DZGX6:YT73_M
M.JVRV:WD,[&58UC#X8&,9' XSQ69:>$_$EM\)[OPJ=.@:\G:0"3[4-@5G+YZ
M=NF*V-4T+7I[/PI?6ME;&_T67]Y:RS@"1#'L)60 XZ XQW]J 'WNOC78O&V@
MWVGQ*-)MERZGSA*)(V=3M*\$;1QSS6[X+_Y$3P]_V#+;_P!%+7*V6@>*+?5O
M&&I36%B[:W;PK%%'=D%'6,I@DKR!N.3Q]W@<\=;X4M;RP\*Z987\"PW-I;1V
M[!9 X;8H7<#[XS0!?U.\;3]+NKU+>6Y:")I!!"N7D(&=H'J>E<M8>.)IO$5E
MH=Y8VT-[>V9N(XX[LNT3A=QCE&P%#COST-;OB>TU&_\ #.HVFDW M]0E@98)
M=Q7:WU'3Z]JXBU\,^(X-?\.:LFCZ9;+IL,\4MM!<GYBZ ;]VWDL<\?F>> "R
MWQ)U*'PV_B"X\."'3K:Z-O>,;P%UQ+Y9:,!?G /7.WGID<UT=UKE]=:O=Z7H
M]G;W#V<227$ES*47+Y*Q@ $Y(&<G@9'6N-OO"OB6^^&&I>&O[-MTN[J[:57^
MU@H%:?SN>.H^[^M:]KH_B;1?$]YJNF6%C-;:O%$UW;3715K>=%VY#;3N7!Z8
M^F.X!/\ ";_DFVF_N_+_ 'ES\G]W]_)Q^%=A=7,-E:375P^R&&-I)&QG:H&2
M?R%<W\/]'U;0/"Z:;JZ6JR132M&8'+95Y&?G(X.6/3/%;^I62:EI=W82,R)<
MPO"S+U 92"1^= '.V/BC5[T:->+H+-INJ'Y6CD+2VZ$9220;=H!&,@'CU/:"
M?QI>3:/J&N:3I\-WIFGS21R S%99EC^^Z#;@8YP#][!Z<9J^%-)\;:1:V>@W
MLFF_V99.%6^C=C-+$IRJ;#P"0 I)/ SU/-1V7AGQ%H.E:SH&FQVES8WLDKVE
MU++L:W$OW@ZX.[')&.OMV +-QX[O)M>TG3M&TN"\CU6R-Y;3O<F,!<?QC;\H
M'?&X^WIG:QXPURY^'NNW45M:V6IZ=<O8W0$K.H^Z-\9 ')WC&>E30^$]5TCQ
MAX>GTZSBGTS2M.^PF22YVNY(Y?;@]^U,?PIK]YX8\6V$MO9P3:M=M=V^+EGP
M3L^1OE 'W.H]?:@#5UW5GL/$OA>UU#1K"=KNXDBCNR^][=]O\ *9&1MYSZ_6
ML^Z\=:_]I\306>@V9_L(;Y9);Q@KIM+_ "X3)8J#QP!ZFK6J:-XFUK4?#.HS
M6^G02Z=<-<7$:W;]QMVJ=ASQ]/3WJLOA;Q"+GQK(R:?MUZ();J+I_P!T1&8\
MM^[]#GCTQ[T 78?&\LVJ>$D%I']C\0V[R*=QWPNL8?![$<X_"H)/B ^GP>(#
MJ%FC2Z7>16D*P$_OWD V\')'7GKP#@=JSW\'^([73/!\]M'I\NH^'M\1A-PP
MCF1D"%@VS((QTQ^/:HIOA]KVJ)XB6]O;*VDU"Z@O;::W#,8YHU7L?X>H]>_M
M0!M6_C>YMM2O(=6T^46%O9&\_M""VF2,;<[HV#J/FP,C'6N>\97VJ:BO@:]N
M[2VAM;K7;.:-4<F2+.2JMD#)(.3CH1CGK6_%HOBOQ)HM[IWBN73;6&:V> +8
M*SEW88$C%C@ =0HZGN,5BW'A?QQJ.G>'["\&C#^Q+^WN$N!-(3<+$" 2-O!Q
MC/J3VQR >HUPGQ9FOH?!W^BL@ADN8$FR#G!D7'3MG@_45W*;MB[\;\?-MZ9]
MJY?Q]H>J>(] 73=+2SWM/'*TES,R!=C!N $;.<8[4 07U[<Z3K3RG3],MKF6
MT\RZUB9#'"^UMJ0[NI;!SR>@Z'MDWGC>+4O!_AG7YM L[F*_U&.'R[B0,;:3
MS&0.GR')^5L'@CCK5_4M&\47'C&TU>.'3)K4V?V=H)YW86DA)+2)\HW9&!V)
MZ<"L"#P'XIC\#:+H!722VF:D+M6-Q(NY%D=P,[#R=_X =\X !KW@?_A>5OY.
MP2'PZ^TL.,^<<9IG_"P-2?X>WOB5+*T$ME=O!)"6;:X$@3(/8_-GGTK3;0=9
MD^)MOXC>*R6Q33OL3*+EC)DMO+ ;,=>,9Z<^U<U<^!?%*>%M;\,V;Z8;&ZNV
MN()Y)'\Q@TBMM88PN,<L">F,<Y !NZKXM\11>,;SP]I.BV5U-#8B]B:2[*;Q
MO"X/RX!Z@#IT.>U1W_CV\^SWUUI&F_;8[.<PB%89F:YVD!RCJA48.X#KG':K
M%IH/B"/XD-XBN(M--K)IZV3K'</O&&W[PI3'7C&??/:JMCX9\5^'-7U"#0+O
M2FT.]N#<A;P.9;5G/S[ HPP] 2/PY) .YM;A;NSAN522-9HUD"2J5=01G# ]
M#ZBLGQ+X@&A0V*1Q)+>:A=QV=M&[[5WMW8@$A0 3P/0=ZUX(O)@CBWO)L4+O
MD.6; QDGN:YWQIX7E\265E)97$=OJ>G727=I-(N5WK_"V.=I]O04 1Q^);^'
MQ:_AJ_AMDNI[4W-C<QEO+DP<%67J",9Z\BL'X=0W&LV^OG5H[*\@&NW#,LL.
MX^:NP*1G@ 8&.,BMR#0-2O/%47B75(+&.[L[)K:TMH)V=2[')=G* C^[@*<
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MWDRZ?>Q%E9LL=X(]B!C';M6&G@34=+TSPW'HVKQ"\T7S0KWD)>.591\PP&R
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M(Q+'CG)/? X%9TGPWU)M$US1(M=CAL+Z[:\@(MB9$=G5B'.[#+\N,8YSGVH
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M'?&VM6GASSGGU/3[L-<>2CH(HPO[T,V/NL/DP#U8>AKT#H,"@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "D%+2"@!:***
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MOB*'QC'HMX-.\O4+*2XLWBC<^0Z$?*^2/,'(Y&W\* .THK@=(\7ZW?Z#>1W
ML(?$-OJ8T\P>0_E@EAAL%\L-F6R#T4UWJY"C<06QR0, F@ 9E1"[L%51DDG
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MI@AL$$#:&3T8>G\54+?Q=XIATCPGK][>6,EIJUW#:36<=J01YF</OW=1MZ
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MC"J, 4M ')^"]!U7PQX?N;">.Q>4W,L\ CN'*X=L[6)0$8]<'-<_9_#G5/\
MA7<?AZZN;2&_M+S[;9W4$CNHE#EAN!4''S$=_7VKTRH;N[M[&TENKJ9(8(EW
M/(YP%'J: .8DT+5=9\0:-J^K16EN=)25HX(9V<2S.H7);:-JC''4\\].8?#_
M (<UO2_"6KZ;=_8)+R\FN)8VCG?8?-))W$ID8SV!S[5U&FZE9ZQI\5_83K/:
MS9,<B@@-@D'&?<&HY=:TZ'6X-&DND749XC-% 0<L@ZD'&/7C.>#0!QP\(:\O
MA7PMI*C33+HUY!<2N;EPL@BSPO[OJ<]^GO6K9>']3@^(U_XAE^R?8[FS2V"+
M,QD4J<YQL Y^M=710 5P-MX3UV"+QDI&G'^W6=H,7+_N]RE/F_=]@<\>F/>N
M^HH X"U\+>(K6Q\)6PCTMO[#;,C?:Y!YO[MH^/W7'#9_3WI->\&ZQXA=C=Q:
M4EW#?^;9:M%(ZW$$ DW*NT1C<0N1]['?KR>XO+VWL(1+<R;%+!% 4LS,>@51
MDD^P&:KZ/K>G:_9&\TNY%Q ',;,%*E6'52" 0?J* -"N2UWP[J[>+['Q-H5Q
M:"YBMC9W%O=EE2:$MN #*"5(//3TKK:* //H_ ^LW6E>+;/4+VQ4ZY(98V@#
MD1-M P0<<<#IS_*E3PMXIN/$OAK5KR;25&CQ20M'')*Y<.@0MN*C)/7!Z8ZG
M/'H%% '!6OA/Q!8Z%XGTB*339H-4FN9+=WDD1E\[@[OE(&WGIG/J*K)X'\0V
M5GX;O=+O+"#6M(M?L4JR,[P7,/'!.T,#D9Z?CQ7HU9,?B;1II-42._C9M+.+
MT ']R<$\\<]#TST- &5+I_BN6VA:XETB[>68_;+*3<MN8-I 1258DY(8DCGI
MTI_@WPLWAA=3P(8(;VZ\^.RMW9HK<8 PI8 DG&3P!T '%:#>*M%73]/OVOE%
MKJ#I':R;&_>LQPH QD9/K6Q0 5Q=MX @77_$-U=3"73=45C':#/[MY5"S/\
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M('4*V6R.<#/3J: ,K0)+F+QK\1Y+0PBX1[5D,REDR(F/(!!/YBLK7-=U;6?
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M)O[K=9VUDUS:2K$ V4&95ST8KD8X]<Y-02WOC:/5],T2/4K(W5YI<MQ+++;
M>1*NWG@X;YFVC@<')SCG4O?A_8WEEX>MS,X;2+E9VD;+-/WD#$G/SM@FM2YT
M&XG\76>NI?(BVUN]OY'D9WJY4G+;NN5';\Z ,S3[W73XRGT/4-0@=/[)CN5>
MVMPA20N4)&XMGE21GCGI7!2'4XO@7JM^VMWK2?:)MX^0;P;DJV3MW?-DD\^W
M3@^HC09QXP.O_;EPUH+0V_D<% Q<'=NZY/ICVKGD^'4I\)ZQX<FUN1[*]D9[
M=1 H\G=().3U8[O<#% #KWQ%J2:]:^'[-K^Z<6 O+BYMT@,V6?"##[4"CG)
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M-I-I3720>2"$RR[@3GDG:.>W84 =CHVK:3>RWNG:6R@Z9+]GFB2(HL;8S@<
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M!(/H.@ ;)R1S9T_5==\3OK$.GZE%8R:1+]CW+"L@N+A5!<L&Z)G@ 8/4Y[4
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %9&M6.JW<UG+IE]! L)?SX;B(R1W"D8"D C'/.?T-:]%
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M+X2N;#7]3U/1=46T75,-=0RP&4"0# >/YEVGGG.173/-'&P1F&]@2J9Y;'7
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M8MI+B?0;[S;Z=X&1$*J1M4GKO?:<9/"GVSZ!5;3KV/4M,M+Z)66.YA295;J
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M&F^*M2U+1_!]E]J$>IZW$TTUR(E^2.-=S[1C;N.0!D8')Q67_:USX4\2^/\
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M&JW%O+IRLL,21H5PXP^<C/(X]NU '+3:YJECXFCL=<NK_3KB;4U%K<J,V5S
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MR/(P\M/ER 3SQQQ78V/AZV%Q'J;WNH7-V(#%;SW>/,MT8<[5*##' R6!/'-
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MP?PDGTSCC-6M4\*W&I)JMJ=6*Z=J2A);5K=7\H>6J'RVS\IPN>00#SBNEHH
MY23P-!_;XU2VU*ZMU:Q6PFA54(DB4C'S$9!XP?Z5F1?#6>+3M+L5\47XBTJX
M6>R @B_=XW=<K\QPV 3P/2N^HH Y"Q\%7%B?$#+K)>36L>8S6P_=G&W(^;GY
M2?QY]JA_X5^R6GA\0:S+;WNB(\5O=16Z9,3+M92K97.!][UYKM:P_%'BBU\*
M:?%>7=M<S1RS+"/(4':6.!N)(P* ,F3P$;C4]?N[G59'36[86T\:0A2JJNU2
M&R>0.O'/M5:+X=3K<:#<2^)K^6;10R6Y\F(*$*A=H&WC@8).3]*[NB@#C8O
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MQDYQP,=#!*)[>.4# =0V/3(S5"UU2XN-=OM.?2[J&&V1&2\<#RYRPY"_3O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Q/Q!N6>Y\,:
M1G$.H:M$)QCAXXSO*'ZD+^5=M7,^-M#GU?3K*[LHQ)J&E7D5];1DX\PH<LF>
MVX9'UQ0!7\4ZCJ>G^*?"\=K?^79WMV8)[;RU)D 1FSN/(' X%0Z5>ZQ<^-?%
MFDRZL6BMH;=[0B%/W'F!R>,?,>G7/05:U/2'\5W&BZQ9:D+5+"0SQ1R6NXF3
M!4A\L",<@KQSFI;3PS>V?B75M;CU6(RZC&D;1-:_*FP$(?OY. 3GU]J ,WP7
M?77B;X6K/K,IN9KJ*ZCG9U5=R^9(N,#CH,5/\+M8GUOX=Z5=W3M)<*C0N[=6
MV,5!]^ *CL]/G\"^#3H]M<MJ5ZYE73XUAV,\CDM\V#@*&8DMP *W/"VA)X:\
M,6&CI(9/LT>&<_Q,268_F30!RGBXW2_%GP6;5(7E\F]V+*Q5?]7SD@'M[5T*
MQZ[<0ZN;IK>RND&VQN+=1($0JI/WUY^8<C'85!JWA2]U+Q9I^OIJ\<,FG+(M
MM";3<H#KM;<=X)/TQ4\N@ZK<WPO+G6HWDCA>.WC6TVQ1LV 9"N\EFV@J,GC<
M?6@#@Y=<\56O@[PKXA_X2 R7&H7,%M);M;)Y)63/S'^(MQR00/0"NALI=?M?
M&&L>'Y=?EN8VTU+VWN);>/? Y<J0   1P3@CT]\R2_#ZXF\,Z/H;:TODZ5<1
MSPR?9/F8I]P-\^,<G/KQTQS?N-#FL?$=WXHNM7A6/[#]FEC:WVJL2DMG=OX.
M2>?TH X==:\6VWPZT[QQ+X@:80^7)<6'V= DT1DVG+==QSU&!_.MY]2CLOB?
MK.JLCM%!X:2Y*#&XJKLV/KQ5'X>:*?$'PXT>UN-8\_38V#S6:1KNW*^X1N^?
MNY ., ^^*ZQ?"<C>,+O7;B_2:*ZM?L<EFUL-IBR2!G=UR>3CGTH Y;4-<UVR
M^']EXYBU.:24B.YN+!U3R&BD8 HO&X;=PPV23@YSGBX-:O=#^(,T>IZI=2:'
M?::]Y8^8% 1D&Z1> "2%!(]JT[/P$EMI,>A3:I/<Z%'*)$M)4&_ 8,(S)W3(
MZ8![9Q575Y]&\:^(K;0?LMS++I%^MQ<2/ R(@12<!B,$,Q48[C)Z8- %>]U'
M7M.3PSHANKB;4-3\Z>X<21+)A%#&)2P 'WQSC.%/K52\UGQAH.EM:ZB3YFH:
MI%9Z;.9(C,B/N)#'&PL N 2.K<YQBNK\5^$X?$\-FXO)["_LI?-M;R#[\1/!
M'N#QD>U4IO %KJ'AZ?3=7U.^U"ZF99/M\C 2QNF=ACQPN,GC_:/K0 [P['XH
MMO$%RFH)(VBR0J8C<SQR312C@C*@94CGGG-9WQAW?\(,NP@-]NM\$C(SO%;G
MASPQ/HSM/J.M7FL7>SRXYKK \I."0H'J0,DY)P*E\5^&D\5Z4FGRW<EM$LR3
M%HU!8E3D=>V: .<MKW6]'^(3Z-<ZXU_%=:0]U&;J)$6.97Q_ !A,9XY^M9UI
MXEU2VU;PBKZK<7J:A+)!?7 A MIWVDCRLA6P#T91@CUZ5TNH^"5U?7!JE[J4
MC.VGR:?)'%$%4QN/F(ZD'D]SVK*B^&,ZQ:*DOBK49/[(D#6O[F(!$ QM QUQ
MCDY]L4 4[77=3/B9-,U?4+[2M4;4RT"3(/LM[;!N(XR%P#M]]Q/4\@#T>ZA:
MYM9(5FD@9UP)8B RGU&017-#P;--]F@O]9FO+&WO1>QPO"H=7#%E7?UV@GIC
M/&,XXKJZ /'KCQ)X@_X5U=(FH79\4:9J$MO-Y03,XCR[':1POE D8&<CCK72
MW&NW&LZ5JNK:/?W,%I:Z.)HY%VG=,R&3HP(RJA0?^NGL#70V_A73+;Q/?^(%
M1C>7T*PR!C\H  !('J0%S_NCWJKIG@NQT?PA=>'+*62.WN1,&D(!8"3.<=N%
M.!]!0!Q6KWD^H^"?AM>7DSRW,VM6#O(W5V.[)-=(Y,GQI,>[;_Q3C %3\PS<
M+S4DWP_CFT+1-*_M>Z6+1KB.XMI%C3=N0?)NR,'&3VYS6E_PC!_X2_\ X20:
MA(+K[']C,0B788]V[ZYW<]: ..\%6-PECXWDBU"ZAEBUB\5"CKC<%4ASQRW0
MGM[47/B+6$\%> ]374)A=:CJ-I;W;87$J/N+ C&!G Y&*ZS0O"":)_:J?VC/
M=0ZG/)<7$<J(!YDF Q! !' QBL2/X6Q"PTVRF\1ZM)!IETEQ9K^[ B"Y*C&W
M#')ZMG@8  S0!9\/DCXH>-BI&?)L.O/_ "S?TKEDCU2'X,:9K&EWEU%-ISRS
MS002F-;B'SFWJ<<CC)!ZCFN\MO"DMIKVKZO#K%RL^IHB2J8D(38"$*\=0">O
M7-9?G6?PZT&QT2:/4]9CNGDBMXX[99&).6*MC P23U]?04 :6B7<.NZS)J]C
M?W$FGQV\<21B8F-Y&7>6*],A60?4MGD4WQ[K]SX>\/1RV:DW-U=Q6D;+C*;V
MY(SQG .,\9QGBKOA'08O#?ABRTV.)(G1-\JH<CS&Y;GN,G ]@*LZ]H=CXCT:
MXTO48R]O,.JG#(1T93V(/(H XN*W\7P7VIF66;3M+DL&\KS;];J:.=,D,A93
MP1U!]R".*Q8M1UZST/P)KC>(+Z>74[^UM;B"0+Y31R#GC&2WR_>)ZD].*[+3
M_ IL;&XAD\0ZM>326YMHI[J19# C?>V#&,GIDY/ ]*@D^'<;Z%HFE#6;Q8M'
MN4N;9_+CW;T^YGY<$#)^N: ,O6=<NVU+Q=;7NJR:5/8V\;Z4JR;-ZE2?,"_\
MM<N-I'..!@$\VGN=2BLO"\>H7]Z\MQ:-)=6$+$7=Q,44\%0NU5);.2H'&37.
M7:)_PF&L/J6K>(=(NS.HA$%F9UG15"K(C>6V-QW':, 9Q746?A+4-773-8O]
M9U*TU2UCE@6:-(XY)H&?*^8A!"L0 3Z>Q% &):^)M?7P##/+-.736S8WET^T
MR6UJ)"&9BN1D# +<]<^]6?[8U'3?$'B>\L]1N-0T32],^U0HTWF1B?828RY!
M+<#=][C(JMXE\*IX7T!;:UO=<EL+K5$N+B6,^<UF 2Y;:%R^6QDMGL>HYN^&
M;<WMTMKI^M7^LZ'-&\=]'?V0CB",IQY9VH=Q)Y !&"<]J (M)F\:7=WH.KHA
MCLYMCWS3:BLD4\<@&"B;?D(SP%]@<]:QO$-[/XH^#6L>)+B\N0T\K>5;K)B.
M.(3A%0KT8\9+$9SWX%=OH'@"WT"XC$6LZK<6$+EX+">8&&,YR.  3CJ > >>
MM4;SX66-Q9ZCI\&LZI:Z7?RF:2QB9/*5RP/RY7(''3..GI0!VMA_R#K7_KBG
M\A7"07VJMXU\:Z=_:]VT5O912VHPN;=F4MA1MQZ=03TR2:[NRM18V4-J)I9A
M$H422D%F^N !^E8 \'A/$.K:S%JUW'/J<(AD0)'M4*,+CY<Y% '!6.HZ];>!
M?"_BB7Q!?W%Q+>PQ36[E?*DB>0J5(QDG_:.3^F/8V!*D D$CJ.U<2?AQ&?"E
MEX>&NWXMK.X6>%Q'%N&TY4'Y.<,<UV@5O*V&0EMN-^!G/KZ4 >.WEUKT7@?Q
M/K0\3:I]HTK5)X;50R!=J2A?G^7YN#TX [#K6Z]UJVC>+O"+2:U>7JZRLJ7<
M,VT1 A P**!\N,X^@^N=63X=P2>&M3T,ZQ?F'4KIKJX=A&6W,P9@/EX!(%7I
MO!D%S=Z'=7&J7[S:/N^SM^Z&XD $L-G/ QQC\Z .9TV[\17<WQ L[#4)KB]M
M9U2Q\]Q\F5)VKP #V''7!-9]QXU_L?P]K]Y:OJEMJ]K9QAM*U-WD:&1I-GG*
M7)W+\X/''RC@9KLX? ]K#_;++JFHB75W22XD#1@HZG(9,)\I[=Z=_P (38W<
MUU-K-S<:M+<6OV(M<A%V0YR0-BKR3R3UX&,4 5);*ZT.6+78=>N)[)+%S/9S
MR-+]KD"%E9-S':>,X4=*YG5-4U2R^%EEXX@UBXEU-!#=3+YC>1(LDBJT)CSM
M 7=C(&?EZY-=;X>\"6>@.,ZEJ>H11J8[>"^G\R*!",85< 9QD9]"1W--@\ :
M=!9KIGVR]?14G$Z::[J8E8-N"YV[B@;G:3UH QQ#?ZSX^UO39-<U2WL?[/@N
M%AAE$;1L^[A6 RH&.W/J>QR/#7BK4M;T#P-IEW?3)+JS7/VJZ1MLDD<!8!0W
M4,V%R0<\'UKN_P#A%(U\07^M1:MJ,=U>PB%U4Q%%4 [=H,9Z9)&<^^:R$^%^
MDQ>'[328=0U-!8S--8W(E436K,<MM95'!)R0<_A0!BVNFG3O%_CLQ7MXQCTR
M"2)WN':1#L<@!R=Q *]\]:=<ZKJ8\/\ PZOTU&<RWMW:0W;I,<3*ZY8,,X)R
M.3]:Z?2O ]EINHWM_+?ZA?3WL"P7)N9LB10".0 /4].!Z5GQ_"_2UM;*WEU7
M6)8["X6:S!N<>0%SA%P.G/7KP.10!5TXWOC32M;N8M:N=/O[?4I;>W>&5@EN
ML9  9 0'R,D[O[WM5?3+6";XV7<JW,TR'1H[E'2Z<JQ,@Y&&P4/]W[OM6W<_
M#G1[C6+G4([K4[5+LAKNTMKHQP7!'7>H&3GOR,_B:T)_".GR^);?78IKNVN8
M85@,=O($CEC5MRJXQD@$#@$=,=* -74K$:EIT]FT\\'FKM$L$K1NA[$,I!'/
MO7B]UKFHOX#M4CN]1?7] O)!J<4>H2JTL,3?O"YSDAMR8S[XX!KW*LFW\-Z9
M;:AJM[';CSM4VBZ)_B 7;@>GJ?<T </XIFAUGP?XNUVVN;E[1[,00)]H<Q-A
M0S.$SM!RP7I_ ?4DV94O=!^(_A>T35]1NXM7@NDNTN9RR$I&'5D085#GCY0!
MC\36_-X'TU_!L7A6WN+RTTU$V,(&3?(N22&+*>I.3C'/MQ3;CP5%=:KI.I3:
MUJK76E*RV[[H?XAAMW[OG(X/Z8/- '%OX@U'2/"OBHC5[IY(O$'V%+F>3S&M
M86\M2V3TX+8[9_&NR.B3:;K,M]#K=R=/GLFA^P3RO,'E +>8K,QP=N<@=:+3
MP#I<%AK%E<W%Y?P:O(9KI;IT.9#U9=JKM/ Z>@I-(^'^EZ+!,EO>ZG+(\1A2
M:XNC(T$9QE(\C"C@=L^] 'F^CR7>F_#WP/K5KJ-ZEU-J<5FR"=O*\DR2*4\O
M[ISM')&<]^F/<ZY,_#W2#H=AH_VB_%EI\XN+9!, 4<$D'.,G!)(^I]JZ@QL;
M<Q>:X8IM\P8W9QUZ8S^&* /$UMI;;P!XHUVWU"\@O+#6KF6V$<[)&K"5<Y0<
M/D''S9]L<UTWB*YGU&^U>*WN+J_FAT^-O)MIVMH].;:S>8T@/S2-U "D@+S@
M'G>/P]TAM!O=%:XOVL;V?[1.AF!+N3N)SC(R0#^'UILOPZT::^DNGGU',\(A
MNHUN2J70 PIE QN(''\\T <W-=^(+CPQX5UD6ESK5G_9P.H6D%RT<S,ZJ1,
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M6XDB\T1C8F2%R 3Z9X^M '<T5Y2?&FO^'?[=T+4KB/4M2LYK:*SO1"J!Q.<
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M:>)-;'AS0;K5FLYKJ.V3>\<)4$+W/S$<#VR?:KFG7J:EI=I?1JR)<PI,JMU
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M ***2@!:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M,DL0X;AB68MD]R?P[2B@#DM4\"QZCH-K8KJETE_;7B7Z:C(JR2&=>C,#P>.
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MA\-?VIJ9TTH(]F^/<(_[F[9G'Z\8SCBDU;P)I^LZ'::=>7=Z\MBP:SO0ZK/
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M#%LCJ>AYJM#%JOC.TUN:VOHK6_M]0FACG^VRH]F(VPH$:C: 5&3_ 'LG/3@
M]1HKS>VTZ36/'LME?:M>SV<VAP7$B6]U)'%([.067!RJG .%(]ZU?A?J%WJ'
M@X?;)Y)WM[J:W625BSE%<[<D]2!QGVH [.BBB@ HHHH **** "BBB@ HHHH
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M93"&W;MN=NXINYVEL9]:ZRB@# @\*0P>*Y?$2ZE?M=21^2T1,?E&/)(3 3.
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%8_B;69O#VA7.JQV:W45JADE0S>6VT?W?E.3[<4 ;%%9.A
M^(+/Q)H<6J:4PE208V2':4<=4;@X(J71-1N-5TQ+RXM%M2Y.V,2^8< D<G ]
M* -&BBB@ HHHH **K0W]M<7MS:0RJ\UMM\Y1_ 6R0#[X'\JLT %%%% !117*
M7/B75+JZU./0-,@O_P"S+A+>:*2?RWE8@,VPGY1M#=SR<],<@'5T49KF+_7M
M;TOPOK>K7VDVT<MBTKP1"YR)85Y#$@'!(SQ_*@#IZ*HZ+?MJFA:?J+H(VNK:
M.<H#D*64-C]:O4 %%% .>E !14%[>VVG64UY>3)#;PH7DD<X"@4ZVN(KNUBN
M86W12H)$;&,@C(H EHHHH ** 0>AHR/6@ HJCINKV.K?:38W"3I;3FWD=#E=
MX ) /?&X#ZYJ]0 449![TF1ZT +117)>(_$FJZ1XGT72K:ULGAU5WCCED=MT
M91<G*@<CGUH ZVBL>TN-;35DM[^VM&M)(683VQ?Y'!7Y6!Z @G!SV-:QD0,J
MEU#-]T$\GZ4 .HIB2QR,ZI(K,APP4Y*GT/I2^8F0-ZY8X SU/^10 ZBN=AUV
M\;X@S^'Y8K<6JZ<M['(NXN29"F#V['MW'-;_ )L?F^5YB^9C=LSSCUQ0 ^BD
MR,XR,T%E ))  ZG/2@!:*9%+'-&)(I%D1NC(<@_C69K^L?V3X;U35+9([E[&
M"27R]^ 2HR02.G2@#6HJG8WWVC3;&XN=D$US$C^46Z,5!*C/)Q5L$, 000>0
M10 M%->6.)2TCJ@ +$L<8 ZFD$T1A\X2)Y6W=OW#;CUSZ4 /HJ-)X9(?.25&
MBQG>&!7'UJAJ_B#3-$M#<WMW$B[E0*'&YF8@  9]_P N: -.BFQR)+&LD;JZ
M,,AE.01]:;+<0P%!--''O.U=[ ;CZ#- $E%<U+KE]%X[MM+9K3^RY]/ENE=<
M[]R,@R6SC;ANP_&N@%S UO\ :!-&8<9\P,-N/KTH EHK-U.^D70[R\TN:VDE
MBB9T9_GCRHS@[2/YURDOB_5F\*^#M5MQ9%M6N[6WO,@G'F$;MF#@<AASG'UH
M [VBBN0T_P 37K>/M<T74GLXK*SMX9K=URI 8_QDG!/(Z8H Z^BHWGAC@\]Y
M46$#=YA8!<>N:6*:*>)989$DC;HZ,"#^(H ?12,P52S$!0,DGM4-M>6M[&9+
M6YAG0$J6B<, 1U&10!/156#4K"ZN)+>WO;::>/[\4<JLR_4 Y%)+JNG6Z.\U
M_:QJCB-R\R@*YZ*<G@^U %NBJ]W?V=@B/>7<%LKMM4S2! Q]!D\FLK4;J^EU
M/1)=-U;3H]/EE87"2$,UR,?*(CZC!/'],4 ;M%<]XQU]="\.ZA/;ZA8VVHQ6
MTD]O'<D$R%5)P%W*23C ]">AZ5)H.MK-X,TC5]6NX(6N+.&6661EC3>R@GKP
M.30!NT55.I6 MXK@WMMY$Q"Q2>:NUR3@!3G!R?2H_P"V=+^QB[_M*S^S%_+$
MWGKL+?W=V<9]J +U%5Q?V;6/VX7<!L]N_P"T"0>7M]=V<8KD]$\1WFH?$34]
M,&I6=[IB6*7%O]F0 *2Y&"P9MQP.3D#V% ':457OI)HM/N9+==TZ1,T8(ZL
M<?K7%>'?$VOW.MZ;#K!LHK*?0%U*9U0IMD+ 'DG P",CM0!WM%9QU_1EM$NS
MJU@+9V*+,;E-C,.P;."?:C4[^".UGMX]4M+.]DMW>!YG4[>#A]I/*@\GM0!H
MT5Y[XCUO7-(\'^';N#6+6XGGN[>VNKF")62<.>64] .#T'?M6D=<U&+XLMHD
MMU'_ &6=&-Z(_+"[7\T)DMU/ )[=?:@#L**\Z?Q7/X@O-5&D>)].TTZ=>+'
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MZS LBZG#?!8;KS&\R)3<,"J'^%<=AZD]:]@3POHZ7!N!:$S&)H?,:5V8(W4
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M^\-Z1J5U)<W=DDDTD?DR/N8%TY^5L'D<G@^M:4,,5M!'!!&D<4:A41!A5 Z
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MG\O9G>2R.958!L;<]/N@'M5W7['2M)\$^';/1KR>YT]/$<!AFF=6##<Q8H5
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MBR6^T(\GF,2B8)W8 SU)]^*W_A)=VT_PXTF"&>.26",K,B,"8R78@-Z'':@
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MCZ58+J%J=%NK&:X;"K@%.YDR>,^F*ZVWOK2ZLQ>6]U!-:D%A-'(&3 ZG<.*
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MO-4LK=Y@&B6:X1"X/0@$\CZ4^75M.AO(;.74+6.ZF ,4#S*'D!Z%5SD]#TH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %P,DM,!P [9RW'')H \BATJQ'ACX<W@$J7MY=PV\LT<C!Y(F4@IO# J, 8
M_2NIT;3;/3OBEX@T6S@6#3;C2XIY;9,A#)NQN]C@GIUKJCX,\.FVMK<Z5#Y-
MLV^!,MB)O5>>#4S>%=#:^FO3IT?VF=2DDH)#,OH3GI0!YIX0L;K4?A+X52RN
MK(7D5Y/-#:WP)BNRKR_(V.> 2PZX*@]JLP1_VQHIL+&VM]&UFTUCSI-(NCNM
MIYA'N,8*@ J5&\#G!'I@UWJ^#/#B6<%HFDVZP02F:%%R!&_]Y>>#]*E?PIH4
MEG#:/IL+0PS&= <Y$AZONSDM[DYH \D\2_89OA7XK"Z3+I>HVVI1R75J9%:.
M&9FB4F(KP5*@'GH6/M7<2-;ZI\5KS2=8BAN+>/2XY;*WN$W(Q+$2. >"W(&>
MN!]:Z*?PGH-SIYL)M+MWM6D,K1$<.Y_B;^\>!R<]*FNO#VD7WV8W-A%(]JNV
M"1L[XQC! ;K@_7F@#QO6H9E\":S92.\ECIWB06^GN68%(]X!0'/1<E1^/I7<
MZ=I5EHGQ@,&FPBVAN=#:6:-"=KR"=0'/JV">3S73W?A?0[[3H=/N-+MGLH6W
M1P!-J*?4 <9IR^&]'35(]3%BGVV- B3DDL%'09STH P_B1H@U/PN]_!$C:AI
M3"^MF90<F,[F3Z$ \>N*Y"YU^.WUW3?B'!IBIHUS&;*Y,<69)2RY$G_?S,?3
M)V^A&/7V574JP#*1@@C@BJ@TG3QIT.GBTA%G 4,4(7"IL(9<#V(!_"@#@+C3
M[*SUSP]I36]LVJ&UGNYH;C:EJ&?'F2LN/G<'("C'&>0!63H%C/JG@6RM-/U#
M3_M=MKD\EK!<*6M[@*TA$>WG"XW,.N-N1R,UZ=J?AW1M:G@FU/2[2\E@_P!6
M\\08K[<]O:H/^$1\.B*2,:-9!))_M# 1 ?O>1OSV/)P1TR: ,OP%=P2VVJVH
MTLZ9>6]Z1=VBL&B20JIS&P !4C#8Z@D^U4/LEN?C?<1F)=D_ALF48X?-Q@Y_
M  5VEEI]IIL!AL[>.&,L78(/O,>I)[D^IJ!]"TJ34VU)].M6O63RS.8@7*^F
M: /$[?2;!?@[J>L_9E_M&TU)C;W.3OAQ<(/E.?EX)Z5[Q+%#=6[131)+%(N&
M1U#*P]".AK+;PIX>:R-D=$T\6I<2&$6ZA"P[D 8-:L44<$210QK'&@VJBC 4
M>@% 'A<:VR_L\6QC:%)VN(S(\6%<#[40"2 #Q_DUT^I62>'_ (BW"Z#:K!-)
MX;N)=D0_ULJO\I/<MG'/4UVR^$/#:0S0C0=.\J:3S9$-LA5F]2"*M?V'I/VZ
M.^_LRS^UQ*%CG\A=Z = &QD"@#S+PQ::'JVD>&=4/B,1ZA:RQYCB2,7#SM@/
M')QO;)SG/;FNI^+/_)+]<_ZYQ_\ HQ*Z"V\-Z)9ZM+JMMI5I%?RY+W"1 .2>
MIS[]_6M&6&*XB:*:-)(W&&1U!##T(- 'E^L>'M/TG4?!5_X>MA;ZG<7\*3-;
MM\T]N5+2E^?F&!RQSUZUCZ+%I?B#PBL^J^(6M=6LKMIKA1%$MXDX=MH!(W$G
M( '?IVQ7K.F^']'T9F;3M-M;5F&"T48!QZ9[#VZ4C>'-%?6%U=M*LSJ*]+HP
MKYF>F<XZXXSUH \W\2QG1Y]:UP16FN:&]ZKWH8!+RQE4HF(V(P0,+@<?J2=;
MPE#91?%/QJQBAC9C8M &0(PW1-G:",@GOBNQ/AK0FOC>G1[#[4T@E:;[.N]G
M'(8G&2<\YJP=)TXZH-4-A;'4 FP71B7S OH&QG')H XOXP11/X/MY'12\>H6
MY1B.5R^#C\*JW&D:=?\ QVGBN[&WGB?P^)722,,KN)PH9@>"<8'/H/2N^U'2
M--U>-(]2T^UO$C;<BW$*R!3ZC(X-5_\ A&]"-T;K^QM/^T%/+,OV9-Q7&W;G
M&<8XQZ4 >*Q)"WPG\./,J%8O$:QAGP=D?FOE<GHOMTKJ;C4M,;XB:OIVI:M:
M65E+:0+IWGPQ-"\1!$BHS<#+GIWQ["N_3POX?CLI;--#TU;68AI81:H$<CH2
MN,$BI;SP_HVH1017NDV-S';C;"DUNCB,>B@C@<#I0!Y5/H>C?VY\.[**0ZG9
M.]["+BY0$SQ*OR@D#YD&3M[8^M6I_P"QM*\=ZQH6I7=IH]A]@ABT_P"T1H8V
M@*G>@,G ^<MGGG\*]*NO#^BWT\,]WI-C/- H2*26W1FC4= I(X'TJ74-&TO5
MO+_M+3K2\\H[H_M$*R;#ZC(XH \YBTAK:UT*+PQKD5[=V5G<"WMM50&.\MBX
M!*D 8Z* W]TCMUR3<Z5=W?PWO6T^#3[5[B]22&9E9$()&W=T*[L[?8BO6K[0
M])U-HVO],L[HQC$9G@5R@]!D<4ZZT?3+ZTBM;O3K2>WB(,<4L*LB$=, C Q0
M!E>,+B[_ .$"U6XT1B]P;-FMV@Y)!'5<=>.1BN-U2.VN?!'@O4/#HC&H+<VL
M=J\"_,00?-1MO.WABW^Z<UZH  ,#@51M-%TJPN'N+/3;.WGD)+R10*C-GKD@
M9YH XK2[2U_X7=K?^CPY7389%^0<-NY8>_O5CXNQQ-X#FEE1#Y=S;G>P'RCS
M5R<]N*ZU-%TJ._:_33+-;QR&:X$"B0D<9+8S5FZM;>]MI+:Z@CG@D&UXI4#*
MP]"#P: /.-7M]*U;XK^&H5CM+NP.G7&(U"O$V#TP.#@CIZBN<NIQI7AS6(X/
M-M]+M?&)6Z6!%98[; XVD$;0VWC&*]?70M(2:&9=*LA+"H2)Q;IN10, *<<#
M ' I\&C:7;),D&FV<2SY\T) JB3/7=@<Y]Z .1\,1:'+XTN]3TGQ%-JMS<V@
M%RL)A,*A2 I?RU'S]0._WNU4_'\4^D^-/"WBR2)I=+T]Y(;Q@,^0)!M$A]AN
MZ^P]:[S3]+T_2;<P:=8VUG"3DQV\2QKGUP!5IE#*58 J1@@]#0!Y]\6KM!\/
M9=3T_498KA7B^S36MTR;PSJ#C:<-QFJ&H>']'F^,=EI\UC!-;2:(YD24;_,;
MS, L3RS8[DD\#TKO[;P[HEE<BXM='L()P21)%;(K _4"ICI.FM>?;#I]H;K=
MN\XPKOSZ[L9S0!POA1;"34O&FFZ[#"LRW9!BGZ?8=@$6,_P@ ].F:Y:U^T6?
MA+X<W.I2E88=8PL\YVXB)?RRQ/0;0,>V*]DNM*TZ^GCGN["UN)HO]7)+"K,G
MT)'%/N[&TU"U:UO+6"YMVZQ31AU/X'B@#R/4-0TG5[WXH&">SNHVTN!XMI#!
MRD,F6'KM)'(Z<<TZ/2-+'ASX=7>CP0)K+SVA,EL%$DB>7F?>1R0 &SGITKT#
MQ)H(N?#6JV6CZ?9I=W]JUL7P(L H5!) )(' QZ4_PEH2:)X?TZ":PM(-0@M8
M[>>6!02Y50I.[ )SC/- &C8:SIVJ7%[;V5TDTUE+Y-RBYS&_H<_S]C5ZHHK:
M"!Y7A@CC>5MTC(@!<^IQU-2T %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M,T.Z11M)(RHBC+,QP /4T .HKB/$GCI[3PA;^(-!6WN;>6\%ONGW8(\PQEE
M/(RI(YZ8KM5=&9E5@64X8 \CZT .HI@FC:5HA(AD499 PR![BGT %%1K/$S2
M*LJ$Q_? 8?+]?2DDN8(HA+)/&D9QAV< '/O0!+16;_;VF_V[_8PND-\(//:,
M,/E7<%&?<D\"KWVB#S_(\Z/SL9\O<-V/I0!)144ES!$&,DT:!<;MS 8STS5.
M_P!=TW3+^RL;N[CBN+QF$2,P!PJEB3Z#Y<9]2!0!HT4V21(HVDD=41069F.
M .I)KA_$'CLKX-_M_P .S6DT8N1 PF4L2#-Y6X ,,="1GJ,<4 =U14:3Q2NZ
M1RH[H<.JL"5/OZ4U+JWDF:%)XFE7[R*X+#ZB@":BLG2?$FEZW=7UO8723-9S
M>2Y5@0S!03M]0-V,^H-.UOQ#IOAZ""74+A8_M$R00IGEW8@<>PSDGL* -2BN
M3B\27@^(TNBS2V9TO^R?[0CE12&!\T)AF+$$<$\ =?:NI\Z+R?.\Q/*V[M^X
M;<>N?2@!]%1P7$-S'YD$T<J9QNC8,,^F17*^.-?U?P\=&?36L2FH:C#8.MS
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M\/ZW<PW&I:3:W4T("I)(F2 .@)[CZT <1-&D?C;X9PI?2:A&D%\BW4@YF A
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M<MA;VA>001[P;CR6@?+3." 2<+D;< \9->F)X5\/I=QW:Z-8BXC 5)?(7<H
MP #CICBFQ^$?#D4"PQZ'IR1),)U1;=0!(!@-C'44 <I\-4M(=5\7IMA28:_<
MK&N &V\' [XX/Y4_XKQPFP\.22I&<:]:AF8#A?FR"?2NTBT?38-4FU.*PMDO
MYEVR7*Q 2..."W4]!^527^G66JVC6FH6D-U;L06BF0.I(.1P: .#GT[3-5^-
M$4<UO;W-JGAP/'&0&CR+DCIT.,GKW]Q7*1W(TOPGIL#OY.A0^)KB*XD"AU@0
M,WE@@@C9NY.1V'K7K'_"*>'OM'V@:+8";R_*WBW7.S;MVYQTQQCTI]MX:T*S
MLKFSMM(L8K6Y&)X4@4++_O#'- &!X7T[2+7Q9J5YINLM?SW<"/<I L?D*00%
M8E!@.1GODC)JA\6UCDT[PQ'*7"-XAM0WEL5;&'S@CD'W'-=QIVE:?H]M]FTV
MRM[2#<6\N",(N?7 J'4- TC5;B*XU#3+2[FAQY;SPJY7!SQD>M 'FWC6TB\-
M>(_#NK:1?3WVJ/=BVCL;RX:Z+1M]XIO)9",#Y@?XOPK9\.O%>^-?&UCK:(TC
MO&$CN ,-:;"!M!_AZYQW//-=?I_AW1=)E:73M)LK21_O/# J$_B!4E_HNEZI
M)%)?Z=:W3Q',;31*Y7Z9% 'D?AZ\2+3_  A:W\X6[AGNVTRYO)=L"VZ_*K,,
MC><'"#(XYSCKAW\MA/\ #_Q- ;BWGEA\2LT;(0H",Z O& ?E4^WYU[U>Z5IV
MI1117UC;7,<3!XUFB#!".A /2HSH6D&2:0Z79,\[^9*Q@4EVQC)XY.* .$UV
MWT?PUXQ\+6S6D-GH-Q/-.Q&/)-WY:K&SYX'RCCW.>V:=X,FT[_A:_C5;&:V,
M4JVC((74ASY9+D8Z_,3GWKOKK2M/OK#[#=6-O-:<#R)(@R<>W2BSTK3]/=GL
M[&VMV< ,T404D !1T'8 #\* ./\ B#>K9ZSX4.H,%T)K]OMI8?)O"?N=Y/&W
M=D\\< ]JY;5[Z*/X@^+KG09H)+R7PZ2C6THRTH(R1C.6"C..O'XUZ_<VMO>V
M[V]U!'/ XPT<BAE;Z@U7L]'TS3V5K+3[6W94$:F*)5(4=!P.E 'G6@2^&-8?
MPOJ$'B.XN;^WVI;6<9@62/*D.KJB!MG!SDX],Y&<F._,'P[\6Q039E37+B2X
MAB93+]G\Y/,(4]MN>HQ7K-GHFE:?=S75GIMI;W$W^LEBA56?ZD"I8=,L+>YN
MKB&SMXYKO!N)%C :7 P-Q[\>M '"V-OX4U?7+75+?6SK%V;1T-O_ *.8_)VY
MQ,J1C !QC=T.*Y6V\.:"/@1+K"Z?;-J']GR@W!&Y@2_J>A&!CT[=:]>M="TF
MQCN([33+.".Y;=.L<"J)#ZL .:D&DZ:+8VPT^T\@MN,7DKMSZXQC- 'FS:1H
MD-Y\. +*T03(ZR;5 \T&V)^;^]\^"<YR3[U!%#9C4/BO:". 6HMXI$AVC8'\
MAR6 Z9W '/KBO3CHVEGR\Z;9GRQA/W"_+SGCCCGFC^Q=*S(?[,L\R##_ +A?
MF&0>>.>0#^% 'D4T5C=>'?A8MREO*C31QR"0 @KLY4Y[9[59\2HME+\1K;1H
MPDK6M@[0VP&2,L)<#I]S.:]3.B:2R*C:79%4^Z#;I@?3BI8],L(;DW,5C;).
M2295B4,<]><9YH \_P!-?PGK6I:5K%MXAN[VZBM)(XX(C"IAA,9++(D<:E5'
M09_B(Q5;PW))HNJ>&K!Y[36]&G\S^R+V$;;FWRA)$@Z%=I()ZY SR!7I4&GV
M5J9/L]G;Q>9]_P N)5W?7 YI+;3+"R<O:V-M Y&"T42J2/P% &+\0$A?X?Z]
MYRQL%L9BN\ X;8<$9[YZ5Q&I&RN-1^%K2"U??$5;)5@1Y*\9[C/ZUZM<6T%W
M"8;F&.:(]4D4,I_ U7&C:6#&1IMF#%_JSY"_)SGCCCDDT <?X(ABM/&_C:WC
M:$*;J"1(XB, -&3T'ZTSXF^2EWX.E?RPZ^(+7+L0"%R<_A7;0:;86L[3V]E;
M0RL"#)'$JL<]>0*6ZTZQOF5KNRM[AE&%,L2N0/;(H X%;JSA^-FJ17=S'%]J
MT>**(-(%:0E^B]R>O2LSPY.VD:GX6M(;JUUO0IWD&ESI\MU9DQMD.!PR[6(/
M''?&!7JC6ELTZ3M;Q&9%VI(4&Y1Z ]A3(-/LK:5I8+.WBD88+QQ*I(^H% ',
M?%(1_P#"M=;,FSB#Y=WKN&,>]<MXA6PT+1/"&K10&VTOSHGU"XL(P&!\DK&[
M$ Y +'K^'->KR11S(4D174]589%)Y,1B,1B3RSU3:,'\* /)M<N/"$.F:OJU
MM]JUM+UK>*ZN6G;[-O# 1EV7'W<9..V <;A51M2TI_'FOOJVMP7=G=^'FCDN
M+0JJR<_,L6"<D+GN3P<FO8%L[5+4VJ6T*VY!!B$8"8/48Z4JV=JI0K;0@HGE
MKA!\J_W1[>U 'D\,VLVDT&D6.HV.O+/I=U'I%_"<3VRB,%1* =I!VH QYW"J
MVJWMMK7P<T73M,<'7()K:&&U0GSXKE&PQV_>! WG)[<U[##:6ULSM!;Q1-(<
MN8T"ECZG'6E2UMXYWG2")9GX:0( S?4]Z /-;.735^)7C$3&Q9QIL),IVC!"
ML),>F2>?PS7.>&-:T^#P_P" 5GN+:VN46[5=3N')6UY(9 ,[=[*5 W\ =CD"
MO;?LT&2?)CR>IVCFE%O"%"B&/ .0-HZ^M '@-Q/%-\*?'-LDSSS#Q TY#+AS
M&9(L.P &,X/8=^*] ODTS4/B-X:U+1I+=XK&VN&OKBW<>4D)C C5F''4Y )Z
M FO0-B#=\J_-][CK]:18HT0HJ*JGJ ,"@#P>TO&7X=->VK2SV]CXH-U>"T8,
MZPAB=V.>,X(SQP#7H7A.;PYJOB>?6-%O+[4;B2S$<]W(6\M5W*50Y4#=U/J
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M.VU*/4))-0WOY<I99<QE"?F( "J .>V.>0#T"/Q?HTWBAO#\5["]XD6]\2#
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MZH&5SG:/E&0<YY['TCTW4K63XC^%]2COKR^MI;*6W67[(R1+(0"(HU50  "
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M'J3&BJN"V>>K,<^^* .SOM9.O^+=;TJ6YURSMK.UA%N;&WG1UD?<6<A5R>@
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MB2ZT"_MC=Z4'V-N63S-JH2X7/W<MMSTR* .J71-)34CJ2Z99+?GK="!1*?\
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M$GF"",29SNV#.?K3I(HY0!)&K@'(W#.#52]U?3[""&:XND59SB';\[2'&?E
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MO\F=-Z;U*MCW!Z4 6J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M.^<\=,=Z +GPO@N+;P#8QS"81[Y3;>=][R"Y,?X;<$>V*[&D "@   #@ 4M
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M!K^_EUO5K*]N;;5O(BAVZS:J%6=?FQ&^.-RY8\>O/:NZIL<:1($C140=%48
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MR,QNH!!!P#@]<'\=SP=/J%QX2TZ75;=8+UH_WB+'Y>>3AMN!M)&"1VS6[10
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M<G\2[NXLOA_JD]LTZE1&)&@^^(C(HDQZ?(6YH Z>*Y@G+B&:.0H<.$8':?0X
MZ4@NK=F15GB+29V .,MCKCUQ7G]GH_AFXUNUU"VUF*]EN+&2W6UMTB$<L&PM
M^\1%' XY/<@5P]AH^FI\%/#VJ"UC6^.IQL;D-MD'^D,N-^05&/0@#KUYH ]Z
MCGAE=TCEC=XSAU5@2I]_2F&]M0\:&YA#R$A%,@RQ!P0/7!KAH=%TNQ^+8L[6
MPMX+6Y\/OYT$<86.0B=1DJ."<$UQMIX>T>;X'RZBMO#_ &I!+,UO.N/-BE6X
M8(BGJ,\?+WW=,F@#TZ'4]2'Q$GTB:>%['^S1=1(D6UE8R;/F;)ST/3'7I6W_
M &C8F]^Q?;+?[5C/D>:N_'^[G-<1Y^H)X\.$5M6/A8$ CY?.$A.#Z#=7+W36
M=Y\ 1>0\:I;R+(TN<3+>>: Q)Z[R3]<$4 >PK>VCSM MS"TJYS&) 6&.O%(M
M]9NBNEU R,XC#"0$%CT7Z^U>=>(/M7@WQ%IWC%K8S27UJNGZE! N=TY7,;#Z
MNH7Z8IGC/0K+2_#_ (0M[J.-YEUNV6>=5VN[.6,AR.1N;D_A0!Z+_:FG>3--
M]OM?*@.)G\Y=L9]&.>/QJ;[3!]F%SY\?D%=WF[QMQZYZ8KS?2]"TC_A<&MV/
M]F6?V1--@D6V\E?+#9QNV8QG!QG&>3ZURNFZG+I_A7PG'<79@T2/6+J*:8*)
M%B +"$/NR,!B3SZ ]0* /;H]0LI;/[9'=V[VN,^<L@*8_P![.*%U&Q>:6%;R
MW:6%-\B"52R+ZD9X'N:\E\7:1HT'A3QC<V>I'4I+F*&YFVB(P12[@H9=@PLA
M&<]R#GO6U_9VG6/C7P,;>RAADN;*Y$\B* 9AY*G#_P!XY.><T =EH7B73/$<
M=Q)IMPDL<,S1!@P._;C+  _=R<9]J?XBUF+P_H%]J<I0FW@>1$9L>8RJ2%_'
M%<E\+)K(VVO11F%+DZS=MY7"R"/<,97J ,XK;^(80_#W7RX7BRE(+=CM('X\
MT 5O#VHZG<PVFLW>NV,VES622743A%-M,0&(5UXV\XPV2,=3730:A97-H;NW
MNX);8 DS1R!DXZ_,#CBO,&N([ _#,74<<>BR0!IGV@)]I-NHC+GIG).,_P!.
M%US3D?Q7XXAB13IDF@&:Z78&1+O:=C8[/L&>.>A]* /3[;4+.\8K:W<$[!%D
M(BD#$*W*MP>A['O61XO\3)X7T=+A8#<WES,MM9VX./-F;[H)[#U-9OPXT32[
M+PAHVHVEI%'=W.G0K-,OWGXW')^I/Z#H *SOBO:W"V>@ZW%;RSPZ/JD5W<I"
MFYA$IRS?AC]?:@#9U&+QC;:%+=6=_IT^J+&7^S/:D0D]2JG=NX[$YSCD<\;#
M:UI]M8VMS?WUM:B>-64W$@BSD9_B(I%U_2&TQ=174;9K1T#K*) 0P/3'J>V.
MN>*X36]4TZX\7Z@$,&G7O]C*MS/J3]87RWE)&2%W>IR0.F#0!Z$VJ:>EU#:M
M?6RW$Z[HHC,H>0>JC.2.#THBU73K@W(AO[60VW^O"3*?*Z_>P?EZ'KZ&O'M
MO[6/PG\-IY[J%4M[^2.61Y!B,E9-H8]NW!JS)/I.I^*OB1;SZO%:V]W'IZ)<
MHX(4[0N[KRH8J&[8/- 'J]GJNG:@'-EJ%K<A!EO)F5]H]\'BEL]5T[4'=+*_
MM;EX_OK#,KE?K@\5Y%K]SK<.B>)K#4(+:ZUE-.MY/[0T[I<6GG8(=3P&VEST
MZ9["NGT1O"^J^)]'U>Q\03:EJ0MWCBBC,(,<17)$JQHI '  ;HQ&* .XU#4+
M32K":^O[B.WMH5W/)(< #_'V[UF>'_%.FZ_X?CU>*X@BA*;Y5:93Y(YQO/\
M"<<\U;\0*6\-ZHJ@DFTE  [_ "&O);;4$_X03X?D30RZ;:7L']IJKY\G)/EF
M0#HH.3SQD"@#V"QU2PU1'>PO;>Z6-BCF&0/M8=CCI5LG R>E<*R.WQF@GTUH
MS"VDG^TBA!#?.1'G_:ST/7 /:K_Q*^V?\*[UG["LK3^4N1$,L4WKO_\ '-U
M&U9Z_I&H/.EGJ=I.UOGS0DJG8!U)YZ>_2HD\4:#)/;0)K%BTMT2L"K.I,A!(
M.WGGD$?45QVE3^%=<U[1=5MM?N-3OE@DCC@!@'E0E#N$RHBD*/\ :[D8ZUP]
MG'IUO\ M/OS!;FZBU%9-X4;RPN#WZYV_I0!Z[#XUT6X\47&A1WUOY]M'NE9I
M0HWYQL&>I !)QTINE:O::;HUW=:IXGM+Z&.ZDS=DI&L8)R(^#@E01^=<[I][
M96WQF\0K=7,$8N;"U6)9' \WMA0?O?A7$79MS\$O%Z Q%TUI]@XRO[^+I^%
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M]6/=&)<A6;:AZ,V =J^YP*+WQ+H^GVMO<W5ZJ17$?FQ$*S$I@'=@ D+@C)/
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M:YGU%VS$^ 650P!"C( &,Y]:SDO#I?Q9B^WVSQ&^T:*&(PQ,T?F+(Q9=P'
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M==TBXLI;R'5;&2UA.))TN$9$/H6!P* *\F@:1;W U&#1;22_A7]U(L:B3@<
M,>E<Q\/_  4NCZ6HUK1K1=2AN'E2<;7SN8L#D=QTR>?3BNNMM>T>\,WV75;&
M?R8Q++Y5PC;$(R&.#P,<YHLM=TG4HYY++4K2X2W&9FCF5A&.H+<\# )SWH :
M?#^CG5?[4.EV9U '/VKR5\S/^]C- \/:,-3.I#2K/[<6W&X\E=^?7..OO2MX
M@T5-/2_;5[ 63DJMP;E/+8@X(#9P>:?>ZSING,BWE];P,ZEE$D@!*CJW^Z.Y
MZ"@#%ETWQ#J7BC&HMIO_  CUM,MQ;+$'\^1U7Y0^3@ ,=W'=1[UL:EH6DZRT
M3:GIMI>&+/EFXA5]F>N,CBN:\7^)+FR?P]-HVI6[6UUK%O970C"R HYY&[G;
MP/U^E=/IVM:7K!G&FZA:W9@;9+Y$H?8??'^>#0!6?PMH$EV]V^C6#7,BE7E,
M"EV!&""<9(QQ3H?#&@V]A/80Z/8QV=QCSH$@4))CID8P:AUO6I+34--TBS"G
M4-19PC."5BC09>0COC@ <9)'O445Z\?BJ2!_$5G+;0V.9+ JGG(ZL-TS,",#
M! Q@#F@"ROA;0%TE=*&CV)T]6WBV,"E-W][!')]^M(?"GAXRP2G1-/\ ,MP!
M"_V=<Q@<C:<<8]JLPZYI%Q82WT&J6,MG%_K+A+A&C3ZL#@5G3Z]_9^MV$-Q/
M#-IVJL4M+A",I+C(0XX8, Q!]1CG.: -2VTG3K*\N+RUL;:"ZN3F>:.(*\A_
MVB.33M0TRPU:U^S:C9P7<&X-Y<\8=<CO@U+<W5O96SW%U/'! @R\DC!57ZDU
M@:OX@@N_"VM76@ZK ;JQMY)&:,+(8F52P#*>F<=Q0!I)X?T:+2WTQ-*LUL'.
M6MA OEL?4KC'84?\(_HW]F-IO]EV?V%FW-;>2OED^I7&*Q?!_B^QU;1M'M[S
M5[236[FS2:6 2*)&8KD_*.GKC'2MF^\1Z+IES]GOM4M+>4!2RRRA=H;IG/3/
M;/6@"SI^FV.E6HM=/M(+2W!+"*",(N3WP*M$ C!Y%9MSK^DV>IP:;<:A!%>W
M&/)@9L-)GI@=ZD_MG3?M%W;F^@66S4/<*S@>4IZ%B>@H C@\.Z+:ZBVH6^D6
M,5XW6=+=0Y_$#/:I9](TVYU&'4)["VEO85VQ7#Q*70<\!L9'4_G3=/UK3-5>
M1+&]AG>, NB-\R@]"1UP>QI=0UG3=*>)+Z]A@>4$QH[?,P'4@=<#N: (W\/:
M-)IO]FOI5DUCOW_9S OE[LYSMQC.:>=#TDF8G3+/,^SS?W"_/LQMSQSC:N/3
M IC^(=&2*SE;5;(1WIQ;-YZXF_W>>?PI=,U_2-:$[:9J=K>" XE,$H8)]<?0
M_E0 _3]&TS25D73M/M;19#EQ!$J;C[X'-+8:1INE&4Z?I]K:&9M\A@B5-Y]3
M@<UQGB7Q@T?B;PQ!H^M0O;W=^MO<V\:JWF*>K!CS@' X]>M=+XMN?LWARX(U
MV#0Y'PL=],%(0YS@!C@D@$4 ;=5+;2M/L[-[.VL;:&U<DM#'$H1B>I(Q@YK$
MO?&>EZ1J^EZ+=7@DO+I-S2%"HVA"=_ QR0.,]ZTI_$>CVUW]EFOXDE$BPD'.
M!(P!5"V,!B""!G/- %JPTVQTJV%OI]G;VD(.?+@C"+^0JU4<\\-K;R3W$L<,
M,:EGDD8*J@=22> *J:?K6G:I--#9W2R308,L14JZ ]"5(!P>QZ&@!;;1M+LU
MN%M=.M(5N23.(X542$]=V!S^-+_8VE^3Y/\ 9MGY6[=L\A<9Z9QCK4$'B31[
MF]CM(K^)II21$.0)2,YV$\/C!S@FJ%SX]\*6GG>=K]B/)=8W*R;L,<X'&?0Y
M].^* -G^S;'<C?8K?*)Y:'RE^5<8VCC@8/2HO[#TD(4_LNRVDY(^SIC/Y>YI
MEWX@TJQCMWFO$(N$,D(B4R%T !+@*"=H!'S=.12'Q#I0L+:]6\62"Z!-N8E9
MVE Y)55!8X')P.!S0!<^QVOV7[+]FA^SXQY.P;,>F.E-;3;%[5;5[*W:W4Y6
M(Q*4!]AC%5$\1Z-)I"ZJFI6YL6;:)M_!;.-N.N[/&WKGM42>*]&D:Z1;F3S;
M6,23PFWD$D:DX!*;=V.?3ISTH SM1\/ZQ>ZO':PW]G:^%_+436,=N/,D(;++
MGH%;H?;/'.:ZJL9O%6B)::==M?*+;4G$=I+Y;;9&/ &<8!/;.,X/I3]0\2Z/
MI4KQWMZL7EE1*VQF2'=]WS& (3.1]XB@#590RE6 *D8((X-1V]M;VD7E6T$<
M,><[(T"C/T%8][XR\.:==BUNM8M4N#&)1&'W,5.,$ 9SG(P.I[58M_$NBW>C
M#6(-2@DL"<"8-P3G&W'7=GC&,^U %R+3[*$ 16=O'M8N-L8&&/!/3K[TMM86
M=FS-:VD$#-]XQ1A<_D*JVFOZ7?+=F&\0&S&;E)08GA&,Y=6 *C'.2*9:^)-(
MO+F2VBO569(O/*2JT1,?]\;@,K_M#B@"\EE:Q7+W,=M"D[_?E6,!F^IZFIZR
MK'Q)I.I7<=K:71DEEC,L68G42H" 61B &7D<@D<BJ.O>,+/0M<TG298;F2>_
M=@"D#L%15))&T'<<X&!DC.3B@#>^RV^^1_(BWR$%VV#+$# SZ\4OV>#C]S'Q
MT^45FW_B72-,>5+N[V/#$)I@L;N8D/1GV@[!UZXZ'TK06ZADLQ=QOYL#1^8K
MQ@ON7&<@#D\>E  ;2V-T+HV\1N -HE*#>!Z9ZU-7G&K^-3KO@?Q->Z/<7NGW
M&ER2HKB$JS; .&WI\I)/*C##CI71>'_%VD:C'8:=_:,;ZG);*S1$DEF"C?AL
M88@YS@]CZ&@#H9H(KB,QS1)(AX*NH(/X&ECBCBB$4<:I&!@(HP /I61<>+-%
MM+H03WFS,WV?S?*?RA+TV&3&P-GC&<YXK3O+RWT^SEN[J4101+N=SV'X=: '
M"UMU";8(AY9+)A!\I/4CTZFG&&(LS&)-S##':,D>]9"^+-%\J_DENVMUL$62
MZ%S"\1B5B0I(8 \[3C%$'BO2+B2XACEG^T01>>UNUK*LK1_WE0KN<?[H- &N
MT,3MN:-"WJ5&:5XTD&'16'HPS7G[>--/\1> GU2YU6[T"*2X94N88VW!5D(4
M [3DD+R!T)KK[[7M/TN<6US+*TPB\UDB@>5ECSC>P0' R#R?0T :=->-)!AT
M5AUPPS7">)O&:"\\+6VGR71LM7E$LDT,$FYX-FX!"!G)R,X^8 =LU?LM<TOP
MU#>6E_KE[>"&03/)<02.;..3!1)7"G'KESG!YXH ZUE5U*L 0>H--\J/R_+V
M+L_NXXK.O?$6F6)A62X:22:(S1QV\33.T8_CVH"=OOTK'OOB!I,":+-:&6\M
MM5G\J.XAB=D'#<<#);*XV]: .I\J,!0$7"\KQT^E*40G)4$XQDCM7-6-]87'
MCZ\CAUN\>[%BI?2I$98HUW#]X 0/FY //?GVL-XUT!7@W7K"&>;R(KDP2>0\
MF2-HEV[#R".O4&@#>9%<890P]",T  9P ,\U@W?C30K'5)=,FN9OM\2>8;=+
M65W9>>5 4EAP>F>!6EI&KV.NZ7!J6FW"W%I,"4D (S@X/!Y!R.AH N*JH"%4
M#)SP*  .@ [\5CWWBK2=/^UF>:8QV9"W,L5M)(D)(!PS*I P""?0'G%<]XY\
M4FR?P_9V;W!@U*_A2:>V1SO@.21&Z#DG ^Z<X^M '=$9&#17+K+'X0\.:GJS
MW.K:A9C==I!<;I)85QDH-WS!1@GYNE<QK/BN>]T/P3K?G76G_:=3M5NU!DBC
M=&0NPP?OIG'/.<4 >GT5@Z=XPT?4CJ"I--;OIZ[[F.\@>!HTQD.0X!VD#.:=
M;^*],GU>#2W^TVUU<QF6V6Y@:,3J.NTD=1Z'!]J -RBN ^+.H7FDZ#IMY8WL
M]K*VI10.T4S(&C8,6!P0.PY[53U?5YM,\9^';7PUK4NHB\G\N^T\W/VD+#QF
M7))*8R>X!Q]: /2Z*R+[Q%9V5[+9+'<W5S#$)YHK6$R&-#G!;L"<' ZG!P*A
M;QAHATRPU""\^TPZA((K00*6:5SGY0.Q&#G.,=\4 ;M%<U+XZT2#2K_4)9+A
M8]/E\F[C^SN7A?T8 ' Z<]/>B#QWH=S%,\<MQF.:.!$,#!IWD&4$8Q\X(Y!'
M&.<XYH Z6BN#\,ZA)=_$OQ%%OOEACM8&%O=L_P"[=BQ.T,2 #Q]WBNGO_$-E
M8:I%I>V>XOY(6N!;P1[F$:G!8]@,\#U/2@#5HKF)O'^@PZ7IFHF6Y:UU*?[/
M ZVSG]YDKM88X.01CKP<9JWIWBW2M1N-1MU>>WFT]!)<QW4+1,B$9#X8=,"@
M#<HKS'Q1X@>^\3^#7LTU2VMKC44VRL62"ZB(R#M#?3[P!Q[5UGC;Q'+X6\,7
M.IP6<ES(F%7;C:A8@!FR1QDCI_\ 7H Z*BN"US4A8^._#-\\FI0Q7<-V)+(L
M[;V15"@1 D;OF)XK?L?%VE7VDW6H SP+:3?9[B">(K+'+D (5ZEB64#&<DC%
M &]17.)XUTQ;J]M+R*\LKNS@^TR6\\!+M#G&]=F[</7'3OC!Q4L/B/H-_;&Z
M07L=J+<3B>2V8(^7";%/\3[B!@9Z_7 !N:CHT%_>6M\KM!?VNX0W" $A6^\I
M!X*GT]@1@UI5RE]XDLM0_M+0YEO=.U-+-[B.&1_*=X\'#H\;'C(Z9!]17/>#
MOB!IUCX6\/6NI)J*K-#'#_:4L#&W:8\;#(>I]^G!YXH [W4]*CU98H;J1C9J
MV^2W &)B""H8]=H(SCOWXX-^L.P\5V&H:CJMA%'<)=:4 ;J.50NW()&"3@Y
M)ST]^:T]/O4U'3X+V))$CG02()!AMIY!([<4 6:*** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "N;^("._P^U]8P2WV&4\>@4D_
MI724UT61&1U#(PPRL,@CT- 'D>HR6&K6?PT@6:VNH%FBCGB$BL-WD X9<_YS
MSUI-6AM;;7_B/9)#''9_V*DQAC10-_E-\P'3//6O3H] T:&*.*+2;!(XN8T6
MV0!/H,<4]M%TIW=WTRR9G^\3 I+?7CF@#R"XL[6P^$7AC5H;.,(TUH-5FC0;
MY+4,2RN>K+NV\&NQUB+[1\4_"MYI+AV:VN3>O"00UOM79N(ZC<>*[2&QM+>V
M:V@M8(H&SF)(PJG/7@<4RQTS3],C:/3[&VM$;JMO"L8/X #U- 'B%_J=A!\!
M=6TAKR$:@E[)&;8L/,!%V&.5'L0<].:ZF_\ $&G:-XYU*66\LKI;W2X(_+GN
MXX?(^]@ N0"C9W':21Z'BO0SHNE&:>8Z;9^;<8,S^0NZ3!!&XXYY Z^E<OJ7
MAG76\27FH6R:%J%K<JBK%J<+;X HP%0J"-N23TZDT <?JVD66F> _ &FO>VN
MH0?V[:^;,C!HY0Q?< >A4 [>>P%='I*VUK\;M6M[810QOH\3-''A06#CG [X
M-=%H_A+3[&SD6\L=/FGFE,TBQ6H6%&*J"(T.=H^49[DY)ZUK)I>GQW0NDL+5
M;@=)5A4..,=<9Z<4 <E=DQ_&S3C<1YBET25+9BH.)1*"_/\ N8_/WIJK#'\<
M<J8E,GA]LA< EO/7KZG'\JZ36M$75)+*[BD$&H6$OFVL^W."1AD8=U8$@CZ'
MJ!5F+3+/SDO)=/LUOB SRI&"P;'.&P"?K0!YS!9W.E^,=5\$VZD:=J\RZFC[
M1B.!C^_3 [$J$'H&K9^*$9?3- BAP+I]=M!;G&=KY;G\!FNW,49F$IC4RA2H
M?'(!ZC/IP*S)=':]UZ#4KV1&CLPPM(%'"LP ,C$]6QP .@)ZYX ,;XB:E8:;
MHEDU_;K*LNH0)$\KLL,$F[(EEVD95<$X[D#IU'#Q:G8R^(O'B#6(+VXN]% C
MD7:HG=8I-PC4=0 /4G@\U['/;PW4+0W$,<T3?>210RGZ@TR.SM8I5DCMH4D5
M/+5E0 A?[H/I[4 >0+IFF7OPR\'IID%O_;;S6QMGMPHD#A@922.0  Q;W K5
M\/WEE'HWCO3_ !!*BW:WMU+<I-C>T+*-A&>HP,#\!7I,%A9VLTDMO:0122??
M>.,*6^I'6B:PL[B>.>:T@DFC^Y(\8++]">10!Y9<:5JMM\)_#6N2!_[7\/JM
MX$=?F:'G=&>X_=X_[YJ]XJ$LWP_N=?CMIW6\O8+^Y2+B1K1'7:,'I^[521T!
M))[UZ6Z))&T<BJR,"&5AD$'L10$18Q&JJ$ P% X ]* .#\-OX5U?Q3#JVD:K
M?:IJ"6K1O,TA98HCR%DX&,D\#KD'T--\0ZYI=A\1X+:XFMM+N_[,+'4[ACEH
MS)_J8U/R[LC.3D\8QZ=U;6=K9HR6MM# K'<PB0*"?4XHEM+:>6.6:WBDDB.8
MV= 2A]B>E 'S_IMUIL_PW\$V,DUNUS;^)(Q/$^"R(TDI(8=@1C(]QGM70>(/
M/3Q7\0(-(*+=G1H0B1XW$ #>% [[<]/:O7EL;-!A;6!026P(P.3R34@MX5D\
MP0QA^NX*,_G0!X]KGB;PWJ,?P^DL+ZT"VM_ 9(PX!MD"@%6_N\@#GKBNO^+;
MHOPOUG<RC<D87)ZGS%X%=<EA912>9':0(Y??N6, [NF<XZ^]321QRKMD17&<
MX89H \HU[4[.S^(/@#5;BYC331:3C[46S'N,1&,],Y('XTW4[T:5=W^H:%J5
MOJ-C-K 2^T*[ ,GVCS0"T)SNSN 8#ICGMBO56M;=T1'@B98VWH"@(5O4>AIO
MV&T%P+C[+!YXSB3RQN&>O/7F@#D_B>;F+PK#>10O<6UE?6]U>VZ+N,T".&9?
MIP"?I63J^IZ3XLT_6KOP?%]KU>32GBDOH%*%%."L1) ^9L' '(V\XXKTH@$$
M$9!ZBHX;>&V39!#'$A).U%"C)ZGB@#R?5[FQ\4> ?"MCHLL;:K%<VHBMXVQ)
M;M&N)-P'*A1G)XZ#VJ*.[TZ75/BN3=6FY[551RXY'D,IQ_P+ X[X[UZZEO#'
M*\J0QK(_WG50"WU/>F_9;?G]Q%SU^0<T >36)M;CPWX0GL/$Z:1K-OI.(&D*
MM!.H"[XW!.,@J.^1UP<<4Y-;$>H>'==\06]SI6CW6FRVOG6,TB1P3F4G>NPY
MVN I&<C&.N*]F-M;E0I@B*CH-@P*>T4;IL9%9/[I&10!Y%J-QH^@MH&N:3!+
M%X7&KR3WD[-+)YLC1[5GPV3M!+#/<@8[&MC2+^QUCXD:]>:6QFAGT6+;(%($
MI#NN5SU' ''<&O13&C1^644IC&TCC\JYFST#58/'ESKLEQ8FTFMA:^0B,'5%
M9F4YSC.3SQB@#RV7Q!IDOPY\%6*7!-SI^K6OVN/RV_<;2^0W'!]NIP?2M2UU
M7P[I^J^)=)\9O?127U_+<0JLMR([N"0 )A8S@G: .1Z#M7L8BC'2-1\V[IW]
M?K2M'&[*S(K,OW21DCZ4 >7VO]GVWQ9\.P) EG';^']D=M*^6MSDX0DG.X+G
MWQFN=CU6&WT>74[1$N['3?%\UU=11_-M@8D+)M'89!!]0*]SVJ6W;1N]<<_Y
MY-((T7=A%&[EL#K]: /,/$6H:?XH\-:_?^$+1KJ62*)KN[CB=/M C<?N1D L
M=@;)'08'4TEEJW@;Q&ZW]I#J-_=6UI,UQYUS<,]I"8V\P'>VTD_=P">3GMFO
M4$1(U"HJJHZ!1@4@BC4,%10&Y8 =?K0!YCX3F>Q\3:)I^GZI#K^C36LK6TT@
M!N=.C"CY&8=5)"K@C.1CM5[Q_=0:9XV\$:I>R>38P3W22S$$JA>,!0<>I!KT
M!(HXRQ1%4MR2HQFG,BN &4-@Y&1GF@#S70=8M-&\0>,-/\2R) ]W=->PM,-O
MVBU9 JJN0,E57!'7.?>MWX9:9>Z1\/\ 3+2_5TG =Q&YY16<LH/X$<=JZQD1
MBI95)4Y!(Z4Z@#Q);^UM/!'Q(TN>81WTFJ7DJPL"#M?8$[8RV.!U/;I6C-JF
MFIK7PP?[5 JQ6DP>0.,1Y@$8!],N"/JI':O6PJ@D@ $]2!UI: /$M!;0VT.7
MPCXGL=2NM>@N) --,]QMNF+EU==IV*#G.[@=Z]'\:'2H_!LL.N"=+*0Q0N\!
M+-"Q8!7!/)VG!SUXZ'I72[5W;L#=C&<<XI: /%Y-8OK/1_$MM,UIXIL;>"V\
MO4G@#Y!D^Y+M/[PIDM_/&:N:)?VDGQ@T^XAO[V_AN-&:*.YFMV59'\W)" *
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M4-7L-+56O;E(BP)5<%F('4A1DX'<XP.]8_P^N(;GX?Z"89DEV6,2.48-M8(
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M2N)=$-I*)XKJ;<(9 5*N">2" PY)Q^-.T_QKH^I7EO;0M<HUVC26CRP,B7(
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MVGVXP*M6MYXAM+3P!KOBE)5M;62=;QW7F/>A2&24=N#R3TSSR:]>6&)2"L:
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M=8M7TR[MHK.X\E3*J_*0H)#$'@DG@<\=ZZ2^OK;3;&>]O)EAMH$+R2,>% H
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M+.^,Z".59HI8)3')%(,X96'0\FJVC>%8=)G2XFU/4]4N(U*QR:A<>9Y>>#M
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MV%G#:6D*0V\*A(XT& H':IJXQO'=TVOWFDV_AJ_EELYX([AO,3$:2C.\D$C
M&#C/3.<8JM-\4=.CC@O$CMYM/FN/(W17B-<*-Q42&'&=A(SUS@YQ0!WE%<A+
MXW:2[U6WTS35O)=,G6&6 W&R>3@%G2/:25&>N><'\;=GXFN;W6]?TA-/A6ZT
ME86!-R=DPD!8<[,J<#G@\G\: -Z>ZM[8QB>>*(RN(XQ(X7>QZ*,]3[5-7DVO
M:]%XKT;X?Z\MG]F-SXA@ 0L'90KNN-V!UVYKH])UW7;SXF:WI4\-L+&R@@VH
ML[?*&W-O'R?,QX!' &.IZD [:N>TS0?#<^O7'BG3X[>YO[GY&NTE\P J-I"\
MD*<#!QZ5O2LZPNT<?F.%)5,XW'TSVKS:S\=6^C?#H:UIOAN*WM4O7M_LD,P4
M*?,V[L[>22?2@#TRBN8TWQ/?3^+9- U+1_L4C6AO+>1;@2AT#!2&P!M;)Z<U
MO:C?V^EZ;<W]V^RWMHFED;T51DT 6:*Y6T\4ZE/<Z.[Z#+_9^K*7CGA<NUNN
MT,IF&W"Y![,0#D<U5N/'-RF@7/B2VTE9]#@D8;_/*SR1JVUI%3;C&0< L"0,
M\=* .THKD9O&5R_B>WT?3M+2Z6[T\7UM<-="-64LHY&"0,$],GV[BC%\2%;P
ME'J\^GI!<'4O[-ECDN,10R;L%VDQ]P#G./:@#O*KRW]G;WD%G-=0QW-P&,,+
MR /)CKM'4X]JX/Q7XLUVV\&:G?VMO:6YMKB*/[0DS21S0R%!OB?:!G+D$GI@
M]:T]4UAK+QCX8L]0T6RDNKXSI%=I,6:W*IE@N4!Y&._K0!V-%><Z/XD\1OJ?
MC*:>*QG32Y=J0^>ZJJJA8!?E.<]R<<]JT9?'4R:?X3ODT^-H=>FAA8&8AH&<
M9X^7Y@.?2@#LW=(HVDD8*B@LS,<  =2:BL[VUU&TCN[*YBN;:0926%PRMSC@
MC@\BN$\.:QKUYXI\8Q7J6ERED8HUMQ*RQJ/+9E5<J<[L_,2/P(X$5MX_>U\!
M^'M9LM!MXX=2O!:+:Q2A!#F1E&T;<'(4^G)H ]'HKD;/Q?=P:SK.GZ[8PVIL
M+,:@KVLIF!@YR#E0=PVGH.?YU4\::L8- O?[+M7M-==4MQ]H9# 67<HD;:=V
M0&Z 8(QSUH [BJ]W?V>GQB2]NX+9&. TT@0$_4FK%>=^"I6U[Q[XLU:^/FRZ
M?=G3K-6Y$$:DAMOH6P": .[MM1LKTXM+RWG."?W4JMQG'8^O%6:Q;K3+?3M4
MN_$=M;,]S]B:.6&",%[C:=RX_P!K[P]]P]*Y[3O'=W+XCT?2;VVLUEU>&21(
M89B9;)E3?Y<RGOCC/'(/'&: .[HKA9O'UW!X)UG7WTR$S:7>R6LEN)SM?8X0
MD-M]3GI4^J>,Y[?7+72X%LK:6:R6[1KYRJ7#$X\F-N &]^>HX- '9T5PTOC7
M49HTL[6R2'5XK&*YNXIK>:58I)%)6+$8R#P>3TXX.3CH/"VN2>(?#]OJ,]A/
M83OE9;>92"C X.,@9'&0: -FBBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ K \;-J*>#-4.E627M[Y.(X'C$@;)&?E((8@9(&.
M2*WZ* /&VTR^U/QE:SVVE^(H;>^T>:R>]O(R'CE?JS G$8'H !Q\H-;OA#6?
M$"Z5IOAJZ\+7EO?6 2V:\GB_T41QX7S%8D;F*C@#.3SG&:]'HH X?PG'>Z7X
MR\365QIEX([V^-Y%=^7^X,910!OSRV>,"M/Q_H=WXB\$:GIMBV+J1 \2\8=E
M8,$.>.<8YXYKI:* /.[J&_\ %ESX14:9>64FFW27=\;B QI$47&Q2<!R6Z%<
MC'-7O#\5PGQ'\37\MC>0VUZELEO+) P5_+0ACGMR>^*[:B@"KJ=A%JFE7FGS
MDB*Z@>!R.NUE*G]#7%>#9]3\'Z/%X;UK2[^;[(S);7MI T\4T98E<[<E2,X^
M8   <UW]% '">*=2\2-I-C=0:1=K:O?*;F"T >[CM@.HP>')_N\@'KGFN6@T
M#5KN\\>V5MH=]8QZS9P-://C;E8SE6?<<NQ/(R3R<^_LE% 'E N-9U6\\$2I
MX7U:&'2WVW)GC",&\K8< D?+_M$C/8&BUTZ]37;&]T#2]5T>]FOP=2LI(F^Q
M20[COD!;Y0Q !&WYLGIWKU>B@#Q_1M)O/#TMUX>O/ D6K2>?(UEJGV>)HG1V
M)!E8C*XW>YQP!Q7K=M$8+6&)MF415/EKM7@8X'8>U2TC,JXW,!DX&3U- '#^
M%K4Z3\1_%MK.QWWYAOK<M_''AE;'^ZV!^(K(TO3M6T+PEK_A.?1KN[FG>X6S
MGA0>3.DP(!9B?DP3R#VZ9KT*_P!)M;^>WN7#1W5LV8;B(X= <;ESW4XP0>#]
M0#5Z@#SJVTFZT/Q#X,LUL;RZATNQFM+F\CA)0,ZQ[3D\XRK?3->BT@(8 @@@
M]Q2T </9374/C;Q3=2:5J"VUS;V\4$OV<D2&-9-V,<]7&/6N2\/6GB;2_#7A
MC3KG1-3?3K<7,=_:VV(YFD9V:/YB0=F&&<$#KGTKV6B@#Q[1=&OK'0=3T?5O
M!5Q=6%QKCS/%&RGRX74X:(A@<J57D8X;CFNO\ Z?JNFKJMK<RWSZ1'.JZ8+_
M /URQ[?FSWVYX&>P[5V+,J+N9@H]2<4M ''_ ! TK5;RSTS4]%B6XOM(O%NU
MMB<>>H!#*#ZX-9>MVGB+X@^"]2LY-);1&9$\B&ZD#-+(KJW.!\J_+@>NX\#
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M]17M9D7:,L>"".N,_ISZ510!Y[KNF^)?^$E\(ZZNFIJ$]B+H744$RH(S*N%
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MOJ!NO,^TG8%\P/C[F<]J]2MKF"]M8KFVF2:"50\<B-E64]"#4M '(-I&M/\
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MH0C$C!7C(/'45W%% 'FUMX&\3>'+ZQU'P_JUG<77V.*TU"._#!)]F K*1DC
M_EWS7>:3;7EKIT::A="ZO"2\LBKM7).<*.RCH/IZU=HH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "J>JZE%H^EW.HSQRR0
MV\9DD$0!8*!DG!(Z#FKE9?B6SGU'PMJ]E;)ON+BRFBB7(&69" ,G@<F@"E_P
MF6EXT)L7&S6P/L;[!@DC=AN<C@UFS_$S1HDU)H[+5I_[-E,=V(K,_N@.K')
M"CWYZX!%<C:W-U/H7@:--!U=GT:[ACNV-F04*Q,K  C<1D<D?+TSDXQ:TJ6>
M"'X@&32]77^T)9)+0'3)\S!D*C'R>I'7Z]* /0)?$=D(;%K59;Z2_C\VVAMM
MNYX\ EOF(  R.21U KC/ FIVNG-XSO)Q/%"NL$"*1?W@9@H$> 3D[B%'/-8O
MAR+5?#EWX9UR;1]5N+0:/_95S;Q6<AFMI!)OW&,@$J>!D#''TJ(Z-K.K6/BE
MK;0+^%_[9358(+^(*ETJXS$03\V>3C!' &<T >AMXXT^"]O;&]LM0M+RTM_M
M1MY(0[2Q=V38S!@#UYXH\-^-].\4W"QV-IJ"(]L+E)IX-L;+G:0&!/S \$?E
MFN?L+RTN;6YU&T\#76CR16;K+,^EXN"[#"QPJJEG&3DG& .O?&_\/#(O@72;
M>>UNK:>UMT@EBN;=XF#*!G 8#(]QQ^1H Z"\NX-/L;B]N7\NWMXVEE?&=JJ,
MD_D*Y^P\<6%]=:? UE?VW]HVSW-D\R(1<(H#$*%9CNP0<$ \UJ>(FOD\-ZDV
MFVZ7%Z+9_)A< AVVG (/7Z=Z\LC6^?Q1X/U]/#GB-S;"X6_DN86+EVB"C"$_
M(H.<8"@]LGB@#L9/B=H\=C-?&PU<VEO<&WN9OLF%MV#;<OD\#/89([@9%:J>
M+;5_&'_"-?8KQ;LV_P!I69O+\IHLXW [\GGC&,^V.:\]O3=W?PO\4V*:/K O
M+S4IY((&TV8,ZR3;U/W>FT'/IT/49W?%-C=-H7ASQ%I,7E:W8-%%"EQ&R,ZR
M@1M&RD ]2#R.,&@#L]&UA=9MYIH[.YMTCF>$&;9\Y1BK%=K-P&!'X59U#4+7
M2M.N+^]E$5M;H9)'/912:;9)INFVUE&<K!$L>3U; ZGW/6L;QYHEUXB\%ZCI
MMC(4NI$#1 -@.RD,%)]#C'XT +%XOM?[3L+&]L;[3WU$'[&]RJ;9B!G;E6;:
M<=FQ^=<FKGQ3\1?$.CZSHUQ<645I!#'$YB_T8.-S/G?P2<'*Y/RCCBK5_P#;
M_&TOA8#2KZPN-.U"*^OOM=NT:1^6#E58@!R3C&W(QR<5+X?^TK\5?$M])IVH
M16=Y%;Q03R6KJCE$P>2.![F@#N;6V2SLX+6,N8X8UC4NQ9B ,#)/4\=:X)O$
M-WXA'C/3KW2IHK6RB,2!FC(C(C+Y;#9R3@C&0,#FO0Z\WC@U#3]<\=6SZ3?R
M)J2>=;W$4):)@8=@7/=MQQ@#CJ<#F@"'P'XQMM-\*>%=.N]/OXX;M5M8[YHP
M(3,<D+UW<\C.,9_$CIM7\;VFE1WMP+"\NK.PD\N\N(0F(CQG + OC(S@<<^A
MKCXK+48? O@BR;2=0-UIVI03W42V[$QI&6W'W^\,8ZTZRMKK0-?U6QO_  5)
MK46H7TEW8WL%K&P"RMNV2L^-F">_OQTH ]1MKF&\M8;JWD62"9!)&Z]&4C(/
MY5F:OX@@TJ_L-.6&2YO]0+BW@C(&X(NYB2Q   _4BM"QB:"PMXGCAC=(E5DA
M&$4@<A1V'I7(^,KC58M?TF,:=J5YH;JXN!IH_>F7^ ,00RIZX('J<<4 <]\0
M=<L?$'@>PU:*VGC:UUF.%XY4_>1NKD.N%)ST[9S76Z9XZLKW6Y=(O;"^TJZ$
M!N8A?(J":(=6!!/([CJ/P.//8_#WB"3P5J=@GA^ZAEM_$7V]( 4 :'(;$?S?
M-CGIP>,9KJ=9T67X@:E;7<=M>:=;6=C=0I)=PM#(\LR; -I&=JC)R>Y&,\T
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "HKF=;6WDG=9&5!DK%
M&SL?HJ@DU+10!YGX&@LK'X<V&DZ[HVH"YCWM+"=,G8Y$KNGS*F,X((Y[U<EN
M;^]\;^$]2N=*O856VN?.VVLC+!YNWRU<@$!L##>ASG%>@44 >;;IWM/B @T[
M4@;_ 'FUS8S#SLVZQC;\O]X?ESTYK$\Q],N?A4MU:WB2VT5Q%-#]F?S%81(#
M\F-QQ[ \#C->R5A:MX8AU;7])UB2]N8IM+=VAC0)L.\ -G*YY ]: ..UK3+J
M^B\<:O!IMTB:A8)96L0MG\ZY=4;+E,;E&6"C('W<\#JEM9:I877@G7DL;R:U
ML=-^P7UL('\Z%B@&X1D D;@ < \#C->GT4 <5I6A-J7C'Q#K=S;.FG:A:1V2
M13QE'E4##L489 [#.">>,8S!\/=#OM--U#?2K-!I3R:=ITG\1BW[F8^Y^1>/
M^>==/XAT)/$6EFPDOKZR4R*_FV4OER<'.,X/%6M,TZWTG3H;&UW^5$#@R.69
MB3DLQ/)))))]30!Y1X9T-=-L!X<UCP"M[J5L[10:B]FCV\REF*N\A^Z #R.O
M8<\58BTH:3XIUVUUSP1+K=O>WKWME=PVB3C]YU1BW"8QW/KVYKUJB@"MI\ M
MM-M8!;PVWEQ*ODPC"1X ^5?8=!7":)'?>%Y_%.FWNE7EW#>7DU[92PPM*EP)
M% ,;%00A! 'S8'7M7HE% 'D5CX?U'0K_ .'%C+9WDS:6+EKV6*!Y(X3,. 7
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M<=<5Z"K!E#*05(R"#P12T >5:YIVJ:3I_C:\O+2P":Y+#'9I--N#,<1JKC
M)R".P/4X&:L:"VLZ'K%C+K7AM6:4K8PWZZF+AXXS]T)&1G;GEB.<<GI7HM]8
MVFIV<EG?6T5S;2##Q2H&5OP-9FB^$= \/2-+I6F0V\K9'F<NP!Z@,Q) X' X
MH U;RTAO[*>SN4#P3QM%(A_B5A@C\C7%^'-,\3>"[+^Q8K.'6-+B9OL<ZW A
MFC4DG;(K#! )Z@].W:NN&JV!U8Z4+N+[>(?/-ON^?9G&['IFKE 'F4?@C7(/
M!GBBQV6K7VO7DLXA68^7;J_JQ'S'CL*U-5\+:K>^'?#DMJMO#K>AO$\:2R$Q
MR;5"NFX#@,!UQVKN:* ./M_#][K7B1M?UFV6Q9+![&&TCE$C .<LY<<=. ,>
MI-<F/!GC*7P;I?AMK72HTTJ]CF2X:Z8_:%5RP. OR#GGJ3Z"O3X-7TZYU6YT
MN&\A>^M55YH%;YD#="1_GJ/6KM 'F^EW6MQ?$KQ@;+3;6X<0V*R"2Y,7S>4V
MTK\IRN=P/0\"NM\*:#_PCN@163LCW#.\]PZ+@-([%FQ[#.!GL!5NVT/3+34I
M]1M[...]G_UTZYW2?[Q[_C6A0 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %4]5U.#1M*N=2NA*;>VC,DGE(78*.IP*N5C>+
MHY)O!NMPPQ2RRRV,T<<<2%V9F0@  #/4B@#,T_XB:'J5O+/"MZL:0Q2H9+<K
MYQD)"I'_ 'VW#;@=_H<3+XZTF.34X;]+G3KC3H/M,\-V@#&+LZE20P)XX.<\
M5R>H:5J=S\)O#8M]*FNKG26MIKG39X61IUC0J\>UASUST.<<9XJ6V;2+_1K^
M_M/AU<QP?93%/%+9B*>XW,H,<87YB ,G/'*C'J #L+7Q1;RW4L%U97FGB.U-
MV9;M46,Q#&2&5B.,\CJ.]5H?&^G/<Z:D]M>VD&IG;975Q&JQSD\@##$J2.0&
M SD8KAO^$:U6>UU?0?#]UJCZ%<:6ZQQ:E"\1M9L@K$C. Q##((Z =36M?0:A
MXN\/^&--?3;NTOK:\MY[[SK9XXX1$#OPQ&ULG[H4GJ.W- '5KXML6AUM_L]V
M&T8_Z7&47=C;ORO."-O/6L^[^(VC6D6CR&WU&4:O#YMH(K8L6&,[>OWNG SU
M'K7/ZBFI:=J7CJS70]2N3K$0>SF@BWQM^XV$%L_*0<\=?3J*S;6WU"W;X;&?
M1]40:7#*+S%E(_E!HPH)V@]2#QU'<#B@#MH_'NGSV1N+:PU&>1+;[5/;)$HE
MMX^?OAF !.TX4$D@9 JXGBW3[FUTV:PCN+YM2C,MM# @#E!U9MQ 4#(&2>I
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M?&MYXL6UN8_#MU:Z=<0NXO'F4J'5MNW'4CW]CQCFM3QG%'-X(UU98U=1I\[
M,,C(C8@_@:H?#G2]0T/P58Z3J5E]FN;4,K8D1U?+%L@J3Z]ZTO%D-Y=>%M2L
M["S:ZN;JWDMT175 I=2-Q+$<#/UH XO0KW1+SP'X?TRXT6Z9KVVM[)IFL6C
M8HH+B0KCW#=R!BNAO_%MY;>,6\,V6C-=7/V#[8DC7"HI&\(-W' SGGD]..>*
MVER^(-+\'Z?I@\+2S7EE910J7N8/+,B( #G?G&1GIFJ\.DZ];?$N'6YK&2[M
MH]$%A)<"2)6DE#>86"[A@$\=N3Z4 5O^%FWO_".3ZV?#<B6VGW!M]3#W(#1.
M&"L(QCY\9'7;Z5JW_C2^C\31:#I^A_:;BXLOMEO))<B-67<!\W!VCKZGIQSD
M<O-X9\1S^ ?$^C#0C'>:IJ4EU$?M,17:[A\L=W4!0/Q'OBQ+-?VOQ7T1QICR
M7*^'BLEJ)D#+^\(."3M/..XX_*@"CXZ\1Q>*OA#K<TUC]DOM/O([:XMW8.8I
M5E0$J>X() /&>:] O/$,S>(9-"TJUBN+V&W%S.T\ICCC4G"C(5B6)]N!7#ZY
MX*UVZ\#Z]:P6*2:IKVHB\DB6X7;;*&5@I8X#'"\D=SZ#-;O]C:QIOCF3Q79:
M:;B/4K-8+RQ,Z++"ZXVL&)VL,* 0".N>: (;_P"(]S!X6GUBVT=&DL+PVFIV
MTMQAK9@VW<"%.Y<D<\<&NBD\0/%J00I;'3H=/^W75V)3^[4[L;1MP0=K'.1P
M#6-HGANTTK3-<;Q#+;0R>(;J66>%Y@%17!Q&&.-Q R<COG'3--\(>%R/A]<6
M%U>RS-J=N\0G=?F6 IY<0 [8CVG'J3ZT -A^(P>]TC=8*UEJDBQHT$C/+"6Q
ML,B[  #GG!./>F7?Q)5+%]2L+%+RRCN/*,<<C&XD0/L9T0(0><D L,@9XIWA
M6U\<6-M:Z%J<%C'9V6R-=2BFW-+$A&%$>.I "DG&!D]<52T#2/'7A<OX>LH-
M.N=(,SM;:C+)AK='8L<Q]6())QTR>N.@!IWTMOX*CUWQ24\X:K=6V-Q*K&NQ
M(PTAVY502Q/!XQW-;NAZM>:E<7<=S:0)#$L;075M/YL5P&W9*MM'3 !'_P!:
MCQ'%J4FE1PZ?:6]\S2JMQ;W+!4EAP=X)((!/':L?P3X:GT&]U>X2U_LW3[UX
MWM],$WF"!@N';(X&XXX!/ 'T !T]QI]M=W5I<S1[Y;1F>$DG"L5*DXZ9P3^=
M<+X#M8KG6_'L4\:20S:J\;HP^\-IR#[<_P Z]#8D*2!DXX'K7(^#]#U71M9\
M13WT$"P:E?-=1-'-N901C!&T?SH JZKXU;3GO[32(+:<:1B.:.:1P\Y";BD>
MU3S@J,GJ<C'>FS>/-4GO--M-+\/&6;4K%[JW6>?RRC+C*R K\N,D9R<G'3.1
M"VB^+O#OBW5+OP]#87NF:M,)Y(KJ4QFWEQAFX'(.,\<^PQ5Y] UX^-]#U9Y8
M)H+*UD@NI#(4:8R8)(0 @ $< GL* ([;Q?X@O]:U;1;;0+-=0T^"&1_,OSY>
M9$W;<B/.>W3'7D=Z$7Q+O)M!T?Q"-'B72;RX2UFS<$S+(6*DJNW!4,.I()]!
MUK5T[1-8T[Q[XBUS[-;26NHQ0K"OV@AP8TV_,-N #]3CWKFX? 7B&+X;Z5X<
MV6)NK/4!=/)]H;8RB0O@?)G/S8Z=J .J;7"GQ'?1#I%K]I;3#<P7OF?.ZA]N
MQODRHSGH3ZUSP^).LMX8?Q&=%M(]/M+PV]XIN29"N\)^[& "06'+8] .];K:
M/K+?$2/Q#]FMA:C2_L;1_:#OW[]^?NXQGC]:YP>!O$/_  K75/#9BL?M5Y>F
MX23[2=BJ9%DY^3.?EQT[T =+K_BF_P!.N-3$%K;V]OIL*2M<:@6CCNV8$F.)
MAQD  ;N>3C;6%/XOU?5M<\#R:='!#::LD]QY$LA#,R0MD,P!^4;LC .2!G%3
M7OAWQ/=>)-8NVL]-GCU*Q6"WFN+EB=/^3:Z*-GS!F);C;G'/I5.R\(>)M/MO
M!-TEM82W>A":&6V-R5#+*@3=OVGIR2 #[9H W[7Q&D'B[Q'!?:=96BZ=9QW$
MMW"V^25,,1N.T= .G./6J]WXVU+2]+TS7]0TZ%-&OI(T9$8F>V63[CL?NL.F
M0,8SU-1_\(AJ5]XH\37%_';II^MV2VA>*<F1-JE=VTJ!SG.,\>]1#PGKVI>%
M;#PKJXM#:6DL7F7T<[%IXHV!4!"N58@ ')P.V>P!:N?%7B276/$6F:?I.F^9
MI4<4HEGNGV,KJ[<X3))"CC@#GYNE=%X8UQ/$GAJPUB.(Q"ZB#F,G.UNA&>_(
M-8$.BZ_#XC\4ZA]CLFAU6"** ?:V#*8T91N^3ONSQTQWK1\!Z/?^'O!UCI&I
M) )[4,FZ&0NK@L2#R!CKT]J .DHHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH ***AN[6*]M9+:;?Y<@P?+D9&_!E((_"@":BO,
M_A]H8U_X:V%Y<ZIJR:A<>:QO([^7>I$C*,98C& .,8JQX5\=36^FZS:>)9O-
MOM&OA8M+%'\USN8K&0H_B8@_H3B@#T2BN;;QE; ZG!_9U\NH:=")Y;)A'YC(
M<X92'*D<?WN*AT/QA]L\+:3J-_:S)>:@J"*"-5S.[+N_=C=]W /+$8 YH ZJ
MBL;1/$UEKMS?VD,<]O>V$@CN;:X4*\9(R#P2"#V()IVO^(K3PY;P7%[%.T,T
MRP!X@I"NQPN[)& ?7I0!KT5D#Q%:'Q0WAXPW O1;?:@2HV-'G;D'///&*X/Q
M+K=N?B#X+U1(KT0M+?QM&,N9F2,(NQ5)!^9B >_7IS0!ZG17%7_BG0M>\':V
MU_;ZG;VUKNM[^W,16>+C/\)(Z=P<>M:5KKVF:?I>B6=G%=327EJK65HN&F:-
M4!RQ9@!@$9);KZT ='17E'CGQ%IVO^&]&U6S>X06VOPV\\;Y#1LK$LK*I()X
M4]_:NWT;Q=9:SK%UI(M+ZSO;>(3>5>0^69(R<!UY/&?7!]J .@HJIJ>I6ND:
M;/J%[+Y5M NYVQGZ #N2< #N367!XMM6UBSTN\L;[3[J]C9[472(!+@9(!5F
MPP'.&P: -^BN7O/'FE6,9N98+QM.6Z^QM?HBF(2Y((QNWD C&0I&:GU3QA9:
M8=0/V2]NHM-"F]EMT4K!D9YW,"2%(8A02!0!T-%<[9>,M/U#7X]'MX+II9M/
M&I0383RY820 0=V0<G&"!TK-?XEZ/%I-QJ,]GJ44-MJ#:?<!H5)BE4J#N*L5
M"_,.<T =I7-:YX-M]9U:/58=4U33+Y8?(:6PG">9&"2%8$$'!)-4G^).FPQQ
M/<Z5K5L);PV2>=:;29 N1QN[CIW]JM6WC>TO$A^SZ7JCW<D+3-9M$D<L2*Y3
M+;W"C+*0 "2<4 :VD:+;Z/&^R:XN;B3'FW-U(9)9,= 3Z#)P!@#)XY-:5<U:
M>.=)U#2+"_L5N;DW\K0V]M'&/.+KG<""0%VX))) ]^17/>!IC/\ $SQVYMI[
M;YK/]S.1N4^6V>A(Y.3P>AH ]&HJEJVJV^C6#7=SO9=ZQI'&NYY'9@JJH[DD
MBN#L[IG^,DD[:1>6MU_84C202/&3+^^3!4ARO3CJ.G/K0!Z317)MX_TY?!D7
MBK[#?G3G<HX"Q^9'B3RLL-^,;O0FKNI^*H+&YNK:WL[B^FLX%N+E8"@\M#D@
M99AEB 2%'XXR* -^BJ&BZQ9Z_H]MJFGR%[6X7<A88/7!!'J""*YT>*M1?XH'
MP[_9LHLX]/,Y96C)<F15$ARW"@!A@?,<].F #L:*Y.;Q_80Z;)JXLKR318YC
M"]^@0J"'V%MN[<4SQNQ^&.:ZM'5T5T8,K#((.010 M%<CJ/Q L=/34[@V-Y+
M8Z7<+;7MPH4;&..54D%@"P!/Y9KK$=9(U=#E6 (/J* '45QT?Q!@GUN[TN#0
M]6EEL[J*WN'2-"L6\X#G#?=_ID\8J.7XF:/$EM=,C'3;BY^SI=++&V#D@.4#
M;@A(ZX]#CF@#M:*Y/4O'5OI\>HW7]FW<VGZ;<BUN[E"GR/A22%)RRC<N3]<
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M#'TSVH ?)+'"A>5U1!U9C@"G5XOXFU.X\4? NYU75[6..8W(:*<X?8#=;3M
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M>W/K5S9J^C7?A7Q+;:-J%Y;6^DKIU_:10,+B(X4Y$;8)^8=O2O5*,@DC/(H
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MM*MXKBYL-1AO/(DE\L2*NX$!L'!^:NEHH Y"TT[65\>W&N7%A$L#Z6EIMCN
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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ML+>".VEOSKBZQ>#SBL8._<44D$GC: <=B:T[?1=8T#QGJFK:;:1WEAK*QO-
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M22(,5,BRJI3MG;SQWSQ5KPSH?C+3([?2-3U/3IM'M,".XA5Q<RHOW4/\*C@
MGDXX[YJOHOA+Q7X<$NC:9JVG'P^\K-$\J/\ :K9&.65 /EX)."3U.<=J +$_
MBGQ#-K_B'2K"QT\?V7%%.DT[O@JZ,V& &=QQ]!@]:Z#PIKG_  DOA;3M8\H1
M-=1!VC!R%8$@@>V0:P+?P]XA@\1>)=1,>EM%JMO'#"OVF3>GEJ54L?+[AB3C
MI@#GK6GX$T34/#GA&ST?43:M+:[D5[:1F5U)+9.Y1@\D8YZ=><  Z2BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHK.U_4Y-
M&T"_U.*V^TM:0/-Y6_9N"@D\\]A0!HT5Q>D>,I(_"&BWVKI&+[48T\E3,JB8
ME S.2<! !DG\!R2*KW'Q3TRUTC5[R2RG>72IEBN(()(WX<X20-D H20,CD9Z
M4 =Y17#WWQ&.FI%+=^&=8AAFO(K2!W1!YID!*D+NW9P#QC@\'!XJ9/'5Q)K-
M[HB>&[_^UH(EGCMVDC DC/\ %OW8 ' /7DXYH ZVXN8+6+S;B:.&/(7?(P49
M)P!D^IXJ6O/=>\6:+K'PZM]:O]"DOK&:=4>VD=5\J4/LY.<\-GE<\5KZAXQE
ML_%Q\-6NAW5U=?8OM<;)*BJR[MHZG@9SR?3H<T =+#:06\DTD48629MTC]2Q
M]R?T':IJX^T\?17NAVM[#IER;R?4?[,-H"&\J<$@[F&<( "2V.G:JFH^.[IO
M#_B;[#8(FKZ(G^D1M,&C4,A99%8#YA@=, YXXH [NBN23Q<;'2]&BO8H_P"T
MK^W\Q%EN%1,*JDN[D?*"6'0$Y/2HM/\ B-IU_I<TZVLWVR*^&G_8XW1VDG/0
M(P."N 3NXX4GM0!UOVB W/V;SH_/V[_*W#=MZ9QUQR.:EKSO1BQ^,]Z9M-AL
M;@Z(&F6%PZR,9\[]V!DXP#D9XKT-RP1BJ[F X&<9- $$U_9VUS#;3W<$4\QQ
M%$\@5I/]T$Y/X58KRC1;N'49O&=QXGL(I=/M-3:26227<;?RD&T*!R2,<8QU
M]ZZR3QE)92:2^IZ4]K8ZJZQV]PLP?RV89191@;"?8MS0!U=%<:_CFZ.NWVE6
MOAN_NI;*>&.9HY$(5)/XN#C@8.W.<9SC%=E0!'-<0VR!YYHXD)QND8*,_C2Q
MS12@&.1'!&X%6!R/6O/?!(A\7Z[K_B/44%P;:_>PL8IE!%O&@!) Z9;?R>O'
M6MR;2;+PG?ZOXELK0^5+: W%I;)EI)$)(*CH"0Q! QSSZT :.O>'+?Q +47-
MW>0K:S+<1BWD"_O%^ZQR">/RK612B*I8L0 -S=3[FN6M/&,TNM6VC7.G16]_
M>61N[5/M6X' SLD^0,C<_P!UNA]*H_\ "Q@? )\5II+-$DYADM_/^8?O/+!!
MV\Y8KQQP3UQR =S17*ZAXPD@U35-/T_3DO9],A6:>$W/ERN&7=^Z3:=_'N.3
MBH=7\?6NGW=_:P):O<6$*RSQ75XMNS%E+!$&#N? Y''4<\T =A16?H>L6^OZ
M)::K:K(L-S'O59%PR]B"/4$$5H4 -DECAC:25U2-1EF8X 'N:;!<0W4"3V\T
M<T+C*21L&5AZ@CK7G\.LZOK">-K/4K:S\FR5XMJ3LPC'D[EV@H-V3R22/8<<
MT/!?BZ;1/!WA.&\TB5=.O"EE'>>:,^:V<'R\?=)'7.>#QTR >IT5Q6K_ !&L
MM.?4O(CMKA=-E\JXC>\6.=V !811D'?@-W*Y((%//CN2XURTTS3M%FN6O=/%
M_;R/.L89"0,-D$K^IZ<<T =E16'X3\21^*=':^6U>UDBGDMYH68-L=#@@,.H
MZ<UF_$G6=4T+P;=7NEF!),K&\LCL&0,0N4 !RW/<C'7F@#I7U&RCOH[%[N!;
MN0$I 9!O8 9.%Z].:LUYKXCDN[?XG>$+H6$4FHO;WBM;P394_* "9&5>,')X
MXP< ]]:R^(,3:1J$^IV2V5[8WXT^6W-PI0R,0%(<X 7G))' 4]: .THKD]#\
M:1ZGXFFT*6.V:9;?[3'<V-R)X'7."I; *N#VQTYK>UK4/[)T'4-2*[OLEM)/
MM]=BEL?I0 Z]U;3=.95OM0M+5F&5$\RH2/;)J>&Y@N0Q@FCE"G#%&#8. <''
ML0?H17&_#*U$G@^+7+LBYU/5=UQ=W! +/R0J^P  &WH.:IZ7KFDZ';^+)]!L
M;B6.TFDO+NU:+R$AD6-0ZACG).S=@#U]J /0Z*X6Q\?7\FD0:E?^'WMX+V.W
M^P;+@.;B67@)T^7'7)[<XSQ6HOB>[M_$T/A_4K&&&[NX'FLI8IR\4I4?,A)4
M%2.O0\?E0!TU%<+<?$.2W\!1^*3I2LGVAH);?[1R")3'E6V\\C/('%6+WQ?J
MP\57OA[3M %Q=06RW,;R781'0G&2<';SP!SGVH [*FNH=&0D@,",J<$?0UA^
M$O$L?BC1WN_L[6MS!.]M=6S-N,,J'E<]^Q_&H/&GBF;PGIEO>QZ=]L66X2!A
MYNPJ6.!C@Y[^E %S0O#&G>'7NFL#=9NI#+,)KEY SGJWS$\GN:V:XP>+=<_X
M26?P^WAV(7QMA=V[?;<Q>7NVDR-MRI![ -G]:-.\<W.J>%[;4[;1I7O)+[[!
M+ CED@8,0SLX7A !G..X% '9UD/X7T:7Q*GB&2R1]42,1+.Q)V@9Z#.,\XSC
M-<\OCF^GT_Q&]GIUK>7>B;&9;>Z+QSHR[_E8+G< #QCJ,5H:=XIN-4M_#DMI
M;VTG]JQ-/,!*W[B-0"2/EYP65><<D4 =156#4K&YOKFR@NX);JVV^?"C@M'G
MD;AVS5JN+@\2E?$7BN!-#MX[S2[>*9Y5F&ZZ!5F4,P7C"@=<]: .THKSRU^(
MNI/I>@:S=Z)%!I6JW"6I87.^5'<D*P7;C;D'OGVKT.@"F=5L%U==)-W$-0:'
MSQ;[OG,><;L>F:N5R=QJMW_PL)](BTRP$W]DO<P7LC$NV)%78V%RJY)) SGC
MI7,>&_&VJV7P^N?$&K>1<;K]H_,+L!&6FVDL #A%![9/&/>@#U.BL7P_JE]J
M0N#=+9R0)M-O>64FZ*Y4CDCKMP>,9/UJ?Q!K=KX<T&[U>\#&&V3<57JQS@*/
M<D@4 33ZOIUMJ5OITU[ E]<9,-N7'F. "20O7'!Y]JQM(TWPS)XEU"_TV5Y=
M6MG\F\;[9*Y4D$A65F((Y.!C (XP1QSNJ2ZVWQ!\#MJUM9H));MD%L6)B)@/
MR,3][']X8S@\#OHQ^*YM/A\7W4^B0I+I$BEDLR7:X)C#!F;:.Q7)QP,^E ';
MT5PUMXWN(=*O-9O&T^]TB&S-RMSIS-S)D#RB&/#<]^N>@P16A!JWBB/4K."Z
MTFUG@O8'D62V9E2U<#(25CG(.0-P4<Y^4T :^I:!I.L7-G<:C80W4MFY>W,H
MSL8]3CH>@Z^@-:5>::5\1]7N](DU^[TJUBT6S:YCOG24F573_5A >H.47)QR
M3PH SIV_BO7WU:SLGTMGBOHVQ<1Z?<*EE)C($I< .ISC<-O3I0!UVHZC9Z1I
M\U_J%PEO:P+NDE<\*/\ ]?&.]2V]Q#=VT5S;R+)#,@DC=3PRD9!'X5Y?HOB#
MQ GPTUK7+^*QU(I-<-);W*-'PKD,#]X$ # 3 ^M=5/XDNY[W2]$TI+5-2O+'
M[;(\P+1VT0VC.P$%LL< 9'0\\8(!U=%>?7?CS5;31?$B-8V9UK0-IN SN(98
MV7<LBC&>1_"3_P "JU;>*==M_%^BZ=JUK8)9ZW!*]LMNSF2%HT#G>3P<@]NA
M[G&2 =O117G^G>+/$]_J>IDV>EQZ=I.H/!>/O<N8E3)*#NP]\9R..M 'H%%>
M>6WCC6KIM(U"VTZ2ZT_4)E62VBTZ<26\3_=D\T_(V.,X '/![U=;Q)XBU/3[
MS5] L+:XMK6Z:WBLI ?-NPC['8/N CYS@$'[OO0!TEMK^EWFM7&CV]VLE_;)
MYDT2@_(,XY.,9SVK2KS"0ZR_Q>UH:,+2.[;28,M>;BL8W>B]3VZ@=_8W['QO
MJNI^#-)U6*UMK66XN&@OKJ8Y@M51BK28+*2"0,#/?&3CD ] HKS$_$+5_P#A
M$/$U["EA/>Z+<^5YQC=(IHSC#!,Y!YZ9QWS6DFN>,H=.CN[ZWTF&VNI(62Z#
MG;9PLN7:4,PW$' &#WH [RBO/+7XA7,.EZY)=PP7<^GWL5K;R0JT*W'F[=A(
M;)7[W)R01TK3GN/&-O/J-M,]D;9; SP:E%;D!)0>8S&9#GC)!Z?7I0!V%%>5
M^%?$M]HWPW\/O+(+N\U68Q6P6W9FCRSL[, V9,8)P-N<X]ZO7/B_Q59Z5K\T
MFF)BPM_M-M>W%G+!'*H&64QY)W XQSC&2<8Y .UUO7-.\.Z8^HZI<>1:HRJS
M[&;!)P. ">M:->8ZWXJ\9Z/X&O/$5U;:*8]MM+;(-[%5<@$,,X)!*G@XZUT?
MBO5]2T.VNM3.H6=IIT,*>6CVIFEFF)8%5PZ]?D &.Y]* .KHKSZ'Q7XBMM/T
MBRU2"%-<U%)+ATMK1YOLT*XQNC#9+$D#J .?3G=\(ZQK&J17L6LZ=);2VTVV
M*<P-"ES&<X8(Q)4C&",GMZT =)16+XLU:[T/PS>:C96S7$\*@A0A?:,@,Q4$
M$A1EL9'2N/N?&&MP^$M:UNQU;2=2MK.&&6VN8[8C>26$D<B>9E6'R'MUZ>@!
MZ517)R:_J4>N^%H2]N;35H)&G3RCO5UBWY5MW3/8C\:H67B+Q)X@T:T\1:!%
M:S64]WY:V$J8?R Y1G,F[A\@G&, 'N: .HT[Q!INJZGJ.G6<[/=:<RI<HT;+
ML+9V\D#.=IY&:TZ\H@;7$\>_$230YK*&6-;.1GN8V?)6%B% ! YYR2>/0YX[
MWPCK;^(_"6F:O+$(I;F$-(@Z!AP<>V02/:@#:HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH *S?$-C+J?AK5;"WQYUU9S0Q[C@
M;F0@9_$UI44 >31Z'XI_X1WPKJ%MHH34O#JFW.GW$R#[6C(J.0<X7[HQD\\G
ML,W?%-IXI\2_#S4[5O#9LKV\>*.&Q@N8G*!7#,[R?*,$#  S^O'IE% ' >-K
M76=;TKPT]GH5VT]MJD%]<0&6$&)8]V5)+X).>,$CUQ3DMM8B^*UYKG]A7C6#
M:7]D2020Y9U;?T\S.#C ]^N!S7>T4 >,R>'?$S_"E?#X\.W7V]=0\[:9X-I3
MS3)G/F>AQ]:ZLVNL-\5;?7?["NQ8'2#9O(9H<HYD\SH'S[?4_GV5[?V>FVQN
M;ZZAMH P4R3.$7). ,GWJR* /(+;0?&%CHL\$.D3E)-?DO+FT6ZC0W5L_P##
MO#<=.0<9!'7FI;?P?KOF>.+8:!9V=KK-E&+58+E?+21(V 0  <[FY) &0>M>
MM44 >87.D^+%3P]XBL]%B^WZ?;&RNM)DND)FAP.0_P!T'<,XY[>XJWKFC^)M
M7TG3-<BTVUM=9TZ\%W#I0F#*4P0R-(  7/7/08Q[UW5WJ5E8RVT5W=PP274G
ME0+(X4R/Z+ZFK5 '"Z5;^([SXAQZ]?:$EC:2:4+1PUXKM&PE+]%')^G&#USQ
M7<L2JDA2Q S@=32T4 >8V?@_5M2TGQII=_8O9+K5V]S;3-*CJN<%0VUB>H&<
M ]ZOSZ5K?B;1M+T#5](-K%;2PO>W;3HR3"+!_=A3N^<CN%V@GJ:[^B@#D]!L
M]4M_&OB&]NM+>"SOS"893-&W^K3;RH.1GJ/UKK*** .%M-$U?P9K6J7.C6 U
M/2=3G^TM9QS+%);2$?,5W85@WID8P*T-73Q3JOAO4FL472[Z2W*6D'G*SAL@
MEF<#"M@$  D#.2?3JJ* /,=+T#Q!#XK\.ZK'X<M;"VAMY8;F(7H9U+!<O(P7
MYF)'&-Q..2.V3<>$?%J_#_4_!L.CP21_:_,AO&NEQ.AG5P-O!7C))/9<#)->
MR44 >;^)]!U77+NY\_PRAO@J#3=5M+U4:V;8/OM\KE5?<>ASD\>J#1_&'A+Q
M'-?:1;1:];:HD7VR.2<6YCG5 IE!.>&ZD 'T["O2:BN+B&TMI;FXE2*")"\D
MCG"JH&22?3% ',S:KXATK5M"L)[6VO8;UG6ZG64(\;DEL(G5E5>^,X'.#UZN
MJEJVGZ@L&J6OV>?S(_W5R@#$H><!O2K= 'GKZ-XBL=7\6K;:3#<V>KYDCG%T
MJODQ! FPCJ"2220, XR<5EW'AKQ*? GA/2$T?-WI5]%<3C[5&!MB)Z'/\6[C
MTP<UZM4%[>VVG64UY>3I!;0KNDD<X"CWH X&UTKQEX9UK4AHEE97^F:K=&\"
MW5QY;6<K_?SC.Y<\\9Z=N\YTKQ OQ(L-8DT][FUM=,:RDN/.B5I7)W;PN> 3
MV]Z[J">*ZMXKB"19(94#QNAR&4C((/<$5)0!QWP\TK5=&T_4K?5+#[,9K^:Z
MC/G*^5D.<?*3@C%7/'V@W7B3P;?:;8L@NGV/&'. Q5@VW/;.,9KI:* .)N--
M\1:AXL\,ZW<:;90BRCN%N(TNMS(9%P!G:-P&!^)/;FL:Y\ Z[=Q>()4GM;.^
MN=4CU/3Y5E+A'3HKC:/?GD<]..>[L?$>CZG?/96>H0S7*H)/+4\LO]Y?[P]Q
MD5J4 <YX:D\5W6)O$=O967EIL$%L_F&5N/G)Z*.#A1GKR>*WYX([FWEMYD#Q
M2H4=3T*D8(J2H;N[MK"V>YO+B*W@09>65PJJ/<F@#BM"T?Q'X'M6TK3[6+6M
M(5V:T!N!#- "22K;AM89)Y!S[>D=MX0UB'0?%\;?9#>^())F2$3'9 '0KR^W
M)QG/2NKL_$NB:A.L%IJMI-.S;5B64;R<%ON]>@)_ ^E:E ' W7@S5;[X>Z/I
M)EM[35]&:"6UE65GC:2)< DX! .6[<<5HV^CZEK/BG2?$&K6D=@VFV\J1VRS
M>:S22 !CN&!M !QW.><5UM% 'D=[X+\7S>#KSPG%;Z<;5+WSX;QK@@RHTWF8
MVX^7&3DG/H >M:K7.JVWQ8U"6STRVN[@Z/;B6#[3L*Y=N48KR >N0.Q]J]'K
M*B\.:7#K<FLQPRC4)!AYOM$AW#^Z1NQM&>!C [4 5O">@OH5A=FX\LWM_>S7
MUUY1)022-G:I(!P!@?A5#X@:#J?B/1K6RTQ+8O'=QW#M/,4&$.<#"GK^E=;1
M0!R#Z3K9^(:>(%M+,VHTS[%L-TP?=OWEL;,8SQ^OM7,P^"/%5MX933D&G/MU
M<WTUNUR_EW43$DQN=G0'''(/X<^JT4 <'H>FZOX>\5:UJ^L2Z/::7?K 2R2E
M1&R)L6-=V!QQ\QZ\8'/$OP]T6"P?6+RSN&FTV6[>/3@<%8X0Q+;"/X3(S_4*
M#75ZII-AK5@]CJ5K'=6KD%HY!D$@Y%6(((;6WCM[>)(H8U")&BX50.@ ["@"
M2N$3PYKJ>*/%>I_9K$PZO:QP0K]I;<I1"@+?)WSGCIC'/6N[HH \PE\%^)&\
M"^'-"6#3O/TJ]BN)'-VVUQ&20!^[ZG=^&.]>FH6,:EU"N0-P!R ?KWIU% '*
MOH^KGXEQ:Z(K3^SET]K$YN&\SEP^[;MQU&,9]\]JR] \+^)?#WAV?287TJ=%
MO&EC$I;%Q$S%F5_E.W(.. WKGU[ZB@#E/"'AB;0+[5KGR+:PM;UXVBTZTE:2
M*)E!#."0N"V1P   HZ]M#Q=X=3Q7X7O=&>8PFX4;)<9V,K!E..XR!6W10!P
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M/IOVY4@\CY3R<>]=I10!P>J>"M0O=,\321R68U7Q!Y<<Q9V\J"-%VJ%.W+'
MZD#)/;'-BZ\,ZS=^(O">JNU@HT6.5)T$C_O#(@0E?EXP!GGUQ[UVE% "'.#C
MD]LUR^@>&+G3IO$ OI+>:WU>YDN&6+<"F\!2N3U&!UX^E=310!P7A[PEXJT)
MX=*7Q#;OX>MWS$OD?Z3Y8.1&6Z =B>3CICM';>"?$FC:IJ$6@^(8+31K^=KE
MTEM_,F@=OO"//'/J>GH>_H-% '*6OAF_LO&EYKL4\#PRV*6<4$C.64)R"6.<
MY/7Z]37/6?P[US3M,TB&VU.P>?2[Z2[C6:)FBE$A.0R]BN?E(]>W6O3** /-
M9?AWKDEGXGM3K5G)'KDBN[-;$%3@9;@\<C '/'.<ULZKX6U>_P!/\.^3J%I%
M>:1,LA1XF>"?"[1D9R"!R/0D^QKL:* /-YOAIJ.H+XA@U'7(G@U9X[@-#;E7
M29 ,'[V HQTY)'<$<[^DZ%XA:&1?$6NQ7A\EH8DMK?RE&1@R,<_,V.W %=31
M0!YQ#\-M2'A"PTB378X[O2IUGTVZ@ML>6P+'YP2=V=V".!\HZ\YT[GPSXFU#
MP_J=GJ6NVMU=7MN;52ML8XH48$,P4'+.>.3P,<=\]I10!QGB#PCJ>O?#N/PR
M]Y:1S&.*.6X"-M(C*D$#/4[1^=)J?A76-6\2Z?JEY<V%Q;6$0,%BZ.(UN.\I
M]2.< ].#UKM** .(UGPAKFKR6^J1ZS!8Z]:3,;>X@@S&(6508V5B21P3SW)K
MH-"T[4;**:75]2%]?3D;GCC\N-%'143)QU))ZG/L,:]% &?K5KJ-WIICTJ]2
MSNQ(CK*Z;UPK E2/0@$?C7+R_#_[>GB)KN>VMI-9MU@=+*(K&K*2?-()^9B3
M[<#W-=Q10!PEOX,\0M=Z%=7OB*V>72MZHL=B I0ILQRV=Q'4YQTP.]1Z3X"U
MK0YGT[3O$S0>&VE:06?V<&558Y9%DZJ#SR.1GCGFN_HH Y.T\(7EIKGB74DU
M. _VVL:^6;0_N0B%!SYG/!YZ5H>$- D\,>&+/1I+M+K[*I595B,>023R-Q]:
MW** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ K/UR[O+#1+R[L(8);F&)I%2=RB'')R0">F>,<],CK6A574[=[S2;RVCQYD
MT#QKN/&2I S0!QFD^,[JT\'Z#/JWV);_ %.)?L[RWFU''EAFDD9D&S_=&[D@
M GM7G^*#6^B:Y<_V;#<7>CL@E^SW8:"5'^ZZ28YZC*XR.E5AX5\5)H7AFYLX
M;.WUCPZAACADG+1W,90(^2 ,9VK@?7/:K_B73_%GB7P3JEE<:?;P7=XL<4-K
M#<JZQ[6W,[NP'7& !G QWR: +.H>-=:TI$FO/"DJ6\]]#:V[?;(]SK)@!MO8
M@]CQ[]Z6+QCK4OB"^\/'P]&FJQVXNK<&\!B,1.W,C;<J<XX4-G/8<T[Q9IFK
M:]IFA+!I>VXMM1@O)5>X4"(1MR,@_,2"<46NCZN/B9=^(GLD2S?35LU4S NS
M!]^<#C';K0!GZKXOCU'X;+K=WX=@O(3,(;JTGE5DC<3"//*G<-W(XK6U+Q3J
MUMXN_P"$>L-#CGD>R:ZAE>["*<.%^88)4#/;)/ QWK#E\(ZZ_P .+OPVEK:)
M<37IG5C<G8J&X\[KMR3@;>GO6\VE:K)\0;;7C:P+:)IC6;CS\OO9P^0-N"!C
M'7O0!5L?'-YJ7AN*\M=%>343J!TV>!7)BMY <-(S@$^6!@DX[X]ZS[GQYJ5W
MH/BQ+&&P74M"3<\T<YEA=&1F#(0 =PVD;3QD=:SE\%^*;31WMXX+*X1M=?49
M[,W)"74+8_=L2N.,<@@@^^,583P=XC>[\:[[738(==LTCA$4[$1LL3(J ;1Q
M\PR>.G YX -*ZU:6.Q\'G5]#M+Q[RZ@CCN7G\SR)"I*R#<@.XA2?8]S6O+XC
MOKR]U.VT*P@NSIC!)S/.T6^3&XQIA3R!CD\9/>L>XT7Q)J&D^%HY[&RAFTJ^
M@N)D6Z+92-"F =OWCN)QT' R>M6].T75O#?B36;G3[6.\T_5I!=;#.$>"<_>
MSD<H>N1DC'0T 0#XB->6.@7NE:/)=0:M.UOAIEC>&4!B5(/'\)YST]>!6IX=
M\376J:WJ^BZE8Q6FH:<8V803&6-DD7<I#%5.1WXKGH?!&JZ3I7A:QL1;W#:;
MJ'VZ\ED?:&+;]RH,'^_P3CH*VM&T+4K/X@^(-;GCA%GJ,4"1;9,N#&NWD8[_
M %H T-;UB^L;ZWM+.SB(DADFDO+N1HX(0I4 %@I^8[N!QP">>E<]'\2[:;PO
M;ZF8(H)I;_\ LYFED)MXY >7,@'W,=#CG(Z<FKOB32=;N/%NE:E9VEIJ%A!$
MR-:W4YC6*4GB8#!!(''0D=L9S6'HWAOQ5I.FSV%QINCW]G/J,UQ<P/,2+A'R
M> RD+@A< Y]\4 =OH-_J.H6UP^HV<-NT<Y2%H)O-CGCVJ1(IP."21CVK"\2>
M,-2T635GBTRW6TTV%9?/O;@PB[)4L4A^4@L ,?4XJQX&\-S^&K+4(67[/:W%
MVTUK9B4R?9HR -N[W()P.!ZGK6-K/ACQ%>ZWXE,=OI]S;ZI9&VM+NXF(DM%,
M>UD"[3PQ)/!'J<]* .UTW4EU?0K74[1,"[MUGB20XQN7(!Q]:X'P]XRU2UTS
MQ;K&M^1-!9:I+;)'$[ ^8HCC1%R,!">_7))Q77^#K'4-,\):;I^IQ0Q7-K;I
M"5BDWC"J%R3@<G&>.GOUKD!X"UN?2_%FBO/;6]MJ6HR:C:7B2-Y@D+*ZJ5 ^
M4 H,G)/H* -2Q\=74VM)IDMA!,\\#R0SVKR^4KJ"2DC-&-N0.&P?I5&Q^(/B
M"_\ "4WB6+PW;?V='9S7&]K_  2T;D$ ;2<;03T&2.W%:VD+XYGA*:Y'IB"W
MC90;:0[KM]I4%LC"+SG@9R!T'!S-)\+:]I_PDF\*/;V;7S036R.+D[")"YW$
M[,C&[ICG'44 6'\<ZK!J&B)/H4?D:W$39*ES^]#A P\P$;54Y[%B![\4^#Q;
M>7EGXIT[4M&LVU#18@9[87!:"XC>,N,,4SRH/!7_ .M6NO#7B">X\%SBVL]V
MAJ1<#[21O)0)\OR>@SVZX]Z>OAG7$U[QI?"WM#'KEO'#;C[0<J4C,>6^7OG/
M'IB@".#QM+8>'/"$UEH=NL&L,ENEO#-L$)(.U5&W&..N1CT-:-IXOU0/XBM+
M[1-^I:1%',D%C*95N%=25"DJ#G*D'CZ9Z5ACP?XB70_!UD+>R,FA7232G[4<
M2!1T7Y.^:EUCPKXJOM2\5S64EM:#5X((H)1=-NC$0.00$X#@D<'C/>@"_9^-
M[V3Q8GAJ>#3VOI[)KB.2WG9TBE&?W<@QD=.O7VYXRM(\1ZS<_#+6-:U2ST[4
MXU:Y=H6D8*ZJ[!EP58;0!P.X[U8@\)^(_P#A--%UT6VBV=O9VIMFM8))"L8/
MWF'R@$G)P..V2>M%GX3\1V7@+6/#.RPE$XG2WF-R^YQ*S'<^4XQGISGU% &O
M;^+&F3PUIVGVEO'?:K8K=[&8B*VB" G@#+=<!>.AY%4V\=WL&D>)!-I]J=9T
M !KF$7!6*2,J65T;:3R!]TCKQGFHHO"&L6DWA75[7[+_ &EI%D+"ZMWE/ESQ
M;0N5;;P>K=/0=J6_\':I/9>+;N)+/^U/$$:P!#(0D$:Q[!\^W+'DD\#MZ4 6
M[7Q?JRZSH4.I:7:V]EK2L+=HKEI)48)O^<;0.1Z$X]:T?'DUW;^!M9ELQ$76
MSEW^8Y7"[""5(_B':L6[T#Q#<77A"9;*R T8YG!NS\QV;/E^3TYYQZ>]=/XF
ML;S4_#6HZ?8"'S[NW> -,Y55#J5)X!SC/2@#D-,U'^S],\'6\NGZ?+K-]:I!
MITV#^YB$*M(S'&>G\(ZG'(SFK]SXSU#39]=TV\LK1]3TZR-_;[9FCCNH!G<P
M&&*L,'Y>><<@<U!>^$-:DTSPM=6LMC'K7A]0B*SLT,Z&,(ZD[05)"CG!Q5J^
M\+ZCJT^MZG=+91W]YIATVTB#EE@C8,69GVY)+-G 7HH'?- %GP=KFO:_:6^H
M:CIMI;6%S9QS0O#,6<N>H*GH.XY/&.^0,6\E.N_&B'2+P!M/TK3_ +9'!(,K
M),6 #X/!(#<>A!KK/"NF76B^%].TN\,)FM(%A+0N65MHQGD#'TK*\1^$[N\\
M16/B70[N&VU>T0PLMPA,5Q$<Y1L<CJ<$4 ;&JZ!9:M?:;?3(!=:=/YT,H W=
M""N?0Y_,"N4U/QUJFDRPS7EI90QRZD+06#.3<^46VB7<#@9ZX(Z8Y.:Z>U_M
M^]FC-_%::? AW%+:X:=Y"#P"Q10J^HP2?4=^!F\!>+W\/R:6+O1Y'CU%;U;J
M17\V[/F%_P!Z0!@C/;/3 Q0!V%GKVHW7B_6] Q:@VEO'/;S^6W\><!UW<XQU
M!&?05C0_$.5_#.@:E=+:6']JW$T+W,P9H+?8SA<\C);:!R0.I]JMRZ#XEM?&
M#ZWITFE,;ZSB@O//$F(G0GYD4?>!ST)'3K5/PYX4\1:%X9M-(N4TG4K9'G:X
MM9F8+(KG<H!*'D$GC&,?F "]<>,;RSM-,@NH($U*_FF53;I)<Q"*,G]Z%CRS
M C;@<?>Y(Q5[PGXBOM;?48+_ $V:V>SE"QW#6\L,=RASAE60 @\<CG''/-<I
M'\-]7TW3-.N-%OK>UU;3KV>YMH79G@6*7&8-V Q7@<X[GZUV^@0:ZL4ESX@N
M+1KN4*!!9*PAA STW$DDYY/'0#M0!LT444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%9.F^*-"UB^GLM.U6UNKF#_6112 D=.1
MZCGJ..U:CNL:,[L%11EF8X 'J: '45CZ/XJT'7[B>WTK5;:[F@_UB1MD@>H]
M1SU'%;% !1110 445#<74%HJ-/*L8=PB9/+,>@ [F@":BH4NH)+J6V20--$
M9%'\.>F3TSWQUZ>M9LOBK1(;F2!K]6:)BLK1HSI$1U#NH*H?8D4 ;%%8DGB_
M0(SIX_M.%QJ,WD6C1Y<2ON*X! (^\",]*VZ "BBB@ HHHH **** "BL[2=<T
M_6_MGV"8R_8[AK:;,;+MD7J.0,]>HK1H ***JZAJ-GI5HUU?W,=O O!>1L<]
M@/4GT')H M45B6WBW1;FY@MOM,D-Q<-MABN;>2%Y3S]T.HR..HZ5MT %%%%
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M9F4</&,G )'0GN!4-WX536/$,/B73]6OM.EEM_LUPD<8!EC#9V_.,H<YY'-
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M ECX=X9G_MVT*HI^]ACQZ?G0!LSW7AK6=2M;:^L$FNY"?LXOM-=22H+':9$
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M \^WU]>+&L^'/$5R/#NHPW-G=:KIER\\R2,T44@=2"JD E0 <#(.1U]^VHH
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M#VMZKXNT+5K(6 M])>1Q'-.ZM,74 ]$(7&.O-)-X5U32O&,FN^&YK1(+U?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HJAJ6N:3HQB&I
MZG:69E.(_M$RIN^F3S5V.1)8UDC=71P&5E.00>A!H =1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MHHH ",]:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
6*** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>davidjkatz_employmentagr004.jpg
<TEXT>
begin 644 davidjkatz_employmentagr004.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***04 +1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %(*6D% "T444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !2"EI!0 M%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4@I:* "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBDH 6BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ I!2T@H 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M *04M(* %HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "DI:*
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MI5YHXU>#4+=]/*EOM(<!  <')[<\4RR\1:/J%O<W%KJ,$D=KG[0=VWRL#/S
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M0TF<;?[I!_2M36=:>R\<:X=.@U!H-2L;<71&FR7 R4(5E"E60A#C:_4YZ8Y
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MD X_ XZ.@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *04M(* %HHHH
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MCM0![TS!%+'H!DUYO+XGDUS4O$$,>OSZ0FGRQ)9R16K. -@9GD!7Y@22,'&
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MVC75>TUQ%)98HW^8<],(BE,\9P.YK?U:%A\4?#DT5E<&""TN8I)TMW*(6"[
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MV?N@RE@,,P).!G [5YIXMM/$.O:#XET^X\/ZM-J)OBUJ81BU6!9%VLHR-[D
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M2VAE@479!!< D@^F2>#Z5?MM<U/PWX]MO#>K7C7VG:C \MA=RJ!*CIRT;E0
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MMI R,PQ^_C!X'7@GCFK%EX]L+W5IM+.G:I;W@A,]O#<V_E-=H.ICW$>G0XH
MZJBN;L_&MA?>%T\06]I>-:R3+"D>U/,9BXC'R[N/F.,$Y]JZ,'*@D$$]CVH
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M%%% !1110 4444 %%%% !2"EI!0 M%%% !1110 4444 %%%% !1110 4444
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MX59^WV?VM;3[7!]I=/,6'S!O9?[P7KCWKR?0]"E\0_#77]/M JW=AK-R^F$
M#R71PZA?3))'_ JZ3PY?+XF\-:EXDUB*6RCN;(VS$##1Q(A\QEXS]]I/P5:
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M:;[.IYV&7^X'QM+>V<U!J'C/PWI5W+:WVM6<$\6/,C:3E<G R/6O-C=6FH_
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MSHLD;(XRK @CVKS3P->Q^ ([OPIXBE6QBAN'DT^]G.R"XB;G <X&X'J"<\T
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MIFF1%M1:6Y;RBA1FW2LR]0,[E&!^5 'H<'BG29]2M]/,TL-S=(7MEG@>+SU
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MNPQACCMI'W[1DX*J03[#GD51/Q"T 65S=![PBT=DNHQ92F2W(ZF1=ORCW/\
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MG=]G7Y2/X<^IXZY(K,BT36]#70K6XTF\O=+F>ZN+ZSL&7"S2MN1'R0"BYQU
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M(KR#<0C?-&Q&&&?4'(_"O-K^:[7X!7EP-2OQ<V\\X6X%PWF.!=,F&;J1C@T
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M:HT5Z\"C+B#<F(^!SB->>.YJO_Q3_BL7&I^']1U'4M>.FW$41>5A]F#1, '
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MI>OR?$#P[JL^G//%9VTL5U/#)$$#R#^$%@Q5>F<9XZ&N^HHH **** "BBB@
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MMTUM"7$"$9!;\!G R<<XQ6E97]KJ.GPW]G*)K6:,21R("=RD9R!UKS"/3_\
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MHUTVI6^H++)"DD?""<R9SNP>#TSU^E=6]IJ,OQ4L]8&EW2V THVK2L4^61I
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MS:X,D-Q \+[3]U@K@'!]:K^-?$C^%?#=QJ4=I+<2+A$V %49B%#/STR1TY-
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M#4+T6J1/*R21!I#&KL<$?>'( XR.37>)N**7 #X^8*<@'V- #J*** "BBB@
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MC!!'-9D_A+Q7_P (YXMTJ/P]%&=7O%N+?[->1>6@W*=O.W@!3V'...X]FHH
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MRN^/Y2@]"X*9[D9]*C\':3JVC:?J\>KQRR0Z5%)I^G,L)9Y8,E]P51DY!C'
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MG6YM=$G@L)9/[6YC59$/EKMW;F.>FWT]AU-:.KZM::'IDM_?2%(8\#@9+$G
M4#N22!7'^ -"ET[4]7C>59K#3+J2TTO(YBC<B21<]\$JN?\ 8-:OQ!T._P!>
M\*R0:7Y9O[>:.Z@23[KLC9VGZT -@\<P7&JW6D)I\YU.*W^TQ0++$PN$R =C
MAMNX>AQTIND^/+?6[+39[#3;J62]GEA>WWH)+?RS\S2 MP!D>_S+ZBJNAZQK
M%S'->3>"7TW[+"Q:/*&6XEZ!(^F%[EB?3W-9-KIFN:#XDLO$=GIUS<2:P/\
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M/[6B:=:7;[;F.$X#%B>=H/W0>0!SC/ !W]%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 444@H 6BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MMN0!G'5CZ "NIT73-;L?&'B;5[C38O*U%(3 $N%)+11[,'C@-U[XH 9\(?\
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M2'>=ZXP 0#C!./6J]U\3%2UCU:RAMKO33/Y)MXW8W13<5,H7&,9'W?3G(S@
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MV,.A('3/4U#XLUS4=>\%>)[C3X;/^R+>*XM6,K,99B@PSJ1\J@'. <[L=5H
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MHHH **** "BBB@ HHHH *04M(* %HHHH **** "BBB@ HHHH **** "BBB@
MI&.U2>>!G@9I:* . ^'2W6FVWB,7VG7]L9M6N;Z(26[ O$^W&/5N#\O6N6B@
MO+7X3PZ?J.C7POHM64VT179*K/,75XPW$A&6^7ZYP.:]HK)U_P .V'B2SCM[
MWSD:&02P302F.2&0 @,K#OR?:@#D/#NJ@>*);_5M'UZ+5+RW%M'/<6 BB*)N
M?RU".V&/)^8\XXQTKF;?0=;;X16&C+HU]_:$>J><\#1;2J"4OG+8'0CO_(X]
M0T;PQ;:/)YK7VI:C<#.R;4;IIFC!ZA<\#IV&?>MN@#SXQZQ8?$[5=0@T:[N;
M._TV)8W&!&&3)(?)X/4 8SSV!S5'P_HMYIGB73[O0-(U'2;26.0ZMIUPP, .
MW*>622-V[NO&.N.0?3Z1E#*5/0C!H QO#.N7&O6$\UWI-QIEQ#.T+V\[!CP
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MWN#)$P1HT*AF57W=<$#'UQ7IM% '%^%V\:+!9:7JVFVUG#9!4EODN5D-RJ<
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MINBR6NO#59+FW#W$)6XMI-H:%\.0,8)]L\<]/8:* *]E/-<V<4US:/:3,,O
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MN;/6%CDGMY;DQM:S*FTG=M.]3CMS]*[FB@#D_AQH.I>&O!\&F:HD"SQR2/\
MN9"_#,6YX&#SV)^M8^L>&?$E[K7B;$-E=V^IV9MK*ZN+@J;-#&59%0*>I.<@
MC.,D]J]$HH \TM/"WB:"\\$2RV5B4\/P20RB.Z),@:)8\C*#D8)QTY'-:^DV
MESH7BGQ+K6L_8[/3]4>#RY)+I1M*)L"MD 98GCGVKM*I:KI&GZW8M9:G:1W5
MLQ#&.09&1R#0!R7PVT&/2[74+F&[:YLGN'@TYB,!+978@#U&]GP<\@ UL>-O
M#/\ PEGAF;3HY$BNE=9[:60$JDJG()QV(R/QK?AABMX$A@C2.*-0J(BX50.@
M '2GT <=/H.J^(-<\/W^KV]M:QZ0SSNL4WF^=*5 &/E&U01GGGH/>L+_ (0[
MQ'!X<\7:)'!8R1:M>3W-O/\ :2"/,*X!7;Q@*<\]Z].HH X9]'U_[5X0E33[
M8KHR,+@&ZP6)B,7R_+[[OTJMX>\/^,O#4$F@6L^G3:/YC?9KYW83VZ,2Q^3&
M&(R<<XS[<5Z%10!QVAZ+K%C\0O$.LW%K ++5! J,L^63RDVY(V\Y^O%:/C3P
M]+XG\,7&FVUR+:Y+)+!*<X5T8,,XYQQVKH** //SHGB[4O%_AO7-0M=*A_LQ
M)HYUCN7;?O4*6'R<>H'MUINB^'O&?AN2\TC3[G39M'FF>6VNIRPFM0Y+,-@&
M'())'(&>_.!Z%10!R3Z%JW_"Q;77$2V>QATTV19[AO,8EPV[&SKQZ_C67H_A
MSQCX=N+O2=,O--;0IIY)+>:8,9[17))4*!AB">,G'\J]!HH Y*R\.ZI:_$:]
MU]C:-8W%DEJ!YS>:"ISN(V8Y],TW1?#-_;ZGXG?4EM?L>M2;P()V9T79LP<H
M!TYSFNOHH X+PSH/C/0[>VT*6^TQ]'M7 CO%#_:&A!R$V_=![9SP#QG%4KCP
M=XGM-%\0^'=-?39M*U$S2V\LTCI+#YG)C("D,,YP2>_X5Z510!G:!:76GZ!8
M65Z83<6\"0L822IV@#(R >U<?IOAGQ?X:U'4+71+W2Y-&O;E[B,W8?S;4N<M
M@#A_8$\X[9KT&B@#A8O"WB'1/%][J6AWEE+8ZFD*W2WY=I$>-=OF#'WB1G@D
M<FL/PUH-_KOPE\.KIUQ;QWUAJ#7L9G!\MVCGE^5L9(!S[UZG+$DT312H'C<8
M92,@BJ^G:5I^DP&#3K*"TA)W&.",(N?7 H YBWT3Q0GC ^()I])</IXM6M5\
MQ<$.S !\'C)'S$=S\O%85O\ #S6X_AE;>&WGT\7UG>K=0R+*YBD D+X;Y 1]
MXC@'H*]/HH \^\9):>(-.M- N=3MD\41W4$L,=D^7@<MDL 3NVK&6))[#..0
M*[NUM8;*TAM+>,1P0QK'&@Z*H& /R%1+I>GKJ;ZDMC;B^==C7(B'F%?0MC.*
MMT <3K_A775\5#Q+X5O[.WO98!;W4%\K-%*H^ZWR\@C^GURV]\':N]UH^N0:
MG#-K]A)(\K3[E@F208:, 9**!]W@^IR3FNXHH XR[\(7E^WB"_G>T_M'5K,6
M*(&8QV\6T@_-@%CDD]!V%1W7A+5;J/PHC/9 :%(CO^\?]]M7:,?+QZ]Z[>B@
M#AM4T2_L9?&FLS/:FVU+3M@16;?'Y43@'D8.=W/I[U3T#0M3\1>"O"UIJ9L1
MI4$%K<D1EFDG54!1"" %P<9Y;..V:[Z\LK74;1[6]MXKBWD&'BE0,K?4&BTL
MK73[9+:SMHK>!!A8XD"J![ 4 <-:>#O%.A:K=P:!KEE#H5Y.\[1W$!>6V9CE
MA'C@^V3@>GKH6WAC5;3QU/X@CFM7A;3A81Q22.7PIW*S-CDD@9^O>NPHH X;
M1/#/B71-(M;&*\TUUBNII9D8/LGCD+,R$8X(+#!YZ5GP_#?4+#[+<:;?V<$D
M&JOJ*V)C8VJAE"A0,YR,9!XY/ &!7I-% 'G/_"N]7EM/%5K<ZS:O'KF)-RVQ
M#+)@<_>P%R.G)]ZU;W0?$=Y)H$\MUIDD^F3>?(0KHLC;&3:!S@88G/KVKL:*
M ..M_">I:-JVM2Z+=VB6.K,9G@GC.;>8C#.N/O ]=IQSCFJH\"76G-X5ATJ>
MU^R:"7;$^[?,S@ACQP.I/U-=W10!ROA[P[J6D^*]?U6XEM'@U:2.39&6W1E%
M*@<C!R#6%\2KE)M:T+3CJEAIY3S;O?J2E8&90%7$@965QEB ".Y/09]'JO>6
M%GJ$0BO;2"YC!R$FC#@'UP: /,[&UU3Q!X>U?PO9SZ!<6L\.[^T-.W^4KNQW
M!C\VY^_WL\\]JZ'6/"NL:IH&@PK?VL.HZ3<17&=C-!,T8P,C@CU[X_6NO@MX
M+6%8;>&.&)1A4C4*H^@%24 ><R^ _$$E]XGNCK5B[:]:+!,GV9E (C,?!R<
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M2<"O19(W>T>(L"[(5W$8!..M 'E?@[QK/X?\$>'1>Z#=KH[1I VI^8FU79B
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "D%+2"@!:*** "BBB@ HHHH
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M 4444 %%%85KXPT2\U>WTR*Y<W%TC26K-"XCN%7.XHY&UL8]?0C(H W:***
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ I!2T@H 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ J*:V@N=GGPQR^6P=-Z!MK#H1GH?>I:* "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M"%38H! W#"\=?>H].\$0V=OIEG<ZG=WUCIDGF6MM.J85@"$W$*"VT$X_#T%
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MR)XE89DB!^Z=ISSQP?:@#TZBN6N?$9A&H:K#.\^DZ?IHNW5%7]\Q5G !Q_=
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MASA"0>>#VZ5JZOJ?BSP[=^'X;W5K*Z74-96VD,5GL/DL00.6.",,.A/(YR*
M/0J*XVVUC5O$FI^(K73+Q+'^RIOLUOF)6\V7;DF0D'Y,X&%P>,Y[5S?_  GN
MO:Q9^$Y=.FM;.75+A[.[CDMBWES(/F(RWW>^.O\ M>@!ZM16?I$&J0Z+#!JU
MY%<:@H827$,>Q6Y.TA>@.,9[9S7 R>+M=B\,Z_')?1#Q'I5]Y"0K ")U;!C
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MX''.0I!X[\=!6Q+K%_/IGA&<ZD\45]:"2Y@A3-W=.8E*[%"D !CEC\H'<XH
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M67:7@E1=P=2 #@@D$'@8S0!HZAXQBM)KY;33+W4$TZ5(KPVJAFC+ 'Y5SE\
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MEV#@1,"(]@&<X[<Y)S0!ZO17G$D.OZM\0M;T>W\3WEI;6UO;3QD1HQ!))VX
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MOG9NY=YCR "J^BY!..@S0!J4444 %%%% !1110 4444 %%%% !1110 4444
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M"VG"PRL?O=LC/?!'4@8%=K10!R6L> ;34==76K#4K_1[\QB*62PD"B90 %#
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ KE/']]JVCZ$FL:9>/%'93))>0K&C>;!N
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M^P->>VB)X*^(VDSQ6=W::9J]NNGW!N0OSW"\I(2&.6;H2?4^M 'K3$A20"Q
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M63=+\,-:-H7$GEH&*'!V>8N_\-N<^V: -.V\6Q7]N;S3=)U.^L <+=PI&$<
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MMPR#M!&"IR".XKC+FVOKGXX7:V%^+*0:&A9S )=R^;TP2,?6K>O0ZGIGP_\
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MI\=GY=PR6^R82>;$/NN<="?2O-M <Z5XCTBR\1V\T%]-/,UMJ]M.SV^HB17
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MM/#_ ,2)+!7+B_0,T9PRQF*(.1W^[G_'TT/$MG9PZEX#N_#\4,4DMZL2?9@
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M 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M4TW9<7=F3$48E5\W8&"EO^!+G'3-/TJ6_GTJVEU.VCMKYXP9H8WWJC>@/?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %<?\4))[?X=ZM=6US<6UQ!&K1R03-&P.]1U!YX)
MKL*X[XHK-<> -2L;6TN[JZND5(HK:W>4DA@>=H.!@'DXH Q]2L+SP[X\\.&U
MU/4KJ#6&FMKZ&>Z8AL)N#H!]PCD_+C&!CJ:P=,6]TKP%JOBXZOJESJ5@]W!
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M@'BN\AC$,*1*SL$4*"[%F./4GDGWK,U7PUI>MWMG=W\,SSV;;[=DNI8_+;U
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M],UTM,FACN()(94#QR*4=3T((P10!R4WAFU\5?#;2]+:9K8"UMI8)H0"8G5
M5('I_2N<.GZKXJ\=6UM=:C#>6^@6\PEN[:V,2&YD78$^^V6488X.!TP*[/1-
M#FT[2VT&[)N=.MP$M)C(0YB[1N!CE1QGH0!GG-;5K:6UC;K;VEO%;P)]V.)
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MQR_U2]T:]^*5]I^\7,;V85TZQ@H07_ $FN@TO18X-=TK7--UW3(8KJ)T,5K
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MH)[<D[5)QD#%= \T4;HCR(KN<(I8 M]/6L^X&MGQ!9FV:R&CB)_M(?=YQ?\
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MS$I2+=(SB)3U"!B0@..BXK1>>&)@LDJ(Q&0&8 FA9XFF:%94,JC+(&&X#W%
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M2.A/J?K6E=7UI9!#=W4%N';:AED";CZ#/4T^XN8+2!I[F>.&%>6DD<*H^I-
M&<?#6D'59=3^Q+]NE0QO/O;<5/4=>GM4">"_#D>ES:8ND6WV&9Q(\!!*EAT;
M!/!]Q6P+JW-L+D3Q>00&$N\;2#WSTI$O+62Y:V2YA:X10[1*X+!3T)'7'O0
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MH?&GB#5-&\0^&K*QN4CBU6Z-M+OA#E/NX*\CUYSF@#J+#1],TK=_9^GVMKN
M5O)B5,@=!P.@J!O#6A,MTK:/8%;M]]P#;I^^;GEN/F/)Z^M<[:>)=6LOB5_P
MBE^T%[!/9_:X;F&/8\(&05<9(Y*G!XZBNFO-=TK3[N*TO-1MH)Y?N))(%)].
MO3/;UH 2;0-'N--CTV?2K*2QCQLMW@4QKCIA<8%3R:983:>=/DLK9[(KM^SM
M$ICQZ;<8J'4==TG2'1-0U&VM7?!"RR!3@G /L,\9Z4M]K>EZ9%#+>W]O!'-_
MJV=P XQG(]L=^E $UCI]GIEJMK86D%K;KRL4$811^ J::&*XA>&>))8G&&1U
M#*P]"#UJE+KNE0:='J$FH6ZVDIVQS>8-KG.,*>_0]/2D.O:0ND_VJ=2M!88S
M]H,HV?GZ^W6@ .@:,;=8#I-@85;>(_LR;0WKC&,U*-(TT7BW@T^T%TO2;R5W
MCC'WL9Z<5%:Z_I%]J+Z?:ZE:S7B)YC01R LJ^I'XC\ZMW5W;V-K)<W4T<,$8
MR\DC!54>YH JMH.CM+<2MI5D9+EE:=C N92"""W'." >>XILWA_1;F[2[GTB
MQDN4(*RO;H7! P,'&>  /PI+7Q%HU[;7-Q;ZI:O#;$"=_- $6>F[/3/O3+7Q
M1H-]>06=KJ]G-<SQ^9%$DP+,N,Y ^G/TH NRZ=93WT-]+9P27< *Q3M&"\8/
M4*W459KE/'7B:VT7PYJBP:M'::I%:M+"H*EMV#M&"".2,>_:M;PU=RWGA+1[
MRZDWS36,,LLC<;F,8))_$T 6+;1],LK@W%KIUG!.009(H%5CGKR!FG+I6G+?
MF_6PM1>'K<"%?,/&/O8STXKC+[QS:ZYX?\4?V)J#VUSI<$KPRJ@W2;(@Q.UU
MX&XX]>,BM7PCXIT[4=(T>SFUBWN-8EL(II8BX$C$H"25'?G.* -Q]'TR22>1
M]-LV><8F9H%)D'HQQST'7TIDF@Z-+*)9-)L'D  #M;(2 !@<X[ "F7/B+1K.
M_6QN=3M8KIF""-Y #N/1?8GTK29@JEF("@9)/04 5KS3;#40@OK*VN@F2HGB
M5]N>N,CBFW6DZ;?+$MWI]I<+$,1B6%7"#T&1QT'Y54L/$^B:M>O8V&IP37(3
M?L0\E>/F7/##D<C(KD[>^UAO!_C9FUFY-WIU[="VN2B;E1(D=5QMVXY(X Z]
MJ .U&BZ4MU]J73+(7'3S1 N_ICKC/3BB+1M+A1$BTVSC2-_,14@4!7QC<..#
MCO6=I.M6]IX+T?4-5O51I;&%WDE;+2,8P3[D]^*O0:]I-SI+:K#J%NU@N=TY
M<!5P<$'/0YXP>: )GTO3Y+T7KV%JUT.D[0J7'_ L9IMSI.G75R+J:PM)+I<;
M)I(%9E(Z<D9X-0V/B+1]2G^SVVH0M<Y(^SN=DO3/W&PW3GITID/B;19]4&FQ
M:C UVV=D>?OXZA3T8CN 3B@"EX>T;6K>X^V^(M4@U"]1&AA,$'E+&C,"?J3M
M3TQM[\FNCKA/B/XLMM,\,:I%8ZRUKJD"#;Y"[B&/1&;:0I(Y R#QQ76Z+*\^
MA:?+*Y>1[:-F8GDDJ"30!>HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** *M]J=CIB1O?7<-NLKB.,RN%W
ML>BCU-6J:\:2%2Z*VT[EW#.#ZCWIU !1110 4444 %%%% !1110 4444 %%%
M% !1110 5QWQ)U632_#UH-[Q6MYJ$%K>3JQ4PV[-^\;<.F0-N>VZNQJMJ.G6
MFK:?-87]NEQ:SKMDB<<,* . N]+L=$^)^F2Z/90Q2/H]T1%%A5D92NT_4]SW
MK)T*QM-?\+:3XA?Q%!!>VTJS3W,=M_I1F!^:)VWY8$G 7'(VX'05W-C\/_"V
MFW=K=6ND1K<6IS#(\CR%#Q_>8]-HQZ=L4^U\">&+/Q VNV^D0QZD79_.#-@,
MW4A<[0>3T% '%^(8&T;6;S5]4T^WU319=1BF&H6I_P!+L71D 1O6,%<8'J?6
MI-.ATCQ5)XNB\0W0@U"VU%T$IE"R6D"8\MHV/W!\I)(Z\YKMV\(Z&]Y)=/9%
MI)9Q<R*9I#&\H.0[)NVD@],CBHM1\$>&M6UF/5[[2+>:_C(82MD9(Z;@#AL8
M'4&@#CIO#>C:]\0!:7(NY[.]T".9P\KJ93YF S=,' !P,#(Z5/I5K%9>-?']
MO '$26%KM#.SD9B<GDDGJ37<-H&F-K*:N;;.H(GEK/YC;@O7;U^[[=*(- TN
MVU.YU**U"WET,3R[V)D'3# G! [#M0!XO;>'K*R^$^@>*-/66'Q%'-"+>=9'
M9I"9MOE[<XQ@GC'8^M="EG:^+]1\5VVIZE8VU[;7KQ;I[?,UO"F/+DC<N-HZ
MG('7).<UWVG^$="TJ>.:RL%A,3L\2"1S'$S#!9$)VJ2.,@"HM6\#^&M<U6+4
M]2TB"XO(\8D8L,XZ;@#AOQ!H T--BAN?#UG%+-_:$,EJBM+,N?M"E1\S _WN
MI'O7C8MX(?@%KTJVMO#(;IE+QQJ&=%NEQD]\9(&:]T    & *YQ? 7A=(;R%
M=(B$5ZXDN(][[9"#D9&<8SSCIF@#C)K*/PY\2-.;0K9A-=Z)<22*6+-<R+\R
M[B2<G('/X=*J:!IECK_AG0]>?7X+>]MYUEDGBMQ]K>;.&B=MY+;B?NXYXP,5
MZ6WAG2'U"TOWM-UW:(([>8R/NC7T!ST_G5>#P7X<MO$#:[#I,":FQ+&<9ZGJ
M0N=H/OC- %CQ/;P7/A;5([B!)X_LLC;'4,"0I(X]<]*\WTV'1;7X8>%(IK55
MN=3FMHU2)5C%U(&)"S/M.8\]>":]6OK&VU*REL[N/S;>48=-Q&X>G%8\O@?P
MW-HXTB32XS8!Q(L.]P$8=UYRI^F* /,;N]U'0K;XBPZ=+;03P1VCK%IX*Q0E
MP1(4')#!0<GCIGBNVT[2_"-S>Z-J%@T9-U:&!+:$H4N(RI8F9<9;&.IZ,?4U
MOV7A+0-.O3>6>E6T5PT MRZKUC'&/3ZGJ>],T/P?X?\ #=Q//H^EP6DL_P!]
MTR21G.!DG ]AQ0!YGX/TF*^^%-G!8W%E9:I<7[%&FB!6Y,<S,(I<#)0XQ^0[
MXKK_  !=1-J6OV,^DKI>KP31->P0$&W8E/E>/ X# 9(/KGN:UAX"\++'/&NB
MVRI/.+B0#(S(,X(YXQN/ P.:U=+T;3]&BECT^V6$2OYDAR69V]2Q))XX]A0!
MQMQ<:;>_%:_TG7A'(G]F1MI\5S@QX);S2H/&X\#/7"GM6/KL>GV^E^ [32[N
MXN[*V\11013SOO+A6<<-W4'(!'& *]!UKPOH?B)H6U?3+>\:'/EF5>5SU_D*
M2_\ "VB:FMHMWIT4BV@ MU!*B+'3: 0!B@#S?QBEK?:;XVO+06NZWD"SW-Z0
MTJRQQKM2 #!0#J&)/S$X%:]_'"WQ8\&7"*A>:PN?,D'5\1XY/>NMG\&^'+J^
MNKV?1K22YND*3R,F2X(P?QQWZTR+P3X;AGM)HM)ACDLQBW*%AY0]L'CW]>]
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 50UK6+/0-&NM5OW*6ULA=R!DGT 'J3@#ZU?KAOB[IEWJ
MOPWU**R5GDB*3LB]61&!;\AS^% &II]]XGU2PAU*.WTZUBFC\V*RG#F3:<%0
MT@.%..ORMCWK3T?49;S0+;4-0@6RF>'?/&S<1,/O<GL,&JEAJ-CXI\(Q7MI.
MX@N( V;>9HVC8#E=RD$$'@CVKS#0M6N9?#?@.YUJ[NKJQU*_F%_+<S-*KR*S
MK K!N NX ^F5R0: /:(+B&ZB$MO-'+&>CQL&!_$4U+NVEN'MX[B%YT&7B5P6
M7ZCJ.M>8^)EO=%\::TWAY/)63PW+/<10C:JRJQ$<F!CY\ @>P/I4%[:V<GPT
M\)ZOH@C35HY[3[/-$,/+*Y"RJQ'+9)<L.^#0!Z-XBU4:3HMU<1W5G#=)"\D(
MNB=K%1D\ [C^'/-1^$M2N-9\(Z3J5V5-Q=6J2R;1@;B,G K@(I;35;7XD+K/
MV5]1AFN(HOM(&Z.W$>(<9Z+G)X[DGO79?#ME?X=Z!M8'%E&#@]#MH S[?Q!X
MBU#Q9KFA69TI&TE8&,LT,F)O,3=C ?Y<=,_-]*T?!'BS_A+]$EO'M#:7-M<O
M:W$.[<%D7!.T]QAA7"WVC:EK7C[X@PZ/JMQ87RP61B,3X60^3]UL<X.,9'(S
MGGI5JVUJTF^#.L)X>M/[,U"RMW2ZLH.)()>CGDYY )#=>/44 >GPWEM<2R1P
MW$,DD1Q(J.&*'T('3H:2*^M)KA[>*ZADG3.^-9 67!P<CJ*\WLH?#$UYHWB&
MUU[<T=M*(K6QCBB9XMA+JZQ\_*!Z\'WK#LY;:%_ %S:-8VUK->,T*[@UUY>U
MMQEER,YS\P"X!QDF@#V-[^SCN?LSW<"S\?NC( W/3CKSD4LEY:PSI!+<PI-)
M]R-G 9OH.IKRJ_AFT+54OI4L];\/SZVKBY7Y;RTN?.QMS_&JL-N.N..!5C0X
MK36/"GC0:] AU*.ZNA=-.!O10N8B">0H&-O;@_B >GRW$$+*LLT<;,"5#L 2
M ,DCZ#K2P7$-U$);>:.6,]'C8,#^(KQ[3M,-_KOPX?7+8375QI]S]H\\#=*%
MC!0..K<$?>_QKI?AS%'::_XTLK=%BMH=5S'"@PB97G Z#I0!W-W?6FGPB:]N
MH+:(L$#S2! 6/09/<TR;4["VD6.>^MHG8 A7E520>AP37GFN7,,GQ0N].U/5
MQIJSZ;$+&26*)T8%G$B@R @$DCZ[1GH!5;4_#5G:?#BTO]!N3J4WAZY-[:74
M^"9$C<LZ*RCE,;@ .#B@#U$75NURUL)XC<*-QB#C<!ZXZXY%16>IZ?J)D%C?
M6UR8CMD$$JOL/H<'BO.M?OCJ7P]U[Q=9I/&U['%'"Z+^]6S210P /3.96]P1
M4F@Z7X<U#7=,U&'Q,^KRSVKQ+:K% B/#M.1+'&B_*#@ -T; H []-6TZ26"*
M/4+5Y)\F%%F4F3&<[1GG&#G'H:HV_BK2;KQ)-H<%W#)=0PK(^V12 22-G7[W
M&<>A%>2:9I]A#\$M U5;>%+]+^(BZV@2+_I1'#=0,=NE==HZV%M\:?$8D6VB
M8VEKY08*I+$8^7W)/;UH ]"N+JWM%1KF>*%7<1J9'"AF/0#/4GTJN^L:9'8_
M;GU&T6TR5\\SJ(\CJ-V<=C7$?%FTMKF#PKY\*.6\06L18CYMC!MRYZ@' _(5
MGZS!IVA_$2PT^>Z70])ELI#8R01Q"/SVDS(#YB,JD@CD8].] 'IGVZT\N&3[
M5!LG($3>8,2$] I[_A4)UK2A;SW!U.R\BW;;-)YZ[8CTPQS@'ZUYA>Z-X>M]
M)T>WT^YDU"T7Q-%'Y]R491O&9$C*A0$)Z@<9S6E8:/I;?&/6+ V%K]C_ +*A
MD^S>4OE[]VW=LZ9P<9QT- 'HDE[:16?VR2ZA2UVA_/:0!-IZ'=TQ52YODO\
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M>G6OF7.H6EF9 1%)<. I;'7&1D#J<$<=Q6'X!UJ]US1;V>^NTNWAU">W2:-
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MS\P /(&>1COGC%4#<VNK?%2RU[2[J%],L=*D6_O8V'ED$DK&S=,C[V.HQS0
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MO!1@I83 ?WA&''MCU- 'H%A?6VIV,-[:2&2WF7?&^TKN7L<$ XK#TW5I-?\
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M^#^M3:LA@N[N"\O9XV7!C,@8@$=CC'':NA^'UG-8?#[0K>X+&46B,0W5=WS
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MA3+K6]*L;I+6ZU&U@G<@".24*<GIU]>WK5^@"CJ.C:7JXC&I:;9WOE$F/[3
MLFPGKC<#CI2W>CZ9J%G'9WNG6ES:QXV0S0*Z+C@84C Q7,Z?K^H>+=?U.VTF
MY^Q:1ILGV>2Z6)7EGGS\P3=E0H'<@DY%:FF2:];^(+RTU26WN-.$"RVMS'$8
MV!R0RR<D9Y'(P,#I0!?FT'1[BW@MYM*L9(;?'DQO;H5CQTV@C _"E_L32?M;
MW?\ 9EE]I==K3>0N]AZ$XSBFVFO:1?W7V6TU.TGGV[A'',I9E]0,\CW%03^+
M/#MLCO-KFGHB2>4S-<I@/C.WKUY% $\F@:-+9M9R:38O:LP<PM;H4+#H=N,9
M]Z=_8>DB2:3^R[+?,JK*WV=,R!1A0QQR .!GI34U_1Y-5&EQZI9M?E=PMUF4
MN1C/3/IS]*@NO%GAZR61KG6]/B$;^6Y:X7Y6_NGGK[4 63HFDE8U.F61$7^K
M'V=/DYSQQQS2OHNE2-*SZ;9L9O\ 6$P*=_.>>.>0#S1<ZSIMG#!+<7]O''.,
MPL9!^\&,Y7UXYXJ-_$&C16=O>/JMDMM<D+!*9UVRDG&%.>3GTH GLM,T_359
M;"QMK4.<L((E3/UP*=>Z=8ZE$L5_9V]U&K!U2>)7 8=" 1U]ZI)XHT&2.[DC
MUBR=+/FX*3*WE#.,M@\#WJ1?$.COIL.HIJ-NUE-((HYP^4=B<  ]SGCZT 2/
MHNE2!@^F6;!V#,&@4[B.A/'6D;0M(?9NTJQ;RQM3-NAVCK@<<5E02:Z/'MS$
MU[#/HAMMRP"##6\GRXR_?=\QQGIV'>^GB719-02Q74K<W+N8TCW??<9W*IZ$
MC!R!T[T 7+33;&P+_8[*WMM^-WDQ*F['3.!SU--ATO3[=Y7AL+6-I01(4A4%
MP>H.!S3[V_M--M7NKZZAMK=/O2S.$4?B:HVOB?0KUIUMM6LY?L\2S2E900B,
M,AB>F"* )?[ T81F,:38!"0Q7[,F"1G!QCW/YTX:%I ='_LJQW1XV'[.F5QT
MQQQ26.N:9J3W$=I>1O);X,T9RK1@C()!P0".0>AJ.S\1:/J%[]CM=0@EN"F]
M$!QYB_WDS]\<=5R* +?]G6/VS[9]CM_M7_/;REW_ /?6,T3:=97%PEQ-:6\L
MR#"R/$K,H]B1D52_X2?1/[233_[3M_M3N8T3=PSCJ@;H6'=<Y]JHV6JVL>LZ
MY=3>*+6>RM_*5K;Y%2Q.,'=)GDL0>#TH U9-$TF58UDTNR=8UVH&MT(4=<#C
M@5-/IUC<RQ2SV=O+)%_JWDB5BGT)'%9T/B[P[<WMM9PZS9O<72!X(Q*,R ],
M?7L.I[5#I'C'2]:UW4-*M)29;-E0EACS&().T>@ '/?- &Q=6%G?!!=VD%P$
M.5\Z,/M/MD<4^&V@M@X@ACB#L7;8H7<QZDXZGWHN;F"SMI+BZFCA@C&YY)&"
MJH]23TJE9:_I6HRS0VM[&\T"[Y8CE75?[Q4X./?&* +-UIUE?%3=V=O<%?NF
M6)7Q],BLGQ%I^OW\EG#HVI6UC9G>EZ7BWR%" !Y?8$<]?;KC!Y^RUFX\7ZEK
M$.F>(6L9K&_6.T$4:R(\:(I?>I&6#,S#J,8&.G/;7NH6NFVXFO)UB1F"+GDN
MQZ*H'))]!S0 ^TM8;&R@M+= D$$:QQJ/X5 P!^0HN+2WNT5+F"*958,JR(&
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M.UQ;J'>.6)XR4/1U# ;E]QQR/6N1\9^)8KF;P\=*U"^B636;>$M'&Z0W*>8
MP#[<-R!WP1GK0!Z/1373S(V0E@&!&5."/H>U>:^#[R*]N/$D.L>(+Q6L=8N+
M: 2:@T9$*XV]QGOS0!Z92 !0   !V%<E9^(M.\.^'[&YU/5I[BUU"8&RN94=
MF:.0AD#MC (#=\<#V-2K\0="8WD8-[]HML'[,;2033*<X:-",N#@\CTR>.:
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MZ?-<:G+,]HXB7[3&S QO&3&6/"J %/88KUS3$V:59IMG7; @Q<',@^4??/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MQ?X<734U$ZU8BS>0Q+-YPVEQ_#]:Y'Q9:Z?;_$GX?6OE0+#$+N,1L!@*(E"
MY]QQ[U1M+72HG^)I4VDAR[!SM)&Z#<1GV8D?44 >F7NI66G6HN;RZBAA) #N
MV Q/8>OX57/B'1ELK:\.J68M[E@L$GG+B4D@ +ZG)'%>0Z9J\>FCP1J&KWEW
M;Z0^C-:K>Q'*PW!8'#-@XRJ ?_6!J7Q1:>'$\,63Z2QGL;KQ) [3SL&2<D?O
M"F0!M[' QD&@#U9/$VB2P7T\6J6LL=CD7)CD#F+Z@<_XU!X5\3V?BK1TO[0@
M;B=T?=!N(7/N0,USLS6,/Q0O(;<V\<DOAX*J1E07(E;@ =2 !^%6/A/>6UQ\
M.])MX;B.2:WBVS(C F-MS<-Z'V/- %CQIXKAT233=/2\%O/>W<<,L@7+10D,
M6<9&,_+@<'KTJ;3]2M_#MB3K/B:.\@N':>SEN$"2"' .&(^\!G[V!UK/^(%Y
M:P:KX0CEN88W&MQ/M=P#MV.,X],D#/O5?3[R/3OBUXB75I8XEO;*W>PEF<*K
M1("'52>/O$DCVS0!V,NMZ5!':R2ZC:JEVZI;MYJXF9B  O/S<D=*?IFK:?K-
MI]JTV\ANH-Q3S(FW+N'49KQU+6TM/!,,5]+!_9=WXN66QCF<!?LGG < ]%(#
MMQQAL]Z]GM+:TM8=MG!#%$YWXA0*K$]^/7UH Y>Z\07NJ^-IO#&D2K;)90K/
MJ%YL#NI;&V- >,D$$D@C':M)+;6[/7;(?VC+>Z9(DBSB:*,2(^,J=R*HV\$=
M,YQSSQR$,W_"#_%/59M19H=%U]4ECNW_ -7'.O&QV/W<Y;&3CD?A)KEQIFI?
M%?PH+1X;U?+N6N1;.'P0H\MI-IZ @XS0!VMUXBT>RNS:W6HV\,RLJLKOC:6^
MZ">@)[ U-J.KV&DPK+>W*Q*^=@P69\#)PHR3QSP*\PTB_M8OA[XJT'79E&L1
MRW:SPR$>9,\F3&R#JV<C:0.PQVJ?P]->>&_%F@IXCE,4=QX>BMHYIVVI',IW
M,A)X#8 ^N* /2(-7TZYTO^TX;V!['87-PKC8%'4D]JXRS\2R:C\7(;&RU2>;
M3&TMY6MF38J2AP,X*ACQSDYZ\<5R%_'/::?K&L012R^'_P#A*8;IHT4E7A7_
M %DBX^\A?:?3Y:WX?$&CZG\;=.NK"_AN('T4Q"6,Y4N9<A<^N/RZ&@#N_$TU
MS:^&=2N[.Y:WN+:VDFC=55N54D A@1CBO/M2\4>(M'^&6E^,%UE;BYE6)YK.
MY@B$<N_C:FU58$9SU/ -=SXSNH+7P7K3W$T<2M93(I=@,L8VP!ZGVKRNQT[^
MS?!_AGQGHP34/[.MD75+-G\\>5P79%8G8Z]>,8^@((![)/JMM9Z?%>7K_9UD
M"X0@LQ8C.T*!ECUX SQ5>/Q+HLND'58]2MVL5?RS*&X#YQM(Z[LD#'7FO.O%
M?B32KK6O#7BC[5<S>&_*F@GN+&>1&MI'"D;_ "V#*> "/;ITJOJM]X8L-%BU
M#1;-Y-/N]:MVDU.]:>6-)1NW3X<Y)7ID\$GOMH ]/L_$6D7]E<WEO?1&"U)%
MPSY0PX&3O#8*\>HIMAXDT?4Y9HK2^1Y($\R564H43LQW <'L>AKR>'4]"E\3
M>/$U2_N[K3KJTM-TH7;)(@ 4NH  P"PY QC&,YY=K)UFYTKQ#H=EJ$/B&,:0
M);?480K3K'YJYAD9>&)4.1W//K0!ZM8^)=&U*^^Q6FH127!3S%3D>8O]Y,CY
MQ[KD52N/'GA6UA\Z;7;,1><;?>K[@7 !(R/3(R>@S7+:I>67B:?P1)HEU')=
MP723N8L%K> )^]#\_)TVD'J>.U8-C=Z6_A_XHDW5E^]N[@J6=3O&T[<8/.6S
MCWH ]H5@RAE(((R".]9,7B?1IOMHCOE9K$9NE"-NA'^T,9'^'/2CPM<177A3
M2989DF4V<0WHP89"#/(]ZY'Q/9ZAHWC^TU'2(F8Z_;MIT^ "L<JC<DI'?"AR
M?9?>@#K5\4:,^EVVII>;[*Z8)#,D;L&8\ <#CGCGOQUK$MO$>FZ/I7B#6G\0
MRZQ9Q73OMB3S!;' (B4KG(Z<YP/;FL?P=IE[IWB>Z\+2+(=(T*8WEI(_5EE4
M^6F?X@I,O/J!Z50BN8+OP]\4(;61)9'GN)$6,@E@80,@#J,@\T ;>I>)FGE\
M(ZO%J4UI8W5QLNH77RHB/(=R264,1G'.<' Q6\OBC0=;T34Y;+7(XH;>-HY[
ME3L:W)'#?,./4'&"17'W&NZ/J-IX!E2ZA>&&\C$GF# 4BW89Y]&(&>@/'45*
M]]9?\)MXY*W, \S281D.,,51PW/<C*Y^HH Z/3O$NB:/X;T<W_B2.Z6Y0)!>
M7!VM<G."V.O?J?Q-:FC>)-'\0>?_ &5?1W)MV"RA005R,C@@'!['H:\C^TVJ
M^ OAJLTT0$.JPM,K,/D52VXL.P&1G/3(KM]*OK-_B[K:07%N3+I]NAVL,O(C
M/D>Y"D9]* .PU#4K32K7[1>2^7&6"#"%F9CP %4$D^P%<SXB\1:'J'A:XG'B
M2?28$N5A>[A1DECD4@E-K+NY'7CO4OCV+2)])L8=7N[BQ22]06]]!)L-K,$<
MJY;L.".>/F[=1Y_XDU&\F^%WBN&]NK6_D^WP1VNHV\:H-0 :)LX7AF55P2./
ME]J /5&\2Z1'KL.AO=L-2E7='"87RZXSD';@C ZYK%U_XB:3I7AVZU*U:6=H
MG,";K:58Q*#MPS;> ">>_! YK*\:I9>+4L],TK4K6'5K>!KZ&^6?'V=0N,!E
M/\>1GL%!/IG \0Z_!XF^!-XMK;)#=6?D17-G",B$I(N2!SE"!D-R,9YR#0!Z
M7!XLT:YU:'2H[F07\T?FQP26TJ,4_O?,HP.*T+34;:]FN8H&=GMG$<H:-EVM
M@''(&>"#QZUQGC61;C1=.\:Z&GVB[TJ7S83M93/ QV2)@CD$<@X[9'7GJM T
M\Z;HT,,@_P!(D+3W!/4RN2S_ /CQ('L!0!2\1:Q/:WVE:/8L%OM3F90YP?*B
M0;I' /4@8 SD9/-8GBCQ4FD:C9>&K;4X[)S#YUYJ%U*"UO #C*[OO2,>!G..
MN#4FLQ26WQ;\.7TA)MKBRN+1=QPJ2#Y_S8<8_P!FJ\@C\._%;4-3U3;#I^JV
M,<<-W(,1I)'UC9N@)'(SC.,<T 3ZSK2:)X9TZ+1=4DO;C5[R*TMKR:7[007(
M#2#L< $X& #VQ4R74VD^-H?#4MY=36.IV+SP2RS%I8YD(#!7SG:5YQV(XXX'
M#67AB\M?#MUKB64_V6U\2#5K"T$9+FTW@$JGJ4Y //R^]=A$@\1_%*SU>R?S
MM,TBQ>,SJ/D:>0D%5;^(A<9QP,CO0!M^'=;FO+_5=%O]IU#2I55Y%! FB==T
M<GL2,@@<9![5D_$&\DTJ?PWJ U.>T@.KPP7"B;9$T1#,V_U^Z/UIFA0O+\7?
M%5VBDPQ6MK SX.-^W=M!Z$@$$_45)\2"8;3P]>-#+);VFMV\]PT<9?RXP'R[
M8' &1S0!H6?CWP[J%OJ$UK>R2?V>N^YC%O()%3^\$*[B/<"K3^+='2#2)VGE
M$.KLB6<GD/MD9QE03CY21SSBN5O+(^)_%U]J^D!Y+2+0Y;,3*NU+F63)558X
MW #J>@.!USCD[?6!-X5\#6"V.IR7&CZM;B^ LY#Y10."O3+''90<8YQQD ]6
MNO%FD6=RT,LTQVW"VK2I;R/&LK8 0N 5!RP'7@G%9MCJ6CVWB7Q)=C6]0GDM
MXHFN[24.8K0 '!C7;W R<9]>]<?JDT=OJUW>^%Y+Z/5Y-0"W&ASQ,\%Y^] ,
MH5A\O&&W@\8QQ6A;W4$/C[QU.WF+%<V4"QR&)RKLD95@#CD@D# _QH Z2S^(
MGAB_N+&&VU!W-\P2!_L\@1G/12Q7 ;V)S5S4_%VDZ3)<K<R3%+0H+J6.%G2W
MW8QO8#CJ.F< Y.!7ET\@7X5>";80S^?;:G \\0@<M&$9BY88R,;A]<\5<0VN
MDZUK^E^)-!U34+?4KV2^LYK*.219XY,8C(4CD8Q@_I0!Z1>>*M+LY7C+S3F.
MV%U)]F@>4)$<X<E0>#@X'7@G&!39_%FF0F-4^T7#O;+>,D$)=HX6Z.P'0>W7
M@\5Q&O6=O'>236/V[P_K]E81^0UI"SVUP N?)*A2K;2=N.O((ST#-8BBNVM;
MJZ75- \20Z3 ZW5C"YAD?:6,#*JE3M88VGDA@.>E 'IUA>V^I:?;7]J^^VN8
MEFB8@C<K#(.#R.#7)>._$=I%X9\06EM-??:[2V;?-9*X^SR%-R;G7I_#G'0'
MG K?\,27LOA;2WU&U2UO#;(98$38(SC[NW^''IVKS>XU&[T71_&_AF]TG4)+
MJ\>]GLY[>U9XYTE0D$N.,KT/L .HQ0!UGASQ';6/A'PQ:W!N;G4+O2XY4AAC
M,DCA8UW,3T'4<DC/;)J\WCOP^NG6%_\ :9FMK^?[/!(MO(<RY*[#Q\IR#UQT
MKA;+4[JT@\)6-]I6K06(TA8))+:S=;AIUVKY18 .B< \$9..<9J7PCH'_"1?
M#C6O#=[8WEE(+R=HGN8BFQRY9"&_B((Y//UH ]'N-=T^UOKBSGE=)+>V^US,
M8VV1Q<_,6Q@?=/'7@U!IWB>PU.]AM(EN8Y)[<W4'G0E!+$-OS*?^!+QUYY%<
M_H/VVX^'U_K>MV*W>H:A9-)-:Q@GS8UB*I&,9^\ 6X[R'%9O@ZWET[Q5;VNB
M2ZI<Z"UJYFBU.%U;3W! 5$9P#SC!0>@/H: .^U35K/1K5;B]D*(\J0QA5+,\
MCG"J .22:J:=XEL=3>_AA2Y6ZL&5;FVDB*R1EN5X[@CD$$BLKX@WUS8:)9S0
M6D\\?VZ+[0]O;B:6"+))=%(.&&  <<9]<5SGA:<67C'Q1/\ V7K,=I?6MM+!
M+/;RR.RHCAF8G+9)/"_>YZ#!P 92^(67P%;>-[M=4_M.&>5O.A;$+[IGC5)%
MSS&OR_*,'/0\DUZ?<^(+6V:"(PW<EU.CO';QP$R%4(#,1T Y'4C.1C)KRQ-+
MU*;]G"?1ETV^748.7MI+9T<@7/F9 8#=\O/&:T==N!%XIL/%]UX>N]3T*\T\
M6;QFSW36[*Y97*'D*<GKZ_0$ ZZ7XB^&8=/L+Y[V007LWD1,+=^) <%7X^4C
MT.#@<9K8T/7+/Q#IYO;'SO*$C1$30M&P93@C# &O.-?A633?#5QI_AJYL[4Z
M_#?FVMM-<R+"H :254!VL3SCJ1CWQZPI#*&&<$9Y&* ./M?%$VK^-M8\-M97
M4-M:VL8,H^5]S;B6W!LJ"-N,<Y]*YGX:^.=/LO FBV^J3WKSRW#P/=/$[QK(
M\KE%:0\9(QZXXSBM2VDGTGXM^(9Y]/OG@O;*W:&:&W:1,(IW$D>A&,=2<8!R
M*Y;3H+ZV^"VD:7)I.JB_M]11I;<:?-O51<&0G&WD;><CZ=: /4-3\5Z?I4EV
MDD=U,+*,27;V\)=8%(R"WX9.!D@<XZ5K6=W!?V4%Y:RK+;SQK)&Z]&4C(/Y5
MY3(\>B^+]9.L^$;S5['6)5N;&X@L?-;E #&ZM@J>.AQCG(QT]/TB'[/I%I%]
MCBL]L0_T:( +%_LC'''3B@"[1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 57O+&TU&W^SWMK#<PDAO+F0.N1T.#5BD9E12S,%
M4#)). !0!5&F6 TT:<+*W^PA=@M_+'EA?3;TQ3$T72X[".P33;1;.,AD@$*[
M%/J%QBHX_$6AS6L]U%K.GO;VY FF6Z0I$2<#<<X&3ZTG_"1Z'Y$$_P#;6G>5
M<,4AD^U)MD8'!"G/)SV% #[?0M(M;,V=OI=G';$[C"L"A"?7&,5S_B;PG=ZA
M=:=)IL6D/9VH=9-.O[;,+[\98;>C8!'0]3^._=:_HUD)C=:M8P>2ZI+YEPB[
M&;. V3P3@X!]#Z53UF:22ZT5[3Q!;6$<ERK&)E1_MR8^XA)[@]1GKF@"AH'@
MNSL9Y[J\TO1H7E41BVL;;$04'.6R/G;/? P.!W)WO[&TO*?\2VS_ '?"?N%^
M7G/'''))J*;Q%HEO+)%-J]BDD<BQ.C7"@J[$A5(SP3@\>QI?^$@T?^TAIW]J
M6GVQF*"'SEW%AC*XS]X9''7F@"]/;P74)BN(8YHCU210P/X&JIT72F14;3+,
MHF=JF!<#/7'%9%GXXT34?$M_H5O?VWGVD:DN9E&]_GW*H/WB@7)QTS[5/X:N
M##X:%Q?^(;75EC,C2:BFQ(]H8YR0=HV],^U &E_9.G>9))_9]KOER)&\E<OG
MKDXYS3[33K&PW_8[.WM]_P![R8PF[ZX'N:ALM;TK4H9IK+4;6XC@_P!<T<JD
M1_[W/'0]:A3Q-H,DUI%'K-@\EYD6RK<*3+@D?+SSR"..XH TY(TEC:.1%=&&
M&5AD$>XJL-*TY;7[*+"U%ONW^5Y*[-WKC&,U;K..OZ.NI#3CJ=H+QFV"$S+N
M+<?+C^]R..O- #_[%TKY?^)99?)]W]POR\YXX]:H:YH$5UHVH0:;86"7MW!)
M#YKJ(\;U*EBRJ2>N<=_6L77_ !=9_P#"6VWAQ-?MM.4V\LES.LL8=)!M5(_G
MR 3N+8ZG:.V:WH;I_#GAG[3XDU>&8VRDSWIB$2L"V%^49YY XZGZT 0>$/#_
M /8'A^RL[FVLUO;>%8'GMQDR!0!DDJ#SCIS]:UH=-L;:=IX+*WBF;.9$B56.
M>O(%>?:WXWGU'0O#6LZ#J:0PWFJVUK=P)L=@'.2C'JK8 R!ZUWFFZYI6L-.N
MFZC;79MVV2B&0/L/OC\: +$-C:6\TDT%K!%+)]]TC"LWU(ZUB:5H^L#6);_7
M=1M[L0O(+&."'RQ$C'JW/+8 'MD]<U?L_$6C:C>FRL]4M)[D*7\J.4,2H."1
MZ@$$9%-\2:];>&?#M[K%TI:*VCW; <%V)PJCZD@4 7)].L;F=9Y[.WEF7 62
M2)688Z8)%1_V/I?[S_B6V?[S[_[A?FYSSQSR :P=,M?$NIZ1!J5QKALKNXC6
M9+..UC:"+(R$;<-[<'!(9?;%7=)U>2U\,6EUXCG2UO,F&<R@1AI0Q7"CN"1Q
MCJ,$4 :G]FV M?LOV*V^S$Y\GREV9]<8Q3I=/LIX$@FM+>2%/N1O&"J_0$8%
M55\0Z,^EMJ8U6S^PJ2K7!F4(#Z$YX/MUJ&/Q7X?ENC;)K5@9Q#YY3[0N1'MW
M;CSTV\_3F@#32UMXV#)!&I  !5 , =*6&"&W5EABCC#,68(H&6/4G'>LVW\3
MZ#=:=+J,&LV#V43;9)Q<+L0^A.>#1:^*-!OK]+"UU>RFNWC$BPI,I9E(R"!]
M#F@#3>&*0Y>-&/J5!IDUK;W*HL\$4JH0RAT#;2.XST-9[^)]#COS8OJELMP)
M/)*L^ )/[F[IN_V<YI+KQ5X?LGN4N=:L(FMB!.K3J#&3G //!X/'7B@#4:&-
M\;XT;'3*@XIX    P!VK(E\4Z%"MDSZK;8OAFU(?/G#_ &<=?PJQ-J-O)=7&
MF07:)J*PF0(5R4!X#D=QF@"ZZ)(A1U5E/56&0:CM[2VLTV6UO% G]V) H_2L
M#P_J5Y8^%GO?$NI(XBD?%[+ +?S(\X5BG\.3P!U(V]SBM;3=:T[5S.MC=I,\
M!"S1\J\1/0,IP5/U% %MH(6F69HHS*H(5RHW >QI9(HYDV2QJZY!PPR,BJ>H
M:SI^E,B7ERL;R*S*@!9BJXW-@ G R,GH.]8MYJVG7^M^'Y;7Q2D"R%Y([*(J
MWVY6! /KM!!(/0T =1M 7;@8QC%(L<:8VHJX&.!CBLQ/$FCR"^*7\3_8 3=A
M<DP@?WACCH?RK)O?'^CVVIZ)9I*SKJ>]UE:)U58@C,&Y'.2% 'H<T =2R*Z[
M74,/0C-"QHBE5154]0!@5EV'B;2-3NKRVLKLS3V6?M*+$^8B.QXZ]<#O@XZ5
M;TS4[/6-/BO[";SK649CDVE0P]1D XH L"&((4$:!3U7:,&E,:%-A12G]W'%
M8+ZK-J7BN31;*810V$4<]]*O+$N3LB'ID*23UQ@#KD8TWBV/6/$EWI5OK-OI
M5A93"WENF=!+<W'\44>_@ =S@G/3'6@#MS'&2247)&#Q0D:1YV(JYZ[1BN2U
M#5+NX\9V/A&RNY8%2Q-]=W0P960-L502" 2QR3CITQ5?2-9U?4M.UFQCN"^M
M:%=M%N9%"7:@93<!TW+P<8P>?:@#M5C1"2B*I/7 QFF_9X "!#'@]?E'-4=
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M23^XR$;@>1P163J7BKP[K4FF"V\2W5JT6J)$JVJ./M,@_P"63#;RAW YZ=Z
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M 0* Q8 9/4XZTM%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%("& (((/((I: "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JM?K>-8
MRKI[PI=,,1O,"50^I ZXZXXSTR.M6:J:EJ=EH^GRW^H7"6]K%C?*_1<D ?J1
M0!S7AZ;Q':^+K[2=3U2/5[)+19_M(MTA:"4M@1$+URN6YY&!ZUH>-]8O] \&
MZEJFEVWVB\MXPR(5+ 98 L0.H4$M^%<UI.G:7)\2;;5_"<L3:?+9RC4VM6S
M[Y'E\@X+]3@= ,]ZN>*O%<MWX'UR[\,-++<V4YM)W6([H=K 2,JD?-A23G\>
MU $/AG7;R]\36<.GZW+KND7-BUQ<SS11K]FDR-H#(J@%N?D/(QG-=_7E?A>P
ML]%^(UO#X0O?M.@WUFTM];QOOBMW4 (^>@9CQCKU[8QZ%HNNV'B"TEN=.E>2
M**9X'+QLA#KU&& - &E1110 5SWB#5-1T_6M#AM;&^N+.YF9+F2TB5_+^Z%\
MPG[J<L21@_*.?7H:* . U/Q%KB>%O%EV8M0TV[TUG:WEF@C\MU&=OEY4[EP
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MXLH',<TCMM\MA_"P/(/MBF6GC/PY?ZG%IUMK%M)=S('CB#'+@C. >F<'IUH
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MO[3[>";*>XB"QW&!G"D$D''.&"GFN-^*OB>.[\#:D-,CU39#.L0U"W)2#>'
M=2P8%A@LN<%<\9S0!ZM10.@KG;KQE8VTTX6TO9X+>[2SFN845HTE8J-I^;/!
M8 G&!0!T5%<;H?C:35?%6NZ=/IUS:6FFK&#),$&P[79F<AN 0%QUZ<XJX/'&
MFB73S/;WMM::BP2TO9X@L,K'.T9SE<@9&X#(Z4 ;]Y:)>VS6\CS(C8W&&1HV
M(SG&Y2"/P-2111P0I##&L<2*%1$& H'0 =A7/ZMXST_21>NUO>74%@5%[-;1
MJZ6Y.#\V6!) ()"@D \USS7T5M\:'N#=N+%_#?VMM\Q\L?O@-P!.%^51Z4 >
MB452TO41JMA'>+:7-LDHW*ER@1\>I7)(_&JU]XBL]/\ $.F:+.DPN=2$AMV"
M@H=B[F!.<C QV[T :U%<I>>/M-T_3]7N[NSU"+^RIEAN8O)5F!8;E(VL5P01
MR2.HSBI+'QSIU[K5MIC6>HVK7<9>UGNK?RXKC !*H2<DX.>F#V)H Z>BN M_
M$&G:7H_B[6M&L-3GGM;AWNH;IMF) FXE5<Y5!G)P,^@Z5KV7BX_V=H:W>GW1
MU/4X=T=LGE!GVQAG<9DP%YZ$Y]J .HHK.T36(M<TX7L5O<6X\V2)HKE KJR,
M58$ GN#5Z:40022E'<(I;:B[F.!T [F@!]86G>&4T_Q-J>N"_N99M0$:RQ.$
MV ("% PN>Y[USZ_%G1FL_MHTO6_L23&&XN?L8\NW(;;\YW<=<\9/J >*W+_Q
MC86AN!:V]SJ1MK=;F867EML1@2OWF7)(&0!DXQZB@"QK7AY=:O\ 3+J2^N8!
MI\WVB..)4PTF" 6+*3C!88&.OM6S7(3?$?1H_P"RC#!?W0U6W>>T-M!O\S:,
MLF,YWCICL>I%9&JZ]+K?B?PW:MHE_+IEW:3W+6<PB4S'8H&Y6<?=#G(;'/(S
M@&@#T:BN,M=8T_POIE[9Z5I^I7^G:2["ZF202>43\[*N]LMM!&0.@]3D5)J7
MQ$TNP?21!9W]^-6B>6S:TB#"0*NXJ,D'=T&,<9YZ4 =?17%Q_$:"74(=.'AW
M7!?S6?VQ+9H$5RN[;CEQCG/7 X]2!5;_ (6I8?V.-5&B:Q]CCD\J\F:%56U;
M=M(;+?,0<?=SUYP>* .]HKGM2\60V>JMIEI9SWUXEF;YUB9558@<=6(RQ/0?
MGBLZ;XD:8FF:%J$-CJ$\&LR"* I&I*MD@JPS][(/ S]: .RHKE;#QU93C6AJ
M-E=Z4^D(LMPET%)\ME)5AM)!S@\#O4MMXPBDUBQT^[TZZLSJ%NUQ:RR;2I4#
M<0^#\C8YP>/>@#I:*XW_ (61I"RV#R(RV5_.+>"X$J,=QSM+(#N56QP3ZC(%
M==<3QVUM+<2MMCB0NY] !DT 245RFG^-'U2/3I;31KEX-2C>2UE\U"ORJ6VR
M$$[&/ QSW],5G^&?'-S=>"_[=UFU*F6Y>*!(&#-*QF9$B4<<]%R>O4T =W17
M/P>*HE\0#0]2M)+"\>W-S"SNK1RH/O88?Q#J1Z<U27QU&T.EWJZ5>-IFIW(M
MK>Y4 MECA79.H0X/.<XP<<T =8&4L5# L.HSR*6O-_#]Q;>&]>\:)9V?F$ZC
M L%I$<-([1*2%_$DGL.<X%>B0-*\"--&(I",L@;=M]LX% $E%8T&NM/XAU#1
M?L96XM($N%<R#9*KE@.V0<J<\?G7/)\3;1_#^DZPND7S0:C>_8E"E6,;[BO(
M!R2=I( ';J* .Z)P,FJTUO::C%$TL<5Q$KB1,X9=PZ'T..U<Y:^+4U*?6=)O
M=$NX;RRMQ+)9EXW,T3CL0VW/8@G\:YY/$[Z/X%\+2^&M$\BPO[R*WCA>?+1J
MTA..^2P#<YXW4 >FT5R]WXO>*_O;"UTX75[86R7%U;K<!9!N!(6,8^=@!D]!
MR.2>*Z.VF-Q:PS%"AD17VGJN1G% $M%4=8U:TT+2+K5+YREM;1F1R!D_0#N2
M>!]:R&\6-9ZMIUCJVFR6*ZE\MI+YHD!DP#Y;X^Z_/')!QUH Z6BN#;XD3O#J
M\MKX7U&<:3<-%=CS8P450"Q&"=QZ\#/ ZTC^-[^_\2^&X=*LEDTO5+:6Z5V<
M*\@51\IR,+M+<C)R0/Q .[$B,[(KJ67&Y0>1GIFG5QVDZGH]KKOBN[;2Y--G
MLQ%)?W,T@8S#86#8!( "CMZ]*FG\:&PETJ34]+DM;#59$BM[CS0QC=QE5E7
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M9^(+CX<>*K#.HZI:PW%L=.N)K=DN9XQ(C/P0&;;CACUP>PKV2B@#SRXOGO\
MXB>&]372M66TBM+B-Y9-/DPC/M"$G!QG!]QGG'-,O+&ZO?BOJA6UO$MKK0&L
M4NS:R>4)2V[&_&.G.<X[9S7HU% 'F/@?5]7LM'T[PK>^$]16^L66-[B2(?9E
M0/\ ZP.3R0,X SDCBH8])UB=_'^B"PO5GU6:62VNF0K 4,>%'F' /9<#.,^@
M->J44 >6>%XX;PZ;93?#Z>PU>W $U]<6:K#$4',B/W8D< =SGH*P9[?68?@]
M?^"Y_#>JRZG:N422.W9XIE\[S/,5QP>O3K^N/<:* (K>7S[:.7RY(]Z@[)!A
ME]B.QKS*_LIXM=O-4\.VFL6&L'4 MS9M;R-::@@<+YA8C8H*Y;=D<YZ]:]2H
MH \LET;4;GQ+X_TK[%=Q?VY#$+2[\DF#B%@=S]!SA<=>>E+<V=[XF\!:%X;;
M2K^TU*WEMDF,\#QI (>&<28VL"%(&#D[AZ&O4J* /,M/O=:\'>(/$.FR^&M1
MU6TU&_DOK.XLX@4)EQE')X4#U/H>,8K+\3:'K.L_$&*94O;2Y@T2)$O(+64V
MWVM)O-"$A<,GYC..XQ7L-% &!X1U^ZU[18I=1TN]T[4$4"XAN;=XQN]4+#!!
MZ^H[UA^.8+VU\6>$O$$&G7E_:Z=)<I<1647F2CS8PJD+Z9!R:[NB@#QSQ!%J
M]YH_CQ/^$<U9)=4DMFM@L'F;L1QC;\I/(P<D J"",YK9U?[1=^(_ $\&G:DT
M5F9&N6^PR@0AHP@W97CD'^?0BO2J* /,HK2^N],^(]I'IM\LM\TSVGFVSH)P
M80@VE@,G(_6F7,,&OZ%X=L]7\,:[;Q00%5O4B=;BSE14 8*F6PQSU&?ESC'(
M]0HH \_TK7];\,^'-.&N:??7XEO'@-V$57BAW@1R3+UW,#GU['DX/H%5[FRM
M[MX6N(A)Y+;T5B=H8="5Z$@C()Z'I4DZ/+!)''*T+LI"R( 2A(Z@$$9'N"*
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M96)I8B&P?;J <>OX[NC7OB?7M-_L;4O#TFD(ELT%S=RS*ZN=A4"-1UR<'/0
M$9.:[NB@#S?PD_BBPM[/PW?>%HEDLL0G5F=3"T*GA@,;BQ48 ]>3CD5Z#?-*
MEA<M!$)I1$Q2-NCM@X!^IJ9F5%+.P50,DDX I: /-/#6@75CXIT^]T;2+W0K
M65)#K-C,X-N6V_((^2"=W.5P,#MT.;9>&?$7_" V^E)I3)J&AZK]N@$TBA+P
MK,[A4(.<%6ZG'./?'KM% '!76DWOC+Q%I>IW&F7&E6^GVMS&?M6WS)))DV8
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M5.W81W8'!QCWQ5S0=<31?%-C>ZJ\AT^_T6UM[&ZCC9T1D'[R-B <,6SQ],T
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MZM#%;V<*6SF25DCVL^P#(4GN0,CGI0!W5AXUT34M8BTNVGF,\\9D@=H'6.<
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MG@D"[O-8J% ;=M()8<D@>N*Q-2BUN&QTR2TT!K33I[MGO;+3 B721% %^8$
M,3G<5((' />LJPTF]MH/$^FWG@JYGTV]O(YE@$L9#1D(I"D/DN "V0>HZYH
MZN[\=1Z=:ZI+?Z)J4+:9%'-<(OE,2CE@&4[\,!M.>_M5VY\6V=MK&D:8]K=M
M-JT,DMLZ!"I")O8'YL@XQVQD]:XN/PUKLOA7Q/H]DU\^D36FW38-3($XEQEE
M!Z[.@&['/MR9 NOZMXI\%:N?#-];PZ;%<I<I(T:L"T2ID MC&3QSD@'CCD W
M;+XC:?>W)2/3-46WBFG@NKEX!Y=JT0RWF$$XX!Z9[>M64\<V8U'3+>YL[FW@
MU5MME<N4*R$C*[@&+)N[9'UQ6)X>\+ZJ_ACQEI%_;2:>^KW]Y-;RL\;CRY5
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M,9R<G(&<5ZF0""",@T (&4]&'YT!@>A!^E>*>%KK1M*\?>*M+L+33QJ=W?\
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M\_F =BPR#ZD ^IK=\2ZPN@>&M2U9@#]EMWD52<!F ^4?B<#\: -,,I<H&&X
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MM9XHPIW*ISR2,X/IFF7OCK4(?$5_HEEX9N;R[M$BE 6X1=\3-@M[8XXZG/0
M$T :^A6OA_PSI<VF:=>116EBY\V.2ZW_ &<MS@EC\N22<'U-;4%Q#=0)/;S1
MS0R#<DD;!E8>H(X-<-//8ZGIWCBWET&"SN;>,BX9MCF=C!N1S@=0"/6L7PAX
MSO- \)>%XM0T&:+1[A([5=1$Z-AVX4F,<A2<\D_AVH ]7I&944LS!5 R23@
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MB4\*L0&02  2<8&>,U4N/"U_?^);#5X=&&E:I#?EKC4+>X01SVX)X9 269E
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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ME>I'R]/7'?!KZEI.O3_#WQ1I,:ZGJ-O++%'I7VN(BX9 5+!LX.T8(!;!/Y4
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M?<RKF2U=PYC.3P2 ,^OXT 7Z*** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !115>YOK.S(%U=P0%NGFR!<_G0!8HID4L<\2RQ2+)&PRKH<@CV-/H ****
M"BBB@ HJK9:C9:E'))8W<%RD<AB=H7#!7'53CN*M4 %%%% !15*]U?3--=4O
MM1M+5V&56>=4)'MDU-;7EK>*6M;F&=5QDQ.& R,CI[4 3T444 %%%% !1110
M 4444 %%%4]3U6QT:P>^U*ZCMK5" TLAP!DX'ZT 7**16#J&4@J1D$=Z6@ H
MI&8*I9B H&23VK,7Q+H;VUO<+J]B8+F4PP2"==LCC^%3GDT :E%%% !1110
M4444 %%%% !115#3-:TW6#<_V==QW'V:3RIMF?D?TH OT444 %%%% !1110
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MXEZQJ\UJQL;NUA@CGWIDL@Y)7.0#VX_*N.U;PKXQU30[^RN-#M;C4/[0$_\
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MQ--!X*UO6=%\,6=K+8WTXN;)9=N\H!YC[E3ENO&.@K?@\337,&@3P1VKQ:C
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M'IUVUO<+]M.\A6"DI\F#C/.<>U;$NF:MK^MZ-J>J:8MDFD"2?R%G65IYV7:
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M &]38Y$E17C=71AD,IR#7GTDO_"6_%6^T6]_>:1HEM'(;4_=FG?!#./X@ >
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ME[;I=2#*0-*H=OHN<FK->1Z!>V;:%XKU/Q390365GKT\[N9B[K,A0(L:[1D
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MXXUK6-1\'Z7K36EFFE7%_:SPQ;CYR)O#([-]WYAU7'&X<GFNM36;O_A8%_I
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M>\,Z;JKQ")[NW25D!R%)'('MF@#5HHHH **** "BBB@ HHHH **** "BBB@
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M^TSSA'"K-CR^2/WBI[@\Y..F.^HH \AF\(>*4\$>*]"72K9Y-4U-[F!XKM0
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MK*>TE9E9T&3&P91@X(^;I[54\)^,M>\37F6\/PP6$5W/:W,ZW88Q,@R,# +
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ML+39NSB01H%^4[.^,^U9FK> _%^H:-K>EM)I,WVR\^U+?32/YTJAU*QGY<*
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MGB+SW\S9YF_?]S&?]G/XT 9VNZ_>:;X OO%,&D6:74AW7=M=Y/*R>6N0."P
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ME*[MB84]!@9/<_C6/)\2VGTSP[?:;I(N!J]R;1XGN CP3#@H>,'D=<CCG'-
M'H%%<YX?\17NI:YK&CZE8PVUWIOE,6@F,B2)(I*X)4'(VG/%0:]XL;3/$MGH
M<1LX9KFW:=)KZ0I'(P;:(E('WB?R'8]* -V36--AU2'2Y+^W6_F!,=L9!YC
M#)(7KT!/X5=KRS7K[5KGQM\/+Q],2+5)(KXFSDEPJ.8@,%L=!UX';BNCLO%^
MIW.EZN#HN_5]-O19M;02EXW+%=LF[;D)AMQXR #0!UD]Q#:P//<2I%#&-SR2
M,%51ZDGI6:WBC0DTZWU!M6M%M+EBD$QE 64@XPOKSQQ63IGBK^UM5UO1V^QR
MM96RRBXLY_,1@P8%3Q\K KZGKVKS@?\ )O7AW_K_ (__ $I>@#VZYN8+*VDN
M;J:.&"-=SR2,%51ZDFF6-]:ZG917EE.D]M*,QRH<AATR*==@-9S@@$&-@0?I
M7D?@_P 4ZYX:^&NB:A<:1 ^@Q?NYYS<$3JK2$"0+C&T$XQG)&#Q0![%17"ZE
MX[N';5CH-LEX-,?RBGD2R-<R@ NB% 0NW(&3GGL!R>JT[5DO= M]6EAEM4DM
MQ/)'*I#1<9((QGCGM0!H45QEGXJUR_L-*UBTT03Z=J%P(_(0GSH822!,Q/RX
M. =N. 1S5+Q%X]U'P[%=7UW8VT-K;WOV=+.5S]HN800IG0YP%RPP".W49% '
M8MK6FKK2:.;R+^T7C,HMP<ML'<^E7ZX+4SCXW:*3_P! B;_T*K=KXGU[4=-L
M-:T[28;C3KNZ$:VZL?.$!) F+9P.@.W' /6@#LJH7NMZ;IM[9V=Y=QQ7-X^R
MWC;.9&]!7/6OB75KJ]\5V"I9"XT8QF&0H^R0-'OPPW9'ID'WQVKG-9U:778O
MAKJLT:1RW>H1RLB9VJ2O09H ]3HKA/$GC;4=!CU2ZD@LK>*RD @MKECYU\@"
MEWC(/ &2/NGIR144FI:S/\8+*Q6]A6Q_LAKI8#$V,-* <_-R^%X;H/3KD ]
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M%X8_L*RN+&%S''K)N4&(BQ8$Q<L6&3@<#/MR>[\0:+;^(M OM(N25BNHC&6
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MH$FC2Z#K8E758I9;E+D3RA_ONZ="2,<@<<CIBNSU3PYX=\80VU[<PQW6U?\
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M.:]6HH XQO#FN77CK3->O!IIA@L7M9XXY7RQ<Y)4%>@Z<GGKQTK/T'PIXNT
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MKMMI@6*-U/FJV<DE5&!C.2>PS0!T-Y\0K6U\07>BQZ)K5U=VA0RBVMU<;&.
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MK)(5P"7^;G'?/<^U<=<Z%XKU/2K&;4/#4TVMV.K17%S>O<1EKB-78A8AGY5
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M,^"8Y9M(N)--&I213WB.H6+?*0#M)RV,C.,#GUKK/#=WXWDAMK?6M'BM([%
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ML<8)JWIWC%]5NY%LK"*6VBO6LYBMUF>$ABN]XMORJ2/[V<$>^.,M_"GBT_\
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M:[G3-)U/0[C2=,T]K3^P+2S\F42 ^>T@Z,,<8/4_4T =#1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !374M&RARA((#+C(]QGBG44 8GAWPQ:>&8KN
M.SN+J1+J=KB03NK?O&^\PP!UX_*MNBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#(UCPSIF
MNW%I<7\<[R6<@E@,=S)'L<=& 5@,^]:]%% !5+5=)L-<TZ73]2MEN+27&^)B
M0#@@CI[@5=HH K6%A::78PV5C;QV]M"NV.*,8"C_ #S5FBB@ HHHH **** "
MBBB@ HHHH *9-$L\+Q.6"N"IV.5./8@@CZBGT4 9^D:)IV@VK6NF6_D0,YD*
M>8S#<>I^8GK6A110 5EV_AS1K76Y]:ATZ!-2G&)+G;ESV_#\.M:E% !1110
M4444 17-O#>6LUK<1K+!,C1R1L,AE(P0?8@U7TK1].T.P2QTNSBM;93D1Q+@
M9]3ZGW-7:* "BBB@ HHHH **** "BBB@ I&4,I4YP1@X.*6B@"AINBZ=I!G_
M +/M5M_/D,LH0G#N>K$9ZG'6K]%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !111B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BH+V]MM.LIKR\
MF2&VA4O)(YP%'K4D4J3PI-$P:.10RL.X/(- #Z*** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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? 4444 %%%% !1110 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>davidjkatz_employmentagr005.jpg
<TEXT>
begin 644 davidjkatz_employmentagr005.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3O7G[:CX?T"\\-6-C$VD:>8KF:UU*YC=W5&;E8]_1GZ_,#@8X^;CG(]5TM?
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M<]CS7*:P8[_7O$?B6U$JZ6/#[Z?YIC8"XG9B0%!&6P"HR.,GZUC7%W&_P_\
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M6JVLI CF,J[')Z;3GG\*YWQKX@DA^'NHZUX?U2+S($W1SP[)5/S $<Y'?\*
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M_P )QX7\B>;^W+/9 P23]YR"02..IR 3QV!JS)XJT"*ULKJ35[-8;X@6KF4
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M_A[Q6#I]]8+]E#SQD0W"#A#&^-K?+@8Z\=*YA[".W^'/CJ5+!H6U'4[@V/\
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M&N-$_MJ+48'T[I]H#?+G.,>N<\8ZYJK<ZQ:ZUHFJ#1]4:*YM48.T2@20. 2
MR..,X[B@#<>&*1U9XT9E^Z2H)'TI=B%PY5=PZ''(KS:]U;54\$>!M475[B*6
MYN;".[)*[9EDQO+DC/Y$=Z]+H 0* 20 ">3[UR^J^&KO4?'&D:Z)+86UA%+$
MT+Y+2"08)Z8&/3G-:</B;1I]0BL8[^,W$VX0@@@2[?O;&(P^/8FFWOBK0].:
M87>HQ1K VV:3!*1-_=9@,*>G!.>1ZT :ZJ%4*H 4#  [4CQI(I61%=3V89%9
MP\0Z4=772OM8%\T7G+"48%TQG<O&"/I4,7BO0YM-GU%-0C^RP3_9I7*L"LO
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M'OW?>W?>SWQ^%=%10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5FZSH.GZ_;Q0:E%+)%
M%()45+B2+##D'Y&&<'D9Z5I44 -C011I&I8JH"@LQ8\>I/)/N:=110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 >=>,[>Y3Q2^I:!K-M;:Y;:<O
MGV-[CR;JVWN0.>ARKY/H1R.M5M/OK#5O%W@>X%I;VR-H\SQ6LI&8>(PH4'J<
M X_V<FO1;C3[*\=7N;.WG92"K2Q*Q!'3&1[G\Z>UI;-)YC6\1?CYB@SQTYH
M\8MM6M-.L/$B/%:R/+XP9+9[DD06[[@5E?'11@GMFM/0]5L4\8>-O-UR"]:6
MP@V7#,B"4K$^XJ%P,#VSVR37J#Z;821/$]E;-&XPR-$I##W&.:<;&S+ES:P%
MB@C),8SM'(7Z#TH \LOKVU3X7> )&N8@BWVF[F#CC;C=^6#GTQ7HWB6.[N/"
MNK1:>3]KDLY5@*]=Y0XQ^-7?L-F5"_98,#H/+%3@!0   !P * /(O"TW@K7=
M*\.P27.H3ZO:>2([#[7,7MYEPK$(6PJK@G/3:/PK-3Q#I_\ PIO7]&O[A(]?
MB>X6\MY!B1Y6E9MP'5AC'/;'->UI;01S/,D,:RO]YU4 M]3WZ"L3QAH$^O\
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M'=S6WE.QC#!3C@')&[H.P)[&I=$OM%OO%^L7=AKEU=7 @A$]JSGR(%P<%00
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M&GZAM91*D:J59=_FKD[Q@$ #.2>P)-7_  ]H,VD:WK5S]IOWM;R59$CNIQ(
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MWMF9C*)-VUAQL.!_%@>N!FN:\/V5F_@/1]'\1:'K,0CNKB1;R"WE5[5]Q99
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M/:OXBUSQI'96=S$+NWM#:27,#+%,\+*S#)&.<8&>#]*]?I&954LQ 4#))[4
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M05)_O8YKK:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M*VL6VW<UK+' V<8<H0ISVYQ0!5C\5Z)+J,%BM^OG7#,D!*,$F93A@CD;6(]
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M -*BGB5-QLO.?<AVKD@8 !QD#\: /1#XTT5=+O[]YIE33V*7D7V=S+ 1_>0
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ME87ADC&T-EN,$>GZ8Y +"_$[3+O2]*N;+[.LNHQ/(JWUVMND(0[6WN<\[N
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MR25K99(E#L9543_ZP?*!D#.&!.=OH =O::5!:WEQ>DM->3X5YY,;@@^Z@P
MH]!WR3DG-7JQF7_A%?"Q6VBO=2%E$2JR3JTK@9/+N0,#^0X!Z5Y]J^NW&N^
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M,QMI69608V]E'8?PYH V6=5QN8#/3)Z]Z4$$9!S7EVLPZ.OQL9=4L([BUDT
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M'/IVH T:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M8I8H5!.,#(!X_P :X[4=T_P3UZQAM[@WDVI.ZPBW<.X:Y#@XQS\H)_"O;Z*
M/.];O(KSXC>$9K<RM#';W:O,(7VH9$"IDXP,D&L'PK!;1Z''X7UWPYJ\VKVC
M^6(G,YM9B')63<#L51P23^&3Q7L5% 'E"W=SHMOXZT/4-.O3=ZA+=W5G-#;/
M(EPDB$* P! *XZ'&/PJO&TH\/?#:!K*_66TNHFF0V<N4"H03]WIDBO7Z* /&
M_%$]YJ=AXTLWT[58;D2N+>TL[1EBG0!0)WD &\D#H6Q@ ;3WV%O77XIZ5K!T
M_4OL5UH7V2)_L4F?-\XG:PQ\O SEL#'->F44 >-^';:!-$E\)^(?#VJWFK02
M-&J,]PUK=G>663=G8JYP22.V>3Q75:4Q_P"%NZ^[0SB*2RMXED:!PC.N25#$
M8Z<]>:[JJFJ63ZCI=S9QW<]H\T91;BW;;)&3W4^M '">&M"N]+\7WV@>4K:%
M97']JVC9SL:4$+$1Z*V]AWX4UZ-63X>T/^P=.-N]]=7]P[;YKJZ?=)(V /P
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ML[B[:VU"VN'BMHR\A1) 3A1R:J+J1E^)=I?G3M4CMCH\D!D>PEPKM*CJ"0I
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M>-Y;ZZM].&BSV^K26[W4EE=RB)EC5R@VG'S$E20.!@9)'%=#I6H-JFC6U_\
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MVF+?+IT7]I/$UX<M)Y7W%))(4=,@ @9/)QFN9BT;55^*4OB%K2,:?)IPL?\
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MISWWV*SMA,2MP<*?,#[>$P22<<8QUXILGBS4[.TULW7AN\>ZTUHQ%':AI$O
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M=QW%_,V^7R 1#'Q@+&#R!@9.>223Z 7+RTAO[*>TN8Q)!.ACD4C(*D8-3T4
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** //O&4UU;_$SP7+9VGVN58[W]R)
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MUM!=I#:RVLL$DQB;#LK!E."#C;C!]:T-.\4:%J]V;73M6M+JX ),<,H9ACU
MI\7B/19]6;2HM3M7U!6*M;+("X(Z\?A0!Q^H_#VZO8+C6(I88/$;ZC'J<>&)
MB5HQM6$G&2NW.3@9)Z8XK671]3U#Q):^)-0LXK>XTZUDBMK..XW^:[CYB7P
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M.I:G9Z18O>W\PAMT^](5)"^YP.E0VFO:5?:?-J%M?0R64(+/< _NP ,D[NA
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M]KU+4)%DNK@1[%.U=JJJY.%4<#))]2: -FBBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .<U>Q\-
M#Q)I=WJD_EZJ[E;#?>2(=V!N"*& YX!&.>^<UT=<GXDUI]/\7^&K!]*L[B.]
MG=8[J5LR0L%);:NWCC'.?48K'/C?Q-/<>)(+31-/WZ(09#)=L59=A; ^4$L0
M/0 >M 'HE5K[4+/3+5KJ^NH;:W7[TDSA5'XFH-#U0:WX?L-42(Q"\MTF$;<[
M=R@X]^O6O/K'4-8U+3OB&-2NH)HK5KB!45"-NV' VC)P/7.23WH ]+L[N"_L
MX;RUE66WG021R+T92,@C\*FKS#PMXHU;2=+\%65[I]LFEZE!':PR+*6F#",%
M688P WIDD#KZ5?N_B!?R6MSJ&BZ7+J-M;W1@%O':3M).JMM9ED52@.<\'L.O
M.* /0**JRSW#Z;Y]E;J\[(&CBN&,0R>S'!*_E7G$/Q*\0GPE9^+9] LQHI?;
M<^7<EI@OF%-ZKC& <#DY)]!S0!ZC7*W>C>#/&>HW+36UEJ%[8N(9WC8B2,]E
M9E()[\=.OO67+XR\27/BO4-$TK0K*?[(D,PD>[(W1.>N"H^;!!QVP>3QF2U\
M7II>G^*M0U33+.QDTRY".EL^?M#E%*Y8J,L=RC.* .RL;"TTRRCL[&WCM[:,
M82*-<*.<G]>:L5R-UXFU31-1T>'6[6T$&JR"W1[<M^XN",JC9SN!Z;ACITJI
MHGBGQ1J^N7-H-#L$M;*_-I>2+=DE%V!LKE1N(SSP.H]R #J]2UG3=&B674[Z
MWM(VX5YY @/3N?J*B@\1:-<W<5K#J=J]Q,2(XQ(-SD DX'?@$UROQE_Y)?JG
M^_!_Z-2MI-236=?BTZYTFY@%O"+V.2XPIWAMHV[2?4Y^N.10!JZ9K&GZREP^
MG7<=REO,UO*R=%D7!*_J*O5P5GXSGM_#7B?4YM.MHGTK5)+1EM@Q5@"@,C<9
M.-Y8\#A:G;QI/9Z%?:P\NG:I9_N4T^6Q8QBXE=BIC8%FV$';^!S[  [:BN:.
MI^);'4KB&ZTJ*_M%LFN([BS'EGS1G]SM9B23QAN.O2L;3?'%_)XLT/1;PZ?+
M)J4$C3PVX826,R)O:-SN8,1R.@.1TH Z[3-;TW63<_V==I<_9I/*E*9PK8SC
M/?@]JAU7Q-HVAW$,&IW\=K)/_JA(#ASZ XQGVKGO 7_(=\:?]AEO_0%K:\7>
M'(O%'AZ>P9O+N!B6UG'WH9EY5@>W/Z$T 6]3\0:7H]A'?:C=BWMI,!9'1L<]
M,\<?C5Z"9+B!)HR2C@,N5*G'T/(KS_PE?W_C1+2+5H#&-"E,5^C8(N+U#@?\
M!4 /_O,OH:U=8\57RZQJ&EZ1$//L($>1WL9KE7D<$JF(R-HP!R2>O3B@#KZ*
MXA/%FM2Z=I=Q=V$&AK,DGVR;45)6&13A8U7>A8MR1C/'K66?B/JK^![77(=.
MM'N!J/V&XB+L QW[<IGD9_VNGO0!Z74%Y>6^GV<MW=RB*WB7<[GHHJEH4FMR
M6DQUZWLH;D3L(Q9NS(T?\).[G/7\L\9P.*TF^UF\N?'4-]J%O/%:/)'L%NRL
M!Y/R[3O(5>O!!).3GF@#T#3[^UU33X+^RE$UK<()(I "-RGH<'FK->3^%?$>
MMZ#X>\%)<P:>VCZB8K%!&7,ZLP.UR3A<9'(QQZFM>_\ '6JRV6H7^AV'VN*S
MO6M4MDL9YGN=A <B1/E3OC(;ISUQ0!Z#17!MXK\2WOC.30=.L=/@#:8M\CWH
M??%N( 5U!&3G@@8ZYSQ@[W@[79_$?AFWU&ZBBBN2\D4RPG*;T<H2IR<@XS0!
MMRRI#$TDC!4498GL*IZ1K6G:]8_;=,N1<6V]H_,"D#<IP1R!7'V5QJTOQHO[
M66^A:V@TQ62+R" J-(.!\_WLXRQSG'05Q_ACQ'KGA?P -4MX-/DTR/5GBECE
MWF:17EP2I! 7&<<@^OM0![?17$:IXPU&35=9L-#A2632T5<&REN/.F*EMF4(
M" # R<\D],<]1HM]<:EHUI>7=C+8W,L8,MM+]Z-NX_P]J ,X>-_#A>=3J:)]
MG8+.9(W01$] Y(POXXK=BECGB26&1)(W&Y71@0P]01UKR[1+N6W\1_$*.+2K
MK46ENE40PA=I)C(P22,9S[T[0O\ A*? GA?POHK6]G<7%Y<M Z2RL3$6#N "
M#C"@#.,]P!T- 'H<VM:=;ZU:Z/+<A;^ZC:2&':WSJO4YQCCZU?KAX->\0P>*
M_#6EZW8Z4DU]#<M*]OO9HVC&?D)/ (V^M(?%NLZAX?U7Q#HT=C)864D@BMY8
MW,EPD1^=MX8!"<-@;3T&>M '<U'/.EM \TI8(@RVU2QQ]!R:\^N_'.O7VL:+
M9^'K33'CU?3FO(&NV?*$+G#;<=^,#\Q7?69N6L;<WJQK=&-3,L1)0/CY@N>V
M<XH HZ/XDTCQ )#I5XMTL9P[HC;0?3)&,\CCK3M.\0Z7JU[<V=C=>;<6QQ.G
MEL#&?1L@8/M7 :Q+>_#CQBUSI=C]HT?7V\M+2,A0E^1A,>@? S^)[ 5U%W<Q
M>!/"$MW*/M5[)(#(P4@W-S(P&<#)ZGISA1@=* .JHKC;#Q!XC_X2);*?37O;
M"6W9Q=1V,EIY4J@G81(QR&QP<]36;:>-]6C\0:%97[6#G4W>&YM8(SOL9 N0
MID#E6/8C@^W:@#T2F3316\#S3R)%%&I9W=@%4#J23T%<'X;\2>+O$&KWBK;:
M0FGZ=J\UC<L#('9$'51D\YQ]<]!@DL^*DC31^&M)>799ZCK$,5R.?WB9^X?8
MG'Y"@#I&\:>'X[<W,FH>7:CI<R0R+"W^[(5VM^!-;J.LB*ZG*L,@^HJKJ&F6
MNIZ3<:9<Q VL\1A9 !PI&./3':N0\2^(-4\/BZ@AGMK6"SL!+:R7,8EDOI%!
M+*$1@0H"C)V\$YX Y .ZK.N-<TZTUFSTF>X*7UX&-O$8V_>;5+-AL8X /?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M6YO[;7SHT=VZHA*DC#D<+NQGVSC(KI= 'BJ+Q%=1:DKOHQAW0R7,D33++D9
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MPIJ'AW6[V\\.W=L+&_D,]Q87:L0)3G+1N.5SQD$'IQ[=#I]M?1F2?4+I)9Y
M!LA4I%&!G@ DDGGECUXX%7J* "H;K[0;246AB%QM/EF7.P-VSCG%35E:AXBT
MW3-6L-,NY)4N;]REN/)<HQQG&_&W/MG/(H 9X;TZ^TK1$M+Z6":Z#N[S1YQ*
MS,69B#T)8GBN-M/ &O6GAC7O#ZW^G?8=3DDDA7:^;;>>5'J.GIW]:]#O+N*Q
MM)+J82>5&-S>7$TC8]E4$G\!5'0_$>E^([ WVDSO<6H)7S/(D0$CKC<HS^%
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MX=/P]T=[JS:[L[V1$DPQ0C;D;AD$9Y% &O)X[UKP_/K^F:S%:7M]I\<$EI+
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M@ 8N>,'G(Z^E5X? LS^&[?PWJ.K"\T>!T*I]GV2O&C;DC9@V" 0O(4$@=NM
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MA@X;Y,@1A#NXY^\,]*W=?U._T;QGX5TRPEAAT[49Y_M$*PC<Q"ER=QZ EL\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M *JSZ;87,PFN+*VEE& 'DB5F&.G)%6J* "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MOX@N]0M[>RO(6T^<V\[3A !(.JC:QS]>E;M !1110 444UW6-&=V"HH)9F.
M!ZF@!U%9-WK+Q/I366GW%_;7\@5KB#&V%"N1(V>W3_. =:@ HHHH ***Q]2\
M16MAJD&E1Q3WFISQF9+2W W",<%V+$*JYXR3R>F: -BBL.V\2"778M&NM-O;
M.[EA>9#*$,;*I4'#*Q!/S#CKZ]L[E !1110 4444 %%%% !1110 457^V0FY
MGM8V\RY@C65XEZA6W!>O')1ORJMH6HW6JZ1#>7NF3Z;<.6#6LS LF"1U'KC-
M &C1110 4453U2^;3;![E+6:Z<.B+##C<Q9PHQD@=6R23T!H N45R[>,95\2
MIH!T.\^WO:F["^;%M\O=MSG=USVJ*#QOY_B72-&.E3P-?K.6>9U!B:'<&7 S
MGD=<XYXS0!UM%%% !116!XR\2-X2\,7.M"R:\6 J&C$@3&Y@H))]R.@- &_1
M38W\R)'QC<H.*=0 45@GQ&P\<IX;:R90UBUX+DR## ,%P%^I/7TH\8^(I?"O
MANYU>+3VO1  602B, $@9)/U[ T ;U%<Y=^*+BU\0SZ5_8=Y(HLWN+>X4C;<
M.HR8U]^0,^O;O5_P]K#:[HT5\]C<6,I+));3C#1NIPP]^1U_E0!J4444 %%%
M% !1110 4444 %%%% !17+'Q/J=U<>;I&BK?:='?&SFD%R$E7:VUW"%<%0<C
M[V3CI74T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% '">/;W4M*OM&U*>VM+G0+6^B:>-=WGJY^5' Z$
M*S9QUSC\.[KGXO"Q=((M3UC4-4@@E69(KKR@"ZG*EBB*6P1D G'KGBKW]D?\
M5%_:_P!NO/\ CV^S_9/,_<?>SOVX^]VSF@#E!_R7MO\ L6__ &XK&\=^)]/F
M7Q%97\=T&M+*:WLD%I(R-*\1#2%@NT==H.>!N/>NV_X16/\ X3,^)_[2O/M1
MMOLGDXC\ORMV[;]W/WN<YS[UJZKIT6KZ1>Z;.SK#=P/!(4.&"LI4X]^: ,'X
M<ZC;ZCX T8P>9_H]I%;OOC*?.L:YQD<CW'!KJ:P7\*VYTG1=.AO[^WATEH6C
M,,H4RB,8"R<<@XY'%;U !5'6='L]?TBYTO4(S):W"[74'!X(((/8@@'\*O44
M <_;>"]$M-8T[58;=UO-/M1:0R>:W,87:-P_B."1D^OL,>>>&M.UGQ!X1\5Z
M5I;:?';WVMW<<MS-(S%$.W.U N&R,8.X=:]?F1Y8'2.5H788$B@$K[C((_,5
MA^%_"D/A6*\BM]0N[F.ZN&N76X"<2-C<054=<#B@#G]/1X/$]IX$@N[B'3=-
MT99G>%]DDS[@@^<<J!UP,<GTXJ@FM^*FT[7](A-QJ-]HVHQ*\T02.6>T;YRJ
MG&/,VC' SSQS79ZGX7M=0UVUUR*YN+/4[>)H5G@*G?&>=K*P((R2>E0?\(=:
MK8>3!?7L-RU[]ODO$9/-DFQC)RNW&., 8P* .!UJZMM:^'^NS6NM:L4@N8/]
M#NI&2XM<LBF.7/)'+$9)^IQ7K=K ;:V2$S2S;1CS)2"S?4@"N<N_ FFZAI^M
M6][<W<\VL+&MU<EE5R(_N!0%"@#Z<\YS6]IMC_9VGPVGVF>Y,:X\V=@7;W.
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M@QQQ,<8"@#<%'*G#')KM[3P9:6RZ?%+J&H7=KI[B2UM[AT*QN R@Y50QP&(
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ME;,BX(\L$8/UXXYSQQ5*;X;>&YM<EU4V\Z23R>9/ EPRPS-G.73.#SSCI[4
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MD] 2, =3SV!(YV3XBVMM=VQO-'U2TTNYD$46ISQ 0DG[I(SN56[$@=1TJO\
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MU2#3+6-9[QU\V1"^T0PYP78X/4\*,<G/0 D:-<)X,E-QX\\<2W'_ !])=01
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M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '/\
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M2<84#GU%/MM8UF#Q):Z1JEE:+%<02R)>6\K;792N$VL/E."3C)R%SZX &Q^
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MJ #G&#ZUT]9?A]M:;24;Q MFM^7;<+0DH%S\O7OBM*.1)5W1NKKDC*G(XX-
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M&%QUSZ4Z.1)8UDC=71AD,IR#^- #J*** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH XCQ79O<^.O"T
M"WM[!%<_:EF2&Y=%8+%D< \'DC<,'GK7*V>CQW">.M*>^U,6.C/YMA$E[*/)
M8QE\Y!RWS*" V0#GC)->EZAX=LM2U>SU2>2Z%S99\@QSLBIG@_*.#D<'/:J2
M>"=)C.JE6O =5&V\/VI\R=O7CCCCL30!S-I?7=Q>_#*YENYVEO;60W/[U@)C
M]EW99<X)SSTJK&\MT?BC8S7$TMK!'^YBDD+K'F%V.T-G&3SQ78-X(T9],L+
MB[$>GONM)%NG$L'R[<*X.X#'&,U'!X!T&TAU&*VCNX1J*A;HI=R9E&,<_-U/
M.3U.3SR: .8NM*LKZX^&SW$.YWA\IF#LIVBU9@,@@CD9K6L;<R?$WQ!8O=7C
M6TFG02!/M4G[LL[YV'.4Z#[N*V9O!VDW&FZ?8R_:VCT]P]JXNI%DCPNW <$'
M&.,9IP\/:?INKW&OQ_;GO&CVNJ3.X=!G"!,XP,\"@#RI=.N5^#-IXP36-3&N
M68-Q#<-=,P ,Q#(4)VD$$Y)&2>I(XKK+%WN_C0DDP*/+X45G RI!,XS[BG>
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MIKO_ %[_ /LPIUM\.?#UJU@4CO66PD$MHCWTS+"?]D;N!71ZAI]IJNGSV%]
ML]K.A22-NC#\* /,Y]';P[-X1U33;V^DEU*:&SOK>6Y:1;F-XR2=K' V@'H
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M\QH>']%M_#N@V>DVI+1V\>TN>KMU9C[DDG\: //+6WU&Y^-WBN/3K^*RE-A
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M!]S'=R>K9[=A7,:5X2N%@MK:S\+ZIH5VH56O?[9WQQXQ\VU7.\\<*5 YYP*
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@"AJ^BZ;K]B;+5+..ZMR=VUQ]T^H(Y
M!]QS52P\+V%@\+^;?7)@QY(N[R281^X#'&??'':MJB@#%M/#&GV7B*[UV%KG
M[==@+,6G8JP'0;>F!V]*A/@S2%U"XOK07=C/=-NN/L=U)"LK>K*IQGD\]>:Z
M"B@"M8V%KIMJ+:SA$40); ))8GJ23R2>Y/)J2YMTNK=X)"X1QAC&Y1L>Q!!'
MX5+10!E>'_#NG^&=-73],65+522L;RLX4DDG&3QDDFLS5?AYX:UC6'U6[L7^
MU2 +,8IGC$P']\*0#7444 <U>^ O#FH:LVI7%BQE>-8I(TF=(Y%484,@(!P.
M.?05!;?#KP_9MIIMX[N,:=(9+8"[D(5C@$\GN !]*ZRB@!LB>9$\99E# C*G
M!'T/8US=OX#T&VM=3M4BNC#J;L]VANY<2%NN?F[_ -:Z:B@#"D\'Z++#IL+V
M\YCTTJ;0?;)AY148!'S]AQSVJI<_#SPO=Z^VM3:8K7CD,^'81NP_B9 =I/U%
M=110!SNO>!O#_B6_@OM3L=]S"-HECD:-F7.=K%2,CZU9?PIHK:CI]_\ 9&2X
MTY/+M#'/(BPKC! 4,%Y'!XY[ULT4 <__ ,(1X?,&IP-92/%J9W7B274KB5L@
M[L%C@Y Y&",4U/ WA^-; +:S@V!+6Y6\F4HQZMP_+'.,GG''05T5% %.^TNQ
MU)[1[RV29K2<7$!;/R2 $!A^9JKKWAG1O$]O'!K%@ETD3;HR6960^S*01T'>
MM:B@"CI.CZ?H5@ECIMJEO;J20JDDDGJ23DD^Y-1:SX>TKQ!#%'JEFDXB;?&V
MXH\9]592&'X&M.B@#.L-"T[3;A[BWA<W#KM,TTSS/MXX#.20.!P..*HIX*\/
MQRNZ6!5))A</ L\@A:0'(8Q;MF<\].O-;]% &.WAC2FUJ;6/+N1?S1&%YEO)
MERA_A #X [C X/(YJE_P@/AO^QI=(^Q3_P!GRR^<\'VV?:SYSD_/Z\_7FNEH
MH \YGT7[7\5;:>33=6&GVNE_8XKM9)$Q*)"<^8&WD;21G/.>:ZR;PEH-SH']
MAS:;%)IVXOY+$GYB22V[.[=DGG.>:VJ* .;B\!>&H=%GTB/3V2RN&#3(MQ*#
M*1T#,&W,!Z$XJ:3P;HDLFG2/!<E].4I:,+Z<&('@XP_IQSVXZ5O44 8=GX/T
M2QDB>"UE BG-Q'&]U*\:2'.6",Q4'YCV[U0?X:^$G25/[) 627SB%GD 5]V[
M*C=\F3_=Q75T4 8/_"%^'_[334DT_P N\2%8%EBFD3"*-J\*P&0.AZCCGBEA
M\&Z!!HUUI"V)?3[IB\T$LTD@9B<DC<Q(.><C'-;M% &3:>&M*LO,:"&;S)(1
M;F5[J5Y%C'\*NS%E'^Z16?\ \(!X:_L0:-]AF_LX2^=]G^V3;=^<Y^_GKS]>
M:Z:B@#)L_#6DV&LR:O;VS#4)(!;O</,[L\8Q@'<QS]T<]>.M:U%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M'4?-^8-;E16]M!:0+#;Q+%$N<*HP.3D_K7G=QIL>I_&6_P!-NKB\:RDT,2O
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M6TM;1+B)X]Q=MQQ\Q/'X ?C749&<9&:\RN;JYL_B5XMN[5<W4/AU98EV[OG
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%4J&.#(<]% SD_2L6Q\57$?Q UJQU+5+-='M[.&X@<A8T7>>,N2<\=\X/H*
M.XHJN]_9I9"]>[@6T*AQ.9 $VGH=W3%+:7EK?P">SN8;B$G DAD#KGZB@">B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M X+XAPW\-OI_B#2-5G^UVEW&L%DK*T5P78(5 QRV"W/.!GI7;?;;47PL?M,/
MVLQ^:(/,'F;,XW;>N,\9K/T[PMH>DR(]AIEO R$LFU>$)ZE0?ND^U6_[*L!J
MYU;[)%_:!A\C[1M^?9G.W/IF@#CA_P E[;_L6O\ VXJA!HEGK'Q5\7V^LQRE
M);2T-J/.>/=%LPY&TC(#XZ]#7<'PWI#:S_;!L8_[1X'V@$AL>G7I[=*EU#1=
M-U26*6^LXIY(01&[#YE!ZC/H>XZ&@#E/ASJD\7A0KK6H[U34);.RN+IPK3QA
MMJ8)^\2<@=2<5W549M%TNXM[2WET^V:&S=9+:,QC;"R_=*CMCVJ]0 4R6*.>
M%X9HUDB=2KHXR&!Z@@]13Z* (5L[9'B=+:%6A3RXF" %%X^5?0<#@>E>2ZGX
M=CTKP_)X[\":HVE*UN+R>QW!K>5<;BNWH&'(QTSP,5[!6(GA#P]&@C31[18A
MC]T$Q&Q'0E.A/N1GB@#@K_4IM<\:6%OJ=]'I(N=$BGM8[NW22+S7/[U</P7P
M=O'. 1W(+-2\&QP?#G_B67Z:O=Z%>&\LYVC& $(9HEP3N7KQD\\=J])U?0-(
MUZ!(-5TZWO(XSE!*@.T^Q[5;M[.VM+-+.W@CBMHTV)$B@*J^@% 'F^JZD^I^
M#?$'C73HY T]FEO9LB8E2 $>:P/7.2_/^P#4FE:'X;N]4T/4K?Q!!.6B>W@M
M;>*%//C:,EDD"#) 7)YZ?C7H=I86EC81V-K;QQ6D:>6D*K\H7TQ698>#_#NE
M2SRV&CVEM).I21XH]K%3U /4#Z8H \N\.:1X>LOA]K'B'4X)Q):3WENDUK*P
ME2)GV;%&=HR6/4<;B>]7K%;5/B3X?@==+AAO-'EADM;3#+Y> $5VXW$XX^4>
M@S7I%GX9T2PTZXT^UTRVCL[DDS0[,K)GKD'K56+P-X6@$ BT"P4P%C$1",J3
MU.>N??MVH \@BTFPB^!$NNQVR+JEE=%[:YR2\)%T!A3V&">.G?K7;FZL+_XB
M^)M(\4M;B(VD0T];E@J^0R'S"A;OGJ1SQ[5U8\%^&QI9TP:/:_8BV\P[?E+>
MM/O_  CX?U2.V2_TBUN1:KLA,R;BB^F3SCVH \_N;BP@\5>&])367MM%32Y1
M8SW2I(DLJR;,Y<;22@.&]&X^]79^!])L-%TJZLM-U1M0MENF8-QLB+!243;Q
MM&<\=,D=JU-3\.Z-K-G%9ZCIEK<V\/\ JHWC&(^WR^G'I5NQL;33;..SL;:*
MVMHQA(HE"JOT H X?XDQ>=J_@R/>\>[64&Y#AA\IY!K,\56S>&_B#X7U.WNY
MM3NKN<VGV.[82/'&V TD7'RXYR??TKOM5\-:-KDT4NIV$5T\7^K,F?E^G-%C
MX:T33;E;FSTJTAN%&U9EB&\#&,!NM '%:!:V/B2]\=V_B".*:=-0>!O.'S16
MJC]R1_='#,",<Y-<S:64NIW'PP;6XO-N+A+J*1V)#2PJF8PQZGY3R.^3G.:]
M<O/#>BZA>&[NM,MI;AEVO(R<R+Z-_>''0YJ2YT+2KR\MKRYT^WEN+4;8)'0$
MQ#_9]* /.I=-L+#3/BAIUI;Q1V<$'FQ0*HV1L;3<2HZ#G^5)K%WI\^N?#1XK
MBVDE#9+(ZE@AB&/PS7HD'A_1[:YN;B'3+5)KH%9Y!$,R@]0Q[CV-5+?P5X8M
M$A6#0=/589#*@\A3A_[W/?CKVH X+RCH^K:?/?6]KK.C7FM&2QU.WPMS:322
M'Y'&/F&[*GV'L!7K C0*%"* #D#'?KFLFW\*Z#:W2W,.DVJ2K)YJL(Q\K_WP
M.@;_ &NOO6Q0 A 92K $'@@]Z\6GT#1SX0^(C'3XB]E?7'V;<N1!A$(V?W3D
M<XZX%>U$ @@C(-92^&="2&XA71K!8KDYG06ZXE/^T,<_C0!YX+&VL=6^&^IV
MT"+J%ZI%U<$DR3AK<%MYZMSR,]/85EZ='IGB71-6M_$'B--.U"/497NX6CB6
M=)%DRI1B-YX 48]-HKUEO#FB.UJS:18DV@Q;$P+^Y'^QQ\OX4R3PQH4VL+J\
MFD6;:BIW"Y,(WY['/<^_6@#SOQ#-IVHIXP\J2W6:&PCCO9M2PSLZQ,42*/@(
M>?O9^\> >M(UEIFLZU\-G>**9;NPF6YSUE5;9"%?'49['BO1I_#6AW6IMJ4^
MDV<MZR&-IWA4L5(P03WXX^G%-@\*^'[9[9X=%T^-[48@=;==T??Y3C(Y)_.@
M#S73K*V,?C;0X;^/28#K,*68"9B24X*J4Z;6*@$=#71>%-5BT[6O$,.N6-CI
M6HVT=N]]=P38M9U(8(XW8V'GH>M=-)X2\.S&4R:'I[&9P\I^SK^\8'(+<?-S
MZT2^&=+&D7>GVNG6*1W*A9%EAWJ^. 7&06P.G/&!R* -6">*Y@CG@E26&10Z
M2(P964\@@CJ*\M\8O87$GCCRS;"2&Q2.ZEO2)&W>461($XV@YSN)^\> :]*T
MK38=(TJVT^W_ -5 FQ> /T' ^@X%5;KPOH-]J3:C=:1937C(8VFDA!8J1C!/
MTX^E ' RP7>H0:-J&DW%AJE];:'$MYI-]\PEB=<ED8YVN2"#Z\9[5VW@J\L+
M_P %Z3<:9#+#9&W"Q12G+(%^7!/?&.O>GKX/\.(L:IHMG&(H_*3RX@I"9)*Y
M'8DG([YYS6O!!%;0)!!$D42#:B(H55'H .E '":7'#JWQ+\666MP0W!B@MTL
MHIT# 6[*=^T'L6QDCOBN+U6.?_A1NII<MY\%MJ?D:?,XRS6RSJ%(/IUQ[8KV
M.^T/2]3N8;F]L8)YX0521U^8*>JY]#Z=*6[T32K^SBL[S3;2XM8@!'#+"K(F
M.F%(P* +L<4<*;(T5%]%&!7GMH+6+XXZH91"F=)A*EL#+F0=/>O0(8(K:%88
M(UCB085$& /H*IW6A:3>ZE#J-UIUM->P*4CG>,%U![ _G^9H \7?1]./P@U[
M6&MD_M*#496ANB3YD1%P -AS\O4\#'6NCOI+;4OB%XATW7-6@L0;>%+,7,$3
M++ 4R^QI!_?R3CV]..^/A7P\;(V9T/3C:E_,,/V9-A;^]MQC/O1?^%M!U1;5
M;[1[*X6U&(!)"I$8]![>W2@"'P=;0V?A:SM;:_N+ZVA#1PW$X&YT5B%((X*X
M'RGN,&JWQ$_Y)WK_ /UY2?RKI$1(HUCC5410%55&  .@ J"^TZRU2V-M?VD%
MU 3DQSQAUS]#0!RC3ZC;_!F.;3PQOTT5#$8N6!\H<K[@<CW%<WH&G:!JZ>%]
M47Q LES"BI%911PB5MZA9(Y HW, -V[/;<:]0LK"STVV6VL;6&V@7[L4*!%'
MT XJE:^&=#L;RXN[72+*&XN 1-+'"H9P>H)QW[^M 'FW@_PQHMSH7BJ\NM,M
MY9;35+^*U++D11A?NJ.@'+<8K$_LC3HOA5X+U**UC6^?4[=6N1_K""[@C=UQ
MP.,X&*]EA\-Z';07$$&CV$4-Q_KHTMU"R<Y^8 <_C49\)^'3;1VQT+3?(C8N
MD7V5-JL>I Q@&@#DM)TS3K+XNZQIMI96T%E+HL1DMHT C<^81EEZ9P<?_KKG
MOL&GO\%M/66*$^1JQCA<<-&#?$'8V<K\OH<XKU(^&M"-VUV='L/M+*4:;[.N
M\J1@@G&<8XJ'_A$/#7V86W_"/Z9Y ;<(OLB;0?7&,9H X:_M]*\+_%%S;6ZV
M-@?#DTERMJFTL%<_-QU; Z]:R+.XM8M8^'DL-UI\-H5D\N"-PTT<)B/^MDR-
MQ/0C: "".:]8'AW11>+>#2;'[4BA%F^SKO"@8 !QG&.*@B\(^'((HXXM"TY4
MCE\Y%%LF%?\ O#CKS^% '&Z9#I4VC>.K.XCLWD_M"\(A<*3M$:$'![ \^U9E
MA=&*#X61WJ[=)> [MQRAN!$!$6[=<E?<^U>ER^'=$GENI9=(L'DNP!<,UNA,
MV/[QQ\WXTH\/Z,-,_LT:39?8-V[[-Y"^7GUVXQF@#A[K3K3_ (3_ ,2P116S
MZ3-HPFU&%TS&+@,VTG^$-M&3GGO7,PV=M8^ OAWJT%M%%J$FKVD<EUM'F,AW
MJ5+'G;@ 8Z  8KV&/0])BL)K&/3+-+28DRP+"H23/7<,8/XU6;PEX<:WCMVT
M'33!$Q:.,VJ;5)[@8X/ H V*\^\"SPQ>*?'322QH!J8)+,!@;:[_ &+LV;1M
MQC;CC%8R^#?#"R&0>'M*#DY+?9(\D^_% 'G5_<VFM>-O$/BKRY)?#^E:-)8O
M-#D?:V(8L(V&.FXKN'3 ]<U5M]2L(?&?P^F&HZ;%:+9W">1#*"+>+R1L220G
M+'/KCD<"O9%M;=+7[*D$2V^TIY00!-OICIBJ,/AK0K<6XAT;3XQ;N9(0EL@\
MMCU*\<'W% 'D!U"*T^'GB*&S;=,NNS-=01%3.+43+O)4Y.,8!R",$YXKM])D
M\+R^(DU^S\2OJ-W'9LDS))#LCMP-V91&B[0#C&><^P-=?#I&FV]Q<W$.GVL<
M]U_Q\2)"H:7_ 'CCYOQJ.UT+2].M;B#3=-L;19P0ZQVRA7.,?,HQN'/2@"?3
MM2LM7L8[W3[J*YMI,[)8FW*<'!_6N/\ $UW9V'Q.\+7-[<06\2VE[^]F<(H.
M$[G\:ZG0]'M]"TM+&V"!%9G.R,1KEF).%'"@9P!Z#OUJ>\TRPU!X'O;*WN7@
M??"TT2N8V]5R.#]* /*7TW3-0'Q/N;NSM;B6W:4PR2J',3>1U7/W3E1R,=/:
MH;/5Y+36/!\FL:K-I^E2^'85MKP+'Y:W!5=X9I%902HQG@X^IKU<:)I($H&E
MV0$W$H%NGS\Y^;CGGUHGT/2;K3UT^XTNRELU.X6[P*8P?4+C% &3X)LM&L-(
MN8M"NWNK)KMY!,61D9B%+>7L 79GL!@'-8OC;5(=%\;^%M0N+J#R4%RC6\LR
M18!0#S0SL%R.!R<G<<=Z[N"WAM8$@MXHX8D&%CC4*JCV Z5R/BWPUJ>JZQ;:
MA:P:1J-M#;/"=/U.(E"S,#O5@#@_*!R.@/K0!QNI:3:1?"GQ?>.^GS_;+R6^
MACA>.7[-O9=J[ER-P&>AQSP:M:[!IOAFP\)7\47V#39Y8VU&ZM(D;#B+$3OE
M64X8DY(///7%=?H7@ZTM/M,M]I6C1?:%13:65L!"NW<=QR/F;YCS@8  ]<]"
MVF6#Z>;![&V:R88-N8E\LCTVXQ0!Y=K'_"):?H^OZC;7]UK,=]) EXT-PBV_
MF%OE9FB4*N,9;V(SR13[*]B;XCZL\VKV%Y/<:"4WVK!4+[N$49.2![DGVZ5Z
M5%HNEP:8^FPZ;:1V#@AK985$; ]<KC!I+;1-)LY()+;3+.%[=#'"T<"J8U/)
M"D#@<G@4 >.V.K0P?#/P43>>586UXO\ :30A)&MP3)L9U96P-W/([>N*T?$M
MAX;F\->,-1TS4VU>XGM$DN9PT+P+(#A"/+4*),9Z<\G/7GU*+1M+@M;BVATZ
MTCM[AB\T2PJ%E8]2PQ@D^]-BT+1X+'[#%I5BEINW>0MN@3/KMQC- &;X-T;2
M]-T&RN=/LK>"6ZLX//DB4 R%4X+8ZGD\^YK(\272VWQ-\+_V@P73FBG6!I!^
M[%T<;>>@;;D#/J<=:[2WMH+2!8+:".&)?NQQ(%4?@*CO=/L]2M_L]_:074.0
MWES1AUR.AP: .+\-V_V7X@>,WLR$TIA"SX'[O[1LR^#TSC&[W(J?X1L#\+M%
M (.$D!QV_>O76IIUC'8FQ2SMUM""# (AL(/)^7&*+33[+3T9+*TM[96.6$,8
M0$^^!0!Q'Q,ECM[_ ,&SS2)'%'KD)>1SA5&#R2>E5+*VTO5?C+KDMU%:W42Z
M7 \;2!74 CD@GV/7T->A7VG66IV_V>_M(+J#<&\N>,.N1T.#WJ)]%TJ2=YGT
MRS:60%7=H%+,",$$XYXH \1T;4TLO#G@.:[NYK728+R]CFN8T1Q!*6(B+;U8
M#JW..!D]J].\'0:+'JFM3Z+J,^I"Z>.:ZNO,C>%I2#D+L &[&"V!W7O6^-$T
MD6<MF-+LA:S<R0B!0C_5<8-6+.RM-/MDMK*VAMH$^[%"@11] .* )Z*** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH Y3Q?XAU+0K[0X+%+1QJ=ZMF?/5CY9/\7!&?I^M)I?BJ\/C:
MZ\*ZM;P+=);"[M[BV)V2QYP<J>5(/N>AK*^)B&34O!J"1XRVM1@.A 9>#R,\
M5L_\(;I=K+JFJ7)FU&_N[9H99[TJ_P"[Q]T* % X' ':@#8U2:[?2[I='FM/
M[1\HF#[0Q\L'H"V.<=?RJ6TGDCTFVFU">W\[R4,\L;8B+X&2I/\ #GI7D^E^
M&])A^!,^J?8H9-0DT>8M<LN7(Y8#/^S@ >F!5ZRN<ZQ\.;&_V'3)='#QI)C8
M]P(EQG/!('3/<G% 'J*3PR0^<DJ-%C.\,"N/K1'/%*6$<J.5QN"L#C(R,UY!
MXBL! /B/:6\2'1ULXYQ%MRD5T5R2@Z XPQ]R*] \'Z#I6E:/;7=A9QPSWEI
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MA>%FB5C&?*4DKGI\V>1U- '5>*_$UKX3T*34KE&E<L(H($^]-*WW4'IG!Y]
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MW&FZ396<SKM>2"!49AG."0/4"M.B@"**UMX)IY8H8TDG8/*ZJ 9& "@D]S@
M?055;0]);51JC:9:'4 ,"Z,*^9_WUC-7Z* *,&BZ7:ZA)J$&G6L5Y)G?.D*A
MVR<G+8S4+^&]#DDNY'T>Q9[S'VEC;J3-@Y&[CGD \UJ44 <%J'@N_N?$%Y>2
M67A[5;.;8((M0MR'ME48"*0&!7J>@ZUN:-X2T_3M#GTRYM;.>&ZE,T]NMN%M
MPQ"C"1G.%^4=<G.3WKH:* (+.RM=/M4M;.WBM[>,82*) JJ/8"G7%M!>0-!<
MPQS0O]Z.10RGZ@U+10!0TS1-*T9'32]-M+)7.7%O"J;C[X%0MX8T%ENE;1M/
M*W;;[@&W3]ZV<Y;CDYYYK5HH S9/#VBS7XOI=)LGNP01,T"E\@ #G&> !^5)
M_P (YHGG74W]DV/FW8(N'\A=TH/4,<<]:TZ* *UCIUEI=L+:PM(+6 =(X8PB
M_D*S9_!OAFYN7N9_#^F2SNQ=Y'M4+,QYR3CK6W10!#;6EM9QF.UMXH$)SMB0
M*,_05!%HVF0W[W\6G6J7;_>G6%0[?4XS5VB@"C_8VE_:IKK^S;3[1,,2R^2N
MYQSU..>II'T/27TY]/;3+,V3XW6_D+L;'3*XQV%7Z* *']AZ3LD3^S+/;(BQ
MN/)7#(OW5/'0=A3M/T?3-*,AT_3[6T,IS)Y$2IN^N!5VB@""\L;34;5[6]MH
M;F!_O13(&4_@:@_L;2_[-.G?V=:_82"#;^2OE_\ ?.,5>HH AM;2VL;6.UM(
M(H+>,;4BB4*JCT %13Z7I]U>1WEQ96\MS$I2.9X@SJIZ@$\@&K=% %(:-I8B
M,0TVS$;$,4\A<$CH<8IEWH.CW]O#;WFEV4\,!W11R0*RQG_9!'%:%% "*JHB
MHBA548  P *K1:9807'VB&QMHYN3YB1*&YZ\@9JU10!6N=/LKTJ;JTMYROW3
M+&&Q],BDFTRPN&1I[&VE9 %0O$K%0.PR.*M44 4;G1M+O+V*\NM.M9KJ'_5S
M20JSI]"1FI9].L;J99KBRMY95P \D2LPQTY(JS10 56N=.L;UP]U96\[*,!I
M8E8@>G(JS10 R.&*&)8HHT2-1A450 !Z 56L=)T[3&E:PL+:U,S;I#!$J;SZ
MG YJY10!G1Z!H\*.D>E62*\PG95@4!I/[YXZ^]6(-.L;69IK>SMX96&&>.)5
M8_4@59HH *SX]"TB'4/[0BTNR2\QCSU@4/\ ]]8S6A10!5GTVQNKN"[GL[>6
MY@SY4KQAFC_W2>159O#FB/:K:MI%BT";ML9MUVKN(+8&.,X&?H*TZ* *3Z1I
MDB1H^G6CK$NR,-"I"+Z#C@5)'IUE#<M<Q6=ND[9+2K$H8YZY.,U9HH JW.FV
M%[()+JRMIW VAI8E8@>F2*+;3;&S<O:V5O QX)BB52?R%6J* *=WI.G:A-%-
M>6%M<2PG,;RQ*Q0^Q(XZFG7&FV-XZO=65M.RC"M+$K$#T&15JB@"K'IEA#<&
MXBL;9)SDF18E#<]><9HCTRPAV^596R;7\Q=L2C#=-PXZ^]6J* *L>F:?%<_:
M8[&V2?)/FK$H;)ZG.,U+';P0R2210QH\IS(RJ 7/J3WJ6B@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M YM,$B09'7'.!U..>* +-GXFT:^E,4%\@D\G[0%E5HR8O[XW 97W'%45\?\
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MEB;_ )Y^9C;N]LYJG!XVL)_%E[HGEW""TA5WF>VD +$MD9VX"@+G<>#G@\4
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MZ?2LBS\4Z3?:E'I\4\BW4L7G0I- \?FIW9"P 8?2M=W6-&=V"HHRS,< #U-
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M,+)KB_L_LEZM_96PNGM'C =XSQE3G:>?>@#H:SK+2(K74+K499#/?7("-,P
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MGSWSM4A1T+'(].,\#IMW/CFP@M=9(M+PWFDP>?<6;1A9 A4L&!)VE<#J"<4
M=117+:-XP2Y\,:/?ZA;S1WFHI&(H(X\F=RFX^6,GY<9.21@#FM31O$%CK;WD
M5MYJ7%E+Y5S!,FUXF[9'3!'(()!H U:*** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH @O+B&ULY9[
MB5(HD4EG=L ?C7#?")Q)\*["TCE"W40G5TSAHR97(R.HX(->@44 >'Z#)X>G
MT.+PMXBM-9N/$-O*8SIQNKL)-('.UUPVQ5Z$MQCDUU'@XV#_ !!\;^>;=F-Q
M \9DP<A$.2">NTXR>QKT? W;L#.,9I: /#+R6.3X->,8TFADDFUB1HD0C<RF
M="/KD!B#SQ]*Z;7;[3QX^^'KV]U;>1%'=!VCD7:BM$H3.. "00/4CBO3:* /
M%1?V;Z!\3RMS WVFYD\CYQ^]RA V_P![)!QCK5RZO;'_ (M>+>X@#0%/,V,,
MQ@Q*K;O[OS @Y[@BO7J* / -=U:VO_!M_LW64Z:UNETNW@(6']Z,R2G!.3ZY
M"\@ 5W&DZO;6WQ;\0/=22Q)>65J]KYD3C>BJ=S8(^4 GDG ')/>O1MJ\\#GD
M\=:,#.<#/K0!XIYDTO@..YLF-Y#IWB9KV]A10S20"9F#%5'(.0W Q@>U=7>3
MVFN_$/P[KFDWD$UAIUI<O?W<<H\M4=<(C'/!SN.#TQDUZ#2 !1A0 /04 >$W
MEU:R? ;4H8)(Q<R:DS")3AR3<[AQU/R#/3H/:O=(9HKB%)H9$DBD4,CHP*L#
MT((ZBGT4 >9>&=>TFU^)?CBXGU&VC@N39F"1I %EV1,&VGHQ!(&!1-%?>(_'
M<GBFWTN<Z;HNGS16B31E&OYF5@0JL,[><9/4X]>/3:* /"1J]O/+X(U)FN=M
MO>DW%M;6#I;V)8'$2(J\MD'NS'&> 15N\@NKU?B)X?M8;@:I?70N8(?)?$D2
MA6(W 8&X#:.<DM7M=% 'F7A;4O"_B'5M/DL-!U'^T[4EY#=F7;9<$,=SD@DG
M@ <GVP<=7X[T^^U3P+K-EIV3=S6S!%4<OW*CW8 C\:Z*B@#S*^NH?%FD^$+.
MPC9=2MKZVGN(3$RM9K$#Y@?CY.F #C/&,U2T/6(?#\FN>%?$6C7E[<W6I33P
M(MH98[U'((/IVYSP/P->M44 >6_VX/"'C?7(?$.G7$EIK$<#P2V]N9HV(C"-
M#@#IG( ].O6DU^[CTG7O .L76GR:7IMM]L1XHK=B+=70"-&5 <$CMCJ#Z5ZG
M10!X3>W:S^$OB0?(NHS=WRRP"6W=-ZEEQC(QG@_+U&#D#!KL?$2Z#>Z#X:BN
MYI[3S55[75+$[3:.D8&2PZ*<[>>/7&,CT6B@#D? %YJ=UI^HIJ9CN&AO6CBU
M".(1B^0*H$N!P>,#(X( ]*S_ !]_H_BOP9J,R,+*UO)?/GV$I%N0!2Q'09[F
MN^HH \:\4:'J&J77BCQ%I%O]HL)#9E4B!#7@A96D*$<D#  8=<'%=%X7OO"V
MM:M;:EI.DWHGM8F,UW>-*HM 5(*9<D,3GH.,9.>!7H=% 'B4>G:AJWPB\1:?
M80S)>_VG+<?9!&P>6+S%;"@C)!'3'7&*ZO69[;QCJWA.ZTB0EK*\^VW,OW?L
MT2K\Z/D?*S':-IYZ]N:]"HH \S\,6KWVC^/;.! +RZU2]>V\Q2N]7C"HP)[$
MD\CU]ZR/!UWH%_;Z+I-SX=U,^(=/DB5XIQ-L@>,@&7).U0 "<<<\ 5['10 V
M21(HVDD=411DLQP!7DVK0S7'AO0/%OAR%[K5=(N2C1(K*\L+.5>,J1GJ?3@$
MFO6Z* /+/$=@NDW7@BR:1IKJ/5A=WL@!;#-R[L?X1N;C/;Z5C^+-66]3QM8/
M;7=O<;,V]M969VW485?W\LBK\P^K 8P,&O:Z* /+=#O+6_\ &/A67R93$FA-
M;EIK=U59"5&TEA@$A6QZ@CU&6PZU%X0\7^)--\0Z?=W%MJ\XN+22&U,R3(5"
M^5@=QP,?XC/JE% 'FL@8?$WPD\EDMHD&G31O%&O[NV+#Y(R1\H.,#'Y=JV?
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M-\G'S _ASTYKU.B@#R&^N-3M=2\=76G:%?N;J:U>%I-/D(=$ 621 Z[68'D
M]>HR!5G36=_',LMIH^N?9[_1GABN;Q78R.7W%G+G]V/0''; Y%>JT4 >(SQ:
MA<_ *3P\FBZM_:5NR0-#]B<EG$^\@8!. HSNZ<@9SQ75RR3:)\33K]Q:WLFD
M:IIJ0+-':R.8)%8$*Z ;E!'J.IQV->AT4 >,^(-$U ^$M9NHM)OA+JVO)>0V
MD5L[NL2D?.ZJOR%L%CGU ZUV4ETS_%.PN%LM1-L=)D@\_P"PRB-9'D1U4MMP
M.%.<].AP:[2B@#*\3.5\,:H%BFE9[62-4AB:1V9E( "J"3R1VKD/!^NMH'P_
MTNP?1-=FU&"#8UJ-,F4[\DXWLH0#WS7HE-=TB1GD9411DLQP * /)3H>M^$?
M!4M]-9B[U+4]82\U);> 3FVB8DL47!!9?7!P6/89JM!87-UXB\7+8Z1K"P:G
MH+1VTMZCDNQ5AEF<DC)X"GGVQ7L@(90RD$'D$=Z6@#QB:+43X9\%:M_PCE[>
M6NAPM;:A8SVV)'!C12Z1MR=I4\D#\LFO0/"#V5TEU?:=X<.CVLVP*9K4033D
M9RQ4?PC( )Z\]L9Z>B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"C?ZM:Z=+!#*7>YN"PA@B
M7<\FT9.!Z =2< 9'/-4K?Q9HUQ87UY]K\I+ [;M)499(&]&4C.3VQG/;-<_X
MA%UHWQ(TGQ'+#+-I+V3V$S1HTAMG9MP?:!D D!2?\GEM;\.ZKK%UXK\3:1'<
M-%)<V4]I;E3']L6W W_*>>H...<<=10!Z3;^*]*FU&>PEDDM+J&#[2T=W&8L
MP_\ /09[#OW'<"HX?&6CS7UE:!YT>_C,EDSP,JW*@9.PD>G/.,Y&,UR^HZG-
M\0/#E]:Z/I%S;W$UA)'--=0&(JY&5A5VQNRW7MCTS5OPGXG;5;32=,;0[R/5
M+-%BNGN+4K';;5VNP<_WL$ #GGG@4 ;:^-=";0KS6?M,HL;*9H+ES ^8G7&0
M5QG@D#BFZCXXT73-2DTZ8WCW:6XN3%#9RN3'D#<,+\PYZC@8.<8KR[56NK3P
M!XR\.-IFHOJ4NJR3JJVS.AB>6-@X;&,$#H"3DY^G4P7J-\9K&<Q7*1_V$MH6
M>VD4"4R[@IR.#M.: .HNO'&C6MO=W+-<R6UGC[5-%;LRP$J& 8=<X([<9YQ7
M02S100//-(D<4:EW=SA54<DDGH*\F\5*O]J:GJ?AH:E9>(8IA%)9"V=X-4 (
M&2N-I&,\\=#]:[GQAI5_K_@+4=.@"I?W-K@+GC?P2N>>N"/QH FC\7:4]Q91
MNT\$=^0MG/-"R1SL1D*K'N>P.,]LU3E^(.AQ3ZE %U"233<&Z"6,I\L$$Y/R
M\  $Y/4=,URU_P"9XO\ "/AO1+2VNH=0M[JV-XLD+H;,1 AV+$ 9R,#US^46
MGZE#!XB^(]PRSA+F*(V[&WDQ+MB9#CCGYF _&@#T^QO;;4K&"]M)1+;3QB2*
M0=&4C(-9%WXQTBS6[E=KB2ULI#%=W,4#/' XZAB!VR,X!QWQ4'P\D#> -%CV
MNKPVJ12*Z%"K* ",$"N.TTW6C^#_ !+X3U2RN)=1>2Z6S\NW9Q>+-G8X;D9W
M$YR> .>E ':ZEXWT72[NVMI7NI9;J$SVXM[627S5 !^3:/FX.>,X[XK7_M*U
M&D_VI(YBM!!]H9Y5*%$V[B6!Y&!V-><Z? =%\8>"=,NO,DFL-*DMIW2%V5)6
M5,#<!CG!'_ZZ[_Q!+=0^'=2DL;1;RZ6VD,5NXR)&VG"D=\^G?I0!0LO&>E7U
MQI\"BYB?4HFFL3+%M%RJ@,=OO@@X.#S7&7M\_B&[\5?;8-<A&GR1BU>R8+):
MA(PY(!;&XG.?48&1BLNVE>7Q/X'U:*PUVY$)N%O)Y[=^)7B"A$3@(H(/0!<=
MS@XZK18+FXU+QQ%]BO(OM\N;5Y[9XUE'DA,AF '44 :/AGQ>NH^$M/U.^@GC
MFNR$A3:&:=CN("8ZG:I)/ X)X%6+GQUHEE;:G+=O<0R:85^U0-"3(@;[K8&<
MJ>/F!QSUKSB*PO)O /A>X.@SWXT"=X]0T^>VYD1@ROL5OO[<CVS]#6IK<4&L
M>!-<;P_X1FL8KFVCBBQI_ESW#[P<!$!.P*/O'C)]J /0-$\2V/B!Y18QW82-
M$D$DUN\:2*XR"I(YZ5POC6_U+PYX]M-:L[J[.F6T$<NIVOGNZ&)Y&C+A"< K
MP> /7UKT+0Y/,T*Q)CEC(@162:)HV4@ $%6 (Y%<]J5M#J?C&]L;JTNVL[O2
MOL;R_9)#'N+L2-^W;T(.<XSWS0!+XWU]K/PI-_9=ROVZ]M97M'5N0BQEVD'T
M4<'U*^M4/"6M0Z3X"T"YO9+Z\OM45%1'E::2>4J3@%VPHP"<Y K%T30M:T_P
M1KD>LPS37-K93:1IJQ0,[O"-P5@%R?F)4>F$4^]0Q7>IZ?X)\(6,]CJT%C$?
M)U1X;61+B$A?D"\;MI)P67MQD9Q0!V<WCS1[71;[5+M+RWCL)_L]U&]NQ>*3
MC@XR,'<,-G!R.>:F7QKI9\P-'>QN)D@A22U=6N'==R^6"/F& >>@QDX%>;:S
M97LOA/QQI-GX?U6.:]O89K:(6S.&7]R>JY&<*Q/TY.<"NK\91:A);^&/$>FV
M-U=#2KGS9[5866<Q,NUB$;!R,=/?/2@"+X@:_:ZEX&\2P6<]Y:ZCI7E^=&':
M)T+$8R5.&4@GN16[H_B[3Y;K3-'D6\BN[FVWP//;LB3[5!;:QZ]<USOBS4;K
MQ5\/]<;3M"U"-+F*..!9+0B>X?<"3M7)"A1U;'.?QDU&&YN?%_P_NHK&^,%C
M%<?:7-G*!%OB55#?+P20?IWH ]"GC::WDC25X6=2HD3&Y"1U&01D>X-<;\+K
MN]O/"UP^H7=Q=3IJ%Q&9+ARSX5L >WTKM78(C.<D 9. 2?R')KA?AA'<V'AJ
M^@O;*\MYQ>SS[)K9T+*S94C<!G..@H [NN2UOPC<Z]=7=Q>^(M1LX5Q]CCL9
MC"D  !WO_?;=GJ<8Q]:U?#GB.V\2Z>]W;VMY:F.0QO!>1>7(IP",C)Z@@]>]
M8/BK7'EU'^QY-$UJYTP#-W):V,CB?TB4\#;_ 'CW'R]R0 8D'B+7[CP!X5@N
MIW@U'6KQ+5[M<!_(RQW@]F9%&#[YK4BGO=)\;WGA2PN72VO-+^UV;S.93:RA
MMC'+9)!X;!)Y'N:CUV.XU_3]%UVRT*\@DT;4UD2UN(=DS6X&URJ=?0A>^W\*
MEABFN?'E]XO>UO#IMGIHM+5! WFSL6WL4CQN(Z 9ZGVYH HWFB:AX3\6>'I=
M)UK5KYM2N_(OK>]N/-62,*6:3&!M*@=N.@^K/'MX6U]$U:Y\3Z1HD$:JNH:4
M^R+S&)W&4C)VCY ..I/K5O2?$MS-?F_N_"_B!M5N2(88Y+-EAM8R1\F\\ <!
MG;'./10*U]8UZ+4(M6T!-&U*6\:%X4CEM6$,P8%0WF?="9[DCH>] '0:9'%#
MI5G';W,EU"L*!)Y)/,:5<##%OXB>N>^:I^)]:?P]X=O=52RENS;Q,_EQX'0$
MY))&%&.>_H#69:W\7@S3_#7AZYM[RY:2*.T^U00[HHV&U 7.?E!9@!P:O^,;
M:>\\%:Y;6T3RSS6$R1QH,LS%"  /6@#D]?OVEU/P3JTPOH6DNBLL.6(?]RS9
M$:D@G/0XS72V7C72+NVU.64W%D^F$"[ANXBDD8;E#MYR&'3')S7+W-_)JC^!
M[FWTS5?*M;D-,S6,GR+Y)3<<#@;CC\">G-9.M:'J^J:U\0?L5A<[[K[!+9F:
MW98[DP ;U!8;3R,8/7MD<T =^GC"Q75#IMW;7MG>-&TT$,L.YKA!U*!"V2/[
MIPWM5.+XBZ'+!8702_6RO9!$EV]JRPHY) #,?4C'&0.^*S?#6K:=?2175KX+
METN:T#?;96TT*T3;2"D6T;G))[#[N<XR*YF[M+^7X1Z%I:Z5J?VZWO8FE@^P
MR[E"R%B?N],,/KSCH: /7KV[AT^QN+VX;9!;Q-+(WHJC)/Y"N*:ZMM5^'MYX
M@\0_;(8-2M&=TM&=C;V[#*A0.,[0&+$<DG/'%=-XAM9-7\):K9VX;S+NQFBC
M#*0<O&0,@\CKT-<A!(U]\!HX+:"XFGDT?[(L4432.90A0KA02/F!'/3OB@"_
MJ%S'H?@K3?$>CRW,EI86D#M%(V3<VN!PP/ <*VX'KD8Z$BNPBNHI[-+N%O,A
M>,2(R G<I&00._%<%JYDC^!/V>2WN([@:5%:&"2)DD\W"Q[=I /WN/?M79:'
M;2:=X;TVUGR9;>TBCDP,G*H >G7I0!QVBZOIFC> =<U#P\FI7$4%Q=.3<@,Z
MRXW,3D@[0>.>?7/6KG@K0[.2#3?$,:7]M?26,<=SOD^6\)4-YCC)W').#D&N
M<T>UO8/A=XLL)=-U%+N[GO#!";*7=() =A V]_T[XKO_  DY;PGI4;PW$,L%
MK%#)'/"T3*RH 1A@#U[]* ,"+Q-)X@U7Q/HDVGWEO#90HF=X1@61GW,5;<H.
M!C'Z<BLKP#XRL]-\'^&;&]AU%A=_Z.+YX6,/G,Q*H7."2<X& 1D$9XJW$UWI
M?C;QH9M,U*2'4(X)()8;<R1D+!L/([[N,#GVQDU@^1?+\-O!MB=*U,W=AJ5O
M+<PKI\P:-(V)8XV\\,.>_..X !Z!JGC&PTN.]F-O=W%OI[A+V>",%;<D \Y(
M+8!!(4$C(K:M[B#4+&*XMY1+;W$8>.1#PRL,@@CV->6V-D_A_P 1:[!JO@ZX
MUJ&_NWOK*]CLEF)\S'[MRP^3&.^,<UZAI\;Q:;:QRPPP2+$H:*$81#@95?8=
M!0!YY#<'P!X^N$UF_NY-$U5-]E=W=U)(MM(N=T1W,>HY#'T YYQT&B0"U_M+
MQ5J=W>6\%SF>.VN;B3R[6 #J4)P&8?,1CC.!C%9WQ7MYK[PY:6EK87=Y/]NA
MFV06SR[54_,20"!P?J<UO^*+&3Q)X)U.RL@RRW=JZQ"5&C.[' (8 CGU% #(
MO&-@VJ6-C<V]W9MJ"EK*2XC"I< #) P25.#T<*:AM_'6EW+V$BPW8L-0F^SV
ME\8QY4LNXKLX.Y22IP64#CK6!X6F:>WLH4\!'3]7MD_?W%Q9)%$"JXRDG4EC
M@# .,D]!SSDJ:G=6'AR^O?#^N3:M;:Q#/>R/;$+ @9CLB3.-G3E1CCDY- '>
M_P#"P=);69=+BM-4EN(;B.WF*6;[8B_1G)^ZON:M6'C*QU&>R$%M=FTOY&CL
M[W:IBG*AB<88LOW&^\!G'%8?A%+F/QOXSN9M/O8HKV2"2W::U=%D"(58!B,=
M3CKSVR*Q-!LGM_$^DW?ANUU735N'SJ^C7-O(MO;*5)+*6 4'/3:><] ,B@#T
MS5-5M-'LQ<WDFQ&=8T4#+2.QPJ*.Y)Z"J-KXGM;C5)=*FMKJUU%(C.EM.JAI
MHP2-R$$J>G3.1GG%8_Q%T[4[BPTG4M*@DNIM*U&*\>UCZS(." .YY_G59U.O
M^/M'\0VMM>)I^F6-P999K5XRSO\ *$56 9B!N/ ([=3B@#/T.WC\=7FJ3ZK;
M:A;W=CK,@M+N,JC6RQ[5$8.3C(!W#&"23Z5H?$;4Y])N=$N;J.];PXLLG]IF
MTW KP!'O*\[,DY'?@>QF^'C2Q?V]#/8WMJ9]7N;N$7%K)$&B=AM.64#/MG/M
M6OK.IWEAKFGQ_8+JZTN>WG%R8(#+Y; Q["P R1@N,#\CB@#*\,2Z<+V]UK2=
M<^U>'7M%)CDNC(+2126;ACE!M.<'ICTP*T8O&FGM?6%O/;W=JFI#_0)YD79<
M\9P,$LIP1@,%)SQ7''P8+S5?$W_".6<^F:=J&D-;%)H7MXY+HG(*HP!"[>"<
M <G&>:L^%IF>WTZTF\!-8ZM;,BW-Y+8*L05,;I$<#+,<?*!SDYY H Z"R\?Z
M;J5T]O96&JSM'<R6LA2T8!)$7<0Q.,9P< \\=N*MV7C#3=0\/#6[>.X:T:7R
M5!0+(7W;,;2<YW<8Z^U8_P -TN84\1)=6M[;F?6;FZ@%S;R1AHG(VD;E YP>
M.OK532_#E_9?$'4+(6F/#CSKJ\;E?E^T%=I0=OO?/[;1ZT :EE/H*?$35IP+
MN'5UTZ-KGSSMB$(/5?7MDCCCCJ<V(_'.FO>:;&]O>16VJ-LL;QXQY5PW8#!W
M+GL64 ]16!J%C<ZIX\\26JVE[%!J&B_88KTVT@C$HWY ;;C&&SG...,T_P &
M:SX@M]'TWPY<^&]0@O;'9;2W<T8%MY2$ L'R-QVC  !YP>E &U?>/=*L('O9
M8;MM*CG-O+J*(#"D@.TC&=Y&[C<%(SWKH;J2,6$TC"1XO+)/D LQ&/X0O)/I
MBO*?#>G3: E[X>U'P*^HW<=Q(;/4/LD<L4R,Q*F21NF,\\YQQC/7U:9Q;6#-
M(&(2/YA#$7/3^%0"3].: .0\-ZWH&A>"=%&E)?2VEY,]O8PRD&:9]S\98@#.
MT]2 ..E=)HVM1ZRMYMM;FVDL[C[--'<*H8/L1^,$@C#CG//;C!KSG1;"*3X;
MZ%HFN>'=3F1)I%N,6DJRVC$R,DJ@+D]0,KG&?PKK/ ,.KVNGWUKJ,UY<6D-T
MRZ?/?(5GDAP/O@_-P<@$@'CTQ0!4C@CM_C5(RF3$F@M(V^5F&?/4< D[1P.!
M@5I/XWTZ&2SDN+>[@TZ]E$-MJ$BJ(97.=H^]O .#@E0#ZUD:A#+>_$Z?%K?+
M:S:')8?:A:R",2M+NQOVXZ<YZ>]8OA2&YM-.MM"O_ "'6+1U@^W-91_9G12!
MYIE/4@<X')/IDX .T;QE:-.WV:RO+JT2\6Q>\@"&-)BX3:1NW8!89.W'O3)?
M&MJEU=)%IU_<6UK=K937<(C*)*2HP07WX!8 G;BN.U#3KV?5H]8T'3M5TG7O
M[1"7%ND4BVMY$),&1SC9@H,YR#UX)P:GU72YW\0-J_A^QU73->%_Y<T:0N+2
M^B$F"\C8V8*#=G.<]CD&@#OO$&J2:)H%]J<=F]VUK"TIA1U4D*,DY)X  SW/
MH#TKS;Q)J\NL>%_ ^NW5M/;SOJ]F6W8995*,S,L:,P.2.,C=["O1_$UK-?>%
M=8M+:,R3SV,T4: XW,R$ <^YKS6<:F_@3P1;IH>JI<:9J5HUS&]DS%4C1E=M
MH!..>,C/I0!W-IXWTR9]6CNX;O3YM*B\^YBNHP&$6,AQM)!!';.?:I+'Q=!=
MW\-E-IM_9S7%L;JU$ZH1.@QG:49L$97@X/(KBM3.O0^,/&&HZ)I=W)//IT4-
MG)+:NJ.Z\/@LN"0,D=B0!SFC38;B'QMH6L0>'==2W%E-!<3749>5I#M^9\MG
M'7KC.#@4 = GQ.TIM,&IG3=673EN#;SW36X"0$/MRWS9(S_=!([X/%=;J%S)
M9V$]S%;273QH6$,;*K/^+$ ?G7DLFBZK<?!_5='_ +)O?M\U_))% 8""09PX
M;L,8!KUMB;O3V*(Z&6,X61=I!(Z$=J .,\,>/C=>"K36M:@DADNIG2#YHP)R
M9'VHGS#&U5P2^WIG/>KG_"QM'%GJLS0W/G:9&);BW3RY&V$<,K*Q0C_@7'?%
M</8:-XB@^'&@QVVA3/J/AZ^:66TND"BZ4F3<(^>>''.,'/&2*Z'5I[_Q!X+U
MM+/PI=Z<L]F8(8IH%2>:5O\ 94_*@ ')ZY[8Y -ZP\<V5]J>F6;:=J5L-3B,
MEG/<0A8Y<)O*\,2"!Z@ XXS745YQ/::@+CX?,FG7I&FI_IA6$_N<P^7@^O.>
MF>*ZO0/$,NM76I6T^EW6GRV4VP+/_P M8R6"N/3.T\?3DYH RM2\6ZA;?$*R
M\.PZ1/)!);/.\B219D&< @%AA0<Y[GL/7E_"^NQ^$H?&++I=[>06^NW,LIM0
MK+#%A26+$@$@#[H)8=P*WM=M[^S^*FC:S'IEW=V9L)+1GMD#>6Y;(W9(VC'<
MUD6=AJ2>&/']HVDWJS:I=WDMFGD$>8LB!5/MD]<_6@#K=0\;:9:BT2U9;N>[
MMA=PQB:.(&(CY7+.0 #T'<GV!(O>&_$FG^*M)&HZ<S>6':*1' #1N.JM@D9Y
M'0D<BO-[#3M9\/7.AZR_ARZU2U;1X--O;,1@SVTD0'S*K<%3ST/J<BO2]!-S
M)8O/<:>FGB:0O%:A0'C3  WX."Y()XZ @<XR0"A?^+[:UN-2CMK*ZOETM5:^
M>WV_N@06P 2"S #) [>_%5IO'^FQ1Z/(MGJ$B:OG[(4B4[_E)'\7?CZ9&<5R
M&IW,L/C+Q3%::=K;65Z8K6[?2[9;D,WE_,V=V8WVL!T/J1DBK\\L-]?>#9]$
MTN_-AI%Q+%.AMF5[8",Q[6![@]1R>] &[)\0+1+.%C87,=^T/GRV%R\<$L*9
M(^;>P&3M. .3UX'-20>/=.U&QTB?28)[V;5A(;:!=J$>6,R;RQ &W('?VS6%
MK=KJGA[X@W6NKH$VNZ5JD$44J0*KRVSIP,*?X2#GJ.2>1CF75SK;7^@_:]!O
M&TB19S<Z=INT@2''EK-R RXSGD+N/.0.0 \1_$6>#PD=2TG3+GSOM9L9S*8P
M;28.%92"3N/)QC(]2*W=3\9V^FR);-9R-?\ DB>6T:XAC:)22!N9GVDG!P%)
MZ=AS7G,NB:XWP^UJP7PY=P3Q:Y]M2"-%VO&9 <1 'YL =ACTK?U1M7TKQL/$
M(\,76IZ5JEI%%-;QQ(]Q;2(3M)7)'0^H'/.,<@&R_P 3=&-AI-Y;VFH7*:HY
MBMUAA4MY@R"A!88;(Q^([5T^E:@=3TN&^:SNK+S028+M-DB8)'S#)QTS]#7!
M:Y;ZM>7_ (/O3H4T M;Y[FXM[:/=]GB/"AB."V.2!TSWZGT.\MQ>6-Q;%MHF
MC:/=CID8S0!S,_CVS@T\ZPVGWC:"&*G4UV%/O;=VS=O*9XR![XP0:S/%.KW%
MSXS\.Z8-(FU#3)TN)VB5H2EWB-=I 9P"%WDX;')!&<"LJTT_6D^%]UX)ETBZ
M_M2-'M(I0F()49SB02=  IY!.>.G(K4NM.NK'QAX/6*UU"XM-'M)K>>Y2$E2
M6C15SZCY23CIQ0!NF+2OA[X-O9K6-X[&S22X6%Y"V&)R$!.< D@ >]4;+4T\
M->%;76M9$UUJ>IM$)#&@\R223[D2@X"JN< <#@GJ3F]X_P!*FUKP%K-A;Y\Z
M2W+( ,[BI#!?QVX_&L37-1U>\^'V@WF@PSW4<SVS7JV1Q*;?;F0)SD'(V\'/
M- &U9:S9>)[K4] O[":UOK+8TT$C X#?,DB.I]@0>""*9X+UZ?5H-2T^];??
MZ1>/9S28 \U0?DDP.A8=1Z@US_A#3[RR^(VLW:^'+K3M.O;6 0LP0*NT$'=A
MOO$]AD\\U>^'ED3J7BO6A&ZPZCJKB M_RT2,E=P]BQ;\J .ZHHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HKD_$GC&30O$>C:4NF7DRWTK RQHI#80G:N6!SG:3GMZUSMCXC7P
M]X^\:K<KJ=W:Q_994BB1IS$#"7<\GY5!/3ISQ0!Z=16%+XKT_P#LZPN[-)[]
MK^+S;6WM5!DD0 $G!(  R <D8) ZFK&@>(;#Q)92W-@T@\F5H)HI4*212+U5
ME/0B@#5HKG]3\7V>F2WJFSOKE+$J+N6WB#+#N7<,Y()X()P#C(S4\'B2UN-<
MU'1XK>Y-[81K+(FT .K?=*G.#^E &S17(Q_$C0)-,TG4<W:VVJ3M!;N;<_>#
M%<-CIR#QU/I3?^%CZ69KJU73M8:_MU5S8BR;SW4@G<JD_=XY)QC(]: .PHK.
MT+6[+Q%HUOJNGNS6TX)7<N&4@X(([$$$51U+Q;:6%S>6\5G?7SV**]W]DB#"
M $9&<D9..<+DX[4 ;]%<%XX\8_9_"VFW>C>;<0:I<PQ+=08P(V;Y@#G(8@%>
MV.>016]H.@V=G;WTMNNH00ZB=SV=Q,<0'!4[,'*YZ\-Z8Q0!OT5Y'X.N/#Y'
MB*+7]=:.6UUFYA@2YUB2-E@7:% !D!(SNY^M=1%XDTSP?H&CI=3:E=P:C.%M
M)FC:5@LKED5V)))56 ZDD+P#0!VE%<9%\2=.FGO+1-(UPZA:X+6/V(^<Z$9#
MA<XV].21U'K4T_Q'T&WT/2-88W366J2K##(D.0C$X(<YP",'(R3\IQF@#K:*
MY2S\5Z9XEFU'1'MM0L;R*$R&WNXVMY)(S_&F#G&<>AK$^'FOQ:7\)="N[YI[
MB:>22"*-/GEFD:9P%7)Y/'<X % 'HU%<XOC&U-WJ%@^G:A'J5E;_ &IK%D0R
MRQ?WHR'*MSQ][KQ4=GXWM-0\-66NVNG7TEO>3K!#$##YA);:#CS,8SD'G(P2
M1@9H Z>BN:U;QK8:2E_(;6[NHM/Q]L>V$9$)(!P0S@D@$$[0<"I9O%UCB/[#
M!<:B[VJWFRUV96)OND[V49.#@9R<'B@#H**XN_,'C_P[I>IZ#?7L9$XDAE@G
M$/E,,@^:,'<!S\HZ\#(!)K8U#Q1;V.J3:=%97E[<V]L+J9+54/EQDD#.YADG
M!X&30!N454LKN#6-(M[R(/\ 9[R!95#?*VQU!&<=#@UY)X3N]#-KXF_X2'7[
MFW>UU2>*!I-6D1XX@0%VKOR<'U!S0![-1U%>?>$?%MY8_#2#7/%#S2%I=D#[
M!YL\;,%C..!DYZ\<<UNIXVTU9]6M[V"[L;C2[<75Q%<*I/E8SN4HS!NF.O6@
M#;LK"VTZW\FUC*(6+,68LS,>I9B26/N235FN>@\76QF9+VPOM/1;)K_S;H1[
M#$NW)RCMR-PX_P#K4R#QI92:Q8:;<65]92:@C/:27"($FQS@88E3CG# 'GUX
MH Z2BN/^)/B6[\->&4DTYD34+RY2TMW<9",V<MCV /XXJU)X*LSILT45Y?IJ
M$D; ZA]KD\TN01N/S8QDYV]/04 =-17.QZVVE0:9I-Q:SWNLM:+)+;6C*[*%
M #.S.5&TMP"3R>G>J-[\2-$LO#DNMO#?/!!*8+B&.',D$@(4I(,X4Y(')P>U
M '436-O<7,%Q,C.\!)C!=MH/KMS@GT)&1VJQ7)#X@6/]I2:<^DZS'=^3YUO$
MUIS=)G!,8!_'YMO%,F^).C0>%)O$+V^H"WMYS;7$'D#SH)0<%7&<*<D=3W%
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MV.Q4-A<,3P",Y ZUP?B6\71_C#I-VEM>7<DFF3?Z/;Y=I&S@;5)P..IX'<T
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MENP5&),@%@I.2H)QGZ\5+'XDU.3QYJ&D?V:39V=HDP*2*7?<6^;'_ < ?XT
M=8KJX)1@P!(R#GD<&EKA?#NN^'M(\,ZKJ=GIUW86ZZG+'-;R'=+)<%E4A5+'
MDG V@]JV4\5I'KJZ-?V%Q:7TT#3VREE<7 7[RJ0?OCT/YT =#17!'XI6?]E-
MJO\ 8>JC3XKC[/<SND:B!M^SGYN><9QG&1SGBNZECCGA:*15>-UPRGD$&@!]
M%>8_#OPYI6L^%;I]0LWED-]<1"5IF#;0Y VD-D #CMT_&ET?Q3+X1UKQ-H.L
MW%S=V6DVXOK29SYDQ@.,H23\Q!90,\]<F@#TVJ5GI=OI]Q<2VV^-)R&:$-^[
M5N<LJ_PDYYQP3SUR3C6?BY[C5AI4VCW5O?26/VZ)&="K)N"X)S\K D9!%9'A
M7Q[)=^!H-?UN)8A<SO'!L=?WK&5U6-0<8P !DGH"2>M ':7]E'J%F]K*\JQ2
M</Y;[2R]QD<@'H<5+;V\-I;QV]O$D,,:A4CC4*J@=  .@KEK#Q+I?BS4=1\-
MW5L8[F"-92HE5U="1AT=#U4X]"#BIO!6M3ZE:ZCI]ZYDO=(O9+*25@ 954_)
M(0.Y4C/N#0!T]%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M7,UL9XFC\Z!MKQY&,J>QJGX=T"+P[I8M$NKF\F9M\UU=/OEF;IEC[  #T %
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M=C.7P".>G/!->W44 >>7$MS>?%;0=3_LK4XK;^S7CD=[1R(G<Y568 @''7G
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MO>_%CPHL(?\ T"UN[B=E' 5P$7/U(/Y5T^MZO#H6D3ZA-#<3K$.(K>,N[D\
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M!%*8)(Y(V65)=VWRRF-VXD@ 8R<U8TSQ!9:I>W-BBW$%Y;JKR6]S$8WV-T8
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ME_MB:VTA'D+><, A%<YRBG?\W. I]* /0Z*S=#L_L-@8'O#=W8<M=2E]Q,K
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M6Y5UP%7:"-P^48/K[5Z?10!XU>V5QX=^'O@G2+Y+E[VWU.WO)T2%I/)C#LS
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MX"TW3[NTNK6[M4*RQW%N\9!+L1@L &X],UV-% !1110 4444 %%%% !1110
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M;F\&;26XMVCCN/9&/?'.#@D<BL_Q0UUXL\'ZS8:-;RE9+9D2:8-#YKY!V(&
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MT86,&(FS=3;3RJ]2!PN<>N.AJ*^D)TKX:@07)-C);M= 6[DPA8PK;ACC!!%
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ME^4953GIVIGB>TOO'VIZ;I,&GW=KHUI=I=W=[=PM#YNT'$<:, QSD\X 'OW
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M,X!Q27_CC1K#4[73V^US7%W#YUN(+5W$JX!&T@88X(Z=.^* .DHKE?\ A/\
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M5NPK(D$:RR>9(% 9]NW<>YQVI]% !1110 4444 %%%% !1110 4444 %%%%
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M66RCT^YB;[3;;/F8 X8$\#MSR>< ]_3:* /+/#-G-9:]HQ\/V&M6>FS;WO\
M3-3MI!#8G:<-$\@&&))'RDY!.<5Z#HFK2:Q:2SRZ;>:>T<[Q>7=Q[68*>''J
MI['ZUI44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MQGO4U<?/J-LGQ2BL3HL1U Z6\D5_YOS-&&^YC''S9Y-9!^)NH'P]>:\OAO\
MXE]C=-!='[8-X 8*2@V_-R>^/QH ]'HKE=8\6W-C/=BVTY#:6UH+HWEW*889
ML@D1QMM(+8'X5B3^--4U/5O!DFE1016&L>=+Y<TI$CE(B=K84@*">HSD@=*
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M T^GW<%U"KE#)"X==PZC(X[T 6J*** "BBB@ HJO>W]IIML;B]N8K>$<;Y&
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MP/\ 4K+AI!^:J![#W-=G10!P#^"]1U!?&5K>BVAM]=8/!)'*7,950%W+M'<
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M5CIUOI>I6UTLEWJ-K<X%W"#S&R #+,, YX'8D<5Z+3)98X(7FE<)'&I9V/0
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M7N.0^0"6'^R/TSFLV/PQKYTCQI8206OF:W/-);2>?\JJZ!0&^7.0/;M7H=%
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MY<98#YL=* (?$5]J5U\4/"/V%K*:UD@N9[3=(VUP8AEF(![=,9KKM7:Y\/\
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MMNRREV@N8G8G!. 01G_Z]=YH<6L)9F77)[9[V0@M':*PBB '1=Q)/J2?7VH
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ME6WND/(8)(%/!'*Y_'F@#J+>XAN[:.XMY4E@E4/'(C95E/0@]Q4E<9JNJ0>
M=*T'2H##!:RR?9C>W0/DP84ME@N.6/ &0!D]A6_H-[?WVGM+J$,$<HE94>W8
MM'*@^[(I/8CF@#4HK(\1ZV-!TQ;A8#<7$TT=M;P!MOF2NV%!/8=R?:LZX\0Z
MIH;ZE+KMG"=.M++[4M];Y168'!BVL2=WH<\YZ4 =117%7?B[5=(L='U75+*U
M6PU&:*&2*)F\RT\S[I+<B0>N *K3>,?$#ZMXITZVT_3$DT...8O),[*Z-&7
MX4$D@>P'O0!WU%<!#XZU:33_  YK,NG6<6E:M/#;,IE8S1O)D!AQMVY!XZXQ
MTS@6IO%&O2Z[XBTNRL=/4Z5'',LTTKD,K(6 ( 'S''T'O0!VM%><P_$/5CHN
M@^()]*M8])U*YCM7C68M,A8E=XXQMR.G7'IVO:GXTU#[3K":1I[W!TN3R?+^
MQSRFZD"AF57C&V/ 8 9SD^@Z@'<45P<_C/79?$FD:19Z-;PMJ5B;H?;)'5X"
M!\P==HQ@Y&!G/'([.T[QY=7&AEY]/B_M;^UVT=8HI#Y3S#G=D\A=H)]>,=Z
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M9X!:LI@NS:RPQW*$=0L@R"#P1DUIZ[J#:3H&H:BD;2/:VTDRHHR6*J2!C\*
M&77B'2;.\-G->I]I49:&,&1T'JP4$J/<X%6;#4K'5(&FL+R"ZB5MC/#(' ;
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MAI]GI=E'96%M%;6T0PD42A5'X"K-8'@_Q$_B;0%OI[0VETDKP7,!.?+D0X8
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MOMSUJ;_A'-=UN/1+/7_L4<&D74=UYUM*SM=/&"$^4J-@YR>3[5V]!( R>@H
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M> ?#6D.AMX-6\1Q;K9P?W<,DA=(V'!XPI(]<UUNMQQ/\5]-LW&(M3T>XMK@
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MDC'F.>,D?W>G?TP 5+[Q1XDL8_#=_(NFBTUJ_MK<VPC=GMTDY_UFX!FQU^4
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M    P!VHHHH **** "BBB@!-HW!L#(XS2T44 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 4-1
MT32]7>!]1L+>Z,#;HO.0-M/J,U> "@   #@ 4M% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *0@$8/2EHH
MC$$0Z1(/HHIWEH/X%_*G44 ,\I/[HH\J/_GFOY4^B@!OEI_<7\J3RH_^>:_E
M3Z* &>5'_P \U_*CRH_^>:_E3Z* &^6G]Q?RH\M/[B_E3J* &^6G]Q?RH\M/
M[B_E3J* &B- <A%!]<4ZBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **:\B1(7D=40=68X IL-Q#<*6@FCE ."48-C\J )**** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** *=YJME831PW$VV616=(U1G8JOWFPH)P,C)Z<CUJO;>(M(O
M+VWL[>]1Y[F#[1 N"!+'_>4D8/X5SGC"*R;78+F#65T77+2VWP74Q'DS1LQS
M$X)P1E<^HZBN7EN)M7CT;6+2R2TU+3-+348K.%L%@)#OB ZA6CS@?[0H ]/O
M-;TZPO$L[BXQ<O$TRPHC.Y1>K84$X]Z@T[Q/HVJR11V=ZKR31F6)&1D:5/[R
M!@"P]QFN&:_M#XOT[6[VX2WEU#3+R;9<.%,,)\KR4.3P2 S8_O%JI>#I%M)/
M"-[KDZ?8H]-,>FSHNR."8C$D<K<Y<J."2!P>,T >B+XJT9M)N=4%VWV*U<QS
M2^3)A&!P01MSP>OIWK6AF2XA2:/=L<;EW*5./H>17CZ7"M\)O%C)?0"-[N\"
MI@$MND.W!SW[<<UW%S,U[:2Q:%/'?7,@MQ>0&\($<!4_<QD*6 (R,>O84 :X
M\1Z2UK#<QWJ2Q3S/!"8E9S(ZE@P4*"3C:W(XXS4=YXIT33]*@U.ZU"*.SN#M
MBDP3N//& ,]CGCCO7FCI=2:)I<'EC0I4UR^:WU(.&BLR))CM92 ,$_( < ]?
M:KRBQF\%:5-!J4FB:[;VLQLHX)R1<-YAW$(?]:)&56Q@GYA0!Z&=>TQ9A$UT
M%8LBDE6"JSC**S8PK'(P#@\CU%7IYX;6"2>XE2*&-2SR2,%50.I)/05YGJ^D
MZJSWFD6UQ;SW&NW5O=W,# L]E@)YC9SC:/+&W.#T S5SQ:/$&HV<5MK%M!8:
M2-3A\VXM)Q*WD L=SAEPH#",G((ZYXH ZN\\5:+I]I'=7=[Y,,N2C/$^2HZM
MC&=O(^;IR.:AU/QMX;T=X5OM6AB\Z$3QD!G#1GHV5!&#BN7D\6066B7-KJVJ
M0SW%Y<SVEE?21+\]OT\UMH *J2PX #%>.N:TI8--;PWH.@Z:XDM[_P F#S=F
M&EMX5#.3D<@JFW/^WQ0!T,WB/2(-3MM.DO%%W<JK11!&)8-G'(&!G!Z^E7+Z
M^MM.LY+N[D\N%,;FVD]3@<#D\D5QMSY(\<P3Z%K=Q)>&Z$6IZ89B\8CV'+E#
M]S&%PPP#T[U+J4DM]I?E>,98=#;[0#97%C?NIWA6YW8&#R< Y!H W)?%6CPV
M]O.]R^R='E3$$A(1#AW8;<JHR,D@#FI+GQ+I%G,L<UZ@!$;&15+1H)#A"S@;
M5#'IDC->::VVJ3Z5I4NH7+6VIQ:7=.]Q<*8UOXPX'V=EX(9T 8XP02,>T6MF
M4:M'=VNEFT$5MIXFT%R0=1'4*N,9,1(7I_"<\#! /5CK-A_:PTOSF-X1G8(F
M('&>6QM''O46H^(M+TFZBM[VX:)I"J[O*=D0L<+N< JF3P-Q&:YNPAMH/&?V
MG0-3GF@FGF&KV;R,Z1, 3Y@W?<;> N.X/' J+QGJMMK6E0VVCZK%->K)!=1V
M"PB3[6-ZN@((R%X!)'3OQ0!WM%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %->1(P"[JN?4XIU9
M&O\ A?1O$\$,.LV0NHX6+Q@R.F"1C^$B@#(\>VNIZCI=M#8Z1'J]B9-]Y:?:
M?*,R@?*H/?YL-_P >M/\!S>'_P#A'Y&T2Q&FHL[+=VLA.^&<8#*V3UX'X588
M7'A:+3]+T/P[+=Z6JL"8;I0T!SD#$A&0<GG=Q5>W\&6&HZ;J"Z[9K(VIW8O)
M[=96"QL %50RD9P!R>Y)]J .I5U<91@P]0<TZLK0?#FD^&;.2TT>T^S02/YC
M)YC/EL 9^8GL!6K0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 C(KKM=0P]",TM%%
M !1110 48&<XY]:** $9%=2KJ&4]01D&@HI96*@LO0D<BEHH 0* 20 "3DX'
M6E(!&",@T44 ( %4   #@ =J-H)!(&1T-+10 @4!BP R>IQUI:** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
HB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>davidjkatz_employmentagr006.jpg
<TEXT>
begin 644 davidjkatz_employmentagr006.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***04 +1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %(*6D% "T444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !2"EI!0 M%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4@I:04 +1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %(*6D% "T444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !2"EI!0 M%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4@I:04 +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %(
M*6D% "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2"EI!0
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ME4ZY;9B"EN&_BZ8XY_#IT-21^/?#$L]Q#'JT;2P*&9!&Y+ G *#'[S)X^7-
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M&OZ=X=T2UN=3U:>YLKR4O9WC0R2;D<AHU8A3@X; SC('K6K/KUI;ZW!I4B7
MFFMVN!)Y9\M47J6;^'&1U]10!J45S\7C+29-0M;-S<P_; 3:3S0,D5QQG",>
MI(Y []NHJC/\2O#4$,LWVBYDB@F\F=DM9"(#G&9./D&>.<9P<9H ZZBN3O?&
MHMO&UCH$6GW,T=Q;--YZ+D-RNTIZ@?-D\>V:O+XNTY[Z*V6*\*37)M8[D6Y\
MEY02"H;V(89Z?*<4 ;U%%% !13)8EFA>)RX5U*DHY1L'T(((/N.:\M\)ZCI8
ME\3Q^(/$=TAL=8N((!<:Q-&RP)C  $@)[\T >JT5R2>(['PKIVF6NIWEY=&^
ME86LQADD)1B60,QSE@N!U+''2HH_B3I,D=XJZ?K)O;-L36'V)OM"J1D.5Z!2
M.Y(ZB@#LJ*Y>\^(&@V>GZ1?M+<2VNJNJ6\D4#,N3_>/8C!R.O'0TND>*M-\6
M2ZCI*PZC87ELH\V"Y4V\P5NCKM;('3GCJ/6@#IZ*X?P1K<5C\,= NKQY99IX
MQ%&@.Z2>0LV%&3R3@GD\ $G&#6HOC2S,6I*]AJ$=]IR"6>P:-//\L_QJ VUU
MZ_=8],=< @'245S,'C6VNM!TW5[;2]1F@U&8101H(BY)S@D>9@#@]\C!R!3]
M4\:6&E&[>2UO9[2R=4O+J"-6C@)QURP8X# G:&Q0!T=%8%[XML[8-]CMKO4S
M';K=2BQ",8XF!*L=S+G(!( R3CI6?JD/_"8V.A:KH6I7T:+,)HYK:8)'M/4R
MH1EL %0O7).<#- '7T5SNJ>+K?3K^]LXM/OKZ2P@6XNQ:JA\I&SCAF&XG:3@
M9X_*MVUN$N[2&YC!"2HLBANN",C- $M%96IZXEA=1V4%K->W\D3S);0E0VQ2
M 6)8@ 9( YY)^N,(_$K1O[*M+_[/?F.>\^Q2((,M;S9P5D /![X&<T =E17'
M1_$&"6[O; :%K(U.W59$LC OF2QGHX.[:!ZY([=3Q1)\2=(C\-6.N_9KYK>[
MG^S;%B!:&7.TJXSQSGIG- '8T9STKE=-\866MZU<^'KO3[_3[IH3)%'>)Y9N
M(CD$I@Y_#@C\#C!^'^M6VA_"VQN;D2RE[N:"&&,;I)9&G<*BY/4^Y[$T >D4
M5S4?B\-J-YI4NE7<.JP6_P!IBM'9,W,?0F-@=I(/&"15?3O'<&J>%8-=M=-N
M62>Z6U2V+H)=Y?9R,X')Z9Z<]* .MHKCY_'R)K>JZ/;:#JMU>Z<BR2)&L8#*
M>=P);&,<@=3G@=:KP?$VPN;;2[Z+2M1_LR^DCA-\R*L<4CG;M.3EL-P2 1UY
MXQ0!W%%<QK'C2VTRXOX8;5KMM/0/=;9D3;D;MJAC\S;<-CI@CG)Q54_$.TEO
M=.M[#2M0OEU&V:XM)(/+Q+C&5Y;Y2"<'=C&#UH [&BO/]5\?7K^!]3U33M+>
M#4+&<VEU#/*I-L^0-W&0_P!X8]:[V%I'B#2Q^6YZKNSC\: "26.+;YDBIN(5
M=QQDGH![T^N'^(L5O#+X:U)K-IKF#68%0Q)ND*D,2J_4@<>U7+/QU;^?K%OK
M%C+I4^EP+=2I+(LFZ$C(8%>,]L>I'6@#K**XJW^(UE+K%GISP0M)?1.]K]EO
M8YB749\IP" CD=.2,\9J#3_B6E[:-J#Z#?0:9#YXNKMG0K T6?E(SR3A0,<9
M8#)P< '>45Q=K\1+277;/2I8[4/J"M]D>"]68;@ 0DNT?NV.>VX>]1O\153P
M%<^*_P"RF\JUG:&6W,^&R)!'D';@\GVH [BBN/G\:7Y\47&@6/AZ2XNH[072
M.UTD:,I.!DX.!^9SVZD&G^/H-2\/:9?PV3"^U"Y:SCLFE'RS*6W9< _* I.<
M=,<9.* .K6Y@>=X$FC:9 "\88%E!Z$CM4M>::9J"Z5\1O%NHZE9Q6*VVF0S3
M^0_F+(!N)<$JN21QTZBK]E\3K&ZUS3-.*6<G]I ^2;.^$[Q/C(65=HVYSC()
M&<_6@#O**XKPYXWU/Q%J3PQ>&I(K."^FLKFZ-VK")D7.=N,G)X]LCDYX[1MP
M1B@!;' )P"?K0 M%<+_PGU\/#NOZBVC6R76B7#PW%FU\02JC.\-Y??\ AXYY
MYK8M_$-WJ,>E-I]C:W"W]D;MB;HJ(QA<#[ASDN!DXZ'CB@#4_MK2OL"W_P#:
M=E]C8X6X\]?+)SCALXZ\5,U]:+>K9-=0"[=2RP&0;RHZD+UQ7F.OS6%_\"GN
M[/2H=-A\V,QVT6'$1%TJD@X')P>W>MK7]J?&#P<0OS/;7@+#@G" \^M '>44
M5P&E>*-67QKXQCU,VPTO2(X&.V5AY,9CD?<HV_,QXSDKC QF@#OZ*X*'XARO
MJ&CQ_8K:>#5&"J+:<O):DCY?-&W'.0"0>.?O8S3M)\:^(-;:Z:R\-VYBL[^:
MSN&>_P !=BY# [,D$\'CC(X/) !W='2O-;;XF:K-X?T?Q WAV/\ LR_N1:ML
MN\RABY4$*5 QE2.6&3Z=:W=-\4ZG-XLO?#FI:5;P7J6(OK;R;DNCINV[68J,
M'=QT/?\ $ Z2QU"SU.V%S874-S 6*B2%PZY!P1D>]6:\WM_&DVF?#6?7M.\.
MV,$5K=2Q26<4^Q$_>[=PPGS$L<GA:W+?Q5J,7C"'0]4TR&W%Y:O<VK0SF1_D
M/*.-H&['/!QVR>M '645P$?Q!O8+W1(-3TZVMI=5N#!]A\\_:;7)(1I%(Z''
M/3&>_2ETGQ)JFGGQ=J&NS6TMMIER5V6ZL#Q$A54!/?=W_B/I0!WU%<58^+]5
M;Q'I]C=:>LUI?JW[ZVMYU^QN!G;(77# ] PV]\CO7:T %%%% !1110 4444
M%%%% !1110 4444 %%%% !2"EI!0 M%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Y_XOT?78M/\5:FF
MH:<UM/I\J*DUJ[2QPK$<HK"0 9.XYVGDC.< #T"B@#A/"6MQ^'?AMH%SKMW$
ML$T5O#;&"WDR-R#:K8+9/!^;@>PJK\7-0LK;3]!@GNX(IO[8MIMCR -Y:EMS
MX/\ ".YZ5Z+10!F:EKVGZ5%8RW$C-'?7$=M T2%PSO\ =Y';WK3HHH ****
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MM<M[=19ZE81LR77RY$<@ VX#8!W8[<\8KN]+:]?2;-M11([XP(;A$.563 W
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MJ&97&%Z@X'.<?TKV.B@#@-.L-<M_B-<:W/H,ZVLFEK:%DN86S(C;N 6!VG
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MJ.UO5\VT&Z>.9&B>-?[Q5P#M]\8J/3_%VA:G=&VMKX>;Y9E42QO%YB#DNA<
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MM9/,WNS[1MVY.<CGI0!V%IX^\.WL=Y)#>2%;7RM_[AR6,OW @ RY)XPN:?\
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M'<&1HRJL0"H&&).0<@XQP><U;UC6;;1;:*6XRSSRB&")2 9'.2 "2 . 222
M *YKP9<1IK.I)<Z-JMAJM_\ Z7/+>K'MF";4PA0XPNX<?[74U+X^T75+^+2M
M3TB"&[N=*N3<&SF.%N$*E649XW8/&?>@!)/B)9I!K.-.NY+K2%62YMHWC9O*
M(SYBD-M8 =><CTK6B\2)<:?HMW!9RR#5MOE('7<@*%\MSC 4'..^!WJOX=-W
M?^?/>^'8M'MVC$8MWV-)*3]XMM& O0 =^2>U9'@?PIJ&AW5[!?R,UC8R2V^E
M+NS^XD8.6/O]U?;:: +-Y\1]+LX4OC$TFDM<_9C>)*F0V[;NV9W; P(S[9 (
MYI;GQW(FIZQIUKX>U"YN=+C260!XE5D8$[MQ; & "!]XY/'!KG?#6D>(O#UN
M?"S^&;.\CB=Q;:S(Z>6(VRP+J5+$C.,=^F<<UJ6=KJO_  EOC.9M&O%@U"VA
MCMI"8PLC1QLA_BXR6R/;- #]0\;W=S/X3ET:Q,UAK#EF9I%5SA&;RP,X!&.2
M>.,5H7GC<12:L++3)KT:452[$<JAU8C/RKU(&>3]<9P:Y>U\/Z_I'AKP5_Q)
MI+FZT:Z<W%LDT>2&5@&4YQCYA[T[Q%H.JZS?7-[!H%S8>)(Y@MAJEG.JQ%!C
M_6DMD@?,.5Y&/I0!ZE7%>'-4AU6#5_&%_N-M!+-'9@@L(K>+(9E&/O,0Q)Z\
M =J[*(2+"@E8/(% =E& 3W(':N \#07NB^#-:\/00QRZEI,UQ';P2]) P+Q$
M\CY6+8S['TH V;+Q;<WUK;W4>D'[/=63WEO*+E64A=OR-@?*V&]QP>:IO\0X
MU\&Z7XG_ +-?['>RK$ZF8;H<OL!Z?,.#69H/A:[MO$(N-*TRZ\/V,L$B:E;2
MRI)#*Y4;#"JL<8))W?+QQBLF7PKXLD^'-KX472(/,LKI6%RUXNV91*6W*,9'
M!YS^&: .YU#Q5+'<ZE#I6G-J!TM ]X1+MP2-VQ.#O? SC@<@9YKE-2U#=\4/
M#.K:;ILDDU_I,LAAPL4C@@%1(3TQQG.<8XSTK2CT_P 5^'?%.K7NF:9;:G8Z
MN4G:-KL1&VF"A3R5^93[#/'YK/I&OGQ]X?U:XLS=QV=G)#=W$3QHI>3NBE@=
MH/'/.!W- '0>%?$1\2:=<2RV3V5W9W3V=U;LX?9*F-P##AAR.:P_'UO&?$'@
MNY(7S5UA(P=O.THQ//X"M#P?::E976O&_P!-EM4O=1>\A9Y8VRK*BX.UCAOD
MSZ<]:C\9Z?J=_?\ AV33["6ZCL-12[GV21J-H5EP-S EOFX[=>: (=<\=RZ4
MNJW,.EF6RTB1([N2:4Q,Y8 _N05(?&>Y'M5FY\8M+K$>EZ3:0W-T;)+XQW%Q
MY)>-LX6,;3N; R>@''/IRGB'PKXHU@^)[>?2[2^>\!_L^^FN54P0\%8D3!PW
M7)X![G@5;U#PWJVLZ;#::SX;@E:WLT2RN+2]59K:8*1G<=OR\*3C.#T#=: +
M3^)]?N_'^BZ;#9V\%M/IAO6BEG96.[:"&PG!7D =_45W-]>0:=87%[=2".WM
MXVED<_PJHR3^0KA8O#7B33_$_AS5F:#5)K?3387LCS>7M;.[S.02P[=,G'O7
M7>(M(37_  YJ&DN^P7<#1!_[I(X/X'!H \]\9:CJ&KP>$=0ETJ"&PN-:LY;>
M8S9F56;*AUVC;N'. QQC!KHO$?C2^T5=5N8=*1K'2PGFRW4K0F=F&2L/R$-@
M8YSUX]ZPI]"\<:AH&AZ7=Z?I?FZ/?VTPN!>$+<)%T.W82O'4^O05-K/ACQ1J
M-SXD26TTZZ^WVYCLKJ68G[,A7F)4*]21][CKD],  VG\87R^*M$TT:9 NG:Q
M"9K:[>X(;A [*4VX#8/'.#ZUMZ)J5WJ?VV2>""."*X>&"2*4OYH0E68@@8^8
M$=^AKCO$6FO=^!=,TZ[N+>P\16+V[6*0S"5A,I")QQD-W[#KSBN[TO3XM)TJ
MUT^ L8[>,1AF.2V!U/N>I^M &=K6O_V?JFF:1:Q)+J.I,_DK(VU$5%W.[$9/
M Z =3Z=:R[7Q3J=U-K.C26=K;Z]I\:RJIF8PSQ'_ ):*=N1WX(.#BI?%'A_4
M;O7]#\0:3Y+WFEO(K6\S[%FBD&U@&P<,!TIUOH%\^N:KX@N8K9;ZZM$L[: 2
MDB.,$D[GV]2QZ $#:.30!B?">VFOO VCW>HV]G,L/FR6DQ!:97,D@<G(XSGJ
M#6[XE\6QZ/J5MI<,MK'>31-<,UUNV)$#C/RC)))X'H&)Z<N\!:%J'AGPA9:-
MJ/V9I;4,!);R,ZN&=F_B5<=<=ZI^*O#^N/K]CXD\,S6O]HV\+6LUO>$B.:$G
M=C(Z$'G_ /5R 8A^*%Z?#]G?Q:*CSOJ:Z;.IE*KN;D-'E1N5AG&<8[UJQ^*/
M$Y\0W.@2:/IJZB;5+NV87A,0C+%3O.T,2",?*O/L.:@U[PUXJU_2--6ZGTMK
MZ#4XKZ2-972&-8\X1#L9F)R22<<]JOOHFN'XA_\ "1+!IQMETTV2QF[D#D[R
M^X_N\8R<=_7VH Q9?B7J \%6.N1:1"T\E_\ 8;F(S8"/NVY3CYL^Y&/>M;3_
M !7K4'C*#P_XATNUM3?0O+8S6LS2*Q3)9&) Y"\]/YUQ7B'P_JGAOX=)8WGV
M/S6UZ*X@,4SR EY"=K91<8]1G/M7H$FC:KJ/B6RUK4(+"-M,MYA9P0W#OOED
M 5F=R@PNT8 "GJ3[4 <KX3\2+X>^'<<GEK+<W&L365I"6P'D>9L GL!DD^P^
ME=&?$NJ6'B>+P[J<=E]JO[=Y=/N8581LZ@EHW4DD$=<@\^@Z5@6GP[UD^$UL
M+BXL;?4[/4SJ=A<0RO(@<L6VN"BG;SCC/Z8/1_V)<77B&S\2>(?L-LVE6TBQ
M+;SLZ L/GD9G5<  ' [=2: *6D^,M2U+PW+</:VT6LQZE_9SV85BJR;@""<Y
MX4E\^@--N?$_B>7QGJ'AO3K'2O-@LUN8IYY9-I!;&6 &<_[(_P"^J-"T[3M2
M^(6H^(-*OEN+ P1%Q"^^)[HAE+ @XR(\ C_;JS%H&MP?$74/$2QZ>UK/8"UB
MC-RX?*G<"W[O !/'!./?I0!SR_$CQ"?"FG>*GTFPBTIIU@NXVD8S,?,*,T8Z
M  CHV3_.MK6_&]S!JVK:=IBPB;3(T+"6UFF\^1EWA!Y?W!C'S'/)Z<5E?\(!
MKTGPNA\*RRZ:MVESYS3+*Y0CS3)P-F>X%:=[X:\4V/B:ZUSPW?:;$VII'_:%
MK?[Y(U=%VAHRH!/''.,_E@ JOXZ\07.I^&;2STBU@?6K:9S'>LZO#)&A)!P.
M%!P>A)'IFLW7O%WB.3X=>*9)FM++5=)NOLDLEHK,DBL4&4W'*G#]3G\#TZ:X
M\+ZK/XJ\-:Q+>6\YTJ.<3L^5:9I5PQ4 $*!V&>G'O6=?>!=4U+1O%NGS7%G&
M-;F%Q"R,S>4Z[<*V5&0=@Y'J>#0!VNE"Y&EVWVN6.6;RP2\<90'CC@LQ_6L"
M+6[M/B#J.E36%H5BTQ;N&6')FE7>5"DG '(/'/4<UN:-%J,.E01ZJUJUVJ@/
M]E#>6,<8!;D_7CZ5A3:!K#>.+O789;)(9=.^PQC<WF)ABX?[N/O'IZ=Z *'A
M?QCJGB2;3I[8Z;/;2NZZA;(K1W%A@-M#!G^;Y@!G:/8<\;GC:\OM.\&:M>Z=
M<)!<V]L\JNT>_&%)XY&#[\X]#6#!X,U6]\1:'K6JG3(+[3<F>ZL=WF7N4 PP
M*@*,Y_O>V,UUFO:6-;\/ZAI9D,?VNW>'>!G;N!&: /+];;45\+?#:0O!<W1O
MK-H!M:,?ZH;0Y)8DYZL,?2M^+QQJNCW/B>T\0164LVE6\=S UF&42B3@*023
M][ S[TR7P;XFN-+\,6L]UI+2:'<0S*4$BAUC4*%/!R3C);CZ58U'P)=ZSX@U
MZZO9K>.RU6R6TQ$[&2+8<J_*@$Y ./UH FT[Q+KS^)K"SFL9[NPNT;SIETNX
MMA9N!D9:0893TSUKMZY+P_HGBJVD@CU_7K>[M;3F(6T)228@8!E8GH.N!U/4
MG'/6T %%%% !1110 4444 %%%% !1110 4444 %%%% !2"EI!0 M%%% !111
M0 4444 %%%% !1110 4444 %%%8?BV\U&P\/RW&F6MS<S*Z!DM5#2[-PW; >
M,X^N,Y[4 ; C6-/W,: @':/NC]!Q7/>$?#ESH$>I"[>VF>ZOYKU'C!RGF')7
MD=L=>]4Y-1U[4M:N-/BLM1T^*>P#6UX40Q0.R@G?G),@)(QTXZ<YK-N6U:U^
M).F^'QK^I26=UI\L[EC"'5P< @B/]* /071)%VNBLOHPR*=6+%=KH%O';:IJ
M4UY-+*_V<^49)I%ZXV1KD[1U('3!-5W\=^&8[*WNWU6-8;B;[.A9'!\P$ JP
MQE2"1G<!C/- '145RT/Q'\)7#PI'JZ;II'BC#0R+N=!EEY7KTQZD@#)(I?\
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M@CN"*DHH JZ?IMCI-FEII]I#:VZ?=CA0*H]\#O5JBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *04M(*
M%HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\RUS4[6+XZ>'O],@5%L9H
M9B9%^5B&(4^A)VX'7GWKTVB@#SCQO<1:1X[T?5M8CG_L%K22U:XA9P;>4MNR
M2AW8( 'X5A^+IO#9\%AM(B%O97FKP3>9(65KH[AYD@$G) R 6[G->QT4 >=^
M+;_35^(?@5S=6OE^;<R$[U(^>(!&^A;H>YK)M+RSE\2_%3R;B%O.M(5CVN/G
M(@=6QZ_,0..Y [UZU10!XRLL:^%_AF2X!M+V(7"8.Z+"G.X=L=\UTMC>6P^+
M'B*0S($?3(560GY6*Y) /0D9Z?X5Z#10!X?X;UB'2O"7@S3[_=8(6O!-J(M\
MRVS%WVQH2I\LN&'..G3U%>__ 'OPV\;6$"7LDT6M?:2LZ2%_*+1$,S,.3A2<
M'G KWBB@#S?Q!J=KJWCGP#J%F[R6OF73F0QLH"L@56.0" 2.">M5-!N(M$T?
MQ?H.M(ZWLMY=3Q1/&7-W'* %,8XWY/&!CKVKU.B@#R+3K"?1/$_PWL[XMYMI
M87"7!.2(F=,*I/0<_*/I73^![ZUN-?\ %:PNQ\W4?/CW*PWIY<:E@2.1N!'%
M=M10!YQXSU*UM_B=X-ED=_+L3=FY=8F81>9$H3) [FD\9K+\01I_A_28+EM.
M-TDVH7KPM'&(E_A1F'S,3TV@].N,UZ110!XUXLDEU+_A,[&XL+^*]5<6-M:V
M\BI<1A>9G9.)#V^8\   9K6LK[[-XI\(ZC)8:@;>316LU86<A(EW)P1C*\*>
M3@8YZ5Z?10!Y#H*6.@7FHZ!X@\)RW]^UY-+9W/V!9Q=H[;ES(1P>>2QP.YKU
M>RC:&PMXGBAB=(E5HX1A$( X7V';VJ>B@#C_ (H^8_P\U.V@C,MQ=>5;0Q@\
MN[R*H _//X5L:??I;ZC%X?%G?;K:S1S=M#^X.,+MWYY?OC%79=-@GU*&^FWR
M20*1"K'Y(R>K ?WB.,GH,XQDYMT %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4@I:04 +1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "D%+2"@!:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\_P#!
M-E<:%>>,-"A58[H7SWUHTAR'25!L..X!3!]Z] JM<6%M<W,%Q(A\^ GRY%8J
MP!QE<CJIP,@\' ]* /)8O#_B:X_L"^N?#<K:KI^IK+?W4MW&9+K[WS+Z(,CC
M( SP#U'5ZK;RZO\ %;PZ$7Y-&M)[FY9>0K2@(J$^IVD@<' )KN*JV6GVVGI*
MMM'M,LAED8L69W/4DGDG@?E0!:HHHH **** &3.T<+ND3RLHR(T(!;V&2!^9
M%>>^ =*UGPOX>O=.U'P_<SM<7DL^(IH&0HX P=T@]#GBO1:* . U:R\1ZC>^
M'KV71F:2RU!KN2..:']S%AD$:DL-S8VL>W/7CB?3-/U?3O'WBC6FTB>2UOT@
M6VV3198Q)M.07X!ZCVZX/%=Q10!Y.]IJVA^$? VGW&F$7]EJ\4?DM,FV7]U,
M<JP)QP>^.?SKHY]'U"\\1ZAXEDTR9)1IG]G6MF98S(^6+,[$-L R<8W$X!/H
M*Z#5?#NFZU<6T]]'.\EJXDA,=U+&$89^8!& SR>>O-:HX&* /,;;PEKR>&O"
M$L5G'#JGAV;Y[669=MQ&1A]K+D D8QG'.<]L]);:?<2>,)O%&IQI86\-B+."
M*:1=X!?<[N5)4#. ,$]\XKJJIZII=EK6F3Z=J, GM)UVR1DD;AG/48(Y H Y
M#P5H26OB;Q#=PW!FTZ*\=+!0<K$9 KSA>V-V![;3[U7TC2O&/A2[U+3--LK&
M^TNYN)+BSN);@Q_92YR5=<$L![=?7GCNM/T^TTJPAL;"W2WM85VQQ(,!15F@
M#S^32?%WAOQ7?:AHEO:ZM8:F(WN(9YA"Z3*@4N#C&#@$@9Z\ 8KMM/2]6PB&
MHR1/=D$RF$80$GHN><#ID\G%6J* /*T\*>*]+\':MX,M+&RN].E6465X;GRV
M1');:RD$ELD\YQ[ULOX?UIM;\%7GV2!8]%@EBN@DP.=\:H-G SC;D\#VS7=T
M4 >=Z)HWC'PM+>Z-IMOIUSI4]Q+-:WLLQ0VH<DX9,$N0><# ]QV=XL\*ZCXE
M%W;3Z1:23QLO]F:L+CRY8  O+X&20VYL#@^U>A44 9=G_;,>JM!<I:OIJ6R"
M.X#GSI)?XMRXP!UZ?_JU*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ I!2T@H 6BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH *04M(* %HHHH **** "BBB@ HHHH **** "BBB@
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M&   /3UR:T*0,I8J&!8 $C/(S2T <3!X"GL;#5='L-8\C1=1=W> VX:6'?\
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MLV\$+3R/*J_:A@[ ",@<=S@],XQQSEOH/B."P^']X=&)GT7S(+BU$Z[@KQA
MY/0#(R0,D#%='HVDZK:_$G7=7N;$I97\$$<<JRHP#1K@Y&=V">G'U H ?IOC
M=]5\()KMOI?[U[H6RV;7&'W;PF"=O!R<X].<U!K/Q#M]-DO_ "$LITTTE;M'
MODCE9@H9EB0CYR,X.=N2"!DT:7X/N=-\>:A=HX&AS2?VC'%GD7CAD?\ #;D\
M]V7'2JMGIOB[POXBUD:7I]KJFE:G=->1F2Y$+6\KXW;L@Y7Z#.!ZT =KI>HV
MVKZ7:ZC9OOM[F)98V(P<$9Y'8US?Q$UO5=#T*WFTQ(LS7<4$DCR%60,X'R@
M]>1GM[U8&J:YI_B72M(NK:"[M+F!O-OE<+)YH!9CY8Z(, 9YY9>?5?'FC7VN
M>&OL^G*DES%<PW"Q.VT2;'#%=W8\=: (]6\7MI]W_9P73(M12W%Q*EW?B*,
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MG?9*L:[CE?,R"?KQZ&DF\+>,=3U70-0U/4M%$VD2NP,,,K>:&4+ELD<D \#
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MBBB@ HHHH *04M(* %HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MGC(ZU>TOQ-J\?C-O#>OV=G'+/;F[LY[-V9&0'!1MP!W#GGOZ"N8U;2=:\/\
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MK(;02PMF3RTW2$D/R,Y4=.5-4-9MO#VB>"U\!R7(GO+BR9+:U/\ K)W).&]
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MN+:*"[A,!+-Y;,PV'=@9W8.<\>_(L>,O#\WBGPQ=:-%=QVHN=H>5XC)@!@W
M##G(% &/XJ\57.C:[:V<]TFD6,MN734)K8S0O/G'EL01M '.3C.>HQST^F->
MS:#:-=RP_;WME,LD/S1^85Y*^HSTK%O= UJX,\0O[">PN+)+9[.YMV:-7&[]
MXOS>X^4]<#D5K>'=$A\.>'K+2()9)8[6/8))#RW<G\R>.U 'FOA[Q%J&@Z#X
MMU2XN?MMP->FLHHVB \V<^6BN<'IC'RCLO'-=':ZOXP_M.XMC9L]H]JSQ7MW
M:"(02C)VLJR$LI'N"#4<?PX=[/Q)IEWJ@;3=6O)+V%8X=LL$S%6W;L\[2HP
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MO(;A[= T+EBK *%"D'&0#G''O3W^'(?P]I.B'7+H6NEW"W$!$,>XLIRNXXY
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M *  !@# HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH *04M(* %HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M/? X Z #L * .7\6>*9-$UV"TNKUM*L9;;=#?M;>;"TY+#9(?X0 %;@@G/7
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M_P!O':@!M_?^(5^(5GX:M]:$=O+I)G:9K6-I-X;:6],\=@%YZ&L.Z\2^+8O
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M'Y4*1EV<HH7>YRS8[GWKA_$PEO/$]Q;0W-S>&/3=QTZ&=[>.!B^1,\BMU^7
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M#-<1SG=(K2R A\_?Z ?-GI6];Z,TOQ"UCP\^JZJ=+ET^.[DB-ZY+R,Q0_/\
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MJ6VA^)--&M6C#7;B:>60V+9C,HPX \WGC&/3WKO*R/$/B.Q\-:-/JMXLTEM
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M*4"%R>HZ9"GN >G%78?"$T&M:IJ::W="748EAD3R8MJJH(3'R]MQ^O>NHHH
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M-Q(0RCH-I;: /0"M.F"6-I6C$B&1>2H89'X4^@ HHHH **** "BBB@ HHHH
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ML]!TZ.PL%E2VC&(TDF>38/0%B2![5FWO@S2K^^O;J9KT&^*F[BCNY%BG 55
M9 <$84 \<\@\5T-% &#JG@[1=8U&VOKJWD6:WB\@>3*T0>+.?+<*1N7/.T\=
M?6JK_#SPS)H$VB-IP-E+(9B"[%D<G.Y3GY3],#MTKJ** .9'@#PX- ET3[$Y
MLIW62<>?('F8="[@[FQ@<$XX%6'\':1+J=EJ+B]:[LD"6\IOILHO<??YSWSU
M[YK>HH 9-#%<0O#/&DL4BE71U!5@>H(/45@6W@?0+/Y(+:=;<'=]E^URF#_O
MT6V8Y/&,5T5% &->>%=)OM:LM7FBF^VV0VVSQW,B+&.X"JP7!'!XY'!K//P[
M\,O;WT$ME/-%?/YEPLUY-)O?/W_F8X;_ &ASCC-=310!RO\ PKKPJ)A,-+VS
M>1Y'FK/('*YSDMNR6_VCSCC.*G7P-X?73++3C:S-:6,PGMHWNY6$3CH1ENW8
M=LGU-='10!Y/JG@J2\\6ZE?:KX-.J>?<!K2\LM1\@I&$50'&Y3NXR6YR2>P%
M=;:>"--N/"J:+K-HMU;^8TB0R3/+]GW'A5D)W<9QGBNKHH HZ1HVG:#IZ6&E
MVD=K;*20D8ZD]23U)]S4,WAW2KC53JDEKF^,?E>>)'#!/[H(/ ]JU** ,$>"
MO#HTZ;3QID?V.=Q)+!O?8[#N1GG_ /5Z5LVMM%9VT=M I6*-=J*6)P/3)YJ6
MB@#)NO#&BWNH'4)M/B^V%=K3QY1V'H64@G\:MQZ5I\6G-IR65NMDP96MQ&-C
M!NN1T.<G/KFK=% &98^'=)TW>;2R2)FB\DL"2P3^Z"3D#V%4_P#A"O#@TZ73
M_P"RXOL<T@EDAW-M=O4C/-;]% &1)X6T.::SFETR"26R3R[=W&YHU] 3Z=O3
MM4VEZ%I>B^?_ &;9QVWGOOEV9^=O4^_O6C10!EV?AO1M/N1<6>G00R!F9=BX
M",W4J.BD]R ,U*NB:6E_-?KI]NMW.I2:81C=(#V8]Q]:OT4 5=/TZSTFQBLM
M/MH[:UBR$BC7"KDY/ZDU:HHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ I!2T@H 6BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH *04M(* %HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ JE>:G%9W-O:A&FNK@GRX4(W%1]YCDC"C(R?<#J15VN'\.W$E]\5?%[3MG[
M!#9VT _NHRL[?FU '<5GV^JH^J2:;<1FWNPK2QHQ!$L0;&]2/J,CJ,CL03Y^
MLWB[Q3I]QJFBW @NDO)5MV-_MBC6.4IY;PA"&RHR223SD$<+6KXTGEM[OP1J
MH51>_P!K16S>4V5V31L) #W' Q]* .[HHHH **** $.0"0,GTKFK#Q=+J6HZ
ME8VVA7K3:=,(9\RP@9(R,?/R".:Z:O.?#D6JR>,_&O\ 9MW:08OHMPN+9I<_
MN>,8=<<XH [;2=3.IQ7!>SGM);>=H'BFVDY !R"I(((8$5H5YGXLOM>T;P!I
MC2:H]OK45W ET8'#;M[GKG)P<<=.XZ<58.CWJ?$&;0QXDUAK&]TPWDP:X'F"
M190GR$#]V"#T4#ICI0!Z)39&98V94+L 2%! +'TYKQ:]US6D^%>K21ZQ>I<:
M9K+Z?%/Y@\QXA(@&]L9) )&0176"#4O#?Q*T>!-7OKZPUJ.=;B*\F#^7*B;P
MR  ;0<8P!@?E0!T'@_Q*?%>BOJ!LS:%;B2 Q&3?RAP3G K?KQG0-=N-"^',0
MM9/)DO\ Q&UB;C:#Y*O(=S\\9 !QGN172:FEQH'CK0]*M+Z^;3M=CN(;B*6Z
MD=HGC0,)(W9BRL<\X.* /0J*\M\/WMY(EYX/OM1OI-;MM46-KDWDGF/;<R"3
M((P#&"N!QDKFK-S)K/BG6?$>FV4BH=,=+>V(U26W:([ PD(1&WDDG[QQQC'4
MD ])HKRT7_B+5?$-MX9O;BRNKBWTC[3+]FOI;9)Y_,*;O,C7<0 .5P.23V&.
MP\%VFM:?H;66O7UO>7D$[*'AF:4K&0&579@"6 /<=,&@#;6\MWOI+)90;F.-
M97C'558D _B5/Y5/7E%L(M'^('Q#U6)9I)-,LH;J)'N9-K-Y#.0WS?,">QSC
MMBK6BZ=XGO&\/^((=5MHX)@CWKO?RR"YCD"Y C9=BMDX7;C'3F@#TVBO+?!6
MDWFNWNN3WGB+6\:=KMU;1(EV0&C"A<-Q[CIC&.,9-<_'-JL?PR\->(O[=U0Z
MF]^D.]KEBFQI7!!3HW3JV3^&!0![E6;H=YJ=[8O+JNFC3[@32(L0E$F4#85L
MCU%<II]M-HWQ+DT6/4]0N+*^TDW#K=71D995DV[E)Y7()X&!^0KDYKZ]B^#V
MM7J:WJ)NK+5WC68W#[T7[0B;2QY8;3G'3F@#VFBO.&:?0OBA!:1:O>&TN](E
MN;@W<YE0.K']X >%QZ+@>U85K<7UG?>"KJ":^>._NC#<7\\S*VH*ZDY,63A>
M?E)(([ 4 >NPWMO<7-Q;Q2J\MLP691U0E0P!_ @U/7C%BY\-6WQ&U#36F2;3
M[G%MOGD=$+* 6*DD,>G)R>!74:;H>L66MZ7JMMJ5C!8R+Y=PAOI9Q>JP!5AO
M&-_&01U^E '?US?C7Q-<>%=(AOX;*.Z5[A(&WRE-FXX!Q@Y^G%<=H$DUGXLT
MFS\0Q7MGJ[RR/'?0W#26FJ#8XP?FPK8.X#'&,#&0*V_BXI;P(X&0QO+;#@9V
M'S5YH [DYP<#)K-T*ZU:[TXRZUIT=A=^8Z^3'.)1L!^4Y'J/\CI7&VUJ^C?%
MA-)@O[^6UU'2'EN!<73R$R!\!U)/RM@8XP/0"JMA#KMW\/YH=-O&NKV'69U,
M=U.0UY%',V8=Y.1E5]>@(Z4 >GT5QG@&]L[R36!;K?VEQ'.@N-+O&)^QOMZ)
MDD;&P2,<50UF:]U[Q[?^'P;62"WL(Y4MYKB6'=O)WN-@Y((0<].W4T >A45Y
M!J.GZOI\G@O3M1\07-U=-J3VMQ-;73@.@R0&SU89QNQGIZ59A\.P2ZUXUT=K
M[4O[-L8X+FWMQ>2821XF8MNSN/*@X)(]NE 'JU4M7NYK#1[R\MXHY98(6D6.
M1RBM@9.2 <<>U>2"\O\ 5- ^&MQ/J=\DUW<B"=XKAE\Q5R 2,X+<?>ZUJBRG
M\,^*M?T&RGN9](N]"DOBEQ.TIMY063@MSAA]2?PH [[PSJTFO>&--U66)8I+
MN!9613D*2.@K5KR?2+UY=&^'&@2F5+#4+=GN&1RHD\N+<L9([$X)'?&.E7_[
M-W?$#6/"2-<#1KW2!>; Y(M9O,* QDGY<\G [CT% 'I-%>5^#W_M6WT[PG?)
MNOM"NY6U$C(#B/(C.>IWEU/OL;/!JN^F0ZAJ'Q&CNKK4&CL<36Z_:Y L;F M
MN'S<X(Z'('84 >N45XW(DNG^'O /B1+V]EU6\OK2WGEFN'</'*C!EVYVXXXX
MSWY/-:$%KJ/C67Q1&=1L(9[74YK:&1ED\^T6/B-D*N-O0G..3NSD<4 >J55U
M'4;72K,W5Y((X@RIGU9F"@#ZDBO-(+!=6^*-K8WNIW%[;3^&H[B9H+F2.*=_
M-"EP%;Y58 ' X_6LC4[..;X?6D5UNN6L/$ILX))VWND0N"NW<>3P * /;*YS
MQKKU_P"&]#&HV5M;SA9XXY?.=AM#N$!  Y.6'<5KSE-+TB9K: %;:%F2%!UP
M"<"O)-4LK#5/A%9^(Y"+C5+BYMYYKHON<NTZAH\]E7) 7H-HH ]GHKB[<)_P
MMS4K8@>3)HL3O%_"Q,K@DCIDC K@/#^IW+^'/!^G3W@CM+[4[Q)I)\NCE2?+
MC<;E)4D],XX&>* /<ZISZI9VVIVFG2SJ+N[#F*+N0HRQ^@_K6!X7\.KX=UK4
MU34XY%O LXL((#'%!V+*NYMNXYX[XXZ5B>)=/L;CXQ^%?/L[>3S;6Z,F^)3O
M*I\I.1SCMZ4 >C45Y3IL,'BGPKXQU+54274K>[NXXIP,26RQJ/+"'JF.O'4Y
M)SDUVO@6_OM3\#:->ZB2;N:U5G8]7]&/N1@_C0!!%XBO=:U^^TS0DMA!IS"*
M[O;E6=1+_P \T0$%B!U)( ]ZN:9J6KOKUYIFIV<"I% DT-W QVS99@?E/W2,
M#C)^O-<C\(V-@?$^A70*7]MJTD[HW4HX4*P]0=I/XBG:MJ^MV'CW6K*SOKFX
MAM]!?4+>T;9CSMVT#.W./;- 'H^]=Y3<-X&=N><>M(\B1[=[JNX[5W'&3Z"O
M'M7AMXO@YI/B/22W]MH;:=+Q#F:6=W59%9NK9)8%3Z =JZ'1H++Q+XN\96VM
MP+//;RI:QQ38816Q3*E,]"QRQ/KM]* /068*I9B  ,DGM7->'M=U#4?$_B'3
M+S[*8=.-OY#VZD;ED0ODDDY.,=.*\[\-:K=ZA;> ],UN5Y=/N9;S+7#9%R8R
M1"K?W@,\ \$X]*Z[P=:VEA\1/&UM91Q0Q!K-_*C& "8B3@#IR30!=\<:_K/A
MXZ0^FM8-'J&H0V!2Y@=BC2;OGRKC(&!QC\:CC\5ZKIOCNR\,:U;VDHU")Y+2
M[LPR_=!)#HQ.. >03V_"G\5D:2S\+(LC1LWB.T =<94X?D9!&?J#5+0_^);\
M4[JT\3;KK598R=(U.4;5>'',2J,*KCG. ,\^HR >DO+'&RJ\BJSG"ACC<?:B
M6:*!0TTJ1J3@%V &?QKRV.WLO%GB/QCI6K:BL-Q%.(A'+$A*VP0;&C+<K@[F
M)'<@]Z>L.G7FNP:?97<>IS6FC+%<76K-OA6V+$AU3'SR,,9;<!MQSS0!Z?)+
M'%'YDDB(G]YF 'YT>;'Y9D\Q-@ZMN&!^->/>'M/U'5/ _@N[L+JSN=4LH+EX
M]/U$DQW$6[8?H5!4 ]!N]*72]3L[C5/">G#3FL-(EU"^%W9W&&C6\&XB/(X(
M#-\HQZ=Q0![ LL;Q^8KJT>,[@<C'UI$GAD<(DL;,5W !@21Z_2O)];L%M=9\
M>Z=:QQG2#H1O'@4?)!=;6VX'120I;\C4-AI=CI]E\,;VTM(X;JXDC$UPG#R!
MH,E6/4CCH>@&!Q0![%14,-U;W+RI!<12O"^R54<,4;KAL=#[&IJ "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *04M(* %H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ KE)-,GT3QQ/KMO$\MCJD*0WJQ
M@EHI(\[),#JN"5..1P>F<=710!QR_#G3H-6O;RSU+4[.VOY/,N[&"<+#,Q^]
MGC<,YYP1Z<"I[_3'U[Q)I*I&T6E:+*9VW(5$TX!5%3(Y"98D],D =\=510 4
M444 %%%% "$9! )'N.U<Y9^$%TZ^O[RSUO4XIK^42W!_<-N8# ^]$<8''%=)
M10!RVH>!;'5+"6UO+_4)#-=+=RS%H][NH 7^# 4;1@  =?6KS>&HCXD&O?VA
M>"]%K]DX\O:8\[L8V?WN<_TXK;HH \M\=>$UTCX?:GI^DKJ5[+?WZ7CHL7FL
M'+J78;$X&!GGCCBNVL_#Z#4(]5N-0O;R\6W,,$MPJ*84;!.%" !C@9)&>,>U
M;E% '+6_@#1H?#=UH,IN+FRN)C.1,Z[DD)SN5E P<\__ %N*L-H<6G2#6KF2
M_P!7O;"VD6V$FPN 1R$"A07; &3R:Z&B@#D_#<1UG69_%-SHEQI=Q);):1QW
M:!9BH)9F8=AD@#//R^].U?P%IFJZ]_;4=WJ.GWSH(YY+&X\KST'9N/IR,=*Z
MJB@#E=5^'VA:F;"2-;FPNM/01VUS93&.1%&?ESSD9)///7GDYW=*TR'2+%;6
M&2>7!+/+/(7DD8]69CU-7:* ,!_"&FOXCN]:WW(FO(UCNH%EQ#.%4J-ZXYX.
M,9Q[52T;X>Z/H5TLEG<:C]G20RQ6<ET6@B?LRH>X[9S^==910!SND>$8=#74
MA9:KJ*G4)GN9F8Q$B9B"SK^[P"<8QT]JH?\ "N-,_P"$;M= &HZG]@M9_M$*
M^9'N5L[A\VS. 23^/IC'8T4 <^?"D;>(H]=;5=0:^2V-JK'RMNP\GCR\9S\V
M?7VXJA+\.M)E\-WF@FZOQ8WEP;F<"1-SN6#==O3('Y5U]% &!=^$-.OM5BU*
MZDN9;J.V-IN+@!HF^\I4  YR<\?3'%94/PPT**"RB^TZJXL91):EKULP@9^1
M<=%Y[<^]=I10!SJ^"M'&H:K=,MQ(FJ*1=6K3-Y+$KM+;?[Q'?\L57\/?#W1/
M#5VMQ9M>RM&"($N+EI$@!Z[%Z#OSUY-=510!SVG>#=/T]-.C^T7MS!II#6D-
MQ+N6)MI7<, $G!.,D@9XQ5W7M LO$E@MC?F7[.)%DVQOMRRG(YZ\&M2B@#%D
M\,6DNNPZVUQ=?VA#;FV27>.$/48Q@\\YQ5)? NF)IZ64=SJ"11WOVY&%R=ZS
M?-E@Q&>2Q)'K^.>GHH S-)T*UTB:[N(GFGN[QE:XN9WW/)M&U<X   '0  5G
M^(_!&C^)[NVO+S[3!>VXVQW-I,8I-O\ =)'4<G\SZUT=% '-R>!]'>/2XU%S
M&FEN9+4).?E<DEG)/+,2223ZU*OA#3UU#4K\7%[]HU)!'<MYY^90,  =!@$@
M8K?HH \M\4>%1IK^%-+TFRU6:PT^]^T2-#N=H4Q_"PYSD9Q[UVZ>%]/\F_&Z
MY:;4$6.XN'E)E9 ,!<GH,$\#'4UMT4 <Y_PA&C'0K/2&6Y:WLI!):/Y["6!A
MTV.#D8J:XLE\.Z?J&IZ=I\^IZDR LKS9EGV]%W'H "< #UXR:W:* .>\,Z=,
ML^HZY?60L[_57C:2#>&,2(@5%8C@G[Q/^]CM35\$Z6K:LPFOC_:R[;P&Y8[Q
MC'X<<?2NCHH YQ_ ^B2Z5INFR1W+VVFRI-;*;N0%&7[IR&[=O2H-6^'7AC6M
M7_M2\L&-TV!*T<SH)@.F\ X/]>]=510!C?\ "+Z7_P )$-="3K?"U^R I.ZJ
M(\YVA0<#G_'K55_ OA]]'NM*^RS"UN9_M+C[5*S"7.=ZLS$J<\\5T=% $%I:
M0V-G%:0*PBB4*H9BQQ[D\D^YKE)OA;X2G-P'L)1#<2>:UNEU(L0?()95#84G
M&..W Q7944 <_?\ @G0=2OK6\N;1S/;1>0C)/(FZ/.=CX8;AGL<Y[U /AYX6
M&@R:)_92FPDE\XQM*Y(?GY@2V0>3T-=/10!D>'_#.D^&+1K;2K7R5?&]F=G9
MR.F68D^O'09XHUCPOHVOW5I<ZG9">:TSY+^8Z%0>H.TC<#W!R#6O10!A7'@_
M0KF^NKQ[)EFNP%N1%/)&DX'0.BL%;\0<]ZVXXTBC6.-51% 5548  ["G44 9
M.I>&=(U:^BOKNT_TR$;4N(I7BD49SC<A!QGMFG:;X=TK2;N:\M+4BZF&V2XE
MD>61AG."[DG&>V:U** ,.T\':!8W(GMM.5")?/6/S',:2?WUC)VJ?< 5)?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !2"EI!0 M%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MOX_T#3_-_L./2&NHHW8L+>1XWRBYYP<$_A^8!Z;I5V]]H]C>2A5DGMXY6"]
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MJ*P8]'M-<UGQ5HEUK5CIPAD6U2WN;57=;5(QY11W8$ 8)X[\YYH ]CGN8+8
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MNBH **** "BBB@ HHHH **** "BBB@ HHHH **** "D%+2"@!:*** "BBB@
MHHHH **** "BBB@ HHHH *I:QJ"Z3HE_J3+N6TMY)ROKM4G'Z5=J.>".YMY(
M)D#Q2H4=3T92,$4 >:ZCKVMZ/X!TSQC_ &NUW(YAEN[;:GDO'(0"B87*E<@
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M)V'C@D\GC%9.FRZHGACP3XDEU[5)KJXO8+>>)Y=T<D<C%6!0#YCP#DY/Z8]
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MW3_<-6]-\-:-I&I7FHV%A%!=WK;IY%)^8]3@$X&3R<8R>M6=3TNRUBQ>RU"
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MWE:%S"SD"1_F() XX[XQ1:7VHVLOP[U#^U+Z:?5U"7HEG+)*IC# ;/NC!Z$
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M(\J;\D$!\X)P3^FE:6*+J^D:O:>(F^RW2%%ME,DB7H92P/SR-@@ MD<X'/%
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M10$3R09'4=!R02P&>>O- '6>+-:U+2=7\-)921?9;_4%M;A#%N8J03D-G@
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ML^'-)\0BV&J6:W'V:3S83N92C?52#@]QT/>J,7@?0H9[R>**\22]0)<,NH7
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MPM"JN97A:)=@QNC Y'.0>,=ZQM*UJZO?AI=RZIXI.E7:WTT"ZI,$S\DO "\
MY48P/>N^N-1M-.C@2ZN?WD@P@VEGDP.2%49/J<#B@">6SMKAE::WAD9?NET!
M(^F:;/86=U)%)<6D$SQ',;21ABGT)'%4+?Q1H5UI\M_;ZK:RVL6W?(D@(4DX
M /N3QCKGBHI_%VBPZ;J%\+II$T]=US%'&QECXR,H1D9'<C% $7B#2]>U2]AM
M[+4[>UTB6%XKU#%F8Y_YYMT!(R,GIUY[;Z(L<:QHH5% "@= !7#3^)K;7?"V
MB:@?$(T":XGAE8%.9N,M"H;&X'</F&>U=7?ZWINER".[NE24H9/+ +/L'5MJ
M@G:/7I0!:M[.UM-_V:VAA\QMS^6@7<?4XZFB.SM8KF2XCMH4GD&))50!G^IZ
MFL^3Q/H4-C:7LFK6@M;M@EO+YHVRL3C ]>?R[T_3/$.D:U<7$&FZA#<RV^WS
M5C;.T'H?<''44 :1 8$$ @\$&H(+&TMI9);>U@BDD^^\<84M]2.M8OB?Q;:^
M&I=-@ECE>:^NHX%VQ,RJI;YB2!UP#@=2>W6M"ZU_3+()]HN=C-#Y^P1LS"/^
M\R@94>YQ0!I4UHT<J716VG<N1G!]14=I>6U_:17=G/'/;RKN26-@RL/8BLFX
M\9>';66[BFU>V62S(6= 23&3G&0/H?IWH VI(TE0I(BNAZJPR#33;PF$0F&,
MQ#^ J-OY5C)XS\.27EI:QZQ;/-=[?("-D.6Z#(X!.1P>:DU'Q5HVDSR0WEX$
M:+;YS+&S+!N&5\Q@"$SVW8H U/LT A\GR(_*/\&P;?RH:UMW#!H(F#8SE <X
MZ5QC:E=_\+BM[);^:33I-$:Z$ ;,>[S-NX =>!WSUKI8/$&EW&E'4X[L?80
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MK8F6=<;CE&#9;KT !]@!VKUN'1M+M[%[*'3K1+1_OP+"H1OJ,8-1GP]HI@6
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M&I2EW$X?0?*&&!!8S!@H/<E><>E=[574K:>]TRYMK:[>SGEC9([A%#-$Q'#
M'KB@#@/#>BWUAXTOO#S1L-!L+C^U+0@C:#("%B(] Q=@/50:])K(\/:(^BV)
M2YOYM1OI2&N+R8 -*0,#@= !T'U[DUKT %%%% !1110 4444 %%%% !1110
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M;Q*5=&!##'4$5P?A_4;73?&?C2SU^>*W:XG2>(W9"K-;[-HVEN&  P?_ -=
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MDZV;N]M4C;?Y(E+<@]^0<#^Z?0T >QZ?XCTO4[^6QMKAOM<2"1H)8GB<H>C
M.!D>XK1GB\^!X_,>/<,;XSAA]*X/49K7Q3XZ\)7VAS"Y2R$\]S<P\K%$Z !'
M]&8_PGD8)XKN[BY@M('GN9HX84&6DD8*J_4G@4 ><^"KB]U?PG=:MK'B?4XA
M;W,\;2!HD4(AP"1LZUTC>*-/\,VNG:?XDU:)-1= F\JQ\W&1O.!@$@9/09R!
M7!^ E\&W?@V_76VTI9I;NY)>X\M9@A.05W?-T.1BK_B77[/6]<\"WB?NHVU)
MI424C=Y7W4D8?PAB,C/J.] '5_\ "Q?"PLIKHZDP6!RDL1MY?-0@9.8]NX
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M*-%TI=&TU+7[1+<RDEYKB8Y>60]6/^'88%:%% !1110 4444 %%%% !1110
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M3=,O4NK*UUZWCO) X8-(?GRY'&2S;OJ:[+4?!/AG5[QKO4-%M+BX*A2\B9.
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH *04M(* %HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M2RQ2+)&PRK(<@CV-8#:/KLB@2:["P'0'3UX_-J%TC7T&U/$*JO8+8( /_'J
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MBBB@ HHHH *04M(* %HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M$SDD#[QXXZDD#'(H Z6BL&V\9Z%=:/=ZHMZ4MK23R;CS8F1XGR!M9"-P))
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M#-!EI8AU*;2<D=QU'<5GP_$[0IK>PNC!J4=C>/Y:WDEJ5A1B< ,_3GVS[XH
M[.BN;T_QKIVH7]_8?9=1M[NSB\\P3VK+)+%G&]%&2PSQTS[5EQ?%;P_);VEV
MT&I16%S(8OMLEMB&)]Q 5VSP3C/? /..: .XHKB+"%+7XOZJ%>39)I$4S"25
MF 8RL"1D_*,*.!@<5HR^.=,ACMKJ2WO!IES-Y$6HA%,#,3M!)#;@I/ 8J ?6
M@#IJ*P+3Q7!=^++GPX=/OX;NWB\XR3+&(WCS@,I#DD$^WUQ5"]^(>FZ;IUC?
M7NG:I##>W9M(2(5?+9QNRC$8.#CG) ) - '745R$?Q"LI+N\LET?6_M]L%;[
M']D_>R(V<.HW8V\=6(Z@=:N6GC;2K_0=/U:U6XE74)#%;6X0>:\@W;EP3@8V
MMDDX&.M '1T5R$_Q%TJVLM8GGL]12;2&5;NU\I6D0,,JPPQ4J1WW5+9^.[*\
MUJUTLZ;J<$E[ \UG)<0JB7(49(3+9SCGD#^60#JJ*Y7P7XDOO$4>IR7=A+;B
M&^EA0ED94"879D-DG.23C'/!K5\36\5UX8U..9=R?9I&QDCD*2.GN* -0,&&
M5((]12UYAX"\8V^F^%O"VEW6G:@D=VJVT=Z8@(6E))"@YR<\\XQQW[=+JWCN
MPTI+V<6\]S:V$GEW<T+)\C9 ;:I(+;=PW8Z9[G( !U5%<9J'Q(L+/56TZWTG
M5K^?[&+V/[) KB6(D ,OS9(Y)Z=JEU/X@Z9IL=[-]GGGBL7"711XPR' + *6
M#,5R,X'YX- '745S=EXRM;_Q'_8UO;3.\FG#4K>8,OES0D@#'.023W':J-Y\
M1;&QT6/4YM,U$QM?-8NL:*YCE5MASAN1G.,9)QTH [*D9U09=@HR!DG'-<WI
M_C*VNM=NM(O+&[TVYAMOM:?:PH$L.<%@03C'<'D?@:X[QYJJZW8^$]0CTNXB
MMYM:M6M[J;8"R$D_=!) ;@CU YQTH ]6HKEM8\<V&DR:@!"]PNG &Z*21J5X
MW$*&8%V"\D#U'.>E._\ B196M_8VEII.I:@;^U-U:O;1J5F4+NPOS9SZY Q[
MT =K37D2)"\CJB#JS' %0V-R;W3[:[,$L!GB60PS+AX]P!VL.Q&<&N(\5:C?
M/\1?#FD_8A<V3I<3&W9U"SL(\ G/'RY/!^OI0!WJ.DB!T964]"IR#3JX[3K_
M $WP[9ZC9Z!I%Q/8:;([70@E#"*0C>Z(K-DD @[1@<X'.:=J'Q"T^UM-'N[6
MQOK^#5CBU>V13EL$[""00V1CI@=R,4 =?15'2+^35-*@O9;&YL7E!)MKE=LB
M8)'(_#/XU3U3Q"FG:Q8Z3%9S7-[>))(@4A454 )+,>G4 =?PH VJ*XM_B18+
MX?M=873;^2&:]^PR+&JLT,N[;@@-EO;:#FK=MXR:?4M0TQ]%O(-1M;07J6TC
MQ[IXB<?*0Q .>,'N: .IHKF--\91:OX<T[6+.T9A?SB"* RC>#N(.?IAF([
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M$XZ@C;GC(SZ9YK=KS/4-%U*V\>:II%I$YTGQ-"LUQ*#@0;"%GQ[LA 'NP]*
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MER'&$'D[.?3Y@5Y[@CM0!T\_Q-\)6Z2.^J$K%*8G*V\C;6 !.<+P.1STK/\
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M"%1CM7)^]G;[8SS7+67B*+0_B9XQ6Z.H3PI!:S);QJ\[1KY>YR!D[0"W/;D
M5L^.=]MXB\):F;2[GMK2\E\TVL#2LI:,A?E7GD\51T=YHOB)XSOYM/U&*VN+
M6W\IVLI2',<>UPI"D,03C SGMD4 =5_PE>F2:?I]Y:-->#45+6D4$>7E &3P
M< 8[[B!GCJ:SY_B)H-KI,VH3F[C6WN?LEQ";<^9#+D#:XZ#KUS@]B:\STJUU
M'2O#WA+4[WPU=WMKIL=S::C8M8L)(P\F]9%1@-W !+#CJ"1FMKQ4D>H>")CH
MWA2\LDNKV"6*&+3V$TVQ@7D=4!VC!P-V"<$]Q0!W^F>+M.U/7)-'2*\M[Q8/
MM,:W5N8O.BSC>N><9XYP?:M34M2M-(TZ>_OIEAMH5W.YYQV P.222  .237$
M7$KW7Q?TC4(K+4?L8TMX6G:PF5%=VW*"2O'!YSTZ'!K5^)&BWVN^"KNUTU!)
M=QO'.D1./-V,&*_4XX]\4 :%OXHM)=7BTNXM;NRO)XVEMH[I%7SU4 G802,C
M/*G!'I5./Q[I4FAZEJZP7IMM,G:WNQY0WQNN-WRYS@9&3_@:R+Y7\9^(/"US
M;Z?J%HNG3->74EU:O 8OEXC&]1N);&=I(P#[5%=^%KT^/[^UBM@_AS6XH[K4
M"V0%DC."@Q_?^0G/4;O2@#L#KUH'T]=LG^G0M/&WRX5%4,6;G@ ,.>1R/6J"
M^-=,%UIT<T5U!;ZD0ME=RQ@13EAE0"#D$CIN S7,>&/#&L2>&M<T;4F:-K:&
M72=-G(*L8>2) <=#E!D?\\Q47A6>62WL-$N? CVVJV;1QS7L]BHML1\&59.,
ML0#C'<CG&30!<^(FN6E]X'UQ8+6]N(;=7B-W 0(DF Q@_,&8 G!(!4'Z<=QI
M<DLND64D\7E3/ C/'G.QBHR,]\&O)(AK>D?#S6O!%SX>U:ZO8TN%@N[> R0S
MHY+AM^>OS'@<^V:]7T26XFT*QDN[>2WN# GFQ2@!E;'.0"0/SH QM1\=Z7I_
M]IN8+N>WTMUCOKB%%*0,<<$%@S8R,[0:?=^-].M=<71UM-0N+N2V^TPB"WW"
M9<@?*21ZYR<#@Y-<!XJ@U[6;7Q=I]]H6J3W>]FTXV\?^B_9P1M;@X>4@'^\W
M(  Q6UIHOI?B!H6I2Z/J5O:Q:(;:1Y8#\DF[(!VYZ@?AD9P>  =-9^.-'O/#
MXU=?M$<9N?L8MY(\3>?NVB/:"?F)QWQCDD<USFEW;S?'&Z7['=66[0@TD5P5
M)9A,,,-K,,8..#VKF[/1M=MM'BOH-)OGN=.\1R:D;)HF0SV[<97/!;&<#.>O
M%=)I,]_JWQ;BUP:#JMI8/H?V;S+N 1[7\XMR">.G3KT.,'- '>:GJ5IH^FW&
MHWTPAM;="\CD9P/H.2>V.]>>:O=R7?Q;\$3R:7<V3NEYS,4S*GDY4?*QP1DY
M!Z;JZ?X@:1J.M>$;BWTG!OXI8KB%&8 2-&X;:<\<X[]\5S4]SK/B'QOX-U?_
M (1G4[6*Q%T+KSE1=C/&%P,MTSW.,]NE '21>.K";0=8U=+*_,.D7,MM=1[8
M]X:, N1\^"!GU_"K5YXIMX9/(M+6>]NEMA=R0QLB^7&?NEBS 9/. "3P?K7!
M?V=KFG:+XZT!-"O+B74KN\N[>Y3 A:.5!@ YR6XQM ZGMR0^XL-6TSQ)%K=[
MX/?5;"]L8;:>U"133VTD8(!QDJ0>N0?3.",$ ]%\/Z]8^)=%@U73F=K>;. Z
MX92#@@CL016+!XGOY_B/<:"=-G2UM[,2;P\9W%GP)#\V0N!@ 9/)R*V]!A>'
M2H_,TZWTYG)?[) J@1 G@';P6QC..,_G7,W-EJ-I\49KU=-NI[+4=.2T%Q 5
M"PLKDL7)/RX!R.N3P* +L_C[3X=/DU86EW)HL4Y@DU! I0$-L+!=VXH&XR!V
MZ$<UU*.LL:R(P9& 96'0@]Z\IL=%URV^'%]X$FTVZ>]W206]W@?9WB9]PD+Y
M^4 $_+UX& :].TVS&G:59V0<N+>!(MQ[[5 S^E 'F-I'X;L?BOXJAU2UL%M_
M)M6ACEMU90Q3+$#! )ZGUK>M]8T#POX8U7Q5IMK.VF3SDM!;1JH5D8PEE4D8
M!9?UZ5%IL6J6'Q+\2:HVAW\MI>0VZPO'Y8SL4J?O..X^O?N*9XNMM:\0^%-?
MTJPT"XMT=8TMX7:)&FE9Q)(^=V-HXYSR2U &H_CV"+5+2PDT755EOH&FL<1H
M?M&.2 -WRG!S\V..N*C/Q%LH_#VJZK-IFH(VE7!M[NU 1I(V&.<AMI7D<@U6
MO]/U>?QEX,OXM*N/LNG07"7CEXQL,D:J!C?D\KSC-<UJ^C:G:>$?B*U[ILL,
M5]</>6[O(F&0$'^%B0>,X(H [2'QU:OK5AIUUI>H6<>I9%E<W$:B.8A02,9W
M+UXR!FL'P=J%AX<A\=7UR3%9VVMRDA$YY"@*JCU) 'U%6Y+6Y\7#PQ$VDWEG
M#I=S%?7$MR%4;HT(5$P3OR2#D<8'/)Q67+X3UO4=$\9V4=C-93WVIB_L7GE0
MK+AE(!VL<9*'@XQD>E '8#Q='!JUAINHZ;=6,^HJQM#*R,LC 9*$JQVMC'!X
MYZU7T[QO%J&E:U>G3;B!])E:&:WE=/,+J,D#!_+U/2J%S::GXMU/PU/<:9<Z
M>-*N3<WC7&T?O%7 1,$[@3SNZ8[YXJ/4- D?XJV\MO,HL;ZT%QJ-OC(9H'7R
MF/;)9EQ_N-0!N7OBV"SNEL#;%]1^SBXEMC-&GEJ3@ LQ ))!&!GH?;-6T^(.
MD:AI.FWMEOD?4"XB@=TC9=GW]Q8X&..YSD8K(UZPUG1/'<NO6&A#6]/U&".&
MY@4J)(9$R%8;NV#_ #SBH-<TOQ%;WVD>)[;0;6YE@2:*[TF-U)6%R"NTXPSC
M&3UYZ9% '7>&_%%EXFBO/LRO%/93M;W$+E248>A4D$'L0:FU37%T_4K#3H[6
M:YN[[S#&J8555 "Q9CP.H'J<U'X<>]N+62[N]*BTM9BIBM!@R*H'60CC<3V[
M#'?-9'BY-7?7]($>EW&IZ)MD%S;6\B+NFXV&3<1E!SQG'KG@4 -N/B/86WAQ
M=9;3KXQB]-A+$H0M%*&VD'#<C/0KFK^G^+X[G7KO2+W3;K39X+3[:IN2A#PY
MP6RI(!!Z@FO/)?#GB9_"%[HZ>&I(YAKIO46&>+R_+W[L+EAP!P.!^%=-K>C:
MIK'C.[D&EW4=A>:!)IC7)>+"22-NR1O)P ><#J.,B@#'\>ZJVN6?A74(]+"V
M$NLVK6MZ[CS&4D_P8RJL I'/.!D"O6:\CNM*\7WGA/P[HD_AR0W.CZA;R/.E
MW"8YHHL@,N6SDC'4#_#UI"S(I9=K$9*YS@^E #J*** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBD% "T444 %%%% !1110 4444 %%%% !1110 4V2-)8
MVCD171P596&00>H(IU-DD2&)Y9&"H@+,Q[ 4 0VMA9V6[[):00;\;O*C"[L=
M,XI8+&TM7D>WM8(GD^^T<84M]<=:S3XLT :6NJ?VO:?86?RQ<"0;-WIGUI]Y
MXHT'3Y[B&[UBQAEMU#3(\Z@Q@XQN&>"<CB@"XFF6$:;$L;95W^9A8E W?WNG
M7WI4T^RCN3<I9VZSG.95B4-SUYQFJC>)=#2VL[E]6LEAO2%M7,RXF.0,+SSR
M0..E.TWQ!H^L_:#INIVEV+<XF,,H8)UZX^AY]J +DEG;33I/);PO-'PDC("R
M_0]12M;0-/YS01F4#&\H-V/3-4;/Q%H^H70M;34K:6<Q^:(U?ED_O =Q[BJ'
MAF\A-AJ5R_B6#5X%O)'^T*4"6Z8!\LE3CY0<Y]Z -/4-+2\LI+>+RH#+A7D\
MA7.W.> W&?3((![&K%E:1:?8P6< (B@C$:9.3@#'-<+>>*&NOBAX9L=,U>22
MPNHKAKBU"@*=L1*-RH8@\D')!V\=Z]!H B:UMWF\YH(FEV[-Y0%MO7&?3VH^
MS08QY,>/]T5@77C+3;?Q?#X;,G^D/;M*\F#B,Y4*O3!)R?IBN;\(>.;2SM=6
MC\3^((_/36KBTMVNF56,:; .%  '/7 '- 'H4EG:S2122VT+O%_JV9 2GT/:
MIJQM0\6^'M+FFAO=9LH988_-EC:4;D7Y<$@<C.Y<>N1BGW?B;1K&-9+B_C6,
MQ+,74%@L;?==B =JGU.!0!IR11S1F.6-70\%6&0?PI5147:BA1Z 8JHVKZ>D
M]I"UW$'O!FVYXFXS\IZ'@9X[5';:[IEW<WMM%=IY]B ;F-P4,0.<%MP& 0"<
M^G/2@"^(T5RX10QZD#DTWR(<D^4F3U.T<UDKXIT6>2&W74/+FNES;AHV4R#I
MN3</F'N,CI7*>&_%UMH\_B.#Q#KK2+;:M)% ]S\SK&%3KM&%7)ZX R>M 'H/
MD0X \J/ .1\HXKFK#PS>6WCO4_$$\]K)!>Q)$(0AW($^Z<GC/K74(ZR(KHP9
M6&0P.017/^,?%<'A'1?MTL$L\CNL<2(C$%B0/F8 @#G//7&!0!T#*K8W '!R
M,B@* 20 ">I]:X75M<6P\=Z'=R:C>1:9=6ER9+>8-&@9-@4B,J&+$L1C!SQB
MNCM/%.BWVB/K$-\GV%',;R.K(5<'&TJ0&#9(&,9.1ZT :=S'++:S1P3>3*R%
M4EVAMC$<-@\'!YQ61X;T.]TF*:75=6?5=2GVK)=-"L7R+G:@5> !N8^Y)JSI
MNOZ=JMS-:VTSBY@4-)!-"\,BJ>AVN <''7I6G0 45Y9XRAU/PMI.@R'7=3GN
MKS5X8+N3[2P5D?<S*JC 4< #OBNU@M%\-SWU_=:O<R::\<0"7<K2F*0,1\I/
M)W;E&.N0,=: -ZBL0>+=$\J^>2\,)L4#W4<\3QO$IZ,48 X/KBL\_$KP@+:>
MX&LQF*"-))&6-SA6Z8PO/H<=#P<&@#JZBN$DDMY$A=$D92%9T+ 'W (S^8K
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M&/#5]H-_JUS<ZE;W8U*X-TZQ6C1;)" ."9&^7 Z=?>NEKS^19Y_C#-H[ZAJ
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MB,\A.[L 5Z]!BM[Q+'IMKXRN]4TZPCN[.VT&8:E#:L$216/R(S+_ !$9/J
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MD:P;GQ]X4LS*)M=LP87\MPK[B&].,U<\*W+WGA/2KA[$V)>UC/V8_P#+,8
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MG4KVXM+B/494F6-(2#$R*%&"2<\#TSFK^I>)](TF66.\NF5H45YO+B>00J>
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M1110 4444 %%%% !1110 4444 %%%% !2"EI!0 M%%% !1110 4444 %%%%
M!1110 4444 %,E<QPNX4N54D*O4^PI]% '@C>(;!O#GA:XBE%H+;7XGDTZ*
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M%QM'//2L;0[.;P[I_P .]/U566ZMKF>2>+&YH%E6787 ^Z,L!D\#!]*]?HH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "D%+10 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_.62)@Q&"0OS94C&.O>JUKX]GGU/3+8Z9'+%J*'8]M.SF!\95904  .<;@2
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M#NP,=^2<>F>M8D*2!DXX'K7!>+?#5]XAEO VB6[W2E3I>I1W(BEMCL7ER.2
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MR5 <$$<\$GKS6Y<^!+B/2],L=*U*" 6=\-1EEN+8R/<3[BV3M=0 23Q].F*
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M5)&^1YC\@<CKPHR0.H7MUH ZNBN,GUW5="\8Z7H>H7<%W!J\4OV:X,.QHI4
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M\^*RMXYN?WB1*&YZ\XI;R^@L8U>=CEVV1HBEF=NN%4<DX!/L 2> :L5QNF7
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M^7-C5-+UV;Q7X-O_ .QBT>G&YDN_LLD8CB\X85%W,I;;W.!GJ.N*]#  & ,
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MO+:_M4NK.XBN+>0926)@RMSC@CK3)]0LK:[M[2>[@BN+DD01/( TI R=HZG
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MU&UTG3I]0O9?*M;="\C[2=JCO@<T^SNX-0L;>]M7\RWN(UEB?!&Y6&0<'V-
M'&S^&O$L7B:PU**_LM1C2U:&3[>K?Z/(6+&6-5XY&%QD'  S571/#'B;2/"=
MIHMS:Z'J5K"\XFM)7<+,C.74Y*, VX],8QWST]#HH \VMOAYJ=C;:=?6=U;Q
M:EIM_-<VEH9':WB@EP&MP^-V,#KCJ3Q6K+X;U>\U+4?$$\5C'JUSIO\ 9L%J
M+AS%%&6W,S2;,ELGH%QQC/.1UUM=07D1DMY4E0.T99#D!E8JP^H((_"IJ /-
M)?!?B5O#?A33$72O,T*\AN6=[V4B;R^@'[K(SD_3 Z]H]3\ ^)K_ $?Q%I1O
MM*>/4[G[1'=RAS<, ZLL;D# 4;< C..P&>/3Z* .1FT37HO%T/B.V.GW$S:8
M+&XM9)7A0$2%]RL%<GKC! ]>^*R-:\ :C-X7NM-TV:SDO-0U+^T;R>X=HUW[
M@V$558XXQR?SKT6B@#@/&GV'Q$VF:''J,5MXFAO(9%CM9LR6^1F4@D [1'N.
M<#/R\<XKN[>".UMHK>%=L42!$'H ,"J\>E:?%J<NIQV-NM],H22Y$8\QE'0%
MNN.!^0JY0!E^(M$@\2>'K[1[ERD5U'L+J 2IZ@X/H0#7&OX0\8:BN@)J>J:1
MNT:Z6:.=(I':8*, N"5YZ9 /KS7HU% '!V?A7Q5H>M:@-%UBP&CZA<-<NEW"
M[RV\CG+>6 0"#[G\/6W)X2U&/QW%K=M>V[V<FG#3[I;A6:4J&W94@@%CT)/3
MK@UV-% ' ^'_  GXJT!1HD.MV;^'8WS#*T;?;%CSGRP>%'<;N3Z =!M:1H6H
M:=XHU[5I9K62/5#$RQ(&!C\M-B\]\CKP*Z2B@#S^/P%J*>#->T#[;:[M6O)+
MGSMK8C#D$C'?&T=^_M6G?>&M2O/%/A[6_/M$.E12QO%\Q\WS%VD@]N.1UKK:
M* .#;P3JC:1XIL3>68_MV=YMVUCY.X $?[7 'I4EQX.U6X/A7==V:C02IX5O
MWV%"_P# > /7FNXHH X/2O!.O>'YKNQT?Q$D.AW$IE6*6WWSV^[.X1MG ]B0
M?IZVXO"6JZ5X@U&]T/5+>*SU(!KFWNX&E*2!=NY"&'4=<FNP) ZG%95GXDTR
M^UZ[T6"60WUI&))4:%E 4G&02 #^% %3P1X<F\)^$[/19KJ.Z-L7Q(D93(9R
MV.2>['GBKGB71?\ A(O#=_I'VEK;[7$8_-5=Q7\,C/TS6K10!RUOX9O;DZ-_
M;5U:RQ:05EA2VB91)*JE5=BQ/0$\#OSGC%96GKHOC#Q_;>(]'N!/!I]HT4\J
M!E265C^[7! R5&\GTW)76:IKEEH\EM'=&=I;DLL4<%O),S;1D\("< =ZQ+3Q
MOX8@MKK[''=Q6]I,R7)BTN=4ADS\P?"84\\YH ZVN=\8>&I?$ME8+;7:6MU8
M7T5] \D>]"Z9P& (..>QKH@00"#D&B@#EK7PK?6_C*?Q&VK0RRS6*V;1&T('
M!W;LA_7MCI^=9$OPXNFT.WMH]=$6I6%Y+>6%[#;;/*:1BS*REVW DD=N,=>_
MH%% &1H>G:G:(\NL:HM_>.JKNC@\J-%'8+D\DGD]^.!BM<@$8(R*S;?6[:YU
M^[T9(K@7%K$DLDC1$1D-T ;H3_GL:TJ ..TSPAJ/AB>Z3PYJD$>G7$IE%A>V
M[2) 2<GRV5U('^R<_6K>M>$!X@T6YL]0U*9KF:1)H[B)=HMW3[IC7)VCKU))
MR>>F.FIK2(KJC.H9\[5)Y;'I0!S:>&;RZUG3M8U6_MY[W3898[7R;8H@:0!6
M=@7))( X! &36,/AS>#P3J7AK^VX-E_=-<//]A.5#,&*@>;Z@<YZ9X[UUFF:
MY;ZK?:E:0P7<;Z?,(9&GA**YQG*$_>'_ -;L03IT <S>^&[Z[\4Z1KTNJ6J'
M38Y$:(6C8D#@!SGS/EX''7'?-<EX+TN^UK0/$EC%JL,%E=:K>12JMONE"LV&
M*OO &1TRIQ7J,D:2QM'(BNC@JRL,@@]014-K86=EO^R6D%OOQN\J,)NQTSCK
MU- '*#P/=6FMW=QI>K+::?>6<5I);FV#O$L:;%$3$X48]0>?KQ6M? &HV]SX
M8E.NP2#P^CQPJ; CS%9 A!Q)QPH_$GMP-N_\8V.GZ]%HLEIJ$E],N^)(K<L)
M%'5@<XP.^<58TWQ1I6IZ@^G1RRP:@B!VM+J%H9=OJ P&X>ZY% &+(T7@:]UC
MQ%KVLP&RU*>+<L=BX,;A0B\AVR-J\\=?RJ;P'H5CIEE?:C80200ZI<M/%&X*
M[(<G8 #R <L^.V^NJEABGC\N:))$R#M=01D'(X-*9$$BQEU#L"RKGD@8R0/;
M(_,4 .KD)K;_ (1_Q_)K+*%T[5[=(+F7.%BGC/[LM[,I*Y]0!GFNOI" 000"
M#V- '+OX6OX]4UVZL]8CBAU8*6AEM/,\MQ&(\[@XR,#IQSCG&0<M_A[?-X=\
M/:2FMVRC1+N.[BE^P,?,:/.T,/-]SG'7CIW[#4]4M]*TZ[OIA))':QF2585W
ML !GH/:ETK4H-8TFTU*V$@@NHEE02+A@",C(]: .6'@74++7K^_T;Q+/IUKJ
M#F6ZM!;+(-Y^\\98_(3]#U[UV%M EK:PV\98I$BHI8Y. ,#)[FI:* "BBB@
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M%N6 1C&4Q]SH,GG'.!P,\=OX?M[JS\/V%I>QQQW%O D+B.3>IV@#(.!UQZ4
M9]YX@N9M>N=#T>&"6]M+=;BX:X<A%#'Y4&.2S8// '!YZ53C\87EPFBV7]D/
M9:UJJRM]FNCQ;+'G<[XY(Z8'&<]1536] \1:?XR_X23PQ]CG:\B2VO;2[8HI
M"_=<,.>.X]N^>'7WA?7'U30_$,=U:SZS8M*MS$6:.&:*3JBG!("CID<XR>:
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M;=H5MYI'NF7&\(Z*53&3C.<X[=X?#OA?QCH4"^'UU.P;0(I/W5T XNQ%NW%
M!A03R-V>,Y'84MOX9\7^'=>U,^';S2Y-(U&X:Y,5Z'W6TC?>*A?O#\?\2 =U
M877V[3[:[$4L(GB67RY5VNFX X8=B,X(KDE\3:V/%.O:%-_9D,EI9B\L99$<
M+*A/)?YNB]"1WY]J["UA:WM(87E>9HT5#(_WG(&,GW-<UXG\(_V]K>D:A%*L
M/V=GAO.N9[9ADQ^X) _ F@#-T'QEJGB#PSHM[;_84O[Z\:WFA:%RL6W<6'WL
M@A5SSUR.F:I7?BW6)_#7C9[:&RT^^T>5T$D0,@8!,ELG;E_0D8''!Q6[H_A
MZ3XWUK6TE'V6\56@MPQ CE8#S6Q_M%$.?<UFP^"M5>S\96]Q+9Q_V^SO$T<C
M/Y1*[<,"HSZY% &%J,FI_P!B?#J:7[/<W37<#0*NZ,$&#Y0Y)8Y]3^E=IX9U
MW5+S6=8T368;47NGF*02VFX121R E>&.01@@UB_\(KXEFT_PM'-_9?F:)-'(
M56>0!E2,(%SL/)Y.<<9Q@]:VM*T75;3QOK.LW"V?V34(H8U6.9FD3R@P!(*
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M;/6UW3QBS#/YFS;@,6.$]NN. 1U,T/@+4K:\\.WD&O*EUIEH;&:3[*/WD/&
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MN88DMX(X8QB.-0BCT &!0 ^BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M-)C)A?<E5YSGC!'N: -JBN0F\6:G>1:K<:!I27T&F7)M71Y"LEQ(I&\1@ C
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M4AB5=DA!CD5=N"-NXMG. #C%>BQ(T<*(\C2LJ@&1P 6/J< #)]@!0 ^BBB@
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M+B5;R1(_LD;+NP@R[%NK'C@  >^>/5K>>.ZMHKB%BT4J!T)!&01D<'D52O=
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MZ;N +J6@E5QAU8=<>G_ZB*-OX1\3V][K^H1Z[91WFJ?9W!CMG CDCVC^]]W
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M444 %%%% !1110 4444 %%%% !1110 4@I:04 +1110 4444 %%%% !1110
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M4U5;FV*HZ@! O[O<#LSC)Z\^E=+:6T=E9P6L.?*AC6--QR< 8&3^% $U%%%
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MC%'#HOAV*)%CC37;0*BC  RW %;WB[69-"TZ">T@#WUY<Q64+",.06)[9&<
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ML  HR3C^(=._'ZAX[\0P>#M5FCGMUU31-56QN)/)&VY3>%# $X0G//!Z<=>
M#UFL?Q'XDL_"VF'4=0BN3:*0'DACW[,D 9],D@5SVEZIKUC\23X>U34HK^WN
M-,^VH5MEB\EP^TJ,9)7KU.:7XP$#X6:T2,_ZC_T?'0!J2^-]+M!;OJ,%_IT%
MQM$<]W:LL>6. &89"?\  L5T2.LB*Z,&1AE6!R"/45SVKQ0:C\.;Q+H 0RZ6
MS-O.=O[O.2?;KGVKA_!VJZP/ /A=;F_-I:.DZ/\ 9U\R[G53B)8EVMGOD@<!
M1R* /69)$BC:21U1%&69C@ >YIU>*:[K&K:W\-#-?7]RDUOK@LG C2,RJLH
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MQG/2M/3_  WK5CXNUC7Q<:>S:E#''Y.U\1F-<*<]_?I784FX;@N1N(SC/.*
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MM#6M$\00Z;?7$"0WT?V;S(9B@PK@,>"!@?U%=CIEG+8Z?%;SW<EY.N3)<2
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MZUM6_@&2$>(B^N7$TFNQ"*X:2",;?DVD@ #G!;';GD'&:7_A G%MX<A&KO\
M\2$YMV-N/GP-HW<^@ XH S[7Q+K>EZAXRT^XG_MB31[6*ZMBT2QLVZ,L4(0
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M$6.X^PN%69 , $$$ X Y]NF>:ZBQLH=.L8;2 -Y<2[078LQ]22>22>23R2:
M.8.HSZ_XWU?0$O+FRM]+MX79K8A7EDD!;.X@\ 8XXY)SGBN(\3:IJ&M?"3Q/
M!J<\AO-&OS9O+'A5N0LB ,P'&<'D#N*]%O\ PI'/XB77K"_N-.U!HO(G>%49
M9X\@@,K C(QP>OU'%5[_ ,!Z??>%KCP^+N[AMKJ4S74J%#).Y8,68LIY) /
M'3'2@#9T6T^QZ5!']IN)\J&W3ON89 XSZ5B7.H3ZQXVN?#T=W-9V]E9)<2-
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M&[%\MQ&X,IG!),A+ @DDGMCT P*Z*WA^SV\</F22[%P7D;<S>Y/K0!+1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%(V=IVXW8XSTH K:AJ-EI5F]Y?W,5M;I]Z25L 5+:W,-Y:0W5
MO()()D62-QT92,@_D:\IBU35]6\ ?$&XU.X@E6*XO+8)'&R[2D:*-I+'"X'3
M&<DG/-:WA[Q+JNF6W@RPO;&T33M3M([>%UF)E1UB!4MQ@A@. .1GKVH [#4O
M#FE:O?6M[?6S2W-J=UNXF=?*.<Y4!@ >G/?%:M<--XQU>XT+5/$.EV-K/IMA
M/(BPNS>9<QQG$DBL#A>C8!!SM]Z==>/4EU'3+6RGL;2/4+!;VVN-0W!)BQQY
M0(( 8=3R>HX- ';T5Q<_C*\-]:Z4EJL&IFP6[NU^SS7(@9L 1[8AGKGDG@ =
M<UL^%-9O==T*.\U'2I],N]S));S(RG(_B&X [3UZ4 ;=%<KXB\5_V1X@LM):
MZLK 7,#2I=7R,8W<, (P0R@'DGD^G'-<]J^K>)I/%'@>WEEMK&2\>Y::W$;.
MGF1QD9)W LI#9 X]>>, 'I=%<@GB74]8&LRZ MG)'I,K6Y29&)NIE7<RJ0PV
M#D $AN<U%IOCG_A)5T>'1$B2YO[:2[E-P"XMHT8(00"-Q+G Y'3- '2:IKFF
MZ+]G_M&[2W^TRB&'<"=[DX &![BM"O*O'FI:A-X/TV?7+1+&:V\00H[;ODD1
M&;$HST4CG!-=WH>IWNLF34$-L-(E(-DRJWF2IC[Y.< $YP,9QUQ0!M45C^*O
M$$/A?PU>ZQ-'YBVZ K&#C>Q(51GMR163J'B+5?#VMZ1;ZLEG-8ZI(+5)K=&0
MP7!'RJV2=RMR >#[4 ==1D9QFO-H_%OC*^L/$-U8V.D?\26^F@=7\PF=8PI*
MK@C#=3D\'(&.":KQ:[J>O^/_  E<V]W'!:7FER7:6[PEA&2,-D[@6/8'@#TZ
MT >@Z=K>G:K=W]K97'FS6$ODW*[&78_IR!GZC(K0KS^'QW+I\?C.[U.TM0FB
M3(JBV!!F+#"[B>Y.T9QQ5R]\2ZSH-SH4^KBRET_5)4MI3;Q.C6TKC*\EB&7.
M03A?7VH [2BO/;GQ+XL:+Q48/[(B70W9ED:*1O.41"39MW#!P?O9]L=Z+SQ^
MXA\.SSW$&CV>JV/VC[7/$94$WRD1$Y&T<G)/4="#R #T*BJ.C37MQH]K-J!M
MS=NF9#;',9/JO)X(P>M8%QK^J6/Q!@T.Z>T73[^SDELIO)8-YJGE&._!PO/
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M&J3W>C6L@D2UDC4%P#N5'8?>4'G&!G R<<5UL<B31)+&ZO&ZAE93D$'H13J
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M[7S52)D&?+E+*<9'1@/^ UD#P%K,^F^)] E>WBL=0OWU&UOUE.\2,RLJF/'
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MX6.-O,B7!PX.<;@367;^ ?$:0Z$DWB>V(T:4?9U33U"^6$*9//+X.!V'7DT
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M/ND\Y(]3C&:[&""*VMXK>% D42!$0=%4# 'Y4 24444 %%%% !1110 4444
M%%%% !1110 4444 %(*6B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MV2G0W1XG_LYOWA1=HW#SO3KCOZ5C^'H-0O\ Q=XT73-9M[1+B[48>V\TLNP
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M;K[;86]WY$T'G1+)Y4R[73(SM8=B.XH Y6V\!S1:]IFLS^)-1N+NQB,&6CB
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MVTD@RIR78.H/!X![CTKM:X^/PA?W=MHUCK6I075EI,R31B*W*/.T8Q&7)8C
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MOTSQB@#HZ\U\7:I>Q_\ "3RV6HWES<:? )8$LI3%'8;4W'S3D+(21G;ACCC
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M.F?2@"#PQI>I:1J&J0WNJ+<P3%)K>U,CR-; Y##<_)4D<#M@UTU96A^'=/\
M#\$D=BDI:4@R33RM+(^.F68DX&3@=!6K0!YOHFGP6_B'X@-&DH6-D"$SLPRU
MN"V03R?<^OM7.Z;]HTGPG\/-5M=1OC/=ZC;6<J-<MY7DL&4IY:X7C'7&<]2:
M]+N?!^EW&H:A?!KN&>_0)<&"Y= V!MS@' ;;QGK@GUJG)\/M%DTS3].:74/L
MVG2B:U47;YB<?=(.<\=O3)H YRW.J^,+_P 4Q6VII!=6=\]K"1<RHUHJ<(P1
M2 <D%CG.>1T&*]"T@SMHUD;FYCNIS F^XC&%E.T9<#T/7\:Q+_X?^'=2UC^U
M9[647;*JS-'.ZB<#'$@!^<8 !SU[UTL44<,211(J1HH5$48"@= !V% #J***
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH *BN+:"[MWM[F&.:%QAXY%#*P]P>#4M% %6QTVQTR%H;"
MRM[2)FW%((EC!/K@#K5JBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "@C(P>E%% "*JK]U0/H*6BB@ HQSGO110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 45EZCK]GI]Y%8[9KJ^E&Y+6V7?)MZ;CR
M JYXW,0/>M)&+QJS(R$@$JV,K['&1^5 #J*** "BBB@ HHHH **** "BBB@
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84 %%%% !1110 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>davidjkatz_employmentagr007.jpg
<TEXT>
begin 644 davidjkatz_employmentagr007.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***04 +1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %(*6D% "T444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !2"EI!0 M%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 444E "T444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !2"EHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MMJ%J(9CB*0S+M<],*<\_A7#Z<C-\7?$,4DB/,^CP!@OKT/7_ #S7#2:E81_
MS0[!KR#[7#J"B2'>-\>+AB2PZKP1R?4>M 'MUYK>E:?<+;WFHVMO,Z[E2655
M)'T)J_7D?BG;;#Q+J^FW>G:QHUQL.K:;/(5D7"*%:&1?52I';TR:]8MY1/;1
M3!2HD0-M;J,C.#0!AW7B_2H/%,?ATW<*WK0M*^YP!$<J%4YZLV[('7 ]ZR/"
MOBB2.#5E\3:I;Q31ZU-8VQF9(]RA4V*,<$\Y_&H=5GL;'XQ:9<7DT$ ET>6,
M/*P4,PE4@ GJ>O%<[<Z=I;>"OB-.;:VDF34+O9*P#.OR(1ACS]XG% 'J6I:O
MIVCPB;4;V"TC;.&F<*#CKUJU#-%<0I-!(DD4BAD=#D,#T(/>O(-/UU+/Q+I[
MZ_K,]A:7V@6HM;HA/+<A<R*S.C ,2<\$=!G/%=[X%M--L/#2VVCW-W=:>DTG
MDSW)4^8"V24*@ IN)P<=CCC!H C\?^)I?"OA^&[B*H9[N*V:X="ZVZL3ND*]
M\ 'CU(HMY-7M]:T<6^J_VGHMV)/-F>-"X8(64AT 7:2#V[#FKOBK4-*L-*1=
M;CC?3KN9;6;S1E5#YP3[9 Y[=>U</8:$_@GQWI-KX7U"2XTG5"YN=,>;S%@0
M#/FJ>PSCD]3QDYX /0I/$&CPZDNFR:G:)>LP18&E <L1D#'KCM1:^(-(O=2F
MTVUU*VFO8<B6WCD!=,'!R.V#7DFBSZ!J'ABXT3Q5JM]#JUO>R//I^4666<R%
ME:/Y=S,<CD'],5T_BTWWA;QC9>(])LO.;5HCIUS$>C3X_P!'9L=/F^4G/2@#
MLAXCT4Z:^HC4[4V:.8VF$@*[QU7Z^U'_  DFB?V='J/]K68LY'\M)C,H5FSC
M:#ZY[5P7B?9X5U[P@;Z\N+;28(IX);^-5^2X< [VRIP6(/./XF]ZP_&$'AV/
MP3J4FDWC7EO=:O!--<2R*T<LI(,A3  Z$;B..<=C0!ZM_P )1H7V-KL:K:M
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MS-U;007LDNH-=!@1+M!;"GD#D # YXK1A\7VAU:VTV]L[S3[B\0O9_:57%P
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M-%SX9T.\T^'3[G2K26SA.8X&C&Q3ZX]:NOJ%E&RJ]W;J6 90T@&0>A'-/%S
MT[0+/&9E&3&'&X?AUH SE\,:&M_!?#2[;[7;JJPS;/F0 8 ![8%:I 8$$9!X
M(K&UWQ5I/AV:RAO[N&.:\F6*-&D52 >KG)X4=S6#9>*;F+XA:SI^IZG9KI-O
M9Q3V[E5B5=YXRY)R<=\X/8"@#83P-X6CF,R:!8"0_>;R1D_7UK:CL[:&T^R1
MV\*6VTKY*H F#U&.F*;+?V<%F+R:[@CM2 PF>0!,'H=QXIUK=VU] L]I<17$
M+=)(G#J?Q'% &=;^%M M4B2#1K&-8IO/C"P*-LF,;AQUJW!I.GVU]<7L%E;Q
MW5R )YDC :3']X]ZP/%/BNVTK5-)T@:C;VDU[.5FF:1,V\2H6R0W +$!02,<
MFIM,U,Z%8>5XF\2:=/))*6MKAG2(R0G 0L.!G/<<<B@#4LM$TW2#<2Z5IEG;
M33?,_E1B/>>V2!T_#\*CT?1AI\]]?3/YE_J$@DN'!X&T;51?]E1P/7D]ZMW&
MI6-H(#<7MO$)V"P[Y /,)Z!<]?PJLWB/1$L(K]M7L1:2DB.;SUVN1UP<\XP<
MT 7;LRBTE,$*S2;?EC9]H;V)[5S7@;PM_8/AZQ@U#3]/34K=2IG@ =B"2?O%
M0>AQ70-J=@FGK?M>VXLV *S^8-A!X&&Z'-,M-:TJ_F\FSU*TN)<$^7%,K, .
MO .>XH 5-'TR*]-['IUHEV6+&=8%#Y/4[L9R<G\Z0Z-I;/*YTVS+RL'D8P+E
MV!R">.3GG-,L]>TC4;HVUEJ=I<3@%C'%,K-@'!. >F16=IM^L.K:[-=>)K.[
MLXVC9;<%%^P#!!#L#_$1W]* -631],ENQ=R:=:/<@@B9H%+@^N[&:NUF6_B/
M1+J[@M;?5[&6XN$\R&))U+.N,Y SDC'-2WFM:7I\ACO-0M;=E +"64+M!Z9S
MTSVS0!//96EU)')<6L,SQ$F-I(PQ0GT)Z547P]HBQO&NCZ>$?&Y1;)AL=,C'
M-7;:ZM[VW2XM)XIX'SMDB<,K8.#@C@\BN?L_&FDZIK&J:5;7L*/91(3.SC:6
M8,6P#U"A02<]_:@#8?1]+DLX[-]-LVM8R2D)@4HI/<+C ZG\ZMHBQHJ(H5%&
M%51@ >@KF_#^J6VF^%]/;5O%%GJ+RNT:7Y=$6X;>0 N#@D<+QZ5>'BSP\T=W
M(NN:>4M/^/AA<J1%SCYN>.>* -9XTDQO16P<C(SCM_6H+73[*Q+FTL[>W+G+
MF*)4W'U.!S6)KVJV=_X2>[L?%%KI4-QM\G4\HZCYN0-Q ).".M:$NO:18L;>
M[U>S2>*#SI!),JL$&/G(SP.1S[T 7#86;7@O#:0&Z"[1,8QO ]-W7%3.B28W
MHK8(89&<$=#5&UUW2KW2#JUOJ%O)IX4L;D2#8H'7)[8]Z;;^(-(N;O['%J5M
M]KSC[.\@67/7[APW3GITH O3V\-U"T-Q#'-$PPR2*&4_4&F?8;3R4A^RP>5'
M]Q/+&U?H.U/N+B&UMY+BXE2*&-2SR.P55 [DGI5.UUW2[UIEM[Z%W@7?*F[#
M(O\ >*GD#WZ4 6)K"SN(HXIK2"2.,AD1XP0I'0@'H:&L+-V=FM8&9VW,3&"6
M.,9/J<5PUGJ=SXOU'4UTWQ*;"XLM1\NVCC59$>%%4L2IQNW%CSGC QWSV-_K
MFE:5-%#?ZC:VTLOW$EE"LPYY /;@\^U %D65HKJZVL(=<;6$8R,=,4];>%)F
MF6*,2MP7"C)_&L[3O$VAZM:W%U8:M9W$%ODS.DHQ&!W;T'!Y-,A\5:)<&81:
MA&SPP_:'3!W^5_?"XR5]P"* --K>!YEF:&-I5Z.5!(_&I:QX/%.BW6C-J\%\
MLFGJVTSJC%<YQQQSSQFF77C#P[97,EM<:Q:QW$:AWA+_ #J",\KUSCG'6@#4
MEL[69]\MM#(W]YT!-21Q1Q)LC147T48%8O\ PF?AK?9K_;5GF]"FW_>#Y\D@
M?3)!'..0?2KFH:]IFE2&.\NUC<1^:RA2Q5/[Q !PO!Y/'% %XQ1M*LK1H9%&
M%<J,CZ&GUCW7BSP_9/;K<ZQ9QFYB,T.91ATQG<#Z8_.L[4_'VB6GA2]UZTN?
MML-N6C"Q(Q/F@<*W'R\D<GCF@#J::L<:8VHJ[1@8&,"J^GWT6HV,5U%NVN,_
M,C+S]" :YM/%EIX@N->TBRFN[::Q4*)TB9&+;2QQN7 Z8YZ\D=C0!UNT!BV!
MDC!-+7"> _&6GW'AS0+#4=4WZQ=0#B4LS.W)Y?&-Q'."<UTFH>)]'TJ:2.]O
M/*,6/.?RW9(<]-[@%4SD?>(ZT -GT:6#5IM4TMXHKBY0)=QR@E)]H(0Y'W6&
M<9&<C@@X!%'P%X=O?"?A:#1;R>WG%NS^7)"&&X,Q8Y!]VJW>^,?#VGWSV5SJ
MD*72Q><8AEF*D@#  .2<C ')]*OZ3J]AKFG1W^FW*W%M)D*Z@CD'!!!P00>Q
MH NT5RUYXPBA\<VOAI;>XS);/-)-]GD.#D!0N!R.6RWW1@<]:Y[P=XWTS3]-
MU&/6]<D>1=7N(8WN&:4I'O"IO8 A%]"<"@#TJBLW4M>T[225NYG#K&962*%Y
M65!_$P0$A?<\5:L;ZUU*RAO+*>.>VF7='+&<JPH L45R>G^-K/4O$&N:6T5S
M;0Z:D8:>2W=?F(9F).,*,!<;L$\XS4&B^)/#V@>#K&YN/$LU]923/#'?W>]G
ME?>1CIG /&>F!UH [.BN=7QUX<::: :@WGQ $PFWE$C G *)MW./=0:H^(-=
M\/ZOX*.H-K]U9:7)*H-[9!UD4A\;3A2R\C!R!UH ["BL74/%NB:5J8TV\O3'
M>M&9%A$,CLZC^[M4Y/L.:6#Q9H=QH<FLQZ@AL(G\MY2K J^0-I4C=NR0,8SS
M0!LT5D6OB;2[O56TI)94U!5W-;20.CA>S'(Z>_3MUXJ_?7]KIEF]W>SI# G5
MV/Y #N3T ')H L45CVOB;3+N]GL5:>.]AB\]K:6W=)&C_O*I&6';CG/'6N-T
MBY_X3?5=<AGN=8M)K34VCL[BV$D2PQQ!/E.1MW$EB0PR<^PH ]*HK'UGQ/I.
M@3VL.IW1@>Z?9$3&Q!//<# Z56T_QOH.H1W[+=O;MIZ>9=1W<+PO&F,ABK '
M'^>] '0T5S]MXQTJZN#;*MXEP;7[9'#):NK2Q>J CYNW'7GI1:>,M*OO#W]N
M6RW<ECYOE*5MVWLV[;@+U/S<=.M '045SUQXVT6VU&YTYGNFOK>,2O;I:2LY
M4]U 7Y@,<D9 ]:K#XB^'6BLKB.XN'L[MQ&MVML_DQN20%=R,*<C&.W?B@#JJ
M*QM6\36>DO-&T-U=/;QB:Y6UCWF",_QOR.."<#+$ X!JE)X^\/K/IT4=Q//_
M &C&TMJT5L[+*%&2%..6[;1D@G! H Z:BN&O_B79)X1U;6+&QO7N-/<P36L\
M7EO!)T4R GA<]QG\ZZO1KU]0T>UNI(Y$>2)2PD3:2<<G'I0!>HKG;WQE8V=U
M-$+6]N(;>X2UGNH(U:**5MN$)W9S\RY(&!G!.>*X[3=<A\,^.?'DL\%_=HKV
MLBQ6J-.RIY;%F/.% SGDCVH ]3H) &2<"N?D\8:<T>FFQ2XU"74HC/:PVRJ&
M>, $L=Y4#&1U(-<=\1M6LO$/PR75;,3)LO8H]DF4>-Q*%=64'&01CO0!Z@2
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M:[\681%"(A:0-LVC;D6\ASC_ 'N?K7I]MIFGV4\D]K8VT$TO^LDBA56?G/)
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M-) TL;()8SAD)&-P]QUK+\-^'O[ LY$EU"ZU&[F(,UW=-EWP,*/8 =![D]Z
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M:'K\7PNT;0O^$>N)-1M+B%W7S[?:HCE#DAO,[C('?KG%6Q#XL\,>)]2O-+T
MZKINLNMR86N8XI+2<J RL<D$<#D9'3GU -(?$>WNM2TNSTK2KK4#J=H;JW>-
MT48!P0V3\N""#GN.,U0UCQYJ<_@;5-1TS3A:7]C=&SNX[B4$V[94%EP,-]X8
MZ?CCF:?3_$(^(>C:K-I,EU;VMB]O<SP20JOF2')VAG#%%Z<C/'0]\C_A&=?O
M_#WC*SFT)X)]1O\ [?9">>%@W*$+E6.UOE//3GK0!V-YXHGM=8M-&%E:_P!I
MSV[7!BEO/+3:&VA4;8=['TP/K6SI5[+J.E6UY-:O:2S(&>"0Y:,]P:XWQ!8:
MCXCACBUKP9]KMWM=R);W</G6DY+9 D9EZC9DC(!'\5=-X4L=0TSPMIUEJDYG
MO880LKEMQSV&>^!@9[XH V**** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBDH 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@#@-)\-7%[XX\0ZEKOA
MZ/[)?"$6SS21R[0BE6! )(#<''MS75W/AO1+R:WEN=*LY9+90L#-$/W0'0+Z
M >U8ND>(KI?%/B6PUJ^LDM=/-J() ODJ/,5F()9CD\ =>W2NHN+NWM(#/<W$
M4,(ZR2.%4?B: *]_HVF:I)#)?V%O<R0Y\IY8PS)GK@]1FK-M;06=O';VT,<,
M$8VI'&H55'H *:+VT-O'<"YA,$A 23S!M8DX&#T.34;ZII\=LUR]];+;JVPR
MF50@;.,9SC.>U #HM.LX+)[**UBCM7W[HE4!3O)+<>Y))^M4H/#&A6VGS:?#
MI%DEG.<RP+"NQSZD8Q5IM6TY(X)'U"U5+CB%C,H$G^Z<\]1TIZ:A927$MNEY
M;M/",R1+*I9!ZD9R* *]EX?T?398Y;+2[.WDBC\J-XH%4JF2< @<#))_&D@\
M/Z-:ZG)J=OI5G%?2$E[A(%$A)ZG=C/-3+J^FO);QKJ%JSW )A43*3* <';SS
M^%5];U:UTZU\N75+2QN9@5@:X(Y;V4D9H 2Y\,Z%>WCWEUHUA-<R(4>62W5F
M93P0216C!!#:P)!;Q1PPH,)'&H55'H .E8/A?7C>>!=,UK5[F&-YK=9)I6(1
M=Q_05J#6M+.FC41J-J;(C<+CSEV8^N<4 /N=*TZ\N8[FZL+6>>/[DLL*LR?0
MD9%1?V#HX6=?[)L<7!S,/LR?O><_-QSSSS5BUOK2]\W[+<PS^2YCD\MPVQAV
M..AK-\3RS1:4#!K=OH[B5&-S.JL"H(+* 2.2.* -2UL[:QMU@M+>&WA7I'"@
M11^ XJ.[TRPOSF\L;:X.W;^^B5^/3D=*AU#7M)TF6.+4-1M;620919I0I(SC
M//;/&:O12I-$DL3J\;J&5E.0P/0B@"&RT^RTV$PV-I;VL1;<4@C"*3ZX Z\4
MRVTK3K*XEN+2PM8)YL^9+%"JL^3GD@9//-,U'6=-TGR_[0OK>U\S.SS9 N['
M7%06WB71+R\M[.WU2UEN+A/,AC20%I%QNRH[C'- %M=,L$OVOULK9;QA@W B
M42$>F[&:633;&6Y>XDLK=YW3RVE:)2S+G.TG&2,]JXOQWXK*>"+S4_#6L1^=
M:7$<4CP;'P2Z@J<@X.#]:ZBP\2Z)JE]=65CJEM/<VN?/C20$IC@_@#Q0!>2Q
MM(H7ACM8$B?[Z+& K?4=Z9;Z986EJUK;6-M#;MUBCB54/X 8K&\+WD*:/?32
M^)H]9B@N9#)>$*BQ  ,4)7@[0>OO6AIGB+2-9EFBL+Z*:6$!I(^5=5/0E3@X
M/KTH G_LG3<8_L^TP.<>2O\ A5M$6-%1%"JHP% P /2LB#Q3HES>-:0ZC$\X
M5V"C/SA?O%3C#8[[<U5\+^+['Q2;W[(LBBWN'B7=&PW*I W9( &3GCK0!T$D
M:2QM'(BNC#!5AD$?2FM;PN(P\,;",@IE0=I'0CTJGK>LVF@:1<:E>E_(@0L0
MB%B<#., >W7IZUG:1XOT[4?"MKKMQ(+2*5$WJX;Y9& .Q<@%SR ,#GM0!K/I
M6G2.SO86K.QRS-"I)/J>*K:MH=OJ=G!$I^S36KB6TGB49@<< @=",9!'0@D5
M-IFL:?K$+RZ?=).L;%) ,AD8=F4\@_44_5+J6QTF\NX8&GE@@>1(5ZN0"0!]
M: '-:)=VL4>HP6]PZX+ QY3<.X!SBJ>K:/\ VS+!!=2 Z:C"22W .9G!RH8Y
M^Z" <=^_'!X?2-5U7Q+X-&KZ%XIEN-8"*]S9&*+9&W!>-4V[ACD*23GCKFNY
MU7Q'I.B.L=_>"*1E+[%1G8(#@L0H)"CU/% !JVC+J$]K>P2FWU&S)-O.,D8;
M&Y&7(W*P R/H1@BK$MB@#W%O;6BWY4E97C_B(ZDCG'XU!=^(M)LM/@OI;V,V
M]P,P-$#(9AC/R*H);CG@&LC5?'^C6&DV>H6\S7<5Y<+!$8HG8 EPK;L#Y2N3
MP<$D8% %^TT*33=,NXK&[5-0O)3-<7LD>XM(V,L%SV PHS@8'7G-W3](L=,T
MR/3[> ?9T.[#_,68G<68GJQ;G/K6,U_I][XSTTP^(9XY_LKL-+7(692,[W4C
M(([9P?US>O/%FB6%RT%S?+&R2B&1_+<QQN>0K2 ;5/(X)'44 ;-%8M_XNT#3
M+Z6RO-3ABN88?/DBY+*F0,\#N6&!U.>*N:1K%AKVFQZAIERMQ:R9"N 1R#@@
M@@$'/8B@"]2$ ]0#WJAKFJ+HNAWFI-%)+]GB+B.-"S.>P '/)Q7(> =3&NW<
ME[%XSN=4,28GL)+5(?*<^VT-@<C^M '>M&CE2Z*Q0[ER,X/3(_,T.B2+M=59
M<@X89''(I)ED>%UBD$<A4A7*[@I]<=ZYGP'?WM]X>N)M2O?M<T5]<Q&<J%#*
MDC*" . ,"@#J:*\[TOQ7:^+=9;S?$$>G632M%I]E!<*DUWM)!D<_> )'RJ,'
MUSFO1* "BL;4_%6DZ3>/:7,TS7$</VB6."WDF,<6<;VV*<#ZU6O/'7AFP2P>
MYU6)$OX_-MFV.1(N,YR!QT[XH Z*BL;2O%>BZS97=W:7@$5FQ6Y\Y&B:' SE
ME< @8YR:X_4_$1O?BAX/BT^\U**VN4N3/;R+)#%,@CRC[6 W<[NOH.G< ])H
MHKE[?5'UC7]3?S9X],T241;8-^Z><+N?<%Y95! "CJ<YSQ0!U%%85GXPT?4-
M#EUFSEGFL8VV>8MNX+MG;A5(!)SQTZU4U/6)=!\0:27\U]/UB?[.ZRDDV\Q7
M*;?0-C!'0'!'?(!U%%%<2GBN36_$/B+P^+2\M8K&VC G3*.'978L6!^48"X[
M]: +VI^%+V?Q$^MZ5X@N=.N)H4AFC,*3QNJY*@!ON\DG@]ZUM(T@:8LLDUU)
M>7T^#/=2@*TF,[1A0   2  /S))K@_AYXZTZ#P;X?M-4O;J2\NG>$W$D;NGF
MM(^U&DQC<1CC/I79:IXLTS2FNQ*+F862AKMK>%G%NI&<N1[<X&3CG% &Y14-
MI=07UG#=VT@D@G19(W'1E(R#^5<+\1UGCU+PN;>_U"U^V:M#:3BVO)(@\;9R
M,*P&??K0!Z!17G>FZA>VGQ9;1-,U"ZU#1VLO.NTGE:<6DF3M D8D\\<$GK[<
M=)JOC+2M(-P9_M,D-HZI=SPPEX[8D C>1]1TR1GF@#H**X"]NVD^+WAYK:\F
M>SN],FE\L3,8GX^5@N<=,<@5N77C;2;.6(S?:!9R7!M1?>5^X$H.W:6Z]1C.
M-N>_!H Z.BN<U+QMI>EM>M+'=R6]A(L5Y<PP[H[=B 0&YR>&&=H.,\XJQJ/B
MBRT^XN(!!=7+VL"W%S]FC#>3&V<,<D9SM/"Y/&<8H VZXVQ\#W^G(+*V\7ZN
MNE+G%MMB,@R<D>:5W ?3GWK7F\3V:;$M[>[O)VMENV@MHPSI$W1CD@<X/ ))
MP< U=TC5['7=*M]3TZ<36LZ[D<#'L00>A!XQ0!9M[>*TM8K:!!'#"@CC0=%4
M# 'Y5+6'K_BO3?#4]C%J N0;V988FC@9UW'U(X_#K[5FI\0],>XNK06&K?VA
M;8+6/V0^<RD9#A<_=QW)'4>HH ZZL?Q%X>@\1V,4$EU<VLL$RSP3VS[6CD7H
M><@_0BJ \=Z2^E:-J<4=W)9:M.MM#*L8^21F*A7!.1R&Z C@^V;$OB[3K;5=
M2T^[2XMGT^T-[-)(JE##DC<NTDGH>, ^U #]-\/S6MP+C4-:O]4E08B\_8BQ
M\8R%C506P2-QR?3'-:MI9P64/E0(54DLQ9BS,3W+$DD^Y-8#^,D"NJZ/J/FF
MQ>_@5O* FC4J#AM^ ?G4X.#C\J?X&UZ[\2>%;/4[RU>&2=2V25VN-QQMP2<
M8'(!H WYX(KF"2">-)89%*.CC*L#P01W%5],T\:99BTCGEEA0_NA*<F-.R9Z
MD#MGG'<UR/Q@0?\ "M=2GW2+) T+(R.RX)E0'@'G@GK6EI_CO3+W7_[&FMK^
MPNI(_-MOML!C%P@!)9?H >#@T =!>VIO+9H//EA5B-S1$!BO<9QQGID<^A!Y
MI;.SMM/LXK2TA2&WA4+'&@P%%8)\:V*2Z>\MI=Q:=J,@BM=0<)Y4C'[O ;<
MV."5 KI: "BN9U7QK9:6E[/]CNKFTL)/+N[B'9MB; )&&8,V P)V@XS]<-;Q
MS8)K=EI\EO/'#?V[7%G>LR"&=0N[@[L@X[$"@#J**YV+Q="=$@U.XT^ZMDNI
M%CM89&CWSENA7YL 8YR2..:JQ?$/10VJQWWFV,^F())XI=K;D. K(4)#9) Q
MG.2* .LHKF5\8JFK2:7=:1?6U[]C-Y#$Y0^;&."-P8A6![$CM5;_ (6%I_\
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MWUK%<-%96PC$@W!<P-D@= >!SU%8'A_5BL/@./4]0%G:OIDRV]Q-&K(9PX4
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M:U_9,\2M$X.R(H25=54$$YPH/.[Z$CT+0=$.CP7WFS+//?7<EW.RIM7<P P
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M*PR!N);MP!W-/G\.:])X2\#Z>NDR_:-'O[:XNQYT6 D60<'?R3G(_7%>H44
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MZ_.0..Y'K76_#"]M[SX=Z,L%S',T%NL4H1PQC8?PMZ'&.#[4 3:!XVM-<O\
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M:D4NK=D;[%>QAR&F<_=&5^;(YSVR<T >A:WK%IH&C76J7I<6]NNY]@RQY
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MV6D-]A/+:5B<#&[=CMG&*MV]AJMEXF\<QMI%U)#JD:R6UPFW8V(2NW)/WMQ
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MJ/YX812,HVR'*@[CEC@#''6J=OH6NF\\411>&8-/M-6TE8(!'<QXC=8Y%"D
M#YB7&>PQU-.UG2O$FL>#?#UG_8$D=S8WMM+)&+J(D)",$DE@,D] ">.N.E '
M57'B6XFUG4=+T;3TOKC38DDNO,N/* 9P2L:_*<L0">< <<UB7'Q-B&CZ)J-G
MH]Q=)J5ZMB\7FJDD$V[!0@]6X..@Z9(S4UII>LZ!XXUO5[?37O[#6(H9"L<L
M:2P2QKMVD,P!!R>03]*P+SP9K5IIFA+:Z6+FZ7Q!_;=^()D5$^8DHN]AD@$
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M6=(7:./S'5253.-Q[#)Z5RN@^&HKF.\O/$>AV3ZG=7+RNTH2X 7HBJQ&0%4
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MD^IKEM:U_2=5T6SGL?%L6FQS7:K'<1%2TQ5L-$%;N<CMQP>E6)O&NGQ>+WT
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MH?&#PY<6>IV4\!T^:+S(Y5*[F^ZA/KSTZ\US@GLO^%5?$&$2V^X:U<F--PR
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MB2.,'.%4=R>I[X7TKHJ /.O#OB?1O$L6BV]II<IURRB,+![=E_LT^7M<ER,
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MM8K>Q"QG5%N@_G1H1A5CQG)7Y<G&.3UXJG8Z!XBT?PKJ_A"+3ENK>X,\=EJ
MF18TCFSGS5)W[EW,?E4YX^M>CA@P!4@@]Q2T >=67AO5-)\>:#+;Z;--I6FZ
M0-.:Z$L8W-UW!2^[';IGZCFL=/"'B2\TS5'&EBPU&'Q ^N:=YTL3+-DY$;E&
M.&^O'3FO7:* ."M[3Q5?^-],U^\T.WLH8;*6"6'[<LCC<P/9<$\9 Z>K"LY_
M!VO7'@#Q;HTD,:W6I:A-=VBF4$;&=6"D]C\I]OF%>G44 <%?Z-X@U+4/"-\^
MF6\1TIVDN(OM0; 9 N <#+#KZ>YIFF^'];\*S:[IVFZ=#J&FZI<2W4$AG$?V
M=W4 I(#R5X&"N3[5Z!10!YM#X%U#2;CP7;V$<<]KH)F:XE:0(96E')5>>Y)Y
MJY;Z1XBM]2\47BZ792#5)H'C@GG#HZ*%21'XXW+NP>1VQ7>T4 <;X-\+RZ'J
MVIWD-G_9>GW:IMTP3"54D!.Z08X4$8P!^G J6?2-8M?B,^NV<$%Q97&G+;2B
M2<H\;(Y8;1@YSG';G.3Z];10!Y9=^#_$=W\,]5\-?8K9+N[O#.C_ &K*!6F\
MTYXSD8Q^-6]1\,^)]0U769Y+?3YXM0L1;VK7-P2=/S&5=4 4@[B<Y&,\9]*]
M(HH \SC\(^);>T\$SQV]@]UH"RQ2PFY95=6C"!MVP^F2,=^]=!\0=$U3Q'X%
MNM&L8X'O+KR@S-)L1=KJY/0G^'&/>NLHH XG4=)\07?BK1M3@L[>*.ULYK>1
MFN<LC2*OS ;>0I'XUSD7@WQC'I6B6ZVNC+<Z;JB7DUP;ER]Z1NR[MLR#AL=S
MZ8Q@^LT4 >92^$O%=C:>)=%L5TVZTG5S/+"\LS)) \H.Y2 OS<XQS[^U=OX8
ML;W2_#&FZ=?^1]HM+:.!C Q92$4*#D@'MZ5K44 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 9
MUOKVDW=W<6EOJ-M+<6REIHDD!:, X.X=N121>(='GTLZG%J5J]B&*^>)!LW
MXQGU]JXOQ;#>^&/&-OXATB!I&UF+^RYXU'"SG_42D>Q&#[#WJ#Q:;?PKKG@]
M+B>YM-"MXYK=KJ, ^3*54*[$J>2-PSC^)CZT =1KGCG1-&\-G65O8+F)SM@$
M4F1*_3;D9Q[GM6[!?6MS9"]AG1[8J6$H/RX'4Y_"O(?%%OH$?@3Q)>Z)<7%[
M%<7EK-<7;ONB:7S1N*$ #(!^8CCD=Q7L%I=V]];)<VD\<\#\I)&VY6'J".M
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M""1)5FFD\DQX;S"8]ORD?>YP./ZTMKKMO;ZGX=L+I)[.,^'XHQ=6EJ7N;B0
M9MPX4LH!!) P<]QW .B\9:TEWI/AO6]%UJ=+2?5K:(O;R[8Y8V?YMP[XVD8/
MN"*M)>7L/QH?3_MUP]E-HGVG[,\G[M'\[;E5^@Z]>37G.GSJWP>\-V'ER_:K
M/6D,\31,"H$TC'MR ",D=,\UWK2*_P <X9U8-#_8'D^8.5\SSBVW/3..<4 6
M?B==7-AH%E>6VH7-F8]0@5S#+Y89&< AB.<8]_K6SHWC+P_X@OIK+3-12>YA
M7<\11D.W.-PW ;AR.1D<UD?%&)I?!P86TMP(KVWE=8HRY"+("Q( )(QFL_5K
M-/%WB_2=4T"97CLK"Y6:\C8JC&5-L2!NY!W$@?=[\D"@#J$\7Z&]]:V?VQED
MNW:.V=X)%CF8=0DA7:Q^AY[5>UC41I6DW-X8Y',<;,JQQ-)D@$C(4$@<=:\J
M\)R:#J%GI6A7FAZI+XBTYHE>UN))Q%"\>!YV2VQ5 &0,>P'(KT_Q)=0VGAS4
M9)FVJ;>11@9+$J<  =2?2@#CO#-U#+I.C^*;[6]5AF:W1;N&42&*[DD'RA$8
M8)#'Y?+'M760^*='GDO8ENG6:R4/<0R02)(BGHVQE#$>X!KSK$__  A/@+4X
M(IIX-%GA.H0QHQDB&S:6*8R=OT[UMWH@U7QY;^)+-E?3++2I([BZ"D+(SD[4
M!_B(Y)],CUH UX_B/X:O(I/[.OFO)Q:M<I%%;RDLHX[+QR1D=0#GI6!X0U&*
M_P!%TGQ7J6K:G#=HC+=1[9?(NS(S!%"$8<@GY0G(Z5+X)N[6V^#L:R PO;VL
ML4J-&597); QC))R/KFN8BANI?A/X3N+:TN;IM%OHY[^RC5A)Y89PWR\$G!X
M]CGD4 >CWGB;1=0TG6K:6^N[%[2$K>!8G2XMU8<.HP3T.0P!%9,OC.RT#2O"
MUI8?;]2AU%HHH[N>*1V:+'+$@9:0@?= SSG'8T1<Z#>>'O$&J:1H]W!OTN2W
MFN[J*19)'*X2,!LLQR>3Z[>3VQ7,D/@OX=:A]GN'ATV[B%V(X69X\*0<H!NZ
MC'3T]: /2M1\5:7I:S-<O.5MXUFN#';N_D(>A? ^7Z=<<XQS3KCQ'IJP6OE2
MRW+7T/FVR6B%WDCP,N,=!R.3CJ.]><F[M-%\7:W_ ,)#X:OKRUU>1+NPECM#
M,S H%:-ES\I' P??VJZMP?!WC>VU*ZT2XM-&O-*6VC2UMS+]DD$A?RR$!QD'
MMP2>^#0!I_"B\EO=%UN26[NKE5UFX2)[IV9_+ 3:#NYZ=C74-XDTY=>?1,SG
M45A,_E"!\,@[AL;3R<=>M<I\*99#:>(5EL[RW,NLW%RAN+=HPR.1C!(Y/RG(
M[59\?Z9?I=Z)XCT:V$^I:;="/R\X\R*7Y""?0$J?;DT ;,7C'2;C1[S5+?[3
M+!92F&X46[!T<8W+M(!)&><50T[4=+?Q1K=[:SZO/?1VT/VBQ='$<0Y "*0!
MN.TY.2.O/6N=L/#.J:+X\CTQ&:XTG4_+U.^F93Q<1<MS_MR>6V/PZ"M73HS)
M\7-:NO(NEC;3HH(Y6@=8W8,2P#%=I(X[_3/8 YSQ7XHGU_X40:^AO=/D^U1L
M"DC1(R&7&#@X<  =>_->@:7XOTC5]5FTVWDG2YCB\\+/ \0DCSC>I8#*Y(Y]
MZ\H8W<OP3M=!_LK5CJ%G=(DD?V)SEEF+,!C.0%[].@Z\5UVOF36/'5@+-+^.
M&XT>YM3<?9)52-Y<; QV\=,\]".<4 =*?&NC+Y$C23K9SS_9XKTPMY#OG  ?
MT)! 8\'UJU%XDLY]6U#2XXKEKVQC626+R^64YP5YP<XKSHQ7NJ_">/P5)I5Y
M%KBJEGY<MM((EV2 ^89<%-NU<Y!YZ#-;:&X\.?$NZEDT[4;R"^TZWA@FMK<N
MN]"05=NBD\')..>30!-J/Q*M?L.BW6DVES<Q:EJ"6@D:+ 4;\.,9Y; ( _'V
M/<"91;^?)F--F]M_!48SSZ8KQ#3[/5++P!X:EFT/4]^F^(1=3PK;,TOE[G8L
MJCDCD#)%>MZW:3Z_X0U"SA62VGO;.2-%DP&1F4@!L$XZ\T 4[;QQH]S>:=!_
MI,::F6%A/)%B.Y*]=O<=L;@,YXS1>^.-)L8+B[D2[?3K:8P7%]%"6BB<'!!_
MB(!X)4$9XS6!X-U[59=.TK0+OPQJ-OJ-@$AGNKF "W1$^4LKYY)48&!U/I67
M86VHV'@76O!=YI=Z^HN]Q#:21P.T5PLK,5D\S&U0"QSN(( ]>* .SU#QOI6G
MZU%I+17UQ=S6YN(A;6K2"1?]DCK]1QZD4EOXYTBZT2/5(A<D278L5MS%B7[0
M3CRR"< _4X]ZY33]-N=*^(7AJ!K:\EAT[0_L<]RMM*T?F#' ;;R*KV%G ?#^
MLV&L>'=6FL[O7IKA52TD62.)LLDR8&<@J,@<@'H>A .D\4:[HU[X/U8:S;:K
M;VD$RV]U'%&?-5ALD&&0E0#N7G.#G&:WKW5K?3I[?2X;:ZN[J2(LEO;X+B-<
M L69@ ,D#);))XS7G%W9ZV? 7B?2@FJZI92ND>DM<VKFZD'!?>"H.T$##,!G
M!]JV+Z]U#1?'T?B3^R=4O]*U+3TMBL%NS36CJQ(#1GD*<_F3^(!5^'NL6FFV
M7BR[NFN8[===DBBCE#R2C.U43')+9(&.:ZI_&^FV]S?VM[;7UI=V5O\ :I+>
M2'>[0]-Z["P8 \'GCG.,&O.AH>OZAHOB66WT*<3_ /"0G58+>^B4+<(I^YC/
M)//J#CK6_!=QZGH.J3Z?X'N-)W:=+ [/IZQS22N JI&J?,R9R22 .!0!KVWQ
M0T"YLS=B+4(X3'&\;RVQ43%VVA4.<%L@CTX//%79/&MN(=:CCTZ\_M'281/-
M92[%<J5)#!MQ4C Z@D^V>*Y7SM;TSX2:)#9Z5?&YMI((;Z%;8_:(XAR[1JPY
M;H 1TSGM52PTZ]3Q1XG-IX?U2&UU31PEL\XR=VQL[V9B=Q;C&2W(R .@!MWF
MMV&L>#?#MYXDL]2@%U-:RJUOC:TC!<,61CA"7Z'#<=.*ZF\\106^HS:?;6EU
M?WD$0FGBM57,2'.W)=E&3@X )/'2O.II=2O?A=H.FC0=7CN[.:T1T:T8DB%E
MWMC!P,#C(Y[ XK<M$O?#OQ#U75I+'4+O2]=MX9$EB@:1X)(QC8Z@9488XX]!
MV- &M)\1- 31M/U97N9+*]G%LLD<!/ER$XVN.H(YXYZ<9XS?TCQ1::OJ][I8
MMKNUO+5%D:*ZC"%T;HRX)XX[X->:W_AO5=-\*6=L^GWLUW=>(O[5EAMX3+]G
MBWG@E<C.,'&>]=1IRW)^,-_?G3[]+*XTU+=+A[9U3>IW$$D<<=_7B@#K=5UF
MWTIK6*1))KF[D\JWMXL;Y& ).,D   $DDUEQ^-+(P:KYEC?QWFEJ'NK(QJTJ
MJ02&7#%6& >0>U4/&6GZG'XE\.>(]/MI;R+3))4N;:+E_+D4*75>Y'H.36;?
M65Y=:OXB\5+IU\(WTC^S;.V\D^=.222VSJHW$ 9QW/3F@#<L_'EA=W6E1FPU
M"WMM55?LMW/$$C=V7<$ZYSCOC![$UI>*-6NM#\-WVI6EB]Y+;PO)L5U4* I)
M9MQ' QR!D^@K@-0@U"?0/AY!'H^IM+IUW:O=+]E8&(1(%8G/3GIZCFO0O$MK
M-J'A/6+2VC+SW%C-%&G0EF0@#\S0!YUKFH2W*_#K7+^TN5NC<('"H'>7=%G(
M"$]3R![\XQ7967CO3)XM::^@NM,?1P&NX[I1N56&58;2V<@=JY<6NKZAI_@:
M3_A'=1B?2IX_/$AC4JBQ;&;!;/WL8'7 / XJ'7/"6LZYK7C=(K.:WBU2WMA9
MW#NH5WAP<'!) )7'(H [*T\:6,^OVNC3V\UK=7<32V^]XW60+R1E&.& YP:T
MM2T.QU>ZM);^!+A+;>5AE4,A+ #)!X.!G'UKFO"MSJVH2VPO?"$>CRVV1=7,
M@CQ(P4C$0 R020<], C)KM78I&S!6<@$[5ZGV% 'E_@SPYI>M0^,[*ZL+?":
MU=6\$RQ+YD"\ !#U4+U X'ZUU&K>/-.TI-0E%O/=0:<_EW<D+QC8V 2 K,"Q
M 8$X'MUS69\/=/U?3M7\3OJ.ESVD&H:C)>6[2&,_*QZ$JQ.>G'3@UGP:7K_A
MOQ#J]O'X8AUW3]0NWN[6Y:2,-"\G)1]W(4'G@?F3B@#;O/B+8P:E;6-II>IW
M\MW9"^MC:Q*PFC/<?-D=^H'3W&4?X@;KW4;"#P[JLE_8P)/+ WE+A6&<EM^!
MQVZ^W6J:Z9J\/Q.TO47TR1[.#2?L,MQ"$6,2%MV0N[.P?3\*CM[+5H_'/BK5
M6T2[-K>V44-N28_WC(N#QOX!S0!;3XEVDEKI6HC2-072-0E2!;YPBA)&X *;
MMQ&006QCCC-68-0TM/B)JMO!H=P-;33Q+)<!D_TB($!57Y\#)_O;>G-<=)X?
M\0?\*M\.Z(-"NS?65]'+-&'BP%1V8D'?SD,,?CTKI[.RU0?%.^UQM)NEL'TI
M+9'9X@6D#!L8W_A]?;F@"%?B@C:);ZZ= ODT<S&*YNWDC M_WGE@[<Y?G&=O
M SU)S6MK7C!],N-22VTJ6ZBTN!)[V5I1$ K D"/<,.VT$D9'89R:XR7PKXBD
M^"MSX8_LB0:DTY95\^+:5,_FYSO].,>OMS5[6](\2ZGJ6NQ7&AK?QW=GY6F2
MS7"+'9@QD,"N3^\R?O '/ R!0!K7GBO5;GQ%X8CTJQCDTW5+>2Z1Y+CRVD41
MAL,-IVXW@]\GTQ4VFZUHUKKWBR\DTF33;FPCAEU"YE*LTR[&*D!2> JCOSGI
MD5D66F^([.W\$7/]@L\NE6DEG<0?:HPR[HHT#DYQC*'@9(&._%6+CPQJ6KZK
MXUAN;*2VM=:MH8K:X,J$!HT*_,%8L 20>G0'.* -/_A-WMO[*N=2T>:TT[5'
M2.VN?.5RA<902K@;,CT+8/7%0W7CJ[%UKMK8^';FYET9E\_?<1QJ4*%]P//.
M!P.3ZXJC_8VOZ[H&B:'JNG&T?3[F"2ZO!,C1RK#T,>"6RV!]Y0!S]*9:Z/KD
M.N>.;M]&G,6LQ1I:8FAR2D9C^8;^,[L_0'OQ0!W&CZG!K6C6>IVP807<*S(&
M&" 1G!]ZX/0-)TZ?XM>-8YM/M)$2.S95>%2%)CR2 1W/6NI\$65[IG@W2]/U
M"U:VNK2!870NK E1C(*DC!KGM-MO$6G^//$6M_\ ".3R6VIK;I$/M4 9?+3:
M2WSGKUXS0!2!_P"$(^*UGINGKMT;6[:21K-,[8)8U+%D7MD <#U-:T'Q F^W
M:,E[I2VEMK+M':!YSYZGG:9(]HVAL=03C(ID'A/6=0\1WGB?5);:#4DM7M]*
MMXW,B6F5(WL2.6R><#&#WKFU\)>+!;^'9/[#L?MNFZA]HNYVO07O&_YZ,V.!
M]<GV&* -[0_&>HK<>*K[7K>W@T_3+DQL8IV8Q[5&%52HW9)Z\9)Z8JUIOQ!6
MZ\0V6F7-I;A+Y3Y,UI<F?RW SME&P;<]B"1FLN?P=KE__P )9HUQ;V\5CK,W
MVJ.^6?.QPJX79C/WE&3QQGVK9\-/XYG:WMO$%K8V<-M_K;F";S'NL=,+T4'@
MDGGT SP =E169H<VLSVDS:W:VUM.)W6);=RP:(?=8^A//'T^E:= !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!S\&D:Q-XBD
MO-5U"WGTZ"4R6%K'#AD8KMR[=R 6 _WLUN3P0W4+0W$4<L3<,DBAE/U!J2B@
M"'[':_9/LGV:'[-MV>3L&S;Z;>F*DCC2*-8XT5$4855& !Z 4ZB@")+>"*:6
M:.&-)9<>8ZJ SXX&3WHAM;>V+F""*(N=S[$"[CZG'6I:* "HXK>&W!$,,<8)
MR0B@9_*I** (_(B$IE$2>8>K[1G\Z>RJZE64,#V(S2T4 1I;PQHR)#&J-]Y0
MH /UI5AB39MB1=F=N% VYZX]*?10 U(HXRQ1%7<<MM&,GU-#Q1R??16Y!^89
MIU% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !BC%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !12$@ DG '4F@$$ @Y!Z$4 +1
M110 4444 %%%("&S@@X..* %HHHH **** "BBB@ HHHH **** "BBFR2)$A>
M1U1!U9C@"@!U%(K*ZAE(92,@@Y!%+0 4444 %%%% !1110 445#!>6UTTJV]
MQ#,87,<HC<-L8=5..A]C0!-1110 4444 %%%% !15>6^LX+R"TENX([F<$PP
MO( \F.3M7J<=\58H **** "BBB@ HJK9:G8:D)C87MO="&0QR&&0.$<#)4XZ
M'D5:H **** "BH+N\M;"V>YO+F&VMT^_+,X15^I/ HL[RWU"RAO+259;>=!)
M'(O1E/((H GHHHH **H:AK6F:4\27]]!;O+]Q9' )'<X]!GD]!WJ:RU"SU&-
MY+*ZAN8T;8SPN'4-@'&1[$?G0!9HHHH **J:GJ=EHVFSZCJ$ZP6D"[I)&!.T
M=.@Y/)[5/;SQ75M%<0.'AE0.CCHRD9!_*@"2BBB@ HHHH **IW&JV-IJ-GI\
M]RB7=[O^SPG[TFT;FQ]!5R@ HJE9:OIVI7-S;V5[!<2VI59UB<-Y9.< X[\&
MI9[VWMIX()9,37!(BC +,V.IP.PR,GH,C/6@"Q167KGB'3/#EJESJEP88Y'$
M:$(S98\ < XZ]3Q5N"_M;FYN+:*4&>W($L9!5EST.#U![$<'!YX- %FBBB@
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ME=:;J<Z2VX1?,,"RA<!B3G&22.IYP*R?"4M_HOB7Q;?3>'M8:VU&^62W9+<
ML/F&2&8'O_CBK7B6'5=5\-):VGAZZAB@U"V^RVV$\P11,K,Y^; !Y &<\>_
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MDAO"UR@*;&VL4X._'?H/<XJ3X>:+)H^EZA<+<R:A;QRR6VFJK _Z-&[E0I.
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MN++(?D#!?N-MY;&<'&VM&W\/^)X+SP]*]E87-MIVG"T:TFNB%CF  \\':=W
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M[S'C@!<]3G)].M5O#_BDZ;X8\+:+:HOVR;2([DR2QNZ1Q@*O1!DDDX[ =<]
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M,EM,)4##(]CU[@_A0!Z=16)J6OM;ZJND:=9&^U(P&X:+S1&D<>< LQSC)R
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MBKN^\0!P3W)/3%:GAB_UZ?4-2M-7M)1:0LK65Y+&L;S*1RKJI(!4\9  /H*
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M>6*W_@21AP6'/0GL,UR7B/PQXFUF?Q+!/IMK??:TV:9=2705+:/'W0A!P_\
MM <D\L!7J%% 'FUEHWB%?%WA:_GT5TMM,T\VD[K<Q-\S*!D#<"0._P".,\9K
MW/ACQ)?6>J206'V.]37QK5D)Y8V68*BJ(V*L=K'!/I[]Z]1JO+?V<-[!92W4
M"74X8PP-( \@'4JO4X]J .)AT[Q)J/Q#TC7[O1H;*WM[*2WF5KQ78%CG("CG
MGI^I'2MCQMH^IZKI]A/HS0_VAIM]'>PQS'"2[0RE">V0QKH+N\MK"V>YO+B*
MW@09>65PBJ/<GBG6]Q#=VT=Q;2I-!*H>.2-@RNIY!!'44 >?-H'B#7/')U;4
M-*BL;&XT5]-E'VM7="S$DC ()YX[8(Y[4V'POX@G\ )X*N[>%50K ^H"0&-X
M ^[*J/FW[0!@@#/.:]'JI?ZKI^E)&]_>P6RR,$C\V0+O8]AGJ?84 <.VD>+O
M#7B?5+G0+*PU+3-4D27RYY_*:V<*%))QRN!VR>/SM>(/#]]K2V]IK&BP:M"M
MLI%S;S+!+;W!+%BA."$^Y[\<AJ[FJFG:I8:M;M<:==PW4*R-&SPN& 8=1D4
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MI0!V%%9^CW]SJ%K+)=V#V4T<SQ&-GW!MIP&4X&5/4<5><E49E4LP!(4'K[4
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M[<AMO.._;FO4:* /+(M*US3?%<GB*XT'2],TE-">TDA-T#';J'WD,%7YCP>
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MVZ/3_L1A%JV#\VXG._UKD_%.DS>&/#]Q;3ZU)'!K&N"YENEM1Y=N'8,XD!+
MQG;TXR3R2,T =/I^H:PWQ!OM&>_6?3[6TBN-QA7?N<D;'88 /&X8'0UUU>:>
M#KS48-5M+*QU_1];L7+&Z&GV"P^2-N0Y9#M!SM&",G/L<>ET >>ZJMXWQHTF
M%=3NDA?3I95B 0K&0P!"@J>NT9/7T(K 2YU?3K#Q[JNF:BMH+#5YIS'Y(<S,
M%0[6)Z+CCCGGK7=ZQX5GU#Q9INOV>IM9SVL+V[KY(DWHQSQGH<]^:I1^![I-
M,\0V7]LIC7)9)9W%IRA==K;?GZ8'&>E %'_A*-2\0:C%I5G'?PD:7#>3OI_D
MAP\H! !F(&T>V22>V.>G\*S:[-H4?_"16JP:BC,C;64^8H^ZY"D@$CJ,]<US
M]Q\/;CS=*OM/U^:PU:PMUM&NX8%Q/ N,*Z$D$@#KTSVZ8ZW2M.&F60A,\EQ,
MS%YKB3&Z5SU8XX'8 #H !VH NT444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 45Q/C;18;?PQXFU
M<RSM>-;/+$_FLOD[8P % .!R"<]\U)X>TNQMO#F@^();F:V>WT]+BZD,[[)5
M,/S%P3@X)W9QU% '945S"^.+%;VPMKJQU"T&HHSV4L\2[9]HS@!6+!B""%8
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M.:+PAHE]J5H!?ZE'$L,9GC19B8@[2$DX1<9//(X&"2!0!N#PY8CQ,?$&Z?\
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MEL$$@<8[Y(ZD5ER>*/$.E^*-,TW6;'3TMM7$BVCV[N6@E5=P24GALY RN.]
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M0[!>,'CKU(/TK-77?%&E^-[+0]4ETVXBU>"9[22&%E^SR1C<58%LLN._4^U
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MVZUHZKIE]>W_ (GU]+"Z$=SH_P#9MK;^7^]F8[B6V]5&6 Y]STKT0'(R.E%
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M<G.>*WM1TG3=7B6+4M/M;R-3E4N(5D /L"#5B""&U@2"WB2*&,;4CC4*JCT
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M5)[E97$DJPHD,9=W=C@  =:R4\:V$FHW>GQV6I/>6:+)/"MJ2R*PR#@=<^U
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M2CKC?R!GG'IQFF>$[3Q/I=I;^'+[PW:_Z(?)36 Z&,Q+T;9]XMC@#C)ZXYH
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M(&%+L,E]O8'@<'L* .O:-'*ET5BAW*2,[3C&1^!/YUPF@_\ )9/%O_7I:?\
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M#<1G*2H'7Z$9%<-;^-=1OO$5UI=O+IT%W;:BL#:==0NDTEMO :5'+A6.TE@
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M6/:>,;6Z\1+H3:;JEO?$%F$MM\B*!D,74E<'D @GGBL7XK12OH.G,EW-$O\
M:=LI1 N&)D&"<J3D8XYQZ@U;O]4U32O'GAC2&OWN++4([KS \*!V>- P+,H
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MK7%NCX8G@@.%'4<=:[K1;Q]:U^\U*UOIWTE(8D@0,/+D=DWLP&,X"LG?KNH
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MU!ZT 7XXUBB2-  B*%4#L!7"ZIX+U?7T%IJMU8/!'?FYM[U%?[7#'YA<(K=
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M;GPG;Z(MC):: P?-W<O&\QQ@C"QL!ZYSWZ5WT9<QH9%59"!N56W 'N <#(_
M4 >.QZKJVL_ C5=3U.XBG,_F,"%(8'[1TZXQV '0"NS7Q;?V/BFTTS6K6SM[
M:^M9;F"2&9G:/RP&829 'W<G(XXKG8? 'B>R^'^I>$;>;1Y8)I&\BX>21&V,
MVXLX"$9& ,#/7KQSK:AX7U_4_$^@ZE/;:4+:PMI;:XB^V2,9!*FQMO[D#@<\
M]?:@",>/M3EBT[4K329KO3KN4*UO%8W'G1Q,?EEW[=C<<D#U&":] ?[C?2N#
M\/\ A?Q;H2+HBZMI[^'HG_<S%9/MBQ9SY?&%'INSD#H/3M;XW:V4IL(H);K'
M[M)Y#&A/NP5B/RH \*TC45O_ (-:/X0CL&>^U9Y8K::X(CMPPG9MV\GEAV4<
MD]CW]1O]6E\):)H6ELYO-1N MHDKJ[Y*1DO(54%FQMZ#KD<CK6+HOP\O/^%<
M)X4UMK5)K5VEL[VRF=VCE+LZO@HNT@MC@G(STJ74/"OBO6]#L#?W>G6^OZ1*
ML]E>V\CO',P!!$BL@*@C&<;L\\=B 5M9U_5=5\'>,[*]TZ2(6EFQ@O%MI(8[
ME&4DX63D$ 8(R:O6GB=]/TSPSHMHH^U3Z3'<R2M;R3B*-510=D8RQ+''4 8/
M/0&W=:1XLU/PCJMIJ=QI,NI7MLULD,)DCMH@V07W$,S-@YZ < >I.=<>#/$2
M6^@ZII=Y86GB#2K063I([R6UQ$ !ACM##IGIUX[9H M67B_7KK0C/)H+VUW'
MJ M)I)T>.%8>IN0'P2@';/XU7MOB!<MIOBB5X;6[?15C=+BU#>5.D@)#;<D@
M*!DX)S@XJQK7AKQ/JNB6#R7^FS:O!>QW<D$J.+-MJX\L#EL G=D\D\\<8;9^
M&O%=IK>O:DNI:5YFI+;,I6%QM>+@J5R<+MR.I)_V: )(O&DT.BWVKO<:;J=@
MB0BTFL-RF65V*^6R$L5()3U/)X[5)IWBC5Y?%=OI<^G2W%C<QNWVR/3Y[=;9
MU&=KF3A@>@(QSVK+?X;R:I_;4MXEAI3ZC;)$(=,9GC$J-O$S;E7+;A@  <9Y
M.:VO#^F>,([J'_A(M5T^:VM,B(62.'N#M*AI2W'0YP!C/.>* -3Q+J=_I6F)
M/I]M%*[3(DDD[A8[>,_>E?)&54#ID=:Y1/'NI26OBR."*PNKG0H%N4N%#QQ3
MQM&7^[EB" N.N#ZBMWQKH&I:]86(TNXMDN+.\2Y\F[!,,X7/RO@$XYST/3\1
M@OX(\0R:CXJN)-1TUQK]E';N1"Z^6PC,9P,G@ \<G/MCD LQ^+M=M-:\.1ZG
M::>+'6U*HMNSF6%]@8%B?E(.>@Z>IQSG>*];U#Q%\-=?U33FLAI12:&-71FD
MFC1BC2!PP"\@D#:<@#D9XV+WPGJM[<>%9FN+-6T1MS@;L3':%X_N\#/?FLD^
M /$-IH.J^&=-U:P70;O>8!/ QF@#G)08(&WDG/)]O0 [W3-QT6SQ@/\ 9T]P
M#M'TS7EUC=:M>^#?B5+J%]%<"*YO[<X@*L2D2J"#NPJ[0!MP3[FO4]+MI[+2
MK2UN9DFFAB6-I$0J&P,9P2?YUQ:^!]9M[/Q7IUMJ%B;#7)YYU,D3^9&TPPV2
M#C"]N.?:@"+1/$&MZ5;>#;6[MK$Z=J=O';(L98S1,(0RL6Z$$ \!1CU-/N/'
M&JWEG<:CH-D;V&&Z:*.U6QF<W**^UF68?(IX)'!Z<\\5:N/">M36_A:-+JP4
MZ&RL25<^=M39^''UYIMEX.UW0[Z^@T/6[>VT6\F,WV>6V+R6Q;[_ )39 'MD
M$#T]0#M8)#-;QRE'C+J&V.,,N1T(]:\O\%:E?:5\/-1NK"WAEE&L3JS3.%CB
M0R -(V2.%&3C(KT\1O#:>7"=SHFU#*2<D#C<>OUKSN/X<:JOA-M)_M2U29-5
M&IQ.(F*,=VXQR*3RN>?P% %FR\<ZBUYXBL$MTU2;3K,7=I)!"\/V@,"0NPD]
M^A&<CI5>#Q9JFL^']4OM)U[3+B*'3I+CS(K4K-;3 !MC1LYX(W '';G/>Z/!
MWB)/$6J:U'KEFES?V(MSLM67RW ^4K\QX!YYSG%3#P/+>ZS=:KJ,MK!<7.G2
M6$WV",H)B_!D?)Y([#GZGB@"W\.6O'\!:/+=W"3&2U1D(C*L 1_$2QW'WX^E
M,F\0:K%\2H?#VVT^QS:<]U&VQMX8-M 8YQC@]!WJ[X.T34?#V@P:9?W\%VML
M@B@,,!CP@Z;LDY8_@./QJG=>&]4F^(,'B2.ZLUAALVM%A9&+$$[MQ.<9S^E
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M.Y6W##''4@X]#6(GPXUM=#L-*/B*W:'3=06\M2UGDN0Y?]Z=V6/S'ICW)SP
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M2&,QHK CAU;)(/&,=<A\FN^(].@T;1=5:VCUC5+V6W2ZA 8"%!N\S;C&_&
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MK^30TLI)+G[?+;;TE12P9/*8G#8Q@C SFK&BR^(M7TG0/$46KPHERPGO[:7
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M\0:O>7>G!Q$\LB?,K8RK87D<'/<YY/ H TO&%U=6?AJXELM0AL)M\:B>52V
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M[:,7MKVT?9+%GJ ?0]Q5&Y^'UC?>'UTF[U359OWZW$MV\RM-*Z_=RS*< <8
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M=+/4;K[5/$+A6!;(/5E)Z@'/7@<UI:[J%S86T>A)I&J:U+>6\D8N?)C,08C
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M1C'.: .UHKSVV\<:X+/PSJU_8Z?'I6L21V[+"[O,LDBDJP&,!<CD<GW]/0J
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MI7%HT4VLP,8(8BIA?D@!BQW#!P3@<C(X.  >J5!=WD%C;-<7,FR->^"23V
MY)/0 <FIZX]KF74_BLMDS V>DZ=YX3)&;B5MH8CH<(&'MN- &Y;^(-.NM?N=
M#BF8ZA;0K/)&8V&$;H<D8[CCWJ'3?%>C:KI\%]:W>;:>9H(Y'C9 74D8)(XS
MCC/7H.:H6>LZM-XWUG1)18^5!9QW%JZQL&^<L '.[G[O;%5?"-]<^,O!%V-7
MBM@TTUQ;,MLI50 Q7(SG!SSGZ&@#LZ"<#)Z5ROPYUJYU[P-I]U>L7O(]\$S]
M=S(Q7=GN2 #]2:@^*$NH6_P^U6?3[T6K)%^\/E[F="0"JG(VDYZX/]: -ZX\
M0:;;:]9Z)+.PU"[5GAC$;$%5!).[&WH.F<\BM.O.-?75H?%O@9%N+.?42MZJ
MRM$T<7,2\E=Q)P.V>3Z4B>.]4TO2=9MM32&\U>QU&.P@>"(JDS2@%"5SVR<C
M(S@#/.: /2**Y/1-7\13>)9+.]TVX.E/!YD=Y+ L+1RYY1@&.01R#QZ'/6NK
M.2IP<''!(S0!7O[ZWTW3[F^N7*P6T;2RE5+$*HR>!R>*;IFI6VKZ7:ZC9LS6
MUS&)8RRE25(R.#7GGA:\UY+;QQ=_VK'<W%GJ,Z(+F'*$HJX)"D$?*N, XJ8>
M+?$L]AX+N+,:?MUE0DXEC;B38S$@@X"\9VXSQC/>@#TBBO-UU[Q=)J/B/15O
MM.$^CQI<?;OLC?O$>/>$\O=@'C[V3QV[U-:^/+[4='\-""V;^T-6MWN)S!%O
M,:)@,44D9)8C&3P,]: /0JR=2\2:;I.JV&FW;S+<W\@C@ A<JQ.>KXVCITSG
MVK"TGQ9>Z=8W\WC"(Z?!#<B.UNY8MGVA&R5RJEL,,'/;I6-XQUB#7I/"%YH%
MW!<$ZQLBE<-L#B-NHX) H ],HKSN'Q-XGTO7-6\/:E]@O;Y--:_T^Y5#!&^#
MMVODX ![Y'3K4FD^+M2?Q=::2TRW\%UISSA_LYB F3&0C\*Z'.,C/UH ] HK
MS7P_XSU&]NX7O-2CCN+5)GU?2)K<130[48KY.>67('4G/7(Z!]CXH\4:A%HV
MK66G7D]O>2(US:FWC6*.!QD,DF[<67(SGAO1: .XUG6+30=+FU&]\[[/"I9S
M#"TA  ))(4' XZG@=S5BQO(M0T^VO8-WDW$2RIN&#M8 C/X&O.M?U+4_$_@/
MQ1J=KJ M+*!+FWCM1"K>;'&"KER>0S8;&",#&<UVOA7_ )$_1/\ KP@_]%K0
M!KT5S/CJ_P!6TCPY+JNDRJ#9D2W$1C#&2'(W[<]& R1VX-4[[Q.\?GZW9WDD
M^DZ?I7VN>!53]](Z[HQNVY4[1DX/\2<>H!V5%<+IM_XQN-1T:\2WGFTVY3=?
M).+94C# %6A*.7P,]&R<>]4M&\5:E?>((--U#4I-/U3[5*MQIES D:-#APA@
M?:2Y'R'DG.#T% '>:AJ$.FZ;=WTH>2.UC:218EW/@#. /7':G:=?)J>FVU]%
M'+''<1K(J3)M=01G!'8UYUH%UJT'AOQO>6^L3/=6&I7J(UU$DBGRU5@V %.X
MCCKM']WM3]6\2>)1I_@:6PU&VB?61#'<&2U#9=HPQ;J..?N@#ZT >ET5Y]%X
MEUW1KSQ9I]V_]LW&F6L=Y9E(1&SAE.58+Z$#H,XS[46^NZQ-JOA.*VUA;N'5
M[9IKI1#'F+:@?<N ,)D[>23TYSU /0:**X^35]2UWQ/X@T/3+PZ>^D01;951
M&\V:52R[MRMA!@< 9.3S0!V%%<.NNZW/K^B>&+FYM[34);%[S4+BU ?[IVA8
M]X(R6R3D' !QZUBZKXN\1:;HWC*S:ZB_M'0FAD@NS O[V&3E=RC(W8SS@#V%
M 'J597B/7[;PSHTVJ7<%S-!%C>+=-S $XR>1QS7*KK&OZ/XM\.6^IZM%>6>L
M07#2Q):K&(6CC\S*D98C'')/<]P!@^)KR_\ %GP@U#Q%_:$L4%QETL1''Y8B
M6? !)7=N^7=D,.>U 'I,VN1P^);;1#9WC23P-.+A8LPH <89O7CI]/6K5W?1
M6EE=7.V2?[,C,\<"[W)"[MH4=3@CCW%<W?ZIJ4/Q)TW2$OMMA>6,TK0K$NY&
M7 #!B#GJ>.G'2L/PJFH6FA^,[F+6+MYK?4[Q4:98WRR!2'/R@YP,8SMQT% '
M?Z9?#4]+M;X6\]N+B)9/)G7:Z9&<,.QJW7G&F>+=1U2'P;I)O#%?:O:&[N[M
M47=L522$!&T,Q[XX /M27WB'7-'U'Q/H3Z@TTEGI+:KI]X\2%PB@@HX "GYN
MAP.* /2**\RT[6/$<,'@G5+K6C<QZPT<%S:FW14^:(L&! W;N.><9[ <5*_B
M34[?Q6^FZI?7>F7+ZD%LA-$GV.[MMXPBN$)$A7/4_>XSS@ 'I%%%<>VL76M>
M/M1\.0W<UE;:=9QRO) %\R21\$<L",!>V.2?;% '3ZA?V^EZ=<W]V_EVUM&T
MLK8)PH&3P*S-)\2?VIJ1LFTJ_M2ULMU%-,BF.1"0,!E8C=R/EZUY[K>L:AK?
MPM\56^HW,C7NC7$EG--"@6.ZVL,$C'H>0,<_6O2_#T;QZ#9&2XDG9X4?=(%&
M,J.!M &* $\0Z[!X;T:;5+JWN)K:#F7R I9%_O89AD9QTR>:HR^*S!IJ:C+H
M.JK9LJOYH$#85L88A92<<Y/'%5/B?_R377O^O;_V84:>WB%]-\.JD%DMB4C%
MWLD9W,?EG'!4 #.W- '6T5Y\MUK6J_$G6=%A\07-OI\=C%<0^3%$2C-Z,5/'
M?G)]ZP4UWQ*OPZTGQ9/KTKW$=XD4ELD*+%-'YQB._C.X]<@@#TSS0!Z_6%XG
M\3P^%[2VN;BSN)XI[A+?="5PC,0!G)!]>@/3M6)?C6+WXA3Z'#XANK6PDTL7
M16..+S%8R,N(VV\#@<G<?<5Q&KZOJE_X)FT_6+D7=YI/B6*S-R$"^<JMP2!W
MY/Z?6@#V^BN-BU&YU_QWKVB?;;BSM=)@M]HMR%:2252V\GJ0HVC'3KG-<R^O
M^)I/!D^JR7TIN?#^J2VNII$JJ+R"-AO9>.& (Y!'1O:@#UBBN!U+Q%(FE^(O
M%>FSS2V=K9JMD&D8PRR;-QD"]P-Z+]5:DL(_$\-QI.LC4K<Z6\&^]CFOFF^T
M[ERK1CR@$;/8''0?4 [^L6U\1Q7/BB[T%K"]@FMXO-2>6+$4Z_+NV-GG&]<_
M6N*TB?Q9K_A_2?$-AJ=I"[R">Y>:^8PO%D[HS%Y>U,=,@Y&.23S7HOV&".]G
MOT7_ $J2,1F1V) 4= !V&>3CK0!:HKS'0M4U*#Q%I>F>(+S4;+51/(79V+V>
MIJ5; B/1<;E.,#IZUZ=0 45P^E3W5UXU\:Z5+?79M+>.T:!1,V82\;,VT]1D
MX_E7,V>K:SJ/A#P%>'6KV&>_OQ;7+*0?,&9.3D9)^4>WL: /7J*\XT:'4'\3
M^,?"R:Q?M%#'!/:7$LY,L,DB$G#==N<<=..E)X6UB[US3]*T6XN;H:M9W,R:
MLZW#AU$1QR>N'+)CIQNQTH ](HKRRQD\2>,-%O\ 5M/U..TU&&^D6W9[R1$M
ME1\&.2$)M.5'.<G)SD=*3Q3?:K9ZA?W6I/?_ -F2VR+::II,[&.Q?8-QDC!&
M06.=QSP1^ !Z=]KM_MPLO-7[28S+Y??9G&?S-35Y=:QVUM\5_$>HI+/.D.DQ
MW<>+AR#U..N"OH.G--TA?$.O:'HWBBVUBWMILB6ZF>]D:*5"?GB:';L7!X&#
MD8ZGK0!Z!XAU9M"T"]U1;5KD6L32M&K;20!D\U/I-\=3T:QOS'Y9NK>.;9G.
MW<H.,]^M>97L\GBKP5XTU>XN[I9[26[MK>*.=HTBBC7A613@EAG.[/7TQ7H7
MA7_D3]$_Z\(/_1:T 5_&'B4^$O#\NLO9-=6\!42JD@5E#,%!&1SR13KC6-7M
M4AEET-6A>6.-S#=AF0,P7=@J,@9R:P?C)_R2K6?K!_Z.CK3DM?$4%_IE[>ZW
M8G3+5WDO(XK4P93R7 +,TC9 8J<<>O:@#J**X/2F_P"$NU+Q+)>WUW'_ &?>
M/9VL-M</#Y*JH/F?*1N9B2?FR/EQBL?3;BYDT'X=:G)>WC75S<I!.QN)")5,
M<K89<X;D#DC- 'I]R\L5K-)!#YTRHS1Q;@N]@.!D],GC-4++59!H]A<ZS;KI
MUW<E(S;%]^V1C@*".M<3 ;D>.?'-C'J%]%!%8PS1!;AF\IV0L2FXG;D^E9-W
M91ZKX6^&U]>27$MW->6T,DS7$FXJT;EN0P^8D#YNOO0![!17FNL2Q^ _&L&H
MW5U>RZ)J-L\"0M<2R""X4 @#<Q^^,@>]=IX;TZ33=$@BG>5[F0>;.9)6<AVY
M(!8G '0#VH UJ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH R/$]M?7WAN_L=/ABEN+J"2 >;)L5
M=R$;LX/3(XK-T;P]=_\ "N$\-:H(X)?L+6+O#)Y@P4V[AD#UZ5U-1PSQ7$?F
M0R)(F2NY&R,@X(S[$$4 <7X8TWQOIUM9Z3J=QIC6-EA5NX68S31I]U"I&!D
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M8M,7L)O(G$L31D/Z88 T <]+X7\176M>'-2O-0TV>72C(7Q R!_,4*0HR<8
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M;^F..*[.6XCB)4G=)L:18UY9@N,X'?J!^(K-\.>(+;Q+IKWUK%-%$L\D&V8
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M"."66253'&20NR1E'7V6@#H**** "BBB@ HHHH **** "BBB@ HHHH ****
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MV>TAGV1>;CEP .IZD$D$]0>*ZC3-/CTK38+**:>9(5VAYY-[GZG^@P!T  H
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M077B=-66TNK2S>UEMS*+R%2%@D!_U;*6R_'\0Q]* .AHKSVT\?ZC=_#O2O%
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MA%&&&/X3YGRCV#=<9K/M_%GBC5M.L=<TC3Y;J">;)L5@14:#<1Q*7SO P<X
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MY$8\HJO[[:8P"A^4[02?O>_3 !U7AWQ':>);2ZN+2&XB%M=/:R)<(%<.F,\
MG'7OS6Q7B5G?ZWHWAOQMK>EZFENMAXANG-L;9'$Y+QY#L><8/&,'KSTQV=[X
MCU74]>ETS3(KY!;V,-Q(;'[,7WR[B,^>P&T!1]T<YY(XR =U7)3?$/28+:UN
M7L]3%O=W MK:7[*=LLA) "\\YP<5I^%9]=GT&$^([1+;4D)1PC*0X'1_E) )
M[CUKF_B<BQVWA!$4*B^)+,*JC  P_ H ZK2]=@U2\N;1;6\MI[9$=TN82F5?
M=@CU^Z:U*YKQIK4V@Z9;R642F]O[N&PCD^4%"Y/S<\<<XSQD\\9K!N)O&NFV
MNO7$DKPV$>GO<6TUP\,TL,R+DKA0 5;'<<4 >AT5X_>7WB^T^& \5'Q8Y>6R
MMW$ LH^&9E!.[KR#S[YZ< ;-_+XDM/B%8:&GB68P:K:22R,;:/\ <%#G]T,<
M<<?-N]3DT =UK&HG2=(N;\6EQ=F!-_D6Z[I']E'<U/:3FZLX+AH9(#+&KF*4
M8=,C.UAZCH:\Z.J>((? 7BP_VW(U]HEY<1Q7A@0O)&D:N PQC/SXR!VJ36=4
M\0+KG@RVLM9>"/5X'6=3;(^&$08N,]^<C/ (S@CB@#T>BO-X-6UJQL?&6GRZ
M_'YNESPK:ZC?JH,:R*K8;:N"1G ^7DGIVH@U;4G\5:KHOVW58[)M&^VP/="-
M)E</MW+@;@IQT8 @@\#B@#L=7U^/3-)_M&WL[K4T\T1;+%1(V=VTG&>@((-:
M]>*VFH:KH7P(TW5],U6XAG+J&#*KC#3%2!D<=<YZUW4FK76L^/K[P[%=RV5M
M86:3.T&T22NY&.2#A5'MR6YZ"@#L**\>U;QAXB@\*:K"-2:+4M'UA+%KI8D_
MTF)F&UF&.&QUVXKK--N=8T[XD?V+>:O)J%I<Z6;S$T2(8Y%D"D)M ^4@]#D\
M=: -;Q3XLM/"5K!=7UI>3032B$/;A"%<] =S \\\]..<5!<>-K/3;F&/6=.U
M'28ICM2YNXT,.X]%+QNP4GWQ7/\ QI3=X+M3D#;J4!^OWA_6MWXD);/\.=>%
MWM\K[(Q&[^^.4_'=MQ[T =34<T\5NJM-(D:LRH"QQEF( 'U)('XUYEHEQJQT
M/P[97-]>,SZ,K"QT_P"6Y+[ALE9VPJJ%&/F8 MZUFW5WJ>M^$_ .H:C?W*WL
M^M16UP(G"JQ620;BH&"WR#GI0!['17GE]?:WK.JZ[I.F->9TM8H(7ANTB;S6
MCW^:^1EN3C'W3@\>G5^'3JTWAJV777A_M38R7#VS C<"1D8X!QC/H: $U[Q%
M#H>BWNIK;37R66?/CMBNZ/"[B3N(X (SC)YZ5HV%V+_3K6\5"@GB24*3G&X
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M,OF;"<!V0GY5/'().#D@5N,\<OATOJ,D3QO:9N7A)*,"GS%2.2.N*\QNM/\
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M:&YZXX[8-$WP^\*SM>&72(V%XYDF7S7VER<E@N["M[K@UTU)N&[;D;L9QWH
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MB0W^EW=HL9C^4[3$.&9 =N?F)/7(Z5VFFZ?<66@PZ?->F:>.#RC<!-G., @
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M7$<_SM&WWD/&,?0<5 ;.T^&T+-ING:YJL>HW3'[/"WG")V&2>2.I'WCD^_J
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MUP8X4VQQY"J%4$DX 4<GJ<GOB@#<HHHH **** "BBB@ HHHH **** "BBB@
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MVT-A<?8K5+:X*"/"@^80/O,6S][(P,>N0#JM2U.73Y[&./3KN[%U.(6>!01
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MW3-+>HT8;?)'RJ=05Y)'MTH ]=HKQ:>PN3X.\:W\FL:NUQI.J7"V?^GR$1;
MA4]>?O=\^V.<[FL7\^@S^&?&=S>7+:?<Q16^IP><WE(9$!68)G (/7CD8[T
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MB."44S.4R.V5P10!W%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MQM'/"^PQ6K9:UJ3^(O[(U#2H[<M;/<)<0W)E1PK(NT913GYN?PZYK=H Y=/
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M(_VL'J!^597@#5+O6/",%[?78NYVGN$\\*JAU69U4@+QC % '34444 %%%%
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M##T/3XM-^-.KPP>=Y3:1$ZB65I,9D[%B3C(Z5K?$?3[^X\*SW^EW-S#>Z?\
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M((/4$51?0='D2))-*L72'_5JUNA"?3CC\*NR11RPM#)&KQ.I5D89!!Z@CTH
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MDG:BA1D]^* )**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_=6>K:;,;N*XN2V64_>7&-AP<?* /2E^#UG!#X4GFC#A_ML\7,KLNT.<84G
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M(^@-.^%%O"GABXE2&-9#J%TN\* <>8>,^E '3Z[X@T_P[9+<ZA.L8>18HTW
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M22 2,MGK7544 <GJ'P\T;4;K4YI9M0CCU($W-O#=,D+OC&_9TW<=\C/:I(/
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M1=0G2XVCNI!+.K.Q\QP<[CD]<]^M;S,%4LQ  &23VI$DCDC$B.K(>0P.1^=
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M;2[C2QI<VGVKV   MFB4Q@ Y'RXQ3%T'1TNXKI=*L1<P@+'*+=-Z   8.,C
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M,JH20)&^9L$]1DG'M4OB;PY8^*M#FTJ_\Q8I"&62,X>-@<AE/K0!S&O7.J^
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M:<S::)/-2)[B5C$WJC,Q*_0'!R<CDT <AXFBM_"-I:Z9INH2+87FO1->>?\
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MP%:GPOO[2[^'^CPVUS%++;VR),B."8VYX8=CP:ZFTT^RL%9;.T@ME8Y80QA
M3[X%.M;.VLHO*M+:&WCSNV1($&?7 H X'Q;?6NF_%?PC=7MQ%;VZ6UYNDE8*
MH^3CDU1\.W%C<:#X[TW7I4$PU"ZDN5E(#&)E&QAGM@<>F!7I<]G:W3Q/<6T,
MS1-NC,D88H?49Z&FSZ=8W-Q'<3V=O+/']R22)69?H2,B@#&\!V^I6G@71H-6
M)-ZELH<'JH_A!]PNT'W%<MIT6EM\6/&_]JI:&/[/9L/M(7&SROF(W=NF:]+J
MM<:=97<L<MS9V\TD9RCR1*Q4^Q(XH \2M4D\,V7@^XU66_L="$M]Y<JY$EL)
M&S$TF 1RI/;C<:]'\#VN@H^JWN@7-U=Q7<RO/=2N6267G.S@9Z\D<?E75SP0
MW,+0SQ)+$PPR2*&4_4&EBABMX4BAC2.-!A410 H] !0 ^BBB@ HHHH ****
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M6 WL5 R2 ?0<\ 4 =K7.:MXOCTZ>]BM=,OM3:P$9O%LE5FBW_= 4D%CCG Z
MBN4\/^(=1N?$5IIVMZQ=Z;K7VF7[3IUQ$JP7$6UPA@;9S@E,?-SM;.>*A\*:
M=>0Z[XZ\G5;\7=O<*$F?:S2'RCAF7;ACTQQCVH ]$T35#K.CV^H-975D9@3]
MGNDV2)@D<C\,_2M"O++'QEK$O@?PD@DFN-7UN617EC$:R%$+%MN[" D!5YZ
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M2VTQN(KV!PMP)6.6?=C[S$#/T'3 K8T/1!HMNZO?WE_<2$&2YO)-[L!T'
M'/ '<GJ:U:* ,/6/#%OK6KZ9J4UY=Q3:;(TENL10*"PP<Y4YX%0S^$+8ZU=Z
MK97][87%]&([O[.R[9L# 8AE.& XR,=37144 <Q=>!=+GAT:"*:[M8-(E6:U
MC@9,>8/XF+*2QZYYYR:L:OX4M]9UC3-4FO[Z*XTTEK<0L@4%AAB04.<@8-;]
M% '):QX L-5ULZQ#J.J:9>R(J7$FGW'E>>HZ;\#KTY]JMS^#-.EU+1;V*:ZM
MSHRLMI%$R[%# !LY4DY P>?UYKHJ* .93P-I2ZIJ]V[W,L&JC-U9/+^X9B,%
MMHP<D>IX/(YQB+P_X"L?#]S'*NI:K>Q0 BUM[RY,D5N",?*N ,X)&?0FNKHH
M X.?X4Z1-9W>G+J6K0Z3<.)/[/CN<0QMO#':"#QD=#D=^N,=Q!"+>WCA#NX1
M0NYVW,<=R>YJ2B@#+B\/Z=#XBNM=2 ?;[F!;>1S_ '%.?S/&?]T>E06'A;3]
M)T*?2=,,ME#,[R-)#MWY=LGE@1T^7D'@"MNB@#DC\/-+;PO:>'VO-0-K97"W
M-K*)5$L++G&U@H&.3U!//TQ8C\&6T/B%]<BU34TO'M/L>3(C 1XX'S(3D'#9
M)//7(XKI:* .1MOAWI,&B_V6]UJ$\*7'VJ"228"2WFR3O1E4$'+$\YK9T[0+
M:PO)[V2>XO;V>-8GN+IE9O+!)" * H7))P ,GDYK5HH XN/X8:''9PVGVO5G
MM[>X6>VC:];%N02<1X^Z,GKU]ZUH/".GVWB:77H9KU+B9466(7+>5(47:K,O
M\3 <<D^O6MZB@#%\2>%]-\4V45OJ"R*T,@D@G@?9+"WJK=JK+X'T8Z!<:1<I
M<7<5R0TT]S,7FD<?=<OUR.,8QC%='10!AV/A>WLY?M#WU]=W:PF"*YNI0\D*
M'J$.T $\9)!)P,DXK/;X>:,WAR30'EOFTZ2;SVB:X));.[KUQNYQZUUE% '-
M3^"[2>>\E_M+58_MJHMTD=SA9@J!.1C@D*,D8)]:L1^$].@UBTU*![F&2T@^
MS011R8B2+CY-N,8^4?E6[10!Q=Q\+_#\ZWD*/J%O97;;Y;&"Z9+?=D$L$' /
M&/3TQ5K5_A]H>LW%I=3&]AO+6,1)=073K,R#^%GR2W?D\\]:ZJB@#G+GP5I=
MQ<Z?.DM[;MIX(MEM[@HJ$YW-CNQR<DY)S1?>"-%U#6[C59X[CS[J)8KE([AT
MCG4# WJ" V!CKZ5T=% '*CX>: -/TZS\NZVZ>[/;RBZ<2(",%=V<[2 !CT%6
M[/PAIECKESJT3W1GN4\N6-YBT3(!A5V=, ' ':M^B@#G;+P5HUA)"(DN&MH)
M?.@M))V>"%^S*A.!CG'8$Y'-">#=.CU/4M16YU 7&HIY=P1=N 1_#CGC;DX]
M*Z*B@#+\/Z!9>&=(CTO3O.^RQL2BRR%RN3D@$]L]O>JMUX/TFZO[J[VW$#WB
M[;M+>X>)+D8Q\X4\G'&>#SUK>HH Q[CPQI-Q<Z9.;=XWTP$6@AF>-8@5VD!5
M(&,<?A4EAX>T[3-5O=2M8YENKT+]H9IW<.5R 2&)&<<?05J44 8^L^&-+UZZ
MLKF^BD,UDQ:)XY60X/WE.#RIP,CVJ*W\'Z/;/JK)%/\ \34_Z6#<R?/QC'WN
M.,_GZ5NT4 <SJ/@#PYJ>DVFG3V<@ALQBU=9W\R$<<*Y)(&!C'2MK2]*L=%L$
MLM/MU@MT)(5<G)/4DGDD^IYJY10!FZWH&F^(K'[%JL#SVI(+1"9T5L<C(4C/
M(!YJ?^S;1M-;3I8C/:NAC:.X=I=RGJ"6))_$U;HH YO1? ?A[P^;@Z;:21-,
MK)N^T2%HT.,JASE1QVY]ZG@\':';:#)H<-K*FF29W6XNI=N#U'WL@')R!P:W
M:* ,!_!>A2+IZM;W&-. 6SQ>SCR0/[OS^G'TP.@ I_\ PB&B_;;^\^SSBYOT
M\NZD%Y-F5?0_/T X&.@X'%;E% '.'P)X=-C967V.86UC)YMK&+R8"%^NY?GX
M([>F3CK4UQX.T*[U"XOKFS>:XN(3!,TES*P>,_PE2V,<Y QP>1S6[10!S=MX
M!\+VDUG-#I$(ELR?(D9W9E]B23N QP#D#MBGGP-X;*7Z+IH1=08M=".:1/,R
M<D<,, GJ!@'O70T4 8\WA;1KBQL[2:T:2.R.ZU9II#)"?]F3=O'Y]AZ4Y_#.
MCRZ9-ITEBCVD[^9,C,Q\YO5SG+G@<L3T'I6M10!DMX:TAYK*9K3,MBI2U?S'
MW0@C!"G/'''TXJUJ6EV6L6;6=_ )[=OO1LQ"M]0#S5RB@#$_X1#P^5A633(9
M8X2#%',3(B8Z85B0,?2K&K^'=(UX6XU2PANOLS[X2XY0\=".>PX[XK3HH Q$
M\'>&X_M>S1+%?M<?E3XA WIQ\OL.!T]!23>#O#EQI4.ES:-:/90MOCA,?"MW
M([YK<HH RF\,Z(^DP:4VEVIL+=Q)%;^6-BL.00/7D_F:U:** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MTM0DMM5GDGN=QB!+2 !L$)QG%=910!3T_38=/T>WTQ'DE@@A$"F0C<4 P 2
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M0LGA]VECCE9<.)1@G!X.._!Q7!&S2'X+:%XB2:Z&KQW*^7=&Y<LFZ<@A03@
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MRJ,S&5@#G'WB2!GK7HN,# JC/HNF7.J0:G/86\E];J5BN'C!= ?0_P">I]:
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MC,7*1($#+C )+*&S@<YQS6MX=U/PIXEU_2=1TRYU"_U2WC8;9&<?9$93NW\
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M"*"3N) ZGIF@#QVTNM"LKS7?#OC./4A>75]+/%%'+<[+Z-VRFU8S@G@#&!T
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MS BMY<;$\_,2N>QP>QJR8],\/^,/&L27#:;:?V-#(TD+9>+[XR@/?)'XD>M
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M-O45WL[I' [R.J(%.YF. !0!R'A#Q;<WWPN3Q3J^))4AN;B81+M!6-Y. /\
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M>YQ0!U.G>'])TF026-E'%(L8A5^698Q_ "2<+[#BJLW@SPW<7=Y=2Z-:-/>
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M#3(-6MGO9XA-%"&^9E*[@?RYQUQS679^/M$U>YUBSAU**T2S4*MW*=H)*Y+
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M?_L32LR'^S++,HQ)_HZ_/SGGCGD _A33H6CF,1G2K'8"2%^SI@$XR>GL/RH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M#5)KF1((8KBX9Y)'"J%#L22>PZ]?2N2,MK=:?X_\4WMI/)H>I3V\%OB0P_:
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M-]&S@U)9:E8ZD)397<%R(9#%(89 ^QQU4XZ&O$?$$ C\"_$-U518#5T^P''
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MUE\FZO(X6>&"3CY68>Y .,@$\XKF?".O2W.C:/H5WX:O%UC3S'"WVFT(BA"
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M:="@8ECC#X !&#W'M4<OQ,\/QV]Y.JZA(ME*8[D)929BP!EF!'RKSU..A]*
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M_M&*]+&W$3B08F=LX ST(.?>O?J* /-I=4LK7XW+=RM)Y,_AX!9!&2!F;(/
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MF?<Z;4R &R#G)P!FC4AJ&GM\0-,30-4N)-5222UEMK8M$X:#:?GZ;@<\=3T
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MW"Q6R@&5YBW[L@=3SCGL ?2M'5=3@MKW5]"NV?3]331X8B]O;F2?4F\G[H8
MX4$X( R>>0!0!Z+?>,_#FFBU-WJ]M']JB\Z#DGS$P3N&.V!5*V\?:3?:Y;V%
MD+JXAFM#<BXCM)65AN55VX7D<MD] 1CK7FND:G97%A\+R\T86UEF2;S/E"$*
M "<]LXP>F?<5V]]=V^C?%S28V46]M<:0]M$$B.TOYRD*H H Z2S\5Z+?Z5=Z
MG;7ADLK,L)Y?)<!"HRPY7/'?'2M:*59H4E3=M<!AN4J<?0\BO.I-'N]*^(-Q
MI%I 'T?Q"XOYSVA:(@RC'</E!_P(^E>D4 5-1U*STFS:[OIUA@5@NX@G+$X
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MLQ;;^&?SS5[QA_R)&O\ _8.N/_1;4 9]M\0] N;S3K<2748U' M)Y;9UBF;
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M-;JTA=&4'Y2V#SCC.>QS7:^&H72TFE_L6#2(99 T-JB*LFW ^:3;P&)SP,X
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M:X+F,1B499QU4>I'H.:CN/%7A^TNY+6XUJQCN(W6-XVG4,K-T!&>#QTH UR
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MMM]H%U<6NV)_FV^6K D,^>,#KZUI6OBR%]:M])U'3KW2[J[1GM!=F,B<+]X
MH[ ,,YP<'% '0U'/"+BWEA+.@D0H61L,,C&0>QKEKWX@:?9V=QJ'V*\FTNWN
M3:27L7E[!(&VG@L#MW'&[&,^W-,U7X@V^EZE_9IT/6KB_:U^U)!#;JQ9.,]&
MZCG/T/7C(!K>&_#-GX8L7MK6>[N&D;=)/=S&21^PR?0>@K:KC[_XAV-E:7]Z
M-.U":STV1(KV5513$S '&UF!8@E0<=,\9J>_\<6MEKR:-%IFI7=W+:?:H/(C
M4K,O'0EACOR<#B@#J:*X3_A9]H=%_M1=#U8V\$K1WY\I0+,JVUMQS\Q[X7/'
M7%=O!-'<P1SPN'BD4.C#H01D&@"2BL"/Q0LWB/4-!CL)C?VEN+@9=0DB$X&&
MSP?J*QG^)EE'HFBZFVDZD8]5N3:QK&JN4D$C(0<-R?E)  .: .XI&=4 +,%!
M( )..3P!7('QRQM]>3^Q;NWU#2;?[2UM<L@WQE2RMN5B/X3D#/\ /&'/K]MJ
M/@?PWJ/BK19[LW-Q;R120,H5)B1M<X8%1R1CF@#THR()!&74.1D+GDCUQ3J\
M_N(8H_CO9.D:*\FANSLJ@%CYF,GUX %=MJ5U+9:;<74-O]HDB0N(MX7=CW/2
M@">6:*"/S)I$C3(&YV '/N:?7C&M:K=^(?A9HFN:I91O<#4H9$F!!8 S$$(!
MST"KCG/X5WUEXUC?5[K3M5TRYTEX;0WR-<R1MO@!PS'8QVD'M0!U-%<-;?$[
M2[B\TM"D0MM3E$,$D=U')(CM]T21J24SQW.,\@5W!(52Q. !DDT +17"M\4=
M)5K&X"Q/I]Y.($DCN4>:/)(#O$.50XZYR!C('2KFL^-VTB#4+UM+=].L+E;:
M:5IA'(Y(7+1H1\X&X?Q#.#C- '75$ES;R2RQ)/&TD6#(BN"4SG&1VZ'\JY+6
M/'-WIWB*ZT.T\-7M]=Q6?VR,1RH/-3<%R.N!][KR2 ,<BJNBL+?QWXO>#32T
MKV=E*;6/8K.Q63(.2%SVR3^- ';VUU;WD"SVL\4\+9VR1.&4XX."*EK@M \6
MZ'IW@72KNPT^'38+NX>WMK1YU15<,VXLYX PI8GD]ADXRI^)D"V>NL-/$]SI
M""61;6Z62*6,C.]),#..A&,CT- '>45A^'=>N]=$TTNC7%A:;(Y+6:61&^T(
MX)R I^7''!]14NK:\NGZEIVEPP&XO[]G\J/=M5409=V;!P!D=B22!0!KU275
M]-?4O[.74+4WV"?LXE7S,#K\N<\5B6/BFZU"XU;2_P"SH[;6M.VEX);D^7)&
MW21'"$D<?W>#@'&:R/AM8+J7@C0;G4=.LW-NIGM;C>7D#LS%F(VC:23V)S0!
MW],CECE3?'(KIDC<IR,@X/ZBN6\;ZM+;#1]%MBRSZS>I;,ZG!2$?-*0?7;Q_
MP+/:K]UJ:Z=J%GX>TBRA>Z-N95B9O*B@@4A<DA3W(  'Y4 :4&J:?<[O(OK:
M7;+Y)V2JV),9V\'[V.<=:MUYUX$L(=2M_&5C?V$4$<NL2I);QG*J=B<J<#N-
MP. >AK>\!:W/K/AUEO&+7VGW,EA<N3R[QG&X^Y&"?<F@#IZK6^HV-Y<W%M;7
MD$T]O@31QR!FCSG&X#IG!Z^AKE_&&K:Q8^(?#5II_P!F$%W>,K^9*R%R(V.T
MX!PO?OD@=*QTU#4M-^(7C673-*2]E%M92OON!$BA8G."<$ECVXQP<D=P#TFB
MN+A^(=G=Z5HEQ!"B7&K0O,J32$)"J<-N8*3][@8'/M6GX4\3/XCAO?.L7M9[
M.X,+<EHY1V=&(&5/T% '0TR6*.>%X9HUDBD4JZ.,A@>H([BL+Q)XF30+O3+5
ME@5K^1T6>ZE,4,>U<X9L'YCD #OSZ52N/&,]E;6$5[96\&I7DLJ+&;DF$1QG
M!EW[<E2-N/ER=XZ<X )M.^'GA32KU+NST>-)HV#H6D=U1@<@A68@8/3 XKIZ
MX>'XBHNE:E<7>F2I<V=TEM$D;9CNFD;$9C=@.#WR.*T)O%%]I%U?#7M)^SV%
MK9F[-_;2&2(X.#'RJG?Z#O0!U%%<9-XSU#2[?2M1UC2X8=+U*6.)7AG+R6QD
MY0R J!C'7!X/K5>?QEX@?4/$=E9Z'9!]%57>2:\;8ZE"_&$R6(Z# '7)H [N
MJ=CJVGZFTZV%[!=&W?9+Y,@<(WH2.]<[:^-#J\6A1:5:JUYJUJ;LB9_DMHEP
M&+8&6^8A0!C//(JEX :Y?Q!XR-Y!'#<?VDH=(FRO$:@$''<8/XT =W1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% '%^,-3L[/Q+X?B>2VM;YQ<-;W]VY$5NNT!^,@.Q!P 3QU]C
MP U2WLM'DE2[%]9VWB\W-^T17YK?C]ZRKQMWX/3!(%>TWNFV.I(BWUE;72QM
MO03Q*X5O49'!I$TO3XQ<A+"U471)N (5'G$\?/Q\WXT ><>,[K1=4\+^);WP
MJL=_?W-M"U_/9R%PT:NHVM@X#%-_&,X!SVK3EU;PWXA5=1\/-#=Z^=,FBMVM
MGS);(8V8!U!P/FPHR,Y;CO7:V.FV.F6WV;3[*WM(,D^5!$L:Y/? &*2RTO3]
M-\S[#8VUKYIW2>1$J;SZG YH \EO+BQU;X'Z/:Z<Z_VO#);16\* "5;M7 ;Y
M>H;[[9ZX.>];&E6.EWGQC\30WD%G<-]DMB%=%.7 !8@'OD FO0TTVPBNS=QV
M5LERV<S+$H<Y_P!K&:1-*TZ.\^V)86JW1);SA"H?)ZG=C.3DT >5?VWI(\ >
M,M(U>YBM]9$UZT\,YQ)*[%C$RC^(8" 8X 4=JDL?$FB_;?#$0O;2PN$T%/\
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M) 7KTR3@\"O5J* .#UGP[XD\6^%+E-1EMM.U-GBFL[>)S(EN\9W#<W=F)()
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MX5]N2<Y..<%0<CKC-:]YXTN8O%]QX;L]!GN;N.T^TQN9T1'&0!D\[5Z\]?\
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MBN2\L.%W[94*@C*]QGD$>]<Y9@?\(O\ %,8&!=7W_H@5+INB^)X;_P +7?\
MPC5K;C3O,2Z4WBF21WBV-,S#.03S_$Q[U9M="UU-$\;VKZ2RR:U+<26H\^,X
M\V/8 WS<8ZGKQ0!'I?B;4/#_ (9\"P+96TFGZC;VUJ]S)*RF%R@P" #G(Z<]
M1S7::=J5W>ZWJELT$ LK-TB29')9W*ABI!&. PZ$]<=C7+7NE1I\'QH6MA;6
M[@TT(J"4,WF1 ;63!Y^8+@#UQWKI_"NG3Z7X:LK>\=I+UD\VZ=NK3/\ ,_\
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M95BMC"V1(2V"<CH!R3],=:V;R9KC1IIK&Y\IFB+Q3! V.,YP?ZT 7:0@,""
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M*W<$J0R1^1(=K.<+SMZ9QSTY'J* .FHK+UOQ%I7ARVCN-5NA;12,$5BK$9)
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M;BH@R!GKC)/'O6KK'Q'L-,CO+F&."ZM+&;R;AEO$64D'#&.,_?VG@\C/.,T
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MJ >U '24444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M]R!DX'XF@#P^'4X+G5/ ^K(;^2*WN'BGACLGC@M7,>!#$@'.,8SEO4D=NO\
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M4EE4E5VYY^8CC.3P*IK#=R:5\18SIFJ@ZG)(UF#8R_O@8]HP-O'/K_2O6J*
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MHWA:VF@T>R2V29_,D()8L>V223@=AVK2MKNVO(VDM;B*=%8H6B<, PZC([T
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M\6^(+'Q)I&I36FHW'VBRGM5FD29615,15#C(VXP1ZYXQF;6;.UM+BS.G/?\
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MASERVT 8Q_"3UZ$>M<W#X!#^(O$,EU(K:/J(,L-MUV3R(4E?'8XZ?[Y]*TO
MGANY\,^'A:W]P+B]9_WDHZ%4 CC ]@B+^M '3T444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!6N]
M.LK_ &?;+.WN-F=OG1*^W/7&1QTI+73-/LG+VEC;6['J8HE0G\A2WU_:Z;;&
MXO)EBB!"Y/))/0 #DD^@YJA_PE>@?V<=0.KVBVHE\DNT@7$F<;"#R&]L9H T
M+K3[*^*?:[2"XV?=\V,/M^F1Q39M,L+BY6YFL;:2=<;97B4L,=,$C/%9O_"9
M>'/M%[ =8M!+8KNN 7QL&<=>_/'&><>M">,O#DFA_P!M+K%K_9V\IYS-@;O[
MN#SGVQF@#1M]*TZTD>2VL+6%W4JS1PJI8'J"0.13X+"SM86AM[2"&)CDI'&%
M4_@*S[7Q1H>I:M/H]GJUO)J$2G?%&V6&.N.QQ[9QWK)\&ZK,VGZ^^J:FUP+#
M5;F%IY]J[(TQC.  ..> .M '4?8[49_T:'G&?D'./_UFA[2V=$1[>%D1PZJ4
M!"L.A'H?>LZS\3Z/?W$MM;WF;B./S3"\3H[)_>56 ++[KD5#;^,M!N])O-4M
M[XRV5G_Q\3)#(1'Z_P .<CJ0.@Y.!0!JFQLS.LYM8/.4DK)Y8W GK@^]6*R;
MOQ+I-C:PW%Q<2*LT?G(JV\C2;!U8H%+*!D9) Q5>Z\:^&K..UDGUJT5;J,RP
MX?=O0 DMQVX/Y$4 6KG1Q?:U;7UXZR0V66M8 IPLA&#(QSR0,@>FX]^FDL4:
MR/(J*'? 9@.6QTR:K:7JEEK.FPZCIUPMQ:3C,<JYPPS@]>>H(JW0 5%]F@W[
M_)CWYSNVC.:X7QA+?VWCOPQ:V^L7UM::G),EQ%'( H"(""N1QR>:VK>'^S-7
MEN1K]S<V=M;,;R"YD#^7D@HZX7KA7&,]#TH Z&."&(YCB1">ZJ!3V174JZAE
M/4$9!KF(OB+X5F^QE-63R[QMD4AB<)NR1AF(PI)!ZXJUI_C/0=3N;RWM;[=)
M:1^=)NC=08^F]21\RY[C- &]17)M\2_"2FU)U4;+ERB2>2^Q6#%<,V,+D@]<
M<<]*@MFN8/B]<6IO[N6UDT;[2())<QQN9MORKT' H [.N6T+PS?Z9XOUS7;J
M]MI5U580T,4++Y9C7:N"6/;.>.M6)O&V@P2+YEVX@:X^S"Z$+F#S?[OF8V]>
M,YQGO5B#Q1IMQXEE\/HT_P#:,49E>-H' "?WMQ&,>] &S16.OB;3FL6NR9TC
M^TFU57@</)*&*E57&6Y!''H?2F0>+=&GM]0F-T8O[.<1W22QLCQ,>GRD9.<\
M8SGM0!#K_AR^UO4;9TUZZL].5#'<V,,:D7"D\@L>1D<?3IBNA  &!P*R-/\
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M<*06R"7 Z#IU.> ><(/B-I+)I=P+34?[/U*5((+\PJ(1(_16RVX8/!.W&>]
M'7T5R5[X_LK/6KW2%TC6;J^M(UE>*VME?<A_B!W#CZXZ\9K*U/XD>=8^';S0
MK*>>VU34([9Y'V*R_,0T6TMP_'4X7GK0!Z%17G23-;?&N[G2TG9W\-B=K=&4
MNS><!CEMN< #KCCK6]IWC>RU3PP^NVUA?^4LXMQ;NL8F+EPF-N_ .X@8)!H
MZ>BD4ED!*E21DJ<9'MQ6/XE\2VOA735U"]M[J6W\Q8V:W0,4+$ $@D<9/;-
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M3L)/,M;E-\;8P<>A'8@Y'X5D>/?$$WA?P5J6K6Z@W$2!8MPR [,%!/T)S^%
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M1U(P0<#@=,]3S@ [BBN%@\<:A<>$O$FKI86OGZ)>SVS1&5MLJQ!2S XR"<G
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M:-=N_/ R>F:W--UCPS:Z^]KH26[27*[[MK9=D421@X<D#:2257KR#GM77T4
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M0RD-R&.,\#H<CV2N;UGPF^H:M_:VG:U?:5J#0K \D 1T>,$D HX(R"3R,=:
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MG):_9$AF$C12[@H[9(*Y)XQP>H&: -'7?'5UHGAV_P!:.BB:VMKPVJ8N=ID
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M&/UJM?:-KL'Q!&O:8EE+:RZ<+69)Y&5U*NSC;@8YR![=>>A .+\.>)M0\(^
M)]1ATJ.?2;35)DN))9]LFQIMN44*0<$@'..>@QS78ZMXVDAU/4[#38H'ET^%
M'<S;R)9&&X1*%!P=N/F/0D<'FN;N?!WBFZ^&NJ>&7L[!;F\O#.)A=G:%:;S3
MQLZC 'XY[8K5G\/>+M-\1RZ[X>.EA]3AB74+*\=RD<B  .K* 6XSV'X]@#KO
M#VL'7= M-4>SGLFG0EK>=2'C()!!R!Z<''(P:YZ'Q9K.HZ7#KFDZ0E[IDMT8
M5AC?]^\08H9@<[0,C[O/'.175:?;W%O81Q7ES]IN.3)+MVAB22<#G &< 9.
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ME@O?[Q'4UT/B+P1-J/\ PC<.E3VMG:Z%/'/"DB,^XIC"\$8&!U[U)K7A"_\
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M_+ZT =A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !16)XC\5Z9X62S?4_M"I=SB"-HX6<!CZD<
M#^9P< XK.LOB%H]XVH1M!J-K<V$'VB6VNK1HYC'_ 'E3J10!UE8_BC05\3^'
M[G1Y;AK>&Y 61T4%L @\9X'('K69IGQ"T35;9[F!+Y+=8%F$LMJP5]S;0B'^
M)]Q P,\G'6IV\;:;#<7EK=6]];7EK;_:FMI(,R/%G&] I(8 \'GC!]* -VS@
M:ULH+=I/,,2!-^W&<#&<5/7'I\2=$8Z=(T&H)9Z@H$%XUL?*,A&1%D<E^",
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M;@S"TG-O-F-EVR#&1\P'K6E0!@R0^(KJ[\R9+""WC@<)!%=.WFRD8!=O+&%
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M=S#<[9!&$;^%ESDMG'.0,9/M6EXR\/ZKKMWH<NG_ &,+IM_'>M]HE92Y7/R
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MFK:=+%IVI"_C9[=P6PQ8*<'N6;/X8]]^P\-ZK;^/[OQ'/<V;07-JMLT,:-N
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MX6VMH5;;O=LGD]@ "2?04 :M%<F_C"XTE=8/B'2Y+.+3HUD6ZAW/#<ANBHQ
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M,EQIUS+8.Y.2WEG )/<[<<UK^*)+J#PMJD]E<FVN(;625)0@8C:I/&>.W6@
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MN)GG #F%1F1RJMD99B0,@@<\&LN\\3:UH][XGT&74H[B\LM-;4["\DMUWF,
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MO,!P0IP?S[CU"B@#R:_\"ZW-X'\2Z-817*6L\T$FF65]<J[QA6#.H8$A02.
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MW&SQ;E&/,0CG..W'4\UW=% '(3>$]1D\2^']7?48YVTF.97\U3NN&E7#'T4
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M<16YN2H>65"V%#!N ".<@?K0!CW_ (CU'^V+?0=+AN0T6G)<S2V\,<K9;Y4
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M#8VER\:)D38VEP-JY49] :WO^$2UN74] U"\\1PW$^DM(V6T\#S3(NQA\K@
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MY))X P._/'(!H:KH.FZWY U&!IA;R":(>:ZA''1@%(Y&3S6B!@ 5SWACQ/\
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M_%J8Z+I.F^*+7Y=0TN\3RR. Z/PZ-_LD4V>YDM?CI,\=G/=$^'@-D&S(_?\
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M6EW(4&4)VNI'UQ^)]>.NTF/4$TZ/^U989+UB6E\@$1J2>%7/. ,#)Z]:NT4
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MSG+.0"3R?X>]5="\"W*Z#KVB^(%LYK75;R:[W6TK%HVDQP-RCE2,@_I7>44
M<%#X?\9)X*F\.W%WIETQ7[.EZT\B.8.A##8?FVY&[/?/)'.UX@\.+K'@ZZTB
M*QLDGN+81!2Y"1-@8(;9D[3R.!G':NCHH Q?"MGJ^G>'[6QUJ6VFNK9!$)X'
M9O,4# )W*,''USUKG[WPKXFL/%NH:QX8U2PA@U-4^U6][&S!)%&W>FWOCUQ_
M+'=44 <8?".I:=KFFZYI=[%<7\=L;34!>$HMVA8OORH.UMY)Z$8..@K5\.^'
MVTI]3O;MXY+_ %2X,]R8Q\B@#:J+GD@ =3U))XSBMZB@#E/!W@Y?"HU2/S5E
MAN;AC;(,XAM\EECP?0N_YUD:-X-\4Z")-%L-<M%\.&5FC+1-]JAC8[F1",*#
MR1N[9R .E>A44 <GHFA:S9>+/$&J77V!;;51%M6"5V>(QH5&<J <YSVQ[US4
M'@/Q?%H>F:<VJ:,W]EZ@E[!(89"T[!F;,ISUY[<GNWKZC10!XPXU+5?%&O74
M>J^%Y(H+@6MQ!J8>+?Y0 ^9%(#('+8+9SCKC%=#<:/K_ (FCT;Q5I%W9Z9KE
MJDENX):2VN8=Q&1QDJ<;EXZ$<\ UV]SHFDWEXEY=:793W2?=FEMT9U^C$9%7
M^E &7H5GJ5I9,VL7J7=_*^^1HDV1IP %0=<8'?DDD^PS;S0+^Y\>V&OK+;+;
M6=N]OY1W%W#X);.,#!'3GIUYXZ:B@#EO#WAW4-(\3:[JD\UM)#JTJ2F-"VZ+
M:I &2/FZ^U3>./#]UXJ\*W6B6L\,'VHIOEE!.T*P;@#KRM='10!RTVF^+)-'
M&G17VE6X,0A,T<4A=5Q@E<M@''0G.*9:^'-4M/%&L:K'/9F&^M$MHH3O)C,8
M(1F;^+J<CCZ\<]910!YLOP^UI/AW9^$EU"PVV\XE-P8WRRB3S -N>#N)&<].
MU!.K-\8;T6$U@MT-%A$R3JS(?G.<8((P?TKTFH%LK1+@W"6L*S$D^8(P&R>O
M/6@#A-0^'=Y+X7MM)L[^V$S:A_:5[<2PG]]-NW?* >!GCOP!6H_A?4[/Q7<>
M(=)O;2.>^MDBOK:>-FC=T&%=2"""!QCTKKJ* .$,?ASP%X570=9O1*VHK.S@
MQD-=NW+A5&<9W  9]!DUH:)X.M[?X=1^&+T2!)K9H[@B0,X9\DX;&"5S@'&/
ME'&*ZAX8I'1WC1F0Y1F4$J?;TI] '%>'?"?B+3OL]GJWB7[=I5HNV&".#RWD
M &%$CYR0!V[D#)XYJZ+X#UW1)O[-M_$[CPT)6=+-80)E0G=Y8DY(&>"1SC.,
M9KOZ* "N9M/!=E!XCUW5)#YL6JQJC6[9*IE<2''3YL+GZ5TU% '!?\*U2'X=
M7'A>UU*2.:283BZ<%OF5@4!&>0%55Q[9Q37\#>()M=?6I?$J?;IM*DT^5DM
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MFNM\-Z/%X?\ #FGZ5$JJ+:%4;;T+=6/XDDUJ44 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M&XW$3$>H4J%!'JU13O\ /=QZ@8X?#Z^)I6N;N(GS8)0RE-Q_@5B0"PY&>P-
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M9HKB%)H9$DBD4,CHP*L#T((ZBGUA>"_M/_"&:2+RP6PG6V56ME! 3' X/(R
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M8$BI*Q]%\*:%X<DFDTC38;-Y@%D,>?F Z=36Q0 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110!%/;P7*!+B&.5 <[9%##/KS40TRP7R=ME;#R#F+$2_NSZKQQ^%6J*
M*T^G6-T%%Q9V\P1BR^9$K;2>21D=:1-,L(X984L;98ICF5%B4*_U&.?QJU10
M!3BTC3;?S/)TZTC\Q/+?9"HW+_=.!R/:GV^GV5IM^S6EO#MSM\N,+C.,XP.^
M!GZ"K-% $1MH&,I:&,^:,294?.,8Y]>*B.F6!MEMC8VWD(VY8O*7:#Z@8QFK
M5% $9@A,RS&)#*HVA]HW >F?2I*** *Z6-I'&8X[6!4+%RJQ@ L>IQZU(+>
M($$,>P,&"[1C(.0?KP*DHH C:WA>=)VAC,R JLA4;E!Z@&GLJNI5E#*>H(R#
M2T4 ,,49B\HQIY?]W:,?E0T,3H$>)&1>BE00*?10 W8GF>9M7?C&['./3-(8
M8B03&A(;<#M'!]?K3Z* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
(@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>davidjkatz_employmentagr008.jpg
<TEXT>
begin 644 davidjkatz_employmentagr008.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***04 +1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %(*6D% "T444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !2"EI!0 M%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4@I:04 +1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %(*6D% "T444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !2"EI!0 M%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M ZZ#QC=3^/)_"HTA1+##]I:?[5QY.X*"!M^]\PX_6NMKSNT@>+]H"_D;I+H
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MPJM'O,RKG@LW(/4 +0!:T'Q5K_B7P3IVLZ9IMF;NXNS'-%)*0D<*NRLP/4G
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MB5<'CL2 3TYZUF:!'!IUA-X2UKP?/?ZW#(_DMY&^"X5G++(SDX"@GD]L>O%
M'=ZC\1= TS5)]-G-ZUW \:R1I:.2 YP&Y'*Y(Y''(QG(J;Q=XHE\.'2DAL)[
M@WU]#;%XP"$#-R/=B 0!^/:LO19U;XK>(9#:W8CGMK>*&=[618V:/=O <KCN
M.^#VJ7XEP73Z1H]S;6]S,++6+:YF%M&7D6-2V2%')ZCI0!3GU:#1OB9<2LNH
MS?:M%CG2R3S)I&<RMD*A)V\*,@8 Q726OBW2[W0[75;5I98[MS%!"$Q*\HSF
M/:?XAM;.>!@G..:YJ+5=_P 5/[1-MJ$-D=$$+^982G]X)&?;D*>0IZ>^.O%<
M5IFEZBGA[3M3&C7UV-)U>ZFNM.>!XVEAF& ZA@-Q&.,>IH ]AT?Q%9:S<7EI
M$LT%[9.$N;6=0LD6X94G!(((Y!!(KF!J5SXG^)M_H9EFATC1;=6FCAE*&YFD
M (#D8.P G@=2.?2M'PB+*ZO+O4M/\.2:5;RQHGG7,'E3SL,Y!7.=J\ $]3G'
M YS7TN\\+_$B_P#$26\UUI&KP*ES]G0N]O*@ #%1R5(!Z9()Z4 0^)M1G\#>
M*/#TME-(=*U2Y^R7=K+*SJA. LB9R5(R20.#CU.:<GBF\\01^,;&73;JUAT^
M-XD<2H#&RHS98JV<DXX&1QR>M)X@TR?QYXDT P6EQ%HVF7!NI[FXC:$RL/NH
MBL QY7DD <\&J40N]*UGQW92Z9J4O]HAKBWFBMR\97R2/O#ON.W R?;&2 "Y
MX*\9V%MX7\+V-W'>AKN&.VCNWA/DO-M^YN/).1C.,9[]:WM5\:VFF"ZF%C>7
M5E8R>7?7<"J4MS@$Y!(9L9&=H.,^O%<3<V.H77PY\#VD6F7YN;&^LYKF(VSA
MHTC#;F/'N/?FG65JWA_6M4TO5_!4FM?;;V2XL+Z.TCE#K(<[)&;[F#W)_E0!
MUFH_$/2]/OS9I9ZC>2&T^V1FUMC()8R1\RXZC!)SP./4BNLC<2Q)( P#*& 8
M8(SZ@]#7%:?!<6_Q$MW?398K>/1ELC+;VS+;K*)-VU/10.AZ=J[>@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH *04M(* %HHHH **** "BBB@ HHHH
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MI,ULT;IJ]RID+$C'EK@LF!NR3C.1QW'20>$=)B\+-X;DBDN-,*%!%.^XJO8
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M5;!SA@/SXH Z*BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MGZFFS6ND6_[/+75O!8I<RZ='%)*H57=MP8J6').<G'KVKUTZ?9$ &SMR @C
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %(*6D
M% "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%9
M7B*?5+31KF[TF2S$]O$\NRZB9U? SC*L-O3KS]* -6BN8\(^+4\6Z+(Z(++5
M;?,5U:2J28).Q*Y!*GJ.GIG-6?"^HZEJ.F3W>J/:C;<30J(86C $<CH6)9VS
MG;GMCWH WJ*JQ:G83V;WD-[;26J EIDE5D7'7+ XXP:IZ5XETG6-/BOK6]A\
MB5G6,NX4L%8KD ]CMR/8T :U%4QJVFM?BQ74+4WAZ6XF7S.F?NYSTY^E9>HZ
MJ+S[ ^C>(-+BC6_2*YWNLGFCO"ISPYR,#K0!T%%<\/%^D76OW&@6>IV8U".+
M(+N&42$D!-N0688R5!R*I>#/%::EX=LIM8U.Q&H74\\<:AEB\T+,R+L0G)X
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MQ<?9LQNT@"M]T9';@X&,C% '?45@1>,=)EO8;+_2TN;F$SVL4MLZ&X0#)V9
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M: -FF--$JNS2H%0X8EAA3[^E9FIZREM>QZ9;VLE[?2PM-]GC95VQ@A2S,Q
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MTN*]DTR9(IX!=;9R"%RZIL.5&[UYP:[&@ HHHH **** "BBB@ HHHH ****
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M81J'(+8&2.YIU% !1110 4444 %%%% !1110 4444 %%%% !1110 4@I:04
M+1110 4444 %%%% !1110 4444 %%%% !114<\$5S;R03QK)#*I1T89#*1@@
MT 1?VE8AXD-[;[IF*1CS5R[#J!SR1[4EUJ=A8R1QW=];6[RG$:RRJA<^P)YK
MP_3_  [HMU\)->OY8(Q?V5W<+9S[R'A97RB)SQDG[HZEO4UHZI<1267BD74D
M*:S_ &#;Q:FVI2)P_P!GW!($&#DL022<!L8!H ]B:]M4N! US"LQQB,R ,<]
M..M-?4;&-)7>\MU2'_6LTJ@)_O<\?C7E4\*6GA'P9XYM<3W&B6D"7PC(9W@>
M-5<'W4,3@^IJYXUL8[CX1:[JEU&))[^1=03S%YB!9%C SR"(PH_%O6@#T<:K
MIS37$(O[4RVREIT$R[H@.I89^4?6I+>^M+NT%W;74$UL03YT<@9..O(XXKS*
MY\-Z6OQ!\(XL+407FGS_ &F,*/\ 2&"!LR#^/DYRV<FL&^>;3-*\<V6GQF+3
M+?6H&F@@A#+' V#+A<8VX49'3'MF@#V:UU;3;Z.62SU"TN(XO]8T,RN$^I!X
MIJ:UI4LT$,>IV3RW"[H46=2THYY49Y'!Z>E<!#8:%KFMW.HP>);?6;N[TQX9
M;>-(?+:,#*M, /E(8K@MSP!VKF/L-C9_"7PAK%K;PIJ*ZA;'[6J@R9WL"-W7
M'&,=..E 'K&G^+M%U/7KO1[2_MY;FV5,[95.]CN)51W*A<G'3-;E<1HEQ9V?
MQ0\6PRW<23W8LFCBDD 9R(F!"CJ>@_.NWH *I6^LZ9>7;6MMJ%K-<+G,22J6
M&.O -9'Q >^3P!K;:<'-T+5MNS.X+_$1COMS7*ZJ;.^T+P#=^'L?:([VW6U$
M)&Y8=F)@?8*,-^M &M?^*/[7\1WV@:/XAL]/N+>WC:&7,<OG3NS#9@YR%"C(
M'.6]L'L;(72V, O6B>[$:^<T((0OCDJ#R!GUKEM*FB_X6IXBB\Q/,-A9D)N&
M< RYX_$?F/6NPH BN;B*TMI+B=PD4:EG8]@*X75O&C:GX/BUWPYJ,<2)>11R
M(8@[.CSB(9S]S(RW3-=_7@XUG3C^SG';?;(YKBW>(2P)*%D7_2@VWCE25!([
MX!/:@#V>QU[2=4O+BTL-2M;FXMSB:**4,R<XY ]^*9%XCT:;4ETZ/4K=KMRR
MI$'Y<K]X*>A(QR!R.]>?Z_&;;XF06NA&WMKF7PU/':K'A%+Y)08'N 1]*J^'
M+CPKK6E>';"YO=2EUC39853368B6"XCPK'  ^5<$DGC YYXH ]>IKND4;22,
MJ(H+,S'  '4DTZB@#G6\>^%$,6[7[#$LAB1A*"I88SSTQR.>E3:AXR\-Z7<3
M6][K5G#-"GF21F0%D7('('3EAQ[UY9H\N@O\/O'-E>26OVV?4;M5B.WSI'_Y
M9!0>6.[ICOG%:6DV]J/BCHFGZRUI+<1^%([62*9E;,V_#)@YRVTMQW&: /2+
M_P 3:+I>/MNHPPC"L6))5 QPI8CA0>Q.,TVX\5:#:WDEI-JUHMQ''YKQ>8"R
MKQ@D#UW+@=\\5YO'=:38ZSXH\/\ BV_O+$7MY)-!&"?+N;9U"H%PIR0%VX'H
M .14^FMI6G?%S2("8K6*T\,K#%'=2J7A;S3A23T?8>G7!/:@#MV\=^%EMK:X
M;7+00W.?*<OP<-MR?[HSQDXI;V]3_A,M/M4\1QP,(7:321&K-/P2&)^\N.OO
MBO*!/I__  K3XCB.>W!EUNX\K8ZY==R%-O/(X;&/?%=-/JFFO\1? CI?V[ :
M=.&82+M&8P%YSU)!&/:@#N$\5Z))IMUJ"7P:UM)6AN)!&_[IU&6##&1@=<]*
M9/XQ\.6LJ13:S9I))$)E0R#<4(!4@=><C'KGBO.)-3LM+T/XE:-=W!74;BZO
M;B&W9&WO&\0(8#'W>O/3 S5W2M1T:3Q-X +W-G]HCT9XCO90ZOLB" YY!/SX
M]><4 =J?'?A<64=X=;M?L\C%0^XX!!P<\?+R1UQUK1O-:T^P:%9YSOF0NB11
MM(Q48RV%!.T9'/3FO(K2_P!';PQ\46-Y98GNK@Q$2K^\RA\O;SSELXQU.:U+
MJ;3KNW\.7^E^+;;1]9ATA!%+,Z-;W$8P&C?)QD,I]QSUQP >I65Y;ZA90WEI
M*LMO,@>.1>C*>AJ>L+P;>R:AX2TZYEL!8LT>/(7[HP<97_9/49[&MV@"CJ&L
M66F,BW,C^8ZEEBBB>5RHZD*@)P,CG'>J4GC#P]%I=MJ;ZM;_ &.Y;9#*"2';
M.,#'.<_E7-37JZ!\6;V_UN1+;3KW3HX;.]F;;&K*V6C+'@$DEN<=*Y75%AT_
MPCXDDOI(8=.U/Q!'-8Q2D 31":,NZJ>JD GCJ!GH1D ]2TKQ3HFMWT]EIVH1
MSW,"AW0*PRIXW+D#<ONN16Q7FLNL:9-\;M)^S:A:21OHS1+Y4RE2S/N5>#U*
MX('<8->E4 07J/)93*DTD+%3B2/&Y?ID$?I7 >"M0O=:^'-KKVK^)KZ&9DE,
MTB+"%3;(R@@>6>P'UKOKZ>&UL9Y[B5(HD0EG=L ?4UX]\.['PA=?#2.'78]*
M@O5\TM*Z1K<JN[<K@D;C@,N#SVH ]%7Q+8Z!'IFD>(-5B.LRP<[8V/G,J\L-
MJX!..G&2< =*8?B%X7%E+=_VDQCAD:.91;2EXBO7>FW<H&>I 'O7-ZGJ46K^
M/_ >K")H[3-\=[]%0QD1LW'R[L9&:J6>/M'Q.'*I=*?LY*G$I,+*2O\ >^8@
M<9ZB@#N=0\9>']*:S%[J4<0O$$ENVQF612,@@@$=!_+UK.OO%.F>(/"&NS:#
MJSBXL[:1F:-3'+$RJ6&5=<@''7'KBN*U&ZM[30_A:]TXC2VFA6?>I_=,L2Y#
M>A!]:T;N);O7/&FO6)WZ9=:-]ECF0$I=3[6'[LC[^!A<CC)^M '5:#XCM8?!
M'AZ\O[F62XN[2%4!#22SR^6,X R6/!)/XFK(\::$-+O=0>ZD2&P<)>(UO)YE
MNWHZ!=P'OC'O7G5D;O31\._$%XMP=,T^RDMKP^4Q-JYCV[GXR%Z#)Z;?>NFT
M;28M8\<^)=61#)H>H64-LVZ/"7;X(9AD?, O&X<'=WQP =8NO:<\6G2K+(4U
M$XM?W$F9/E+=-N1\H)YQP*J7WC#1M.8M<W$BVZS?9Y+H1,88Y,@;6<# .3C/
M0'@D&N9\ :7JEK?3Z;J7SVWAYY+.SE+Y,HDVNK'T*QE5_P"!8[5S^A6UC9Z=
M>^%_$NBZM=ZBEU+Y48,[07H9RZ-E3L7)/). ,9/? !Z1J?BO3-*>=9C/*+4*
M]T\$+2+;J1D,Y'08YXR<<XQ574([W5-6T+4M&U:X%D?WDD<2*T$T1P<LW4'!
M(&,\D=,$UQ4<<&C>+/$-EXCTK5I;74IA+:260GDBE0H%,9$9Y(P!R/R&*]+T
M2VCL]$L[>&R^PQ)$ EMNW>4.RD^H[^] &;J?C/2M*DO1,+J6.QQ]JE@@:1(2
M1D*Q'?!'3ID9Q70UY1XG@:+5M8U/P]+?VFKK((Y]-DMFEMM5& /ND8.0=I(/
M&.W6O5(F9X49TV.5!9<YP?2@!]>;6WBF'PWXR\8Q:A<:G=P0-;211(DEP84,
M6YR .$7+>PKTFN%L+M=$^(7BN6_M[M(K[[*]JZ6LDBS!(=K!2JD$@\8ZT =$
M/$^E2Z99W]K<&[BO<_95MU+/-@$G:O7C!SG&,<XKC_&_B6WU3P'>:AIE]=6D
MMA?10W,99H7C/FJK*X],-]*YT>'K_P +1Z#JMWH=Q=Z9'->FYL+5/,>T29@R
M?*#S@*,XZ8K3UZ*TO?!&J2:%X7O[5;NZM6&+*037)2579B@!(4+T)Z\_B =O
M8>,M)O\ 5Y],4W$%Q%";@?:8&B62('!="P&1[U'9^.-'O;C3HT-PD6I%A97$
MD16.<KU /4'TW 9KG=;:[_X6?;:I:Z7>74$>AS1KFUD$;REBRQLVW S[],US
M"/<W5QX-U)],UD36MZ?MENMA+'#:G:<1Q1!<;1@\@$\?,: .U\-7D]GKOC(2
M/?WZ6U["L4>\RN%:-3A03T!8G'I5+P'%+XCL=-U^]GU>/4E+RR3^9M@G1G;$
M6TD@H.,8 QCKZS^%I9;3QGXTO;FTU".VN)8)(2UC+B0)'M8K\OS'/&!Z<<59
M^%2W4'@*RL[VUO;:YMVD5X[N%T8 NQ&-RCC!'3.* .UK'\0>([3PW;0W%[#<
MM#+*(@\*!@K,<*&Y&,GOTK8K(\4:*GB'POJ6DN/^/F!E0^C]5/X, ?PH 1?$
M=J?$J:"\%S%>O ;A=ZJ$9!P2#GGGC Y_#FH&\760BA*VUV]Q<3R06]JJH99V
MC)#E?FQM!!RQ('OR*\^FT;Q;/HVC>,FM)&\3V#1P)9/DEH,>4P;W9F:0GLI
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M2*SM)H;EC 6$3.BJN2N1U!S@G'>K7@NSU+2?$WB>UN=-G6"\U*6]CNS@1%&
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ME4M5-4L4U32;W3Y&*I=0/ S#L&4J3^M '*S>/I+31-/\07>DF'0[UT43F?\
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MN?$%KIVH/:>;Y2QD1"1VW;.%W_WN,$@G(P#72QL7C5F1D) )1L97V."1^1H
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M8YX(]#6%;>*[Y?%\.AZGH_V-;RWDGLI!.)&?9]Y7 &%..>"1TYKFY=4M]7\
M^/T71+;39+5KJ*9(RK>9*(\EV( RV>_L* /2X)X;JWBN+>5)894#QR(<JRD9
M!![@BI*X32-:OK+POX0TS3K2-Y[K28I6N+DLL$*)$F2Q /)R,#CZU7N?B5<Q
M>#;;6XM(229K_P#L^:);@%5D#;24./F!P<=.U 'H=%9>@WFJ7MC))J^FKI]R
ML[HL2RB0,@/RMD>H_E6)K_C1+#4KS3+&;3EN[.%9IOM]QY2G=DJBXYS@9)/
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MGM0 ^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I!2T@H 6BBB@ HHHH
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MC-J-OI=G%>S9,EPD*AWSURV,\T >??#KP]HEWJ/BJ:;3[:26U\0W*P?*/W2
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MQTZ9KUO(R!D9/.*6@#A?"<\>J7MO/#X'_L&6WW?:9KFRCC).TKLA888\G);
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MDEO);NW6*0J67Z[21^1K@?%_AF]U^^U"5=!_XF$.S^Q]6MKE(GC.Q3^\RP.
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MPJ+.4'F",DJ&QS@GJ,U)10 4444 %%%% !1110 4444 %%%% !1110 4444
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M-P[$9[C->)-?VH_9]O-+,P%[;WFV6$@Y4FYSCTSCG'7%=WX@FMI?B-90V,\
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M?&&FO>W=E/%=VMU;6WVMH9H26>'.-ZA=VX9[=1W%0>/KR_M/!EY/IE@M[/\
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MX4B?:L.Y7+XQP5 VDDG))S7:P>*[5M6M--N[.^L+B\C,EJ+J-0)@!D@%6.&
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M'J5N!:*&GWML\M3T8[L?*>QZ&HHO%WAZ>[M+2+6;-Y[L9MT64$R#V^O;U[4
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M%93@]&&0-R^XR*LZPTB:->O%*\4B0.ZNF,J0"1UH NT5Y"^LZO;?"2U\8?\
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M.2,G:03@8.2<C&..IH WOMUI]E:Y^U0?9T)#2^8-@P<')Z=>*GKQD6UN_P
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MG9&Q*_FAMHXZXYQUY'K7HY@B9RYB0N0 6*C)QR*<\4<C*SHK%#E21G!]J /
M=,OGL=%TS6?*GET_3/$MQ-?*L;'RT?A7(QVY]P2/6NO\1^(/#%SX;UC6=.T:
M'4+.ZDMUO;Q[9_+D(< $C +A,9.".<#/->GA%"; H"^@'%((8EA\E8T$6,;
MHQCTQ0!Y-H]];R_%F2:+5+G4ENO#S1Q7<D/$S^=D[0J@;1@\CC@\YK-O-9TJ
MY^ VF0"]B\^U>UC9#P1(LBEEYZD+DG'0<]Z]L5$7&U5&!M&!T'I0J*@(10H)
M).!C)/4T >>Q:G!I'Q2U#4]4NX(M*U/3X5T^_DD40_)RT8?IDEBW7FN9OEM=
M.\'ZK+>3PQ6&J^(TN+""4[5>W$Z%F53_  $ MTQC!Z$5[510!YL=5TZ3XYV/
MV:_MG230_*!BE4AG,F]5X/7;@@>AS7;>([RVL?#FH3W=Q%!$+=U+R.%&2" ,
MGN20!6G10!X9H&C)<?#W0/$_AW9<:UH9+7%H&W><NXET*G.U]N""!G'KQC=\
M3^*-/URV\.>)['S[O2M.N7;4HK>1DFMA)&4#,%(88R?K]#7JU% 'D6K?V;JG
MAG4-;\'Z/<W:Q7-K=3SR^;F^$4FXH _S-M Y/X#)%:6I:K9_$#0-7/AC3)9;
MV73Y+:6]E@\ED/!%ON8#<22<@' []17I=% 'E.HSIXK\'>'-'TN.5=8MKFU,
ML.PJ]@8U^=GSC:  0"<;LC&:ETUXT\0?$F:6-Q'<QQ^2S1-B4")E(7CYOF(&
M!ZUZC10!XOI^IS>&?^$,\0WEI=-I46CG3;QDC8FTDR"69<9'W1VZ#OQG3\=7
M4.I?#^1].TB6VBN=2BF@1+5EDN%#*7E*!<C)SUY( />O5:* //;RX2;XRZ-=
MQK*UM_9<D9E$3; S'<H)Q@$BN:MKZXL_#7CHV^D-?S7&N27$5O-:-(KPLZ_O
M0A'S 8S[$ FO9Z* /)M/2.7XIQW"1:U<V5YH+6OVNZMY<RR&7)ZJ @P.F%4'
MH.><]YW'P!FT-K.^3488A T#6D@)D\[<5''.!R<<5[310!YKON--\?:+XCEM
MYY=(N]&6Q:9(6;[-)NW?,H&5!P!G %8?B73YF\,>/;^.SN%M]9N8/L$!MV+2
ME-NZ0)U&X@D$@<#->S44 >?:S?0W'Q/\(7,0F>!+>Y#R"!]JF15"9..,D=_Q
MKN;V\BT^RFNY]_E0J7;8A=L>P')-6** .#TGP]:>(?#-[?7]S?(=8+SWD(W*
M%R,!-I7)V*%7ZKQ7*01Z[J_PEET9-/O6U'1KB,P![>2-;V&)P5*EA@_+V!S\
MH]:]GHH X[2=>3Q4[W%MX>N[69;1HY;F]MO+921_J48\MSR<<<>I%5O 6I&R
M^&L*7=E>6LFE6C+.MU"T7S)N) +#GIU''/KD#NJHZGI<6K1107,DGV97W2P+
MC;..ROZKGDCOC!XR* .%\#ZJ/"?@OPCI%]8ZA))J"DB:.'=' 9),J)#_  Y,
MB@5Z15::P@GN()I Q\CF./>0@/8E>A([9Z=JLT >*/:ZC#\,_%OA\Z/JCW\F
MHS,BQV<C*X:164J0.00"<C\<9&=S5O-FUGX?RP:?JAAL0_VAUT^?]R#&$&[*
M<<@]?KT.:]/HH \=T&P;2M/E\,:IX(N=0O[>5UM[Q[;?:7.YRRN[_=4 $$_3
MUXK:THR6_P 0_&%S/I^HQVMS;6\<,PTZ8QN4CVL%PG.#TQU[5Z110!R7PT2:
MW\ :7:7%M<VUQ;1F.6*XMWB8'<3T8#(P1R.*I>)+>]M?B9X<UB/3[N[M$MI[
M9S;1%RCMC;N[*.>I.*[JB@#RRP@O$C^(Z-INHAM0DD%H#9R#SMT3*-I*X(SW
M[52NM.O--D\-:Q=^$Y];LH]&BTZ\LC:"6:WDCYWJC#GDD<<8[]*]?+ ,%)&3
MT&>M+0!A>%8@NFR3)H4.BQ32;X[1(EC<+@ -(%X#'GCL,5B>-=!U,Z]HOBO0
M[<75]I;,DMH6 ,T#@A@I/&X G'U]L5W%% '/Q>([G4!'%I^C:BD[.%D:]MFA
M2 9Y8EL;^.@3.?4=:Y[1K?4O"OB'Q5'<Z5=7MGJ5R;ZSDMXPZR,P^:-O[IS@
M9;CJ>*]!HH \@B\-:EX<TSP59_8+NXEL]1:^O?LR&1(%?=E0>1QD#"]<$CKF
MNBTS[1:>/O%U_)INH_9KR"W$,@MFQ(T2,K ?B1CUKO:* /"TM[S1OA_\/[.^
MT^ZAN[/Q%'O@>/#MF21QMSP<AA^-=?J]AKU]KVM>)]%M98+B+1OL%BL\81YI
M#)O9@K<C P!NZGMCKT_B'PK;^))["6YOKV#[#.MQ MNR +*N=K_,A)(STZ>U
M;PZ4 >0V5AJ__"7>%-;3PKJ4:6\,T-[-<2*TSNR[2[Y8G:"21GD\X'3*W>A:
M]=_";7M%&B72:C=Z@\T4+-'\RM.),YW8X (/O7KM% ' ^-=-O+NQ\/ZKIA:Q
MUR*YCMXMZ@OLE&V1" <' RW7@(3FNWL[2"PLH+.V01P01K'&@[*!@"LV'POI
M</B6?Q (I&U"90I9Y&94^4+E5/ ) QD>_J:V: .0\8:;'K%[:V-_X=EU+3C$
M["ZMBJS6LV1@J2P(R/3N!GBN;;2_$\%IX,2YL;Z_N--O7GN9C)&S+"2ZJK'<
M-SA",XS]:]3HH \JUBP\6+K/C:ZT33+J*74H[1;2XWHN1$-L@!W94D$X./RJ
M;2])UV#Q]I^NP^%?L=DVGM:R0F\1I$;S Q=S_$Q'3DDX&2.WI]% 'E4/AKQ
MOPFUK0FTB5=0NKB5XH_/B(*O('!SOP,#MZUZ3I2RKI%DL\<D<RP(KI(06#
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M"&Z\)?8(OMTTQ82?:%\L*91)UZYXQT[UZE9^8+* 2QF.01@,A(.TXZ9%3T4
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M\>HZ9>_&F"^6XMY(/^$>Q%*Q  ?S\\$]#M)/T.>E ':0:_I-UHR:O!?PO8.
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MA+V+RR(R"0XY/RX!]^.E5O\ A.[#[5I<#6&HJ=54O8L8E(G4#<2,-D?*0<,
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M;NRT2:TM+J6?60[6EOA5;"#+EB3M&![\UD>(/B')!X*N=6TJQF6ZBO/L$J7
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M6D% "T444 %%%% !1110 4444 %%%% !1110 4C*&4JP!!&"#WI:1F"J68X
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M%>%+<8B QN8DG&!SP.>.PYIMWXVNG\::%IFGV$\]A?6CW8E1HLSH5!4KN88
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MS G=P0#E0V:K7G@S4;#3_!6EZ=;&ZBT2[CN;F?>B!L9W;06SDDDX]QS7I-%
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MA\_[!+&HEECS@,GS;6&??COBO,;;2M:>TU'4;;2K]GL?%DFL+9S6CQM<P-@
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MSVUN+B:-=RQ&38&_X%SBO&M>U:X\3?"+3=>U2SC-T=11HI]JLP4SL"JX&0
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MMV6X[#'/XLUOPUJ%_K3ZC8:%)I^O1W@^SZM;3HL4L <<S+ORWR<$;<D@=!D
M V?#FOZUJGC7Q%875K;QVE@\,0"SDE,JS!@-@W%LC.2,8'6MO6M>BTF6QM$B
M^T:A?RF*UM@X0N0-S,2>BJ!DG![<$D5AZ-IVL:9\1/$5PUAYFFZF8)4O&G4;
M=D>TKMQDG/3H,#K4GC#0]1N]7T#7])B6YO-'FD)M6D">='(H5\,> P &,\=:
M +>G^*)KW5-1T5[!+?6K)%E$$DY,4T;='60+G'8_+G-<[X!T\>(O#=I>:WI]
MM<20:A/=0W33,TOG"9QDC:, 8 ')R%''IJV^EWTGBVZ\77&ERQS)8+8V]B)(
MS*XW[V<L&V#K@#/04[X=V.JZ3X<_LS5=,>TEBFED5_.CD5P\C/QM)((W8.10
M!I:AK\D>J2Z3I=M'>:A#;_:98WF,:HN<*"0K'<QS@8[$^F:,'C07=GHJPZ9<
MQZGJWF"*SN<QF(1YWLYQPHQUP2<C YK.UC2/$.C^.)/$GA^R@U..^MUM[RTE
MF$)0I]UU<_EC'_UC4]!\1MJVB>)T\BZU.R,JW%@D@5&AD &R-C@97KEL;CGH
M,"@"]'XRN6.LV3:2!K.E()I+,3_+-$1D/$^WYO3! YXJ>P\6G4]!T/4K.S25
MM6D"+$L_^JX8MD[>=H5L\=1CFFZ+H5R?%VI>*+V)K66ZMX[6*U+ABJ+R68KD
M;B>P)P!U.>*'A+P;=:!XBU.66?S-+25WTN+/^J$N&EX[8( 'X^M $&J_%"RT
M^*:]@CL[JPM[K[/*$OE%R0&VLZ18^90WN"0">G-2W?CZ_P#[>O\ 2-*\.3:C
M-:V\=RK)<JHDC<C!Y''!SCK]*I:!HOC'PH;GP_IMK8SZ.TTDEI?R38:V5SG#
M)C+D$G'KZXZ:>FZ-J]I\2=0UB6U1[&YLXK;S_-&\LG\;)TY]L=N* (M6\?S:
M3%=7L^E*EA;:A]A;S;@I/)@A3)&A7#+DC^+D FM*]\52+KNI:3I]G%<3:=9K
M=7!EF,8^;)5%PIYP,Y/J/PX;6?!_BW4]-URVN=)L;R^ENA+!J;W0WR1"166)
M%(^0 9XR!P>"3DW-3_MZ[\;:C<:5I%I=S1V4%K?PV^H>2P+@L48LN&(!&& &
M ?P !N0_$))] T;4190QRZN["WB>YPJ(HRS.VS(QC& #SCGFM7PQXH/B";4;
M:6S-O/8R*K.CF2&56R59'(&>!R,9!KEVTO6-2TO2;W0-,MM&U+P]=/ FG23K
M+#)&RKO7S%'<$<]<[@>:Z>*3Q8='O+R2WT\:FRJ+:P$I,28)R6DQDD@^@ P!
MZF@#HZ*9"93!&9E592HWA#D!L<X/IFGT %%%% !1110 4444 %%%% !1110
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MXWG4,N>F03D=1^=7@01D'(- !14-O=VUV)#;7$4PC<QN8W#;6'53CH>1Q4U
M!1139)$AC>21U2- 69F. H'4D^E #J*BM[F"\MX[BVFCF@D&Y)(V#*P]01UH
MN+F"T@:>YGCAB7EI)7"J/J30!+15>2_LXI;>*2[@22YSY"-( 9<#/RCOQZ58
MH **** "BBFI(D@)C=7 )4E3G!!P1]0: '4444 %%%% !1110 4444 %%%%
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M4[HWMM+;RQ J[#YDD#NN!G&",\9^E %VX^(5G_Q(9-/T^YOK;6MPMYHF48<
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M^$]/&G)<6^GL\>IV!O(U%P#C8P.XAE!))4XR1T[U5E\->(ET#QAID6D6L?\
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MVNP%:6XOE 0!E;@#.>A]/QH S;[3-3\1^*/!M[9:9<6D.EJ9;B]GVIN7"XC
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MKS+FUU-=4>;[-_K)5X5<;OE0+@8Z\=:O6WAB>T\6ZIX@BU"/S;^)(FB:W)5
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MUT<<,IY]#P<@5E?$G6;JQT_2])L;C[-<:U?1V7GJV&BC8_.R^^.,]LT 7/\
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M2F1(F'6-\@<^A'7TZF@">PTOPSJEFEY86>G7-M(2$EBB1E;!(."!SR"*M?\
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M9S:9%>-',7G83,'GV94!<#!8=3SST[@'K']E6'_/G;_]^E_PH_LJP_Y\[?\
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MO86\L$IO+<R"0R,&:15###9]^F!TKM8=-L;:X:X@LK:*=^&D2)59OJ0,U:H
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M*M#N+$%MW7)ZXQCC%=)6)_PDUO/?7-GIUG>:C):N8[AK94"1/P=I:1E!;D<
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MN$5@?.WEL$],=JMWG_"0ZA!J!_LE;>)[)XHK;[2A:69^-SD< *JCN?O'KC@
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M\RSVLES;%C#,C>A8###N.?K6AK.N#3;S3M/@B$VH:C(T=O&S;5&U2S,QP3@
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M!,A D"9B&,'&5)+8[\=ZG\13ZBWQ6\+11- %:WNVMU<L5SY8R6 [XR.*H_\
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M#1!90Q7+.CR2A]T9.,8SQ@$>^.U=&="U74/$&GZ[JB6(N-,MY4M+6"9F1I9
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M?"'1]0U+4;IKT:JJR.A5 _\ I10;@!@X X'3ZU[#,CR0ND<K1.RD"10"5/J
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MWGV*XFTM8M.O;62[BNHKGS=J( <.NT8;!Z GH>3B@#K**YC0?%5WK3:?+_9
M2PU"$S0W4-R)0@ !"R#:-K8/0$\@C-=/0!%)=6\1823Q(5QNW.!C/3-2UYWX
MUL;27XE>!_,M87\^:Z$NZ,'S-L2[=WKCMGI5R;QY?G5]=TS3O#$]W+H^PR$7
M2(K*R%O0X.!P!G/MB@#H_$'AW3_$VG'3]365[5B&:-)60,001G'7! -:,$0@
M@2(.[A!C=(VYC]3WJEH.L0>(-!LM6M@5BNHA(%/5<]0?<'(_"LK4?%%VM[JE
MIHVE?VA+I42R70:8IN8KN$<8"L6<KSV&2!WX .FHKFAXIENYK"QT_3V&IW5G
M]M>VO2T)MH\[?G^4G.[@#'8GMSCW_P 19K+PUJ]__8V[4-'F\F^M/M( CR1M
M<,1EE8$$<9ZT =[17(0>+M17Q2FBZAH@M7N[>2>P(N@YDV=5< 80XYX)%8S?
M$O4XO#4GB&?PXD>G6UV;>[)O 73$GEY0!?FP<9Z<],CF@#TBBN2UOQM!I^JS
MZ7:&U>ZMX!-*;F8HH+9V(-JL=Q SZ 8ZYXCTKQR==MM'2PT\QW^H)+*\%RY0
M6Z1G#$G&3R5 P.<YXQ0!V-59-1LH=0AT^2[@2\G4O% S@.ZCJ0O4@5P^M>)O
M$CZ##,NF#2YQJ\5E*)W;]ZOG( T9 ^XW()(Z9QGK6K-J!3X@Z397NC61NIK*
M5XK])-SIMV[D *@@9/K0!UM%<5+XVO9O#M[XDTW3([G2;.20%6E*RSQ1G#R+
MQ@ $-@'J!U'2I9?&-_/KMII^E:5!=PW^GF]L[DW6Q67*_?&W*CYNVX]..N #
ML**Y[PAXCD\1Z9=/<V\<%[8WDME=1QL602QGDJ2!D'(/XTS7O$EUHGB/0[)K
M.)M/U.8VYNVD(,4N"57&,'=T'/K0!TE9>HSZ1?W)\/WEVOVFYA,GV5)VCD>/
M."?E(..H]^?>L*S\;%]:\3:9?):02:+")PT<Q?S8RI8L1@8Q\H(YY-1)K=W_
M ,)]8Z9=Z'IT6H3Z6TZWBR;W7!_U>=H(7=GN<]: -^W@T7P=H8B66.PTV#[O
MGW!*I[ N3CZ"M.">.YMXYX7#Q2H'1AT92,@UY-<ZIJNL?#'QQ/JKP.T5U<PK
MY9;"[-JX4'HO'YDFMS1O%.JZ;-X3TR_TVWCL=4MQ#!(DY:52D0(+C&.?0$X]
M>U 'H-9NG>'](TB[NKO3].M[:XNF+3R1IAG.<\GZG-2ZOJ TG1KW43"\XMH7
ME\N/[S;1G KE+'Q;JNHZ9+J-E_9EU8C3Y+I;J'>525"N874G(.TMSQ]..0#N
M**X)_'=\GA;PKKAM;;9J]W#;7$7S93S"<%3GMM/7U%6[CQ5J][%KD_A[3X+Q
M-(N?LIB=CONI%"F0*0?EV[L<@Y(H Z.+6M,GU>328;Z"34(HS+);HX+HH(&2
M!TY(Z^M7Z\XNI-3_ .%MV\^G6,"WEQX=RZ7,F%B_?J3NVYR1TX[GTKIO!GB2
M3Q1H)O9[46UU#/);7$2MN42(<':?2@#H:*Y^\UZ>7Q.WA_3!!]JBM/M<TLX+
M*@+;57:""2>3UX '7-9T?BW5C#H-C=:0MGKFJR2JT$K[HX4BR7DXY((Q@<9S
MUXS0!V-%<//XRU6SD\1Z?<V%I_:6E6AOH&$C"*Y@P3NZ$J1C&,]>^*BM/&>N
M+-X8GU+3K&*PUTK&HBE9I(G9-RD]B#Z=O4T =7JNOZ7HJ%M0NUBPGF, K.53
M."Y"@D*">6/ ]:=HVNZ7X@LWN])O8KNW20Q-)&> PP2/R(_.N(TQM4E^+'B*
MUDDL9<V-MYBO"Q4Q_-\B_,=N=QSU'MZVK#Q:-+\+WL[Z98VMU'JSZ7;6EK\D
M<DVX(N3CZDG'0=* .N;6]-368]'-Y'_:+H76W!RVT#))]/QJ_7G=[+J%M\5M
M";5IK(QQZ;=2"2!&0*/EW!@6;@8Z\9YXJ*/XB:Q<PZ?J-EHEW=6EU* UK'IE
MSYB0DG$@FQY;<8. ._7C- 'I-%>>3^+?%3W7BBVM;31D?0\2%I7D8.AC\P#
MQR0#SP >QH/B'6-<U/P5=6-S!9V^J133M!)"TF&6+D,0Z[A\QP.,'GF@#L[;
M7--N]9O-(@NE>_LE1KB':04##*\XP<@CI6@3@9/2N/LM=U)O$_BRR_LNSDGT
M^WAEMA;Y$ER65R%=SQGY0!Z9/6J&G>.=0?Q9H6BW9T^9]2BF-PEJC V4L:;S
M&7WLKD$%3C&",]\4 =?I.N:;KD=Q)IMTMPEO,8)2H(VN "1R.>".1Q2ZKK6G
MZ*EL^H7'DK<W"VT)V,VZ1ONKP#C..IXKF/AZH%YXP;>Q)U^X!4]!\J<C_/:K
M?CK7KSP_::7<VT%I-'/J,-M(MPA8KN/WEP1@C% '5U%<W,%G;2W-S*D,$2EY
M)';"JHY))["N.G\1>(I_'VH>'+!=+CB@L5NHYYXY&89.,$!AG]/7GI7)^+?$
M>H>*?@,=<;[/;"X"K<PHC$LPG"?*V[Y1E<X(;@XH ]-T[Q)I6JW\]A:W+?;(
M$$CP30O$X0]& =02/<9'2M6N/NM:OXO&%CX<C>P.I7%J]S/>BV("0J<*JIO)
M))SU; ]#6-J'Q!U;3]'\4)+;V UC0)%W+AC%/$^-CA=V5X(R-QQZT >DT5Y]
MJOB7QCI>G65^]MHCI?7]O!;P+YNX)+V9LX# \9 ([X[5-#K_ (J?QE?>&-VC
MM.EFE[%=>1*$12VTJ4WY8YQSN7N>>E '=T5PMOXNUJZ\(6.J&VT^VE-V]OJ%
MQ+)B&V5)&1I I8%LE<!<]2.M8.H^,-8U;P7XQC@O8H;C2&"I>16[(9X67(PK
M'Y&/][D8/ Z&@#T?4]=T_1[G3[>]F:.2_G%O;X1F#2$< D#C\:T:XK4-6UG1
M_P#A%(FEL)X;^[CM9B+=E8 H6!7+D#A<=_PJQ#K>L:[<:Y_8SVL$.E7!M(_.
MC,AN)D4,X;##:OS!>.<Y.>U '6T5YQ#X\UC6+#PE>:3!8PIK4DL,L=RKL8Y$
M#9(((RN5/&,GU'6MKPEKVJ7_ (@\1Z)JSVTTVDRP[)[>(QAUE0L 5+'D8QUH
M ZVL6?Q9H]OJCZ8\UP;Y!N-O'9S.^W.-P"H<KGC<.,]ZVJ\SU&]N[+XZYLK(
M7DTGA_8(C*(_^6Q.<D'TH [O3M;L=4N;FVMFG$]L$:6.:VDA90V=IPZC(.T]
M/2M&N/O]6UBU\+^(M;DTVWL-3LD?R1*OFAXHT#C+ C=DL_3@$XYP<X;>*O%5
MO;>#[V6XTV6/7O*B:$6S+Y321AE?=NYY.2,#T'K0!Z917!0^(]>MYO&&GW-S
M9SW.BVT5S#<K:D!P\;.5,8?J-N!\W>L^7Q;XJTSPYX?\47\NFRZ=>&W%W:Q0
MLKQI*!AP^[DY(.W'&<<XS0!W.G>(-/U74]1TZTDD:YTYD6Y5XF3:7!*]0,\
MUJ5YM!JD?AOQ7\2-7F4R);0V<P3/WCY387VR<#\:MW^OZ]H-EH6LW=S%>6FH
MSPPWEL(E46_FCY3$1@D \'<6S[=@#OJ*X2+Q1?:5XAU_2]=N<_9[87>GM#"H
M,T)..G.7#87'0YZ5)?Z[K$>M6/AJ-IWU!]/^VW4]HD/F+\VT!!*0@&[/)#'
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M>"$U"WU.RGU>].FZC,)9;0+'M7IE4.W*@[1W^G-=1%$D,211J%C10JJ.@ X
MI]% '&-\.[==*U+2[?6-1AL+]Y&: %&6,2'+A<KW..3DCG&,FK-]X)&I:CH]
M]=ZO=R2Z6DB1XCC42"0;7W87NH XQCM755E:MK::;=V-C'"UQ?7[.+>$,%!V
M+N8LQZ <>O)'% '+?\*KLAI5MIJ:[K*6UE<BYLT$RXMR&+  ;>>3U;)';&3G
M>M/"<-EXGFUN'4M0#3QQI-;&7,<C(FQ6;C)./?KS5&'QM-=6[QVV@7W]J10/
M/+83$1NJJVWY2?O;CG;C@X/2M/PSK\_B&QEN9]%O]**2E%CO4VLXP"& ].:
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M!)+)&PD41JA&%8X^[G\: +%IXJN-0TSP_>6>GPS'5SDHMR<0)M+%B=G.,8/
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MD-C8WAM[P->%G($GEL8P%PV">I(]@>M+XKNM3D^)_@D6@MFC<7DEN))& ?\
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M5 6(+ I@-\QY&*U-(TJUT32;73+)"MM;($0,<D^I)]2<D_6@"[1110 4444
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M;&V ?RV#(2&;/R9Y89]N@P.*SE^&UJ/#^IZ*VM:DUIJ-P;B<%8<EV(+$'R^
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M&5'%S\BH91)_=SD;<8]\YH ZG7O%%]ILUZ8[:VMK.TM4N!>7[E([AFSB)#P
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M -$3N8AO,."3[' ]>M1^'?!.J:&MO93>*;B[T>U<-;V9MD1@ <HK2 DLHQT
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M(6X')/))))]L '/W6K>*[3Q!X8MCKD3Q:_!(K(;-,6S+&K;T[L>?XB1G/&,
M-_M_Q#8Z)XXLFU;SKW0<2V]\\";G5HS(%*_=R.F<8^M='-X.GN;_ ,-WDNJ
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MR^U*>^OH('M[>>5$'E*V-Q"@8+$ 9)].V30!C_#C4/$'B#0[/Q!JFJQ36]U
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M9-\\T<2$XW.P49_&N'L_'U[?G3KNTT:>XT^]N?)Q';S%XHRQ F+[-A' ) /
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M='Q+IUK?6Q>QTK[?;7T=HR[AM.X!6;!YZ,,CV-3:?X@U>Q\.^%]*BW7%]?V
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M>5I"\F!N.YB2<G- &G1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MJ:C<0W=O&6MKR,@)+C+,A8 [3GH./2@#IZ*** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \=AED\/
M^(/B7JUF]U+<Z>D#PJ]P[J2T3<N"?F SD9S@#C%;][-?:#<>$+ZPU.[O4U.Z
MCM;Q)YS(DZR(6\P G"D8)^7 QQTKJE\*Z0NMWNK"V;[3>QB.Y4R,8Y0%VY*9
MVD[21TZ$^IINF^%-)TI[1K>*9A9AEM%EG>18 W!"!B<<<9Z@<9Q0!2^(MNL_
MP^US<\J&.SED!CD9,D*>#@C(]CP:XRYTJ,^,?A[9K=7J++8W+-(+ES(,PJ2
MY)*CMQC';%>IW]C;:GI]Q87D?F6UQ&T4J9(W*1@C(YK%L_ ^@V,]A/%;3FXL
M%9;>5KN4L@*A3_%S\H ^@ H \XM?%.K6OAJ#3VOY"C^))=,-Y<SL&6%>0K2]
M1D\;AR #BN^\*6.K:9J>IVFH:E#<6[>7-;VBRR3-; Y!!D?D@D9 /H<59;P+
MX;?2;W2WT[?9WLQN)XGGD;=*>2X);*GW&*N>'_#>E^&+%K32[<Q1LV]V9R[N
M>F2QY- ')>(Y3:?&3PK<7K!;"2UFAMV8?*MP<YY[$C:!6QXUU>_TA]"%I]D9
M+_5H+)UN("^S=N.]<,.1M&*WM5TBPUS3WL=3M4N;9R"4?U'(((Y!]Q6='X.T
M=;FUGECNKE[.026PNKR:986 P"JLQ&1C@XR/6@#E%CO+GQ9XNF?5-5,>BRV]
MS;6L,Y".WD!RA&"2I/!7W]:S9=0OX/ &A^,;'4+J75I[B SQO<LT=SO?8T7E
MD[1UXP 1MKTBP\/Z;IFHWU_:0R)<WS!KEFGD<2$=#M9B!@<<#IQ5>T\(Z'8S
MK+;V10).;A(C-(T22G^-8RVQ3R>0.YH \\U*]N%T;XC0+>W:_P!F7"RVC+<R
M!H2R9PISTSGCISTZ5?/VS5?'FEZ3<ZK?BTO/#JW$ZP7#1[I-P^88Y4\ \8SC
M!XR#U>H> O#.JWUY>WNEK+/> "X/G2 /@;0=H8 $#N!GWK&N/!KW'Q#T^]2S
MEAT:STLV2-%=-$RMN)&"C!MN#C^G>@"]\.+N^N?#EQ!?W+73V-_/9Q3N<M)'
M&VU23W/;/M7,^.+RZDE\5SZ=>W;R:;9Q;F%R88[-L!\($.7=N"=V !QGM7IE
MA86NEV,-E90K#;0KM1%SP/J>3]361J/@CPYJVH75_?:7'-<W47DSN7<!UQM&
M0#C('1L9'8T <<MF^N>.VBO]1OC:W7AJ.ZDACN71%=GVD@ \#Y0<#OUS53P_
MK-UJVE^ =+U6[FDM-2@N6N&9R#</%Q&C..<=\9Y(&<UZ!:^#]!LI1+;6'E2>
M1]FW)*X)CZE3\W(SD_4YZTR7P5X<GT:'2)=+B:P@?S(8BS?NF]5.<KU/0T 8
M?P[M(;'4O%UK \C11ZN0IDD+D#RTXW'DXZ<^E7O%VY/$'A-TEF3S-2,3JLK!
M'4PR'!7.#R!R16UI'AW1]!,YTK3X+4SMNE,8Y<^YI^HZ)IVJSVLU[;^;):OY
MD#;V7RV]1@CF@#SC0='@,?CV#3Y+?3KIM1>VMYR-H3<J87CD DXXYYK>\#7A
M76=7TR]THZ9JT*0M<0PR^9;.OS!7C_NY[CV]<UT$_A/0;FZO;J;2X'GO5"W+
MD',@&.O_ 'ROY"K6FZ-IVD"46%JD)E(,C9+,^!@98Y)P.!Z4 </XZL+?4_B9
MX&L[K?Y$HO@X21D) B4XRI!P<8/J*Y/5Q>:?HVMV<,UPUAIOB&WCL9FD+-&K
M$&1 _7:"0.O>O8]4T/3-;2)=2LHKCR6WQ,PPT;>JL.0?I1-H>E7&CMI$MA;M
MI[#:;<H-F,YZ?7G/K0!Y[<R&7XA>,[2VU-++?I,:K-N^6&5N-QQT/(R>O>JE
MQ--;Z#XNTS4=-.EZU#I(N,V%PWV>5$#A)$((*G<2"#UVCT->AQ^$/#L2R*FC
M60$D(@?]T#NC'\)]O7U[TMOX3T&UL[BTBTNW$%P )D8;O, & #G.0!VZ4 <#
M:6$>IZO\/XKJ6Z>*YT)FG07,BK)MBBQD ^I.?7OFLR'5[C3O#VE:?/>BWT<>
M(+JREGN09$6-"QB1CN!V[NN3_#SQD'U6/PSHD4UO+'I=JLELGEP.(QF-?13V
M'L*;_P (MH/]FSZ=_9-I]CN&WRP>4-KM_>(]?>@#BFT6=-.NK'0]=L+MVOH;
MB&TE4_8\[79H!AF(!"[]O08&, \0VYOM7\/1P:996EIJ5IJDJW>CWLF^WG=4
M&]$89XPRL >,_2NZ7PKH*Z1'I2Z3:"QB?S$A$8PK_P![UW<]>M$WA70;C3X[
M"72K5[:)BZ(4^ZQX+ ]=Q]>M %7P1>VU]X9C:VM);01SSQR6\L@<Q2"1MZAA
MP5#$@>V*\V\>7<%[/XSFLY9'N--A@222\?\ X]V)X%JHP5SCYF)Z]CG->R6=
ME:Z=:1VME;Q6]O&,)%$H55^@%9U]X3\/ZE>2WE[H]G/<RQF)Y7B!9E(QC/T.
M,]: . 6RM=>^*-E#J*_:K>7PLL\D;.=CR&7!) .#]/4#N!65X3U>:[T#X?V6
MLR[])NFNUE>9_EFDC9UBC?U7'0'@D#TKU6+PMH,$ZSPZ19QRK%Y"NL0!$>,;
M<^F.U'_"*Z!_9?\ 9?\ 8]E]@W^9]F,*^7N]=O3- ')?#B&VM?$_C:WM%1($
MU% B(> -IX'M5GQOI][?ZQ:OIXTW49;:U=Y-&U$?),C$#>AZ!Q@KD] >V>>M
MT_1M,TGS/[/T^VM3(07,,03=@8&<>PJ/4O#VCZS(DFI:9:7<B+M5IH@Q YX!
M/;DT >9Z?;Z;XA\7>$HC!-)I+^'G,=O<L2Q 8##X^]T'7@XSBJWAV\ANO _A
MC2KAQ<32:E<1VJ7,FVW98R^!+D$LH!&U.YVC(Q7JDGAS19;Z.]?2[0W42"..
M;RAN50,  ]ACM5<>#_#8LOL0T/3_ ++YOG>3Y"[=^,;L8ZX[T >-SW._X->)
M+7[1'*MMKQCA6,_*L?FQXVC)PN2<<FO2XXHT^-,LBCYY-!^;YLYQ.,<=JWY?
M#&A31212:/8M'+/]H=# N&E_OD8Y/O3H_#NC1:FFIQZ7:+?(H1;@1#> %V@9
MZXQQ0!S?Q9BC?X>WC.2'2>W*,&*D$S(#C'L36!J,5QX?\8^*8/#D0CE;P\MR
MD$.>9@[#>1W?'.>I]Z]/NK*UOHQ'=VT-Q&#D++&'&?H:;'IUC%<BYCLK=)PN
MWS5B4-CIC.,XH \RU"TTPZ1X-U3PS'$M_=7=O#YD?WIX67]\)L<N,*2V[)&#
M6Q\-+73K0:[!%'9I?1ZM=1L(PGF",.,#@ [>G8#VKL+31M+L+F6XL].M;>>4
MDO)%"JLQ/7) ]A4L&G65K=W%W!:0Q7%R09I40!I,=-Q[T <#\0=/M-0\=^";
M:[B$D-Q+<QS(21O41@@'';D_F:YW[+HB^(?$7AG6]1CTBW@BCBT\7"(0+4+P
M8I),D-N)/!R3_N\>P3Z?974\<]Q9V\LT?W))(E9E[\$CBF7FDZ=J$T,UY86U
MQ+ =T3RQ*Q0\]"1QU- 'FUG'HVG_ !-T^6YBAP?#<,ZR7D2+/),)>'(Q_K3C
MGOFN;T.]T^+7/ EY87%G;Q33W09!*&N0A!_X^).-Q+9XP /4U[E)96LMS'<R
M6T+W$8PDK1@LOT/45"FCZ9'MV:=:+M?S%VP*,-_>''7WH \9N8+-?!_Q#1EC
M6./7QY>.J?O(Q\O<'&>E=UIEOI^G_%:X@T]8H8Y]$CE=(SCS'\YOF([MCN>:
MZC^P-&V,G]DV&UB"1]F3!(Z'I[G\ZEBTG38+A+B'3[2.=!M61(5#*,8P"!GI
MQ]* .7^(\]HMCHUM=*A-QJD(B>:0K"C@,0TF"-RC'W<C)Q7EU])"? 'BJVDN
M()#'XEW1; $ C9T^9%S\JGJ,?G7O]S:V]Y#Y-U;Q3Q9SLE0,,_0TW[#:;Y'^
MRP;Y""[>6,L0,#/K@<4 ><V>DZ3+\5=>T5+>!=.O-%C\VWC4*CMOQNP.IP>O
M6G^#;:\EO4\*7\9,'A>??YK(,7 /-L?P4L3[JOO7=:G83R:=.NDO;6>H%<0W
M#P!PA]Q],BF:'IDVG6CM>W"W.H7+B6ZG5=JN^T*-JYX4!0 /;/4F@#,^(AU$
M> -8.E+*UWY(P(OOE=PWXQSG9NZ<^E<HU]X>U*QO+_P3@ZVVB/$J6F46! ,C
M<!P) 3@=_P .:]2J*"UM[4.+>"*$.Q=A&@7<QZDXZF@#S"?[#>:=X!N_#(@6
M]-["K^3CS/LXC/GJ_J!@ Y[X[D5A3Z5H+>#?&,*PP)J]OK$XLD0@SQOO'E+&
M <C)XPOOUQ7M<=K! \LL%O"DLAR[*H4N?<@<U@^&_#DFE2ZA-?I9S3W%_->0
MRQIEHO,/*@D9XP.1U]* .'OEO;;XC@VP3^VF\(N25P&>Y!X)]6R!U]!47@V;
MPWJP\.3PZK?R:W8H8WM$CBC:([/WIDQ&"4]V)R2.<DUZ[]GA\WS?)C\S^_M&
M?SIJ6EM'-+*EO$LLO^L=4 +_ %/>@#RWPMJ2:'J^GVUU>:;JNE0Z=/-::K;@
M+-;P* S+,JYXQCGN1ZYKTS2M5L=;TV'4=-N%N+28$QR*" <'!X/(Y!I_V&WC
M286\4<#R@AGCC4'.,9/'/;KZ4W3-.@TJQ6UM]Q4,SLS8W.S$LS'  R22> !0
M!YWH6F:/J'QA\9K/:6=P\0LY85=%;:X0%F ]0V,GU^M8?A2XTG5+/3=*U/4=
M4C\266H;Y+!(XXW,^YBS[Q'N*E<EB6Z<'MGV=((8Y"Z1(KMU8* 32B&(2F41
MH)#U?:,G\: /"4M?#TOA'XAPW<=G_:0UF[6T7:IGW97RE0?>P7!''O6[X>TF
MPOOBA=VFLVUM=W,>B6ID2X <^: N]L'JV>IZ\^]=GX0\+W'A]]8>\DMIWO\
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M.X:WO="5;>1H7596$;  9'4[AC/)[9!J2P@A&M_"QC$@%MILHN3L_P!6Q@4
M/QP=V>N.<]Z]?HH \*=0?!FM02QNT8\7&9(/*+;K<NIRJX^YC<>!CK79%M,C
M^(GB.Y98S&VCQ(9#&2K$;]RJ<<_+LR![5Z'10!Y#IVHK:Z%X"22VN85CMY(I
M;Z*T>26V<(%,87:=I;IDJ>.G7-<]:%T\'>';2YM+Q6M?%:3S+/;.,1;G+-R.
M0,\XZ9KW^B@#@O$;Q1?$CPG%:CRBD5Z&=(B4C:5%V$X&.6!^IKF?"UK!OT_P
M]KNCZ[+K=A>^<&:68VFY9"PG!W; ,$GIR<CO7L=% 'EFBR2V?B'3ET22_N-/
MN+R62ZTR_M6+6)*L6ECD(&U3G &2&W<=\=WX<\26?B?3GO+.*YA$<IADBNHO
M+D1@ >1]"#^-;!Y&*K65C!I\!B@5L,Q=V=BS.QZEF/)/_P!84 <A>SS:!\2I
M-5U"*9]*OK!+:&>*)Y?)E5B=A"@E0V<YQ@D5QLFB7=AJNAW1LKUK*;Q)-J,<
M"VKO]F@; 5F !V9/S8/3/0'->U44 (J*B[44*H[ 8%>:))<PZU\0I;;1Y[M[
MF.(VT-S:N(KHI"5902,,,\8SSVZUZ910!XG%9:CJ/B:W-M:ZR#=^'9K!)[JR
M:%(9B,!0H4"-%X[?3-=+X1U.6\L=&TJ_\)7D.HZ3$8)KJXM0(H%5=K&-^K%U
M &%'?T )]'HH \O\+1W.F:[IL6E)JK:%Y4TES:ZG8N&TX[<@12,H)RW&T;N,
MU@K%=OX*\*6O]F:D)[;Q.+J:-K&8&.$2R,7/R\#$B_KZ''MU% 'D=]'<-JWQ
M2=;"_*7UC%%:L+*4B=UA:,A/EY^=@..W/09IXCN6'PN_T"__ -"C"76;.7]R
M?*6/Y_E^7Y@>O;GIS7K-% 'C=YI6JZC+\08K'3[PS37MM<VXDADB6Y6)@657
MP,D[<#!Y[>M7X(=.UC3=1U!_!.N1JMD;:X2]DE-Q+N9?DA#,20/F;.!R!CJ<
M>JT4 <-X&35+?5+RT$]_=Z#';Q_9;C4[=HKE7R<QY8*751W([X'>IO%L-_9>
M*O#OB"&UGN[&R,T-U%;HSR1B10!($'+8Q@XR<'I79T4 >3:]HEY=V'CG5;2P
MOL:W%!!9VP@??*47#.R8RN3TW8Z'U%>C^'RW_".Z<K1RQNEM&C)+&496"@$$
M$ ]16E10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110!2FUC3;>]6RFO[>.Y=E58GD 8L>@ ]3Z
M=:@?Q)HB6,]ZVJV@MK=_+FE\T;8F]&/8_6N%U/\ M"U\23R:-]NN))M2C:XT
M>^M7>)P&4?:(9,#8 %!SDJ#QZ"L#7+:]ATGXAZ*-.OY;[4+];FV2&U=Q)&S+
M@A@,=B,>M 'KU]K>EZ;&DE[J%O;HZ[U,D@&5[M].1S6%J'BP:7XVAL+V[LX-
M(;2WO#/(=I#"1%'S$XQ@G\ZYB.[N=$\1ZF^MZ)JFHZ5K5E;16WDVAE\L)&0\
M+)U7)9C@U?BL"GQ%T&9]$N(+2UT1XE"PN\=L^X%4+@%2P4$=3S^% '>V=Y;:
MA:17=G<1W%O*-T<L3!E8>Q%5;G7](L[O[+<ZE:PSY52CR@$%ON@^A/8=ZYSX
M76US9>#5MKNWN;>5;J=A%<0O$55I&*X# <$<\>M8=DU_I[Z[H&M^&=0UF6[U
M%[JVN%M\VTX8@IO?I'MVC.>@'&>A /0+[7-*TQF6^U"WMR@#/YD@&P$X!;T!
M/3-,N_$>B6-PMO=:M9PS,@D6-YE#%3P"!GH<\>M<=IT=SI.I>,++7=+O+Z'4
M;EKBWEAM7E6XB9-HB+("%V@!?FQUS[UDZ/H6J:3XE\!Q:A:W<[6&GW"74ZV[
MR)"S [$+J"./N]>U '7^*/'.G:'X+G\0V4T%\NW%L(Y 5E<L%ZCL"<GZ&J^E
M:IJC^);2WF\3:-=V4Z-)';K%LNI %(X&<;0P)S[&N#NM.U-_@[XDTM=)U,W=
MQJSO;6PLI=S1^=&X(&WA<!CZ?C7;:U)//X[\'W,%G?-;1QW/FRBREQ$70*F\
M[?EYSP>G4XH ?X[\:IH6CS-I5_9G4(IXXFB==_WG *@@@!@"3CDX'3O71ZAX
MBTC2Y'COM0AA9 IDW'_5ANA<C[H.."<9KRF>SUE?AA/X6N=%U.;6H;\/+,EJ
MSQW&ZY$GFB0#!X//.1CG@<:DUG<6GBOQ%;:QX=UO4[#6F$D$UD\FQE,84Q2A
M7"KCH"W\L8 .[OO%WA_39Y(+O5[6.:./S6CW[F">N!S[_3)Z"JM_XWTBRO='
MMDD>Y&J%C#)!&SKL"%BP*@[N@&!S\V>U8ECI<MI\0!<S:9*MG%X=CLMR1/(B
MR*Y+1JQR3\N.>_UKG]'TS5=+L/AU//I%^QTMKN.[BC@)>,R(0N1Z$GKT'K0!
MWMKJZ1:WK\EUK]I+8V<<3M;>4$-D"IR7?ONP3@],?G=L]=T_6'N;73;U?M<2
M!F1XF#1AA\K%&P2*XC5[351J?CR>UT62\-[;6:6T<\!:.;8&$G7@E0V0">2.
M,T>&;74++X@ZAJUQI^LR6=SID:BZNXP9&93DY53\I.,!0!],<T =9X(U2[UO
MP7I>I7SA[JXAWR,%"@G)["J]KXAMK.?7KS4?$5K-86LR*$$.S[)\N=K-_&3D
M?YXH^'5O<V7@/2K.\MIK:YMXS')%,A4@Y/YCGK7)>(=-U*_L?B'#;Z7?,]^]
MN;3,)Q,%2-&V_0J?PYH [RR\5:'J%Z;.TU".:?R?/5%5OGC_ +R'&'';Y<\\
M5S-EXAO=<O\ 4+Z#6WTVUTV^>-X)[+,,ENFW<69@"KG)(^88].].C2X'BOPI
M=#2[Y8K?3)89Y/LQ C9A&%5OQ1OIGWK/.BZSJ/A7Q+:V^GRPW-QK#:A:QW0"
M+<1B1'"GGC=L(PV.OI0!V]KXDTJ\NI+6.X=+A(_-,4T$D3,G]Y0Z@LON,BLT
M_$;PF(6E_MA#&L)G+K%(0$#!"<A?[Q QUY'K5.XMKK7/%WA_6UTVZM8M+BN&
MG\Y KLSH%$2C/S<Y.>G P>:P7\/:JWP.?08](F352OE_9_D!)\[>6R#C&.<Y
MH [%_''AU+JXM3J!-Q GF-$L$A9DQG<@"_.N!U7(JP?%>AC2;+5!?H]I>N([
M5T1F:9R2 JJ!N)R#QC/%9"VEX/B7'JXT^Y%@-$-MYC8)$GF!]I&<YP.OKWKF
M-/TGQ#8>"/#.GRZ-,/LU_(;WREC:XA0NS*T1)(&=PRR_,!G!% '7ZCX\TBST
MV"]MC/>)+?)9,(8')BD+A6#KC*L,_=(W$X %2C5HI_&5I!'K3QJ]B\G]ER6C
M*S_,/WI9@"N.F#7G]KX<UNW\-ZU ^B7F]?$ZZDD3.)&E@WH>#NRS  YYY]<U
MT&LZ-JNM>/8+Z&TN[.UET2:S:Y.S=!*Y)&0&/3/;(H Z>'QAH4]U;P)?'-S(
M8K>5H9%BF<<;4D*[&/H 3GM4,_CKPW;/=)+J)S:3"&XVP2,(6/3>0I"CG[QX
M]^*Y5]#UG5_ VA>&9M,ELKVPGMUGGW+Y2)"?]8C@\E@O  R"><#FJ^IZ%K-U
MX>\>6L>DS^=JMX)+,?*!*N$&>O'W3UQUH ]4!! (.0>]%9-E>7HNK*S;2Y5M
MC9AY+IG4>7(,#RRO7.,G(XXK6H **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M \6T(_X *LT4 -5%084 #T%.HHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MWH TJ*** "BBB@ HHHH ***Q]"\2V'B)[Y;$7"FRF\B83P-$P;&?NM@C\0*
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MW::CHZVL4:J\%S%<>;'*#VZ*0P[C'XT :]%85[XA>R\7:5H361*ZA',ZW!D
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MVQM862Y(Q'G.".AZ#G_9'I6MIFFVND:?%8V:%88\XW,69B226)/)))))/<T
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M"Q)(R"..O.2/P]*KRZCK-\_Q'TVZUB<+IEO$UK);JL3)F)Y"!P>N ">N!U%
M'I:7,$EO'<)-&T,H4QR!@58-C;@]\Y&/K4M>+207,7@?X<N-8U&-+K4;2)D1
MD"J&7C V]BHQG.,D\FNEN-4UG7-;UG2-(NK^/^R$C@66%X59Y67.^3>/F'&
M  .&]1@ ]$HKS2[U7Q:?%'A'2KC48;&;4;>Y6]C@C650\:\LI]3U Z*>Q[[7
M@K5;^75_$>A7]W)>G2;E%BNI0HD=)%W -M &1@\@"@#L:*Y[QMKTOAOPK=:C
M;A3.&CBC+C*JSN%W$=P,Y_"LR_\ [5\(M>ZS)K3W^E)922M:W9!E>X4%AY9
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MUEM&TJS;4=2B427$:R"-+=#T+N>A/90"3UQBM^O-?AP7C\<>.H+\D:FU\DC
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M$UKJDMQ9I:O8ZC+8[$D+@[ O.<#N3VKHZ\^^$T*6^F^)8(]VR/Q!=HNYBQP
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M@"*XMX;NUEMKB-9()D,<B,,AE(P0?8BN4M_AEX:MX;2-8;IOLDPEA9[J0LF
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MV[$<=\;68G)SDKW!KK:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MPF0/N)YS@Y& !VSUJ]=^'/$FJ^&]1L=5U>SFN[JV:TC,,+1Q(K#YG9<G<Y_
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M8:O"8A;PQ$&W*1J0WF$_-GOP.IJ9O!>MQ:9XFTRWU2Q-EK$UQ,BR6[;XS/\
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ML>8LZ_=8 # 4# VC''OS0!GW6IZUH_BVZT ZG)-;7FF27=E<S(ADMY4)W*<
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MU;NC:)9Z%9?9K3S6W-NDEGD,DDC>K,>2>WT% '#VQ%C^T!>_;/E-_I*K8L>
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MJN"VXD\_*!SDFNRH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MZH5&%R?DX8')SGVQ@]#;Z]XAM?&FE6.I?8'T_689G@C@5M]NT:AL%C]_(/7
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M9G6*2.(%AN?"M&WRJN5R23[FO5ZIZEI.G:S;?9M3L;>\@SD)/&' /J,]#[T
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MCTZ/Q%X;U2^\7:'KVE7-G&]@LL4J72L04< $J%ZD<\$@>]11^&]9$WBMY)+
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %9T.@:/;ZH^IPZ79QW[DEKE85$C9
MZY;&>:T:* "BBB@!" 000"#U!ID%O#:Q"*WACBC'1(U"@?@*DHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MECN84F56Z@,H(!]^:K:7JLNHW&H12:;=V:VEP84>X7 N /XT]5]Z -*BBB@
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M?[/@^U7*%)Y0OS2J>S'N..]3Z;I.GZ/;&VTVSAM("Q;RX5VKD]3@4 7****
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M5] ,5YS+XAO[7Q9]AUB_O]+N)=15+3=$K65U;EQA%<*2)"H.<D')]#@-CO\
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MD<%"B\>4,8 9N@'RBM2'1K;5?%/Q%AO9+N2"W2!H8S<R;59HF;=C/)!&1V%
M'K5<QX?\1WNJ^+/$FCW5O!&FDM L;1$DOYBLW)/L!V]:XG0-9FU6W^'VF:K.
M\EK>VD[S!V.VY>,;45\GYAC)P>IQ6QX"M+:P^(GCVVM$6.!);/8B]%S&Y('H
M 2>.U 'HM87C'6+SP_X4O]6L88)IK6/S-DQ.TCOTK*\:M:7.L>'],D#7%W-/
M))!9.X6WFVH<F;(.57.0 #D_G7&6\S)\.OB%8M-$T=M<W"01Q'Y$38N0@))"
M@G]: /0-2\07UEXC\-V"0V[6NJM(LK'=O0K$7^7MU'?-=+7#>(65?%W@$LP
M,\XR3W-N0*[2XMXKJW>"9=T4@VLN2,C\* ):*\"@T>$?!2T\3P3W?]OVLH-K
M<^>V\'S]@C49QMP3QW)KIM'\.Z?KGQ0\7P:K'*P@%C-' )V4!S'N+  ]FR/8
M,1WH ]%TMM8-QJ']J"S$(N"+,6Y8MY7;?G^+Z5H*Z,6"LI*G# 'H:\8DN;S2
M-"^)TNDEXIH;] AC)S&A*AV'H0I8Y]JWM9M+#3M4\#ZEX8C1'N[N.!C NW[1
M:LA+,^/O8 SD\@F@#TK<N<;ADG&,TM>6_#_P[IM]KOB6]N(6>?3_ !#/]E)D
M;$6T8X&>X.#Z[5]!74_$"XL(/"S1ZC)<I%<7$,*B"01EW+C:K,00J$CYCCIG
MKTH Z>.2.5-\;JZ^JG(H66-W95=69/O ')'UKR>QW6/C?Q=:0W^G64TNBJ_^
MB_)#!, P!QGDJ.2< X["HM#TJ+7AX'9+:TC?35WWDKO$WVD;."H!W,6(W<@$
M9R>: /73(@;:74-P,9Y_SP:3S8_-\KS$\S&=F><?2O+_  SX:TC4?B1XO>ZM
M!(UA>VDUM\[#RW"%LC!]16-H:Z3XC\)QW6IZ^;+5K2\,EP(X46[6XWG #?>;
M=G 'X=N #VEIHTD5&D17;[JE@"?I2O)'']]U7@MR<<#J:\@C32_$6J^+M.U_
M5[>PODOY!^_B19%MUQY3QNW(  SQZD]^;-GHVG7_ ,7K.&\B:\B;PQ',YNEP
MT[^:%W2+T)(QD$8R!Z"@#U0SPC9F6,>9]SYA\WT]:626.%=TLBHO3+' KQJ7
M0=+3X2^)9A:HTUC=WBVDC'<UL$G.T1D_<'';&<\UJWVHVLWCF.TUO4K:UM9M
M(A>QDNXTDBDSDR<OP&/'/< 4 >HF1!MRZ_-]WGK]*IW>LZ=8Z;/J-Q>P+:0;
MO,E\P$ KU'U[8ZYKR]M#T6%/!5I!>R:G:KJDUO'=2,%9X]CY0,,;H]PQZ'D<
M@\LFL+.TU+XJ:=;6L,5E#ID4T5NB )&YMF)95Z Y[B@#U"VUS3Y]%@U5[F&"
MUEB20M-(JA-P!PQS@'FK\<L<T8DB=70]&4Y!_&O)M/LX;WPQX*.AZAID6M6M
MGYL=I<(&AN6\J,2!]O(<!@0>N"?<UV/P^OX+WP[,D-@+"2VO;B&X@1@T:S;R
MS^61U3+<>G3M0!U5%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 <GJGAG5)/'5OXETN]M8F^PFQG
MCN(V;Y-^_*8/7/'/ZUCIX'UY?"GB'13>:;_Q-[J6X\P+)^[\PY88[XP,?C76
MKXBM&\5MX<\JY%X+0W>]H\1E P7AL\G)]/QK7H \]3P-KVFWUGJVB:M:6NI"
MTCM+Z.6-I(+A8QM1L9R#@#IC^>>UTNRFL;%8KFZ:ZN&)>69AMW,>N .@[ =@
M*ND@#). *:CI+&LD;!D8!E8'((/>@#S6&2^D^,VO?V5<67G#3H%9;@,P/T*G
MJ/3OGM5V3X?7U@FARZ'JEO#>:?-<33O=6V])WFQO;:",$8P,'IQGU[:+3;&&
MX-Q%96\<Y))D6)0W/7G&:LT >:W7PTU6\T+Q#H\FO0&#5[X7AD:TRZME&.<,
M!U0# [9ZYXZ+Q1X;U'7]'TI(KZVBU+3KV&^25H3Y3R(",%<Y .[U[5U%% '*
M2>$KNX\:PZ_<WUO-$NG?V?+;FW(\Q2=S-G=@9)/&.GYUGZ'X'UG0Y#I</B-S
MX:5BT5IY(\\ G)C\S^[UY'.#QBN[H) !)X H X[5O"6I:ZILM2OK*:P%X;F*
M3[.WVF!0^X(C[L=/EW8X'&#V[&L#4O%UCIVH:):^3/<+K$@2VN(=IBY&02<^
MG/ -;] '.6O@W3[;Q9J>NY+F^B"-;MRBL1AVQT)8!1T['UJKI?@Q]"\$7'A[
M3+U!)-Y@-S<1&3A^.@8<A-JCG^$?2NMHH X>7P+J,GACP_IJ:W'%>Z)-')!=
M):_*RHI4!D+=<'KG\*U+3PO/9^)[W71J0DN;JU2V826XX"=&X8<YY/0'L!72
M44 8?A'P[_PBGAVWT9+LW,-N6\MVCVMAF+$'DYY)J*/PR\?C>;Q,+X%Y;46C
M6_D\; VX<YZY[_I70U3NK\1VE]):QF\N+13FWB8;F?;N"<]"01^8H Y=_ 4]
MOXAO-0TCQ#>Z;9Z@YDO;*)%97<XRR%ON$XY(&?0U=O/"4TXO[:WU4V^FWL"6
M[69MU=8E5-GR$G@D8Z@C@<5MZ5>2ZAI=M=SV<UE+-&':WF^_&3V-7* /+9+6
MWL?BWI&G:7?);"ST(6D3-MD *N<1L"<EMN#U!XSR*Z&]^'6F7_AV73)KBX%U
M)=F_;4$(67[2?^6@QP/3'88^M=C10!R:^!+>\T:\T_7]2N]9>ZC$1GGPC1HI
MRNP+P"" <]20,YZ4[0_!CZ;C^T]<O]8\N)H8%NB L2D '&.2Q QN)S@G'4YZ
MJL+Q!XD&@7FCP/923+J5ZEF)%< 1LW0D=3WH 9X2\,-X4TTZ<FJ7-Y:(2+>.
M94'DIDG&5 +')/)]NE&L^%QJNOZ;K,.I7%E=62O'F)$8/&^-R_,#@\=1705!
M)=V\5W!:O*%GG#&-.[!<;C^&1^= '.CP5';76K-IVI7%E:ZLS/=V\:*WSL,,
M\9(^0GOU]L5T&G:?:Z5IUO8640BMK>,1QH.P%5].O[V[O=0ANM+ELX[:4)!*
M\BL+A<?>&.@]C6C0!R[^#%'B;5-:M]6O+<ZG$B7,"*A5F1-BMDJ3P">.A/7T
MJFWPYM&\&6_A8ZI>_88)1(C[8_,X;<!G;C&3GI7:44 <;??#Z*?7Y-9T_6]2
MTNZN4"7GV-E5;C QN((P&]_Z\UUEI:PV-I#:VZ!(84"(H[ 4AO;87ZV/FK]J
M:(S"/OL! S^9 J>@#F9O!L=XI@O=5O+JQ-Z;W[+*D17=O+A=VS=M#'.,^V<<
M57U'P!;7]YK$JZMJ5M;ZNF+NU@D4([;=NX$J2.,9 .#WXXKKJ* .5C\#6UO!
MH:VVIW\4^BQO':SYC8[&5596!7!&% Z5E^)DMM.T;7=$AAU&]UC5["1_M'V<
MMY[E3&J[E 4$<?+@ #GU-=]10!RFK^!;/7(=*FENKJQU33HU2*]L9-D@&,%<
MD'*_4?S--U#X>Z3JFA)IUY<7LEQ'/]I743-_I F_O[L8Z #&,  8Z"KGBGQ,
M_AIM((LA<QZAJ$5@6\[88R^<-C:<\ ^G:NAH Y?_ (0>SD\-ZAH]WJ&I7OV]
M-D]W<W'F2D Y7!/  ). !CFMO2M/;3-/CM6O+F\9!S/<N&=OK@ ?D*NT4 8,
M/A6"W\17NNQZA>K>WD(AD/[LJ%'W<#9V]\^^:SV^'FFMX8M_#QO]1^PV\XGC
M&^/<&#%L9V=-Q)_^M76.6$;%%#. =H)P"?KVK!\'^)6\5:3/>O9BT:&ZDMC&
M)?,!*'&<X'7Z4 9]Y\/+"\OM4G?5-5CBU2,+>6\4X1)6"[=QPN0<=AP>X(XI
MP^'NGJ=&D74=46XTI#'%.+GYWC*A2C'' P /EQCD]>:W7N]3'B&.T735;2S;
M&1K[S@"LN[&S9UZ<YK1H YH>"-+_ +7U2]:2Y>#4UQ=6)DQ [;=I8J.22/4G
MGGK@BMH7P\TWP_+NM=0U21(U86L-Q<"2.U+#[T:D8##G!(/4UUU56U&U758]
M,,H^UR0/<",'D(K*I)_%Q^OI0!G>&?#%MX5L'L;*[NYK9G,BI<%#L8DEB"J@
M\D]\^V*7Q%X:M_$L5I'<WEW EK.MS&+<H/WB_=8EE/3GCISSFMJB@#G1X0M3
MXG_X2":_O9[LVILV23R_+>$G)0J$'&>?7\.*H:-\,]!T._2YM)+\I$QD@M9;
MDO# Y_B5#QD9."<X/-=C1F@##T;PM9:*FI1Q2W%Q%J5Q)<W,=R5=6=P W&T<
M$#I6;HGPWT'0=1%W:F]D2-S)!;3W+/# V>J)TR,\$YQ]:V4\2:3)IE_J27D;
M6=BSI-,""H*#+8/?KCZU?M;E+RSANH\B.:-9%W=<$9&: ,&7P/I4EUJ$L<EY
M!#J1S?6L,Y6*X/<D=5)'!VE<]ZM:AX7L=1GTZ1Y;F$::P>T2WDV+&P& < <\
M<8.1C([FMJB@!DD230-#*H='4JP8?>!&#FN)3X4>'TM;>V^TZN8K6<3VJF_?
M%L<YQ&!PH)[]?>NH:75_^$A2);:V_LC[.6><R'S?-SPH7IC'?_)T<B@#G(O!
M6FPQZLB7%[MU9=MV&GSO&-O&1\OR_+QV^@JM<_#S1+G3],M=]["^F#;9W,%P
M4FB7^Z'';ZUUF<5S?B/Q#>:+K&@VD-M!)!J5X+9Y'<[DX).% QT'7/X4 3Z%
MX1TKPY=7=SIXN1+=MNE\VY>0$\<X)QGCJ>?>K.IZ#;:G?VE\\]W!<VBR)&]O
M,4^5\;@1T(^4=?2M/(]:&=40NS!5 R6)P * .>N?!&B76C6NF-#,D=K-]HAF
MCG99EER27\P')8DG)/7-8.O>"-,T?PWXAGTBSO9]2U*R:WPLLDS2,4V@D9(S
MW+'U//-:&D>)M7UC4O%5A!;V GTMHTL\NVQV="P+MZ9QT [UTNGR7G]FVS:H
M+>.]9 )E@8F/?W"D\XH YKP;X;M[?0="GNUOFN[*U15AO)'Q;R; 'VJWX@'G
M X'%37_PZ\-ZCKLFL3V<@N9B#.L<[I'-C^^H.#[COWS74)(D@)C=6 )4E3G!
M'44B2QR,RHZL4.& .=I]#0!DP^&-.@\1S:\IN3?RQB)F-P^T(#D*%SC&?:JZ
M^"]'6>9V6YDBFNC>26TER[0M,7+[MA./O'..G XR,UT-0S7=M;C,UQ%&,[<N
MX'/7'- '/:C\/O#6J:]_;-UI^;L@"39(R++CIO4$!OQZ]\U/J_@O0];U2'4K
MNVD%Y$HC\V&9XBZ?W&VD;E]C6M<7(\MX;:>W%XT1:%9&X)P<$@<E<^E8I\31
MZ+HNE/X@N[)M0O)8K<_8W_=N[MMW+N.=HSDGV/TH :GP^\,IX:;P^=-#Z<S^
M9LDD9F#_ -X,3E3UZ8ZGU-+:^ ?#EGH<ND16+_99G225C/)YCLA!4[P=PP0,
M $ 56LO%-U+\0=1T6X:R73;>P2[BF3(8[F ^9B<8QZ"NK\V,0^=YB>5MW;]P
MVXZYSZ4 9^EZ#8:1-//;"=[B<*))[FX>:1@N=J[G).!D\=.:BUKPMHWB&:VF
MU.S\V:V)\F1)7C90>",J02#Z'BM$7EJ;<W N83 .L@<;1^/2C[;:YB'VF',O
M^K'F#Y_IZT <W-\-O"4\%S =*V0W,PGECBN)8U9QTX5@ .^!Q4E]X0TZ.X36
M;6UNKK6+&$_8O.U*?[P7A22Y&&Z'/7)SFM"P\2Z9J>M7VE6ES'+/9!/,*N""
MS;CM'J0%Y],CWJKXXU74-"\'ZCJFFO MQ:Q^8!/&74C.#T88//O]* &>&[;5
M;N\FUS7=.AL+^6".V2VCE$IC126)+#NS,>!G  [YKI",C!Z5SRWNJ74'AZXA
MO=/@CN41[N.=3OF!0'$7/!SG_/75N-6TZT61KG4+6$1D*YDF5=I/0')X)P?R
MH P/^%:^#_*EB_L2$)),)BH=_E8'(V\_*/88![U=B\&:!!-=S16!22[3R[AE
MFD'F+V!^;H,8'I6J-1L3>+9B]MS=.N]8?-7>R^H7.<>]9*:C/8:QK,^JZQIJ
MZ7!'&\4((62W&,,9"?4]* !O!'AMM'327TF%[&.3S8XG9F\MO523E>G8C]:L
MZ5X7T/1+F6XTS2[:UFE #R1I\Q &!S_G/4U7T;Q?HVM:&-6BOK:*VR0QEF4&
M,;B%W9/RD@9P:EU/Q5HNE:%+K,^HVS629 DCE#!V ^ZN.K''2@"?6/#^D^((
MH8M5L8KI(7\R,2#[K>H(K/E\">%YENE;1;8"[V^>$!3?MZ#@CCV'%/N=2;4+
MC1Y=)UW3HH))B9HV*R&Y0 Y5"#U!';W],'2O=8TS39$COM0M;9W("K-*JDYX
M'4T 9\W@W0+C[!YNGAO[/ 6T_>O^Y&<\?-6Q<RR0V[R10//(H^6)&4%OQ8@?
MK4<^HV-K-'%<7EO%)("4224*6 !)(!/. "?PI-/U.PU:W-QIUY;W<(8H9()
MZAAU&1WH XKX<^"4T3P_:IK.DQ)JMO(Y\PNKJ26)5U ) 8# W8#<5UMKH&DV
M.HSZC;:?;QWLY)EN GSMGU;KCVZ54\4>+-,\)V,<]_,@DFD6.&$N TA+ $CV
M .2>E8<OBR:U^)"64^JV?]@R:0;X28554^9M!\S)R/R'- '46F@Z/82SR6FE
MV<#W VS-% JF4>C8'/XTS3/#>C://)-IVFV]M))G+1IC /4#^Z/88%6(=5TZ
MXTT:E#?6\EB5+"X60&/ XSNZ=:6QU2PU-9&L+R"Y$;;7\J0-M/H<=* (['1-
M*TR>:>PTZUM99CF5X851G.<_,0.?QJ:_T^SU6SDL[^UANK:3[T4R!E/X&I+F
MY@L[=Y[F:.&%/O22,%4=NIJB/$6BM8RWPU:R^R1/LDF,ZA4;^Z3G@^U &?J'
MA'3O[+N$T?3M.L]1^QO;6MP;93Y0(( Z=.3^?>N9L_ TMQ:VEK<^$_#FFR1%
M#)?VCEI1M(YC 0$-QU+'WSTKM1XDT,W<MJ-8L?M$49EDC^T+N1 ,EB,\#%+%
MXCT2;3'U*/5[%K%&VM<"==@/H6SC/M0 ZTT#1[&^DO;32[*"[D)+SQ0*KMGK
MD@9- T#1AJG]J#2K(:AG/VH6Z^;GIG=C--MO$>B7NH?V?:ZM937FW=Y$<ZL^
M,9S@'/3FL7PAJNI7>I>)K;4[O[0FGWWDPRF-8P$V!L<>F>_Y^@!N7?A_1M0O
MH[V\TFQN+N/&R>6W5G7'(PQ&>*23P]HTVHMJ$FDV3WK##7#0*9",8P6QGIQ2
MVNO:3?7 M[74;:68IYBHD@)9/[R_WA[CBDM?$.CWUK<75IJ=K/!;9\Z2.0,L
M>.NXCI0!"GA3P[':RVJ:%IJV\S!I(A:IM<CH2,8)YJ6Y\.:)>64%E<Z1836L
M'^IADMT9(_\ =!&!^%0R>+/#T3PI)K5@K31^:@,Z\IC=NZ\#'.>E1-XV\,+I
M\=^VNV M9',:2><,%AC(]<C(SZ9H T)M%TJX:!I],LY3;J%A+P*WE@= N1P/
MI3TTK3HKB2XCL+5)Y,AY%A4,V>N3C)I+W5;'3X8Y;JY1%D_U>/F+\9^4#D\<
M\53/BOP^+:TN/[9L?)O'\NW;SU_>MG&%YYYX/I0!(?#6A-:1VK:-IYMXMWEQ
M&V3:F[&[ QQG S]*T+>WAM+=+>VACAAC&U(XU"JH] !TK(@\7:#=6=]=VFIP
MW45BNZX^SDR%!C(.!R<^U2>&]?M_$NC0:E;)(B2J&VNA! /3J,'CTR* ->BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** /-M;L=2O/C(D>F:@FGRR>'B#<^1YK*HN!G /RYR1ZX&
M?:LZ'QQK]L'\,7+-/K$6J"P^W0I&K2Q%"^Y5<A!(0 .>/F!YKNM2\,M=>)8?
M$%EJ4UI?Q6IM,%!)$T9;<<J<<YQR#V%4[_X?Z9J.@MITUQ=?:6NOMO\ : <"
M<7&?]8"!@<<  8  ^M '*:\/%O\ PB7BR#47O;?3DM3/9332P?:&4#]Y$_E[
MLKSU&#CC/-:&I7NL>%?#OAO5UUBZGTM&@348I(H?EB=0 P*Q@@*2!ZD?G6Y:
M^"1_8FHV&J:S?ZG/?6[6SW4[#<D9!X0=!USWR>O059@\)QMX1G\/:GJ%SJ,,
MT7E-+,%5E7:  H4 #& 1UYY.: .7@\97EAXSUVQO+^XN].^RR2Z8WE1+NDBX
MEC4JN6(;*@G^Z>O4R2:CXAO-:N/#D-W=37&GV4<EQ/ \,3O-*"<_,N-JX& !
MWY)XKH[GP1H]U::#;/$RQZ+,DUMMQDE1T;CD$X)]2*BU_P $VNM:Q!K%OJ-_
MI>IQ1^2;FRD"F2/.0K @@@'V_I@ Y^/7_%/G:+X>U 1G6'AFFO6M)HU:0(0J
MA6(VJ3NW, ,_+Q@&L_Q)J7C?P_X'U*YNM1%O/;WD?V63]W)(\+N%"R8& 1SR
M,9KJM4^'FEZEIMA;K=W]O>6+F2'4HI_])W,<N6?ON[_IBF:E\/H-5\.OI%UK
M.I2&:59+BZD9'EEVG*C)7"J#T  [^IH AT^?6],^)":5>ZR^H6E[I\EUY;PJ
M@A=9%&$QSMPW0D_4UH?$-9#\/];>.XF@:.TD<-$VTG"G@GTJ5O"TC^)[37GU
MBZ:XMK?[-Y?EQ['0D%L_+G+$9XZ=JUM6TV#6=(O-,N=WD74+0N5." PQD>]
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M R<(1&,K]/2LSQ-H\^L>'M0TVQ:W@EOHFADED0G"LI!/'4\T >?RV^B:E8^
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M$8& 1Q@]?QYK2:6;PIXK\0:)/<7EP-6M@^D--=2-\SMY9B!+<89@<CD*"2:
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M3P7^]MEDAU:VDD0$!E9)"7)'4$ C)]&'K7LUT1<:9.82)!)"VPH<ALKQCUH
M\SU_QU/J_@&PUS2KNXL&?4HXY45=N8C*P +,/[J@G:?4>U>@:5XET76[FXMM
M,U&"ZFM\&18ST!Z$>H]QD5XP^HVG_"D]!TZ1]MS:ZC&L\4B%2I$S%AR.2 02
M!T!&>HKLO$%U#J/CJ^M-+O(&O;GPQ/;V[1RC_6LX*#<.AQR/;F@#M+?Q/HMU
MJ$=C#J$37$H)B&"%EQUV,1M?'^R36G++'!$\LLBQQH"S.YP% ZDGL*\I\+76
M@ZO#HFF75CK#:_ICQAK2:2=4MI$ #/G.U5QG'KP,5UWQ*T[4-5^'^JVFEHSW
M;(K+&G5PKJS*/7(!X[]* -6P\3:-J=R]M:WR-.D7G&-U:-C'_? 8#*^XXIMG
MXIT2_O(+6VU"-Y;@.;?A@LX7[QC8C#X_V2:YB'Q=HOB6&XU'3="N;W4;?3YA
M*);9D*+M),!?')9@!M&>I-<7%JL$MUX#OT>\,5M<,DUM':.L%FWEX$*87+-P
M1R6)QS0!ZT_BO18[^&R:\(EFF^SQ'R7V/(#@H'QM)!ZC/%%SXJT6SOOL=Q>B
M-_,$1D*-Y2R'HC28V!O8G->>VC/8ZUIYT+4FN["\U,/<:#>1[I+<F0EI8SC*
MJI&[T]SFLW3&TN/3+CPCXMTW6I]4%U(RVL+3>7=[I"ZNNT[0,MU..F2: /;:
MQ!XOT(WT%I]O7?/(8H9#&WDR2#.467&PMP1@'.>*NZC;3SZ%=VMMA+B2V>.+
M+?=8J0.?KWKRU-FK?""#PF+:8:_#Y5M]D:,B2&59!B0^B  G=TQQ[4 ;_B/Q
M5%)XYLO#DES>V]@;:62Z:VCE21G'"@,HW8')RO!XYQD'KM.MSH.AK'J.JR72
MVRLTEY=E5.T<Y8].!W-<5?3+!\8]$>:=W6#2WMYIQ&=IE)X#'& 3G.*ZSQE*
M\/@[59$TU=29;=B+1T+K+[$#DCOQZ4 +9^+=$OKMK6*\9)A";@+/"\6^(=77
M>HW+[C-4%^(_A)UMW36(V2>;R5<1OM#YQACM^3GNV!7'66H0Q>-?#6I,^JW4
M L)HI;A[&1(HV(3"*H7"A<-GK@=6.*RK*2.+X)ZO9O%)]K:_=EA\EM[$S!@0
M,9/R@G/M0!ZO;>*M)N_$<^@0RSG4H%+21&VD4*O][<5VX/8YP>U6]*U>TUFV
MDN+,S&..5X6,L#Q'>IPPPX!.#D9]01VKC?&45Y'>:-XM\.M&UWN%C(K' FBF
M(5<\<[7(./KZ5VNEV$>EZ7:V,9)6"-4W'JQ Y)]R<D_6@"W1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% '.7O@K3+[7;C5S-?03W4*PW26]P42X0< ,!STXX(X_&N,U_P -0>&W
M\.6,$7B-])L_.8WNGR-)- S   JOW5P3R!GCW.?5J* //]*\/SZS;ZG92ZGX
MB;0[N#RF&IX68L<9V;EW!2,@Y [8]:W]0\&:7JWAB+0-3:XN[6';Y4DC@2H5
M&%(90.0.,XY[YKH:* .>M_!>D1Z7=6%X+G4X[I!'-)J$[3.R@Y5<GH >1C'/
M/6F:'X)T[0$<6MWJ4C>68HFN+II/(3^[&#PO0=L\=:9J7B343J.I6&A:9'?W
M.F)$]PDLOE[R_(1#@C=MYR>.0/I3T7Q=K'B/P)_;NEZ+#)J#2LB63W.T85]I
M^<@<X&>U %D> -'_ .$;M] ,M\=/MY1-$GGD,K!MP^8#. 36BWAFRDU^WUN2
M2X>_@@^SH[2<>7W4C&#D]3UK9JO=WUM8)$]U,L0EE2&/=_$[G"J/<DT <UIW
MPX\/Z5JIO;1;M(_-\];+[0WV99,Y#"/ID'IGIQCH*N1>#=-ABU>-);O9JY)O
M 9C^\)&"1_=R..,<?A70,2%)4 MC@$XS6!X3\0W'B&#4WN;2*VDLM0DLRD4W
MFJ=BJ<[L#NQ[=J (6\":,8M'13>1_P!D96T>.Y97"'@H6')4@8]<=ZZ&XMH;
MNTEM)XP\$T9CD0]&4C!'Y5+5>[OK:R:W6XE"-<2B&(=V<Y.!^ )_"@#(T[P=
MI6F"S2,W4L-DVZUAGN&D2$XP"JD]@2!G..U9VG-J7B3Q)!>ZIX>;3;;2FF^S
MO<.KO+(WRAEQR%V9)]21UQ7844 %<C<_#/PO=K?)-92M%>RF:2+[3((UD)R7
M5<X5O<#VZ5UU% &':^$M'LK][ZWBNDNGA\AI#?3DE/3E_4DYZY)/6JS> /#+
MZ%_8QTX_81-YZ(9Y"T<G7<K%MRGZ&NEHH PM+\'Z)H^IMJ5G:RK?/'Y3SR7,
MLC.O^UN8Y^IJ]JVC:?KMD+34K<3PAUD4;F4JXZ,K*001Z@T:GK%GI!LQ=R%6
MO+E+6%0,EG;I^'4GZ5D:=XCN[OQ]J_A^6&!;>RMHIHY%SO8OZ]OTH U[+1;"
MP\XPPLSS ++)/*\SNHZ*6<DD<GC..369I'@7PSH.HM?Z9I,5O<DDAP[,%)Z[
M020O'' ''%=%10!E:?X;TC2M1N]0LK,175V[23/O8@LQ!8@$X7) S@#.!4JZ
M'IBV=_:"SC$&H/))=)SB5G&&)^HHU/6K+29;&*ZEVRWMPMO @Y+N?;T'<UH4
M 9E]X=TC4M#71;RQBFTY46-8&SA0HPN#U! '4'-0:5X2T'1=-N-.L-,ACM+@
M8GC;,GFC&,,6))&.,$ULDA022 !R2:"0H))  [F@#G]'\#>&] :=M*TQ;5YE
M*/(DKEPI.2%8ME1GL"*>O@OP\ND0Z4-.'V"&7SHX#*Y57ZY'S=<DFMTL 0"0
M">@]:0NBLJLRAFS@$\F@!IA1H/))?9MVYWMNQ_O9S^.:Q;3P9H%@CI9V3VRN
MQ=UAN)4#,>YPW)]ZW@<C(IK2(KJC.H=\[5)Y..N* ,5_!^@O#:PG3P([5VD@
M"R.NQV))88/WB2>>O-2KX7T=;ZYO5M6%U<H8YI?/DW.I[$[NG/'IVJMXG\2+
MH<FEVJ-"+G4;Q+93(>(E(8ER.,XVXQD=?:KFB'6!;3#67LY'64^3-:@JLD6!
MAF4YVMUX!(H XGQCX25(?#VFZ)X=N+C3K/44NYXX9E"+&-VY5#N""<YXP.>N
M:[2W\.Z5%:742V;*+T#[27E9I),# #/N)( XQG%8^I^,XI?#?B'4-"GMIIM'
M,BDR?.CE(U<XVD''S;<^H-;/AW4VU7P_I=W.\7VJYLH;B5$.,%D!.!U R: (
MX_"FAQZ(=&73HSII;=]G8LRJ<YR,GCGGBDN=/?1M(OYO#VGPRZDZ[T6:0_OG
M P SDY/'3)_*IM+;5?MNIKJ4UD\"S_Z(+<$.L>,XDR?O?2M"*X@GSY,T<F.N
MQ@?Y4 9'AVPO8DNM2U6*"+4[]E>:.%MRQ*JA5CW?Q8Y.?5C1J'@_P[JVJ)J=
M_H]K<7B8Q+(F2<=,]CCWK;KE;+QE%=?$"]\--&JQQVX>WG_Y[2*?WJ@]#MR.
MG0JV: -+6?"NA>(6A;5]+M[MH1B-I%Y4>F1V]JU(88K:".""-(XHU"(B#"JH
MX  ["EEEC@C:2618XUZLYP!^-"RQO%YJR(8\9WAAC'KF@#$F\%>&9[V\O)=$
MLWN;Q66>0Q\N&Z_0GN1S5BV\,:%9SQ3VVE6L,T47DI(D8#*G]T'KCVK0CN[:
M5I%CN(G:+'F!7!*9&1GTXYI+2]M;^W$]G<PW,)) DAD#J2.O(XH SE\*Z FG
M7&G+H]FME<-OF@$0".W]XCUX'/7@4FG>$_#VDW$-Q8:-96\\*>7'*D(WJO/0
M]>YY]ZT+;4+*\EFBM;RWGDA;;*D4JL4/HP!X/UIO]J:?O@3[=:[[AF2%?.7,
MC*<,%YY(P<XZ8H 34]*L-9L)+'4K2*ZMI,;HY5R#CH?K[U2C\)>'8KE+F/1;
M%)XT")(L"AE4#& <=,<8K1AOK.YN)[>"Z@EG@($T:2!FC)Z;@.1^-,75-/;4
M#IZWUJ;T#<;<3+Y@'KMSF@"I;>%]!M+6ZM;?1[**"[&+B-(%"RCG[PQSU-6M
M-TC3M&MC;Z98V]G"6W%((P@)]3CO3;C6M*M0_P!HU.RA\N01/YDZKM<C(4Y/
M!QSBLS5_&>BZ+KFGZ3>7MO'/=EBQ>956% A;<Y)XR0 /7/M0!O30Q7$+PSQI
M+$XVNCJ&5AZ$'K6;IWAG0M)N/M&G:196LV"OF0P*K 'J,@5J@Y&15"UUS2;Z
M^EL;34[.>[ASYD$4ZLZXZY .>* &WWA_1]4NDN;_ $NSN9T78LDT*LP7.<9(
MZ>U-U+P[HVLO$^I:7:7;0C$9FA5B@]L]*6?Q%HML@:?5[&-3-Y +7"@>9P=G
M7K@CCW%6-0U*QTJU-SJ%W!:P X\R9PHSZ9/?VH IGPOH!NY;LZ-8&XESOE,"
M[FSP<G'O7,>+_!!OM-T[3M TC3(+6+48[ZX0D1*^W.5VA3G(/>KG@'Q!>Z^=
M?:[O(;N*UU)X+:6% JF(*I4C'7.<YR>O6NHO]1LM+M3<W]W#:P X,DSA%SZ9
M/?VH @L]$TJQLI;2VTVU@MYQB6%(E"OD8(88YXXYJ"+PKX?@2W2+1-/1;=F>
M$+;J-A;[Q''!/'Y58&N:2=.CU#^T[/[%)PEQYZ[&/H&SC/M34U_1Y)+V--4L
MRUC_ ,?0\]?W'^_S\OXT ,'AK05@: :)IPA9M[1_94VEO4C'7DUE#1=8GUT6
M]Q_9D7AJUD2:UM[>(B1F4956'W0 V&X]![ULKKND/8-?KJMBUFK;6N!<(8P?
M0MG&:OJRNH92&4C((.010 M4[S2=.U&:WFO;"VN9;=M\+S1*QC/JI(XJ.77=
M)AU)-.EU*U2]<A5@:4!R3T&/7VHU#7M)TF5(M0U*UM7<;E6:4*2.F>>WO0 M
MQH>DW=LMM<:792P*_F")X%*AO7!&,]>:E33+"-IV2QME-PH28K$H\Q0, -QR
M ..>U5U\0Z.]S9VRZG:M->IYEL@E!,R\\KZC@_E4,NNZ;>VFIQV6M6D4UFA6
M>8NI%JQ! +@D <@]?2@"Y)I&FRV*V,FG6CV:8VV[0J8UQTPN,5)_9]E]@^P_
M9+?['MV?9_+'E[?3;C&/:N8'B_3M"TO0[;4=;@O[N]"+]J "K(N"3+QP!\IQ
MZFMFQ\3Z'J=Z;.QU2UN+D+N,4<@9@/4B@"W:Z7I]BX>TL+6W8)Y>Z*%4.W.=
MO Z9/2GWEA9ZC#Y-]:07,6<[)XPZY^A%-T_4K+5;8W%A<Q7$(8H7C;(W#J/J
M*9J6L:?I$2R7]TD(;.T')9L#)PHY.!R<"@"TD4<2HL<:HJ+M4*,!1Z#T' IJ
MVMNC[U@B5O4( :JMKFEKI2:F;^W-B^-DZN"K$G  (ZDGC YS4,?B71)=-GU$
M:G;+:6[;)I)'V")O[K!L%3R.#SS0!932=-C2-$T^T5(I#+&JPJ CGJPXX/)Y
MJQ';PQ,6CAC0D8RJ@5CV_C+PW=7D5I!K5F]Q+#YZ1^8 2FW=GV^7G!YQS3K/
MQ=X>O]/NK^VUFSDM+4XGF\T!8_3)/KV]>U &G'9VL5Q+<1VT*3R@"214 9P.
MF3U-*+.V (%O#@]?D%9%MXS\-WFI6^G6^LVDEY<(LD42ORP(W#\2.<=:L7OB
M31].N#!>7T<+*RH[,#L1F^Z&;&U2<C )'44 ::1I&FQ$55'\(&!47V*U_P"?
M:'_OV*R;SQEX<T^YN;>ZUBUCFM0/.0ODIGH#CO[=:L#Q+HS:7:ZDE_'):7;;
M;=XP7,K<\*H&2>#P!D8/I0!-<Z5'=ZA:W,TC&.U^:* * H?D;LXST/3.._7%
M77C212LB*RGLPR*QXO%NASV#WL5^K0)<?921&^XS?\\PN-Q;V S5/4/'6BV?
MAZ_U>*66X2R)26)()!(DF,A74KE/JP % '0I;01-NCAC1O54 -2%5+!BH+#H
M<<BN-N?$>G:@GAN677YM+N+B:)UM8XV!NBV!Y9#+G82<;NGOZ;VJ>)-)T>1H
M[VZ*.D?G2+'$\ACCSC>^T':ON<#@^E &K16)>^,/#VGQV<EUJ]K''>KNMWWY
M61?[V1P![GBI-"\3Z-XD6Y.DWHN#;.$F78R,A/(R& .#S@]#@T :P4+T &3G
MBE QTJGJ6JV6D6Z3WTWEI)(L48"EF=VZ*JJ"6)] *S)/&N@0Z=?7TEY(D-A(
M([L&VE#P$]-R;=P!]2,4 ;]%8+^,M#CN=*MWN9EDU4!K+-I*!,#@\';@<$$Y
MQC/-27/BO1K.6YBN+IXWMIH[=U-O)DR/]Q%^7YV/4!<\<T ;5%8"^--!_L^]
MO9+QX8K!PETLT$B/"QZ!E*YY^E1V?COPS?\ VPVNJ)(MG"LTS"-\*C="#C#$
M],#)SQUH Z.BN M]=^T_%NTM8I]22*;2Y'DL[C?$B,'7:^Q@ <@,,_7H017;
M:AJ%KI6GSW]],L-K;H7ED;.% ^G)H LT5C:?XGTW4M1?3XWFAO%B$ZPW$+1-
M)$>CKD<CZ=.^*JMXZT%#;LUQ.(;J0Q6TXMI#'.X."J$*<G(./7MF@#HZ*Y?4
MOB#X;TG4);"[O)4NH6021_9I,KO. ?N]/<<=/45:O_&.CZ:S-=2S+;1S?9Y;
ML0L88Y,XVL^,#G@GH#P2,&@#>HK$U3Q7I>DFX,[3R):H)+I[>%I5@4\@N5''
M'..3CG&*KS^.= @O[>R%U+-/<P?:(%@MY)/-3 (*8'S9SVSC!SC% '1T5Q__
M  LWPR;)KI;BZ=(R1<*EI(6ML':3*,?)SZUO7VMVEBT$>);B:=#)%%;1F1F0
M#EL#^'D<^I ZF@#2HKEI?B)X9ATRRU![YUM[R;[/$Q@<8D!P5<D80C_:QP">
M:G@\9:;=_P!H);07SW-E$LS6[6S1R2(V=K('QD''7\Z .BHK#\(Z])XD\-V>
MIRVTEN\\8<JR;0<_W<]1[U:U/6[73)H+9UFGN[@,8;:!-TCA>I] !D<D@<CG
MF@"@GAB1_%$FL7>KWEU '$EM82$>3 X7;N [G!./KGD\UT-<Q/X_T&W\/W>L
MO+<?9[.4PW$8MW\R&0'&QUQ\IS@9.!R.:OZ#XET_Q(MTU@+C9;N$9I82@?(R
M&7/4$=__ *U &Q1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% '#7%R_B#XAZKX=NKNXMK>ST])+>
M."9HFD9_O2Y4@G;D #H":SFO;^U\0>%/!UUJ\U]%*MR;R]4F)YVC#;8\@Y&.
M-V#DX'/45TGB/P)H_B;4+?4+HW=M?0+L6YLYS%(4_NDCJ.3^=37?@S1KG3]/
MM$ADMCIK^99SP2$2PMW(8YSGG.[(/4YH X35+W4K$>/]"BU'4?LVG627MG<>
M>?,@+)N,>_.XKGI[ C-/LWO].U_X?7?]K:E/)K-N_P!MCN+@M&W[A6 "=!@G
MTSZYKN'\':;-INHV4SW4AU,@WMPTO[V< 8 + <+CC"@ #/')IC^"M,D?1G,M
MYNT90ED1-CRQ@#G YX '.>!0!SWA>Q@B^*?BZ!#-LMA9O&#<2$Y:'G.6^8?7
M-<C;23VW[.MY=6UU<6T\%S(4>"5HSS<;2#@C(PQXKU*R\(6-AJU]JD%U?B\O
ME"W$C3YWX4JO&., \8JH/A[H@\-S>']]Z=-FD\UX3<DY.=W7KC/./6@"E<7B
MZU\3)_#NH,XLK;31/%;K(R"=V;#,V",[1P!VR3UQCG?$VB0VEGX3LY]6N=5N
M+7Q);VCW,LC*ZHP9]A(/) *_-UZ<\5V6L^ =%U[[#)?&[:ZLEV0W:7#)-MST
M+CD_CSR?4U+=^!M#N_#]KHH@EM[6UF6X@:"9DD249^??U+<GDYZT =#'&L42
M1IG:@"C)).![GDUX_I7AVWUG1_&-Z-3OK22TUJ\D@-G<-%'&ZJIW;>YSP<^G
M&*]=MK>.TM8;:+=Y<2"--S%C@# R3R?J:P3X(T;[1>NBW44-]+YMU:QW+K#,
MYZED!QSWQU[YH X+0M9UCQK>PZ9J1@67^Q8IUBF=T69G/S2X0CG&W']T]/:2
M\\/M;S>"[36;U-5O(-4>U>?+_P"KV.P0Y/S$<9/M@]*[GQ%X&T'Q0;5M1M&$
MMJ"(I8',3JO]W*]O:GW_ (*T/4='LM+DMI([:R<26_D3-&Z,,C.X'.3DY)Y.
M<]: .1UO['X/\?-/=Q-)I&MV+Q>623MG3G8G/&\8&.YQ5'PI'<R0Q> M64'4
M;#4!<SMO+EK8 2AMQZY9EC/3@XKTV?1=/N8[".:V5H["59;923A&52JGWP">
MM*FD64>MRZPL.+Z6!;=Y,]44E@,?4_RH \RL+6X\;:7K%R^M6MA?6E_+F81R
M>=9"-OD /F !-HSC&"<]ZEACG\9^(/$.DWFI6;S6L4"0&>V?>BM$"9HE#KL8
MLQ.>2/E%==??#SPQJ6OG6[G30UXQ!DQ(RI(1C!90<'IWZ]\U+K_@3PYXEOX;
M[4]/$EU%QYL<C1LZ_P!UBI&10!Q%QIAN/''@S3;[5;C4D:QN4GG21XA<; 0"
M0&^H)!^;GUKH?AM"EB?$VEP,PM;/69DMXB2?*0JK;1[9)K=E\(:)-JMCJ;6T
MJW=B@CM6CNI46)0,;0@8+@C@C'/?-/T?PMI.@W=U=:=%<1S7;%IVDNYI1(W]
MXAV(W>_6@#D_B786=SK_ (+>>UAE9]72)BZ!MR$9*G/4<=*JP:#INK_%GQ'8
M7EN'LETRV40*2J8Q@<#T[>GX"N]UO0-+\1V:6FK6@N(4D$J#<RE7'0@J01U/
M?O5>+PGHL%Y/=PVC1W$\7DR2)/(I9,8"\-T Z#MVH \OLM1D.B^ M+O;N-+&
MX>\1WOD,L3M&Q6)7&Y<CG !.,@<<5W_A#1(] OM6M(M56Y21TG^R11%(K4MN
MX0%FP#C.W/&!V(JS_P (+X:.@/H;:8K::[^9Y#RNP5LYRI+94_0BM'1=!TOP
M[IXL=(LX[6V!W;$R<GU).23[DT <7\1["SN/$_@MI[2"5I-3$4A>,-N3&=IS
MU&>U4!!!XL\0^*=%O;S3X9K:3R;>*XM"[P6_EKM>$[U"\Y.0.N#TP!Z#K?A[
M2O$=I':ZM9K<PQ2B9%+%=KCH000>]4-7\">%]>N;>XU+1K>:6W 6-AE,*.BD
M*1D#T.10!Y]/H-EK/CGPYIMYJ%UJ5K<:/,LEQYKI]H"Y4-U/4 '(X/!YS6I8
M^&-(N_B;J^EW%LTUC;:5:H())&9&Z@%AW( X].O6NWD\+:++J\&JM8C[=  (
MI5D9?+ &   < 8'3&#3'\(Z&^ISZD;-A>7"E99EGD5F4]1PW3VH \?2UB7X0
MZ7K8+?VI::BD-O=-(6DC19RH13GY1CM74>--,N%UC7=6:RM-;TDVZ0WL!<)<
MZ>$3<6A+ C[K[_4GZ5V!\!^&3I@TTZ6GV(2>8(/-?8&]<;JEE\%^'KB=IYM-
M261U5)&>1V\Q5 "A\GY@ !P<T :FFW,-YI=I=6Y<PS0I)&7&&*E01GWP:\LT
MZ.Q\0_#WQ??ZFHDUJ&:[:=Y<&2V>,$Q*C=5"@#&.^ZO7  H    X %8]SX4T
M&\OY+V?2[=YY<>:=N!+CIO4</C_:!H \ZU&V75M+^&U[K%E;37UU<P)<221!
MFE3RV(#$CD'@D=,FO6A!"+?[.(HQ!MV>7M&W;C&,=,8[5EZMX6T;7+J"YU*R
M$\T 'E,9'79SG(P1@^_6M9$6-%11A5  'M0!X]86EC:^!_B9Y-O;12)?ZC#'
ML15(C$:X48_A'ITJ?3]&L-,G^&>HV4"075U&$N)4X:8-;9^8]^G&>E>A3^$?
M#]Q-J$LNDVS2:@H6Z?;@R@>I'ZXZ]Z='X5T&*WM(/[)M'CL^+;S8Q(8><_*6
MR1S0!Y]I6GVTLGQ*T\7:Z;#+=I&)P.(RR]2/3)Y^IK7\(O/8>-)]+UC1[.SU
M<Z>K)<:=@6]S"KXR5QE6!/?M]!77'PUH9^T_\2>Q_P!*_P"/C%NH\[G/S\?-
MSZT_3-!TK1WE?3[**!Y<!G7)8@=%R>0H[ <#TH ;K^JC1]'FN5VM<-B*VC8X
M\R9SMC7\6(KS7Q1H>N^']#T?79%LI)O#LWVB26&5VDN%=AYV05'WB2>O<UZC
MJ&DZ=JJQKJ-A;7:Q-OC$\2N$;U&1P:=>:;8ZA9_8[VS@N+;C]S-&'3CIP>*
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MJ:]*-A9F\^V&T@-UC'G&,;\>F[&:K:MIJ7EI.\-K:R7QA:**28;2NX8^\%)
MY["@#RZ&[AL_#7PMO;F=+>VBF59)W.$7,1&">V>E3:;J6EWWB;XFL+JVEBN+
M:W>$,PQ*%@?+*#U ..1QT/<5W?A?0)=.\&V&B:Q%:7+6T0B8*3)&X'0X91^6
M*V_L=J-_^C0_O,!_D'S8Z9]<8% 'DD-]9P>"OAG=SSPBVAO8EEE9\)&?+<?,
M1TP?7\>,UL^+C-H7B33?&.B1?:6U&,:9/&#A9"_^H?\ [Z !/IC%>@/86<MN
M;>2T@>$D,8VC!4D=#C&,\5A?V/K=YXI>YU.^M)-%MY5GLK:*,B02!< NW<#+
M''/.#QC% &SI.GKI6DVMBKM)Y,85I&ZNW=C[DY)^M<-K>O6OAKXL0WFN-]GT
MZYTH6]K=,I*)()"S GL2,?I7HM,DBCF7;+&DBYSAE!% 'E$T^E:9K'@[4M-M
M?LOA*.[NE\R0,D8ED7Y)2&Z*3N"D].>@(JSJ:PR>*_&.J0RP'2)-"\BXEWCR
MY+G!VC/0L$X]L@5Z>T<;Q^6Z*R=-I&1^5,^SP&$0^3'Y0_@VC;^5 'C5Z^E#
MPK\+DW603[5:F5<KC[@WEO\ @1YSWZUMO/I__"9_$&WCEM]\VEPYC5A\[+%(
M&X[D<9KT@V5J553;0D+T!C'%4]7TO[7I-]!9PVR75Q"\2R2+@*6!!8D#)ZYQ
MW]1UH \K>VTK6OAAX1L-%>R_MOS+8P>5@21R+@S,<<@  EB?;VJK:G0EN]>\
M/>,=0U>WO[C4)7-G"\GE7BNVY&554Y)XQ]!7JOA+2+G1?#>GV-^EH;RU@6W:
M6VR0ZJ  <D ] ,ULF*-I%D,:F1> Q'(_&@#SC3FL(OC$P=H8A;^'8X=DTH9H
MV$F2I)ZD+U.<_K7)^&Y-&O/!.AVMQK;Z3JD6I73V=Y#MVV\F6.) < *RG@<
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M>S*H50J@  8 ':EH \@9+;PWXGURR\1Z+JES::I()K26Q662.1"@4Q,J-VP
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MQ_9DG+_*I505PY7#+W[Y[Z?A/5;?3=4UR'6]-L]"U"".%[N6%U6TD3+!) W
M4DDC#')P/0T =Y++'#$\LKK'&BEF=S@*!U)/85PWB3QA-=>!9]<\+:C;AHIU
MC.Z+>7!F$0(R0%SU!(.1^==N1!>6W(CG@E7/9E=3^A%>'V7V6']G>[EC@C%Q
MYX+[#M=P+Q<<CGV'I0![?%=VT\TL,-Q%)+"<2(C@LA]P.E-%_9M>M9+=P&Z4
M;C )!O ]=N<UYOJEB/#_ ,3;== M%MY;G0[HE8E&9Y5Y4L3]YLA>3D^O6LGP
MW;:/K?A_P_?S^)A'J=I.C^3#%$MT;@G#J?XWW$G.<Y!R: /4?$'B#3_#>EO?
M:A.D:YVQH6P9'/11[_RZFK4^J:?:VBW=Q?6T-LQP)I)E5"?]XG%<A\6K>W?P
M)/<3+'F"XMR'91P#,@(R>@_PK'UK4;%?B3:63ZO:V&E/I96S<Q1/;F;S2LBC
M=\H8C /TQWP0#TI[^SBBBEDNX$CF(6-VD #D] #WS[5&NKZ:\:2+J-HR.I9&
M$RD,!U(.>0.]>0:OX?T:RTOPC8VER-3M5\3)"MPZ)@HY)>-"O&S=G('&0?2M
M[4O"7AW3_B5X7M+;2;.*WGM[SS(1&-LA4*PW#^+!)/.>GM0!WK:]HZ6T5RVJ
MV*P2MMCE-P@5SZ YP34UYJ5AIRHU]>VUJKG"&>54#'VR>:\?T_P_HDFA_$GS
M].M"MI=W0MBR#]QA,C9_=YQTQT K;F@O)[C1-2T34K2;68= C\W3+X9CN[=N
M25;LQ8=?]W/'4 ]+AGBN85F@E26)QE71@RGZ$56&L:8;XV(U&S-X#@V_GKYF
M?3;G-<_X5OEN_AE;7>B6+VK?8Y/LUL[;MKC< ,]QN'!],5Q0^Q7WP$B=2PU.
MW(V$9,ZWXEZ?WO,9_P ?FH [+Q-XKMK/Q)I.A+J]O9"Z,S7<XEC#PJB JOS9
M"EBPY(Z XZYJ9]9G\&^$)KSQ3JUO>S0[S%*BB)K@8RBXZ%S[?_7K%UJ2=?B'
M\.4O2IO#!>"8(> _DID_3(-:?Q6_Y)CKG_7%?_0UH 6_UZ=/&&@-:ZQ;R:)>
MQW)E5 A3]U'G=YF>@)/ITK8U*_AU#PW>3Z5KEG;9C94U .DD<+>I.<<>]<SK
MQT?6_%_@V,/:7MBQO%VAPZ,1$N%/8]N#7-"SM4TSXK6BV\(MX"\L400;8W\E
MCN4=CGN* /3EU2STC2+%M7UBTWM$B&ZED6-9WP,L.<<GGCUK0M[F"[MTN+::
M.:%QE)(F#*P]B.#7G)M;F^B\)7NAZS:VVMVVD+)#9W89X;F)D3=SP1TZCGIF
MNF\!ZI:ZMX0M;FUL?L,8:1&@#;E1PYW;3W7=G'M0!6^(?B>]\+Z%'=:;!Y]U
MYJR/'C.($(:4_3'&>VZNHM+J&^LX;NWD$D$T:R1N.C*1D&N/MH+GQ/K.I:Q9
M75A)I_EMIMN)8VE#(#^]8%7 &YOE[Y$8/>L7P5?_ &#P[XB\%7VH)!>Z(DR1
MW)X)@8%EE"]<+GWP-M '?KK^CO,\*ZI9F1,AE\]<\'![]CQ3)/$FB0W+6TFK
MV*SK(L31FX4$.V=JD9ZG!X]J\LT!]-UZT\$Z:VH:5$=)<,VZ^A8W0*X")&#O
MRW&0ZKCD8-;'A_2M,U'XE^.TFL[2=X);.2W$D:MY;^6264'H=P&?<<T =^VN
MZ2FH+I[:G:"\9M@@,R[RW]W&>OMUHO\ 7=)TN58[_4K6U=L$+-*JG!. >>Q-
M>-:"VBZOX6MM(UW7]8BUBRO'D;2HUA$S70=FS&?*WDDDGEN,G)P,UI7EWIA\
M3^+M(\3^(M1T<W<P943RA'<VQ0*H4M&S9 R" ?IR#0!ZG<Z]I%G/)!<ZI9Q3
M1Q^:Z/.H94X^8C/ Y'/O58^+O#BV]O.VNZ<(KABL+FY3#D'!QSZUQ&GZ?HUK
M\1?"\&=[0Z)(L"WP3[0"K+L9A@'?LW8X! !X&#6!;6VF#P'\3I&BM05U6\2-
MB%&%!!C ]!N/ '<\4 >QW^JV&EQJ]]=PP*^2N]L;L#)P.^!4)\1:*([20ZM9
M;+O/V=O/7$N.NWGG%>;2ZW9:9XQT^?6K^>RTV]T2!+"^A?$>5YD0M@CG*G\%
M]J@U2W\+V%AX1M+'#:7)X@26/[6VX2HR'+J&Y\O>0,XQQGH1D ]%;QEX>.D7
M>J0ZK;W%K:9$K0/O*G&<8'<XXJUX?UF#7]#M-2@9/WT2.Z*V?+8J&*D^HS7G
M4\L1\9_$NV@D3=)HZ$1(1EF$+ G ZD$X/U]Z[/P#J=EJ?@G2/L=S'/\ 9[.&
M&7RSD)((URI/J.X[9% &D_B+2%OEL6U"%;EY/)5,_>D_N ]"P[CJ.]<?X<\7
MP:;>>(XO$>MJL<.L/;6LETX4[0J_*  !@9Y/OS6&M]_8NJQ/IFJV^MZ-<:P5
M;29O^/JSG,I):/'. V3@C&"?4FH=/N=(ETWXHM-/9MYUQ/M8R+EQL.W!ZD;N
MF.] 'J]_K.GZ:(_M=TB&0%HU +,X'4A1DD#/)[5R'CG6W?1= U/1-786]QJU
MO"7M9!LG1F(8$]3]W'!]<^W.P^(M(BU7PS$;R#3I_P"P(L:N/WK,N0I@B7E-
M^X$Y(;&,8KG].U&QC^%NCVDUU;I<VWB*-I4G)1TQ,23CC! .3G@ GIQ0!Z1J
M%[?6_P 7]'LDOKC[%<V$TCVQ;]WN7@'&/YYKK[V_M=.M_M%Y.D,6X*&8]6)P
M !W)/  Y-<#J>HV,OQK\.^7>6[YTZ91ME4\MRHZ]QR/6K'Q'NYM'U/POKLZ2
M2:-I]ZYOE12VPNFQ)",=%RW/N.YH ZRV\0:3=VEU=0W\/DVA*W#.=GDD==X;
M!7\:CL?$NCZC>R6=O>K]JCC\TPR(T;[/[P# $K[CBO._%4UAX@\/ZEJ_A33A
M=VYN;6XU"YC1E^UK$Q)0*0-VT $D>O<YQKZK>6GB3QOX2U#0;R"Z2R$\UY/!
M*"(H&4##GMD_PGG@\<' !N/\1/"4<9D.N6Y03>0S*&8*_'4@<#D?,>/>F77C
M2VA\=6GAQ$D.^V>::0P.<'*A IQ@CELGD=.:\TMM5TG_ (5O\1%-]9^=<ZO=
M&(>8NZ4-M,>W^\#M8C'H<=ZWH-:LT^(GA;5YYD6UO/#_ ),4D>9 TH<%D&W.
M2.] ';6WCKPS>:C'I]MJ\,MU).UNB*K<R*,D9QCIWZ'H.:G7Q;H3W$$(U!/]
M(D\F"4HPBE?.-J2$;&.>, DUY[X+^S:SH?CVSTRZM'U2YU2^EMF5E+E64+'(
M#_=RQ ;IR?6JUQ/'XB^%FD>&K!?+\06\MO$UCR)K9HW 9V7JJ@<[CQS0!U^G
MWMVGQAU73FO+F2S.EQW"P/(2B/OP2J]N*ZN^U.TTT1_:9&#2DK'''&TCN0,G
M:B@L<#DX'%<'8ZE8GX\:A$+R!I#I"0 >8,F17W%/]X#)(]C3?B&\>F>*=&UK
M54OSH*02VUQ-9S21M;NS*58F-@V#@#_(H Z6?QYX;MM)_M234&^Q"0PO*MM*
MWE." 5<!<H<D<, :TX]<T^766TA))3>K")V3R)-H0]"7V[1G![]JX0S^#[3P
MEJ#VUDYL-<G6.-K^>4?;9G_CS+EE4<'?[9';-7P\]YID>N^ [Z5I=5>VD^R:
MJ 2+E3& JL3G#)D#![?J =S%XQT*:_MK1+WYKIBEM(T3B*=AU"2$;6/T/>B^
M\7Z-IUR(KFXD2,2^3)<^2Y@BDX&UY<;0<G'7@]<5Q?@WQ#IUWI&A^'+O0;AM
M?TDQ1M;2VC 6Q7Y?/+D84;<MGJ2<#J#69IMQI=I#J/A3Q'I&J7>KBXGDAM%>
M=HKY6D:16&#L R1DD #J><T =]J7C[PYI5S>6MQ>NUW: -+;Q0.S@<\@ <@
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MTZTAU&?4([=%N[A$CEE'5E7.T?AN-6JJZCJ-KI-A+>WDJQPQCDD]3T 'J2>
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MP."%.>3]*DN]<TFPNDMKS4K2WG<@+'+,JL2>@P3WH M):6T<IE2WB60YRX0
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M=["FJ_$>:021I=HC0;HV'F8B92%XY.X@8%>K44 >%V#_ -D6/A+5]5T>ZO\
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MIY=!T>>_2_ETJQDO(P EP]NAD7'3#8R,5/!J-E=2>7;WEO*^W?MCE5CMSC.
M>F>,TEGJ>GZ@TBV5];7)C.'$,JOM/O@\4 5(O#&@P17,4.BZ=%'=+LG6.V11
M*OHV!S^-7K.RM=.M([2RMXK>WC&$BB0*JCV J*+5M.GO&LX=0M9+I/O0I,I<
M?50<TQ]<TB,X?5;%2)/*^:X0?/P=O7KR./>@!;_1M+U22*34--L[MXL^6UQ
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M_P!./H .@%<WX6\(@ZKXDEUG1;F%+_49;F,M< 1S1-C"ND<A#<[CA@1S[XH
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MI_Q[HZ9\KV4]0.!Q[5-;>&="L[>Y@M]'L(HKK(N$6W4"4'LPQR.>AH \UN]
MLDM/$=S;>(K;5IKW1Y6>SL;9%B8H!LD.PL PS@<<\]<&NO\ A[X=TK3O#>DZ
MM:VNR^N]+MA/-O8F0; >03CC/Y #H*V+/PIH&GZ=/I]II%I#:7'^NB6,8D_W
MO6M"RL;33;2.TLK>.WMXQA(XUVJH^E ' O!81_'EFFBMU'_"/^;EU4#?]H'S
M<_Q>_6N;NM$L#X!\=:A+:*U];ZI=M#,_+PD.I!0_PG/]W&>]>M7NA:5J-];7
MU[I]M<75K_J)9(PS1_0U$/#&@K:36HT:P%O,V^6(6Z[';U88P30!Q$:)+\2O
M!>H-$1=7>CRM-+CB0B-<?B,G\Q6=;0C0K_3YKRWM-9T6ZUDRVFJVY"W%O<2.
M<+(#]X9R#Z=^@%>E)X<T2.XM[A-(L5FMAM@D$"[HAZ*<<#Z4VV\-:'9W8N[;
M2;*&<,7#I"H(8YRPXX)R<GJ: +FHW]OI>FW-_=/LM[:)I9&]%49->:>(?#7B
M&]\"W%TT5E%JD=P=962*1C*LP^8*."#A $'/\(KTJ_TVQU6U-KJ%G!=VY(8Q
M3QAU)'0X/%*=/LC8?8#:0FSV[/(V#9M]-O3% 'G/BCQ%#XA^'?A[78KB!(I-
M0M99[)I% N2K?/;Y/&<C//&%YJUI.D:9KGBKQ'KKV6GR6UQ:Q1)$_E3.6 ;<
M[!2VW/ ]\>W-_P 3>"EDTRUM_#VE:,D,5TL]Q8S0B.*Z ! #%1V)STYQ3-$\
M'1R7\=]>^&=%T9$1T-M9XD:<,,8D8*J[>^W!Y .1C! .#TS38+'X"+XAL;9E
MU8P-%+=19,A@^TX=?IL'Y"MV6+3[AI-<\.>)4U#6%TF>&UMK.*)#LV$C>J#(
MVL%QG^+:.]>E6&C:9I=L]M8:=:VL$GWXH8516^H P:33M#TG1S(=-TRSLS)]
M\V\"Q[OK@<T >4^&T\/:UI_A&=O%(>\LFC\G388H5F#G D1@!O*G#;B>""23
M5*WT32#X)^)<SZ?:A[?5+Q(&\L#R@N"@7^Z >PKV*VT'1[.^DO;;2K*&[E!#
MSQVZJ[9ZY(&33#X<T,P7$']CV'DW+!IH_LR;9".[#')^M 'GUU965CXS^'%Q
M8P10RW<=P9YHP T^85;+MU;DD\YZU@Z<FC:SX;OM-\3>*+O3]2AU&6:XLF%N
MLK2^865H\Q^8S$$ 88^@XP*]D_L;2BT+?V;9Y@&(CY"_NQ_L\<?A1)HFE3:D
MNI2Z;9O?* %N6@4R#'3YL9H \]TW1](N_BWXNCO;&UE06=N^V:-2,LGSM@]S
MGD]>3ZUS=K<0IX,^%US-.%@BU,!Y2X 7#-P3T'3'X&O9FT;2WGDG?3;-II01
M)(8%+.#UR<9--;0='>S-FVE6)M2P<PFW39N'0[<8S[T %OKFE7E^+&VU&UFN
MC")Q%'*&8QGHPQU'3GW%:%5H]/LHKS[7':0)<^4(?.6,!_+!R%SUQ[59H **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HKAE\1>)=;\0SP^'9O#C:7;S^3*9Y7DN5VG:[;$( &0< XS@'/-=M*S)$[I
M&9&520BD L?09X_.@!]%<8NN>*]/\1:1:ZO9:8UGJ<CQ!;,R&2W8(6&XGAA@
M') %=G0 4444 %%%9OB"[N]/\/W]]9-")[:!YE$T9=6VJ3@@,#SCUH TJ*Y3
MX?\ BYO&/AO[9<Q)!J$$K07<" @(XY& <G!!!_/TJBGC6]OOB</#-@ELMA%
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M^BDD#UY.!P>:O^'O$%GXDTS[=9K*BK(T,D4R;7CD4X96'J* -6BBB@ HHHH
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MD@9YQFK= !7GWA^XA;XS>+ LT9+6EJ  PYPO/Y5Z#4$=G:PD&*VA0CH5C H
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ME62YMYK9+A<A0OR$X*\ >H]JW],TY=-M3%YTMQ+(YDFGEQOE<]6. !T &
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M5*]-I'%.HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HIKND:,\C*J*,EF. !3NM !11
M31(A=D#J74 LH/(!Z9_(T .HIJ.DB[D8,OJIR*&D1&16=59SA03@L?:@!U%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M\.#M^;'WL?6/P_+<6,^E6&@:LFMZ5=12BTAG"_:M+;RS@L<_<&=I!QUXSQD
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M_L^";X?I83_:K.SO/GF12VT!0-S<?+SZ_P!*+Z2Q?Q=X]_M*"YN=+NK2T0K
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MU6WC:5YAMW955!)XY/''>@"H/#^H=_$^K?\ ?,'_ ,;I1H-\!@^)-7/X0?\
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MYD*20MV# ^OJ,BL;Q]XEN]"LM/L]+V_VKJMVEI;,ZY6/)&YR#P<<#!/4^QH
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M]"UI=3T*&[T^+3_M(>WNBT-U$0^Y0Y48("YXSU%+I_BFSM="\*6NGV"Q3:Q
M!96AE(2)%CWG<V"<*,#IDY% '8T5QTGC6[AT_P 0SR:.OGZ&&^T1"Y^_A X9
M24'RE3D=^V.A,6G^.KVXN/#K7FAFWLM=C'D3+<AV1S'O^9< ;3S@YS@9('2@
M#MJ*Y"T\8W>I3SG3]/MKB"WU$6,Z+='[1"/-$9D:,(0!U;[W09SUQUS,%4L<
MX SP,T +17"V_P 0IS/H3WNDK:VVLW!MX4:<_:(CDA6>,H,*<=0>,CK4,WQ
MU<)XA\CPW&7T(EKGS+]0IC";LJ0I)8C<<8 P.N>* /0*CBGAG,@BECD,;;'"
M,#M;K@^AY''O7.Q>+!J;:5;:5:K/<ZC8_;]L[E$BA.T?,0I.26P!CLW(QSC?
M# R)+XLMWLHK01ZW+^[A.4!VH"%X'' /0=>@H [^BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .
M*\77=E8>./!]U?3PP0J]V#+,P55)B&.3TYKGY++2=4\2?$BXN(;6[>.V@,32
M /L_T7DKGH<CJ/2O3+S3[+4%C6]L[>Y6-Q(@FC#A6'0C(X/O4 T+1UWXTJQ'
MF##XMT^89S@\<\@4 >/Z9J[V\'@>XU'57L--;27AAOMB.D5QG&&+J54[5 !X
M[^]>@_#_ $[3--T_45TC4YM1M)KQIC<$)Y1D8#<(]H P..G&>!T-="VBZ4]B
M]BVF6;6;G<UN8%\MCZE<8JU#!%;0I#!$D42#"HBA54>@ Z4 <#X^BL)O'/@=
M-36!K-I[H.)\;"?*&T'/'+8X[UR7B&P?3;OQ?-X=MYDT7?9?;%LXU*;E;,P0
M$$<+C< ,#)!&*]IN;2VO8?)N[>*>+.=DJ!AGZ&E@MH+:!8((8XH5X$<:A5'X
M"@#S[1V\+:MXD75X/$-WK<QLVBN#*(1#'!][]\%C0#GH&Y_ 5QX2RMO@QX5U
M"".&&Z74X&,Z[0X(E8$[NO;U_*O:H](TV&WEMXM.M$@EQYD:PJ%?ZC&#49T'
M1C$L1TFP,:DLJ?9DP"<9.,=\#\A0!Y5)?V U[QAI'B_Q%=Z2;NZ8I$J1>7<6
MC*%CVLT;'( Z C!/'.:T-9EL[/7?AK:K/*JPR2!5O743!/+"H7'&">!T'IUK
MTR33K&5X7DL[=WA&(F:)28QZ+QQ^%.>RM))3+):PO(>K-&"3QCK]* //;%K<
M?%_Q7!$\7FRZ7$1&A&YFQSQW/(/XBKGP?O[6;X>Z=81W$;W=HKK<P@_-"3*^
M P[$^]=N+6W642B"(2#HX09_.EAMK>V\SR((HO,8N^Q NYCU)QU/O0!P_C&Z
MFT[Q_P"$M0O7$6A0M.LLS'"1SM&50N>@ZX!/O533YH8_'_BO6;>\@&A26,2S
MW D A-R !PV=I(7&?]X?CZ++%'/$T4T:R1L,,CC((]P::MM EN+=88UA P(P
M@"@?3I0!YK\./%6AZ#\)=(FU+4H(4B=HI,'>49I9"H8+DC(!//85Z;'(DT22
MQNKQNH964Y# ]"#5*^TFVO;&6T $$<O$AB1067N,XXZ]>H[8JY%%'!"D,2!(
MXU"HHZ #@"@#PKQCJ]E=Z#XVLK20Z?<)?%I;!(V>6Y*O'F>1FSM3C@+M QR3
MG%=/I.J:3>_%V&]^U6\B?\(^@AE?:,/OR<$\YVY//./:O33!"Q<F)"7&&)4?
M-]?6I.E '@VC7\-MX7TR[P);'3O$TEQ?16XSY41W;)"J_P  /([<"NKT36--
MU7XV75YITXGMY]$5%FC1MKL)1GG'/ QGIQCM7IQ (((R#VIJ1I&,(BKP!P,<
M"@#!\<P2W/@/788(GEE>QE5$12S,=IX '6N-N5TWQ-#X*C\/S02ZAI]Q!)+-
M;+N-K L9WJ^/N9( VG!)[<&O4J0*%SM &3GB@#P_0HM$FTC_ (1;Q3_;1UR&
MZ?\ XEX>8+<N7+K(@4;0#G.> .3TKW #  _KFEP,Y[T4 >/:6VF0Z/X_T?4X
ME.H7VK7C063)^_N%8#RBB]6^;)!' ZU- 5T?QW\/M/U"YB2[M-*>WN 9 =DA
MC "D^I/ ]>U>MT4 >(Z?J6D'P5\3 ]U:&2ZU&]:'+*3*K#]T5_O MG;COG%:
M6B^(K?2_%FFZSJTY73;_ $*"VM[M?GB29,&2,E1\K9S^5>N44 >%WU];-\)_
M&T&YXY)]9F:%9HVC\S=*K +N RV%8E1R,<BNCU/6=+G^(?P^>.[MI46WN=S;
MP0A>)0GT)8$#WKU&B@#PNXN+.[\)_$:1;IPCZL;B"2!-^_:Z$,/5<[<GL#GZ
M]/X>\0:+X@^(%MJ\FMV8U 6!L8K. 2[9#NWEMTB)SZ+@^N379^*?#_\ PDNC
M_81>RV4J3)/%/$ VUT.5RIX89[&H+/0-3>ZAFUO6QJ*0.)(H8[18$#@8#'!)
M)')ZXR>G H U-8MS=Z)?VRIO,UM)&%'?*D8KQPZO%<^#_ >GVT-[)=Z7K%HM
MZBVDA,+(K[U/R\L!DX&3Q7N%% 'FNDZGHMCXZ\<1:BR1BYEM@%DB.9@8!\@X
MY8Y/R=?:L'PYIVI>"]0\+:CKD<JZ2EA/;L[H2+!Y)"Z[^ZY7:N3P#Q7HVB^'
M;W2O$.KZI-J4%PNINCR0K:F,H44(N&WGC YR/RKHJ /(]6L9C:_$35K6&4V.
MJP10VBB)MUQ*(\,RC&2,DX/0\]N:TM7DCD\8?#R:TCD%K;1W'FLL3*L*M$JJ
M&X^7D$8..E>E44 9.A^(['Q!]L%F+A6M)C#(L\+1G()&0#U&0?R-8_CUFAC\
M/7?DS20VNLPS3&&)I"B!) 6VJ"<9([=ZZ*QTZ&P\]D:22:=_,EFE.7<]!D^@
M& !V JY0!YW:W:-\:+J_,5PEJ=#$/FO X42"3>5SCJ%!./PZUR5K#<PZ!H.H
MKINH7%MI>K7;WEI"DD4JQ3,X215&"< YX]<=S7N-% '*>$;;2#=7M_H^E7EO
M'.D:27=YYHDN&7<,8E.X[0?O'KG'.*J?$;0[_4+;2-7TJW-U>Z-?)=K:@X\Y
M 1N4>_ (_&NVHH P;?Q997D -M:ZBUTW M7LI4=6]&W* N#P6)Q[US]N;G0_
MBAJVH:E;3_8]4M+=;>XAC>5(W08:,E5R,G)&0,UWU% 'C5UI-WINE6TK65R(
M+OQ:FHPVAMG)AM]QY< $KG@X/(R.*ZNU:1?B[J%\;6\^R-I$42S?9)-A8.6P
M#MQTKNJ* /%Y5DTWX9Z;'<Z?>120>(TD:"2U='=3<,R[5(&[*D8Q]*WM>ANM
M4\5GQ#I&FR7L6GZ/<1-'- R+<R-]V(!@"W!)( ]NIKJO%?AEO%%K;6K7[6L,
M$Z7!"Q!BSH<KR3P*WD#+&H=@S@ ,P&,GUQ0!XW;/<?\ "2^!=5&FZY)':I<1
MW6^R=%A=H=JQQQ  *JD$9 Q@#)..)[6SOA\/O'UL=,U(7%_JEW+:Q&RE#2I(
M%V,!MS@X/T[XKU^B@#S77K"^MO"/A?Q)80/_ &QHL<*?9YE9&F615C>(@X.2
M2,?US7=Z+8'3-'M;1V#2HF97 QOD8[G;\6+'\:H2^%UN/% UF?5-1DC3:T>G
MF;_1T=00'V>O.?KSZ8WJ .)\8W5W%XCT6(V-X-./F&2_L8/-F1R,"(8!:,-Q
MEAR>!D<UP\UMJ#>!-=TE=(UE[IM>^T('M))&:/S4;)8;MQVJ23D_7)%>W44
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MA>QEN(U5+@ 9(&&)!P0<, >:Y/0_#VH7WA/QQI+V\]G<:IJ-Y/;-<Q,BLD@
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M(W;AC:<@8% 'H]%<[9:YJ1\7RZ%>::JPK:B>*]293YI&T-E.JC+$#Z'\.BH
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M44 )@$@X&1T-<]J&@:GJ/B2&YEUIAH:*C/I@@7]Y(K;@2_7&0"1[8Z&NBHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MDD<,:/*<R,J@%SZD]Z9'9VL4B21VT*.B!%94 *J.@'H/:IZ* "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
=HHH **** "BBB@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>davidjkatz_employmentagr009.jpg
<TEXT>
begin 644 davidjkatz_employmentagr009.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***04 +1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %(*6D% "T444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !2"EI!0 M%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4@I:04 +1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %(*6D% "T444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !2"EI!0 M%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4@I:04 +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%&021GD4UI$1D5G56<X4$X+'&<#UX!H =1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %(*6D% "T444 %%%% !1110 4444 %%%%
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MLA\QBQ7!//((.>:YCPYI<-M\.]9\3VD$C:U8S7PM95=B8P?E.!GD 9/.>>:
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MWD#%)XF"C+8<' ]37C*^';&R^'/A+7-+A>'Q 9;40SQ,QDF+D!D//*[=QP>
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ML;74K:6Z52_EJXR5!P2/4 ^E-A\3:'<7<5K!J]E+/-(\4:),K%W4 LHQU(#
MX]Z\_P!%O/"OB2+PU,-7OKS4[22)H+"-D#V[C ?<H0$(H!R2<$#C)(S?^'%I
MI-WJ7BNX,%G->1>(;EXY"JLZ)A=I4]0.6P1[T =_=WEM86LEU>3QP01C+R2,
M%5?J:JVVOZ3>6UQ<P:C;M#;MMG8N%\H^C9^[^-<K\19I;._\*W\Z,VD6VIJU
MZPZ1DC$;MVV@DDD^U4;HVT_Q7GU"R>![ :$PU"=&'E%BYV!S]TM@<9YP* .V
ML?$6C:G>"TL=2MKBX,(G$<;@DQDX#?3D?F*=?:]I.F7*6U]J-M;SO&THCDD
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MU>PUS38M0TRY2YM)<[)$S@X.#P>0<]C6;J7C?PWI%W<6M]JL,5Q;IOECVLS
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MGCV%85AXSLKV_P!.M7M+NV_M2)IK"655VW"J-QQM8E3MP<,!U]>*T];DO(=
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MBKNC>'=*\/QS1Z5:"W29MTBB1F!/K@D\\_C6F2%4LQ  &23VH!# $$$'D$4
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M))/7TZ]*WO%!NQH<ALM:M]'G#H1=W"*R* 02"&XY&10!I)96L=HEHMM$+:,
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M!W%%>?\ BS6VT/XE>&&N-4FM]-GANC<1&0^6Q6/Y?E'4Y;@<Y.,5M_\ "?\
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M;-V@T]EB8,XV_(.BY) )VXQU]#Z9J.@:7JUU;W5_9I//;'="[$YC/JO/!_\
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MV$,,J#QV!/%>Y2V\,Y4S0QR;#E=Z@X/MFG21QS1F.5%=&ZJPR#^% '+>"?[
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M@%&C W $]#CDGC-='\//M,?_  D27.G7MF9=9N;F/[3"4#(Y&,>O3MQ7:T4
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M$G9C=@?*.1W)Z"LOR;]/!?@6R.D:F;C3K^UFNT%HY,21A@Q/'/48QG->KT4
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "D%+2"@!:*** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHK \8^(
MX?#&@/>27$%O++(MO \X)0.QZD#DA1EB.X4T ;]%8?AE]6GLC=:EJVG:C#,J
MM;R6$!1 .<\EFW=O3I4'C/Q+%X:TF*0WEK:7%U,L$,MT"8T)Y9F Y("@\=S@
M<9H Z.BL3PU)J=Q9-=7^KZ?J44V&MY;& HF.<\[VS^F,5MT %%%% !117*:W
MXDNSXJLO"VB^4+^:(W-U/*I9;: '&0,C<Q/ &>.IH ZNBN?FM_$-E=Z>T&H?
M;K5IPMXDL"*ZH0?F0K@8!QD$$X)YXYT;_7-+TIPE_J%O;,5W8ED"\9QD^@SQ
MF@"_169>^(M'TZXMX+S4K:"6Y ,"O( 9,G V^OX5,VKZ>NH26#7D*W<<7G/"
M6PRI_>/H/>@"[16/8^*M!U)[A+35;61K==\OSXVI_>YZK[CBH3XU\,J$+:Y8
MJ'B:92TP 9%8J6&>V01[XXH WJ*Q;/Q=X?U#4X]-M-6MIKR6(3)"K?,4(R#]
M<'..N*I:;JUG;7>N7UUXKMKRRCE4F,[$CLA@_)O!Y)]_RH Z>BL2S\7^'[_4
M(;"UU:VENIXA-'$K<LI 88]\$''7!JY<ZUIUI(\=Q=1QF,@/N/"9Z9],YH O
MT5%%/'<1AXGW(W1A7)>&-4U6]\:>)].O;]I;;2Y85@3RD7<)$+?,0H)QQTQ^
M- '9454U+5++2+0W5_<I;P!@NY^['@ #J2?05G?\)CX?_LVYU#^TH_LUJXCN
M'V-F%CT#+C*_B* -RBL9O%FB)<:? U\!+J*AK13&_P"^!Z8XJ]!J=I<W]S8Q
M2,US;!3,AC8;<].2,'/M0!;HHK+U>PO]0EM$M-3EL($=FG: *9)!C"J-RD 9
M.2?;WX -2BO-O#J:[KUWXIM#XHU*%]/OFM;60)"0 !D%AY?//TJS:^)X_#GB
MCQ##XBUQVMH(+-H5D7=M9ED+[%1<D< ]">F: /0**Y37=;TFXBT*6/Q+)8K=
MW44EM]F&[[8"<!",'Y22,^E:6J>*]&T9YEOKJ1/(QYS);R2+%D9 9E4A21V)
MH V:**X7QYXNO?#EW8RV<8DLK*2.?5B#RD$C&-0!W))8_P# !ZT =U14$EY;
M16+7LDZ):K'YK2L<*$QG.?3%8X\9Z";RUM#=RI<748E@22UE0R(?XAE1Q_*@
M#?HKF+;XA^%;N_ALH-71[F:X-M'&(GYD !Q]W@<C!/!YP>#5F+QGH,U_:V2W
MK"2\9DM7:"18YRO79(5VMZ<'GM0!O45A7GC'0K!Y1<WC)'%-]GEG\ES#')_=
M:0+M!Y[GCO4%[X]\-:?>W-G<:B?M-LH:6*.WDD90>^%4Y''..G>@#I**Y>/X
MB>%II;)(M4#K>,J12K"_E[FZ*S[<*Q_ND@UH:MXGTS1GD6Z>8F&,2S^3 \OD
MQDXWOM!VC@^_!..#0!L45SMSX[\-VDUM%+J0WW,(G@"0R/YJ$ @KM4Y)R.!S
MSTK/U/XBZ7!X+NO$.FI/>)"YAV>0Z^7+P,2 @;0"1G/KQUH [*BH;:Y2[MUG
MC654;.!+$T;<''*L 1^(KE-#UO0K4^)-1CUV_NK>&X\RZ%VK[;5B/N1J5!QT
M&!GMB@#L:*S-/UVUU&]ELDCN8;J*)97BN(&C(1B0IR1@Y*GH>U5=9\8Z'H&H
MV]AJ5VT-S<*SQ+Y+L& !)P0,$\8QG.2..: -VBN>TKQMH6KZ?>WL%T\<=BVV
MY2>)HWB/NI&>>V.O3K3T\7Z5]NN+*?[3;74%M]J,4UNX9HLX+* #NY[#GVH
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MM%BGTVT:.*WM[S=)-/(@5N"!A0!PO)R3Z#/?>(-&3Q!H5UI<ES-;+<+M,L)
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MU''-%-O\J1'V,4;:P.UAU!]#[4 <7\/1=)?>*#<Z?>VJ7.JR7<#7,#1[XW
M(R.OR]*I>,)[M/B3X7OX=&U6[M=+6Y-Q+;6K.O[V,*H4]^>OI7HM% '(7UWJ
M'BB6\T./3+^PL9;&9)KJZB" NPV*JX//5F)'H/6N8&CZQJ_PZT_P5<Z/<6][
M!)##<S2*/)2)&SYB2=&)4 8'.3VQ7JU% 'F'C#19M;N+MK?0+VVU^UE TG4[
M7"AU 3F1\]!\WWAT'RY->EVXE%M$)V5I@@\PJ, MCG'XU)10 4444 %%%% !
M1110 4444 %%%% !1110 4444 %(*6D% "T444 %%%% !1110 4444 %%%%
M!1110 4444 <QXW\7#PCID%TMJUU)),H9%!.R$$>9(<=@"/Q85T27,$EJMTD
MR-;L@D64-\I4C.<^F.:XQ[2]\3ZGK-W%'9SZ;)"VE0B:5AE03YS@ $<O\O\
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MN-EXDUNBR(A1L,&0 8#8SQGWQFM#_A*=#^V"T_M. 2F8VXR?E\T=8]WW=_\
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MZQK73/$+W7Q NKCP_<0+K-JJVJ^=&[%A$8PN W^UDGH,'K4?]CZVND_#^/\
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M(S+(R#JX _A&1R>.16%\-=0EU+1M5FDO;F\1=6N8X9;AB7\H$;1STX[8'TH
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MJ(2)N&" >Q]QTJC=:]-_;TFC:=:17-U#;+<S>;<>4%5F(4#"L23M/8 <<\T
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M6?:2<' &%YSVYIMK\2()[2\\W3RM]#?1V,,,<V^.Y>0D1E)-H^4X))QQ@\4
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MC<:?(X\B9I-Y=O+(.UAM]<XZ<5WFDZ8=-@E\VY>ZNIY/,GN)%"F1L #@<
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MBBB@ HHHH **** "BBB@ HHHH *04M(* %HHHH **** "BBB@ HHHH ****
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MF9=KXP/F' QT[9(Q5&'P/XC3P?X2TEUTXSZ/JD5Y*1</M*(6./N=3N(]L=Z
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MR/2@#M:8\L<9422(I8X4,P&3[5S5MXUBG\06ND2Z5?6K7L#S64MP%47 09(
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M$]R.32:A;_:].N+8W#VXEC*&5-N5SQD;@1^8H \AT2&3Q1\$;#PS:65W]JN
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MX8R22BN"!G)(W$''48Z5/X@\':IXDMKNPOKFP:WDNO.M+LQM]HM$R#A#Z\$
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MO_+3GM67H\%W#K.D:CX?TO5=)FO;K_B<Z5/!(+5$*DM(I90H(.,;3SG&."*
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M\.Z]+I.G%;RU\M(I(K<X)5R5.]E4$XSSTX/%>H^)[*;5_!^KV5F \UU92QQ
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M0,@:+^ZV2W*'L1DGTJK?V&JVOCJP\86.FW-Q;SV7V&\LLHL\0WE@X!.",XR
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M+J=BJ:/#(KK]E?\ >!E"L?O\<+QU_&@#+TOQ5K+VNMZ5J-Q"OB*UO$M;=5B
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M"[@D_P GR$C'(W<\<UR^D^)-5O\ P)XEU+7=+M-5M(;JX#V_GX&U,97#+@(
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MZ];ZYK$=SI#:AH]PZ&U,4T9=1Y2*ZE'91M+!CUZD\<UT%S=VUE"9KJXB@B!
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M)=$:0-;*]KNF1?,#[2V0, \\#KZ"O2+6*2&TABEE$LB(%:0+MW$#KCG%2T4
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 <\_C;0H[E8FNG\MKG[&+D0N8?/SCR]^,9_3WS45Y
MX_\ #MC>ZA92W4[76GJ&N88[65F4$9S@+R ,$L.!D<\UY7J]U/J/AHE]+O[2
M_MM726?3;:S=;>W7S?O'"XD9NN<G/.  *Z31M8LQX_\ '%].D\,=W;6WD^;
MX8[(2'7IU!X(]J ._;Q-I7]EV>HQ7!GAO0#:K#&SR3\9PJ ;B< D\<8.<5RO
MP_U&6_\ %GC(&XO9((KF!88[MGW1?*V5PW(YS[5Q7A>YN-&TOP1K4]K>RZ?I
ML=W:WR10NS6SR,2K%,9((*\C_P"M7:>!9VE\;^+[C['?107LL$T$D]J\:LHC
M(ZD<=1P>>>E '=WM[;:=:275W,L4$>-SM[G 'N22  .23BL8^--%CFO8+B6X
MM[BS@^TS0S6L@D\K^^J[<L/7&<=\50^)&G:EJ/A0'2H7N+BTNH;LV\;%6F6-
MMQ4$$'/?CGCCFL;2Y]$U:WO=6TOPYJL<\=C+"\]Y#*\G(XB12S%^2<@<#'O0
M!OV7Q"\/:A<Z=!!<7'_$PP+>1[9UC9B,[-Y&W=[9]NM8.K:D^M?$]O#EU'J(
MTU=(:3RX"T9\UI@OF_*0< #@^YXK%N;6]/P_\ VRZ7J?VC3]4M);J(6,VZ)(
MPV]B-N<#(^O:NBC$\GQJDOQ9WZV;:']D%R;.41^;YP?;N*XZ<YZ4 :MMXGT?
M1-,2">^O;FTLY!:3:G-&SH) =IWN!CKP6Q@'J:FUCQWH.AZA]@O+B;[48#.L
M<=M(^Y ,Y4@8;OT)Q@YQ7#:6MU9?#+5?!-]IEW)K:I<PP1+;,RW'F,Q24/C;
MMW-U)&-OKBM2WTV[T[XD>&EEMKN:&RT064UTEK(T7F\?QA<<_7CO0!T]SXWT
M2V@>=I9WAAACGN)([=V%NC@,I?C@D$''4#G%7)_$>GQ)"8#+>-/!]IC2TB,I
M:+L_'8YX]>V:X:SOKKPKXO\ $=AJVAZA?V>LW7GVDMO;^<LH*@&-AT&!QSV!
MSQ4>L176C^+K+5-3\+RWNDW6G16K1V$)E-E(K,0NU?X?F XZXX]* .WB\6Z1
M<Z1;:E:3/=1W3F*"*)#YLD@SE IP01@YSC&.:Y3P)>O=_$7QB-E_!"J6A6VO
MG8O$2C%ARQQSD\$CTXQ5>]M;S1M6\/\ B'3_  O-'I=O)<)+86D6Z=%E"@2F
M,?Q'!R!D@<&K_A+[9-\2_%6I2:3J-M9WT=KY$MS;F,-LCP>OUZ?G@T ==KNN
M6?AW2)M3O_.^S0C+&*)I"/P'0>YP/>L2Q^(FCWVIV]@MOJ$,EW%YEE)/;[([
MOC)6-B<$CIS@>A.0:7XF_P#)-=>_Z]C_ #%8GV>;Q/!X)2SLKN(:=+#=W,]Q
M;M$(U2+&P%@ Y8D?=STS0!L_\+"T\^&+[7DT[4GM["Y:VNX@D8DB90-Q(+X(
M!('!/7ICFC5OB)I6D:G_ &<]GJ=Q=FT^UK%;VI8NG'W<D9.,GC@;6YR,5Q%S
M9:Q8>%/&OAQ-!U.XN[W4+BY@EB@S"\<FT@A^YX^Z.?UK;TJTU!/B-HFH3:7?
M1VT>@)922-"2(YM^<$CCIWZ<\XYH Z6X\:6D3W'E:=J-S%:F-;J:*- (&<!@
MK!F#9PRDX!QGGO4L'BR"?4M9TX:=?+>:5&LLD3>5^^5@2IC._!R!_$5ZC.*X
M_P 5:;<RZUJ%]HMCK&GZ^LBI#-;1,]MJ"A5QYO\   ,E<MCIWZ"[<QZQI/CC
M7+P:)<WL.JV$$4,EJ%*K*@((8DC:/FSDCM^% &O;>/\ 3;_3=&N;&UNYKC6?
M-^Q6A")(_EYWEB6VJ!C/7Z9/%1R?$;28?#LNL/:WX2WNS97,(B!>"8,%*L0=
MN,L.03G/&3Q7':%:>(M+\-^$M/N]#U);"W^T"^6UP+C<263!#!E0[N<$$XP>
M.M%]!UF+P'XFT7_A']1CEN]=^U6ZHH<>47C/#!B> AYZ=.: /2+7QI%=ZS>:
M2ND:C'>Q6_VJVAF5(S=QYVY3<PQSV;!^G.&^!/$MYXIT!=0N]/GMM\DA61S'
ML8>8P"KABWR@ $D#)Z9K+FCNY_B[IVK)IU\+'^R3;-,T# )(S[P#Z<'GT/%3
M?"ZSU+2O"HTK4M.N+6:VGFRTNW:^YRPV8)R,'KT^M %SQ[XDO?#6BPS6-E)/
M)<7$<'FJR 1;F Z,022,@<8SU([WKKQ(89(K2#2KRXU1X3.U@KQ!XH\XR[;]
M@R>!ACD^P)%#XBZ;=ZEX5"V5M+<SP7=O<"&+&Y@D@+8!ZG&>*SU&JV/C\>(F
MTR]?2]2T];>2-4#RVTB.2NY5)(4J3TS@GF@#J- \067B/3VN[+S5\N5H9H9E
MVR0R+]Y''8BLGQQXCU#P]:Z:;"PEN#=W\-N\BL@V!G&5 9AEF&0.PZDCC+?!
M.BW6G3:]J5U"UNVJZ@]S' V-R1]%W8X#'DD9XR.^:C^(MC?7FCZ;-86+WLEE
MJEM=O#& 7*(Q)VY(Y_\ KT 8LUU_97Q6FU"/3;Z6YNM!W?8HXPT@?S1P6#%!
MTY.[ ]3D5TUEXTT^^\/P:I%%.99IS:K987SO/!P8\$@9&"<DXQSTK,AN;R7X
MC1ZG-HVI6]K_ &0UN7>$,!(9 ^T[2>=H^F>.:XJW\+Z\VAO=QZ*\UU8Z]/?+
MIUY&H2[ADPO\7&0,_3\J /3]$\3V^L:C?Z7)!)9ZG8D>=:RLK':1E74J2"#^
M8/4=*I_$;3H-0^'^M":&*1[>TEGB:1 VQE0G<OH<9&1ZTSPBDDUQ->_\(C;>
M'H3&$ ,<8GE;.3G9T48'!Y)/;'.AXQBN;GP?J]G9VLMS<W=G+;Q1Q;<[G0J"
M22 !DT <1X8T_P (7^B>%K!+6S76Y+:&Y^T6T*B57B".Q9QC.3P>3G-=%K/Q
M$T[2'O'^S2W-K8R"*ZFBDC!1LX8*C,&?;D9P/Y'&CX0T][;PGH4%_9&&]L;1
M(2) "T;! K8()X..U<?;V>N>&]:U6P_X0^+6[>]O9;NSO5>,!?,.XI(6R1@G
MK^6: .MO?$MO=N]AINFS:RS6JW$T<1146*0'9N+D EP#A?0'.._'?#?7[30?
MAA822HS2W%[-%;VX959V,C'&6(   )))X ]< Z-O;:[X6\:ZE?+HTNIV>LP6
M^YK$HHMYHD*%=K,,(>N>W'6N;TWPOXGL/!^BW"Z&LM_I&HSSMI]PZ$7,,N0=
MIR0" >_U]B =@/B9IXTW6+AM.O3<Z2P^TVT120A""1('#;2G!Y!R/2I%^(4+
MJA&BZDOVF>&&P:1 BWAE!8,I)X 523G';N<5G:BFKZQX)UN.'PE_9SWMM]GM
M[5#'Y[L0V6?!"JHXP.O7VI^H6_B%/"GA:TLM-O3! 8HM4M8942<QH@!"MN P
M2/X2"1W&30 GB?6K?Q'\/_%MK=:<UO>:;"Z3P3[9 DFS>K*PX/7(/!KJ?"/_
M ")6@_\ 8.M__1:UY[_86NQ6/CBU@\-7$$6KQ+]DC2>(JO[K;V;[Q/)[=>3W
M]#\*1W$'A/2K:ZMI;:XM[2*"2.3&0RH%/0D8X]: +FK:C%I&DW6H3_ZNWC+D
M=V(Z*/<G 'N:X7P%>:KI/BK6/#.O7/GW4R+JEO(1C<).)%'L&X ]C6WXEAN]
M7UK3-)?2KN32%F6>ZN8Y%4%E^XOW@V V&)']T8K%\7^'+NPUK0-;\-Z9>WE]
M97)\X?:MP:!AAU)D?@^F/4T :VL>.FTSQ%-H<.@:E>7B69NXUAV'SDW!?EP3
M@?>^]@Y7 !R*Y72=8D\.^+/&4>C>&KF\82VT[VMMLB6%3""2<_Q$EN "3@UT
M$,.I2_%6+6SHU['82:,+(R.8_DD\[S/F <G '&1GFELK36-"\;^)[_\ LBXO
M+75/L[VSP2QX#1Q["&#,"N2>O(P/S *^H>*_#^LOX2U"329;R&\O56SNF8!;
M:<DC:1G=N!'ICCK4FG^*-;F\<>)+&734DATV" I!#<C=A@S9&X!2S9&<D  #
MDUDR>!]4TS1/"&G6EN]Z^G:JFHWDBNBJHW,S*NYAG&[ ]<=NE:T&F:WIWQ*\
M0ZA'I+7.GZG;0!)TG1=AC3:5P3DDGIT'O0 RP^)LE_HC:RGAG4CI_P!E:99H
M\.'D$@3RU'4G)Z^QZ@9K3C\77CZQ<Z')I<,6KBR%[;1FY+1S(3@@L$RI![%>
M>U8&D:)XJT?X-IHEG:-;ZW;[A@3H-ZM,7;8ZL<'82,G&#^!J+2=#UJ#XAV&L
M0^%DT[3WTXVD@%XC/&2X8O(1DLV.G4G R1V (YO$[3_":WUKQ/H,6JVTSJ[(
MLPP"9" 6# %<$@ +N/TKMK[7G@UI-!TJR2ZU!;8W+H\OE111YVKE@K<D\  =
MB>*X1_#_ (GN?A%+X6D\/[;R(I%$WVN,B3$N\OU&!@ #DG)Z8YKHGTW5[#QP
MOBFUTZ>>WO[1;6]L0\0FA93\C@E]K#L0&XSGGL $_P 1XH?#4^JC2+II[.[%
MG?V8D3?:R;@O)_B!)&" <^U7-*\7W5UXJ.@ZIHDNF32VQNK1I)TD,J X(8+P
MK#TR>G7UYO4_"FM?\(YKKVNG--J6N:E'=-;^?&JVT<<BLH))P6(7G!(R?;)U
M[K3]7NOB=I&N+H]PEA!9/;S.\L.Y&?G. YR!T./?&>X!W%>:?$FXUB[$L^C;
MMGAQHK^39_RUESG9]%B+,1_MBO1;J66"UEEAMWN)54E8495+GTRQ 'XURN@>
M&()M&DGU[1E.J7,DDUVLI1][,<X!4D%0,*,]@,T :UQXHTZW\*KXB+L]D\*R
MQB,9:3=C:JCNQ) QZU0;Q'K<5Q/:3Z D5P+)KN"3[2S0'! ,;N$^5QG. #GU
M[UQNF>#O$EQX!U3PC=6DEDD,QGTF[>YC?@2!TC<*20<]QD<GT&>NTJ7Q?J\?
MDZWIUMI420LLC1W"S&Y<J0. /D7G/7.0!TS0 OPYUC4]>\&V>I:FL1>XWNLB
MR$ELR/P5V@*!P  3QZ5UE>:Z++XG\#_#9+:30[5IM-.TF6_15EC+LS./3@@
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M@/F5/ES_ +?L:[Z@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *04M%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4E+2"@!:*** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHK*\2
MOJD?AN__ +%MVN-2:(I;HLBH0QXW;FX&,YY]* -6BO-_AY9^&8=;O1!HMYI7
MB.*+_2(+^9Y9#&2/G1F)#*3QD?U%;OQ \27/ASP_$=/&=1O[E+.U)C+['?\
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MY@V[E;.P8#?P\$^U,NM5V^._#%EJGA^S_M"[MIG2[$V]K9E3+HORC/89SW-
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M!]* .RHKS]?'6K7>G6FKZ;I4UY:SR _8X["?S/)).'$I^0G&#MQCL">M6/\
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M#.EO9N7N(S)G$.0H4$=>>2>/0]@#U.LO7_$.F^&=-;4-5F:&V4@%EC9^3TZ
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M<LBB5!DHX;)P<C##UZ55\)>*?$GB6[,KZ=IT6G6]Y<6EVR3,9%9/NE 1@C.
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M)$3C>A7/ID8H \A:75)OA5X5N;FX@NI9=3LI(LHT9!,F?G;+;B3W 'TKI/\
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M1K6U\V*>YV!CG<RE4Y &.>IXX%=%J_AN_P!0\8:1KMO?V\*Z<DB"&2W+F02
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MQ@A2WROQG/(R!QCBJ:?#+4(/#MUHD7B(-;37PO%,UIDIA]_56&XD@9SQZ 4
M:>I7WB:7QZVAV&HV-O:RZ:URCO:%VA(D5<XW?.>>.5'/0XYP'\9^(F^&U_JJ
M7=JNH:7J)L9Y3;9\\"54W*-V%/S@]"..@KK5\/:J?&<?B"35;;:EC]D-LMH0
M""P8G<7S]X _3BL9OAO.WA75M .MKY&I7IO))/L?S*Q8.0/GQC*KU]Z +&K7
M_B:3XA1Z%8:G9VUG/IS7*LUGO>/:ZJ>K88\\=  >AQSCVOCC64\#3W5S+$U[
M;:S_ &5/>B'"HF\ S%>G /TS74MX8OF\76FOG58M]O9FT, M,*ZD@L<[^"2!
M]*XW7_#]QX1\+3VKZU<&WU/6$N)KF&RRML6.YV=<MNC.T#:>^,Y!H Z;3-3U
M=_B+>Z(]^USIUM91W(D:%-VYB1L9E ';<, =*[*O,?!,FH6^KVMKI?B.PUG2
M79S<1VFDI;)"NUB&WQX7<6VC;WSGM7IU ' :A?>*[OXB77AVPUFTL[8Z<MXD
MOV'S&B_>%<<MAB<=20,9PO&:P;GQMXLB\,Q9GM8M6M->&D73M;Y6?H0X&?E!
M'7 YSD8K2O?M5S\<B-.U*&U<:%Y;.\0E5F$Q)C(R/FQ\W7/'IFM*_P#AU]JT
M.TT^'5C#)'J!U.XN6M@[7%P6W;B-P &2>!VQZ4 1C4M<A\3:?X1N];66\GBF
MO)[V"U2-Q"#A$53E0<YR2#T_&H8M7\27=WXI\,V]\?[7TI4FL+OR4_TA'3<J
M2 KMSG@D ?H:W]9\*MJMUI>IIJ!M=:TX$1WD<(*N&&'5HR?NGGC/&>M7=&T"
M'2KJ^OGD-QJ6H.KW5R5V[]HVJH7LH' '/N30!SOASQ)<^)=-\._9K^=+IT>7
M4<1QG'E_*R-\ORDN5QC'RAO2J6G>(/$]UIGC5('%_J&FWS062I$J':,=!T)
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M0C<VIL=068K*!D1R< *3T!&1FJ^F^.O$VN:>]W8>%X8H5%PCSW%Y\D4D9/!
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !2"EI!0 M%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 445F^(+2^U#P_?6>F7$=O>3PM''-)G"
M9X)XYSC./?% #;+Q+H6I7AL['6;"ZN@"?)AN4=^.O .>*N7U_9Z9:/=W]U#:
MVR8W2SR!%7)P,D\=37%^$+Z\TO6U\,Z]I.GVVI"V\VUN]/CQ%<0J0"#D9##C
MCO[=^QO],LM3$*WUNEPD,GFHD@RN[! )7H<9.,]^>HH S['QCX<U34$L+#6K
M*ZNG)"Q02AR<#)Z=L#K6W7%Z98P7GQ+O[RWMXH;72+1;-/+C"AIY<.YXZX41
MC\37:4 %%%% !65K'B32= :!=3N_LYG;;%F-FWMZ# //M6K7 ?%ABFD^'G5&
MD9=>M"$7&6^]P,D#/U- '3V?BC1[[4([""Z;[7(K.D4D,D98#J1N4=*V*YJ.
M:ZUK5[I7TEM/NM-C1[&>\4/\\BNK'$;X*X &-W]*YG_A/-:?X?>'O$T:6)DO
M+M;>ZA,#[<-*4RAW_+C:>N<Y[4 >EU3U35;+1=/EO]0F\FUB&7DVEL#Z $UQ
MMQXF\6W7B[5] TJSTGS;+R)5>=Y"/)?[V<8RW(/8#!Z\5AV$NM:QX(^($FJ7
MT,J)->P%%MBC;HXD 8'<0%VK]W&><[J /5+2ZAOK*"\MGWP3QK+&V"-RL,@X
M/(X-35YKHOB+7-&C\%VMY%8-I>JV\5M&D0<S1,(5*L6)VD'N,#'OUIUUXY\0
M7-O-J.B:<UY;1W1CAM$TZ9VN(E?8S"<'8#PQ P> .<\4 >D45YW/XG\97GC"
M]T+2K71XVBM8[R/[8),A&;!5R#PW(Z# P>M>B4 037MK;W5O;33HD]R6$,;'
MF0J,G'T'-3UX]X\U&"ZOKKQ%;ZM:K>>'+J-;*S,RAY-I_P!(RI.3G(7_ +9'
MUKN/$'BMK;P-'XATJ-I8IUAD60Q&3R8G(W2,BG)VJ22 >HH ZFBN"E\6:E9^
M&]2UF*]LM8LD:%;:ZLH"VQ&.)&DC#$EE!!(RN?;FH=2\6:O9^"=7\0:=JFDZ
MG#:^6]K,L)PZ'&Y9%#Y5QN'IVX% 'H=%<MJVO:G9>-]$T>W^RFVU*WN'/F1M
MO1XT!'S!L8)(XQVZUBZ#K_C35X[F^CBTB:"RN+NVGMD+J\KQY"!">%Y"CD]"
M3[  ]#HKSBP\9:N_BGP_I4EU93MJUM,9XT@.VSN(X]Y4.&PX!^4C.>.HS6=<
M>-/&,7A75M?,FD"/2+^2WFB6%R9PL@0@?-\@YSW)]J /6**Y&;Q!?:MXH?0=
M)ECM##8+>37$B>8=S\(@7H!W)Y[ >M9]WXLU^QAT73-1LA#K=VLTMT+&'[3L
MCC.,HN[JV1U)QSD4 =]17FP\:^(['PW>WFJ:1=PK;WZ1"\:S*M]E8G,IBSG<
MH&".G(//(KJ/"6I76JVEW<R:E9ZC9F;_ $.YM@ 6CV@X< \."2"..W% '0U2
MU75K+1;+[7?R.D.]8QLB:1F9CA0%4$DDGL*NTR2&.4H9(T<HV]-R@[6]1Z'D
MT <\GCO0Y+V:R0ZDUU"H>6$:5=%T4]"5\O(!J6P\8Z/J>M0:5:23O<36@O$+
M6[HIB..06 SUQQT.0<$$5@Z+_P EH\3_ /7A:_RJGK-GJ'_"XK"+2);6S9]#
MD42O%O$8\[)(0$9.2.I Y)YQ@@'I-%>9Z9X]U5M!CM[E%N-7&M2Z0TT,7W_+
M!9I%3(&=O &<9]N*W_#&H>(Y==U"SU2TNFTQ4$EG>W,*12$\9C<(<$\\$ <
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MM%4=9U./1M$OM3E0NEI \[*O5@JDX_2N*TV_\:7CZ%J<$5S);7>QK^*X^S+
ML3@'=#M8N"N>C9S^E 'H=%>:SZ]XBT_Q;=>$KO4V-QJ+))I&H&*(".,9,BNN
MW!8 $#CDX^[6KJ>J:I/XGD\/VDFI%+2Q2>6>R^S"61W9E!/FX4 ;<_*.2>PZ
M@':T5Y[9ZYXG:]T#P[K)CL-1O/M$EQ<Q%&=XXQ\H4#<H9LC/7 !QUXB\57WB
MKPOX1N+J;5TDGBU1%M9D1"SVS, %E!0#=UR5% 'H],BECF4M%(KJ&9"5.0""
M01]001^%<I>37_\ PL#^RTU.Z2SNM)EG,:[/W4BR1J&0[<CACUS7&>$-<O='
M^&&@3B>ZGO-8U%K0<QMY;--*69-^ 6.#C<2-Q';B@#V&BN1\/'Q3%XDO(M0A
MN&T22$/!)>20&:.48!7]T>5/)R?2I/&VI:EI46GW-M%?OIPF;[>=.C5YU7:=
MI 8'Y=W7'/\ 4 ZJBO*[SQ%?QZ1X9O\ 3?$KW\-[X@BLVE54^>W=F.R0;1AP
M  < ?UJYK'BO4_#_ (A\8NTTEQ:V&FPW-I;N@PCOD=0,E=W7GCF@#T9V*QLP
M1G(!(5<9/L,\5D^&_$-OXFTZ2]M[>>!8[B2W:.< ,&0X/0D?K679V&NB_P!%
MU.'7A-92Q9U&.<@K,64;#$  %Y..,<8ZGKYU"VLZ+\.]=URQUNXMWT[6)FCM
MXT3RY?WP5O,)&6SGV''2@#W&N<U+Q7]DN+^&QTJ\U-].,8NTM0"Z[QD!%ZN0
M""1V!_"M^&3S[:.7&WS$#8!Z9%>9Z1I<D?B+QS<IJNI++:RHRE9\!V^S@@L
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M)SO(.,L3UP!Q]<UZ9IUQ9:KIMMJ%HJO;7,:RQ,4QE6&0<'IQ5GR(NT:#_@-
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M75!=++.SV[+ \2HP\H(.@););KGZ "72='G^QZ_+X:UNRLM2U*YCG'DVVZ&
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M4+DW$KF*,,&+;F P.A8 ^V*[BLS7M3N=(TPW5II=QJ4H=5^SV_WL$X)^@ZT
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MFIPRS6[&2(.X'(W8<^WR@;LG.,&+3/&&L7O@^XNY7L8KNRU1K"\NW 2*.-&
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M1D=0RL,%2,@CTI:* &0PQ6\2Q0QI'&HPJ(H 'T I]%% !1110 4444 %%%%
M!1110 4444 %%%% ",JNI5@"#V(I:** "BBB@ HHHH **** "BBB@ I,#.<#
M([TM% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M+]R!LY!Z$9Y_(TNJWVDW/BFR\1Z9JMW9W\$#6LJR:1<R1SQ$Y"L JD8/.<T
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M@A0"22!U/>N*\,0:1X@\57GC+3;:5(IK9+:.>2)H_M# DLX!Y/&Q<X[&NVH
MX_XBZCK.E:':76C7JVTQO887WQ*ZLKL%YSR.2.G-8S^(M8\*^+M:L-3U1M4M
M8]#;5HO,A6,HRL5*C:.A(]^WX]/XN\,S>*;*UM4U'[&D%PESD0>869#E>I'&
M:J7?@N2_\6OKEUJ2R)+IYTV6V^S8#PDY;YMW!))Y[#CWH PM4\0ZWH_@72?&
MC:B;@,()KZR")Y3Q2D96/C<K+N !W'ISFK'AZ&ZN?B7XTC_M2]#6R6:(6=''
MS1R'[NW  +$@?GG-:5AX%:VTRWT6ZU:6\T6VE62&UDA ?"MN1&D!^95(!Z#.
M!VXJVWA6>'Q3?:YI^KS6IOHD6XMS$LB.Z A&R>0!G[H(S0!R=MXOUB/P=I@G
MO]^I:CKC:9]L:)1Y:>:RE@N-N0J\<8Y[UJ^(-2U[P98:Q?S:C#>V#)$NGK.!
MYT4K,$;<0%!0$Y_3BGQ_#>&7PK<:#J.IR7$;7)N[>>.(1203%F8L,$@\L>/\
MBY;^!8Y]+O;3Q!JMYK4EW"8&EGPGEID'"*O .0I)Y)*B@"O'%XSMM766 ^=8
MO;2+)'>SQL1,%)1DV*."< CICI63X1\0W^H^(;"QU'4KZTU2&*3^T-,U"-$$
M[;>'@(7E0<G&>GTR=?2_ =S:64EKJ7B2^U1%@>*T\]0/LY92A<8.6;#$ D\9
M-7+#PA+%JNF:AJ>K2ZC-I<;I9LT*QL-Z[6+D?>.WCMZ\GF@#J*XU=1N_$/C?
M7="COKBQM])@M]K6^ TDD@W[B2#P  ,=#DYS795SE]X4W^)3K^F:A)I]_)#Y
M%SB,2).@Z94]&'8C\<T <%=^+/$K^%[!#J1@U2V\2C1;J>.)-DX!SNP1QVZ$
M=Z]/T33[S3+ V][JDVI2>:[+/,BJP4G(4[>#CU_ETK U'X?6E[I-A80ZA=6P
MM+W^T&E4*[S7&2?,8L#SDDXZ<^U==&&6-0[;F  +8QD^N* ,+QMKTGACP;J>
ML0H'FMXQY8/3<S!03[ L#^%<[KM]JOA:3PYJ46JW-[;7UU%97L4Q4B0R XD3
MCY2".@X/YD]MJFF6FLZ7<Z;?1>;:W*&.1,XR#[]C6#I_@UK?^SXM1U:?4K73
M)!)90S1(OELHPA9ARY49P3]>M ''Z79R_P!D?$LM>WDY26[B"NP??^X&">,D
M]AC J+2[K5- T/X>WL6L74L&H26UE+9,J"$1NG&!C.1@'))S[=*[%O ^V\UZ
M2VUB[M[;603+;JJD)(R[6<$C.2.W0=>PQ!-\/O.TO0K ZW=+%HLL<MJPBCSN
M3A"W'.!Q[T 8ZW_BCQ1IVI7^A3R0WD-_+#:G[0@AB6-]NQX\'<649R>A88P.
MK)AXGUOQW=:/'XFGT^'^RX;Q3;QI(JNS\A3@97J,GD@#GJ#K-\-H8M;NKW3M
M;U+3[2^<R7ME;.%29CU(/5,\YQZ\8K4M/"(L_%K:_%J4P+6XM?LHAC$8B!RJ
MY"YX/?.>U '2C@=<^]<GK.J2S^.]*\-B[EM+>:TFNI3&=K3E2%6-7ZC'S,<'
M/ KK*YSQ1X-LO%$EG<O<W-EJ%DQ:VO+5]LD>>H]"#C_/- '/:A?:UX>72]!N
M-9^US:EK'D+<J!YT%J1D*3_?XQN(Z'U -37%YJ>C^.SH$>H7<NGZAILEQ"[L
M));65"<D,P/RD?WL\XK4F\!:;<:*+*:XNY;L3K=C4GDW7 N% "R;NG   &,8
M'2K$?A3$]Q?7&IW%QJTEM]E2^>- T,><D*@&W)/)./TH \ZT[4?$3_#SPYXD
M_P"$DOC?W.H) ZN%:(QO,T9!7')'7.?;TQUU@NI:?\2)]$?7+^ZM+G1S=YN"
MA:.42A,IA0 ,$\8Q1'\-UA\*V/A^+7KY+6RN1<PN(HBP(;>HY7D!LG\<'BM1
MO"DS^*H]?.MW@N$M/LA18HMI3(8_P]2PS0!YZNH:_#\+].\4?\)'J+WRW@38
MS*8V3[0T>'&/FX[Y[ <5V$ OM.^(\>CMJ][=V-[I<EQ(EPXW)(L@&Y"H&T$-
MT&!Q5H_#[3CX8C\/?;]0_L])O.5=\>X-OW]=G3=S_P#6K3;PW"_B.VUQ[Z\:
M[MX#;JN8PA0X)! 3N0#U^F* /-[SQ#JB_!:?4HM4N_[1MM0:'[1YIWX^T;<$
M]_D(ZUNW45]JGQ4U'0)=;U*+3GTD7/EP2A"K&3;A2!D#'X\=:NS_  NTBXL[
M^P:_U-=.NY_M M$GQ'$^X,2O'.2.^<9XYYK7@\(V]OXBEUQ-1U WTEK]D+.Z
M,!'U Y3J#@Y.23USS0!Y]#XEUB?X5^'-9EU*Y^U)JD<$Q1POVB,3%<.<<_*,
M?SKIOM$WBWQ7XHT22^N;%=,BACM!!(T;*[H6,QVD;L';@'C ]ZMK\.-,70(=
M$&H:D;&&Y^U(A>,D2;MV<E,D9)./>I]8\!V&K:G#J:ZAJ5CJ*Q"&:ZLI_*>X
M0=GP,'\ /T& #'U WAU/1M*N]7GU=_L,BS6E@Q@DFE5@IF=U8!%4@CD]<\$\
M#C[Z:YU?X?\ A6ZU*:YDN4\1I:DR3'<$$KC#$8!8!0-W7CK7ID_@?2Y+ZPN[
M>>^LI+.V^R#[+<%/,ASG:QZGGG((.>^:K#X;Z(NB?V2DU^ELMV+R$BY):"0$
MD%,C Y8]B3GD]* *$\]SI_Q<L;".\NFL!HTDHMGF+(&5MN>>IP.IR:Q;>ZOM
M9^%4WC9=0NH=;1)KM62X<1((W8"/RL["NQ<8(R<YSWKME\'V:>)+775OM0^U
MVT'V= TJLICZE3N4DY.223GG@CBHAX$T=$N;:-KJ/3;J7SIM.60"!VZGC&0"
M>2H(!]* .=1[O7O&FAK/?ZA:V^H: ;JXM89RBAB8\@8Y7KU!!XZ\FLS2I_$-
M]X*U&UT^XFO9--\036XAENF2:YMH_F,0DSG=SUST%>B/X;LGU^#6A)<)=P0F
MWBV2818SR5VXP1GUYX'H*SD\!:5#"8K>YU"#-\VH[XKC#?:&4J7SCN&/'3VH
M B\ W]E?VFI/:G489!=?OK#4&9I;-MB@IEB3M."P_P!X]*ZR1!+$\9+ ,I4E
M6*D9]".0:H:7HMMI4EW-&\LUU>2"2XN)B"\A"A1G        %:# LA4,5)&,
MCJ* /&-/:_M/ 6J>,!JFJ7&IZ?+>16Z/<%HPI?9EE.=VW);\!V QN:-HNM6F
MI:7XC34["&P:$F:-)YI&O0ZY3=O."^><@#J>W%=CH_A33-%T^ZL+=9I;.Z+&
M6"XD,B'=G=P?7)R*JZ)X#T'P_=I<6,-QF+=Y,<MR\B0[OO;%8X4D<9ZXH \Y
MUQ_M7P6_X2T7T\NLS-'*]TDSJ5+3!6B !P% )7 XXSWKK8XU?XT7]BSN;6?0
M/,DMRYV,S3!6;&< X %8WCWX=6-KX/U*+P]IU]+>7<R/':Q2R/$C>8K,P3.U
M?E!&<>PKN-0\*Z/KVH6^KW$-S'=+#Y6^.62!GC/.QP""1[&@#S>]W0_"9Y;>
M[N5^S:X\<3I<,,I]J*X.#\PV^M:^O:)'K7Q?.DSWVHQVESH33.L-TZX?SL K
MR0.@.!QQ]:Z,_#CP[_9#:6D5U%://]H>..Z=0SYR#C.!@]ACH/2M-/"NFIKT
M&MYNFU"& 6XE:Y<[H^N",X///UH \]LK#4?&QU^)=4@MKJPU![6%YA(9[5(R
M/+9=KJ,'&<D<G.<UI:3.OBCQUJ&CZY.M[#IVG6K01[2D=P[J&><+G@Y( ],U
MT.J?#OPSK&M'5KNP;[6X E,4SQK-C^^%(!_KWJUJW@S0M9O[>_N;1DNX%")/
M;3/"^S^X2A&5Y(Q0!S_P?C6+P?=1KG:NI7*C)). WJ>M=O?SR6NG75Q%$9I(
MHG=(QU<@$@?C5'0?#>E^&;62VTJW:"*1R[*968;CW )('7MBM:@#QN>!)_@[
M!XQMYW3Q#$HN_MX<[VD\T!D/JIY7;TZ<5:.@6_B3XH:C8ZDU['#+H\-S)#'=
M.-LI<$]^Q[=/;I7=0>"M!MIY'BM'6*287#6OG.8/-SG?Y6=N<@=NPJS'X8TJ
M+Q ^NI#.-2==C3?:I2"O]TKNV[?;&!0!KUYWX_L([KQCX/C,MQ&MS=2PS".=
MU#1[,E<*>,\C(P>>M>B5POCO1KW6/$'A=H-.N;FUL[MI;IX9 A12  0=P.<\
M_+R,4 <5XC-UX(E\5Z;H,L\&E?9;28CS&;[*9)=C%#G<,@'@'/.>U=99>%H;
M;5HM277;,6U_9M +/3;=K=+H!2XDR)6.X8^^.W&>:ZZW\-Z1;6M[;+9B2*^)
M-UY[M,TW&/F9R2>..O%4=(\!^&M!CG32]-^S&=#&[I/(7"DY(5RVY03CH10!
MY7I?ARPNO@=)XDF:Z?5!I]PGF_:9,;5E;:-H.,#;TZ9))S6WJVAV5IX@\#F
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MB9=-R2*,8;/? Z]*Z<:QKFF_$2QT:]O(+NUU*SEEC1(/+\F1.< Y)*D<<Y-
M';5DVOB73+VYU.WMY9I)=,*BZ06\FY"V2 !MRW SP#7#-XOUZROO#QN+N.XD
MOM3^PWT,,(-K'N8@"*3 9F  SRPSD<5N^&_^2D>-_K8_^B30!TVE:I::UI<&
MI6$ADM;A=T;E2NX9QG!Y'2HM<URQ\.Z5+J6HO(EK%]]HXFDQZ<*#CGN>*Q/A
ME_R3;0O^O?\ ]F-1_%/_ ))EKO\ UP'_ *&M '7@Y (Z&EK@]4U+Q+X:UC0I
MKG4;?4-/U*Z6RG@%L(O)=@2K1D$MCY3PQ/Z\5=,UOQ?XBT;3M<TB/ N)/,>"
M9HOLYB#E2@_Y:!L '=GKGC&* /1JSWUJT37X]%/G?;)+<W"XB8IL!Q]_& <]
MO\16A7&WFKZK#\4[#1EO!_9]SI\L_E>4ORN#@'/4T =E17D46O>*KKP9XAUW
M^W]DNCZA.L<0M4VRK&5^5_8C/3'7J:]:A<R0QN<9903B@!]%<?XUU;4O#UYH
MVJ17C)HYO$@U&,HA"(_"ON*Y #8SSW&,5C+XYGT_Q-XBLKRZNKBT2W>73&,,
M:&1XR5EC0A?F(? !/]T]>I /2:S8-;M+G7KO1D6<75K$DLC-$1&0W3#="?\
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MFUNI+22.< -O3&>A([^M<II>I:CK7BM?#>HZCG[!IBS3S:=,T?VB8OM)W#G
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MQ@FMK&&&XG%Q*B[6E";-WOCM5BB@#,\0Z);>(] O=(N\B&ZC*%@,E#U##W!
M/X5F77@;2;H>'@591H<@>#N7 '1C[L%8^X]ZMZ)XGMM<U75].AMKF";2Y$CF
M\]5&XL"01@GC [^M;= '.S^&)Y?&T/B5=3*-%;?91;>2"IC+;FYS]XGO].*2
MU\*O!XROO$4FH&1[NW%LT A"A4'3!SG/O5K5O$":?>"PMK.:_OS UR;: J&$
M2G&[YB!R< #J3]*3PWXA_P"$CLYKD:7J.GK'+Y82_A\MW& =P&3QS0!@GX=$
M^!Y?"G]NW36+D*C/"A:.,-O"C&,G..3V':KA\'7+^)=*UN36"TNG6YMTC%L
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ML(KU+*2]MDNWY2!I5#M]%SDU6UW4!8Z;+Y>H6=G=NA^SM=8*E@,XV[E+?@:
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M9>+9NR%P<#G/]-"]\%W%];:_-)>0_P!IZU +227RR8X(0I7:BYR3R2<GD^E
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M1B)YFN9&W(.@(+8(X]*IVW@7PY;:7=Z8--22RNG+O!*[.JYYPF3\G))XQR:
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M9$&UF<D9R3NQ@C&!G/- 'H>GWL6IZ9:W\ 80W,*3('&"%8 C/O@U9K&\(_\
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MIWDE]S');<222>>3S5W4]?N(;"SGT?2;C5Y;Q/-ACB98EV8!W,[\+PPP.I_
MXKZ%XRL]6\.7VKW,$MA_9TDL5]#+\S0/&,L,CKQ@\4 06_P]T:T2X6UGU& 2
MW?VP;+QSY<N/O+G/)[YSGH>.*FN/ FAWMGJ,%_"]Y)J+H]S<3,/,9D&U""H
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MN0>3$(HYMB;E4# XQMX''2N4B^&5O#X6D\-IKNIC39)1+Y>V'*G<'P#LX&X
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M10!@2>$-.DTJ]L&DNR+XYNI_//G3#&-K/U*X.,=,4C>#=*?3M/LV^TEM-/\
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MBO3M#TC3/#-A#H]@WEQ@N\<4DNYCDECC/) S0!K4V1S'$[A2Y520HZGVIU%
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M4M;:"8R!)-X-S-"8B=T[# YZ[><'OFNET6WALU^(4$$:1PK<.553TS;*3^M
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M.#Q_6NROVN$TZZ:T4-<K$YA4]WP=H_/% #EN[9KI[5;B(W"*&:(.-Z@]"1U
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MAZ">T>+R62:_+ETQCYF())QW)SWS5.]TJZU#3;2PN/"\#0687[,5U!D>':,
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MI>(-!O/%-M'!K/AO2KM8SN0M=2*RGV95! ]LUVVY!CYASTYZT$JI&2 3[]:
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M0='AU)M2BTJQCOV)+72VZ"4D]<MC-%KH.CV5W+=VFE6,%S,"))HK=%=P>H)
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MHWC>$]@48!N>W'/;-+8>*],U">YMD^UQ7=M'YTEK/:R),8\X#JA&6!]LG\:
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M]]#Y%PC7+;'CYPNWT&<CT-10?#GP];SZ?<+'=FXL 5@F:[D+A>P)ST7L.@H
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M3YS[5XSCC'7VKT21$DC9)%5HV!#*PR".X-8FH^$M*O[(626=I;6S2*\JPVR
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M:]ZHH \DUF;1-0\$>(]0T#2[O;J%JL(O)%E:2[DSPJJV6(4#[W3G Z&K7B^
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MN10R94J<'IP>14E% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M .\2K L?<DU./"ND+K']K"*X^W^1]F\_[9-N\O&-OW_Q^O/7FMFB@#SSQ+X
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M<%L9R<5YS$LMK\&?#%N+28WUMJ44KV_DMYB[9F8DJ!D#'?W]ZZO0K@6?Q?\
M$XFBG U2"SELW$+%942/#-N P "0.<4 >A51U'6++2VACN9&,TY(AABC:220
M@9.%4$X'<]!WJ]7":_\ :=*^)VD:[<Q2/I!L)+-Y4B+BVD+;MS8R0& "YZ4
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M%\+>]\](;<L^2F =B G.,$@#CF@#KE^)&B_V#?ZL\-]$FG2K%>VTD(6:W+'
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M+O-#%WW$ N4!/WF QTS6K=>*M L[2SNKC5[-(+PA;9_-!$N2!\N.HR1D]N]
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MMW8SQGC&#SQ0!U-%<?XS\16$>AZQ9K+J&^WMR9[BP#?Z,V,KN=>0>A('0=<
MUK^$7>7P7H4DCL[MIUNS,QR23&N230!LT5SU[XUT>P;?.T_V/S_LS7JPEH%E
MSC:6'OQG&,\9R#2#QGIG]JZGILD=S%=:=;FYF25 NZ,=U.<$?Y.* .BHKEKC
MQ_HUE;Z;-?)?6@U)PMN)K9@3GH3V'T//M4FD^.]#U>2_C66:TEL(_-N([V$P
M,L?]_#=O_K>M '2UA>(?#1\0S61;5]1LH("WG06DQC6Y5@/E?';C]3]:9#XQ
MTY]0AL9H+VVN+BW:YMTGMR#.BC)V 9);'.T@-[5D)\5?#DMM:W<:Z@UG//\
M9S=?9&$4+Y( =CTSCH,GD9 H [2**."%(8D"1QJ%11T ' %/KG]2\766G7&H
M0+:WEX^FPK->"U16\E6!(SE@22!G SQUJ2[\46]N[1V]E>WTT=NMS-%:JA:*
M-L[2VYE&3@X )/'2@#<HKG8O&>F7L%@^EI/J4E] US##;! _EJ0&8[V4##$+
MC.<]N#6GH^KP:WI$.I6T<R12[MJ3+M<;6*D$9X.0: +]<_J'A5-1\4Z;K\FH
MW23:=O\ (A18]@#J%<'*Y.0/7C/%48?']I/INL7J:/JV-(E,5W%LB\Q2 2Q
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M_HJQS(ND6 2==DJBV0"1<YPW'(R :D&CZ6!@:;9@>5Y&/(7_ %?79T^[[=*
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M&(-D.#U8@8PH')ZXYJF+;4FC^(X_L?4,:K$?L6;5@928C']>I'7MD^M>K44
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MC#SCP$R%QD]O7M6C'KVFRZU-HZ3L=0AC\V2'RG!"?WLXP1SV-8OB?1[?Q5X
MN8=.$2RR0K<6CP$$"5 "F"/]T+GTKA;R\\0,-$^(=M;R)>7873GLG;@1.NU"
M>.GG;FZ]&7IS0!V]_K>F:EKFAI;>))[*474BBS$++]L*Y5D8, 0 5(STR".O
M35NO%FC6=Q+#-=./*F6"61()'CCD;&$9PI4$[AP3W%<;XN6WT34O -A]K3=:
M7J"1Y' 8ILVEVR> 3GD]ZR=<N8+#5-4U'PWJ?G7,FHB&]\.7JB07<H=5+Q*3
MD'@-D<<=L8H ]*U/Q3H^CM(+ZZ:-82JS2+$[I"6QMWLH(7.1U(ZCUK626.2)
M94=6C9=RNIR"/4&O&A/HVG:WXDT7QDFL+)>7TMS;K!-<F*ZADQM0+&V"V/EZ
M8Z#/%>L:';+9:%8VRVK6JQ0JJP-*9#$,<*6/)QTH P;CXF^$+9)'DUA"L4OE
M.4AD;:W'7"].1STJQJ7C_P ,:3(D=WJJ*SP?:%"1N^8\ @\ ]017':=J6D:=
M<_$.ROWC\VXO)-L&WYK@/$ $4 ?,<G&!D\Y[YJEHL,.A^(/AYIFJR1K>V^GW
M"2K)RT3R %$;T/)4?YR >C2>,-%2**1+F6<2VRW8%O;R2E83T=@JDJ#[XZ'T
MKE?'GB")(/".N:=K<L>FSZO;I,\$VV*2$DLV['7[N"#[@BGZ3>1>%OB!XEBU
MAC;0:EY-Q93LI\IU1"IC!QC</[OY=JY2>PDT/PWX1CNE>W#^*8[Y;>3[UO;L
M[%=P_AXP3GH2: /2X_%6B:[IVKQ6NHSPM:PL+D^3)%- K*<.%90W3D$#M7%:
M_J\>F>%?!&I6'B749M..JP13W<\K(9X=S,YDR 3C9CGMGK6G)>6Z_$/Q9RP#
MZ1&BOL.UG4/E0<8)^8<#W]#7,>5-'\*O LK6\Q73-7@GO5$+,T$:O)N9D SC
MD?G0!Z9IOC30-;EO+6ROG:XMD+RPF"1)0O\ >564%A[@'M7/P^*[/P[X&TJZ
ML+O4M<BN[E8(KRZC=V;,NQBQP",?,%'4X'7K4JM;ZW\1K+Q%829TW3].DCGO
M -L<C.?E0$_>QR3C@''?BN4@E,7P7T=GAG4V&JQRW*&%MT:"Y9RQ7&<;2#0!
MZA=^)-.LE7SC<F0PF<Q1VLCR)&/XF15)4?4#.#Z4G_"4Z0^GV-[!=&XBOSBT
M6%&=YB 20J@9XP<YP!WQ7G>I:K8Z9X]N]8UNSU&31-8M(?L=S'#*IC9,J495
MPPSDL,CN/>II9[?PGKOA_75T:>R\-_9KBV$:0L6M"[AA(ZX+#>%Z=N_/% &]
MX"U"2]USQ7&;R^N((+V-(A>%MT?[L;AA@-OS9X %2^/+[^R+GP[J+ZC/:6XU
M2.*X F*QM&4D8[@.O*BJ/@.^BO/&?C":*.[6&ZG@FA,ENZ(R^4!N!(X)R#@X
M.,<=:T/B%NCM_#]V89I(+36H)YS%&SF.,*X+$+S@$C\Z +-I\0/#UY;:A-'/
M<*=/!:YA>UD65$!^_LV[MOOCCOBM&+Q+IDVGZ=?1RRM;ZBZI:L(7S(6!(XQD
M< GGL#7-V5G'X@^)4GB"TCWZ5'I/V)Y7B*K<2,^[ R!N 7&3T[>N*O@;1[[3
MM?O]'G;?IF@3.+!MQ.[SP' /NBDC_MI0!Z#/-%;023S.L<4:EW=C@*H&23^%
M8=IXRTB\NK&W5YXVU")IK)I(6 N45=S%/H"#@X//%:&O33V_A_49K6R%[.EM
M(T=L1D3':<*1WSTQWKR:UNUEU[P1K2VVL3_9C/'=_P"@R*D,CPX$4<8 "J#P
M,#&,9;B@#MY/BAX9CAN)O-OFAM;C[/<N+&7%NW _>97Y1DXYYR#Q5R\\>^'[
M+4(+%[J62XN(!<0+#;N_G*<8V8'SDYZ+GH>F*X7P_J=K'HGC_2Y(;F>YNM9O
MTB@AMW<REP% !"D9SUST')XJ;3K)/!.O^"HM4,IGCTBXMYWB1I0AWHPSM&=H
M+$9Z=* -/QIK]GXE^%^M7^CWUW;SV1PZAI()8G5@&1U&#R"1@\?E6U=R:8WB
MOPQ'=7FIQZ@T,AMH8BZV\W[O+>8<;20!G&<],UR&L:5<RZ!X]U:UM+UH]=,2
M65O';R-(^Q0"^S;E0Q)/(' K;U:Y,OB_P-=QV.H/#;+<&>06$V(@\.Q=WR\?
M-V/3J: -[4O&VC:7%<W%P\YM+2<6US=)$6CAD.!M)ZG!(S@'&:74/&FE:?<:
MA#BXN3IT*3WK6\>\6Z,"RLW(SP,\9XYKC?#FI7OA275?#&H^'M2OIYK^6>SE
MA@\R&X1SD%G)PN#U)Z9J#Q-/J%]?>*M,OM(U)K@V&VQ&GV[+#<L8<&1W&-^"
M<!6)  P 6Z@&SK>MV5EXZ\,:K%<WD]KJ-C<F.* R2B8XC*;(QW(8G.![TGBG
MQ-IWB7X;>(;G2[N\@N+!&62,%X)H9!V=>#@\\'CKZ<9VE7<FGVW@+5;K3]1C
MLK/2Y;2XD%H[&)RD0!95!8*2C ''Z$&H=9TVYETKQYK45C>E-=2&"QMTMG:2
M39'MWE ,J&.3\P''7K0!W_\ ;D-C:V-J(Y[N^EM1,MM;@-(4  +')  R0,DC
M)/%6-"U[3_$>FB^TZ5GB#F-U="C1N.JL#R"*\\U>.>QU[2/$EYH%QJVCS:6E
MG<0K:%IK6126W>6P# =0?U[9[KPI!;0Z4\EGH:Z-;SRF2.V\E8G(P!N=1T8X
MZ=0, \T 8.M1^3\7_"\B23#[1:W8D4RL4.U!CY2<#J>@K1/CW2?]'F6*[>PG
MO/L4=^B*T)EW%<<-NQD8W;<>]9GB&64?%7PQ,EE?2P6T-Q'--':2-&C2* @+
MA<=1R<\=\5QVHQZOK&DQW=]X>US^U[+6(KBXC2$^0D:RD8A7.&^4@EE!)/).
M* /3;?Q9%<Z]J.BII>H"]L8A,RL(@)5/W2AW\Y_ #H<'BH;#QK9ZEX>@UFUT
M_4'AGNOLJ0E8UEW[MO(+X W<=<]\8YK'\6:)K-YXC\/Z]H,36UY)&]E>/( 6
MAAD7(9@#@E#D@ XSCM4/AWPI>Z%X\O;*"(KX;0C4K<XZ7#H8BH/TWDCM\M '
MH%Q/%:VTMQ/(L<,2%W=NBJ!DD_A7.Q>.-.8:9+/:WMK9ZHZQV5W-&OES,W*#
MABR[AR-P&:O^*M+FUOPIJNF6[[)KJUDBC.<#<1P#[$\'VKB+NVU;Q5X3T/0)
MM+O+74;2ZMOM[S1;8HUB^\ZO]UP<<!2>O.,4 =(WCNS.NW6CP:7JUQ=VD\44
M_E6VY8Q)C:Y.?N\_7'., FMW5M4M-$TFYU.^<I:VR%Y&"DG'L!7,^'(KN+XA
M>*[F;3[N*UOFMC;SNA"/Y<6QOISTSUK6\9/K">$=1;081-J?E@0H0ISE@&P&
MX)V[B,T -T[Q0MYKO]C76G7-E>/;?:X1*499(<A<Y4G# GE?U-:.K:M9Z)IS
MWU[)LB4A0 ,L[$X55'<D\ 5P6C6=]!X]TS4XO#FJ6]I)ISVTTURZ/(9"Z,7D
M)<G'RD9/)QP.E=!\0]%U'6O#*C2 KZA9W45Y!&Q $C1G.W)H G@\96BZE?Z?
MJ=I<:;<65K]MD\[:R&#^]N4D9'<?EFH_^$V@AETY[[3KNSL-2=4L[R7:59F&
M5#@'*%NV1]<<UF7O]O\ CGPU?Z?+I$VAK-:21L+MU)DF(^4+MR0@YR2 3Q@=
M:HW>F:OXG\)Z'X=O-)N+.XMYX/MT[[?+C2+JR')W%L#& <9YQ0!T-MXR%U#K
MPBTR<W>BOMG@,B /QNRK9QT!/-49OB58K::%<P:5J4Z:R=MOM1<YY^4_-UR/
MISDD52N;76-,\3>+([?1+F\@UF%'M[F-T6-6$11E?N.>G!)K%T_0/$$>D> H
M)-"NU?1[AI+O,D/"G."/GYZ].M '06'C75]1\;V6D'09K1'T]KJ6&>51( 95
M0,PQQC#\ Y.<UVFHZA:Z5IUQ?WLHBMK=#)*Y!.U1UX%<KJ5IJ-I\4;#6;?2Y
MKNTFTQK%Y(2@\IO-5\N20=N ?7V&>NOXQT.3Q)X0U/2(9/+EN82L;'IN!! /
ML2 #[&@"G'XT1)]-_M#2[JQM=38)9W,C(RLS#*JX!RA(Z9KGV-SKWQ'U73-5
MT87-BNGQ1>3).I6)'=MS@>IP.G/RCFI;K3M7\5Z-X?TF^TNZL9;*ZAFOKB0Q
M[/W2G.S#'=N;&,# !.>F#HZ=!J:?$O5-1DT>ZCL+FTBMTN&>+&Y"Q)(#DX.[
MCC/M0!OWEW8>%O#YGE,BV=G$%4;B[D# 502<DDX R:SK?Q5)'J4]GK&ES:;Y
M=F;U9FD$L9C4X8%EZ,/3GV-'CO0;OQ'X1NK"PE$=Z&2:W); WHP8 GMTK(B;
MQ5XOT:ZTO5]&71(9+.6"XD:99#-*RE!L ^Z@SN)//0#(R2 6W\>);6^G:E>Z
M5/;:+J#(L-\TBG9O^XTB=55AC!R>O.*)O&]R=5UO3+#PY>W5YI0B9D\Z- ZN
M"<[LD#@<#DG/08.,630=;UKX?Z?X-U'27@>(P6]Q>>;&8?)B93N3#;B650 -
MHY)SBK^FVNJV7CCQ=J+Z)>-::A%;BV=7A^<Q1LI&-^1DGC/XXH 6'XEV\UOH
M^HC1[U-&U*5;=;YV0;)FR NS.XC((+=..,U8N_'5RNN:MHVG>&[Z^OM.1'9!
M+&BNK G(;) XQ@?>.>@P:Y%?#WB1?AGX8T9M"NFOM/U))[A/.A.(T=FR"7[A
M@ /8C@==/2]0NK7XO>+)(=)NKH/:6A=(7C#QMY8(!#, <\C(/!'OF@#9_P"%
ME:,VBZ9?*1#-J+21Q0WD@@6-X_OB1VX4*>.Y.1@&L#6_BC/<>"-<OM%MHDOM
M.D6"Y=;A94A#G:DL; 8D!/3ITY%12^"/$.B-I'B+1K:&XU2VN[JYN=->8!2M
MPW*(QX!5<#TSD^QUO%=AXH\7?#[7+6328[.YN!"+2Q-PKO\ )(K,6<?*"0.!
MGC;UYH T[_QQ'I0M+.]BLK;5)H3.8+O44AC6,,0"9".K8X ![]AFLY?BI:3Z
M)I.I6>E75PM_?C3V19$!BF/\.<_-D<@C@\9(JIJ-AXML/%%EXNTG0H[F2>P%
MG>:8]VBNH#;@V_[N>@[X]^UCQ#IOB?7[7P[-<:4B7%KK4&H2V\,Z,((4S\FX
MD;W[\#'..U %UO&^IF#Q!;OH(L]5TJU%TL,]R'CDC()#;D'4;3Q^&>]:/@+4
MM3U;P=IU[J:1^;-"KB592YDR,Y(VC:?;GZUE7>A:M=^*_$LZV!CM=2TH64,[
M2ICS 'Y8 D@'<.V>.E:7@"VU;3_"5EIVK:<ME+9Q+ H\\2&3;QN^7@ \8Y)^
MG< ZBBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** ,B[\+Z+?:LNJW-@DE\H 6<LVX#I@<U67P/X:
M6TN;0:3%Y%RX>=-S8D8=SSSUJS-)J*>*81]NL$TIK5MUL_$[2@YW _W=O7TQ
M[\7?[3T_[/\ :/MUMY&[;YGFKMSZ9SC- #K"QMM,L8K*SB$-M"NV.,$D*/09
MJCI?AG1M%O)[S3K"."XN!B61227YSSDU;GU73K5=UQ?VL(\LRYDF5?D&,MR>
MG(Y]Q5*TFO)?$MT3JEC+IQMT:"TC \U3W=CGE3V_SD 6#PKH-MK3ZQ!I-I'J
M+YS<+&-W/!(]#[CGKZTJ^&-#74CJ TJT%V7\PR>6,E\D[_3=DGYNOO5JWU?3
M;NX:WMM0M)IU^]%',K,/J <US'C7Q2^EG3XM*U:P6Z.H007-L=LDI1W"G S\
MN,^AZCI0!OW?AO1+_4%O[O2K.>Z48\V2$,2.V<]<=L].U37FC:7J,L4M[IMG
M<R0_ZIYX%<I_NDCC\*J0M?GQ=.#JMH^GBU&VP51YR2;AER>NW''XC\;O]KZ;
M]O\ L/\ :-I]LY_T?SE\S_OG.: )YK:"X,1FACD,3B2,NH.QAD;AGH>3S[U6
MOM$TG5)8Y=0TRRNY(_N/<6Z2%?H2#BLRS\7Z1J]]JFG6&I6HN+,;/,:12"VT
MDD#(W!>,D>XJ?0KN6#PQ!<ZOK-C>NJL9K^$JD+?,><YQQT^HH G/AS0S-<3'
M1M.\VY!$[_94W2@G)#''S9/K7,>(O!<CW^ERZ+H^@3:?:^9YNF7< CB9GV_O
M!M4C=A<<BNOM]5TZ\MI+FVO[6>"/[\L4RLJ_4@X%1PZ[I%Q=16T&JV,MQ*N^
M.)+A&=UZY !R1Q0!B^&?#)TS5+K4WTS3-+>:(0K:Z;G9M!SN<[5#-V&%&!GK
MGC>OM+T_5(UCU"QMKM%.56XA60 ^P(-6Z* *C:7I[Z>;![&V:R(P;<PJ8R.O
MW<8I;?3;"T=7MK*VA=4$8:.)5(4=%X'3VJU10!3M])TVTEGEMM/M(9+C)F>.
M%5,F>NX@<_C3!HFDB(Q#2[(1L0Q7[.F"1G!QCW/YU?HH C@@AMH5A@B2*)?N
MI&H51] *BFTVQN)6EFLK>21EV,[Q*25]"2.E6:* *DFEZ?-*DLMA:O)& $=H
M5)4#H <<8IZV%FEP+E;2!9QG$HC ;DY/.,]2?SJQ10!Q_A[PO>V?B+6]2U:V
MTV5=0N%N(O+<R-"54*!\R#MSD$?2NKGMH+E0MQ#'*JL& D4, 1T//>I:* (A
M;0!)$$$863[XV##?7UIKV5I):"T>UA:V  $)C!0 =..E3T4 9VJ:/!JMK%:2
MD);*X9D5%^8#^$$CY0>AQS@]16C110!#]DMA))(+>+?*09&V#+D=,GOBG&WA
M+%C#&6/4E1FI** (OLMOC'D1?]\"B2V@E14DAC=4(*AE! (Z8J6B@!CPQ28\
MR-&QTW*#BAX8I  \:,!T!4'%/HH 0    8 Z 4CQQR8WHK8Z;AG%.HH :R*Z
M[74,/0C-)Y,>_?Y:;_[VT9I]% #1&BIL5%"?W0.*55"J%4  = .U+10 4A /
M49I:* "D*@D$@$CH?2EHH ,<YI&W%3M(#8X)&0#2T4 <WX:\.7VAZEK%W=:G
M#>+J5R;DHEJ8C&V , [VR, #IGCK72444 %%%% !1110 4444 %%%% !1110
M!0UFPGU31[FRMK^>PFF3:MU!C?'SU&?R]>>"#S2:-I2Z/IXMOM,]U(S%Y;BX
M(,DKGNQ  Z8 ]  *T** "D8$J0I ;'!(S@TM% '/^%_#!\-'4MM\URNH7DE[
M)OB"E97QNQ@]..GZTZ[\.RW/BRTUX:BR&UB:%(/)4@HV-P+=<DJ,>E;U% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !6/:>&K&RU^ZUN)[C[==JJSLTI*R!1A05Z<#TK8HH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M5RWCS4M5L]":TT%0VKW2R>3SRBHA9W [G@*/]IUH ZFBL;PIK\7B?PO8:Q$
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MD#!.3QSU- '7T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M1\5-&N9HI4MI]-FMHFA@9PTK2JP7Y0<$X)K=_P"$<O?^AEU4_P#?K_XBG?\
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M#@$TS4[/XB6>J_V1=M97&AKIQ9&C9H)!(&/F?-C '<9S6/X9T34]&L1X;O\
MP39WEW"YC@U<Q1/ Z$D[Y"0&^4'H!DXQQUKU=)$DW;'5MIVM@YP?0TZ@#S73
M;'7_  KJGB73QHT^HV6KW,MY:W-LR!8WD&"D@8@J!QR,]. :Z/X>V-]I?@;3
M-/U&SDM;JVC\MT=E;/.<C:3QSWYXKIZ* .,\9:7J6H>(_"MQ96,EQ!87QGN'
M5T 1<8Z,P)_"J.GZ5J]MK_CN^DTFX\K5(XOL8#Q9E*QLA'W^.2.N.*]!HH Y
M_P $6EWI_@O2;&_M9+6ZM;=89(W96Y48R"I(Q^-8FLV7B'0O'3^(M&TO^U[2
M_M4MKJU698Y(F0G:REN,<\_B:[F21(8GEE=4C0%F=C@*!U)/8412QS1)+$ZR
M1N RNIR&!Z$'N* .$U#2_$CZWH/BHV22WEMYL-UID$Z_)#)TVNV S+P3TR>!
MP*)_"NHZKJ/BS5FB^RR:II?]GVEO,X+#Y""S[20/F(Q@GC/TKO:* /*8-)\5
M7(\#Q3^&V@31)4%Q*UY$20$VDA5.,< ]<YXQWJ:WT?7X]-\?1_V#<>9K$LC6
M:M+#\X="G/S\8Z\UZA10!YG_ &-XAM]5\$ZG!HCRG3-/>TN87N(T,;F,*"3D
M@KD'ID^U-T?2O%OA:_OM)M_#UCJVG7-W)-!J$MRD9C#G)$@(+-C)Z#U]:].H
MH XO3]'U>V^)MUJ\]JTEC-IL=I]I\Q!F13DMLSD*>?QK%\.7U]9^.?'@LM)F
MOW:YA*[)8T4-Y9P&+," ?4 ]^/7TX\C%8>B^$]-T'4;R_LVNS<7N#<--<O)Y
MA'0D,3R.F?2@#CX?"^O:(WA^Q33H=9TJVM'6>V^T+%&ET[ES(RL/F0 D*,''
M7&:HVOAOQ1%X+M-(?0HUFM=:%X!'=Q[6C$QD.,XQU '?KD#OZU10!QGC'2-6
MO->\+ZSIED+IM-N)6FMVF6,XD0+G<>.".<9]JS/$/AS4=<O);N#1%LM<AN%^
MQZO:W*JI0,,^;R&8 9&,'./X:]&JJ-1L3J!T\7D!O0AD-N)!Y@48YV]<<C\Z
M ,O3=7U6;Q-J&EWVG0Q6\,8DM[F*;>9%)Q\R_P )/) ]CUZU'XV\/7'B3PZU
MK9W"P7L,T=U;2,/E$B'*@^QZ9[=:WHX(82YBB1#(V]RJ@;F]3ZFH8=3L+F]F
MLH+RWENH0&EA20,R ]-P'2@#EED\=:OHM[%<6=EHUX+5UA>*Y\XRS%<*>GR*
M/J3G'8<\W8^%_$J:]X5U/_A'K&V&FK-'=AK\-).TD81I78*<YZ_Q$]\5ZO10
M!YUH&E>,O"T5QX=T^PT^;2Q,[66HO<;/LZ.2QW18)8@DX&1]<5<L--UFR\;Z
M_JLFE33VMU:PV\#B>+=*8P021N&-V>/Z5W-% '+?#O2]0T/P39:7J=K]GN;8
MR*5$BN&!<L""#_M8Y]#4&L:%J=KX[L_%6E1+=YM?L-Y:%PC&/=N#H2<$@]CC
MZUV%% '"IX9U/[%XLU V\:ZIXA01BV$PV0*L1C3+XY/))P.^.<9KHO"MK>:?
MX6TNPOX%AN;2UCMW"R!U.Q0N0??%;%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %-]6TV/4
M/L#ZA:+>[=_V=IE$FWUVYSBF0:YI%U:SW5OJMC+;0?ZZ:.X1DC_WB#@?C7)?
M$)9M%O\ 1/%]G;O-+I\_V>ZCB7+26\O!'N0<8]S6#9:=K>D^+I=%NX5E@\3[
M;ZX\KF.W96!G3W4J0N?4B@#:L/%XM/'?B.+5=<@&C6T%M+:O*8T1?,!;A@!N
MZ\<FM[7;Z*:'29K3Q-;::DMU'(K91Q>1GCRUR>=V1R*Y33ETB?XP>+C?_8G2
M.RMUS-M(4;,..>G'!KF9;VQ;X7>!56YMR\.N0!@)!E 'DSGTP,?I0!['?ZYI
M6E2+'?ZA;6SL-P660*=N<9/H,\9/%<SJ^OS:;\1-)BEU98]&N+&>>59"BQ K
MMPV[&>_<]ZQ?^$@T72/&?BS3?%)\B'5%C:WGE#%+BV,03RU*^A+=.Y/>HWDT
M9/B)X.@\J&UMK?39EAMKEP6A'R^6#N.0Q&,9YH ])T[4['5[-;S3KN&ZMF)
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M/GM$3$D[6;-,9 SCEE+C;QS@G':M;X?3&;Q5XQF$%TD5S>I+"\MN\890N.K
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MLB1 D 9W 8'!(&>W'-9"^'-4@TWQ#IVC6&J1Z%=:68K;3[QU9H[EL\1[GX0
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MF()*1':0Q 7UZD#%97BKPKJ?B.>[AGT;3Y)FD_XE^KI<>7-:*,$%@%W'!R0
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MR,]/Q]>WT:+4TLVDU>:%[N5]YC@!\N$8 V*3R1QG)ZDGH,"@#1HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@!KHDB[74,N0<$9Y'(H,:&19"BEU!"L1R,]<5S]_<6W_  FFE0GQ
M$UO,(Y<:4F")_ESN;N  ,C/IQ[QS_$+PE;*S2:[:[5E\DLA+#=@'J >.1ST&
M>M '0&UMRY<V\18YRQ09.>M'V.VQC[/#C_<%4=1\0Z7I;Q)=W1#2H9$$<;R'
M8,98[ <+R/F.!61<^/\ 1XM<TS3(7EN#?0FX$L,#R*(]NY<;022<@^PZXXH
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M@ HHHH **** "BBB@ K+\0Z%!XCT>33KB>X@5F1UEMWVNK*P93Z'! X-:E%
M'.67AF\6>%]7\07NJQP,'CADBCB3>#D,VQ06(/(R<9YQG&.CHHH **** $9=
MR%22,C&0<&H+*R@L+<00!MN<EG<NSGU9B22?<FK%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% %'6=(L]>TJ;3;]&:WFQG8Y5@00001T
M((!_"LS2_"4&GRI)<:KJVIF-@T2W]V9%0CH=HP&(XP6R01D<UT-% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !17D$8T^^\<Q2^+]*UO3[^ZNR+*62XQ:.%/
M[N/Y3@-M X[G/KBO7Z "BO/=#BDM?C-KEN;NZGC.F12 3RE]I+]NP'L*M>*_
M!VEWFGZIK.KW=RUY#')+;W*SL@M H)41J" #P,D\L2?8  [BBL;PF^HR^$=)
MDU8L;]K6-IRPPVXCO[^OO6S0 4444 %%>9>(M>U&Q\::7XB20#P];W;:1.,\
M$N0'E/\ LAU"_6/WKK?%?BNW\)6EM<W-E=W,=Q,L :W52$8]-V2#S[ ]* -\
MLJE06 +' !/4]:&941G=@JJ,DDX %>7ZIJZ7/C#POKLGA[5+:\BNKRU\B2']
M_*H@;;M ."I+=<X'/.!FM6;QKIFM:#K]EJNAZE'+90'[?IKA1)Y+ _,IW $8
M&<@T =X"" 0<@]Z*\XNO$]QIFG^![7P]IPAT_4FB5$DE&X1[,B/G/;&6/I5\
M_$A6UF_TFW\.:Q<7=B\:W"11HQ4.?O<,>,8/KST&": .XHKC[GX@VEK";R33
M[D::+_\ L_[02H8R9V[@F<E,\9Z^U,M/$>JS?$#6=,>R+6MC:Q,D4<JEFW;C
MOP<9)PHQGC\: .PBFBG3?#(DBY(W(P(R#@CCWI]<'X;\3>'=+\%RW^G:9-86
MOV][=+,D&22X9\;1\Q&23TS@ >@K:B\5A/$ T*_T^:UOY;=KBU42*Z7(7[RJ
MV1\PQT...: .BHK@8?BC!-HO]M'0-233([G[/<3DQ_NCNV@[0V3R1G' SU-=
M]0 49Q17)?$Z&*;X<:X98T?9;%EW*#M([CT- '69'J*6O-;>U\)7WAK1M,FT
M;9<7\4,"SKIK1,K[-V\2,@!(*YZ\^]='J'C.#2?$3:3J5J;57MWGMKJ23]W/
MM_@4X^__ +/7ZY% '3T5SLGBA[:UTI;K3)8=2U27R[:P,BEQ@;BSGH H&3C.
M.._%5SXW@M+35I-6L9K&739DA8,W[N=G^YY4C!0P/N!CJ<"@#JJ*XN+XAVQO
M[RQDM8IKB&U:[B-A=I/',B_>7?\ *%<8)(/8<$U4B^)Q_LK2M9N_#UY;:-?,
M$:\,JL(6)P,J.=N?XN/H: ._HKC] UW6-1\=^(].N8+9;/3_ +/&H2=B5W(S
MY V#<3D9Y&,#K70ZUJ@T;1KK43;37/D)N$,*Y=SG  'U- %^BN4@\9[-:U#2
M]1LHXIK.Q-\6M;GSPR#[R\JI##C@CO4OA_Q5<:^UC-'I\'V&\@:9;B"[\[RB
M-N$D 0!7.[ID]#Z4 =-15'6=0.DZ+>ZB(#/]EA>8QA@I8*"3R?85R#?$:Y@M
MM!O;CPY<+9:TT<=NZ7*,XE=<JI7@8)Z$L..2!TH [VBN1LO&LKW&OV>H:1+#
M?Z/"MP\%M)Y_G(REEVG ^;C&,4W3_&=W<:Y::1=Z;;P7=[9M=0QK=EFB8*"8
MY@4!1OF[ _2@#L**XRP\=37N@ZM?/I'E7VG7?V-K#[1N=Y,JJC.W^(L .#FN
MQC+F)#*JK(5&Y5;< >X!P,_7 H =17,S^)[RXN-5CT73HKU=*?R[@RW'EEY-
MH8H@"MD@$<G SQ[CFM5\<7^IS>#[G0!"-/U6[P?,F*2,5!W1OA2% /4@G..F
M.H!Z'#?V=Q=36T%W!+<08\V)) S1YZ;@.1T/6K%>5VEYJ6F_$SQF^EZ5%=7
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MPRGYU<EL-M'/&./2LWP[XTU/7/#R([PQZZ=2%F\8@*JJ_?W;6.<>4&;GN,4
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M,Q,7*J0G5AD#/3'.,XYI6.A:OI_CNRUVT\(_9;%--:U>&.[A,N_?G<Y+?,Q
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M*Y1U65 =KC# $=".QKROPMXPM?"OA^^6;2M4FLX=5NA-=00;HK=?-(!9B<G
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M7+.L$\<C)C<$8$KD9&?J.10!Q?B?2?$7C#0HM)FTZUT\F>*2:=KOS% 1@QV
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M3296>))R1',C@!T)&2,CO@UM+K.F'6?['2\A.HB,RFV4Y94&.2!T^\.O6K]
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MWARJY)!X' XQ]*S+G2KK^S_'^KK972C78#!96R0.TC[8&0.4"Y7<Q/W@/?%
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MQ$$LIP?KCCW]L@%Z/XIVMSHVF:C::->W"WM]]@9$9-T4W7;UY)'(Z#W%6?\
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M@9L_0  =2:T([&]UOQKI_B.73;JRMM.LI$CBG*"6:63J H8X"@$9)&2>..:
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MP"#G\QUYJAXRL?%/B3P!?6LFC,;V^GC,5C'/&1;1HZM\[DKEFVG[N<9 [$T
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M2;LDQR#:#P<8//T& : 'P^-]9:S\9PP7%G<S:#"EQ!=R6S()D:-G(*;AR-I
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M7CKM-UC3M8B>33[R*X$;;9 A^9&]&7JI]C5R2-)HGBE17C=2K(PR&!Z@CN*
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M%7\B5)&PLN2N0J]6'.,8[UCVG@+Q)9^%/#OV2:RMM?T"63R29&>&XC<Y96(
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M:14/FF088M\OIV'3BHE\"PV\NJQ66IW5KINJDM<V484J&88<HQ&4W#K^F.*
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M&V5!90'.$)8# #'@9(S7F&O1ZI<Z-I$NH7IM=433[Q3=W"F);V,. (&7LTB
M-V8'H,YQ!JA*ZK!=16#V&VRTWS-#9B/[1&>$CY!!B) ]RIW#% 'JC>(M)77E
MT0WBG4F7<( K$@8SR0,#@9Y-+J'B#2]*G2&]N?*9F5<^6S*I8X7<P!"Y/ R1
MFN:M4A3QJMUH.JW,D4EQ,-8LI7=XXR%.' 8?(=RJ  >0>!@5'XRU>#6](2RT
M358WU F&YBL3#O%ZFX,JD$9VG'+#@=SC- '>44#..>M% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% #)(8I?]9$C_ .\H-'DQ>9YGE)OQC=M&<?6GT4 1/;6\A!>"
M)B!@90' I?L\'E^7Y,>S.=NT8S]*DHH B%M;A"@@B"GDKL&#3TBCC^XBKQCY
M1CBG44 ->-'0HZ*RGJ",BCRH\H=BY3[O'W?IZ4ZB@! JJS,% +=2!UI2 1@C
M(-%% "*JHH50%4<  8 HV@D$@9'0TM% "!0&+ #)ZG'6E(!ZC-%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
I10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>davidjkatz_employmentagr010.jpg
<TEXT>
begin 644 davidjkatz_employmentagr010.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***04 +1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %(*6D% "T444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !2"EI!0 M%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4@I:04 +1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %(*6D% "T444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MN(74^8KXZCC))R1R>M5M+?P_K^@^((_$UV+?58-3E:>7<L=S&$<&/R\C.,
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MA]L%Q-!+)<R.C1O-O&X1[0!OVXW8]1[UZWI=AI=E TFE6]M%%.0[-;J,2$
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M93Y"!58GJW'!SQS0!7U'Q!I&D2B+4-0@MY"N_:[<A<XW'T7/&3Q3KS7M)L#
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MVTBJP2+!R2H ]LXSD8S6M\2)A:6&A7T@;[-:ZU;37#*K,40$Y.%Z]J -^_\
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M3^%[F*YTO489[QA-"$8)D$I\^<'KSC'O7J0R0,C!]* %HHHH **** "BBB@
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MED27<%\O9C.[) Q[TMIXJT^ZUA](>.[M]11/,>WEMV^5.SEUR@4^N[KQUXH
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M.[;N(W;@F<C=C'X$&GW7C>&'7[W1+;2-2O+ZV@6?9#&N)%)ZJ2P&/<X]!DT
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M04M(* %HHHH **** "BBB@ HHHH **** "BBB@ HHHH \#T?1=%N_@;]K-K
M=9^T21VD\8 N/M'FGRT#=>X^7T.<5V'B2&Z\(^*K#Q%96RRRZQ"-,NU"CFY(
M_<O[Y8;3[5WZ:/ID=Z;U-.M%NR<F=8%$A/\ O8S60FEZ]>^)3/JMU8-H]K-Y
MUE!;QMYK-M*CS2>.,DC'?!XQB@#7TC3ETK2;:Q4AO*C"L^ -[?Q,<=R<G\:\
MWTZ_TVVT7XCVDEU;179OK]EB9U#[/)49 ZXR,>F:]5JC/HFE74DTEQIEG,\V
MWS6D@5B^.F[(YQ[T >8WEI9::/AC<V4,,%Q+/"CS(H#NK1#<"W4@Y_6K0MM*
M6Z^)=I=3?8=/=[=)9+< >4&A +8'N3GUYKOCX:T(A =%TXB/[@^RI\O.>...
M:DBT+1X'D>'2K&-I1B0I;H"XSG!P.>0#0!Q_A.XOX/&+:7JGV"_E73!):ZO9
MC9YL&]0%= 2H.3D$<8!QWK7\73IJ$]AX7BDB\_4G+S*_(%O'\SY (.&(5/HS
M>E;UEI>GZ:'%A8VUJ'^]Y$*IN^N!S1)I6G2WRWTEA:O=IC;.T*F1<=,-C- '
MG>NM/X.^(6C>);^YM%M=27^R[P0QF-1U*.<L<XP 3V IFKZYINC?$O6A=WMG
M,+[2XHO+N;@1"(_-A,MP58'<2"2/3I7H]YI>GZB4-[8VUR4^X9X5?;],CBN/
MU?PGK4GB&ZOK*#PY?VUR(E6/5;9RULJ+C:FW((Y)[<L: .1UO1M+TSPA\/[,
MW.GWL::U;QS74)4QR*2V_P";NO0?@*T_$,FF>&?B)907MQ)HNCSV#K:36H5(
MUF,A:4-E2!G*\\=O6NYTGPM86%I)'<6EC,\LQG94M52)&*JI")SM&%'<DDD]
MZU;FPL[VW%O=6D$\ QB.6,,HQTX(Q0!XW?)IV@GP_=Z?>ZFGA)-0N))KX'<%
ME=%"R*-A&S)< [>NXCJ,KXNMO#Z_#KQ9>Z-?SWZW4EN\ES+(&C>?S%SLPH&[
M;U(]?K7LTEM!+;&VD@C> KM,3("I7TQTQ48TZQ6VCMA9VX@C^Y$(EVK]!C H
M \^OH-%_X65X1C5-/V-8W "*%Y8!"G'0]R/H:Y*ZGEATWQBU@S&QM?$<5U<Q
M6I!;[.I!=D'3J%))!''->W#3K(,K"SM]RXVGRER,=,<4^&SM;9BT%M#$2,$Q
MH%S^5 'EL=QX4U*XU'6K#5KS4YSH\L=S<W$BB*&,C*I)\JC<6S@=?E-94<^F
M0^!?AM-'<6D4J:I:ERKJK8RPDSC]<_C7LRV5HL+0K;0B)SED$8VGZBFG3K)D
M5&L[<HN=JF)<#/7'% '"^&+ZVM?BOXQLII@+B\:TDMXP&)=!$<D<=!D<].:/
MB#<VL/B_P.)9HD<:D20S@$#;@'Z9(KT#R8O.\[RT\W;MW[1NQZ9]*?0!Y/IE
MYI,?B[XFSW,EJ8TBA^]L)*B%@X&>.N >V<9K+T7Q!:Z&/ ^NWTF_1$TAK"2Y
M3,BVUP<'#!<D$A0/IGTKVRFR11S1F.5%=#U5AD'\* /'_'.I>'Y?AE=RZ.D=
MM9W>IQRQ,^8_M3[U:215;!(SWZ<>E;6LZG9:)\8;#6=1N4@TZZT)K>"X/*R2
M";=M&,\[2#[YKT@    8 [4UXXY"I=%8H<J2,[3ZB@#Q-=8CAL8K]EF;3K#Q
M9<3ZE&8V!B1I'V.ZXSA20<>H]:M:AJUMK_Q*U=O#]XDT]WX5E@M)8B5WS>9D
M!6]>.OMCM7L6Q-A3:NTYR,<'/6D2*.( 1QJ@ "@*,<#H* /)_"FI>$]<30+0
M0ZA-X@T]XU^Q2W%P/LKH )&Y.T* #QT. N.:]$T+Q/H_B7[9_95X)S9RF&==
MI4JWT('!P<'H<&M18HTD>18U5WQO8#!;'3)[U4L-,BL9KBXWM+<W# RS. "0
M,[5X   R?Q)/4DT >?M=:3IGQCUZ;7)+6VAN-.A6"2\PJR 8W!2W![9 K&CL
M)O#?@VUU&XCD@TI?%*7\,;(?]&LRQ"E@!\H[X_VA7LK(C[=Z*VT[AD9P?6E(
M#*58 @C!![T >4VFK6>M?$_7Y].>2XAN- V0NL+XD()Z''(/8]#VS75_#;5+
M/4_ 6CK:2F0VMI%;S?(RA9%0!EY')!':NLHH \'\4Z_!?>%?%,,+S:?>6^I%
MVTV"WXR)D)GF;:3S[$#.!@UTFCZIH6K_ !EU8FXL[A+K3(8X5E RY!!*;6YS
MP#MZ\9[5ZI10!XA876B6;ZUX5\90ZM+J$^H2R16T33[;Y6;<A14.W.0.N!TY
MX./0_&LL%C\,-76=DM0=,DA1)9<X8QD!-Q^\<\>IKK** /&=2UC1DTSX8^1?
MV2^5<P-)LE4;!L"N3CH-V0<]\U;T[5+?3O"GBOPSXA=5UIY;HB)QAK[SL[&C
M'\>20,#I@=*];HH \F$LOA;5_AW_ &ZTRF'3I[=V$;2'SF1 (QMR2W &,=N*
MZ/XLNI^&FK0@YEF5%CC'WG/F*< =3P"?PKMJ* /-=9U*S'C#X?2_: 8HEG:1
MU.40/#L4MCIEN,GWJF+ZP:?XF,9H3]IC40G_ )[?Z/L^7^]\W'&>3[UZM10!
MXXES90>#_ALKLBRVU] \H"\Q*$<.6_NC<5SFMRTN+>Z\9^.X+6832WEA L
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M/8-@XSZ\5<LKR&PNOB"LT>J*E]91/;RWD$F^4>04RQ(X)8@ '!YQ@8P/8Z*
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MS7&7.F:O/\'+S1AH^I?V@VHF1(&MVR4,_F9'& ,9[]?KBO:J1F"J68@ =2:
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M]*[>B@#R&ST/7+7X.2Z&='NSJ;W>]80%.!YXDR3N Q@>O6MRYU:2S^*T<_\
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MG&?. DR<#((PV1TQ7I$"R)!&LKAY H#N!C<<<G':I** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ I!2T4 %%%% !1110 4444 %%%% !1110 4444
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M& O.#QC+'CFM7P?KFFCP[:^#==T>:;7;*<A+*:V9Q(X<L)=^"H'.2Q/3/7N
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MWD$$;[R-Q52 1D9%=3K.^P^+6D:HUI=2VT^F26BO! SCS-^X*<#"Y&>3@>N
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M"8 15Y&0 OH3B@#HM%\3>&-!\*7^JV]WJ<NGIJ$JSO<12R21S'!8$$91>G7
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MG@EETM3?:%<'S[5[E%#JPQN#@D8'&1UZX![^IIN*+O #X&X*<@'V- #J***
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MVE)N,;KD'>0!C>,].I&,=#0!KZ/IK:18K8K<&6UA^2V#CYXXQT0MGYL= >N
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M_OM*U&;PE/KUAJ$=_)<*;/! 42E<[FV.5P<=#S[#-;=_XJM;2:]C@M+N^^P
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M#,^Z3[0IB61V+^6K=.,_S-=D"" 0<@]"*Y.'P-:G3KJVNA:?Z=('NDM[14B
M"E0(U).PX/+\MUZ<8ZN.-8HDC081 %4>@% 'C,MK97O[/45M!%#+>2,%A2,
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MWP<'\,]J[=(8HR-D:+C(&% QGDT^@#SW5I+;7OB-X3U'3+R.:UL(+F>ZN()
M52-D 0,W0;FSP>P:N$N+F"3X%ZY']HC+_P!L-L4,"3F=6&!],GZ5[VD:1+MC
M147T48%.H A6ZMWM1=+/$;<KN$H<;,>N>F*\A\,ZJNF? *]NK>&"ZG@,P:&6
M,2J-\Q&67NH!W<]A7LE! (((R#VH \-U22ROO&5I'I6JW&H27N@W5M%=G<5D
MF=2JA, *N"1D* %[]S71^"?&&E77AW0O#[6<DFO67E6[6<ULVZ!D^5I22,*
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MDBMG=[>56W#<@&X CCIU]*Q-:T;41X,\2W*Z5>-=ZYJL=S!:0PL\BQ))&07
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M .W#X7,D@U.UM4D=3&0C+@<JW0]?\X- &CJFJV.BV+WNH7"P6ZD*6())).
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M#P.#D ]LUT-K.US:Q3/;RV[.H8Q2[=Z>QVDC/T)KAM4\/W*_$VUGL63['JT
M?4XB<?\ 'NRE' '7)94/L37?T >;ZM=+K7Q/D\/ZIH]S>6 T@NELWE%5+2[6
MGY?C@* ?O#)P!DU:M_'>@>']+LX81=2Z-"ZVB7[SH_0[=Q!;>4!&-V.W'&#2
MF.Y/QAGOCIUX+%]'%B+O[,Y7S?.W8!Q]W!SGIQUK!\)VVK:%I(\-7O@?[7?6
MSM%;ZBT4;6\BEB0[N>0 #VR3@#@T ==XGUN*ZTS6=.M=-NM22W@9;M[=E58R
M5W;<EAN8#!*C/!'KBLKP=XCL]&^'GABV<&6\N;3,, =$+!?O$LQ"@#(ZGOW-
M5[5-;\/7_BS2I-%O;ZUU.>:\LKNV4,"TJ@%'R?E P /H>O%<_8Z'X@TK2O">
MKGPS->G3[:2RO=-EV;RC-N$B+D\Y/?GCH!S0!V<WQ0T>+0+G5#;7C&TN1:W,
M"*K-%(2!@D':0<\$$YK0C\8F184&A:K'=W%S);V]M/&L;2!$WF3+-@+CWSGC
M%<EXOM]2UGP/<Q6?AB:R,]Y"UM:16X\YD1@6>3;\JD]A[=3GC=\676IS:EHA
MCTO4;S091(U[#:)ME+;?D5U)!V\G(R,]_0@&5X]U:R\3_"37;D6KQ364ODR1
M3 %H9D=0<$$@\-U!Z&O1[7_CTA_ZYK_*O(+W3=63P'XOT2+PQ>V\MYJ#RVL4
M$:M'M8QD!=IZ (<G  X&<FN^/B6>TU71-.;1KS[+J$6W[6PV^3(%)V,A&<X4
MG]>F30!MZIJ5MH^E76I7C,MM:Q-+(57)P!G@5@GQ?=-8SSQZ#<LR69NX3Y\3
M1RJ". ZL1GG)]NF:V->>2/0;YHK :@_DL!:$9$_'*?B.*X31O#EU8:GJ<6@P
M:C:Z#=:;*'L;T%4BN6^Z(@QR.,Y(RON>, &WIGC&Z/A?0;N\TFZEO]42)88H
M2A\TF,.9,YPB]>O/M5/6?B$T?A+7;[3M/F%_I<K6US%*Z 6[] ^02&'/09]\
M5BK+XB_X1;PG:2>'M7&GV82UU.UB*K-.$B"J1AL^7N'()&1P>*SH_#^N'0?'
MEA%X9GLUOY!<6L:F,+@;2$7:<%L9Z< C&2: ._O/'%G81V:7-OY5[=1&9+>2
MYB0"('[Y=F"X/&!G/MP2+7AOQ-8^+K W>G321&WG,5Q"=I(8#E21D$<@@J>?
M7J*XW44\16FN:3XLT_PY<7=NUB+&\TZ<IYZ(K[E<#)^;)SWZ<XSQMW/B75-#
M\./K<WA1HQ+<9>UBE19(8=N3+*<8SD'CW'- ';5REQXZMH]/GU:"PN;K1;>0
MI+?Q,FW .UF5<[F53D$@=C@'K75 AT!YPPKR_1=&UK1_ >K>!Y-,N)9F6X@L
MKI0I@>*4G#LW\)4L201GTS0!T=]X\AMM22QM-'U&_DFLC>VK6ZH5N4&W[OS9
M'#?Q =,#)(SU%I,US9P3O#) TL:N8I0-T9(SM;'<=#7":9H5[HOCC1%CLKJ>
MPL=$&FM>!5"E]RD'&[.,*>W%>@T %%%% !1110 4444 %%%% !1110 4444
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M!![\<FDO_&NAZ;JB:;<7$INI(//C2*W=_,7CA"!\Q.>@S0!T-%85CXPT74-
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MN=MI;DD@ !1U)_7BG:SXIT36/!6M/J-EJ:VMM(UI?V\2#SH64 GE6QCISG%
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M, '945R\_C)5N]5BL]-FO(M*D2*Z:*1=P9@#\J$Y( /)XZ' .#CJ* "BBB@
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MPDRNTJ"JD$]\5[C7GD'@K5HC=PW5AX6U-9YI)/MMY:MY[;V+'> "#C.  PX
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M.H((!'4?G6AL WE JLW)..IQC)]>@_*J.CZ1;Z-:/# 6=I9#+-(P ,CG )P
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MJ3,KDJPVG:!_%NZ#DU[08XVD61D4NH(5B.1GK@TT00B<SB)!*1M,FT;B/3-
M&?I_B+2M4U6_TRSNQ)>:>P6YBV,-A/N1@_AFM2J5MID5OJ%S?EFDN+C"EF
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MC,=L$/F@@=%X52/7 K T]]-/AKXI^<]IYIO;[;O*[B-AV8S_ +73WZ<T >S
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MGD):-HQU;<2,$=ZO^(=-U3P_X9\,^(XD-QJ^B1Q17BC&Z>!@%D3CJ0<8_$T
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M4-ZLD,F.,[N">^.]<[K/B&]T'Q-X*BN-?5M,O89S>S2)'&DOEQ AR<?+DMG
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M:;[=&M91YJ_WERO(]^@!S5_4M4LM(M1<7TXBC9UC3Y2S.['"JJ@$LQ/0 $T
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M^H66MZ5#?6,XFM+E-T<D9(R#Q]0?U!H N45Y7X8U+1XSXE37_$ES&]EK-U#
MD^M3(ZP)MV@+Y@)'WN<$FNUM+ZWT/0[%);RYOY+EF^R!LM/.&)=5^8Y)52 2
M3T7)Q0!OT5SD'C&UF.JHVGZA%/I21R7<$D:!D5]QR,,0V I)VD\=,GBB?QI8
M6ZZ!+):WGV?7#$MK,%3:K2#<JN-VX''H"/>@#HZ*Y?4/'6GZ<;N5[*_FL;*X
M%M=7L,:&*&3C((+!SC<,D*1SUK.D&SXUVH669EDT220HTK,@/FH,J"<+D =
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MS-J?AFYU5-)$5S!=BS-A)<XD$I<)M;Y?E.6''/'I78(6**74*^/F .0#]>]
M#J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MF>/],\0WT@_L&[TC['!>8/EV\V\,0YZ)NQC)QTQVI=$\,IKH\;I<1NFC:U<
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MGA>/IP:+^_N/"GQ)U74-3T^_O-+UBW@AMI+6 S['0$&(J.1N)8CUS]<>CT4
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MS=N/]6J\AF]R .>:[VB@#RBW\+^($^%NO>'VTB47]Y<RR0CSH=I5W##)W\8
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MR(I'S$ GCWK7;4-7G\;ZKKECX;UB);G1DM;62>VV%92_RY&>!D@GN ,D8YH
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M&/F0*R,-N!QR<YYP<UIS^,+O3X/",&GZ/:21:S -BI/Y21,(MP0#:0%Y'/.
M#P3BH+#PIX@M/#OB?0]NFF'4I+MK>;SW!)G!^\-AQMS[Y]N\LGA?Q \G@QU.
MGJ=#&+@_:'/F#RQ&=O[ON,GG']: '0_$![33/$\NL6*1W6@.!+':R%UE#C,>
MTD#&> ?S]JLQ^*]3B\2:3HUU96;-JENUS%(DSKY2K@LA&T[B <@_*#Z"N>\0
M:5>^';#QUK-\VF"VU<1"$2.T@5@-BAU* <EAWP/PJ31FU'1=6TR34-)TJXX6
MQMKBUU1YY5B8@9C20<CH6((.T>V* /33G!QR:\\M_&,UGIGC"]@\/6,%SI%R
MQG2*?:)SMR79@@);CTYZ9[UZ&<X..M><_P#"&:^=/\96Y&F!]?D9XC]IDQ%N
M7:=W[OG'7B@"S:>.M3CU3PW%JFF6L5EK\0-O)!,S/&^Q6^<%<8.X8 /'>N\;
M(4[0"V. 3BN O/!^N3_\(7Y::9G0 AF9KA\R$*%(0^7T(4'GOQVS7H% 'E]C
M?:WJWACQ\VJS64L<$UY;A4C;Y62! -N20%QSCKDDU<TGQ3JND1^$K.^TVV73
M=4@BMH'28F9'$:D,PQMP>> >/7M4T/A3Q!:6'BW3HQI<UMK-Q<7$+R2R(RF5
M0N&&P@;0,\9S[4V^\*^([R'PDOE:4K:'+'))_I<A$NU=N!^ZXR!G]/>@ O?B
M%=?9IM1TO3Q>V<%R81!'%,\UPBOL9T8+LZY(&3D#.0>*[V&43P1RJ&"NH8!E
MP0",\@]#7!:;X4\6>'Y+S2]&U/3DT&>9I(&F5S<6@<Y8( -K=3C)]_:N^C3R
MXT0,S!0!ECDGZGN: '4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MSFMBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M1EW*5R5R,9'45D:%X:L/#INS8&X NYFN)A+,7#2-]YN>A.!6Q10 4444 8EU
MX3T:]\1PZ]<VIEU"%%2-FD;:NTY!VYQD$\<5MT44 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 <Y+X"\+RW[WITB))W8NYB=XU=CU+*I"
MD^Y%;<5C:0-$T-K#&T4?E1E8P"B?W1Z#VJQ10 4444 %%%% !1110 4444 %
M9FJ>']+UMX7U&U^T&%@T>YV 1AT8 '&??K6G10 @ 50!G &.3FEHHH ****
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M^%](\1SMX>NKFXNM=ENH+=94#/%*5 ;.2!C!)!KT6B@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ J*2Y@A;;+-&C$9PS &I:YWQ!H.G2V.MZ
MC+:B:ZGL&B+,H9E5%8@)Z<L3QWQ0!MB\M6.!<PD]>)!1:7MK?P>?9W,-Q%DK
MYD,@=<@X(R.XK@OAOH&EZC\-?#\UQ90F9 91*$ 8D.PP3CD$9!'<$BN=\&>*
M;KPKX(EN_P"Q'N-*BU.9+FY695,8:3:-J8);!(STZT >O_;;47PL?M,/VLQ^
M:(/,'F;,XW;>N,\9J>N3_M*Q7XIC36T9%U!M+,PU'<-S1!P-F,9^]GJ>U+X?
M\82^(DL+NUT^)M/O)'C\V.YWO 55B/,3;\N=N.IQD>HR =716%XP\1/X4\,W
M6LK8F\6W +1B0)U( .2#W(Z UD1^.[N'6M-L]3T":RMM54_89S.KEWVYV.N!
ML)R,<GK]< ':45PVG?$"ZO&N+B?0)+;3+.XN8+V\:Y4K"8AG.,?-D@CCOCK5
MF7QM<6-MI.H:II2VVEZG(D44R7/F/$9!E#(NT  CJ0QQ0!V%5[B_L[2>W@N;
MN"&6X8I!')(%:5O10>I^E<_8>*KJX\8ZMX?N]/@M?L-NMQ',UT3YZ-T8#8,
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M* "BBB@ HIDTT5O"\T\J11(,L[L%51ZDGI2Q2QS1)+$ZR1NH9'4Y# ]"#W%
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M.PU^6R,&EW$5RT]O*[27+Q@A,J5 3.<GEO0>M6O%/A!M?UC2-0@F2%K=VBO
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MZ6VF$J31R.FY=R'(!&1P:IZEX4OM?N3>:E>16UU#9S6UG]DR1"TJX:0ENIP
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M<D9J[T&30!RT/AK4KJ31_P"V]3@O$TIO-C$<!0S3!2J2.2QZ MP.YSVK,M/
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M8:29+9#87L5S%'-;S8Y5FW9VAN>,]^.E=MIT%W;Z/:V]W<":\C@5)9\</(%
M+?B>: .0;XB2Q-IMY/I)BTG4+\V$3O,5N VXJ',14?*2.S9''TI]YXXUA=0U
M^RL?#1GET<(SM)>HBLC(7ST/) &!SWR1T/*3>$/&-UH]A#<Z18S:E9:K'>7%
M^]X#+>A78C!V_*H! P3P ,"NILM%UY=3\67=W8P*VL6T21"*X#!72$QG.0,
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M:1%6:4S;$;<.W)R/0#N<CMH= NKO5(M:OM1M[B[@MWALFA@(B17QN<J6.YB
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M,\B$D%CD=2Q)XYSVKL(1(L*+,ZO*  S*NT$^H&3C\Z 'T444 %%%% !1110
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M]Q7FVL^*#XB\$^,=+U32_P"S]5TNU;SH'<2IAD)1U8 9SC^5;&GZY=Z;X?\
M"UG:Z>)EN--1Y;N>0QP6X2)3\[A3@G.!0!VE%>>CXG22^%;?6[;1#<!M0^P3
MQQ72G8VX*"C$ .#D8Z=?QK8T?Q7>W?BV?P[JFDK87:V8OHBER)@\1;;S@ !@
M>,<^V: .JJI=:G86,]O!=WD$$UPX2&.20*TC$XPH/)Z]JR/$WBF+P]=Z7:,L
M DU&5XTEN9O*ACVKGYFP>3P ,<_A7'>-M2U"Z7P?=W&E-'>1Z^$6U24'S-I8
M*5=@HPV 03C@T >ITUW6-&=V"HHRS,< #U-<I:>+]0\S7;74-"=;[2H4N%@L
MYO/^T(X)4*=JG=E2",?G2Z=XOEN/%L7A^ZMK19Y+-KDFVN_-,3*0#&ZE00>:
M -8^)]"&F2:E_:]E]AC<QM<><NS>!DJ&S@GV%:<,T=Q!'-$X>.10Z,.A!&0:
M\8LQ_P 61\8_]?UW_P"AK7K.@?\ (N:7_P!>D7_H H T:*X.X\?W5E<63W]A
M;V<%W?BT6UN)BETL9?:)]N/NY'3Z<G-/?Q;XDO-<U_1]*T&RDN-*\H^9+>$1
MN'3>!]T'<1@ 8P,'+=,@'<U!>WMKIUG+=WD\<%O$NYY)&PJCW->?+\3[J[TO
M0+ZPT:*0:I=FR:*2Y*O%,,C;]S&W@'=GOTJR?%.H7L?BCPYK=A;VFI6FFO<(
MUM*TD4T3(1N4D C!('- '<VMU!?6<-W:RK+;SHLD<B]&4C((_"IJ\OT_Q/J7
MAWP'X,N(8+9],N((+:YN9BQ-N2 H8X/*]O;%=U8ZA=WFO:C;@0&PM-L8D4'>
M92H8KUQ@ KSZMCL: -:JU_J-EI=L;F_NX+6 '!DF<(N>O4_0U9K \<!3X#U\
M.0%_L^?)/^X: )X_%?AZ8Q"/6]/?S6"1[;E#O). !SR2:V*\U\*:G'/X3\'Z
M!/I-S+:7T"QR7,JA8U*1-*-I!))RG'3H3UXK9LO%.IW3^*K=H+19]$<"-@&V
MR@IOY&<CCB@#L:1F"J68@ #))[5Y^WCW5Y++PG-::1:2-KRXP]RR^6^TG^[]
MT<'.2<9&"<9-.U;Q7=?$+3[+4DL[('2)+B2T0LX4^<BG+ X+8'!Z ,10!VFF
MZMI^L023Z==Q744<AB9XCE0XQD9[]15VO*K37M:\/:3XNU.RT^TGM;/6KF68
MS3%6D&5R$ !P0.Y_"NFNO&@EOX;'3D!E:RCO)'>"64('^XN(U)R<$Y/3'?-
M'7T5YZ?B!K1T_0)_^$<-O<:G>_8Y+>ZD:)D?GD J/EP <_7@UVFCRZE/I4,F
MKVL-M?G=YL4$F]!AB!@^XP?QH O5!>WMMIMC/>WDRPVT"&221NBJ.2:RO$WB
M-/#UO9CRS)<7MRMM"H5F )!)8A020 "<#D]*P6\7ZD;'Q&EUHOG)IUFUS'<2
M02PV]T@4EDPZY##D8Y!]J .SLKVWU&Q@O;242VUQ&LL4@! 92,@\^U5;37M+
MOM5NM+M;V.:]M &GB3)\O)(Y/3.0>.M<%JGB/6;N/P!)8-:V<&JO')) J-@'
MR]P7@CY!GI[4V%];3XL^*%TB&RDO#IUL2]T[+&I"^BY)R?<?7U /4**X6Q^(
M/]HZ'X?N$MA%>:LDKE1&\RPK&<.VU!N;G  XZ]>*JW7C_6;#PMK&IW.B!9=*
MF16DE26&.YC9@ \889SSR">/4T >B5B'Q=H0OYK$7X:[AYDA6-V91ZD =/>G
MZ!=:U>0W$NL6EI;*SAK46\I?,94'YLCJ"2/Z>O'?;)[+XV:L\&FW5^S:1""E
MLT0*_/U/F.HQ]#0!U<J>'?&MG-:RB+4(+>4+-"VY=CXSAAP?0\UL6EK#8VL5
MK;ILAB7:BY)P/QKD9]?O;3PMKGB5-&CLKZ R"2"\D*EDBSM)VY!8@\8.#D<]
MZI3>+_%%IJ>@PSZ;I30ZXA6W"SN&AD"!LN2,$<]%&>V3QD ]!HKSV/QSK4.E
M>+/M5EI[ZCX?8%O*D=894*EAC.3D =.]'_";>(-/3P_J6LZ;8)H^KM%"6MY&
M,MO)(N59L\%3Z#IZD]0#LM-UO3=7DNH]/NTN&M)/*GV@_(V,XR1S^%:%>;6.
MNP^&;KXAZQ>1GR[6]C;RU&TN3$@4=.Y(Y]\\ULZCXEU?P]?:+_;$-K)::K<+
M:9MD96MIW'R Y8AUZC("],T =A17!Z?XMULS>*]/U%;!-3TG:;5(X'"SJX)C
M;!D).XX& 1@GJ<U=N_$NHV^IP:+MC^WI9+<W=Q%8S7$:LQ*A%1#N&2K')/0#
MKG@ Z^BN#MO'.HR6NG6M[I4NGZQ=R2JR/:RRJJ1@$RK&H#E264 <8R<GBMOP
MOK6J:HU_!JFGR0/;2XAN?L\D,=S&>C*K_,I'0@D_K0!T-%<N_B"_U/Q3J>A:
M,UI$^F01O<374;2!I) 2J!59<  9)R>N,5SUU\1M4'@X:I:Z?:G4K;5/[+O;
M5F8KYH8 [&XX((()Z9[XH ])JO?7MOIUE+>7<GEP0KN=@I; ^@!-5-$;7&MY
M_P"WH[!)Q,?)^Q,Y4QX&,[N=V<UR>D2ZQ+KGC6*^U&*XCMML846I3 ,&Y0IW
MD #<<@Y)ZY&: .UTW4;75]-M]0LI/,MKA \3X(W*>AP>:M5Y/X<\2:UX>\'^
M"7E@L6TN_F@T_P L;S.N\-MDW9"]ONX_'TW-0\9ZM+'JLNB6)N&L;EK>.W-C
M/*;DH0'Q*ORISD#.>G/6@#N98HYX7BE0/&XVLIZ$>E<_;3^&/#5Q/9:?;PP3
M<//!86K2,N<X+K&IQT/6KEWJMS%X/GU=;-XKI+!KH6LH^9'$>[8P]0>#7.?"
M2)/^%?VU^)1<7>H2RW-U,QY>4L0=QYZ8 _"@#K-,UG3M929].NX[E89/*E*?
MP/@':?< C([5>KST>)YH(O&EUIFCBUO--#3W37,@>*65(N-H4YY1%YX[=\TR
MV\8^(X-#TF_U"'2Y&UPVL.G) 7!CDE7+-*#U4=<*<\X]Z /1:*Y!=>U;3?&%
MOX;U&2VF.H6TDUC>) 5PZ<LCINZ <@@CTZ\UD7GCO6;;X8VGBA8;'[6T_E2P
MM$^P_OC'Q\^1P,]30!Z-17#7NL>++SQ?J?A_2I-+MQ!:)<1W$T;L5W,P (SR
M3MZ\ <\'BM;P5X@O/$6BS2ZE:I:ZC:74EI=11YV"1".5SS@@B@#1M=>L;S7;
M_1HFD^VV*1O,K1D+AQD8/0UI5Q<7B75I/&'B32-MF(].LTGMV\MOF+ GY^>>
M/3%8NE^,/%%SX:\.>(IWTTVM]=QVT]LL3!F$DI0.&SQCCY<'ODT >G455U.>
MYM=+NKBSMUN+F.)FBB9P@=@. 6/ 'O7#:%XQU&?QEIFDS7MKJ%MJ%D\[2PP%
M%AE3[RHX)61>V03TZT >AT5SWB?7Y=*GTK3;38+[5;G[/#)(,K$ ,LY'<@=!
MW)%8VJ^)O$'A'2=<O-9M(+VWM6B73IXL(UTTAQAT!.-I(' &0.!0!W5%<7J&
MO:KX=\2Z-IVIWD%U:ZR[P),D'EM;S #: ,G<I) YY'<FL6/Q;XAE\#>*]16Y
MB-]HFI7%O&ZVXQ)'$%^\N<#J22/2@#TZF^8GF>7O7?C=MSSCUQ7"ZMK7B>3Q
M!I&EZ1=:<AU#39+@F>$DQ.H3YC@\@EL 8'?KBJ'AH:\_Q5U>#4M8$TEK8VWF
M+'"!&=PR50'[HR2<]30!Z717-^*M>GTR?2=+L2JZAJUSY$4KKN6)0-SN1D9(
M'0>IK/@U?5[+QK)X4O+W[0+JQ-W9W_E(LD9#;2KJ %;UR /3'< &E<^,]-M;
MY(&BNY(#=_8FO(HMT*3\#8Q!R.3C., \9R*Z*N"^%MO=IHEY)->^;#]ONU\K
MR@OS><<MGKSSQ[UIWNK7^I>+[CPWIUX+#[+9+=37*HKR,S,0JJK @*,9)P>H
M''6@#JJ*X63Q!K]L/#?A_4FMK;7M5>83W$&&2*./)+(&X+,N,9& 2>#C%5YO
M$>M:9K&N^&YM0CGO(=-.HV%\]L"0@)#)(JE5+#'!  ]1VH ]"HKRJ'Q/XJ@T
M_P &ZM+JEO<+K<D5K):-:JB*SJ<2;A\V0>2!@'IQ5^+6_$EIK'B?0I=7AN9[
M&P2]MKR2S4%00=RE%(!]CV]Z /1J*\C@\1^-;?PAH7B^?5+>[LI9(EO+%;14
M/EL^S?OZ[LD=  ,]^^E+XC\5Z[_;$_AZUO=UE>R6EJB+:FWD,9 /F&1Q)R<_
M=Q@$=3F@#T@RQB58BZB1E+*A/) QD@>@R/S%.KS"W&J3?&:+[7J-W;LOA\73
MVZ^4XBS,N^$?*1MRH^8?,<?>J.S\0^-=>TNQU_1+*]E\^?=]E<VBVK6^XC:"
M7\P/@?>]<\8Q0!ZG44RP-L\]8SD[5W@=3V&:\_GO?$]]KWB^PBUY;6'3(H)H
M&CM$++NC9]O.>..2<G@8QS64=0U/Q+_PKO5'U6ZM)+UI%EC@$>P2+$^9 K*0
M2<=\@ \ =: /4KNX6PT^:X\F218(R_E0IEF &<*.Y]J9IE]_:>EVM\+>>W%Q
M$LGDSKMD3(SAAV-)J2W/]D7 M;KR+D1'9.8P^T@==O0UP@\3:LOA#P/JO]H$
MRZC>VMO>CRT(E5PV[M\IR.V* /1ZHZQJ8T?2+G4#:W-V($W>1;)OD?V4=ZXV
M\UW6U\8^*=,@U'9!9Z6EW;!H$;RWQD]AD<=\]:R'O_&%O\,9_%,OB)?-ETR&
M:.%;1/W;<9;<>I8'GC@DX[4 >IV\WVBVBFV/'YB!]D@PRY&<$=C4AZ5Y]KGB
M'4M/M-$N[V:_M]%FL-]YJ%E"LC13%5*LX*MA>O0=:-/US4-6U+1?#J:]')*^
MGMJ-UJ-HJ9N$$FQ%0$87.<GC/RX'K0!NV_C*VN]/UJY@T[46ETF4Q36OE RN
MP4-\H!.<Y]:WK.X-W907)AE@,L:N8IAATR,[6'8CH:\JTZ35=(TOXD36VJ'[
M?97+3K=O A9]L.[!&,= !G'OBM[3?$%_K)\*Z2U^UM/?:.NI7=S&$\R0A4&Q
M000,EB2<=%XH [J26.&,R2NJ(.K,< 5G7.M"W\166D?V??2&ZB>3[5'%F"+;
MV=L\$_U'K7$>*M.UN'P7'%K.LM/<0:I L<EL0GFQ-.@0RC:/G SP.,^M;5Y=
MZKIWQ#\/::-3DETZ\MKDO"\:[BT:KABP&3][VZ4 =C17FUMK6M>(/!>I^*['
M6&M9+>2>2UMEC5H3%$3A7!7<2P!).1C(QC%.@UK7?$&O: UEJ[6%CK&E27+6
MXMT=H&7R\E6/4_-QG('/'H >CT5QWP^U;4=0M];L=2NVO)M+U2:S6Y=55I%7
M!!(4 9YKL: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** /-)?#>LZEJ^F:I_88TO6[?4%:YU&"
MXC$=Q; G(8*2S%A@8*_\"[5%<^'/%%H/&NG6&E6]Q;:XTTT5V]VJ;?,CP4V8
MSG)QDD#O]?4** /+8= \8:!J^EZ]I>E6MQ,^G)8ZE8?;  ?+&$D#D 9P!Q@X
MZ<YS6EK6E^)K^3PY<W-B;JXM-2%_<I;R1A(4VD")"[*6(R.3P3DY'2O0** .
M0T>RU6+XB:[J5QI<L-A>0010S-+&<F,-DE0Q(!W<?3G%97CJ:>#XD^ I;:V-
MS*KWV(5<*6'E)G!/&<9/.,^HZUZ)6/?>%])U'6K35[J*X>^M#FWD%W,HBR,'
M:H8*,@ 'CGOF@#E-5\,:I?:=XOU 6!&H:Y EK!:+*F8T12JL[$[<G.2 3@8
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M4+Z'3+">]N/,\F!"[^7&TC8'HJ@DU%HVKVNNZ1;:I9%S;7*[XRZX)&<=/PH
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M0>0&'8YZ=35'7O%-Z-<NM%TC?'-:0)+-,-/EN_G?)1,1GY>%R2>QX'<:^@:
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MA^],<'>&.?XVPQ]<4^_\(7,WBU]?L-<N+&2:V6UN(EB60,H.05+?</X'U[T
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M <8-<\5MX'U[7CXA/FZ3?S)%&+6/$RQN 5DXZ$=-NW'/)XQZM8W(O-/MKH#
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M;:Q4AL =, 9H ]/HKSVXUO6=;U'5M+TQ[]9=+CA59K!K8B25X]^Y_-8$H>
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MA;3G3]^)FVIM'.2<C&,9S47A^'1XM(C;0A ;&0EEDA;<)"/E)W=6^[C.3TH
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MI8Z3 DU_<QP([B--QY=CT50.2?855M/$ND7MY%9Q7@6[E!9+::-HI2 ,D['
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MNUE!&<$=CS0!A>(/#,VIZWI6MV-ZMMJ&F>8L7G1>9$ZR##!E!!Z="#5._P#
M%CK.F:G%JL[37^HO')+=Q+L,;1C$?EC)P%YXR<Y.3S77T4 <SX:\.:MIC)+K
MGB"76)H4\NWW0+&(U.,DXY9C@#<3Z^IIGQ'FBA^'>N^;(B;[.1%W,!N8@X ]
M372SS1VT$D\S;8XU+,Q[ =:S-$UW3/%%E-<V&Z6WAN&@)EC*Y9<9(!Y[]P*
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MQ4C;C' '0 "DA\"M_;-YJ5[KEY=27UC]CND,<:K(N".P^4#/ 7'3DGG/7T4
M<$WPRBF\,6ND7&MWCSV#J^G7J(L<EIMZ!=N,^Y)ST]!5R;X?P:EH%WIVMZM>
MZC<W)0F]?:DD>PY0( ,* 23[Y-=C10!QMKX&O5\1:=K=_P")[V\N[*)HE)MX
MDW(?X3A?S/7GJ*["0.T3B-PDA4A6*Y /8XXS3J* .#;X=3OX0OO#1UO_ $2\
MG:9W%H R[GWD#YL8W"M-_"-Q)XBT;66U;][IEN;<1_9QMD###$_-P3^GO74T
M4 5-5TZ'5])O--N"XANH7A<H<, PP<'UYKC8OAO.KZ'+/XHU&:;1R5MF,48
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MOX\U#5];^$<NO2W$,=G>-#*MB8 2D9E79\X/+< G(QR1@5UNC>$=?CMH]/\
M$'B%-1TV!&CCCCM_+>8%2H\ULG( /3N<$DXK'N?AKKDWA*;PFOB*W.C"13;M
M):%IT0.&VL0P! P>@!/'0<4 ;<>LZN_Q+U#PV;N/[*VE?;8'\@;X7,@3'7##
MOS7,GQOXH7P1HNIK-8->W6L_V=-O@.TCS&4$$' 'R\\'K74WWA35W\70>(=.
MU:U@N6L/L-UYMH7#+NW;D&\8.>Q)Q[UCQ_#744T#3](.N0-%9ZH-221K0EB0
MS-L.' /+'GCZ4 6YM;\06VI6_AJZN/,U)[:6\EO=/M0<1"0*@5') .3R3D8
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M?A.VB&TRQ2SE!\MK ASSZ%L;5'7DGHIKF_'2:E:?$&#4O"4CS^((]-;[79%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MMEHFF3ZEJ,X@M( &DD*EMH) Z $GDB@"Y14<$T=S;QSPL'BD4.C#N",@U)0
M444C,%4L3@ 9- "T50T;6M/\0:9'J.EW'VBTD+!9-C+D@X/# 'J*OT %%%%
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MOFG6?BCQAJ/B_6-'M+'1_)TJYMA,[-)N,4@);;R,MCGH ,'KD5;U'PIK4_\
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MQ?=V7BN?0TN[73)/LJR6$EY 6CO)3G*[MP"@8 ]<GVP:$?PZUE/!<GA\:O8
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M3T'/'/ YS0!IT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110!YJGA+Q1I.F^(/#^F+IMQI.HF>6">
MXE99(3*IW(5"X;GH<CKD^E.@\->*+;6_!]RUK8RQ:):-;3;+H@/NC"%E!7J
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MUJ6XBTZ\2>2VV^<@!#1ELX# C(/RG@\U=N+B.UMY)Y2PCC7<Q52QQ]!DG\*
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MZG@F-_J,M^#$"-ADQE>?3;U]ZZ:L[7=:M?#VCSZI>K,UO!C<(8R[<D#@#ZT
M8VJ^&;Q?%T'BG1)K=;X6_P!DN;>YR([B+=G[R@E6'K@YP!567P5<'0?$,"7-
MN=2U]G-U.48(@*[0%7))VCU/))/' '91NLL:R(<JP# XQP:=0!F>';"XTGP]
M8:;<M$[V=O';AXR<.$4*#@]"<=.:Y9O"/B/2/%.H:CX9U:QAL=5D\V[M[V%I
M/*DQR\>TC)/H2/QP*W;WQEHVGZU_9$[7OV\J76&.PGD+J.K*50AA[C-6].\0
M6&J7DMG +I+B.,2M'<V<L!VDD CS%&>0>E &1'X9U&#Q?8:NEU!+;VE@;(K*
M6\V3<0Q<MTSD=,?_ %LJW\#:M!X6\1Z,M[9'^V;N:X\PJ_[H2C##'?&!CI7H
M%9=IK]E>Z]?Z-")_M=BJ-*6B*H0PR-K'@T <E>IJ4'Q!\-0K<627L>E7*N&5
MC'+AHQ@<Y'8]^A'O4M_X"N[W0_$4)O;?^T]>D1KF;RV$<:( $51DDX ZGKD]
M*VM<U+0-%U73#?V"M>W]TEO;S+:;CYC' S)C ]>N>#CI714 <<WA"^BU?1M<
ML[V"+4K&S^PSHR,8KB'J!UR"#S]:D!TSP6FH:UXBU.!)]6ND$TOED("%VI&H
MY. JGD^YX' ZVHYH(;A D\4<JA@P#J& (Z'GO0!R?@#0;;1O#MS/IJ%4OYY+
MBV$V<I$2?*4]PN/FQVWFLH^ -8/@35/#1U"Q_P!.N7F\[RW^16?>1C/)R !]
M:]%HH XV?PMK-UXET'5IKVS(TVV>"2,JY\W>H5F'/!X%5-"\#:YH"RZ3:>(4
M_P"$=:9G2 VY\^)"23&LF[ !S@G&>XP:[N22.&)Y975(T!9F8X"@=237.GQQ
MHXM'OME^=.0\WRV4IA(_O A<E>/O ;?>@#.M/">KVVI^*KTWEDQUR-55=C_N
M652@SSR,$GZXJC!\/M6M=(\+Q6VKVT=]H+R[)&@9HI$<8.5W [@.G/<UWEG=
MPW]C;WENQ:"XC66-B,95AD''T-3T 9'B'17U[PM>Z,UVT+W4!B-PJ\@^N/0]
MQZ&N5B\#^(3J^@ZI/KMEY^DP26ZI%9$(4*[1C+9W$=3TZ8'KT\OBBPA\66_A
MQH[K[;/$TJ,82(MJC)^8XS^&?0XK:H Y;PSX8O='T*_TR^OH)Q=S3R[H82FS
MS22>K'/4U1L/ ]ZF@Z9X?U#4+>;2M/E20"*%EDN C;D5\L0!G&<9S@=*[>D5
MU<91@PR1D'/(."/SH Y^P\/7=GXPU37'OX9(K^.*(VXMBI01@[?GWG)^8YX_
M*N<'PZU5_"%GX>FUZT,-C<1RVTGV!B0(V+#/[P9)S@]L>_->B4UW2-&=V544
M99F. ![T <OK/AK5;SQ#INN:=JMO;7EM;M;2K-:F2-T8@L5&X$'(&.?Q]<,_
M#2_?PU>Z3)KRR,VH_P!H6LAM@-C[RQW\_-G/;&*Z^?Q%:6_B>TT!XKC[5=0O
M-&^S]WM7K\V>O3IZUKT <E)X3U*'Q#%X@L-6A34WMQ;WJRVQ,-PH/#!0P*D=
MN3QQ[U1U7X=27_AVXTR+5EBGO+\ZA=W,EL7\R7<" J[QM48 QD\#K7=T4 85
M]I.L3ZE97MMJ]O#Y5N\-Q!):-)%.6*G=M\P;2-O')X)%9^E>#[S0M-TRRTS6
MOL\=O>O=7:K;+LN%8DF-5S\B\X')Q[UUM% !45PL[6[BVDCCF(^5Y8RZCZJ"
M"?S%2T4 <SX+\+W?A/29M/EU*&\C:9YD9;4Q%68Y.?G;(STZ5DV_@'4K?0O$
M>EC7+4KKEQ-<2/\ V>V8C*,. /-Y&!QGI[UWE% ' S?#S44O=-U33?$K6.KV
MMJEG/.EIOCN8DZ!HR_7@9.X].,5U^CZ?)IFGK!/=R7EP6+S7,@ ,CD\G X Z
M  = !5^N:@\9VMS=^(+6*POS/HD2231^4-TNY690@!R20O?'44 8=_\ #>\N
MK3Q!I\'B)H-.UFZ>[>(V8=TD;!(WEN5R!Q@'@<^M_3?!NJ6/BJSUN;78+C[/
MIXT]H?L)7='NW9!\S@Y ['@=^M=-I5^-4TJUOQ;SVPN(Q)Y-PFV1,]F'8U<H
M Y4^$[VV\4ZOK>F:O';MJJ1+<1S6OF[?+7:I0AUP<9Z@\FJE[\/T:V\.VFFW
MT=I:Z+<BZ59+<RM-(,G+-O'4DD\=^U=K10!RR>$KJU\8ZIK]CJ_DC4HHUFMG
MM@XWQIM0[MP..Y'4^HK.A^'3#X:_\(;/K!9$.8KJ*WV%<2>8,KN.[GW%=U7+
M:KXZL](L]2O9],U)['3I?)GN8TCV;L@?*"X9N6 R!0!5M/!.HQ^+;3Q'=^))
M9[N.U^RSJMHB+(F\, O)VC(YZDY."*I6WPNBB\)2>')]9N)+2*<SV#)$J-:M
MN+ YY+D$GK@8/0=:V9_&D5JA>YT?4X0;22\C+"(B5$ +!2LA&[!S@XX!K6T+
M6(/$&A6>K6JND-U&)$5\;ESV..,T 9L'AN[?48=5U/48;S4K6V:"TD6U\N.(
MM]Y]F\Y8X .".!@8S4GA#PV_A71?[+^W?:X5D=XV,.QEW,68'DYY-;]% &'J
MVC:E=:Q;:EINKBS>&"2%H9;?SHY0Q4Y(W+TV]CW^N>?3X;"W721:ZKY7]G7C
MWPS; AYG)+<!@%3& %'3'6NF\2ZZGAK0+G5I+2>ZBMUW.D)4$#U^8CCZ9/M6
ME!*)H(Y0,!U#8],C- '$ZM\.3K%WXAFN-8=4UJ.*.1(X,>4(B#'@[N>G.>OM
M4D?@34%U^PUR;Q1=3ZA:V[0,\EM'M<'& %'09!SU)R<$5VU% '"P_#N6'P5?
M>&%UK-M=RM(TIM1O4,=S ?-CKCGMS^'9V4,UO910W$RS2HNUI%CV!O3C)QQ[
MU/10!YPWPG/]D#28_$VH)807(N;.#RHR('WELDXR_4]3CGI53196F^*7B.VL
M/$*I,UM;0AY(TE\]D1@YX*_.I].!DY'2O4JQ?$GB%?#EG;7,EE-<QS7,=N6C
M90(R[!06R>F3VS^% 'GOCRPT_0%\&Z3;:C]D:#4Q/)<L5,BYSNF?(QRV221B
MNZ3POOFU&]N[XSZC?6_V7[0(540P\_+&O.,DDG).3CT KHJY?5?%LUM=7L.D
MZ3+JITUXUOD@D D7>,@1K@[V P2./J2"  4"++P-X;T[PL\5[JWVJ.:WMD$
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M:*Y%S:1BZ^6U8-N^08ZYSR<D9..Y/;W-S#9VLMS<2+%!"ADD=C@*H&23^%2
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M981$D2DY8A<GYF(&3GH !CG,_BC08_$_AR\T>2X>W6X"_O4 )4JP8'!Z\J*
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MXY&,8S7H&GM<OIMJ]YY7VIH4,WDG*;\#=M/<9SBN4G^'=LVM7.I6FL:E8&^
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M0E05//S#!/!XS0![@"",CH:*\[O[G4D\9Z?X6L+EQ FFF]'VF^E1IW+E<>8
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M2O#Z+'X?L%2\GO(Q"NRYN/ORKCAC]1B@#2HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@##U;PK8
M:QX@TG6+@N)]-+E O23.,!O4 @$>],TSPI9Z1KVM:Q9MMN-4*LP9<K&P') S
M_$<$_2M^L36O$UOHFK:1I\]K<.^J3^1%*@78K?[63G]* *F@>%)] TO4K*+4
M_.%[/)<!W@QY;R?>P-W(]!6:/ATO_"':?X>;5Y<:;=)=6ER(5#(RDD C.&^\
M:[BB@#EW\)W+^+;3Q#_;#-<V]I]DVO;J0Z$Y).".<^F,>]4!\/YO^$8U;0GU
MMVAU.X>>64VPWJ7.6 ^;&"0/I7;T4 >0>)'ATWQ%;V.JZS>:;#8Z?%!;W+:2
M+J&Z.2254HX5AA 3U.*[GP;/J=Q93M>7SWUGN46EQ+9?9)&'(8&/ X&!@X&>
M>.AK4U[59-%TJ2]BTV\U%U95%O9IND.3C('H*T(V\R-'*,A8 [6ZCV- &!K_
M (8?6-7TK5;;5+C3[S3O,"/$B.'20 ,I# CL/I6%>_#+[7I&JZ6?$%Z;74KL
M7<HEB1V#C:20V <DJOM@8 %=]6;KVLQ^']'N-3GMKB>"W0R2B#:651U.&89Q
M[<T 9ESX6N+WQ!:ZK=:H)!#:O:O;_9@$E1\;\G.1G:/I6')\+A)H;:#_ ,)'
MJ(T=9A+!:^7&QA ;<%#D$D#MG]:[+1=576M)M]1CM;BVBN$$D:W&T,5(R#A6
M.,C!J_0 R)&CA1&D:5E4 R. "Q]3@ 9/L *YV#P?';S:]*FI7);6N9\JGR';
MM^3CTXYS72T4 <E)X#MY-,T"P;4[OR]#F2:U;;'N8H,*&^7! ''&,U3O/AK#
M>6NMV7]N:C'I^JS/<O:KLVI,QR6SC<1G!VY ^M=S63!XCTVY\377A^*<-?VL
M"3R(.@5CC'U'RD_[PH R?^$#@BU:#5;/6-2M+Y;=;>XFA:/_ $I5X!=2A7('
M0@#%5$^&&D#PH?#\EY?RP+<&ZMYRZK+;RY)W(P4>IZYZUV]% &)H7AM=%=YI
MM2O]3NF01BXOI0[*@_A7  '/).,DXR3@5M,JNI5@"I&"#T(I:* .5;X>Z%_P
MAMQX6CB>+3YY3*Q4C>&WA\YQVP!]!BK/B/PE!XBMM.MVO;BSAL+A+F%;=4X=
M/N'YE/ R>*DM_$GG^-+KPXUD\;06BW0G,@(=2VT  =._>MV@#F[GP?!-XE&O
M1:E?VUVT"0S"%U59MIRI8;>QQP, XP01D5E#X9VH\&R^%O[9U'^SI9/,8;8M
MWWMY&=G3=@_A7<T4 <Y_PBC?\)%'KG]LWOVY+(V1;RX<.F=V2-G7=S_]:LL_
M#6T_X12\\-_VQJ'V"[G,\@Q%NR6W$ [.FX _A6S>^)D37!HFF6C:AJ*IYDZH
MX2.V4]#(_.">P )/I18^)6N/$KZ#=Z9<VEVML;H.Q5HI$#*IV,.O+#J ?:@#
M9MH?L]M%#YC2>6H7>^,MCN< #]*P_P#A$;5?%5UX@AO;V"XNXDCGBCD C<H,
M*Q!&>!VSCU%=#10!R1^'VFGPI'X;^WZ@-.CE\T+NCW9W^9UV?WCG_P"M46I?
M#C3K[66U:WU35M-NYE NGL+GROM..[X&,_3%=E37=8T9W8*B@EF8X 'J: ([
M2UALK2*UMTV0Q($1<DX ]SR?J:Y:^^'FF7VIZM=M?:E#%JL>V\M8;C9'(0NT
M-P,].V<'N".*ZFTNH;ZS@N[9_,@GC66-P"-RL,@\^QJ:@#S"[\.'2O%/@_2[
M*XUXPZ=!<*;]+=I1&76-8U9MACVX0C&.."<$YJYXZ\/BQ^'FOV]C#?ZCJ>J,
MKR.L+32S/E1R$7"J%7@8 &*]#K*U_P 067AVP2YNR[O+(L-O!$,R3RMPJ(.Y
M- %/3O#\#W-GJL]]J-Y+!"R6GVQ50P*X )VA%.[ QE@3^M5HO EG%H^K:6NJ
M:F;;59I)KK+QEBTGW\'9P&[@?ACFI-5\3:EHFGK?W^@G[.9$1C#=*[0AB!ND
M!   SR5+?ES734 <GK'@#3M:LM.CGOM1CO-.&VUOX)A'.B^F5 !Z#MGCZY=<
M> -+GL+"W6ZU&*>QN#=17BW&9VE(P69F!W9XZCMCIQ5N_P#$;V/C'2=!:RW)
MJ,<LBW/FXV^6N2-N/<=^]6M-U+4+F_U.&^THV-M:R!;>X:8.MRF,[@,?+CCK
MZ^U &*OPXT8G5!/<ZG<1ZFBK<QRWC%78 #?QC+<#KP.P K2L/"UM9SV4TUY>
M7SV$9CM/M3(?)!&TD;5&6P,;FR<9YY-4]/\ %-_JS:?>:?HPN=&O)Y(A=QW(
M\R-5)42-&5'RDJ>C$X[9XKJ: .8L/ NFV4&KVTMQ=WEMJ[O+>0W)0J\CXW.-
MJ @\=C@>G2CPWX&TWPS.LMO>:E=&-#'"EY<F1( >NQ< #/K_ /7KIZ* *.L:
M5!K>ES:?<R31Q2E27A?8ZE6# @]CD"LT>#]/FGN+C4)KC4;B>S-B9;K9E83D
ME0%51R3U()]ZOV5WJ4VK:C;W6FBWLH2GV6Z$X;[0"N6^4<K@\<]:T: .+'PR
MT=;;3HUO]86?3F/V6[%Z?-C0J%V XP%P , 4]?ACX=6VU6VVWIAU+F5'NG8(
MV5.]<D_-E0=QR?PXKL:* .6O? 6F7UMIL<E[JJW.GN[PWJWK_:#O^^"YY(/'
MI[8J.+X<:##9:Q:+]M,.K#%P&N6//'(SQNR =QR3W)R:WM6OKFQMXOL=D;RY
MFE$21[]BC()+.V#M4 'G![#J:P[+Q7J-[X@U70TTBW%[IR1/)F].QQ(,C:?+
MSQ[B@"*^^&VAZCI]G;W$NHM<V9)AO_M;&Y&>OSGM[8P.V*Z'1]'L]"TY+*R1
MQ&"69Y'+O(QZLS'DD^I_D*Y_2?&-YJ'C*'0KC2A:++I0U$,TI,@RX38R[1@@
M[O7H*Z^@#'U[PUI_B'[(]V)8[FSD\VVN8'V2PMZJ?3ID'(.!3K7P_:V=M>)#
M-<"XO3NN;S>/.D.-H.['& ,# &.V*UJ* ,S0=#M?#NEQZ;8R3FUBXC2:3?L'
MH"><4S7O#UGXCMH;>^DN5BAE695@EV?.O*DD<\&M:B@#$D\,6LGB!=<-U>B_
M6W^S!UE 7R\YQMQCKSTZU0/@#1VT"[T1YKY["[F\Z:-[@DLY.XG<>>3@GGJ*
MZJL[^UH[I-3BTS9=WECF-HM^U3+MW!"W;J,^F: *;^%+*35].U1[F]:ZT^,Q
M6[&;A5(PV1C!R.I/]*AA\$Z1%9ZO:/\ :9H-6=I+Q))C\[GJPQ@@_2MC2Y;V
M?2[:74;9+6]>,&:%)-X1NX#=ZMT <DOPYT%?L3AM0\^T4HEP+Z42LA !0N#G
M;@ 8&,#I0GPV\-1Z7=Z:EO<K:W,XN"@NI/W;@Y!3GY>>XY/?-=;10!SG_"%:
M7_:NFZD9K]KK3E*V[/=,V,_>SG[V[)SGK1-X'T6:6^/EW$<%^_F7=M%<.D4[
M=RR@]\\XQGOFI?&.O3^&O"U[K%M;PW#6RABDLI0$9QP0#DY(XX^M;%K,;BTA
MF( ,D:N0.V1F@#(F\)Z=-XCM==W7*7EI&(81'*5C5.Z[.F#6>/AWHH2Y7S]2
M)N;E;R1_MCAO.&<2 CD-SV]!Z5UN1G&>:Y>U\2WUQXYU;P]]CMPMG9I<0R>:
MV9"QP QQ\H^@/XT :VF:'9Z5/=7$/FR75T5,]Q,Y=Y-HPH)/8#H!ZGN37)_%
M&TGU33](L(=,O[U%U*&XN/LL9.(5)#_,""&P>,'-;7@;Q'<>*_#2:K<P102/
M-+'Y<1) "L5')Z]*;X^\1WOA/PA=ZS96UO</!M!6=V &Y@H. /FY8<9'UH O
M:;X>T^R>6Y"3W%Q<PK%)+>2-+(8P.$.[H.3D=SR<FL[1?AYX:\/:F]_IUD\4
MQ#! 9G98MW!V GY202,]<<5U"MN4'OBER,XSS0!BZ7X4TC1K"ZL=/BN(;>Z+
M-*OVN9CD]2"6)4GU&#4*>"M!C\.C05LW_LY&WQQM/(QB;.0R,6+*0>>"*Z"C
M(H R['P_I]@\\JI)//<1K%--=2M,[H!@*2Q/'7@8&23U-8$?PK\)1JB"QG,4
M<_GQ1&[EVQ-S]T;OEY.>/05V>1ZU0U;6;'1;:*>]F"++,D$:Y&7=V   []<_
M0&@".S\/:78:W>:Q;6OEWUXB1SR!VPRH %&W.!P!T%:=9<LFM?\ "16Z0Q67
M]BF!C-*SMYWF9X"CIC\^_3O5OO$*OX?UF^T=X)YM.$JYD),9=$#$?+R1SCMR
M#0!NLH92IS@C'!P?SK%T;PEH^@7=Q=:;%<QRW+%YB][-()&/5F5W(+>^,U/H
M.IOJ7A;2]5N_*CDNK**XEV\(I9 QQD\#GN:TD=70.C!E89# Y!% &$O@S14O
MKZ]6.\%S?IY=S)_:$^9%[#[_ !CH,=.V*@;X?>%W\/)H,FF>9IL<AECADGD8
MQL>NUBVY1[ @<GU-1+XIN9/B3%X>C%I)I\FG->"9"6?<'V8SG&.O;TKJF8*I
M9B  ,DGM0!GZ)H6F>'--33M)M$M;526"*2<D]22<DGW)["HM=\,:-XEC@35K
M%;C[.^^)MS(R'OAE(.#QD9P<5)H^NZ?KL=Q)I]PDJ03-"Q5@<E3@GZ9S@]\5
M=BN()RXAFCD*'#;&!VGT..E '/O\/_"LB72'1H!'=LK3(A95<J !P#@#@' X
MR,]>:TKSP]I6H:5'IMY:">UB(:-9'9F0CHRN3N!'8@YK3J(W, N! 9HQ,1D1
MEAN(]<=: ,^U\-Z39Z?/8PVI$-P,3,TKM)(/]J0G<?3DU6?P7X>?P^=";3E.
MF%Q(+?S'PK YRISE>G8COZFMB:[M[8J)[B*(O]T2.%W?3-/>6.-D5Y$5G.%!
M8 L?;UH R(/"6AVNJQ:G!8".\AC$4<JR.-J 8"@9QM]NE02>!?"\MY>W<FB6
MC3WJE;ABOW\]3CH"<GD8/)YK=AGAN%+0RI(H.TE&! /IQ7'^(?%5W8^*?#]C
MI]Y82VM[>?9KF-5WR)\N?O!L#Z;<^] &R_A#P])-I\S:1:[].&+0A,>4,Y&
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MM)GG,R%6>=W!WF3<"&W9)/'7&,8J]H6@V^A0W0BDDFGN[A[FXGD #22-WP
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M6XZJH&>?^6@STK,TN7Q9?Q^'M:M[L+;3^7)J+372-%)&^,A$Q\A7/&#GL<T
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M!(S@T >SW]SK46L:?#8Z?;SZ?*6^UW#S[&A Z87'S9_SCK6K7 :S8Q:5\0_
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M%1Y5"*4EW.,DCH<C\ZXG2-,TR+X*Z#JQMX4U!-4B9;H\2 BZ(P&Z@;<\=.]
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M@%L9;8*0\(Z(R,"I XP<9X%:>E:)9Z1ISV<"M(LKO).\IW/,[_>9SW)K1HH
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M&\U2SL+FSM[B8)->R^3 G=V"EC^  /-7* *FEV7]FZ196)D,IMH$A\QNK;5
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MIEN+4Y@D\UU,9SG*X(P??K0!YW<PZ=X:E^(-H);NPTI8+*15L7R\;2AU)0'
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M\D\DD2[9D/-L?J0Q8_\ 7,>M=MJFCI;O>ZWHVEV,GB%X/+CFF7;OQT#,.?\
M]0&>*/#>G7UM#<W^KB$:K?N)+A8"3'&%4*J*3R0 ,\]V/;% %;X@Q1R_#[7_
M #$5]MC,R[AG!"'!'O7*S7%LFN> [&6.W&C30,7  ,;W1A4H''3/.1G/)'UK
MTR6*.>%X9HUDB=2KHXR&!Z@CN*S%\+Z$FB_V,NDV?]G9W?9_*&W=_>_WO?K0
M!R_ANU>P^*OB6UL5$6E&V@E>&,8C6X8#D < E>3QSD'TJIXZTRQOOB9X(AN;
M:-TNOML=P",>:JQJ0K>HSV->@V6GV>G0F&QM(+:(MN*0QA 3ZX'>J]UH6D7U
M]%?7>EV4]W%CRYY8%9TQR,,1D4 ><N-.MO'^K>'+Z\M]-LEL;>/38;B"-HC
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M;)UCGQT5BH;&?7!KS;0-,N]7\/>'_$X\1Q6SJZ374Z+(7N"Q >&3,F#EOE
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MU#6].L-2M;QYKJX^S;KRU=93MP_F#C'R@;<8X S0![')<P12+')-&CL"55F
M) ZX%2UY%XMT]HIM>U&_MH=;T&Y94OGCPEWIC*J\Q[L@@ AL#N3VSGUJ&59X
M(YDSLD4,N?0C- "&>)7"-*@<D*%+#.3R!^AH^T0"X^SF:/SB-WE[ANQZXZUY
MEH_AG2]1^(GC)IK)99+&ZL[BT4R.JI+Y6X'@COZUS^AVT'BKPI:ZIJ'BBUL=
M1MKDS7+?95^UI<!SCYMP8DKM4+C!& !P, 'M<EY;0S)#+<0I*_W49P&;Z#O1
M-=VULR+/<11,_P!T.X4M],]:\;\9BRN-!\;WEFUNICO522ZO65YC.FS]W"
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M-2V'@;2M-\/W6AVL]^EC<YWK]J;*YSNVGMG)SZUT<ID$3F%5:3:=@<X!/;)
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MA>7=DL]S8#%O+*[,RCW)/S=/XLU4N_ ?AB_OKJ]N='MY+BZ'[YB6 <XQG .
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M!KW]N?V/:_VENW>?MYW?WL=-WOC-; GB:9H1*AE49*!AN ]<4//%&"7E10"
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M /3C.,XXKE?AGX7:_P# ]K;ZK/J*6T<SF;2YHO+C+B4NI.5#$$;25SM/?O0
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MNM/C\NW<W3_*I&#D9YR ,YZXK,N?A?X5NA<(]G<+!<2^<]O'=RK%OR"6"!L
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M\B/;MH"7%I]H<%9KDX#,0>"P7.,^I/>M;X9&UAU/QC96(B6UBUAWC6(@@94
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M^IP /PJI<:)I5WI\>GW&FVDUG$H6."2%61 .  ","@#SX6-AI_Q4\+PVEK!
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M%IB7=AXYT8:E9VADU&W$3Q(5@$K+$=NS+85GPK>N3]* /5HIX9QF*5)!URC
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M<@3W]K$3*(0'F5<R'HG)^][=:S[[Q9HVGZ]9Z+/?0+>W.XB-I -@ S\WH2<
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MV-Q+'K)G"_+Q_K4'H#-LP/3-6#>Z.GB[XCI?W"&T:PMA.D+CS&589/,VC/4
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M]/ANX@X210?GC9#^3 ']* +=%%% !1110 4444 %%%% !1110 4444 %%%%
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M,Y>$KT*N3N&.@YZ<4 >93QRRZ5\3]+O8U%K9113V]IYS2QV[M$S'86 [@'H
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MOD YJ2+PEH-O>)=PZ;%%<1Q^4CH2I5/[HP>![=* ,?X=_P#'KXC_ .Q@OO\
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MV"0>'OB/I:QDZ1ITT,M@A.5AE=0T@4^@)'R]!GW-=%-IEEH7Q7\)?V7 UO\
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M<RJI!]/][% 'K)=0A<L @&=V>,>M<CI'BFYNO'.OZ7=7%G_9UC!!)!+&-O\
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MQU;3]3ENXK*[BGDM)C!<*AR8W'53_GUH N4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7(_$?5]5\/
M>#[K6M*NHHI+3:6CDA#B3<ZKUSQC)-==7"_&%T3X6ZPK,H+"$*"<9/FH>* -
M2[M_$EI/9O%KMK.9+M%:VDM%C\R,MEPAW9W! S=\[3Q6M'KND3?:?*U6Q?[*
M,W&VX0^2/5^?EZ=ZYO4],\/Z%/8^(S?W*FR=FCB:^DG%R7B9%1%=R-QW<$<G
MOUS7,^.B;;6;O7-#ADDAM(EC\1PV\H03Q$@A"0"=X7.2.0IZ\T >F'6=+&G#
M43J5G]B/ N?/7RSSC[V<=:D34K"2Q^W)>VS6>,_:%E4QX_WLXKSO5O$6D67C
M/PEJTDT8\-R6<L5K<+Q!#,<!<XX4[05YQC)Z8-9_BB]T6QT[3-0T*2XM]"77
MO/OKVT D3S&0YD7>&4J&QT&W<..: /34U_1Y+.2\75;+[-&^R24SJ%1O0G/!
M]C20^(=%N;XV,&K6,MT$W^2EPI?;C.< ^G/TKS'7K+0)_"_C#5=,UBXUFXN;
M%6N;AC$T2LO"?ZM%&_&?<#KC-6;K3=,DL/A_)HB6L>L?:+>1'M\!FAV9G)QU
M&,YSW/O0!W6@>+M'\27%]#IUW%(UI.T. XW2!54EU'7;EL9Z'%:E[J%GIT2R
MWMU%;HS;5,CA=Q]!ZG@\"N-\ ZC9+K'BS33=0B^.NW,PM]X\S9MC&[;UQD$9
MI_C;5[#3_$OAZ.Y-M:73>>UOJ=XY6&V&P!^,A6<@X&X\?C0!U46LZ9-IO]HQ
M:A;/9?\ /=904SG&,^N>,>M.L-6T_51*;"]@N1$VV3RG#;#Z''0^U>,Z1<:-
M>:+K6G7/B4V-T?%,D]G>@J"C[0T<CIP C%6[ 9^E=]X&O;N?4_$-KJ-M:?VC
M:SQ)<WUF3Y=V?+&&P>%8* "!0!U5[J-EIL:O>W44"L<+YC ;C[#O61KGC/1]
M%\+S:^;J*ZM%7]W]GD#>:V<!01QUX/I6#J=RUA\:=*EU$[;&XTN2WLI'.$6X
M,@+ '^\5 'OD5QGB:U;_ (0CXCRV&Z32)M1@EMBH^5GWQF=EP,%=W&1_=- '
M=:GXEGM_'7AY(M5B&B7L%U+,I50H\I.I<\XR?;I756>LZ9?Z<VH6FH6TUFN[
M=.DH*+CKD]L5P>M:AI&K_$KP1+'<VEU;-#>%&W!D9MJ[2.Q^88'N/45R6I73
M1S^,OL>9;*UU^UO+R*U8;C .9&Q_O!2>.HYH ]DB\1:+-%<2QZK9^7; &=C,
MH$0/0MD\ ]B:J/XT\,QHSOKVGA%5'8^>O"M]TGGH:X:]N/"6L6NJZMI=W+JM
MR-'FCGN)YCY<2%2423.!N+]!U&#TQ6AX5\,:%XA^%%I!';6?GW>F+;RW$2+O
M#@;L%ASD/@X]10!VKZ_I,>H6^GR:A MY<J&@@9L/(",Y4=ZRO$.LVLMJT%GX
MHM-*N8+N-)GD"L3SS%ACU(].?SKSEY_$>I>&[#Q;/%+#=^$V\MX2HW71C;;<
M-NZ[=@Q]0_M6GX[D\CX;65S?LD%W?ZG#>2)(P#+N?=M//\";5/\ NT >E7^N
M:7I;,M]?P6[+'YK!VQM3.-Q]!GC)IMYK^DV$$4UU?PQQRQ^:A+=4XR_^Z,C)
MZ#-<!XONK>+7-2U31?$-G#?1Z>GVS3;[:UOJ$.UF4*2>I!(ROJ.F23F0:W::
M;XJW^(VN]$T[5=)M/L&UF5(E13NA8X/(+GT]^HH ]@M[B&[MX[BWECFAD4,D
MD;!E8'H01U%9$WC#PY;W;6LNMV(N%E6!H_.!8.QP%('0\&F>#;+3K#PU;V^D
M07$.G!G:W%P2692Q.X9Y ;)(SV-<?HITO4?C#XQCD-E<RF&U$ ?8YWHGS;<]
MU8#..A H [J;Q)HUO?)9S:C DSR>4H9L*9/[F[[N[_9SGVI]_KVEZ9(T=Y=I
M&R*'<8+>6O\ >; .U>#R<#BO)/#<OAZYT.+PQXI74Y/$5O<.)---Q<?OI=[.
MK *=O.0V[CUSBM?2-=L])U;QIHVONR:C>7LLEO$\32&XMVC"QA>#N 48Q]?>
M@#T2+7M*G-CY=]"?MZ[K7G'G#&?E]>!FJ5WXBTF[T_5X8-:BLIK2,I/-(-K6
MC,"$8J^._(SP:X2.^M])\'_#75+Z3R;&V=/.F()6/=;NH)QT&2*CM-7L9_%?
MQ*NUFVP7&GVS122(4##[.1GY@.N1CUR,4 =KI_B71=(\/:0-1\2P7)N(@L5W
M.=C7/;=CL/?]:T(O%6B7%A;7L%^DT-UN\CRE9WEVG#;4 W'!'/'%>2-?6 \%
M?#))[BWVQ:C$TRNX.U5R&+#L 2,YZ9KI/%-[IWASQ[8W^J)<VWA^ZT[R([JR
MFDB2*?S6D;/E$'Y@0??&>U '>)XBT>32EU./48'LV;8LB-G+?W0!R6_V<9]J
MY7PMKUSJ7Q(\16(U.>[L+:WA:&.5 GE,W+# 52".G(SZUSEU<:3H&H^'_$.F
MV%Y%X66^N)KFXD:60/+)$JI<%7RP&=PS[D]QG5\)ZI9:E\7?$ES92&6"XLK8
MQR+&P5]HP2"1T]^_:@#3^(^JWNBCPY=6VI2VD$VLV]O<J"H1HCN+;B1D?=]0
M,9K8MO&_AN\LKJ\MM6AFAM!NN#&&9HU_O%0,@>^,5@?%A%_LSP[/-'NM+?7K
M66Y8KN5(@'W,WHO/.?6GP6EGK_Q(&KZ4\%QIRZ8]K?W$1#QW#,PVQY'!( R3
MS@8'>@#ID\2Z3)IMIJ,=RSVEVX2"1(7.\GI@!<\XX]:T+N-Y;.9(YY('*'$L
M87<I]1N!'Y@UY_X/TG4K/7Y] NPYTO0)GFL9"<B5)0?*4^NP&3\2/2N_O+F"
MSLIKBYECB@C0L[R,%51[D]* .,^'WB8R_#/2-6U[4"]Q<R21^;)RTKF9U50
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MF'S,6/S,V.,EN<G% ':Z?XPB;P[I5[?VMS'?7ZHL-H$7S+B0J&)0;L;><Y)
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MOCZ9%5;/Q%HVHQ7,EEJ=K<):@F=HY PCQUW8Z4/XBT:.Q@O6U.V%M< F&02
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M'1]0T?\ M>UU&WDT\9S<;\*OL<]#['FGZ9KFFZPTZ6-TLLD! EB(*/'GIE6
M(![''/:@"=].LI"Y>SMV+OO<M$IW-C&3QR<<9]*DM[:"TA6&V@CAB7HD:!5'
MX"JVH:UIFE/ E_?6]L]PXCA21P&=B<<#J>OX=ZJ:3XLT#7$NWTW5K:X6TSYY
M5\; /XCG'R_[73WH U+FUM[R$PW4$4\1ZI*@93^!I3!"8# 8D,)7:8RHVE?3
M'3%9=CXJT/4;I[:VU"-I5C,P#*R!XQU=2P 9?=<BJ$GQ"\*QA]NKQ3,J2.$@
M5I&<1_>*@#YL<]/0^AP = MC:($"VL"B, )B,#:!T ]*5+2VBSY=O$FX8.U
M,CTKBF\4V?B/P?IU^^NR>'Y)YXW#!-K2$'/EKO'S@@C)7(^HXKJ=4U[3=&Q]
MNN?+)4N0L;2%5'5B%!(4?WCQ0!:BL;.&%H8K6".)CED2,!2<YR1]:EBABA7;
M%&D:YSA5 &:S;KQ)I%I!:S/>JZ72EX/(5IC*H )90@)(&1STY%7+"_M=4LH[
MRRG6>VER4D3HV#CC\10!/Y:%&38NULY7'!SUILL$,P EBCD Z!E!Q4E0W<+7
M%K)$D\L#,.)8L;E]QD$?F*  VENQ4FWB)7&TE!Q]*=+!#. )8DD Z;U!Q7G_
M (!\6'_A ],UGQ+JUQ+/J$KQ!WARBL)610-B87/'WNIKL_[=T[^W?[$-P1J)
MB\X0M&PW)_>!(P1]#0!H]*B2V@CD,B0QJYZL% )_&O/O''BZ Q::FCZI=I-_
M:D$.Z!&$$^7 =/-VE3@9R WKUQBNOU+Q-I6DSO#=32>9%'YTPBA>7R8^?G?:
M#M7@\G'0^E &IY4?F^;L7S,8WXYQZ9JOJ%H]W9SQP-%%</&R)-)'OV9&.F03
M^=9EQXU\.6L=G++J]N(KQBMO(#E7QU.X< >YXJF/B-X6:UNIQJ1(MI/+DC\B
M3S,]1A-NXC'.0,4 :/AO1)-&\,6.CWDT-W]EB6(.L6T,% QD$GFM@  D@ $G
M)]ZS&\1:6-(M=46Y,EK=[?LYBC9VE+#("J 6)P#QCC!]*HR^.O#MOI$NISZA
MY-O#/]GE$D3J\<O]UD(W _44 =%371)$*.JLIZJPR#6#9>-="U'4+FQL[J2>
MY@A-P42"0^9&#C='Q^\&>/ESGM3?"7BR#Q78RW$5M<P&.:1"LL#( %=E W'@
MM@ D G&: .@**R%&4%",%2.,4H55&%  ]A67?^(=.TS5K#3+N25+F_;;;_N6
M*NWIN P#[$U2N/'&@6DNJ175W)!)I@#72R6\@*@YP1\OS XX(SZT ="0""",
M@]0:I:G8S7>CW%E87C:?-)&5BN(D#&(^H4\5D67C[PUJ&J6NG6^HAKBZ0/!F
M-PDF0#@.1M+8/3.0>.M3WOC'1+"XGBGN)=MLXCN)DMY'BA8XX>0 JIY&<GC/
M- %K0-&.BV#12WDM[=ROYMS=RJ TSX R0.!@!0!Z 5J5@:CXST'2M2BTZZOL
M7<L)GCC2-G+K_L[0<D]@.35S0O$&F^)+%[S3)VEBCE:%]T;(R.O52K $'D4
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MO<RK&N2QV2HQ4 =6(0X'?(K?;Q FI>,?"VHV^F:K]BBMKR)YGLW4*2L7)'4
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M88\X5$4\;SD')X [&K-Q;>(]/U[26M]3FO\ 3)9FCO(YH(@Z#RV*MN15^7<
M.G4CF@#HXH8K>)8H8TCC485$4  >P%-N+6WNT"7,$4R [@LB!@#Z\UF#Q7X>
M-VMH-;L#<-+Y"QBX4DR?W>O7VJ5_$.C1WOV-]3M5N/,\K8TH!W_W?][VZT 7
MV@A?&^*-L# RH.!2K#$K[UB0.?X@HS5,:WIC:A<6"WT)O+:/S9H WSHG]XCK
MCD?G5;_A+/#_ -EM[DZS8B&X<QPN9E D8'!"^N#Q0!IBVMQ"T(@B\ILDIL&T
MYY/% MH%A6$0QB)/NH%&T?051TKQ'HVN231Z7J=K>/"?WBPR!BOO]/?I6G0
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M;NN6$G)'& ?0_3%8H^)NEW?B+1M.TU+BYMKX2L]R+64 ! >%&W+'<.<# [T
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MP'RIR%9B5;L,(>N,]LB@#H***YZ_\9Z78279:.[FM[)PEW=00%XK=N"0Q'/
M()P#C/- '0T5S\OC'38]=TW20EQ(^I(7M+A$!AE4+N)#YYP*CL_&FGWL>LLE
MM>QMHYQ=I*BH5X)XRW/ )STQ0!TE%<J_C[3%U$Z<+'5FOOLJW7V9;)MY4G&
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M&P?,5)&-W _K+K'Q(L]-_M"2WBM;J+3Y?*F0WR1SNP(W^7&1\VWD<E<D$#-
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M=:/'J2V/F:M)$;R5S(T</,<(.,(I/)P!U/4DGCI6A10 4444 %%%% !1110
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MA<)"6B\\G;LW#H<G&>F>,YXIFG:1>VOC+4]0_M#4);*>, V]PX,2O\I!B'4
M#=GW(ZX-<$\RV>K-=>%Y[CSKG5]E[H%W%YB.1*0T\>1E!\N_>#@<9(QBO7Z
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MA1W(XSCUH Z+7?$MGX>EL$O(KAA?3BVA>- 5\P]%))&,\_D:2W\3VESXEN=
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M5@&<CCK@#C[Q)&* .TU'XAR6OB.^T2T\.:C>W5GY1?RBO*NP&[@G@ @^O/(
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M@,D+N SC!JMJ'C31[+3M6N4FDFETN/?<VZ0OYB$@E=RXRH.T\GC'/3F@#H"
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M]GI^IR:9=28V74<8<I@@G@XZC(ZCK2:'I(T;3A;M<275P[&6XN9  TTA^\Q
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M/!P<=#0!TU%8!\::$'CS=N())C;I=&!Q T@.-HEQLZ@CKC(J>W\3:9<^(Y]
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MC89(B>C9W;2IP<$&M?0O$#ZY<7:?V3?V<,(C:*>YCV+<*ZYRGT[@\C(S@\
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M&]P*B-S!?^.;>2PU6]O5O_#\UI;WK0,BF9FP!&%4!0,CV7N>IKVVD"A0
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MC"7UY(=(N2.K02@G?]4VEA_]:O0*PK'PQ':>(;K5Y=2U"[:5BT-O<3;XK8L
M#Y:]CU'L"1W.0#9M[>&TMHK>WC6*&) D:*,!5 P *X2]2X\-_%"XU^Z@O+C2
M=0L$MS/%&TPM9%884HH+!3USCJQKOZ* /)KO0]0M_!/C><V5Z]QKU[+):6J0
M.[[#]TLH!V$\GG';//%>A^&7+>&M.1HIXGBMHXG2:%HV#*H!&& /7OTK6HH
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MACB$9X\SC)&1GMUQTK3\ 6=]IO@K3=.U&REM+JTB$3I(R-DCN"K$8_6NEHH
MXK7--U>+XC:7KMCI7V^VCL9+5R+A(_*9F!W'=R1C(XSUK";1]?F\+>-K$Z#=
MK/JUW--:*98.5=5 R0_'2O4J* /*K;2?%OAK4K'7=(T/[=]ITV&SU#3IKJ.)
MTDB4*KA\E<<>_?@9X]%T8ZD^GB;5D2*[F8NT$;!E@!Z(&P-V!U/<D]L5H44
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 4=0UG3=)V?VA?06V\$J)' ) ZGZ#N>@K,UWQGHV@
MVNGW$]Y"Z7\\<4#(X*LK, 7W#C: 2<^U<_87T6G_ !9\1)K<D</VJTM_[/EG
M;:C0J#O12>,[CDCVKE$@32? VE23L(](C\7I-;-(?D2T\T[6Y_AZG/3!SWH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MCA< LW4@$D@>N#VKI656QN4'!R,CH:6B@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH ** <C(HH **** "BBB@ HHHH **** "BBB@ HHR#1
M0 444UG5,;F"Y.!DXR?2@!U%%% !1110 4444 %%%% !1110 44TR1K(L;.H
M=ONJ3R?H*=0 4444 %%%1&Y@6.20S1A(SAV+#"_4]NM $M%("" 0<@]"*6@
MHHHH **** "BBB@ HHHH **;)(D,;22NJ(HRS,< #W-,M[F"\MTN+::.>%QE
M)(G#*P]B.#0!+1110 445!/?6EM-##/=0Q2S-MBC=P&<^BCJ?PH GHHHH **
M** "BBB@ HHHH **J7>J:?8W%O;W=[;P37+A((Y) K2-Z*#R:MT %%%% !11
M10 452CU?3IM6DTN*]@>_BC\R2W5P71>!EAVZCKZU=H **** "BJ%[K>F:=>
M6UI>7\$-S=.$@A=QOD).!@=3S5N>>*UMY;B>18X8D+R.QP%4#))/H!0!)15>
MPO[74[&&]LIEGMIEWQR)T8>M6* "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *SM5TH:JUHLES/
M%!#+YDD<,KQF7Y2 "RD' )SCH<5HTC,%4L<X SP,G\J /,O#6F#5O%7C;39]
M0U0P6L\4=K_ITRF ,C$[?F'?IGT[TEAJ9\-?$368+R34M0*Z;:DI!').6?!W
ML$R=@.,XX'..IJ_X)6>/QQXNN9K&_@@U"XBDM9)[.2-9%52"<E0!U'7!-2V3
MR6GQ1U_49;+4!9R64,4<RV4K*[(6W $+S_7MF@#H;?Q3I=YI-AJ-G(]U'J /
MV6.)<O(0"6&.Q&#G.,8J71/$-AKZW0LVD6:TE,-Q!,A22)QV8']#T->36.E:
MK:>'O"U^_AJZU%=*ENXK[39K9EDV32%E=%888@8Z9Z]NWIOA:*V(N[RT\/KH
MT$Y4!)+=89Y2N<LX';G SSU/0B@"YJ_B"ST:>SMI1)->7S,EK;0@%Y2HW-C)
M   [DBLI_B#HD/AZ\UJ?[7'!8W!M;N,P$O!*" 58#(ZD#.<<]:K>-9=1CUC0
M1#IM[<Z;YDANYM/CW7$9VX50>J*3U92#@=1W\]O=*U=? WC?14\/:NL]_JQN
M;13 T@=#+&P&X$Y.U6)/3CKDT =5XE\36&H'0]5C34K:.UUV*!_.CDC$J&-V
M!6/^,$XQQGCWKH+/QKI&M)JMA+;:C:W5I$QGLY[=TG,1XWJHR2#D<CD9'2H?
M%BW-UI?AW4+2PN[A+/4X+J>)(2)5C".I.PX8D%AQC-59[&6\\97GBH6EW'9V
MVDFRB0V["6Y=F+$B/&[ R!R!S[#- %=/$]MX>\*^%D\/:=>7&FZA=16T,DKA
MF1&<G'S-DL0& '0>V,5L:IX_TW2KU[&6QU26]2W6Y-O#:,S["VTD=B!SD]..
MN<"N0ALM43X9^#PNCZBUSI&IV\MU:_9R)0J;]Q53C=]X8QZ^QKH;22XN/BR=
M0;2[^&V;1%MC++;$*LOG%]FX9'0CH2/?B@"]=>/]+M5N;AK:^?3[2X%K=WJQ
M?NX)>!M8$AC@L 2%.":AB\77<WQ+E\/#3KA;6"R\TOA#O9I% DZ\(!GWY/'2
MN(\266OZKHWBFUN=!U:74/MNZU^SH%MA )$(95#?O'(!))#'Z8KI%AU1?B<N
MJ'2M1%KJ6BI;+,J+FW??D^9SA2!SW]J -R7QYI45K_:'EW3Z/YGE'4TC#0A]
MVTYYW8SD;MNWCK3-6\?Z7I.K3Z6UIJ-S>16QN1';VQ?S$R!\OKU)STX//2N4
ML=,UJ#X6W7@BXT:X;5%1[:*15S;R([DB7S/N@ ')!PW'2M/1-%O-'^)<;_9;
MF33XM"ATY;OR_E:1&!Y].!UZ4 ;EOH<__"<G7X+J_CM9K0+-!--F)V.-NV,\
MH1@D^YX'6GV?C&UU"YM!:V%Y+8WD[007Z[#"[*&)Z-N ^4@$@9KI*\NT?2;J
MVU_3[[0M-U72)KF??JMA.A^Q;,'<ZYX#9Q@*<\\@#- 'IL\\=M;RSS,$BB0N
M['L ,DUS%AX]L+^XTU!8WL$.J([6$\PC"7!49VC#$J2.FX#-;^KM>)HU\VGQ
M)->BWD-O&_W7DVG:#[$XKRBVTW7+FY\%ZC)X>U9KJRN&;4)KAEW%RN/E4M\J
M CT48QC- ':IX_M'\.:OK/\ 9>H!-)NGM;J ^7YBL@!8CY]I W>M5)O&E[-X
MZTK2;/3)Y;*YL#>%E>+,JMMVL,L,!?FSSD^A%<[>:7KMEHGC?08/#]Y<R:K>
MSW5M<1%!$4D5>ISG<-IXQR2.G6M*UT_6-/\ $?A/4GT.ZD2#138SK$8R\4@V
M_>.[&W@GJ>_% &=X7\31^%K;QC++I^HWT5OKUR\K6L>\0Q ( 26(R !T&2 ,
MXQS7=WOBJWCN+6STRVDU.^NK?[7';P.JX@X_>,S$  D@#N2?K7%6MEJP\)>/
M;5]%OEN-4O;J6T3R_P#6)*@5#R>.F2#TJQHNG:SHNO:-KATR[FM)M&BTV\@
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MF+"K, !N^;@C'.,]: .JU#Q+>"[2WTS3TD0Z>;]KJ[D:&%5SA4W!2-QZG)&
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MP.AX]ZIV?Q/M[K2M.U<Z'J,6EWEPMO\ :GV81V8J.,Y(R.2.!G'- '>4A(!
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M/EVCA.3V&!DX&,<]:B@\=:I<W.J:?!X3NY-4TUAY\ N4\O8RAE(D[DCHH!H
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M'+XBM+[[58FRO+"\>SN(?,WKO4 Y5L#((8=J -:[U"ST\1&\NX+<32"*/S9
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M9R@M59MJGA#E0>O0\UT5YJ^H?VO<6%GIUO>Q16?GR9N-IW,2%3&TCG#'GL*
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MAB*AG]AN('YFO./!D?B#PYX8?1[_ ,'7MT9)IG?R[BV,95V)P<R#L?2O3:*
M/.-7LO$VIZMX/U&?0Y2]G=2W-U'%-#BW5^%C!+#<5&,G&#^E7]'LM:L?'GBO
M59=(N#97Z6_V;$L67:--IXW\9KN** /&I+;5/#_@7P'8WNCLE]9Z["GV8RQG
MS21*058$@?>[XP?SKK9-+U+4=?U#Q-+I$UO(FEMI]K9M)&9IB6+%B0Q11T &
M[U/I70ZSX9TW7I[2;4%N'>TD$L CN9(PCC.&PK ;AD\]:U@, #T]: /*K#PG
MXAMO"_@V[&GJ-3\/2R>;8O*@\Z-^#L8$KNQC&<9.<GUZ?3=(GF\:W?B[4;?^
MST%DMG#!,Z%\;MS.Y4E1S@ 9/?I77U3U;2K+6]+N--U&$36EPNV2/<1D9SU'
M(Y H X_P9X?2R\4Z_-%-YNFVMVZZ?'CY87E57G"^P;"^V&'K5;3+'QEX5U?4
M=.T_2[34],O[N6[AO)+H0_93(<E77!9L=>!SGKZ=UINF6>CZ=#86$"P6L*[4
MC7M[YZDD\DGDFK= 'GUS8^,/#?BV\U/2;&#7+35EA%Q$TRV[0RQQB/?D@Y4@
M9P!^ []OIJ7J:?$-1DC>[(+2F(?("23M7U S@$\D#)JU10!YGXAT'Q/J&I^)
M8?[)MM0BO+5H]-N[BZ 6U1HRK(J8X<DGYN,\9.!45SH.K:IHMC8:[X*BNE@L
M(HK>6WOHQ/;2@8/S';@<(>"0,?Q5ZC10!G:#;7UGH%A;:G<?:;Z*!$GFSG>X
M')SW^M</KOAWQ)J&K^)%;2K._@O;9HM.N[FZQ]D4Q;654P<$MSD8]S7I-5+3
M5=/U"XN8+.]M[B6V(6=(I QC)S@-CH>#^5 'GMAHGB9/$7A"^N=#5(])L6M+
MCR[R-_O(%!&<=,9(Q]">M;?@G3M9L-6\12ZEI[VL&H7QNX,S(^ 0!@A2<'@>
MU=E10!QOQ!TK5=7@T1-+T_[4UGJD-](?.1,+'G(^8\D[N/QJ"RT_6[7XCZQK
M9T8_9+JRCAC874>6=!GIGC/3\*[FJ.I:SINC^1_:%[#;&XD$<(D;!D8]E'4]
M10!Y9HO@GQ3I6B^'[J&P@&KZ#<W#K;RW"[+J.?.X!AG:0#WKH](TCQ)#XE\0
MZW?:/8!-5M85-JMYN(9$*[2=F#G."3C';-=]10!QGAOPU<3?#*+PQKUH+=A;
M-:R!9%DR.S C\_PJWX1T74M%\*"'4FCN]6=<3-N #;5"(,X/1%7L><^M;-KK
M6F7VHW.GVE]!/=VO^OBB<,8N2,-CH<@\=:34M<TO2);>+4+^WMY;EQ'!'(X#
M2,2!A1U/)'YT <';^!]?M?!/AVUADM(]9T"Y,\0$I:*X7+90G:"N0V.E7M.T
M#Q'=^-[K7]2M+&R@O=*%D\,=T97B.<_W &]^@YZG%=]10!Y=%X*\61^#-.\.
M9T@QZ;>1S1RF63_2$64OA@%_=_ANS[=:DU3P;XIOX_%4+'2YO[6S]GNI97:2
M&/'$ &T87/?..IP<UZ;10!P$'ASQ)_PEOAW6+F#3BFGV36LZQW3Y.X8RN4YQ
M[XS78ZU:W=[H=]:V%R;6[F@=(9Q_RS<@@'\Z:^MZ9'K46C->Q?VC+&9%M@<M
MM'<^GXT[2]9T[6X9YM-NDN8X)FMY&3.%D7&1^HH \]M_!?BI;GPM<^7H=NVB
MM*&BC>0B3>H#2%B,EB<G'KWYIX\$^(9/#?C#3'CT])=<OI+J%A<L0@<@D-^[
M[;1]<]J]-HH \_C\+>)M+UVSUO2Y-.:=K".QOK2>9_+;9]V1&"YS[8]>3FM3
MP)X<U3PW::G#J4UI*;N_EO%-ONXWD<'/3H..?J:ZRB@#E?&'A[4=7OM!U'3'
MMOM&EW9F\NY9E5U(P>0"<BHM,\/:SIWC#7]=;[!+_:4,*1H)73#1IMR?E. >
MO4X]ZZ^B@#R^V^'WB/2]%T&73=0M$UO1?-C0R.[P7$4AR5;Y05QVQGI],=SH
M=MK*+-<ZY=6[W4VT""T#"&%1G[N[DDDDDGV':M>B@#G?%WA.'Q39VVVX:TU&
MRF%Q97:KN,4@(/([@X&16;K^B>)?%'A6XT&_&E6YN0J2WD,TC<!@V1$4'/&,
M;ZZV]O;;3K.2[NY5B@C&6=NW8?4DX '<UD0^,]!F>YB6\87%O*L,EL\#K-O8
M951&5W,2 3P#T/H: ,VX\-:H_CC1=9B-H;33K5K9@TK"20, "V-A QZ9Y]11
M;>&M5T+Q/J^I:+)9RVFJD2RVUT[H8I@,;U(#;@<DD<?6M'0_&N@>(]0GL-+O
M6FNK="\L3021E &VG.Y1SGMUK?H \_E^'4UIX=T.UTJ]A;4M*OOMPFN4(CG=
MB2X(7E0<\8SC ^M5;OPSKEA-XM\0:EJ&GR+?Z2T;QPPN-I2)A@9/ 'J<D^@K
MTJH+NRM=0MVM[VVAN8&^]'-&'4_4'B@#@]"T+4O$/@SPG:ZC]B72[>"UN7"%
MG>X"HIC0J5 7MDY;..V:[G4K62^TN[M(IVMY)X7B291DQEE(##W&<U):V=M8
MVZV]G;PV\"<+'"@11] .*FH \PA\ >)TLO#47V_1HVT*;=&D=O)MD&,%V.>6
M)ZC YR<\XK0/A3Q#)X=\4Z;(-+$FMW$LR.MQ)B(2*JD']WS@*.>,Y[5W]% '
MGEMX+\0Z5=:7JND7NGP:E!81Z?>P3;W@N4C&$?( 8-P.WMGKG8\%^&=3\.RZ
MV^H7MK<?VC?R7H\B)EVE^O4GC@<=O4UU= (/0YH Y'QI831ZAH7B.U@>:32K
MH^>L:Y8V\BE9",<G'#8]C3M?TWQ!KES:W&C:MIB::JK*D<T#3"5^H<D, 0."
M!T[]<8ZRF0PQ6\0BAC2.->B(H 'X"@#G;:XU?P_I-]?>(]2M[Z7(^SQ6T'E
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MY<9W=>""2>]=3X%T^]TW4K^"T.I+X;\M&M8M35EEBE).Y$##=L QUXSG&>I
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M+&X>14X!3D@'..I/4^@%=S7(^']#UK0M/UU;K4++-Y-->12P0-F&1\DY!)W
M'! K2\)'63X?A_MVX2YO-S8G6+RC*F?E8I@;21V],9P<B@#<HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HKEK_P :?9?%<OAR#1KZZOEL_M<?EE LJ[@HP2W SG);'3OD5E_\
M+/B_L+^V#H&I"TMY3#J#-L7[(P?8003ESG!^7IGG!XH [VH;J%[BVDBCN);=
MF&!+$%++]-P(_,&L#6O&5GI<XMH$CN;GR!<E'N4@ 0YVX+D9+8. /3G'&<R/
MXG:;=0Z++8Z??7::JSQIY07,<B@EHR,YW#C_ &<'.<4 ;_A?PU:^$]$CTBRN
M+F:UB9FC^T%2R[B21E5&1DD\YZUKO(D94.ZJ6.%R<9/H*XE/B',_]J6P\-7_
M /:>EG==6GFQX2/;N#[\[2".@')K#\6:M9:G>> _$UC9W$[3W1,2(@WN-A(3
MKUW?AU)- 'JE85IX4L+3Q'=:X9KR>ZG;>$GG+1PG;M.Q>@XR._!('%9EI\0;
M('6(M9LKC2+G28A-<13%7W1GHR,I(;)P/J13;3XA6=QK]OH[VH%S=P-+:^1=
M13!RHR8VVG"MCU..O- '945Q_A7QU)XJEA:WT"_@LI/,4W<A4HCH<;3@]^.1
MQV[&NPH **R==UHZ-'9+':275Q>W*VL,:G: Q!.6;G:H"DDX/TK$_P"%@6\.
ME:Y=7MB8)M&N$MYXQ,&1F<J%(? ^7+#D@8[T =C17+7?B^72M+U*_P!6TLP0
MV:1/')#.)8[@2,5!5\# ! SGIG/3&4E\9-IL.I7&LZ>MK:V=O'/'<6\_G1W.
M\L L9VKDY '/]X=N: .JHKF1XKGL]=T[3-9TO["=2!%I*D_FJ7 R8W^4;6QZ
M9!]:@'C66YLX]4TW2)+_ $=[O[,+BWD+2L-VPR+&%.4#<9W9QSC% '4+=6[W
M,ELL\37$:AGB#@LH/0D=0#@_E4M<AI^IV*^//$,":$;>_@M8YIKM&#/=)R%
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M:\:166EVMI?Z5:1R37;3M*)B(V>/]WM7H,@G/IU % '?U!/96ETP:XM89F'
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M)JBPJ%CG=GC\I-HX* '/7KQ[UT6F:3I^C6GV73;.&TM]Q;RX5VKD]3BKE '
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M"=(%5;>Z@A\IX]N"K8+-E@>_'':KUMX9GEUC3M5UK4([^ZTZ)X[4QVWDJK.
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M'\TC+L<#HHY//3BM+7/'>D:O\/KS4=2\-3W4=G<K!>Z?<.J&"4$ 9/4C+#!
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MV36U=K,^?N==HW 2IM&TD8Z%OTK-T+Q%J^IIXS;5M/M[RTLKJ6W^RQSY 5$
M* ,H!4C)+$@\GY>U85MX<\4-J'A;53X4BBO]/E;[=--?HTMT[)@R.P!.W.3C
M+$9P!@5M:9I7B#2+CQK =$>XM]1N)KFVFCN8P9#( H4*2,$9R22.AQGC(!K:
M3XHL;?PMX;32],$<NJ($L=/$N BA2S%FQG:JC)."?8YIQ\<M;MKEI>:3)'J6
MD0?:I+>*=766'&=Z.0N0.X(!^M<[8^&=?M=!\'ZG%ICKJ_AW?#+8RS1@SQNN
MURC!BN<<C)'?IWT=3\/ZKJM_K^O'37BGNM%;2K.S:1/-.XL2SD-L')'0G@4
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M4$.M0S[]0O3UGCD79,@X_N85>!]T=.M %@^)KR;6/"/VS1[!8]6,K1S2.3+
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M9Z:;Z]D6-BYSNV",[L?-M)Y'\/7GC*T_QU?3:WI-M-:0W%MJ2C)M(I<V;$9
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M&.#$&W*%QP>I/S#\:UWX)\0_9O%6EZ??:;%INMSRW(>5',J/(H#KCI@D#GG
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M%"J % P .U "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MJ/-9E;*9R<9P!C&"35Q+G5KCXU?9EU)/LJZ(;B*-H,A4>9 R\,/F.T?,?RH
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M:ZKP@WB#^QGC\21*EW%,R1/O5FEBXVL^W@-R0<>F>] &_1110 4444 %%%%
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MFVD]2 2.>IK02S\3ZCX]T?7;G1H;*TM[66"6-KU7==Y')VC!Z9 &>G45WE%
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M.%PS0C SNX)Z'H,\<^@DX&3TK.TG7M,US[5_9MVMP+67R9BJD!7QG'(YZ]J
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M-1TVZL96=([F%X69#A@&!!(/KS5BB@#@H_AQ=&UT2*?Q-=.^C2AK1EMHE54
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MMM578,<_)U&T#WSVQ0!U>K^*6L-3M]%@>W6_:T^U222QR/&BYVJ-J\G<V>_
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M.3],#KG@ U-5\97\>OZMH^G"P6_LHE>VL[O<LE]E-Q\LY X/RXP<D'I7;#)
MSUK@?%?A;7/$QOK*YL=(FM9F0V5X\S+/8$*NXC"?-\P8CD9SSP>.[MXC#;11
M-(TA1 I=NK8'4^] ' ^)/'>J^'X=4OKBTLK>VL[E8H+6X8B>]CR TD9!X'/'
MRGIR:VY/$=Y?>(9]'TJ.!)8+!;QWNE8[F?(15 (XXY;)QTKEM5\!^)K_ $_Q
M3IPNM*>+59S/%=2JYG(W*RQ,<8"KMP#SCTYXJ:B=8O/&,D6FW.B/?Z7I\-K=
M+/--;<OEB%9&#. -OWN 3P 2: .ATOQCK.L>%--U:WTZWB:]G*22.6,=G&N[
M=(^2N0"O8@<]:KQ>.;Z^\,^*;B&UTV\GT;<2ZNPM[F'9OW <G[N>,X/KBJPT
MW6O$5A816":-;C0K\QM:*[265TH08Y SE=WH0&]QQ8?P;XDCC\6QQW6E3+KT
M>W+"2/86BV,< -@#/ YSZB@"YJGBG7+/4/#-II^F6$T>L0MC?,R%)!%O],!1
MQZDX(QTJK_PGFJ6FE>*/MMC;RZAH4T:,;8.8V23!#D'YL*,D@=A4S>'/$DE_
MX4N#%I"+HBL)%6YD_>[H_+.W]WQ@<_7CWIEKX8\4V.L^)-1M)M*B?5;BWFCW
M2.X41L R,-@R&3=TZ'\P 4M>\3:Y/X)\0:CIVJZ9-:0VL;VM_9Q-EBQ<2)CS
M#M=1LY/3/3T[7PQ]J_X1K3C=S1RR-;1D-&A7C8,9RQR??]*Y.7X?W-Y:>) R
MZ?ICZO:+ +>R9FA$BDDRME5Y)(!P.@ZDFNM\.6FIV.AVUKJKVC7$*+&/LH;8
M%4 #EN23C/0=<=LD Y?5+_6C\7M+TR&^@2S_ +/DN%B: D9W!3NPPR>.#T&>
MAKFM*U37M';X@:AI-O8/#9:K/<S&Z9B9 HRR*%Z':"<D]QQ7;ZWX;U*X\9Z;
MXBTJXM4E@MGM)DN@Q&QCG<NWJPYX)P:Q+?P=XDBTCQ?:-_9._7Y994(N)"(?
M,7:0?W?.!R/7VH TYO&<E[):6VF8BEGTZ*_:4V4UV$$GW%VQ8/8\DCIW[:_A
M/6;_ %S0DNM3TN;3;Q7:.2&5&7)'\2A@#M/49^E<I#X)\2Z8NBZCH]_I\&K6
M5A'IUU#,7>WN(D'RMD ,#WQC\>.>ZTNUN[6T(OKPW5U(V^1PNU 2 -J+SA1C
M@9)[GDT 8VI^(YO^$OM?"^FF%+V6U:[EGG0NL<8.T *&!+$^I  ]:Y'Q+XNU
M>Z\)^+=-$]O9:OHP"W,D4999X7'RM'ELH2#SG=CZD8ZG6O"]Y)XLM/%.C7$*
M:C! ;66WN<B*>(G."R\J1G(.".!Q5*^\!/?Z/XGWW$2ZMKZJ)9 I\N/8 $4=
M\<<GOG..U &3XAN=1;Q-\/[AGL[J]F:Z9'6-HHOFB7!P26X!]><=JMQ^/-4T
MW3/$*ZU;6KZCI5W%:QFU5Q',9<;#MR6'WLD#)QTYJV/".M7-WX5O+Z]L!-H>
M[<D,;[9-R!, DY& .O<]A4&H_#N;5V\1BZOHHTU:>&YA:%#OMI8@ I!)YSCG
MIU- %FT\1>(Y=<FTY;'[3"]F9H+Y]-N+6-)@>8W#YSD<@@^U'@/7_%'B6RL]
M6U&VTV+2[FW<@0[_ #1(KX'4D;2,^_'O5S1-,\7Q#S-;UFQN)(4*01V\+(CM
MC >4YR3C/R@ 9/TQ;\&:#<^&/"]KHUS<Q7)MMRI+&A3*EBW()/.2: #Q5XA;
M0+6Q2%$>\U&]BL;;S,[%=S]YL<D  G Z]/>LR3Q%K6G>,(O#=X;&:34+5YM/
MNDA>-?,3)9'7<V>!G((^E:?BWPT/$VFV\4=TUI>6=REW:3A=P25.F1W'/J*K
MIX?U*ZUJWUO4KBSDO[*"2&SCAC81(7/S.V3DD@ 8&,<\GK0!R%CX[\57/@_3
MO%<RZ6+,WHMY[2*-PTBM*8\AB3MP2.,'.,Y[5J$3M\;]0%J\:7!\.#RVD4LH
M;SA@D C(_$5%!\.]7M_ 4'A>/5;+9%="X\\V[9($@D QN_O9_"M4:)>Z;XSN
M?&6I:C9):IIIM[B-(G&R-3O+[B?4>G3\Z *6B>+]9O\ P]+'>&RB\1IJ?]GM
M;I"VR-LYS@OEAL#/G(! /I7?#(49.3W-<'X:@T?Q'XZOO%^D2/-9&UBA$FUE
M22X^8,P5@#N6,HN<?Q,/6N]H Y"+7]7E\8>(=&5[,)96<5Q:L86X+;N'^;GI
MVQ7+:7XT\6S^&/#_ (GN9=.-G>WRVL]HD)#,KRL@</GY2, !<'IDDYP.K3PS
MJL7B[5];CO;+;?VRVXA:%LH%SM.=W/7GBLBW^'^KVW@G2O#B:I8E=/NUN1,U
MN^7VR>8HQN]20?;% 'H;9*G:0&QP2,UX]92:I-X9^)S7VH+=>4]W"Q,.UF*P
M[000V%&!C;C\:]@CW^4GFE3)@;MO3/?'M7"R>!-3CC\4VUKJUNMGKLDLI22V
M)>-I%VMEMW(')& .<<]<@&7X=UCQ#H]KX$BGELI=)U2TBM1;QQ,)(L0!E??G
MYB<<C  Z<_>JS<>,/$&H6-SJF@6LEQY%V\,-B+)F2XC1RC$R]FX+#& .AS5V
M7P9K1L/"MO%J=BC:!L(8V['SMB[ #\W *]?>BP\$:SHNH7\>D>(Q;:-?3M.]
MLUL&DA+'+>4Y.![9!QZ9YH MP>(-5N/B#-H8>VCMSH_VV)6A.^.1G50)/FYQ
MSP-O7\:I^!-9\4>);:UU:\N-.&G%[F*6*.%E=BKX1ADG'0C!_7/&C'X7OXO'
M4WB*._@$;6 L4@>%G(4-N#$[ASFK/@_P_=^&=)DT^XO8;M//DECD2$QGYV+$
M$;CW/% #O&NIW^B^#]3U/36@6YM83*OG(74@=> 1S_G%<_=>(O$<^M^%;2PN
M=/BCUBPDG<2P,YC98U;)PPW#+< ;>G6NI\3:-)XA\.WNDI<K;"[C,32M%YF%
M/7 W#FLF/PC>1ZGX<O/[5@(T2U>V5/LA_>AE56)/F<<*,=>_6@#$L/'.IV6A
M:S%J AOM5T[55TR&54\I)V=@$9@"=N,G(]!UR:=>VVHVOQ3\)I?:@EZ6M[PJ
MY@$;(?+&1P>5Z8'4<\GM9F^&RW=GK]O=:J3_ &K>"^22&#8UO*IRI!+'<./:
MIH_"/B"?7='U?4O$=O-<::)5'EZ>%\Q7 !S\W!('7ITXH J6.K>*M7TSQ7%!
M>VZZGIE\\-J8;8!'"Q@A=K;CR3UR>>^*GT+7[_Q!H?A9X-3D2\NP[WQ6!/NQ
M@B08(PN'VJ/][/-;/AOPW<:#J&LW,E_%<+J=T;HHEN8_+<@ \[VR, ?C2>'?
M"-KX=U;6KZWE9AJ5QYRQ8PL((RP4=.6R>W;TH Y\^-[_ $G2O%]]JC07#:3>
M"WMDBC,:MN5=H/)/)89Y]<4FH66L6WC[P<^H:M]K26:Y)C\A$\E_LSYV$=5Z
M_>R>!S5X_#\WEKXAM-4U&.XMM:E\]UBM3&T,@"A2K%VZ;1U'7O2+X,UR2_T2
M[O/%;7#Z2[-&18JID#(4.X[CDD$C/Z9YH HGQ%K4?A;QI,VH!KO1;J9;:;RX
M\E%C5@&7&.I//&?;%2OKNLW-EHDDNI"P@O-)CN!-;1)+<7%T0I*+$5;* ')P
M._458O\ P!=7#>((;77FMK'7"SSPFT5V5RFTX?</E/'&,^A'6BT\!WVG7UE=
M67B.:)XM-CTV?=;*^^-.C)DXC/X,.Y!H P+S7I_$?PY\':Q?O'!//K%MYKJ"
M%!61UW8[9VY_&O5J\_C^'%Y!X6TK08=?40Z;>"ZBD:S^8[6+*O$@[LV3WXQC
M'/?(&"*'(+X^8J, GV'.* ."M-6\0^+-/U+5_#^HI;&UO'M[2RDC0Q3K&0&,
MK%2P+<XVD8&/K3?%&LZY:W>LB/4GL?LEDL]C!91)<-,P4L[3 HQ1 0%!RH//
M)JVO@*[L]5U&72/$EWIVG:C*9KFSCA5B';[S1N>4)]<'^6"X\ 3'4=8EL=>G
ML[+5;=()[98%<@)'Y:[7/(&.HQD^HH S+O7_ !/?W?@A;#4;:S77;%Y)P;0.
MJO\ 9P^>6R<$Y XY')(XID7B/Q-I9\3:!>7]I=ZII]NEU9ZA.J0(T3G!,@X4
M%?U_G2U2R?0/$?@#1?\ A(X3=6?GQI-/$@"(( B*4!'#8V\G)).#74:GX"35
M].U=+S4I/[1U)XG>[BB"B+RB#&JH2?E!!.,Y.3S0!D6_BZ]TO7=6CDOKW5--
MM=#?5(S>6JP2,R-@A2$3*D#@X_.M;21XIN1H.K)JL-U:7L?FW]NRQB.)74,O
MDE5#'!./F8Y%(O@2XN-;.I:IK\UZ9M/.GW41MD19HRV2!C[H]1R?>D\/^ [G
M0Y8()?$M_>Z3:.&M-/D1 J8R5WL.7"G! X ('I0!B3ZKK-YX?^(-I=:W*+K2
M-[P2VD2PE4$)<+T)P2#SG=QU%/FU#5-"\%^#KVTU>XFAN+BSBFB=(3OCD4?(
M&"C &.#UY.2:Z*W\&!?^$C2YU%Y8=>5A<(D03RRR;,H<G^'US5&X^'LUSX=T
MS19=?G:WT^:*6)C;IG]V $7C' QSW)/6@"AJ.MZ_X@U;7[30#J$?]F.+:!K9
MK=4\\#<6D\WYB,G;@<8!/)QB/5?$7B#3Y=.;Q(+S2+!K']_>:=&LJ0W>_&9#
MAL(  0.AW'.>VWJ/@62?7Y=9TO7KW2;JYC5+P6J*4G*C 8JP(#8XS_\ 7S:;
MPG/#<NUAK$T%K):"UDMI8Q,C\L3(=Q^^=YR>_?- &IX?EEF\/:?)/?PW\S0)
MYEW 04F;'++CC!-:#E@C%,;L<;C@9]ZXR#PU=Z)J/AVQT._U!=/L(REQ#(1Y
M+QDDEF./F<D\ =.O Z];?6<6HZ?<V,^[R;F)H9-IP=K @X/8X- 'F5IXCUF'
M5/"\CZK<7;:A<M;7Q$:_8V)#$>2=H)VX RN0<<DG-5H=0\4WWA[QG?MXGN(V
MT*_NT@$=O$#)Y*@@.<8V\= !R223P!T47PU>.WTB)O$NI/\ V3(&L_W<0$:@
M$ 8V\GGJ<]!Q4UKX FM=(U_3AKDC1ZW++-<L;9<AI1A]O/<?E0!!IOB2Y\7:
MMIVFQW,^GHVC1:E<FV*[F>7;M0,P. .3QUR/0@O^&4,UM;^)X;BX>YE37[E6
MF< ,_P D?)P ,_05(/AVL']DSV&MWEEJ&GVJV7VJ%$S- OW4=2"#C Y]ORU?
M#/A5?#4FHNFIWMX;ZX:YD%P4P'.,D;5')P,]N.@H H^.[C6+-M"DTG5&M#/J
M<-K)&8E=) YZGC=QCH",YK%M5U^7Q[JOA4^)[XV@LH[Q;@Q1>>C%L%58* %)
MYQMZ<#'6NQ\0>'UU]+-7OKBU^R7*749@"9\Q,[<[E/'/2J\7A9(?%MSXB6_N
M/M5Q:BU:,JFP*#D$<9SGWH Y+3M?UF]\!>'KN[UI()9-0>VNY5C_ 'UTB22(
M$B4*?G;:.@SU.15:TO\ Q)KNC^,+&QU*^@O=*N=U@T@43;2N[RG]>X&>>?:M
ML?#.*/2],M8-=U&&;3;J2YMKE!'N0R$EQC;@@DGKG&?3BE_LVR^'<^I>(9;S
M6;^._EC66!(UE/F'C>< 'K] ,X Z4 2^'M6;Q.^@7=C>W MHK'S[U/,)W2$[
M%1\CDAEEST^YZ&NMOTEDT^X2&X>WE,;;)D"DH<<$!@0?Q%87@K0X=(TNZN5L
M_LDVIW<E[)"0 8PY^5?;"XX[$FN@N8FGMI(DE:)G4J)% )7W&010!X]8>(/$
M7_"$^$_%$FO7,LUWJ,=I/;,D8B>,R.AR,9+?+USWX Q74VUSJ/BO6O%,$>JW
M>GKI<RVUF+=E 5PI)=^/FR<<'C ]\U8_X5M8KX4TWP\FJ7Z6NG77VJ"0>7YF
M\,6&3LP0"Q/2M#_A$!!K-[J5AJMU:/J"*+V-$0K(RC =01\K8SSSUZ4 >=R:
MS=^++/X>:C=W%Q#<3ZB\$XAEVHSIE?,7'&3C.1TR0*]GC3RXU3<S;0!ECDGZ
MURM_X TVXTC1M/L;BYT[^QY!+9RVY4LI[D[@0<\D^YKJ+>+R+:*'S))?+0+Y
MDARS8'4GN: //=)TUG^+?B1!>7T12SMF602Y+9W>H((!X Y'%9,6HZAJ7PB\
M;'4KV6\EM[J[MTEEQG8H4 8  'X#O7>6GA;[)XGO->&K7KW%W$(9(W6/8%7.
MT !<C&3W^N:SH?A[;0>'M6T5=6OS;:I,\TY(BW;G^_@[. >/ICB@#'AU2^N7
M\.^'K..=D&A1WDJPW?V=I,A4&'QG Y/&.2/3!Z?P;%KUOI,UMXAFCFN(;AUA
M<2!W,/!3S"  7&2.G( -4;_X>65_9Z0G]J:E;7NE1B&"_MI%CF,8_A8A<$<#
MM_,UOZ+H\.B61MXYI[B1W,DUQ<OOEF<@#<Q[G  '8  #@4 :-%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %07EG;ZA936=W"LUO.AC
MDC8<,I&"*GHH IZ7I5AHFG1:?IMK';6L0PD:#@>ON3[FKE%% !1110 4444
M%%%% !1110 4444 %%%% !65J7AK0]9E674M(L;N1>CS0*S?F1FM6B@"."WA
MM8$@MX8X84&$CC4*JCT '2I*** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH *1E5T*.H96&"",@BEHH BM[:"T@2"VACAA082.-0JJ/8#@5+11
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M#2B$Y*J3ZD4ZBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BFJZOG:P;
M:<'!S@^E1&]M1>"S-S#]J*[A#Y@WE?7;UQ0!/1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M)A3'(<$?PY/SA>E:,_'Q$EN(XW"/J]NL^CS2'S)'\H;;M #T7)R.5^0G.0,
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%** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>davidjkatz_employmentagr011.jpg
<TEXT>
begin 644 davidjkatz_employmentagr011.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***04 +1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %(*6D% "T444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !2"EI!0 M%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4@I:04 +1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %(*6D% "T444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !2"EI!0 M%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MMF,1MD@H<$C&/H!BK/C.6%KG0[%[JY\VXNR4L("%^V!5)*NQ(P@ZGUX&"<4
M=717D&D0Z[?Z-XOT6RO8K:YM]706T,ETYC R&:%7X;:0",#'4],FNF\"7$3:
MUK4,ME<Z7J2I!]ITR23S(XL!\/$XX*MGH.ZGUH [FBN5\;31[='M#<3B6XOE
M$=I$=HN\*Q,;MD;4[D\].AZ5G^ ?M4.N>*[&XQ&EO>1>7;I.TL<.Z(,0A8 X
MR<]!0!W5,F,@AD,*HTNT[ Y(4MVR0#@?A7!?%Y&_X1.VECGGAE%_ @>*4K@,
MW/'0].X-,BT>+PU\4])BTNXG$&I6<YO;=YFDW-&!ME.<\DD#- &]X#\1W7BK
MPK#JMY###,\LJ%(<[0%<J.I)[5N:BUZFFW+:<D,EZ(F,"3$A&?' ;';->.^'
MI;3_ (51HEI<R7.ZZUIHX;> A1<OYK$1N2"!&>_7IT-6K9)X)OB5I3)#;)!8
M17$<%C(R10RF!F^3ICD#/3..G:@#U;3&OGTNT;4DBCOC$IN$B.45\?,![9J6
MXN[>TM);JXGCBMX5+22,V%4#J2?;%>/W5I'>Z1\*XY7F43"..0QRLA9?*!QD
M'Z\]>33]1T^UL+WXC:+!"B:5'I2WD=MM#+%,8CET4]#D9X[X]J /1KC4M0U/
M1M+U'PZ;7R[F6&23[:&7_1V^]@#^/D8[5%KFMW-OKVFZ'92P03WD4TS7$T;2
M+&L8'& 1R2PY) P#W(K@'L[:#X8^")_L\44XU&PD<Q@)DLPR3C )( Y/I6UX
MDTVPD^,7A7S+*V?[1;W9FW1*?,(3@MQSCMF@"U;^(O$E]=7FA+-I=MK=C:K(
MSE&>&>1F8(%R00"%!.,X+8[&NVLC=-8VYO5B2[,:^<L1)0/CYMI/.,YK@?#]
MA9_\+D\5G[)!F*WM&C_=CY"5R2/0UV7B*[M;'PWJ5S>RS0VL=LYED@_UBK@C
M*_[7I[T 7TGBD=ECE1F7J%8$BE,T2L%,J EMH!8<GT^M>0::D-CXJ\!;8]/M
MX;FSN$\N,AIOL_D J9I. Q.,_= !W<FLJ'0M+_X5)XKO/L\4UQ:W]R+>X(.8
MMKKC9GE/PQGO0![E<2B*%CYT<3$$(\GW0W;(R,_3(KE_!7B.]U3PO>ZGK+1+
M+;W5PC[$V*BQG&,9/IW)K T/4(=8\>W5GXA%O-LTBUDL4N54AE9-TS@'C)8X
M/?"^@K,\(?9[KP-'X>A8A-2UJ>W*QL 5@5B[^O!1=O\ P.@#TC1KZX'ANTOM
M:FCAGFC\Z7?A%BW98)Z?*"%S_LYK4>:*.$S/(BQ ;BY8  >N:X6>99/C1%8Z
M@J-;'1B;&.1<J9/,^<KVW;1CZ5PGB6R^S^!/&-G&(WTNRUJ)-/;DF$LR&1$)
MZ*"V.#W:@#W2*>&??Y,L<FQBC[&!VL.H..AI);JWMW1)IXHV<$J'< M@9.,]
M<#DU3TG0M+T*.9-,LX[99W\R01Y^9L8R??BN(\9:=877Q7\$K<VL#K<+>K-N
M0?O0(AM#?WA['U]Z /08+ZTNK475O=036Q&1-'(&0_B.*99ZG8:A;M/97UM<
MPH<-)#*KJI]R#BO(]3MM'T&X\86RQ%M%EN[!4MXY!%#%=,26!."%480M@=.*
MG)LY?%_BNVN;O2[MI]!5GCMT"Q&1=QP%+-DJ #GK]* /0=8\9:#H^D7.H2ZG
M9R+#%YBQQSJ6DR#M"C/.<8%)>7<E_>Z+=:3X@L8K%IW$L8V2"\&#\J-GJ"#T
M_IBO-H=%TN#X RZI!90)?3:6$EN%7YW'F9P3WY_EBNF\5-IT_BOP1=6+V;-_
M:#QB:+:WR"-B5!';GITYH [>YU73K*YBMKJ_M8)Y?]7%+,JL_.. 3DU2D6\_
MX2Z!EUF!+/[(P;3"BEW<-_K0<YP,@>GYUYYIVH^'YW\:Z+XTGA@N9=0DD?SF
M*-);C;Y7ED\D#' 'K[UL0?8Q\4M#,=MY/VCP\X,<H'F8W)A7SR2 "._>@#LY
M==TB!HEEU2R0S2&*,-.HWN.JCGD]./>EU'6]+T<1G4M1M;3S/N>?*J;OID^X
M_.O(M-T?P_<^ /'#75O8M<P:A>B$[1YD)'^J5>XRW0#KG'K5BWO;>%KJRU6Z
MBL-33P_;Q:C/?,9'G+)PD:$XR,_,3DDD<=30!Z'K'C30]$U+3;&[O[=);YN,
MR@!$VL0['LI( !]_:M"\U_2-/EBBO-3M())0#&LDRJ6!Z'D]#7D-AJ=BFG_"
MV=[V!8[=I8IY&E $?[L#:QSQP1P?6I;>^T*75/%FE^+];N;&2YOGD$98+'<6
MQ \O;E23@#IGZ=Z /:@<C(Z5FZAXAT;29U@U'5+.UE8!@DTRJ<$X!Y/ SQFI
M-&BC@T.PBB6=8DMXU1;@YD "C&X_WO6O+_$NK:>VH^/;598-/N/LD<<RS,7E
MOF$3;-BG(51NQ\H).<_+B@#T_4=;TO2$C?4=0MK59 2AED"[@.I'L,C\ZM6U
MS!>6L5S;2I-!*@>.1#E64\@@^E>4:?.EWI^@7WA[Q%:V^MVVA01-:WA#6UU&
M!\R'D$,&4@D<CBN^\$WRZCX*TB[2R%DDELNVW!.$ X&,]L#(]B* +6J>)-&T
M658M1U*WMI"H;:[<A<XW$=ESW/%:2.LB*Z,&1@"K*<@CU%>4>*=:TL>)?%UB
M9TTZ]_LY(F8H9);W,9(1%.5"C< <#)SVQFNL^&5[#>_#O13%-YIBMUBD//#*
M.1^% &]J>MZ;HZJ=0O(X-ZLRALDE5Y8X'. #DGH.]<KXMUNZAU7PA<:3JK&Q
MU#48X9%A*-'-&><YQG\CBLO4O$&G^%_B?J__  DS&/3M3L(4M)Y8V>,!,AX^
M >I;)_#U%5/$=QI4,?@ 6$*6-@-85[>)SLQ%DX?!Y .<\^HH ]!OO%&B:9</
M!>:C#"\959"V=L9;[H9L84GW(J34O$.DZ3)Y=]>I$_E^<5P6*QYQO. <+GC)
MXKR;Q?KVG3Z=XWTXRC3[D2LOV.*)FEO"JKB9R0<)Q_#C&W)/-:6IZIIMS<IJ
MNB>)(K'4ETJ/?!?)_HU_""X"[6P2<AAD<X(QUS0!Z)=^)]&L51KB_C4/ +D;
M59L1'HYP#M7W.!P:T;6YAO;2&ZMI!)!/&LD;CHRL,@_D:\BO-2MW>'5[74T\
M.>(X](A:;3KW!M;F'#$1D'G(Y'J,CCJ:].\-3M=>%]+G:Q%B7M8S]E P(?E'
MR@=@* *U]XS\.:;>7%G=ZO;1W-NF^6+)+*..PZGD<=:A'C[PJ4LG&MVQ6]QY
M!!/.20,\?+R"/FQR*YDZCI\/QXN))KRU14T'RV9Y% 5Q+N(SV(4$GVS7$75Y
M8-\"O$,$$MJLC:JVQ(R S SJRG&<GY0<>R^U 'MNIZ_IFCG;>W!1@GF,L<3R
M%$_OL$!*KP?F.!QUJI=^-?#=B]JEQK%LINXS+!ABP=-I;=D=L ]>O3K7GVK:
MOI.E_$'4[O7;N_BTC5[6W:QO+*:7RG54*LC>6>>23CGK[TETVCZ7XH^'%K!%
M]ALH'O&2WN9"TD:2 >67#<KN)R >G3M0!V[?$?PBNG-?G6X?LZR&)L(Y<,.N
M4V[NXYQBL;QCX@&E>,/!U]_;+P:/=?:&N )@(9%$>4; ^]G=[_P]\5@0WM@V
MK?%@1W%N6EME$>&'SGR74@>OSD#ZD5%;W=G'I'PQU>9D>PT]'BN[A<NMNQA
M ? ./F Y/3% 'I>D^+M US3;G4-/U.*6UML^>[ IY6.NX, 1T/44U?&.@F:Y
MA>^,$UM#]HECN(9(6$?3> Z@D>XS7FOBC0[[6M0\2^(O#T#2V1@ME"1,5%^T
M<BO(RXQD!5VY'7!QS6SI&M^%=>?^U=,TZ]DFM+:7[5->R3?Z,A0CR\L2&9B1
MP,\9/4#(!U^D>-?#NO7ZV.F:FEQ<M#YP0(ZY3.,Y( _#KWJ/QQ<:9!X8F_M;
M6+O2;5G0&ZM"PD4@Y !4$\XQTK+^$_V?_A7NEQ+&$N;>-HYE,95D8N6(.1WX
M--^+YW?#/5+=0S33F)(D52Q8B16( 'LI/X4 ;5]XQT#2-1ATN\U!DO)(A+'%
MY,CM(O08PIW$^@Y]JN:%K^F^)-/-]I=P9H0YB?<C(R..JLK $$9KA;C4;27X
ML>&KI'9H!I;Q^8(VP'?E0>.":O\ PZO()M9\7+&S?OM5>XBRA >,JH# D<C(
M- '7:IK5CHXMQ>2E9+F3RK>)%+/*_P#=4#^?0=ZRYO'?A^WT>\U.>ZEC@LY?
M(N5:W?S(I/[K+C([<].>M97Q"U!K"ZT$R6C_ &)[B03ZA#;&::T^3Y?+ !VL
MW(W8. /7%<!-'-#X>^(&E1Z=K#SWUPLMMYMM+([J=I&YL$[B.>>F.<4 >L6G
MC31;[4FT^VFG>Y\EIXE-NZB=!G)C) #].HX.>,TRS\;:3?\ AZXUVW6Z:QMV
M*NQ@(;(.#A3R<&N7O[@GXB^#+P0WTUM!93)-<?8I<*SIM7=\ORDD=^G>I8M%
MN;+XFW.EVNT:)?[-8N(P<;)D.W'T9]C'_=- 'H<,GG0I)L=-ZAMKC##/8CL:
MY:]^(WAZQN;^V>2\>XL2/M$,=G*71<9+D;?N <ENG(YY%=97F.G:Q:Z1\6/'
M+W45U('BLB!;VSS$XAZ?(#@G/&>M ':-XITMM/L+RUDDO!J"[K.*W0L\V!DX
M'&,#J6P!WK,D^(_AZ+19-3EEN4CBN?LD\36["2&;^XXZ+]<X]ZX"#POJGA/3
MO#^K7>C2ZI9P"X6ZT^%2TMNLSADVJ#R1@ @=/U&AXK@M)O!<TVE^&+JS^V7M
MO+'&MH_GR;'RTCJH.!@D -@]3Z4 =YI7C'3-7UF?2HX[RWNHH!<J+JW:(2Q9
MQO7/49]<5R7CO7K75+#1)[/[>L#:O;K;W<9Q!<?O &7ALD8!()7!V\&G>(+&
M\UKXB+)8P7:0S^'9K5+MK>14CDD)VY)''4'VK*^V:L_@/3/#DOAG51J6E7-H
MD^R &,K'*IW(^<-D+VZ9.>.: .T_M+0U^(DT>S4?[8332S9CD\HPJ_.U?XCD
M]5!SCBJL?Q2T&2Q-^+?4Q8I<?9YKDVA"0OG WG/\LD9&0,BJTPNS\78-8.F7
MXL4T5K9Y?L[$++YA?;QUX[C(SQ7,1Z9JR?"#6M'_ +&U ZA<7[/%#]G;+*95
M<'/0# - 'I>I>);>QU"33X+:XOKV& 7,T-N!F.+.-Q+$ D\X4')Q5G0=<L_$
M>DQ:G8>:;64GRVD3;NQW ],Y'X&O/]1U&\@^(%UJ.EZ5JPEFTR%+GR+19^K-
MC*%T*,-I )SG^[C!/5> Y=-B\.II.G17T']FGR98+^/9,K'Y\L!QSNSD<4 :
MFJZ[!IES:68C>YO[PL+>UC*AGVC+')(  '<UCR>/]-@T34]0GM;R.?2F"7UD
M4!EA8C(S@X*GLP.#5;Q+I^IVGCK0_$MG:27MI!#):7<,7,D:OR'5>^#UQS@=
M*P_$'AK4]3M/&>I6VES+-J\$%M:6^5#R!.LCC/RYZ#)S@<]: .U\/>)%\0^>
MT>FWUK$BQO')<Q;5G1UR&0]Q_P#6KGOBGJVH:=HEI#:6SF&YO8(I95D4!@7Y
MCQG/S 8/;!(KK-!\T:!8)/;RV\L<"(\4N-RE0 >A([>M<U\2]/U'5=)TVUTW
M3Y[N1-0AN',94!40Y.=Q'//% "Z)=V.F>,+O2H/#\NG:A?VGVYP)E:-PC;!P
MI(4DL>@Y[UD^(/B/=MX5U*ZTS2YH9[74CI<SR2I^ZD#*"1@G.=V!],_78U=-
M4A\8:1XAL]$N;R'[%-:30H\:2Q%F1E)#, 1\I'7C-<F/#'B:7P7XNM7T=H[R
M\ULZC;PBXC(E7S48J#]$)R<9X^E '?IXFD7Q%:Z+<Z7-!<75J]S&QE1E^0@%
M3@]>1[<UC7?Q*M[7PUK6LMI-VPTB^:QGB#I_K 57.<_=RP' )]J9JBZ__P )
M-H/B2/P]+,([:>WGLXKB,RQ;R"I))"_P\X)QGO7+W/A3Q5>>"_&>DMHFVYU;
M5VO+<BYCVD&5&/4CC"'GJ<CB@#MD\;2M^[ET*[MKJ:X,-E%<NL8N$"[S(6/"
M*!USDY(')XJ_X;\56_B&;4;3R3;WVG3>5<P[PX&<[65A]Y2 ?3ITK"\9Z-K5
M[-H'B#2=-2YO-,9Q+IMTZ#S8Y  PSDKN&T$<^_.,5O>&/[0DM9+B^T2VT;S,
M;+.)U=AC.6=E &3Q@#.,>^  6M:UJ/2$MHUC-Q>WDODVMLK8,K8R>>R@ DGL
M!]!7)^)=9;6_!7C*PO\ 2C:W6FVK;E=A(C9C+*Z-@9_+@UH>.M&UF\;2-8T!
M8Y=2TFX,J6TK;5F1UVNN>QQ_6JVI+XJ\0^$=:CN]'6SDN[)K>VT]+A)'WL""
M[N=H Y' )[]^* +6GZU<V6A^&M-L+%;J\NM.20"64Q1HB1IDLVUN<L !CUIL
M?C^W?0-/OWM5M[F]OFL$@GG 1)59@VZ0 C;\IY YX%94VE^)V_X1I&T9;O3K
M6Q$%UITMVB 3@!0[X)#I@<#G&<XSQ5+1_#NOV.D7.E:GX4L+_3Y]5FGEA6Y1
MB8GR0T8;:%VG;C)!()X% '07'CF>PM0-3TH6%Y)J/V"%)[C;"_R!O-\W;C9@
MG'&21CKG&_HFHWVHQ7?]H:=]AE@N#"%$OF+*NU6#JV!D'<1T[?A7%Z?X;UG3
M-$DTR;2%U71YKYF33;R9'DM[;9\H#D[=V_! !( [CK6YX$T&_P##]GJ%O<-.
MEB]SOL;6XF$LEO%@?*6&1USP"<>IS0!HZWK=UIVH:;I]CIQN[B^:3#NYCBB5
M%W$NP5L9R ..37-3_$QH?#0U4:*[RQ:B=-NX%N5(AE# <-CYP<C&!5[QAIVO
M7>NZ/<6-C!J>E0;_ +382W/DJ[L,*[9!#*O7&#SVKDAX0\6IH&L:3_9&GC[5
MK?\ :2/'= )MWHVU05R -F.>>>GJ =G8^,;C_A*)-$UG2?[,=K8W=O(;E90\
M:G#;\<(1]2.O-<9\1]8O==\"P:B-'A339KV(VUR\^9O+WC:^S;\H?'][.,9K
MI-8\.ZGJ_CVTU-[(IIO]FRV,["=1(ID!R0.0<9Q^O-<[?>&O'%UX&A\(R:78
M2)920B*_%[@2QHP(&PC(( &<_@#0!W6J2K>>,-,LG \BPA?49G;HK8,<>?\
MOJ0_\!K)N?'US%X?C\40Z6LWA]I=K.)2)UBW;?.VXQC/\/7&#Z@;VFZ;<RMJ
MUQJ<2137["/9'+O"0JFT -@=R[=/XJY.Q\*^(H/ <G@J:*T: EK==1$O'V=F
MW%MF,[P"0!TSCF@"WJ7C?75\47>A:-X=AOYH;5+N-C>!!)&S =P IQGC)_3G
MNT+%%++M8CD9S@UQ&G>']2TWXD2ZG#8(-).FQZ?&?/&Y0A!!V^F!CUKN* "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ I!2T@H 6BBB@ HHHH **** "
MBBB@ HHHH **** "FR1I+&\<B*\;@JRL,@@]013J* .2T7X<Z!H.HB[LQ=L(
MV+P6\MRSPP,>Z(>,\]3G':GR?#[1)[35[69KN2+5I/-N@TW63(8.O'RMD#IQ
M[5U5% '*6WP^TBUU.VU);C4WOX+<P"XEO7=W7L6R<''4#I[<"F#X=:*-".BB
M;4!I_G>?Y0N3P^=V<]>O./6K]]X@N;/QGI6AFRC-OJ$4TBW/G'<#&H)&S'^T
M.<T>'?$%QK.H:U:7-DEJ^FW0M_DF\P/E0V[.!C@CB@!9/"EE+KT6MM<WIOXH
M/LZR>=_!W&,8Y//UJHG@'2$MG@\_46#7GV\,;M]RSX(WAAR#S].*ZFB@#.TO
M1+/2'NI;<2/<7;B2XN)G+R2D# R3V X Z"J_B#PMI?B9+;^T(Y?,M7+P303-
M%)&2,'#*0>15E=4CO(M233#'<75D[0E&;:OG! P4MSC[RY/;GTJ;3I+V73H)
M-1@B@O&0&6*)]ZJWH#@9H YO_A6?A827#K8S)Y[I(X2ZE7YE((88;(;(!+=2
M>];FF:'9Z5-<3P^;+=7&WSKB>0R2.%&%!8]@.P]SU)K2HH R/$'AG2_$UO!#
MJ44C&WE$L,D4K1O&X[JRD$5#H_@[0M!U&:_TZR\JXF14=C(S?=&,_,3R1U/4
M]^IK=HH XKXGZ-?Z_P"&8M.T_3Y+QVNXI)%5T4!%.6R68=O2MK3_  UIEKYM
MS'!=I<W,'DR2W%Y+).B'^ 2%V*X/]T]>:VZH6^L6-YJ5[IUK<QR7=FJ&9 V=
MA;. ?RH Q_\ A7GA?^Q/['.G,U@)1,L;7,K;'R3N5BV5/)S@C/>I(_ 7AB&2
MYDBTF*-KJ 6\Q1V7>@XP<'N.IZGOFM'0FU9](A.N"S&H9;S?L9)CZG&,\YQC
M/OFK\4T4\8DAD21#T9&!!_$4 8'_  @OASRK2+^SVV6;;K9?M$O[D^J_-QT[
M59@\*Z+;:E<:C'99N[A2DTDDKOYBGJ&#$@CV-:GVF LB^?'ND)"#>,L1UQZX
MJ6@#FSX!\+'3X; :1$MK#(94B1W4!SCYC@\G@8)Z=JGF\':#<:C!J$MB7NX
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M'FE)$0S@2D==A/#XP>F: -$VT#3^>88S+MV^85&['IGTI\<:1($C140=%48
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M4MY&"[R IR!C;R/FZ<CGD9 .GHK!O?&&CV$DOG2S&W@E\BXNHX6:&!^.'<#
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MJ"!M4@#YN?IR.<=+FCZ]<ZG<P(^G!+>XMC<Q7<-P)HF *C;D ?-\V<>W!/8
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M["Y#(CJ9KP+$&1K@@ %C][O@YY->M7=I;W]G-:7<*36\R%)(W&0RGJ#6#:^
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MI/!?K;2PW,-L7B*I#M;YAWSQ@9-9UD=;TWX*VUK8:5<C5+:)(Y;>2URZC?\
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M=8H"9K5T.1NCQNP<GUY/TKE_$7A[5G\$>+FCTV[DN=?U))[6VCA+.L:NC!G
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M=3L;/^SI[25KD1AHV;OC=TY^I]* -R?XC:5;+874L;#3+Z80178D1L,<[69
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M]/-[;22S^7C!4$2 KE0,G)&XYQ@<\9?_  L76F\-7NKQ>'[=AI-S);ZF#=X
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MS#C..G' )YQP,TR?Q-HUK>"UGU"*.0RB %LA/,(SLWXV[O\ 9SF@#495=2K
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M0;71U!5AZ$'K0!Y+X#TC6?$7PGTS1IA8Q:-<,WFSK*YG,0F8LFS;@$D$;MW
M/3->N1QK%$D:#:B *H'8"JNG:3IVD0M#IMA;6<3'<4MXEC!/K@"KE !1110
M4444 %%%% !1110 4444 %%%% !1110 4@I:* "BBB@ HHHH **** "BBB@
MHHHH **** "BBH+R=+:QN)Y-_EQ1L[;!\V ,G'O0 R/4K"6]>RCO;9[M!EX%
ME4NH]USD4LNHV,%W':37MO'<R?<A>50[?0$Y->&0WNFI!X!N;2ZL;>V75=R1
M-*KW21ECN::3(ZYY&T 9')K:U*ZL[]/&WAYKS3)[G4KL&"YDO(4(^5,*RLP;
M]V!P5!'!QS0!ZU/?V=L%,]W!$&5F!DD"Y"C)//8#DU%<:OIEG%#+<ZC:01S
M&)Y9U4./]DD\_A7G&L>'M&B\:^ M-ELK2:">TNX93%$JI.%B4@L!U7.2!ZFJ
M9CTB#Q5X@\.ZYK3Z)9^1%#90NMNL4EIL^ZKRQMT;=W'//44 >L75_9V-N+B\
MNX+>$D 232!%)/3DG%2PS17$*30R))$XRKHP(8>H(KQV&\LM)\4Z+;3Z_JFF
MZ)_9'EZ9>W0A(<^:0<F2-E&4V$' .W:#C.*[WP%8:3IWA^2#1-0N;[3_ +3(
MT<TS*5).-PC*JHV;L]!US0!'+XUTW4X=9MM%U2T-[8QDHY99!(P0N=BAOF
MP3ZY]*3P7XKAU3PUHC:IJ5K_ &O?0&3R2ZH\G)Y"#^@KFM-OK:+Q7\2+.2>)
M+B8(T43, [@6[9P.IQBN?CAT_2_A-X-UFWM;1+U-2MI//V@,S;V!!8<D8&",
M]O:@#V*\UW2=/N4M[W4[.WF<@+'+,JL<].">]9]WXQT>T\46V@/>0?:Y49WS
M,JB+&W:IS_$V[@=>*\Q\8ZII][IGCJUL;J"SE^T!;BVN&+W%Y)&JY9 Q^2,!
M3C /W<_*,5LQ:OI__"R/"E^]_;_9I=#:%)S*-DDFX J&S@MGC YS0!ZA<W4%
MG;/<74T<,$8R\DC!54>Y-0V&J6&JQO)I][!=+&VQS#(&VMZ''0US7Q&O]/L-
M&TXZC;K*DNI0)'))(R1029)$DA!&47&2">?;K7.>!]3M9/BIXG1=8M[YKN&W
M9)8=JI,RJ=VP+P0O3.3[DF@#TF]U*QTU$:]NX;<.=J>8X7<>O'K4?]LZ9_9J
M:C_:%J;)\;;@2KL;)P #G!.>*XGQ!K-OX>^+-A?ZT?(TJ;2FM[:ZD!\N*?S"
MS#/8E0O/T]ZS+^YTG2;CPEJ6F6[P^%(]4F:61@Q1I)$(28[^0@=FP3P,9':@
M#T=-=TJ2RN+Q-1MFM[8XGD$@(B/^UZ?C1_;NDE;)O[1MMM\0+5O,&)B>@4]_
MPK@+RW.I^-O%=WHLGVBSF\/F"Y:'#1R76&V*&'5@F/IN]Q6!:^)=(D\&_#ZW
MCO4>6RU.U^U*JL?).R088@<'/0=3@^E 'I\OC;PQ#<?9VUNS,WF^3L23<2_]
MT8ZG_$>M'A;Q79^*K6XGM$D18IY(@'C8956P#D@#)QG'49YKDO KZ3?^/?&;
M%K.XF:^BEAR59L*I^9>_!/4=#2>"_%VB:!X7U7^T;PQ-9:C<FY41.QBWSD+D
M 'J2/U]#0!Z7)(D4;22.J(@+,S'  '4DU@1^._"TS0K'KMF_G2>6A5\@MG &
M>V2#C/7M6O!J5E<Z8NI174+6+1><+C> FS&=Q/88KQ#3M2TB/X':C"]W9BY;
M4,["Z[R?/5@<=3\H)'L#Z4 >T:CKFG:2P6[G97V&0K'$\C*@.-Q"@D+[GBL7
MQ%X[TW1+#3+F$M=C49X8X'B1FC*NP!;<!C@9('4D=.M8>EZW9:/\0]?OM5O[
M>+3]8@MYM-OGE7R)$C4AD5^F06SC/OWKE;O3I])\!6-[-!-!IR>+%U"-'0C[
M/:%B%)'4#H?^!4 >V+<PFU%T7VP[/,+."N%QG)STX]:RK/Q9HE_<Q6]O?9DF
MB,T/F1/&)D')9"P <#_9)I-9OX[GP7J%];V,FH0R64C+:M&R&=2I^7:0&Y'M
MG!KRFPU>RD\2?#Z_CO+JXM8%N8I"MFR06S&$!8HP%[8(/+'C)- 'IC?$#PJD
M<<AUF#RWE\D.%8JK9Q\QQA1GC<<#WKI"0 22 !U)KQ*YF@?X4^/)8W5OM>K3
MS0D+CS(VE4JPX^8$ D'GC/I7J=K?I=>"TO;-$U$-8[DC5MPG(3[O?J1B@!;7
MQ9HEY=6]O!>DO<AC;LT+JDP ).QRH5L $\$U0E\<^&;R0Z=!KB"[FD:VC$0;
M<),9P#C Z\$\9Z<UYM9:S:W-UX)OEDNW2UO'CGMX;)T@L6,9 @10N6(((R2S
M'&> <5V7@F.&76O&!>$&275'G@9X^778%#*2.1DD9'K[T 4?AY\0]*/@_1H-
M<US?JUP\JNT^]B6,K[0SXVJ=N, D<8KI5U#3!XZN@-=OY;R.S)?2T5WA15(R
MX55Y;MU)ZUY[HOD77P:'@I[>0^(F#QG3Y(&$L;M.65V!'RJ 5;<> .]=) IM
M?C!ID9:2:.#0OL;W!C)!E#YP6QC)'- &AHOQ)TR[T._UC4_.L;2WNY(0[VDN
M @8*NX@$%O4#IZ5J1>._#D\!E@OVF_T@6JHD$FZ24C<%4;<MD<Y'&.]>7.\T
M/PE\4:))8WRW[7\I6,VKX.9E( .,'(#'CLIKL?$.HI'8^$Y(;)C9/,/.OXK(
MS2695,#:NTE23E=V#C'3I0!IZWX_L+#PC?ZS9PW,\MJ3"\!@97AFQTE!'R 9
M&2>O;.16W<>(K"VAMF;[09KHL+>V^SN)I"O7$; , ,=2 .G/(KR0V5S-H/Q&
MLXM.U<M<LEQ!Y\,N^10 >6/);OMSG&<BNMNM3E_X3G1O%26=Z^AW&GR63N]J
MX:V<N&#E,;@&P%SC''I0!T+>-] 30KG5WO'2VM7,5PK0OYD,@ZHZ8RISQR,5
M;T7Q)IFORW::?*\AM602%HV4$,NY64G[RD=".OTP3YMK>FW,FC_$;54LKK[+
MJQ@CLH_L[;I#&N&<*!D L<AB!G&>]=WJ'BBQ\.>'=.O9[.^:UD,<)\FU;,"[
M<[G4@%5 '/'X4 ;UY=V^GV4]Y=2B*W@0R2.>BJ!DFN:U?6[?5O#VKVL0U*QN
MX["2X7?&\$@4*=K!OKV!SP<XK8\1>0?#>H"YL9;ZW:!A):Q EY5(Y50.<GMB
MO.[-;VR.MV%A<ZKJVB?V5,D1NK*0SVTQX6%6*AW!],'&!GW -SP?XUTT:+X7
MTJY>[%W=644:320MY<DHC!*^9T+?B>N#SD5K7/CS0[5[EI))_LEK<_9+B\6$
MF&*;@;6;ZD#.,<]:X-H+Q/#'PYC.EZIYFGWD4EV@T^8M"J@@E@%__76?XG35
M=8\,>);230]5CU'^T/.BM;6S=(/)$B_O/E $K-@Y)RWH  30!VLYDC^.-K$L
M\_DRZ(\C1&5BF[S<9"DX' [5-\-3((O%,+S32K!XANHHS-*TC!0$P,L235%K
MF6X^,&GZH--U1+/^R#;M*]A*%61I-P4G;@<?ET/-7?AT)HIO%*SV=Y;FXURX
MNX3<6LD0DB<*%8%E&?NGCJ* .AU;6[:SG&G^1=W=W-$9/L]FO[Q8^A<MD!1G
M@'()/3)KD?A]K]I:>"[F]GEN95DU6XBA1]TD\C%_D3!R2V,=>G4G )J6YFU'
MPU\3=0U*XTO4-0TS5;6&.*>R@,QMFCR"C*.0"26S[CWQQXT?Q"_AZ6[_ +#O
MI7T[Q'-?C3IDV?:('R/EQR6'S=,_>XS0!W^I?$"WM-(UB:'3;PZGI<>^;3Y@
MJR(N,B0D,04]U)JUI7BEW\-Z3<WME=G4+V%#';J(]\YV!F=<-M5><Y8KCC.,
M@5S?V5=<\,^([C2_!]SI4MQIDMNIO(!'<W$A4X4#).T8'7J2,=*S;VVO6T[P
MEK4WA2[U2ST^S-C=Z;<VBF5?E3,J1L,GE".<=!C .2 =;/\ $G0[;1)M4F2]
M1;>Y^RW,'DYDMY,XQ)@[5'3G.#GCO4;?$W1HIHHY['68?.NFM8VDL' =@,@C
MU# \ <^PKG_$%A)?^ ;H:7X1DTS[7<V[P6<%H$G8)(&9I0G"\9P#S^>!K^.%
MN=0U'PE<VEA?31VNHQW<^RV<F./!SD8Z^W6@"['\1+&62]MTT?6FU"R(\ZQ%
MH/."$9#_ 'MNWTYR>PJIKWB/POJ_AWP]J][;WMU8W5]$]HT *F.<$A=^&&,'
M((R>G>DTQI;3XA>*KZ33]1%K>06ZQ2_9'*NT2,& P,]QCU[5Q\&D:O#\)?#&
MDMH^HF_L]5$\\(MFRB+*[D],='7]?0T >A7OCNUM->O-$CTG5;J_MH//\N"
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MX*-;38PQ5BN[;]T^O'0T 0G7O$EU\1/#EE-!;6L,VG-=R6I=P02 &#<?>7D
M?F?3I?&_B.X\)^&+C68+..Z6W*^8CRE,!F"@C .>6'''UK C\)>(;'7O"^I1
M7-K>S6.GFPO99W8=?^6@[L>O!QG'49XL_&'_ ))7K?TA_P#1T= #T\7ZS:^)
M['2]6T6"WAU2)VL98KDO^\5=WER';\IQW&0,]^M4-*^(NI76AS:_?:+;V^CV
MHN%N94NMSAXSA0JD#(8X7/KG@#&=4:/JVL:KI.J:A:V=N-)21[>&.Y9_.E9
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MZ;<3S33:?:2RS((Y7>%69U!!"L2.1P.#Z"H#X<T,Q+$=&TXQJQ94-JF 3C)
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M'FW((F ."K[5/ED?\"%5OAEK6KZ]H%S>:MY3,;R8*Z2$XPYRH4CA1P!R?PH
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M P..>2*-6\0:9H;VJ:A<&)[N98856-G+N3@#Y0<?C7*^(?\ DL/@S_KWO?\
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M  !)S7'S07VE>*K7QY9:+=R1W\SVUUIL5A*9DCZ";:5X<[<G@9!P,\FO6J*
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M"3S;ZSBB5P[]V1C]PGN0,_RKL[:VBL[2&U@79#"BQQKZ*!@#\A4M% !1110
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M#;P2#TYZ'UK,U2ZTOPQ\1+XZ[+>6&CWUI"MA+:R21P#8&WH?+QSEB0/]KWH
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MFBV[#,9,YW>G'U]J .D\0>/H=*O-0M+-;&:;38UDN4N;U8"^1NV1C!+-CGG
MY [\=%H&MVWB/0;/5[,.L%TF]5<89><$'Z$$5Q8M/%GAOQ;J.J:3HRZCINM-
M')):R7*Q26LP7:23R"..<9_3GO;!;M;*/[<\;71!:3R_NJ2<[1Z@=,GDXS0!
MPGBBX;7/B?HGA*Y(.E"V;4+F$G G8%@BGU4$9*]#WS6AXZDT+3[;2WU*SG0Q
M7L+V=Q;6P?RYE8,J_P# MI&/3\*?XL\*7U]KNE^)M"EMX]8TX,FRXSY=Q$<Y
M0D D'DX/N:@\4:;K7BZTTNT326L#;WT-Y-+<W$94!.2J["Q).>,@4 %WXWU?
M_A)+W1=-\--<W-O:QW2K)=+&S*S8.>P(';/6K%QXQOWM=7U'3=)2YTW2II(I
MFDF*2S&/_6&-=I! Y R1D@U'9Z5JL/Q6O]:?3G&G7%BEHDWFQY#*=VXKNS@]
M/7VJG8:!KNAV7B'0[6SCN["_EFEL)S.J"'S1\R2 _-@'D$!B: -.V\9_;==\
M/VUM;Q/I^MVDES#/YI$B;%#$,F,?Q =>Q]*R;SXB:A:Z%XGOETFW>70[O[,R
M_:#M<<#?]WU(X_6EF\)ZOH+>#I]&MX-1.B02VT\<DWDF02*HW@D' !4G'/6N
M=\0Z)K6D>!O']QJ<%K''J-R+F,Q3%CRZ#&,=/?(/L* .P3QCJMGXHTVPUG1X
MK2PU8LME.D^]U<#(608P"1Z$\]S7:5QTNF:AXJU/P_?W]F+&WTU_M9Q,',TI
M4!0N.B<DDM@]!CO6[H<NM2V\YURUM+>83L(A:R%U:/\ A)R.O^<"@#4KBOBY
M_P DMUO_ '(__1J5VM<O\0M'U'Q#X-O='TR*)Y[K:NZ638J ,&ST.>F* .&^
M)&H)?:+X=MGLKS2Y%NH)%U2YB"Q6X"GC>I8@GC';BN\U'Q!=R^(8_#^B?96O
MOLAO)I[D,T<49.U>%(+,3VR, 9]*R/$VB>)/%GA/_A'6LK'3XIA$)[E[HRE0
MC*WR*$&2=HZD5,WA&]T3Q1I^M: 8I88=/73KFTN)2K21IC8ZM@_,.,YZ@>]
M'.^*?%^KZC\/_$D*BWT_4]+F^R7ZKN8.CD -$W& P)Z^_L:U/$S:Q'XZ\'>3
M'9S:F8+]>2R0CY8^3U; '8<DT[4_ -[J'AGQ3&7MEU77)UGV[V,400KL7.,D
MX!R<=6]!5^31_$U]XH\/ZU>0Z2@L(YUFCCN9,_O0H^7,?.W;ZC.>W6@"WX+\
M1W^N1ZK:ZK#;1ZAIEZ]K,UKN\I\<AEW$D?CZ5G_%B_U+3? T\^G72VY:6.&8
ME,LR.P4@'/'7\O2K?A'0-6T35]?N;];+R=3O&NT\B=W9"<#:047/US^%6O'7
MAR?Q5X4N=+M9XX;AG22-I0=N58-@XY ..M '+^)1JJ?%'PHMNUI-J)LKL!W1
MHX@<=2N2< =L\^H[6;?XA7EOH6I'5+:V.KV6J#2U2V#F.5V(V,%Y;&"3M&2=
MIQUJW+H'B6\\;:)K]TNDA;&*6*6.*>0$B08^7*<[?<C/^S64WP\UB^@\1+=7
M%E:3WVH)J5C/;2O(UO,A^7(*+V[CUZ4 ;NA>(]:O/$\VFWNFROIYMQ+#?KI\
MUJH<'!C99">>X(-6OB#JUSH?@'6-0L_,%Q'!MC:,?,A8A=P^F[.?:CP[9>+1
M<+/XEU'3W$491(=/1@LC'&7<MCG@X  ')/IC>O;.#4+&XLKJ,26]Q&T4B'^)
M6&"/R- &%X%M8;+X?Z,+-&826<<_SG#.[KO8L>>26/K7&R>-WL_ >N:UX8TQ
M+5+34'29;TALRNR[]@5O5P>?RKI- T+Q)X4LSI5E<V&IZ9$2+3[6[PS0KV4E
M48.!]!_AD_\ "N=0@^'^I^';:^MC<:G>M=SS2!@D>64[5 Y/W ,G'4_2@#1E
M\0>(['5M.T745TR._P!7N9/LCP!W2&"./>^_.-S@\#& <YXQBH9_%NKZ?J'B
M#1+MK4ZA8:>=2LKA86"3Q+G(==W7(P<$=3C%:?B3PU?ZQ-HVKV=Q!;:YI3L\
M6_<T#AP!(AQS@@=>U$?A6:_O]4U/6)8A>7]A_9RQVQ+)!"<D@$@%B68G.!V&
M* ,O_A+=6ET?P5J8>VC_ +9N88;J!8CC#JS$J2V1C:!WZUGQ^(O'.I77B>"Q
MET:-M&FPNZ!SYHVEMOWN,XZG\A3X/ GBK^QM!T^76M,0:)=QRVQCMG8.B!@"
M^2,MA@,# Z\GC$'AJ/69O%GCR+2Y[.,R7B(99@VZ-MA&X =>_!QR.M '<>$M
M>_X2;PIIVL&,1/<Q;G0=%8$A@/;(.*I>(M6U*QUFVMTN+>RT^6W=A<%!+-).
M",1I$#N8;<DX![=*U= T>'P_H-EI4#LZ6T83>W5SU9C]22?QK!U?PQK4WCB#
MQ%I.J6MN/L/V*2.Y@:38I?>60!@-W3KZ=Z .>3QSXFNO#WA+4;9--#ZM>M93
MI)%(/G#NH88)VKA,D8S[@5>A\;:EHMWXNM=<:WN_[#@BN(I8(C%YH=<A2,G'
M.!GW-4K/X>>)K#3M&L8]7T^6+2]1-]&7B=2W+$H<9Z[SD]LUJ7/@2\U+7_$]
MQ?7%J;#7+9+<I'N\R+8N$;T)SR: .<\6MJS:O\/K[4;V&X%UJD#^0D.Q86;9
MPI!R0,G[V>1Z<5Z_7F,_@#Q9J!T!-0\0Z<Z:)<I- ZV;;W"8P7^8 GY0,#'U
M->G#H,G)H \HTE]3NK+XD-=ZB]SY+W$&UHE!8+"0N,=,#L*BT'6==\/>&O U
MR]Y;2Z;J,MMIWV(6_*!U.'\S.2W'3&.>_6NH'@[4X-1\3&UU*V2PUH,_E/ 6
M=)63823D97J<#G..1SFI/X"U27P]X:TI=6LU.AW45RDAM6(E,?W 1OXZG///
M&,4 07_B?Q-J7]LR:!97C-8W;6EJL<,+0RLF _FEW#\G.-H&!CK7?6,MQ/I]
MM-=P?9[F2)6EAW;O+<@$KD=<'(KC!X&UC3O$E]J&@>(O[/LM2E\Z\M6MA)AS
M]YXR> 3[COWP!7;6UNEI:PV\98I$BQJ7;)( P,GN: ):*** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MI",@@$CW':@"H=)TUEE5M/M"LSB20&%<.PZ,>.3[FAM(TUS.6TZT8W'^N)A4
M^9_O<<_C7$Z!-KVJ^+O$^D3^)KY8-*D@6!H[>V#,)$+'=F(@XQVQ72V%_P#V
M58N=:UB&9'N?+M;J9HT,RMC:,* -P)9>!SC/>@#1_LG3OL!L/[/M?L9ZV_DK
MY?7/W<8Z\U-;VEM:!A;6\4(<@MY:!=Q  &<>P _"LP>+/#Q6]8:U8%;''VD^
M>N(LG W<\<\?7BIF\1Z*FG0:@VJV8L[@A89C,H60YQA3GD^U &BZ)(NUU5AZ
M,,TS[/!MV^3'MSG&T8K.M/$.CZS=7FFZ;J]O+>P!A(L#JSQ=LX.0<$CL1GK7
M/?#O6KJZ\+ZC=ZSJ!F^RZA<1&XG*KB-",9( % '9BW@!R(8P?7:*:UK;M&T;
M01%'X92@P?J*H6GB31[YYX[:_B>2W3S98^0ZH>C[2,E3Q@C@Y%$/B71;C2I=
M4AU*"2PB.'N5;,:_CTH TC#$V=T:'/!RHYI41(UVHJJ/11BLS4/$FD:4B->W
MJ0AH_-P5)(CZ;R ,JON<"I+K7M+L[.WNY;Q##<\P-&#(91C.5"@DC'/% %YX
M8I""\:,1T+*#2NB2##JK#K@C-5].U*RU>PBOM/N8[FUE!*21G(.#@_B#QBJ
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MB<3K;%=K'$C=!G'3WZ#(YY%68/%NCW-Y#;0RW#/.\D<+BTE\N5HPQ8*^W:V
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M]>U;VO\ _(N:I_UZ2_\ H!KSKX>ZIJUM\+-'CM="\^W),;3&92NQIR';9U.
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M!GCC "J$4\;BV>2"!CH:I?\ "1^)I+;Q+H]LUO+KVB%)89##\MW"PW#*YX;
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MBXALM9AGN!;QF1ECVNI;:.3RPZ5V=% '!6.KH?B-?7\NGZI#;R:3%&&?3YB
MZ/([+E5() 8="<G@9-<AH-SJ&D^"-%M;G3=5MX%U6;[;+%8OY\*-N*%,KD;M
MP!9>0"1P37ME% 'BDNFZC<:1\0M.M?#^IP"[2*XM?M$19I JKD;\DLW&0,D\
MG.#7K.@7_P#:.C6\_P!DN[4; H2ZC\MS@ 9V]1SGKCIZ8-:5% 'DFFV5\/!_
MBGPM)I5XFIW]]<^1OMW\IED(VR&7&P #GKGC@$UJ^*/#]_I&E^%K[1GC.LZ6
M8=.#MPLL;J(SD=\'#>V#7HU8$?A.W7Q5)K\NH:C/(Q#1VLD_^CQ-M*;E0#K@
MD9.>IH U["RAT[3[>RMUVPP1K&@]@,?G7FE_%J6F^)/'L)T;4+E-:M(S:36\
M6^/Y861MQSP06''4XX!XKU.B@#R*WTV.Y\*>'K+6]#UNQFL;%3%J5E$QN+>4
M':5PFXX8<\CMR!P:NR6^OSV/@JXUC3[RZU*QOC-<2QQ$LD&'4%P.-Q^0D#)X
M]Z]0HH \_LEN[?Q3XUN9--U#R+^.$6TGV8XD*1%"!CGJ>_:N8L[74-(\,^!X
MCI.I+K&GRW!*0QJTBI@EAY;,H=3N3)W#&.N:]GK!UOPG9:WJ-KJ+75_9WULI
M1+BRN#$Q0G)4]05SS@B@#*\%7-H-0U.%[#5+/5KQ_MEP=0MUB\X<+E-K,NU>
M!C.1GG.<U5U]-:N_%EW:7>BW>H:0UJHL%MW58?-(.\SY89YQC.1QP,FNKTO1
M8-+:647%U=7,N ]Q=2[W('11T"CV 'KUK2)P,GI0!Y'H-KK5GIG@:RN/#NIH
M^EW$C7#;4("E'4'[W'+]#S@'CIGI-6L[^S^)]AXA73[FYT\:6UH[6ZAV20R;
MAE<YQCN,UVZ.KH'1@RD9!!R#2T >6>(O"NKWOA#Q2UOITCZCK]Y%+':(R#R8
MXV3&\EL;B%).">3CWK>UR/4QXU\.:U;:/=W,$=O<03(AC#1,^W;NRP&/E.2"
M?QXSVM% '">%-/UBQ\1>+IYM-EMUU"X$]I-*R%&PN #AMPY]NE<BVC^([RW\
M.7MUX8OY=7L=62?4+J::)GE 8\1_-Q'ST^51QUY->RB>%IV@$J&95#-&&&X
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MFWNXKI//SL8H2=I(R1GUP:Z:B@#C[WPK>>)KN:X\0"UMU6QFL[:&SE:7R_.
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M(^'=IK.F^&_L]@UVT#6L$J@0DR[<GCG)/0 UO:?XPFE\4SZ%JNE/ITWV3[=
MWGK+NA#;3OV_=8'L"1[^O#1^%O%4?PN7PY_8+&]_M 3D_:X=NSS?,SG=UXQC
M\:Z:Z@U4?$6#Q'<:.UOID.D-;3S37$.(R6\PE@'/RKR"?KU% $W_  GT[:9I
M6K1Z0K:;JEP+:WD-R0ZLS%4+J$. V.Q."17:2F40.8E1I=IVJ[$*6[ G!P/?
M%>-Z'_;UAH=C>7O@X7FCVK&_@\O5%$<>[YO,2)N<*I)56/'L>:]EC<21JX!
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M'W>8R\E-I^96*G&1[$XS73WWB"0>+(/#=BL0O&LGOI))PQ54#!%  QDEB>_
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M]61F^X3ZX//X =I:VR6=G!:Q%C'#&L:EFR< 8&3W/% $U%%% !1110 4444
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M2>  RHL;N5R<=@>]:'B::TA\-7[7NHRZ=;F%E:[A)#Q9'WEQSF@#6HKF=/\
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M;?7)H8VN)FD8(H4 98D]*Z.^\366G>(=/T2>*Y^U:AN^SLL>4;:,M\V>PY-
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MH8DU*W,C0$M#*CLDD3$=592"#T_*FZ-X:TS0R7M(Y7G*;&GN)GFD*YSC<Q)
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MX@TTV-\)/+WK(K12%'1U.596'0@U3TWPQ'92I+=ZGJ.IR1.6B^VS;EC/8A0
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MM"LC2;7A=0Q(9<'/W2.#0!U]%<?/XZ:WOO$]JVEEFT%(I'*3C]ZLBEQC(&"
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MP02/3ITP>:CT_P 1:M>:3X'T_P"U!Y]5M99IY);HP/,4487>%8@G=NXY.W%
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M-)U2\3;<W%N&DXQN8<%L>^,_C0!O4444 %%%% !1110 4444 %%%% !1110
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ML+&._P!"42&#SWVS1E2X<,5XR <<=>M=S7)ZMX._M#QK8:W%/Y,(A,5_$/\
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M?'_BA/#FE^*KW3--70YV1+E(G<SH&;;Y@S\H&>W)^G:[/X;\1)K6H>)-3O\
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M6A6PU:51:)"FV4-< -YC,"22&XVD8 '>O0M!\"OHAB1_$&I7MM:Y%E;SE=D
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M.82'>IC5,@KC'.\=ZR;;X@.(-:%Y81BZL-033H(89B1<S/@* 2!MR3U[#)H
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M#M;?6I+75-$&VRU"* 9"D %70L0P('(R/YY[BB@#B/\ A7@O;O59]:UB6_\
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MUB:VG@G)5+B!CG:64$@@\C@\U/X>\.R:9J>LZO>R1O?ZM*CS)%G9&B+M1 2
M6P,Y) SGH* .;N?'5]$WA"]6^TS^S=86,77[AB\;$<D8?"KN(3G[I]:D\3^+
MO$&AVEU?VBZ?<VO]II8P+)&Z-S@,2=Q!^;<N>/NYYS@.M_AE!#X:U_1VN0ZW
MTKM9'! M$W%XU'?Y7))]:M:WX*NM0\':7H=K=1)):3Q7$L\VYO,=268\=V8D
MY]Z !?%.KZ/K>JVGB".R>WMM+;4XGL@P(1#AT.X\G/0\?2JUGXL\137.CW"Z
M>UW97Y47$46G3QFT5P"K>:_RNHSS@#U%:&I>%K[5_$D][=2VHL+G2WTR:%"W
MF;'.68-TSGIQ53P[X8\6:2+?2[W7[6YT2T93"4A9;ET7[D;-T"\#/4D#&<&@
M"'2/$/C'5M1U!DM=*-CIFI36MPJE_,E54! 3WR1R>NX<<<R>#O%=]XAOX&_M
M2PN8I(7>ZLA;F&XLI!MPA!<EESN!;'7'K6AX=\.ZMI UY9[RU(U.ZENT:%6!
MAD< 8YZ@;1S5>'PIJCZWI^MW<FF?VE96[QF:")T-TS+M_>'/W1R<<\],4 <7
MX;\0Z[X<^'7A_4XQ9_V4+UK:6W9&,LBO,X+AL@*0<X&/?/:N^&N:H?B#=^'B
M+00_V7]MMG"MD'S-F'YY_#%<^WP]UEO -GX8^WV -K="X6<1O\V'+X(^IQUZ
M5OP>']5_X3]?$D\]EY9TX6#0QJV0-_F%@3WW<?2@#DAXX\72^#7\4Q1Z8;;3
M[B2.[MMKAIU60J2I_@P"O'.<$Y[5ZE:W$=Y:0W,1S'-&LBY]",BO)_ NBWWB
M+P!?:4US;Q:9<ZA.LS*A,VWS,LHYQSCKVST->M0PQV\$<,2!(XU"(HZ  8 H
M ?7G>J^+M;>R\5W^G2VMJN@2F)+>XBW^?M4%F8@@C.?EQCH.N>/1*\9><W?B
M;7+]?$_A^W"7SK+9ZO:KO"QD*F?F!*@C*_0'O0!UG_"0ZU;>+O"%A<7$,EOK
M-M.\\?V;RRC)'O&,LQ'4 C)Z>]9\OBOQ!:^'?&<XN[6>ZT6Y,<$KV^ 4"@\J
M"/FY^GUK2N-$U?Q(/#GB**[M;+5].:;!>!GAE20%"P4LK#*@, 3D9P:K)\.]
M3&E^)+!]?A==<?S)7>R^96( 9AM<#G'3''J: +8\3ZAJ&HZ#H5I+';WM]IJZ
MC<W;1[PJ8 VHO3)8]^ /6N:TW5[KPE<>.;B>2*[U!M2MX862,JLDLB *2,\8
MSDC(Y! (XKHKSP'J!DT74M.UM;76M+MA:";[-F&>$9^5HRQ(^N[^F&#X<R7B
M:\FLZR;Q=7:.4F.V$+02H %=2&/3' ].N>20"QH.I>*5\2"SU"SN[G2YH2WV
MR>WC@:"09.W:K'<I&,=P?SKF-+U75?#GP)L=0L+J!+FWE=79XO,#[KED.WD
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M"^9*Q8*%!(( ')/'/%9&OR^,-"\,V&IWFLI/)IMX!J8L@ );4L/F(*\. 1G
MZ'/O6UK'@$:HVF7L6LWEEK-A"(%U"W #21_W67IW/3')_"F:K=Z=X4TF'0[F
M&_U>[U99E :,R-=2;1G>PX7.0/0 =@* -71[I]5UW4;^"]DETQ!'! @8&-WV
M[G=>.1\RKU/(:M^LGPOH<?AOPSI^CQ$,+6$(S#HS]6;\6)/XUK4 <SX[UZX\
M/^'XY;-TBN;JZAM(YI%RL1=L%R.G R>>,X^E9NI7NI^&/%>A6YU"ZOK#5W>U
ME68(6BEQE9$(' ZY'(XKIM>T*P\2://I>HQL]O,!RK;65@<AE/8@\UFV/A26
M*XM;G4M9NM2N+*-DM'FC11"6&-^ /F?&!DY[\<T <"-2\3-X&\0:XWB6Z-SH
M^HS+"@BC59%C< B3 Y!'88 ]Z]>MY#+;12-C<Z!CCW%<:OPZ4>'M5T7^WKXV
MVI7#3SGRHLY8Y<#Y> 3CZ8XKK-.M'L=.M[62Y>Y:% GG.JJ6QTR% 'Y"@"U7
M!07&H>+[_P 46]KJ]SIT^FW'V2SBC.WRV50?-<=7#-D 'C:.*[VN2U;X?V&I
M:\VL6VHZEI=S.H2[_L^?RA<J.F_CKVR* ,^UU6]UOQK_ ,(W<W[B*QTM)[B>
MR8Q?:)V(4D$<A1SP#U)SG&*Y;6?%.OVG@KQ+#_:ES]NT#4HX$O%"C[3$SJ%#
MG;G< >=N.W6O0KSP98R7MA?:=//I=[90_9TGM=N6A_YYL&!##OSSFH-2\ :7
MJ>@S:/)<WL4%S.;F[DB:/S+F4D-N=BAYR!]W XQTXH S;9K_ $WXEQZ'+K-Y
M>VE]I3SR+-( T<BOC<FT#8""1@?T%8_@;3R-(\;RV]]>V\\6M7R1R).3C 4@
ME6R"W^T1GWKL9/!\<OB.#7FUC4A?PVWV56'D[2G4Y'E]2>?KTP.*KZ;X$ATJ
MTU.VM=<U=4U*1YK@LT))D?&YP?*X) QZ8/3." #!TS7;[4=)\"Z5/?W$<FK6
M[S75TKXDD6./)0-U!8D<CG XZUF3W4_@[4OB/=V=Q--+!;6!@DN7:5H]P=02
M3DL%W9YSP.]=>WP\TM] T_27O=18:=)OL;L2JD]OQC"LJ@8^H/Z#$UIX#TFW
MO+ZZN)K^^DOX!!="ZN6995"E?F48!."?IGC% &79Z1XC&J:7?PZI%%ITD12\
MW:I+<FXW+\CQAXPJ-DYXP.>G&*XI+O61\,-2\3'Q%JQOM.U!A"IN3L*B95PP
M_BR">N1[5Z-H'P_TKP[<&6TN]3E5<_9XKBZ,D=MG(_=IT'!QDY/ZT)\/M(3P
MO<>'C/>O87,IFF#2C<[$[B<A>.0#@8Z?6@#G[*RAN?C?=2&2Z&_1([@ 74GR
ML91P/FQM_P!G[OM46F:A?KX,\:>=K]S;R6NMW%K!>SYF>-%,:JJCKDYP .[9
MKKI?!FFRZY9:QYU['>6L M]T4Y031@Y59 /O '\^^:AD\ Z)+INIV$HNI(-2
MG^TSAYR3YV0?,4_PMP.GI0!E:!<7\'Q%>P;[;;V$VD?:%L[R\:XD5UF"AR69
MMI(.,!B..>:XF*:XM?@!JMY:7=S:W$%](4>WE:,\W"J02#R,$UZ7;> M)MM2
MAU(7&I/?1VWV8W+WKEY%]6.>2.PZ>W%-_P"%>Z%_PC<OA_%Y_9LTOG/%]I;Y
MFSGKUQG!QZ@4 <[J.FV\WQFT1F:X#7&DR/*R7,B$D'CD,,#CH.#44=U?:!XA
MUWPI/?7\SZFJ2Z-/-<R.ZASL=0Q)/[LG=QS@$FNTN_"&DWUU875REP]S8Q&&
M.47#JS(>JN01N!]ZSM#DU+Q#KT>K:MX=;2EL(Y8K;SY%>1V<@%ACH-J_CN/7
M - '4VT"VMM% C2.L:A0TCEV..Y8\D^YJ6BB@#R_Q<@O[CQ5<VC3WL]C:@K-
M]H,$>FLD>_"$$EI"<-PH'0%A4T]K+JOB#P3)<:AJ*?VAILS7217+QJY$49X7
M^$G><D8/O72WW@+P[J.HWM[<V;M)?)LN46=UCE.,!F0'!8#H<<=>O-26O@K0
M[273I8H;KS=.39;.;V;*#N,;\'. #D<@ = !0!YQ'K5SX>L-?T>WN)X[!/$<
M-BDIF8M:P2$%R')R!A2 >Q;-=%+I6G:'\6_#D=@GD1W-E=#RM[,I8!3D G@D
M#D]\>M=*O@CP\J:DC6+R)J7-XDUS+(LQSD$AF(R"!@CD4EEX%\.V%Y9WD%@Q
MN;(%;>62XED:-3V&YCQZ#H.<=: .BK/UR%9]"OD9I%'D.<QR,C @9ZJ0:T*I
M:P7_ +&O!'%),[0LBI&,LQ(P/YT >*PZ;)8_"WP[XOL+N[&N02QHK^<Q$D;2
M[/*V9P5/!P!DG.<YKH=-T.VU'XB^-//:]E_LN:QNK5%N9,^9Y;-@G))&1P#D
M#)QUK;\ >#8;#PIHZ:QI\Z:C9DOY,]PTD<<FXX=4W% <'J!GKWKI+#PSI6FZ
MQ=ZM:0S)>WA!N)#<RL),=,J6(X[<<=L4 >:!8=:^$5WXK>3;XD@\VX:^'$T$
MJ2?ZO/!50H5=O3!Z<U=71[;Q#\0].75Q.?MWAH3W4 N)%5W,J93&>%SSM&!Q
M]:[D^#]!-Q/-_9ZC[1*)IXA(XBE<'.YH\[&.><D5SVI:+=:K\4[2_GTJ^738
M-/>V%U'<"+$A?((*.'VXR/QH X&_LIK#0FT87-R]CIWBR*ULY/.;B)L,4QG!
M*G')Z'.,5U'B?PWIOAO4?!-MIJ31P_VZ&"O,[@;LL>"?7OUKN;CPGH=UI]O8
M3:>AMH)?/CC#LN),YWD@Y+9R<G)Y/K5B_P!!TW4WM'O;<S/9L'MV:5\QL.C
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH KI?6DM[-91W,374*J\D(<%T5LX)';.*L5QUKJMDOCS7+:#0BNKQ64<K
MS^8NZYC!(4#LHZ=2.W'%4+7XER7&EZ'K+Z))#I&I7 M6F:=2\<C,5!"XY7*G
M)X/H/4 [74=4L-(M3<ZC>06L ZO,X4?K5B*:.XA2:&19(G4,CH<A@>A![UP%
M]?:E)\7H-.DL;2:%])D,<<ER=NPRX9S^[.&( &WD<=:G@\4Q:7X:GU#0=$63
MP[IDCPD1R[)"J'YWC0C!4'/5@3@_B =+KWAS3_$EM';:CYQAC<2!8Y60%AT)
MQUQVK41 B*@)(48RQ)/YFN*U'QY=KKEMI6C:*=0DO-.-_:R&X$:R+CC.1\OX
M]\>N:B_X3C7)]6U72K?PY$EYI]I'<N)[T!1N!8@E5//0#'ODB@#O**\_7XCW
M;Z7H^NC0F30[Z6."25KA3*CN2N50=5##&20?:KWB/QG>Z)+J;II<8L],C222
M:[F,/VHL"Q2 [2&8 'OUP* .RJI;ZI87=[=65O=PRW5J0)X4<%H\\C<.V:XF
MY\5:OJ'C'PQ!I8M5T_4;%KY$F=E=@4!^? (& W &>1UZ5=L_$5E8:QXPFNM(
M@L3I<<,]S<0$-)<AD9@3@#D  8/<T =I17&R>,M0TW^Q[K6=*BM[#5I4AC>*
M8L]N[C*"4%0/J0>"*J77C77O,\2)9:'9O_8;;I7EO" Z!-_RX3.['K@#U- '
M>T50T35(];T.QU2%2D=W DP4]5W#./PJ_0 UHT9U=D4LOW21R/I3J** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *:Z)*C)(BNC#!5AD&G44
M5K+3K'38FBL;.WM8V.XI!$J GUP!UJS110 54ETK3I[H74UA:R7 (/FO"I?(
MZ<D9XJW10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ###$TGF&
M)"_]XJ,_G3Z** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\>E20W$%QYGDS1R^6YC?8P;:PZJ<=#[4 24444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!YYIDQU
M_P",6MI??O(-"@B2SA;E4>0 M)C^]VSZ5J^(+W2K;QIX>6ZLKLZH7E%C)$B;
M908R'4L3P &!Y].*CU/PMJ%GXQ'BKP\]N;J:+R+ZSN6*)<*,;6# ':PP.<'^
M>77VAZOKGBWP_JUS;VUE!I!F<H)S*\ID0+@#: ,8ZY[T 4;'QIX@N]5U*-]'
MLH['2KYH;Z?[2?DA";MRY W$<D\#C ]2"Y\<ZI9^&K;Q9-86QT*9E+1(S&XC
MA=L+(3]TGD94=,]35WP_X?U&.7Q-#J]K;K9ZQ<R3#R;@LP5T"%3\HQP,Y![U
MF1^#]>F\$#P9>O:?8598OMZ2G>;=7# >7M^]@!>N._M0!K67B34[SQGK/A]5
MLB+:T2YM9PK8.\_*'&>>W(Q6!'\1]9F\.^&M1ATNSDEU74#8RH9&4*V]E&W/
M8A>I/7L:V+KPYKEAXZEUS0_L#6]Y9):3)<LR^05/#J%'S#'\.1]17$ZGH>M^
M&?#O@K3+DV4UY#X@1H-LC["69V 8D<<GL* .\T'Q-J[^*[KPWXBL[.WOA;"\
MMGLY&>.6+=M/+8.X'V'?TK4\2:IJ.FQ68TZUCD:>X$<MS.?W-K'@DN_(/; Z
M<GKTS7T_2+^?Q7-X@U18(76T^QVMO#(9-J%]S,S%1\Q(7@< #WJOXST76M4N
M-&N]'>UD^P7)FEL[MBL4X(P"2 >5Y(]SGM0!@R^*9O$?@'QQ!<"V:73H+FW\
M^VSY<R^42& ))'YFJVL2G^S/A?(%4%KNUXVC S#Z?C5F+P9XGBM_%UN9M)D7
M7@[!RTB;&=-IXP>%R?7=@?=JY>^$M;NM/\'P*-/5]"FBEES</B3RUV@+^[[C
MGGITYZT =GJ>HV^DZ7=:C=OLM[:)I9".NU1DX]ZXNY\:ZKINA:3XHOXK/^Q+
MYHS+$BL)K:.3[C;MV&ZKN&!WQFNRU;3+?6=(O-,N@3!=0M$^.H!&,CWKC$\%
M:M>>%=/\*ZO-8RZ;9R1YN8F?S98HSE$V$84D  G<?I0!"DFIGXXF&2:S96T(
MO&5A8[8_M!P/O?>/&3T.!Q71>-'O-.\"ZM-I$B6LMO:R2*5C!P I)VC( /OS
M]*I-X?UG_A9:^)533_L:Z?\ V>(OM#^9L\S?O_U>,]MN?QKH->TTZSX>U+3
MZHUW:R0*[#(4LI ./8G- ' ZV-1CT[P PD@N+O[=%Y65,2<P-C=RQX]1U]*M
M1^/-2T=_%5MKT=G<7&BBW:)[-&C2;S@-H(9F(.2,XSWZU*?"_BNX@\-+>7.C
ML^D7(F?RQ(H9538JC(.21DDG')Z<<NU'X?2ZQJGBJ6]N(1:Z[##&H0$O T0P
MC<\-R <<?6@"?2O$/B&3Q3;65S83W&F7,3,]S_9TMO\ 9I0,[26/S(<<'KDU
MH_$%;EO 6N&VN$AVV,S2%H]Q91&V0.1@GUY^E5_#FB^*X)8/^$CURVO(;3/D
MK;1%&F."H:5CUP"> .N"2<5J>*M,OM:\.7NEV,MO"]Y$T#R3 D*C @D =^:
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M:/;ZP^KPZ=;IJ+H(VN0GSE0,8S] !^%3:II.GZW8M9:G:175LQ!,<@R,CH:
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M)+ZVE>0",1VTC2J'\IE VL1][!]*]3TC1-+T2*9=+M(K=+A_-D\O^-L 9/X
M?S[FH9?"V@3Z;%ITNCV+V4+;H[<P+L4^H&,5IPPQ6T$<$$:QQ1J%1$& H'0
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MVRI]F=$#!E;J<YP=V1QP!TH [H,"2 02IP<'H:6N"^%LEU<:;K<]W>SW,O\
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M_AIEGETUT\O9+,S,J]@&ZC&!BM+2],MM'TZ*QM?,\J,<&1R[,3R26/)-7**
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M%G3>'Q;6?E?V0;R*7!WL?,"*K'L,[N@/45S%OX]\4R^#9/%4D&DI96EV8[B
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MOUH YJT?Q/=:[XKT%O$]RD.F"*>"Z^S1><PDC9MN<8"@CTR<=138?%7B"^\
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MHW_VL0&V$6Y/*\HG.S&S.,\YSGWJ&Q\%6-F^GB2^U&\@TY@]G!=3!DB<+M#
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M;1V\9<I&N 9'+L?<D\D^YKFM0^'VBZC?:E=2/?1C4HRMU!#=,D4C8VARHX+
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MR7%O.RDL]F?G)+GGY=A3/9F%=_<^&=/6X@U*.WN;C4+&)A:;[^8>^W)8C#$
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M5'(PD"-.RE0<Y QV'?FO6M)\%>'="@NH=,TN*V6Z!68HS;G7TW$Y ]@<4?\
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M98UD>,LO3<K%6'X$$5YEX>F,WB.RT77QK%AK#02+.KWDCVVI83F2-@V%/5L
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M\--;W%O(YL;C>8W4GE<KG'J.E '0^"-:U#7-+OY=3-NUQ;:C/:YMT*H0C8!
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MCJFY@J[CC)/0#WK%L/$\-]XJU#P^UG<6]U9PK,&EVD2H21N7:3QTZX//3@T
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M(EE>(NI421XW+GN,@C/X5)10!SND>"M*TCPU+X=!GN]*D5E^SW3*P4,26 (
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M&LFDTPN9!%),[%6)SE6)RIR3T]3ZFNEH/3B@#F[;P'X>M=$N-(CLY#:71S<
MW$F^7_><-N(]LXJU)X4T>:?39Y()VETP8M&^URYBXP?XN>!CG/%5/"'B*\\0
M'6DO;6&WET[4I+(")BP8*!SD@=<^@KI: .>\,>&8O#T^J30QI M_<><8(Y'=
M5/.6);^(YYP   !SC)LW7A?2;S7(=:GAG.H0KLCF6ZE78O<!0P ![\<UL44
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M=1>5<0QS1Y!V2*&&1[&I    !@#M6!:>-O#-_>VUG::U:33W+LD*1OG>RC)
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M'A'7GU:X6ZDU2."X"!56X3SF7YN,]$ X(!R<@UL>+M2U/3=>U,ZK<:I8Z1-
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M_%#_ &A%=7+7 F^]Y>S,1!/8;?EQTV@]3DT([=[N_P#A3!XABCF+VMV)8[I
M0P\I=@8-U.-O7O7K=QI.G7=TMU<:?:S7" !99(59ACD8)&:ENK*UOH_+N[:&
MXCSG;+&''Y&@#R6ZT^+3K;XF-IJQ0Z&UGL18\"/[1Y1\P+VX)P0._':K6KM#
M$OPOG4QI.9H$,@P&V&( C/7'/ZUZ:^FV,MFMI)96SVRXQ"T2E!CI\N,5#_86
MCGR_^)58_NAB/_1T^3G/'''))_&@#RO5K^QAUKQ]H\VHV#2:JL<<<MU=1PB!
M_+(VL'()5<@Y0-^=:=Y=Z3H&I>#]-74-/MYH-,D$>KW#CR=NU%8JNX!G<KG)
M.!SUS6I<>$==37+ZY@7PY?V]Y<F9I-3LV>:)2  @(.&  P,XZ5TVF>';#3]-
MMK1K:VF\AVE5C H"NS%F*+_ ,DX Z4 >,27MD_PVGCCNXY3:^)P\K$!2B&4D
M,PXV@@9["O0M1O=+G^)'A&ZM9;5OM%O>!9D*_O1M3;@]2.&QV/:NS.GV1AFA
M-G;^5.Q>5/*7;(QZEACD_6GFTMBRL;>(LN #L&1CI0!Y-I-[:M\,/%FDZXT*
M:Q%)=_:X9&^>25B3&P!Y.3M"D9Z"I].@AC\9>!K?61 =431W%PLY4R>: FW=
MGG<,''?@UZD]G:R7*7#VT+3IPLK("R_0]12M:V[2^:T$1DR#O*#/'O0!XSI3
M:/=:=XGL;C6!IH_X2IWLKF%AB"3.8VQG&T[2/2NW\#:C?7=_K=KJ*6<]W:RQ
MI)J5C_JKO*94D= X7&0/4>U=9]AL_P#GU@Y_Z9BI8XHX5VQ1JB]<*,"@#S_X
MKM;,GA*&Y:$QMXAM2Z2D8*?,&R#VYY[<US_B1FN?&OC"UT6:)KJX\/*B0P$%
MI7SR !U;9D8Z\C%>ORV\,^/-ACDQTWJ#BD6UMUE\U8(A)G.\(,_G0!Y;H%WX
M5UZZT.[BU'4[G5=/&?LTCE?L8P!)YGR@*@ QR<'@#K67X:TV/4OA-XB.DP02
MZRMQ=A'B"F8!CR >HW("/>O9Q;PJ7(AC'F??PH^;Z^M$5O#!GRH8X\]=B@9H
M \L\-7OA;Q/?^'[FVO\ 5KW5[+E+21R/LG $A?Y0-O '7G@"LG5M5T^T^'WC
M?03*J:B-1NG%JD3 B,S JV,<+@C!Z<BO:DABC9F2-%9SEBJ@%C[T&&(LS&-"
M6QN.T<XZ9H \NT.^TJY^*FGS-/:MM\,Q)&SD9$HD)(&>C;<GUQ[5S6E:D;'3
M+;4&GW:-8^*KB6\6,;]B,/W;X ^X#D_4@\U[S@9SCFD*@@@@$'@@T >1WVKV
M?B#QYK8\/W:R3WOAEH;:6)&Q)*'?H<8Z8&?;KD4_POJ?@_7;;0X/(U&76M.,
M;&TGN;G%FR8#R'+;%4 9QT/ QSBO6$C2, (BJ  .!C@=J!&BNSJBAVQN8#D_
M6@#SGX<W>C7=[XIFC^R2S1ZS<7*2* SF,\*Z]3C!8 CU([UW.BZS9Z_I,.IV
M#.UM-NV%T*'@E3P>>H-7Z* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .=U'QC9Z9KT.BRV.H
MR7DZLT B@RLH498J<\X[U;T_Q!!?ZF^GM9WMK<K#YP6YBV;TS@E3DYP2,^F1
MZUS/BQKE/B?X+:TBBEF\J^VI+*8U/[M<Y8*Q'Y5N6D>M7T^J+J BT^8%8[&>
MV*RE$*J6VLZ#.67D%>WT- '0T5YKX<US7]4U9O#&H:JUKJNESNUY<H(,W<).
M4V)L('!&<8VXYR3Q>AU'7/%T>ORZ)J@T^?3-0>QM8RJF)VCVEFERI8@[B,#&
M,=^M '>45Y]?:WKNI^(=2T>Q-R6L+2'>=.> $7$B[MY\Y@2@XP ,'G)[50GU
M'QN)O"-G?:BFG7]_)/;W<<<$<JY1&(DXSSC!QT!'(QQ0!ZA3(I8YX4FA=9(I
M%#(ZG(8'D$'TKQ_6[S7;?3?&GAK4=;N[K[!8B]MKM%2-WC92#%)A>F3VY..H
M'%>C>#(&M_!NCAKB6;=90L#*0=N8UX& .* -VBO)/%7B;7-'T_6]5BU6>XEL
MM241K9HK6L-OO5?+E9E ,AW'(!8@D=!6GXLUW4M-UN]CO[S4=*TR6",:=J-O
M&KV\4I!W>=\I(RV!SQ@<8ZT >B3R-% \B0O,RC(CC*AF]AN('YD5S>B^-8_$
M.GM?:9HFJ3P+(T3'=;@AEZ@@RY__ %UTD#^9!&^Y7W*#N0Y4\=0?2O)?AW)K
MW_"NM6&@PV/GK=701G=O,,O4<$;<\J!SCIGO0!ZEI6I1:OI=OJ$$<L<<Z;@D
MH =?4, 3@@U<K@/%U_JZ>*O">GZ7J\EI%>S3170CC1P&1 W.1][YCP3C@'!Q
MSEVD6O7FO>+?#0\3:@L&F)%/;3Y43%I(RP5GQ]T'L /RXH ]3JGJU^=+TFZO
MEMI;G[/&9#%$5#,!R<;B!TKS*75_$.K:!X#O(M>N+2XU.98;DQ1)L8[7)?&.
MO'3.WOCBKF-5T[7/%'A>^U&[U+39]$>]MYKA@9(@=R,A8 =3DC_=H [[1-43
M6]"L=4CC:)+N!)E1CDJ&&<'\ZOUY;I.K7 T_X=>'8YY;:WU&P\VXDC8HSB.$
M$1JPY&3R2.<#KS5O;JLWBOQ!X-BU:\2%[%;ZPNS.QEMF)V[2W5EW<X)/% 'H
M]%>;>#]5O/$&EZ+I5S=WD>IZ?<2G53Y[A\Q';M8]]Y=#Z85O2J\,GB+QC9:O
M<Z?>16E[:ZC+#;RG4I8Q:B-\!7A5"K9 .=Q.=WL* /4:1B0I*KN(' SUKS1K
MO6?%NK:YIEO<0+<:?!#'!+!JDMNJ2/&'\X+&A\P;B,;CC"XQR<]SX>34(] L
MXM5NX+N_C3RYYX#E'9203T'/'/'7- %+PCXF;Q387MRUD;1K6]DM#&9=^2F,
MG.!W/Z5T%>&6=C=+X#\6ZS::OJ%G<Z?K%W- EO-LCW*RD[@/O9'')('IUSV'
MB"XN+S6[^*"[O;N6+3$86EG<-;K9N0Q\V1PP&2,8&&/'3'- 'H=%>6/J'B"[
M\(^$]7\B]U>V^QEM1MK.Y:*XD+*H60;""V,'CU/XCMO!U_:ZCX6L[BSO)[N(
M[AON"?-4[C\KY).Y>A^E %GQ%JTFA>'K[58[7[2;2%IFB\S9E5!)YP>P]*J0
M:YJ5W'X?GM='\VUU*$2W,WV@#[("@8<8^?.2.W2N(NYV\5> O&>KWMS<B6W:
M\@A@BN'1(4B0A5*J0&SU.X'.[T J5Y[NVO/A@(+VZC@N8%CF@24B-P(%(RHZ
M]>_I0!ZC17EVMW-SI6OWD^N)>_V=/>(UKK=C<.5M%#*/)E0-\JY&#V)/(ST=
MH_G>/4\4B75;BSU.SU%[>S>.0C[$B\*P52,EOF!/?D=* .LN/$L\'CZS\-FS
MC\JXM'N1<>:2WRG&W;CCGODUT=><O)YGQ=\.2"X%UNT.0B=1@2\_>&/7K^-9
M-BT_B#X5W_BV6\N8M>@^U723),RFW,;,1$!G 7:H!7'.<GGF@#URBO*=:OM5
MO(;/7K[3IK[2Y-*B>XMK.;9<Z9*06,P3@DX/!ZC;V'5+&[7Q'K2>'5N+;4-/
MM]'MFM?M,TD)NMR_/, O);A>OW><=30!ZO7.>'_$=UJWB#7]*N[&.V?2I(D!
MCF,@D$BE@<X&.,<8KCK1KX:UX<\(ZUK::C 1=/<2(Q_TEH\;(G;J=N22#UP
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M6G$.O-=W,CPRC#S[F!5UXY&,<^@]*]:\+3QW'A72I(F++]DB7.".0H!Z^XH
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MRMN[?N&W'KGTI4D23=L=6VG:VTYP?0T 87A+1I=%TEX9%:!993*EF9C,+8$
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MY:3=@G<2<888P/?/9)XHT*02%-6LR(H$N9/WH^6)@"K'T!R,?4>M %#5M/\
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MM9<[)(SP<'!^A]JB_MW3O[8ETG[0?M\4)N&A,3Y\L8&X'&",D#C- &@ %
M '  J%+.UBN'N([:%)W&'E6,!F^IZGJ:S;7Q5HM[IT]_;7OF6\$_V:0B-PPE
MX^3:1N+?,. .]9.N>*="O?#6I'_A()]*6%TAFN4C=)K=R00-K+G) QTZ$T =
M5+;03LK2PQR%?NEU!Q]*=+%',A26-9$/56&16+<^*M#T>Z@TR^U55NS;^:!*
M#N=0/O<#&3CH.2>@J2P\5Z)J6A3:U;7Z'3X2RRRNK)Y97J"I (/(XQW% &F;
M2V965K>(JP (*#! Z?E338V9"@VL&$^Z/+'R_2LRV\6:/=ZL-*2:=;\KO^SR
M6LJ,%[,<J,#W-:5_?VNEV,U[?3I!;0KNDD?H!_GM0!(]M!(Y>2&-V*[2S*"<
M>GTJ6L6U\5Z/=W5Q:+<217-O#]HDAN('A<1?WP' )'N*JZ;X\\-ZOJ%K8V.H
M^=<71D$*"%QN*9W DK@<*3SUQ0!T1C0R"0HI<# ;'('UKG[CP]J=WXH^WW&O
MRMI"%)(]+6!0HD3&"9.I&X;L>N.PK7U'4K72K47%W)L1G6- %+,[L<!54<L2
M>PK@-&UY[SXA>*8I;W5$L8;"-O(D#A[=F^]M3'!Y&" >QYH ]*HP,YQSZUR_
MA_6M*MO"&ESVE_?ZE;W#-#:RW.9+BY8,W7(!/W6ZXP!SBKR>*M*?3)+\R3)'
M'<?93&\#K(9L@>6$(R6R1T% &U17&>(->L]9\(>)8["]N[74-+M97EC1VAFA
M<1LRYQV..QP:O:9K]O8^%O#[WLTL]Y>VL*Q1HI>6=_+!8@=?<D\#N: .EHK!
MA\8Z+-IFH7QN'BCTYS'>1R1,)(6_NE<9)/;&<]JJ:EXDTJ\TK6+6].J6 M[9
M6N2D+K+&DFX*R[03_"W(SC'/>@#J:*Y!?&GAWP_H^@03WEV8KVUB^R2S0N[2
M(4&TNP&-Q&,CKD]*TM-\7Z/J=OJ4R2RP?V9S>)<Q-&\(V[@2",X(!/X4 ;M%
M<Z/&NDB]TZTD6[CEU*/S+(-;L?/7KD;<XP,$AL$ UL:CJ%KI.G7&H7TPAM;=
M#)+(03M ^G)H M45S]EXPT^\O?L3P7EM<M;&[ABFAR9X1_$FTG/^[PWM6=!\
M3/#]S9VE[$M\UG<3_9S<_9F\N%]VT!SVR?KP1G% '8T5BVOB:RN_$=YH,<5P
M+ZS022AT 7:>A!SR#[?CBKVF:C'JMD+J&*6.,LRKYH )VD@D8)XR#]?I0!<H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@#A/$VHZFFOWUM;ZG-Y4>G&2&TTX*9HI!DF24N-JKC
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MWB9=F^\1\G&>^/3M0!CWNK:AK7B;3= !1HY=%2_EC^VO:&5V;;PT:EN "<#
M^;GH*Q];3Q-H^D^&K._\0RM=GQ%!9M+:7!8F!OF42DJ-S@8ZC!&"0<UV&I?#
M[1]5ATW[3-?"[TY0EM>Q3>7.JCH-R@ C\/YFBX^'^E3V&G68N;^*.PN1>1,D
MP+-.#D2.S*2S<GKQ[4 <G>6LMGJOC30)-3U*ZLSHXU"/SKIRT<F'SA@1P2 2
MO0],8KJOAE:QVWP\T5D:4F6U1V\R5G )'8$G:/88%:(\*V!UB]U.:2YGGO8?
ML\ZR2?(T6/N;0 ,#)YZ\GFI?#OANR\,:<+&P>Y>$'Y?M$QD*KV49Z*,G@>M
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M6LFHPQPWK1*9XXFW*CXY /<9KRCPMI=G_P *[\:7"P^7/%=Z@J2QL490J@J
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M-\;Q9E*KT4,XP!G))P3V!KE](\01>%/$/C8FRU*]MX;M)72W!E\E!$"SL7(
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M@@?S&FSC8$QN)_#IFLGQ)X@\/:MX1O)+_4=4TVSANDMYY((I(IHY1M8*1M)
M^9>V.: .D\0:9+K7A^^TN&Y2V-Y"\#2M%YFU6!5L#<.<$XYIOAS2IM#\/V6E
M3727/V2)84E2(QY10 ,C<W.!US^%5-3\9Z-I&K'2KJ6?[=Y)F6&.W=C(!V3
M^8^PSWI;'QAHVH: =9MYY#;+)Y+(8F\T2Y \O9C._) P/6@#>HKGH?&NC/#J
M+7$LMG+IR[[JWNHRDD:GH=O\0.1C&<DXIT?B_3=M]]JCN[)K*!;B=+J$H1&V
M0".QR01@=^* $T3PN=*U.YU"YUC4=3GD+B+[9(&6!&8,50  #)"_]\C&*Z"L
MG3?$%OJ5_+8_9;RVN8XA,T=S#L^0G (.2#R#T]*TIYX;6WDGN)4BAC4L\CL
MJ@=22>@H DHKGK7QGIEQ?65I)'=VIOP39R7,.Q)\#/RGU(.0#@FN.GO%\6?$
M+5]"U;3;^33TM(4ABV!6MG9LF7.[Y3TPPYP/KD ]2HJO;Q)I^GQ0M/(Z6\04
MS3OEB%'WF/<\9)K"L_&MG?7.GQ0Z?J'EZB)&LYVC01S!%9B1\V1D+QN SD=N
M: .EHKEU\>Z0_A@^(5CNSIZS>0[>4-R-O"<C/3<0*MZKXJL],N+N!;:[O9;.
M#[1=+:JI\B/!(+%F49(!(4$DCG% &[17F6LZQ8_\+!\)Z[:&XN;>[L+J14@W
M2-+A!M"IG&[DCM[UVOAWQ'9^);.:>UBN;>2"9H)[>Z0)+$X[, 3CJ#UH V**
MQ?%'B>R\):.^J:A%=26Z$!OL\6\C)P,] .2!R1UK/@\?:9+KITB6RU2VN'C>
M6V:>U*K=*@R?*Y);@9 P,T =517%Z9\3=%U1MT=IJD-LJS&2ZGM=L,9B^\&8
M$X.,$#W ZG%:%OXRMI-5ATNXTZ_M+VYMVN+6*<1C[0%&2JD.0' YVMC% '24
MF]=^S<-V,[<\X]:YG3?'%CJ?AW4M:CLKV*#3WDCGBF$:R!D^\,;\ CW(JO'J
M&BW?Q%M$FTR_M]>&FETDEP$6 L,J<.03N)['H>: .OHKD[GQ]I]O93:H+2[D
MT:"X-O+J"!2@8$*6"YW% QQN Z^HYK27Q+;2>)I- C@G:[6R^W(^4\N2/<%&
M"&SG)[B@#:HKD[?Q_IUQI<5U]FN(YY=0.F1VTA0,UP.",[L;1SSGMTZ"M?1-
M9;6!?+)8W%E-9W/V>2.8J26V*^05)!!#C!H U:*** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \VD
ME,?[04(O<['T4I9%NF[?EL>^ _O6E\0-4U73)]!CLY+$P:AJEO9E+FU,IC=F
MRL@.X<J5! QU[UO>(/#&F^)(H!>I(EQ;/YEM=0.4E@?U5A]!P<@X'%4Y/!ZW
MUW83ZOK%_J(L)TN;>*41(HE7.USL123SZXH Y2"TUO5_B'X@T=_%.IP1645K
M/&82JC<PW,-N/N]1CZ9)Q3+2^U/Q-\/M6\4PZM=VNJ0RW$MLL<Q$=ND1.(VC
M'RME1R6!)W?2NQT_PDFG^*[_ ,0#5+V6XO@JRQ.(_+*J,*.$!X^N?7-5O^$!
MT^.34([:]O[;3M0<R76GPR*(9&/WB/EW+G'.TB@#%TK6-1U'QUX?EEDG@MM3
MT#[5-:B5]@ERN2%)P, CI6%?:EK'_"'>+)(-4U!9++Q&UK!()R3'%OB4*2<D
MJ-QXR.O6O0-8\'6.K7>G745U>Z=<6"&*&2QE\L^60 4/!&.!^5<IXO\ #%EX
M>\$ZQ:Z>NJW,VJ7R7)CC\R8AO-1FQM'&%7J>3@<T 698M2\+?$708(M7U#4+
M365FCN8;J7?MD1=WF*,84>H& !7>7UP;33[FY5=YAB:0+ZX!.*R-)\/6T=Y%
MJ\][>ZE<K$4MI;X*&@1N2%4*N">,DC)QBM\@$8/(H \FNKW4$^$MMXUMM5N?
M[814NY':X8Q29DP\1CSL"\D 8R,=>M3M9WWB#XG:EITNM:O96G]EPW0@@N2G
MER%AT] .>.]=3!X TB" V2RWC:29_/&F-*#;A]V[IC=MW#=MW;<]JM0>$[6W
M\6S^)%OKXWD\?E/&77RB@Z+C;G //7- &^1D8KQ^.<^%?#_Q"U;2UE6ZM-2>
M.##LX3<L0W%22"06SD@]*]@KGHO!>DQZIJEZWVF1=3S]IM9)V,#$KM9MG3)'
M<Y]L4 <QKJS>'%\*:OI%]>3R7=[!9W(EN))5NHY5)+%68@$8+#&,9KT@\C%<
M_IW@_3M.>UQ+>7,5D<V<%S,7CMN"!L'? . 6R0.A%= >10!Y1IVFEK[Q=J3Z
MCJ,DFAZ@]Q9Q&\=@"L .&R26!X'.>%P.IRN@Z;J>KV7ASQ3#J]A;N6A>\NE>
M0R76X@/"_.TY;  Q\I  P*[[2?#.GZ-<WL]J;EGO7+W FN'D5V/!;#$C. !]
M*HZ;\/\ PWI&H_;;*P,3"0RK%YSF%'_O+&3M!';CCM0!RWAK0-+G^)_CF)[-
M%6$V1B,9*-&6B8L592"I)[@UB>%+"PA^&UWXGO\ 6+^QNXEN;;[:LS.8T:7
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MTS4]&\7R^$9Y);C3DE75UG(X*D'*$=OWP#8'H:]1*AL9 .#GFC:-V[ SC&:
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M)YRC(5)Q@@]<9]Z /:J*\POY1X)\=:ANB>YM]=M#_9ZR$L$N%/S0*#T5RRG
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M.)-C<H<9Y';BFV&O:3JEQ);V.H6]Q-&NYDC<$[<XW8[CW'%>>^,KC1-;\/\
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M:F :S!.S(Z[?+ (+G'\(P!GIQ0!T"_$GPFUK/<#5.('V21^1)Y@."?N;=V,
M\XQ6I)XFTA-/L+U;HS0WY M/)C:1IB06^55!/0$GCC'-<;:ZCI\?Q9\42/<P
M*#ID2>:9 %RN=ZY]1QGTQ7,^'%T>]^&WA2SO-6N-+U"VEN&M[V!@/LLN]B!)
MGHK*PZXSZ\T >OZ1K=AKMM+<:?*TD<4S02;HV0JZXW*0P!R,U'?^(=.TZ[6T
MEDDDNFC:7R+>%YG" X+$(#@9XY[UA?#N_P!2O]*U ZG%;O)%>O&E];Q>6E\
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MYO?^/CR!C'F?CG&><?@* .JHHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\WR))I'"OZJ2Q*GZ$5T=<UKOBB6RUZP\/:7;1W.K7J&;]Z^V."('!=\<GH<
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M&U=W$$S02%HV7#KU R!G'3([YJMJ7B+3=*NDM;F65KEXFF$,$#S.(UZL0@)
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M 2<\#&2+WA3Q3:^*K"XG@3R9[6X>VN8=X?9(O7##AE/9AUH WJ*** "BBB@
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MIOG2W$UU;M"1O3:(QN ).>3@8P.O:MOQC')/X,UFW@@EGFGLIH8HHD+,SLA
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M '<7^MZ9I<BQWU]!!(REPCMSM'5L>@]>E*^LZ9'I\6H-?V_V2;'E3"0%9,]
MI'4GT%<'XFU:Q@\=W=JTG]E7C:9M%Z4,DEXA.?*B4Y7@]3M+'H*XWP[K<6D:
M/X U:YCEDTK3?M<%[*B,1;2R$A2V!Z']3[4 >UVNOZ3>:;+J%OJ-L]I$2LLO
MF ",CJ&S]TC(X/-0VWBC1;N[:TAOT-TL9E,#*RR!!CYMI ..1SCFO/M?U32%
MT.'7-"TN1]&77(+S4)DA91<##%Y-K#)56\LYZ$_0FKEEK.GZ[\:;"]TR?S[9
MM"<+*$(5OWO8D#/I]<CJ#0!VW_"3Z)_9\.H#4[<V<\GEQW ;,;-G&-W3.>/K
M52*\LO\ A-;M1XB+R1V69-+++L@ 89E/H>0.?4_AY);:I;6GP@;0GED&I6>H
MJ;NV1"6B7[4#E^.G3'J2*[N/4+23XT_:A<1B ^'1'O8[1N\\MM.>AV\XZXH
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M7Q'KX$D6N7%O;?:GRPB4J!T& ,GKP.M=JGB?1Y-:31TO0VH.GF+"(V^9,9W
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M>M ')CX<>%TTU;!+"184F$T96YD#Q,,XV-NRHY/ ..34H^'OA=6O6732OVU
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M %2^T+2M2E@EO+"":2W!$3LGS(",$ ]<$=NE+<Z#H]Y:P6MSI5E-;VYS#%)
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MUM[*VCMK6"*"",82*) JJ/0 <"LJ;Q?X<@\GS-;L%\Z3RHSYZD,W0@<^];5
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MUXL0RMD@#.<C.."P .1@F@#I**YO4/&NG6 OW%O>7,&GR"*[F@12L+G!VG+
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M[LFOK9+9_-ME8J9%(P1D<@<\D=!7F-GJ^G1>._ ]RVL6\]O%83(3" (+?]T
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M.G3;BN]Y%WPH#_=1BQ/OBO8J* /-(C>ZA\*=;U76;9QJ6HV+0F!@=V40QJH
M&>7#/C'\>/>JM_<)_9'PW8+(1:SP&X B8F$+%M)<8RN#QS7JM% '":9+$/C)
MK+JC!9M.AC64*Q21U)+ -C&0,< ]O7-;WC.6./P9K"R*SF6SEC1%0N69D(
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M S@/(!U('4XH XN6SUO1O'FNWMEHLE_;:S;VZQSK.B) \:LI#@G=C!SD GL
M>W,_9M9T/PAX L[[2RE_::PB?9Q,A+C;(>#G .#T)ZU['6-K7A?3M?N+2:_-
MR6LY5F@$<[($D'1L ]1ZT 9FFZ/>7?C^Z\47=J]G&-/73[>"1U9V&\NSMM)
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M,L"3*TD8_P!I0<CKWJTS*B%W8*JC)). !7E-UI%I;:K\/+_1H8(M2FD4SM"
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MOA^'2WU*75K6.TCD\EY&?&V3^X1U#?[)&:6S\5Z%J&JOIEIJ<$UZB%S$A))
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MOF52"<=/UH V**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH CG@ANH'AN(HY8G&&210RL/0@]:SK
M?PQH5I*DD&D62/&=T9$*_NS_ + _A_#%7KJ\M;& SWES#;P@X,DSA%'XFLW5
M_%&DZ/X=FUR:\@DLT0M&T<@(F;!PJ$<$G&* +?\ 8NE?VD-2_LRS^WC_ )>O
M(7S>F/OXS^M1WGA[1M0O5O+W2K*XN57:)98%9L>F2.?Z5S-_XKNQXK\*_8[V
MS?0M42X,[*%;:T<1?_69QC/L,;3D\\==9ZG8:C:FZLKVVN;=209895= 1UY!
MQ0 E_I>GZK L&HV-K>0JVX1W$*R*#ZX8$9KG_%OA<:AX7U/3]$TZPAN[^/RW
ME($7'')*J2>@&/\ "MRVUS2+Q)7M=4LITA ,C17",$!Z$X/%-A\0:-<&00ZK
M8R>7%YS[;A3MC_OGG[OOTH K^'="M-'TRU5=-LK:]6!(YWMXU!<@8)W  G)Y
MY]:V:IV&K:?JGF?8;V"X,1 D6*0,4)Z;AU'0]:N4 58=-L+>ZGNH;*VCN+C_
M %\R1*'E_P!X@9/XTVSTC3=.=WL=.M+5WSN:"%4+9.><#FN:\<ZQJNCWGA\:
M?>"*/4=3AL95:)6PKYRP)[\#VK5\K5;35;+=K$=Q;'>US#+$B-L"G#J1@\-M
M!_WJ -RJ,^C:5<W,ES/IEG+/(AC>62!69D(P5)(R1[53;Q?X<58F.NZ=MEE,
M,9^TKAW&,@'/.,C\ZLP:_H]SJ4NFP:I:27L0)>!9E+KCKQGMW]* 'S:-I=QY
M?G:;9R^6H1-\"MM4= ,C@5//96EU"L-Q:PS1+]U)(PRCZ UDOXU\+QH'?Q!I
MJJ93"&-RN"XQD9SVR/S%96I:QJ5O\4="TN*])TV]M9I7@"+@LB\'=C/?U[4
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MW8VWAIO)L;_[)=S&[7]V,'+ 8^;&.GN/6D'C^>&[T5+[2X[4:K<_9UMWN/\
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MTYYP6^0X/& >E4G^(%]:7VCB^L+>!=3OQ9?8&D_TJVW,0DDG)&" #C ZC!-
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MOGECC"M*WJQ')_\ KFO-M7\4:UK1\#7NG36]I::K<*Q@DB9B)%!R&8,-R9Z
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M<>WTST+:)XEUKP;JG@S5()PR'R['5W9-LR(P9#( Q8'Y0,X->F44 <9X8O\
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MN_%8.DW.E1^$?A_'JNFSW#.;<6DZD".*8QG&[Y@3P#Q@U-8VNN^&]:\26/\
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M\ \9Z@=,]SGDXS0!T=%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 5[VPL]2MFMKZUAN8&Y,4T8=
M3^!IHTRP%G'9_8;;[-%CRX?*78F/08P*;J&JZ?I,:R:A>P6J.<*9I N<<GKZ
M#D^@YK$U/Q]X=TV[TNW;5;&3[>YVR"Y78D>UCYA;IC*[1SR3[4 ='#!#;1"*
M")(HQT2-0H'X"I*SKW7](TUD6]U.TMRZAQYLRK\I. W/1<\9Z9J:\U.QT^T6
MZO+N&&!B%61W #$] /4GL!UH G,$)A,)BC\ILY3:-ISR>*CN;"SO"INK2"<K
MPIEC#8^F:Y'QGKLW_"-V6K:!K*"'[=!%(UOLD656D52I)!QCGI@]C6YJFL6S
M+?Z9::B(=4BMVEQ&H=XAC(8@@C'UXH T9=.L9YA-+9V\DHQAWB4L,=.<5,(8
MA,9A$@E9=I?:-Q'IGTKB/ /C.SO_  QH<&K:U;R:W>1L3')(HD<[VQP/8<5U
M6H:[I6E2"._OX+>0H9-KO@A!P6([*/4\4 6A:6RP/ MO$(7SNC"#:V>N1[TL
M=M!#"L,4,:1+T14 4?A7%_$+5;RTTS0;_2=5EBAN-3MX6\@H4GC<YSNP3T'&
M" 03UXKH]:UC3]/A>WN=46QN)(6=&!4NBCJX# C )')&* -)HE"DI%&7 ^4$
M8&?KCBLW1]%&G3WM_.ZRZE?NKW,JC"X481%'95' [GD]ZY[X=^(7N?AGI6K:
MYJ&^>=I0TTI^9V\YPH '4X   ]*W7\7^'H]+?4I-7M8[1)#$[R/M*R#JA4\A
MO]G&?:@#:IOEH!C8N,YZ=ZQD\7Z!*LIAU.&8Q3_9F2$&1S+@G:%4$L< G@'H
M?2K^F:K8ZQ:FYT^X6>$.8RZ@C##J.?2@"V44L&*@L.AQS05### $>AI:YT>.
M_"S7ZV2:W:/<O.MLJ(Q;=(W 4$#!_D,C/44 =%2!0 , #'I6/_PE6B?;(;4W
MP#S3&WB<QN(I)?[BR8V%N", YR,=:IWWC_POIKW4=SJJ+):LJSQK&[,F>A(
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MMJ&M+M0@B.1G#;F!! [8Y[9K;M-3^UZG?6:VDR+9LJ-.Q78[%0V%P<Y 8$Y
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M2=3MKPPX\P0ON*YSC/Y&@#4HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MAJ=HJ>6'5%0J_8@A@.?3&>Q=X=\=6>G:"UQX@^SVYFU66TCN[2(^3>,/^6P
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M4^+/#NK2Z;<Z?;Z.)9I1-M$CRLJXC7!.0"#D]#VSFNY!# $$$'D$=Z6@#AO
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MH%O<Q_%?Q5=26=W';7,%LL,[V[K'(43#88C'!/KSVH Z[5-4L]&T^2]OIA%
MF!G&2Q)P% [DD@ 5F67B_3;G4+JPN%GT^[MH!<R17JB,^5W<')&!CGGBJ'Q&
MTW4K[P];7.DP?:;S3;Z&_2W[R^622H]^?TK+O[N_^('AS5+*ST&^TIYK)HVN
M-1A\IF?.1$O.2N<Y.,>W- &[;^-]-FN[&*6WOK:#4,"SN[B';#.3T .<@D<@
M,!D=*DU'QA9:?/=HMI?7D=E_Q^3VL0=+?C.&.020,$A02 ><5RE[:WOBSPEX
M>T1].O+._M[FW:[,]JZ) (@=[*Y&ULXP-I.=WIFI]&COO#$OBG2K_3;Z\BO+
MJ:]LYX+=I5N!*.8V(&%8$8.X@<YZ4 ;^H>/-&T^;34Q=W*ZE&TEK+;0,Z2 *
M6P#W8XP%&3DBDT[QYHU_IVI7;_:;-]-?9=6UU"5FC)^Z-@SG=T&,Y/%<7'IU
MQX-7X;6-['+<3VLMT)4MD,C O&Q. .6"[NW. <9I_B'PIJ/B&X\3:[864BO)
M]D%I;7,7E_:_)(9MR-@X. H# 9QZ4 =FGC6Q&HS:==V6H6=]'!]I2WEA#/-'
MW*!"V<=QU&#QP:SH?BEH$UG)?>1J2V26PN/M36I\MLN$V @\ON(&/UX-9_A^
M6UG:2_B\!3:+);0,)IY;+]ZQ88V0A06;D\G'0=.>*UHVMV_P4L[>QT:\&I6R
M1PS6LEOB4!7&YD5QACCD'!Y]Q0!U!\:1!]2MFTG48M0L;871M)1&&DC/1E8.
M5QD$'G(P>*I>'/&[77@RQUC5K6>.:Z<)$B!#Y[,QPL8![ ?Q8X!)]:YRSM-2
MG\=75Q:^']7M[&_T%K59;TY;S-Y.Z5BQ(.#C!);IQBL^'1-;N/AYX='_  CM
MQ)<^'KG=/I]XB@7B_,&V+SG (P2.YQF@#TO1/%5EK>HW^FI#/;7]B5\ZWN N
M[:WW6!5F!!]0>XI/$WBB#PO;VUQ=6-Y<03S+!YEN$*QLQPN_<RX!/?I5#P@R
MWC27L/A-?#\.S85FMTBFE;(/1>BC'?J3T&.=?Q+HD/B/PY?:3. 5N8BJD_PO
MU5OP8 _A0!6_X2JV'C)?#$EG=QW;VYN4F;9Y3H#C(.[=G/&,?I6#JWB#0-1O
M_#TNJZ-J/G'53!8.=NQ)U;;O)1]I&0?4_*3C%8-WX:\4S>&-)\1O%N\86EQ#
MA#U$./*,9([')D;TW-Z5K>+-#GLX?!EIIFGW-S!I>H0S3>0A;;&@P6/J23GU
M/- &A9^(;K6_&VN^';K2I/L%I#"C O&<%PS%W^;.&&T #.,<XS7+_#SQE;Z#
M\//#L%UINH&S>1H)+\1 0Q.\S[<DD$CD9(! Z9SQ6]:17^C?$[7[]M*O;FRU
M6WMGCN((P5C\M"K!LG.>F !GFN5;2-9_X4?8>'O[#U!M2BN!O@\KL)O,SG/3
M!_.@#V=B0I(4L0.@[UY7K.L77B;P'XV75-,:-+*6=(27C=(C'&F%RK9+9);.
M,<XSQ7J4,GG0QR['3>H;:XPPR.A'8UYC=6.O?V)XZT?^P+EVOY[BXMYXY$*2
M"14557)!)X)/''3KB@#3\+>,HX;?PUHESI5_;)=V4<=K>2HHCF=(E) &<@8Z
M$@9[>M6M3^)6DZ8+J>2)WLK2Y^S3S)+'NW9VDJF[<RAC@GV. <5C7>F:M<0_
M#PIH]Y_Q+7C-V"$!BQ&$Y^;U!/T]^*33;?Q/X;N;[0!X9AU:VN+F:6TU$R(L
M2K(2Q$H()X).?7H,\4 >F(Z2QK)&P9& 96!R"#WKS[P<8_'&JZKXBU1$N+>V
MO'L].MI 'CA5 ,R $??8GKU':O0(E9(45V#.J@,P&,GUQVK@M+TG5O 6L:F+
M'3Y]5T#4)S=+';,@FM)#]X;6(#*>,8.1CIWH EM)O#NB>-M2_LH2?;GM/W^E
MV]LX8LK$AUR @#9QG(4G!SSS+HOQ)M-8T]=3;2-1M-*^SS3O?3(OE)Y;$%20
M>IQQCOP,\U#I-IJD_CK5O%,FD7=M:2::EM#;S&,3RN#N.%#$#T^8BL_PQX2U
M*Y^#DWA'5+.33[SRY4#2,K*6:1G4@HQXR1GIWH Z$>-?)N-*.H:3<V=CJI5+
M6Z=U8*[#*K( ?D+#IR>>*G3Q8S6_B!FTV19M%;$T7FJ?,&P294_[ISS7/S:7
MKGBC1="T75-*GL)+*XAFN[MI(FC?RA_RS"L22QQU P,^F":GI_B.UU7Q=;V.
MB"\M]:B#07(N418SY C*L#SGY<C P<CD=0 :0^(43PZ')%HNHS?VS;O-;B((
MW*KG8>>#R.3@#UJ_X7\6IXBEO[.>PGT[4[!PMS9SD$J&&58$=01WKB;:/5O#
M[?#JVN=):2]MHKJ%[6.=-Q'EJ"020I..<9_&NO\ #VC77_"5:UXEO+=[1K](
MH(;:1U9U2,8+-M) )/8$X ]Z -+6]>&DW&GVD=J]S>:A*8;= =J @;B7;!V@
M >A/M7/3?$F&#PUJVJOI%RTNDW1M+N".5&"OD#<'R,KDCD#/M5KQM#K\MUI#
M:98MJ.F+(_\ :%C'.L+3 K\F68C*@Y)7OT/%<)-X6\30^&/%^CP^%PB:I>+/
M;+;7,6Q!N4[0"5X 4C/'.,#'( /0;'QD9_$\6BWNDW-@;JU-U:2S.I\U1]X,
MH)V$=<$_E7+^.-=;7/ KZG!I"/IANX1!>RR 2*!.G[P(5X1L$ @YY'&*O:GH
M^K:GXVT;4%T:ZAL8--DM9R9X@T9E!''SY.WO^F:PKG0/&;?#BZ\$MH<-P8#&
MD%^MVBI-&LRL,+US@<YQP#SG@@'L%<-;:Y#'J'C0Z3H<%MJFGB.2Y>>7;]I)
M1BK'8&X"C(]<G..M=M$TC0HTJ*DA +*K;@#Z9P,_E7"Z9H.KGQ1XUN+BP:WM
M=;AB2VE>6-MI2)D.X*Q(R6R/IVH 71O&5Y#X-\.W>IQ6K7FJ;(HI)+HQQL2A
M8M(Q3Y"<'"@-DX ]NJT?4+O4$NA>:>;*6WG,.WS-ZR#:K;U; RIW8Z=OPKB-
M-TS7%\!:7HFK^$8;V"W'D7%J;J-F9%4XD4D@ YQ@9SUY'%=!X&T6\T/2KFWF
M26"T>X,EE9S3>:]M$0/D+ D?>W' )QGK0 [Q-XLN/#^JZ780Z+/?OJ+.D)BE
M5?G5<XP>W3)[#)YQ5%_'I4&VDM;&RU2"!)KJTU#4%AV%LD(K '<V!GH ,KGK
M4GBBRUBZ\7>'+VQTI[FUTV:229Q/&F0Z%, ,<DC.?\\4]0TCQ/H7CB\U[P_:
MV^I6>J)&MY:33B%D>,;596(/&/KUZ4 ,_P"%G&X'AYM/T*YN1K0E6-3*J.CQ
MCYEP>,9Q\V1QD\]*<WQ&N;2PUU=0T(P:KHRB6>T%R"CQ,,JZOMY[<8K.\4G5
M;7QIX DN$BO=1\V^=HHV$:9,:G8I(Z < GKCG&:MZWX4UG6[7Q+?_9XXK[5;
M2.QMK1YA^ZC4Y+.PR"Q))P,X ')[ %Y/'MQ!9K<:KHXTU+J2&/3WN+I0D_F(
M6)8X_=A0.<YZ@=:A3XE6\<.O?:+:%Y=)1)/,M;CS8)U<@ A]O&"0&X..>M3Z
M[X<UC4O#6C/8O#:ZUH\J3PH[;XI&12A4GC 8'KC_ .M8B;QE>:///?6&FPW;
M*D<>GB;?&X+CS#(Q&!E<@ 9QSU/% !+XT;3M(U#5-3M;=K*WABEM[BQN/.CN
M3(2NU257!!"_@P-1V?C2YGUU-*.FQS//;O+!/:S,T>]03Y;ED&TX'!Y%<]-\
M-)M2AU>*UA&@65Y;IY=BDWF(MTL@;S@%^51A0N!U!)P,5TFAR>.)8P=:M=.A
M:U! 6"8DWK8P"3@A$YST)R!P!P0#%M/B=?7.@:1K[Z"D>EWUTMJ[_:\R*Q<I
ME5"\J,=R#[=ZN:=KVO-\2/$-A<+;2V=G;0R)#$6W!/F;*C'S.<X.<=!CI6-;
M^!?$EO\ #72O#0CL&N;.^%P\GVI@CJ)3(!]S/.<?AFMR3PWX@3QCJVKV;6<4
M>JV$<#.TS;[615(RH"_-SCG(_3! &0^/KN/5-#AU&QM[9-8D\I+0RG[5:DYV
M&12.C8 Q@8/<TWPUJVOW.H>+6O8[&<6EV8@C3-&BA8U(494_+@DDGJ>U92^"
MO%;6?AU3!HD5QI-ZMS,ZS2$W; <R.VW.X]^N22<CI70:;HGB/2-;\030KIUQ
M::C+]I0O(Z2>9L"[,8(49&<\],8YR "@OCBZL/AYHWB.'2+-+*9D2XB20HMJ
MC/M# !3E1QGI70ZCXG33KZ_$D:M8Z?8?;+F922PSNVH!T)(5CU';UJEX9\+W
M$'PZ3POKD4'%N]LY@E+AE;/S9*C!Y_3K4>B>"I(?A]/X>UB[-Q=7D31W-PIW
M<[0B$9'\*J@_"@".Q\8ZK<:OI2?V8+K3]2',MI%*?L?&1YCE=K9Z$C&.>#Q2
M>'_%^H:]JD2PG33!]JFANK,;EN[15#[6<$X.2J@\ #=WJ3PWI7C2R6UT[5]1
MTZ33;,J%N+=7%Q<(OW5;/"]!GKG!'?-5_P#A$]6U#6](U+4;?2X+ZPG6674K
M21O.N$ 8&,IL P<C)+'O@4 =?JW_ "![[_KWD_\ 037E?AOQ;KWAWP/X;U&Z
ML-/;PVRQ6KO'*YN(P24\PC&W&1T&37K5W!]JLY[?=M\V-DW8SC(QFN(L? ]_
M)X3TWPMJTEHVG64B.\L,CE[A4;<%*E1L&<9(8\# ]: &ZGXXU-GU&?1+3[5%
MIURUN;464\KW3)P^V1!M3D\9W=,G&:SM<N]:N_B3X*F@E@MA=VUU)##/ ^8@
M859EE7<,M]-N".:U;?PIXFT/7=3DT#5=/32M2G:X>"[A9FMY&QN9,<'UP2!4
M^H^&=9F\7>'M5@DM)8-&AEB!N+A_-N"\80EL(0IR,]3F@!MMKFJ:@FLR>'8-
M/2#2YY(9$DA;_2[A1NDVE6&P9( )#$GK5"Y^(.IWVG^%K_0[*T,&N3>1BZ9M
MT<@W!@<8X!4\\D@<"M*R\+ZSH&IZRVBSV4FGZK*;DQ73.K6TS??9=H.\'K@X
MZ#FHCX%N++3/#&FZ7/ MMH=R+DM/NW3M\VX<<+DNQ[]1Z<@%>3Q;KL+-I%TM
MO%K5K:_:+J2VL9[N)BS,(U14Y&0N22>.@SSCIO"FL7NN>';:^U'39M.NVW++
M;RHRX()&0&P<'J,UCZ_X6UL^)5\0^&=4M[2]EA%O=0W:%X94!RIXY##G_P"M
MSGI-(M;VTTY(]1O?MEX27EF";%))SA5[*. /ISS0!@>)=:UJPU0P6DEA8V:V
MC2K<W:&4SS9XB2-75N "2>:Q[7QUKFIZ3X2O["QL -9D>&9)G<%757R5P#A<
MH3W/;WK4U3POK,WC&?6-.U"SCANK(6<GVF$R/  2<Q $#G/.3U]:R=%\">(-
M)TOP[9-J&FR+HUR\Z?NW&\-O&TG/HY.?H,<9(!+'X]OM(?Q5:Z\EI-<Z*(6B
M>U!B2?SERBX8D@YP#U_2H]6CUR/XA>"CJES8S1O+<D"W@:,QOY#9&2S;A[\=
M/>IK[X>7.KZKXGGOKRV6WUN*%5$:,7MWB&(W&3@],GI4_P#PBGBB[U+0;W4=
M>L9)M)D<[H[,@RAD*DM\WWB#CC '7F@#N')5&*KN8#(7.,^U>>Z9XNUA=<T*
M#4KJQ<:H\D-S:118-E($9E42ABK'C!!YST Z5W6H6SWNFW5I'<26[SPO&LT9
MPT98$;A[C.:X.'P#X@%OX?CFU^R/]B2Y@5+'"LH4J&;YLEN1W [G- %30+?7
M;CXE^-XHM6M(YD6R5Y'L2ZD&)BNU?,&W&3U)S[=*K^%O%FJZ=\-M,U&\G%W<
MZG?-:VP%LQ9)'ED+.P#9DZ$@ #L,\Y'6:'X<U73?&6M:Y<7%D\6J^3YD4:N&
MC\I"JX)ZYSS6);_#.^'@]- N-=!-C<BYTNXA@VM!(&9@S98[OO$8X ]Z +5M
MXC\3J->CELW,-K:&ZLK^ZL7A5R!EHW3=R?0@CIS5OP-J7B;7+2TUC4Y=._LR
M[LE=(H582I+GDG/&TC/TX'."2Z'PWXDFTJ]35]>@O;Z6V>V@VVYBAC#C#,RJ
M?G8\=>F..IK5\(Z-<^'O"]CI%U-%,]HGEB2)2H8#IP>] '-_$H:M]I\-+8ZH
MEK!/J]O"8S"')?)97//(!4?+Q]:K3V^NR?%/4(=.OK.*Y.B0;KF: L!B1^B
M]VR>3P/6NE\8>&[GQ%:Z<;&\BM+S3[Z.\AEEB\Q<KD8(R#W]>U0V?AG5;;Q5
M/KLNLV\\DMBMF4:R*_=)8/D/_>)XP../>@#G=-^(=_J/ASPX%MF;5=4EGBD,
M$8;:L.=[HK$ D_+@$\9)YQ@])X2U+Q!>3ZE;ZWI\T,<,N;.ZDC5#-&<\,JD@
M,N.HX.17/0_"VXMO#VG6EOKWE:GI=S)<6-_%;%=GF'+HRER&!X_ =^<]?X?T
MO5+&&276M5_M*_EP#(L(BCC4=%51[DDD\G\!0!LT444 %%%% !1110 4444
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MB;2%.WGD_C6[\,H+BR^'^E65Y:W%M=6\962*>)D()8D=1SP1779!)&>E% '
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MB=YGQN8D%NHR0".?7BMCP)HFJ>'SJ,.I1R26FEE[32R%W/) 6\PGW)RB_P#
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M9&,]:Q+B22]^('@74[C3XK.YN[:]:2-6W.!Y2E0S%5)(!Z8X)-0ZCX!U2==
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M9C,2[%+?N^<CD@'CISUK"U#2-5\/>'? ND&XM'OK75XXXY &*,/+EZC@]\4
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MLUJ6+JY&[+[QSP,<<>] &+8:MXF\2Z0NOZ'=VR)]L:--.E1=CPK(4)=_O!R
M3P0!GH>M,U'Q!X@U6\UJ/0/M"/I<QMX8XH(G6>0(&(E+MD*2<#;CUR>@=8_#
MS4-)U&[ATSQ+/;:!=S--+8"!2ZEOO*DG\(/L,@>_-6;GP-J,'B6^U?0?$<FE
MIJ&#=V_V59E9@,;UR1M/X'G)YZ4 =1I%Q>W>CVD^HVGV.]DB!G@W!O+?N 03
MQ7"/XCUJQN_%FE:AJVR_LHEN=,D^SH1+$QPN5 ^9MY5#TY(Q7H%C9I86,%I&
MTCI$@4/(VYF]V/<GJ:Q]2\)6>I^+=+\0RR,)K"-X_+ ^67)RN[_=.2/?![4
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M.GC4HY+.1B&BRP*_-@E@5QGC/' S0!TU]K&G:;/;07EY%#-=2+%!&Q^:1V.
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MI7$^,)$B\<>!V?&#>7"\^IA('ZD4 =+JNMV6CFVCN6=I[J3R[>")"\DK8R<
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MA!4C'N/Z58H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH \_\ B=*MI=>$KZ8,MK;:U$\T@4L$
M&#R<55TO4+ _%WQ#?2NJP-IL*J\J%<X&77Y@.0!R.V.>E>DE0PPP!&<\BEH
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MQX %:6A1ZDWB3PG<3Z+J%O!::.UI,\L7^KD.T ''KLS[9&<<X]+H!!S@].M
M'CB>']??1];FM-,G6\B\4G6K:"9=GVB+(P 3P#WP?2MFWNM4U;XF:7K_ /PC
M6KVMBFG26[FXB1&5BV<D;LX_4]A7I5(S*H!9@,D 9/>@#QVXTK6)OAOXNTE=
M&OQ>7^JR3VR&+_6(\BL#UXX4YS[>M;^I07]UXW\#:A%I=\;>PBG6Z8PX\HR1
M!%S]#UQG%>A[UWA-PWD9VYYQZTI (P1D4 >)VB74MAJ.FW'AO6[OP]+J,MPM
MO:I'(C!9,C;(6#%25S@#G/!KV/3[Z#4].MK^V+&"YB66,L,':PR,CMUKFK'X
M>Z?ILNVTU76XK#.1IZW["!><X&/F ]MU=7%%'!$D42*D:*%55& H'0"@#B=7
MLM3L/BI9:_;Z9/?6<NE&P8P%<Q/YN_<V3]W![9/'2N;M=-U<>"/'5B=$U 7.
MJ:C<W%JAC WI*!M/7C[IS^%>NTUI$5U1G4.^=JD\MCKB@#R<:)JNCW^FZK+X
M336[2ZTRVM;JU=(S/:21+C(#9!!R>A^N,"O1]!MI+;2U$MC;6!=BXM+=0%A!
M_A)7@MW)'&3@9QDZ=% '%?$K3=2U?1;*TTS3IKN5+Z&X?8R* J$D\LPYIEQ9
MZII/Q /B2#3[F\T_4;-+:YAC*F6V=6^5MI/*\G.#QR:[8R(KJC.H9L[5)Y..
MN*=0!Y)K7A+7)?#6NO;Z5++?:UJR7@M0\68(D8$;F+ !B ?ND]<>IKH/&.G:
MY)J6A^*-%TX7=Q8)(EQID[JK/'(!D \C<".Q/MGOW=1PSQ7$0E@E26,Y =&#
M X.#R/<4 ><^)VU'4_!ES+J&AI:3W5Q;PZ?IWG*)EEW\2!U&-_)(4G "Y/4B
MH=.-U<ZW<0^(]#U:VO\ 5;5M-CU*X>*150J[>6!$ !_$V?;DBNXUO3-$\1H-
M'U/RII%Q<+")MLJ8X#K@AAC.,^],T;PO8Z,XE6>_O;@ JL]_=/.Z@]0NXX7\
M ,T <6GA_P 077P['@6[TR1)%"VW]IB2,P>4KA@X7=OSM &W;U[CK6L;;4[/
MXCIJ,.A7TVG6^CM8+*LD.7<2!P0#(#@A<<XY/IS7<U#/>6MJ\*7%S#"T[^7$
MLCA3(W]U<]3["@#R6\\/>)+OX1ZIH'_"/W*:C<W[2QQF>$C8TPER3O[ 8^N/
MPN:S/KDOCNYN]#\/W$\BV$-M?&WOH8I$W$MM<.&4L% QM.0".>1CU2N=U/P/
MX?U;4WU&YM)4O)%"R2V]S)"9 .F[8PS^- &!:>(KK0O"UO!I?A=[=-.NEM+N
MSFNTS A 8%6!(D8[EX!SEL8KT&LJTM=#@G32[>.S^T6@$ZP<-)'N)^?G)R3G
MYNIK5H X2[L=<A^*;>(K?1);BQ72_L'%Q$K,WF[]P!;IVYP:EUM/$6L:7K=I
M#H/V:&ZT^6!$:>(O--(NP.Q!P J@=\G/M7;54EU2P@U"#3Y;V!+VXR8K=I!Y
MC@ DD+U(P#S[4 >?/HOB%=(\$6PT%I)-$>)[D&YBQ\B&/Y<MR?XA^'.>D[:5
MJUIXC\<ZK<Z<T=CJ5DJPR^<AQY4++D@'//4?KBNZM=4L+ZXN+>TO;>XFMB!.
MD4@8QDYP&QTZ'\J74=/@U2PELKDR^3*I5Q%*T9(/494@T >:Z/INH^,?AOX>
MT2:P%OI_E6[2WRW"L&CCP0%7[VXX .1@<\GC.BWAC5-2\9>*Y+RQ>WTS6+ 6
M27 E1BNU2N[:#G!SD?KBNTT;1K+0-,BT[3DDCM8L^6CRM)M'H"Q)Q[5?H \Y
MD\.>(-:\(6'A/5;.&&.W>)9[])PR211,"-BCYMS  <@ <G/8V/%^EVVN>*]!
M^P7R"[$LMK?Q1,&WVFW=(D@'09"KSW<5WU9=AX<TC2]3O=2LK"*&]O6W7$PR
M6<YSWZ<\X% '/^+=#UT:[I?B/PT+>6\L8GMY+*9MBSQ.1P&Z C&?P'I@PZYH
M?BC7=+LM35[2QUNQNEN[6SW^9$H"E3&[X&2P8Y(&.WO787^IV.E0)-J%W#:Q
M/((U>9PH+'H,GO5J@#"T"3Q%=C[5KL%M8'9L6RMY/-YR,NS_ (<*.@/))Z6O
M$6EMK?AO4M+201M=VTD*N1D*64@$U-J>K6&C6Z7&HW<=M"\BQ*\AP"[' % U
MC36U1]+6^MVOXXS*]N) 71!CEAV'S#KZT <':^'_ !;*O@YI['3X/[")C>,W
M9;S%$7EA]P7Y<]E ;KR1TIT'A'Q!%H'C*P,%B9==NIYH3]J;;&)1C#?)U'7C
MK[5W6F:QIVLPRS:9>P7D44AB>2!PZAP 2,C@\$?G5V@#@8/#OB32=:L-;L([
M&>8Z;'87UE+<LB$ITD20(??@KT^M4YO FO7VE:G'<7-A;W_]L_VQI\\+,RK*
M  %=2.G'7GKTKN]7UO2]!M!=:K?06<!;:'E?&X]<#U/THN-:TVUU6VTN>]AC
MOKI2T$#-AG ZX'Y_D?2@#GY+/Q?J6BZA%J2:6EQ+9O;Q06TS^6[N,%V8KD8'
M0 'J>:=8:7K]AX%TS2EM]/EO+2.*WEAEF)AN(E7:P+;,C(_V3^-=;5&UUK3;
M[4KO3[6\BFN[3'VB)#DQYS@'WX/% '"W'P[NY?#?B;3K);338]5,36]C'*SP
M0LA!9LX&"^ , 8&!UJ]<:%XKFU_1M8+:2YMK5H);.1Y/*@<G_6QG'S-MXY"\
M<=ZZO4=;TS29+:._O8H)+J588$<_-(Y.  /J:OT >5Q> ?$ZZ#I^ERRZ2_V'
M7!J:R+(Z>8H9V((V'!)8#OCWKH-7\)7^N>(-1N+IK6+3[_2/[-=8Y6:5"'9Q
M(,H <%L8SVS[5VE% 'F\GA3QA=Z9H-E=W&C$Z+?03Q3#S"9DC4@%A@8/(X&<
MYZC'-GQ%X/UGQ)%-;WD>E&870ELM51F6XM(PX8 *$^8@9 ^8#UZ9/?T4 %<I
M_86MV/C+5=9TZ:PDM]1A@#Q7&]7#1!@ ",@ [N3@_3O6Q8^(=*U+5KS2[.[6
M:[L@#<(BG$>>@+8QG@\9K3H \U7P-XA3X;#PHKZ9YOVCS3<F>3;CSA,/E\OU
MXZ^_M5N[\(^);FZ\1%-1TV.+6H C.\;R20?)M\I3P"G)^;W)VYKOZ* .!/@[
MQ EWX<U.&_TU=1TRU:SE#1.8O+( #*,Y+ #O@'VKOATYHHZT >8^'!JTOCKQ
MY'I;6:A[F%#+,6S$WEG#!0,/CGY25^M:TW@&2RM?"XT*\A@N- ,@C-S$7282
M+B3(!&"3D^V:ZFQT/2-+F>;3]*L;2608=[>W2-F'7!( S4NH:A;:78R7EX[)
M;Q#+NL;/M'J0H)Q[T <)<> =>D@\3K_;]J\NO+&DKM:%=@5-IQANXR,>G?-=
M+/IVO'3-+AMKVRCGMF N4>)FBGCVE=O7(['OS3I?&.B0V-O?//<?8K@IY=R+
M24QG><*2VW !/<^HK>H X)?AT\>A:K:VU[#:75[?1W\:PP_Z/;O&P955/0[1
MG_ZU$G@;7+WQ(^M7OB&(3RZ7)I[BWM-NP,2<H=V1@D')R<YZ#&.[=@B,YSA1
MDX!)_(=:HZ+K-EK^F)J&GN[VSNZ*SH5)*L5/!Y'(- '%0^!/$T5MH:?\)/9A
M]&<BV TX;-GEE,L-V2V#[#KUK1MO!>I1^'?$6E2:M:_\3JXN)F=;1CY/G?>
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MUYO5972:496/!XPH!R>_'2N5\)^*+O3?"5CID<._4[K6+JU#1 ," [22. Q
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M AW.JY)SD'YN,9Y]* .PHKC+ Z;HNJ17,$6J1W^HP>7'I1D4K)LY,NW)"GD
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M7!17.75D+D-GGN.WOGT.B@#C=0\!R:QH<UMJ>N74^I/.ES%?H@C,$B9V;$'
M4;FXS_$><UK:'HNI6$OGZMKDNJ7"Q>5&?(6%%7().T$Y8X&23VXQSG<HH YO
MQ)X6EUS6-%U2VU)K&ZTMY2C>2) RR*%88)&#@<'GZ&H+?PA<Z7J.JW&CZN;6
M+5'\ZXBDM_,V2D8:2,AEVD]3D-S^5:NO>(;3P[!;37D5P\=Q<);JT*;@K.0
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MT5G?7L&GG;>36L8=83C)!R06(!!.T' /-33^*+ )8BR$FHRW\9FMHK3:Q>,
M9<DD!5Y R2.2!UKE=#BOO"R>*-*N])O;I;J\GO+*2"!I4N1*/N$J"$((P=V!
MSGI6-8:!X@^'\WAW5(K"?5XX=,;3[^VM!OEC)D:4%?[P!;;VX6@#MH?'>EW&
MFV=U##=/-=W;64=IM42^<N=RG+;1C!.<XK+\1ZW8^)? OBR 0W-O=:7!*)H9
M&VO'(J%E.48@C\>>]5M=U7Q--::7>G1-2ATV>[8W5I8@&\CB"_+DJ05+-DG:
M<@8&0<UAV6FZI!:>/K1?#FIVZZM"6LPR!@2T1 4D,?F);GJ!SDCN >F>%Y!+
MX2T:13D/8P,#QWC7TJG?^+[.RNM4@BM;J[;2H5GO3 $_=*P) Y8$G:"<#L/I
M4_@^.:#P9HEO<12PW$-C#%+'*A5E=4 ((/N*\]UM[JV\9^)A::3K,MCJ"16E
MZVFVZ7 <B,9;E@4;:^,8]#W% '=P^,+&YT_3+F&WN7EU3)L[7Y!+*H7<6^]@
M*!R23Z=^*KCQS9MI^L3C3K_[5I!_TRPVIYZKC.X#=AE(Y!!YQ7,26A74?"7B
M/0M,OY-.TA);"XL'B(N+=2NW.P\L1W R3QC-;^@:1=3>.->\27$#P6MY%#;6
MT4J;7=4'S.R]LG@;OFQZ#% &G#XIAN=+T>_M[*YE35640QHT990RELM\V,
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M26UEV_,I&0RL#AE_$'VKFOAYI\7B30M'\3:E:,NJ(\THO8Y &GW.P*OCDJ
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M%E6Y21]B-M+$D;^"0>AS77V<&N1ZT[75[:S:6+9$C18BLIFS\SL>@'L/7VY
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MO@#;M&2.< 'WSS0!ZC4$5Y;SW-Q;13*\UN5$R \H6&0#]1S^->5PWFKZ=9^
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MR]JPRE3*[YY)V]%&,#/)ZX%4?%FE:BWB'P_XBTV#[4=+>99[96 =XI% 8IG
M+#'3(S774A(4$L0 .I- '%6^D7USXJUGQ.]A+&LVFK96ELQ42R#)9F(+87G
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M2K*[^RW-Q&%27G'!!P<<X(&#[&KFGZ#H^D.[Z;I-C9.XPS6UND9;Z[0,UH4
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M4CQ2*C7$ ^ZK848(XY7!X]>:A3X6:.FBQ::+[4Q]GN3<VEPLX$MJQ8DB,XP
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M6_=,/NGWQT&>@XJU9^$=)L/$=UKL"3"[N3O=3*?*#XVEPG3<1D9]SZFMVB@
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M2^'],U+1+(LD^I16=TLSA9('\P;HMN#DD C/8'/-59[FZTWXNM/::,9=0N]
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MKBV>[DN)E+)%&#M&%!!8EO<8KE?$?B_6!X<\8:<SP6FK:/&I,T*$K/#(/E=
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M$&B0+MES(F-V5)XZC!'OFM6]GU;2?%GABP_MB:YL[V6XCG6:&+?)MA=P2RJ
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MBBB@ HHHH **** "FHBHNU1@9)_,YIU% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% %<Z?9&Y^TFT@\_.?-\L;L^N<9JQ110 4444
M %%%% !1110 4444 (0&&" 1Z&@ *,  #VI:* "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **K)J-E)?O81W<+W:)O>!7!=5SC)'4<FF7^K:=I?E?;[ZWMC,X2(32!2[$X
M &>O6@"Y1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110!!>7MK80>?=W$<$>0NZ1
ML9)Z >I]J@CUO2I?(\O4[-OM#E(<3J?,8=57GD^PK%\9Z>FIII4$6K?V9JB7
M?G:?*R[U:54;*LIX(*EO?T]*Y#4EG\2:9961M[>QUF'6K@JUO(3%)=102.LJ
M$\X+A<^ASGF@#T^ZOK.Q6-KNZ@MQ(^Q#-($W-Z#/4^U00ZYI%Q,D,&JV,LKN
MT:HEPC,S#JH /)'<5Y\=:;Q'=>'-9O8?L?E:E%:Q0RG:1-L?SR >H#!4'^Z?
M6L:S=LEM0,:>'X_%=U-<72'#P2K)^ZW'/",QP2/SP: /7DU.PD>X2.]MG>V&
M9U6528AC/S 'CCUIUC?VFIV<=Y8W$=Q;29V2QME6P<<&N*L#=/XS\:M:7=K'
M$&MC()8C(6'V=>A#KC\C47@>>6+X=:(]A<>=J2Z8Y@T\RHJRG</G(."=IP.H
M'S>] ';R:MIT2W;/>P*+,@7!+C]T2,@-Z$@CCWJ)M>TI-,FU)]0MULX&*S3,
MX"QMD##>AR1P?45Y->(T&G^-+.ZLK^WWW%AF=YHB8YR(R)9"I('S8=CTQQQ6
MGIL5E>Z-JVEZUK@TS48]78S:E'/&L=],$!!"L-N I7*#H5&3G- 'H2>)M$DL
MXKM-4M6MY4:1)!(""BG:S>R@\$]!6H"" 0<@]Z\J;^U+32(_$$JVES=WVEMI
M@L7!1IV#OY3Q*H/$@.XK@  YR #C1U1O%>E_#^YTM=,4BVTQ8?MT5T'E)$8#
M$1A1T^8 [L\ T =E<>(=(M;*6]FU"!+6)MK3;LH6YX!Z,>#P,FH9O%GA^WLK
M6\EUBS6VNP3!(91B3'7'TSSZ5QNF^(;'PY+=VUY?6-[HNFPV_P#9MT1'&5F=
M6'E C"YV\[N,!CGCFKEA<6.G>![NZT6ZM;S4)9Y8XIK<AHUNKAP=D;=-H9UZ
M=ER>] '4S>)]#M[.UNYM5M4M[O)MW,@Q*!_=]>WYUJ22)#$\LKJD:*69F. H
M'4DUY[XBLX]%CLDT+6I(?$&G6445MIJR I>(&QAHSR<X;D'CJ>E;.O7-TZZG
M:Z[';Z?X:>+9_:$=Z4F!)4#(V_*"21UH T[?Q5HEW9?:[>_26 W'V961&.^7
M&=JC&6..>,]_2GR^)-(BM8KEKU3#)&\JLBLV$3[[$ 94*>"3C!X/->=ZHET^
MAV%M+K,LJ1ZQ_P 2SQ!-(I$*"'<'=L8?+%X^>#ZUE:KND\-:0T0&C7,5C?/Y
MXE;[/>C?B2('J?-YD!ZCC'/( /6+OQ+H]C<6<$]Z!+>@&W5$9_,!Z8V@]:FU
M77-/T6$27TSH"I;$<3R,%&,L54$A1D9/09YKB9#'+>Z1>:+=SV.NI%:I/HAF
M/EF @91D(XV*S'<.F.>3BMSQ%K>G7VFW.F6OB*/3[V4R0(ZJ'8NORL@!')R0
M,#GGB@#IXI8YX4FB=7CD4,CJ<A@>013ZR_#?VS_A&M-_M"VCM;L6R"6"-=JQ
MD#H!V^G:M2@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
$% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>davidjkatz_employmentagr012.jpg
<TEXT>
begin 644 davidjkatz_employmentagr012.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHI P+%01D=1GI0 M%%(SJBEG8
M*HZDG % "T44C,%4LQ 4#))[4 +10"" 0<@]#10 44W>GF>7N7?C.W/./6G4
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M >TM(B,%9U!.< GKCK3J\F\8:7_9SZS=C3['4_#RQ1074*8BNM."(,&(D8P
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M[.-B19R4X;#')/./QI]QX^MH=/EU>/3[F;0HI3%)J$;+@8;:6"$[BH;()]N
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MB@".[T72M0N8KF]TVSN9XO\ 5RS0*[)]"1D4MSI&F7LRS76G6D\J@!7E@5F
M'0 D5+97UIJ5HEW8W,-S;R?<EA<,K?0BEN[RVL+=KB\N(H(5(!DE8* 2<#D^
M] $-OH^F6ER;FVTZTAG.<RQP*K'/7D#-2W=A9ZA&([VT@N8P<A9HPX!]<&LJ
M^\8:%9:'=ZO_ &C;S6MKE9#"X<[P,[,#^+VK+G^(^C6]KHCF:%IM3DC0QK+D
M0!ERQ9L?P].V: -;7K37!IUM#X7ETZTE28;Q=1$IY6#D*%[YQ_B*NZ1I_P#9
M6E069E,KH"9)2,&21B6=L>[$G\:COM?TC3 AO=1MH Z>8-[@?)_>/H/?I3[K
M7-)LC;BZU.SA^T#,/F3JOF#&<KD\C'>@"S<VEM>P&"[MXIX3R8Y4#*?P-12:
M5ITID,EA:N9%"ONA4[@!@ \<@"J$/B_PW.JM%KVFN&1I!BY3[J_>/7H*M6.N
MZ5J>F-J5EJ%M/9)G?.D@VKCDY/;'O0!/_9]D<9M(/E&!^[''Z5895="CJ&5A
M@@C((K)3Q3H,D=U(-5M0MH ;C?)M\H'H6!Z ]CT-64UK3)+."\2^@:VN&"PR
MJX*R$G  /?)H EBTZQ@MS;PV=O' 3N\I(E"Y]< 8H.GV1 !L[<@=!Y8X_2K-
M9=_XDT?3+AH+W4(8'0*9-QXC#'"[ST7/;.,T &K:2MSI-[;V5O:I<W$#Q*[+
MM W*1DD GO53P?H#^'O#5AI]RML]U;1>4TT(^^![D ^GY5E>.O%?]C1Z-:VD
M[HVHZC;P22QQEML#$[BI (W$# QD\\#O6WX?LKJUCN9)=7N-0M;B7S+5;B+:
M\"'^ L>6Y[D T ::6MO'*94@B60YRX0 G/7FG)!#'([QQ(KORS*H!;Z^M8'_
M  EEC<^*I_#<33I.EON>986^5BVT 97'8G=]W]:P?"'C.RM-)E@\0Z]&UX-1
MN($>X8!BJR%5S@87IQG'?TH W=(T77$UJ:_UW5X;V.-Y/L,$5N(Q"K'J3U+!
M?E'L3R<UT4D:2H4D170]589!JAJ6O:;I#!;RX*N5WE$C:1@G]XJH)"_[1X]Z
MLV-]::E9Q7EC<17%M*,I+$P96'L10!.JA5"J % P .@I:YWQ#/:#6="@DU^;
M3K@W6Z.VB/\ Q^#&"C#'3W__ %@NO'7AFSFO(9M6B\VS.)XT5G9."3PH). #
MG'3OB@#HJ*H2:UIT=C;WOVD207(!@,*F0RY&1L502W&3P.@K@-&\0)=ZYX\C
MN=>O8]*MH[=8IWW+):EXR'*@J-K!^V,Y'2@#TZBN6L?%.A:5I&AP2ZK>70OH
MT2TN9K>5WNB> 2P3[QZX.#5[5]<TN);_ $ZZO;FTD2U,DLT<,B^2C @.)-I4
M'.<<]1[4 ;=8?B[0Y_$GAJ[TB&XA@^U+L>26(R87KP R\YP0>G'2HM&U?3++
MPAI=RNI7%[;21)'!/(C/-<G']T#<6."<8Z#VKE/#OB5%\>>*YY[W4CIEM:02
MF&Z24M;G!9QY>,KCGH/TH ] TNWN;32[:VNYHIIXD"-)%&45L< X)..,=ZN5
MCCQ3HS6^F7 NV,.J.J6<GDR;968$J,[>"0#UQTJM=^--'L[IXI6N/)BG%M-=
M+;L8(I2<;&?& <D#T!(R10!T-%<9-YL7Q@LT%S<&&72)G,+2DQAA(@R%Z XK
MLZ "F31":&2)BP5U*DJ<$ C'!KGK7QSHEW<6J1O.(+R=K:UNWA(AGE!(VJWK
ME6 ]<57NOB+H5K+J$6V_EET]]MS'%9N6C&,[R,9"^YH BTSP7J6EVL>GP^+]
M3_LN)#&EOY,/F!#V\W9N[]1@CMC%=7:VL%C9PVEM&(X($6.-!T50, ?E6=/X
MDT^.SL;BW9[QM07=9PVX!><8W94$@  <DD@#OBN3^&UPUQKWC$G[6%6_15CN
MF9I(_E.5.2>ASW(]* /0Z*S-?UJ/P]H\^ISVES<P0 O*+8*61 "2V&8<#';G
MVJG<>+;.UUO2=+FM;Q7U52;6?:IC8A=Q!^;((&.V.: -^BN9MO&]A=SVWD65
M\]G=7)M8+Y40PR."0>0VX#*GDJ,XXS3;SQWIMA^^GM;X::+C[,VI"-?LZONV
MG)W;MN[C=MVY[T =,X+(P5MK$<-C.#6-X9\.KX:L9K2.^N+J.29Y\SJ@*LY+
M-C:!P2<UMUQ&E^)KOQ!XT\0>'KO2;J*QM8H8FR\8*%U=BSE7SAAM "YQCG&3
M0!VP((R"#VXI:\I\ ^,[71? _AVUNK*^,$TS6S7PC'DQR-*^T%B<GZ@8%=EK
M'C.TTHWYBM+B]73EW7IMR@\D;=Q'S,-S!<L0,X% '2456T^_MM4T^WO[.42V
MUQ&)(W'=2,BN7U'Q3J-O\1[#P]%I[FUDM7G:0.F9N0.,GY0O/N3V[T =C17%
MV_Q'M+G4)+1-$U@>3=_9;F1H!BW^4$.^"<+U_(^U6++QY:7DVCDV%Y%::P[I
M9W+[2K,N2 P!)7(!Q^N* .K9E12S$!1U). *48(R.E><?$+7+;6/!'B.&UTR
M6_M;0-#)=*4V1S*.2 3D[21D@>O7!K4TWQ-!I?AW0=/CB^TW[Z3%<"+S4C 0
M(HR6<@#).!UZ'TH [.BL?PSXCLO%6BIJ=B)$0NT<D4@ :-U."IP2/_K$4FN^
M(H=%N=.L_)\Z\U&5HK>,R!%)52Q)8]!QCN22,"@#9HKF)_&D%K9PM=6,T%]<
M74EI!9R.@9V0\MNS@)CG=Z$=20#4MOB/ICVVKFZ@EBNM+E2&6WC=9#*SG$?E
ML" P8].GOB@#LJ*YD^+)H+Z^L;S1+Q+JVM?M:B ATECS@X=MJA@>H/IP3618
M?$V&YTDZO=Z+>V>EFV\Z*ZD92DK[P@C'^T2>^.A/09H [VBN)B^(4,VHWFEQ
M06DNH1V;7=L(;Y989PN=R[P,JPQG!'2M/P-J]]KOA&PU*^2(27$8?=')NW9S
MG(P-N#QCGIUH Z.BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** .*GOI=8^)MQX>GN)XK"TTQ;@1V
M\[1-)(SXW%E(; &,#.,DGTQR6H75[>^ _'6E:E<W-T-%FDCMKEI6#2(1D*Y4
MC>0.N<]17H^J^%[34]7MM62YN['4K>,Q+<VCJ&:,G.Q@RLK+GG!'6JMUX)T^
MY\.7&B"ZO88+N1I+N:-T\VY9OO%V*GKQT Z # XH M>$;6.U\)Z6(S*0]I"Y
M\R5GY*+TW$X'L.*R_',:-=>%)"/F778 #Z923/\ *N@T;2QHVF16"WES=1PJ
M$C:X*%E4  +E57(&._/O5+Q!X9B\0RV;S:E?VHLY1/$MJR*!(,X8[D)R 2.N
M/:@#A_%M_=B/Q=<V%_?W4MFBNDL-P\$.GLB F/Y6_>.3R1MQS@D5;U?4;C1M
M=\)>([J^G73M1B%K?H]PXA21XP4DVYVCG(/%;5W\.-&O+K5)7N-12+4U;[3;
M1712%I",&38!R_?G(SVK3;PEI4WAJ+0;I);JRB*$?:9#(Y*L&&6/TQ]..E '
MGFB:S>FYUSP]+<7\4^KRQ7.CO-<R-*+64X)4L<C8H+8['(.<5ZY#$L$$<*%R
MJ*%!=RS$#U)Y)]S5&?0K"YUZSUJ6'=>V<4D4+YZ!\9_'@@?[QK1H \U@T_\
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M,H>*68C+%"./3) QGZ'%?Q_JMCIJ:(MVL EEU%#;W%U(R06TB@GS'VD9 &<
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M70+^SDN)IX['5+JTA:9MS"-'PH)[U3U@R1_&7PXJSS^7-97)>+S6V9"\$+G
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M]1U&)?[0O(+R*:9EP\B"/Y"3U.0 ?^!'UK'U*RLY-#^*"I%&$M[Q'B6/Y0C
M8R /Q_6@#V34M;T_2DA:ZN$#37,=K&@8%FD=@H '_ @3Z#FM"O&?$GA71;#2
MO!]_%9*]UJ6MV#7LTQ,C3;E;=DMGAB<D=#7L,=O!';+;Q1HD"KL6.,;55>F
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MS7G?@/3K^RUB[T"[5GL/#LSBRF<Y,@F&Y,\?>1"P/_72ND\>65_J7@36;/3
MS7<ULRHB]7'\2CW*Y'XT <_KWB.WO?$/A)]+OM147-^$,826*&XAV/EN0%<
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M86,QBNO+L7_<@#EWR!M4>^#P<#BG7WC8IXNT32+.RN)K>^@>Z,ZH#YD>S*[
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M*[;P5?6<FL:F9K#5K/6;_;<3MJ5H(//5 $'EA21M7(&,DC=SG- %GQGXFO\
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M[F6UA>>+_5RM&"R?0]12FTMFE\UK>(R9SO*#.?K0!XXSZ%;^)O%.C^*]5O\
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M7.,@L3G'IZ"@#N**\?UZ[O[3PO\ $'[-JFH1&POXS;,+IRT8*QY4,22%^8\
MUL*MYX?\7^%&CU/4[U=5M;A;N.XN&='9(@X<*>%.>/E _GD Z?QMXCG\*>%K
MK6H+..[^S[=T;RF/AF"@CY3GDCCCZUT->(Z\W_"1_ R]\3WTL[:E.VYL3L$0
M?:0@C" [0H '&.H!/-=9?7%YXB\=:[X?9HUCL[6$V\;7,D)PZDM*NT'+ E1G
MM@8ZF@#T*BO([^PU)->\!:/?Z]>7,LK7L%[/;W,B+-Y:\=Q\P!*EASUYR*L>
M(-.O] EDS!=:YH5M9) [17A%[8;029, C<2"#GK\HZ <@'IC7ULFHQV!E7[5
M)$TRQYYV*5!/YL*L5Y79+IE_\5/#UW;;;N&YT'S!<,K*7*N-KX)R#\O0UEZG
M<2KINGZW97,\H?Q BQZI+(5DN092K1J@SB,!<?,1G;]WF@#VC..M%>7#1[;7
M/B'XSTK4'NKBQ6UMI%MWNI-H8H3_ 'NF22!T&:IZ!JTFIV?@+2-7NS):WUK<
M/.LK_P#'RZ?*B.?XA@DX/4@9S0!VN@^)+[4O&/B'0[RVMHETP0&-X79BXD4M
MR2!VQV]>M=1D&O'H=*2T\4?$73-,OX](#Q6$<,SL=D9=>%SU4$MMXZ;N.@KH
M/!DJ6WBN[T^^T0:+JWV-7\BW<-;3QASF6/'0Y(!!YZ9S0!VDNI0)JB:8CJU\
M]N]PL9;'RJ57)[@$N.W8^E8W@KQ%?>(;/5)-1MX+>:SU*:R"0[L80+R2W).2
M>P[<5COI&G_\+L67[+$)'T4W#D#!:03H QYY. !^%<?>Z+9R>"_'.IR1N+RP
MUNZDM629U$#@H0R@$ -SUQF@#VTD#J<50U36['1VLDNY=LEY<);0(,;F=CZ>
M@ZDUPD\-MXBU^R@NHH]4N&T2.6>VOB!;6P8\RC@DR,<CCH!U'%<M';P:KX7^
M&ESJ,,5Y/-J(@EEN$$C21AWPC$Y)7V/% 'NE)D9QD9KD?B7;Q'X::R@!1(K4
ME%C8H!C@# QD>W2N272[/0_$/PZOM/A\JZOD:.ZE+LS3*85.&))SC/'I@8Z4
M >M&6-9%C9U#MDJI/)QUP*I3ZO:0ZO!I7G(;V>-Y5BW#(5<?,1U R0/S]*\M
MTZVL_$7PZ\1ZSJ2[?$%M/=.]S(0)[.2,EHT1^J@ *,#CDU=LK2VU#QQX4O=8
ML;-KVYT$W%RTL*Y:9?+^8Y_B'.#V% '7^%M<OM1.LIJSVB2V>J/9QF$%5*A$
M9?O$DGYC6C?'5QK>F?8YK%--/F"[28-YKG&4$>..QSGM7FNI:+87WAWXBW]U
M )KBUOKE[<NQ(A=8(R&4= V>_7@5?CD$WB'X7ZE<,7N[JQE\V5VY<FU4]_=C
M^= 'I;W$,8)DFC4 A268#!/04LTT5O&9)I$CC'5G8 #\37BT^BZ;<6'Q/66T
M1Q9327%L&)(BD,1.Y1G ;(Z]:W8KP37G@6YU>>&[M[G2 7MI6!;SFC0^=M/W
MNI7URU 'IP(/0@_2LN%M5'B>Y6:YL3I7V=3!"H/GA\_,S=MO^/MS@?#CPNWA
MS3=1>>RAM9KV^EF2-0N](,_NT8CC(Y.,G&<5GVUE:M\;M8A,*E+G0E,RD</F
M0*<_@ * .^^UVVZ-?M$6Z0D(-XRQ'7'K4.JZK9:)IL^H:A<)!;0J69W./P'J
M3V'>O#H].LK3X/66M16\:ZG!J:K!=$$O$%NB J'^$8SQTY/>O4?B9%'+\.=<
M,D:/LM6==R@[6]1Z&@"KKGB>_BU+PK)IMU:_V?J=VD%Q%Y>^0$J6(W[L#C Q
MC/O72WER;W1KQ])O[59Q&Z1W!8/'%(!U;'H>HKSS6;+3KSP]X MUC@:&34+5
M9XXL ,6MR2&V^HQD=P>:J2Z7I]KK_P 2=+@LK>.P_LN*X%LL0\M9!$Q#!>@.
M>>.] 'IEK?K8:%:7&M:E9"0Q();H.(XI'(ZJ2>A[5H0S17$0E@E26,YPZ,&!
MP<'D>]>6:;I]S>^%/ MQIM]91ZM:V#O;65\F8KI3&JN..0P!'(]3VS76?#W4
M;?4/"H^SZ:VG&WN9H9K7.5CE#EG"'NNYCCTZ=J %\?>*9?"?A[[9:P&XNVD&
MR(+GY%^:1C[! W/8D5T5E=PZA8P7ELX>">-9(V'=2,BN41+GQ%X@U"_MDM9]
M.AC?3$\V5L-R#,P !!YPG/\ SS/8UC> [F33='USP3?7P@O]&$@BF[BW==R2
M#UV[OPXH [XZQI@D:,ZC9AU)!4SKD$<'C-#ZOID<OE2:C:+)O6/8TZ@[FSM7
M&>IP<#OBO)=#73_$ND^"=-2?2P^DW(DFD%S"WFH,@ 1[M^9#M)#*".<\UMZ+
MX;\/7OQ.\713Z992_9S9R11F)=L9*%F(4<9+ 9/^- '?-K.EKJ2Z:VHV@OF&
M1;F9?,/_  '.:2\UO2M.N([>]U*TMII/N)-,J%OP)KQ[0O[%UKPJ=-UWQ'J5
MMJEO?-+-ID8MTG:Z#D@IF+>S$_[1]\"KPNM,OM5\8Z)XI\27.E//?2$V[K;H
ML]M@"(JSQL2=H& #GH0,T >IW.N:3922QW6IV<,D,?FR)).JE$R!N()X&2!G
MWJ%_$^@QPVLKZUIZQW?_ ![L;E )>WR\\\\5YYINF:=)\6M+M[BT:6,>%XV5
M=116F9A+@-)QS)M'/>L[^R=%_P"%5>,Y$M+,M;WUY'$X 8QA928U!_AQD$ >
MN>] 'KNH:KI^DQ"74+VWM4.<--(%SCKUIK:UI2I;L=2LPMR"T)\]<2 #)*\\
MC /2O,)=66V\;:9)K&O/IMI>:%"MG?Q+"8Y&SF12TJ,!DD'C' 7/:J5_I>@:
M?IG@RWTXO?:<VOB.*:]VGS8FR'VE0N8]Q/;!/J",@'J$_BS08-%N=7&JVLMC
M;$K)+#('&X#[O'4^U6=$UFVUS1K;48'CVS0I(ZJX;RRRAMI/MFO-)HH;3Q%\
M4[6W2.&+^R(V$48"KG[.V3@?7]:[3X?WMIJ?@#1UBFAN!'910S*K!@K!!E6Q
MQGU% &A)XK\.Q;/,US3EWR&)2;E,,PQD#GJ,C\ZFN_$.C6$LL5WJME!)%'YL
MB23JI1,@;B,\#) _&O);&QT%_"WQ*2[CL?/CU.]6(,%#QX_U07N/GS@#OFK&
MGZ7;OX\\(:?KMM;R7+>'-D\4ZJ2SXQ@@]3@$?@: /3[SQ-HFGM$+S5;2'S55
MT+R@#:WW6)Z ''!/!J;4-:TW2XDDO;R*%9 63)R6 QD@#D@9&3VKRNWO=#L=
M8\5^'_%>HW.G>?=.T46[;'/:,H6-5PO91M 'X<YJSI^J6/A7QK+'X@,UEI-Y
MI,%OI[WN6"(H^:)FQP3G)S^/- '2^*=:N(]4\)3Z7J_^AZAJ"0R11;&2>,@G
M<&QGL!P>]=-'K6F2O>)'?0.]E@7*J^3#G.-P[9P?RKSK6IM!L;'P,FG&.QL(
M]:5[>*9RI\HB3,F'^8*3R"?[PK2DUS3=%\>^*1J-VENUY8V;6JL"3/A90?+
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MKC'7 X'(Y/&>,U;MO%>A7FL#2;;4H9;TH75%SAP.NUL;6([@$D5Y?%J>C?\
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M#=Q- WE9QY@#@97W[=\5R7B72-5'PX:X@LI)M4>[BU2[M8W8.[>8KM&".3M
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M);)96HC.]Q'M#.4QE<D,?FQT^E &[J/Q'<QVITS0M5=)=0@MFEFA2,,'(;Y
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M9448",H.,=??D\\UMUSL&OWK?$"X\/3VL"6RZ>+V*9)"SM^\V8(P .<^OUH
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M RPW##J$<C!]O7MFJ,OQ+\,Q13R_:;AUMYS!/LM)"8B,99QMRJ\]3C.#C.*
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M781Z7I=K8QG*P1A-W]X]R?<G)_&N*\;:I9Z)XX\,:E=7T2");A6MYI1&H1E
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M1G*2*'4XQP1D5S-GX"TNR588[S57L%78MA)?R-;A?[NW/*^Q)%=2    , 4
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M#D ;6*_WL'KC(]:L33WT<NOZ+JB6>HS-X?G:VU2P3#/"%(VRH"1NSC&/PZT
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M=Q;2&1US'@GY<!B 3CK@9Q75^(Y/M?Q%\.OI$BKNTR[B26,85&>/]V&/;G&
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M"73I+=%8_,S;B2"Q/09'I[U2\+1QII]GX;U7P/*^NV16+SI+8&V(4@";S.G
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MME11EL%';! &<-@T_2O%T.JRZ=Y>FWT=MJ2,]K<N(RC #/S88E20,@$=/0Y
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MT>G1Z8MTJM,RMM:3!=QM^\-I^7H/[W/%=_B7 $M+V*TCFTVXF\O=%.6N$4G
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M[:W+S26*OFV)&5+,O(Z X'..3Q5;PAKJP> _#C7DEQ=7MW:KL109)92!DGZ
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MG(R#@]^HXJ:[N[>PLYKNZE6*WA0R22,<!5 R2:9I]FNGZ;:V:'*P1+$">^T
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M=\$3Z"\ME/*?,\F16=5Q(23NX[9XQU]JS[;X?:A;>&_#EO%?6\>K:!,TEO.
MS12JQ^96'!&1@=\8]Z )KCQ9K>EZCKVC7:V<E[9Z>=1L+GR65)XE^\'4-]X'
MC@X/M6CX)U3Q'KEA;:KJG]FK87=G')"ELKB19#][=DD8^GT[9,=WX6U._DUK
M4+FXM#J5]8'3[9%#>5;Q'.[)ZL23GH.@'K6IX1TF\T+PQ9:3>O!)):1B)9("
M<.H'!((X- &Y1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% #719$9'4,C##*PR"/0TUH(6\O=$A\
MH[H\J/D.,9'IP2/QJ#4=4L-)@6?4+N&VC9MBM*X&YO0>IX/Y55;Q-H:6]G<-
MJMIY-ZVRVD\T;96R!@'IGD4 6&T;2WOC>OIMFUV3GSS IDSC'WL9Z<57'AG0
M A0:'INPD$K]DCP2,X/3W/YTMQXDT:UNKFUGU&!+FVC\V6$M\ZIQSMZGJ.GK
M7&:[XW;5? XUSP[J1MVBO(HY41%9BC3! &W#Y<CGCGG% '<OHNE2)&CZ99LD
M6WRU:!2$VYVX&.,9./3-69K6WN'B>:"*1H6WQET!*-ZC/0^XJE8>(-'U6]N+
M.PU.UN;FWSYT44H9DP<'('OQ3%\2Z*VH+8C4K<W#2&)5W<-(.J!NA8<94'(S
MTH TEAB1]ZQ(K>H4 TR"SMK9Y7@MH8GE;=(T:!2Y]3CJ:RKSQCX;T][A+K6[
M&)K=UCF!F'[MVSA3CH>#Q['TJIINIV4%_K]_+XIAO;*)T+PY7988!!7<.N3Z
M],4 ;PL;1;PWBVL NBNTS",;R/3=UQ4IAB+[S$F_KNVC-8\?C#P[-=P6B:Q:
M&XG8)%'O^9V] .].@\6:#=7L=G#J<+32LRQ=0LK+]X(V-K$=P"<4 :WE1^9Y
MGEIO_O;1G\Z<0",$9KC;+X@Z)K<^MV4.I+:):(0MTZE,#;S)\P  !( SUQ6G
MHE]:Z9X.M+J\UW^T;=$R=1E&#-EC@XYR>0 .2>* -_:,YP,],TA1"X8JI8="
M1R*RHO%.AS6=Y=#4H$BLCMNO-)C: ]MZM@KGMD<U7M?&_AJ\OK6R@U>!KF[4
M-!&<@OD9'4<$C! /)!'J* -^BH+V[BL+*:[GW^5"A=_+0NV!Z  DUS^@>-;#
M5_"AU^Y8V=LNYW,L;*JKO8+@D88X ^[GDXH ;XH\.:CK6M:'?6ES:1)I<YN
MLR,2[$8(R#@#%=2.G/6LS3O$&FZK>3V=M.XN[<!I8)H7BD53T;:X!(]^E+KG
MB#2_#>GF_P!7NUMK8';O*LV3Z  $T :5%<T/B!X7-R]O_:J>8L?FK^[?$J[M
MN8SC$G/'R9YJQ;^,=!N=!GUN._'V"W<QRNT;JR,"!M*$;LY(XQSD4 ;M%<^V
MMV&NV6I6%O/>6MW%!O>-HY+>9%.=KC(!P2.H^A]*SO"7B.&+PGX8AU"XN9]0
MO[)9%/ER3/)M4;F9@#C[PY/K0!V-%86J^+]'T5YA>RS+%;LJ7,Z0.\<#-C:'
M8# SN'TR,XS6XK*Z!U(96&01T(H 6BL#_A,]%^TPQ>=-Y4]R;.*Y\A_)><$K
MY8?&"<@C/0D$9S52[^(GARSN=0MFN+F2XT_'VB&*TD9ESDDXV_= &2W09'/(
MH ZJBL%O&6AB?285NI'?5E#V6R!R)1C/7&!@')!((K2M]3@N=2NK"-9O.M@I
MD+1,$^89&&Z'Z YH N450U'5[73)+:&;S'N+IF6"")-SR%1N; ]@,DFLT>,]
M+,=C(4NUCO+LV2.T!4+,&*%&SRIRIZ^E '0T5BIXHTUM;OM)D:2"YLH/M,QF
M7:@BSC=NZ8JO:^,-'U'4+73-US#-J$+2VGFQ-%YZ 9)0]1QSS@XH Z*BO+/!
M?CBST;PY+'JTM_,L>IS12711YE@5I"$,LA)QD\<\]/7)]2)"J2<X SP,T +1
M7(Z?\2/#^I:H-/MS=^9YTL#226[(B-&NYMQ/W> >O/RG@<9O1^,--:]L[:6.
M[MQ? FREFAPES@9PN,D''(# $Y&* .@HKBI/BEX=2">=4U&2"UN#!=R)9N1;
M$'&Z3^Z,_CP>*W;KQ):0RQ0VD-QJ,\MO]J6*S56/E=FR2%P>W.3VS0!L45RM
MU\0M!M/#T6ML]P]H\WD-MA.Z*3."LF<!"">Y'XUE:A\1)6GTI-,T;4#'=:H;
M*1KB-8F.T9(578'D="< 8/?B@#OZ*YZZ\7VML;\K87\\6GX6\EA5&6%M@<J?
MG!) (R0"!GKUKH: "BN8G\=:7;V:ZB\-V=(,WD_VFJ*8,YV[OO;MN[C=MQ[X
MYJ'6/B'I6BZS/I4UEJD]U#;BY(MK;S T><;AST'//3@T =;13&E1(#-(VR-5
MWL6XVC&>:\K\<ZT^JS^$;F#3;V&TEURT-O>NX"3(2V1LW;ESP1D<@?A0!ZL&
M4L5# L.HSR*6N/LM3T&W\;>(G2TN8-1M[5);^XE)*-&H^7:NX]AG@"K>G^,(
MKR6V,]A-9VEU:O>074LL9C:%=I)8ACM.&!P?SXH Z6D#*20""1U /2N6A\;P
MOJ6E0RZ9>16>K%EL;Q@"DA RNY<[DW#D9&?;KC,\,7FF^'I/&T]Q*MO9VFJ&
M63)+;%,49SCD\G- '>US>J>"M/U+5Y-5CN]2T^]F14FEL+IH3,%^[N X..U(
MOC".'5['3]4TZZT[^T>+*69D9)&Z[&VD[&QC@]<XSFJX\<)++%+:Z7/<Z9)?
MBP^VQRI\LA?9ED)W ;N/R/<4 ;^EZ1:Z1 \=N9G:1MTDL\S2R2'&,EF)/0?2
MKU<=%X]670M=U,:1<!M%N)(+J#S4W?(,LRGH<5'=?$>VAN=+MH-'U&ZGU.P^
MW6T<*J2P*AMO7KC.>W'>@#M:*Y#4O'<=G#.]OIDUP]G"DUY$\J1/"&3?L ;[
M[@$$J/7KGBIAXUAOOLBZ'9MJ,EQ9_;@AD$1\G.WC(Y;/&.!QR1QD ZFBJFEW
MPU/2;+4%B>(74"3"-_O)N4'!]QFN8U/Q\MA#J%]'I4T^EZ;>?8[RX$H5T?*@
ME4/WE!8#.1[ T =E17(ZAXVGM_%%UX>LM O+V_AM/M2!98T60;@.I. .3R>>
M,8.:6U\>VEYX:T[4X+.;[5J$YM;>Q<A7,P8JRD] !M))]!Z\4 =2)X3.8!*A
MF"[C'N&X#UQZ4YI$5E5G4,V< GDXZUYOX5,Q^,7B0W%A'93&QA+QQ.'5B3G<
M& &<^X!K0^,,49^&6K3F-3+$(C'(1\R$RH#@]LCB@#L5U"R:01K=VY<G 42#
M)/IC-6:X9X_"NH2:-IZ:/LGN)E:&==.:$Q-&AEW!V0#G9C .2":M3^-+X:]J
MNCV?ANYN+JPB28$W$:+(C9YSDA>G ZG/08- '7T5P%O\2VN-,TK6AH4Z:)>2
MI!+>/,H,,C';]WJ4#?*6X^E7;[QGJ:>(]0T'3_#DEU?V\"SQ;KI$25"2-Q;^
M'D  'DD] !F@#H-;.G/I[6NI7RVD-S^[W>?Y3-GC:#D'G../6GZ-I%MH6EPZ
M=9F;[-"-L:RR%RJ]@"><#TKS'QCK]CXN\ :9J\=GY-Q#K$,$D<H!D@D#X9<_
ME^!%=U=>)+F77+[1]&L8KR[L(4EN?.G\I5+Y*(#@DL0">F!QSS0!T=%<$_Q,
MC;P]IFM6VE.]K<W@LKKS)O+-G(6V_/\ *<CW^GK6[?>)#IVH:H;F*$:9IMH+
MB>X61BX)!.S;MQG"YZ]U]: +.D^&-%T.]O;W3;"."YO7,EQ*&9BY))[DX&23
M@8%:]<'9_$NSF\0:9ILHL&CU)&:.2TOEG:!@,[954?*2.X)&<^F:K'XKV32V
MD\,$$]C<7(@Q%<[KF-6X61H]N,'.<;L@$<=J /120 23@#J:KV5_9ZE:K=6-
MU#<V[YVRPN'4XX/(J2X,@MY#%$LLFT[8V;:&/H3@X_*N!L/&ECIG@'1M3M=)
MM=,M[^]-JL0;;!:YD=2[L%&!\I/0<GJ.M 'H5%9>BWNH7BW0U"UAA\N4+!)!
M(72>,JI$@)'<DC';'4UBZ]XLU/3/%VG:#9:/#=O?PR212-=>7R@R=PVG ]QD
M^U '745PUK\09(=%U275M/6'5=/O5L6M8)=ZRR/CR]K8X!SWZ8_"K<OBC4=,
M\36.A:O:VJ/J<3FRNH&8IYJC)C=3SW^]WST% '745Q?PWU+5]7T>\O=4N8IB
M]].J[58%=KD8&2<* .!^IJ?Q7XJU+0=;T73[+2X;P:F[Q*SW&PAPN0,8P!T)
M.3QGB@#K:*X1O%^NL_\ 9QL;:UU6"W$MV/)FNHHW9CLC'E#(RJ[LD\9'!YJ?
M3_&6H:M:Z/;1:6;#6-065Y8+Y746R1\,Y4@%P25P.,YZ\&@#M**X(^,=9@M/
M%RSPZ>;OP\JR80.$G4QE\XW97('OCWJ]>>+;NVU3PE;BW@:+7%/F9SNB(C#\
M'/(YQ^% '0V.LZ=J=U>VUE=)--8R^3<HN?W;XZ'_ .MZ'TJ]7 6WBR_5?&CQ
M:9IT<VBMO^1F FQ&SEF.,DX [#ZU!_PG/B*TTRSU+4M,L8[75/LT6G+"[R2&
M27J749) &6VJ,]!DGF@#T:J%UK>FV6J6FF7%Y''>WF?(@/+/@$G@=N#R:Y'_
M (3N^TN766UC3I6L;&T%S#>K9RVJ3,2%\K$F<,6( YYK/\33:W'XN\"S:E]C
M DO6S' C!H7:/!0L6(<<GD =.G- 'IM%9OB":[MO#]_<6,T<-S# \B/)'O V
M@GID>GK^=<9H7B+5+'P3X5C,EO>:EK!CB@,B%?+4J6=W^?+X )XVYR* /1:*
MY6P\1:A%XXE\,:LEL[M9B\M;FV1D#KNVLK*6;!!]Z?X\\0:CX9\/KJ6G16LK
MBXBB=+C=@AV"\8(YYH Z>BN,_P"$KU+2?%%SINNI9&U32WU,2V@?=$J-AE8$
MG=QT( SCIZ4;WQGK&F^$M-\7W"V;Z9<>4]Q9I$P>**0\,'W<L,C/RX/;% 'H
M-9NDZ_IFMZ8^I6%T)+-'=&E92@!0X;[P''O7&Z3=:S<_%G7H?[1MY(8;"$PH
MT#;0C990,/P<GD\Y]!VI3Z_JGB'X/^(KZ1K2VFB^U0N(86VF-000OS9!/J<_
M2@#K3K/ACQ!J<.EW$<%S</%Y]LEW:G;,A&2T1=<,..WIGI70PPQ6\*PPQI'$
M@PJ(H 4>P%>:2:QK?A?P)X9UC&FW%@D-M'=2&S?S+:W=4&Y2).2._3.1P*[>
MSOI[[7[U(9XFT^U2.,A8^6F8;C\V>@4H>!_%[4 :Y( R3@5FQ:]ITVOR:&D[
M'48X#</$8V&$R!G<1@\D=#7.?$J6]BTC3#:WOV9'U2UCE 0'<#(,9)[ @''?
M%9FI_P!K+\7;*WL;JV6[DT%D>XGB)4 3Y)" C)XZ9H ](HKS>R^(.H-H5E'<
MPQ2:O<:M+IA:",E?W9):14+9/&!C/4_A70^'-2\17.LZE:ZM8,MA&%>SO&C$
M;2 CYE90QY![\9Q0!T]%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 <+XOU2QL_&WAV*>:*QN5BN
M)(K^[<B",$!64+D!G(Z9/'H<XKA=.U.S_P"%<Z\HO!-]G\1K<N=N&6'[3$?,
M*@?*#@G&!W]*]NGM+:ZV?:+>*;RV#IYB!MK>HST-!L[4I,AMH2L^?-78,29X
M.[U_&@#SD:UIFH?&_3IK2_MYHGT5XTD20%7?S"=JGH3CL/>N=?5=,N?@1#8F
M[MVE@G@2>%G&5S=9PP[< GGM7L\5E:P,C0VT,91-BE(P-J^@QT')XI!8V:A@
MMI -S%VQ&.6/4_6@#S;6D\CXJ16^BF""=_#4Z6ZQX5=^X[.![X/X5ES7-KJO
MP1L-*LMB:] \$$-J6Q/'=)* QV]0<;FSZ$U[!]EM]P;R(MPQ@[!D8Z4BVELE
MRURMO$)V&&E" ,1Z$]: //;2#1-3^,'B&UO8+.ZD:PMU5)55^1DNN#WX4_A3
M-*U70[?QA\1&U"6W-G$;6:;=AD95A /'<AA@C'4@=:]'6W@63S%AC$F<[@HS
M^=-^R6W/^CQ<]?D'- 'F.B:M87U__P )KK]S#]JO"MGI6G1S*[PPR, OR]=[
M9))[ _@.537-+DTWP/<P7T4%I:ZJA;3XE++9KN<_.Y!8L?<C/.!7O L[96#+
M;Q!@<@A!D4X6\(  BCP&W8VC[WK]: /,M!U6QM/&/CZUN[A8GGD25(Y01\@A
MY8Y& .0,G') KGO#]XUIX,^'FJ%U.E:?>3#4"OS"%F+JC/@\ ;B>G&17MYAB
M8L6C0EAAB5'(]Z1((HT*)$BHW50H - 'G%[LNOB'JVM6%S"VD)X?\BZN$D!C
M><LQ5<YP6"X/L"/6N7CN[6#X:_#IGN(HWAUN"24;@"JJ[ABWH ",GW%>Y(BQ
MJ%10JCH , 4M $-Q&MW92Q*P*S1E00>H(]:\2TV[D?X;>%9;:.>>/P_J$<^J
MVRQ/N11(QZ$?,5R&P.G!KW.B@#@D,7B#XH:3K6C3)/96FG2)=W$3?*V__5QD
M]VSEL=L<]J?\8%:7X9ZG;Q*TD\S0B.- 2SD2HQP!UX!/X5W5% 'GVM3VTWQ+
M\%31%7@B@NMSJN50LBA,GH,D$"N>N=66TLO&\\.GB[1]7BDQ);>8JQ?(IF52
M,/M*DC&><$\5[%10!Y!8ZO96WC[4=1:?4Y[2[T,>5=7-O(3*?,.2 %&U>P
M'H.>:_@;5Y?"?]CF]$]UIVI6:Q/,T#&:PFC !B.!GR^1CCJ<^I/L]% 'C=G+
M8:+J6L:'XGT34KR6_O)KJU>U$DD=Y'(<A2 P&[L<@#CD\5ZSID!M=)M+<P)
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M<L6  ]LY[8K(OO"&L>(++QO9&WFL3J-W%<V3S%=DA0+PP!.,E>_L>V*]5HH
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MQDERBJA8>RJ@/T-='K7A;1/$5S97&K:?'=R63%H/,9L*3C.0#AONC@YZ5L4
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M_2@#2B^(?A2:>UBCUF(FZ8+$VQ]A8]%+8VJ3Z$@U5TVXN(_BKK%BUW<R6O\
M9T-PD,DQ9(V+L"54GCMT_P *\ZTI[/7O@99^%[ ";6YW_=VZH=RG[3DR$XX0
M+_%T[9R*ZB2&6Z^(VN6UMYHGFT#[%#<F-A'YP+9&[UZ'KV- '8CQCH)DB7[<
M=DTWD13F&00O)G&T2[=A.01UZBI[3Q)I5]K=YHUO/(VH6:AIX6MY%V@]#DJ
M0<\8)S7FJPSZA\';?PHVEW::[&4MEMC P,<BR B7=C:%Q\V[..?6M_QGI6H:
M;K.C:WH93[?/_P 2FZ=C@R)(,(Y]2C#=QS^ H ZH^)M,^P)=H\[K+(T4,8MY
M!),ZYR$0@%ONGD#'&<XJ*U\7:-=:;<WPN3&EK+Y%Q%)&PEBES@(4QG<20 !G
M/;-<GXUTRXT23PO?VEA=WVDZ0LD%U!:.PFVNJJKJ%()((Y^O/K6?K6F"_P!
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!Y5XKU.
MUO?%IM-<U3Q3X=M$<6]I<V;F"VG/&69\'DL2!VPN<\UZE#&(88XE9F"*%!=B
MS' [D\D^]<3XFU6U\4:%K7ANVTS4)=0<-;+'-9NJ*_\ #(9"-@4$!@<Y..!6
M]%J2Z3?Z/X?DMKZ>6:W(%XD685,:\[VSP3CCKUH RKP7EK\4=)7^U+V2UO+.
MY9K1G A0IY>"% &3\QY8D^F*K_$6_N+:*QC>+7$TH%YKZZT@[9(PH^4$@Y"\
MDG']T5)K5UY?Q,T%_LM\\,%K<QRS1V<KQHTGE[ 652/X3].^*V=3\20:7J26
M,^FZI+YD>Y9K>S>:-CG&W*YP?J .>M !X373_P#A'+:72]2NM1M)LR)<W5PT
MTC9[$MR,=,=L5MUQ>AV\G@GPI>W<NF7D_P!HOY+I=/L8Q+)"LKC:@&0#M&,X
MX'/6NS!R <8^M "U'<01W5O)!,NZ.12K#)&1]14E07=W#96\D\Q?8@R1'&SL
M?HJ@D_@* /(? VI:'J_@:UM?$>N73:O<7#6AC?5I?/9FDVH?+W\8R.H_AS7H
MRZQ'I M]%"WFJZE;6:23"!07*@;=[%V RQ!XR2>:Y;X56*-X-;3=2TRYMI8;
MYKD075O(FW]YOC(9U&[!4=.?7K5U1=^&/B-K&IW5M>7.EZS#!LFMH'G,$D2D
M;&5 6 ().<8R: -"Y^(F@P:';:PKW4UG/,("T4#$Q/D J_\ =()Z'GTS4UMX
MULKM84AL-2-Y/-+#'920".8^7C>V'(4*,CDD=<=>*X*]T34=-\,3,=/NY'U+
MQ2-2BMH;=G>& R C>%X4X7IVSCUQT?B=]3TGQGI/BRPTZZU*P^Q/97D-M'F:
M-&8.K!#R3G'&.,>] &W:>-])O-(34(A<!GNC9+:O'MF-P#S'@G&?QP!R2,&K
M.D^*++5M6OM)$-Q:ZC8A6FMK@*&VL,A@59@1R.AKC_%-KK>MV.FZW%H"O!8Z
M@+C^R9U7S9X2FURZ\KOR20.H!SUXKH/"4]M>R27=EX3DT*W,>UFN;6."61L]
M JDG:,'KCG&* .J(# @@$'@@UY/HE_<^&?BA?02RN-"U2\:Q@5Y&98;A41E4
M9)QNWD>YQZ5ZQN7U%><:IX=F\2>'O$UH(;FVNVU$W^GO)&4W.L:!""?4J1Z\
MYH J_%O5;IX(-.L;EXHK:XMY+UHV*L?,<K&F1TR ['Z#UKM+[78M*OAH^GZ9
M/>74=K]J,%OL4)%N*YRQ&22#@#KCM7$>)]'U>?P!;"33Y;G7;Z^BO[V.V7=M
M*D97).!M4*H&>U;.IR:AJ'C!5O-'U*[T5K-?LT4(5(Y)"3O%QN(/&1@'CJ<$
MT 6;S5_#FMV_AG6+FWN95GN%ET]\,OERD'[V#[$8.16GJOB@::U[Y&GW%['I
MZ"2\>)T41*1N/WF&Y@OS8';'.>*X&PM;^R\!>$M-O[&XMKJSU6.-UFQ\W+G(
MPQ.!D#)Q],5>FTNYT/QIK,][X4/B'3M3D%S!/%%%++ ^ IC;?C"\#'/ QUYP
M =A8^,--U*]TVWM%GE34K9[FUG"CRW5,;@>=RD%@.1UK-G^(VGVVDZI?RV%^
M!I=S]ENU"H?+DX'7=RN6 S^E4-1LM7T[7?">K)HS20V<5S#=6NEJN(O, V *
M2 0,<GID9KF;O2=?;PKXVM3H6H1W6JZG]HM0@1^-Z-U#=@IYZ>] '>IXXMV#
MI)IE];SO.8K2.Y41?:@%#;U9B %P<DGITZ\5<\->*[/Q+]MBBBD@N[&7RKF"
M0AMA/0AE)# X."*YWQ78ZK/-X;\1Z?IYU#^SA(EUI\ZA994D"J2 W&X;<UIQ
M:OJ-KHMWJEIX3>-_W:PZ<&2.XE^;#,VW(  .0.3P>F: .MKCOBE;0S_#G6))
M(D:2&'S(G8#*-D<J>QQZ5UZ,6C5F4JQ )4]O:N<\?V-YJG@?5-.T^T>YNKF+
MRXXU('.1R22 * .0UJ[N-*^%WAFVATX-:W L%NMKJH?<4+H1WWX()[Y.:[O0
MM%LM.:ZOX-+73KN_8/=1))N!*Y . =HX/8#KS7(ZUI&L7/PY\.Z3!I-S)>VC
M61GC#QC9Y6W=R6P>AQBO1(G,D2N49"1G:^,CZXH HZWK-OH=BMQ.'=Y95@@A
M3[TTK'"H/<G\N37!Z?)>CXVWDLVDPVMR?#Q;RXY0PF/GK\Q<*#G@#D<8],5N
M_$'1-4U:PTN[T:*.>]TK4(KY+>1]@F"YRN3P#SWJK90:S>_$B'7;CP_<65DV
MDM9.TD\1=7,H?D*QXX.,9//:@"<_$&'_ (0JR\4#39OLEQ-Y3QM( \1\TQ@D
M=^12>(/B+I^BW5_;Q&RGDT]0US'-?)!(21NVQJ02[8^@Y SG..2E\/>*5^&J
M>$HO#SO-:WF_[0;N,)*GVCS 4YR3@\[MO SDGBMZ"#Q5X7\2ZI/I^@#5M.U>
M07>U;M(GM9B@#*V[@@D#D=O7H0#MM(U6UUS2+74[)RUM<QB2,D8.#V(]1TK#
M^(6M:GH'A&YO],BB:562-GD<J8P[! RC!R<L.N/7GH>@T];I=/@%[Y?VK8#*
M(A\BMW"^PZ ^U87Q!TJ^UKP1J%AIL(FNW,3QQ%PN_9*CD9/ .%- $]SX@NH+
MJSTM-/AEUJXB><VJW.(XXE8 N9"F<9(&-N<GVS3_  [XDCUU[^U>W>UU#3IO
M)N[=FW!">5*M@!E(Y!X^E<]=:?KH\8Z5XQATAB7LFL+W3A.AEBC+[U=22%)R
M>1GH!C/.-7PUHEU;^(O$'B"^A%O-JLL2QV^X,R11)M4L02-QY) SCCGT .H(
MR,&O+?!NJQ^&_#_C>_2SEG2W\172I;VZ<DDHJ@ =!DCZ"O4CTKRR'P_XLLO#
M7BFWLK%XKK4-9DOHU%S&AEMW9=R!PQV.0#SVSP<T =!>>(O[2?Q!X=O]/ACN
M;;33<GRYQ/&RD$ '*@A@1T(]#7+^#_&5WX<\"^'#>:!<?V.X2W;45G4["S'#
M&,9.W)QDX_EF]9Z!KA\67MW#X9MM-L;S1OL:C[6G[IM[$EPH.6.>V>WS<G$N
MG>'-8NO -AX-O=.EM!"T:7=X98VC:-)-_P"[VL6). .0N,D]L$ W[KQ=-+_:
MS:)IHU)-)<QW1,_EEI%&62/Y3N*C&<XYXJC+\1%D;P\VFZ1/>PZXCF!Q*J[7
M522C ]"#C)SC&3SBH]&TO6O"6M^(4M]-?4+#4[I[ZUDBE0&*5A\RR!RIQG&"
M,\"LNW\$ZEH-SX(CLK.2]BT8W$EY*DJ*"TPY"!B"<-D]N,=3T /0M(NKN]TJ
MWN;^Q-C=2+F6V+A_+.>FX<&JNO:]'HHLH5C$][?SBWM8-^W>QY))[*!R3@]O
M6M>N1\<:#J>I2:-JVC)#-J&D77GK;S/L69",,N['!Z8/3K0!@:.UVOQ5\4&3
M38#=_P!F0Y@BF!28YX^8J,9&,Y![]:O:?XPL=)\!:/J5MI%MID%]>&U6W,FR
M&W)=P6=E7@?(>W4_C4FGVWB@>.KCQ!>:'!':SZ<MN8([Q6E0J[,!T"L23W(
M##GC%0:3I6N6?@FPT>[\.17:QW4OVRUGEB9987,C@H<D9#,G7'0_6@"SK?CC
M5M T.?4+O0(W,=^EJGE764EC94*R(2HSDL1CU'6IXO&&JQ>)H]#U71(M/EO8
MI'TZ5KL2+,R?P/@?*<<\9_&N'\5>'[OPY\/[^)$DBM)=9MY;"RFF\PP)\ORE
MAD %L\ G QR:[]M*O==\5:1JVH::+*#2HY6C5Y5=Y)I J\;<@* #R3DG' H
MSG^(%VOP^LO%(TR']]/Y,MN9S\O[XQ JVWGIGD"K=OK&KK\0-7M;MK5=-M+*
M*8 .PV(6D^;&.6^49Z  #&:Y5_"/C%O [>$Q8:?Y5K=B6*[^U'_2%\_S/N[?
MDQDY)STP!WKH[G0]<N?%MY--I]F^FZOID=G>LMV<P;2^X+\@+Y#D X'J<=*
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MPQ2[&PK/%@C/R \]>I'2NK@TO4Y/$]IXUTJTA/V^P2WO;">78RC((9'"D$C
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M:2-;-;:.65H!Y;22;U!RY 4 !<9)]!36\7>(=*LO$,^I:2TMMIUJ+BSO#"T
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M5S3M$T[2)B+,%)'^8JTK,2/8$GVK"U#XAV>GP:C>MIUV^FZ;>_8KJY!4;7R
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M[:W5O=P23>:ES;O$?FE=@1N49R&!XKLZ* .6^(FC7^N^"KVRTT;[O='*D6[
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MNN)HF8;H&8 %<@=1UZ<5<;PYXD3Q!=:C!H^F06USHIL!:PW.! =Y(&=@SU[
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MR<9(R <X.#ZYAF\"O'K]CJ>G:O+;"#3%TN59(_,>2 ,&R'R-K\?>P?I78T4
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MFE^&YK;Q%/KVH7L5Q?RVPM?]'M_(38&+ D;F+-T&2>W %=#10 4444 %%%%
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M766N;<1@.K RHQ]\ (><8.10!Z-;^-H;E"%TK4(KA[AH;>"X01&=54,906(
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MF.XBO<?\O*G<7(_VF+'\:+/3O&TVG77]JZKIJ7RV[1VGV)'$9D(XDDW#)QZ
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MUHD_=R%@P.!C/W5!Y[<8J]<^#]1N]>T'6+C7_-N=)63!>S7]Z9!M?.U@ ,<
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M' _&(F3X?7-I'&\MQ/-$(XHT+LV'#$X'8 =?IZU9;4?"EA<PW>C:;$=3)^SV
MZ6UFT6\R$##$* %R 23T _"NUHH \O6ZA-Q\3" ^;B,"$^4W[W%OY?R\?-\W
M'&>OO52.^@M_!'P_BE682VM[;O.@@<M$J(ZL6 &1@D5ZW10!YU::_I.D>/\
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M'/Z9KFSX;\6Z=X5U_P )VVFVUY97+3FRO#=A"J2$MM92,ELD\],GJ *]3HH
M\O@\->+= U+1]=TNPL[JY32X]-OK W6T$)C:ZN1C/ R,<?[6<UZ%I)U)[(2Z
MJL,=U(Q8PPMN2(=E#8&[IDG'4G'&*O44 4=8$[:->);6[7$SPLB1*RJ6)&.K
M$ =<UR'A*'Q%X>\'6.BW/ADW$MO"R%A>0[&)8G!R>!SZ&N]HH X&/1?$=SXS
M\-ZWJ%M&WV.UF2[99$&UY!G:@'55SMSU.W/U@AT#7#X;\:6)TORY=9N+B>U#
M3IP)$" -@G!^7/&1SUKT6J=[JNG:=)#'>WUM;/.P2)9I54R-D#"@GGDCIZT
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M*Q^8R[?,8%B2<?P@@#/4\&NEHH X!/AY?KX-U3PX=<M3#J$[S-*-/(*;VW,
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M#L-:\=0:?>:A:V@L)I=/ ,Z7-^L#.VW=LC!!W-@CK@9.,]<:EEXFM=0\'?\
M"26\4HM_LKW CD&'&T'*GWRI%<R+'Q?H/B:\U/2--AO]/U?9/<64]TL3VLVP
M*?GY!' Z9_3-=I8V]T=*6#598[BY=6\\QKM3YB3M4>@!VC/) YYH XWX86T>
ML>&O^$GU(0W>J:K)*\TS+G8@8H(EST4 =/<]:T)HM,^'EGJNHP0JMM?74;16
M<*A"9V 3:N3C!(![8^:J'A_2?$?@6"31['3X]9T82/)9LEPL,L 8YV.'X89)
MY!]?PL^*O#6M^*O#KH]Q;VM]'<Q75I "6CC9,_*[8RQ.3SC P..I(!='BJZM
M/$UOH.JZ=%!<WD#S64L-P7CF*#+1DE5*L.O0C'Y5SP^)^HMX<?7T\,L=/M[L
MV]T1=J60!@I9!M^;D]\?UK:_LO4]=\0:3K.J::MB-)21X[?SED>69UV\$' 4
M#IGDG'3%<U%X-\0)\--1\.OI]L]Y<WK3HQN1L52X?.<9R,8QCO0!U%OXMOE\
M41:)J>C?8Y+VWDGL2+D2-)LZI( ,(V.>"P]ZP5^)FLOH=_K2>%0UAIUT\%VR
MWH+ *0"RC;\V,Y/3^=:NH:1K=]\0/#VN+81):V,,L<X:Y&X&08. !SC]:Y7P
MC:ZQJOA+Q-H]E9VQM[W4[R$W<LW^JW'#'9M.X@<CGGVH [#4?&5S%!<7=C80
M&QAL8[Q;F^N#;I.7!8)&=I!.%YR1@L/K4%SX[O/M'A=+'1!<KX@MFFAW701H
MR(]Y# KC !&2#G&< G -.;PIKMOJES;6D.GW6FMIT5G93WDC%K+;&4;" <[N
M"2".W/&*K6/AOQ3!=>"))["R9= ADAF\N[^\K1"($97J -WXX]Z -)?&NL_V
M/K\AT2!]4T.7;<6Z7#;)4V[@T;;<DXYP0*UK'Q)/J<.@2V4$$RZG";B5O,8"
M&, 9(^7DY8+@XYK,T2&]T77O$>JZ_'8V&GZE+$\;O=@[2J"/:V0!SC/Z4?#S
M1(-.CU2[M9_.T^6[DCTY>"L5N')PA_NER^/4!30!M>*/$47ARTM)97AB%U<K
M;">X8B*$E6;<Y';Y<?4CD#FN2\;:A?7?A&UN+NRB,T.M6ODBUEWI<*'4JR,P
M'WLX]CGFNO\ $EM?W=G;Q6=C9W\1F_TJUNV 26+8W )5N=VT].U<1/X(UNTT
M#[#I=I;+"VJQ7\5DUXQ2T1"K;%8CG<02<8 SWH Z*T\6ZC'XEU/1-3TR$75O
MIYU&W2RE:4RQABNSE5^?..GK5/3_ ![<R>(M$TN^M+1'U>-W$$4Q,]DRIOVS
M*1U(X[<@\<5'J7AGQ%?^-=1UBU:VLEGT,Z=%-YY+QR%]^_ 7L>/U]JS+#P9X
MIBO/"=VUKHUNVC-*LBQR.3+O0*TK''+$C./4\GT $L"IT?XIQ87BXNFQM]8/
M7\/\YKL_ TS3^ M D;J;"']$ K$MO"6LP6GC&)C8%M=>1H<3/^[WH4^8[.P.
M>/IQUKH_"^F76B>%=.TNZ,+3V=NL):)R5;:,9R0",_2@#S+PUK^L^'?"GB+4
M['3+:YL;/6;F6Y,LY1W7>H(C !&0.<L1[ UVFM>+;ZTGD-K;VL%@E@+I+V_8
MJD\AZ1(!@YQCGD\]*S(?!.M1>"_$6A?\2X2:K=33QN+A]L8D(X/[O)QC\?:E
M'A#Q*NLM=B;2I(Y--2R3SVDD-F0NUC$,#(;J?N^G;D =+X_OWT?PQK<-G:PZ
M9JTJ07+SLQ-JS$C)(P"IP1DX[9ZUK:KXKFT>;6;F9()M/L!%&BQ ^;)<28Q'
MUQQN4].C#T-4=+\$73_"QO"6KRVWF&!HD>$%@AR65B3U(;!Z#T]ZM7'@C[?X
M /AZ[OC]ME"RS7RKEFN P8R>_(Q]* ':7XHU.?Q-#I5WILDEM/ 9%O8;2>*.
M*09RC^8HZ@<'/MCFJOC.ZUB'Q1X5M[*Z@CMKB\8%'B8EG6-S\Q!'RX[>OTK2
MT&R\6+) ?$6H:=(ENIQ]A1U:=L8S(3QC!)P!C.#QC%'BS0M2U:ZT6]TF>TCN
MM-NS/MN@Q1U*%3]WG/- ',M<:Y;_ ! \9MHL5B9EM+)WFNV;8FV-R %498GG
MN,8_"KMM\0VU+2- :UA$5_JUN\SGR))UMU0[6;8GS-EN!R/<U=M/#^NP>(?$
M.HR?V<Z:K;PPIMF<%3&K*&(V'KN)QGC&,GK6':_#K6].T?0#I^I65OK.B"6.
M*8JS17,;DDJXP".O;/\ @ =1X/U_4]:@O8]5TV2TN+2?RA-Y$D4=RO9T#@$
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MYG<HFY6?&_;QC!P.N<5,?!*P7VF:E8:G-:ZE8VBV1F\M76XA'19$XY[Y!'-
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MQEE7+6UP,/&<XP:Y#PW-JT?B3Q=X=GU:\GBLA!+:7<^QYE\U"S?P[2 P.!C
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M)/&,D>]=%XG\,KXG@M(9=1NK2.VG6X @6,[G4Y4G<IZ'M^>:VXU9(D5W+L
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MQ7;UE7^I:A;:WIMG;Z1+<VESO^T7BRA1;8'&5/7/^<T 8M]\/K+4]6U&_O\
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MGW.CQK-/;NRR,R,,J5*D@Y/'7@U.GBR>!+F74M)>"WBLFODGMYA.DJ CY5(
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MMVEM]VQRQ&#AAN&!ZCK4^I>"[C4]!BM9M<G_ +4BO4OUU#R5.)D^[^[Z;0.
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MZ39W&I2"\TB1)+&]BB",FQ0H#+DA@0.1QGBIY_"C71U.YN-1:34+^T^Q&8Q
M)#%SE43/&<DDDGG'IB@"EX"F\1:II&GZWJVLQ7,%W9*?LJVBIM?/W]XZDCJ,
M8YXQ5'Q7JVKVUSKLMIJEQ&VG6BS6MM8Q)(!\A9FN-Z\ D8 W [02 3S74>%]
M$D\.:!;:2]Z;N.V79%(T00A.P.#SCUK%O/ /VF_UN2'7;^UL]90_:K2()@OM
MV[@Q&0,=0,9Z$XXH S;C7M?O?%OAK3K74H[2#4]+:ZF"VROM?:#D9/Y=O4&J
MPOO%,_A+Q%%I^ON^KZ%?31I(8(BUQ"JJP#J5(!P6 (QDBMZR\"FSU31M1;6K
MN>YTNU-JADC3#H1CD #';\N<G)J*5++X?/J&K3OJ=^-8O5,D4-N)-DA!Q@+@
M@'&._:@"?P_KC>)KS3KO3M2F-A'8K/<QE8SODD)"JQ"Y!7:^0,?PU#X\U'6-
M-N?#O]E:B+87NIQV4J/"LBL'#?,>_&.@(]ZT?!F@0:!HKK%9+9R7EQ)=R0C'
M[LNQ*H<?W5VCJ1D'%87Q.4SOX8@CEFB=-9AF>2%=S0H P,G0@ $CDC% %%M8
M\0>&_$>M:#=:Y!=H='?4K2^OU5/L[AMF'VC&W//2K6E:EJP\66>FIJ&I/9ZA
MIDLBSWT<>?-0J!)&N P'S='&#QQ6S>>!;+5K;5%U2]NKNXU*W2W>Y.Q6CC4[
M@J # &[YN^35>/X?1IJMEJKZ_K$FHVL+0"X>5<NG!56&W& 1GI\W.[- '):,
M?$7B7X<7>MZAXHO D=O>*]O#"B&3;NVDL!D<CMVXXYSW?@.V:#P'HF;F>4RV
M$$@,A!\O,2_*O'0=LYI-!\%VNA^&KK0!>W-U8W D4B8(&4/G=@JHZY/7-7/#
M7AY/#6E)I\=_>WD<8"HUW)N*(!A54    >U 'G&BVDHT;XF2R:A>S^3->P[9
M9 P<"' +<=0!CL/:M*W?5M';P/?IKES<0ZDT-I-9LBBW$;0D@JH&X$;1R223
M[<5T,O@&S:XUN2#4]1MH]7W&X@BD7R]SC:[ %3R1QSG&<CG%6)O!D-Q:Z-!+
MJNHD:0Z26Q4Q ED!56;Y.>#CT- '*VM[XM\6Z;=:MHUQ#:3I>R)!YE\1%$D;
M[=CQ"(AMP&22V<D$$#Y:2,:]KOQ!U?2D\4WEI;165O=(;8(RJS8.U3MY3K[D
M8R>H.[<?#;2I=:N=0AO]4LX;Q]]W8VMR8X+ACUW*!W[\\Y-:MKX4M;/Q3<:_
M#>78N+B)89(<Q^444?*H&S(QVYS0!Q-G>>+O%VG7>K:-=P6\\=^ZP-)?LL<*
M(V/+D@$1#97DDMG)!! XK7TS4+GQCXDU^QFOKFRBTR.&&%;*8QYD="S2YZL,
MXVY^4C!P<U=F^'&D/KD^I07>I6D=T_F7=E:W)C@N&]74>O?!YS6A<^$;.37&
MUFSNKO3KV2$03/:,@$J#IN5E89'8XR* /,]7UN\\0_!R/4M4>9K^RU)+=Y8Y
M#&LQ69?GVK@=,=1P0<8KU.30YQJ.F3VNL7T%K9ES+:F0RBYW#C>SY;CZGVQ6
M?J7@+2M1\-6WAX37EKIL!#"*W=<NP.[+,RDDYR>O)/-+JWARXO=8T&ZCO=0,
MNGR%FG\]41ER-P=% W%@-O  P3GT(!3^)\^IV7A/[=I>I7%E+#<0JWDE0&#R
M*OS9&>,] 1UYS6;=1:SX?\?:7IZ^(-3O+'6X+D2>>49K:2-0V^/Y,*.0 ,'^
M5:/Q4CFNO ]Q8V]K>7,UQ-#B.TMWE;"RHS'Y =O /)K4LO#=N9AJ?]H:E->-
M;>1!<W.WS((S@D*I0 ,<#)92W'- 'G6GZSKFE_"UO'4NO7U]<I#)#':SD>22
MUP8U=AC)89SVZ <"NGUU[_PM?^&;FQOKR\MK^\CT^\AN+AI/-\P9$BY/R,-I
M/RX'M6]I'@W3=)\-W'A\RW5YILX<-%=.&P'R6 *@$ DD_4\4NF^#]/TY[%FG
MO+Q=/!%DEW('%N#Q\N ,D#@%LD#H: .5AU2Y\*^)]?T?4+N[O&NXDGT1;B[8
MF7=\IA4D\,'(&>N.2:NW$.HZ+XL\#V)UB^G2=;B*[224LL[I 6WG/.=W..@X
MP!BNHU'P]I^J:OI>IW,9-UIKN]NP/=EP0?4=#]0*;J7AVTU75K#4YI[I+BP8
MM;^5)M5"PPQQCG(X.>U '"--)XQ\'^+]6N+Z\ADMWN[:WAAG:-(4B3@,@.&9
MNK;L]>,"I+;4KW4-3\/>&86$4 T"*[*FYD@-PQ"J &09^4 G (Z^U=#>_#G0
M[S4[Z]62^M?MZ,MW;VMP8X9BP(+,@X+<Y],\D&DO_AQH%_H^GZ<XO(_[._X]
M;F.Y;SXAZ!SDX]N@[8H YYKS5]&O="\)ZCK(N!?:A*DUU'(_F1PJ@=(6DR&#
M-N4;NI%:7AZQ_LWXK>(((KBXE@?3[:0+/*9"GS., MEL?>/7C/TK:NO VAWF
M@0Z/-!*889/.CG$S>>)?^>GF==WO4FE>#M*TC5O[4A:[EOC ('GGN7=I%&>6
MR<,>>IZ8&,4 ;]%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %1&YMQ<K;&>(7#*7$6\;BHZG'7%
M<G\2-=U30?#T$VEK"&GNXK=Y'D*L@9A]T 'KR,YX]#6+J#7-E\7["Z@TB&34
MKC1I/-C@E 5F$@ 9I"H)   SM)Z "@#TNBN3L/&DFH:+]JAT:X%\NH_V;+:%
MLB*4-ABS@'Y .=V/PK.U/QSJ$>A>)WM;*S&H:*!O877F1,K*2'4A>2,8VG'3
MK0!WC#<I7)&1C(ZBLG1?#EAH$EX]B;C-Y,9Y_-F9]TAZMSW.!^5)X6N+V[\,
M:;/?K&)Y+:)MR2F0N"@.YB5&"><CGZFL_4_%DMMXCGT2QM;:>\AM%NA%/<^4
MT^2P"1C:<GY><XZCWP =117,Q^+)?^$HTK0Y].,3ZA8F[\SS3F,@<HRE1SGC
MK5"W^( EAU!'TTB]MM5&DPP1S;A/,>AW%1M7&221P : .QN+B"T@>>YFCAA0
M9:21@JJ/<GI3HY(YHDEB=7C=0RNIR&!Z$'N*X7Q1JE]>>&_%NE:EHS0_9M*E
MFCNT)>"7,;<*S*/F!]C^%1>'?%-_86/A"PN]'\JQU&TBMX+CSP9!(L0.60#
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M=Y8HQ)&A>1MS@%(U')=AD#'<URVGW&N)J_B;3K.6ZLV.F1W-E%J5WYYAE<R
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M1G.<_A6_#)YL$<F,;U#8],BL[1;_ %._6\.I:2=.\JY:. &82&:,='XZ9]*
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M^">@ZC%#')J>D1?;+7Y,[]C$F,@CD,HZ>H%=EX-N(/$C2^+EM!"+R.."V#H
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M]>\6:UHMIJ,^F66CPP1JMHB!FDD0L&)93\J@ !1QUSVKD+CQEXEO/"^BR)J
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M7C)W$@YX.XGZ#WIOAWP;KND^5I]_XGDOM%M&1[:$0A)3M(95=\Y*@@<#KC'
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M)(O49(((/<$$'-;E% '-W'@K3KK2M1LI+B\WZF1]MN]ZF:< 8"DE<!0. %
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MX%S: BW:*[EC6($8(558*,@8.!S6U10!'-$L\+1.7"L,$HY1OP(((_"N?LO
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MRVTZ!X94,;J>C*1@C\JX!/ACY?@3^PQJ);48[A)X+\@YB,;?N]OIA...Y)H
MSO$=_JEQ+X4O9Y;:=I?$!6S\M&A4QX=$+'+9!X;CL:TV\=ZAH"^*HM>6UNI=
M%C@ECDM4,0E$H^52&+8(/?/?I6AK_A*\OG\,0::UK'9Z+<Q3_OG;<XC& H 7
M'3OG\*KWO@6YU?5?%$E_-!'9ZW!% !"[,\7E#Y7Y4 Y."5_4T %]XFUGPW/H
M=WJ\UI=:=J]PELXAA,36LCC*D$L=R\'.<'O[5T7BB?5;3PY>W>B^2;ZWB:5(
MYHRXDV@DK@$')[5B+X3U/4X-#M-?N;26#1[A+A)+?=ON9(P50L",(.<D#=D]
MQ79T >97'Q"OHK;PEJ:W%J=-U0)]O'V<[K?)"EMV["KO.WGTXSS6[J&M:U#%
M?W5M-8K8Q:@EL)[A0BPQ @2RDEP'PQ*!1@Y4]>E4K7X8V<'AC7M#>Y9[?4'?
M[,#R+6/<7C50?1R6/K4]_P""K\^%M!L-.U&-;W29H[@FX4O#<R#)8N.O+$MG
MU_, %*V\8:V++Q9'!%_:ESI"0R6K&U:%Y5D4L=T9QDJ 2,8W#'3-:O@W7Y=?
MFN9X=9MM3T\1KM*P>3-#+D[DD3/ QC!QZ]<9JI#X4\46^KZSJ,6NV/G:D(&R
M+5E\MXCPHPWW,9!SDGVK3TCPN]GXKN_$-P;6.YN;5;=XK1&5'(;<9&R>6Z <
M< 'DYH =XCU+4;34K*W@NH;*SF23=<;!-,THQMCCBZMD;B< \#MUIW@?6[SQ
M!X6@OK]$6Z$LL,FQ2H)1V7.#TSCI4.K^'-5N?%MIKNFZG;Q&*U>U:&ZMS*J!
MF!+I@C#<=^N*E\&>'K[PSI<UA=W\-W%Y\DL)C@\M@'8L=W."<MV  Q0!SGAF
M8ZE\8_%DUV0TUA!!:VH/\$399L#W.#GWKMM1M[..2/5[A2)+".1PZ]=A7Y@?
M4< X]0*Q-6\(W$GBB/Q-H>H)8ZIY0@G26+S(;F/T< @@CC!!["M&'2]0NY_-
MUF]AEB".BVEM$R1_,""7)8ESM)'8#)X)P0 <E-XIUY/ D/CB*>-X"!/+I9B7
M:("X7"OPV\#G)R#Z5)%K7B'6O&^IZ+I^LV]K9"PBN[>?[$'= Y&.&/)P>I_*
MK=EX$N[;PZWA>754GT'S,JK0$3^5OW>46#8QGC=C."1@<$7X?"M[:^,[_P 0
MV^I6R_:K5;9;=K-B(POW3D2#//7@?A0!R$_BSQ7:>!+'Q;-J-JRPSB">R2U
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M*.>&2&5 \<BE74]"",$5Q.B_#VZT6X2UB\3WTGA^.0R1Z6\2\<Y"F3[Q3/\
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MS $  , >-WR@[CDY]N*;/X!M;E-(\W6=7:72V\R"8S(S%_[S%D.>,#'3 Z4
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "HQ!$'WB) ^<[MHS4E% !1110 4@ 484 #T%+10 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MH[^O3K0!Z4"" 0<@]"*\?U'Q'J]G#8:I;ZI=W<S:TMO-<P$?87B9R/)56/)
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M=W[:[XBL[:SU#R/LL-M!)Y@CCW;F);U8A>!V4>M '21Q1Q0K#'&J1*H5448
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M)8:/IFE+(NGZ?:VBRG,@@A5 Y]3@<T >;:W;VEOX2\%ZKX<C6._:[M8X)8$
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MH% '>U ;NV%^+'S5^TF(S>7WV @9_,_S]*\6NY=4LOA=?>)?[?U>6^L-298
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MZB@#U^BO&;[4KKP9)\0+/2;B=;6T2SE@$LS2M"TVU9&!8D]"3SGD"M]M+O\
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M\IWQQ>&R753R<2Y('O@4 =O;Z]I%W>_8[?4[.6YP3Y23*6..N #SC'/I3?\
MA(=%-K+<C5K%H(3B61;A"J'T)!XKRFSU73UN? ERVKZ;#90S-Y-FDP;[+&87
M \V5CG=D $<#.1SBM75+6^T[QOK?AZVM7>S\50"2.3:#'!)C9.QS_LG=[G:.
M] 'HIUG3!]C/V^WQ>G;;$2 B8_[)[_A4=MX@T>\O19VVIVDUR02(HY06('7
M[XK@?!7GSP3:/JRS9\*Q36KRC@2ELA'7W$0(_P"!BHO"\\NE:[X=L#?6VO:1
M<1RC2;J+Y;BS0)RL@'WEQA23T(&<8 H ]5HHHH **** "BBB@ HHHH ****
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MG'7FNAS10 A 8$$ @\$&L-/!VA0F;[/:26J3G,L5K<RPQN>^41@IS].:W:*
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M\O\ [YQBFR:+I4MA]@DTVS:SSD6Y@4Q@^NW&.YJ]534-3L=*M_M%_=16\1.
MTC8R?0>OK^% $MK:6]C:QVMI!%!;QC"11(%51[ <"H5TC35O3>KI]H+LDDSB
M%?,R1@_-C/3BJ5UXL\/V4%K/<:O9I%=Y^SOY@*RX./E(Z\U;CUG3IM6ETJ.\
MB:_B7?) #\RKZD?C0 )HFDQPB%-,LEB602A%MT #C^+&.OOUJX8HVE64HID4
M$*Y'(!QD ^^!^0K&F\6Z)%.]O'?)<W2,%-O;?O)"=P4X ZX)Y].<]*BT2]51
MK%U<>([;4;6.Y9MRA%6T7:#L+ X.!SDT ;BV\"F4K#&#,<RD*/G.,?-Z\ #G
ML*KVFE:=82/)9Z?:VTCC#-#"J%OJ0*KV'B/1M4DGCLM2MYGMT#S!7_U:GN<]
M!1IWB+1]6NYK2PU"&>XA 9XU/.T]&&>H]QQ0!J4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!S_
M (R\2'PSH:W4<:R75Q.EK;(_W3*YP,^PP2?I63>:[K/A_P 6:5H]]>6]W!K$
M4B6\[0;#%<( <$ \H<CCK[UN>*O#EOXJT&73)Y7@8LLD4Z#+12*<JP]<5GP^
M&=2O-6T_5=<U"UN;S38Y%LUM[9HT5W4*TCY<EB0.@V@?K0!F>#=;\6>(;O[3
M<RZ6-.M+RYL[M41A)(R'Y63J%'(&"?4\Y&-_QIJE_HOA#4M3TUH%N;6(RCST
M+J0.HP".:@\'>&+GPO:W\$^H0W@N[N2[REL8MK/C<.7;(X&/ZU=\4Z--XA\.
M7ND0W<=K]KC,3RO"9,*>N &7GWS^% '')XF\5V.G:5/?R:?<2ZXUNEG#;Q[6
MARA>0DLP5CM P,C+-Z<&S)X@\6Z'8>(;K4--DN+*RL_/L;B=8UD=P/F618V(
MP#SD < UH:AX'?5O!EEHE[J8%W8&-[2^MH#&8WC&$;:6;)QUY&?:L_6K'6-!
M\":Q?ZSX@N=1OUM#!'/;VZQ"!7*@D*N<\X+-UP. .X L&NZ\/$/ABQCOX[F#
M6;-[J=WM@WD;45OEVE<(2P4;MQSCDU#;>*=9E\/>.+AKI?/T2YN$M7\I>5C3
M< PQ@^_2LCP[)-IES:?\(_XKT/66EEC26RM-,2%WC) +,Z,2N!DY88X_ ]%?
M?#VYFN=?6QU^2ST[6UD:YM?LJN1*R%2P<D';T)7OZB@"C]HEU7Q!\,-8N70W
M-Q:SO(%7&6>TW$CT&:C\4^*M?T:WU6\2\3[1978\JSM8!-#]G^7F=]N8W.XD
M#*].A'-:L7@?5K:7PR8/$41CT&(QQI+8!O-RGEG)#C V<#OW)-5[WX<7ES9Z
MWIT/B6>#3-2G>Y6W^RHQCE8ACE\Y9<C[HV_7U (H5U!_CC=PG5)S$FCB9(RJ
ME54R@% ,=.!SU]ZI)X\UC3_#/BR^NY(;J[T_66T^T_=!$49502!R0,EN23VS
M72+X.O4\56GB!=>D^U+9BTO/]%3_ $E0VX8[)SC. >.XZU6B^'-K+I&OZ9J-
MZ;J#6;MKV0I%Y;12L0<J<G@$# /XYS0 FH:IK?AOQ7H-G<:@U_I^K%[9Y)8$
M#0SA<J1L"_*?0YZ'FN9B\1>,;CPAXBUX:Y KZ/?31I"+--LR1E<ACU (/&.?
M?T[6R\*7OVZQO=9UG^T9].1ULB+81!&8;3(X#'>^.,\#D\<UF1?#RYA\-:QH
MBZZ?)U6X>>9_L@W*7^^!\W? ^F#Z\ $/BKQ+J&E:F1>W%YIFE2VB-:ZC;6ZR
M1)<$G(F)5B!]W QCKWQCM]-9WTNT:2>.X<PH6FC;*R':,L#W!ZUSLWA/5)EN
M%;Q$VR[M1;7$9LT9& R R@GY6P<'J#@<5T.F:=;Z1I=KIUHI6WM8EBC#')V@
M8&3ZT <+XNUW5[*Z\1>1J,B?8;);BRAL$5S&54L[7)9<*"=N%SDJ#@9IAUKQ
M!JFJ>#8H-8%E'K6E-<7"I;HVUQ&C$ID=?G.,Y QT-:E]\/8[O5]9N8]:OK:R
MUF/;?6<03$C;2N0S E1@]!U]<<5+IG@*/3KG1+EM<U*>72(#;P!A$$*%0I!
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M_DW.P ^;%(&SG(&X'D@\D\UV>F^ O#NDZ1>:9:V3"WO%V7!:9R[K_=W9R![
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MVH%P%64*"H8+C P#TX!]R 3R*EN/"6C;X;N+3$EO+.,BT+S.-N.B@Y. 3UH
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M*L Q&0?<<T 24BNKYVL#M.#@]#Z5X)I-E%I?P=G\4VGVA=5A>6W$Z2.2D+W
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M6GCMT0Z!OS(% +_:#@\_Q>_6@#6\$^*;C6+/46UBYM$N(=5GLH0@\L.$V@
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M9T?6@WVG34MRJAB,%U;><,>I.,'T'&-O7_$=CX=T>ZU.Z$TT%J0LJVR>8RG
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M,:A$C0855'  '85SUS\/O"EY<7\]QHMN\E_S<$EAN/\ > S\K'N5P3ZUTM%
M'/#P-X;4$1Z8L2LH1UAEDC5U ^ZP5@&4]P<@DDG)-;Z1I'&L<:*J*-JJHP /
M0"G44 <T/A_X35+E!H=KLN9%ED7G&X'(VC/RC(Z+@'O6_P#9+?[%]C$2K;[/
M+$:_* N,8&.G%344 9NG>'])TJRFL[&PAAM9L^9"HRC9ZY!XY[^M5]-\(>'=
M'-P=.T:SMC<(4E:., LIZKGT]NE;5% &3I_AG1=*EBDLM.@A>%2L1 SY8/4+
MG[N?:HG\'>&Y9;N230[!GNV#W!:!3YAW!N>.<L 3ZD<UMT4 94?AK18=3CU*
M+3+:.\C01I*B;2JC@*,=O:IK'1-*TRZN;JQTZVMI[IM\\D405I#[D=>>?Q-7
MZ* *>H:5I^K11QZA9PW*QN'C\Q 2C#^)3U!]Q33HVF'3FT]M.M6LFR6MVA4H
MQ/))7&#5ZB@"O96%GIML+>QM(+6!>D4$811^ XJ&\T72]0O+>[O=/M;BYM\B
M&66(,R9ZX)Z5>HH QQX4\.""2 :!I8AD8.\?V./:S#."1CD\G\Z?'X8T"&>"
M>+0]-2:WQY,BVJ!H\=-IQQ^%:M% &=#X?T6WN_M<&D6$5SNW^<EL@?=ZY SG
MWJU>6-IJ-J]K?6L-U;OC=%/&'1L<\@\5/10!6MM/LK.R%E;6EO#: %1!'&%0
M ]1M Q7,>(?!D3Z(]MX9T[1K*5YXY+B%[15BNXT.[RGVC."<?ECO7844 <%H
MW@R1]0MKG4O#OAO2UMG+C^S(LR2M@@ MM7"8/(YSCTKL[33;&P+FSLK:V+XW
M>3$J;L>N!S5JB@"I;:5IUG<RW-K86L$\O^LEBA56?ZD#)I1IMB+S[8+*V%T?
M^6_E+OZ8^]C/2K5% %!=#TA!(%TJQ42##@6Z#<,YP>.>0#^%-.@:,R*ATFP*
MKG:IMDP,]<<5HT4 5I].L;F:.:>RMY98L>6\D2L4QTP2.*:=,T]KIKIK&V-P
MWWI3"N\_4XSV'Y5;HH KM8VCQ/$UK 8Y!AT,8PP]QWJ9$2*-8XU5$4855& !
M[4ZB@"![*UDN4N7MH6N$X65HP67Z'J*<UO \GF-#&S_WBH)_.I:* "H/L5KY
MSS?9H?-<@L_EC+$=,GO4]% #'ABDD21XD9T^ZQ4$K]#VI%@A2'R5B018QL"C
M;^5244 ,CBCAC$<4:H@Z*HP!2O&DF-Z*V#D9&<'UIU% #'ACD=6>-&9>5)4$
MCZ4^BB@!AAB+,QC3<PPQVC)'H:411@J0B@K]TXZ?2G44 8WB&PUN_@M5T365
MTN1)@TSM;K-OCP<@!NAZ5H:?91Z=IUO91%F2",(&;JV!U/N>I]S5FB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MP5;6Z8M<*KLIF)ZEV!W-^)- 'FMWIFG:#X0\+W*)<1P:Y/I\>K3&X9A(@C)
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MOATVGV0Z#I9MM^_R?L<>S=ZXQC/O4PT#1A>Q7HTFP%W$JK'.+9-Z!1@ -C(
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M:@;D3"-=TB&.+< 6W$<GV'2I/B9?SZ=X+FEB63R'GACNWC;#1P,X#G\1\O\
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M/K>GQ@2^22UR@ ?KMZ]>17F?AZY\/:[X9T&UNM<U!]5T^2,QZ7&(DG2Y3@X
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M&#@I?6SV.WS$W$^:S _NVV;/E_O$]1G'8:AJ%KI=A-?7LOE6T(W2/M+;1ZX
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MM3NY%9;?^R$B$S*0F\."5W=,XYQ0!K?\+%\+F.SE342\-V55)DA=HT9C@*[
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M.'^B 7DP\GTVD/P1T![# Z"N@ZU4U/4(=+T^6\FR50 *B_>=B<*B^Y) 'N:
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MYVXRV.>GO7H6H>&-(U/3K6QN+7$-HZR6QC=D>%EZ,K Y!]\TZW\.Z9;QWJM
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MG)S0!Q?C;0]/TSP5XEM4NVNU26&[BM9E!6QWR 80]@<-QG@>F<G5U>UMM/\
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MV:$L6$0=,D GG&><=/SJ]K__  D!\2VT]KX?34K*T3?!F_6$><007*D')"G
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M7CK3@   !@"@#S'4])O[#XA:AI5A;LVF>*;;?<,?N0,A"S-CU:,_BS+VJQX
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MVWGMWXZ&NNT^RDU?XDOXEAM[FVL8--%D#<V[P/.Y?<2%<!MJC')'7ITKM**
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MM5NKN$P$8AVR#]\W95]?Z5YY;:5IUY\2O#D4Q;489M!+/-=1X:YVM\K.#UX
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MU&,M.$ <GSW'WNO2NPU:Q_L_Q_J,&@V\-K<GPG.+=+5=C>:)1LX QGICO^E
M'?1:UI4^H-I\6IV4EZI(:W2=3(".N5SGCO44OB30H(S)-K6G1HLI@+/=( )
M,E,D_> (XZUY;X<D\-:[HWASSO$6HOJME)'Y.G1M"LT<_1P!Y88J>2Q)P1R3
MD5+'I^F/X3^)TIM;1Y8[R\"-Y:DH!$I7'I\V>G<4 >@W_C+0].\16VAW&H6T
M=Y,I9E>95\O@;0<]VR,#J:WZ\VMM1@@USP%=7UW'&'T.;=+-(!N8I 3R>IZU
MU?C?[=_P@^M?V:&-W]CD\O:<-TYQ[XSCWH N6WB'1KR_^PV^J6DMW@D0K,I9
M@,Y('?&#G'3!J)_%/A]+I;5M:L//:581&+A2?,/1<9Z\=/\ &N U)[+5O _@
MA]%EC&I)<VBV1C W1E0!*"!SM #;A[5:\'Z;I5Y\0/&OGVEI,\5[;O%O16*$
M*3E?3D Y'<4 >DS31V\+S32)'%&I=W=@%51R22>@K-M?$VAWGG^1JMHQMT$D
MP,H&Q3T8YZ#WZ5E?$B_M-.\!ZE+?61O('58FA\QD!W, "S+R #R<>F.]<38Z
MSIC?%Y);O7+"^@GT#R#*@5(&<S9\M1DY^7GDD]>?0 ]'C\6^'9;FUMX];L&F
MN_\ CW03KF3G QSSD@@>O:IK;Q%I%Y>W-G;:A#+<VN?/B0Y:/'][TZ&O';==
M-@^"GA>ZA6UBN/[3@9I5"J^\3$$YZY '7T%=;XN34O#GBZSUS0;<2C6X_P"S
M;E5("B?K!*?7JP)]![T =]I^I6>JVOVJPN$N(-Q7>AXR#@C\#7%IXHCT'QSK
M\&O:]LTZ.&V>V%SL4(S[R57:!G[ON<"NVL;.+3["WLX!B*"-8U]< 8Y]ZX$/
MI<7Q>UXZL;)8SI<!4W07D G=@L,8Y&>?3\ #MVUK35TV'4?MD36DVWRI4.X2
M$] N.6)]!S5/_A,/#O\ 9HU ZQ:+;&3R0S28/F?W-IYW?[.,UY';(WARU\.Z
MC>O=V?AI[^^,,D(96M8Y"/);N<$!NW1CZU:\7KX;C^&WBF\T:[GN5U":V+7,
M\I(N)5E4L(]P&2%ZD#^1H ]8T[Q+HNK:E=:?I^IVUQ=VO^NBC?)7G!^N#P<=
M#33XHT47\5D=0C6::1HHBP(220'!17(VLP/! .<\5PNK7=J/BMI*65U;([Z#
M+#!LD4#<3E%';TP*P/#,WAG5=!T?0=2;5?\ A(M.GV?V6ES.,S(QP_=5  ))
M&,#/M0!U]_X@_MWQ;J>@QZC?:?%:VBF&XMX95*3LS NYP!M7 ^]A3D\GC$ND
M>(['P_X)U'4Y/$-UXF6UFD,ERD1/S[0?+&T$*O(Y)P-QY["+1]6T]OB_XA4:
MA;,6L;95 D'5=VY<YY(SGCUKF-.NH;OX;_$I()DF/]J7TJB-@QV,%(;CL<'G
MV- 'J^AZJFM:+::@D<D?GQ*Y1XV3!*@D#<!D<]>AK-OO'WA339KB&[UVT22V
M8)*H8L5;)&W@'G@Y'48YJ3P3J-IJ7@W2I+.82I':Q0LP! #JBAASUP:Y&WU'
M2M.^,GBEM4N;:!7T^W :X( *A1N&3[8X[T =S)XBTF.TM+H7J2Q7G_'MY ,K
M3<9.U4!+8'7 X[UC>(_$&B7GA)[H>)SI5M+,(UO8#B175LE-I&=WRD$8S7 Z
M-<1^%])\.VVI,NEQW<]]-:W\D)+VT;$;512,*S@YY!P.V352\U"R;X3^-["*
MZEEN!JKL!.C+(P:9"I8$#YB%)QUX/% 'LMYJME9Q0137,OF7"'RA%&TDK@#E
M@JJ3QD<XQR/6N6^%VJ76K:3K<US?SWRQZS/%!+,V6\H!-HZ#'7.,#K5!_$5A
MH'CJTU#5I=FF:AH\,5E>X+1JZL2R9'0ME3^ J7X2W4$]GXF6(MSKMS* 4*_(
MVW:<$#'0\=1B@#M)-<TZ'6HM'DN"M_+&98X3&WSJ.I!Q@X^M49_&?A^VTVYU
M&?4!':VLYMIF>)P4E&,J5*YS\P[=ZYKQ==P:)\3/#6M:B_D:<+:XMS/M+ 2,
M/E4X!QG/%<EXBU*WF\ >/K<^9'//K:O'%+&RLP)@(QD=<(QQU !R!0!ZMIOB
MW0]6U:;2[&_66[B3S-FQ@'3.-R,1AQGNI(KC?B?XIB7PRQTG4K^&XCNTB$UL
MDB1.=X#IYH&TD8/ /8^E'B/4["Z^(6B+IU_;":32[J&&6.0 !Y OE#<.F3T_
M2N3U;7K63X/P>&WM[BVUFPE@AN;0V[DADD&6R!CYNO7DF@#V+5/$>F:.9!=R
MRYBC\Z40P/*8DY^9M@.T<'D^A]#52Z\<^&[-('EU6(I<1--"R*S"157<<$#D
MX[=<\=:X74KS2=)\?:O+XGM]16PU1(9K&ZB:X",HC"M&RH1SGG!'&>>M)?7>
MDZ5X@\!0PV":9:QS73_9;@DM!')PCL"?E+'D ],X[4 >H:?JEGJNDPZG8RF:
MTGC\R-U0Y9?IC.?;&:\_U+QC+XB\%>,9(!>6$VFR3QP/$LD3KY:K]YQP&W$_
M+GIC(KTI$6-%1%"JHP%48 %>,Q72P^&?B;I+Q3_;9=2O)4C6!SN63 3D#!W'
M.!G/'I0!WGASQII5_;Z/82W4@U&ZM$=-\,@29@@+A)"-KD9YP31HFKZ%;?\
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M#)I!HVEJCHNFV863[X$"X;Z\<TMWJ^F6$GEWFH6EN^ =LTRH<'@'D]S5P$,
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M7*))$L:QG<&50[@[N<\ #G.<UV$7AO1X+*ZM$L8_*N_^/G)):;_?8G<WXDT
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M 4<LIOM4TO2-?6:&9799KFQ3/S*00QPW(.>V1P!7MTD,4J[9(T<9SAE!YIX
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M\\[ N2#D#^ZW)P !VJKX4N=0N/"=WX@UZ)H;RZA"E/+.Y(XU*@%0,Y+F1O\
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M6,O#Y>2&. ,YYSC'>@#=D\:P&74_LNG75U!IMQ]FN7B9-ROQDA"V2HW#GV.
M<5T=S<1VEK-<S';%$AD<XS@ 9->7:_H5[JNIW.IV.AZCI7BE+@K:7]K(/(N$
M5MJM+DX "C!! )'3((%>F7+W46ES/%&DMXL+%$_A>0+P/H30!BZ9XNCU(6<X
MT^>.QNX6GBN_,1XPH7=A]I)5L=OKSQ5:7Q]96^EV>LS65TFBW<PBCO2%^4$X
M5W7.50GH>O3(&:YNS\)W$VM,=+TO4-"M+ZSGBU:UDE4V^^2,A3& 2"VXYRO
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ME!]XN>0/Q H Z.'P_HUO%!%#I-C''!N\E5MT CW?>VC'&<<^M2_V1I@C,?\
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MR7&IVL4^\1E7D PY&0I/0,1R >>1ZTEYXDT33KF:VO-6LH)X8O.ECDF4,B9
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M9R<4 :@C0 @(H!Z@#K2@!1@  >@K*MM9TW6VNK"TOGCNXE_>Q;3%/$".&V.
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MS))</(61E!Y;)*D$9_2KUA):Q?$[PW%J<L)U"#P\$GWNA9;@%<[B?XL;O?\
M"O4O)B\WS/+3S/[VT9_.@PQ%]YB0MZ[1F@#S_P"$ES;2:3KL,,T3%-9N6"(P
M.$)&TX'8\XKHO'BL_@#Q J@LQT^;  S_  &MY(HXR2D:*3_=&*>1D8- 'D?]
MMVJZEX!UYI\Z!:VKVLUSL(C@G:)5!8D8QGY<\ $$9X(KI/#,'VCXB^)M5L)
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M Z%"D+'Y3@\C.,X('&*[&B@#COB9;:A+X5CN=.MWN9+"]@O9+9!DS)&^2O\
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M\4<3,8(F9R"V <8R,CZBNJ\:Z7>VWB;3=:T3'GZJATBZ ;;\KJ2DO3DI@GZ
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M+A9X\OL610<*XRQXZ@_2JOC&[M]+^)_@_4K^>.VLDBO$>XF8*BL8Q@$G@9H
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M& 1CMV-4M2NHO$'C*U\/V5\+6+2E^TF1$5RTXRJH X(.U26.,X..A%8?G_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\.$GM+R-K&],ERK6LF8TW-AC\O3IS0!Z)!\2_#5RMMY4UXTMS$TL$/V*7?*
MVTA!M^<YSPN>A]#6A8>--!U'0VU>WO?]&200NK(1(LI( C*==Q)  QSGBL76
M]2MM,^*.DW%RLIB;2;A=\<32;,RQX)"@D#MGU(KD=0T'57NKWQ;I]K/)9#7X
M-06R\LJ\T,:E7D"'G)))&<$@9]* /3[3Q-IUSJ,VGR&6TO88O/:"Z3RV,7]\
M=B/7!X[XIECXIL=0N;.&&&\5;U#);3/ 5CE0#=N#=!D<@'![XQ7*:C%_PD/C
M2P\16$$TNGZ9IUP+@20M'Y[.IVPX89/4D\$#ZFLG1K&?^T;;3_#5WJ7]DWMK
M.MQ9ZA!)_P 2QS&P5HW8 CYCMV@GC)]P =U_PFVC*]HTDD\=K>3?9[:\>$B&
M63) 4-[X."1@XX-33>*]/AN5B\JZ>(W:V7VA(2T8F+!-I/;DXSC';.>*\]\)
M+:0Z78^'K_P/(_B"R=8W>:S4P\'_ %QEZ8 (/KG&,U-,'@UQ[_PW%J-GJDVH
MXNM'FMW-K=@2[3,"5VKPI?>#V_, ]8K%O_$]E8W5U;+#=W4EI&);H6L6_P E
M2,C=[D G R<<XZ5M5P&C/<^%?%WB2+5+:ZDM-3N1>6=S! \P?*X,1V@D,,
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M?M!D-S)M"B3S .$ZY 'ZUI7/ASQ=I?BJZUWP[-IC?VJB"_L[QW,<<B@ .C*
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M XCEXR55L89O]D9.>.O% '345D:'XETWQ";I+)YEFM'$<\%Q"T4D9(R,HP!
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M-SE$=U1&S'M8\')4DDC@<9S5S3-0T$?$+7BNG7%GJT5HCWEU._R/$N I4;B
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MITBXCLO"7BGPQKBO_:KS795)5.Z^$F=CQCJV20.,XXJOI-M+I7C7P'8Z@_\
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M-O<*M[H?V2&=H7$9D*D8W8Q^M3^$];O9=+T?P_=^%;Z/5-/,<,LMQ; 6\ 0
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MN9H[K9DPD$AQM8CL>.W%1Q^.;8:K9:?=Z;>6TFH1O)9%C&WG;1DH=K':V,$
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M3XFZ[;WDMLFE:?9)*0"_RQG<V[&,%N.>P [U@:CX$\6W?A[5M*,>F33W-_\
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M)\BA2HV@Y!.2>F!ZUDW/@GQE-H6LZ6)=%;[5>B[6ZDWF6XQ*KJKG&%P%'KP
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M'5O$&D26"V5A+,(()(BYN4BR&)<,-N2&Q@=AUHN/!>JS67A.!;BQ1M!E21B
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MIM+#H&;ECW&X+_#0!W\MS! \:2S1QM(=J*[ %CZ#UITLL<$;22R+'&HRS.<
M?4UY_HEDGB[5O&=YJ(69([MM*M5D&3;K$O)7TRS!L@YR!TQ7*Z3XH;4X_A[/
MXD</I<T5Q'))<',;W*,41I,\$_*"">YSVH ]JBFBGB62&1)(VZ,C @_B*=N
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M&T1DMX5V1HTC/M7L,L2<#H!V'%<</&VJ)JVIZ'/IMNFM0/%]BM_,<K=QN>9
MVW@ 9)XXP:;J&K:^GQ1T720]JMJUC).T:LP#MP&)/?&#M'Y^P!WE%>>W?Q&N
M19W&IZ=IZ75I!=&!;95D,]P@;:9$(4J.<_*0<@$Y'2K!\7^(;[Q1JFB:5I%B
MS6MO'/'-<7#*I5QD;AMSD\#;CCG+4 =U17EU]XPUC7_#O@_5M):WLTU+4HX)
M89-S9<%\@D8^3,?3&3QSZ^GQ"01()2IDVC>5& 3WP/2@!U5=1TVSU:R>SOX%
MGMG^_$Q.UO8CN/:L3Q!KNH:=J<5M;I:6MI]G:634+[/DA\@)$,$?,>OT[&N>
MB^(VIWGAGPYK-GI%NZZI>?8I(GN"K+)EQ\O&-OR'DG/(X- '?6-C;:;9QV=G
M$(;>(;8XU)PH]!Z"K%<+#XJ\1R7_ (AT8V6G'5M,@CN;?RR[13JP)V'."&[9
M]^E2Z/XNU#7-#\.7=G]C:YU.1_M">4Q6%$#%S][/RD!<GJ6'3I0!T]OHVFVF
MI7.I6]C;QWMS@33J@#OCU/X"KU%<9/KWB2Y\5ZKH.FPZ2K6MO'/'/,SMM#D@
M!E&,G Z C&<Y/2@#LZ*X/1OB!+K>D^'1!;P1ZIJ\LL;(S%DA$6[S'QP6'RC
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M(SPS?-@'GIW.*[BZ\*P7?BRU\1/J-\MU:H8HHE\KRPA^\N"FXY]<YYX(K?H
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MS#<0,2%EA<.IP<'!''4&FW&H6=I<V]O<74,4URQ6"-W"M(1R0H/4T 6:***
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M8IET>X\RV866&= NT!SOY..,]/7.:[ZB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ ) !).
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MG9'D6_F@A$;U(& 2*B2VU&6Q^($3:1J"?VKYGV/,63)NA\O@9P.1GG!P>>E
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M=-\6^&+F[T.TT6TU'3YKB2:UU.2=8Q LC%B)$P6;!)/'7C\/1XU9(D5FWL
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M+0SHY+,NWDJ 3P!T''O73:'9ZE:VCOJ]\EU?3-ND\I2L4?& J*>WN>22?8
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MFU'=.T N$2*)W,B'&-N =Q.<X&3C)Z"@#I*P+KP]<7'C&RU\7T2K:P/ MO\
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M(NM-EGFAANHVBE:';N*,,,/F! R">V:31=*CT/1[73()YIH;6,11M-MW!0,
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M;Z*^@BD8*LC)D;<GC^+OBNCT_3K72[-+2SB\N%23@L6)).223R22<DGDU:H
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MT75=5UO2]9UJ&SAGTN&0006\K.LDLB@,Q8J"H&, <GG-<U_PK_Q!_P *TO\
MPIYNF"6ZNC,+CSI,*ID$F,;.3D8_&O4** .&\0>'=>UVRO\ 3KNRT6[L[F)5
MMVGF??9R>6 S*1'\PW#(^Z>O/.!V.GVIL=-M;1I6F:"%(C(W5]H R?<XS5BB
M@#C?$EG)IWC;0O%"[OLJ(]A?%03LC?E'/^R'QD]L@]JGNM'UF7QY!X@MDT][
M6&Q>T1'N'#R;F#;LA"!R ,<\<^U=40&!! (/!!IL,,5O#'##&D<4:A$1% 55
M P  .@% 'G$O@?Q%<^ ];\/2OI8FU*]:Y69)I-J!Y!(P(V9)!  ]0>V.9[KP
M9XEM?$*>(M U'3[34+BU2VO[>X5I(7V  ,I !)PHZC\:]#HH X;6_".MWJ^'
M##>VUU/IE]]NN9KIFC,[YR0H4-M7DX'8 #FIKGPMK=OXSU+5]&U"SM[;5HH4
MO3-$SRQF-2H:+^'.TC[V1GL>E=G10!YK:_#[7].TOP_/9ZM8+K>C1O#&S0/Y
M$L3CE'YR2.3N 'T[U<L_!WB!)_%$]WJ&FNVNVZQLD4+J(W$>S<"2?E&6XY)X
MY%=]10!Y[_P@VL#2_"EH+RQWZ!,LF_:^)PO &/X>.^3S^5,\0:;J?A]_%WBA
M[^"*.^L4B1(T9S$RC:C$'@_>YXX!)[5Z+2$!@00"#P0: /'?#$VJZ-<:>;#4
M/"&J1N4A6"R+?:9$. VT\[< ;CVX)->QU!!9VMJ2;>VAA+=3&@7/Y5/0!S7B
MWPA#XIDTJ1YV@>QN?,9DZR1,-LD6?1A@'VXHM?"$%IX]O?$\<Q!NK586M\?*
M)!P9/KM '_?7K72T4 <?8>%M436O$=S?7EH]KK:*LBP(P>,+'Y8P22.GMUK#
M;X?>(9/"FDZ%)J^G-'IMU'/&WV=QE8^5!^;J<G/X8[FO3** .*NO"&I:IXJO
M-1U&ZLFL+S33IDMO&CA_+)+9#$_>RQIEKX+U5]*TW1-5U>"ZTO3[A)4982)I
MEC.8T<DD8'&2!R%'UKN** .*O?!>I_\ "3:QJ6EZS':6VLQ1I>QM;[Y 40J"
MC$X&0>X-4D^'FIPZ3X7BAUV+[=H4C&.9[7*,C *5V[AT X)//M7H5% #44JB
MJS%R  6.,GWXXIU%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
4% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>davidjkatz_employmentagr013.jpg
<TEXT>
begin 644 davidjkatz_employmentagr013.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***04 +1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %(*6D% "T444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !2"EI!0 M%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4@I:04 +1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %(*6D% "T444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !2"EI!0 M%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4@I:04 +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !129 (!(R>E+D9QGGTH *
M*175UW(P89(R#FEH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M;V.TM;S7;F.Q\UB-ZE@ !WQD'KT[UZ;0!Q%]XWLM7\/^('\/:O EYIL<S(P
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M'S"GRKC+].>G/';-=#9^*KO_ (2:72-5T@V"&U>\MYS<+)OC1@&W@#Y6&X<
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M>AUSWAOPL?#EWJ<ZZC+<C4;EKJ5'C50)6ZD8[<=*Z&@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *04M(* %HHHH **** "BBB@ HHHH **** "BBB@
M K#\6^'Y/%'AVXT=+[[&EQ@2R"(2$KG. ,C'('-;E,FFBMH))YY%CBC4N[N<
M!5 R23V% &#-X:GN[_1[^YU:4W6F;]C10HJR;QM.X'/\/'!'KQ58>"4^S>(8
M&U6[9==W?:<I'\FY=AV?+Q\O'.?7K75 @C(Z44 <FW@939Z#;)K%ZB:(5-L0
MD1+%5VC=E>?E..WYU<M/"XMM8U74)-3NI_[355GA=(PN%4JN"%!& ?6N@ILC
M,D3LJ%V )" @%CZ<\4 <6GPVM8M.TNVBUO5DFTN1FL[H2)OB0KM* ;=N,>HS
M[XJ1/AOIBIK<;ZAJ<L>L1A;A9)P?FP/G''+<=\@<X%:OA+Q*GBO1#J26KVH$
MTD)C=PQ!4X/(J,>*#_PGI\+M8.A^PF]6Y,@PR[@N HYZYZXZ=* (6\%12II!
MFUK599M+<R0S-)&69R,9;*'/'&.GX\T^X\'6[:Q=ZG9:C?:=/?($O?LS)B?
MP&(96VL!W7%=)10!S5SX(TV;^QEMKB[L8M'YLX[8IM0XQD[E8DD=<FK&G^%K
M?3O$U_KR7U[)=7RJLZ2%-A"\*  H(P.!S]<UNT4 9VNZ%I_B/29M,U. 36TG
M.,X*D=&4]B*Q].\!:7INE7=C'=ZE+]KC\J6>>Z+R^7_<5OX5Y[ 5U-% '/W?
M@[3KR_TN^>6Z2YTR/R[62*0(5&,'.!SD<<\53G^&_AJXUF?5&M9EDN'\RXAC
MN'6*9LYRZ X//)'0]QUKK*K6%_:ZG9I=V<HEMW+!)%Z-ABI(]L@T 8&N_#WP
M[XBU5-2OK207:J$9X)FC\Q1T#;3SZ?Y%6M8\':+K::<MS;R1?V=Q;&VE:$QK
M@ J"I! P ./2MZJ>HZG::5%%)=RA!+-'!&,\L[L%4 =^2/PH PXOAYX8@T[4
MK"/30MOJ)W7"B5^3G(QS\N#CICH*F7P/H*26$B072O89^S,M[,I0G[QX?DG)
MR3R:BA\17Y^(\WAN>U@2T733?1SJS%F_>*F#D #J>.>W-=-D;=V1C&<T <]%
MX&T&%]2=(+K?J<?EWC&^G)F7WR_IQGT)'0UR_B7P);J=+M+;PQ'JVA6-M,BV
MHO62>-V*G*LQR1A< ;AR3[5Z/%-%/&)(9$D0]&1@0?Q%$LT4$9DFD2-!U9V
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M=%9FB:_IWB"VEGT^5W$,ABE22-HWC<=F5@"#2:SJ$MNL-C9%/[2O"4MPPR$
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !2"EI!0 M%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4@I:04 +1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !117#>'M9U2;QOXIT_4=6WV&C" H&AC4L)$+DL0/X<=L4
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M-3G\1ZI;ZA>VT96?[40@F? 7Y<$8+$#&.] 'H=%<[<>,=#TFZ&EZEJD8U**
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MF\V7RHEC7.   !V '?/))[UI.&*,$(#8X)&0#]* %IDTJ00R32';'&I9CCH
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MI8@!F^7GV..U7))O%VEZ1K4=]J"65J;B$V%U=R++<)$S@.A" [FQPO!))_(
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M(<X!QZ9SV[XPE\*:[>^$=5METZ:VU"'77U>S2=DVSC?E5R&.#C/7'.*]<HH
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M;RV<B06X/F%[92F5D3:ZX);))[D =* /3JJ7VIVFFFU%U*$:ZG6WA&,EY&Z
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MSM[?P5\2;6.*$00:COAC11LB)6/[H' /..*V]5TG3UU3P!<>'XX8;QKA7+P
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M\#"YGF<F\=7R[*)#N8+T)]CZ4 >J:;XHT75]3GTZQOEFNX$$CQ[&7*9QN4D
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M(^CJRVI:Y88!&WYL8S@<?3KFNCH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "D%+2"@!:*** "BBB@ HHHH **** "BBB@ HHHH *JZGIUOJVEW6G7:
MEK>ZB:*0 X.UA@X/8U:HH YY?!UAFW2>ZO[JTMI%E@M+BX+QQLN-IY^9L8!
M8D U#K/@'0=;UH:O<17$5]L$;RVT[1&5>F&VGGCCZ<5T]% '-ZUX%T'7?L+7
M%L\$MBNRVFM)3"\:_P!T%>W\OQJ2^\%Z)?Z+9Z4]O)%;64@EMS#,R2(XS\V\
M'.3DY)/.<]:CT#Q-/J_B;Q#H\]E';G27A4.DQ?S1(K,#]T8X XYZGFNC.<'
M!/;- &1#X7TJ#7_[;CBF%_Y MP_VA]HB'\&W.W&><8Z\U5MO ^@VER\D-M(L
M+3?:!:><_P!G67.=XBSM!S[8X%-\&>)+CQ-8ZC/<VL5L]IJ$UF$C<N,)CG)
MSU]!724 80\(Z0NNW.M*EVFH7,9BEF6]F&5(QC ;  [8'! (P14^@^&],\-6
MTMOI44L44LAD='GDD&X]2-Y.,]\=:M7^J6>F&U6ZF"-=3K;PKW=VZ ?D3^%7
M* *6KZ18Z[I<^F:E;BXLYP!)&21G!!'(Y&" ?PI=0TJRU2W2"\@$BQL'C8,5
M:-AT96!!4^X.:N5S^J^(RN@ZW>Z.;>XFTL2"3S6.S<D8D(^7KPP';G/I0!HP
MZ-8VVF-I]M$UO;N2S>3(R.23DG>#NR3U.<FI+33+*PM6MK2W2")R2PC^4L3U
M)(Y)]^M0Z%J+:GH6FWDWEK<75I%<.B< %E!. 3G&35XRQK*L1D02,,JA/)'L
M* *>EZ+IVBQR1Z=;"!)6WNJL2"QZGD]3FJ0\(Z'#>W6H0Z5;&_N(W1Y906+A
MA@@YSP1Q]*W*@%[:F-Y!<PE$.'82#"_4]J */A[0[?P]I2V-LL2)O9RL*;$!
M/95R<#\3ZFHQX2\.B=YQH>G^=)]^3[.NYOJ<<UHF_LUB64W< C8D*YD&#]#5
M&T\2Z5?:W>:1;7<<EU:*AE"L, MN^4>I&WD=LB@!&\+: UB]DVBZ>;5Y?.>$
MVZ[&DQC<1C!..]2)X<T2.YAN5TBQ$\"".*7[.NZ-1T"G' %68]2L)KU[**]M
MGNXQEX%E4NH]USD=1^=,DUG2XL>9J5FFZ0Q#=.HRXZKUZ\]* ,+Q1X7BNO#&
MIV&B:3I\=W?0M 7"K" "/O$A23@X.*U-$T:TT^R1_P"R[*TO)8E%S]G4'<<=
M"VT;ORJ"]\7Z+8>(K?0Y[Z!;V96<JT@ C QC=GH3D8'4UJW=_9V C-Y=P6XD
M8(GFR!=S'L,]30!%9Z/IFGNSV6G6EL[C:S0P*A(]#@=*?:Z986!<V5E;6S/R
MQAB5-WUP.:;9:MIVHSW$-E?VUS+;-MF2&57,9]& /'0_E3(-;TJYOC8P:E:2
M78S^Y292_'7C/;O0!E>'-(UV&Z?4?$E_:W5^(V@A6TC*1I&6W$\\ECA<]OE'
M7K6Y=V%G?HJ7EI!<JAW*LT8< ^HSWJO-KNDV]Z+*;4[2.Z9@@A>90Q8\@8SU
M/I27VOZ1ID_DWVIVMM)@$K+*%P#P"<],]L]: +<]I;75N;>XMXI8",&.1 RD
M?0\4^*&*WA2*&-(XD&%1% "CT '2J-_KVDZ8RK>ZA;P%D\SYW PG]X^B]LGC
M--NO$.CV2P-<:C;HL\?FQ'?G='Q\_'\/(^;IR.: +@LK42-(+:$.V=S>6,G/
M7)]Z=#:V]N28((HBW78@7/Y50N?$>CVD,$TVHP!+B/SHBK;M\>,[P!GY<?Q=
M*CN?%6@6B6KSZS8HETNZ F=?WB^HYY'OTH U9(HY0!)&K@'< PS@^M.V@,6P
M-Q&"<<X_R36%I_C3P[JMY#:6&J0W$\R[XTC#'<N<9Z=,\9]>*TK+5;+49KJ&
MTF\R2UD\J<;2-C^AR.O_ -;UH MLJNI5@&4C!!&012@   # %<UIOC*RU/Q;
MJ.A0I*&LTC!=X77=(Q?(Y'W0%7!Z'/&:MKXLT-KJ*#[>@\Z3RHI65A%+)G&Q
M9"-C-D'@'- &U145U=065K+<W4R0P1*7DD<X50.I)K/L/$>EZC?364,[I=0Q
M^:T4\+PL8\XW@.!E<_Q#B@#5HK#MO%^B75[;VL=TX:Y)6VD>"1(IR.HCD*A7
M/T)SVJO=>/?#=G-?PRZ@3+8$"YCC@D=DR"<X522!CDC@<9ZB@#I*YW4?#$M_
MXPTSQ +]8SIZ21QP>1D,'&&RV[KZ<<>])'X[\.37ME:QZ@'^V[1!,(V\IV89
M">9C:'(_ASFH=0^(7AW3;R\LYKF=[JSV^=#%;.[#()R !R !DGH,CGD4 =31
M7 >*+Y-5?P=K>D:G*UC-JT,;"*5E29&)X*]"05[]*Z#3O%^GZGK=_I%O!>B\
ML1NG62W*@#MC/7/4>M &_16?I6K0ZOI:ZA;P7"PODHLJ;6<#N!GH>WK6-'X^
MTJ31]2U46^H"VTV8P76;<AHW498%<Y^7C/IF@#J:*QG\2V:0:=,(+N1-0A,T
M/DPF0[0N[)5<GH1V/) ZG%<*?%NF>$_AD;OPQ;:C<P&XDABDNE+>5(7 )?<<
M@9/ QS[<F@#U.BO+=9U..P^*^B:FUKJ1,^F3,;,!I)2V< +'D@'')Q@=2>]=
MWX>\167B6PDNK-)XC#,T$T-PFR2*1>JL,GGD=^] &O17D^IZQING_$?5+;QO
M#*EI=+&NDW+EOL\:;?FP0?D<GJPY&.H&*Z[1Y+?PKX:A22\DU%;B[D^QLDOF
MR7 DD9HU#,?F.TC))Q@$YQ0!U58FJ>&H=5UO3=5>^O(;C3BYMUB\O:"Z[6R&
M0YR./Y8JE#X\TD'5H]0WV$^EJ)+B*8J24/W60J3N!R!QSD@5+#XM\S5QI,ND
M7T%_):&[MXI-F)5!QMW!B%;/8XH Z&26.%"\KJB#&68X'I3J\JN/%UAX@^%S
M:MXJT*ZN-/><EEMG4@$3,%&0P( ^5<GKFN]O=>BL]6AT>UM)KN^>$SF&':HC
MB!VAF+$  G@#O@^E $VO:);>(M'FTR[DN(X92I+V\A1Q@@C!_"IM+TRTT;38
M-/L8A%;PKA5SDGN23W).22>I-<O<_$C3K;PY?:PUA?'^S[C[->VV$$EN^X+\
MWS8(R1@KG-7;#QG'=^)X]#N-+O+*2XMS<VLLVW$R X)P"2I[X;!]0* .GI R
MMG:0<'!P>AK,UO4GLHH+6U ;4+US%;+C(4XR9&']U1R?P'4BO.-/O;CPI\+O
M&<\4\SW-KJ=W$D[MNDWLRH')[G+ YH ]82:*1W1)$9HSAU5@2IZX/I3'NK>.
MX2W>>)9Y!E(V<!F'L.IKSG4HO^$0/@:\LXV1Y)X]/O6C&1,LJC)<]2=_S GG
M)/J:R[6ZTS5/"?C5=>N88-8AO[AW>1P)8B@_<E,G.!M 4#KSZT >KR6%M+?0
MWK1XN805613@E3U4^H[X/< U85U<$JP8 D<'/(X-<GI'B>Y_X5G8:]?0LU[+
M:1XB/!GF;"ICC^-BN/\ >K&\ 37F@^)M:\'ZI.T\X(U*WN'/,RR8\S\ ^?S-
M 'HU%4-;U/\ L;1KK4!:3W9@3<(+==SN<X  _&L&+QG,NOW6A76G0C48K+[9
M'';7@E5P#@HQ*KM8=<8(QSF@#K:CGGAMH'GN)4BA0;GDD8*JCU)/2N#L?B5<
MW>BZ-K3^'GCTS4;H6K2BZ#/$S.44A=OS+D#)R,<\'J=C4M>N;VYU;3=)T^"\
M_LZ,"[-Q*45F92PC3"MEL8)SP,@=^ #H;.]MM0M([NSGCGMY!E)8VRK#.,@]
MQ4]<;\*)C/\ ##0W*;,1.F,_W9&7/XXS56Y\>WUI=:9)<Z9!;VU]J'V$6LTQ
M6[4&0HLNP@#:2,XYX(Y.> #O**Y#3_%&IGQY?^'=4@LH$BM?M=M)&S9EC+8S
MD^G0_CZ4VU\5ZE+#HUG);V7]KZNKSPH'81Q0*NX._4DD$<#N<9XS0!U-]?6V
MFV%Q?7DHBMK>,R2R$$[5 R3@<T6%];:GI]O?6<HEMKB,212 $;E(R#@\UQS>
M,[O[/XETR]TZT;6-'MC/)#YI\BXA*%@PX)Z8!4CN.>>);'Q;<7>B>&8+*UMH
MM3UFV\U$VGR;9%0%F*@@D#( &1DGJ* .BTW7]*UB[O;73[V.YFLF"7 CR0C'
M.!GH>AZ>E:+,J*68A5 R23@ 5YUX ^V_\+#\>?VAY'VH268<P A#^[?! ))&
M1@XR<9J2XNM=D^-4&GK?VJ6D>DM<1QFW9AL:558$;Q\_R<-T _AH [#1=>TW
MQ#;37.EW'GPPS- [;&7#J 2,, >XK2KQCP[K/B#0O#OBK5--MM.DL;+6KN:X
M%PS^9* R[E0# 7 YR<\]JZR_\;3WNH-9:&60Q6D5T\QTV>[#&52T:8CQM&!D
MD^N ,@X .[K-TC7;#7#>BPD=_L=RUK-NC9<2+U R.?J*J^%-8U#7/#\5WJ>E
M3:;? E)8)5906'\2[AG:>HSTZ<XS7'CQOX@3PMXNOFBTT7NB7SPKMC?RV10,
M\;LY]\T >F45YV/$GC%=7T*)HM(:#7;>0VZ 2?Z,ZQ>8"[?Q\9X &<=NM1/X
MQ\0VVC^,+>1K"75?#Q5_M'DL(YHF0N/DW9#8![D=.O< ])HKS>'Q-XKL[CPW
MJ^H&RFT?6Y((&MK>([[9I5'EL7/7)// '&!UJ0>)?$&L>%]5\2Z/<0(ME<3"
MWLG@W)/%$<'>?O!C@D;2 .!@]: /1*S;O6HK37+#2FM;N22\5V6:.+,4>T?Q
MMVSVKB]3\=2>9I%Z]U/I.BZAIZ3Q7HMA)&+AC_JY6(.U0,=,9R>1BM-=6UJ/
MQ)X7M9=0M)K/4K20S""($F1(@Q8/D@J2V1@#IWH ZRYNDMK6XGVM+Y"%VCB&
MYS@9P!ZGL*@T?4X]9TBVU&*"X@2X3>(KB/9(OLP[5PGA8:E#J7CMEUB>66WN
MF$9GC1OF\I<.P"CH   "!QTINE^-]1U'P_X-MY)Q%J6O22"6Y6-3L2,G<57&
M-QP ."!D\4 >ET5Y_/X@U;2_$NK^&9=0:>3^RSJ5C>O"F^/!(9'"@*W0D' ]
M\UC6OB;Q-%X;\)>);O68Y(M0O(+2YM!:J$*.64OG[V_Y<\$#)Z8XH ]9HKF?
M'/B&?P]HUJUJ42ZO[V&QAE<96(R$Y<CV4-^..U9MUJ&I^'O'&CZ/)J%Q>Z?K
M<<R*\^SS;>6-=Q92% P01P0<'IZ4 :E_XN6VENQ9:7>ZG'8SI;W;6:AVC=@#
MA4ZM@,"<=,]\'&^]S#'/# \BK+-GRT/5L#)Q]!7"_#VREBUGQ6YOKQQ'K,JL
MDI0B0[$^8X7.>>,$#&.*JZS8R2_&_1C_ &A>H&TZ20*D@"IM;[H&.A[]SZ]*
M /2:*\HUCQ#K-F#?6^IW,\R:RL#R6ZJ;(0M(%$7S8W-@C)7=@YY&.+WC'5M4
M\(:\+D7TL^F:M$\ 6:8@:?+D 2\#/EY89],]>0" >DT5P&LW=]8ZAX=\+VU]
M/<F_BFDGN9+KRI)]BCA9 IVYSGY0#QQBH9;;QGI^A7]KYJWK1WD4L$$5Z3=&
MTR2\?F%5.[Y3ANIYYR* /1:*Y+P)JUGJ=MJ M;R_<Q3@-9ZBQ-Q9_(!L;<22
M,J2"2<Y/I61'=74GB3Q[I#WUXUK;VL,]O_I#!H6:(L=C [@,X_*@#T2BO&;;
M4M:NM ^'+KKNH1/J$QAN&60$N!GYB6!W'_>R/4&K>H^(M3\$-XW@@OKF_2Q@
MMKBU-](96B>9MAY/502#CIQ[T =WK'B272O$VAZ3]A$D6J.Z?:/-P8RJEB-N
M.>@[CK705YGJNA0Z;XV\$7<$]Y.T]S-YTEQ<M*'?R3AL$X!//W<#CIQ5*R&O
M>-M#NM7L[R*RU&*]E$=T=1E06H1R!&81&5*[<9R><Y/H #UFBO++?1;G7_B%
MJMM>ZYJ"P"QM+N,65VP17)/*Y_AR&P,8P1W QZF.E !1110 4444 %%%% !1
M110 4444 %%%% !1110 4@I:04 +1110 4444 %%%% !1110 4444 %%%% !
M67XCBO)_#M_#IU['97DD)2&XD.%C8\ Y[?7M6I5/5=+MM9TR?3[P.;>8 /L<
MJW!!&".1R!0!Y.VO2Z+:Z[/'I]_HVNV>D,WV">4S0MEU!N(V)()SC/'.!DGF
MMC74?P_'X5UW1;J9Y;R]M[:[!N&D%['*.IR2&8=0>V?3BNRA\*Z7'-+/.DUY
M-+;&T>2[F:4F$G)3D]">O<U'I_@[1]--J(HYY([-MUI%/</(EN>1E%8X& <
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M[BZO9_,@U-[H9\A75TA1<97&W'.!R3SU/4KIFMS^-]'UJXTV*.&VL9+>94N
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MSA1C//84 <Y8^./&=_X+D\4KIFC1V"V4\XW22%]\;''R^A (QGJ,Y&0*T/\
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M'&\F%(;YADC!(V^IJ+XC:&-+^'/B2&76+F]$4L-Q:P22/_HL<DRJ$)W?.O#
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MW+RI; \'RU8X7CC/7'%=#0 4444 %%%% !1110 4444 %%%% !1110 4444
M%(*6D% "T444 %%%% !1110 4444 %%%% !1110 5%=6T5Y:36LZ[H9HVC<
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MP/I[VKM;/ $$<MC.G3&. 5(!!'I]15KP)K\GB3PA97UP"+M08+D' /FH=K'
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M(  QQ7K% !1110 4444 %%%% !1110 4444 %%%% !1110 4@I:04 +1110
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M-7=%C)"@,PP02"<D=,#-1>+K2PU+7H'EM-:L[R*R$MGK.G6\S-&2S9B8*I[
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M,6FK6>EYN+B]^QBS><AD;<5.XA#C&-QXX7)SVK T?1-7@\?:3K2^&8=+T_\
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M&+$G@9))))P .>P [5SVG^-M1U76[BPM/#5P8[._^R7DS7*8B7;D/C^+W /
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M(&VL"H&1SCD"@#E?#MT=0L?#VCZA(^HW4%]>1V,%PX\BZ@C!422L5.0OS!0
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MUHE_J O[O2;.>[&,320AF&!CJ:LP:3IUK>2WD%A;174IS),D2AV.,<G&>PH
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M:3S#4TEBSM9OE4X9?H2>1ZU!#IEQIWC/4O!J0,VDZM.NK*X)Q''G]\GXNJ#
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M4 <9\/[FV:_\4Q1,V9=8ENDW1E0\;)&-PX (W!AFCX=6[;_$^H!2MM>ZU</
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M*F\=Z5J>J:?I<FDP+/<6&J07IB,@0NJ9R 6XSSWKJJ9++'!$TLTB1QH,L[L
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M]C=:/:J$B$$3":=0,*LI/&/4#.<<GDUT.K^(--T/[(+Z9D:[G6WA"H6W.S
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M!CTU)5D/F/*Y1-BAG8L0J]E&< 9-1:EX1L-4\6Z7X@GSY]A&Z!!TD)(*[O\
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MFGMTN)%@E<8Y:(-L/09R.>^:Z"B@#!U/P?I&L:O;ZI>+=F[MO]0\=Y+&(L@
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MC"\27,?.UU5_F7W!SBJEUXAU*R\?V^@W#V26=_:22V4ODMN,J'E&^?!P/FX
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MJ%W%=WNF6=S<PC$<TT"NZ?0D9%.U#2--U9(TU'3[6\6,Y07$*R!3[9'%7:*
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M7$-O.-LOD%0SK_=R0<#Z<\=:TZ* *FF6"Z9IEO8I-+,EN@C1Y=N[:. #M '
MP.G:K=%% &%8>#]&T[Q%=Z[!;N=0NB6>220L%)ZE0>%SC'';CI6[110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4@I:04 +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 445!=WEM86KW-W/'!!&,O)(V%4>YH GHK&/BWP\MDEZVM6 M)&V
M).9U",WH&SC-:=S=0VEH]U,^V&-=S, 6P/7 H FHJIINJ66L62WFGSK/;/\
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MR3+YT( 5@"I!+^A% '745C6'B&.>'47O[:33&T]OWZW+J<)M#!]RDC;C/?\
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M:&UN#$PAG<=51\8// ]3TS2)XSTB32M3U$?:1!IDK178-NP>)E +?+UP >M
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M5(^7& !@GCTKK* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I!2T@H
M6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J*Y :U
ME5@""A!![\5+5>^%R;&86<<4EP5PBS2%$)]R 2/RH \DT:&.X_9JBBE4,C(X
M(_[>C6]X?O[KP7J:^#M:EDELI0?['U&3&)%Q_J6]&'0>OY4NE^"]>L_A:OA*
M5]-%PC$+<+-(R;3*9,D; <Y.,?CGM74>(?#5KXM\//IFKQ*K, RO$Q)BD'1E
M) /^2* *_P /O^2>>'_^O"+_ -!%9GQ/LI!X=A\06B!K_0ITOH<]&4$;U/L5
MY_"NB\-:5)H?AG3=*FD622TMTA9TZ,5&,C-:,\,=S!)!,@>*12CJW1@1@@T
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MGMYSI%EYMMCR'\E<Q8_NGM^%-G\*>'KJ[FN[C0].EN)CF65[9&9SQU)'/04
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M7(S@^HIU !1110 4444 %%%% !1110 4444 %%%% !1110 4@I:04 +1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "D%+10 4444 %%%% !1110 4444 %%%% !1110 4444 >=Z+X6
M\8>'1-H.G:E8?V"SL\%U*K&YMU8Y**O0GDX)X[^U:BZ!K<?Q)F\2*FGM:260
ML?+-PXD"B0-O_P!7C/\ LY_&NPHH X2T\):O/J?BC^U!9?V?X@54D6WN7,D
M$93(S& Q/'<=*L^'="\6:=';:;J>LV4^EV; 12PQNMS,B_=1SG '3.,D@8[F
MNRHH \_T7P9XE\/23Z3INMVD?AV69I45H&-S K'+1QG.T#K\QSC.0*TT\,ZI
M9>.[_7[&ZLS;WMM'%)#.CEP8Q@ $'H>Y.?H:ZVB@#FO!OA^]\/:1<6%_-:W
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MY&[07=N,_NI5.".?P/XUC+XRU+4?B=+X7TT6<5E;6IFEN)X6D:1E8*RIAU
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MN(DZS0223(X^H '7^E:GCZ_BUWPY+IEE+OMY],FU*>5"?]2B9C&>VYROX(]
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M&,;L"3C[Z.!D'@ UD>*-+U/0O%?A'Q+X:B4W&I6T=HWRY1I3&%!;'JIS_P
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MG,B@$\Y4$?7%>G:GXRTO6-"MM2>YA@LEURW6U>92K2QQR1[W /H=W/' YYH
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M]3\1:]8^(= L(O#SSVU]_P ?EQ$Q=;8^F<8XZY/7M0!U5%%% !1110 4444
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M18VMI;P%NIBC"Y_(>PJ5H8G<NT2,Q7825!)7T^E/HH B2UMXT9$@B57X8!
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !12;UW%=PW#DC-+0 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !7->+?%/_"/P0P6L0N-2N3B&'!/MD@<]
M> .]=%+(L,3RN<(BEB?85Y]X+@?Q%XDU#Q1=H0JOY=LI_AXQ^BX'U)K>A".L
MY[+\7T);Z(GLO UUK!&H>)M1N9+F09\B)@HC'IT_08_&DO-.U'P*RZAIMU/=
MZ,I N+29]Q0$\LO'3I_7-=]39(TFB>*10R.I5E/0@]15?69M^]JNW0.5$5G=
MP7]G%=6T@DAE4,C#N*GKA_"[2>'O$]]X:G=OLTF;BQ+=P>H!_P \J:[BLJM/
MDE9;=!IW"BBBLQA37D2*-I)'5$499F. !ZDUEZ_XBL?#MB;B[D!D/^KA4_/(
M?8>GO7*V^AZQXUD6^U^5[/3?O0641P2/4_XGGZ5M"C=<\G9?UL)OHCK;+Q%H
M^I7;6MGJ,$TZY^16Y./3U_"M.O-M.TVQ?XFQ1:/:BWMM+A*SD<[FP1UR<GY@
M,]>#7I!ZT5Z<8-<O57U$FV5[V^MM/MFN+N9(85ZLW2GV]S%=0)/ X>)QN5AT
M(KSSXIW<DR:=HT !ENY0=N?^ C]3^E=_86D>GZ?!:QJ L2!1@4I4^6G&;W8[
MZV+5(2>QI:9(P2-F/0#-9#,'3O$;7_BC4-(%OA+10?.SU)KH :X/X> W<NLZ
MK(/FN+HHI]A_^NNZ! 7<3VR:UKQ4:G+$2=T9?B+6(M#T6XO9GQM4A!CJQ' _
M.L[P+ITUEH@N+G_CXO',[Y[9Z5@3R2>./%D=O$6_L?3I,RMGY97ZX]\_R!KT
M-%5 H7H!@5<_W=-0ZO<6[N2444A.*YRA:*Y>Q\6"]\8W>B)!\D";O-![^E=1
M52BX[B3N%%%%2,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "J][=I96%Q=/]R&-I
M#] ,U8KF_'EZ=/\ !.JR@_,T)C!]V^7^M &IH>HOJVB6>H/$(S<1"38#G&16
MA6/X5B>#PKI43C#+:Q@C\*UR<4 9>O\ B"S\.:<;V]WE-P15099B>P%:B-O0
M-@C(S@UYMXFD/B+XA:1I"9-O9S"63T9E 8_7&5'XFO2ATH **** "BBB@ HH
MHH ***0T <+X;FEN_B1XEF:1S'&D42J6X&">WX&N[K@? 69/$?BB;UN%0'Z%
M_P#&N^H ***S-=UA-$TUKIHS+(2$BB!P9'/  H TZ*YSP]XH?5+N?3M1LFT_
M5(!O:W=MVY#T93W':NCH "<5G6.NZ;J5Y=6EG=QS3VIVS(IR5-0^)KN6S\/W
M;V^?M#J(H<==[G:OZFN1\$:5'8^-M<2W&(;2""W9N[R$99C[Y!_.@#T6BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH Q/%\[V_A'4Y(VVMY!7/UX_K5?P';QV_@W3_+_Y:*TC'U)8_P#Z
MOPI_C= _@W4@0Q'E@_*,]&!I_A2X@/AC2(ED4.UJ"J="=H 8X]B?UKI_YA].
M_P"A/VC=HHHKF*.$\;(;/Q1X;U.('S//\ER&QE=PX].C-^==W7#?$,AKSP["
M.'>]!4GZJ.OXBNYKHJ_PH/U_,E;L*SM;UJUT'3)+ZZ)*KPJ+U=CT K1KSZ.-
MO'7B]IY4(T?2G**IY$TF?RP<#/L!ZU-&FI-N6RW&WV)_#6@SZU?MXF\019FD
M(-K;,/EC7LV/Y#\>]:_BWQ1#X?LQ%&#)J%PI%O&HSSTR?;^=,\4^+8-!C6VM
ME%SJ4ORQP*>5ST+?X=ZI^&/"TXO#K^OL9M5E.Y5;I#V^F<?E6[][][5VZ+^N
MA/DB_P"#M ?1=,>:Z8OJ%XWG7+'J">0OX9/XDUT$AP,XSBGTR3Y06/0#)YKD
MG-SES/=E+1'D5DMSK_Q4634(G!@8ND;+C:BYV\?4UZ^.@K@O T1U#5]<UJ<E
MI&G:W1L_PCGBN^KHQ<KR4>RL** UG:Y/]FT'4)QR8[>1Q]0I(_E6@>E<QX_N
M3;^#KX*VUI5$8[=3C'Y9K"DKS2\QMV1%\.[8VWA& GK*[2$^N35'Q)KUUJ^I
M?\(WH7S2O_Q\7 Y5%[C/K6=+K%S-I-CX8\/9>[\E%N)UY6(8YY[FNO\ #?AR
MV\.Z>(8<-.WS32XY=N]=,TJ<G4EOT7ZD*[T18T+1;?0=,BLK8':O+,>K-W)K
M4H[4W=UP#7'*3E*[>IHE8?5+5+R/3]/N+N0@"&)GY[XZ?KBK+2JGWSM^M>??
M%+7[:+0UTR*96ENG <(P)"#DUI2IN<U&PF[(;\,+)ITU#79_];=R;!QT .3^
MIKT<$&O*;;Q+=7>F6FA^$[*<%0%:Y(VA/4Y]*]/M89(;>))93(ZH SG^(^M:
MXJ,N?FEUZ"B[D]%%%<Q04444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !17'ZAXBUN#Q];>'+:'3_*
MN;1KI)Y Y90I(*D \\XY]_;F;0/%ES>^)K_PUJUE';:I9Q+/NMY#)%+&<?,"
M0"#EAP10!U5%%-+J'"%AO(R%SR10 ZN0^)8#^#)H"<&>:*,?4N*Z^N-\<AKG
M4/#>GAN)]11V7U"#<: .LM(?L]I#"#D1HJY^@Q4>I7B6&GS74C86)2W^%6>
MM<;J&L6US-)?7+.^EVDPA@A09-U<9QP.X!Z>XSVH J>&-/9?&FH,[&3[!;)$
MTC=6ED/F,?R('X"N^KROPM<^,;M-2UC3;#3O*O;QW*74C"3Y3MQQQ@8P*VI?
MB&++2M0?4-/:VU2PP9;,O]X$X#*W<4 =U1533;P:AIMM>!#'YT2R;&ZC(SBK
M>: "BN.\2^/K31;Z'2[*+[=J<T@185<!5)_O-VKH9]8M-.LDGU.Y@M&V@N'D
M& >X]Z -"BO--0^)=S<^)(M/\+6<6L1"(O*JED;@]B>#6C+XO\4RPD6G@R=)
M ,L]S<!5'Z<T =U2'IFN;\#>(YO%'AM-2N(DBE,KHRIT&#6QJM_%I>E7=],<
M1P1,Y_ 4 <9\,G\R3Q YZF]Z_F?ZUZ!7GGPE<S:/J5P5 ,UWOS]5!_K7H= !
M7.3I_:?B^*-UW6^G1>;S_P ]7X''L.?QKH6.T9-87A-Q>6%SJ9'-[<R2*3UV
M [5_0?K0!E>.HCIK:=XF@!$NGSJLQ7J\#'# _GFNR4AD!!R",@BN5\?ZMIEG
MX9OK.]E'FW5NZQ0JNYV;!(( ]QUK,\/^/+>'P[IYU#3]4B18$5KIK?,;8&,[
M@>E '2ZY<1QSV"2;2OFM,<^B*3_/%8OP\Q)H-UK4YV-J5S)<L6.,+G"@_@*J
M#5;#Q1X[CM+2Y6XM%TN0[XSD R$#\\"K.D_#J"RM4M+[5;V_M(O]7;.VV,#.
M>0.OXT =A;W,%TF^WF25<XW(P89_"IJX2SL8/#/Q(ALK!!;Z?J-D[^0G"+(A
M'('8D']*VO\ A*X'\8GPY#;223)#YLLRD;8P>@- '0T449H **0LH(!(!-+0
M 44F1G&>:6@ JIJ>HP:5IT]]<MMA@0NQJTSJOWF ^IKC?B5,T.@V)S^Y;4(%
MF'JF3D?GB@#&O?$?BW2OL?B'4?L\>D3S*CV*J-\4;=&+=2?:O2U8,H8=",US
MVK: ^O:E9FZE7^RK8B46Z_\ +9QTW>PKH@ !@=* "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH J:I;17FDW=O.^R*2%U=LXV@@\UYS\.+6\U&^C
MO9KEOLFF(T$"C^(ODD'VYS^7I6YX]UB0QP>'=/(:^U!@CC/W$/'/IG^0-1>%
M[7_A%/$MQH4TG[F[B2:V=C]]U&' XQGK^ %=U-.-"7=[>G4AZR.ZHILDB11F
M21U1%Y+,< ?C7&^)O'^GZ?;RVVFRB[OV!5?+Y6,^N>AQZ"N6G2G4=HHIM+<K
M7MP?$GQ)M+&(+]FT<F9VZEGRN?UVC\#7>UXUX)\6VNAW#0W5H7>[E'G7C2\J
M.V01T')//>NMU3X@+-<C3O#=L=0O'.T/@A%_Q^O ]ZZZ^&J<RA%:)?\ #LF,
ME:YT/BB]^P^&M1F5PLGD.$RV#DC''O7GGA[5=4GT2#0O#-JRR_?NKYP %+'G
M'I@<9ZG' K9LO M]K=R=0\5WDCRM]VWB?A!Z9Z#Z"NOT+2$T/2TL(Y?,C1F*
MML"G!.0#CJ??O2YZ=&#BO>=_E_P0LV[F=H'A"TT9_MEQ(U[J;$E[N7)//H">
M/KU_E71T45QSG*;O)E)6"L7Q7?\ ]G>&[ZXW;2(]JG_:/ _4ULL<#CK7%>,'
M_M;6M)\/("RRR^=<$?PJHR/Y']*NC%.:OLM0>QJ^#=-.G>%K.)AB61/,DXY+
M-S70U''@1@#@8X%2=JB<G*3D^H+8J:GJ$&EZ=/>W+;88ERQ'UQ7C_BSQS'XE
M>TTZ)6M-/:5?,FD^\><9%>Q7=M!J%K):W$:30R<.C#((S7 76AZ?J7CV'31;
MQBQL+7YX0H"Y.<5TX1TXMRDM43-,ZKPUH^E:1IBQZ8R2(W+S@Y9SCJ36X!Q7
MG\_AC4_"DLE_X9N'F@ZR6$QR".^TUT?AOQ/:^(K4M&#%<1G;+ _WE/\ 45G5
M@Y?O(NZ_$I:*Q4\6^+QH"PVMM;_:]0N6VQ0 ^O<UQ9\0>+[[Q):Z;?L^DBZ.
M8U@0$@'UK1\.Q)KGCO6-:NV!CLV\N'/08/!.>F,5BWGB'4+OQZ=9TVUEN[6S
M/DKL3(*XPW/J:ZZ5.,?=2NTM6^[V(NSKQ\/S<?-J.O:G<L>6Q+M%<AH_AW2]
M8^(-Q#"DL^F60(<R-DLXXQGTSG\JW[GQ9XEU>T^S:;X=GMII?E$LQX4?_JKD
MM6\'ZCX8TMM0N=06*1W"B.)B69CWR/2JHJ>L9RLWHOZ0:+8]KM+&VLX%CMH(
MX4'\,:[15JL?PP]Z_ANQ>_8M<M&-Y;J:V*\V=U)IFB"BBBI **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@#SO7+>2Y^-.C)%>3VK?V3*?,A"%OOGCYU8?I6=9VS:#\8I=*N'_MI-
M=L29YKE5::%%!^1L87RSMQC:,Y'ISW=]X3T34M2&HW=D9+P+M6;SG#*OH,-P
M/85)9>'],T9KFYTO3H4O)4^:1B2\F.@9SDXSB@#SO3M/32M=U/X>FS7[+?72
M7MM((^/LA.Z568>A4H,\_/7H3Z5H2^);*\9($U:&U:&V42;6$.>0$SR!GKCC
M-5?#\.LWEX^K:_96UG<B+R(+>&;S?+7.7);IEB%X'3;[UJS:1I]QJUOJLMI&
M]_;(R0SD?,BMU _,_G0!<R*XWQ0P7QSX3#?=,LV#[[*Z2_74%"G3X[9F+?/Y
M[%0![8%<[J_A_6M:GLYKI;!9+23S(6BFD4JWKTH L>(]7GGOHO#FEDF]N5S/
M(/\ EWA/5CZ$\XJE>QVVF^*M"TP1@6D-E.\"GO*H&#[G&[\ZETSP_KFD3W=Q
M:_V<9[M]\TDKR.Q/UQTKFOB)H?B66WL]=%RK3V#']U:KE54@AFYY/ICWH [+
MP';-:^#[(/\ >DWR\_[;EA^A%9WC'X?P^+=2MKHW9MO+C:.78N2XSD?E4VD6
M/B:WT:QAM;O3EA2!%42Q.6^Z.N"!5]+?Q3AM]YIF>V(7_P : ,FT3QIHEM'8
M1VEAJ4$*A8K@S&-R!TW#'6K"Z;XKUE2NJZA;Z9;D_-#8#<[#T+MT_"M#[-XH
M_P"?_3?_  ';_&FO:>*& "ZCIJGU^S,?_9J &77@?0;O28M.DLP(XCN216(D
M5O[V_KGWJK9?#KPY:3"::V>]E!RK7LIEQ],U;6R\5=]5TWZBS;_XND-AXK_Z
M#=A^%B?_ (N@#9M]/L[5]]O:P1.!MW(@!QZ<598!E(/(/%<^--\3$#.OVX/_
M %X#_P"*I/[*\2'AO$<7X6"__%4 <[8:+XN\,1W.EZ%#I\UC).TL,]PY!B#'
M)&T=<5)/X U76F1O$'B:XN(BP,UI @2)P.<>M;ZZ1X@!^;Q(I'M8(/ZT_P#L
MG7?^AA/X6:?US0!C> ((]/N-?TR,;5M[S*H,\*1Q_*NWKS72M*U2S^(.LV8U
MR2-[F%+A9/(0[^3V/'&?TKJUT36!RWB>Z/TM8!_[)0!I:NMT^CWB60S<M"XB
M&<?,0<5F:#%+H7@BSCNHRLUI: RIG)W 9-/.CZN1C_A)+P>_V>'_ .(IO]@Z
MFX*S>([R2,C#(;>  CT.$H XG3[B&Y^'^M>+KYQ/>WL4RHQZQ+RJ1K^/\Z[W
MPS9M:^%=,M)4&4MD#*1_L]*XH?!Z%9"J^(=06T\P2BV54V;LYZ=/TKKSH6HD
MG'B740/0)#Q_XY0!S$/AZXT+XIPWVGV &G7L+++Y:X6)L#GT'(_6O1!6!_PC
MU^3SXEU3'MY7_P 13O\ A';G&/\ A(M7^N^/_P"(H Y;XDWE]IFN^'[W3$62
M]W2Q1H1G.X 4VU\%:_H5W#KFEWL=WJLR$7\5T<)*3SP1TP>E=2WAC>RO-K&I
M3.G^K=VCW)ZX.SBG#PY)_P!!W6#];A?_ (F@#(:7X@:@_E"VTO3(CP92YE8#
MV'2JT'ASQU;R30CQ3#)!*V?.DAW2(/\ 9'05T8\.G SK&K$^OVG_  %-/AE2
M#_Q-M7_"\/\ A0!@7_PY6;3YIO[8U*;5]I:*ZDG(P_;Y1QBM?P5K[:UH2)=$
MKJ-JQ@NXVZAU.,_CC/XU83PRD;9_M76&]FO7(KB/$_A+5O#U]<>(]#U&[<2L
M/MT*@%_*'5E_O$#UR: -&\UB\T?XIW G%]/93:<'2"WA:7!# 9PHXY'6DBT+
MQAJ]\VNC6#I4DA(BLRF\)%V##IN[UGZ!!::UXXWC7+N^@ETD-'(LIB=?WO*D
MK@\5VG_"'Z?U-SJA/_81F_\ BJ ,63X=S:BK2:SXBU*[N3DH4?RTC;U"BLS6
MM!\:W.A3:#*EAJELP BO)7V2K@Y!([D8KK?^$/TL\%M0_P#!C/\ _%T#P=I
M_@OC]=1N/_BZ -'18;VWT:TAU&1)+M(E65TZ%@.:OUS[>$M$C7=(MR!G&7U"
M?^KT[_A#M%_YX7/_ (&S_P#Q= &]17.Q>$_#T^_RH?-V-M8B[D;!]#\W6G#P
M7X?!)&G#_OZY_P#9J .@HK _X0W0#_S#E_[[?_XJD/@KP\>NEPM_O%C_ #-
M&^2!U('UI/,3^^OYU@GP3X=*X.D6Y'I@TH\%^'  /['M?^^* -LSPCK*@_X$
M*8;RU!P;F$?]M!60/!GAS_H"V?U\L4J^#?#BDE=$L03W\D?X4 :ZWELS!5N(
M23P ''-35C0^%]%MKE)X-)LXY$.5=8@"IK8'3F@!:*** "BBB@ KS/XB^)+V
MVU6/2[2]>UB2'S)6B)#,QSA21VQC\Z],K%O?"VE:CK46JW4+27$0 "LV4.,X
MR/Q_2M\/.$)\TU<F2;6AY_I?A*:\LAKVOZS-8M,0$=VPY7&!EB>,CMZ5>D\+
M>#YE!E\22RR 8#-=H<?I7I,L23)MD177.<,,BH196X^[;PC_ ( /\*N6,JMW
M3L"@CST>%? X15?6B6 Y/VM!N_2MS2U\%:.2;.XT]7(VEVF#L1W&2373_9(/
M^>$7_? _PI?LL(Z0Q?\ ? _PK*5>K)6E)C44CSW5?#O@S4+[[3'K$5KN.9(X
M9%VM],_=_E[5OZ3>>$]#MA#87=G&,89]^7?ZGJ:Z3R(QTA0#_=%'DQ]XTQ]!
M1*M4E'ED] 25S*/BO0Q_S%;;\7_^M3'\8^'XU+/JMN%'5MW _'%/US6=/T*U
M$DJ!IF.(H4'S2-V %<_!H&J^*AY^O.UI9,<I8Q84D?[1%$:5US2=D%RU>_$G
MPY;+B"[>]E/2.V0N36%+\0=5U!R-/MX+)/[UYN)_("N\T_1-.TN)8[*TCB &
M,@9)_$U?V8]*(SA'97]0/,VUK4'B+W?BM8@/O"VLV./S6L/0EM]4N+K4K_6=
M41Q(8XI88WW.@[\+7=^-M1F%O#HMBQ^VZ@VS@<JG\1_*NBTG3XM+TRWLH5Q'
M#&%'OQR:V]M.%.^BOY$\NIP*6VF@Y'B+Q&2/6.3_ .)JY"=.V$3:QKTT?=#'
M(#^BYKT"DYK!UJC6Y7*CDH/$&A:18%88=0CA3DYM93^))%8'A3Q):R:AJVM7
M$&I2_;9ML.RSD<"-1@<A?6NF\7Z-JVN645A8SQPV\C_Z2S$ABO7C'O6SI6G1
M:7IMO90KB.% H]_>GS*--V>K#J90\7V).%L=6)_[!\O_ ,37.ZNMA=WG]HZ?
M:ZSIVH@8$\5A)A_9ACFO1*6LXRE!W3&>$"S\46\]W;VUIJBVMZX,\T=BX..A
M."OH3QQ7H'AR[M= TJ*RMM!UGY?]8YL2"[8Z]:[:BM:N(G45I"Y3GSXE)7C0
MM9)_Z],?S-<!XSB\1>)M13[/HVH)8P;3%NA 8G')(S7L%-) .*FG5=.7,@:N
M><>'_'=_;W?]AZOHVH/?HN8A%"@W+[Y<5U/_  D=U_T+>M?]\1?_ !RN;U\&
MX^*>C+ /GBBS(?;).*]$JZT4K2757$F8 \0WI^[X:U@G_:$('_HRE_MW4C]W
MPQJ7XRP#_P!GK>HK HP1K6K$9_X1F^'UGA_^+I#J^N'IX:GQVS=Q _SK?HH
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M]PNS*2[$8/8<]*V/#8UB/3YH=;E6:ZBN9%694""6/.4; X'!Q^%<_P"&]?\
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MYQ5GP]X?U;1O%^OW;&T;3=2F6Y#AF\P-MQLVXP,'G.?3CG@ ZZBBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH 0\"LS6M8MM$TN6]N7"A1A1_>;L!6
MDY"H2>@KA-/C?QAXGN+J\4?V9ITI2"+.0\@/WC6M."=W+9";[%GPUHMQJ5Q_
MPD.M(6NY?F@A?I"O;'OTKLQQ0J@# %+4U*DIN[!*RL%5[RZBM+.:XF.V.-"S
M$^@J5F*@DXP/Y5P]Y/-XSUQM,M79-(M&!NI1_P MFZ[1[4Z5/G=WL@;L.\(6
ML^LZM>>)KQ& F.RT5_X4'\0^M=PH(Z]:C@@CMX4AB4+&B[54= *EHJU'4E>U
MD"5@HHHK,84444 %%%% !1103@9- !4<KJBDL0% ).?2HKB^MK62*.>9$>8[
M8PQ^\?:N3\<:[-'%%HFF_-J-]\@"G[B]R:TITW.22)DTD4O"3/KWBO4]?9 8
M4'D0GMP><?A7H596@Z-!H>D0V4 P%&6/JQZFM6G7FISNMEHAQV"BBBLAA111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 V2-)4*2(KH>JL,@U&MI;(CHEO$JO\ >4(
M&^OK4U% $45M! 3Y,,<>>NQ0,_E3HX8H01%&B G)VJ!DT^B@!,#.<#/3-* !
MT%%% #514&%4*,DX ]>33J** "BBB@ HHHH **** "BBB@#+\1:%;>)=#GTJ
MZEFBCE*MYD#;71E8,I!]00*S=/\ "U[%/;R:MXCOM52V(:*&6..--PZ,^U<N
M1U&3UYKIJ* "BBB@"O:6-O8B46Z%3+(9)&9BS,Q[DDD^P]  !Q5BBB@ HHHH
M **** &2Q)/"\4B[D=2K#U!X-)!!#:P)!;Q)%#&-J1HH55'H .E244 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH #TKF-7\%V6I7GVZ"26QO3UFMVVEOJ.]=/150G*#O%V
MXU? 8N"HU75K[4(E/^JD?"GZXKI[2PMM/MQ!:6Z11#^! !5NBG.I*>DF)*P"
MDI:*@84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%(3M4DYX&>!F@!:*AMKJ"\A
M\ZWD$B9*Y'8@X(/H00014U !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 -CBCB!$:*@9BQ"C&2>2?K3J** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **0D $DX ZDTD<B2QK)&ZNC#*LIR"
M/4&@!U%5[>_L[N62*VNX)I(CB1(Y Q3Z@'BK% !1110 4444 %%%% !1110
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ME#_0V0?*KY(;)]^_% 'I]%>6>&=4U6X\2O:/>^7=B"\-O+*\C0:F?,^1USP
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
8% !1110 4444 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>davidjkatz_employmentagr014.jpg
<TEXT>
begin 644 davidjkatz_employmentagr014.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *044"@!:*** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@!*!1B@4 +1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %(*6D% "T444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !2"EI!0 M%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4@I:04 +1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %(*6D% "T444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !2"EI!0 M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M@I:04 +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MLWS?\"/I7L% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4@I:04 +1110 4444
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M%YB(F$D,P(R-K84Y([$>HZUE-\0=;G^(UQX/M-,T\31#(GEG?:?W8?LN>AH
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MQ?1I;I9B">1+CRS$Y,WREE(*GYEXXZCUJ'PA>)\,OB'>Z'KS0&UU#]Y;ZM,
M&8$\%I/[IQSDX##/J:]SHH ^>;E_#.N_'/5CJMY8RZ/<0E1</.HCW>2@!5\X
MR"#@YZBO2= \6:3'!#X=L]2M+JWTG2%6[O4?$?F+LC0*>AS\W3/85WM% 'SG
M\*-,TB?3[JZU/;;W=EJ-O<6\[0LS#RSN=!@9Y'&/<<5ZC=>+X-1T9[J:&>&
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !2"EI!0 M%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4@I:04 +1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %(*6D% "T444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !2"EI!0 M%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4@I:04 +1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %(*6D% "T444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !2"EI!0 M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M@I:04 +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %(*6D%
M"T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2"EI!0 M%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4@I:04 +1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %(*6D% "T444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !2"EI!0 M%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4@I:04 +1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %(*6D% "T444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !2"EI!0 M%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4@I:04 +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %(*6B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **C*.;A9/-8(%*F/ P3D<YZ]C^=24 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 !IH!\PG<V,8V
M]J=10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MHF<;X0_FR?P(2>BD\'OR.1@YV["X-WIUK<L8R9HED)C;<N2 >#W% %BBBB@
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MH56ED+L1[L>2?<U/0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M.,=1SFO1:* .*TG1M8T30I-.CTR"_LYKM_*LKJ[_ ./6W8#:A8JP8 YX'0'
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M^604S_" ,$YYR2.>.QHH \_D^&SMH\&G'48[B-=.DL66ZA+K'N?>'C&[Y2I
M SGA5YXKH&T"[N9+>WOKZ*?3[26":W40D3;X@,;W+$'YAG@ ]JZ"B@#&OM.U
M>^M9;5M1LEAF66.4&R8DHW  _><$+D9.0?2KVF:?!I.E6FG6V?(M85A3=UPH
MP,^_%6Z* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
HB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>rdnt-20221231_g1.jpg
<TEXT>
begin 644 rdnt-20221231_g1.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_[@ .061O8F4 90     !_]L 0P " 0$!
M 0$" 0$! @(" @($ P(" @(%! 0#! 8%!@8&!08&!@<)" 8'"0<&!@@+" D*
M"@H*"@8("PP+"@P)"@H*_]L 0P$" @(" @(% P,%"@<&!PH*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*_\  $0@#
MP 3* P$B  (1 0,1 ?_$ !\   $% 0$! 0$!           ! @,$!08'" D*
M"__$ +40  (! P,"! ,%!00$   !?0$" P $$042(3%!!A-180<B<10R@9&A
M""-"L<$54M'P)#-B<H()"A87&!D:)28G*"DJ-#4V-S@Y.D-$149'2$E*4U15
M5E=865IC9&5F9VAI:G-T=79W>'EZ@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>H
MJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KAXN/DY>;GZ.GJ\?+S]/7V
M]_CY^O_$ !\!  ,! 0$! 0$! 0$        ! @,$!08'" D*"__$ +41  (!
M @0$ P0'!00$  $"=P ! @,1! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P
M%6)RT0H6)#3A)?$7&!D:)B<H*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E
M9F=H:6IS='5V=WAY>H*#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6V
MM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_:  P#
M 0 "$0,1 #\ ^/?V'_V'_P!N3_@KK^W)\=_A1\*/V[O$'@C_ (0CQ!J%^[ZM
MX@U.6*6)]3FA6*-891MVX^F.*^P/^(3;_@J9_P!)=O\ RH:Y_P#'J/\ @TV_
MY2F?M=_]O'_I\GK]_J /P!_XA-O^"IG_ $EV_P#*AKG_ ,>H_P"(3;_@J9_T
MEV_\J&N?_'J_?ZB@#\ ?^(3;_@J9_P!)=O\ RH:Y_P#'J/\ B$V_X*F?])=O
M_*AKG_QZOW^HH _ '_B$V_X*F?\ 27;_ ,J&N?\ QZC_ (A-O^"IG_27;_RH
M:Y_\>K]_J* /P!_XA-O^"IG_ $EV_P#*AKG_ ,>H_P"(3;_@J9_TEV_\J&N?
M_'J_?ZB@#\ ?^(3;_@J9_P!)=O\ RH:Y_P#'J/\ B$V_X*F?])=O_*AKG_QZ
MOW^HH _ '_B$V_X*F?\ 27;_ ,J&N?\ QZC_ (A-O^"IG_27;_RH:Y_\>K]_
MJ* /P!_XA-O^"IG_ $EV_P#*AKG_ ,>H_P"(3;_@J9_TEV_\J&N?_'J_?ZB@
M#\ ?^(3;_@J9_P!)=O\ RH:Y_P#'J/\ B$V_X*F?])=O_*AKG_QZOW^HH _
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M_P#'J/\ B$V_X*F?])=O_*AKG_QZOW^HH _ '_B$V_X*F?\ 27;_ ,J&N?\
MQZC_ (A-O^"IG_27;_RH:Y_\>K]_J* /P!_XA-O^"IG_ $EV_P#*AKG_ ,>H
M_P"(3;_@J9_TEV_\J&N?_'J_?ZB@#\ ?^(3;_@J9_P!)=O\ RH:Y_P#'J/\
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M_P!)=O\ RH:Y_P#'J/\ B$V_X*F?])=O_*AKG_QZOW^HH _ '_B$V_X*F?\
M27;_ ,J&N?\ QZC_ (A-O^"IG_27;_RH:Y_\>K]_J* /P!_XA-O^"IG_ $EV
M_P#*AKG_ ,>H_P"(3;_@J9_TEV_\J&N?_'J_?ZB@#\ ?^(3;_@J9_P!)=O\
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M#\ ?^(3;_@J9_P!)=O\ RH:Y_P#'J/\ B$V_X*F?])=O_*AKG_QZOW^HH _
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M_P#'J/\ B$V_X*F?])=O_*AKG_QZOW^HH _ '_B$V_X*F?\ 27;_ ,J&N?\
MQZC_ (A-O^"IG_27;_RH:Y_\>K]_J* /P!_XA-O^"IG_ $EV_P#*AKG_ ,>H
M_P"(3;_@J9_TEV_\J&N?_'J_?ZB@#\ ?^(3;_@J9_P!)=O\ RH:Y_P#'J/\
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M_LV?M=3:%X*^)NB:3>W>C:]X4TW4+2PEN9[^WE*8@2X=%6U658S.,R<%PAP
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MB0,0-WE@DCX3_P"#H/\ X)AI^WQ^P+>?%OX=Z +CXC_!N*YU[0?)CS-J&F;
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MK4=];K<P6NHRRH7B0K\BN%<@$A<N/U\HH _'S_@DO^PA_P %!?V5_P#@LO\
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M#\]/^#D+_@EGXS_X*;_L5:79? O0(;SXH^ /%%OJ/@X/.L+3V]PZ6]];>8Q
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M#+_P3XGT7Q5J-XJSZ[I=_!>P74OF(\4EA=SXV_=82!#DC&X9(^^:** /@O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M6II9);JZOIY898;P7#RL9(986A(6-5C58XU4 ^;?@3\+_P!KK]B+]HSXH?\
M!.SPY\??&/Q1^'/B+]G_ %;QI\(-7\<:B;[7?"NIV]Q%8/I#7F UQ"[7<,L)
M?!40LB@;79_ [:Z\)VG_  9CGRUC-L?@V]N4Q_R_-K)C*X_O_:B1CKN]Z_5;
MX+_L]>&_@[>:AXHN?%VO^+O%>LVUO;:WXT\774,VHWL$&\PPX@BA@@A0RRL(
M;>**/?+(^TO([-YFO_!,?]GL(_@YM;\3-\.7\>?\)E_PJ$W=K_PC@UG[6+[S
MO+%O]I\G[=_I?V0W!M?..[R<86@#YC_X)D:-\0- _P""QW[1%A\:1<+XAD^
M?PK;3!>D^8UNFF2Q7I7/4"^24-_MY[UV'_!"V/5Y=>_;)UA%<:%>_ML>-VT0
MG[DK+]D2XDC]4,JL,C@LK]\U]0?%[]D?P;\4/B_I/[0OAWQUXD\#>/M)\/7.
M@+XN\(-9?:;O29I4F:QN([ZVN8)HEG1)D+1[XGW%'422!^B_9\_9^^%G[+WP
METOX*_!O0&T_0]*,TB+-<O//<W$TKSW%S/*Y+S3S3222R2,26=V- ':4444
M%>2:5X^\2>+_ -J_Q3\&M6NE&B:+X8L=0L4@79*)IF97W..6&!P.U>MUX7X!
M_P"4@GC_ /[$32O_ $8U 'KG_"#Z1_S\WO\ X%M1_P (/I'_ #\WO_@6U;%%
M &/_ ,(/I'_/S>_^!;4?\(/I'_/S>_\ @6U;%% &/_P@^D?\_-[_ .!;4?\
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M#Z1_S\WO_@6U'_"#Z1_S\WO_ (%M6Q10!C_\(/I'_/S>_P#@6U'_  @^D?\
M/S>_^!;5L44 8_\ P@^D?\_-[_X%M1_P@^D?\_-[_P"!;5L44 8__"#Z1_S\
MWO\ X%M1_P (/I'_ #\WO_@6U;%% &/_ ,(/I'_/S>_^!;4?\(/I'_/S>_\
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MZ1_S\WO_ (%M6Q10!C_\(/I'_/S>_P#@6U'_  @^D?\ /S>_^!;5L44 8_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^0/\ @OQ_RAL_:$_[
M)_-_Z.BK^,*O[/?^"_'_ "AL_:$_[)_-_P"CHJ_C"H _?[_@TV_Y2F?M=_\
M;Q_Z?)Z_?ZOP!_X--O\ E*9^UW_V\?\ I\GK]_J "BBB@ HHHH **** "BBB
M@ KPOP#_ ,I!/'__ &(FE?\ HQJ]TKPOP#_RD$\?_P#8B:5_Z,:@#W2BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@#Y _X+\?\H;/VA/\ LG\W_HZ*OXPJ_L]_X+\?\H;/VA/^R?S?^CHJ
M_C"H _?[_@TV_P"4IG[7?_;Q_P"GR>OW^K\ ?^#3;_E*9^UW_P!O'_I\GK]_
MJ "BBB@ HHHH **** "BBB@ KPOP#_RD$\?_ /8B:5_Z,:O=*\+\ _\ *03Q
M_P#]B)I7_HQJ /=**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** /D#_ (+\?\H;/VA/^R?S?^CHJ_C"K^SW
M_@OQ_P H;/VA/^R?S?\ HZ*OXPJ /W^_X--O^4IG[7?_ &\?^GR>OW^K\ ?^
M#3;_ )2F?M=_]O'_ *?)Z_?Z@ HHHH **** "BBB@ HHHH *\+\ _P#*03Q_
M_P!B)I7_ *,:O=*\+\ _\I!/'_\ V(FE?^C&H ]THHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^0/^"_'
M_*&S]H3_ +)_-_Z.BK^,*O[/?^"_'_*&S]H3_LG\W_HZ*OXPJ /W^_X--O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^
M0/\ @OQ_RAL_:$_[)_-_Z.BK^,*O[/?^"_'_ "AL_:$_[)_-_P"CHJ_C"H _
M?[_@TV_Y2F?M=_\ ;Q_Z?)Z_?ZOP!_X--O\ E*9^UW_V\?\ I\GK]_J "BBB
M@ HHHH **** "BBB@ KPOP#_ ,I!/'__ &(FE?\ HQJ]TKPOP#_RD$\?_P#8
MB:5_Z,:@#W2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M,RGBN06ZUV+_ (-26_9B3PW,OQ)%@?A,?!.!]O/BG_A(/[/.G^7U\W.9L?\
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M[_X%M0!L45C_ /"#Z1_S\WO_ (%M1_P@^D?\_-[_ .!;4 ;%%8__  @^D?\
M/S>_^!;4?\(/I'_/S>_^!;4 ;%%8_P#P@^D?\_-[_P"!;4?\(/I'_/S>_P#@
M6U &Q16/_P (/I'_ #\WO_@6U'_"#Z1_S\WO_@6U &Q16/\ \(/I'_/S>_\
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M #\WO_@6U'_"#Z1_S\WO_@6U &Q16/\ \(/I'_/S>_\ @6U'_"#Z1_S\WO\
MX%M0!L45C_\ "#Z1_P _-[_X%M1_P@^D?\_-[_X%M0!L45C_ /"#Z1_S\WO_
M (%M1_P@^D?\_-[_ .!;4 ;%%8__  @^D?\ /S>_^!;4?\(/I'_/S>_^!;4
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M(/I'_/S>_P#@6U &Q16/_P (/I'_ #\WO_@6U'_"#Z1_S\WO_@6U &Q16/\
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M03Q__P!B)I7_ *,:O=*\+\ _\I!/'_\ V(FE?^C&H ]THHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /D#_@OQ_RAL_:$_P"R
M?S?^CHJ_C"K^SW_@OQ_RAL_:$_[)_-_Z.BK^,*@#]_O^#3;_ )2F?M=_]O'_
M *?)Z_?ZOP!_X--O^4IG[7?_ &\?^GR>OW^H **** "BBB@ HHHH **** "O
M"_ /_*03Q_\ ]B)I7_HQJ]TKPOP#_P I!/'_ /V(FE?^C&H ]THHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH ^0/\ @OQ_RAL_:$_[)_-_Z.BK^,*O[/?^"_'_ "AL_:$_[)_-_P"CHJ_C
M"H _?[_@TV_Y2F?M=_\ ;Q_Z?)Z_?ZOP!_X--O\ E*9^UW_V\?\ I\GK]_J
M"BBB@ HHHH **** "BBB@ KPOP#_ ,I!/'__ &(FE?\ HQJ]TKPOP#_RD$\?
M_P#8B:5_Z,:@#W2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /D#_ (+\?\H;
M/VA/^R?S?^CHJ_C"K^SW_@OQ_P H;/VA/^R?S?\ HZ*OXPJ /W^_X--O^4IG
M[7?_ &\?^GR>OW^K\ ?^#3;_ )2F?M=_]O'_ *?)Z_?Z@ HHHH **** "BBB
M@ HHHH *\+\ _P#*03Q__P!B)I7_ *,:O=*\+\ _\I!/'_\ V(FE?^C&H ]T
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_$I(/FC;#+W!_KQ_X)V?\%0/V6O^"EG[.NG_ +0'P*\6I"S!8/$GAB_D O\
M0+[;E[:X4?B4D'RR+AE[@ 'T716;_P )CX8_Z#4'_?5'_"8^&/\ H-0?]]4
M:5%9O_"8^&/^@U!_WU1_PF/AC_H-0?\ ?5 &E16;_P )CX8_Z#4'_?5'_"8^
M&/\ H-0?]]4 :5%9O_"8^&/^@U!_WU1_PF/AC_H-0?\ ?5 &E16;_P )CX8_
MZ#4'_?5'_"8^&/\ H-0?]]4 :5%9O_"8^&/^@U!_WU1_PF/AC_H-0?\ ?5 &
ME16;_P )CX8_Z#4'_?5'_"8^&/\ H-0?]]4 :5%9O_"8^&/^@U!_WU1_PF/A
MC_H-0?\ ?5 &E16;_P )CX8_Z#4'_?5'_"8^&/\ H-0?]]4 :5%9O_"8^&/^
M@U!_WU1_PF/AC_H-0?\ ?5 &E16;_P )CX8_Z#4'_?5'_"8^&/\ H-0?]]4
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M_L[3_P#GQA_[]"C^SM/_ .?&'_OT*FHH A_L[3_^?&'_ +]"C^SM/_Y\8?\
MOT*FHH A_L[3_P#GQA_[]"C^SM/_ .?&'_OT*FHH A_L[3_^?&'_ +]"C^SM
M/_Y\8?\ OT*FHH A_L[3_P#GQA_[]"C^SM/_ .?&'_OT*FHH A_L[3_^?&'_
M +]"C^SM/_Y\8?\ OT*FHH A_L[3_P#GQA_[]"C^SM/_ .?&'_OT*FHH A_L
M[3_^?&'_ +]"C^SM/_Y\8?\ OT*FHH A_L[3_P#GQA_[]"C^SM/_ .?&'_OT
M*FHH A_L[3_^?&'_ +]"C^SM/_Y\8?\ OT*FHH A_L[3_P#GQA_[]"C^SM/_
M .?&'_OT*FHH A_L[3_^?&'_ +]"C^SM/_Y\8?\ OT*FHH A_L[3_P#GQA_[
M]"C^SM/_ .?&'_OT*FHH A_L[3_^?&'_ +]"C^SM/_Y\8?\ OT*FHH A_L[3
M_P#GQA_[]"C^SM/_ .?&'_OT*FHH A_L[3_^?&'_ +]"C^SM/_Y\8?\ OT*F
MHH A_L[3_P#GQA_[]"C^SM/_ .?&'_OT*FHH A_L[3_^?&'_ +]"C^SM/_Y\
M8?\ OT*FHH A_L[3_P#GQA_[]"C^SM/_ .?&'_OT*FHH A_L[3_^?&'_ +]"
MC^SM/_Y\8?\ OT*FHH A_L[3_P#GQA_[]"C^SM/_ .?&'_OT*FHH A_L[3_^
M?&'_ +]"C^SM/_Y\8?\ OT*FHH A_L[3_P#GQA_[]"C^SM/_ .?&'_OT*FKP
M/_@H#_P4:_9Y_P""=/PNMO&_QAOKW5/$&O7/V'P)\/O#D'VK6_%6HL0J6MG;
M+\SDLR!I"-B;U!.YD5@#\7/^#H__ (()?"SX,>'=9_X*;_LHW.A>%M*FU",_
M$7P+<7<-G ]U/(%6]TU7*J7=V_>6J\DDO&/O+7X15_79^S3_ ,$Y?VAOVY_C
M+HW_  4!_P""RUC93ZEI,_VSX2?LXVL_VC0/ D9Y2YO@?DU#4R,%G8%$(Z'$
M<<'RC_P6;_X-0O\ AJ#]H[2?VA?^">M[X?\ !_\ PF'B!$^)?AG46\BPT_S&
M)EUBS11]3):KC<Q#)C+  '\^_P #/@KJ?QE\86MEJ&JR>'_"=OJMA;^,?'MU
MI%U=:;X7M;JY2!;R\-O&YCC#-@9QN(VCDU_9M_P2^_X)[_LC_P#!/?\ 91T'
MX4?LIVVGZOI6I6<.I:GXY5HKB?Q5/)&"+^2>/*NC*1Y:H3&B$!>Y+/V$?^"5
M'[(/[ W[(;_L=_#KX<V&MZ'K-DT?CR^\0V$4\WBR>2/9-+>JP*NC*2JP\I&A
MV@=2?DW6?"7[0'_!O'XKN?&WPKTSQ#\2_P!B?4[][CQ!X0B>2]UOX//*Y:2[
MLMQ+W6D[F+/$26BR6)W!Y)@#]/\ ^SM/_P"?&'_OT*/[.T__ )\8?^_0K!^#
M_P 8?A=^T!\,M%^,WP5\=Z;XF\+>(K%;S1=<TFX$L%U"W<$="""K*<,K*58
M@@=)0!#_ &=I_P#SXP_]^A1_9VG_ //C#_WZ%344 0_V=I__ #XP_P#?H4?V
M=I__ #XP_P#?H5-10!#_ &=I_P#SXP_]^A1_9VG_ //C#_WZ%344 0_V=I__
M #XP_P#?H4?V=I__ #XP_P#?H5-10!#_ &=I_P#SXP_]^A1_9VG_ //C#_WZ
M%344 0_V=I__ #XP_P#?H4?V=I__ #XP_P#?H5-10!#_ &=I_P#SXP_]^A1_
M9VG_ //C#_WZ%344 0_V=I__ #XP_P#?H4?V=I__ #XP_P#?H5-10!#_ &=I
M_P#SXP_]^A1_9VG_ //C#_WZ%344 0_V=I__ #XP_P#?H4?V=I__ #XP_P#?
MH5-10!#_ &=I_P#SXP_]^A1_9VG_ //C#_WZ%344 0_V=I__ #XP_P#?H4?V
M=I__ #XP_P#?H5-10!#_ &=I_P#SXP_]^A1_9VG_ //C#_WZ%344 0_V=I__
M #XP_P#?H4?V=I__ #XP_P#?H5-10!#_ &=I_P#SXP_]^A1_9VG_ //C#_WZ
M%344 1)8V4;!X[.)6'0K& 14M%% 'R!_P7X_Y0V?M"?]D_F_]'15_&%7]GO_
M  7X_P"4-G[0G_9/YO\ T=%7\85 '[_?\&FW_*4S]KO_ +>/_3Y/7[_5^ /_
M  :;?\I3/VN_^WC_ -/D]?O]0 4444 %%%% !1110 4444 %>%^ ?^4@GC__
M +$32O\ T8U>Z5X7X!_Y2">/_P#L1-*_]&-0![I1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MJ2Y$EC?6Y.Z*56# 'E7"DJ2*]NH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^0/^"_'_ "AL
M_:$_[)_-_P"CHJ_C"K^SW_@OQ_RAL_:$_P"R?S?^CHJ_C"H _?[_ (--O^4I
MG[7?_;Q_Z?)Z_?ZOP!_X--O^4IG[7?\ V\?^GR>OW^H **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%17M[9Z;9S:CJ-W%;V]O$TD\\\@1(T499F8\   DD\
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M\I!/'_\ V(FE?^C&KW2O"_ /_*03Q_\ ]B)I7_HQJ /=**** "BBB@ HHHH
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MX&RYT^Y4 R6EU"?F@GC) 9&]0P+*RL0#U"BBB@ HHHH **** "BBB@ HHHH
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M HHHH **** "BBB@ HHHH **** "BBB@ HHKX=_;L_X*E^/K+XS/_P $[_\
M@F+X&L?B;^T/?P?\3FYGD)\/_#FU; .H:S.N0KJ""EJ/G8[<C+1QS 'H'_!1
M?_@J+\,/V$K;1OA=X6\'ZA\2_C9XX)@^&WP<\+-YFIZQ,<@3S8!^R6:E6+W#
MC&$?:&V-M\W_ &'_ /@ES\3]9^-EM_P48_X*J^,-/^(GQ[ECW>%O#UH-_ASX
M96S'<MEI4#$JUPO&^[.6+#Y68[II?0/^"='_  2T\ _L27&L_'#XF>.;[XI?
M'GQR/-^(GQB\31AKV^<X)M+1#D65DFU0L$>,A$W$A(U3ZJH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OS
MY_;!_P"">/Q__9-^.NK?\%+?^"0EC:6WC/46%Q\7_@5/-Y&B?$NW4EGFB4?+
M::J,NR3* )&8D_,\HG_0:B@#PC_@G_\ \%#OV?\ _@HO\'I/B9\&KZ[T_5M'
MNCI_C?P+KT/V?6?"NIKD26=[;M\T;!E<*^-K[3@Y5@ON]?$'_!0#_@F-\2-8
M^,,?_!1C_@F?XNL?A]^T9HEJ$U."X&S0_B/8)@G2]8B4A69@H6.YX92$#,-D
M4D/H/_!.#_@IU\-_V]M#UGP)X@\(7WP[^,O@246GQ0^$'B0[-2T*Y&%,L8('
MVFT<D&.X08(==P4L 0#Z>HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH ^0/^"_'_*&S]H3_LG\W_HZ*OXPJ_L]_P""_'_*&S]H3_LG
M\W_HZ*OXPJ /W^_X--O^4IG[7?\ V\?^GR>OW^K\ ?\ @TV_Y2F?M=_]O'_I
M\GK]_J "BBB@ HHHH **** "BBB@ KPOP#_RD$\?_P#8B:5_Z,:O=*\+\ _\
MI!/'_P#V(FE?^C&H ]THHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ ILLL4$33SR*B(I9W=L!0.I)["L3XF?$WX>?!CP!J_Q5^+/C33?#OAO0;)
M[S6=;UB[6"VLX%'S.[L0%';W) &20*_-F_\ $_[4?_!PEK$WAWX;7WB7X/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MB_;CSO 'PVL&\WPS\+X&(98K2(EDN;X87?=,6PZ@HSE$EH X?X9?L??M0_\
M!9WQ_I'[4G_!4;P??^!/@7I-ZFH_"W]EV6=EEU,J<PZIXE(QYLA&&2R/" [6
M"CS!/^E&EZ7IFAZ9;Z+HNG06=G9P)!:6EK"L<4$2*%5$50 J@   #   %3T4
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 5XI^WA^P)^SO_P %$O@E-\%OV@/#
MLS?9YQ>>&?$VE2^1JOAS45YBOK&X W0RH0#W5P-KJR\5[710!^=G[*_[??[1
M'[!7QPT7_@G%_P %??$4-U<ZO-]D^"O[1WE>3I7CN%2!'9:BQ)6SU5054ASB
M4D9)9DEN/T3KSO\ :H_93^ ?[:GP/UK]G;]I3X=V7B7PKKD.VYLKI</!(,[+
MB"0?-#,A.4D0AE/?!(/P=\)OVG_VB/\ @B-\2=&_9(_X*,^.-1\;_L[ZW?)I
MWP?_ &D=04O/X?9N(=%\1L!A-H&V.\.%*KD_('%L ?IK145E>V6IV4.HZ==Q
M7%O<1+)!/!('21&&596'!!!!!'!!J6@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH ^0/^"_'_*&S]H3_ +)_-_Z.BK^,*O[/?^"_'_*&S]H3_LG\W_HZ
M*OXPJ /W^_X--O\ E*9^UW_V\?\ I\GK]_J_ '_@TV_Y2F?M=_\ ;Q_Z?)Z_
M?Z@#\\_^"NW[!_C;Q1X_TK_@H-^P[\88?#'QK\.>(?"7AO5O#^I3&7P_XRC_
M .$@T^73K'5XHR'B,-S<6\ZS)^\$?RX(9'3W[_@GK^W)H_[87[..M_&#XG?"
MY?AGXJ^'_BS5?#?Q7\.ZM=Q-#H&N:<J_;BMUPDD'END@FR!L?DG!)L?M!_L%
M7GQ8\;ZK\1_AK^TQX\\"ZAXAUWPSJ'B'3=)DTZZTV[DTC4+6XBN5@OK*X\FY
M$5L$#Q,B.R1><DJIL.7X^_X)7?!#QG^S<O[,.A_%KXE^$]&N_&$WBKQ1K7A3
MQ-%;ZMXGUB6X-S+=ZA=26\C3,]QB4HH1,I&H4)&B* <UHOP0\9_&/XG_ !C_
M ."B^F:+=Z=KWB3X./X"^#-A) T-XNBP&ZO5OYD8!HY;R_G62.)L,EO;VQ<)
M)))''\56UUX3M/\ @S'/EK&;8_!M[<IC_E^;63&5Q_?^U$C'7=[U^A7[.?\
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MC_L7Z7_R(/[0_P"T=X4Q]W_A'?CCJ,>WZ>9O_P!K_OH^V#_APKJ&B?/\/_\
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M#I\K:=::W\)1I<EQ*$.U5DB9XD<G[I=2FX+N^7)K^5C]JO\ X:._X:/\:?\
M#7O_  D'_"S?^$@N/^$U_P"$IW?;_M^[]YYN[\-N/EV[=OR[: #_ (:K_:._
MX:._X:]_X71X@_X6;_PD']M_\)K]O;[?]OW;O.\S_P =VXV[?DQM^6OW_P#V
M+_\ @YZ_:2_;?^!?AK]FS]GK]G=/$O[66O3OID=E-;+;^&H88XMTGB"YFW@Q
MPJN6>V49WJ55L,@/\X%>@?LJ_P##1W_#1_@O_AD+_A(/^%F_\)!;_P#"%?\
M"+;OM_V_=^[\K;^.[/R[=V[Y=U ']>7_  3X_P""4UU^R;XKUC]J+X\_%5/B
MM^T-XUBSXU^*NOVA>2%6 _XE^FQG"V5DG"JD84N%&0JJD<?UE]B\;_\ 0;LO
M_ 8_XUR_[*O_  T=_P ,X^"_^&O/^$?_ .%F_P#"/V__  FO_"+;OL'V_;^\
M\K=^&['R[MVWY=M>@4 8_P!B\;_]!NR_\!C_ (T?8O&__0;LO_ 8_P"-;%%
M&/\ 8O&__0;LO_ 8_P"-'V+QO_T&[+_P&/\ C6Q10!C_ &+QO_T&[+_P&/\
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M;LO_  &/^-'V+QO_ -!NR_\  8_XUL44 8_V+QO_ -!NR_\  8_XT?8O&_\
MT&[+_P !C_C6Q10!C_8O&_\ T&[+_P !C_C1]B\;_P#0;LO_  &/^-;%% &/
M]B\;_P#0;LO_  &/^-'V+QO_ -!NR_\  8_XUL44 8_V+QO_ -!NR_\  8_X
MUSOQ9^#&E?'?X;:S\'_C)H6@^)/#'B&Q>SUK0]7TP36]W"W564]P<$,,%6 8
M$$ CNJ* /RIM-8_:B_X-X]=M?"_C;7]:^(_[%>HZ@L&F>(WMY=0UGX//*^$@
MN0,R76D[F"JXRT7"@;MJ7'Z4>!?%K_$_P;I?Q$^'/Q%T+7=!UNQCO-(UC2F6
M>VO+>10R2QR(2KJP(((.*Z/7] T+Q7H5[X7\4:+::EIFHVLEKJ&G7]LLT%U!
M(I5XI(W!5T925*D$$$@BOS*\;_!S]H/_ ((!^-=3^/'[)'A?7/B+^R'JM])?
M_$3X-6DC7.J?#9G8M-JNB;SF6R!)>6U)^09;(&Z6, _2C[%XW_Z#=E_X#'_&
MC[%XW_Z#=E_X#'_&OS(_X*Y?\'-W[*O[)_[*^C:]^Q'\2- ^)/Q&^(^A?;/!
MBV,OG6FAVK[D^WWZ<-'(C!E6T<+(9$8.%5&SV'_! _\ X+X?#C_@JI\.(_A#
M\7KG3_#OQS\.Z>&UO1(R(H/$4" !M1L5)_&6 9,1.1E"" #]!_L7C?\ Z#=E
M_P" Q_QH^Q>-_P#H-V7_ (#'_&MBB@#'^Q>-_P#H-V7_ (#'_&C[%XW_ .@W
M9?\ @,?\:V** ,?[%XW_ .@W9?\ @,?\:/L7C?\ Z#=E_P" Q_QK8HH Q_L7
MC?\ Z#=E_P" Q_QH^Q>-_P#H-V7_ (#'_&MBB@#'^Q>-_P#H-V7_ (#'_&C[
M%XW_ .@W9?\ @,?\:V** ,NSM/%J72/?:M:O$&_>(EN02/8UJ444 ?('_!?C
M_E#9^T)_V3^;_P!'15_&%7]GO_!?C_E#9^T)_P!D_F_]'15_&%0!^_W_  :;
M?\I3/VN_^WC_ -/D]?O]7X _\&FW_*4S]KO_ +>/_3Y/7[_4 %%%% !1110
M4444 %%%% !7A?@'_E()X_\ ^Q$TK_T8U>Z5X7X!_P"4@GC_ /[$32O_ $8U
M 'NE%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 5#J6I:=H^G3ZOJ]_#:VEK"TUU=7,H2.&-069V9
MB J@ DD\ "N/_:)_:/\ @?\ LF?"#6/CS^T5\2=,\)^$]"M_-U'5]4FVJO\
M=C11EI97/RI$@9W8A54DXK\]=/\  G[7'_!P'J4'BGXU:=XF^"G[&OGK/H_@
M3SFLO$_Q7A#!HY]09#NL=,? 985.Z13N!;,<T8!L?%+]NC]J;_@KC\0M7_93
M_P""1/B67PC\+-*O6T[XH?M736K&%".)M/\ #:G'VJYVG!N@0J [D9,Q2O\
M8/[#7[ W[-/_  3Q^#<?P9_9N\%FR@GF^U>(-?U&7[1JOB"].=]Y?7) :>9B
M6/95SM147"CTCX6_"SX;_!'X>Z1\)OA#X'TSPWX:T&R6TT;0]&LU@MK2%>B(
MB@ <Y)/4DDG))-;] !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %?G!_P %\/\ @@?\./\ @JI\.)/B]\(;;3_#OQS\.Z>5
MT36Y (H/$4" E=.OF _"*<Y,1.#E"0/T?HH _A#_ .&5/VCO^&CO^&0O^%+^
M(/\ A9O_  D']B?\(5]@;[?]OW;?)\O_ ,>W9V[?GSM^:OZG?^"!_P#P0/\
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MP!_P]#_X*V:;_P C)_P;Y>.HL?,_]E_&_0;W">HV(,MU^7_&C_A[]^WGIO\
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M:C\'O%ZD"Z\(_&[P[<>&KNU). ));D?95.<C F/2OLCPEXR\(>/_  _;^+/
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M2F"ZOHI0L$(6%"Z*=TEP1E64D _FTN)WNKB2YE5 TCEF$<:HH).>%4 */8
M=JN^$_%?B3P)XJTSQQX.UJXTW5]&U"&^TK4;20I+:W,+B2*5&'W65U5@>Q K
M[O\ ^(7'_@NO_P!&,_\ F3?#'_RSH_XA<?\ @NO_ -&,_P#F3?#'_P LZ /Z
M;O\ @DQ^WQX;_P""E/[!G@7]J?2Y;>/5]1T_[#XRTZW( L-;MP([N+;_  JS
MXEC!Y\J:,]Z^CZ_%'_@V&_8-_P""PO\ P3,^,OC+X0_M9_LKW&A_"3QUIXOF
MU1?'6A7RZ1K=N,1R^1:WTLI6>$M"Y1&.Z.W)PJL1^UU !1110 4444 %%%%
M!1110 4444 ?('_!?C_E#9^T)_V3^;_T=%7\85?V>_\ !?C_ )0V?M"?]D_F
M_P#1T5?QA4 ?O]_P:;?\I3/VN_\ MX_]/D]?O]7X _\ !IM_RE,_:[_[>/\
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M'\XM@#CGCU?_ (=@?\%2/VKO]*_X*%_\%<O$&@Z1<?\ 'S\._P!F?2%\-V:
M_>B.JS*UY<1-]TK(@X[\U^A5% 'RK^S!_P $2_\ @F!^R3J*>)_AE^R5X=U'
MQ)YOG2^+_&J/KVJR3DY:<7%^TK1.3R3%L')XKZI5510B*  ,  =*6B@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M"/[3M/+6YO?M#W-S^]V&(-&I,QASQFOR%K^RW_@X6^ WQ2_:6_X(Z?&GX/\
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MD_7]% 'P!_Q"X_\ !"C_ *,9_P#,F^)__EG1_P 0N/\ P0H_Z,9_\R;XG_\
MEG7W_10!\@?LN?\ !!7_ ()/?L7?';0OVE_V:/V4_P#A&O&WAK[5_8FM_P#"
M=:[>?9OM%K+:S?N;J^EA?=#/*GS(<;LC# $?7]%% !1110 4444 %%%% !11
M10 4444 ?('_  7X_P"4-G[0G_9/YO\ T=%7\85?V>_\%^/^4-G[0G_9/YO_
M $=%7\85 '[_ '_!IM_RE,_:[_[>/_3Y/7[_ %?@#_P:;?\ *4S]KO\ [>/_
M $^3U^_U !1110 4444 %%%% !1110 5X7X!_P"4@GC_ /[$32O_ $8U>Z5X
M7X!_Y2">/_\ L1-*_P#1C4 >Z4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !7BO[=7[?_P"S5_P3N^#S?%_]HSQ>]N+J;[)X;\-Z7%]HU;Q%
M?'&RSL;8$-/*Q*CLB;@795YKS#_@H;_P58\+?LF^*],_9:_9V^'5U\7_ -HK
MQ?%CP=\)O#TP+VZL.+_5)A\MA9(/G+N5+*#C:@>5.;_85_X)3^*?#'QA7]O_
M /X*3_$6U^+?[1=_#BPO/)/]@^ ;<Y(T_1+9QB+;N(-R0)'^8C:7D:4 \V^%
M'[!W[4?_  5C^(VD?M:_\%@/#C^&/AOI5ZNH_"[]E&"Z+VMJ1S%?^(F 'VR[
MVG/V9@$0$JRKNEA;](;"PL=*L8=,TRRBMK:VB6*WMX(PB1(HPJ*HX50   .
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M^0/^"_'_ "AL_:$_[)_-_P"CHJ_C"K^SW_@OQ_RAL_:$_P"R?S?^CHJ_C"H
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M2OV7_"_QE^.E]&YC^Q_"'X0:I?LT@_A5KF.W5C[@D<]: /OZBOS\_P"'GO\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\@?\%^/^4-G[
M0G_9/YO_ $=%7\85?V>_\%^/^4-G[0G_ &3^;_T=%7\85 '[_?\ !IM_RE,_
M:[_[>/\ T^3U^_U?@#_P:;?\I3/VN_\ MX_]/D]?O]0 4444 %%%% !1110
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M>FV<<-G9:_XFL-)AMH$4*D<:2R($0* %51@   5\R?$7_@XW_P""/W@35O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?('_  7X
M_P"4-G[0G_9/YO\ T=%7\85?V>_\%^/^4-G[0G_9/YO_ $=%7\85 '[_ '_!
MIM_RE,_:[_[>/_3Y/7[_ %?@#_P:;?\ *4S]KO\ [>/_ $^3U^_U 'P9^V#^
MW;\4+O\ ;PO/V"? ?QBM?AC<Z/I_@/6=,NSIT,^J^+AJOBB"PNUM/M.8A;6L
M(Q*HC>21IB-R)$^_ZK^"4O[3<OPHU/2?C5?>&9?&EAK&HV>G:UI^CS6UA?VB
M3L+*]>V,\CJS0&-I(UE ,@<*R*1CYB_X*K_L[?LB_M^>&;GX;Z_>2Z5\5OA9
M\2/!=IHWC7P]=BS\1^$?[7UC3(TO;*=#O$;Q7$@7>#&9K=CMW1*P[7_@CI\<
M/VC?C1^S#XBTK]IOQC9^+]:^'OQ2U_P3IGQ(T^R%O#XVT_3)U@BU<(I*;G?S
M8G*$J7MW()Y) +7_  2?_:[^+_[4W[%U[\>_VH-3\/Q:]IWCGQ3IFJW&@6#V
MFGP6^FZI<VRF-)))'5%CA!R[LW<DFO$(?^"G/[1EU_P3PD_X+,0SV?\ PK:/
MQ(U['\)QHJ>>_@I=7.G->&Z)\W^U/*!O@ PM]F+<Q%OW]:?_  1?\&GXK_\
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MQS0!2_X9\_X(NZG_ ,CU_P '-GQI\3@_?37?VT;%U;VQ&B<8R/HQJ@W[+_\
MP;":BQ7QY_P5/OO%)S\_]O\ [45W+O/?/ESIGG!_X"*W/^&(_P#@H=I/_'__
M ,$ OV'=6V\M_9>HVD&\?W5\ZSX/N>*OK\$O^"@>CJ%O?^#9;]F[51&.1I7Q
M,\/V_F#L%\ZR^7'?/IQ0!S6G_L;?\&;%M<"_U7XI_";5KK&#=:Q\?]7G8CK@
M@ZEMZY/3N:[#0?A#_P &>?A=0VGZM^S3*$Y_T_QO]LZ9/_+:Y?/7^7H*J_\
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M^!;4 ;%%8_\ P@^D?\_-[_X%M1_P@^D?\_-[_P"!;4 ;%%8__"#Z1_S\WO\
MX%M1_P (/I'_ #\WO_@6U &Q16/_ ,(/I'_/S>_^!;4?\(/I'_/S>_\ @6U
M&Q16/_P@^D?\_-[_ .!;4?\ "#Z1_P _-[_X%M0!L45C_P#"#Z1_S\WO_@6U
M'_"#Z1_S\WO_ (%M0!L45C_\(/I'_/S>_P#@6U'_  @^D?\ /S>_^!;4 ;%%
M8_\ P@^D?\_-[_X%M1_P@^D?\_-[_P"!;4 ;%%8__"#Z1_S\WO\ X%M1_P (
M/I'_ #\WO_@6U &Q16/_ ,(/I'_/S>_^!;4?\(/I'_/S>_\ @6U &Q16/_P@
M^D?\_-[_ .!;4?\ "#Z1_P _-[_X%M0!L45C_P#"#Z1_S\WO_@6U'_"#Z1_S
M\WO_ (%M0!L45C_\(/I'_/S>_P#@6U'_  @^D?\ /S>_^!;4 ;%%8_\ P@^D
M?\_-[_X%M1_P@^D?\_-[_P"!;4 ;%%8__"#Z1_S\WO\ X%M1_P (/I'_ #\W
MO_@6U &Q1679^$M-L;I+N&XNBT;94/<L1^(K4H ^0/\ @OQ_RAL_:$_[)_-_
MZ.BK^,*O[/?^"_'_ "AL_:$_[)_-_P"CHJ_C"H _?[_@TV_Y2F?M=_\ ;Q_Z
M?)Z_?ZOP!_X--O\ E*9^UW_V\?\ I\GK]_J /,?CI^QA^RE^TO>VVK_'/]GO
MP=XFU&TN+.2#5M8\-VMQ=JEM=17*0>=)&S^2SQ*'BSM="R,"&(KN;/P+X)T[
MP='\.]/\':5!X?ALA9PZ%#I\2V:6P7:(1"%V",+QL QCC%:M% '+?##X'?!7
MX(V5UIOP7^$'A;PA;7LHDO+?POX?MM/2=QG#.L"*'(R>3D\FFI\!_@='\3F^
M-D?P9\*+XS==K^+AX=MAJ;#RQ%@W6SS2/+ 3[WW1CIQ75T4 <S\3O@M\'/C;
MI5OH7QF^$WAGQ=96DYGM+/Q/H-O?Q0RE2AD1)T8*VUF7(&<$CH:Z#3]/L-)L
M(-+TNRAMK6VA6*VMK>,)'%&H 5%4<*H   '  J:B@ HHHH *\+\ _P#*03Q_
M_P!B)I7_ *,:O=*\+\ _\I!/'_\ V(FE?^C&H ]THHHH **** "BBB@ HHHH
M *_G!_X+U?\ !!7_ (*P_MH_\%8OBM^TO^S1^RG_ ,)+X)\2_P!A?V)K?_"=
M:%9_:?L^A:?:S?N;J^BF3;-!*GS(,[<C*D$_T?44 ?R!?\0N/_!=?_HQG_S)
MOAC_ .6='_$+C_P77_Z,9_\ ,F^&/_EG7]?M% '\X/\ P05_X(*_\%8?V+O^
M"L7PI_:7_:7_ &4_^$:\$^&O[=_MO6_^$ZT*\^S?:-"U"UA_<VM]+,^Z:>)/
ME0XW9.%!(_H^HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH _ '_ (/G/^;7?^YV_P#<!7X U_7[_P %SO\ @AC_ ,/H_P#A5W_&47_"
MM?\ A6O]M_\ ,D_VS_:/]H?8/^GVV\GR_L/^WN\W^';\WP!_Q Q_]91?_,)_
M_?J@#\ :*_?[_B!C_P"LHO\ YA/_ ._5'_$#'_UE%_\ ,)__ 'ZH _?ZBBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@#Y _X+\?\H;/VA/^R?S?^CHJ_C"K
M^SW_ (+\?\H;/VA/^R?S?^CHJ_C"H _?[_@TV_Y2F?M=_P#;Q_Z?)Z_?ZOP!
M_P"#3;_E*9^UW_V\?^GR>OW^H **** "BBB@ HHHH **** "O"_ /_*03Q__
M -B)I7_HQJ]TKPOP#_RD$\?_ /8B:5_Z,:@#W2BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#Y _X+\?\
M*&S]H3_LG\W_ *.BK^,*O[/?^"_'_*&S]H3_ +)_-_Z.BK^,*@#]_O\ @TV_
MY2F?M=_]O'_I\GK]_J_ '_@TV_Y2F?M=_P#;Q_Z?)Z_?Z@ HHHH **** "BB
MB@ HHHH *\+\ _\ *03Q_P#]B)I7_HQJ]TKPOP#_ ,I!/'__ &(FE?\ HQJ
M/=**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** /D#_@OQ_RAL_:$_[)_-_Z.BK^,*O[/?\ @OQ_RAL_:$_[
M)_-_Z.BK^,*@#]_O^#3;_E*9^UW_ -O'_I\GK]_J_ '_ (--O^4IG[7?_;Q_
MZ?)Z_?Z@ HHHH **** "BBB@ HHHH *\+\ _\I!/'_\ V(FE?^C&KW2O"_ /
M_*03Q_\ ]B)I7_HQJ /=**** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH ^0/^"_'_ "AL_:$_[)_-_P"CHJ_C"K^SW_@OQ_RAL_:$
M_P"R?S?^CHJ_C"H _?[_ (--O^4IG[7?_;Q_Z?)Z_?ZOP!_X--O^4IG[7?\
MV\?^GR>OW^H **** "BBB@ HHHH **** "O"_ /_ "D$\?\ _8B:5_Z,:O=*
M\+\ _P#*03Q__P!B)I7_ *,:@#W2BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#Y _X+\?\H;/VA/^R?S?
M^CHJ_C"K^SW_ (+\?\H;/VA/^R?S?^CHJ_C"H _?[_@TV_Y2F?M=_P#;Q_Z?
M)Z_?ZOP!_P"#3;_E*9^UW_V\?^GR>OW^H **** "BBB@ HHHH **** "O"_
M/_*03Q__ -B)I7_HQJ]TKPOP#_RD$\?_ /8B:5_Z,:@#W2BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#Y
M _X+\?\ *&S]H3_LG\W_ *.BK^,*O[/?^"_'_*&S]H3_ +)_-_Z.BK^,*@#]
M_O\ @TV_Y2F?M=_]O'_I\GK]_J_ '_@TV_Y2F?M=_P#;Q_Z?)Z_?Z@ HHHH
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M_P# "\_^,T ?1E%?.?\ P]N_X)T?]'2:+_X 7G_QFC_A[=_P3H_Z.DT7_P
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M.?\ P]N_X)T?]'2:+_X 7G_QFC_A[=_P3H_Z.DT7_P  +S_XS0!]&45\Y_\
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M_P  +S_XS1_P]N_X)T?]'2:+_P" %Y_\9H ^C**^<_\ A[=_P3H_Z.DT7_P
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M . %Y_\ &: /HRBOG/\ X>W?\$Z/^CI-%_\  "\_^,T?\/;O^"='_1TFB_\
M@!>?_&: /HRBOG%_^"N7_!.9&53^U'H_S' QIUZ?SQ!Q3O\ A[=_P3H_Z.DT
M7_P O/\ XS0!]&45\Y_\/;O^"='_ $=)HO\ X 7G_P 9H_X>W?\ !.C_ *.D
MT7_P O/_ (S0!]&45\Y_\/;O^"='_1TFB_\ @!>?_&:/^'MW_!.C_HZ31?\
MP O/_C- 'T917SG_ ,/;O^"='_1TFB_^ %Y_\9H_X>W?\$Z/^CI-%_\  "\_
M^,T ?1E%?.?_  ]N_P""='_1TFB_^ %Y_P#&:/\ A[=_P3H_Z.DT7_P O/\
MXS0!]&45\Y_\/;O^"='_ $=)HO\ X 7G_P 9H_X>W?\ !.C_ *.DT7_P O/_
M (S0!]&45\Y_\/;O^"='_1TFB_\ @!>?_&:/^'MW_!.C_HZ31?\ P O/_C-
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M_P#A[=_P3H_Z.DT7_P  +S_XS1_P]N_X)T?]'2:+_P" %Y_\9H ^C**^<_\
MA[=_P3H_Z.DT7_P O/\ XS1_P]N_X)T?]'2:+_X 7G_QF@#Z,HKYS_X>W?\
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M_P  +S_XS1_P]N_X)T?]'2:+_P" %Y_\9H ^C**^<_\ A[=_P3H_Z.DT7_P
MO/\ XS38_P#@KE_P3FE7<O[4>CCG'S:=>C^<% 'T=17SG_P]N_X)T?\ 1TFB
M_P#@!>?_ !FC_A[=_P $Z/\ HZ31?_ "\_\ C- 'T917SG_P]N_X)T?]'2:+
M_P" %Y_\9H_X>W?\$Z/^CI-%_P# "\_^,T ?1E%?.?\ P]N_X)T?]'2:+_X
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MX;I8F(P2HE5@I([BMJB@#AO^&7_V:?\ HWCP+_X25G_\:H_X9?\ V:?^C>/
MO_A)6?\ \:KN:* .&_X9?_9I_P"C>/ O_A)6?_QJC_AE_P#9I_Z-X\"_^$E9
M_P#QJNYHH X;_AE_]FG_ *-X\"_^$E9__&J/^&7_ -FG_HWCP+_X25G_ /&J
M[FB@#AO^&7_V:?\ HWCP+_X25G_\:H_X9?\ V:?^C>/ O_A)6?\ \:KN:* .
M&_X9?_9I_P"C>/ O_A)6?_QJC_AE_P#9I_Z-X\"_^$E9_P#QJNYHH ^=OVT/
MV=_V?] _98\;ZSH7P,\'65Y;Z([V]U:>&+2.2)MR\JRQ@J?<5VOPV_9G_9PN
M_AWH%U=?L_>")99=%M7DDD\*6;,[&%2228\DD]Z[GXD?#[PY\5? NI_#OQ=%
M*^FZM;&"\6"4HY0D'AAT/%:6C:5::#H]IH>GJP@LK:." .V2$10JY/<X H X
M_P#X9?\ V:?^C>/ O_A)6?\ \:H_X9?_ &:?^C>/ O\ X25G_P#&J[FB@#AO
M^&7_ -FG_HWCP+_X25G_ /&J/^&7_P!FG_HWCP+_ .$E9_\ QJNYHH X;_AE
M_P#9I_Z-X\"_^$E9_P#QJC_AE_\ 9I_Z-X\"_P#A)6?_ ,:KN:* .&_X9?\
MV:?^C>/ O_A)6?\ \:H_X9?_ &:?^C>/ O\ X25G_P#&J[FB@#AO^&7_ -FG
M_HWCP+_X25G_ /&J/^&7_P!FG_HWCP+_ .$E9_\ QJNYHH X;_AE_P#9I_Z-
MX\"_^$E9_P#QJC_AE_\ 9I_Z-X\"_P#A)6?_ ,:KN:* .&_X9?\ V:?^C>/
MO_A)6?\ \:H_X9?_ &:?^C>/ O\ X25G_P#&J[FB@#AO^&7_ -FG_HWCP+_X
M25G_ /&J/^&7_P!FG_HWCP+_ .$E9_\ QJNYHH X;_AE_P#9I_Z-X\"_^$E9
M_P#QJC_AE_\ 9I_Z-X\"_P#A)6?_ ,:KN:* .&_X9?\ V:?^C>/ O_A)6?\
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ML_\ XU1_PR_^S3_T;QX%_P#"2L__ (U7<T4 <-_PR_\ LT_]&\>!?_"2L_\
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MT4 <-_PR_P#LT_\ 1O'@7_PDK/\ ^-4?\,O_ +-/_1O'@7_PDK/_ .-5W-%
M'#?\,O\ [-/_ $;QX%_\)*S_ /C5'_#+_P"S3_T;QX%_\)*S_P#C5=S10!PW
M_#+_ .S3_P!&\>!?_"2L_P#XU1_PR_\ LT_]&\>!?_"2L_\ XU7<T4 <-_PR
M_P#LT_\ 1O'@7_PDK/\ ^-4?\,O_ +-/_1O'@7_PDK/_ .-5W-% 'RY^T_\
ML_\ P&T?XP_!JQTGX)>$;6"_\:RQ7T-MX;M42XC^SL=D@6,!USS@Y%>U?\,O
M_LT_]&\>!?\ PDK/_P"-5J^-_A3X1^(/B+PYXH\1PSM=^%M2:^TDPSE%68H4
M)8?Q#!Z5TE '#?\ #+_[-/\ T;QX%_\ "2L__C5'_#+_ .S3_P!&\>!?_"2L
M_P#XU7<T4 <-_P ,O_LT_P#1O'@7_P )*S_^-4?\,O\ [-/_ $;QX%_\)*S_
M /C5=S10!PW_  R_^S3_ -&\>!?_  DK/_XU1_PR_P#LT_\ 1O'@7_PDK/\
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M .&_X9?_ &:?^C>/ O\ X25G_P#&J/\ AE_]FG_HWCP+_P"$E9__ !JNYHH
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M]D_]EG1A\8O$NGVUUX>T*;4?''B.8A8I=2N9&O-4NLGD":\EFEVC))<#DXH
M\S_8]_X*C?#C]I&P^*GA_P",?PL\0?!GQS\#@DOQ6\%^.98'?1K.2WDN8K^.
MYMV:*YM'ABD<2H>B$XVLC.RQ_P""G&CZ7IGPL^*?Q4^!VL>%?AC\:M7LM+\
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MGX#^ U]J/V[4O#WAZ&/7]3SDZCJLF9K^\/\ M37<D\Q]Y#0!Z?1110 4444
M%%%% !1110 4444 %%%% !7D'[=?[7^@?L(_LP>*OVH_%?PQ\2^*]+\)Z:][
MJ.F^%HK<SK"N 96-Q+&BQJ2NX@LP!)"-@BO7Z^4O^"YO_*(#]HG_ +);J?\
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MT)9@!D[^4W][^R;_ ,7$\8_$S]IFX^=/%?BZ30_#DC=5T31'EL(E!Z-')?\
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MB[2] T?21=^09Y+JY1)I=VQ_EM[87-VX"DF.U<#!YKQ?]M3X9:;^W9XI\/\
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MC) KE]-_;TOO"OQG^'?P@_:3^ VI_#L_%Z*=?AWJ=WK4%['+?Q0_:&TG4!$
M+&_:'<Z1JT\,GE2(LY=0K>/7G['&H_\ !0'_ (-Y?!'[(.B>+8M"U'QE^SIX
M0BTK5;A6,,%Y!I^GW5OYNP%A$TL$:N5!(1F(!/!\4_;$\8_MF_M0_M(?L/?L
M>?&SX"Z+X7^(>A?&C3?B9XTN]!\9)J:KIWAZWD6\O0D4(^S65U)=>7&9G5S(
M1%L8@M0!^JE%%% !1110 4444 %%%% !1110 4444 %5-=U.31='N=6ATF[O
MWMX6=+*Q16FG8#A$#,J[B>!N95&>2!DU;HH \3_85_;=\&_MU? 2]_:"\-^
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MB_4+:>W\*02PBV;[.8;>*6XE%LJVZSW;W$RQ;P) 992_O%%% !1110 4444
M%%%% !1110 4444 %%%% !7BO@G]B#P7X&_;'\4?MNV'Q7\9W7BGQ?H%IHFM
M:9>3:>=->PM7D>VA2-+-9$\MI9&#"3>VX[V8<5[510!\J?%__@E+X<^+_P >
M/$?[0[?MR?M&^%]<\2PPVUU;>"OB1%IEI;6D.\PVD$<=IF.%#)(P4L27D=V+
M.[,?1OV?/V(_AY^SQ>^&]4TGX@^-/%%_X8T+5M.M]8\<:^=3O[U]2O;>[O+R
MZN7027%PQM;:)78XCAA6-%5<Y]EHH \9\=_LC>*?%_QPU'XS:!^VI\9O"UKJ
M^EPV.H^!M!UG2Y-#9(U*^9#%>Z?<36<S _-+;30N2 <@\UWW@+X0^"OA+\*;
M#X-_".Q;PSHNDZ=]CTE=.VR26B\GS UPLGFREB79Y0Y=V9GW%B3U%% 'SW\!
M_P#@G1\-OV=?V7O&?[)O@+XO>/)_#OC5]8EN;W4[ZR:^T^?5&F>\FMIH;2+8
M[R3R2#>'"-C:% Q78?M2_LE^#_VJ/V>[K]F;5/B#XM\%^&KZ*&WO3\/]2AL+
MF:RC7;]B,CPR[;=AM#HH4NJ["2C.C>J44 ?,OP,_X)A^%?@M\7="^+VL?MC?
MM!_$&3PYYKZ5X=^(_P 3WU+1XYGA>$3M:"&-'E1)'V,V=A;(Y ([#XE?L0>"
M_B?^UWX)_;/U;XK^,[/Q-\/M+O\ 3O#6F:?-IXTZ*UO4C6[C>.2S>23S?)C)
M8R;E*C84Z5[510 4444 %%%% !1110 4444 %%%% !1110 4444 >+?M+_L0
M^"OVH?BI\-_B[XM^*GC+1=0^%7B!M;\)6OAZ>P2WCOVA>!II5N+.9I<Q2/'M
M+;<,2%#<UF_MA?L!^'OVR_$OA/Q-XF_:7^+O@I_!<LMQHMO\-_%D.E1B[D1H
MVNW/V9W>81.\:MNPBNX4+YCEO>Z* /FGX5?\$Q/AW\-H[\^)/VD?C+\0[C4]
M>T/4KB\^)WCLZS+$FE7HO[>S@,D2BWMWN4BDF2,*9?)C#$JN*](_:-_9QUWX
M^S^&M1\,_M/_ !.^&-]X8U*2\AO/AQJMC$NH;T"&&\M[^SN[>ZB&,A7B.UN0
M17IU% '"_"']GOP/\(!K^IVUWJ&O:]XMNTN?%WBGQ%)'-?:S(D0AC$OEQQQ1
MQI$ B00QQPH"Q6,%W+>9> ?^"9WP!\ 2^#-!M_$/BC4O!7PV\2R>(/AQ\-M5
MO;5]%\-:@3*898 ENMS*+<SS?9X[B>:.#>#&JF*$Q_0]% '$^!?@AI/PZ^'^
MO^!_"_BW6+>Y\1:QK.JWGB$/ U]%=ZC<S7#2H6B,>8?-6.$.CJL<$2,'"\_+
MVA?\$0OAQH&A-X0M/^"@'[5IT.>\GN=1T-?C.\-M?M/*TMR)Q#;(SB=Y)#*=
MP9S(Q)R<U]KT4 ?+WQV_X);>%/CI\=[G]H)?VR/C[X+U6318M(LM-^'OCV'2
MK#3K"/:WV:WB2T)1'=1(^6)=@N20B!?6/V6/V9/#7[*'PSD^''A[XC>-O&$U
MWJLVI:IXH^(GB635]8U&XD")NGN7 +A(HXH4& %CB1>V:])HH **** "BBB@
M HHHH **** /D#_@OQ_RAL_:$_[)_-_Z.BK^,*O[/?\ @OQ_RAL_:$_[)_-_
MZ.BK^,*@#]_O^#3;_E*9^UW_ -O'_I\GK]_J_ '_ (--O^4IG[7?_;Q_Z?)Z
M_?Z@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BOCS_@L+_P %A?AM_P $>_AMX.^)'Q(^#NN>,8/&.N3Z;;6VAW\,#V[Q
M0B4NQEX((.,"O@3_ (C>?V6?^C'OB!_X45C_ (4 ?M]17X@_\1O/[+/_ $8]
M\0/_  HK'_"C_B-Y_99_Z,>^('_A16/^% '[?45^(/\ Q&\_LL_]&/?$#_PH
MK'_"C_B-Y_99_P"C'OB!_P"%%8_X4 ?M]17X@_\ $;S^RS_T8]\0/_"BL?\
M"C_B-Y_99_Z,>^('_A16/^% '[?45^(/_$;S^RS_ -&/?$#_ ,**Q_PH_P"(
MWG]EG_HQ[X@?^%%8_P"% '[?45^(/_$;S^RS_P!&/?$#_P **Q_PH_XC>?V6
M?^C'OB!_X45C_A0!^WU%?B#_ ,1O/[+/_1CWQ _\**Q_PH_XC>?V6?\ HQ[X
M@?\ A16/^% '[?45^(/_ !&\_LL_]&/?$#_PHK'_  H_XC>?V6?^C'OB!_X4
M5C_A0!^WU%?B#_Q&\_LL_P#1CWQ _P#"BL?\*/\ B-Y_99_Z,>^('_A16/\
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M>?V6?^C'OB!_X45C_A0!^WU%?B#_ ,1O/[+/_1CWQ _\**Q_PH_XC>?V6?\
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M7X@_\1O/[+/_ $8]\0/_  HK'_"C_B-Y_99_Z,>^('_A16/^% '[?45^(/\
MQ&\_LL_]&/?$#_PHK'_"C_B-Y_99_P"C'OB!_P"%%8_X4 ?M]17X@_\ $;S^
MRS_T8]\0/_"BL?\ "C_B-Y_99_Z,>^('_A16/^% '[?45^(/_$;S^RS_ -&/
M?$#_ ,**Q_PK]HOAEXWM/B;\-O#WQ(L+&2U@\0Z'::E#;3,"\23PI*$8C@D!
M\$CTH W**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MC;'_ .-5W]% ' ?\,G_LL_\ 1M7P_P#_  C;'_XU1_PR?^RS_P!&U?#_ /\
M"-L?_C5=_10!P'_#)_[+/_1M7P__ /"-L?\ XU1_PR?^RS_T;5\/_P#PC;'_
M .-5W]% ' ?\,G_LL_\ 1M7P_P#_  C;'_XU1_PR?^RS_P!&U?#_ /\ "-L?
M_C5=_10!P'_#)_[+/_1M7P__ /"-L?\ XU1_PR?^RS_T;5\/_P#PC;'_ .-5
MW]% ' ?\,G_LL_\ 1M7P_P#_  C;'_XU1_PR?^RS_P!&U?#_ /\ "-L?_C5=
M_10!P'_#)_[+/_1M7P__ /"-L?\ XU1_PR?^RS_T;5\/_P#PC;'_ .-5W]%
M' ?\,G_LL_\ 1M7P_P#_  C;'_XU1_PR?^RS_P!&U?#_ /\ "-L?_C5=_10!
MP'_#)_[+/_1M7P__ /"-L?\ XU1_PR?^RS_T;5\/_P#PC;'_ .-5W]% ' ?\
M,G_LL_\ 1M7P_P#_  C;'_XU1_PR?^RS_P!&U?#_ /\ "-L?_C5=_10!P'_#
M)_[+/_1M7P__ /"-L?\ XU1_PR?^RS_T;5\/_P#PC;'_ .-5W]% ' ?\,G_L
ML_\ 1M7P_P#_  C;'_XU1_PR?^RS_P!&U?#_ /\ "-L?_C5=_10!P'_#)_[+
M/_1M7P__ /"-L?\ XU1_PR?^RS_T;5\/_P#PC;'_ .-5W]% ' ?\,G_LL_\
M1M7P_P#_  C;'_XU1_PR?^RS_P!&U?#_ /\ "-L?_C5=_10!P'_#)_[+/_1M
M7P__ /"-L?\ XU1_PR?^RS_T;5\/_P#PC;'_ .-5W]% ' ?\,G_LL_\ 1M7P
M_P#_  C;'_XU1_PR?^RS_P!&U?#_ /\ "-L?_C5=_10!P'_#)_[+/_1M7P__
M /"-L?\ XU1_PR?^RS_T;5\/_P#PC;'_ .-5W]% ' ?\,G_LL_\ 1M7P_P#_
M  C;'_XU1_PR?^RS_P!&U?#_ /\ "-L?_C5=_10!P'_#)_[+/_1M7P__ /"-
ML?\ XU1_PR?^RS_T;5\/_P#PC;'_ .-5W]% ' ?\,G_LL_\ 1M7P_P#_  C;
M'_XU1_PR?^RS_P!&U?#_ /\ "-L?_C5=_10!P'_#)_[+/_1M7P__ /"-L?\
MXU1_PR?^RS_T;5\/_P#PC;'_ .-5W]% ' ?\,G_LL_\ 1M7P_P#_  C;'_XU
M1_PR?^RS_P!&U?#_ /\ "-L?_C5=_10!P'_#)_[+/_1M7P__ /"-L?\ XU1_
MPR?^RS_T;5\/_P#PC;'_ .-5W]% ' ?\,G_LL_\ 1M7P_P#_  C;'_XU1_PR
M?^RS_P!&U?#_ /\ "-L?_C5=_10!P'_#)_[+/_1M7P__ /"-L?\ XU1_PR?^
MRS_T;5\/_P#PC;'_ .-5W]% ' ?\,G_LL_\ 1M7P_P#_  C;'_XU1_PR?^RS
M_P!&U?#_ /\ "-L?_C5=_10!P'_#)_[+/_1M7P__ /"-L?\ XU1_PR?^RS_T
M;5\/_P#PC;'_ .-5W]% ' ?\,G_LL_\ 1M7P_P#_  C;'_XU1_PR?^RS_P!&
MU?#_ /\ "-L?_C5=_10!P'_#)_[+/_1M7P__ /"-L?\ XU1_PR?^RS_T;5\/
M_P#PC;'_ .-5W]% ' ?\,G_LL_\ 1M7P_P#_  C;'_XU1_PR?^RS_P!&U?#_
M /\ "-L?_C5=_10!P'_#)_[+/_1M7P__ /"-L?\ XU1_PR?^RS_T;5\/_P#P
MC;'_ .-5W]% ' ?\,G_LL_\ 1M7P_P#_  C;'_XU1_PR?^RS_P!&U?#_ /\
M"-L?_C5=_10!P'_#)_[+/_1M7P__ /"-L?\ XU1_PR?^RS_T;5\/_P#PC;'_
M .-5W]% ' ?\,G_LL_\ 1M7P_P#_  C;'_XU1_PR?^RS_P!&U?#_ /\ "-L?
M_C5=_10!P'_#)_[+/_1M7P__ /"-L?\ XU1_PR?^RS_T;5\/_P#PC;'_ .-5
MW]% ' ?\,G_LL_\ 1M7P_P#_  C;'_XU1_PR?^RS_P!&U?#_ /\ "-L?_C5=
M_10!P'_#)_[+/_1M7P__ /"-L?\ XU1_PR?^RS_T;5\/_P#PC;'_ .-5W]%
M' ?\,G_LL_\ 1M7P_P#_  C;'_XU1_PR?^RS_P!&U?#_ /\ "-L?_C5=_10!
MP'_#)_[+/_1M7P__ /"-L?\ XU1_PR?^RS_T;5\/_P#PC;'_ .-5W]% ' ?\
M,G_LL_\ 1M7P_P#_  C;'_XU1_PR?^RS_P!&U?#_ /\ "-L?_C5=_10!P'_#
M)_[+/_1M7P__ /"-L?\ XU1_PR?^RS_T;5\/_P#PC;'_ .-5W]% ' ?\,G_L
ML_\ 1M7P_P#_  C;'_XU1_PR?^RS_P!&U?#_ /\ "-L?_C5=_10!P'_#)_[+
M/_1M7P__ /"-L?\ XU1_PR?^RS_T;5\/_P#PC;'_ .-5W]% ' ?\,G_LL_\
M1M7P_P#_  C;'_XU1_PR?^RS_P!&U?#_ /\ "-L?_C5=_10!P'_#)_[+/_1M
M7P__ /"-L?\ XU1_PR?^RS_T;5\/_P#PC;'_ .-5W]% ' ?\,G_LL_\ 1M7P
M_P#_  C;'_XU1_PR?^RS_P!&U?#_ /\ "-L?_C5=_10!P'_#)_[+/_1M7P__
M /"-L?\ XU1_PR?^RS_T;5\/_P#PC;'_ .-5W]% ' ?\,G_LL_\ 1M7P_P#_
M  C;'_XU1_PR?^RS_P!&U?#_ /\ "-L?_C5=_10!P'_#)_[+/_1M7P__ /"-
ML?\ XU1_PR?^RS_T;5\/_P#PC;'_ .-5W]% ' ?\,G_LL_\ 1M7P_P#_  C;
M'_XU1_PR?^RS_P!&U?#_ /\ "-L?_C5=_10!^#O_  >A?!SX1?#+]F/X+7_P
MW^%?AOP]/=>/-0CN9M#T.WM'E060(5C$BE@#S@U^T?[)_P#R:S\-/^R?Z-_Z
M0PU^0'_![S_R:S\#_P#LH&H_^D(K]?\ ]D__ )-9^&G_ &3_ $;_ -(8: ._
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /D
M#_@OQ_RAL_:$_P"R?S?^CHJ_C"K^SW_@OQ_RAL_:$_[)_-_Z.BK^,*@#]_O^
M#3;_ )2F?M=_]O'_ *?)Z_?ZOP!_X--O^4IG[7?_ &\?^GR>OW^H **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#\0?^#WG_
M )-9^!__ &4#4?\ TA%?K_\ LG_\FL_#3_LG^C?^D,-?D!_P>\_\FL_ _P#[
M*!J/_I"*_7_]D_\ Y-9^&G_9/]&_](8: ._HKC_C]\-_%GQ?^#?B'X9^!?BY
MK'@/5]9T\V]AXPT".-[W2I"0?.A$@*EA@CGCFOC'_AS]^W7_ -)Z?V@/_!3I
M?_Q% 'W]17P#_P .?OVZ_P#I/3^T!_X*=+_^(H_X<_?MU_\ 2>G]H#_P4Z7_
M /$4 ?>VK:MI6@:5<Z[KNIV]E8V5N\]Y>7<RQQ01(I9Y'=B JJH)+$@  DU_
M,U_P<,_\'(OBK]KCQ5>?LA?L$>/=0T7X7:+J"_V[XVTFY>VNO%EU"X9?)D4A
MXK%'4,N"&F90YPH53]O_ /!5G_@B9_P5:\<_L8>*-&^"/_!6+XL?%RX6W\W5
M_AAXH2WLX_$=FGS/;Q2VQ3=+QN$,@*2D;<@[<_S,ZMI.JZ!JMSH6NZ9<65]9
M7#P7EG=PM'+!*C%7C=& *LK @J0"""#0!_3=_P &Z'_!Q?I7[:^E:5^Q-^VS
MXJM[+XOV5N(/"WBF[=8XO&<2+Q&YX"Z@JCE>!. 67Y]RG]AJ_A3_ &-?V8OV
MCOVP/VCO#'P+_91\+ZAJ7C;4M0232Y-/F:'^SO+8,;V2=?\ CWBAP':4D;<#
M&6(!_J6^'W_!'/\ X*-Z?X'TFQ^('_!?'XX2ZW%I\2ZJ^E:59&V\\*-PC:<-
M*Z@\!W.YL;C@G  /T6HKX!_X<_?MU_\ 2>G]H#_P4Z7_ /$4?\.?OVZ_^D]/
M[0'_ (*=+_\ B* /OZJ?B'P]H?BS1+GPWXETJ"^L+R(QW5I<QADD4]B#^>>Q
M (KX\^ /_!,;]K_X0?&3P]\3/'7_  6-^-'CS2-&U!;B_P#!_B#3=/2RU6,
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M?#*\MH=)CTZSO8KJ:"YF5(;NV+9=)X6>,)L$C1.Z(P!%^V!XF_:2_P"":/\
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M/^U1X5T/0/@Q^VMXX^"MUI6H27%[JG@>UMI9=2C9-HAE$X("J?F&.<U\X?\
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M_CL/XXM+3Q/X?\,V*7%Z=(D@N!<7$:NRC,)$<V-P+F,1KEI " ?,/["VK_\
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M);F, 0N2)SB+AAOS@$ T/^#?[XW?'CXP_"CXS:3XZ^)VO_$#X:>$/C?K6A?
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MG<_LY_$H^,/ 'QD\$7_C'PU%\/=3>\TJUTO53<7L\J"#B-(B&##(DSA-Q!
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M/QX\:_L[_M-_LL^*_%7P=U3P9I<UCX@T_P"&MUXETJYNY9+M;W3KNVLX)YB
MD=K(':%HAO<,Z$*& (/V7[#X&_LA_!?XG_M%Z7^TI<>*O@[K^N)XK\):U=>,
M;KQ'%IFE_P!F65LUE9SN\TDL/VFWF,$$;.<SK&@)PM=!X4_X*%_#F]_:@T7]
MD+XK?"3QQ\-O&7BOPW=:YX*B\;0:=]F\16MKS=+;36%[=*LT*$2/#/Y4@0[@
MI&:_/+PM_P $K?C7<_L=_MJ_"C]BGX<Z[X5^&/C[Q9X9\0?L[_#+XAVEQ8O)
M>Z3-;:AJG^A7^V:SM;ZYMTMHH[H1L4B4NJ(0Q^@/V;)_AY^VQI__  C_ (-_
MX([:W^S_ .+(O">K6'BCQUX_^$5EHC^'I[O3;BS:'1;Q56>]=Y9E_>Q(L1MD
MEWLCO'&P![?=_P#!5C]G^PN/ASXAO? ?C>/P#\6?','A'X?_ !4&FV;Z'JVI
MW#2I:*JK=&]C@N'AD6&Y>U6%\*^_RY(W;G?V6/\ @HM\2OC7^V!^T'\(OB9^
MSYKO@[PA\'=5L--?7M3U;13;::G]FO?RWM\\=\T@\])(RBPK,D<:(93$YE5?
M*?\ @EE^TI^UW\,?V>?AU_P3@^+7_!/?XFZ+\2/AE8V7A/4_&FH^' /!#:78
M%(4U:'5C(J76;1%9;>$&62?"_(A:5,?5/V:/CS\0?VA?^"@G[*S_  I\7Z-%
M^T-H=HW@/XD-I+#P_P"4_A)=/8R7F<;ENU$+P*&F(?<$V!G4 ^DF_P""I_P*
MTS3/AYX_\:_#?QYX;^'?Q5U>UTWP)\4M<TNSCT6_GO%W6!D5+M[RRCNUYAEN
MK:%#N7>R;ESD?$?_ (*\_!KP+\>/B!^S7X=_9M^.'C7QC\-UT>;7]'\$?#LW
MLLMKJ,DB)>6ZM,C2P1; TC[1E9%,8EP^WYG^)GP[^-G[=_\ P1[\!?\ !,/Q
M#^SAX_\ !OQ6B;P;X:\9S:WX-O;72_#L>BZA8R7VKPZJT0L;J%[>RD: 6T\L
MCFY1 N1)L]R_9BT;QMI/_!:?]I7Q[K/PJ\96/AKQ=X&\&:?X;\4WWA"^ATS4
M+G3(K\7D<=T\0B.PW,85MVV3G86Q0!]K4444 ?B#_P 'O/\ R:S\#_\ LH&H
M_P#I"*_7_P#9/_Y-9^&G_9/]&_\ 2&&OR _X/>?^36?@?_V4#4?_ $A%?K_^
MR?\ \FL_#3_LG^C?^D,- '?T444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% 'R!_P %^/\ E#9^T)_V3^;_ -'15_&%7]GO_!?C
M_E#9^T)_V3^;_P!'15_&%0!^_P!_P:;?\I3/VN_^WC_T^3U^_P!7X _\&FW_
M "E,_:[_ .WC_P!/D]?O]0 4444 %%%% !1110 4444 %%%% !1110 4444
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M]&6?^8XL_P#X_1_PWS_P>2_]&6?^8XL__C] '[_45^ /_#?/_!Y+_P!&6?\
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M+/\ ^/T?\-\_\'DO_1EG_F.+/_X_0!^_U%?@#_PWS_P>2_\ 1EG_ )CBS_\
MC]'_  WS_P 'DO\ T99_YCBS_P#C] '[_45^ /\ PWS_ ,'DO_1EG_F.+/\
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M?^C+/_,<6?\ \?H_X;Y_X/)?^C+/_,<6?_Q^@#]_J*_ '_AOG_@\E_Z,L_\
M,<6?_P ?H_X;Y_X/)?\ HRS_ ,QQ9_\ Q^@#]_J*_ '_ (;Y_P"#R7_HRS_S
M'%G_ /'Z/^&^?^#R7_HRS_S'%G_\?H _?ZBOP!_X;Y_X/)?^C+/_ #'%G_\
M'Z/^&^?^#R7_ *,L_P#,<6?_ ,?H _?ZBOP!_P"&^?\ @\E_Z,L_\QQ9_P#Q
M^C_AOG_@\E_Z,L_\QQ9__'Z /W^HK\ ?^&^?^#R7_HRS_P QQ9__ !^C_AOG
M_@\E_P"C+/\ S'%G_P#'Z /W^HK\ ?\ AOG_ (/)?^C+/_,<6?\ \?H_X;Y_
MX/)?^C+/_,<6?_Q^@#]_J*_ '_AOG_@\E_Z,L_\ ,<6?_P ?H_X;Y_X/)?\
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M%^/^4-G[0G_9/YO_ $=%7\85?V>_\%^/^4-G[0G_ &3^;_T=%7\85 '[_?\
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8-6U#7+22&U=G1M[J@W$?+T'K7X6T ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140483009097744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COVER PAGE - USD ($)<br> $ in Billions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Feb. 23, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-33307<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">RadNet, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">13-3326724<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1510 Cotner Avenue<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Los Angeles,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">90025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">310<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">478-7808<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $.0001 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">RDNT<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity a Well-known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity a Voluntary Filer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity's Reporting Status Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57,836,244<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text">Portions of the registrant&#8217;s definitive proxy statement for the 2023 Annual Meeting of Stockholders are incorporated herein by reference in Part III of this annual report on Form 10-K to the extent stated herein. Such proxy statement will be filed with the Securities and Exchange Commission pursuant to Regulation 14A not later than 120 days after the close of the registrant&#8217;s fiscal year.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000790526<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140483008995232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>AUDIT INFORMATION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_AuditorInformationAbstract', window );"><strong>Auditor Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Ernst & Young LLP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Los Angeles, California<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">42<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_AuditorInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Auditor Information [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_AuditorInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140483010385168">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>CURRENT ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 127,834<span></span>
</td>
<td class="nump">$ 134,606<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="nump">166,357<span></span>
</td>
<td class="nump">135,062<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DueFromRelatedPartiesCurrent', window );">Due from affiliates</a></td>
<td class="nump">18,971<span></span>
</td>
<td class="nump">5,384<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">54,022<span></span>
</td>
<td class="nump">49,212<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">367,184<span></span>
</td>
<td class="nump">324,264<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract', window );"><strong>PROPERTY, EQUIPMENT AND RIGHT-OF-USE ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">565,961<span></span>
</td>
<td class="nump">484,247<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use-assets</a></td>
<td class="nump">603,524<span></span>
</td>
<td class="nump">584,291<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_PropertyPlantAndEquipmentNetIncludingRightOfUseAssets', window );">Total property, equipment and right-of-use-assets</a></td>
<td class="nump">1,169,485<span></span>
</td>
<td class="nump">1,068,538<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsAbstract', window );"><strong>OTHER ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">677,665<span></span>
</td>
<td class="nump">513,820<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets</a></td>
<td class="nump">106,228<span></span>
</td>
<td class="nump">56,603<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNoncurrentNet', window );">Deferred financing costs</a></td>
<td class="nump">2,280<span></span>
</td>
<td class="nump">2,135<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Investment in joint ventures</a></td>
<td class="nump">57,893<span></span>
</td>
<td class="nump">42,229<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred tax assets, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">14,853<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepositsAssets', window );">Deposits and other</a></td>
<td class="nump">53,172<span></span>
</td>
<td class="nump">36,032<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">2,433,907<span></span>
</td>
<td class="nump">2,058,474<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>CURRENT LIABILITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable, accrued expenses and other</a></td>
<td class="nump">369,595<span></span>
</td>
<td class="nump">263,937<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DueToAffiliateCurrent', window );">Due to affiliates</a></td>
<td class="nump">23,100<span></span>
</td>
<td class="nump">23,530<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="nump">4,021<span></span>
</td>
<td class="nump">10,701<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liability</a></td>
<td class="nump">57,607<span></span>
</td>
<td class="nump">65,452<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayableCurrent', window );">Current portion of notes payable</a></td>
<td class="nump">12,400<span></span>
</td>
<td class="nump">11,164<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">466,723<span></span>
</td>
<td class="nump">374,784<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>LONG-TERM LIABILITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liability</a></td>
<td class="nump">604,117<span></span>
</td>
<td class="nump">577,675<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermNotesPayable', window );">Notes payable, net of current portion</a></td>
<td class="nump">839,344<span></span>
</td>
<td class="nump">743,498<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liability, net</a></td>
<td class="nump">9,256<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other non-current liabilities</a></td>
<td class="nump">23,015<span></span>
</td>
<td class="nump">16,360<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">1,942,455<span></span>
</td>
<td class="nump">1,712,317<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>RadNet, Inc. stockholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock - $.0001 par value, 200,000,000 shares authorized; 57,723,125 and 53,548,227 shares issued and outstanding at December 31, 2022 and 2021 respectively</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in-capital</a></td>
<td class="nump">436,288<span></span>
</td>
<td class="nump">342,592<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(20,677)<span></span>
</td>
<td class="num">(20,421)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(82,622)<span></span>
</td>
<td class="num">(93,272)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total RadNet, Inc.'s stockholders' equity</a></td>
<td class="nump">332,995<span></span>
</td>
<td class="nump">228,904<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">158,457<span></span>
</td>
<td class="nump">117,253<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity</a></td>
<td class="nump">491,452<span></span>
</td>
<td class="nump">346,157<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and equity</a></td>
<td class="nump">$ 2,433,907<span></span>
</td>
<td class="nump">$ 2,058,474<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_PropertyPlantAndEquipmentNetIncludingRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Property Plant and Equipment Net Including Right of Use Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_PropertyPlantAndEquipmentNetIncludingRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNoncurrentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs classified as noncurrent. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNoncurrentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositsAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositsAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueFromRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of receivables to be collected from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth, at the financial statement date. which are usually due within one year (or one business cycle).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueFromRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToAffiliateCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of payable due to an entity that is affiliated with the reporting entity by means of direct or indirect ownership. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e603758-122996<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToAffiliateCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity method investee and investment in and advance to affiliate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140483009039488">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock - par value (in dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock - authorized (in shares)</a></td>
<td class="nump">200,000,000<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock - issued (in shares)</a></td>
<td class="nump">57,723,125<span></span>
</td>
<td class="nump">57,723,125<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock - outstanding (in shares)</a></td>
<td class="nump">53,548,227<span></span>
</td>
<td class="nump">53,548,227<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140483003516080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>REVENUE</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue</a></td>
<td class="nump">$ 1,430,061<span></span>
</td>
<td class="nump">$ 1,315,077<span></span>
</td>
<td class="nump">$ 1,071,840<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueNotFromContractWithCustomer', window );">Provider relief funding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">9,110<span></span>
</td>
<td class="nump">26,264<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>OPERATING EXPENSES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_OperatingExpensesExcludingDepreciationAndAmortization', window );">Cost of operations, excluding depreciation and amortization</a></td>
<td class="nump">1,264,346<span></span>
</td>
<td class="nump">1,123,274<span></span>
</td>
<td class="nump">965,902<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnTerminationOfLease', window );">Lease abandonment charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">19,675<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">115,877<span></span>
</td>
<td class="nump">96,694<span></span>
</td>
<td class="nump">86,795<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets', window );">Loss on sale and disposal of equipment and other</a></td>
<td class="nump">2,529<span></span>
</td>
<td class="nump">1,246<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Loss on impairment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,170<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance costs</a></td>
<td class="nump">946<span></span>
</td>
<td class="nump">744<span></span>
</td>
<td class="nump">4,353<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">1,383,698<span></span>
</td>
<td class="nump">1,241,633<span></span>
</td>
<td class="nump">1,062,420<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">INCOME FROM OPERATIONS</a></td>
<td class="nump">46,363<span></span>
</td>
<td class="nump">82,554<span></span>
</td>
<td class="nump">35,684<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherExpensesAbstract', window );"><strong>OTHER INCOME AND EXPENSES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense</a></td>
<td class="nump">50,841<span></span>
</td>
<td class="nump">48,830<span></span>
</td>
<td class="nump">45,882<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity in earnings of joint ventures</a></td>
<td class="num">(10,390)<span></span>
</td>
<td class="num">(10,967)<span></span>
</td>
<td class="num">(7,945)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1', window );">Non-cash change in fair value of interest rate swaps</a></td>
<td class="num">(39,621)<span></span>
</td>
<td class="num">(21,670)<span></span>
</td>
<td class="nump">2,528<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_GainLossOnExtinguishmentOfDebtAndOtherExpenses', window );">Loss (gain) on extinguishment of debt and related expenses</a></td>
<td class="nump">731<span></span>
</td>
<td class="nump">6,044<span></span>
</td>
<td class="num">(4,047)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expenses</a></td>
<td class="nump">1,833<span></span>
</td>
<td class="nump">1,438<span></span>
</td>
<td class="nump">120<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other expenses</a></td>
<td class="nump">3,394<span></span>
</td>
<td class="nump">23,675<span></span>
</td>
<td class="nump">36,538<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">INCOME (LOSS) BEFORE INCOME TAXES</a></td>
<td class="nump">42,969<span></span>
</td>
<td class="nump">58,879<span></span>
</td>
<td class="num">(854)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="num">(9,361)<span></span>
</td>
<td class="num">(14,560)<span></span>
</td>
<td class="num">(895)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">NET INCOME (LOSS)</a></td>
<td class="nump">33,608<span></span>
</td>
<td class="nump">44,319<span></span>
</td>
<td class="num">(1,749)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="nump">22,958<span></span>
</td>
<td class="nump">19,592<span></span>
</td>
<td class="nump">13,091<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">NET INCOME (LOSS) ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</a></td>
<td class="nump">$ 10,650<span></span>
</td>
<td class="nump">$ 24,727<span></span>
</td>
<td class="num">$ (14,840)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">BASIC NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS (in dollars per share)</a></td>
<td class="nump">$ 0.19<span></span>
</td>
<td class="nump">$ 0.47<span></span>
</td>
<td class="num">$ (0.29)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">DILUTED NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS (in dollars per share)</a></td>
<td class="nump">$ 0.17<span></span>
</td>
<td class="nump">$ 0.46<span></span>
</td>
<td class="num">$ (0.29)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_EarningPerShareBasicAndDilutedAbstract', window );"><strong>WEIGHTED AVERAGE SHARES OUTSTANDING</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">56,293,336<span></span>
</td>
<td class="nump">52,496,679<span></span>
</td>
<td class="nump">50,891,791<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">57,320,870<span></span>
</td>
<td class="nump">53,421,033<span></span>
</td>
<td class="nump">50,891,791<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_HealthCarePatientServiceMember', window );">Service fee revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>REVENUE</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue</a></td>
<td class="nump">$ 1,278,016<span></span>
</td>
<td class="nump">$ 1,166,743<span></span>
</td>
<td class="nump">$ 931,722<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rdnt_CapitationArrangementsMember', window );">Revenue under capitation arrangements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>REVENUE</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue</a></td>
<td class="nump">$ 152,045<span></span>
</td>
<td class="nump">$ 148,334<span></span>
</td>
<td class="nump">$ 140,118<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_EarningPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Earning Per Share, Basic and Diluted</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_EarningPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_GainLossOnExtinguishmentOfDebtAndOtherExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) On Extinguishment Of Debt And Other Expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_GainLossOnExtinguishmentOfDebtAndOtherExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_OperatingExpensesExcludingDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Expenses, Excluding Depreciation And Amortization</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_OperatingExpensesExcludingDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2443-110228<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnTerminationOfLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on termination of lease before expiration of lease term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 40<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123386189&amp;loc=SL77918607-209975<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnTerminationOfLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) included in earnings related to the fair value of the hedged item in an interest rate fair value hedge, offset by the gain (loss) on the hedging instrument to the extent that the fair value hedge is determined to be effective.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueNotFromContractWithCustomer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue that is not accounted for under Topic 606.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueNotFromContractWithCustomer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_HealthCarePatientServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_HealthCarePatientServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rdnt_CapitationArrangementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rdnt_CapitationArrangementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140483009076816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">NET INCOME (LOSS)</a></td>
<td class="nump">$ 33,608<span></span>
</td>
<td class="nump">$ 44,319<span></span>
</td>
<td class="num">$ (1,749)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Currency translation adjustments</a></td>
<td class="num">(3,943)<span></span>
</td>
<td class="num">(65)<span></span>
</td>
<td class="num">(101)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Change in fair value cash flow hedge,&#160;net of taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(19,372)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Change in fair value of cash flow hedge from prior periods reclassified to earnings</a></td>
<td class="nump">3,687<span></span>
</td>
<td class="nump">3,695<span></span>
</td>
<td class="nump">3,448<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">COMPREHENSIVE INCOME (LOSS)</a></td>
<td class="nump">33,352<span></span>
</td>
<td class="nump">47,949<span></span>
</td>
<td class="num">(17,774)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Less comprehensive income attributable to noncontrolling interests</a></td>
<td class="nump">22,958<span></span>
</td>
<td class="nump">19,592<span></span>
</td>
<td class="nump">13,091<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">COMPREHENSIVE INCOME (LOSS) ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</a></td>
<td class="nump">$ 10,394<span></span>
</td>
<td class="nump">$ 28,357<span></span>
</td>
<td class="num">$ (30,865)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140482999542960">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENT OF EQUITY - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Acquisitions And Asset Purchases</div></th>
<th class="th"><div>DeepHealth, Inc.</div></th>
<th class="th"><div>Radnet, Inc. Stockholders' Equity</div></th>
<th class="th">
<div>Radnet, Inc. Stockholders' Equity </div>
<div>Acquisitions And Asset Purchases</div>
</th>
<th class="th">
<div>Radnet, Inc. Stockholders' Equity </div>
<div>DeepHealth, Inc.</div>
</th>
<th class="th"><div>Common Stock</div></th>
<th class="th">
<div>Common Stock </div>
<div>Acquisitions And Asset Purchases</div>
</th>
<th class="th">
<div>Common Stock </div>
<div>DeepHealth, Inc.</div>
</th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th">
<div>Additional Paid-in Capital </div>
<div>Acquisitions And Asset Purchases</div>
</th>
<th class="th">
<div>Additional Paid-in Capital </div>
<div>DeepHealth, Inc.</div>
</th>
<th class="th"><div>Accumulated Other Comprehensive (Loss) Income</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th"><div>Noncontrolling Interests</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,314,328<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance, value at Dec. 31, 2019</a></td>
<td class="nump">$ 233,139<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 151,685<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 262,865<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (8,026)<span></span>
</td>
<td class="num">$ (103,159)<span></span>
</td>
<td class="nump">$ 81,454<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Shares issued under the equity compensation plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">491,674<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,920<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">12,463<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,463<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,463<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Issuance of common stock for sale of unregistered securities for the DeepHealth acquisition (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">823,615<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Issuance of common stock for acquisitions</a></td>
<td class="nump">33,011<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,011<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,011<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest', window );">Tax effect on gain on sale of noncontrolling interest</a></td>
<td class="num">(551)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(551)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(551)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions paid to noncontrolling&#160;interests</a></td>
<td class="num">(1,985)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,985)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax', window );">Change in cumulative foreign currency&#160;translation adjustment</a></td>
<td class="num">(101)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(101)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(101)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Change in fair value cash flow hedge,&#160;net of taxes</a></td>
<td class="num">(19,372)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19,372)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19,372)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Change in fair value of cash flow hedge from prior periods reclassified to earnings</a></td>
<td class="nump">3,448<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,448<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,448<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="num">(1,749)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,840)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,840)<span></span>
</td>
<td class="nump">13,091<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,640,537<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance, value at Dec. 31, 2020</a></td>
<td class="nump">258,303<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">165,743<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">307,788<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(24,051)<span></span>
</td>
<td class="num">(117,999)<span></span>
</td>
<td class="nump">92,560<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of stock upon exercise of options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53,960<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of stock upon exercise of options</a></td>
<td class="nump">488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Shares issued under the equity compensation plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,212,758<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">471,162<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">25,284<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,284<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,284<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions paid to noncontrolling&#160;interests</a></td>
<td class="num">(2,426)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,426)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax', window );">Change in cumulative foreign currency&#160;translation adjustment</a></td>
<td class="num">(65)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(65)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(65)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Change in fair value cash flow hedge,&#160;net of taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Change in fair value of cash flow hedge from prior periods reclassified to earnings</a></td>
<td class="nump">3,695<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,695<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,695<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">44,319<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,727<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,727<span></span>
</td>
<td class="nump">19,592<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Issuance of stock for acquisitions (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">82,658<span></span>
</td>
<td class="nump">91,517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Issuance of stock for acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,498<span></span>
</td>
<td class="nump">$ 2,413<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,498<span></span>
</td>
<td class="nump">$ 2,413<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,498<span></span>
</td>
<td class="nump">$ 2,413<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited', window );">Forfeiture of restricted stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,365)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited', window );">Forfeiture of restricted stock</a></td>
<td class="num">(81)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(81)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(81)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_AdjustmentsToAdditionalPaidInCapitalGainOnContributionOfAssetsToSubsidiary', window );">Gain on contribution of assets to majority owned subsidiary</a></td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest', window );">Contribution from noncontrolling partner</a></td>
<td class="nump">123<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">123<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest', window );">Sale to noncontrolling interests, net of taxes</a></td>
<td class="nump">$ 11,610<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,206<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,206<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,404<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2021</a></td>
<td class="nump">53,548,227<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53,548,227<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance, value at Dec. 31, 2021</a></td>
<td class="nump">$ 346,157<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">228,904<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">342,592<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(20,421)<span></span>
</td>
<td class="num">(93,272)<span></span>
</td>
<td class="nump">117,253<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of stock upon exercise of options (in shares)</a></td>
<td class="nump">25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">203,678<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of stock upon exercise of options</a></td>
<td class="nump">$ 295<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">295<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">294<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Shares issued under the equity compensation plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">725,577<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">204,160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_SharesIssuedSharesSettlementOfContingentConsideration', window );">Issuance of common stock to settle DeepHealth contingent consideration (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">781,577<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">23,543<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,543<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,543<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions paid to noncontrolling&#160;interests</a></td>
<td class="num">(893)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(893)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax', window );">Change in cumulative foreign currency&#160;translation adjustment</a></td>
<td class="num">(3,943)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,943)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,943)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Change in fair value cash flow hedge,&#160;net of taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Change in fair value of cash flow hedge from prior periods reclassified to earnings</a></td>
<td class="nump">3,687<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,687<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,687<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">33,608<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,650<span></span>
</td>
<td class="nump">22,958<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Issuance of stock for acquisitions (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,465,294<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Issuance of stock for acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 63,311<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 63,311<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 63,311<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited', window );">Forfeiture of restricted stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(26,710)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited', window );">Forfeiture of restricted stock</a></td>
<td class="num">(75)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(75)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(75)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest', window );">Contribution from noncontrolling partner</a></td>
<td class="nump">19,139<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,139<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest', window );">Sale to noncontrolling interests, net of taxes</a></td>
<td class="nump">$ 6,623<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,623<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,623<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2022</a></td>
<td class="nump">53,548,227<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57,723,125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance, value at Dec. 31, 2022</a></td>
<td class="nump">$ 491,452<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 332,995<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 436,288<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (20,677)<span></span>
</td>
<td class="num">$ (82,622)<span></span>
</td>
<td class="nump">$ 158,457<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustment to Additional Paid in Capital, Income Tax Effect from Sale of Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_AdjustmentsToAdditionalPaidInCapitalGainOnContributionOfAssetsToSubsidiary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments to Additional Paid in Capital, Gain on Contribution Of Assets To Subsidiary</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_AdjustmentsToAdditionalPaidInCapitalGainOnContributionOfAssetsToSubsidiary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interest, Increase Contribution From Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_SharesIssuedSharesSettlementOfContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares Issued, Shares, Settlement Of Contingent Consideration</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_SharesIssuedSharesSettlementOfContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11178-113907<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126961718&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in noncontrolling interest from sale of a portion of the parent's controlling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569655-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares (or other type of equity) forfeited during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of forfeited shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph c(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140483003503872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>CASH FLOWS FROM OPERATING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 33,608<span></span>
</td>
<td class="nump">$ 44,319<span></span>
</td>
<td class="num">$ (1,749)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income (loss)&#160;to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">115,877<span></span>
</td>
<td class="nump">96,694<span></span>
</td>
<td class="nump">86,795<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Amortization of operating lease right-of-use assets</a></td>
<td class="nump">68,847<span></span>
</td>
<td class="nump">73,967<span></span>
</td>
<td class="nump">67,915<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnTerminationOfLease', window );">Lease abandonment charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">19,675<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions', window );">Equity in earnings of joint ventures, net of dividends</a></td>
<td class="num">(5,952)<span></span>
</td>
<td class="num">(6,260)<span></span>
</td>
<td class="nump">1,577<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization and write off of deferred financing costs and loan discount</a></td>
<td class="nump">2,693<span></span>
</td>
<td class="nump">3,254<span></span>
</td>
<td class="nump">4,413<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets', window );">Loss on sale and disposal of equipment and other</a></td>
<td class="nump">2,529<span></span>
</td>
<td class="nump">1,246<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss (gain) on extinguishment of debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,496<span></span>
</td>
<td class="num">(4,047)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Loss on impairment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,170<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfDeferredHedgeGains', window );">Amortization of cash flow hedge</a></td>
<td class="nump">3,687<span></span>
</td>
<td class="nump">3,695<span></span>
</td>
<td class="nump">3,448<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnDerivatives', window );">Non-cash change in fair value of interest rate swap</a></td>
<td class="num">(39,621)<span></span>
</td>
<td class="num">(21,670)<span></span>
</td>
<td class="nump">2,528<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">23,770<span></span>
</td>
<td class="nump">25,203<span></span>
</td>
<td class="nump">12,405<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_IncreaseDecreaseInNoncashItem', window );">Non cash item in other expenses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">242<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in value of contingent consideration</a></td>
<td class="num">(325)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract', window );"><strong>Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(30,078)<span></span>
</td>
<td class="num">(5,890)<span></span>
</td>
<td class="nump">25,206<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherCurrentAssets', window );">Other current assets</a></td>
<td class="num">(3,327)<span></span>
</td>
<td class="num">(15,777)<span></span>
</td>
<td class="nump">6,588<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="num">(12,166)<span></span>
</td>
<td class="nump">662<span></span>
</td>
<td class="num">(5,425)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes', window );">Deferred taxes</a></td>
<td class="nump">13,356<span></span>
</td>
<td class="nump">19,834<span></span>
</td>
<td class="num">(611)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Operating lease liability</a></td>
<td class="num">(68,943)<span></span>
</td>
<td class="num">(72,553)<span></span>
</td>
<td class="num">(53,906)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Deferred revenue</a></td>
<td class="num">(7,316)<span></span>
</td>
<td class="num">(28,319)<span></span>
</td>
<td class="nump">37,941<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable, accrued expenses and other liabilities</a></td>
<td class="nump">49,778<span></span>
</td>
<td class="nump">9,915<span></span>
</td>
<td class="nump">45,069<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">146,417<span></span>
</td>
<td class="nump">149,491<span></span>
</td>
<td class="nump">233,759<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>CASH FLOWS FROM INVESTING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBuildings', window );">Purchase of imaging centers and other operations</a></td>
<td class="num">(129,961)<span></span>
</td>
<td class="num">(77,691)<span></span>
</td>
<td class="num">(31,265)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="num">(119,451)<span></span>
</td>
<td class="num">(137,874)<span></span>
</td>
<td class="num">(94,172)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Purchase of intangible assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(5,130)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from sale of equipment</a></td>
<td class="nump">3,904<span></span>
</td>
<td class="nump">625<span></span>
</td>
<td class="nump">828<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInterestInJointVenture', window );">Equity contributions in existing and purchase of interest in joint ventures</a></td>
<td class="num">(1,441)<span></span>
</td>
<td class="num">(1,441)<span></span>
</td>
<td class="num">(1,635)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(246,949)<span></span>
</td>
<td class="num">(221,511)<span></span>
</td>
<td class="num">(126,244)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Payments on term loan debt</a></td>
<td class="num">(53,750)<span></span>
</td>
<td class="num">(619,529)<span></span>
</td>
<td class="num">(43,296)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities', window );">Principal payments on notes and leases payable other than term loan debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(3,302)<span></span>
</td>
<td class="num">(3,562)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Additional deferred finance costs on revolving loan amendment</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(938)<span></span>
</td>
<td class="num">(741)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Proceeds from debt issuance, net of issuance costs</a></td>
<td class="nump">147,996<span></span>
</td>
<td class="nump">717,307<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_ProceedsFromGovernmentAssistance', window );">Proceeds from paycheck protection program loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToMinorityShareholders', window );">Distributions paid to noncontrolling interests</a></td>
<td class="num">(893)<span></span>
</td>
<td class="num">(2,426)<span></span>
</td>
<td class="num">(1,985)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets', window );">Proceeds from sale of economic interest in majority owned subsidiary</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">13,073<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Proceeds from revolving credit facility</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">128,300<span></span>
</td>
<td class="nump">250,900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLinesOfCredit', window );">Payments on revolving credit facility</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(128,300)<span></span>
</td>
<td class="num">(250,900)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions', window );">Proceeds from issuance of common stock upon exercise of options</a></td>
<td class="nump">294<span></span>
</td>
<td class="nump">488<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by (used in) financing activities</a></td>
<td class="nump">93,647<span></span>
</td>
<td class="nump">104,673<span></span>
</td>
<td class="num">(45,561)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">EFFECT OF EXCHANGE RATE CHANGES ON CASH</a></td>
<td class="nump">113<span></span>
</td>
<td class="num">(65)<span></span>
</td>
<td class="num">(101)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS</a></td>
<td class="num">(6,772)<span></span>
</td>
<td class="nump">32,588<span></span>
</td>
<td class="nump">61,853<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">CASH AND CASH EQUIVALENTS, beginning of period</a></td>
<td class="nump">134,606<span></span>
</td>
<td class="nump">102,018<span></span>
</td>
<td class="nump">40,165<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">CASH AND CASH EQUIVALENTS, end of period</a></td>
<td class="nump">127,834<span></span>
</td>
<td class="nump">134,606<span></span>
</td>
<td class="nump">102,018<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid during the period for interest</a></td>
<td class="nump">39,151<span></span>
</td>
<td class="nump">29,042<span></span>
</td>
<td class="nump">39,521<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Cash paid during the period for income taxes</a></td>
<td class="nump">$ 587<span></span>
</td>
<td class="nump">$ 1,950<span></span>
</td>
<td class="nump">$ 5,069<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_IncreaseDecreaseInNoncashItem">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase Decrease In Noncash Item</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_IncreaseDecreaseInNoncashItem</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ProceedsFromGovernmentAssistance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Government Assistance</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ProceedsFromGovernmentAssistance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDeferredHedgeGains">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense charged against earnings by an Entity to record deferred gains and losses on hedge instruments. Examples include gain on economic hedges, amortization of gain on designated fair value hedge and so forth.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDeferredHedgeGains</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2443-110228<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnTerminationOfLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on termination of lease before expiration of lease term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 40<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123386189&amp;loc=SL77918607-209975<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnTerminationOfLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the undistributed income (or loss) of equity method investments, net of dividends or other distributions received from unconsolidated subsidiaries, certain corporate joint ventures, and certain noncontrolled corporations; such investments are accounted for under the equity method of accounting. This element excludes distributions that constitute a return of investment, which are classified as investing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBuildings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for acquisition of buildings (properties) whether for investment or use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBuildings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInterestInJointVenture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the investment in or advances to an entity in which the reporting entity shares control of the entity with another party or group.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInterestInJointVenture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from the acquisition of or improvements to long-lived, physical assets used to produce goods and services and not intended for resale, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate cash proceeds received from a combination of transactions in which noncurrent assets are sold, which may include the sale of a business, an investment in an affiliate (including an equity method investee), property, plant and equipment and intangible assets. Excludes sales of trading, available-for-sale, and held-to-maturity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for debt, mandatory redeemable security, and principal payment for finance lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a),(b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140483009177040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 01, 2022</div></th>
<th class="th"><div>Jan. 20, 2022</div></th>
<th class="th"><div>Oct. 22, 2021</div></th>
<th class="th"><div>Aug. 24, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_EquipmentAcquiredAndLeaseholdImprovements', window );">Equipment acquired and leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 111,800,000<span></span>
</td>
<td class="nump">$ 63,900,000<span></span>
</td>
<td class="nump">$ 52,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">565,961,000<span></span>
</td>
<td class="nump">484,247,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Investment in joint ventures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 57,893,000<span></span>
</td>
<td class="nump">$ 42,229,000<span></span>
</td>
<td class="nump">34,528,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Finance lease debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_ArizonaDiagnosticsGroupMember', window );">Arizona Diagnostics Group</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Investment at cost</a></td>
<td class="nump">$ 12,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDividendsReceived', window );">Received a dividend from the partnership</a></td>
<td class="nump">4,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Fair value of investment</a></td>
<td class="nump">$ 8,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember', window );">Aidence</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Shares issued (in shares)</a></td>
<td class="nump">359,002<span></span>
</td>
<td class="nump">1,141,234<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned', window );">Value of RadNet stock issued in acquisition</a></td>
<td class="nump">$ 6,800,000<span></span>
</td>
<td class="nump">$ 30,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember', window );">Quantib</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">965,058<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned', window );">Value of RadNet stock issued in acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_DRTLLCMember', window );">DRT LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1', window );">Shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued', window );">Value of shares issued in acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_TangentAssociatesLLCMember', window );">Tangent Associates LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67,658,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned', window );">Value of RadNet stock issued in acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_EquipmentAcquiredAndLeaseholdImprovements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_EquipmentAcquiredAndLeaseholdImprovements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncash or Part Noncash Acquisition, Noncash Financial or Equity Instrument Consideration, Value Issued</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity method investee and investment in and advance to affiliate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued as [noncash or part noncash] consideration for a business or asset acquired. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDividendsReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Dividends received on equity and other investments during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3337-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDividendsReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_ArizonaDiagnosticsGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_ArizonaDiagnosticsGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_DRTLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_DRTLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_TangentAssociatesLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_TangentAssociatesLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140483099688784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NATURE OF BUSINESS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock', window );">NATURE OF BUSINESS</a></td>
<td class="text">NATURE OF BUSINESS<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a national provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. At December 31, 2022, we operated directly or indirectly through joint ventures with hospitals, 357 centers located in Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Our centers provide physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Our services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. The vast majority of our centers offer multi-modality imaging services. Our multi-modality strategy diversifies revenue streams, reduces exposure to reimbursement changes and provides patients and referring physicians one location to serve the needs of multiple procedures.  In addition to our center operations, we have certain other subsidiaries that develop Artificial Intelligence ("AI") products and solutions that are designed to enhance interpretation of radiographic images. Our operations comprise two segments for financial reporting purposes for this reporting period, Imaging Centers and Artificial Intelligence. For further financial information about these segments, see Note 5, Segment Reporting.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements include the accounts of RadNet, Inc. as well as its subsidiaries in which RadNet has a controlling financial interest. The consolidated financial statements also include certain variable interest entities in which we are the primary beneficiary (as described in more detail below). All material intercompany transactions and balances have been eliminated upon consolidation.   All of these affiliated entities are referred to collectively as &#8220;RadNet&#8221;, &#8220;we&#8221;, &#8220;us&#8221;, &#8220;our&#8221; or the &#8220;Company&#8221; in this report.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounting regulations stipulate that generally any entity with a) insufficient equity to finance its activities without additional subordinated financial support provided by any parties, or b) equity holders that, as a group, lack the characteristics which evidence a controlling financial interest, is considered a Variable Interest Entity (&#8220;VIE&#8221;). We consolidate all VIEs in which we are the primary beneficiary. We determine whether we are the primary beneficiary of a VIE through a qualitative analysis that identifies which variable interest holder has the controlling financial interest in the VIE. The variable interest holder who has both of the following has the controlling financial interest and is the primary beneficiary: (1) the power to direct the activities of the VIE that most significantly impact the VIE&#8217;s economic performance and (2) the obligation to absorb losses of, or the right to receive benefits from, the VIE that could potentially be significant to the VIE. In performing our analysis, we consider all relevant facts and circumstances, including: the design and activities of the VIE, the terms of the contracts the VIE has entered into, the nature of the VIE&#8217;s variable interests issued and how they were negotiated with or marketed to potential investors, and which parties participated significantly in the design or redesign of the entity.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIEs that we consolidate as the primary beneficiary consist of professional corporations which are owned or controlled by individuals within our senior management and provide professional medical services for centers in Arizona, California, Delaware, Maryland, New Jersey and New York.  These VIEs are collectively referred to as the Group.  RadNet provides non-medical, technical and administrative services to the Group for which it receives a management fee, pursuant to the related management agreements. Through the management agreements we have exclusive authority over all non-medical decision making related to the ongoing business operations and we determine the annual budget. The Group has insignificant operating assets and liabilities, and de minimis equity.  Substantially all cash flows of the Group after expenses, including professional salaries, are transferred to us. We consolidate the revenue and expenses, assets and liabilities of the Group.  The creditors of the Group do not have recourse to our general credit and there are no other arrangements that could expose us to losses on behalf of the Group. However, RadNet may be required to provide financial support to cover any operating expenses in excess of operating revenues.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Group on a combined basis recognized $189.1 million, $179.6 million, and $147.6 million of revenue, net of management services fees to RadNet, for the years ended December 31, 2022, 2021, and 2020, respectively and $189.1 million, $179.6 million, and $147.6 million of operating expenses for the years ended December 31, 2022, 2021, and 2020, respectively. RadNet, Inc. recognized $786.5 million, $749.2 million, and $600.7 million of total billed net service fee revenue for the years ended December 31, 2022, 2021, and 2020, respectively, for management services provided to the Group relating primarily to the technical portion of billed revenue.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cash flows of the Group are included in the accompanying consolidated statements of cash flows. All intercompany balances and transactions have been eliminated in consolidation. In our consolidated balance sheets at December 31, 2022 and December 31, 2021, we have included approximately $110.3 million and $89.2 million, respectively, of accounts </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">receivable and approximately $16.2 million and $14.4 million of accounts payable and accrued liabilities related to the Group, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At all of our centers not serviced by the Group we have entered into long-term contracts with medical groups to provide professional services at those centers, including supervision and interpretation of diagnostic imaging procedures. The medical groups maintain full control over the physicians they employ. Through our management agreements, we make available to the medical groups the imaging centers, including all furniture, fixtures and medical equipment therein.  The medical groups are compensated for their services from the professional component of the global net service fee revenue and after deducting management service fees paid to us, we have no economic controlling interest in these medical groups. As such, the financial results of these groups are not consolidated in our financial statements.</span></div>We also own a 49% economic interest in ScriptSender, LLC, which provides services for secure data transmission of medical information. Through a management agreement, RadNet provides management and accounting services and receives an agreed upon fee. ScriptSender LLC is dependent on us to finance its own activities, and as such we determined that it is a VIE but we are not a primary beneficiary since we do not have the power to direct the activities of the entity that most significantly impact the entity&#8217;s economic performance.  We have continued to finance ScriptSender during it's development phase and our maximum exposure to loss is $3.3 million, which represents our receivable balance from the entity.  Maximum exposure to loss is the loss that we would absorb in the event that all of the assets of ScriptSender are deemed worthless.  We paid operating expenses for the venture of $2.1 million and $1.6 million for the years ended December 31, 2022, and December 31, 2021, respectively.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI https://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI https://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140483011289520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PRINCIPLES OF CONSOLIDATION &#8211; The operating activities of subsidiaries are included in the accompanying consolidated financial statements (&#8220;financial statements&#8221;) from the date of acquisition. Investments in companies in which we have the ability to exercise significant influence, but not control, are accounted for by the equity method. All intercompany transactions and balances, with our consolidated entities and the unsettled amount of intercompany transactions with our equity method investees, have been eliminated in consolidation. As stated in Note 1 above, the Group consists of VIEs and we consolidate the operating activities and balance sheets of each. Additionally, we determined that our unconsolidated joint venture, ScriptSender, LLC, is also a VIE as it is dependent on our operational funding but we are not a primary beneficiary since RadNet does not have the power to direct the activities of the entity that most significantly impact the entity&#8217;s economic performance. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">USE OF ESTIMATES - The financial statements have been prepared in accordance with U.S. generally accepted accounting principles (GAAP), which requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. These estimates and assumptions affect various matters, including our reported amounts of assets and liabilities in our consolidated balance sheets at the dates of the financial statements; our disclosure of contingent assets and liabilities at the dates of the financial statements; and our reported amounts of revenues and expenses in our consolidated statements of operations during the reporting periods. These estimates involve judgments with respect to numerous factors that are difficult to predict and are beyond management&#8217;s control. As a result, actual amounts could materially differ from these estimates.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">REVENUES &#8211; Our revenues generally relate to net patient fees&#160;received from various payors and patients themselves under contracts in which our performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period when our obligations to provide diagnostic services are satisfied. Our performance obligations for diagnostic services are generally satisfied over a period of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payor (Medicare, Medicaid, managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent upon the terms provided by Medicare and Medicaid, or negotiated with managed care health plans and commercial insurance companies. The payment arrangements with third-party payors for the services we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As it relates to the Group, this service fee revenue includes payments for both the professional medical interpretation revenue recognized by them as well as the payment for all other aspects related to our providing the imaging services, for which we earn management fees. As it relates to other centers, this service fee revenue is earned through providing the use of our </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">diagnostic imaging equipment and the provision of technical services as well as providing administration services such as clerical and administrative personnel, bookkeeping and accounting services, billing and collection, provision of medical and office supplies, secretarial, reception and transcription services, maintenance of medical records, and advertising, marketing and promotional activities.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenues are based upon the estimated amounts we expect to be entitled to receive from patients and third-party payors. Estimates of contractual allowances under managed care and commercial insurance plans are based upon the payment terms specified in the related contractual agreements. Revenues related to uninsured patients and copayment and deductible amounts for patients who have health care coverage may have discounts applied (uninsured discounts and contractual discounts). We also record estimated implicit price concessions (based primarily on historical collection experience) related to uninsured accounts to record self-pay revenues at the estimated amounts we expect to collect.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under capitation arrangements with various health plans, we earn a per-enrollee amount each month for making available diagnostic imaging services to all plan enrollees under the capitation arrangement. Revenue under capitation arrangements is recognized in the period in which we are obligated to provide services to plan enrollees under contracts with various health plans.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our total service fee revenues for the years ended December 31, 2022, 2021, and 2020 are presented in the table below.  Our imaging center revenue is displayed as the estimated service fee, broken down by classification of insurance coverage type.  Additional revenues are earned from our management services provided to joint ventures and our software and AI subsidiaries.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In Thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial insurance</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">785,128&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743,462&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">584,035&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311,124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280,911&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217,928&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,279&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,731&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,619&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Workers' compensation/personal injury</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,339&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,478&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other patient revenue</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,849&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,398&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,314&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management fee revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,630&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software and teleradiology</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,238&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,525&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,798&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,428&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,436&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue under capitation arrangements</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152,045&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148,334&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140,118&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Imaging center segment revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,425,665&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,313,662&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,071,840&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AI segment revenue</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,396&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,415&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,430,061&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,315,077&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,071,840&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">GOVERNMENT ASSISTANCE: COVID-19 PANDEMIC AND CARES ACT FUNDING -  On March 11, 2020 the World Health Organization (WHO) designated COVID-19 as a global pandemic.  To aid businesses and stimulate the national economy, Congress passed The Coronavirus Aid, Relief, and Economic Security ("CARES") Act, which was signed in to law on March 27, 2020.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Beginning in the second quarter of 2020 and through the twelve months ended December 31, 2021, we received funding from the various programs established by the CARES Act as follows:</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:23.5pt">$39.6 million total of accelerated Medicare payments received, $39.5 million for the twelve months ended December 31, 2020 and $0.1 million for the twelve months ended December 31, 2021.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="padding-left:45pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:23.5pt">$4.0 million from the Paycheck Protection Program during the twelve months ended December 31, 2020.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:23.5pt">$35.4 million total Provider Relief Funding, $26.3 million received for the twelve months ended December 31, 2020 and $9.1 million received for the twelve months ended December 31, 2021.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The accelerated Medicare payments were recorded to deferred revenue in our consolidated balance sheet and are being applied to revenue as services are performed beginning in 2021.  Based on terms released on October 1, 2020, through the Continuing Appropriations Act, 2021 and Other Extensions Act, such accelerated payments are interest free for inpatient acute care hospitals for 29 months (seven months for medical groups), and the program currently requires CMS to recoup the payments </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">beginning one year after receipt by the provider, by withholding future Medicare fee-for-service payments for claims at a rate of 25% for the first 11 months, and 50% for the 6 months afterward, until the full accelerated payment has been recouped.  The program currently requires any outstanding balance remaining after 29 months to be repaid by the provider or be subject to an interest rate currently set at 4%. We applied the accelerated Medicare payments to revenue in the amount of $8.4 million for the twelve months ended December 31, 2022 and $30.2 million for the twelve months ended December 31, 2021.  As of December 31, 2022, approximately $1.0 million  of Medicare payments received remain in d<span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjc0ODc3OTE4MzYxNA_386ac154-db8d-4eee-8934-81984fec863f">eferred revenue</span>.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The $4.0 million secured from the Paycheck Protection Program was accounted for as debt and in December 2020 we met the eligibility requirements under the government guidelines for forgiveness and the loans were written off to gain on extinguishment of debt.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Provider Relief Funding is displayed as such on our consolidated statements of operations in the year received.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The CARES Act also provides for the deferral of the employer-paid portion of the social security payroll tax with 50% due by December 31, 2021 and 50% due by December 31,2022. We elected to defer $16.3 million of this tax through December 31, 2020 which has been paid as of December 31, 2022.  The CARES Act also provided a refundable employer tax credit ("ERC") equal to 50% of qualified wages, including certain health insurance costs, that can be used to offset payroll tax liabilities.  In the year ending December 31, 2021, we recognized an employee retention credit as a reduction to cost of operations totaling of $7.7 million.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ACCOUNTS RECEIVABLE &#8211; Substantially all of our accounts receivable are due under fee-for-service contracts from third party payors, such as insurance companies and government-sponsored healthcare programs, or directly from patients. Services are generally provided pursuant to one-year contracts with healthcare providers. We continuously monitor collections from our payors and maintain an allowance for bad debts based upon specific payor collection issues that we have identified and our historical experience.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into factoring agreements with various institutions and sold certain accounts receivable under non-recourse agreements in exchange for notes receivables from the buyers. These transactions are accounted for as a reduction in accounts receivable as the agreements transfer effective control over and risk related to the receivables to the buyers. Proceeds on notes receivables are reflected as operating activities on our statement of cash flows and on our balance sheet as prepaid expenses and other current assets for the current portion and deposits and other for the long term portion.   Amounts remaining to be collected on these agreements were $15.4 million and  $17.7 million at December 31, 2022 and December 31, 2021, respectively.  We do not utilize factoring arrangements as an integral part of our financing for working capital.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ACCOUNTS PAYABLE AND ACCRUED EXPENSES - Accounts payable and accrued expenses were comprised of the following (in thousands):</span></div><div style="text-align:justify;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.502%"><tr><td style="width:1.0%"/><td style="width:67.931%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.951%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.665%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.953%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,678&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,461&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181,574&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,420&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued salary and benefits</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,072&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,425&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional fees</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,271&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,631&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369,595&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263,937&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SOFTWARE REVENUE RECOGNITION &#8211; We have developed and sell Picture Archiving Communications Systems (&#8220;PACS&#8221;) and related services. The PACS sales are made primarily through our sales force and generally include hardware, software, installation, training and first-year warranty support. Hardware which is not unique or special purpose, is purchased from a third-party and resold to customers with a small mark-up.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have determined that our core software products, such as PACS, are essential to most of our arrangements as hardware, software and related services are sold as an integrated package.  Revenue is recognized when a performance obligation is satisfied by transferring a promised good or service to a customer. </span></div><div style="text-align:justify;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December 31, 2022, 2021 and 2020, we recorded approximately $13.2 million, $10.5 million, and $8.6 million, respectively, in revenue related to our software business which is included in net service fee revenue in our consolidated statement of operations. At December 31, 2022 we had deferred revenue of approximately $0.9 million associated with these sales which we expect to recognize into revenue over the next 12 months.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SOFTWARE DEVELOPMENT COSTS &#8211; When we develop our own software and artificial intelligence solutions we capitalize and amortize those costs over their useful life. Costs related to the research and development of new software products and enhancements to existing software intended for resale to our customers are expensed as incurred.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONCENTRATION OF CREDIT RISKS &#8211; Financial instruments that potentially subject us to credit risk are primarily cash equivalents and accounts receivable. We have placed our cash and cash equivalents with one major financial institution. At times, the cash in the financial institution is temporarily in excess of the amount insured by the Federal Deposit Insurance Corporation, or FDIC. Substantially all of our accounts receivable are due under fee-for-service contracts from third party payors, such as insurance companies and government-sponsored healthcare programs, or directly from patients. We continuously monitor collections and maintain an allowance for bad debts based upon our historical collection experience. In addition, we have notes receivable stemming from our factoring of accounts receivable as stated above.  Companies with which we factor our receivables are well known established buyers of such instruments, have agreed to assume the full risk of their collection.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CASH AND CASH EQUIVALENTS &#8211; We consider all highly liquid investments that mature in three months or less when purchased to be cash equivalents. The carrying amount of cash and cash equivalents approximates the fair market value.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DEFERRED FINANCING COSTS &#8211; Costs of financing are deferred and amortized using the effective interest rate method.  Deferred financing costs are related to our revolving credit facilities. Deferred financing costs, net of accumulated amortization, were $2.3 million and $2.1 million for the twelve months ended at December 31, 2022 and 2021, respectively.  See Note 8, Credit Facilities and Notes Payable for more information on our revolving lines of credit.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PROPERTY AND EQUIPMENT &#8211; Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation and amortization of property and equipment are provided using the straight-line method over the estimated useful lives, which range from 3 to 15 years. Leasehold improvements are amortized at the lesser of lease term or their estimated useful lives, which range from 3 to 15 years. Maintenance and repairs are charged to expense as incurred.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BUSINESS COMBINATION &#8211; When the qualifications for business combination accounting treatment are met, it requires us to recognize separately from goodwill the assets acquired and the liabilities assumed at their acquisition date fair values. Goodwill as of the acquisition date is measured as the excess of consideration transferred over the net of the acquisition date fair values of the assets acquired and the liabilities assumed. While we use our best estimates and assumptions to accurately value assets acquired and liabilities assumed at the acquisition date, our estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, we record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. Upon the conclusion of the measurement period or final determination of the values of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to our consolidated statements of operations.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GOODWILL AND INDEFINITE LIVED INTANGIBLES &#8211; Goodwill totaled $677.7 million and $513.8 million at December 31, 2022 and December 31, 2021, respectively. Indefinite lived intangible assets at  were $24.1 million at December 31, 2022 and $20.6 million at December 31, 2021 and are associated with the value of certain trade name intangibles and in process research and development (IPR&amp;D). Goodwill, trade name intangibles and IPR&amp;D are recorded as a result of business combinations. When we determine the carrying value of goodwill exceeds its fair value, an impairment charge would be recognized which should not exceed the total amount of goodwill allocated to that reporting unit. We determined fair values for each of the reporting units using the market approach, when available and appropriate, or the income approach, or a combination of both. We assess the valuation methodology based upon the relevance and availability of the data at the time we perform the valuation. If multiple valuation methodologies are used, the results are weighted appropriately.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We tested goodwill, trade name and IPR&amp;D for impairment&#160;on October 1, 2022.  In 2020 we ceased employing certain indefinite lived trade names with a total value of $4.2 million and they were written off in full as of December 31, 2020.  Our annual impairment test as of October 1, 2022 noted no other impairment, and we have not identified any indicators of impairment through December 31, 2022.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LONG-LIVED ASSETS &#8211; We evaluate our long-lived assets (property and equipment) and intangibles, other than goodwill and indefinite lived intangible assets, for impairment when events or changes indicate the carrying amount of an asset may not be recoverable. Accounting standards requires that if the sum of the undiscounted expected future cash flows from a long-lived asset or definite-lived intangible is less than the carrying value of that asset, an asset impairment charge must be recognized. The amount of the impairment charge is calculated as the excess of the asset&#8217;s carrying value over its fair value, which generally represents the discounted future cash flows from that asset or in the case of assets we expect to sell, at fair value less costs to sell.  At December 31, 2021 we recorded a <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjc0ODc3OTE4MzYxMw_9c7fb964-0c31-457d-ab68-df24d21cb8df">write off charge</span> of $7.1 million in leasehold improvements for </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">facilities that we abandoned. See the Leases discussion below for more information.  Other than this, we determined that there were no events or changes in circumstances that indicated our long-lived assets were impaired during any periods presented.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">INCOME TAXES &#8211; Income tax expense is computed using an asset and liability method and using expected annual effective tax rates. Under this method, deferred income tax assets and liabilities result from temporary differences in the financial reporting bases and the income tax reporting bases of assets and liabilities. The measurement of deferred tax assets is reduced, if necessary, by the amount of any tax benefit that, based on available evidence, is not expected to be realized. When it appears more likely than not that deferred taxes will not be realized, a valuation allowance is recorded to reduce the deferred tax asset to its estimated realizable value. For net deferred tax assets we consider estimates of future taxable income in determining whether our net deferred tax assets are more likely than not to be realized. See Note 10, Income Taxes, for more information.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LEASES - We determine if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (&#8220;ROU&#8221;) assets, current operating lease liabilities, and long term operating lease liability in our consolidated balance sheets. Finance leases are included in property and equipment, current finance lease liability, and long-term finance lease liability in our consolidated balance sheets.  ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As most of our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. We use the implicit rate when readily determinable. We include options to extend a lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term. For a contract in which we are a lessee that contains fixed payments for both lease and non-lease components, we have elected to account for the components as a single lease component, as permitted. For finance leases, interest expense on the lease liability is recognized using the effective interest method and amortization of the ROU asset is recognized on a straight-line basis over the shorter of the estimated useful life of the asset or the lease term. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ROU assets are tested for impairment if circumstances suggest that the carrying amount may not be recoverable. No events have occurred such as fire, flood, or other acts which have impaired the integrity of our ROU assets as of December 31, 2022. Our facility leases require us to maintain insurance policies which would cover major damage to our facilities. We maintain business interruption insurance to cover loss of business due to a facility becoming non-operational under certain circumstances. Our equipment leases are covered by warranty and service contracts which cover repairs and provide regular maintenance to keep the equipment in functioning order.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After a management review of post pandemic patient traffic to centers during the fourth quarter of 2021, it was noted that although overall volumes had returned to pre-pandemic levels, certain imaging locations did not experience the same levels of activity as beforehand.  This was due in part to lower utilization rates of commercial space from telecommuting, accompanied by the migration of those workers out of congested urban centers to residential areas.  Based on this analysis, management decided to consolidate volumes into fewer centers and reduce administrative office space in response to the demographic changes experienced.  To complete the closure of these locations, we took a lease abandonment charge of approximately $12.6 million at December 31, 2021. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UNINSURED RISKS &#8211; On November 1, 2013 we entered into a high-deductible workers&#8217; compensation insurance policy. We have recorded liabilities of $3.9 million and $3.5 million at December 31, 2022 and December 31, 2021, respectively, for the estimated future cash obligations associated with the unpaid portion of the workers compensation claims incurred.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and our affiliated physicians carry an annual medical malpractice insurance policy that protects us for claims that are filed during the policy year and that fall within policy limits. The policy has a deductible which is $10,000 per incidence for all years covered by this report.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2008, in order to eliminate the exposure for claims not reported during the regular malpractice policy period, we purchased a medical malpractice claims made tail policy, which provides coverage for any claims reported in the event that our medical malpractice policy expires. As of December 31, 2022, this policy remains in effect.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into an arrangement with Blue Shield to administer and process claims under a self-insured plan that provides health insurance coverage for our employees and dependents. We have recorded liabilities as of December 31, 2022 and 2021 of $7.4 million and $6.3 million, respectively, for the estimated future cash obligations associated with the unpaid portion of the medical and dental claims incurred by our participants. Additionally, we entered into an agreement with Blue </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shield for a stop loss policy that provides coverage for any claims that exceed $250,000 up to a maximum of $1.0 million in order for us to limit our exposure for unusual or catastrophic claims.&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EMPLOYEE BENEFIT PLAN &#8211; We adopted a profit-sharing/savings plan pursuant to Section 401(k) of the Internal Revenue Code that covers substantially all non-professional employees. Eligible employees may contribute on a tax-deferred basis a percentage of compensation, up to the maximum allowable under tax law. Employee contributions vest immediately. We can elect to provide a matching contribution in the amount to a maximum of 1.0% per 4.0% of employee contribution, and have done so since 2017.  We contributed $3.0 million in matching for each of the twelve months ended December 31, 2022 and December 31, 2021.  For the year ended December 31, 2020, we elected not to provide a matching contribution.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EQUITY BASED COMPENSATION &#8211; We have one long-term incentive plan that we adopted in 2006 and which we first amended and restated as of April 20, 2015, and again on March 9, 2017, and currently as of April 15, 2021 (the &#8220;Restated Plan&#8221;). The Restated Plan was approved by our stockholders at our annual stockholders meeting on June 10, 2021. We have reserved 16,500,000 shares of common stock for issuance under the Restated Plan which can be issued in the form of incentive and/or nonstatutory stock options, restricted and/or unrestricted stock, stock units, and stock appreciation rights.  Terms and conditions of awards can be direct grants or based on achieving a performance metric and we also consider probability of achievement of performance conditions when determining expense recognition. For the awards where vesting is probable, equity-based compensation is recognized over the related vesting period. Stock options and warrants generally vest over <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjQzNTk_cd22a3ff-fb8c-47a1-9018-2d91908dd609">three</span> to five years and expire <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjQzNzk_0e815b97-2caf-4c2a-88cf-151ad3b1dacb">five</span> to ten years from date of grant.  We determine the compensation expense for each stock option award using the Black Scholes, or similar, valuation model.  Those models require that our management make certain estimates concerning risk free interest rates and volatility in the trading price of our common stock. The compensation expense recognized for all equity-based awards is recognized over the awards&#8217; service periods. Equity-based compensation is classified in operating expenses within the same line item as the majority of the cash compensation paid to employees.  In connection with our acquisition of DeepHealth Inc. on June 1, 2020, we assumed the DeepHealth, Inc. 2017 Equity Incentive Plan, including outstanding options awards that can be exercised for our common stock.  No additional awards will be granted under the DeepHealth, Inc. 2017 Equity Incentive Plan.  See Note 11, Stock-Based Compensation, for more information.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FOREIGN CURRENCY TRANSLATION &#8211; For our operations in Canada, Europe and the United Kingdom, the functional currency of our foreign subsidiaries is the local currency. Assets and liabilities denominated in foreign currencies are translated using the exchange rate at the balance sheet dates. Revenues and expenses are translated using average exchange rates prevailing during the reporting period. Any translation adjustments resulting from this process are shown separately as a component of accumulated other comprehensive income (loss). Gains and losses related to the foreign currency portion of international transactions are included in the determination of net income.  The following is a reconciliation of Foreign Currency Translation amounts for the years ended December 31, 2022, 2021 and 2020 is provided below (in thousands):</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:50.584%"><tr><td style="width:1.0%"/><td style="width:58.148%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.956%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:37.339%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.957%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency Translation</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(276)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency Translation Adjustments</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(101)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(377)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency Translation Adjustments</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(442)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency Translation Adjustments</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,943)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,385)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">OTHER COMPREHENSIVE INCOME (LOSS) &#8211; Accounting guidance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">establishes rules for reporting and displaying other comprehensive income (loss) and its components. Our foreign currency translation adjustments,  changes in the fair value of cash flow hedges, and the amortization of balances associated with derivatives previously classified as cash flow hedges are included in other comprehensive income (loss). The components of other comprehensive income (loss) for the twelve month periods ended December 31, 2022, December 31, 2021, and December 31, 2020 are included in the consolidated statements of comprehensive income (loss).</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">COMMITMENTS AND CONTINGENCIES - We are party to various legal proceedings, claims, and regulatory, tax or government inquiries and investigations that arise in the ordinary course of business. With respect to these matters, we evaluate the developments on a regular basis and accrue a liability when we believe a loss is probable and the amount can be reasonably estimated. Based on current information, we do not believe that reasonably possible or probable losses associated with pending legal proceedings would either individually or in the aggregate, have a material adverse effect on our business and </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">consolidated financial statements. However, the outcome of these matters is inherently uncertain. Therefore, if one or more of these matters were resolved against us for amounts in excess of management's expectations, our results of operations and financial condition, including in a particular reporting period in which any such outcome becomes probable and estimable, could be materially adversely affected.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DERIVATIVE INSTRUMENTS </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2016 CAPS</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarter of 2016, we entered into two forward interest rate cap agreements ("2016 Caps"). The 2016 Caps matured in September and October 2020. The 2016 Caps had notional amounts of $150,000,000 and $350,000,000, respectively, which were designated at inception as cash flow hedges of future cash interest payments associated with portions of our variable rate bank debt. Under these arrangements, we purchased a cap on 3 month LIBOR at 2.0%. We were liable for a $5.3 million premium to enter into the caps which accrued to current liabilities on our balance sheet and paid over the life of the 2016 Caps.  The gain or loss of the hedge (i.e. change in fair value) was reported as a component of accumulated other comprehensive income (loss) in the consolidated statement of equity.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A tabular presentation of the effect of derivative instruments on our consolidated statement of comprehensive (loss) income, net of taxes is as follows (amounts in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.836%"><tr><td style="width:1.0%"/><td style="width:28.663%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:34.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.389%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Interest Rate Contracts</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the twelve months ended</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Gain (Loss) Recognized on Derivative, net of taxes</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location of Gain (Loss) Recognized<br/>in Income on Derivative</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#8212;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#8212;</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$788</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Loss</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2019 SWAPS</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2019, we entered into four forward interest rate agreements ("2019 swaps").  The 2019 swaps have total notional amounts of $500,000,000, consisting of two agreements of $50,000,000 each and two agreements of  $200,000,000 each.   The 2019 swaps will secure a constant interest rate associated with portions of our variable rate bank debt and have an effective date of October 13, 2020. They will mature in October 2023 for the two smaller notional and October 2025 for the two larger notional. Under these arrangements, we arranged the 2019 swaps with locked in 1 month LIBOR rates at 1.96% for the $100,000,000 notional and at 2.05% for the $400,000,000 notional. As of the effective date, we will be liable for premium payments if interest rates decline below arranged rates, but will receive interest payments if rates remain above the arranged rates.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At inception, we designated our 2019 Swaps as cash flow hedges of floating-rate borrowings. In accordance with accounting guidance, derivatives that have been designated and qualify as cash flow hedging instruments are reported at fair value. The gain or loss on the effective portion of the hedge (i.e. change in fair value) is reported as a component of accumulated comprehensive income (loss) in the consolidated statement of equity.  The remaining gain or loss, if any, is recognized currently in earnings.  The cash flows for both our $400,000,000 notional interest rate swap contract locked in at 2.05% due October 2025 and our $100,000,000 notional interest rate swap contract locked in at 1.96% do not match the cash flows for our First Lien Term Loans and so we have determined that they are not currently effective as cash flow hedges. Accordingly, all changes in their fair value after April 1, 2020 for the $400,000,000 notional and after July 1, 2020 for the $100,000,000 notional will be recognized in earnings.&#160;As of July 1, 2020, the total change in fair value relating to swaps included in other comprehensive income was approximately $24.4 million, net of taxes.  This amount will be amortized to interest expense through October 2023 at approximately $0.4 million per month and continuing at approximately $0.3 million per month through October 2025.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A tabular presentation of the effect of derivative instruments on our consolidated statement of comprehensive loss of the 2019 swaps is as follows (amounts in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:28.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:34.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.065%"/><td style="width:0.1%"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Interest Rate Contracts - Effective Portion</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the twelve months ended</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Loss Recognized on Derivative, net of taxes</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location of Loss Recognized<br/>in Income on Derivative</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#8212;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#8212;</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(20,160)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Loss</span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A tabular presentation of the effect of derivative instruments on our statement of operations of the 2019 Swaps for the Swaps that became ineffective in 2020 is as follows (amounts in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Interest Rate Contracts - Ineffective Portion</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the twelve months ended</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of gain (loss) recognized in income on derivative (current period ineffective portion)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of gain (loss) recognized in Income on derivative (current period ineffective portion)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of loss reclassified from accumulated other comprehensive income (loss) into income (prior period effective portion)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of loss reclassified from accumulated other comprehensive income (loss) into income (prior period effective portion)</span></td></tr><tr style="height:8pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$39,621</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmY3ZDdlMDY0Y2UzOTQyYWVhZjFkMzRhNTc4MTBmMjA1L3RhYmxlcmFuZ2U6ZjdkN2UwNjRjZTM5NDJhZWFmMWQzNGE1NzgxMGYyMDVfMy0yLTEtMS03NjcxMw_04d809f9-cf99-45ef-aa56-16be46b5f8b6">Other Income (Expense)</span></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(3,687)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Interest Expense</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$21,670</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmY3ZDdlMDY0Y2UzOTQyYWVhZjFkMzRhNTc4MTBmMjA1L3RhYmxlcmFuZ2U6ZjdkN2UwNjRjZTM5NDJhZWFmMWQzNGE1NzgxMGYyMDVfNC0yLTEtMS03NjcyMQ_2c91ab05-c7d0-4ed6-a9f1-aefed9da243a">Other Income (Expense)</span></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(3,695)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Expense</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(2,528)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmY3ZDdlMDY0Y2UzOTQyYWVhZjFkMzRhNTc4MTBmMjA1L3RhYmxlcmFuZ2U6ZjdkN2UwNjRjZTM5NDJhZWFmMWQzNGE1NzgxMGYyMDVfNC0yLTEtMS0yOTQ4OQ_869911ef-bcba-451f-8629-1684d55fda21">Other Income (Expense)</span></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(3,448)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Expense</span></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONTINGENT CONSIDERATION - </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Aidence Holding B.V.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 20, 2022, we completed our acquisition of all the equity interests of Aidence Holding B.V. ("Aidence") an artificial intelligence enterprise centered on lung cancer screening.  As part of the purchase agreement, we will pay up to $10.0 million consideration upon the completion of two identified milestones in RadNet common shares or cash at our election.  This contingency had a value of approximately $7.2 million on December 31, 2022. The amount is reviewed quarterly and adjusted to fair value based on the yield rate of S&amp;P B-rated corporate bonds and the probability of FDA approval, which has been currently determined by management to be 80% for milestone one and 70% for milestone two.  In addition, there is a remaining general holdback of $4.0 million to be issued in shares of our common stock subject to adjustment for any indemnification claims.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Quantib B.V.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 20, 2022, we completed our acquisition of all the equity interests of Quantib B.V. ("Quantib") an artificial intelligence enterprise centered on prostate cancer screening.  As part of the purchase agreement, we will issue 18 months after acquisition, 113,303 shares of our common stock with an initial fair value at the date of close of $3.0 million subject to adjustment for any indemnification claims and will be adjusted to fair value in subsequent periods. This contingency had a value of approximately $2.1 million as of December 31, 2022. In addition, there is a general holdback of $1.6 million to be issued in cash subject to adjustment for any indemnification claims.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Montclair</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 1, 2022, we completed our acquisition of Montclair Radiological Associates. As part of the purchase agreement, we recorded $1.2 million in contingent consideration to be determined by obtaining specific EBITDA targets within a defined time frame.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Heart and Lung Imaging Limited</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2022, we completed our acquisition of 75% of the equity interests of Heart and Lung Imaging Limited. The purchase included $10.2 million in contingent milestone consideration and cash holdback of $0.6 million to be issued 24 months after acquisition subject to adjustment for any indemnification claims, which will be adjusted to fair value in </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">subsequent periods.  The milestone contingency had a value of approximately $11.1 million as of December 31, 2022.   The contingent consideration is determined by the achievement of a specific number of physician reads.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A tabular rollforward of contingent consideration is as follows (amounts in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">     </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.964%"><tr><td style="width:1.0%"/><td style="width:12.505%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.480%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.505%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.480%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.505%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.480%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.505%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.480%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.505%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.480%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.505%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.480%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.505%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.485%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="42" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the twelve months ended December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Entity</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Account</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 1, 2022 Balance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Issuance of contingent consideration</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of  income (loss) recognized on contingent consideration</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Currency Translation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022 Balance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aidence</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Long Term Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,453&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(362)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,158&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quantib</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued Expenses &amp; Other Long Term Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,581&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(903)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,709&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Montclair</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued Expenses</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Heart and Lung Limited</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued Expenses &amp; Other Long Term Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,814&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">566&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,656&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">   </span></div><div style="margin-top:5pt;text-align:justify;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Fair Value Measurements section below for the fair value of contingent consideration at December 31, 2022.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FAIR VALUE MEASUREMENTS &#8211; Assets and liabilities subject to fair value measurements are required to be disclosed within a fair value hierarchy. The fair value hierarchy ranks the quality and reliability of inputs used to determine fair value. Accordingly, assets and liabilities carried at, or permitted to be carried at, fair value are classified within the fair value hierarchy in one of the following categories based on the lowest level input that is significant to a fair value measurement:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;1&#8212;Fair value is determined by using unadjusted quoted prices that are available in active markets for identical assets and liabilities.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;2&#8212;Fair value is determined by using inputs other than Level&#160;1 quoted prices that are directly or indirectly observable. Inputs can include quoted prices for similar assets and liabilities in active markets or quoted prices for identical assets and liabilities in inactive markets. Related inputs can also include those used in valuation or other pricing models such as interest rates and yield curves that can be corroborated by observable market data.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;3&#8212;Fair value is determined by using inputs that are unobservable and not corroborated by market data. Use of these inputs involves significant and subjective judgment.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Derivatives:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the estimated fair values of certain of our financial assets that are subject to fair value measurements, and the classification of these assets in our consolidated balance sheets, as follows (in thousands):</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Current Assets and Deposits and Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 SWAPS - Interest Rate Contracts</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,302&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,302&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other non-current liabilities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 SWAPS - Interest Rate Contracts</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,319&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,319&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of these contracts was determined using Level 2 inputs. More specifically, the fair value was determined by calculating the value of the difference between the fixed interest rate of the interest rate swaps and the counterparty&#8217;s forward LIBOR curve. The forward LIBOR curve is readily available in the public markets or can be derived from information available in the public markets.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Contingent Consideration:</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the estimated fair values of contingencies and holdback relating to our Aidence Holding B.V. and Quantib B.V. acquisitions on January 20, 2022, and the Heart and Lung Imaging Limited acquisition on November 1, 2022 that are subject to fair value measurements and the classification of these liabilities on our consolidated balance sheets, as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:49.779%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.632%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other non-current liabilities</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aidence Holding B.V. milestone consideration</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quantib B.V. holdback of 113,303 shares of RadNet common stock</span></div></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,709&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,709&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Montclair Radiological Associates</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Heart and Lung Imaging Limited</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,656&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,656&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of these liabilities was determined using Level 3 inputs.  For Aidence Holding B.V., the  milestone contingent liability was adjusted to fair value based on the yield rate of S&amp;P B-rated corporate bonds and the probability of FDA approval.  For the Quantib B.V holdback shares, the fair value was determined by calculating the value of estimated shares issuable as of the reporting date (which was $18.83) translated at the current exchange rate at December 31, 2022, the time period related to the contractual settlement term, and the probability of issuing the shares.  For Montclair Radiological Associates the contingent consideration is determined by obtaining specific EBITDA targets within a defined time frame.  For Heat Lung Imaging Limited the contingent consideration is determined by the achievement of a specific number of physician reads.  As significant inputs for the contingent consideration of Aidence B.V., Quantib B.V., Montclair Radiological Associates and Heart Lung Imaging Limited are not observable and cannot be corroborated by observable market data they are classified as Level 3.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Long Term Debt</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the estimated fair value and carrying amount of our Truist (Term Loan Agreement) and Barclays (First Lien Term Loans) long-term debt as follows (in thousands):</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:46.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.713%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Face Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan Agreement and First Lien Term Loans</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">843,594&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">843,594&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">864,125&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:46.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.713%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Face Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan Agreement and First Lien Term Loans</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">766,973&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">766,973&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">767,875&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Barclays revolving credit facility had no aggregate principal amount outstanding as of December 31, 2022 and December 31, 2021, respectively.  Our Truist revolving credit facility had no aggregate principal amount outstanding as of December 31, 2022 and December 31, 2021, respectively.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair values of our long-term debt, which is discussed in Note 8, was determined using Level 2 inputs for the Barclays and Truist term loans. Level 2 inputs primarily related to comparable market prices.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider the carrying amounts of cash and cash equivalents, receivables, other current assets, current liabilities and other notes payables to approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization or payment. Additionally, we consider the carrying amount of our capital lease obligations to approximate their fair value because the weighted average interest rate used to formulate the carrying amounts approximates current market rates.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EARNINGS PER SHARE - Earnings per share is based upon the weighted average number of shares of common stock and common stock equivalents outstanding, net of common stock held in treasury, as follows (in thousands except share and per share data):</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to RadNet, Inc. common stockholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,650&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,727&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,840)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BASIC NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding during the period</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,293,336&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,496,679&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,891,791&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net income (loss) per share attributable to RadNet, Inc. common stockholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.19&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.47&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.29)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DILUTED NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</span></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,293,336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,496,679&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,891,791&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add nonvested restricted stock subject only to service vesting</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,139&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259,539&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add additional shares issuable upon exercise of stock options, warrants and holdback shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">855,395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">664,815&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares used in calculating diluted net income per share</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,320,870&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,421,033&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,891,791&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in fair value associated with contingently issuable shares</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(724)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to RadNet, Inc's common stockholders for diluted share calculation</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$9,926</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$24,727</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(14,840)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net income (loss) per share attributable to RadNet, Inc. common stockholders</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and non-vested restricted awards excluded from the computation of diluted per share amounts as their effect would be antidilutive:</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested restricted stock subject to service vesting</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329,159&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issuable upon the exercise of stock options</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152,723&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,792&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">554,444&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">INVESTMENTS IN EQUITY SECURITIES- As of December 31, 2022, we have three equity investments for which a fair value is not readily determinable and we do not have significant influence and therefore the total amounts invested are recognized at cost.  In accordance with accounting guidance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">if there is no readily determinable fair value, the guidance allows entities the ability to measure investments at cost less impairment, whereby impairment is based on a qualitative assessment.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medic Vision, based in Israel, specializes in software packages that provide compliant radiation dose structured reporting and enhanced images from reduced dose CT scans.  Our investment of $1.2 million, represents a 14.21% equity interest in the company.  No observable price changes or impairment in our investment was noted as of the year ended December 31, 2022.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Turner Imaging Systems, based in Utah, develops and markets portable X-ray imaging systems that provide a user the ability to acquire X-ray images wherever and whenever they are needed. On February 1, 2018, we purchased 2.1 million preferred shares in Turner Imaging Systems for $2.0 million.  On January 1, 2019 we funded a convertible promissory note in the amount of $0.1 million that converted to an additional 80,000 preferred shares on October 11, 2019.  No observable price changes or impairment in our investment was noted for the year ended December 31, 2022.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WhiteRabbit.ai Inc., based in California, is currently developing an artificial intelligence suite which aims to improve the speed and accuracy of cancer detection in radiology and improve patient care. On November 5, 2019 we acquired an equity interest in the company for $1.0 million and also loaned the company $2.5 million in support of its operations.  No observable price changes or impairment in our investment was noted for the year ended December 31, 2022.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">INVESTMENT IN JOINT VENTURES &#8211; We have 13 unconsolidated joint ventures with ownership interests ranging from 35% to 55%. These joint ventures represent partnerships with hospitals, health systems or radiology practices and were formed for the purpose of owning and operating diagnostic imaging centers.&#160;&#160;Professional services at the joint venture diagnostic imaging centers are performed by contracted radiology practices or a radiology practice that participates in the joint venture.&#160;&#160;Our investment in these joint ventures is accounted for under the equity method, as we do not have a controlling financial interest in such ventures. We evaluate our investment in joint ventures, including cost in excess of book value (equity method goodwill) for impairment whenever indicators of impairment exist. No indicators of impairment existed as of December 31, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Joint venture investment and financial information</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of our investment in joint ventures during the years ended December 31, 2022 and December 31, 2021 (in thousands):</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:84.090%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.710%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,528&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity contributions in existing and purchase of interest in joint ventures</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,441&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in earnings in these joint ventures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,967&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distribution of earnings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,707)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,229&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity contributions in existing and purchase of interest in joint ventures</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,712&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in earnings in these joint ventures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,390&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distribution of earnings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,438)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,893&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We charged management service fees from the centers underlying these joint ventures of approximately  $22.2 million, $19.6 million and $11.3 million for the years ended December 31, 2022, 2021 and 2020, respectively.  We eliminate any unrealized portion of our management service fees with our equity in earnings of joint ventures.  As we have the ability to exercise significant influence over our joint venture entities, we consider them related parties.  Amounts transacted between ourselves and the entities in the ordinary course of business are disclosed on our balance sheet in the due from/to affiliate accounts.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of key unaudited financial data for these joint ventures as of December 31, 2022 and 2021, respectively, and for the years ended December 31, 2022, 2021 and 2020, respectively, (in thousands):</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance Sheet Data:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,304&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,186&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134,694&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,592&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29,588)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,919)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,952)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,370)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net assets</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,458&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,489&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Book value of RadNet joint venture interests</span></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,564&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,930&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost in excess of book value of acquired joint venture interests accounted for as equity method goodwill</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,329&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,299&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total value of RadNet joint venture interests</span></td><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,893&#160;</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,229&#160;</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145,256&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129,023&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,921&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,169&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,893&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,850&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;text-align:justify"><span><br/></span></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December 31, 2022 and 2021, we made an additional equity contributions of $1.4 million each year to Arizona Diagnostic Radiology Group ("ADRG", our joint venture with Dignity Health).</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2022, we contributed eight of our imaging centers to ADRG of $12.7 million and recorded a loss of $0.5 million which was calculated as the difference between the sale price and carrying value of such imaging centers which included equipment and other assets and an allocation of goodwill to such imaging centers.  We recorded $4.5 million of the sale price as an offset to due to affiliates while the remaining $8.3 million was recorded as investment in joint venture on our balance sheet.  We accounted for the transaction as an adjustment to our equity investment for the value of the assets contributed.  To maintain our 49% economic interest in ADRG, we received a distribution from the partnership of $4.5 million to reduce our overall investment to $8.3 million.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140483008326352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RECENT ACCOUNTING STANDARDS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract', window );"><strong>Accounting Standards Update and Change in Accounting Principle [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock', window );">RECENT ACCOUNTING STANDARDS</a></td>
<td class="text">RECENT ACCOUNTING STANDARDS<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting standards adopted</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Over the course of 2020 through 2022, the FASB issued different Accounting Standards Updates (ASUs) in regards to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848).  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASU 2020-04 and ASU 2021-01 addressed optional expedients and exceptions for applying generally accepted accounting principals to certain contract modifications, hedging relationships, and derivatives that referenced London Inter-bank Offered Rate (LIBOR) or another reference rate expected to be discontinued.  The provisions originally were set to expire on December 31, 2022.  The date of LIBOR cessation was finalized as June 30, 2023, which is beyond the current sunset date of Topic 848 and hence the need to extend the time allotted for accounting relief. ASU 2022-06 deferred the sunset date of the provision out to December 31, 2024. The adoption of the provisions under these ASUs did not have a material effect on our consolidated financial statements.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, the FASB issued ASU 2021-10 ("ASU 2021-10"), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Assistance (Topic 832), Disclosures by Business Entities about Government Assistance.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASU 2021-10 requires entities to provide disclosures on material government assistance transactions for annual reporting periods. The disclosures include information around the nature of the assistance, the related accounting policies used to account for government assistance, the effect of government assistance on the entity&#8217;s financial statements, and any significant terms and conditions of the agreements, including commitments and contingencies. The new standard was effective for financial statements issued for annual reporting periods beginning after December 15, 2021. As ASU 2021-10 only impacts annual financial statement footnote disclosures, the adoption did not have a material effect on our consolidated financial statements.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the FASB issued ASU 2021-08 ("ASU 2021-08"), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations (Topic 805), Accounting for Contract Assets and Contract Liabilities from Contracts with Customers.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASU 2021-08 requires an acquirer in a business combination to recognize and measure contract assets and contract liabilities in accordance with Accounting Standards </span></div>Codification Topic 606. ASU 2021-08 is effective for fiscal years beginning after December 15, 2022 and early adoption is permitted. The adoption did not have a material effect on our consolidated financial statements.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI https://asc.fasb.org/topic&amp;trid=2122394<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126986314&amp;loc=SL124402458-218513<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126986314&amp;loc=SL124402458-218513<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 11.M.Q2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038215&amp;loc=d3e31137-122693<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL122150809-237846<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=122038215&amp;loc=SL108384541-122693<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL126732908-238011<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (f)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL126732908-238011<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL126732908-238011<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140483011097552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS COMBINATIONS AND RELATED ACTIVITY<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock', window );">BUSINESS COMBINATIONS AND RELATED ACTIVITY</a></td>
<td class="text">BUSINESS COMBINATIONS AND RELATED ACTIVITY<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Imaging Center Segment</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022 and 2021, we completed the acquisition of certain assets of the following entities, which either engage directly in the practice of radiology or associated businesses.  The primary reason for these acquisitions was to strengthen our presence in the Delaware, Maryland, New Jersey and New York markets.  We made a fair value determination of the acquired assets and assumed liabilities and the following were recorded (in thousands):</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">2022:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"/><td style="width:12.734%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.133%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.478%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.922%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.975%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.170%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.934%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Entity </span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date Acquired</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Purchase  Consideration</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property &amp; Equipment</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Assets</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible Assets</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IFRC LLC*^</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/1/2022</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,200</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,910</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,703</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,271</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,703)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IFRC LLC*^</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/1/2022</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,800</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,103</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">857</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,697</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(857)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Montclair Radiological Associates, P.A.*#</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10/1/2022</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,877</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,414</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,665</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,690</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,168)</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,124)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Heart and Lung Imaging Limited+</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/1/2022</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,000</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,200</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,800</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chelsea Diagnostic Radiology, P.C.*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/1/2022</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,800</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,132</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North Jersey Imaging Center, LLC*</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/9/2022</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$142,781</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$22,015</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$7,225</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$106,045</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$16,325</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$(2,145)</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$(6,684)</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*Fair Value Determination is Final</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">^ IFRC LLC acquisitions consisted of three subsidiaries of IFRC, one of which was purchased separately by a joint venture with Calvert Medical Imaging Centers, LLC.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">#</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Montclair Radiological Associates includes a liability for $1.2 million in contingent consideration.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">+See detailed description of the Heart and Lung Imaging Limited acquisition below. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">2021:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.502%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.600%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Entity </span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date Acquired</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Purchase  Consideration</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property &amp; Equipment</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Assets</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible Assets</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personal Health Imaging PLLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/1/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,995</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">576</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">608</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,355</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(608)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP Elmont LLC*</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/1/2021</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,194</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,112</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,005</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP Freeport LLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/1/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,065</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,668</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,328</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Broadway Medical Imaging LLC*</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/1/2021</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,155</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,076</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(446)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3235 Hempstead LLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/1/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,386</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,667</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,649</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SLZM Realty LLC*</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/1/2021</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,671</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,617</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,974</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2012 Sunrise Merrick LLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/1/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,428</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,741</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,617</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(335)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP Bayside LLC*</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/1/2021</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,545</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,385</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,191</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,191)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP Laurelton LLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/1/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,658</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,530</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,418</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,418)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP Smith LLC*</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/1/2021</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,978</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,581</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,214</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,214)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP 907 Northern LLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4/1/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">562</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">507</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,817</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,817)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">William M. Kelly MD, Inc.* ^</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5/1/2021</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,750</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">990</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,379</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,710</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,379)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60th Street MRI, LLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5/1/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP Parkchester LLC*</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5/1/2021</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(311)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP Eastern LLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6/1/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,868</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,801</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,951</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,951)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tangent Associates LLC**</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/24/2021</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,025</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">379</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,636</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mid Delaware Imaging P.A.</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/1/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,023</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,260</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">William M. Kelly MD, Inc.* ^</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/6/2021</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,404</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">701</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,653</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">William M. Kelly MD, Inc.* ^</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/31/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,346</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,197</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(323)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$79,716</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$35,949</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$12,993</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$40,864</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$2,671</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$232</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$(12,993)</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*Fair Value Determination is Final</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">** All stock purchase through issuing 67,658 shares of our common stock.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">^ William M. Kelly MD acquisitions consisted of various subsidiaries purchased separately.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Heart and Lung Imaging Limited</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On November 1, 2022, we acquired a 75% controlling interest in Heart and Lung Imaging Limited (&#8220;HLI&#8221;).  HLI is a teleradiology concern which operates in the United Kingdom with the National Healthcare Service to screen high risk populations for cardiac and lung conditions.  HLI&#8217;s operations are included in our imaging center segment for reporting purposes. The transaction was accounted for as the acquisition of a business with a total purchase consideration of approximately $31.9 million, including: i) shares with a fair value of $6.8 million (359,002 shares issued at $19.06 per share), ii) cash of $6.3 million and iii) contingent consideration of $10.8 million ($10.2 million in contingent milestone consideration and cash holdback of $0.6 million to be issued 24 months after acquisition subject to adjustment for any indemnification claims) and iv) noncontrolling interest of $8.0 million. We recorded $0.6 million in current assets, $15.8 million in intangible assets, $0.6 million current liabilities and $16.2 million in goodwill in connection with this transaction.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As part of the purchase price allocation, we determined the identifiable intangible assets are customer relationships and trade names. The fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using a rate of 19.0%. The cash flows were based on estimated earnings from existing customers, and the discount rate applied was benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Artificial Intelligence Segment</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Aidence Holding B.V.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On January 20, 2022, we completed our acquisition of all the equity interests of Aidence Holding B.V. ("Aidence") an artificial intelligence enterprise focused on lung cancer screening.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Aidence is reported as part of our artificial intelligence segment and was acquired to enhance our AI capabilities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The transaction was accounted for as an acquisition of a business and total purchase consideration was determined to be approximately $45.2&#160;million including i) 1,117,872 shares issued at $26.80 per share with a fair value of $30.0&#160;million ii) cash of $1.8&#160;million and iii) contingent consideration of $11.9&#160;million ($7.4&#160;million in milestones to be settled in shares or cash at our election and a share holdback of $4.5&#160;million) and iv) a settlement of a loan from RadNet of $1.5&#160;million.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In addition we paid certain seller closing costs through the issuance of 23,362 shares at a fair value of $0.6&#160;million.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As a result of this transaction, we recorded $1.0&#160;million in current assets, $0.2&#160;million in property and equipment, $27.7&#160;million in intangible assets (including developed technology of $21.1&#160;million and IPR&amp;D of $5.5&#160;million), $3.2&#160;million in current liabilities, a deferred tax liability of $3.5&#160;million, and $22.9&#160;million in goodwill.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In performing the purchase price allocation, we considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of the Aidence business.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As part of the purchase price allocation, we determined the identifiable intangible assets are developed technology, IPR&amp;D, trade names, and customer relationships. The fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using rates ranging from 15% to 17%. The cash flows were based on estimates used to price the transaction, and the discount rates applied were benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The developed technology consists of artificial intelligence powered applications for lung nodule management and early lung cancer diagnosis and reporting.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The IPR&amp;D asset relates primarily to an in-process project for a customer relationship management offering to manage patients that are found with Incidental Pulmonary Nodules and has not reached technological feasibility as of the acquisition date. The asset recorded relates to one project, and the Company expects to complete the project in the next twelve months. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The useful lives for the developed technology asset was set at 7 years, for customer relationships 5.4 years, and trade names was 7 years. The calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. Factors contributing to the recognition of the amount of goodwill were primarily based on anticipated strategic and synergistic benefits that are expected to be realized from the acquisition. These benefits include expanding the Company's AI capabilities to drive revenue growth.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Quantib B.V.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 20, 2022, we completed our acquisition of all the equity interests of Quantib B.V. ("Quantib") an artificial intelligence enterprise focused on prostate cancer screening.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Quantib is reported as part of our artificial intelligence segment, and was acquired to enhance our AI capabilities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transaction was accounted for as an acquisition of a business and total purchase consideration was determined to be approximately $42.3&#160;million including i) 965,058 shares issued at $26.80 per share with a fair value of $25.9&#160;million ii) cash of $11.8&#160;million and iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">contingent consideration consisting of 113,303 shares with a fair value at the date of close of $3.0&#160;million and cash of $1.6&#160;million both to be released 18 months after acquisition subject to adjustment for any indemnification claims. As a result of this transaction, we recorded $2.4&#160;million in current assets, $0.1&#160;million in property and equipment, $21.3&#160;million in intangible assets (including developed technology of $19.6&#160;million and IPR&amp;D of $0.7&#160;million), $0.7&#160;million in current liabilities, $6.7&#160;million in long-term debt and deferred tax liabilities, and $26.4&#160;million in goodwill.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In performing the purchase price allocation, we considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of the Quantib business.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As part of the purchase price allocation, we determined the identifiable intangible assets are developed technology, IPR&amp;D, trade names, and customer relationships. The fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using rates ranging from 50% to 55%. The cash flows were based on </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">estimates used to price the transaction, and the discount rates applied were benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The developed technology consists of artificial intelligence powered applications for neurological and prostate imaging scans and reporting.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The useful lives for the developed technology asset was set at seven years, customer relationships three years, and trade names seven years. The calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. Factors contributing to the recognition of the amount of goodwill were primarily based on anticipated strategic and synergistic benefits that are expected to be realized from the acquisition. These benefits include expanding the Company's AI capabilities to drive revenue growth.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As disclosed above, for the acquisitions of Aidence and Quantib, the Company uses the income approach to determine the fair value of developed technology and IPR&amp;D acquired in business combinations. This approach determines fair value by estimating the after-tax cash flows attributable to the respective assets over their useful lives and then discounting these after-tax cash flows back to a present value. The Company bases its revenue assumptions on estimates of relevant market sizes, expected market growth rates, expected trends in technology and expected product introductions by competitors. The value of the in-process projects is based on the project's stage of completion, the complexity of the work completed as of the acquisition date, the projected costs to complete, the expected introduction date, the estimated cash flows to be generated upon commercial release and the estimated useful life of the technology. The Company believes that the estimated developed technology and IPR&amp;D amounts represent the fair value at the date of acquisition and do not exceed the amount a third-party would pay for the assets. The significant assumptions used to estimate the fair value of intangible assets include discount rates and certain assumptions that form the basis of the forecasted results, specifically, revenue growth rates, EBITDA margins and obsolescence factors. These significant assumptions are forward looking and could be affected by future economic and market conditions.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Subsidiary activity</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Formation of majority owned subsidiaries</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Frederick County Radiology, LLC</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2022 we formed Frederick County Radiology, LLC ("FCR"), a partnership with Frederick Health Hospital, Inc. ("Hospital").  The operation offers multi-modality services out of six locations in Frederick, Maryland.  We contributed the operations of four centers to the enterprise and Hospital contributed $5.4 million in fixed assets, $3.0 million in equipment, and  $11.0 million in goodwill.  As a result of the transaction, we recognized a gain of $6.6 million to additional paid in capital and retained a 65% controlling economic interest in FCR and Hospital retains an $11.1 million or 35% noncontrolling economic interest in FCR.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Advanced Radiology at Capital Region, LLC</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 15, 2022 we entered into Advanced Radiology at Capital Region, LLC, a partnership with Dimension Health Corporation. ("Dimension"), an affiliate of the University of Maryland.  The operation will provide multi-modality services out of two yet to be determined locations in the Largo, Maryland area.  The venture was initially capitalized with nominal amounts of $5.1&#160;thousand for a 51% economic interest  from us and $4.9&#160;thousand from Dimension for a 49% economic interest.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Simi Valley Imaging Group, LLC</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2021 we entered into the Simi Valley Imaging Group, LLC, a partnership with Simi Valley Hospital and Health Services ("Simi Adventist").  The operation will offer multi-modality imaging services out of two locations in Ventura County, California.  Total investment in the venture is $0.4 million. RadNet contributed $0.3 million in assets for a 60.0% economic interest and Simi Adventist contributed assets totaling $0.1 million for a 40.0% economic interest.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sale of ownership interest  in a majority owned subsidiary</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective September 1, 2021 we completed the sale of a 24.9% ownership interest in our majority owned subsidiary West Valley Imaging Group, LLC for $13.1 million to Tarzana Medical Center, LLC.  After the sale, our ownership interest in the subsidiary has reduced from 75.0% to 50.1% and we retain a controlling financial interest in the subsidiary.  We recognized in additional paid in capital on our consolidated balance sheets, $4.2 million excess in consideration over the carrying value of the sold economic interest.  Post the sale of our ownership interest we acquired from Tarzana Medical Center, LLC, certain tangible and intangible business assets for purchase consideration of approximately $5.2 million.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures. This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=2122178<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI https://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140483099688784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT REPORTING<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">SEGMENT REPORTING</a></td>
<td class="text">SEGMENT REPORTING<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our reportable segments are described below:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Imaging Center</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. The vast majority of our centers offer multi-modality imaging services, a strategy that diversifies revenue streams, reduces exposure to reimbursement changes and provides patients and referring physicians one location to serve the needs of multiple procedures.  We also provide teleradiolgy services in the United Kingdom though our Heart&amp;Lung Health subsidiary.  Included in the segment is our eRad subsidiary, which designs the underlying critical scheduling, data storage and retrieval systems necessary for imaging center operation.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Artificial Intelligence ("AI")</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our AI segment develops and deploys clinical applications to enhance interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our chief operating decision maker ("CODM"), who is also our CEO, evaluates the financial performance of our segments based upon their respective revenue and segmented internal profit and loss statements prepared on a basis not consistent with GAAP.  We do not report balance sheet information by segment since it is not reviewed by our CODM.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The table below present segment information reconciled to our financial results, with segment operating income or loss including revenue less cost of operations, depreciation and amortization, and other operating expenses to the extent specifically identified by segment (in thousands):</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.619%"><tr><td style="width:1.0%"/><td style="width:32.994%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.965%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.410%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.965%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:1.999%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.967%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Twelve Months Ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Revenue:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,425,665&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,313,662&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,071,840&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,396&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,415&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total revenue</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,430,061&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,315,077&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,071,840&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Cost of Operations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,240,593&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,130,543&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">967,250&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">23,753&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5,333&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,822&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total cost of operations</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,264,346&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,135,876&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">970,072&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:23pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 8.2pt;text-indent:-7.2pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Depreciation and Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">109,524&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">96,174&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">86,396&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6,353&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">520&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">399&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total depreciation and amortization</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">115,877&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">96,694&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">86,795&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 8.2pt;text-indent:-7.2pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Loss on Disposal of Equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,506&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,319&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,200&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total loss (gain)</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,529&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,319&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,200&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Severance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">926&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">744&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,353&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total severance</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">946&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">744&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,353&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Income from Operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">72,116&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">77,882&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">12,641&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(25,753)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(4,438)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(3,221)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total income from operations</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">46,363&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">73,444&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">9,420&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For proper comparative purposes, Imaging Center segment revenue for the years 2021 and 2020 exclude Provider Relief Funding of $9.1 million and $26.3 million for the twelve months ended December 31, 2021 and 2020, respectively as it represents a form of direct Government stimulus.  No such funds were received for the twelve months ended December 31, 2022.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI https://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140483006391872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">GOODWILL AND OTHER INTANGIBLE ASSETS</a></td>
<td class="text">GOODWILL AND OTHER INTANGIBLE ASSETS<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is recorded as a result of business combinations. The following is a reconciliation of Goodwill by business segment for the years ended December 31, 2021 and December 31, 2022 is provided below (in thousands):</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">                </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.672%"><tr><td style="width:1.0%"/><td style="width:33.882%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.482%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.596%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.482%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.937%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.482%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.139%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Imaging Center</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Artificial Intelligence</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">448,269&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,610&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">472,879&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,864&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,864&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Measurement period and other adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489,210&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,610&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">513,820&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,551&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,697&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169,248&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disposals</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,200)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,200)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Measurement period and other adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(106)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,028&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,272)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,244)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">606,483&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,182&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">677,665&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of goodwill from these acquisitions that is deductible for tax purposes as of December 31, 2022 is $154.9 million.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other intangible assets are primarily related to our business combinations and software development.  They include the estimated fair values of such items as service agreements, customer lists, covenants not to compete, acquired technologies, and trade names.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total amortization expense was $10.1 million, $4.4 million, and $3.7 million for the years ended December 31, 2022, 2021 and 2020, respectively.  Intangible assets are amortized using the straight-line method over their useful life determined at acquisition. Management service agreements are amortized over 25 years using the straight line method.  Software development is capitalized and amortized over the useful life of the software when placed into service.  Trade names are reviewed annually for impairment.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables shows annual amortization expense, by asset classes that will be recorded over the next five years (in thousands):&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:22.464%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.332%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted average amortization period remaining in years</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Management Service Contracts</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,287&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,287&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,287&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,287&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,287&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,958&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20,393&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8.9</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Covenant not to compete and other contracts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,319&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">891&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">642&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">356&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,320&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.1</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Customer Relationships</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,244&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,244&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,112&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">991&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">816&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,396&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,803&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18.6</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Patent and Trademarks</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">298&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">298&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">298&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">298&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">298&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">322&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,812&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.4</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Developed Technology &amp; Software</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,297&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,297&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,297&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,257&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,722&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,196&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">38,066&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.7</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trade Names amortized</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">702&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.5</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trade Names indefinite life</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,100&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,100&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">IPR&amp;D</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,032&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,032&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Annual Amortization</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,750&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,094&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,713&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,266&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,272&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">53,133&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">106,228&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI https://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140483006068048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">PROPERTY AND EQUIPMENT</a></td>
<td class="text">PROPERTY AND EQUIPMENT<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment and accumulated depreciation and amortization are as follows (in thousands):</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical equipment</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">649,034&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560,301&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer and office equipment, furniture and fixtures</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,467&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,766&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software development costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,015&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">501,963&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">441,921&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment originally acquired under finance/capital lease</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,971&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,984&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment cost</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,320,700&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,161,222&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(754,739)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(676,975)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">565,961&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">484,247&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in our property and equipment at December 31, 2022  is approximately $73.4 million total of construction in process amounts consisting of $26.6 million in medical equipment, $5.3 million in computer and office equipment, $0.4 million in software development and $41.1 million in leasehold improvements.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in our property and equipment at December 31, 2021 is approximately $18.1 million total of construction in process amounts consisting of $2.6 million in medical equipment, $6.1 million in computer and office equipment, and $9.3 million in leasehold improvements.</span></div>Depreciation and amortization expense of property and equipment, including amortization of equipment under finance leases, for the years ended December 31, 2022, 2021 and 2020 was $105.6 million, $92.3 million, and $83.1 million, respectively.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI https://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140483006088000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CREDIT FACILITIES AND NOTES PAYABLE<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">CREDIT FACILITIES AND NOTES PAYABLE</a></td>
<td class="text">CREDIT FACILITIES AND NOTES PAYABLE<div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022 and December 31, 2021 our debt obligations consisted of the following (in thousands):</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Lien Term Loans collateralized by RadNet's tangible and intangible assets</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">714,125&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">721,375&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount on First Lien Term Loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,127)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,213)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan Agreement collateralized by NJIN's tangible and intangible assets</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,000&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,500&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount on NJIN Term Loan Agreement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,254)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt obligations</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">851,744&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">754,662&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,400)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,164)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term portion debt obligations</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">839,344&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743,498&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a listing of annual principal maturities of notes payable exclusive of all related discounts and repayments on our revolving credit facilities for years ending December&#160;31 (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:84.090%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.710%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,750&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,750&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,500&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,500&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,750&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">677,875&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total notes payable obligations</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">864,125&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had no outstanding balance under our $195.0 million Barclays Revolving Credit Facility at December 31, 2022 and had reserved an additional $7.6 million for certain letters of credit.  The remaining $187.4 million of our Barclays Revolving Credit Facility was available to draw upon as of  December 31, 2022.  We also had no balance under our $50.0 million Truist Revolving Credit Facility related to our consolidated subsidiary NJIN at December 31, 2022, and with no letters </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of credit reserved against the facility, the full amount was available to draw upon. At December 31, 2022 we were in compliance with all covenants under our credit facilities.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Amendments to Credit Facilities</span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Barclays: Second Amended and Restated First Lien Credit and Guaranty Agreement</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 23, 2021, we entered into the Second Amended and Restated First Lien Credit and Guaranty Agreement (the  "Restated Credit Agreement") which provides for $725.0 million of senior secured first lien term loans (the "First Lien Term Loans") and a $195.0 million senior secured revolving credit facility (the "Barclays Revolving Credit Facility"). The proceeds of the First Lien Term Loans were used to refinance loans outstanding under our prior first lien credit agreement and provide funding for current and future operations. Total costs of the Restated Credit Agreement amounted to approximately $14.9 million segregated as follows: $8.8 million capitalized to discount and deferred finance cost, $6.0 million charged to loss on early extinguishment of debt and related expenses and $0.1 million written off to interest expense.  Amounts capitalized will be amortized over the remaining terms of the respective credit facilities under the Restated Credit Agreement.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Truist: Second Amended and Restated Revolving Credit and Term Loan Agreement</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 7, 2022, we entered into the Second Amended and Restated Revolving Credit and Term Loan Agreement (the "Restated Credit and Term Loan Agreement") which provides for a $150.0 million of a secured term loan (the "Truist Term Loan") and a $50.0 million secured revolving credit facility (the "Truist Revolving Credit Facility").  Both loans were secured by our simultaneous entry into the Second Amended and Restated Guaranty and Security Agreement on the same date.  The proceeds were were used to refinance the outstanding balance under our prior term loan agreement and provide funding for current and future operations. Total costs of the Restated Credit and Term Loan Agreement amounted to approximately $2.7 million segregated as follows: $2.0 million capitalized to discount and deferred finance cost and $0.7 million expensed to loss on extinguishment of debt and related expenses in other expense.  Amounts capitalized will be amortized over the remaining terms of the respective credit facilities under the Restated Credit and Term Loan Agreement.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All obligations under the Second Amended and Restated Credit and Term Loan Agreement bear interest at either a SOFR or a Base Rate (each as defined in the Restated Credit and Term Loan Agreement), plus an applicable margin according to the following schedule:</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.128%"><tr><td style="width:1.0%"/><td style="width:8.790%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.761%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.226%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.226%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.697%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.700%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pricing Level</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Leverage Ratio</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Applicable Margin for SOFR Loans</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Applicable Margin for Base Rate Loans</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Applicable Margin for Letter of Credit Fees</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Applicable Percentage for Commitment Fee</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than or equal to 3.00:1.00</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.50%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.50%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.45%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">II</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 3.00:1.00 but greater than or equal to 2.50:1.00</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.25%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.40%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">III</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 2.50:1.00 but greater than or equal to</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00:1.00</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.00%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.35%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IV</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 2.00:1.00 but greater than or equal to 1.50:1.00</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.75%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.75%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.75%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.30%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">V</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 1.50:1.00</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.50%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.30%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Senior Credit Facilities:</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;text-decoration:underline">First Lien Term Loans:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The First Lien Term Loans under the Restated Credit Agreement bear interest at either a Eurodollar Rate or an Alternate Base Rate (in each case, as defined in the Restated Credit Agreement), plus an applicable margin.  The applicable </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">margin for Eurodollar Rate term loans under the Restated Credit Agreement is 3.25% per annum, with a reduction to 3.0% per annum upon delivery by us of financial statements evidencing a first lien net leverage ratio of 3.50 to 1.00 or less.  Such statements were delivered by us on May 27, 2021. At December 31, 2022 the effective Eurodollar Rate and the Alternate Base Rate for the First Lien Term Loans under the Restated Credit Agreement was 4.73% and 7.50%, respectively and the applicable margin for the Eurodollar Rate and Alternate Base Rate First Lien Term Loans under the Restated Credit Agreement was 3.00% and 2.00%, respectively.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Restated Credit Agreement provides for quarterly payments of principal for the First Lien Term Loan in the amount of approximately $1.8 million.  The  First Lien Term Loan will mature on April 23, 2028 unless otherwise accelerated under the terms of the Restated Credit Agreement.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Truist Term Loan:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Truist Term Loan currently bears interest at a three month SOFR election of 4.28% plus an applicable margin and fees based on Pricing Level III described above.</span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The scheduled amortization of the Truist Term Loan begins March 31, 2023 with quarterly payments of $1.9 million, representing 1.00% of the original principal balance. At scheduled intervals, the quarterly amortization increases by $0.9 million, with the remaining balance to be paid at maturity.  The Truist Term Loan will mature on October 10, 2027 unless otherwise accelerated under the terms of the  Credit Agreement.</span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:54pt"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Revolving Credit Facilities:</span></div><div style="padding-right:4.5pt;text-align:justify"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Barclays Revolving Credit Facility:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Barclays Revolving Credit Facility under the Restated Credit Agreement is a $195.0 million senior secured revolving credit facility. Associated with the Barclays Revolving Credit Facility are deferred financing costs, net of accumulated amortization, of $1.7 million at December 31, 2022.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revolving loans borrowed under the Barclays Revolving Credit Facility bear interest at either a Eurodollar Rate or an Alternate Base Rate (in each case, as defined in the Restated Credit Agreement) plus an applicable margin which adjusts depending on our first lien net leverage ratio, according to the following schedule:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.181%"><tr><td style="width:1.0%"/><td style="width:31.850%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.342%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.508%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">First Lien Leverage Ratio</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Eurodollar Rate Spread</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Base Rate Spread</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&gt; 3.50x</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.25%</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25%</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&gt; 3.00x but &#8804; 3.50x</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.00%</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00%</span></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8804; 3.00x</span></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.75%</span></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.75%</span></div></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, the effective interest rate for borrowings on revolving loans under the Barclays Revolving Credit Facility stood at 9.5%.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For letters of credit issued under the Barclays Revolving Credit Facility, letter of credit fees accrue at the applicable margin for Eurodollar rate revolving loans which is currently 3.00% and fronting fees accrue at 0.125% per annum, in each case on the average aggregate daily maximum amount available to be drawn under all letters of credit issued under the Restated Credit Agreement. In addition, a commitment fee of 0.50% per annum accrues on the unused revolver commitments under the Barclays Revolving Credit Facility.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Barclays Revolving Credit Facility will terminate on April 23, 2026 unless otherwise accelerated in accordance with the terms of the Restated Credit Agreement.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Truist Revolving Credit Facility:</span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Associated with the Truist Revolving Credit Facility of $50.0 million are deferred financing costs, net of accumulated amortization, of  $0.6 million at December 31, 2022.  As of December 31, 2022, NJIN had no borrowings under the Truist Revolving Credit Facility. </span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:54pt"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Truist Revolving Credit Facility bears interest with different margins based on types of borrowings at a Pricing Level III as noted in the pricing grid above.  The Truist Revolving Credit Facility terminates on the earliest of (i) </span></div><div style="padding-right:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">October 7, 2027, (ii) the date on which the Revolving Commitments are terminated pursuant to Section 2.8 of the Truist Restated Credit Agreement, or (iii) the date on which all amounts outstanding under the Truist Restated Credit Agreement have been declared or have automatically become due and payable (whether by acceleration or otherwise).  </span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:54pt"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Recent Amendments to prior Credit Facilities</span></div><div style="padding-right:4.5pt;text-align:justify"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Barclays Credit Facilities:</span></div><div style="margin-top:10pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 28, 2020, RadNet Management, Inc. and RadNet, Inc. entered into Amendment No. 8, Consent and Incremental Joinder Agreement to Credit and Guaranty Agreement (the "Eighth Amendment").  The Eighth Amendment amended the prior first lien credit agreement to add $57.5 million of revolving commitments to the prior Barclays revolving credit facility increasing the maximum borrowing capacity under the prior Barclays revolving credit facility to $195.0 million while leaving the maturity date of July 1, 2023 unchanged.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 18, 2019 we entered into the following two amendments to the prior first lien credit agreement: (i) Amendment No. 6, Consent and Incremental Joinder Agreement to Credit and Guaranty Agreement (the &#8220;Sixth Amendment&#8221;); and (ii) Amendment No. 7 to Credit and Guaranty Agreement (the &#8220;Seventh Amendment&#8221;).  Among other things, the Sixth Amendment amended the prior first lien credit agreement to issue $100.0 million in incremental first lien term loans and to add an additional $20.0 million of revolving commitments to the prior Barclays revolving credit facility.  The Seventh Amendment amended the prior first lien credit agreement to extend the maturity date of the prior Barclays revolving credit facility by an additional two years to July 1, 2023, unless sooner terminated in accordance with the terms of the prior first lien credit agreement.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The prior first lien credit agreement was amended and restated by the Restated Credit Agreement described above, and the prior first lien term loans and prior Barclays revolving credit facility under the prior first lien credit agreement were refinanced and replaced by the First Lien Term Loans and the Barclays Revolving Credit Facility provided under the Restated Credit Agreement described above.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;text-decoration:underline">Truist Credit Facilities:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On August 31, 2018, under the Amended and Restated Revolving Credit and Term Loan Agreement (A&amp;R Agreement), NJIN secured a term loan commitment of $60.0 million and established revolving credit facility of $30.0 million.  The agreement had a maturity date of August 31, 2023 and was refinanced on October 10, 2022 by the Second Amended and Restated Revolving Credit and Term Loan Agreement.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-top:10pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Paycheck Protection Program</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Paycheck Protection Program (PPP) includes funds available for loans to small business and Medicare providers to support operations during the COVID-19 pandemic. The funds are administered by the Small Business Administration (SBA), through approved lenders and do not require collateral or personal guarantees.  We received our loans based on being a Medicare provider. The terms and conditions for participation require entities to certify that economic uncertainty related to the COVID-19 pandemic makes the loan necessary to support their current operations, and that they will use the funds to retain workers (e.g., by paying salaries, providing paid sick/medical leave and health insurance benefits) and pay certain debts (mortgage obligations) and expenses (e.g. rent, utilities, telephone).  The loans have a 1.0% fixed interest rate and are due in 2 years.  The loans are eligible for forgiveness subject to salary limitations and employee retention levels. Certain of our consolidated subsidiaries received four loans totaling $4.0 million.  We accounted for the funds received as debt and recorded a liability for the full amount of proceeds received and accrued interest over the term of the loans.  In December 2020 we met the eligibility requirements for forgiveness and the loans were written off to gain on debt extinguishment.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140483006176288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">LEASES</a></td>
<td class="text">LEASESOur material lease contracts are for facilities and advanced radiology equipment.   In regards to our imaging, administrative and warehouse facilities, the most common initial lease term varies in length from 5 to 15 years. Including renewal options negotiated with the landlord, we can have a total span of 10 to 35 years at these locations, and we do not enter into purchase options on the underlying property.  We also lease smaller satellite X-Ray locations on mutually renewable terms, usually lasting one year.  Leases for advanced radiology and office equipment have terms generally lasting from 5 to 8 years.  All leases are classified as operating or finance for accounting purposes, depending on the terms of the agreement.  Our Incremental Borrowing Rate ("IBR") used to discount the stream of lease payments is closely related to the interest rates <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">charged on our collateralized debt obligations and our IBR is adjusted when those rates experience a substantial change.  During 2021, we satisfied all liabilities classified as finance leases, and only operating leases remain.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The components of lease expense were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:58.197%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.251%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.252%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="6" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,475&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,578&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Depreciation of leased equipment</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,896&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,068&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Interest on lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total finance lease cost</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,896&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,114&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1) Operating lease cost above for the year ended December 31, 2021 included $12.6 million in lease abandonment charges.  Please see our discussion in the Leases section of Note 2, Summary of Significant Accounting Policies.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Supplemental cash flow information related to leases was as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="6" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Operating cash flows from operating leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,004&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,288&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Operating cash flows from financing leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Financing cash flows from financing leases</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,304&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use &amp; Equipment assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Operating leases</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,080&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186,695&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1) On December 31, 2021 we reduced our liability and eliminated the related right-of-use assets for future lease options at facilities that we elected to abandon.  The amount of liability and right-of-use asset reduction amounted to approximately $3.3 million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Supplemental balance sheet information related to leases was as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(In thousands, except lease term and discount rates)</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Leases</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">603,524&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">584,291&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liability</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,607&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,452&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">604,117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577,675&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total operating lease liabilities</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661,724&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">643,127&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance Leases</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment at cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,971&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,984&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTozNDY2MGIzODgyOWY0NDQ5YWU5YzQ1YmYzZTBlZmM1ZC90YWJsZXJhbmdlOjM0NjYwYjM4ODI5ZjQ0NDlhZTljNDViZjNlMGVmYzVkXzExLTAtMS0xLTI5NDg5_464c3404-1439-4afe-a7f8-0d3a4f94b53d"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTozNDY2MGIzODgyOWY0NDQ5YWU5YzQ1YmYzZTBlZmM1ZC90YWJsZXJhbmdlOjM0NjYwYjM4ODI5ZjQ0NDlhZTljNDViZjNlMGVmYzVkXzExLTAtMS0xLTI5NDg5_bc4c3e84-e956-46a8-b461-0698bb31e9ec">Accumulated depreciation</span></span></span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,171)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,287)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment, net</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,801&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,697&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Remaining Lease Term</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases - years</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Discount Rate</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Maturities of lease liabilities were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"/><td style="width:59.904%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:37.896%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Operating Leases</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year Ending December 31,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,371&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,436&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,941&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,872&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,136&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499,326&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total Lease Payments</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">941,082&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(279,358)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661,724&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, we have additional operating leases for facilities and medical equipment that have not yet commenced of  approximately $11.8 million.  These operating leases will commence in 2023 with lease terms of 1 to 15 years.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140483006170128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text">INCOME TAXES<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December 31, 2022, 2021 and 2020, we have the following income (loss) before income taxes (in thousands):</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">US Domestic</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,529&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,806&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(986)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,560)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before income taxes</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,969&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,879&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(854)</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December 31, 2022, 2021 and 2020, we recognized income tax expense comprised of the following (in thousands):</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal current tax</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(256)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State current tax</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">371&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,191)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,608)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign current tax</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal deferred tax</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,470&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,831&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(303)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State deferred tax</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,863&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,902&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,035&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign deferred tax</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,430)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,361&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,560&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">895&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the statutory U.S. federal rate and effective rates is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"/><td style="width:60.854%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.178%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.551%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.551%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.178%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.551%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.551%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.779%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.407%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="24" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal tax</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,023&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,365&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(179)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State franchise tax, net of federal benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">595&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,198&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">779&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Non deductible expenses</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(93)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Officer Compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">759&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests in partnerships</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,821)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,114)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,748)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(249)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Return to provision</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,530)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,252)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PPP Loan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(850)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred true-ups and other</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,451)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,009&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,840&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign rate differential</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(737)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncertain tax provisions</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(749)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(321)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,036&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other differences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,361&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,560&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">895&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred income taxes reflect the net tax effects of temporary differences between carrying amounts of assets and liabilities for financial and income tax reporting purposes and operating loss carryforwards.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our deferred tax assets and liabilities comprise the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating losses</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,124&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,663&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,941&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142,347&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,440&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,387&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,993&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,071&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,711&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,541&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,532&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,095)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,066)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Deferred Tax Assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216,316&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210,548&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,214)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,134)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38,820)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33,973)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,640)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,133)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use asset</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(129,802)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(128,868)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outside basis difference</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,015)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,081)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,587)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Deferred Tax Liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(225,572)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(195,695)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Deferred Tax (Liability) Asset</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,256)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,853&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, we had federal net operating loss carryforwards of approximately $231.5 million, which is comprised of definite and indefinite net operating losses.  We had federal net operating loss carryforwards of approximately $165.2 million, which expire at various intervals from the years 2026 to 2037, and had carryforwards of $66.3 million of net operating losses which do not expire.  Federal net operating losses generated in tax years following December 31, 2017 carryover indefinitely and may be used to offset up to 80% of future taxable net income.  We also had state net operating loss carryforwards of approximately $271.7 million, which expire at various intervals from the years 2024 through 2042. As of December 31, 2022, $24.9 million of our federal net operating loss carryforwards acquired in connection with the 2011 acquisition of Raven Holdings U.S., Inc. and the 2019 acquisition of Nulogix Health, Inc. are subject to limitations related to their utilization under Section 382 of the Internal Revenue Code.  We also had foreign net operating loss carryforwards of approximately $19.8 million, which begin to expire from years 2023 to 2027, in addition to $11.0 million which do not expire and are carried over indefinitely.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We considered all evidence available when determining whether deferred tax assets are more likely-than-not to be realized, including projected future taxable income, scheduled reversals of deferred tax liabilities, prudent tax planning strategies, and recent financial operations. The evaluation of this evidence requires significant judgment about the forecasts of future taxable income, based on the plans and estimates we are using to manage the underlying businesses. In evaluating the objective evidence that historical results provide, we consider three years of cumulative operating income. As of December 31, 2022, we have determined that deferred tax assets of $216.3 million are more likely-than-not to be realized. We have also determined deferred tax liabilities of $38.8 million are related to book basis in goodwill that has an indefinite life.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We file consolidated income tax returns in the U.S. federal jurisdiction and various states and foreign jurisdictions. We continue to reinvest earnings of the non-US entities for the foreseeable future and therefore have not recognized any U.S. tax expense on these earnings. With limited exceptions, we are no longer subject to U.S. federal, state and local, or non-U.S. income tax examinations by tax authorities for years before 2018.  We do not anticipate the results of any open examinations would result in a material change to our financial position.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the total gross amounts of unrecognized tax benefits for the years ended are as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of year</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,088&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,484&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,320&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to prior year tax positions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,382&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to current year tax positions</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expiration of the statute of limitations for the assessment of taxes</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(999)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(713)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(221)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase (decrease) related to change in rate</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of year</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,144&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,088&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,484&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2022, we had unrecognized tax benefits of $4.1 million of which $3.4 million will affect the effective tax rate if recognized.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize accrued interest and penalties related to unrecognized tax benefits in income tax expense. During the year ended December 31, 2022 the Company accrued approximately $2 thousand of interest and penalties. As of December 31, 2022, accrued interest and penalties amounted to approximately $0.4 million.  We do not anticipate the uncertain tax position to change materially within the next 12 months.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On March 27, 2020, the United States enacted the Coronavirus Aid, Relief and Economic Security Act (CARES Act). The Cares Act is an emergency economic stimulus package that includes spending and tax breaks to strengthen the United States economy and fund a nationwide effort to curtail the effect of COVID-19. The CARES Act provides sweeping tax changes in response to the COVID-19 pandemic, some of the more significant provisions are removal of certain limitations on utilization of net operating losses, increasing the loss carryback period for certain losses to five years, and increasing the ability to deduct interest expense, as well as amending certain provisions of the previously enacted Tax Cuts and Jobs Act. At December 31, 2020, we have taken advantage of the accelerated tax depreciation related to qualified improvement property and the Paycheck Protection Program loan allowed under the CARES Act.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On December 27, 2020, the United States enacted the Consolidated Appropriations Act of 2021 (&#8220;CAA&#8221;). The CAA includes provisions extending certain CARES Act provisions and adds coronavirus relief, tax and health extenders.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Inflation Reduction Act 2022 which incorporates a Corporate Alternative Minimum Tax (CAMT) was signed on August 16, 2022.  The changes will affect for the tax years beginning after December 31, 2022.  The new tax will require companies to compute two separate calculations for federal income tax purposes and pay the greater of the new minimum tax or their regular tax liability.  We will be monitoring the impacts of the act to determine if this will have a impact on us for years beginning after December 31, 2022. As of year-end it is not expected to have a material impact for us.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The Creating Helpful Incentives to Produce Semiconductors (CHIPS) Act of 2022 was signed into law on August 9, 2022 to boost domestic semiconductor manufacturing and encourage US research activities.  The act provided a 25% investment credit intended to promote domestic production of semiconductors. This act is not expected to have a material impact for us.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The Tax Cuts and Jobs Act of 2017 subjects a U.S. shareholder to tax on global intangible low-taxed income ("GILTI") earned by certain foreign subsidiaries. An entity can make an accounting policy election to either recognize deferred taxes for temporary basis differences expected to reverse as GILTI in future years or to provide for the tax expense related to GILTI in the year the tax is incurred as a period expense only. We have elected to account for GILTI in the year the tax is incurred.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140483006208672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">STOCK-BASED COMPENSATION</a></td>
<td class="text">STOCK-BASED COMPENSATION<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Incentive Plans</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have one long-term equity incentive plan, the RadNet, Inc. Equity Incentive Plan, which we first amended and restated April 20, 2015, again on March 9, 2017 and currently as of April 15, 2021 (the "Restated Plan&#8221;). The Restated Plan was most recently approved by our stockholders at our annual stockholders meeting on June 10, 2021.  We have reserved for issuance under the 2017 Restated Plan 16,500,000 shares of common stock.  We can issue options (incentive and non-qualified), stock awards, stock appreciation rights, stock units and cash awards under the Restated Plan.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Options</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain options granted under the Restated Plan to employees are intended to qualify as incentive stock options under existing tax regulations. Stock options generally vest over <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzgyNA_592b111d-5e4b-4ce1-b2c6-e023d3e9049f">three</span> to five years and expire <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzg0NA_4b31c3d7-9086-4991-8c69-3f75d38c24fd">five</span> to ten years from the date of grant.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes all of our option transactions for the twelve months ended December 31, 2022:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:44.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.822%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.822%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.822%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.824%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding Options<br/>Under the 2006 Plan</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise price<br/>Per Common Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Remaining<br/>Contractual<br/>Life(in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2021</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473,939&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.38&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229,975&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25,000)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.75&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">678,914&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.07</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,416,774&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 31, 2022</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483,969&#160;</span></td><td style="background-color:#eeeeee;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.01&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.93</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,381,451&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aggregate intrinsic value in the table above represents the total pretax intrinsic value (the difference between our closing stock price on December 31, 2022 and the exercise price, multiplied by the number of in-the-money options as applicable) that would have been received by the holder had all holders exercised their options on December 31, 2022.  As of December 31, 2022, total unrecognized stock-based compensation expense related to non-vested employee awards was $1.1 million which is expected to be recognized over a weighted average period of approximately 2.32 years.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:174%">DeepHealth Options</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of fiscal 2020, in connection with the completion of the DeepHealth acquisition, we granted&#160;412,434&#160;options at a grant date fair value of $16.93&#160;per share unit to DeepHealth employees in replacement of their stock options that were outstanding as of the closing date.  As of December 31, 2022, total unrecognized stock based compensation expense related to non-vested DeepHealth options was approximately $0.6 million which is expected to be recognized over a weighted average period of approximately 0.74 years.</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"><tr><td style="width:1.0%"/><td style="width:46.197%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.550%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.161%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.550%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.161%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.550%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.912%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.550%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.069%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outstanding Options<br/>Under the Deep Health Plan</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise price<br/>Per Common Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Remaining<br/>Contractual Life<br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2021</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320,660&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(203,678)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2022</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,982&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.80</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,202,771&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,909&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.80</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,448,198&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Awards (&#8220;RSA&#8217;s&#8221;)</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Restated Plan permits the award of restricted stock awards (&#8220;RSA&#8217;s&#8221;). As of December 31, 2022, we have issued a total of 7,892,930 RSA&#8217;s of which 536,767 were unvested at December 31, 2022 . The following summarizes all unvested RSA&#8217;s activities during the twelve months ended December 31, 2022:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSA's</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average<br/>Remaining<br/>Contractual<br/>Term (Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSA's unvested at December 31, 2021</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">456,075&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.06&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes during the period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">649,901&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.33&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(563,731)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,478)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.76&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSA's unvested at December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">536,767&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.01</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.84&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine the fair value of all RSA&#8217;s based of the closing price of our common stock on award date.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other stock bonus awards</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Restated Plan also permits the award of stock bonuses not subject to any future service period. These awards are valued and expensed based on the closing price of our common stock on the date of award. During the twelve months ended December 31, 2022 we issued 41,000 shares relating to these awards, approximately amounting to $0.8 million of compensation expense.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance based stock units ("PSUs")</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2022, we granted certain employees PSUs with a target award of 25,683 shares of our common stock. The PSUs will vest in two equal parts, starting three years from the grant date based on continuous service, with the number of shares earned (0% to 200% of the target award) depending upon the extent to which we achieve a performance condition as determined by the board of directors over the period from January 1, 2022 through December 31, 2022.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance based stock options ("PSOs")</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2022, we granted certain employees PSOs to purchase a maximum of 111,925 shares of our common stock. The PSOs will vest in three equal parts, starting three years from the grant date based on continuous service, with the number of shares earned (0 shares to 111,925 shares) depending upon the extent to which we achieve a performance condition as determined by the board of directors over the period from January 1, 2022 through December 31, 2022.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long Term Incentive Plan shares ("LTIPs")</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we issue stock-based compensation to certain employees in our AI segment in the form of Stock Units and Restricted Stock Awards, subject to certain restrictions.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The awards represent a form of long term incentive and are reflective of a general practice within the software industry.  The units and shares vest ratably over a <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzM4NDgyOTA3MDIzMDM_73f2d802-1880-44ce-b1e9-1beab990455e">two</span> to four year period, conditioned on continued employment through the vesting periods. We determine the fair value of all LTIPs based on the closing price of our common stock on the award date.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes all unvested LTIPs activities during the twelve months ended December 31, 2022:</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.099%"><tr><td style="width:1.0%"/><td style="width:61.642%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.822%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.545%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.822%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.545%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.824%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">LTIPs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Remaining<br/>Contractual<br/>Term (Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Fair Value</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LTIPs unvested at December 31, 2021</span></td><td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes during the period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180,612&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.56&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited or Canceled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,141)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LTIPs unvested at December 31, 2022</span></td><td colspan="2" style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169,471&#160;</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.69</span></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.56&#160;</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Plan summary</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div>In summary, of the 16,500,000 shares of common stock reserved for issuance under the Restated Plan at December 31, 2022, there remain 2,017,233 shares available for future awards.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140483006144400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENTS</a></td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI https://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140483008949408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">PRINCIPLES OF CONSOLIDATION</a></td>
<td class="text">PRINCIPLES OF CONSOLIDATION &#8211; The operating activities of subsidiaries are included in the accompanying consolidated financial statements (&#8220;financial statements&#8221;) from the date of acquisition. Investments in companies in which we have the ability to exercise significant influence, but not control, are accounted for by the equity method. All intercompany transactions and balances, with our consolidated entities and the unsettled amount of intercompany transactions with our equity method investees, have been eliminated in consolidation. As stated in Note 1 above, the Group consists of VIEs and we consolidate the operating activities and balance sheets of each. Additionally, we determined that our unconsolidated joint venture, ScriptSender, LLC, is also a VIE as it is dependent on our operational funding but we are not a primary beneficiary since RadNet does not have the power to direct the activities of the entity that most significantly impact the entity&#8217;s economic performance.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">USE OF ESTIMATES</a></td>
<td class="text">USE OF ESTIMATES - The financial statements have been prepared in accordance with U.S. generally accepted accounting principles (GAAP), which requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. These estimates and assumptions affect various matters, including our reported amounts of assets and liabilities in our consolidated balance sheets at the dates of the financial statements; our disclosure of contingent assets and liabilities at the dates of the financial statements; and our reported amounts of revenues and expenses in our consolidated statements of operations during the reporting periods. These estimates involve judgments with respect to numerous factors that are difficult to predict and are beyond management&#8217;s control. As a result, actual amounts could materially differ from these estimates.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">REVENUES</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">REVENUES &#8211; Our revenues generally relate to net patient fees&#160;received from various payors and patients themselves under contracts in which our performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period when our obligations to provide diagnostic services are satisfied. Our performance obligations for diagnostic services are generally satisfied over a period of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payor (Medicare, Medicaid, managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent upon the terms provided by Medicare and Medicaid, or negotiated with managed care health plans and commercial insurance companies. The payment arrangements with third-party payors for the services we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As it relates to the Group, this service fee revenue includes payments for both the professional medical interpretation revenue recognized by them as well as the payment for all other aspects related to our providing the imaging services, for which we earn management fees. As it relates to other centers, this service fee revenue is earned through providing the use of our </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">diagnostic imaging equipment and the provision of technical services as well as providing administration services such as clerical and administrative personnel, bookkeeping and accounting services, billing and collection, provision of medical and office supplies, secretarial, reception and transcription services, maintenance of medical records, and advertising, marketing and promotional activities.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenues are based upon the estimated amounts we expect to be entitled to receive from patients and third-party payors. Estimates of contractual allowances under managed care and commercial insurance plans are based upon the payment terms specified in the related contractual agreements. Revenues related to uninsured patients and copayment and deductible amounts for patients who have health care coverage may have discounts applied (uninsured discounts and contractual discounts). We also record estimated implicit price concessions (based primarily on historical collection experience) related to uninsured accounts to record self-pay revenues at the estimated amounts we expect to collect.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under capitation arrangements with various health plans, we earn a per-enrollee amount each month for making available diagnostic imaging services to all plan enrollees under the capitation arrangement. Revenue under capitation arrangements is recognized in the period in which we are obligated to provide services to plan enrollees under contracts with various health plans.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesPolicyTextBlock', window );">ACCOUNTS RECEIVABLE</a></td>
<td class="text">ACCOUNTS RECEIVABLE &#8211; Substantially all of our accounts receivable are due under fee-for-service contracts from third party payors, such as insurance companies and government-sponsored healthcare programs, or directly from patients. Services are generally provided pursuant to one-year contracts with healthcare providers. We continuously monitor collections from our payors and maintain an allowance for bad debts based upon specific payor collection issues that we have identified and our historical experience.We have entered into factoring agreements with various institutions and sold certain accounts receivable under non-recourse agreements in exchange for notes receivables from the buyers. These transactions are accounted for as a reduction in accounts receivable as the agreements transfer effective control over and risk related to the receivables to the buyers. Proceeds on notes receivables are reflected as operating activities on our statement of cash flows and on our balance sheet as prepaid expenses and other current assets for the current portion and deposits and other for the long term portion.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">SOFTWARE REVENUE RECOGNITION</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SOFTWARE REVENUE RECOGNITION &#8211; We have developed and sell Picture Archiving Communications Systems (&#8220;PACS&#8221;) and related services. The PACS sales are made primarily through our sales force and generally include hardware, software, installation, training and first-year warranty support. Hardware which is not unique or special purpose, is purchased from a third-party and resold to customers with a small mark-up.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div>We have determined that our core software products, such as PACS, are essential to most of our arrangements as hardware, software and related services are sold as an integrated package.  Revenue is recognized when a performance obligation is satisfied by transferring a promised good or service to a customer.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock', window );">SOFTWARE DEVELOPMENT COSTS</a></td>
<td class="text">SOFTWARE DEVELOPMENT COSTS &#8211; When we develop our own software and artificial intelligence solutions we capitalize and amortize those costs over their useful life. Costs related to the research and development of new software products and enhancements to existing software intended for resale to our customers are expensed as incurred.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">CONCENTRATION OF CREDIT RISKS</a></td>
<td class="text">CONCENTRATION OF CREDIT RISKS &#8211; Financial instruments that potentially subject us to credit risk are primarily cash equivalents and accounts receivable. We have placed our cash and cash equivalents with one major financial institution. At times, the cash in the financial institution is temporarily in excess of the amount insured by the Federal Deposit Insurance Corporation, or FDIC. Substantially all of our accounts receivable are due under fee-for-service contracts from third party payors, such as insurance companies and government-sponsored healthcare programs, or directly from patients. We continuously monitor collections and maintain an allowance for bad debts based upon our historical collection experience. In addition, we have notes receivable stemming from our factoring of accounts receivable as stated above.  Companies with which we factor our receivables are well known established buyers of such instruments, have agreed to assume the full risk of their collection.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">CASH AND CASH EQUIVALENTS</a></td>
<td class="text">CASH AND CASH EQUIVALENTS &#8211; We consider all highly liquid investments that mature in three months or less when purchased to be cash equivalents. The carrying amount of cash and cash equivalents approximates the fair market value.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredChargesPolicyTextBlock', window );">DEFERRED FINANCING COSTS</a></td>
<td class="text">DEFERRED FINANCING COSTS &#8211; Costs of financing are deferred and amortized using the effective interest rate method.  Deferred financing costs are related to our revolving credit facilities. Notes Payable for more information on our revolving lines of credit.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">PROPERTY AND EQUIPMENT</a></td>
<td class="text">PROPERTY AND EQUIPMENT &#8211; Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation and amortization of property and equipment are provided using the straight-line method over the estimated useful lives, which range from 3 to 15 years. Leasehold improvements are amortized at the lesser of lease term or their estimated useful lives, which range from 3 to 15 years. Maintenance and repairs are charged to expense as incurred.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationsPolicy', window );">BUSINESS COMBINATION</a></td>
<td class="text">BUSINESS COMBINATION &#8211; When the qualifications for business combination accounting treatment are met, it requires us to recognize separately from goodwill the assets acquired and the liabilities assumed at their acquisition date fair values. Goodwill as of the acquisition date is measured as the excess of consideration transferred over the net of the acquisition date fair values of the assets acquired and the liabilities assumed. While we use our best estimates and assumptions to accurately value assets acquired and liabilities assumed at the acquisition date, our estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, we record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. Upon the conclusion of the measurement period or final determination of the values of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to our consolidated statements of operations.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy', window );">GOODWILL AND INDEFINITE LIVED INTANGIBLES</a></td>
<td class="text">GOODWILL AND INDEFINITE LIVED INTANGIBLESGoodwill, trade name intangibles and IPR&amp;D are recorded as a result of business combinations. When we determine the carrying value of goodwill exceeds its fair value, an impairment charge would be recognized which should not exceed the total amount of goodwill allocated to that reporting unit. We determined fair values for each of the reporting units using the market approach, when available and appropriate, or the income approach, or a combination of both. We assess the valuation methodology based upon the relevance and availability of the data at the time we perform the valuation. If multiple valuation methodologies are used, the results are weighted appropriately.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">LONG-LIVED ASSETS</a></td>
<td class="text">LONG-LIVED ASSETS &#8211; We evaluate our long-lived assets (property and equipment) and intangibles, other than goodwill and indefinite lived intangible assets, for impairment when events or changes indicate the carrying amount of an asset may not be recoverable. Accounting standards requires that if the sum of the undiscounted expected future cash flows from a long-lived asset or definite-lived intangible is less than the carrying value of that asset, an asset impairment charge must be recognized. The amount of the impairment charge is calculated as the excess of the asset&#8217;s carrying value over its fair value, which generally represents the discounted future cash flows from that asset or in the case of assets we expect to sell, at fair value less costs to sell.  At December 31, 2021 we recorded a <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjc0ODc3OTE4MzYxMw_9c7fb964-0c31-457d-ab68-df24d21cb8df">write off charge</span> of $7.1 million in leasehold improvements for facilities that we abandoned. See the Leases discussion below for more information.  Other than this, we determined that there were no events or changes in circumstances that indicated our long-lived assets were impaired during any periods presented.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">INCOME TAXES</a></td>
<td class="text">INCOME TAXES &#8211; Income tax expense is computed using an asset and liability method and using expected annual effective tax rates. Under this method, deferred income tax assets and liabilities result from temporary differences in the financial reporting bases and the income tax reporting bases of assets and liabilities. The measurement of deferred tax assets is reduced, if necessary, by the amount of any tax benefit that, based on available evidence, is not expected to be realized. When it appears more likely than not that deferred taxes will not be realized, a valuation allowance is recorded to reduce the deferred tax asset to its estimated realizable value. For net deferred tax assets we consider estimates of future taxable income in determining whether our net deferred tax assets are more likely than not to be realized. See Note 10, Income Taxes, for more information.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">LEASES</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LEASES - We determine if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (&#8220;ROU&#8221;) assets, current operating lease liabilities, and long term operating lease liability in our consolidated balance sheets. Finance leases are included in property and equipment, current finance lease liability, and long-term finance lease liability in our consolidated balance sheets.  ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As most of our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. We use the implicit rate when readily determinable. We include options to extend a lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term. For a contract in which we are a lessee that contains fixed payments for both lease and non-lease components, we have elected to account for the components as a single lease component, as permitted. For finance leases, interest expense on the lease liability is recognized using the effective interest method and amortization of the ROU asset is recognized on a straight-line basis over the shorter of the estimated useful life of the asset or the lease term. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ROU assets are tested for impairment if circumstances suggest that the carrying amount may not be recoverable. No events have occurred such as fire, flood, or other acts which have impaired the integrity of our ROU assets as of December 31, 2022. Our facility leases require us to maintain insurance policies which would cover major damage to our facilities. We maintain business interruption insurance to cover loss of business due to a facility becoming non-operational under certain circumstances. Our equipment leases are covered by warranty and service contracts which cover repairs and provide regular maintenance to keep the equipment in functioning order.</span></div>After a management review of post pandemic patient traffic to centers during the fourth quarter of 2021, it was noted that although overall volumes had returned to pre-pandemic levels, certain imaging locations did not experience the same levels of activity as beforehand.  This was due in part to lower utilization rates of commercial space from telecommuting, accompanied by the migration of those workers out of congested urban centers to residential areas.  Based on this analysis, management decided to consolidate volumes into fewer centers and reduce administrative office space in response to the demographic changes experienced.  To complete the closure of these locations, we took a lease abandonment charge of approximately $12.6 million at December 31, 2021.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_UninsuredRisksPolicyTextBlock', window );">UNINSURED RISKS</a></td>
<td class="text">UNINSURED RISKS &#8211; On November 1, 2013 we entered into a high-deductible workers&#8217; compensation insurance policy. We and our affiliated physicians carry an annual medical malpractice insurance policy that protects us for claims that are filed during the policy year and that fall within policy limits.<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2008, in order to eliminate the exposure for claims not reported during the regular malpractice policy period, we purchased a medical malpractice claims made tail policy, which provides coverage for any claims reported in the event that our medical malpractice policy expires. As of December 31, 2022, this policy remains in effect.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div>We have entered into an arrangement with Blue Shield to administer and process claims under a self-insured plan that provides health insurance coverage for our employees and dependents.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PostemploymentBenefitPlansPolicy', window );">EMPLOYEE BENEFIT PLAN</a></td>
<td class="text">EMPLOYEE BENEFIT PLAN &#8211; We adopted a profit-sharing/savings plan pursuant to Section 401(k) of the Internal Revenue Code that covers substantially all non-professional employees. Eligible employees may contribute on a tax-deferred basis a percentage of compensation, up to the maximum allowable under tax law. Employee contributions vest immediately.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationRelatedCostsPolicyTextBlock', window );">EQUITY BASED COMPENSATION</a></td>
<td class="text">EQUITY BASED COMPENSATION &#8211; We have one long-term incentive plan that we adopted in 2006 and which we first amended and restated as of April 20, 2015, and again on March 9, 2017, and currently as of April 15, 2021 (the &#8220;Restated Plan&#8221;). The Restated Plan was approved by our stockholders at our annual stockholders meeting on June 10, 2021. We have reserved 16,500,000 shares of common stock for issuance under the Restated Plan which can be issued in the form of incentive and/or nonstatutory stock options, restricted and/or unrestricted stock, stock units, and stock appreciation rights.  Terms and conditions of awards can be direct grants or based on achieving a performance metric and we also consider probability of achievement of performance conditions when determining expense recognition. For the awards where vesting is probable, equity-based compensation is recognized over the related vesting period. Stock options and warrants generally vest over <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjQzNTk_cd22a3ff-fb8c-47a1-9018-2d91908dd609">three</span> to five years and expire <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjQzNzk_0e815b97-2caf-4c2a-88cf-151ad3b1dacb">five</span> to ten years from date of grant.  We determine the compensation expense for each stock option award using the Black Scholes, or similar, valuation model.  Those models require that our management make certain estimates concerning risk free interest rates and volatility in the trading price of our common stock. The compensation expense recognized for all equity-based awards is recognized over the awards&#8217; service periods. Equity-based compensation is classified in operating expenses within the same line item as the majority of the cash compensation paid to employees.  In connection with our acquisition of DeepHealth Inc. on June 1, 2020, we assumed the DeepHealth, Inc. 2017 Equity Incentive Plan, including outstanding options awards that can be exercised for our common stock.  No additional awards will be granted under the DeepHealth, Inc. 2017 Equity Incentive Plan.  See Note 11, Stock-Based Compensation, for more information.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">FOREIGN CURRENCY TRANSLATION</a></td>
<td class="text">FOREIGN CURRENCY TRANSLATION &#8211; For our operations in Canada, Europe and the United Kingdom, the functional currency of our foreign subsidiaries is the local currency. Assets and liabilities denominated in foreign currencies are translated using the exchange rate at the balance sheet dates. Revenues and expenses are translated using average exchange rates prevailing during the reporting period. Any translation adjustments resulting from this process are shown separately as a component of accumulated other comprehensive income (loss). Gains and losses related to the foreign currency portion of international transactions are included in the determination of net income.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">COMPREHENSIVE INCOME (LOSS)</a></td>
<td class="text">COMPREHENSIVE INCOME (LOSS) &#8211; Accounting guidance<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">establishes rules for reporting and displaying other comprehensive income (loss) and its components. Our foreign currency translation adjustments,  changes in the fair value of cash flow hedges, and the amortization of balances associated with derivatives previously classified as cash flow hedges are included in other comprehensive income (loss). The components of other comprehensive income (loss) for the twelve month periods ended December 31, 2022, December 31, 2021, and December 31, 2020 are included in the consolidated statements of comprehensive income (loss).</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text">COMMITMENTS AND CONTINGENCIES - We are party to various legal proceedings, claims, and regulatory, tax or government inquiries and investigations that arise in the ordinary course of business. With respect to these matters, we evaluate the developments on a regular basis and accrue a liability when we believe a loss is probable and the amount can be reasonably estimated. Based on current information, we do not believe that reasonably possible or probable losses associated with pending legal proceedings would either individually or in the aggregate, have a material adverse effect on our business and consolidated financial statements. However, the outcome of these matters is inherently uncertain. Therefore, if one or more of these matters were resolved against us for amounts in excess of management's expectations, our results of operations and financial condition, including in a particular reporting period in which any such outcome becomes probable and estimable, could be materially adversely affected.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">DERIVATIVE INSTRUMENTS</a></td>
<td class="text">DERIVATIVE INSTRUMENTS The gain or loss of the hedge (i.e. change in fair value) was reported as a component of accumulated other comprehensive income (loss) in the consolidated statement of equity. The 2019 swaps will secure a constant interest rate associated with portions of our variable rate bank debt and have an effective date of October 13, 2020. They will mature in October 2023 for the two smaller notional and October 2025 for the two larger notional.As of the effective date, we will be liable for premium payments if interest rates decline below arranged rates, but will receive interest payments if rates remain above the arranged rates.At inception, we designated our 2019 Swaps as cash flow hedges of floating-rate borrowings. In accordance with accounting guidance, derivatives that have been designated and qualify as cash flow hedging instruments are reported at fair value. The gain or loss on the effective portion of the hedge (i.e. change in fair value) is reported as a component of accumulated comprehensive income (loss) in the consolidated statement of equity.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">FAIR VALUE MEASUREMENTS</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FAIR VALUE MEASUREMENTS &#8211; Assets and liabilities subject to fair value measurements are required to be disclosed within a fair value hierarchy. The fair value hierarchy ranks the quality and reliability of inputs used to determine fair value. Accordingly, assets and liabilities carried at, or permitted to be carried at, fair value are classified within the fair value hierarchy in one of the following categories based on the lowest level input that is significant to a fair value measurement:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;1&#8212;Fair value is determined by using unadjusted quoted prices that are available in active markets for identical assets and liabilities.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;2&#8212;Fair value is determined by using inputs other than Level&#160;1 quoted prices that are directly or indirectly observable. Inputs can include quoted prices for similar assets and liabilities in active markets or quoted prices for identical assets and liabilities in inactive markets. Related inputs can also include those used in valuation or other pricing models such as interest rates and yield curves that can be corroborated by observable market data.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;3&#8212;Fair value is determined by using inputs that are unobservable and not corroborated by market data. Use of these inputs involves significant and subjective judgment.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of these contracts was determined using Level 2 inputs. More specifically, the fair value was determined by calculating the value of the difference between the fixed interest rate of the interest rate swaps and the counterparty&#8217;s forward LIBOR curve. The forward LIBOR curve is readily available in the public markets or can be derived from information available in the public markets.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Contingent Consideration:</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the estimated fair values of contingencies and holdback relating to our Aidence Holding B.V. and Quantib B.V. acquisitions on January 20, 2022, and the Heart and Lung Imaging Limited acquisition on November 1, 2022 that are subject to fair value measurements and the classification of these liabilities on our consolidated balance sheets, as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:49.779%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.632%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other non-current liabilities</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aidence Holding B.V. milestone consideration</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quantib B.V. holdback of 113,303 shares of RadNet common stock</span></div></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,709&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,709&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Montclair Radiological Associates</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Heart and Lung Imaging Limited</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,656&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,656&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of these liabilities was determined using Level 3 inputs.  For Aidence Holding B.V., the  milestone contingent liability was adjusted to fair value based on the yield rate of S&amp;P B-rated corporate bonds and the probability of FDA approval.  For the Quantib B.V holdback shares, the fair value was determined by calculating the value of estimated shares issuable as of the reporting date (which was $18.83) translated at the current exchange rate at December 31, 2022, the time period related to the contractual settlement term, and the probability of issuing the shares.  For Montclair Radiological Associates the contingent consideration is determined by obtaining specific EBITDA targets within a defined time frame.  For Heat Lung Imaging Limited the contingent consideration is determined by the achievement of a specific number of physician reads.  As significant inputs for the contingent consideration of Aidence B.V., Quantib B.V., Montclair Radiological Associates and Heart Lung Imaging Limited are not observable and cannot be corroborated by observable market data they are classified as Level 3.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair values of our long-term debt, which is discussed in Note 8, was determined using Level 2 inputs for the Barclays and Truist term loans. Level 2 inputs primarily related to comparable market prices.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider the carrying amounts of cash and cash equivalents, receivables, other current assets, current liabilities and other notes payables to approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization or payment. Additionally, we consider the carrying amount of our capital lease obligations to approximate their fair value because the weighted average interest rate used to formulate the carrying amounts approximates current market rates.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">EARNINGS PER SHARE</a></td>
<td class="text">EARNINGS PER SHARE - Earnings per share is based upon the weighted average number of shares of common stock and common stock equivalents outstanding, net of common stock held in treasury, as follows (in thousands except share and per share data):<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsPolicy', window );">EQUITY INVESTMENTS AT FAIR VALUE</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">INVESTMENTS IN EQUITY SECURITIES- As of December 31, 2022, we have three equity investments for which a fair value is not readily determinable and we do not have significant influence and therefore the total amounts invested are recognized at cost.  In accordance with accounting guidance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">if there is no readily determinable fair value, the guidance allows entities the ability to measure investments at cost less impairment, whereby impairment is based on a qualitative assessment.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">INVESTMENT IN JOINT VENTURES</a></td>
<td class="text">INVESTMENT IN JOINT VENTURES &#8211; We have 13 unconsolidated joint ventures with ownership interests ranging from 35% to 55%. These joint ventures represent partnerships with hospitals, health systems or radiology practices and were formed for the purpose of owning and operating diagnostic imaging centers.&#160;&#160;Professional services at the joint venture diagnostic imaging centers are performed by contracted radiology practices or a radiology practice that participates in the joint venture.&#160;&#160;Our investment in these joint ventures is accounted for under the equity method, as we do not have a controlling financial interest in such ventures. We evaluate our investment in joint ventures, including cost in excess of book value (equity method goodwill) for impairment whenever indicators of impairment exist. No indicators of impairment existed as of December 31, 2022.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">ACCOUNTING STANDARDS ADOPTED AND ACCOUNTING STANDARDS NOT YET ADOPTED</a></td>
<td class="text">RECENT ACCOUNTING STANDARDS<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting standards adopted</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Over the course of 2020 through 2022, the FASB issued different Accounting Standards Updates (ASUs) in regards to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848).  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASU 2020-04 and ASU 2021-01 addressed optional expedients and exceptions for applying generally accepted accounting principals to certain contract modifications, hedging relationships, and derivatives that referenced London Inter-bank Offered Rate (LIBOR) or another reference rate expected to be discontinued.  The provisions originally were set to expire on December 31, 2022.  The date of LIBOR cessation was finalized as June 30, 2023, which is beyond the current sunset date of Topic 848 and hence the need to extend the time allotted for accounting relief. ASU 2022-06 deferred the sunset date of the provision out to December 31, 2024. The adoption of the provisions under these ASUs did not have a material effect on our consolidated financial statements.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, the FASB issued ASU 2021-10 ("ASU 2021-10"), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Assistance (Topic 832), Disclosures by Business Entities about Government Assistance.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASU 2021-10 requires entities to provide disclosures on material government assistance transactions for annual reporting periods. The disclosures include information around the nature of the assistance, the related accounting policies used to account for government assistance, the effect of government assistance on the entity&#8217;s financial statements, and any significant terms and conditions of the agreements, including commitments and contingencies. The new standard was effective for financial statements issued for annual reporting periods beginning after December 15, 2021. As ASU 2021-10 only impacts annual financial statement footnote disclosures, the adoption did not have a material effect on our consolidated financial statements.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the FASB issued ASU 2021-08 ("ASU 2021-08"), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations (Topic 805), Accounting for Contract Assets and Contract Liabilities from Contracts with Customers.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASU 2021-08 requires an acquirer in a business combination to recognize and measure contract assets and contract liabilities in accordance with Accounting Standards </span></div>Codification Topic 606. ASU 2021-08 is effective for fiscal years beginning after December 15, 2022 and early adoption is permitted. The adoption did not have a material effect on our consolidated financial statements.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_UninsuredRisksPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Uninsured Risks [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_UninsuredRisksPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (a)-(d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6909625&amp;loc=d3e227-128457<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126907703&amp;loc=d3e12565-110249<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 450<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6491354&amp;loc=d3e6049-115624<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationRelatedCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationRelatedCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941378&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredChargesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for deferral and amortization of significant deferred charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredChargesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41675-113959<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21D<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=SL94080555-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI https://asc.fasb.org/topic&amp;trid=2175825<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for indefinite-lived intangible assets (that is, those intangible assets not subject to amortization). This accounting policy also may address how the entity assesses whether events and circumstances continue to support an indefinite useful life and how the entity assesses and measures impairment of such assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=109226317&amp;loc=d3e202-110218<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PostemploymentBenefitPlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for postemployment benefits. Postemployment benefits are benefits provided to former or inactive employees, their beneficiaries, and covered dependents after employment but before retirement, except for: a) benefits provided through a pension or postretirement benefit plan, b) individual deferred compensation arrangements, c) special or contractual termination benefits, and d) stock compensation plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 712<br> -URI https://asc.fasb.org/topic&amp;trid=2197446<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PostemploymentBenefitPlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5033-111524<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10178-111534<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10149-111534<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its research and development and computer software activities including the accounting treatment for costs incurred for (1) research and development activities, (2) development of computer software for internal use, (3) computer software to be sold, leased or otherwise marketed as a separate product or as part of a product or process and (4) in-process research and development acquired in a purchase business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 50<br> -Section 25<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=16397303&amp;loc=d3e19347-109286<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 40<br> -Section 30<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=118172244&amp;loc=d3e17916-109280<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140483005504384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock', window );">Schedule of Service Fee Revenue</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our total service fee revenues for the years ended December 31, 2022, 2021, and 2020 are presented in the table below.  Our imaging center revenue is displayed as the estimated service fee, broken down by classification of insurance coverage type.  Additional revenues are earned from our management services provided to joint ventures and our software and AI subsidiaries.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In Thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial insurance</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">785,128&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743,462&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">584,035&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311,124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280,911&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217,928&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,279&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,731&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,619&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Workers' compensation/personal injury</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,339&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,478&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other patient revenue</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,849&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,398&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,314&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management fee revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,630&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software and teleradiology</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,238&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,525&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,798&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,428&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,436&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue under capitation arrangements</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152,045&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148,334&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140,118&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Imaging center segment revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,425,665&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,313,662&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,071,840&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AI segment revenue</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,396&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,415&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,430,061&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,315,077&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,071,840&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Schedule of Accounts Payable and Accrued Expenses</a></td>
<td class="text">Accounts payable and accrued expenses were comprised of the following (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.502%"><tr><td style="width:1.0%"/><td style="width:67.931%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.951%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.665%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.953%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,678&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,461&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181,574&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,420&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued salary and benefits</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,072&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,425&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional fees</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,271&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,631&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369,595&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263,937&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Effect of Derivative Instruments on Comprehensive (Loss) Income</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A tabular presentation of the effect of derivative instruments on our consolidated statement of comprehensive (loss) income, net of taxes is as follows (amounts in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.836%"><tr><td style="width:1.0%"/><td style="width:28.663%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:34.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.389%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Interest Rate Contracts</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the twelve months ended</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Gain (Loss) Recognized on Derivative, net of taxes</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location of Gain (Loss) Recognized<br/>in Income on Derivative</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#8212;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#8212;</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$788</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Loss</span></td></tr></table></div>A tabular presentation of the effect of derivative instruments on our consolidated statement of comprehensive loss of the 2019 swaps is as follows (amounts in thousands):<div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:28.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:34.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.065%"/><td style="width:0.1%"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Interest Rate Contracts - Effective Portion</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the twelve months ended</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Loss Recognized on Derivative, net of taxes</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location of Loss Recognized<br/>in Income on Derivative</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#8212;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#8212;</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(20,160)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Loss</span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A tabular presentation of the effect of derivative instruments on our statement of operations of the 2019 Swaps for the Swaps that became ineffective in 2020 is as follows (amounts in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Interest Rate Contracts - Ineffective Portion</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the twelve months ended</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of gain (loss) recognized in income on derivative (current period ineffective portion)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of gain (loss) recognized in Income on derivative (current period ineffective portion)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of loss reclassified from accumulated other comprehensive income (loss) into income (prior period effective portion)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of loss reclassified from accumulated other comprehensive income (loss) into income (prior period effective portion)</span></td></tr><tr style="height:8pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$39,621</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmY3ZDdlMDY0Y2UzOTQyYWVhZjFkMzRhNTc4MTBmMjA1L3RhYmxlcmFuZ2U6ZjdkN2UwNjRjZTM5NDJhZWFmMWQzNGE1NzgxMGYyMDVfMy0yLTEtMS03NjcxMw_04d809f9-cf99-45ef-aa56-16be46b5f8b6">Other Income (Expense)</span></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(3,687)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Interest Expense</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$21,670</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmY3ZDdlMDY0Y2UzOTQyYWVhZjFkMzRhNTc4MTBmMjA1L3RhYmxlcmFuZ2U6ZjdkN2UwNjRjZTM5NDJhZWFmMWQzNGE1NzgxMGYyMDVfNC0yLTEtMS03NjcyMQ_2c91ab05-c7d0-4ed6-a9f1-aefed9da243a">Other Income (Expense)</span></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(3,695)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Expense</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(2,528)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmY3ZDdlMDY0Y2UzOTQyYWVhZjFkMzRhNTc4MTBmMjA1L3RhYmxlcmFuZ2U6ZjdkN2UwNjRjZTM5NDJhZWFmMWQzNGE1NzgxMGYyMDVfNC0yLTEtMS0yOTQ4OQ_869911ef-bcba-451f-8629-1684d55fda21">Other Income (Expense)</span></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(3,448)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Expense</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock', window );">Schedule of Business Acquisitions by Acquisition, Contingent Consideration</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A tabular rollforward of contingent consideration is as follows (amounts in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">     </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.964%"><tr><td style="width:1.0%"/><td style="width:12.505%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.480%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.505%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.480%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.505%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.480%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.505%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.480%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.505%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.480%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.505%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.480%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.505%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.485%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="42" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the twelve months ended December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Entity</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Account</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 1, 2022 Balance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Issuance of contingent consideration</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of  income (loss) recognized on contingent consideration</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Currency Translation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022 Balance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aidence</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Long Term Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,453&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(362)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,158&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quantib</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued Expenses &amp; Other Long Term Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,581&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(903)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,709&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Montclair</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued Expenses</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Heart and Lung Limited</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued Expenses &amp; Other Long Term Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,814&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">566&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,656&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock', window );">Schedule of Fair Value of Assets and Liabilities</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the estimated fair values of certain of our financial assets that are subject to fair value measurements, and the classification of these assets in our consolidated balance sheets, as follows (in thousands):</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Current Assets and Deposits and Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 SWAPS - Interest Rate Contracts</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,302&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,302&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other non-current liabilities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 SWAPS - Interest Rate Contracts</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,319&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,319&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the estimated fair values of contingencies and holdback relating to our Aidence Holding B.V. and Quantib B.V. acquisitions on January 20, 2022, and the Heart and Lung Imaging Limited acquisition on November 1, 2022 that are subject to fair value measurements and the classification of these liabilities on our consolidated balance sheets, as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:49.779%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.632%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other non-current liabilities</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aidence Holding B.V. milestone consideration</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quantib B.V. holdback of 113,303 shares of RadNet common stock</span></div></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,709&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,709&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Montclair Radiological Associates</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Heart and Lung Imaging Limited</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,656&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,656&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the estimated fair value and carrying amount of our Truist (Term Loan Agreement) and Barclays (First Lien Term Loans) long-term debt as follows (in thousands):</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:46.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.713%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Face Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan Agreement and First Lien Term Loans</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">843,594&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">843,594&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">864,125&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:46.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.713%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Face Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan Agreement and First Lien Term Loans</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">766,973&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">766,973&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">767,875&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Earnings Per Share</a></td>
<td class="text">Earnings per share is based upon the weighted average number of shares of common stock and common stock equivalents outstanding, net of common stock held in treasury, as follows (in thousands except share and per share data):<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to RadNet, Inc. common stockholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,650&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,727&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,840)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BASIC NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding during the period</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,293,336&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,496,679&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,891,791&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net income (loss) per share attributable to RadNet, Inc. common stockholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.19&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.47&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.29)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DILUTED NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</span></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,293,336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,496,679&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,891,791&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add nonvested restricted stock subject only to service vesting</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,139&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259,539&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add additional shares issuable upon exercise of stock options, warrants and holdback shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">855,395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">664,815&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares used in calculating diluted net income per share</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,320,870&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,421,033&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,891,791&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in fair value associated with contingently issuable shares</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(724)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to RadNet, Inc's common stockholders for diluted share calculation</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$9,926</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$24,727</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(14,840)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net income (loss) per share attributable to RadNet, Inc. common stockholders</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and non-vested restricted awards excluded from the computation of diluted per share amounts as their effect would be antidilutive:</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested restricted stock subject to service vesting</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329,159&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issuable upon the exercise of stock options</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152,723&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,792&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">554,444&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsTextBlock', window );">Schedule of Investment in Joint Ventures</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of our investment in joint ventures during the years ended December 31, 2022 and December 31, 2021 (in thousands):</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:84.090%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.710%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,528&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity contributions in existing and purchase of interest in joint ventures</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,441&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in earnings in these joint ventures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,967&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distribution of earnings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,707)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,229&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity contributions in existing and purchase of interest in joint ventures</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,712&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in earnings in these joint ventures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,390&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distribution of earnings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,438)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,893&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock', window );">Schedule of Joint Venture Investment and Financial Information</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of key unaudited financial data for these joint ventures as of December 31, 2022 and 2021, respectively, and for the years ended December 31, 2022, 2021 and 2020, respectively, (in thousands):</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance Sheet Data:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,304&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,186&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134,694&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,592&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29,588)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,919)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,952)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,370)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net assets</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,458&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,489&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Book value of RadNet joint venture interests</span></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,564&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,930&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost in excess of book value of acquired joint venture interests accounted for as equity method goodwill</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,329&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,299&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total value of RadNet joint venture interests</span></td><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,893&#160;</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,229&#160;</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145,256&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129,023&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,921&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,169&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,893&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,850&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_ScheduleOfForeignCurrencyTranslationAmountsTableTextBlock', window );">Schedule Of Foreign Currency Translation Amounts</a></td>
<td class="text">The following is a reconciliation of Foreign Currency Translation amounts for the years ended December 31, 2022, 2021 and 2020 is provided below (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:50.584%"><tr><td style="width:1.0%"/><td style="width:58.148%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.956%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:37.339%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.957%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency Translation</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(276)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency Translation Adjustments</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(101)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(377)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency Translation Adjustments</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(442)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency Translation Adjustments</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,943)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,385)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Joint Venture Investment and Financial Information</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ScheduleOfForeignCurrencyTranslationAmountsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Foreign Currency Translation Amounts</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ScheduleOfForeignCurrencyTranslationAmountsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13467-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByBalanceSheetGroupingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of contingent payment arrangements including the terms that will result in payment and the accounting treatment that will be followed if such contingencies occur, including the potential impact on earnings per share if contingencies are to be settled in common stock of the entity. The description also may include the period over which amounts are expected to be paid, and changes in the amount since the previous reporting period. This also includes contingent options and commitments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of revenue by reporting categories or types of financial instruments, including derivatives but excluding dividends and interests, from trading for own account by broker dealers.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=35711157&amp;loc=d3e42567-110969<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140483006264832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS COMBINATIONS AND RELATED ACTIVITY (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock', window );">Schedule of Business Acquisitions Acquired Assets and Assumed Liabilities</a></td>
<td class="text">We made a fair value determination of the acquired assets and assumed liabilities and the following were recorded (in thousands):<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">2022:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"/><td style="width:12.734%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.133%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.478%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.922%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.975%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.170%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.934%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Entity </span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date Acquired</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Purchase  Consideration</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property &amp; Equipment</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Assets</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible Assets</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IFRC LLC*^</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/1/2022</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,200</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,910</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,703</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,271</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,703)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IFRC LLC*^</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/1/2022</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,800</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,103</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">857</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,697</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(857)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Montclair Radiological Associates, P.A.*#</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10/1/2022</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,877</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,414</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,665</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,690</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,168)</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,124)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Heart and Lung Imaging Limited+</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/1/2022</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,000</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,200</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,800</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chelsea Diagnostic Radiology, P.C.*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/1/2022</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,800</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,132</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North Jersey Imaging Center, LLC*</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/9/2022</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$142,781</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$22,015</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$7,225</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$106,045</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$16,325</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$(2,145)</span></td><td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$(6,684)</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*Fair Value Determination is Final</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">^ IFRC LLC acquisitions consisted of three subsidiaries of IFRC, one of which was purchased separately by a joint venture with Calvert Medical Imaging Centers, LLC.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">#</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Montclair Radiological Associates includes a liability for $1.2 million in contingent consideration.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">+See detailed description of the Heart and Lung Imaging Limited acquisition below. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">2021:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.502%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.600%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Entity </span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date Acquired</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Purchase  Consideration</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property &amp; Equipment</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Assets</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible Assets</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personal Health Imaging PLLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/1/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,995</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">576</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">608</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,355</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(608)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP Elmont LLC*</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/1/2021</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,194</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,112</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,005</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP Freeport LLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/1/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,065</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,668</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,328</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Broadway Medical Imaging LLC*</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/1/2021</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,155</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,076</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(446)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3235 Hempstead LLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/1/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,386</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,667</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,649</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SLZM Realty LLC*</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/1/2021</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,671</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,617</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,974</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2012 Sunrise Merrick LLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/1/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,428</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,741</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,617</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(335)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP Bayside LLC*</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/1/2021</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,545</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,385</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,191</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,191)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP Laurelton LLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/1/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,658</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,530</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,418</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,418)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP Smith LLC*</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/1/2021</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,978</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,581</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,214</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,214)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP 907 Northern LLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4/1/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">562</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">507</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,817</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,817)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">William M. Kelly MD, Inc.* ^</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5/1/2021</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,750</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">990</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,379</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,710</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,379)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60th Street MRI, LLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5/1/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP Parkchester LLC*</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5/1/2021</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(311)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP Eastern LLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6/1/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,868</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,801</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,951</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,951)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tangent Associates LLC**</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/24/2021</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,025</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">379</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,636</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mid Delaware Imaging P.A.</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/1/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,023</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,260</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">William M. Kelly MD, Inc.* ^</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/6/2021</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,404</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">701</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,653</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">William M. Kelly MD, Inc.* ^</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/31/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,346</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,197</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(323)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$79,716</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$35,949</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$12,993</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$40,864</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$2,671</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$232</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$(12,993)</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*Fair Value Determination is Final</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">** All stock purchase through issuing 67,658 shares of our common stock.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">^ William M. Kelly MD acquisitions consisted of various subsidiaries purchased separately.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1486-128463<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140483006162768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT REPORTING (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Segment Reporting Information, by Segment</a></td>
<td class="text">The table below present segment information reconciled to our financial results, with segment operating income or loss including revenue less cost of operations, depreciation and amortization, and other operating expenses to the extent specifically identified by segment (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.619%"><tr><td style="width:1.0%"/><td style="width:32.994%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.965%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.410%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.965%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:1.999%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.967%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Twelve Months Ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Revenue:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,425,665&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,313,662&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,071,840&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,396&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,415&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total revenue</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,430,061&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,315,077&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,071,840&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Cost of Operations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,240,593&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,130,543&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">967,250&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">23,753&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5,333&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,822&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total cost of operations</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,264,346&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,135,876&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">970,072&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:23pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 8.2pt;text-indent:-7.2pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Depreciation and Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">109,524&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">96,174&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">86,396&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6,353&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">520&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">399&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total depreciation and amortization</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">115,877&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">96,694&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">86,795&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 8.2pt;text-indent:-7.2pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Loss on Disposal of Equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,506&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,319&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,200&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total loss (gain)</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,529&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,319&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,200&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Severance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">926&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">744&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,353&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total severance</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">946&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">744&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,353&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Income from Operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Imaging Centers</span></td><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">72,116&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">77,882&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/><td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">12,641&#160;</span></td><td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">AI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(25,753)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(4,438)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(3,221)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total income from operations</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">46,363&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">73,444&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">9,420&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140483006271616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock', window );">Schedule of Goodwill and Other Intangible Assets</a></td>
<td class="text">for the years ended December 31, 2021 and December 31, 2022 is provided below (in thousands):<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">                </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.672%"><tr><td style="width:1.0%"/><td style="width:33.882%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.482%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.596%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.482%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.937%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.482%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.139%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Imaging Center</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Artificial Intelligence</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">448,269&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,610&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">472,879&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,864&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,864&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Measurement period and other adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489,210&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,610&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">513,820&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,551&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,697&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169,248&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disposals</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,200)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,200)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Measurement period and other adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(106)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,028&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,272)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,244)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">606,483&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,182&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">677,665&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of Annual Amortization Expense</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables shows annual amortization expense, by asset classes that will be recorded over the next five years (in thousands):&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:22.464%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.332%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted average amortization period remaining in years</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Management Service Contracts</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,287&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,287&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,287&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,287&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,287&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,958&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20,393&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8.9</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Covenant not to compete and other contracts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,319&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">891&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">642&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">356&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,320&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.1</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Customer Relationships</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,244&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,244&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,112&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">991&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">816&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,396&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,803&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18.6</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Patent and Trademarks</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">298&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">298&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">298&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">298&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">298&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">322&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,812&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.4</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Developed Technology &amp; Software</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,297&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,297&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,297&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,257&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,722&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,196&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">38,066&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.7</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trade Names amortized</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">702&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.5</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trade Names indefinite life</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,100&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,100&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">IPR&amp;D</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,032&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,032&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Annual Amortization</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,750&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,094&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,713&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,266&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,272&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">53,133&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">106,228&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140483006144400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment and accumulated depreciation and amortization are as follows (in thousands):</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical equipment</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">649,034&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560,301&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer and office equipment, furniture and fixtures</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,467&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,766&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software development costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,015&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">501,963&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">441,921&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment originally acquired under finance/capital lease</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,971&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,984&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment cost</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,320,700&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,161,222&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(754,739)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(676,975)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">565,961&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">484,247&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140483008260592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CREDIT FACILITIES AND NOTES PAYABLE (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of Revolving Credit Facility, Notes Payable, and Capital Lease Obligations</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022 and December 31, 2021 our debt obligations consisted of the following (in thousands):</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Lien Term Loans collateralized by RadNet's tangible and intangible assets</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">714,125&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">721,375&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount on First Lien Term Loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,127)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,213)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan Agreement collateralized by NJIN's tangible and intangible assets</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,000&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,500&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount on NJIN Term Loan Agreement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,254)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt obligations</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">851,744&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">754,662&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,400)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,164)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term portion debt obligations</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">839,344&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743,498&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of Annual Principal Maturities of Notes Payable</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a listing of annual principal maturities of notes payable exclusive of all related discounts and repayments on our revolving credit facilities for years ending December&#160;31 (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:84.090%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.710%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,750&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,750&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,500&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,500&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,750&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">677,875&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total notes payable obligations</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">864,125&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_ScheduleOfLeverageRatioTableTextBlock', window );">Schedule of Leverage Ratio</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All obligations under the Second Amended and Restated Credit and Term Loan Agreement bear interest at either a SOFR or a Base Rate (each as defined in the Restated Credit and Term Loan Agreement), plus an applicable margin according to the following schedule:</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.128%"><tr><td style="width:1.0%"/><td style="width:8.790%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.761%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.226%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.226%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.697%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.700%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pricing Level</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Leverage Ratio</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Applicable Margin for SOFR Loans</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Applicable Margin for Base Rate Loans</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Applicable Margin for Letter of Credit Fees</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Applicable Percentage for Commitment Fee</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than or equal to 3.00:1.00</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.50%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.50%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.45%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">II</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 3.00:1.00 but greater than or equal to 2.50:1.00</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.25%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.40%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">III</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 2.50:1.00 but greater than or equal to</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00:1.00</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.00%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.35%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IV</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 2.00:1.00 but greater than or equal to 1.50:1.00</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.75%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.75%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.75%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.30%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">V</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 1.50:1.00</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.50%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.30%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">per annum</span></div></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revolving loans borrowed under the Barclays Revolving Credit Facility bear interest at either a Eurodollar Rate or an Alternate Base Rate (in each case, as defined in the Restated Credit Agreement) plus an applicable margin which adjusts depending on our first lien net leverage ratio, according to the following schedule:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.181%"><tr><td style="width:1.0%"/><td style="width:31.850%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.342%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.508%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">First Lien Leverage Ratio</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Eurodollar Rate Spread</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Base Rate Spread</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&gt; 3.50x</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.25%</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25%</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&gt; 3.00x but &#8804; 3.50x</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.00%</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00%</span></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8804; 3.00x</span></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.75%</span></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.75%</span></div></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ScheduleOfLeverageRatioTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Leverage Ratio [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ScheduleOfLeverageRatioTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140482999529200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of Lease, Cost</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The components of lease expense were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:58.197%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.251%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.252%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="6" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,475&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,578&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Depreciation of leased equipment</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,896&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,068&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Interest on lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total finance lease cost</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,896&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,114&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1) Operating lease cost above for the year ended December 31, 2021 included $12.6 million in lease abandonment charges.  Please see our discussion in the Leases section of Note 2, Summary of Significant Accounting Policies.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock', window );">Schedule of Cash Flow, Supplemental Disclosures</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Supplemental cash flow information related to leases was as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="6" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Operating cash flows from operating leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,004&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,288&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Operating cash flows from financing leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Financing cash flows from financing leases</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,304&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use &amp; Equipment assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Operating leases</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,080&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186,695&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1) On December 31, 2021 we reduced our liability and eliminated the related right-of-use assets for future lease options at facilities that we elected to abandon.  The amount of liability and right-of-use asset reduction amounted to approximately $3.3 million.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_AssetsAndLiabilitiesLesseeTableTextBlock', window );">Schedule of Assets and Liabilities Lessee</a></td>
<td class="text">Supplemental balance sheet information related to leases was as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(In thousands, except lease term and discount rates)</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Leases</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">603,524&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">584,291&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liability</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,607&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,452&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">604,117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577,675&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total operating lease liabilities</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661,724&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">643,127&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance Leases</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment at cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,971&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,984&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTozNDY2MGIzODgyOWY0NDQ5YWU5YzQ1YmYzZTBlZmM1ZC90YWJsZXJhbmdlOjM0NjYwYjM4ODI5ZjQ0NDlhZTljNDViZjNlMGVmYzVkXzExLTAtMS0xLTI5NDg5_464c3404-1439-4afe-a7f8-0d3a4f94b53d"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTozNDY2MGIzODgyOWY0NDQ5YWU5YzQ1YmYzZTBlZmM1ZC90YWJsZXJhbmdlOjM0NjYwYjM4ODI5ZjQ0NDlhZTljNDViZjNlMGVmYzVkXzExLTAtMS0xLTI5NDg5_bc4c3e84-e956-46a8-b461-0698bb31e9ec">Accumulated depreciation</span></span></span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,171)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,287)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment, net</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,801&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,697&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Remaining Lease Term</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases - years</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Discount Rate</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Maturities of Operating Lease Liability</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Maturities of lease liabilities were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"/><td style="width:59.904%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:37.896%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Operating Leases</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year Ending December 31,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,371&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,436&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,941&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,872&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,136&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499,326&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total Lease Payments</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">941,082&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(279,358)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661,724&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_AssetsAndLiabilitiesLesseeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>[Table Text Block] for Assets And Liabilities Lessee [Table]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_AssetsAndLiabilitiesLesseeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of supplemental cash flow information for the periods presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140483009008048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Schedule of Income before Income Tax, Domestic and Foreign</a></td>
<td class="text">For the years ended December 31, 2022, 2021 and 2020, we have the following income (loss) before income taxes (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">US Domestic</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,529&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,806&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(986)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,560)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before income taxes</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,969&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,879&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(854)</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Components of Income Tax Expense</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December 31, 2022, 2021 and 2020, we recognized income tax expense comprised of the following (in thousands):</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal current tax</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(256)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State current tax</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">371&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,191)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,608)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign current tax</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal deferred tax</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,470&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,831&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(303)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State deferred tax</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,863&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,902&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,035&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign deferred tax</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,430)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,361&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,560&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">895&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Reconciliation of Income Tax Expense</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the statutory U.S. federal rate and effective rates is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"/><td style="width:60.854%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.178%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.551%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.551%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.178%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.551%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.551%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.779%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.407%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="24" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal tax</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,023&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,365&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(179)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State franchise tax, net of federal benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">595&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,198&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">779&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Non deductible expenses</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(93)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Officer Compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">759&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests in partnerships</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,821)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,114)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,748)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(249)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Return to provision</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,530)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,252)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PPP Loan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(850)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred true-ups and other</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,451)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,009&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,840&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign rate differential</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(737)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncertain tax provisions</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(749)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(321)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,036&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other differences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,361&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,560&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">895&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets and Liabilities</a></td>
<td class="text">Our deferred tax assets and liabilities comprise the following (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating losses</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,124&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,663&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,941&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142,347&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,440&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,387&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,993&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,071&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,711&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,541&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,532&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,095)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,066)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Deferred Tax Assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216,316&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210,548&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,214)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,134)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38,820)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33,973)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,640)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,133)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use asset</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(129,802)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(128,868)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outside basis difference</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,015)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,081)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,587)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Deferred Tax Liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(225,572)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(195,695)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Deferred Tax (Liability) Asset</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,256)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,853&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock', window );">Schedule of Unrecognized Tax Benefits</a></td>
<td class="text">A reconciliation of the total gross amounts of unrecognized tax benefits for the years ended are as follows (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of year</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,088&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,484&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,320&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to prior year tax positions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,382&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to current year tax positions</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expiration of the statute of limitations for the assessment of taxes</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(999)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(713)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(221)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase (decrease) related to change in rate</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of year</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,144&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,088&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,484&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 55<br> -Paragraph 217<br> -URI https://asc.fasb.org/extlink&amp;oid=126976462&amp;loc=d3e36027-109320<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140483009094576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Options Activity</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes all of our option transactions for the twelve months ended December 31, 2022:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:44.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.822%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.822%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.822%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.824%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding Options<br/>Under the 2006 Plan</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise price<br/>Per Common Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Remaining<br/>Contractual<br/>Life(in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2021</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473,939&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.38&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229,975&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25,000)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.75&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">678,914&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.07</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,416,774&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 31, 2022</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483,969&#160;</span></td><td style="background-color:#eeeeee;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.01&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.93</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,381,451&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"><tr><td style="width:1.0%"/><td style="width:46.197%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.550%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.161%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.550%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.161%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.550%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.912%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.550%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.069%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outstanding Options<br/>Under the Deep Health Plan</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise price<br/>Per Common Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Remaining<br/>Contractual Life<br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2021</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320,660&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(203,678)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2022</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,982&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.80</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,202,771&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,909&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.80</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,448,198&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock', window );">Schedule of RSA Activity</a></td>
<td class="text">The following summarizes all unvested RSA&#8217;s activities during the twelve months ended December 31, 2022:&#160;<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSA's</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average<br/>Remaining<br/>Contractual<br/>Term (Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSA's unvested at December 31, 2021</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">456,075&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.06&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes during the period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">649,901&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.33&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(563,731)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,478)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.76&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSA's unvested at December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">536,767&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.01</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.84&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock', window );">Schedule of LTIPs</a></td>
<td class="text">The following summarizes all unvested LTIPs activities during the twelve months ended December 31, 2022:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.099%"><tr><td style="width:1.0%"/><td style="width:61.642%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.822%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.545%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.822%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.545%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.824%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">LTIPs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Remaining<br/>Contractual<br/>Term (Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Fair Value</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LTIPs unvested at December 31, 2021</span></td><td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes during the period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180,612&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.56&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited or Canceled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,141)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LTIPs unvested at December 31, 2022</span></td><td colspan="2" style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169,471&#160;</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td colspan="3" style="background-color:#dbdbdb;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.69</span></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.56&#160;</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock units.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140483003625776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NATURE OF BUSINESS (Details Narrative)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>center </div>
<div>loan</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_NumberOfCenters', window );">Number of centers | center</a></td>
<td class="nump">357<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | loan</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues', window );">BRMG and NY Groups revenues</a></td>
<td class="nump">$ 189,100<span></span>
</td>
<td class="nump">$ 179,600<span></span>
</td>
<td class="nump">$ 147,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense', window );">BRMG and NY Groups operating expenses</a></td>
<td class="nump">189,100<span></span>
</td>
<td class="nump">179,600<span></span>
</td>
<td class="nump">147,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax', window );">Management services provided to BRMG and NY Groups</a></td>
<td class="nump">786,500<span></span>
</td>
<td class="nump">749,200<span></span>
</td>
<td class="nump">$ 600,700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">BRMG and NY Groups accounts receivable</a></td>
<td class="nump">2,433,907<span></span>
</td>
<td class="nump">2,058,474<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">BRMG and NY Groups accounts payable</a></td>
<td class="nump">$ 1,942,455<span></span>
</td>
<td class="nump">1,712,317<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_ScriptSenderLLCMember', window );">ScriptSender LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity interest percentage</a></td>
<td class="nump">49.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Book value of RadNet joint venture interests</a></td>
<td class="nump">$ 3,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_ScriptSenderLLCMember', window );">ScriptSender LLC | Operating Expense | Equity Method Investee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty', window );">Expenses with related party</a></td>
<td class="nump">2,100<span></span>
</td>
<td class="nump">1,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember', window );">Variable Interest Entity, Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">BRMG and NY Groups accounts receivable</a></td>
<td class="nump">110,300<span></span>
</td>
<td class="nump">89,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">BRMG and NY Groups accounts payable</a></td>
<td class="nump">$ 16,200<span></span>
</td>
<td class="nump">$ 14,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_NumberOfCenters">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Centers</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_NumberOfCenters</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense between the reporting entity and the Variable Interest Entity (VIE).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph d<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5747-111685<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the amount of pre-tax income (loss) derived by the reporting entity from the Variable Interest Entity (VIE).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph d<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5747-111685<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income between the reporting entity and the Variable Interest Entity (VIE).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph d<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5747-111685<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_ScriptSenderLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_ScriptSenderLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=us-gaap_OperatingExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=us-gaap_OperatingExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_EquityMethodInvesteeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_EquityMethodInvesteeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140482998189888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Summary of Net Revenue) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue</a></td>
<td class="nump">$ 1,430,061<span></span>
</td>
<td class="nump">$ 1,315,077<span></span>
</td>
<td class="nump">$ 1,071,840<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rdnt_ImagingCenterSegmentRevenueMember', window );">Imaging center segment revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue</a></td>
<td class="nump">1,425,665<span></span>
</td>
<td class="nump">1,313,662<span></span>
</td>
<td class="nump">1,071,840<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rdnt_CommercialInsurance1Member', window );">Commercial insurance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue</a></td>
<td class="nump">785,128<span></span>
</td>
<td class="nump">743,462<span></span>
</td>
<td class="nump">584,035<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rdnt_Medicare1Member', window );">Medicare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue</a></td>
<td class="nump">311,124<span></span>
</td>
<td class="nump">280,911<span></span>
</td>
<td class="nump">217,928<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rdnt_Medicaid1Member', window );">Medicaid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue</a></td>
<td class="nump">38,279<span></span>
</td>
<td class="nump">34,731<span></span>
</td>
<td class="nump">25,619<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rdnt_WorkersCompensationPersonalInjury1Member', window );">Workers' compensation/personal injury</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue</a></td>
<td class="nump">51,339<span></span>
</td>
<td class="nump">44,235<span></span>
</td>
<td class="nump">33,478<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rdnt_HealthCarePatientServiceOtherMember', window );">Other patient revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue</a></td>
<td class="nump">31,849<span></span>
</td>
<td class="nump">19,398<span></span>
</td>
<td class="nump">25,314<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rdnt_HealthCareManagementServiceMember', window );">Management fee revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue</a></td>
<td class="nump">22,235<span></span>
</td>
<td class="nump">19,630<span></span>
</td>
<td class="nump">11,253<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rdnt_SoftwareAndTeleradiologyMember', window );">Software and teleradiology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue</a></td>
<td class="nump">14,238<span></span>
</td>
<td class="nump">10,525<span></span>
</td>
<td class="nump">10,798<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_HealthCareOtherMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue</a></td>
<td class="nump">19,428<span></span>
</td>
<td class="nump">12,436<span></span>
</td>
<td class="nump">23,297<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rdnt_CapitationArrangementsMember', window );">Revenue under capitation arrangements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue</a></td>
<td class="nump">152,045<span></span>
</td>
<td class="nump">148,334<span></span>
</td>
<td class="nump">140,118<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rdnt_AIMember', window );">AI segment revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue</a></td>
<td class="nump">$ 4,396<span></span>
</td>
<td class="nump">$ 1,415<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rdnt_ImagingCenterSegmentRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rdnt_ImagingCenterSegmentRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rdnt_CommercialInsurance1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rdnt_CommercialInsurance1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rdnt_Medicare1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rdnt_Medicare1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rdnt_Medicaid1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rdnt_Medicaid1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rdnt_WorkersCompensationPersonalInjury1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rdnt_WorkersCompensationPersonalInjury1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rdnt_HealthCarePatientServiceOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rdnt_HealthCarePatientServiceOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rdnt_HealthCareManagementServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rdnt_HealthCareManagementServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rdnt_SoftwareAndTeleradiologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rdnt_SoftwareAndTeleradiologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_HealthCareOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_HealthCareOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rdnt_CapitationArrangementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rdnt_CapitationArrangementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rdnt_AIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rdnt_AIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140483008958640">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Accounts Payable and Accrued Expenses) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">$ 102,678<span></span>
</td>
<td class="nump">$ 86,461<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">181,574<span></span>
</td>
<td class="nump">93,420<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued salary and benefits</a></td>
<td class="nump">62,072<span></span>
</td>
<td class="nump">62,425<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Accrued professional fees</a></td>
<td class="nump">23,271<span></span>
</td>
<td class="nump">21,631<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Total</a></td>
<td class="nump">$ 369,595<span></span>
</td>
<td class="nump">$ 263,937<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140482918981456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Narrative)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="2">24 Months Ended</th>
<th class="th" colspan="1">40 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Nov. 01, 2022 </div>
<div>USD ($) </div>
<div>center</div>
</th>
<th class="th">
<div>Jan. 20, 2022 </div>
<div>USD ($) </div>
<div>loan </div>
<div>shares</div>
</th>
<th class="th">
<div>Nov. 05, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 01, 2018 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>incentivePlan </div>
<div>investment </div>
<div>jointVenture</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 01, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 15, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jul. 01, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 11, 2019 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2019 </div>
<div>USD ($) </div>
<div>agreement</div>
</th>
<th class="th">
<div>Jan. 01, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2016 </div>
<div>USD ($) </div>
<div>agreement</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GovernmentAssistanceStatementOfFinancialPositionExtensibleEnumeration', window );">Government Assistance, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Deferred revenue<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_ContractsReceivableFactoringReceivable', window );">Factoring receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,400,000<span></span>
</td>
<td class="nump">$ 17,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,430,061,000<span></span>
</td>
<td class="nump">1,315,077,000<span></span>
</td>
<td class="nump">$ 1,071,840,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Deferred financing costs, net of accumulated amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,300,000<span></span>
</td>
<td class="nump">2,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">677,665,000<span></span>
</td>
<td class="nump">513,820,000<span></span>
</td>
<td class="nump">472,879,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">513,820,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite lived intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,100,000<span></span>
</td>
<td class="nump">20,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Loss on impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">4,170,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration', window );">Impairment, Long-Lived Asset, Held-for-Use, Statement of Income or Comprehensive Income [Extensible Enumeration]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Gain (Loss) on Termination of Lease<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_OperatingLeaseLeaseAbandonmentCharge', window );">Lease abandonment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WorkersCompensationLiabilityCurrent', window );">Workers' compensation liability, current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,900,000<span></span>
</td>
<td class="nump">3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_MedicalMalpracticeDeductiblePerIncidence', window );">Medical malpractice deductible per incidence</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch', window );">Employer matching contribution, percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent', window );">Employee contribution, percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanCostRecognized', window );">Expected employee contribution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans', window );">Number of plans | incentivePlan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Shares authorized (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Accumulated other comprehensive income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 332,995,000<span></span>
</td>
<td class="nump">228,904,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">228,904,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestments', window );">Number of investments | investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_NumberofUnconsolidatedJointVentures', window );">Number of unconsolidated joint ventures | jointVenture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_ManagementServiceFees', window );">Management service fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,200,000<span></span>
</td>
<td class="nump">19,600,000<span></span>
</td>
<td class="nump">11,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_MedicVisionMember', window );">Medic Vision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentAggregateCost', window );">Total net assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity interest percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14.21%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_TurnerImagingSystemsMember', window );">Turner Imaging Systems</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Investment at cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_EquityMethodInvestmentSharesPurchased', window );">Shares purchased (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion', window );">Preferred stock issued upon conversion (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_TurnerImagingSystemsMember', window );">Turner Imaging Systems | Promissory note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Convertible promissory note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_WhiteRabbitaiIncMember', window );">WhiteRabbit.ai Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Investment at cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToFundLongtermLoansToRelatedParties', window );">Payments to fund loan to related parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_ArizonaDiagnosticsGroupMember', window );">Arizona Diagnostics Group</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity interest percentage</a></td>
<td class="nump">49.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Investment at cost</a></td>
<td class="nump">$ 12,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_EquityMethodInvestmentAdditionalContribution', window );">Additional contribution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_NumberOfAssetsSold', window );">Number of assets sold | center</a></td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity', window );">Different between the sales price and carrying value</a></td>
<td class="num">$ (500,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDividendsReceived', window );">Received a dividend from the partnership</a></td>
<td class="nump">4,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Book value of RadNet joint venture interests</a></td>
<td class="nump">8,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember', window );">Forecast</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_MonthlyAmortizationOfDeferredHedgeGains', window );">Monthly amortization of deferred hedge gains</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember', window );">Forecast | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_MonthlyAmortizationOfDeferredHedgeGains', window );">Monthly amortization of deferred hedge gains</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember', window );">Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Accumulated other comprehensive income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=rdnt_Caps2016Member', window );">2016 Caps | LIBOR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeBasisSpreadOnVariableRate', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditDerivativesByContractTypeAxis=rdnt_September2020CapMember', window );">September 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditDerivativesByContractTypeAxis=rdnt_October2020CapMember', window );">October 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 350,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecuritiesFinancingTransactionAxis=rdnt_Caps2016Member', window );">2016 Caps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetNumberOfInstrumentsHeld', window );">Number of forward interest rate cap agreements | agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized', window );">Interest rate caps premium liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,300,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecuritiesFinancingTransactionAxis=rdnt_A2019SWAPSMember', window );">2019 SWAPS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetNumberOfInstrumentsHeld', window );">Number of forward interest rate cap agreements | agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecuritiesFinancingTransactionAxis=rdnt_A2019SWAPSMember', window );">2019 SWAPS | 2019 SWAPS - Interest Rate Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecuritiesFinancingTransactionAxis=rdnt_A2019SWAPSMember', window );">2019 SWAPS | 2019 SWAPS - Interest Rate Contracts | LIBOR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeBasisSpreadOnVariableRate', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.96%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecuritiesFinancingTransactionAxis=rdnt_A2019SWAPSMember', window );">2019 SWAPS | October 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetNumberOfInstrumentsHeld', window );">Number of forward interest rate cap agreements | agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecuritiesFinancingTransactionAxis=rdnt_A2019SWAPSMember', window );">2019 SWAPS | October 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetNumberOfInstrumentsHeld', window );">Number of forward interest rate cap agreements | agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecuritiesFinancingTransactionAxis=rdnt_A2019SWAPS1Member', window );">2019 SWAPS1 | 2019 SWAPS - Interest Rate Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecuritiesFinancingTransactionAxis=rdnt_A2019SWAPS1Member', window );">2019 SWAPS1 | 2019 SWAPS - Interest Rate Contracts | LIBOR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeBasisSpreadOnVariableRate', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.05%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember', window );">Quantib</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration to guarantee share value issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,709,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod', window );">Business combination, contingent consideration, liability, period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares', window );">Business acquisition, equity interest issued or issuable, additional number of shares | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">113,303<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution', window );">Business acquisition, equity interest issued or issuable, fair value of additional shares issued after execution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember', window );">Quantib | Contingent Milestone Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration to guarantee share value issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember', window );">Quantib | Cash Holdback</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration to guarantee share value issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_MontclairMember', window );">Montclair</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration to guarantee share value issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_HeartAndLungImagingLimitedMember', window );">Heart and Lung Imaging Limited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">16,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration to guarantee share value issued</a></td>
<td class="nump">$ 10,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,656,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod', window );">Business combination, contingent consideration, liability, period</a></td>
<td class="text">24 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_HeartAndLungImagingLimitedMember', window );">Heart and Lung Imaging Limited | Contingent Milestone Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration to guarantee share value issued</a></td>
<td class="nump">$ 10,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_HeartAndLungImagingLimitedMember', window );">Heart and Lung Imaging Limited | Cash Holdback</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration to guarantee share value issued</a></td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember', window );">Aidence</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Purchase agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones', window );">Number of identified milestones | loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration to guarantee share value issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,158,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneOne', window );">Percent of FDA approval and payout, milestone one</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneTwo', window );">Percent of FDA approval and payout, milestone two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember', window );">Aidence | Contingent Milestone Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration to guarantee share value issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember', window );">Aidence | Cash Holdback</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration to guarantee share value issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceContractAxis=Health Insurance Member', window );">Reinsurance Policy, Type [Axis]: Health Insurance Member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SelfInsuranceReserve', window );">Self-insurance accrual</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,400,000<span></span>
</td>
<td class="nump">6,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade Names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite lived intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Loss on impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment of long lived asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based payment award, award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-based payment award, expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Restated Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based payment award, award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-based payment award, expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Blue Shield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_MedicalInsuranceStopLossPolicyClaimAmount', window );">Stop loss policy claim amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Dignity Health | Glendale Advanced Imaging | Joint Venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityOwnershipPercentage', window );">Economic interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Propery and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">PP&amp;E useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">PP&amp;E useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based payment award, award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-based payment award, expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Restated Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based payment award, award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-based payment award, expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Blue Shield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_MedicalInsuranceStopLossPolicyClaimAmount', window );">Stop loss policy claim amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Dignity Health | Glendale Advanced Imaging | Joint Venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityOwnershipPercentage', window );">Economic interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Propery and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">PP&amp;E useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">PP&amp;E useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=rdnt_ImagingCentersMember', window );">Imaging Centers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 606,483,000<span></span>
</td>
<td class="nump">489,210,000<span></span>
</td>
<td class="nump">448,269,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">489,210,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rdnt_PatientServicesNetMember', window );">Net service fee revenue | eRAD</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,200,000<span></span>
</td>
<td class="nump">10,500,000<span></span>
</td>
<td class="nump">8,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rdnt_BarclaysMember', window );">Barclays</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Total credit facilities outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rdnt_TruistMember', window );">Truist</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Total credit facilities outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemAxis=rdnt_COVID19PandemicMember', window );">C O V I D19 Pandemic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_AdvanceMedicarePayments', window );">Advance medicare payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">39,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_ProceedsFromProviderReliefFunding', window );">Proceeds from provider relief funding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">9,100,000<span></span>
</td>
<td class="nump">$ 26,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_RepaymentOfAdvanceMedicarePayments', window );">Repayment of advance medicare payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,200,000<span></span>
</td>
<td class="nump">$ 8,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GovernmentAssistanceAmountCumulative', window );">Amount in deferred revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_CaresActRefundableClaimPercentage', window );">Refundable claim percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_SocialSecurityTaxEmployerDeferralCARESAct', window );">Deferred social security taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct', window );">Reduction in deferred social security taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemAxis=rdnt_COVID19PandemicMember', window );">C O V I D19 Pandemic | Paycheck Protection Program Loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLoans', window );">Proceeds from loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_AdvanceMedicarePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Advance Medicare Payments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_AdvanceMedicarePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition, Equity Interest Issued or Issuable, Additional Number of Shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition, Equity Interest Issued or Issuable, Fair Value Of Additional Shares Issued After Execution</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Liability, Percent Of FDA Approval And Payout, Milestone One</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Liability, Percent Of FDA Approval And Payout, Milestone Two</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Liability, Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Number Of Identified Milestones</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_CaresActRefundableClaimPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cares Act, Refundable Claim Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_CaresActRefundableClaimPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ContractsReceivableFactoringReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contracts Receivable, Factoring Receivable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ContractsReceivableFactoringReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_EquityMethodInvestmentAdditionalContribution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Additional Contribution</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_EquityMethodInvestmentAdditionalContribution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_EquityMethodInvestmentSharesPurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Shares Purchased</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_EquityMethodInvestmentSharesPurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Securities without Readily Determinable Fair Value, Number Of Investments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) in Social Security Tax, Employer, Deferral, CARES Act</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ManagementServiceFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Management service fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ManagementServiceFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_MedicalInsuranceStopLossPolicyClaimAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Medical Insurance, Stop Loss Policy Claim Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_MedicalInsuranceStopLossPolicyClaimAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_MedicalMalpracticeDeductiblePerIncidence">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Medical Malpractice Deductible Per Incidence</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_MedicalMalpracticeDeductiblePerIncidence</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_MonthlyAmortizationOfDeferredHedgeGains">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Monthly Amortization Of Deferred Hedge Gains</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_MonthlyAmortizationOfDeferredHedgeGains</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_NumberOfAssetsSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Assets Sold</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_NumberOfAssetsSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_NumberofUnconsolidatedJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Unconsolidated Joint Ventures</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_NumberofUnconsolidatedJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_OperatingLeaseLeaseAbandonmentCharge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Lease Abandonment Charge</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_OperatingLeaseLeaseAbandonmentCharge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ProceedsFromProviderReliefFunding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Provider Relief Funding</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ProceedsFromProviderReliefFunding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_RepaymentOfAdvanceMedicarePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Repayment Of Advance Medicare Payments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_RepaymentOfAdvanceMedicarePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Plans</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_SocialSecurityTaxEmployerDeferralCARESAct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Social Security Tax, Employer, Deferral, CARES Act</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_SocialSecurityTaxEmployerDeferralCARESAct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for each share of convertible preferred stock that is converted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21506-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanCostRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanCostRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage employer matches of the employee's percentage contribution matched.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetNumberOfInstrumentsHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of derivative instruments of a particular derivative asset or group of derivative assets held by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetNumberOfInstrumentsHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeBasisSpreadOnVariableRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage points added to the reference rate to compute the variable rate on the interest rate derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeBasisSpreadOnVariableRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentAggregateCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the aggregate cost of investments accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentAggregateCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between amount at which an investment accounted for under the equity method of accounting is carried (reported) on the balance sheet and amount of underlying equity in net assets the reporting Entity has in the investee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unearned premium revenue under contracts issued by an insurance entity that provide protection to the holder of a financial obligation from a financial loss in the event of a default.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GovernmentAssistanceAmountCumulative">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cumulative government assistance recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 832<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128342832&amp;loc=SL128342943-244231<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GovernmentAssistanceAmountCumulative</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GovernmentAssistanceStatementOfFinancialPositionExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes government assistance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 832<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128342832&amp;loc=SL128342943-244231<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GovernmentAssistanceStatementOfFinancialPositionExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of income or comprehensive income that includes impairment of long-lived asset held for use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2921-110230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2921-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToFundLongtermLoansToRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with extending a long-term loan to a related party. Alternate caption: Payments for Advances to Affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToFundLongtermLoansToRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDividendsReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Dividends received on equity and other investments during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3337-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDividendsReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received from principal payments made on loans related to operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SelfInsuranceReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions) of accrued known and estimated losses incurred as of the balance sheet date for which no insurance coverage exists, and for which a claim has been made or is probable of being asserted, typically arising from workmen's compensation-type of incidents and personal injury to nonemployees from accidents on the entity's property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SelfInsuranceReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=SL6759159-111685<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WorkersCompensationLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations and payables pertaining to claims incurred of a workers compensation nature. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WorkersCompensationLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_MedicVisionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_MedicVisionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_TurnerImagingSystemsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_TurnerImagingSystemsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_WhiteRabbitaiIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_WhiteRabbitaiIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_ArizonaDiagnosticsGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_ArizonaDiagnosticsGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=rdnt_Caps2016Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=rdnt_Caps2016Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditDerivativesByContractTypeAxis=rdnt_September2020CapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditDerivativesByContractTypeAxis=rdnt_September2020CapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditDerivativesByContractTypeAxis=rdnt_October2020CapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditDerivativesByContractTypeAxis=rdnt_October2020CapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuritiesFinancingTransactionAxis=rdnt_Caps2016Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuritiesFinancingTransactionAxis=rdnt_Caps2016Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuritiesFinancingTransactionAxis=rdnt_A2019SWAPSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuritiesFinancingTransactionAxis=rdnt_A2019SWAPSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditDerivativesByContractTypeAxis=rdnt_October2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditDerivativesByContractTypeAxis=rdnt_October2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditDerivativesByContractTypeAxis=rdnt_October2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditDerivativesByContractTypeAxis=rdnt_October2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuritiesFinancingTransactionAxis=rdnt_A2019SWAPS1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuritiesFinancingTransactionAxis=rdnt_A2019SWAPS1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=rdnt_ContingentMilestoneConsiderationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=rdnt_ContingentMilestoneConsiderationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=rdnt_CashHoldbackMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=rdnt_CashHoldbackMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_MontclairMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_MontclairMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_HeartAndLungImagingLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_HeartAndLungImagingLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReinsuranceContractAxis=Health Insurance Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReinsuranceContractAxis=Health Insurance Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=rdnt_RestatedPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=rdnt_RestatedPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=rdnt_BlueShieldMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=rdnt_BlueShieldMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=rdnt_DignityHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=rdnt_DignityHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=rdnt_GlendaleAdvancedImagingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=rdnt_GlendaleAdvancedImagingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis=rdnt_JointVentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis=rdnt_JointVentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=rdnt_ProperyAndEquipmentNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=rdnt_ProperyAndEquipmentNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=rdnt_ImagingCentersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=rdnt_ImagingCentersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rdnt_PatientServicesNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rdnt_PatientServicesNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=rdnt_ERADMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=rdnt_ERADMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_BarclaysMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_BarclaysMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_TruistMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_TruistMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnusualOrInfrequentItemAxis=rdnt_COVID19PandemicMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnusualOrInfrequentItemAxis=rdnt_COVID19PandemicMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_PaycheckProtectionProgramLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_PaycheckProtectionProgramLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140483008290304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Reconciliation of Foreign Currency Translation) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CumulativeTranslationAdjustmentSummaryRollForward', window );"><strong>Currency Translation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">Beginning Balance</a></td>
<td class="num">$ (442)<span></span>
</td>
<td class="num">$ (377)<span></span>
</td>
<td class="num">$ (276)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease', window );">Currency Translation Adjustments</a></td>
<td class="num">(3,943)<span></span>
</td>
<td class="num">(65)<span></span>
</td>
<td class="num">(101)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">Ending Balance</a></td>
<td class="num">$ (4,385)<span></span>
</td>
<td class="num">$ (442)<span></span>
</td>
<td class="num">$ (377)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5A<br> -URI https://asc.fasb.org/extlink&amp;oid=123594809&amp;loc=SL116692626-108610<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in cumulative translation adjustment before transfers included in determining net income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CumulativeTranslationAdjustmentSummaryRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CumulativeTranslationAdjustmentSummaryRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140483010292384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Derivatives) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Change in fair value cash flow hedge,&#160;net of taxes</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (19,372)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Change in fair value of cash flow hedge from prior periods reclassified to earnings</a></td>
<td class="num">$ (3,687)<span></span>
</td>
<td class="num">$ (3,695)<span></span>
</td>
<td class="num">$ (3,448)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration', window );">Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</a></td>
<td class="text">Interest expense<span></span>
</td>
<td class="text">Interest expense<span></span>
</td>
<td class="text">Interest expense<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember', window );">Interest Rate Cap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Change in fair value of cash flow hedge from prior periods reclassified to earnings</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 788<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">2019 SWAPS - Interest Rate Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Change in fair value cash flow hedge,&#160;net of taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(20,160)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Amount of gain (loss) recognized in income on derivative (current period ineffective portion)</a></td>
<td class="nump">39,621<span></span>
</td>
<td class="nump">21,670<span></span>
</td>
<td class="num">(2,528)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">2019 SWAPS - Interest Rate Contracts | Interest Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Change in fair value of cash flow hedge from prior periods reclassified to earnings</a></td>
<td class="num">$ (3,687)<span></span>
</td>
<td class="num">$ (3,695)<span></span>
</td>
<td class="nump">$ 3,448<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of income or comprehensive income that includes gain (loss) from derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OffsettingAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OffsettingAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140483003721920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Contingent Consideration) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionContingentConsiderationLineItems', window );"><strong>Business Acquisition, Contingent Consideration [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Amount of income (loss) recognized on contingent consideration</a></td>
<td class="num">$ (325)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember', window );">Aidence</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionContingentConsiderationLineItems', window );"><strong>Business Acquisition, Contingent Consideration [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Beggining balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration', window );">Issuance of contingent consideration</a></td>
<td class="nump">11,453<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Amount of income (loss) recognized on contingent consideration</a></td>
<td class="num">(362)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation', window );">Currency Translation</a></td>
<td class="nump">67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Ending balance</a></td>
<td class="nump">11,158<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember', window );">Quantib</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionContingentConsiderationLineItems', window );"><strong>Business Acquisition, Contingent Consideration [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Beggining balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration', window );">Issuance of contingent consideration</a></td>
<td class="nump">4,581<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Amount of income (loss) recognized on contingent consideration</a></td>
<td class="num">(903)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation', window );">Currency Translation</a></td>
<td class="nump">31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Ending balance</a></td>
<td class="nump">3,709<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_MontclairMember', window );">Montclair</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionContingentConsiderationLineItems', window );"><strong>Business Acquisition, Contingent Consideration [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Beggining balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration', window );">Issuance of contingent consideration</a></td>
<td class="nump">1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Amount of income (loss) recognized on contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation', window );">Currency Translation</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Ending balance</a></td>
<td class="nump">1,200<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_HeartAndLungImagingLimitedMember', window );">Heart and Lung Imaging Limited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionContingentConsiderationLineItems', window );"><strong>Business Acquisition, Contingent Consideration [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Beggining balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration', window );">Issuance of contingent consideration</a></td>
<td class="nump">10,814<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Amount of income (loss) recognized on contingent consideration</a></td>
<td class="nump">566<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation', window );">Currency Translation</a></td>
<td class="nump">276<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Ending balance</a></td>
<td class="nump">$ 11,656<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination Contingent Consideration Arrangements Change In Currency Translation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration Arrangements, Issuance Of Contingent Consideration</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionContingentConsiderationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionContingentConsiderationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_MontclairMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_MontclairMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_HeartAndLungImagingLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_HeartAndLungImagingLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140483002422064">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Fair Value Measurements) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract', window );"><strong>Accrued expenses and other non-current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price</a></td>
<td class="nump">$ 18.83<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Term Loan Agreement and First Lien Term Loans</a></td>
<td class="nump">$ 864,125<span></span>
</td>
<td class="nump">$ 767,875<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract', window );"><strong>Accrued expenses and other non-current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Term Loan Agreement and First Lien Term Loans</a></td>
<td class="nump">843,594<span></span>
</td>
<td class="nump">766,973<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Quantib B.V.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract', window );"><strong>Accrued expenses and other non-current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Business combination, contingent consideration</a></td>
<td class="nump">3,709<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Heart and Lung Imaging Limited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract', window );"><strong>Accrued expenses and other non-current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Business combination, contingent consideration</a></td>
<td class="nump">11,656<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Aidence</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract', window );"><strong>Accrued expenses and other non-current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Business combination, contingent consideration</a></td>
<td class="nump">11,158<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Montclair</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract', window );"><strong>Accrued expenses and other non-current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Business combination, contingent consideration</a></td>
<td class="nump">1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | 2019 SWAPS - Interest Rate Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Other Current Assets and Deposits and Other</a></td>
<td class="nump">23,302<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Accrued expenses and other non-current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,319<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract', window );"><strong>Accrued expenses and other non-current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Term Loan Agreement and First Lien Term Loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 1 | Quantib B.V.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract', window );"><strong>Accrued expenses and other non-current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Business combination, contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 1 | Heart and Lung Imaging Limited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract', window );"><strong>Accrued expenses and other non-current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Business combination, contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 1 | Aidence</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract', window );"><strong>Accrued expenses and other non-current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Business combination, contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 1 | Montclair</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract', window );"><strong>Accrued expenses and other non-current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Business combination, contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 1 | 2019 SWAPS - Interest Rate Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Other Current Assets and Deposits and Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Accrued expenses and other non-current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract', window );"><strong>Accrued expenses and other non-current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Term Loan Agreement and First Lien Term Loans</a></td>
<td class="nump">843,594<span></span>
</td>
<td class="nump">766,973<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 2 | Quantib B.V.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract', window );"><strong>Accrued expenses and other non-current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Business combination, contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 2 | Heart and Lung Imaging Limited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract', window );"><strong>Accrued expenses and other non-current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Business combination, contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 2 | Aidence</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract', window );"><strong>Accrued expenses and other non-current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Business combination, contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 2 | Montclair</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract', window );"><strong>Accrued expenses and other non-current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Business combination, contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 2 | 2019 SWAPS - Interest Rate Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Other Current Assets and Deposits and Other</a></td>
<td class="nump">23,302<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Accrued expenses and other non-current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,319<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract', window );"><strong>Accrued expenses and other non-current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Term Loan Agreement and First Lien Term Loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 3 | Quantib B.V.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract', window );"><strong>Accrued expenses and other non-current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Business combination, contingent consideration</a></td>
<td class="nump">3,709<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 3 | Heart and Lung Imaging Limited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract', window );"><strong>Accrued expenses and other non-current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Business combination, contingent consideration</a></td>
<td class="nump">11,656<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 3 | Aidence</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract', window );"><strong>Accrued expenses and other non-current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Business combination, contingent consideration</a></td>
<td class="nump">11,158<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 3 | Montclair</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract', window );"><strong>Accrued expenses and other non-current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Business combination, contingent consideration</a></td>
<td class="nump">1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 3 | 2019 SWAPS - Interest Rate Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Other Current Assets and Deposits and Other</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Accrued expenses and other non-current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_HeartAndLungImagingLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_HeartAndLungImagingLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_MontclairMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_MontclairMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140483010367264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Earnings Per Share) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss) attributable to RadNet, Inc. common stockholders</a></td>
<td class="nump">$ 10,650<span></span>
</td>
<td class="nump">$ 24,727<span></span>
</td>
<td class="num">$ (14,840)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>BASIC NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average number of common shares outstanding during the period (in shares)</a></td>
<td class="nump">56,293,336<span></span>
</td>
<td class="nump">52,496,679<span></span>
</td>
<td class="nump">50,891,791<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net (loss) income per share attributable to RadNet, inc. common stockholders (in dollars per share)</a></td>
<td class="nump">$ 0.19<span></span>
</td>
<td class="nump">$ 0.47<span></span>
</td>
<td class="num">$ (0.29)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>DILUTED NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average number of common shares outstanding during the period (in shares)</a></td>
<td class="nump">56,293,336<span></span>
</td>
<td class="nump">52,496,679<span></span>
</td>
<td class="nump">50,891,791<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesRestrictedStock', window );">Add nonvested restricted stock subject only to service vesting (in shares)</a></td>
<td class="nump">172,139<span></span>
</td>
<td class="nump">259,539<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants', window );">Add additional shares issuable upon exercise of stock options, warrants and holdback shares (in shares)</a></td>
<td class="nump">855,395<span></span>
</td>
<td class="nump">664,815<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average number of common shares used in calculating diluted net income per share (in shares)</a></td>
<td class="nump">57,320,870<span></span>
</td>
<td class="nump">53,421,033<span></span>
</td>
<td class="nump">50,891,791<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_AdjustmentToNetIncomeAttributableToAssumedShareSettlements', window );">Changes in fair value associated with contingently issuable shares</a></td>
<td class="num">$ (724)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Net income (loss) attributable to RadNet, Inc's common stockholders for diluted share calculation</a></td>
<td class="nump">$ 9,926<span></span>
</td>
<td class="nump">$ 24,727<span></span>
</td>
<td class="num">$ (14,840)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income (loss) per share attributable to RadNet, Inc. common stockholders (in dollars per share)</a></td>
<td class="nump">$ 0.17<span></span>
</td>
<td class="nump">$ 0.46<span></span>
</td>
<td class="num">$ (0.29)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember', window );">Nonvested restricted stock subject to service vesting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract', window );"><strong>Stock options and non-vested restricted awards excluded from the computation of diluted per share amounts as their effect would be antidilutive:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Weighted average shares for which the exercise price exceeds average market price of common stock (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">329,159<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Shares issuable upon the exercise of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract', window );"><strong>Stock options and non-vested restricted awards excluded from the computation of diluted per share amounts as their effect would be antidilutive:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Weighted average shares for which the exercise price exceeds average market price of common stock (in shares)</a></td>
<td class="nump">152,723<span></span>
</td>
<td class="nump">47,792<span></span>
</td>
<td class="nump">554,444<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_AdjustmentToNetIncomeAttributableToAssumedShareSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustment To Net Income Attributable To Assumed Share Settlements</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_AdjustmentToNetIncomeAttributableToAssumedShareSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1828-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1757-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1707-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesRestrictedStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of restricted stock determined by relating the portion of time within a reporting period that restricted shares have been outstanding to the total time in that period. Restricted shares are subject to sales, contractual, regulatory or other restrictions that prevent or inhibit the holder from freely disposing of them before the restriction ends.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e2646-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesRestrictedStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140483010417616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Investment in Joint Ventures) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward', window );"><strong>Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Beginning balance</a></td>
<td class="nump">$ 42,229<span></span>
</td>
<td class="nump">$ 34,528<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_EquityContributionsInExistingAndPurchaseOfInterestInJointVentures', window );">Equity contributions in existing and purchase of interest in joint ventures</a></td>
<td class="nump">9,712<span></span>
</td>
<td class="nump">1,441<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity in earnings in these joint ventures</a></td>
<td class="nump">10,390<span></span>
</td>
<td class="nump">10,967<span></span>
</td>
<td class="nump">$ 7,945<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentDividendsOrDistributions', window );">Distribution of earnings</a></td>
<td class="num">(4,438)<span></span>
</td>
<td class="num">(4,707)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Ending balance</a></td>
<td class="nump">$ 57,893<span></span>
</td>
<td class="nump">$ 42,229<span></span>
</td>
<td class="nump">$ 34,528<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_EquityContributionsInExistingAndPurchaseOfInterestInJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity contributions in existing joint ventures</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_EquityContributionsInExistingAndPurchaseOfInterestInJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentDividendsOrDistributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of distribution received from equity method investee for return on investment, classified as operating activities. Excludes distribution for return of investment, classified as investing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21D<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=SL94080555-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentDividendsOrDistributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity method investee and investment in and advance to affiliate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140483003537760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Key Financial Data on Joint Ventures) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_KeyFinancialDataForJointVentures', window );"><strong>Balance Sheet Data:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Current assets</a></td>
<td class="nump">$ 367,184<span></span>
</td>
<td class="nump">$ 324,264<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Current liabilities</a></td>
<td class="num">(466,723)<span></span>
</td>
<td class="num">(374,784)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Total value of RadNet joint venture interests</a></td>
<td class="nump">57,893<span></span>
</td>
<td class="nump">42,229<span></span>
</td>
<td class="nump">$ 34,528<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net revenue</a></td>
<td class="nump">1,430,061<span></span>
</td>
<td class="nump">1,315,077<span></span>
</td>
<td class="nump">1,071,840<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">33,608<span></span>
</td>
<td class="nump">44,319<span></span>
</td>
<td class="num">(1,749)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_JointVentureInterestMember', window );">Joint Venture Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_KeyFinancialDataForJointVentures', window );"><strong>Balance Sheet Data:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentAggregateCost', window );">Total net assets</a></td>
<td class="nump">106,458<span></span>
</td>
<td class="nump">75,489<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Book value of RadNet joint venture interests</a></td>
<td class="nump">49,564<span></span>
</td>
<td class="nump">34,930<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets', window );">Cost in excess of book value of acquired joint venture interests accounted for as equity method goodwill</a></td>
<td class="nump">8,329<span></span>
</td>
<td class="nump">7,299<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Total value of RadNet joint venture interests</a></td>
<td class="nump">57,893<span></span>
</td>
<td class="nump">42,229<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember', window );">Equity Method Investment, Nonconsolidated Investee or Group of Investees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_KeyFinancialDataForJointVentures', window );"><strong>Balance Sheet Data:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Current assets</a></td>
<td class="nump">39,304<span></span>
</td>
<td class="nump">37,186<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Noncurrent assets</a></td>
<td class="nump">134,694<span></span>
</td>
<td class="nump">73,592<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Current liabilities</a></td>
<td class="num">(29,588)<span></span>
</td>
<td class="num">(12,919)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Noncurrent liabilities</a></td>
<td class="num">(37,952)<span></span>
</td>
<td class="num">(22,370)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net revenue</a></td>
<td class="nump">145,256<span></span>
</td>
<td class="nump">129,023<span></span>
</td>
<td class="nump">101,921<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 21,169<span></span>
</td>
<td class="nump">$ 21,893<span></span>
</td>
<td class="nump">$ 16,850<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_KeyFinancialDataForJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Key Financial Data For Joint Ventures</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_KeyFinancialDataForJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentAggregateCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the aggregate cost of investments accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentAggregateCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the entity's ownership percentage in the investee multiplied by the investee's total equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity method investee and investment in and advance to affiliate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_JointVentureInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_JointVentureInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140483006166896">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Deferred Revenue Recognition) - Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, remaining performance obligation, amount</a></td>
<td class="nump">$ 0.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue, remaining performance obligation, expected timing of satisfaction, period</a></td>
<td class="text">12 months<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140482991900032">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>BUSINESS COMBINATIONS AND RELATED ACTIVITY (Details - Assets and Liabilities Assumed)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Nov. 01, 2022 </div>
<div>USD ($) </div>
<div>loan </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 24, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 09, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 01, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 01, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 01, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 06, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 01, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 01, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 01, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 01, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 01, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 01, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 677,665<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 513,820<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 472,879<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_IFRCLLCSubsidiaryOneMember', window );">I F R C L L C Subsidiary One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total Purchase Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property &amp; Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,910<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right of Use Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,703<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Right of Use Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,703)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_IFRCLLCSubsidiaryTwoMember', window );">I F R C L L C Subsidiary Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total Purchase Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property &amp; Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right of Use Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">857<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,697<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Right of Use Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(857)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_MontclairRadiologicalAssociatesPAMember', window );">Montclair Radiological Associates, P.A.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total Purchase Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 94,877<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property &amp; Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,414<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right of Use Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,665<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">79,690<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,168)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Right of Use Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,124)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration to guarantee share value issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_HeartAndLungImagingLimitedMember', window );">Heart and Lung Imaging Limited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total Purchase Consideration</a></td>
<td class="nump">$ 32,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property &amp; Equipment</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right of Use Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">16,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther', window );">Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Right of Use Liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration to guarantee share value issued</a></td>
<td class="nump">$ 10,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,656<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Shares issued (in shares) | shares</a></td>
<td class="nump">359,002<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="nump">$ 15,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_ChelseaDignosticRadiologyPCMember', window );">Chelsea Dignostic Radiology, P.C.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total Purchase Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property &amp; Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">568<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right of Use Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,132<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Right of Use Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_NorthJerseyImagingCenterLLCMember', window );">North Jersey Imaging Center, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total Purchase Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 104<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property &amp; Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right of Use Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Right of Use Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_IFRCLLCMember', window );">I F R C L L C</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationNumberOfSubsidiariesAcquired', window );">Number of subsidiaries acquired | loan</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_IFRCLLCMember', window );">I F R C L L C | Joint Venture With Calvert Medical Imaging Centers LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationNumberOfSubsidiariesAcquired', window );">Number of subsidiaries acquired | loan</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_PersonalHealthImagingMember', window );">Personal Health Imaging PLLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total Purchase Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,995<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property &amp; Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">576<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right of Use Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">608<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,355<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Right of Use Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(608)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_ZPElmontLLCMember', window );">ZP Elmont LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total Purchase Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,194<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property &amp; Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right of Use Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,005<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Right of Use Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_ZPFreeportLLCMember', window );">ZP Freeport LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total Purchase Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,065<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property &amp; Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,668<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right of Use Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,328<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Right of Use Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_BroadwayMedicalImagingLLCMember', window );">Broadway Medical Imaging LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total Purchase Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,155<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property &amp; Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,076<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right of Use Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">446<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Right of Use Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(446)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_A3235HempsteadLLCMember', window );">3235 Hempstead LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total Purchase Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,386<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property &amp; Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right of Use Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,649<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Right of Use Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_SLZMRealtyLLCMember', window );">SLZM Realty LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total Purchase Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,671<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property &amp; Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,617<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right of Use Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,974<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Right of Use Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_A2012SunriseMerrickLLCMember', window );">2012 Sunrise Merrick LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total Purchase Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,428<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property &amp; Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,741<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right of Use Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">335<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,617<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Right of Use Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(335)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_ZPBaysideLLCMember', window );">ZP Bayside LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total Purchase Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,545<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property &amp; Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,385<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right of Use Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,191<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Right of Use Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,191)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_ZPLaureltonLLCMember', window );">ZP Laurelton LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total Purchase Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,658<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property &amp; Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,530<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right of Use Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,418<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Right of Use Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,418)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_ZPSmithLLCMember', window );">ZP Smith LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total Purchase Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,978<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property &amp; Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,581<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right of Use Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">347<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Right of Use Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,214)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_ZP907NorthernLLCMember', window );">ZP 907 Northern LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total Purchase Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 562<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property &amp; Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">507<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right of Use Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,817<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Right of Use Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,817)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_WilliamMKellyMDIncMember', window );">William M. Kelly MD, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total Purchase Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,346<span></span>
</td>
<td class="nump">$ 4,404<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property &amp; Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99<span></span>
</td>
<td class="nump">701<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">990<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right of Use Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">323<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,379<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,197<span></span>
</td>
<td class="nump">3,653<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,710<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Right of Use Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(323)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,379)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="nump">$ 50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_A60thStreetMRILLCMember', window );">60th Street MRI, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total Purchase Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property &amp; Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right of Use Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">290<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Right of Use Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_ZPParkchesterLLCMember', window );">ZP Parkchester LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total Purchase Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">263<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property &amp; Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">213<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right of Use Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">311<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Right of Use Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(311)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_ZPEasternLLCMember', window );">ZP Eastern LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total Purchase Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,868<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property &amp; Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,801<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right of Use Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,951<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Right of Use Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,951)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_TangentAssociatesLLCMember', window );">Tangent Associates LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total Purchase Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property &amp; Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right of Use Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">379<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Right of Use Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Shares issued (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67,658,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,636<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_MidDelawareImagingPAMember', window );">Mid Delaware Imaging P.A.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total Purchase Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property &amp; Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">590<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right of Use Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,260<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Right of Use Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_BusinessAcquisitionsMember', window );">Business Acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total Purchase Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">142,781<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">79,716<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property &amp; Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,949<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right of Use Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,993<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">106,045<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,864<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,145)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">232<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Right of Use Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,684)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12,993)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,325<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,671<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessCombinationNumberOfSubsidiariesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Number Of Subsidiaries Acquired</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessCombinationNumberOfSubsidiariesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets (Liabilities), Other</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Operating Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Right Of Use Asset</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_IFRCLLCSubsidiaryOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_IFRCLLCSubsidiaryOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_IFRCLLCSubsidiaryTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_IFRCLLCSubsidiaryTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_MontclairRadiologicalAssociatesPAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_MontclairRadiologicalAssociatesPAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_HeartAndLungImagingLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_HeartAndLungImagingLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_ChelseaDignosticRadiologyPCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_ChelseaDignosticRadiologyPCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_NorthJerseyImagingCenterLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_NorthJerseyImagingCenterLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_IFRCLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_IFRCLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=rdnt_JointVentureWithCalvertMedicalImagingCentersLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=rdnt_JointVentureWithCalvertMedicalImagingCentersLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_PersonalHealthImagingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_PersonalHealthImagingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_ZPElmontLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_ZPElmontLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_ZPFreeportLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_ZPFreeportLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_BroadwayMedicalImagingLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_BroadwayMedicalImagingLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_A3235HempsteadLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_A3235HempsteadLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_SLZMRealtyLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_SLZMRealtyLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_A2012SunriseMerrickLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_A2012SunriseMerrickLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_ZPBaysideLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_ZPBaysideLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_ZPLaureltonLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_ZPLaureltonLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_ZPSmithLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_ZPSmithLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_ZP907NorthernLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_ZP907NorthernLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_WilliamMKellyMDIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_WilliamMKellyMDIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_A60thStreetMRILLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_A60thStreetMRILLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_ZPParkchesterLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_ZPParkchesterLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_ZPEasternLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_ZPEasternLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_TangentAssociatesLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_TangentAssociatesLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_MidDelawareImagingPAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_MidDelawareImagingPAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_BusinessAcquisitionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_BusinessAcquisitionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140482917361472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS COMBINATIONS AND RELATED ACTIVITY (Details - Narrative)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Nov. 01, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 15, 2022 </div>
<div>USD ($) </div>
<div>location</div>
</th>
<th class="th">
<div>Apr. 01, 2022 </div>
<div>USD ($) </div>
<div>center </div>
<div>location</div>
</th>
<th class="th">
<div>Jan. 20, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 01, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 01, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>location</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Aug. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 677,665,000<span></span>
</td>
<td class="nump">$ 513,820,000<span></span>
</td>
<td class="nump">$ 472,879,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">565,961,000<span></span>
</td>
<td class="nump">484,247,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Gain (loss) on disposition of property plant equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,529,000)<span></span>
</td>
<td class="num">(8,319,000)<span></span>
</td>
<td class="num">(1,200,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInterestInJointVenture', window );">Payments to acquire additional interest in subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,441,000<span></span>
</td>
<td class="nump">1,441,000<span></span>
</td>
<td class="nump">1,635,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Investment in joint ventures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57,893,000<span></span>
</td>
<td class="nump">42,229,000<span></span>
</td>
<td class="nump">34,528,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1', window );">Contributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest', window );">Sale to noncontrolling interests, net of taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,623,000<span></span>
</td>
<td class="nump">11,610,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Purchase of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,130,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=rdnt_TarzanaMedicalCenterLLCMember', window );">Tarzana Medical Center, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Purchase of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional Paid-in Capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest', window );">Sale to noncontrolling interests, net of taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,623,000<span></span>
</td>
<td class="nump">4,206,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_FrederickCountyRadiologyLLCMember', window );">Frederick County Radiology, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_NumberOfCentersContributed', window );">Number of centers contributed | center</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=rdnt_FrederickHealthHospitalIncMember', window );">Frederick Health Hospital, Inc. | Frederick County Radiology, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Fair value of investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=rdnt_SimiValleyImagingGroupLLCMember', window );">Simi Valley Imaging Group, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Investment in joint ventures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=rdnt_SimiAdventistMember', window );">Simi Adventist</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Investment in joint ventures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=rdnt_FrederickCountyRadiologyLLCMember', window );">Frederick County Radiology, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_NumberOfLocationOfferingMultiModalityServices', window );">Number of location | location</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=rdnt_FrederickCountyRadiologyLLCMember', window );">Frederick County Radiology, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest', window );">Economic interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=rdnt_FrederickCountyRadiologyLLCMember', window );">Frederick County Radiology, LLC | Additional Paid-in Capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Gain (loss) on disposition of property plant equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=rdnt_FrederickCountyRadiologyLLCMember', window );">Frederick County Radiology, LLC | Frederick Health Hospital, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest', window );">Minority partner ownership percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=rdnt_FrederickCountyRadiologyLLCMember', window );">Frederick County Radiology, LLC | Fixed Assets | Frederick Health Hospital, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=rdnt_FrederickCountyRadiologyLLCMember', window );">Frederick County Radiology, LLC | Medical equipment | Frederick Health Hospital, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=rdnt_AdvancedRadiologyAtCapitalRegionLLCMember', window );">Advanced Radiology at Capital Region, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_NumberOfLocationOfferingMultiModalityServices', window );">Number of location | location</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest', window );">Economic interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInterestInJointVenture', window );">Payments to acquire additional interest in subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=rdnt_AdvancedRadiologyAtCapitalRegionLLCMember', window );">Advanced Radiology at Capital Region, LLC | Dimension Health Corporation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest', window );">Economic interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentAggregateCost', window );">Total net assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=rdnt_SimiValleyImagingGroupLLCMember', window );">Simi Valley Imaging Group, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest', window );">Economic interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_NumberOfLocations', window );">Number of locations | location</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1', window );">Contributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=rdnt_SimiValleyImagingGroupLLCMember', window );">Simi Valley Imaging Group, LLC | Simi Valley Imaging Group, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Investment in joint ventures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=rdnt_SimiValleyImagingGroupLLCMember', window );">Simi Valley Imaging Group, LLC | Simi Adventist</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest', window );">Economic interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Investment in joint ventures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=rdnt_WestValleyImagingGroupLLCMember', window );">West Valley Imaging Group, LLC | Subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_NoncontrollingInterestPercentOfOwnershipSold', window );">Noncontrolling interest, percent of ownership sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_ProceedsFromSaleOfInterestInMinorityShareholders', window );">Proceeds from sale of interest in minority shareholders</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Noncontrolling interest, ownership percentage by parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Software developed for internal use</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Amortization period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Amortization period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade Names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Amortization period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember', window );">Measurement Input, Discount Rate | Valuation, Income Approach | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Contingent consideration liability, measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember', window );">Measurement Input, Discount Rate | Valuation, Income Approach | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Contingent consideration liability, measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_HeartAndLungImagingLimitedMember', window );">Heart and Lung Imaging Limited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Business acquisition, percentage of voting interests acquired</a></td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred</a></td>
<td class="nump">$ 31,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Common stock issued as consideration</a></td>
<td class="nump">$ 6,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Shares issued (in shares) | shares</a></td>
<td class="nump">359,002<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionSharePrice', window );">Price per share (dollars per share) | $ / shares</a></td>
<td class="nump">$ 19.06<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Consideration transferred</a></td>
<td class="nump">$ 6,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration to guarantee share value issued</a></td>
<td class="nump">$ 10,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,656,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod', window );">Business combination, contingent consideration, liability, period</a></td>
<td class="text">24 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue', window );">Business combination, noncontrolling interest</a></td>
<td class="nump">$ 8,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets', window );">Current assets acquired</a></td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="nump">15,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities', window );">Liabilities</a></td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">16,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_HeartAndLungImagingLimitedMember', window );">Heart and Lung Imaging Limited | Measurement Input, Discount Rate | Valuation, Income Approach</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Contingent consideration liability, measurement input</a></td>
<td class="nump">0.190<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_HeartAndLungImagingLimitedMember', window );">Heart and Lung Imaging Limited | Contingent Milestone Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration to guarantee share value issued</a></td>
<td class="nump">$ 10,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_HeartAndLungImagingLimitedMember', window );">Heart and Lung Imaging Limited | Cash Holdback</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration to guarantee share value issued</a></td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember', window );">Aidence</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Shares issued (in shares) | shares</a></td>
<td class="nump">359,002<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,141,234<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Consideration transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration to guarantee share value issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,158,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets', window );">Current assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities', window );">Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities', window );">Settlement of loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred tax liabilities acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember', window );">Aidence | Software developed for internal use</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Amortization period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember', window );">Aidence | In-process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember', window );">Aidence | Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Amortization period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years 4 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember', window );">Aidence | Trade Names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Amortization period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember', window );">Aidence | Other Sellers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Common stock issued as consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Shares issued (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,117,872<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionSharePrice', window );">Price per share (dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember', window );">Aidence | Certain Seller</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Common stock issued as consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Shares issued (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,362<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember', window );">Aidence | Contingent Milestone Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration to guarantee share value issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember', window );">Aidence | Cash Holdback</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration to guarantee share value issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember', window );">Quantib</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Common stock issued as consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Shares issued (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">965,058<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Consideration transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration to guarantee share value issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,709,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod', window );">Business combination, contingent consideration, liability, period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets', window );">Current assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities', window );">Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities', window );">Long-term liabilities assumed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember', window );">Quantib | Software developed for internal use</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember', window );">Quantib | In-process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember', window );">Quantib | Other Sellers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionSharePrice', window );">Price per share (dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember', window );">Quantib | Measurement Input, Discount Rate | Valuation, Income Approach | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Contingent consideration liability, measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember', window );">Quantib | Measurement Input, Discount Rate | Valuation, Income Approach | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Contingent consideration liability, measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember', window );">Quantib | Contingent Milestone Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration to guarantee share value issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember', window );">Quantib | Cash Holdback</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration to guarantee share value issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember', window );">Quantib | Business Acsuition Contingent Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Common stock issued as consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Shares issued (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">113,303<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Liability, Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_NoncontrollingInterestPercentOfOwnershipSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interest, Percent Of Ownership Sold</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_NoncontrollingInterestPercentOfOwnershipSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_NumberOfCentersContributed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Centers Contributed</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_NumberOfCentersContributed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_NumberOfLocationOfferingMultiModalityServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Location Offering Multi-Modality Services</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_NumberOfLocationOfferingMultiModalityServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_NumberOfLocations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Locations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_NumberOfLocations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ProceedsFromSaleOfInterestInMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Sale Of Interest In Minority Shareholders</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ProceedsFromSaleOfInterestInMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the fair value of the noncontrolling interest in the acquiree at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure contingent consideration liability from business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of financial liabilities assumed (as defined) which have been recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentAggregateCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the aggregate cost of investments accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentAggregateCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity method investee and investment in and advance to affiliate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage investment held by the managing member or general partner of the limited liability company (LLC) or limited partnership (LP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 272<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6373374&amp;loc=d3e70478-108055<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage investment held by members or limited partners of limited liability company (LLC) or limited partnership (LP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 272<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6373374&amp;loc=d3e70478-108055<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The parent entity's interest in net assets of the subsidiary, expressed as a percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of an asset or business acquired in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in noncontrolling interest from sale of a portion of the parent's controlling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569655-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInterestInJointVenture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the investment in or advances to an entity in which the reporting entity shares control of the entity with another party or group.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInterestInJointVenture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=rdnt_TarzanaMedicalCenterLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=rdnt_TarzanaMedicalCenterLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_FrederickCountyRadiologyLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_FrederickCountyRadiologyLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=rdnt_FrederickHealthHospitalIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=rdnt_FrederickHealthHospitalIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=rdnt_SimiValleyImagingGroupLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=rdnt_SimiValleyImagingGroupLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=rdnt_SimiAdventistMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=rdnt_SimiAdventistMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=rdnt_FrederickCountyRadiologyLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=rdnt_FrederickCountyRadiologyLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=rdnt_FrederickCountyRadiologyLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=rdnt_FrederickCountyRadiologyLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=rdnt_FixedAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=rdnt_FixedAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=rdnt_AdvancedRadiologyAtCapitalRegionLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=rdnt_AdvancedRadiologyAtCapitalRegionLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=rdnt_DimensionHealthCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=rdnt_DimensionHealthCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=rdnt_SimiValleyImagingGroupLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=rdnt_SimiValleyImagingGroupLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=rdnt_WestValleyImagingGroupLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=rdnt_WestValleyImagingGroupLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=srt_SubsidiariesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=srt_SubsidiariesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=us-gaap_IncomeApproachValuationTechniqueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=us-gaap_IncomeApproachValuationTechniqueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_HeartAndLungImagingLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_HeartAndLungImagingLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=rdnt_ContingentMilestoneConsiderationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=rdnt_ContingentMilestoneConsiderationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=rdnt_CashHoldbackMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=rdnt_CashHoldbackMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_AidenceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=rdnt_OtherSellersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=rdnt_OtherSellersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=rdnt_CertainSellerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=rdnt_CertainSellerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_QuantibMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=rdnt_BusinessAcquisitionContingentConsiderationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=rdnt_BusinessAcquisitionContingentConsiderationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140482991808976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT REPORTING (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1">24 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue:</a></td>
<td class="nump">$ 1,430,061<span></span>
</td>
<td class="nump">$ 1,315,077<span></span>
</td>
<td class="nump">$ 1,071,840<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Cost of Operations</a></td>
<td class="nump">1,264,346<span></span>
</td>
<td class="nump">1,135,876<span></span>
</td>
<td class="nump">970,072<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and Amortization</a></td>
<td class="nump">115,877<span></span>
</td>
<td class="nump">96,694<span></span>
</td>
<td class="nump">86,795<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Loss on Disposal of Equipment</a></td>
<td class="nump">2,529<span></span>
</td>
<td class="nump">8,319<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance</a></td>
<td class="nump">946<span></span>
</td>
<td class="nump">744<span></span>
</td>
<td class="nump">4,353<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_OperatingIncomeLossExcludingReliefFunding', window );">Income from Operations</a></td>
<td class="nump">46,363<span></span>
</td>
<td class="nump">73,444<span></span>
</td>
<td class="nump">9,420<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemAxis=rdnt_COVID19PandemicMember', window );">C O V I D19 Pandemic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_ProceedsFromProviderReliefFunding', window );">Proceeds from provider relief funding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">9,100<span></span>
</td>
<td class="nump">26,300<span></span>
</td>
<td class="nump">$ 35,400<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=rdnt_ImagingCentersMember', window );">Imaging Centers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue:</a></td>
<td class="nump">1,425,665<span></span>
</td>
<td class="nump">1,313,662<span></span>
</td>
<td class="nump">1,071,840<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Cost of Operations</a></td>
<td class="nump">1,240,593<span></span>
</td>
<td class="nump">1,130,543<span></span>
</td>
<td class="nump">967,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and Amortization</a></td>
<td class="nump">109,524<span></span>
</td>
<td class="nump">96,174<span></span>
</td>
<td class="nump">86,396<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Loss on Disposal of Equipment</a></td>
<td class="nump">2,506<span></span>
</td>
<td class="nump">8,319<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance</a></td>
<td class="nump">926<span></span>
</td>
<td class="nump">744<span></span>
</td>
<td class="nump">4,353<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_OperatingIncomeLossExcludingReliefFunding', window );">Income from Operations</a></td>
<td class="nump">72,116<span></span>
</td>
<td class="nump">77,882<span></span>
</td>
<td class="nump">12,641<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=rdnt_AIMember', window );">AI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue:</a></td>
<td class="nump">4,396<span></span>
</td>
<td class="nump">1,415<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Cost of Operations</a></td>
<td class="nump">23,753<span></span>
</td>
<td class="nump">5,333<span></span>
</td>
<td class="nump">2,822<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and Amortization</a></td>
<td class="nump">6,353<span></span>
</td>
<td class="nump">520<span></span>
</td>
<td class="nump">399<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Loss on Disposal of Equipment</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_OperatingIncomeLossExcludingReliefFunding', window );">Income from Operations</a></td>
<td class="num">$ (25,753)<span></span>
</td>
<td class="num">$ (4,438)<span></span>
</td>
<td class="num">$ (3,221)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_OperatingIncomeLossExcludingReliefFunding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Income (Loss) Excluding Relief Funding</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_OperatingIncomeLossExcludingReliefFunding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ProceedsFromProviderReliefFunding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Provider Relief Funding</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ProceedsFromProviderReliefFunding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnusualOrInfrequentItemAxis=rdnt_COVID19PandemicMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnusualOrInfrequentItemAxis=rdnt_COVID19PandemicMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=rdnt_ImagingCentersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=rdnt_ImagingCentersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=rdnt_AIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=rdnt_AIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140482998098544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS (Details - Schedule of Goodwill) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">$ 513,820<span></span>
</td>
<td class="nump">$ 472,879<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Additions</a></td>
<td class="nump">169,248<span></span>
</td>
<td class="nump">40,864<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Measurement period and other adjustments</a></td>
<td class="nump">41<span></span>
</td>
<td class="nump">77<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">Disposals</a></td>
<td class="num">(4,200)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Currency translation</a></td>
<td class="num">(1,244)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">677,665<span></span>
</td>
<td class="nump">513,820<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=rdnt_ImagingCentersMember', window );">Imaging Centers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">489,210<span></span>
</td>
<td class="nump">448,269<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Additions</a></td>
<td class="nump">120,551<span></span>
</td>
<td class="nump">40,864<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Measurement period and other adjustments</a></td>
<td class="num">(106)<span></span>
</td>
<td class="nump">77<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">Disposals</a></td>
<td class="num">(4,200)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Currency translation</a></td>
<td class="nump">1,028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">606,483<span></span>
</td>
<td class="nump">489,210<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=rdnt_AIMember', window );">AI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">24,610<span></span>
</td>
<td class="nump">24,610<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Additions</a></td>
<td class="nump">48,697<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Measurement period and other adjustments</a></td>
<td class="nump">147<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">Disposals</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Currency translation</a></td>
<td class="num">(2,272)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">$ 71,182<span></span>
</td>
<td class="nump">$ 24,610<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e961-128460<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of divestiture of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=rdnt_ImagingCentersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=rdnt_ImagingCentersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=rdnt_AIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=rdnt_AIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140482998119184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS (Details - Narrative) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount', window );">Goodwill deductible for tax purpose</a></td>
<td class="nump">$ 154.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortization', window );">Amortization expense</a></td>
<td class="nump">$ 10.1<span></span>
</td>
<td class="nump">$ 4.4<span></span>
</td>
<td class="nump">$ 3.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rdnt_ManagementServiceContractsMember', window );">Management Service Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Amortization period</a></td>
<td class="text">25 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentForAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentForAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rdnt_ManagementServiceContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rdnt_ManagementServiceContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140483002622528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS (Details - Annual Amortization Schedule) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Amortization year 2023</a></td>
<td class="nump">$ 11,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Amortization year 2024</a></td>
<td class="nump">11,094<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Amortization year 2025</a></td>
<td class="nump">10,713<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Amortization year 2026</a></td>
<td class="nump">10,266<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">Amortization year 2027</a></td>
<td class="nump">9,272<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Amortization year thereafter</a></td>
<td class="nump">53,133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite lived intangible assets</a></td>
<td class="nump">24,100<span></span>
</td>
<td class="nump">$ 20,600<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets</a></td>
<td class="nump">106,228<span></span>
</td>
<td class="nump">$ 56,603<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade Names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite lived intangible assets</a></td>
<td class="nump">7,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareDevelopmentMember', window );">Software development costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite lived intangible assets</a></td>
<td class="nump">17,032<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rdnt_ManagementServiceContractsMember', window );">Management Service Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Amortization year 2023</a></td>
<td class="nump">2,287<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Amortization year 2024</a></td>
<td class="nump">2,287<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Amortization year 2025</a></td>
<td class="nump">2,287<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Amortization year 2026</a></td>
<td class="nump">2,287<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">Amortization year 2027</a></td>
<td class="nump">2,287<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Amortization year thereafter</a></td>
<td class="nump">8,958<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Amortiztion total</a></td>
<td class="nump">$ 20,393<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted average amortization period remaining in years</a></td>
<td class="text">8 years 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rdnt_CovenantNotToCompeteMember', window );">Covenant not to compete and other contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Amortization year 2023</a></td>
<td class="nump">$ 1,319<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Amortization year 2024</a></td>
<td class="nump">891<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Amortization year 2025</a></td>
<td class="nump">642<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Amortization year 2026</a></td>
<td class="nump">356<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">Amortization year 2027</a></td>
<td class="nump">72<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Amortization year thereafter</a></td>
<td class="nump">40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Amortiztion total</a></td>
<td class="nump">$ 3,320<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted average amortization period remaining in years</a></td>
<td class="text">3 years 1 month 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Amortization year 2023</a></td>
<td class="nump">$ 1,244<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Amortization year 2024</a></td>
<td class="nump">1,244<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Amortization year 2025</a></td>
<td class="nump">1,112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Amortization year 2026</a></td>
<td class="nump">991<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">Amortization year 2027</a></td>
<td class="nump">816<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Amortization year thereafter</a></td>
<td class="nump">12,396<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Amortiztion total</a></td>
<td class="nump">$ 17,803<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted average amortization period remaining in years</a></td>
<td class="text">18 years 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rdnt_PatentAndTrademarksMember', window );">Patent and Trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Amortization year 2023</a></td>
<td class="nump">$ 298<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Amortization year 2024</a></td>
<td class="nump">298<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Amortization year 2025</a></td>
<td class="nump">298<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Amortization year 2026</a></td>
<td class="nump">298<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">Amortization year 2027</a></td>
<td class="nump">298<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Amortization year thereafter</a></td>
<td class="nump">322<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Amortiztion total</a></td>
<td class="nump">$ 1,812<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted average amortization period remaining in years</a></td>
<td class="text">6 years 4 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rdnt_DevelopedTechnologySoftwareMember', window );">Developed Technology &amp; Software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Amortization year 2023</a></td>
<td class="nump">$ 6,297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Amortization year 2024</a></td>
<td class="nump">6,297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Amortization year 2025</a></td>
<td class="nump">6,297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Amortization year 2026</a></td>
<td class="nump">6,257<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">Amortization year 2027</a></td>
<td class="nump">5,722<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Amortization year thereafter</a></td>
<td class="nump">7,196<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Amortiztion total</a></td>
<td class="nump">$ 38,066<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted average amortization period remaining in years</a></td>
<td class="text">6 years 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade Names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Amortization year 2023</a></td>
<td class="nump">$ 305<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Amortization year 2024</a></td>
<td class="nump">77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Amortization year 2025</a></td>
<td class="nump">77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Amortization year 2026</a></td>
<td class="nump">77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">Amortization year 2027</a></td>
<td class="nump">77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Amortization year thereafter</a></td>
<td class="nump">89<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Amortiztion total</a></td>
<td class="nump">$ 702<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted average amortization period remaining in years</a></td>
<td class="text">4 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rdnt_ManagementServiceContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rdnt_ManagementServiceContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rdnt_CovenantNotToCompeteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rdnt_CovenantNotToCompeteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rdnt_PatentAndTrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rdnt_PatentAndTrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rdnt_DevelopedTechnologySoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rdnt_DevelopedTechnologySoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140483010291824">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization', window );">Equipment at cost</a></td>
<td class="nump">$ 13,971<span></span>
</td>
<td class="nump">$ 13,984<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Total property and equipment cost</a></td>
<td class="nump">1,320,700<span></span>
</td>
<td class="nump">1,161,222<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization', window );">Accumulated depreciation</a></td>
<td class="num">(754,739)<span></span>
</td>
<td class="num">(676,975)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Total property and equipment</a></td>
<td class="nump">565,961<span></span>
</td>
<td class="nump">484,247<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember', window );">Land</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">250<span></span>
</td>
<td class="nump">250<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Medical equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">649,034<span></span>
</td>
<td class="nump">560,301<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Computer and office equipment, furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">119,467<span></span>
</td>
<td class="nump">144,766<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 501,963<span></span>
</td>
<td class="nump">$ 441,921<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation and amortization from plant, property, and equipment and right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140483003684704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT (Details - Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization expense</a></td>
<td class="nump">$ 105,600<span></span>
</td>
<td class="nump">$ 92,300<span></span>
</td>
<td class="nump">$ 83,100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in Progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">73,400<span></span>
</td>
<td class="nump">18,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=rdnt_MedicalEquipmentMember', window );">Medical Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConstructionInProgressGross', window );">Construction in progress, gross</a></td>
<td class="nump">26,600<span></span>
</td>
<td class="nump">2,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=rdnt_ComputerandOfficeEquipmentMember', window );">Computer and Office Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConstructionInProgressGross', window );">Construction in progress, gross</a></td>
<td class="nump">5,300<span></span>
</td>
<td class="nump">6,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember', window );">Software development costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">36,015<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConstructionInProgressGross', window );">Construction in progress, gross</a></td>
<td class="nump">400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">501,963<span></span>
</td>
<td class="nump">441,921<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConstructionInProgressGross', window );">Construction in progress, gross</a></td>
<td class="nump">$ 41,100<span></span>
</td>
<td class="nump">$ 9,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConstructionInProgressGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConstructionInProgressGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=rdnt_MedicalEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=rdnt_MedicalEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=rdnt_ComputerandOfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=rdnt_ComputerandOfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140483002655808">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CREDIT FACILITIES AND NOTES PAYABLE (Details - Schedule of Debt) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt</a></td>
<td class="nump">$ 851,744<span></span>
</td>
<td class="nump">$ 754,662<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt obligations</a></td>
<td class="nump">851,744<span></span>
</td>
<td class="nump">754,662<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less current portion</a></td>
<td class="num">(12,400)<span></span>
</td>
<td class="num">(11,164)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term portion debt obligations</a></td>
<td class="nump">839,344<span></span>
</td>
<td class="nump">743,498<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=rdnt_TermLoanMember', window );">Term Loan | First Lien Term Loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt</a></td>
<td class="nump">714,125<span></span>
</td>
<td class="nump">721,375<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Discount on debt</a></td>
<td class="num">(11,127)<span></span>
</td>
<td class="num">(13,213)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt obligations</a></td>
<td class="nump">714,125<span></span>
</td>
<td class="nump">721,375<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=rdnt_TermLoanMember', window );">Term Loan | Restated Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt</a></td>
<td class="nump">150,000<span></span>
</td>
<td class="nump">46,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Discount on debt</a></td>
<td class="num">(1,254)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt obligations</a></td>
<td class="nump">$ 150,000<span></span>
</td>
<td class="nump">$ 46,500<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=rdnt_TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=rdnt_TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_FirstLienTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_RestatedAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_RestatedAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140483007564784">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CREDIT FACILITIES AND NOTES PAYABLE (Details - Annual Note Payable Maturities)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract', window );"><strong>Maturities of Notes Payables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 14,750<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2024</a></td>
<td class="nump">14,750<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2025</a></td>
<td class="nump">18,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2026</a></td>
<td class="nump">18,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">2027</a></td>
<td class="nump">119,750<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive', window );">Thereafter</a></td>
<td class="nump">677,875<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total notes payable obligations</a></td>
<td class="nump">$ 864,125<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140482998101296">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CREDIT FACILITIES AND NOTES PAYABLE (Details - Additional Information) - Revolving Credit Facility<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Letters of credit outstanding, amount</a></td>
<td class="nump">$ 7,600,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Barclays</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Credit facility, borrowings available</a></td>
<td class="nump">187,400,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">SunTrust | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facilities available</a></td>
<td class="nump">50,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">First Lien Credit Agreement | Barclays | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Total credit facilities outstanding</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">First Lien Credit Agreement | SunTrust | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Total credit facilities outstanding</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">First Lien Credit Agreement Eighth Amendment | Barclays | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facilities available</a></td>
<td class="nump">$ 195,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LettersOfCreditOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LettersOfCreditOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=rdnt_BarclaysMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=rdnt_BarclaysMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=rdnt_SunTrustMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=rdnt_SunTrustMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementEighthAmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementEighthAmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140482914498656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CREDIT FACILITIES AND NOTES PAYABLE (Details- Second Amended and Restated First Lien Credit and Guaranty Agreement) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 23, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Oct. 07, 2022</div></th>
<th class="th"><div>Aug. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Deferred financing costs, net of accumulated amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,300,000<span></span>
</td>
<td class="nump">$ 2,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 1,496,000<span></span>
</td>
<td class="num">$ (4,047,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAxis=rdnt_BarclaysMember', window );">Barclays</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="nump">$ 6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Barclays</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Deferred financing costs, net of accumulated amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember', window );">Medium-term Notes | Barclays</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Total credit facilities outstanding</a></td>
<td class="nump">725,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember', window );">Medium-term Notes | Truist</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Total credit facilities outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | Revolving Credit Facility | Truist</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facilities available</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | Revolving Credit Facility | First Lien Credit Agreement Eighth Amendment | Barclays</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facilities available</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">195,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | Revolving Credit Facility | First Lien Credit Agreement Eighth Amendment | Truist</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facilities available</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Deferred financing costs, net of accumulated amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=rdnt_FirstLienCreditAgreementSeventhAmendmentMember', window );">Amendment No. 7 First Lien Credit Agreement | Barclays</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Issuance costs</a></td>
<td class="nump">14,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountCurrent', window );">Debt instrument, unamortized discount, current</a></td>
<td class="nump">8,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfDeferredCharges', window );">Amortization of deferred charges</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=rdnt_FirstLienCreditAgreementSeventhAmendmentMember', window );">Amendment No. 7 First Lien Credit Agreement | Truist</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountCurrent', window );">Debt instrument, unamortized discount, current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="nump">$ 700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDeferredCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of amortization of deferred charges applied against earnings during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDeferredCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of debt discount to be amortized within one year or within the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=rdnt_BarclaysMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=rdnt_BarclaysMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=rdnt_TruistMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=rdnt_TruistMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementEighthAmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementEighthAmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=rdnt_FirstLienCreditAgreementSeventhAmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=rdnt_FirstLienCreditAgreementSeventhAmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140482998244736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CREDIT FACILITIES AND NOTES PAYABLE (Details - Margin Spread Based on Leverage Ratio, Debt Instrument) (Details) - Restated Agreement<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIMember', window );">Pricing Level I</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum', window );">Leverage ratio, greater than</a></td>
<td class="nump">3.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIIMember', window );">Pricing Level II</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum', window );">Leverage ratio, greater than</a></td>
<td class="nump">2.50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_DebtInstrumentCovenantLeverageRatioMaximum', window );">Leverage ratio, less than</a></td>
<td class="nump">3.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIIIMember', window );">Pricing Level III</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum', window );">Leverage ratio, greater than</a></td>
<td class="nump">2.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_DebtInstrumentCovenantLeverageRatioMaximum', window );">Leverage ratio, less than</a></td>
<td class="nump">2.50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIVMember', window );">Pricing Level IV</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum', window );">Leverage ratio, greater than</a></td>
<td class="nump">1.50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_DebtInstrumentCovenantLeverageRatioMaximum', window );">Leverage ratio, less than</a></td>
<td class="nump">2.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelVMember', window );">Pricing Level V</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_DebtInstrumentCovenantLeverageRatioMaximum', window );">Leverage ratio, less than</a></td>
<td class="nump">1.50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Pricing Level I</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="nump">2.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Unused capacity, commitment fee percentage</a></td>
<td class="nump">0.45%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Pricing Level I | Eurodollar Rate Spread</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">2.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Pricing Level I | Base Rate Spread</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">1.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Pricing Level II</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="nump">2.25%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Unused capacity, commitment fee percentage</a></td>
<td class="nump">0.40%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Pricing Level II | Eurodollar Rate Spread</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">2.25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Pricing Level II | Base Rate Spread</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">1.25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Pricing Level III</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Unused capacity, commitment fee percentage</a></td>
<td class="nump">0.35%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Pricing Level III | Eurodollar Rate Spread</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Pricing Level III | Base Rate Spread</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Pricing Level IV</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="nump">1.75%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Unused capacity, commitment fee percentage</a></td>
<td class="nump">0.30%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Pricing Level IV | Eurodollar Rate Spread</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">1.75%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Pricing Level IV | Base Rate Spread</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">0.75%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Pricing Level V</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="nump">1.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Unused capacity, commitment fee percentage</a></td>
<td class="nump">0.30%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Pricing Level V | Eurodollar Rate Spread</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">1.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Pricing Level V | Base Rate Spread</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">0.50%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_DebtInstrumentCovenantLeverageRatioMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Leverage Ratio, Maximum</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_DebtInstrumentCovenantLeverageRatioMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Liquidity Ratio Required, Minimum</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_PricingLevelIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_RestatedAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_RestatedAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_PricingLevelIIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIIIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_PricingLevelIIIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIVMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_PricingLevelIVMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelVMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_PricingLevelVMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_EurodollarMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_EurodollarMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_BaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140483010431056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CREDIT FACILITIES AND NOTES PAYABLE (Details - Senior Credit Facilities)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember', window );">Medium-term Notes | Truist | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPayment', window );">Debt periodic payment</a></td>
<td class="nump">$ 1.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_DebtInstrumentPeriodicPaymentPercent', window );">Debt periodic payment, percent of total amount</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease', window );">Debt periodic payment, amortization increase</a></td>
<td class="nump">$ 0.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember', window );">Medium-term Notes | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate | Truist</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.28%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienTermLoanMember', window );">First Lien Term Loans | Term Loan | Barclays</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal', window );">Periodic payment, principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Barclays</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Amendment No. 6 First Lien Credit Agreement | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_DebtInstrumentLeverageRatio', window );">Debt instrument, leverage ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Amendment No. 6 First Lien Credit Agreement | Line of Credit | Eurodollar Rate Spread</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.73%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Amendment No. 6 First Lien Credit Agreement | Line of Credit | Eurodollar Rate Spread | 3.5 or less</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Amendment No. 6 First Lien Credit Agreement | Line of Credit | Eurodollar Rate Spread | &#8804; 3.00x</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Amendment No. 6 First Lien Credit Agreement | Line of Credit | Base Rate Spread</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Amendment No. 6 First Lien Credit Agreement | Line of Credit | Base Rate Spread | &#8804; 3.00x</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_DebtInstrumentLeverageRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Leverage Ratio</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_DebtInstrumentLeverageRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_DebtInstrumentPeriodicPaymentPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Periodic Payment, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_DebtInstrumentPeriodicPaymentPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Periodic Payment Terms, Amortization Increase</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments including both interest and principal payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments applied to principal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPaymentPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=rdnt_TruistMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=rdnt_TruistMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_FirstLienTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=rdnt_TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=rdnt_TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=rdnt_BarclaysMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=rdnt_BarclaysMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementSixthAmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementSixthAmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_EurodollarMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_EurodollarMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_LeverageRatioFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_LeverageRatioFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_LeverageRatioThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_LeverageRatioThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_BaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140483002697264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CREDIT FACILITIES AND NOTES PAYABLE (Details - Revolving Credit Facilities) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Aug. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Deferred financing costs, net of accumulated amortization</a></td>
<td class="nump">$ 2,300,000<span></span>
</td>
<td class="nump">$ 2,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Barclays</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Deferred financing costs, net of accumulated amortization</a></td>
<td class="nump">$ 1,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="nump">9.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Truist | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facilities available</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Amendment No. 6 First Lien Credit Agreement | Line of Credit | Eurodollar Rate Spread</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="nump">4.73%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Amendment No. 6 First Lien Credit Agreement | Line of Credit | &#8804; 3.00x | Eurodollar Rate Spread</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember', window );">Letter of Credit | Barclays | Letter of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="nump">0.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Unused capacity, commitment fee percentage</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember', window );">Letter of Credit | Amendment No. 6 First Lien Credit Agreement | Line of Credit | &#8804; 3.00x | Eurodollar Rate Spread</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=rdnt_BarclaysMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=rdnt_BarclaysMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=rdnt_TruistMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=rdnt_TruistMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementSixthAmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementSixthAmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_EurodollarMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_EurodollarMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_LeverageRatioThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_LeverageRatioThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140483002499312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CREDIT FACILITIES AND NOTES PAYABLE (Details - Margin Spread Based on Leverage Ratio) - Line of Credit - Revolving Credit Facility - First Lien Credit Agreement<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">&gt; 3.50x</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_DebtInstrumentLeverageRatio', window );">Debt instrument, leverage ratio</a></td>
<td class="nump">3.50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">&gt; 3.00x but &#8804; 3.50x | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_DebtInstrumentLeverageRatio', window );">Debt instrument, leverage ratio</a></td>
<td class="nump">3.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">&gt; 3.00x but &#8804; 3.50x | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_DebtInstrumentLeverageRatio', window );">Debt instrument, leverage ratio</a></td>
<td class="nump">3.50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">&#8804; 3.00x</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_DebtInstrumentLeverageRatio', window );">Debt instrument, leverage ratio</a></td>
<td class="nump">3.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Eurodollar Rate Spread | &gt; 3.50x</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">3.25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Eurodollar Rate Spread | &gt; 3.00x but &#8804; 3.50x</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">3.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Eurodollar Rate Spread | &#8804; 3.00x</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">2.75%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Base Rate Spread | &gt; 3.50x</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">2.25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Base Rate Spread | &gt; 3.00x but &#8804; 3.50x</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Base Rate Spread | &#8804; 3.00x</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">1.75%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_DebtInstrumentLeverageRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Leverage Ratio</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_DebtInstrumentLeverageRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_LeverageRatioOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_LeverageRatioOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_LeverageRatioTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_LeverageRatioTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_LeverageRatioThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_LeverageRatioThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_EurodollarMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_EurodollarMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_BaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140483010516512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CREDIT FACILITIES AND NOTES PAYABLE (Details - Recent Amendments to Prior Credit Facilities)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Apr. 18, 2019 </div>
<div>USD ($) </div>
<div>amendment</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>loan</div>
</th>
<th class="th">
<div>Oct. 07, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 23, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 28, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 31, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAxis=rdnt_BarclaysMember', window );">Barclays</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_DebtInstrumentNumberOfAmendments', window );">Number of amendments | amendment</a></td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAxis=rdnt_BarclaysMember', window );">Barclays | Medium-term Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Total credit facilities outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 725,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAxis=rdnt_TruistMember', window );">Truist | Medium-term Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Total credit facilities outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementSixthAmendmentMember', window );">Amendment No. 6 First Lien Credit Agreement | Barclays | Medium-term Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Total credit facilities outstanding</a></td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rdnt_PaycheckProtectionProgramLoansMember', window );">Paycheck Protection Program Loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rdnt_PaycheckProtectionProgramLoansMember', window );">Paycheck Protection Program Loans | C O V I D19 Pandemic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">PPP loans, maturity term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_DebtInstrumentNumberofLoansReceived', window );">Number of PPP loans received | loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Truist | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facilities available</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | First Lien Credit Agreement Eighth Amendment | Barclays | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity', window );">Line of credit facility, increase borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 57,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facilities available</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 195,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | First Lien Credit Agreement Eighth Amendment | Truist | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facilities available</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Amendment No. 6 First Lien Credit Agreement | Barclays | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity', window );">Line of credit facility, increase borrowing capacity</a></td>
<td class="nump">$ 20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_DebtInstrumentExtensionPeriod', window );">Debt instrument, extension period</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_DebtInstrumentExtensionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Extension Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_DebtInstrumentExtensionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_DebtInstrumentNumberOfAmendments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Number Of Amendments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_DebtInstrumentNumberOfAmendments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_DebtInstrumentNumberofLoansReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Number of Loans Received</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_DebtInstrumentNumberofLoansReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line of Credit Facility, Increase Borrowing Capacity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LineofCreditFacilityIncreaseBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=rdnt_BarclaysMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=rdnt_BarclaysMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=rdnt_TruistMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=rdnt_TruistMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementSixthAmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementSixthAmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_PaycheckProtectionProgramLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_PaycheckProtectionProgramLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnusualOrInfrequentItemAxis=rdnt_COVID19PandemicMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnusualOrInfrequentItemAxis=rdnt_COVID19PandemicMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementEighthAmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementEighthAmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140483007616496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Details - Additional Information)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount', window );">Operating lease not yet commenced</a></td>
<td class="nump">$ 11.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Operating lease, term of contract</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Operating lease, renewal term</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_LesseeLeaseTermofContract', window );">Lease term of contract</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1', window );">Operating lease, lease not yet commenced, term of contract</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Operating lease, term of contract</a></td>
<td class="text">15 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Operating lease, renewal term</a></td>
<td class="text">35 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_LesseeLeaseTermofContract', window );">Lease term of contract</a></td>
<td class="text">8 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1', window );">Operating lease, lease not yet commenced, term of contract</a></td>
<td class="text">15 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LesseeLeaseTermofContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee Lease Term of Contract</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LesseeLeaseTermofContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee Operating Lease Lease Not Yet Commenced Undiscounted Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease not yet commenced, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140483009174416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Details - Lease Cost) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="nump">$ 107,475<span></span>
</td>
<td class="nump">$ 121,578<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityAbstract', window );"><strong>Finance lease cost:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Depreciation of leased equipment</a></td>
<td class="nump">2,896<span></span>
</td>
<td class="nump">3,068<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestExpense', window );">Interest on lease liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_FinanceLeaseCost', window );">Total finance lease cost</a></td>
<td class="nump">$ 2,896<span></span>
</td>
<td class="nump">3,114<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_OperatingLeaseLeaseAbandonmentCharge', window );">Lease abandonment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,600<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_FinanceLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance Lease Cost</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_FinanceLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_OperatingLeaseLeaseAbandonmentCharge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Lease Abandonment Charge</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_OperatingLeaseLeaseAbandonmentCharge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140483006746416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Details - Supplemental Cash Flows) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_CashFlowLesseeAbstract', window );"><strong>Cash paid for amounts included in the measurement of lease liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flows from operating leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 108,004<span></span>
</td>
<td class="nump">$ 110,288<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestPaymentOnLiability', window );">Operating cash flows from financing leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Financing cash flows from financing leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,304<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract', window );"><strong>Right-of-use &amp; Equipment assets obtained in exchange for lease obligations:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Operating leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 88,080<span></span>
</td>
<td class="nump">$ 186,695<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_OperatingLeaseRightOfUseAssetDecreaseDueToAbandonment', window );">Operating lease asset decrease due to abandonment</a></td>
<td class="nump">$ 3,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_OperatingLeaseLiabilityDecreaseDueToAbandonment', window );">Lease liability, decrease due to abandonment</a></td>
<td class="nump">$ 3,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_CashFlowLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash Flow Lessee [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_CashFlowLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_OperatingLeaseLiabilityDecreaseDueToAbandonment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Liability, Decrease Due To Abandonment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_OperatingLeaseLiabilityDecreaseDueToAbandonment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_OperatingLeaseRightOfUseAssetDecreaseDueToAbandonment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Right-of-Use Asset, Decrease Due To Abandonment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_OperatingLeaseRightOfUseAssetDecreaseDueToAbandonment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Right Of Use Asset Obtained In Exchange For Lease Liability [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestPaymentOnLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest paid on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestPaymentOnLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140483010242624">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LEASES (Details - Supplemental Balance Sheet) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract', window );"><strong>Operating Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">$ 603,524<span></span>
</td>
<td class="nump">$ 584,291<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liability</a></td>
<td class="nump">57,607<span></span>
</td>
<td class="nump">65,452<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities</a></td>
<td class="nump">604,117<span></span>
</td>
<td class="nump">577,675<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">661,724<span></span>
</td>
<td class="nump">643,127<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract', window );"><strong>Finance Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization', window );">Equipment at cost</a></td>
<td class="nump">$ 13,971<span></span>
</td>
<td class="nump">$ 13,984<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]</a></td>
<td class="text">Property Plant and Equipment Net Including Right of Use Assets<span></span>
</td>
<td class="text">Property Plant and Equipment Net Including Right of Use Assets<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization', window );">Accumulated depreciation</a></td>
<td class="num">$ (12,171)<span></span>
</td>
<td class="num">$ (9,287)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Equipment, net</a></td>
<td class="nump">$ 1,801<span></span>
</td>
<td class="nump">$ 4,697<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_WeightedAverageRemainingLeaseTermAbstract', window );"><strong>Weighted Average Remaining Lease Term</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating leases - years</a></td>
<td class="text">10 years 10 months 24 days<span></span>
</td>
<td class="text">10 years 4 months 24 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_LeasesWeightedAverageDiscountRateAbstract', window );"><strong>Weighted Average Discount Rate</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Operating leases</a></td>
<td class="nump">6.40%<span></span>
</td>
<td class="nump">6.30%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance Lease Assets And Liabilities Lessee [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeasesWeightedAverageDiscountRateAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Leases Weighted Average Discount Rate [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeasesWeightedAverageDiscountRateAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Lease Assets And Liabilities Lessee [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_WeightedAverageRemainingLeaseTermAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Remaining Lease Term [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_WeightedAverageRemainingLeaseTermAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated amortization of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140483003421280">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LEASES (Details - Maturities of Operating and Finance Lease) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Operating Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 92,371<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">92,436<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2025</a></td>
<td class="nump">88,941<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2026</a></td>
<td class="nump">85,872<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2027</a></td>
<td class="nump">82,136<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">499,326<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total Lease Payments</a></td>
<td class="nump">941,082<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less imputed interest</a></td>
<td class="num">(279,358)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total</a></td>
<td class="nump">$ 661,724<span></span>
</td>
<td class="nump">$ 643,127<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140483005471840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details - Income (Loss) Before Income Taxes ) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">US Domestic</a></td>
<td class="nump">$ 59,529<span></span>
</td>
<td class="nump">$ 58,806<span></span>
</td>
<td class="num">$ (986)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Foreign</a></td>
<td class="num">(16,560)<span></span>
</td>
<td class="nump">73<span></span>
</td>
<td class="nump">132<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income (loss) before income taxes</a></td>
<td class="nump">$ 42,969<span></span>
</td>
<td class="nump">$ 58,879<span></span>
</td>
<td class="num">$ (854)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140483007555392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details - Income Tax Expense) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal current tax</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (256)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations', window );">State current tax</a></td>
<td class="nump">371<span></span>
</td>
<td class="num">(2,191)<span></span>
</td>
<td class="num">(1,608)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Foreign current tax</a></td>
<td class="nump">87<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal deferred tax</a></td>
<td class="nump">6,470<span></span>
</td>
<td class="nump">9,831<span></span>
</td>
<td class="num">(303)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State deferred tax</a></td>
<td class="nump">5,863<span></span>
</td>
<td class="nump">6,902<span></span>
</td>
<td class="nump">3,035<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">Foreign deferred tax</a></td>
<td class="num">(3,430)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">$ 9,361<span></span>
</td>
<td class="nump">$ 14,560<span></span>
</td>
<td class="nump">$ 895<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current and deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current and deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140482998068256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details - Reconciliation of the Statutory U.S. Federal Rate and Effective Rates) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Federal tax</a></td>
<td class="nump">$ 9,023<span></span>
</td>
<td class="nump">$ 12,365<span></span>
</td>
<td class="num">$ (179)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes', window );">State franchise tax, net of federal benefit</a></td>
<td class="nump">595<span></span>
</td>
<td class="nump">4,198<span></span>
</td>
<td class="nump">779<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther', window );">Other Non deductible expenses</a></td>
<td class="nump">305<span></span>
</td>
<td class="num">(93)<span></span>
</td>
<td class="nump">224<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount', window );">Officer Compensation</a></td>
<td class="nump">759<span></span>
</td>
<td class="nump">291<span></span>
</td>
<td class="nump">77<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense', window );">Noncontrolling interests in partnerships</a></td>
<td class="num">(4,821)<span></span>
</td>
<td class="num">(4,114)<span></span>
</td>
<td class="num">(2,748)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Changes in valuation allowance</a></td>
<td class="nump">6,124<span></span>
</td>
<td class="num">(249)<span></span>
</td>
<td class="num">(33)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes', window );">Return to provision</a></td>
<td class="nump">234<span></span>
</td>
<td class="num">(2,530)<span></span>
</td>
<td class="num">(2,252)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_EffectiveIncomeTaxRateReconciliationPPPLoanAmount', window );">PPP Loan</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(850)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherAdjustments', window );">Deferred true-ups and other</a></td>
<td class="num">(1,451)<span></span>
</td>
<td class="nump">5,009<span></span>
</td>
<td class="nump">4,840<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential', window );">Foreign rate differential</a></td>
<td class="num">(737)<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxContingencies', window );">Uncertain tax provisions</a></td>
<td class="num">(749)<span></span>
</td>
<td class="num">(321)<span></span>
</td>
<td class="nump">1,036<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherReconcilingItems', window );">Other differences</a></td>
<td class="nump">79<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">$ 9,361<span></span>
</td>
<td class="nump">$ 14,560<span></span>
</td>
<td class="nump">$ 895<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_EffectiveIncomeTaxRateReconciliationPPPLoanAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, PPP Loan, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_EffectiveIncomeTaxRateReconciliationPPPLoanAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 740<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126970579&amp;loc=d3e23163-113944<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to noncontrolling interest income (loss) exempt from income taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherReconcilingItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority noncontrolling interest income (loss), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, increase (decrease) in enacted tax rate, prior year income taxes, increase (decrease) in deferred tax asset valuation allowance, and other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherReconcilingItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in income tax contingencies. Including, but not limited to, domestic tax contingency, foreign tax contingency, state and local tax contingency, and other contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140482918839360">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INCOME TAXES (Details - Deferred Tax Assets and Liabilities) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating losses</a></td>
<td class="nump">$ 68,124<span></span>
</td>
<td class="nump">$ 57,663<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals', window );">Accrued expenses</a></td>
<td class="nump">3,941<span></span>
</td>
<td class="nump">3,275<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_DeferredTaxAssetsOperatingLeaseLiabilities', window );">Operating lease liability</a></td>
<td class="nump">142,347<span></span>
</td>
<td class="nump">141,440<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits', window );">Equity compensation</a></td>
<td class="nump">4,387<span></span>
</td>
<td class="nump">2,993<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts', window );">Allowance for doubtful accounts</a></td>
<td class="nump">3,071<span></span>
</td>
<td class="nump">2,711<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">6,541<span></span>
</td>
<td class="nump">7,532<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(12,095)<span></span>
</td>
<td class="num">(5,066)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total Deferred Tax Assets</a></td>
<td class="nump">216,316<span></span>
</td>
<td class="nump">210,548<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesAbstract', window );"><strong>Deferred tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="num">(9,214)<span></span>
</td>
<td class="num">(12,134)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill', window );">Goodwill</a></td>
<td class="num">(38,820)<span></span>
</td>
<td class="num">(33,973)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets', window );">Intangibles</a></td>
<td class="num">(18,640)<span></span>
</td>
<td class="num">(9,133)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets', window );">Operating lease right-of-use asset</a></td>
<td class="num">(129,802)<span></span>
</td>
<td class="num">(128,868)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_DeferredTaxLiabilitiesOutsideBasisDifference', window );">Outside basis difference</a></td>
<td class="num">(20,015)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesOther', window );">Other</a></td>
<td class="num">(9,081)<span></span>
</td>
<td class="num">(11,587)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total Deferred Tax Liabilities</a></td>
<td class="num">(225,572)<span></span>
</td>
<td class="num">(195,695)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Net Deferred Tax (Liability) Asset</a></td>
<td class="num">$ (9,256)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net Deferred Tax (Liability) Asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,853<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_DeferredTaxAssetsOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Operating Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_DeferredTaxAssetsOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liabilities, Operating Right-Of-Use Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_DeferredTaxLiabilitiesOutsideBasisDifference">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liabilities, Outside Basis Difference</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_DeferredTaxLiabilitiesOutsideBasisDifference</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from compensation and benefits costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from intangible assets including goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 740<br> -Section 25<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126966508&amp;loc=d3e9972-128506<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 740<br> -Section 25<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126966508&amp;loc=d3e9979-128506<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140482991797312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details - Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating losses</a></td>
<td class="nump">$ 68,124<span></span>
</td>
<td class="nump">$ 57,663<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized', window );">Deferred tax assets, tax benefit may not be realized</a></td>
<td class="nump">216,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill', window );">Deferred tax liabilities goodwill</a></td>
<td class="nump">38,820<span></span>
</td>
<td class="nump">33,973<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits</a></td>
<td class="nump">4,144<span></span>
</td>
<td class="nump">$ 5,088<span></span>
</td>
<td class="nump">$ 5,484<span></span>
</td>
<td class="nump">$ 4,320<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized', window );">Unrecognized tax benefits, tax impact if recognized</a></td>
<td class="nump">3,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod', window );">Unrecognized tax benefits, income tax penalties and interest accrued during period</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Unrecognized tax benefits, income tax penalties and interest accrued</a></td>
<td class="nump">400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_ForeignOperatingLossCarryforwardsSubjectToExpiration', window );">Foreign Operating Loss Carryforwards, Subject To Expiration</a></td>
<td class="nump">19,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_ForeignOperatingLossCarryforwardsNotSubjectToExpiration', window );">Foreign Operating Loss Carryforwards, Not Subject To Expiration</a></td>
<td class="nump">11,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Tax Authority</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating losses</a></td>
<td class="nump">231,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Operating loss carryforwards, subject to expiration</a></td>
<td class="nump">165,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration', window );">Operating loss carryforwards, not subject to expiration</a></td>
<td class="nump">66,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local Jurisdiction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforward</a></td>
<td class="nump">271,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_RavenHoldingsMember', window );">Raven Holdings | Domestic Tax Authority</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Operating loss carryforwards, subject to expiration</a></td>
<td class="nump">$ 24,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Tax Benefit May Not Be Realized</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ForeignOperatingLossCarryforwardsNotSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Foreign Operating Loss Carryforwards, Not Subject To Expiration</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ForeignOperatingLossCarryforwardsNotSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ForeignOperatingLossCarryforwardsSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Foreign Operating Loss Carryforwards, Subject To Expiration</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ForeignOperatingLossCarryforwardsSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued During Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unrecognized Tax Benefits, Tax Impact If Recognized</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are not subject to expiration dates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are subject to expiration dates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 740<br> -Section 25<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126966508&amp;loc=d3e9972-128506<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 740<br> -Section 25<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126966508&amp;loc=d3e9979-128506<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_RavenHoldingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_RavenHoldingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140483007534960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details - Unrecognized Tax Benefit) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefit, Balance at beginning of year</a></td>
<td class="nump">$ 5,088<span></span>
</td>
<td class="nump">$ 5,484<span></span>
</td>
<td class="nump">$ 4,320<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Increases related to prior year tax positions</a></td>
<td class="nump">55<span></span>
</td>
<td class="nump">317<span></span>
</td>
<td class="nump">1,382<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Increases related to current year tax positions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Expiration of the statute of limitations for the assessment of taxes</a></td>
<td class="num">(999)<span></span>
</td>
<td class="num">(713)<span></span>
</td>
<td class="num">(221)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate', window );">Increase (decrease) related to change in rate</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefit, Balance at end of year</a></td>
<td class="nump">$ 4,144<span></span>
</td>
<td class="nump">$ 5,088<span></span>
</td>
<td class="nump">$ 5,484<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unrecognized Tax Benefits, Increase (Decrease) Change in Enacted Tax Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140483002874128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION (Details Narrative)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jan. 31, 2022 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>incentivePlan </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 15, 2021 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans', window );">Number of plans | incentivePlan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=rdnt_RestatedPlanMember', window );">Restated Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance', window );">Shares available for future issuance, options, warrants, shares of restricted stock and other bonus awards (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,017,233<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_DeepHealthIncMember', window );">DeepHealth, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized stock-based compensation expense | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized expense weighted average period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 months 26 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Options granted (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16.93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Nonvested restricted stock subject to service vesting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">Stock-based compensation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,892,930<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">RSA's unvested (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">536,767<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=rdnt_FutureServiceMember', window );">Future Service</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue', window );">Issuance of stock upon exercise of options | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Shares issuable upon the exercise of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized stock-based compensation expense | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized expense weighted average period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 3 months 25 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Shares issuable upon the exercise of stock options | DeepHealth, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">412,434<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=rdnt_PerformanceBasedStockOptionsMember', window );">Performance Based Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based payment award, award vesting period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="nump">111,925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=rdnt_LongTermIncentivePlanSharesMember', window );">LTIPs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">RSA's unvested (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">169,471<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based payment award, award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-based payment award, expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Restated Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based payment award, award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-based payment award, expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | LTIPs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based payment award, award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based payment award, award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-based payment award, expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Restated Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based payment award, award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-based payment award, expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | LTIPs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based payment award, award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Plans</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-based Payment Award, Options, Grants In Period, Gross, Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of common shares reserved for future issuance related to deferred compensation arrangements with individuals.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=rdnt_RestatedPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=rdnt_RestatedPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_DeepHealthIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_DeepHealthIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=rdnt_FutureServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=rdnt_FutureServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=rdnt_PerformanceBasedStockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=rdnt_PerformanceBasedStockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=rdnt_LongTermIncentivePlanSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=rdnt_LongTermIncentivePlanSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140483008273344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION (Details-Outstanding options and warrants)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Beginning Balance (in shares) | shares</a></td>
<td class="nump">473,939<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares) | shares</a></td>
<td class="num">(25,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Ending Balance (in shares) | shares</a></td>
<td class="nump">678,914<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable at the end (in shares) | shares</a></td>
<td class="nump">483,969<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise price Per Common Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Beginning Balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 9.38<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollars per share) | $ / shares</a></td>
<td class="nump">11.75<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Ending Balance (in dollars per share) | $ / shares</a></td>
<td class="nump">15.72<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable at the end (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 11.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_WeightedAverageRemainingContractualLife', window );"><strong>Weighted Average Remaining Contractual Life(in years)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Balance at end of period</a></td>
<td class="text">6 years 25 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2', window );">Exercisable at the end</a></td>
<td class="text">4 years 11 months 4 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_AggregateIntrinsicValue', window );"><strong>Aggregate Intrinsic Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate value outstanding | $</a></td>
<td class="nump">$ 4,416,774<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate value exercisable | $</a></td>
<td class="nump">$ 4,381,451<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember', window );">Equity Option</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares) | shares</a></td>
<td class="nump">229,975<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise price Per Common Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 28.36<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_DeepHealthIncMember', window );">DeepHealth, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Beginning Balance (in shares) | shares</a></td>
<td class="nump">320,660<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares) | shares</a></td>
<td class="num">(203,678)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Ending Balance (in shares) | shares</a></td>
<td class="nump">116,982<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable at the end (in shares) | shares</a></td>
<td class="nump">76,909<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise price Per Common Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Beginning Balance (in dollars per share) | $ / shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollars per share) | $ / shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Ending Balance (in dollars per share) | $ / shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable at the end (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_WeightedAverageRemainingContractualLife', window );"><strong>Weighted Average Remaining Contractual Life(in years)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Balance at end of period</a></td>
<td class="text">6 years 9 months 18 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2', window );">Exercisable at the end</a></td>
<td class="text">6 years 9 months 18 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_AggregateIntrinsicValue', window );"><strong>Aggregate Intrinsic Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate value outstanding | $</a></td>
<td class="nump">$ 2,202,771<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate value exercisable | $</a></td>
<td class="nump">$ 1,448,198<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_AggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate Intrinsic Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_AggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_WeightedAverageRemainingContractualLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Remaining Contractual Life abstract</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_WeightedAverageRemainingContractualLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term of exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_DeepHealthIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_DeepHealthIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140483003368112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION (Details - RSU's and LTIPs)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jan. 31, 2022 </div>
<div>tranche </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based payment award, award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based payment award, award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward', window );"><strong>RSA's</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Outstanding, beginning balance (in shares)</a></td>
<td class="nump">456,075<span></span>
</td>
<td class="nump">456,075<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">649,901<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(563,731)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,478)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Outstanding, ending balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">536,767<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms', window );">Weighted-Average Remaining Contractual Term (Years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 3 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Beginning balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 20.06<span></span>
</td>
<td class="nump">$ 20.06<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26.33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23.76<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Ending balance (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23.84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">RSA's unvested (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">536,767<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=rdnt_PerformanceBasedStockUnitsMember', window );">Performance Based Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward', window );"><strong>RSA's</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">25,683<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches', window );">Number of vesting traches | tranche</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based payment award, award vesting period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=rdnt_PerformanceBasedStockUnitsMember', window );">Performance Based Stock Units | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Award vesting rights, percentage</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=rdnt_PerformanceBasedStockUnitsMember', window );">Performance Based Stock Units | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Award vesting rights, percentage</a></td>
<td class="nump">200.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=rdnt_PerformanceBasedStockOptionsMember', window );">Performance Based Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches', window );">Number of vesting traches | tranche</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based payment award, award vesting period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=rdnt_PerformanceBasedStockOptionsMember', window );">Performance Based Stock Options | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Award vesting rights, percentage</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=rdnt_PerformanceBasedStockOptionsMember', window );">Performance Based Stock Options | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available in grant (in shares)</a></td>
<td class="nump">111,925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=rdnt_LongTermIncentivePlanSharesMember', window );">LTIPs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward', window );"><strong>RSA's</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">180,612<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms', window );">Weighted-Average Remaining Contractual Term (Years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 8 months 8 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Beginning balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19.56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Ending balance (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19.56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">RSA's unvested (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">169,471<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod', window );">Share Based Compensation Arrangement By Share Based Payment Award, Equity Instruments Other Than Options, Forfeited Or Cancelled In Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11,141)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue', window );">Share Based Compensation Arrangement By Share Based Payment Award, Equity Instruments Other Than Options, Forfeited Or Cancelled Weighted Average Grant Date Fair Value | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=rdnt_LongTermIncentivePlanSharesMember', window );">LTIPs | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based payment award, award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=rdnt_LongTermIncentivePlanSharesMember', window );">LTIPs | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based payment award, award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share Based Compensation Arrangement By Share Based Payment Award, Equity Instruments Other Than Options, Forfeited Or Cancelled In Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share Based Compensation Arrangement By Share Based Payment Award, Equity Instruments Other Than Options, Forfeited Or Cancelled Weighted Average Grant Date Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement by Share-Based Payment Award, Number Of Vesting Tranches</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of equity instruments other than options outstanding, including both vested and non-vested instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=rdnt_PerformanceBasedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=rdnt_PerformanceBasedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=rdnt_PerformanceBasedStockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=rdnt_PerformanceBasedStockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=rdnt_LongTermIncentivePlanSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=rdnt_LongTermIncentivePlanSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>rdnt-20221231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:rdnt="http://www.radnet.com/20221231"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="rdnt-20221231.xsd" xlink:type="simple"/>
    <context id="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i85e5b321a4fb4792b5778ddcc45d31e2_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="icfa616adc19f40628e3dfcc4deec4d62_I20230223">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <instant>2023-02-23</instant>
        </period>
    </context>
    <context id="i04caedaa83604a6990f3710c9c56c537_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibbc4f4e3e435497ba4218694b84e7170_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i72c8ccfb1d004dff8edb67a140b34692_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic8c322d1717c4ac1bdf35faa1ec15017_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i08ae2120de2d443a9249395c939d9db2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8827fd8aae0c45ac99829a7fb259f75c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CapitationArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i8b9fb24ebf5447db9eb3e2b703507952_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CapitationArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i93e177287d564fa0be95b081ae11ddd8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CapitationArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i88190c6477b54e7c8dd36138e1b559d5_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2d953a41c6d9468dbca0b44fc5f607e3_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia3e2118a10c34ab7a36716b00a6d7689_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i631fe7e868d0484cb4e25a85cae0a91e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iac4cd4d1f8df442897db11d5620d8aff_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5ce0185d244440a4acb3004eca085a56_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i404f0df0019f440299547782ff0ce012_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i99fcac4f0fc74d8aace4c8852be510de_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibbbe6648075f46b597abbe27ffaf1a51_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibd177ca06f0e4f359d97359a10eeb1bd_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i006b7ea314fc4246a62dc2614396fb18_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i298a24d3aaec41ea8698fd195ead858e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9d5e574cdbd04637a34823f382a6c58a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic79d3a1f3d0f4fc49bb4724de0a7156c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i081fa83c5ad549cebb5ab4d974f827b3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i101eecb916e744b7aaed50d001dc9bab_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i23849d87eb184c1b9a2d7f9eb8115fbb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0b2862b69f4a469795d00c8dfea6afd9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iff5a453e0ae34e3ea23964a503b82dff_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5dcbd877ab784f1894ed73e70da01d83_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifb50bc5a13564f6a97eb669524009c18_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib946969776ca45ccae82cbfc0c191797_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i949f0d96ac8d4f8facf965ee05a37476_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8e0d2a5109214eacb7c4927e040de2c1_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9f3ededd5ee04ec4aa19a0abbf3d7f77_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic1adea4000aa4578a36583c8f938f522_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AcquisitionsAndAssetPurchasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i63bfeffb69d140e6b2f2ea03ff67d0bf_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AcquisitionsAndAssetPurchasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8a58f6df7fad437ea356f767cbc04a2e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AcquisitionsAndAssetPurchasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic6418d4bd1d040b8a16164a6790b1f63_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AcquisitionsAndAssetPurchasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id1f7abf905284fcaa40bc6081a6bd921_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i886a120ecc15453ab356ce266fd3fcf8_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i28b7664a3050400f83608253e0d1c4ba_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i972be9663bfb45d4a202f7cf617a88c3_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic6625f4cf6e34dd2acb014782fcfff34_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i27608790e25740878c35acf6d5e205e7_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6567c2edd74c415e809b3f8dfbc69d6f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibd09aa04b85b458ca4b4ac2d646daf7b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib0b5e62c4b8e424ba71aa7824dcf3fa1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2cbbe88e8caf4501bfffaebc7f2878cf_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6ada6464a5b842509b8bf074c4eab6e6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie96fcf0fd181417d9610fba554c8f505_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib0d0862fed0f44bf87195bfcd4b82674_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie1933fa68c2f4a878ab49bbb7e97074b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0eb334b8be644046940eed543ae94157_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i98a74a949db8402da4aef3fe694b8e90_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="idf1451719c2f414a821e66141f27fa18_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AcquisitionsAndAssetPurchasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib31322494eca4d5aa1547d0971dc8ac9_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AcquisitionsAndAssetPurchasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iab8ee29b0f704d5582d80f8a1f293200_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AcquisitionsAndAssetPurchasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ibc05bb1c3a004d69a9dd0f6792cba7d0_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AcquisitionsAndAssetPurchasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id1688320e5de4822882dee9ca4e4c9cb_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if0cf47a4282e4868ac20435f2c4eb0f9_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id48fff5740844b57bc700c378e450fa7_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i8850d8ea71334023bc7208f43133ccc1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i90205585203d45b9a541218bf94ecb8f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9617cb12c1c84a2495a0468f42ec6183_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib807cb0974544fe1bde03d660c5eaaf7_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic8a329c56c57456a87d52725a451b145_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i14c67953a7094a6fbf13726da1a68618_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i50107d7096d5469e97d67a3ff03b72b3_D20221101-20221101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2022-11-01</endDate>
        </period>
    </context>
    <context id="i7182ccdde7ae4a0fa8aa3492db312246_I20221101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-01</instant>
        </period>
    </context>
    <context id="i651e6cbf14d5467d82c4f381868cde06_D20221101-20221101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:ArizonaDiagnosticsGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2022-11-01</endDate>
        </period>
    </context>
    <context id="i0852a96e84d740afa49bfe5d275671e7_I20221101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:ArizonaDiagnosticsGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-01</instant>
        </period>
    </context>
    <context id="ib7f3ec194c084b988bc8b154c1692068_I20220401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:FrederickCountyRadiologyLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:FrederickHealthHospitalIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-01</instant>
        </period>
    </context>
    <context id="i76afbed304204c709d14268fe2fc7759_D20220120-20220120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-20</startDate>
            <endDate>2022-01-20</endDate>
        </period>
    </context>
    <context id="iebda58f2b50646b69966fddb55d1e9eb_I20220120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-20</instant>
        </period>
    </context>
    <context id="i0037eb0ed88b4354b067862baa4cefa3_D20220120-20220120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-20</startDate>
            <endDate>2022-01-20</endDate>
        </period>
    </context>
    <context id="ic091556638644c818849ee8b176872d4_I20220120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-20</instant>
        </period>
    </context>
    <context id="i0a34e2b02c7643fd994177cb578613e4_D20211022-20211022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DRTLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-22</startDate>
            <endDate>2021-10-22</endDate>
        </period>
    </context>
    <context id="i12d9fd3f8cce41bd8567698b43e666dd_D20210824-20210824">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:TangentAssociatesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-24</startDate>
            <endDate>2021-08-24</endDate>
        </period>
    </context>
    <context id="i22bc4ace41264830b19ecc0fff6de4f9_I20210824">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:TangentAssociatesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-24</instant>
        </period>
    </context>
    <context id="i5d60f61c473f4e6fb2d9dbbff4ddca06_I20210101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:SimiValleyImagingGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-01</instant>
        </period>
    </context>
    <context id="i1f28b0b82f124664841343311ab008f6_D20210101-20210101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-01-01</endDate>
        </period>
    </context>
    <context id="i890b17585af645948aa4f2d397196445_I20210101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:SimiAdventistMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-01</instant>
        </period>
    </context>
    <context id="i247583bd1aa946988c453d719d97edc0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i087e7761e7004e5c94660aa94d151210_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1795eae17b55485abc0e544e061a5958_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:ScriptSenderLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6562ef04abd84649a113083dcc1c41e7_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:ScriptSenderLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:OperatingExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i735b0a42768a4a3bb87d2987dc055d34_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:ScriptSenderLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:OperatingExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5a0a659fcb0242ad8761501bd118570a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CommercialInsurance1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1f6559bea918495a87128bf382ef7d5a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CommercialInsurance1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9d2544245c6946048647d180b4e3e7e7_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CommercialInsurance1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if9e89507dbdf4fca9acbc6d655b0924f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicare1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6010c9500ed44ea7ac66cbb102ea5441_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicare1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i67dc9135b9ab4673a47ea479a7047db1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicare1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id3adc65b8a2046e69efeb8d95f9b16e0_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicaid1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6ee2b0d6cc73495f962207b14a58c057_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicaid1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i72206c79090b41468a17cf51393b0102_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicaid1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibc941d1b7b8b42c1b2b229203d2d1f68_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:WorkersCompensationPersonalInjury1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4c9a14a2aa8d4c7c92e4d32b28aa7ae3_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:WorkersCompensationPersonalInjury1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ibeee80a28c534eb29afad1b7014b9af5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:WorkersCompensationPersonalInjury1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i72030050603b4a6492bb961b6905bcdd_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCarePatientServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i26f7c190fd9c4fe4b401e5498a9420a5_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCarePatientServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ibb79b974d4be492a91371479cbb32335_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCarePatientServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6d125c78b6c146b6a159d4a476805404_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCareManagementServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iecbeb484fb484458a8ffbf37a3d961c9_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCareManagementServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1abd100dae3f4030bbd2f3ea40e56b5e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCareManagementServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie2a7006c766b4cac84f74a1f76450698_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:SoftwareAndTeleradiologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i508713e09e2f4d37aa8f9bcfe4c9028b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:SoftwareAndTeleradiologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia70d2c625846491db5b174a1557fbcb8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:SoftwareAndTeleradiologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic8b9db45f8f642ba842535ed1f326b09_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i87b7580faff74b7e95b97fc7b8c8893a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i25437a7752974cd98b29076a22f18504_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia31edfbd04f643e3b9f3f2aeff39f4ca_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:ImagingCenterSegmentRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i57f34400483a431dbea4dc0dabc4bc32_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:ImagingCenterSegmentRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3094571dace8441cabbda1c2dbba52bf_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:ImagingCenterSegmentRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ied16739f0ee74364a87daf31d0d396a3_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:AIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i460e15926d1d435b8a643a732b488ddf_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:AIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i63b1d1c0666a4b70a0380796de7d23ed_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:AIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="idece277420ff4a9fa6789878bb4d04bc_D20200101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i506dbb6a5e1c4160b81aac201c17a8cf_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i50ecee342add4902a22e3378fadbd827_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic8140fafc99c43f698a11c6792fc6450_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:PaycheckProtectionProgramLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if6fd3b8a94554fd9a4f614d18e1c3d63_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i60bbb306d434427baf7094fc97918fdc_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i74debba71c9649e0ab1a9f9fa2f11ff8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id1424599069048eca25bf6f55f5a8042_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibb757d76ce5b4ce18bf379dfb73a3226_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i52b880c3739c4f62a055717f8fc7fe42_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:PatientServicesNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ERADMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i808cdb9ce8d34cef9d7fda485b899b3d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:PatientServicesNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ERADMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ifea7caca315b42ef9d31633ec1af9648_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:PatientServicesNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ERADMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib5869b7b9a94482aabb1927c7e98515c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2023-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia02f2d80dbdb4136890d844ee82e5b49_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rdnt:ProperyAndEquipmentNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib6d26e6f10e14cd5ac6652e62c41e88f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rdnt:ProperyAndEquipmentNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i08bec0508e764dbfb8c49be4488435e0_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if16babfd8b114d728c8e4199a210fee5_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i808152f195914b788e6da3420f3e8cb9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8537d011842e4b6199b64ca17ec351e6_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i422a4c2558d84288a00576b3a91e71c6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:ReinsuranceContractAxis">
                    <us-gaap:ReinsuranceContractAxis.domain>Health Insurance Member</us-gaap:ReinsuranceContractAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6c48d7e622fc4e26963a033683816e48_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:ReinsuranceContractAxis">
                    <us-gaap:ReinsuranceContractAxis.domain>Health Insurance Member</us-gaap:ReinsuranceContractAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i65433954d0d74893ad517dc34d70e910_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rdnt:BlueShieldMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i94d07cae465b4a45933c903e5b869937_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rdnt:BlueShieldMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id1fdbe2d3c964be6888f0365aa0b975b_I20210415">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <instant>2021-04-15</instant>
        </period>
    </context>
    <context id="i482c7936fa5a4a3396fa482dbd02d9a1_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rdnt:RestatedPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7258cf171ca64de4a7443899de9f7975_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rdnt:RestatedPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i9758ca019cab44059e02dbe1b53445b3_I20161231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:Caps2016Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-12-31</instant>
        </period>
    </context>
    <context id="ie96d50e803ed49a29734c6b96972c575_I20161231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditDerivativesByContractTypeAxis">rdnt:September2020CapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-12-31</instant>
        </period>
    </context>
    <context id="ia630db7cb89b488da168bd28e8987f04_I20161231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditDerivativesByContractTypeAxis">rdnt:October2020CapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-12-31</instant>
        </period>
    </context>
    <context id="i2e6a00bde60944ccb589e7330bf8c34a_I20161231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">rdnt:Caps2016Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-12-31</instant>
        </period>
    </context>
    <context id="i5e878af77c394477a09c4eedcb52e0b2_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i632dbbb6dc124502b35355b0bb82bf56_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i46bd994b9ae04e96b753c7e89fbf1818_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9f99c4d1a5b6480abea6d0ff11b1fee6_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i5c59e16c960f444e80b8f6cd2c3aff6d_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditDerivativesByContractTypeAxis">rdnt:October2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="ie2a260029b444ab89b7e9377824da6fc_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditDerivativesByContractTypeAxis">rdnt:October2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i19c179308c4b45ca97aed3c7ba7f064d_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i0b43962e0b0141068c1c9e2b72b13361_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="iefafe9554bff40dcb084b9218d53528b_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPS1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i193fb1139b6443c59e7e807e0683c634_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPS1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i23d7f29089b64d22895c3d43381dbb7f_I20200701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-01</instant>
        </period>
    </context>
    <context id="ib04c7e5c38284425adee6a4423c7156c_D20200701-20231031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2023-10-31</endDate>
        </period>
    </context>
    <context id="i9048c2d946984a73a9b463cc83780401_D20231101-20251031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-01</startDate>
            <endDate>2025-10-31</endDate>
        </period>
    </context>
    <context id="i477bfe5294834112a6af03501b8e3fa5_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i9b432aaed4704e9eaaee35896216be8f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie48b611c24514f819e0afaa0b9e33107_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i07817c4f1db542b1bd7ec426e43a3030_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i58d81670414d4f9b8cc9fd7500dd2200_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i063f2f5729ee435f8d4852d04201ea0c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1355b8403e694c14801d61d67f909c67_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:ContingentMilestoneConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i239e3d4ca4304f1ab838f88d83fe9529_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:CashHoldbackMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie27fb48dea7a43e496f5d4e770f84de3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:ContingentMilestoneConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i11ed45440ab0437dbd546007b43ffbf8_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:CashHoldbackMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iec85947be77b4e02afe08d88f3901b7e_I20221001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MontclairMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-01</instant>
        </period>
    </context>
    <context id="i315f9ce8303d42fbb74147d9754e4496_I20221101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-01</instant>
        </period>
    </context>
    <context id="iec83e5acff394eac92ff9ba28bb2e1ec_I20221101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:ContingentMilestoneConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-01</instant>
        </period>
    </context>
    <context id="if870a8803b5347588b2a78fdf3b1dabf_I20221101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:CashHoldbackMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-01</instant>
        </period>
    </context>
    <context id="i350d6392e4a642769b8a9824e7855129_D20221101-20221101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2022-11-01</endDate>
        </period>
    </context>
    <context id="i72596dac70a143edab1f533e55146f8a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:ContingentMilestoneConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia30202f136744654aca43922c68c719e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i60714a92713744d0a7ef51e5a96354bd_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if47d16ba9eb44f57b85358ec1634a856_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie3798b3922a04943acbf92ec8317c957_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6a2b769e8cef41f6ac4d466fe758123d_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic0237b2107cb4cbf8ff50093346bdf89_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i453f8cd3681340bbadd382f3b137a70c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MontclairMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5398be82ea374f1981ccf7e382e72ef3_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MontclairMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1cf96aa8943147168551f098e2d58c2a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MontclairMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibf93bd34e5d546fcbe757031ae9bb387_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5e47a0bf0feb4c3b8860d3345451141f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie490b42ee8164ea9be2f0eda5934c310_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i804d8cc7449544638b1eefbdb8975b75_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i68ac6da733e34c689df37c278c132480_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iaa27e287074e451696981ce012df35d6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i39f8a4ef27dd454bb81ce09e12cfb471_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i79c1f314aa17465097ef0df412a24c6c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i06780380ef034b1a885d689dfb1011eb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2abc2bb208ac4de69fd3a4d8e27425a2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0d33c478c74c4c5ebaae8d80880f704a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i00898b4e70c54a4384ea59c45556e995_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if895037caf4f4ecdb06fe18bfec769a6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3b7afa03cd544db6979077730ed44669_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i073ba5e6253341968d7e3516327451a9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iec52dfb722a4447db7f7c2e52080d41b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if060f0a3047f484587fcaf8727158a53_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie81addc4a43045808d4c9dbf8c419ac8_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4f30a42447ea455195dbea5eb27643c7_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4a9534b2492f4341a32a7b6c05873d87_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MontclairMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7d69f978a5e545b59d1932ca7f532e37_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MontclairMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i63cacf5ad31b4575a01903e9faa4d633_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MontclairMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i262f245ca0594ae0ac2e01228b468096_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MontclairMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ife7c65edeb504ccfb67de601c6de474e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7761dd1ec2754fbd87eac5dbd64b9695_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0ce47813748d41d199f7f86a1dfd426b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4d11c112b7384fe3b9ac73abcd84790d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i68cb6719a36646579aa32aed365bd98e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i93f4dc716811412781fdf04a461f52d0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6d6f4cc7b7b3447bbb1069e43d3898ab_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6183df40beac48aaad7cae1b8fc18cf7_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i872140f492c640d8b8e8a6c1e04bd0d6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i133140d2b4cb48a9bbe5445819d6ad6a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icc57a71039044ca88fabf7ced3a359f8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id0f9e4af159e4119a9b961b547b9038e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4eb1b2eda4f64d6e9ef32ec67df449b3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:BarclaysMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8cfe249b156b4148afe2824bb962e98f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:BarclaysMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9eddaf97c45f47fc9a3e3499d9c2b938_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:TruistMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iedc6b67a64d84652974967909a8eed47_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:TruistMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i97956fc643d247dbb60da5865beb89eb_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i5457051aa2ff41adadb9d14aeb2cf08f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4fb9164d19204098ae94cbd87a23b9c8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6a2f8fa41f874e60b776bf0389800e5e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6a13cd9e9617451c8d173c251b8d9e0e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i733c80ddcad5463c9dbb1c25b49f2c67_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i66d4d733653e4eb4a3ad6c433ebdfb6a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:MedicVisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i47e82ebf9ddc4469a95c70fcc3d63d41_D20180201-20180201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:TurnerImagingSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-02-01</startDate>
            <endDate>2018-02-01</endDate>
        </period>
    </context>
    <context id="i9104bade5d0a4187930fd11fdbf5d05b_I20190101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:TurnerImagingSystemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-01-01</instant>
        </period>
    </context>
    <context id="ie8654cdfc8db49acb180ade8667b818b_I20191011">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:TurnerImagingSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-10-11</instant>
        </period>
    </context>
    <context id="ic070f0614e2e4747984c1d8809073028_D20191105-20191105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:WhiteRabbitaiIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-05</startDate>
            <endDate>2019-11-05</endDate>
        </period>
    </context>
    <context id="ia3c6f10cf71d436f8d6f89d025cb5660_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rdnt:DignityHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">rdnt:JointVentureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:GlendaleAdvancedImagingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4b1c789f4aa54283a927ee786764619c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rdnt:DignityHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">rdnt:JointVentureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:GlendaleAdvancedImagingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6bc50d516cca4bf2ac566ca32f16fa45_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i556dfe7e8b354868acf1bd22f0b04c11_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8217add0ca2e4d579d49cd56dd4ce0dc_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:JointVentureInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9eecc7ea77b94b6d843c47a92a34de8c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:JointVentureInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ida002f69ec1f41d5b17282e7b20fc172_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0acf107e72724cc497da946604ddb76c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1616cf57656c47db88833796ec62d482_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i825f9b68a0534968996704634645bbdc_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:ArizonaDiagnosticsGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i04323c12bfcc46fca5f3765bc9b181de_I20220101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:IFRCLLCSubsidiaryOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-01</instant>
        </period>
    </context>
    <context id="i45f00f44ca7b4343afb1b0392c335273_I20220101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:IFRCLLCSubsidiaryTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-01</instant>
        </period>
    </context>
    <context id="i9e2bd41f61084dc99c6046940c937f26_I20221001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MontclairRadiologicalAssociatesPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-01</instant>
        </period>
    </context>
    <context id="i29413aeb2a174d91ba07be32e53f164d_I20221201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:ChelseaDignosticRadiologyPCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-01</instant>
        </period>
    </context>
    <context id="i1c31a5dab37e45d28652fdb0fa620376_I20221209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:NorthJerseyImagingCenterLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-09</instant>
        </period>
    </context>
    <context id="i78a124f13cce4bf08e493835bf6a3457_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:BusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie8d992d40a6c4dd78532f351f5124719_I20221101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:IFRCLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-01</instant>
        </period>
    </context>
    <context id="ic4d32c5f421b43f999b15581ffd8c753_I20221101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:IFRCLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:JointVentureWithCalvertMedicalImagingCentersLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-01</instant>
        </period>
    </context>
    <context id="i892eb956660d4426a7b9ce4343939007_I20210201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:PersonalHealthImagingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-01</instant>
        </period>
    </context>
    <context id="ia8d26a04836f440696fff1b778498ee4_I20210201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:ZPElmontLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-01</instant>
        </period>
    </context>
    <context id="i03820b19954941189242f879d3d1aa9b_I20210201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:ZPFreeportLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-01</instant>
        </period>
    </context>
    <context id="ia0ea208abb7a45c18b6150540a583cc3_I20210201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:BroadwayMedicalImagingLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-01</instant>
        </period>
    </context>
    <context id="i35c9649190e94adda0f107310a8a289e_I20210201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:A3235HempsteadLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-01</instant>
        </period>
    </context>
    <context id="i0ab3ab4d55ef4b02aa47ad2b6dad4bc7_I20210201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:SLZMRealtyLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-01</instant>
        </period>
    </context>
    <context id="i579ab9cf65534af294a6f7e07668dd6a_I20210201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:A2012SunriseMerrickLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-01</instant>
        </period>
    </context>
    <context id="ie5f5572dd74743ab9a87be7f25a33b9f_I20210301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:ZPBaysideLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-01</instant>
        </period>
    </context>
    <context id="i902807f4b9a9416c9b47104b5ad819a0_I20210301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:ZPLaureltonLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-01</instant>
        </period>
    </context>
    <context id="ifc21e27c33b04e1daa07fac76223e671_I20210301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:ZPSmithLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-01</instant>
        </period>
    </context>
    <context id="ibc6548d74e7444118bd3d64d387c8399_I20210401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:ZP907NorthernLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-01</instant>
        </period>
    </context>
    <context id="ib8ef5a13ccba4f0081c5203b3d794eca_I20210501">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:WilliamMKellyMDIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-01</instant>
        </period>
    </context>
    <context id="iace4174421504d128d1891aedd6863a3_I20210501">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:A60thStreetMRILLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-01</instant>
        </period>
    </context>
    <context id="iaaf8fe80680b48ab82ec3deb6b41a4af_I20210501">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:ZPParkchesterLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-01</instant>
        </period>
    </context>
    <context id="i4a182964d2994db6afa278022e5ec78c_I20210601">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:ZPEasternLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-01</instant>
        </period>
    </context>
    <context id="id7aacc9fd1cc4c3e8c39d3650be587c0_I20211201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MidDelawareImagingPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-01</instant>
        </period>
    </context>
    <context id="i759bb752ba514fd0a9e92dbd00a4ba03_I20211206">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:WilliamMKellyMDIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-06</instant>
        </period>
    </context>
    <context id="iff8ceedaa8534baf9af84ee6fdb44f29_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:WilliamMKellyMDIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibb914ba8860c4d42942ab37aebd6805d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:BusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i95d5f4cf07934fb790f6972ad191259f_I20221101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HeartAndLungImagingLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:IncomeApproachValuationTechniqueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-01</instant>
        </period>
    </context>
    <context id="ia40099a2511a4e60a8a104b2b81cfad0_D20220120-20220120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rdnt:OtherSellersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-20</startDate>
            <endDate>2022-01-20</endDate>
        </period>
    </context>
    <context id="ic8ce100f294545feaf01b49a483d7835_I20220120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rdnt:OtherSellersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-20</instant>
        </period>
    </context>
    <context id="ifb0178640b0547a4a348e983673f24ad_I20220120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:ContingentMilestoneConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-20</instant>
        </period>
    </context>
    <context id="i38534e3fc3794da0bea27b49adae6a77_I20220120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:CashHoldbackMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-20</instant>
        </period>
    </context>
    <context id="if0842a81b02a40418df2e51489f2137e_D20220120-20220120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rdnt:CertainSellerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-20</startDate>
            <endDate>2022-01-20</endDate>
        </period>
    </context>
    <context id="if97396e4c19841b98639a9937dfa4fa7_I20220120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-20</instant>
        </period>
    </context>
    <context id="ie9fc3884748a4f9c85f668dbc7c8621a_I20220120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-20</instant>
        </period>
    </context>
    <context id="iaf4d7228420748d7a6ca4943a5dc578d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:IncomeApproachValuationTechniqueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id2af135c82bc4cca8c8fab8df3985632_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:IncomeApproachValuationTechniqueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1073a8921d2c4ba78783ba6bcf89733f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i2500cde4d73845a3ac979c61b31fffb3_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if7c3caf821ac4264bfedf6a1cf1e1cff_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic20227de97324a8da0150abd7d29ff60_I20220120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rdnt:OtherSellersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-20</instant>
        </period>
    </context>
    <context id="if4f8df70221f4cb2841fe32fb6094aa8_D20220120-20220120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:BusinessAcquisitionContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-20</startDate>
            <endDate>2022-01-20</endDate>
        </period>
    </context>
    <context id="i79751a12a5c14657a85da985b3d864c7_I20220120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">rdnt:CashHoldbackMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-20</instant>
        </period>
    </context>
    <context id="i68c4c04cc28b411e853a2689c03e9923_I20220120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-20</instant>
        </period>
    </context>
    <context id="i6165260d2cac4c499c9451f3f1214d18_I20220120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-20</instant>
        </period>
    </context>
    <context id="if1af841cdb3f4cd0ad5ac44de8df9eb9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:IncomeApproachValuationTechniqueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5fc2355ac8fb4b73b314ebd1371b0448_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:IncomeApproachValuationTechniqueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib5968e7309954164b239ff2880b7fa11_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i14058b49fc714ecb8b39c3fe337c4c47_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iab70d35c2cb440ccba0a783f0cdde440_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ifac3d3f48c90447d9920ba9922709d73_I20220401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:FrederickCountyRadiologyLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-01</instant>
        </period>
    </context>
    <context id="i2f87ecd615944571b918d5b62820eda3_I20220401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:FrederickCountyRadiologyLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-01</instant>
        </period>
    </context>
    <context id="i38c6fdf76c844677a1750f13333889fa_I20220401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:FrederickCountyRadiologyLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rdnt:FixedAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:FrederickHealthHospitalIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-01</instant>
        </period>
    </context>
    <context id="i9f0903465ba04ac2995029cdb8fbb03f_I20220401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:FrederickCountyRadiologyLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:FrederickHealthHospitalIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-01</instant>
        </period>
    </context>
    <context id="i63d0ac5d5bab47479964de4ca123d1f5_D20220401-20220401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:FrederickCountyRadiologyLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-01</endDate>
        </period>
    </context>
    <context id="ibb19233e68ff4d41a7e808f8715f8f2c_D20220401-20220401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:FrederickCountyRadiologyLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-01</endDate>
        </period>
    </context>
    <context id="i18b22b6c335a45639d3204cacdeb3610_I20220401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:FrederickCountyRadiologyLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:FrederickHealthHospitalIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-01</instant>
        </period>
    </context>
    <context id="i3feff49292e04c30a61b84bfc33cae41_D20220401-20220401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:FrederickCountyRadiologyLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:FrederickHealthHospitalIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-01</endDate>
        </period>
    </context>
    <context id="i241f863ca19c468d9943aac255502e19_I20220615">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:AdvancedRadiologyAtCapitalRegionLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-15</instant>
        </period>
    </context>
    <context id="i59cfe8ed7dfb4ae09b7c26c7e2734e56_D20220615-20220615">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:AdvancedRadiologyAtCapitalRegionLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-15</startDate>
            <endDate>2022-06-15</endDate>
        </period>
    </context>
    <context id="i37eb4b7a2a86440dbba3d35c820120cb_I20220615">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:AdvancedRadiologyAtCapitalRegionLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:DimensionHealthCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-15</instant>
        </period>
    </context>
    <context id="ic5a702b1c1bc4189a7b7944db5b5fabd_D20220615-20220615">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:AdvancedRadiologyAtCapitalRegionLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:DimensionHealthCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-15</startDate>
            <endDate>2022-06-15</endDate>
        </period>
    </context>
    <context id="i987cdd48ce1c4476ae4f5b205442e647_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:SimiValleyImagingGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibc1689b570374d14852bee5675a09ab0_I20210101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:SimiValleyImagingGroupLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:SimiValleyImagingGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-01</instant>
        </period>
    </context>
    <context id="if68e59e75ef34799af1d02aff32b5aae_D20210101-20210101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:SimiValleyImagingGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-01-01</endDate>
        </period>
    </context>
    <context id="ia3b6622be19547c48017c645b19e93da_I20210101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:SimiValleyImagingGroupLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:SimiAdventistMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-01</instant>
        </period>
    </context>
    <context id="i90a1726c6bee4422b356584ebb692aa7_D20210101-20210101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:SimiValleyImagingGroupLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:SimiAdventistMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-01-01</endDate>
        </period>
    </context>
    <context id="i9086fb31eefc4ef396dce636b41d760c_D20210901-20210901">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:WestValleyImagingGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-09-01</endDate>
        </period>
    </context>
    <context id="i428ad0d44a1346558061485e679164b4_I20210831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:WestValleyImagingGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-31</instant>
        </period>
    </context>
    <context id="idd38436b6e0c4c099ae9632c1d4929cf_I20210901">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:WestValleyImagingGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-01</instant>
        </period>
    </context>
    <context id="i9ed54666eaf94b7bb7053f98d1280ca4_D20210901-20210901">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-09-01</endDate>
        </period>
    </context>
    <context id="i237fcfddc1b842039f5586e2d3b311f4_D20210901-20210901">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">rdnt:TarzanaMedicalCenterLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-09-01</endDate>
        </period>
    </context>
    <context id="ib5726eab9b6d42fa88ccbbd9685ed8a6_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ImagingCentersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i70656be41c694318a241edacdeceec2c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ImagingCentersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6f9bff8ba8074226b0ec1f1f6f82e960_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ImagingCentersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i74a6538627074503a346c001073d75b6_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:AIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4ae0b29c79ef48768e36dcfc86e3ae27_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:AIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i752bed455bf6494e806b337523329451_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:AIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i668dae88a2914d8f85a4a37e9114214e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ImagingCentersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iad55eccace614330a9a10e68dc84d72a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:AIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idba042321a6d496fb90b273b2d065e08_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ImagingCentersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8fff7583d4414b91a34f6aefc3dae941_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:AIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i611c6f40576041af971fff090e96cc52_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ImagingCentersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i24072ed80ca2499296f569d92fce4296_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:AIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic1e54694556947f19c007ab6032e164a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:ManagementServiceContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i414955456ed943bfb2a5a55163f53cf9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:ManagementServiceContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4aa6fe1b19fa4032b19af61fea4d1770_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:CovenantNotToCompeteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1302a37a97cd4b139f598c14f70e6a6f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:CovenantNotToCompeteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iddb0cd692be2450194003830cb8eade8_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8d300af724bd42fa81df479bcd52a561_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:PatentAndTrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5f97cf28159d4af1b51bd03a44af0b3e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:PatentAndTrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i5437e74731804fadaa4b067a3e9a1079_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:DevelopedTechnologySoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i79c0ea2a5c9d4435ba5a05f5371abd25_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:DevelopedTechnologySoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia5494245554a4a8c8f993a496d898612_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ide5c8507870d42c2934aea55608ad13f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i24d947bc9cc64b21a3c0655f38ee8f28_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie3d853d4f3b647c5b17405fc7cbc9ec7_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i86f01866d4c84b9bbfb9f6decd26c6f6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i00b2de31a74241f0b34c082e030c3988_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id97a7eba2f0b4e619a60a313e21c6dd0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia8674635644f472eba0908b3c0584e97_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibdcafabfcf7040c3b97ef14ac3b23f01_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idd3d3e3e547648dd8ffe8630809ea423_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i86ebeca091034ef29127281116eaa2a8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i628e73d9b5b54e3bab985a48e170406a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6dc531e92c3b4e048c61c11ad6d1e801_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i08ea7357bc1b48619f5f3b7216b20254_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie245ad8af20a43b28a6758228cc88b11_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rdnt:MedicalEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iab7ce7f316034c05b56c7a6f0d599bb4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rdnt:ComputerandOfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie1c8ab68fe024b7a8859d4b269c75b02_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7fd7963b7541486ba64acd58081d4289_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rdnt:MedicalEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia4939d9e3309469392b03a7b6fed19d2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rdnt:ComputerandOfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i522481570141465585681f5b994a0bcb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i54b3674416244d4db4d21de83d7cbbde_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7864c4b6f44e46a09a513ac84d7d21ec_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i38719d8a10de43ad8f49713e3df85eba_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i78f5077e0f824294be47554965869037_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2923158472984ab081c98c126fa64e96_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementEighthAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia72ba28711ea41c3b84011425ee45d0f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2d9d403debfc473bafd93ca110c28e57_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1d36672d0c054968b7578c42cf79bd8c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:SunTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic33fc421ee274ecb81ba734b51c43318_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:SunTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib78b9355051b47d5a52646928c50c333_I20210423">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-23</instant>
        </period>
    </context>
    <context id="i659ee446c43548e9bf27ed0a4061b5ab_I20210423">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:FirstLienCreditAgreementSeventhAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-23</instant>
        </period>
    </context>
    <context id="i56152cb4c4e24493b5d3fdbbd09acf47_D20210423-20210423">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-23</startDate>
            <endDate>2021-04-23</endDate>
        </period>
    </context>
    <context id="ie23d788887204110a462554db069f44b_D20210423-20210423">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:FirstLienCreditAgreementSeventhAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-23</startDate>
            <endDate>2021-04-23</endDate>
        </period>
    </context>
    <context id="ieec8243d9ccc44119f604da882ab8f72_I20221007">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:TruistMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-07</instant>
        </period>
    </context>
    <context id="i6ecd3750a3b74bbda768365b8ab639d7_I20221007">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementEighthAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:TruistMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-07</instant>
        </period>
    </context>
    <context id="i199f459e5ce14f77a34aef36dbc62bff_I20221007">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:TruistMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:FirstLienCreditAgreementSeventhAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-07</instant>
        </period>
    </context>
    <context id="iccbc7b1f30b74634bd5e6b0535972448_D20210423-20210423">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:TruistMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:FirstLienCreditAgreementSeventhAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-23</startDate>
            <endDate>2021-04-23</endDate>
        </period>
    </context>
    <context id="i8b41d8242f3040fb8331b37d34fcd9d2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4318f7e3746943799936274358bb5174_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i2ee298d0e61e459396a35b628ee2244d_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i25ec9150f13743ed97836354e90ebc7e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id97b4431c3884e1faeb084da481dbb28_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1571e82796a8423a8fe38d602a05f3eb_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia957fac5b3fc45788abdc13188550c17_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib804538af1af4cbda91f1ab7a1b84f7b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i557a45553f2a40f7b25201fe169750a7_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4f520487af9f4cf3a4d4e00bacc10a81_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i312118f202904e5e9d26cd7cb00d4237_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i856b0cb40d214a9b97efb4927aab7f8f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie662bee09b1e4c1c86dbd8597e67cc62_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i99932cd267fb439fa22c5eb34b7ae0f0_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i839055751cc8442db5204c49d1284938_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i69798f67de99449889ab8f63e5cf75a3_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i15eb2be8a2ff48a9809e5a01d2e32851_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia5b95a7d5c6a44a18f1590d4463611c0_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if100b11b6bb44e928235b214abe522c1_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i13cb963d1f784637aecd1c03103d2861_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iab1c1f0acbf94f9f961d2a94fecafbce_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i702897b2a6b14e748e4098af38ad1e19_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ic20f8711184c443c87d2fa221b9f3d6b_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="id37173de0c834f2b9f115f5a5a19cc27_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia9b5190de9024ab58119dd3bf9d43ea3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia4b317995bde4bada86bdf0ce0b815cd_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i70fb120699d84c7f82b9624968f97599_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ice18c3446a25450bb2c8f0569aa819e7_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i2e033e1356e54eb3be45b1693fd1314c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:TruistMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6a3f767fc5374ada83d6ae22aa651dd9_D20230331-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:TruistMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-31</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i04e208e3692545da8ee7fd87c877961c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:TruistMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i3519d8c4e9ee47ba8c1300676d007bb0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2463bc0c023b4f5aa0e500c7b7681aec_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i928b06213e75428c90178a1d1b5152f7_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6f6c0892ace746fbaf4c00e519257a16_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id93b58eb3f8545c19a363c18ea54314e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id934500bc63546f682c7f9670a1350a8_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i8268de3b978748b782a432f7902bf9eb_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i278e51ae3e69452d872b324b2fceb548_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id603dde9dba24bd185acda0ba6834023_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1dadee5b8a024acb8b292c439ee5d113_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id994e3544668477991d25e93154861e5_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iae4da6a9b69c4e0f8084fdf5c94b4fb0_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia3b1eb6913ea4657973a8239914f6e42_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementEighthAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:TruistMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i92fc6849db614c54bc09a2666a961e01_I20200828">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementEighthAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-28</instant>
        </period>
    </context>
    <context id="i0632c03edc1443a6b0a38f3cd1a783d9_I20190418">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-04-18</instant>
        </period>
    </context>
    <context id="i09ba2d9a36f045b797d41b04329dd854_I20190418">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-04-18</instant>
        </period>
    </context>
    <context id="i1c5c4e38ab5d4390807495b2aa90ba6a_I20190418">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-04-18</instant>
        </period>
    </context>
    <context id="ia96560b5f1de48ab9fbe2db67aecf4d1_D20190418-20190418">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-18</startDate>
            <endDate>2019-04-18</endDate>
        </period>
    </context>
    <context id="iaa6deb986aee4e51833223a5764529e4_I20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:TruistMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-08-31</instant>
        </period>
    </context>
    <context id="i67ae41392b3144c99363c75225255999_I20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:TruistMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-08-31</instant>
        </period>
    </context>
    <context id="i85a7d0e0c6ca48769139d10c3a615b9e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:PaycheckProtectionProgramLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ifc2f697097964cab9a6567723aee030c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:PaycheckProtectionProgramLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie7dff0590fe940f8998c972ad3a5986d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:PaycheckProtectionProgramLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic1e56ddb23564f81949b77940a641b57_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0118bb2b3716434fb951fa28970f2707_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ice63a1a32cb9452b8b46714c1c61a7da_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib19ac757adb3497f895598bf7d1fb0f6_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i8cff5897a0c648b19e7125d13cd0a0f5_D20211231-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <startDate>2021-12-31</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1c9c24367d914d6f8d3b8b89c6ac650c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i01d34ce5690d41ac9b7da0025a908d74_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if220aac49baf4022b602bb8b0e79c955_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:RavenHoldingsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1012d26028ec46ccb4bd6809233ed3bc_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i094c5d904be44087995cd941fc4d5daf_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i44c5111cc15c410d9c005a8bde3cad3a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i3d5bebaa0e7442d1b5f5cca875bb344e_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i9acfb04e9f5b4b67ac85b9574a34698b_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i3f429bcc5e2b462cb9501b7c563ba31b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i910ced2457b140f4b0ed9010ea0b124a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i913337c7aa3b4295af9870b33b64248f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3b0bb841e3944cc1903ad3a519ea4d82_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie0a58125fd60480dad3bda99ec884d22_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0787e0bf64654960aed460942168553d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia1c839443b66471eb59beee8617975d2_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:FutureServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6277f9dca3d1402c9da0e7e331ab1e01_D20220101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i0f44d430f1174158bf7fe50617e713ac_D20220101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i62c3cbb4a9964a25abbdcb253fb4024f_D20220101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i50296a953a0a449b97171c09173e2621_D20220101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="idaacd756f4c9498d91cf9c5a87b822e2_D20220101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="icec298142c894a2b86d0c42a0627070b_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:PerformanceBasedStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i2c047b53ccb14b03a3aee6426354f41c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:LongTermIncentivePlanSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4881d8775eb54b72a12eb858c7e4a554_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:LongTermIncentivePlanSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if4019e7dc01941058ad36f53dc8d3d21_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:LongTermIncentivePlanSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5b0e1dc8b96c4fc384f33bcb572e740a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:LongTermIncentivePlanSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia7b8b14610224ea59f307a3d2cbe26ba_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:LongTermIncentivePlanSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2d84eba07ea94e52a84e38c42643cc0b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rdnt:RestatedPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="center">
        <measure>rdnt:center</measure>
    </unit>
    <unit id="loan">
        <measure>rdnt:loan</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="incentiveplan">
        <measure>rdnt:incentivePlan</measure>
    </unit>
    <unit id="agreement">
        <measure>rdnt:agreement</measure>
    </unit>
    <unit id="investment">
        <measure>rdnt:investment</measure>
    </unit>
    <unit id="jointventure">
        <measure>rdnt:jointVenture</measure>
    </unit>
    <unit id="location">
        <measure>rdnt:location</measure>
    </unit>
    <unit id="amendment">
        <measure>rdnt:amendment</measure>
    </unit>
    <unit id="tranche">
        <measure>rdnt:tranche</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV80L2ZyYWc6NjJjOTQ4ODQyYjI0NDlmNGEyNzY4ZGFmMzhjYWJmY2YvdGFibGU6ZmUzNTQ5YmY5MDhjNGYwYTk1ZTFiYzIzYWUxNGU2Y2YvdGFibGVyYW5nZTpmZTM1NDliZjkwOGM0ZjBhOTVlMWJjMjNhZTE0ZTZjZl8zLTEtMS0xLTI5NDg5_cb7e5e94-8829-45e1-93a1-b23e2971b9c5">0000790526</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV80L2ZyYWc6NjJjOTQ4ODQyYjI0NDlmNGEyNzY4ZGFmMzhjYWJmY2YvdGFibGU6ZmUzNTQ5YmY5MDhjNGYwYTk1ZTFiYzIzYWUxNGU2Y2YvdGFibGVyYW5nZTpmZTM1NDliZjkwOGM0ZjBhOTVlMWJjMjNhZTE0ZTZjZl80LTEtMS0xLTI5NDg5_cae92718-9cca-4743-afc3-2e8d0a9cab54">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV80L2ZyYWc6NjJjOTQ4ODQyYjI0NDlmNGEyNzY4ZGFmMzhjYWJmY2YvdGFibGU6ZmUzNTQ5YmY5MDhjNGYwYTk1ZTFiYzIzYWUxNGU2Y2YvdGFibGVyYW5nZTpmZTM1NDliZjkwOGM0ZjBhOTVlMWJjMjNhZTE0ZTZjZl82LTEtMS0xLTI5NDg5_692829a0-57fd-47cd-b8ec-a426464853de">FY</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV80L2ZyYWc6NjJjOTQ4ODQyYjI0NDlmNGEyNzY4ZGFmMzhjYWJmY2YvdGFibGU6ZmUzNTQ5YmY5MDhjNGYwYTk1ZTFiYzIzYWUxNGU2Y2YvdGFibGVyYW5nZTpmZTM1NDliZjkwOGM0ZjBhOTVlMWJjMjNhZTE0ZTZjZl83LTEtMS0xLTI5NDg5_1c415ddf-00cd-4818-81de-aaca427f3dd3">2022</dei:DocumentFiscalYearFocus>
    <us-gaap:GovernmentAssistanceStatementOfFinancialPositionExtensibleEnumeration
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjc0ODc3OTE4MzYxNA_386ac154-db8d-4eee-8934-81984fec863f">http://fasb.org/us-gaap/2022#ContractWithCustomerLiabilityCurrent</us-gaap:GovernmentAssistanceStatementOfFinancialPositionExtensibleEnumeration>
    <us-gaap:ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjc0ODc3OTE4MzYxMw_9c7fb964-0c31-457d-ab68-df24d21cb8df">http://fasb.org/us-gaap/2022#GainLossOnTerminationOfLease</us-gaap:ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i482c7936fa5a4a3396fa482dbd02d9a1_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjQzNTk_cd22a3ff-fb8c-47a1-9018-2d91908dd609">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i482c7936fa5a4a3396fa482dbd02d9a1_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjQzNzk_0e815b97-2caf-4c2a-88cf-151ad3b1dacb">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmY3ZDdlMDY0Y2UzOTQyYWVhZjFkMzRhNTc4MTBmMjA1L3RhYmxlcmFuZ2U6ZjdkN2UwNjRjZTM5NDJhZWFmMWQzNGE1NzgxMGYyMDVfMy0yLTEtMS03NjcxMw_04d809f9-cf99-45ef-aa56-16be46b5f8b6">http://fasb.org/us-gaap/2022#InterestExpenseDebt</us-gaap:DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration>
    <us-gaap:DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmY3ZDdlMDY0Y2UzOTQyYWVhZjFkMzRhNTc4MTBmMjA1L3RhYmxlcmFuZ2U6ZjdkN2UwNjRjZTM5NDJhZWFmMWQzNGE1NzgxMGYyMDVfNC0yLTEtMS03NjcyMQ_2c91ab05-c7d0-4ed6-a9f1-aefed9da243a">http://fasb.org/us-gaap/2022#InterestExpenseDebt</us-gaap:DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration>
    <us-gaap:DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmY3ZDdlMDY0Y2UzOTQyYWVhZjFkMzRhNTc4MTBmMjA1L3RhYmxlcmFuZ2U6ZjdkN2UwNjRjZTM5NDJhZWFmMWQzNGE1NzgxMGYyMDVfNC0yLTEtMS0yOTQ4OQ_869911ef-bcba-451f-8629-1684d55fda21">http://fasb.org/us-gaap/2022#InterestExpenseDebt</us-gaap:DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration>
    <us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTozNDY2MGIzODgyOWY0NDQ5YWU5YzQ1YmYzZTBlZmM1ZC90YWJsZXJhbmdlOjM0NjYwYjM4ODI5ZjQ0NDlhZTljNDViZjNlMGVmYzVkXzExLTAtMS0xLTI5NDg5_464c3404-1439-4afe-a7f8-0d3a4f94b53d">http://www.radnet.com/20221231#PropertyPlantAndEquipmentNetIncludingRightOfUseAssets</us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTozNDY2MGIzODgyOWY0NDQ5YWU5YzQ1YmYzZTBlZmM1ZC90YWJsZXJhbmdlOjM0NjYwYjM4ODI5ZjQ0NDlhZTljNDViZjNlMGVmYzVkXzExLTAtMS0xLTI5NDg5_bc4c3e84-e956-46a8-b461-0698bb31e9ec">http://www.radnet.com/20221231#PropertyPlantAndEquipmentNetIncludingRightOfUseAssets</us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ice63a1a32cb9452b8b46714c1c61a7da_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzgyNA_592b111d-5e4b-4ce1-b2c6-e023d3e9049f">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="ice63a1a32cb9452b8b46714c1c61a7da_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzg0NA_4b31c3d7-9086-4991-8c69-3f75d38c24fd">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i2c047b53ccb14b03a3aee6426354f41c_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzM4NDgyOTA3MDIzMDM_73f2d802-1880-44ce-b1e9-1beab990455e">P2Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMTIvZnJhZzo0YTY2ZjE3NjIwZWE0OGIxYjY2ZjA2ZDU4YjQzNGQ2YS90ZXh0cmVnaW9uOjRhNjZmMTc2MjBlYTQ4YjFiNjZmMDZkNThiNDM0ZDZhXzUwNQ_5417e950-dfa1-4d82-8b72-23528ccc1b93"
      xsi:nil="true"/>
    <dei:DocumentType
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xL2ZyYWc6NzQ2NDBiODZkOGQ5NGJjZjhhZGNjMmNmYmM1MmZlODgvdGV4dHJlZ2lvbjo3NDY0MGI4NmQ4ZDk0YmNmOGFkY2MyY2ZiYzUyZmU4OF8zNDk3_70f600a1-a24e-4c9c-84e5-292025229b07">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xL2ZyYWc6NzQ2NDBiODZkOGQ5NGJjZjhhZGNjMmNmYmM1MmZlODgvdGV4dHJlZ2lvbjo3NDY0MGI4NmQ4ZDk0YmNmOGFkY2MyY2ZiYzUyZmU4OF8zNDk4_030ce708-81db-4e1c-8d65-0b72715f0eb2">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xL2ZyYWc6NzQ2NDBiODZkOGQ5NGJjZjhhZGNjMmNmYmM1MmZlODgvdGV4dHJlZ2lvbjo3NDY0MGI4NmQ4ZDk0YmNmOGFkY2MyY2ZiYzUyZmU4OF8yMTE_7bb12c30-9643-496c-a752-869178a4c117">2022-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xL2ZyYWc6NzQ2NDBiODZkOGQ5NGJjZjhhZGNjMmNmYmM1MmZlODgvdGV4dHJlZ2lvbjo3NDY0MGI4NmQ4ZDk0YmNmOGFkY2MyY2ZiYzUyZmU4OF8yMTE_2edb23db-874b-4e5e-bd07-fb4f54e6f705">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xL2ZyYWc6NzQ2NDBiODZkOGQ5NGJjZjhhZGNjMmNmYmM1MmZlODgvdGV4dHJlZ2lvbjo3NDY0MGI4NmQ4ZDk0YmNmOGFkY2MyY2ZiYzUyZmU4OF8zNTAy_19cbbded-fbe3-4d30-9c1d-145d5ec8452a">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xL2ZyYWc6NzQ2NDBiODZkOGQ5NGJjZjhhZGNjMmNmYmM1MmZlODgvdGV4dHJlZ2lvbjo3NDY0MGI4NmQ4ZDk0YmNmOGFkY2MyY2ZiYzUyZmU4OF8zNTAz_d66d9137-d283-4c0f-88cd-dbb7c1c59a74">001-33307</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xL2ZyYWc6NzQ2NDBiODZkOGQ5NGJjZjhhZGNjMmNmYmM1MmZlODgvdGV4dHJlZ2lvbjo3NDY0MGI4NmQ4ZDk0YmNmOGFkY2MyY2ZiYzUyZmU4OF8zNDk1_5fcff722-235f-4a21-985d-66051b4d9eef">RadNet, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xL2ZyYWc6NzQ2NDBiODZkOGQ5NGJjZjhhZGNjMmNmYmM1MmZlODgvdGFibGU6M2E4ZjZiMDcyNGZmNDY0ZThhZTdhNjlhZjkxZTZkNDkvdGFibGVyYW5nZTozYThmNmIwNzI0ZmY0NjRlOGFlN2E2OWFmOTFlNmQ0OV8wLTAtMS0xLTI5NDg5_22855676-26a2-4a49-b6b0-e665f40456f3">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xL2ZyYWc6NzQ2NDBiODZkOGQ5NGJjZjhhZGNjMmNmYmM1MmZlODgvdGFibGU6M2E4ZjZiMDcyNGZmNDY0ZThhZTdhNjlhZjkxZTZkNDkvdGFibGVyYW5nZTozYThmNmIwNzI0ZmY0NjRlOGFlN2E2OWFmOTFlNmQ0OV8wLTItMS0xLTI5NDg5_fa8d8b46-364c-4fbf-8e04-2085d79483d9">13-3326724</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xL2ZyYWc6NzQ2NDBiODZkOGQ5NGJjZjhhZGNjMmNmYmM1MmZlODgvdGFibGU6M2E4ZjZiMDcyNGZmNDY0ZThhZTdhNjlhZjkxZTZkNDkvdGFibGVyYW5nZTozYThmNmIwNzI0ZmY0NjRlOGFlN2E2OWFmOTFlNmQ0OV8zLTAtMS0xLTI5NDg5_8803e92b-c012-4989-9c15-ae96a2a38b30">1510 Cotner Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xL2ZyYWc6NzQ2NDBiODZkOGQ5NGJjZjhhZGNjMmNmYmM1MmZlODgvdGFibGU6M2E4ZjZiMDcyNGZmNDY0ZThhZTdhNjlhZjkxZTZkNDkvdGFibGVyYW5nZTozYThmNmIwNzI0ZmY0NjRlOGFlN2E2OWFmOTFlNmQ0OV80LTAtMS0xLTI5NDg5_ed6bbad0-d6c1-4ab6-9169-d6d344819567">Los Angeles,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xL2ZyYWc6NzQ2NDBiODZkOGQ5NGJjZjhhZGNjMmNmYmM1MmZlODgvdGFibGU6M2E4ZjZiMDcyNGZmNDY0ZThhZTdhNjlhZjkxZTZkNDkvdGFibGVyYW5nZTozYThmNmIwNzI0ZmY0NjRlOGFlN2E2OWFmOTFlNmQ0OV80LTEtMS0xLTI5NDg5_181d2a79-5ca8-44e0-b029-f2f5b7f274eb">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xL2ZyYWc6NzQ2NDBiODZkOGQ5NGJjZjhhZGNjMmNmYmM1MmZlODgvdGFibGU6M2E4ZjZiMDcyNGZmNDY0ZThhZTdhNjlhZjkxZTZkNDkvdGFibGVyYW5nZTozYThmNmIwNzI0ZmY0NjRlOGFlN2E2OWFmOTFlNmQ0OV80LTItMS0xLTI5NDg5_394a08e3-c804-4dfa-be23-14eee7becfc4">90025</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xL2ZyYWc6NzQ2NDBiODZkOGQ5NGJjZjhhZGNjMmNmYmM1MmZlODgvdGV4dHJlZ2lvbjo3NDY0MGI4NmQ4ZDk0YmNmOGFkY2MyY2ZiYzUyZmU4OF8zNDk5_1be2fa27-b317-44ef-811b-2efcf86bff61">310</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xL2ZyYWc6NzQ2NDBiODZkOGQ5NGJjZjhhZGNjMmNmYmM1MmZlODgvdGV4dHJlZ2lvbjo3NDY0MGI4NmQ4ZDk0YmNmOGFkY2MyY2ZiYzUyZmU4OF8zNTA5_cb49c18c-15f3-4271-b0a3-50b475b41b32">478-7808</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xL2ZyYWc6NzQ2NDBiODZkOGQ5NGJjZjhhZGNjMmNmYmM1MmZlODgvdGFibGU6MzY0ZGZiMWUzZjg5NDI0ZjhjNDUxODU4MzM1MzJjMzEvdGFibGVyYW5nZTozNjRkZmIxZTNmODk0MjRmOGM0NTE4NTgzMzUzMmMzMV8xLTAtMS0xLTI5NDg5_7f28fc42-04e1-4b29-b4e3-0b3fc510871d">Common Stock, $.0001 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xL2ZyYWc6NzQ2NDBiODZkOGQ5NGJjZjhhZGNjMmNmYmM1MmZlODgvdGFibGU6MzY0ZGZiMWUzZjg5NDI0ZjhjNDUxODU4MzM1MzJjMzEvdGFibGVyYW5nZTozNjRkZmIxZTNmODk0MjRmOGM0NTE4NTgzMzUzMmMzMV8xLTEtMS0xLTI5NDg5_c36644d0-7d82-4e16-8156-52e8d4cacc48">RDNT</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xL2ZyYWc6NzQ2NDBiODZkOGQ5NGJjZjhhZGNjMmNmYmM1MmZlODgvdGFibGU6MzY0ZGZiMWUzZjg5NDI0ZjhjNDUxODU4MzM1MzJjMzEvdGFibGVyYW5nZTozNjRkZmIxZTNmODk0MjRmOGM0NTE4NTgzMzUzMmMzMV8xLTItMS0xLTI5NDg5_3c41f380-f664-4ce1-a40c-2f4c435f4f7f">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xL2ZyYWc6NzQ2NDBiODZkOGQ5NGJjZjhhZGNjMmNmYmM1MmZlODgvdGV4dHJlZ2lvbjo3NDY0MGI4NmQ4ZDk0YmNmOGFkY2MyY2ZiYzUyZmU4OF8zNTA0_588e0c6a-4975-49b6-a40d-6569643bfeef">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xL2ZyYWc6NzQ2NDBiODZkOGQ5NGJjZjhhZGNjMmNmYmM1MmZlODgvdGV4dHJlZ2lvbjo3NDY0MGI4NmQ4ZDk0YmNmOGFkY2MyY2ZiYzUyZmU4OF8zNTA2_65d717de-3449-4932-bbbe-4048adc9b521">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xL2ZyYWc6NzQ2NDBiODZkOGQ5NGJjZjhhZGNjMmNmYmM1MmZlODgvdGV4dHJlZ2lvbjo3NDY0MGI4NmQ4ZDk0YmNmOGFkY2MyY2ZiYzUyZmU4OF8zNTAw_f1cd8843-20de-48d4-a4b1-560b7d7edf2a">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xL2ZyYWc6NzQ2NDBiODZkOGQ5NGJjZjhhZGNjMmNmYmM1MmZlODgvdGV4dHJlZ2lvbjo3NDY0MGI4NmQ4ZDk0YmNmOGFkY2MyY2ZiYzUyZmU4OF8zNTA3_e2790930-c03b-4d5e-a0cb-26ae0e3f4837">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xL2ZyYWc6NzQ2NDBiODZkOGQ5NGJjZjhhZGNjMmNmYmM1MmZlODgvdGFibGU6ZDQ3NDU4ZmNmMjI2NGI4MDkxZTk1MTdiYzdkZDY2MjUvdGFibGVyYW5nZTpkNDc0NThmY2YyMjY0YjgwOTFlOTUxN2JjN2RkNjYyNV8wLTAtMS0xLTI5NDg5_23d8e0d2-082d-4d5d-8b01-2a5eda428222">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xL2ZyYWc6NzQ2NDBiODZkOGQ5NGJjZjhhZGNjMmNmYmM1MmZlODgvdGFibGU6ZDQ3NDU4ZmNmMjI2NGI4MDkxZTk1MTdiYzdkZDY2MjUvdGFibGVyYW5nZTpkNDc0NThmY2YyMjY0YjgwOTFlOTUxN2JjN2RkNjYyNV8xLTMtMS0xLTI5NDg5_c466613d-fc06-4afc-8f50-3916b6f52ac7">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xL2ZyYWc6NzQ2NDBiODZkOGQ5NGJjZjhhZGNjMmNmYmM1MmZlODgvdGFibGU6ZDQ3NDU4ZmNmMjI2NGI4MDkxZTk1MTdiYzdkZDY2MjUvdGFibGVyYW5nZTpkNDc0NThmY2YyMjY0YjgwOTFlOTUxN2JjN2RkNjYyNV8yLTMtMS0xLTI5NDg5_258e330a-a940-425f-af07-139d85c154c3">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xL2ZyYWc6NzQ2NDBiODZkOGQ5NGJjZjhhZGNjMmNmYmM1MmZlODgvdGV4dHJlZ2lvbjo3NDY0MGI4NmQ4ZDk0YmNmOGFkY2MyY2ZiYzUyZmU4OF8zNTEw_0ec553f0-8d9b-4041-bd76-222ff1969852">true</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xL2ZyYWc6NzQ2NDBiODZkOGQ5NGJjZjhhZGNjMmNmYmM1MmZlODgvdGV4dHJlZ2lvbjo3NDY0MGI4NmQ4ZDk0YmNmOGFkY2MyY2ZiYzUyZmU4OF8xNzU5MjE4NjA0OTA3Ng_bd7d2045-01dc-4c07-a2f3-e776efd46888">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="i85e5b321a4fb4792b5778ddcc45d31e2_I20220630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xL2ZyYWc6NzQ2NDBiODZkOGQ5NGJjZjhhZGNjMmNmYmM1MmZlODgvdGV4dHJlZ2lvbjo3NDY0MGI4NmQ4ZDk0YmNmOGFkY2MyY2ZiYzUyZmU4OF8yODEw_6e9dc371-5f1a-4500-af39-20b60917679c"
      unitRef="usd">1000000000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="icfa616adc19f40628e3dfcc4deec4d62_I20230223"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xL2ZyYWc6NzQ2NDBiODZkOGQ5NGJjZjhhZGNjMmNmYmM1MmZlODgvdGV4dHJlZ2lvbjo3NDY0MGI4NmQ4ZDk0YmNmOGFkY2MyY2ZiYzUyZmU4OF8zMDYy_f70858c2-c5cd-4490-900a-a42a381bc5e8"
      unitRef="shares">57836244</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xL2ZyYWc6NzQ2NDBiODZkOGQ5NGJjZjhhZGNjMmNmYmM1MmZlODgvdGV4dHJlZ2lvbjo3NDY0MGI4NmQ4ZDk0YmNmOGFkY2MyY2ZiYzUyZmU4OF8zNTAx_d9fe02c5-214d-4915-983c-0cfcb18532ad">Portions of the registrant&#x2019;s definitive proxy statement for the 2023 Annual Meeting of Stockholders are incorporated herein by reference in Part III of this annual report on Form 10-K to the extent stated herein. Such proxy statement will be filed with the Securities and Exchange Commission pursuant to Regulation 14A not later than 120 days after the close of the registrant&#x2019;s fiscal year.</dei:DocumentsIncorporatedByReferenceTextBlock>
    <dei:AuditorName
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81Mi9mcmFnOjYxZGE2MWY1ZmNhZjRjNmM5OTBkYzdlZmQ3ZTAyODdjL3RleHRyZWdpb246NjFkYTYxZjVmY2FmNGM2Yzk5MGRjN2VmZDdlMDI4N2NfMzU1NQ_a4f60e0a-1145-4511-ac33-2aa29d1a9629">Ernst &amp; Young LLP</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81Mi9mcmFnOjYxZGE2MWY1ZmNhZjRjNmM5OTBkYzdlZmQ3ZTAyODdjL3RleHRyZWdpb246NjFkYTYxZjVmY2FmNGM2Yzk5MGRjN2VmZDdlMDI4N2NfMzU1Nw_8ff3287b-de36-403d-8667-b33e33413970">Los Angeles, California</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfNC0xLTEtMS0yOTQ4OQ_23a77391-bd62-46c2-be9e-d10e0b54b5d1"
      unitRef="usd">127834000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfNC0zLTEtMS0yOTQ4OQ_8be1b183-a64e-4126-adc6-24173d9073fd"
      unitRef="usd">134606000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfNS0xLTEtMS0yOTQ4OQ_4d2c6ccd-4c6a-4c37-bd7e-b3385640e5f0"
      unitRef="usd">166357000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfNS0zLTEtMS0yOTQ4OQ_20503b60-b4f8-4596-a0c4-a140df979823"
      unitRef="usd">135062000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:DueFromRelatedPartiesCurrent
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfNi0xLTEtMS0yOTQ4OQ_d3793a0c-a43f-4da3-8516-04283c1e6407"
      unitRef="usd">18971000</us-gaap:DueFromRelatedPartiesCurrent>
    <us-gaap:DueFromRelatedPartiesCurrent
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfNi0zLTEtMS0yOTQ4OQ_0f5238b5-c19f-419b-93f7-7bc7145a33b6"
      unitRef="usd">5384000</us-gaap:DueFromRelatedPartiesCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfNy0xLTEtMS0yOTQ4OQ_f6b2b496-07a8-4b6c-bd78-80e678945aba"
      unitRef="usd">54022000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfNy0zLTEtMS0yOTQ4OQ_502e0cca-a9a3-4226-9620-10b0ac504858"
      unitRef="usd">49212000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfOC0xLTEtMS0yOTQ4OQ_484a02bb-3087-4060-a865-8c49bf2e51f5"
      unitRef="usd">367184000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfOC0zLTEtMS0yOTQ4OQ_25f9d1e6-53e5-4a9f-ae7a-e4df58f55d41"
      unitRef="usd">324264000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMTAtMS0xLTEtMjk0ODk_8a1c47a6-d934-4503-a38b-0c1554c82ffe"
      unitRef="usd">565961000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMTAtMy0xLTEtMjk0ODk_2aa65719-7222-4fd8-9aa7-f042256af721"
      unitRef="usd">484247000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMTEtMS0xLTEtMjk0ODk_bd451d67-9fbe-4c77-aa37-557f8fba3b85"
      unitRef="usd">603524000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMTEtMy0xLTEtMjk0ODk_92634f85-47a1-48e6-9ffc-ae44e11e43c2"
      unitRef="usd">584291000</us-gaap:OperatingLeaseRightOfUseAsset>
    <rdnt:PropertyPlantAndEquipmentNetIncludingRightOfUseAssets
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMTItMS0xLTEtMjk0ODk_bcf00137-3bfc-4c98-b50b-073c3f2aaed4"
      unitRef="usd">1169485000</rdnt:PropertyPlantAndEquipmentNetIncludingRightOfUseAssets>
    <rdnt:PropertyPlantAndEquipmentNetIncludingRightOfUseAssets
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMTItMy0xLTEtMjk0ODk_a3075092-1e77-4e17-964c-c7a0702bda1c"
      unitRef="usd">1068538000</rdnt:PropertyPlantAndEquipmentNetIncludingRightOfUseAssets>
    <us-gaap:Goodwill
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMTQtMS0xLTEtMjk0ODk_c4a751d9-fc8f-4aa3-8f49-aef4841e0746"
      unitRef="usd">677665000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMTQtMy0xLTEtMjk0ODk_67db10ae-62e0-41fc-a7c7-30896cc9edcd"
      unitRef="usd">513820000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMTUtMS0xLTEtMjk0ODk_10c0c68e-bb65-44c6-b11e-b9345532c0cb"
      unitRef="usd">106228000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMTUtMy0xLTEtMjk0ODk_fb2fe312-5bea-49ca-b45c-892b0c83e59a"
      unitRef="usd">56603000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:DeferredFinanceCostsNoncurrentNet
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMTYtMS0xLTEtMjk0ODk_7f95cb34-01c9-4b81-964f-24768c12578c"
      unitRef="usd">2280000</us-gaap:DeferredFinanceCostsNoncurrentNet>
    <us-gaap:DeferredFinanceCostsNoncurrentNet
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMTYtMy0xLTEtMjk0ODk_a78c080c-af96-4157-86d3-844c6eaeee66"
      unitRef="usd">2135000</us-gaap:DeferredFinanceCostsNoncurrentNet>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMTctMS0xLTEtMjk0ODk_c066835a-ff8b-4a1a-ba67-107178278dd6"
      unitRef="usd">57893000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMTctMy0xLTEtMjk0ODk_acf76537-476d-4190-88de-2e6284bcd5ff"
      unitRef="usd">42229000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMTgtMS0xLTEtMjk0ODk_3ef560b3-e2de-49a2-bb45-6625abe5dd9d"
      unitRef="usd">0</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMTgtMy0xLTEtMjk0ODk_ba3c6a11-fd59-435c-b3b7-a83b1a24e230"
      unitRef="usd">14853000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DepositsAssets
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMTktMS0xLTEtMjk0ODk_2f52d126-9273-4157-abc2-700c99c3bd2a"
      unitRef="usd">53172000</us-gaap:DepositsAssets>
    <us-gaap:DepositsAssets
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMTktMy0xLTEtMjk0ODk_a2c0f5e5-dd76-4380-8599-0a2064a60bac"
      unitRef="usd">36032000</us-gaap:DepositsAssets>
    <us-gaap:Assets
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMjAtMS0xLTEtMjk0ODk_a646a4e6-5b40-4d47-99ee-527faadeb748"
      unitRef="usd">2433907000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMjAtMy0xLTEtMjk0ODk_00df06c0-fa3c-4366-b6a9-58df4aae1be7"
      unitRef="usd">2058474000</us-gaap:Assets>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMjMtMS0xLTEtMjk0ODk_58d04c82-42e1-4ec9-9fb0-d0bee37c82b3"
      unitRef="usd">369595000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMjMtMy0xLTEtMjk0ODk_ebf74ef9-2c17-4b08-aaf0-219a17351aae"
      unitRef="usd">263937000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:DueToAffiliateCurrent
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMjQtMS0xLTEtMjk0ODk_fe901214-6fd8-4c21-87a7-2b15c417f475"
      unitRef="usd">23100000</us-gaap:DueToAffiliateCurrent>
    <us-gaap:DueToAffiliateCurrent
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMjQtMy0xLTEtMjk0ODk_c7c93604-0873-4534-a141-bd771b33def3"
      unitRef="usd">23530000</us-gaap:DueToAffiliateCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMjUtMS0xLTEtMjk0ODk_c8af268e-6913-462e-a5bb-154050756d75"
      unitRef="usd">4021000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMjUtMy0xLTEtMjk0ODk_10c01c21-28f8-4582-b6a9-142b72ad7dfa"
      unitRef="usd">10701000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMjctMS0xLTEtMjk0ODk_2abc4866-4c9b-4ead-8380-54fa68f4b7d1"
      unitRef="usd">57607000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMjctMy0xLTEtMjk0ODk_1dfc1d20-a0a0-428c-889d-a69dbeedc0af"
      unitRef="usd">65452000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:NotesPayableCurrent
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMjgtMS0xLTEtMjk0ODk_b8916b49-83af-4fbd-bb57-e851d666523e"
      unitRef="usd">12400000</us-gaap:NotesPayableCurrent>
    <us-gaap:NotesPayableCurrent
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMjgtMy0xLTEtMjk0ODk_a756941e-4246-4547-a263-5dfb5eca44ee"
      unitRef="usd">11164000</us-gaap:NotesPayableCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMjktMS0xLTEtMjk0ODk_9b670596-9247-40ca-8dd3-9ce9e2cd7341"
      unitRef="usd">466723000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMjktMy0xLTEtMjk0ODk_aa703e7d-0d04-457c-b2b2-ac278f03942c"
      unitRef="usd">374784000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMzItMS0xLTEtMjk0ODk_4b24f35a-b954-4586-8ae5-f1fcd923c831"
      unitRef="usd">604117000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMzItMy0xLTEtMjk0ODk_16d7d576-d2e7-4dc7-bde6-f0ad886ec6bd"
      unitRef="usd">577675000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LongTermNotesPayable
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMzMtMS0xLTEtMjk0ODk_1a2a0485-e811-4468-ba35-fa60f397b7dd"
      unitRef="usd">839344000</us-gaap:LongTermNotesPayable>
    <us-gaap:LongTermNotesPayable
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMzMtMy0xLTEtMjk0ODk_488fc16c-ef21-4779-852d-056014c3b7d3"
      unitRef="usd">743498000</us-gaap:LongTermNotesPayable>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMzQtMS0xLTEtNzY0NzE_90c00864-ca24-42b9-a417-b449d27410d3"
      unitRef="usd">9256000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMzQtMy0xLTEtNzY0NzE_4bc3fdc8-7168-4e76-a59a-60fbb3723705"
      unitRef="usd">0</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMzQtMS0xLTEtMjk0ODk_269cfbe6-0673-495d-abd5-a15089c9da8f"
      unitRef="usd">23015000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMzQtMy0xLTEtMjk0ODk_173c7f07-7ac6-42f5-a8ca-4f4224545538"
      unitRef="usd">16360000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMzUtMS0xLTEtMjk0ODk_6c769617-d896-414a-b6e5-d2f7272b934e"
      unitRef="usd">1942455000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMzUtMy0xLTEtMjk0ODk_15539b15-0886-4d44-882a-3de8565c51b6"
      unitRef="usd">1712317000</us-gaap:Liabilities>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMzgtMC0xLTEtMjk0ODkvdGV4dHJlZ2lvbjphNDcwNmEwODRkY2U0ZDA1OThiMmM4OGM2OWMwYzcyMV8xOQ_5e1c1fb4-3ac3-4dc9-bdb9-d8d5f78c356d"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMzgtMC0xLTEtMjk0ODkvdGV4dHJlZ2lvbjphNDcwNmEwODRkY2U0ZDA1OThiMmM4OGM2OWMwYzcyMV8xOQ_848af894-0e30-4505-a98c-925f50625f2d"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMzgtMC0xLTEtMjk0ODkvdGV4dHJlZ2lvbjphNDcwNmEwODRkY2U0ZDA1OThiMmM4OGM2OWMwYzcyMV8zMw_2070e395-c987-4770-98a2-4d86807d71e7"
      unitRef="shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMzgtMC0xLTEtMjk0ODkvdGV4dHJlZ2lvbjphNDcwNmEwODRkY2U0ZDA1OThiMmM4OGM2OWMwYzcyMV8zMw_8926c1b8-e8f3-4d7c-bce3-3ab03bedf96c"
      unitRef="shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMzgtMC0xLTEtMjk0ODkvdGV4dHJlZ2lvbjphNDcwNmEwODRkY2U0ZDA1OThiMmM4OGM2OWMwYzcyMV81NQ_4fe09bdd-bb46-477d-a799-557c9e8981e0"
      unitRef="shares">57723125</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMzgtMC0xLTEtMjk0ODkvdGV4dHJlZ2lvbjphNDcwNmEwODRkY2U0ZDA1OThiMmM4OGM2OWMwYzcyMV81NQ_f53f4714-a3e4-4207-8dd1-d2ec87afab78"
      unitRef="shares">57723125</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMzgtMC0xLTEtMjk0ODkvdGV4dHJlZ2lvbjphNDcwNmEwODRkY2U0ZDA1OThiMmM4OGM2OWMwYzcyMV82Mg_55de06ba-509a-447d-b539-ef82ef895ccd"
      unitRef="shares">53548227</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMzgtMC0xLTEtMjk0ODkvdGV4dHJlZ2lvbjphNDcwNmEwODRkY2U0ZDA1OThiMmM4OGM2OWMwYzcyMV82Mg_76dabad5-7334-41d1-bafe-ca275a62a79a"
      unitRef="shares">53548227</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMzgtMS0xLTEtMjk0ODk_ad823a5d-d251-408d-b548-a6f10eeee66a"
      unitRef="usd">6000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMzgtMy0xLTEtMjk0ODk_854c03e3-e744-4c1b-824a-f6712ae0fbd7"
      unitRef="usd">5000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMzktMS0xLTEtMjk0ODk_89eb245b-1c44-41aa-8a24-b97d256e7a28"
      unitRef="usd">436288000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfMzktMy0xLTEtMjk0ODk_3ab6a354-38b5-43e1-8440-8121fe3fb8f6"
      unitRef="usd">342592000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfNDAtMS0xLTEtMjk0ODk_9e2c456b-8990-4bd8-ba6b-dbe5393b8c70"
      unitRef="usd">-20677000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfNDAtMy0xLTEtMjk0ODk_f0a036ac-fb3c-423d-96cd-16285eb0b7ad"
      unitRef="usd">-20421000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfNDEtMS0xLTEtMjk0ODk_d58bda4b-3c8c-4bb1-a421-00352cda0a09"
      unitRef="usd">-82622000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfNDEtMy0xLTEtMjk0ODk_60633d48-97ff-4b01-8594-17ebe3390fe0"
      unitRef="usd">-93272000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfNDItMS0xLTEtMjk0ODk_4ae7083b-b84a-4fea-b319-f13e50d0699f"
      unitRef="usd">332995000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfNDItMy0xLTEtMjk0ODk_2be2f495-5323-471e-a136-8f844943d03c"
      unitRef="usd">228904000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfNDMtMS0xLTEtMjk0ODk_d6720d9d-926f-4856-adc4-8497f2645248"
      unitRef="usd">158457000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfNDMtMy0xLTEtMjk0ODk_40d6afb3-789c-4597-a678-5259c8db89fe"
      unitRef="usd">117253000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfNDQtMS0xLTEtMjk0ODk_e9935f6a-ec37-433c-af11-f7124e8337aa"
      unitRef="usd">491452000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfNDQtMy0xLTEtMjk0ODk_38adc072-836b-40e1-8325-404f8f8000fa"
      unitRef="usd">346157000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfNDUtMS0xLTEtMjk0ODk_d4b3fa62-f886-420b-8cd3-191d3b8db520"
      unitRef="usd">2433907000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81NS9mcmFnOjQ3ZmI1MzIxYmJkZjRkNmZiYzlmNzZiODc2YTU2NjAwL3RhYmxlOmU5ZWQ1NTI5ZTRhYjQ5NjFhMDliZWIyOWQ0OTk1MTM0L3RhYmxlcmFuZ2U6ZTllZDU1MjllNGFiNDk2MWEwOWJlYjI5ZDQ5OTUxMzRfNDUtMy0xLTEtMjk0ODk_9f1a0388-0b50-4b34-8a08-a45c79f4cb93"
      unitRef="usd">2058474000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i72c8ccfb1d004dff8edb67a140b34692_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMy0xLTEtMS0yOTQ4OQ_e2ba9a36-5dc0-433f-ac59-aaa6aa10a781"
      unitRef="usd">1278016000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic8c322d1717c4ac1bdf35faa1ec15017_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMy0zLTEtMS0yOTQ4OQ_508581d3-4649-4f34-be3a-fb1984e0fe81"
      unitRef="usd">1166743000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i08ae2120de2d443a9249395c939d9db2_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMy01LTEtMS0yOTQ4OQ_b1eeafdd-5da4-4965-9913-b9a4e27deb00"
      unitRef="usd">931722000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8827fd8aae0c45ac99829a7fb259f75c_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfNC0xLTEtMS0yOTQ4OQ_7f536d2c-5bd9-450e-8c88-26de8a7acfa1"
      unitRef="usd">152045000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8b9fb24ebf5447db9eb3e2b703507952_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfNC0zLTEtMS0yOTQ4OQ_decf7007-4abd-4802-8f35-719f1d3796d6"
      unitRef="usd">148334000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i93e177287d564fa0be95b081ae11ddd8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfNC01LTEtMS0yOTQ4OQ_d25fbe33-ff77-4c10-9558-d0abece4ee67"
      unitRef="usd">140118000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfNS0xLTEtMS0yOTQ4OQ_ef372cba-fab0-4113-b710-81cdb206f6f4"
      unitRef="usd">1430061000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfNS0zLTEtMS0yOTQ4OQ_44563d78-5b8d-4475-bec7-79221a1e8cd0"
      unitRef="usd">1315077000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfNS01LTEtMS0yOTQ4OQ_a097a7bb-914b-4069-a487-87ea78257902"
      unitRef="usd">1071840000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueNotFromContractWithCustomer
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfNi0xLTEtMS0yOTQ4OQ_55a6c759-a691-45ed-b21a-46156d7579ea"
      unitRef="usd">0</us-gaap:RevenueNotFromContractWithCustomer>
    <us-gaap:RevenueNotFromContractWithCustomer
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfNi0zLTEtMS0yOTQ4OQ_b8443b72-87e0-4b78-b5ac-535fffcb1173"
      unitRef="usd">9110000</us-gaap:RevenueNotFromContractWithCustomer>
    <us-gaap:RevenueNotFromContractWithCustomer
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfNi01LTEtMS0yOTQ4OQ_816a7272-6920-4315-8579-baea6dc3b30d"
      unitRef="usd">26264000</us-gaap:RevenueNotFromContractWithCustomer>
    <rdnt:OperatingExpensesExcludingDepreciationAndAmortization
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfOC0xLTEtMS0yOTQ4OQ_b1c4bfc4-58df-4725-9ed2-a8337ac1dd10"
      unitRef="usd">1264346000</rdnt:OperatingExpensesExcludingDepreciationAndAmortization>
    <rdnt:OperatingExpensesExcludingDepreciationAndAmortization
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfOC0zLTEtMS0yOTQ4OQ_ed838f7c-fb68-48c3-b8a3-31de36e62ae1"
      unitRef="usd">1123274000</rdnt:OperatingExpensesExcludingDepreciationAndAmortization>
    <rdnt:OperatingExpensesExcludingDepreciationAndAmortization
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfOC01LTEtMS0yOTQ4OQ_eec35004-611b-496d-930e-c11cad278df2"
      unitRef="usd">965902000</rdnt:OperatingExpensesExcludingDepreciationAndAmortization>
    <us-gaap:GainLossOnTerminationOfLease
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfOS0xLTEtMS0yOTQ4OQ_49011bc3-82b3-4eb0-9b8f-49403ea0c1e2"
      unitRef="usd">0</us-gaap:GainLossOnTerminationOfLease>
    <us-gaap:GainLossOnTerminationOfLease
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfOS0zLTEtMS0yOTQ4OQ_631b41cb-bb83-46b9-9bf4-6b683d0250a5"
      unitRef="usd">-19675000</us-gaap:GainLossOnTerminationOfLease>
    <us-gaap:GainLossOnTerminationOfLease
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfOS01LTEtMS0yOTQ4OQ_72dcabf2-73ae-4381-9415-775bc4e1355e"
      unitRef="usd">0</us-gaap:GainLossOnTerminationOfLease>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMTAtMS0xLTEtMjk0ODk_293e5ce2-3d7c-4f1c-a138-d96e90f7ccc6"
      unitRef="usd">115877000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMTAtMy0xLTEtMjk0ODk_4e2fa667-fae1-4c5a-abd5-8f3d873721a0"
      unitRef="usd">96694000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMTAtNS0xLTEtMjk0ODk_9739309d-43f3-4590-a84d-f62645347a6c"
      unitRef="usd">86795000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMTEtMS0xLTEtMjk0ODk_6cdb49c3-9a1b-4223-9b1d-37c46429d3ef"
      unitRef="usd">-2529000</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMTEtMy0xLTEtMjk0ODk_fdbf1e48-031b-4b17-baf6-512ab3cda186"
      unitRef="usd">-1246000</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMTEtNS0xLTEtMjk0ODk_927cc024-0b04-4d4d-9df4-09323b7d8b8c"
      unitRef="usd">-1200000</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMTItMS0xLTEtMjk0ODk_126c44ac-1d64-4832-bbc1-5261d28ad2f3"
      unitRef="usd">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMTItMy0xLTEtMjk0ODk_02a103d6-993a-4ed0-8d42-d0d94e653d15"
      unitRef="usd">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMTItNS0xLTEtMjk0ODk_ba82b981-0755-4a2a-9a73-ee7dc4e8549d"
      unitRef="usd">4170000</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:SeveranceCosts1
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMTMtMS0xLTEtMjk0ODk_91b98ead-62f3-4c40-9209-8dfcbb3a1603"
      unitRef="usd">946000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMTMtMy0xLTEtMjk0ODk_4dde0347-b45d-4501-bd74-fd709da4faf1"
      unitRef="usd">744000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMTMtNS0xLTEtMjk0ODk_dd260ee8-d183-4c68-9e52-85064fa4ef10"
      unitRef="usd">4353000</us-gaap:SeveranceCosts1>
    <us-gaap:OperatingExpenses
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMTQtMS0xLTEtMjk0ODk_231a4eed-e73f-4e6a-b1d8-77f17819594f"
      unitRef="usd">1383698000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMTQtMy0xLTEtMjk0ODk_73698403-efc0-4acb-8208-85e88548b0b5"
      unitRef="usd">1241633000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMTQtNS0xLTEtMjk0ODk_c5fba895-8e75-492f-b79b-51ef90002f74"
      unitRef="usd">1062420000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMTUtMS0xLTEtMjk0ODk_bac10ba7-235b-4616-a633-587c3bb8f383"
      unitRef="usd">46363000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMTUtMy0xLTEtMjk0ODk_f760d4bb-7a52-4337-9864-b6c7bce7b7f4"
      unitRef="usd">82554000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMTUtNS0xLTEtMjk0ODk_8a660091-2fe2-4368-adee-0c3486e8d58d"
      unitRef="usd">35684000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpenseDebt
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMTgtMS0xLTEtMjk0ODk_d5610241-c7bc-4972-aafd-9e766290e4fc"
      unitRef="usd">50841000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMTgtMy0xLTEtMjk0ODk_241d3ad9-e793-494c-8fd0-f7579d580821"
      unitRef="usd">48830000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMTgtNS0xLTEtMjk0ODk_f0d95958-9009-4c7a-97a1-f0a31a1bcad5"
      unitRef="usd">45882000</us-gaap:InterestExpenseDebt>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMTktMS0xLTEtMjk0ODk_ad4c4dc6-6397-42c8-b01b-8d77af8e729f"
      unitRef="usd">10390000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMTktMy0xLTEtMjk0ODk_be4f4248-74bf-41b5-ad14-3104bbcfe52f"
      unitRef="usd">10967000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMTktNS0xLTEtMjk0ODk_08ec1e4c-4597-4ad9-aaca-e006dd6ca9d9"
      unitRef="usd">7945000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMjAtMS0xLTEtMjk0ODk_16c52c2c-745a-4753-b0ec-7fd774201edb"
      unitRef="usd">39621000</us-gaap:IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1>
    <us-gaap:IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMjAtMy0xLTEtMjk0ODk_f1883fcf-1c68-4586-ba78-3ea6c62d80a0"
      unitRef="usd">21670000</us-gaap:IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1>
    <us-gaap:IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMjAtNS0xLTEtMjk0ODk_3b8416b2-055a-4fad-b012-f84e699f3218"
      unitRef="usd">-2528000</us-gaap:IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1>
    <rdnt:GainLossOnExtinguishmentOfDebtAndOtherExpenses
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMjItMS0xLTEtMjk0ODk_2abd6c89-0fa8-4780-ada5-3e97ed8d4b6a"
      unitRef="usd">-731000</rdnt:GainLossOnExtinguishmentOfDebtAndOtherExpenses>
    <rdnt:GainLossOnExtinguishmentOfDebtAndOtherExpenses
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMjItMy0xLTEtMjk0ODk_64043d58-2fb4-4e37-9ce4-d158492e01b5"
      unitRef="usd">-6044000</rdnt:GainLossOnExtinguishmentOfDebtAndOtherExpenses>
    <rdnt:GainLossOnExtinguishmentOfDebtAndOtherExpenses
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMjItNS0xLTEtMjk0ODk_45b19cab-299c-42a0-9748-f8f12606a283"
      unitRef="usd">4047000</rdnt:GainLossOnExtinguishmentOfDebtAndOtherExpenses>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMjMtMS0xLTEtMjk0ODk_7be4af29-65dc-48b0-9085-ccef3baac479"
      unitRef="usd">-1833000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMjMtMy0xLTEtMjk0ODk_7eb3726a-7012-4401-b60b-90c3518019e1"
      unitRef="usd">-1438000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMjMtNS0xLTEtMjk0ODk_4b82bb7b-f129-4fba-be6c-343b91a6af75"
      unitRef="usd">-120000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMjQtMS0xLTEtMjk0ODk_f49ba89c-e176-423e-840b-39b08087869d"
      unitRef="usd">-3394000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMjQtMy0xLTEtMjk0ODk_2e0d88f0-efe5-4545-9b46-ea13cab4ab32"
      unitRef="usd">-23675000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMjQtNS0xLTEtMjk0ODk_5f351cd3-a788-47bb-8126-d32b3f601219"
      unitRef="usd">-36538000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMjUtMS0xLTEtMjk0ODk_e28769b1-36d4-442c-af8f-a49c2807adbf"
      unitRef="usd">42969000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMjUtMy0xLTEtMjk0ODk_9b7de2ee-d856-4ca6-bb96-00783384dd5f"
      unitRef="usd">58879000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMjUtNS0xLTEtMjk0ODk_b43467a5-eefc-44be-8d46-da7edf914e81"
      unitRef="usd">-854000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMjYtMS0xLTEtMjk0ODk_38a7542a-6a57-4b5a-b431-17477524d445"
      unitRef="usd">9361000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMjYtMy0xLTEtMjk0ODk_bf88c924-e976-4063-b3ea-fae8dbbdf61f"
      unitRef="usd">14560000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMjYtNS0xLTEtMjk0ODk_8b0b421b-332c-4a7a-95fc-ea4455ecfe2a"
      unitRef="usd">895000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMjctMS0xLTEtMjk0ODk_1e258e74-1203-4acc-b7db-eb66dde472f0"
      unitRef="usd">33608000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMjctMy0xLTEtMjk0ODk_319a7815-2009-473f-a47b-fdf3fd825467"
      unitRef="usd">44319000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMjctNS0xLTEtMjk0ODk_24448e84-034f-4034-a6ce-511dae559d26"
      unitRef="usd">-1749000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMjgtMS0xLTEtMjk0ODk_17fab1c3-d1e1-4516-b90f-49ff4968cebe"
      unitRef="usd">22958000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMjgtMy0xLTEtMjk0ODk_64466c3c-b207-4283-8544-245e03165a2c"
      unitRef="usd">19592000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMjgtNS0xLTEtMjk0ODk_f150c186-dc4c-4497-b63b-aca302780c99"
      unitRef="usd">13091000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMzAtMS0xLTEtMjk0ODk_920ef47f-e019-4c7c-ad8c-0114b828bd5e"
      unitRef="usd">10650000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMzAtMy0xLTEtMjk0ODk_290be361-b28f-4579-835e-342a960106c4"
      unitRef="usd">24727000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMzAtNS0xLTEtMjk0ODk_2603723a-2476-4663-a8b6-cee8a88ae2e5"
      unitRef="usd">-14840000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMzItMS0xLTEtMjk0ODk_efff96d1-648f-4395-9c3b-16d80d1f58ae"
      unitRef="usdPerShare">0.19</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMzItMy0xLTEtMjk0ODk_1d40e043-7774-4b0d-8c6e-2154926c6834"
      unitRef="usdPerShare">0.47</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMzItNS0xLTEtMjk0ODk_046dbd7b-b16e-4a25-830d-806ec4c6b941"
      unitRef="usdPerShare">-0.29</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMzQtMS0xLTEtMjk0ODk_d14c0e8e-4182-4590-bf27-eea7c2548c32"
      unitRef="usdPerShare">0.17</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMzQtMy0xLTEtMjk0ODk_9f228fdb-9989-42e5-8ba9-f1177465babf"
      unitRef="usdPerShare">0.46</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMzQtNS0xLTEtMjk0ODk_b50ee219-09f5-4bbe-85a3-f0e215e3541e"
      unitRef="usdPerShare">-0.29</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMzctMS0xLTEtMjk0ODk_f3eb5f93-387d-4ff2-96b7-0f0b14ac1b9a"
      unitRef="shares">56293336</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMzctMy0xLTEtMjk0ODk_9537b1d2-c0ab-4712-a161-5da10d607119"
      unitRef="shares">52496679</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMzctNS0xLTEtMjk0ODk_f2ab258f-393c-4a83-b09f-ea7a720db75d"
      unitRef="shares">50891791</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMzgtMS0xLTEtMjk0ODk_cedbfdb0-9ed2-439d-a904-c822190c0efb"
      unitRef="shares">57320870</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMzgtMy0xLTEtMjk0ODk_bdf0a84f-8ffd-4b59-be58-9e641cd3bc51"
      unitRef="shares">53421033</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV81OC9mcmFnOjIyNWZhYWU5YjZjZjQyNzdhOTdiYjRjYTQ5MDc2NjY2L3RhYmxlOjI4ZGY4MzBkNTMyNjQ5NjI4NWZiY2NlZDQxZTI2MzZlL3RhYmxlcmFuZ2U6MjhkZjgzMGQ1MzI2NDk2Mjg1ZmJjY2VkNDFlMjYzNmVfMzgtNS0xLTEtMjk0ODk_fbf79b25-f4d4-40c6-9e80-bce339326d46"
      unitRef="shares">50891791</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ProfitLoss
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82MS9mcmFnOjkwODkzZGY3ZGQ2NDQ1OWI4MDgzY2ExMDRmMDE2YWQ5L3RhYmxlOjE1ZDllZGQ2YzZlNjQ3NTJiMmZjNjk2ZTAxYTYxOTRjL3RhYmxlcmFuZ2U6MTVkOWVkZDZjNmU2NDc1MmIyZmM2OTZlMDFhNjE5NGNfMi0xLTEtMS0yOTQ4OQ_82f3597c-6dcb-4846-81de-753bc234899a"
      unitRef="usd">33608000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82MS9mcmFnOjkwODkzZGY3ZGQ2NDQ1OWI4MDgzY2ExMDRmMDE2YWQ5L3RhYmxlOjE1ZDllZGQ2YzZlNjQ3NTJiMmZjNjk2ZTAxYTYxOTRjL3RhYmxlcmFuZ2U6MTVkOWVkZDZjNmU2NDc1MmIyZmM2OTZlMDFhNjE5NGNfMi0zLTEtMS0yOTQ4OQ_dbae9924-0c85-416e-8618-e1548f190241"
      unitRef="usd">44319000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82MS9mcmFnOjkwODkzZGY3ZGQ2NDQ1OWI4MDgzY2ExMDRmMDE2YWQ5L3RhYmxlOjE1ZDllZGQ2YzZlNjQ3NTJiMmZjNjk2ZTAxYTYxOTRjL3RhYmxlcmFuZ2U6MTVkOWVkZDZjNmU2NDc1MmIyZmM2OTZlMDFhNjE5NGNfMi01LTEtMS0yOTQ4OQ_56fd8f7e-80b3-4a04-8f0a-06d912919b38"
      unitRef="usd">-1749000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82MS9mcmFnOjkwODkzZGY3ZGQ2NDQ1OWI4MDgzY2ExMDRmMDE2YWQ5L3RhYmxlOjE1ZDllZGQ2YzZlNjQ3NTJiMmZjNjk2ZTAxYTYxOTRjL3RhYmxlcmFuZ2U6MTVkOWVkZDZjNmU2NDc1MmIyZmM2OTZlMDFhNjE5NGNfMy0xLTEtMS0yOTQ4OQ_995b36b9-b5d7-4c99-8e4b-28970ca88293"
      unitRef="usd">-3943000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82MS9mcmFnOjkwODkzZGY3ZGQ2NDQ1OWI4MDgzY2ExMDRmMDE2YWQ5L3RhYmxlOjE1ZDllZGQ2YzZlNjQ3NTJiMmZjNjk2ZTAxYTYxOTRjL3RhYmxlcmFuZ2U6MTVkOWVkZDZjNmU2NDc1MmIyZmM2OTZlMDFhNjE5NGNfMy0zLTEtMS0yOTQ4OQ_f4cbfa0a-d524-44e8-8ac2-9a63b46937c5"
      unitRef="usd">-65000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82MS9mcmFnOjkwODkzZGY3ZGQ2NDQ1OWI4MDgzY2ExMDRmMDE2YWQ5L3RhYmxlOjE1ZDllZGQ2YzZlNjQ3NTJiMmZjNjk2ZTAxYTYxOTRjL3RhYmxlcmFuZ2U6MTVkOWVkZDZjNmU2NDc1MmIyZmM2OTZlMDFhNjE5NGNfMy01LTEtMS0yOTQ4OQ_e1ff6b4d-f1c5-482b-abfe-a4e5738b34a4"
      unitRef="usd">-101000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82MS9mcmFnOjkwODkzZGY3ZGQ2NDQ1OWI4MDgzY2ExMDRmMDE2YWQ5L3RhYmxlOjE1ZDllZGQ2YzZlNjQ3NTJiMmZjNjk2ZTAxYTYxOTRjL3RhYmxlcmFuZ2U6MTVkOWVkZDZjNmU2NDc1MmIyZmM2OTZlMDFhNjE5NGNfNC0xLTEtMS0yOTQ4OQ_4fb01974-eb89-4452-b37d-a4cf897d5830"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82MS9mcmFnOjkwODkzZGY3ZGQ2NDQ1OWI4MDgzY2ExMDRmMDE2YWQ5L3RhYmxlOjE1ZDllZGQ2YzZlNjQ3NTJiMmZjNjk2ZTAxYTYxOTRjL3RhYmxlcmFuZ2U6MTVkOWVkZDZjNmU2NDc1MmIyZmM2OTZlMDFhNjE5NGNfNC0zLTEtMS0yOTQ4OQ_72b65fc5-b840-4ed2-8204-f8ec81211d1e"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82MS9mcmFnOjkwODkzZGY3ZGQ2NDQ1OWI4MDgzY2ExMDRmMDE2YWQ5L3RhYmxlOjE1ZDllZGQ2YzZlNjQ3NTJiMmZjNjk2ZTAxYTYxOTRjL3RhYmxlcmFuZ2U6MTVkOWVkZDZjNmU2NDc1MmIyZmM2OTZlMDFhNjE5NGNfNC01LTEtMS0yOTQ4OQ_80235c12-8172-44c5-b18f-bb14b61bb2b9"
      unitRef="usd">-19372000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82MS9mcmFnOjkwODkzZGY3ZGQ2NDQ1OWI4MDgzY2ExMDRmMDE2YWQ5L3RhYmxlOjE1ZDllZGQ2YzZlNjQ3NTJiMmZjNjk2ZTAxYTYxOTRjL3RhYmxlcmFuZ2U6MTVkOWVkZDZjNmU2NDc1MmIyZmM2OTZlMDFhNjE5NGNfNS0xLTEtMS0yOTQ4OQ_5f6d9c71-5598-4cd7-9fbf-1e539ac7b80b"
      unitRef="usd">-3687000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82MS9mcmFnOjkwODkzZGY3ZGQ2NDQ1OWI4MDgzY2ExMDRmMDE2YWQ5L3RhYmxlOjE1ZDllZGQ2YzZlNjQ3NTJiMmZjNjk2ZTAxYTYxOTRjL3RhYmxlcmFuZ2U6MTVkOWVkZDZjNmU2NDc1MmIyZmM2OTZlMDFhNjE5NGNfNS0zLTEtMS0yOTQ4OQ_abfcd1a7-8d71-45ab-89e2-aa0ac4b6222e"
      unitRef="usd">-3695000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82MS9mcmFnOjkwODkzZGY3ZGQ2NDQ1OWI4MDgzY2ExMDRmMDE2YWQ5L3RhYmxlOjE1ZDllZGQ2YzZlNjQ3NTJiMmZjNjk2ZTAxYTYxOTRjL3RhYmxlcmFuZ2U6MTVkOWVkZDZjNmU2NDc1MmIyZmM2OTZlMDFhNjE5NGNfNS01LTEtMS0yOTQ4OQ_ec7ab212-14ca-4b4a-8e96-09c555da8110"
      unitRef="usd">-3448000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82MS9mcmFnOjkwODkzZGY3ZGQ2NDQ1OWI4MDgzY2ExMDRmMDE2YWQ5L3RhYmxlOjE1ZDllZGQ2YzZlNjQ3NTJiMmZjNjk2ZTAxYTYxOTRjL3RhYmxlcmFuZ2U6MTVkOWVkZDZjNmU2NDc1MmIyZmM2OTZlMDFhNjE5NGNfNi0xLTEtMS0yOTQ4OQ_aef73133-279d-4ed1-96c0-6b50bb47fbea"
      unitRef="usd">33352000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82MS9mcmFnOjkwODkzZGY3ZGQ2NDQ1OWI4MDgzY2ExMDRmMDE2YWQ5L3RhYmxlOjE1ZDllZGQ2YzZlNjQ3NTJiMmZjNjk2ZTAxYTYxOTRjL3RhYmxlcmFuZ2U6MTVkOWVkZDZjNmU2NDc1MmIyZmM2OTZlMDFhNjE5NGNfNi0zLTEtMS0yOTQ4OQ_2488e892-93ee-4063-a00a-08cb26f38803"
      unitRef="usd">47949000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82MS9mcmFnOjkwODkzZGY3ZGQ2NDQ1OWI4MDgzY2ExMDRmMDE2YWQ5L3RhYmxlOjE1ZDllZGQ2YzZlNjQ3NTJiMmZjNjk2ZTAxYTYxOTRjL3RhYmxlcmFuZ2U6MTVkOWVkZDZjNmU2NDc1MmIyZmM2OTZlMDFhNjE5NGNfNi01LTEtMS0yOTQ4OQ_31e42284-49a4-49c4-8404-5f90e22d806e"
      unitRef="usd">-17774000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82MS9mcmFnOjkwODkzZGY3ZGQ2NDQ1OWI4MDgzY2ExMDRmMDE2YWQ5L3RhYmxlOjE1ZDllZGQ2YzZlNjQ3NTJiMmZjNjk2ZTAxYTYxOTRjL3RhYmxlcmFuZ2U6MTVkOWVkZDZjNmU2NDc1MmIyZmM2OTZlMDFhNjE5NGNfNy0xLTEtMS0yOTQ4OQ_2245b11d-29df-4ff0-917b-d6203feb32da"
      unitRef="usd">22958000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82MS9mcmFnOjkwODkzZGY3ZGQ2NDQ1OWI4MDgzY2ExMDRmMDE2YWQ5L3RhYmxlOjE1ZDllZGQ2YzZlNjQ3NTJiMmZjNjk2ZTAxYTYxOTRjL3RhYmxlcmFuZ2U6MTVkOWVkZDZjNmU2NDc1MmIyZmM2OTZlMDFhNjE5NGNfNy0zLTEtMS0yOTQ4OQ_c59f1d8f-8cb6-4264-9ec9-8ca9f38458b1"
      unitRef="usd">19592000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82MS9mcmFnOjkwODkzZGY3ZGQ2NDQ1OWI4MDgzY2ExMDRmMDE2YWQ5L3RhYmxlOjE1ZDllZGQ2YzZlNjQ3NTJiMmZjNjk2ZTAxYTYxOTRjL3RhYmxlcmFuZ2U6MTVkOWVkZDZjNmU2NDc1MmIyZmM2OTZlMDFhNjE5NGNfNy01LTEtMS0yOTQ4OQ_832f07cc-e9fc-4e05-bacc-8f1cfa5fc3fd"
      unitRef="usd">13091000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82MS9mcmFnOjkwODkzZGY3ZGQ2NDQ1OWI4MDgzY2ExMDRmMDE2YWQ5L3RhYmxlOjE1ZDllZGQ2YzZlNjQ3NTJiMmZjNjk2ZTAxYTYxOTRjL3RhYmxlcmFuZ2U6MTVkOWVkZDZjNmU2NDc1MmIyZmM2OTZlMDFhNjE5NGNfOS0xLTEtMS0yOTQ4OQ_0726d927-60fe-44ff-ab04-75c2f78d594e"
      unitRef="usd">10394000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82MS9mcmFnOjkwODkzZGY3ZGQ2NDQ1OWI4MDgzY2ExMDRmMDE2YWQ5L3RhYmxlOjE1ZDllZGQ2YzZlNjQ3NTJiMmZjNjk2ZTAxYTYxOTRjL3RhYmxlcmFuZ2U6MTVkOWVkZDZjNmU2NDc1MmIyZmM2OTZlMDFhNjE5NGNfOS0zLTEtMS0yOTQ4OQ_faa6757f-9371-4660-8a44-07be01afb90e"
      unitRef="usd">28357000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82MS9mcmFnOjkwODkzZGY3ZGQ2NDQ1OWI4MDgzY2ExMDRmMDE2YWQ5L3RhYmxlOjE1ZDllZGQ2YzZlNjQ3NTJiMmZjNjk2ZTAxYTYxOTRjL3RhYmxlcmFuZ2U6MTVkOWVkZDZjNmU2NDc1MmIyZmM2OTZlMDFhNjE5NGNfOS01LTEtMS0yOTQ4OQ_8e317d47-eed6-4f7a-a07b-8935812ca1f9"
      unitRef="usd">-30865000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i88190c6477b54e7c8dd36138e1b559d5_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMTgtMS0xLTEtMjk0ODk_a6d68748-efcd-4f3e-8468-2ee8beb8a0ff"
      unitRef="shares">50314328</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i88190c6477b54e7c8dd36138e1b559d5_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMTgtMy0xLTEtMjk0ODk_955836d5-b4ea-42d9-9f15-2d3d0d88be85"
      unitRef="usd">5000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2d953a41c6d9468dbca0b44fc5f607e3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMTgtNS0xLTEtMjk0ODk_984a2dcc-7212-43e2-a8fd-90db9db88b20"
      unitRef="usd">262865000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia3e2118a10c34ab7a36716b00a6d7689_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMTgtNy0xLTEtMjk0ODk_3cd6f327-96ad-4d1f-8109-bf28422fabdd"
      unitRef="usd">-8026000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i631fe7e868d0484cb4e25a85cae0a91e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMTgtOS0xLTEtMjk0ODk_3b28f266-78b1-4530-ab58-dc51945e60e3"
      unitRef="usd">-103159000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iac4cd4d1f8df442897db11d5620d8aff_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMTgtMTEtMS0xLTI5NDg5_6f94fd25-2085-4ae8-bcf6-fdc9d65c847c"
      unitRef="usd">151685000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5ce0185d244440a4acb3004eca085a56_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMTgtMTMtMS0xLTI5NDg5_e5a1f620-42c3-429a-9ca1-00f7dc3e6258"
      unitRef="usd">81454000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i404f0df0019f440299547782ff0ce012_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMTgtMTUtMS0xLTI5NDg5_5a009793-cd26-4b72-a369-739758e7de75"
      unitRef="usd">233139000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i99fcac4f0fc74d8aace4c8852be510de_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMjAtMS0xLTEtMjk0ODk_c63c6ed2-495f-4af0-8611-0d2850c6791e"
      unitRef="shares">491674</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="ibbbe6648075f46b597abbe27ffaf1a51_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMjEtMS0xLTEtMjk0ODk_752a1662-a732-48b4-a887-ca36703653a1"
      unitRef="shares">10920</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ibd177ca06f0e4f359d97359a10eeb1bd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMjItNS0xLTEtMjk0ODk_3292c0ff-ddbe-4d97-b708-aabe2698d4b1"
      unitRef="usd">12463000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i006b7ea314fc4246a62dc2614396fb18_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMjItMTEtMS0xLTI5NDg5_29d7d7ad-4d65-42a1-815d-54b599008f0a"
      unitRef="usd">12463000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMjItMTUtMS0xLTI5NDg5_a1bef0d6-522f-476f-8eeb-0417d79c08a4"
      unitRef="usd">12463000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="i99fcac4f0fc74d8aace4c8852be510de_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMjMtMS0xLTEtMjk0ODk_8d834108-9be5-471b-87fc-339951a63544"
      unitRef="shares">823615</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="ibd177ca06f0e4f359d97359a10eeb1bd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMjMtNS0xLTEtMjk0ODk_b57914de-165e-4566-9eaa-37238d2f14e3"
      unitRef="usd">33011000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="i006b7ea314fc4246a62dc2614396fb18_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMjMtMTEtMS0xLTI5NDg5_e719c83a-1786-48b3-b62f-e70baa28b4ca"
      unitRef="usd">33011000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMjMtMTUtMS0xLTI5NDg5_45765f61-9da9-4890-9d79-b699c79cb19f"
      unitRef="usd">33011000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <rdnt:AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest
      contextRef="ibd177ca06f0e4f359d97359a10eeb1bd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMjQtNS0xLTEtMjk0ODk_2436c494-b8fd-443c-8db4-7d1eff14ff3d"
      unitRef="usd">551000</rdnt:AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest>
    <rdnt:AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest
      contextRef="i006b7ea314fc4246a62dc2614396fb18_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMjQtMTEtMS0xLTI5NDg5_86e20f80-1a87-4b15-8bf6-c40c8d5d2144"
      unitRef="usd">551000</rdnt:AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest>
    <rdnt:AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMjQtMTUtMS0xLTI5NDg5_4724c19d-319b-4471-8148-5b96d2f286c0"
      unitRef="usd">551000</rdnt:AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i298a24d3aaec41ea8698fd195ead858e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMjUtMTMtMS0xLTI5NDg5_2096a531-b513-42e8-ab68-3943b7f3bb6c"
      unitRef="usd">1985000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMjUtMTUtMS0xLTI5NDg5_de535a47-0933-4130-8014-20cda8efef40"
      unitRef="usd">1985000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
      contextRef="i9d5e574cdbd04637a34823f382a6c58a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMjYtNy0xLTEtMjk0ODk_a825f07b-896e-47e5-af27-e1236aa19e15"
      unitRef="usd">-101000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
      contextRef="i006b7ea314fc4246a62dc2614396fb18_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMjYtMTEtMS0xLTI5NDg5_036176da-ba36-4217-8e5c-f743452a683a"
      unitRef="usd">-101000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMjYtMTUtMS0xLTI5NDg5_5b5d9ec7-d658-41c0-992b-b77a89982aa0"
      unitRef="usd">-101000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i9d5e574cdbd04637a34823f382a6c58a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMjctNy0xLTEtMjk0ODk_a48a2e15-a4dd-4300-802f-e20879a215d6"
      unitRef="usd">-19372000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i006b7ea314fc4246a62dc2614396fb18_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMjctMTEtMS0xLTI5NDg5_ce97bd56-ec5a-4e5f-8f02-ff1a1db622cc"
      unitRef="usd">-19372000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMjctMTUtMS0xLTI5NDg5_ee9b34d7-2804-4aae-a277-42c90217d84c"
      unitRef="usd">-19372000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i9d5e574cdbd04637a34823f382a6c58a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMjgtNy0xLTEtMjk0ODk_50526dbe-df04-4228-9cf4-66ab7384f4c2"
      unitRef="usd">-3448000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i006b7ea314fc4246a62dc2614396fb18_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMjgtMTEtMS0xLTI5NDg5_d020d2d9-741a-415b-adf4-76cfb1004aa7"
      unitRef="usd">-3448000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMjgtMTUtMS0xLTI5NDg5_a87f07a9-51fa-49dd-af48-6f476c0485c7"
      unitRef="usd">-3448000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:ProfitLoss
      contextRef="ic79d3a1f3d0f4fc49bb4724de0a7156c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMjktOS0xLTEtMjk0ODk_f49ac660-2262-4a0d-80a4-ad377815b401"
      unitRef="usd">-14840000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i006b7ea314fc4246a62dc2614396fb18_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMjktMTEtMS0xLTI5NDg5_e2ea232a-3203-4a56-8a28-e977cf9e578f"
      unitRef="usd">-14840000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i298a24d3aaec41ea8698fd195ead858e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMjktMTMtMS0xLTI5NDg5_4fb1b172-d8af-4d3a-a5d8-ea29a843b973"
      unitRef="usd">13091000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMjktMTUtMS0xLTI5NDg5_6e68ccf5-79dc-4a25-b1f5-b1249d0dd062"
      unitRef="usd">-1749000</us-gaap:ProfitLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i081fa83c5ad549cebb5ab4d974f827b3_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMzAtMS0xLTEtMjk0ODk_11f355ab-1bc3-4235-8f5b-da3f5b0ce796"
      unitRef="shares">51640537</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i081fa83c5ad549cebb5ab4d974f827b3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMzAtMy0xLTEtMjk0ODk_db9f7a18-f954-4f27-9633-0a823ac307a0"
      unitRef="usd">5000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i101eecb916e744b7aaed50d001dc9bab_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMzAtNS0xLTEtMjk0ODk_a6a68d86-6fc8-45d9-a16c-37c03923b9ea"
      unitRef="usd">307788000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i23849d87eb184c1b9a2d7f9eb8115fbb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMzAtNy0xLTEtMjk0ODk_fd97def1-2b7e-4534-95b5-05f663e75a9f"
      unitRef="usd">-24051000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0b2862b69f4a469795d00c8dfea6afd9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMzAtOS0xLTEtMjk0ODk_114a5857-00bc-4349-a1ce-c27803bad650"
      unitRef="usd">-117999000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iff5a453e0ae34e3ea23964a503b82dff_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMzAtMTEtMS0xLTI5NDg5_9a7f7611-7a52-472e-b17e-4bcad0882bce"
      unitRef="usd">165743000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5dcbd877ab784f1894ed73e70da01d83_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMzAtMTMtMS0xLTI5NDg5_7b62877e-0a0b-4cbd-b29d-833084db8984"
      unitRef="usd">92560000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifb50bc5a13564f6a97eb669524009c18_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMzAtMTUtMS0xLTI5NDg5_dbdc1479-5931-4dda-8f2c-bf7a9a9b0d5b"
      unitRef="usd">258303000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ib946969776ca45ccae82cbfc0c191797_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMzEtMS0xLTEtMjk0ODk_42e69304-9603-4500-9d8c-81da17e51da2"
      unitRef="shares">53960</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i949f0d96ac8d4f8facf965ee05a37476_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMzEtNS0xLTEtMjk0ODk_0f30a3d7-a065-47b6-8fa8-0ff241f0710a"
      unitRef="usd">488000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i8e0d2a5109214eacb7c4927e040de2c1_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMzEtMTEtMS0xLTI5NDg5_311d5b20-47e0-4e54-8420-9fd856947b87"
      unitRef="usd">488000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMzEtMTUtMS0xLTI5NDg5_f4f40e95-5218-42de-9c1f-d6c21f5b8209"
      unitRef="usd">488000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="ib946969776ca45ccae82cbfc0c191797_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMzItMS0xLTEtMjk0ODk_bba99d32-852a-480f-a989-b88de89fcb17"
      unitRef="shares">1212758</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i9f3ededd5ee04ec4aa19a0abbf3d7f77_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMzMtMS0xLTEtMjk0ODk_aa2888a3-3bd9-4be8-a55d-b5e70dc11279"
      unitRef="shares">471162</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i949f0d96ac8d4f8facf965ee05a37476_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMzQtNS0xLTEtMjk0ODk_468e2fee-8eb3-42ca-a7c7-37b962935eea"
      unitRef="usd">25284000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i8e0d2a5109214eacb7c4927e040de2c1_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMzQtMTEtMS0xLTI5NDg5_4b063d64-ba06-4ce7-bae7-40a62b26aba7"
      unitRef="usd">25284000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMzQtMTUtMS0xLTI5NDg5_7dafe557-f9f3-47a0-95c6-814da23b84d4"
      unitRef="usd">25284000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="ic1adea4000aa4578a36583c8f938f522_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMzUtMS0xLTEtMjk0ODk_083011f4-6cd7-4dca-8236-86d97b34d41d"
      unitRef="shares">82658</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i63bfeffb69d140e6b2f2ea03ff67d0bf_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMzUtNS0xLTEtMjk0ODk_4fd56e80-9d25-48fa-83d9-f0bfdd255833"
      unitRef="usd">2498000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i8a58f6df7fad437ea356f767cbc04a2e_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMzUtMTEtMS0xLTI5NDg5_8fe4a4d5-982c-4350-a506-a55e20a83f74"
      unitRef="usd">2498000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="ic6418d4bd1d040b8a16164a6790b1f63_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMzUtMTUtMS0xLTI5NDg5_6fa8ad91-a28b-4050-a26a-91c8da65cc6e"
      unitRef="usd">2498000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="i9f3ededd5ee04ec4aa19a0abbf3d7f77_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMzYtMS0xLTEtMjk0ODk_14b6d434-2d2b-4230-8158-9aa3e5f643a5"
      unitRef="shares">91517</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="id1f7abf905284fcaa40bc6081a6bd921_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMzYtNS0xLTEtMjk0ODk_dd0fdceb-8e7e-4f0b-b5c7-6ee9f8ed59f0"
      unitRef="usd">2413000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i886a120ecc15453ab356ce266fd3fcf8_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMzYtMTEtMS0xLTI5NDg5_e3123f33-a062-479e-972f-8f7dccb08296"
      unitRef="usd">2413000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i28b7664a3050400f83608253e0d1c4ba_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMzYtMTUtMS0xLTI5NDg5_31c4fda3-fa05-4f4c-8245-c78f9484938e"
      unitRef="usd">2413000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
      contextRef="ib946969776ca45ccae82cbfc0c191797_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMzctMS0xLTEtMjk0ODk_7c729bbb-7dbe-4352-962e-693075a7b1a6"
      unitRef="shares">4365</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="i949f0d96ac8d4f8facf965ee05a37476_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMzctNS0xLTEtMjk0ODk_cf0ff9d6-5008-4094-b1ca-3b48581e2c22"
      unitRef="usd">81000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="i8e0d2a5109214eacb7c4927e040de2c1_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMzctMTEtMS0xLTI5NDg5_fb247a63-302f-478c-980b-d4f2b7e92ee8"
      unitRef="usd">81000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMzctMTUtMS0xLTI5NDg5_9fc5c593-665b-45b8-b2b1-596c1925f5dc"
      unitRef="usd">81000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited>
    <rdnt:AdjustmentsToAdditionalPaidInCapitalGainOnContributionOfAssetsToSubsidiary
      contextRef="i949f0d96ac8d4f8facf965ee05a37476_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMzgtNS0xLTEtMjk0ODk_b90286a8-7a3d-470f-a7d6-6f654ed0acc9"
      unitRef="usd">4000</rdnt:AdjustmentsToAdditionalPaidInCapitalGainOnContributionOfAssetsToSubsidiary>
    <rdnt:AdjustmentsToAdditionalPaidInCapitalGainOnContributionOfAssetsToSubsidiary
      contextRef="i8e0d2a5109214eacb7c4927e040de2c1_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMzgtMTEtMS0xLTI5NDg5_3f685992-7243-4866-bac6-5ca7423f22a5"
      unitRef="usd">4000</rdnt:AdjustmentsToAdditionalPaidInCapitalGainOnContributionOfAssetsToSubsidiary>
    <rdnt:AdjustmentsToAdditionalPaidInCapitalGainOnContributionOfAssetsToSubsidiary
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMzgtMTUtMS0xLTI5NDg5_1f9d1b5f-62fe-4c64-975a-701a387437e7"
      unitRef="usd">4000</rdnt:AdjustmentsToAdditionalPaidInCapitalGainOnContributionOfAssetsToSubsidiary>
    <rdnt:NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest
      contextRef="i972be9663bfb45d4a202f7cf617a88c3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMzktMTMtMS0xLTI5NDg5_023612db-d7a6-418a-bfe4-1a811f8a4fca"
      unitRef="usd">123000</rdnt:NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest>
    <rdnt:NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfMzktMTUtMS0xLTI5NDg5_195a57e7-e9ba-4bb0-a45e-eaed4e10fe56"
      unitRef="usd">123000</rdnt:NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest>
    <us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest
      contextRef="i949f0d96ac8d4f8facf965ee05a37476_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNDAtNS0xLTEtMjk0ODk_b9ccde98-3e18-4acc-8980-50acc3760c0c"
      unitRef="usd">4206000</us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest>
    <us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest
      contextRef="i8e0d2a5109214eacb7c4927e040de2c1_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNDAtMTEtMS0xLTI5NDg5_8bd9269a-ba1c-4d33-b9bb-f50e5d36a409"
      unitRef="usd">4206000</us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest>
    <us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest
      contextRef="i972be9663bfb45d4a202f7cf617a88c3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNDAtMTMtMS0xLTI5NDg5_b347a752-5ba2-463a-b2b5-f59be2e08d98"
      unitRef="usd">7404000</us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest>
    <us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNDAtMTUtMS0xLTI5NDg5_fbcba8f3-6bc0-4349-8479-32514042285c"
      unitRef="usd">11610000</us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i972be9663bfb45d4a202f7cf617a88c3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNDEtMTMtMS0xLTI5NDg5_7469b8fc-46e1-49bd-8f7b-85d4adbee422"
      unitRef="usd">2426000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNDEtMTUtMS0xLTI5NDg5_34e5164a-c61a-465b-a252-bdaaa68fe80e"
      unitRef="usd">2426000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
      contextRef="ic6625f4cf6e34dd2acb014782fcfff34_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNDMtNy0xLTEtMjk0ODk_8669b3b6-7b06-44ae-a15e-1766c462294a"
      unitRef="usd">-65000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
      contextRef="i8e0d2a5109214eacb7c4927e040de2c1_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNDMtMTEtMS0xLTI5NDg5_2ba6380e-7386-4c7d-847b-2a662c443357"
      unitRef="usd">-65000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNDMtMTUtMS0xLTI5NDg5_d1fdc007-9eb8-46da-b527-6d72145ed75e"
      unitRef="usd">-65000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="ic6625f4cf6e34dd2acb014782fcfff34_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNDQtNy0xLTEtMjk0ODk_9016d2f4-2e25-4f7f-85f6-09590cc79778"
      unitRef="usd">-3695000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i8e0d2a5109214eacb7c4927e040de2c1_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNDQtMTEtMS0xLTI5NDg5_c7fb5496-718a-4fa7-bdda-1aaf3b8d5b65"
      unitRef="usd">-3695000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNDQtMTUtMS0xLTI5NDg5_3e09c9db-fd2b-4613-9cd0-b14b39972e45"
      unitRef="usd">-3695000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:ProfitLoss
      contextRef="i27608790e25740878c35acf6d5e205e7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNDUtOS0xLTEtMjk0ODk_f727f97c-0654-4a53-abbd-e6ce4a5e270c"
      unitRef="usd">24727000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i8e0d2a5109214eacb7c4927e040de2c1_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNDUtMTEtMS0xLTI5NDg5_41d921ad-9fd6-47ea-af40-4d98e06506ce"
      unitRef="usd">24727000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i972be9663bfb45d4a202f7cf617a88c3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNDUtMTMtMS0xLTI5NDg5_6df5ace8-837e-4950-bef2-43ab3eaa9a50"
      unitRef="usd">19592000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNDUtMTUtMS0xLTI5NDg5_9ffcffd6-0129-4ac0-b27c-8b24e4b0db85"
      unitRef="usd">44319000</us-gaap:ProfitLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i6567c2edd74c415e809b3f8dfbc69d6f_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNDYtMS0xLTEtMjk0ODk_84304518-0f53-435c-8b50-741c76d89e36"
      unitRef="shares">53548227</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6567c2edd74c415e809b3f8dfbc69d6f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNDYtMy0xLTEtMjk0ODk_09a300a7-9dd0-4a62-b895-8cf4815ac6ee"
      unitRef="usd">5000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibd09aa04b85b458ca4b4ac2d646daf7b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNDYtNS0xLTEtMjk0ODk_574db440-36d0-4fb0-b328-eafaea243f04"
      unitRef="usd">342592000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib0b5e62c4b8e424ba71aa7824dcf3fa1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNDYtNy0xLTEtMjk0ODk_49c18de9-48e9-4c6a-b7f4-9d7cf4413146"
      unitRef="usd">-20421000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2cbbe88e8caf4501bfffaebc7f2878cf_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNDYtOS0xLTEtMjk0ODk_f5e8abcb-ccb0-48a1-8139-eaab01803752"
      unitRef="usd">-93272000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6ada6464a5b842509b8bf074c4eab6e6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNDYtMTEtMS0xLTI5NDg5_378507f8-66de-4e57-815f-2f6c7f97acc4"
      unitRef="usd">228904000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie96fcf0fd181417d9610fba554c8f505_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNDYtMTMtMS0xLTI5NDg5_251c66e0-bcf3-431f-ae76-eac62a43664f"
      unitRef="usd">117253000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNDYtMTUtMS0xLTI5NDg5_97280d1b-8faa-42bc-a6b9-f8a16bdb0b04"
      unitRef="usd">346157000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ib0d0862fed0f44bf87195bfcd4b82674_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNDctMS0xLTEtNjIxNTI_b9f035ee-bba5-4b42-b7ed-38f7eb2d1f72"
      unitRef="shares">25000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ib0d0862fed0f44bf87195bfcd4b82674_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNDctMy0xLTEtNjQ1MTY_23112a33-dc2f-483d-b099-af65ca7481a3"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ie1933fa68c2f4a878ab49bbb7e97074b_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNDctNS0xLTEtNjIyMjA_29a9b7d1-a4b9-4eb5-8654-3899ccefea50"
      unitRef="usd">294000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i0eb334b8be644046940eed543ae94157_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNDctMTEtMS0xLTYyMzMw_509bebb5-f8f3-4b44-99a0-4dccce848e31"
      unitRef="usd">295000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNDctMTUtMS0xLTYyNDQz_a90f7752-8b8e-4c68-b037-695c974eeb69"
      unitRef="usd">295000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="ib0d0862fed0f44bf87195bfcd4b82674_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNDgtMS0xLTEtNjIxNjA_8c32d6eb-d7ad-4244-bdb7-e0683a678f70"
      unitRef="shares">725577</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <rdnt:SharesIssuedSharesSettlementOfContingentConsideration
      contextRef="i98a74a949db8402da4aef3fe694b8e90_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNDktMS0xLTEtNjIxNjg_21c658b4-2d64-4c05-a83e-44b11c40d119"
      unitRef="shares">781577</rdnt:SharesIssuedSharesSettlementOfContingentConsideration>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i98a74a949db8402da4aef3fe694b8e90_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNTAtMS0xLTEtNjk5MjU_76756cbe-c4df-454e-9911-434d2906854e"
      unitRef="shares">204160</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ie1933fa68c2f4a878ab49bbb7e97074b_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNTAtNS0xLTEtNjIyMjg_2ac190bf-dff1-40cb-aeaf-ce9d0993b28f"
      unitRef="usd">23543000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i0eb334b8be644046940eed543ae94157_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNTAtMTEtMS0xLTY0NTA0_9ff17458-48a6-4ea0-a5e4-9a7bf6b5e332"
      unitRef="usd">23543000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNTAtMTUtMS0xLTYyNDUx_70560c6c-dcd7-43e4-b3bc-659c3992adb9"
      unitRef="usd">23543000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="idf1451719c2f414a821e66141f27fa18_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNTEtMS0xLTEtNjIxNzc_acb26c6d-b792-4d31-8358-b80c6ab4b97b"
      unitRef="shares">2465294</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="ib31322494eca4d5aa1547d0971dc8ac9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNTEtNS0xLTEtNjIyMzY_cd97bd92-f46c-4251-b0d7-45bdb331d3e8"
      unitRef="usd">63311000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="iab8ee29b0f704d5582d80f8a1f293200_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNTEtMTEtMS0xLTYyMzQw_20f42515-8a89-4b7d-a2b9-4f749b7fc25f"
      unitRef="usd">63311000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="ibc05bb1c3a004d69a9dd0f6792cba7d0_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNTEtMTUtMS0xLTYyNDU5_7e2512ac-5fbe-4589-a1c1-ff6da7aebdc6"
      unitRef="usd">63311000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
      contextRef="ib0d0862fed0f44bf87195bfcd4b82674_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNTItMS0xLTEtNjIxODc_84c3ccbe-3fad-4357-b894-9544c163cc8c"
      unitRef="shares">26710</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="ie1933fa68c2f4a878ab49bbb7e97074b_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNTItNS0xLTEtNjIyNDQ_ef0425f6-59d8-4b55-ad19-6462f9a46243"
      unitRef="usd">75000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="i0eb334b8be644046940eed543ae94157_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNTItMTEtMS0xLTYyMzQ4_be1eb15c-acdb-4444-a3d7-3f8718cc6d4c"
      unitRef="usd">75000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNTItMTUtMS0xLTYyNDY3_892da4ec-7300-4290-bef8-3d983957da6f"
      unitRef="usd">75000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited>
    <rdnt:NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest
      contextRef="id1688320e5de4822882dee9ca4e4c9cb_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNTQtMTMtMS0xLTYyNDEw_f160b3b3-95e4-4902-895e-630f6d6dae57"
      unitRef="usd">19139000</rdnt:NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest>
    <rdnt:NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNTQtMTUtMS0xLTYyNDc2_d6ecedcc-8a27-4f71-ae07-aaa174feee11"
      unitRef="usd">19139000</rdnt:NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest>
    <us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest
      contextRef="ie1933fa68c2f4a878ab49bbb7e97074b_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNTUtNS0xLTEtNjIyNTM_72497f6c-4899-40f5-b753-a062ae69173d"
      unitRef="usd">6623000</us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest>
    <us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest
      contextRef="i0eb334b8be644046940eed543ae94157_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNTUtMTEtMS0xLTYyMzYy_0e00eb52-bcfd-40e8-bb3f-e77758c16af4"
      unitRef="usd">6623000</us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest>
    <us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNTUtMTUtMS0xLTYyNDg0_bd60c394-0b42-4ba5-9c3f-72c3948fc399"
      unitRef="usd">6623000</us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="id1688320e5de4822882dee9ca4e4c9cb_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNTYtMTMtMS0xLTYyNDE4_59877a91-32c4-4971-a17a-209405ce5d4a"
      unitRef="usd">893000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNTYtMTUtMS0xLTYyNDky_14cc0db5-1656-4f2f-b277-bcd65d2d5aee"
      unitRef="usd">893000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
      contextRef="if0cf47a4282e4868ac20435f2c4eb0f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNTgtNy0xLTEtNjIyODI_b6ae2a7f-bcb1-48b7-86c6-4449950e41d9"
      unitRef="usd">-3943000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
      contextRef="i0eb334b8be644046940eed543ae94157_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNTgtMTEtMS0xLTYyMzcw_0eed0ff5-102a-4f28-aa5b-13eda6196b99"
      unitRef="usd">-3943000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNTgtMTUtMS0xLTYyNTAw_d6e268a3-061e-4b4d-9246-72d97a5450a6"
      unitRef="usd">-3943000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="if0cf47a4282e4868ac20435f2c4eb0f9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNTktNy0xLTEtNjIyOTA_f232b4eb-7b40-4e04-951e-45fc66f2f611"
      unitRef="usd">-3687000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i0eb334b8be644046940eed543ae94157_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNTktMTEtMS0xLTYyMzc4_47bfc339-6508-443c-95b8-3bd87a31c728"
      unitRef="usd">-3687000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNTktMTUtMS0xLTYyNTA4_dad26efc-2a3f-41e0-8aa4-bb607a318cb2"
      unitRef="usd">-3687000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:ProfitLoss
      contextRef="id48fff5740844b57bc700c378e450fa7_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNjEtOS0xLTEtNjIzMTQ_16fcb529-0f2c-42e4-9d97-e132a2b9f7c8"
      unitRef="usd">10650000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i0eb334b8be644046940eed543ae94157_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNjEtMTEtMS0xLTYyMzk0_79d55b82-84cc-4203-aaa0-60cbd74c896c"
      unitRef="usd">10650000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="id1688320e5de4822882dee9ca4e4c9cb_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNjEtMTMtMS0xLTYyNDI2_710c96f9-4baf-45b8-a048-fe06c1b6af3d"
      unitRef="usd">22958000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNjEtMTUtMS0xLTYyNTI0_df6f3d6b-db07-46f0-ae78-36f571b84778"
      unitRef="usd">33608000</us-gaap:ProfitLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i8850d8ea71334023bc7208f43133ccc1_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNjEtMS0xLTEtNjIxOTY_b9d47f81-a827-4ae9-8aaf-19e1551604e7"
      unitRef="shares">57723125</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8850d8ea71334023bc7208f43133ccc1_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNjEtMy0xLTEtNjIyMTI_687102a8-bdf6-4dd9-a277-c85a3d1315ee"
      unitRef="usd">6000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i90205585203d45b9a541218bf94ecb8f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNjEtNS0xLTEtNjIyNjE_71abc8fc-8a5b-4c4f-9a49-c2c45c707777"
      unitRef="usd">436288000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9617cb12c1c84a2495a0468f42ec6183_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNjItNy0xLTEtNjIyOTg_e9f283f0-261b-42ad-9e4d-514947e2d0ce"
      unitRef="usd">-20677000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib807cb0974544fe1bde03d660c5eaaf7_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNjItOS0xLTEtNjIzMjI_4a666409-5f7b-43d1-8472-e39fcc8c28f4"
      unitRef="usd">-82622000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic8a329c56c57456a87d52725a451b145_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNjItMTEtMS0xLTYyNDAy_6c3364e4-4a5f-4b14-b016-671c4605fb9d"
      unitRef="usd">332995000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i14c67953a7094a6fbf13726da1a68618_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNjItMTMtMS0xLTYyNDM0_543c9b51-acba-4da5-a7f9-39dcd29fd997"
      unitRef="usd">158457000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82NC9mcmFnOjAyZjZkMzQ4YjFjNDQ3ZjFhNjYzOGMzYzAzNzE2NmVmL3RhYmxlOmRmODBhODlkMDQ2ZjQ5MjViZmMzNmRiZjdkYWJjOWQzL3RhYmxlcmFuZ2U6ZGY4MGE4OWQwNDZmNDkyNWJmYzM2ZGJmN2RhYmM5ZDNfNjItMTUtMS0xLTYyNTI0_249681df-a49c-43b7-9b59-bcb7f3ce9d6d"
      unitRef="usd">491452000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMy0xLTEtMS0yOTQ4OQ_2c99273a-9d3f-4d64-92cb-4ea103d4fca9"
      unitRef="usd">33608000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMy0zLTEtMS0yOTQ4OQ_3b32e2b9-d1f6-417d-9e9e-878a32b2bc36"
      unitRef="usd">44319000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMy01LTEtMS0yOTQ4OQ_8ee3688a-d28e-4697-b20e-1354bc41a610"
      unitRef="usd">-1749000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNS0xLTEtMS0yOTQ4OQ_ceeb3ac9-30e7-43fc-9a7a-61d3be44e8d8"
      unitRef="usd">115877000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNS0zLTEtMS0yOTQ4OQ_dfd9a464-3500-4de3-bd47-29c3a9e03a0c"
      unitRef="usd">96694000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNS01LTEtMS0yOTQ4OQ_848804ea-42a8-40e1-b7ee-c2210d8a6f4b"
      unitRef="usd">86795000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNi0xLTEtMS0yOTQ4OQ_8315c1f9-59ee-4f11-a375-c4483f3efe57"
      unitRef="usd">68847000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNi0zLTEtMS0yOTQ4OQ_f8073d9a-7978-4a65-8959-81b2a4a6f41c"
      unitRef="usd">73967000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNi01LTEtMS0yOTQ4OQ_d60343f0-66f7-43ab-94e7-73e29d84aac8"
      unitRef="usd">67915000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:GainLossOnTerminationOfLease
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNy0xLTEtMS0yOTQ4OQ_8b24335b-d28b-4364-962e-2e413c36ec4a"
      unitRef="usd">0</us-gaap:GainLossOnTerminationOfLease>
    <us-gaap:GainLossOnTerminationOfLease
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNy0zLTEtMS0yOTQ4OQ_4b9280d3-ffae-4533-8f2b-7f73b57d2aee"
      unitRef="usd">-19675000</us-gaap:GainLossOnTerminationOfLease>
    <us-gaap:GainLossOnTerminationOfLease
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNy01LTEtMS0yOTQ4OQ_9ea730bc-09fb-48ba-a152-2c6808383425"
      unitRef="usd">0</us-gaap:GainLossOnTerminationOfLease>
    <us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfOC0xLTEtMS0yOTQ4OQ_3d0641fd-d3b6-4d28-9f7f-25925401ad15"
      unitRef="usd">5952000</us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions>
    <us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfOC0zLTEtMS0yOTQ4OQ_24be0095-0673-42a5-8b92-d4b06873ed5d"
      unitRef="usd">6260000</us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions>
    <us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfOC01LTEtMS0yOTQ4OQ_362067ee-0374-47e9-9415-4e390ef307fa"
      unitRef="usd">-1577000</us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfOS0xLTEtMS0yOTQ4OQ_3f2a8a2f-ca68-4d03-af45-98a91ec38ea0"
      unitRef="usd">2693000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfOS0zLTEtMS0yOTQ4OQ_f02bdceb-6b4b-4bce-9ead-bf470a1a3461"
      unitRef="usd">3254000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfOS01LTEtMS0yOTQ4OQ_ec24a12b-38b2-4cd0-894a-ccd426927f1d"
      unitRef="usd">4413000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMTAtMS0xLTEtMjk0ODk_21b7f550-618b-4f9e-a655-c502550de012"
      unitRef="usd">-2529000</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMTAtMy0xLTEtMjk0ODk_ecc7f933-3ad7-47f2-8e6a-6b9cae87f26c"
      unitRef="usd">-1246000</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMTAtNS0xLTEtMjk0ODk_943c4c19-f321-422f-804c-036ce3ae7d67"
      unitRef="usd">-1200000</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMTEtMS0xLTEtMjk0ODk_dcf56240-65bb-415c-b992-e4652b307700"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMTEtMy0xLTEtMjk0ODk_d625c4a0-c9f2-4e31-a036-48496a599561"
      unitRef="usd">-1496000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMTEtNS0xLTEtMjk0ODk_e8396a67-b3bd-4b94-9cff-aaf1c647caeb"
      unitRef="usd">4047000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMTQtMS0xLTEtMjk0ODk_ab176dda-5921-40ed-a319-5c1a94d3d215"
      unitRef="usd">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMTQtMy0xLTEtMjk0ODk_167564e7-7cf5-45e5-b298-eb629e72a48f"
      unitRef="usd">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMTQtNS0xLTEtMjk0ODk_5d7a1dad-c022-4e57-973b-1eaebd45da06"
      unitRef="usd">4170000</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:AmortizationOfDeferredHedgeGains
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMTUtMS0xLTEtMjk0ODk_f31564b3-5f07-4995-8de0-5a4db54cd7dd"
      unitRef="usd">3687000</us-gaap:AmortizationOfDeferredHedgeGains>
    <us-gaap:AmortizationOfDeferredHedgeGains
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMTUtMy0xLTEtMjk0ODk_6718fdd1-2478-4fcf-87ff-380aa2928517"
      unitRef="usd">3695000</us-gaap:AmortizationOfDeferredHedgeGains>
    <us-gaap:AmortizationOfDeferredHedgeGains
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMTUtNS0xLTEtMjk0ODk_d11ce372-33f6-4dd1-b234-0c8bd6b134f5"
      unitRef="usd">3448000</us-gaap:AmortizationOfDeferredHedgeGains>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMTYtMS0xLTEtMjk0ODk_d8d17153-30f6-4959-9ce7-73d173d9e9e6"
      unitRef="usd">39621000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMTYtMy0xLTEtMjk0ODk_be76fc91-3f2a-4527-ba61-9eb9531c9e5e"
      unitRef="usd">21670000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMTYtNS0xLTEtMjk0ODk_0714c338-14dc-4b72-9981-e4591b295c27"
      unitRef="usd">-2528000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:ShareBasedCompensation
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMTctMS0xLTEtMjk0ODk_1c6662cd-35c0-4bde-8328-0d8d8bf012b6"
      unitRef="usd">23770000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMTctMy0xLTEtMjk0ODk_e2154b6e-c9c6-4899-b473-7d1adb9d5234"
      unitRef="usd">25203000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMTctNS0xLTEtMjk0ODk_6dcf6d31-73fb-45dc-b7ec-830bea2bc8ea"
      unitRef="usd">12405000</us-gaap:ShareBasedCompensation>
    <rdnt:IncreaseDecreaseInNoncashItem
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMTgtMS0xLTEtMjk0ODk_44350d1c-9761-4e1e-a5ee-a9e9968c9844"
      unitRef="usd">0</rdnt:IncreaseDecreaseInNoncashItem>
    <rdnt:IncreaseDecreaseInNoncashItem
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMTgtMy0xLTEtMjk0ODk_4af1b636-b32d-4e41-aff7-237b6cf725c7"
      unitRef="usd">0</rdnt:IncreaseDecreaseInNoncashItem>
    <rdnt:IncreaseDecreaseInNoncashItem
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMTgtNS0xLTEtMjk0ODk_f4e40cca-3ab9-460f-a362-a850aeae0026"
      unitRef="usd">-242000</rdnt:IncreaseDecreaseInNoncashItem>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMTktMS0xLTEtMjk0ODk_f2744a91-f02e-41a3-b4e0-7ffd1ea5a65c"
      unitRef="usd">-325000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMTktMy0xLTEtMjk0ODk_7bc516c9-4872-48f6-95e8-1e1fa422074d"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMTktNS0xLTEtMjk0ODk_2ee39d4f-c825-4085-9045-e49c34b9ada6"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMjEtMS0xLTEtMjk0ODk_d0697343-5bf3-469e-aa94-f20f0eb550b3"
      unitRef="usd">30078000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMjEtMy0xLTEtMjk0ODk_a5905a64-03f8-4ac8-aa99-a04dda87d973"
      unitRef="usd">5890000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMjEtNS0xLTEtMjk0ODk_a3b5764c-157a-438f-8b8a-74384467648c"
      unitRef="usd">-25206000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMjItMS0xLTEtMjk0ODk_b5f7841c-57c1-4bb9-b5f2-4e40fae4a9c3"
      unitRef="usd">3327000</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMjItMy0xLTEtMjk0ODk_ccbf9c1c-0620-4c5e-8d7c-27a8e4655f52"
      unitRef="usd">15777000</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMjItNS0xLTEtMjk0ODk_994e3c4f-56cb-499f-84b6-f5802811f7f0"
      unitRef="usd">-6588000</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMjMtMS0xLTEtMjk0ODk_00822cd4-9deb-47dd-82df-f05be026755d"
      unitRef="usd">12166000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMjMtMy0xLTEtMjk0ODk_f0103793-cd5a-4f41-ba95-e38f83174dc7"
      unitRef="usd">-662000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMjMtNS0xLTEtMjk0ODk_79dec725-b525-45fb-a9c9-b5c73cf91ad9"
      unitRef="usd">5425000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMjQtMS0xLTEtMjk0ODk_6b4869ca-805b-4cf3-913e-dcdd5f030600"
      unitRef="usd">-13356000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMjQtMy0xLTEtMjk0ODk_23a4783f-59ca-4f3e-b2b5-142e1fda3da2"
      unitRef="usd">-19834000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMjQtNS0xLTEtMjk0ODk_400d50aa-157a-4a0b-a47d-e4ee87a6393c"
      unitRef="usd">611000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMjUtMS0xLTEtMjk0ODk_0e01495a-c3fc-437f-8d24-aa315a6ed9b7"
      unitRef="usd">-68943000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMjUtMy0xLTEtMjk0ODk_ef5a2132-e84f-4e7f-8074-f49dc1221444"
      unitRef="usd">-72553000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMjUtNS0xLTEtMjk0ODk_86a278a8-c831-46a5-a6e1-2a9ec0fbc987"
      unitRef="usd">-53906000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMjYtMS0xLTEtMjk0ODk_99255ce8-8a0d-4511-a35b-8a3ca12e7c0e"
      unitRef="usd">-7316000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMjYtMy0xLTEtMjk0ODk_b2f5e370-9434-4865-8c19-0f3143a0ac2c"
      unitRef="usd">-28319000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMjYtNS0xLTEtMjk0ODk_e139456d-3458-464e-9110-992cfbd34ec0"
      unitRef="usd">37941000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMjctMS0xLTEtMjk0ODk_fffcc93f-bb94-4b30-88d4-f05db7f2cafe"
      unitRef="usd">49778000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMjctMy0xLTEtMjk0ODk_cd116a8b-792b-4696-b9d4-889e9d65d971"
      unitRef="usd">9915000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMjctNS0xLTEtMjk0ODk_c3d4410e-681e-4dbc-b8cc-5383b7ae9012"
      unitRef="usd">45069000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMjgtMS0xLTEtMjk0ODk_a4b14a8f-93a0-4c81-9c95-ae015a6f7826"
      unitRef="usd">146417000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMjgtMy0xLTEtMjk0ODk_bd1dd80e-5d1f-42de-963e-e8ddbca416ae"
      unitRef="usd">149491000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMjgtNS0xLTEtMjk0ODk_2ca62773-50da-4ab7-8db9-d2d17350f30f"
      unitRef="usd">233759000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireBuildings
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMzAtMS0xLTEtMjk0ODk_55389320-2521-442a-93ea-7d097aa174b1"
      unitRef="usd">129961000</us-gaap:PaymentsToAcquireBuildings>
    <us-gaap:PaymentsToAcquireBuildings
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMzAtMy0xLTEtMjk0ODk_e9875478-a64a-48ef-8ccd-6168101dcc8f"
      unitRef="usd">77691000</us-gaap:PaymentsToAcquireBuildings>
    <us-gaap:PaymentsToAcquireBuildings
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMzAtNS0xLTEtMjk0ODk_90bc6fb6-3182-4aa0-98fa-87217df5eb6e"
      unitRef="usd">31265000</us-gaap:PaymentsToAcquireBuildings>
    <us-gaap:PaymentsToAcquireOtherPropertyPlantAndEquipment
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMzItMS0xLTEtMjk0ODk_e5733212-0a13-4334-9f67-cc94917df805"
      unitRef="usd">119451000</us-gaap:PaymentsToAcquireOtherPropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireOtherPropertyPlantAndEquipment
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMzItMy0xLTEtMjk0ODk_ce552f12-d153-4333-bfb8-b0d126407f5c"
      unitRef="usd">137874000</us-gaap:PaymentsToAcquireOtherPropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireOtherPropertyPlantAndEquipment
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMzItNS0xLTEtMjk0ODk_7d03adbe-8e83-4308-8566-123c0672af8a"
      unitRef="usd">94172000</us-gaap:PaymentsToAcquireOtherPropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMzMtMS0xLTEtMjk0ODk_3ed9e6fe-0c28-40c2-aeda-87f8505f3df4"
      unitRef="usd">0</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMzMtMy0xLTEtMjk0ODk_3486480a-02dc-4038-94d9-25259c25a9ab"
      unitRef="usd">5130000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMzMtNS0xLTEtMjk0ODk_6b3edd73-b625-4738-9373-db1870a95139"
      unitRef="usd">0</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMzQtMS0xLTEtMjk0ODk_f9359571-5f12-4087-b158-4c155c03b737"
      unitRef="usd">3904000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMzQtMy0xLTEtMjk0ODk_7e44e2e1-211e-4017-8027-e86f101b40b3"
      unitRef="usd">625000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfMzQtNS0xLTEtMjk0ODk_c9e98a4b-a1e6-4044-90e1-cadeb1ab7325"
      unitRef="usd">828000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireInterestInJointVenture
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNDAtMS0xLTEtMjk0ODk_38dc6555-65f6-4051-b8ed-2584f0519ac0"
      unitRef="usd">1441000</us-gaap:PaymentsToAcquireInterestInJointVenture>
    <us-gaap:PaymentsToAcquireInterestInJointVenture
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNDAtMy0xLTEtMjk0ODk_4f1ed210-ef9b-48d2-a55e-346e1debd61a"
      unitRef="usd">1441000</us-gaap:PaymentsToAcquireInterestInJointVenture>
    <us-gaap:PaymentsToAcquireInterestInJointVenture
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNDAtNS0xLTEtMjk0ODk_9363146d-4839-4d73-8e66-f74593505486"
      unitRef="usd">1635000</us-gaap:PaymentsToAcquireInterestInJointVenture>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNDEtMS0xLTEtMjk0ODk_7fb45614-da55-4262-a0c7-a780669d5423"
      unitRef="usd">-246949000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNDEtMy0xLTEtMjk0ODk_be12d4fa-f995-4d83-96b6-5a665c7d2ab8"
      unitRef="usd">-221511000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNDEtNS0xLTEtMjk0ODk_a3040bf6-651e-49a9-97cc-08ecc530ad87"
      unitRef="usd">-126244000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:RepaymentsOfDebt
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNDMtMS0xLTEtNzcwMzI_f049c71a-59b0-40f0-8239-d1194a1dcf36"
      unitRef="usd">53750000</us-gaap:RepaymentsOfDebt>
    <us-gaap:RepaymentsOfDebt
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNDMtMy0xLTEtNzcwMzI_086c6434-6c92-4eae-8a84-7742bab3a28d"
      unitRef="usd">619529000</us-gaap:RepaymentsOfDebt>
    <us-gaap:RepaymentsOfDebt
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNDMtNS0xLTEtNzcwMzI_c4daf8eb-df72-4550-8f06-93e6e6c74cac"
      unitRef="usd">43296000</us-gaap:RepaymentsOfDebt>
    <us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNDMtMS0xLTEtMjk0ODk_aa6cb4a2-ec8c-492c-b3bc-fc2058bb5fd5"
      unitRef="usd">0</us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities>
    <us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNDMtMy0xLTEtMjk0ODk_e09b2e0a-76c6-447c-8abe-087224cbfd88"
      unitRef="usd">3302000</us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities>
    <us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNDMtNS0xLTEtMjk0ODk_7e58a9b4-38b2-45f8-a8f3-1170dd07bd7f"
      unitRef="usd">3562000</us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNDUtMS0xLTEtMjk0ODk_56148619-25f0-4dcc-afec-9b6344363f75"
      unitRef="usd">0</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNDUtMy0xLTEtMjk0ODk_042ca89a-7e54-4343-a807-df9e8e129e7a"
      unitRef="usd">938000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNDUtNS0xLTEtMjk0ODk_030522dc-7cd1-4ed9-b517-a2518c9b70c9"
      unitRef="usd">741000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNDYtMS0xLTEtMjk0ODk_a25f4411-2611-48ae-be99-c5c9a96bba86"
      unitRef="usd">147996000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNDYtMy0xLTEtMjk0ODk_f3ee9cc7-fd10-4601-a599-ebbd7399dd56"
      unitRef="usd">717307000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNDYtNS0xLTEtMjk0ODk_32b9cc64-4649-4e47-a7ad-b4a9329f224e"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfDebt>
    <rdnt:ProceedsFromGovernmentAssistance
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNDctMS0xLTEtMjk0ODk_075ae98a-60ee-47ef-81e1-c3c4585ddbe5"
      unitRef="usd">0</rdnt:ProceedsFromGovernmentAssistance>
    <rdnt:ProceedsFromGovernmentAssistance
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNDctMy0xLTEtMjk0ODk_950c8622-a4b6-4b7e-a2b4-d948e385f0a4"
      unitRef="usd">0</rdnt:ProceedsFromGovernmentAssistance>
    <rdnt:ProceedsFromGovernmentAssistance
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNDctNS0xLTEtMjk0ODk_716c9851-4f36-455b-bc2c-a9d08d81dd44"
      unitRef="usd">4023000</rdnt:ProceedsFromGovernmentAssistance>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNDgtMS0xLTEtMjk0ODk_7776b5ec-f202-46ac-82d4-9faf28b99b32"
      unitRef="usd">893000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNDgtMy0xLTEtMjk0ODk_e6ad9807-0680-4ca8-80ac-dd3497713782"
      unitRef="usd">2426000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNDgtNS0xLTEtMjk0ODk_274b9f83-4bab-403c-a623-040500d38533"
      unitRef="usd">1985000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNDktMS0xLTEtMjk0ODk_7ce9b692-dd85-43f8-a90e-2c1569875b9d"
      unitRef="usd">0</us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets>
    <us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNDktMy0xLTEtMjk0ODk_bdd55f1f-c027-4636-a9de-4bc077a5376e"
      unitRef="usd">13073000</us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets>
    <us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNDktNS0xLTEtMjk0ODk_c15907b9-4ded-4ee7-b8b3-050e37e2fa25"
      unitRef="usd">0</us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNTEtMS0xLTEtMjk0ODk_72bf550f-91f9-4a45-aa58-6c9db533baa2"
      unitRef="usd">0</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNTEtMy0xLTEtMjk0ODk_263856dc-469e-4701-bfb8-5ca17238d7f8"
      unitRef="usd">128300000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNTEtNS0xLTEtMjk0ODk_3aa7b9cf-3127-45c4-a2af-c69ef2fb4297"
      unitRef="usd">250900000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNTItMS0xLTEtMjk0ODk_c460763f-10e4-4d86-9087-b382b428d69b"
      unitRef="usd">0</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNTItMy0xLTEtMjk0ODk_23b55b97-820e-496f-a603-0b547f8c80d4"
      unitRef="usd">128300000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNTItNS0xLTEtMjk0ODk_06545cde-6b96-4556-a542-0fbe6691602c"
      unitRef="usd">250900000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNTQtMS0xLTEtMjk0ODk_32c69898-152e-4a9f-9f29-f7ff74775733"
      unitRef="usd">294000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNTQtMy0xLTEtMjk0ODk_21fe2ec4-e0bd-4792-bad9-de7bf338ee26"
      unitRef="usd">488000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNTQtNS0xLTEtMjk0ODk_eff2f035-deba-484d-9357-398887cabf0e"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNTUtMS0xLTEtMjk0ODk_7372b930-d2f5-4094-870e-8436760b9eb9"
      unitRef="usd">93647000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNTUtMy0xLTEtMjk0ODk_31fba30e-b3fa-4aee-9603-8c7cfc40c875"
      unitRef="usd">104673000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNTUtNS0xLTEtMjk0ODk_cf4753a8-85f2-46f3-937e-6974122d5c34"
      unitRef="usd">-45561000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNTYtMS0xLTEtMjk0ODk_d6b39ef9-82ad-41ab-845d-ddaaf6a59a14"
      unitRef="usd">113000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNTYtMy0xLTEtMjk0ODk_e8cf22f0-5d24-4d81-9054-3cde8d2066cb"
      unitRef="usd">-65000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNTYtNS0xLTEtMjk0ODk_ca4ac324-6545-475d-b765-2550558e301a"
      unitRef="usd">-101000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNTctMS0xLTEtMjk0ODk_898ab2b7-ed9c-47eb-a87d-e512deb167bd"
      unitRef="usd">-6772000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNTctMy0xLTEtMjk0ODk_305a2cc8-b50c-44a1-9d15-ed62d6b98571"
      unitRef="usd">32588000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNTctNS0xLTEtMjk0ODk_293686d7-47b2-42db-9b29-d59f824321c9"
      unitRef="usd">61853000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNTgtMS0xLTEtMjk0ODk_30c0eec1-8261-4c38-955e-c46c3ef2633d"
      unitRef="usd">134606000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ifb50bc5a13564f6a97eb669524009c18_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNTgtMy0xLTEtMjk0ODk_8df57236-f24d-4cb1-90d1-a355a6877a27"
      unitRef="usd">102018000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i404f0df0019f440299547782ff0ce012_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNTgtNS0xLTEtMjk0ODk_63b36f53-21bd-4b3e-8fb1-ae8a55cd02c8"
      unitRef="usd">40165000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNTktMS0xLTEtMjk0ODk_c718a634-82e2-4bc7-a06e-4f224a6cfe28"
      unitRef="usd">127834000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNTktMy0xLTEtMjk0ODk_a1d9fc9e-6588-445e-98ea-0ffe6e371c64"
      unitRef="usd">134606000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ifb50bc5a13564f6a97eb669524009c18_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNTktNS0xLTEtMjk0ODk_3168b237-ee19-42c2-8004-22ada9591337"
      unitRef="usd">102018000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNjEtMS0xLTEtMjk0ODk_70c0ccd4-99a7-4c09-a93c-fc9ff8a0226f"
      unitRef="usd">39151000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNjEtMy0xLTEtMjk0ODk_69f7a3ab-8115-44fd-9cd6-9aaa2af93ae2"
      unitRef="usd">29042000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNjEtNS0xLTEtMjk0ODk_8fe42390-cb42-42f0-82d0-4c8dc20b29b3"
      unitRef="usd">39521000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNjItMS0xLTEtMjk0ODk_9ce3a030-8cc1-4343-a9bc-eaf9aa19d143"
      unitRef="usd">587000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNjItMy0xLTEtMjk0ODk_7dd46ab0-787b-47cd-962b-a21455af2ff0"
      unitRef="usd">1950000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RhYmxlOjZhYmYzY2NmZjZkZTQ0NzA4ODljYjM4NTQ1ZWUwNjM0L3RhYmxlcmFuZ2U6NmFiZjNjY2ZmNmRlNDQ3MDg4OWNiMzg1NDVlZTA2MzRfNjItNS0xLTEtMjk0ODk_cc5c5ba3-794a-4a6a-b3a8-a213fcff11f7"
      unitRef="usd">5069000</us-gaap:IncomeTaxesPaidNet>
    <rdnt:EquipmentAcquiredAndLeaseholdImprovements
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RleHRyZWdpb246NDM2NWMxMTMwMzU0NGRjMGFkNmNmZTQzMmE2YjIzOTZfNDA1_9cc486d2-225a-4200-90b0-18fa179b226e"
      unitRef="usd">111800000</rdnt:EquipmentAcquiredAndLeaseholdImprovements>
    <rdnt:EquipmentAcquiredAndLeaseholdImprovements
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RleHRyZWdpb246NDM2NWMxMTMwMzU0NGRjMGFkNmNmZTQzMmE2YjIzOTZfNDA5_9f0ac2cc-7e80-45d7-95ef-7f74212495fe"
      unitRef="usd">63900000</rdnt:EquipmentAcquiredAndLeaseholdImprovements>
    <rdnt:EquipmentAcquiredAndLeaseholdImprovements
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RleHRyZWdpb246NDM2NWMxMTMwMzU0NGRjMGFkNmNmZTQzMmE2YjIzOTZfNDE3_f9de490c-ab00-469a-be13-23b4006cc319"
      unitRef="usd">52000000</rdnt:EquipmentAcquiredAndLeaseholdImprovements>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="i50107d7096d5469e97d67a3ff03b72b3_D20221101-20221101"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RleHRyZWdpb246NDM2NWMxMTMwMzU0NGRjMGFkNmNmZTQzMmE2YjIzOTZfMTA5OTUxMTYzNzg5Nw_6cdc681c-b381-4d96-bb43-0de024e0a22f"
      unitRef="shares">359002</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned
      contextRef="i7182ccdde7ae4a0fa8aa3492db312246_I20221101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RleHRyZWdpb246NDM2NWMxMTMwMzU0NGRjMGFkNmNmZTQzMmE2YjIzOTZfMTA5OTUxMTYzNzk1MA_756644e2-6964-4e31-9bf7-c65735968a93"
      unitRef="usd">6800000</us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="i651e6cbf14d5467d82c4f381868cde06_D20221101-20221101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RleHRyZWdpb246NDM2NWMxMTMwMzU0NGRjMGFkNmNmZTQzMmE2YjIzOTZfMTA5OTUxMTYzODkzNA_12ff0ac4-14c8-4ea5-9706-3e522d75b1c7"
      unitRef="usd">12700000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:ProceedsFromDividendsReceived
      contextRef="i651e6cbf14d5467d82c4f381868cde06_D20221101-20221101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RleHRyZWdpb246NDM2NWMxMTMwMzU0NGRjMGFkNmNmZTQzMmE2YjIzOTZfMTA5OTUxMTYzODk0NQ_f4ec59f2-d3ea-4a52-8e8e-e46b5389dac1"
      unitRef="usd">4500000</us-gaap:ProceedsFromDividendsReceived>
    <us-gaap:EquityMethodInvestments
      contextRef="i0852a96e84d740afa49bfe5d275671e7_I20221101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RleHRyZWdpb246NDM2NWMxMTMwMzU0NGRjMGFkNmNmZTQzMmE2YjIzOTZfMTA5OTUxMTYzODk1Mg_6d511b35-26ba-4e2a-bf75-5574f0cea5be"
      unitRef="usd">8300000</us-gaap:EquityMethodInvestments>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ib7f3ec194c084b988bc8b154c1692068_I20220401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RleHRyZWdpb246NDM2NWMxMTMwMzU0NGRjMGFkNmNmZTQzMmE2YjIzOTZfMTA5OTUxMTYzNzcwOA_fb713c13-5e77-4ca0-a288-777ea1be193e"
      unitRef="usd">8400000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="i76afbed304204c709d14268fe2fc7759_D20220120-20220120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RleHRyZWdpb246NDM2NWMxMTMwMzU0NGRjMGFkNmNmZTQzMmE2YjIzOTZfMTA5OTUxMTYzNzcwMA_92e7cdd6-0fe3-4fc7-803b-9b7aaf8d13be"
      unitRef="shares">1141234</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned
      contextRef="iebda58f2b50646b69966fddb55d1e9eb_I20220120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RleHRyZWdpb246NDM2NWMxMTMwMzU0NGRjMGFkNmNmZTQzMmE2YjIzOTZfMTA5OTUxMTYzNzcwNA_8af89aa1-57df-4017-8cf8-e097b72936c8"
      unitRef="usd">30600000</us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="i0037eb0ed88b4354b067862baa4cefa3_D20220120-20220120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RleHRyZWdpb246NDM2NWMxMTMwMzU0NGRjMGFkNmNmZTQzMmE2YjIzOTZfMTA5OTUxMTYzNzY5MA_f24052bd-5277-42cd-ac3d-df688c14f2d8"
      unitRef="shares">965058</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned
      contextRef="ic091556638644c818849ee8b176872d4_I20220120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RleHRyZWdpb246NDM2NWMxMTMwMzU0NGRjMGFkNmNmZTQzMmE2YjIzOTZfMTA5OTUxMTYzNzY5NA_72ed632f-94df-4aa7-b932-e604682fd9d3"
      unitRef="usd">25900000</us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned>
    <us-gaap:NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1
      contextRef="i0a34e2b02c7643fd994177cb578613e4_D20211022-20211022"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RleHRyZWdpb246NDM2NWMxMTMwMzU0NGRjMGFkNmNmZTQzMmE2YjIzOTZfMTA5OTUxMTYzNTk2OQ_f10cb3a1-029e-4f0b-ba40-42743f8acc82"
      unitRef="shares">15000000</us-gaap:NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1>
    <rdnt:NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued
      contextRef="i0a34e2b02c7643fd994177cb578613e4_D20211022-20211022"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RleHRyZWdpb246NDM2NWMxMTMwMzU0NGRjMGFkNmNmZTQzMmE2YjIzOTZfMTA5OTUxMTYzNTk3Mw_9cd8a7b4-2994-4860-9c14-a296e2ff687e"
      unitRef="usd">400000</rdnt:NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="i12d9fd3f8cce41bd8567698b43e666dd_D20210824-20210824"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RleHRyZWdpb246NDM2NWMxMTMwMzU0NGRjMGFkNmNmZTQzMmE2YjIzOTZfMTA5OTUxMTYzNTk4MA_ca456b3b-f0ac-428f-8305-323aff1f7135"
      unitRef="shares">67658000</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned
      contextRef="i22bc4ace41264830b19ecc0fff6de4f9_I20210824"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RleHRyZWdpb246NDM2NWMxMTMwMzU0NGRjMGFkNmNmZTQzMmE2YjIzOTZfMTA5OTUxMTYzNTk4NA_a169ca5d-7334-4c8b-9e66-cce52e66e9c5"
      unitRef="usd">2000000</us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i5d60f61c473f4e6fb2d9dbbff4ddca06_I20210101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RleHRyZWdpb246NDM2NWMxMTMwMzU0NGRjMGFkNmNmZTQzMmE2YjIzOTZfMTA5OTUxMTYzNjkyMg_66a5ee59-dff0-4c30-b82d-93ff8a9145c3"
      unitRef="usd">400000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1
      contextRef="i1f28b0b82f124664841343311ab008f6_D20210101-20210101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RleHRyZWdpb246NDM2NWMxMTMwMzU0NGRjMGFkNmNmZTQzMmE2YjIzOTZfMTA5OTUxMTYzNjkxMw_560cca55-a10a-454c-91a5-308bfc5d8076"
      unitRef="usd">300000</us-gaap:NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i890b17585af645948aa4f2d397196445_I20210101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RleHRyZWdpb246NDM2NWMxMTMwMzU0NGRjMGFkNmNmZTQzMmE2YjIzOTZfMTA5OTUxMTYzNjkwNg_59c57a5c-17a2-4297-b74d-c8ee6b4731da"
      unitRef="usd">100000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:FinanceLeaseLiability
      contextRef="ifb50bc5a13564f6a97eb669524009c18_I20201231"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV82Ny9mcmFnOjQzNjVjMTEzMDM1NDRkYzBhZDZjZmU0MzJhNmIyMzk2L3RleHRyZWdpb246NDM2NWMxMTMwMzU0NGRjMGFkNmNmZTQzMmE2YjIzOTZfMTA5OTUxMTYzOTUwMg_669750a8-1a4a-4188-a2fa-9a831cba1a22"
      unitRef="usd">20000</us-gaap:FinanceLeaseLiability>
    <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83My9mcmFnOjIyNGJmNDY1YTJmYzRiYzVhNjY5ZDQyYzMzMzljOTIyL3RleHRyZWdpb246MjI0YmY0NjVhMmZjNGJjNWE2NjlkNDJjMzMzOWM5MjJfNzE5OA_5215db7f-1cee-4a35-b9fd-4d9443181fb2">NATURE OF BUSINESS&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are a national provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. At December 31, 2022, we operated directly or indirectly through joint ventures with hospitals, 357 centers located in Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Our centers provide physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Our services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. The vast majority of our centers offer multi-modality imaging services. Our multi-modality strategy diversifies revenue streams, reduces exposure to reimbursement changes and provides patients and referring physicians one location to serve the needs of multiple procedures.  In addition to our center operations, we have certain other subsidiaries that develop Artificial Intelligence ("AI") products and solutions that are designed to enhance interpretation of radiographic images. Our operations comprise two segments for financial reporting purposes for this reporting period, Imaging Centers and Artificial Intelligence. For further financial information about these segments, see Note 5, Segment Reporting.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements include the accounts of RadNet, Inc. as well as its subsidiaries in which RadNet has a controlling financial interest. The consolidated financial statements also include certain variable interest entities in which we are the primary beneficiary (as described in more detail below). All material intercompany transactions and balances have been eliminated upon consolidation.   All of these affiliated entities are referred to collectively as &#x201c;RadNet&#x201d;, &#x201c;we&#x201d;, &#x201c;us&#x201d;, &#x201c;our&#x201d; or the &#x201c;Company&#x201d; in this report.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounting regulations stipulate that generally any entity with a) insufficient equity to finance its activities without additional subordinated financial support provided by any parties, or b) equity holders that, as a group, lack the characteristics which evidence a controlling financial interest, is considered a Variable Interest Entity (&#x201c;VIE&#x201d;). We consolidate all VIEs in which we are the primary beneficiary. We determine whether we are the primary beneficiary of a VIE through a qualitative analysis that identifies which variable interest holder has the controlling financial interest in the VIE. The variable interest holder who has both of the following has the controlling financial interest and is the primary beneficiary: (1) the power to direct the activities of the VIE that most significantly impact the VIE&#x2019;s economic performance and (2) the obligation to absorb losses of, or the right to receive benefits from, the VIE that could potentially be significant to the VIE. In performing our analysis, we consider all relevant facts and circumstances, including: the design and activities of the VIE, the terms of the contracts the VIE has entered into, the nature of the VIE&#x2019;s variable interests issued and how they were negotiated with or marketed to potential investors, and which parties participated significantly in the design or redesign of the entity.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;VIEs that we consolidate as the primary beneficiary consist of professional corporations which are owned or controlled by individuals within our senior management and provide professional medical services for centers in Arizona, California, Delaware, Maryland, New Jersey and New York.  These VIEs are collectively referred to as the Group.  RadNet provides non-medical, technical and administrative services to the Group for which it receives a management fee, pursuant to the related management agreements. Through the management agreements we have exclusive authority over all non-medical decision making related to the ongoing business operations and we determine the annual budget. The Group has insignificant operating assets and liabilities, and de minimis equity.  Substantially all cash flows of the Group after expenses, including professional salaries, are transferred to us. We consolidate the revenue and expenses, assets and liabilities of the Group.  The creditors of the Group do not have recourse to our general credit and there are no other arrangements that could expose us to losses on behalf of the Group. However, RadNet may be required to provide financial support to cover any operating expenses in excess of operating revenues.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Group on a combined basis recognized $189.1 million, $179.6 million, and $147.6 million of revenue, net of management services fees to RadNet, for the years ended December 31, 2022, 2021, and 2020, respectively and $189.1 million, $179.6 million, and $147.6 million of operating expenses for the years ended December 31, 2022, 2021, and 2020, respectively. RadNet, Inc. recognized $786.5 million, $749.2 million, and $600.7 million of total billed net service fee revenue for the years ended December 31, 2022, 2021, and 2020, respectively, for management services provided to the Group relating primarily to the technical portion of billed revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The cash flows of the Group are included in the accompanying consolidated statements of cash flows. All intercompany balances and transactions have been eliminated in consolidation. In our consolidated balance sheets at December 31, 2022 and December 31, 2021, we have included approximately $110.3 million and $89.2 million, respectively, of accounts &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;receivable and approximately $16.2 million and $14.4 million of accounts payable and accrued liabilities related to the Group, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At all of our centers not serviced by the Group we have entered into long-term contracts with medical groups to provide professional services at those centers, including supervision and interpretation of diagnostic imaging procedures. The medical groups maintain full control over the physicians they employ. Through our management agreements, we make available to the medical groups the imaging centers, including all furniture, fixtures and medical equipment therein.  The medical groups are compensated for their services from the professional component of the global net service fee revenue and after deducting management service fees paid to us, we have no economic controlling interest in these medical groups. As such, the financial results of these groups are not consolidated in our financial statements.&lt;/span&gt;&lt;/div&gt;We also own a 49% economic interest in ScriptSender, LLC, which provides services for secure data transmission of medical information. Through a management agreement, RadNet provides management and accounting services and receives an agreed upon fee. ScriptSender LLC is dependent on us to finance its own activities, and as such we determined that it is a VIE but we are not a primary beneficiary since we do not have the power to direct the activities of the entity that most significantly impact the entity&#x2019;s economic performance.  We have continued to finance ScriptSender during it's development phase and our maximum exposure to loss is $3.3 million, which represents our receivable balance from the entity.  Maximum exposure to loss is the loss that we would absorb in the event that all of the assets of ScriptSender are deemed worthless.  We paid operating expenses for the venture of $2.1 million and $1.6 million for the years ended December 31, 2022, and December 31, 2021, respectively.</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
    <rdnt:NumberOfCenters
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83My9mcmFnOjIyNGJmNDY1YTJmYzRiYzVhNjY5ZDQyYzMzMzljOTIyL3RleHRyZWdpb246MjI0YmY0NjVhMmZjNGJjNWE2NjlkNDJjMzMzOWM5MjJfMjMz_3a7f8c16-c140-4237-b962-918077c7675c"
      unitRef="center">357</rdnt:NumberOfCenters>
    <us-gaap:NumberOfReportableSegments
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83My9mcmFnOjIyNGJmNDY1YTJmYzRiYzVhNjY5ZDQyYzMzMzljOTIyL3RleHRyZWdpb246MjI0YmY0NjVhMmZjNGJjNWE2NjlkNDJjMzMzOWM5MjJfMzg0ODI5MDcxMjg1NQ_5000b2ee-ee6c-4e63-8474-feeefa8fea3f"
      unitRef="loan">2</us-gaap:NumberOfReportableSegments>
    <us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityRevenues
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83My9mcmFnOjIyNGJmNDY1YTJmYzRiYzVhNjY5ZDQyYzMzMzljOTIyL3RleHRyZWdpb246MjI0YmY0NjVhMmZjNGJjNWE2NjlkNDJjMzMzOWM5MjJfNDU3MQ_146b486c-b855-4ea8-8952-8aec22f80658"
      unitRef="usd">189100000</us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityRevenues>
    <us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityRevenues
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83My9mcmFnOjIyNGJmNDY1YTJmYzRiYzVhNjY5ZDQyYzMzMzljOTIyL3RleHRyZWdpb246MjI0YmY0NjVhMmZjNGJjNWE2NjlkNDJjMzMzOWM5MjJfNDU3NQ_f87d1acd-deff-42d8-8310-a22f4e5ddff5"
      unitRef="usd">179600000</us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityRevenues>
    <us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityRevenues
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83My9mcmFnOjIyNGJmNDY1YTJmYzRiYzVhNjY5ZDQyYzMzMzljOTIyL3RleHRyZWdpb246MjI0YmY0NjVhMmZjNGJjNWE2NjlkNDJjMzMzOWM5MjJfNDU4Mw_2b2f3459-91ea-40d7-b7f1-d35b8ea45b0d"
      unitRef="usd">147600000</us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityRevenues>
    <us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityExpense
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83My9mcmFnOjIyNGJmNDY1YTJmYzRiYzVhNjY5ZDQyYzMzMzljOTIyL3RleHRyZWdpb246MjI0YmY0NjVhMmZjNGJjNWE2NjlkNDJjMzMzOWM5MjJfNDY5NQ_b8706717-c5de-45b6-be28-ff81d1229942"
      unitRef="usd">189100000</us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityExpense>
    <us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityExpense
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83My9mcmFnOjIyNGJmNDY1YTJmYzRiYzVhNjY5ZDQyYzMzMzljOTIyL3RleHRyZWdpb246MjI0YmY0NjVhMmZjNGJjNWE2NjlkNDJjMzMzOWM5MjJfNDY5OQ_f695afc3-aab8-45ba-84e5-dd60350eb5df"
      unitRef="usd">179600000</us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityExpense>
    <us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityExpense
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83My9mcmFnOjIyNGJmNDY1YTJmYzRiYzVhNjY5ZDQyYzMzMzljOTIyL3RleHRyZWdpb246MjI0YmY0NjVhMmZjNGJjNWE2NjlkNDJjMzMzOWM5MjJfNDcwNw_5e092261-4ded-4925-b690-b6956820046e"
      unitRef="usd">147600000</us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityExpense>
    <us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83My9mcmFnOjIyNGJmNDY1YTJmYzRiYzVhNjY5ZDQyYzMzMzljOTIyL3RleHRyZWdpb246MjI0YmY0NjVhMmZjNGJjNWE2NjlkNDJjMzMzOWM5MjJfNDgwNg_84af274f-314c-4771-97aa-adb88bc0481f"
      unitRef="usd">786500000</us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax>
    <us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83My9mcmFnOjIyNGJmNDY1YTJmYzRiYzVhNjY5ZDQyYzMzMzljOTIyL3RleHRyZWdpb246MjI0YmY0NjVhMmZjNGJjNWE2NjlkNDJjMzMzOWM5MjJfNDgxMA_8a93e01e-69bf-47a0-adc5-54e38be3199b"
      unitRef="usd">749200000</us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax>
    <us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83My9mcmFnOjIyNGJmNDY1YTJmYzRiYzVhNjY5ZDQyYzMzMzljOTIyL3RleHRyZWdpb246MjI0YmY0NjVhMmZjNGJjNWE2NjlkNDJjMzMzOWM5MjJfNDgxOA_83b9b001-f793-4141-864f-63a37f09d0eb"
      unitRef="usd">600700000</us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax>
    <us-gaap:Assets
      contextRef="i247583bd1aa946988c453d719d97edc0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83My9mcmFnOjIyNGJmNDY1YTJmYzRiYzVhNjY5ZDQyYzMzMzljOTIyL3RleHRyZWdpb246MjI0YmY0NjVhMmZjNGJjNWE2NjlkNDJjMzMzOWM5MjJfNTI3OQ_306c8a58-b1f1-478a-be73-8c03476a0ba3"
      unitRef="usd">110300000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i087e7761e7004e5c94660aa94d151210_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83My9mcmFnOjIyNGJmNDY1YTJmYzRiYzVhNjY5ZDQyYzMzMzljOTIyL3RleHRyZWdpb246MjI0YmY0NjVhMmZjNGJjNWE2NjlkNDJjMzMzOWM5MjJfNTI4Ng_1f9f01da-46ec-4031-ba3e-4ff55fdf820a"
      unitRef="usd">89200000</us-gaap:Assets>
    <us-gaap:Liabilities
      contextRef="i247583bd1aa946988c453d719d97edc0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83My9mcmFnOjIyNGJmNDY1YTJmYzRiYzVhNjY5ZDQyYzMzMzljOTIyL3RleHRyZWdpb246MjI0YmY0NjVhMmZjNGJjNWE2NjlkNDJjMzMzOWM5MjJfNTM0NQ_143b7f37-18fc-4fa3-8246-b1c1eb5ca312"
      unitRef="usd">16200000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i087e7761e7004e5c94660aa94d151210_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83My9mcmFnOjIyNGJmNDY1YTJmYzRiYzVhNjY5ZDQyYzMzMzljOTIyL3RleHRyZWdpb246MjI0YmY0NjVhMmZjNGJjNWE2NjlkNDJjMzMzOWM5MjJfNTM1Mg_73cf6a5b-7578-4c59-a0ef-d649e3824df0"
      unitRef="usd">14400000</us-gaap:Liabilities>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i1795eae17b55485abc0e544e061a5958_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83My9mcmFnOjIyNGJmNDY1YTJmYzRiYzVhNjY5ZDQyYzMzMzljOTIyL3RleHRyZWdpb246MjI0YmY0NjVhMmZjNGJjNWE2NjlkNDJjMzMzOWM5MjJfNjI2OQ_9d41f947-becb-4603-8e97-ad28e7020201"
      unitRef="number">0.49</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments
      contextRef="i1795eae17b55485abc0e544e061a5958_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83My9mcmFnOjIyNGJmNDY1YTJmYzRiYzVhNjY5ZDQyYzMzMzljOTIyL3RleHRyZWdpb246MjI0YmY0NjVhMmZjNGJjNWE2NjlkNDJjMzMzOWM5MjJfNjg5Nw_9288a247-8354-4561-9637-e295f6d929d7"
      unitRef="usd">3300000</us-gaap:EquityMethodInvestments>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="i6562ef04abd84649a113083dcc1c41e7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83My9mcmFnOjIyNGJmNDY1YTJmYzRiYzVhNjY5ZDQyYzMzMzljOTIyL3RleHRyZWdpb246MjI0YmY0NjVhMmZjNGJjNWE2NjlkNDJjMzMzOWM5MjJfNzEzOA_24046bf4-4b05-4049-b747-0d135f5aaf8e"
      unitRef="usd">2100000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="i735b0a42768a4a3bb87d2987dc055d34_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83My9mcmFnOjIyNGJmNDY1YTJmYzRiYzVhNjY5ZDQyYzMzMzljOTIyL3RleHRyZWdpb246MjI0YmY0NjVhMmZjNGJjNWE2NjlkNDJjMzMzOWM5MjJfNzE0NQ_174fccca-7752-4bcc-a4a3-c9dc0494a03c"
      unitRef="usd">1600000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDA4MDY_b2d54bb5-4748-4d2d-a063-e1370066c767">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;PRINCIPLES OF CONSOLIDATION &#x2013; The operating activities of subsidiaries are included in the accompanying consolidated financial statements (&#x201c;financial statements&#x201d;) from the date of acquisition. Investments in companies in which we have the ability to exercise significant influence, but not control, are accounted for by the equity method. All intercompany transactions and balances, with our consolidated entities and the unsettled amount of intercompany transactions with our equity method investees, have been eliminated in consolidation. As stated in Note 1 above, the Group consists of VIEs and we consolidate the operating activities and balance sheets of each. Additionally, we determined that our unconsolidated joint venture, ScriptSender, LLC, is also a VIE as it is dependent on our operational funding but we are not a primary beneficiary since RadNet does not have the power to direct the activities of the entity that most significantly impact the entity&#x2019;s economic performance. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;USE OF ESTIMATES - The financial statements have been prepared in accordance with U.S. generally accepted accounting principles (GAAP), which requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. These estimates and assumptions affect various matters, including our reported amounts of assets and liabilities in our consolidated balance sheets at the dates of the financial statements; our disclosure of contingent assets and liabilities at the dates of the financial statements; and our reported amounts of revenues and expenses in our consolidated statements of operations during the reporting periods. These estimates involve judgments with respect to numerous factors that are difficult to predict and are beyond management&#x2019;s control. As a result, actual amounts could materially differ from these estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;REVENUES &#x2013; Our revenues generally relate to net patient fees&#160;received from various payors and patients themselves under contracts in which our performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period when our obligations to provide diagnostic services are satisfied. Our performance obligations for diagnostic services are generally satisfied over a period of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payor (Medicare, Medicaid, managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent upon the terms provided by Medicare and Medicaid, or negotiated with managed care health plans and commercial insurance companies. The payment arrangements with third-party payors for the services we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As it relates to the Group, this service fee revenue includes payments for both the professional medical interpretation revenue recognized by them as well as the payment for all other aspects related to our providing the imaging services, for which we earn management fees. As it relates to other centers, this service fee revenue is earned through providing the use of our &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;diagnostic imaging equipment and the provision of technical services as well as providing administration services such as clerical and administrative personnel, bookkeeping and accounting services, billing and collection, provision of medical and office supplies, secretarial, reception and transcription services, maintenance of medical records, and advertising, marketing and promotional activities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our revenues are based upon the estimated amounts we expect to be entitled to receive from patients and third-party payors. Estimates of contractual allowances under managed care and commercial insurance plans are based upon the payment terms specified in the related contractual agreements. Revenues related to uninsured patients and copayment and deductible amounts for patients who have health care coverage may have discounts applied (uninsured discounts and contractual discounts). We also record estimated implicit price concessions (based primarily on historical collection experience) related to uninsured accounts to record self-pay revenues at the estimated amounts we expect to collect.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under capitation arrangements with various health plans, we earn a per-enrollee amount each month for making available diagnostic imaging services to all plan enrollees under the capitation arrangement. Revenue under capitation arrangements is recognized in the period in which we are obligated to provide services to plan enrollees under contracts with various health plans.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our total service fee revenues for the years ended December 31, 2022, 2021, and 2020 are presented in the table below.  Our imaging center revenue is displayed as the estimated service fee, broken down by classification of insurance coverage type.  Additional revenues are earned from our management services provided to joint ventures and our software and AI subsidiaries.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;In Thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial insurance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;785,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;743,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;584,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;311,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;280,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Workers' compensation/personal injury&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other patient revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Management fee revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software and teleradiology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue under capitation arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Imaging center segment revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,425,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,313,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,071,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;AI segment revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,430,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,315,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,071,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;GOVERNMENT ASSISTANCE: COVID-19 PANDEMIC AND CARES ACT FUNDING -  On March 11, 2020 the World Health Organization (WHO) designated COVID-19 as a global pandemic.  To aid businesses and stimulate the national economy, Congress passed The Coronavirus Aid, Relief, and Economic Security ("CARES") Act, which was signed in to law on March 27, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;Beginning in the second quarter of 2020 and through the twelve months ended December 31, 2021, we received funding from the various programs established by the CARES Act as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:23.5pt"&gt;$39.6 million total of accelerated Medicare payments received, $39.5 million for the twelve months ended December 31, 2020 and $0.1 million for the twelve months ended December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:45pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:23.5pt"&gt;$4.0 million from the Paycheck Protection Program during the twelve months ended December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:23.5pt"&gt;$35.4 million total Provider Relief Funding, $26.3 million received for the twelve months ended December 31, 2020 and $9.1 million received for the twelve months ended December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;The accelerated Medicare payments were recorded to deferred revenue in our consolidated balance sheet and are being applied to revenue as services are performed beginning in 2021.  Based on terms released on October 1, 2020, through the Continuing Appropriations Act, 2021 and Other Extensions Act, such accelerated payments are interest free for inpatient acute care hospitals for 29 months (seven months for medical groups), and the program currently requires CMS to recoup the payments &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;beginning one year after receipt by the provider, by withholding future Medicare fee-for-service payments for claims at a rate of 25% for the first 11 months, and 50% for the 6 months afterward, until the full accelerated payment has been recouped.  The program currently requires any outstanding balance remaining after 29 months to be repaid by the provider or be subject to an interest rate currently set at 4%. We applied the accelerated Medicare payments to revenue in the amount of $8.4 million for the twelve months ended December 31, 2022 and $30.2 million for the twelve months ended December 31, 2021.  As of December 31, 2022, approximately $1.0 million  of Medicare payments received remain in d&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjc0ODc3OTE4MzYxNA_386ac154-db8d-4eee-8934-81984fec863f"&gt;eferred revenue&lt;/span&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The $4.0 million secured from the Paycheck Protection Program was accounted for as debt and in December 2020 we met the eligibility requirements under the government guidelines for forgiveness and the loans were written off to gain on extinguishment of debt.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Provider Relief Funding is displayed as such on our consolidated statements of operations in the year received.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The CARES Act also provides for the deferral of the employer-paid portion of the social security payroll tax with 50% due by December 31, 2021 and 50% due by December 31,2022. We elected to defer $16.3 million of this tax through December 31, 2020 which has been paid as of December 31, 2022.  The CARES Act also provided a refundable employer tax credit ("ERC") equal to 50% of qualified wages, including certain health insurance costs, that can be used to offset payroll tax liabilities.  In the year ending December 31, 2021, we recognized an employee retention credit as a reduction to cost of operations totaling of $7.7 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ACCOUNTS RECEIVABLE &#x2013; Substantially all of our accounts receivable are due under fee-for-service contracts from third party payors, such as insurance companies and government-sponsored healthcare programs, or directly from patients. Services are generally provided pursuant to one-year contracts with healthcare providers. We continuously monitor collections from our payors and maintain an allowance for bad debts based upon specific payor collection issues that we have identified and our historical experience.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have entered into factoring agreements with various institutions and sold certain accounts receivable under non-recourse agreements in exchange for notes receivables from the buyers. These transactions are accounted for as a reduction in accounts receivable as the agreements transfer effective control over and risk related to the receivables to the buyers. Proceeds on notes receivables are reflected as operating activities on our statement of cash flows and on our balance sheet as prepaid expenses and other current assets for the current portion and deposits and other for the long term portion.   Amounts remaining to be collected on these agreements were $15.4 million and  $17.7 million at December 31, 2022 and December 31, 2021, respectively.  We do not utilize factoring arrangements as an integral part of our financing for working capital.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ACCOUNTS PAYABLE AND ACCRUED EXPENSES - Accounts payable and accrued expenses were comprised of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.502%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.931%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.951%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.665%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.953%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued salary and benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued professional fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;369,595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;263,937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;SOFTWARE REVENUE RECOGNITION &#x2013; We have developed and sell Picture Archiving Communications Systems (&#x201c;PACS&#x201d;) and related services. The PACS sales are made primarily through our sales force and generally include hardware, software, installation, training and first-year warranty support. Hardware which is not unique or special purpose, is purchased from a third-party and resold to customers with a small mark-up.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have determined that our core software products, such as PACS, are essential to most of our arrangements as hardware, software and related services are sold as an integrated package.  Revenue is recognized when a performance obligation is satisfied by transferring a promised good or service to a customer. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:54pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the years ended December 31, 2022, 2021 and 2020, we recorded approximately $13.2 million, $10.5 million, and $8.6 million, respectively, in revenue related to our software business which is included in net service fee revenue in our consolidated statement of operations. At December 31, 2022 we had deferred revenue of approximately $0.9 million associated with these sales which we expect to recognize into revenue over the next 12 months.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;SOFTWARE DEVELOPMENT COSTS &#x2013; When we develop our own software and artificial intelligence solutions we capitalize and amortize those costs over their useful life. Costs related to the research and development of new software products and enhancements to existing software intended for resale to our customers are expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CONCENTRATION OF CREDIT RISKS &#x2013; Financial instruments that potentially subject us to credit risk are primarily cash equivalents and accounts receivable. We have placed our cash and cash equivalents with one major financial institution. At times, the cash in the financial institution is temporarily in excess of the amount insured by the Federal Deposit Insurance Corporation, or FDIC. Substantially all of our accounts receivable are due under fee-for-service contracts from third party payors, such as insurance companies and government-sponsored healthcare programs, or directly from patients. We continuously monitor collections and maintain an allowance for bad debts based upon our historical collection experience. In addition, we have notes receivable stemming from our factoring of accounts receivable as stated above.  Companies with which we factor our receivables are well known established buyers of such instruments, have agreed to assume the full risk of their collection.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CASH AND CASH EQUIVALENTS &#x2013; We consider all highly liquid investments that mature in three months or less when purchased to be cash equivalents. The carrying amount of cash and cash equivalents approximates the fair market value.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;DEFERRED FINANCING COSTS &#x2013; Costs of financing are deferred and amortized using the effective interest rate method.  Deferred financing costs are related to our revolving credit facilities. Deferred financing costs, net of accumulated amortization, were $2.3 million and $2.1 million for the twelve months ended at December 31, 2022 and 2021, respectively.  See Note 8, Credit Facilities and Notes Payable for more information on our revolving lines of credit.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;PROPERTY AND EQUIPMENT &#x2013; Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation and amortization of property and equipment are provided using the straight-line method over the estimated useful lives, which range from 3 to 15 years. Leasehold improvements are amortized at the lesser of lease term or their estimated useful lives, which range from 3 to 15 years. Maintenance and repairs are charged to expense as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;BUSINESS COMBINATION &#x2013; When the qualifications for business combination accounting treatment are met, it requires us to recognize separately from goodwill the assets acquired and the liabilities assumed at their acquisition date fair values. Goodwill as of the acquisition date is measured as the excess of consideration transferred over the net of the acquisition date fair values of the assets acquired and the liabilities assumed. While we use our best estimates and assumptions to accurately value assets acquired and liabilities assumed at the acquisition date, our estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, we record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. Upon the conclusion of the measurement period or final determination of the values of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to our consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;GOODWILL AND INDEFINITE LIVED INTANGIBLES &#x2013; Goodwill totaled $677.7 million and $513.8 million at December 31, 2022 and December 31, 2021, respectively. Indefinite lived intangible assets at  were $24.1 million at December 31, 2022 and $20.6 million at December 31, 2021 and are associated with the value of certain trade name intangibles and in process research and development (IPR&amp;amp;D). Goodwill, trade name intangibles and IPR&amp;amp;D are recorded as a result of business combinations. When we determine the carrying value of goodwill exceeds its fair value, an impairment charge would be recognized which should not exceed the total amount of goodwill allocated to that reporting unit. We determined fair values for each of the reporting units using the market approach, when available and appropriate, or the income approach, or a combination of both. We assess the valuation methodology based upon the relevance and availability of the data at the time we perform the valuation. If multiple valuation methodologies are used, the results are weighted appropriately.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We tested goodwill, trade name and IPR&amp;amp;D for impairment&#160;on October 1, 2022.  In 2020 we ceased employing certain indefinite lived trade names with a total value of $4.2 million and they were written off in full as of December 31, 2020.  Our annual impairment test as of October 1, 2022 noted no other impairment, and we have not identified any indicators of impairment through December 31, 2022.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;LONG-LIVED ASSETS &#x2013; We evaluate our long-lived assets (property and equipment) and intangibles, other than goodwill and indefinite lived intangible assets, for impairment when events or changes indicate the carrying amount of an asset may not be recoverable. Accounting standards requires that if the sum of the undiscounted expected future cash flows from a long-lived asset or definite-lived intangible is less than the carrying value of that asset, an asset impairment charge must be recognized. The amount of the impairment charge is calculated as the excess of the asset&#x2019;s carrying value over its fair value, which generally represents the discounted future cash flows from that asset or in the case of assets we expect to sell, at fair value less costs to sell.  At December 31, 2021 we recorded a &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjc0ODc3OTE4MzYxMw_9c7fb964-0c31-457d-ab68-df24d21cb8df"&gt;write off charge&lt;/span&gt; of $7.1 million in leasehold improvements for &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;facilities that we abandoned. See the Leases discussion below for more information.  Other than this, we determined that there were no events or changes in circumstances that indicated our long-lived assets were impaired during any periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;INCOME TAXES &#x2013; Income tax expense is computed using an asset and liability method and using expected annual effective tax rates. Under this method, deferred income tax assets and liabilities result from temporary differences in the financial reporting bases and the income tax reporting bases of assets and liabilities. The measurement of deferred tax assets is reduced, if necessary, by the amount of any tax benefit that, based on available evidence, is not expected to be realized. When it appears more likely than not that deferred taxes will not be realized, a valuation allowance is recorded to reduce the deferred tax asset to its estimated realizable value. For net deferred tax assets we consider estimates of future taxable income in determining whether our net deferred tax assets are more likely than not to be realized. See Note 10, Income Taxes, for more information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;LEASES - We determine if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (&#x201c;ROU&#x201d;) assets, current operating lease liabilities, and long term operating lease liability in our consolidated balance sheets. Finance leases are included in property and equipment, current finance lease liability, and long-term finance lease liability in our consolidated balance sheets.  ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As most of our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. We use the implicit rate when readily determinable. We include options to extend a lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term. For a contract in which we are a lessee that contains fixed payments for both lease and non-lease components, we have elected to account for the components as a single lease component, as permitted. For finance leases, interest expense on the lease liability is recognized using the effective interest method and amortization of the ROU asset is recognized on a straight-line basis over the shorter of the estimated useful life of the asset or the lease term. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ROU assets are tested for impairment if circumstances suggest that the carrying amount may not be recoverable. No events have occurred such as fire, flood, or other acts which have impaired the integrity of our ROU assets as of December 31, 2022. Our facility leases require us to maintain insurance policies which would cover major damage to our facilities. We maintain business interruption insurance to cover loss of business due to a facility becoming non-operational under certain circumstances. Our equipment leases are covered by warranty and service contracts which cover repairs and provide regular maintenance to keep the equipment in functioning order.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;After a management review of post pandemic patient traffic to centers during the fourth quarter of 2021, it was noted that although overall volumes had returned to pre-pandemic levels, certain imaging locations did not experience the same levels of activity as beforehand.  This was due in part to lower utilization rates of commercial space from telecommuting, accompanied by the migration of those workers out of congested urban centers to residential areas.  Based on this analysis, management decided to consolidate volumes into fewer centers and reduce administrative office space in response to the demographic changes experienced.  To complete the closure of these locations, we took a lease abandonment charge of approximately $12.6 million at December 31, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;UNINSURED RISKS &#x2013; On November 1, 2013 we entered into a high-deductible workers&#x2019; compensation insurance policy. We have recorded liabilities of $3.9 million and $3.5 million at December 31, 2022 and December 31, 2021, respectively, for the estimated future cash obligations associated with the unpaid portion of the workers compensation claims incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We and our affiliated physicians carry an annual medical malpractice insurance policy that protects us for claims that are filed during the policy year and that fall within policy limits. The policy has a deductible which is $10,000 per incidence for all years covered by this report.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2008, in order to eliminate the exposure for claims not reported during the regular malpractice policy period, we purchased a medical malpractice claims made tail policy, which provides coverage for any claims reported in the event that our medical malpractice policy expires. As of December 31, 2022, this policy remains in effect.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have entered into an arrangement with Blue Shield to administer and process claims under a self-insured plan that provides health insurance coverage for our employees and dependents. We have recorded liabilities as of December 31, 2022 and 2021 of $7.4 million and $6.3 million, respectively, for the estimated future cash obligations associated with the unpaid portion of the medical and dental claims incurred by our participants. Additionally, we entered into an agreement with Blue &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shield for a stop loss policy that provides coverage for any claims that exceed $250,000 up to a maximum of $1.0 million in order for us to limit our exposure for unusual or catastrophic claims.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;EMPLOYEE BENEFIT PLAN &#x2013; We adopted a profit-sharing/savings plan pursuant to Section 401(k) of the Internal Revenue Code that covers substantially all non-professional employees. Eligible employees may contribute on a tax-deferred basis a percentage of compensation, up to the maximum allowable under tax law. Employee contributions vest immediately. We can elect to provide a matching contribution in the amount to a maximum of 1.0% per 4.0% of employee contribution, and have done so since 2017.  We contributed $3.0 million in matching for each of the twelve months ended December 31, 2022 and December 31, 2021.  For the year ended December 31, 2020, we elected not to provide a matching contribution.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:54pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;EQUITY BASED COMPENSATION &#x2013; We have one long-term incentive plan that we adopted in 2006 and which we first amended and restated as of April 20, 2015, and again on March 9, 2017, and currently as of April 15, 2021 (the &#x201c;Restated Plan&#x201d;). The Restated Plan was approved by our stockholders at our annual stockholders meeting on June 10, 2021. We have reserved 16,500,000 shares of common stock for issuance under the Restated Plan which can be issued in the form of incentive and/or nonstatutory stock options, restricted and/or unrestricted stock, stock units, and stock appreciation rights.  Terms and conditions of awards can be direct grants or based on achieving a performance metric and we also consider probability of achievement of performance conditions when determining expense recognition. For the awards where vesting is probable, equity-based compensation is recognized over the related vesting period. Stock options and warrants generally vest over &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjQzNTk_cd22a3ff-fb8c-47a1-9018-2d91908dd609"&gt;three&lt;/span&gt; to five years and expire &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjQzNzk_0e815b97-2caf-4c2a-88cf-151ad3b1dacb"&gt;five&lt;/span&gt; to ten years from date of grant.  We determine the compensation expense for each stock option award using the Black Scholes, or similar, valuation model.  Those models require that our management make certain estimates concerning risk free interest rates and volatility in the trading price of our common stock. The compensation expense recognized for all equity-based awards is recognized over the awards&#x2019; service periods. Equity-based compensation is classified in operating expenses within the same line item as the majority of the cash compensation paid to employees.  In connection with our acquisition of DeepHealth Inc. on June 1, 2020, we assumed the DeepHealth, Inc. 2017 Equity Incentive Plan, including outstanding options awards that can be exercised for our common stock.  No additional awards will be granted under the DeepHealth, Inc. 2017 Equity Incentive Plan.  See Note 11, Stock-Based Compensation, for more information.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;FOREIGN CURRENCY TRANSLATION &#x2013; For our operations in Canada, Europe and the United Kingdom, the functional currency of our foreign subsidiaries is the local currency. Assets and liabilities denominated in foreign currencies are translated using the exchange rate at the balance sheet dates. Revenues and expenses are translated using average exchange rates prevailing during the reporting period. Any translation adjustments resulting from this process are shown separately as a component of accumulated other comprehensive income (loss). Gains and losses related to the foreign currency portion of international transactions are included in the determination of net income.  The following is a reconciliation of Foreign Currency Translation amounts for the years ended December 31, 2022, 2021 and 2020 is provided below (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-align:justify;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:50.584%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.148%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.956%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.339%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(276)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(101)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(377)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(442)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,943)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,385)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;OTHER COMPREHENSIVE INCOME (LOSS) &#x2013; Accounting guidance&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;establishes rules for reporting and displaying other comprehensive income (loss) and its components. Our foreign currency translation adjustments,  changes in the fair value of cash flow hedges, and the amortization of balances associated with derivatives previously classified as cash flow hedges are included in other comprehensive income (loss). The components of other comprehensive income (loss) for the twelve month periods ended December 31, 2022, December 31, 2021, and December 31, 2020 are included in the consolidated statements of comprehensive income (loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;COMMITMENTS AND CONTINGENCIES - We are party to various legal proceedings, claims, and regulatory, tax or government inquiries and investigations that arise in the ordinary course of business. With respect to these matters, we evaluate the developments on a regular basis and accrue a liability when we believe a loss is probable and the amount can be reasonably estimated. Based on current information, we do not believe that reasonably possible or probable losses associated with pending legal proceedings would either individually or in the aggregate, have a material adverse effect on our business and &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;consolidated financial statements. However, the outcome of these matters is inherently uncertain. Therefore, if one or more of these matters were resolved against us for amounts in excess of management's expectations, our results of operations and financial condition, including in a particular reporting period in which any such outcome becomes probable and estimable, could be materially adversely affected.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;DERIVATIVE INSTRUMENTS &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;2016 CAPS&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the fourth quarter of 2016, we entered into two forward interest rate cap agreements ("2016 Caps"). The 2016 Caps matured in September and October 2020. The 2016 Caps had notional amounts of $150,000,000 and $350,000,000, respectively, which were designated at inception as cash flow hedges of future cash interest payments associated with portions of our variable rate bank debt. Under these arrangements, we purchased a cap on 3 month LIBOR at 2.0%. We were liable for a $5.3 million premium to enter into the caps which accrued to current liabilities on our balance sheet and paid over the life of the 2016 Caps.  The gain or loss of the hedge (i.e. change in fair value) was reported as a component of accumulated other comprehensive income (loss) in the consolidated statement of equity.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A tabular presentation of the effect of derivative instruments on our consolidated statement of comprehensive (loss) income, net of taxes is as follows (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.836%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.663%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Interest Rate Contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the twelve months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount of Gain (Loss) Recognized on Derivative, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location of Gain (Loss) Recognized&lt;br/&gt;in Income on Derivative&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$788&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;2019 SWAPS&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the second quarter of 2019, we entered into four forward interest rate agreements ("2019 swaps").  The 2019 swaps have total notional amounts of $500,000,000, consisting of two agreements of $50,000,000 each and two agreements of  $200,000,000 each.   The 2019 swaps will secure a constant interest rate associated with portions of our variable rate bank debt and have an effective date of October 13, 2020. They will mature in October 2023 for the two smaller notional and October 2025 for the two larger notional. Under these arrangements, we arranged the 2019 swaps with locked in 1 month LIBOR rates at 1.96% for the $100,000,000 notional and at 2.05% for the $400,000,000 notional. As of the effective date, we will be liable for premium payments if interest rates decline below arranged rates, but will receive interest payments if rates remain above the arranged rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At inception, we designated our 2019 Swaps as cash flow hedges of floating-rate borrowings. In accordance with accounting guidance, derivatives that have been designated and qualify as cash flow hedging instruments are reported at fair value. The gain or loss on the effective portion of the hedge (i.e. change in fair value) is reported as a component of accumulated comprehensive income (loss) in the consolidated statement of equity.  The remaining gain or loss, if any, is recognized currently in earnings.  The cash flows for both our $400,000,000 notional interest rate swap contract locked in at 2.05% due October 2025 and our $100,000,000 notional interest rate swap contract locked in at 1.96% do not match the cash flows for our First Lien Term Loans and so we have determined that they are not currently effective as cash flow hedges. Accordingly, all changes in their fair value after April 1, 2020 for the $400,000,000 notional and after July 1, 2020 for the $100,000,000 notional will be recognized in earnings.&#160;As of July 1, 2020, the total change in fair value relating to swaps included in other comprehensive income was approximately $24.4 million, net of taxes.  This amount will be amortized to interest expense through October 2023 at approximately $0.4 million per month and continuing at approximately $0.3 million per month through October 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A tabular presentation of the effect of derivative instruments on our consolidated statement of comprehensive loss of the 2019 swaps is as follows (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.065%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Interest Rate Contracts - Effective Portion&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the twelve months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount of Loss Recognized on Derivative, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location of Loss Recognized&lt;br/&gt;in Income on Derivative&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$(20,160)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A tabular presentation of the effect of derivative instruments on our statement of operations of the 2019 Swaps for the Swaps that became ineffective in 2020 is as follows (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Interest Rate Contracts - Ineffective Portion&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the twelve months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of gain (loss) recognized in income on derivative (current period ineffective portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location of gain (loss) recognized in Income on derivative (current period ineffective portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of loss reclassified from accumulated other comprehensive income (loss) into income (prior period effective portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location of loss reclassified from accumulated other comprehensive income (loss) into income (prior period effective portion)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$39,621&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmY3ZDdlMDY0Y2UzOTQyYWVhZjFkMzRhNTc4MTBmMjA1L3RhYmxlcmFuZ2U6ZjdkN2UwNjRjZTM5NDJhZWFmMWQzNGE1NzgxMGYyMDVfMy0yLTEtMS03NjcxMw_04d809f9-cf99-45ef-aa56-16be46b5f8b6"&gt;Other Income (Expense)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$(3,687)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Interest Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$21,670&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmY3ZDdlMDY0Y2UzOTQyYWVhZjFkMzRhNTc4MTBmMjA1L3RhYmxlcmFuZ2U6ZjdkN2UwNjRjZTM5NDJhZWFmMWQzNGE1NzgxMGYyMDVfNC0yLTEtMS03NjcyMQ_2c91ab05-c7d0-4ed6-a9f1-aefed9da243a"&gt;Other Income (Expense)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$(3,695)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$(2,528)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmY3ZDdlMDY0Y2UzOTQyYWVhZjFkMzRhNTc4MTBmMjA1L3RhYmxlcmFuZ2U6ZjdkN2UwNjRjZTM5NDJhZWFmMWQzNGE1NzgxMGYyMDVfNC0yLTEtMS0yOTQ4OQ_869911ef-bcba-451f-8629-1684d55fda21"&gt;Other Income (Expense)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$(3,448)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CONTINGENT CONSIDERATION - &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Aidence Holding B.V.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 20, 2022, we completed our acquisition of all the equity interests of Aidence Holding B.V. ("Aidence") an artificial intelligence enterprise centered on lung cancer screening.  As part of the purchase agreement, we will pay up to $10.0 million consideration upon the completion of two identified milestones in RadNet common shares or cash at our election.  This contingency had a value of approximately $7.2 million on December 31, 2022. The amount is reviewed quarterly and adjusted to fair value based on the yield rate of S&amp;amp;P B-rated corporate bonds and the probability of FDA approval, which has been currently determined by management to be 80% for milestone one and 70% for milestone two.  In addition, there is a remaining general holdback of $4.0 million to be issued in shares of our common stock subject to adjustment for any indemnification claims.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Quantib B.V.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 20, 2022, we completed our acquisition of all the equity interests of Quantib B.V. ("Quantib") an artificial intelligence enterprise centered on prostate cancer screening.  As part of the purchase agreement, we will issue 18 months after acquisition, 113,303 shares of our common stock with an initial fair value at the date of close of $3.0 million subject to adjustment for any indemnification claims and will be adjusted to fair value in subsequent periods. This contingency had a value of approximately $2.1 million as of December 31, 2022. In addition, there is a general holdback of $1.6 million to be issued in cash subject to adjustment for any indemnification claims.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Montclair&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 1, 2022, we completed our acquisition of Montclair Radiological Associates. As part of the purchase agreement, we recorded $1.2 million in contingent consideration to be determined by obtaining specific EBITDA targets within a defined time frame.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Heart and Lung Imaging Limited&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 1, 2022, we completed our acquisition of 75% of the equity interests of Heart and Lung Imaging Limited. The purchase included $10.2 million in contingent milestone consideration and cash holdback of $0.6 million to be issued 24 months after acquisition subject to adjustment for any indemnification claims, which will be adjusted to fair value in &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;subsequent periods.  The milestone contingency had a value of approximately $11.1 million as of December 31, 2022.   The contingent consideration is determined by the achievement of a specific number of physician reads.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A tabular rollforward of contingent consideration is as follows (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;     &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.964%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.505%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.480%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.505%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.480%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.505%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.480%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.505%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.480%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.505%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.480%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.505%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.480%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.505%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.485%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="42" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the twelve months ended December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Entity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Account&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 1, 2022 Balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Issuance of contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of  income (loss) recognized on contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Currency Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022 Balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aidence&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Long Term Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(362)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Quantib&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued Expenses &amp;amp; Other Long Term Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(903)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Montclair&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued Expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Heart and Lung Limited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued Expenses &amp;amp; Other Long Term Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;   &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:40.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See Fair Value Measurements section below for the fair value of contingent consideration at December 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;FAIR VALUE MEASUREMENTS &#x2013; Assets and liabilities subject to fair value measurements are required to be disclosed within a fair value hierarchy. The fair value hierarchy ranks the quality and reliability of inputs used to determine fair value. Accordingly, assets and liabilities carried at, or permitted to be carried at, fair value are classified within the fair value hierarchy in one of the following categories based on the lowest level input that is significant to a fair value measurement:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;1&#x2014;Fair value is determined by using unadjusted quoted prices that are available in active markets for identical assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;2&#x2014;Fair value is determined by using inputs other than Level&#160;1 quoted prices that are directly or indirectly observable. Inputs can include quoted prices for similar assets and liabilities in active markets or quoted prices for identical assets and liabilities in inactive markets. Related inputs can also include those used in valuation or other pricing models such as interest rates and yield curves that can be corroborated by observable market data.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;3&#x2014;Fair value is determined by using inputs that are unobservable and not corroborated by market data. Use of these inputs involves significant and subjective judgment.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Derivatives:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes the estimated fair values of certain of our financial assets that are subject to fair value measurements, and the classification of these assets in our consolidated balance sheets, as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Current Assets and Deposits and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 SWAPS - Interest Rate Contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 SWAPS - Interest Rate Contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair value of these contracts was determined using Level 2 inputs. More specifically, the fair value was determined by calculating the value of the difference between the fixed interest rate of the interest rate swaps and the counterparty&#x2019;s forward LIBOR curve. The forward LIBOR curve is readily available in the public markets or can be derived from information available in the public markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Contingent Consideration:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes the estimated fair values of contingencies and holdback relating to our Aidence Holding B.V. and Quantib B.V. acquisitions on January 20, 2022, and the Heart and Lung Imaging Limited acquisition on November 1, 2022 that are subject to fair value measurements and the classification of these liabilities on our consolidated balance sheets, as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aidence Holding B.V. milestone consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Quantib B.V. holdback of 113,303 shares of RadNet common stock&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Montclair Radiological Associates&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Heart and Lung Imaging Limited&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair value of these liabilities was determined using Level 3 inputs.  For Aidence Holding B.V., the  milestone contingent liability was adjusted to fair value based on the yield rate of S&amp;amp;P B-rated corporate bonds and the probability of FDA approval.  For the Quantib B.V holdback shares, the fair value was determined by calculating the value of estimated shares issuable as of the reporting date (which was $18.83) translated at the current exchange rate at December 31, 2022, the time period related to the contractual settlement term, and the probability of issuing the shares.  For Montclair Radiological Associates the contingent consideration is determined by obtaining specific EBITDA targets within a defined time frame.  For Heat Lung Imaging Limited the contingent consideration is determined by the achievement of a specific number of physician reads.  As significant inputs for the contingent consideration of Aidence B.V., Quantib B.V., Montclair Radiological Associates and Heart Lung Imaging Limited are not observable and cannot be corroborated by observable market data they are classified as Level 3.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Long Term Debt&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes the estimated fair value and carrying amount of our Truist (Term Loan Agreement) and Barclays (First Lien Term Loans) long-term debt as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.713%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Face Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan Agreement and First Lien Term Loans&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;843,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;843,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;864,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.713%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Face Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan Agreement and First Lien Term Loans&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;766,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;766,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;767,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our Barclays revolving credit facility had no aggregate principal amount outstanding as of December 31, 2022 and December 31, 2021, respectively.  Our Truist revolving credit facility had no aggregate principal amount outstanding as of December 31, 2022 and December 31, 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair values of our long-term debt, which is discussed in Note 8, was determined using Level 2 inputs for the Barclays and Truist term loans. Level 2 inputs primarily related to comparable market prices.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We consider the carrying amounts of cash and cash equivalents, receivables, other current assets, current liabilities and other notes payables to approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization or payment. Additionally, we consider the carrying amount of our capital lease obligations to approximate their fair value because the weighted average interest rate used to formulate the carrying amounts approximates current market rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;EARNINGS PER SHARE - Earnings per share is based upon the weighted average number of shares of common stock and common stock equivalents outstanding, net of common stock held in treasury, as follows (in thousands except share and per share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss) attributable to RadNet, Inc. common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,840)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;BASIC NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of common shares outstanding during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,293,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,496,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,891,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic net income (loss) per share attributable to RadNet, Inc. common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DILUTED NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of common shares outstanding during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,293,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,496,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,891,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add nonvested restricted stock subject only to service vesting&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add additional shares issuable upon exercise of stock options, warrants and holdback shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;855,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;664,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of common shares used in calculating diluted net income per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,320,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,421,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,891,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes in fair value associated with contingently issuable shares&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(724)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss) attributable to RadNet, Inc's common stockholders for diluted share calculation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$9,926&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$24,727&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$(14,840)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted net income (loss) per share attributable to RadNet, Inc. common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options and non-vested restricted awards excluded from the computation of diluted per share amounts as their effect would be antidilutive:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested restricted stock subject to service vesting&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;329,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares issuable upon the exercise of stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;554,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;INVESTMENTS IN EQUITY SECURITIES- As of December 31, 2022, we have three equity investments for which a fair value is not readily determinable and we do not have significant influence and therefore the total amounts invested are recognized at cost.  In accordance with accounting guidance&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;if there is no readily determinable fair value, the guidance allows entities the ability to measure investments at cost less impairment, whereby impairment is based on a qualitative assessment.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Medic Vision, based in Israel, specializes in software packages that provide compliant radiation dose structured reporting and enhanced images from reduced dose CT scans.  Our investment of $1.2 million, represents a 14.21% equity interest in the company.  No observable price changes or impairment in our investment was noted as of the year ended December 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Turner Imaging Systems, based in Utah, develops and markets portable X-ray imaging systems that provide a user the ability to acquire X-ray images wherever and whenever they are needed. On February 1, 2018, we purchased 2.1 million preferred shares in Turner Imaging Systems for $2.0 million.  On January 1, 2019 we funded a convertible promissory note in the amount of $0.1 million that converted to an additional 80,000 preferred shares on October 11, 2019.  No observable price changes or impairment in our investment was noted for the year ended December 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;WhiteRabbit.ai Inc., based in California, is currently developing an artificial intelligence suite which aims to improve the speed and accuracy of cancer detection in radiology and improve patient care. On November 5, 2019 we acquired an equity interest in the company for $1.0 million and also loaned the company $2.5 million in support of its operations.  No observable price changes or impairment in our investment was noted for the year ended December 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;INVESTMENT IN JOINT VENTURES &#x2013; We have 13 unconsolidated joint ventures with ownership interests ranging from 35% to 55%. These joint ventures represent partnerships with hospitals, health systems or radiology practices and were formed for the purpose of owning and operating diagnostic imaging centers.&#160;&#160;Professional services at the joint venture diagnostic imaging centers are performed by contracted radiology practices or a radiology practice that participates in the joint venture.&#160;&#160;Our investment in these joint ventures is accounted for under the equity method, as we do not have a controlling financial interest in such ventures. We evaluate our investment in joint ventures, including cost in excess of book value (equity method goodwill) for impairment whenever indicators of impairment exist. No indicators of impairment existed as of December 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Joint venture investment and financial information&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of our investment in joint ventures during the years ended December 31, 2022 and December 31, 2021 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.090%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity contributions in existing and purchase of interest in joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity in earnings in these joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distribution of earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,707)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity contributions in existing and purchase of interest in joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity in earnings in these joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distribution of earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,438)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We charged management service fees from the centers underlying these joint ventures of approximately  $22.2 million, $19.6 million and $11.3 million for the years ended December 31, 2022, 2021 and 2020, respectively.  We eliminate any unrealized portion of our management service fees with our equity in earnings of joint ventures.  As we have the ability to exercise significant influence over our joint venture entities, we consider them related parties.  Amounts transacted between ourselves and the entities in the ordinary course of business are disclosed on our balance sheet in the due from/to affiliate accounts.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of key unaudited financial data for these joint ventures as of December 31, 2022 and 2021, respectively, and for the years ended December 31, 2022, 2021 and 2020, respectively, (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance Sheet Data:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncurrent assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29,588)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,919)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncurrent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37,952)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,370)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net assets&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Book value of RadNet joint venture interests&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,930&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost in excess of book value of acquired joint venture interests accounted for as equity method goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total value of RadNet joint venture interests&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the years ended December 31, 2022 and 2021, we made an additional equity contributions of $1.4 million each year to Arizona Diagnostic Radiology Group ("ADRG", our joint venture with Dignity Health).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 1, 2022, we contributed eight of our imaging centers to ADRG of $12.7 million and recorded a loss of $0.5 million which was calculated as the difference between the sale price and carrying value of such imaging centers which included equipment and other assets and an allocation of goodwill to such imaging centers.  We recorded $4.5 million of the sale price as an offset to due to affiliates while the remaining $8.3 million was recorded as investment in joint venture on our balance sheet.  We accounted for the transaction as an adjustment to our equity investment for the value of the assets contributed.  To maintain our 49% economic interest in ADRG, we received a distribution from the partnership of $4.5 million to reduce our overall investment to $8.3 million.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDA3Nzg_f00d341c-94a3-4403-b0d4-5d3c57befa32">PRINCIPLES OF CONSOLIDATION &#x2013; The operating activities of subsidiaries are included in the accompanying consolidated financial statements (&#x201c;financial statements&#x201d;) from the date of acquisition. Investments in companies in which we have the ability to exercise significant influence, but not control, are accounted for by the equity method. All intercompany transactions and balances, with our consolidated entities and the unsettled amount of intercompany transactions with our equity method investees, have been eliminated in consolidation. As stated in Note 1 above, the Group consists of VIEs and we consolidate the operating activities and balance sheets of each. Additionally, we determined that our unconsolidated joint venture, ScriptSender, LLC, is also a VIE as it is dependent on our operational funding but we are not a primary beneficiary since RadNet does not have the power to direct the activities of the entity that most significantly impact the entity&#x2019;s economic performance.</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDA3NzE_51ca7580-285e-4f18-8c74-d8aa20a9fd61">USE OF ESTIMATES - The financial statements have been prepared in accordance with U.S. generally accepted accounting principles (GAAP), which requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. These estimates and assumptions affect various matters, including our reported amounts of assets and liabilities in our consolidated balance sheets at the dates of the financial statements; our disclosure of contingent assets and liabilities at the dates of the financial statements; and our reported amounts of revenues and expenses in our consolidated statements of operations during the reporting periods. These estimates involve judgments with respect to numerous factors that are difficult to predict and are beyond management&#x2019;s control. As a result, actual amounts could materially differ from these estimates.</us-gaap:UseOfEstimates>
    <us-gaap:RevenueRecognitionPolicyTextBlock
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDA4MDM_308e3fc8-1459-4fb2-b65b-aa456f97d8ad">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;REVENUES &#x2013; Our revenues generally relate to net patient fees&#160;received from various payors and patients themselves under contracts in which our performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period when our obligations to provide diagnostic services are satisfied. Our performance obligations for diagnostic services are generally satisfied over a period of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payor (Medicare, Medicaid, managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent upon the terms provided by Medicare and Medicaid, or negotiated with managed care health plans and commercial insurance companies. The payment arrangements with third-party payors for the services we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As it relates to the Group, this service fee revenue includes payments for both the professional medical interpretation revenue recognized by them as well as the payment for all other aspects related to our providing the imaging services, for which we earn management fees. As it relates to other centers, this service fee revenue is earned through providing the use of our &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;diagnostic imaging equipment and the provision of technical services as well as providing administration services such as clerical and administrative personnel, bookkeeping and accounting services, billing and collection, provision of medical and office supplies, secretarial, reception and transcription services, maintenance of medical records, and advertising, marketing and promotional activities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our revenues are based upon the estimated amounts we expect to be entitled to receive from patients and third-party payors. Estimates of contractual allowances under managed care and commercial insurance plans are based upon the payment terms specified in the related contractual agreements. Revenues related to uninsured patients and copayment and deductible amounts for patients who have health care coverage may have discounts applied (uninsured discounts and contractual discounts). We also record estimated implicit price concessions (based primarily on historical collection experience) related to uninsured accounts to record self-pay revenues at the estimated amounts we expect to collect.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under capitation arrangements with various health plans, we earn a per-enrollee amount each month for making available diagnostic imaging services to all plan enrollees under the capitation arrangement. Revenue under capitation arrangements is recognized in the period in which we are obligated to provide services to plan enrollees under contracts with various health plans.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:ScheduleOfPrincipalTransactionsRevenueTextBlock
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDA3ODM_ea309984-0871-4667-af93-7906717c003b">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our total service fee revenues for the years ended December 31, 2022, 2021, and 2020 are presented in the table below.  Our imaging center revenue is displayed as the estimated service fee, broken down by classification of insurance coverage type.  Additional revenues are earned from our management services provided to joint ventures and our software and AI subsidiaries.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;In Thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial insurance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;785,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;743,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;584,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;311,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;280,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Workers' compensation/personal injury&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other patient revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Management fee revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software and teleradiology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue under capitation arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Imaging center segment revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,425,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,313,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,071,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;AI segment revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,430,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,315,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,071,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfPrincipalTransactionsRevenueTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5a0a659fcb0242ad8761501bd118570a_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmE0YzU3MjkwZWQ5YTQ3NWRhZTU5MGM1YjQzNDM3M2M5L3RhYmxlcmFuZ2U6YTRjNTcyOTBlZDlhNDc1ZGFlNTkwYzViNDM0MzczYzlfMS0xLTEtMS0yOTQ4OQ_cf6e0cfc-6d37-4593-aa1e-276d09e9fa02"
      unitRef="usd">785128000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1f6559bea918495a87128bf382ef7d5a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmE0YzU3MjkwZWQ5YTQ3NWRhZTU5MGM1YjQzNDM3M2M5L3RhYmxlcmFuZ2U6YTRjNTcyOTBlZDlhNDc1ZGFlNTkwYzViNDM0MzczYzlfMS0zLTEtMS0yOTQ4OQ_597d8783-5308-4a50-b3a5-d196d0f2c0fb"
      unitRef="usd">743462000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9d2544245c6946048647d180b4e3e7e7_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmE0YzU3MjkwZWQ5YTQ3NWRhZTU5MGM1YjQzNDM3M2M5L3RhYmxlcmFuZ2U6YTRjNTcyOTBlZDlhNDc1ZGFlNTkwYzViNDM0MzczYzlfMS01LTEtMS0yOTQ4OQ_334a6abe-0e80-4ab9-b821-b1d519cdeed9"
      unitRef="usd">584035000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if9e89507dbdf4fca9acbc6d655b0924f_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmE0YzU3MjkwZWQ5YTQ3NWRhZTU5MGM1YjQzNDM3M2M5L3RhYmxlcmFuZ2U6YTRjNTcyOTBlZDlhNDc1ZGFlNTkwYzViNDM0MzczYzlfMi0xLTEtMS0yOTQ4OQ_0130684e-bc85-49ac-9121-c962e9fb390f"
      unitRef="usd">311124000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6010c9500ed44ea7ac66cbb102ea5441_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmE0YzU3MjkwZWQ5YTQ3NWRhZTU5MGM1YjQzNDM3M2M5L3RhYmxlcmFuZ2U6YTRjNTcyOTBlZDlhNDc1ZGFlNTkwYzViNDM0MzczYzlfMi0zLTEtMS0yOTQ4OQ_b4e2742b-27b9-4028-9856-5230a6f375e2"
      unitRef="usd">280911000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i67dc9135b9ab4673a47ea479a7047db1_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmE0YzU3MjkwZWQ5YTQ3NWRhZTU5MGM1YjQzNDM3M2M5L3RhYmxlcmFuZ2U6YTRjNTcyOTBlZDlhNDc1ZGFlNTkwYzViNDM0MzczYzlfMi01LTEtMS0yOTQ4OQ_461d6ea5-d97b-46dc-b32c-e3810d868fef"
      unitRef="usd">217928000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id3adc65b8a2046e69efeb8d95f9b16e0_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmE0YzU3MjkwZWQ5YTQ3NWRhZTU5MGM1YjQzNDM3M2M5L3RhYmxlcmFuZ2U6YTRjNTcyOTBlZDlhNDc1ZGFlNTkwYzViNDM0MzczYzlfMy0xLTEtMS0yOTQ4OQ_1833d6e0-f87a-44bb-8f68-093f19cb9587"
      unitRef="usd">38279000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6ee2b0d6cc73495f962207b14a58c057_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmE0YzU3MjkwZWQ5YTQ3NWRhZTU5MGM1YjQzNDM3M2M5L3RhYmxlcmFuZ2U6YTRjNTcyOTBlZDlhNDc1ZGFlNTkwYzViNDM0MzczYzlfMy0zLTEtMS0yOTQ4OQ_02894861-0d29-4169-863e-2ae368de7fda"
      unitRef="usd">34731000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i72206c79090b41468a17cf51393b0102_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmE0YzU3MjkwZWQ5YTQ3NWRhZTU5MGM1YjQzNDM3M2M5L3RhYmxlcmFuZ2U6YTRjNTcyOTBlZDlhNDc1ZGFlNTkwYzViNDM0MzczYzlfMy01LTEtMS0yOTQ4OQ_b49f2d76-b455-49e2-93c1-0487e1f327bd"
      unitRef="usd">25619000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibc941d1b7b8b42c1b2b229203d2d1f68_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmE0YzU3MjkwZWQ5YTQ3NWRhZTU5MGM1YjQzNDM3M2M5L3RhYmxlcmFuZ2U6YTRjNTcyOTBlZDlhNDc1ZGFlNTkwYzViNDM0MzczYzlfNC0xLTEtMS0yOTQ4OQ_c636e02f-f1a7-4aa0-8db5-0502a8fc3864"
      unitRef="usd">51339000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4c9a14a2aa8d4c7c92e4d32b28aa7ae3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmE0YzU3MjkwZWQ5YTQ3NWRhZTU5MGM1YjQzNDM3M2M5L3RhYmxlcmFuZ2U6YTRjNTcyOTBlZDlhNDc1ZGFlNTkwYzViNDM0MzczYzlfNC0zLTEtMS0yOTQ4OQ_c2e95eca-48e1-417d-a6cb-0c2937e909af"
      unitRef="usd">44235000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibeee80a28c534eb29afad1b7014b9af5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmE0YzU3MjkwZWQ5YTQ3NWRhZTU5MGM1YjQzNDM3M2M5L3RhYmxlcmFuZ2U6YTRjNTcyOTBlZDlhNDc1ZGFlNTkwYzViNDM0MzczYzlfNC01LTEtMS0yOTQ4OQ_d85c080a-6142-4fcd-b833-748741fc199f"
      unitRef="usd">33478000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i72030050603b4a6492bb961b6905bcdd_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmE0YzU3MjkwZWQ5YTQ3NWRhZTU5MGM1YjQzNDM3M2M5L3RhYmxlcmFuZ2U6YTRjNTcyOTBlZDlhNDc1ZGFlNTkwYzViNDM0MzczYzlfNS0xLTEtMS0yOTQ4OQ_45c27a45-2b70-4c5d-bf20-c4e75590ac49"
      unitRef="usd">31849000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i26f7c190fd9c4fe4b401e5498a9420a5_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmE0YzU3MjkwZWQ5YTQ3NWRhZTU5MGM1YjQzNDM3M2M5L3RhYmxlcmFuZ2U6YTRjNTcyOTBlZDlhNDc1ZGFlNTkwYzViNDM0MzczYzlfNS0zLTEtMS0yOTQ4OQ_e68d8fc3-1287-4ebe-8218-e009c1b148b4"
      unitRef="usd">19398000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibb79b974d4be492a91371479cbb32335_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmE0YzU3MjkwZWQ5YTQ3NWRhZTU5MGM1YjQzNDM3M2M5L3RhYmxlcmFuZ2U6YTRjNTcyOTBlZDlhNDc1ZGFlNTkwYzViNDM0MzczYzlfNS01LTEtMS0yOTQ4OQ_01265597-9285-408c-a5f1-b9e6d58476a2"
      unitRef="usd">25314000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6d125c78b6c146b6a159d4a476805404_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmE0YzU3MjkwZWQ5YTQ3NWRhZTU5MGM1YjQzNDM3M2M5L3RhYmxlcmFuZ2U6YTRjNTcyOTBlZDlhNDc1ZGFlNTkwYzViNDM0MzczYzlfNi0xLTEtMS0yOTQ4OQ_900af79b-a743-4561-a14e-4a146c78895d"
      unitRef="usd">22235000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iecbeb484fb484458a8ffbf37a3d961c9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmE0YzU3MjkwZWQ5YTQ3NWRhZTU5MGM1YjQzNDM3M2M5L3RhYmxlcmFuZ2U6YTRjNTcyOTBlZDlhNDc1ZGFlNTkwYzViNDM0MzczYzlfNi0zLTEtMS0yOTQ4OQ_4c41c1b9-624a-4fb3-8dbe-dad036b2ea0a"
      unitRef="usd">19630000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1abd100dae3f4030bbd2f3ea40e56b5e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmE0YzU3MjkwZWQ5YTQ3NWRhZTU5MGM1YjQzNDM3M2M5L3RhYmxlcmFuZ2U6YTRjNTcyOTBlZDlhNDc1ZGFlNTkwYzViNDM0MzczYzlfNi01LTEtMS0yOTQ4OQ_8f23a721-b746-40ef-81d2-533d7cb0b842"
      unitRef="usd">11253000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie2a7006c766b4cac84f74a1f76450698_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmE0YzU3MjkwZWQ5YTQ3NWRhZTU5MGM1YjQzNDM3M2M5L3RhYmxlcmFuZ2U6YTRjNTcyOTBlZDlhNDc1ZGFlNTkwYzViNDM0MzczYzlfNy0xLTEtMS0yOTQ4OQ_f02d49de-8c6a-43e0-bf0f-8b8e6d57877d"
      unitRef="usd">14238000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i508713e09e2f4d37aa8f9bcfe4c9028b_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmE0YzU3MjkwZWQ5YTQ3NWRhZTU5MGM1YjQzNDM3M2M5L3RhYmxlcmFuZ2U6YTRjNTcyOTBlZDlhNDc1ZGFlNTkwYzViNDM0MzczYzlfNy0zLTEtMS0yOTQ4OQ_7890d241-8228-42db-9af4-1cc084556f24"
      unitRef="usd">10525000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia70d2c625846491db5b174a1557fbcb8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmE0YzU3MjkwZWQ5YTQ3NWRhZTU5MGM1YjQzNDM3M2M5L3RhYmxlcmFuZ2U6YTRjNTcyOTBlZDlhNDc1ZGFlNTkwYzViNDM0MzczYzlfNy01LTEtMS0yOTQ4OQ_078435e3-dbc8-4f43-a697-224ecfda7e0a"
      unitRef="usd">10798000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic8b9db45f8f642ba842535ed1f326b09_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmE0YzU3MjkwZWQ5YTQ3NWRhZTU5MGM1YjQzNDM3M2M5L3RhYmxlcmFuZ2U6YTRjNTcyOTBlZDlhNDc1ZGFlNTkwYzViNDM0MzczYzlfOC0xLTEtMS0yOTQ4OQ_40dc2879-27b1-40fb-b84c-123897457cfb"
      unitRef="usd">19428000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i87b7580faff74b7e95b97fc7b8c8893a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmE0YzU3MjkwZWQ5YTQ3NWRhZTU5MGM1YjQzNDM3M2M5L3RhYmxlcmFuZ2U6YTRjNTcyOTBlZDlhNDc1ZGFlNTkwYzViNDM0MzczYzlfOC0zLTEtMS0yOTQ4OQ_19c6aa49-35ea-4219-bd96-9a3b6ce99355"
      unitRef="usd">12436000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i25437a7752974cd98b29076a22f18504_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmE0YzU3MjkwZWQ5YTQ3NWRhZTU5MGM1YjQzNDM3M2M5L3RhYmxlcmFuZ2U6YTRjNTcyOTBlZDlhNDc1ZGFlNTkwYzViNDM0MzczYzlfOC01LTEtMS0yOTQ4OQ_96649dc5-fdec-403c-a3d3-5a3435ebaf36"
      unitRef="usd">23297000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8827fd8aae0c45ac99829a7fb259f75c_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmE0YzU3MjkwZWQ5YTQ3NWRhZTU5MGM1YjQzNDM3M2M5L3RhYmxlcmFuZ2U6YTRjNTcyOTBlZDlhNDc1ZGFlNTkwYzViNDM0MzczYzlfOS0xLTEtMS02MTU2Ng_decea57d-665d-4e44-804d-c69eead66f91"
      unitRef="usd">152045000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8b9fb24ebf5447db9eb3e2b703507952_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmE0YzU3MjkwZWQ5YTQ3NWRhZTU5MGM1YjQzNDM3M2M5L3RhYmxlcmFuZ2U6YTRjNTcyOTBlZDlhNDc1ZGFlNTkwYzViNDM0MzczYzlfOS0zLTEtMS02MTU3NA_5431945f-3d69-4beb-9de6-470cee2dac0e"
      unitRef="usd">148334000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i93e177287d564fa0be95b081ae11ddd8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmE0YzU3MjkwZWQ5YTQ3NWRhZTU5MGM1YjQzNDM3M2M5L3RhYmxlcmFuZ2U6YTRjNTcyOTBlZDlhNDc1ZGFlNTkwYzViNDM0MzczYzlfOS01LTEtMS02MTU4Mg_4b8bf74f-3b60-4679-a680-7a243f209ba6"
      unitRef="usd">140118000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia31edfbd04f643e3b9f3f2aeff39f4ca_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmE0YzU3MjkwZWQ5YTQ3NWRhZTU5MGM1YjQzNDM3M2M5L3RhYmxlcmFuZ2U6YTRjNTcyOTBlZDlhNDc1ZGFlNTkwYzViNDM0MzczYzlfOS0xLTEtMS0yOTQ4OQ_ec3806f0-b08f-454a-b120-da9bce9b54bf"
      unitRef="usd">1425665000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i57f34400483a431dbea4dc0dabc4bc32_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmE0YzU3MjkwZWQ5YTQ3NWRhZTU5MGM1YjQzNDM3M2M5L3RhYmxlcmFuZ2U6YTRjNTcyOTBlZDlhNDc1ZGFlNTkwYzViNDM0MzczYzlfOS0zLTEtMS0yOTQ4OQ_26432108-4fd7-440f-a9ec-4509aad86b2e"
      unitRef="usd">1313662000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3094571dace8441cabbda1c2dbba52bf_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmE0YzU3MjkwZWQ5YTQ3NWRhZTU5MGM1YjQzNDM3M2M5L3RhYmxlcmFuZ2U6YTRjNTcyOTBlZDlhNDc1ZGFlNTkwYzViNDM0MzczYzlfOS01LTEtMS0yOTQ4OQ_7067cc7c-25ce-421e-a275-fc21805f2b26"
      unitRef="usd">1071840000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ied16739f0ee74364a87daf31d0d396a3_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmE0YzU3MjkwZWQ5YTQ3NWRhZTU5MGM1YjQzNDM3M2M5L3RhYmxlcmFuZ2U6YTRjNTcyOTBlZDlhNDc1ZGFlNTkwYzViNDM0MzczYzlfMTAtMS0xLTEtMjk0ODk_021b80f5-a053-4445-b2c9-3cae729950a8"
      unitRef="usd">4396000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i460e15926d1d435b8a643a732b488ddf_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmE0YzU3MjkwZWQ5YTQ3NWRhZTU5MGM1YjQzNDM3M2M5L3RhYmxlcmFuZ2U6YTRjNTcyOTBlZDlhNDc1ZGFlNTkwYzViNDM0MzczYzlfMTAtMy0xLTEtMjk0ODk_b954f933-23f5-4b6f-a8c8-a635ddc258b0"
      unitRef="usd">1415000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i63b1d1c0666a4b70a0380796de7d23ed_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmE0YzU3MjkwZWQ5YTQ3NWRhZTU5MGM1YjQzNDM3M2M5L3RhYmxlcmFuZ2U6YTRjNTcyOTBlZDlhNDc1ZGFlNTkwYzViNDM0MzczYzlfMTAtNS0xLTEtMjk0ODk_044df8d2-00fa-498c-8cd5-f5f7a2d1bb98"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmE0YzU3MjkwZWQ5YTQ3NWRhZTU5MGM1YjQzNDM3M2M5L3RhYmxlcmFuZ2U6YTRjNTcyOTBlZDlhNDc1ZGFlNTkwYzViNDM0MzczYzlfMTEtMS0xLTEtMjk0ODk_8dc8781b-a595-4a03-b4d6-07e4ead458b4"
      unitRef="usd">1430061000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmE0YzU3MjkwZWQ5YTQ3NWRhZTU5MGM1YjQzNDM3M2M5L3RhYmxlcmFuZ2U6YTRjNTcyOTBlZDlhNDc1ZGFlNTkwYzViNDM0MzczYzlfMTEtMy0xLTEtMjk0ODk_cc268b86-5bc1-4768-b31d-ef405454f565"
      unitRef="usd">1315077000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmE0YzU3MjkwZWQ5YTQ3NWRhZTU5MGM1YjQzNDM3M2M5L3RhYmxlcmFuZ2U6YTRjNTcyOTBlZDlhNDc1ZGFlNTkwYzViNDM0MzczYzlfMTEtNS0xLTEtMjk0ODk_2735b195-cac0-4148-8a79-1ce9d8d17ca2"
      unitRef="usd">1071840000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <rdnt:AdvanceMedicarePayments
      contextRef="idece277420ff4a9fa6789878bb4d04bc_D20200101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNTk0MA_d8b8b54a-6e97-48a3-88fe-9473358de801"
      unitRef="usd">39600000</rdnt:AdvanceMedicarePayments>
    <rdnt:AdvanceMedicarePayments
      contextRef="i506dbb6a5e1c4160b81aac201c17a8cf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNTk5Mg_697ff1b4-d66d-4509-ac2b-66c48fd58e93"
      unitRef="usd">39500000</rdnt:AdvanceMedicarePayments>
    <rdnt:AdvanceMedicarePayments
      contextRef="i50ecee342add4902a22e3378fadbd827_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNjAzMA_b3abf76f-c44b-4801-9a9a-572c419a1778"
      unitRef="usd">100000</rdnt:AdvanceMedicarePayments>
    <us-gaap:ProceedsFromLoans
      contextRef="ic8140fafc99c43f698a11c6792fc6450_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNjA2Ng_f3295110-9bf9-4868-be20-586051ccacdf"
      unitRef="usd">4000000</us-gaap:ProceedsFromLoans>
    <rdnt:ProceedsFromProviderReliefFunding
      contextRef="idece277420ff4a9fa6789878bb4d04bc_D20200101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNjE1OA_43cc6981-d90c-4bb4-b1ed-279b929a175c"
      unitRef="usd">35400000</rdnt:ProceedsFromProviderReliefFunding>
    <rdnt:ProceedsFromProviderReliefFunding
      contextRef="i506dbb6a5e1c4160b81aac201c17a8cf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNjE5Mg_516b7e79-432b-4dae-b2fe-b3400212ddd6"
      unitRef="usd">26300000</rdnt:ProceedsFromProviderReliefFunding>
    <rdnt:ProceedsFromProviderReliefFunding
      contextRef="i50ecee342add4902a22e3378fadbd827_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNjI1NA_8e91d02a-64dd-478d-9f5f-db0016b15db8"
      unitRef="usd">9100000</rdnt:ProceedsFromProviderReliefFunding>
    <rdnt:RepaymentOfAdvanceMedicarePayments
      contextRef="i50ecee342add4902a22e3378fadbd827_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTc0ODkxNg_30067b24-ae9e-4be8-818c-32fd67616ce3"
      unitRef="usd">8400000</rdnt:RepaymentOfAdvanceMedicarePayments>
    <rdnt:RepaymentOfAdvanceMedicarePayments
      contextRef="if6fd3b8a94554fd9a4f614d18e1c3d63_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTcyMDg4Mg_c5748cda-9613-4e0d-968b-c23bf668e75d"
      unitRef="usd">30200000</rdnt:RepaymentOfAdvanceMedicarePayments>
    <us-gaap:GovernmentAssistanceAmountCumulative
      contextRef="i60bbb306d434427baf7094fc97918fdc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTcyMDE5NQ_4ba00297-70de-4132-895c-38e21ad36cc7"
      unitRef="usd">1000000</us-gaap:GovernmentAssistanceAmountCumulative>
    <us-gaap:ProceedsFromLoans
      contextRef="ic8140fafc99c43f698a11c6792fc6450_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNjgzNg_f3295110-9bf9-4868-be20-586051ccacdf"
      unitRef="usd">4000000</us-gaap:ProceedsFromLoans>
    <rdnt:CaresActRefundableClaimPercentage
      contextRef="i74debba71c9649e0ab1a9f9fa2f11ff8_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNzI5Mg_103d0dba-18b8-46f6-937d-28bd8201a00a"
      unitRef="number">0.50</rdnt:CaresActRefundableClaimPercentage>
    <rdnt:CaresActRefundableClaimPercentage
      contextRef="i60bbb306d434427baf7094fc97918fdc_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNzMyNA_dfd05a40-a68a-420c-9aae-ddb49b3dc121"
      unitRef="number">0.50</rdnt:CaresActRefundableClaimPercentage>
    <rdnt:SocialSecurityTaxEmployerDeferralCARESAct
      contextRef="id1424599069048eca25bf6f55f5a8042_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNzM2OQ_96a9a619-4144-4b7e-9944-c644d4f38824"
      unitRef="usd">16300000</rdnt:SocialSecurityTaxEmployerDeferralCARESAct>
    <rdnt:CaresActRefundableClaimPercentage
      contextRef="id1424599069048eca25bf6f55f5a8042_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNzQ5MA_45990f30-bbed-493b-9e85-4792273be0ac"
      unitRef="number">0.50</rdnt:CaresActRefundableClaimPercentage>
    <rdnt:IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct
      contextRef="ibb757d76ce5b4ce18bf379dfb73a3226_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNzcwNA_0f682cd4-a43c-45fc-ac3f-3884ba732a78"
      unitRef="usd">7700000</rdnt:IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct>
    <us-gaap:ReceivablesPolicyTextBlock
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDA4NTA_e43b08ce-08ea-4b23-9f2f-099bb977ae1d">ACCOUNTS RECEIVABLE &#x2013; Substantially all of our accounts receivable are due under fee-for-service contracts from third party payors, such as insurance companies and government-sponsored healthcare programs, or directly from patients. Services are generally provided pursuant to one-year contracts with healthcare providers. We continuously monitor collections from our payors and maintain an allowance for bad debts based upon specific payor collection issues that we have identified and our historical experience.We have entered into factoring agreements with various institutions and sold certain accounts receivable under non-recourse agreements in exchange for notes receivables from the buyers. These transactions are accounted for as a reduction in accounts receivable as the agreements transfer effective control over and risk related to the receivables to the buyers. Proceeds on notes receivables are reflected as operating activities on our statement of cash flows and on our balance sheet as prepaid expenses and other current assets for the current portion and deposits and other for the long term portion.</us-gaap:ReceivablesPolicyTextBlock>
    <rdnt:ContractsReceivableFactoringReceivable
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTY5NDAyMw_29f3f010-7b83-4c08-9e8f-549a37273702"
      unitRef="usd">15400000</rdnt:ContractsReceivableFactoringReceivable>
    <rdnt:ContractsReceivableFactoringReceivable
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTY5NDAxNg_4fb38af4-dfaa-49cd-bfc1-ef132f02d9cd"
      unitRef="usd">17700000</rdnt:ContractsReceivableFactoringReceivable>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDk0NzgwMjM2NjExNw_bc139f30-4181-4297-8cbb-e6d8276a68a4">Accounts payable and accrued expenses were comprised of the following (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.502%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.931%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.951%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.665%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.953%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued salary and benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued professional fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;369,595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;263,937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccountsPayableCurrent
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjg0MWMwYzI3MGQzNjQ1MDE5YTI1NGZkYjNkOWQ2MGUzL3RhYmxlcmFuZ2U6ODQxYzBjMjcwZDM2NDUwMTlhMjU0ZmRiM2Q5ZDYwZTNfMi0xLTEtMS01NzgyNg_34268587-5ce4-4294-9167-7e71c9af4490"
      unitRef="usd">102678000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjg0MWMwYzI3MGQzNjQ1MDE5YTI1NGZkYjNkOWQ2MGUzL3RhYmxlcmFuZ2U6ODQxYzBjMjcwZDM2NDUwMTlhMjU0ZmRiM2Q5ZDYwZTNfMi0zLTEtMS01NzgyNg_c7bfff03-99ca-4caf-8845-0f40d36a6fcb"
      unitRef="usd">86461000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjg0MWMwYzI3MGQzNjQ1MDE5YTI1NGZkYjNkOWQ2MGUzL3RhYmxlcmFuZ2U6ODQxYzBjMjcwZDM2NDUwMTlhMjU0ZmRiM2Q5ZDYwZTNfMy0xLTEtMS01NzgyNg_4919187f-03b9-4606-ac1e-d6e309609e26"
      unitRef="usd">181574000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjg0MWMwYzI3MGQzNjQ1MDE5YTI1NGZkYjNkOWQ2MGUzL3RhYmxlcmFuZ2U6ODQxYzBjMjcwZDM2NDUwMTlhMjU0ZmRiM2Q5ZDYwZTNfMy0zLTEtMS01NzgyNg_de00dbf1-25db-4c5c-9272-a5b19b9d5d36"
      unitRef="usd">93420000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjg0MWMwYzI3MGQzNjQ1MDE5YTI1NGZkYjNkOWQ2MGUzL3RhYmxlcmFuZ2U6ODQxYzBjMjcwZDM2NDUwMTlhMjU0ZmRiM2Q5ZDYwZTNfNC0xLTEtMS01NzgyNg_a6d3ef2c-3185-4513-abd0-524f0ea32fe1"
      unitRef="usd">62072000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjg0MWMwYzI3MGQzNjQ1MDE5YTI1NGZkYjNkOWQ2MGUzL3RhYmxlcmFuZ2U6ODQxYzBjMjcwZDM2NDUwMTlhMjU0ZmRiM2Q5ZDYwZTNfNC0zLTEtMS01NzgyNg_7ab7ab16-8e67-4963-b9a2-dcefd488883a"
      unitRef="usd">62425000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjg0MWMwYzI3MGQzNjQ1MDE5YTI1NGZkYjNkOWQ2MGUzL3RhYmxlcmFuZ2U6ODQxYzBjMjcwZDM2NDUwMTlhMjU0ZmRiM2Q5ZDYwZTNfNS0xLTEtMS01NzgyNg_08948f7e-7794-47f1-971b-13709fddb3b0"
      unitRef="usd">23271000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjg0MWMwYzI3MGQzNjQ1MDE5YTI1NGZkYjNkOWQ2MGUzL3RhYmxlcmFuZ2U6ODQxYzBjMjcwZDM2NDUwMTlhMjU0ZmRiM2Q5ZDYwZTNfNS0zLTEtMS01NzgyNg_f54feb61-a0cd-4e54-85f3-228dfe7fe930"
      unitRef="usd">21631000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjg0MWMwYzI3MGQzNjQ1MDE5YTI1NGZkYjNkOWQ2MGUzL3RhYmxlcmFuZ2U6ODQxYzBjMjcwZDM2NDUwMTlhMjU0ZmRiM2Q5ZDYwZTNfNi0xLTEtMS01NzgyNg_be9456ef-a352-4808-8911-0b1e582e5e54"
      unitRef="usd">369595000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjg0MWMwYzI3MGQzNjQ1MDE5YTI1NGZkYjNkOWQ2MGUzL3RhYmxlcmFuZ2U6ODQxYzBjMjcwZDM2NDUwMTlhMjU0ZmRiM2Q5ZDYwZTNfNi0zLTEtMS01NzgyNg_1e22ad23-5fc2-4bc4-a541-fc04a164977a"
      unitRef="usd">263937000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDA4MjE_c729a612-e65e-4061-93a1-65900d6d0cdf">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;SOFTWARE REVENUE RECOGNITION &#x2013; We have developed and sell Picture Archiving Communications Systems (&#x201c;PACS&#x201d;) and related services. The PACS sales are made primarily through our sales force and generally include hardware, software, installation, training and first-year warranty support. Hardware which is not unique or special purpose, is purchased from a third-party and resold to customers with a small mark-up.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;We have determined that our core software products, such as PACS, are essential to most of our arrangements as hardware, software and related services are sold as an integrated package.  Revenue is recognized when a performance obligation is satisfied by transferring a promised good or service to a customer.</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i52b880c3739c4f62a055717f8fc7fe42_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTY5NDA2Mw_5df38f07-8af1-4ad0-9fa2-08338f7b09c4"
      unitRef="usd">13200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i808cdb9ce8d34cef9d7fda485b899b3d_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTY5NDA1Ng_1bf8b267-fc1b-4836-8b22-cab8ce2578d6"
      unitRef="usd">10500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifea7caca315b42ef9d31633ec1af9648_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTY5NDA0OQ_59d679dd-6a89-4755-800d-cd2156d49770"
      unitRef="usd">8600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="ib5869b7b9a94482aabb1927c7e98515c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTY5NDA3MQ_fe85c05b-616c-4502-ba88-b74fddc57432"
      unitRef="usd">900000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="ib5869b7b9a94482aabb1927c7e98515c_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTAxNTg_ce0269d2-414b-4039-90f0-c81a27ac0732">P12M</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:ResearchDevelopmentAndComputerSoftwarePolicyTextBlock
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDA4MDc_e85d1356-0380-4526-9d7e-fae1cd392005">SOFTWARE DEVELOPMENT COSTS &#x2013; When we develop our own software and artificial intelligence solutions we capitalize and amortize those costs over their useful life. Costs related to the research and development of new software products and enhancements to existing software intended for resale to our customers are expensed as incurred.</us-gaap:ResearchDevelopmentAndComputerSoftwarePolicyTextBlock>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDA4MTM_96789813-1dde-4337-b9ed-1f156a9cd2dc">CONCENTRATION OF CREDIT RISKS &#x2013; Financial instruments that potentially subject us to credit risk are primarily cash equivalents and accounts receivable. We have placed our cash and cash equivalents with one major financial institution. At times, the cash in the financial institution is temporarily in excess of the amount insured by the Federal Deposit Insurance Corporation, or FDIC. Substantially all of our accounts receivable are due under fee-for-service contracts from third party payors, such as insurance companies and government-sponsored healthcare programs, or directly from patients. We continuously monitor collections and maintain an allowance for bad debts based upon our historical collection experience. In addition, we have notes receivable stemming from our factoring of accounts receivable as stated above.  Companies with which we factor our receivables are well known established buyers of such instruments, have agreed to assume the full risk of their collection.</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDA4MTU_fabfdf28-c492-4e23-80a2-2e3300639a10">CASH AND CASH EQUIVALENTS &#x2013; We consider all highly liquid investments that mature in three months or less when purchased to be cash equivalents. The carrying amount of cash and cash equivalents approximates the fair market value.</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:DeferredChargesPolicyTextBlock
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDA4MTA_92ea48b0-5f97-409a-bd4e-eb28ef6c506d">DEFERRED FINANCING COSTS &#x2013; Costs of financing are deferred and amortized using the effective interest rate method.  Deferred financing costs are related to our revolving credit facilities. Notes Payable for more information on our revolving lines of credit.</us-gaap:DeferredChargesPolicyTextBlock>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTE5OTI_45b72012-bd43-427b-a1b8-47672a79193e"
      unitRef="usd">2300000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTE5OTk_6a3cce32-b0d3-46de-b8c0-3cf793271c42"
      unitRef="usd">2100000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDA3Njc_78df791d-a33a-432b-a62b-ec48a9943500">PROPERTY AND EQUIPMENT &#x2013; Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation and amortization of property and equipment are provided using the straight-line method over the estimated useful lives, which range from 3 to 15 years. Leasehold improvements are amortized at the lesser of lease term or their estimated useful lives, which range from 3 to 15 years. Maintenance and repairs are charged to expense as incurred.</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ia02f2d80dbdb4136890d844ee82e5b49_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTI0NTI_fe44c549-f293-4437-adda-bc937c49dd66">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ib6d26e6f10e14cd5ac6652e62c41e88f_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTI0NTg_ce8cc1b1-4648-4f5a-949e-27553582054f">P15Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i08bec0508e764dbfb8c49be4488435e0_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTI1Nzc_945e2faa-c4b3-45e2-80de-d797ec4940a7">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="if16babfd8b114d728c8e4199a210fee5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTI1ODM_2c0873ae-ab80-4818-b220-92c65d7a913e">P15Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:BusinessCombinationsPolicy
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDA4MTE_2865a021-d45a-4245-8556-6e918cf1e68f">BUSINESS COMBINATION &#x2013; When the qualifications for business combination accounting treatment are met, it requires us to recognize separately from goodwill the assets acquired and the liabilities assumed at their acquisition date fair values. Goodwill as of the acquisition date is measured as the excess of consideration transferred over the net of the acquisition date fair values of the assets acquired and the liabilities assumed. While we use our best estimates and assumptions to accurately value assets acquired and liabilities assumed at the acquisition date, our estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, we record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. Upon the conclusion of the measurement period or final determination of the values of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to our consolidated statements of operations.</us-gaap:BusinessCombinationsPolicy>
    <us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDA4NTg_bf473e9a-c311-4f91-a5d1-91662039a2f1">GOODWILL AND INDEFINITE LIVED INTANGIBLESGoodwill, trade name intangibles and IPR&amp;amp;D are recorded as a result of business combinations. When we determine the carrying value of goodwill exceeds its fair value, an impairment charge would be recognized which should not exceed the total amount of goodwill allocated to that reporting unit. We determined fair values for each of the reporting units using the market approach, when available and appropriate, or the income approach, or a combination of both. We assess the valuation methodology based upon the relevance and availability of the data at the time we perform the valuation. If multiple valuation methodologies are used, the results are weighted appropriately.</us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy>
    <us-gaap:Goodwill
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTM3OTE_d24f03c5-ddaa-4ad1-8cd5-173aca08d682"
      unitRef="usd">677700000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTM3OTg_e1107e86-0fe4-4ca7-90c4-6ba0b5c799ed"
      unitRef="usd">513800000</us-gaap:Goodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTM4NzM_23123592-edc7-4c7a-a1c9-3226910ef17f"
      unitRef="usd">24100000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMzg0ODI5MDc4NjYzMQ_4b3d19ab-c0a5-4c59-8c62-b9ac078480aa"
      unitRef="usd">20600000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="i808152f195914b788e6da3420f3e8cb9_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTQ4MDQ_ba4ce47f-df6d-4e30-9128-3d54eb5d7e84"
      unitRef="usd">4200000</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDA3NTE_025f76ea-b966-44f1-879d-27828595a221">LONG-LIVED ASSETS &#x2013; We evaluate our long-lived assets (property and equipment) and intangibles, other than goodwill and indefinite lived intangible assets, for impairment when events or changes indicate the carrying amount of an asset may not be recoverable. Accounting standards requires that if the sum of the undiscounted expected future cash flows from a long-lived asset or definite-lived intangible is less than the carrying value of that asset, an asset impairment charge must be recognized. The amount of the impairment charge is calculated as the excess of the asset&#x2019;s carrying value over its fair value, which generally represents the discounted future cash flows from that asset or in the case of assets we expect to sell, at fair value less costs to sell.  At December 31, 2021 we recorded a &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjc0ODc3OTE4MzYxMw_9c7fb964-0c31-457d-ab68-df24d21cb8df"&gt;write off charge&lt;/span&gt; of $7.1 million in leasehold improvements for facilities that we abandoned. See the Leases discussion below for more information.  Other than this, we determined that there were no events or changes in circumstances that indicated our long-lived assets were impaired during any periods presented.</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="i8537d011842e4b6199b64ca17ec351e6_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTU4MDQ_9b6c0cac-f0bb-40af-8a8e-cf33e7101a58"
      unitRef="usd">7100000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDA4NDM_a5dbed53-a8a7-4f34-8719-a3db63812c67">INCOME TAXES &#x2013; Income tax expense is computed using an asset and liability method and using expected annual effective tax rates. Under this method, deferred income tax assets and liabilities result from temporary differences in the financial reporting bases and the income tax reporting bases of assets and liabilities. The measurement of deferred tax assets is reduced, if necessary, by the amount of any tax benefit that, based on available evidence, is not expected to be realized. When it appears more likely than not that deferred taxes will not be realized, a valuation allowance is recorded to reduce the deferred tax asset to its estimated realizable value. For net deferred tax assets we consider estimates of future taxable income in determining whether our net deferred tax assets are more likely than not to be realized. See Note 10, Income Taxes, for more information.</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDA3OTc_85d47c31-1f2e-48ef-a185-35a32eac6e5c">&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;LEASES - We determine if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (&#x201c;ROU&#x201d;) assets, current operating lease liabilities, and long term operating lease liability in our consolidated balance sheets. Finance leases are included in property and equipment, current finance lease liability, and long-term finance lease liability in our consolidated balance sheets.  ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As most of our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. We use the implicit rate when readily determinable. We include options to extend a lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term. For a contract in which we are a lessee that contains fixed payments for both lease and non-lease components, we have elected to account for the components as a single lease component, as permitted. For finance leases, interest expense on the lease liability is recognized using the effective interest method and amortization of the ROU asset is recognized on a straight-line basis over the shorter of the estimated useful life of the asset or the lease term. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ROU assets are tested for impairment if circumstances suggest that the carrying amount may not be recoverable. No events have occurred such as fire, flood, or other acts which have impaired the integrity of our ROU assets as of December 31, 2022. Our facility leases require us to maintain insurance policies which would cover major damage to our facilities. We maintain business interruption insurance to cover loss of business due to a facility becoming non-operational under certain circumstances. Our equipment leases are covered by warranty and service contracts which cover repairs and provide regular maintenance to keep the equipment in functioning order.&lt;/span&gt;&lt;/div&gt;After a management review of post pandemic patient traffic to centers during the fourth quarter of 2021, it was noted that although overall volumes had returned to pre-pandemic levels, certain imaging locations did not experience the same levels of activity as beforehand.  This was due in part to lower utilization rates of commercial space from telecommuting, accompanied by the migration of those workers out of congested urban centers to residential areas.  Based on this analysis, management decided to consolidate volumes into fewer centers and reduce administrative office space in response to the demographic changes experienced.  To complete the closure of these locations, we took a lease abandonment charge of approximately $12.6 million at December 31, 2021.</us-gaap:LesseeLeasesPolicyTextBlock>
    <rdnt:OperatingLeaseLeaseAbandonmentCharge
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTk2OTk_4887e745-2a94-468d-a860-faa334ebebb6"
      unitRef="usd">12600000</rdnt:OperatingLeaseLeaseAbandonmentCharge>
    <rdnt:UninsuredRisksPolicyTextBlock
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDA4MTg_742002cc-d905-4d46-bd27-2b4d1c8c321b">UNINSURED RISKS &#x2013; On November 1, 2013 we entered into a high-deductible workers&#x2019; compensation insurance policy. We and our affiliated physicians carry an annual medical malpractice insurance policy that protects us for claims that are filed during the policy year and that fall within policy limits.&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2008, in order to eliminate the exposure for claims not reported during the regular malpractice policy period, we purchased a medical malpractice claims made tail policy, which provides coverage for any claims reported in the event that our medical malpractice policy expires. As of December 31, 2022, this policy remains in effect.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;We have entered into an arrangement with Blue Shield to administer and process claims under a self-insured plan that provides health insurance coverage for our employees and dependents.</rdnt:UninsuredRisksPolicyTextBlock>
    <us-gaap:WorkersCompensationLiabilityCurrent
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjA0NzA_ef1370ef-8634-43e7-8b1d-a7a44b19d7d3"
      unitRef="usd">3900000</us-gaap:WorkersCompensationLiabilityCurrent>
    <us-gaap:WorkersCompensationLiabilityCurrent
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjA0Nzc_9fc23310-4d4d-4a9a-afda-bcdc0110aabe"
      unitRef="usd">3500000</us-gaap:WorkersCompensationLiabilityCurrent>
    <rdnt:MedicalMalpracticeDeductiblePerIncidence
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjA4ODM_f7d175a4-a559-4f6b-a964-7d9481cddcd4"
      unitRef="usd">10000</rdnt:MedicalMalpracticeDeductiblePerIncidence>
    <us-gaap:SelfInsuranceReserve
      contextRef="i422a4c2558d84288a00576b3a91e71c6_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjE1MTM_90f05120-0b8d-4e5b-a41d-55d0c02ddf19"
      unitRef="usd">7400000</us-gaap:SelfInsuranceReserve>
    <us-gaap:SelfInsuranceReserve
      contextRef="i6c48d7e622fc4e26963a033683816e48_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjE1MjA_b2c86452-7944-4a87-bbd6-b846c386c836"
      unitRef="usd">6300000</us-gaap:SelfInsuranceReserve>
    <rdnt:MedicalInsuranceStopLossPolicyClaimAmount
      contextRef="i65433954d0d74893ad517dc34d70e910_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjE4MTE_3d008877-4676-4a67-90f6-181bae45e294"
      unitRef="usd">250000</rdnt:MedicalInsuranceStopLossPolicyClaimAmount>
    <rdnt:MedicalInsuranceStopLossPolicyClaimAmount
      contextRef="i94d07cae465b4a45933c903e5b869937_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjE4MzM_2b1336ff-4dbb-44ab-b6ff-db6c4eb58be4"
      unitRef="usd">1000000</rdnt:MedicalInsuranceStopLossPolicyClaimAmount>
    <us-gaap:PostemploymentBenefitPlansPolicy
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDA3ODA_49c2c22c-9c28-4478-86e5-5d4c2c3b5e6f">EMPLOYEE BENEFIT PLAN &#x2013; We adopted a profit-sharing/savings plan pursuant to Section 401(k) of the Internal Revenue Code that covers substantially all non-professional employees. Eligible employees may contribute on a tax-deferred basis a percentage of compensation, up to the maximum allowable under tax law. Employee contributions vest immediately.</us-gaap:PostemploymentBenefitPlansPolicy>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjIzNDE_47dbd0d8-efca-4b02-ac4c-5df5e1214d67"
      unitRef="number">0.010</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjIzNDg_7d040754-07bc-4a24-bc31-a9c76b07071c"
      unitRef="number">0.040</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjI0MjI_fd6a7a7b-dee5-4dd1-a677-00eec79c6baf"
      unitRef="usd">3000000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjI1MTA_e3c1eb01-8490-4001-b5d6-f1e0d1d50a0a"
      unitRef="usd">0</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:CompensationRelatedCostsPolicyTextBlock
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDA3ODY_91c853be-4023-46ef-9bc6-db761930b00d">EQUITY BASED COMPENSATION &#x2013; We have one long-term incentive plan that we adopted in 2006 and which we first amended and restated as of April 20, 2015, and again on March 9, 2017, and currently as of April 15, 2021 (the &#x201c;Restated Plan&#x201d;). The Restated Plan was approved by our stockholders at our annual stockholders meeting on June 10, 2021. We have reserved 16,500,000 shares of common stock for issuance under the Restated Plan which can be issued in the form of incentive and/or nonstatutory stock options, restricted and/or unrestricted stock, stock units, and stock appreciation rights.  Terms and conditions of awards can be direct grants or based on achieving a performance metric and we also consider probability of achievement of performance conditions when determining expense recognition. For the awards where vesting is probable, equity-based compensation is recognized over the related vesting period. Stock options and warrants generally vest over &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjQzNTk_cd22a3ff-fb8c-47a1-9018-2d91908dd609"&gt;three&lt;/span&gt; to five years and expire &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjQzNzk_0e815b97-2caf-4c2a-88cf-151ad3b1dacb"&gt;five&lt;/span&gt; to ten years from date of grant.  We determine the compensation expense for each stock option award using the Black Scholes, or similar, valuation model.  Those models require that our management make certain estimates concerning risk free interest rates and volatility in the trading price of our common stock. The compensation expense recognized for all equity-based awards is recognized over the awards&#x2019; service periods. Equity-based compensation is classified in operating expenses within the same line item as the majority of the cash compensation paid to employees.  In connection with our acquisition of DeepHealth Inc. on June 1, 2020, we assumed the DeepHealth, Inc. 2017 Equity Incentive Plan, including outstanding options awards that can be exercised for our common stock.  No additional awards will be granted under the DeepHealth, Inc. 2017 Equity Incentive Plan.  See Note 11, Stock-Based Compensation, for more information.</us-gaap:CompensationRelatedCostsPolicyTextBlock>
    <rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDk0NzgwMjM2NjExOA_57d3d608-f38f-48c2-ba8d-927c730ae962"
      unitRef="incentiveplan">1</rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="id1fdbe2d3c964be6888f0365aa0b975b_I20210415"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjQwMjU_7d71d979-39f7-46db-b21b-49eb41072229"
      unitRef="shares">16500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i7258cf171ca64de4a7443899de9f7975_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjQzNjU_e6ad3728-93ce-4f3d-98ed-6ccb66de1331">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i7258cf171ca64de4a7443899de9f7975_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjQzODU_4308b39c-c602-42cd-b496-41bdb8a5c0d9">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDA3Nzc_683013e3-0e2e-40ee-97c0-faa56ffff057">FOREIGN CURRENCY TRANSLATION &#x2013; For our operations in Canada, Europe and the United Kingdom, the functional currency of our foreign subsidiaries is the local currency. Assets and liabilities denominated in foreign currencies are translated using the exchange rate at the balance sheet dates. Revenues and expenses are translated using average exchange rates prevailing during the reporting period. Any translation adjustments resulting from this process are shown separately as a component of accumulated other comprehensive income (loss). Gains and losses related to the foreign currency portion of international transactions are included in the determination of net income.</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <rdnt:ScheduleOfForeignCurrencyTranslationAmountsTableTextBlock
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDk0NzgwMjQzOTAyMw_5e8b2713-db60-446e-851a-ff320bbc501a">The following is a reconciliation of Foreign Currency Translation amounts for the years ended December 31, 2022, 2021 and 2020 is provided below (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:50.584%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.148%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.956%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.339%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(276)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(101)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(377)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(442)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,943)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,385)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</rdnt:ScheduleOfForeignCurrencyTranslationAmountsTableTextBlock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="i404f0df0019f440299547782ff0ce012_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjY4MDRjZTRmMmVjMTRmMzM5N2Y1MTBiNDE4MzcwNmZjL3RhYmxlcmFuZ2U6NjgwNGNlNGYyZWMxNGYzMzk3ZjUxMGI0MTgzNzA2ZmNfMS0yLTEtMS03MzgwMQ_0399f6bf-8b9b-4484-8abd-a4b1f9201c25"
      unitRef="usd">-276000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjY4MDRjZTRmMmVjMTRmMzM5N2Y1MTBiNDE4MzcwNmZjL3RhYmxlcmFuZ2U6NjgwNGNlNGYyZWMxNGYzMzk3ZjUxMGI0MTgzNzA2ZmNfMi0yLTEtMS03MzgwMQ_53769d39-c349-46bb-b5bc-a47a3848249a"
      unitRef="usd">-101000</us-gaap:CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="ifb50bc5a13564f6a97eb669524009c18_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjY4MDRjZTRmMmVjMTRmMzM5N2Y1MTBiNDE4MzcwNmZjL3RhYmxlcmFuZ2U6NjgwNGNlNGYyZWMxNGYzMzk3ZjUxMGI0MTgzNzA2ZmNfMy0yLTEtMS03MzgwMQ_108f526c-59d7-4c9d-90b3-377ed8acf5a4"
      unitRef="usd">-377000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjY4MDRjZTRmMmVjMTRmMzM5N2Y1MTBiNDE4MzcwNmZjL3RhYmxlcmFuZ2U6NjgwNGNlNGYyZWMxNGYzMzk3ZjUxMGI0MTgzNzA2ZmNfNC0yLTEtMS03MzgwMQ_3432c366-c206-47bb-a75c-175df7e7d484"
      unitRef="usd">-65000</us-gaap:CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjY4MDRjZTRmMmVjMTRmMzM5N2Y1MTBiNDE4MzcwNmZjL3RhYmxlcmFuZ2U6NjgwNGNlNGYyZWMxNGYzMzk3ZjUxMGI0MTgzNzA2ZmNfNS0yLTEtMS03MzgwMQ_f49d697c-b51e-42b0-bb19-de8bc5ae6872"
      unitRef="usd">-442000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjY4MDRjZTRmMmVjMTRmMzM5N2Y1MTBiNDE4MzcwNmZjL3RhYmxlcmFuZ2U6NjgwNGNlNGYyZWMxNGYzMzk3ZjUxMGI0MTgzNzA2ZmNfNi0yLTEtMS03MzgwMQ_8212757c-7338-47fd-955b-f434c899cb1a"
      unitRef="usd">-3943000</us-gaap:CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjY4MDRjZTRmMmVjMTRmMzM5N2Y1MTBiNDE4MzcwNmZjL3RhYmxlcmFuZ2U6NjgwNGNlNGYyZWMxNGYzMzk3ZjUxMGI0MTgzNzA2ZmNfNy0yLTEtMS03MzgwMQ_f8c4da39-775c-467c-82d4-a648247185ad"
      unitRef="usd">-4385000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDA3NzU_4cf55960-9b15-40e1-8f01-f75a72201a8e">COMPREHENSIVE INCOME (LOSS) &#x2013; Accounting guidance&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;establishes rules for reporting and displaying other comprehensive income (loss) and its components. Our foreign currency translation adjustments,  changes in the fair value of cash flow hedges, and the amortization of balances associated with derivatives previously classified as cash flow hedges are included in other comprehensive income (loss). The components of other comprehensive income (loss) for the twelve month periods ended December 31, 2022, December 31, 2021, and December 31, 2020 are included in the consolidated statements of comprehensive income (loss).&lt;/span&gt;</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <us-gaap:CommitmentsAndContingenciesPolicyTextBlock
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDA4MDE_4bf64625-1cb6-4d5c-a008-1e36b7db2067">COMMITMENTS AND CONTINGENCIES - We are party to various legal proceedings, claims, and regulatory, tax or government inquiries and investigations that arise in the ordinary course of business. With respect to these matters, we evaluate the developments on a regular basis and accrue a liability when we believe a loss is probable and the amount can be reasonably estimated. Based on current information, we do not believe that reasonably possible or probable losses associated with pending legal proceedings would either individually or in the aggregate, have a material adverse effect on our business and consolidated financial statements. However, the outcome of these matters is inherently uncertain. Therefore, if one or more of these matters were resolved against us for amounts in excess of management's expectations, our results of operations and financial condition, including in a particular reporting period in which any such outcome becomes probable and estimable, could be materially adversely affected.</us-gaap:CommitmentsAndContingenciesPolicyTextBlock>
    <us-gaap:DerivativesPolicyTextBlock
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDA4NjA_0606be69-1766-4981-bdde-c40dd5018151">DERIVATIVE INSTRUMENTS The gain or loss of the hedge (i.e. change in fair value) was reported as a component of accumulated other comprehensive income (loss) in the consolidated statement of equity. The 2019 swaps will secure a constant interest rate associated with portions of our variable rate bank debt and have an effective date of October 13, 2020. They will mature in October 2023 for the two smaller notional and October 2025 for the two larger notional.As of the effective date, we will be liable for premium payments if interest rates decline below arranged rates, but will receive interest payments if rates remain above the arranged rates.At inception, we designated our 2019 Swaps as cash flow hedges of floating-rate borrowings. In accordance with accounting guidance, derivatives that have been designated and qualify as cash flow hedging instruments are reported at fair value. The gain or loss on the effective portion of the hedge (i.e. change in fair value) is reported as a component of accumulated comprehensive income (loss) in the consolidated statement of equity.</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:DerivativeAssetNumberOfInstrumentsHeld
      contextRef="i9758ca019cab44059e02dbe1b53445b3_I20161231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjc4ODc_d170bf90-e595-449d-8fdb-dd55f8d13a3d"
      unitRef="agreement">2000</us-gaap:DerivativeAssetNumberOfInstrumentsHeld>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="ie96d50e803ed49a29734c6b96972c575_I20161231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjgwMzM_02264690-fd7b-4c1d-ab78-368e9e5c9c66"
      unitRef="usd">150000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="ia630db7cb89b488da168bd28e8987f04_I20161231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjgwNDA_ef1cebef-0fc6-4fb2-acee-4771c553178f"
      unitRef="usd">350000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeBasisSpreadOnVariableRate
      contextRef="i2e6a00bde60944ccb589e7330bf8c34a_I20161231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjgyNjg_608ea0cc-6cdd-4b01-837d-37590824f118"
      unitRef="number">0.020</us-gaap:DerivativeBasisSpreadOnVariableRate>
    <us-gaap:FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized
      contextRef="i9758ca019cab44059e02dbe1b53445b3_I20161231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjgyOTM_bc9ad75d-94f2-402b-a209-fea0f604e05f"
      unitRef="usd">5300000</us-gaap:FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized>
    <us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDA4MzM_46ab0b24-3922-45af-8acb-b017fb58dc9d">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A tabular presentation of the effect of derivative instruments on our consolidated statement of comprehensive (loss) income, net of taxes is as follows (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.836%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.663%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Interest Rate Contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the twelve months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount of Gain (Loss) Recognized on Derivative, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location of Gain (Loss) Recognized&lt;br/&gt;in Income on Derivative&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$788&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;A tabular presentation of the effect of derivative instruments on our consolidated statement of comprehensive loss of the 2019 swaps is as follows (amounts in thousands):&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.065%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Interest Rate Contracts - Effective Portion&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the twelve months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount of Loss Recognized on Derivative, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location of Loss Recognized&lt;br/&gt;in Income on Derivative&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$(20,160)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A tabular presentation of the effect of derivative instruments on our statement of operations of the 2019 Swaps for the Swaps that became ineffective in 2020 is as follows (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Interest Rate Contracts - Ineffective Portion&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the twelve months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of gain (loss) recognized in income on derivative (current period ineffective portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location of gain (loss) recognized in Income on derivative (current period ineffective portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of loss reclassified from accumulated other comprehensive income (loss) into income (prior period effective portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location of loss reclassified from accumulated other comprehensive income (loss) into income (prior period effective portion)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$39,621&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmY3ZDdlMDY0Y2UzOTQyYWVhZjFkMzRhNTc4MTBmMjA1L3RhYmxlcmFuZ2U6ZjdkN2UwNjRjZTM5NDJhZWFmMWQzNGE1NzgxMGYyMDVfMy0yLTEtMS03NjcxMw_04d809f9-cf99-45ef-aa56-16be46b5f8b6"&gt;Other Income (Expense)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$(3,687)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Interest Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$21,670&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmY3ZDdlMDY0Y2UzOTQyYWVhZjFkMzRhNTc4MTBmMjA1L3RhYmxlcmFuZ2U6ZjdkN2UwNjRjZTM5NDJhZWFmMWQzNGE1NzgxMGYyMDVfNC0yLTEtMS03NjcyMQ_2c91ab05-c7d0-4ed6-a9f1-aefed9da243a"&gt;Other Income (Expense)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$(3,695)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$(2,528)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmY3ZDdlMDY0Y2UzOTQyYWVhZjFkMzRhNTc4MTBmMjA1L3RhYmxlcmFuZ2U6ZjdkN2UwNjRjZTM5NDJhZWFmMWQzNGE1NzgxMGYyMDVfNC0yLTEtMS0yOTQ4OQ_869911ef-bcba-451f-8629-1684d55fda21"&gt;Other Income (Expense)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$(3,448)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i5e878af77c394477a09c4eedcb52e0b2_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjA2Y2E4MDgzZDhlMDQ4NzA5YzRlOGQ4YzJkYjJhMDNjL3RhYmxlcmFuZ2U6MDZjYTgwODNkOGUwNDg3MDljNGU4ZDhjMmRiMmEwM2NfMy0xLTEtMS0yOTQ4OQ_99248f48-9c4f-4954-9f5c-f8878933494c"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i632dbbb6dc124502b35355b0bb82bf56_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjA2Y2E4MDgzZDhlMDQ4NzA5YzRlOGQ4YzJkYjJhMDNjL3RhYmxlcmFuZ2U6MDZjYTgwODNkOGUwNDg3MDljNGU4ZDhjMmRiMmEwM2NfNC0xLTEtMS0yOTQ4OQ_03a68c1f-b4a7-4d17-b78e-58ee371e2e6f"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i46bd994b9ae04e96b753c7e89fbf1818_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjA2Y2E4MDgzZDhlMDQ4NzA5YzRlOGQ4YzJkYjJhMDNjL3RhYmxlcmFuZ2U6MDZjYTgwODNkOGUwNDg3MDljNGU4ZDhjMmRiMmEwM2NfNS0xLTEtMS0yOTQ4OQ_20d398ef-5172-4538-81ff-9eccf0ab1e06"
      unitRef="usd">788000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:DerivativeAssetNumberOfInstrumentsHeld
      contextRef="i9f99c4d1a5b6480abea6d0ff11b1fee6_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjg4NDQ_94e91105-7932-45e5-ac07-d0fde990edf2"
      unitRef="agreement">4000</us-gaap:DerivativeAssetNumberOfInstrumentsHeld>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i9f99c4d1a5b6480abea6d0ff11b1fee6_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjg5NDM_2938326a-c99d-42ff-b1e0-bbacd0b3e3f9"
      unitRef="usd">500000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNumberOfInstrumentsHeld
      contextRef="i5c59e16c960f444e80b8f6cd2c3aff6d_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjc0ODc3OTExMDU3Ng_d29bfc61-35c2-49e3-b90e-b32891c276f1"
      unitRef="agreement">2</us-gaap:DerivativeAssetNumberOfInstrumentsHeld>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i5c59e16c960f444e80b8f6cd2c3aff6d_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjg5Nzk_06c27837-45b2-4c33-8f74-dc395bf4e89d"
      unitRef="usd">50000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNumberOfInstrumentsHeld
      contextRef="ie2a260029b444ab89b7e9377824da6fc_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjc0ODc3OTExMDU4NA_938168ac-525e-4084-aeeb-b3daae1e7671"
      unitRef="agreement">2</us-gaap:DerivativeAssetNumberOfInstrumentsHeld>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="ie2a260029b444ab89b7e9377824da6fc_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjkwMTA_c02c4305-ba32-4e68-bb66-7ff14536b37e"
      unitRef="usd">200000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeBasisSpreadOnVariableRate
      contextRef="i19c179308c4b45ca97aed3c7ba7f064d_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjkzNzY_9d2e4445-edd9-4389-aad8-6cadb84dc8bf"
      unitRef="number">0.0196</us-gaap:DerivativeBasisSpreadOnVariableRate>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i0b43962e0b0141068c1c9e2b72b13361_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjkzODc_5bb350a3-acf8-403d-86dd-c757cab8e4b0"
      unitRef="usd">100000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeBasisSpreadOnVariableRate
      contextRef="iefafe9554bff40dcb084b9218d53528b_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjk0MDY_521a19bf-ea60-46a0-8411-d8cc3ea699a2"
      unitRef="number">0.0205</us-gaap:DerivativeBasisSpreadOnVariableRate>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i193fb1139b6443c59e7e807e0683c634_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMjk0MTc_5e8a1dce-9584-47c8-903a-ce9440f951a5"
      unitRef="usd">400000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i193fb1139b6443c59e7e807e0683c634_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMzAxMzk_5e8a1dce-9584-47c8-903a-ce9440f951a5"
      unitRef="usd">400000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeBasisSpreadOnVariableRate
      contextRef="iefafe9554bff40dcb084b9218d53528b_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMzAxOTI_521a19bf-ea60-46a0-8411-d8cc3ea699a2"
      unitRef="number">0.0205</us-gaap:DerivativeBasisSpreadOnVariableRate>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i0b43962e0b0141068c1c9e2b72b13361_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMzAyMjA_5bb350a3-acf8-403d-86dd-c757cab8e4b0"
      unitRef="usd">100000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeBasisSpreadOnVariableRate
      contextRef="i19c179308c4b45ca97aed3c7ba7f064d_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMzAyNzM_9d2e4445-edd9-4389-aad8-6cadb84dc8bf"
      unitRef="number">0.0196</us-gaap:DerivativeBasisSpreadOnVariableRate>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i193fb1139b6443c59e7e807e0683c634_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMzA0OTI_5e8a1dce-9584-47c8-903a-ce9440f951a5"
      unitRef="usd">400000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i0b43962e0b0141068c1c9e2b72b13361_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMzA1MzU_5bb350a3-acf8-403d-86dd-c757cab8e4b0"
      unitRef="usd">100000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:StockholdersEquity
      contextRef="i23d7f29089b64d22895c3d43381dbb7f_I20200701"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMzA3MDU_2f5500da-683f-4e3f-9219-75ccc9d8d00e"
      unitRef="usd">24400000</us-gaap:StockholdersEquity>
    <rdnt:MonthlyAmortizationOfDeferredHedgeGains
      contextRef="ib04c7e5c38284425adee6a4423c7156c_D20200701-20231031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMzA4MTI_5edc2de0-6ec3-4c1d-8c5e-e8c92568d23b"
      unitRef="usd">400000</rdnt:MonthlyAmortizationOfDeferredHedgeGains>
    <rdnt:MonthlyAmortizationOfDeferredHedgeGains
      contextRef="i9048c2d946984a73a9b463cc83780401_D20231101-20251031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMzA4NTc_a0b67b05-9117-4c7b-9b4f-c20c379dda0b"
      unitRef="usd">300000</rdnt:MonthlyAmortizationOfDeferredHedgeGains>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i477bfe5294834112a6af03501b8e3fa5_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmVkMjE4OGRjNDI0NjQzNzZhNDVhMjE1MTFkNjQyMDBhL3RhYmxlcmFuZ2U6ZWQyMTg4ZGM0MjQ2NDM3NmE0NWEyMTUxMWQ2NDIwMGFfMy0xLTEtMS0yOTQ4OQ_5a96721a-50f3-4cc9-b95c-abb8d1e15419"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i9b432aaed4704e9eaaee35896216be8f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmVkMjE4OGRjNDI0NjQzNzZhNDVhMjE1MTFkNjQyMDBhL3RhYmxlcmFuZ2U6ZWQyMTg4ZGM0MjQ2NDM3NmE0NWEyMTUxMWQ2NDIwMGFfNC0xLTEtMS0yOTQ4OQ_51b79261-7a15-4d85-8d72-086ef0e31143"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="ie48b611c24514f819e0afaa0b9e33107_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmVkMjE4OGRjNDI0NjQzNzZhNDVhMjE1MTFkNjQyMDBhL3RhYmxlcmFuZ2U6ZWQyMTg4ZGM0MjQ2NDM3NmE0NWEyMTUxMWQ2NDIwMGFfNS0xLTEtMS0yOTQ4OQ_91aeb7ab-6196-4b97-a9bd-162862663dd6"
      unitRef="usd">-20160000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i477bfe5294834112a6af03501b8e3fa5_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmY3ZDdlMDY0Y2UzOTQyYWVhZjFkMzRhNTc4MTBmMjA1L3RhYmxlcmFuZ2U6ZjdkN2UwNjRjZTM5NDJhZWFmMWQzNGE1NzgxMGYyMDVfMy0xLTEtMS02MTc5MQ_e656b8dc-7b8b-48a8-b215-b1850bfda30b"
      unitRef="usd">39621000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i07817c4f1db542b1bd7ec426e43a3030_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmY3ZDdlMDY0Y2UzOTQyYWVhZjFkMzRhNTc4MTBmMjA1L3RhYmxlcmFuZ2U6ZjdkN2UwNjRjZTM5NDJhZWFmMWQzNGE1NzgxMGYyMDVfMy0zLTEtMS02MTc5OQ_4a335e79-d5fe-418f-84b4-1ddd124f6b62"
      unitRef="usd">-3687000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i9b432aaed4704e9eaaee35896216be8f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmY3ZDdlMDY0Y2UzOTQyYWVhZjFkMzRhNTc4MTBmMjA1L3RhYmxlcmFuZ2U6ZjdkN2UwNjRjZTM5NDJhZWFmMWQzNGE1NzgxMGYyMDVfMy0xLTEtMS0yOTQ4OQ_991e1445-2a65-40ff-bc93-faa6cb9a97e9"
      unitRef="usd">21670000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i58d81670414d4f9b8cc9fd7500dd2200_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmY3ZDdlMDY0Y2UzOTQyYWVhZjFkMzRhNTc4MTBmMjA1L3RhYmxlcmFuZ2U6ZjdkN2UwNjRjZTM5NDJhZWFmMWQzNGE1NzgxMGYyMDVfMy0zLTEtMS0yOTQ4OQ_7edc9d0f-1985-4a94-9e00-da817356cb4f"
      unitRef="usd">-3695000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="ie48b611c24514f819e0afaa0b9e33107_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmY3ZDdlMDY0Y2UzOTQyYWVhZjFkMzRhNTc4MTBmMjA1L3RhYmxlcmFuZ2U6ZjdkN2UwNjRjZTM5NDJhZWFmMWQzNGE1NzgxMGYyMDVfNC0xLTEtMS0yOTQ4OQ_b71561d6-5183-4f7d-8d68-eff7424070cf"
      unitRef="usd">-2528000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i063f2f5729ee435f8d4852d04201ea0c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmY3ZDdlMDY0Y2UzOTQyYWVhZjFkMzRhNTc4MTBmMjA1L3RhYmxlcmFuZ2U6ZjdkN2UwNjRjZTM5NDJhZWFmMWQzNGE1NzgxMGYyMDVfNC0zLTEtMS0yOTQ4OQ_eed20e28-58f0-46b8-a04a-fc7dced46975"
      unitRef="usd">3448000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="iebda58f2b50646b69966fddb55d1e9eb_I20220120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTcwODE0NQ_b36e653b-2ef0-495b-a5cf-73cbd0335e3e"
      unitRef="usd">10000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <rdnt:BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones
      contextRef="iebda58f2b50646b69966fddb55d1e9eb_I20220120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTcwODE1Mw_20fd4966-e9e7-439e-b31e-138af7a07f5f"
      unitRef="loan">2</rdnt:BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i1355b8403e694c14801d61d67f909c67_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTcwODEzMw_85f9c27a-49d4-4c9e-9027-3c37a26f3ee7"
      unitRef="usd">7200000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <rdnt:BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneOne
      contextRef="iebda58f2b50646b69966fddb55d1e9eb_I20220120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTcwODE1OQ_7aaa291a-fecf-4b7e-99f1-2bad0840d798"
      unitRef="number">0.80</rdnt:BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneOne>
    <rdnt:BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneTwo
      contextRef="iebda58f2b50646b69966fddb55d1e9eb_I20220120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTcwODE2Mw_3ca5320f-e308-48bb-a4c1-42f666be432e"
      unitRef="number">0.70</rdnt:BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneTwo>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i239e3d4ca4304f1ab838f88d83fe9529_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTc0Mzc3Nw_51d8fb7d-673d-4325-bc5d-8e6b178a3671"
      unitRef="usd">4000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <rdnt:BusinessCombinationContingentConsiderationLiabilityPeriod
      contextRef="i0037eb0ed88b4354b067862baa4cefa3_D20220120-20220120"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTY5NTA4NA_f508bef7-6a10-4446-9cdb-28f1f1a80666">P18M</rdnt:BusinessCombinationContingentConsiderationLiabilityPeriod>
    <rdnt:BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares
      contextRef="ic091556638644c818849ee8b176872d4_I20220120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTcwODE2Nw_95c4c485-5bca-48ed-a0ea-3826ca51cbc5"
      unitRef="shares">113303</rdnt:BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares>
    <rdnt:BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution
      contextRef="ic091556638644c818849ee8b176872d4_I20220120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTcwODE3Mw_dc9b5cd7-bb7a-4fe0-85d8-e86552291872"
      unitRef="usd">3000000</rdnt:BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ie27fb48dea7a43e496f5d4e770f84de3_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTc0Mzg4OQ_0965bc0a-3d06-4411-b798-d2a5fcc3f644"
      unitRef="usd">2100000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i11ed45440ab0437dbd546007b43ffbf8_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTc0MzgwMA_1e6d489a-7b6e-44fc-96a5-22f208aa785e"
      unitRef="usd">1600000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="iec85947be77b4e02afe08d88f3901b7e_I20221001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTcyOTg5Mg_b74b3591-d12d-4fa9-9215-cb651179f5e3"
      unitRef="usd">1200000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="i315f9ce8303d42fbb74147d9754e4496_I20221101"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTc0Mzg5Nw_5a25d7cd-423e-48d8-bede-a9532ed233ca"
      unitRef="number">0.75</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="iec83e5acff394eac92ff9ba28bb2e1ec_I20221101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTcyOTA5Mw_c1873b3a-f808-4387-a77f-fadf7bad2143"
      unitRef="usd">10200000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="if870a8803b5347588b2a78fdf3b1dabf_I20221101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTcyOTE1Ng_2739444f-6cbb-4c92-9f8e-b795c3927c6d"
      unitRef="usd">600000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <rdnt:BusinessCombinationContingentConsiderationLiabilityPeriod
      contextRef="i350d6392e4a642769b8a9824e7855129_D20221101-20221101"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTcyOTE3Mw_ce981d75-6722-4b77-bc6c-efa5202bae0a">P24M</rdnt:BusinessCombinationContingentConsiderationLiabilityPeriod>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i72596dac70a143edab1f533e55146f8a_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTc0Mzk2Ng_e9bc7a20-83ac-4768-94e1-6d30d853ad70"
      unitRef="usd">11100000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDk0NzgwMjQxNDU0MQ_2c3b9f96-cfa6-4616-aba6-6ef0ba5c9f47">&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A tabular rollforward of contingent consideration is as follows (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;     &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.964%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.505%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.480%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.505%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.480%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.505%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.480%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.505%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.480%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.505%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.480%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.505%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.480%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.505%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.485%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="42" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the twelve months ended December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Entity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Account&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 1, 2022 Balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Issuance of contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of  income (loss) recognized on contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Currency Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022 Balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aidence&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Long Term Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(362)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Quantib&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued Expenses &amp;amp; Other Long Term Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(903)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Montclair&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued Expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Heart and Lung Limited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued Expenses &amp;amp; Other Long Term Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ia30202f136744654aca43922c68c719e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmQ1MWUyYjY2Y2U0NTQ0MjA5MDY3NzM2ZGY3YzVhMjIzL3RhYmxlcmFuZ2U6ZDUxZTJiNjZjZTQ1NDQyMDkwNjc3MzZkZjdjNWEyMjNfMi0yLTEtMS02NDc3Ng_56c4dedf-cf6a-4d56-a4d0-16a8470d8df7"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <rdnt:BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration
      contextRef="i60714a92713744d0a7ef51e5a96354bd_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmQ1MWUyYjY2Y2U0NTQ0MjA5MDY3NzM2ZGY3YzVhMjIzL3RhYmxlcmFuZ2U6ZDUxZTJiNjZjZTQ1NDQyMDkwNjc3MzZkZjdjNWEyMjNfMi00LTEtMS02NDc4NA_eee9ca6f-4bad-4d8a-aab6-7f22ad843858"
      unitRef="usd">11453000</rdnt:BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i60714a92713744d0a7ef51e5a96354bd_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmQ1MWUyYjY2Y2U0NTQ0MjA5MDY3NzM2ZGY3YzVhMjIzL3RhYmxlcmFuZ2U6ZDUxZTJiNjZjZTQ1NDQyMDkwNjc3MzZkZjdjNWEyMjNfMi02LTEtMS02NDc5Mg_754d9f01-149d-4c10-a597-552e3abc6f7a"
      unitRef="usd">-362000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <rdnt:BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation
      contextRef="i60714a92713744d0a7ef51e5a96354bd_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmQ1MWUyYjY2Y2U0NTQ0MjA5MDY3NzM2ZGY3YzVhMjIzL3RhYmxlcmFuZ2U6ZDUxZTJiNjZjZTQ1NDQyMDkwNjc3MzZkZjdjNWEyMjNfMi03LTEtMS02NDgwMA_72c163eb-0280-458b-bee0-05b5a92ffe6d"
      unitRef="usd">67000</rdnt:BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="if47d16ba9eb44f57b85358ec1634a856_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmQ1MWUyYjY2Y2U0NTQ0MjA5MDY3NzM2ZGY3YzVhMjIzL3RhYmxlcmFuZ2U6ZDUxZTJiNjZjZTQ1NDQyMDkwNjc3MzZkZjdjNWEyMjNfMi04LTEtMS02NDgwOA_664bfc72-ecf8-4761-8af2-2fb9961bf13a"
      unitRef="usd">11158000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ie3798b3922a04943acbf92ec8317c957_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmQ1MWUyYjY2Y2U0NTQ0MjA5MDY3NzM2ZGY3YzVhMjIzL3RhYmxlcmFuZ2U6ZDUxZTJiNjZjZTQ1NDQyMDkwNjc3MzZkZjdjNWEyMjNfMy00LTEtMS03MzA3Mw_61e01552-73c6-4bcd-81f0-70d1b854d7fd"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <rdnt:BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration
      contextRef="i6a2b769e8cef41f6ac4d466fe758123d_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmQ1MWUyYjY2Y2U0NTQ0MjA5MDY3NzM2ZGY3YzVhMjIzL3RhYmxlcmFuZ2U6ZDUxZTJiNjZjZTQ1NDQyMDkwNjc3MzZkZjdjNWEyMjNfMy02LTEtMS03MzA5MQ_2a6535ef-03e3-4d3a-a6cf-f8e0586c17e2"
      unitRef="usd">4581000</rdnt:BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i6a2b769e8cef41f6ac4d466fe758123d_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmQ1MWUyYjY2Y2U0NTQ0MjA5MDY3NzM2ZGY3YzVhMjIzL3RhYmxlcmFuZ2U6ZDUxZTJiNjZjZTQ1NDQyMDkwNjc3MzZkZjdjNWEyMjNfMy04LTEtMS03MzEwMg_6b54bbea-e039-4a3f-a8b6-8e4c80671d48"
      unitRef="usd">-903000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <rdnt:BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation
      contextRef="i6a2b769e8cef41f6ac4d466fe758123d_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmQ1MWUyYjY2Y2U0NTQ0MjA5MDY3NzM2ZGY3YzVhMjIzL3RhYmxlcmFuZ2U6ZDUxZTJiNjZjZTQ1NDQyMDkwNjc3MzZkZjdjNWEyMjNfMy0xMC0xLTEtNzMxMTA_7c1c106b-7079-41c7-9129-363a6ef76b95"
      unitRef="usd">31000</rdnt:BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ic0237b2107cb4cbf8ff50093346bdf89_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmQ1MWUyYjY2Y2U0NTQ0MjA5MDY3NzM2ZGY3YzVhMjIzL3RhYmxlcmFuZ2U6ZDUxZTJiNjZjZTQ1NDQyMDkwNjc3MzZkZjdjNWEyMjNfMy0xMi0xLTEtNzMxMTg_91574904-337e-48ec-afd7-15f11feed085"
      unitRef="usd">3709000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i453f8cd3681340bbadd382f3b137a70c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmQ1MWUyYjY2Y2U0NTQ0MjA5MDY3NzM2ZGY3YzVhMjIzL3RhYmxlcmFuZ2U6ZDUxZTJiNjZjZTQ1NDQyMDkwNjc3MzZkZjdjNWEyMjNfNC00LTEtMS03Mjk3NQ_049f9413-3342-433e-a7b9-c4b251bd68f1"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <rdnt:BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration
      contextRef="i5398be82ea374f1981ccf7e382e72ef3_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmQ1MWUyYjY2Y2U0NTQ0MjA5MDY3NzM2ZGY3YzVhMjIzL3RhYmxlcmFuZ2U6ZDUxZTJiNjZjZTQ1NDQyMDkwNjc3MzZkZjdjNWEyMjNfNC02LTEtMS03Mjk4Mw_c4490def-d9af-4966-a2d5-045c3686642d"
      unitRef="usd">1200000</rdnt:BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i5398be82ea374f1981ccf7e382e72ef3_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmQ1MWUyYjY2Y2U0NTQ0MjA5MDY3NzM2ZGY3YzVhMjIzL3RhYmxlcmFuZ2U6ZDUxZTJiNjZjZTQ1NDQyMDkwNjc3MzZkZjdjNWEyMjNfNC04LTEtMS03Mjk5MQ_44c8184e-2904-4d90-92bb-09f4f4196462"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <rdnt:BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation
      contextRef="i5398be82ea374f1981ccf7e382e72ef3_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmQ1MWUyYjY2Y2U0NTQ0MjA5MDY3NzM2ZGY3YzVhMjIzL3RhYmxlcmFuZ2U6ZDUxZTJiNjZjZTQ1NDQyMDkwNjc3MzZkZjdjNWEyMjNfNC0xMC0xLTEtNzI5OTk_fe5d4816-1680-418c-95b8-402a083c6e29"
      unitRef="usd">0</rdnt:BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i1cf96aa8943147168551f098e2d58c2a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmQ1MWUyYjY2Y2U0NTQ0MjA5MDY3NzM2ZGY3YzVhMjIzL3RhYmxlcmFuZ2U6ZDUxZTJiNjZjZTQ1NDQyMDkwNjc3MzZkZjdjNWEyMjNfNC0xMi0xLTEtNzMwMDc_bd977963-931a-4773-aee0-178872124e3a"
      unitRef="usd">1200000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ibf93bd34e5d546fcbe757031ae9bb387_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmQ1MWUyYjY2Y2U0NTQ0MjA5MDY3NzM2ZGY3YzVhMjIzL3RhYmxlcmFuZ2U6ZDUxZTJiNjZjZTQ1NDQyMDkwNjc3MzZkZjdjNWEyMjNfNS00LTEtMS03MzAxNw_5db10869-f64d-4f7a-9c1d-76b1c28436d2"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <rdnt:BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration
      contextRef="i5e47a0bf0feb4c3b8860d3345451141f_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmQ1MWUyYjY2Y2U0NTQ0MjA5MDY3NzM2ZGY3YzVhMjIzL3RhYmxlcmFuZ2U6ZDUxZTJiNjZjZTQ1NDQyMDkwNjc3MzZkZjdjNWEyMjNfNS02LTEtMS03MzAzMw_e1f5c1e9-4d2c-4667-bb0a-6151a93f00b5"
      unitRef="usd">10814000</rdnt:BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i5e47a0bf0feb4c3b8860d3345451141f_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmQ1MWUyYjY2Y2U0NTQ0MjA5MDY3NzM2ZGY3YzVhMjIzL3RhYmxlcmFuZ2U6ZDUxZTJiNjZjZTQ1NDQyMDkwNjc3MzZkZjdjNWEyMjNfNS04LTEtMS03MzA0MQ_dec566a5-82e3-4259-84ae-a21759292e55"
      unitRef="usd">566000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <rdnt:BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation
      contextRef="i5e47a0bf0feb4c3b8860d3345451141f_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmQ1MWUyYjY2Y2U0NTQ0MjA5MDY3NzM2ZGY3YzVhMjIzL3RhYmxlcmFuZ2U6ZDUxZTJiNjZjZTQ1NDQyMDkwNjc3MzZkZjdjNWEyMjNfNS0xMC0xLTEtNzMwNDk_b77b22b3-0f63-4bda-b1df-4ee8417d4267"
      unitRef="usd">276000</rdnt:BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ie490b42ee8164ea9be2f0eda5934c310_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmQ1MWUyYjY2Y2U0NTQ0MjA5MDY3NzM2ZGY3YzVhMjIzL3RhYmxlcmFuZ2U6ZDUxZTJiNjZjZTQ1NDQyMDkwNjc3MzZkZjdjNWEyMjNfNS0xMi0xLTEtNzMwNTc_d14b8c7a-5876-4bd9-a79f-73c254c25dca"
      unitRef="usd">11656000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDA4Mjg_3ead4853-0613-47be-8b54-e2aed1e272b6">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;FAIR VALUE MEASUREMENTS &#x2013; Assets and liabilities subject to fair value measurements are required to be disclosed within a fair value hierarchy. The fair value hierarchy ranks the quality and reliability of inputs used to determine fair value. Accordingly, assets and liabilities carried at, or permitted to be carried at, fair value are classified within the fair value hierarchy in one of the following categories based on the lowest level input that is significant to a fair value measurement:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;1&#x2014;Fair value is determined by using unadjusted quoted prices that are available in active markets for identical assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;2&#x2014;Fair value is determined by using inputs other than Level&#160;1 quoted prices that are directly or indirectly observable. Inputs can include quoted prices for similar assets and liabilities in active markets or quoted prices for identical assets and liabilities in inactive markets. Related inputs can also include those used in valuation or other pricing models such as interest rates and yield curves that can be corroborated by observable market data.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;3&#x2014;Fair value is determined by using inputs that are unobservable and not corroborated by market data. Use of these inputs involves significant and subjective judgment.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair value of these contracts was determined using Level 2 inputs. More specifically, the fair value was determined by calculating the value of the difference between the fixed interest rate of the interest rate swaps and the counterparty&#x2019;s forward LIBOR curve. The forward LIBOR curve is readily available in the public markets or can be derived from information available in the public markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Contingent Consideration:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes the estimated fair values of contingencies and holdback relating to our Aidence Holding B.V. and Quantib B.V. acquisitions on January 20, 2022, and the Heart and Lung Imaging Limited acquisition on November 1, 2022 that are subject to fair value measurements and the classification of these liabilities on our consolidated balance sheets, as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aidence Holding B.V. milestone consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Quantib B.V. holdback of 113,303 shares of RadNet common stock&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Montclair Radiological Associates&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Heart and Lung Imaging Limited&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair value of these liabilities was determined using Level 3 inputs.  For Aidence Holding B.V., the  milestone contingent liability was adjusted to fair value based on the yield rate of S&amp;amp;P B-rated corporate bonds and the probability of FDA approval.  For the Quantib B.V holdback shares, the fair value was determined by calculating the value of estimated shares issuable as of the reporting date (which was $18.83) translated at the current exchange rate at December 31, 2022, the time period related to the contractual settlement term, and the probability of issuing the shares.  For Montclair Radiological Associates the contingent consideration is determined by obtaining specific EBITDA targets within a defined time frame.  For Heat Lung Imaging Limited the contingent consideration is determined by the achievement of a specific number of physician reads.  As significant inputs for the contingent consideration of Aidence B.V., Quantib B.V., Montclair Radiological Associates and Heart Lung Imaging Limited are not observable and cannot be corroborated by observable market data they are classified as Level 3.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair values of our long-term debt, which is discussed in Note 8, was determined using Level 2 inputs for the Barclays and Truist term loans. Level 2 inputs primarily related to comparable market prices.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We consider the carrying amounts of cash and cash equivalents, receivables, other current assets, current liabilities and other notes payables to approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization or payment. Additionally, we consider the carrying amount of our capital lease obligations to approximate their fair value because the weighted average interest rate used to formulate the carrying amounts approximates current market rates.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:FairValueByBalanceSheetGroupingTextBlock
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDA4Mjk_a9f50e4b-5bcf-407a-b6a7-fd88a5d39c91">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes the estimated fair values of certain of our financial assets that are subject to fair value measurements, and the classification of these assets in our consolidated balance sheets, as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Current Assets and Deposits and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 SWAPS - Interest Rate Contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 SWAPS - Interest Rate Contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes the estimated fair values of contingencies and holdback relating to our Aidence Holding B.V. and Quantib B.V. acquisitions on January 20, 2022, and the Heart and Lung Imaging Limited acquisition on November 1, 2022 that are subject to fair value measurements and the classification of these liabilities on our consolidated balance sheets, as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aidence Holding B.V. milestone consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Quantib B.V. holdback of 113,303 shares of RadNet common stock&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Montclair Radiological Associates&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Heart and Lung Imaging Limited&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes the estimated fair value and carrying amount of our Truist (Term Loan Agreement) and Barclays (First Lien Term Loans) long-term debt as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.713%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Face Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan Agreement and First Lien Term Loans&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;843,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;843,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;864,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.713%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Face Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan Agreement and First Lien Term Loans&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;766,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;766,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;767,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FairValueByBalanceSheetGroupingTextBlock>
    <us-gaap:DerivativeAssets
      contextRef="i804d8cc7449544638b1eefbdb8975b75_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjg2NTU5YTQ4MzBkNTQ5MDU4MjVlYTBiZTRjY2M4M2VmL3RhYmxlcmFuZ2U6ODY1NTlhNDgzMGQ1NDkwNTgyNWVhMGJlNGNjYzgzZWZfMy0xLTEtMS0yOTQ4OQ_a35bfaf7-b1a4-4c00-b39b-1b16d18af25b"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i68ac6da733e34c689df37c278c132480_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjg2NTU5YTQ4MzBkNTQ5MDU4MjVlYTBiZTRjY2M4M2VmL3RhYmxlcmFuZ2U6ODY1NTlhNDgzMGQ1NDkwNTgyNWVhMGJlNGNjYzgzZWZfMy0zLTEtMS0yOTQ4OQ_2f7f0bbf-9a51-4e3e-8a2e-9aa2f02e60d9"
      unitRef="usd">23302000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="iaa27e287074e451696981ce012df35d6_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjg2NTU5YTQ4MzBkNTQ5MDU4MjVlYTBiZTRjY2M4M2VmL3RhYmxlcmFuZ2U6ODY1NTlhNDgzMGQ1NDkwNTgyNWVhMGJlNGNjYzgzZWZfMy01LTEtMS0yOTQ4OQ_8f4492a4-4e9a-4e22-8c6b-92a166c62688"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i39f8a4ef27dd454bb81ce09e12cfb471_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjg2NTU5YTQ4MzBkNTQ5MDU4MjVlYTBiZTRjY2M4M2VmL3RhYmxlcmFuZ2U6ODY1NTlhNDgzMGQ1NDkwNTgyNWVhMGJlNGNjYzgzZWZfMy03LTEtMS0yOTQ4OQ_a684e9f0-3b9f-475d-8858-344a7eab8064"
      unitRef="usd">23302000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeLiabilities
      contextRef="i79c1f314aa17465097ef0df412a24c6c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjJjZDY1YTcwZmYzOTRiNjU4ZDcxMjUyMTljNDgzNDU1L3RhYmxlcmFuZ2U6MmNkNjVhNzBmZjM5NGI2NThkNzEyNTIxOWM0ODM0NTVfMy0xLTEtMS0yOTQ4OQ_ff947cda-5883-4ea0-b207-8ed8b4f31ddb"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i06780380ef034b1a885d689dfb1011eb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjJjZDY1YTcwZmYzOTRiNjU4ZDcxMjUyMTljNDgzNDU1L3RhYmxlcmFuZ2U6MmNkNjVhNzBmZjM5NGI2NThkNzEyNTIxOWM0ODM0NTVfMy0zLTEtMS0yOTQ4OQ_7b902d12-52c6-4576-8444-07b735ba9366"
      unitRef="usd">16319000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i2abc2bb208ac4de69fd3a4d8e27425a2_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjJjZDY1YTcwZmYzOTRiNjU4ZDcxMjUyMTljNDgzNDU1L3RhYmxlcmFuZ2U6MmNkNjVhNzBmZjM5NGI2NThkNzEyNTIxOWM0ODM0NTVfMy01LTEtMS0yOTQ4OQ_505221e1-c466-4b35-a343-8fd8ef263fac"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i0d33c478c74c4c5ebaae8d80880f704a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjJjZDY1YTcwZmYzOTRiNjU4ZDcxMjUyMTljNDgzNDU1L3RhYmxlcmFuZ2U6MmNkNjVhNzBmZjM5NGI2NThkNzEyNTIxOWM0ODM0NTVfMy03LTEtMS0yOTQ4OQ_ec26685a-025b-40b2-ba03-60c0c69fcae9"
      unitRef="usd">16319000</us-gaap:DerivativeLiabilities>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="i00898b4e70c54a4384ea59c45556e995_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmY2YzI5MjZkYjJhNTQ1NWNhNWFmMTM1NTY0ZGY2NDAwL3RhYmxlcmFuZ2U6ZjZjMjkyNmRiMmE1NDU1Y2E1YWYxMzU1NjRkZjY0MDBfMy0xLTEtMS02MTg3NA_c860fc47-0178-4a5c-823b-d66fbbfba525"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="if895037caf4f4ecdb06fe18bfec769a6_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmY2YzI5MjZkYjJhNTQ1NWNhNWFmMTM1NTY0ZGY2NDAwL3RhYmxlcmFuZ2U6ZjZjMjkyNmRiMmE1NDU1Y2E1YWYxMzU1NjRkZjY0MDBfMy0zLTEtMS02MTg3NA_c624660e-90d7-4dfe-bcd8-cbda0472685d"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="i3b7afa03cd544db6979077730ed44669_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmY2YzI5MjZkYjJhNTQ1NWNhNWFmMTM1NTY0ZGY2NDAwL3RhYmxlcmFuZ2U6ZjZjMjkyNmRiMmE1NDU1Y2E1YWYxMzU1NjRkZjY0MDBfMy01LTEtMS02MTg3NA_c9c8531c-c896-4ef8-a26d-19b7aab2958a"
      unitRef="usd">11158000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="i073ba5e6253341968d7e3516327451a9_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmY2YzI5MjZkYjJhNTQ1NWNhNWFmMTM1NTY0ZGY2NDAwL3RhYmxlcmFuZ2U6ZjZjMjkyNmRiMmE1NDU1Y2E1YWYxMzU1NjRkZjY0MDBfMy03LTEtMS02MTg3NA_569e5961-5d6c-4b28-97b2-5642673b4719"
      unitRef="usd">11158000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <rdnt:BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares
      contextRef="ic091556638644c818849ee8b176872d4_I20220120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmY2YzI5MjZkYjJhNTQ1NWNhNWFmMTM1NTY0ZGY2NDAwL3RhYmxlcmFuZ2U6ZjZjMjkyNmRiMmE1NDU1Y2E1YWYxMzU1NjRkZjY0MDBfNC0wLTEtMS02MTg3NC90ZXh0cmVnaW9uOmUzOGNmZTcyN2YxYzQyODM4MzJiMmNhMmE1ZGUyOTkyXzEwOTk1MTE2Mjc4NDA_95c4c485-5bca-48ed-a0ea-3826ca51cbc5"
      unitRef="shares">113303</rdnt:BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="iec52dfb722a4447db7f7c2e52080d41b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmY2YzI5MjZkYjJhNTQ1NWNhNWFmMTM1NTY0ZGY2NDAwL3RhYmxlcmFuZ2U6ZjZjMjkyNmRiMmE1NDU1Y2E1YWYxMzU1NjRkZjY0MDBfNC0xLTEtMS02MTg3NA_fc257a47-be79-4570-a60f-b60219fedfdb"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="if060f0a3047f484587fcaf8727158a53_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmY2YzI5MjZkYjJhNTQ1NWNhNWFmMTM1NTY0ZGY2NDAwL3RhYmxlcmFuZ2U6ZjZjMjkyNmRiMmE1NDU1Y2E1YWYxMzU1NjRkZjY0MDBfNC0zLTEtMS02MTg3NA_13b10e02-a13d-46ff-b9e1-7c7bf5c5582e"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="ie81addc4a43045808d4c9dbf8c419ac8_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmY2YzI5MjZkYjJhNTQ1NWNhNWFmMTM1NTY0ZGY2NDAwL3RhYmxlcmFuZ2U6ZjZjMjkyNmRiMmE1NDU1Y2E1YWYxMzU1NjRkZjY0MDBfNC01LTEtMS02MTg3NA_ce21e361-62bd-4fca-97af-493c9cd3107a"
      unitRef="usd">3709000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="i4f30a42447ea455195dbea5eb27643c7_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmY2YzI5MjZkYjJhNTQ1NWNhNWFmMTM1NTY0ZGY2NDAwL3RhYmxlcmFuZ2U6ZjZjMjkyNmRiMmE1NDU1Y2E1YWYxMzU1NjRkZjY0MDBfNC03LTEtMS02MTg3NA_77142a05-e0ed-411f-9db1-ef98e8093b63"
      unitRef="usd">3709000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="i4a9534b2492f4341a32a7b6c05873d87_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmY2YzI5MjZkYjJhNTQ1NWNhNWFmMTM1NTY0ZGY2NDAwL3RhYmxlcmFuZ2U6ZjZjMjkyNmRiMmE1NDU1Y2E1YWYxMzU1NjRkZjY0MDBfNS0xLTEtMS02OTEwOQ_ab9396cb-1dcd-4117-9a39-03b56d5acc9f"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="i7d69f978a5e545b59d1932ca7f532e37_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmY2YzI5MjZkYjJhNTQ1NWNhNWFmMTM1NTY0ZGY2NDAwL3RhYmxlcmFuZ2U6ZjZjMjkyNmRiMmE1NDU1Y2E1YWYxMzU1NjRkZjY0MDBfNS0zLTEtMS02OTEwOQ_d837f50e-72e0-473c-b256-95e7d9fa8c42"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="i63cacf5ad31b4575a01903e9faa4d633_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmY2YzI5MjZkYjJhNTQ1NWNhNWFmMTM1NTY0ZGY2NDAwL3RhYmxlcmFuZ2U6ZjZjMjkyNmRiMmE1NDU1Y2E1YWYxMzU1NjRkZjY0MDBfNS01LTEtMS02OTEwOQ_44ef94c7-764e-49dc-977a-46a9e40ae468"
      unitRef="usd">1200000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="i262f245ca0594ae0ac2e01228b468096_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmY2YzI5MjZkYjJhNTQ1NWNhNWFmMTM1NTY0ZGY2NDAwL3RhYmxlcmFuZ2U6ZjZjMjkyNmRiMmE1NDU1Y2E1YWYxMzU1NjRkZjY0MDBfNS03LTEtMS02OTEwOQ_ed2eaa45-4f34-4028-8926-52554cff8929"
      unitRef="usd">1200000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="ife7c65edeb504ccfb67de601c6de474e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmY2YzI5MjZkYjJhNTQ1NWNhNWFmMTM1NTY0ZGY2NDAwL3RhYmxlcmFuZ2U6ZjZjMjkyNmRiMmE1NDU1Y2E1YWYxMzU1NjRkZjY0MDBfNS0xLTEtMS02NzE1Ng_bc123414-3c1b-4ef3-8770-06c9e4580cfc"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="i7761dd1ec2754fbd87eac5dbd64b9695_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmY2YzI5MjZkYjJhNTQ1NWNhNWFmMTM1NTY0ZGY2NDAwL3RhYmxlcmFuZ2U6ZjZjMjkyNmRiMmE1NDU1Y2E1YWYxMzU1NjRkZjY0MDBfNS0zLTEtMS02NzE1Ng_f8048dcb-2e6d-4a27-846d-35ad3dbbc5e5"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="i0ce47813748d41d199f7f86a1dfd426b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmY2YzI5MjZkYjJhNTQ1NWNhNWFmMTM1NTY0ZGY2NDAwL3RhYmxlcmFuZ2U6ZjZjMjkyNmRiMmE1NDU1Y2E1YWYxMzU1NjRkZjY0MDBfNS01LTEtMS02NzE1Ng_dc67ee96-fc09-4ccd-a1c3-14d663b6f06e"
      unitRef="usd">11656000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="i4d11c112b7384fe3b9ac73abcd84790d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmY2YzI5MjZkYjJhNTQ1NWNhNWFmMTM1NTY0ZGY2NDAwL3RhYmxlcmFuZ2U6ZjZjMjkyNmRiMmE1NDU1Y2E1YWYxMzU1NjRkZjY0MDBfNS03LTEtMS02NzE1Ng_6c6ec160-a8c0-4c85-be0f-8551f3dcda45"
      unitRef="usd">11656000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:SharePrice
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTcxNTczMQ_583c4c7b-ec08-4252-b8f5-4e817b5aef72"
      unitRef="usdPerShare">18.83</us-gaap:SharePrice>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i68cb6719a36646579aa32aed365bd98e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjE3N2I2MmI2NDYzZDQ4ZTBiODZiYTlkY2Y0ZmE2MTdjL3RhYmxlcmFuZ2U6MTc3YjYyYjY0NjNkNDhlMGI4NmJhOWRjZjRmYTYxN2NfMi0xLTEtMS0yOTQ4OQ_b28a1114-15ab-4617-a7ec-759d1785dabb"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i93f4dc716811412781fdf04a461f52d0_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjE3N2I2MmI2NDYzZDQ4ZTBiODZiYTlkY2Y0ZmE2MTdjL3RhYmxlcmFuZ2U6MTc3YjYyYjY0NjNkNDhlMGI4NmJhOWRjZjRmYTYxN2NfMi0zLTEtMS0yOTQ4OQ_6a092ada-94f8-40a0-acc2-8cdd8d90dab9"
      unitRef="usd">843594000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i6d6f4cc7b7b3447bbb1069e43d3898ab_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjE3N2I2MmI2NDYzZDQ4ZTBiODZiYTlkY2Y0ZmE2MTdjL3RhYmxlcmFuZ2U6MTc3YjYyYjY0NjNkNDhlMGI4NmJhOWRjZjRmYTYxN2NfMi01LTEtMS0yOTQ4OQ_f9e40bfc-6145-4a32-8aa7-8fc4808c3691"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i6183df40beac48aaad7cae1b8fc18cf7_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjE3N2I2MmI2NDYzZDQ4ZTBiODZiYTlkY2Y0ZmE2MTdjL3RhYmxlcmFuZ2U6MTc3YjYyYjY0NjNkNDhlMGI4NmJhOWRjZjRmYTYxN2NfMi03LTEtMS0yOTQ4OQ_1b1a29d0-de57-420d-b813-3f9f80deba73"
      unitRef="usd">843594000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjE3N2I2MmI2NDYzZDQ4ZTBiODZiYTlkY2Y0ZmE2MTdjL3RhYmxlcmFuZ2U6MTc3YjYyYjY0NjNkNDhlMGI4NmJhOWRjZjRmYTYxN2NfMi05LTEtMS0yOTQ4OQ_41ce3148-858f-4fbb-b2ef-c4de92a1983d"
      unitRef="usd">864125000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i872140f492c640d8b8e8a6c1e04bd0d6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmEyYjdiYWE1N2Q0NzQyYmVhZDUzZmM1YTM0ZDUwMmIxL3RhYmxlcmFuZ2U6YTJiN2JhYTU3ZDQ3NDJiZWFkNTNmYzVhMzRkNTAyYjFfMi0xLTEtMS0yOTQ4OQ_e993d2d0-950d-4ec0-9318-1eb0cc21a416"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i133140d2b4cb48a9bbe5445819d6ad6a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmEyYjdiYWE1N2Q0NzQyYmVhZDUzZmM1YTM0ZDUwMmIxL3RhYmxlcmFuZ2U6YTJiN2JhYTU3ZDQ3NDJiZWFkNTNmYzVhMzRkNTAyYjFfMi0zLTEtMS0yOTQ4OQ_3f083a59-0095-4b40-9f18-2e3cefbb866c"
      unitRef="usd">766973000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="icc57a71039044ca88fabf7ced3a359f8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmEyYjdiYWE1N2Q0NzQyYmVhZDUzZmM1YTM0ZDUwMmIxL3RhYmxlcmFuZ2U6YTJiN2JhYTU3ZDQ3NDJiZWFkNTNmYzVhMzRkNTAyYjFfMi01LTEtMS0yOTQ4OQ_d00e7a0a-ba27-4197-95de-5da5d2787581"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="id0f9e4af159e4119a9b961b547b9038e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmEyYjdiYWE1N2Q0NzQyYmVhZDUzZmM1YTM0ZDUwMmIxL3RhYmxlcmFuZ2U6YTJiN2JhYTU3ZDQ3NDJiZWFkNTNmYzVhMzRkNTAyYjFfMi03LTEtMS0yOTQ4OQ_8c5b6270-f457-4010-88d8-d9401ed14ef5"
      unitRef="usd">766973000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmEyYjdiYWE1N2Q0NzQyYmVhZDUzZmM1YTM0ZDUwMmIxL3RhYmxlcmFuZ2U6YTJiN2JhYTU3ZDQ3NDJiZWFkNTNmYzVhMzRkNTAyYjFfMi05LTEtMS0yOTQ4OQ_1c3a061b-d89a-414d-b5d8-326f9c95e18b"
      unitRef="usd">767875000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:LineOfCredit
      contextRef="i4eb1b2eda4f64d6e9ef32ec67df449b3_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMzM0OTE_4e7f01bc-a17f-4f1e-9552-e912c9a522c0"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="i8cfe249b156b4148afe2824bb962e98f_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMzM0OTE_603e8e54-d0c5-4b69-ab97-f60d9ea6482d"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="i9eddaf97c45f47fc9a3e3499d9c2b938_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMzM2MDg_41eb79b5-5e91-427e-b3cc-11957c6bfb6c"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="iedc6b67a64d84652974967909a8eed47_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMzM2MDg_8de8df85-e878-4be1-9bc6-4f27884f4a6f"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDA4NTQ_9d0b2261-540b-48bf-adee-a9ed0c5feaa8">EARNINGS PER SHARE - Earnings per share is based upon the weighted average number of shares of common stock and common stock equivalents outstanding, net of common stock held in treasury, as follows (in thousands except share and per share data):</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDA3NjU_3a72b8f0-c98b-415b-9ffd-a7e2c6cb19cb">Earnings per share is based upon the weighted average number of shares of common stock and common stock equivalents outstanding, net of common stock held in treasury, as follows (in thousands except share and per share data):&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss) attributable to RadNet, Inc. common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,840)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;BASIC NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of common shares outstanding during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,293,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,496,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,891,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic net income (loss) per share attributable to RadNet, Inc. common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DILUTED NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of common shares outstanding during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,293,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,496,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,891,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add nonvested restricted stock subject only to service vesting&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add additional shares issuable upon exercise of stock options, warrants and holdback shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;855,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;664,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of common shares used in calculating diluted net income per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,320,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,421,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,891,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes in fair value associated with contingently issuable shares&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(724)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss) attributable to RadNet, Inc's common stockholders for diluted share calculation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$9,926&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$24,727&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$(14,840)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted net income (loss) per share attributable to RadNet, Inc. common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options and non-vested restricted awards excluded from the computation of diluted per share amounts as their effect would be antidilutive:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested restricted stock subject to service vesting&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;329,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares issuable upon the exercise of stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;554,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmRmMWNhNzE2YTVlZjQxMGJhMDY4ZTdiYTEzOTg0YTVhL3RhYmxlcmFuZ2U6ZGYxY2E3MTZhNWVmNDEwYmEwNjhlN2JhMTM5ODRhNWFfMi0xLTEtMS0yOTQ4OQ_819ed944-8c2c-4ac4-9c0a-29d0e13c5196"
      unitRef="usd">10650000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmRmMWNhNzE2YTVlZjQxMGJhMDY4ZTdiYTEzOTg0YTVhL3RhYmxlcmFuZ2U6ZGYxY2E3MTZhNWVmNDEwYmEwNjhlN2JhMTM5ODRhNWFfMi0zLTEtMS0yOTQ4OQ_875cc96c-4fa5-4d96-9319-0c84f51fcd3f"
      unitRef="usd">24727000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmRmMWNhNzE2YTVlZjQxMGJhMDY4ZTdiYTEzOTg0YTVhL3RhYmxlcmFuZ2U6ZGYxY2E3MTZhNWVmNDEwYmEwNjhlN2JhMTM5ODRhNWFfMi01LTEtMS0yOTQ4OQ_cbd44ee6-cc14-4aa7-97b7-c13dda96fa17"
      unitRef="usd">-14840000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmRmMWNhNzE2YTVlZjQxMGJhMDY4ZTdiYTEzOTg0YTVhL3RhYmxlcmFuZ2U6ZGYxY2E3MTZhNWVmNDEwYmEwNjhlN2JhMTM5ODRhNWFfNS0xLTEtMS0yOTQ4OQ_dd1209ac-281d-4371-8ec8-a642818768ea"
      unitRef="shares">56293336</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmRmMWNhNzE2YTVlZjQxMGJhMDY4ZTdiYTEzOTg0YTVhL3RhYmxlcmFuZ2U6ZGYxY2E3MTZhNWVmNDEwYmEwNjhlN2JhMTM5ODRhNWFfNS0zLTEtMS0yOTQ4OQ_cd1ed13f-6b11-446b-b8cd-23764ea0fbdd"
      unitRef="shares">52496679</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmRmMWNhNzE2YTVlZjQxMGJhMDY4ZTdiYTEzOTg0YTVhL3RhYmxlcmFuZ2U6ZGYxY2E3MTZhNWVmNDEwYmEwNjhlN2JhMTM5ODRhNWFfNS01LTEtMS0yOTQ4OQ_e9651785-11d6-43aa-a9db-53921d0b5a4d"
      unitRef="shares">50891791</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmRmMWNhNzE2YTVlZjQxMGJhMDY4ZTdiYTEzOTg0YTVhL3RhYmxlcmFuZ2U6ZGYxY2E3MTZhNWVmNDEwYmEwNjhlN2JhMTM5ODRhNWFfNi0xLTEtMS0yOTQ4OQ_0735a6d4-58b1-4faf-b12b-97610937369b"
      unitRef="usdPerShare">0.19</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmRmMWNhNzE2YTVlZjQxMGJhMDY4ZTdiYTEzOTg0YTVhL3RhYmxlcmFuZ2U6ZGYxY2E3MTZhNWVmNDEwYmEwNjhlN2JhMTM5ODRhNWFfNi0zLTEtMS0yOTQ4OQ_20edc25f-8438-4587-978f-2204c1a56895"
      unitRef="usdPerShare">0.47</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmRmMWNhNzE2YTVlZjQxMGJhMDY4ZTdiYTEzOTg0YTVhL3RhYmxlcmFuZ2U6ZGYxY2E3MTZhNWVmNDEwYmEwNjhlN2JhMTM5ODRhNWFfNi01LTEtMS0yOTQ4OQ_75fb85f9-9de0-4e83-92e8-f14c94f949e2"
      unitRef="usdPerShare">-0.29</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmRmMWNhNzE2YTVlZjQxMGJhMDY4ZTdiYTEzOTg0YTVhL3RhYmxlcmFuZ2U6ZGYxY2E3MTZhNWVmNDEwYmEwNjhlN2JhMTM5ODRhNWFfOC0xLTEtMS0yOTQ4OQ_b2806af3-dd3d-43b9-98ac-e8f4f4b5f19a"
      unitRef="shares">56293336</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmRmMWNhNzE2YTVlZjQxMGJhMDY4ZTdiYTEzOTg0YTVhL3RhYmxlcmFuZ2U6ZGYxY2E3MTZhNWVmNDEwYmEwNjhlN2JhMTM5ODRhNWFfOC0zLTEtMS0yOTQ4OQ_98d1c0d3-9240-4b69-a851-0c33df1f0513"
      unitRef="shares">52496679</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmRmMWNhNzE2YTVlZjQxMGJhMDY4ZTdiYTEzOTg0YTVhL3RhYmxlcmFuZ2U6ZGYxY2E3MTZhNWVmNDEwYmEwNjhlN2JhMTM5ODRhNWFfOC01LTEtMS0yOTQ4OQ_ef46b989-32ab-4846-ab2d-b4b1226763a1"
      unitRef="shares">50891791</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesRestrictedStock
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmRmMWNhNzE2YTVlZjQxMGJhMDY4ZTdiYTEzOTg0YTVhL3RhYmxlcmFuZ2U6ZGYxY2E3MTZhNWVmNDEwYmEwNjhlN2JhMTM5ODRhNWFfOS0xLTEtMS0yOTQ4OQ_96f9fa4e-c0ae-404b-b1a1-5a9ab8384f0d"
      unitRef="shares">172139</us-gaap:WeightedAverageNumberOfSharesRestrictedStock>
    <us-gaap:WeightedAverageNumberOfSharesRestrictedStock
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmRmMWNhNzE2YTVlZjQxMGJhMDY4ZTdiYTEzOTg0YTVhL3RhYmxlcmFuZ2U6ZGYxY2E3MTZhNWVmNDEwYmEwNjhlN2JhMTM5ODRhNWFfOS0zLTEtMS0yOTQ4OQ_4bd88578-9087-43e9-abe2-b06491ac43c9"
      unitRef="shares">259539</us-gaap:WeightedAverageNumberOfSharesRestrictedStock>
    <us-gaap:WeightedAverageNumberOfSharesRestrictedStock
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmRmMWNhNzE2YTVlZjQxMGJhMDY4ZTdiYTEzOTg0YTVhL3RhYmxlcmFuZ2U6ZGYxY2E3MTZhNWVmNDEwYmEwNjhlN2JhMTM5ODRhNWFfOS01LTEtMS0yOTQ4OQ_80a05cf6-e007-46cb-ad5b-b4d71ccd868b"
      unitRef="shares">0</us-gaap:WeightedAverageNumberOfSharesRestrictedStock>
    <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmRmMWNhNzE2YTVlZjQxMGJhMDY4ZTdiYTEzOTg0YTVhL3RhYmxlcmFuZ2U6ZGYxY2E3MTZhNWVmNDEwYmEwNjhlN2JhMTM5ODRhNWFfMTAtMS0xLTEtMjk0ODk_ec5279bd-b2cc-46de-9785-7e589d5cfe6b"
      unitRef="shares">855395</us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants>
    <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmRmMWNhNzE2YTVlZjQxMGJhMDY4ZTdiYTEzOTg0YTVhL3RhYmxlcmFuZ2U6ZGYxY2E3MTZhNWVmNDEwYmEwNjhlN2JhMTM5ODRhNWFfMTAtMy0xLTEtMjk0ODk_bd239f76-a25b-4b68-8e80-36435be71373"
      unitRef="shares">664815</us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants>
    <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmRmMWNhNzE2YTVlZjQxMGJhMDY4ZTdiYTEzOTg0YTVhL3RhYmxlcmFuZ2U6ZGYxY2E3MTZhNWVmNDEwYmEwNjhlN2JhMTM5ODRhNWFfMTAtNS0xLTEtMjk0ODk_fa308016-f216-4646-bd96-6d3a53fa2a32"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmRmMWNhNzE2YTVlZjQxMGJhMDY4ZTdiYTEzOTg0YTVhL3RhYmxlcmFuZ2U6ZGYxY2E3MTZhNWVmNDEwYmEwNjhlN2JhMTM5ODRhNWFfMTEtMS0xLTEtMjk0ODk_4cca8635-5cce-4068-9957-38655ef7f2ec"
      unitRef="shares">57320870</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmRmMWNhNzE2YTVlZjQxMGJhMDY4ZTdiYTEzOTg0YTVhL3RhYmxlcmFuZ2U6ZGYxY2E3MTZhNWVmNDEwYmEwNjhlN2JhMTM5ODRhNWFfMTEtMy0xLTEtMjk0ODk_6175364b-ec50-4028-ab6e-341fe92b07fb"
      unitRef="shares">53421033</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmRmMWNhNzE2YTVlZjQxMGJhMDY4ZTdiYTEzOTg0YTVhL3RhYmxlcmFuZ2U6ZGYxY2E3MTZhNWVmNDEwYmEwNjhlN2JhMTM5ODRhNWFfMTEtNS0xLTEtMjk0ODk_7852c99b-bfac-40b4-b48c-c94fefcae488"
      unitRef="shares">50891791</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <rdnt:AdjustmentToNetIncomeAttributableToAssumedShareSettlements
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmRmMWNhNzE2YTVlZjQxMGJhMDY4ZTdiYTEzOTg0YTVhL3RhYmxlcmFuZ2U6ZGYxY2E3MTZhNWVmNDEwYmEwNjhlN2JhMTM5ODRhNWFfMTItMS0xLTEtNjUzNDI_d150f1e8-2a06-4dff-b2ac-178603bdd2cc"
      unitRef="usd">-724000</rdnt:AdjustmentToNetIncomeAttributableToAssumedShareSettlements>
    <rdnt:AdjustmentToNetIncomeAttributableToAssumedShareSettlements
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmRmMWNhNzE2YTVlZjQxMGJhMDY4ZTdiYTEzOTg0YTVhL3RhYmxlcmFuZ2U6ZGYxY2E3MTZhNWVmNDEwYmEwNjhlN2JhMTM5ODRhNWFfMTItMy0xLTEtNjUzNzk_8b4189ed-bc75-4854-a432-6253ef5b32ee"
      unitRef="usd">0</rdnt:AdjustmentToNetIncomeAttributableToAssumedShareSettlements>
    <rdnt:AdjustmentToNetIncomeAttributableToAssumedShareSettlements
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmRmMWNhNzE2YTVlZjQxMGJhMDY4ZTdiYTEzOTg0YTVhL3RhYmxlcmFuZ2U6ZGYxY2E3MTZhNWVmNDEwYmEwNjhlN2JhMTM5ODRhNWFfMTItNS0xLTEtNjUzODc_9d90b697-b9ab-4d62-a526-d1039d6123ab"
      unitRef="usd">0</rdnt:AdjustmentToNetIncomeAttributableToAssumedShareSettlements>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmRmMWNhNzE2YTVlZjQxMGJhMDY4ZTdiYTEzOTg0YTVhL3RhYmxlcmFuZ2U6ZGYxY2E3MTZhNWVmNDEwYmEwNjhlN2JhMTM5ODRhNWFfMTMtMS0xLTEtNjUzNTg_d0ce0d82-2814-497b-a1c4-82d40f44f668"
      unitRef="usd">9926000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmRmMWNhNzE2YTVlZjQxMGJhMDY4ZTdiYTEzOTg0YTVhL3RhYmxlcmFuZ2U6ZGYxY2E3MTZhNWVmNDEwYmEwNjhlN2JhMTM5ODRhNWFfMTMtMy0xLTEtNjUzOTk_f1fda5ac-c19e-46d8-b5b4-040f9a9ab8ad"
      unitRef="usd">24727000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmRmMWNhNzE2YTVlZjQxMGJhMDY4ZTdiYTEzOTg0YTVhL3RhYmxlcmFuZ2U6ZGYxY2E3MTZhNWVmNDEwYmEwNjhlN2JhMTM5ODRhNWFfMTMtNS0xLTEtNjU0MDc_2005c0ab-b9af-44d8-ba50-6ae9e777ca85"
      unitRef="usd">-14840000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmRmMWNhNzE2YTVlZjQxMGJhMDY4ZTdiYTEzOTg0YTVhL3RhYmxlcmFuZ2U6ZGYxY2E3MTZhNWVmNDEwYmEwNjhlN2JhMTM5ODRhNWFfMTItMS0xLTEtMjk0ODk_091c0158-981f-4ae1-9bf9-ba280cc902fa"
      unitRef="usdPerShare">0.17</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmRmMWNhNzE2YTVlZjQxMGJhMDY4ZTdiYTEzOTg0YTVhL3RhYmxlcmFuZ2U6ZGYxY2E3MTZhNWVmNDEwYmEwNjhlN2JhMTM5ODRhNWFfMTItMy0xLTEtMjk0ODk_b7c2cb2e-ddf1-4b4e-9446-9b628cd268a1"
      unitRef="usdPerShare">0.46</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmRmMWNhNzE2YTVlZjQxMGJhMDY4ZTdiYTEzOTg0YTVhL3RhYmxlcmFuZ2U6ZGYxY2E3MTZhNWVmNDEwYmEwNjhlN2JhMTM5ODRhNWFfMTItNS0xLTEtMjk0ODk_d09981b2-ade6-48f4-bfcf-92fd30705d87"
      unitRef="usdPerShare">-0.29</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i97956fc643d247dbb60da5865beb89eb_D20220101-20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmRmMWNhNzE2YTVlZjQxMGJhMDY4ZTdiYTEzOTg0YTVhL3RhYmxlcmFuZ2U6ZGYxY2E3MTZhNWVmNDEwYmEwNjhlN2JhMTM5ODRhNWFfMTUtMS0xLTEtMjk0ODk_a36d892c-e576-4869-866e-b84c25d5579b"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i5457051aa2ff41adadb9d14aeb2cf08f_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmRmMWNhNzE2YTVlZjQxMGJhMDY4ZTdiYTEzOTg0YTVhL3RhYmxlcmFuZ2U6ZGYxY2E3MTZhNWVmNDEwYmEwNjhlN2JhMTM5ODRhNWFfMTUtMy0xLTEtMjk0ODk_f349b8f0-6f96-4d9f-bcc5-1f6ae300d713"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i4fb9164d19204098ae94cbd87a23b9c8_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmRmMWNhNzE2YTVlZjQxMGJhMDY4ZTdiYTEzOTg0YTVhL3RhYmxlcmFuZ2U6ZGYxY2E3MTZhNWVmNDEwYmEwNjhlN2JhMTM5ODRhNWFfMTUtNS0xLTEtMjk0ODk_1ce44663-dad9-4008-b318-3ccf304b72d5"
      unitRef="shares">329159</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i6a2f8fa41f874e60b776bf0389800e5e_D20220101-20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmRmMWNhNzE2YTVlZjQxMGJhMDY4ZTdiYTEzOTg0YTVhL3RhYmxlcmFuZ2U6ZGYxY2E3MTZhNWVmNDEwYmEwNjhlN2JhMTM5ODRhNWFfMTYtMS0xLTEtMjk0ODk_ba163edd-f980-48b6-b2a9-9f28a5ab12c4"
      unitRef="shares">152723</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i6a13cd9e9617451c8d173c251b8d9e0e_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmRmMWNhNzE2YTVlZjQxMGJhMDY4ZTdiYTEzOTg0YTVhL3RhYmxlcmFuZ2U6ZGYxY2E3MTZhNWVmNDEwYmEwNjhlN2JhMTM5ODRhNWFfMTYtMy0xLTEtMjk0ODk_97b15154-d7ea-40cc-93d9-c8c44597dace"
      unitRef="shares">47792</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i733c80ddcad5463c9dbb1c25b49f2c67_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmRmMWNhNzE2YTVlZjQxMGJhMDY4ZTdiYTEzOTg0YTVhL3RhYmxlcmFuZ2U6ZGYxY2E3MTZhNWVmNDEwYmEwNjhlN2JhMTM5ODRhNWFfMTYtNS0xLTEtMjk0ODk_55f2c5d7-71eb-422e-bbfc-c23e8965fb04"
      unitRef="shares">554444</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:EquityMethodInvestmentsPolicy
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDA3NzY_5d7dd4ac-a8f3-4463-89d6-68705be0681c">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;INVESTMENTS IN EQUITY SECURITIES- As of December 31, 2022, we have three equity investments for which a fair value is not readily determinable and we do not have significant influence and therefore the total amounts invested are recognized at cost.  In accordance with accounting guidance&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;if there is no readily determinable fair value, the guidance allows entities the ability to measure investments at cost less impairment, whereby impairment is based on a qualitative assessment.&lt;/span&gt;</us-gaap:EquityMethodInvestmentsPolicy>
    <rdnt:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestments
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNjU5NzA2OTg4MzMxOA_5e120e9f-ac3d-4f68-9410-d59636c76b13"
      unitRef="investment">3</rdnt:EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestments>
    <us-gaap:EquityMethodInvestmentAggregateCost
      contextRef="i66d4d733653e4eb4a3ad6c433ebdfb6a_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMzU5Njg_ee2e9302-d3de-4816-98c5-1913cb8463a8"
      unitRef="usd">1200000</us-gaap:EquityMethodInvestmentAggregateCost>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i66d4d733653e4eb4a3ad6c433ebdfb6a_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTY3MTExNA_522a39b0-0c34-4e79-b49b-6e21fbc4bc14"
      unitRef="number">0.1421</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <rdnt:EquityMethodInvestmentSharesPurchased
      contextRef="i47e82ebf9ddc4469a95c70fcc3d63d41_D20180201-20180201"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMzYzNDQ_b6f8a361-ef51-4281-9fff-25d61e75eb99"
      unitRef="shares">2100000</rdnt:EquityMethodInvestmentSharesPurchased>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="i47e82ebf9ddc4469a95c70fcc3d63d41_D20180201-20180201"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMzYzOTQ_67815294-6e25-4829-b0b6-1989e14d62ca"
      unitRef="usd">2000000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:ShortTermBorrowings
      contextRef="i9104bade5d0a4187930fd11fdbf5d05b_I20190101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMzY0NzU_9588e311-da91-42a8-b2e8-9f9a05cef72f"
      unitRef="usd">100000</us-gaap:ShortTermBorrowings>
    <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion
      contextRef="ie8654cdfc8db49acb180ade8667b818b_I20191011"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMzY1MTA_d2af7084-a33f-4ac9-8661-cddd634d4fa7"
      unitRef="shares">80000</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="ic070f0614e2e4747984c1d8809073028_D20191105-20191105"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMzY5MTg_aaee44ee-9bbc-41ae-83d9-d7a7b42ff366"
      unitRef="usd">1000000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToFundLongtermLoansToRelatedParties
      contextRef="ic070f0614e2e4747984c1d8809073028_D20191105-20191105"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMzY5NDk_387a9eee-cb84-4bed-a664-ac684c887831"
      unitRef="usd">2500000</us-gaap:PaymentsToFundLongtermLoansToRelatedParties>
    <us-gaap:InvestmentPolicyTextBlock
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDA4MzU_0e4420dc-0cee-4a2a-9c8f-3c21a611d47a">INVESTMENT IN JOINT VENTURES &#x2013; We have 13 unconsolidated joint ventures with ownership interests ranging from 35% to 55%. These joint ventures represent partnerships with hospitals, health systems or radiology practices and were formed for the purpose of owning and operating diagnostic imaging centers.&#160;&#160;Professional services at the joint venture diagnostic imaging centers are performed by contracted radiology practices or a radiology practice that participates in the joint venture.&#160;&#160;Our investment in these joint ventures is accounted for under the equity method, as we do not have a controlling financial interest in such ventures. We evaluate our investment in joint ventures, including cost in excess of book value (equity method goodwill) for impairment whenever indicators of impairment exist. No indicators of impairment existed as of December 31, 2022.</us-gaap:InvestmentPolicyTextBlock>
    <rdnt:NumberofUnconsolidatedJointVentures
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMzcxMTc_385c7d89-6f82-4fcd-b2c0-ad784edd0c91"
      unitRef="jointventure">13</rdnt:NumberofUnconsolidatedJointVentures>
    <us-gaap:VariableInterestEntityOwnershipPercentage
      contextRef="ia3c6f10cf71d436f8d6f89d025cb5660_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMzcxODg_c49d3534-d01a-4ed6-80ce-194a40df6562"
      unitRef="number">0.35</us-gaap:VariableInterestEntityOwnershipPercentage>
    <us-gaap:VariableInterestEntityOwnershipPercentage
      contextRef="i4b1c789f4aa54283a927ee786764619c_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMzcxOTQ_88e61cfd-466a-45d5-aa9e-9d6ee0b6c0f4"
      unitRef="number">0.55</us-gaap:VariableInterestEntityOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentsTextBlock
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDA4Mzc_30ef043f-2f6d-40a6-bdc5-83ccfa11f2d0">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of our investment in joint ventures during the years ended December 31, 2022 and December 31, 2021 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.090%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity contributions in existing and purchase of interest in joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity in earnings in these joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distribution of earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,707)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity contributions in existing and purchase of interest in joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity in earnings in these joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distribution of earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,438)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EquityMethodInvestmentsTextBlock>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="ifb50bc5a13564f6a97eb669524009c18_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjMxNjUyMjQ5N2EyMzQyMWFhNDMzNTk3ZWRlNjNmNDlmL3RhYmxlcmFuZ2U6MzE2NTIyNDk3YTIzNDIxYWE0MzM1OTdlZGU2M2Y0OWZfMC0xLTEtMS0yOTQ4OQ_da7dbff5-816d-4f8d-ab1a-304fcfc49f82"
      unitRef="usd">34528000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <rdnt:EquityContributionsInExistingAndPurchaseOfInterestInJointVentures
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjMxNjUyMjQ5N2EyMzQyMWFhNDMzNTk3ZWRlNjNmNDlmL3RhYmxlcmFuZ2U6MzE2NTIyNDk3YTIzNDIxYWE0MzM1OTdlZGU2M2Y0OWZfMS0xLTEtMS0yOTQ4OQ_523ee4fb-a989-4ab1-9265-d09d8f420e3f"
      unitRef="usd">1441000</rdnt:EquityContributionsInExistingAndPurchaseOfInterestInJointVentures>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjMxNjUyMjQ5N2EyMzQyMWFhNDMzNTk3ZWRlNjNmNDlmL3RhYmxlcmFuZ2U6MzE2NTIyNDk3YTIzNDIxYWE0MzM1OTdlZGU2M2Y0OWZfMi0xLTEtMS0yOTQ4OQ_71a4a6d3-9d0b-459c-9a85-b077b4de909a"
      unitRef="usd">10967000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentDividendsOrDistributions
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjMxNjUyMjQ5N2EyMzQyMWFhNDMzNTk3ZWRlNjNmNDlmL3RhYmxlcmFuZ2U6MzE2NTIyNDk3YTIzNDIxYWE0MzM1OTdlZGU2M2Y0OWZfNy0xLTEtMS0yOTQ4OQ_ae6d60ea-2190-400c-88f6-32ec30a0c169"
      unitRef="usd">4707000</us-gaap:EquityMethodInvestmentDividendsOrDistributions>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjMxNjUyMjQ5N2EyMzQyMWFhNDMzNTk3ZWRlNjNmNDlmL3RhYmxlcmFuZ2U6MzE2NTIyNDk3YTIzNDIxYWE0MzM1OTdlZGU2M2Y0OWZfOC0xLTEtMS0yOTQ4OQ_3d714637-4ba0-4421-9dd5-c93f038fe43a"
      unitRef="usd">42229000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <rdnt:EquityContributionsInExistingAndPurchaseOfInterestInJointVentures
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjMxNjUyMjQ5N2EyMzQyMWFhNDMzNTk3ZWRlNjNmNDlmL3RhYmxlcmFuZ2U6MzE2NTIyNDk3YTIzNDIxYWE0MzM1OTdlZGU2M2Y0OWZfOS0xLTEtMS0yOTQ4OQ_7491b7b4-8482-4b21-abe5-c90e30fa601d"
      unitRef="usd">9712000</rdnt:EquityContributionsInExistingAndPurchaseOfInterestInJointVentures>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjMxNjUyMjQ5N2EyMzQyMWFhNDMzNTk3ZWRlNjNmNDlmL3RhYmxlcmFuZ2U6MzE2NTIyNDk3YTIzNDIxYWE0MzM1OTdlZGU2M2Y0OWZfMTAtMS0xLTEtMjk0ODk_1f67f20f-12d3-457c-a221-6d6a43e9c895"
      unitRef="usd">10390000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentDividendsOrDistributions
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjMxNjUyMjQ5N2EyMzQyMWFhNDMzNTk3ZWRlNjNmNDlmL3RhYmxlcmFuZ2U6MzE2NTIyNDk3YTIzNDIxYWE0MzM1OTdlZGU2M2Y0OWZfMTEtMS0xLTEtMjk0ODk_49261a40-0d5d-4df3-85f1-41beeeb647a1"
      unitRef="usd">4438000</us-gaap:EquityMethodInvestmentDividendsOrDistributions>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjMxNjUyMjQ5N2EyMzQyMWFhNDMzNTk3ZWRlNjNmNDlmL3RhYmxlcmFuZ2U6MzE2NTIyNDk3YTIzNDIxYWE0MzM1OTdlZGU2M2Y0OWZfMTItMS0xLTEtMjk0ODk_1a11f547-d46c-4ae0-a409-fcb2e3d0ec9c"
      unitRef="usd">57893000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <rdnt:ManagementServiceFees
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDAzNTE_2bf813dc-f1bd-4c91-a964-8eedf49f8322"
      unitRef="usd">22200000</rdnt:ManagementServiceFees>
    <rdnt:ManagementServiceFees
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDAzNTU_d5c8bec9-b7a1-4b44-bb24-531628e15da7"
      unitRef="usd">19600000</rdnt:ManagementServiceFees>
    <rdnt:ManagementServiceFees
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDAzNjI_0c806156-ee75-4d2a-81fb-b4bf57d499ee"
      unitRef="usd">11300000</rdnt:ManagementServiceFees>
    <rdnt:JointVentureInvestmentAndFinancialInformationTableTextBlock
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfNDA3NjA_2bac19c5-78b5-4ab9-97e2-feae08fe2454">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of key unaudited financial data for these joint ventures as of December 31, 2022 and 2021, respectively, and for the years ended December 31, 2022, 2021 and 2020, respectively, (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance Sheet Data:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncurrent assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29,588)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,919)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncurrent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37,952)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,370)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net assets&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Book value of RadNet joint venture interests&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,930&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost in excess of book value of acquired joint venture interests accounted for as equity method goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total value of RadNet joint venture interests&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</rdnt:JointVentureInvestmentAndFinancialInformationTableTextBlock>
    <us-gaap:AssetsCurrent
      contextRef="i6bc50d516cca4bf2ac566ca32f16fa45_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjAxZGVhMjhlNTgyYTRkYzE5YTMyY2ZhZmFmMGIxM2Q3L3RhYmxlcmFuZ2U6MDFkZWEyOGU1ODJhNGRjMTlhMzJjZmFmYWYwYjEzZDdfMi0xLTEtMS0yOTQ4OQ_cc053636-ffa2-4f88-8e23-5db3df8f5fc7"
      unitRef="usd">39304000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i556dfe7e8b354868acf1bd22f0b04c11_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjAxZGVhMjhlNTgyYTRkYzE5YTMyY2ZhZmFmMGIxM2Q3L3RhYmxlcmFuZ2U6MDFkZWEyOGU1ODJhNGRjMTlhMzJjZmFmYWYwYjEzZDdfMi0zLTEtMS0yOTQ4OQ_e2061bb0-30e3-46b1-ab53-9c7b8d9f91d9"
      unitRef="usd">37186000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="i6bc50d516cca4bf2ac566ca32f16fa45_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjAxZGVhMjhlNTgyYTRkYzE5YTMyY2ZhZmFmMGIxM2Q3L3RhYmxlcmFuZ2U6MDFkZWEyOGU1ODJhNGRjMTlhMzJjZmFmYWYwYjEzZDdfMy0xLTEtMS0yOTQ4OQ_982c39a0-5e43-444a-9954-0c9873e91108"
      unitRef="usd">134694000</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="i556dfe7e8b354868acf1bd22f0b04c11_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjAxZGVhMjhlNTgyYTRkYzE5YTMyY2ZhZmFmMGIxM2Q3L3RhYmxlcmFuZ2U6MDFkZWEyOGU1ODJhNGRjMTlhMzJjZmFmYWYwYjEzZDdfMy0zLTEtMS0yOTQ4OQ_037584f9-de8d-462e-9e0a-b892081644af"
      unitRef="usd">73592000</us-gaap:AssetsNoncurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i6bc50d516cca4bf2ac566ca32f16fa45_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjAxZGVhMjhlNTgyYTRkYzE5YTMyY2ZhZmFmMGIxM2Q3L3RhYmxlcmFuZ2U6MDFkZWEyOGU1ODJhNGRjMTlhMzJjZmFmYWYwYjEzZDdfNC0xLTEtMS0yOTQ4OQ_b5f53663-737a-406a-9bae-422373a1b2eb"
      unitRef="usd">29588000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i556dfe7e8b354868acf1bd22f0b04c11_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjAxZGVhMjhlNTgyYTRkYzE5YTMyY2ZhZmFmMGIxM2Q3L3RhYmxlcmFuZ2U6MDFkZWEyOGU1ODJhNGRjMTlhMzJjZmFmYWYwYjEzZDdfNC0zLTEtMS0yOTQ4OQ_4cf7c3cd-4f9f-4dfe-bad8-594876a809bf"
      unitRef="usd">12919000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="i6bc50d516cca4bf2ac566ca32f16fa45_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjAxZGVhMjhlNTgyYTRkYzE5YTMyY2ZhZmFmMGIxM2Q3L3RhYmxlcmFuZ2U6MDFkZWEyOGU1ODJhNGRjMTlhMzJjZmFmYWYwYjEzZDdfNS0xLTEtMS0yOTQ4OQ_6700a293-e9a4-49a4-a3ae-451c6d4136ac"
      unitRef="usd">37952000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="i556dfe7e8b354868acf1bd22f0b04c11_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjAxZGVhMjhlNTgyYTRkYzE5YTMyY2ZhZmFmMGIxM2Q3L3RhYmxlcmFuZ2U6MDFkZWEyOGU1ODJhNGRjMTlhMzJjZmFmYWYwYjEzZDdfNS0zLTEtMS0yOTQ4OQ_ef38c759-c719-449c-adab-f112339d4d1f"
      unitRef="usd">22370000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:EquityMethodInvestmentAggregateCost
      contextRef="i8217add0ca2e4d579d49cd56dd4ce0dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjAxZGVhMjhlNTgyYTRkYzE5YTMyY2ZhZmFmMGIxM2Q3L3RhYmxlcmFuZ2U6MDFkZWEyOGU1ODJhNGRjMTlhMzJjZmFmYWYwYjEzZDdfNi0xLTEtMS0yOTQ4OQ_63b57a51-8805-4084-ab10-8efd7b3edd31"
      unitRef="usd">106458000</us-gaap:EquityMethodInvestmentAggregateCost>
    <us-gaap:EquityMethodInvestmentAggregateCost
      contextRef="i9eecc7ea77b94b6d843c47a92a34de8c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjAxZGVhMjhlNTgyYTRkYzE5YTMyY2ZhZmFmMGIxM2Q3L3RhYmxlcmFuZ2U6MDFkZWEyOGU1ODJhNGRjMTlhMzJjZmFmYWYwYjEzZDdfNi0zLTEtMS0yOTQ4OQ_67d525a9-2a6c-4c15-8255-c13121837041"
      unitRef="usd">75489000</us-gaap:EquityMethodInvestmentAggregateCost>
    <us-gaap:EquityMethodInvestments
      contextRef="i8217add0ca2e4d579d49cd56dd4ce0dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjAxZGVhMjhlNTgyYTRkYzE5YTMyY2ZhZmFmMGIxM2Q3L3RhYmxlcmFuZ2U6MDFkZWEyOGU1ODJhNGRjMTlhMzJjZmFmYWYwYjEzZDdfNy0xLTEtMS0yOTQ4OQ_3d510955-1d7f-44e6-ae26-bb368af855f6"
      unitRef="usd">49564000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i9eecc7ea77b94b6d843c47a92a34de8c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjAxZGVhMjhlNTgyYTRkYzE5YTMyY2ZhZmFmMGIxM2Q3L3RhYmxlcmFuZ2U6MDFkZWEyOGU1ODJhNGRjMTlhMzJjZmFmYWYwYjEzZDdfNy0zLTEtMS0yOTQ4OQ_5409aede-ae92-4669-8588-6800009a8372"
      unitRef="usd">34930000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentUnderlyingEquityInNetAssets
      contextRef="i8217add0ca2e4d579d49cd56dd4ce0dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjAxZGVhMjhlNTgyYTRkYzE5YTMyY2ZhZmFmMGIxM2Q3L3RhYmxlcmFuZ2U6MDFkZWEyOGU1ODJhNGRjMTlhMzJjZmFmYWYwYjEzZDdfOC0xLTEtMS0yOTQ4OQ_9bff0508-edf4-4890-978f-e2d9be68f2a6"
      unitRef="usd">8329000</us-gaap:EquityMethodInvestmentUnderlyingEquityInNetAssets>
    <us-gaap:EquityMethodInvestmentUnderlyingEquityInNetAssets
      contextRef="i9eecc7ea77b94b6d843c47a92a34de8c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjAxZGVhMjhlNTgyYTRkYzE5YTMyY2ZhZmFmMGIxM2Q3L3RhYmxlcmFuZ2U6MDFkZWEyOGU1ODJhNGRjMTlhMzJjZmFmYWYwYjEzZDdfOC0zLTEtMS0yOTQ4OQ_245a7777-43eb-4bbf-be73-c83106814df2"
      unitRef="usd">7299000</us-gaap:EquityMethodInvestmentUnderlyingEquityInNetAssets>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i8217add0ca2e4d579d49cd56dd4ce0dc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjAxZGVhMjhlNTgyYTRkYzE5YTMyY2ZhZmFmMGIxM2Q3L3RhYmxlcmFuZ2U6MDFkZWEyOGU1ODJhNGRjMTlhMzJjZmFmYWYwYjEzZDdfOS0xLTEtMS0yOTQ4OQ_27cbc02d-f901-42d2-b037-965aa1f6e2d4"
      unitRef="usd">57893000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i9eecc7ea77b94b6d843c47a92a34de8c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOjAxZGVhMjhlNTgyYTRkYzE5YTMyY2ZhZmFmMGIxM2Q3L3RhYmxlcmFuZ2U6MDFkZWEyOGU1ODJhNGRjMTlhMzJjZmFmYWYwYjEzZDdfOS0zLTEtMS0yOTQ4OQ_79796d67-f3e8-4158-b4a4-10aa7d3c52c9"
      unitRef="usd">42229000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:Revenues
      contextRef="ida002f69ec1f41d5b17282e7b20fc172_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmIxM2VjMDExMTg0NDQ5ZDk4Yjg4NWVkNWZkYzdiNDI0L3RhYmxlcmFuZ2U6YjEzZWMwMTExODQ0NDlkOThiODg1ZWQ1ZmRjN2I0MjRfMS0xLTEtMS0yOTQ4OQ_78067dde-a626-43ed-819a-08940dce3c1d"
      unitRef="usd">145256000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0acf107e72724cc497da946604ddb76c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmIxM2VjMDExMTg0NDQ5ZDk4Yjg4NWVkNWZkYzdiNDI0L3RhYmxlcmFuZ2U6YjEzZWMwMTExODQ0NDlkOThiODg1ZWQ1ZmRjN2I0MjRfMS0zLTEtMS0yOTQ4OQ_111a9a20-5e3a-4783-abae-701f76e3e0b6"
      unitRef="usd">129023000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1616cf57656c47db88833796ec62d482_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmIxM2VjMDExMTg0NDQ5ZDk4Yjg4NWVkNWZkYzdiNDI0L3RhYmxlcmFuZ2U6YjEzZWMwMTExODQ0NDlkOThiODg1ZWQ1ZmRjN2I0MjRfMS01LTEtMS0yOTQ4OQ_55a3afc4-8ffd-4ff8-87f3-19c5f582ab21"
      unitRef="usd">101921000</us-gaap:Revenues>
    <us-gaap:ProfitLoss
      contextRef="ida002f69ec1f41d5b17282e7b20fc172_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmIxM2VjMDExMTg0NDQ5ZDk4Yjg4NWVkNWZkYzdiNDI0L3RhYmxlcmFuZ2U6YjEzZWMwMTExODQ0NDlkOThiODg1ZWQ1ZmRjN2I0MjRfMi0xLTEtMS0yOTQ4OQ_1a6fe5bc-b001-4b1e-a99c-6f5b87a25ed3"
      unitRef="usd">21169000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i0acf107e72724cc497da946604ddb76c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmIxM2VjMDExMTg0NDQ5ZDk4Yjg4NWVkNWZkYzdiNDI0L3RhYmxlcmFuZ2U6YjEzZWMwMTExODQ0NDlkOThiODg1ZWQ1ZmRjN2I0MjRfMi0zLTEtMS0yOTQ4OQ_1465571c-aa3d-4421-a757-a4184fe88026"
      unitRef="usd">21893000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i1616cf57656c47db88833796ec62d482_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RhYmxlOmIxM2VjMDExMTg0NDQ5ZDk4Yjg4NWVkNWZkYzdiNDI0L3RhYmxlcmFuZ2U6YjEzZWMwMTExODQ0NDlkOThiODg1ZWQ1ZmRjN2I0MjRfMi01LTEtMS0yOTQ4OQ_1e9acaab-4dfb-4be1-9702-6415d612af6e"
      unitRef="usd">16850000</us-gaap:ProfitLoss>
    <rdnt:EquityMethodInvestmentAdditionalContribution
      contextRef="i825f9b68a0534968996704634645bbdc_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTczODkwNA_8f6d343b-deea-4085-af95-b9b03a303a16"
      unitRef="usd">1400000</rdnt:EquityMethodInvestmentAdditionalContribution>
    <rdnt:EquityMethodInvestmentAdditionalContribution
      contextRef="i825f9b68a0534968996704634645bbdc_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTczODkwNA_c03a82bd-3b4f-4ce3-9544-ddda71746d3e"
      unitRef="usd">1400000</rdnt:EquityMethodInvestmentAdditionalContribution>
    <rdnt:NumberOfAssetsSold
      contextRef="i0852a96e84d740afa49bfe5d275671e7_I20221101"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTc0Mzc2OA_136fab7a-7cb8-4bc3-ae4a-a49f9979ca22"
      unitRef="center">8</rdnt:NumberOfAssetsSold>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="i651e6cbf14d5467d82c4f381868cde06_D20221101-20221101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTczOTA4Ng_1aaa1bed-a09c-479a-adff-2444909b8b6a"
      unitRef="usd">12700000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity
      contextRef="i0852a96e84d740afa49bfe5d275671e7_I20221101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTc0MDU1MA_2bafd1bd-7f32-4fa5-8d47-7f57982c89a4"
      unitRef="usd">-500000</us-gaap:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity>
    <us-gaap:ProceedsFromDividendsReceived
      contextRef="i651e6cbf14d5467d82c4f381868cde06_D20221101-20221101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTc0MDc5Ng_210420d2-02bc-4b3e-bf5b-3b4033be213e"
      unitRef="usd">4500000</us-gaap:ProceedsFromDividendsReceived>
    <us-gaap:EquityMethodInvestments
      contextRef="i0852a96e84d740afa49bfe5d275671e7_I20221101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTc0MDg3NA_d0a8208e-eab0-4f56-bb65-7f44052b50f2"
      unitRef="usd">8300000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i0852a96e84d740afa49bfe5d275671e7_I20221101"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTczOTI1NA_e40eb071-db23-41c7-ac58-05a3363aa096"
      unitRef="number">0.49</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:ProceedsFromDividendsReceived
      contextRef="i651e6cbf14d5467d82c4f381868cde06_D20221101-20221101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTc0Mzc2MA_ea4d77dd-0196-41b8-8532-93dfea72e033"
      unitRef="usd">4500000</us-gaap:ProceedsFromDividendsReceived>
    <us-gaap:EquityMethodInvestments
      contextRef="i0852a96e84d740afa49bfe5d275671e7_I20221101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83Ni9mcmFnOmY3MmZkYWFlYWRlNzRkZjFiNjUzMGZkNWZhNDA1NTQ1L3RleHRyZWdpb246ZjcyZmRhYWVhZGU3NGRmMWI2NTMwZmQ1ZmE0MDU1NDVfMTA5OTUxMTczOTM3Mg_d0a8208e-eab0-4f56-bb65-7f44052b50f2"
      unitRef="usd">8300000</us-gaap:EquityMethodInvestments>
    <us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83OS9mcmFnOjZjZTNiOGNjYjhmMTQ4Mjg4NWRlNTk1NzdlYTFlOTQ1L3RleHRyZWdpb246NmNlM2I4Y2NiOGYxNDgyODg1ZGU1OTU3N2VhMWU5NDVfNDAzNA_236ad15b-7c46-4030-80f2-1415514a8bd1">RECENT ACCOUNTING STANDARDS&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounting standards adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Over the course of 2020 through 2022, the FASB issued different Accounting Standards Updates (ASUs) in regards to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform (Topic 848).  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ASU 2020-04 and ASU 2021-01 addressed optional expedients and exceptions for applying generally accepted accounting principals to certain contract modifications, hedging relationships, and derivatives that referenced London Inter-bank Offered Rate (LIBOR) or another reference rate expected to be discontinued.  The provisions originally were set to expire on December 31, 2022.  The date of LIBOR cessation was finalized as June 30, 2023, which is beyond the current sunset date of Topic 848 and hence the need to extend the time allotted for accounting relief. ASU 2022-06 deferred the sunset date of the provision out to December 31, 2024. The adoption of the provisions under these ASUs did not have a material effect on our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2021, the FASB issued ASU 2021-10 ("ASU 2021-10"), &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Government Assistance (Topic 832), Disclosures by Business Entities about Government Assistance.  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ASU 2021-10 requires entities to provide disclosures on material government assistance transactions for annual reporting periods. The disclosures include information around the nature of the assistance, the related accounting policies used to account for government assistance, the effect of government assistance on the entity&#x2019;s financial statements, and any significant terms and conditions of the agreements, including commitments and contingencies. The new standard was effective for financial statements issued for annual reporting periods beginning after December 15, 2021. As ASU 2021-10 only impacts annual financial statement footnote disclosures, the adoption did not have a material effect on our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2021, the FASB issued ASU 2021-08 ("ASU 2021-08"), &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations (Topic 805), Accounting for Contract Assets and Contract Liabilities from Contracts with Customers.  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ASU 2021-08 requires an acquirer in a business combination to recognize and measure contract assets and contract liabilities in accordance with Accounting Standards &lt;/span&gt;&lt;/div&gt;Codification Topic 606. ASU 2021-08 is effective for fiscal years beginning after December 15, 2022 and early adoption is permitted. The adoption did not have a material effect on our consolidated financial statements.</us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV83OS9mcmFnOjZjZTNiOGNjYjhmMTQ4Mjg4NWRlNTk1NzdlYTFlOTQ1L3RleHRyZWdpb246NmNlM2I4Y2NiOGYxNDgyODg1ZGU1OTU3N2VhMWU5NDVfNDAzNA_60742bc4-4128-4030-8a32-9ae25a6118ec">RECENT ACCOUNTING STANDARDS&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounting standards adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Over the course of 2020 through 2022, the FASB issued different Accounting Standards Updates (ASUs) in regards to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform (Topic 848).  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ASU 2020-04 and ASU 2021-01 addressed optional expedients and exceptions for applying generally accepted accounting principals to certain contract modifications, hedging relationships, and derivatives that referenced London Inter-bank Offered Rate (LIBOR) or another reference rate expected to be discontinued.  The provisions originally were set to expire on December 31, 2022.  The date of LIBOR cessation was finalized as June 30, 2023, which is beyond the current sunset date of Topic 848 and hence the need to extend the time allotted for accounting relief. ASU 2022-06 deferred the sunset date of the provision out to December 31, 2024. The adoption of the provisions under these ASUs did not have a material effect on our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2021, the FASB issued ASU 2021-10 ("ASU 2021-10"), &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Government Assistance (Topic 832), Disclosures by Business Entities about Government Assistance.  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ASU 2021-10 requires entities to provide disclosures on material government assistance transactions for annual reporting periods. The disclosures include information around the nature of the assistance, the related accounting policies used to account for government assistance, the effect of government assistance on the entity&#x2019;s financial statements, and any significant terms and conditions of the agreements, including commitments and contingencies. The new standard was effective for financial statements issued for annual reporting periods beginning after December 15, 2021. As ASU 2021-10 only impacts annual financial statement footnote disclosures, the adoption did not have a material effect on our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2021, the FASB issued ASU 2021-08 ("ASU 2021-08"), &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations (Topic 805), Accounting for Contract Assets and Contract Liabilities from Contracts with Customers.  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ASU 2021-08 requires an acquirer in a business combination to recognize and measure contract assets and contract liabilities in accordance with Accounting Standards &lt;/span&gt;&lt;/div&gt;Codification Topic 606. ASU 2021-08 is effective for fiscal years beginning after December 15, 2022 and early adoption is permitted. The adoption did not have a material effect on our consolidated financial statements.</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfNDk2OA_4553d01e-d7b6-4174-b2cc-16564d8d5d38">BUSINESS COMBINATIONS AND RELATED ACTIVITY&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Acquisitions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Imaging Center Segment&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2022 and 2021, we completed the acquisition of certain assets of the following entities, which either engage directly in the practice of radiology or associated businesses.  The primary reason for these acquisitions was to strengthen our presence in the Delaware, Maryland, New Jersey and New York markets.  We made a fair value determination of the acquired assets and assumed liabilities and the following were recorded (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;2022:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.734%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.824%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.133%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.922%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.975%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.170%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.934%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Entity &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Date Acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Purchase  Consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Property &amp;amp; Equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Right of Use Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intangible Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Right of Use Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IFRC LLC*^&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1/1/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,200&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,910&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,703&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,271&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,703)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IFRC LLC*^&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1/1/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,800&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,103&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;857&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,697&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(857)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Montclair Radiological Associates, P.A.*#&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10/1/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,877&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,414&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,665&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,690&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,168)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,124)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Heart and Lung Imaging Limited+&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11/1/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,200&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,800&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Chelsea Diagnostic Radiology, P.C.*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12/1/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,800&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;568&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,132&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;North Jersey Imaging Center, LLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12/9/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$142,781&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$22,015&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$7,225&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$106,045&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$16,325&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$(2,145)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$(6,684)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*Fair Value Determination is Final&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;^ IFRC LLC acquisitions consisted of three subsidiaries of IFRC, one of which was purchased separately by a joint venture with Calvert Medical Imaging Centers, LLC.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;#&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Montclair Radiological Associates includes a liability for $1.2 million in contingent consideration.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;+See detailed description of the Heart and Lung Imaging Limited acquisition below. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Entity &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Date Acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Purchase  Consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Property &amp;amp; Equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Right of Use Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intangible Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Right of Use Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Personal Health Imaging PLLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2/1/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,995&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;576&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;608&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,355&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(608)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ZP Elmont LLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2/1/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,194&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,112&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,005&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ZP Freeport LLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2/1/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,065&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,668&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,328&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Broadway Medical Imaging LLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2/1/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,155&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,076&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;446&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(446)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3235 Hempstead LLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2/1/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,386&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,667&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,649&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SLZM Realty LLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2/1/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,671&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,617&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,974&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2012 Sunrise Merrick LLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2/1/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,428&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,741&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;335&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,617&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(335)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ZP Bayside LLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3/1/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,545&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,385&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,191&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,191)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ZP Laurelton LLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3/1/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,658&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,530&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,418&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,418)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ZP Smith LLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3/1/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,978&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,581&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,214&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;347&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,214)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ZP 907 Northern LLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4/1/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;562&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;507&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,817&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,817)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;William M. Kelly MD, Inc.* ^&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5/1/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,750&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;990&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,379&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,710&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,379)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60th Street MRI, LLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5/1/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;290&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ZP Parkchester LLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5/1/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;263&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;311&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(311)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ZP Eastern LLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6/1/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,868&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,801&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,951&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,951)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tangent Associates LLC**&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8/24/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;379&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,636&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mid Delaware Imaging P.A.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12/1/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;590&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,260&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;William M. Kelly MD, Inc.* ^&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12/6/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,404&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;701&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,653&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;William M. Kelly MD, Inc.* ^&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12/31/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,346&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;323&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,197&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(323)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$79,716&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$35,949&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$12,993&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$40,864&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$2,671&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$232&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$(12,993)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*Fair Value Determination is Final&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;** All stock purchase through issuing 67,658 shares of our common stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;^ William M. Kelly MD acquisitions consisted of various subsidiaries purchased separately.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Heart and Lung Imaging Limited&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On November 1, 2022, we acquired a 75% controlling interest in Heart and Lung Imaging Limited (&#x201c;HLI&#x201d;).  HLI is a teleradiology concern which operates in the United Kingdom with the National Healthcare Service to screen high risk populations for cardiac and lung conditions.  HLI&#x2019;s operations are included in our imaging center segment for reporting purposes. The transaction was accounted for as the acquisition of a business with a total purchase consideration of approximately $31.9 million, including: i) shares with a fair value of $6.8 million (359,002 shares issued at $19.06 per share), ii) cash of $6.3 million and iii) contingent consideration of $10.8 million ($10.2 million in contingent milestone consideration and cash holdback of $0.6 million to be issued 24 months after acquisition subject to adjustment for any indemnification claims) and iv) noncontrolling interest of $8.0 million. We recorded $0.6 million in current assets, $15.8 million in intangible assets, $0.6 million current liabilities and $16.2 million in goodwill in connection with this transaction.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;As part of the purchase price allocation, we determined the identifiable intangible assets are customer relationships and trade names. The fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using a rate of 19.0%. The cash flows were based on estimated earnings from existing customers, and the discount rate applied was benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Artificial Intelligence Segment&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Aidence Holding B.V.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On January 20, 2022, we completed our acquisition of all the equity interests of Aidence Holding B.V. ("Aidence") an artificial intelligence enterprise focused on lung cancer screening.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Aidence is reported as part of our artificial intelligence segment and was acquired to enhance our AI capabilities.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The transaction was accounted for as an acquisition of a business and total purchase consideration was determined to be approximately $45.2&#160;million including i) 1,117,872 shares issued at $26.80 per share with a fair value of $30.0&#160;million ii) cash of $1.8&#160;million and iii) contingent consideration of $11.9&#160;million ($7.4&#160;million in milestones to be settled in shares or cash at our election and a share holdback of $4.5&#160;million) and iv) a settlement of a loan from RadNet of $1.5&#160;million.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In addition we paid certain seller closing costs through the issuance of 23,362 shares at a fair value of $0.6&#160;million.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;As a result of this transaction, we recorded $1.0&#160;million in current assets, $0.2&#160;million in property and equipment, $27.7&#160;million in intangible assets (including developed technology of $21.1&#160;million and IPR&amp;amp;D of $5.5&#160;million), $3.2&#160;million in current liabilities, a deferred tax liability of $3.5&#160;million, and $22.9&#160;million in goodwill.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In performing the purchase price allocation, we considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of the Aidence business.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;As part of the purchase price allocation, we determined the identifiable intangible assets are developed technology, IPR&amp;amp;D, trade names, and customer relationships. The fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using rates ranging from 15% to 17%. The cash flows were based on estimates used to price the transaction, and the discount rates applied were benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The developed technology consists of artificial intelligence powered applications for lung nodule management and early lung cancer diagnosis and reporting.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The IPR&amp;amp;D asset relates primarily to an in-process project for a customer relationship management offering to manage patients that are found with Incidental Pulmonary Nodules and has not reached technological feasibility as of the acquisition date. The asset recorded relates to one project, and the Company expects to complete the project in the next twelve months. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The useful lives for the developed technology asset was set at 7 years, for customer relationships 5.4 years, and trade names was 7 years. The calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. Factors contributing to the recognition of the amount of goodwill were primarily based on anticipated strategic and synergistic benefits that are expected to be realized from the acquisition. These benefits include expanding the Company's AI capabilities to drive revenue growth.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Quantib B.V.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 20, 2022, we completed our acquisition of all the equity interests of Quantib B.V. ("Quantib") an artificial intelligence enterprise focused on prostate cancer screening.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Quantib is reported as part of our artificial intelligence segment, and was acquired to enhance our AI capabilities.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The transaction was accounted for as an acquisition of a business and total purchase consideration was determined to be approximately $42.3&#160;million including i) 965,058 shares issued at $26.80 per share with a fair value of $25.9&#160;million ii) cash of $11.8&#160;million and iii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;contingent consideration consisting of 113,303 shares with a fair value at the date of close of $3.0&#160;million and cash of $1.6&#160;million both to be released 18 months after acquisition subject to adjustment for any indemnification claims. As a result of this transaction, we recorded $2.4&#160;million in current assets, $0.1&#160;million in property and equipment, $21.3&#160;million in intangible assets (including developed technology of $19.6&#160;million and IPR&amp;amp;D of $0.7&#160;million), $0.7&#160;million in current liabilities, $6.7&#160;million in long-term debt and deferred tax liabilities, and $26.4&#160;million in goodwill.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In performing the purchase price allocation, we considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of the Quantib business.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;As part of the purchase price allocation, we determined the identifiable intangible assets are developed technology, IPR&amp;amp;D, trade names, and customer relationships. The fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using rates ranging from 50% to 55%. The cash flows were based on &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;estimates used to price the transaction, and the discount rates applied were benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The developed technology consists of artificial intelligence powered applications for neurological and prostate imaging scans and reporting.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The useful lives for the developed technology asset was set at seven years, customer relationships three years, and trade names seven years. The calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. Factors contributing to the recognition of the amount of goodwill were primarily based on anticipated strategic and synergistic benefits that are expected to be realized from the acquisition. These benefits include expanding the Company's AI capabilities to drive revenue growth.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;As disclosed above, for the acquisitions of Aidence and Quantib, the Company uses the income approach to determine the fair value of developed technology and IPR&amp;amp;D acquired in business combinations. This approach determines fair value by estimating the after-tax cash flows attributable to the respective assets over their useful lives and then discounting these after-tax cash flows back to a present value. The Company bases its revenue assumptions on estimates of relevant market sizes, expected market growth rates, expected trends in technology and expected product introductions by competitors. The value of the in-process projects is based on the project's stage of completion, the complexity of the work completed as of the acquisition date, the projected costs to complete, the expected introduction date, the estimated cash flows to be generated upon commercial release and the estimated useful life of the technology. The Company believes that the estimated developed technology and IPR&amp;amp;D amounts represent the fair value at the date of acquisition and do not exceed the amount a third-party would pay for the assets. The significant assumptions used to estimate the fair value of intangible assets include discount rates and certain assumptions that form the basis of the forecasted results, specifically, revenue growth rates, EBITDA margins and obsolescence factors. These significant assumptions are forward looking and could be affected by future economic and market conditions.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Subsidiary activity&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Formation of majority owned subsidiaries&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Frederick County Radiology, LLC&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 1, 2022 we formed Frederick County Radiology, LLC ("FCR"), a partnership with Frederick Health Hospital, Inc. ("Hospital").  The operation offers multi-modality services out of six locations in Frederick, Maryland.  We contributed the operations of four centers to the enterprise and Hospital contributed $5.4 million in fixed assets, $3.0 million in equipment, and  $11.0 million in goodwill.  As a result of the transaction, we recognized a gain of $6.6 million to additional paid in capital and retained a 65% controlling economic interest in FCR and Hospital retains an $11.1 million or 35% noncontrolling economic interest in FCR.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Advanced Radiology at Capital Region, LLC&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 15, 2022 we entered into Advanced Radiology at Capital Region, LLC, a partnership with Dimension Health Corporation. ("Dimension"), an affiliate of the University of Maryland.  The operation will provide multi-modality services out of two yet to be determined locations in the Largo, Maryland area.  The venture was initially capitalized with nominal amounts of $5.1&#160;thousand for a 51% economic interest  from us and $4.9&#160;thousand from Dimension for a 49% economic interest.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Simi Valley Imaging Group, LLC&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 1, 2021 we entered into the Simi Valley Imaging Group, LLC, a partnership with Simi Valley Hospital and Health Services ("Simi Adventist").  The operation will offer multi-modality imaging services out of two locations in Ventura County, California.  Total investment in the venture is $0.4 million. RadNet contributed $0.3 million in assets for a 60.0% economic interest and Simi Adventist contributed assets totaling $0.1 million for a 40.0% economic interest.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Sale of ownership interest  in a majority owned subsidiary&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Effective September 1, 2021 we completed the sale of a 24.9% ownership interest in our majority owned subsidiary West Valley Imaging Group, LLC for $13.1 million to Tarzana Medical Center, LLC.  After the sale, our ownership interest in the subsidiary has reduced from 75.0% to 50.1% and we retain a controlling financial interest in the subsidiary.  We recognized in additional paid in capital on our consolidated balance sheets, $4.2 million excess in consideration over the carrying value of the sold economic interest.  Post the sale of our ownership interest we acquired from Tarzana Medical Center, LLC, certain tangible and intangible business assets for purchase consideration of approximately $5.2 million.&lt;/span&gt;&lt;/div&gt;</us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfNDk3MA_ccd3db48-4e04-416e-a2b2-970f568a1869">We made a fair value determination of the acquired assets and assumed liabilities and the following were recorded (in thousands):&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;2022:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.734%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.824%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.133%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.922%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.975%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.170%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.934%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Entity &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Date Acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Purchase  Consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Property &amp;amp; Equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Right of Use Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intangible Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Right of Use Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IFRC LLC*^&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1/1/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,200&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,910&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,703&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,271&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,703)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IFRC LLC*^&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1/1/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,800&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,103&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;857&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,697&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(857)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Montclair Radiological Associates, P.A.*#&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10/1/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,877&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,414&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,665&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,690&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,168)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,124)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Heart and Lung Imaging Limited+&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11/1/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,200&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,800&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Chelsea Diagnostic Radiology, P.C.*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12/1/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,800&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;568&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,132&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;North Jersey Imaging Center, LLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12/9/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$142,781&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$22,015&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$7,225&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$106,045&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$16,325&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$(2,145)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$(6,684)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*Fair Value Determination is Final&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;^ IFRC LLC acquisitions consisted of three subsidiaries of IFRC, one of which was purchased separately by a joint venture with Calvert Medical Imaging Centers, LLC.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;#&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Montclair Radiological Associates includes a liability for $1.2 million in contingent consideration.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;+See detailed description of the Heart and Lung Imaging Limited acquisition below. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Entity &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Date Acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Purchase  Consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Property &amp;amp; Equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Right of Use Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intangible Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Right of Use Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Personal Health Imaging PLLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2/1/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,995&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;576&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;608&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,355&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(608)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ZP Elmont LLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2/1/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,194&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,112&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,005&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ZP Freeport LLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2/1/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,065&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,668&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,328&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Broadway Medical Imaging LLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2/1/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,155&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,076&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;446&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(446)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3235 Hempstead LLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2/1/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,386&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,667&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,649&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SLZM Realty LLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2/1/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,671&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,617&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,974&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2012 Sunrise Merrick LLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2/1/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,428&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,741&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;335&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,617&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(335)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ZP Bayside LLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3/1/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,545&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,385&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,191&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,191)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ZP Laurelton LLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3/1/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,658&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,530&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,418&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,418)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ZP Smith LLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3/1/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,978&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,581&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,214&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;347&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,214)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ZP 907 Northern LLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4/1/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;562&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;507&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,817&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,817)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;William M. Kelly MD, Inc.* ^&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5/1/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,750&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;990&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,379&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,710&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,379)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60th Street MRI, LLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5/1/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;290&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ZP Parkchester LLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5/1/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;263&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;311&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(311)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ZP Eastern LLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6/1/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,868&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,801&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,951&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,951)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tangent Associates LLC**&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8/24/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;379&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,636&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mid Delaware Imaging P.A.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12/1/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;590&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,260&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;William M. Kelly MD, Inc.* ^&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12/6/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,404&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;701&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,653&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;William M. Kelly MD, Inc.* ^&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12/31/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,346&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;323&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,197&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(323)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$79,716&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$35,949&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$12,993&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$40,864&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$2,671&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$232&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$(12,993)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*Fair Value Determination is Final&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;** All stock purchase through issuing 67,658 shares of our common stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;^ William M. Kelly MD acquisitions consisted of various subsidiaries purchased separately.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i04323c12bfcc46fca5f3765bc9b181de_I20220101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfMS0yLTEtMS03NDU5MA_7ab1eee5-fb40-4e85-a19d-e394c8d30dd7"
      unitRef="usd">8200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i04323c12bfcc46fca5f3765bc9b181de_I20220101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfMS0zLTEtMS03NDU5MA_e10373b0-c3be-4238-9f1c-75463627f56d"
      unitRef="usd">2910000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset
      contextRef="i04323c12bfcc46fca5f3765bc9b181de_I20220101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfMS00LTEtMS03NDU5MA_d76d255c-9b3a-4537-bfa4-888debb57ac6"
      unitRef="usd">1703000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="i04323c12bfcc46fca5f3765bc9b181de_I20220101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfMS01LTEtMS03NDU5MA_e15a6dc7-fc69-49cc-ab09-baf3db29ba0f"
      unitRef="usd">5271000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i04323c12bfcc46fca5f3765bc9b181de_I20220101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfMS02LTEtMS03NDU5MA_b792dc48-0b47-4834-9b23-f686fcade227"
      unitRef="usd">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther
      contextRef="i04323c12bfcc46fca5f3765bc9b181de_I20220101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfMS03LTEtMS03NDU5MA_9af017ce-519b-43c8-bf8d-3c7aa37744f0"
      unitRef="usd">19000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="i04323c12bfcc46fca5f3765bc9b181de_I20220101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfMS04LTEtMS03NDU5MA_8c7f657f-51b5-4608-9daf-1d0e9d24ccbe"
      unitRef="usd">1703000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i45f00f44ca7b4343afb1b0392c335273_I20220101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfMi0yLTEtMS03NDU5OA_6b0960f9-c850-4036-970e-8f5859f8907c"
      unitRef="usd">4800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i45f00f44ca7b4343afb1b0392c335273_I20220101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfMi0zLTEtMS03NDU5OA_4ef211bc-390e-419e-84fc-3d5043717611"
      unitRef="usd">2103000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset
      contextRef="i45f00f44ca7b4343afb1b0392c335273_I20220101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfMi00LTEtMS03NDU5OA_7c576ff7-458f-4ffb-bf70-25a013917f78"
      unitRef="usd">857000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="i45f00f44ca7b4343afb1b0392c335273_I20220101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfMi01LTEtMS03NDU5OA_3f8a385c-a306-44bf-9301-c761ca0ea60f"
      unitRef="usd">2697000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i45f00f44ca7b4343afb1b0392c335273_I20220101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfMi02LTEtMS03NDU5OA_d12a308d-fd40-48a8-8b83-202dd4aa72db"
      unitRef="usd">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther
      contextRef="i45f00f44ca7b4343afb1b0392c335273_I20220101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfMi03LTEtMS03NDU5OA_b5400b8d-f287-4f8b-9394-42cbab7ec3b1"
      unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="i45f00f44ca7b4343afb1b0392c335273_I20220101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfMi04LTEtMS03NDU5OA_3391c265-5e70-42aa-9dfd-5e7fb2f8281a"
      unitRef="usd">857000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i9e2bd41f61084dc99c6046940c937f26_I20221001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfMy0yLTEtMS03NDYwNg_d71cd718-196f-4130-9451-312b4d4fe646"
      unitRef="usd">94877000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i9e2bd41f61084dc99c6046940c937f26_I20221001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfMy0zLTEtMS03NDYwNg_e3cc2745-4d9b-4c5c-b1b4-81a5226d3630"
      unitRef="usd">16414000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset
      contextRef="i9e2bd41f61084dc99c6046940c937f26_I20221001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfMy00LTEtMS03NDYwNg_db687c44-7160-4c95-a5af-c8662941a296"
      unitRef="usd">4665000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="i9e2bd41f61084dc99c6046940c937f26_I20221001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfMy01LTEtMS03NDYwNg_650020ef-f0ba-4c50-b45d-5d1901e8869e"
      unitRef="usd">79690000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i9e2bd41f61084dc99c6046940c937f26_I20221001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfMy02LTEtMS03NDYwNg_90540568-5f28-4ad3-b2ff-af658269b0a1"
      unitRef="usd">400000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther
      contextRef="i9e2bd41f61084dc99c6046940c937f26_I20221001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfMy03LTEtMS03NDYwNg_8421487b-0254-4b1a-a168-85f88602441c"
      unitRef="usd">-2168000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="i9e2bd41f61084dc99c6046940c937f26_I20221001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfMy04LTEtMS03NDYwNg_125c49d0-129b-45b2-ae2c-e5f4d1d016c6"
      unitRef="usd">4124000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i315f9ce8303d42fbb74147d9754e4496_I20221101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfNC0yLTEtMS03OTIwMg_d23b8455-8ad6-425b-9b56-a8097afd3f31"
      unitRef="usd">32000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i315f9ce8303d42fbb74147d9754e4496_I20221101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfNC0zLTEtMS03OTIwMg_90452e2c-acdc-4cc5-89a1-e03a2796a015"
      unitRef="usd">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset
      contextRef="i315f9ce8303d42fbb74147d9754e4496_I20221101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfNC00LTEtMS03OTIwMg_854d0fc7-3ae4-4168-9ecf-e0be6e43ff0b"
      unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="i315f9ce8303d42fbb74147d9754e4496_I20221101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfNC01LTEtMS03OTIwMg_039e2ef3-0168-4ae6-992b-a2689bfbe262"
      unitRef="usd">16200000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i315f9ce8303d42fbb74147d9754e4496_I20221101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfNC02LTEtMS03OTIwMg_f1a56a93-9f78-447a-aad9-8f41f166035d"
      unitRef="usd">15800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther
      contextRef="i315f9ce8303d42fbb74147d9754e4496_I20221101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfNC03LTEtMS03OTIwMg_8147235b-2743-4919-b0cd-1225890a0b07"
      unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="i315f9ce8303d42fbb74147d9754e4496_I20221101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfNC04LTEtMS03OTIwMg_6c559959-3c61-4b1a-bbc3-cae8fc162933"
      unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i29413aeb2a174d91ba07be32e53f164d_I20221201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfNC0yLTEtMS03NDYxNA_c3d29a9f-0aa0-449c-ba22-41b136a14666"
      unitRef="usd">2800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i29413aeb2a174d91ba07be32e53f164d_I20221201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfNC0zLTEtMS03NDYxNA_507f23c7-2bad-4126-97ca-15598c49281d"
      unitRef="usd">568000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset
      contextRef="i29413aeb2a174d91ba07be32e53f164d_I20221201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfNC00LTEtMS03NDYxNA_9ce22718-37df-4b34-906c-64c13863f99b"
      unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="i29413aeb2a174d91ba07be32e53f164d_I20221201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfNC01LTEtMS03NDYxNA_5101c9ea-d328-442b-a077-1bac5cd926d9"
      unitRef="usd">2132000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i29413aeb2a174d91ba07be32e53f164d_I20221201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfNC02LTEtMS03NDYxNA_9fac63e3-1fd4-4443-9e8f-89b3b27fff7e"
      unitRef="usd">100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther
      contextRef="i29413aeb2a174d91ba07be32e53f164d_I20221201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfNC03LTEtMS03NDYxNA_6922be16-8f96-4801-878c-073b1e6e9af3"
      unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="i29413aeb2a174d91ba07be32e53f164d_I20221201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfNC04LTEtMS03NDYxNA_f7939189-0910-43ec-8383-377dc3c2a1ff"
      unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i1c31a5dab37e45d28652fdb0fa620376_I20221209"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfMS0yLTEtMS02Mjg0Nw_327f323c-1bec-4fcb-95a4-0c587baa5ec2"
      unitRef="usd">104000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i1c31a5dab37e45d28652fdb0fa620376_I20221209"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfMS0zLTEtMS02Mjg0Nw_1505aa4f-fc5f-4b2e-86e9-02bbea1e0fb3"
      unitRef="usd">20000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset
      contextRef="i1c31a5dab37e45d28652fdb0fa620376_I20221209"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfMS00LTEtMS02Mjg0Nw_eac30a4e-d7a5-4af3-9023-ccb32bc154df"
      unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="i1c31a5dab37e45d28652fdb0fa620376_I20221209"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfMS01LTEtMS02Mjg0Nw_2c6f3c83-d01a-44ff-9bc4-dbcb746e9772"
      unitRef="usd">55000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i1c31a5dab37e45d28652fdb0fa620376_I20221209"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfMS02LTEtMS02Mjg0Nw_0180918d-7332-44b0-954e-1fde16529cf8"
      unitRef="usd">25000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther
      contextRef="i1c31a5dab37e45d28652fdb0fa620376_I20221209"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfMS03LTEtMS02Mjg0Nw_28d67590-8320-42c5-8107-4c1db1d3b0c4"
      unitRef="usd">4000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="i1c31a5dab37e45d28652fdb0fa620376_I20221209"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfMS04LTEtMS02Mjg0Nw_80c6fe19-1b45-4044-8d71-0c19c99ae11e"
      unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i78a124f13cce4bf08e493835bf6a3457_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfNS0yLTEtMS02MDIyOQ_2a8751c0-c602-4f55-ac98-8c41e7183dd5"
      unitRef="usd">142781000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i78a124f13cce4bf08e493835bf6a3457_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfNS0zLTEtMS02MDIyOQ_bc82e580-8229-4dbe-a1a7-d60c3674d18d"
      unitRef="usd">22015000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset
      contextRef="i78a124f13cce4bf08e493835bf6a3457_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfNS00LTEtMS02MDIyOQ_2c849461-2301-4d48-9297-4587e7a8b2fe"
      unitRef="usd">7225000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="i78a124f13cce4bf08e493835bf6a3457_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfNS01LTEtMS02MDIyOQ_51e31c0e-ed92-4e8a-a785-a1cf7e8cdf26"
      unitRef="usd">106045000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i78a124f13cce4bf08e493835bf6a3457_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfNS02LTEtMS02MDIyOQ_0c0b7828-29bd-4603-bde5-46ac5c2f0992"
      unitRef="usd">16325000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther
      contextRef="i78a124f13cce4bf08e493835bf6a3457_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfNS03LTEtMS02MDIyOQ_6ee3b4f2-0701-466c-be12-e589d7b8dfe6"
      unitRef="usd">-2145000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="i78a124f13cce4bf08e493835bf6a3457_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjQ4ZGUxYTNmZDJiNzRiOTNiZjg0MGUzOTg2NjNhZDQ3L3RhYmxlcmFuZ2U6NDhkZTFhM2ZkMmI3NGI5M2JmODQwZTM5ODY2M2FkNDdfNS04LTEtMS02MDIyOQ_38398696-a77b-4c2f-ba1e-0d7a0510fb74"
      unitRef="usd">6684000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <rdnt:BusinessCombinationNumberOfSubsidiariesAcquired
      contextRef="ie8d992d40a6c4dd78532f351f5124719_I20221101"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY1MjM4Nw_c330400e-3414-47a9-9618-36c9fdbe5a66"
      unitRef="loan">3</rdnt:BusinessCombinationNumberOfSubsidiariesAcquired>
    <rdnt:BusinessCombinationNumberOfSubsidiariesAcquired
      contextRef="ic4d32c5f421b43f999b15581ffd8c753_I20221101"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMjc0ODc3OTEyNTAyMA_3a8aab58-74da-490e-90a6-8ff403c8af64"
      unitRef="loan">1</rdnt:BusinessCombinationNumberOfSubsidiariesAcquired>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i9e2bd41f61084dc99c6046940c937f26_I20221001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY1MjcwNQ_d442fbf0-64bf-4737-aedd-f50681f16747"
      unitRef="usd">1200000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i892eb956660d4426a7b9ce4343939007_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMS0yLTEtMS0yOTQ4OQ_f6731087-3744-4d63-a077-d0fc1c47dd71"
      unitRef="usd">2995000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i892eb956660d4426a7b9ce4343939007_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMS0zLTEtMS0yOTQ4OQ_0b11558e-0542-45b4-b76d-cbb0666d52e9"
      unitRef="usd">576000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset
      contextRef="i892eb956660d4426a7b9ce4343939007_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMS00LTEtMS0yOTQ4OQ_f4cb27bf-c6d7-4852-8fa0-a39dac8f3241"
      unitRef="usd">608000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="i892eb956660d4426a7b9ce4343939007_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMS01LTEtMS0yOTQ4OQ_954668ac-1bb0-4c51-bf1e-2ab71dd963c8"
      unitRef="usd">2355000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i892eb956660d4426a7b9ce4343939007_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMS02LTEtMS0yOTQ4OQ_435524a7-bd8f-468a-bea0-c4ff3b4d3f8f"
      unitRef="usd">50000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther
      contextRef="i892eb956660d4426a7b9ce4343939007_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMS03LTEtMS0yOTQ4OQ_f99f5110-9571-4cf5-b091-4a6e9b510b4a"
      unitRef="usd">14000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="i892eb956660d4426a7b9ce4343939007_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMS04LTEtMS0yOTQ4OQ_661040a6-dea4-4cc4-99a3-a7fc2c1eea02"
      unitRef="usd">608000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="ia8d26a04836f440696fff1b778498ee4_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMi0yLTEtMS0yOTQ4OQ_40a0c42b-158b-4c1c-ba60-6152a188ac39"
      unitRef="usd">2194000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="ia8d26a04836f440696fff1b778498ee4_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMi0zLTEtMS0yOTQ4OQ_6542b1cb-8f43-4910-afdc-0544ec99ff0d"
      unitRef="usd">1112000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset
      contextRef="ia8d26a04836f440696fff1b778498ee4_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMi00LTEtMS0yOTQ4OQ_93d348b5-41c4-458c-b299-67097fe5b85e"
      unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="ia8d26a04836f440696fff1b778498ee4_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMi01LTEtMS0yOTQ4OQ_c6b65f0f-f54e-4f55-bba6-309f433658f0"
      unitRef="usd">1005000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="ia8d26a04836f440696fff1b778498ee4_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMi02LTEtMS0yOTQ4OQ_5c7e2411-ba00-40bd-af41-01364b8cc2ff"
      unitRef="usd">50000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther
      contextRef="ia8d26a04836f440696fff1b778498ee4_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMi03LTEtMS0yOTQ4OQ_0becf64f-307d-44b2-a8d3-290fd23f02a0"
      unitRef="usd">27000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="ia8d26a04836f440696fff1b778498ee4_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMi04LTEtMS0yOTQ4OQ_120dac3e-7080-4248-8873-3b95b19039eb"
      unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i03820b19954941189242f879d3d1aa9b_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMy0yLTEtMS0yOTQ4OQ_f32bb3e9-decc-4817-8aa3-99e9c515b92f"
      unitRef="usd">6065000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i03820b19954941189242f879d3d1aa9b_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMy0zLTEtMS0yOTQ4OQ_2b85d9cf-7800-4849-acf1-b79eddc3cd64"
      unitRef="usd">4668000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset
      contextRef="i03820b19954941189242f879d3d1aa9b_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMy00LTEtMS0yOTQ4OQ_dd9b3969-2735-4533-9ca3-b1525d77480b"
      unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="i03820b19954941189242f879d3d1aa9b_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMy01LTEtMS0yOTQ4OQ_7dcd3739-4f55-4915-bd3d-c9555d7f85b9"
      unitRef="usd">1328000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i03820b19954941189242f879d3d1aa9b_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMy02LTEtMS0yOTQ4OQ_6eea7d2d-b9b1-4418-bbb3-c175b8ba5144"
      unitRef="usd">40000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther
      contextRef="i03820b19954941189242f879d3d1aa9b_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMy03LTEtMS0yOTQ4OQ_b9a07c37-3b6c-44e7-9f88-b8ef534e1b04"
      unitRef="usd">29000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="i03820b19954941189242f879d3d1aa9b_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMy04LTEtMS0yOTQ4OQ_5e7db57b-e711-4a7d-98a2-4f1704aacb17"
      unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="ia0ea208abb7a45c18b6150540a583cc3_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfNC0yLTEtMS0yOTQ4OQ_a259845b-d71b-45d5-b7c5-c9db278e675b"
      unitRef="usd">1155000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="ia0ea208abb7a45c18b6150540a583cc3_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfNC0zLTEtMS0yOTQ4OQ_550b87b4-6959-4722-a26f-947fa786380c"
      unitRef="usd">1076000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset
      contextRef="ia0ea208abb7a45c18b6150540a583cc3_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfNC00LTEtMS0yOTQ4OQ_56cd47f3-f21f-4ced-aab4-b2b34b40aa76"
      unitRef="usd">446000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="ia0ea208abb7a45c18b6150540a583cc3_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfNC01LTEtMS0yOTQ4OQ_1fee6a23-c32e-413f-8ead-e2decf24aa63"
      unitRef="usd">6000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="ia0ea208abb7a45c18b6150540a583cc3_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfNC02LTEtMS0yOTQ4OQ_17c88afc-0f15-455b-915d-bdd38ffd9bb8"
      unitRef="usd">50000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther
      contextRef="ia0ea208abb7a45c18b6150540a583cc3_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfNC03LTEtMS0yOTQ4OQ_5b5d0ba9-a2c9-4f3a-8a2b-259f785c9b5c"
      unitRef="usd">23000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="ia0ea208abb7a45c18b6150540a583cc3_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfNC04LTEtMS0yOTQ4OQ_ce49d221-f5d1-4deb-8934-270ae3c76809"
      unitRef="usd">446000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i35c9649190e94adda0f107310a8a289e_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfNS0yLTEtMS0yOTQ4OQ_b0870908-18bd-4e5b-aace-3bd82a365c0a"
      unitRef="usd">9386000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i35c9649190e94adda0f107310a8a289e_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfNS0zLTEtMS0yOTQ4OQ_825750d9-f076-44ed-a7b1-90dedbcbeaef"
      unitRef="usd">5667000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset
      contextRef="i35c9649190e94adda0f107310a8a289e_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfNS00LTEtMS0yOTQ4OQ_134463f2-56bb-4f34-b5e0-ec81bac7cc61"
      unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="i35c9649190e94adda0f107310a8a289e_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfNS01LTEtMS0yOTQ4OQ_25825027-12dc-4f31-9b53-bf177e9a48bc"
      unitRef="usd">3649000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i35c9649190e94adda0f107310a8a289e_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfNS02LTEtMS0yOTQ4OQ_6ef6ca09-184c-4d18-bde7-1c0584e0e3e1"
      unitRef="usd">70000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther
      contextRef="i35c9649190e94adda0f107310a8a289e_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfNS03LTEtMS0yOTQ4OQ_9c505754-94d7-4e12-8920-6afe4a244c76"
      unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="i35c9649190e94adda0f107310a8a289e_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfNS04LTEtMS0yOTQ4OQ_1d0df79b-a933-4250-9f82-26afc1a1dcda"
      unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i0ab3ab4d55ef4b02aa47ad2b6dad4bc7_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfNi0yLTEtMS0yOTQ4OQ_9dc67f73-8024-4d9c-820a-f32096f4f6a6"
      unitRef="usd">13671000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i0ab3ab4d55ef4b02aa47ad2b6dad4bc7_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfNi0zLTEtMS0yOTQ4OQ_00ef53f5-1d51-48a7-9e54-5db1e0f3572b"
      unitRef="usd">4617000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset
      contextRef="i0ab3ab4d55ef4b02aa47ad2b6dad4bc7_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfNi00LTEtMS0yOTQ4OQ_3c2908f0-f438-4074-8a12-7959a4fe1ce5"
      unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="i0ab3ab4d55ef4b02aa47ad2b6dad4bc7_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfNi01LTEtMS0yOTQ4OQ_600ef6b0-d23d-4df9-93b7-a9e079d1e01b"
      unitRef="usd">8974000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i0ab3ab4d55ef4b02aa47ad2b6dad4bc7_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfNi02LTEtMS0yOTQ4OQ_5780543d-af0f-4f9a-94f7-ee1ce97144cb"
      unitRef="usd">80000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther
      contextRef="i0ab3ab4d55ef4b02aa47ad2b6dad4bc7_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfNi03LTEtMS0yOTQ4OQ_8a3da106-6025-48a9-82cd-a6cf720904ab"
      unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="i0ab3ab4d55ef4b02aa47ad2b6dad4bc7_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfNi04LTEtMS0yOTQ4OQ_de14df60-7894-47cd-8153-2b8c11b3a3a7"
      unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i579ab9cf65534af294a6f7e07668dd6a_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfNy0yLTEtMS0yOTQ4OQ_c2ac48d2-4b40-471a-86fd-9ab003e5e2e5"
      unitRef="usd">11428000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i579ab9cf65534af294a6f7e07668dd6a_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfNy0zLTEtMS0yOTQ4OQ_e44326b9-7ce6-4068-8005-350aada63d82"
      unitRef="usd">2741000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset
      contextRef="i579ab9cf65534af294a6f7e07668dd6a_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfNy00LTEtMS0yOTQ4OQ_309e9018-9ed9-4c5f-b03a-50688a6aa38c"
      unitRef="usd">335000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="i579ab9cf65534af294a6f7e07668dd6a_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfNy01LTEtMS0yOTQ4OQ_3da239e0-ac17-491b-b8ca-c540c8fdb524"
      unitRef="usd">8617000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i579ab9cf65534af294a6f7e07668dd6a_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfNy02LTEtMS0yOTQ4OQ_aff022b2-5b9c-4f19-9b04-a840b110df3d"
      unitRef="usd">70000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther
      contextRef="i579ab9cf65534af294a6f7e07668dd6a_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfNy03LTEtMS0yOTQ4OQ_ea43e6c9-5728-4cc5-bf47-b4e57e250a8c"
      unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="i579ab9cf65534af294a6f7e07668dd6a_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfNy04LTEtMS0yOTQ4OQ_2a72f09f-274a-457c-965f-8f8d9f958645"
      unitRef="usd">335000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="ie5f5572dd74743ab9a87be7f25a33b9f_I20210301"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfOC0yLTEtMS0yOTQ4OQ_15645fca-fefc-4d05-94b0-ff53d4049681"
      unitRef="usd">3545000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="ie5f5572dd74743ab9a87be7f25a33b9f_I20210301"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfOC0zLTEtMS0yOTQ4OQ_9cb0b5ac-9694-454a-a930-cd8138ec431c"
      unitRef="usd">3385000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset
      contextRef="ie5f5572dd74743ab9a87be7f25a33b9f_I20210301"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfOC00LTEtMS0yOTQ4OQ_74da3f3a-65f8-4783-9ce5-fd37c8b8332d"
      unitRef="usd">2191000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="ie5f5572dd74743ab9a87be7f25a33b9f_I20210301"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfOC01LTEtMS0yOTQ4OQ_603fe2a1-97ce-4749-b52f-d9db06259e9c"
      unitRef="usd">40000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="ie5f5572dd74743ab9a87be7f25a33b9f_I20210301"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfOC02LTEtMS0yOTQ4OQ_c8129246-b468-4040-835f-2b3f0073cb9a"
      unitRef="usd">50000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther
      contextRef="ie5f5572dd74743ab9a87be7f25a33b9f_I20210301"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfOC03LTEtMS0yOTQ4OQ_48953abd-9228-4ed0-8dca-e910e9b5448a"
      unitRef="usd">70000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="ie5f5572dd74743ab9a87be7f25a33b9f_I20210301"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfOC04LTEtMS0yOTQ4OQ_96dc8019-e5e2-4486-9de0-64dc2bee4e36"
      unitRef="usd">2191000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i902807f4b9a9416c9b47104b5ad819a0_I20210301"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfOS0yLTEtMS0yOTQ4OQ_778066e6-323a-4e9f-aae9-da4b7d899f45"
      unitRef="usd">2658000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i902807f4b9a9416c9b47104b5ad819a0_I20210301"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfOS0zLTEtMS0yOTQ4OQ_0bef6201-8588-4e03-a010-78612c77b3f9"
      unitRef="usd">2530000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset
      contextRef="i902807f4b9a9416c9b47104b5ad819a0_I20210301"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfOS00LTEtMS0yOTQ4OQ_a5f8eaa3-4ceb-408f-b912-685589e18a59"
      unitRef="usd">1418000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="i902807f4b9a9416c9b47104b5ad819a0_I20210301"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfOS01LTEtMS0yOTQ4OQ_9699ff03-5aad-4686-a0f8-d1b21afb2c42"
      unitRef="usd">32000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i902807f4b9a9416c9b47104b5ad819a0_I20210301"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfOS02LTEtMS0yOTQ4OQ_c2b46bdb-6857-4863-97cd-4d954ec488a3"
      unitRef="usd">50000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther
      contextRef="i902807f4b9a9416c9b47104b5ad819a0_I20210301"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfOS03LTEtMS0yOTQ4OQ_e754cac5-da08-4a68-b82c-221948a30bc4"
      unitRef="usd">46000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="i902807f4b9a9416c9b47104b5ad819a0_I20210301"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfOS04LTEtMS0yOTQ4OQ_c9008686-7f06-43da-94bc-98dffa2d7682"
      unitRef="usd">1418000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="ifc21e27c33b04e1daa07fac76223e671_I20210301"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTAtMi0xLTEtMjk0ODk_209fa9a2-7780-4816-b778-435ffae3f6a7"
      unitRef="usd">3978000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="ifc21e27c33b04e1daa07fac76223e671_I20210301"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTAtMy0xLTEtMjk0ODk_22c242b2-07d6-40f6-89cf-2dbe485a17b8"
      unitRef="usd">3581000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset
      contextRef="ifc21e27c33b04e1daa07fac76223e671_I20210301"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTAtNC0xLTEtMjk0ODk_ee7f41ed-004f-4d64-be1a-f40ff5f9cd36"
      unitRef="usd">2214000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="ifc21e27c33b04e1daa07fac76223e671_I20210301"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTAtNS0xLTEtMjk0ODk_1dc6d136-6f06-450b-9203-30cb9481b8d1"
      unitRef="usd">347000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="ifc21e27c33b04e1daa07fac76223e671_I20210301"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTAtNi0xLTEtMjk0ODk_f0afc138-df45-4c9c-bb01-b33c496bd226"
      unitRef="usd">50000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther
      contextRef="ifc21e27c33b04e1daa07fac76223e671_I20210301"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTAtNy0xLTEtMjk0ODk_e4e10256-cc79-419c-890b-60c7ebc3b336"
      unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="ifc21e27c33b04e1daa07fac76223e671_I20210301"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTAtOC0xLTEtMjk0ODk_e72be863-1fdc-4c07-ab35-6cc5c6a1c4a7"
      unitRef="usd">2214000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="ibc6548d74e7444118bd3d64d387c8399_I20210401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTEtMi0xLTEtMjk0ODk_b4a28389-ae58-4ba9-9cfd-063d6a05dcc4"
      unitRef="usd">562000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="ibc6548d74e7444118bd3d64d387c8399_I20210401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTEtMy0xLTEtMjk0ODk_457d1741-92ed-40f0-a817-736a15404a25"
      unitRef="usd">507000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset
      contextRef="ibc6548d74e7444118bd3d64d387c8399_I20210401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTEtNC0xLTEtMjk0ODk_d9323fc4-b5dd-4b33-89a8-c424b58a8bdc"
      unitRef="usd">1817000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="ibc6548d74e7444118bd3d64d387c8399_I20210401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTEtNS0xLTEtMjk0ODk_df65bbad-ed57-49ed-a93b-f50692edeed5"
      unitRef="usd">5000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="ibc6548d74e7444118bd3d64d387c8399_I20210401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTEtNi0xLTEtMjk0ODk_51656c5c-565b-46e8-b0ec-4098c96a825f"
      unitRef="usd">50000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther
      contextRef="ibc6548d74e7444118bd3d64d387c8399_I20210401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTEtNy0xLTEtMjk0ODk_a4b857cb-1851-4bda-b242-f6251cda1ce5"
      unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="ibc6548d74e7444118bd3d64d387c8399_I20210401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTEtOC0xLTEtMjk0ODk_0f70224b-c6c5-4c33-99bc-1145c1620351"
      unitRef="usd">1817000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="ib8ef5a13ccba4f0081c5203b3d794eca_I20210501"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTItMi0xLTEtMjk0ODk_01d7068e-d29b-4f53-bb01-7041587e3805"
      unitRef="usd">3750000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="ib8ef5a13ccba4f0081c5203b3d794eca_I20210501"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTItMy0xLTEtMjk0ODk_62f53f8d-31fc-4ea6-9ed6-749968717c19"
      unitRef="usd">990000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset
      contextRef="ib8ef5a13ccba4f0081c5203b3d794eca_I20210501"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTItNC0xLTEtMjk0ODk_866e6009-80ae-4c33-822b-8d8c98173820"
      unitRef="usd">1379000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="ib8ef5a13ccba4f0081c5203b3d794eca_I20210501"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTItNS0xLTEtMjk0ODk_12a74292-5b83-4975-8f75-180bc838105a"
      unitRef="usd">2710000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="ib8ef5a13ccba4f0081c5203b3d794eca_I20210501"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTItNi0xLTEtMjk0ODk_68c117e6-1ee8-4dc8-8465-01300538ae2a"
      unitRef="usd">50000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther
      contextRef="ib8ef5a13ccba4f0081c5203b3d794eca_I20210501"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTItNy0xLTEtMjk0ODk_b72f922d-64cf-4652-baf7-bb3dde5e1a94"
      unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="ib8ef5a13ccba4f0081c5203b3d794eca_I20210501"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTItOC0xLTEtMjk0ODk_ff12b6ec-b5c9-4465-8862-6e98bbb2fd6e"
      unitRef="usd">1379000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="iace4174421504d128d1891aedd6863a3_I20210501"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTMtMi0xLTEtMjk0ODk_7c9a9c74-c823-4588-b5ce-ac65f61af026"
      unitRef="usd">400000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="iace4174421504d128d1891aedd6863a3_I20210501"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTMtMy0xLTEtMjk0ODk_6f3a0cd4-5436-47b1-b8a4-94d895c7d0bf"
      unitRef="usd">85000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset
      contextRef="iace4174421504d128d1891aedd6863a3_I20210501"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTMtNC0xLTEtMjk0ODk_fd286cab-b5a7-4289-b772-8b5689452304"
      unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="iace4174421504d128d1891aedd6863a3_I20210501"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTMtNS0xLTEtMjk0ODk_172fdde8-04cb-4531-a8a8-2430802eed50"
      unitRef="usd">290000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="iace4174421504d128d1891aedd6863a3_I20210501"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTMtNi0xLTEtMjk0ODk_7e282a9c-9045-4af9-8f25-2f71514de24a"
      unitRef="usd">25000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther
      contextRef="iace4174421504d128d1891aedd6863a3_I20210501"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTMtNy0xLTEtMjk0ODk_a5467900-00b7-48ca-b3d0-185df906e595"
      unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="iace4174421504d128d1891aedd6863a3_I20210501"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTMtOC0xLTEtMjk0ODk_548a1522-57f2-4ffc-b402-65bf7013c627"
      unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="iaaf8fe80680b48ab82ec3deb6b41a4af_I20210501"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTQtMi0xLTEtMjk0ODk_dbcf5030-b486-4b49-bce3-d14d30b5fa78"
      unitRef="usd">263000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="iaaf8fe80680b48ab82ec3deb6b41a4af_I20210501"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTQtMy0xLTEtMjk0ODk_a66f1dd1-d3fe-4393-a377-f8ae5684f141"
      unitRef="usd">213000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset
      contextRef="iaaf8fe80680b48ab82ec3deb6b41a4af_I20210501"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTQtNC0xLTEtMjk0ODk_134b52aa-f04a-446c-9c1b-9f3f3ecdf1c6"
      unitRef="usd">311000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="iaaf8fe80680b48ab82ec3deb6b41a4af_I20210501"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTQtNS0xLTEtMjk0ODk_0f64d673-239b-489c-a0fa-dc5a449da113"
      unitRef="usd">0</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="iaaf8fe80680b48ab82ec3deb6b41a4af_I20210501"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTQtNi0xLTEtMjk0ODk_c7c08a1d-995a-47e0-962f-63477622e23b"
      unitRef="usd">50000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther
      contextRef="iaaf8fe80680b48ab82ec3deb6b41a4af_I20210501"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTQtNy0xLTEtMjk0ODk_b473a34e-1752-48cc-bfb8-82de360688c4"
      unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="iaaf8fe80680b48ab82ec3deb6b41a4af_I20210501"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTQtOC0xLTEtMjk0ODk_7ca94bbc-1be4-42ef-867e-ab7f651587a5"
      unitRef="usd">311000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i4a182964d2994db6afa278022e5ec78c_I20210601"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTUtMi0xLTEtMjk0ODk_d8e54bc4-7f15-4bc0-84f0-628bb4cb3b5d"
      unitRef="usd">2868000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i4a182964d2994db6afa278022e5ec78c_I20210601"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTUtMy0xLTEtMjk0ODk_ceefe9f0-e9c0-491f-9101-ec85854cb852"
      unitRef="usd">2801000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset
      contextRef="i4a182964d2994db6afa278022e5ec78c_I20210601"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTUtNC0xLTEtMjk0ODk_d240d631-6151-4501-8a09-4d436e646f01"
      unitRef="usd">1951000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="i4a182964d2994db6afa278022e5ec78c_I20210601"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTUtNS0xLTEtMjk0ODk_046a97e9-dd29-4474-a72d-b4dd106041aa"
      unitRef="usd">17000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i4a182964d2994db6afa278022e5ec78c_I20210601"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTUtNi0xLTEtMjk0ODk_7adb44eb-dd69-4edd-a454-2cf15ac6c336"
      unitRef="usd">50000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther
      contextRef="i4a182964d2994db6afa278022e5ec78c_I20210601"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTUtNy0xLTEtMjk0ODk_64e26fc9-aeb0-401e-bb0a-2c6fe95c8f27"
      unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="i4a182964d2994db6afa278022e5ec78c_I20210601"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTUtOC0xLTEtMjk0ODk_63a7a73b-8a62-4590-8e6b-a396c0218d05"
      unitRef="usd">1951000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i22bc4ace41264830b19ecc0fff6de4f9_I20210824"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTYtMi0xLTEtMjk0ODk_11a86418-4efc-4d12-8108-de1bc02853e9"
      unitRef="usd">2025000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i22bc4ace41264830b19ecc0fff6de4f9_I20210824"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTYtMy0xLTEtMjk0ODk_58ec83c9-a85f-4fa8-b537-f0997926bc92"
      unitRef="usd">10000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset
      contextRef="i22bc4ace41264830b19ecc0fff6de4f9_I20210824"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTYtNC0xLTEtMjk0ODk_ae273998-8dbe-4d39-878f-500866911a09"
      unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="i22bc4ace41264830b19ecc0fff6de4f9_I20210824"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTYtNS0xLTEtMjk0ODk_f905f38a-fb5d-41e0-b76a-0de9ab1764f5"
      unitRef="usd">379000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i22bc4ace41264830b19ecc0fff6de4f9_I20210824"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTYtNi0xLTEtMjk0ODk_64a74a89-e123-4fc1-885b-a97b0e636ee8"
      unitRef="usd">1636000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther
      contextRef="i22bc4ace41264830b19ecc0fff6de4f9_I20210824"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTYtNy0xLTEtMjk0ODk_3077c06b-fda8-40f7-bd15-4e7771448419"
      unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="i22bc4ace41264830b19ecc0fff6de4f9_I20210824"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTYtOC0xLTEtMjk0ODk_53b6a664-c953-47d5-933c-02f4947974ee"
      unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="id7aacc9fd1cc4c3e8c39d3650be587c0_I20211201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTctMi0xLTEtMjk0ODk_8384a329-a925-47c1-b9d0-a382d727eea3"
      unitRef="usd">6023000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="id7aacc9fd1cc4c3e8c39d3650be587c0_I20211201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTctMy0xLTEtMjk0ODk_6354f776-a8b6-4211-874d-3323fb50519e"
      unitRef="usd">590000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset
      contextRef="id7aacc9fd1cc4c3e8c39d3650be587c0_I20211201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTctNC0xLTEtMjk0ODk_5e6e2ab3-8efd-4795-aebe-e9092bf6aa50"
      unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="id7aacc9fd1cc4c3e8c39d3650be587c0_I20211201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTctNS0xLTEtMjk0ODk_2b31b2fb-b94e-432d-920b-30175c25267c"
      unitRef="usd">5260000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="id7aacc9fd1cc4c3e8c39d3650be587c0_I20211201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTctNi0xLTEtMjk0ODk_1b5a67c3-d2c2-4f69-a9b9-f2a15e9d9272"
      unitRef="usd">150000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther
      contextRef="id7aacc9fd1cc4c3e8c39d3650be587c0_I20211201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTctNy0xLTEtMjk0ODk_3e536522-acd4-4db1-913f-05e826904b06"
      unitRef="usd">23000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="id7aacc9fd1cc4c3e8c39d3650be587c0_I20211201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTctOC0xLTEtMjk0ODk_7349180a-f300-4913-9ef2-0dbac4eda4ec"
      unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i759bb752ba514fd0a9e92dbd00a4ba03_I20211206"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTgtMi0xLTEtMjk0ODk_819b9d64-9025-43bf-ac12-f0d0ef13d671"
      unitRef="usd">4404000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i759bb752ba514fd0a9e92dbd00a4ba03_I20211206"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTgtMy0xLTEtMjk0ODk_153315c1-386f-4707-8382-2cef1b40d8f2"
      unitRef="usd">701000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset
      contextRef="i759bb752ba514fd0a9e92dbd00a4ba03_I20211206"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTgtNC0xLTEtMjk0ODk_84fc80a8-dbe0-461d-a0a9-f985699a5e95"
      unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="i759bb752ba514fd0a9e92dbd00a4ba03_I20211206"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTgtNS0xLTEtMjk0ODk_cb3db720-eb9c-4d5e-b911-62433ee07932"
      unitRef="usd">3653000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i759bb752ba514fd0a9e92dbd00a4ba03_I20211206"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTgtNi0xLTEtMjk0ODk_cf75625b-94d1-4d8a-95e1-f8ccb7fa8dfe"
      unitRef="usd">50000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther
      contextRef="i759bb752ba514fd0a9e92dbd00a4ba03_I20211206"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTgtNy0xLTEtMjk0ODk_0092262a-d67a-4f2c-8b61-08f84321fb47"
      unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="i759bb752ba514fd0a9e92dbd00a4ba03_I20211206"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTgtOC0xLTEtMjk0ODk_886554fe-1cef-45c6-995b-75898a7e8133"
      unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="iff8ceedaa8534baf9af84ee6fdb44f29_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTktMi0xLTEtMjk0ODk_fa20b021-557e-484e-87d2-856e80334aea"
      unitRef="usd">2346000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="iff8ceedaa8534baf9af84ee6fdb44f29_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTktMy0xLTEtMjk0ODk_d7eb0d8b-e5f3-422d-a2b4-4951a545cf82"
      unitRef="usd">99000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset
      contextRef="iff8ceedaa8534baf9af84ee6fdb44f29_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTktNC0xLTEtMjk0ODk_6ceb1136-8798-40e5-a76d-2377490f93ff"
      unitRef="usd">323000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="iff8ceedaa8534baf9af84ee6fdb44f29_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTktNS0xLTEtMjk0ODk_19b28c12-abb2-4096-bd2e-f360a4e59e0e"
      unitRef="usd">2197000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="iff8ceedaa8534baf9af84ee6fdb44f29_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTktNi0xLTEtMjk0ODk_30d38be0-fd61-43fa-b8df-2d869dbef120"
      unitRef="usd">50000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther
      contextRef="iff8ceedaa8534baf9af84ee6fdb44f29_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTktNy0xLTEtMjk0ODk_a668a3f3-5e6c-4322-8492-b9ef97621e65"
      unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="iff8ceedaa8534baf9af84ee6fdb44f29_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMTktOC0xLTEtMjk0ODk_a41865d4-7426-4df5-9244-20754c14b4c4"
      unitRef="usd">323000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="ibb914ba8860c4d42942ab37aebd6805d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMjAtMi0xLTEtMjk0ODk_a786d1ce-5e7a-4604-912f-bac954a3858c"
      unitRef="usd">79716000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="ibb914ba8860c4d42942ab37aebd6805d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMjAtMy0xLTEtMjk0ODk_10807c14-c4ab-434f-b785-e422dae8ea4a"
      unitRef="usd">35949000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset
      contextRef="ibb914ba8860c4d42942ab37aebd6805d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMjAtNC0xLTEtMjk0ODk_bc7bab56-c82b-4ef4-b19b-89a1f288605e"
      unitRef="usd">12993000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="ibb914ba8860c4d42942ab37aebd6805d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMjAtNS0xLTEtMjk0ODk_6d1107f7-3b52-49e5-9258-80034c149b7d"
      unitRef="usd">40864000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="ibb914ba8860c4d42942ab37aebd6805d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMjAtNi0xLTEtMjk0ODk_91df56e0-58cb-4284-93be-3ea0964965fe"
      unitRef="usd">2671000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther
      contextRef="ibb914ba8860c4d42942ab37aebd6805d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMjAtNy0xLTEtMjk0ODk_2349084f-1319-4d7f-861e-f7f195cc4d68"
      unitRef="usd">232000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="ibb914ba8860c4d42942ab37aebd6805d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RhYmxlOjNjMTA1MmY0OWIzYzRlZTg5MjRkYjZhMzZlZmFiZDliL3RhYmxlcmFuZ2U6M2MxMDUyZjQ5YjNjNGVlODkyNGRiNmEzNmVmYWJkOWJfMjAtOC0xLTEtMjk0ODk_287b9b09-034f-4e8e-8e9e-b56c30170c12"
      unitRef="usd">12993000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="i12d9fd3f8cce41bd8567698b43e666dd_D20210824-20210824"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfNjc2_be04497d-f17c-4368-bfb2-37638d3dde59"
      unitRef="shares">67658000</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="i315f9ce8303d42fbb74147d9754e4496_I20221101"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY1NTEzNw_97b096e0-cc64-4749-8652-c46fa3ddfeb6"
      unitRef="number">0.75</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i350d6392e4a642769b8a9824e7855129_D20221101-20221101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY1NTE1Mw_412ccc3e-eecb-4c0e-8ceb-bd1494b8a531"
      unitRef="usd">31900000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
      contextRef="i350d6392e4a642769b8a9824e7855129_D20221101-20221101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY1NTE3MQ_a41823d3-1d5e-49d7-b582-7db9c31215e5"
      unitRef="usd">6800000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="i350d6392e4a642769b8a9824e7855129_D20221101-20221101"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY1NTE4MQ_cf27f190-edcf-4640-be90-9d9042eaf4d7"
      unitRef="shares">359002</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionSharePrice
      contextRef="i315f9ce8303d42fbb74147d9754e4496_I20221101"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY1NTE4OQ_54849221-0565-4336-8f88-9e88524a1269"
      unitRef="usdPerShare">19.06</us-gaap:BusinessAcquisitionSharePrice>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i350d6392e4a642769b8a9824e7855129_D20221101-20221101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY1NTIwNQ_602c4cc8-beb9-413e-943c-2303e1dbec30"
      unitRef="usd">6300000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i315f9ce8303d42fbb74147d9754e4496_I20221101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY2MzQ2Nw_54af6721-1f3c-4912-9dbb-628166e8fc30"
      unitRef="usd">10800000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="iec83e5acff394eac92ff9ba28bb2e1ec_I20221101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY1NTIzNw_c1873b3a-f808-4387-a77f-fadf7bad2143"
      unitRef="usd">10200000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="if870a8803b5347588b2a78fdf3b1dabf_I20221101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY1NTI1Mg_2739444f-6cbb-4c92-9f8e-b795c3927c6d"
      unitRef="usd">600000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <rdnt:BusinessCombinationContingentConsiderationLiabilityPeriod
      contextRef="i350d6392e4a642769b8a9824e7855129_D20221101-20221101"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY1NjUzOQ_ce981d75-6722-4b77-bc6c-efa5202bae0a">P24M</rdnt:BusinessCombinationContingentConsiderationLiabilityPeriod>
    <us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue
      contextRef="i315f9ce8303d42fbb74147d9754e4496_I20221101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY2MzU3MQ_1fceb202-4ef9-4d7c-abd1-c7f5cc877631"
      unitRef="usd">8000000</us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets
      contextRef="i315f9ce8303d42fbb74147d9754e4496_I20221101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY1NTI2Nw_ad5ca104-ae82-406b-8d16-79b72d8ba439"
      unitRef="usd">600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i315f9ce8303d42fbb74147d9754e4496_I20221101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY1NjUxMw_a64292aa-6007-4e25-813c-a4d6283e5a61"
      unitRef="usd">15800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
      contextRef="i315f9ce8303d42fbb74147d9754e4496_I20221101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY1NTI4Mg_01005cbd-daf5-41a3-96ce-a8ef053e1517"
      unitRef="usd">600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities>
    <us-gaap:Goodwill
      contextRef="i315f9ce8303d42fbb74147d9754e4496_I20221101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY1NTQzNA_f6bb8d9f-279f-49f1-a86f-ca216de69059"
      unitRef="usd">16200000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="i95d5f4cf07934fb790f6972ad191259f_I20221101"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY2NTEyOQ_8e30b8a2-cc99-47e2-bbce-3c2065d26b0e"
      unitRef="number">0.190</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i76afbed304204c709d14268fe2fc7759_D20220120-20220120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY3Njg0OQ_e131e93d-7185-4bc0-8b77-4d15b20e9a39"
      unitRef="usd">45200000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="ia40099a2511a4e60a8a104b2b81cfad0_D20220120-20220120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY3Njg1Nw_f502538a-d281-4a67-a523-f1d8f7fe4f28"
      unitRef="shares">1117872</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionSharePrice
      contextRef="ic8ce100f294545feaf01b49a483d7835_I20220120"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY3Njg2MQ_0cb1a2a1-952e-4cee-bcf9-dd774a7952d5"
      unitRef="usdPerShare">26.80</us-gaap:BusinessAcquisitionSharePrice>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
      contextRef="ia40099a2511a4e60a8a104b2b81cfad0_D20220120-20220120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY3Njg2NQ_305f3861-e64a-4c60-bb2a-90ed0589d5ca"
      unitRef="usd">30000000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i76afbed304204c709d14268fe2fc7759_D20220120-20220120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY3Njg2OQ_1561222d-7dd1-4ba3-8494-f101d235abfd"
      unitRef="usd">1800000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="iebda58f2b50646b69966fddb55d1e9eb_I20220120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY3NjkwMQ_d7088ddf-531b-4221-9e05-5a3909112c31"
      unitRef="usd">11900000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ifb0178640b0547a4a348e983673f24ad_I20220120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY3Njg3Nw_78f5b074-9a28-44df-8f9a-2cc900e9f83d"
      unitRef="usd">7400000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i38534e3fc3794da0bea27b49adae6a77_I20220120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY3Njg4NQ_8f8cf454-c920-4c1f-a322-b0828c2226d6"
      unitRef="usd">4500000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities
      contextRef="iebda58f2b50646b69966fddb55d1e9eb_I20220120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY3Njg5Mw_c88b6f08-cd86-4dda-94fb-d0debc4610d3"
      unitRef="usd">1500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="if0842a81b02a40418df2e51489f2137e_D20220120-20220120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY3NjkyMQ_35e4812a-64b9-4877-8fba-6e03f8327e1c"
      unitRef="shares">23362</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
      contextRef="if0842a81b02a40418df2e51489f2137e_D20220120-20220120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY3NjkyNQ_14ab5bc7-52cd-482c-bf19-6124ba51468f"
      unitRef="usd">600000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets
      contextRef="iebda58f2b50646b69966fddb55d1e9eb_I20220120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY3NjkyOQ_eeaba242-ca16-4bb4-9802-2a3bca7803dd"
      unitRef="usd">1000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="iebda58f2b50646b69966fddb55d1e9eb_I20220120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY3NjkzOA_100eb7f3-77bc-4716-8aec-74846a2a66c3"
      unitRef="usd">200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="iebda58f2b50646b69966fddb55d1e9eb_I20220120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY3Njk3OQ_6b28c8f0-ce78-4c0c-997d-09191e283555"
      unitRef="usd">27700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="if97396e4c19841b98639a9937dfa4fa7_I20220120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY3NzAxOQ_83eb4da9-8401-4ade-8b35-e34c8a3c3663"
      unitRef="usd">21100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="ie9fc3884748a4f9c85f668dbc7c8621a_I20220120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY3Njk5NQ_a66a0eda-4c5a-4e72-b10e-9ae85b8b1b09"
      unitRef="usd">5500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
      contextRef="iebda58f2b50646b69966fddb55d1e9eb_I20220120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY3NzAwMw_c15e088a-116f-4975-b924-102dd846f94b"
      unitRef="usd">3200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="iebda58f2b50646b69966fddb55d1e9eb_I20220120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY3NzAxMQ_cb927906-0e97-45c5-8391-3f6a5d1d3dcf"
      unitRef="usd">3500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:Goodwill
      contextRef="iebda58f2b50646b69966fddb55d1e9eb_I20220120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY3NzAyNw_42a53e05-ea5f-4894-9d15-75380c0ece5f"
      unitRef="usd">22900000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="iaf4d7228420748d7a6ca4943a5dc578d_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY4NTI0Ng_9c9c55f2-ebfe-44e5-9559-1edb49223915"
      unitRef="number">0.15</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="id2af135c82bc4cca8c8fab8df3985632_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY4NTI1MA_e2ac30f2-9da6-43b0-8e28-3efdf54eaa2a"
      unitRef="number">0.17</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i1073a8921d2c4ba78783ba6bcf89733f_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY4NjM4MA_85e6d5aa-ba2b-42e3-a440-9db107913416">P7Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i2500cde4d73845a3ac979c61b31fffb3_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY4NjM4NQ_01256fbc-9dd3-42e4-ba8e-e88d035f0e31">P5Y4M24D</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="if7c3caf821ac4264bfedf6a1cf1e1cff_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY4NjM5MA_77159aa4-dc39-4826-a020-76ce493bd6c2">P7Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i0037eb0ed88b4354b067862baa4cefa3_D20220120-20220120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY4MDQwMQ_cd566391-6067-4ef6-a42b-abf693ba09b0"
      unitRef="usd">42300000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="i0037eb0ed88b4354b067862baa4cefa3_D20220120-20220120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY4MDQwOQ_4c3c0d40-27fe-4a37-91d3-08460eab47e8"
      unitRef="shares">965058</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionSharePrice
      contextRef="ic20227de97324a8da0150abd7d29ff60_I20220120"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY4MDQxMw_3a85ae03-0370-4783-9a7c-f8188c4bcf9c"
      unitRef="usdPerShare">26.80</us-gaap:BusinessAcquisitionSharePrice>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
      contextRef="i0037eb0ed88b4354b067862baa4cefa3_D20220120-20220120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY4MDQxNw_64915d40-61a2-40af-a671-de1adc34dc2e"
      unitRef="usd">25900000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i0037eb0ed88b4354b067862baa4cefa3_D20220120-20220120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY4MDQyNQ_88f29167-2a6e-426e-b605-1ec1e59386c6"
      unitRef="usd">11800000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="if4f8df70221f4cb2841fe32fb6094aa8_D20220120-20220120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY4MDQzNw_5719bd15-310c-4443-9926-0ed2222da213"
      unitRef="shares">113303</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
      contextRef="if4f8df70221f4cb2841fe32fb6094aa8_D20220120-20220120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY4MDQ0MQ_120b4c94-69a8-4d13-9b6c-e069d571bbfb"
      unitRef="usd">3000000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i79751a12a5c14657a85da985b3d864c7_I20220120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY4MDQ0OQ_bdd47519-a0bc-4a7b-8c8e-eee3027c33d4"
      unitRef="usd">1600000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <rdnt:BusinessCombinationContingentConsiderationLiabilityPeriod
      contextRef="i0037eb0ed88b4354b067862baa4cefa3_D20220120-20220120"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY4MDQ1Nw_f5777d06-557e-4420-b9df-916f7fb20416">P18M</rdnt:BusinessCombinationContingentConsiderationLiabilityPeriod>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets
      contextRef="ic091556638644c818849ee8b176872d4_I20220120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY4MDQ2Mw_8bca68e5-c300-4506-99d5-c544cc101f96"
      unitRef="usd">2400000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="ic091556638644c818849ee8b176872d4_I20220120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY4MDQ3Mg_537c2435-7c98-4476-a903-dcad88081abf"
      unitRef="usd">100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="ic091556638644c818849ee8b176872d4_I20220120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY4MDQ4MA_c0e8a4d0-43f3-43e9-a62a-1df085911d4e"
      unitRef="usd">21300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i68c4c04cc28b411e853a2689c03e9923_I20220120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY4OTI1MQ_6dce6329-dbd5-4004-a959-86c194827ca2"
      unitRef="usd">19600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i6165260d2cac4c499c9451f3f1214d18_I20220120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY4OTI2Ng_7bda8b00-d1cb-41ed-a9bd-28782b5d2a79"
      unitRef="usd">700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
      contextRef="ic091556638644c818849ee8b176872d4_I20220120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY4MDUwMA_2c113dfb-131a-499e-b9d1-cd1465c79047"
      unitRef="usd">700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities
      contextRef="ic091556638644c818849ee8b176872d4_I20220120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY4MDUwOA_a65da63e-48d2-4f59-ace9-9942f7e8a95f"
      unitRef="usd">6700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities>
    <us-gaap:Goodwill
      contextRef="ic091556638644c818849ee8b176872d4_I20220120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY4MDQ4OA_ad55feb4-b661-4dbe-9c33-3ca7fc47de46"
      unitRef="usd">26400000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="if1af841cdb3f4cd0ad5ac44de8df9eb9_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY4MzYyOA_c5ad68c1-26bb-4872-a046-9cb71683f8df"
      unitRef="number">0.50</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="i5fc2355ac8fb4b73b314ebd1371b0448_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY4MzYzMg_098514ff-ef9f-4627-81e8-acd3d6451e09"
      unitRef="number">0.55</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ib5968e7309954164b239ff2880b7fa11_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfNDk0NzgwMjM4NDIzMg_8d83b7e0-fe29-42b9-8d6b-bfb96f445796">P7Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i14058b49fc714ecb8b39c3fe337c4c47_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY4NDc4NQ_63c98db3-499b-4925-bbcf-343945117eb3">P3Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="iab70d35c2cb440ccba0a783f0cdde440_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfNDk0NzgwMjM4NDIzNA_8bbc9ece-a338-474a-a0fd-8f19be92af8b">P7Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <rdnt:NumberOfLocationOfferingMultiModalityServices
      contextRef="ifac3d3f48c90447d9920ba9922709d73_I20220401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTYzNDU3NA_67a6ad8e-237c-46da-94d8-92e266496c67"
      unitRef="location">6</rdnt:NumberOfLocationOfferingMultiModalityServices>
    <rdnt:NumberOfCentersContributed
      contextRef="i2f87ecd615944571b918d5b62820eda3_I20220401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTYzNDU4NA_a86834a7-c338-498b-abd8-3bd2e68a4408"
      unitRef="center">4</rdnt:NumberOfCentersContributed>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i38c6fdf76c844677a1750f13333889fa_I20220401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTYzNDU4OQ_fe358fe1-35cf-4522-80b6-91828f1dae11"
      unitRef="usd">5400000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i9f0903465ba04ac2995029cdb8fbb03f_I20220401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTYzNDU5Mw_49d6de5e-8902-4005-8235-a08dac4b2a1a"
      unitRef="usd">3000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Goodwill
      contextRef="ib7f3ec194c084b988bc8b154c1692068_I20220401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTYzNDU5Nw_fd0d5c5c-9559-4da7-90a4-6a7dd2096be9"
      unitRef="usd">11000000</us-gaap:Goodwill>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="i63d0ac5d5bab47479964de4ca123d1f5_D20220401-20220401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTY4OTA5MA_01bbd81c-e506-4a9f-959d-50e131684cd7"
      unitRef="usd">6600000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest
      contextRef="ibb19233e68ff4d41a7e808f8715f8f2c_D20220401-20220401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTYzNDYwMQ_86ae20b8-2428-4402-9bd0-10ec95a51140"
      unitRef="number">0.65</us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest>
    <us-gaap:EquityMethodInvestments
      contextRef="i18b22b6c335a45639d3204cacdeb3610_I20220401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTYzNDYwNQ_0e851b43-0d2c-469e-ac05-bf018dac9f3b"
      unitRef="usd">11100000</us-gaap:EquityMethodInvestments>
    <us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest
      contextRef="i3feff49292e04c30a61b84bfc33cae41_D20220401-20220401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTYzNDYwOQ_8c12d2d6-1995-494f-bb29-0f25f2c90c52"
      unitRef="number">0.35</us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest>
    <rdnt:NumberOfLocationOfferingMultiModalityServices
      contextRef="i241f863ca19c468d9943aac255502e19_I20220615"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTYzNDY1Ng_b64364e8-3dd4-4f0f-a536-76fa9c2976a2"
      unitRef="location">2</rdnt:NumberOfLocationOfferingMultiModalityServices>
    <us-gaap:PaymentsToAcquireInterestInJointVenture
      contextRef="i59cfe8ed7dfb4ae09b7c26c7e2734e56_D20220615-20220615"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTYzNDY2Mw_591292f8-2a0a-47b5-9284-8c00a88261fb"
      unitRef="usd">5100</us-gaap:PaymentsToAcquireInterestInJointVenture>
    <us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest
      contextRef="i59cfe8ed7dfb4ae09b7c26c7e2734e56_D20220615-20220615"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTYzNDY3MQ_09a298b2-2432-410d-ae48-29f2487ecb18"
      unitRef="number">0.51</us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest>
    <us-gaap:EquityMethodInvestmentAggregateCost
      contextRef="i37eb4b7a2a86440dbba3d35c820120cb_I20220615"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTYzNDY3OQ_1c437dfc-c26c-44bb-9ed0-869e55141221"
      unitRef="usd">4900</us-gaap:EquityMethodInvestmentAggregateCost>
    <us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest
      contextRef="ic5a702b1c1bc4189a7b7944db5b5fabd_D20220615-20220615"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfMTA5OTUxMTYzNDY3NQ_eb7d5072-b069-4e40-98f1-a81cbc64080c"
      unitRef="number">0.49</us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest>
    <rdnt:NumberOfLocations
      contextRef="i987cdd48ce1c4476ae4f5b205442e647_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfNjU5NzA2OTgyNTkxNg_8d27f76d-f04a-4c5f-9999-b272bf2139dc"
      unitRef="location">2</rdnt:NumberOfLocations>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="ibc1689b570374d14852bee5675a09ab0_I20210101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfNDA5MA_6fa95bfd-f116-4911-b4e9-d20dea0ab5ed"
      unitRef="usd">400000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1
      contextRef="if68e59e75ef34799af1d02aff32b5aae_D20210101-20210101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfNDExMw_5f2e23ac-3308-4bd2-b2a4-08ec04504c44"
      unitRef="usd">300000</us-gaap:NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1>
    <us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest
      contextRef="if68e59e75ef34799af1d02aff32b5aae_D20210101-20210101"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfNDEzMg_524238ea-d043-472d-a9b8-5e4ec37cdc39"
      unitRef="number">0.600</us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="ia3b6622be19547c48017c645b19e93da_I20210101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfNDIwMA_bff21b95-097d-4438-b801-b41a1c476145"
      unitRef="usd">100000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest
      contextRef="i90a1726c6bee4422b356584ebb692aa7_D20210101-20210101"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfNDIwOQ_535871e7-56ba-43cb-a45e-e10feffb4b07"
      unitRef="number">0.400</us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest>
    <rdnt:NoncontrollingInterestPercentOfOwnershipSold
      contextRef="i9086fb31eefc4ef396dce636b41d760c_D20210901-20210901"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfNDM0NQ_8bb1825b-4436-48b7-b9eb-3d18597f8b76"
      unitRef="number">0.249</rdnt:NoncontrollingInterestPercentOfOwnershipSold>
    <rdnt:ProceedsFromSaleOfInterestInMinorityShareholders
      contextRef="i9086fb31eefc4ef396dce636b41d760c_D20210901-20210901"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfNDQzNQ_d1230edf-e3ae-445d-9e8f-875d69a649a2"
      unitRef="usd">13100000</rdnt:ProceedsFromSaleOfInterestInMinorityShareholders>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="i428ad0d44a1346558061485e679164b4_I20210831"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfNDU0NQ_dae15d3d-6b6a-4751-8573-c724f1f7b34a"
      unitRef="number">0.750</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="idd38436b6e0c4c099ae9632c1d4929cf_I20210901"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfNDU1MQ_8223b3ad-b5d1-4455-bc94-ca0ac68653ed"
      unitRef="number">0.501</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest
      contextRef="i9ed54666eaf94b7bb7053f98d1280ca4_D20210901-20210901"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfNDcwMQ_af12a1d1-2b96-41fb-a435-c8482e7e7bd2"
      unitRef="usd">4200000</us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="i237fcfddc1b842039f5586e2d3b311f4_D20210901-20210901"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84Mi9mcmFnOjQwZDRiOGE1MGMzYTRiZTg4MGIyNzZjOTg4NGZiMzlkL3RleHRyZWdpb246NDBkNGI4YTUwYzNhNGJlODgwYjI3NmM5ODg0ZmIzOWRfNDk2Mg_f3a104de-f4f0-4873-ad1c-096658ffbb04"
      unitRef="usd">5200000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGV4dHJlZ2lvbjozODBlMmQ4YTNiZjY0OGFjYWYyYTFlZTZmODk2Y2ZmNF80OTQ3ODAyMzI3ODkz_5e265b91-97c2-4f06-9414-859f8fd5bee9">SEGMENT REPORTING&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Our reportable segments are described below:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Imaging Center&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Our Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. The vast majority of our centers offer multi-modality imaging services, a strategy that diversifies revenue streams, reduces exposure to reimbursement changes and provides patients and referring physicians one location to serve the needs of multiple procedures.  We also provide teleradiolgy services in the United Kingdom though our Heart&amp;amp;Lung Health subsidiary.  Included in the segment is our eRad subsidiary, which designs the underlying critical scheduling, data storage and retrieval systems necessary for imaging center operation.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Artificial Intelligence ("AI")&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our AI segment develops and deploys clinical applications to enhance interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Our chief operating decision maker ("CODM"), who is also our CEO, evaluates the financial performance of our segments based upon their respective revenue and segmented internal profit and loss statements prepared on a basis not consistent with GAAP.  We do not report balance sheet information by segment since it is not reviewed by our CODM.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The table below present segment information reconciled to our financial results, with segment operating income or loss including revenue less cost of operations, depreciation and amortization, and other operating expenses to the extent specifically identified by segment (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.619%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.994%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.965%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.965%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:1.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.967%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Twelve Months Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Revenue:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Imaging Centers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,425,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,313,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,071,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;AI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,430,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,315,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,071,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Cost of Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Imaging Centers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,240,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,130,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;967,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;AI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;23,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;5,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total cost of operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,264,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,135,876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;970,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:23pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 8.2pt;text-indent:-7.2pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Depreciation and Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Imaging Centers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;109,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;96,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;86,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;AI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;6,353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;115,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;96,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;86,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 8.2pt;text-indent:-7.2pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Loss on Disposal of Equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Imaging Centers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;AI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total loss (gain)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Severance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Imaging Centers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;AI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total severance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Income from Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Imaging Centers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;72,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;77,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;12,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;AI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(25,753)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(4,438)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(3,221)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total income from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;46,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;73,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;9,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;For proper comparative purposes, Imaging Center segment revenue for the years 2021 and 2020 exclude Provider Relief Funding of $9.1 million and $26.3 million for the twelve months ended December 31, 2021 and 2020, respectively as it represents a form of direct Government stimulus.  No such funds were received for the twelve months ended December 31, 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGV4dHJlZ2lvbjozODBlMmQ4YTNiZjY0OGFjYWYyYTFlZTZmODk2Y2ZmNF80OTQ3ODAyMzI3ODk0_50270c62-a6d4-4785-8dd3-88d033894a61">The table below present segment information reconciled to our financial results, with segment operating income or loss including revenue less cost of operations, depreciation and amortization, and other operating expenses to the extent specifically identified by segment (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.619%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.994%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.965%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.965%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:1.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.967%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Twelve Months Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Revenue:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Imaging Centers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,425,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,313,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,071,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;AI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,430,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,315,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,071,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Cost of Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Imaging Centers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,240,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,130,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;967,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;AI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;23,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;5,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total cost of operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,264,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,135,876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;970,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:23pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 8.2pt;text-indent:-7.2pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Depreciation and Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Imaging Centers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;109,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;96,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;86,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;AI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;6,353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;115,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;96,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;86,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 8.2pt;text-indent:-7.2pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Loss on Disposal of Equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Imaging Centers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;AI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total loss (gain)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Severance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Imaging Centers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;AI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total severance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Income from Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Imaging Centers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;72,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;77,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#f8f8f8;padding:0 1pt"/&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;12,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#f8f8f8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.57pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;AI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(25,753)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(4,438)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(3,221)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total income from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;46,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;73,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;9,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:Revenues
      contextRef="ib5726eab9b6d42fa88ccbbd9685ed8a6_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8zLTEtMS0xLTU3OTM1_f54527a2-4e81-4eee-a1ae-3a479c28cd06"
      unitRef="usd">1425665000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i70656be41c694318a241edacdeceec2c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8zLTMtMS0xLTU3OTM1_657d6014-9d88-420c-9257-330f3f260e28"
      unitRef="usd">1313662000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6f9bff8ba8074226b0ec1f1f6f82e960_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8zLTUtMS0xLTYzMjMw_b4037c23-c15f-408d-aae0-32bb2c88e60a"
      unitRef="usd">1071840000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i74a6538627074503a346c001073d75b6_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV80LTEtMS0xLTU3OTM1_5a5773d1-01fa-428c-8e89-41bf67060717"
      unitRef="usd">4396000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4ae0b29c79ef48768e36dcfc86e3ae27_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV80LTMtMS0xLTU3OTM1_81550aab-920a-4786-b2a5-fb705dd2575c"
      unitRef="usd">1415000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i752bed455bf6494e806b337523329451_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV80LTUtMS0xLTYzMjMw_a39260d7-0114-4082-ba90-4ed6aa84ce6a"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV81LTEtMS0xLTU3OTM1_6b7e7e9f-2e09-423c-92d1-35385f9439f8"
      unitRef="usd">1430061000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV81LTMtMS0xLTU3OTM1_d61dcbf3-3779-463a-bf92-bd0e6fc35ac6"
      unitRef="usd">1315077000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV81LTUtMS0xLTYzMjMw_0808558c-5714-48a5-8c2a-330dedc9d1a9"
      unitRef="usd">1071840000</us-gaap:Revenues>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="ib5726eab9b6d42fa88ccbbd9685ed8a6_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV84LTEtMS0xLTU3OTQ0_1e62584c-a982-4f2d-b803-ccc1902588bf"
      unitRef="usd">1240593000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="i70656be41c694318a241edacdeceec2c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV84LTMtMS0xLTU3OTQ0_98e2226d-8f58-43f5-92ce-8c385787479b"
      unitRef="usd">1130543000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="i6f9bff8ba8074226b0ec1f1f6f82e960_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV84LTUtMS0xLTYzMjMw_1c3f8ea7-e750-4d28-b119-612c3509056e"
      unitRef="usd">967250000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="i74a6538627074503a346c001073d75b6_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV85LTEtMS0xLTU3OTQ0_e7782eb8-192f-425f-997d-286ce40f25fe"
      unitRef="usd">23753000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="i4ae0b29c79ef48768e36dcfc86e3ae27_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV85LTMtMS0xLTU3OTQ0_173dad3e-dda9-4524-8bd5-4a0067e55ad2"
      unitRef="usd">5333000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="i752bed455bf6494e806b337523329451_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV85LTUtMS0xLTYzMjMw_88df5ba9-f189-47ca-a92a-dca4dd9f1bb7"
      unitRef="usd">2822000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8xMC0xLTEtMS01Nzk0NA_3fb3cc14-0c6d-484e-9486-8b7ff41426f6"
      unitRef="usd">1264346000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8xMC0zLTEtMS01Nzk0NA_c6220029-8db5-41eb-937b-da23ee5ba76a"
      unitRef="usd">1135876000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8xMC01LTEtMS02MzIzMA_389a06b5-e0ca-4f7b-9544-82ca859e1c1f"
      unitRef="usd">970072000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ib5726eab9b6d42fa88ccbbd9685ed8a6_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8xMy0xLTEtMS01Nzk0OA_dd9cbde8-4e5d-4d6c-855b-de88bbd3b527"
      unitRef="usd">109524000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i70656be41c694318a241edacdeceec2c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8xMy0zLTEtMS01Nzk0OA_17b3635d-b09b-40a9-b98f-6b5c05ae0036"
      unitRef="usd">96174000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i6f9bff8ba8074226b0ec1f1f6f82e960_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8xMy01LTEtMS02MzIzMA_45f250a1-8848-476c-a08c-00934df1eccd"
      unitRef="usd">86396000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i74a6538627074503a346c001073d75b6_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8xNC0xLTEtMS01Nzk0OA_ce751523-4e0f-473d-aab8-73b205e92762"
      unitRef="usd">6353000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i4ae0b29c79ef48768e36dcfc86e3ae27_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8xNC0zLTEtMS01Nzk0OA_76354b0f-cc6c-4e45-8524-c00887bf75e0"
      unitRef="usd">520000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i752bed455bf6494e806b337523329451_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8xNC01LTEtMS02MzIzMA_f75ed4d3-4515-4c62-a993-2033e6664f53"
      unitRef="usd">399000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8xNS0xLTEtMS01Nzk0OA_99b1069b-889d-4e95-94b3-1e3418079593"
      unitRef="usd">115877000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8xNS0zLTEtMS01Nzk0OA_541915a6-64f6-4d84-8e14-3bd5d6dfeea1"
      unitRef="usd">96694000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8xNS01LTEtMS02MzIzMA_f32e2747-0154-4298-8188-88afb6c74ae5"
      unitRef="usd">86795000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="ib5726eab9b6d42fa88ccbbd9685ed8a6_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8xOC0xLTEtMS01Nzk0OA_677f4100-de2f-443a-92e7-5261ea655f24"
      unitRef="usd">-2506000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="i70656be41c694318a241edacdeceec2c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8xOC0zLTEtMS01Nzk0OA_31d1f8f9-0dd5-453c-94fc-3a3b433d1121"
      unitRef="usd">-8319000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="i6f9bff8ba8074226b0ec1f1f6f82e960_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8xOC01LTEtMS02MzIzMA_a42e44cf-05aa-41c4-8065-71adf673351d"
      unitRef="usd">-1200000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="i74a6538627074503a346c001073d75b6_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8xOS0xLTEtMS01Nzk0OA_3d035aa5-b63e-405a-95aa-d5061c129063"
      unitRef="usd">-23000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="i4ae0b29c79ef48768e36dcfc86e3ae27_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8xOS0zLTEtMS01Nzk0OA_66f61af2-c2b6-4ab1-8450-e94325617807"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="i752bed455bf6494e806b337523329451_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8xOS01LTEtMS02MzIzMA_2d9f99f6-65f5-4ef8-ae27-bd5b280f424b"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8yMC0xLTEtMS01Nzk0OA_820a9f1f-5c9d-4ec2-b087-7b325f17c8bd"
      unitRef="usd">-2529000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8yMC0zLTEtMS01Nzk0OA_c13b1dd8-16fe-4b67-ab99-4b072826b100"
      unitRef="usd">-8319000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8yMC01LTEtMS02MzIzMA_4a472623-2eae-40ab-bb35-c98be78936fa"
      unitRef="usd">-1200000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:SeveranceCosts1
      contextRef="ib5726eab9b6d42fa88ccbbd9685ed8a6_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8yMy0xLTEtMS01Nzk0OA_7a92c6bc-92c0-4da1-ad81-d0803dd3a778"
      unitRef="usd">926000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i70656be41c694318a241edacdeceec2c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8yMy0zLTEtMS01Nzk0OA_ae15be74-878f-4766-a900-fe2cb6e13367"
      unitRef="usd">744000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i6f9bff8ba8074226b0ec1f1f6f82e960_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8yMy01LTEtMS02MzIzMA_12997c71-ae0b-42a5-852f-d9562775d417"
      unitRef="usd">4353000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i74a6538627074503a346c001073d75b6_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8yNC0xLTEtMS01Nzk0OA_6f53ef74-2bb0-4bec-9fd7-c81bc08b899f"
      unitRef="usd">20000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i4ae0b29c79ef48768e36dcfc86e3ae27_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8yNC0zLTEtMS01Nzk0OA_955e78a1-6d69-413c-b43d-0cc6dbeb114b"
      unitRef="usd">0</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i752bed455bf6494e806b337523329451_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8yNC01LTEtMS02MzIzMA_71df385c-8871-4dc5-b793-746ed216e5d6"
      unitRef="usd">0</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8yNS0xLTEtMS01Nzk0OA_6b86d06d-de52-4abb-85b1-746410fdc373"
      unitRef="usd">946000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8yNS0zLTEtMS01Nzk0OA_15856548-f8d6-45c2-8384-7681147abbdc"
      unitRef="usd">744000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8yNS01LTEtMS02MzIzMA_fb2569a8-ff5d-42d4-a995-cea1c97a88fb"
      unitRef="usd">4353000</us-gaap:SeveranceCosts1>
    <rdnt:OperatingIncomeLossExcludingReliefFunding
      contextRef="ib5726eab9b6d42fa88ccbbd9685ed8a6_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8yOC0xLTEtMS01Nzk0OA_cdfc179d-aa5c-47ca-aa5d-8e337bce85ac"
      unitRef="usd">72116000</rdnt:OperatingIncomeLossExcludingReliefFunding>
    <rdnt:OperatingIncomeLossExcludingReliefFunding
      contextRef="i70656be41c694318a241edacdeceec2c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8yOC0zLTEtMS01Nzk0OA_026af416-1f87-4626-8cfe-fe4355442f73"
      unitRef="usd">77882000</rdnt:OperatingIncomeLossExcludingReliefFunding>
    <rdnt:OperatingIncomeLossExcludingReliefFunding
      contextRef="i6f9bff8ba8074226b0ec1f1f6f82e960_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8yOC01LTEtMS02MzIzMA_d36f4c0d-83d4-4d5e-bc01-1f8cf4f26a66"
      unitRef="usd">12641000</rdnt:OperatingIncomeLossExcludingReliefFunding>
    <rdnt:OperatingIncomeLossExcludingReliefFunding
      contextRef="i74a6538627074503a346c001073d75b6_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8yOS0xLTEtMS01Nzk0OA_5ecc4843-f92f-4d5c-b2d3-d7e626d09b88"
      unitRef="usd">-25753000</rdnt:OperatingIncomeLossExcludingReliefFunding>
    <rdnt:OperatingIncomeLossExcludingReliefFunding
      contextRef="i4ae0b29c79ef48768e36dcfc86e3ae27_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8yOS0zLTEtMS01Nzk0OA_ebba234e-dcc5-472e-b37a-e5fa6b28ead5"
      unitRef="usd">-4438000</rdnt:OperatingIncomeLossExcludingReliefFunding>
    <rdnt:OperatingIncomeLossExcludingReliefFunding
      contextRef="i752bed455bf6494e806b337523329451_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8yOS01LTEtMS02MzIzMA_b0b2fe6e-7f67-4a0c-a93f-91d51c3e4985"
      unitRef="usd">-3221000</rdnt:OperatingIncomeLossExcludingReliefFunding>
    <rdnt:OperatingIncomeLossExcludingReliefFunding
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8zMC0xLTEtMS01Nzk0OA_365d9ff7-a0cf-4a11-bb29-0ac3a9c971e2"
      unitRef="usd">46363000</rdnt:OperatingIncomeLossExcludingReliefFunding>
    <rdnt:OperatingIncomeLossExcludingReliefFunding
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8zMC0zLTEtMS01Nzk0OA_19f2cbe3-d200-4512-89f7-8920c5f5a926"
      unitRef="usd">73444000</rdnt:OperatingIncomeLossExcludingReliefFunding>
    <rdnt:OperatingIncomeLossExcludingReliefFunding
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGFibGU6MThlMDlmNjcxMzUxNGU1NzgxNDM0NTgyNjU2NjU0NWEvdGFibGVyYW5nZToxOGUwOWY2NzEzNTE0ZTU3ODE0MzQ1ODI2NTY2NTQ1YV8zMC01LTEtMS02MzIzMA_1dcb1810-1be1-45ca-9544-f2c38be2ca53"
      unitRef="usd">9420000</rdnt:OperatingIncomeLossExcludingReliefFunding>
    <rdnt:ProceedsFromProviderReliefFunding
      contextRef="i50ecee342add4902a22e3378fadbd827_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGV4dHJlZ2lvbjozODBlMmQ4YTNiZjY0OGFjYWYyYTFlZTZmODk2Y2ZmNF8zODQ4MjkwNjk5ODg5_8e91d02a-64dd-478d-9f5f-db0016b15db8"
      unitRef="usd">9100000</rdnt:ProceedsFromProviderReliefFunding>
    <rdnt:ProceedsFromProviderReliefFunding
      contextRef="i506dbb6a5e1c4160b81aac201c17a8cf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGV4dHJlZ2lvbjozODBlMmQ4YTNiZjY0OGFjYWYyYTFlZTZmODk2Y2ZmNF8xMDk5NTExNjMwNzIz_516b7e79-432b-4dae-b2fe-b3400212ddd6"
      unitRef="usd">26300000</rdnt:ProceedsFromProviderReliefFunding>
    <rdnt:ProceedsFromProviderReliefFunding
      contextRef="if6fd3b8a94554fd9a4f614d18e1c3d63_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMzQwL2ZyYWc6MzgwZTJkOGEzYmY2NDhhY2FmMmExZWU2Zjg5NmNmZjQvdGV4dHJlZ2lvbjozODBlMmQ4YTNiZjY0OGFjYWYyYTFlZTZmODk2Y2ZmNF8zODQ4MjkwNjk5ODk4_2728673a-10ed-4b39-a406-d18094653628"
      unitRef="usd">0</rdnt:ProceedsFromProviderReliefFunding>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RleHRyZWdpb246ZDgwMTVkODBhY2Q2NDBkMTgzZjlkNWUzYTFmYTEyYmVfMTE3Mg_8da29869-e637-4e3b-be98-d3166e8c6015">GOODWILL AND OTHER INTANGIBLE ASSETS&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill is recorded as a result of business combinations. The following is a reconciliation of Goodwill by business segment for the years ended December 31, 2021 and December 31, 2022 is provided below (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;                &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.672%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.482%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.482%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.937%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.482%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Imaging Center&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Artificial Intelligence&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;448,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;472,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Measurement period and other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;489,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;513,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Disposals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,200)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,200)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Measurement period and other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(106)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,272)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,244)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;606,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;677,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amount of goodwill from these acquisitions that is deductible for tax purposes as of December 31, 2022 is $154.9 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other intangible assets are primarily related to our business combinations and software development.  They include the estimated fair values of such items as service agreements, customer lists, covenants not to compete, acquired technologies, and trade names.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total amortization expense was $10.1 million, $4.4 million, and $3.7 million for the years ended December 31, 2022, 2021 and 2020, respectively.  Intangible assets are amortized using the straight-line method over their useful life determined at acquisition. Management service agreements are amortized over 25 years using the straight line method.  Software development is capitalized and amortized over the useful life of the software when placed into service.  Trade names are reviewed annually for impairment.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables shows annual amortization expense, by asset classes that will be recorded over the next five years (in thousands):&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.464%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.332%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Weighted average amortization period remaining in years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Management Service Contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;20,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8.9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Covenant not to compete and other contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.1&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Customer Relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;18.6&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Patent and Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6.4&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Developed Technology &amp;amp; Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;38,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Trade Names amortized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Trade Names indefinite life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;IPR&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total Annual Amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;53,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;106,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RleHRyZWdpb246ZDgwMTVkODBhY2Q2NDBkMTgzZjlkNWUzYTFmYTEyYmVfMTE3Nw_a3f2a3fd-3ecb-46e0-a0b7-6667f857d11d">for the years ended December 31, 2021 and December 31, 2022 is provided below (in thousands):&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;                &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.672%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.482%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.482%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.937%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.482%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Imaging Center&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Artificial Intelligence&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;448,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;472,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Measurement period and other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;489,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;513,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Disposals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,200)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,200)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Measurement period and other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(106)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,272)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,244)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;606,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;677,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
    <us-gaap:Goodwill
      contextRef="i668dae88a2914d8f85a4a37e9114214e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOjdiOGRiNjU1MDJmMjQyOWJiYmE3MWM0ZDQ1ZGFmODJkL3RhYmxlcmFuZ2U6N2I4ZGI2NTUwMmYyNDI5YmJiYTcxYzRkNDVkYWY4MmRfMS0yLTEtMS03MDY5OQ_42726449-2d5b-4255-9e94-214d0672dfac"
      unitRef="usd">448269000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="iad55eccace614330a9a10e68dc84d72a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOjdiOGRiNjU1MDJmMjQyOWJiYmE3MWM0ZDQ1ZGFmODJkL3RhYmxlcmFuZ2U6N2I4ZGI2NTUwMmYyNDI5YmJiYTcxYzRkNDVkYWY4MmRfMS00LTEtMS03MDY5OQ_774b04d8-3098-4f4f-b9a9-6aa0fa8faaee"
      unitRef="usd">24610000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ifb50bc5a13564f6a97eb669524009c18_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOjdiOGRiNjU1MDJmMjQyOWJiYmE3MWM0ZDQ1ZGFmODJkL3RhYmxlcmFuZ2U6N2I4ZGI2NTUwMmYyNDI5YmJiYTcxYzRkNDVkYWY4MmRfMC0xLTEtMS0yOTQ4OQ_24ce4033-20d3-4857-b451-0ccc0b7022b4"
      unitRef="usd">472879000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i70656be41c694318a241edacdeceec2c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOjdiOGRiNjU1MDJmMjQyOWJiYmE3MWM0ZDQ1ZGFmODJkL3RhYmxlcmFuZ2U6N2I4ZGI2NTUwMmYyNDI5YmJiYTcxYzRkNDVkYWY4MmRfMi0yLTEtMS03MDY5OQ_dd480d20-9b40-463a-96f3-82b7eb56d126"
      unitRef="usd">40864000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i4ae0b29c79ef48768e36dcfc86e3ae27_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOjdiOGRiNjU1MDJmMjQyOWJiYmE3MWM0ZDQ1ZGFmODJkL3RhYmxlcmFuZ2U6N2I4ZGI2NTUwMmYyNDI5YmJiYTcxYzRkNDVkYWY4MmRfMi00LTEtMS03MDY5OQ_1eb30abc-1c12-4868-a00e-b5a879b78ca8"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOjdiOGRiNjU1MDJmMjQyOWJiYmE3MWM0ZDQ1ZGFmODJkL3RhYmxlcmFuZ2U6N2I4ZGI2NTUwMmYyNDI5YmJiYTcxYzRkNDVkYWY4MmRfMS0xLTEtMS0yOTQ4OQ_86461191-4f3c-4c30-999a-f70f7196c337"
      unitRef="usd">40864000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i70656be41c694318a241edacdeceec2c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOjdiOGRiNjU1MDJmMjQyOWJiYmE3MWM0ZDQ1ZGFmODJkL3RhYmxlcmFuZ2U6N2I4ZGI2NTUwMmYyNDI5YmJiYTcxYzRkNDVkYWY4MmRfMy0yLTEtMS03MDY5OQ_c76d2c2c-ea5f-4bca-aa8f-7f78944a52eb"
      unitRef="usd">77000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i4ae0b29c79ef48768e36dcfc86e3ae27_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOjdiOGRiNjU1MDJmMjQyOWJiYmE3MWM0ZDQ1ZGFmODJkL3RhYmxlcmFuZ2U6N2I4ZGI2NTUwMmYyNDI5YmJiYTcxYzRkNDVkYWY4MmRfMy00LTEtMS03MDY5OQ_83981126-9bf8-4d2c-bf21-f4683226d63c"
      unitRef="usd">0</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOjdiOGRiNjU1MDJmMjQyOWJiYmE3MWM0ZDQ1ZGFmODJkL3RhYmxlcmFuZ2U6N2I4ZGI2NTUwMmYyNDI5YmJiYTcxYzRkNDVkYWY4MmRfMi0xLTEtMS02MDQwMg_c9807050-b2a0-4863-9712-0d42899ef54d"
      unitRef="usd">77000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:Goodwill
      contextRef="idba042321a6d496fb90b273b2d065e08_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOjdiOGRiNjU1MDJmMjQyOWJiYmE3MWM0ZDQ1ZGFmODJkL3RhYmxlcmFuZ2U6N2I4ZGI2NTUwMmYyNDI5YmJiYTcxYzRkNDVkYWY4MmRfNC0yLTEtMS03MDY5OQ_9d2290ca-20fb-4ead-9859-61f6ca13dc61"
      unitRef="usd">489210000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i8fff7583d4414b91a34f6aefc3dae941_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOjdiOGRiNjU1MDJmMjQyOWJiYmE3MWM0ZDQ1ZGFmODJkL3RhYmxlcmFuZ2U6N2I4ZGI2NTUwMmYyNDI5YmJiYTcxYzRkNDVkYWY4MmRfNC00LTEtMS03MDY5OQ_bbd70f6d-2fcc-41cf-a92a-260c4ec2e1f7"
      unitRef="usd">24610000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOjdiOGRiNjU1MDJmMjQyOWJiYmE3MWM0ZDQ1ZGFmODJkL3RhYmxlcmFuZ2U6N2I4ZGI2NTUwMmYyNDI5YmJiYTcxYzRkNDVkYWY4MmRfMi0xLTEtMS0yOTQ4OQ_658d5f5b-1ca5-4bec-b7fc-be69c21d1a34"
      unitRef="usd">513820000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ib5726eab9b6d42fa88ccbbd9685ed8a6_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOjdiOGRiNjU1MDJmMjQyOWJiYmE3MWM0ZDQ1ZGFmODJkL3RhYmxlcmFuZ2U6N2I4ZGI2NTUwMmYyNDI5YmJiYTcxYzRkNDVkYWY4MmRfNi0yLTEtMS03MDY5OQ_430279c8-cf3a-4f55-bebb-c82fffd60e2d"
      unitRef="usd">120551000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i74a6538627074503a346c001073d75b6_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOjdiOGRiNjU1MDJmMjQyOWJiYmE3MWM0ZDQ1ZGFmODJkL3RhYmxlcmFuZ2U6N2I4ZGI2NTUwMmYyNDI5YmJiYTcxYzRkNDVkYWY4MmRfNi00LTEtMS03MDY5OQ_1b96fe6d-5d4b-407c-8339-d3600b66d2c1"
      unitRef="usd">48697000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOjdiOGRiNjU1MDJmMjQyOWJiYmE3MWM0ZDQ1ZGFmODJkL3RhYmxlcmFuZ2U6N2I4ZGI2NTUwMmYyNDI5YmJiYTcxYzRkNDVkYWY4MmRfMy0xLTEtMS0yOTQ4OQ_80cda6f4-58e8-46f6-947d-bc71a08581b0"
      unitRef="usd">169248000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="ib5726eab9b6d42fa88ccbbd9685ed8a6_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOjdiOGRiNjU1MDJmMjQyOWJiYmE3MWM0ZDQ1ZGFmODJkL3RhYmxlcmFuZ2U6N2I4ZGI2NTUwMmYyNDI5YmJiYTcxYzRkNDVkYWY4MmRfNy0yLTEtMS03Mjc5OQ_394d74aa-5cbb-4543-a2ba-9e6655dea957"
      unitRef="usd">4200000</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="i74a6538627074503a346c001073d75b6_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOjdiOGRiNjU1MDJmMjQyOWJiYmE3MWM0ZDQ1ZGFmODJkL3RhYmxlcmFuZ2U6N2I4ZGI2NTUwMmYyNDI5YmJiYTcxYzRkNDVkYWY4MmRfNy00LTEtMS03Mjc5OQ_5d042427-b2d1-49d6-b7d0-0ed0ef209345"
      unitRef="usd">0</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOjdiOGRiNjU1MDJmMjQyOWJiYmE3MWM0ZDQ1ZGFmODJkL3RhYmxlcmFuZ2U6N2I4ZGI2NTUwMmYyNDI5YmJiYTcxYzRkNDVkYWY4MmRfNy02LTEtMS03Mjc5OQ_e780ac1e-09ca-40bd-b0ae-4c9ffdbeb74c"
      unitRef="usd">4200000</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="ib5726eab9b6d42fa88ccbbd9685ed8a6_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOjdiOGRiNjU1MDJmMjQyOWJiYmE3MWM0ZDQ1ZGFmODJkL3RhYmxlcmFuZ2U6N2I4ZGI2NTUwMmYyNDI5YmJiYTcxYzRkNDVkYWY4MmRfNy0yLTEtMS03MDY5OQ_d1bfe439-fbd7-4b34-9905-7a8f9e1b8a51"
      unitRef="usd">-106000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i74a6538627074503a346c001073d75b6_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOjdiOGRiNjU1MDJmMjQyOWJiYmE3MWM0ZDQ1ZGFmODJkL3RhYmxlcmFuZ2U6N2I4ZGI2NTUwMmYyNDI5YmJiYTcxYzRkNDVkYWY4MmRfNy00LTEtMS03MDY5OQ_c2166ec4-f693-4c17-bfe3-83c2f31edc7e"
      unitRef="usd">147000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOjdiOGRiNjU1MDJmMjQyOWJiYmE3MWM0ZDQ1ZGFmODJkL3RhYmxlcmFuZ2U6N2I4ZGI2NTUwMmYyNDI5YmJiYTcxYzRkNDVkYWY4MmRfNS0xLTEtMS0yOTQ4OQ_d3b01326-0e9f-47ff-94a8-41b0494d68fa"
      unitRef="usd">41000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="ib5726eab9b6d42fa88ccbbd9685ed8a6_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOjdiOGRiNjU1MDJmMjQyOWJiYmE3MWM0ZDQ1ZGFmODJkL3RhYmxlcmFuZ2U6N2I4ZGI2NTUwMmYyNDI5YmJiYTcxYzRkNDVkYWY4MmRfOC0yLTEtMS03MDY5OQ_637aa0d3-3954-4f4b-b538-92a566b72af6"
      unitRef="usd">1028000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i74a6538627074503a346c001073d75b6_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOjdiOGRiNjU1MDJmMjQyOWJiYmE3MWM0ZDQ1ZGFmODJkL3RhYmxlcmFuZ2U6N2I4ZGI2NTUwMmYyNDI5YmJiYTcxYzRkNDVkYWY4MmRfOC00LTEtMS03MDY5OQ_e810f968-9a22-4a71-bcdd-b7297ab4e92e"
      unitRef="usd">-2272000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOjdiOGRiNjU1MDJmMjQyOWJiYmE3MWM0ZDQ1ZGFmODJkL3RhYmxlcmFuZ2U6N2I4ZGI2NTUwMmYyNDI5YmJiYTcxYzRkNDVkYWY4MmRfNi0xLTEtMS02MDQ2NA_467bf98c-f9e4-4071-afd7-43c747bac960"
      unitRef="usd">-1244000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="i611c6f40576041af971fff090e96cc52_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOjdiOGRiNjU1MDJmMjQyOWJiYmE3MWM0ZDQ1ZGFmODJkL3RhYmxlcmFuZ2U6N2I4ZGI2NTUwMmYyNDI5YmJiYTcxYzRkNDVkYWY4MmRfOS0yLTEtMS03MDY5OQ_88b7b71b-1cf2-4216-ae97-04a59dcc0a59"
      unitRef="usd">606483000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i24072ed80ca2499296f569d92fce4296_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOjdiOGRiNjU1MDJmMjQyOWJiYmE3MWM0ZDQ1ZGFmODJkL3RhYmxlcmFuZ2U6N2I4ZGI2NTUwMmYyNDI5YmJiYTcxYzRkNDVkYWY4MmRfOS00LTEtMS03MDY5OQ_f77414f7-b682-42aa-adf7-26212cd05eb0"
      unitRef="usd">71182000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOjdiOGRiNjU1MDJmMjQyOWJiYmE3MWM0ZDQ1ZGFmODJkL3RhYmxlcmFuZ2U6N2I4ZGI2NTUwMmYyNDI5YmJiYTcxYzRkNDVkYWY4MmRfNi0xLTEtMS0yOTQ4OQ_9a67e51a-794a-4c83-8571-85364e98f647"
      unitRef="usd">677665000</us-gaap:Goodwill>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RleHRyZWdpb246ZDgwMTVkODBhY2Q2NDBkMTgzZjlkNWUzYTFmYTEyYmVfMjk2_743b7058-6172-43cf-b79d-e1b5a0b352eb"
      unitRef="usd">154900000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <us-gaap:AdjustmentForAmortization
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RleHRyZWdpb246ZDgwMTVkODBhY2Q2NDBkMTgzZjlkNWUzYTFmYTEyYmVfNjAz_1da72e36-a702-4d54-872b-2f79c4fcf2be"
      unitRef="usd">10100000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RleHRyZWdpb246ZDgwMTVkODBhY2Q2NDBkMTgzZjlkNWUzYTFmYTEyYmVfNjA3_90e77761-afea-4d7f-a7fd-7eda11aeaef4"
      unitRef="usd">4400000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RleHRyZWdpb246ZDgwMTVkODBhY2Q2NDBkMTgzZjlkNWUzYTFmYTEyYmVfNjE1_5dbf6a53-6e42-4261-b0f5-c658ca8d88ba"
      unitRef="usd">3700000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ic1e54694556947f19c007ab6032e164a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RleHRyZWdpb246ZDgwMTVkODBhY2Q2NDBkMTgzZjlkNWUzYTFmYTEyYmVfODMw_4d88f5cd-75e1-493b-b968-a991df907026">P25Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RleHRyZWdpb246ZDgwMTVkODBhY2Q2NDBkMTgzZjlkNWUzYTFmYTEyYmVfMTE3OQ_4264ea3e-fe91-41f8-9276-d443c4f5495d">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables shows annual amortization expense, by asset classes that will be recorded over the next five years (in thousands):&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.464%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.332%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Weighted average amortization period remaining in years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Management Service Contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;20,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8.9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Covenant not to compete and other contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.1&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Customer Relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;18.6&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Patent and Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6.4&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Developed Technology &amp;amp; Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;38,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Trade Names amortized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Trade Names indefinite life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;IPR&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total Annual Amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;53,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;106,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i414955456ed943bfb2a5a55163f53cf9_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfMS0xLTEtMS0yOTQ4OQ_a3541cda-caca-46a9-8f15-b58476de6ca2"
      unitRef="usd">2287000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i414955456ed943bfb2a5a55163f53cf9_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfMS0zLTEtMS0yOTQ4OQ_6f4593e4-f76d-4751-9415-f5850fe32cbb"
      unitRef="usd">2287000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i414955456ed943bfb2a5a55163f53cf9_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfMS01LTEtMS0yOTQ4OQ_ab962601-f527-4c90-a500-e4a72e06943b"
      unitRef="usd">2287000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i414955456ed943bfb2a5a55163f53cf9_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfMS03LTEtMS0yOTQ4OQ_1579a147-d925-4490-9062-f6df2519fbbf"
      unitRef="usd">2287000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="i414955456ed943bfb2a5a55163f53cf9_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfMS05LTEtMS0yOTQ4OQ_e82e07b3-654e-4da2-85b0-9c397461da30"
      unitRef="usd">2287000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="i414955456ed943bfb2a5a55163f53cf9_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfMS0xMS0xLTEtMjk0ODk_bb7778fb-038d-4f85-869c-c46847d76d52"
      unitRef="usd">8958000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i414955456ed943bfb2a5a55163f53cf9_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfMS0xMy0xLTEtMjk0ODk_a24400d2-0343-4afe-9cf8-848affc55bfb"
      unitRef="usd">20393000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="ic1e54694556947f19c007ab6032e164a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfMS0xNS0xLTEtMjk0ODk_ab81959a-60ac-4ac2-bb0a-e41bce5a5f4c">P8Y10M24D</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i4aa6fe1b19fa4032b19af61fea4d1770_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfMi0xLTEtMS0yOTQ4OQ_07046127-b82d-412c-9aa8-477f689ae488"
      unitRef="usd">1319000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i4aa6fe1b19fa4032b19af61fea4d1770_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfMi0zLTEtMS0yOTQ4OQ_599afd8a-55b2-4d49-94b2-bab1e8b5eb45"
      unitRef="usd">891000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i4aa6fe1b19fa4032b19af61fea4d1770_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfMi01LTEtMS0yOTQ4OQ_64be64e1-2917-42d4-8a46-43ba89e69bba"
      unitRef="usd">642000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i4aa6fe1b19fa4032b19af61fea4d1770_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfMi03LTEtMS0yOTQ4OQ_ebd0d2dd-8848-48bc-9563-01694e7a25c9"
      unitRef="usd">356000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="i4aa6fe1b19fa4032b19af61fea4d1770_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfMi05LTEtMS0yOTQ4OQ_39cf3ae0-510e-4be4-a400-0208e2d2fed5"
      unitRef="usd">72000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="i4aa6fe1b19fa4032b19af61fea4d1770_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfMi0xMS0xLTEtMjk0ODk_52cb0e1b-cf2e-4f2f-9006-90ce2c269b52"
      unitRef="usd">40000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i4aa6fe1b19fa4032b19af61fea4d1770_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfMi0xMy0xLTEtMjk0ODk_98ac2321-1d73-4c3f-94a3-4128bf52b01b"
      unitRef="usd">3320000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="i1302a37a97cd4b139f598c14f70e6a6f_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfMi0xNS0xLTEtMjk0ODk_02718fee-912b-4567-a85d-4531e80010e9">P3Y1M6D</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="iddb0cd692be2450194003830cb8eade8_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfMy0xLTEtMS02OTc0OA_1d3a4987-480c-401f-90b3-10e39abb7ca4"
      unitRef="usd">1244000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="iddb0cd692be2450194003830cb8eade8_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfMy0zLTEtMS02OTc0OA_04f73774-ab72-4411-92e1-7ceeea3fd030"
      unitRef="usd">1244000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="iddb0cd692be2450194003830cb8eade8_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfMy01LTEtMS02OTc0OA_724ed811-b30b-4426-915c-ef9efdde8be6"
      unitRef="usd">1112000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="iddb0cd692be2450194003830cb8eade8_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfMy03LTEtMS02OTc0OA_6644e00a-2e36-4b36-aa63-9e9e7f5502eb"
      unitRef="usd">991000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="iddb0cd692be2450194003830cb8eade8_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfMy05LTEtMS02OTc0OA_a79450a2-ce65-4f7b-841d-2854e0ec644a"
      unitRef="usd">816000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="iddb0cd692be2450194003830cb8eade8_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfMy0xMS0xLTEtNjk3NDg_de597f28-f089-4774-8152-457f4c53c4da"
      unitRef="usd">12396000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="iddb0cd692be2450194003830cb8eade8_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfMy0xMy0xLTEtNjk3NDg_e76e2f55-8161-4b42-a51f-4e72a34738b4"
      unitRef="usd">17803000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="i14058b49fc714ecb8b39c3fe337c4c47_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfMy0xNS0xLTEtNjk3NDg_148a501e-9b51-438d-bb09-c5e160d4fec1">P18Y7M6D</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i8d300af724bd42fa81df479bcd52a561_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfNC0xLTEtMS02OTc2MQ_11615ae9-9850-470d-a9bb-c528afe9dda1"
      unitRef="usd">298000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i8d300af724bd42fa81df479bcd52a561_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfNC0zLTEtMS02OTc2MQ_c6c31c6a-a640-4b29-b23f-ad1f2504aeef"
      unitRef="usd">298000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i8d300af724bd42fa81df479bcd52a561_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfNC01LTEtMS02OTc2MQ_f221c10c-44d8-4435-a0b0-d0b22a1fd829"
      unitRef="usd">298000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i8d300af724bd42fa81df479bcd52a561_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfNC03LTEtMS02OTc2MQ_6bd830d8-b0b2-4c2e-a992-a6cec809bba1"
      unitRef="usd">298000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="i8d300af724bd42fa81df479bcd52a561_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfNC05LTEtMS02OTc2MQ_d3745204-b370-4702-bc43-e83be9913280"
      unitRef="usd">298000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="i8d300af724bd42fa81df479bcd52a561_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfNC0xMS0xLTEtNjk3NjE_a1a11204-5735-427c-80e5-d7aa811b6e85"
      unitRef="usd">322000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i8d300af724bd42fa81df479bcd52a561_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfNC0xMy0xLTEtNjk3NjE_358efc0d-3071-4523-9475-61155c0492b5"
      unitRef="usd">1812000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="i5f97cf28159d4af1b51bd03a44af0b3e_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfNC0xNS0xLTEtNjk3NjE_4c1a59cc-5166-4a74-97ea-207dedd181b2">P6Y4M24D</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i5437e74731804fadaa4b067a3e9a1079_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfMy0xLTEtMS0yOTQ4OQ_f7055cdf-9efd-46eb-83c3-ac6f6a02cd5f"
      unitRef="usd">6297000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i5437e74731804fadaa4b067a3e9a1079_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfMy0zLTEtMS0yOTQ4OQ_1b7e7a31-beec-4ed4-b97a-27bd5fa88778"
      unitRef="usd">6297000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i5437e74731804fadaa4b067a3e9a1079_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfMy01LTEtMS0yOTQ4OQ_de0b085d-9338-4966-8cc9-d134b645eba3"
      unitRef="usd">6297000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i5437e74731804fadaa4b067a3e9a1079_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfMy03LTEtMS0yOTQ4OQ_32dfbe6c-31bb-4637-9e5b-bfec1d902611"
      unitRef="usd">6257000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="i5437e74731804fadaa4b067a3e9a1079_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfMy05LTEtMS0yOTQ4OQ_8ac905d2-e778-4a73-9154-ec70cc122fd6"
      unitRef="usd">5722000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="i5437e74731804fadaa4b067a3e9a1079_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfMy0xMS0xLTEtMjk0ODk_4a47d3d6-a821-4105-8c70-729eadd126ce"
      unitRef="usd">7196000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i5437e74731804fadaa4b067a3e9a1079_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfMy0xMy0xLTEtMjk0ODk_6da866a9-c670-4662-9b37-2bff60b29875"
      unitRef="usd">38066000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="i79c0ea2a5c9d4435ba5a05f5371abd25_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfMy0xNS0xLTEtMjk0ODk_e49ca10a-1e93-413e-8586-35ca3a1c28b1">P6Y8M12D</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="ia5494245554a4a8c8f993a496d898612_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfNC0xLTEtMS0yOTQ4OQ_c90e676e-8923-4f18-99de-ba9d82b42b77"
      unitRef="usd">305000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="ia5494245554a4a8c8f993a496d898612_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfNC0zLTEtMS0yOTQ4OQ_3ed213e7-dc8d-4c1f-a918-6c1114c84f72"
      unitRef="usd">77000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="ia5494245554a4a8c8f993a496d898612_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfNC01LTEtMS0yOTQ4OQ_d429dec4-6c23-40bb-ac29-0acc80f59f16"
      unitRef="usd">77000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="ia5494245554a4a8c8f993a496d898612_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfNC03LTEtMS0yOTQ4OQ_b09a9d7b-3c91-4084-9763-d5e3ed303ca0"
      unitRef="usd">77000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="ia5494245554a4a8c8f993a496d898612_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfNC05LTEtMS0yOTQ4OQ_9ed819ac-cbde-4e2d-81c0-95aef4613dcf"
      unitRef="usd">77000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="ia5494245554a4a8c8f993a496d898612_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfNC0xMS0xLTEtMjk0ODk_a7afdfe2-f476-4b72-bbc4-d69f6ee177cd"
      unitRef="usd">89000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ia5494245554a4a8c8f993a496d898612_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfNC0xMy0xLTEtMjk0ODk_858fe2e4-790b-4ff5-a5ab-3b608b41d5e7"
      unitRef="usd">702000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="iab70d35c2cb440ccba0a783f0cdde440_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfNC0xNS0xLTEtMjk0ODk_72404f14-4f70-4b90-860d-0061a00185e9">P4Y6M</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ide5c8507870d42c2934aea55608ad13f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfNS0xMS0xLTEtMjk0ODk_75b24a68-cfb3-4200-b1c8-cd3d79ed2c52"
      unitRef="usd">7100000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ide5c8507870d42c2934aea55608ad13f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfNS0xMy0xLTEtMjk0ODk_6beb459b-1491-4587-8d7d-556873029175"
      unitRef="usd">7100000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i24d947bc9cc64b21a3c0655f38ee8f28_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfNi0xMS0xLTEtMjk0ODk_b5dc6602-eba2-45c9-909a-b7f5ef8e390b"
      unitRef="usd">17032000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i24d947bc9cc64b21a3c0655f38ee8f28_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfNi0xMy0xLTEtMjk0ODk_eda3216c-c6c0-437b-a251-3ec935f891d8"
      unitRef="usd">17032000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfNy0xLTEtMS0yOTQ4OQ_f12fda51-188f-4996-ab56-25e68b36b945"
      unitRef="usd">11750000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfNy0zLTEtMS0yOTQ4OQ_a6e8aca6-56c8-404e-8a0f-1154d6434771"
      unitRef="usd">11094000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfNy01LTEtMS0yOTQ4OQ_38aea5b9-d39c-403e-9074-346508cf2520"
      unitRef="usd">10713000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfNy03LTEtMS0yOTQ4OQ_a96a353d-b26a-461e-bc0c-d27b8741d598"
      unitRef="usd">10266000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfNy05LTEtMS0yOTQ4OQ_ad17efd1-821b-4e83-b178-dd96c12fd9b0"
      unitRef="usd">9272000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfNy0xMS0xLTEtMjk0ODk_b3d8dbe1-aaa1-459e-8739-009ce47f9634"
      unitRef="usd">53133000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV84NS9mcmFnOmQ4MDE1ZDgwYWNkNjQwZDE4M2Y5ZDVlM2ExZmExMmJlL3RhYmxlOmNkOWEyMzk4ZTU2MzRkZWJhZjA2OTlhYmRlZmZiNDE1L3RhYmxlcmFuZ2U6Y2Q5YTIzOThlNTYzNGRlYmFmMDY5OWFiZGVmZmI0MTVfNy0xMy0xLTEtMjk0ODk_ec2e652e-aa82-4800-a999-b8a09aba3e33"
      unitRef="usd">106228000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85MS9mcmFnOjVkZTIwNzU2YmQ5YTQxMWRiYzI4NjJhODYxOWIzOGQzL3RleHRyZWdpb246NWRlMjA3NTZiZDlhNDExZGJjMjg2MmE4NjE5YjM4ZDNfNTY3_2cacab2f-562d-44ba-b3d4-0868ca243442">PROPERTY AND EQUIPMENT&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment and accumulated depreciation and amortization are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;649,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;560,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer and office equipment, furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software development costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;501,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;441,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment originally acquired under finance/capital lease&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property and equipment cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,320,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,161,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(754,739)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(676,975)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;565,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;484,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Included in our property and equipment at December 31, 2022  is approximately $73.4 million total of construction in process amounts consisting of $26.6 million in medical equipment, $5.3 million in computer and office equipment, $0.4 million in software development and $41.1 million in leasehold improvements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Included in our property and equipment at December 31, 2021 is approximately $18.1 million total of construction in process amounts consisting of $2.6 million in medical equipment, $6.1 million in computer and office equipment, and $9.3 million in leasehold improvements.&lt;/span&gt;&lt;/div&gt;Depreciation and amortization expense of property and equipment, including amortization of equipment under finance leases, for the years ended December 31, 2022, 2021 and 2020 was $105.6 million, $92.3 million, and $83.1 million, respectively.</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85MS9mcmFnOjVkZTIwNzU2YmQ5YTQxMWRiYzI4NjJhODYxOWIzOGQzL3RleHRyZWdpb246NWRlMjA3NTZiZDlhNDExZGJjMjg2MmE4NjE5YjM4ZDNfNTcw_7dd19b31-2949-4e20-a7bd-05d3059c350d">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment and accumulated depreciation and amortization are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;649,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;560,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer and office equipment, furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software development costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;501,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;441,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment originally acquired under finance/capital lease&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property and equipment cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,320,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,161,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(754,739)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(676,975)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;565,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;484,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ie3d853d4f3b647c5b17405fc7cbc9ec7_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85MS9mcmFnOjVkZTIwNzU2YmQ5YTQxMWRiYzI4NjJhODYxOWIzOGQzL3RhYmxlOmUwNWZmY2Q3MDY3ZTRlZjBiOGRkOGI2OWExYjUyNzU1L3RhYmxlcmFuZ2U6ZTA1ZmZjZDcwNjdlNGVmMGI4ZGQ4YjY5YTFiNTI3NTVfMi0xLTEtMS0yOTQ4OQ_12bea3f8-67a7-4f4f-bf4b-2c0137a85a90"
      unitRef="usd">250000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i86f01866d4c84b9bbfb9f6decd26c6f6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85MS9mcmFnOjVkZTIwNzU2YmQ5YTQxMWRiYzI4NjJhODYxOWIzOGQzL3RhYmxlOmUwNWZmY2Q3MDY3ZTRlZjBiOGRkOGI2OWExYjUyNzU1L3RhYmxlcmFuZ2U6ZTA1ZmZjZDcwNjdlNGVmMGI4ZGQ4YjY5YTFiNTI3NTVfMi0zLTEtMS0yOTQ4OQ_ae3612c1-ae29-4746-81e3-a83cf1655df9"
      unitRef="usd">250000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i00b2de31a74241f0b34c082e030c3988_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85MS9mcmFnOjVkZTIwNzU2YmQ5YTQxMWRiYzI4NjJhODYxOWIzOGQzL3RhYmxlOmUwNWZmY2Q3MDY3ZTRlZjBiOGRkOGI2OWExYjUyNzU1L3RhYmxlcmFuZ2U6ZTA1ZmZjZDcwNjdlNGVmMGI4ZGQ4YjY5YTFiNTI3NTVfMy0xLTEtMS0yOTQ4OQ_213b4b75-1204-4956-99d2-f22ba00526c2"
      unitRef="usd">649034000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="id97a7eba2f0b4e619a60a313e21c6dd0_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85MS9mcmFnOjVkZTIwNzU2YmQ5YTQxMWRiYzI4NjJhODYxOWIzOGQzL3RhYmxlOmUwNWZmY2Q3MDY3ZTRlZjBiOGRkOGI2OWExYjUyNzU1L3RhYmxlcmFuZ2U6ZTA1ZmZjZDcwNjdlNGVmMGI4ZGQ4YjY5YTFiNTI3NTVfMy0zLTEtMS0yOTQ4OQ_15be0112-50d2-4bb9-b3aa-b5bb10dd7062"
      unitRef="usd">560301000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ia8674635644f472eba0908b3c0584e97_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85MS9mcmFnOjVkZTIwNzU2YmQ5YTQxMWRiYzI4NjJhODYxOWIzOGQzL3RhYmxlOmUwNWZmY2Q3MDY3ZTRlZjBiOGRkOGI2OWExYjUyNzU1L3RhYmxlcmFuZ2U6ZTA1ZmZjZDcwNjdlNGVmMGI4ZGQ4YjY5YTFiNTI3NTVfNC0xLTEtMS0yOTQ4OQ_524487f5-0bf6-4d01-86c0-13719508d0ea"
      unitRef="usd">119467000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ibdcafabfcf7040c3b97ef14ac3b23f01_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85MS9mcmFnOjVkZTIwNzU2YmQ5YTQxMWRiYzI4NjJhODYxOWIzOGQzL3RhYmxlOmUwNWZmY2Q3MDY3ZTRlZjBiOGRkOGI2OWExYjUyNzU1L3RhYmxlcmFuZ2U6ZTA1ZmZjZDcwNjdlNGVmMGI4ZGQ4YjY5YTFiNTI3NTVfNC0zLTEtMS0yOTQ4OQ_be24980b-3d40-4623-8b00-855c083bce22"
      unitRef="usd">144766000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="idd3d3e3e547648dd8ffe8630809ea423_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85MS9mcmFnOjVkZTIwNzU2YmQ5YTQxMWRiYzI4NjJhODYxOWIzOGQzL3RhYmxlOmUwNWZmY2Q3MDY3ZTRlZjBiOGRkOGI2OWExYjUyNzU1L3RhYmxlcmFuZ2U6ZTA1ZmZjZDcwNjdlNGVmMGI4ZGQ4YjY5YTFiNTI3NTVfNS0xLTEtMS0yOTQ4OQ_d1ccfc59-b0d9-493d-883f-4e08d18e8878"
      unitRef="usd">36015000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i86ebeca091034ef29127281116eaa2a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85MS9mcmFnOjVkZTIwNzU2YmQ5YTQxMWRiYzI4NjJhODYxOWIzOGQzL3RhYmxlOmUwNWZmY2Q3MDY3ZTRlZjBiOGRkOGI2OWExYjUyNzU1L3RhYmxlcmFuZ2U6ZTA1ZmZjZDcwNjdlNGVmMGI4ZGQ4YjY5YTFiNTI3NTVfNS0zLTEtMS0yOTQ4OQ_83d10fb2-e29d-4b4f-bb20-53229643b6b2"
      unitRef="usd">0</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i628e73d9b5b54e3bab985a48e170406a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85MS9mcmFnOjVkZTIwNzU2YmQ5YTQxMWRiYzI4NjJhODYxOWIzOGQzL3RhYmxlOmUwNWZmY2Q3MDY3ZTRlZjBiOGRkOGI2OWExYjUyNzU1L3RhYmxlcmFuZ2U6ZTA1ZmZjZDcwNjdlNGVmMGI4ZGQ4YjY5YTFiNTI3NTVfNi0xLTEtMS0yOTQ4OQ_2b2180db-3b49-4f92-98ae-e9d3f6aa2d55"
      unitRef="usd">501963000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i6dc531e92c3b4e048c61c11ad6d1e801_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85MS9mcmFnOjVkZTIwNzU2YmQ5YTQxMWRiYzI4NjJhODYxOWIzOGQzL3RhYmxlOmUwNWZmY2Q3MDY3ZTRlZjBiOGRkOGI2OWExYjUyNzU1L3RhYmxlcmFuZ2U6ZTA1ZmZjZDcwNjdlNGVmMGI4ZGQ4YjY5YTFiNTI3NTVfNi0zLTEtMS0yOTQ4OQ_e40cb279-87c4-48ea-9ee4-1cc1dac06f99"
      unitRef="usd">441921000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85MS9mcmFnOjVkZTIwNzU2YmQ5YTQxMWRiYzI4NjJhODYxOWIzOGQzL3RhYmxlOmUwNWZmY2Q3MDY3ZTRlZjBiOGRkOGI2OWExYjUyNzU1L3RhYmxlcmFuZ2U6ZTA1ZmZjZDcwNjdlNGVmMGI4ZGQ4YjY5YTFiNTI3NTVfNy0xLTEtMS0yOTQ4OQ_62c687f1-d49d-4f3f-90b1-762c752c3e8a"
      unitRef="usd">13971000</us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85MS9mcmFnOjVkZTIwNzU2YmQ5YTQxMWRiYzI4NjJhODYxOWIzOGQzL3RhYmxlOmUwNWZmY2Q3MDY3ZTRlZjBiOGRkOGI2OWExYjUyNzU1L3RhYmxlcmFuZ2U6ZTA1ZmZjZDcwNjdlNGVmMGI4ZGQ4YjY5YTFiNTI3NTVfNy0zLTEtMS0yOTQ4OQ_9c8b40aa-fab8-4102-bc05-346e58380cb2"
      unitRef="usd">13984000</us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85MS9mcmFnOjVkZTIwNzU2YmQ5YTQxMWRiYzI4NjJhODYxOWIzOGQzL3RhYmxlOmUwNWZmY2Q3MDY3ZTRlZjBiOGRkOGI2OWExYjUyNzU1L3RhYmxlcmFuZ2U6ZTA1ZmZjZDcwNjdlNGVmMGI4ZGQ4YjY5YTFiNTI3NTVfOC0xLTEtMS0yOTQ4OQ_e69749cb-1e38-482e-8b36-885e92583d5f"
      unitRef="usd">1320700000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85MS9mcmFnOjVkZTIwNzU2YmQ5YTQxMWRiYzI4NjJhODYxOWIzOGQzL3RhYmxlOmUwNWZmY2Q3MDY3ZTRlZjBiOGRkOGI2OWExYjUyNzU1L3RhYmxlcmFuZ2U6ZTA1ZmZjZDcwNjdlNGVmMGI4ZGQ4YjY5YTFiNTI3NTVfOC0zLTEtMS0yOTQ4OQ_ce745406-7946-4de0-8c59-2da7c1796390"
      unitRef="usd">1161222000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85MS9mcmFnOjVkZTIwNzU2YmQ5YTQxMWRiYzI4NjJhODYxOWIzOGQzL3RhYmxlOmUwNWZmY2Q3MDY3ZTRlZjBiOGRkOGI2OWExYjUyNzU1L3RhYmxlcmFuZ2U6ZTA1ZmZjZDcwNjdlNGVmMGI4ZGQ4YjY5YTFiNTI3NTVfOS0xLTEtMS0yOTQ4OQ_e8b18a88-f0ce-48d6-a890-6d998699153a"
      unitRef="usd">754739000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85MS9mcmFnOjVkZTIwNzU2YmQ5YTQxMWRiYzI4NjJhODYxOWIzOGQzL3RhYmxlOmUwNWZmY2Q3MDY3ZTRlZjBiOGRkOGI2OWExYjUyNzU1L3RhYmxlcmFuZ2U6ZTA1ZmZjZDcwNjdlNGVmMGI4ZGQ4YjY5YTFiNTI3NTVfOS0zLTEtMS0yOTQ4OQ_1fb1b08a-72ea-49cc-a3b2-7502ebb40e44"
      unitRef="usd">676975000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85MS9mcmFnOjVkZTIwNzU2YmQ5YTQxMWRiYzI4NjJhODYxOWIzOGQzL3RhYmxlOmUwNWZmY2Q3MDY3ZTRlZjBiOGRkOGI2OWExYjUyNzU1L3RhYmxlcmFuZ2U6ZTA1ZmZjZDcwNjdlNGVmMGI4ZGQ4YjY5YTFiNTI3NTVfMTItMS0xLTEtMjk0ODk_437c11e7-9500-409d-ad84-8afde0252734"
      unitRef="usd">565961000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85MS9mcmFnOjVkZTIwNzU2YmQ5YTQxMWRiYzI4NjJhODYxOWIzOGQzL3RhYmxlOmUwNWZmY2Q3MDY3ZTRlZjBiOGRkOGI2OWExYjUyNzU1L3RhYmxlcmFuZ2U6ZTA1ZmZjZDcwNjdlNGVmMGI4ZGQ4YjY5YTFiNTI3NTVfMTItMy0xLTEtMjk0ODk_f5ab751b-3359-4cef-a619-dbc11d166d9e"
      unitRef="usd">484247000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i08ea7357bc1b48619f5f3b7216b20254_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85MS9mcmFnOjVkZTIwNzU2YmQ5YTQxMWRiYzI4NjJhODYxOWIzOGQzL3RleHRyZWdpb246NWRlMjA3NTZiZDlhNDExZGJjMjg2MmE4NjE5YjM4ZDNfMjEw_8bf23b17-59ce-4ef5-b559-8ce10b0e8c80"
      unitRef="usd">73400000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:ConstructionInProgressGross
      contextRef="ie245ad8af20a43b28a6758228cc88b11_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85MS9mcmFnOjVkZTIwNzU2YmQ5YTQxMWRiYzI4NjJhODYxOWIzOGQzL3RleHRyZWdpb246NWRlMjA3NTZiZDlhNDExZGJjMjg2MmE4NjE5YjM4ZDNfMjY4_c0a8651a-babb-495d-88c3-2a6fb282ecbd"
      unitRef="usd">26600000</us-gaap:ConstructionInProgressGross>
    <us-gaap:ConstructionInProgressGross
      contextRef="iab7ce7f316034c05b56c7a6f0d599bb4_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85MS9mcmFnOjVkZTIwNzU2YmQ5YTQxMWRiYzI4NjJhODYxOWIzOGQzL3RleHRyZWdpb246NWRlMjA3NTZiZDlhNDExZGJjMjg2MmE4NjE5YjM4ZDNfMjkz_aeb3fe79-124e-4cc4-886f-488df07d8e64"
      unitRef="usd">5300000</us-gaap:ConstructionInProgressGross>
    <us-gaap:ConstructionInProgressGross
      contextRef="idd3d3e3e547648dd8ffe8630809ea423_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85MS9mcmFnOjVkZTIwNzU2YmQ5YTQxMWRiYzI4NjJhODYxOWIzOGQzL3RleHRyZWdpb246NWRlMjA3NTZiZDlhNDExZGJjMjg2MmE4NjE5YjM4ZDNfMTA5OTUxMTYyODgyMA_bfe759a9-af4b-48db-925e-0aa59dd4409c"
      unitRef="usd">400000</us-gaap:ConstructionInProgressGross>
    <us-gaap:ConstructionInProgressGross
      contextRef="i628e73d9b5b54e3bab985a48e170406a_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85MS9mcmFnOjVkZTIwNzU2YmQ5YTQxMWRiYzI4NjJhODYxOWIzOGQzL3RleHRyZWdpb246NWRlMjA3NTZiZDlhNDExZGJjMjg2MmE4NjE5YjM4ZDNfMzM0_06aa4769-50c9-4600-aa04-cf777a7e8306"
      unitRef="usd">41100000</us-gaap:ConstructionInProgressGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ie1c8ab68fe024b7a8859d4b269c75b02_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85MS9mcmFnOjVkZTIwNzU2YmQ5YTQxMWRiYzI4NjJhODYxOWIzOGQzL3RleHRyZWdpb246NWRlMjA3NTZiZDlhNDExZGJjMjg2MmE4NjE5YjM4ZDNfMTA5OTUxMTYyOTE3Mw_36e8fcff-0ae3-490f-aada-49125b57fa08"
      unitRef="usd">18100000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:ConstructionInProgressGross
      contextRef="i7fd7963b7541486ba64acd58081d4289_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85MS9mcmFnOjVkZTIwNzU2YmQ5YTQxMWRiYzI4NjJhODYxOWIzOGQzL3RleHRyZWdpb246NWRlMjA3NTZiZDlhNDExZGJjMjg2MmE4NjE5YjM4ZDNfMTA5OTUxMTYyOTE3OQ_3fdc29e6-55c9-4c42-8670-853aa4bf3089"
      unitRef="usd">2600000</us-gaap:ConstructionInProgressGross>
    <us-gaap:ConstructionInProgressGross
      contextRef="ia4939d9e3309469392b03a7b6fed19d2_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85MS9mcmFnOjVkZTIwNzU2YmQ5YTQxMWRiYzI4NjJhODYxOWIzOGQzL3RleHRyZWdpb246NWRlMjA3NTZiZDlhNDExZGJjMjg2MmE4NjE5YjM4ZDNfMTA5OTUxMTYyOTE4Ng_3e4c7fb8-58a6-4ee2-b085-cb51bf85867f"
      unitRef="usd">6100000</us-gaap:ConstructionInProgressGross>
    <us-gaap:ConstructionInProgressGross
      contextRef="i6dc531e92c3b4e048c61c11ad6d1e801_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85MS9mcmFnOjVkZTIwNzU2YmQ5YTQxMWRiYzI4NjJhODYxOWIzOGQzL3RleHRyZWdpb246NWRlMjA3NTZiZDlhNDExZGJjMjg2MmE4NjE5YjM4ZDNfMTA5OTUxMTYyOTI0Mg_704f2389-e263-4609-a0c7-5a43169ed1d3"
      unitRef="usd">9300000</us-gaap:ConstructionInProgressGross>
    <us-gaap:DepreciationAndAmortization
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85MS9mcmFnOjVkZTIwNzU2YmQ5YTQxMWRiYzI4NjJhODYxOWIzOGQzL3RleHRyZWdpb246NWRlMjA3NTZiZDlhNDExZGJjMjg2MmE4NjE5YjM4ZDNfNTM0_c2a258f4-257b-45c4-b98c-b1512a9bdb00"
      unitRef="usd">105600000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85MS9mcmFnOjVkZTIwNzU2YmQ5YTQxMWRiYzI4NjJhODYxOWIzOGQzL3RleHRyZWdpb246NWRlMjA3NTZiZDlhNDExZGJjMjg2MmE4NjE5YjM4ZDNfNTM4_41cca87f-0796-41b5-b01b-5b54d077bb25"
      unitRef="usd">92300000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85MS9mcmFnOjVkZTIwNzU2YmQ5YTQxMWRiYzI4NjJhODYxOWIzOGQzL3RleHRyZWdpb246NWRlMjA3NTZiZDlhNDExZGJjMjg2MmE4NjE5YjM4ZDNfNTQ2_d61f0743-e761-4798-bbb1-a420f9d63f61"
      unitRef="usd">83100000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfOTg3Mg_dbf636de-464e-4180-b30c-273134e8b608">CREDIT FACILITIES AND NOTES PAYABLE&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2022 and December 31, 2021 our debt obligations consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;First Lien Term Loans collateralized by RadNet's tangible and intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;714,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;721,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount on First Lien Term Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,127)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,213)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan Agreement collateralized by NJIN's tangible and intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount on NJIN Term Loan Agreement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,254)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;851,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;754,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,400)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,164)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term portion debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;839,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;743,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a listing of annual principal maturities of notes payable exclusive of all related discounts and repayments on our revolving credit facilities for years ending December&#160;31 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.090%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;677,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total notes payable obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;864,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We had no outstanding balance under our $195.0 million Barclays Revolving Credit Facility at December 31, 2022 and had reserved an additional $7.6 million for certain letters of credit.  The remaining $187.4 million of our Barclays Revolving Credit Facility was available to draw upon as of  December 31, 2022.  We also had no balance under our $50.0 million Truist Revolving Credit Facility related to our consolidated subsidiary NJIN at December 31, 2022, and with no letters &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;of credit reserved against the facility, the full amount was available to draw upon. At December 31, 2022 we were in compliance with all covenants under our credit facilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Amendments to Credit Facilities&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt;text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Barclays: Second Amended and Restated First Lien Credit and Guaranty Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 23, 2021, we entered into the Second Amended and Restated First Lien Credit and Guaranty Agreement (the  "Restated Credit Agreement") which provides for $725.0 million of senior secured first lien term loans (the "First Lien Term Loans") and a $195.0 million senior secured revolving credit facility (the "Barclays Revolving Credit Facility"). The proceeds of the First Lien Term Loans were used to refinance loans outstanding under our prior first lien credit agreement and provide funding for current and future operations. Total costs of the Restated Credit Agreement amounted to approximately $14.9 million segregated as follows: $8.8 million capitalized to discount and deferred finance cost, $6.0 million charged to loss on early extinguishment of debt and related expenses and $0.1 million written off to interest expense.  Amounts capitalized will be amortized over the remaining terms of the respective credit facilities under the Restated Credit Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Truist: Second Amended and Restated Revolving Credit and Term Loan Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 7, 2022, we entered into the Second Amended and Restated Revolving Credit and Term Loan Agreement (the "Restated Credit and Term Loan Agreement") which provides for a $150.0 million of a secured term loan (the "Truist Term Loan") and a $50.0 million secured revolving credit facility (the "Truist Revolving Credit Facility").  Both loans were secured by our simultaneous entry into the Second Amended and Restated Guaranty and Security Agreement on the same date.  The proceeds were were used to refinance the outstanding balance under our prior term loan agreement and provide funding for current and future operations. Total costs of the Restated Credit and Term Loan Agreement amounted to approximately $2.7 million segregated as follows: $2.0 million capitalized to discount and deferred finance cost and $0.7 million expensed to loss on extinguishment of debt and related expenses in other expense.  Amounts capitalized will be amortized over the remaining terms of the respective credit facilities under the Restated Credit and Term Loan Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All obligations under the Second Amended and Restated Credit and Term Loan Agreement bear interest at either a SOFR or a Base Rate (each as defined in the Restated Credit and Term Loan Agreement), plus an applicable margin according to the following schedule:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.128%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.790%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.226%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.226%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.697%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pricing Level&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Leverage Ratio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Applicable Margin for SOFR Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Applicable Margin for Base Rate Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Applicable Margin for Letter of Credit Fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Applicable Percentage for Commitment Fee&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;I&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater than or equal to 3.00:1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.50%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.50%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.45%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;II&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than 3.00:1.00 but greater than or equal to 2.50:1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.25%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.25%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.25%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.40%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;III&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than 2.50:1.00 but greater than or equal to&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00:1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.00%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.35%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IV&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than 2.00:1.00 but greater than or equal to 1.50:1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.75%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.75%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.75%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.30%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;V&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than 1.50:1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.50%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.30%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Senior Credit Facilities:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;text-decoration:underline"&gt;First Lien Term Loans:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The First Lien Term Loans under the Restated Credit Agreement bear interest at either a Eurodollar Rate or an Alternate Base Rate (in each case, as defined in the Restated Credit Agreement), plus an applicable margin.  The applicable &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;margin for Eurodollar Rate term loans under the Restated Credit Agreement is 3.25% per annum, with a reduction to 3.0% per annum upon delivery by us of financial statements evidencing a first lien net leverage ratio of 3.50 to 1.00 or less.  Such statements were delivered by us on May 27, 2021. At December 31, 2022 the effective Eurodollar Rate and the Alternate Base Rate for the First Lien Term Loans under the Restated Credit Agreement was 4.73% and 7.50%, respectively and the applicable margin for the Eurodollar Rate and Alternate Base Rate First Lien Term Loans under the Restated Credit Agreement was 3.00% and 2.00%, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Restated Credit Agreement provides for quarterly payments of principal for the First Lien Term Loan in the amount of approximately $1.8 million.  The  First Lien Term Loan will mature on April 23, 2028 unless otherwise accelerated under the terms of the Restated Credit Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Truist Term Loan:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Truist Term Loan currently bears interest at a three month SOFR election of 4.28% plus an applicable margin and fees based on Pricing Level III described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:54pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The scheduled amortization of the Truist Term Loan begins March 31, 2023 with quarterly payments of $1.9 million, representing 1.00% of the original principal balance. At scheduled intervals, the quarterly amortization increases by $0.9 million, with the remaining balance to be paid at maturity.  The Truist Term Loan will mature on October 10, 2027 unless otherwise accelerated under the terms of the  Credit Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:54pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Revolving Credit Facilities:&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Barclays Revolving Credit Facility:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Barclays Revolving Credit Facility under the Restated Credit Agreement is a $195.0 million senior secured revolving credit facility. Associated with the Barclays Revolving Credit Facility are deferred financing costs, net of accumulated amortization, of $1.7 million at December 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revolving loans borrowed under the Barclays Revolving Credit Facility bear interest at either a Eurodollar Rate or an Alternate Base Rate (in each case, as defined in the Restated Credit Agreement) plus an applicable margin which adjusts depending on our first lien net leverage ratio, according to the following schedule:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.181%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.850%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.342%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.508%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;First Lien Leverage Ratio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Eurodollar Rate Spread&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Base Rate Spread&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&amp;gt; 3.50x&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.25%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.25%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&amp;gt; 3.00x but &#x2264; 3.50x&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.00%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2264; 3.00x&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.75%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.75%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2022, the effective interest rate for borrowings on revolving loans under the Barclays Revolving Credit Facility stood at 9.5%.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For letters of credit issued under the Barclays Revolving Credit Facility, letter of credit fees accrue at the applicable margin for Eurodollar rate revolving loans which is currently 3.00% and fronting fees accrue at 0.125% per annum, in each case on the average aggregate daily maximum amount available to be drawn under all letters of credit issued under the Restated Credit Agreement. In addition, a commitment fee of 0.50% per annum accrues on the unused revolver commitments under the Barclays Revolving Credit Facility.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Barclays Revolving Credit Facility will terminate on April 23, 2026 unless otherwise accelerated in accordance with the terms of the Restated Credit Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Truist Revolving Credit Facility:&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt;text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt;text-align:justify;text-indent:54pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Associated with the Truist Revolving Credit Facility of $50.0 million are deferred financing costs, net of accumulated amortization, of  $0.6 million at December 31, 2022.  As of December 31, 2022, NJIN had no borrowings under the Truist Revolving Credit Facility. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt;text-align:justify;text-indent:54pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt;text-align:justify;text-indent:54pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Truist Revolving Credit Facility bears interest with different margins based on types of borrowings at a Pricing Level III as noted in the pricing grid above.  The Truist Revolving Credit Facility terminates on the earliest of (i) &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;October 7, 2027, (ii) the date on which the Revolving Commitments are terminated pursuant to Section 2.8 of the Truist Restated Credit Agreement, or (iii) the date on which all amounts outstanding under the Truist Restated Credit Agreement have been declared or have automatically become due and payable (whether by acceleration or otherwise).  &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt;text-align:justify;text-indent:54pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Recent Amendments to prior Credit Facilities&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Barclays Credit Facilities:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 28, 2020, RadNet Management, Inc. and RadNet, Inc. entered into Amendment No. 8, Consent and Incremental Joinder Agreement to Credit and Guaranty Agreement (the "Eighth Amendment").  The Eighth Amendment amended the prior first lien credit agreement to add $57.5 million of revolving commitments to the prior Barclays revolving credit facility increasing the maximum borrowing capacity under the prior Barclays revolving credit facility to $195.0 million while leaving the maturity date of July 1, 2023 unchanged.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 18, 2019 we entered into the following two amendments to the prior first lien credit agreement: (i) Amendment No. 6, Consent and Incremental Joinder Agreement to Credit and Guaranty Agreement (the &#x201c;Sixth Amendment&#x201d;); and (ii) Amendment No. 7 to Credit and Guaranty Agreement (the &#x201c;Seventh Amendment&#x201d;).  Among other things, the Sixth Amendment amended the prior first lien credit agreement to issue $100.0 million in incremental first lien term loans and to add an additional $20.0 million of revolving commitments to the prior Barclays revolving credit facility.  The Seventh Amendment amended the prior first lien credit agreement to extend the maturity date of the prior Barclays revolving credit facility by an additional two years to July 1, 2023, unless sooner terminated in accordance with the terms of the prior first lien credit agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The prior first lien credit agreement was amended and restated by the Restated Credit Agreement described above, and the prior first lien term loans and prior Barclays revolving credit facility under the prior first lien credit agreement were refinanced and replaced by the First Lien Term Loans and the Barclays Revolving Credit Facility provided under the Restated Credit Agreement described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;text-decoration:underline"&gt;Truist Credit Facilities:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On August 31, 2018, under the Amended and Restated Revolving Credit and Term Loan Agreement (A&amp;amp;R Agreement), NJIN secured a term loan commitment of $60.0 million and established revolving credit facility of $30.0 million.  The agreement had a maturity date of August 31, 2023 and was refinanced on October 10, 2022 by the Second Amended and Restated Revolving Credit and Term Loan Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Paycheck Protection Program&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Paycheck Protection Program (PPP) includes funds available for loans to small business and Medicare providers to support operations during the COVID-19 pandemic. The funds are administered by the Small Business Administration (SBA), through approved lenders and do not require collateral or personal guarantees.  We received our loans based on being a Medicare provider. The terms and conditions for participation require entities to certify that economic uncertainty related to the COVID-19 pandemic makes the loan necessary to support their current operations, and that they will use the funds to retain workers (e.g., by paying salaries, providing paid sick/medical leave and health insurance benefits) and pay certain debts (mortgage obligations) and expenses (e.g. rent, utilities, telephone).  The loans have a 1.0% fixed interest rate and are due in 2 years.  The loans are eligible for forgiveness subject to salary limitations and employee retention levels. Certain of our consolidated subsidiaries received four loans totaling $4.0 million.  We accounted for the funds received as debt and recorded a liability for the full amount of proceeds received and accrued interest over the term of the loans.  In December 2020 we met the eligibility requirements for forgiveness and the loans were written off to gain on debt extinguishment.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfOTg2OA_fdbcf2df-699f-43d9-a1c0-72c83ae1ed47">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2022 and December 31, 2021 our debt obligations consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;First Lien Term Loans collateralized by RadNet's tangible and intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;714,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;721,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount on First Lien Term Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,127)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,213)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan Agreement collateralized by NJIN's tangible and intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount on NJIN Term Loan Agreement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,254)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;851,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;754,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,400)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,164)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term portion debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;839,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;743,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:LongTermDebt
      contextRef="i522481570141465585681f5b994a0bcb_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOmRjNTNhNDE2MzA5YjQ1NDE5M2I5Njk2ODRkYWViNmRhL3RhYmxlcmFuZ2U6ZGM1M2E0MTYzMDliNDU0MTkzYjk2OTY4NGRhZWI2ZGFfMS0xLTEtMS0yOTQ4OQ_fb7bb527-481a-4901-962e-b2290cf48596"
      unitRef="usd">714125000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i54b3674416244d4db4d21de83d7cbbde_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOmRjNTNhNDE2MzA5YjQ1NDE5M2I5Njk2ODRkYWViNmRhL3RhYmxlcmFuZ2U6ZGM1M2E0MTYzMDliNDU0MTkzYjk2OTY4NGRhZWI2ZGFfMS0zLTEtMS0yOTQ4OQ_26eeea88-47b8-49d3-a6fa-67694124376d"
      unitRef="usd">721375000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i522481570141465585681f5b994a0bcb_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOmRjNTNhNDE2MzA5YjQ1NDE5M2I5Njk2ODRkYWViNmRhL3RhYmxlcmFuZ2U6ZGM1M2E0MTYzMDliNDU0MTkzYjk2OTY4NGRhZWI2ZGFfMi0xLTEtMS0yOTQ4OQ_aacfc4d2-a8ae-4a16-8f32-fb684cbdc9a1"
      unitRef="usd">11127000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i54b3674416244d4db4d21de83d7cbbde_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOmRjNTNhNDE2MzA5YjQ1NDE5M2I5Njk2ODRkYWViNmRhL3RhYmxlcmFuZ2U6ZGM1M2E0MTYzMDliNDU0MTkzYjk2OTY4NGRhZWI2ZGFfMi0zLTEtMS0yOTQ4OQ_8f39c874-6a5d-44aa-a711-c1098c6ff3f1"
      unitRef="usd">13213000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:LongTermDebt
      contextRef="i7864c4b6f44e46a09a513ac84d7d21ec_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOmRjNTNhNDE2MzA5YjQ1NDE5M2I5Njk2ODRkYWViNmRhL3RhYmxlcmFuZ2U6ZGM1M2E0MTYzMDliNDU0MTkzYjk2OTY4NGRhZWI2ZGFfMy0xLTEtMS0yOTQ4OQ_8395a2f5-2c78-451c-ae69-e5523eb70a84"
      unitRef="usd">150000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i38719d8a10de43ad8f49713e3df85eba_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOmRjNTNhNDE2MzA5YjQ1NDE5M2I5Njk2ODRkYWViNmRhL3RhYmxlcmFuZ2U6ZGM1M2E0MTYzMDliNDU0MTkzYjk2OTY4NGRhZWI2ZGFfMy0zLTEtMS0yOTQ4OQ_30df9359-1e44-46ad-8dda-2f311bb0f57a"
      unitRef="usd">46500000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i7864c4b6f44e46a09a513ac84d7d21ec_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOmRjNTNhNDE2MzA5YjQ1NDE5M2I5Njk2ODRkYWViNmRhL3RhYmxlcmFuZ2U6ZGM1M2E0MTYzMDliNDU0MTkzYjk2OTY4NGRhZWI2ZGFfNC0xLTEtMS0yOTQ4OQ_6055d763-2d45-4148-b601-66745c6f0d89"
      unitRef="usd">1254000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i38719d8a10de43ad8f49713e3df85eba_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOmRjNTNhNDE2MzA5YjQ1NDE5M2I5Njk2ODRkYWViNmRhL3RhYmxlcmFuZ2U6ZGM1M2E0MTYzMDliNDU0MTkzYjk2OTY4NGRhZWI2ZGFfNC0zLTEtMS0yOTQ4OQ_219c6e85-b984-4367-8f06-a847273dd6c1"
      unitRef="usd">0</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:LongTermDebt
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOmRjNTNhNDE2MzA5YjQ1NDE5M2I5Njk2ODRkYWViNmRhL3RhYmxlcmFuZ2U6ZGM1M2E0MTYzMDliNDU0MTkzYjk2OTY4NGRhZWI2ZGFfNS0xLTEtMS0yOTQ4OQ_ecfd2b3c-6313-4bb9-ac58-2ab94bc741ef"
      unitRef="usd">851744000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOmRjNTNhNDE2MzA5YjQ1NDE5M2I5Njk2ODRkYWViNmRhL3RhYmxlcmFuZ2U6ZGM1M2E0MTYzMDliNDU0MTkzYjk2OTY4NGRhZWI2ZGFfNS0zLTEtMS0yOTQ4OQ_c254cade-e081-4045-bebc-8ff07bedfa44"
      unitRef="usd">754662000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtCurrent
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOmRjNTNhNDE2MzA5YjQ1NDE5M2I5Njk2ODRkYWViNmRhL3RhYmxlcmFuZ2U6ZGM1M2E0MTYzMDliNDU0MTkzYjk2OTY4NGRhZWI2ZGFfNi0xLTEtMS0yOTQ4OQ_ecabfdb1-ccb6-4760-9d62-025296c508c0"
      unitRef="usd">12400000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOmRjNTNhNDE2MzA5YjQ1NDE5M2I5Njk2ODRkYWViNmRhL3RhYmxlcmFuZ2U6ZGM1M2E0MTYzMDliNDU0MTkzYjk2OTY4NGRhZWI2ZGFfNi0zLTEtMS0yOTQ4OQ_1e4527ea-ef12-4567-9f14-38112b9569e3"
      unitRef="usd">11164000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOmRjNTNhNDE2MzA5YjQ1NDE5M2I5Njk2ODRkYWViNmRhL3RhYmxlcmFuZ2U6ZGM1M2E0MTYzMDliNDU0MTkzYjk2OTY4NGRhZWI2ZGFfNy0xLTEtMS0yOTQ4OQ_22b7758d-7d9f-4be8-8cd5-c01b2d378ec3"
      unitRef="usd">839344000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOmRjNTNhNDE2MzA5YjQ1NDE5M2I5Njk2ODRkYWViNmRhL3RhYmxlcmFuZ2U6ZGM1M2E0MTYzMDliNDU0MTkzYjk2OTY4NGRhZWI2ZGFfNy0zLTEtMS0yOTQ4OQ_87bcddd8-d90c-4730-9a39-6a7a44319718"
      unitRef="usd">743498000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfOTg2Mg_65597823-e62e-4510-baef-297cc5093b27">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a listing of annual principal maturities of notes payable exclusive of all related discounts and repayments on our revolving credit facilities for years ending December&#160;31 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.090%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;677,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total notes payable obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;864,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOmYyMDIzNTVkYzAzNTQxODA5YTRkMzU2YzZmYjE3MTQzL3RhYmxlcmFuZ2U6ZjIwMjM1NWRjMDM1NDE4MDlhNGQzNTZjNmZiMTcxNDNfMC0xLTEtMS0yOTQ4OQ_f7a13e4e-e7e3-4060-a0cc-3595521370e7"
      unitRef="usd">14750000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOmYyMDIzNTVkYzAzNTQxODA5YTRkMzU2YzZmYjE3MTQzL3RhYmxlcmFuZ2U6ZjIwMjM1NWRjMDM1NDE4MDlhNGQzNTZjNmZiMTcxNDNfMS0xLTEtMS0yOTQ4OQ_1e9ca1e8-c8e1-47c2-b87b-b2efeaadb2c1"
      unitRef="usd">14750000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOmYyMDIzNTVkYzAzNTQxODA5YTRkMzU2YzZmYjE3MTQzL3RhYmxlcmFuZ2U6ZjIwMjM1NWRjMDM1NDE4MDlhNGQzNTZjNmZiMTcxNDNfMi0xLTEtMS0yOTQ4OQ_5293cd2c-7ed1-4276-9627-a205b4d14bed"
      unitRef="usd">18500000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOmYyMDIzNTVkYzAzNTQxODA5YTRkMzU2YzZmYjE3MTQzL3RhYmxlcmFuZ2U6ZjIwMjM1NWRjMDM1NDE4MDlhNGQzNTZjNmZiMTcxNDNfMy0xLTEtMS0yOTQ4OQ_fa77c5df-0a10-4a87-af14-dbd3d6972945"
      unitRef="usd">18500000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOmYyMDIzNTVkYzAzNTQxODA5YTRkMzU2YzZmYjE3MTQzL3RhYmxlcmFuZ2U6ZjIwMjM1NWRjMDM1NDE4MDlhNGQzNTZjNmZiMTcxNDNfNC0xLTEtMS0yOTQ4OQ_04dc23d5-1609-4686-b83a-badd2a9e2ae3"
      unitRef="usd">119750000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOmYyMDIzNTVkYzAzNTQxODA5YTRkMzU2YzZmYjE3MTQzL3RhYmxlcmFuZ2U6ZjIwMjM1NWRjMDM1NDE4MDlhNGQzNTZjNmZiMTcxNDNfNS0xLTEtMS0yOTQ4OQ_f3a182fe-6642-4c62-ba54-cc4d784ce54a"
      unitRef="usd">677875000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOmYyMDIzNTVkYzAzNTQxODA5YTRkMzU2YzZmYjE3MTQzL3RhYmxlcmFuZ2U6ZjIwMjM1NWRjMDM1NDE4MDlhNGQzNTZjNmZiMTcxNDNfNi0xLTEtMS0yOTQ4OQ_a43fccaf-cb2e-4843-a508-d65b945ca995"
      unitRef="usd">864125000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:LineOfCredit
      contextRef="i78f5077e0f824294be47554965869037_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfMzg2_28c23e62-6d7a-4aef-a86d-5cecb17b9c89"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i2923158472984ab081c98c126fa64e96_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfNDE5_c6f1edb7-82b7-4798-bba4-2c325c4e1618"
      unitRef="usd">195000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="ia72ba28711ea41c3b84011425ee45d0f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfNDk0_5b5276db-d608-4c1a-b921-83c5f68c87f8"
      unitRef="usd">7600000</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
      contextRef="i2d9d403debfc473bafd93ca110c28e57_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfNTQz_6f8cb3c9-51f5-4820-9fc0-5a61afd00d8b"
      unitRef="usd">187400000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:LineOfCredit
      contextRef="i1d36672d0c054968b7578c42cf79bd8c_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfNjM5_62e087ef-8b49-44a9-8018-36db80f157ee"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ic33fc421ee274ecb81ba734b51c43318_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfNjYw_f3516232-3e0f-48cd-8c7d-09db7c72f629"
      unitRef="usd">50000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCredit
      contextRef="ib78b9355051b47d5a52646928c50c333_I20210423"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfMTE2MQ_58b12361-5722-4b08-8961-f06ed5aa3544"
      unitRef="usd">725000000</us-gaap:LineOfCredit>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i2923158472984ab081c98c126fa64e96_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfMTI0MA_c6f1edb7-82b7-4798-bba4-2c325c4e1618"
      unitRef="usd">195000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="i659ee446c43548e9bf27ed0a4061b5ab_I20210423"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfMTU4MQ_366a54f6-3da1-4034-b46a-a9ea98ba76f7"
      unitRef="usd">14900000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:DebtInstrumentUnamortizedDiscountCurrent
      contextRef="i659ee446c43548e9bf27ed0a4061b5ab_I20210423"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfMTYwNw_c6ff1f5b-d3db-4a34-84fe-b80ab12b01e2"
      unitRef="usd">8800000</us-gaap:DebtInstrumentUnamortizedDiscountCurrent>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i56152cb4c4e24493b5d3fdbbd09acf47_D20210423-20210423"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfMTcwMg_599104dc-6168-4724-bd6d-5ea1201a61dd"
      unitRef="usd">-6000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:AmortizationOfDeferredCharges
      contextRef="ie23d788887204110a462554db069f44b_D20210423-20210423"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfMTc1Nw_8a196050-565e-4296-80c8-db255e9acaab"
      unitRef="usd">100000</us-gaap:AmortizationOfDeferredCharges>
    <us-gaap:LineOfCredit
      contextRef="ieec8243d9ccc44119f604da882ab8f72_I20221007"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfMTA5OTUxMTY0OTM2OQ_14350059-4ce8-4469-b6c7-aa2e91e1c50b"
      unitRef="usd">150000000</us-gaap:LineOfCredit>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i6ecd3750a3b74bbda768365b8ab639d7_I20221007"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfMTA5OTUxMTY0OTY4Nw_95e8b813-fd88-412e-8184-4306cd03d62d"
      unitRef="usd">50000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="i199f459e5ce14f77a34aef36dbc62bff_I20221007"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfMTA5OTUxMTY1Mjc0OA_9bd12a7d-0c83-42c0-84b2-9246036e0859"
      unitRef="usd">2700000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:DebtInstrumentUnamortizedDiscountCurrent
      contextRef="i199f459e5ce14f77a34aef36dbc62bff_I20221007"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfMTA5OTUxMTY1Mjc2Ng_a15a0a71-6f16-4a91-9fbd-88ddae9c5503"
      unitRef="usd">2000000</us-gaap:DebtInstrumentUnamortizedDiscountCurrent>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="iccbc7b1f30b74634bd5e6b0535972448_D20210423-20210423"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfMTA5OTUxMTY1Mjc4Mw_87c83058-0d62-47bc-bc11-d022d6de8536"
      unitRef="usd">-700000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <rdnt:ScheduleOfLeverageRatioTableTextBlock
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfMTU5NDI5MTg2MzM3NjQ_8b962515-3c73-44e1-83b6-b6f3f16cdf64">&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All obligations under the Second Amended and Restated Credit and Term Loan Agreement bear interest at either a SOFR or a Base Rate (each as defined in the Restated Credit and Term Loan Agreement), plus an applicable margin according to the following schedule:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.128%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.790%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.226%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.226%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.697%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pricing Level&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Leverage Ratio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Applicable Margin for SOFR Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Applicable Margin for Base Rate Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Applicable Margin for Letter of Credit Fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Applicable Percentage for Commitment Fee&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;I&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater than or equal to 3.00:1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.50%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.50%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.45%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;II&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than 3.00:1.00 but greater than or equal to 2.50:1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.25%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.25%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.25%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.40%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;III&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than 2.50:1.00 but greater than or equal to&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00:1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.00%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.35%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IV&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than 2.00:1.00 but greater than or equal to 1.50:1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.75%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.75%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.75%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.30%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;V&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than 1.50:1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.50%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.30%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revolving loans borrowed under the Barclays Revolving Credit Facility bear interest at either a Eurodollar Rate or an Alternate Base Rate (in each case, as defined in the Restated Credit Agreement) plus an applicable margin which adjusts depending on our first lien net leverage ratio, according to the following schedule:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.181%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.850%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.342%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.508%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;First Lien Leverage Ratio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Eurodollar Rate Spread&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Base Rate Spread&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&amp;gt; 3.50x&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.25%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.25%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&amp;gt; 3.00x but &#x2264; 3.50x&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.00%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2264; 3.00x&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.75%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.75%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</rdnt:ScheduleOfLeverageRatioTableTextBlock>
    <rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum
      contextRef="i8b41d8242f3040fb8331b37d34fcd9d2_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOjBmNmFhYzUyZTNjNTRmODJhNjI0ODZiYTQ4YTQ5M2IxL3RhYmxlcmFuZ2U6MGY2YWFjNTJlM2M1NGY4MmE2MjQ4NmJhNDhhNDkzYjFfMS0xLTEtMS02Mzg2OC90ZXh0cmVnaW9uOjdiNmEwNjRmZWY0NjQ3NTFhOWI4Y2JiNzc1Y2EyODkwXzI5_0a4127c4-9126-4d64-8b3f-db91728c3f6b"
      unitRef="number">3.00</rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i4318f7e3746943799936274358bb5174_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOjBmNmFhYzUyZTNjNTRmODJhNjI0ODZiYTQ4YTQ5M2IxL3RhYmxlcmFuZ2U6MGY2YWFjNTJlM2M1NGY4MmE2MjQ4NmJhNDhhNDkzYjFfMS0yLTEtMS02Mzg2OC90ZXh0cmVnaW9uOjg4MWRlNWY4YmE0ZTRmYWVhMjA3YzgyMGQ3NjU4YjgzXzU_5a4986b5-52dd-41cb-a8aa-86ddbc8d4914"
      unitRef="number">0.0250</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i2ee298d0e61e459396a35b628ee2244d_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOjBmNmFhYzUyZTNjNTRmODJhNjI0ODZiYTQ4YTQ5M2IxL3RhYmxlcmFuZ2U6MGY2YWFjNTJlM2M1NGY4MmE2MjQ4NmJhNDhhNDkzYjFfMS0zLTEtMS02Mzg2OC90ZXh0cmVnaW9uOmI2NzQzMTFmNzkyMTQ5YTJiZTg2MjRjNWNiZGIwNTMwXzU_f0ecc19b-9264-4931-8c59-3210c593dfd9"
      unitRef="number">0.0150</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="i25ec9150f13743ed97836354e90ebc7e_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOjBmNmFhYzUyZTNjNTRmODJhNjI0ODZiYTQ4YTQ5M2IxL3RhYmxlcmFuZ2U6MGY2YWFjNTJlM2M1NGY4MmE2MjQ4NmJhNDhhNDkzYjFfMS00LTEtMS02Mzg2OC90ZXh0cmVnaW9uOjIwNjc3ZGE2MjRiMTQyMzI4ZmIwODU3NWEzN2Y1NGJmXzU_a4b23842-3479-4e77-a4b5-8a8b438cd843"
      unitRef="number">0.0250</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="i25ec9150f13743ed97836354e90ebc7e_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOjBmNmFhYzUyZTNjNTRmODJhNjI0ODZiYTQ4YTQ5M2IxL3RhYmxlcmFuZ2U6MGY2YWFjNTJlM2M1NGY4MmE2MjQ4NmJhNDhhNDkzYjFfMS01LTEtMS02Mzg2OC90ZXh0cmVnaW9uOmIwYjM2MWUyMDMyMzQ1MjY5N2Q1OWU4MmVkNGE2NGQwXzU_e6b1c0a9-97ee-42eb-8de0-dcf118792331"
      unitRef="number">0.0045</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <rdnt:DebtInstrumentCovenantLeverageRatioMaximum
      contextRef="id97b4431c3884e1faeb084da481dbb28_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOjBmNmFhYzUyZTNjNTRmODJhNjI0ODZiYTQ4YTQ5M2IxL3RhYmxlcmFuZ2U6MGY2YWFjNTJlM2M1NGY4MmE2MjQ4NmJhNDhhNDkzYjFfMi0xLTEtMS02Mzg2OC90ZXh0cmVnaW9uOmQ3ODFkY2Q3MzhjMDRlOGViOWMzYzdkOWNhNTRkNTJiXzE0_5052a5f5-fd31-4a9b-b693-4c7b91dace11"
      unitRef="number">3.00</rdnt:DebtInstrumentCovenantLeverageRatioMaximum>
    <rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum
      contextRef="id97b4431c3884e1faeb084da481dbb28_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOjBmNmFhYzUyZTNjNTRmODJhNjI0ODZiYTQ4YTQ5M2IxL3RhYmxlcmFuZ2U6MGY2YWFjNTJlM2M1NGY4MmE2MjQ4NmJhNDhhNDkzYjFfMi0xLTEtMS02Mzg2OC90ZXh0cmVnaW9uOmQ3ODFkY2Q3MzhjMDRlOGViOWMzYzdkOWNhNTRkNTJiXzUx_e006a772-6bf4-4905-8555-72f4770a8b9d"
      unitRef="number">2.50</rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i1571e82796a8423a8fe38d602a05f3eb_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOjBmNmFhYzUyZTNjNTRmODJhNjI0ODZiYTQ4YTQ5M2IxL3RhYmxlcmFuZ2U6MGY2YWFjNTJlM2M1NGY4MmE2MjQ4NmJhNDhhNDkzYjFfMi0yLTEtMS02Mzg2OC90ZXh0cmVnaW9uOjVjMGI1NDliY2FhZTRiZmRhYWRkM2IzMzVmMGY4NGVlXzU_92e02792-b01e-4a8a-9307-32437ffc24ab"
      unitRef="number">0.0225</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ia957fac5b3fc45788abdc13188550c17_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOjBmNmFhYzUyZTNjNTRmODJhNjI0ODZiYTQ4YTQ5M2IxL3RhYmxlcmFuZ2U6MGY2YWFjNTJlM2M1NGY4MmE2MjQ4NmJhNDhhNDkzYjFfMi0zLTEtMS02Mzg2OC90ZXh0cmVnaW9uOmUyODU4ZWJlOGJkNzQxNTBiZWY5MzhmYWM1OTMzYmM5XzU_85212080-5b23-4f3c-858c-560b25669221"
      unitRef="number">0.0125</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="ib804538af1af4cbda91f1ab7a1b84f7b_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOjBmNmFhYzUyZTNjNTRmODJhNjI0ODZiYTQ4YTQ5M2IxL3RhYmxlcmFuZ2U6MGY2YWFjNTJlM2M1NGY4MmE2MjQ4NmJhNDhhNDkzYjFfMi00LTEtMS02Mzg2OC90ZXh0cmVnaW9uOmI2MWM4YmQxMmMwMjRiOGI4MGY5OTMxODQ5Mjk1YjYxXzU_addf6e6e-d705-4721-a4a5-b43e85fdb777"
      unitRef="number">0.0225</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="ib804538af1af4cbda91f1ab7a1b84f7b_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOjBmNmFhYzUyZTNjNTRmODJhNjI0ODZiYTQ4YTQ5M2IxL3RhYmxlcmFuZ2U6MGY2YWFjNTJlM2M1NGY4MmE2MjQ4NmJhNDhhNDkzYjFfMi01LTEtMS02Mzg2OC90ZXh0cmVnaW9uOmI2MDI4ZGMzNDc0ZDQwN2Q4MTRkMzUwN2JjYTg0OTdhXzU_0f5ba1fa-39dc-416c-9c29-073740dd4b60"
      unitRef="number">0.0040</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <rdnt:DebtInstrumentCovenantLeverageRatioMaximum
      contextRef="i557a45553f2a40f7b25201fe169750a7_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOjBmNmFhYzUyZTNjNTRmODJhNjI0ODZiYTQ4YTQ5M2IxL3RhYmxlcmFuZ2U6MGY2YWFjNTJlM2M1NGY4MmE2MjQ4NmJhNDhhNDkzYjFfMy0xLTEtMS02Mzg2OC90ZXh0cmVnaW9uOmFjNWNlZjZjN2Q2YzRlZWZiMTEzMGQ1YzQzYTYxZmYxXzE1_ba46fd7f-5b77-4ca4-aa86-d11efc3fcbdf"
      unitRef="number">2.50</rdnt:DebtInstrumentCovenantLeverageRatioMaximum>
    <rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum
      contextRef="i557a45553f2a40f7b25201fe169750a7_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOjBmNmFhYzUyZTNjNTRmODJhNjI0ODZiYTQ4YTQ5M2IxL3RhYmxlcmFuZ2U6MGY2YWFjNTJlM2M1NGY4MmE2MjQ4NmJhNDhhNDkzYjFfMy0xLTEtMS02Mzg2OC90ZXh0cmVnaW9uOmFjNWNlZjZjN2Q2YzRlZWZiMTEzMGQ1YzQzYTYxZmYxXzUy_cb1db7e9-3aa8-45a1-9ec4-8c200d635911"
      unitRef="number">2.00</rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i4f520487af9f4cf3a4d4e00bacc10a81_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOjBmNmFhYzUyZTNjNTRmODJhNjI0ODZiYTQ4YTQ5M2IxL3RhYmxlcmFuZ2U6MGY2YWFjNTJlM2M1NGY4MmE2MjQ4NmJhNDhhNDkzYjFfMy0yLTEtMS02Mzg2OC90ZXh0cmVnaW9uOjU4NDA3MzI4YzI0ODQ5NmVhMjQ4YTFiZjdhYzIxNzdmXzU_d1c5f8b0-26a7-453d-b9e6-b807fe6ceb25"
      unitRef="number">0.0200</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i312118f202904e5e9d26cd7cb00d4237_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOjBmNmFhYzUyZTNjNTRmODJhNjI0ODZiYTQ4YTQ5M2IxL3RhYmxlcmFuZ2U6MGY2YWFjNTJlM2M1NGY4MmE2MjQ4NmJhNDhhNDkzYjFfMy0zLTEtMS02Mzg2OC90ZXh0cmVnaW9uOmExZGJlYjE5OTZkMjQwMzc5YjIxMTk3YzZkNjJhYzgzXzU_f03f178d-a3d6-4585-b379-eeefe77f2b0b"
      unitRef="number">0.0100</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="i856b0cb40d214a9b97efb4927aab7f8f_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOjBmNmFhYzUyZTNjNTRmODJhNjI0ODZiYTQ4YTQ5M2IxL3RhYmxlcmFuZ2U6MGY2YWFjNTJlM2M1NGY4MmE2MjQ4NmJhNDhhNDkzYjFfMy00LTEtMS02Mzg2OC90ZXh0cmVnaW9uOjFkYWQ2YWI5ZjYwOTQzYzg5YjcxMzJmZDgxMzY2YmYzXzU_43fc644e-900b-4503-82a9-748f28614c59"
      unitRef="number">0.0200</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="i856b0cb40d214a9b97efb4927aab7f8f_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOjBmNmFhYzUyZTNjNTRmODJhNjI0ODZiYTQ4YTQ5M2IxL3RhYmxlcmFuZ2U6MGY2YWFjNTJlM2M1NGY4MmE2MjQ4NmJhNDhhNDkzYjFfMy01LTEtMS02Mzg2OC90ZXh0cmVnaW9uOmQ2ZWRhNmMxZjU1ODQxNGVhMDdiOTJkMDY4OWJlZWEwXzU_01b5aac0-490f-4dba-acc4-171f74f5070c"
      unitRef="number">0.0035</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <rdnt:DebtInstrumentCovenantLeverageRatioMaximum
      contextRef="ie662bee09b1e4c1c86dbd8597e67cc62_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOjBmNmFhYzUyZTNjNTRmODJhNjI0ODZiYTQ4YTQ5M2IxL3RhYmxlcmFuZ2U6MGY2YWFjNTJlM2M1NGY4MmE2MjQ4NmJhNDhhNDkzYjFfNC0xLTEtMS02Mzg2OC90ZXh0cmVnaW9uOmE5ZjRjMWMxNzljZDRhODU5ZTc0MTRhMjllNDBjZDJmXzE0_d7c94fdd-43e6-4937-8210-d15f916bf002"
      unitRef="number">2.00</rdnt:DebtInstrumentCovenantLeverageRatioMaximum>
    <rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum
      contextRef="ie662bee09b1e4c1c86dbd8597e67cc62_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOjBmNmFhYzUyZTNjNTRmODJhNjI0ODZiYTQ4YTQ5M2IxL3RhYmxlcmFuZ2U6MGY2YWFjNTJlM2M1NGY4MmE2MjQ4NmJhNDhhNDkzYjFfNC0xLTEtMS02Mzg2OC90ZXh0cmVnaW9uOmE5ZjRjMWMxNzljZDRhODU5ZTc0MTRhMjllNDBjZDJmXzUx_0c8fd2d8-0b20-40eb-a302-ed61a1fc759c"
      unitRef="number">1.50</rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i99932cd267fb439fa22c5eb34b7ae0f0_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOjBmNmFhYzUyZTNjNTRmODJhNjI0ODZiYTQ4YTQ5M2IxL3RhYmxlcmFuZ2U6MGY2YWFjNTJlM2M1NGY4MmE2MjQ4NmJhNDhhNDkzYjFfNC0yLTEtMS02Mzg2OC90ZXh0cmVnaW9uOjcyMzJjMmYyODAyNDQxZDdiNTI1ZWZiYWQ4ZTZiNmE2XzU_64ad564f-7ab3-4fb1-9454-1638992a8f0c"
      unitRef="number">0.0175</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i839055751cc8442db5204c49d1284938_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOjBmNmFhYzUyZTNjNTRmODJhNjI0ODZiYTQ4YTQ5M2IxL3RhYmxlcmFuZ2U6MGY2YWFjNTJlM2M1NGY4MmE2MjQ4NmJhNDhhNDkzYjFfNC0zLTEtMS02Mzg2OC90ZXh0cmVnaW9uOjg2NjI4Zjg0ZGI4ZDQzYTk5MzI2MmM1NWRhMzJmNTJkXzU_08b106d3-7950-4162-816b-4daf8a2a8412"
      unitRef="number">0.0075</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="i69798f67de99449889ab8f63e5cf75a3_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOjBmNmFhYzUyZTNjNTRmODJhNjI0ODZiYTQ4YTQ5M2IxL3RhYmxlcmFuZ2U6MGY2YWFjNTJlM2M1NGY4MmE2MjQ4NmJhNDhhNDkzYjFfNC00LTEtMS02Mzg2OC90ZXh0cmVnaW9uOjI0YzNjMDEyNmNjYjQ1ODlhMzYyMDM2NWNjZTU1ZGQzXzU_a39c47c3-98e3-4792-ba5e-10ec82321978"
      unitRef="number">0.0175</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="i69798f67de99449889ab8f63e5cf75a3_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOjBmNmFhYzUyZTNjNTRmODJhNjI0ODZiYTQ4YTQ5M2IxL3RhYmxlcmFuZ2U6MGY2YWFjNTJlM2M1NGY4MmE2MjQ4NmJhNDhhNDkzYjFfNC01LTEtMS02Mzg2OC90ZXh0cmVnaW9uOjI2OWU0ZjE3N2IxNjRkNWY4Y2M1ZmU1MGI5NTRkZmE2XzU_6b093134-9817-4ffe-bee8-31bfdc810824"
      unitRef="number">0.0030</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <rdnt:DebtInstrumentCovenantLeverageRatioMaximum
      contextRef="i15eb2be8a2ff48a9809e5a01d2e32851_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOjBmNmFhYzUyZTNjNTRmODJhNjI0ODZiYTQ4YTQ5M2IxL3RhYmxlcmFuZ2U6MGY2YWFjNTJlM2M1NGY4MmE2MjQ4NmJhNDhhNDkzYjFfNS0xLTEtMS02Mzg2OC90ZXh0cmVnaW9uOjUxYTQ3NGExYzE0MTRkNGY5YzY0ODA3OTEyOTM4MWMxXzE0_2cb09600-14b3-4dca-81d1-22a320e6ffa9"
      unitRef="number">1.50</rdnt:DebtInstrumentCovenantLeverageRatioMaximum>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ia5b95a7d5c6a44a18f1590d4463611c0_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOjBmNmFhYzUyZTNjNTRmODJhNjI0ODZiYTQ4YTQ5M2IxL3RhYmxlcmFuZ2U6MGY2YWFjNTJlM2M1NGY4MmE2MjQ4NmJhNDhhNDkzYjFfNS0yLTEtMS02Mzg2OC90ZXh0cmVnaW9uOjA5ZjYyNzYxODllYzQzZWViYTY5OGI2MjVhZTY4MzFkXzU_888d848f-d2a9-43c7-97b3-947f91c1d09c"
      unitRef="number">0.0150</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="if100b11b6bb44e928235b214abe522c1_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOjBmNmFhYzUyZTNjNTRmODJhNjI0ODZiYTQ4YTQ5M2IxL3RhYmxlcmFuZ2U6MGY2YWFjNTJlM2M1NGY4MmE2MjQ4NmJhNDhhNDkzYjFfNS0zLTEtMS02Mzg2OC90ZXh0cmVnaW9uOjM1MjNlMWNiNmMyMTQyZDVhMjU4MWM0YTU5Y2I1YzJhXzU_4946ef18-4018-49e8-a661-daead96b245e"
      unitRef="number">0.0050</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="i13cb963d1f784637aecd1c03103d2861_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOjBmNmFhYzUyZTNjNTRmODJhNjI0ODZiYTQ4YTQ5M2IxL3RhYmxlcmFuZ2U6MGY2YWFjNTJlM2M1NGY4MmE2MjQ4NmJhNDhhNDkzYjFfNS00LTEtMS02Mzg2OC90ZXh0cmVnaW9uOjJlNzVjZjVlZDEyYTQ3NTU4Y2M0YmI2YWE5OTcyOGExXzU_b6d5d50f-61ec-406e-8b42-012c5b95e1ec"
      unitRef="number">0.0150</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="i13cb963d1f784637aecd1c03103d2861_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOjBmNmFhYzUyZTNjNTRmODJhNjI0ODZiYTQ4YTQ5M2IxL3RhYmxlcmFuZ2U6MGY2YWFjNTJlM2M1NGY4MmE2MjQ4NmJhNDhhNDkzYjFfNS01LTEtMS02Mzg2OC90ZXh0cmVnaW9uOmRlODIzYjhmOWY3MzQzZTliZjU3ODdlMzI4MzU2OTgxXzU_74006324-2846-4e91-8a56-5206d564495e"
      unitRef="number">0.0030</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="iab1c1f0acbf94f9f961d2a94fecafbce_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfMjI5Mg_f7d9a304-80b9-49be-84e3-7c23f4c9b279"
      unitRef="number">0.0325</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i702897b2a6b14e748e4098af38ad1e19_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfMjMyNg_da586858-a197-4a66-9d19-75e90eb90caf"
      unitRef="number">0.030</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <rdnt:DebtInstrumentLeverageRatio
      contextRef="ic20f8711184c443c87d2fa221b9f3d6b_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfMjQyOQ_47b14c01-83fe-4e90-b1bd-759307cc90ea"
      unitRef="number">3.50</rdnt:DebtInstrumentLeverageRatio>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="id37173de0c834f2b9f115f5a5a19cc27_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfMjYzNg_f40dd372-c177-4405-85c4-007fd327f548"
      unitRef="number">0.0473</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="ia9b5190de9024ab58119dd3bf9d43ea3_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfMjY0Mw_d4229174-2d6c-4166-9f9d-fc45ad478865"
      unitRef="number">0.0750</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ia4b317995bde4bada86bdf0ce0b815cd_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfMjc5Ng_568a45c6-634f-4d68-a550-c53e098ed99b"
      unitRef="number">0.0300</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i70fb120699d84c7f82b9624968f97599_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfMjgwMw_fb87253b-6c4b-4f98-a84e-8508351a3c9c"
      unitRef="number">0.0200</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal
      contextRef="ice18c3446a25450bb2c8f0569aa819e7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfMjk1Nw_605fb0ca-ed9e-4442-909b-6f3546d48df8"
      unitRef="usd">1800000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i2e033e1356e54eb3be45b1693fd1314c_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfMTA5OTUxMTY0OTEwMQ_b53715f8-b583-41ca-a892-67d94d46c073"
      unitRef="number">0.0428</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentPeriodicPayment
      contextRef="i6a3f767fc5374ada83d6ae22aa651dd9_D20230331-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfMTA5OTUxMTY0OTQxMA_05837fc6-ec51-4249-9003-92f824916ccc"
      unitRef="usd">1900000</us-gaap:DebtInstrumentPeriodicPayment>
    <rdnt:DebtInstrumentPeriodicPaymentPercent
      contextRef="i6a3f767fc5374ada83d6ae22aa651dd9_D20230331-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfMTA5OTUxMTY0OTU0NA_412409f9-d1a9-4e6b-879d-9a2884af1416"
      unitRef="number">0.0100</rdnt:DebtInstrumentPeriodicPaymentPercent>
    <rdnt:DebtInstrumentPeriodicPaymentTermsAmortizationIncrease
      contextRef="i04e208e3692545da8ee7fd87c877961c_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfMTA5OTUxMTY0OTU4NA_41f7a07a-f504-417a-b992-2027b8723057"
      unitRef="usd">900000</rdnt:DebtInstrumentPeriodicPaymentTermsAmortizationIncrease>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i2923158472984ab081c98c126fa64e96_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfNDc2OA_c6f1edb7-82b7-4798-bba4-2c325c4e1618"
      unitRef="usd">195000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i2d9d403debfc473bafd93ca110c28e57_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfMTA5OTUxMTY1NTkwMw_1d2b97a8-0d65-4747-967a-7208662b2dd0"
      unitRef="usd">1700000</us-gaap:DeferredFinanceCostsNet>
    <rdnt:DebtInstrumentLeverageRatio
      contextRef="i3519d8c4e9ee47ba8c1300676d007bb0_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOmY4MjliNzM5ODFhYjRlYWRiNzgyOTg2NzY4ZDg2MjMxL3RhYmxlcmFuZ2U6ZjgyOWI3Mzk4MWFiNGVhZGI3ODI5ODY3NjhkODYyMzFfMi0wLTEtMS0yOTQ4OS90ZXh0cmVnaW9uOjY4ZDBiNWIyODY4YTRhNGNiZjRjYWQ5NzdiNjlkMWY3XzY_fc707e01-2c6f-4430-a8bb-dfc934149332"
      unitRef="number">3.50</rdnt:DebtInstrumentLeverageRatio>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i2463bc0c023b4f5aa0e500c7b7681aec_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOmY4MjliNzM5ODFhYjRlYWRiNzgyOTg2NzY4ZDg2MjMxL3RhYmxlcmFuZ2U6ZjgyOWI3Mzk4MWFiNGVhZGI3ODI5ODY3NjhkODYyMzFfMi0xLTEtMS0yOTQ4OS90ZXh0cmVnaW9uOmMyODQyYTdmOWQyYzQ2NzI5ZTA5ZDBhODAxYWU0ODVkXzQ_d5caa135-ab3b-4670-a892-81e5289b5d53"
      unitRef="number">0.0325</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i928b06213e75428c90178a1d1b5152f7_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOmY4MjliNzM5ODFhYjRlYWRiNzgyOTg2NzY4ZDg2MjMxL3RhYmxlcmFuZ2U6ZjgyOWI3Mzk4MWFiNGVhZGI3ODI5ODY3NjhkODYyMzFfMi0yLTEtMS0yOTQ4OS90ZXh0cmVnaW9uOjNmMDIwNmE1NTY0ODQ4YmZiZjIxOGFlZDg5NzJkYTcxXzQ_85b29603-3660-4b71-9fd6-6d19d24dcefd"
      unitRef="number">0.0225</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <rdnt:DebtInstrumentLeverageRatio
      contextRef="i6f6c0892ace746fbaf4c00e519257a16_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOmY4MjliNzM5ODFhYjRlYWRiNzgyOTg2NzY4ZDg2MjMxL3RhYmxlcmFuZ2U6ZjgyOWI3Mzk4MWFiNGVhZGI3ODI5ODY3NjhkODYyMzFfMy0wLTEtMS0yOTQ4OS90ZXh0cmVnaW9uOjFiZTQwNmYwNzkzNTRjYmRhYjUxYTRhOGZjN2Y4M2ZhXzY_246ebf80-587b-4085-a14b-691236cbc2c9"
      unitRef="number">3.00</rdnt:DebtInstrumentLeverageRatio>
    <rdnt:DebtInstrumentLeverageRatio
      contextRef="id93b58eb3f8545c19a363c18ea54314e_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOmY4MjliNzM5ODFhYjRlYWRiNzgyOTg2NzY4ZDg2MjMxL3RhYmxlcmFuZ2U6ZjgyOWI3Mzk4MWFiNGVhZGI3ODI5ODY3NjhkODYyMzFfMy0wLTEtMS0yOTQ4OS90ZXh0cmVnaW9uOjFiZTQwNmYwNzkzNTRjYmRhYjUxYTRhOGZjN2Y4M2ZhXzE2_3c630bc5-118e-47fb-bda6-358097a5d673"
      unitRef="number">3.50</rdnt:DebtInstrumentLeverageRatio>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="id934500bc63546f682c7f9670a1350a8_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOmY4MjliNzM5ODFhYjRlYWRiNzgyOTg2NzY4ZDg2MjMxL3RhYmxlcmFuZ2U6ZjgyOWI3Mzk4MWFiNGVhZGI3ODI5ODY3NjhkODYyMzFfMy0xLTEtMS0yOTQ4OS90ZXh0cmVnaW9uOjFlZjNiZDQzMDExYzQ3MGViNTU2ODM3YWYxMDcyMGMwXzQ_3591e8fc-8952-4ba3-a423-e792f04ee406"
      unitRef="number">0.0300</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i8268de3b978748b782a432f7902bf9eb_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOmY4MjliNzM5ODFhYjRlYWRiNzgyOTg2NzY4ZDg2MjMxL3RhYmxlcmFuZ2U6ZjgyOWI3Mzk4MWFiNGVhZGI3ODI5ODY3NjhkODYyMzFfMy0yLTEtMS0yOTQ4OS90ZXh0cmVnaW9uOjU4YzgwY2VkNWNiNTQ0MGZhNjhjYzZmMDhlMTZkMDhhXzQ_11df197b-a58b-41d9-a234-922a8ad478f8"
      unitRef="number">0.0200</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <rdnt:DebtInstrumentLeverageRatio
      contextRef="i278e51ae3e69452d872b324b2fceb548_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOmY4MjliNzM5ODFhYjRlYWRiNzgyOTg2NzY4ZDg2MjMxL3RhYmxlcmFuZ2U6ZjgyOWI3Mzk4MWFiNGVhZGI3ODI5ODY3NjhkODYyMzFfNC0wLTEtMS0yOTQ4OS90ZXh0cmVnaW9uOmU0Y2Q0NjJiNjA0MDQzOWU4N2MxMmQzNDk2YWIwOWYwXzY_85f3dd76-29ae-4e14-8676-b9d49b23ca95"
      unitRef="number">3.00</rdnt:DebtInstrumentLeverageRatio>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="id603dde9dba24bd185acda0ba6834023_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOmY4MjliNzM5ODFhYjRlYWRiNzgyOTg2NzY4ZDg2MjMxL3RhYmxlcmFuZ2U6ZjgyOWI3Mzk4MWFiNGVhZGI3ODI5ODY3NjhkODYyMzFfNC0xLTEtMS0yOTQ4OS90ZXh0cmVnaW9uOjllNGNhZWJkMjVlOTQ5YzViMTQ1OTU5MTM4YjA2YzI3XzQ_05a66731-62a7-4287-9ca0-a32ee576a6d9"
      unitRef="number">0.0275</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i1dadee5b8a024acb8b292c439ee5d113_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RhYmxlOmY4MjliNzM5ODFhYjRlYWRiNzgyOTg2NzY4ZDg2MjMxL3RhYmxlcmFuZ2U6ZjgyOWI3Mzk4MWFiNGVhZGI3ODI5ODY3NjhkODYyMzFfNC0yLTEtMS0yOTQ4OS90ZXh0cmVnaW9uOjFiYTZkNjdiZDNlMDRlN2Y5MzJiNmU4MWJmZDJhMjQ5XzQ_4594ed60-a08b-485b-b8a2-91334ce7a5e3"
      unitRef="number">0.0175</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="i2d9d403debfc473bafd93ca110c28e57_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfNTM4OA_113a2980-7835-4f3b-9cc5-c76c9b3cf74c"
      unitRef="number">0.095</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="id994e3544668477991d25e93154861e5_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfNTU3Nw_c12aa6a1-0f68-4a63-8b9d-ab56975afcbd"
      unitRef="number">0.0300</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="iae4da6a9b69c4e0f8084fdf5c94b4fb0_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfNTYwOA_194f962b-3e56-4a1f-bcfe-dd048de0c5cd"
      unitRef="number">0.00125</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="iae4da6a9b69c4e0f8084fdf5c94b4fb0_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfNTgwOA_ad771064-1920-409a-9c98-de7bfa3d1881"
      unitRef="number">0.0050</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i6ecd3750a3b74bbda768365b8ab639d7_I20221007"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfMTA5OTUxMTY0NzE4NA_95e8b813-fd88-412e-8184-4306cd03d62d"
      unitRef="usd">50000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="ia3b1eb6913ea4657973a8239914f6e42_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfMTA5OTUxMTY1MjU0NA_a65faa19-4eca-4756-9731-af3ca8b98093"
      unitRef="usd">600000</us-gaap:DeferredFinanceCostsNet>
    <rdnt:LineofCreditFacilityIncreaseBorrowingCapacity
      contextRef="i92fc6849db614c54bc09a2666a961e01_I20200828"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfNzA0MQ_5a84366e-58bd-41d6-9c60-3aa39556af9f"
      unitRef="usd">57500000</rdnt:LineofCreditFacilityIncreaseBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i2923158472984ab081c98c126fa64e96_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfNzIxMw_c6f1edb7-82b7-4798-bba4-2c325c4e1618"
      unitRef="usd">195000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <rdnt:DebtInstrumentNumberOfAmendments
      contextRef="i0632c03edc1443a6b0a38f3cd1a783d9_I20190418"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfNzMyNA_07906c9f-19af-43a4-a33f-cc206fc1076a"
      unitRef="amendment">2000</rdnt:DebtInstrumentNumberOfAmendments>
    <us-gaap:LineOfCredit
      contextRef="i09ba2d9a36f045b797d41b04329dd854_I20190418"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfNzY4Mg_b91fbfd4-ae67-47c5-8714-72077a2b3848"
      unitRef="usd">100000000</us-gaap:LineOfCredit>
    <rdnt:LineofCreditFacilityIncreaseBorrowingCapacity
      contextRef="i1c5c4e38ab5d4390807495b2aa90ba6a_I20190418"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfNzc0Nw_49880fe4-a65d-4a9b-873a-d4d0cbe8a2dd"
      unitRef="usd">20000000</rdnt:LineofCreditFacilityIncreaseBorrowingCapacity>
    <rdnt:DebtInstrumentExtensionPeriod
      contextRef="ia96560b5f1de48ab9fbe2db67aecf4d1_D20190418-20190418"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfNzk4Ng_f275a681-72df-43f2-82e3-8275d3d7b938">P2Y</rdnt:DebtInstrumentExtensionPeriod>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="iaa6deb986aee4e51833223a5764529e4_I20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfMTA5OTUxMTY1NzY4OA_ca92c5e7-8897-4b02-a354-f1d9798e954e"
      unitRef="usd">60000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i67ae41392b3144c99363c75225255999_I20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfMTA5OTUxMTY1Nzg0OQ_c62bb085-c690-4ad3-9fce-ede2bc901eab"
      unitRef="usd">30000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i85a7d0e0c6ca48769139d10c3a615b9e_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfOTM1Mw_fc2186be-f471-4ceb-be5b-b2bf3cb04684"
      unitRef="number">0.010</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentTerm
      contextRef="ifc2f697097964cab9a6567723aee030c_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfOTM5MQ_f3494e01-43e7-41f2-8fea-8b64aa7dffab">P2Y</us-gaap:DebtInstrumentTerm>
    <rdnt:DebtInstrumentNumberofLoansReceived
      contextRef="ifc2f697097964cab9a6567723aee030c_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfOTU0Ng_21b10cc1-c3fb-4f6d-95cf-1622e23d57ea"
      unitRef="loan">4</rdnt:DebtInstrumentNumberofLoansReceived>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ie7dff0590fe940f8998c972ad3a5986d_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV85Ny9mcmFnOmU4NjhlMmJiMzUzMDQxZmNhNjBkNmQ4NDU5OTQzYzhkL3RleHRyZWdpb246ZTg2OGUyYmIzNTMwNDFmY2E2MGQ2ZDg0NTk5NDNjOGRfOTU2NA_a7e287f8-960d-4e04-9867-a1517f4f1ca5"
      unitRef="usd">4000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90ZXh0cmVnaW9uOmEyZmUyZjYyM2Q4ZTQ5MjdhZDY3ZWMxMDE1NzQ5YzEzXzIwNDY_5b88b17a-eb66-4ea8-a13f-40f257e5ad48">LEASESOur material lease contracts are for facilities and advanced radiology equipment.   In regards to our imaging, administrative and warehouse facilities, the most common initial lease term varies in length from 5 to 15 years. Including renewal options negotiated with the landlord, we can have a total span of 10 to 35 years at these locations, and we do not enter into purchase options on the underlying property.  We also lease smaller satellite X-Ray locations on mutually renewable terms, usually lasting one year.  Leases for advanced radiology and office equipment have terms generally lasting from 5 to 8 years.  All leases are classified as operating or finance for accounting purposes, depending on the terms of the agreement.  Our Incremental Borrowing Rate ("IBR") used to discount the stream of lease payments is closely related to the interest rates &lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;charged on our collateralized debt obligations and our IBR is adjusted when those rates experience a substantial change.  During 2021, we satisfied all liabilities classified as finance leases, and only operating leases remain.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;The components of lease expense were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.197%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.251%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.252%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Finance lease cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Depreciation of leased equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Total finance lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1) Operating lease cost above for the year ended December 31, 2021 included $12.6 million in lease abandonment charges.  Please see our discussion in the Leases section of Note 2, Summary of Significant Accounting Policies.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Supplemental cash flow information related to leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.345%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Operating cash flows from operating leases &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Operating cash flows from financing leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Financing cash flows from financing leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use &amp;amp; Equipment assets obtained in exchange for lease obligations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1) On December 31, 2021 we reduced our liability and eliminated the related right-of-use assets for future lease options at facilities that we elected to abandon.  The amount of liability and right-of-use asset reduction amounted to approximately $3.3 million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Supplemental balance sheet information related to leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.345%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(In thousands, except lease term and discount rates)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;603,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;584,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of operating lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;604,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;577,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;661,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;643,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment at cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTozNDY2MGIzODgyOWY0NDQ5YWU5YzQ1YmYzZTBlZmM1ZC90YWJsZXJhbmdlOjM0NjYwYjM4ODI5ZjQ0NDlhZTljNDViZjNlMGVmYzVkXzExLTAtMS0xLTI5NDg5_464c3404-1439-4afe-a7f8-0d3a4f94b53d"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTozNDY2MGIzODgyOWY0NDQ5YWU5YzQ1YmYzZTBlZmM1ZC90YWJsZXJhbmdlOjM0NjYwYjM4ODI5ZjQ0NDlhZTljNDViZjNlMGVmYzVkXzExLTAtMS0xLTI5NDg5_bc4c3e84-e956-46a8-b461-0698bb31e9ec"&gt;Accumulated depreciation&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,171)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,287)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted Average Remaining Lease Term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases - years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.4&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted Average Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Maturities of lease liabilities were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.904%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.896%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year Ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Total Lease Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;941,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(279,358)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;661,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2022, we have additional operating leases for facilities and medical equipment that have not yet commenced of  approximately $11.8 million.  These operating leases will commence in 2023 with lease terms of 1 to 15 years.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="ic1e56ddb23564f81949b77940a641b57_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90ZXh0cmVnaW9uOmEyZmUyZjYyM2Q4ZTQ5MjdhZDY3ZWMxMDE1NzQ5YzEzXzIzMQ_c1528c36-70ed-4537-84ef-d4d77a2ddeba">P5Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i0118bb2b3716434fb951fa28970f2707_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90ZXh0cmVnaW9uOmEyZmUyZjYyM2Q4ZTQ5MjdhZDY3ZWMxMDE1NzQ5YzEzXzIzNw_cc2c1cd7-8c5d-4d46-9a1f-d10695543ebd">P15Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="ic1e56ddb23564f81949b77940a641b57_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90ZXh0cmVnaW9uOmEyZmUyZjYyM2Q4ZTQ5MjdhZDY3ZWMxMDE1NzQ5YzEzXzMyNQ_cc5c9a6a-f619-44c7-81de-045b0e4c33c8">P10Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="i0118bb2b3716434fb951fa28970f2707_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90ZXh0cmVnaW9uOmEyZmUyZjYyM2Q4ZTQ5MjdhZDY3ZWMxMDE1NzQ5YzEzXzMzMQ_82ead483-baf4-4efb-a28b-653a34131580">P35Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <rdnt:LesseeLeaseTermofContract
      contextRef="ice63a1a32cb9452b8b46714c1c61a7da_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90ZXh0cmVnaW9uOmEyZmUyZjYyM2Q4ZTQ5MjdhZDY3ZWMxMDE1NzQ5YzEzXzYxNA_91b629ae-29af-43a8-8d4b-4d0b0b917785">P5Y</rdnt:LesseeLeaseTermofContract>
    <rdnt:LesseeLeaseTermofContract
      contextRef="ib19ac757adb3497f895598bf7d1fb0f6_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90ZXh0cmVnaW9uOmEyZmUyZjYyM2Q4ZTQ5MjdhZDY3ZWMxMDE1NzQ5YzEzXzYyMA_0c08b362-95e7-4031-a7d3-498446bcecb7">P8Y</rdnt:LesseeLeaseTermofContract>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90ZXh0cmVnaW9uOmEyZmUyZjYyM2Q4ZTQ5MjdhZDY3ZWMxMDE1NzQ5YzEzXzIwNDI_2bfe29e8-f122-4f25-992c-5fa25aacd24f">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;The components of lease expense were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.197%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.251%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.252%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Finance lease cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Depreciation of leased equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Total finance lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1) Operating lease cost above for the year ended December 31, 2021 included $12.6 million in lease abandonment charges.  Please see our discussion in the Leases section of Note 2, Summary of Significant Accounting Policies.&lt;/span&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTo3ODJiYmM2OWUzMGE0MjNmOTZkNTc3OGM5ZDc2MGMyZi90YWJsZXJhbmdlOjc4MmJiYzY5ZTMwYTQyM2Y5NmQ1Nzc4YzlkNzYwYzJmXzQtMS0xLTEtMjk0ODk_d33f9420-2798-45ab-afed-e4dd3a7a78ac"
      unitRef="usd">107475000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTo3ODJiYmM2OWUzMGE0MjNmOTZkNTc3OGM5ZDc2MGMyZi90YWJsZXJhbmdlOjc4MmJiYzY5ZTMwYTQyM2Y5NmQ1Nzc4YzlkNzYwYzJmXzQtMi0xLTEtMjk0ODk_bf1b0633-fc02-49bc-8943-81f278a78806"
      unitRef="usd">121578000</us-gaap:OperatingLeaseCost>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTo3ODJiYmM2OWUzMGE0MjNmOTZkNTc3OGM5ZDc2MGMyZi90YWJsZXJhbmdlOjc4MmJiYzY5ZTMwYTQyM2Y5NmQ1Nzc4YzlkNzYwYzJmXzctMS0xLTEtMjk0ODk_d4d42cdb-316a-4eb0-ac0f-579643f611e6"
      unitRef="usd">2896000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTo3ODJiYmM2OWUzMGE0MjNmOTZkNTc3OGM5ZDc2MGMyZi90YWJsZXJhbmdlOjc4MmJiYzY5ZTMwYTQyM2Y5NmQ1Nzc4YzlkNzYwYzJmXzctMi0xLTEtMjk0ODk_8632ba7f-4e83-4ab7-b7db-65e4f18380f9"
      unitRef="usd">3068000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTo3ODJiYmM2OWUzMGE0MjNmOTZkNTc3OGM5ZDc2MGMyZi90YWJsZXJhbmdlOjc4MmJiYzY5ZTMwYTQyM2Y5NmQ1Nzc4YzlkNzYwYzJmXzgtMS0xLTEtMjk0ODk_3c5935db-c900-4e8e-9a38-6347af3cf5a8"
      unitRef="usd">0</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTo3ODJiYmM2OWUzMGE0MjNmOTZkNTc3OGM5ZDc2MGMyZi90YWJsZXJhbmdlOjc4MmJiYzY5ZTMwYTQyM2Y5NmQ1Nzc4YzlkNzYwYzJmXzgtMi0xLTEtMjk0ODk_f8da1ad0-cbef-484c-8caf-a7c6ce0a5363"
      unitRef="usd">46000</us-gaap:FinanceLeaseInterestExpense>
    <rdnt:FinanceLeaseCost
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTo3ODJiYmM2OWUzMGE0MjNmOTZkNTc3OGM5ZDc2MGMyZi90YWJsZXJhbmdlOjc4MmJiYzY5ZTMwYTQyM2Y5NmQ1Nzc4YzlkNzYwYzJmXzktMS0xLTEtMjk0ODk_3f4e3620-9544-43ae-a8ac-5a21d3aac4f8"
      unitRef="usd">2896000</rdnt:FinanceLeaseCost>
    <rdnt:FinanceLeaseCost
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTo3ODJiYmM2OWUzMGE0MjNmOTZkNTc3OGM5ZDc2MGMyZi90YWJsZXJhbmdlOjc4MmJiYzY5ZTMwYTQyM2Y5NmQ1Nzc4YzlkNzYwYzJmXzktMi0xLTEtMjk0ODk_4140bf8f-cd3b-40fb-89e4-6a893fa927c7"
      unitRef="usd">3114000</rdnt:FinanceLeaseCost>
    <rdnt:OperatingLeaseLeaseAbandonmentCharge
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90ZXh0cmVnaW9uOmEyZmUyZjYyM2Q4ZTQ5MjdhZDY3ZWMxMDE1NzQ5YzEzXzEyMjY_72371db8-b949-41ef-bca8-5633360ad578"
      unitRef="usd">12600000</rdnt:OperatingLeaseLeaseAbandonmentCharge>
    <us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90ZXh0cmVnaW9uOmEyZmUyZjYyM2Q4ZTQ5MjdhZDY3ZWMxMDE1NzQ5YzEzXzIwMzU_f0ac15e1-65aa-464f-88de-3e99fc95d231">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Supplemental cash flow information related to leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.345%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Operating cash flows from operating leases &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Operating cash flows from financing leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Financing cash flows from financing leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use &amp;amp; Equipment assets obtained in exchange for lease obligations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1) On December 31, 2021 we reduced our liability and eliminated the related right-of-use assets for future lease options at facilities that we elected to abandon.  The amount of liability and right-of-use asset reduction amounted to approximately $3.3 million.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock>
    <us-gaap:OperatingLeasePayments
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTowMWYxYWE4MTMzYmQ0OTc2YmY2ZTA3MWFjNzBiNjQxYy90YWJsZXJhbmdlOjAxZjFhYTgxMzNiZDQ5NzZiZjZlMDcxYWM3MGI2NDFjXzQtMS0xLTEtMjk0ODk_9d85e171-76a0-49bc-ac29-bcf1cea0b891"
      unitRef="usd">108004000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTowMWYxYWE4MTMzYmQ0OTc2YmY2ZTA3MWFjNzBiNjQxYy90YWJsZXJhbmdlOjAxZjFhYTgxMzNiZDQ5NzZiZjZlMDcxYWM3MGI2NDFjXzQtMi0xLTEtMjk0ODk_536b588b-1979-4fab-b485-7835d50cb97c"
      unitRef="usd">110288000</us-gaap:OperatingLeasePayments>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTowMWYxYWE4MTMzYmQ0OTc2YmY2ZTA3MWFjNzBiNjQxYy90YWJsZXJhbmdlOjAxZjFhYTgxMzNiZDQ5NzZiZjZlMDcxYWM3MGI2NDFjXzUtMS0xLTEtMjk0ODk_3288c59e-d92c-4fd9-ad46-026857ba667c"
      unitRef="usd">0</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTowMWYxYWE4MTMzYmQ0OTc2YmY2ZTA3MWFjNzBiNjQxYy90YWJsZXJhbmdlOjAxZjFhYTgxMzNiZDQ5NzZiZjZlMDcxYWM3MGI2NDFjXzUtMi0xLTEtMjk0ODk_3deb9788-32dc-4782-8242-df0a0aab45b9"
      unitRef="usd">46000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTowMWYxYWE4MTMzYmQ0OTc2YmY2ZTA3MWFjNzBiNjQxYy90YWJsZXJhbmdlOjAxZjFhYTgxMzNiZDQ5NzZiZjZlMDcxYWM3MGI2NDFjXzYtMS0xLTEtMjk0ODk_75fdeb22-4060-4abb-a3bb-401e98f4c31c"
      unitRef="usd">0</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTowMWYxYWE4MTMzYmQ0OTc2YmY2ZTA3MWFjNzBiNjQxYy90YWJsZXJhbmdlOjAxZjFhYTgxMzNiZDQ5NzZiZjZlMDcxYWM3MGI2NDFjXzYtMi0xLTEtMjk0ODk_c246f0dd-a4c9-4b3c-b2d0-cdc59eed1516"
      unitRef="usd">3304000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTowMWYxYWE4MTMzYmQ0OTc2YmY2ZTA3MWFjNzBiNjQxYy90YWJsZXJhbmdlOjAxZjFhYTgxMzNiZDQ5NzZiZjZlMDcxYWM3MGI2NDFjXzgtMS0xLTEtMjk0ODk_04d5ab4b-d080-419b-8eb8-5cc38db7b85b"
      unitRef="usd">88080000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTowMWYxYWE4MTMzYmQ0OTc2YmY2ZTA3MWFjNzBiNjQxYy90YWJsZXJhbmdlOjAxZjFhYTgxMzNiZDQ5NzZiZjZlMDcxYWM3MGI2NDFjXzgtMi0xLTEtMjk0ODk_95310301-c2c1-496b-9b4b-57a91d1d91af"
      unitRef="usd">186695000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <rdnt:OperatingLeaseRightOfUseAssetDecreaseDueToAbandonment
      contextRef="i8cff5897a0c648b19e7125d13cd0a0f5_D20211231-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90ZXh0cmVnaW9uOmEyZmUyZjYyM2Q4ZTQ5MjdhZDY3ZWMxMDE1NzQ5YzEzXzEwOTk1MTE2Mjk4NDY_6cdf49a6-839d-4a1c-b85c-faecf1465b97"
      unitRef="usd">3300000</rdnt:OperatingLeaseRightOfUseAssetDecreaseDueToAbandonment>
    <rdnt:OperatingLeaseLiabilityDecreaseDueToAbandonment
      contextRef="i8cff5897a0c648b19e7125d13cd0a0f5_D20211231-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90ZXh0cmVnaW9uOmEyZmUyZjYyM2Q4ZTQ5MjdhZDY3ZWMxMDE1NzQ5YzEzXzEwOTk1MTE2Mjk4NDY_d0ca2c3b-e3d2-4b1a-83b3-f75643936d79"
      unitRef="usd">3300000</rdnt:OperatingLeaseLiabilityDecreaseDueToAbandonment>
    <rdnt:AssetsAndLiabilitiesLesseeTableTextBlock
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90ZXh0cmVnaW9uOmEyZmUyZjYyM2Q4ZTQ5MjdhZDY3ZWMxMDE1NzQ5YzEzXzIwMzk_1715e5a6-b598-4cb6-821f-2e8389611764">Supplemental balance sheet information related to leases was as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.345%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(In thousands, except lease term and discount rates)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;603,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;584,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of operating lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;604,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;577,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;661,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;643,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment at cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTozNDY2MGIzODgyOWY0NDQ5YWU5YzQ1YmYzZTBlZmM1ZC90YWJsZXJhbmdlOjM0NjYwYjM4ODI5ZjQ0NDlhZTljNDViZjNlMGVmYzVkXzExLTAtMS0xLTI5NDg5_464c3404-1439-4afe-a7f8-0d3a4f94b53d"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTozNDY2MGIzODgyOWY0NDQ5YWU5YzQ1YmYzZTBlZmM1ZC90YWJsZXJhbmdlOjM0NjYwYjM4ODI5ZjQ0NDlhZTljNDViZjNlMGVmYzVkXzExLTAtMS0xLTI5NDg5_bc4c3e84-e956-46a8-b461-0698bb31e9ec"&gt;Accumulated depreciation&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,171)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,287)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted Average Remaining Lease Term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases - years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.4&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted Average Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</rdnt:AssetsAndLiabilitiesLesseeTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTozNDY2MGIzODgyOWY0NDQ5YWU5YzQ1YmYzZTBlZmM1ZC90YWJsZXJhbmdlOjM0NjYwYjM4ODI5ZjQ0NDlhZTljNDViZjNlMGVmYzVkXzQtMS0xLTEtMjk0ODk_5c3908ec-a850-47f5-a108-bb302d92f794"
      unitRef="usd">603524000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTozNDY2MGIzODgyOWY0NDQ5YWU5YzQ1YmYzZTBlZmM1ZC90YWJsZXJhbmdlOjM0NjYwYjM4ODI5ZjQ0NDlhZTljNDViZjNlMGVmYzVkXzQtMi0xLTEtMjk0ODk_0323fbf3-fe6f-4d27-bf0b-626cb10a2019"
      unitRef="usd">584291000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTozNDY2MGIzODgyOWY0NDQ5YWU5YzQ1YmYzZTBlZmM1ZC90YWJsZXJhbmdlOjM0NjYwYjM4ODI5ZjQ0NDlhZTljNDViZjNlMGVmYzVkXzUtMS0xLTEtMjk0ODk_c18ab1fd-ef50-4cc9-a394-99377454baaa"
      unitRef="usd">57607000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTozNDY2MGIzODgyOWY0NDQ5YWU5YzQ1YmYzZTBlZmM1ZC90YWJsZXJhbmdlOjM0NjYwYjM4ODI5ZjQ0NDlhZTljNDViZjNlMGVmYzVkXzUtMi0xLTEtMjk0ODk_873383c6-73c1-4aee-b0e3-d3102bcb43ac"
      unitRef="usd">65452000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTozNDY2MGIzODgyOWY0NDQ5YWU5YzQ1YmYzZTBlZmM1ZC90YWJsZXJhbmdlOjM0NjYwYjM4ODI5ZjQ0NDlhZTljNDViZjNlMGVmYzVkXzYtMS0xLTEtMjk0ODk_adaeae30-2257-485b-bd2a-2efcfbb34a42"
      unitRef="usd">604117000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTozNDY2MGIzODgyOWY0NDQ5YWU5YzQ1YmYzZTBlZmM1ZC90YWJsZXJhbmdlOjM0NjYwYjM4ODI5ZjQ0NDlhZTljNDViZjNlMGVmYzVkXzYtMi0xLTEtMjk0ODk_131d4156-0c7c-4ddb-8fa2-ceba8a68d1fc"
      unitRef="usd">577675000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiability
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTozNDY2MGIzODgyOWY0NDQ5YWU5YzQ1YmYzZTBlZmM1ZC90YWJsZXJhbmdlOjM0NjYwYjM4ODI5ZjQ0NDlhZTljNDViZjNlMGVmYzVkXzctMS0xLTEtMjk0ODk_86ade26a-88da-4c6e-90ef-545ed49dfeb3"
      unitRef="usd">661724000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTozNDY2MGIzODgyOWY0NDQ5YWU5YzQ1YmYzZTBlZmM1ZC90YWJsZXJhbmdlOjM0NjYwYjM4ODI5ZjQ0NDlhZTljNDViZjNlMGVmYzVkXzctMi0xLTEtMjk0ODk_048bb0a4-cfd5-4cae-a6ac-e3dcb4c14629"
      unitRef="usd">643127000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTozNDY2MGIzODgyOWY0NDQ5YWU5YzQ1YmYzZTBlZmM1ZC90YWJsZXJhbmdlOjM0NjYwYjM4ODI5ZjQ0NDlhZTljNDViZjNlMGVmYzVkXzEwLTEtMS0xLTI5NDg5_e2366280-c259-40c7-90f1-906c70dee0d9"
      unitRef="usd">13971000</us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTozNDY2MGIzODgyOWY0NDQ5YWU5YzQ1YmYzZTBlZmM1ZC90YWJsZXJhbmdlOjM0NjYwYjM4ODI5ZjQ0NDlhZTljNDViZjNlMGVmYzVkXzEwLTItMS0xLTI5NDg5_ee57ddbe-9e29-4a2c-8585-206bf6fb3909"
      unitRef="usd">13984000</us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTozNDY2MGIzODgyOWY0NDQ5YWU5YzQ1YmYzZTBlZmM1ZC90YWJsZXJhbmdlOjM0NjYwYjM4ODI5ZjQ0NDlhZTljNDViZjNlMGVmYzVkXzExLTEtMS0xLTI5NDg5_de8f105b-dd3f-4a20-8a52-f629f32a5f07"
      unitRef="usd">12171000</us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTozNDY2MGIzODgyOWY0NDQ5YWU5YzQ1YmYzZTBlZmM1ZC90YWJsZXJhbmdlOjM0NjYwYjM4ODI5ZjQ0NDlhZTljNDViZjNlMGVmYzVkXzExLTItMS0xLTI5NDg5_92dcf491-35d1-4af0-83a4-dc2ef1c25475"
      unitRef="usd">9287000</us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTozNDY2MGIzODgyOWY0NDQ5YWU5YzQ1YmYzZTBlZmM1ZC90YWJsZXJhbmdlOjM0NjYwYjM4ODI5ZjQ0NDlhZTljNDViZjNlMGVmYzVkXzEyLTEtMS0xLTI5NDg5_caed2bbc-9604-4a83-82bc-9d5cb41b8ec2"
      unitRef="usd">1801000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTozNDY2MGIzODgyOWY0NDQ5YWU5YzQ1YmYzZTBlZmM1ZC90YWJsZXJhbmdlOjM0NjYwYjM4ODI5ZjQ0NDlhZTljNDViZjNlMGVmYzVkXzEyLTItMS0xLTI5NDg5_d4cf05bd-6b7c-4d46-a664-df3223d602cd"
      unitRef="usd">4697000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTozNDY2MGIzODgyOWY0NDQ5YWU5YzQ1YmYzZTBlZmM1ZC90YWJsZXJhbmdlOjM0NjYwYjM4ODI5ZjQ0NDlhZTljNDViZjNlMGVmYzVkXzE4LTEtMS0xLTI5NDg5_e53c7c89-214b-4633-b36b-da0819596ce2">P10Y10M24D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTozNDY2MGIzODgyOWY0NDQ5YWU5YzQ1YmYzZTBlZmM1ZC90YWJsZXJhbmdlOjM0NjYwYjM4ODI5ZjQ0NDlhZTljNDViZjNlMGVmYzVkXzE4LTItMS0xLTI5NDg5_9f10de71-07b9-4c5b-b951-b2f02a63e0d6">P10Y4M24D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTozNDY2MGIzODgyOWY0NDQ5YWU5YzQ1YmYzZTBlZmM1ZC90YWJsZXJhbmdlOjM0NjYwYjM4ODI5ZjQ0NDlhZTljNDViZjNlMGVmYzVkXzIyLTEtMS0xLTI5NDg5_5416b4e3-b35b-460a-847d-7a42da92f6ee"
      unitRef="number">0.064</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTozNDY2MGIzODgyOWY0NDQ5YWU5YzQ1YmYzZTBlZmM1ZC90YWJsZXJhbmdlOjM0NjYwYjM4ODI5ZjQ0NDlhZTljNDViZjNlMGVmYzVkXzIyLTItMS0xLTI5NDg5_a84d3acb-e7d1-40c2-8721-7e03301fd4d7"
      unitRef="number">0.063</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90ZXh0cmVnaW9uOmEyZmUyZjYyM2Q4ZTQ5MjdhZDY3ZWMxMDE1NzQ5YzEzXzIwNDM_0444f58c-c0c6-465e-8312-5d52b98989d4">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Maturities of lease liabilities were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.904%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.896%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year Ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Total Lease Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;941,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(279,358)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;661,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTo1MDhlYWJjODU1MjM0OWQ5OTZmNDkyYjA0Y2ZiNDQ5OS90YWJsZXJhbmdlOjUwOGVhYmM4NTUyMzQ5ZDk5NmY0OTJiMDRjZmI0NDk5XzMtMS0xLTEtMjk0ODk_75e1041b-e2b1-4630-8160-d7321b33f7b5"
      unitRef="usd">92371000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTo1MDhlYWJjODU1MjM0OWQ5OTZmNDkyYjA0Y2ZiNDQ5OS90YWJsZXJhbmdlOjUwOGVhYmM4NTUyMzQ5ZDk5NmY0OTJiMDRjZmI0NDk5XzQtMS0xLTEtMjk0ODk_dbcc09eb-55fb-4549-9db8-5e3897e38a85"
      unitRef="usd">92436000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTo1MDhlYWJjODU1MjM0OWQ5OTZmNDkyYjA0Y2ZiNDQ5OS90YWJsZXJhbmdlOjUwOGVhYmM4NTUyMzQ5ZDk5NmY0OTJiMDRjZmI0NDk5XzUtMS0xLTEtMjk0ODk_4d7b699f-3157-47ac-84f9-d5e5c4152ff0"
      unitRef="usd">88941000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTo1MDhlYWJjODU1MjM0OWQ5OTZmNDkyYjA0Y2ZiNDQ5OS90YWJsZXJhbmdlOjUwOGVhYmM4NTUyMzQ5ZDk5NmY0OTJiMDRjZmI0NDk5XzYtMS0xLTEtMjk0ODk_eed0ec7c-a912-4736-ad47-fee2125ecb0f"
      unitRef="usd">85872000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTo1MDhlYWJjODU1MjM0OWQ5OTZmNDkyYjA0Y2ZiNDQ5OS90YWJsZXJhbmdlOjUwOGVhYmM4NTUyMzQ5ZDk5NmY0OTJiMDRjZmI0NDk5XzctMS0xLTEtMjk0ODk_96d44903-6088-4c87-8d8b-993b2d0b7ab8"
      unitRef="usd">82136000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTo1MDhlYWJjODU1MjM0OWQ5OTZmNDkyYjA0Y2ZiNDQ5OS90YWJsZXJhbmdlOjUwOGVhYmM4NTUyMzQ5ZDk5NmY0OTJiMDRjZmI0NDk5XzgtMS0xLTEtMjk0ODk_18f93d3d-b18b-4417-95a0-5dd5482b8ed3"
      unitRef="usd">499326000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTo1MDhlYWJjODU1MjM0OWQ5OTZmNDkyYjA0Y2ZiNDQ5OS90YWJsZXJhbmdlOjUwOGVhYmM4NTUyMzQ5ZDk5NmY0OTJiMDRjZmI0NDk5XzktMS0xLTEtMjk0ODk_b9dff2d6-85b5-4803-914e-627b1e30dcab"
      unitRef="usd">941082000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTo1MDhlYWJjODU1MjM0OWQ5OTZmNDkyYjA0Y2ZiNDQ5OS90YWJsZXJhbmdlOjUwOGVhYmM4NTUyMzQ5ZDk5NmY0OTJiMDRjZmI0NDk5XzEwLTEtMS0xLTI5NDg5_9351b12d-f2a5-4bf3-ad94-34472cd97b9e"
      unitRef="usd">279358000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90YWJsZTo1MDhlYWJjODU1MjM0OWQ5OTZmNDkyYjA0Y2ZiNDQ5OS90YWJsZXJhbmdlOjUwOGVhYmM4NTUyMzQ5ZDk5NmY0OTJiMDRjZmI0NDk5XzExLTEtMS0xLTI5NDg5_e5ff420e-e5d4-4cd9-9122-5939673eaa11"
      unitRef="usd">661724000</us-gaap:OperatingLeaseLiability>
    <rdnt:LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90ZXh0cmVnaW9uOmEyZmUyZjYyM2Q4ZTQ5MjdhZDY3ZWMxMDE1NzQ5YzEzXzE5NDc_89d35649-2584-419a-a094-5b6cd98b227c"
      unitRef="usd">11800000</rdnt:LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount>
    <us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1
      contextRef="ic1e56ddb23564f81949b77940a641b57_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90ZXh0cmVnaW9uOmEyZmUyZjYyM2Q4ZTQ5MjdhZDY3ZWMxMDE1NzQ5YzEzXzIwMTc_89ef3028-caa5-43d9-893e-dca2aa258e5c">P1Y</us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1>
    <us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1
      contextRef="i0118bb2b3716434fb951fa28970f2707_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDAvZnJhZzphMmZlMmY2MjNkOGU0OTI3YWQ2N2VjMTAxNTc0OWMxMy90ZXh0cmVnaW9uOmEyZmUyZjYyM2Q4ZTQ5MjdhZDY3ZWMxMDE1NzQ5YzEzXzIwMjM_09c28e94-c3c1-42f0-8876-fe1e5d5086f8">P15Y</us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90ZXh0cmVnaW9uOmRlNDcyZGZjNTQ5MzQ0NzhhMWY4MjM2NjVkYTk3YWQxXzQ5MzQ_4aff2f1b-8b42-4c04-a591-9316b8d9f2f7">INCOME TAXES&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the years ended December 31, 2022, 2021 and 2020, we have the following income (loss) before income taxes (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;US Domestic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(986)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,560)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(854)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the years ended December 31, 2022, 2021 and 2020, we recognized income tax expense comprised of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal current tax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(256)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State current tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,191)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,608)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign current tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal deferred tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(303)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State deferred tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign deferred tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,430)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the statutory U.S. federal rate and effective rates is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.854%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.178%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.551%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.551%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.178%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.551%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.551%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.407%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="24" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal tax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(179)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State franchise tax, net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Non deductible expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(93)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Officer Compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncontrolling interests in partnerships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,821)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,114)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,748)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(249)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Return to provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,530)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,252)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;PPP Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(850)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred true-ups and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,451)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign rate differential&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(737)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Uncertain tax provisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(749)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(321)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred income taxes reflect the net tax effects of temporary differences between carrying amounts of assets and liabilities for financial and income tax reporting purposes and operating loss carryforwards.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our deferred tax assets and liabilities comprise the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating losses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,095)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,066)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Deferred Tax Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,214)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,134)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38,820)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33,973)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,640)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(129,802)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(128,868)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outside basis difference&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,015)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,081)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,587)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Deferred Tax Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(225,572)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(195,695)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Deferred Tax (Liability) Asset&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,256)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2022, we had federal net operating loss carryforwards of approximately $231.5 million, which is comprised of definite and indefinite net operating losses.  We had federal net operating loss carryforwards of approximately $165.2 million, which expire at various intervals from the years 2026 to 2037, and had carryforwards of $66.3 million of net operating losses which do not expire.  Federal net operating losses generated in tax years following December 31, 2017 carryover indefinitely and may be used to offset up to 80% of future taxable net income.  We also had state net operating loss carryforwards of approximately $271.7 million, which expire at various intervals from the years 2024 through 2042. As of December 31, 2022, $24.9 million of our federal net operating loss carryforwards acquired in connection with the 2011 acquisition of Raven Holdings U.S., Inc. and the 2019 acquisition of Nulogix Health, Inc. are subject to limitations related to their utilization under Section 382 of the Internal Revenue Code.  We also had foreign net operating loss carryforwards of approximately $19.8 million, which begin to expire from years 2023 to 2027, in addition to $11.0 million which do not expire and are carried over indefinitely.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We considered all evidence available when determining whether deferred tax assets are more likely-than-not to be realized, including projected future taxable income, scheduled reversals of deferred tax liabilities, prudent tax planning strategies, and recent financial operations. The evaluation of this evidence requires significant judgment about the forecasts of future taxable income, based on the plans and estimates we are using to manage the underlying businesses. In evaluating the objective evidence that historical results provide, we consider three years of cumulative operating income. As of December 31, 2022, we have determined that deferred tax assets of $216.3 million are more likely-than-not to be realized. We have also determined deferred tax liabilities of $38.8 million are related to book basis in goodwill that has an indefinite life.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We file consolidated income tax returns in the U.S. federal jurisdiction and various states and foreign jurisdictions. We continue to reinvest earnings of the non-US entities for the foreseeable future and therefore have not recognized any U.S. tax expense on these earnings. With limited exceptions, we are no longer subject to U.S. federal, state and local, or non-U.S. income tax examinations by tax authorities for years before 2018.  We do not anticipate the results of any open examinations would result in a material change to our financial position.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the total gross amounts of unrecognized tax benefits for the years ended are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increases related to prior year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increases related to current year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expiration of the statute of limitations for the assessment of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(999)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(713)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(221)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase (decrease) related to change in rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December 31, 2022, we had unrecognized tax benefits of $4.1 million of which $3.4 million will affect the effective tax rate if recognized.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize accrued interest and penalties related to unrecognized tax benefits in income tax expense. During the year ended December 31, 2022 the Company accrued approximately $2 thousand of interest and penalties. As of December 31, 2022, accrued interest and penalties amounted to approximately $0.4 million.  We do not anticipate the uncertain tax position to change materially within the next 12 months.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On March 27, 2020, the United States enacted the Coronavirus Aid, Relief and Economic Security Act (CARES Act). The Cares Act is an emergency economic stimulus package that includes spending and tax breaks to strengthen the United States economy and fund a nationwide effort to curtail the effect of COVID-19. The CARES Act provides sweeping tax changes in response to the COVID-19 pandemic, some of the more significant provisions are removal of certain limitations on utilization of net operating losses, increasing the loss carryback period for certain losses to five years, and increasing the ability to deduct interest expense, as well as amending certain provisions of the previously enacted Tax Cuts and Jobs Act. At December 31, 2020, we have taken advantage of the accelerated tax depreciation related to qualified improvement property and the Paycheck Protection Program loan allowed under the CARES Act.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On December 27, 2020, the United States enacted the Consolidated Appropriations Act of 2021 (&#x201c;CAA&#x201d;). The CAA includes provisions extending certain CARES Act provisions and adds coronavirus relief, tax and health extenders.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Inflation Reduction Act 2022 which incorporates a Corporate Alternative Minimum Tax (CAMT) was signed on August 16, 2022.  The changes will affect for the tax years beginning after December 31, 2022.  The new tax will require companies to compute two separate calculations for federal income tax purposes and pay the greater of the new minimum tax or their regular tax liability.  We will be monitoring the impacts of the act to determine if this will have a impact on us for years beginning after December 31, 2022. As of year-end it is not expected to have a material impact for us.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;The Creating Helpful Incentives to Produce Semiconductors (CHIPS) Act of 2022 was signed into law on August 9, 2022 to boost domestic semiconductor manufacturing and encourage US research activities.  The act provided a 25% investment credit intended to promote domestic production of semiconductors. This act is not expected to have a material impact for us.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;The Tax Cuts and Jobs Act of 2017 subjects a U.S. shareholder to tax on global intangible low-taxed income ("GILTI") earned by certain foreign subsidiaries. An entity can make an accounting policy election to either recognize deferred taxes for temporary basis differences expected to reverse as GILTI in future years or to provide for the tax expense related to GILTI in the year the tax is incurred as a period expense only. We have elected to account for GILTI in the year the tax is incurred.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90ZXh0cmVnaW9uOmRlNDcyZGZjNTQ5MzQ0NzhhMWY4MjM2NjVkYTk3YWQxXzQ5NDc4MDIzNDExMzM_3728fc66-bea5-4951-a2ff-14109c444bb1">For the years ended December 31, 2022, 2021 and 2020, we have the following income (loss) before income taxes (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;US Domestic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(986)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,560)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(854)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpjOTFmNzg1MWU1NmI0N2EzOWI2MDE0YTk1NGJhYzkxOC90YWJsZXJhbmdlOmM5MWY3ODUxZTU2YjQ3YTM5YjYwMTRhOTU0YmFjOTE4XzItMS0xLTEtNzg2OTk_92cdfcae-f5cf-4805-9bc2-b07c6acd0f5a"
      unitRef="usd">59529000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpjOTFmNzg1MWU1NmI0N2EzOWI2MDE0YTk1NGJhYzkxOC90YWJsZXJhbmdlOmM5MWY3ODUxZTU2YjQ3YTM5YjYwMTRhOTU0YmFjOTE4XzItMy0xLTEtNzg2OTk_3eb906e0-9dae-4b51-b4ad-33bfc4226370"
      unitRef="usd">58806000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpjOTFmNzg1MWU1NmI0N2EzOWI2MDE0YTk1NGJhYzkxOC90YWJsZXJhbmdlOmM5MWY3ODUxZTU2YjQ3YTM5YjYwMTRhOTU0YmFjOTE4XzItNS0xLTEtNzg2OTk_032518b7-2ee5-41c3-bb36-d8d3b39362b4"
      unitRef="usd">-986000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpjOTFmNzg1MWU1NmI0N2EzOWI2MDE0YTk1NGJhYzkxOC90YWJsZXJhbmdlOmM5MWY3ODUxZTU2YjQ3YTM5YjYwMTRhOTU0YmFjOTE4XzMtMS0xLTEtNzg2OTk_60313160-bdf3-4ae0-a7d3-c7183c3bd9fc"
      unitRef="usd">-16560000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpjOTFmNzg1MWU1NmI0N2EzOWI2MDE0YTk1NGJhYzkxOC90YWJsZXJhbmdlOmM5MWY3ODUxZTU2YjQ3YTM5YjYwMTRhOTU0YmFjOTE4XzMtMy0xLTEtNzg2OTk_2d3b1831-174a-4132-ab86-2137d647c2bd"
      unitRef="usd">73000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpjOTFmNzg1MWU1NmI0N2EzOWI2MDE0YTk1NGJhYzkxOC90YWJsZXJhbmdlOmM5MWY3ODUxZTU2YjQ3YTM5YjYwMTRhOTU0YmFjOTE4XzMtNS0xLTEtNzg2OTk_0ec7c4e6-4885-4135-85e1-69d69a8d5730"
      unitRef="usd">132000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpjOTFmNzg1MWU1NmI0N2EzOWI2MDE0YTk1NGJhYzkxOC90YWJsZXJhbmdlOmM5MWY3ODUxZTU2YjQ3YTM5YjYwMTRhOTU0YmFjOTE4XzQtMS0xLTEtNzg2OTk_3477fb99-f32b-4e24-8298-5b40a0c42a63"
      unitRef="usd">42969000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpjOTFmNzg1MWU1NmI0N2EzOWI2MDE0YTk1NGJhYzkxOC90YWJsZXJhbmdlOmM5MWY3ODUxZTU2YjQ3YTM5YjYwMTRhOTU0YmFjOTE4XzQtMy0xLTEtNzg2OTk_f69cdca6-2dd2-4df6-adf8-1f7ff0d6b5db"
      unitRef="usd">58879000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpjOTFmNzg1MWU1NmI0N2EzOWI2MDE0YTk1NGJhYzkxOC90YWJsZXJhbmdlOmM5MWY3ODUxZTU2YjQ3YTM5YjYwMTRhOTU0YmFjOTE4XzQtNS0xLTEtNzg2OTk_51bb2c30-264d-4a06-badf-4ca0e387ae83"
      unitRef="usd">-854000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90ZXh0cmVnaW9uOmRlNDcyZGZjNTQ5MzQ0NzhhMWY4MjM2NjVkYTk3YWQxXzQ5Mjc_592a2e72-aa54-424e-ab43-685862c05479">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the years ended December 31, 2022, 2021 and 2020, we recognized income tax expense comprised of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal current tax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(256)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State current tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,191)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,608)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign current tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal deferred tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(303)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State deferred tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign deferred tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,430)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTphN2Q2ZTRhMTQxMWY0MzQzYjRhZDQ2NzIwNDgyNTY0OC90YWJsZXJhbmdlOmE3ZDZlNGExNDExZjQzNDNiNGFkNDY3MjA0ODI1NjQ4XzItMS0xLTEtMjk0ODk_305351ee-108a-4954-92c8-50c91ed919a0"
      unitRef="usd">0</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTphN2Q2ZTRhMTQxMWY0MzQzYjRhZDQ2NzIwNDgyNTY0OC90YWJsZXJhbmdlOmE3ZDZlNGExNDExZjQzNDNiNGFkNDY3MjA0ODI1NjQ4XzItMy0xLTEtMjk0ODk_51f7c7a4-5277-4639-90da-5da2af7a626a"
      unitRef="usd">0</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTphN2Q2ZTRhMTQxMWY0MzQzYjRhZDQ2NzIwNDgyNTY0OC90YWJsZXJhbmdlOmE3ZDZlNGExNDExZjQzNDNiNGFkNDY3MjA0ODI1NjQ4XzItNS0xLTEtMjk0ODk_d71af590-805e-4e46-9b4d-556cf819270b"
      unitRef="usd">-256000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTphN2Q2ZTRhMTQxMWY0MzQzYjRhZDQ2NzIwNDgyNTY0OC90YWJsZXJhbmdlOmE3ZDZlNGExNDExZjQzNDNiNGFkNDY3MjA0ODI1NjQ4XzMtMS0xLTEtMjk0ODk_059e55dd-5e70-4de6-8c90-84c045720705"
      unitRef="usd">371000</us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTphN2Q2ZTRhMTQxMWY0MzQzYjRhZDQ2NzIwNDgyNTY0OC90YWJsZXJhbmdlOmE3ZDZlNGExNDExZjQzNDNiNGFkNDY3MjA0ODI1NjQ4XzMtMy0xLTEtMjk0ODk_15b24cb3-4d40-4c92-a6dd-a032c4df28d6"
      unitRef="usd">-2191000</us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTphN2Q2ZTRhMTQxMWY0MzQzYjRhZDQ2NzIwNDgyNTY0OC90YWJsZXJhbmdlOmE3ZDZlNGExNDExZjQzNDNiNGFkNDY3MjA0ODI1NjQ4XzMtNS0xLTEtMjk0ODk_7bcce65d-4093-429e-b230-4575d856501f"
      unitRef="usd">-1608000</us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTphN2Q2ZTRhMTQxMWY0MzQzYjRhZDQ2NzIwNDgyNTY0OC90YWJsZXJhbmdlOmE3ZDZlNGExNDExZjQzNDNiNGFkNDY3MjA0ODI1NjQ4XzQtMS0xLTEtNzU5NDI_cccafbc1-95f0-4475-a4be-481e906b77ed"
      unitRef="usd">87000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTphN2Q2ZTRhMTQxMWY0MzQzYjRhZDQ2NzIwNDgyNTY0OC90YWJsZXJhbmdlOmE3ZDZlNGExNDExZjQzNDNiNGFkNDY3MjA0ODI1NjQ4XzQtMy0xLTEtNzU5NDI_837f5b99-6009-44e7-939b-e466b895b446"
      unitRef="usd">18000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTphN2Q2ZTRhMTQxMWY0MzQzYjRhZDQ2NzIwNDgyNTY0OC90YWJsZXJhbmdlOmE3ZDZlNGExNDExZjQzNDNiNGFkNDY3MjA0ODI1NjQ4XzQtNS0xLTEtNzU5NDI_0699fcf0-0005-4ddb-9131-b319950faf5b"
      unitRef="usd">27000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTphN2Q2ZTRhMTQxMWY0MzQzYjRhZDQ2NzIwNDgyNTY0OC90YWJsZXJhbmdlOmE3ZDZlNGExNDExZjQzNDNiNGFkNDY3MjA0ODI1NjQ4XzUtMS0xLTEtMjk0ODk_73c02d5e-5f5f-4b11-bd80-8e9cfc7fed96"
      unitRef="usd">6470000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTphN2Q2ZTRhMTQxMWY0MzQzYjRhZDQ2NzIwNDgyNTY0OC90YWJsZXJhbmdlOmE3ZDZlNGExNDExZjQzNDNiNGFkNDY3MjA0ODI1NjQ4XzUtMy0xLTEtMjk0ODk_2e90b2e6-8e1e-4455-8d7b-617ba34e4eac"
      unitRef="usd">9831000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTphN2Q2ZTRhMTQxMWY0MzQzYjRhZDQ2NzIwNDgyNTY0OC90YWJsZXJhbmdlOmE3ZDZlNGExNDExZjQzNDNiNGFkNDY3MjA0ODI1NjQ4XzUtNS0xLTEtMjk0ODk_3dd160a3-6b6f-4a6b-962f-234633486428"
      unitRef="usd">-303000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTphN2Q2ZTRhMTQxMWY0MzQzYjRhZDQ2NzIwNDgyNTY0OC90YWJsZXJhbmdlOmE3ZDZlNGExNDExZjQzNDNiNGFkNDY3MjA0ODI1NjQ4XzYtMS0xLTEtMjk0ODk_3a25ce92-e25a-40ae-97ed-2d14415da65d"
      unitRef="usd">5863000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTphN2Q2ZTRhMTQxMWY0MzQzYjRhZDQ2NzIwNDgyNTY0OC90YWJsZXJhbmdlOmE3ZDZlNGExNDExZjQzNDNiNGFkNDY3MjA0ODI1NjQ4XzYtMy0xLTEtMjk0ODk_a5e9120f-eee4-4005-96ba-435b514776cd"
      unitRef="usd">6902000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTphN2Q2ZTRhMTQxMWY0MzQzYjRhZDQ2NzIwNDgyNTY0OC90YWJsZXJhbmdlOmE3ZDZlNGExNDExZjQzNDNiNGFkNDY3MjA0ODI1NjQ4XzYtNS0xLTEtMjk0ODk_9095f910-9024-416d-acf8-352c030ed2ec"
      unitRef="usd">3035000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTphN2Q2ZTRhMTQxMWY0MzQzYjRhZDQ2NzIwNDgyNTY0OC90YWJsZXJhbmdlOmE3ZDZlNGExNDExZjQzNDNiNGFkNDY3MjA0ODI1NjQ4XzgtMS0xLTEtNzU5NTA_4b645365-4cf4-4826-8da1-bf647f7da9bf"
      unitRef="usd">-3430000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTphN2Q2ZTRhMTQxMWY0MzQzYjRhZDQ2NzIwNDgyNTY0OC90YWJsZXJhbmdlOmE3ZDZlNGExNDExZjQzNDNiNGFkNDY3MjA0ODI1NjQ4XzgtMy0xLTEtNzU5NTA_15a0b517-3d1a-45f3-b25d-b4f288d79a3a"
      unitRef="usd">0</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTphN2Q2ZTRhMTQxMWY0MzQzYjRhZDQ2NzIwNDgyNTY0OC90YWJsZXJhbmdlOmE3ZDZlNGExNDExZjQzNDNiNGFkNDY3MjA0ODI1NjQ4XzgtNS0xLTEtNzU5NTA_ca3fec43-9a8a-47bc-ae8d-1e369b659d67"
      unitRef="usd">0</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTphN2Q2ZTRhMTQxMWY0MzQzYjRhZDQ2NzIwNDgyNTY0OC90YWJsZXJhbmdlOmE3ZDZlNGExNDExZjQzNDNiNGFkNDY3MjA0ODI1NjQ4XzgtMS0xLTEtMjk0ODk_71a327c6-5d69-47b6-8c6e-61f1ffa1142b"
      unitRef="usd">9361000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTphN2Q2ZTRhMTQxMWY0MzQzYjRhZDQ2NzIwNDgyNTY0OC90YWJsZXJhbmdlOmE3ZDZlNGExNDExZjQzNDNiNGFkNDY3MjA0ODI1NjQ4XzgtMy0xLTEtMjk0ODk_516eec83-dfcd-419c-9d0f-f9288e549438"
      unitRef="usd">14560000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTphN2Q2ZTRhMTQxMWY0MzQzYjRhZDQ2NzIwNDgyNTY0OC90YWJsZXJhbmdlOmE3ZDZlNGExNDExZjQzNDNiNGFkNDY3MjA0ODI1NjQ4XzgtNS0xLTEtMjk0ODk_1be86abd-f2fc-4e94-be6b-2591155d9e5f"
      unitRef="usd">895000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90ZXh0cmVnaW9uOmRlNDcyZGZjNTQ5MzQ0NzhhMWY4MjM2NjVkYTk3YWQxXzQ5NDA_021f1336-908c-4197-9c1b-4d6670b238c8">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the statutory U.S. federal rate and effective rates is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.854%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.178%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.551%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.551%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.178%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.551%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.551%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.407%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="24" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal tax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(179)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State franchise tax, net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Non deductible expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(93)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Officer Compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncontrolling interests in partnerships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,821)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,114)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,748)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(249)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Return to provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,530)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,252)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;PPP Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(850)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred true-ups and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,451)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign rate differential&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(737)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Uncertain tax provisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(749)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(321)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzItMS0xLTEtMjk0ODk_230e029b-7c1e-42c2-980b-3e0ba63f8da3"
      unitRef="usd">9023000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzItNS0xLTEtMjk0ODk_4047e4cc-4724-41dd-8094-a3c8ad538d84"
      unitRef="usd">12365000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzItOS0xLTEtMjk0ODk_a0c31b97-4f0d-4b80-9cb3-0630664fe73c"
      unitRef="usd">-179000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzMtMS0xLTEtMjk0ODk_a2100cba-8d8b-474a-adc3-cfac8c1a1802"
      unitRef="usd">595000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzMtNS0xLTEtMjk0ODk_5290d697-a56d-4043-bec5-87efbdfca708"
      unitRef="usd">4198000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzMtOS0xLTEtMjk0ODk_368ee22a-beff-4df8-922e-0d51b004c7f6"
      unitRef="usd">779000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzQtMS0xLTEtMjk0ODk_ab242155-5a7f-4805-9329-aede1610903d"
      unitRef="usd">305000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzQtNS0xLTEtMjk0ODk_bb2bbc46-8340-4258-9f9f-dc5de9e8f8d1"
      unitRef="usd">-93000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzQtOS0xLTEtMjk0ODk_b7b41041-fbd5-4243-a6b0-fa899c77f78c"
      unitRef="usd">224000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzUtMS0xLTEtNzcxNDA_1534dc30-4cb7-4150-b7b6-35767c1d7d14"
      unitRef="usd">759000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzUtNS0xLTEtNzcxNDg_6f706c75-8a18-49bb-90a0-d2b9faebe9ef"
      unitRef="usd">291000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzUtOS0xLTEtNzcxNTY_10559dd6-a8a2-4ec6-88d5-42baf18038bf"
      unitRef="usd">77000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:IncomeTaxReconciliationMinorityInterestIncomeExpense
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzUtMS0xLTEtMjk0ODk_62220a46-0244-42d8-a5aa-c492dc4fa36f"
      unitRef="usd">4821000</us-gaap:IncomeTaxReconciliationMinorityInterestIncomeExpense>
    <us-gaap:IncomeTaxReconciliationMinorityInterestIncomeExpense
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzUtNS0xLTEtMjk0ODk_f5203571-cc6c-4920-b07d-a56d3ebb51ed"
      unitRef="usd">4114000</us-gaap:IncomeTaxReconciliationMinorityInterestIncomeExpense>
    <us-gaap:IncomeTaxReconciliationMinorityInterestIncomeExpense
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzUtOS0xLTEtMjk0ODk_90f3cf25-e7f1-4654-a936-1b5f3f719f81"
      unitRef="usd">2748000</us-gaap:IncomeTaxReconciliationMinorityInterestIncomeExpense>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzYtMS0xLTEtMjk0ODk_b20aef3c-b4db-448a-b67f-5cccc1bf526f"
      unitRef="usd">6124000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzYtNS0xLTEtMjk0ODk_c0e334db-ada4-48e7-a0d0-0d7d551857aa"
      unitRef="usd">-249000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzYtOS0xLTEtMjk0ODk_a81cd0ff-709a-4b7d-87a4-f46551982df6"
      unitRef="usd">-33000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzctMS0xLTEtMjk0ODk_1a2ec169-0c46-4997-8e81-d14102995c18"
      unitRef="usd">234000</us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzctNS0xLTEtMjk0ODk_1f562315-ee8e-4184-9e83-e86d8d475028"
      unitRef="usd">-2530000</us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzctOS0xLTEtMjk0ODk_1fb2ec87-07ba-4445-98a3-faecabda6e13"
      unitRef="usd">-2252000</us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes>
    <rdnt:EffectiveIncomeTaxRateReconciliationPPPLoanAmount
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzgtMS0xLTEtMjk0ODk_74108667-91d7-479f-b288-17128a7c9196"
      unitRef="usd">0</rdnt:EffectiveIncomeTaxRateReconciliationPPPLoanAmount>
    <rdnt:EffectiveIncomeTaxRateReconciliationPPPLoanAmount
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzgtNS0xLTEtMjk0ODk_ebfc80c4-8200-4bcb-b183-6d3365e4caa8"
      unitRef="usd">0</rdnt:EffectiveIncomeTaxRateReconciliationPPPLoanAmount>
    <rdnt:EffectiveIncomeTaxRateReconciliationPPPLoanAmount
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzgtOS0xLTEtMjk0ODk_2054a516-19cb-4ef0-a515-e43c70deb85b"
      unitRef="usd">-850000</rdnt:EffectiveIncomeTaxRateReconciliationPPPLoanAmount>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzEwLTEtMS0xLTI5NDg5_2ae68545-f95c-4dfe-a01e-595be29884e8"
      unitRef="usd">-1451000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzEwLTUtMS0xLTI5NDg5_f2d320aa-324f-4edd-ba04-36b98ed3d5b6"
      unitRef="usd">5009000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzEwLTktMS0xLTI5NDg5_7d6af867-69d0-4e52-b6d7-be59eac5c921"
      unitRef="usd">4840000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzEyLTEtMS0xLTc3MTY4_098ebae3-eafc-4e45-abd5-4cb962ca2486"
      unitRef="usd">-737000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzEyLTUtMS0xLTc3MTc2_42c2f328-cf3c-4d1a-b4fd-d3ee213b97b0"
      unitRef="usd">4000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzExLTktMS0xLTc3ODEw_03b6b1e0-22bc-4d55-a49b-f9437952c440"
      unitRef="usd">-1000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationTaxContingencies
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzExLTEtMS0xLTI5NDg5_94404b92-bd44-438c-ae73-be8be8b66f21"
      unitRef="usd">-749000</us-gaap:IncomeTaxReconciliationTaxContingencies>
    <us-gaap:IncomeTaxReconciliationTaxContingencies
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzExLTUtMS0xLTI5NDg5_b2737eac-30f6-4e1c-be92-c4fbf1d8b1be"
      unitRef="usd">-321000</us-gaap:IncomeTaxReconciliationTaxContingencies>
    <us-gaap:IncomeTaxReconciliationTaxContingencies
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzExLTktMS0xLTI5NDg5_b3985469-8eb1-4484-9d77-66d88a49712e"
      unitRef="usd">1036000</us-gaap:IncomeTaxReconciliationTaxContingencies>
    <us-gaap:IncomeTaxReconciliationOtherReconcilingItems
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzEyLTEtMS0xLTI5NDg5_367df38f-44ee-4929-84a4-a674ca2951fe"
      unitRef="usd">79000</us-gaap:IncomeTaxReconciliationOtherReconcilingItems>
    <us-gaap:IncomeTaxReconciliationOtherReconcilingItems
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzEyLTUtMS0xLTI5NDg5_cc9f6807-4bb3-4784-a2fa-cbfe6a54fee0"
      unitRef="usd">0</us-gaap:IncomeTaxReconciliationOtherReconcilingItems>
    <us-gaap:IncomeTaxReconciliationOtherReconcilingItems
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzEyLTktMS0xLTI5NDg5_cb43c3c4-a3bc-4730-9019-92188d4d95e1"
      unitRef="usd">2000</us-gaap:IncomeTaxReconciliationOtherReconcilingItems>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzEzLTEtMS0xLTI5NDg5_18d27e61-a690-42ca-be57-e13437f4fee9"
      unitRef="usd">9361000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzEzLTUtMS0xLTI5NDg5_7869dd7b-6e05-49a7-9d13-1d0e0a111237"
      unitRef="usd">14560000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpmZGRjMTg2ZTEyNWE0NmIzYmMxZTQxZjA1YzlmMTE2OS90YWJsZXJhbmdlOmZkZGMxODZlMTI1YTQ2YjNiYzFlNDFmMDVjOWYxMTY5XzEzLTktMS0xLTI5NDg5_f11dafac-6fee-4679-b2b0-f76e7d49308a"
      unitRef="usd">895000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90ZXh0cmVnaW9uOmRlNDcyZGZjNTQ5MzQ0NzhhMWY4MjM2NjVkYTk3YWQxXzQ5Mzg_559dc19a-d427-41ec-84f7-0e2ef023769b">Our deferred tax assets and liabilities comprise the following (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating losses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,095)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,066)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Deferred Tax Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,214)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,134)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38,820)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33,973)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,640)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(129,802)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(128,868)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outside basis difference&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,015)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,081)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,587)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Deferred Tax Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(225,572)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(195,695)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Deferred Tax (Liability) Asset&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,256)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpiNzU0MWMyZWUxNzA0OTQ1YmI2YTYwNTAxNWU4NDNhZS90YWJsZXJhbmdlOmI3NTQxYzJlZTE3MDQ5NDViYjZhNjA1MDE1ZTg0M2FlXzItMS0xLTEtMjk0ODk_90bb5b23-c3c8-4f16-8082-5a54642f128a"
      unitRef="usd">68124000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpiNzU0MWMyZWUxNzA0OTQ1YmI2YTYwNTAxNWU4NDNhZS90YWJsZXJhbmdlOmI3NTQxYzJlZTE3MDQ5NDViYjZhNjA1MDE1ZTg0M2FlXzItMy0xLTEtMjk0ODk_f0d04d2f-3a3e-44fd-b884-cdcbd4b9170e"
      unitRef="usd">57663000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpiNzU0MWMyZWUxNzA0OTQ1YmI2YTYwNTAxNWU4NDNhZS90YWJsZXJhbmdlOmI3NTQxYzJlZTE3MDQ5NDViYjZhNjA1MDE1ZTg0M2FlXzMtMS0xLTEtMjk0ODk_81cc7692-190f-4c41-aa68-91db713d3e7c"
      unitRef="usd">3941000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpiNzU0MWMyZWUxNzA0OTQ1YmI2YTYwNTAxNWU4NDNhZS90YWJsZXJhbmdlOmI3NTQxYzJlZTE3MDQ5NDViYjZhNjA1MDE1ZTg0M2FlXzMtMy0xLTEtMjk0ODk_4284aacf-4877-4114-9556-37befcab657d"
      unitRef="usd">3275000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals>
    <rdnt:DeferredTaxAssetsOperatingLeaseLiabilities
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpiNzU0MWMyZWUxNzA0OTQ1YmI2YTYwNTAxNWU4NDNhZS90YWJsZXJhbmdlOmI3NTQxYzJlZTE3MDQ5NDViYjZhNjA1MDE1ZTg0M2FlXzQtMS0xLTEtMjk0ODk_356401a2-0069-4024-a57e-8c069a043829"
      unitRef="usd">142347000</rdnt:DeferredTaxAssetsOperatingLeaseLiabilities>
    <rdnt:DeferredTaxAssetsOperatingLeaseLiabilities
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpiNzU0MWMyZWUxNzA0OTQ1YmI2YTYwNTAxNWU4NDNhZS90YWJsZXJhbmdlOmI3NTQxYzJlZTE3MDQ5NDViYjZhNjA1MDE1ZTg0M2FlXzQtMy0xLTEtMjk0ODk_4f8d845c-f1a1-4945-a93a-9503a1722731"
      unitRef="usd">141440000</rdnt:DeferredTaxAssetsOperatingLeaseLiabilities>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpiNzU0MWMyZWUxNzA0OTQ1YmI2YTYwNTAxNWU4NDNhZS90YWJsZXJhbmdlOmI3NTQxYzJlZTE3MDQ5NDViYjZhNjA1MDE1ZTg0M2FlXzctMS0xLTEtMjk0ODk_8d82cb1f-e624-4c96-a711-01c4c3b1483d"
      unitRef="usd">4387000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpiNzU0MWMyZWUxNzA0OTQ1YmI2YTYwNTAxNWU4NDNhZS90YWJsZXJhbmdlOmI3NTQxYzJlZTE3MDQ5NDViYjZhNjA1MDE1ZTg0M2FlXzctMy0xLTEtMjk0ODk_48084dae-e993-4865-bcf7-5de0489c0000"
      unitRef="usd">2993000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpiNzU0MWMyZWUxNzA0OTQ1YmI2YTYwNTAxNWU4NDNhZS90YWJsZXJhbmdlOmI3NTQxYzJlZTE3MDQ5NDViYjZhNjA1MDE1ZTg0M2FlXzgtMS0xLTEtMjk0ODk_08802b3b-2e62-4b50-acff-088e7d63cbdd"
      unitRef="usd">3071000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpiNzU0MWMyZWUxNzA0OTQ1YmI2YTYwNTAxNWU4NDNhZS90YWJsZXJhbmdlOmI3NTQxYzJlZTE3MDQ5NDViYjZhNjA1MDE1ZTg0M2FlXzgtMy0xLTEtMjk0ODk_6797bf5d-457f-4427-b193-955d214b5bf0"
      unitRef="usd">2711000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpiNzU0MWMyZWUxNzA0OTQ1YmI2YTYwNTAxNWU4NDNhZS90YWJsZXJhbmdlOmI3NTQxYzJlZTE3MDQ5NDViYjZhNjA1MDE1ZTg0M2FlXzktMS0xLTEtMjk0ODk_c8e4bdfe-df53-4a98-af1a-4ff1bd4c4d9d"
      unitRef="usd">6541000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpiNzU0MWMyZWUxNzA0OTQ1YmI2YTYwNTAxNWU4NDNhZS90YWJsZXJhbmdlOmI3NTQxYzJlZTE3MDQ5NDViYjZhNjA1MDE1ZTg0M2FlXzktMy0xLTEtMjk0ODk_933324d9-9701-40b5-afb6-29bd1177e1a5"
      unitRef="usd">7532000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpiNzU0MWMyZWUxNzA0OTQ1YmI2YTYwNTAxNWU4NDNhZS90YWJsZXJhbmdlOmI3NTQxYzJlZTE3MDQ5NDViYjZhNjA1MDE1ZTg0M2FlXzEwLTEtMS0xLTI5NDg5_e039d5aa-2540-4064-a252-fbc697fb9ce5"
      unitRef="usd">12095000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpiNzU0MWMyZWUxNzA0OTQ1YmI2YTYwNTAxNWU4NDNhZS90YWJsZXJhbmdlOmI3NTQxYzJlZTE3MDQ5NDViYjZhNjA1MDE1ZTg0M2FlXzEwLTMtMS0xLTI5NDg5_c0169986-aab6-4462-b7d4-e63360faa05d"
      unitRef="usd">5066000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpiNzU0MWMyZWUxNzA0OTQ1YmI2YTYwNTAxNWU4NDNhZS90YWJsZXJhbmdlOmI3NTQxYzJlZTE3MDQ5NDViYjZhNjA1MDE1ZTg0M2FlXzExLTEtMS0xLTI5NDg5_b6c5c469-0819-4113-ad7c-66b5981f5a57"
      unitRef="usd">216316000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpiNzU0MWMyZWUxNzA0OTQ1YmI2YTYwNTAxNWU4NDNhZS90YWJsZXJhbmdlOmI3NTQxYzJlZTE3MDQ5NDViYjZhNjA1MDE1ZTg0M2FlXzExLTMtMS0xLTI5NDg5_4f778b1d-eff7-41b2-b31b-b26d37a6e636"
      unitRef="usd">210548000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpiNzU0MWMyZWUxNzA0OTQ1YmI2YTYwNTAxNWU4NDNhZS90YWJsZXJhbmdlOmI3NTQxYzJlZTE3MDQ5NDViYjZhNjA1MDE1ZTg0M2FlXzEzLTEtMS0xLTI5NDg5_08e22f20-3ba4-45e3-b627-69631e6635f7"
      unitRef="usd">9214000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpiNzU0MWMyZWUxNzA0OTQ1YmI2YTYwNTAxNWU4NDNhZS90YWJsZXJhbmdlOmI3NTQxYzJlZTE3MDQ5NDViYjZhNjA1MDE1ZTg0M2FlXzEzLTMtMS0xLTI5NDg5_a546f94b-ebaf-4adb-87bc-3a165a7a983d"
      unitRef="usd">12134000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpiNzU0MWMyZWUxNzA0OTQ1YmI2YTYwNTAxNWU4NDNhZS90YWJsZXJhbmdlOmI3NTQxYzJlZTE3MDQ5NDViYjZhNjA1MDE1ZTg0M2FlXzE0LTEtMS0xLTI5NDg5_5201b994-ab9a-4ca2-a817-a11ce724244b"
      unitRef="usd">38820000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpiNzU0MWMyZWUxNzA0OTQ1YmI2YTYwNTAxNWU4NDNhZS90YWJsZXJhbmdlOmI3NTQxYzJlZTE3MDQ5NDViYjZhNjA1MDE1ZTg0M2FlXzE0LTMtMS0xLTI5NDg5_8680dab9-4045-45d7-bf5f-2f3eb57736b7"
      unitRef="usd">33973000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpiNzU0MWMyZWUxNzA0OTQ1YmI2YTYwNTAxNWU4NDNhZS90YWJsZXJhbmdlOmI3NTQxYzJlZTE3MDQ5NDViYjZhNjA1MDE1ZTg0M2FlXzE1LTEtMS0xLTI5NDg5_f3156a11-65af-4057-8fdb-a260dfb025cc"
      unitRef="usd">18640000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpiNzU0MWMyZWUxNzA0OTQ1YmI2YTYwNTAxNWU4NDNhZS90YWJsZXJhbmdlOmI3NTQxYzJlZTE3MDQ5NDViYjZhNjA1MDE1ZTg0M2FlXzE1LTMtMS0xLTI5NDg5_e24b389d-9016-4cfa-8ab4-d85650ff197d"
      unitRef="usd">9133000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets>
    <rdnt:DeferredTaxLiabilitiesOperatingRightOfUseAssets
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpiNzU0MWMyZWUxNzA0OTQ1YmI2YTYwNTAxNWU4NDNhZS90YWJsZXJhbmdlOmI3NTQxYzJlZTE3MDQ5NDViYjZhNjA1MDE1ZTg0M2FlXzE2LTEtMS0xLTI5NDg5_2ea9d3c2-3869-4437-9e82-d563457646ed"
      unitRef="usd">129802000</rdnt:DeferredTaxLiabilitiesOperatingRightOfUseAssets>
    <rdnt:DeferredTaxLiabilitiesOperatingRightOfUseAssets
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpiNzU0MWMyZWUxNzA0OTQ1YmI2YTYwNTAxNWU4NDNhZS90YWJsZXJhbmdlOmI3NTQxYzJlZTE3MDQ5NDViYjZhNjA1MDE1ZTg0M2FlXzE2LTMtMS0xLTI5NDg5_7db66f76-e955-4afa-9bfb-3070e5e1806f"
      unitRef="usd">128868000</rdnt:DeferredTaxLiabilitiesOperatingRightOfUseAssets>
    <rdnt:DeferredTaxLiabilitiesOutsideBasisDifference
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpiNzU0MWMyZWUxNzA0OTQ1YmI2YTYwNTAxNWU4NDNhZS90YWJsZXJhbmdlOmI3NTQxYzJlZTE3MDQ5NDViYjZhNjA1MDE1ZTg0M2FlXzE3LTEtMS0xLTI5NDg5_181aa13e-b0bd-4b05-a78d-d2e15524ca2a"
      unitRef="usd">20015000</rdnt:DeferredTaxLiabilitiesOutsideBasisDifference>
    <rdnt:DeferredTaxLiabilitiesOutsideBasisDifference
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpiNzU0MWMyZWUxNzA0OTQ1YmI2YTYwNTAxNWU4NDNhZS90YWJsZXJhbmdlOmI3NTQxYzJlZTE3MDQ5NDViYjZhNjA1MDE1ZTg0M2FlXzE3LTMtMS0xLTI5NDg5_809f2c69-adab-4846-83bf-93f97434eaec"
      unitRef="usd">0</rdnt:DeferredTaxLiabilitiesOutsideBasisDifference>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpiNzU0MWMyZWUxNzA0OTQ1YmI2YTYwNTAxNWU4NDNhZS90YWJsZXJhbmdlOmI3NTQxYzJlZTE3MDQ5NDViYjZhNjA1MDE1ZTg0M2FlXzE4LTEtMS0xLTI5NDg5_8078e7d3-00f0-4a65-98bc-be6167ade3cc"
      unitRef="usd">9081000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpiNzU0MWMyZWUxNzA0OTQ1YmI2YTYwNTAxNWU4NDNhZS90YWJsZXJhbmdlOmI3NTQxYzJlZTE3MDQ5NDViYjZhNjA1MDE1ZTg0M2FlXzE4LTMtMS0xLTI5NDg5_0f49fd93-e0b4-4dc0-94d5-7d95292c4ecb"
      unitRef="usd">11587000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpiNzU0MWMyZWUxNzA0OTQ1YmI2YTYwNTAxNWU4NDNhZS90YWJsZXJhbmdlOmI3NTQxYzJlZTE3MDQ5NDViYjZhNjA1MDE1ZTg0M2FlXzE5LTEtMS0xLTI5NDg5_7e8a13f8-c5bb-49a5-90b1-ac21679b9861"
      unitRef="usd">225572000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpiNzU0MWMyZWUxNzA0OTQ1YmI2YTYwNTAxNWU4NDNhZS90YWJsZXJhbmdlOmI3NTQxYzJlZTE3MDQ5NDViYjZhNjA1MDE1ZTg0M2FlXzE5LTMtMS0xLTI5NDg5_4fba1650-f123-44a3-904e-4796f642927c"
      unitRef="usd">195695000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpiNzU0MWMyZWUxNzA0OTQ1YmI2YTYwNTAxNWU4NDNhZS90YWJsZXJhbmdlOmI3NTQxYzJlZTE3MDQ5NDViYjZhNjA1MDE1ZTg0M2FlXzIxLTEtMS0xLTI5NDg5_c6135d26-41b9-4620-b677-63a1a0359990"
      unitRef="usd">9256000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTpiNzU0MWMyZWUxNzA0OTQ1YmI2YTYwNTAxNWU4NDNhZS90YWJsZXJhbmdlOmI3NTQxYzJlZTE3MDQ5NDViYjZhNjA1MDE1ZTg0M2FlXzIxLTMtMS0xLTI5NDg5_c93b58ae-0325-4b80-bb31-f19424331330"
      unitRef="usd">14853000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i1c9c24367d914d6f8d3b8b89c6ac650c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90ZXh0cmVnaW9uOmRlNDcyZGZjNTQ5MzQ0NzhhMWY4MjM2NjVkYTk3YWQxXzYxNA_1c818024-026b-4913-b794-f29527f2eb68"
      unitRef="usd">231500000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
      contextRef="i1c9c24367d914d6f8d3b8b89c6ac650c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90ZXh0cmVnaW9uOmRlNDcyZGZjNTQ5MzQ0NzhhMWY4MjM2NjVkYTk3YWQxXzYyNw_ca385c09-7906-436a-a65e-e4cdafe7a209"
      unitRef="usd">165200000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration
      contextRef="i1c9c24367d914d6f8d3b8b89c6ac650c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90ZXh0cmVnaW9uOmRlNDcyZGZjNTQ5MzQ0NzhhMWY4MjM2NjVkYTk3YWQxXzY5OA_2abd158c-7b26-42c9-a61e-ac90bff338f0"
      unitRef="usd">66300000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i01d34ce5690d41ac9b7da0025a908d74_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90ZXh0cmVnaW9uOmRlNDcyZGZjNTQ5MzQ0NzhhMWY4MjM2NjVkYTk3YWQxXzk2Ng_11624267-7280-476c-ac73-8dc51fc2a373"
      unitRef="usd">271700000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
      contextRef="if220aac49baf4022b602bb8b0e79c955_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90ZXh0cmVnaW9uOmRlNDcyZGZjNTQ5MzQ0NzhhMWY4MjM2NjVkYTk3YWQxXzEwNDg_b68003ec-5e27-4dc7-b69e-5ab690de5470"
      unitRef="usd">24900000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <rdnt:ForeignOperatingLossCarryforwardsSubjectToExpiration
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90ZXh0cmVnaW9uOmRlNDcyZGZjNTQ5MzQ0NzhhMWY4MjM2NjVkYTk3YWQxXzM4NDgyOTA3MDc2NTg_60a8ba01-c799-47ed-8872-1c23357dd004"
      unitRef="usd">19800000</rdnt:ForeignOperatingLossCarryforwardsSubjectToExpiration>
    <rdnt:ForeignOperatingLossCarryforwardsNotSubjectToExpiration
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90ZXh0cmVnaW9uOmRlNDcyZGZjNTQ5MzQ0NzhhMWY4MjM2NjVkYTk3YWQxXzM4NDgyOTA3MDc3Mjk_49588387-cfc2-4ba5-ba25-0e3ea1df2835"
      unitRef="usd">11000000</rdnt:ForeignOperatingLossCarryforwardsNotSubjectToExpiration>
    <rdnt:DeferredTaxAssetsTaxBenefitMayNotBeRealized
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90ZXh0cmVnaW9uOmRlNDcyZGZjNTQ5MzQ0NzhhMWY4MjM2NjVkYTk3YWQxXzE5ODk_44940926-e206-4619-8b12-d2aae82e67c8"
      unitRef="usd">216300000</rdnt:DeferredTaxAssetsTaxBenefitMayNotBeRealized>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90ZXh0cmVnaW9uOmRlNDcyZGZjNTQ5MzQ0NzhhMWY4MjM2NjVkYTk3YWQxXzIwOTk_0e611729-3485-4003-86b5-acd5a94f5733"
      unitRef="usd">38800000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill>
    <us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90ZXh0cmVnaW9uOmRlNDcyZGZjNTQ5MzQ0NzhhMWY4MjM2NjVkYTk3YWQxXzQ5Mjk_0dd96da5-0a55-46c0-b55b-344e15cd6b34">A reconciliation of the total gross amounts of unrecognized tax benefits for the years ended are as follows (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increases related to prior year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increases related to current year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expiration of the statute of limitations for the assessment of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(999)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(713)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(221)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase (decrease) related to change in rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTo2ODcyYjVjMTEyMDY0MTk5YTk4OWJkODkxZjllNGUxZC90YWJsZXJhbmdlOjY4NzJiNWMxMTIwNjQxOTlhOTg5YmQ4OTFmOWU0ZTFkXzItMS0xLTEtMjk0ODk_31b0368b-85b4-459f-ae18-c013079cd40f"
      unitRef="usd">5088000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ifb50bc5a13564f6a97eb669524009c18_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTo2ODcyYjVjMTEyMDY0MTk5YTk4OWJkODkxZjllNGUxZC90YWJsZXJhbmdlOjY4NzJiNWMxMTIwNjQxOTlhOTg5YmQ4OTFmOWU0ZTFkXzItMy0xLTEtMjk0ODk_269ef468-cf68-4cbf-9671-1b2df44e20af"
      unitRef="usd">5484000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i404f0df0019f440299547782ff0ce012_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTo2ODcyYjVjMTEyMDY0MTk5YTk4OWJkODkxZjllNGUxZC90YWJsZXJhbmdlOjY4NzJiNWMxMTIwNjQxOTlhOTg5YmQ4OTFmOWU0ZTFkXzItNS0xLTEtMjk0ODk_ac948333-56e5-471d-9eda-a4db6c6555f1"
      unitRef="usd">4320000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTo2ODcyYjVjMTEyMDY0MTk5YTk4OWJkODkxZjllNGUxZC90YWJsZXJhbmdlOjY4NzJiNWMxMTIwNjQxOTlhOTg5YmQ4OTFmOWU0ZTFkXzMtMS0xLTEtMjk0ODk_4198a654-3893-4aeb-9a2e-6ea120b9a748"
      unitRef="usd">55000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTo2ODcyYjVjMTEyMDY0MTk5YTk4OWJkODkxZjllNGUxZC90YWJsZXJhbmdlOjY4NzJiNWMxMTIwNjQxOTlhOTg5YmQ4OTFmOWU0ZTFkXzMtMy0xLTEtMjk0ODk_b4501797-c1cc-47d8-8626-668abb387ecd"
      unitRef="usd">317000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTo2ODcyYjVjMTEyMDY0MTk5YTk4OWJkODkxZjllNGUxZC90YWJsZXJhbmdlOjY4NzJiNWMxMTIwNjQxOTlhOTg5YmQ4OTFmOWU0ZTFkXzMtNS0xLTEtMjk0ODk_cd20b637-c455-4fd4-9dbc-9261fe7b0f77"
      unitRef="usd">1382000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTo2ODcyYjVjMTEyMDY0MTk5YTk4OWJkODkxZjllNGUxZC90YWJsZXJhbmdlOjY4NzJiNWMxMTIwNjQxOTlhOTg5YmQ4OTFmOWU0ZTFkXzQtMS0xLTEtMjk0ODk_68ea8dee-9585-47d1-8daf-e64be3d6e3db"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTo2ODcyYjVjMTEyMDY0MTk5YTk4OWJkODkxZjllNGUxZC90YWJsZXJhbmdlOjY4NzJiNWMxMTIwNjQxOTlhOTg5YmQ4OTFmOWU0ZTFkXzQtMy0xLTEtMjk0ODk_f8be2536-6b71-4327-af11-fb9c6c35fd2a"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTo2ODcyYjVjMTEyMDY0MTk5YTk4OWJkODkxZjllNGUxZC90YWJsZXJhbmdlOjY4NzJiNWMxMTIwNjQxOTlhOTg5YmQ4OTFmOWU0ZTFkXzQtNS0xLTEtMjk0ODk_76ae3353-491c-4d25-8b71-f40ab133f599"
      unitRef="usd">3000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTo2ODcyYjVjMTEyMDY0MTk5YTk4OWJkODkxZjllNGUxZC90YWJsZXJhbmdlOjY4NzJiNWMxMTIwNjQxOTlhOTg5YmQ4OTFmOWU0ZTFkXzUtMS0xLTEtMjk0ODk_ce52ca20-bbf2-4f9c-a68d-756cede3a153"
      unitRef="usd">999000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTo2ODcyYjVjMTEyMDY0MTk5YTk4OWJkODkxZjllNGUxZC90YWJsZXJhbmdlOjY4NzJiNWMxMTIwNjQxOTlhOTg5YmQ4OTFmOWU0ZTFkXzUtMy0xLTEtMjk0ODk_e50db56d-b599-4fe6-857b-e0f3058a95a6"
      unitRef="usd">713000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTo2ODcyYjVjMTEyMDY0MTk5YTk4OWJkODkxZjllNGUxZC90YWJsZXJhbmdlOjY4NzJiNWMxMTIwNjQxOTlhOTg5YmQ4OTFmOWU0ZTFkXzUtNS0xLTEtMjk0ODk_58c859df-e4e9-477a-ad86-75f80ebeb63d"
      unitRef="usd">221000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <rdnt:UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTo2ODcyYjVjMTEyMDY0MTk5YTk4OWJkODkxZjllNGUxZC90YWJsZXJhbmdlOjY4NzJiNWMxMTIwNjQxOTlhOTg5YmQ4OTFmOWU0ZTFkXzYtMS0xLTEtMjk0ODk_cf41de8c-1ea5-4b19-a737-0e3f94e5a391"
      unitRef="usd">0</rdnt:UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate>
    <rdnt:UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate
      contextRef="ib67a0f654c0f46d989303955d47bd4d0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTo2ODcyYjVjMTEyMDY0MTk5YTk4OWJkODkxZjllNGUxZC90YWJsZXJhbmdlOjY4NzJiNWMxMTIwNjQxOTlhOTg5YmQ4OTFmOWU0ZTFkXzYtMy0xLTEtMjk0ODk_989cc2db-7c37-4856-acd1-885ff8ebc865"
      unitRef="usd">0</rdnt:UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate>
    <rdnt:UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate
      contextRef="i0ac00245c2aa421b93a8c7a5ae1e31d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTo2ODcyYjVjMTEyMDY0MTk5YTk4OWJkODkxZjllNGUxZC90YWJsZXJhbmdlOjY4NzJiNWMxMTIwNjQxOTlhOTg5YmQ4OTFmOWU0ZTFkXzYtNS0xLTEtMjk0ODk_340db602-3afc-43a1-b2fc-3e15c0731776"
      unitRef="usd">0</rdnt:UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTo2ODcyYjVjMTEyMDY0MTk5YTk4OWJkODkxZjllNGUxZC90YWJsZXJhbmdlOjY4NzJiNWMxMTIwNjQxOTlhOTg5YmQ4OTFmOWU0ZTFkXzctMS0xLTEtMjk0ODk_489e5838-c3ca-49cd-87b1-09915ad22878"
      unitRef="usd">4144000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTo2ODcyYjVjMTEyMDY0MTk5YTk4OWJkODkxZjllNGUxZC90YWJsZXJhbmdlOjY4NzJiNWMxMTIwNjQxOTlhOTg5YmQ4OTFmOWU0ZTFkXzctMy0xLTEtMjk0ODk_98514185-4262-4935-ab21-4de6590e4577"
      unitRef="usd">5088000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ifb50bc5a13564f6a97eb669524009c18_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90YWJsZTo2ODcyYjVjMTEyMDY0MTk5YTk4OWJkODkxZjllNGUxZC90YWJsZXJhbmdlOjY4NzJiNWMxMTIwNjQxOTlhOTg5YmQ4OTFmOWU0ZTFkXzctNS0xLTEtMjk0ODk_af4a1fdb-8af7-437a-a5bb-0e629a4618de"
      unitRef="usd">5484000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90ZXh0cmVnaW9uOmRlNDcyZGZjNTQ5MzQ0NzhhMWY4MjM2NjVkYTk3YWQxXzI4ODU_c29eb604-cd10-4e1d-96f4-6c530be6dc25"
      unitRef="usd">4100000</us-gaap:UnrecognizedTaxBenefits>
    <rdnt:UnrecognizedTaxBenefitsTaxImpactIfRecognized
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90ZXh0cmVnaW9uOmRlNDcyZGZjNTQ5MzQ0NzhhMWY4MjM2NjVkYTk3YWQxXzI4OTc_39ec519e-8991-4d09-9a3d-ab1608059e75"
      unitRef="usd">3400000</rdnt:UnrecognizedTaxBenefitsTaxImpactIfRecognized>
    <rdnt:UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90ZXh0cmVnaW9uOmRlNDcyZGZjNTQ5MzQ0NzhhMWY4MjM2NjVkYTk3YWQxXzMxMjY_32ff587d-af9c-4b0f-af63-d20cdebe3d88"
      unitRef="usd">2000</rdnt:UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDYvZnJhZzpkZTQ3MmRmYzU0OTM0NDc4YTFmODIzNjY1ZGE5N2FkMS90ZXh0cmVnaW9uOmRlNDcyZGZjNTQ5MzQ0NzhhMWY4MjM2NjVkYTk3YWQxXzMyMjM_5b4e4b6f-80b8-49bd-bdae-40005f40be81"
      unitRef="usd">400000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzMxMjQ_a367e1c6-e47e-4923-87c6-6f95c80591e3">STOCK-BASED COMPENSATION&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Stock Incentive Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have one long-term equity incentive plan, the RadNet, Inc. Equity Incentive Plan, which we first amended and restated April 20, 2015, again on March 9, 2017 and currently as of April 15, 2021 (the "Restated Plan&#x201d;). The Restated Plan was most recently approved by our stockholders at our annual stockholders meeting on June 10, 2021.  We have reserved for issuance under the 2017 Restated Plan 16,500,000 shares of common stock.  We can issue options (incentive and non-qualified), stock awards, stock appreciation rights, stock units and cash awards under the Restated Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Options&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain options granted under the Restated Plan to employees are intended to qualify as incentive stock options under existing tax regulations. Stock options generally vest over &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzgyNA_592b111d-5e4b-4ce1-b2c6-e023d3e9049f"&gt;three&lt;/span&gt; to five years and expire &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzg0NA_4b31c3d7-9086-4991-8c69-3f75d38c24fd"&gt;five&lt;/span&gt; to ten years from the date of grant.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following summarizes all of our option transactions for the twelve months ended December 31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.822%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.822%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.822%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.824%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding Options&lt;br/&gt;Under the 2006 Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Exercise price&lt;br/&gt;Per Common Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Life(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;473,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;229,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;678,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.07&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,416,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;483,969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.93&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,381,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Aggregate intrinsic value in the table above represents the total pretax intrinsic value (the difference between our closing stock price on December 31, 2022 and the exercise price, multiplied by the number of in-the-money options as applicable) that would have been received by the holder had all holders exercised their options on December 31, 2022.  As of December 31, 2022, total unrecognized stock-based compensation expense related to non-vested employee awards was $1.1 million which is expected to be recognized over a weighted average period of approximately 2.32 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:174%"&gt;DeepHealth Options&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the second quarter of fiscal 2020, in connection with the completion of the DeepHealth acquisition, we granted&#160;412,434&#160;options at a grant date fair value of $16.93&#160;per share unit to DeepHealth employees in replacement of their stock options that were outstanding as of the closing date.  As of December 31, 2022, total unrecognized stock based compensation expense related to non-vested DeepHealth options was approximately $0.6 million which is expected to be recognized over a weighted average period of approximately 0.74 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.197%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.550%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.161%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.550%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.161%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.550%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.912%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.550%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.069%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Outstanding Options&lt;br/&gt;Under the Deep Health Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Exercise price&lt;br/&gt;Per Common Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual Life&lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;320,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(203,678)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116,982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.80&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,202,771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.80&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,448,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Stock Awards (&#x201c;RSA&#x2019;s&#x201d;)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Restated Plan permits the award of restricted stock awards (&#x201c;RSA&#x2019;s&#x201d;). As of December 31, 2022, we have issued a total of 7,892,930 RSA&#x2019;s of which 536,767 were unvested at December 31, 2022 . The following summarizes all unvested RSA&#x2019;s activities during the twelve months ended December 31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSA's&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Term (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSA's unvested at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;456,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;649,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(563,731)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,478)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSA's unvested at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;536,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.01&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We determine the fair value of all RSA&#x2019;s based of the closing price of our common stock on award date.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other stock bonus awards&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Restated Plan also permits the award of stock bonuses not subject to any future service period. These awards are valued and expensed based on the closing price of our common stock on the date of award. During the twelve months ended December 31, 2022 we issued 41,000 shares relating to these awards, approximately amounting to $0.8 million of compensation expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Performance based stock units ("PSUs")&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2022, we granted certain employees PSUs with a target award of 25,683 shares of our common stock. The PSUs will vest in two equal parts, starting three years from the grant date based on continuous service, with the number of shares earned (0% to 200% of the target award) depending upon the extent to which we achieve a performance condition as determined by the board of directors over the period from January 1, 2022 through December 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Performance based stock options ("PSOs")&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2022, we granted certain employees PSOs to purchase a maximum of 111,925 shares of our common stock. The PSOs will vest in three equal parts, starting three years from the grant date based on continuous service, with the number of shares earned (0 shares to 111,925 shares) depending upon the extent to which we achieve a performance condition as determined by the board of directors over the period from January 1, 2022 through December 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Long Term Incentive Plan shares ("LTIPs")&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, we issue stock-based compensation to certain employees in our AI segment in the form of Stock Units and Restricted Stock Awards, subject to certain restrictions.&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The awards represent a form of long term incentive and are reflective of a general practice within the software industry.  The units and shares vest ratably over a &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzM4NDgyOTA3MDIzMDM_73f2d802-1880-44ce-b1e9-1beab990455e"&gt;two&lt;/span&gt; to four year period, conditioned on continued employment through the vesting periods. We determine the fair value of all LTIPs based on the closing price of our common stock on the award date.  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following summarizes all unvested LTIPs activities during the twelve months ended December 31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.099%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.642%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.822%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.822%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.824%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;LTIPs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Term (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;LTIPs unvested at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited or Canceled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,141)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;LTIPs unvested at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.69&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Plan summary&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;In summary, of the 16,500,000 shares of common stock reserved for issuance under the Restated Plan at December 31, 2022, there remain 2,017,233 shares available for future awards.</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzM4NDgyOTA3MDIwMDQ_ee4cdd4b-6e5a-4583-bec2-af01477df12d"
      unitRef="incentiveplan">1</rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="id1fdbe2d3c964be6888f0365aa0b975b_I20210415"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzQ2MQ_7d71d979-39f7-46db-b21b-49eb41072229"
      unitRef="shares">16500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ib19ac757adb3497f895598bf7d1fb0f6_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzgzMA_6d37fcd3-aebd-42ad-8104-0058070a7662">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="ib19ac757adb3497f895598bf7d1fb0f6_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzg1MA_3891af07-1236-4326-9c1b-10735cbf3dfa">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzMxMjY_6778dd9a-d3cb-4c95-8801-9eb676f887db">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following summarizes all of our option transactions for the twelve months ended December 31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.822%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.822%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.822%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.824%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding Options&lt;br/&gt;Under the 2006 Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Exercise price&lt;br/&gt;Per Common Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Life(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;473,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;229,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;678,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.07&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,416,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;483,969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.93&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,381,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.197%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.550%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.161%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.550%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.161%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.550%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.912%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.550%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.069%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Outstanding Options&lt;br/&gt;Under the Deep Health Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Exercise price&lt;br/&gt;Per Common Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual Life&lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;320,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(203,678)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116,982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.80&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,202,771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.80&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,448,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZToyZGFhNzg2NTJlZTU0MDc2YjY3ODA5MzRlYzNiZTBjNS90YWJsZXJhbmdlOjJkYWE3ODY1MmVlNTQwNzZiNjc4MDkzNGVjM2JlMGM1XzEtMi0xLTEtMjk0ODk_72440b0d-7310-463d-a458-79b4cc25de77"
      unitRef="shares">473939</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="ibbc4f4e3e435497ba4218694b84e7170_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZToyZGFhNzg2NTJlZTU0MDc2YjY3ODA5MzRlYzNiZTBjNS90YWJsZXJhbmdlOjJkYWE3ODY1MmVlNTQwNzZiNjc4MDkzNGVjM2JlMGM1XzEtNC0xLTEtMjk0ODk_bb0ffad8-c6a3-4039-afeb-ee0340c87ff5"
      unitRef="usdPerShare">9.38</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i1012d26028ec46ccb4bd6809233ed3bc_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZToyZGFhNzg2NTJlZTU0MDc2YjY3ODA5MzRlYzNiZTBjNS90YWJsZXJhbmdlOjJkYWE3ODY1MmVlNTQwNzZiNjc4MDkzNGVjM2JlMGM1XzItMi0xLTEtMjk0ODk_2abd873a-eb3f-424a-a795-8feb9d17a0d0"
      unitRef="shares">229975</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i1012d26028ec46ccb4bd6809233ed3bc_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZToyZGFhNzg2NTJlZTU0MDc2YjY3ODA5MzRlYzNiZTBjNS90YWJsZXJhbmdlOjJkYWE3ODY1MmVlNTQwNzZiNjc4MDkzNGVjM2JlMGM1XzItNC0xLTEtMjk0ODk_b97e6c69-8ca4-4659-a8ee-893459584f7a"
      unitRef="usdPerShare">28.36</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZToyZGFhNzg2NTJlZTU0MDc2YjY3ODA5MzRlYzNiZTBjNS90YWJsZXJhbmdlOjJkYWE3ODY1MmVlNTQwNzZiNjc4MDkzNGVjM2JlMGM1XzMtMi0xLTEtMjk0ODk_2a3105c6-e766-494f-9316-ab2c443dffc7"
      unitRef="shares">25000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZToyZGFhNzg2NTJlZTU0MDc2YjY3ODA5MzRlYzNiZTBjNS90YWJsZXJhbmdlOjJkYWE3ODY1MmVlNTQwNzZiNjc4MDkzNGVjM2JlMGM1XzMtNC0xLTEtMjk0ODk_5d2a550a-a418-40b6-a83c-27920f25dec6"
      unitRef="usdPerShare">11.75</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZToyZGFhNzg2NTJlZTU0MDc2YjY3ODA5MzRlYzNiZTBjNS90YWJsZXJhbmdlOjJkYWE3ODY1MmVlNTQwNzZiNjc4MDkzNGVjM2JlMGM1XzUtMi0xLTEtMjk0ODk_36e2ab0b-a5f8-452c-93c7-db8baeb87e33"
      unitRef="shares">678914</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZToyZGFhNzg2NTJlZTU0MDc2YjY3ODA5MzRlYzNiZTBjNS90YWJsZXJhbmdlOjJkYWE3ODY1MmVlNTQwNzZiNjc4MDkzNGVjM2JlMGM1XzUtNC0xLTEtMjk0ODk_1bc0ff06-0df4-4f3d-b245-5f57d01807f6"
      unitRef="usdPerShare">15.72</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZToyZGFhNzg2NTJlZTU0MDc2YjY3ODA5MzRlYzNiZTBjNS90YWJsZXJhbmdlOjJkYWE3ODY1MmVlNTQwNzZiNjc4MDkzNGVjM2JlMGM1XzUtNi0xLTEtMjk0ODk_ad2ca416-25c0-4a9a-a8fc-2f82dcb54184">P6Y25D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZToyZGFhNzg2NTJlZTU0MDc2YjY3ODA5MzRlYzNiZTBjNS90YWJsZXJhbmdlOjJkYWE3ODY1MmVlNTQwNzZiNjc4MDkzNGVjM2JlMGM1XzUtOC0xLTEtMjk0ODk_aee96d35-f921-428c-b71c-f8944b2429f1"
      unitRef="usd">4416774000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZToyZGFhNzg2NTJlZTU0MDc2YjY3ODA5MzRlYzNiZTBjNS90YWJsZXJhbmdlOjJkYWE3ODY1MmVlNTQwNzZiNjc4MDkzNGVjM2JlMGM1XzYtMi0xLTEtMjk0ODk_a4f73a80-508e-4dd7-9688-564266c95fed"
      unitRef="shares">483969</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZToyZGFhNzg2NTJlZTU0MDc2YjY3ODA5MzRlYzNiZTBjNS90YWJsZXJhbmdlOjJkYWE3ODY1MmVlNTQwNzZiNjc4MDkzNGVjM2JlMGM1XzYtNC0xLTEtMjk0ODk_a0d61877-3fbc-4f18-b61c-4fc753302029"
      unitRef="usdPerShare">11.01</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZToyZGFhNzg2NTJlZTU0MDc2YjY3ODA5MzRlYzNiZTBjNS90YWJsZXJhbmdlOjJkYWE3ODY1MmVlNTQwNzZiNjc4MDkzNGVjM2JlMGM1XzYtNi0xLTEtMjk0ODk_829d20c3-f055-4cbe-9c61-e2942ae7572d">P4Y11M4D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="i04caedaa83604a6990f3710c9c56c537_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZToyZGFhNzg2NTJlZTU0MDc2YjY3ODA5MzRlYzNiZTBjNS90YWJsZXJhbmdlOjJkYWE3ODY1MmVlNTQwNzZiNjc4MDkzNGVjM2JlMGM1XzYtOC0xLTEtMjk0ODk_de1a3fdb-af19-4700-9671-09cb2693ac39"
      unitRef="usd">4381451000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="i094c5d904be44087995cd941fc4d5daf_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzE1MzQ_115fd655-6827-4c15-80d9-273d93fc231b"
      unitRef="usd">1100000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i44c5111cc15c410d9c005a8bde3cad3a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzE2MjA_76ffafb3-9194-4ed0-a162-bcfc4b5b34dd">P2Y3M25D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i3d5bebaa0e7442d1b5f5cca875bb344e_D20200401-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzE3NjI_a48bebb5-4769-4aba-9bce-3bb80ffc518c"
      unitRef="shares">412434</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i9acfb04e9f5b4b67ac85b9574a34698b_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzE4MDM_8d3ccf6e-c2cc-4207-9ea6-b33fdb2caa3e"
      unitRef="usdPerShare">16.93</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="i3f429bcc5e2b462cb9501b7c563ba31b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzIwNTE_81728ed0-90ea-4e36-a935-59c19133c0a2"
      unitRef="usd">600000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i910ced2457b140f4b0ed9010ea0b124a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzIxMzc_79202a66-b748-4e19-9125-9ede3e6731bb">P0Y8M26D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i913337c7aa3b4295af9870b33b64248f_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZTowYWEyMDJlNmJiOTM0NGRjOWYxZWY1MWJkM2IyOWMzOS90YWJsZXJhbmdlOjBhYTIwMmU2YmI5MzQ0ZGM5ZjFlZjUxYmQzYjI5YzM5XzEtMi0xLTEtMjk0ODk_0f7e03af-1791-4231-b747-295ba91556fb"
      unitRef="shares">320660</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i913337c7aa3b4295af9870b33b64248f_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZTowYWEyMDJlNmJiOTM0NGRjOWYxZWY1MWJkM2IyOWMzOS90YWJsZXJhbmdlOjBhYTIwMmU2YmI5MzQ0ZGM5ZjFlZjUxYmQzYjI5YzM5XzEtNC0xLTEtNTg0MTg_de9b3d88-e652-40fe-ae54-9cfa56cff105"
      unitRef="usdPerShare"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i910ced2457b140f4b0ed9010ea0b124a_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZTowYWEyMDJlNmJiOTM0NGRjOWYxZWY1MWJkM2IyOWMzOS90YWJsZXJhbmdlOjBhYTIwMmU2YmI5MzQ0ZGM5ZjFlZjUxYmQzYjI5YzM5XzMtMi0xLTEtMjk0ODk_3daa22cd-9233-4885-b6b1-3d44b90612d8"
      unitRef="shares">203678</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i910ced2457b140f4b0ed9010ea0b124a_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZTowYWEyMDJlNmJiOTM0NGRjOWYxZWY1MWJkM2IyOWMzOS90YWJsZXJhbmdlOjBhYTIwMmU2YmI5MzQ0ZGM5ZjFlZjUxYmQzYjI5YzM5XzMtNC0xLTEtNTg0MTg_929299a9-96a6-46dd-9ebc-24e1289150e9"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i3f429bcc5e2b462cb9501b7c563ba31b_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZTowYWEyMDJlNmJiOTM0NGRjOWYxZWY1MWJkM2IyOWMzOS90YWJsZXJhbmdlOjBhYTIwMmU2YmI5MzQ0ZGM5ZjFlZjUxYmQzYjI5YzM5XzQtMi0xLTEtMjk0ODk_46792936-2820-4822-9de9-bd60fa2e5ae8"
      unitRef="shares">116982</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i3f429bcc5e2b462cb9501b7c563ba31b_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZTowYWEyMDJlNmJiOTM0NGRjOWYxZWY1MWJkM2IyOWMzOS90YWJsZXJhbmdlOjBhYTIwMmU2YmI5MzQ0ZGM5ZjFlZjUxYmQzYjI5YzM5XzQtNC0xLTEtNTg0MTg_a6171d63-578b-4914-a3ef-0ff6423e57dd"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i910ced2457b140f4b0ed9010ea0b124a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZTowYWEyMDJlNmJiOTM0NGRjOWYxZWY1MWJkM2IyOWMzOS90YWJsZXJhbmdlOjBhYTIwMmU2YmI5MzQ0ZGM5ZjFlZjUxYmQzYjI5YzM5XzQtNi0xLTEtMjk0ODk_f683c2da-4000-4d43-848b-829fe76fd102">P6Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i3f429bcc5e2b462cb9501b7c563ba31b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZTowYWEyMDJlNmJiOTM0NGRjOWYxZWY1MWJkM2IyOWMzOS90YWJsZXJhbmdlOjBhYTIwMmU2YmI5MzQ0ZGM5ZjFlZjUxYmQzYjI5YzM5XzQtOC0xLTEtMjk0ODk_ea44db3f-7f30-407b-8e68-8f96bdfb1a1d"
      unitRef="usd">2202771000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i3f429bcc5e2b462cb9501b7c563ba31b_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZTowYWEyMDJlNmJiOTM0NGRjOWYxZWY1MWJkM2IyOWMzOS90YWJsZXJhbmdlOjBhYTIwMmU2YmI5MzQ0ZGM5ZjFlZjUxYmQzYjI5YzM5XzUtMi0xLTEtMjk0ODk_f903c9fc-79a5-4e16-aac7-8b217fb323f8"
      unitRef="shares">76909</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i3f429bcc5e2b462cb9501b7c563ba31b_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZTowYWEyMDJlNmJiOTM0NGRjOWYxZWY1MWJkM2IyOWMzOS90YWJsZXJhbmdlOjBhYTIwMmU2YmI5MzQ0ZGM5ZjFlZjUxYmQzYjI5YzM5XzUtNC0xLTEtNTg0MTg_e4220e7b-82af-4323-9563-fcf218fd11cb"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
      contextRef="i910ced2457b140f4b0ed9010ea0b124a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZTowYWEyMDJlNmJiOTM0NGRjOWYxZWY1MWJkM2IyOWMzOS90YWJsZXJhbmdlOjBhYTIwMmU2YmI5MzQ0ZGM5ZjFlZjUxYmQzYjI5YzM5XzUtNi0xLTEtMjk0ODk_54c21fa3-1098-4d2d-b1ea-11b1c728e814">P6Y9M18D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="i3f429bcc5e2b462cb9501b7c563ba31b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZTowYWEyMDJlNmJiOTM0NGRjOWYxZWY1MWJkM2IyOWMzOS90YWJsZXJhbmdlOjBhYTIwMmU2YmI5MzQ0ZGM5ZjFlZjUxYmQzYjI5YzM5XzUtOC0xLTEtMjk0ODk_88587d61-1760-46fa-bd8d-f97747ebf51a"
      unitRef="usd">1448198000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="i3b0bb841e3944cc1903ad3a519ea4d82_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzIyOTQ_8150f139-bbb7-42d5-9c8f-dac7114dbe51"
      unitRef="shares">7892930</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ie0a58125fd60480dad3bda99ec884d22_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzIzMTI_73986ccc-de53-43b2-b1fc-c7b22b84b97c"
      unitRef="shares">536767</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzMxMTg_bd6cfc83-3b8b-4bca-8c16-b43cefa270aa">The following summarizes all unvested RSA&#x2019;s activities during the twelve months ended December 31, 2022:&#160;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSA's&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Term (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSA's unvested at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;456,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;649,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(563,731)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,478)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSA's unvested at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;536,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.01&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="i0787e0bf64654960aed460942168553d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZTo5MDVkMzAwYmY3OGY0MjAxODYzY2U5Njk3YzY0ZjBjZS90YWJsZXJhbmdlOjkwNWQzMDBiZjc4ZjQyMDE4NjNjZTk2OTdjNjRmMGNlXzEtMS0xLTEtMjk0ODk_338b97a4-8790-43e2-9459-dc8395da5928"
      unitRef="shares">456075</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i0787e0bf64654960aed460942168553d_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZTo5MDVkMzAwYmY3OGY0MjAxODYzY2U5Njk3YzY0ZjBjZS90YWJsZXJhbmdlOjkwNWQzMDBiZjc4ZjQyMDE4NjNjZTk2OTdjNjRmMGNlXzEtNS0xLTEtMjk0ODk_df9e351b-c733-414c-9a64-c7a024c27605"
      unitRef="usdPerShare">20.06</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i3b0bb841e3944cc1903ad3a519ea4d82_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZTo5MDVkMzAwYmY3OGY0MjAxODYzY2U5Njk3YzY0ZjBjZS90YWJsZXJhbmdlOjkwNWQzMDBiZjc4ZjQyMDE4NjNjZTk2OTdjNjRmMGNlXzMtMS0xLTEtMjk0ODk_78177af7-9f1d-4341-80e6-979b5ebdb744"
      unitRef="shares">649901</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i3b0bb841e3944cc1903ad3a519ea4d82_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZTo5MDVkMzAwYmY3OGY0MjAxODYzY2U5Njk3YzY0ZjBjZS90YWJsZXJhbmdlOjkwNWQzMDBiZjc4ZjQyMDE4NjNjZTk2OTdjNjRmMGNlXzMtNS0xLTEtMjk0ODk_f1f1e93b-ff72-49be-aec8-434008ed8a0c"
      unitRef="usdPerShare">26.33</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i3b0bb841e3944cc1903ad3a519ea4d82_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZTo5MDVkMzAwYmY3OGY0MjAxODYzY2U5Njk3YzY0ZjBjZS90YWJsZXJhbmdlOjkwNWQzMDBiZjc4ZjQyMDE4NjNjZTk2OTdjNjRmMGNlXzQtMS0xLTEtMjk0ODk_f3d3e369-c7d4-4fdb-87b2-198384554dfa"
      unitRef="shares">563731</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i3b0bb841e3944cc1903ad3a519ea4d82_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZTo5MDVkMzAwYmY3OGY0MjAxODYzY2U5Njk3YzY0ZjBjZS90YWJsZXJhbmdlOjkwNWQzMDBiZjc4ZjQyMDE4NjNjZTk2OTdjNjRmMGNlXzQtNS0xLTEtMjk0ODk_9d738cdb-ee5d-486a-a131-1c17826e6537"
      unitRef="usdPerShare">21.62</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i3b0bb841e3944cc1903ad3a519ea4d82_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZTo5MDVkMzAwYmY3OGY0MjAxODYzY2U5Njk3YzY0ZjBjZS90YWJsZXJhbmdlOjkwNWQzMDBiZjc4ZjQyMDE4NjNjZTk2OTdjNjRmMGNlXzUtMS0xLTEtMjk0ODk_c169616c-90b3-4e00-8f72-07b8bc07b073"
      unitRef="shares">5478</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i3b0bb841e3944cc1903ad3a519ea4d82_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZTo5MDVkMzAwYmY3OGY0MjAxODYzY2U5Njk3YzY0ZjBjZS90YWJsZXJhbmdlOjkwNWQzMDBiZjc4ZjQyMDE4NjNjZTk2OTdjNjRmMGNlXzUtNS0xLTEtMjk0ODk_8289f15a-d2b6-47ce-bd7d-fcdbc23bcb3e"
      unitRef="usdPerShare">23.76</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="ie0a58125fd60480dad3bda99ec884d22_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZTo5MDVkMzAwYmY3OGY0MjAxODYzY2U5Njk3YzY0ZjBjZS90YWJsZXJhbmdlOjkwNWQzMDBiZjc4ZjQyMDE4NjNjZTk2OTdjNjRmMGNlXzYtMS0xLTEtMjk0ODk_0838214b-4976-472d-b8a0-3e1c9b7fd682"
      unitRef="shares">536767</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
      contextRef="i3b0bb841e3944cc1903ad3a519ea4d82_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZTo5MDVkMzAwYmY3OGY0MjAxODYzY2U5Njk3YzY0ZjBjZS90YWJsZXJhbmdlOjkwNWQzMDBiZjc4ZjQyMDE4NjNjZTk2OTdjNjRmMGNlXzYtMy0xLTEtMjk0ODk_be5366fb-1994-43da-8590-7bf4c973f488">P1Y3D</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ie0a58125fd60480dad3bda99ec884d22_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZTo5MDVkMzAwYmY3OGY0MjAxODYzY2U5Njk3YzY0ZjBjZS90YWJsZXJhbmdlOjkwNWQzMDBiZjc4ZjQyMDE4NjNjZTk2OTdjNjRmMGNlXzYtNS0xLTEtMjk0ODk_22e4e7fb-918c-46e4-be80-809bd4912957"
      unitRef="usdPerShare">23.84</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="ia1c839443b66471eb59beee8617975d2_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzI4MTc_b2b75db0-f2dc-4fb8-b17e-cdf0f7dec501"
      unitRef="shares">41000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <rdnt:ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue
      contextRef="ia1c839443b66471eb59beee8617975d2_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzI4ODA_41fed97f-f14c-4e83-a64b-eb7cbff9721e"
      unitRef="usd">800000</rdnt:ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i6277f9dca3d1402c9da0e7e331ab1e01_D20220101-20220131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzM4NDgyOTA3MDIwNTM_3c24aab5-223f-4c5c-87af-f4054bc62b27"
      unitRef="shares">25683</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches
      contextRef="i6277f9dca3d1402c9da0e7e331ab1e01_D20220101-20220131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzM4NDgyOTA3MDIwNjY_d1ef6dbd-2ccb-44b4-a9d3-274162063eb8"
      unitRef="tranche">2</rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i6277f9dca3d1402c9da0e7e331ab1e01_D20220101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzM4NDgyOTA3MDIwNzI_12ed73e1-2ac6-4d1a-9f8c-d039f51930a5">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i0f44d430f1174158bf7fe50617e713ac_D20220101-20220131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzM4NDgyOTA3MDIwNTc_311ae493-a783-4e5c-ad0b-dc6bcef1b6ba"
      unitRef="number">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i62c3cbb4a9964a25abbdcb253fb4024f_D20220101-20220131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzM4NDgyOTA3MDIwNjE_05524a72-0958-4872-98e5-c7d63508e604"
      unitRef="number">2</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i50296a953a0a449b97171c09173e2621_D20220101-20220131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzM4NDgyOTA3MDIwODI_26c786ca-30f8-443a-9ee0-810dc6c623c1"
      unitRef="shares">111925</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches
      contextRef="i50296a953a0a449b97171c09173e2621_D20220101-20220131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzM4NDgyOTA3MDIwODY_72a29977-04a1-462a-8315-4c31a66cdf09"
      unitRef="tranche">3</rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i50296a953a0a449b97171c09173e2621_D20220101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzM4NDgyOTA3MDIwOTM_882ac929-0ea5-4e12-9d38-b2cd4e0b9c2d">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="idaacd756f4c9498d91cf9c5a87b822e2_D20220101-20220131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzM4NDgyOTA3MDIxMDE_d95ea9f5-9796-400d-a134-21566dcf6275"
      unitRef="number">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="icec298142c894a2b86d0c42a0627070b_I20220131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzM4NDgyOTA3MDIxMDU_0a649be8-de81-4c88-8852-d48185bbba5a"
      unitRef="shares">111925</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i4881d8775eb54b72a12eb858c7e4a554_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzY1OTcwNjk3NzIzNjU_efd6afe4-b312-4ede-8302-70a869bfa512">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzQ5NDc4MDIzMzAzNjA_0ca1dc4f-5257-44d1-bcb6-8a8a590cb699">The following summarizes all unvested LTIPs activities during the twelve months ended December 31, 2022:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.099%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.642%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.822%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.822%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.824%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;LTIPs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Term (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;LTIPs unvested at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited or Canceled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,141)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;LTIPs unvested at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.69&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"/&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#dbdbdb;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="if4019e7dc01941058ad36f53dc8d3d21_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZTo0NmY4ZjE2M2Y5YzY0YTVjODIzZGIxZjhmYTlmYTRiNC90YWJsZXJhbmdlOjQ2ZjhmMTYzZjljNjRhNWM4MjNkYjFmOGZhOWZhNGI0XzEtMS0xLTEtNjA2Njk_152f08f2-2dd0-4409-bc01-c3687e860045"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="if4019e7dc01941058ad36f53dc8d3d21_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZTo0NmY4ZjE2M2Y5YzY0YTVjODIzZGIxZjhmYTlmYTRiNC90YWJsZXJhbmdlOjQ2ZjhmMTYzZjljNjRhNWM4MjNkYjFmOGZhOWZhNGI0XzEtNS0xLTEtNjA2Njk_d36c7e3a-f7e5-482a-b03f-718fbd09b915"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i5b0e1dc8b96c4fc384f33bcb572e740a_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZTo0NmY4ZjE2M2Y5YzY0YTVjODIzZGIxZjhmYTlmYTRiNC90YWJsZXJhbmdlOjQ2ZjhmMTYzZjljNjRhNWM4MjNkYjFmOGZhOWZhNGI0XzMtMS0xLTEtNjA2Njk_8a66f918-3b05-4ad5-bd7b-75ebd030b7ac"
      unitRef="shares">180612</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i5b0e1dc8b96c4fc384f33bcb572e740a_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZTo0NmY4ZjE2M2Y5YzY0YTVjODIzZGIxZjhmYTlmYTRiNC90YWJsZXJhbmdlOjQ2ZjhmMTYzZjljNjRhNWM4MjNkYjFmOGZhOWZhNGI0XzMtNS0xLTEtNjA2Njk_d1260c6c-01d0-441a-9bda-fa9c00d6c43d"
      unitRef="usdPerShare">19.56</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod
      contextRef="i5b0e1dc8b96c4fc384f33bcb572e740a_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZTo0NmY4ZjE2M2Y5YzY0YTVjODIzZGIxZjhmYTlmYTRiNC90YWJsZXJhbmdlOjQ2ZjhmMTYzZjljNjRhNWM4MjNkYjFmOGZhOWZhNGI0XzUtMS0xLTEtNjA2Njk_d8e5f156-5834-4cb8-8ab5-e77227924299"
      unitRef="shares">11141</rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod>
    <rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue
      contextRef="i5b0e1dc8b96c4fc384f33bcb572e740a_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZTo0NmY4ZjE2M2Y5YzY0YTVjODIzZGIxZjhmYTlmYTRiNC90YWJsZXJhbmdlOjQ2ZjhmMTYzZjljNjRhNWM4MjNkYjFmOGZhOWZhNGI0XzUtNS0xLTEtNjA2Njk_308f5385-3387-4aad-a9f0-c0a8e5c74d34"
      unitRef="usdPerShare">19.50</rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ia7b8b14610224ea59f307a3d2cbe26ba_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZTo0NmY4ZjE2M2Y5YzY0YTVjODIzZGIxZjhmYTlmYTRiNC90YWJsZXJhbmdlOjQ2ZjhmMTYzZjljNjRhNWM4MjNkYjFmOGZhOWZhNGI0XzYtMS0xLTEtNjA2Njk_99018221-b73b-4b6e-856f-e3b98b589d71"
      unitRef="shares">169471</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
      contextRef="i5b0e1dc8b96c4fc384f33bcb572e740a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZTo0NmY4ZjE2M2Y5YzY0YTVjODIzZGIxZjhmYTlmYTRiNC90YWJsZXJhbmdlOjQ2ZjhmMTYzZjljNjRhNWM4MjNkYjFmOGZhOWZhNGI0XzYtMy0xLTEtNjA2Njk_965b5df1-5c65-4381-a1c2-ee835be0ca25">P2Y8M8D</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ia7b8b14610224ea59f307a3d2cbe26ba_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90YWJsZTo0NmY4ZjE2M2Y5YzY0YTVjODIzZGIxZjhmYTlmYTRiNC90YWJsZXJhbmdlOjQ2ZjhmMTYzZjljNjRhNWM4MjNkYjFmOGZhOWZhNGI0XzYtNS0xLTEtNjA2Njk_fc20160a-dc44-4df6-a4d8-487aed7ebbc8"
      unitRef="usdPerShare">19.56</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="id1fdbe2d3c964be6888f0365aa0b975b_I20210415"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzI5ODY_7d71d979-39f7-46db-b21b-49eb41072229"
      unitRef="shares">16500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance
      contextRef="i2d84eba07ea94e52a84e38c42643cc0b_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xMDkvZnJhZzpiOWQwMzJlYmI5Yjk0MzgzYTBlOWE2ZmE2YzA4ZWExZC90ZXh0cmVnaW9uOmI5ZDAzMmViYjliOTQzODNhMGU5YTZmYTZjMDhlYTFkXzMwNzg_93a65523-f3f4-43d7-8bd9-335ebb2416aa"
      unitRef="shares">2017233</us-gaap:DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance>
    <dei:AuditorFirmId
      contextRef="i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmYzZjgwNzcxOTQ0ZjRmYzU4MDE1YWJkYTQyZGM0N2QxL3NlYzpmM2Y4MDc3MTk0NGY0ZmM1ODAxNWFiZGE0MmRjNDdkMV8xNTEvZnJhZzo4OTM3OGM0ZmY4Mjc0NzZhYTM3Y2JlMGEyZTI3YjdkNC90YWJsZTo3MDVkYWU3OGE4YzE0MmNjODYyZWNhYjE1YWY3OGVkMy90YWJsZXJhbmdlOjcwNWRhZTc4YThjMTQyY2M4NjJlY2FiMTVhZjc4ZWQzXzUtMC0xLTEtMjk0ODkvdGV4dHJlZ2lvbjoxZjM2ZGFlZjI0MjQ0MDE1ODk2MzVhZGQ1M2FkOGM3OF83MQ_44daf3f0-ce1d-4dfa-bcc0-156162ebdb03">42</dei:AuditorFirmId>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>104
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MIJ5EU0384BO3*DP KF,"?A;YZ[1L(8-<-A4H?TNIQ6;6K!IE5@V +;4RM\(
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M2'4!?+]@3&X/U UVQ?S]?P%02P,$%     @ W8MA5GB?'>5- @  P04  !@
M  !X;"]W;W)K<VAE971S+W-H965T,BYX;6R-E&UOFS 0Q[^*Q:2^JD)"'C:E
M 2D/C18I3:.TW31->^' !:SZ@=FF=-]^MB$LDPCJ&^RS[_[^G?'=K!3R564
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M0Z<WO)9DD1 M)-KPZA7;Y_!S?E1:FD?QJRWC2F_4KF<+9:IR'$/HF4I0(-_
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MELG>C>)'R8BG4E8(-%O%V9*!'<9_,_-U! Y<SZE0,=DY8Q$<601&%N%'@Q,
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MG* 73YIUP^>OO]+-P^"KP7Q*BO1JO_VO;%/>O;E87DB;]"9YW)8_[[_8Z6E
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MI:X,%*"JXA.Y% DG1?^*YE.A/3N>&ANH(\4?F;N7F;NO(C1'"?P_+E\EX,'
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M\A"3CR68G9.',1B=P%L8QLYH?S /_LJAJ0WX/K4<3JCR$GEE)V,39D5)X=D
MLTTI8E-52&1X/B\H?6C)[62"R:TTQZ^8I_;:H3KN@&$#WA'^N<3H'Q!8]A5P
MHI2B7F0ET>H:3$>V$VDIP++SSKD^I8ZN6)IY#Y/Q9/IY]/YF8A*E,W"( <!+
M3K)20)QCRB:VQ Q,-*<LE''BFFK,ACD$1^(<U8L-3?HF;-R24N(\C1'_DV*-
MHH:HQ$?#."=FN<^Y%RST@%77PJ(=\$):LY*&C=957E0!UT: 1C^A<VK$:.IS
M$DP4)!&2PP$? 88$6(]+U-DF9E?8B(63.J8@,W(9G+()PG*2(X@(D6HY*(FD
MAI+#="*"<5%@@(284I=?Q9@29.[640\GG&ACB+1\>H.<:/+"@ *<U2=M;6*S
M]3@5'%89EY5-]P "1D9PVOB$^2/-TA,R)O)"N8/'J4F'$@VH9,1YO;!ZZ*G:
M$N&Y:J%>[[53-=:0DCUKDT"6LQX:%L%-45$*!MJE1$'RUYCABHNO;@R6X]MV
MQ?(GO=Y[3-VIJ$"UL;L]SN'/!5L1"EO+ DT^DY4,1?.#8NG-T>'DL^9'&@Y#
MP05&L5- 0@]SWHEM*%W%HO6._K/6,!QF7V=%7+IOZ\>3#+T]<"'T"P RIFQ(
M6W]L[0GWBM=!Y^@R&NKNPY[K Y(QU7, #"V]=INK!56E< 4.,=D2QT<9U8D!
M^R8 M"Z[NX$GY!TV-Q<YA5#R4@.A%/&@'8_9OBRGR#5'L!('7.]'OQ&R8K '
M_OCP:7+E3?[K?G([H[JPD>9%$&IF1,Z#Y95R#HKH@9@(#*<B4T=$00:<]HA,
M"PE9'O_40A?2[3N3'7J];M\_.\? Y<69/SRC9^IS]RYZ_NGYT+L<^$-0V_KS
M K@KWW)%(97CP;!G?;][WL=_AOU3\V0M44M%-1C\.\?XIW\VZ$F$[= ;G%WZ
MIY>G\%/_;.!?#LZ]V=WUXQ?0^KJ0!S75W8?;::V 5L-7!&9L B+#>%=@SO(^
M#LG%&N7A$N0'"(7AVRJ5"'3AS;8%2)$MC+T?C6>F$)93V(D;UI8*!WP,"2!"
MNPHBY21NM,E#8DH/ 8>$JE%Q(-EM6'L>;:@210>E?8)6>"C@1"< D?A-:<1^
M'NNF#;$JJ%',=(*\=;Q?92RQK6*NA83]_A.T,W I:1#DXRH'&594G0D_ ^@6
MVLRO5\LP"0C8T;J@(GM ,E8$@5>LT#+ U.=)M>XX)[%;.!IF6$ZD \? $HC'
MCNI'DG+-+T8DR?"@(D5MT*#IT9#,7<JU'AD7,N$6:M+,3F[X%2P_FQ*J)WVH
M:BK84_6$S]J*IJ>MT1>,(I0")F%=9%CCE)O,"+JPAI0=[_KU&1R3P#%6(@60
MFL[@P#J</OS:M8%#C@J 1WMF_^(B(Q52V9J)6LV#H;$.&ULF<ZO2L8"NO9CC
M!4>I;K(">+8A.QDVT6ZL#*.H=0IT.Y=6213D#IGR)E8U+):V1,/D.\WILQ5D
MYG@61S0%S]'K]<5S[UB$N@*$NKF[IZC_^&[V:&L.OR 7;0P^<1G>)JTS+4A;
M3!7-7,(":U\HTMU9(A;61B<T25_1.RM4LO_">#T(,WLF9J5QCG[)O$K !YD#
MAX_ITQU3I5 496>]3NO3YY&JS:Z\<OUIND19,*$3]0WL2LK,ZL>I=B(2^PLF
M 6IK-K(80K+.2B9BXY^L#?"(QW>W8Z#C S=*8.?$P^1J^N@]3&?_8>EZ;:IH
M$2[S2M:#@+/.2J5]%QTYJKABBCTGLMMX8QJUR8;"Z,,SK-:M86Y8BA;FUDD0
M*K:LZ66J"&B.PLT!*2J)W[/<*?UUS&=B^#)>J<*7Q'6QW"VO=EY H0/)P6(O
M6CN;SBB38AE(^$H7!$A,[5I%J'Q MLB" X=4NUMCJ1PC1(!E7E]-QYW_CT[@
M:URU'W#-&MY5:[$&!0 "R6O[QD]K^@$>6B0KDWTB4],8IYPQ:G->I'&$VD50
MVC7EB/\,T/%(4F9>]SRHR.MKBLA42VZ1Z\+-2.'2%35I:R&KG1"%"OF5#2>3
MD#%#QBZ%87FCV:^2_80?)O_Y:?IY=#.Y=4%3.<6-,-8R7BSAN!*P9&+=6N,(
M/"!_E4OP%K,%$EB%K2:LJ3# 9 P=\4 :HBHEQV!E4,>"C0#O%VY'[[#[. _B
M7$K!P$].*CB*J\GUY 'PR[N>WHYNQYCAK>L'1F:8QWH47-8K>LZ%>F"W0F?4
MK%M:#X?KOJ@K/8 =EU4$^YDUY0YZ+DO(0!: !$8Q<:M] _FD[)DE*TX=FY4&
MFLG1C^L[L4$R0/JO3$;N]?#:G+H9G#LU35WXWIAW<6UV06_=DJC=B^]#*:&,
MN(8[=BETF3;HP9%FY (:$GSXA[O[R</C;\2_R+JL\_5I@HL/ B^FLU-MB3:H
MB&A)Y/.9-5W:@6>=HX%N7&V7F'@.+WR,2USOG]M$N2S_8$$F-N*>X!9UTYHQ
M=&Q%CS$CGJF#CEN*.$J# #5 'NJ=LOW:\6XP<8@9+JQU@TF53>A9)I;:,R0
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MG.M>=.=D8<U5@I%8JDVJE18F+)0Q?8\<4Z5B6O+-G1RE)!J:)*2XC1#@9(<
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MU!>-,;IU1FY49$W!7MV&\LZR=+G!?X$.-F7W;!8'N%8]2]^5TZVU4K@H72A
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MS^E@T85_S.B["0T+T'LNM'K!!IHOL>'?4$L#!!0    ( -V+85:-31F/&Q0
M $4_   9    >&PO=V]R:W-H965T<R]S:&5E=#$S+GAM;.U;"6_;2++^*PV-
M,\_.<F21$G7D GPD&\\ZB=?.9+#[\ 9HD2V)"45J2<J.YM?O5]4'25ER,L=B
M=_$&"&*)8M==7U4UF\_N\N)3N5"J$I^7:58^[RRJ:O7D^+B,%FHIRVZ^4AE^
MF>7%4E;X6LR/RU6A9,R+ENEQT.L-CY<RR3HOGO&UJ^+%LWQ=I4FFK@I1KI=+
M66Q.59K?/>_X'7OA.IDO*KIP_.+92L[5C:I^6%T5^';LJ,3)4F5EDF>B4+/G
MG1/_R>F [N<;/B3JKFQ\%J3)-,\_T9>+^'FG1P*I5$4549#X<ZO.5)H2(8CQ
M#T.SXUC2PN9G2_T5ZPY=IK)49WGZ8Q)7B^>=<4?$:B;7:76=W[U61I^0Z$5Y
M6O+_XD[?&PXZ(EJ75;XTBR'!,LGT7_G9V*&Q8-S;LR P"P*66S-B*<]E)5\\
M*_([4=#=H$8?6%5>#>&2C)QR4Q7X-<&ZZL7I#S<7;U_>W(BS=V].+]Z>O+]X
M]_9&G+P]%]<O+T_>OSP7)V?O+SY<O/_;L^,*_&C5<61HGVK:P1[:?B#>Y%FU
M*,7++%9QF\ Q!'72!E;:T^!!BN<JZHJ^[XF@%P0/T.L[[?M,K[]/^W6)*V4I
MSO+E-,FD#I0L%B=EB80XB?ZQ3LJ$K_[OR;2L"@31_^TRA&8SV,V&$NM)N9*1
M>MY!YI2JN%6=%]]^XP][3Q]08N"4&#Q$_3>Z\/>BW316*2Z6<IYD<W&FLDH5
MXD;-D<B5.%\7=)6\QV;&!SCS3HDH7ZY25:E85 N%5*WMGL]$I(H*\"(D.:6D
M*W33+$^!*$0.E'&O*D%ID40+H1+\7N#R'+ BXJ0  J0; 0JT;D5.3")%= H9
M)WF:SS<B+XA\'B62A)B:N%!E5[SG-0E!%E!(EI )6$BDRI:DI;B3I:AR@3 !
M:_P.X=>%8(]GX&?XGZM4WLE">>(-2*8P@R?> KV^5T6I-FP6^OHW@!D2O?@$
ME;OB1X7/,?B)F4P*<2O3-32#P8JE#5MC%I:H@ [&6D0/']=+7$H3.4U2MA5?
M;YOQ3A4*&D9Y@605ARQNOBYQ8WGTA'WV!(D,4V\$H$9IAQ.G]WDE4W&U+J(%
M\!&Y!,B.5:'%NBI00 JL^58N5T_%2ZQ9<2PP_I/4/V#-B1;VSWD>WR5I*BZR
M2F;S9)JZG]ZQ3UN++AOJ7+RZ/A.7EV>/?Q+^L7_,$3;V4)I$X$W\GO"]4:\O
M0B\8^>+;;\:!'SP5_D0<\O6CG<L'WIB7^U@X#D?X-)R,W&+[]Q _'3'.12FY
MYMJ$5!+!)B<VI!";5]V3[N-OA-^S]"=@,!H)?^@-_ &X#8>A&$W I"<&8'P(
MSL/QD3@<>'XP.!*OE2PJ=MOE&MZR&7:9+!.$[)^$[P3O!UX/!+8E!2.RAQ^R
M7MN_GBU46BHISA,YS_(2&>)4V9#P9]W'P@\LBX!IA,.Q6P]I^P&TNT_Y;5Y4
M"QO>;6#PV.9$=Z+I^KT!(LTM#4,1A&+@OA_X@\ ;C7UQ$$!'/Q0'(R_ '0=^
M;^CU!O1AZ/7I EEO$![AP] ;CF&^QZ_(.Q\X<<Y;B9.4XA4^I^(G%P;MO(XH
MH$O"!<ZQ0BGT,%/$>"(+BCU<I86>R#-&%8U"A 8KDQ.Q*-5*(B,4<&B*)!<?
M\P0Y< LKK)%U=T L<2;36V2*>*-B#IZVJ4JV55=\\^58 ])$Z3JF)'<IOV'0
M.O"[ ;J(-&6],]*L @M*QZB9M5WQIQO% ".3%-*#5E0DJR;./!R.+0B?4NO7
M9;#_#T:0*]@XIS" 9BG<836ZXA UD>\3G$Q"$8Z&8M@;XUL?,1HBJP;B$!>.
MQ-^OQ,MT";N*[77^9  8\M$5N8Q$GO+JH,85K'^%"%LA:;8H(,*!$(03XP:%
M?C &7(A@XJZ=%KF,[^3F7B"UR4$4B X1H,I@ '58D#[P9C \ H;T0UABN4+<
MRWAKZ<3KCW$[)*GE[GO#P42,[J?_S>7?WXAKLNEF6P*L 1Q#([^F,_8FHX$8
MWZ<3]&"YFW56)'#<&U442?1IFZ#O#0)RRFC@BSX4&#/IAE"'N,H^.I4;"C%-
MH&\)]+T0(-*'>B$[S"?3PBPC#<<3G]=>2N1L6B$TVZM1($+B'O:IW@S\,:Q(
MJV'<0_[.JV^6E.S;?">C,7$?$Y4 P=0?C&BIDYNO\OI);Z0A515&@($E$PZ)
M'TJ*-X;:88L 7SL2/U+RRZ5XTQ5_P2B$(#GWD"L1T/TG$=;RC+!V,B$]^J,)
M6=3O;9'#]2/D '1!PTCCXYOK"X/GC@[5,9C2N1 $@_">9Z'4%1H=S)LE-8MM
M$L&P+P*_CZZ_+MQ-07!=)YVDQ<8BP]HEX^&8JQ4%_"3$_Z,M/7#Q2+R7&@4;
M($J$'HOQ<3"PI'J0W:_7DF%\;]@?WE/H31*[-J_&$=1_5T$YFY%LX:11[+Q@
M2.69L]!>?-!?H#8TAO8&J)RCGM_,Q[#?5/5K*?:=Z?H(W,F$H("3H6TX7$5U
M1;\R\H?BH!]Z$Z3_@4_PV!<'@QX,/T"9Y@P_") (!X?ZQZ\JQ;#\"4 <XR^2
MW%91JKWY>K[ ;>6:3#H<<<:5"]B9RS#UVQ@E +]Z:1<J[=#W@?)^BY*.IK==
MX'>5\>Z7*N"[#&EZJY93A+296'G4J1MT,0H?<0DNT(/3TH0*/9* 2O,7J!^2
M(X+>T]>7%_S)?WH$B2XOR(120$!5SS9@$5%JZ+Z$BJGI$KB0_Y QP;^ >IPO
M=2M"U]^R2UP]C"B6;S"ZTNA$4TZ$I,_$ N54 )+AI7RU3J4V*?4:6 #[1:Q"
M2BI C%B;G"7E2!H]+8U O(YXF.8E)OG(GXG1/-*C9&E&26)1<)FD'^&A5>[&
M-<SI62GUM@^U83**\G5&6LYXSMLU9$HW]&D3P(C<E+C@:S5(O&*U*O+/$(^[
MNH.^WYW8WLHS6D"T)R(YLA%J"#=&.) Y&';'KB<[[(<3- 6!74&13J%2(;4F
MW=Y0K,@$]-L1>(!R),N%H=)W5,CD"?^ZI[_C%7ZOR9B^[NL-<1512=UMFPKQ
M80$6>1I/)5*5Z/:Z0T<'@3)55HM@()9Z/TC.R)5-#R#?/F),IP4R_K@N*^=D
MF='H'JMEELS0SO#=U/XNRR.MZ.V1R!#AN_*(Q!EW>U8<GJ/=A-L2E!1>%P4Q
MU8.S!P.%#0,E],^UE.Z>)@U+8'O,QE#2-NW<-JG:S)G9H32IAPQN!' 7-4FL
M" M,X^T"<E50*DJ,[]HJC"YV3\#LI,!7\.(, J7JOOR<;WJ345$VF?1=)"NS
M/U#0GD,FES:QVI'+#.[1I(2#[3DO8D$Y-3=W IF5SAH9+3RW \$1-,.( (WR
MC]H6I=Z-B)/29JXF) 5A%S&G='BDI7($S*HI0S4,6HL!,,VP'LA4 ./49^ ]
M8XK1O:REL2PU(TB;)EA/2DU5%BUX1R;6KBK4#.PRC8>LXE+?;64L%*:[3/.L
MMG!IF<<J=5SO>/>8,ATC(.U:1;D.WTBN$L 0HJ @/Z(WX=$&A2R9,VN[M79"
MKL;WUTA%4NVT^Z%+->A[F:UIZRKH-6I0O=U&"+N-A A,DDGA:K5QR<0%=B>7
MPXZYW*&,1% Y29.FI(S?*V[?9SDLKWVD2X.D"F5J"NAV'2,D@T9YWM%RB<!B
M[^%C*P395J._*;CPDLH6Q(K7GUR0=5VJ?F7I( 7W5@YVYT-E@T@V4Y3A<:N0
M#,(66I@Z0F6$IL>1-Q[M*@\!RDBO+@][:DV_5Z-ANW[X#:S[ROK1*'BH'Z/N
MH(EQKF:41DN 0Y7JLFX;MD*SA_CDC_I)#6U9&C5:E670#2V+&ONEH<P^9W>D
MN31)=RWCMZHR^H5U&;@ DU@W(Y0.*XF&W>XREX@D6#%*<T8<2L32=9Z<Y3"Z
M#J(9.G6O/W3N@"+W+-XH$ SE0#!5KE,#YVVLY]RLZY/?]-6.^K15L%=VGX0L
MH^PN">X+1MW1@W6,-GMMF,7J5J4@A.!4T2(SN^-0)/"[?BM"+JZN>4?FG'\.
M&[X!S_Y6,W&_- )RZ?$9!GGB)3\WMJHX4FMZ&IP/@J 1;XTJRNZ$YO2$TA:;
MAXNDC645@S1:DKG(>6]H!C?D5 Q,95/TV$K,UKQ'!\#B\&KOKY-L,MU@@* ?
MX4\0X$V7&>:8C,')B,8APZXQ58E7&.+->TQEM0AHP>5?W@CL\KQ7>]EKM@/:
M);M;A_^05D$/.06QQ#>& Q_S%L#('WUMXU *+E-8HVV\5<3W= UEW38PU7]K
MWT!Z[LQI,_9R%.XKI:N<-(BU/E%CN..JG>7Q.J4'4QDXNY*+5@M5K%G68_U(
M(='UT0UM6K8:13@H="C1S,V/W!*0HI& $OX[^#RB*FM\KROR[B!L"I7/8&X.
MK=Q<1AH!@3+&=<+L@CJ2=6;<<X&TI6SA'6G:RJ7VZ2WKJC5 TD%W$A7!V32J
M3GPER\0 F71/*YL]0PP%M?)698/X5G<(2L.6T;..LC.T;30.J<\K7.?[;"=G
M'FUJPYC)/E.?,5#=J?16F<%+<T5,S]8I\/96E?99YNX8T?)1FM)?F&HD-O O
MTI\G_-V30XA&P-RU-40P)4/"9F :F5T#:RGUF9V\&^1RA+F^R\'&?:!Q,).I
MJOD8= ?L63 GP9P;8-:ZMKS2-4'OTR33=64BB1C1BGF6-*5'.5GK/L0->0P"
M=3@[D)$ Y"A9L1)TM*!2"" 6M-QDJI@G_! .Z*%F23-4M?==]X@H3).?R1 6
M+AJQQE8N54W%[*X0$7"R@&L"ZW_*[::8>,0% @5L;E4&&\^+_*Y:=,5?UR3_
M]%\T9[2H'W;,UU\S7R GRHIP]?Z,89G\^AG#^^\=,H+&?E%KR)@,0Z]7[ZK^
MXA$C")MM6FO$^&4SABE0)!;-^SY:[5Y__U8:)&0<,S64^G<S\S3::+=CI4>"
M>N]FFM/>BTFH5'&.^N/?=[_JE_;_07NBVM'_^U_7__LM7__*_M^?-,QUO__O
MU3/&D=?ZNK?_/QBV;TK1B7]'80LAIKJ9V#D@)+;_I(@<_#\:"2Q@_3$2_&XC
M0=CCD2 ,_Q@)?N-(D*EUX9I@$L957OL$IT0)WCD#_(:&M*2VQ+:;>QI2?61G
M3TO:(/!'2_K?W9("#"GIJ/ C/J=PC.>BJ?7$M[&13;H96/5:,Q9BLMR%/,S>
M JD^0=GR]NZP;95+YV)4+-?51?4)9 [$I*Q9.GYED]ET8T/.VHS;E.^H5#9@
M3%8Z2!CF7924Y# RHCU4:Z(8U%O9:% E<W!F>)5[N/%>+35%YMQKI875J65M
M2_$&OU>E<R&?4%T9[V3M>DC]V*VDQY!\&E:4""TDLHLY<UE'@4;;QJ]T&#?6
M#[O;_G!WP,CQFJ?F2G]B*:8;GEY4E5"N:?FW:M?VA@0URW4N-09R!#&0<*[[
M4CT2<:G@^L7?/YMM3P9P.OE;3T[[]Q"\)@_<:;:JZTT!SZ"74;2I8(- C5L-
M/^I$!N3S80$4T!5WY$N@*]<$TR2[JM.LV29\9C7Z.<MOQ8%"C;M5!DC:9+XF
MCQC8>'@SL;:5CELC0=-^W%SFO(U#Z&X/GFNHE-29%_%WU%IMX(]UBBB1FQI,
M.&>T+F4RUXV^[LQ=%-LNP6JT RKN@[^%PNW>(8N;A^ =#S8;-8E,')&7-$['
MHQ)(/M6BYPWD!.4\BYJFZ.+:Z&GSYN7IQ?OS$\HIE&S-.9^6>:K*B/'2],,6
MQ/=IK[?4BCM9Q&CK\T_\[):T8%O2.#J;Z:!$GIF&%Y4KRY>FWIBD;IX9N;%'
M<C;Z71Y*&?UFCBEV2_D1G38ETAWUN*TC/*^ MXJ/#)Z183?-P\UTX/==)DY0
M$%-[5(?Z9;(LZ'QIZ6'GU=EUYXB>9U# (&-X!Y+[NGJM.57Z.B^Y"]-'KK#6
M7N@<Z7ARIV'TOF4IEG!>\AUZ/,E;BJ4^@@-'K[FFEPD&H]PV8@@0Q[)^P8#/
M/;ANP<1ZX]@-#1U\=$J?-+95HK&A0BZQDK8H'83M"6R6?&X,0JW9&[\VIE)]
M,&+K$5?=X]R;E-7.01G1]S,?I9I3;NAS,*W3)_8Q'PU=])2/9E'=!YM&E)**
M*0RW#F.Y<&R>RH*GV[;0!'C'AK2I!W) 11\4MTZF[",*A>-;&O7B.KH(OLZ,
MK-=HQ$AM$ZK?K]%[^&$=JNPJ#?'YUY/:&;+G[IT[$[)G>8%NW9P+/^RXWSGD
M,\ID=&8&8LV!,C03I:EH=0RVHYO[4-2N6SJ%^X48K^YR=.B5*4J-,;85^,3[
M$KB5UX%/."1-[;9'[27=C)@@%+2QP$'$VI-W*%AL;=&/-GWW*HQYZ!#ZCW;X
MDMO=M3GT,^A.&JOHE]JRFLA@LH,(<"Y9)G0Z,FV\+O'G(E^O:O>;O5:-5?Z]
M "!+/$QEI^>;2UR <[3K0+BQ;CGL\*V(,]I!**O[V,7>90#;]JT;!G?XN.7.
M#^PP:4#7H]<C$M@M2\BAO/V99.@=],:;<;]U,NK@0:\&IJX]"-!"KEY[5\R4
M8.V:8:_;V^5ALD9;]Q9-0X-W9TG)UA:=<?INRG"[3#F%J'AIIS0Q0NZM;AOQ
MDFLI-?,W:E4U3YSZ]]^M*PT;*0)$Z*,][*@:[&?X(]VU/T+UFR;]ANJ(R?>R
M^%EFTKV4T'@!".#'^ZM6/(_9[Q:,[ZDE6?"0C)[6#INCL&MV=&#Z1WI[7AF4
MIH>%#2RNM^/V,W G!DVA2;*'*DJ>F1/(&3JF)-:O$LJ4M_#X%5TJB8/&R0BS
ML9!DV\=K[)Y")(MB0\*V1@]0CW>%T!7M]#2=O,>.S5/(;+4'G..YSK-N5ML;
M%_6#B3J#OOK4;..L4W?7N[#'C5>;,7O,^05NFI8!"OHM9W?5O2-^HE^-KF_7
M+YB_,3UMJF98VNN.PHXH]$O;^DN5K_A%Z6E>5?F2/RZ4A/!T WZ?Y7EEOQ #
M]^;\BW\"4$L#!!0    ( -V+85:*DSE:GP<  )80   9    >&PO=V]R:W-H
M965T<R]S:&5E=#$T+GAM;)58:V_;.!;]*X2G*!) 8UNR_$J3 &Z:Z00S:8(D
ML[/ 8C_0TK7-K21J2"J)]]?ON:1DNVT2['R)]> ]]]QS'Z1R^J3-5[LA<N*Y
M+"I[UMLX5Y\,!C;;4"EM7]=4X<U*FU(ZW)KUP-:&9.Z-RF*0#(>302E5U3L_
M]<]NS?FI;ERA*KHUPC9E*<WV(Q7ZZ:P7][H'=VJ]<?Q@<'Y:RS7=D_NCOC6X
M&^Q0<E52996NA*'566\1GWQ,>;U?\ ]%3_;@6G D2ZV_\LU5?M8;,B$J*'.,
M(/'S2!=4% P$&G^UF+V=2S8\O.[0?_&Q(Y:EM'2ABS]5[C9GO5E/Y+223>'N
M]-.OU,8S9KQ,%];_%4]A;3+OB:RQ3I>M,1B4J@J_\KG5X<!@-GS%(&D-$L\[
M./(L/TDGST^-?A*&5P.-+WRHWAKD5,5)N7<&;Q7LW/G]Y>?KRR\/XN[R]N;N
MX>K+Y].! RR_'&0MQ,< D;P"$2?B6E=N8\5EE5/^+<  ?':DDH[4Q^1-Q$^4
M]<4HCD0R3)(W\$:[($<>;_1:D+1&'3EQ1[4V3E5K\:_%TCJ#DOCW2_$&M/1E
M-&Z3$UO+C,YZZ -+YI%ZY^]_BB?##V]P37=<T[?0_[^$_$T(<=,8=! '+Y<%
M"1OTL$(:0@G;S*@EY6+)+7HBKDJY9HTNL(2,M_WN46LO:J,?%>Q%O=E:E2E9
M692OVPC5KL]D+9>J4$YAD=-B)3.^DXZ$V\"UDNM*6P4B52X<AHKSN'J%5Y;0
M;.$-;K3)R=B^N(?<*L-S565%DQ-Z85V14]"%K*YDE='.^]'UW=5Q)#)=UHU#
M?.@EO3829,71Q0/>U/#M#&8#E<KZ,7.XY/:2UU1-5I THJ0<$584P6/9+8H$
MFM](JYLJC[IP/!F9*UWH-6#^^;.16P"MBD8;;3-=;WU0&@IP5@K)W"!E1GF#
M(/KB =(\2NO@Z3_:*+=E0332D'GY+6Y7,"WA6_U<ZEP6O*:+VK8*14(*KG%'
M8.$VTH'?(ZS5BI-AZ)&JAG@%R1*+#;RSKO0,5<"#TV5(E<O&6/)9R3:R6K<9
MV6=>(K>^E/ 4 Y6,81('!:$K$H7.I OZ>GXA_151SL&$2&H4YJ$*?Y*0A=6=
M*^$PR8.LB,?NR\!#_5$I5O$W^,YUB4>Z66^\9K\B>>Z]+.L/OS<@AML"!6J;
MI57(E]GVQ56HI+S#ZJH;9<D ="?S@_61>-JH;,-MH]8(CRV0?3+%UE<\\J4R
M60C>/O,&K;E&86 R0VEML,VU0CFCZ)&7;:VCTD(+1&.!+[#1[OLG]!NV8./U
MZXL%YM>*E2W &Y(4:DU<\T>]Q57OV#?KXFH70HXL%[INNXCJ0F^MR$#*4Y1U
M7:B0&-^=5&U"_[!3C#87<L8)XN*'!?-J*T"5G!CJ"@!2.30:M0- <D_5&\F]
M#8BEP?$@P@]ZVD6<4LM#( JUU!0E.A>A[QL(^>=0LHVB51<^],@I4[Y/2_D5
MNASU+FX^7?>..2>:\^4+AI-V<7D3"1:X@9N0I)7BZ<#" <Z?9CC6MK-V$Y%W
M^%PTM?:UH+A!;4W^Z+#K&2;=&OBJ@5H5PQJ]4LZ_+;2UPH<84"%FC5F;LQ:2
M?8!KI=%24%ZA *"?E^WS8G'K*S_7_GV8V3 H/-EP3%-5.(NQ#LOM+M=6^=SY
MN@VVCSC"\%C?!DD@59@M81/PTU[X'8RMNZ(_ #<$?AC8?G1ZC+V&,$/38FYX
MWIWU/E,@@VH0J&6O19C6_*(3L4"Y(W[KI_VNP &(,H5C%2BPF++D3?N__D%T
M,#KWSC"S<$P,6PRGFIZ]I)PX;A99%!B/.1[Q[,L/13OR/:\;"UA[?"(>GJA
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MM#/ ]4(INQ^X -U?T>P?4$L#!!0    ( -V+85:K);S87!   .0V   9
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MW$V+PN;"KF2HWAX@+JPR]^K@W<M?!F?]USLD'9>2CG=1_[,+])>)BDLKTIF
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M>GM@Q5[HX%+I)FA0I+5EJS4G^RBM+4*EX=D]WTL"P:/<S=M=F-:7AEOV2,6
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M<,'FLR"9Q4<FAV0Y#Q,0X (2$ %3>\;\D6:2@'/S*%@XY^8)Z#->]*S>QCB
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M\BGAINJXIRU8:#A(J!WJ9(!IG(!4:*+ /UHG53<%..5B.5><[5KO(#11+;Q
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M:6.M/[*VTRS_'MM)0Y':BHOML6<>OY/,.&V5?C85@$6O@DN3X<K:>A9%IJA
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M&XQTUQ*=854=RG"KK"OJL*S<*P+:.[CSG5+V:/@+AG<I_P-02P,$%     @
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MW5 (\+Z<K(&_0-15 .MYZ@TE9N<R8K?.V=(3J28,#BX13@N'WO.OEG?#$H1
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M\-WPBE0#FQE@F8A\1G*@<48S6 0!JJ@Q2^ L?^(HB"(G7W(.GP! 40H$ 1+
M93*?% N$AP/] 83#L>0)IP),[I0,,C*:YJ6$CU()4,E/B^XRG\V8B#D0MB+^
MF 2A9UAVB$^N8[B^#4]>Z!JFXY$;E@#+@,RQ+)CD$CLTC<@"@%9@1+!(3^ )
M<4+##B+BN$;@P&?/\*V(?(: RH3\!40T@S0@E?#.YC"DQ,.S+Z58$L\R'"<B
MKFO8@-(!&H*0W(%N!)G#"A10K4 PB]"-B!493A0B%L=RR<U*D"T#(V \" _F
M^HY)@'[;<\BP+;T"8KN@"<_3_'%)+,0?$LLT/-O#OR"JR0 8+C!KV8;K^,1V
M##L*:F<A)5BN(#&=\T(;!Q4@6DV0))9G&Z8+\-P0N'3AWS0L*R2#=0N5[''6
M9M0"A"!#'Q8"CPX\V?!D!LB_J=2^L< %B?BXS/+(SS^%MF7_2D;*^>H9Q_C5
M,0W3M]2S8WD ,%#/-> ]L<5K8HMW<&RIHJ(D]W2I7%39;!R+$DS\ZAN:!)-=
MT68OBNYHT^":MW#1"A>K<)$%$TQ9H^ 2QH%&C &3/(70@>KHJ8A2.=#)Z^V
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MI-51F\YW6/FS1MY62M<F[V^W]!<83Z<Z9CP%5><9V\A>.T*V3B];>4:!:NP
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M441F5)1-SFM2**#B4NIAU15Z0> 3-AT"%:*$G$NELS#X\88 "R1.%*-O[::
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M&&.UT-WKKIM8U;0OJH6R2,!VN,('L=!N WXOE+*[B3/0/[''_P-02P,$%
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MFG8%^=G9\N[+<G'W\!WFGV]@\?7;Q^7MXO,#G#WPE41S/@DL!7&F0;8#O.H
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M7?DZ:C-ANQ/<1%W=K)0OS8DVU("(9RONGPJ3*O%D7[^%[>#X165TQB>^J0G
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M   9    >&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;-59:V_;-A3]*Q=>,;1
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M'X\<1GEKV,6R_FZ1S0U9KHK'^97_LGY?;Z=KOLSS^A1^L\BWO\R4R][LU^[
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MBU%-HEJ":BFJ*4IK1_VA0#K1KTWZIED6M":*:B:J6:AFHYJ#:BZJ>:CFHUJ
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M/^K]DW,=Y4R6LUC.9CF'Y5R6\UC.9[F Y4*6BUA.L%S,<I+E$I9+64YA7.<
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MRG(*XSKQWZB:CO154W:VANVCCH[[J./+_MD:MHZ*<C;+.7NN.5LS[FOINNS
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MR**<Q7(VRSDLY[*<QW(^RP4L%[)<Q'*"Y6*6DRR7L%S*<@KC.MG>Z-%.SKI
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M#=X97\KUNEP\/KS/LYN\VFY0__EM6:[W7VP'^%96OSV^G%_^/U!+ P04
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M+!XI55)9TR4!JO3PB]H$^5!M4JGD@PE,]  3/8)^%\B'0TMLN!>-]X4)[/0
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M&; X0'W_D*;YCS?% QFW#^ <_ ]02P,$%     @ X(MA5BU\4.M\!@  -AP
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M_B*69!%0)!F:$@] 5V@4P0P",(3V!77J?EVQP*-<F]OI.QO).U4KWG1-H]F
M>=\<DEA$8;N%6\<HIXBZ-NVVO7=V%'<CB[M1FC_]WFPT0./A'(W&@\GC$%T\
M3&:S2_0TG*+9Y]YTB'KS^734?Y[W^@]#-)^@:<\!^)7"WR P>9R,T6P^&?SR
M>?+@#*<S'0^-*G.N2F=.1<Z.N&]FW#=+<^Y+LCI1#Y$-Y;#:HB@.%]!9V3++
MK[2=PL(M)/1/5>5>S-6'7%&TIMQG'KKP7X&7.N[3,30/\J;1Q!W+LIJY--0
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MQ$G,8Z(E7()X6TR.',_SD:TPUL39ON.KRH3&H@ZD[-64/2/E.\I%CUKC9$4
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M=N]&^U_8;G<C_X/YTZ,/L<X[Y6'&MBQ03K"<9#G%<IKE#,O5+&=9SK&<9[G
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MY0S+699S&-?*6*WJ,IA=8D+)ME50+F0YP7*2Y13+:98S+&=9SF%<*WVUMLH
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ML?\K7U#\_J<TW1V_* ?XFF9_W'WL5_\/4$L#!!0    ( ."+858BC$H<$@8
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M_ T@"R'-@.;'AT-->'A\N*638_#5>V+@=A7@B@\_MPK(1MS\'-R2'2UXDF_
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M?)P?"%9E\O/)&\SDWL)!3!:RI'/F2TTL/_++;P1=9Z=F3U0(FF27*X)#PE2
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M?:GNW;'15[4Y5A?GCW0NMH2!7+-O(*+Y:/(I%]V!*V$'#R.=-$\7K2EDM1+
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M''C99\N)9(7I;7,F5:<TPU0=3<#U O4\82IE-='MLC[LHE]02P,$%     @
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M7B/I[C7 ^;;B?/N&='/XCR3?ODAR.P@<.:;!Z<@/G$0>N,(4SSADQ_@-UPH
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MI4B+&]3GJR213R=% =NM&*?_ %!+ P04    " #@BV%6C?W5K/@%  "V+P
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M]XVJ@IH/H#0"2J-0-%O]VGS L.8#!C4?0&D$E$:A:+8PM?F W>9#^T0(:CV
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M8"%D<8$^?Y]EZGFG**!>SG+R/U!+ P04    " #@BV%6"D^LSQL#  ![#
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M<]E!3K)LX.5$B[SH@3.AL:,6PP3O/""- 7Z?"Z&W$[-!=8L*_P!02P,$%
M  @ X(MA5LY.^5"5 P  RPT  !D   !X;"]W;W)K<VAE971S+W-H965T-C,N
M>&ULK5=K;YLP%/TK%INF35K+(PFA78+4)JTV:=.J98_/#ER"-6,SVS3MOY]M
M*,N#L*;*EP0_[KGW'"[7UY,U%[]E#J#00T&9G#JY4N6EZ\HDAP++<UX"TRL9
M%P56>BA6KBP%X-0:%=0-/"]T"TR8$T_LW)V()[Q2E#"X$TA618'%XS50OIXZ
MOO,T\8VL<F4FW'A2XA4L0/TH[X0>N2U*2@I@DG"&!&13Y\J_G/N>,; [?A)8
MRXUG9*@L.?]M!I_2J>.9B(!"H@P$UG_W, -*#9*.XT\#ZK0^C>'F\Q/ZK26O
MR2RQA!FGOTBJ\JD3.2B%#%=4?>/KC] 0&AF\A%-I?]&ZWCL.'9144O&B,=81
M%(35__BA$6+#P!\>, @:@V#7X)"'06,P>*Z'86,PM,K45*P.<ZQP/!%\C839
MK=',@Q736FOZA)GWOE!"KQ)MI^+/-U>+FP5Z.P>%"97H#"VJLJ2@7ZW"%,VP
MS-&M3@[Y3B_]6,S1V]?OT&M$&/J>\TIBELJ)JW0@!LY-&J>SVFEPP*D?H"^<
MJ5RB&Y9"N@W@:@8MC>")QG70BSB'Y!P-_/<H\ *_*Z#GFP<=YO,7>]]B,VA?
MRL#B#0[@6=5+3%*D/VR$"UXQ);7F":VT7$9\E0,J ,M*V#>%>(:H'@*B!"\)
M)8J O.P@<ET['G8[-D7F4I8X@:FCJX@$<0]._.:5'WH?ND0])=C\1&!;@@];
MP8=]Z/'7$@16A*U08J3/3,*C3/ "\7;%ZMN5[->]V,=J6H.-+)@IVO>Q[T6>
M-YRX]YMJ=6SSO2"*VFU;.HQ:'48OU"$C#+.D7X=>[&-UJ,'"#8+>C@3[.X9A
M-_VPI1_VTK]M2;Z$?B_VL?3#_]+?WS$8;*3)E@#C5H!Q;^&QQ_X9S\XJ74K>
MX*+\@&[^5*2T-09+";H,\:4^*5A=AN AR3%;@:U3=0'B2TI6V)SIW05H?$J5
M3@DV/Q'8EO!1*WSTS _O<'[U(ARK7+17/Z)(UYF='-O?Y4=A>#'JSK*+ENS%
M,63KQ-+-6B+L,*T *8[P4C<7G)G4ZU+C8B\TG?X[\<]ZXS@V/TX$MB69[_WK
MT[Q>T3YO'>^/[X_5JX'_CV#]01RKV*G0:LG<C2ZW +&RMP6)$M,=U9UB.]O>
M2*YL'[XS/S,W%=L]_X.IKSE?L%@1)G5>9AK2.Q]KN41]<Z@'BI>VEUYRI3MS
M^YCKVQ8(LT&O9YRKIX%QT-[?XK]02P,$%     @ X(MA5KVXX/,-!   &P\
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M-Y$ 2/229X6X&212[JX=1T0)Y%1<L1T4ZDG,>$ZENN5;1^PXT$UEE&<.<=W
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MK1C3Z"%+<W4V6&F]?N\X*EZQC*IW8LUR<V<A9$:U.95+1ZTEHTD9E*4.<=W
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MKAA-F"P:F/L+(?332=%!O0]I]C]02P,$%     @ X(MA5LK1\FJ< P  < L
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M-13I\O'DZ^W5/WZZO)CXE%S=WMSY7R877Z]OOY"/E.=!&&7D2Y"F@93_$_E
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M@QE/Y0[B[X])DK_]D!EL7MDW_C]02P,$%     @ X(MA5C"0Y"QQ!0  B1L
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M^%PDV0;J^\<XEF]OL@HVS\ ;_@=02P,$%     @ X(MA5KD4[<Q3 P  M!4
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MVJ5QD L9>3T\$MP>:4#M.*2VBZD8_1!2:5K5N %(MB6/:<Z10J[4+!XUA])
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MY2_+[YV3N_>"<WU;,3S]!5!+ P04    " #@BV%6'YV%;PD"  #8*@  $P
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M&5!+ 0(4 Q0    ( -V+858'04UB@0   +$    0              "  0
M  !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ W8MA5FO"46'N    *P(
M !$              ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%
M  @ W8MA5IE<G",0!@  G"<  !,              ( !S $  'AL+W1H96UE
M+W1H96UE,2YX;6Q02P$"% ,4    " #=BV%6?$>]A_H'  #8+P  &
M        @($-"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%
M  @ W8MA5GB?'>5- @  P04  !@              ("!/1   'AL+W=O<FMS
M:&5E=',O<VAE970R+GAM;%!+ 0(4 Q0    ( -V+858F\S/5N0<  ,P@   8
M              " @< 2  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"
M% ,4    " #=BV%6=V;*J*H"  !9!P  &               @(&O&@  >&PO
M=V]R:W-H965T<R]S:&5E=#0N>&UL4$L! A0#%     @ W8MA5@>#2Q8."
MT24  !@              ("!CQT  'AL+W=O<FMS:&5E=',O<VAE970U+GAM
M;%!+ 0(4 Q0    ( -V+859'\DU,  0  #D,   8              " @=,E
M  !X;"]W;W)K<VAE971S+W-H965T-BYX;6Q02P$"% ,4    " #=BV%6LJ%;
MVV\2  ")_@  &               @($)*@  >&PO=V]R:W-H965T<R]S:&5E
M=#<N>&UL4$L! A0#%     @ W8MA5N7_2^=Z"P  630  !@
M ("!KCP  'AL+W=O<FMS:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0    ( -V+
M85;&*W8J208   (U   8              " @5Y(  !X;"]W;W)K<VAE971S
M+W-H965T.2YX;6Q02P$"% ,4    " #=BV%6'V<^5- +  "/'@  &0
M        @('=3@  >&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0
M   ( -V+858TEU(K;"P  +"%   9              " @>1:  !X;"]W;W)K
M<VAE971S+W-H965T,3$N>&UL4$L! A0#%     @ W8MA5L,FN5RN!0  E0T
M !D              ("!AX<  'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q0
M2P$"% ,4    " #=BV%6C4T9CQL4  !%/P  &0              @(%LC0
M>&PO=V]R:W-H965T<R]S:&5E=#$S+GAM;%!+ 0(4 Q0    ( -V+85:*DSE:
MGP<  )80   9              " @;ZA  !X;"]W;W)K<VAE971S+W-H965T
M,30N>&UL4$L! A0#%     @ W8MA5M97"1-Y!@  R@X  !D
M ("!E*D  'AL+W=O<FMS:&5E=',O<VAE970Q-2YX;6Q02P$"% ,4    " #=
MBV%6-IVQ,,$#   A"0  &0              @(%$L   >&PO=V]R:W-H965T
M<R]S:&5E=#$V+GAM;%!+ 0(4 Q0    ( -V+85:K);S87!   .0V   9
M          " @3RT  !X;"]W;W)K<VAE971S+W-H965T,3<N>&UL4$L! A0#
M%     @ W8MA5B1LQ!V3!P  "!(  !D              ("!S\0  'AL+W=O
M<FMS:&5E=',O<VAE970Q."YX;6Q02P$"% ,4    " #=BV%6C<Z,5"T/  ">
M)@  &0              @(&9S   >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM
M;%!+ 0(4 Q0    ( -V+8597UN1AC0D  ",:   9              " @?W;
M  !X;"]W;W)K<VAE971S+W-H965T,C N>&UL4$L! A0#%     @ W8MA5B(W
M]:0& @  HP0  !D              ("!P>4  'AL+W=O<FMS:&5E=',O<VAE
M970R,2YX;6Q02P$"% ,4    " #=BV%6W"E"W!,I   ]@P  &0
M    @('^YP  >&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    (
M -V+85;B"KI-7PX  %(N   9              " @4@1 0!X;"]W;W)K<VAE
M971S+W-H965T,C,N>&UL4$L! A0#%     @ W8MA5D+F?><W!P  DQ   !D
M             ("!WA\! 'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"
M% ,4    " #=BV%69IF1V",$  !8"0  &0              @(%,)P$ >&PO
M=V]R:W-H965T<R]S:&5E=#(U+GAM;%!+ 0(4 Q0    ( -V+859NCHO+%P4
M &X+   9              " @:8K 0!X;"]W;W)K<VAE971S+W-H965T,C8N
M>&UL4$L! A0#%     @ W8MA5L73<7%' P  [@8  !D              ("!
M]# ! 'AL+W=O<FMS:&5E=',O<VAE970R-RYX;6Q02P$"% ,4    " #=BV%6
M!\XOL]L%  "G#P  &0              @(%R- $ >&PO=V]R:W-H965T<R]S
M:&5E=#(X+GAM;%!+ 0(4 Q0    ( -V+858NO\2(S@4  /$.   9
M      " @80Z 0!X;"]W;W)K<VAE971S+W-H965T,CDN>&UL4$L! A0#%
M  @ W8MA5N],G]L)!P  %Q(  !D              ("!B4 ! 'AL+W=O<FMS
M:&5E=',O<VAE970S,"YX;6Q02P$"% ,4    " #=BV%6JUP.+B($  !*"P
M&0              @(')1P$ >&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+
M 0(4 Q0    ( -V+8594(.RT6@4  %X;   9              " @2), 0!X
M;"]W;W)K<VAE971S+W-H965T,S(N>&UL4$L! A0#%     @ W8MA5@"LAQTP
M!@  5BP  !D              ("!LU$! 'AL+W=O<FMS:&5E=',O<VAE970S
M,RYX;6Q02P$"% ,4    " #=BV%6 LW\7MX"  #%!P  &0
M@($:6 $ >&PO=V]R:W-H965T<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    ( ."+
M85:8/_+!H#H  )_"!  9              " @2]; 0!X;"]W;W)K<VAE971S
M+W-H965T,S4N>&UL4$L! A0#%     @ X(MA5F8$.&OC @  5 @  !D
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M=#0P+GAM;%!+ 0(4 Q0    ( ."+85:[EP\3C ,  .0*   9
M  " @2BS 0!X;"]W;W)K<VAE971S+W-H965T-#$N>&UL4$L! A0#%     @
MX(MA5MK70'Q*!0  )AD  !D              ("!Z[8! 'AL+W=O<FMS:&5E
M=',O<VAE970T,BYX;6Q02P$"% ,4    " #@BV%6+]4A(Y4"  #B!0  &0
M            @(%LO $ >&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4
M Q0    ( ."+859&)91SP34  (B:!  9              " @3B_ 0!X;"]W
M;W)K<VAE971S+W-H965T-#0N>&UL4$L! A0#%     @ X(MA5EH;B\0J)@
MZY0" !D              ("!,/4! 'AL+W=O<FMS:&5E=',O<VAE970T-2YX
M;6Q02P$"% ,4    " #@BV%6(HQ*'!(&   %)0  &0              @(&1
M&P( >&PO=V]R:W-H965T<R]S:&5E=#0V+GAM;%!+ 0(4 Q0    ( ."+85:&
M-$*RB 0  (05   9              " @=HA @!X;"]W;W)K<VAE971S+W-H
M965T-#<N>&UL4$L! A0#%     @ X(MA5JX3[*HR P  G L  !D
M     ("!F28" 'AL+W=O<FMS:&5E=',O<VAE970T."YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( ."+859 G*33H@(  /@&   9              "
M@4(_ @!X;"]W;W)K<VAE971S+W-H965T-3,N>&UL4$L! A0#%     @ X(MA
M5HMU^K]E P  8PX  !D              ("!&T(" 'AL+W=O<FMS:&5E=',O
M<VAE970U-"YX;6Q02P$"% ,4    " #@BV%6ICVMS;<'  "640  &0
M        @(&W10( >&PO=V]R:W-H965T<R]S:&5E=#4U+GAM;%!+ 0(4 Q0
M   ( ."+85:-_=6L^ 4  +8O   9              " @:5- @!X;"]W;W)K
M<VAE971S+W-H965T-38N>&UL4$L! A0#%     @ X(MA5C897:7,!@  <CH
M !D              ("!U%," 'AL+W=O<FMS:&5E=',O<VAE970U-RYX;6Q0
M2P$"% ,4    " #@BV%6:]8_GRP%  !1(@  &0              @('76@(
M>&PO=V]R:W-H965T<R]S:&5E=#4X+GAM;%!+ 0(4 Q0    ( ."+8588Q_!O
M1P0  &47   9              " @3I@ @!X;"]W;W)K<VAE971S+W-H965T
M-3DN>&UL4$L! A0#%     @ X(MA5GN-I'_3!P  VE(  !D
M ("!N&0" 'AL+W=O<FMS:&5E=',O<VAE970V,"YX;6Q02P$"% ,4    " #@
MBV%6"D^LSQL#  ![#   &0              @('"; ( >&PO=V]R:W-H965T
M<R]S:&5E=#8Q+GAM;%!+ 0(4 Q0    ( ."+8597**-="P,  %$)   9
M          " @11P @!X;"]W;W)K<VAE971S+W-H965T-C(N>&UL4$L! A0#
M%     @ X(MA5LY.^5"5 P  RPT  !D              ("!5G," 'AL+W=O
M<FMS:&5E=',O<VAE970V,RYX;6Q02P$"% ,4    " #@BV%6O;C@\PT$   ;
M#P  &0              @($B=P( >&PO=V]R:W-H965T<R]S:&5E=#8T+GAM
M;%!+ 0(4 Q0    ( ."+85;IF/JI_0(   D+   9              " @69[
M @!X;"]W;W)K<VAE971S+W-H965T-C4N>&UL4$L! A0#%     @ X(MA5N1G
MM57; @  + @  !D              ("!FGX" 'AL+W=O<FMS:&5E=',O<VAE
M970V-BYX;6Q02P$"% ,4    " #@BV%6WI\S1$@#   G"P  &0
M    @(&L@0( >&PO=V]R:W-H965T<R]S:&5E=#8W+GAM;%!+ 0(4 Q0    (
M ."+85;,1-A_J@0  %$0   9              " @2N% @!X;"]W;W)K<VAE
M971S+W-H965T-C@N>&UL4$L! A0#%     @ X(MA5L_G>:!C!   U!   !D
M             ("!#(H" 'AL+W=O<FMS:&5E=',O<VAE970V.2YX;6Q02P$"
M% ,4    " #@BV%6AV@"$G,%  "3)   &0              @(&FC@( >&PO
M=V]R:W-H965T<R]S:&5E=#<P+GAM;%!+ 0(4 Q0    ( ."+85;*T?)JG ,
M ' +   9              " @5"4 @!X;"]W;W)K<VAE971S+W-H965T-S$N
M>&UL4$L! A0#%     @ X(MA5J:OHF,&"@  OF\  !D              ("!
M(Y@" 'AL+W=O<FMS:&5E=',O<VAE970W,BYX;6Q02P$"% ,4    " #@BV%6
M,)#D+'$%  ")&P  &0              @(%@H@( >&PO=V]R:W-H965T<R]S
M:&5E=#<S+GAM;%!+ 0(4 Q0    ( ."+858/H/2IY0@   ]/   9
M      " @0BH @!X;"]W;W)K<VAE971S+W-H965T-S0N>&UL4$L! A0#%
M  @ X(MA5KD4[<Q3 P  M!4   T              ( !)+$" 'AL+W-T>6QE
M<RYX;6Q02P$"% ,4    " #@BV%6EXJ[',     3 @  "P
M@ &BM ( 7W)E;',O+G)E;'-02P$"% ,4    " #@BV%6$GCI1&0%   6,0
M#P              @ &+M0( >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @
MX(MA5L?7<T]' @  U2L  !H              ( !'+L" 'AL+U]R96QS+W=O
M<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ X(MA5A^=A6\) @  V"H  !,
M             ( !F[T" %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&     %(
,4@!U%@  U;\"

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>465</ContextCount>
  <ElementCount>528</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>175</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>13</UnitCount>
  <MyReports>
    <Report instance="rdnt-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - COVER PAGE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/COVERPAGE</Role>
      <ShortName>COVER PAGE</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="rdnt-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Document - AUDIT INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/AUDITINFORMATION</Role>
      <ShortName>AUDIT INFORMATION</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="rdnt-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="rdnt-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="rdnt-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="rdnt-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="rdnt-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - CONSOLIDATED STATEMENT OF EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY</Role>
      <ShortName>CONSOLIDATED STATEMENT OF EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="rdnt-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="rdnt-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="rdnt-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - NATURE OF BUSINESS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/NATUREOFBUSINESS</Role>
      <ShortName>NATURE OF BUSINESS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="rdnt-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="rdnt-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - RECENT ACCOUNTING STANDARDS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/RECENTACCOUNTINGSTANDARDS</Role>
      <ShortName>RECENT ACCOUNTING STANDARDS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="rdnt-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - BUSINESS COMBINATIONS AND RELATED ACTIVITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITY</Role>
      <ShortName>BUSINESS COMBINATIONS AND RELATED ACTIVITY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="rdnt-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - SEGMENT REPORTING</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SEGMENTREPORTING</Role>
      <ShortName>SEGMENT REPORTING</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="rdnt-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETS</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="rdnt-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - PROPERTY AND EQUIPMENT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/PROPERTYANDEQUIPMENT</Role>
      <ShortName>PROPERTY AND EQUIPMENT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="rdnt-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLE</Role>
      <ShortName>CREDIT FACILITIES AND NOTES PAYABLE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="rdnt-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - LEASES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/LEASES</Role>
      <ShortName>LEASES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="rdnt-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/INCOMETAXES</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="rdnt-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - STOCK-BASED COMPENSATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/STOCKBASEDCOMPENSATION</Role>
      <ShortName>STOCK-BASED COMPENSATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="rdnt-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - SUBSEQUENT EVENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SUBSEQUENTEVENTS</Role>
      <ShortName>SUBSEQUENT EVENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="rdnt-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="rdnt-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="rdnt-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - BUSINESS COMBINATIONS AND RELATED ACTIVITY (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYTables</Role>
      <ShortName>BUSINESS COMBINATIONS AND RELATED ACTIVITY (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITY</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="rdnt-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - SEGMENT REPORTING (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SEGMENTREPORTINGTables</Role>
      <ShortName>SEGMENT REPORTING (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.radnet.com/role/SEGMENTREPORTING</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="rdnt-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETS</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="rdnt-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - PROPERTY AND EQUIPMENT (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/PROPERTYANDEQUIPMENTTables</Role>
      <ShortName>PROPERTY AND EQUIPMENT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.radnet.com/role/PROPERTYANDEQUIPMENT</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="rdnt-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Tables)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLETables</Role>
      <ShortName>CREDIT FACILITIES AND NOTES PAYABLE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLE</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="rdnt-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - LEASES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/LEASESTables</Role>
      <ShortName>LEASES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.radnet.com/role/LEASES</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="rdnt-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000030 - Disclosure - INCOME TAXES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/INCOMETAXESTables</Role>
      <ShortName>INCOME TAXES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.radnet.com/role/INCOMETAXES</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="rdnt-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - STOCK-BASED COMPENSATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables</Role>
      <ShortName>STOCK-BASED COMPENSATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.radnet.com/role/STOCKBASEDCOMPENSATION</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="rdnt-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0000032 - Disclosure - NATURE OF BUSINESS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative</Role>
      <ShortName>NATURE OF BUSINESS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/NATUREOFBUSINESS</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="rdnt-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0000033 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Summary of Net Revenue)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofNetRevenue</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Summary of Net Revenue)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="rdnt-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0000034 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Accounts Payable and Accrued Expenses)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsAccountsPayableandAccruedExpenses</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Accounts Payable and Accrued Expenses)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="rdnt-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0000035 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="rdnt-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0000036 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Reconciliation of Foreign Currency Translation)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsReconciliationofForeignCurrencyTranslation</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Reconciliation of Foreign Currency Translation)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="rdnt-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0000037 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Derivatives)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Derivatives)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="rdnt-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0000038 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Contingent Consideration)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsContingentConsideration</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Contingent Consideration)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="rdnt-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0000039 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Fair Value Measurements)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Fair Value Measurements)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="rdnt-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0000040 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Earnings Per Share)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Earnings Per Share)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="rdnt-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0000041 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Investment in Joint Ventures)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsInvestmentinJointVentures</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Investment in Joint Ventures)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="rdnt-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>0000042 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Key Financial Data on Joint Ventures)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Key Financial Data on Joint Ventures)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="rdnt-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>0000043 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Deferred Revenue Recognition)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDeferredRevenueRecognition</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Deferred Revenue Recognition)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="rdnt-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>0000044 - Disclosure - BUSINESS COMBINATIONS AND RELATED ACTIVITY (Details - Assets and Liabilities Assumed)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsandLiabilitiesAssumed</Role>
      <ShortName>BUSINESS COMBINATIONS AND RELATED ACTIVITY (Details - Assets and Liabilities Assumed)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="rdnt-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>0000045 - Disclosure - BUSINESS COMBINATIONS AND RELATED ACTIVITY (Details - Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative</Role>
      <ShortName>BUSINESS COMBINATIONS AND RELATED ACTIVITY (Details - Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="rdnt-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>0000046 - Disclosure - SEGMENT REPORTING (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SEGMENTREPORTINGDetails</Role>
      <ShortName>SEGMENT REPORTING (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/SEGMENTREPORTINGTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="rdnt-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>0000047 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Details - Schedule of Goodwill)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS (Details - Schedule of Goodwill)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="rdnt-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>0000048 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Details - Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsNarrative</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS (Details - Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="rdnt-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>0000049 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Details - Annual Amortization Schedule)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS (Details - Annual Amortization Schedule)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="rdnt-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>0000050 - Disclosure - PROPERTY AND EQUIPMENT (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetails</Role>
      <ShortName>PROPERTY AND EQUIPMENT (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/PROPERTYANDEQUIPMENTTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="rdnt-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>0000051 - Disclosure - PROPERTY AND EQUIPMENT (Details - Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetailsNarrative</Role>
      <ShortName>PROPERTY AND EQUIPMENT (Details - Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/PROPERTYANDEQUIPMENTTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="rdnt-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>0000052 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Details - Schedule of Debt)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt</Role>
      <ShortName>CREDIT FACILITIES AND NOTES PAYABLE (Details - Schedule of Debt)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLETables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="rdnt-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>0000053 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Details - Annual Note Payable Maturities)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAnnualNotePayableMaturities</Role>
      <ShortName>CREDIT FACILITIES AND NOTES PAYABLE (Details - Annual Note Payable Maturities)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLETables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="rdnt-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>0000054 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Details - Additional Information)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAdditionalInformation</Role>
      <ShortName>CREDIT FACILITIES AND NOTES PAYABLE (Details - Additional Information)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLETables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="rdnt-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>0000055 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Details- Second Amended and Restated First Lien Credit and Guaranty Agreement)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSecondAmendedandRestatedFirstLienCreditandGuarantyAgreement</Role>
      <ShortName>CREDIT FACILITIES AND NOTES PAYABLE (Details- Second Amended and Restated First Lien Credit and Guaranty Agreement)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLETables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="rdnt-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>0000056 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Details - Margin Spread Based on Leverage Ratio, Debt Instrument) (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails</Role>
      <ShortName>CREDIT FACILITIES AND NOTES PAYABLE (Details - Margin Spread Based on Leverage Ratio, Debt Instrument) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLETables</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="rdnt-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>0000057 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Details - Senior Credit Facilities)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities</Role>
      <ShortName>CREDIT FACILITIES AND NOTES PAYABLE (Details - Senior Credit Facilities)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLETables</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="rdnt-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>0000058 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Details - Revolving Credit Facilities)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities</Role>
      <ShortName>CREDIT FACILITIES AND NOTES PAYABLE (Details - Revolving Credit Facilities)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLETables</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="rdnt-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>0000059 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Details - Margin Spread Based on Leverage Ratio)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio</Role>
      <ShortName>CREDIT FACILITIES AND NOTES PAYABLE (Details - Margin Spread Based on Leverage Ratio)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLETables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="rdnt-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>0000060 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Details - Recent Amendments to Prior Credit Facilities)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstoPriorCreditFacilities</Role>
      <ShortName>CREDIT FACILITIES AND NOTES PAYABLE (Details - Recent Amendments to Prior Credit Facilities)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLETables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="rdnt-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>0000061 - Disclosure - LEASES (Details - Additional Information)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/LEASESDetailsAdditionalInformation</Role>
      <ShortName>LEASES (Details - Additional Information)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/LEASESTables</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="rdnt-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>0000062 - Disclosure - LEASES (Details - Lease Cost)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/LEASESDetailsLeaseCost</Role>
      <ShortName>LEASES (Details - Lease Cost)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/LEASESTables</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="rdnt-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>0000063 - Disclosure - LEASES (Details - Supplemental Cash Flows)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/LEASESDetailsSupplementalCashFlows</Role>
      <ShortName>LEASES (Details - Supplemental Cash Flows)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/LEASESTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="rdnt-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>0000064 - Disclosure - LEASES (Details - Supplemental Balance Sheet)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet</Role>
      <ShortName>LEASES (Details - Supplemental Balance Sheet)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/LEASESTables</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="rdnt-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>0000065 - Disclosure - LEASES (Details - Maturities of Operating and Finance Lease)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease</Role>
      <ShortName>LEASES (Details - Maturities of Operating and Finance Lease)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/LEASESTables</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="rdnt-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>0000067 - Disclosure - INCOME TAXES (Details - Income (Loss) Before Income Taxes )</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/INCOMETAXESDetailsIncomeLossBeforeIncomeTaxes</Role>
      <ShortName>INCOME TAXES (Details - Income (Loss) Before Income Taxes )</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/INCOMETAXESTables</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="rdnt-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>0000068 - Disclosure - INCOME TAXES (Details - Income Tax Expense)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/INCOMETAXESDetailsIncomeTaxExpense</Role>
      <ShortName>INCOME TAXES (Details - Income Tax Expense)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/INCOMETAXESTables</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="rdnt-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>0000069 - Disclosure - INCOME TAXES (Details - Reconciliation of the Statutory U.S. Federal Rate and Effective Rates)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/INCOMETAXESDetailsReconciliationoftheStatutoryUSFederalRateandEffectiveRates</Role>
      <ShortName>INCOME TAXES (Details - Reconciliation of the Statutory U.S. Federal Rate and Effective Rates)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/INCOMETAXESTables</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="rdnt-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>0000070 - Disclosure - INCOME TAXES (Details - Deferred Tax Assets and Liabilities)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/INCOMETAXESDetailsDeferredTaxAssetsandLiabilities</Role>
      <ShortName>INCOME TAXES (Details - Deferred Tax Assets and Liabilities)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/INCOMETAXESTables</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="rdnt-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>0000071 - Disclosure - INCOME TAXES (Details - Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/INCOMETAXESDetailsNarrative</Role>
      <ShortName>INCOME TAXES (Details - Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/INCOMETAXESTables</ParentRole>
      <Position>70</Position>
    </Report>
    <Report instance="rdnt-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>0000072 - Disclosure - INCOME TAXES (Details - Unrecognized Tax Benefit)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/INCOMETAXESDetailsUnrecognizedTaxBenefit</Role>
      <ShortName>INCOME TAXES (Details - Unrecognized Tax Benefit)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/INCOMETAXESTables</ParentRole>
      <Position>71</Position>
    </Report>
    <Report instance="rdnt-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>0000073 - Disclosure - STOCK-BASED COMPENSATION (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative</Role>
      <ShortName>STOCK-BASED COMPENSATION (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables</ParentRole>
      <Position>72</Position>
    </Report>
    <Report instance="rdnt-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>0000074 - Disclosure - STOCK-BASED COMPENSATION (Details-Outstanding options and warrants)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants</Role>
      <ShortName>STOCK-BASED COMPENSATION (Details-Outstanding options and warrants)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables</ParentRole>
      <Position>73</Position>
    </Report>
    <Report instance="rdnt-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>0000075 - Disclosure - STOCK-BASED COMPENSATION (Details - RSU's and LTIPs)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUsandLTIPs</Role>
      <ShortName>STOCK-BASED COMPENSATION (Details - RSU's and LTIPs)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables</ParentRole>
      <Position>74</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 5 fact(s) appearing in ix:hidden were eligible for transformation: us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1, us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod -  rdnt-20221231.htm 4</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-K" original="rdnt-20221231.htm">rdnt-20221231.htm</File>
    <File>a10k2022exhibit211.htm</File>
    <File>a10k2022exhibit231.htm</File>
    <File>davidjkatz_employmentagr.htm</File>
    <File>q42022exhibit311.htm</File>
    <File>q42022exhibit312.htm</File>
    <File>q42022exhibit321.htm</File>
    <File>q42022exhibit322.htm</File>
    <File>rdnt-20221231.xsd</File>
    <File>rdnt-20221231_cal.xml</File>
    <File>rdnt-20221231_def.xml</File>
    <File>rdnt-20221231_lab.xml</File>
    <File>rdnt-20221231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>rdnt-20221231_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1465">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="37">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>110
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "rdnt-20221231.htm": {
   "axisCustom": 1,
   "axisStandard": 42,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2022": 1465,
    "http://xbrl.sec.gov/dei/2022": 37
   },
   "contextCount": 465,
   "dts": {
    "calculationLink": {
     "local": [
      "rdnt-20221231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "rdnt-20221231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "rdnt-20221231.htm"
     ]
    },
    "labelLink": {
     "local": [
      "rdnt-20221231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "rdnt-20221231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "rdnt-20221231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 879,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 13,
    "http://xbrl.sec.gov/dei/2022": 4,
    "total": 17
   },
   "keyCustom": 83,
   "keyStandard": 445,
   "memberCustom": 110,
   "memberStandard": 52,
   "nsprefix": "rdnt",
   "nsuri": "http://www.radnet.com/20221231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - COVER PAGE",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.radnet.com/role/COVERPAGE",
     "shortName": "COVER PAGE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000010 - Disclosure - NATURE OF BUSINESS",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://www.radnet.com/role/NATUREOFBUSINESS",
     "shortName": "NATURE OF BUSINESS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - RECENT ACCOUNTING STANDARDS",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://www.radnet.com/role/RECENTACCOUNTINGSTANDARDS",
     "shortName": "RECENT ACCOUNTING STANDARDS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - BUSINESS COMBINATIONS AND RELATED ACTIVITY",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITY",
     "shortName": "BUSINESS COMBINATIONS AND RELATED ACTIVITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - SEGMENT REPORTING",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://www.radnet.com/role/SEGMENTREPORTING",
     "shortName": "SEGMENT REPORTING",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETS",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - PROPERTY AND EQUIPMENT",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://www.radnet.com/role/PROPERTYANDEQUIPMENT",
     "shortName": "PROPERTY AND EQUIPMENT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLE",
     "shortName": "CREDIT FACILITIES AND NOTES PAYABLE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - LEASES",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://www.radnet.com/role/LEASES",
     "shortName": "LEASES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - INCOME TAXES",
     "menuCat": "Notes",
     "order": "19",
     "role": "http://www.radnet.com/role/INCOMETAXES",
     "shortName": "INCOME TAXES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "false",
     "longName": "0000002 - Document - AUDIT INFORMATION",
     "menuCat": "Cover",
     "order": "2",
     "role": "http://www.radnet.com/role/AUDITINFORMATION",
     "shortName": "AUDIT INFORMATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - STOCK-BASED COMPENSATION",
     "menuCat": "Notes",
     "order": "20",
     "role": "http://www.radnet.com/role/STOCKBASEDCOMPENSATION",
     "shortName": "STOCK-BASED COMPENSATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": null,
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - SUBSEQUENT EVENTS",
     "menuCat": "Notes",
     "order": "21",
     "role": "http://www.radnet.com/role/SUBSEQUENTEVENTS",
     "shortName": "SUBSEQUENT EVENTS",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "menuCat": "Policies",
     "order": "22",
     "role": "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfPrincipalTransactionsRevenueTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "menuCat": "Tables",
     "order": "23",
     "role": "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfPrincipalTransactionsRevenueTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - BUSINESS COMBINATIONS AND RELATED ACTIVITY (Tables)",
     "menuCat": "Tables",
     "order": "24",
     "role": "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYTables",
     "shortName": "BUSINESS COMBINATIONS AND RELATED ACTIVITY (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - SEGMENT REPORTING (Tables)",
     "menuCat": "Tables",
     "order": "25",
     "role": "http://www.radnet.com/role/SEGMENTREPORTINGTables",
     "shortName": "SEGMENT REPORTING (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)",
     "menuCat": "Tables",
     "order": "26",
     "role": "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - PROPERTY AND EQUIPMENT (Tables)",
     "menuCat": "Tables",
     "order": "27",
     "role": "http://www.radnet.com/role/PROPERTYANDEQUIPMENTTables",
     "shortName": "PROPERTY AND EQUIPMENT (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Tables)",
     "menuCat": "Tables",
     "order": "28",
     "role": "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLETables",
     "shortName": "CREDIT FACILITIES AND NOTES PAYABLE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - LEASES (Tables)",
     "menuCat": "Tables",
     "order": "29",
     "role": "http://www.radnet.com/role/LEASESTables",
     "shortName": "LEASES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i04caedaa83604a6990f3710c9c56c537_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - CONSOLIDATED BALANCE SHEETS",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i04caedaa83604a6990f3710c9c56c537_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000030 - Disclosure - INCOME TAXES (Tables)",
     "menuCat": "Tables",
     "order": "30",
     "role": "http://www.radnet.com/role/INCOMETAXESTables",
     "shortName": "INCOME TAXES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000031 - Disclosure - STOCK-BASED COMPENSATION (Tables)",
     "menuCat": "Tables",
     "order": "31",
     "role": "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables",
     "shortName": "STOCK-BASED COMPENSATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i04caedaa83604a6990f3710c9c56c537_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "rdnt:NumberOfCenters",
      "reportCount": 1,
      "unique": true,
      "unitRef": "center",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000032 - Disclosure - NATURE OF BUSINESS (Details Narrative)",
     "menuCat": "Details",
     "order": "32",
     "role": "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative",
     "shortName": "NATURE OF BUSINESS (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i04caedaa83604a6990f3710c9c56c537_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "rdnt:NumberOfCenters",
      "reportCount": 1,
      "unique": true,
      "unitRef": "center",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfPrincipalTransactionsRevenueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000033 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Summary of Net Revenue)",
     "menuCat": "Details",
     "order": "33",
     "role": "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofNetRevenue",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Summary of Net Revenue)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfPrincipalTransactionsRevenueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "ia31edfbd04f643e3b9f3f2aeff39f4ca_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i04caedaa83604a6990f3710c9c56c537_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000034 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Accounts Payable and Accrued Expenses)",
     "menuCat": "Details",
     "order": "34",
     "role": "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsAccountsPayableandAccruedExpenses",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Accounts Payable and Accrued Expenses)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i04caedaa83604a6990f3710c9c56c537_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i04caedaa83604a6990f3710c9c56c537_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "rdnt:ContractsReceivableFactoringReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000035 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Narrative)",
     "menuCat": "Details",
     "order": "35",
     "role": "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i04caedaa83604a6990f3710c9c56c537_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "rdnt:ContractsReceivableFactoringReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "ibbc4f4e3e435497ba4218694b84e7170_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000036 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Reconciliation of Foreign Currency Translation)",
     "menuCat": "Details",
     "order": "36",
     "role": "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsReconciliationofForeignCurrencyTranslation",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Reconciliation of Foreign Currency Translation)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i404f0df0019f440299547782ff0ce012_I20191231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000037 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Derivatives)",
     "menuCat": "Details",
     "order": "37",
     "role": "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Derivatives)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i5e878af77c394477a09c4eedcb52e0b2_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000038 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Contingent Consideration)",
     "menuCat": "Details",
     "order": "38",
     "role": "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsContingentConsideration",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Contingent Consideration)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i60714a92713744d0a7ef51e5a96354bd_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "rdnt:BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i04caedaa83604a6990f3710c9c56c537_I20221231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharePrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000039 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Fair Value Measurements)",
     "menuCat": "Details",
     "order": "39",
     "role": "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Fair Value Measurements)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i04caedaa83604a6990f3710c9c56c537_I20221231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharePrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i04caedaa83604a6990f3710c9c56c537_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i04caedaa83604a6990f3710c9c56c537_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000040 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Earnings Per Share)",
     "menuCat": "Details",
     "order": "40",
     "role": "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Earnings Per Share)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": "0",
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfSharesRestrictedStock",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:EquityMethodInvestmentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "ibbc4f4e3e435497ba4218694b84e7170_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000041 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Investment in Joint Ventures)",
     "menuCat": "Details",
     "order": "41",
     "role": "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsInvestmentinJointVentures",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Investment in Joint Ventures)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:EquityMethodInvestmentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "rdnt:EquityContributionsInExistingAndPurchaseOfInterestInJointVentures",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i04caedaa83604a6990f3710c9c56c537_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetsCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000042 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Key Financial Data on Joint Ventures)",
     "menuCat": "Details",
     "order": "42",
     "role": "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Key Financial Data on Joint Ventures)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "rdnt:JointVentureInvestmentAndFinancialInformationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i8217add0ca2e4d579d49cd56dd4ce0dc_I20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentAggregateCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "ib5869b7b9a94482aabb1927c7e98515c_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000043 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Deferred Revenue Recognition)",
     "menuCat": "Details",
     "order": "43",
     "role": "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDeferredRevenueRecognition",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Deferred Revenue Recognition)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "ib5869b7b9a94482aabb1927c7e98515c_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i04caedaa83604a6990f3710c9c56c537_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000044 - Disclosure - BUSINESS COMBINATIONS AND RELATED ACTIVITY (Details - Assets and Liabilities Assumed)",
     "menuCat": "Details",
     "order": "44",
     "role": "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsandLiabilitiesAssumed",
     "shortName": "BUSINESS COMBINATIONS AND RELATED ACTIVITY (Details - Assets and Liabilities Assumed)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i04323c12bfcc46fca5f3765bc9b181de_I20220101",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i04caedaa83604a6990f3710c9c56c537_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000045 - Disclosure - BUSINESS COMBINATIONS AND RELATED ACTIVITY (Details - Narrative)",
     "menuCat": "Details",
     "order": "45",
     "role": "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative",
     "shortName": "BUSINESS COMBINATIONS AND RELATED ACTIVITY (Details - Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i1f28b0b82f124664841343311ab008f6_D20210101-20210101",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000046 - Disclosure - SEGMENT REPORTING (Details)",
     "menuCat": "Details",
     "order": "46",
     "role": "http://www.radnet.com/role/SEGMENTREPORTINGDetails",
     "shortName": "SEGMENT REPORTING (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OperatingCostsAndExpenses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "ibbc4f4e3e435497ba4218694b84e7170_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000047 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Details - Schedule of Goodwill)",
     "menuCat": "Details",
     "order": "47",
     "role": "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS (Details - Schedule of Goodwill)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i04caedaa83604a6990f3710c9c56c537_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000048 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Details - Narrative)",
     "menuCat": "Details",
     "order": "48",
     "role": "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsNarrative",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS (Details - Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i04caedaa83604a6990f3710c9c56c537_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i04caedaa83604a6990f3710c9c56c537_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000049 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Details - Annual Amortization Schedule)",
     "menuCat": "Details",
     "order": "49",
     "role": "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS (Details - Annual Amortization Schedule)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i04caedaa83604a6990f3710c9c56c537_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfPrincipalTransactionsRevenueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
     "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueNotFromContractWithCustomer",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i04caedaa83604a6990f3710c9c56c537_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000050 - Disclosure - PROPERTY AND EQUIPMENT (Details)",
     "menuCat": "Details",
     "order": "50",
     "role": "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetails",
     "shortName": "PROPERTY AND EQUIPMENT (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i04caedaa83604a6990f3710c9c56c537_I20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000051 - Disclosure - PROPERTY AND EQUIPMENT (Details - Narrative)",
     "menuCat": "Details",
     "order": "51",
     "role": "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetailsNarrative",
     "shortName": "PROPERTY AND EQUIPMENT (Details - Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i04caedaa83604a6990f3710c9c56c537_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000052 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Details - Schedule of Debt)",
     "menuCat": "Details",
     "order": "52",
     "role": "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt",
     "shortName": "CREDIT FACILITIES AND NOTES PAYABLE (Details - Schedule of Debt)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i04caedaa83604a6990f3710c9c56c537_I20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i04caedaa83604a6990f3710c9c56c537_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000053 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Details - Annual Note Payable Maturities)",
     "menuCat": "Details",
     "order": "53",
     "role": "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAnnualNotePayableMaturities",
     "shortName": "CREDIT FACILITIES AND NOTES PAYABLE (Details - Annual Note Payable Maturities)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i04caedaa83604a6990f3710c9c56c537_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "ia72ba28711ea41c3b84011425ee45d0f_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LettersOfCreditOutstandingAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000054 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Details - Additional Information)",
     "menuCat": "Details",
     "order": "54",
     "role": "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAdditionalInformation",
     "shortName": "CREDIT FACILITIES AND NOTES PAYABLE (Details - Additional Information)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "ia72ba28711ea41c3b84011425ee45d0f_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LettersOfCreditOutstandingAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i04caedaa83604a6990f3710c9c56c537_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredFinanceCostsNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000055 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Details- Second Amended and Restated First Lien Credit and Guaranty Agreement)",
     "menuCat": "Details",
     "order": "55",
     "role": "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSecondAmendedandRestatedFirstLienCreditandGuarantyAgreement",
     "shortName": "CREDIT FACILITIES AND NOTES PAYABLE (Details- Second Amended and Restated First Lien Credit and Guaranty Agreement)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i56152cb4c4e24493b5d3fdbbd09acf47_D20210423-20210423",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:GainsLossesOnExtinguishmentOfDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "rdnt:ScheduleOfLeverageRatioTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i8b41d8242f3040fb8331b37d34fcd9d2_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000056 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Details - Margin Spread Based on Leverage Ratio, Debt Instrument) (Details)",
     "menuCat": "Details",
     "order": "56",
     "role": "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails",
     "shortName": "CREDIT FACILITIES AND NOTES PAYABLE (Details - Margin Spread Based on Leverage Ratio, Debt Instrument) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "rdnt:ScheduleOfLeverageRatioTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i8b41d8242f3040fb8331b37d34fcd9d2_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i6a3f767fc5374ada83d6ae22aa651dd9_D20230331-20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentPeriodicPayment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000057 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Details - Senior Credit Facilities)",
     "menuCat": "Details",
     "order": "57",
     "role": "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities",
     "shortName": "CREDIT FACILITIES AND NOTES PAYABLE (Details - Senior Credit Facilities)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i6a3f767fc5374ada83d6ae22aa651dd9_D20230331-20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentPeriodicPayment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i04caedaa83604a6990f3710c9c56c537_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredFinanceCostsNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000058 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Details - Revolving Credit Facilities)",
     "menuCat": "Details",
     "order": "58",
     "role": "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities",
     "shortName": "CREDIT FACILITIES AND NOTES PAYABLE (Details - Revolving Credit Facilities)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "iae4da6a9b69c4e0f8084fdf5c94b4fb0_D20220101-20221231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityCommitmentFeePercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i3519d8c4e9ee47ba8c1300676d007bb0_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "rdnt:DebtInstrumentLeverageRatio",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000059 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Details - Margin Spread Based on Leverage Ratio)",
     "menuCat": "Details",
     "order": "59",
     "role": "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
     "shortName": "CREDIT FACILITIES AND NOTES PAYABLE (Details - Margin Spread Based on Leverage Ratio)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i3519d8c4e9ee47ba8c1300676d007bb0_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "rdnt:DebtInstrumentLeverageRatio",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
     "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0632c03edc1443a6b0a38f3cd1a783d9_I20190418",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "rdnt:DebtInstrumentNumberOfAmendments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "amendment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000060 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Details - Recent Amendments to Prior Credit Facilities)",
     "menuCat": "Details",
     "order": "60",
     "role": "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstoPriorCreditFacilities",
     "shortName": "CREDIT FACILITIES AND NOTES PAYABLE (Details - Recent Amendments to Prior Credit Facilities)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0632c03edc1443a6b0a38f3cd1a783d9_I20190418",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "rdnt:DebtInstrumentNumberOfAmendments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "amendment",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i04caedaa83604a6990f3710c9c56c537_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "rdnt:LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000061 - Disclosure - LEASES (Details - Additional Information)",
     "menuCat": "Details",
     "order": "61",
     "role": "http://www.radnet.com/role/LEASESDetailsAdditionalInformation",
     "shortName": "LEASES (Details - Additional Information)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i04caedaa83604a6990f3710c9c56c537_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "rdnt:LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000062 - Disclosure - LEASES (Details - Lease Cost)",
     "menuCat": "Details",
     "order": "62",
     "role": "http://www.radnet.com/role/LEASESDetailsLeaseCost",
     "shortName": "LEASES (Details - Lease Cost)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000063 - Disclosure - LEASES (Details - Supplemental Cash Flows)",
     "menuCat": "Details",
     "order": "63",
     "role": "http://www.radnet.com/role/LEASESDetailsSupplementalCashFlows",
     "shortName": "LEASES (Details - Supplemental Cash Flows)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i04caedaa83604a6990f3710c9c56c537_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000064 - Disclosure - LEASES (Details - Supplemental Balance Sheet)",
     "menuCat": "Details",
     "order": "64",
     "role": "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet",
     "shortName": "LEASES (Details - Supplemental Balance Sheet)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i04caedaa83604a6990f3710c9c56c537_I20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i04caedaa83604a6990f3710c9c56c537_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000065 - Disclosure - LEASES (Details - Maturities of Operating and Finance Lease)",
     "menuCat": "Details",
     "order": "65",
     "role": "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease",
     "shortName": "LEASES (Details - Maturities of Operating and Finance Lease)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i04caedaa83604a6990f3710c9c56c537_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000067 - Disclosure - INCOME TAXES (Details - Income (Loss) Before Income Taxes )",
     "menuCat": "Details",
     "order": "66",
     "role": "http://www.radnet.com/role/INCOMETAXESDetailsIncomeLossBeforeIncomeTaxes",
     "shortName": "INCOME TAXES (Details - Income (Loss) Before Income Taxes )",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000068 - Disclosure - INCOME TAXES (Details - Income Tax Expense)",
     "menuCat": "Details",
     "order": "67",
     "role": "http://www.radnet.com/role/INCOMETAXESDetailsIncomeTaxExpense",
     "shortName": "INCOME TAXES (Details - Income Tax Expense)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000069 - Disclosure - INCOME TAXES (Details - Reconciliation of the Statutory U.S. Federal Rate and Effective Rates)",
     "menuCat": "Details",
     "order": "68",
     "role": "http://www.radnet.com/role/INCOMETAXESDetailsReconciliationoftheStatutoryUSFederalRateandEffectiveRates",
     "shortName": "INCOME TAXES (Details - Reconciliation of the Statutory U.S. Federal Rate and Effective Rates)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i04caedaa83604a6990f3710c9c56c537_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000070 - Disclosure - INCOME TAXES (Details - Deferred Tax Assets and Liabilities)",
     "menuCat": "Details",
     "order": "69",
     "role": "http://www.radnet.com/role/INCOMETAXESDetailsDeferredTaxAssetsandLiabilities",
     "shortName": "INCOME TAXES (Details - Deferred Tax Assets and Liabilities)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i04caedaa83604a6990f3710c9c56c537_I20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i88190c6477b54e7c8dd36138e1b559d5_I20191231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000007 - Statement - CONSOLIDATED STATEMENT OF EQUITY",
     "menuCat": "Statements",
     "order": "7",
     "role": "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY",
     "shortName": "CONSOLIDATED STATEMENT OF EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i88190c6477b54e7c8dd36138e1b559d5_I20191231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i04caedaa83604a6990f3710c9c56c537_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000071 - Disclosure - INCOME TAXES (Details - Narrative)",
     "menuCat": "Details",
     "order": "70",
     "role": "http://www.radnet.com/role/INCOMETAXESDetailsNarrative",
     "shortName": "INCOME TAXES (Details - Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i04caedaa83604a6990f3710c9c56c537_I20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "rdnt:DeferredTaxAssetsTaxBenefitMayNotBeRealized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "ibbc4f4e3e435497ba4218694b84e7170_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000072 - Disclosure - INCOME TAXES (Details - Unrecognized Tax Benefit)",
     "menuCat": "Details",
     "order": "71",
     "role": "http://www.radnet.com/role/INCOMETAXESDetailsUnrecognizedTaxBenefit",
     "shortName": "INCOME TAXES (Details - Unrecognized Tax Benefit)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CompensationRelatedCostsPolicyTextBlock",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i04caedaa83604a6990f3710c9c56c537_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "rdnt:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans",
      "reportCount": 1,
      "unitRef": "incentiveplan",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000073 - Disclosure - STOCK-BASED COMPENSATION (Details Narrative)",
     "menuCat": "Details",
     "order": "72",
     "role": "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
     "shortName": "STOCK-BASED COMPENSATION (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i2d84eba07ea94e52a84e38c42643cc0b_I20221231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "ibbc4f4e3e435497ba4218694b84e7170_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000074 - Disclosure - STOCK-BASED COMPENSATION (Details-Outstanding options and warrants)",
     "menuCat": "Details",
     "order": "73",
     "role": "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants",
     "shortName": "STOCK-BASED COMPENSATION (Details-Outstanding options and warrants)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "ibbc4f4e3e435497ba4218694b84e7170_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "ib19ac757adb3497f895598bf7d1fb0f6_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000075 - Disclosure - STOCK-BASED COMPENSATION (Details - RSU's and LTIPs)",
     "menuCat": "Details",
     "order": "74",
     "role": "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUsandLTIPs",
     "shortName": "STOCK-BASED COMPENSATION (Details - RSU's and LTIPs)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i3b0bb841e3944cc1903ad3a519ea4d82_D20220101-20221231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "menuCat": "Statements",
     "order": "8",
     "role": "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "rdnt:EquipmentAcquiredAndLeaseholdImprovements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000009 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)",
     "menuCat": "Statements",
     "order": "9",
     "role": "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20221231.htm",
      "contextRef": "i0e98a7d0c2654e91a8b90353a9167848_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "rdnt:EquipmentAcquiredAndLeaseholdImprovements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 175,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.radnet.com/role/COVERPAGE"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r733",
      "r734",
      "r735"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID",
        "terseLabel": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.radnet.com/role/AUDITINFORMATION"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r733",
      "r734",
      "r735"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location",
        "terseLabel": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.radnet.com/role/AUDITINFORMATION"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r733",
      "r734",
      "r735"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name",
        "terseLabel": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.radnet.com/role/AUDITINFORMATION"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.radnet.com/role/COVERPAGE"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.radnet.com/role/COVERPAGE"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r733",
      "r734",
      "r735"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.radnet.com/role/COVERPAGE"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.radnet.com/role/COVERPAGE"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.radnet.com/role/COVERPAGE"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.radnet.com/role/COVERPAGE"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r736"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.radnet.com/role/COVERPAGE"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.radnet.com/role/COVERPAGE"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r731"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.radnet.com/role/COVERPAGE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.radnet.com/role/COVERPAGE"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.radnet.com/role/COVERPAGE"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.radnet.com/role/COVERPAGE"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.radnet.com/role/COVERPAGE"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r730"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.radnet.com/role/COVERPAGE"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.radnet.com/role/COVERPAGE"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity's Reporting Status Current"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.radnet.com/role/COVERPAGE"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsandLiabilitiesAssumed",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r730"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.radnet.com/role/COVERPAGE"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.radnet.com/role/COVERPAGE"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r730"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.radnet.com/role/COVERPAGE"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.radnet.com/role/COVERPAGE"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r737"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.radnet.com/role/COVERPAGE"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.radnet.com/role/COVERPAGE"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r730"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.radnet.com/role/COVERPAGE"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r730"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.radnet.com/role/COVERPAGE"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r730"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.radnet.com/role/COVERPAGE"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r730"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.radnet.com/role/COVERPAGE"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity a Voluntary Filer"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.radnet.com/role/COVERPAGE"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r738"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity a Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.radnet.com/role/COVERPAGE"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r733",
      "r734",
      "r735"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.radnet.com/role/COVERPAGE"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsandLiabilitiesAssumed",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.radnet.com/role/COVERPAGE"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r729"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.radnet.com/role/COVERPAGE"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r732"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.radnet.com/role/COVERPAGE"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.radnet.com/role/COVERPAGE"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "rdnt_A2012SunriseMerrickLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2012 Sunrise Merrick LLC",
        "label": "2012 Sunrise Merrick LLC [Member]",
        "terseLabel": "2012 Sunrise Merrick LLC"
       }
      }
     },
     "localname": "A2012SunriseMerrickLLCMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsandLiabilitiesAssumed"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_A2019SWAPS1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2019 SWAPS1 [Member]",
        "label": "2019 SWAPS1 [Member]",
        "terseLabel": "2019 SWAPS1"
       }
      }
     },
     "localname": "A2019SWAPS1Member",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_A2019SWAPSMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2019 SWAPS [Member]",
        "label": "2019 SWAPS [Member]",
        "terseLabel": "2019 SWAPS"
       }
      }
     },
     "localname": "A2019SWAPSMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_A3235HempsteadLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3235 Hempstead LLC",
        "label": "3235 Hempstead LLC [Member]",
        "terseLabel": "3235 Hempstead LLC"
       }
      }
     },
     "localname": "A3235HempsteadLLCMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsandLiabilitiesAssumed"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_A60thStreetMRILLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "60th Street MRI, LLC",
        "label": "60th Street MRI, LLC [Member]",
        "terseLabel": "60th Street MRI, LLC"
       }
      }
     },
     "localname": "A60thStreetMRILLCMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsandLiabilitiesAssumed"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_AIMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "AI",
        "label": "AI [Member]",
        "terseLabel": "AI",
        "verboseLabel": "AI segment revenue"
       }
      }
     },
     "localname": "AIMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill",
      "http://www.radnet.com/role/SEGMENTREPORTINGDetails",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofNetRevenue"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_AcquisitionsAndAssetPurchasesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquisitions And Asset Purchases",
        "label": "Acquisitions And Asset Purchases [Member]",
        "terseLabel": "Acquisitions And Asset Purchases"
       }
      }
     },
     "localname": "AcquisitionsAndAssetPurchasesMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustment to Additional Paid in Capital, Income Tax Effect from Sale of Noncontrolling Interest",
        "label": "Adjustment to Additional Paid in Capital, Income Tax Effect from Sale of Noncontrolling Interest",
        "negatedTerseLabel": "Tax effect on gain on sale of noncontrolling interest"
       }
      }
     },
     "localname": "AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_AdjustmentToNetIncomeAttributableToAssumedShareSettlements": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustment To Net Income Attributable To Assumed Share Settlements",
        "label": "Adjustment To Net Income Attributable To Assumed Share Settlements",
        "terseLabel": "Changes in fair value associated with contingently issuable shares"
       }
      }
     },
     "localname": "AdjustmentToNetIncomeAttributableToAssumedShareSettlements",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_AdjustmentsToAdditionalPaidInCapitalGainOnContributionOfAssetsToSubsidiary": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments to Additional Paid in Capital, Gain on Contribution Of Assets To Subsidiary",
        "label": "Adjustments to Additional Paid in Capital, Gain on Contribution Of Assets To Subsidiary",
        "negatedTerseLabel": "Gain on contribution of assets to majority owned subsidiary"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalGainOnContributionOfAssetsToSubsidiary",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_AdvanceMedicarePayments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Advance Medicare Payments",
        "label": "Advance Medicare Payments",
        "terseLabel": "Advance medicare payments"
       }
      }
     },
     "localname": "AdvanceMedicarePayments",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_AdvancedRadiologyAtCapitalRegionLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Advanced Radiology at Capital Region, LLC",
        "label": "Advanced Radiology at Capital Region, LLC [Member]",
        "terseLabel": "Advanced Radiology at Capital Region, LLC"
       }
      }
     },
     "localname": "AdvancedRadiologyAtCapitalRegionLLCMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_AggregateIntrinsicValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate Intrinsic Value",
        "label": "Aggregate Intrinsic Value",
        "terseLabel": "Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "AggregateIntrinsicValue",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "stringItemType"
    },
    "rdnt_AidenceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aidence",
        "label": "Aidence [Member]",
        "terseLabel": "Aidence"
       }
      }
     },
     "localname": "AidenceMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsContingentConsideration",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ArizonaDiagnosticsGroupMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arizona Diagnostics Group",
        "label": "Arizona Diagnostics Group [Member]",
        "terseLabel": "Arizona Diagnostics Group"
       }
      }
     },
     "localname": "ArizonaDiagnosticsGroupMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_AssetsAndLiabilitiesLesseeTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Table Text Block] for Assets And Liabilities Lessee [Table]",
        "label": "Assets And Liabilities Lessee [Table Text Block]",
        "terseLabel": "Schedule of Assets and Liabilities Lessee"
       }
      }
     },
     "localname": "AssetsAndLiabilitiesLesseeTableTextBlock",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/LEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "rdnt_AuditorInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Auditor Information [Abstract]",
        "label": "Auditor Information [Abstract]"
       }
      }
     },
     "localname": "AuditorInformationAbstract",
     "nsuri": "http://www.radnet.com/20221231",
     "xbrltype": "stringItemType"
    },
    "rdnt_BarclaysMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Barclays [Member]",
        "label": "Barclays [Member]",
        "terseLabel": "Barclays"
       }
      }
     },
     "localname": "BarclaysMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAdditionalInformation",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstoPriorCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSecondAmendedandRestatedFirstLienCreditandGuarantyAgreement",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_BlueShieldMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Blue Shield [Member]",
        "label": "Blue Shield [Member]",
        "terseLabel": "Blue Shield"
       }
      }
     },
     "localname": "BlueShieldMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_BroadwayMedicalImagingLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Broadway Medical Imaging LLC",
        "label": "Broadway Medical Imaging LLC [Member]",
        "terseLabel": "Broadway Medical Imaging LLC"
       }
      }
     },
     "localname": "BroadwayMedicalImagingLLCMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsandLiabilitiesAssumed"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_BusinessAcquisitionContingentConsiderationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Acquisition Contingent Consideration",
        "label": "Business Acquisition Contingent Consideration [Member]",
        "terseLabel": "Business Acsuition Contingent Consideration"
       }
      }
     },
     "localname": "BusinessAcquisitionContingentConsiderationMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Acquisition, Equity Interest Issued or Issuable, Additional Number of Shares",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Additional Number of Shares",
        "terseLabel": "Business acquisition, equity interest issued or issuable, additional number of shares"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestIssuedOrIssuableAdditionalNumberOfShares",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "rdnt_BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Acquisition, Equity Interest Issued or Issuable, Fair Value Of Additional Shares Issued After Execution",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Fair Value Of Additional Shares Issued After Execution",
        "terseLabel": "Business acquisition, equity interest issued or issuable, fair value of additional shares issued after execution"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestIssuedOrIssuableFairValueOfAdditionalSharesIssuedAfterExecution",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_BusinessAcquisitionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Acquisitions",
        "label": "Business Acquisitions [Member]",
        "terseLabel": "Business Acquisitions"
       }
      }
     },
     "localname": "BusinessAcquisitionsMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsandLiabilitiesAssumed"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination Contingent Consideration Arrangements Change In Currency Translation",
        "label": "Business Combination Contingent Consideration Arrangements Change In Currency Translation",
        "terseLabel": "Currency Translation"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInCurrencyTranslation",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsContingentConsideration"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration Arrangements, Issuance Of Contingent Consideration",
        "label": "Business Combination, Contingent Consideration Arrangements, Issuance Of Contingent Consideration",
        "terseLabel": "Issuance of contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsIssuanceOfContingentConsideration",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsContingentConsideration"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneOne": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration, Liability, Percent Of FDA Approval And Payout, Milestone One",
        "label": "Business Combination, Contingent Consideration, Liability, Percent Of FDA Approval And Payout, Milestone One",
        "terseLabel": "Percent of FDA approval and payout, milestone one"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneOne",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "rdnt_BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneTwo": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration, Liability, Percent Of FDA Approval And Payout, Milestone Two",
        "label": "Business Combination, Contingent Consideration, Liability, Percent Of FDA Approval And Payout, Milestone Two",
        "terseLabel": "Percent of FDA approval and payout, milestone two"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityPercentOfFDAApprovalAndPayoutMilestoneTwo",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "rdnt_BusinessCombinationContingentConsiderationLiabilityPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration, Liability, Period",
        "label": "Business Combination, Contingent Consideration, Liability, Period",
        "terseLabel": "Business combination, contingent consideration, liability, period"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityPeriod",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "rdnt_BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration, Number Of Identified Milestones",
        "label": "Business Combination, Contingent Consideration, Number Of Identified Milestones",
        "terseLabel": "Number of identified milestones"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationNumberOfIdentifiedMilestones",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "integerItemType"
    },
    "rdnt_BusinessCombinationNumberOfSubsidiariesAcquired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Number Of Subsidiaries Acquired",
        "label": "Business Combination, Number Of Subsidiaries Acquired",
        "terseLabel": "Number of subsidiaries acquired"
       }
      }
     },
     "localname": "BusinessCombinationNumberOfSubsidiariesAcquired",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsandLiabilitiesAssumed"
     ],
     "xbrltype": "integerItemType"
    },
    "rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsandLiabilitiesAssumed": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets (Liabilities), Other",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets (Liabilities), Other",
        "verboseLabel": "Other"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsLiabilitiesOther",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsandLiabilitiesAssumed"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsandLiabilitiesAssumed": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Operating Lease Liabilities",
        "label": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Operating Lease Liabilities",
        "negatedLabel": "Right of Use Liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsandLiabilitiesAssumed"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsandLiabilitiesAssumed": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Right Of Use Asset",
        "label": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Right Of Use Asset",
        "verboseLabel": "Right of Use Assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsandLiabilitiesAssumed"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_COVID19PandemicMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "C O V I D19 Pandemic",
        "label": "C O V I D19 Pandemic [Member]",
        "terseLabel": "C O V I D19 Pandemic"
       }
      }
     },
     "localname": "COVID19PandemicMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstoPriorCreditFacilities",
      "http://www.radnet.com/role/SEGMENTREPORTINGDetails",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_CapitationArrangementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Capitation Arrangements [Member]",
        "label": "Capitation Arrangements [Member]",
        "terseLabel": "Revenue under capitation arrangements"
       }
      }
     },
     "localname": "CapitationArrangementsMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofNetRevenue"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_Caps2016Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "2016 Caps [Member]",
        "terseLabel": "2016 Caps"
       }
      }
     },
     "localname": "Caps2016Member",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_CaresActRefundableClaimPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cares Act, Refundable Claim Percentage",
        "label": "Cares Act, Refundable Claim Percentage",
        "terseLabel": "Refundable claim percentage"
       }
      }
     },
     "localname": "CaresActRefundableClaimPercentage",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "rdnt_CashFlowLesseeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Flow Lessee [Abstract]",
        "label": "Cash Flow Lessee [Abstract]",
        "terseLabel": "Cash paid for amounts included in the measurement of lease liabilities:"
       }
      }
     },
     "localname": "CashFlowLesseeAbstract",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsSupplementalCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "rdnt_CashHoldbackMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Holdback",
        "label": "Cash Holdback [Member]",
        "terseLabel": "Cash Holdback"
       }
      }
     },
     "localname": "CashHoldbackMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_CertainSellerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Certain Seller",
        "label": "Certain Seller [Member]",
        "terseLabel": "Certain Seller"
       }
      }
     },
     "localname": "CertainSellerMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ChelseaDignosticRadiologyPCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Chelsea Dignostic Radiology, P.C.",
        "label": "Chelsea Dignostic Radiology, P.C. [Member]",
        "terseLabel": "Chelsea Dignostic Radiology, P.C."
       }
      }
     },
     "localname": "ChelseaDignosticRadiologyPCMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsandLiabilitiesAssumed"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_CommercialInsurance1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commercial Insurance1 [Member]",
        "label": "Commercial Insurance1 [Member]",
        "terseLabel": "Commercial insurance"
       }
      }
     },
     "localname": "CommercialInsurance1Member",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofNetRevenue"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ComputerandOfficeEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Computer and Office Equipment [Member]",
        "label": "Computer and Office Equipment [Member]",
        "terseLabel": "Computer and Office Equipment"
       }
      }
     },
     "localname": "ComputerandOfficeEquipmentMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ContingentMilestoneConsiderationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Milestone Consideration",
        "label": "Contingent Milestone Consideration [Member]",
        "terseLabel": "Contingent Milestone Consideration"
       }
      }
     },
     "localname": "ContingentMilestoneConsiderationMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ContractsReceivableFactoringReceivable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contracts Receivable, Factoring Receivable",
        "label": "Contracts Receivable, Factoring Receivable",
        "terseLabel": "Factoring receivable"
       }
      }
     },
     "localname": "ContractsReceivableFactoringReceivable",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_CovenantNotToCompeteMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Covenant Not To Compete [Member]",
        "terseLabel": "Covenant not to compete and other contracts"
       }
      }
     },
     "localname": "CovenantNotToCompeteMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_DRTLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "DRT LLC",
        "label": "DRT LLC [Member]",
        "terseLabel": "DRT LLC"
       }
      }
     },
     "localname": "DRTLLCMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_DebtInstrumentCovenantLeverageRatioMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Leverage Ratio, Maximum",
        "label": "Debt Instrument, Covenant, Leverage Ratio, Maximum",
        "terseLabel": "Leverage ratio, less than"
       }
      }
     },
     "localname": "DebtInstrumentCovenantLeverageRatioMaximum",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Liquidity Ratio Required, Minimum",
        "label": "Debt Instrument, Covenant, Liquidity Ratio Required, Minimum",
        "terseLabel": "Leverage ratio, greater than"
       }
      }
     },
     "localname": "DebtInstrumentCovenantLiquidityRatioRequiredMinimum",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "rdnt_DebtInstrumentExtensionPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Extension Period",
        "label": "Debt Instrument, Extension Period",
        "terseLabel": "Debt instrument, extension period"
       }
      }
     },
     "localname": "DebtInstrumentExtensionPeriod",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstoPriorCreditFacilities"
     ],
     "xbrltype": "durationItemType"
    },
    "rdnt_DebtInstrumentLeverageRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Leverage Ratio",
        "label": "Debt Instrument, Leverage Ratio",
        "terseLabel": "Debt instrument, leverage ratio"
       }
      }
     },
     "localname": "DebtInstrumentLeverageRatio",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities"
     ],
     "xbrltype": "pureItemType"
    },
    "rdnt_DebtInstrumentNumberOfAmendments": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Number Of Amendments",
        "label": "Debt Instrument, Number Of Amendments",
        "terseLabel": "Number of amendments"
       }
      }
     },
     "localname": "DebtInstrumentNumberOfAmendments",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstoPriorCreditFacilities"
     ],
     "xbrltype": "integerItemType"
    },
    "rdnt_DebtInstrumentNumberofLoansReceived": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Number of Loans Received",
        "label": "Debt Instrument, Number of Loans Received",
        "terseLabel": "Number of PPP loans received"
       }
      }
     },
     "localname": "DebtInstrumentNumberofLoansReceived",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstoPriorCreditFacilities"
     ],
     "xbrltype": "integerItemType"
    },
    "rdnt_DebtInstrumentPeriodicPaymentPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Periodic Payment, Percent",
        "label": "Debt Instrument, Periodic Payment, Percent",
        "terseLabel": "Debt periodic payment, percent of total amount"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPaymentPercent",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities"
     ],
     "xbrltype": "percentItemType"
    },
    "rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Periodic Payment Terms, Amortization Increase",
        "label": "Debt Instrument, Periodic Payment Terms, Amortization Increase",
        "terseLabel": "Debt periodic payment, amortization increase"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPaymentTermsAmortizationIncrease",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_DeepHealthIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "DeepHealth, Inc. [Member]",
        "label": "DeepHealth, Inc. [Member]",
        "terseLabel": "DeepHealth, Inc."
       }
      }
     },
     "localname": "DeepHealthIncMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_DeferredTaxAssetsOperatingLeaseLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDetailsDeferredTaxAssetsandLiabilities": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Operating Lease Liabilities",
        "label": "Deferred Tax Assets, Operating Lease Liabilities",
        "terseLabel": "Operating lease liability"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLeaseLiabilities",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsDeferredTaxAssetsandLiabilities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Tax Benefit May Not Be Realized",
        "label": "Deferred Tax Assets, Tax Benefit May Not Be Realized",
        "terseLabel": "Deferred tax assets, tax benefit may not be realized"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxBenefitMayNotBeRealized",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDetailsDeferredTaxAssetsandLiabilities": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Liabilities, Operating Right-Of-Use Assets",
        "label": "Deferred Tax Liabilities, Operating Right-Of-Use Assets",
        "negatedTerseLabel": "Operating lease right-of-use asset"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesOperatingRightOfUseAssets",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsDeferredTaxAssetsandLiabilities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_DeferredTaxLiabilitiesOutsideBasisDifference": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDetailsDeferredTaxAssetsandLiabilities": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Liabilities, Outside Basis Difference",
        "label": "Deferred Tax Liabilities, Outside Basis Difference",
        "negatedLabel": "Outside basis difference"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesOutsideBasisDifference",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsDeferredTaxAssetsandLiabilities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_DevelopedTechnologySoftwareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Developed technology [Member]",
        "label": "Developed Technology &amp; Software [Member]",
        "terseLabel": "Developed Technology &amp; Software"
       }
      }
     },
     "localname": "DevelopedTechnologySoftwareMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_DignityHealthMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dignity Health [Member]",
        "terseLabel": "Dignity Health"
       }
      }
     },
     "localname": "DignityHealthMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_DimensionHealthCorporationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Dimension Health Corporation",
        "label": "Dimension Health Corporation [Member]",
        "terseLabel": "Dimension Health Corporation"
       }
      }
     },
     "localname": "DimensionHealthCorporationMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ERADMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "eRAD [Member]",
        "terseLabel": "eRAD"
       }
      }
     },
     "localname": "ERADMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_EarningPerShareBasicAndDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Earning Per Share, Basic and Diluted",
        "label": "Earning Per Share, Basic and Diluted [Abstract]",
        "terseLabel": "WEIGHTED AVERAGE SHARES OUTSTANDING"
       }
      }
     },
     "localname": "EarningPerShareBasicAndDilutedAbstract",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "rdnt_EffectiveIncomeTaxRateReconciliationPPPLoanAmount": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDetailsReconciliationoftheStatutoryUSFederalRateandEffectiveRates": {
       "order": 10.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, PPP Loan, Amount",
        "label": "Effective Income Tax Rate Reconciliation, PPP Loan, Amount",
        "terseLabel": "PPP Loan"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationPPPLoanAmount",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsReconciliationoftheStatutoryUSFederalRateandEffectiveRates"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_EquipmentAcquiredAndLeaseholdImprovements": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Equipment Acquired and Leasehold Improvements",
        "terseLabel": "Equipment acquired and leasehold improvements"
       }
      }
     },
     "localname": "EquipmentAcquiredAndLeaseholdImprovements",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_EquityContributionsInExistingAndPurchaseOfInterestInJointVentures": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity contributions in existing joint ventures",
        "label": "Equity Contributions in Existing and Purchase of Interest in Joint Ventures",
        "terseLabel": "Equity contributions in existing and purchase of interest in joint ventures"
       }
      }
     },
     "localname": "EquityContributionsInExistingAndPurchaseOfInterestInJointVentures",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsInvestmentinJointVentures"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_EquityMethodInvestmentAdditionalContribution": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investment, Additional Contribution",
        "label": "Equity Method Investment, Additional Contribution",
        "terseLabel": "Additional contribution"
       }
      }
     },
     "localname": "EquityMethodInvestmentAdditionalContribution",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_EquityMethodInvestmentSharesPurchased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investment, Shares Purchased",
        "label": "Equity Method Investment, Shares Purchased",
        "terseLabel": "Shares purchased (in shares)"
       }
      }
     },
     "localname": "EquityMethodInvestmentSharesPurchased",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "rdnt_EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestments": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Securities without Readily Determinable Fair Value, Number Of Investments",
        "label": "Equity Securities without Readily Determinable Fair Value, Number Of Investments",
        "terseLabel": "Number of investments"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfInvestments",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "integerItemType"
    },
    "rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease Assets And Liabilities Lessee [Abstract]",
        "label": "Finance Lease Assets And Liabilities Lessee [Abstract]",
        "terseLabel": "Operating Leases"
       }
      }
     },
     "localname": "FinanceLeaseAssetsAndLiabilitiesLesseeAbstract",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "rdnt_FinanceLeaseCost": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/LEASESDetailsLeaseCost": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease Cost",
        "label": "Finance Lease Cost",
        "totalLabel": "Total finance lease cost"
       }
      }
     },
     "localname": "FinanceLeaseCost",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsLeaseCost"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_FirstLienCreditAgreementEighthAmendmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First Lien Credit Agreement Eighth Amendment",
        "label": "First Lien Credit Agreement Eighth Amendment [Member]",
        "terseLabel": "First Lien Credit Agreement Eighth Amendment"
       }
      }
     },
     "localname": "FirstLienCreditAgreementEighthAmendmentMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAdditionalInformation",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstoPriorCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSecondAmendedandRestatedFirstLienCreditandGuarantyAgreement"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_FirstLienCreditAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "First Lien Credit Agreement [Member]",
        "terseLabel": "First Lien Credit Agreement"
       }
      }
     },
     "localname": "FirstLienCreditAgreementMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAdditionalInformation",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_FirstLienCreditAgreementSeventhAmendmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First Lien Credit Agreement Seventh Amendment [Member]",
        "label": "First Lien Credit Agreement Seventh Amendment [Member]",
        "terseLabel": "Amendment No. 7 First Lien Credit Agreement"
       }
      }
     },
     "localname": "FirstLienCreditAgreementSeventhAmendmentMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSecondAmendedandRestatedFirstLienCreditandGuarantyAgreement"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_FirstLienCreditAgreementSixthAmendmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First Lien Credit Agreement Sixth Amendment [Member]",
        "label": "First Lien Credit Agreement Sixth Amendment [Member]",
        "terseLabel": "Amendment No. 6 First Lien Credit Agreement"
       }
      }
     },
     "localname": "FirstLienCreditAgreementSixthAmendmentMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstoPriorCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_FirstLienTermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "First Lien Term Loan [Member]",
        "terseLabel": "First Lien Term Loans"
       }
      }
     },
     "localname": "FirstLienTermLoanMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_FixedAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixed Assets",
        "label": "Fixed Assets [Member]",
        "terseLabel": "Fixed Assets"
       }
      }
     },
     "localname": "FixedAssetsMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ForeignOperatingLossCarryforwardsNotSubjectToExpiration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign Operating Loss Carryforwards, Not Subject To Expiration",
        "label": "Foreign Operating Loss Carryforwards, Not Subject To Expiration",
        "terseLabel": "Foreign Operating Loss Carryforwards, Not Subject To Expiration"
       }
      }
     },
     "localname": "ForeignOperatingLossCarryforwardsNotSubjectToExpiration",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_ForeignOperatingLossCarryforwardsSubjectToExpiration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign Operating Loss Carryforwards, Subject To Expiration",
        "label": "Foreign Operating Loss Carryforwards, Subject To Expiration",
        "terseLabel": "Foreign Operating Loss Carryforwards, Subject To Expiration"
       }
      }
     },
     "localname": "ForeignOperatingLossCarryforwardsSubjectToExpiration",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_FrederickCountyRadiologyLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frederick County Radiology, LLC",
        "label": "Frederick County Radiology, LLC [Member]",
        "terseLabel": "Frederick County Radiology, LLC"
       }
      }
     },
     "localname": "FrederickCountyRadiologyLLCMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_FrederickHealthHospitalIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frederick Health Hospital, Inc.",
        "label": "Frederick Health Hospital, Inc. [Member]",
        "terseLabel": "Frederick Health Hospital, Inc."
       }
      }
     },
     "localname": "FrederickHealthHospitalIncMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_FutureServiceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future Services [Member]",
        "label": "Future Service [Member]",
        "terseLabel": "Future Service"
       }
      }
     },
     "localname": "FutureServiceMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_GainLossOnExtinguishmentOfDebtAndOtherExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain (Loss) On Extinguishment Of Debt And Other Expenses",
        "label": "Gain (Loss) On Extinguishment Of Debt And Other Expenses",
        "negatedLabel": "Loss (gain) on extinguishment of debt and related expenses"
       }
      }
     },
     "localname": "GainLossOnExtinguishmentOfDebtAndOtherExpenses",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_GlendaleAdvancedImagingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Glendale Advanced Imaging [Member]",
        "terseLabel": "Glendale Advanced Imaging"
       }
      }
     },
     "localname": "GlendaleAdvancedImagingMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_HealthCareManagementServiceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care, Management Service [Member]",
        "label": "Health Care, Management Service [Member]",
        "terseLabel": "Management fee revenue"
       }
      }
     },
     "localname": "HealthCareManagementServiceMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofNetRevenue"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_HealthCarePatientServiceOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care, Patient Service Other [Member]",
        "label": "Health Care, Patient Service Other [Member]",
        "terseLabel": "Other patient revenue"
       }
      }
     },
     "localname": "HealthCarePatientServiceOtherMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofNetRevenue"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_HeartAndLungImagingLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Heart and Lung Imaging Limited",
        "label": "Heart and Lung Imaging Limited [Member]",
        "terseLabel": "Heart and Lung Imaging Limited"
       }
      }
     },
     "localname": "HeartAndLungImagingLimitedMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsandLiabilitiesAssumed",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsContingentConsideration",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_IFRCLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "I F R C L L C",
        "label": "I F R C L L C [Member]",
        "terseLabel": "I F R C L L C"
       }
      }
     },
     "localname": "IFRCLLCMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsandLiabilitiesAssumed"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_IFRCLLCSubsidiaryOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "I F R C L L C Subsidiary One",
        "label": "I F R C L L C Subsidiary One [Member]",
        "terseLabel": "I F R C L L C Subsidiary One"
       }
      }
     },
     "localname": "IFRCLLCSubsidiaryOneMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsandLiabilitiesAssumed"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_IFRCLLCSubsidiaryTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "I F R C L L C Subsidiary Two",
        "label": "I F R C L L C Subsidiary Two [Member]",
        "terseLabel": "I F R C L L C Subsidiary Two"
       }
      }
     },
     "localname": "IFRCLLCSubsidiaryTwoMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsandLiabilitiesAssumed"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ImagingCenterSegmentRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Imaging Center Segment Revenue",
        "label": "Imaging Center Segment Revenue [Member]",
        "verboseLabel": "Imaging center segment revenue"
       }
      }
     },
     "localname": "ImagingCenterSegmentRevenueMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofNetRevenue"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ImagingCentersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Imaging Centers",
        "label": "Imaging Centers [Member]",
        "terseLabel": "Imaging Centers"
       }
      }
     },
     "localname": "ImagingCentersMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill",
      "http://www.radnet.com/role/SEGMENTREPORTINGDetails",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_IncreaseDecreaseInNoncashItem": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase Decrease In Noncash Item",
        "label": "Increase Decrease In Noncash Item",
        "negatedTerseLabel": "Non cash item in other expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInNoncashItem",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) in Social Security Tax, Employer, Deferral, CARES Act",
        "label": "Increase (Decrease) in Social Security Tax, Employer, Deferral, CARES Act",
        "terseLabel": "Reduction in deferred social security taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures",
        "label": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures [Roll Forward]",
        "terseLabel": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures [Roll Forward]"
       }
      }
     },
     "localname": "InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsInvestmentinJointVentures"
     ],
     "xbrltype": "stringItemType"
    },
    "rdnt_JointVentureInterestMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Joint Venture Interest",
        "label": "Joint Venture Interest [Member]",
        "terseLabel": "Joint Venture Interest"
       }
      }
     },
     "localname": "JointVentureInterestMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Joint Venture Investment and Financial Information",
        "label": "Joint Venture Investment and Financial Information [Table Text Block]",
        "terseLabel": "Schedule of Joint Venture Investment and Financial Information"
       }
      }
     },
     "localname": "JointVentureInvestmentAndFinancialInformationTableTextBlock",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "rdnt_JointVentureMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Joint Venture [Member]",
        "terseLabel": "Joint Venture"
       }
      }
     },
     "localname": "JointVentureMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_JointVentureWithCalvertMedicalImagingCentersLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Joint Venture With Calvert Medical Imaging Centers LLC",
        "label": "Joint Venture With Calvert Medical Imaging Centers LLC [Member]",
        "terseLabel": "Joint Venture With Calvert Medical Imaging Centers LLC"
       }
      }
     },
     "localname": "JointVentureWithCalvertMedicalImagingCentersLLCMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsandLiabilitiesAssumed"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_KeyFinancialDataForJointVentures": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Key Financial Data For Joint Ventures",
        "label": "Key Financial Data For Joint Ventures",
        "terseLabel": "Balance Sheet Data:"
       }
      }
     },
     "localname": "KeyFinancialDataForJointVentures",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"
     ],
     "xbrltype": "stringItemType"
    },
    "rdnt_LeasesWeightedAverageDiscountRateAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leases Weighted Average Discount Rate [Abstract]",
        "label": "Leases Weighted Average Discount Rate [Abstract]",
        "terseLabel": "Weighted Average Discount Rate"
       }
      }
     },
     "localname": "LeasesWeightedAverageDiscountRateAbstract",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "rdnt_LesseeLeaseTermofContract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee Lease Term of Contract",
        "label": "Lessee Lease Term of Contract",
        "terseLabel": "Lease term of contract"
       }
      }
     },
     "localname": "LesseeLeaseTermofContract",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsAdditionalInformation"
     ],
     "xbrltype": "durationItemType"
    },
    "rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee Operating Lease Lease Not Yet Commenced Undiscounted Amount",
        "label": "Lessee Operating Lease Lease Not Yet Commenced Undiscounted Amount",
        "terseLabel": "Operating lease not yet commenced"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsAdditionalInformation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_LeverageRatioAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leverage Ratio [Axis]",
        "label": "Leverage Ratio [Axis]",
        "terseLabel": "Leverage Ratio [Axis]"
       }
      }
     },
     "localname": "LeverageRatioAxis",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities"
     ],
     "xbrltype": "stringItemType"
    },
    "rdnt_LeverageRatioDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Leverage Ratio [Axis]",
        "label": "Leverage Ratio [Domain]",
        "terseLabel": "Leverage Ratio [Domain]"
       }
      }
     },
     "localname": "LeverageRatioDomain",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_LeverageRatioFiveMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leverage Ratio Five",
        "label": "Leverage Ratio Five [Member]",
        "terseLabel": "3.5 or less"
       }
      }
     },
     "localname": "LeverageRatioFiveMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_LeverageRatioOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leverage Ratio One [Member]",
        "label": "Leverage Ratio One [Member]",
        "terseLabel": "> 3.50x"
       }
      }
     },
     "localname": "LeverageRatioOneMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_LeverageRatioThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leverage Ratio Three [Member]",
        "label": "Leverage Ratio Three [Member]",
        "terseLabel": "\u2264 3.00x"
       }
      }
     },
     "localname": "LeverageRatioThreeMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_LeverageRatioTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leverage Ratio Two [Member]",
        "label": "Leverage Ratio Two [Member]",
        "terseLabel": "> 3.00x but \u2264 3.50x"
       }
      }
     },
     "localname": "LeverageRatioTwoMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_LineofCreditFacilityIncreaseBorrowingCapacity": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line of Credit Facility, Increase Borrowing Capacity",
        "label": "Line of Credit Facility, Increase Borrowing Capacity",
        "terseLabel": "Line of credit facility, increase borrowing capacity"
       }
      }
     },
     "localname": "LineofCreditFacilityIncreaseBorrowingCapacity",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstoPriorCreditFacilities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_LongTermIncentivePlanSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long Term Incentive Plan Shares",
        "label": "Long Term Incentive Plan Shares [Member]",
        "terseLabel": "LTIPs"
       }
      }
     },
     "localname": "LongTermIncentivePlanSharesMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUsandLTIPs"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ManagementServiceContractsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management Service Contracts [Member]",
        "terseLabel": "Management Service Contracts"
       }
      }
     },
     "localname": "ManagementServiceContractsMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule",
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ManagementServiceFees": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Management service fees.",
        "label": "Management Service Fees",
        "terseLabel": "Management service fees"
       }
      }
     },
     "localname": "ManagementServiceFees",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_MedicVisionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Medic Vision [Member]",
        "terseLabel": "Medic Vision"
       }
      }
     },
     "localname": "MedicVisionMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_Medicaid1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicaid1 [Member]",
        "label": "Medicaid1 [Member]",
        "terseLabel": "Medicaid"
       }
      }
     },
     "localname": "Medicaid1Member",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofNetRevenue"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_MedicalEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medical Equipment [Member]",
        "label": "Medical Equipment [Member]",
        "terseLabel": "Medical Equipment"
       }
      }
     },
     "localname": "MedicalEquipmentMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_MedicalInsuranceStopLossPolicyClaimAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medical Insurance, Stop Loss Policy Claim Amount",
        "label": "Medical Insurance, Stop Loss Policy Claim Amount",
        "terseLabel": "Stop loss policy claim amount"
       }
      }
     },
     "localname": "MedicalInsuranceStopLossPolicyClaimAmount",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_MedicalMalpracticeDeductiblePerIncidence": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medical Malpractice Deductible Per Incidence",
        "label": "Medical Malpractice Deductible Per Incidence",
        "terseLabel": "Medical malpractice deductible per incidence"
       }
      }
     },
     "localname": "MedicalMalpracticeDeductiblePerIncidence",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_Medicare1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicare1 [Member]",
        "label": "Medicare1 [Member]",
        "terseLabel": "Medicare"
       }
      }
     },
     "localname": "Medicare1Member",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofNetRevenue"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_MidDelawareImagingPAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mid Delaware Imaging P.A.",
        "label": "Mid Delaware Imaging P.A. [Member]",
        "terseLabel": "Mid Delaware Imaging P.A."
       }
      }
     },
     "localname": "MidDelawareImagingPAMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsandLiabilitiesAssumed"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_MontclairMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Montclair",
        "label": "Montclair [Member]",
        "terseLabel": "Montclair"
       }
      }
     },
     "localname": "MontclairMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsContingentConsideration",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_MontclairRadiologicalAssociatesPAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Montclair Radiological Associates, P.A.",
        "label": "Montclair Radiological Associates, P.A. [Member]",
        "terseLabel": "Montclair Radiological Associates, P.A."
       }
      }
     },
     "localname": "MontclairRadiologicalAssociatesPAMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsandLiabilitiesAssumed"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_MonthlyAmortizationOfDeferredHedgeGains": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Monthly Amortization Of Deferred Hedge Gains",
        "label": "Monthly Amortization Of Deferred Hedge Gains",
        "terseLabel": "Monthly amortization of deferred hedge gains"
       }
      }
     },
     "localname": "MonthlyAmortizationOfDeferredHedgeGains",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncash or Part Noncash Acquisition, Noncash Financial or Equity Instrument Consideration, Value Issued",
        "label": "Noncash or Part Noncash Acquisition, Noncash Financial or Equity Instrument Consideration, Value Issued",
        "terseLabel": "Value of shares issued in acquisition"
       }
      }
     },
     "localname": "NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling Interest, Increase Contribution From Noncontrolling Interest",
        "label": "Noncontrolling Interest, Increase Contribution From Noncontrolling Interest",
        "terseLabel": "Contribution from noncontrolling partner"
       }
      }
     },
     "localname": "NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_NoncontrollingInterestPercentOfOwnershipSold": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling Interest, Percent Of Ownership Sold",
        "label": "Noncontrolling Interest, Percent Of Ownership Sold",
        "terseLabel": "Noncontrolling interest, percent of ownership sold"
       }
      }
     },
     "localname": "NoncontrollingInterestPercentOfOwnershipSold",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "rdnt_NorthJerseyImagingCenterLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "North Jersey Imaging Center, LLC",
        "label": "North Jersey Imaging Center, LLC [Member]",
        "terseLabel": "North Jersey Imaging Center, LLC"
       }
      }
     },
     "localname": "NorthJerseyImagingCenterLLCMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsandLiabilitiesAssumed"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_NumberOfAssetsSold": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Assets Sold",
        "label": "Number Of Assets Sold",
        "terseLabel": "Number of assets sold"
       }
      }
     },
     "localname": "NumberOfAssetsSold",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "integerItemType"
    },
    "rdnt_NumberOfCenters": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Centers",
        "label": "Number Of Centers",
        "terseLabel": "Number of centers"
       }
      }
     },
     "localname": "NumberOfCenters",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative"
     ],
     "xbrltype": "integerItemType"
    },
    "rdnt_NumberOfCentersContributed": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Centers Contributed",
        "label": "Number Of Centers Contributed",
        "terseLabel": "Number of centers contributed"
       }
      }
     },
     "localname": "NumberOfCentersContributed",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative"
     ],
     "xbrltype": "integerItemType"
    },
    "rdnt_NumberOfLocationOfferingMultiModalityServices": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Location Offering Multi-Modality Services",
        "label": "Number Of Location Offering Multi-Modality Services",
        "terseLabel": "Number of location"
       }
      }
     },
     "localname": "NumberOfLocationOfferingMultiModalityServices",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative"
     ],
     "xbrltype": "integerItemType"
    },
    "rdnt_NumberOfLocations": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Locations",
        "label": "Number Of Locations",
        "terseLabel": "Number of locations"
       }
      }
     },
     "localname": "NumberOfLocations",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative"
     ],
     "xbrltype": "integerItemType"
    },
    "rdnt_NumberofUnconsolidatedJointVentures": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Unconsolidated Joint Ventures",
        "label": "Number of Unconsolidated Joint Ventures",
        "terseLabel": "Number of unconsolidated joint ventures"
       }
      }
     },
     "localname": "NumberofUnconsolidatedJointVentures",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "integerItemType"
    },
    "rdnt_October2020CapMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "October 2020 [Member]",
        "terseLabel": "October 2020"
       }
      }
     },
     "localname": "October2020CapMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_October2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "October 2023 [Member]",
        "label": "October 2023 [Member]",
        "terseLabel": "October 2023"
       }
      }
     },
     "localname": "October2023Member",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_October2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "October 2025 [Member]",
        "label": "October 2025 [Member]",
        "terseLabel": "October 2025"
       }
      }
     },
     "localname": "October2025Member",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_OperatingExpensesExcludingDepreciationAndAmortization": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Expenses, Excluding Depreciation And Amortization",
        "label": "Operating Expenses, Excluding Depreciation And Amortization",
        "terseLabel": "Cost of operations, excluding depreciation and amortization"
       }
      }
     },
     "localname": "OperatingExpensesExcludingDepreciationAndAmortization",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_OperatingIncomeLossExcludingReliefFunding": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Income (Loss) Excluding Relief Funding",
        "label": "Operating Income (Loss) Excluding Relief Funding",
        "terseLabel": "Income from Operations"
       }
      }
     },
     "localname": "OperatingIncomeLossExcludingReliefFunding",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/SEGMENTREPORTINGDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease Assets And Liabilities Lessee [Abstract]",
        "label": "Operating Lease Assets And Liabilities Lessee [Abstract]",
        "terseLabel": "Finance Leases"
       }
      }
     },
     "localname": "OperatingLeaseAssetsAndLiabilitiesLesseeAbstract",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "rdnt_OperatingLeaseLeaseAbandonmentCharge": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Lease Abandonment Charge",
        "label": "Operating Lease, Lease Abandonment Charge",
        "terseLabel": "Lease abandonment charges"
       }
      }
     },
     "localname": "OperatingLeaseLeaseAbandonmentCharge",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsLeaseCost",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_OperatingLeaseLiabilityDecreaseDueToAbandonment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Liability, Decrease Due To Abandonment",
        "label": "Operating Lease, Liability, Decrease Due To Abandonment",
        "terseLabel": "Lease liability, decrease due to abandonment"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityDecreaseDueToAbandonment",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsSupplementalCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_OperatingLeaseRightOfUseAssetDecreaseDueToAbandonment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Right-of-Use Asset, Decrease Due To Abandonment",
        "label": "Operating Lease, Right-of-Use Asset, Decrease Due To Abandonment",
        "terseLabel": "Operating lease asset decrease due to abandonment"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetDecreaseDueToAbandonment",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsSupplementalCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_OtherSellersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Sellers",
        "label": "Other Sellers [Member]",
        "terseLabel": "Other Sellers"
       }
      }
     },
     "localname": "OtherSellersMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_PatentAndTrademarksMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Patent and Trademarks",
        "label": "Patent and Trademarks [Member]",
        "terseLabel": "Patent and Trademarks"
       }
      }
     },
     "localname": "PatentAndTrademarksMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_PatientServicesNetMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Patient Services, Net [Member]",
        "label": "Patient Services, Net [Member]",
        "verboseLabel": "Net service fee revenue"
       }
      }
     },
     "localname": "PatientServicesNetMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_PaycheckProtectionProgramLoansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Paycheck Protection Program Loans",
        "label": "Paycheck Protection Program Loans [Member]",
        "terseLabel": "Paycheck Protection Program Loans"
       }
      }
     },
     "localname": "PaycheckProtectionProgramLoansMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstoPriorCreditFacilities",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_PerformanceBasedStockOptionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Performance Based Stock Options",
        "label": "Performance Based Stock Options [Member]",
        "terseLabel": "Performance Based Stock Options"
       }
      }
     },
     "localname": "PerformanceBasedStockOptionsMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUsandLTIPs"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_PerformanceBasedStockUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Performance Based Stock Units",
        "label": "Performance Based Stock Units [Member]",
        "terseLabel": "Performance Based Stock Units"
       }
      }
     },
     "localname": "PerformanceBasedStockUnitsMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUsandLTIPs"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_PersonalHealthImagingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Personal Health Imaging",
        "label": "Personal Health Imaging [Member]",
        "terseLabel": "Personal Health Imaging PLLC"
       }
      }
     },
     "localname": "PersonalHealthImagingMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsandLiabilitiesAssumed"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_PricingLevelIIIMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pricing Level III [Member]",
        "label": "Pricing Level III [Member]",
        "terseLabel": "Pricing Level III"
       }
      }
     },
     "localname": "PricingLevelIIIMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_PricingLevelIIMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pricing Level II [Member]",
        "label": "Pricing Level II [Member]",
        "terseLabel": "Pricing Level II"
       }
      }
     },
     "localname": "PricingLevelIIMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_PricingLevelIMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pricing Level I [Member]",
        "label": "Pricing Level I [Member]",
        "terseLabel": "Pricing Level I"
       }
      }
     },
     "localname": "PricingLevelIMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_PricingLevelIVMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pricing Level IV [Member]",
        "label": "Pricing Level IV [Member]",
        "terseLabel": "Pricing Level IV"
       }
      }
     },
     "localname": "PricingLevelIVMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_PricingLevelVMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pricing Level V [Member]",
        "label": "Pricing Level V [Member]",
        "terseLabel": "Pricing Level V"
       }
      }
     },
     "localname": "PricingLevelVMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ProceedsFromGovernmentAssistance": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds From Government Assistance",
        "label": "Proceeds From Government Assistance",
        "terseLabel": "Proceeds from paycheck protection program loans"
       }
      }
     },
     "localname": "ProceedsFromGovernmentAssistance",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_ProceedsFromProviderReliefFunding": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds From Provider Relief Funding",
        "label": "Proceeds From Provider Relief Funding",
        "terseLabel": "Proceeds from provider relief funding"
       }
      }
     },
     "localname": "ProceedsFromProviderReliefFunding",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/SEGMENTREPORTINGDetails",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_ProceedsFromSaleOfInterestInMinorityShareholders": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds From Sale Of Interest In Minority Shareholders",
        "label": "Proceeds From Sale Of Interest In Minority Shareholders",
        "terseLabel": "Proceeds from sale of interest in minority shareholders"
       }
      }
     },
     "localname": "ProceedsFromSaleOfInterestInMinorityShareholders",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_PropertyPlantAndEquipmentNetIncludingRightOfUseAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Property Plant and Equipment Net Including Right of Use Assets",
        "label": "Property Plant and Equipment Net Including Right of Use Assets",
        "totalLabel": "Total property, equipment and right-of-use-assets"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNetIncludingRightOfUseAssets",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_ProperyAndEquipmentNetMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Propery and Equipment, Net [Member]",
        "terseLabel": "Propery and equipment, net"
       }
      }
     },
     "localname": "ProperyAndEquipmentNetMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_QuantibMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quantib",
        "label": "Quantib [Member]",
        "terseLabel": "Quantib",
        "verboseLabel": "Quantib B.V."
       }
      }
     },
     "localname": "QuantibMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsContingentConsideration",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_RavenHoldingsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Raven Holdings [Member]",
        "label": "Raven Holdings [Member]",
        "terseLabel": "Raven Holdings"
       }
      }
     },
     "localname": "RavenHoldingsMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_RepaymentOfAdvanceMedicarePayments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Repayment Of Advance Medicare Payments",
        "label": "Repayment Of Advance Medicare Payments",
        "terseLabel": "Repayment of advance medicare payments"
       }
      }
     },
     "localname": "RepaymentOfAdvanceMedicarePayments",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_RestatedAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restated Agreement [Member]",
        "label": "Restated Agreement [Member]",
        "terseLabel": "Restated Agreement"
       }
      }
     },
     "localname": "RestatedAgreementMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_RestatedPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restated Plan [Member]",
        "terseLabel": "Restated Plan"
       }
      }
     },
     "localname": "RestatedPlanMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right Of Use Asset Obtained In Exchange For Lease Liability [Abstract]",
        "label": "Right Of Use Asset Obtained In Exchange For Lease Liability [Abstract]",
        "terseLabel": "Right-of-use &amp; Equipment assets obtained in exchange for lease obligations:"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsSupplementalCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "rdnt_SLZMRealtyLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "SLZM Realty LLC",
        "label": "SLZM Realty LLC [Member]",
        "terseLabel": "SLZM Realty LLC"
       }
      }
     },
     "localname": "SLZMRealtyLLCMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsandLiabilitiesAssumed"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ScheduleOfForeignCurrencyTranslationAmountsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Foreign Currency Translation Amounts",
        "label": "Schedule Of Foreign Currency Translation Amounts [Table Text Block]",
        "terseLabel": "Schedule Of Foreign Currency Translation Amounts"
       }
      }
     },
     "localname": "ScheduleOfForeignCurrencyTranslationAmountsTableTextBlock",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "rdnt_ScheduleOfLeverageRatioTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Leverage Ratio [Table Text Block]",
        "label": "Schedule Of Leverage Ratio [Table Text Block]",
        "terseLabel": "Schedule of Leverage Ratio"
       }
      }
     },
     "localname": "ScheduleOfLeverageRatioTableTextBlock",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "rdnt_ScriptSenderLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Script Sender LLC [Member]",
        "terseLabel": "ScriptSender LLC"
       }
      }
     },
     "localname": "ScriptSenderLLCMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_September2020CapMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "September 2020 [Member]",
        "terseLabel": "September 2020"
       }
      }
     },
     "localname": "September2020CapMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Based Compensation Arrangement By Share Based Payment Award, Equity Instruments Other Than Options, Forfeited Or Cancelled In Period",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award, Equity Instruments Other Than Options, Forfeited Or Cancelled In Period",
        "negatedTerseLabel": "Share Based Compensation Arrangement By Share Based Payment Award, Equity Instruments Other Than Options, Forfeited Or Cancelled In Period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledInPeriod",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUsandLTIPs"
     ],
     "xbrltype": "sharesItemType"
    },
    "rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Based Compensation Arrangement By Share Based Payment Award, Equity Instruments Other Than Options, Forfeited Or Cancelled Weighted Average Grant Date Fair Value",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award, Equity Instruments Other Than Options, Forfeited Or Cancelled Weighted Average Grant Date Fair Value",
        "terseLabel": "Share Based Compensation Arrangement By Share Based Payment Award, Equity Instruments Other Than Options, Forfeited Or Cancelled Weighted Average Grant Date Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedOrCancelledWeightedAverageGrantDateFairValue",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUsandLTIPs"
     ],
     "xbrltype": "perShareItemType"
    },
    "rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Plans",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Plans",
        "terseLabel": "Number of plans"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "integerItemType"
    },
    "rdnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number Of Vesting Tranches",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number Of Vesting Tranches",
        "terseLabel": "Number of vesting traches"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUsandLTIPs"
     ],
     "xbrltype": "integerItemType"
    },
    "rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-based Payment Award, Options, Grants In Period, Gross, Value",
        "label": "Share-Based Compensation Arrangement By Share-based Payment Award, Options, Grants In Period, Gross, Value",
        "terseLabel": "Issuance of stock upon exercise of options"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_SharesIssuedSharesSettlementOfContingentConsideration": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares Issued, Shares, Settlement Of Contingent Consideration",
        "label": "Shares Issued, Shares, Settlement Of Contingent Consideration",
        "terseLabel": "Issuance of common stock to settle DeepHealth contingent consideration (in shares)"
       }
      }
     },
     "localname": "SharesIssuedSharesSettlementOfContingentConsideration",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "rdnt_SimiAdventistMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Simi Adventist",
        "label": "Simi Adventist [Member]",
        "terseLabel": "Simi Adventist"
       }
      }
     },
     "localname": "SimiAdventistMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_SimiValleyImagingGroupLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Simi Valley Imaging Group, LLC",
        "label": "Simi Valley Imaging Group, LLC [Member]",
        "terseLabel": "Simi Valley Imaging Group, LLC"
       }
      }
     },
     "localname": "SimiValleyImagingGroupLLCMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_SocialSecurityTaxEmployerDeferralCARESAct": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Social Security Tax, Employer, Deferral, CARES Act",
        "label": "Social Security Tax, Employer, Deferral, CARES Act",
        "terseLabel": "Deferred social security taxes"
       }
      }
     },
     "localname": "SocialSecurityTaxEmployerDeferralCARESAct",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_SoftwareAndTeleradiologyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Imaging On Call [Member]",
        "label": "Software and Teleradiology [Member]",
        "verboseLabel": "Software and teleradiology"
       }
      }
     },
     "localname": "SoftwareAndTeleradiologyMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofNetRevenue"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_SunTrustMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "SunTrust [Member]",
        "label": "SunTrust [Member]",
        "terseLabel": "SunTrust"
       }
      }
     },
     "localname": "SunTrustMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAdditionalInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_TangentAssociatesLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangent Associates LLC",
        "label": "Tangent Associates LLC [Member]",
        "terseLabel": "Tangent Associates LLC"
       }
      }
     },
     "localname": "TangentAssociatesLLCMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsandLiabilitiesAssumed",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_TarzanaMedicalCenterLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tarzana Medical Center, LLC",
        "label": "Tarzana Medical Center, LLC [Member]",
        "terseLabel": "Tarzana Medical Center, LLC"
       }
      }
     },
     "localname": "TarzanaMedicalCenterLLCMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_TermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Term Loan [Member]",
        "terseLabel": "Term Loan"
       }
      }
     },
     "localname": "TermLoanMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_TruistMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Truist",
        "label": "Truist [Member]",
        "terseLabel": "Truist"
       }
      }
     },
     "localname": "TruistMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstoPriorCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSecondAmendedandRestatedFirstLienCreditandGuarantyAgreement",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_TurnerImagingSystemsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Turner Imaging Systems [Member]",
        "label": "Turner Imaging Systems [Member]",
        "terseLabel": "Turner Imaging Systems"
       }
      }
     },
     "localname": "TurnerImagingSystemsMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_UninsuredRisksPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Uninsured Risks [Policy Text Block]",
        "label": "Uninsured Risks [Policy Text Block]",
        "terseLabel": "UNINSURED RISKS"
       }
      }
     },
     "localname": "UninsuredRisksPolicyTextBlock",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued During Period",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued During Period",
        "terseLabel": "Unrecognized tax benefits, income tax penalties and interest accrued during period"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unrecognized Tax Benefits, Increase (Decrease) Change in Enacted Tax Rate",
        "label": "Unrecognized Tax Benefits, Increase (Decrease) Change in Enacted Tax Rate",
        "terseLabel": "Increase (decrease) related to change in rate"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsUnrecognizedTaxBenefit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unrecognized Tax Benefits, Tax Impact If Recognized",
        "label": "Unrecognized Tax Benefits, Tax Impact If Recognized",
        "terseLabel": "Unrecognized tax benefits, tax impact if recognized"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsTaxImpactIfRecognized",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_WeightedAverageRemainingContractualLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted Average Remaining Contractual Life abstract",
        "label": "Weighted Average Remaining Contractual Life",
        "terseLabel": "Weighted Average Remaining Contractual Life(in years)"
       }
      }
     },
     "localname": "WeightedAverageRemainingContractualLife",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "stringItemType"
    },
    "rdnt_WeightedAverageRemainingLeaseTermAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted Average Remaining Lease Term [Abstract]",
        "label": "Weighted Average Remaining Lease Term [Abstract]",
        "terseLabel": "Weighted Average Remaining Lease Term"
       }
      }
     },
     "localname": "WeightedAverageRemainingLeaseTermAbstract",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "rdnt_WestValleyImagingGroupLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "West Valley Imaging Group, LLC [Member]",
        "label": "West Valley Imaging Group, LLC [Member]",
        "terseLabel": "West Valley Imaging Group, LLC"
       }
      }
     },
     "localname": "WestValleyImagingGroupLLCMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_WhiteRabbitaiIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "WhiteRabbit.ai Inc. [Member]",
        "label": "White Rabbit.ai Inc. [Member]",
        "terseLabel": "WhiteRabbit.ai Inc."
       }
      }
     },
     "localname": "WhiteRabbitaiIncMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_WilliamMKellyMDIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "William M. Kelly MD, Inc",
        "label": "William M. Kelly MD, Inc [Member]",
        "terseLabel": "William M. Kelly MD, Inc."
       }
      }
     },
     "localname": "WilliamMKellyMDIncMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsandLiabilitiesAssumed"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_WorkersCompensationPersonalInjury1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Workers' Compensation/Personal Injury1 [Member]",
        "label": "Workers' Compensation/Personal Injury1 [Member]",
        "terseLabel": "Workers' compensation/personal injury"
       }
      }
     },
     "localname": "WorkersCompensationPersonalInjury1Member",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofNetRevenue"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ZP907NorthernLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ZP 907 Northern LLC",
        "label": "ZP 907 Northern LLC [Member]",
        "terseLabel": "ZP 907 Northern LLC"
       }
      }
     },
     "localname": "ZP907NorthernLLCMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsandLiabilitiesAssumed"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ZPBaysideLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ZP Bayside LLC",
        "label": "ZP Bayside LLC [Member]",
        "terseLabel": "ZP Bayside LLC"
       }
      }
     },
     "localname": "ZPBaysideLLCMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsandLiabilitiesAssumed"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ZPEasternLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ZP Eastern LLC",
        "label": "ZP Eastern LLC [Member]",
        "terseLabel": "ZP Eastern LLC"
       }
      }
     },
     "localname": "ZPEasternLLCMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsandLiabilitiesAssumed"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ZPElmontLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ZP Elmont LLC",
        "label": "ZP Elmont LLC [Member]",
        "terseLabel": "ZP Elmont LLC"
       }
      }
     },
     "localname": "ZPElmontLLCMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsandLiabilitiesAssumed"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ZPFreeportLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ZP Freeport LLC",
        "label": "ZP Freeport LLC [Member]",
        "terseLabel": "ZP Freeport LLC"
       }
      }
     },
     "localname": "ZPFreeportLLCMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsandLiabilitiesAssumed"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ZPLaureltonLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ZP Laurelton LLC",
        "label": "ZP Laurelton LLC [Member]",
        "terseLabel": "ZP Laurelton LLC"
       }
      }
     },
     "localname": "ZPLaureltonLLCMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsandLiabilitiesAssumed"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ZPParkchesterLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ZP Parkchester LLC",
        "label": "ZP Parkchester LLC [Member]",
        "terseLabel": "ZP Parkchester LLC"
       }
      }
     },
     "localname": "ZPParkchesterLLCMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsandLiabilitiesAssumed"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ZPSmithLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ZP Smith LLC",
        "label": "ZP Smith LLC [Member]",
        "terseLabel": "ZP Smith LLC"
       }
      }
     },
     "localname": "ZPSmithLLCMember",
     "nsuri": "http://www.radnet.com/20221231",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsandLiabilitiesAssumed"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidatedEntitiesAxis": {
     "auth_ref": [
      "r309",
      "r574",
      "r575",
      "r579",
      "r580",
      "r635",
      "r688",
      "r783",
      "r786",
      "r787"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Axis]",
        "terseLabel": "Consolidated Entities [Axis]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidatedEntitiesDomain": {
     "auth_ref": [
      "r309",
      "r574",
      "r575",
      "r579",
      "r580",
      "r635",
      "r688",
      "r783",
      "r786",
      "r787"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Domain]",
        "terseLabel": "Consolidated Entities [Domain]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r306",
      "r307",
      "r438",
      "r466",
      "r693",
      "r695"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Domain]",
        "terseLabel": "Investment, Name [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvesteeNameDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r420",
      "r421",
      "r422",
      "r423",
      "r495",
      "r643",
      "r675",
      "r689",
      "r690",
      "r710",
      "r717",
      "r728",
      "r788",
      "r854",
      "r855",
      "r856",
      "r857",
      "r858",
      "r859"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/LEASESDetailsAdditionalInformation",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUsandLTIPs",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r420",
      "r421",
      "r422",
      "r423",
      "r495",
      "r643",
      "r675",
      "r689",
      "r690",
      "r710",
      "r717",
      "r728",
      "r788",
      "r854",
      "r855",
      "r856",
      "r857",
      "r858",
      "r859"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/LEASESDetailsAdditionalInformation",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUsandLTIPs",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OwnershipAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Axis]",
        "terseLabel": "Ownership [Axis]"
       }
      }
     },
     "localname": "OwnershipAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_OwnershipDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Domain]",
        "terseLabel": "Ownership [Domain]"
       }
      }
     },
     "localname": "OwnershipDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r381",
      "r644",
      "r711",
      "r727",
      "r781",
      "r782",
      "r791",
      "r862"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofNetRevenue"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r381",
      "r644",
      "r711",
      "r727",
      "r781",
      "r782",
      "r791",
      "r862"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofNetRevenue"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r420",
      "r421",
      "r422",
      "r423",
      "r486",
      "r495",
      "r523",
      "r524",
      "r525",
      "r642",
      "r643",
      "r675",
      "r689",
      "r690",
      "r710",
      "r717",
      "r728",
      "r780",
      "r788",
      "r855",
      "r856",
      "r857",
      "r858",
      "r859"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/LEASESDetailsAdditionalInformation",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUsandLTIPs",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r420",
      "r421",
      "r422",
      "r423",
      "r486",
      "r495",
      "r523",
      "r524",
      "r525",
      "r642",
      "r643",
      "r675",
      "r689",
      "r690",
      "r710",
      "r717",
      "r728",
      "r780",
      "r788",
      "r855",
      "r856",
      "r857",
      "r858",
      "r859"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/LEASESDetailsAdditionalInformation",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUsandLTIPs",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r306",
      "r307",
      "r438",
      "r466",
      "r694",
      "r695"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioForecastMember": {
     "auth_ref": [
      "r496",
      "r764"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forecast [Member]",
        "terseLabel": "Forecast"
       }
      }
     },
     "localname": "ScenarioForecastMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r327",
      "r496",
      "r739",
      "r764"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "auth_ref": [
      "r390"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Axis]",
        "terseLabel": "Investment, Name [Axis]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r327",
      "r496",
      "r739",
      "r740",
      "r764"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]",
        "terseLabel": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_SubsidiariesMember": {
     "auth_ref": [
      "r793",
      "r849",
      "r850",
      "r851"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsidiaries [Member]",
        "terseLabel": "Subsidiaries"
       }
      }
     },
     "localname": "SubsidiariesMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r25"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Accounts Payable and Accrued Liabilities, Current",
        "terseLabel": "Accounts payable, accrued expenses and other",
        "verboseLabel": "Total"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsAccountsPayableandAccruedExpenses"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r22",
      "r726"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsAccountsPayableandAccruedExpenses"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r386",
      "r387"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r27"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsAccountsPayableandAccruedExpenses"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "auth_ref": [
      "r27"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Professional Fees, Current",
        "terseLabel": "Accrued professional fees"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsAccountsPayableandAccruedExpenses"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": {
     "auth_ref": [
      "r280",
      "r288",
      "r289",
      "r578",
      "r696",
      "r746"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.",
        "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]",
        "terseLabel": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent"
       }
      }
     },
     "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r276",
      "r278",
      "r279",
      "r280",
      "r592"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.",
        "label": "Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsReconciliationofForeignCurrencyTranslation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r39",
      "r40",
      "r41",
      "r272",
      "r669",
      "r680",
      "r683"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r38",
      "r41",
      "r191",
      "r631",
      "r676",
      "r677",
      "r746",
      "r747",
      "r748",
      "r761",
      "r762",
      "r763"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive (Loss) Income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r99"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Amortization period"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r16",
      "r726"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in-capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r531",
      "r532",
      "r533",
      "r761",
      "r762",
      "r763",
      "r837"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentForAmortization": {
     "auth_ref": [
      "r66",
      "r104"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.",
        "label": "Amortization",
        "terseLabel": "Amortization expense"
       }
      }
     },
     "localname": "AdjustmentForAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r146",
      "r147",
      "r498"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income (loss)\u00a0to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AmortizationOfDeferredCharges": {
     "auth_ref": [
      "r47"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of amortization of deferred charges applied against earnings during the period.",
        "label": "Amortization of Deferred Charges",
        "terseLabel": "Amortization of deferred charges"
       }
      }
     },
     "localname": "AmortizationOfDeferredCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSecondAmendedandRestatedFirstLienCreditandGuarantyAgreement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfDeferredHedgeGains": {
     "auth_ref": [
      "r756"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense charged against earnings by an Entity to record deferred gains and losses on hedge instruments. Examples include gain on economic hedges, amortization of gain on designated fair value hedge and so forth.",
        "label": "Amortization of Deferred Hedge Gains",
        "terseLabel": "Amortization of cash flow hedge"
       }
      }
     },
     "localname": "AmortizationOfDeferredHedgeGains",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "auth_ref": [
      "r46",
      "r457",
      "r608",
      "r756"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs",
        "terseLabel": "Amortization and write off of deferred financing costs and loan discount"
       }
      }
     },
     "localname": "AmortizationOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Weighted average shares for which the exercise price exceeds average market price of common stock (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r77"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r77"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetAcquisitionAxis": {
     "auth_ref": [
      "r831"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by asset acquisition.",
        "label": "Asset Acquisition [Axis]",
        "terseLabel": "Asset Acquisition [Axis]"
       }
      }
     },
     "localname": "AssetAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetAcquisitionDomain": {
     "auth_ref": [
      "r831"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset acquisition.",
        "label": "Asset Acquisition [Domain]",
        "terseLabel": "Asset Acquisition [Domain]"
       }
      }
     },
     "localname": "AssetAcquisitionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r231",
      "r245",
      "r269",
      "r302",
      "r365",
      "r371",
      "r377",
      "r392",
      "r424",
      "r425",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r433",
      "r434",
      "r574",
      "r579",
      "r594",
      "r726",
      "r784",
      "r785",
      "r852"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "terseLabel": "BRMG and NY Groups accounts receivable",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r263",
      "r273",
      "r302",
      "r392",
      "r424",
      "r425",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r433",
      "r434",
      "r574",
      "r579",
      "r594",
      "r726",
      "r784",
      "r785",
      "r852"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures": {
       "order": 1.0,
       "parentTag": "us-gaap_EquityMethodInvestmentAggregateCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "terseLabel": "Current assets",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "CURRENT ASSETS"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsNoncurrent": {
     "auth_ref": [
      "r302",
      "r392",
      "r424",
      "r425",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r433",
      "r434",
      "r574",
      "r579",
      "r594",
      "r784",
      "r785",
      "r852"
     ],
     "calculation": {
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures": {
       "order": 2.0,
       "parentTag": "us-gaap_EquityMethodInvestmentAggregateCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.",
        "label": "Assets, Noncurrent",
        "terseLabel": "Noncurrent assets"
       }
      }
     },
     "localname": "AssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUsandLTIPs"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BaseRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum rate investor will accept.",
        "label": "Base Rate [Member]",
        "terseLabel": "Base Rate Spread"
       }
      }
     },
     "localname": "BaseRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r569",
      "r715",
      "r716"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsandLiabilitiesAssumed",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
      "http://www.radnet.com/role/INCOMETAXESDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsContingentConsideration",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r161",
      "r162",
      "r569",
      "r715",
      "r716"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsandLiabilitiesAssumed",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
      "http://www.radnet.com/role/INCOMETAXESDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsContingentConsideration",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionContingentConsiderationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition, Contingent Consideration [Line Items]",
        "terseLabel": "Business Acquisition, Contingent Consideration [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionContingentConsiderationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsContingentConsideration"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned": {
     "auth_ref": [
      "r175"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity.",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Value Assigned",
        "terseLabel": "Value of RadNet stock issued in acquisition"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": {
     "auth_ref": [
      "r175"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of equity interests issued or issuable to acquire entity.",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares",
        "terseLabel": "Shares issued (in shares)"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsandLiabilitiesAssumed",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsandLiabilitiesAssumed",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "auth_ref": [
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.",
        "label": "Business Acquisition, Percentage of Voting Interests Acquired",
        "terseLabel": "Business acquisition, percentage of voting interests acquired"
       }
      }
     },
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount": {
     "auth_ref": [
      "r177"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.",
        "label": "Business Acquisition, Goodwill, Expected Tax Deductible Amount",
        "terseLabel": "Goodwill deductible for tax purpose"
       }
      }
     },
     "localname": "BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionSharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.",
        "label": "Business Acquisition, Share Price",
        "terseLabel": "Price per share (dollars per share)"
       }
      }
     },
     "localname": "BusinessAcquisitionSharePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue": {
     "auth_ref": [
      "r165"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the fair value of the noncontrolling interest in the acquiree at the acquisition date.",
        "label": "Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value",
        "terseLabel": "Business combination, noncontrolling interest"
       }
      }
     },
     "localname": "BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r170",
      "r171",
      "r174"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "verboseLabel": "Consideration transferred"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable": {
     "auth_ref": [
      "r170",
      "r171"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.",
        "label": "Business Combination, Consideration Transferred, Equity Interests Issued and Issuable",
        "terseLabel": "Common stock issued as consideration"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "auth_ref": [
      "r572",
      "r755"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "terseLabel": "Change in value of contingent consideration",
        "verboseLabel": "Amount of income (loss) recognized on contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsContingentConsideration"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh": {
     "auth_ref": [
      "r176"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.",
        "label": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High",
        "terseLabel": "Purchase agreements"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r169",
      "r172",
      "r571"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beggining balance",
        "terseLabel": "Contingent consideration to guarantee share value issued"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsandLiabilitiesAssumed",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsContingentConsideration",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Contingent Consideration, Liability [Abstract]",
        "terseLabel": "Accrued expenses and other non-current liabilities"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput": {
     "auth_ref": [
      "r590"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of input used to measure contingent consideration liability from business combination.",
        "label": "Business Combination, Contingent Consideration, Liability, Measurement Input",
        "terseLabel": "Contingent consideration liability, measurement input"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityMeasurementInput",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative"
     ],
     "xbrltype": "decimalItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent": {
     "auth_ref": [
      "r169",
      "r173"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.",
        "label": "Business Combination, Contingent Consideration, Liability, Noncurrent",
        "terseLabel": "Business combination, contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets": {
     "auth_ref": [
      "r164"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets",
        "terseLabel": "Current assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities": {
     "auth_ref": [
      "r164"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities",
        "terseLabel": "Liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": {
     "auth_ref": [
      "r164"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities",
        "terseLabel": "Deferred tax liabilities acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities": {
     "auth_ref": [
      "r163",
      "r164"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of financial liabilities assumed (as defined) which have been recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Financial Liabilities",
        "terseLabel": "Settlement of loan"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r164"
     ],
     "calculation": {
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsandLiabilitiesAssumed": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill",
        "terseLabel": "Intangible assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsandLiabilitiesAssumed",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "auth_ref": [
      "r163",
      "r164"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "terseLabel": "Intangible assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities": {
     "auth_ref": [
      "r164"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities",
        "terseLabel": "Long-term liabilities assumed"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r163",
      "r164"
     ],
     "calculation": {
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsandLiabilitiesAssumed": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "netLabel": "Property and equipment",
        "verboseLabel": "Property &amp; Equipment"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsandLiabilitiesAssumed",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r164"
     ],
     "calculation": {
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsandLiabilitiesAssumed": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
        "totalLabel": "Total Purchase Consideration"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsandLiabilitiesAssumed"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis": {
     "auth_ref": [
      "r160"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures related to transactions that are recognized separately from the acquisition of assets and assumptions of liabilities in the business combination by type of transaction.",
        "label": "Business Combination, Separately Recognized Transactions [Axis]",
        "terseLabel": "Business Combination, Separately Recognized Transactions [Axis]"
       }
      }
     },
     "localname": "BusinessCombinationSeparatelyRecognizedTransactionsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain": {
     "auth_ref": [
      "r160"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of transaction that is recognized separately from the acquisition of assets and assumptions of liabilities in a business combination by transaction.",
        "label": "Business Combination, Separately Recognized Transactions [Domain]",
        "terseLabel": "Business Combination, Separately Recognized Transactions [Domain]"
       }
      }
     },
     "localname": "BusinessCombinationSeparatelyRecognizedTransactionsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessCombinationsPolicy": {
     "auth_ref": [
      "r157"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.",
        "label": "Business Combinations Policy [Policy Text Block]",
        "terseLabel": "BUSINESS COMBINATION"
       }
      }
     },
     "localname": "BusinessCombinationsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": {
     "auth_ref": [
      "r1",
      "r75",
      "r83"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Business Description and Basis of Presentation [Text Block]",
        "terseLabel": "NATURE OF BUSINESS"
       }
      }
     },
     "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r68",
      "r265",
      "r691"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r69"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "CASH AND CASH EQUIVALENTS"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r62",
      "r68",
      "r74"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "CASH AND CASH EQUIVALENTS, end of period",
        "periodStartLabel": "CASH AND CASH EQUIVALENTS, beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r62",
      "r221"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r120"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Promissory note"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": {
     "auth_ref": [
      "r119",
      "r684"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.",
        "label": "Commitments and Contingencies, Policy [Policy Text Block]",
        "terseLabel": "COMMITMENTS AND CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r761",
      "r762",
      "r837"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock - par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock - authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock - issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r15",
      "r126"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)",
        "terseLabel": "Common stock - outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r15",
      "r726"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock - $.0001 par value, 200,000,000 shares authorized; 57,723,125 and 53,548,227 shares issued and outstanding at December 31, 2022 and 2021 respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationRelatedCostsPolicyTextBlock": {
     "auth_ref": [
      "r134"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.",
        "label": "Compensation Related Costs, Policy [Policy Text Block]",
        "terseLabel": "EQUITY BASED COMPENSATION"
       }
      }
     },
     "localname": "CompensationRelatedCostsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ComponentsOfDeferredTaxAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of Deferred Tax Assets [Abstract]",
        "terseLabel": "Deferred tax assets:"
       }
      }
     },
     "localname": "ComponentsOfDeferredTaxAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsDeferredTaxAssetsandLiabilities"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r42",
      "r283",
      "r285",
      "r293",
      "r665",
      "r672"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "COMPREHENSIVE INCOME (LOSS) ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r185",
      "r186",
      "r198",
      "r283",
      "r285",
      "r292",
      "r664",
      "r671"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "terseLabel": "Less comprehensive income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r184",
      "r198",
      "r283",
      "r285",
      "r291",
      "r663",
      "r670"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "COMPREHENSIVE INCOME (LOSS)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for comprehensive income.",
        "label": "Comprehensive Income, Policy [Policy Text Block]",
        "terseLabel": "COMPREHENSIVE INCOME (LOSS)"
       }
      }
     },
     "localname": "ComprehensiveIncomePolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r242",
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "CONCENTRATION OF CREDIT RISKS"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]",
        "terseLabel": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]"
       }
      }
     },
     "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable": {
     "auth_ref": [
      "r192",
      "r199"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of information required and determined to be disclosed concerning the effects of any changes in a parent's ownership interest in a subsidiary on the equity attributable to the parent which may have occurred during the period. The changes represented by this element did not result in the deconsolidation of the subsidiary.",
        "label": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table]",
        "terseLabel": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table]"
       }
      }
     },
     "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r188",
      "r698"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "PRINCIPLES OF CONSOLIDATION"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConstructionInProgressGross": {
     "auth_ref": [
      "r114"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress, Gross",
        "terseLabel": "Construction in progress, gross"
       }
      }
     },
     "localname": "ConstructionInProgressGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConstructionInProgressMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress [Member]",
        "terseLabel": "Construction in Progress"
       }
      }
     },
     "localname": "ConstructionInProgressMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContingentConsiderationByTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of contingent consideration.",
        "label": "Contingent Consideration by Type [Axis]",
        "terseLabel": "Contingent Consideration by Type [Axis]"
       }
      }
     },
     "localname": "ContingentConsiderationByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContingentConsiderationTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of contingent payment arrangement.",
        "label": "Contingent Consideration Type [Domain]",
        "terseLabel": "Contingent Consideration Type [Domain]"
       }
      }
     },
     "localname": "ContingentConsiderationTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r469",
      "r470",
      "r483"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion": {
     "auth_ref": [
      "r13",
      "r14",
      "r127",
      "r128",
      "r467"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued for each share of convertible preferred stock that is converted.",
        "label": "Convertible Preferred Stock, Shares Issued upon Conversion",
        "terseLabel": "Preferred stock issued upon conversion (in shares)"
       }
      }
     },
     "localname": "ConvertiblePreferredStockSharesIssuedUponConversion",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CreditDerivativesByContractTypeAxis": {
     "auth_ref": [
      "r213"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type of contract of credit derivatives.",
        "label": "Credit Derivatives Contract Type [Axis]",
        "terseLabel": "Credit Derivatives Contract Type [Axis]"
       }
      }
     },
     "localname": "CreditDerivativesByContractTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditDerivativesContractTypeDomain": {
     "auth_ref": [
      "r213"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents major types of credit derivative contracts.",
        "label": "Credit Derivatives Contract Type [Domain]",
        "terseLabel": "Credit Derivatives Contract Type [Domain]"
       }
      }
     },
     "localname": "CreditDerivativesContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAdditionalInformation",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstoPriorCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSecondAmendedandRestatedFirstLienCreditandGuarantyAgreement",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAdditionalInformation",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstoPriorCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSecondAmendedandRestatedFirstLienCreditandGuarantyAgreement",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease": {
     "auth_ref": [
      "r840"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) in cumulative translation adjustment before transfers included in determining net income.",
        "label": "Cumulative Translation Adjustment, Net of Tax, Period Increase (Decrease)",
        "terseLabel": "Currency Translation Adjustments"
       }
      }
     },
     "localname": "CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsReconciliationofForeignCurrencyTranslation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CumulativeTranslationAdjustmentSummaryRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Cumulative Translation Adjustment Summary [Roll Forward]",
        "terseLabel": "Currency Translation"
       }
      }
     },
     "localname": "CumulativeTranslationAdjustmentSummaryRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsReconciliationofForeignCurrencyTranslation"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r759",
      "r827",
      "r830"
     ],
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDetailsIncomeTaxExpense": {
       "order": 6.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "Federal current tax"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsIncomeTaxExpense"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "auth_ref": [
      "r759",
      "r827"
     ],
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDetailsIncomeTaxExpense": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Foreign Tax Expense (Benefit)",
        "terseLabel": "Foreign current tax"
       }
      }
     },
     "localname": "CurrentForeignTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsIncomeTaxExpense"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r167"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer Relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r125",
      "r301",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r451",
      "r458",
      "r459",
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "CREDIT FACILITIES AND NOTES PAYABLE"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r7",
      "r8",
      "r9",
      "r232",
      "r234",
      "r244",
      "r309",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r441",
      "r447",
      "r448",
      "r449",
      "r450",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r609",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r757"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAdditionalInformation",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstoPriorCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSecondAmendedandRestatedFirstLienCreditandGuarantyAgreement",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Basis spread on variable rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r9",
      "r234",
      "r244",
      "r462"
     ],
     "calculation": {
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAnnualNotePayableMaturities": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-Term Debt, Gross",
        "totalLabel": "Total notes payable obligations"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAnnualNotePayableMaturities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r223",
      "r225",
      "r435",
      "r609",
      "r706",
      "r707"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Debt instrument, face amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstoPriorCreditFacilities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r449",
      "r593",
      "r706",
      "r707"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Term Loan Agreement and First Lien Term Loans"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "auth_ref": [
      "r29",
      "r223",
      "r464",
      "r609"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.",
        "label": "Debt Instrument, Interest Rate, Effective Percentage",
        "terseLabel": "Effective interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r29",
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Debt instrument, interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstoPriorCreditFacilities"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSecondAmendedandRestatedFirstLienCreditandGuarantyAgreement",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r30",
      "r309",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r441",
      "r447",
      "r448",
      "r449",
      "r450",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r609",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r757"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAdditionalInformation",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstoPriorCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSecondAmendedandRestatedFirstLienCreditandGuarantyAgreement",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentPeriodicPayment": {
     "auth_ref": [
      "r30",
      "r240"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the required periodic payments including both interest and principal payments.",
        "label": "Debt Instrument, Periodic Payment",
        "terseLabel": "Debt periodic payment"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPayment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentPeriodicPaymentPrincipal": {
     "auth_ref": [
      "r30"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the required periodic payments applied to principal.",
        "label": "Debt Instrument, Periodic Payment, Principal",
        "terseLabel": "Periodic payment, principal"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPaymentPrincipal",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r30",
      "r127",
      "r129",
      "r130",
      "r131",
      "r222",
      "r223",
      "r225",
      "r241",
      "r309",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r441",
      "r447",
      "r448",
      "r449",
      "r450",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r460",
      "r609",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r757"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSecondAmendedandRestatedFirstLienCreditandGuarantyAgreement",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Term",
        "terseLabel": "PPP loans, maturity term"
       }
      }
     },
     "localname": "DebtInstrumentTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstoPriorCreditFacilities"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "auth_ref": [
      "r222",
      "r225",
      "r789"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount.",
        "label": "Debt Instrument, Unamortized Discount",
        "negatedLabel": "Discount on debt"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountCurrent": {
     "auth_ref": [
      "r222",
      "r225"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of debt discount to be amortized within one year or within the normal operating cycle, if longer.",
        "label": "Debt Instrument, Unamortized Discount, Current",
        "terseLabel": "Debt instrument, unamortized discount, current"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSecondAmendedandRestatedFirstLienCreditandGuarantyAgreement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredChargesPolicyTextBlock": {
     "auth_ref": [
      "r268"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for deferral and amortization of significant deferred charges.",
        "label": "Deferred Charges, Policy [Policy Text Block]",
        "terseLabel": "DEFERRED FINANCING COSTS"
       }
      }
     },
     "localname": "DeferredChargesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common shares reserved for future issuance related to deferred compensation arrangements with individuals.",
        "label": "Deferred Compensation Arrangement with Individual, Common Stock Reserved for Future Issuance",
        "terseLabel": "Shares available for future issuance, options, warrants, shares of restricted stock and other bonus awards (in shares)"
       }
      }
     },
     "localname": "DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r759",
      "r828",
      "r830"
     ],
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDetailsIncomeTaxExpense": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "terseLabel": "Federal deferred tax"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsIncomeTaxExpense"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsGross": {
     "auth_ref": [
      "r224"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Gross",
        "terseLabel": "Issuance costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSecondAmendedandRestatedFirstLienCreditandGuarantyAgreement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsNet": {
     "auth_ref": [
      "r224",
      "r789"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Net",
        "terseLabel": "Deferred financing costs, net of accumulated amortization"
       }
      }
     },
     "localname": "DeferredFinanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSecondAmendedandRestatedFirstLienCreditandGuarantyAgreement",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsNoncurrentNet": {
     "auth_ref": [
      "r224"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs classified as noncurrent. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Noncurrent, Net",
        "terseLabel": "Deferred financing costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsNoncurrentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r156",
      "r759",
      "r828"
     ],
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDetailsIncomeTaxExpense": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Foreign Income Tax Expense (Benefit)",
        "terseLabel": "Foreign deferred tax"
       }
      }
     },
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsIncomeTaxExpense"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r538",
      "r539"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred tax assets, net"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r11",
      "r12",
      "r233",
      "r243",
      "r550"
     ],
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDetailsDeferredTaxAssetsandLiabilities": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "negatedTotalLabel": "Total Deferred Tax Liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsDeferredTaxAssetsandLiabilities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r538",
      "r539"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred tax liability, net"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r759",
      "r828",
      "r830"
     ],
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDetailsIncomeTaxExpense": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "terseLabel": "State deferred tax"
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsIncomeTaxExpense"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r551"
     ],
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDetailsDeferredTaxAssetsandLiabilities": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Total Deferred Tax Assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsDeferredTaxAssetsandLiabilities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "auth_ref": [
      "r825"
     ],
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDetailsDeferredTaxAssetsandLiabilities": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.",
        "label": "Deferred Tax Assets, Net",
        "totalLabel": "Net Deferred Tax (Liability) Asset"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsDeferredTaxAssetsandLiabilities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r154",
      "r826"
     ],
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDetailsDeferredTaxAssetsandLiabilities": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "terseLabel": "Net operating losses"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsDeferredTaxAssetsandLiabilities",
      "http://www.radnet.com/role/INCOMETAXESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are not subject to expiration dates.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration",
        "terseLabel": "Operating loss carryforwards, not subject to expiration"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are subject to expiration dates.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration",
        "terseLabel": "Operating loss carryforwards, subject to expiration"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "auth_ref": [
      "r154",
      "r826"
     ],
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDetailsDeferredTaxAssetsandLiabilities": {
       "order": 6.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.",
        "label": "Deferred Tax Assets, Other",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsDeferredTaxAssetsandLiabilities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits": {
     "auth_ref": [
      "r154",
      "r826"
     ],
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDetailsDeferredTaxAssetsandLiabilities": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from compensation and benefits costs.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits",
        "terseLabel": "Equity compensation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsDeferredTaxAssetsandLiabilities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals": {
     "auth_ref": [
      "r154",
      "r826"
     ],
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDetailsDeferredTaxAssetsandLiabilities": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals",
        "verboseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsDeferredTaxAssetsandLiabilities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts": {
     "auth_ref": [
      "r154",
      "r826"
     ],
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDetailsDeferredTaxAssetsandLiabilities": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable.",
        "label": "Deferred Tax Asset, Tax Deferred Expense, Reserve and Accrual, Accounts Receivable, Allowance for Credit Loss",
        "terseLabel": "Allowance for doubtful accounts"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsDeferredTaxAssetsandLiabilities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r552"
     ],
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDetailsDeferredTaxAssetsandLiabilities": {
       "order": 7.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedLabel": "Valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsDeferredTaxAssetsandLiabilities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilities": {
     "auth_ref": [
      "r148",
      "r825"
     ],
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDetailsDeferredTaxAssetsandLiabilities": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.",
        "label": "Deferred Tax Liabilities, Net",
        "negatedTotalLabel": "Net Deferred Tax (Liability) Asset"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsDeferredTaxAssetsandLiabilities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Liabilities, Gross [Abstract]",
        "terseLabel": "Deferred tax liabilities:"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsDeferredTaxAssetsandLiabilities"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets": {
     "auth_ref": [
      "r154",
      "r826"
     ],
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDetailsDeferredTaxAssetsandLiabilities": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from intangible assets including goodwill.",
        "label": "Deferred Tax Liabilities, Goodwill and Intangible Assets",
        "negatedLabel": "Intangibles"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsDeferredTaxAssetsandLiabilities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill": {
     "auth_ref": [
      "r154",
      "r179",
      "r180",
      "r826"
     ],
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDetailsDeferredTaxAssetsandLiabilities": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from goodwill.",
        "label": "Deferred Tax Liabilities, Goodwill",
        "negatedLabel": "Goodwill",
        "terseLabel": "Deferred tax liabilities goodwill"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsDeferredTaxAssetsandLiabilities",
      "http://www.radnet.com/role/INCOMETAXESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesOther": {
     "auth_ref": [
      "r154",
      "r826"
     ],
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDetailsDeferredTaxAssetsandLiabilities": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other.",
        "label": "Deferred Tax Liabilities, Other",
        "negatedLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsDeferredTaxAssetsandLiabilities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": {
     "auth_ref": [
      "r154",
      "r826"
     ],
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDetailsDeferredTaxAssetsandLiabilities": {
       "order": 6.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.",
        "label": "Deferred Tax Liabilities, Property, Plant and Equipment",
        "negatedLabel": "Property and equipment"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsDeferredTaxAssetsandLiabilities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanCostRecognized": {
     "auth_ref": [
      "r494"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for defined contribution plan.",
        "label": "Defined Contribution Plan, Cost",
        "terseLabel": "Expected employee contribution"
       }
      }
     },
     "localname": "DefinedContributionPlanCostRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.",
        "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay",
        "terseLabel": "Employee contribution, percent"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerMatchingContributionPercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage employer matches of the employee's percentage contribution matched.",
        "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Match",
        "terseLabel": "Employer matching contribution, percent"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerMatchingContributionPercentOfMatch",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DepositsAssets": {
     "auth_ref": [
      "r743"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 8.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment in the future.",
        "label": "Deposits Assets",
        "terseLabel": "Deposits and other"
       }
      }
     },
     "localname": "DepositsAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationAndAmortization": {
     "auth_ref": [
      "r66",
      "r113"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.",
        "label": "Depreciation, Depletion and Amortization, Nonproduction",
        "terseLabel": "Depreciation and amortization expense"
       }
      }
     },
     "localname": "DepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r66",
      "r360"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 18.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 5.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization",
        "verboseLabel": "Depreciation and Amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SEGMENTREPORTINGDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetNotionalAmount": {
     "auth_ref": [
      "r832",
      "r833",
      "r834"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payments on the derivative asset.",
        "label": "Derivative Asset, Notional Amount",
        "terseLabel": "Notional amounts"
       }
      }
     },
     "localname": "DerivativeAssetNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetNumberOfInstrumentsHeld": {
     "auth_ref": [
      "r201",
      "r203"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of derivative instruments of a particular derivative asset or group of derivative assets held by the entity.",
        "label": "Derivative Asset, Number of Instruments Held",
        "terseLabel": "Number of forward interest rate cap agreements"
       }
      }
     },
     "localname": "DerivativeAssetNumberOfInstrumentsHeld",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DerivativeAssets": {
     "auth_ref": [
      "r274",
      "r275",
      "r593",
      "r695"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Asset",
        "terseLabel": "Other Current Assets and Deposits and Other"
       }
      }
     },
     "localname": "DerivativeAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeBasisSpreadOnVariableRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage points added to the reference rate to compute the variable rate on the interest rate derivative.",
        "label": "Derivative, Basis Spread on Variable Rate",
        "terseLabel": "Basis spread on variable rate"
       }
      }
     },
     "localname": "DerivativeBasisSpreadOnVariableRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeGainLossOnDerivativeNet": {
     "auth_ref": [
      "r835"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.",
        "label": "Derivative, Gain (Loss) on Derivative, Net",
        "terseLabel": "Amount of gain (loss) recognized in income on derivative (current period ineffective portion)"
       }
      }
     },
     "localname": "DerivativeGainLossOnDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration": {
     "auth_ref": [
      "r835"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of income or comprehensive income that includes gain (loss) from derivative.",
        "label": "Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]",
        "terseLabel": "Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]"
       }
      }
     },
     "localname": "DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r206",
      "r207",
      "r210",
      "r212",
      "r695"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeLiabilities": {
     "auth_ref": [
      "r274",
      "r275",
      "r593",
      "r695"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability",
        "terseLabel": "Accrued expenses and other non-current liabilities"
       }
      }
     },
     "localname": "DerivativeLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r200",
      "r202",
      "r204",
      "r205",
      "r214",
      "r308"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "DERIVATIVE INSTRUMENTS"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DevelopedTechnologyRightsMember": {
     "auth_ref": [
      "r168"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property.",
        "label": "Developed Technology Rights [Member]",
        "terseLabel": "Software developed for internal use"
       }
      }
     },
     "localname": "DevelopedTechnologyRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r500",
      "r527",
      "r528",
      "r530",
      "r534",
      "r718"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "terseLabel": "STOCK-BASED COMPENSATION"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DomesticCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.",
        "label": "Domestic Tax Authority [Member]",
        "terseLabel": "Domestic Tax Authority"
       }
      }
     },
     "localname": "DomesticCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DueFromRelatedPartiesCurrent": {
     "auth_ref": [
      "r271",
      "r426",
      "r427",
      "r428",
      "r432",
      "r433",
      "r434",
      "r634",
      "r692",
      "r760"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of receivables to be collected from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth, at the financial statement date. which are usually due within one year (or one business cycle).",
        "label": "Due from Related Parties, Current",
        "terseLabel": "Due from affiliates"
       }
      }
     },
     "localname": "DueFromRelatedPartiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DueToAffiliateCurrent": {
     "auth_ref": [
      "r5",
      "r227",
      "r255",
      "r760"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payable due to an entity that is affiliated with the reporting entity by means of direct or indirect ownership. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Due to Affiliate, Current",
        "terseLabel": "Due to affiliates"
       }
      }
     },
     "localname": "DueToAffiliateCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r294",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r330",
      "r332",
      "r342",
      "r343",
      "r344",
      "r346",
      "r583",
      "r584",
      "r666",
      "r673",
      "r701"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "netLabel": "Basic net (loss) income per share attributable to RadNet, inc. common stockholders (in dollars per share)",
        "terseLabel": "BASIC NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic [Abstract]",
        "verboseLabel": "BASIC NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS"
       }
      }
     },
     "localname": "EarningsPerShareBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r294",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r332",
      "r342",
      "r343",
      "r344",
      "r346",
      "r583",
      "r584",
      "r666",
      "r673",
      "r701"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "netLabel": "Diluted net income (loss) per share attributable to RadNet, Inc. common stockholders (in dollars per share)",
        "terseLabel": "DILUTED NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Diluted [Abstract]",
        "verboseLabel": "DILUTED NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS"
       }
      }
     },
     "localname": "EarningsPerShareDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Diluted, Other Disclosure [Abstract]",
        "terseLabel": "Stock options and non-vested restricted awards excluded from the computation of diluted per share amounts as their effect would be antidilutive:"
       }
      }
     },
     "localname": "EarningsPerShareDilutedOtherDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r77",
      "r78"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "EARNINGS PER SHARE"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r598"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "terseLabel": "EFFECT OF EXCHANGE RATE CHANGES ON CASH"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount": {
     "auth_ref": [
      "r821",
      "r823"
     ],
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDetailsReconciliationoftheStatutoryUSFederalRateandEffectiveRates": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Amount",
        "terseLabel": "Officer Compensation"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsReconciliationoftheStatutoryUSFederalRateandEffectiveRates"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r27"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Accrued salary and benefits"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsAccountsPayableandAccruedExpenses"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r529"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Unrecognized expense weighted average period"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "auth_ref": [
      "r820"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized stock-based compensation expense"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "terseLabel": "Shares issuable upon the exercise of stock options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenue from External Customer [Line Items]",
        "terseLabel": "Revenue from External Customer [Line Items]"
       }
      }
     },
     "localname": "EntityWideInformationRevenueFromExternalCustomerLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofNetRevenue"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services.",
        "label": "Equipment [Member]",
        "terseLabel": "Medical equipment"
       }
      }
     },
     "localname": "EquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r126",
      "r258",
      "r287",
      "r288",
      "r289",
      "r310",
      "r311",
      "r312",
      "r316",
      "r324",
      "r326",
      "r347",
      "r393",
      "r468",
      "r531",
      "r532",
      "r533",
      "r556",
      "r557",
      "r582",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r631",
      "r676",
      "r677",
      "r678"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvesteeMember": {
     "auth_ref": [
      "r89",
      "r651",
      "r653",
      "r655",
      "r657",
      "r659",
      "r661"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An entity that issued voting stock held by an investor and that is accounted for under the equity method of accounting by the investor.",
        "label": "Equity Method Investee [Member]",
        "terseLabel": "Equity Method Investee"
       }
      }
     },
     "localname": "EquityMethodInvesteeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentAggregateCost": {
     "auth_ref": [
      "r21"
     ],
     "calculation": {
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the aggregate cost of investments accounted for under the equity method of accounting.",
        "label": "Equity Method Investment, Aggregate Cost",
        "terseLabel": "Total net assets",
        "totalLabel": "Total net assets"
       }
      }
     },
     "localname": "EquityMethodInvestmentAggregateCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity": {
     "auth_ref": [
      "r93"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between amount at which an investment accounted for under the equity method of accounting is carried (reported) on the balance sheet and amount of underlying equity in net assets the reporting Entity has in the investee.",
        "label": "Equity Method Investment, Difference Between Carrying Amount and Underlying Equity",
        "terseLabel": "Different between the sales price and carrying value"
       }
      }
     },
     "localname": "EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentDividendsOrDistributions": {
     "auth_ref": [
      "r44",
      "r61",
      "r66",
      "r252"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of distribution received from equity method investee for return on investment, classified as operating activities. Excludes distribution for return of investment, classified as investing activities.",
        "label": "Proceeds from Equity Method Investment, Distribution",
        "negatedLabel": "Distribution of earnings"
       }
      }
     },
     "localname": "EquityMethodInvestmentDividendsOrDistributions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsInvestmentinJointVentures"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis": {
     "auth_ref": [
      "r262",
      "r302",
      "r392",
      "r594"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by nonconsolidated equity method investee. Excludes information consolidated by reporting entity.",
        "label": "Equity Method Investment, Nonconsolidated Investee [Axis]",
        "terseLabel": "Equity Method Investment, Nonconsolidated Investee [Axis]"
       }
      }
     },
     "localname": "EquityMethodInvestmentNonconsolidatedInvesteeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain": {
     "auth_ref": [
      "r262",
      "r302",
      "r392",
      "r594"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nonconsolidated equity method investee. Excludes information consolidated by reporting entity.",
        "label": "Equity Method Investment, Nonconsolidated Investee [Domain]",
        "terseLabel": "Equity Method Investment, Nonconsolidated Investee [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvestmentNonconsolidatedInvesteeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember": {
     "auth_ref": [
      "r741",
      "r758",
      "r771",
      "r839"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nonconsolidated equity method investee or group of nonconsolidated investees. Excludes information consolidated by reporting entity.",
        "label": "Equity Method Investment, Nonconsolidated Investee or Group of Investees [Member]",
        "terseLabel": "Equity Method Investment, Nonconsolidated Investee or Group of Investees"
       }
      }
     },
     "localname": "EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "auth_ref": [
      "r91"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
        "label": "Equity Method Investment, Ownership Percentage",
        "terseLabel": "Equity interest percentage"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets": {
     "auth_ref": [
      "r93"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the entity's ownership percentage in the investee multiplied by the investee's total equity.",
        "label": "Equity Method Investment, Underlying Equity in Net Assets",
        "terseLabel": "Cost in excess of book value of acquired joint venture interests accounted for as equity method goodwill"
       }
      }
     },
     "localname": "EquityMethodInvestmentUnderlyingEquityInNetAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r90",
      "r366",
      "r742"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "terseLabel": "Book value of RadNet joint venture interests",
        "verboseLabel": "Fair value of investment"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentsPolicy": {
     "auth_ref": [
      "r61",
      "r92",
      "r220"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.",
        "label": "Equity Method Investments [Policy Text Block]",
        "terseLabel": "EQUITY INVESTMENTS AT FAIR VALUE"
       }
      }
     },
     "localname": "EquityMethodInvestmentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquityMethodInvestmentsTextBlock": {
     "auth_ref": [
      "r95"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.",
        "label": "Equity Method Investments [Table Text Block]",
        "terseLabel": "Schedule of Investment in Joint Ventures"
       }
      }
     },
     "localname": "EquityMethodInvestmentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EstimateOfFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r449",
      "r593",
      "r706",
      "r707"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as an estimate of fair value.",
        "label": "Estimate of Fair Value Measurement [Member]",
        "terseLabel": "Estimate of Fair Value Measurement"
       }
      }
     },
     "localname": "EstimateOfFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EurodollarMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate based on U.S. dollar denominated deposits at foreign banks or foreign branches of U.S. banks.",
        "label": "Eurodollar [Member]",
        "terseLabel": "Eurodollar Rate Spread"
       }
      }
     },
     "localname": "EurodollarMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]"
       }
      }
     },
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "auth_ref": [
      "r215",
      "r218",
      "r219"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTextBlock": {
     "auth_ref": [
      "r215",
      "r218"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table Text Block]",
        "terseLabel": "Schedule of Fair Value of Assets and Liabilities"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r449",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r588",
      "r639",
      "r640",
      "r641",
      "r706",
      "r707",
      "r712",
      "r713",
      "r714"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementBasisAxis": {
     "auth_ref": [
      "r215",
      "r217",
      "r449",
      "r706",
      "r707"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement basis.",
        "label": "Measurement Basis [Axis]",
        "terseLabel": "Measurement Basis [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementBasisAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosureItemAmountsDomain": {
     "auth_ref": [
      "r449",
      "r706",
      "r707"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.",
        "label": "Fair Value Measurement [Domain]",
        "terseLabel": "Fair Value Measurement [Domain]"
       }
      }
     },
     "localname": "FairValueDisclosureItemAmountsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r449",
      "r487",
      "r492",
      "r588",
      "r639",
      "r712",
      "r713",
      "r714"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r449",
      "r487",
      "r492",
      "r588",
      "r640",
      "r706",
      "r707",
      "r712",
      "r713",
      "r714"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r449",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r588",
      "r641",
      "r706",
      "r707",
      "r712",
      "r713",
      "r714"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "terseLabel": "FAIR VALUE MEASUREMENTS"
       }
      }
     },
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r449",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r639",
      "r640",
      "r641",
      "r706",
      "r707",
      "r712",
      "r713",
      "r714"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinanceLeaseInterestExpense": {
     "auth_ref": [
      "r616",
      "r622",
      "r725"
     ],
     "calculation": {
      "http://www.radnet.com/role/LEASESDetailsLeaseCost": {
       "order": 2.0,
       "parentTag": "rdnt_FinanceLeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense on finance lease liability.",
        "label": "Finance Lease, Interest Expense",
        "terseLabel": "Interest on lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsLeaseCost"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseInterestPaymentOnLiability": {
     "auth_ref": [
      "r618",
      "r624"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest paid on finance lease liability.",
        "label": "Finance Lease, Interest Payment on Liability",
        "terseLabel": "Operating cash flows from financing leases"
       }
      }
     },
     "localname": "FinanceLeaseInterestPaymentOnLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsSupplementalCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r614",
      "r628"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "terseLabel": "Finance lease debt"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Liability [Abstract]",
        "terseLabel": "Finance lease cost:"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsLeaseCost"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "auth_ref": [
      "r617",
      "r624"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for principal payment on finance lease.",
        "label": "Finance Lease, Principal Payments",
        "terseLabel": "Financing cash flows from financing leases"
       }
      }
     },
     "localname": "FinanceLeasePrincipalPayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsSupplementalCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "auth_ref": [
      "r613"
     ],
     "calculation": {
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization",
        "totalLabel": "Equipment, net"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization": {
     "auth_ref": [
      "r842",
      "r845"
     ],
     "calculation": {
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseRightOfUseAsset",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated amortization of right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, Accumulated Amortization",
        "negatedTerseLabel": "Accumulated depreciation"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAmortization": {
     "auth_ref": [
      "r616",
      "r622",
      "r725"
     ],
     "calculation": {
      "http://www.radnet.com/role/LEASESDetailsLeaseCost": {
       "order": 1.0,
       "parentTag": "rdnt_FinanceLeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, Amortization",
        "terseLabel": "Depreciation of leased equipment"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsLeaseCost"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization": {
     "auth_ref": [
      "r841"
     ],
     "calculation": {
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseRightOfUseAsset",
       "weight": 1.0
      },
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before accumulated amortization, of right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, before Accumulated Amortization",
        "terseLabel": "Equipment at cost"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet",
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r615"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes finance lease right-of-use asset.",
        "label": "Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unearned premium revenue under contracts issued by an insurance entity that provide protection to the holder of a financial obligation from a financial loss in the event of a default.",
        "label": "Financial Guarantee Insurance Contracts, Unearned Premium Revenue",
        "terseLabel": "Interest rate caps premium liability"
       }
      }
     },
     "localname": "FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule": {
       "order": 3.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five",
        "terseLabel": "Amortization year thereafter"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r105"
     ],
     "calculation": {
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule": {
       "order": 6.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "Amortization year 2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r105"
     ],
     "calculation": {
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "terseLabel": "Amortization year 2027"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r105"
     ],
     "calculation": {
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule": {
       "order": 4.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "Amortization year 2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r105"
     ],
     "calculation": {
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "Amortization year 2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r105"
     ],
     "calculation": {
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule": {
       "order": 5.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "Amortization year 2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r408",
      "r410",
      "r411",
      "r413",
      "r645",
      "r649"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule",
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule",
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r98",
      "r102"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule",
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r103",
      "r645"
     ],
     "calculation": {
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Amortiztion total"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1": {
     "auth_ref": [
      "r645"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Assets, Remaining Amortization Period",
        "terseLabel": "Weighted average amortization period remaining in years"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "FOREIGN CURRENCY TRANSLATION"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]",
        "terseLabel": "Computer and office equipment, furniture and fixtures"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnDispositionOfAssets": {
     "auth_ref": [
      "r756",
      "r775",
      "r779"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property",
        "negatedLabel": "Loss on sale and disposal of equipment and other",
        "negatedTerseLabel": "Loss on sale and disposal of equipment and other"
       }
      }
     },
     "localname": "GainLossOnDispositionOfAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": {
     "auth_ref": [
      "r66"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment",
        "negatedNetLabel": "Loss on Disposal of Equipment",
        "terseLabel": "Gain (loss) on disposition of property plant equipment"
       }
      }
     },
     "localname": "GainLossOnSaleOfPropertyPlantEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/SEGMENTREPORTINGDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnTerminationOfLease": {
     "auth_ref": [
      "r612"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 20.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on termination of lease before expiration of lease term.",
        "label": "Gain (Loss) on Termination of Lease",
        "negatedTerseLabel": "Lease abandonment charges"
       }
      }
     },
     "localname": "GainLossOnTerminationOfLease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r66",
      "r123",
      "r124"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedLabel": "Loss on extinguishment of debt",
        "negatedTerseLabel": "Loss (gain) on extinguishment of debt"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSecondAmendedandRestatedFirstLienCreditandGuarantyAgreement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r267",
      "r396",
      "r662",
      "r704",
      "r726",
      "r772",
      "r774"
     ],
     "calculation": {
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsandLiabilitiesAssumed": {
       "order": 6.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      },
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Goodwill, ending balance",
        "periodStartLabel": "Goodwill, beginning balance",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsandLiabilitiesAssumed",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r398",
      "r704"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Additions"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetImpairment": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 6.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.",
        "label": "Goodwill and Intangible Asset Impairment",
        "terseLabel": "Loss on impairment",
        "verboseLabel": "Loss on impairment"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetImpairment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r110"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "GOODWILL AND OTHER INTANGIBLE ASSETS"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy": {
     "auth_ref": [
      "r106"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for indefinite-lived intangible assets (that is, those intangible assets not subject to amortization). This accounting policy also may address how the entity assesses whether events and circumstances continue to support an indefinite useful life and how the entity assesses and measures impairment of such assets.",
        "label": "Goodwill and Intangible Assets, Intangible Assets, Indefinite-Lived, Policy [Policy Text Block]",
        "terseLabel": "GOODWILL AND INDEFINITE LIVED INTANGIBLES"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r402"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Currency translation"
       }
      }
     },
     "localname": "GoodwillForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillPurchaseAccountingAdjustments": {
     "auth_ref": [
      "r158",
      "r773"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Purchase Accounting Adjustments",
        "terseLabel": "Measurement period and other adjustments"
       }
      }
     },
     "localname": "GoodwillPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit": {
     "auth_ref": [
      "r400",
      "r704"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of divestiture of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Written off Related to Sale of Business Unit",
        "negatedTerseLabel": "Disposals"
       }
      }
     },
     "localname": "GoodwillWrittenOffRelatedToSaleOfBusinessUnit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GovernmentAssistanceAmountCumulative": {
     "auth_ref": [
      "r607"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cumulative government assistance recognized.",
        "label": "Government Assistance, Amount, Cumulative",
        "terseLabel": "Amount in deferred revenue"
       }
      }
     },
     "localname": "GovernmentAssistanceAmountCumulative",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GovernmentAssistanceStatementOfFinancialPositionExtensibleEnumeration": {
     "auth_ref": [
      "r607"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes government assistance.",
        "label": "Government Assistance, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Government Assistance, Statement of Financial Position [Extensible Enumeration]"
       }
      }
     },
     "localname": "GovernmentAssistanceStatementOfFinancialPositionExtensibleEnumeration",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_HealthCareOtherMember": {
     "auth_ref": [
      "r792"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Service provided for maintenance, diagnosis and treatment of physical and mental health, classified as other.",
        "label": "Health Care, Other [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "HealthCareOtherMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofNetRevenue"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HealthCarePatientServiceMember": {
     "auth_ref": [
      "r792"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Service provided to patient for maintenance, diagnosis and treatment of physical and mental health. Excludes service to resident in health care facility.",
        "label": "Health Care, Patient Service [Member]",
        "terseLabel": "Service fee revenue"
       }
      }
     },
     "localname": "HealthCarePatientServiceMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration": {
     "auth_ref": [
      "r414"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of income or comprehensive income that includes impairment of long-lived asset held for use.",
        "label": "Impairment, Long-Lived Asset, Held-for-Use, Statement of Income or Comprehensive Income [Extensible Enumeration]",
        "terseLabel": "Impairment, Long-Lived Asset, Held-for-Use, Statement of Income or Comprehensive Income [Extensible Enumeration]"
       }
      }
     },
     "localname": "ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_ImpairmentOfLongLivedAssetsHeldForUse": {
     "auth_ref": [
      "r66",
      "r112",
      "r116"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).",
        "label": "Impairment, Long-Lived Asset, Held-for-Use",
        "terseLabel": "Impairment of long lived asset"
       }
      }
     },
     "localname": "ImpairmentOfLongLivedAssetsHeldForUse",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "auth_ref": [
      "r111",
      "r117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.",
        "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]",
        "terseLabel": "LONG-LIVED ASSETS"
       }
      }
     },
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InProcessResearchAndDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In process investigation of new knowledge useful in developing new product or service or new process or technique or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for improvement to existing product or process.",
        "label": "In Process Research and Development [Member]",
        "verboseLabel": "In-process research and development"
       }
      }
     },
     "localname": "InProcessResearchAndDevelopmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeApproachValuationTechniqueMember": {
     "auth_ref": [
      "r216"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation approach converting future amounts to single current discounted amount.",
        "label": "Valuation, Income Approach [Member]",
        "terseLabel": "Valuation, Income Approach"
       }
      }
     },
     "localname": "IncomeApproachValuationTechniqueMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "auth_ref": [
      "r303",
      "r563"
     ],
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDetailsIncomeLossBeforeIncomeTaxes": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "terseLabel": "US Domestic"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsIncomeLossBeforeIncomeTaxes"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r43",
      "r229",
      "r238",
      "r254",
      "r365",
      "r370",
      "r376",
      "r379",
      "r667",
      "r703"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      },
      "http://www.radnet.com/role/INCOMETAXESDetailsIncomeLossBeforeIncomeTaxes": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "terseLabel": "INCOME (LOSS) BEFORE INCOME TAXES",
        "totalLabel": "Income (loss) before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/INCOMETAXESDetailsIncomeLossBeforeIncomeTaxes"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "auth_ref": [
      "r303",
      "r563"
     ],
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDetailsIncomeLossBeforeIncomeTaxes": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsIncomeLossBeforeIncomeTaxes"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r44",
      "r66",
      "r90",
      "r237",
      "r252",
      "r362"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "negatedLabel": "Equity in earnings of joint ventures",
        "terseLabel": "Equity in earnings in these joint ventures"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsInvestmentinJointVentures"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions": {
     "auth_ref": [
      "r66"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the undistributed income (or loss) of equity method investments, net of dividends or other distributions received from unconsolidated subsidiaries, certain corporate joint ventures, and certain noncontrolled corporations; such investments are accounted for under the equity method of accounting. This element excludes distributions that constitute a return of investment, which are classified as investing activities.",
        "label": "Income (Loss) from Equity Method Investments, Net of Dividends or Distributions",
        "negatedLabel": "Equity in earnings of joint ventures, net of dividends"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r415",
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r150"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r304",
      "r542",
      "r548",
      "r554",
      "r561",
      "r564",
      "r566",
      "r567",
      "r568"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "INCOME TAXES"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r305",
      "r325",
      "r326",
      "r363",
      "r540",
      "r562",
      "r565",
      "r674"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      },
      "http://www.radnet.com/role/INCOMETAXESDetailsIncomeTaxExpense": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.radnet.com/role/INCOMETAXESDetailsReconciliationoftheStatutoryUSFederalRateandEffectiveRates": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "Provision for income taxes",
        "totalLabel": "Income tax expense"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/INCOMETAXESDetailsIncomeTaxExpense",
      "http://www.radnet.com/role/INCOMETAXESDetailsReconciliationoftheStatutoryUSFederalRateandEffectiveRates"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r286",
      "r536",
      "r537",
      "r548",
      "r549",
      "r553",
      "r555"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "verboseLabel": "INCOME TAXES"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r823"
     ],
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDetailsReconciliationoftheStatutoryUSFederalRateandEffectiveRates": {
       "order": 12.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount",
        "terseLabel": "Changes in valuation allowance"
       }
      }
     },
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsReconciliationoftheStatutoryUSFederalRateandEffectiveRates"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r823"
     ],
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDetailsReconciliationoftheStatutoryUSFederalRateandEffectiveRates": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount",
        "terseLabel": "Foreign rate differential"
       }
      }
     },
     "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsReconciliationoftheStatutoryUSFederalRateandEffectiveRates"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r541"
     ],
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDetailsReconciliationoftheStatutoryUSFederalRateandEffectiveRates": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount",
        "terseLabel": "Federal tax"
       }
      }
     },
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsReconciliationoftheStatutoryUSFederalRateandEffectiveRates"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense": {
     "auth_ref": [
      "r823"
     ],
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDetailsReconciliationoftheStatutoryUSFederalRateandEffectiveRates": {
       "order": 11.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to noncontrolling interest income (loss) exempt from income taxes.",
        "label": "Effective Income Tax Rate Reconciliation, Noncontrolling Interest Income (Loss), Amount",
        "negatedTerseLabel": "Noncontrolling interests in partnerships"
       }
      }
     },
     "localname": "IncomeTaxReconciliationMinorityInterestIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsReconciliationoftheStatutoryUSFederalRateandEffectiveRates"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther": {
     "auth_ref": [
      "r823"
     ],
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDetailsReconciliationoftheStatutoryUSFederalRateandEffectiveRates": {
       "order": 6.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount",
        "terseLabel": "Other Non deductible expenses"
       }
      }
     },
     "localname": "IncomeTaxReconciliationNondeductibleExpenseOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsReconciliationoftheStatutoryUSFederalRateandEffectiveRates"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationOtherAdjustments": {
     "auth_ref": [
      "r823"
     ],
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDetailsReconciliationoftheStatutoryUSFederalRateandEffectiveRates": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Amount",
        "terseLabel": "Deferred true-ups and other"
       }
      }
     },
     "localname": "IncomeTaxReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsReconciliationoftheStatutoryUSFederalRateandEffectiveRates"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationOtherReconcilingItems": {
     "auth_ref": [
      "r823"
     ],
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDetailsReconciliationoftheStatutoryUSFederalRateandEffectiveRates": {
       "order": 9.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority noncontrolling interest income (loss), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, increase (decrease) in enacted tax rate, prior year income taxes, increase (decrease) in deferred tax asset valuation allowance, and other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount",
        "terseLabel": "Other differences"
       }
      }
     },
     "localname": "IncomeTaxReconciliationOtherReconcilingItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsReconciliationoftheStatutoryUSFederalRateandEffectiveRates"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes": {
     "auth_ref": [
      "r823"
     ],
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDetailsReconciliationoftheStatutoryUSFederalRateandEffectiveRates": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount",
        "terseLabel": "Return to provision"
       }
      }
     },
     "localname": "IncomeTaxReconciliationPriorYearIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsReconciliationoftheStatutoryUSFederalRateandEffectiveRates"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r823"
     ],
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDetailsReconciliationoftheStatutoryUSFederalRateandEffectiveRates": {
       "order": 7.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount",
        "terseLabel": "State franchise tax, net of federal benefit"
       }
      }
     },
     "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsReconciliationoftheStatutoryUSFederalRateandEffectiveRates"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationTaxContingencies": {
     "auth_ref": [
      "r823"
     ],
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDetailsReconciliationoftheStatutoryUSFederalRateandEffectiveRates": {
       "order": 8.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in income tax contingencies. Including, but not limited to, domestic tax contingency, foreign tax contingency, state and local tax contingency, and other contingencies.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Contingency, Amount",
        "terseLabel": "Uncertain tax provisions"
       }
      }
     },
     "localname": "IncomeTaxReconciliationTaxContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsReconciliationoftheStatutoryUSFederalRateandEffectiveRates"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r70"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Cash paid during the period for income taxes"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "verboseLabel": "Accounts payable, accrued expenses and other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredIncomeTaxes": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.",
        "label": "Increase (Decrease) in Deferred Income Taxes",
        "negatedLabel": "Deferred taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredRevenue": {
     "auth_ref": [
      "r697"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Deferred Revenue",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1": {
     "auth_ref": [
      "r206",
      "r208"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 5.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) included in earnings related to the fair value of the hedged item in an interest rate fair value hedge, offset by the gain (loss) on the hedging instrument to the extent that the fair value hedge is determined to be effective.",
        "label": "Increase (Decrease) in Fair Value of Hedged Item in Interest Rate Fair Value Hedge",
        "negatedTerseLabel": "Non-cash change in fair value of interest rate swaps"
       }
      }
     },
     "localname": "IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "auth_ref": [
      "r755",
      "r846"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation for operating lease.",
        "label": "Increase (Decrease) in Operating Lease Liability",
        "terseLabel": "Operating lease liability"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherCurrentAssets": {
     "auth_ref": [
      "r755"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 19.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in current assets classified as other.",
        "label": "Increase (Decrease) in Other Current Assets",
        "negatedLabel": "Other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherCurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": {
     "auth_ref": [
      "r755"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent assets classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Assets",
        "negatedLabel": "Other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants": {
     "auth_ref": [
      "r333",
      "r334",
      "r335",
      "r344"
     ],
     "calculation": {
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants",
        "terseLabel": "Add additional shares issuable upon exercise of stock options, warrants and holdback shares (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToCallOptionsAndWarrants",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r409",
      "r412"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-Lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-lived Intangible Assets [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Indefinite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Indefinite-lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Indefinite lived intangible assets"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r100",
      "r106"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r97",
      "r101"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Other intangible assets",
        "totalLabel": "Other intangible assets"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebt": {
     "auth_ref": [
      "r49",
      "r455",
      "r465",
      "r708",
      "r709"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
        "label": "Interest Expense, Debt",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpenseDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseMember": {
     "auth_ref": [
      "r211"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing interest expense.",
        "label": "Interest Expense [Member]",
        "terseLabel": "Interest Expense"
       }
      }
     },
     "localname": "InterestExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r295",
      "r298",
      "r299"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Cash paid during the period for interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateCapMember": {
     "auth_ref": [
      "r724"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract in which the cap writer, in return for a premium, agrees to limit, or cap, the cap holder's risk associated with an increase in interest rates. If rates go above a specified interest-rate-level (the strike price or the cap rate), the cap holder is entitled to receive cash payments equal to the excess of the market rate over the strike price multiplied by the notional principal amount.",
        "label": "Interest Rate Cap [Member]",
        "terseLabel": "Interest Rate Cap"
       }
      }
     },
     "localname": "InterestRateCapMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r724"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "2019 SWAPS - Interest Rate Contracts"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "auth_ref": [
      "r391",
      "r861"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment in financial asset.",
        "label": "Investment, Policy [Policy Text Block]",
        "terseLabel": "INVESTMENT IN JOINT VENTURES"
       }
      }
     },
     "localname": "InvestmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures": {
     "auth_ref": [
      "r744"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity method investee and investment in and advance to affiliate.",
        "label": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Investment in joint ventures",
        "verboseLabel": "Total value of RadNet joint venture interests"
       }
      }
     },
     "localname": "InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsInvestmentinJointVentures",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LandMember": {
     "auth_ref": [
      "r792"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Part of earth's surface not covered by water.",
        "label": "Land [Member]",
        "terseLabel": "Land"
       }
      }
     },
     "localname": "LandMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r847"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Schedule of Lease, Cost"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/LEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetails",
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsAdditionalInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r621"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsAdditionalInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r620"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "LEASES"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1": {
     "auth_ref": [
      "r844"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease not yet commenced, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Lease Not yet Commenced, Term of Contract",
        "terseLabel": "Operating lease, lease not yet commenced, term of contract"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsAdditionalInformation"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r848"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Schedule of Maturities of Operating Lease Liability"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/LEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r628"
     ],
     "calculation": {
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total Lease Payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r628"
     ],
     "calculation": {
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r628"
     ],
     "calculation": {
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r628"
     ],
     "calculation": {
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r628"
     ],
     "calculation": {
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r628"
     ],
     "calculation": {
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r628"
     ],
     "calculation": {
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r628"
     ],
     "calculation": {
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "auth_ref": [
      "r843"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Renewal Term",
        "terseLabel": "Operating lease, renewal term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsAdditionalInformation"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r843"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Operating lease, term of contract"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsAdditionalInformation"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r629"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "LEASES"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/LEASES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LetterOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).",
        "label": "Letter of Credit [Member]",
        "terseLabel": "Letter of Credit"
       }
      }
     },
     "localname": "LetterOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LettersOfCreditOutstandingAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.",
        "label": "Letters of Credit Outstanding, Amount",
        "terseLabel": "Letters of credit outstanding, amount"
       }
      }
     },
     "localname": "LettersOfCreditOutstandingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAdditionalInformation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r26",
      "r302",
      "r392",
      "r424",
      "r425",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r433",
      "r434",
      "r575",
      "r579",
      "r580",
      "r594",
      "r702",
      "r784",
      "r852",
      "r853"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "terseLabel": "BRMG and NY Groups accounts payable",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r20",
      "r236",
      "r250",
      "r726",
      "r758",
      "r771",
      "r839"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r28",
      "r264",
      "r302",
      "r392",
      "r424",
      "r425",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r433",
      "r434",
      "r575",
      "r579",
      "r580",
      "r594",
      "r726",
      "r784",
      "r852",
      "r853"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures": {
       "order": 3.0,
       "parentTag": "us-gaap_EquityMethodInvestmentAggregateCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "negatedLabel": "Current liabilities",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "CURRENT LIABILITIES"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesNoncurrent": {
     "auth_ref": [
      "r2",
      "r3",
      "r4",
      "r9",
      "r10",
      "r302",
      "r392",
      "r424",
      "r425",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r433",
      "r434",
      "r575",
      "r579",
      "r580",
      "r594",
      "r784",
      "r852",
      "r853"
     ],
     "calculation": {
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures": {
       "order": 4.0,
       "parentTag": "us-gaap_EquityMethodInvestmentAggregateCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.",
        "label": "Liabilities, Noncurrent",
        "negatedLabel": "Noncurrent liabilities"
       }
      }
     },
     "localname": "LiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Noncurrent [Abstract]",
        "terseLabel": "LONG-TERM LIABILITIES"
       }
      }
     },
     "localname": "LiabilitiesNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest": {
     "auth_ref": [
      "r79"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage investment held by the managing member or general partner of the limited liability company (LLC) or limited partnership (LP).",
        "label": "Limited Liability Company (LLC) or Limited Partnership (LP), Managing Member or General Partner, Ownership Interest",
        "terseLabel": "Economic interest"
       }
      }
     },
     "localname": "LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest": {
     "auth_ref": [
      "r79"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage investment held by members or limited partners of limited liability company (LLC) or limited partnership (LP).",
        "label": "Limited Liability Company or Limited Partnership, Members or Limited Partners, Ownership Interest",
        "terseLabel": "Minority partner ownership percent"
       }
      }
     },
     "localname": "LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r9",
      "r234",
      "r244"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-Term Line of Credit",
        "terseLabel": "Total credit facilities outstanding"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAdditionalInformation",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstoPriorCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSecondAmendedandRestatedFirstLienCreditandGuarantyAgreement",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityAxis": {
     "auth_ref": [
      "r23",
      "r757"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of lender, which may be a single entity (for example, but not limited to, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit.",
        "label": "Lender Name [Axis]",
        "terseLabel": "Lender Name [Axis]"
       }
      }
     },
     "localname": "LineOfCreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAdditionalInformation",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstoPriorCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSecondAmendedandRestatedFirstLienCreditandGuarantyAgreement",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityCommitmentFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.",
        "label": "Line of Credit Facility, Commitment Fee Percentage",
        "terseLabel": "Commitment fee percentage"
       }
      }
     },
     "localname": "LineOfCreditFacilityCommitmentFeePercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditFacilityLenderDomain": {
     "auth_ref": [
      "r23",
      "r757"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the lender, which may be a single entity (for example, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit, including a letter of credit facility.",
        "label": "Line of Credit Facility, Lender [Domain]",
        "terseLabel": "Line of Credit Facility, Lender [Domain]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLenderDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAdditionalInformation",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstoPriorCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSecondAmendedandRestatedFirstLienCreditandGuarantyAgreement",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCreditFacilityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Line of Credit Facility [Line Items]",
        "terseLabel": "Line of Credit Facility [Line Items]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAdditionalInformation",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstoPriorCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r23"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Credit facilities available"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAdditionalInformation",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstoPriorCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSecondAmendedandRestatedFirstLienCreditandGuarantyAgreement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": {
     "auth_ref": [
      "r23"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).",
        "label": "Line of Credit Facility, Remaining Borrowing Capacity",
        "terseLabel": "Credit facility, borrowings available"
       }
      }
     },
     "localname": "LineOfCreditFacilityRemainingBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAdditionalInformation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityTable": {
     "auth_ref": [
      "r23",
      "r757"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Line of Credit Facility [Table]",
        "terseLabel": "Line of Credit Facility [Table]"
       }
      }
     },
     "localname": "LineOfCreditFacilityTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAdditionalInformation",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstoPriorCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.",
        "label": "Line of Credit Facility, Unused Capacity, Commitment Fee Percentage",
        "terseLabel": "Unused capacity, commitment fee percentage"
       }
      }
     },
     "localname": "LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Line of Credit"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAdditionalInformation",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstoPriorCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSecondAmendedandRestatedFirstLienCreditandGuarantyAgreement",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LondonInterbankOfferedRateLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.",
        "label": "London Interbank Offered Rate (LIBOR) [Member]",
        "terseLabel": "LIBOR"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateLIBORMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r9",
      "r234",
      "r247",
      "r448",
      "r463",
      "r706",
      "r707"
     ],
     "calculation": {
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.",
        "label": "Long-Term Debt",
        "terseLabel": "Debt",
        "totalLabel": "Total debt obligations"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r25"
     ],
     "calculation": {
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-Term Debt, Current Maturities",
        "negatedTerseLabel": "Less current portion"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive": {
     "auth_ref": [
      "r121",
      "r309",
      "r790"
     ],
     "calculation": {
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAnnualNotePayableMaturities": {
       "order": 6.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAnnualNotePayableMaturities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r121",
      "r309",
      "r453"
     ],
     "calculation": {
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAnnualNotePayableMaturities": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAnnualNotePayableMaturities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": {
     "auth_ref": [
      "r121",
      "r309",
      "r453"
     ],
     "calculation": {
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAnnualNotePayableMaturities": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAnnualNotePayableMaturities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [
      "r121",
      "r309",
      "r453"
     ],
     "calculation": {
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAnnualNotePayableMaturities": {
       "order": 5.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAnnualNotePayableMaturities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r121",
      "r309",
      "r453"
     ],
     "calculation": {
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAnnualNotePayableMaturities": {
       "order": 4.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAnnualNotePayableMaturities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r121",
      "r309",
      "r453"
     ],
     "calculation": {
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAnnualNotePayableMaturities": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAnnualNotePayableMaturities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r270"
     ],
     "calculation": {
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.",
        "label": "Long-Term Debt, Excluding Current Maturities",
        "terseLabel": "Long-term portion debt obligations"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermNotesPayable": {
     "auth_ref": [
      "r30"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.",
        "label": "Notes Payable, Noncurrent",
        "terseLabel": "Notes payable, net of current portion"
       }
      }
     },
     "localname": "LongTermNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r30"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-Term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAdditionalInformation",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstoPriorCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSecondAmendedandRestatedFirstLienCreditandGuarantyAgreement",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r30",
      "r122"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-Term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAdditionalInformation",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstoPriorCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSecondAmendedandRestatedFirstLienCreditandGuarantyAgreement",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maturities of Long-Term Debt and Capital Lease Obligations [Abstract]",
        "terseLabel": "Maturities of Notes Payables [Abstract]"
       }
      }
     },
     "localname": "MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAnnualNotePayableMaturities"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputDiscountRateMember": {
     "auth_ref": [
      "r838"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using interest rate to determine present value of future cash flows.",
        "label": "Measurement Input, Discount Rate [Member]",
        "terseLabel": "Measurement Input, Discount Rate"
       }
      }
     },
     "localname": "MeasurementInputDiscountRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "auth_ref": [
      "r589"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Axis]",
        "terseLabel": "Measurement Input Type [Axis]"
       }
      }
     },
     "localname": "MeasurementInputTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Domain]",
        "terseLabel": "Measurement Input Type [Domain]"
       }
      }
     },
     "localname": "MeasurementInputTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MediumTermNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instruments with maturities ranging from five to ten years.",
        "label": "Medium-term Notes [Member]",
        "terseLabel": "Medium-term Notes"
       }
      }
     },
     "localname": "MediumTermNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstoPriorCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSecondAmendedandRestatedFirstLienCreditandGuarantyAgreement",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock": {
     "auth_ref": [
      "r0",
      "r181"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures. This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.",
        "label": "Mergers, Acquisitions and Dispositions Disclosures [Text Block]",
        "terseLabel": "BUSINESS COMBINATIONS AND RELATED ACTIVITY"
       }
      }
     },
     "localname": "MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITY"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r34",
      "r235",
      "r249",
      "r302",
      "r392",
      "r424",
      "r427",
      "r428",
      "r429",
      "r433",
      "r434",
      "r594"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": {
     "auth_ref": [
      "r132"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.",
        "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "negatedLabel": "Distributions paid to noncontrolling\u00a0interests"
       }
      }
     },
     "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestOwnershipPercentageByParent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage.",
        "label": "Noncontrolling Interest, Ownership Percentage by Parent",
        "terseLabel": "Noncontrolling interest, ownership percentage by parent"
       }
      }
     },
     "localname": "MinorityInterestOwnershipPercentageByParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r297"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by (used in) financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "CASH FLOWS FROM FINANCING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r297"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "CASH FLOWS FROM INVESTING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r62",
      "r64",
      "r67"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "CASH FLOWS FROM OPERATING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r45",
      "r67",
      "r239",
      "r253",
      "r262",
      "r282",
      "r284",
      "r289",
      "r302",
      "r315",
      "r319",
      "r320",
      "r321",
      "r322",
      "r325",
      "r326",
      "r340",
      "r365",
      "r370",
      "r376",
      "r379",
      "r392",
      "r424",
      "r425",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r433",
      "r434",
      "r584",
      "r594",
      "r703",
      "r784"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income (loss) attributable to RadNet, Inc. common stockholders",
        "totalLabel": "NET INCOME (LOSS) ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r189",
      "r197",
      "r282",
      "r284",
      "r325",
      "r326",
      "r748"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "terseLabel": "Net income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": {
     "auth_ref": [
      "r331",
      "r336",
      "r337",
      "r338",
      "r339",
      "r341",
      "r344"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted",
        "terseLabel": "Net income (loss) attributable to RadNet, Inc's common stockholders for diluted share calculation"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Standards Update and Change in Accounting Principle [Abstract]",
        "terseLabel": "New Accounting Pronouncements and Changes in Accounting Principles [Abstract]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": {
     "auth_ref": [
      "r260",
      "r313",
      "r314",
      "r317",
      "r318",
      "r327",
      "r328",
      "r329",
      "r388",
      "r389",
      "r394",
      "r395",
      "r558",
      "r559",
      "r560",
      "r581",
      "r585",
      "r586",
      "r587",
      "r595",
      "r596",
      "r597",
      "r610",
      "r611",
      "r630",
      "r632",
      "r646",
      "r647",
      "r648",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Text Block]",
        "terseLabel": "RECENT ACCOUNTING STANDARDS"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/RECENTACCOUNTINGSTANDARDS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "ACCOUNTING STANDARDS ADOPTED AND ACCOUNTING STANDARDS NOT YET ADOPTED"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1": {
     "auth_ref": [
      "r71",
      "r72",
      "r73"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued as [noncash or part noncash] consideration for a business or asset acquired. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Noncash or Part Noncash Acquisition, Noncash Financial or Equity Instrument Consideration, Shares Issued",
        "terseLabel": "Shares issued (in shares)"
       }
      }
     },
     "localname": "NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1": {
     "auth_ref": [
      "r71",
      "r72",
      "r73"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value of an asset or business acquired in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Noncash or Part Noncash Acquisition, Value of Assets Acquired",
        "terseLabel": "Contributions"
       }
      }
     },
     "localname": "NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest": {
     "auth_ref": [
      "r133",
      "r187",
      "r190"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in noncontrolling interest from sale of a portion of the parent's controlling interest.",
        "label": "Noncontrolling Interest, Increase from Sale of Parent Equity Interest",
        "terseLabel": "Sale to noncontrolling interests, net of taxes"
       }
      }
     },
     "localname": "NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r182",
      "r468",
      "r761",
      "r762",
      "r763"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Noncontrolling Interests"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r48"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "negatedTotalLabel": "Total other expenses"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NotesPayableCurrent": {
     "auth_ref": [
      "r25"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.",
        "label": "Notes Payable, Current",
        "terseLabel": "Current portion of notes payable"
       }
      }
     },
     "localname": "NotesPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r766"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OffsettingAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Offsetting Assets [Line Items]",
        "terseLabel": "Offsetting Assets [Line Items]"
       }
      }
     },
     "localname": "OffsettingAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OffsettingAssetsTable": {
     "auth_ref": [
      "r35",
      "r36"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about derivative and financial assets that are subject to offsetting, including enforceable master netting arrangements.",
        "label": "Offsetting Assets [Table]",
        "terseLabel": "Offsetting Assets [Table]"
       }
      }
     },
     "localname": "OffsettingAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingCostsAndExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.",
        "label": "Operating Costs and Expenses",
        "verboseLabel": "Cost of Operations"
       }
      }
     },
     "localname": "OperatingCostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SEGMENTREPORTINGDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpenseMember": {
     "auth_ref": [
      "r211"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing expenses associated with normal operations.",
        "label": "Operating Expense [Member]",
        "terseLabel": "Operating Expense"
       }
      }
     },
     "localname": "OperatingExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "OPERATING EXPENSES"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r365",
      "r370",
      "r376",
      "r379",
      "r703"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "INCOME FROM OPERATIONS"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r623",
      "r725"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating lease cost"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsLeaseCost"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid [Abstract]",
        "terseLabel": "Operating Leases"
       }
      }
     },
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r614"
     ],
     "calculation": {
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      },
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Total",
        "totalLabel": "Total operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease",
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r614"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current portion of operating lease liability",
        "verboseLabel": "Current portion of operating lease liability"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r614"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Long-term operating lease liability",
        "verboseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r619",
      "r624"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating cash flows from operating leases"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsSupplementalCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r613"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "rdnt_PropertyPlantAndEquipmentNetIncludingRightOfUseAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use-assets",
        "verboseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "auth_ref": [
      "r756"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 21.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense for right-of-use asset from operating lease.",
        "label": "Operating Lease, Right-of-Use Asset, Amortization Expense",
        "terseLabel": "Amortization of operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r627",
      "r725"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Operating leases"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r626",
      "r725"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Operating leases - years"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r152"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforward"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwardsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Operating Loss Carryforwards [Line Items]",
        "terseLabel": "Operating Loss Carryforwards [Line Items]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLossCarryforwardsTable": {
     "auth_ref": [
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.",
        "label": "Operating Loss Carryforwards [Table]",
        "terseLabel": "Operating Loss Carryforwards [Table]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Assets [Abstract]",
        "terseLabel": "OTHER ASSETS"
       }
      }
     },
     "localname": "OtherAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax": {
     "auth_ref": [
      "r277",
      "r278"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 3.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax",
        "terseLabel": "Change in fair value cash flow hedge,\u00a0net of taxes"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax": {
     "auth_ref": [
      "r278",
      "r281"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 4.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax",
        "negatedTerseLabel": "Change in fair value of cash flow hedge from prior periods reclassified to earnings",
        "terseLabel": "Change in fair value of cash flow hedge from prior periods reclassified to earnings"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax": {
     "auth_ref": [
      "r37",
      "r39"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax",
        "terseLabel": "Change in cumulative foreign currency\u00a0translation adjustment"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r37"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Currency translation adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Expenses [Abstract]",
        "terseLabel": "OTHER INCOME AND EXPENSES"
       }
      }
     },
     "localname": "OtherExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r31"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other non-current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "negatedLabel": "Other expenses"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ParentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests.",
        "label": "Parent [Member]",
        "terseLabel": "Radnet, Inc. Stockholders' Equity"
       }
      }
     },
     "localname": "ParentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.",
        "label": "Payments of Debt Issuance Costs",
        "negatedTerseLabel": "Additional deferred finance costs on revolving loan amendment"
       }
      }
     },
     "localname": "PaymentsOfDebtIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBuildings": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for acquisition of buildings (properties) whether for investment or use.",
        "label": "Payments to Acquire Buildings",
        "negatedLabel": "Purchase of imaging centers and other operations"
       }
      }
     },
     "localname": "PaymentsToAcquireBuildings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r53",
      "r570"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "terseLabel": "Consideration transferred"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireEquityMethodInvestments": {
     "auth_ref": [
      "r53"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.",
        "label": "Payments to Acquire Equity Method Investments",
        "terseLabel": "Investment at cost"
       }
      }
     },
     "localname": "PaymentsToAcquireEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireIntangibleAssets": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.",
        "label": "Payments to Acquire Intangible Assets",
        "negatedTerseLabel": "Purchase of intangible assets",
        "terseLabel": "Purchase of intangible assets"
       }
      }
     },
     "localname": "PaymentsToAcquireIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireInterestInJointVenture": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the investment in or advances to an entity in which the reporting entity shares control of the entity with another party or group.",
        "label": "Payments to Acquire Interest in Joint Venture",
        "negatedLabel": "Equity contributions in existing and purchase of interest in joint ventures",
        "terseLabel": "Payments to acquire additional interest in subsidiaries"
       }
      }
     },
     "localname": "PaymentsToAcquireInterestInJointVenture",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from the acquisition of or improvements to long-lived, physical assets used to produce goods and services and not intended for resale, classified as other.",
        "label": "Payments to Acquire Other Property, Plant, and Equipment",
        "negatedLabel": "Purchase of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquireOtherPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToFundLongtermLoansToRelatedParties": {
     "auth_ref": [
      "r751",
      "r849"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with extending a long-term loan to a related party. Alternate caption: Payments for Advances to Affiliates.",
        "label": "Payments to Fund Long-Term Loans to Related Parties",
        "verboseLabel": "Payments to fund loan to related parties"
       }
      }
     },
     "localname": "PaymentsToFundLongtermLoansToRelatedParties",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToMinorityShareholders": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.",
        "label": "Payments to Noncontrolling Interests",
        "negatedLabel": "Distributions paid to noncontrolling interests"
       }
      }
     },
     "localname": "PaymentsToMinorityShareholders",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r794",
      "r795",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800",
      "r801",
      "r802",
      "r803",
      "r804",
      "r805",
      "r806",
      "r807",
      "r808",
      "r809",
      "r810",
      "r811",
      "r812",
      "r813",
      "r814",
      "r815",
      "r816",
      "r817",
      "r818",
      "r819"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [
      "r794",
      "r795",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800",
      "r801",
      "r802",
      "r803",
      "r804",
      "r805",
      "r806",
      "r807",
      "r808",
      "r809",
      "r810",
      "r811",
      "r812",
      "r813",
      "r814",
      "r815",
      "r816",
      "r817",
      "r818",
      "r819"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PortionAtFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r591"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured at fair value for financial reporting purposes.",
        "label": "Portion at Fair Value Measurement [Member]",
        "terseLabel": "Portion at Fair Value Measurement"
       }
      }
     },
     "localname": "PortionAtFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PostemploymentBenefitPlansPolicy": {
     "auth_ref": [
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for postemployment benefits. Postemployment benefits are benefits provided to former or inactive employees, their beneficiaries, and covered dependents after employment but before retirement, except for: a) benefits provided through a pension or postretirement benefit plan, b) individual deferred compensation arrangements, c) special or contractual termination benefits, and d) stock compensation plans.",
        "label": "Postemployment Benefit Plans, Policy [Policy Text Block]",
        "terseLabel": "EMPLOYEE BENEFIT PLAN"
       }
      }
     },
     "localname": "PostemploymentBenefitPlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r745"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDividendsReceived": {
     "auth_ref": [
      "r754"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Dividends received on equity and other investments during the current period.",
        "label": "Proceeds from Dividends Received",
        "terseLabel": "Received a dividend from the partnership"
       }
      }
     },
     "localname": "ProceedsFromDividendsReceived",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfDebt": {
     "auth_ref": [
      "r752"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.",
        "label": "Proceeds from Issuance of Debt",
        "terseLabel": "Proceeds from debt issuance, net of issuance costs"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": {
     "auth_ref": [
      "r55",
      "r145"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.",
        "label": "Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised",
        "terseLabel": "Proceeds from issuance of common stock upon exercise of options"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLinesOfCredit": {
     "auth_ref": [
      "r56",
      "r757"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Proceeds from Lines of Credit",
        "terseLabel": "Proceeds from revolving credit facility"
       }
      }
     },
     "localname": "ProceedsFromLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLoans": {
     "auth_ref": [
      "r63"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received from principal payments made on loans related to operating activities.",
        "label": "Proceeds from Loans",
        "terseLabel": "Proceeds from loans"
       }
      }
     },
     "localname": "ProceedsFromLoans",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.",
        "label": "Proceeds from Sale of Property, Plant, and Equipment",
        "terseLabel": "Proceeds from sale of equipment"
       }
      }
     },
     "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets": {
     "auth_ref": [
      "r750"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate cash proceeds received from a combination of transactions in which noncurrent assets are sold, which may include the sale of a business, an investment in an affiliate (including an equity method investee), property, plant and equipment and intangible assets. Excludes sales of trading, available-for-sale, and held-to-maturity securities.",
        "label": "Proceeds from Sales of Business, Affiliate and Productive Assets",
        "terseLabel": "Proceeds from sale of economic interest in majority owned subsidiary"
       }
      }
     },
     "localname": "ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r262",
      "r282",
      "r284",
      "r296",
      "r302",
      "r315",
      "r325",
      "r326",
      "r365",
      "r370",
      "r376",
      "r379",
      "r392",
      "r424",
      "r425",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r433",
      "r434",
      "r573",
      "r576",
      "r577",
      "r584",
      "r594",
      "r667",
      "r703",
      "r722",
      "r723",
      "r748",
      "r784"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "netLabel": "Net income",
        "terseLabel": "NET INCOME (LOSS)",
        "totalLabel": "NET INCOME (LOSS)",
        "verboseLabel": "Net income (loss)"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]",
        "terseLabel": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization": {
     "auth_ref": [
      "r777",
      "r842",
      "r845"
     ],
     "calculation": {
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation and amortization from plant, property, and equipment and right-of-use asset from finance lease.",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization",
        "negatedLabel": "Accumulated depreciation"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization": {
     "auth_ref": [
      "r778",
      "r845"
     ],
     "calculation": {
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization",
        "totalLabel": "Total property and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization": {
     "auth_ref": [
      "r744",
      "r776",
      "r841"
     ],
     "calculation": {
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization",
        "totalLabel": "Total property and equipment cost"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r115"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetails",
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r118",
      "r685",
      "r686",
      "r687"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "PROPERTY AND EQUIPMENT"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENT"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r114",
      "r266"
     ],
     "calculation": {
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Property and equipment, gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetails",
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetails",
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r115",
      "r251",
      "r668",
      "r726"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "rdnt_PropertyPlantAndEquipmentNetIncludingRightOfUseAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment, Net, Including and Excluding Capital Leased Asset [Abstract]",
        "terseLabel": "PROPERTY, EQUIPMENT AND RIGHT-OF-USE ASSETS"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r115",
      "r685",
      "r686"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "verboseLabel": "PROPERTY AND EQUIPMENT"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r115"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Schedule of Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetails",
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "PP&amp;E useful life"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ReceivablesPolicyTextBlock": {
     "auth_ref": [
      "r767",
      "r768",
      "r769",
      "r770"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.",
        "label": "Receivable [Policy Text Block]",
        "terseLabel": "ACCOUNTS RECEIVABLE"
       }
      }
     },
     "localname": "ReceivablesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]",
        "terseLabel": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]"
       }
      }
     },
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsUnrecognizedTaxBenefit"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReinsuranceContractAxis": {
     "auth_ref": [
      "r860"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by reinsurance contract.",
        "label": "Reinsurance Contract [Axis]",
        "terseLabel": "Reinsurance Policy, Type [Axis]"
       }
      }
     },
     "localname": "ReinsuranceContractAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r493",
      "r633",
      "r634"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]",
        "terseLabel": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionAxis": {
     "auth_ref": [
      "r257",
      "r633",
      "r634",
      "r851"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party transaction.",
        "label": "Related Party Transaction [Axis]",
        "terseLabel": "Related Party Transaction [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionDomain": {
     "auth_ref": [
      "r257"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transaction between related party.",
        "label": "Related Party Transaction [Domain]",
        "terseLabel": "Related Party Transaction [Domain]"
       }
      }
     },
     "localname": "RelatedPartyTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty": {
     "auth_ref": [
      "r226"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.",
        "label": "Related Party Transaction, Expenses from Transactions with Related Party",
        "terseLabel": "Expenses with related party"
       }
      }
     },
     "localname": "RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r493",
      "r633",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r851"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]",
        "terseLabel": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfDebt": {
     "auth_ref": [
      "r753"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.",
        "label": "Repayments of Debt",
        "negatedLabel": "Payments on term loan debt"
       }
      }
     },
     "localname": "RepaymentsOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLinesOfCredit": {
     "auth_ref": [
      "r58",
      "r757"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Repayments of Lines of Credit",
        "negatedTerseLabel": "Payments on revolving credit facility"
       }
      }
     },
     "localname": "RepaymentsOfLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for debt, mandatory redeemable security, and principal payment for finance lease obligation.",
        "label": "Repayment of Long-Term Debt, Long-Term Lease Obligation, and Capital Security",
        "negatedLabel": "Principal payments on notes and leases payable other than term loan debt"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebtAndCapitalSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock": {
     "auth_ref": [
      "r108",
      "r109",
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its research and development and computer software activities including the accounting treatment for costs incurred for (1) research and development activities, (2) development of computer software for internal use, (3) computer software to be sold, leased or otherwise marketed as a separate product or as part of a product or process and (4) in-process research and development acquired in a purchase business combination.",
        "label": "Research, Development, and Computer Software, Policy [Policy Text Block]",
        "terseLabel": "SOFTWARE DEVELOPMENT COSTS"
       }
      }
     },
     "localname": "ResearchDevelopmentAndComputerSoftwarePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r77"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Nonvested restricted stock subject to service vesting",
        "verboseLabel": "Restricted Stock"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUsandLTIPs",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r17",
      "r132",
      "r248",
      "r679",
      "r683",
      "r726"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r258",
      "r310",
      "r311",
      "r312",
      "r316",
      "r324",
      "r326",
      "r393",
      "r531",
      "r532",
      "r533",
      "r556",
      "r557",
      "r582",
      "r676",
      "r678"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r356",
      "r357",
      "r369",
      "r374",
      "r375",
      "r381",
      "r382",
      "r384",
      "r481",
      "r482",
      "r644"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Service fee revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofNetRevenue"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r484",
      "r699"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "SOFTWARE REVENUE RECOGNITION"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueNotFromContractWithCustomer": {
     "auth_ref": [
      "r749"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue that is not accounted for under Topic 606.",
        "label": "Revenue Not from Contract with Customer",
        "terseLabel": "Provider relief funding"
       }
      }
     },
     "localname": "RevenueNotFromContractWithCustomer",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "auth_ref": [
      "r699",
      "r700"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.",
        "label": "Revenue [Policy Text Block]",
        "terseLabel": "REVENUES"
       }
      }
     },
     "localname": "RevenueRecognitionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "auth_ref": [
      "r471"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "terseLabel": "Revenue, remaining performance obligation, amount"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDeferredRevenueRecognition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDeferredRevenueRecognition"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": {
     "auth_ref": [
      "r472"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period",
        "terseLabel": "Revenue, remaining performance obligation, expected timing of satisfaction, period"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDeferredRevenueRecognition"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": {
     "auth_ref": [
      "r472"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in YYYY-MM-DD format.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDeferredRevenueRecognition"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about expected timing for satisfying remaining performance obligation.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDeferredRevenueRecognition"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r290",
      "r302",
      "r356",
      "r357",
      "r369",
      "r374",
      "r375",
      "r381",
      "r382",
      "r384",
      "r392",
      "r424",
      "r425",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r433",
      "r434",
      "r594",
      "r667",
      "r784"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "terseLabel": "Net revenue",
        "verboseLabel": "Revenue:"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SEGMENTREPORTINGDetails",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "REVENUE"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAdditionalInformation",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstoPriorCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSecondAmendedandRestatedFirstLienCreditandGuarantyAgreement",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r625",
      "r725"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Operating leases"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsSupplementalCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.",
        "label": "Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Accounts Payable and Accrued Expenses"
       }
      }
     },
     "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r77"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable": {
     "auth_ref": [
      "r178"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of information about a contingent payment arrangement including the terms that will result in payment and the accounting treatment that will be followed if such contingency occurs, including the potential impact on earnings per share if the contingency is to be settled in shares of common stock of the entity. The description also may include the period over which amounts are expected to be paid, and changes in the amount since the previous reporting period. This also includes contingent options and commitments.",
        "label": "Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table]",
        "terseLabel": "Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsContingentConsideration"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of contingent payment arrangements including the terms that will result in payment and the accounting treatment that will be followed if such contingencies occur, including the potential impact on earnings per share if contingencies are to be settled in common stock of the entity. The description also may include the period over which amounts are expected to be paid, and changes in the amount since the previous reporting period. This also includes contingent options and commitments.",
        "label": "Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block]",
        "terseLabel": "Schedule of Business Acquisitions by Acquisition, Contingent Consideration"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r161",
      "r162",
      "r569"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsAssetsandLiabilitiesAssumed",
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": {
     "auth_ref": [
      "r161",
      "r162"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]",
        "terseLabel": "Schedule of Business Acquisitions Acquired Assets and Assumed Liabilities"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r209"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.",
        "label": "Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Effect of Derivative Instruments on Comprehensive (Loss) Income"
       }
      }
     },
     "localname": "ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented.",
        "label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]",
        "terseLabel": "Schedule of Cash Flow, Supplemental Disclosures"
       }
      }
     },
     "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/LEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r155"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Schedule of Components of Income Tax Expense"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "terseLabel": "Schedule of Revolving Credit Facility, Notes Payable, and Capital Lease Obligations"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r151"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Deferred Tax Assets and Liabilities"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r765"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Earnings Per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Reconciliation of Income Tax Expense"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable": {
     "auth_ref": [
      "r87"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular presentation of the description and amount of revenues from a product or service, or a group of similar products or similar services, reported from external customers during the period, if the information is not provided as part of the reportable operating segment information.",
        "label": "Revenue from External Customers by Products and Services [Table]",
        "terseLabel": "Revenue from External Customers by Products and Services [Table]"
       }
      }
     },
     "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofNetRevenue"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Schedule of Equity Method Investments [Line Items]",
        "terseLabel": "Schedule of Equity Method Investments [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsTable": {
     "auth_ref": [
      "r94",
      "r262",
      "r302",
      "r392",
      "r594"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available.",
        "label": "Schedule of Equity Method Investments [Table]",
        "terseLabel": "Schedule of Equity Method Investments [Table]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r98",
      "r102",
      "r645"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule",
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r704"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "auth_ref": [
      "r759"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.",
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "terseLabel": "Schedule of Income before Income Tax, Domestic and Foreign"
       }
      }
     },
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r106",
      "r107"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity.",
        "label": "Schedule of Indefinite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Indefinite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": {
     "auth_ref": [
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.",
        "label": "Schedule of Intangible Assets and Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Goodwill and Other Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
        "label": "Schedule of Maturities of Long-Term Debt [Table Text Block]",
        "terseLabel": "Schedule of Annual Principal Maturities of Notes Payable"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock": {
     "auth_ref": [
      "r138"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock units.",
        "label": "Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]",
        "terseLabel": "Schedule of RSA Activity"
       }
      }
     },
     "localname": "ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock": {
     "auth_ref": [
      "r138"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested shares.",
        "label": "Schedule of Nonvested Share Activity [Table Text Block]",
        "terseLabel": "Schedule of LTIPs"
       }
      }
     },
     "localname": "ScheduleOfNonvestedShareActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock": {
     "auth_ref": [
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of revenue by reporting categories or types of financial instruments, including derivatives but excluding dividends and interests, from trading for own account by broker dealers.",
        "label": "Schedule of Principal Transactions Revenue [Table Text Block]",
        "terseLabel": "Schedule of Service Fee Revenue"
       }
      }
     },
     "localname": "ScheduleOfPrincipalTransactionsRevenueTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r115"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetails",
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r84",
      "r85",
      "r86",
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SEGMENTREPORTINGDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r84",
      "r85",
      "r86",
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SEGMENTREPORTINGTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r497",
      "r499",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUsandLTIPs"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r135",
      "r139",
      "r140"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Schedule of Options Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": {
     "auth_ref": [
      "r721",
      "r824"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the change in unrecognized tax benefits.",
        "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]",
        "terseLabel": "Schedule of Unrecognized Tax Benefits"
       }
      }
     },
     "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r102"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Schedule of Annual Amortization Expense"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember": {
     "auth_ref": [
      "r836"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixed rate on U.S. dollar, constant-notional interest rate swap that has its variable-rate leg referenced to Secured Overnight Financing Rate (SOFR) with no additional spread over SOFR on variable-rate leg.",
        "label": "Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]",
        "terseLabel": "Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate"
       }
      }
     },
     "localname": "SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SecuritiesFinancingTransactionAxis": {
     "auth_ref": [
      "r228"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of securities financing transactions, including, but not limited to those measured at fair value or cost.",
        "label": "Securities Financing Transaction [Axis]",
        "terseLabel": "Securities Financing Transaction [Axis]"
       }
      }
     },
     "localname": "SecuritiesFinancingTransactionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SecuritiesFinancingTransactionTypeDomain": {
     "auth_ref": [
      "r228"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement of financing transaction securities held.",
        "label": "Securities Financing Transaction [Domain]",
        "terseLabel": "Securities Financing Transaction [Domain]"
       }
      }
     },
     "localname": "SecuritiesFinancingTransactionTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r353",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r379",
      "r384",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r418",
      "r419",
      "r704",
      "r862"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill",
      "http://www.radnet.com/role/SEGMENTREPORTINGDetails",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r353",
      "r354",
      "r355",
      "r365",
      "r368",
      "r373",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r383",
      "r384",
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "SEGMENT REPORTING"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SEGMENTREPORTING"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SEGMENTREPORTINGDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SelfInsuranceReserve": {
     "auth_ref": [
      "r31"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions) of accrued known and estimated losses incurred as of the balance sheet date for which no insurance coverage exists, and for which a claim has been made or is probable of being asserted, typically arising from workmen's compensation-type of incidents and personal injury to nonemployees from accidents on the entity's property.",
        "label": "Self Insurance Reserve",
        "terseLabel": "Self-insurance accrual"
       }
      }
     },
     "localname": "SelfInsuranceReserve",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeveranceCosts1": {
     "auth_ref": [
      "r66"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.",
        "label": "Severance Costs",
        "terseLabel": "Severance costs",
        "verboseLabel": "Severance"
       }
      }
     },
     "localname": "SeveranceCosts1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SEGMENTREPORTINGDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r718"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "terseLabel": "Share-based payment award, award vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUsandLTIPs",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r517"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedTerseLabel": "Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUsandLTIPs"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r517"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeited (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUsandLTIPs"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r515"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUsandLTIPs"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r515"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUsandLTIPs"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r512",
      "r513"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "terseLabel": "RSA's unvested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUsandLTIPs"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r512",
      "r513"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Ending balance (in dollars per share)",
        "periodStartLabel": "Beginning balance (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUsandLTIPs"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted-Average Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUsandLTIPs"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms": {
     "auth_ref": [
      "r141"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms",
        "terseLabel": "Weighted-Average Remaining Contractual Term (Years)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUsandLTIPs"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r516"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "Vested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUsandLTIPs"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r516"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUsandLTIPs"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUsandLTIPs"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber": {
     "auth_ref": [
      "r136",
      "r137"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of equity instruments other than options outstanding, including both vested and non-vested instruments.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number",
        "periodEndLabel": "Outstanding, ending balance (in shares)",
        "periodStartLabel": "Outstanding, beginning balance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUsandLTIPs"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]",
        "terseLabel": "RSA's"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUsandLTIPs"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r720"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized",
        "verboseLabel": "Shares authorized (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r144"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Number of shares available in grant (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUsandLTIPs"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "periodEndLabel": "Exercisable at the end (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "periodEndLabel": "Exercisable at the end (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Options granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r144"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "periodEndLabel": "Aggregate value outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r504",
      "r505"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Ending Balance (in shares)",
        "periodStartLabel": "Beginning Balance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r504",
      "r505"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Ending Balance (in dollars per share)",
        "periodStartLabel": "Beginning Balance (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted Average Exercise price Per Common Share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": {
     "auth_ref": [
      "r144"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued under share-based payment arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period",
        "terseLabel": "Stock-based compensation (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUsandLTIPs"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Exercised (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks of a company.",
        "label": "Share Price",
        "terseLabel": "Share price"
       }
      }
     },
     "localname": "SharePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": {
     "auth_ref": [
      "r794"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of vesting of award under share-based payment arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage",
        "terseLabel": "Award vesting rights, percentage"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUsandLTIPs"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r719"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period",
        "terseLabel": "Share-based payment award, expiration period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r144"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
        "periodEndLabel": "Aggregate value exercisable"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r141"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Balance at end of period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r142"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term of exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Exercisable at the end"
       }
      }
     },
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShortTermBorrowings": {
     "auth_ref": [
      "r6",
      "r232",
      "r246",
      "r726"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.",
        "label": "Short-Term Debt",
        "verboseLabel": "Convertible promissory note"
       }
      }
     },
     "localname": "ShortTermBorrowings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortTermDebtTypeAxis": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of short-term debt arrangement.",
        "label": "Short-Term Debt, Type [Axis]",
        "terseLabel": "Short-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "ShortTermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtTypeDomain": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.",
        "label": "Short-Term Debt, Type [Domain]",
        "terseLabel": "Short-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "ShortTermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r75",
      "r300"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SoftwareDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Internally developed software for sale, licensing or long-term internal use.",
        "label": "Software Development [Member]",
        "terseLabel": "Software development costs"
       }
      }
     },
     "localname": "SoftwareDevelopmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule",
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations": {
     "auth_ref": [
      "r759",
      "r822",
      "r829"
     ],
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDetailsIncomeTaxExpense": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current and deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current and deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "State and Local Income Tax Expense (Benefit), Continuing Operations",
        "terseLabel": "State current tax"
       }
      }
     },
     "localname": "StateAndLocalIncomeTaxExpenseBenefitContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsIncomeTaxExpense"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State and Local Jurisdiction"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r261",
      "r353",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r379",
      "r384",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r416",
      "r418",
      "r419",
      "r704",
      "r862"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill",
      "http://www.radnet.com/role/SEGMENTREPORTINGDetails",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r33",
      "r126",
      "r258",
      "r287",
      "r288",
      "r289",
      "r310",
      "r311",
      "r312",
      "r316",
      "r324",
      "r326",
      "r347",
      "r393",
      "r468",
      "r531",
      "r532",
      "r533",
      "r556",
      "r557",
      "r582",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r631",
      "r676",
      "r677",
      "r678"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r310",
      "r311",
      "r312",
      "r347",
      "r644"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": {
     "auth_ref": [
      "r14",
      "r15",
      "r132"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.",
        "label": "Stock Issued During Period, Shares, Acquisitions",
        "terseLabel": "Issuance of stock for acquisitions (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "auth_ref": [
      "r32",
      "r126",
      "r127",
      "r132",
      "r452"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.",
        "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities",
        "terseLabel": "Issuance of common stock for sale of unregistered securities for the DeepHealth acquisition (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r14",
      "r15",
      "r126",
      "r132"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "Shares issued under the equity compensation plan (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares (or other type of equity) forfeited during the period.",
        "label": "Shares Issued, Shares, Share-Based Payment Arrangement, Forfeited",
        "negatedLabel": "Forfeiture of restricted stock (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensationForfeited",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r14",
      "r15",
      "r126",
      "r132",
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "negatedTerseLabel": "Exercised (in shares)",
        "terseLabel": "Issuance of stock upon exercise of options (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueAcquisitions": {
     "auth_ref": [
      "r33",
      "r126",
      "r132"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued pursuant to acquisitions during the period.",
        "label": "Stock Issued During Period, Value, Acquisitions",
        "terseLabel": "Issuance of stock for acquisitions"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": {
     "auth_ref": [
      "r33",
      "r126",
      "r132"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities.",
        "label": "Stock Issued During Period, Value, Conversion of Convertible Securities",
        "terseLabel": "Issuance of common stock for acquisitions"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited": {
     "auth_ref": [
      "r143"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of forfeited shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-Based Payment Arrangement, Forfeited",
        "negatedTerseLabel": "Forfeiture of restricted stock"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensationForfeited",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r33",
      "r126",
      "r132"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Issuance of stock upon exercise of options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option).",
        "label": "Equity Option [Member]",
        "terseLabel": "Equity Option"
       }
      }
     },
     "localname": "StockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r15",
      "r18",
      "r19",
      "r88",
      "r726",
      "r758",
      "r771",
      "r839"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "terseLabel": "Accumulated other comprehensive income",
        "totalLabel": "Total RadNet, Inc.'s stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "EQUITY"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r182",
      "r183",
      "r196",
      "r258",
      "r259",
      "r288",
      "r310",
      "r311",
      "r312",
      "r316",
      "r324",
      "r393",
      "r468",
      "r531",
      "r532",
      "r533",
      "r556",
      "r557",
      "r582",
      "r599",
      "r600",
      "r604",
      "r631",
      "r677",
      "r678",
      "r758",
      "r771",
      "r839"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending balance, value",
        "periodStartLabel": "Beginning balance, value",
        "totalLabel": "Total equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Note [Abstract]",
        "terseLabel": "RadNet, Inc. stockholders' equity:"
       }
      }
     },
     "localname": "StockholdersEquityNoteAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r605",
      "r637"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r605",
      "r637"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r605",
      "r637"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]",
        "terseLabel": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r636",
      "r638"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "SUBSEQUENT EVENTS"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUBSEQUENTEVENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TradeNamesMember": {
     "auth_ref": [
      "r166"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trade Names [Member]",
        "terseLabel": "Trade Names"
       }
      }
     },
     "localname": "TradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrealizedGainLossOnDerivatives": {
     "auth_ref": [
      "r66"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.",
        "label": "Unrealized Gain (Loss) on Derivatives",
        "negatedTerseLabel": "Non-cash change in fair value of interest rate swap"
       }
      }
     },
     "localname": "UnrealizedGainLossOnDerivatives",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r535",
      "r544"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Unrecognized tax benefit, Balance at end of year",
        "periodStartLabel": "Unrecognized tax benefit, Balance at beginning of year",
        "terseLabel": "Unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsNarrative",
      "http://www.radnet.com/role/INCOMETAXESDetailsUnrecognizedTaxBenefit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": {
     "auth_ref": [
      "r543"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued",
        "terseLabel": "Unrecognized tax benefits, income tax penalties and interest accrued"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r546"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "terseLabel": "Increases related to current year tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsUnrecognizedTaxBenefit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r545"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "terseLabel": "Increases related to prior year tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsUnrecognizedTaxBenefit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": {
     "auth_ref": [
      "r547"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.",
        "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations",
        "negatedLabel": "Expiration of the statute of limitations for the assessment of taxes"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsUnrecognizedTaxBenefit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnusualOrInfrequentItemAxis": {
     "auth_ref": [
      "r51"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by an event or transaction that is unusual in nature or infrequent in occurrence, or both.",
        "label": "Unusual or Infrequent Item, or Both [Axis]",
        "terseLabel": "Unusual or Infrequent Item, or Both [Axis]"
       }
      }
     },
     "localname": "UnusualOrInfrequentItemAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstoPriorCreditFacilities",
      "http://www.radnet.com/role/SEGMENTREPORTINGDetails",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UnusualOrInfrequentItemDomain": {
     "auth_ref": [
      "r51"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event or transaction that is unusual in nature or infrequent in occurrence, or both.",
        "label": "Unusual or Infrequent Item, or Both [Domain]",
        "terseLabel": "Unusual or Infrequent Item, or Both [Domain]"
       }
      }
     },
     "localname": "UnusualOrInfrequentItemDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstoPriorCreditFacilities",
      "http://www.radnet.com/role/SEGMENTREPORTINGDetails",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r80",
      "r81",
      "r82",
      "r348",
      "r349",
      "r351",
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "USE OF ESTIMATES"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationTechniqueAxis": {
     "auth_ref": [
      "r216"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by valuation approach and technique.",
        "label": "Valuation Approach and Technique [Axis]",
        "terseLabel": "Valuation Approach and Technique [Axis]"
       }
      }
     },
     "localname": "ValuationTechniqueAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ValuationTechniqueDomain": {
     "auth_ref": [
      "r216"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation approach and technique.",
        "label": "Valuation Approach and Technique [Domain]",
        "terseLabel": "Valuation Approach and Technique [Domain]"
       }
      }
     },
     "localname": "ValuationTechniqueDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/BUSINESSCOMBINATIONSANDRELATEDACTIVITYDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense": {
     "auth_ref": [
      "r195"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense between the reporting entity and the Variable Interest Entity (VIE).",
        "label": "Variable Interest Entity, Measure of Activity, Expense",
        "terseLabel": "BRMG and NY Groups operating expenses"
       }
      }
     },
     "localname": "VariableInterestEntityActivityBetweenVIEAndEntityExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax": {
     "auth_ref": [
      "r195"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the amount of pre-tax income (loss) derived by the reporting entity from the Variable Interest Entity (VIE).",
        "label": "Variable Interest Entity, Measure of Activity, Income or Loss before Tax",
        "terseLabel": "Management services provided to BRMG and NY Groups"
       }
      }
     },
     "localname": "VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues": {
     "auth_ref": [
      "r195"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of income between the reporting entity and the Variable Interest Entity (VIE).",
        "label": "Variable Interest Entity, Measure of Activity, Revenues",
        "terseLabel": "BRMG and NY Groups revenues"
       }
      }
     },
     "localname": "VariableInterestEntityActivityBetweenVIEAndEntityRevenues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableInterestEntityOwnershipPercentage": {
     "auth_ref": [
      "r194"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly).",
        "label": "Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage",
        "terseLabel": "Economic interest"
       }
      }
     },
     "localname": "VariableInterestEntityOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_VariableInterestEntityPrimaryBeneficiaryMember": {
     "auth_ref": [
      "r193",
      "r574",
      "r575",
      "r579",
      "r580"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Interest Entities (VIE) in which the entity has a controlling financial interest (as defined) and of which it is therefore the primary beneficiary. A controlling financial interest is determined based on both: (a) the entity's power to direct activities of the VIE that most significantly impact the VIE's economic performance and (b) the entity's obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE. VIEs of which the entity is the primary beneficiary are included in the consolidated financial statements of the entity.",
        "label": "Variable Interest Entity, Primary Beneficiary [Member]",
        "terseLabel": "Variable Interest Entity, Primary Beneficiary"
       }
      }
     },
     "localname": "VariableInterestEntityPrimaryBeneficiaryMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r331",
      "r344"
     ],
     "calculation": {
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Weighted average number of common shares used in calculating diluted net income per share (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r330",
      "r344"
     ],
     "calculation": {
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare": {
       "order": 3.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Weighted average number of common shares outstanding during the period (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesRestrictedStock": {
     "auth_ref": [
      "r76"
     ],
     "calculation": {
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of restricted stock determined by relating the portion of time within a reporting period that restricted shares have been outstanding to the total time in that period. Restricted shares are subject to sales, contractual, regulatory or other restrictions that prevent or inhibit the holder from freely disposing of them before the restriction ends.",
        "label": "Weighted Average Number of Shares, Restricted Stock",
        "terseLabel": "Add nonvested restricted stock subject only to service vesting (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesRestrictedStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WorkersCompensationLiabilityCurrent": {
     "auth_ref": [
      "r27"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations and payables pertaining to claims incurred of a workers compensation nature. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Workers' Compensation Liability, Current",
        "terseLabel": "Workers' compensation liability, current"
       }
      }
     },
     "localname": "WorkersCompensationLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    }
   },
   "unitCount": 13
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/subtopic&trid=2122178",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "https://asc.fasb.org/topic&trid=2122149",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(23))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b),(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "40",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=118172244&loc=d3e17916-109280",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "50",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=16397303&loc=d3e19347-109286",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "https://asc.fasb.org/topic&trid=2144416",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2420-110228",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "https://asc.fasb.org/topic&trid=2155823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12317-112629",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12355-112629",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f(1))",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "c(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(a)-(d)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=6909625&loc=d3e227-128457",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e961-128460",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6578-128477",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6613-128477",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966325&loc=d3e6819-128478",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "b",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966325&loc=d3e6819-128478",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(4)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(3)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "c",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "740",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966508&loc=d3e9972-128506",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "740",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966508&loc=d3e9979-128506",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "https://asc.fasb.org/topic&trid=2303972",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4613674-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569655-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=SL6759159-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "d",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5747-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4M",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591554-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(24))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5708775-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13476-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL6224234-111729",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "320",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=35711157&loc=d3e42567-110969",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "(c)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(2))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e689-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(23))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(25))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(n))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-30)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=SL108384541-122693",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "250",
   "URI": "https://asc.fasb.org/topic&trid=2122394",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1707-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1757-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1828-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225877-175312",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "https://asc.fasb.org/topic&trid=2134510",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)(1)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)(2)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(26))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(8))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130561-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130564-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org/topic&trid=49130388",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "712",
   "URI": "https://asc.fasb.org/topic&trid=2197446",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(a)(5))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=114868883&loc=SL114871943-224233",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e7008-128479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594809&loc=d3e13220-108610",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594809&loc=SL116692626-108610",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "https://asc.fasb.org/topic&trid=2175825",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342832&loc=SL128342943-244231",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21D",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=SL94080555-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123386189&loc=SL77918607-209975",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918631-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918666-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/subtopic&trid=77888251",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "https://asc.fasb.org/topic&trid=2122774",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(1)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(2)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(3)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(25))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(21))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "450",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491354&loc=d3e6049-115624",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=SL120174063-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "217",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126976462&loc=d3e36027-109320",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r729": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r730": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r731": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r732": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r733": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r734": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r735": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r736": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r737": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r738": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(10))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r751": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r752": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r753": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r754": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3337-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r755": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r756": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r757": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r758": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r759": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2646-109256",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r760": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r761": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r762": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r763": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r764": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r765": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r766": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r767": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r768": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r769": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r770": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r771": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r772": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r773": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r774": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r775": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2443-110228",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r776": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r777": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r778": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r779": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r780": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r781": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r782": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r783": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r784": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r785": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r786": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r787": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r788": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r789": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r790": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r791": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r792": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r793": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r794": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r795": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r796": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r797": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r798": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r799": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r800": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r801": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r802": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r803": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r804": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r805": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r806": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r807": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r808": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r809": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r810": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r811": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r812": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r813": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r814": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r815": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r816": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r817": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r818": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r819": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r820": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r821": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "740",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126970579&loc=d3e23163-113944",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r822": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r823": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r824": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r825": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r826": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r827": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r828": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r829": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "https://asc.fasb.org/topic&trid=2134479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r830": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r831": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=6911878&loc=d3e8732-128492",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r832": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r833": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r834": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r835": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r836": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=124256753&loc=SL5864739-113975",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r837": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r838": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r839": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r840": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r841": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r842": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r843": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r844": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r845": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r846": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r847": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r848": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r849": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r850": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r851": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r852": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r853": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r854": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r855": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r856": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r857": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r858": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r859": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r860": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=99397103&loc=d3e6811-158387",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r861": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r862": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=126960272&loc=d3e32014-111567",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(b)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>111
<FILENAME>0000790526-23-000003-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000790526-23-000003-xbrl.zip
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M,#(R97AH:6)I=#(S,2YH=&W=6&UOVS80_KY?<76P= 6L=]OR6PUD3HH6=;/
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M]+<JP)3R6[,0R2<OTMU[2[171D64(@Y3T.+D<7S]>U]WC\^6)*Z(D@.DSN%
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M-^1V<&XD<FX8/B14<:;[_DR1LYZ>"#ZP?,G9,L#0_?Q;__,?N813(OX#@'S
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M(_.:O<?H&J:NQNOO'9@W3A2(&!?IV8I N>L*$V\:ZN@O %@C%?1TIO1MYH6
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MLVC%3!,.<5F!M^%=]<<*>66]+LY?1_X!WR-2@3ZF)J'71O.<O#0)89XCYT"
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MFCII82BR,>--;JXH_$ WA+<T0+5 OZU<YN;2FX''-:/9R7R *<C5_F+ER4:
M'97H'DZ)0$T0R*YP6;>C\B<OZ;(1 ">JH9@14F#ZQB!7AQ]F]OF(E\<#D5O#
M<3*YUJ]5G:U;"_>(14T%ZER$2F\8SX%]XEITE\JO>539Y% !CBE[GTVY0P)X
MR<XD@@C*$&,<Y0JP#N6O+'A?OL+=>3<>#@D@HE2U^#9C!DCO]G6"_\X"W=:@
M'M8'10>]4C[JZZ0NL"I)C12+!(%WUF[5Q5QI#&T7I#,3VDP8?WF7$W,&_SX0
M4K*<U+UUC1@(N(Q]:O9F@B0ES82__5$<3:>]!X*I?F%C+-,3?6M=MG:ZEP$1
M 7>]%-_>O%8>V4G>@M)8(ON]P0/= W4W5F[!S=MWSMO1>8@S;YGPA!6Y4XQV
M(+&V/;G%.30-H&>N[]*C1JG@D/.-,L$;5*[P?T698C&?.<P&/2:>IS9A1-6Q
MWE=LXZRS?WT\.Y"#2GA>?4_\-V-ROZCVC?1XHP=HT&_ADAI1!"KM(!EN21M;
M0/YAQ,G4+)AAK 04KW([R9MD2>4D:6F?3VFB -;04'*5BN.>-A:W@4$&$TM'
MY.Z<]9#H]A[YG;6(DS:8U,A$49JC!Z[.C_[SY 33W-+01%*^@]H\37!)D999
M<.* _K,LX,J':V%=:2$](X6=(K>=X.8 O>-B952M-,I3"8\]\ZWI?,\A?XZY
M[(GD@/'Z@TLYOI&4([^XK#F/&:4<P0,%/Z4*>9< %['/[HV&R*3^"A-K6KG5
MV2L*O5:0]T[DR"V$HKC2FWHY0='JG=Q)OI0@\=C= ^_.J"FKC3B\)LJC::P=
M@08W826_:?NBBQ1J1*^%GQ2$9*5[@5;PV;R,LFB["AZ.CKYHW.+X4\8MCB?B
M%L>?(VZ1LA''KU;H4 OXDNAGE[L.6KV\TBD0^=K1TS3Y*/W(J&"O[J[L@(4T
M1J:D[*3T( #93_UTEP75#8ELL" '2/6\51@:Z_+$?OQ5(A("33[V05-OI.P\
MG2\0B.6:9GL;M7EWRL)*BP#&J7]WV71D)\/X"Q@AGI=BOH /6&):^^#*[**Z
M!K45@CS"G:TDPB!^D+.+$W(^M35L[DXK WXF@ZE8:*'S&QX*4G@O@*Q]&685
M2@Q<"TT%C2NVDYI[V,EE!3*C#6F39":6SSM(-9?,5WD=!;&V_@:5:/P.\4)+
MC#;GU',S2.KOA%-D!7CT5U;[=M4RU!C_'^/YT9!V@J4V<A^PV2D_,.K=CD>;
M.,,P&=AWE:OXO.,EXJ6?8B[Z@N\J^<W2QZA^UQG.)=EI393,C/13  )]?L-W
M[G!V?&DWQ0+E.ST#C"MQN'S9C7<G'9=O0#JC*JJ^XG)2Q4KQ.[U_433$B\P#
M;(6E-7^9OQ$VWKJOT8J=!V*8-8\N7^5LE_B[ZPMD3L)-S!+'D1O:[<18Z=@<
M7.05(NCXR>Z1@6F['4HPW00CC\H=M1K3LPE\]EE"%Y(?O*%?W.[S]14DAN[-
MS!5[C6;0I3MQ\P":/%L.MWY#&V$O8_>9-?XLSWVCE2$\(&;W$;W%U(>&*-!B
M@C%IBG9M/XB<2)GWXQ!%%<K6AE3><*LF+;;CQ/WNG>B0&6U.J>O*-ZG(5MQ>
MM&ZZT)&-,@G,C[4>D%'2K3[32N.HZ>4TJ?W0[,S*E8PBQ@<#,H&&["#I'&QW
M5=ECRFJ]L>R$06??P#YW!&/]\^I,N31SVCLJ(N ^[3]_KU(GGG0G-VS[(2GN
M,O#@W,0$Y9MZHCA3E[\'/[!CIMI+YEFT$R/#-6@:IV:34O#6I-)W("5].%VM
MWF$5.ZXFX&-F\4QW_80T,WPC_9-(*2^=;OH&%C)GUGFPY&9;:S5CDB6-/*-Q
M)$S%*8)"+GBB,.7JS&B F,Z33R_&>RO*U$UFTS(IW^F2C8I(6^FO67I=8=)+
M*U1X5G7%U7[2;N*OZ$XX:1L&.,650WS%D,[0ND2NEB#YVDH_W\248U='&W_H
MA36FDT@L.QJU-6@.TTHW%V,/\V1!I4GCP_0UVKX4D(L9)K-4B9,\3W5KG2CC
MI!U@8B*M#(F,!X](:#N.[OR#0UY+O0S8R4;V%#5BBIR UBJU$7OPNUN^-H.+
M7*4'T[=9I9.$HE%"9H^!'*ZT&-QHL2154*/Z=Q+(0"'B%.A; US !H4?00/I
M,1BY#LS@SI7X-OM10FQX94546N<N9'/TVK(U*0_"PFW3>Z_2T8WI/K1>1==E
M.9;(F>K6W-GME]!&7(.$W LW"1G=7)CBXWH/<;$\KA*F_18"!<_^JP%XTEV_
M'8TXG6;9 <^Z*>')\!N=,^[&G0ZNNQ_I?C>32*X#XXHZ&YK;XW5Q=P3*DVV#
MVM& P'U,E&#H:)?@Q T?.SWYXR_JR9]\2D_^9,*3/_D<GGR4&E0#0-U7':#J
MQEZ-YY]!YOI1S+5./7-^M-R6D-#$H&8WKHH;2 !R)Q*:\23V<5P]K75VR=I"
M+[;U.HY=1.$6&[V?%][;+2\P.?CUBTL%E[,HTB.GW:T?)S=WB\WQA&$5^*Y2
M816L!O[M1ZMP=]PX>YWLD!:5*TE2*\;UGW-1=_'>[-V?C<>7@X9VH'&(Q^FI
MJ#I66Z:#^Q247LJ&N@@H]2N=Q!9>/1XM=C<Y96X?M=X!V:$X3N^CBD+PSH+6
M7N VGG3$H[2\HII(:MJ\NY*69>EX)/&'FA;'95YS^$KL&L:/V);,*R_,?R[?
MOKAX\\;\YZ>+UQ<O?QC/$8E\_&L;CPI+%6LT9WO7Y!AZX;.7SU^=O?CUD;EX
M_NJ7E[]>7#PRYO79^8N+M^;YV8NS'R^>7[QXF]&^GAV8\[-_7YZ;GP_,/\_>
M_E]CGMX^,MN:]1=Y']4?AB=W<TKAQP/SU#9K]OJ?'YP?9'S+;8L\%7?;[Q+W
M)U]4W-_[E.+^WH2XO_<YQ/W%__GI\NGE6W/&>'SQP^4YX>KR[)?+M[^:LQ]?
M7P!WNR%^[S-#?/#/TY?GO_*_/[U]_LOW_Q]02P,$%     @ X(MA5F&D @VW
M"   JT   !0   !Q-#(P,C)E>&AI8FET,S$Q+FAT;>U<;7/:2!+^?K]BEM3E
MI4H("4PPV'&5C<F%VL1.V:2R^^EJD$8PYY%&.S,"<[]^NT?BQ082G,U>X*)\
M4)#FK7NF]?33/2.?_G)YW1W\_K%'QB86Y..GB_?]+JE4:[7/C6ZM=CFX).\&
M']Z3(]?SR4#11'/#94)%K=:[JI#*V)BT4ZM-IU-WVG"E&M4&-S7LZJ@FI-3,
M#4U8.3O%)W!E-#S[Q^DOU2JYE$$6L\200#%J6$@RS9,1^1PR?4>JU:)65Z8S
MQ4=C0^I>O4$^2W7')S0O-]P(=C;OY[26WY_6[""G0QG.SDY#/B$\?%/A#:_5
M;M3K]#5K>T>L.3SV&'W=:+3\>LOWCAK^OWT0L@;5\S;:S 1[4XEY4ATS'+]S
M5'=;S=2<3'EHQAW?\_Y9L57/3B.9&!A/0?O\9][-6F>&W9LJ%7R4=*Q*)_8!
M3T*0ON.WCU-3R3N;-PBDD*KSS+/_3K"D&M&8BUGGQ8#'3),K-B4W,J;)"T?#
MPE0U4SS**VK^7P92@L#V=IHKT8)^!$_87"F_CFKT?GO7O^@/2,-W_8<Z;)8^
M (&9^MN%/=HH[/-G_FOO9(_$W#RGW=[-H/^VWST?]*^OX*VZN?UT?C4@@^N]
ME]P_)I_<6[?KDMM>UTKO-YK>WHM]?DO.+Z\_#GJ7!S7;\SEN>'5R_98,WO7(
M[?G-Q?E5[[9Z_=O[WN_DO#O DKKGU?=>FRTOYX]!BKY#WLDI52'YETLNF!HQ
MY9 /[J7KD( IPZ,9,6-JGC]K'N^+R'LU?[Z;B[/+M4_&=,*(8A/.IN#,S9AK
MN$NE,D0FY*U4,?&]ZJ]$1N2&AE?,.*2?!#!"L[TO^N[5Y->?,/D75,.4PS3'
M,W*7R*E@X8@Y#]8@E"!:(H%MP<B4)X0F,Y(E1F4,- /^9:D8+ XE,=PI3@6)
M: "/%)$Q-\3(O-Y:A80%3&NJ9E@EIG<,QEWI4\.S$(2!(87E<3 &5@BX MX&
MU1)H#I*$3)'IF =CHC.\+-M/F6)%)ZA S+4 @H=<<<K-&!34*0NL@-AO"J+)
M$-2<0+.0#&>KTU!:VQ9A&M_#VAB)> +KB::Q7#\'3 VJ0[%:*>=)!)! ,9*
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M_7!\1;W1_+E\Q;#T%8?H*W:FV6LN8W>"OK/G &\SX2$Z!*IE8H&):G FF.%
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M?>Y^!T)^0!RXY/^O@_L/$^?_!5!+ P04    " #@BV%6CL,D#1$%  !4&@
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MJ8^+3YYP;*_5>8L]^3G_ U!+ P04    " #@BV%6F'F@*_X$  #D&0  %
M '$T,C R,F5X:&EB:70S,C(N:'1M[5EM;]LV$/Z^7W%UL38%;+W93OS6 *[M
MH,;:.(A5M/TTT"(5$Z5(E:+C>+]^1\I*FCC9^F%;;:Q!(,BZX_&Y>X[4G3AX
M-IZ-XL\7$UB:3,#%AS?OIB.H-7S_8W/D^^-X#&_C]^^@Y04AQ)K(@ANN)!&^
M/SFO06UI3-[S_?5Z[:V;GM)7?GSI6U,M7RA5,(\:6CL=V"=X982>_C)XUFC
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M\)GA*=[D*UVL"#)FE 7HXF=S=SM@3O2"2%8T9C>";6"8N##:W*VCG"":=N<
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M8$-US78.">[*"M<1!'=#R )KBY5Y>LA3'_N>/''87LOS#W<2<_HG4$L#!!0
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MW>:'?_?WCIZYO==OU.:'@P][0I;M5X^-)$QF[\,Z[+]Z_+X19_\_ARH?_3[
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M<M;SH\[.]<\?OGB)BV=W<2>="+4"IS6F:#':#"@ZK%3K*J+FK)W2X4MS.P^
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MDF18LDF:Q6.;O3>N@H#)%DHQF$EI:-L_<JW5PNIAN_@5=HMQQT'<KSQT-BZ
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M$DO47MR^A@(U4<PYU1*<4D52,Z7NN^OO,J$6$G:4M]54%TQB<4JNQ@+1F:)
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MM2B]E7%["QQ.7( ?9$BJM:'DJ#TP)F)3%1=TR0K*RUQX??G0O!7'&!64F',
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M 1GZ( ,73J)D*Y3<BN2T2A]&@FDM50&"U[5UG+H?)'J083?S1,57280#!;(
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ML#'LKQ'ZPJ==&5?G6%*2I$VAI'*EA.BLJ=;IZ@2QH&=]Z+JN$&X;C3F) H'
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ML;BW!Y+Q'+CU>JG_E57TZ2 7]RL7#H\"P]$3 PX-B\>!!XZYY=@\T#G8I7U
M=7T.<C%PJT)("FTP<B++]VUN)(R'NF_'S/:-. RW&:GO]DRZ?5RZ+=:MX7@&
M]TT/SFX?O&#F)]SR8U<W$>W6XN&3TE7WQ@:/84@/BG'3L,"!XR4L<D(L#W(\
MWV=A'!G@#?J.HT>&-XC&=K#K8-\^LF"$OFX[EL\2@R5V%,8L,."?H<>,T+<3
M;S@SMD0P!G85)32.QQ#<W4I,9NO GZ8#S)EPPPTP?=J# O?'8YT[R$5?!O_9
M"9#;]CV6!*"M$HO9L<UU/6119.C,-WJ@K9ZVV7F//#>HQKO)AF68AN$G<,]
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M,,/B-H4IF&7U>5K&8XRIMB4'"H"+J@!X+ (6HB3B*Y,#6\"!%=W1PMK*4XR
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M?X&!'_ EBK(\9V?-71/Q8E57J<*"K]&IAK.D4WO(FMLL4W=4#V\/ME3-]98
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MEQ7W5"F:4[$C*:YV<B\B;;:$Q:G6TT(5[.*(,GA#5BY>LP#%G%8TS9>&EPG
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M:K%DB[&JR70S:>BC;VK1^2D/:@XAC'H[B5:; !*YOJ+E9877T=G,+:.;L]3
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ML2VWP9")QY)L9IPRT2 X.R;C/*P;Y]TC1&\0MQRZ99FYW3/TNZ1,[W<"_\P
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MM2:]V_9Y[ A!1:)_IWC*@LO;3#J@Y1P38*A67 "4ZLQ0=G0:H3VF4:$8A+M
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M(U2/L7+!!,[)_< S67A=INP=0B8@^HO>X=%G 6!P&2VN,.KK0L6U;0=DT>^
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M5U&P<.?H3 76>O>VZL4#"'([[O$\)LO+S"G-A00ZL-3VZT"GLG"KEM%Q?)L
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MY5]X(G;B!3C6O*MW'U^_^9\WKU7BU=>S2;=:;F*>$^M_IOJE1Z/ (?7E6K"
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MM2WV5?X5Y*Z:BJ5W3\J8BMA91V)M))4>HU]E#8X3-3>F7JIJ6]5!8M,QW(=
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M1W,:)0*&_@9S3V/8.>Z11+[E,*SGP>6,R\2GX ^XP-+AQQ//V2!+8!N31-(
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MU;$""+<6Z \G068R@%9'-SI>[S V]V8R^U5".H#<E5DF,)$"KYWL1S6& B5
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MXW3*@[+ ,=$N/U"%:5P.32D,T+)76SH7I),5RS^"2B0(OG#1*R([!X':.%!
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MPQ^/?TV>"G_LTK \GC)VE5D;7C/Q8RK"9,LD($6+4ZL,[7?LWG9:XVD7AA[
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M@*[MFGB[B;>O7WK9LAP3<*_2Q&E9K=Y: :FSH4G?ZO1VQB5G((9;=ML$W$W
MO9[,>>&VK4;7%-SOJN"^[ZZ^+-R'T?(.0JZF8H6$#;:$D"2!:T5'%0.>JYVN
M!C<>1,'[6RH2H1KKD^EQS\T979XF'V A'P KE[&?0NS+.OIH1:R9^0GC:1K[
M@TS&B;$UQ(J.)"-!20!)Y/G4=8'B_MB,A'M_9+YL0  _I_Z-G\ZLO%@^BK%U
MPXWOB<0J5=1C9!\1 E(18L(!_9Y$H_26QX)ET^N8#_%U04 =5++I-(JI.A]?
M"+,'NLC74?N)T-?S\?,DB(4.+?5,': 17_@IO,Y;(YG@JMB<1%P3)8M=11J&
MF%&QL,\OCCJIH->PV^WV-DD%K8[=::Z.F6\=3W?L?F>]>/J)#]LS204FJ6#/
M=*M'4D$#*76/&G=Z5HP)S)O O G,F\!\G6[7Y31[+:@#H\PI1DWX:@(F@THR
M-F'5M7Q3U K> +^O%^+H6$[7%,BOQUA-J[F3.J.SOQF<IH')7T:7]U&2,(;=
M3_UD&B4\0%]1U=M$/C"CI97C.E:[L5;&T=E0Q+'<EJ'('$4Z#:.ZKTVP<&*4
M]O6I]3$*GWD\&3./[!WT]8^X'[,;'F0$Z8L!@E@D*8MY*EARRZ=K54B<O<IU
M>='L6QW76<OJ-M2Z<!VKTUVO2\C94^OB$I,8VH_ 6V=Q7["'71@C^M^Y7!BR
M;$Z'-?^Z%0?NE6(U9+&+IM7J= VIUB%5Q^JUMZM8.3M273:M9K^YW26P";'.
MXA(PR;\[+-X0V)<D]-:"+J\7+6O(FQ=]=Q=5:8:0%]W6+D(KAI 73F\7<1>#
MLW4?&._RJI256;6U1US2:WED8KKRBO^O,$K91/ 0.&"4%37D:Y/Q&%*1EV_(
M7P])^:K)B"Y&3%^BD!!U__)#62O$^'0:1S_\"4]%,&,7#;O+8#J!SB>XZ-B-
M_ _1B W%((5A,<\V\Y-Q'F="=V6<>:EL$>:->7R-J<\(O"9;E04SB]V.?6\,
M?PLHE3J-L).9CYG0^(Q*<_9B,?33<B,S2G'^%L/KTLHZ?N&Q%_"97IQC,_95
M"/8Q2@7KL5=RG+?%./@,?IBPSWQ&J;PY$6 $A(4+Z5.8%TTD"DF.T5S5-#$!
M.84_X++O2*U>TO2&_N2'0WB0V'0][E9;VG+M+N4I1S+A_ 61$(BJ4H6EY"H_
MJ,1\HWB$#V U6;KZD06QO-X45SWVV S?<JI3+/\[C@MQ<2V>#6+!OS_C(YCL
M"Q[< @L]>5Y-#_?#9W.DGZ?::MH\@!L>6T*]IP9_JCT@'65U</?/V;60V\M+
M2'X3S NB!,7A) I]K.68PFF3'1%!D&'Q"$D($)K7).V([Z6 B3R/R](1>!S6
MBU$<+ 899RD;1K=A_F6$G0R9&(VPQ -$SH2#$(995E B,?Z3@%Q[)^43'.;T
M&5!D*":^QZ:PO&B(<A.E'TE7D&F1:D^Y4 G"QAS%-$CH4 K?:2R*P>3*8!!!
MET8,RT5 S""ZG0.NI"DA!>977_2;'% I"BPPBX&U"O+ _\<+(0M2&>3212MP
M\P@OFDRRO)YCXE_'.4XFKOPVBK\CO*9'Q3IPIX34(',2P>M2V'Q\&PSM(Q>B
ME.8XM"2<Q/X$/H>EP3S@;)-$#R1D)T=M->_(F5@EL8\OT%2$(349_1!F,!)(
M%WH]EYTXY\AAJ5MQF"$9^1!>"_=7S%77SA$"AP)S>\)FP&\QK#^FVYA%6#."
M*Y)'$0DP=T4[_?(=G5;2P^7E7KIA TGBTG5:.NXVPW*I8)44T/<C[8 _F7(_
MEK4WHW)%%-D$^+<,1TD2D2;XVX7CVIV**G$;^RFMG?J-JBG2R\=1,,07Q,"\
M=+4N6777=O1HFUR\&U]B-1/1[PJRO]I8-A^S**;5OY;J)#!U@T23)[E9 N;*
MTQ:G',X^;A3H:,A@ 9PP8'TLI6,AGV@%DL-IP!:]>9#]HF6[%?X$+I]) 8:<
MFHJ0>!6#\UD0[$+9>VSJ+;,"#VJ_;ECV]TZG08BYIHS'6,[7;=J=WE9=>5L.
MJ*![J&1KVDYO+]##QS:L*><SY7S[IEL]ROGJQ6'+';"YU#>M>$T)HBE!-"6(
M1U>".!S@_SN7Q /"!F;;2.W')5P-V>VBW;!ZK>U*Q,Z.5JV>U6NN591A:.5:
M#6?_;'4&%T(+#,!-+@/M+0BC4-P-FU&_;YJEU6?".UM:S1*K:J>]O,(ZK,\<
M9H_-V[06LZ]$JZV0*H]/:F(9EK._%IOG0D6W;S5::]G[AHIWX7M83F,7_3@,
M'NE==&ZVEK;/WCQO\@A"M<O#;67H43[$R5$61#6&M11[5#<(U;D;002S'_
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M-L"N]Z$J%99"2]RDDBW/,!>$999V.]KN6#3H6C'FH(0%8'L7GP:T2"0EX,M
M!8RSM%?H@6/^MH&<8V,'(IP>_'UP_ 58G;Q/^H=V(E&Y0-LQYU(S320""1#"
M@)S2"A B5T?/1"@2G$DB;[1D!*"SI\78@^(1Q#?1RP4@:6FQ2 0"?)&$H5@?
MD@?@N)Q(@B1?G]6 V"@1-+U*(L1:?M$'528)2T,IK[2IXI4='$Q4T&&&9(0\
M&K9:(RU%4/!VH6BS_L([7H9+YO#3/$Y$U)'P6[1U-)H6+3$&=;68EEX)M+**
MS0%? "$A"19'M"!SNBET@70\6$0-,X*W72:#@OI+." _5FI?B$4ZNAJN5+(,
MCFI1%A&096#PR9O37A\A%X#MZ9KZ6Q+I!0^(-/Q<NQ2\BZ\ UJSN&6TWD4DN
MF?2!WTH@*(DRI2NI9U+D ZA 7@)7NI"6:[GH^'E1J-_YFW*$A@8'[N=P9M2!
M082&M:D;%5R+:XL*10?8+Y*;&CLEUQ!9K_:KX$8KSRM?,SXRC@<1%^DPD;Q:
M O4A4%"W5ABTL+D,SU9CUS,7,>=LH*.66%F@>SEV:$QI-P/4$!&E@/L#TQG;
MT,CR"]9<PRG4=7$>&<\B5+ZSBT)RC7&S?"5NIUI,6?X2JB@V!((5& U8'U(F
M ?K.Q?I4267<A9#]* BL2DIO1Z94W:.Q[J.$]JA@1U>)N);,9 +["R&BD"(-
MY=%2*6D39#5X&$# - -!BNQL-% "'G[3Y=>ER70QZM9,*"GYL\+Z*-!0$E(=
M >I[4%BE!"'BN>2(Y0_@\Q*3:D9:7UP#+2X6?)MC.X,2("=4=4NX(O@^ &D/
M=&5VE?>+KJ-"SI1S</(Q2B%^23M9,N<LC86TN0&Z/4F47>52!'0;JMLNET+F
M#M;:;T7.*&O09+T6. XK+Z3"S=B#!1^G.) 'OD0%*9^>W:7PO902@%H7^/<2
MA76YB!)90(^"9_VZLH[24:I%DQ!1+U1MMO/;H)++%6N\<7(WHUR4?KD:>95[
MG!Q55(#Q*LF+N7U#$5[V)2#'4F@,I_&+>(3^MWRHU-'QC_,1G!E^&78!3Z09
MBHIB[<=74JCF:;\ONCK<9?KSIQ #N61_POX9 S- #U[Q \#7KI#<79_<>'G_
M^*-VTM\:)OVYDUMLSJ2_NYG>,X$L13L)1/%H,.A*G287(3(B-&UTY$!B4+GF
MI)H29LE@@GST":][#:N5;IKK!3G)*%@.-($/9#_%L"0/((E>.E0<$96@*VFU
MO@0!,F%_2,MSK%U(9V)A)H[M;.2\OTKS-H!_ %\9=A4/+\P2)8,KQ4AQQ&D=
MJZ,=5'9TX2,H13K(B?0:[ZJT62:$_T*%K] '9P]1RB"E*BCM+!G[9DHA-+&%
M*DQ2,V=JTFK4E^^MZW]J7Y6:"?\"+7<$V(+AGQ)Z2I,KGKB^3)5CJU!H"]T&
MT!#C..B3E=^6:EN.@9@N;OSU^/6U+_N31ZB^>=.I1KLJA*_=:M(;H%MUJ)1Z
M?#Y4LC_77BLHPA> SH!YZ+0%X3E,E00:BPR)#QD<*11OYL.HD#]Y@2.X!;!)
M8\"'FQKV#9?!N.*U+X'V5%@NY(.DT*IF39/2LJ];/'JE_$A;E8A^AC I<0R^
M"C'@T8??([;U^$_)QJJ1I'.TE[HICTH:OD<KURV)4"K_<S=;D4CI8EAPI"2O
M*XP%]17F=N6,*(*2A2&O,*FT@^K[G+O'L7-C(?A> N9\.CWY^W#_X%0[/?AX
M>/!>>__E>%][_<CY"'+%>>-7Y^]Q#[=(J*^A>__+QR]G<I>'QQ^>+VUBY]V;
M(L;P22%4!H@+##76WH_0K8R^D5R[0 ;<[Q7>Z@1-]%!:_?#3"\G,"W24WEQI
M*I2A-X5GDHWG-_D0K"$931NHF%=<C?ZN?-- GUWT$)5&"!\.LR08#<O9P<K@
MSD#QN$HRZ>$#W.LEH>3HE1/PE=^A54 >Q< KTYD,T4^?-QZI,>BEGT/-2T6'
M330S()G*)>$OAEYZMN&MW9N.]J%T5*@IR!$&9N2073SK7XKF\-F_1G!QVEE)
MO*]W_OKK;.>-%J7P#PS:2=VL5"# =I7;DQ92-T76A9[N$N;_F4]!3/D8,"HG
M:DY_\2N4<=(J)(-;*M= (56' GKW+GE> ;2CP0;+N<_*C)5I4I(]CG X<QUM
MX*EDD(R#G:(<>8LH(P6@<OI+R[.(,DD@P3][8EBWO^#O-Q-KER)0+G M9& S
MDC%:D65P=QBH5">= $J:S8-)-!)C7VV)1^]!+!2;E7'0F](G5OKK"K5"Q;]S
MJ96 UJ=2U90^HRY-"0+MSS(O!0UEC/;DN3QLP?B'I4%\.;:\!^A> C8M'4V5
M>  @<>G6DMDGH(6 ,'@)O'MW;^_DR_'Y&?#NO8/#OW?__'A010/.1@&RFZ$*
MVDAWB?(X5 J40E')'J27M9*YTPZ]L20L@CZ@?VMU_5NOG IS7*;*#UDQ0B+S
MF%)4Y6HL#J[E(N.]7%>^1=@:)A9,Z/Z=,=5/>MTK+_!@E.6C(B<#Z) @)YH6
MXY/O5*Q7<L#"1ZEP!U2>9"C#^:5B6IQ=>I;&H1%I"ZK$A[&EH5Q@''7V8-+'
M6I@+8>&CKZF]29Z/1$6;2E=/$+V4=5%&*FLZ\UA1?@F8_.>7L\/C@[,S;>_D
MZ,_#X]WSPY/C"I6_8FP'J?S_P!:1Z1SCH$PPRC&5!^.4O2#I%YKBV$<U!,XU
M+)SU GFDKGQZ18!^5-D1DE6 5@AXK7+3Y'U?I&ET#;)/<?\BX!S*AZ/*/3<1
M?<;8.GXGI7B2J5\KCY2,26LQYNA=\>X(78P?RO5Y%:N>>4#R=EY8/TJ$(*/.
M2UM7.LC5P:7/ C2/K Q!J2R?X<*U:YNI?K/\*8%P+A-@']>%2Q,P-,!<T5MR
M'%*\G%$!8OGBN2]<#-*9,^@JOW$B-69A<E*1K:,N'9/ E*B9"(#7@HL%W'OC
M]*4RQ:.07:!@*&8CU9XJ*#YGD]=E^%+C$1*?,F,*&;HL""IY"@NIC%"E=,0Q
M/(^+E?C:T;Z4'@NTP[NCO"8L9T^%7!=S),#2+V) O"Y=QP@RO5%4.F?W60!)
M7$DS"ME$G&0YYA: 3E++"*M#8B*^.R\E;%&>Q5;G/7TX.=G_>OCQH[8+5MOA
M\?[!^\/CP_,#[>/AWP?XP?GN\8=#4 O&60(5QQEBLQ;4^!W7[;B3.K]-K8XW
M_F@XH\B;\G<SZOVT5G_8EZF6R1#9QY4TU$$G499/@4I2$WUELKK9L>A]KTRC
MX]SV,UIEO<#J:5@+^E9H7+>=@%V"!MSG/5';6%[8 548$I5WGH67A1\.3I:J
M\,SKPT^G_X_W!G_LOQES<OVV5:L')M%]*C5SGDQ#)07%("8XEF':PHV293+A
MJSI=);.4.H]!K+S&Z)$*T5<''_2*P&AV 3Q<YOD$$W$XQ>KR2_D56E<U4TBB
M3\T@JMZ*>E!8>END0C/.?AH!*DAMJQ9JKHL@E.C2YU2I]?4G45Q7G%DZU95"
M#P_H*@%D[)F2>##6]J5>*0.!?61(M>=D-GQ=>< +2(>7RM$IC8X*>=0/0(FX
M3",@\(N;:>\P&(/BJLK'+W:#S/&F/!'P,EY*,I!84G8622>3KP'BB;4>!J('
MW?EO3PIA!Z(WTHO7JVQB_%2QC4F;!TER<>AM"]CE5[1$<X3*Q3QRG2111,8Q
MG:AD*;B DW"8(LLI&!- ]%#6+1AXE6%A)X/UFTJJ+%E-,LT)QZ\M+!->D%1%
MQZ]8QYQ@R[(T1/++ZPR++!!78^14\:C2(*<YH@'[P\!,D3-=H_NAG"<B'YHZ
MDLP=18(O M[CAU1TJS10I+^E;J3<X#%1/4?["-:MOZT(A,\P]M4P\IGPYAY;
MO&\-4_-JG^97DIP*#'[7ZTC.B@2DQ84D;7!_^>"^M[G!_:9P^S,A5(V)I6NS
MZ(J<[+32+RKD';O*[RY'D;E/T8*Z%!0?\2A3'+0OLTJE7'\"EK Y=97S><MN
MI%S$ ,S#,>2:O^^-S26O ;R&JBJ$G_61/DYY=(S.L\-^V)FN#IDTT\&\3Z*$
M9TF995=7Z&\+#IE3(2)T?$W2V#)4B4^KR6A(>6*8SB?/.\CP^:]D$2XET7_O
M)+$5>X;K4I^QF,6A[1G4YD'$F1F%S(WH/\S9J3WT[K]4%+"2IK+*']W/?)"+
MM^5?_HB2?-#E-V^3OMR/?.B/@M\7(AB%QU2%OP28^KJ0*[[?\6P+14O1\+9X
M<2%U.E+J3#4M*+ZC'>I["[\V.G3QH[<LZSD=QS"76O:./KW-;,<[PX[4U$",
M&KN[8U1?W+-D<XZEMA:AZT0RJ;<R9H6_VGGW&:,_,EWD2AESGS%@4/Q[OZHC
MR[5=6>%ZI'P(ITG^<P)$MS>I:#A_:(*L69C>,5]LOD\S^&=?VQMEF>B'-^.:
M;;R:SG,F>: 32$4:AT**MKDAU8EB01!96(VQZ+?U6L(OZ ^(4/=$>14A&\9H
MI I'5/$(?&HLZNH^GA'PZ9\82%'ID[4B/576J5+I:Y4/<0'IL(1T69Y3%'Q@
M3CP8$QI05S_M)6$]6E][7#G?-KC<K\G$<Y<#"R\>D"C-E8>UO)/Q30+-S-2.
MSB]GA=.D,M8S5K .1EFJ:WN\ST&'ZVO[$B=U[:]1_P*SI&6M?5+DI'["O W
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M;,*LYZI%$UQ4F:6*77RD"Q9S4# K9YB-JHBSK!94)1!%'DM7J$ R_C 9CHJ
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MA.E&(C!D#Q:JNW/:(3T?I6]9A]B";(!4(^P.*ULD2]KE6<;[%RIM8LM:Q*[
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MRA;77QO"!S4U,D+3L9GP*0<]!E06B_O4<3WFM0;*1C&SL]EP4&RY9AAPP+3
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MF\;(_[DW&>>0KTG4NV9V]E/(FW6K)JP[/"O<O_F_IY/R_^'HM-ZP/P?#28K
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M)=+WL>D[%;=DV4;F92:*YT0@*"!62T<T94X87>L^Z<;0=[E2;R\__&<5)XH
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MQ8WA4=7MAUG[AX8=NJN+(^%TVT^I(7H 2H2J),R^>*N"&Y)<=LEQ$)G"RJH
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MU/Z"Q=^?0M1I0X7C;O[3#5-_O#GI_893A\5/'5Y=30S=WS[0'*S.M3B"L98
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M;QZM,=L:CVS%D<N5;;V3QIW>!/.8.XT+T*@2JH0JH4JH4@L\P0BF7*/40 V
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M[_2^.\Y*)(N5,M+679;DG6V?6[*W93Q2AZE7DC-X^H83I;P3P.&$15Y%G1!
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M&O8':=AYG)RX-%4VS4CN#6A86%VB<I80;\" )IPA.04V9,K69;98>/A<-6S
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MYM81+0PEF?&%S-(B,2S%]5XL9VW6N^Y*-@)GYFN#;6+L[,K604N[!1T -.J
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M8.KVP#8)U5_Q9 GIV$<J9&;U+D+L%?,G\:DN5!1C_5_M[6^T=D'N0]1^$@'
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M-XHDBX'_^3?,:/Y]H_4F%-%%EM<R\N'U)@U'W?QL7TP7'G1CQE6U\J.I_;O
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MB!;)7>^WQQ.9>9TDF=2<L0S=M@*\M<+!;L\,S]AJCS_RHA_"'G<"T)-Q1.:
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MHK!&YBSA,'?CNP=&MHS77QLI3GMIQL5OH5KI+X,Q/ 9C.0DYQFB\E;G&BPT
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MXG6ZTGX96DR&Y2AG, V$(D&]1%PHB33G'&'E%!/.&B;EVB:1ZXR8"BPJL%@
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M ($"==P[KJUQ+@K.A28F2 O_+Q2!7J4WY]?!T&1T'4M8,RL,PM@(Q!T'&$H
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M(^.Q1;FJ923,"V+DVB;!ZU+@I[9X?RB#+#;V]EY$GQ646P%=!72C,%ZI+$X
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M5^HQQ]_QWO;W@^@%5<8%Y*CW@'\AYI@Q@504V@1 QB@!_[00ZR#.+I%=IC+
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M0.)_SUJ#BWH<''7#;N$'+:IE_-5MM_S%:IX<[?B?CQ??OH931[G\=NPOOIW
MR?#UR]&WWS^SQN_Y1-FEC6;]_-O)W^3;"3QS^S-I;']), 9K7.X? .B'P*U'
M5B>&.)SW2)L@D=0*"Q>QU,2OU2*<KZ=Y%WMG\848;[?Q9>=3L[[3:'ZJ[39J
M.W]_WFWNUS[MO/_\<;>YN_,)U;;ZV<BS'7TL2NLSLE[+E+!>.X^U(_LCUF:*
M0:TK8IB,C>7>QF"M9A)S*XW!B2F"O?%">L'4P>YMYH_=QH<;A5Q*NKL6?;ZV
M@ +/X!$6Q**+[0@  5"0\?N#;?6^Y!*5HXJO8V1Z0P*"5?19"CKO]D(_=E9=
M 'H\&1]_%HW++0J"$:]?UG_N;1V(" 0334+6LX!XRJ7?.<$H"".9]$JZ[*@9
M'/5BG))D:K'8JMHU091E/\Z/6OZH9L=KB+;ZM4YW4.N5FPB[?[V+1= 4$%WH
M%I<4M)=CI%L)!)E.SEI,,$+'EQ<.CF(OPD-B8:\<= >V?14AU1I%:^2PJ5[T
M71CD,O\Z #KM#S9JM=U.S7H/5&#S>$4UT_S[65'0M'9XUBJ^&,'_,S%N,>)O
M+9AYR\_!RNNU9Y[/G4]OI7+)RQV\?0.O]WF]V)71.M9LN]T][]> , I.+KZT
MKM7.1#/HUDZB[9_EH<?H9[A7M7;LPX:>G,+0^0N I3P+=S'V69Z2L[D#"*"3
MK?WW#!9T4$A@N60MW)\OVK@ZRV^<EG?+3'><N2^Q!Q,:P^I,O!X#""9?6GU
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M9..6BA*C31\OR3,SJ6V8Q)8)).]DK@Z>Z];G-@/M7!4ZIQVW6[D5PB!WJ+@
MJNG%HJA]*(H##\TD.<ENUA%5UK" "^*T#1=NO7D^P2.W^E=-6B9J"5_U[[V]
M@48W9RCG!]W,,A_U9RA*!^=B&ZUAGG:NEE]4HBH3Q,N'#YMM#'IP;I?IYBX.
MSF,L:A_U8_O',(.^R/,>=7X8YI2#> ,+U<NNMWQMD6Q]UH=CO5\FM(=6W[>[
MPY8.>:)NJ!/VCV*\*O,6SF)QK/\K%Y@<2?6C7//^:RFB5/4@6U /,C*QKB_;
M@^S6;F)S= =[GL3PXO@95WO'FDYTPH=17OWN=5I],RL;;SAAG#6.MT#(M)X8
M+Y#23N0L"X.,BA2E"(JL3A$D _YZ$\:_QWS*V;/0*BI[7!5?"'9@1X?JM%XU
MPZPW.EG)S9-UO2SL\.03>OT)Z><OD;:M!7M,VK:B&]+0Q:=MDPW)U*.&O?L[
MP9YILF:1.>8S+39F'@-[>>J]D UVJHI*Z;P;XYT;YK-7Z$;X5(B,VX!)O\WT
M3=YJ>;MI-;S%<+CDFWR;L^2Q;_PPF^4K6#GR6MGB?5GSNVB--YCRUC]T+U^I
M/^WUNM2D\P('0:3WEKM$K1=2>LMH(J!N<#&O2VVK()\A,;T%%]G6SV^_?SFJ
MY];PS<.+_>;'[_N7.V*_6;_8I]^.OIU\.*G_OONS3O]F4RZR[0_?OWW=N=C[
M_3/,[8\C4"R.Z\WV4?WRC^-\W_[7_?/]XYW+;]OAMDQ*[[%@DDF4DLT54[5&
M.E*&1' L))U$\FIMDYEUAA_:9/X!B/TH)]G#I*H*>UXY]@@A0XHJ:L<$UU);
MGWTSE";L,/>$S)O34F'/<V'/Y03V1(HE<0XCAB-#7+H<SBT8,EXY'4PR)!C
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M^,A\[M-+N%BG8MDJ.U4AV14 W6S!D@A645%%N??<J& -EQ+S$)R2_KZ^.Q4
M_0H FC1Z$$*LL307@V(6<:49LKG(A,(D*1E9Q$[FI'>SCNFB&K]5 %0!T#,
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MR62=LDAYIT%0\@S9R"WH5"89HXRWE*YM%C0PS3EPEF;:ATTYS"=VN<']@GV
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M)A/(V6-PKRGATE$F+--9F[5-(Z^/,JI 6HCUJO3-(Z""=5 ALG'"R$"<H(H
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M+7FA8 +QV1MB>$Q"H5B84&MAGJ069NGBJ$]P,!5T,X&NR[7HX"SXTK7,)R#
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M=ITQB@:(P"V4'AW:)1^5H3)6*N-+T6GOGEVC,IPV*K*0T)$HN1^* K&,9X+
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MNBA,*L;+=#4=RV1U[T09'P!H72B+7$CG<T3K<@.W^;%DS#U[.?GHI,G<2ZI
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M.3*)\GSNY(@&P9F5F_^Z1!T;!C8.>G-7)<A5.;E3EMI<E@ 'YRP+59OM7(G
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M42:_./29O<#G7[&NUVD.^E=_96+0OG)\S/VL%[YVWWRJ])3L3?P\[)Z[R [
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M&_*"3CF6VL:X/MJ0W,6!QZ^^]SP/LN=[^"=#YL%9S"FCQ,K C4S.X)P"[&@
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MW+/6'>;JU/J=6F?0K;D18 ".+==HVR'R<Y9"KY/ZQ_F[(?Z(S<Y1#JU;K=6
M0T[@)KXY"#&31BW")+2J2R;;Z-9^V.8@5J30&_C#6J,?6Q5+P$/]:&3?_T$W
M5AD1O7K-PP1V6C#H9J-7_=[Y$=L6WJJU._T\0AC44>S'^I"7NGG8T1^V84(/
M&A&^D,?9[UH82::!7A&W^]Q,.GW;S-L)J(^GE=S4(G!I&W:18SLG^]_R8'9F
M&S@/!GW=Z:Y/#/%FQM%SX_OM;^NG7TFPBD8FD548^#X(CK2B#M&DC.?))^IR
MP#9>G8W['--]?:Y5OVUKA++JMUYU]M7@J)22^: \@D$;5(+U3P$IT,8(L='&
ME-L]K\X>F)\O>F;AN>!N/<:4"T]M+L[I#+/:*RML))&1T<+C\<+/-@8O"W_;
MA=\D7T5P25K!D(P\>WU!!!Q. GDI<H_,H+6S*VML=38_8[SP0V, -("3:+N]
M6H0=*<Q: L/6#)6,Y,6L@P+2RQIW Y2*$] GWEZJKXRV%;A@UD\.JMOT8*?/
M^P_*>U&M%?N'G5 #C:$:!&@>@UY,@R;H$BGK+/W8;<'G0@ULF FK9K6V9=OV
M8)B3.:N33-V\NOI(LK<'H*DT_$51]B0*+@T7 GZH1 Q(MK).8D8CD=Q>NG--
M">](M7G= ,3$=S OX7Q.UJLI^5+MNS&LPW!@[)^K!WT'SWE!OF$C]R_"H)N7
MXYE)],[&UO%7#C*;A ?N$C&7/& .N1SP9XTA(1D,VYI<6:-G;KG1@JZ-Y'=6
MT&H3@@:2^ND2A3C;N=X>-4 5J@0FB_F4^.0K3HHF:,;53<97.SZ,[=I1TWKX
M BCOG;%49EW[7+6M!+,;?S3B<76;]L V09O/$&RTCD#QKM3S!:B1:__CNG^N
M7;S0-0#X+=7M(@ ^^4,PO)NQDZZ!P.M!?]"-D]R^.50V=[/W:!?&\Q=8]M^?
MF=QO[6ZR7%.42AXMBRC%W":5I!R_KB0*',QVG@0W O;@"-O=49:%[B![X!Z'
MD7&8?4[-9N>X F=>:S E#SO'O1$&+C5 ZC5W,MQ-:KZ9_QWYLBIOE\LX\MEK
M/@'0-CQN+8'@C<C@CT8;_MX9P-A#[]\O?F&D@6E]T&A7/GA1354UT#/'_M!#
M#U/6M$>]^&+\XN78)=IH5P]>?>GEZ%HC;W^.Z)MRT%<K,WS[Y7$C] ]?&+-*
MI<FG3B/7\^C&PW?):G4@-77:,'R/TE4N^95O@ZY_Y7O775:M*B9_ZZK7OR=^
M\ZIEK&6L9:QEK->-5:\R1F]TU5\<\OTR$6/VHY=$>7C8>&/W?F(:](U"&D!]
M8S>(T'["C\^?]^.+Y_WX\GD_OGK&CP]62#?:!*-ZSI.0SWN>\?./G7 U._3"
M7;0\1^7=NK%E&^ULJX(!69F2%V;L43?IO=DT3;A7/XW<JZ_@2]EY/%/G[E>/
M?65LVY(%RMYL9A;7N6U9@F%O]MQSG QQPHT07,@8#&<N.6J%%8)(E@3SR=PT
M%O8:1^(E+L1MN/_N<6S^B%LPF,/GD*/;VOZ^\V7S9.OT.]_?_4RW3C]^W__R
M]^'^MW6ZL]N$SWQL[K?V&]MPW>D(VCWZ0>SMOCW=V3UL;N_NG6Z_^=C<:[UN
M5=D$U3C_:>VWWN*MW7_2UFQQ(<L$)SY8Y&VN62JM03H1@9S07,D0I;>TRL/7
MMZX,-B^,'FL7R\*&A0T7QX9[H+7L'G<*"2Z0!$^GVUXF+@R+'"6@/,25(,AP
M(,$DM, I,NJ=*R182+"0X$.2X&$WQD*#"Z1!,JT+.B.IQ 1XCZI<M1XC*S!&
MD>=01"SS@A<:+#18:/ !:?!U9] M++A %F13+$B$,I9PA8*A G$.+&BPI"C)
MD*@@)CF7"@L6%BPL^) L")\M++A %A13+!@U:'S*,93C2!$/EB(M'%"A9T9Q
M28)EN+!@8<'"@@_$@NOY_+M0X5T<D9P=DWS[CG<VOG]U3BFEDT.8Z8!XT@)I
M:3SR7&JN@I)!T)4U73=B447)"Q<6+ER>YUXN+MR.SZ&+Y7W2W<E%NK.4@QP$
M"G3'&>(V1=#ZDD:::YN2%P*6-<>@U9FY=;'.1\9W\UQCGF=Z#/"_JX3+:Z#^
M<1R^-:G_O*]"N\@3R[6\=]1O3RDYUFEBA+%(8NL!]9XBY[!%D1/G(Y!XRLUK
M]7EUF7&^YCP1=8\H<.[5J/C)5.V3B8ZQ_JHXNK,'IY<^^$.W<EC\IF^M3)$X
M8I+E@'QX89,D*5H>B%*XA(D],GJ8+;2(%>:2Y/[UFH()1*A'QN8>=$HEJ8V-
M7.O<RH&1V>I3UZH$=[>YS]&!I:#S[L*6"N[FP=UT9)(PL%A!6P1:=ZX"Q TR
M'%XYZTC43D3'!>S*9L[FCP5U3QAUPSB9@KMY<#<="B.YBY)'L%H,48C3P)&V
M7"+.G-4F2N-R.1[)YZS 7G#W='$W#,PHL)L'=M.Q%]$%'&@(2&L.RJ5VH&8*
MR1 FTO"H+!7>K*PQ(0OL"NPF(P$*[.:!W?1A/S,^,1LQ$@1'!%L?1["*&&&*
M=:2!IAA R[RD$V=!W3-$W=3)<X'>7(Z5Z<-E0;W#L(;()PK82S0A@[&$'SY2
M3T'3S(?+'!?L/3OLE9/.16-OZJ33:.LIHP21H!CBG@'VN&79OZE=$M1AXD#=
MK#/Z>.!WH\.6907>I6>,A&%JF;)&^< =828)HWUND8:C!!"6,\9EQ=OT&2.F
MBN@4(S*$.L2%5,AJ$> 5(U'G$M,QFW?G)<U_YXSQ*53M>#7NQ/ Q#ON5]PX;
M1S<Y9WP4O>07OA>'X+ /TE 7*1>8&+@BTPQ[IZ,-49<#R$?&'2?GO>1W=CW>
M6?]* K/<:(6XQAYQ3+*:[!@"RF#&.J>\Y5?UDO^]F*1E##LJ0'\(H)<2#(O'
M]^D4OC&H<TPICJS+[:TX(<C02)#R(-26I8!SODG!=\%WJ2[P.!!.IA"N*(]!
M ZX=PZ#\<RK!#! >Q61B"K"X+LJ,<$)NW=:Z(+P@O)S/+@##; K#4G(>,;:H
MZDS&76Y/9B5#)IJHDA"X:D)IY@U'*@@N""Y'O7>"8#&%8*L,+)JER$<I$"C=
M#FE. J): +*C!X#;E35-YHRP* @N""X)RP_E*QN?*6]_^\ZV-PZ^ABB,2E2C
MA+7),?H<:2+ K!8J<2^8YP% 3FB=F8+S@O-R1+U$4#ZY".6H9*2@60. )0&-
MFU-D!4F(1T4MXXIIE_W>JJ[QHI)QEQ'*MSO>6U807W[<S;& 137)*\(C8-4Q
MXUF*C"G//5?EN'M9L;L]M0T3KBW0;D3&"<!N+A[B'#;(BPBX##Q%3P"[>E4^
MDYS:][:?&U'D%-JJEVK+=K\_^^Q9'1C&-BG*7> T64U"XLHX'P2U0I+[.KPN
M&_6-P;[]ZL+Y--WZ\)7 ]BQL-,AH@4'EQ@%9XQQ@G6J;H@G! M:IF;-"4(GC
M?)KP*^FQOX6ZTRG4>>D9\=(B*SF@SE&#'&4)V4 2%9C;&%-!74%=28^]'>[(
M%.X2K(TG.1"+!PT_F$ 6.XP"=I1:DH*FIN"NX*X<O]X*=FP*=M(%S3 @SN%<
M#<+3"$JFH;#[^>@USDGI1<DLL"MGIK>#G9B"76"*"XHY<DQ5MAU%SG.&HF8N
M&D,8U;C KL"NY,<NP*]RX2SSV^972RPA&7Q"@9;)J?)(XRA04!;6DS@9M5A9
M8[0DIS\_\)73QT6#[^0B^)C0,7D<$,.*(-@$&3)<"20)$<)C;J@3.697SQNS
M6Q)D%WAB*))1/E%-A G<)N($<0$SR^$7[%@L)X;+BK?MJ<V.>V*%\1X)(B7B
M5G%D5+2P;"K$$(@FCJZLR57^W!-D-^*/V.P<Q5#;C?ZP#3<].*G]MVT=O:Q]
MZJ3^L>W&DBU[Q<8L.%-1<<6(QCS98"UW6"K+HK$$J]+5_9$1R42V[+B@4U(8
M]N>04$ZM05Q&AS3S#%DOD[28@@Z6@$?JU"RJ>],R!@T5H#\$T$NV[-UERY[U
MJ'2PL)81Y&+TB,? D3,*] 3E -E6:Z5TP7?!=\F6?2P(GRY '")V.-?&,8QI
MQ V8 ]I[@P)AW$DNHK.L(+P@O+29?B0 GRYUS&A(+DJ/&'$.5'2F0%D7#KD<
M%1P,II*0"N"B +P O'107GJ 3Q=5UM8;+ )%$93Q[,MCN=X%1]$K[#VA- 6Y
MLB;J:MZCJP+P O"2:_O0N;;CFI;<<A58D,AJ2A G6("BKC!2U$00;$*ECRMK
MJDY*JFV!>3GL7B8D3U6#EL%J*:U!7N8P+RDI,@[4<NI2DMA1HU6.--%U+)\R
ME)]1JJTR'D=+K? FY"!V9X7%(@FFB'6!BG)POJS8G:XL';GQ0+06D6AR_786
MD19:(B:\999XJEVVIE?5,\FTK=)K:]LV7]$.Q2^&YYYI:P4WG'(A!"AM5GN=
MC,E5A6701DM"2Z;MTF%](M-V;%>#51VED@!P0P'JB6AD3(C(61,T=9PZI6";
MQN+11*05^-TA_$JF[:TR;<_<U3%0V%45"EX'Q#U)R!J GO2$$.XU3XJ"F3NG
MK[J [@F#KB3:_GZB[=DQ,*>PMWD..,N;'78.64\-PM9[C9,PB<@"NP*[DF>[
MB#S;,>H<-J!,*H>8-P10IW,8MF0HB C[(,/,6UQ05U!7TFP7D68[1IW)[0&,
M]<@[,.=XI %IXC$RPL;$)6'!IX*Z@KJ29;NX+-NQ_]0JFT**%"6N<F%_19%S
MH'8&:9*,D2CEP\J:-@5[SPY[U;EC@==OY=&.X:6%!G!%CI3)O6]2$L@*"_JE
MDU@[3D"Q5+"UX9)%^W"'@=8I')CPU#O.L??.8JLT2]B'$.$OY3!P6=$V?1BH
M*,<\$9[;6^2J@ 8C+7% &$MB,29:Y#:S?%4\]RS:R5/"1CO$5,EOK=E(SRQ[
M]K__CP9 OWPZ01QEE<HJE54JJU16J:Q26:7EL==#%%X+K#38&IQZ:ABWT0H!
M9J -A*6;VNMOS[2U2ZV-S9^^.<BS^*;3"<>-9K-$#B_,X/@TZSU3PE%NI48^
M.88XQ1@YXN'7P((R,5 O:)4#@/$3#APNV"[8?@+8GLX*<-%Q81PB/)\%"ZV0
M#BH@6%>M&*:&Y*R @NU'B.T'UZZ>3KSYV_<?J^IK&T\RQOPF@E+.NLK4EJDM
M4UNFMDSMDD[M'+8,Y<%PY;SQ7G)'B64>2R$2TS'J1&_<.KC8,@]FRS1F_11.
M!"\EIB@ZF[N!>X,,-A8YE41,.C*#7=5,&+/'$XE0$%D0^7@0.>5=B,$R2J1'
M7GJ,.%,.62H(8M$;)I(V).B"R">H?OR^Z>\CL$)WF>9LM].WS=IZNSW(_TS$
M-UWE4^ET0^RBX9!?,)C!T!D  ]7&(QU]H-\Y>I'GM]=I-L+9F[^4J67SC?SK
M[J=AJ2$UQR:'N;= B58SB;F5QN#$%,&PZ0GI!5.E-/TCV_(N*4U/: H6MCBB
M=4+<&(FL$Q)1$:5V3#K#<TL94E=B7H?ZPO!T/_ME8</"ADO(AJ5^_^))<+J:
M@I516V\E@H74B&,>D;8X(4($#Y(SKA2I2! ;7DBPD& AP8<@P=+D8,$T.%W=
M@ND<(.,,"LQXH$$6D<&*(\:EP-HG*B@&&L1U15BAP4*#A08?@ 9+)X@%L^!T
MM1%KI&6"!>2HM(A+$I'SV*- E=,J)X<:7;$@G;ON;&'!PH*%!4N[C"5DP>GJ
M+S80%5,@2%/B$(^:(4>41B$8Z;//T#C0!4V=JGG;9102+"182+"T%%E6)IP-
MTV%!!Q<)LM;FE ,3D5;,((R-CUPE(QE?61.L3E@QBPL7%BZ\/1=>4O2H1$+=
M+>E-1T)Y&J6@$4A/4\0UQL@:8Y#3%AOK+(N,92M8UBG53YOU;OK1*H;HS[Z%
M1X%_0^/'VFQ!&_@] Z;1'E2;^=K_P,?&%VW9[D&C73VVJ*XZG#W7_?.\$DYU
MU>K'0HF X"DF4--,0(?16!>6];X&,T-+UPUF"/?$DL9*$<-YXLD+C8FP+EA.
M@^<JD*^&K#SX=&[O[&[65 W5KJN#A:/15@7LJ10\&F*U,Y@)9@V12G-]@SI8
M[[N=(X##R?NF;??7VV'S?P>-HU9L]S<:/=_L] ;=N OW^ZO9\=\?EB[%UI@N
MO_WS?7_W+=SG,]UK92K[\'/KR\?&WNE;OOWM[\.=C;V?.U^ WMY\. 7J:\;_
M?#S9_Q*.'.5R^\O'YM:W=;:]N]_8WV@> CW^W'_S][>M;P=TJ[4)W]\4>]^V
M^/[&=@)J9%^IM]XZFI"0-"#.G46@\W&$M=3>4LXXI\.-#G ;PWK><@Q16&N%
MDY22$V9,</F(1#'M-,,85/((.] 1K$*_.X@K:^\_[KS?_+B[5UO?WJAM?OC\
M]OW6YO;NE16O*IF<(HOAROSZQA<'RA)FDD8N@G=<2><4=5SX@ ,')L\!YLO%
M)P\$A><+ '_\585 C&,P;8:;7.H7-GOE L(B,"R,9P*':;FRA,K 01O@F60Y
M-TY(CJ.3C :-F9T&P.1.5^W6N<)9N_^"R;.][KYWD+$PU&P[U.)8$JK?K/>#
MUJ!I^S& HGK4!:URB,'JS0ESO&:[L69[H(LVFYWC7NV/1KO6/^P,8%RA]^\7
ML]O3<DW!4NWHM8OCF$MY&EV(TU4%RM/+HTZOD3_SHAMA$1L_XLOC1N@?CBV:
MB2^.U%!\_A7K0.,<]*_^RDST]_6ZVJ^^=M_3K,S4/$_\/.R>J[@'$;ENM-^1
MS;ZF%[9Y;$]Z*W]>U%E!89V:^NE9NWINKMGE?KEK3;&18CX&)A*UCG ?K',Z
MPJ=-C,0D%^G*-9KV;#3_RA6C^B7G@;V0U?\I2P<6MFF/>O'%^,7+T.@=->W)
MBT:[6I[J2R]'HQH)9![8E!%3C7/X]FB6C5G5@N6)'N4NC&X\6H/5:@VFS*_A
M>XJN2D.O?!NODBO?N^ZRA*Q*IG[KLM>_)]@=#=;<Z+*/(S_DUP2 +R']:3/7
M+/UCS6B3U6-M1!];+G9KC-07U$?R\2W>1'69J[PHUY7$7<)ES:K\0A[W)BUV
MG\Z<D:=3/?F&R'@'*O>\98,>RTG%#:?@RJ.*VS__ QU1W/#!YSBCB"R SA1X
M8DYRY84CBF.1O/+.F^AO?$9QI2OA3;?36YJVLK_K4!@=0'P^WOZRW]JC']C6
MQA[;W_W8W/_V5V/GS<?O.V_>TITOFS_WOGT^@6O.'$#L[ZZ3_=;^M_T-?[S]
M+32WW_S3VGKSEN^_^<#WONW!_5\WMG??LNW<0KHQDY=&J(N6)8VDL@IE)RYR
MB3M$/29,62VLP<!S<R>EW1H(#UP"KA!:(;0I0M,R8:(E6*9><V><2\XD"=05
MJ/0RR8K02"&T^R6TF1RSR"2AGB ;J4%<<8DTB0Q9S7PB4HB0S*,BM,=0+?&&
M8-N*(0_EW ?\R,HF+IY3,'8T1$:LXI23A!WC'FL:,<.>&7WC\C:_XI1'$,+Q
M. AG-K.?$N:X4P(1BCGB1DAD3* H4>HLQ@(V![JR)KFI8S9G5FLI9G/G  P&
M]-Y<%PRPQZ,DQDIL&6&1$B]#P(O:U L %P; Z1V?"!<Q+!$2&&#'G3/(,6N1
M$\X1'(+"$@ H)*XS3.X?@,_!)?2JTSH:]&.W.K;MI-3P\7R3K]?2H L('.03
M7'@_ 0;@=>^I]-I:/"E9+4%O94+FJ"I%@9ZPP=HQCX7FT2S,=5)(:3&DE+OQ
M39&2H)QKE03"+DG$ R9(YUIWA"EB!-8!1YM+79@ZEW.V=BX5]!\3EEWP-EF7
M?%*8@U+OC(J)< NO*$N8% 5CZ; \K6"X2+G1V"$6.$9<4H:TPQAI(<!88\Y'
M"@H&X;RNYDY5?NY]%FX(N$^=U#_.(6 A_HC-SC" S'=Z_9MH$4^;8$)@@446
M!5>2ZQ!T2E%+AC4VT7+*BK*P9 3S:499",3[Y 78+3@8Q T+2&N6$(^@*! =
MM59Z98W).B:B>!"6#']:1A<]:.@$,QX3-80JJ@DA,EI+K;Z+#1Y,J!C0:>QV
M"O3F@][TWJY9(#@YBB(U 7&7SS\=Q4@P2HWDS$E'S\HC%^?!G<231-N+AYUF
MJ#5:1]W.CYB%OG@'KB0<2754+!@GG."1.>N,%I;K2+*%(6W9\)>,=6:C+JBC
M1., %H7+B2#)4&2TC2B:P)*$;2,(L;(F,*D;.6^N>_$./"8L!R\8B89ZD(2(
MN?:2>$)LD(%$7;P#2XCE:0TB<NP=509IY3D"&K;(Q,@1Z/0D6(]E,F9EC7/
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M"\/=!</MS,8_1&D4-]XA$ADPG*81Y39'2&L!UBYP7! )&*[.**XK_&B"L1_
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M7QHO+',E$MX>%>3[HD2'RTH6!>R$H:+6+I$NP\WB3.(B)!'4.PX(3SDWS(G
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MW6^D_F5-Y*H!VY?6A\.&$<8!1H@"ZR-%Y&+4B!&7@M<$:\H+A_[[/!=\8J+
ML,W.9-3X>;W]CW/VO[FI>W<G 41$1UT$;I\2U]9H;**PF 0:&=6"5"<!KXF\
M]Q9@_W8&]V&-+ZMGK8O5['H]@.N)UD4+QK',FINKY\W-.L]NVN(D@'K 7HDQ
M(CP[?H*W8-X%V'"I911'F9*]J[#K?..J/[*JSEBR03@CK K"2\NY)3H187#@
M7#))B*]\M&]'5^_QT2[GJ*GSQD7K#(RL3LYYV-[Z#O=OB>:7-;CF][WM3;C^
MQ>?"$Z.U#IKKA$*.F>+,*V04**WA*AGB2<!WGIB\!Y94P<;SPD:"+SE"G'2.
M\V@HV.?"Y4@J%P6EOLK5>#NP<8\#MT[J^XU.?:O1;G3KN73[^?9*SM7XEK=U
MW-K\)EITC;0NOA99V-QP&1/1B./\PX!=9:4D*%A8*2,=Y2)FXZJ"C0HV)ID#
MS#LC62!):6 8RD8?@&0P@EG(,;N5=_<M(<<]WMVOG<;%]_WM_>^=[975\\)0
MV/R6W3*XU5V#^^0<#W_>!.,A(X>3002!$Y(D>H /&9%VG"),J,\<-,++%>%X
M(')4KM^71Y7*]?L<&'-/+/=&I[FR!I_=ZS:W8/:R4;/9:6_O?V/-E=#)&:;P
M3+2YN5M@C )IDHQR1$$.$/!2@K05$@F*98Y(X:9D)^_9]?O?HFOZU>OE8S2
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M#S5+,9N+&#GB HA+[FO@/<B,S>(RP2658:'(78-=IA,' ^!9_YP >;LA&J?
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M&X-=&XZU@IL'R!LOY"TIBY5%26 .5 -^<P:H!JR,RMX1AH7*<8/3X*;8D+(
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M"."((YATA2P11"6>B+=BX1.?;D%N%5FT>:YSQEBO?X-"7>%"T773'0_]P_F
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M:,^"8W=J_H,:I3T TF:_P6M<_:5!X05XS61D:-YFTT4QXDL9FNMX9!%N<=^
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M@_GVG6$N.3Z7T/M/DINF5LRQA60#^2OV?)& /XIG(5JMD?=8([=G0^Z"$^F
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MY CX9S(P)D7DWEI=P4D%)XOOICT66"H >1" 3#MC% MN!9&(&, .'A-&\*M
MD3.O<(A."[>VH<53PCM+BQNKL$4VWH:N99UU-#SI%QKEW5S<9\6VREXX7>UA
M8:JBVM)F.!KV!\>Q,ZA"5'-$Q0^G!2(6R+@MFEL'8I_:*+7@ B4C?*Z!&Y'%
M)")AA(O4:,TC\"I2YZ+*5:OBW@ODGU4P\JHP\N4ZC"0:&,76(D9Y G85 G(6
M<\2D,SH&%H23:QNBCO&3*QE56%)AR<NFJ%58\KQ8\OTZEJ@@;=)2(6D"!BP1
M%#D9%')1F&B]\(:2(GV>S_IJJX(EJ[!W]D>W![]V:KTLF19:"=PWL+Z6;:_8
M9MI"NVNC0;H6QMJ:&*L*#A\&A^=7'EI^KSV^CX% .1L9BC:!AQ;!5[-%"5WO
MC*3>4JZS2@F;K;RT H&K*N"]I/Y9A1MSQXTO$[CAZ3ZGGB9&-?(Y;94'8I'C
M*:# 8J2$.:,<!AI5[955T+&P>V45B+PHB)Q=^6*>[6Q].-W'S$E'(D:4N@PB
M L@'-PXEPYDR@GK. 42>$AI>6OQ8A3VS+QT/K;&M3A:JODHMJ^H[+I '!G]X
M#PV +HWPQRK#[!&@-[4G9@#4N#,4 >/EB#/MD8TJ2\KJ_/]2IAR 4D]*S%_:
MR%,5Q5[Z[+(*,9Z,&%/;7XXJIJ+UB,% (AZ)![   /$\N42"=L2! ;&JWFN%
M&$NT[S6+$]6^UW/X6F,0848++@W2T9%<8HPC$Y1"4@:MP>M2A,9\% <S6>U[
MO>%]KU*0>KSAY1\I0KV\(:<%K.11#,GEGSH'VX-X7-&FQV]MC1"/2142TPG
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MVE!+$2:$;=<ZP,B[5^DBW7Z_YFVO=PX(<&I[H;B+/3GI=<_ ^ >Q?5[[KP<
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M$3C5QM-_,F$N(^:@U6Y=7&;7=>)@0@>WW<V9=(7$<3X8,N80^<^%Y/5Y#@8
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MY$/-2N:#F3PAPXC,^@^><Q92\@I@7]R8)U1IER^LH3^"_3W1V.?/_L804!'
MYT"":0(H K5"8/ !.=&(8P<@H)E'5!F*4]Z>\7)M@Y#UI_N""XP&RWZ/GQ#
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MI!"9",G-,. M:]LN=^ 0ZJI*J.&"<6X[F(@*FH\$BB<'ON7Y-%0]RR-@ID\
MTO]%GVXQ^; T7_<]SR"N:QE$,XGG!;ZGF7KH 3X982D?19./VX-?BFF":829
MR:[IR(8#O[D.-?%LG*6;BD,MQ4 NHVD2(D+1>?/[/4PH3!3N3DB]CHAG@83
MT*- \:H08-@3OQ'1._@7XVD#_P;$*6#$W1))AZ'Q0/+Z[#E>+ S\($JHWXT3
ML,GN -B&3#X<)#,W(HN' :K&O9O&9*1LMJ>Y 0YBS%T&YB+6M]-%K*<H=)U>
MXC<(1K&D%GF(6KW6XDZBJ6BN15Q3)PHQ#-=S;=56?<550:=KEO:63F(9&GT9
MZM7WCW]IEF\[ED]DL&8 ]0P=K#%*%=E1%5",X _JOKKS6575BJM-,G7.X1#6
M7^80+D_<2H=P=7)V]<O6B.:ZMBTK!E%EP]*([.BJ*1L^>&F6A5%Y5UC]RW )
MGR4VI4NX"N&X//WE.. +NIHK*Y17B0?3*] =V=/\P*"*Y_I:4'"7,"#$#VS3
MPC0^PW4"5_5#US>)8WN.IM'QC9R5F_Q;CDGP_H-?@6M2XH8F4JI9,AA: 9[
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M@DO\A,:7V4<W"=O$/TS Y[N/D]_2.RSS]IZ79!J4[,)]\:C;Y?;7!6JDF-'
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M]CY@\MKAGV*HW.( Y&GZ$;2Y*5'+^>G*4,L*$.,M$7%,(!;GY-TQ8Z >+R6
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MN6GB-BB8%Z!F70+Z#?VX%#N1(9:.[QX)R#R>:YK+FKP.8W,N8H9U[&<:N-P
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MFA3R59:(O3G/<YD\39-U[^D]@OT,G(V-EMC;^<$/DP_H6TG8O_1R=;!TJ_T
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M*.*_7$#C0D!CCG[]R_\!4$L#!!0    ( ."+85;@'HCT?2\  'CG 0 5
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M+K^Y[&X^^4)@F^+?/Y],:.X.I/0<54Q01*9A.*TAV&R@&)5IFG&37.ID& L
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MZU_&91U>W&9Y>YVT(W]*XW,"\PX3$C *"LC47H[9!%:"=>3>Y4@65R0!KL0
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M:4&$385^2_M__OFVB-[0Z\T[?YV<TG]_/3@Z/3E^??SVX-W>Z2']]B:(U5N
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MER(8WU8;M"U:HW;:ZYIG^Q\"K;V'H\MZ$?K O(';]._A[/Q"5V=GXR_U-.Q
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M@K'X5%6;%UUP[0L_JNO@)D]$O77CU7AVWLS&*PX7ZW@^&PFCC9:.$DDYFE?
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M*!?T8."OOY2&TC!2H" :-$VY*CVD V/$.: $E&+4:N:8?W*FKK'^1=0=ZWN
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MP_<_?SAZ>_CR\/7FXO[QXJP<:349=]7U!;UOL78K:]![S-YE#^K.^EI9A,3
M&Q%BM-G(Y'-PZ,^H8*T%8%FZ4>_1>RX#R^/)W\8)#J>Y:<^6MM;ZT27)\#5.
MIYWZR<O%;-Z<0?OV,NU+Z>"22$1+5G*L2Y6HZ$TI-Q\C%9G';JD%#UDE'@NV
M_Y9Y,08:I?,6-XF2<;D9Y_67.%DD=#_*U1C\7RHWIH)$EF>T=!F^SJ0X'&AC
MRE32AU-P-KE<O1?I(V#N?GG=#>-N;L##:G  ]_'*F<T#18;6RX>V20OT?0ZF
MZ1C:S^,(LY7K8]&WX9D9PE0H#9.<)-89(,)KG&SDUD-M4V^0B>PJ=_9IZ/KT
MNG\..;'KB1RUZVFLS' >F5!H?',!"L4:-;$0'1'"4AXDU:!JY,-N&_O)ZC,^
M/1N:BEJI?."_98(;A[L#J(H)(K<"V7UN2'\=W51X)0'O3/N&1Z#:.?37'24R
M,R!!Y4P,2XS[(+,VG2Z+/R^MWY'DL2.E/T2NM?,VUBT95H6PUA6,ULO?IA1@
MUCYJ@>BHQ%7-,$N"48PPJP)P[DV\7GCSEAR.>X?:;3Y')7TT@PFS=@^3E\T9
M;F!Q7'JJS!9MZ?K-+N(FVF>5-%$\XHQ=#L1QSDG0@4JAO7*Q6^',V\?8G7*'
M4$537XZUW^1WD,;1MQ=8$OX^!I^)@)!+DED@UIA( J7&9UR[/.M61/#:@_='
MD7TD5KO=X@K+.&VP< :07>!$4,9Q4L")-SX2QIQ"F2=%'7V ]BX>O&_:>YS$
M*J8W+;'\UK2_HV^ *T,Y+5_Z$!_PYV9:UHC_NVB_;D""MV XHT3Y$O?.E!'/
M%260@Q<R*>%3-[5V'7%_]#V(C"L>$B]!KGJ7O<1%Y0,BQ,FO38NC^2FT&Z)F
MEK-+@AA>DB@,.)2 H"1['@233@DJ.W&@PV#[H_[:DJU80>D:OG=^ZD^6,9LU
MQ$WR3'"XA2A'LJ2&R%"2>YG+:"MH:0*/R76LZGOO4/NH]1I2K5@4:96ZW>3Y
M'X@-78A/,(%VT]MET]@N*&$L%%.B[$BH1UR(!'Z)H(.Q1EK1[46_>YS]T79%
M>0Y0A.B2BU?7G,BE8)P)PJ- _H$$XB2/J$6T_IGCT:O:ET"W MD+%M03=<7Z
M02NGSY=NI"N!MB7W;5G2:.,X4)R0S)XXRTOEOE*TCY8[KD8+PR.+EG=[T>\:
M92\47%>6%>OLK'IB'&ZFYD*.Z  2!T@WF8(@'H(C6D(H^2GHS?-."MT\\;L/
M;3U*-+>&.)XJQ:97OY!'CK3;=)INO44D6"X %\\0M53>>QYI"M)SR,(@1QZ6
M1%.KXPC2]AS:^=</$S^=E_*Y_[,8GY>UX>W%$;"2C@4N%.%"AI(R*(@%Y@F5
M.3IF:-2T]FY[/ZI^:T[Z7"*(FUC4!_]U52R/6QZ\$:6<AL8W->I(++Z?1"K%
ME7 @G.EV=?*6 7:?IU)9O=\N3Q6D.$#&"4XY J1E=;FWC9_.1I(&3;7WQ'AN
MRZ;IB"LMNI(JCJNR8%/MTJ@W0.R-ZNN(N78@_BH:_/[S&)_Y$29CR&\6TY(2
M-3(19++E7J^/I9.]L\0;BWLH56CZ&.&529W>[7N'VAM5#R#9VB'\CW"^6G:.
M\FW+D0!O;?0(R@E<A&1@Z,%0AA:TE<GD:)PWG11__UC[I?G*LAW@>O//S6=H
MIP7*P6PVGLT+QH.STO/WY>)L,5G:1R-E61:E-("2UI82[V4[RA*!@A"AW/)W
MM;N>=<&U-UP93!D#7";;AO&B;_!1?C.>XB=C/_G0S,:K2K7SDK(2)O!ZNCA;
M7L]LIB-F-64L(.L9E-N^*9(08SGL,%X8$)97;]E4!?B?@G+#JK/V"48)M\T.
MXAP];]Q-2T;CRXD?GUVM J\%-50Q(B"B?-"))&@_*X+6E%,Q1\DZEG.Y=ZB]
MH<< DJU_BE%X>0QQT8[G7S_Y+Z_/SB?-5VA?00;T["<O#SZ^/D;X(Q<])!DS
MH;:@I&A?VT #0;O*\9R=S+EC.9^N0^X7#X:1=,6CCE7D=QI;\#-X!:M_#Z?=
M<2?O70832#FJ*8TT$W['&&%12LX4HTET3!9\/(C]XLRNM%']P&1]*6CV$2*,
M/Y=%[PW^V+3HIEU^-*(^&9630G01RIF.(]:K2) ."0SUDN7<;4OI--Y^<6,
M&0_0NN Q-\5TL;Z3C@2<1-M<IDQ"\I$8;:(2(>K8[4[*OMWU&]B('5I56T)M
MO6.LJU4/TLK"AI?-;%[JDHP8%1[W34582A2I+RD)G ')5ED>+-5"^,H4N@7*
MWM&DALBW4*%W"89;I_W+#"WOR=MQAI%U3&;<.0C5H=Q!!4<<PXU1Q.P,SS'S
M2"O3H@.LO:-(;55LH4OO[L,_-TWZ8SR9C"2EU&?J25:)$QFM0>^+<Z(D%]%E
MH:'ZJ>)F[+U3_*.$ND6[O0.RA].U-.'M^#.D0W2TIR<EWK)JMWFQEUT -L9K
MZS@E.2 )9=*E_V9.A$MNT%BVT<O:&\9#,>X=6P95TA9658C:KH"@**Z!/3P[
M]^.VB&9DI*6N2,0YB59WAD1LSA0E8A($&XP/M4L"=,&U=^RIKHPMC.G=5_<2
MRMMF>K*D^1+B/V&2WC0M[H=7PL2;7M'EED,+IR5"_!E6'VX/&#MF7:D[3;2Q
M:'*%X(D3+)'(N<Y""N^JMUH==$)[Q]'GH_XMY.[=$_AR=D?YV_G-+B<XHBE0
MHT))P"DY@SEZ? 5-)B "^(@K.JUN<W<"ML=DJZ6.+:3I%UV^J"S[MD0SEU\.
M@I^F9GEV]O+4MR<PBC)19]"13%POU^Q(@M<%(<L\Y1*XZI8GT66TO6'!,/+=
MPH#>K7BWW.7;-#K_^G+1EMJS(UYJ#:?22T&G2*01%EF*-A^:>S9X;A.7M1>-
M#K#VABQ#J6(+7?HEY:\2?2;O_.2\Q"/'$5Y!R6XO6^$':'%W'">81AA!.2K5
M-!.=[3+,'8BG 8@5(K(8K.(/NO!^_XA[PX7AY+PEQZY_&3>8Y(O*"Q]A!NUG
M&$G@(4F+MCU+J;1GSB18Q@F#$#)50>CJSOLV''M#B6K"WL* &G4N+FMO',^;
M\[?-;/:AF8SCUV5BQ2K5:Y2,LD8(3M#%\Z7?O">!!HF[G,@:F$D)XD,6A/N'
MW!OU#RCI+83H'<E]520-:7EF-0Z+96T %,CF8/R=G\?3<IGMZN]7R3='>?G+
MTG/;4 ^&>%7B2M%8XG*.!!>T&"6 \E"[N&AOT'O#MJ=1XQ8B]@XZ/WX&HR!I
MR+A[DF"D(Y(R2D) 2RLYG\'9G*4.SX:!?U'O<8K;PKG>(>E;H)=3V8\0FY/I
M^%^01DY)RY6@A*G2%DA N:TKT(@S2D'BSOK4J;]L?WI]"^S/PJ0>ZMA"FGZ9
MOL>GOH47?E907KI]5RYCO_AZ^2?K"Q8'?_@VO5\4T1[E,J'9R%+F.35 8J*T
MF(&4.&TET2JSF)D*8'PG^ZH.GKUATE/I: O/>@>(>T]C^=O9P6)^VK3+-X<;
MR@*@OZEDV>)+TE'@W!*=:,3IX29/:\>%JD]B;ZCZ/-2\A;B]J[T\>D;++[_"
MK,1@T408-XF-HL05/?)$A F<2$\-<=PH0I/@/.)6X'CM!).:^/^B:RWE;F%J
M[V#Z$FFX?S+A^F1>?SD?MYM">CB54?(N!P^1)%&ZN#% 2U:S1"ADB 8T&-NI
MP/-#:5H#_'YR=.=JW4+0W@G@KQ#&Y^6=R^51Y&;)/YS.YNUB>7FW'$Z.M. Y
M4)V)R&BO2,U+5%%RDGW@N/RCCV7J.\!=D.T=M090R)8;U14RN[^%V12A^\DZ
MYB@M\T)9G'9&>Q;=;D9"5J*<42DA.1AQO4!*=;I\ VCO6?)X\6\A1^]<[TMT
MN$F/9\?G+?AT-/W5M^-RZ>6CG\,(O4R'JQO#E8[94H[;(5K*"0V).2TRNMVU
MS:X.L/:8*'54L84NO4\(+NY?_[SPN(/. 2Z.-2YN4;U9S!<ME(['L;0K;.%L
MO#A;7XGYU+R *^$;BANJ,J6M<L"-5%)KB*<I$P;)"D>%TM<+Q/5F5MT9[!T)
MGU#!6_C:^R#A>-[$WT^;"3YNMFIX.7).*<F#(2RRTBZ5>N+0?B/.4F\,*QG0
MM>VCFRCVCC<]!;U%]_TJB+]#LIY.ON(NV\['_UJ:\4=Y<^'JGY!.X&>4VFPD
ME9/"E.L5H8#D&@C:9K941#6:&V>0L]T.M[L-N#>*'TS*6ZC0.WG\Q6*&DYV5
M]*R "US!65:S,;J TWEIYUY*8-THI?JQ?'>4CQ;SDCD\^]5/%O#/\<GIJ/3<
M#<J6:^#(9Q02)U9G2ZAARO'@HKI>?ZKW$E)W!GO#PF>@X"U\[5=(I/M<+CS.
MA+\9YS&D=^,)S.8-_N<CRU3&71<-1"4XD8H[$B2@%ZH]HRE28W6WXKMU\.P-
MY9Y*1UMXUCLZWWT:%\FL(\Z$#<6&TQ2*GUJRUIBFQ 8??'(Q&\6>;/&[@+DW
M=-N5JK;0JU_EDD< OLA">O/JX.#\O&T^^W(I[8/_VBSF%Z_-T11&VLN8C$P$
MK0=-I!04;4N+$RUE%&)0S-/:B]O#4>X-!Y^7/K<PM5]J_& S^_1',Q+.Y&AY
M)DDYP"7>XNN7J"%6&",Y4,&NU\_8-5,1Y5],'42?6\I=]NL]^;B9E<,KE;+)
M.E#"34F4TDF@\Y4322$FZIEDH6.WK$=#^(MC#]?$%@+UR_K?P#Z(*(MU!<UE
MM.:P]"=!EA_.9@M(1VWYMT2=#U(:KPXLODTQ&:68N.<<2$9+M30801>IY*HS
M:R.-"33K6(.Y&J3])-AN-;6%</VJ>3]X&F_\N%TZXJ5$]69&JYFL_O0@STL)
M+8C+G-"11)<\:1\)C8"60^*,.!U]N4D3+ ^,:]VM5.+02/_D]!Q2KUM8V_OD
MH,CH*+]L ;&.O$F*"I,)SR7],XA 7/2"F.AYLMHIPVJ7A[XZ_MY0I[=PMVBZ
MWSG!BK3K*J!CF)4Z?6CR?02?QI.OKP Y>8;[^U4"7^9Y?$:>KZKF&PY69UQ4
MM2A5FBPH%(;%)3=X)ZFBX)3HM K5P;,WA'DJ'6WA6>]#B-4TW@&"3Y>X#DY.
M6CCQ\V7YOQ&SV?(4*0FN--XH^8^EJQ0!*)][GV+,E1>:#K#VADY#J6(+77JG
M_&_'>/3'%-K9Z?C\2M5SZ7R220!!_\$1Z6PF/DI/</_,$!2HJ&I?VNX,[D]"
MG;YJV4*@WL']34N73\W22&MA._39B J@(7*][O*44T*FQXB"B4 M!X.K9&7^
M=,6V=_091"E;V-,O=K\=U,I:_[!HXVE)EAY1I4P H4D,.N,*R1()5 LBH@I)
M2L=MQ_)"G8;;&RH,).$M).B=<GY\VK3S3VA>O6C:MOEC/#V9C0(-F?ND2*E/
M@694F7*6FB@9LK8F4-#U+^'<@+$W;*@EZBUM;'IGCK]LD)GMJG1-N\[J629Z
M7?7;?SE?AC[Q#V?%;\^!TRR9+J6-D+(VH]]NC2=>00"75*352\X_ N;>T6=H
M56VA5_\ZXQ=[8>D[6 KM%4]NV7GR4_,1)KYDE_JVN'PCPTK0AQFB;<DF5?@^
M!%!HDJ-@9'*. :M="_8!\/:.3D.I9@N-^L675XY^DW^9QF8Z:R;C5*#]9X-B
M_14GL"@!<):EU!$D43EH-*6R)#8H32 F0%EH06GH9*=T&&QOF#"(=+>HOW>@
M=G,_8A-X?CV=HV6US2$#HYW+FA$MK2?29$Y<R;LRR%X+P42J:T=Q.X/;&]X,
MJY8M!.J9)^ZG?I4->@SMYW&$-X"<IH .EL<Y*^5*'SGAB)=)$Z_1[G9&"YZZ
MM5/:^OB]T74E"6Y1:K_"++>$]RZ.G:X6E1DQ]*6D+U76- #23V9BH^8$. .D
MI;; :2==/V34_:+ 8/+>PHQ^N=6;<X%5,>?C9I)&CH(45'*2T*O&62M'7)0.
MX05)G> VFF[U3F\^>[^TW%-V6W39.\2YG7BOQAD=H%)D]07,_P"8OO1M^[7T
MVUK>N46Q_#)% )/RT?JN4A0B<J4D2=X73SM[=(5TR=&)25D'F<7:]?]K8=\;
MDCVI4K>PLW=%$913!$BST@?NU?ASJ?N;UCT&(8V\-Y(SY]%M*O>]([?$1[2@
M?<Y4:X:"LK4O$=T):.]X5$_\6\C1.[1Z6]S?< O2V$Q8\(@+25I.C1+AD%7D
MTE'J:P<Z_BQG+S5$OJ5K=/]*W/$4TF("1_E6 7Q:=B"-@3FM@R+99ELR^3P)
MD4>2J,BTM+B6O+8#VQ5;1;+XR>3IHO!#J&)++7_\%4X_S?\>)\T,TC]^G+<+
MN/P0[67X,G\]6;I5__AQ!B<W&T\]G&>_3!>SA9\<M8?3W,+_+/"116('7\:S
MD3>0O8F9)"M9B>)0XM%7(RZA&VZECX;7KEEU!YR*;#I%X;1Q$8#@IZ7U#SI?
MM[)K&/4WPZAA&ZV&8<BKY?+="=P(E>47D_ENN+("5G.CVG"$7)O'3:Y44V,W
M>O30P<Z)XI#]WEI-;,J&2)XD<5X![J^&!1DD6%D[H>0)"+)Z]#/CQT-$7Y$7
MJS[J1[\>OF+N@T='[&P<WRVMO9%.THK <#NFY<)4.67TB5/"8DR:19ZMZ-B:
M?MOC=V^D5I1_4U5X-]59H71<F%^6LUM2EUK&O"EY22:BL>R!$HMF%9%44Q^0
MN.@Z57ZW;Z+8:_N@I]"WE)ZL2X/W_@S6;.^":R"+X#9,3V,,]-79G13H*? !
MMO];\1FG(BZ!FG!36IQY_&)C0@=,0V3!49%\_6J2NR3"/9O^KGCP$#G7WN8_
M^*^X#,;?<0F<0UP6R&V;D]:OTD/6&Q?.5>E8ZEKB1D@D.$<"!4XLIU(&G:.U
MW>X;=QEM]T9 '<4T0TJUHCFPNO&'CYKXKQ=0D+A.%3*'+$I'!"#!@R5*!T]M
MY"98U4G!WSYW'U390U*UW]5/[6(\FZ^!*$5I4,!(3N4\1&E*@HP.OY,BHFGJ
M;>K6R.WJ4_=!88^64D5;:];.2W"SM(H\:M>9%"M?,68M/4MH.V:-L]*.6*0,
MP?\4@A"0$%:7+14'N+*=XD^76^EM8^^EF5U%T%MJT%10_ QGN$8TV\1[.H!Z
MB(7=C04W@>S6K*ZCHYL*KR3@BJOTW> 8!2.#T^7JAR@E5"T)2B X8#$#91:W
MD.]/Z[?8T#M4^D/D6M]\GH\OD^5F[V&S\42&YD"R@?!4[GDI)G&&4A *5FB5
M>>:V6R+:;2/L;JNN*/VFMN@&"),=S_U\U4MD717C>'5@-UO2%[)@,@I&DA4E
M24HS8KWS1#"?O8^@):\=,;L3T%[NZO55L>4^7?^6VTLLZ]>@"YB!@F?? 'F:
MB%E%1=WHM=U7R@-$S+X%);@Q-# @6N-F)G$#(R[E1&)*+N$ZYCFK?H=R>)7?
M$QO;E<8?(MS:F_OKCP>O-GZDL29J$8EVIO0SPR\VH4OJHW9<\A+^ZW;N=?G,
MW?O:/23;]!=+[1#6X9D_*=V'H=Q)V81GA,T^A=*7($M 0%D0KZ,D6F8>C,J2
MQFZE9+<]_;O56&]15?:1EJ7:EPN%2E9;I2W)Z G@E+(B7F9& H]).*HLQ$XM
MYN_QB2X&W$MSZ?$BW9(+VUNOFZ6A XR*L8XK0^\^NO%(X5]77P_)#?&";MRQ
M% 0#9TK9"E7<,4>\\IPHECE74CMUO=CL\U3@'8&*NOI[B, JZ^T=2NIL<;8&
M(BVG(D1!$NX0Z)\KG(?RC&1/#75"&QXZ=86^1W/?#+K;L,2CQ=[4D%E%BV8)
MQ'^Y B1R"QZ,)1H$;@0EYSE08$1Q%IT4 F+NU$WM/N5='?0[5-ZC93: 6WCK
MUO[BZR=\Q,HS<B"E"HR8@):;M( V7'8.#6C4BLC)QUP[?M0!UEZ:14.I9<NM
MD<&84P!N8A\=( X48>H [VGB3M55VY4Z/?6RR\7G"E3*O><:W48(+N,J:_ M
MTCD0*VRPV@1M9.U(U9-1YY[XU7-@SD/44?W@:HGOZU5DER<P@4N7C9%H]G(@
MDHE(K,5M-84LHF<Q*M>MC^)=HSRC&XF/U4DSA$ '.-)Z"WX&I9_GX5GIAK+J
ME[>QF5SR%L$0JHP@DN9RV@:*L&A8 .%US+7OBMT!9W](45OV VP9I;/)O%TL
M\Q,/5QF*,-M@<Q%G7.[;VZ@]+GZX[GDF,O)6&9FUYY36YL5=>/:/&-6D/\ =
M@</I6L+PMMRO/YS.T5<KY0A7Y4)>?'WG_V_3OISXV>J\)SH!63E%HJ2:2%W*
M:P>()*LD:+(1)*UM6#P0XEY[.$.JZR:[>A=ZN0?N)=@KZ:!=( _D_3P"[M-X
M0X/2X&&4JZ;# ;:]QT"G7'#J>2#:*XK0<R;!F( S<9E*"92RVGWFGPWM[O&D
MGCOK'J*Z =CVJ?4)"IS-UAX,&G8N>.*]5T0F;4H[:G0(',LJ9DJ#K5WWXSJ&
MW1M3@RNNJ2CU 3RPCS">SA:MGT98UL_S<76?C-F0)).E,9:/1$J.'@!83Y+(
M#*A**+5.AVL/(,,M4/;:0*HA_INL>'1-L7)R\;(4.H/VW..,"U&7>(3B$(U'
M!\)11J31CKB<'5&.4>4H!? USEJWC;V7^J\BZ)N*?W2]L.6Q%YRO6T(<H,>W
MC =<A[C)]^D LF8*15=@NT^PZ*_#9E<*J)V)T1FLH:6WE>>$2R>)9!QW..\-
MT<YQKD2@&CKYX,^;)7=D<3P121XB]]I1_!>3!1R?CF&2UF:.S]PH-*,)2]P3
MJ5PF%G#-9%)K*9PQD5^[LG_;1=YK3]YQ:L PTF]JB:YV+NNK\0F*\^L_P4_F
MIVL\N-N)B#HAD:<2 HR.^%0:,WAP,24=J.N6<KSEX7NGS;X"',#QV])4=[DB
M95R--"A?KDGI$MK5)'#G"<LL>L,C&,\JF_RW0-E+DZ^F^+>PHK<GN W7JGG<
MYB7H@G"@4.>]X)XFL%E%EQWXT5\/.UI'K@$5*B?-2V2DU$@5^,)88QPNG0C<
M:RZ$JWWZ\D1$N2<4^40\>8#X:QN _[7 A7,<-LFK+HE$2X=U!8)(QW">I82&
M42HIC?^3IEOCZF\>N_MH8669-U4$5MOF>]=,YW'BQ^T:"UCN(4A/J$.;13K*
M2= A$U\*W"MI4M;=;HQ?>_!>J:^/T&J_>VALML5H>;N8GJQO6+T=GXWG<.%1
M>.&<5)$XR!FM6?0H0O;H8+ L07&;*>_6JNR^D?9*Q57%6C$W8@GNH#0>B)NL
M=2M2,H%S IZZ4@ !T#Y-BB@J<%>)"EV.;GERWSQVK[3Y>(%5K,J38#QZ"R=^
MLNI;M@H,9<NLL8I(73K"6RY),!J=1<6,T!E P%W'<#.(?SMI/O^$CU[92_C-
MI9FT9<"]=+;Z"G;+DOSH-;E@6<'81&\[ .G@1]VOZ:NC[M9!ZBW_IJ+L*NZO
M-_ X+R(HR0@S&?$HW.=]BARW?0:2JNA2NLO%>0XZO,5W&4R%#Q%9;=/HYPE,
MDY_ 0?I<SES3>A]?[P(T2!<5+^T$B^F=2H$?)2+Z9,"XLPCW>E?I6[;-.X?9
MW3;:3_3-('(;((>A[!L7YRH0 ]=<4R)H*:<HHB76<J2H4($;:A*8Z@VOKHR_
ME[MI;T%O>8U[IP)OP&QN.W6 ,]0MM&^0/-&%LT>KYA8=]Q#K$)?(OD4E(9BL
M< NR$BB1.0;B!1=E_3$A6,@TU"X O@LEWW<U;" =/T2:M3?DCS";+]N\(Z2-
M+\8#"Z 8DAX],$D=&AE6"A)IMC)SDZ3N%IVX^>PGN*S10]1-/3D-48X0XJ)%
MZ<'LS7B*1@&: Y]:/YWY>!'>MN@\)TXE<3P#V@66$F=C(BHQ&]!D9"Q7[R1W
M+ZJ]WJ$K*V7+V_[H6$<WB%?N,'4!.ECEPFX8GZBH864E/XA#/14T2-'#CG@A
M:>F"D43[<FW:\T2L*2^68T(:ZX-RM7.:GY9(]Y5*?"8\>HA>:ML?+_WYC%.F
M-]GX5!DH75DSLYY(+7"G%@(W:2Z5+Q5?*.O81NR;YSY%@;XAA-_4D5SM$\L#
MQ.&.?SOX<+P!(S/-V>.^++4A4MF(!A?UA(:DA0DN:M;Q_./:D_=1D;VD5_M]
MO 3#-B>IPIIE<(D&GTN.A"A+$,Y+@$ZX.'&KNE7.O/'H_5;F8^0WP(WMERVD
M\?P5M.//?C[^#+,77S<W72[JF6CJ?0BES9#UO+0S-,1)IXA1-"9J;=2Q4SVX
MAUSIOQ_67CL*M=6R91WH7<C\!L:K"-<O2A>, SD)'> ]C7]07;?W<:>27H:H
M)-(!JA B98<+I-%6X&O$"U2%-HR#;+B5W*O!5Y]=4><>C^ Y,.<AZJAM?1S#
M^7RY:Z+&*!JX%UNHTH[I3+)C@<B0! D2G2)F/'514H'_[V2";'_^[NV0ZGIH
MZ@JQMH-P%.?-#4!H6I6RN4AD7^*G&2()N*.BJQME8.CO&M'M2M*VI^^93GL+
ML/:;>@E(;+R6&(*4GA)#&<XHE@*YUF:"I,O1JV29['9L<./1>ZO+QXBN=N+B
M)1IU46)*.J.])U9;AAL,3LQSK_''A*Y*4CPS_4!%JCU7Y&-$5S&-<3/;RWE>
M=L[\.)[]OBJO8JTTG )18 V1VI8+K\F1S$5($+-DOO9ED+OP[+5W5TT16Y;M
M1S=BN ENR\O0!=Q@O=YOQ_54_=YKJ?%6?E12P0"NVYT8O060RAG"M2G-_3(G
MSGI+;':.)>%BKNZS[9X>]SAK3\..ATA^X,.:%#GD'"-A(2"40!/QK)3NLHDK
M&5UPE'4R%)[ZL*:>P.\XH'F(M 9(%SDLU^IA-O_HYW#\QX4/X7E0 (X1)6W!
M@EM=$!Q="@5>) 9:<U7Y1=Z.9 ^T7E'4 ZSGO_IV7 R;@FJ5P>:E-9(:!*!T
M,7 D02HZM%BM]$E0-(EK9P==Q[#71F O@6\A0.]F$E<!;<ZY.D :R-R[B>9I
MC+Q^:KI#YSU$//#KOT86F-54,2! (> :QQ1QT;#2)$=QEBAGU5/U=Z7T>TRW
MH77^$,D.H.NWS325VN&X#04__?TH9]R/4L'W]O#%T<=-U,GK)#0+!,V2$A#&
MI=-3 20:$7P"#OJZ^=:_P'\78+NW!/IJ\'IE_^KB'R)]>-.GM^QX\Z\OF[/S
M9GK1I]=(*+5W2XIT.60*EJ.M(BGQV:+G0@W5K#8W[@2TUX9"/55L64MZ%V6_
M!FI3D*L#JH$,AZV GKB]>7_--4-)?8#]93LXCX1W,GHBH-3,=1;]&XON3J0Q
M9<NUC-5+H>^0"EW;GN^("0\1]@ ,.(AQ<;:8E!LQ/R.<M\UL]A[F+_WL],VD
M^>.?D$[@@V\1[GJSXY2"!LBXNT%IP&AP[J "R=Q8@;XTPZVV,C<>"''W5D<%
MQ3:[TTI%$Z24?KQX7XXC3-'\:E:Y+4%+SVDD(2M7KE25,H_E2I533$ RD%2G
MWD+WE*K=.OA>FAAU1+UE >E5XGP#Y)?I[!SB.(\A;=+6.J"J6-GZ5B"[KV1=
M04O-4!*N7+KZ=G!)"^9B@G*_A:'7%3.""X)8K3*SE.(BV*D)[O-2^QVEJ7>E
M]8<(=B!MOVE:B'ZVV7M\*;0+&4APL=R>S8EX817Q.C@)Z &GZR6R>JGZV]%W
M6^:XDEJV*+J'3(<(*2S"#/YG48S@S^MV>*NJ-2E)46J$A4AQXZ*(S2,X$I71
M##C@?E8]F+ =RE[N\37%O^7=?W1/BSMP;3*O.B ;ZH;Q;:">*)!00W?W\Z&'
MW(>X.'PK0,<B%:7<.Z0LB11,D0! "1<:M[^8$H_5"Q?LEA#WA1-VRH>'B'MX
M'EQ>:.5>.4K L=(:.5+B#*Z'T:L8@0L90^T4HZU GN"68AU%W:W^1TBY=@C@
M8E-<14+>P?RT28?3SS";7T;2KGX*<%%^ATL>8\J.: 6)2$X]\9 B3L-+XU(P
MX$45\_'Q&/?2V-BIXK;DNO=BW&W UF]7%V@5@P]WHWF"",3.U-H,JI+*_NL]
M",$$Q4*0)*52*1ZR)MYH31P%YAVE/H5.IQ[/D"QWQ2V>(5<>HHG:F;'O((WC
MK^,BM_7&JIR+SCM-!!44)ZD\<5R:TJU=.N&2H]<WJ-NJ]E]_]&Z#%S6%WE23
M6.T+BI\6[13:=575XZ\XR;--@UCF57;<6>+*!BFU#Z1,C)1VQ,9095SH5O_B
M]C'V0Z.59%C[U?SM=#R'CSZ$\=R/#Z=Q#4F$H&Q)\(T:EYYE$S!KD7?1<VN8
M%RJ&;I6&MC]_/U1:07:U[RL>M.-_-5/_:NQ/ILUL/HZSG]MF<9%CS;2.99(6
M2FMH94K;#[!$<^.RX!9T1ZW>.<Q^*+>>) >XRGA\VK3S3]">O8)P&?[PWB0M
MD',ZE3L47%D$A>N(,C)X(3+BK5Y!;AN0O73MZHE^RSO?/TAT'=4F7Z(#KJ%B
MR-LA/5$$N;_6[N-!#XD/$36\!1[G45&PDN#ZA]0/FA-/)2TEFH70D680^GLF
MPGV1XYWQX"&"'J*T4'-VABOGV$\^>%P*-[?LA,N2@R$RAY+2Q-'F](C,.)T9
MKHI<52]YO!7($T2-:ZCI>KV@WC(>X)AYTY0*P87QU!>I'L.Y;_T<)E\_0FQ.
MIN-_0;I2V&^5A.FSI\8Q03@4)R33Y95<07),,FM.J87:^:F/A+K7YL4NU+?%
M .E=2/$1N#<;9@?D _?M?3#HI^WG.R@W^O.QAUX'V @?/P%N1!"<&6*T"41Z
MAGZ\P84\@39*<V=T[I1N^_T2\AYCZOOBXT/463O*]I\-2OE7W" 6[::GHU!9
M4PEH:0;'B#0"A:"40L/3 ^4B:FFZE8>X^>RGZX0YL%::>B(=P/(J=1+&TQ.$
MA-_-QOC0I2!>?+WP,Y2*&4K>86*EQD&YX^(\?@%KI>-9.)NKU_*\#]1>6U-U
M5;+%;NH=R;L%X14/I0O"H6H(WP?NB2H(U]5J-\[TU,@@+OY]0*T+.7+&2(IB
M[8_ZDDIM1&F5&:,.KG91NR>BS'V5@Y^8,0]11/6R5!?HWHTG,)LW4_@&YB9L
MD81/"A?79$7II6(\<4:4PJD!$D,!,-;M(+?;>$]0[+*NEIIA15S["+]<<_QG
M,TG!Q]_7<+(2%H0.!!3C1%H 8I771 !CE@7J-73+P;CY[/W2;C_1W?H^__M/
MUZ3S%G]<_F+Y>9G]1\@_E']_^7AX(:D__OCC;ZU/4YC_+39G/RV%=/S+NW<'
M'__[Z,WQX<_O#]\<OCQX_^G@Y<NC7]Y_.GS_\X>CMX<O#U\?OX*Y'T]F[WW;
M+@M[C:Y9P[/QV?GDWJ+2CQ[KI\NY?3OG]8#?\&&X6<*7.4P3H*['Z1\_CKD2
M64"VR6HFDW(AJ6B\$B8*B#F:T:-'[=E3]#:K&"4&AR5[9*2D8X'C L*%7%9A
M*<?1S!,J<W3,T*AI[>W]?E3]TA=6#9R7V4^^A0_^:WGV;,0M#]X(3H+4%'T
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M78P\)UPZ223C.)=Y;XAVCG,E M70*MIZV2IYYKS^0"+9QNZU]VM?#:_A_.L
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MKN=\&5SA7SG+Y_C3:?9Q:??EYK#/6G-*$\DB Y&:">)C*2F'#KK5ECK-:B<
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M.UBQKX]X=0DT1M",*I)R@<1X($YZ2V*V5HN $;1L=7;X$@A]QOWIA\]MC'>
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M^<UI)?;I0HZF:/ I-\^>94_9!U UEJR5R)IZ!SN[R'N,=C67^B9(9'Z[)'I
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M9T=3RF(]()K:Q-6-43J"JSZIE%*M<0Z>WD'"'J]9]=?5!/?!]]U[ZZ"QUJ)
M.LD1;HX*8L0* 2NFZJ,MLO<^=("M8_U.I_&H'DKKV#WWF:B-81P:1Y:MK<B9
M/3"M-)2DO(R$$4WO[/%A9XE&Z?7Q^M$Q^,Y5.CA$IN=8/SI*5T-J"+<!>C8C
M2%2%+Q:<:HP(K"A(0BK(Z*76A0-8U[M?Z)#K1_OK?@2^L]>/9K*(U1K@_:S%
MW;$-([,1O+19"Y)!&'R&]:.C=#:J?G0,X+TOO.[<O*R,G90B4V0%KTRXZFQ"
MAQ(D1>LR48QZK4!DP[W6=X]^ZB=Y!\ ZWCI\+\VUH0Z1Y_X3?(@B]W$L]P!^
MHPYW0*UWFOT^N:1/P:++H*I58"QO.WS:9' R-6;B&-TZ]\^^M;CA?)U#B6/
MZJV\]\O3S#M\$^OSZ^N=O<3@18@(JJ6BC0T20AOVX97/R5I)5@^;GG#/P^<[
M%OO O>B(5>]3\(X\-P+9XH2L=56R>4TFV;J%0&JIJR8D8W&\\HY->]N@->FG
M]U6B-J!9VQ2@:N? E,2G.Z\7C Y1"2V-6:]]'Z2_HU/@-GCU]F/N2/2OKT53
MP6DM',B8(_MHQ4!0?%)8)W,6GMWQ-*Q6Z;ZG'XW^MD&K8P;C.X'^]75#\%Y'
MWA 42MX0E&JC+CTV?@S1QBUXN3YS9H#VCDQYVV U>6+@JI35A49CD<":6'D+
M*!$29FR#$I21F%V.TT[]/8: L1.^<W80#I'KN780CM+9T,ZQ;0"?LX-05*=T
MK@5BC1R?*<W'BI8>O*LA:*525M-6MQQ>!^$D=C &Y][^\\U\D/5IU2$ZFX.O
MD$OK8?-!0'2\A5:, 5W*.N.P(WS#"_9=#[ M_(O.V$W0_W>[,.JJ[;686"IE
M(&4+F&J(SZ]J0$6#6EG';D9O5HAU&8[E.-\)VPG<M]ORW+0_#)!HHF/\>VGV
M<X#OIJ4'5+X#Q!,<W/=(IGG'*898E-K*C%9ED-$3F[K01A47D^Q=$C:7TA\Y
MK*?6^1AD)]#UJ\OEHBP^?\;ES96-TS)I4P"E:)PVD3V16 18%9475OE"O:.T
M=1GF/\-WU<NB(Z@3G-RMV:<M[5J:Y W5:'EIHC6R9<UR>98F"^W8N+T)IG>!
MWET)GKR"=P#T<'KZ/M#9Z6)YIWS@E"9LVMOPOMGF*SZ^VK6VNT0<>45G*/&W
M:UU-E9QK<UU\46BS&CPZ\=XW3]-7EQ/9$AQ"]5ISC-#:2VUP;=2(*Q4#/9FI
MB(-;-+2V$55T_+FMYJ0J!RF;"$)GD9,MR9G>]"-/KUEFC%ULW2PS1A/3MMG=
MN5X_28Z$"RY +"3 I%0@1&FAM?:@REH9,ZS@X8&7/&U5=X5P\KO$UV<7M*3S
MBV9UKRK[XA>G?]YNBE!"&)6%A4C-W2*+@"5F4#+'(&-@>*:]8'Q$P*=M*]/K
M9/(1BBS7Z:*<YO?X]^JWR].S?/H'?CYQH3J/J8+T*;>2 S;S8 QXS2Y ]!)Y
M1YC4<C9)=HPFTT4+DV>RUJ0\B;S;!3[HVH@N7C\*Y/@_%A#\VQ#XOS+7.4WD
M&5C&*,P[WH;><RJNV^S5!G>BBN7(/F>PR4OV?"A#,E*#)A&2<,9&-ZS"><C;
MGK;&IP&UXYS$QP5L@UK.;X_T>WV6V1\^IQ/ML@ID;+O>::1,24/$; $9D&!S
MR%EVL(.-[S]VR^@#_$PC%/D "R5)#R2I=8!R7,2GF 0BE#I2--5->U <1!]L
MOT-A/*H'W <;(EHI6WE6T I,E@@A>0*;#8=:,@5E>X<HA]T'.TJOC_?!CL%W
MKA;((3(]QS[84;H:T@NY#="S&8'WCLBW:4[HP:36D[#J4"DF%QD$1MG[5#CD
M/MC^NA^![^Q]L$5B5=H0Z"A:/;S+$#*R@QN*JM$BROP<^V!'Z6Q4'^P8P&>:
MHU)#U#D)J$;Q@AL_$,:8P:,74N=8"TX[6/N8#OX=\9W\GO'V6(\!<CW7*NA1
M.AL\1V4+P.>L@JXY&R.]!O*MVZ.E58(,!; **DYA*.NTR4_,$+:8HS*%'8S!
M>;:QJJ?_^7Z\1PXRVD02G)1\5@55(+IJH/'$$44JV:\QI(P=JGK/6_=]8[2M
MH@8-5=T5Y=XYZJ^"MGNL-PL\NY;)*;;MREZ/TZ)5_R-"+$Z"8N\E$)'6M8[3
M_-T7')62=\!NB@D7]\V -S+ZH(T#JKG=>?$B$V*"ED-O0[LII.Y,G/?(<2Q>
MWLX83\&N>?]@Z"%2337^YEZ)]C3T9F>-/6(".\ ]PR;P=3RH-L)RM)EURUHJ
M=FR2JAS@EL('D$1A57S"1O#82)N9;& ,RA./.+H^DE0.7F-(H,FT:F]G +-.
M('V4199BT4_)G[NW 2H=]/, +^X6X'8?>W/7]4B4L@LZ@]:FW5TI 3'Y"'S.
MQ1J<<;X,8P/9M[?647.[XC3!%_HK6\_EER;3V\4%W8Q/JKXZ;Z*%+(/EQ7EV
M1/UJ<&,2Q23A[3H)ULX?Z;V"/&EM]X-X@JNX[SJWM"LIM^8,DH;7)07[H$Y;
M<$59%DRP.?8N[COD?M5=7/*=L)VG7W6(1,^M7W64E@;T+FX!\3S]JC5F:2E&
M=@L"'SE)9 @V%:B5HJ-D;7"]I]4?:K]J9YV/07:.?E7ABQ:U[6*ZU0J;:B&5
MK  3VDKL9@7Q+/I51^GEL7[5,:!.WZ]:J43-_P4JM?F/Q4",R8!0PEA?.':L
MN;.*#[!?=1<%[P#H!-_P!\J7'-*]^Y.69VW0^2^G9WC6",R:B!\6=?GU;UZ?
M%?K/A[_PCUO""^&T=.@@KTBS.;B )*J&H$WU,D>TV'N"Q$X"/WGCF4]=DU)9
MKPY#KU5V;K6=2=&ZD!0$4A9\#88,:D9G;2MYBDSDVWCV'0#K78-_'T?B$'F.
M@HE\%/"/D5AO@]HL3.2(JUD'X+QQUQ19%BU8K9,/.2>]7B*_;RV.8R+OJL0Q
M8$VJO%].__SJ2:"UI>TO2@H))@>$@+) KA8UQA1]D.,5^.T%A\#*.@;VC3K<
M$K-)9W-\9(W<"*6,0%UMAHS.MPZ[RB>TU9"RCPF-"K@>1@U1Y*TW'(TFMT5M
MXMS3G:KJ1,*NIMNR6V<;G:2&F"R"M38:%8NGVIL28Y,L3]TOZHKU!)UG]\GU
MIK'8+&_J( ?(-U5)PB.R[:DXH8LF!YC'SFJ8:<NX(V<F_AJ4UE"CH,8_RQ('
M&< 8+S+_UBOJ7K2P%S-YK'QA+U8R!OW>/MY/_*C/^/=-]LZKB)+M$=!@:-W7
M H))[4JPH)$J:X?#0N6[S]U#OK,KZ(L^B'4O35A>GIY_JW&E8)R7P"\L[):8
M"M%Q %*B$#)1H_X?%E;=?NHQ*6YKM*:X#;U,Y_3O2W927OW9/)6;4BE%2A8=
M)11EVG! GR *=E94*;%0CL''W@,S-XAR+"Y<#Z2_-P _@0%<V_<0P29RW38*
MM1^?K8OJ'C>''7"?9V?XFG@W&E6[32HA@DE. *[NE6Q)"7VR:KUAX*D9Q"/>
MV;SV, ;NZ>W@YNY!\Q8H=,OF5P<F\KD7"O'&&K/#X*34W1/?]PHROU_025$/
MJW\+E#?Z=+-3^][?%#TIN^_F5\Y$\#MPS6L<OR@]QW%)4ZC&.%$Q:^-]Y?5G
MEW+U SE^-[]\@G#]*[=.%-IK4R74TDB/E*T<<'@"5-5&9WV*W:N<'A1HBLN)
M7_$_IU\NO_RT6"X7?S6 \0_^FXN_3X2I09)LXR";\Y_10?2\\]N$0EL7<I*]
MJSG'R'<@X=)6MC+DVJ*+7B:A7*BT9$FOJA3HY>+\XOPM79R@$0X%!QZ2O.6C
M@:/&6%3CLTTEDXT2<^^FC VB')-E]$![[W3!E>T2M2;(.4L^XUOE>XT5B''Q
M*J;L1.]M],#I@J<TF*DT,SF9QP/$YRFTK*WU4!VI1G+'<B9A(/DD1(A"U>YG
MT>%2T,]E/)WT,45S\#T(O%Q\^7)ZT>3^A6Z;N"M!^6P\2-4"#-?Z8P);?"DH
M<JK9^S!'JG:#>,=D/5-I98)VEOM$_>?9Y3F5&S=KD^!%9Q5=B:"<]F!"MBU>
M#4!5*9364G^&L:V%/7;CZJ^QCA66#PE^==7N8YMTHRMD;]I5.[)@F"(4CIB#
M=1&][%UHO5&8N5ALYS60\3@?,*,M^>ID+@Y4+!F,C0C!*P%6."NC"U79WET:
MAU-MU$F[C_/:CD%Y+DK3(3(]1U[;4;H:PFVZ#=!S&8%(63FK"JAB..*7B;WM
M1 :*L#YBD(FP]_W*(?/:=M?]&'SWP&M;'48;P)M&JB8YU$)3&JN7UKG4UNO?
M>^K<4^"U':6SD;RVPP&?X)+U#5U<T'*-F<6$6*TA 3YZ!%,T0G0"0;JJJDJ6
M<'T&RN[^XCUR'('N=X9W\BO5J\[R[((*)"&)5, 8Q7M<00>)G6*6QROI>F>@
M#X?*>!J/;T>4YR0T'B+7<R4T'J6SH42VVP ^)Z%Q#%XDU!&,D++M>)[/)"LA
M:F$39LS)]F:]/'1"XTGL8 S.>R4TUMJC,!0A1&PT Y6/P!(="%ES,,Y)S,,J
MR)\HH?$H16U-:#P&Y2E<P4U]$B5DXS$(J(D"&&H2>LVK-\:7G))%,<=-]/'Y
M"%T0GRGK=:=<?XA\/SK11FMR;(_1-FK81R>:4Z2Q1 6K9FE3.99*VA:0NGB4
M)=H8N[-H/ZE.M$FM9 SZ$W>B!2&%L^3 AL0G'!5>9Q49E*9@ ^^C*@T;WW[P
MG6BC0'^@$VT,8I-VHF$M29GHP:;(?A"R[QMJ&\)43,TB!&W%,-4=>"?:UHK;
M&JVY9AGH;$E%TFT2"V\RVK9@)K./*8LRPCKO8N^TWB'-,IC(A=L5Z2EJ3NZG
M!1XBU7.=:#!*8\/8[+>!>[Z)!J8UVD:V>8ILZ<8A08JA@B03K&WGC.E>$G+@
M$PTFL($Q*,\ST<!'57S,'C"5YFDJ/I-$5;SU)1&ELA)M[U[D[Z4X&*;T4?IY
M?*+!&'#GRN45)ZT2+;0HF@\WP>Y(D))%E)&0@XQDJ'OL=1"YO"E4OBO DY*Y
MK3:Q*&- ;3P($5=3N5RKE\X@K91!A%)*>+1-\+!H,?OZ;1U@FX,<<X@\1T&.
M.0KXQW@5MT%M#G+,1$I;WA0@<V@)1K5)-ZT&72:OR-=4U;JSM6\MCB/'[*K$
M,6!-JKS;](!!%EN5+GR>MR(P[W1+TDBP,FKI@W%5;;&M'A:IXBC@!Y$JCD%M
M G_HNP$*K FOT3FPRK$\.A9 QX<VH2"6)8?J>A>W'<K8F&EN/W9"> (*Q7OX
MTH=(]-R&QXS2TN.#1+:!>)[A,25GRPYY!*F$8]]<<W#/YU'+J#O^3>O^$D]4
MZ6.'QW36^1ADYQ@>8TPJ*E"&6'AEIK@(:&N%J%L)A3*.SZ+.FC[(X3&C]/+8
M\)@QH!X.9<ZON/QT>G;53MS&I11^Y6T/Y:[$/9ES'GWS3 0ZXQ!8X]%)B-Y:
MRZ:CDD%4,3(0!44U.B7KW4 >G4=EF)).Q^<J=;$6G W$KBR;,#IV/"49)7+%
MY.J4MYS=Z'16[O7=JK0[()Y(U-941X!:-5J%6-N @L2KE>CXM\ZLS[[<$)<\
M\)(#2=)NI=P[<4HO("?ANAG(AR *(J%%X(B['>/D640JH$4.', )(SUUMNRG
MRD^QC9U,JH^92J^NPCK2T89836LI:DTF/@('\P&D92N/2?@4YF#_/J">[UWL
MH0_.A]+S?6_ZDUV\G#GHYQW0,SS!$MMT29!<%I%J*<+V[@%Z&N4AHS0\I#QD
M#-+S500,D>JYEH>,TMBPTH!MX)[/&"J&7"Q%L,6F-C8T0(@F0D[.%)):N?+<
MRD,FL($Q*,]3'B*TM=DD!\8GWNL4"\/N38"D6A['RQ+<E)7:!U8K,$H_CY>'
MC %W@ACCO@DHLF87L@24MO4U205H6CMR9%=)2C[=L'>C]U/HZ=GEQ-\1Y0GZ
M?N]M:A\BTW-D>AFEJR%L']L /1?3BR]5Y,3[F]:)]S?,"4(V$BKRSYKC(N]Z
MIT<.F>FEN^['X#L[TXN5(H>: EC?AN4H8R$9CHX1C41AC2?=>^]_"DPOHW0V
MBNEE#.!S5$/(1")D-! Q\U'G^)>@!,M36+X:BA#X_*HA=CGZ=T)X@C;>>]*#
M0R1Z;M40H[3T>&9\&XCGJ8;@$RV$4#U@,(&WME(A5NLX@B7*GE1(W=G1#[4:
MHK/.QR [1S5$+1%%+ 1"ILJ!JRB00BC@C4@<<CHI1&_'[B"K(4;IY;%JB#&@
M3G!^MR1Z6]JU-.1,RE@,L(?"2TLJ /H2@'A9)0H*I3M1WUT)GKR"=P!T'E:V
MHEO$D0P4[UOY33!M=E6%K-A!$=FZK'M_Q4^!E6T7%VU'E"=HUMW(.31$KN?*
MRC9*9T/9N+8!?$Y6-NVC\;9X"#::=AO-\6.V&JPT.I H,7?OWS]T5K9)[& ,
MSG.QLEV?48E\RSMH\,+G=D9%2,(Y<!4IMB1"S690N=?#[SD@YK51RAC"O+8%
MDKUY5;YOH*)DHFCCK[-2J<U"KI"0SS5EHM79>U/J%@UBQW-\=X!MCJ[-(?(<
M1=?F*. ?:_C;!K4YNC95M8%ME,#I-L[%L%RQU *YG2P^$V\A_K"T.*YKLZL2
MQX UJ?+>G=T$=(H#NLJO!>G;T9&EABB\ =D:(2A30.7&Z^_K\P^@8W,4Z!LU
MN!UBDQZ*'_]:W+2@U!245A7PZOR7[.%)8T%8DZMT6&RIXY7X]?E'H\3M$)NM
M?]IX%X05[%\IP8YZ=HW:5L@VCZT*H=C2\I/OG^ZDR"U1ZU@X<KZ\./D-SSY=
M79776$IJ_5_*6/:4BQ60/.\,Q7D91,62\J!>&G[JK9"3?_<MW+SSPN/P6+?'
ML&-;]%<A;FZP!X@QYDIIB$K[?YZ/>ZT[@+^NOAV0Z[BYKHM3O(E16+;KUL!@
MT'#TRL8(RDO,04A'8M"(IGTK<(/#VE]_8P#KK+=?&:DOEU]NL@R\<1!:/I.K
M5[RAL$@8HH"2I3,L">DPJ+#Z$<W=>>E\9^-.L"]Z8-;1+5T)@O^Y)8@.4MM*
M!6K%RH+458K(06P-T=DDY?R@!/ICRKO]TB>HO*TQV_CES=Y#_ANUH:Y?!S2<
M7RS>+T\7RSO>P2F=WQ6\9ROY4 %FZBC?"H^UQG)I<C8Q66'1F^),\-DA5O9P
MM38RFH&-Y4-%F;*_7$BO%1]*(+#- U%! FI)8-G%)Q*&O)R%T+Y+?WE[RF+M
MR:_/\I+PG'Y:+)>+OUI%X_7LXQ.9D*,9IX"2:=]SB+P9LT?LJR839$A2V<<^
M@?&O/;3>XC$&<#?6FPSL*0A%[\'@>G>_1U:I*Q\,$5QHW2TAM,NCG, )6P-5
MQ<YQ]_[1$?(=@P5-KI?>]T%K:;W+!MB[^FWO/DF-(#"7!))*$TZRCQ%2FWYA
MJ"7B4*AAB:_'WG0,ZN\/Z03=1K>7?2*M:W=5!")J#<9Z"8%"8P$4[!=2JX;O
M/4KX]ON/0>D[X]JQL/P> WS5?+P6S+\G]L+*"4G^,'W6X*IOXVQ#!I3.0D'%
MQU7UYKL&TD$?]-IKCD&QG<&<O#2-5TTOOBPN66J?G(M&($39EIMB@)@B1^6U
MZF UFB*G'1?[399CL(2N>'>L<[A?KM=G%[2D\XM6.OOA@G\I;*TM),-/=((Y
M1&,U;TPFY=8DS\OW68'2WD1--<ONK#/#I3M>6^FFDPDX6>]*^I&67TYD]DKX
M4,#E3&#($:2*"A)*XPI6CQ//EVU2'*\UC,;X>ZW[[F[_HKY9X-GJ]N;T3RHG
MD0IE;2-D%!X,1R.0'!]PMFKI)6(Q66[M^:^][!A4/0FPWRL^3,=(%G-V&'6"
MJE:]&L2!:"H2(M90K,JQ3CIZY@ 9R7K? 8S'^5 8R>[IQE<VDK4<O4I:M>A5
M <%4#R4Y1<'7:$7O<O>GP$TR2KN/<Y.,07DN6HHA,CU';I)1NAK"3[$-T',9
M 9%V1LD".9K5[ B"6,R*>,OEI-&+()^L\L=SDW37_1A\9^<FX5V-G94<P&EO
MP9BD()#1O-K*!Z,T0L3>S:U/@9MDE,Y&<9., 7QR^N.K#GV.4*1#!(Y7^)R3
M.0$JW<:2Y#:*IBA<+_Q]%LVONQS_.Z(\0;)@8]O7$+F>:_/K*)T-;7K<!O Y
MFU\S&2&S(-"E.#[_@F+Y HM;50C)9RN[,_H?>O/K)'8P!N>YFE]?G7[Z_>+W
MKRG.&SJM'%2D4D$H[UM58!NVJAUP3)V#5-I&M9:$&-D+>^]K#Z@U=I2JAK3&
M[HYS[Z:@39)^./W/]X(&GQ59!D [RRXRJ@0!M0 5C%:\A"#,;@9QWUN/V1YV
M1KGW!O$>_\Z_4_X_[Y>+"\H-9O[ITQ*_K&Y ;X8PLUV*9!&""[J-\68$LC!@
M90Y9^2PJ#NL8&_*V8U!_=U0GKBJY&Q<+S>>@YU6K5NV2*KO"0E8(":E1*D;A
M3&>_8),LQQ4L=$%\ E+#>V_46YGQ\N92:X!\4\TQ>$2V/4TTZ*+) >:QLQIF
M&I!S1\Z4*9 I!;3EO=-@\9 B>=!15Z=D+DKVOF?8CYD\-O-@+U8R!OW>WL1/
M_*C/^/?-"6>#$D5[#5E*WBQ5$R6(!)%$=E*7:)0:Y#?<?>Z!Y)ZW!GW1!['>
MD<''Y>7I^8U/&DFU,OG0> L$"Z(4)%<32('\IZ$64?,@U=U^ZC$I;FNT9I@X
ML]IDC*3L6F=G-#*#B<8UPJ< WB!JJ[VP$GOOPD]B^-1.+MRN2$]04[IATLH0
MJ9[K\*E1&ALV>&@;N.<;/N6<-22U!,N;'6]0FN4,.K9S1002+%9W:MM#'SXU
M@0V,07F>X5/157*"15"I6C"D":)$#S)ES+G4DM9O=(]Y^-0H_3P^?&H,N!-D
M>']E42Z_M,K4MXL+NO$@44L4[4P+PJK&5938@]0%BL3LK0B81.\9)/<*<A1*
MWQWB"3[S?YY=GE_BYW?+UV=U2?^^;,7J%_1EM:G9DFQ(*8/4@47+5"#5F%;4
M $GEDKSJG=-[0)SC\OUZX3Y!.\D&T:Z_@"'"3>0)/BC8?AS";FH<9AX[Z&"^
MO>/&AZW>&ALM6!E;1L)P,,P1,!2TDH@P2]F;'7\/!O*(L[@?^Q@#?>];NY?O
M_O7Z9QG?XUFA+Z?Y^I1S-5(I7H!RK>G!R$;1QGY.J2ASS(+=FV&L%/<^?G[W
MH"/^BZ[@;70-.U+TO'GUXL.K#]=T+R]*63T./S,4B^67QI%X=E>:8;P[ YZZ
M,YG.6,G7&')2]4EYG53(VAAVW$JI5M=DI9$87#@9\/P=HS(Z/R=ZT]A(?J;S
MO#S]XQJ"ZXX5XTV2C85+Z)9D9FN#Z)%MT!'JDE(HH7=3QB,B[1R'KA[_CATV
MQN_LT^H]S8=FEVQQ=K'$?'&B'7J*BOTP+PR85/C[L/RY69-3$OSEI4"3+/HA
MJ?80LG2TC>\"UKY:F((+YQX)?Z,S^@L_K_HMT9B0%7OGQC:J'L\X)&DYSA)>
MJYQU0M]]8OK#(AV_A6R+?W_:XZ_K;K(LOAFML4H:6P38R/;*EEHAF.@;=R6#
M02I:/RPSM?$5QZ'ECC!VK#ZZ)=5=PUO]\G9Q\3]T\7+QA9UU=J[_>59.SW/C
M:Z!RS=L0^/PV[&M#U$& J>0@*8E0DPLNJM+&CHS0_C8R')UY3*Z(*6J6!DI^
M]\23)X*H:M_N[DIB@$)%B$X6T-J+FF)EQ+HG0K83]3C,;$Y]39%;O1>2J[O$
MDL@5XQ!D"KR#^LC'HS4)$A6/45*PIG<[Y0/BS-9^/[F1[([VOEOP[Y)M"^&4
M("DX^"\9C'$)T* "5XJ,+DDJ_9C%]WKKWDM[]_+]CT%Q0IKX(6(<']__*/ W
M\,5O@]R4BK0YD946.,CE",=X;%1_+8WKM=;&AY0&$2;M6X&#^/Z[Z&\$8)/R
M_7N#@=>B@*0V8$I!#DL-@2]5*JE]]#2HO/AI\/V/@GTCW_\8S";E^T\HHJB"
M@%^JP(A(D#2O+H;JDZ.6D.\Q^N9 ^/ZW5M[6F,W!]__Z[<MWO[[Z^.+__7IO
M_A:7S:__<^VV<%@6X:''[9P^&"SK6MZ@4O5!Z&P:+RQ:#-+5C$F7JHLJ.IP\
M].#=8HYO0=+B_/PE/_3ONEC^A<MR_LW+=L(7D2H!*>3HF_TG: 7+D'FCQV@"
MAO5!BCO''@/$VKU5O=)RR4$@_N<%^Y(7YYO?>4(VJ^1SA)AR!:/)M]%@ GQU
MH8981<C])[D/%F_^X+VWU7S?WCZ-;B:A/ADLZH?+]+^4+SXN7OWGC]/E*MUW
MPL(E@1RWUDH(QD8'H>H$VI(F[:7,W=,.NTG\K(UM5PU.PK@Q6/JWBXO[%N"#
M3(;82Z\Z<KB<? 7,U/CG52G!5_8?]KBYW2_TL[;"#GJ<H,7[@2TZD58"G80B
M%8'QJ15"Y@+)M8R?$E9WIP-[3J=E)^3[#QI8LVC^X2<Z8\ O?L6_V8A_XB
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M%'9[,I1'. GV8R=CX._=__<;_DEG_[7X7'@/_4J8';2UK8I5\?D+1KH,*'R
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M39UZJ*3E(N&=5;X-M]<1DBZ3*R4'KBM#,&G#1192$E5!B2=BP:VP3-"B5\T
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M#@]GT[:-C;BT"^AE\N "Z77.5DME0^!*7NUH&\SIPT/42@'%6+Q!X5?,O[]
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M\WU[W^>6YYQ[S_XNX[/B\/"N=][5?FNM=\(,?XI/!38>L[*U @36"0#GX'\
M_P>PX;!O^'D_P ^ #P$^&;  U@FL'JN?ZU8/(<'53V$A(4$A$6$1D;^1J+@8
M3*(B(F*28N(2JP=\MEY28OWJ#ZN3_!OK.F%!06$)41%1B?_;![\#V"0FV"$T
M*"B@"JS;)""X28#? R#A-0K_;7D"P/]^"*P3%!(6$867(0D/J-L(+U]0$%ZT
M,+QB^+>Q\.\!H4W"F[<;'!:1/NDMJGI)QO!F=I&8VI&J3EFG]Z#ZGO.7X\0E
MY.05MBAJ[-#4VKEKK]$^X_T'3"R.6EI9V]@>.W7ZC+.+JYN[CZ^??T!@4/"5
MJQ&14='7KL??2DA,2DY)S;ES]UYNWOT'^<4ECTN?E#U]]KRZIK:NOJ&QJ;FK
MNZ>WK__5P.#(Z-CXQ.34-(E&G_OXZ?.7K]^^,W\N_?K-6H;^K*S*)0 ("ORW
MXY_*M0F6:]VJ#417Y1)8%[4Z8).0\'8#D<V'3XIZ7Y)6-;PI)G,DNZBJ4UQM
MCQ,H>_[R>PDY];TT#>:J:'^3[/^:8''_CR3[[X+]72X2L%Y0 #:>X"8 !4#+
M+"0WB0^$.4#:!,8 DT*S[LHBM_2HB/&!6VH]B@GL]DJZU G7TI3?!XI<2US]
ME"+GOF5J+R"@6V2>Q ,^8!O)!P83F_A _U,^$&]/_+037T?AMN*^_;S.Y3U"
M="#_Z<!D>R+U&?Y77CCG:0B><YV(>[HV=&WHVM"UH6M#UX:N#5T;NC9T;>C:
MT+6A_UE#/S>P9N"&)0I'+256(1?P<P12=R\*//UZZ(H#J)=(NC=[I^S[RILK
MGJK-+WH""@)1QJ>^H7/PX 2RSIB[E="#X.@0B! #AZ: Z*P_%@$,<3[@RPOG
M*LOB%$X+L+E\0*0 -W@*%4)D1_.!T8^_V5ST#108U, IW<-JX0,-65QS!S1Q
M##AI*?,?0BX]Q#H41VZ8%MY%)(V,\L29; W.IDF>&><*7O<I9-'5G"[GCKV5
M6C13IWPL]CV)X20)Y%QXA:A[<*;].;>H->H%1Q<2G,.GM,N_E'?')YDAGWW/
MCRC?0=O+8E7;*?JTNP'];=A-?*#SKC.+#TB;'^2-$I'MVX+#GT,D#V5A]0E]
M?.Q0UW=Y]WN]O]+[<WSS)Z;O+V_SOX&RQP7Q 6B7->,@6P0[W#S)D&7[P=/L
MK]N_5U?;X9K[,LVXQP,G[3%]=E.R#]%8KE[:O>>G;/H':ZF>2[E*C6JH8(_7
M7SKN,/I^2:7_>E41GD*4XD@SLVA]1#"+[GQ3KIQ&D0F<=#_1\N2$C5V+:7+^
MSF(-FVV&INOCQ(:%%#F3?"#N :[3CF=R%M?IA17"=6XE^A.2HPI%JYE7<TEY
M/7Q@R]<)T/P92U-ZL#FBX(.UJH>T<+GIFXW$Q3D)EY D@'NTF*B'.@\+L5.S
M/RL!"7JB4HF@)3Z3#\A$(%6BSU..9YV&/.B,ZPJH^@L/:PL\G>PD4XHRC9K3
M+<S8?MG';Y!ON,5SVN790M@)V,<6R18\B46V ZP$TW 4M;CY<PH5EQ2ELKUA
MQ(@(';EJ^SM-.\33W]3N4K@JR7KC_?+GK=6/X\_%)E>;O%809<S(0D@^(%3"
M;>8#U HDZ!@^5<:Z#QJGX\+M* @*1G TS$@)H1S4+E>=YS7^*<;CF^["X_RC
M!M;!667'WLYO:<(=/'T\346)!+/G44"G1;(Q"U9"?"36%#N&W(@]\'T?3H:W
M@11=?5"^WQW[T(]5WC>ZU\;(P[DQU55%W##@)WKY7+/5AJB<CX(LN52.#/<^
M*E@?TEYD9,'+V@5E\P'A;6-$:BE6]3W&$ZPY-4ZHU34] B9FK7>O;,<KM_5V
MC"DM/+A]S7Y7[];S>YU:2I<:$K*^$6^A0>=P2"N+D09/(UK'K<;Y(&^R9G6X
MCZ2=S!4G%O8.'?#/G*4KW=RZ\I=<^J$';Z36%V^Z9_W70\)6/QO1[PFR4!"S
MA"=1PC[!>X4'3_.!:1^:=3>%M-2C<F $JZT77\RY"H7.27D<FY#NSA]G?)2;
MC"R_Y!VZV6.&S'ULD+GYN8K&X*T[0;^0D/XD1P8->SDW$07C0TU9=]8T:@[[
MQ S%5/W1$X)&:([^ZJL;^^3I)'DE+&_S],#!QD9;L_IS7X),[PH>0I;C:N5[
MXT$E*BK#?#]")+A0S7P#^*2H$M>%*NK^[!6,]JO/P=4<(O;J%.S3^NWMI0_+
M"V-67&H#1Q;),J_BEGM0=U2!7V?FH_+#67*5L:RZO%=^R,"&QI_%2[10<M2U
MD!2U[ /3C9S)N:Q;.- =.7V%BF-<81_'CN# DVWRZ-%:/G"+E)=B+FU!S5I_
M.'A%KLS;[U*T(VF&]'IK9$??RU###V8#2RW6VP;^Q%#+.')(GL2I:S!F#6,.
M<=OP]/6SNE!5&<:JP"*M=RGZ^BMEA/VUBCECG'^<4,*;(_X2;V^)W'-;WD6_
M@;JB11A"0FHX1DL)C^2U^[WY7@R"V\Y!SX4+?$.MKQ,SW\G9"3U>"9K$Z-+5
M]A6"P>L\8@)+F^IR]H??WAV0((EIL:L]&8U8"(6=1HY;@Z*^P$GB+B#)QIU\
MH'8YE2<?B!.[^J 44J(YB'NXEM;5= ?$1-[Y?IY.<B9>$VY[F6/LK;"D(5;^
M4Q;@5A03E5O5X(D*N$]0%]#0/C8=R?A-12=?CI:<T^^JM&;K>TR8'7A".MCV
MZ9>T&W+/PO+M(874&(^OT_<.D;5"TY^WA'QVR*2 )U&0#B*12$U "Q*I%>'P
MC#)C)4P5 E/EB^6=[OSPN-I&70(CE^V2[H#I0E+>*';ZB*5M-3_1X6.X>*\#
M57Q,.YZ;:ZX;C$*B_)%)2.6(#',E.Z(BA+">?%$9NO2I6^/37>/U:3DGWOEN
M\_VRCF@.1^)S%'@J/',"!SHC;J!!&^1T.5V*$N?#_/0IMY1IVM=L6;LYV+;L
MM4Z/JUM=SV6-EMI]U2WV5?>OO61HUW4#V$<N'90Z:XZ\Z3'(D^V..<I-(?HY
M3"<Y09US?" !N4&OU7LN1"SBS]ZO/8Z5-<KFKP>J6W-__BK]H.-HE=R2;!CF
M?.8G91K&)5/F(G62(Q].1W$V!<PY]%:>ZC??W/K^E!-TACZ#58J<^-7T-DND
M3/?NJ.5FW;'SQLUD]><C@D+G:D2V8:)@1QZ"#)B;*;P-;= <M0D7C%*R?PJ%
MV+2U3V!.:>3>UL<X"!F;F-KZ72_N.73[C8)V0>"CNT*>.=L'MB&;T-4N_0]=
M6'AN@9D2DP^<A0[34<!L=+EEYLJ7SEF=NMW?%3UR#J>>V7["T%A;UNG58._I
MAR5?$&1)GJ0GF$359-B58CMP-5&=E(V<*]!2^::6#A5$:QR)8F.!S/<X2?SK
M?B60M7PK]')*XL6;=QLF49LY]D^C]6G#R68^CX.(%UI&KMJUD#W,I+\,R.C,
M([=R>@_-31#Q6=">?2OH#'S],D.)?0QS>MS#A3FSG*2K@7=I-2U[6*=\)"1M
M^G),:STHG>5]"/D<7RO/D7G->LY-:1<,0=:B&7FP6JACH1CCDF_#5V(CP#3Z
M06+JB?Q.K$-]:>\+O+J!7%<M6-IE_7 X0;A\?E@$2N)MIH@%>6FSD=-P%/R:
MTN,-?P[_V?IJG/6C8R9CZJW(I7>G,.%4HB3'!O0B@(O]BGM-<M,(05&*D55E
M9]?W1X28A<I4[4,E9#]PJ"(,H*']=JS/J\%5B*MS6:@!^0#+AEMB%"X9[4'?
M4+3C'EU__4,U^]:&:%W]O5..C_/V51]/9\XT5RT=(#T./: N^'LEE9/&+2>&
M+Y*O4!LX6[O!))8\F,30+#?N0BL'Y9KDUE#);?+'H\=+4SEF!L.LDQ>K?M1E
M]/GIB*M%[E= @TY$<@U/XB 8Q=L@!5FR17A#^+HQDGQ<^XZO^?:,V0Q"]"G[
M,5T=C:9"WJS3_9MZRK*ASF?2W^[1%.[:"B"F%;692E1KQBI&V())'/E^.HZS
MB>1 7G)BHA(7K]YMJF8.IW&V/_D0?'UCZ(Y1YZ"%HD2%RAZV9HR?VZ;*R8MW
MN\AF];_TH6U?&%_8 =%+/(D MA.<?8UQ0102\C3TX#%F]WB$%5B6:C2O%!@A
MYOS:99]4;IR1DX:MZN5;LE99XC=Z-B(FKVLS$3SQ/VP7F/4T*I0 :2,9UK!M
MEX@P>*>'Y"/CVI4H4.*HU:1U')S$"TQC["^XD=.NR8WLSSV?<#3G50ZFJ$O5
MM*(*-@!X#$_NYTG *"<LQHWC T$.&Z!^UL\V\$<1*&W;/+9@%EX*>0UZQKC>
MJUC4:*C.O;:Q7_GYP5OI;ZNXI;QWSW=89FT08'^SQ%KA.G?"\/&86(]DX&$$
M_\4)YI:VJW&"B750$?A\LC<R'Y6UEVORQO.LW9.O8'!N]9#,;;/-6S_HZ+-;
MFW?8;K";3,9LAP5X#DME;;X-_JS&R\ S%I'Z&4$5ELR #J(LM6JDU3:4-K/=
M.61+>&V(18B.R)NN5W*\@/6;T-'H^S=K;V"?P8RGB-1'IW"=!GS 3\J:U3+6
M+F4[YREJ,1:J6T>6/!A[(>R1QX.YAE2;^&[50;/IC;MU;@EFM]PV)4S%L)Z,
MH$*)T]H=N+K$FS2EAR+#_=?77R]MS[IVM<8NL.)-RY8QH/_3=V >?1<N>(;A
M0D,>%XR&]OP<AN&MGZ! 3#9#TT.41;Z<G?"M311IOAM=K-"M0#V:@3U],L%Q
M_XLE6GC?,*1%[$1!QGM8_F,X:CY:B(#QGM-%'Q_=RPV;LXN;#1E2.N9S>>1#
MI^Q@J]61;UN/V*KE[K^50-HGN$WP-[V1F(JJE>_"Q1?J@]8W,+'TIZ%&A.1V
MU5#I+L5S?YX0F^V"7CPFE=Q.6;_A#1^(N'SCK^;X/T@: =J%[!N^B0<OAG?C
MI_ T!"/K.><<9,K4MVA(ZG''I41H2[FPD:Z^;;;.(RLC,@)%^1.[OZ8S/WU.
MOS'8CKX#:_50ZW9F61_L,I%Y78A;4FP/:-G!X^$V+\C%M=;>Z#-X-TI.,:VM
M'2_$RG&_I;JQ]$FB&_*2WD*GVR&4/3$<"6F'8'M0]8L=65/C.#^D'/0&$S)>
M4FVN_?Z'6>/>C.6=X?>R!G!U9C&MWTYAO,[NQ]1?-.\C].M#N\H85>SKO"[X
MRL[$:5'6:<@%#IZRDV!4S\-3W8JXS(H(ANC1[-\7YAU=SPYZ:8N1Y!J3[VQ+
M+BZO4>CQ > "+*Z9-X-K6.1(J\'U+AB,4^1->:G'LSRA9R_(=L^F<.<"N]E;
M-08MGKI+YE89_MFD,[&\1<_7X-57I9W--U#^6H1[/[!:F$,CJ!!".@R$<@3V
M(>@V1A8RHDI&_\X2.>Q7UO:PK[W^5+#Q3W6BO[S&N=&/HZY:^!#[*]OV_QS$
MOQX6PW7ZH2[@22X\\1FF/D_B !5%2G(=P1H&H:2]T8E( <X!VJ^V]UE)].;J
M5 ^E^\+EMC'JMS]X'EN6VO7*[*[!?2M+ /M[\DL 1Y;(D_R*HMXFRID9@?-S
MB(6T"'J:_I;I#S-0@!OX)5,-;:BEX3H3D!IBN?N5<1_Y]*O&2TGJ6V.?L7=R
M+C1S'^/\PP$,=LQL>Q1MGK E&N4PH7]5$GJX8U2S<$8]=[S[!KDDTO> H.D5
M]"TD&-.I-I>U\/7,9>NDWPOK?\/M;-4CQ#B2])HG8<"^C.VGB$00LPH/P IV
M_:[(!Q(Y1N>69[?A83"1J]#?\;(V72Z']B@F\&/T^\,!!N6ACJXWGO<@D40J
M09,:P)%9IHERI+&H:=/>YN\<YW=J8T3:P:JFWOK[RF5G=53L8HM4?T8Y:!8@
M<ZJU0['W'H!9K/M<&!P"AZ&=LT2V-G:4#U2KE()DVDQ9A_V)>?O1B/"-Y.#;
MT4T_ZG3-9^D!,5:!0*)9EZKZJSBZU07QNRYP/-13&-_8%[!O*>"EY0[\5#AM
M&$X>UF !723O<; ))5ZOUM/0YL[;QK%M.6)E;'V2G*JNFO<#R74>G_L @!M=
M3-Q"#-$GM[!68)EC<)T=1$E<P"))GM7+U%A<&&>>.ATW?[B^\=W5P%LB'VV#
MZ_=X:J2^.A_ON#O/=+RWMBH7D]//D IGI4+QH%T/NDZ>,3Q'R"C4F,0B.!KO
M?^AB#*C2H66EE6]+RUQCRT[G;!D9.[N;;:=QR_N3Z@'&BP81I7TW8N]88B4"
M*: KCAS3"X>$_8PH3\*'BB2%N#+E^^"./C7'X1(H;PF^PQ]24;";KE2RDWM/
MWMLDN7F81=S_ 8 H).(5K!ST<Y2.[T9NP)QX.?*BXAQ3)3[@N85?["9;Q@A=
MYJZUZFV)YJ1.H8N''R'>XL@>O WZK=R;N- V398JMQAU7GM(VW%R<2^S.'K"
M(=G@1=(5GZC]-XT$#6J6-HM]V)]GD&NQ_KYS5RZ;S$J$>NG(&W#KDH(U=:!E
MR/T(%X<NQP:XC2YRCDTXEPNWZAJ]\JBY "/5)I9<BN!&XVOG<LREX2[P$0S]
M]X/8&&Q' UZ.I_QUW1P=U=GX @[U@:P]P8K^'1%* IFN]TO<WA]2'[CPM'%)
ML36$)V;+OH"QAVTSR!M$(HA^A#23V _-#AWD EOS/?-1.>O,/)3+$T%&DGIM
MFO:1T5DY]A>[TZ&OHSL [&/> %'!?!<G%I(NPGA#;: *+K$Y*SE4K:T.S.#5
MZX=?8/AF>*'J9!.-$J_<:=[4^JC#7ZI)>D2;J@_M3^))E#*E>>(1;.5OBI2.
MNR^SZ,@>A\TO;M)B3YVIE_;X^E4U2$^?M$/8+W!,M7BW=KN?_X:G)UN[:2C&
M-V8--8\C6T8+6"# ^7AN.*/=A",//:1>"J<3I*.3#AL.T(@R1_4N7<W;3>K:
MGC@W>,.HQG\_ASY0"]0*K#RPQ!IA)RGU:(Y,O#44Q3Z+.<:MX.V$&EB7&D'A
M,=A!7E^/3"@/<F:UZ]J=O++]=*J-1M.X<G&<^([;!Q(VTU[>_A,6\IX/^!.@
MG9J,(+8SKK-N5H_;:I25:@A=H5/B.5OHIMGT84109 CK]=#.)P;'64O=ZL"Q
M[$?W9-?EG'V4OE%&\+=)25N37.3E6</<34??GE9IW$+H04$[EGLHT'Y-G@29
M#4#Z<_@N-'F^JUVL&5SN(:<=C'*:Y!BLFXU^/K'3)\?6C1&JJ%5T4]D[<_P\
MNG;__=>&3]-=&)SLQU6U3H_\SEEHKX]#! .<&>@F7*A\@KZ >)XX'PB!?]@%
MP=6&4.]D+3*1=,M9^EN\(_3@O)%V2\BTDW9(0IW'Y==*>5;"@SGI"NO$=BS&
M$ZE->&5.+%LLD @Z(41QG7LBAEQHD16C!X=F"YB[!NVX^TA*?R[X-^>_(Y??
MSW$]6W7DTZDOYV0,SN(AD[*C[UOWP%?;RR0F<DQ+/::"5K UM/(0224;Y_V5
MM*Q3]:<S-AV2>/X($ 4 X0@D&"IRLP@B\,340)^N6<WWC#KE/4ZC&/N0I]^6
M7^J\_-"IF1QQ.F?GIIL;TA\_<]I]>-L[T:\:LG]\F T\"2,FA?4"]F3V-QQH
MXQ"/DS/")_&!#:VRM/D,"[IY$\TH[B#:LUWQ7*M=X(LGJ18A0OXQON$[G:V\
M=^O'%7C JRR#N3-Y(\A:!*.<[8CK1&+-,!?']5LMP':V*VJ#N0[I6^[.2IRO
MQ_=UKPIN[?L\$O+4LK>D(D-@@_N1[Y",P,H!*I$D24/UH-(+]T)2U&%9BZ?1
M=VB,^@?Z:96Z/+_1 D?;C_4)4Q<U##I\=XX[V:2PZ2W'.()P\%IPD$S\7%0/
MD20ZMX\ 5PJ\KCD')BLMAMZV;].3F?ZY+;Z\]_XFZ9.Y=\Y^O!>>/^OJ^B<C
MY\3(03M6*[<!12TM5.'"9@T.3\?7$7OQ\MBWYMJ@=7(69X]U8JWGJ6.IHSVL
MBV:)EIDSU-POIU6U1FQ_2-XWN"BA<V2G,(#-AXL5&]P%-@72[%](H>-(OSA:
MYH8CG*VZGR>O1AMU^EQB!05D(@SE GW=MOCF&IY,Q12\.G_(*H\GWLF^\!4%
MGL1-M72BZ]&)9J+7:&E(16LL&!BU_.R2+F$Z0K) K?GH&:FFRK1T@1L=D80A
M/@"W9/A>'*0ESU'4G$.18N:*:N[TKC0D^%9/OEC0S14C[*AA;HV,FWM]5B=4
M]4CFX".MR- B%PES>)WQWKA/(JAUQ'ER#W(E^_M5@1EX[9Y$ZK/K!,YF-+6]
M@&T)$5@1YL9@+*LMO'A([QY]O+:]OC7_P,<C[VPOO'K'N)$QOS/TC4B'>?"2
M9P!/\@HSO@OULCX-C@QUIC5'.KXG#RUNY*E(<6D9P^@S!1W:QVK)XG^I?K /
MT+FXN>A^V!2CP;0@.*Y[ ,;;G\@_1\-@O?O%6/&!$8\5J'NNC".'.@8)P.XD
M SG GZ0V[@-.T./H$CJE4]M>TXI)2=N 1R3B[1JS*W_H%Q7.?K]VMOB'R$[5
M5)OEDN8;I_>+_L M&+,O\H9QH",?F!ZVYL)^Z8^3=G@:?<7EVK8<I7F<ZM*)
MEO2;NJ5OW,S/OK)Y)7PWT=G9U\]GONX/O"BA)FXNW'!1;Z! *WW%Z-?TY8RK
MBULHWR*O$WOPTLCU,WE5A3YE'55NTV\&S7H"*QACQTZ+7'.K:I!E)L+EN7 B
MMZ'U##S-#$B!N^$.5.W;&CHZXWI>[X& -DBR& JT?X18K[' "GTB&<AP/YN0
MHLE&_Q4&8.0/ J*,AG[4:@0LT&B5VKTX><R9#7DA+Z++CX&SZ80W><V%)5'*
ME96MMN/3CV]+9S4G_[CXM"?R'H<-V["C70-ZP(3S0@M;:O8;6@4340+%T'<\
MH\6&=Q>JY)L>18M^^!!<?RFM(%#E0XFG5.?TBUR,R4)_KEGS,A(Z@&2UPM%[
M$]>IA0K QYG@%R;9UZ")>;>)B%B?XTR])CH*$7W]6EW$$3WOW*-9]C8E.0;&
M.6:/+0WZ"N[AK[P476B3_2,%2^^Q.@N6#%=*BQQY4Y8+-]]\ W8DOQX/SM/?
M/J/=I/,!T:'B;W<.JPY7<E-I:@\8]CTA.KOVI%Q6J')J@NW4&86B%L-9Q-%A
MZ@Y/HH%]@*/*O=MN_!U!(Z:X7+=F]7<7M*'L]UW_J]\U<[S2^;/= 3W="9I8
MQO39NSINNZ,?(:8&M9<RV=1%CMPIEC>DR?;@8+A/87L6YQNG+!1# 3@"1_5.
MIY="W @:\5UN7Y3Q!?/7$:'J)P])6"-R?9N"'.4#; ^@"K%BL"0)L&+/M1OC
M.H%V5?C4OFX1TOI!*)W'2YGO( >1(O%%T)YC#07.J1Y#NZ9[/\P#*NY*W/?]
M,H$;ILTF[IJ(W4 5IVI_P4/JRPS4'(5LRA,? )-8!= 3W:P4C M-K&RRM/:&
MY=;E2RV=.H-I7=>R-L66)%!NWA".E3HD+'/R/X20VW"=6-0G*7RM)O?.'^*O
MJV<XWBZL&-A6$!^XNP_[#L]R^,P'WK]W828<0A(I_W"K9AP2_"<W=?[#UK>^
MJ;ZAM2%GY(=0[D['QU4V1??&TC<>IL;M[\4:<D1A(SBLNA-XA ] 6LLI,$8C
MI[2I-9@@2) I,N&!VL0Y^/XWV4-_8Z#<T.Y"?0U]]4SMF@M_7%-?N=L\OAIA
MU5/'-K4$,$,(QD&V#^^]HP=D095?\)M#)A O^"HV9+4;[7@@9&(FE+6;]&W"
M97(/92;AU=$[KQJD$H-<]7/Y@"ZNTPY'?8!6T4517R+7P8Y4A:Q!=[<0MI*@
M@]01GB:D;=O:D':*K:C;H_W4K?)-=O_%+LDGSDG7V\^E!8;^./5K)17@-')A
M@*0^X -(K":N,\)<&_:F0&(@,C&/)P3^[LT)PDN:;:_T]# G7'>QK1\IY-%-
MK_G:!;[9:%^O>6E[R W7;0[X>%@73MC.O\7&-(XGZ<*V7]6,(O$\']CX#0M
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M1@$Q#V7>L=8D:D'E8?=RR[:\4_P817I_L>#4&UKR.8RW?TKUQW]:565M9[/
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MNH28.#(,8FD,U/JDP0M8,;?($:_6',>Q:94%K]\=R@]V7\K3#SQ/EBH4M=(
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M'7UQ<U\H5T(V'6XM&W9UVF \D:XNJA\%IFS\"VX@]3AF/T8Z-&AI138=OM;
MU9?+VOMY)W*: WUSLKE%&:,[0M..IV@X ^H2><^7-=]Z#C!%\(^S./%\S1Y(
M<RSG+[W,KL)&$,BVB)^:_4CJ=.JC/*VLZ)LBC/GY3?DBB]W':RJR3UUP,2HY
M>UOIVMM;HC&K,%Z?_S*1[]\SX75)O2"T&P_KST_E<X;=!*@F]0&'G! %O&9H
MSB1U.)S!-S@]1::3.OV47^!J*QO^!2&:$RB)0&+\/6RT."CKRE<7 A_NCX&(
M2Y<0D*M!ZU8"][,5G%D'DX5 =O"\8*FSY&0M>K(R6G%.*$'4KL#2\5QOP6W4
MG#0XU3<:^@0)* =K"BX9C;P_I?**_I%WO_C7N<C/G1N)[Z[4Z4F)8/!=_P/B
M^=?O-/%#TW^C>R: \BFP\2GCS^U.^C0RBIM=V(GN<6;*\C7\A<"& X(2(3"%
MELHI<V!Z[J_[Y?UUQ\N(@K]Z_[E+Y]??N[G<#7G!)%1?E#OS%>N8,T2\(-_*
MG3LV3G@52J"%G\%[]]7;$J^\^M0Z*-?3WEPTF5"CZNGN]P''?$R%3J1)+@T2
MZ,%Y4H:&67T#2R!EV,+Q:&2(U^_<C UXL8W:MPYC%)<A^Z N:],CMJ]8UG;J
MH#,B[C1&EB*>PP\OS;;CQ%$9&&-,J8(RF[!6F8)8IF90AJE 8:AUS7!-;."N
M=.2\>4YZ 3!#B,.4ADS9HRWB :<\(?53H5.R,K@;UIJ_G(N+^,:"VV=?8_U\
M[;?@X80HS*4Z>A#WHHB<PHOBUZ=<9V\T-;7M+XL_T+,IKZJJ*N%\=77,Y@2%
M]4UY1:SC " :M<+QW^@MR<1 Q\%A,J)-X8G#/[C]*-5%N8AX(7\U.$3F'! "
M:--Z199/W2LHB.<3PQ07(JS[OH/%_L/FG+K+\XM\E(O'%B 61-57J'6:$2_"
M]F&<D"9.*.4H0:;D(2LAF.?9&Y!,TNM9>\O^$OY#8%GK[^'CK"-WF,N\1<?2
MX-0@I"Q8"-Q%(U%]Y<Q2IWXVS_XOH^C*05:N$!@;10V;*@2NXQ&E-KZ!_U<A
M\()G/XR,<#=%%DYI3?,L%LDC8,]^?G3>TNI&8]L[%UL&D(N=R)\!5-[P%=C<
M'RB5O4UJ(JT45%)9SF"3ZE+IN&3^,=PP2,=Y\'2>A9Q#::W.7IV+*!0ND,<'
M @3U4U_ FQL%2]T;EI;UL0'],2N1)F2EX#[."S=,&5/)]'\D?= ##H8<N:C9
M7N]T*]\Z'A*R*=.=867^X<_=Y.?GKPUFKB'?/07(CDL4P4G-B 9T(WN1D61E
MXU$P9(N\FCE2MV^-4W$M0 J&%9=&D*"MWB8HEEW$QN'\1\ZWLZ<9_%VP()]H
M48K2Z=Q%VQ>*A\;!FHQEV[Y3X A$VE5013+SO1*:QNY,M%X9NN,7M6]\N@C.
M;UVLWWB%;&;F6#/YA)CZOH(SO0OSDJ%$9;YD0$N<'+D RJ.:>_IZMK.\U\>R
MV+9KSLZ.::=TT[]AYC\2YSB*B PJ?F,L0C=*)E@9<2::W<TS/F/^&WMO&M;4
MLK6+!E$142*=]$1I1*6S 5' Q&8!(F)4% 3$B(B "%'IHH1,I6]%4$!!B(HT
MBO2=M)%>14!Z:4."2AM):,*$)#-GLO9WSW.?O=;^OG/N?;Y[]MYW_:@?>5(U
M:]2L&F^-=XY1HXI-8<P/'7C].<AGWF-;B,JBJ&DUH;D.#^IBV)>_SFHMYD7C
M2IICO"-!26$,S9[@:\)TKVY^^['4I_-D2U^,+NK>"HZ&X<J_A%'L#GCV7L4W
M7G0Q16HJ*/#V6Q@/;&KZE&BAO@_GG$.98@\81U#;5D$":<Z+-OX\24%0',D1
M-3I52<<5<VJRT2D9Q;/?=A_7&PI"+>UGG)E8C?O1 ;7'&7HEL"TY"VZ#\C(&
M87.A.35S+(]QZ";U,') +?)T>#435"I9&6.FL>^!ZY@H+/0)5&1B:J%-Q?U%
M,R.2S-;<%"6J12GK17.)CZ3 LD3:!(I)"&6@2MV=FW&(&H&C^ON:$A+*YH]E
M9AF+3478?9561#.G[4^ONA-7XXRSN;@D+5-VS>I129*VT1U!]K $S2IU9=--
MY!GU$)I8:$%I<PDIH^,(*AD-4ZC "YC1A(+I0D(:^T$56, BGWMRW;P]G"*A
M_?I1^=1@,>M& ZP2S52]!>LZ%*B\Q!7W&W4/\D$A*:MI:S<6281&S-LSHVOR
MO(*\E.F\ZT\!JO?"#TF!%!JP@8"ME?N-A&+B@A<8RG5;UAXPL'_BPWPAB%@;
MM4[AWL:.O[/HQR ,<3UHQ\%RY5C(&3Z"55:_)%<65&6=F:P(F)?V_'HG]ZL_
M3$LLM?-BAO%-AX#W0^GQA>^.@O5_<^9) G_SY;%@%-><GEW9*3B*7/7\;3C[
M?WG^X)'\3]??'VO'@(),>1I^II;I5D^%<:!6!SGDBA9G9J1J>FW6'K>NH+B9
M.ZF^.^97[O2LQS-XT_B-X MU68+Y_VV?M/YQ^;<-\M) T9$-.FN(.Y@F;U@Z
M="!*EXH$_7XK]*MVM.W5$1_I;5LKZZH:^_'\&</'1^2EEED<+%!K 1F1>C&R
MB\ W06A#BU,F(;!)[AK%"4QFC9T-P]* 4)>&;%4/ 8OC9VFEQRIC;4A7.&IB
MM^6H33H#5$CDQ[MAKB'O24F[&%>.%ZM2[H>5X.(XAC9@#/W2C4:GXHZT1^N+
M"V[N.]P2_67?:P5S 0Z'[<!+J!$@-5'6ZY+[5[\!@<Z9,"%+TK1SUQU&[W^F
M\*#F[NN;5?.'$%6Y-M\6=]PW:H:$QW_/+XU<=;<S,S*]:8;#YHVK,7YV.@.0
M"M&6=9/BVF>$)31[5G7MO?Y0L7_7FI3L6K6AXN@%[]\-B);D9#]#W\K*%.4(
M52W5PCT7C 55XPB(>U\%)_($P788M['PLG:'VJ]?).V!AO@($2^WK/T_)_/&
MS,WR3 S@F3HVNY<K7N._B@QQE-$4:$=EXDE>(E>'E3B6ON#AR$'5H8+DTCFZ
M@>"%7,<R*_1H;+LM@K,2P8794^CJO9,VZ+W0+!NF70%2A+:F3OSBO?$F(%P.
M'P*U&>HFJ)H9<MZ6&J.8 4#M9ZK\,DNGF=P?,^H=1)UJ#N3JO"$DGB^SY",.
MHT>L^K\!17-)")[@.ZP2\11XFUED@E8!4UB"OS%_II8/ WDW\OOK]O:-Q\<#
MMB .4BCC6!%MY?F(FTA06YTA3X]5Y_K;$/526VH/^"IE,?N;M<\LG3'M?4YE
M'B&#RCHP=KBK-[8/2-#L$ZIO"ZQ?:L+(H56HE[/'U)<RYB;=J[$[=PIVH/<!
MM7ZK"3Q1:[['49N LMG[L^-1C /0ELI$W".*Q7W7V/9YYRB?P[<OPQ11# $:
MTG$KF!E_> :'>%F0MBQFK.]B)WJK6:;+[&3%W-QO<_.Q4<U=ZB4.L+55:T49
M':%^R[R$74/ZW(L6Z#4Z76Z'$H7:X#U6XGQEI4K@C_:,P671$<8>]<-8/1AN
MD*L9V]))':AR7CAE-.+R@<Z%93ZBFU#$#F899P:?&\::^NO*:CM9]FU8;D1@
M(+EI2%0$[)_CKL8J6!)UP+/N.MQ[4V19:*]V9OS,G.WD!K6886'UD3>$2/9J
MV,8OPKPQN8%27,;=JD[SK4W9*K,TE0!#.$G";NBXG.\:/N)B[+7[FWA0E5]/
M'G@-!>KD,=0Y[0.&T$9OYOQH32)&'RW'@RTT^?YG2.9F<RL'75$AZR@E4UDI
MWWH*TP,[(Y$WO8=0SZYDD1LI ZC+#[C=W9 N\32E6_R0X9. X1>1SF?$XC\H
M>$9]%6K"*1;'@,K6 8O[7T"#.*8]+H:/*#Y=;I1ZEHD-1>\:N='K>VXI1./P
MQJTG+HX&Y.Q;N2:W3(8VXIFS[)T=F-$D>$9*@&^^T 8AECZM.?25O4H;N,SR
M^%0\G:,F6G!M;6GLE+ZTOJ\R+:STBT>H4\O^S6];<%^I'\C]ZFQ;7N)";1K4
MABDB!QB)""46- <;Z;A=Z8QA#TA:/4K]$:XZ9T$,Y2.$3('/&]&'^(@A>'[>
MH!\?07V46HV6 ' 4IEL,]T7:J#/O"W7E\50/]X'U(H>/6 _3)KC%>F"H=;5!
MSA$4T/%__,J<?^V$[M;S@:L^"7C]+@*U%X&KLZ"&=".^/PWFG=D8FAP3&T+)
M_YNOS$NCO<@_[5C7KPS>8D]4$7HR,QYR/CC\(!B!0$ZL1$!'**M^.&W*W_QP
MFX"YPA@PPO#WP"!3>+J>MM2CN.]>(*?9$="M55<#\W(>J(%DI,'=7P4M_Z?C
M4;5&F*7#GF6/A/,1&[2#G=GDH@G;X&Y,34E!Q+5!73',YS'#6W=>!_)0_P4E
M/)IUXY['8P^\GOTQ$9<'M0GT,Q$'V\_=_@9=: 8#V4]YR5SU2DB</"!4*W>=
M6LU[2:\\>+LK=UDHB]N(\%FP#G>#+4Y+)*@N'2R,DP1JCZ"%71OOY2PUVBLK
M'U))NR0Z&E/WWA^ 1&!:LS:<^=4Q"T8E8TC\4_$UF$F!=2.SI80YV7G0?Z?@
ME"W,> :RV;'@;0X*:D/K\C))6E0>N7YD Y/7]";+_8H2H 7XKKT[VJ(9K'QT
M^/O9D9IK?3!TCL%H"X3T)Y[EU53I;[<,9&^&L4WQ=G/LC64NNEIC3@<2]85G
M;@EJHY3%U%*%H(^4?.=&NSQQ@L'860-J@^(M%]^!._;FPH/.5U2J0V05I2+;
MQJ^WMN #3N8C4"=@@7/)3#ML&!]1*L109 'LJ[PW7'MVS!:0VB ]8L243CFT
M2^AI/6/@E'RYF+%,R$5'17'#P $*/AL\SHL'7%%PRP(^@J$X2AGPI:GQ$?W<
MXZ,Q6^RFDD@_MZO/#2X],GMXZES3977%3A/%Z14D:Y:K,,XA<HUQH0-",ZNA
MPHW,QJ9JUO4^!FKS0K0E_;4<E)YM-WO-[8TN0\\QKFGMM4?[A\TW0E.731,X
M1S#G,>[XP63V#7C,)*)D)<C@6("0%LH\G!N]'_O B''<IDIEE[.3A^AT.+7P
MH:132JS44Z(=D\/6Y6531HN4].$EYJH#[HX)GJU!<46[\)9G0'>.9K-7BW;&
M^5^A9UG[<[LTG]9K)0KL+PD@L:ZS6D6@#:O1$O&\##[BACQRL)G=NIKX$Q2J
M [8P7@[36G1$B898B:.C'W$_.=K)HJ\Z!@9.5"&+E5MV>H_L\%$;A'D+>,N=
MW#"[$#,H!&T,YYSC6LYCQJ:-D^DV'0NN_K>=G.48[:=5)X^@+A.->6F4:T"_
M73U[0*<1>$@5K5&8O.?^_%9_OQNT([_3H?2!Y&Y3.7/EM4=>K+L@@T"L(WYB
M2?_M; J&(&&U2I^/\M[V-:T,BFLMX$(O2W>7E.=NF(FSLRM69SWRSJ'"NL[$
MSW+%VD>?3_O3\K[MKZTH^>H_9P]V7R(\^$'\7KGYI$UWW-T)H1)_,^8T#547
M$R1WA E3<UP(6HE9?1\AHB,ZD6]S_,'7F\%2A)4S0O#&Q,$.R-/+YRB.\$B5
M8QA:8XI<VRGTX0X&43'STHJNKWZ<V1,^PB6KV0@F"B+FD.@9D-H<N!KNVI\]
MZOV<.HVA85C5?$2XMX@W9@AJN?!@""B92^()YJ'!28X-J852))K(*^*80!V7
MA9E:Y3'W]".-SKI=<4+-:'9JG,!>>1%'6',??1@VHN"%47NE9E_,?G8B_$I^
M3*_H/:=,$S%,1YI'\LOE0],_ID3;;XT,)D9=?UT&6VEXS!6*S!"\;!EV+,P8
MN3DR_M:L3F-[U+WX45^A0QHNO6.RBJ*FCDGD!H!YNVQ&)-?-6DF4%V>DSG)F
MA_2- EH+E #J)ORBE)GA^E3O$*UJ86]GA&?;WO, +9\R6H,I)O^B7)\%=PC5
MPYT97.+:@LGL!V $7NT:IFG X\DK@@R2=F>(<T:(PI6!Y3VYFCP-X]R^&Q=$
MR0?JAO=-;;IK\&1$M*2R^M2]2T.O'P-CBU-4"9(>48"77*6N5,:*H3<'&0F]
MK%7ZYE%EEFL[Z9/UUD#CU,1]Y%&<%!)4F^5*'6>'\988, 2ORV:EQF:V0Y5U
M0%%[L#M1,V%T\;?NCW$_C]PC3CY"E_1P55?#32BC3S";B4>,/,=0_;VX<$C]
MSF9J>(T.&##;X"M]S6N?L;>*G?XAHV/[DQ#M,&WA*L#:L;:YH\I4YW[-.G"P
M"2//M41A-Q$EF(KLRMOJ!^75-B3,QNTY\-E- E+:#(N1P4L#/'^_4%+I)7/]
M,PS7CU#)CF;-V)*^+,Q[16H.YQH\/[0PC?,&!6F9]3%!D&)D+;QLT*B)5+G.
M;7R$93H(G QI&T!3-<^\S>*N<_\J-/X1?GD 4 O/O@N52NJE,B]JP !S$V:X
MBS14?\N'O1<9[3@-Z^H=C+U?G9!YM@-,::X\O!>O_=Q)-):.(1D1,$UD!>)9
M:9P$T9VU" N^O>TT&-GLL6R4TB''*8Q ?*\1XPJ"LAS,A& =>0UZ$\&RUO8B
M G F8.M[![P4O):U.B2A"[W_X.OK/W/Y;_PR3)3E7(&&*9+:? 1>I/V;^@=
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MNULT_FSTI;&N+YL7\E(2INTCH<UF^/YP(_U]7+.M0K2]S--"@^T1 &T;U&X
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MJPZQK#]4D.LITL8:DQ4E!0&L*T_2GJ@JR7@9625$I]NZ&!S.",W,WJ"9DQ:
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M 7R@,L\#:\#L8^!=5J(]:)WM @C7:(%O,:)< S 8\%.:;BD?N)"?--4N,,/
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M9S.B[TY6TT+:[LKRV>'WHRGZ\ZB Y"C':/O/V5,2GU$Y9K97:"]$OA!$,79
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MO7:V'][4_@'U^.*NTD%"G5X75 D["F/9T]*HL%;\:!>3%N_1CI0V:;2@(R2
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M=&G6; 91J\R-%T5<U\]UUD8Q8<H@P0D+(?>1,DIDDD*2A F,&>(APRF3B56
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M;3.MD@(-YQT;?9S_YY>+^[^ #Z=WYQ_!V?7GF_.KN]/[B^LK.\(P1=V,07K
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M_OZBACO_JOZSE@:!8A8371<BP2E6VRF60L4"*928!S'RF%#L8)59NV^FL1'
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MO]Y\RH70[\XJ$Y\PWP\$0S"-N:)R@C6G8 HYY5PJ4B<\->H-MV^"L9'W7V]
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MF]6_KE:_T5A]C<K$LG+UEUJ#^_&LOH7[9BQ/P4!^H%$\#79.IB%6J-5;U:L
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M$<%4R6A'F"9 F]%BQ_#U3'YOFJQL]E@Y 97,X+(-3VMRLT"H(PHSF7%0HK*
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MRRI95W%@P2W>W19D#5BM&[QZIK<:JFL):C'!6==06?!=-Y -1'QNT-D1X&%
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M/_92PBB#<2P(1$@$$.NFOCRE4L;8B\,T,DY1WQY_;%^7O]Z 6D2@9+2(.^^
MSB!"?QP@/3/P)A8N9=IV@&(1@3\.G('"[H8/C%V,?;_FK8'U';<-%TW?+_-&
M"+WE,L>X>64;*,:LFR8T;F=1_)+/BV*"92(30B*(I?:.!"2$)"+*!O=BBF6
M9!A;^7</33@V2MMLPKE0%E11-1ZWC*T?PMDPU-XA>GU'WFM1=6)U+2Q827L"
M2GD[C,4;(M-5:/[0=,-&Z@V5WPK<F][G1BZ?2):74:D/KQ^(>CBT]2;$0@W]
M\ISING*-1T]0A#'U"&0A5203)D*1#*8P"G&<8"H]C*UJ))E./#:R6??V:1W
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MX3NR7A\#EUR?J/=,3TO M>Q "P^NY;+<DOH+:!0 =P,!;N&XZQ/X@9QX72^
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MMVLB^$L;62ZFV1;X==CS9J+W,?TYL$B.W976XNJ>=4=B[!#8J.+MGM"W8C]
M"STKD-X*38X:@,JFRR#!=I9?S'F<(,("'XK0TVD;4@Q3O08JF)]@%)%0$BM7
MTK#=J<GZMG;5ZD7 E^?.Z9Y,>;>94SME<V!1K;:2[H1 =3&K<G_(O@FS>LOA
MCA4S</:D,YH-4);3C#[793I/M/HQ93O-J#A:QM/P]J[G7*J#,__(UH_GZIFJ
MR=6FD$"3I-'S4"1U7:P@\1A$H8P@EC2$'B94AH0$062E6":-3E:N5M5X8WN<
MQ8!FPV5YQ^0-O?K>'*3[H?""!O!L6ZUB@.R7-A0Y.ZUBT.3(YU3,27A_0L7B
MW@Y9)+YDJV)]E8EE=9#O[&$EA%:SIMB7# @CW(=!R%.(HM2#E$H,!6:,IH)Q
M8E'GHKVMJ<E,B19HN* ^E;H!;)&>X 2_[4+CF+6!]:6%L--EP>R2"9AQTIHW
MX,0CQDL18&;+7C8 PUNZ^2%?LJ6>L5U5>UFK+:MU_?(Y$Q[''"60<*KD( T#
M2*B/8)*F@?2%CSBSRG[;TM;4Y&"SWSM?@D6Y6;QS%:PVALT\#T>\#2X()4I0
MPIQM=\S72-UY&09T.'(NVEH:U:<P,/FM*V%R2^?:X-E2E.=G5QE]T9.C&_4F
M7#P]+_)7L?I*UNPQ6S[L_5VHETQ)6<AB3]#0@V$4Q6I"@WR8QDD*!8\#$8:2
M^K'5A*8[E*D)3@U9 +:#=:;W*#-C%\1!!YD)TCBT#ZQ7M1%@%R709LQ 8PAH
M+-F[: 9J8\KSQ'6_%?\&?E_E15ESP&D!\YY$NZMMWA7(V&7/>Q)VH")ZWR=V
MD]D;LMK.'&*&0AP'"*9>PB$2GH0X"-7,#"&!913[W*X0P>[#IR:%MX0OQ5I[
M$.RW*FWV8[Y0O*E/3&\!;ZFS>9I',WWKRL[ BE7!<CB[:K/7D7#L/7I4*3AD
MU-N/^^ U7;)S9D]Z'VJ^_+L@B_7C>;YZSJLM4_5[YY'0"R*!(0TB_?T& J8R
MYC (912E(DVPV:X#H]:F]D%O\((*,-A!;)/[\13)!N$5E]0-[9^TL-:E\/I)
M^FSR9#JD<:RDF%U>0LNDEX:LM&>X//60$=-9&MJSG[O2]*8^B_UWZFTI8V!7
MND?4L^LDB5PF+/5X D,6)EIF*<28I)"B))%4^4\>L]K<U=K:U&2V7H7>H 4-
MW(Y9*=NI-O.DG!$XL-CVX*[C4OT)3IPNT!]KZP.6Y4^8?7@Q_M1-';.TZ0)'
MGTBA)W=/.C!6G0M:K73&%MW:I]?M)6I:KW]U]H.L>#4+V4D:5NX-N'\DR^OG
M<IO\];90TIL*QYO=4LU*WPM9W(O54S$77A 3ZL<0^QQ#1' *24@0E"SR$P^Q
MA%"KT-BDK)N:5#:X85,-?+LO<@<ZT-C!+_\AR*KXU3+SVY38-\T7-R7,$QH;
M2J-A:37890;L4 /H*]B]KJ8'E/S,ZKC%7I[!:D^8+CT :I9F8(>GV?N*]<??
M48<I$B;Y$KC*:C<IV\;-A3<ITX\,]M,$:>=<<)'-SQ0&KG%\69"'.:->&F,L
M(&8DAB@./4@")"$CG,K0BZC'I,G _N[)4QM4-^" 1F<V7KZGJWVLZD7"P..$
MH?W&DGS4U@-R6 CVVT/^_6_JGDH)U0]; 7S_I%'$YZ@!S8=__(*N*]--2E\E
M$5EQ][P2A%\O_R2K3.?4U'NSYS&1B.+$AX'4)9V)\" E2+G=%&-/*#>;V6UJ
M,6AS:A]J"104)5*]P>5[C;7,16F[U'R:<=,U9:<\#KYXW*"=@8K.NPV=#>3R
M+(#+M6!C@IPM^IYN<>3576,*WB_CFM_:,:E4=4I^^5!NN3G/B_4\C AG2F*@
MYZ<)1 G&$). 0![+$+-8!(Q:%8I]W\34I&6#L-XUQQ1&RP1.[VDT$Y!^Y RL
M%UM>ZNUQYVW$V.<Y.FJ[JQQ%[QL8-[_040/?Y08Z?F6'A=VF9&!9<NMZ*>JE
M,DD1PY%,82H%UR5> YCR%,& ,5^B-$DB%!@OYQYN8VI?]O]\6/]O$/X6><?3
M<QG39[!0VY^4@;_H33')JI">@MAE4?8(019+L?V)&FD!M@MA=NNO[52TKKH>
MN76\M=9V['LKK"<N[7P.(%N+*^4?\4OU*BP?,N45G16%T&DYZQ#)V5.^6F?_
M(O4>MRSG_CQ- L\/,85!' @UG8I\B)$0D&$O]"*9L#"P6G'MB&-J:KD)WI+Z
MI2<[F.O,PV"U">AF2_"J5QFL3Q9TZC,S?VJ$GAA8HBL+8&D"V-H *B-VDV'L
MV@%NVO-"=SFOT(=(=V<9.J$8^YQ#'ZH.G('H];AN4OI[GO,?V6)1%__FGU]6
M57H,]>PYH6GBT4A BJF:$LI$ZM-5"$;8%T2H]]AG5E/"ML:F)HIGG)=5T2UE
MKI5/,RUSQ=+ @M7 G($&**B0.M<D$T(<"4]K4Z.JBXG1;R7$Z)YN.O%5K![4
M5U<^N:@^C+,E_YP5SWG]3_4S6^3%BWK'ML7?.(H2+OT 4N5R081E DF(&12,
M$2PB%GBQ5;+8;C"FIBV?_KB[_'9Q=P?.K[]^NOQV=G]Y_:TJAGI[<75V?_$9
MG)W?7_YY>?\?=N+3L9/,9&EXZ@<6K-J 6J]JS&4^H5TCP(X5X*]!RNKU8]*1
MTG4$,:H&]B/JK3KV?%KGU#EZH;_,(7:YO%GE#^KA11TY29 (HP!C&)(P@BA2
MKE5*TQ2J>2@1(DP33JSFHVV-34T#=['J*66#UCIESG%ZS73-%6D#J]<QO@8X
M867"B+N,.,>;&CL3SDFC#V3 .7U/Y]+RS_FRW!XDFZQ2]^1G-1_<I$;V!!>1
MB"44"=%5Y1,E($GJPX"SE"?JC]BWS+EET.K4E&2;(Y#\!*2$^K^LZ\@;D&TJ
M)XXI'%Q7&KQ5G>F:2YT>L,(\2'YJ*Y;<U8HW:'/L,O'F-!RH$&]Q<\_PT/)=
M4&KK+&V^$('2 "/EQ<0D0!!Y)(38$VK*EW)&8HQPX%GY,U:M3TV6&O#E#.-=
M0'=GFF'R@3GH',O@DVO*1XI&.6&[>X3*AC77(2NCMC\FAF5#R]&@EM5#NLG=
MIY<B6RH73DDKS99EF%TG5GU89O\2_)(KK<UDN06K%MDZSJ:@[5034'][>1)\
M1Y)W_CCWHB!)64B@0$FB7#9!H7JW4RC\D/-$2IQX1KLQQH,\-6'=\_=V,IT!
M4MMFIZ(C]+F9]$ZK)P?6Z\98L&/M#&SM!;L&-RJ^66C0(K]C%ZBMGNW[KU<&
M6?"LI7Z\7G(T/HP >-1!9;P.>#L2C=ARURQ,Y3&CXCZOVRZ/%MVL\F>Q6K_J
M3%!K!48?0'K6U\VQQ-+'(8(XH@2B5 B( YW!.R:AQ[T@9%3,E^*!K(5A96Y+
M!$:"E%:"M(MC.%VZ40]ZU)N!=<WM&G8I-Z+!;)O0R:Y+S(:*(6@>*RU4A1RL
M\T;.Z].E#?I9F==N757:OCC)>H?\49VX<Y9BRJ[UD;-0=:+F?:*J;H\9.3-"
M?=SRXJ=8L:S0NOWMI5PW(%'@"TYTZJN40B1C 4G*$L@B'E(_CJ.4QO-J6]S%
MTE 8G:.T^:;WL0[W<>^ !&0-5*\#H3[B7[(E*+1QHR4F.-JU9O+ZH9TUL  [
M2!"P20&P8^<,5)9.X'#_J4[XZ /Z1_']]SAD?XI>9P?E3S;4]=SM\TJPJDZ.
M^GDA2CA+OKNW<H[BD",A0ICP)*R+7#/.( L%X93'84*-SL';-#J].,L6<^F,
M[6X+MSUY:\!YD'HIHB2 '(5Z[$4A)"CPH0Q\%DL:$Y0&\^]B1?./8GVW\1%Y
M/QN6=[,QT367 P]SNW!U6*@&;,YGAR//Y@0Y._-LT.3(AY[-27A_ZMGBWJZU
MNY?B6E:E2;X05E8J^F/YHL<FHEXD7;<H?WK*RJ)I7X2H<V.3!S'WU8P@1LB#
M4N_20C[!D":ZT(@G4A*F''&/VY7V[HAD:J-$!1JP&O4,L UN((5HB@(HY+8%
MP;MVE9F>C=(! XN<MD$'JNJ:1HT9,U!WROFF4[:V &4,N#G=*1U*CO<DU%E%
M\JXX1BY8WI.N]_7,^SZPPY'SRB._EDVNRV(>1![!'DD@36.B=_S[$&/L0S\D
M8<R\ !%DY#D??OS4U*\"J+_!10/1XD#U>_;:M:L_)P,+4DW'M=RDI.U'A\71
M\EZTC'2JW(8>N]/D1ZUO/4C^_J[QSI ?1;QW?/SX51W$:EL0]S[_)M95NMZS
M=54*1<<7[O-Z=:X,2-R)]7I11BC4BY@$*/*TYY>@!*((1Q#K6:J,$8X#(1CS
MC$Y"]L0Q-?D[?]1!G$+O1Y<D6X'O9/$B]![<7/OQR@,IZ[GJ*E&9NFZY7KR"
M3%E6!HBKB+"%//3H/@-9':=3!M;?K1'@/@?*C*;:]ZXA^D^U*564%^P8,TY_
M6.CZ./TRT@ P8/_8C1?]66T=6'H\?KP1J#\'>T.5@\=U&--NR"M[%.R?-ZM\
M+<J#*.4Q%/)TE9-E<Q J%9AX$G$8>EQ"%/H(8B^F$/L"B2"DB'F)\>AETN+4
MQJD&,]B"!C5J4,*VD#TCQ@T&'-<\#K]QHYW"+AFEC+BT&"Q<<SK2L-#]];13
M?1MZ6O7=Z$'C*;F-77N:;76C\UQ5NX'MNMKMF51RJ&LX?%$WS",18,R$A+Z'
M"42>UFVA\U7Y."5Q2OV0&I6X=X!E:HJ^EP1)IZ/2NTU6@FC,SA)3G>P@LU#S
M2+0// "T)JB:E96S65D!8L>D&2@[!&AS@+9GE$15IJ0.GZSJ))*I)*PRI<PB
M:97Q(SLNY0G5BMA/H*IK(5S+ICC"/(D"'B5A DF$==!&1)!PY?9&./4%]].0
M<ZOT5:>;G)I*OLEP/ -K720HEU7A;@78<DWN-.>&BV].F1QZE:T$J[>]O4F+
M?%^3>7Z*3/NU-&-^7"V:G6YPW-4Q8P+>+8.9W]DQ$Q99OZS*TQHZ++U\T)_4
M9T'UEN9S\IRMR:)L\YHNLH<J9KTY@BNQ)R3&' 8TB2#2F1I(&(8P2HB(O) E
M-/&LLF%UAC(UH=I:HC^H;\H;+XO3Z[")40("USUE)F/C\#^PO.U3K\V I;!I
M0\KM4K4IE>J!'6,&.4K=GU-7";*Z QDW259OPMXERNK_1#MI+5;K^7G^LE0-
M/9/5^O6;>EW/?F;%G @2A F7,"(A@XB% <0Z?[//TXCX<1HCLP2DQQJ8F@SN
M8@0:I/K$%$Q#W3M*8[N:N2!G8(VRYL58=DX9WR8FZMX=(5'_VHK(T<>.(@VG
MC&H^^)/7=5B0^'?QJB:%9,DRLOA,UN1+OOH_>;9<_RF6:YU8;QYC+D*/15"Y
M.[Y>3Z<0!UX*?8K4- T'C,7F&X1.M3:U#_P34?]D MP]"K$&&K%AJBHS;@V6
M'5PR-O!7KZ""#=:2+*#0@A(N:/"ZI,]BI<$EC2.M,O2CTVZEP92>UE6&DP\9
M;X7!U)Z]U07CF[JL^RJQRI=D\7=!%NO'RR?RH":[]8)9( (681I 0A-]K)_X
MD*)40AI@02(O\22+S9=[CS<T-7%MH((**ZC!@INKJW.;1<D6:DW6==T0-O1R
M[A&NNBSBMO!ELW;KAK>QEFP/\^=JH?8T%^WKLRWWC[@L>]J*_=58@^L_/J_7
M=IVCF+-$>DA@-2LERHU%2>!!C%FL-X@R'\62$;OZK /AG)I0[ZP>5OE:)Y"Z
M:[=;S:)_$^BL@0>)@9)T'5E)GFB2K@-=,\',7+LH_]NFXSI ]9 YN XUU\$5
M_[1X$7>/F5CPVNGQ8D()CT+(8XJ5_XT2J+QQ#T8XE@E)!4NET3+/P:=/3<LU
M/E !M/ 9WW%FX%CW86)HH=R2T,6#?L>&A=O<AY61?&4K=NP<Y6/6MWK'[VX:
MSR4^AG?/#SYZD9TX<9'-+Y0>KE_U7O35<[XJ^_E.=;<HH[ZKU_.<BSDF7A0@
M&D/ELC*($!*01'$"_4 YL5&"/=\S"L@:MC<U :L@@SW,,U"B5C2#&CG0T,T^
M:5/>VR5O #8'%D$71!I__9;T'/#8"L%^>\B__TT]J7+6U ];'\WT^:-(AZ6Q
MC9C8WC9R_KUO^;)*\:0S 6J,NI9*>2#F^F5=*->,J^G_;;Y8?,E7^OHYTZGX
M(C^%?NP+B'@8P)02"8D7T$0B(5AL-=L>#?G4)._V[NS?+ LMC=?+9I/O2?;=
MP +K('6?LAY6YH/*?K!#P SL4 #^TB2 F@6'&WQ&[[F/SO=GC?N_1Q[ KMWA
M+#]@9P#=QKG]+:5-CMMY%*8L0"*%C"9J4!)) M5@Q*",B) \"#T?$YM!Z7 S
M4QM!MGNA&2D>@5SD/PJ@7RZ0[V\YMQQFCI!L-B;TIVY@ 7^W@[S!Z$Y=VSEP
M)(5'&AE5M]H-?2LR)Z[NI@@73\^+_%6(NW7._EE)47/@VH\8BM5LFB!?1P!C
M!E,28I@*Q F*<< 2JX-[1UN:FBZ42EULDWR\/"M/H\P#765Q+=.5%=H*)106
M^8%.4VXF$4Z('-'-V[AOV^&PR;\\0.'/D^PXTH_C[8PJ(2?-?:LBIV_HL'R@
MO9X7]6TJ?^5:RHR)36+\^LV.8HK3B*90,AXH,6$Z'3T.8$!9$DA,4V%V:L2H
MM:D)2H.W7$VL$!L4A>C LL$"A$ON!M:05MJZ+%&<Y,]BR<(ECR,M8?3DTVY1
MPY2?UD6.DP\9;]'#U)Z]11#CFSI([C5;Y^H1BK2H?GMC(E(1^!R&J=[(HV05
MDB2.( DBP64<\R RFL4=?OS41+4&"#1""PUX3YN!:/8B8^CYV X/743Q/2$6
M*MB+F)%DSXX@.Y4[:G^KK+V_:SP=.XIX3[B.7]6QJ-LJ9T+PXHL"\SG[GG&Q
MY,6M8$)OGYJS-/4D3A.88'V:QI=Z+Z*70(]1Y*$(^2*U"C^UMC8U'6MP 0)X
MC;4*0ND9IS[1M%0@'K-GRY)MK82;S3.=T3BP C8X*]HV2$$#U6'9-1-&7!59
M:VUKW))J)F:_*Z!F=%/'Y5H]=[TLBA?!/[^LLN7#35D<[$^=N75G7MN4W5%O
MO,\Q5LZ1@"&7GII_)K$.9@D81\)'ZG>)1ZVR%E@CF)KL:.SE*;Y-+*L,<^V&
MN#H%M^R[QG"M=$C"APZ&E?Q6X$&%'E3P9Z T0.\PT9?4-H"-$0Y7++ORYVKE
MT;K]<5<0N]+S;B6P\X,Z2J%8R,ME\;+2'_.M*,3JN]X-Y\M$21Z46-<O2'P$
M">(!C!&B,46J<[A5??9#C4Q-T#1&F#4@ 6%L]4(6EN)UB$Q#?>I)T= 2I."!
M#3Y0 W0H+RWFNU*00TV,*Q(M1K[3@;9KNWWJNO2)WOFF1*1:HCI[63_F*WUH
M8![[# G?8S"D 8/(DPP2CV)(>2)27W@RCJC-%]_2UM0^_ IJ[<1 0#9 N]=L
M;6/:3 X<\3=\A%U35\*<@7K=<XO4G3P8T.%()=I:&E4L#$Q^JQDFMW2M%RK%
M:B7X/?FY<X3H]SSG/[+%XFSY+O%E\Z>Y3W&L'(@ (NG%$"$9PA1A?1B?("4L
MD1 )GN^6M3<HPM@1B]&'DU8?SBZBX;Z?!IEM0<ONG<$QB@2'H3[@@ 3E.A]"
M"B7G49P*YA%BM25CV*X8M<QK90A8DY]@L7->\V'D'C(;'4;A?>"Q8T.Y,F+W
MB.P,G/PJ.I0E[<F7LUJE77&,7,"T)UWOJYKV?6#7.)\2<;U$="WK4B3+<H/M
M2CR*99%]%_5OFXR7! 4!EHC!@/IJWBMT*@."?!CA4"0I#[PTL$J6;-G^U%1Q
M []*\+N#NRG9TS4KJ6W'F,;X!J-[\ B? Z8[Q/0Z\>4LHF?7^LCQO$[4O(_F
M=7M,S]WY=:KY8AYX)(D#&4&$ UV(- K5M!Z'$$4HD%Z(4A$J0<MU-E.C+^Q=
M"U:2M6EGN _I7K>QL_]>U#@[[L#?$&DF0+WH&5ABMOON+TYQTGW#_5N[7>^U
MWSS_8[;9OS7OZ [[=Q?:YP+^2GYF3R]/]9X:XC$O)?KS#5+U-4=) %-?N2>A
M'S/*D!?XTFB+P[LG3\WGJ,&9)_O=YZG].^UE_<#?9XW+X0ZCH];VR.>[_[S1
M$OD>-&,W@^_A"SH.H[J*4ITZIW%  \93YD4$QBQ5 ZD4'DRQ%T(JO2016' >
M6*V('6AC:E_B]?W?+V[!V=W=Q?V=Y?!Y@$## ;0?+4,/H1I=D^)K"(>\Q7Q7
M(^F!%L8=2X^;^&XT;;FT8SR /0K^LA#7LDFA5>;&*K)R2?W3Z\Z_[O71K3E1
M+C(-:0AE*!.(A#YV0E,&HR@EC! 4X@A9!00L 4Q-$QK\>IJZ28RW:\),G[W?
M^07XJ[3#-CQ@VT^&\8$!V1\Z0."<>/MH04?V7(4+;)L?-U[0D9QW 8.NS^FX
M)8 4CV5%D^)1'RWY3A;Z2/#9^IRL5J]J'E-N.YI3Q),TI#[41T"J@R'41PAB
MY$F* QX+NV4CHU:G)GT:;7GRJ3SL+[:X+;<&&#%NIF?.>1Q8Q#84EC_L0)X!
ML@8-ZFI+H\.] S8LN=I%8-3FN/L);&AXM[/ ZN9N6E1EO%9/%#=DG:GGWXG5
M]XR)Y@2P)S"-(@P3C^F2*1Z#F @!@X!Y"<8I"OS(1H3:FYN:^M3@@!0"K,1W
ML6SY0KJP:R8X[C@;6&GJA/0:J4XP4F(%#8?N<P:8\>)(6TXT-JJHF!G^5DT,
M[^I2$62E0__KUQOU-NA2;9OSLM_$^G+)%B]E.J3LX7%]+?\HZL7F>8C\($8A
M@WX@I/)OF')M8B^"G&)&PU@@CE.359+N$*:YC/)<FS(KW9WJF+<>OE<:/<PE
M?"G4?+@TP*941J<^:A>H<9@?6+0:_* TH&1Z>[Q>V0 V1H#2"CT75';4 :G!
M>\"FC,G0/3%6@9-A>L2R#DH?,MLKI'1Z\HBU4_I8OE]5I=>3^M5;V9FR7ZE?
M7*[%DQIR"..8!PD47AA#%#,.,5<_"=_W$ VB&!&C\E0FC4W-EST4OP)_:;B@
MQ&L9+&SEV<RO=<7>P -$=^(Z%P]I8\1Q!9"#37U(&8\VHX_5XFB]IYN Z.=<
MR_.5X-GZ"V%ZU^1K%>Z.(BZ2D.IJ=B2$2&?>I(0&T,.Q\$D0!%18K48>;6EJ
MTE&^ZWJ+7 D5-%B[K3(<Y]=,-9RP-K!D="7,6C!.DN%(+8ZW,ZI4G#3WK4Z<
MOJ&;2/RQ?"E>R.)Z=;F4*S5-4SZ-UI[/^1/)EG-/HL@GU(<T371F%$]"S((8
MAK'T&9&QI 3;"$5K:U,3BQJLKKNPA5N.E#/]NT_Y^A'\54&W5(YVTLW4PQF5
M RN($Q:MY<2('4>2TM[6J+)B9/9;:3&[J6_"[[PHRFB_K!*)%]5(&:1^I#1$
M0$\Y(,H3"0E, XP@Y4&:AA%*6-?,WP?;FYK$["2SSG6)P%W W9R24X2;B8M#
M&@>6EUX,]L@,WLJ+\Q3AAUO[H%SAK:8?3QK>?EN'8/T]6?V++,E7Y1(QLCA7
MLB565U?G]8H419(%H:=W7'(=E/>4J-!(P-A/RFF.2%*CK5>GFYJ:J-1@08T6
M5'!GP*Z"=SN[!N%T9YP-K" M='7)9]G.FT40W!E_(P6[N[QV=I%L(T9:(];M
M3Q@O,FUDR5X$VNR.;D[:/_+5/Y4N[9:.:8[9OIZ_K%:JL3D+$NR%Q(,H#I2C
MQI2<$C]6ZIKZ)/!\G(:);^.H&;0Y-5VM(?\;8+MUHYK3_J\SP"K<=@Z;"?EF
M3IMC2@>6W0V;>U6XKK9LGI]@T]IYL^#'D0-GTN*H3IP%!6\=.9M;NQ2 [E:3
MFARJ2?UF(6XN/9RF*$4P(@F'*!04INIW,&*$A8PAQH@W_RY6-#>K)CT<5)OO
M<Q?P<)]IOYT"0_:J@0LZD9X::UEOQTRPM1/L&MJ</FI,+?<D[!@+:FOK_0C7
M._T^D6ZW*>L]C>X?JT+X![\&ED7'A^^;]OKE [8_8BGTX5G<KZH^0GM=RC^)
MU9IDRSNQ6(A5/=/&B 4,13&4/N-5^3B:T@#&88 3$K.81]R\XM/[!J8V.ZDA
M@@JC356B ^09C*T]*1EX3-QGHU.QI@.TV-1GZD?/6"69S%X:R])+QTUOK[9T
MX+X1"RP=1[U?4ZGEN@[2M=W+_I4L256=</]H!0]PG"81ACQ-)41$_1])6*I3
M\D2$(?7(U"BUKEES4Y.U+4S[LRN&!!N(G5/:!I:^O;,K._09'U_I])*:*Z-3
M+D?2R=Z<VBFH,46M>GKZ*>.IJ[%%>UIK?E??? [Z9.*71?[C[N7Y>5&V0Q:?
MLX(M\N)%O4CE6N6]^+G^I"SZYSQ)"!((,Z7&B$#D8P0)"3B,/2_QN!=A+[':
M?=T1Q]2T>C?)0'E$5ULR [NV@!UCNN9TL.LKL]CY"#TPL.Q;DE_OC0#:%%#:
M,DBJATYL.L_X8(?B@Q(_=*+J>/Z';H_KJ*./^6I]+U9/G_+5*O^1+1^*><K3
M,&8X@3[E'D21Y\'49S%4;R]/8^&)T$_-@NXMK4PO7GZ>+U5#:YV*6)]_?,J*
M(E^]@F6^MCQP?8A30RWKQ]/0.J7100T/?!;4X?)>B]FN!.5 "^.*Q7$3WPE!
MRZ7=/O++)5L)4HC/HOKOY?*,L?QEN:ZKZE7[.4.:1CR4,(DY@BCU/8C#2'E&
M810%0J=[B4*[<@TFS1J]WJ-69F@PJ@EK ]+N\S=BVTP/G#$XCD T<,$O#>!?
M0;8$&T9O3S-JK1TV%#D2$Z,F1U47&Q+>RHW5O7;ZPT4VOQ/L996M7_V WF=K
M]>9S3(0?\A1& 8HA\@C1YU\#& H<I51(A#QI,@,[]/"I3:M*4-JM]X-?Z*^@
M@6NF)P?9:]>-OIP,K ^V=!B+09O=!S[Z0K#?'O+O?U.W5=^[^F'[F1]\V"B?
M<YL9S6?;>DW?6,H?R]5F3?">_/PDED)F2@CRQ>)+M??[S10]3 2C*<80ISB
MB 0$IC)*(0M1',L4Q5%H5S:C,Y2I??J[D_I=6\JB-XTU7>,HUOUD&TH9DOT1
MHRE'B0?:$E";,E) I2NGSF,JUD ^**S2E;#CD97.3^PFK+?BF;SJ^$UQ+:_T
M[HOF&/!<>&&2R(3",,8Z"4@40LQ$"CT424F4EJ)T4QOOWEP^CS;889IU/X)(
MWM1H0;[4ZX/YXKL^#L:J$^NR/BMM)Y+'.3?3P'X4CB-Q6XQ:Y$J4VY/^[J3K
M)!6.E.EX.Z,*STESW^K*Z1NZ%N9^T$]5C\]7^OS=-O:['="Y\+&:.R%(<80A
M"H,($NP3& N:QES$88+LTI.?;G-R'M;%[U\OOMV#VXN;Z]O[RV^_VU;L/LVR
MH=ODEKNA_:,*+=C W5E;4I[0(#Z0.4'.*GZ?;G'D N#&%+RO!VY^:S?!T3G1
MUJ]?Q?HQYY?+[Z)8EPG2E&7YLL@7&=?^0/4'(>I4%T&4"JDW,X4R50(4!$S7
M1XBA$#1F/. ^#5,; >J 86J"5)D *AO UH@9>&,&:.SHF(2D2W^92=G O3"P
MM W1 =9BUX-"1^+7!<&H8MB#HK?BV.=1?:-E;TO7GBUY4[WV3?@%^\)+]:ZC
M%-$((B^,(/75["^($RZ3R$^(9759>PQ3$\O=,$V#N#S+4I5:VMIE=72M3R?9
MQL@&H7[$X-@[BDOZ-WTQ3E#,FD3GT3!S!!\4!K.FZ'C\R_Y1'1U**05;;XK<
MWI.?MTJ']7FCI8[IE%M^[Q[)2GPBA>"[!Y,O?C)1%-O8W-F37HJ<^P%E:>01
M2 /)(<*ASFO'(RA)' M"0^DSJQP&K@%.35VOI<R8DM%=Y)8^INLN-'1 /[!C
MAO9.&].:PMYZ04);!_;-FY5_J.O(@E]J<WZ=@=)N6!H.ZL@I.%NM5!NB\G(K
MDQVZL@-UABL_US6\<9W@@<A]YR$/U4Z'(U-W.<O(HEF^5D^^>'I>Y*]B]5E(
MH=[DQ?G9[<7=&5O/91!$GEY3CD440^1'J?*=!8&)D#Z77B1#;K1+Q*[9J<EX
MA4]][D5I 2AJ$\":_#3=A6])?+M,#T?GT(YO16 #6DOL##2X9Z!!/@,E=J#
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M.!%(^?]26'W,+6U-[;LNL8'0[FMNX]+LPW;$T,#?N$9953Z;@0IHE2Y%$3;
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M@+T&Z-W/BRDKWLBD/<*L<G],*^]KG=UI4IG%K=<ZF%69#1<O9 H4#;]6*;X
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MH86TO,O: Z29&7T>/)[7!$MDK*W>P\H[LFWW=-"K!7M8P8]VZI$GSZW9^:3
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M6^]&^;=B42=,UX5=QP11&LJ00A*@#"*!4I@SR6$8)B+!&<Y1;+6YV&I]:/N
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MC8.$81+'L<B87;:7([T-S2!LA 65M&!#W(YN*<>A-B,?9P!Z)ITSL.N0A\4
M$V?Y5H[UU7->%0.U=_.GF+SDM!*>^L7*Z87IVR6!)4*Y$% *S"$2,E';41[
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MC1@N'ZZ^7C^!7T:7US?73]=7CV!T^Q7<WCVIG^Y'?Q]]N;FR+?"['U\SFG"
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M,V#JH^+,P[=?JSB'V[^#7^>SY9M.%<"TIV()YH*)XKL^>>\$H!E=#BX>WW7
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MW#_8 ?:]6FBE8*45V%0=;.H.Z#O8?+#1'U0 Z*#X"H(+L (!J.^DAN$"M$"
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M@CGLAN<)K8#9]L%"+?0%J,4&*V0W! <;YP\>3QFL ?-UW& ^<+?G#M: [!U
MV#_!,5]C,9M/7L6T+!*M_<7OQ=MJUU$B1$4N89!$.L26)#"/$=5-<%B@Z_/F
M,K5*'3L^5O]HJ1(5;,EJF4+1 *T9$WD"K&7J.8Q5"X:- 1R^<@P:1NHV7^"T
MRGNQ_P:WV'$%%\7P:CS7?A3GZLV97:H?[Z?/DS_'PR!*1!S'"$8TU:U_TPC2
M'&.(:9X2&0:<("-+IF&,OG%#)2:HY;P 6E*%(]"RFC%$$Z#-S. )II89P0DA
M8SHPP.  #<P$^^O+Y/W?U-T5 Z@?UA]^TS,[^> -E%I^Z":7NAD# \86KXNR
M6\32O+@3<YTO>CV:_/FKX"_B@4S7KCDBA$0\1#!G@8 H"0E41H*$3'=O0'DF
M4![;& B6X_>-&#;$WS2TR_R^BRIO6NL!2D4N0*6*G4UA.T-F=D:+N+?,-$Z0
MMV":."+HR5RQ';U3$\81FEVSQO4Q;DRXZLYZ]4.GUXC9ZE %48336-$=";,<
MHE@DZJ<X@#CA'&<\3U)I593^Z$A]8[?[AZO'P?/-W2_@ZG\]7-T]V3:2.0ZI
M&4EY :IE.EJW;EX*V4JSO9-0>.*5X^-TRB GU=WEBM,WN-2Q78R?I\JWJE?6
M,,I)G@K= 3ZF.B0_A306F?HI3%G J0A"H[HZ!Y[=MR]_*9U-V=1ML)J_\#,A
M:/O4IA;,)?AJ!P:;,K'.<'15#]88%LN:KP<5;R[NNGU+AU5<#\JZ7:[U\"4.
M_/-E,2O&VMN;O-)B7,YNU;KG14VV^FE6\+I]SV8>\(VN+JHTN9='+A[R,$F$
M,EM@1C/=%#XBD"2<0$$"%&129A$SK[S=DI!]8\2EP#IC@ZU$UC^N9;:@B;:F
MUH!V>S!A+?/W4D.PH>(%6,L-M@0'FVI>@-5$W\NCM_1@HBT6EAY,>$<KU.=-
MO-V*U_*,-"Z=;8W=W1K<,GI;BWG;8[GM5?Q6C"?38OZQJK668TD#DH50AEQG
MJ@8"8BX99&D:)B3)0DFQS1;%[@!]6XUW"J(5M9B6Q[5[,)IM2YP#3MN>RT:3
M^;^ NO!!Y]7DC@'D:8]B[_&=;DT<4VYW1^+H=8Z!J&KM%%4VZK4BHC$KR.AA
M,BL["ZRVU:(HX.IC#V!"2*+3*Q D.$*0\TQ0100\S2.KF%2#0?M&#2N9M:6^
MDAHLQ;8.R;>: #,"\0UKZZ1R-J+V$:T6$/D*;C49LMLX5PL0]D)>;>X]8V]B
MP-0B4SUV%43&E+V!9  )U3W>,X(@S7D*,0I2+J(@R;C1&?&)<?I&/"OG8U-4
M!T_Q *(67OUY.'7EF&]*Z;++VH"5@V-\'F9=^[9&KY>;/WH<"".7\L#MW7N%
MQW4XZ-@U7.YFJ'T;3P49%?]<'UK?C[^*:?%.=(>@V5"D84P%3:%4+ D1DP)2
MY9[!,,GR",5YDDCN4-CIQ+!&+W3W99V4*P*9#MFH\_.*,9"Z_-J[+KM5E3RL
MNY=,=?>2V9^VG5U.S8:9P>8#W&X8=BTIV"D\M"&O/S/-$!A/%MJIT3HUS@Q5
MW[7+3&\[KRMS9?*)2YV5=R?F0]V%C^=!"A'& B(:8TA2GL X$@'CDF.<664?
M'1FG;R;9JMVPK$S@\4N5J'@!QE7]?;(13$9>=7GT?SKD(QU#W8Q</&#9,JGH
M\E?K[?'+"D$EHO]VS4<P\-RJ>7>43VG3?$358RV:CUWNN)NT:BGZ)%ZT\?HH
MWO3;KQL R,GTM?P(OGS4ORP[C0YCE$1*F @2IONRI"&!A",.XS3 F41APH/0
M:G/)7H:^\<MF ^=:3K#2 FRH<0'HQ^J*JGFN[?:3PXP9[D:U.P]M;TZU,@7V
M^U7N(/K:OG*0H-O=+'>(]C:WSGB4?2+48,$+-?NZ;OXPBX)8(,%@QH@RI 1F
M$',40!K+(!6QI%%H=-"V\]R^$5LM&M"RF2<X;0+5S#UGJ-\RGQAI;I6X=$!/
MIV2ES>=TEJ!T0/C-I*1#OW;83![POR^JPMK/D\&J7?8#*?C-^)*\%7,RJEH:
M/9,?58OE:R7E$]$,<*3[&)5!GM,\A33#H?)X$(48)3F,>!2D6,I89IG%-DM+
M8O9T6T;)#T3=RGH,=-5M_=\9J9;9\>'#=XOMVQ;FVV"+_).FKR/>6BFGC_C7
MZ@&MG]Y7JS6\6':BTW-<MRO7GSQXJF?7-CJ@D]FUV-3_W%GNZ##@TV;;[ERA
MO;EH/(]H8=CNSC':PVSK_*/%8<YH&?@P+9@RL@E&$0DC&$4ZO89E I(L3&'(
M*9<Y1YF4TKK17_GHOMG9I63@38OFT):O0LO0RW?"H&WGO53_H5%]M]9W6YKZ
M;%A7/;C[-G-;"AUL#K=]Q9E)L/I@XI),IQ_*G=;]XV;#!*>Q$,J,9E&D/LHD
M4DYO)B+()0DD5K8VPU;;?\>'ZMM'6O;J7:5YCG0_%+8AKV-.[#["9A^R']Q:
M_K#76;%E^Y@M,5M(BCT*A>^LV/V!/B<M]JC"1_-BC]_AX*__,A)CKDR! 7_7
MAQ+\YI6\J#'J")PTC"*>!@%D8:KK'=($8BP#F(4Y16DD* ERX_BOQJ'ZQA1+
M8<%26E"+:^$]-6-KX.9Z0ZQECC@*EN_\4B- &AV*YB=TYQL8:;)EYIO=X1[I
MQ"8O8QW,H+R$+V(L9#&?*;=AJDLQSQ[%;#'2W*,]!V6=3*8/0OVIKUU&HLZ&
M*<\BJ9L!B 1K6S\-(,Y8"+,$L83%E+#<B"Q\"M4W6ED)#Z:BBE503O^;EAU\
M"#(%<^7<OTVL(DZ]SJ&9X=+US+1,7YOJE-LK2X7*/9=2);!2J=IT*94"E5;E
M+0\G)\TI(LL7RA[#MLX6J?/8+E\@'@H \_9LUR@Q.K\9S^;3<JNR>GS!ZI[A
M:L@Q*][(:)BP'*,,$<A%K,\Z@Q#FC$2Z&&R<YI@FE!@U:[$;MF_DNY03O%6"
M7FCFK42UC1(S0MV,3/UCV3)=5C%D*XDOP K7AR6N#R=Q=8@KLX')6YB9T: =
M1YW9 +$?A&9UM\L)<-GD:##FRP8>A9C="O6/HHS>6+=U3+,@0DA@R$.20\3S
M"&(9QC ($R;SC&6$&C7+M!JU;YRT&?14Z0#(F(,-+4"EALVIG>D,F)RTMH!K
MV^>G%8R#@S#6\6)&73?/0-;FE+,%A#LZN]S'LFQC9C(!OG8$;-%K/FTT?5B'
M9XB6^FV?#-K>[$#W=2,6'<W"OH\GH\G+Q[)'2[W1Q608A6$B8!R& 40I9Y"F
M40Y3' H<T!!A9I3*;C9<WPA^)3!82UPW!EP*;D% I]$VX'2O&+9N;)Z$SR7K
M]#2.%@SN%<^.J'N-ZWR-J^?=6F-<&DGY]%.Z8V-CC;9HV/PNMTV 58/1^M7-
M4BIDE <P9"B!*,AS2+,\@R$F'.4I0818M7[9>7[?&/8WH3P8,@)B*::=,[^+
MGIG7?@8F+3/FNMVL_TKI1[3VY&WO/KU3M_J(:KO^\['+SDW>6KG>99<HPLK-
MP4=%'./%AEN!"0X8SCG,=;]EA&@&:9B'4/ X%U'&*156^WB6X_?MR]_.&)J^
M%TR :Z$WZTNY7=.RS.;"C"=:1+AE'MD$=R4[V!1^B;.-3WU&.I85@-Y3L<Q&
M_Z0T+"MHCJ=@V3W&C?)N)V,^&9>1II2,_W$OI9@*_DCFXO;FR_UCO0@'- FR
M1+F+.$811$F.88X4T>64Q43;,2PUVANT&K5O]%:*9D=B9NB:49=WS%HFK$I>
ML!(8U!(#+3+XJ13ZYQ:,(BN<//&2V9B=LI$5#+L<9'>S&_/41#8;9B%G7% .
M,<*Z@:\NL8HS IDRHY0)1>.86UE1RP?WC3]TM.O4Q11:(95B% @<(IAPG"ND
MPA22)$\AYC&-*4]2F?+ANYJS29M8;0[0'EJU9/_N")49I[JHWS)M+D7R1XB[
M2GKBO-5C.Z6U765VF6OO]XZ>X(+.Q/]9*,?RZEW7G5ZWK HE3C)&8(@2#!$E
M A*$4YCR-"2IR*1 5O6@CPW4-_):RPDJ0=W+O1Z#UM"#\P!8VZZ:"U;VGM@)
M('RY7,>&Z=:W.J'LGA-UZGJ72(HJ)7^C$(;AJWOB[AZ]N<L:#1M26G_GI["R
M.8OW@EE7F<-NV%F>KY]$I/E$_?CM'9ZAG]1A^]3\].7GE?0K"SKK4WD%_49J
M;M7NKHXB'09Q$"*4<!B+7$*$40AIGG&8I"@C(8DE9U8[(#:#]\X6T#(#OBP!
M."<_W*KZ&0%O9A6T!6?+?+LJHUA!6H:::<FWB@M4PH.?:O%_]E\<T 8USQ4#
MC8;^E#*"-J <JRUH]0P'D^22O,VB($SKC43)8A%SQB"2(H5(I"'$RB^!<2I8
MEN:!Q-@\A'/[V7WC("V9KL5A4P=^!RT#H\T=@Y:)8Z6^[R"1PQHW&A4[MW1G
M2!R6=<MX.'*)PZ>VRO>M/F.=]7OU@XV4<3)^>12C0LCKQ5C_98AI$!*64(AI
MCB#**(<DU#TA)6,RC@.,6&+\%1H/V[</M%[!RO2L6@F[K@WF@!M\R*W V/(W
MOD[UK[&L2XZO! >5Y* 6O15L+;RU5C#NR'GSAK4=VUI#UDC$YD_KCJ.M-=RB
M;_N[W5S!9:4E7:5)UQ=/0H$C%*:0(JFLJ22,84X5CZ, ZZ9_$4H$L?'V=I[?
M-ZZ^U(TBWG2!,[Z8ZI=]_EV MRJ;5F<0V!4B/ :JF2=W!E0M\_%2LK(4W,4&
M-=15O<I\Y>5%%V!-*0,V+][+:']_KML1F#QY9[M/[]0!.Z+:KH]U[#+'.)@R
M#V-=U$5G#"_3-#[J?+S9UX7X;T&FSPIE,4P9YBR/,42(ZSJHG$ 2"0;#7.29
MX@A"J%5]!6L)^L8BZBU*+,-CK$$WXY!6H6R992K9-^FC%/]BE;OU<:&+5%!1
MTY#6 91*> RA<<7/5SB-]?C=AM:XPK,79N/\( <']N;Z\?+V]E*?C!6\(-./
MYS\GR^0:BG.<1@@F6:BH+"<QI#C-H&0YCP-* BJ8L<=Z?)R^$=8-N :/X!+<
MJO]=@K7 0$ELX4PU &O@F?J!JVW3IP$IEWROIG?1W.'T UU''J;3RV;G39[&
MH]%];+B].W_QM Y;#J+!Y794.9O.AX_B3<WZ=T7&@Q=%NJ]EC_F%-C??R'3^
MH6OR?YV\DF(\S&*<I0D*(.*,*.]0<(BCG$%.9224(2AB;-3]RVK4OM'HII1E
M=P?P1R6H(2/80=Y,J:T!V3+!.F!HS U.F#19<NJ!&U:<^MO:@K,;JQ-:<5)_
M23)N-[LVHI^P?WR?C-0=,YW7-O\8(N5',A&E,(LBS2\DAWF6(RBDY'F<)VD6
M9\/Y9$Y&9C[F_A!69+(:J+T/X5F/ 1Z)=NG+>F]__<L,S#;$_DN96#K_L.TQ
MOX>M8NXX5!8N)(+I.@@I@C@(=6)+3%+!94"H43-M3]AVT7MHHR?C9/Y=3 &;
MO+Y-Q7<QGA7OND>LWF0]&U@S'_T\N%JFXZ>M%ZX2#PSF\VE!%_,RN4ZYX ]D
MVI3=;!_0>1017Z&<^P-T&\1Y5,&]\,WC5Y[1 ^&+HG!^J5YY];Y7@633J6Z.
MK!G]R\?ZDMKS'NAJSM7HZQ)=LWO]X3Q_)^/[M_)$\WHRE:*8+]3K]S=1O'Q7
M']?@73GT+^(7]?#Y5_6U79-B^KONNSR,,RPR(5,8LC35J2X1S"D2,(F#(,P#
MB6)N5'NE7VKUC>=JV17+_52, 9^,1F0ZT^<98*;!.!Y U>=7QY!5>R%LGYA<
M:PM+=<$F)& #D[)_Y<9U-2Z@!.9B2?\;V( 2'#!7Z( :G@NP = %6$($:HQ
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M=C1U1/-&AMJ]ISMR.B+M%B\=N\:U2L!\7CZM;!);KX$XHW&4A(%NV)A 1&4
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M6/_X,B6O8#0AIH>!9K@;;'?Y1+-EKED!J64%:V'!6EJ?X%ELD?D$L:,]LW/
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M8F@,$X0E3ED&4Q9RB$24P9QAA2[C.4I$$C-J1;8>8.VDEN%D\H\UJ(^$ZWW
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MH9\WD;<3,IX]"B:*=\&'+,]8&$H&0YQCB))(P#SA":1QF*<\)K$@Q#&;X>"
M?:/T2D@=9_GP\ !&6E0PK65U#K<_#+71R9]7 %L_\ML)KE^#68H,'ML!TCEM
MX6Q /RMKP1K8<Y(6&E&RR%DX_)S/2EEHU*HA8Z'Y/@=6_K*8%6,QFPV8,OEG
M97.-JI#"JDA"V=+U?EJFQM&16+?@J&19ILH-69H0BM(,TB"7$,DD53])"1E!
MB3+'J906F6C>Q.H;PR\5 V2MV0405662=36?JO'S9%KE/2O]+@!9M\89KS[
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M(U[?K-Y5AUFR7'<L6<[S[#GO#70T)Y^R9;#6#6PIMQFYI@,/RO"$B01+#2]
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M=!.W 3;W/=NFA[I$DTVFHG@9'V_X=JB?(@U"'$0QA8&,<HB0T-47$PYY'/!
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M\C1D$8><8V5N<&UN")% P5" 8A(09M9][/@0??L@RW*F;THVP!=3O:$__RY
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MR4W2U6C4!X-K2N>XK%S)3E?NKQ]2BY?8EDF94G0&YZ KMB7R?1]*#U^2[Q)
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M1(0Y$%,F8!"$CBMP((+8R(W'L/^Q$85\QI!%+\8]@.N9+CW"V#-]Z'@N+C)
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M".)Z7BSRTB^VN%M\Y_G3=SR_>RDK<]YF97H(SO[D:J>?L[-7GN-G_EDVO;C
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M8%\J;<#0;6)] #H&YR@CX 5ZELKB\BZWRS0X:Y-#+EWM+-PF>OH-$WL#R2O
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MC?*5T+@+4NM2>LL=H'[[2_8O<0K9C\+;\?0?-"VW$6.5[#SARI?C5< =BKE
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MA#^/P6<B(.12=!V(-2:20*GQ&:VL9\W2%Y]\N)L4LK9!<(CT^J'Y8=K0SAE
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M>!"!N.@%,='S9+53AM6>HO%X_6:P.]57J+TEW;5=7.V/=:/R(<Q*0U_TB+^
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MB-0?NM3.6@\.'Z]U[.AO*Y_MAW<\&\%]ML2E\L@/3!#GI2>&N6C+N+/H:@]
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MRG6@UAXX$,\PN[SNC=XRI4(DP6G @R($](.\(MDI&XS@UH;:Y29;2.D6;9W
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MB[Z'Z7QGX_DP%1:&W]%$Q\5TF:GZ[N\X6B1([U&TN&N^+5:ZN\Q/N5]5 (#
M'0(>B':F;!^?B2_/?O@;F@2E@<?:+ZMU.>C6+6SI&K%#)?? 1A[(\YN[YS^P
M*ME.,?K$*+&ZY'%K*XD5.9 LE6"B%&&%VD\I+;+3[7UFERB=]!,RO=T]G_SM
MI@8QRZQ1NHXP#;XD.W(2EE-TG(DR41?5T[G:+6V!!YHZSJ_I"W@:@7I/3?8
MF4]N@#>5K#9HF60DN/LED1Z]^""]("I9@.2T";3VY>BSA/01@_OJ>E);\#U
MS[O;;Z/)'<"2A=4%[9H1ZI.(!F7!43:E\D\1GY)$1IS@5J'V9>U7QZW$=)SI
MU2:*ZBB@!T@ZT-Y_N$\3#RE1YKDER2C<0:JT$.,N$\?!\:0A9U/[H;$6[7T9
M,7_JGN-^8.C!)MAR&7(YOX'IPYB(AW V0/+4>$-0HIQ(:1SQ4(JL--.,FVPD
MD[6-[&XD]O$ ;QM'S6ZXJBBU!Y@]4,:K@3\##]*DY!1)@44BP0<2G#,$.$-V
M00J=:M_P5R&\E\E+=:!5UR;OH>=_0,'5Q?@[K![UAN-_FPS'\]_QMT4EK5=>
M;5_YV"58#670?BU6%()'Y= %9KI4/T=+;$#?1-.0G8@9(JWN&5:OQ5J^%3^(
M%*5[-DYGZ7LIJ?PZ.<MY.!KZ.<RN%F&&^]5/RYJSV20N_Q3_[@\J^#(9C=Y/
MIG_Y:1IPL,FK((C(H0Q;"YZX<M#1S!656M&@FS6(;(.ZWA9[[0*J'][[.]=A
M#WR''V6P(]\#/*ULC)J2)"TEDDJ)H@==AJ5%ZR.*0=8N*#N(X&XPW!.P_93U
M=RS-'SCT_6KNIX<]$B\5\.Z_%\/YW;*)>LGG*8F,%^-W?P]GQ:@@?Y\7TWCC
M9QA\;SJC7_QX6 Z8\(X:@S*V$<K-("4H7XRG%6>>HBM'GUZH;3'/!Y/2S35%
MOW#<@5)[8:\W:4#%WU^Q_Q'F-Y/T2#$#81)C(F6"FQ&94C023[,LW1HP[HC)
M@*C=J[P18=WD4/<+M^UIL@?P?)Z-M\/OI45OFEV6F/AAJPZXE5$#LT2Y5++'
MM2;.N41*#:')3G* ZNE=.U'831I-/P';HFX/2!^[1I93#UQA8:21Y<4P^](;
MQUI'+&48CZA(4:[69%Z[/6#[KG#U'.Y^(OMXFC_0%7XW3KVX5/L_<'??+^JM
MG_O)D:_67EO_V!=L.\FC_6NVQ*7B97RY,9H1F4(B7LI /)=>9 ["Y]HO_^VU
M/'IX%-WB(ZT>.YG263N926)EZ$S@@@01+'%:*.=,4DKQRCPWHZRW]V:[H&1[
M)FXUI?36>RW=--&A0?&EXFNL?@"PS&.S6D@=P9((M#3V# %/'3Q_J+'!6>8U
MA-J/9CL3V9=LV'I(:>28UE+;J>%RG=+$G+9@F"?<EPS+Q'!C>RJ(BDHZ+H.*
MME-D]B'#M67@' +3/;1X:D"]G"Y[CY:KN=4?S-9Y<]PZC=Q1$F*DQ8TNA;R6
M$RH5RCAYIT3U-G4U"#\A,.\#KT/@7$77'0)\-IV_>I+]_*< )<=T:3B89C&K
M1(E2&0U'1(Z=#ID(],(R!,9I:G33A80\PC/^VP.6#Z6Q+[F/U?V$HRJO8Y!N
MXV,S:$O1*!@>79IY1:1/I1T<9<1:&DRBR?IF@U1>@>'+5'1C)X^+@DDK*NEZ
M7MWC6XW-@]IF;K3(* 0H,Q:-0#9$),&QB(X2\I!TED(\*9_:\CBZ?8WN<%-3
MA9/Z\NR!Y_>J^?YPG\D;?1(0<R(J RW%Y9EX%0T)3%IEJ)?UASDUIZ[;+D]'
M")9;4E37ENGI#>S[R?3'6WH-E,<4(N&V3"R@-A ;O2,9%-H?F] 19HWLTVLK
M]?RZ94_U3MJ2=0]LUVI2WOEZ8HY.PE,N 55O3=E<:,P3]R0YDZ73# 2M;9Y^
M(*##'+6ZBGV:O;ZWE'L#D4=SE;SGS&3A"4@:UR-"F8DDJ2"C,AG/_=IW%$]I
MZ# )[ A V5/6/<#*H_F(&[2KZ%GB.A,0#!W$A&Y=2,F0G)@P:&\3>HJ5T?(S
M%1TF7[6*EP/EW8O<DT<\/ (^"RS <BP2^&4*C2).:4&L29E'_)^0M=/XGB6D
MPRRH8R%G3ZGW CS/>WIGU]?3Y2+GD]E\$#6R(*(E69>N!@Y*D01W)"4IK,<=
M M6?QQN0U6$24JO JJV1#MN5OLS2;)"D<HQ#($(F3Z35I>FET82;4!)5DZ+A
M.,!J%GA5;__8%9AVDWP/W*+GV?AMC&H9W0W'UZN?7XP_P7P]NCQ'!X%%1ZP%
M/,4M%6B( ;E,RC#EN*?5)\GO3&0W;2&[ ETM;?4 CH?E?&H,3W50CM 8T5%@
MEA%OJ29"J<Q21+>3UV]=WW:VKST]F!Y/B[V8]_$%OL-X@92KH+6/!CW39$L;
M@9R( Q/098TJNZ19]K4OJ39K-X*2.STH[27;'ABRS]-)'LZ7PRJY9X9G(8D.
M'CT"$S-Q1@="<[1">!XIK7TI];!ZLWM+>GK V%/ E5HB=Y?D_W9-]'IC?($X
MN1X/"P&MY_>_L/2Q4_N;2J']K'ZC/+I8UA+PL>0?('R=$HY$%R-XAE;K:7>(
M'F?UWXNS/*"7[\,T3Z:WI0[H,HR&UTNEOOO[&Y3VC%^'M_A7+O,5_NDLX^KX
ML]5+J LI&+"X(;6G1":N29#:$2.R3PJ/<)UJ5UW5H;RW50&[H&S+$7I,I?;@
M #Z8ZV6# SRV5FE&-&L,W%T@07-+I,^*6(F_2&6LXD$QU$G?(/T#!]U"NPL,
MUMX&^P/BG[ ='C(4?-8:24PDBPQ$:B:(CS(2YCBUVE*G6>UGLWK4=YM.^T_8
M!OL!X52VP" 9SO T+0/S2MVP=+X\4BK"- =+(\U!=(+N$[??>Z)F'_#NI,)3
MP>5+LOV\K$)G RTIA1054;FT7+,N$N24$F6#R<9:RUWM\3BU:#]QLWQ$=-<&
MPC^@F>CVRX#!$S:/>BDR8#VZ%GDJB?N+D7_=3T%O?KNZ^/3NZNK\\N.;BT]G
M7R\N/UV=?7K[Y=V'LZ_OWIZ=?[WX_>+K?ZS)6KU%^7%ZE-JQGMFXCWZJK5U!
M/>W(H=*UU9O%# W3;'8^N0W#\<J<CM.2BK/XWXOA; F-^TL&3@U7W@<B3<*0
MAB>T74)E(G3@U''G#-1^/MN-PGKE$)MU'RTR>W/WZ-]6CC8%I[2TI?2R/$7%
MXE,D<$1F3[V7#'+UJ_M=:>S6+VP18=M+)%I07@_<P&>X6EXT))%0,BF7 <J>
M2%\*W,HH91VTX2!%%*'V!?,64OI20]&&_B?UE=%33)7?3N]KS<$"9YEA<,1*
MOAO$3*Q0D5"(4E-J4M2U+=RK1/7#I!VD^@9PVE\/75=U7;S_<O[AP_E].L?=
MY1C6]9$HAZ"2$(1KBU9>&" N6DT,@^2#X5&:\)I[]\H:_4/' 9J<U!=K[]#Q
M]:_)F@WG5)(,-TZ,#H__P% T"=G@F7,=;8C9\_W0<;]&MQ<)QT3'?F+M&AT?
M)^-Y'/GA](M/P\EH<CV,?O20#/;Y;-.!1$K*O(WH'\J">)&(=0+E%(V*26F#
MMK<15!HNV&V%<8NX:4/@78/H5_#3.<89'Q;CZXM;?ST<7W\8W@[GD-;,!"VX
M"=R@>,J.X"82JY4C8++A7"H?1#-#\]I*W0[T;A$V547<-5[.;V T _]V>#V>
MS.;#N-D*=Y_/-]PX1'EV&(X&C=Q$0XFU*"P#V7FP^,/@&P'FU:6Z*:XY F+J
M"KEKR'R:3.<W_U:^=;>&_SF45B!X!*^YD2F[!-P2'Q'V,C)/O,3PDE$=LU$4
M[--6?EL@\^I2W930' $R=87<-636'MK&*3-4668X0;_=E?,4*2^_6"U<2/@#
M9W>*A': 0O7"EN.YMWL(KVNU?\;/3,9^A"?F:'ZSQO&:CV@AA,2!:!8%D5I'
MXCS^CAMP,2N'T9QJ!((7%NFFB.0(D*@EV*X!\I^?WXUNT0M_@+<*G%$(@H#5
MN129EA'41A$N'#?H/Z&DFKFG/WVZFS*0(X#A,"%V#X'W*(-O>-P]T"^8S(J5
MSMZY/(A0R@@2+D@,+J4H-$JBF6UXYN,=57T<!0>'2;)K)+R93GSZR]]]A%0"
M\4UH]8#JR!E:-DU$QMA*EL[OZ!CC0:A07,OG,RD;H>*5A9HAY!2O46M*N&NT
MG DNU*]P^VTV!Y\>>(@Z:9]+BR91;)\O,175&'QSXR*#X#-O=H!L6: 9.D[Q
M&K6&1+M&Q=6'__SXI3A%=P_T@W)1^2")P>4P4*(*8VL,F;1GT7DM7:+-[,8S
M'V^&AE.\'#U4DETCX8Q3QJ\6X^EP!A]Q]6'\\X$1:YS47C.BLD-(9UX:='E-
MDF>VW,Z%*)I%H"^MT@P;IW@#6DVV78/D/S^_\7>S88('\IG4+DF,EY0L0V:<
MT,0'])URMCEE8!2ET]#W?/KM9H XQ0O. ^78/0P^^,441O/)^!&.%<*5Z42$
M,R5'1IG" "?.1*^5*973S6S$<U]O!H53O+@\6);=@^'J=CB_>2#>JYR-#4!8
MXGCJ9:F)"]X0;7UV0G*DO9G_\/3+S4!PBE>6!\FP>P X:I;W[S!]A&$CH$Q>
M]B3IX@M3)XGUWA-E-"" :5*ZZ<'PW/>;@>$4+RLKR+-K2/PQ'(V&_O;C_X'1
MZ.[CVXMQO,>UQ;B810(QHE X<&(I"L50](#0]P'9$!3;5F@&BU.\MJPBTZZ!
M<:;I_.9JCN*8?_QR\>C XY;K%!,!* ,6T.,AC@M/A 2!07,JA7;- HSG%VB6
MRW6*MY@U)-HU*O[S\V<__3/>E+$;CUYLP8<4DLDD2$0WNL5 /(^1,&Z,2-8[
M29MU]'_^^\TP<8KWEA7DV3TDWOE"_:,#D"J1P* 3)&/61);7.N>0?.N-\-(I
MEY\.O=W^U/7DV\V@<(J7E ?*L6L8?/7CZ])8]S[)\%' G&G,CC$2!49&TI1W
M6YDCX:ANRP-7T'#>Q_8UFL'B%&\K*\FU:WA\'*:W,/)_H3C7CS/W2:@Q!4EU
M\,1X[M$K\@P![M![CIHJYABX9!O!8_L:S>!QBA>6E>3:-3R>J^Y:LY$I.,T3
M(TG8DG,*FH2H.-$@#0;>5&G5#![;UV@&CU.\OJPDUP[AD6 X^ #7?O1N/!_.
M[Y9561A%9^Y$(%F5UYI@6!D+4(JTG#:*)>3KR;W5#_5K,XC_<CWY_J_XZ57I
M&O[FH6+MF07[,HZSQ1K(0\7<,4)65*]WBP\>7'"6Z$QS&3DBT8]. 54LC414
MHTOU4B?"U^'Q>+5N*M,.5M>D@NRZ/C0>]Y7]8SB_.?>C[S"=_Y@#LDHN?N0U
M)1I5"E$2D24M977((6>F-$LQ-!CN:&J6@K77\MW!97\U;QN3V8[,^UE!_>&^
MV8\%)E@&2S)'@<F2)1"$X"1"CDY()7.HW2OL)7KZ,B6SF_K\_=32(X@]ZJ&Q
M;MSS/Y N$HI^F(=%8JOV,6M_,/TRF:2_AJ/1V7/M9#[!?( >75+6!F+8<F)2
M-!@3RC)07G@,!@+E3V?_MM'.I08KO2OYWA-K6T#<I>)[,,-H3S$\R_[GZ>0;
MGD%WGT=^7,H7RT"4;V40Q<!'CGI!'5%T?XI+Y(B-&HAE4D>GP=G<D]VP&V.]
M*WCO=&^T"(I.1XW\$,'O*)-G^XU]&5[?S"_S;[/57QXPI3)EI>@[Z3*;4:)'
M)C/Z9BYGYO#_0#9[XVV1R-[5Z!\&]5[IM!>#=#8GV\#AMLS&4@)N-2F4$<^H
MP<T)-EHJA+"U1VQNUNY=17\=>[J7:+N.ZFL> JN_\NC/+TNJS@!#7..=P9T1
MV+*SCB*V]'+/V464=V0)3)MV;P=:>]<YH#OSUY:&_UEG_"5Z/;Z,$_D 'FE[
M^/E *8]*,HGP4#(5:: H'2B7A-)!])KJI(]^VF\EMW?]#WIV[M?1<R^&)C\C
MEO/)<B0.2@1_5]+OI^LFO2LV[P94@ N\C,7!>!=/-$^)H^CK"*>%X3XI3H\0
MV;U&9N\Z-[06IU556(_NYQ[);C-G%1>!V7QV@?L0M^&T_+/LV4^+<M5]F:]N
M4#GKGPXR""-C\,0%,$2J$(@5Z'A)[W1(5#FKVNJN?!CEO6LP41>Y1U1KC\!<
MP^%"0?GQ]?#^+R_]K:\W?GP?;"B/+*1D"579E=%(FE@K2P,HD$Q2XU/U82I'
M9;!W[3;Z=_E6%R0]C$COK<+CZ<9KB0R"4EPEI@D-9<)III9X'2DQZ) 9[8WU
MDN[K:+^T</\:@+3C,U<3?C_'H.PT7>*3GQ9/Z_N3-ITMS-1X6.G8$S2V\-C-
MO(R<K6&(9A*9B42**(F->/Z#L:"X<1RT:/]TZ].\#!64YDPE8G!'EX=\19R&
M0#QDZHS4PHK:@U__T?,R=D'8P?,R=E%>CSS9IWWZ<Q21TP#$,,>(!"&)RY03
MZFQ)F<W*\=H8_&?,R]A)_PWG9>RBC)YBZL?T:VL2CRQ:PITO/6QY(E;92$QR
M-&6J+ ]P!'2=P+R,G52_\[R,7?30==#P:B]MXX#1D(#X3)>- P0)NB3A4^&8
M5=Q[GAI%"57:E7=8/+F35G=J5[Z+B+O&R]D00^RXF?UA=$[@@B),E,H_CSZ
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M\'I75?)Y$B/FW6H9+S<32[8LU_E"O+H$FA>@2Y>P+Z.3GM-?<$K-\I.2>;-
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MXGK]8['\\N)D\]A9O/&I)A)+:VM/0]J0<U@GP%N'+MF0=6N+]BEZ!@'1_L6
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MCIN!;HF.K8#71E2][9+7"/S'?)[_G)Z=$6VO29"SS_4^X,:*;_XT066L0)T
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M]F_SLTRZM_P=OT9<3*R36B-G(+ .5^.F-ENRKAXQ\:R+=,BVRT?>\>7]X>$
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MGW%!UT FS7 W\+VEN\W^32KVO<1TSW</<J-I&SJ.<+U).)51D56R9(5 &<W
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M$-=3/WUR&A1G,FII=2[]S%#=F;P3=2<[U<F18'<*N^-CK+FD?CON))E#3"&
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M4$L! A0#%     @ X(MA5H[#) T1!0  5!H  !0              ( !KE4
M '$T,C R,F5X:&EB:70S,C$N:'1M4$L! A0#%     @ X(MA5IAYH"O^!
MY!D  !0              ( !\5H  '$T,C R,F5X:&EB:70S,C(N:'1M4$L!
M A0#%     @ X(MA5NI*' /%CP0  $4S !$              ( !(6   ')D
M;G0M,C R,C$R,S$N:'1M4$L! A0#%     @ X(MA5M9U<RX_'@  &E<! !$
M             ( !%? $ ')D;G0M,C R,C$R,S$N>'-D4$L! A0#%     @
MX(MA5N >B/1]+P  >.<! !4              ( !@PX% ')D;G0M,C R,C$R
M,S%?8V%L+GAM;%!+ 0(4 Q0    ( ."+858"6Z/*"O   +U>"@ 5
M      "  3,^!0!R9&YT+3(P,C(Q,C,Q7V1E9BYX;6Q02P$"% ,4    " #@
MBV%6%453"S/T  !HK@$ %               @ %P+@8 <F1N="TR,#(R,3(S
M,5]G,2YJ<&=02P$"% ,4    " #@BV%6^APG-)RN 0 ];Q$ %0
M    @ '5(@< <F1N="TR,#(R,3(S,5]L86(N>&UL4$L! A0#%     @ X(MA
M5@:Z2B,8&@$ %Y@, !4              ( !I-$( ')D;G0M,C R,C$R,S%?
=<')E+GAM;%!+!08     #@ . *8#  #OZPD    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
